0 -DOCSTART- JJ B-NP O
0 -EMPTYLINE- NN I-NP O
1 RECORD NNP I-NP O
1 #661 VBZ O O
2 753455514 CD O O
2 ACH NNP B-NP O
2 15453858 CD O O
2 0683793 CD O O
2 10/8/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Hypotension NNP I-NP O
2 , , O O
2 NSTEMI NNP B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/25/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 11/20/2004 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 URBIETA NNP I-NP O
5 , , O O
5 MARY NNP B-NP O
5 079-03-97-6 CD O O
6 Si NNP B-NP O
7 Service: NNP I-NP O
7 RNM NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 11/17/04 CD O O
8 AT NNP B-NP O
8 11:15 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 VANALSTIN NNP I-NP O
11 , , O O
11 MIKEL NNP B-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ACETYLSALICYLIC NNP I-NP B-m
16 ACID NNP I-NP I-m
16 325 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 COLACE NNP I-NP B-m
17 ( ( O I-m
17 DOCUSATE NNP B-NP I-m
17 SODIUM NNP I-NP I-m
17 ) ) O I-m
17 100 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 BID NNP I-NP B-f
18 ENALAPRIL NNP I-NP B-m
18 MALEATE NNP I-NP I-m
18 10 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 BID NNP I-NP B-f
19 Instructions: NNP I-NP O
19 hold NN I-NP O
19 on IN B-VP O
19 mornings NNS B-NP O
19 of IN B-VP O
19 dialysis NN B-NP O
20 Alert NNP I-NP O
20 overridden: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 0/20/04 CD O O
20 by IN B-VP O
20 : : O O
21 DEFINITE NNP B-NP O
21 ALLERGY NNP I-NP O
21 ( ( O O
21 OR NNP B-NP O
21 SENSITIVITY NNP I-NP O
21 ) ) O O
21 to TO O O
21 ACE NNP B-NP O
21 INHIBITORS NNP I-NP O
22 Reason NNP I-NP O
22 for IN B-VP O
22 override: NN B-NP O
22 following VBG O O
22 K NNP B-NP O
22 , , O O
22 HD NNP B-NP O
22 MWF NNP I-NP O
23 Previous NNP I-NP O
23 Alert NNP I-NP O
23 overridden NNP I-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 4/14/04 CD O O
23 by IN B-VP O
23 : : O O
24 DEFINITE NNP B-NP O
24 ALLERGY NNP I-NP O
24 ( ( O O
24 OR NNP B-NP O
24 SENSITIVITY NNP I-NP O
24 ) ) O O
24 to TO O O
24 ACE NNP B-NP O
24 INHIBITORS NNP I-NP O
25 Reason NNP I-NP O
25 for IN B-VP O
25 override: NN B-NP O
25 following VBG O O
25 k NN B-NP O
25 Previous NNP I-NP O
25 Alert NNP I-NP O
25 overridden NNP I-NP O
26 Override NNP I-NP O
26 added VBD B-VP O
26 on IN B-VP O
26 4/29/04 CD O O
26 by IN B-VP O
26 : : O O
27 DEFINITE NNP B-NP O
27 ALLERGY NNP I-NP O
27 ( ( O O
27 OR NNP B-NP O
27 SENSITIVITY NNP I-NP O
27 ) ) O O
27 to TO O O
27 ACE NNP B-NP O
27 INHIBITORS NNP I-NP O
28 Reason NNP I-NP O
28 for IN B-VP O
28 override: NN B-NP O
28 home NN I-NP O
28 regimen NNS I-NP O
28 , , O O
28 following VBG O O
28 k NN B-NP O
29 Previous NNP I-NP O
29 Alert NNP I-NP O
29 overridden NNP I-NP O
30 Override NNP I-NP O
30 added VBD B-VP O
30 on IN B-VP O
30 4/29/04 CD O O
30 by IN B-VP O
30 VREELAND NNP B-NP O
30 , , O O
30 DARIO NNP B-NP O
30 R NNP I-NP O
30 , , O O
30 M.D NNP B-NP O
31 DEFINITE NNP I-NP O
31 ALLERGY NNP I-NP O
31 ( ( O O
31 OR NNP B-NP O
31 SENSITIVITY NNP I-NP O
31 ) ) O O
31 to TO O O
31 ACE NNP B-NP O
31 INHIBITORS NNP I-NP O
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: NN B-NP O
32 home NN I-NP O
32 regimen NNS I-NP O
32 , , O O
32 following VBG O O
32 k NN B-NP O
33 NPH NNP I-NP B-m
33 NPH NNP I-NP B-m
33 NPH NNP I-NP B-m
33 NPH NNP I-NP B-m
33 HUMULIN NNP I-NP I-m
33 HUMULIN NNP I-NP I-m
33 HUMULIN NNP I-NP I-m
33 HUMULIN NNP I-NP I-m
33 INSULIN NNP I-NP I-m
33 INSULIN NNP I-NP I-m
33 INSULIN NNP I-NP I-m
33 INSULIN NNP I-NP I-m
33 ( ( O I-m
33 ( ( O I-m
33 ( ( O I-m
33 ( ( O I-m
33 INSULIN NNP B-NP I-m
33 INSULIN NNP I-NP I-m
33 INSULIN NNP I-NP I-m
33 INSULIN NNP I-NP I-m
33 NPH NNP I-NP I-m
33 NPH NNP I-NP I-m
33 NPH NNP I-NP I-m
33 NPH NNP I-NP I-m
33 HUMAN NNP I-NP I-m
33 HUMAN NNP I-NP I-m
33 HUMAN NNP I-NP I-m
33 HUMAN NNP I-NP I-m
33 ) ) O I-m
33 ) ) O I-m
33 ) ) O I-m
33 ) ) O I-m
34 2 CD O B-do
34 UNITS NNP B-NP I-do
34 QAM; NNP I-NP B-f
34 3 CD O B-do
34 UNITS NNP B-NP I-do
34 QPM NNP I-NP B-f
34 SC NNP I-NP B-mo
34 2 CD O B-do
34 UNITS NNP B-NP I-do
34 QAM NNP I-NP B-f
34 3 CD O B-do
34 UNITS NNP B-NP I-do
34 QPM NNP I-NP B-f
35 NTG NNP I-NP B-m
35 1/150 CD O I-m
35 ( ( O I-m
35 NITROGLYCERIN NNP B-NP I-m
35 1/150 CD O I-m
35 ( ( O I-m
35 0.4 CD O I-m
35 MG NNP B-NP I-m
35 ) ) O I-m
35 ) ) O I-m
36 1 CD O B-do
36 TAB NNP B-NP I-do
36 SL NNP I-NP B-mo
36 Q5MIN NNP I-NP B-f
36 X NNP I-NP I-f
36 3 CD O I-f
36 PRN NNP B-NP I-f
36 Chest NNP I-NP B-r
36 Pain NNP I-NP I-r
37 ZOCOR NNP I-NP B-m
37 ( ( O I-m
37 SIMVASTATIN NNP B-NP I-m
37 ) ) O I-m
37 40 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QHS NNP I-NP B-f
38 Food/Drug NNP I-NP O
38 Interaction NNP I-NP O
38 Instruction NNP I-NP O
39 Avoid NNP I-NP O
39 grapefruit NN I-NP O
39 unless IN B-VP O
39 MD NNP B-NP O
39 instructs NNS I-NP O
39 otherwise RB O O
40 Override NNP B-NP O
40 Notice: NNP I-NP O
40 Override NNP I-NP O
40 added VBD B-VP O
40 on IN B-VP O
40 4/29/04 CD O O
40 by IN B-VP O
41 HASSEL NNP B-NP O
41 , , O O
41 EDWARDO NNP B-NP O
41 D NNP I-NP O
41 , , O O
41 M.D NNP B-NP O
42 on IN B-VP O
42 order NN B-NP O
42 for IN B-VP O
42 NEPHROCAPS NNP B-NP B-m
42 PO NNP I-NP B-mo
42 ( ( O O
42 ref JJ O O
42 # # O O
42 12327843 CD O O
42 ) ) O O
43 POTENTIALLY NNP B-NP O
43 SERIOUS NNP I-NP O
43 INTERACTION: NNP I-NP O
43 SIMVASTATIN NNP I-NP B-m
43 &amp; NNP I-NP O
43 NIACIN NNP I-NP B-m
43 , , O O
44 VIT NNP B-NP B-m
44 B-3 NNP I-NP I-m
44 Reason NNP I-NP O
44 for IN B-VP O
44 override: NN B-NP O
44 home NN I-NP O
44 regimen NNS I-NP O
45 Previous NNP I-NP O
45 override IN B-VP O
45 information: JJ B-NP O
46 Override NNP I-NP O
46 added VBD B-VP O
46 on IN B-VP O
46 4/29/04 CD O O
46 by IN B-VP O
46 GALIPEAU NNP B-NP O
46 , , O O
46 ENRIQUE NNP B-NP O
46 R NNP I-NP O
46 , , O O
46 M.D NNP B-NP O
47 DEFINITE NNP I-NP O
47 ALLERGY NNP I-NP O
47 ( ( O O
47 OR NNP B-NP O
47 SENSITIVITY NNP I-NP O
47 ) ) O O
47 to TO O O
47 HMG NNP B-NP O
47 CoA NNP I-NP O
47 REDUCTASE NNP I-NP O
48 INHIBITORS NNP I-NP O
48 Reason NNP I-NP O
48 for IN B-VP O
48 override: NN B-NP O
48 md NN I-NP O
48 aware JJ O O
48 , , O O
48 home NN B-NP O
48 regimen NNS I-NP O
49 IMDUR NNP I-NP B-m
49 ( ( O I-m
49 ISOSORBIDE NNP B-NP I-m
49 MONONIT.( NNP I-NP I-m
49 SR NNP I-NP I-m
49 ) ) O I-m
49 ) ) O I-m
49 30 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 QD NNP I-NP B-f
50 Food/Drug NNP I-NP O
50 Interaction NNP I-NP O
50 Instruction NNP I-NP O
51 Give NNP I-NP O
51 on IN B-VP O
51 an DT B-NP O
51 empty JJ I-NP O
51 stomach NN I-NP O
51 ( ( O O
51 give JJ O O
51 1hr CD O O
51 before IN B-VP O
51 or CC O O
51 2hr CD O O
51 after IN B-VP O
52 food NN B-NP O
52 ) ) O O
53 NEPHROCAPS NNP B-NP B-m
53 ( ( O I-m
53 NEPHRO-VIT NNP B-NP I-m
53 RX NNP I-NP I-m
53 ) ) O I-m
53 2 CD O B-do
53 TAB NNP B-NP I-do
53 PO NNP I-NP B-mo
53 QD NNP I-NP B-f
54 Alert NNP I-NP O
54 overridden: NNP I-NP O
54 Override NNP I-NP O
54 added VBD B-VP O
54 on IN B-VP O
54 4/29/04 CD O O
54 by IN B-VP O
55 SCHMALZRIED NNP B-NP O
55 , , O O
55 EZEQUIEL NNP B-NP O
55 L NNP I-NP O
55 , , O O
55 M.D NNP B-NP O
56 POTENTIALLY NNP I-NP O
56 SERIOUS NNP I-NP O
56 INTERACTION: NNP I-NP O
56 SIMVASTATIN NNP I-NP B-m
56 &amp; NNP I-NP O
56 NIACIN NNP I-NP B-m
56 , , O O
57 VIT NNP B-NP B-m
57 B-3 NNP I-NP I-m
57 Reason NNP I-NP O
57 for IN B-VP O
57 override: NN B-NP O
57 home NN I-NP O
57 regimen NNS I-NP O
58 NEXIUM NNP I-NP B-m
58 ( ( O I-m
58 ESOMEPRAZOLE NNP B-NP I-m
58 ) ) O I-m
58 20 CD O B-do
58 MG NNP B-NP I-do
58 PO NNP I-NP B-mo
58 QD NNP I-NP B-f
59 TOPROL NNP I-NP B-m
59 XL NNP I-NP I-m
59 ( ( O I-m
59 METOPROLOL NNP B-NP I-m
59 ( ( O I-m
59 SUST NNP B-NP I-m
59 REL NNP I-NP I-m
59 ) ) O I-m
59 ) ) O I-m
59 200 CD O B-do
59 MG NNP B-NP I-do
59 PO NNP I-NP B-mo
59 QHS NNP I-NP B-f
60 Food/Drug NNP I-NP O
60 Interaction NNP I-NP O
60 Instruction NNP I-NP O
61 Take NNP I-NP O
61 consistently RB O O
61 with IN B-VP O
61 meals NNS B-NP O
61 or CC O O
61 on IN B-VP O
61 empty JJ B-NP O
61 stomach NN I-NP O
62 DIET: NNP I-NP O
62 House NNP I-NP O
62 / VBD B-VP O
62 2 CD O O
62 gm NN B-NP O
62 Na NNP I-NP O
62 / NNP I-NP O
62 ADA NNP I-NP O
62 2100 CD O O
62 cals/day NN B-NP O
62 / NNP I-NP O
62 Low NNP I-NP O
62 saturated VBD B-VP O
62 fat JJ B-NP O
63 low JJ I-NP O
63 cholesterol NN I-NP O
63 / NNP I-NP O
63 Renal NNP I-NP O
63 diet JJ B-NP O
63 (FDI) NNP I-NP O
64 ACTIVITY: NNP I-NP O
64 Walking NNP I-NP O
64 as IN B-VP O
64 tolerated VBN O O
65 FOLLOW NNP B-NP O
65 UP NNP I-NP O
65 APPOINTMENT( NNP I-NP O
65 S NNP I-NP O
65 ): NNP I-NP O
66 Dr NNP I-NP O
66 Alan NNP I-NP O
66 Mcratt NNP I-NP O
66 ( ( O O
66 cardiology NN B-NP O
66 at IN B-VP O
66 Lumamer NNP B-NP O
66 Medical NNP I-NP O
66 Center NNP I-NP O
66 ) ) O O
66 4:00pm CD O O
66 5/19/04 CD O O
66 scheduled VBN O O
66 , , O O
67 Primary NNP B-NP O
67 care NN I-NP O
67 physician JJ O O
67 2 CD O O
67 weeks NNS B-NP O
67 , , O O
68 ALLERGY: NNP B-NP O
68 Lisinopril NNP I-NP O
68 , , O O
68 Zocor NNP B-NP O
68 ( ( O O
68 hmg JJ B-NP O
68 coa NN I-NP O
68 reductase NN I-NP O
68 inhibitors NNS I-NP O
68 ) ) O O
69 ADMIT VBP O O
69 DIAGNOSIS: NNP B-NP O
70 hypotension NN I-NP O
71 PRINCIPAL NNP I-NP O
71 DISCHARGE NNP I-NP O
71 DIAGNOSIS NNP I-NP O
71 ;Responsible JJ O O
71 After IN B-VP O
71 Study NNP B-NP O
71 for IN B-VP O
71 Causing NNP B-NP O
71 Admission NNP I-NP O
71 ) ) O O
72 Hypotension NNP B-NP O
72 , , O O
72 NSTEMI NNP B-NP O
73 OTHER NNP I-NP O
73 DIAGNOSIS;Conditions NNP I-NP O
73 , , O O
73 Infections NNP B-NP O
73 , , O O
73 Complications NNP B-NP O
73 , , O O
73 affecting VBG O O
73 Treatment/Stay NNP B-NP O
74 1 CD O O
74 NIDDM NNP B-NP O
74 2 CD O O
74 AI/AS NNP B-NP O
74 , , O O
74 bicuspid JJ B-NP O
74 aortic JJ I-NP O
74 valve NN I-NP O
74 , , O O
74 LVH NNP B-NP O
74 3 CD O O
74 HTN NNP B-NP O
74 4 CD O O
74 s/p NN B-NP O
75 thyroglossal NN I-NP O
75 duct NN I-NP O
75 cyst NN I-NP O
75 excision NN I-NP O
75 5 CD O O
75 h/o NN B-NP O
76 noncompliance NN I-NP O
76 with IN B-VP O
76 meds NNS B-NP O
76 6 CD O O
76 3 CD O O
76 vessel NN B-NP O
76 cad NN I-NP O
76 ( ( O O
76 coronary JJ B-NP O
76 artery NN I-NP O
77 disease NN I-NP O
77 ) ) O O
77 7 CD O O
77 ESRD NNP B-NP O
77 ON NNP I-NP O
77 HD NNP I-NP O
77 ( ( O O
77 end JJ B-NP O
77 stage NN I-NP O
77 renal JJ B-NP O
77 disease NN I-NP O
77 ) ) O O
77 8 CD O O
77 CHF NNP B-NP O
77 , , O O
77 unclear JJ B-NP O
78 etiology NN I-NP O
78 ( ( O O
78 congestive JJ B-NP O
78 heart NN I-NP O
78 failure NN I-NP O
78 ) ) O O
78 9 CD O O
78 hyperlipidemia NN B-NP O
79 ( ( O O
79 hyperlipidemia NN B-NP O
79 ) ) O O
79 10 CD O O
79 h/o NN B-NP O
79 syphilis NN I-NP O
79 ( ( O O
79 H/O NNP B-NP O
79 syphilis NN I-NP O
79 ) ) O O
80 OPERATIONS NNP B-NP O
80 AND NNP I-NP O
80 PROCEDURES: NNP I-NP O
81 none NN I-NP O
82 OTHER NNP I-NP O
82 TREATMENTS/PROCEDURES NNP I-NP O
82 ( ( O O
82 NOT NNP B-NP O
82 IN NNP I-NP O
82 O.R NNP I-NP O
82 ) ) O O
83 Persantine NNP B-NP B-m
83 and CC O O
83 viability NN B-NP O
83 cardiac VBP O O
83 PET NNP B-NP O
83 scan JJ O O
83 5/19/04 CD O O
84 BRIEF NNP B-NP O
84 RESUME NNP I-NP O
84 OF NNP I-NP O
84 HOSPITAL NNP I-NP O
84 COURSE: NNP I-NP O
85 erate NN I-NP O
85 global JJ B-NP O
85 LV NNP I-NP O
85 systolic JJ B-NP O
85 dysfunction NN I-NP O
86 3 CD O O
86 The DT B-NP O
86 results NNS I-NP O
86 are VBP O O
86 essentially RB O O
86 unchanged JJ O O
86 from IN B-VP O
86 his PRP$ O O
86 prior JJ B-NP O
86 study NN I-NP O
87 of IN B-VP O
87 February NNP B-NP O
87 , , O O
87 2003 CD O O
88 CC: NNP B-NP O
88 Hypotension NNP I-NP O
88 after IN B-VP O
88 dialysis NN B-NP O
89 HPI: NNP I-NP O
89 56 CD O O
89 yo NNS B-NP O
89 male JJ O O
89 with IN B-VP O
89 h/o JJ B-NP O
89 ESRD NNP I-NP O
89 , , O O
89 CAD NNP B-NP O
89 , , O O
89 CHF NNP B-NP O
89 ( ( O O
89 EF NNP B-NP O
89 20-25% CD O O
89 ) ) O O
89 admitted VBN O O
89 for IN B-VP O
90 hypotension NN B-NP O
90 after IN B-VP O
90 HD NNP B-NP O
90 He PRP O O
90 was VBD B-VP O
90 in IN B-VP O
90 his PRP$ O O
90 USOH NNP B-NP O
90 until IN B-VP O
90 2 CD O O
90 days NNS B-NP O
90 PTA NNP I-NP O
90 when WRB O O
90 he PRP O O
91 developed VBD B-VP O
91 stomach NN B-NP O
91 upset NN I-NP O
91 , , O O
91 diarrhea NN B-NP O
91 , , O O
91 dry JJ B-NP O
91 heaves NNS I-NP O
91 , , O O
91 and CC O O
91 a DT B-NP O
91 dry JJ I-NP O
91 cough NN I-NP O
91 He PRP O O
92 denied VBD B-VP O
92 recent JJ B-NP O
92 travels NNS I-NP O
92 , , O O
92 and CC O O
92 had VBD B-VP O
92 remote VBN O O
92 Abx NNP B-NP B-m
92 use NN I-NP O
92 At IN B-VP O
92 Stodun NNP B-NP O
92 Hospital NNP I-NP O
92 , , O O
93 he PRP O O
93 had VBD B-VP O
93 5.5 CD O O
93 liters NNS B-NP O
93 removed VBD B-VP O
93 and CC O O
93 afterwards NNS B-NP O
93 his PRP$ O O
93 BP NNP B-NP O
93 was VBD B-VP O
93 66/30 CD O O
93 1 CD O B-do
93 liter NN B-NP I-do
93 of IN B-VP O
94 NS NNP B-NP B-m
94 was VBD B-VP O
94 given VBN O O
94 and CC O O
94 his PRP$ O B-r
94 BP NNP B-NP I-r
94 rose VBD B-VP O
94 to TO O O
94 73/40 CD O O
95 ROS: NNP B-NP O
95 Chronic NNP I-NP O
95 PND NNP I-NP O
95 , , O O
95 uses VBZ O O
95 1 CD O O
95 pillow NN B-NP O
95 , , O O
95 gained VBD B-VP O
95 8kg CD O O
95 in IN B-VP O
95 2 CD O O
95 weeks NNS B-NP O
95 but CC O O
95 compliant JJ O O
96 with IN B-VP O
96 meds NNS B-NP O
96 , , O O
96 no DT B-NP O
96 melena NN I-NP O
96 , , O O
96 no DT B-NP O
96 BRBPR NNP I-NP O
97 Physical NNP I-NP O
97 Exam NNP I-NP O
97 T NNP I-NP O
97 97 CD O O
97 p85 NN B-NP O
97 BP NNP I-NP O
97 114/67-&gt;160/97 JJ B-NP O
97 rr NN I-NP O
97 16-24 JJ O O
97 89% CD O O
97 RA NNP B-NP O
98 Chronically NNP I-NP O
98 ill VB O O
98 appearing VBG O O
98 , , O O
98 NAD NNP B-NP O
99 Neck: NNP I-NP O
99 Supple NNP I-NP O
100 Chest: NNP I-NP O
100 Bibasilar NNP I-NP O
100 rales VBZ O O
101 CVS: NNP B-NP O
101 palpable JJ B-NP O
101 S3 NNP I-NP O
101 , , O O
101 Lat NNP B-NP O
101 displaced VBD B-VP O
101 PMI NNP B-NP O
101 , , O O
101 II/VI NNP B-NP O
101 SEM NNP I-NP O
101 at IN B-VP O
101 RUSB NNP B-NP O
101 , , O O
101 JVP NNP B-NP O
101 &lt; VBZ O O
101 7cm CD O O
102 Abd: NNP B-NP O
102 Soft NNP I-NP O
102 NT NNP I-NP O
102 ND NNP I-NP O
102 , , O O
102 + NNP B-NP O
102 BS NNP I-NP O
102 , , O O
102 no DT B-NP O
102 HSM NNP I-NP O
103 Ext: NNP I-NP O
103 Trace NNP I-NP O
103 pedal NN I-NP O
103 edema NN I-NP O
103 , , O O
103 hyperpigmentation NN B-NP O
103 in IN B-VP O
103 sock NN B-NP O
103 distribution NN I-NP O
104 Labs: NNP I-NP O
104 WBC NNP I-NP O
104 5 CD O O
104 , , O O
104 TnI NNP B-NP O
104 0.37 CD O O
104 , , O O
104 CK NNP B-NP O
104 153 CD O O
104 , , O O
104 CKMB8.2 NNP B-NP O
104 ( ( O O
104 chronically RB O O
104 elevated VBN O O
104 cardiac JJ B-NP O
105 enzymes NNS I-NP O
105 ) ) O O
106 EKG: NNP B-NP O
106 NSR NNP I-NP O
106 , , O O
106 1st CD O O
106 deg NN B-NP O
106 AVB NNP I-NP O
106 , , O O
106 LAE NNP B-NP O
106 , , O O
106 LVH NNP B-NP O
106 , , O O
106 old JJ B-NP O
106 TWI NNP I-NP O
106 in IN B-VP O
106 1 CD O O
106 , , O O
106 L NNP B-NP O
106 , , O O
106 V5 NNP B-NP O
106 , , O O
106 V6 NNP B-NP O
106 , , O O
106 more RBR O O
106 pronounced JJ B-NP O
107 ST NNP I-NP O
107 dep NN I-NP O
107 in IN B-VP O
107 V5 NNP B-NP O
107 than IN B-VP O
107 6/4 CD O O
108 CXR: NNP B-NP O
108 R NNP I-NP O
108 pl NN I-NP O
108 effusion NN I-NP O
108 , , O O
108 CMG NNP B-NP O
109 Assessment: NNP I-NP O
109 Hypotension NNP I-NP O
109 after IN B-VP O
109 dialysis NN B-NP O
109 in IN B-VP O
109 setting VBG O O
109 of IN B-VP O
109 GI NNP B-NP O
110 upset/diarrhea/vomiting NN I-NP O
110 , , O O
110 likely RB O O
110 was VBD B-VP O
110 dehydrated VBN O O
110 The DT B-NP O
110 BP NNP I-NP O
110 rose VBD B-VP O
110 after IN B-VP O
111 fluids NNS B-NP O
111 and CC O O
111 his PRP$ O O
111 current JJ B-NP O
111 hypoxia NN I-NP O
111 is VBZ O O
111 likely JJ O O
111 from IN B-VP O
111 mild JJ B-NP O
111 pulm NN I-NP O
111 edema NN I-NP O
112 Although IN B-VP O
112 chronically RB O O
112 elevated VBN O O
112 cardiac JJ B-NP O
112 enzymes NNS I-NP O
112 , , O O
112 there EX O O
112 is VBZ O O
112 concern NN B-NP O
112 about IN B-VP O
113 new JJ B-NP O
113 ishemia NN I-NP O
113 , , O O
113 and CC O O
113 concern NN B-NP O
113 for IN B-VP O
113 PE NNP B-NP O
113 given VBN O O
113 hypoxia NN B-NP O
113 in IN B-VP O
113 ED NNP B-NP O
114 Hospital NNP I-NP O
114 course NN I-NP O
115 1 CD O O
115 CVS: NNP B-NP O
115 Ischemia: NNP I-NP O
115 NSTEMI: NNP I-NP B-r
115 NSTEMI: NNP I-NP B-r
115 NSTEMI: NNP I-NP B-r
115 NSTEMI: NNP I-NP B-r
115 NSTEMI: NNP I-NP B-r
115 contined VBD B-VP O
115 medical JJ B-NP O
115 management NN I-NP O
115 with IN B-VP O
115 asa NN B-NP B-m
115 , , O O
115 beta NN B-NP B-m
116 blocker NN I-NP O
116 , , O O
116 imdur NN B-NP B-m
116 , , O O
116 zocor NN B-NP B-m
116 , , O O
116 ntg JJ O B-m
116 prn VBP O B-f
116 The DT B-NP O
116 CkMB NNP I-NP O
116 peaked VBD B-VP O
116 at IN B-VP O
116 12 CD O O
116 and CC O O
116 Tni NNP B-NP O
116 to TO O O
116 4 CD O O
116 His PRP$ O O
117 cardiologist NN B-NP O
117 ( ( O O
117 Dr NNP B-NP O
117 Benisek NNP I-NP O
117 ) ) O O
117 recommended VBD B-VP O
117 PET JJ O O
117 scan JJ O O
117 to TO O O
117 assess VB O O
117 for IN B-VP O
117 viable JJ B-NP O
118 myocardium NN I-NP O
118 and CC O O
118 ischemia VB O O
118 His PRP$ O O
118 last JJ B-NP O
118 stress JJ I-NP O
118 test NN I-NP O
118 1 CD O O
118 year NN B-NP O
118 ago RB O O
118 showed VBD B-VP O
118 only RB O O
119 scarring VBG O O
119 with IN B-VP O
119 no DT B-NP O
119 ischemia NN I-NP O
119 In IN B-VP O
119 the DT B-NP O
119 past NN I-NP O
119 , , O O
119 pt's JJ B-NP O
119 wife NN I-NP O
119 refused VBD B-VP O
119 for IN B-VP O
119 him PRP O O
119 to TO O O
119 go VB O O
120 for IN B-VP O
120 CABG NNP B-NP O
120 They PRP O O
120 are VBP O O
120 reconsidering VBG O O
120 this DT B-NP O
120 option NN I-NP O
120 currently RB O O
121 The DT B-NP O
121 results NNS I-NP O
121 of IN B-VP O
121 the DT B-NP O
121 PET NNP I-NP O
121 scan JJ O O
121 are VBP O O
121 as IN B-VP O
121 follows: JJ O O
122 - : O O
122 A DT B-NP O
122 small JJ I-NP O
122 region NN I-NP O
122 of IN B-VP O
122 myocardial JJ B-NP O
122 scar/hibernation NN I-NP O
122 along IN B-VP O
122 with IN B-VP O
122 mild JJ B-NP O
123 residual JJ I-NP O
123 stress NN I-NP O
123 induced VBD B-VP O
123 peri-infarct JJ B-NP O
123 ischemia NN I-NP O
123 in IN B-VP O
123 the DT B-NP O
123 distal JJ I-NP O
123 LAD NNP I-NP O
124 distribution NN I-NP O
125 - : O O
125 Moderate NNP B-NP O
125 global JJ B-NP O
125 LV NNP I-NP O
125 systolic JJ B-NP O
125 dysfunction NN I-NP O
126 - : O O
126 The DT B-NP O
126 results NNS I-NP O
126 are VBP O O
126 essentially RB O O
126 unchanged JJ O O
126 from IN B-VP O
126 his PRP$ O O
126 prior JJ B-NP O
126 study NN I-NP O
126 of IN B-VP O
126 February NNP B-NP O
126 , , O O
127 2003 CD O O
128 The DT B-NP O
128 family NN I-NP O
128 was VBD B-VP O
128 called VBN O O
128 to TO O O
128 stress VB O O
128 the DT B-NP O
128 importance NN I-NP O
128 of IN B-VP O
128 follow JJ O O
128 up IN B-VP O
128 with IN B-VP O
129 cardiology NN B-NP O
129 ( ( O O
129 They PRP O O
129 have VBP O O
129 missed VBN O O
129 appointments NNS B-NP O
129 in IN B-VP O
129 the DT B-NP O
129 past NN I-NP O
129 ) ) O O
130 Pump: NNP B-NP O
130 ( ( O O
130 EF NNP B-NP O
130 20-25% CD O O
130 ) ) O O
130 , , O O
130 increased VBD B-VP O
130 enalapril NN B-NP B-m
130 to TO O O
130 10mg CD O B-do
130 bid NN B-NP B-f
130 , , O O
130 BNP NNP B-NP O
130 was VBD B-VP O
130 sent VBN O O
130 and CC O O
131 pending VBG O O
131 and CC O O
131 echo VB O O
131 revealed VBN O O
131 EF NNP B-NP O
131 30% CD O O
131 , , O O
131 Mod NNP B-NP O
131 AI NNP I-NP O
132 Rhythm: NNP I-NP O
132 no DT B-NP O
132 events NNS I-NP O
132 occurred VBD B-VP O
132 on IN B-VP O
132 telemetry NN B-NP O
133 2 CD O O
133 Pulm: NNP B-NP O
133 monitored VBD B-VP O
133 sats NNS B-NP O
133 with IN B-VP O
133 fluid JJ B-NP O
133 restriction NN I-NP O
133 RA NNP I-NP O
133 sats VBZ O O
133 improved VBN O O
133 to TO O O
134 97% CD O O
135 3 CD O O
135 Renal: NNP B-NP O
135 HD NNP I-NP O
135 MWF NNP I-NP O
135 , , O O
135 home NN B-NP O
135 renal NN I-NP B-m
135 meds NNS I-NP I-m
135 He PRP O O
135 was VBD B-VP O
135 dialyzed VBN O O
135 to TO O O
135 a DT B-NP O
135 weight NN I-NP O
135 below IN B-VP O
136 his PRP$ O O
136 previous JJ B-NP O
136 baseline NN I-NP O
136 per IN B-VP O
136 cardiology NN B-NP O
136 recommendations NNS I-NP O
136 In IN B-VP O
136 the DT B-NP O
136 past NN I-NP O
136 he PRP O O
137 has VBZ O O
137 had VBN O O
137 elevated VBN O O
137 RH NNP B-NP O
137 filling NN I-NP O
137 pressures NNS I-NP O
137 after IN B-VP O
137 HD NNP B-NP O
137 The DT B-NP O
137 Ryi NNP I-NP O
137 was VBD B-VP O
138 called VBN O O
138 by IN B-VP O
138 the DT O O
138 attendting VBG O O
138 renal JJ B-NP O
138 physician NN I-NP O
138 ( ( O O
138 Dr NNP B-NP O
138 Slemp NNP I-NP O
138 ) ) O O
138 about IN B-VP O
138 his PRP$ O O
138 goal NN B-NP O
139 weight VBD B-VP O
140 4 CD O O
140 ID: NNP B-NP O
140 Blood NNP I-NP O
140 cx NN I-NP O
140 were VBD B-VP O
140 no DT B-NP O
140 growth NN I-NP O
141 5 CD O O
141 GI: NNP B-NP O
141 He PRP O O
141 was VBD B-VP O
141 continued VBN O O
141 on IN B-VP O
141 his PRP$ O O
141 home NN B-NP B-m
141 nexium NN I-NP I-m
142 6 CD O O
142 Proph: NNP B-NP O
142 SQ NNP I-NP B-mo
142 heparin NN I-NP B-m
142 was VBD B-VP O
142 used VBN O O
142 for IN B-VP O
142 DVT NNP B-NP B-r
142 prophylaxis VBP O I-r
143 ADDITIONAL NNP B-NP O
143 COMMENTS: NNP I-NP O
143 It PRP O O
143 is VBZ O O
143 very RB O O
143 important JJ O O
143 that IN B-VP O
143 you PRP O O
143 attend VBP O O
143 your PRP$ O O
143 follow VBP O O
143 up RP O O
143 appointment NN B-NP O
143 with IN B-VP O
144 the DT B-NP O
144 cardiologist NN I-NP O
144 , , O O
144 Dr NNP B-NP O
144 Ivrin NNP I-NP O
145 Please NNP I-NP O
145 take VB O O
145 the DT B-NP O
145 medications NNS I-NP O
145 listed VBN O O
145 above IN B-VP O
145 and CC O O
145 do VB O O
145 not RB O O
145 take VB O O
145 enalapril NN B-NP O
145 on IN B-VP O
146 mornings NNS B-NP O
146 of IN B-VP O
146 dialysis NN B-NP O
147 Please NNP I-NP O
147 adhere RB O O
147 to TO O O
147 your PRP$ O O
147 dietary JJ B-NP O
147 restrictions NNS I-NP O
147 If IN B-VP O
147 you PRP O O
147 gain VBP O O
147 more JJR O O
147 than IN B-VP O
147 3 CD O O
147 kg NN B-NP O
148 between IN B-VP O
148 dialysis NN B-NP O
148 sessions NNS I-NP O
148 please VBP O O
148 restrict VB O O
148 your PRP$ O O
148 fluid NNS B-NP O
148 intake VBP O O
148 The DT B-NP O
148 diet JJ I-NP O
149 guidelines NNS I-NP O
149 will MD O O
149 be VB O O
149 coordinated VBN O O
149 by IN B-VP O
149 the DT B-NP O
149 staff NN I-NP O
149 at IN B-VP O
149 Chapmed NNP B-NP O
149 Gamette NNP I-NP O
149 Medical NNP I-NP O
149 Center NNP I-NP O
150 DISCHARGE NNP I-NP O
150 CONDITION: NNP I-NP O
150 Stable NNP I-NP O
151 TO NNP I-NP O
151 DO/PLAN: NNP I-NP O
152 see VB O O
152 above IN B-VP O
153 No DT B-NP O
153 dictated JJ I-NP O
153 summary NN I-NP O
154 ENTERED NNP I-NP O
154 BY: NNP I-NP O
154 PASSINO NNP I-NP O
154 , , O O
154 TERRY NNP B-NP O
154 D NNP I-NP O
154 , , O O
154 M.D NNP B-NP O
154 ( ( O O
154 EN8 NNP B-NP O
154 ) ) O O
154 11/17/04 CD O O
154 @ $ O O
154 11 CD O O
155 ****** JJ B-NP O
155 END NN I-NP O
155 OF NNP I-NP O
155 DISCHARGE NNP I-NP O
155 ORDERS NNP I-NP O
155 ****** NNP I-NP O
156 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #5091 VBZ O O
4 798348513 CD O O
4 CMC NNP B-NP O
4 42176106 CD O O
4 6273542 CD O O
4 0/12/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 LEFT NNP I-NP O
4 IST NNP I-NP O
4 TOE NNP I-NP O
4 INFECTION NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/12/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/7/2006 CD O O
7 ATTENDING: NNP B-NP O
7 KIRTLAND NNP I-NP O
7 , , O O
7 AHMAD NNP B-NP O
7 F NNP I-NP O
7 D NNP I-NP O
7 C NNP I-NP O
8 ADMITTING NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
9 Peripheral NNP I-NP O
9 vascular JJ B-NP O
9 disease NN I-NP O
10 LIST NNP I-NP O
10 OF NNP I-NP O
10 PROBLEMS NNP I-NP O
10 AND NNP I-NP O
10 DIAGNOSES: NNP I-NP O
11 Chronic NNP I-NP O
11 kidney NN I-NP O
11 disease NN I-NP O
11 , , O O
11 diabetes VBZ O O
11 , , O O
11 peripheral JJ B-NP O
11 vascular JJ I-NP O
11 disease NN I-NP O
11 , , O O
12 congestive JJ B-NP O
12 heart NN I-NP O
12 failure NN I-NP O
12 , , O O
12 aortic JJ B-NP O
12 stenosis NN I-NP O
12 , , O O
12 coronary JJ B-NP O
12 artery NN I-NP O
13 disease NN I-NP O
13 status NN I-NP O
13 post NN I-NP O
13 CABG NNP I-NP O
13 , , O O
13 anemia NN B-NP O
13 , , O O
13 hypertension NN B-NP O
14 HISTORY NNP I-NP O
14 OF NNP I-NP O
14 PRESENT NNP I-NP O
14 ILLNESS: NNP I-NP O
15 A NNP I-NP O
15 79-year-old JJ B-NP O
15 male NN I-NP O
15 with IN B-VP O
15 history NN B-NP O
15 of IN B-VP O
15 non-insulin JJ B-NP O
15 dependent NN I-NP O
16 diabetes NNS I-NP O
16 , , O O
16 coronary JJ B-NP O
16 artery NN I-NP O
16 disease NN I-NP O
16 , , O O
16 congestive JJ B-NP O
16 heart NN I-NP O
16 failure NN I-NP O
16 , , O O
17 hypertension NN B-NP O
17 , , O O
17 chronic JJ B-NP O
17 renal JJ I-NP O
17 failure NN I-NP O
17 , , O O
17 recently RB O O
17 1.5 CD O O
17 months NNS B-NP O
17 status NN I-NP O
18 post NN I-NP O
18 left VBD B-VP O
18 toe JJ B-NP O
18 amputation NN I-NP O
18 on IN B-VP O
18 7/1/06 CD O O
18 complicated VBN O O
18 by IN B-VP O
18 acute NN B-NP O
18 on IN B-VP O
19 chronic JJ B-NP O
19 renal JJ I-NP O
19 failure NN I-NP O
19 and CC O O
19 delirium NN B-NP O
19 requiring VBG O O
19 postoperative JJ B-NP O
20 dialysis NN I-NP O
20 from IN B-VP O
20 9/8/06 CD O O
20 through IN B-VP O
20 9/27/06 CD O O
20 The DT B-NP O
20 patient NN I-NP O
20 presented VBD B-VP O
21 on IN B-VP O
21 3/26/05 CD O O
21 for IN B-VP O
21 a DT B-NP B-r
21 nonhealing JJ I-NP I-r
21 ulcer NN I-NP I-r
21 for IN B-VP O
21 three CD O O
21 weeks' JJ B-NP O
21 duration NN I-NP O
21 , , O O
22 exposed VBD B-VP O
22 bone NN B-NP O
22 on IN B-VP O
22 the DT B-NP O
22 left JJ I-NP O
22 great JJ I-NP O
22 toe NN I-NP O
22 and CC O O
22 was VBD B-VP O
22 admitted VBN O O
22 for IN B-VP O
23 debridement NN B-NP O
23 and CC O O
23 antibiotics NNS B-NP B-m
23 An DT B-NP O
23 MRA NNP I-NP O
23 on IN B-VP O
23 10/3/06 CD O O
23 demonstrated VBN O O
23 on IN B-VP O
24 the DT B-NP O
24 right NN I-NP O
24 a DT B-NP O
24 multifocal JJ I-NP O
24 high-grade JJ I-NP O
24 stenosis NN I-NP O
24 of IN B-VP O
24 the DT B-NP O
24 proximal NN I-NP O
24 , , O O
25 anterior JJ B-NP O
25 tibial NN I-NP O
25 , , O O
25 the DT B-NP O
25 tibioperoneal JJ I-NP O
25 trunk NN I-NP O
25 and CC O O
25 the DT B-NP O
25 proximal NN I-NP O
25 , , O O
26 posterior JJ B-NP O
26 tibial JJ I-NP O
26 arteries NNS I-NP O
26 and CC O O
26 included VBD B-VP O
26 peroneal JJ B-NP O
26 artery NN I-NP O
26 at IN B-VP O
26 the DT B-NP O
27 midcalf NN I-NP O
27 , , O O
27 two-vessel JJ B-NP O
27 runoff NN I-NP O
27 and CC O O
27 on IN B-VP O
27 the DT B-NP O
27 left NN I-NP O
27 diffuse NN I-NP O
27 high-grade JJ B-NP O
28 stenoses NNS I-NP O
28 of IN B-VP O
28 the DT B-NP O
28 anterior JJ I-NP O
28 tibial NN I-NP O
28 , , O O
28 posterior JJ B-NP O
28 tibial JJ I-NP O
28 arteries NNS I-NP O
28 and CC O O
29 occlusion NN B-NP O
29 of IN B-VP O
29 the DT B-NP O
29 peroneal JJ I-NP O
29 artery NN I-NP O
29 in IN B-VP O
29 the DT B-NP O
29 dorsalis NN I-NP O
29 pedis VBZ O O
29 The DT B-NP O
30 patient NN I-NP O
30 now RB O O
30 presents VBZ O O
30 with IN B-VP O
30 bleeding VBG O O
30 from IN B-VP O
30 the DT B-NP O
30 site NN I-NP O
30 of IN B-VP O
30 the DT B-NP O
30 left NN I-NP O
30 toe NN I-NP O
31 amputation NN I-NP O
31 beginning VBG O O
31 two CD O O
31 weeks NNS B-NP O
31 ago RB O O
31 associated VBN O O
31 with IN B-VP O
31 throbbing VBG O B-r
32 pain NN B-NP O
32 , , O O
32 soreness NN B-NP O
32 , , O O
32 erythema NN B-NP O
32 and CC O O
32 swelling NN B-NP O
32 and CC O O
32 exacerbated VBD B-VP O
32 blood NN B-NP O
33 pressure NN I-NP O
33 when WRB O O
33 walking NN B-NP O
33 and CC O O
33 only RB O O
33 treated VBN O O
33 by IN B-VP O
33 narcotics NNS B-NP B-m
34 PAST NNP I-NP O
34 MEDICAL NNP I-NP O
34 HISTORY: NNP I-NP O
35 Stage NNP I-NP O
35 IV NNP I-NP O
35 chronic JJ B-NP O
35 kidney NN I-NP O
35 disease NN I-NP O
35 secondary JJ O O
35 to TO O O
35 diabetes NNS B-NP O
35 with IN B-VP O
35 the DT B-NP O
36 baseline NN I-NP O
36 creatinine NN I-NP O
36 of IN B-VP O
36 2.3 CD O O
36 , , O O
36 non-insulin-dependent JJ B-NP O
36 diabetes NNS I-NP O
36 since IN B-VP O
37 1998 CD O O
37 , , O O
37 peripheral JJ B-NP O
37 vascular JJ I-NP O
37 disease NN I-NP O
37 , , O O
37 congestive JJ B-NP O
37 heart NN I-NP O
37 failure NN I-NP O
37 with IN B-VP O
38 an DT B-NP O
38 EF NNP I-NP O
38 of IN B-VP O
38 55% CD O O
38 on IN B-VP O
38 7/13/06 CD O O
38 , , O O
38 aortic JJ B-NP O
38 stenosis NN I-NP O
38 status NN I-NP O
38 post NN I-NP O
38 AVR NNP I-NP O
38 , , O O
39 coronary JJ B-NP O
39 artery NN I-NP O
39 disease NN I-NP O
39 status NN I-NP O
39 post NN I-NP O
39 CABG NNP I-NP O
39 , , O O
39 anemia NN B-NP O
39 and CC O O
40 hypertension NN B-NP O
41 PAST NNP I-NP O
41 SURGICAL NNP I-NP O
41 HISTORY: NNP I-NP O
42 Aortic NNP I-NP O
42 valve FW O O
42 replacement NN B-NP O
42 with IN B-VP O
42 a DT B-NP O
42 Carpentier-Edwards NNP I-NP O
42 valve NN I-NP O
42 , , O O
43 pulmonary JJ B-NP O
43 hypertension NN I-NP O
43 prior RB O O
43 to TO O O
43 the DT B-NP O
43 AVR NNP I-NP O
43 , , O O
43 status NN B-NP O
43 post NN I-NP O
43 ablation NN I-NP O
43 for IN B-VP O
44 atrioventricular JJ B-NP O
44 nodal JJ I-NP O
44 reentry NN I-NP O
44 , , O O
44 tachycardia NN B-NP O
44 , , O O
44 CABG NNP B-NP O
44 x4 NNP I-NP O
44 , , O O
44 and CC O O
44 PFO NNP B-NP O
45 closure VBP O O
45 7/13/06 CD O O
45 status NN B-NP O
45 post NN I-NP O
45 left VBD B-VP O
45 first JJ B-NP O
45 toe JJ I-NP O
45 amputation NN I-NP O
45 10/3/06 CD O O
46 complicated VBN O O
46 by IN B-VP O
46 delirium NN B-NP O
46 and CC O O
46 acute JJ B-NP O
46 renal JJ I-NP O
46 dysfunction NN I-NP O
47 MEDICATIONS: NNP I-NP O
48 Aspirin NNP I-NP B-m
48 , , O O
48 Lopressor NNP B-NP B-m
48 , , O O
48 Norvasc NNP B-NP B-m
48 , , O O
48 Zocor NNP B-NP B-m
48 , , O O
48 Plavix NNP B-NP B-m
48 , , O O
48 PhosLo NNP B-NP B-m
48 , , O O
48 Prandin NNP B-NP B-m
48 , , O O
49 Nephrocaps NNP B-NP B-m
49 , , O O
49 Epogen NNP B-NP B-m
49 , , O O
49 Calcitriol NNP B-NP B-m
50 ALLERGIES: NNP I-NP O
51 No NNP I-NP O
51 known VBN O O
51 drug NN B-NP O
51 allergies NNS I-NP O
52 SOCIAL NNP I-NP O
52 HISTORY: NNP I-NP O
53 Lives VBZ O O
53 alone RB O O
53 , , O O
53 separated VBN O O
53 from IN B-VP O
53 wife NN B-NP O
53 , , O O
53 retired JJ B-NP O
53 firefighter NN I-NP O
53 Former NNP I-NP O
54 smoker NN I-NP O
54 with IN B-VP O
54 a DT B-NP O
54 distant JJ I-NP O
54 history NN I-NP O
54 of IN B-VP O
54 five-pack JJ B-NP O
54 years NNS I-NP O
54 Seldom NNP I-NP O
54 alcohol NN I-NP O
55 use NN I-NP O
56 FAMILY NNP I-NP O
56 HISTORY: NNP I-NP O
57 Diabetes NNP I-NP O
57 in IN B-VP O
57 the DT B-NP O
57 father NN I-NP O
57 and CC O O
57 the DT B-NP O
57 daughter NN I-NP O
57 Father NNP I-NP O
57 had VBD B-VP O
57 diabetes NNS B-NP O
57 , , O O
58 was VBD B-VP O
58 a DT B-NP O
58 smoker NN I-NP O
58 and CC O O
58 an DT O O
58 alcoholic JJ O O
58 and CC O O
58 died VBD B-VP O
58 of IN B-VP O
58 a DT B-NP O
58 myocardial JJ I-NP O
58 infarction NN I-NP O
59 at IN B-VP O
59 age NN B-NP O
59 65 CD O O
60 PHYSICAL NNP B-NP O
60 EXAMINATION NNP I-NP O
60 ON NNP I-NP O
60 ADMISSION: NNP I-NP O
61 VITAL NNP I-NP O
61 SIGNS: NNP I-NP O
61 Temperature NNP I-NP O
61 99.8 CD O O
61 , , O O
61 heart NN B-NP O
61 rate NN I-NP O
61 79 CD O O
61 , , O O
61 blood NN B-NP O
61 pressure NN I-NP O
62 170/90 CD O O
62 , , O O
62 respiratory NN B-NP O
62 rate NN I-NP O
62 20 CD O O
62 , , O O
62 oxygen NN B-NP O
62 saturation NN I-NP O
62 100% CD O O
62 on IN B-VP O
62 room NN B-NP O
62 air NN I-NP O
63 On IN B-VP O
63 exam NN B-NP O
63 , , O O
63 in IN B-VP O
63 general JJ O O
63 , , O O
63 elderly JJ B-NP O
63 man NN I-NP O
63 in IN B-VP O
63 no DT B-NP O
63 acute NN I-NP O
63 distress NN I-NP O
64 HEENT: NNP I-NP O
64 Normocephalic NNP I-NP O
64 , , O O
64 atraumatic JJ B-NP O
64 No NNP I-NP O
64 scleral JJ B-NP O
64 icterus NN I-NP O
65 NEURO: NNP I-NP O
65 Alert NNP I-NP O
65 and CC O O
65 oriented VBN O O
65 x3 NNP B-NP O
66 CARDIAC: NNP I-NP O
66 Regular NNP I-NP O
66 rate NN I-NP O
66 and CC O O
66 rhythm NN B-NP O
66 Split NNP I-NP O
66 S2 NNP I-NP O
66 , , O O
66 mild JJ B-NP O
66 systolic JJ I-NP O
67 murmur NN I-NP O
67 , , O O
67 2/6 CD O O
67 radiating NN B-NP O
67 to TO O O
67 the DT B-NP O
67 carotids NNS I-NP O
67 bilaterally RB O O
67 , , O O
67 heard RB O O
67 best JJS O O
67 at IN B-VP O
68 the DT B-NP O
68 right JJ I-NP O
68 second JJ I-NP O
68 intercostal JJ I-NP O
68 space NN I-NP O
68 No NNP I-NP O
68 bruits VBZ O O
68 bilaterally RB O O
69 RESPIRATORY: NNP B-NP O
69 Clear NNP I-NP O
69 to TO O O
69 auscultation VB O O
69 bilaterally RB O O
69 , , O O
69 no DT B-NP O
69 rales NNS I-NP O
69 , , O O
70 wheezing VBG O O
70 or CC O O
70 rhonchi VB O O
71 GI: NNP B-NP O
71 Soft NNP I-NP O
71 , , O O
71 nontender NN B-NP O
71 , , O O
71 firm NN B-NP O
71 , , O O
71 nondistended VBD B-VP O
71 , , O O
71 positive JJ B-NP O
71 bowel NN I-NP O
71 sounds NNS I-NP O
71 , , O O
72 no DT B-NP O
72 rebound NN I-NP O
72 , , O O
72 no DT B-NP O
72 guarding NN I-NP O
72 , , O O
72 no DT B-NP O
72 masses NNS I-NP O
73 EXTREMITIES: VBP O O
73 2+ CD O O
73 edema NNS B-NP O
73 bilaterally RB O O
73 No NNP B-NP O
73 clubbing NN I-NP O
73 , , O O
73 no DT B-NP O
73 cyanosis NN I-NP O
73 A NNP I-NP O
74 cold NN I-NP O
74 right JJ B-NP O
74 foot NN I-NP O
74 , , O O
74 left VBD B-VP O
74 lower JJR B-NP O
74 extremity NN I-NP O
74 great JJ B-NP O
74 toe JJ I-NP O
74 amputation NN I-NP O
74 site NN I-NP O
75 bandage NN I-NP O
75 with IN B-VP O
75 bloody JJ B-NP O
75 drainage NN I-NP O
75 Radial NNP I-NP O
75 pulses VBZ O O
75 2+ CD O O
75 bilaterally RB O O
76 Femoral JJ B-NP O
76 pulses NNS I-NP O
76 2+ CD O O
76 bilaterally RB O O
76 PT NNP B-NP O
76 pulse NN I-NP O
76 palpable NN I-NP O
76 , , O O
76 DP NNP B-NP O
76 pulse RB O O
77 palpable JJ O O
77 on IN B-VP O
77 the DT B-NP O
77 right NN I-NP O
77 and CC O O
77 the DT B-NP O
77 left NN I-NP O
77 PT NNP I-NP O
77 pulse VBZ O O
77 1+ CD O O
77 and CC O O
77 DP NNP B-NP O
77 pulse NN I-NP O
77 was VBD B-VP O
78 not RB O O
78 palpable JJ B-NP O
79 EKG: NNP I-NP O
79 Left NNP I-NP O
79 axis VBZ O O
79 deviation NN B-NP O
79 with IN B-VP O
79 left JJ B-NP O
79 ventricular JJ I-NP O
79 hypertrophy NN I-NP O
79 , , O O
80 question NN B-NP O
80 of IN B-VP O
80 lateral JJ B-NP O
80 ischemia JJ I-NP O
81 HOSPITAL NNP I-NP O
81 COURSE NNP I-NP O
81 AND NNP I-NP O
81 PROCEDURES: NNP I-NP O
82 Procedures: NNP I-NP O
82 0/9/06 CD O O
82 , , O O
82 Irrigation NNP B-NP O
82 and CC O O
82 debridement NN B-NP O
82 of IN B-VP O
82 the DT B-NP O
82 left JJ I-NP O
83 great JJ I-NP O
83 toe NN I-NP O
83 with IN B-VP O
83 extension NN B-NP O
83 of IN B-VP O
83 amputation NN B-NP O
83 to TO O O
83 the DT B-NP O
83 transmetatarsal NN I-NP O
84 joint JJ O O
84 8/14/06 CD O O
84 and CC O O
84 6/21/06 CD O O
84 , , O O
84 left VBD B-VP O
84 toe RP O O
84 I&amp;D NNP B-NP O
84 with IN B-VP O
84 left JJ B-NP O
84 popliteal JJ I-NP O
85 bypass NN I-NP O
85 graft NN I-NP O
85 to TO O O
85 the DT B-NP O
85 anterior JJ I-NP O
85 tibial JJ I-NP O
85 artery NN I-NP O
85 with IN B-VP O
85 right JJ B-NP O
85 saphenous JJ I-NP O
86 vein NN I-NP O
86 graft NN I-NP O
86 and CC O O
86 Vac NNP B-NP O
86 placement VBP O O
86 Serial JJ B-NP O
86 debridements NNS I-NP O
86 on IN B-VP O
86 4/25/06 CD O O
86 , , O O
87 1/30/06 CD O O
87 and CC O O
87 8/26/06 CD O O
87 Foot NNP B-NP O
87 had VBD B-VP O
87 been VBN O O
87 debrided VBN O O
87 so RB O O
87 that IN B-VP O
87 the DT B-NP O
88 amputation NN I-NP O
88 on IN B-VP O
88 the DT O O
88 first JJ O O
88 and CC O O
88 second JJ B-NP O
88 toes NNS I-NP O
88 are VBP O O
88 down RB O O
88 to TO O O
88 the DT B-NP O
88 level NN I-NP O
88 of IN B-VP O
89 the DT B-NP O
89 tarsometatarsal NN I-NP O
89 joint JJ B-NP O
90 HOSPITAL NNP I-NP O
90 COURSE: NNP I-NP O
91 The DT B-NP O
91 patient NN I-NP O
91 was VBD B-VP O
91 admitted VBN O O
91 on IN B-VP O
91 5/22/06 CD O O
91 for IN B-VP O
91 treatment NN B-NP O
91 with IN B-VP O
91 IV NNP B-NP B-mo
92 antibiotics NNS I-NP B-m
92 and CC O O
92 presumed JJ B-NP O
92 operative JJ I-NP O
92 intervention NN I-NP O
93 Neuro NNP I-NP O
93 and CC O O
93 Psych: NNP B-NP O
93 The DT B-NP O
93 patient NN I-NP O
93 has VBZ O O
93 delirium VBN O B-r
93 postoperatively RB O O
93 for IN B-VP O
94 which WDT O O
94 he PRP O O
94 was VBD B-VP O
94 placed VBN O O
94 on IN B-VP O
94 soft JJ B-NP O
94 restraints NNS I-NP O
94 and CC O O
94 received VBN O O
94 Zyprexa NNP B-NP B-m
95 This DT O O
95 resolved VBD B-VP O
95 quickly RB O O
95 Did NNP B-NP O
95 well RB O O
95 for IN B-VP O
95 the DT B-NP O
95 duration NN I-NP O
95 of IN B-VP O
95 admission NN B-NP O
95 in IN B-VP O
96 terms NNS B-NP O
96 of IN B-VP O
96 mental JJ B-NP O
96 status NN I-NP O
96 Alert NNP I-NP O
96 and CC O O
96 oriented VBN O O
96 x3 NN B-NP O
96 at IN B-VP O
96 the DT B-NP O
96 time NN I-NP O
96 of IN B-VP O
97 discharge NN B-NP O
98 Cardiac: NNP I-NP O
98 Upon NNP I-NP O
98 admission NN I-NP O
98 , , O O
98 potassium NN B-NP O
98 was VBD B-VP O
98 noted VBN O O
98 to TO O O
98 be VB O O
98 elevated VBN O O
98 and CC O O
99 the DT B-NP O
99 patient NN I-NP O
99 had VBD B-VP O
99 EKG NNP B-NP O
99 changes NNS I-NP O
99 associated VBN O O
99 with IN B-VP O
99 hyperkalemia NN B-NP O
99 Both NNP I-NP O
100 the DT B-NP O
100 Renal NNP I-NP O
100 and CC O O
100 Cardiology NNP B-NP O
100 services NNS I-NP O
100 were VBD B-VP O
100 consulted VBN O O
100 and CC O O
100 assisted VBN O O
101 with IN B-VP O
101 his PRP$ O O
101 perioperative JJ B-NP O
101 management NN I-NP O
101 in IN B-VP O
101 terms NNS B-NP O
101 of IN B-VP O
101 cardioprotection NN B-NP O
102 and CC O O
102 possible JJ B-NP O
102 need NN I-NP O
102 for IN B-VP O
102 dialysis NN B-NP O
102 No NNP I-NP O
102 further JJ B-NP O
102 events NNS I-NP O
102 The DT B-NP O
103 hyperkalemia NN I-NP O
103 resolved VBD B-VP O
103 He PRP O O
103 remained VBD B-VP O
103 hemodynamically RB O O
103 stable JJ O O
103 He PRP O O
104 received VBD B-VP O
104 aspirin RB O B-m
104 and CC O O
104 Zocor NNP B-NP B-m
104 for IN B-VP O
104 coronary JJ B-NP B-r
104 coronary JJ I-NP B-r
104 artery NN I-NP O
104 disease NN I-NP O
104 related JJ B-NP O
105 event NN I-NP O
105 prophylaxis NN I-NP O
105 Blood NNP I-NP B-r
105 Blood NNP I-NP B-r
105 Blood NNP I-NP B-r
105 Blood NNP I-NP B-r
105 pressure NN I-NP I-r
105 pressure NN I-NP I-r
105 pressure NN I-NP I-r
105 pressure NN I-NP I-r
105 was VBD B-VP O
105 controlled VBN O O
105 with IN B-VP O
105 isosorbide JJ B-NP B-m
106 dinitrate NN I-NP O
106 , , O O
106 Norvasc NNP B-NP B-m
106 , , O O
106 lisinopril NN B-NP B-m
106 , , O O
106 and CC O O
106 Lopressor NNP B-NP B-m
107 Pulmonary: NNP I-NP O
107 No NNP I-NP O
107 events NNS I-NP O
107 Maintained VBD B-VP O
107 oxygen RP O O
107 saturation NN B-NP O
107 greater JJR O O
107 than IN B-VP O
108 90% CD O O
108 on IN B-VP O
108 room NN B-NP O
108 air NN I-NP O
109 Renal: NNP I-NP O
109 Creatinine NNP I-NP O
109 was VBD B-VP O
109 stable JJ O O
109 in IN B-VP O
109 the DT B-NP O
109 mid NN I-NP O
109 3s CD O O
109 and CC O O
109 trended VBD B-VP O
109 down RB O O
109 to TO O O
110 2.6 CD O O
110 at IN B-VP O
110 the DT B-NP O
110 time NN I-NP O
110 of IN B-VP O
110 discharge NN B-NP O
110 below IN B-VP O
110 his PRP$ O O
110 baseline NN B-NP O
110 of IN B-VP O
110 4-5 JJ B-NP O
110 Voiding NNP I-NP O
111 without IN B-VP O
111 difficulty NN B-NP O
111 at IN B-VP O
111 the DT B-NP O
111 time NN I-NP O
111 of IN B-VP O
111 discharge NN B-NP O
111 Maintained VBN O O
111 on IN B-VP O
111 his PRP$ O O
112 renal JJ B-NP B-m
112 medications NNS I-NP I-m
113 FEN/GI: NNP I-NP O
113 Tolerated VBD B-VP O
113 regular JJ B-NP O
113 diet JJ I-NP O
113 Lactulose NNP I-NP B-m
113 and CC O O
113 Colace NNP B-NP B-m
113 to TO O O
113 prevent VB O O
114 constipation NN B-NP B-r
114 constipation NN I-NP B-r
114 while IN B-VP O
114 taking VBG O O
114 narcotics NNS B-NP B-m
114 , , O O
114 also RB O O
114 had VBD B-VP O
114 Dulcolax NNP B-NP B-m
114 p.r.n JJ B-NP B-f
114 p.r.n NN I-NP B-f
115 Zinc NNP I-NP B-m
115 and CC O O
115 vitamin NNP B-NP B-m
115 C NNP I-NP I-m
115 was VBD B-VP O
115 started VBN O O
115 per IN B-VP O
115 the DT B-NP O
115 Nutrition NNP I-NP O
115 consult NN I-NP O
116 Hematology: NNP I-NP O
116 He PRP O O
116 received VBD B-VP O
116 heparin NN B-NP B-m
116 for IN B-VP O
116 DVT NNP B-NP B-r
116 prophylaxis VBD B-VP I-r
116 His PRP$ O O
117 hematocrit NN B-NP O
117 remained VBD B-VP O
117 stable JJ O O
117 He PRP O O
117 had VBD B-VP O
117 some DT O O
117 oozing VBG O O
117 from IN B-VP O
117 the DT B-NP O
117 right JJ I-NP O
118 thigh NN I-NP O
118 but CC O O
118 this DT O O
118 resolved VBN O O
118 with IN B-VP O
118 a DT B-NP O
118 pressure NN I-NP O
118 dressing VBG O O
119 ID: NNP B-NP O
119 He PRP O O
119 was VBD B-VP O
119 treated VBN O O
119 throughout IN B-VP O
119 his PRP$ O O
119 hospitalization NN B-NP O
119 with IN B-VP O
120 vancomycin NN B-NP B-m
120 , , O O
120 levofloxacin NN B-NP B-m
120 and CC O O
120 Flagyl NNP B-NP B-m
120 for IN B-VP O
120 methicillin-resistant JJ B-NP B-r
120 methicillin-resistant JJ I-NP B-r
120 methicillin-resistant JJ I-NP B-r
121 Staphylococcus NNP I-NP O
121 aureus NN I-NP O
121 that WDT O O
121 grew VBD B-VP O
121 from IN B-VP O
121 the DT B-NP O
121 wound NN I-NP O
121 after IN B-VP O
121 the DT O O
121 first JJ O O
122 and CC O O
122 second JJ B-NP O
122 irrigation NN I-NP O
122 and CC O O
122 debridement VB O O
122 The DT B-NP O
122 levofloxacin NN I-NP B-m
122 and CC O O
123 Flagyl NNP B-NP B-m
123 were VBD B-VP O
123 discontinued VBN O O
123 prior RB O O
123 to TO O O
123 discharge VB O O
123 He PRP O O
123 will MD O O
123 continue VB O O
124 his PRP$ O O
124 vancomycin NN B-NP B-m
124 at IN B-VP O
124 the DT B-NP O
124 time NN I-NP O
124 of IN B-VP O
124 discharge NN B-NP O
124 Please NNP I-NP O
124 see VB O O
124 addendum NN B-NP O
124 for IN B-VP O
125 antibiotic JJ B-NP B-m
125 plan NN I-NP O
126 Endocrine: NNP I-NP O
126 Diabetes VBZ O O
126 controlled VBD B-VP O
126 He PRP O O
126 was VBD B-VP O
126 maintained VBN O O
126 on IN B-VP O
126 his PRP$ O O
127 Prandin NNP B-NP B-m
127 and CC O O
127 insulin NN B-NP B-m
127 sliding VBG O B-do
127 scale NN B-NP I-do
127 for IN B-VP O
127 glycemic JJ B-NP B-r
127 glycemic JJ I-NP B-r
127 control NN I-NP I-r
127 control NN I-NP I-r
127 He PRP O O
127 also RB O O
128 received VBD B-VP O
128 vitamin JJ B-NP B-m
128 D NNP I-NP I-m
129 His PRP$ O O
129 incision NN B-NP O
129 remained VBD B-VP O
129 clean JJ O O
129 , , O O
129 dry JJ O O
129 and CC O O
129 intact JJ O O
129 without IN B-VP O
129 erythema NN B-NP O
129 or CC O O
130 exudate NN B-NP O
130 He PRP O O
130 was VBD B-VP O
130 afebrile JJ O O
130 with IN B-VP O
130 stable JJ B-NP O
130 signs NNS I-NP O
130 at IN B-VP O
130 the DT B-NP O
130 time NN I-NP O
130 of IN B-VP O
131 discharge NN B-NP O
132 ACTIVITY NNP I-NP O
132 INSTRUCTIONS: NNP I-NP O
133 He PRP O O
133 is VBZ O O
133 nonweightbearing VBG O O
133 on IN B-VP O
133 the DT B-NP O
133 left NN I-NP O
133 lower JJR B-NP O
133 extremity NN I-NP O
133 to TO O O
133 protect VB O O
133 the DT B-NP O
134 open JJ I-NP O
134 toe NN I-NP O
135 COMPLICATIONS: NNP I-NP O
136 None NNP I-NP O
137 DISCHARGE NNP I-NP O
137 LABS: NNP I-NP O
138 Laboratory NNP I-NP O
138 tests NNS I-NP O
138 at IN B-VP O
138 the DT B-NP O
138 time NN I-NP O
138 of IN B-VP O
138 discharge NN B-NP O
138 include VBP O O
138 sodium NN B-NP O
138 138 CD O O
138 , , O O
139 potassium NN B-NP O
139 4.1 CD O O
139 , , O O
139 chloride RB O O
139 111 CD O O
139 , , O O
139 bicarbonate NN B-NP O
139 21 CD O O
139 , , O O
139 BUN NNP B-NP O
139 35 CD O O
139 , , O O
139 creatinine NN B-NP O
140 2.6 CD O O
140 , , O O
140 calcium NN B-NP O
140 9.0 CD O O
140 , , O O
140 magnesium NN B-NP O
140 1.9 CD O O
140 , , O O
140 vancomycin FW O O
140 19.5 CD O O
140 , , O O
140 white JJ B-NP O
140 blood NN I-NP O
141 cell NN I-NP O
141 count NN I-NP O
141 7.3 CD O O
141 , , O O
141 hemoglobin NN B-NP O
141 9.9 CD O O
141 , , O O
141 hematocrit NN B-NP O
141 30.2 CD O O
141 , , O O
141 platelets NNS B-NP O
141 221 CD O O
142 DISCHARGE NNP B-NP O
142 MEDICATIONS: NNP I-NP O
143 His PRP$ O O
143 medications NNS B-NP O
143 at IN B-VP O
143 discharge NN B-NP O
143 include VBP O O
143 aspirin JJ O B-m
143 325 CD O B-do
143 mg JJ O I-do
143 p.o JJ O B-mo
143 daily JJ O B-f
143 , , O O
144 vitamin JJ B-NP B-m
144 C NNP I-NP I-m
144 500 CD O B-do
144 mg NN B-NP I-do
144 p.o NN I-NP B-mo
144 b.i.d NN I-NP B-f
144 , , O O
144 calcitriol VBP O B-m
144 0.5 CD O B-do
144 mcg NNS B-NP I-do
144 p.o JJ O B-mo
144 daily RB O B-f
144 , , O O
145 Colace NNP B-NP B-m
145 100 CD O B-do
145 mg NN B-NP I-do
145 p.o JJ O B-mo
145 daily RB O B-f
145 , , O O
145 heparin JJ O B-m
145 5000 CD O B-do
145 units NNS B-NP I-do
145 subcutaneous JJ B-NP B-mo
145 t.i.d NN I-NP B-f
145 , , O O
146 isosorbide JJ B-NP B-m
146 dinitrate NN I-NP I-m
146 10 CD O B-do
146 mg NN B-NP I-do
146 p.o NN I-NP B-mo
146 t.i.d NN I-NP B-f
146 , , O O
146 lactulose JJ O B-m
146 30 CD O B-do
146 mL NN B-NP I-do
146 p.o NN I-NP B-mo
147 t.i.d NN I-NP B-f
147 , , O O
147 lisinopril VBZ O B-m
147 50 CD O B-do
147 mg NN B-NP I-do
147 p.o JJ O B-mo
147 daily RB O B-f
147 , , O O
147 Lopressor NNP B-NP B-m
147 50 CD O B-do
147 mg NN B-NP I-do
147 p.o NN I-NP B-mo
147 q.6h VBD B-VP B-f
148 Simethicone NNP B-NP B-m
148 80 CD O B-do
148 mg NN B-NP I-do
148 p.o NN I-NP B-mo
148 q.i.d NN I-NP B-f
148 , , O O
148 vancomycin FW O B-m
148 1 CD O B-do
148 g NN B-NP I-do
148 IV NNP I-NP B-mo
148 every DT B-NP B-f
148 other JJ I-NP I-f
148 day NN I-NP I-f
148 , , O O
149 zinc NN B-NP B-m
149 sulfate NN I-NP I-m
149 220 CD O B-do
149 mg NN B-NP I-do
149 p.o JJ O B-mo
149 daily JJ O B-f
149 for IN B-VP B-du
149 two CD O I-du
149 weeks NNS B-NP I-du
149 , , O O
149 Zocor NNP B-NP B-m
149 80 CD O B-do
149 mg NN B-NP I-do
149 p.o JJ O B-mo
150 daily RB O B-f
150 , , O O
150 Norvasc NNP B-NP B-m
150 10 CD O B-do
150 mg NN B-NP I-do
150 p.o JJ O B-mo
150 daily JJ O B-f
150 , , O O
150 Nephro-Vite JJ O B-m
150 one CD O B-do
150 tab NN B-NP I-do
150 p.o JJ O B-mo
150 daily RB O B-f
150 , , O O
151 Prandin NNP B-NP B-m
151 0.5 CD O B-do
151 mg NN B-NP I-do
151 p.o NN I-NP B-mo
151 with IN B-VP B-f
151 each DT B-NP I-f
151 meal NN I-NP I-f
151 , , O O
151 Aranesp NNP B-NP B-m
151 40 CD O B-do
151 mcg NN B-NP I-do
151 subcutaneous JJ O B-mo
152 every DT B-NP B-f
152 week NN I-NP I-f
152 , , O O
152 sliding VBG O B-do
152 scale JJ B-NP I-do
152 insulin NN I-NP B-m
152 , , O O
152 insulin JJ O B-m
152 aspart RB O I-m
152 4 CD O B-do
152 units NNS B-NP I-do
153 subcutaneous JJ O B-mo
153 with IN B-VP B-f
153 breakfast NN B-NP I-f
153 and CC O I-f
153 dinner NN B-NP I-f
153 , , O O
153 Dulcolax NNP B-NP B-m
153 10 CD O B-do
153 mg NN B-NP I-do
153 PR NNP I-NP B-mo
153 daily RB O B-f
153 , , O O
154 Tylenol NNP B-NP B-m
154 p.r.n NN I-NP B-f
154 , , O O
154 Dilaudid NNP B-NP B-m
154 2-4 CD O B-do
154 mg NN B-NP I-do
154 p.o NN I-NP B-mo
154 q.4h NN I-NP B-f
154 as IN B-VP I-f
154 needed VBN O I-f
154 for IN B-VP O
154 pain NN B-NP B-r
154 , , O O
155 milk NN B-NP B-m
155 of IN B-VP I-m
155 magnesia NN B-NP I-m
155 as IN B-VP B-f
155 needed VBN O I-f
155 for IN B-VP O
155 constipation NN B-NP B-r
155 , , O O
155 Reglan NNP B-NP B-m
155 for IN B-VP O
155 nausea NN B-NP B-r
155 , , O O
156 oxycodone NN B-NP B-m
156 for IN B-VP O
156 pain NN B-NP O
156 5-10 JJ B-NP B-do
156 mg NN I-NP I-do
156 p.o NN I-NP B-mo
156 q.4h NN I-NP B-f
156 hours NNS I-NP I-f
156 as IN B-VP I-f
156 needed VBN O I-f
156 for IN B-VP O
156 pain NN B-NP B-r
156 , , O O
157 Zyprexa NNP B-NP B-m
157 Zyprexa NNP I-NP B-m
157 5 CD O B-do
157 5 CD O B-do
157 mg NN B-NP I-do
157 mg NN I-NP I-do
157 p.o NN I-NP B-mo
157 p.o NN I-NP B-mo
157 q.8h NN I-NP B-f
157 q.8h NN I-NP B-f
157 as IN B-VP I-f
157 as IN B-VP I-f
157 needed VBN O I-f
157 needed VBN O I-f
157 for IN B-VP O
157 anxiety NN B-NP B-r
157 or CC O O
157 agitation NN B-NP B-r
157 , , O O
158 Maalox NNP B-NP B-m
158 p.r.n NN I-NP B-f
158 upset JJ B-NP B-r
158 stomach NN I-NP I-r
159 DISPOSITION: NNP I-NP O
160 To TO O O
160 rehabilitation VB O O
161 PHYSICIAN NNP B-NP O
161 FOLLOWUP: NNP I-NP O
162 The DT B-NP O
162 patient NN I-NP O
162 will MD O O
162 follow VB O O
162 up RP O O
162 with IN B-VP O
162 Dr NNP B-NP O
162 Odo NNP I-NP O
162 at IN B-VP O
162 030-524-6194 NNP B-NP O
162 To TO O O
163 call VB O O
163 Dr NNP B-NP O
163 Barkalow NNP I-NP O
163 to TO O O
163 be VB O O
163 seen VBN O O
163 within IN B-VP O
163 one CD O O
163 to TO O O
163 two CD O O
163 weeks NNS B-NP O
163 after IN B-VP O
164 discharge NN B-NP O
165 eScription NN I-NP O
165 document: VBZ O O
165 8-9296036 JJ B-NP O
165 EMSSten NNP I-NP O
165 Tel NNP I-NP O
166 Dictated NNP I-NP O
166 By: NNP I-NP O
166 TEAR NNP I-NP O
166 , , O O
166 DON NNP B-NP O
167 Attending: NNP I-NP O
167 BOHRER NNP I-NP O
167 , , O O
167 DENVER NNP B-NP O
168 Dictation NNP I-NP O
168 ID NNP I-NP O
168 3849823 CD O O
169 D: NNP B-NP O
169 11/5/06 CD O O
170 T: NNP B-NP O
170 11/5/06 CD O O
171 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #21234 VBZ O O
2 676980641 CD O O
2 VUOC NNP B-NP O
2 41868797 CD O O
2 7675401 CD O O
2 10/24/2003 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 VOLUME NNP I-NP O
2 OVERLOAD NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 10/24/2003 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/21/2003 CD O O
4 ATTENDING: NNP B-NP O
4 JONAS NNP I-NP O
4 STARNS NNP I-NP O
4 M.D NNP I-NP O
5 Discharge NNP I-NP O
5 date NN I-NP O
5 to TO O O
5 be VB O O
5 determined VBN O O
6 DISCHARGE NNP B-NP O
6 DIAGNOSIS: NNP I-NP O
6 Congestive NNP I-NP O
6 heart NN I-NP O
6 failure NN I-NP O
7 OTHER NNP I-NP O
7 ASSOCIATED NNP I-NP O
7 PROBLEMS: NNP I-NP O
8 1 CD O O
8 Congestive NNP B-NP O
8 heart NN I-NP O
8 failure NN I-NP O
8 , , O O
8 EF NNP B-NP O
8 of IN B-VP O
8 33% CD O O
8 , , O O
8 etiology NN B-NP O
8 unknown JJ O O
9 2 CD O O
9 Hypertension NNP B-NP O
10 3 CD O O
10 Dyslipidemia NNP B-NP O
11 4 CD O O
11 Acute NNP B-NP O
11 renal JJ B-NP O
11 failure NN I-NP O
12 5 CD O O
12 History NN B-NP O
12 of IN B-VP O
12 paroxysmal JJ B-NP O
12 atrial JJ I-NP O
12 fibrillation NN I-NP O
12 with IN B-VP O
12 rapid JJ B-NP O
13 ventricular JJ I-NP O
13 response NN I-NP O
14 6 CD O O
14 Anemia NNP B-NP O
15 7 CD O O
15 Gastritis NNP B-NP O
16 HISTORY NNP I-NP O
16 OF NNP I-NP O
16 PRESENT NNP I-NP O
16 ILLNESS: NNP I-NP O
16 This DT O O
16 is VBZ O O
16 a DT B-NP O
16 63-year-old JJ I-NP O
16 female NN I-NP O
16 with IN B-VP O
17 history NN B-NP O
17 of IN B-VP O
17 congestive JJ B-NP O
17 heart NN I-NP O
17 failure NN I-NP O
17 in IN B-VP O
17 the DT B-NP O
17 past NN I-NP O
17 with IN B-VP O
17 an DT B-NP O
17 ejection NN I-NP O
18 fraction NN I-NP O
18 of IN B-VP O
18 55% CD O O
18 to TO O O
18 60% CD O O
18 in IN B-VP O
18 March NNP B-NP O
18 of IN B-VP O
18 2003 CD O O
18 , , O O
18 who WP O O
18 presented VBD B-VP O
18 with IN B-VP O
19 bilateral JJ B-NP O
19 lower JJR I-NP O
19 extremity NN I-NP O
19 edema NN I-NP O
19 as RB O O
19 well RB O O
19 as IN B-VP O
19 increasing VBG O O
19 shortness NN B-NP O
20 of IN B-VP O
20 breath NN B-NP O
20 The DT B-NP O
20 patient NN I-NP O
20 reports NNS I-NP O
20 that IN B-VP O
20 she PRP O O
20 has VBZ O O
20 not RB O O
20 been VBN O O
20 taking VBG O O
20 her PRP$ O O
21 Lasix NN B-NP B-m
21 as IN B-VP O
21 she PRP O O
21 was VBD B-VP O
21 prescribed VBN O O
21 due JJ O O
21 to TO O O
21 the DT B-NP O
21 inconvenience NN I-NP O
21 of IN B-VP O
21 going VBG O O
21 to TO O O
22 the DT B-NP O
22 bathroom NN I-NP O
22 frequently RB O O
22 She PRP O O
22 was VBD B-VP O
22 feeling VBG O O
22 overwhelmed VBN O O
22 by IN B-VP O
22 so RB O O
22 many JJ B-NP O
23 medicines NNS I-NP O
23 Currently RB O O
23 , , O O
23 she PRP O O
23 is VBZ O O
23 feeling VBG O O
23 better RBR O O
23 with IN B-VP O
23 improved JJ B-NP O
24 breathing NN I-NP O
24 No NNP I-NP O
24 fever NN I-NP O
24 , , O O
24 chills NNS B-NP O
24 , , O O
24 or CC O O
24 chest JJS B-NP O
24 pain NN I-NP O
25 PAST NNP I-NP O
25 MEDICAL NNP I-NP O
25 HISTORY: NNP I-NP O
26 1 CD O O
26 Congestive NNP B-NP O
26 heart NN I-NP O
26 failure NN I-NP O
26 with IN B-VP O
26 ejection NN B-NP O
26 fraction NN I-NP O
26 of IN B-VP O
26 55% CD O O
26 to TO O O
26 60% CD O O
27 in IN B-VP O
27 March NNP B-NP O
27 of IN B-VP O
27 2003 CD O O
28 2 CD O O
28 Deep NNP B-NP O
28 venous JJ B-NP O
28 thrombosis NN I-NP O
28 bilaterally RB O O
28 with IN B-VP O
28 PE NNP B-NP O
28 in IN B-VP O
28 March NNP B-NP O
28 2003 CD O O
29 3 CD O O
29 Acute NNP B-NP O
29 renal JJ B-NP O
29 failure NN I-NP O
29 , , O O
29 nephrotic JJ B-NP O
29 syndrome NN I-NP O
30 4 CD O O
30 Pneumonia NNP B-NP O
31 5 CD O O
31 Iron NNP B-NP O
31 and CC O O
31 folate JJ B-NP O
31 deficiency NN I-NP O
31 anemia VBD B-VP O
32 6 CD O O
32 Paroxysmal NNP B-NP O
32 atrial JJ B-NP O
32 fibrillation NN I-NP O
32 with IN B-VP O
32 rapid JJ B-NP O
32 ventricular JJ I-NP O
33 response NN I-NP O
34 7 CD O O
34 Nonsustained VBD B-VP O
34 ventricular JJ B-NP O
34 tachycardia NN I-NP O
35 8 CD O O
35 Insulin-dependent JJ B-NP O
35 diabetes NNS I-NP O
35 mellitus VBP O O
36 9 CD O O
36 Hypertension NNP B-NP O
37 10 CD O O
37 Cholesterol NNP B-NP O
38 11 CD O O
38 Chronic NNP B-NP O
38 knee NN I-NP O
38 and CC O O
38 back RB O O
38 pain NN B-NP O
39 12 CD O O
39 Arthroscopic NNP B-NP O
39 knee NN I-NP O
39 surgery NN I-NP O
39 bilaterally RB O O
40 13 CD O O
40 Gastritis NNP B-NP O
41 14 CD O O
41 Benign NNP B-NP O
41 colon NN I-NP O
41 polyps NNS I-NP O
41 greater JJR O O
41 than IN B-VP O
41 10 CD O O
42 15 CD O O
42 Cataracts NNS B-NP O
43 16 CD O O
43 Glaucoma NNP B-NP O
44 MEDICATIONS NNP I-NP O
44 AT NNP I-NP O
44 HOME: NNP I-NP O
45 1 CD O O
45 Lasix NNP B-NP B-m
45 120 CD O B-do
45 mg NN B-NP I-do
45 p.o NN I-NP B-mo
45 b.i.d VBD B-VP B-f
46 2 CD O O
46 Atenolol NNP B-NP B-m
46 50 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 q.d $ O B-f
47 3 CD O O
47 Iron NNP B-NP B-m
47 sulfate NN I-NP I-m
47 300 CD O B-do
47 b.i.d NN B-NP B-f
48 4 CD O O
48 Folate NNP B-NP B-m
48 1 CD O B-do
48 mg NN B-NP I-do
48 q.d NN I-NP B-f
49 5 CD O O
49 NPH NNP B-NP B-m
49 insulin NN I-NP I-m
49 20 CD O B-do
49 units NNS B-NP I-do
49 q.d RB O B-f
50 6 CD O O
50 Oxycodone NNP B-NP B-m
50 5 CD O B-do
50 mg NN B-NP I-do
50 to TO O I-do
50 10 CD O I-do
50 mg NNS B-NP I-do
50 q.4-6h JJ B-NP B-f
50 p.r.n NN I-NP I-f
50 pain NN I-NP B-r
51 7 CD O O
51 Senna NNP B-NP B-m
52 8 CD O O
52 Multivitamins NNP B-NP B-m
53 9 CD O O
53 Zocor NNP B-NP B-m
53 40 CD O B-do
53 mg NN B-NP I-do
53 p.o NN I-NP B-mo
53 q.d VBD B-VP B-f
54 10 CD O O
54 Norvasc NNP B-NP B-m
54 10 CD O B-do
54 mg NN B-NP I-do
54 p.o NN I-NP B-mo
54 q.d VBD B-VP B-f
55 11 CD O O
55 Accupril NNP B-NP B-m
55 80 CD O B-do
55 mg NN B-NP I-do
55 p.o NN I-NP B-mo
55 q.d VBD B-VP B-f
56 12 CD O O
56 Miconazole NNP B-NP B-m
56 2% CD O I-m
56 topical JJ B-NP B-mo
56 b.i.d NN I-NP B-f
57 13 CD O O
57 Celexa NNP B-NP B-m
57 20 CD O B-do
57 mg NN B-NP I-do
57 p.o NN I-NP B-mo
57 q.d VBD B-VP B-f
58 14 CD O O
58 Avandia NNP B-NP B-m
58 8 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 q.d VBD B-VP B-f
59 15 CD O O
59 Nexium NNP B-NP B-m
59 20 CD O B-do
59 mg NN B-NP I-do
59 p.o NN I-NP B-mo
59 q.d VBD B-VP B-f
60 16 CD O O
60 Albuterol NNP B-NP B-m
60 p.r.n JJ B-NP B-f
61 SOCIAL NNP I-NP O
61 HISTORY: NNP I-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 has VBZ O O
61 a DT B-NP O
61 history NN I-NP O
61 of IN B-VP O
61 3-packs-per-day JJ B-NP O
62 smoking NN I-NP O
62 for IN B-VP O
62 30 CD O O
62 years NNS B-NP O
62 and CC O O
62 no DT B-NP O
62 alcohol NN I-NP O
63 FAMILY NNP I-NP O
63 HISTORY: NNP I-NP O
63 No NNP I-NP O
63 family NN I-NP O
63 history NN I-NP O
63 of IN B-VP O
63 heart NN B-NP O
63 disease NN I-NP O
64 PHYSICAL NNP I-NP O
64 EXAM: NNP I-NP O
64 On IN B-VP O
64 presentation NN B-NP O
64 , , O O
64 T NNP B-NP O
64 97.3 CD O O
64 , , O O
64 BP NNP B-NP O
64 143/70 CD O O
64 , , O O
64 pulse RB O O
64 57 CD O O
64 , , O O
64 98% CD O O
65 on IN B-VP O
65 2 CD O O
65 liters NNS B-NP O
65 This DT O O
65 is VBZ O O
65 an DT B-NP O
65 obese JJ I-NP O
65 female NN I-NP O
65 in IN B-VP O
65 no DT B-NP O
65 apparent JJ I-NP O
65 distress NN I-NP O
65 , , O O
66 sitting VBG O O
66 up RP O O
66 in IN B-VP O
66 bed NN B-NP O
66 HEENT: NNP I-NP O
66 Extraocular NNP I-NP O
66 movements NNS I-NP O
66 intact JJ B-NP O
66 Sclerae NNP I-NP O
67 anicteric NN I-NP O
67 Neck: NNP I-NP O
67 Supple NNP I-NP O
67 , , O O
67 JVP NNP B-NP O
67 at IN B-VP O
67 14 CD O O
67 cm NN B-NP O
67 Chest: NNP I-NP O
67 Crackles NNP I-NP O
68 bilaterally RB O O
68 , , O O
68 left VBD B-VP O
68 greater JJR O O
68 than IN B-VP O
68 right RB O O
68 , , O O
68 half DT B-NP O
68 way NN I-NP O
68 up IN B-VP O
68 both DT B-NP O
68 lung NN I-NP O
69 fields NNS I-NP O
69 with IN B-VP O
69 mild NNS B-NP O
69 decreased VBN O O
69 breath NN B-NP O
69 sounds NNS I-NP O
69 at IN B-VP O
69 the DT B-NP O
69 bases NNS I-NP O
70 Cardiovascular: NNP I-NP O
70 Regular NNP I-NP O
70 rate NN I-NP O
70 and CC O O
70 rhythm NN B-NP O
70 Normal NNP I-NP O
70 S1 NNP I-NP O
70 and CC O O
70 S2 NNP B-NP O
70 No NNP I-NP O
71 murmur NN I-NP O
71 , , O O
71 rubs NN B-NP O
71 , , O O
71 or CC O O
71 gallops NNS B-NP O
71 Abdomen: NNP I-NP O
71 Soft NNP I-NP O
71 , , O O
71 nontender NN B-NP O
71 , , O O
71 and CC O O
72 nondistended VBD B-VP O
72 with IN B-VP O
72 positive JJ B-NP O
72 bowel NN I-NP O
72 sound NN I-NP O
72 and CC O O
72 no DT B-NP O
72 hepatosplenomegaly NN I-NP O
73 Extremities VBZ O O
73 with IN B-VP O
73 3+ CD O O
73 edema NN B-NP O
73 as RB O O
73 well RB O O
73 as IN B-VP O
73 areas NNS B-NP O
73 of IN B-VP O
73 erythematous JJ O O
73 and CC O O
74 shiny JJ B-NP O
74 shallow JJ I-NP O
74 ulcerations NNS I-NP O
74 Neurologically RB O O
74 , , O O
74 euthymic JJ O O
74 without IN B-VP O
75 focal JJ B-NP O
75 deficits NNS I-NP O
76 LABORATORY NNP I-NP O
76 DATA: NNP I-NP O
76 On IN B-VP O
76 admission NN B-NP O
76 , , O O
76 significant JJ O O
76 for IN B-VP O
76 sodium NN B-NP O
76 147 CD O O
76 , , O O
77 potassium NN B-NP O
77 3.4 CD O O
77 , , O O
77 chloride RB O O
77 110 CD O O
77 , , O O
77 CO2 NNP B-NP O
77 26 CD O O
77 , , O O
77 BUN NNP B-NP O
77 23 CD O O
77 , , O O
77 creatinine NN B-NP O
77 1.6 CD O O
77 , , O O
77 and CC O O
78 glucose VB O O
78 69 CD O O
78 CBC NNP B-NP O
78 was VBD B-VP O
78 significant JJ O O
78 for IN B-VP O
78 white JJ B-NP O
78 count NN I-NP O
78 of IN B-VP O
78 6.7 CD O O
78 , , O O
79 hematocrit NN B-NP O
79 39.4 CD O O
79 , , O O
79 and CC O O
79 platelets NNS B-NP O
79 of IN B-VP O
79 258 CD O O
79 Her NNP B-NP O
79 CK NNP I-NP O
79 was VBD B-VP O
79 432 CD O O
79 Her NNP B-NP O
80 troponin NN I-NP O
80 was VBD B-VP O
80 less JJR O O
80 than IN B-VP O
80 assay VB O O
80 Her PRP$ O O
80 BNP NNP B-NP O
80 was VBD B-VP O
80 greater JJR O O
80 than IN B-VP O
80 assay NN B-NP O
80 and CC O O
81 D-dimer NNP B-NP O
81 was VBD B-VP O
81 50 CD O O
81 and CC O O
81 69 CD O O
82 Chest NNP B-NP O
82 x-ray NN I-NP O
82 showed VBD B-VP O
82 decreased JJ B-NP O
82 lung NN I-NP O
82 volumes NNS I-NP O
82 with IN B-VP O
82 moderate JJ B-NP O
82 cardiac JJ I-NP O
83 enlargement NN I-NP O
83 EKG NNP I-NP O
83 showed VBD B-VP O
83 sinus JJ B-NP O
83 bradycardia NN I-NP O
83 with IN B-VP O
83 a DT B-NP O
83 rate NN I-NP O
83 of IN B-VP O
83 59 CD O O
83 , , O O
84 axis NN B-NP O
84 of IN B-VP O
84 -36 NNP B-NP O
84 and CC O O
84 no DT B-NP O
84 acute NN I-NP O
84 changes VBZ O O
85 ASSESSMENT: NNP B-NP O
85 This DT O O
85 is VBZ O O
85 a DT B-NP O
85 63-year-old JJ I-NP O
85 woman NN I-NP O
85 with IN B-VP O
85 history NN B-NP O
85 of IN B-VP O
86 congestive JJ B-NP O
86 heart NN I-NP O
86 failure NN I-NP O
86 who WP O O
86 presented VBD B-VP O
86 with IN B-VP O
86 likely JJ B-NP O
86 congestive JJ I-NP O
87 heart NN I-NP O
87 failure NN I-NP O
87 exacerbation NN I-NP O
88 HOSPITAL NNP I-NP O
88 COURSE NNP I-NP O
88 BY NNP I-NP O
88 SYSTEM: NNP I-NP O
89 1 CD O O
89 Cardiovascular: NNP B-NP O
89 Ischemia: NNP I-NP O
89 There EX O O
89 was VBD B-VP O
89 concern NN B-NP O
89 regarding VBG O O
89 acute NN B-NP O
90 and CC O O
90 subacute JJ B-NP O
90 silent NN I-NP O
90 ischemia NN I-NP O
90 given VBN O O
90 new JJ B-NP O
90 ST-T NNP I-NP O
90 wave NN I-NP O
90 changes NNS I-NP O
90 in IN B-VP O
91 lateral JJ B-NP O
91 leads NNS I-NP O
91 on IN B-VP O
91 the DT B-NP O
91 EKG NNP I-NP O
91 The DT B-NP O
91 patient NN I-NP O
91 was VBD B-VP O
91 continued VBN O O
91 on IN B-VP O
91 her PRP$ O O
92 aspirin NN B-NP B-m
92 as RB O O
92 well RB O O
92 as IN B-VP O
92 statin NN B-NP B-m
92 She PRP O O
92 was VBD B-VP O
92 ruled VBN O O
92 out RP O O
92 for IN B-VP O
92 an DT B-NP O
92 MI NNP I-NP O
92 with IN B-VP O
93 negative JJ B-NP O
93 troponins NNS I-NP O
93 x VBP O O
93 3 CD O O
93 She PRP O O
93 was VBD B-VP O
93 continued VBN O O
93 on IN B-VP O
93 a DT B-NP O
93 low-dose JJ I-NP B-do
94 short-acting JJ I-NP O
94 beta-blocker NN I-NP B-m
94 ( ( O I-m
94 Lopressor NNP B-NP I-m
94 ) ) O I-m
94 She PRP O O
94 was VBD B-VP O
94 also RB O O
94 continued VBN O O
94 on IN B-VP O
95 an DT B-NP O
95 ACE NNP I-NP B-m
95 inhibitor NN I-NP I-m
95 with IN B-VP O
95 this DT O O
95 switched VBN O O
95 to TO O O
95 captopril VB O B-m
95 as IN B-VP O
95 a DT B-NP O
96 short-acting JJ I-NP O
96 ACE NNP I-NP B-m
96 inhibitor NN I-NP I-m
96 , , O O
96 which WDT O O
96 was VBD B-VP O
96 titrated VBN O O
96 up RP O O
96 as IN B-VP O
96 tolerated VBN O O
97 for IN B-VP O
97 a DT B-NP B-r
97 goal NN I-NP I-r
97 blood NN I-NP I-r
97 pressure NN I-NP I-r
97 of IN B-VP O
97 systolic NN B-NP O
97 of IN B-VP O
97 120 CD O O
97 An DT B-NP O
97 adenosine NN I-NP B-m
97 MIBI NNP I-NP O
98 was VBD B-VP O
98 performed VBN O O
98 which WDT O O
98 was VBD B-VP O
98 negative JJ O O
98 for IN B-VP O
98 perfusion NN B-NP O
98 defects NNS I-NP O
98 However RB O O
98 , , O O
99 echo VBP O O
99 showed VBN O O
99 global JJ B-NP O
99 hypokinesis NN I-NP O
99 with IN B-VP O
99 depressed JJ B-NP O
99 ejection NN I-NP O
99 fraction NN I-NP O
100 Cardiology NNP I-NP O
100 consult NN I-NP O
100 was VBD B-VP O
100 called VBN O O
100 and CC O O
100 they PRP O O
100 recommended VBD B-VP O
100 further RBR O O
100 workup NN B-NP O
101 with IN B-VP O
101 cardiac JJ B-NP O
101 catheterization NN I-NP O
101 However RB O O
101 , , O O
101 the DT B-NP O
101 patient NN I-NP O
101 refused VBD B-VP O
101 the DT B-NP O
102 catheterization NN I-NP O
103 Rhythm: NNP I-NP O
103 The DT B-NP O
103 patient NN I-NP O
103 has VBZ O O
103 a DT B-NP O
103 history NN I-NP O
103 of IN B-VP O
103 atrial JJ B-NP O
103 fibrillation NN I-NP O
104 However RB O O
104 , , O O
104 she PRP O O
104 remained VBD B-VP O
104 in IN B-VP O
104 normal JJ B-NP O
104 sinus NN I-NP O
104 rhythm NN I-NP O
104 throughout IN B-VP O
104 her PRP$ O O
105 admission NN B-NP O
105 She PRP O O
105 was VBD B-VP O
105 monitored VBN O O
105 by IN B-VP O
105 cardiac JJ B-NP O
105 telemetry NN I-NP O
105 with IN B-VP O
105 several JJ B-NP O
106 episodes NNS I-NP O
106 of IN B-VP O
106 6 CD O O
106 to TO O O
106 10 CD O O
106 beats NNS B-NP O
106 of IN B-VP O
106 nonsustained JJ B-NP O
106 ventricular JJ I-NP O
107 tachycardia NN I-NP O
107 Her PRP$ O O
107 electrolytes NNS B-NP O
107 were VBD B-VP O
107 carefully RB O O
107 monitored VBN O O
107 and CC O O
108 repleted VBN O O
108 as IN B-VP O
108 necessary JJ O O
108 She PRP O O
108 remained VBD B-VP O
108 asymptomatic JJ O O
108 with IN B-VP O
108 the DT B-NP O
108 runs NNS I-NP O
109 of IN B-VP O
109 NSVT NNP B-NP O
109 and CC O O
109 was VBD B-VP O
109 continued VBN O O
109 on IN B-VP O
109 her PRP$ O O
109 beta-blocker NN B-NP B-m
109 Given NNP I-NP O
109 her PRP$ O O
109 history NN B-NP O
110 of IN B-VP O
110 atrial JJ B-NP B-r
110 fibrillation NN I-NP I-r
110 as RB O O
110 well RB O O
110 as IN B-VP O
110 depressed JJ B-NP B-r
110 ejection NN I-NP I-r
110 fraction NN I-NP I-r
110 , , O O
111 she PRP O O
111 was VBD B-VP O
111 restarted VBN O O
111 on IN B-VP O
111 Coumadin NNP B-NP B-m
111 Coumadin NNP I-NP B-m
112 Pump: NNP I-NP O
112 The DT B-NP O
112 patient NN I-NP O
112 presented VBN O O
112 with IN B-VP O
112 a DT B-NP O
112 frank JJ I-NP O
112 fluid NN I-NP O
112 overload NN I-NP O
112 with IN B-VP O
113 elevated JJ B-NP O
113 JVP NNP I-NP O
113 , , O O
113 lower JJR B-NP O
113 extremity NN I-NP O
113 edema NN I-NP O
113 , , O O
113 and CC O O
113 a DT B-NP O
113 BNP NNP I-NP O
113 greater JJR O O
113 than IN B-VP O
114 assay VB O O
114 She PRP O O
114 was VBD B-VP O
114 aggressively RB O O
114 diuresed VBN O O
114 with IN B-VP O
114 a DT B-NP O
114 goal NN I-NP O
114 of IN B-VP O
114 greater JJR O O
114 than IN B-VP O
115 -2 JJR B-NP O
115 liters NNS I-NP O
115 a DT B-NP O
115 day NN I-NP O
115 She PRP O O
115 responded VBD B-VP O
115 to TO O O
115 80 CD O B-do
115 mg NN B-NP I-do
115 of IN B-VP O
115 IV NNP B-NP B-mo
115 Lasix NNP I-NP B-m
115 t.i.d VBD B-VP B-f
115 Her PRP$ O O
116 creatinine NN B-NP O
116 was VBD B-VP O
116 carefully RB O O
116 followed VBN O O
116 and CC O O
116 did VBD B-VP O
116 increase VB O O
116 on IN B-VP O
116 8/21/03 CD O O
116 , , O O
117 at IN B-VP O
117 which WDT O O
117 point NN B-NP O
117 diuresis NN I-NP O
117 was VBD B-VP O
117 put VBN O O
117 on IN B-VP O
117 hold NN B-NP O
117 The DT B-NP O
117 patient NN I-NP O
117 diuresed VBD B-VP O
118 about RB O O
118 3 CD O O
118 to TO O O
118 4 CD O O
118 liters NNS B-NP O
118 each DT B-NP O
118 day NN I-NP O
118 during IN B-VP O
118 her PRP$ O O
118 hospital JJ B-NP O
118 stay NN I-NP O
118 until IN B-VP O
119 2/16/03 CD O O
119 At IN B-VP O
119 this DT B-NP O
119 point NN I-NP O
119 , , O O
119 she PRP O O
119 was VBD B-VP O
119 thought VBN O O
119 to TO O O
119 be VB O O
119 very RB O O
119 close RB O O
119 to TO O O
120 euvolemic VB O O
121 Given NNP B-NP O
121 the DT B-NP O
121 patient's NN I-NP O
121 echo JJ B-NP O
121 findings NNS I-NP O
121 with IN B-VP O
121 depressed JJ B-NP O
121 ejection NN I-NP O
122 fraction NN I-NP O
122 and CC O O
122 global JJ B-NP O
122 hypokinesis NN I-NP O
122 , , O O
122 a DT B-NP O
122 workup NN I-NP O
122 for IN B-VP O
122 dilated VBN O O
123 cardiomyopathy NN B-NP O
123 was VBD B-VP O
123 begun VBN O O
123 The DT B-NP O
123 patient NN I-NP O
123 did VBD B-VP O
123 not RB O O
123 wish VB O O
123 for IN B-VP O
123 further JJ B-NP O
124 investigation NN I-NP O
124 with IN B-VP O
124 cardiac JJ B-NP O
124 catheterization NN I-NP O
124 or CC O O
124 a DT B-NP O
124 cardiac JJ I-NP O
124 MRI NNP I-NP O
124 Her NNP I-NP O
125 other JJ B-NP O
125 labs NN I-NP O
125 were VBD B-VP O
125 unremarkable JJ O O
125 including VBG O O
125 a DT B-NP O
125 TSH NNP I-NP O
125 , , O O
125 which WDT O O
125 was VBD B-VP O
125 normal JJ O O
125 , , O O
126 an DT B-NP O
126 ANA NNP I-NP O
126 which WDT O O
126 was VBD B-VP O
126 negative JJ O O
126 , , O O
126 iron NN B-NP O
126 studies NNS I-NP O
126 which WDT O O
126 did VBD B-VP O
126 not RB O O
126 show VB O O
126 iron NN B-NP O
127 overload NN I-NP O
127 , , O O
127 and CC O O
127 thiamine NN B-NP O
127 which WDT O O
127 is VBZ O O
127 pending VBG O O
127 at IN B-VP O
127 the DT B-NP O
127 time NN I-NP O
127 of IN B-VP O
127 this DT B-NP O
128 dictation NN I-NP O
128 The DT B-NP O
128 patient NN I-NP O
128 will MD O O
128 require VB O O
128 close JJ B-NP O
128 followup NNS I-NP O
128 with IN B-VP O
128 careful JJ B-NP O
129 fluid JJ I-NP O
129 balance NN I-NP O
129 monitoring NN I-NP O
129 as RB O O
129 well RB O O
129 as IN B-VP O
129 followup NN B-NP O
129 with IN B-VP O
129 congestive JJ B-NP O
130 heart NN I-NP O
130 failure NN I-NP O
130 service NN I-NP O
131 Pulmonary: NNP I-NP O
131 She PRP O O
131 initially RB O O
131 presented VBD B-VP O
131 with IN B-VP O
131 shortness NN B-NP O
131 of IN B-VP O
131 breath NN B-NP O
132 However RB O O
132 , , O O
132 this DT O O
132 resolved VBN O O
132 with IN B-VP O
132 diuresis NN B-NP O
132 She PRP O O
132 has VBZ O O
132 a DT B-NP O
132 history NN I-NP O
132 of IN B-VP O
132 PE NNP B-NP O
132 as RB O O
133 well RB O O
133 as IN B-VP O
133 DVT NNP B-NP O
133 and CC O O
133 an DT B-NP O
133 elevated JJ I-NP O
133 dimer NN I-NP O
133 was VBD B-VP O
133 found VBN O O
133 on IN B-VP O
133 admission NN B-NP O
133 There EX O O
134 was VBD B-VP O
134 initial JJ B-NP O
134 concern NN I-NP O
134 for IN B-VP O
134 pulmonary JJ B-NP O
134 embolism NN I-NP O
134 , , O O
134 but CC O O
134 the DT B-NP O
134 resolution NN I-NP O
134 of IN B-VP O
135 symptoms NNS B-NP O
135 with IN B-VP O
135 diuresis NN B-NP O
135 and CC O O
135 a DT B-NP O
135 history NN I-NP O
135 that WDT O O
135 was VBD B-VP O
135 not RB O O
135 suggestive JJ O O
135 of IN B-VP O
136 pulmonary JJ B-NP O
136 emboli NN I-NP O
136 , , O O
136 did VBD B-VP O
136 not RB O O
136 require VB O O
136 further JJ B-NP O
136 followup NN I-NP O
136 with IN B-VP O
136 spiral JJ B-NP O
137 chest NN I-NP O
137 CT NNP I-NP O
138 Heme: NNP I-NP O
138 The DT B-NP O
138 patient's NN I-NP O
138 hematocrit NN I-NP O
138 was VBD B-VP O
138 followed VBN O O
138 The DT B-NP O
138 patient NN I-NP O
138 has VBZ O O
139 chronic JJ B-NP B-r
139 folate NN I-NP I-r
139 and CC O O
139 iron-deficiency NN B-NP B-r
139 anemia NN I-NP I-r
139 and CC O O
139 she PRP O O
139 was VBD B-VP O
139 continued VBN O O
140 on IN B-VP O
140 folate NN B-NP B-m
140 and CC O O
140 iron NN B-NP B-m
140 replacement NN I-NP O
141 Endocrine: NNP I-NP O
141 The DT B-NP O
141 patient NN I-NP O
141 was VBD B-VP O
141 continued VBN O O
141 on IN B-VP O
141 NPH NNP B-NP B-m
141 20 CD O B-do
141 units NNS B-NP I-do
141 for IN B-VP O
141 her PRP$ O B-r
142 known JJ O O
142 diabetes VBZ O O
142 Her PRP$ O O
142 blood NN B-NP O
142 sugars NNS I-NP O
142 were VBD B-VP O
142 in IN B-VP O
142 excellent JJ B-NP O
142 control NN I-NP O
142 on IN B-VP O
143 this DT B-NP O
143 regimen JJ I-NP O
143 Avandia NNP I-NP B-m
143 was VBD B-VP O
143 held VBN O O
143 given VBN O O
143 it PRP O O
143 contraindication NN B-NP O
143 in IN B-VP O
144 heart NN B-NP O
144 failure NN I-NP O
145 Renal: NNP I-NP O
145 The DT B-NP O
145 patient's NN I-NP O
145 creatinine NN I-NP O
145 was VBD B-VP O
145 1.6 CD O O
145 on IN B-VP O
145 admission NN B-NP O
145 , , O O
145 which WDT O O
145 is VBZ O O
145 up IN B-VP O
146 from IN B-VP O
146 about IN B-VP O
146 0.8 CD O O
146 in IN B-VP O
146 March NNP B-NP O
146 of IN B-VP O
146 2003 CD O O
146 Her NNP B-NP O
146 urine NN I-NP O
146 eosinophils NNS I-NP O
146 and CC O O
147 sediment NN B-NP O
147 were VBD B-VP O
147 unremarkable JJ O O
147 , , O O
147 but CC O O
147 frank VBD B-VP O
147 proteinuria NNS B-NP O
147 was VBD B-VP O
147 noted VBN O O
147 which WDT O O
148 is VBZ O O
148 consistent JJ O O
148 with IN B-VP O
148 her PRP$ O O
148 known VBN O O
148 nephrotic JJ B-NP O
148 syndrome NN I-NP O
148 Her NNP I-NP O
148 creatinine NN I-NP O
149 remained VBD B-VP O
149 stable JJ O O
149 in IN B-VP O
149 the DT O O
149 1.5 CD O O
149 to TO O O
149 1.6 CD O O
149 range NN B-NP O
149 until IN B-VP O
149 8/21/03 CD O O
149 , , O O
149 when WRB O O
149 her PRP$ O O
150 creatinine NN B-NP O
150 bumped VBD B-VP O
150 to TO O O
150 2 CD O O
150 and CC O O
150 kept VBD B-VP O
150 rising VBG O O
150 until IN B-VP O
150 8/3/03 CD O O
150 , , O O
150 when WRB O O
150 it PRP O O
151 reached VBD B-VP O
151 2.7 CD O O
151 Repeat NNP B-NP O
151 urine JJ B-NP O
151 electrolytes NNS I-NP O
151 , , O O
151 urine JJ B-NP O
151 eosinophils NNS I-NP O
151 and CC O O
152 sediment NN B-NP O
152 were VBD B-VP O
152 sent VBN O O
152 at IN B-VP O
152 this DT B-NP O
152 point NN I-NP O
152 and CC O O
152 they PRP O O
152 are VBP O O
152 pending VBG O O
152 at IN B-VP O
152 the DT B-NP O
152 time NN I-NP O
153 of IN B-VP O
153 this DT B-NP O
153 dictation NN I-NP O
153 The DT O O
153 most RBS O O
153 likely JJ B-NP O
153 explanation NN I-NP O
153 for IN B-VP O
153 increasing VBG O O
154 creatinine NN B-NP O
154 was VBD B-VP O
154 aggressive JJ B-NP O
154 diuresis NN I-NP O
154 and CC O O
154 intravascular JJ B-NP O
154 volume NN I-NP O
155 depletion NN I-NP O
155 Diuresis NNP I-NP O
155 was VBD B-VP O
155 put VBN O O
155 on IN B-VP O
155 hold NN B-NP O
155 on IN B-VP O
155 3/15/03 CD O O
155 and CC O O
155 10/5/03 CD O O
156 Given NNP B-NP O
156 her PRP$ O O
156 increased JJ B-NP O
156 creatinine NN I-NP O
156 , , O O
156 her PRP$ O O
156 ACE NNP B-NP B-m
156 inhibitor NN I-NP I-m
156 dose NN I-NP O
156 was VBD B-VP O
156 halfed VBN O O
157 on IN B-VP O
157 10/5/03 CD O O
157 The DT B-NP O
157 plan NN I-NP O
157 is VBZ O O
157 to TO O O
157 continue VB O O
157 to TO O O
157 monitor VB O O
157 her PRP$ O O
157 creatinine NN B-NP O
158 function NN I-NP O
158 , , O O
158 follow VBP O O
158 up RP O O
158 on IN B-VP O
158 her PRP$ O O
158 urine JJ B-NP O
158 chemistries NNS I-NP O
158 and CC O O
158 if IN B-VP O
158 her PRP$ O O
159 creatinine NN B-NP O
159 resolves NNS I-NP O
159 , , O O
159 to TO O O
159 resume VB O O
159 gentle JJ B-NP O
159 diuresis NN I-NP O
159 as IN B-VP O
159 necessary JJ B-NP O
160 Infectious NNP I-NP O
160 Disease: NNP I-NP O
160 The DT B-NP O
160 patient NN I-NP O
160 was VBD B-VP O
160 found VBN O O
160 to TO O O
160 have VB O O
160 a DT O B-r
160 a DT B-NP B-r
160 UTI NNP I-NP I-r
160 UTI NNP I-NP I-r
160 with IN B-VP O
160 E NNP B-NP O
161 Coli NNP I-NP O
161 that WDT O O
161 was VBD B-VP O
161 sensitive JJ O O
161 to TO O O
161 Bactrim NNP B-NP B-m
161 and CC O O
161 she PRP O O
161 was VBD B-VP O
161 treated VBN O O
161 with IN B-VP O
162 Bactrim NNP B-NP B-m
162 with IN B-VP O
162 resolution NN B-NP O
163 Rheumatological: NNP I-NP O
163 The DT B-NP O
163 patient NN I-NP O
163 with IN B-VP O
163 known VBN O O
163 chronic JJ B-NP O
163 pain NN I-NP O
163 as RB O O
163 well RB O O
163 as IN B-VP O
164 arthritis NN B-NP O
164 Her NNP I-NP O
164 Celebrex NNP I-NP B-m
164 was VBD B-VP O
164 held VBN O O
164 given VBN O O
164 her PRP$ O O
164 increased JJ B-NP O
164 creatinine NN I-NP O
165 and CC O O
165 its PRP$ O O
165 propensity NN B-NP O
165 to TO O O
165 cause VB O O
165 fluid JJ B-NP O
165 retention NN I-NP O
165 Her PRP$ O O
165 joint JJ B-NP O
165 exam NN I-NP O
166 revealed VBD B-VP O
166 swollen JJ B-NP O
166 PIP NNP I-NP O
166 joints NNS I-NP O
166 of IN B-VP O
166 both DT B-NP O
166 hands NNS I-NP O
166 as RB O O
166 well RB O O
166 as IN B-VP O
166 marked VBN O O
167 swelling NN B-NP O
167 over IN B-VP O
167 both DT B-NP O
167 wrists NNS I-NP O
167 A VBP O O
167 rheumatoid JJ B-NP O
167 factor NN I-NP O
167 was VBD B-VP O
167 sent VBN O O
167 and CC O O
167 that IN B-VP O
168 came VBD B-VP O
168 back RB O O
168 negative JJ O O
168 For IN B-VP O
168 her PRP$ O B-r
168 pain NN B-NP I-r
168 , , O O
168 she PRP O O
168 was VBD B-VP O
168 given VBN O O
168 oxycodone RP O B-m
168 p.r.n JJ O B-f
169 Once RB O O
169 her PRP$ O O
169 acute JJ B-NP O
169 renal JJ I-NP O
169 failure NN I-NP O
169 resolves NNS I-NP O
169 , , O O
169 she PRP O O
169 may MD O O
169 be VB O O
169 transitioned VBN O O
170 to TO O O
170 Celebrex NNP B-NP B-m
170 or CC O O
170 other JJ B-NP O
170 antiinflammatory NN I-NP B-m
170 medications NNS I-NP I-m
170 which WDT O O
170 may MD O O
170 be VB O O
171 more JJR O O
171 effected JJ O O
171 for IN B-VP O
171 her PRP$ O B-r
171 arthritis NN B-NP I-r
171 arthritis NN I-NP B-r
171 ANA NNP I-NP O
171 came VBD B-VP O
171 back RB O O
171 negative JJ B-NP O
172 Psyche: NNP I-NP O
172 She PRP O O
172 was VBD B-VP O
172 continued VBN O O
172 on IN B-VP O
172 Celexa NNP B-NP B-m
172 for IN B-VP O
172 depression NN B-NP B-r
173 Code NNP I-NP O
173 status: CC O O
173 Full NNP B-NP O
173 code NN I-NP O
174 FOLLOWUP: NNP I-NP O
174 The DT B-NP O
174 patient NN I-NP O
174 needs VBZ O O
174 to TO O O
174 follow VB O O
174 up RP O O
174 with IN B-VP O
174 the DT B-NP O
174 congestive JJ I-NP O
175 heart NN I-NP O
175 failure NN I-NP O
175 service NN I-NP O
175 as RB O O
175 well RB O O
175 as IN B-VP O
175 her PRP$ O O
175 primary JJ B-NP O
175 care NN I-NP O
175 physician JJ B-NP O
176 DISCHARGE NNP I-NP O
176 MEDICATIONS NNP I-NP O
176 ( ( O O
176 at IN B-VP O
176 the DT B-NP O
176 time NN I-NP O
176 of IN B-VP O
176 this DT B-NP O
176 dictation NN I-NP O
176 on IN B-VP O
177 8/3/03 CD O O
177 ): JJ O O
178 1 CD O O
178 Aspirin NNP B-NP B-m
178 81 CD O B-do
178 mg NN B-NP I-do
178 p.o NN I-NP B-mo
178 q.d VBD B-VP B-f
179 2 CD O O
179 Colace NNP B-NP B-m
179 100 CD O B-do
179 mg NN B-NP I-do
179 p.o NN I-NP B-mo
179 b.i.d NN I-NP B-f
180 3 CD O O
180 Iron NNP B-NP B-m
180 sulfate NN I-NP I-m
180 325 CD O B-do
180 mg NN B-NP I-do
180 p.o NN I-NP B-mo
180 q.d VBD B-VP B-f
181 4 CD O O
181 Prozac NNP B-NP B-m
181 20 CD O B-do
181 mg NN B-NP I-do
181 p.o NN I-NP B-mo
181 q.d VBD B-VP B-f
182 5 CD O O
182 Folate NNP B-NP B-m
182 1 CD O B-do
182 mg NN B-NP I-do
182 p.o NN I-NP B-mo
182 q.d VBD B-VP B-f
183 6 CD O O
183 Lasix NNP B-NP B-m
183 160 CD O B-do
183 mg NN B-NP I-do
183 p.o NN I-NP B-mo
183 q.d NN I-NP B-f
183 ( ( O O
183 this DT B-NP O
183 dose NN I-NP O
183 was VBD B-VP O
183 held VBN O O
183 on IN B-VP O
183 3/15/03 CD O O
183 and CC O O
184 8/3/03 CD O O
184 and CC O O
184 should MD O O
184 be VB O O
184 held VBN O O
184 until IN B-VP O
184 creatinine JJ B-NP O
184 increases NNS I-NP O
184 and CC O O
185 restarted VBN O O
185 once RB O O
185 symptoms NNS B-NP O
185 and CC O O
185 sign NN B-NP O
185 of IN B-VP O
185 fluid NN B-NP O
185 overload NN I-NP O
185 occur NN I-NP O
185 ) ) O O
186 7 CD O O
186 NPH NNP B-NP B-m
186 human JJ B-NP I-m
186 insulin NN I-NP I-m
186 20 CD O B-do
186 units NNS B-NP I-do
186 subcu VBD B-VP B-mo
186 q.p.m RB O B-f
187 8 CD O O
187 Zestril NNP B-NP B-m
187 30 CD O B-do
187 mg NN B-NP I-do
187 p.o NN I-NP B-mo
187 q.d VBD B-VP B-f
188 9 CD O O
188 Oxycodone NNP B-NP B-m
188 5 CD O B-do
188 mg NN B-NP I-do
188 to TO O I-do
188 10 CD O I-do
188 mg NNS B-NP I-do
188 p.o JJ B-NP B-mo
188 q.4-6h JJ I-NP B-f
188 p.r.n NN I-NP I-f
188 pain NN I-NP B-r
189 10 CD O O
189 Senna NNP B-NP B-m
189 tablets NNS I-NP I-m
189 2 CD O B-do
189 mg NNS B-NP I-do
189 p.o JJ O B-mo
189 b.i.d RB O B-f
190 11 CD O O
190 Aldactone NNP B-NP B-m
190 25 CD O B-do
190 mg NN B-NP I-do
190 p.o NN I-NP B-mo
190 q.d NN I-NP B-f
190 ( ( O O
190 this DT B-NP B-m
190 medication NN I-NP I-m
190 was VBD B-VP O
190 held VBN O O
190 on IN B-VP O
191 3/15/03 CD O O
191 and CC O O
191 8/3/03 CD O O
191 given VBN O O
191 increasing VBG O O
191 creatinine NN B-NP O
191 and CC O O
191 should MD O O
191 be VB O O
192 held VBN O O
192 until IN B-VP B-du
192 creatinine JJ B-NP I-du
192 decreases NNS I-NP I-du
192 ) ) O O
193 12 CD O O
193 Multivitamins NNS B-NP B-m
193 with IN B-VP I-m
193 minerals NNS B-NP I-m
193 one CD O B-do
193 tablet NN B-NP I-do
193 p.o NN I-NP B-mo
193 q.d VBD B-VP B-f
194 13 CD O O
194 Coumadin NNP B-NP B-m
194 5 CD O B-do
194 mg NN B-NP I-do
194 p.o NN I-NP B-mo
194 q.h.s VBD B-VP B-f
195 14 CD O O
195 Zocor NNP B-NP B-m
195 40 CD O B-do
195 mg NN B-NP I-do
195 p.o NN I-NP B-mo
195 q.h.s VBD B-VP B-f
196 15 CD O O
196 Toprol NNP B-NP B-m
196 XL NNP I-NP I-m
196 p.o NN I-NP B-mo
196 q.d NN I-NP B-f
197 16 CD O O
197 Imdur NNP B-NP B-m
197 30 CD O B-do
197 mg NN B-NP I-do
197 p.o NN I-NP B-mo
197 q.d VBD B-VP B-f
198 17 CD O O
198 Bactrim NNP B-NP B-m
198 one CD O B-do
198 tablet NN B-NP I-do
198 p.o NN I-NP B-mo
198 b.i.d NN I-NP B-f
198 for IN B-VP B-du
198 7 CD O I-du
198 days NNS B-NP I-du
198 ( ( O O
198 started VBN O O
198 on IN B-VP O
199 4/12/03 CD O O
199 ) ) O O
200 18 CD O O
200 Prednisolone NNP B-NP B-m
200 acetate NN I-NP I-m
200 0.125% CD O I-m
200 one CD O B-do
200 drop NN B-NP I-do
200 OU NNP I-NP B-mo
200 q.i.d VBZ O B-f
201 19 CD O O
201 Nexium NN B-NP B-m
201 40 CD O B-do
201 mg NN B-NP I-do
201 p.o NN I-NP B-mo
201 q.d VBD B-VP B-f
202 20 CD O O
202 Albuterol NNP B-NP B-m
202 inhaler NN I-NP I-m
202 2 CD O B-do
202 puffs NNS B-NP I-do
202 inhaler JJ B-NP B-mo
202 q.i.d NN I-NP B-f
202 p.r.n NN I-NP I-f
202 wheezing VBG O B-r
203 21 CD O O
203 Miconazole NNP B-NP B-m
203 nitrate JJ B-NP I-m
203 powder NN I-NP I-m
203 topical JJ B-NP B-mo
203 b.i.d NN I-NP B-f
203 p.r.n NN I-NP I-f
204 ADDENDUM: NNP I-NP O
204 The DT B-NP O
204 patient NN I-NP O
204 was VBD B-VP O
204 restarted VBN O O
204 on IN B-VP O
204 Coumadin NNP B-NP B-m
204 on IN B-VP O
204 4/12/03 CD O O
204 for IN B-VP O
205 known VBN O B-r
205 paroxysmal JJ B-NP I-r
205 atrial JJ I-NP I-r
205 fibrillation NN I-NP I-r
205 Her NNP I-NP O
205 INR NNP I-NP O
205 needs VBZ O O
205 monitoring NN B-NP O
206 with IN B-VP O
206 a DT B-NP O
206 goal NN I-NP O
206 INR NNP I-NP O
206 of IN B-VP O
206 2 CD O O
206 to TO O O
206 3 CD O O
207 The DT B-NP O
207 patient's NN I-NP O
207 discharge NN I-NP O
207 is VBZ O O
207 pending VBG O O
207 resolution NN B-NP O
207 of IN B-VP O
207 acute JJ B-NP O
207 renal JJ I-NP O
208 failure NN I-NP O
208 At IN B-VP O
208 the DT B-NP O
208 time NN I-NP O
208 of IN B-VP O
208 this DT B-NP O
208 dictation NN I-NP O
208 , , O O
208 creatinine NN B-NP O
208 is VBZ O O
208 still RB O O
209 elevated VBN O O
209 and CC O O
209 this DT B-NP O
209 dictation NN I-NP O
209 will MD O O
209 be VB O O
209 updated VBN O O
209 with IN B-VP O
209 medications NNS B-NP O
209 as RB O O
210 well RB O O
210 as IN B-VP O
210 a DT B-NP O
210 course NN I-NP O
210 of IN B-VP O
210 resolution NN B-NP O
210 of IN B-VP O
210 her PRP$ O O
210 acute JJ B-NP O
210 renal JJ I-NP O
210 failure NN I-NP O
211 eScription NN I-NP O
211 document: VBZ O O
211 2-6024257 JJ B-NP O
211 ISSten NNP I-NP O
211 Tel NNP I-NP O
212 Dictated NNP I-NP O
212 By: NNP I-NP O
212 WINDOVER NNP I-NP O
212 , , O O
212 COURTNEY NNP B-NP O
213 Attending: NNP I-NP O
213 FLOCKHART NNP I-NP O
213 , , O O
213 JAKE NNP B-NP O
214 Dictation NNP I-NP O
214 ID NNP I-NP O
214 0246887 CD O O
215 D: NNP B-NP O
215 8/3/03 CD O O
216 T: NNP B-NP O
216 8/3/03 CD O O
217 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #28218 VBZ O O
4 325114627 CD O O
4 TVMC NNP B-NP O
4 43861883 CD O O
4 9103772 CD O O
4 5/0/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 URINARY NNP I-NP O
4 TRACT NNP I-NP O
4 INFECTION NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 8/28/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/17/2006 CD O O
7 ATTENDING: NNP B-NP O
7 VENIER NNP I-NP O
7 , , O O
7 IRWIN NNP B-NP O
7 MD NNP I-NP O
8 INTERIM NNP I-NP O
8 SUMMARY NNP I-NP O
9 DATE NNP I-NP O
9 OF NNP I-NP O
9 DISCHARGE: NNP I-NP O
9 To TO O O
9 be VB O O
9 determined VBN O O
10 ADMISSION NNP B-NP O
10 DIAGNOSIS: NNP I-NP O
10 Altered NNP I-NP O
10 mental JJ B-NP O
10 status NN I-NP O
11 DISCHARGE NNP I-NP O
11 DIAGNOSIS: NNP I-NP O
11 Altered NNP I-NP O
11 mental JJ B-NP O
11 status NN I-NP O
12 SECONDARY NNP I-NP O
12 DIAGNOSES: NNP I-NP O
13 1 CD O O
13 Non-small NNP B-NP O
13 cell NN I-NP O
13 lung NN I-NP O
13 cancer NN I-NP O
14 2 CD O O
14 Right NNP B-NP O
14 MCA NNP I-NP O
14 embolic JJ O O
14 stroke VBD B-VP O
15 3 CD O O
15 Graves' NNP B-NP O
15 disease NN I-NP O
16 4 CD O O
16 Depression NNP B-NP O
17 5 CD O O
17 Attention NNP B-NP O
17 deficit NN I-NP O
17 disorder NN I-NP O
18 6 CD O O
18 Hypertension NNP B-NP O
19 7 CD O O
19 Asthma NNP B-NP O
20 8 CD O O
20 Temporal NNP B-NP O
20 lobe NN I-NP O
20 epilepsy NN I-NP O
21 9 CD O O
21 History NNP B-NP O
21 of IN B-VP O
21 subclavian JJ B-NP O
21 steal JJ I-NP O
21 syndrome NN I-NP O
22 10 CD O O
22 Urinary NNP B-NP O
22 tract JJ B-NP O
22 infection NN I-NP O
23 HISTORY NNP I-NP O
23 OF NNP I-NP O
23 PRESENT NNP I-NP O
23 ILLNESS: NNP I-NP O
23 This DT O O
23 is VBZ O O
23 a DT B-NP O
23 64-year-old JJ I-NP O
23 lady NN I-NP O
23 who WP O O
23 has VBZ O O
23 a DT B-NP O
24 past JJ I-NP O
24 medical JJ I-NP O
24 history NN I-NP O
24 of IN B-VP O
24 right JJ B-NP O
24 upper JJ I-NP O
24 lobe NN I-NP O
24 lung NN I-NP O
24 cancer NN I-NP O
24 , , O O
24 status NN B-NP O
24 post NN I-NP O
25 chemotherapy NN I-NP O
25 x2 NN I-NP O
25 cycles NNS I-NP O
25 , , O O
25 as RB O O
25 well RB O O
25 as IN B-VP O
25 x-ray JJ B-NP O
25 therapy NN I-NP O
25 Her NNP I-NP O
26 chemotherapy NN I-NP O
26 has VBZ O O
26 included VBN O O
26 VP-16 NNP B-NP B-m
26 and CC O O
26 cisplatin VB O B-m
26 She PRP O O
26 is VBZ O O
26 status NN B-NP O
27 post NN I-NP O
27 a DT B-NP O
27 large JJ I-NP O
27 right NN I-NP O
27 middle JJ B-NP O
27 cerebral JJ I-NP O
27 artery NN I-NP O
27 stroke NN I-NP O
27 in IN B-VP O
27 10/22 CD O O
27 , , O O
28 status NN B-NP O
28 post NN I-NP O
28 a DT B-NP O
28 right JJ I-NP O
28 carotid NN I-NP O
28 endarterectomy NN I-NP O
28 on IN B-VP O
28 0/23/06 CD O O
28 She PRP O O
28 has VBZ O O
29 been VBN O O
29 at IN B-VP O
29 the DT B-NP O
29 Neot NNP I-NP O
29 Addy NNP I-NP O
29 Hospital NNP I-NP O
29 since IN B-VP O
29 her PRP$ O O
29 last JJ B-NP O
29 Ry NNP I-NP O
29 Hospital NNP I-NP O
29 admission NN I-NP O
29 She PRP O O
29 was VBD B-VP O
29 there RB O O
29 for IN B-VP O
29 stroke NN B-NP O
29 rehabilitation NN I-NP O
29 and CC O O
30 completed VBD B-VP O
30 a DT B-NP B-du
30 ten-day JJ I-NP I-du
30 course NN I-NP I-du
30 of IN B-VP O
30 vancomycin NN B-NP B-m
30 for IN B-VP O
30 a DT B-NP B-r
30 MRSA NNP I-NP O
30 urinary JJ B-NP O
30 tract NN I-NP O
31 infection NN I-NP O
31 She PRP O O
31 was VBD B-VP O
31 found VBN O O
31 , , O O
31 on IN B-VP O
31 the DT B-NP O
31 day NN I-NP O
31 of IN B-VP O
31 admission NN B-NP O
31 , , O O
31 by IN B-VP O
31 her PRP$ O O
31 son NN B-NP O
31 to TO O O
32 be VB O O
32 difficult JJ O O
32 to TO O O
32 arouse VB O O
32 The DT B-NP O
32 patient NN I-NP O
32 was VBD B-VP O
32 brought VBN O O
32 to TO O O
32 the DT B-NP O
32 Dalupe NNP I-NP O
32 Health NNP I-NP O
32 Systems NNP I-NP O
32 by IN B-VP O
32 Emergency NNP B-NP O
32 Services NNPS I-NP O
32 The DT B-NP O
32 blood NN I-NP O
32 pressure NN I-NP O
32 was VBD B-VP O
32 66/44 CD O O
32 , , O O
32 a DT B-NP O
33 pulse NN I-NP O
33 of IN B-VP O
33 100 CD O O
33 , , O O
33 a DT B-NP O
33 respiratory NN I-NP O
33 rate NN I-NP O
33 that WDT O O
33 was VBD B-VP O
33 normal JJ O O
33 and CC O O
33 blood NN B-NP O
33 sugar NN I-NP O
34 of IN B-VP O
34 133 CD O O
34 She PRP O O
34 denied VBD B-VP O
34 complaints NNS B-NP O
34 of IN B-VP O
34 chest NN B-NP O
34 pain NN I-NP O
34 , , O O
34 shortness NN B-NP O
34 of IN B-VP O
35 breath NN B-NP O
35 , , O O
35 nausea NN B-NP O
35 , , O O
35 vomiting VBG O O
35 , , O O
35 diaphoresis NN B-NP O
35 She PRP O O
35 denied VBD B-VP O
35 any DT B-NP O
35 other JJ I-NP O
36 pain NN I-NP O
37 PAST NNP I-NP O
37 MEDICAL NNP I-NP O
37 HISTORY: NNP I-NP O
38 1 CD O O
38 Non-small NNP B-NP O
38 cell NN I-NP O
38 lung NN I-NP O
38 cancer NN I-NP O
38 , , O O
38 diagnosed VBD B-VP O
38 7/24 CD O O
38 , , O O
38 stage NN B-NP O
38 3 CD O O
38 , , O O
39 present NN B-NP O
39 in IN B-VP O
39 the DT B-NP O
39 right JJ I-NP O
39 upper NN I-NP O
39 lung NN I-NP O
39 , , O O
39 status NN B-NP O
39 post NN I-NP O
39 neoadjuvant JJ B-NP O
39 XRT NNP I-NP O
39 and CC O O
40 two CD O O
40 cycles NNS B-NP O
40 of IN B-VP O
40 chemotherapy NN B-NP O
41 2 CD O O
41 Right NNP B-NP O
41 MC NNP I-NP O
41 embolic JJ B-NP O
41 stroke NN I-NP O
41 in IN B-VP O
41 4/10 CD O O
42 3 CD O O
42 Status NNP B-NP O
42 post NN I-NP O
42 right RB O O
42 carotid VBZ O O
42 endarterectomy NN B-NP O
42 on IN B-VP O
42 0/23/06 CD O O
43 4 CD O O
43 Graves NNS B-NP O
43 disease VBD B-VP O
44 5 CD O O
44 Depression NNP B-NP O
45 6 CD O O
45 Diabetes VBZ O O
46 7 CD O O
46 Hypertension NNP B-NP O
47 8 CD O O
47 Asthma NNP B-NP O
48 9 CD O O
48 Temporal NNP B-NP O
48 lobe NN I-NP O
48 epilepsy NN I-NP O
49 10 CD O O
49 History NNP B-NP O
49 of IN B-VP O
49 subclavian JJ B-NP O
49 steal NN I-NP O
49 syndrome NN I-NP O
50 PAST NNP I-NP O
50 SURGICAL NNP I-NP O
50 HISTORY: NNP I-NP O
51 1 CD O O
51 Bilateral NNP B-NP O
51 salpingo-oophorectomy JJ O O
51 30 CD O O
51 years NNS B-NP O
51 ago RB O O
52 2 CD O O
52 History NNP B-NP O
52 of IN B-VP O
52 radioactive JJ B-NP O
52 iodine NN I-NP O
52 for IN B-VP O
52 Graves' NNP B-NP O
52 disease NN I-NP O
52 30 CD O O
52 years NNS B-NP O
53 ago RB O O
54 PHYSICAL NNP B-NP O
54 EXAMINATION NNP I-NP O
54 ON NNP I-NP O
54 ADMISSION: NNP I-NP O
54 Notable NNP I-NP O
54 for IN B-VP O
54 being VBG O O
54 alert JJ O O
54 and CC O O
55 oriented JJ B-NP O
55 x2 NN I-NP O
55 , , O O
55 nonconversant JJ O O
55 , , O O
55 angry JJ O O
55 and CC O O
55 in IN B-VP O
55 pain JJ B-NP O
55 Neurological NNP I-NP O
55 exam NN I-NP O
56 was VBD B-VP O
56 notable JJ O O
56 for IN B-VP O
56 a DT B-NP O
56 left JJ I-NP O
56 upper JJ I-NP O
56 femoral JJ I-NP O
56 paralysis NN I-NP O
56 with IN B-VP O
56 increased JJ B-NP O
57 deep JJ I-NP O
57 tendon NN I-NP O
57 reflex NN I-NP O
57 on IN B-VP O
57 the DT B-NP O
57 left NN I-NP O
57 , , O O
57 bilateral JJ B-NP O
57 lower JJR I-NP O
57 extremities NNS I-NP O
57 with IN B-VP O
58 2+ CD O O
58 Achilles NNS B-NP O
58 patellar JJ B-NP O
58 reflexes NNS I-NP O
58 Her PRP$ O O
58 heart NN B-NP O
58 was VBD B-VP O
58 tachycardic JJ O O
58 , , O O
58 but CC O O
58 no DT B-NP O
59 murmurs NN I-NP O
59 , , O O
59 rubs NN B-NP O
59 or CC O O
59 gallops NNS B-NP O
59 Lungs NNS I-NP O
59 were VBD B-VP O
59 clear JJ O O
59 to TO O O
59 auscultation VB O O
60 except IN B-VP O
60 for IN B-VP O
60 bibasilar JJ B-NP O
60 rales NNS I-NP O
60 Her PRP$ O O
60 abdomen NNS B-NP O
60 was VBD B-VP O
60 full JJ O O
60 , , O O
60 nontender NN B-NP O
60 and CC O O
61 nondistended VBD B-VP O
61 Her NNP B-NP O
61 extremities NNS I-NP O
61 had VBD B-VP O
61 no DT B-NP O
61 cyanosis NN I-NP O
61 or CC O O
61 edema NN B-NP O
61 and CC O O
61 had VBD B-VP O
62 2+ CD O O
62 DP NNP B-NP O
62 pulses NNS I-NP O
62 In IN B-VP O
62 the DT B-NP O
62 emergency NN I-NP O
62 room NN I-NP O
62 , , O O
62 her PRP$ O O
62 pulse NN B-NP O
62 was VBD B-VP O
62 100 CD O O
62 and CC O O
62 her PRP$ O O
63 blood NN B-NP O
63 pressure NN I-NP O
63 was VBD B-VP O
63 148/60 CD O O
63 She PRP O O
63 was VBD B-VP O
63 somnolent JJ O O
63 She PRP O O
63 had VBD B-VP O
63 1 CD O B-do
63 gm NN B-NP I-do
63 of IN B-VP O
64 vancomycin NN B-NP B-m
64 , , O O
64 magnesium NN B-NP B-m
64 and CC O O
64 Levaquin NNP B-NP B-m
64 500 CD O B-do
64 mg NN B-NP I-do
65 ALLERGIES: NNP I-NP O
65 Penicillin NNP I-NP O
65 , , O O
65 for IN B-VP O
65 which WDT O O
65 she PRP O O
65 has VBZ O O
65 a DT B-NP O
65 hive JJ I-NP O
65 reaction; NN I-NP O
66 valproic NN I-NP O
66 acid NN I-NP O
66 , , O O
66 sulfa NN B-NP O
66 drugs NNS I-NP O
66 Demerol NNP I-NP O
66 causes VBZ O O
66 hypotension NN B-NP O
67 MEDICATIONS NNP I-NP O
67 ON NNP I-NP O
67 ADMISSION: NNP I-NP O
67 Mechanical NNP I-NP O
67 soft JJ B-NP O
67 diet NN I-NP O
67 , , O O
67 aspirin RB O B-m
67 81 CD O B-do
67 mg NN B-NP I-do
67 , , O O
68 baclofen VBD B-VP B-m
68 5 CD O B-do
68 mg NN B-NP I-do
68 t.i.d NN I-NP B-f
68 , , O O
68 B12 NNP B-NP B-m
68 1000 CD O B-do
68 mg NN B-NP I-do
68 daily RB O B-f
68 , , O O
68 iron NN B-NP B-m
68 sulfate NN I-NP I-m
68 325 CD O B-do
68 mg JJ O I-do
69 daily RB O B-f
69 , , O O
69 Cymbalta NNP B-NP B-m
69 20 CD O B-do
69 mg NN B-NP I-do
69 p.o NN I-NP B-mo
69 b.i.d NN I-NP B-f
69 , , O O
69 Neurontin NNP B-NP B-m
69 100 CD O B-do
69 mg NN B-NP I-do
69 b.i.d NN I-NP B-f
69 , , O O
70 Lamictal NNP B-NP B-m
70 200 CD O B-do
70 mg NN B-NP I-do
70 b.i.d NN I-NP B-f
70 , , O O
70 Prilosec NNP B-NP B-m
70 20 CD O B-do
70 daily RB O B-f
70 , , O O
70 levothyroxine NN B-NP B-m
70 , , O O
71 Glucophage NNP B-NP B-m
71 500 CD O B-do
71 once RB O B-f
71 a DT B-NP I-f
71 day NN I-NP I-f
71 , , O O
71 Reglan NNP B-NP B-m
71 10 CD O B-do
71 once RB O B-f
71 a DT B-NP I-f
71 day NN I-NP I-f
71 , , O O
71 niacin RB O B-m
71 500 CD O B-do
71 once RB O B-f
72 a DT B-NP O
72 day NN I-NP O
72 , , O O
72 Senna NNP B-NP B-m
72 2 CD O B-do
72 tabs NN B-NP I-do
72 b.i.d NN I-NP B-f
72 , , O O
72 Zocor NNP B-NP B-m
72 20 CD O B-do
72 mg NN B-NP I-do
72 once RB O B-f
72 a DT B-NP I-f
72 day NN I-NP I-f
72 , , O O
72 Nicoderm NNP B-NP B-m
73 patch NN I-NP O
73 , , O O
73 Colace NNP B-NP B-m
73 100 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 b.i.d NN I-NP B-f
73 , , O O
73 Lopressor NNP B-NP B-m
73 100 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 b.i.d NN I-NP B-f
73 , , O O
74 lidoderm VBZ O B-m
74 5% CD O I-m
74 patch NN B-NP I-m
74 to TO O O
74 the DT O O
74 low JJ O O
74 back RB O O
74 She PRP O O
74 also RB O O
74 had VBD B-VP O
74 p.r.n VBN O B-f
74 p.r.n JJ B-NP B-f
74 p.r.n NN I-NP B-f
74 p.r.n NN I-NP B-f
74 p.r.n NN I-NP B-f
74 p.r.n NN I-NP B-f
74 p.r.n NN I-NP B-f
74 of IN B-VP O
75 Tylenol NNP B-NP B-m
75 , , O O
75 ducolox NN B-NP B-m
75 , , O O
75 Mylanta NNP B-NP B-m
75 , , O O
75 lactulose RB O B-m
75 , , O O
75 Seroquel NNP B-NP B-m
75 100 CD O B-do
75 mg NN B-NP I-do
75 , , O O
75 prednisone NN B-NP B-m
76 50 CD O B-do
76 mg NN B-NP I-do
76 , , O O
76 and CC O O
76 Dilaudid NNP B-NP B-m
76 1 CD O B-do
76 mg NN B-NP I-do
77 SOCIAL NNP I-NP O
77 HISTORY: NNP I-NP O
77 Divorced NNP I-NP O
77 with IN B-VP O
77 two CD O O
77 children NNS B-NP O
77 No DT B-NP O
77 alcohol NN I-NP O
77 use NN I-NP O
78 recently RB O O
79 FAMILY NNP B-NP O
79 HISTORY: NNP I-NP O
79 Father NNP I-NP O
79 died VBD B-VP O
79 of IN B-VP O
79 a DT B-NP O
79 MI NNP I-NP O
79 at IN B-VP O
79 73 CD O O
79 Her PRP$ O O
79 mother NN B-NP O
79 died VBD B-VP O
79 in IN B-VP O
80 her PRP$ O O
80 80s CD O O
80 of IN B-VP O
80 emphysema JJ B-NP O
81 LABORATORY NNP I-NP O
81 DATA: NNP I-NP O
81 The DT B-NP O
81 patient NN I-NP O
81 had VBD B-VP O
81 a DT B-NP O
81 creatinine NN I-NP O
81 of IN B-VP O
81 1 CD O O
81 , , O O
81 her PRP$ O O
81 ALT NNP B-NP O
81 was VBD B-VP O
82 25 CD O O
82 , , O O
82 AST NNP B-NP O
82 was VBD B-VP O
82 35 CD O O
82 , , O O
82 her PRP$ O O
82 hematocrit NN B-NP O
82 was VBD B-VP O
82 33 CD O O
82 , , O O
82 her PRP$ O O
82 white JJ B-NP O
82 count NN I-NP O
82 was VBD B-VP O
82 6.6 CD O O
82 , , O O
83 and CC O O
83 her PRP$ O O
83 platelets NNS B-NP O
83 were VBD B-VP O
83 241 CD O O
83 , , O O
83 000 CD O O
83 She PRP O O
83 had VBD B-VP O
83 normal JJ O O
83 differential JJ O O
84 Her PRP$ O O
84 albumin NN B-NP O
84 was VBD B-VP O
84 3.5 CD O O
84 Her NNP B-NP O
84 urinalysis NN I-NP O
84 was VBD B-VP O
84 dark JJ O O
84 , , O O
84 with IN B-VP O
84 3+ CD O O
85 leukoesterase NN B-NP O
85 , , O O
85 negative JJ B-NP O
85 nitrates NNS I-NP O
85 , , O O
85 greater JJR O O
85 than IN B-VP O
85 200 CD O O
85 white JJ B-NP O
85 blood NN I-NP O
86 cells NNS I-NP O
86 per IN B-VP O
86 high JJ B-NP O
86 peripheral NN I-NP O
86 , , O O
86 2-4 JJ B-NP O
86 red JJ I-NP O
86 blood NN I-NP O
86 cells NNS I-NP O
86 per IN B-VP O
86 high JJ B-NP O
87 peripheral NN I-NP O
87 , , O O
87 1+ CD O O
87 bacteria NNS B-NP O
87 Her PRP$ O O
87 EKG NNP B-NP O
87 showed VBD B-VP O
87 a DT B-NP O
87 sinus NN I-NP O
87 rhythm NN I-NP O
87 of IN B-VP O
87 100 CD O O
88 Her PRP$ O O
88 left JJ B-NP O
88 bundle JJ I-NP O
88 branch NN I-NP O
88 block NN I-NP O
88 with IN B-VP O
88 a DT B-NP O
88 QTc NNP I-NP O
88 of IN B-VP O
88 500 CD O O
88 , , O O
88 but CC O O
88 no DT B-NP O
88 change NN I-NP O
89 compared VBN O O
89 to TO O O
89 baseline VB O O
90 Her NNP B-NP O
90 head NN I-NP O
90 CT NNP I-NP O
90 showed VBD B-VP O
90 an DT B-NP O
90 old JJ I-NP O
90 right NN I-NP O
90 middle VBZ O O
90 cerebral JJ B-NP O
90 artery NN I-NP O
90 implant JJ B-NP O
91 HOSPITAL NNP I-NP O
91 COURSE: NNP I-NP O
91 The DT B-NP O
91 patient NN I-NP O
91 was VBD B-VP O
91 admitted VBN O O
91 for IN B-VP O
91 initial JJ B-NP O
92 presentation NN I-NP O
92 with IN B-VP O
92 somnolence NN B-NP O
92 and CC O O
92 altered VBD B-VP O
92 mental JJ B-NP O
92 status NN I-NP O
92 with IN B-VP O
92 one CD O O
93 hypotensive JJ B-NP O
93 blood NN I-NP O
93 pressure NN I-NP O
93 by IN B-VP O
93 EMS NNP B-NP O
93 , , O O
93 but CC O O
93 subsequently RB O O
93 no DT B-NP O
94 hypotension NN I-NP O
94 in IN B-VP O
94 the DT B-NP O
94 absence NN I-NP O
94 of IN B-VP O
94 fluid JJ B-NP O
94 resuscitation NN I-NP O
94 Her NNP I-NP O
94 urine JJ B-NP O
95 culture NN I-NP O
95 appeared VBD B-VP O
95 to TO O O
95 indicate VB O O
95 an DT B-NP B-r
95 infection NN I-NP I-r
95 , , O O
95 and CC O O
95 so RB O O
95 she PRP O O
95 was VBD B-VP O
95 covered VBN O O
96 with IN B-VP O
96 antibiotics NNS B-NP B-m
96 initially RB O O
96 It PRP O O
96 was VBD B-VP O
96 also RB O O
96 determined VBN O O
96 that IN B-VP O
96 she PRP O O
96 had VBD B-VP O
97 a DT B-NP O
97 significant JJ I-NP O
97 polypharmacy NN I-NP O
97 and CC O O
97 enumerable JJ B-NP O
97 sedating NN I-NP B-m
97 medications NNS I-NP I-m
97 at IN B-VP O
98 her PRP$ O O
98 rehabilitation NN B-NP O
98 and CC O O
98 there EX O O
98 was VBD B-VP O
98 suspicion NN B-NP O
98 that IN B-VP O
98 the DT B-NP O
98 medications NNS I-NP O
99 contributed VBD B-VP O
99 to TO O O
99 her PRP$ O O
99 initial JJ B-NP O
99 presentation NN I-NP O
99 of IN B-VP O
99 somnolence NN B-NP O
99 and CC O O
99 altered VBD B-VP O
100 mental JJ B-NP O
100 status NN I-NP O
101 1 CD O O
101 Infectious NNP B-NP O
101 disease: VBD B-VP O
101 The DT B-NP O
101 patient NN I-NP O
101 was VBD B-VP O
101 initially RB O O
101 treated VBN O O
101 with IN B-VP O
102 vancomycin NN B-NP B-m
102 for IN B-VP O
102 a DT B-NP B-r
102 presumed JJ I-NP I-r
102 repeated JJ I-NP I-r
102 MRSA NNP I-NP I-r
102 UTI NNP I-NP I-r
102 However RB O O
102 , , O O
102 her PRP O O
102 urine JJ B-NP O
103 culture NN I-NP O
103 did VBD B-VP O
103 not RB O O
103 grow VB O O
103 any DT B-NP O
103 bacteria NNS I-NP O
103 , , O O
103 it PRP O O
103 only RB O O
103 drew VBD B-VP O
103 out RP O O
103 yeast JJ O O
103 Thus RB O O
103 , , O O
104 she PRP O O
104 was VBD B-VP O
104 transitioned VBN O O
104 over IN B-VP O
104 to TO O O
104 a DT B-NP O
104 ciprofloxacin NN I-NP B-m
104 700 CD O B-do
104 mg NN B-NP I-do
104 p.o NN I-NP B-mo
104 b.i.d NN I-NP B-f
105 regime NN I-NP O
105 for IN B-VP O
105 a DT B-NP O
105 total NN I-NP O
105 of IN B-VP O
105 12 CD O B-du
105 days NNS B-NP I-du
105 for IN B-VP O
105 a DT B-NP B-r
105 presumed JJ I-NP O
105 urinary JJ I-NP O
105 tract NN I-NP O
106 infection NN I-NP O
107 2 CD O O
107 F/E/N: NNP B-NP O
107 She PRP O O
107 was VBD B-VP O
107 tolerating VBG O O
107 oral JJ B-NP O
107 food NN I-NP O
107 and CC O O
107 medications NNS B-NP O
107 and CC O O
107 a DT B-NP O
108 Nutrition NNP I-NP O
108 consult NN I-NP O
108 was VBD B-VP O
108 obtained VBN O O
108 She PRP O O
108 had VBD B-VP O
108 calorie NN B-NP O
108 counts NNS I-NP O
108 which WDT O O
109 showed VBD B-VP O
109 adequate JJ B-NP O
109 intake NN I-NP O
109 She PRP O O
109 did VBD B-VP O
109 not RB O O
109 have VB O O
109 any DT B-NP O
109 other JJ I-NP O
109 metabolic JJ I-NP O
110 abnormality NN I-NP O
110 that WDT O O
110 required VBD B-VP O
110 correction NN B-NP O
111 3 CD O O
111 Cardiovascular: NNP B-NP O
111 The DT B-NP O
111 patient's NN I-NP O
111 primary JJ B-NP O
111 cardiovascular JJ I-NP O
112 abnormality NN I-NP O
112 was VBD B-VP O
112 a DT B-NP O
112 prolonged JJ I-NP O
112 QTc NNP I-NP O
112 which WDT O O
112 occurred VBD B-VP O
112 in IN B-VP O
112 the DT B-NP O
112 setting NN I-NP O
112 of IN B-VP O
113 prior JJ B-NP O
113 use NN I-NP O
113 of IN B-VP O
113 Haldol NNP B-NP B-m
113 and CC O O
113 other JJ B-NP O
113 antipsychotics NNS I-NP B-m
113 for IN B-VP O
113 behavioral JJ B-NP B-r
113 behavioral JJ I-NP B-r
114 modification NN I-NP O
114 Her NNP I-NP O
114 QTc NNP I-NP O
114 was VBD B-VP O
114 monitored VBN O O
114 with IN B-VP O
114 serial JJ B-NP O
114 EKGs NNP I-NP O
114 The DT O O
115 longest JJS O O
115 it PRP O O
115 had VBD B-VP O
115 reached VBN O O
115 was VBD B-VP O
115 530 CD O O
115 ms NN B-NP O
115 Haldol NNP I-NP B-m
115 was VBD B-VP O
115 discontinued VBN O O
115 in IN B-VP O
116 order NN B-NP O
116 to TO O O
116 preserve VB O O
116 the DT B-NP O
116 QTc NNP I-NP O
116 In IN B-VP O
116 addition NN B-NP O
116 , , O O
116 she PRP O O
116 was VBD B-VP O
116 given VBN O O
116 some DT B-NP O
117 amounts NNS I-NP O
117 of IN B-VP O
117 Seroquel NNP B-NP B-m
117 and CC O O
117 her PRP$ O O
117 QTc NN B-NP O
117 was VBD B-VP O
117 continued VBN O O
117 to TO O O
117 be VB O O
117 monitored VBN O O
118 4 CD O O
118 Heme/Oncology: NNP B-NP O
118 The DT B-NP O
118 patient NN I-NP O
118 has VBZ O O
118 a DT B-NP O
118 history NN I-NP O
118 of IN B-VP O
118 stage NN B-NP O
118 III NNP I-NP O
119 non-small NN I-NP B-r
119 cell NN I-NP I-r
119 lung NN I-NP I-r
119 cancer NN I-NP I-r
119 status NN I-NP O
119 post NN I-NP O
119 XRT NNP I-NP O
119 and CC O O
119 chemotherapy NN B-NP B-m
119 and CC O O
120 is VBZ O O
120 followed VBN O O
120 by IN B-VP O
120 her PRP$ O O
120 outpatient JJ B-NP O
120 oncologist NN I-NP O
120 , , O O
120 as RB O O
120 well RB O O
120 as IN B-VP O
120 the DT B-NP O
121 outpatient JJ I-NP O
121 psychosocial JJ I-NP O
121 oncology NN I-NP O
121 social JJ B-NP O
121 worker NN I-NP O
121 , , O O
121 as RB O O
121 well RB O O
121 as IN B-VP O
121 the DT B-NP O
122 psychosocial JJ I-NP O
122 oncology NN I-NP O
122 physician NN I-NP O
122 whose WP$ O O
122 name NN B-NP O
122 is VBZ O O
122 Chet NNP B-NP O
122 Nave NNP I-NP O
123 5 CD O O
123 Neurological: NNP B-NP O
123 The DT B-NP O
123 patient NN I-NP O
123 is VBZ O O
123 status NN B-NP O
123 post NN I-NP O
123 both DT O O
123 a DT B-NP O
123 large JJ I-NP O
123 right JJ I-NP O
124 MCA NNP I-NP O
124 stroke NN I-NP O
124 , , O O
124 as RB O O
124 well RB O O
124 as IN B-VP O
124 a DT B-NP O
124 right-sided JJ I-NP O
124 carotid NN I-NP O
124 endarterectomy NN I-NP O
124 from IN B-VP O
125 a DT B-NP O
125 previous JJ I-NP O
125 admission NN I-NP O
125 Her NNP I-NP O
125 neurological JJ B-NP O
125 deficits NNS I-NP O
125 are VBP O O
125 consistent JJ O O
126 with IN B-VP O
126 her PRP$ O O
126 prior JJ B-NP O
126 neurological JJ I-NP O
126 deficits NNS I-NP O
126 Specifically RB O O
126 , , O O
126 they PRP O O
126 include VBP O O
127 a DT B-NP O
127 left-sided JJ I-NP O
127 hemiparesis NN I-NP O
127 , , O O
127 as RB O O
127 well RB O O
127 as IN B-VP O
127 agnosia NN B-NP O
127 on IN B-VP O
127 the DT B-NP O
127 left JJ I-NP O
127 side NN I-NP O
128 Her NNP I-NP O
128 mental NN I-NP O
128 status NN I-NP O
128 included VBD B-VP O
128 intermittent JJ B-NP O
128 disorientation NN I-NP O
128 She PRP O O
128 was VBD B-VP O
129 generally RB O O
129 at IN B-VP O
129 her PRP$ O O
129 best JJS O O
129 , , O O
129 alert NN B-NP O
129 and CC O O
129 oriented VBN O O
129 to TO O O
129 herself VB O O
129 , , O O
129 as RB O O
129 well RB O O
129 as IN B-VP O
130 her PRP$ O O
130 age NN B-NP O
130 , , O O
130 as RB O O
130 well RB O O
130 as IN B-VP O
130 her PRP$ O O
130 location NN B-NP O
130 in IN B-VP O
130 the DT B-NP O
130 Domo NNP I-NP O
130 Ings NNP I-NP O
130 Hospital NNP I-NP O
130 However RB O O
130 , , O O
130 she PRP O O
130 would MD O O
130 intermittently RB O O
130 loose VB O O
130 track NN B-NP O
130 of IN B-VP O
130 where WRB O O
131 her PRP$ O O
131 location NN B-NP O
131 was VBD B-VP O
131 and CC O O
131 believed VBD B-VP O
131 that IN B-VP O
131 she PRP O O
131 was VBD B-VP O
131 in IN B-VP O
131 Naimas NNP B-NP O
131 West NNP I-NP O
131 Hospital NNP I-NP O
131 , , O O
131 not RB O O
131 in IN B-VP O
132 the DT B-NP O
132 hospital NN I-NP O
132 She PRP O O
132 was VBD B-VP O
132 also RB O O
132 intermittently RB O O
132 confused VBN O O
132 She PRP O O
132 also RB O O
132 is VBZ O O
133 complicated VBN O O
133 , , O O
133 given VBN O O
133 her PRP$ O O
133 histories NNS B-NP O
133 of IN B-VP O
133 seizures NNS B-NP O
133 and CC O O
133 stroke VBD B-VP O
133 It PRP O O
133 was VBD B-VP O
134 considered VBN O O
134 initially RB O O
134 that IN B-VP O
134 her PRP$ O O
134 altered JJ B-NP O
134 mental JJ I-NP O
134 status NN I-NP O
134 was VBD B-VP O
134 due JJ O O
134 to TO O O
135 polypharmacy VB O O
135 However RB O O
135 , , O O
135 her PRP O O
135 sedating VBG O B-m
135 medications NNS B-NP I-m
135 were VBD B-VP O
136 discontinued VBN O O
136 including VBG O O
136 her PRP$ O O
136 Reglan NN B-NP B-m
136 was VBD B-VP O
136 discontinued VBN O O
136 as RB O O
136 well RB O O
136 as IN B-VP O
136 her PRP$ O O
137 baclofen NN B-NP B-m
137 , , O O
137 Dilaudid NNP B-NP B-m
137 and CC O O
137 trazodone VB O B-m
137 Her PRP$ O O
137 Cymbalta NNP B-NP B-m
137 was VBD B-VP O
137 continued VBN O O
137 per IN B-VP O
138 the DT B-NP O
138 recommendations NNS I-NP O
138 of IN B-VP O
138 the DT B-NP O
138 Psychiatry NNP I-NP O
138 consult VBD B-VP O
138 The DT B-NP O
138 psychiatric JJ I-NP O
139 consultants NNS I-NP O
139 also RB O O
139 suggested VBD B-VP O
139 a DT B-NP O
139 one-to-one JJ I-NP O
139 sitter NN I-NP O
139 At IN B-VP O
139 no DT B-NP O
139 time NN I-NP O
139 was VBD B-VP O
140 the DT B-NP O
140 patient NN I-NP O
140 actively RB O O
140 suicidal VBD B-VP O
140 or CC O O
140 homicidal VB O O
140 It PRP O O
140 was VBD B-VP O
140 also RB O O
140 later RB O O
141 decided VBD B-VP O
141 that IN B-VP O
141 her PRP$ O O
141 Dilaudid NNP B-NP B-m
141 would MD O O
141 be VB O O
141 discontinued VBN O O
141 In IN B-VP O
141 addition NN B-NP O
141 , , O O
142 her PRP O O
142 standing VBG O O
142 Seroquel NNP B-NP B-m
142 was VBD B-VP O
142 made VBN O O
142 p.r.n NN B-NP B-f
142 In IN B-VP O
142 addition NN B-NP O
142 , , O O
142 the DT B-NP O
143 patient's NN I-NP O
143 family NN I-NP O
143 also RB O O
143 suggested VBD B-VP O
143 that IN B-VP O
143 the DT B-NP O
143 patient's JJ I-NP O
143 base NN I-NP O
143 mental JJ B-NP O
144 status NN I-NP O
144 did VBD B-VP O
144 not RB O O
144 improve VB O O
144 despite IN B-VP O
144 removing VBG O O
144 all PDT O O
144 the DT B-NP O
144 medications NNS I-NP O
144 At IN B-VP O
145 this DT B-NP O
145 point NN I-NP O
145 , , O O
145 a DT B-NP O
145 Neurology NNP I-NP O
145 consult NN I-NP O
145 was VBD B-VP O
145 obtained VBN O O
145 This DT B-NP O
145 Neurology NNP I-NP O
146 consult NN I-NP O
146 is VBZ O O
146 pending VBG O O
146 at IN B-VP O
146 the DT B-NP O
146 time NN I-NP O
146 of IN B-VP O
146 this DT B-NP O
146 dictation NN I-NP O
146 and CC O O
146 will MD O O
146 be VB O O
147 reported VBN O O
147 in IN B-VP O
147 a DT B-NP O
147 later JJ I-NP O
147 dictation NN I-NP O
147 Given VBN O O
147 the DT B-NP O
147 patient's JJ I-NP O
147 history NN I-NP O
147 of IN B-VP O
148 complex JJ B-NP B-r
148 seizures NNS I-NP I-r
148 and CC O O
148 olfactory JJ B-NP B-r
148 hallucinations NNS I-NP I-r
148 , , O O
148 she PRP O O
148 was VBD B-VP O
148 continued VBN O O
149 on IN B-VP O
149 her PRP$ O O
149 Lamictal JJ B-NP B-m
149 Lamictal NNP I-NP B-m
149 , , O O
149 as RB O O
149 well RB O O
149 as IN B-VP O
149 her PRP$ O O
149 Cymbalta NNP B-NP B-m
149 , , O O
149 which WDT O O
149 was VBD B-VP O
149 for IN B-VP O
149 her PRP$ O O
150 history NN B-NP O
150 of IN B-VP O
150 depression NN B-NP B-r
151 6 CD O O
151 Pain: NNP B-NP O
151 The DT B-NP O
151 patient's NN I-NP O
151 pain NN I-NP O
151 in IN B-VP O
151 her PRP$ O O
151 left JJ B-NP O
151 hand NN I-NP O
151 existed VBD B-VP O
151 and CC O O
151 she PRP O O
152 was VBD B-VP O
152 treated VBN O O
152 with IN B-VP O
152 tramadol NN B-NP B-m
152 and CC O O
152 Tylenol NNP B-NP B-m
152 for IN B-VP O
152 this DT O B-r
152 this DT B-NP B-r
152 pain NN I-NP I-r
152 pain NN I-NP I-r
152 She PRP O O
152 could MD O O
153 not RB O O
153 specifically RB O O
153 describe VB O O
153 this DT B-NP O
153 pain NN I-NP O
154 7 CD O O
154 Endocrine: NNP B-NP O
154 The DT B-NP O
154 patient NN I-NP O
154 was VBD B-VP O
154 maintained VBN O O
154 on IN B-VP O
154 Novolog NNP B-NP B-m
154 sliding VBG O B-do
155 scale NN B-NP O
155 for IN B-VP O
155 diabetes NNS B-NP B-r
155 She PRP O O
155 was VBD B-VP O
155 also RB O O
155 continued VBN O O
155 on IN B-VP O
155 a DT B-NP O
155 replacement NN I-NP O
155 dose NN I-NP O
156 levothyroxine JJ B-NP B-m
156 levothyroxine NN I-NP B-m
156 for IN B-VP O
156 her PRP$ O O
156 history NN B-NP O
156 of IN B-VP O
156 Graves' NNP B-NP B-r
156 and CC O O
156 a DT B-NP O
156 history NN I-NP O
156 of IN B-VP O
157 radioiodine NN B-NP B-r
157 ablation NN I-NP I-r
157 For IN B-VP O
157 behavioral JJ B-NP O
157 modification NN I-NP O
157 , , O O
157 as RB O O
157 well RB O O
157 as IN B-VP O
158 for IN B-VP O
158 intermittent JJ B-NP B-r
158 agitation NN I-NP I-r
158 and CC O O
158 disorientation NN B-NP B-r
158 , , O O
158 the DT B-NP O
158 patient NN I-NP O
158 was VBD B-VP O
159 maintained VBN O O
159 on IN B-VP O
159 p.r.n NN B-NP O
159 Seroquel NNP I-NP B-m
159 Seroquel NNP I-NP B-m
159 100 CD O B-do
159 100 CD O B-do
159 mg NN B-NP I-do
159 mg NN I-NP I-do
159 p.o NN I-NP B-mo
159 p.o NN I-NP B-mo
159 b.i.d NN I-NP B-f
159 b.i.d NN I-NP B-f
159 , , O O
159 as RB O O
159 well RB O O
159 as IN B-VP O
160 Zydis NNP B-NP B-m
160 Zydis NNP I-NP B-m
160 5 CD O B-do
160 mg NN B-NP I-do
160 p.o NN I-NP B-mo
160 b.i.d NN I-NP B-f
160 p.r.n NN I-NP I-f
160 This DT O O
160 was VBD B-VP O
160 titrated VBN O O
160 from IN B-VP O
160 standing VBG O O
160 to TO O O
161 p.r.n VB O B-f
161 over IN B-VP B-du
161 the DT B-NP I-du
161 course NN I-NP I-du
161 of IN B-VP I-du
161 her PRP$ O I-du
161 hospitalization NN B-NP I-du
161 in IN B-VP O
161 order NN B-NP O
161 to TO O O
161 try VB O O
161 to TO O O
162 decrease VB O O
162 any DT B-NP O
162 sedating JJ I-NP B-m
162 medications NNS I-NP I-m
162 that WDT O O
162 may MD O O
162 be VB O O
162 altering VBG O O
162 her PRP$ O O
163 alertness NN B-NP O
163 and CC O O
163 orientation NN B-NP O
164 NOTE: NNP I-NP O
164 This DT B-NP O
164 dictation NN I-NP O
164 will MD O O
164 be VB O O
164 addended VBN O O
164 at IN B-VP O
164 a DT B-NP O
164 later JJ I-NP O
164 date NN I-NP O
164 with IN B-VP O
165 discharge NN B-NP O
165 medications NNS I-NP O
165 , , O O
165 as RB O O
165 well RB O O
165 as IN B-VP O
165 further JJ B-NP O
165 hospital NN I-NP O
165 course NN I-NP O
165 and CC O O
165 the DT B-NP O
166 patient's JJ I-NP O
166 neurological JJ I-NP O
166 state NN I-NP O
166 , , O O
166 as RB O O
166 well RB O O
166 as IN B-VP O
166 any DT O O
166 follow VBP O O
166 up RP O O
166 that DT O O
166 is VBZ O O
166 to TO O O
167 be VB O O
167 planned VBN O O
168 eScription NN B-NP O
168 document: NN I-NP O
168 1-9584080 JJ B-NP O
168 SSSten NNP I-NP O
168 Tel NNP I-NP O
169 Dictated NNP I-NP O
169 By: NNP I-NP O
169 OCHILTREE NNP I-NP O
169 , , O O
169 RYAN NNP B-NP O
170 Attending: NNP I-NP O
170 LAMORE NNP I-NP O
170 , , O O
170 SERGIO NNP B-NP O
171 Dictation NNP I-NP O
171 ID NNP I-NP O
171 6454134 CD O O
172 D: NNP B-NP O
172 7/3/06 CD O O
173 T: NNP B-NP O
173 7/3/06 CD O O
174 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #29786 VBZ O O
4 369675973 CD O O
4 BSMC NNP B-NP O
4 15255122 CD O O
4 7520614 CD O O
4 6/11/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Esophagitis NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 10/2/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/8/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 STANSBURY NNP I-NP O
8 , , O O
8 ELLSWORTH NNP B-NP O
8 977-84-02-0 CD O O
9 Na NNP B-NP O
9 Port NNP I-NP O
9 Gardvi NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 6/19/04 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 SAMLAND NNP I-NP O
14 , , O O
14 ABRAHAM NNP B-NP O
14 BENTON NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
14 , , O O
14 M.P.H NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 CLONAZEPAM NNP I-NP B-m
19 0.5 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Override NNP I-NP O
20 Notice: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 2/8/04 CD O O
20 by IN B-VP O
21 BLASING NNP B-NP O
21 , , O O
21 TITUS NNP B-NP O
21 N NNP I-NP O
21 , , O O
21 M.D NNP B-NP O
22 on IN B-VP O
22 order NN B-NP O
22 for IN B-VP O
22 DIFLUCAN NNP B-NP B-m
22 PO NNP I-NP B-mo
22 ( ( O O
22 ref JJ O O
22 # # O O
22 62332050 CD O O
22 ) ) O O
23 POTENTIALLY NNP B-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 CLONAZEPAM NNP I-NP B-m
23 &amp; NNP I-NP O
23 FLUCONAZOLE NNP I-NP B-m
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 Aware JJ B-NP O
25 DIFLUCAN NNP I-NP B-m
25 ( ( O I-m
25 FLUCONAZOLE NNP B-NP I-m
25 ) ) O I-m
25 100 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QD NNP I-NP B-f
25 X NNP I-NP B-du
25 12 CD O I-du
25 doses NNS B-NP I-du
26 Starting VBG O O
26 Today NNP B-NP O
26 ( ( O O
26 9/4 CD O O
26 ) ) O O
26 INDICATIONS: NNP B-NP O
27 Other: NNP I-NP O
27 suspected VBD B-VP O
27 esophageal JJ B-NP O
27 candidiasis NN I-NP O
27 in IN B-VP O
27 poorly RB O O
28 cnotroled VBN O O
28 diabetic JJ B-NP O
29 Alert NNP I-NP O
29 overridden: NNP I-NP O
29 Override NNP I-NP O
29 added VBD B-VP O
29 on IN B-VP O
29 2/8/04 CD O O
29 by IN B-VP O
30 SHRIMPLIN NNP B-NP O
30 , , O O
30 BRYANT NNP B-NP O
30 C NNP I-NP O
30 , , O O
30 M.D NNP B-NP O
31 POTENTIALLY NNP I-NP O
31 SERIOUS NNP I-NP O
31 INTERACTION: NNP I-NP O
31 CLONAZEPAM NNP I-NP B-m
31 &amp; NNP I-NP O
31 FLUCONAZOLE NNP I-NP B-m
32 POTENTIALLY NNP I-NP O
32 SERIOUS NNP I-NP O
32 INTERACTION: NNP I-NP O
32 CLONAZEPAM NNP I-NP B-m
32 &amp; NNP I-NP O
32 FLUCONAZOLE NNP I-NP B-m
33 Reason NNP I-NP O
33 for IN B-VP O
33 override: NN B-NP O
33 Aware NNP I-NP O
34 LISINOPRIL NNP I-NP B-m
34 5 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QD NNP I-NP B-f
35 Override NNP I-NP O
35 Notice: NNP I-NP O
35 Override NNP I-NP O
35 added VBD B-VP O
35 on IN B-VP O
35 5/19/04 CD O O
35 by IN B-VP O
36 BERDAR NNP B-NP O
36 , , O O
36 EZRA NNP B-NP O
36 N NNP I-NP O
36 , , O O
36 M.D NNP B-NP O
37 on IN B-VP O
37 order NN B-NP O
37 for IN B-VP O
37 KCL NNP B-NP B-m
37 IMMEDIATE NNP I-NP I-m
37 RELEASE NNP I-NP I-m
37 PO NNP I-NP B-mo
37 ( ( O O
37 ref JJ O O
37 # # O O
37 57130577 CD O O
37 ) ) O O
38 POTENTIALLY NNP B-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 LISINOPRIL NNP I-NP B-m
38 &amp; NNP I-NP O
38 POTASSIUM NNP I-NP B-m
39 CHLORIDE NNP I-NP O
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: NN B-NP O
39 Aware NNP I-NP O
40 Previous NNP I-NP O
40 override IN B-VP O
40 information: JJ B-NP O
41 Override NNP I-NP O
41 added VBD B-VP O
41 on IN B-VP O
41 5/19/04 CD O O
41 by IN B-VP O
41 INGARGIOLA NNP B-NP O
41 , , O O
41 DENNY NNP B-NP O
41 L NNP I-NP O
41 , , O O
41 M.D NNP B-NP O
42 on IN B-VP O
42 order NN B-NP O
42 for IN B-VP O
42 KCL NNP B-NP B-m
42 IV NNP I-NP B-mo
42 ( ( O O
42 ref JJ O O
42 # # O O
42 64707487 CD O O
42 ) ) O O
43 POTENTIALLY NNP B-NP O
43 SERIOUS NNP I-NP O
43 INTERACTION: NNP I-NP O
43 LISINOPRIL NNP I-NP B-m
43 &amp; NNP I-NP O
43 POTASSIUM NNP I-NP B-m
44 CHLORIDE NNP I-NP O
44 Reason NNP I-NP O
44 for IN B-VP O
44 override: NN B-NP O
44 Aware NNP I-NP O
45 MOM NNP I-NP B-m
45 ( ( O I-m
45 MAGNESIUM NNP B-NP I-m
45 HYDROXIDE NNP I-NP I-m
45 ) ) O I-m
45 30 CD O B-do
45 MILLILITERS NNP B-NP I-do
45 PO NNP I-NP B-mo
45 QD NNP I-NP B-f
46 Starting VBG O O
46 Today NNP B-NP O
46 ( ( O O
46 9/4 CD O O
46 ) ) O O
46 PRN NNP B-NP O
46 Constipation NNP I-NP B-r
46 , , O O
46 Upset NNP B-NP O
46 Stomach NNP I-NP O
47 MAALOX-TABLETS NNP I-NP B-m
47 QUICK NNP I-NP I-m
47 DISSOLVE/CHEWABLE NNP I-NP I-m
47 1-2 JJ B-NP B-do
47 TAB NNP I-NP I-do
47 PO NNP I-NP B-mo
47 Q6H NNP I-NP B-f
48 PRN NNP I-NP O
48 Upset NNP I-NP B-r
48 Stomach NNP I-NP I-r
49 PROTONIX NNP I-NP B-m
49 ( ( O I-m
49 PANTOPRAZOLE NNP B-NP I-m
49 ) ) O I-m
49 40 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 QD NNP I-NP B-f
50 LIPITOR NNP I-NP B-m
50 ( ( O I-m
50 ATORVASTATIN NNP B-NP I-m
50 ) ) O I-m
50 20 CD O B-do
50 MG NNP B-NP I-do
50 PO NNP I-NP B-mo
50 QHS NNP I-NP B-f
51 ATENOLOL NNP I-NP B-m
51 25 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 QD NNP I-NP B-f
52 ECASA NNP I-NP B-m
52 ( ( O I-m
52 ASPIRIN NNP B-NP I-m
52 ENTERIC NNP I-NP I-m
52 COATED NNP I-NP I-m
52 ) ) O I-m
52 81 CD O B-do
52 MG NNP B-NP I-do
52 PO NNP I-NP B-mo
52 QD NNP I-NP B-f
53 REMERON NNP I-NP B-m
53 ( ( O I-m
53 MIRTAZAPINE NNP B-NP I-m
53 ) ) O I-m
53 15 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 QHS NNP I-NP B-f
54 CELEXA NNP I-NP B-m
54 ( ( O I-m
54 CITALOPRAM NNP B-NP I-m
54 ) ) O I-m
54 20 CD O B-do
54 MG NNP B-NP I-do
54 PO NNP I-NP B-mo
54 QD NNP I-NP B-f
55 METFORMIN NNP I-NP B-m
55 500 CD O B-do
55 MG NNP B-NP I-do
55 PO NNP I-NP B-mo
55 BID NNP I-NP B-f
56 DIET: NNP I-NP O
56 House NNP I-NP O
56 / NNP I-NP O
56 ADA NNP I-NP O
56 2100 CD O O
56 cals/dy NN B-NP O
57 ACTIVITY: NNP I-NP O
57 Resume NNP I-NP O
57 regular JJ B-NP O
57 exercise NN I-NP O
58 FOLLOW NNP I-NP O
58 UP NNP I-NP O
58 APPOINTMENT( NNP I-NP O
58 S NNP I-NP O
58 ): NNP I-NP O
59 Please NNP I-NP O
59 call VB O O
59 you PRP O O
59 MD NNP B-NP O
59 on IN B-VP O
59 Monday NNP B-NP O
59 to TO O O
59 schedule VB O O
59 an DT B-NP O
59 appointment NN I-NP O
59 in IN B-VP O
59 the DT O O
59 next JJ O O
59 2 CD O O
59 weeks NNS B-NP O
59 Monday NNP I-NP O
59 , , O O
60 ALLERGY: NNP B-NP O
60 NKA NNP I-NP O
61 ADMIT NNP I-NP O
61 DIAGNOSIS: NNP I-NP O
62 esophagitis NN I-NP O
62 , , O O
62 chest NN B-NP O
62 pain NN I-NP O
62 , , O O
62 coronary JJ B-NP O
62 heart NN I-NP O
62 disease NN I-NP O
62 , , O O
62 hypertension NN B-NP O
62 , , O O
62 NIDDM NNP B-NP O
62 , , O O
63 depression NN B-NP O
64 PRINCIPAL NNP I-NP O
64 DISCHARGE NNP I-NP O
64 DIAGNOSIS NNP I-NP O
64 ;Responsible JJ O O
64 After IN B-VP O
64 Study NNP B-NP O
64 for IN B-VP O
64 Causing NNP B-NP O
64 Admission NNP I-NP O
64 ) ) O O
65 Esophagitis NNP B-NP O
66 OTHER NNP I-NP O
66 DIAGNOSIS;Conditions NNP I-NP O
66 , , O O
66 Infections NNP B-NP O
66 , , O O
66 Complications NNP B-NP O
66 , , O O
66 affecting VBG O O
66 Treatment/Stay NNP B-NP O
67 NIDDM NNP I-NP O
67 anxiety NN I-NP O
67 s/p NN I-NP O
67 appy JJ B-NP O
67 HTN NNP I-NP O
67 cad NN I-NP O
67 s/p VBD B-VP O
67 10/6 CD O O
67 cath NN B-NP O
67 with IN B-VP O
67 Lcirc NNP B-NP O
67 stent NN I-NP O
67 dyslipidemia NN I-NP O
68 depression NN I-NP O
68 ( ( O O
68 depression NN B-NP O
68 ) ) O O
69 OPERATIONS NNP B-NP O
69 AND NNP I-NP O
69 PROCEDURES: NNP I-NP O
70 MIBI NNP I-NP O
70 4/11/04 CD O O
70 with IN B-VP O
70 small JJ B-NP O
70 perfusion NN I-NP O
70 defect NN I-NP O
70 and CC O O
70 no DT B-NP O
70 reversibility NN I-NP O
71 OTHER NNP I-NP O
71 TREATMENTS/PROCEDURES NNP I-NP O
71 ( ( O O
71 NOT NNP B-NP O
71 IN NNP I-NP O
71 O.R NNP I-NP O
71 ) ) O O
72 None NN B-NP O
73 BRIEF NNP I-NP O
73 RESUME NNP I-NP O
73 OF NNP I-NP O
73 HOSPITAL NNP I-NP O
73 COURSE: NNP I-NP O
74 59 CD O O
74 yo NNS B-NP O
74 female JJ O O
74 with IN B-VP O
74 NID NNP B-NP O
74 DM NNP I-NP O
74 , , O O
74 GERD NNP B-NP O
74 , , O O
74 HTN NNP B-NP O
74 , , O O
74 Depression NNP B-NP O
74 , , O O
74 known VBN O O
74 CAD NNP B-NP O
74 s/p NN I-NP O
75 circumflex NN I-NP O
75 stent NN I-NP O
75 2002 CD O O
75 , , O O
75 admitted VBN O O
75 with IN B-VP O
75 atypical JJ B-NP O
75 chest NN I-NP O
75 pain NN I-NP O
75 Cath NNP I-NP O
75 in IN B-VP O
76 2003 CD O O
76 showed VBD B-VP O
76 2-V JJ B-NP O
76 disease NN I-NP O
76 , , O O
76 admission NN B-NP O
76 for IN B-VP O
76 chest NN B-NP O
76 pain NN I-NP O
76 in IN B-VP O
76 2003 CD O O
77 resulted VBD B-VP O
77 in IN B-VP O
77 a DT B-NP O
77 mibi NN I-NP O
77 being VBG O O
77 done VBN O O
77 , , O O
77 revealing VBG O O
77 no DT B-NP O
77 ischemia NN I-NP O
77 , , O O
78 no DT B-NP O
78 arrhythmias NN I-NP O
78 , , O O
78 negative JJ B-NP O
78 enzymes NNS I-NP O
78 Presented VBN O O
78 with IN B-VP O
78 36-48 JJ B-NP O
78 hours NNS I-NP O
78 of IN B-VP O
78 chest NN B-NP O
79 pain NN I-NP O
79 , , O O
79 deep JJ B-NP O
79 boring/squeezing NN I-NP O
79 in IN B-VP O
79 lower JJR B-NP O
79 left NN I-NP O
79 chest NN I-NP O
79 , , O O
79 xyphoid JJ B-NP O
79 region NN I-NP O
79 , , O O
80 suprasternal JJ B-NP O
80 notch NN I-NP O
80 Pain NNP I-NP B-r
80 Pain NNP I-NP B-r
80 is VBZ O O
80 reproducible JJ O O
80 on IN B-VP O
80 palpation NN B-NP O
80 , , O O
80 does VBZ O O
80 not RB O O
81 radiate VB O O
81 , , O O
81 is VBZ O O
81 accompanied VBN O O
81 by IN B-VP O
81 diaphoresis NN B-NP O
81 , , O O
81 no DT B-NP O
81 dyspnea NN I-NP O
81 , , O O
81 nausea/vomiting VBG O O
82 Unrelieved VBN O O
82 by IN B-VP O
82 nitroglycerin JJ B-NP B-m
82 Minimal NNP I-NP O
82 relief NN I-NP O
82 with IN B-VP O
82 morphine JJ O B-m
82 4 CD O B-do
83 mg NN B-NP O
83 in IN B-VP O
83 ED NNP B-NP O
83 No NNP I-NP O
83 relief NN I-NP O
83 with IN B-VP O
83 maalox NN B-NP B-m
83 , , O O
83 po JJ B-NP B-mo
83 lidocaine NN I-NP B-m
83 susp NN I-NP I-m
83 First NNP I-NP O
83 set VBD B-VP O
83 cardiac JJ B-NP O
84 enzymes NNS I-NP O
84 negative JJ B-NP O
84 PE: NNP I-NP O
84 Nl NNP I-NP O
84 cardiac JJ B-NP O
84 exam NN I-NP O
84 Chest NNP I-NP O
85 wall NN I-NP O
85 compression NN I-NP O
85 over IN B-VP O
85 left VBD B-VP O
85 lower JJR B-NP O
85 ribs NN I-NP O
85 reproduces NNS I-NP O
85 pain-no JJ B-NP O
86 superficial JJ I-NP O
86 erythema NN I-NP O
86 , , O O
86 swelling VBG O O
86 Lungs NNS B-NP O
86 CTAB NNP I-NP O
87 Abd NNP I-NP O
87 benign NN I-NP O
87 Ext NNP I-NP O
87 without IN B-VP O
87 C/C/E; NNP B-NP O
87 pulses VBZ O O
88 symmetric JJ B-NP O
88 EKG: NNP I-NP O
88 NSR NNP I-NP O
88 79 CD O O
88 bpm NN B-NP O
88 , , O O
88 normal JJ B-NP O
88 axis NN I-NP O
88 and CC O O
88 intervals NNS B-NP O
88 1 CD O O
88 mm NNS B-NP O
89 ST NNP I-NP O
89 segment NN I-NP O
89 depression NN I-NP O
89 V3-V5 NNP I-NP O
89 , , O O
89 inverted VBD B-VP O
89 Ts NNP B-NP O
89 in IN B-VP O
89 V3-V5 NNP B-NP O
89 C/W NNP I-NP O
89 EKG NNP I-NP O
89 findings NNS I-NP O
90 in IN B-VP O
90 July NNP B-NP O
90 2004 CD O O
90 CXR: NNP B-NP O
90 negative JJ O O
90 for IN B-VP O
90 effusions NNS B-NP O
90 , , O O
90 infiltrates NNS B-NP O
90 , , O O
91 edema RB O O
91 , , O O
91 normal JJ B-NP O
91 bony NN I-NP O
91 structures NNS I-NP O
92 A/P: VBP O O
92 59 CD O O
92 yo NNS B-NP O
92 woman NN I-NP O
92 with IN B-VP O
92 known JJ B-NP O
92 coronary JJ I-NP O
92 diseae NN I-NP O
92 presenting VBG O O
92 with IN B-VP O
92 atypical JJ B-NP O
93 chest NN I-NP O
93 pain NN I-NP O
94 CV: NNP I-NP O
94 r/o NN I-NP O
94 MI NNP I-NP O
94 with IN B-VP O
94 negative JJ B-NP O
94 cardiac JJ I-NP O
94 enzymes NNS I-NP O
94 mibi VBP O O
94 on IN B-VP O
94 10/22 CD O O
94 showed VBD B-VP O
94 small JJ B-NP O
95 perfusion NN I-NP O
95 defect NN I-NP O
95 without IN B-VP O
95 reversibility NN B-NP O
96 Pulm: NNP I-NP O
96 No NNP I-NP O
96 active JJ B-NP O
96 issue NN I-NP O
97 Endo: NNP I-NP O
97 NIDDM NNP I-NP O
97 SSI NNP I-NP O
98 Renal: NNP I-NP O
98 No NNP I-NP O
98 active JJ B-NP O
98 issues NNS I-NP O
99 Neuro: NNP I-NP O
99 No NNP I-NP O
99 active JJ B-NP O
99 issues NNS I-NP O
100 Psych: NNP I-NP O
100 MDD-continue NNP I-NP B-r
100 MDD-continue NNP I-NP B-r
100 MDD-continue NNP I-NP B-r
100 remeron NN I-NP B-m
100 , , O O
100 celexa NN B-NP B-m
100 , , O O
100 clonazepam NN B-NP B-m
101 GI: NNP I-NP O
101 Esophagitis NNP I-NP B-r
101 responded VBD B-VP O
101 quickly RB O O
101 to TO O O
101 KBL NNP B-NP O
101 and CC O O
101 diflucan JJ B-NP B-m
101 Tolerating NNP I-NP O
101 PO NNP I-NP O
102 on IN B-VP O
102 AM NNP B-NP O
102 of IN B-VP O
102 discharge NN B-NP O
102 Will NNP I-NP O
102 complete VB O O
102 two CD O B-du
102 week NN B-NP I-du
102 course NN I-NP I-du
102 of IN B-VP O
102 Fluconazole NNP B-NP B-m
103 Consider NNP I-NP O
103 outpatient NN I-NP O
103 EGD NNP I-NP O
103 if IN B-VP O
103 sx VBN O O
103 do VBP O O
103 not RB O O
103 improve VB O O
103 with IN B-VP O
103 tx JJ B-NP O
104 ADDITIONAL NNP I-NP O
104 COMMENTS: NNP I-NP O
105 DISCHARGE NNP I-NP O
105 CONDITION: NNP I-NP O
105 Stable NNP I-NP O
106 TO NNP I-NP O
106 DO/PLAN: NNP I-NP O
107 No NNP I-NP O
107 dictated VBD B-VP O
107 summary JJ B-NP O
108 ENTERED NNP I-NP O
108 BY: NNP I-NP O
108 ELIZARRARAS NNP I-NP O
108 , , O O
108 HERSCHEL NNP B-NP O
108 , , O O
108 M.D NNP B-NP O
108 , , O O
108 PH.D NNP B-NP O
108 ( ( O O
108 UD060 NNP B-NP O
108 ) ) O O
108 6/19/04 CD O O
108 @ $ O O
108 12:06 CD O O
108 PM NNP B-NP O
109 ****** JJ B-NP O
109 END NNP I-NP O
109 OF NNP I-NP O
109 DISCHARGE NNP I-NP O
109 ORDERS NNP I-NP O
109 ****** NNP I-NP O
110 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #43317 VBZ O O
4 490509054 CD O O
4 LTH NNP B-NP O
4 72565548 CD O O
4 3910463 CD O O
4 5/26/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 atrial JJ B-NP O
4 fibrillation NN I-NP O
4 , , O O
4 calcaneous JJ B-NP O
4 fracture NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/26/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/18/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 STRAUSBERG NNP I-NP O
8 , , O O
8 EMILIO NNP B-NP O
8 R NNP I-NP O
8 557-96-58-8 JJ B-NP O
9 Car NNP I-NP O
9 Rock NNP I-NP O
9 E NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 4/14/04 CD O O
11 AT NNP B-NP O
11 07:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 CT NNP I-NP O
12 scan NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 BLEICHNER NNP I-NP O
14 , , O O
14 DERICK NNP B-NP O
14 STUART NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 ECASA NNP I-NP B-m
17 ( ( O I-m
17 ASPIRIN NNP B-NP I-m
17 ENTERIC NNP I-NP I-m
17 COATED NNP I-NP I-m
17 ) ) O I-m
17 325 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 Alert NNP I-NP O
18 overridden: NNP I-NP O
18 Override NNP I-NP O
18 added VBD B-VP O
18 on IN B-VP O
18 6/9/04 CD O O
18 by IN B-VP O
19 LOESER NNP B-NP O
19 , , O O
19 VALENTIN NNP B-NP O
19 GUADALUPE NNP I-NP O
19 , , O O
19 M.D NNP B-NP O
19 , , O O
19 M.P.H NNP B-NP O
20 POTENTIALLY NNP I-NP O
20 SERIOUS NNP I-NP O
20 INTERACTION: NNP I-NP O
20 WARFARIN NNP I-NP B-m
20 &amp; NNP I-NP O
20 ASPIRIN NNP I-NP B-m
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: JJ B-NP O
21 heart NN I-NP O
22 VITAMIN NNP I-NP B-m
22 B12 NNP I-NP I-m
22 ( ( O I-m
22 CYANOCOBALAMIN NNP B-NP I-m
22 ) ) O I-m
22 1 CD O B-do
22 , , O I-do
22 000 CD O I-do
22 MCG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 Number NNP I-NP B-du
23 of IN B-VP I-du
23 Doses NNP B-NP I-du
23 Required NNP I-NP I-du
23 ( ( O I-du
23 approximate JJ B-NP I-du
23 ): NN I-NP I-du
23 5 CD O I-du
24 DIGOXIN NNP B-NP B-m
24 0.25 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QD NNP I-NP B-f
25 COLACE NNP I-NP B-m
25 ( ( O I-m
25 DOCUSATE NNP B-NP I-m
25 SODIUM NNP I-NP I-m
25 ) ) O I-m
25 100 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 BID NNP I-NP B-f
26 LASIX NNP I-NP B-m
26 ( ( O I-m
26 FUROSEMIDE NNP B-NP I-m
26 ) ) O I-m
26 60 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 BID NNP I-NP B-f
27 HOLD NNP I-NP O
27 IF: NNP I-NP O
27 sbp&lt;105 NN I-NP O
27 and CC O O
27 call VB O O
27 HO NNP B-NP O
28 OXYCODONE NNP I-NP B-m
28 5 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 Q6H NNP I-NP B-f
28 PRN NNP I-NP I-f
28 Pain NNP I-NP B-r
29 COUMADIN NNP I-NP B-m
29 ( ( O I-m
29 WARFARIN NNP B-NP I-m
29 SODIUM NNP I-NP I-m
29 ) ) O I-m
29 5 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QPM NNP I-NP B-f
30 Starting VBG O O
30 Today NNP B-NP O
30 March NNP I-NP O
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 No NNP I-NP O
31 high JJ B-NP O
31 Vitamin-K NNP I-NP O
31 containing VBG O O
31 foods NNS B-NP O
32 Override NNP I-NP O
32 Notice: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 6/9/04 CD O O
32 by IN B-VP O
33 GLUSZEK NNP B-NP O
33 , , O O
33 MAX NNP B-NP O
33 JORDON NNP I-NP O
33 , , O O
33 M.D NNP B-NP O
33 , , O O
33 M.P.H NNP B-NP O
34 on IN B-VP O
34 order NN B-NP O
34 for IN B-VP O
34 ECASA NNP B-NP B-m
34 PO NNP I-NP B-mo
34 ( ( O O
34 ref JJ O O
34 # # O O
34 23344198 CD O O
34 ) ) O O
35 POTENTIALLY NNP B-NP O
35 SERIOUS NNP I-NP O
35 INTERACTION: NNP I-NP O
35 WARFARIN NNP I-NP B-m
35 &amp; NNP I-NP O
35 ASPIRIN NNP I-NP B-m
36 Reason NNP I-NP O
36 for IN B-VP O
36 override: JJ B-NP O
36 heart NN I-NP O
36 Previous NNP I-NP O
36 override IN B-VP O
36 information: JJ B-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 6/9/04 CD O O
37 by IN B-VP O
37 TUMMINIA NNP B-NP O
37 , , O O
37 KING NNP B-NP O
37 G NNP I-NP O
37 VALENTINE NNP I-NP O
37 , , O O
37 M.D NNP B-NP O
37 , , O O
37 M.P.H NNP B-NP O
38 on IN B-VP O
38 order NN B-NP O
38 for IN B-VP O
38 LIPITOR NNP B-NP B-m
38 PO NNP I-NP B-mo
38 ( ( O O
38 ref JJ O O
38 # # O O
38 90217884 CD O O
38 ) ) O O
39 POTENTIALLY NNP B-NP O
39 SERIOUS NNP I-NP O
39 INTERACTION: NNP I-NP O
39 WARFARIN NNP I-NP B-m
39 &amp; NNP I-NP O
39 ATORVASTATIN NNP I-NP B-m
40 CALCIUM NNP I-NP O
40 Reason NNP I-NP O
40 for IN B-VP O
40 override: NNP B-NP O
40 home NN I-NP O
40 40mg CD O O
41 METOPROLOL NNP B-NP B-m
41 ( ( O I-m
41 SUST NNP B-NP I-m
41 REL NNP I-NP I-m
41 ) ) O I-m
41 300 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 QD NNP I-NP B-f
42 HOLD NNP I-NP O
42 IF: NNP I-NP O
42 sbp&lt;100 NN I-NP O
42 , , O O
42 hr&lt;55 JJ B-NP O
42 Food/Drug NNP I-NP O
42 Interaction NNP I-NP O
42 Instruction NNP I-NP O
43 Take NNP I-NP O
43 consistently RB O O
43 with IN B-VP O
43 meals NNS B-NP O
43 or CC O O
43 on IN B-VP O
43 empty JJ B-NP O
43 stomach NN I-NP O
44 Override NNP I-NP O
44 Notice: NNP I-NP O
44 Override NNP I-NP O
44 added VBD B-VP O
44 on IN B-VP O
44 6/9/04 CD O O
44 by IN B-VP O
45 TRAUTMAN NNP B-NP O
45 , , O O
45 BRENTON NNP B-NP O
45 STAN NNP I-NP O
45 , , O O
45 M.D NNP B-NP O
45 , , O O
45 M.P.H NNP B-NP O
46 on IN B-VP O
46 order NN B-NP O
46 for IN B-VP O
46 DILTIAZEM NNP B-NP B-m
46 PO NNP I-NP B-mo
46 ( ( O O
46 ref JJ O O
46 # # O O
46 68655693 CD O O
46 ) ) O O
47 POTENTIALLY NNP B-NP O
47 SERIOUS NNP I-NP O
47 INTERACTION: NNP I-NP O
47 METOPROLOL NNP I-NP B-m
47 TARTRATE NNP I-NP I-m
47 &amp; NNP I-NP O
48 DILTIAZEM NNP I-NP B-m
48 HCL NNP I-NP I-m
48 Reason NNP I-NP O
48 for IN B-VP O
48 override: NN B-NP O
48 home NN I-NP B-m
48 med VBD B-VP I-m
49 Previous NNP B-NP O
49 override IN B-VP O
49 information: JJ B-NP O
50 Override NNP I-NP O
50 added VBD B-VP O
50 on IN B-VP O
50 6/9/04 CD O O
50 by IN B-VP O
50 RYKERT NNP B-NP O
50 , , O O
50 DARRIN NNP B-NP O
50 Q NNP I-NP O
50 PORFIRIO NNP I-NP O
50 , , O O
50 M.D NNP B-NP O
50 , , O O
50 M.P.H NNP B-NP O
51 on IN B-VP O
51 order NN B-NP O
51 for IN B-VP O
51 TIAZAC NNP B-NP B-m
51 PO NNP I-NP B-mo
51 ( ( O O
51 ref JJ O O
51 # # O O
51 86614276 CD O O
51 ) ) O O
52 POTENTIALLY NNP B-NP O
52 SERIOUS NNP I-NP O
52 INTERACTION: NNP I-NP O
52 METOPROLOL NNP I-NP B-m
52 TARTRATE NNP I-NP I-m
52 &amp; NNP I-NP O
53 DILTIAZEM NNP I-NP B-m
53 HCL NNP I-NP I-m
53 Reason NNP I-NP O
53 for IN B-VP O
53 override: NN B-NP O
53 home NN I-NP B-m
53 med VBD B-VP I-m
54 Previous NNP B-NP O
54 override IN B-VP O
54 information: JJ B-NP O
55 Override NNP I-NP O
55 added VBD B-VP O
55 on IN B-VP O
55 6/9/04 CD O O
55 by IN B-VP O
55 WEIGHT NNP B-NP O
55 , , O O
55 YONG NNP B-NP O
55 E NNP I-NP O
55 ANTOINE NNP I-NP O
55 , , O O
55 M.D NNP B-NP O
55 , , O O
55 M.P.H NNP B-NP O
56 on IN B-VP O
56 order NN B-NP O
56 for IN B-VP O
56 DILTIAZEM NNP B-NP B-m
56 SUSTAINED NNP I-NP I-m
56 RELEASE NNP I-NP I-m
56 PO NNP I-NP B-mo
56 ( ( O O
56 ref JJ O O
56 # # O O
57 76960054 CD O O
57 ) ) O O
58 POTENTIALLY NNP B-NP O
58 SERIOUS NNP I-NP O
58 INTERACTION: NNP I-NP O
58 METOPROLOL NNP I-NP B-m
58 TARTRATE NNP I-NP I-m
58 &amp; NNP I-NP O
59 DILTIAZEM NNP I-NP B-m
59 HCL NNP I-NP I-m
59 Reason NNP I-NP O
59 for IN B-VP O
59 override: NN B-NP O
59 home NN I-NP O
59 emd IN B-VP O
60 Number NNP B-NP B-du
60 of IN B-VP I-du
60 Doses NNP B-NP I-du
60 Required NNP I-NP I-du
60 ( ( O I-du
60 approximate JJ B-NP I-du
60 ): NN I-NP I-du
60 5 CD O I-du
61 ACCUPRIL NNP B-NP B-m
61 ( ( O I-m
61 QUINAPRIL NNP B-NP I-m
61 ) ) O I-m
61 20 CD O B-do
61 MG NNP B-NP I-do
61 PO NNP I-NP B-mo
61 QD NNP I-NP B-f
62 HOLD NNP I-NP O
62 IF: NNP I-NP O
62 sbp&lt;105 NN I-NP O
62 and CC O O
62 call VB O O
62 HO NNP B-NP O
63 Number NNP I-NP B-du
63 of IN B-VP I-du
63 Doses NNP B-NP I-du
63 Required NNP I-NP I-du
63 ( ( O I-du
63 approximate JJ B-NP I-du
63 ): NN I-NP I-du
63 4 CD O I-du
64 TIAZAC NNP B-NP B-m
64 ( ( O I-m
64 DILTIAZEM NNP B-NP I-m
64 EXTENDED NNP I-NP I-m
64 RELEASE NNP I-NP I-m
64 ) ) O I-m
64 240 CD O B-do
64 MG NNP B-NP I-do
64 PO NNP I-NP B-mo
64 QAM NNP I-NP B-f
65 Starting NNP I-NP O
65 IN NNP I-NP O
65 AM NNP I-NP O
65 March NNP I-NP O
65 Food/Drug NNP I-NP O
65 Interaction NNP I-NP O
65 Instruction NNP I-NP O
66 Avoid NNP I-NP O
66 grapefruit NN I-NP O
66 unless IN B-VP O
66 MD NNP B-NP O
66 instructs NNS I-NP O
66 otherwise RB O O
67 Alert NNP B-NP O
67 overridden: NNP I-NP O
67 Override NNP I-NP O
67 added VBD B-VP O
67 on IN B-VP O
67 6/9/04 CD O O
67 by IN B-VP O
68 PLACK NNP B-NP O
68 , , O O
68 MILES NNP B-NP O
68 ALONSO NNP I-NP O
68 , , O O
68 M.D NNP B-NP O
68 , , O O
68 M.P.H NNP B-NP O
69 POTENTIALLY NNP I-NP O
69 SERIOUS NNP I-NP O
69 INTERACTION: NNP I-NP O
69 METOPROLOL NNP I-NP B-m
69 TARTRATE NNP I-NP I-m
69 &amp; NNP I-NP O
70 DILTIAZEM NNP I-NP B-m
70 HCL NNP I-NP I-m
70 Reason NNP I-NP O
70 for IN B-VP O
70 override: NN B-NP O
70 home NN I-NP O
70 med VBN O O
71 LIPITOR NNP B-NP B-m
71 ( ( O I-m
71 ATORVASTATIN NNP B-NP I-m
71 ) ) O I-m
71 80 CD O B-do
71 MG NNP B-NP I-do
71 PO NNP I-NP B-mo
71 QD NNP I-NP B-f
72 Alert NNP I-NP O
72 overridden: NNP I-NP O
72 Override NNP I-NP O
72 added VBD B-VP O
72 on IN B-VP O
72 6/9/04 CD O O
72 by IN B-VP O
73 ALLGIER NNP B-NP O
73 , , O O
73 JOEL NNP B-NP O
73 JUNIOR NNP I-NP O
73 , , O O
73 M.D NNP B-NP O
73 , , O O
73 M.P.H NNP B-NP O
74 POTENTIALLY NNP I-NP O
74 SERIOUS NNP I-NP O
74 INTERACTION: NNP I-NP O
74 NIACIN NNP I-NP B-m
74 , , O O
74 VIT NNP B-NP B-m
74 B-3 NNP I-NP I-m
74 &amp; NNP I-NP O
75 ATORVASTATIN NNP I-NP B-m
75 CALCIUM NNP I-NP I-m
76 POTENTIALLY NNP I-NP O
76 SERIOUS NNP I-NP O
76 INTERACTION: NNP I-NP O
76 WARFARIN NNP I-NP B-m
76 &amp; NNP I-NP O
76 ATORVASTATIN NNP I-NP B-m
77 CALCIUM NNP I-NP O
77 Reason NNP I-NP O
77 for IN B-VP O
77 override: NNP B-NP O
77 home NN I-NP O
77 40mg CD O O
78 NIASPAN NNP B-NP B-m
78 ( ( O I-m
78 NICOTINIC NNP B-NP I-m
78 ACID NNP I-NP I-m
78 SUSTAINED NNP I-NP I-m
78 RELEASE NNP I-NP I-m
78 ) ) O I-m
78 1 CD O B-do
78 GM NNP B-NP I-do
78 PO NNP I-NP B-mo
78 QHS NNP I-NP B-f
79 Override NNP I-NP O
79 Notice: NNP I-NP O
79 Override NNP I-NP O
79 added VBD B-VP O
79 on IN B-VP O
79 6/9/04 CD O O
79 by IN B-VP O
80 RATTEE NNP B-NP O
80 , , O O
80 LEWIS NNP B-NP O
80 IRA NNP I-NP O
80 , , O O
80 M.D NNP B-NP O
80 , , O O
80 M.P.H NNP B-NP O
81 on IN B-VP O
81 order NN B-NP O
81 for IN B-VP O
81 LIPITOR NNP B-NP B-m
81 PO NNP I-NP B-mo
81 ( ( O O
81 ref JJ O O
81 # # O O
81 90217884 CD O O
81 ) ) O O
82 POTENTIALLY NNP B-NP O
82 SERIOUS NNP I-NP O
82 INTERACTION: NNP I-NP O
82 NIACIN NNP I-NP B-m
82 , , O O
82 VIT NNP B-NP B-m
82 B-3 NNP I-NP I-m
82 &amp; NNP I-NP O
83 ATORVASTATIN NNP I-NP B-m
83 CALCIUM NNP I-NP I-m
83 Reason NNP I-NP O
83 for IN B-VP O
83 override: NNP B-NP O
83 home NN I-NP O
83 40mg CD O O
84 LANTUS NNP B-NP B-m
84 ( ( O I-m
84 INSULIN NNP B-NP I-m
84 GLARGINE NNP I-NP I-m
84 ) ) O I-m
84 66 CD O B-do
84 UNITS NNP B-NP I-do
84 SC NNP I-NP B-mo
84 QPM NNP I-NP B-f
85 INSULIN NNP I-NP B-m
85 LISPRO NNP I-NP I-m
85 MIX NNP I-NP I-m
85 75/25 CD O I-m
85 74 CD O B-do
85 UNITS NNP B-NP I-do
85 SC NNP I-NP B-mo
85 QAM NNP I-NP B-f
86 INSULIN NNP I-NP B-m
86 LISPRO NNP I-NP I-m
86 MIX NNP I-NP I-m
86 75/25 CD O I-m
86 54 CD O B-do
86 UNITS NNP B-NP I-do
86 SC NNP I-NP B-mo
86 QPM NNP I-NP B-f
86 QPM NNP I-NP B-f
87 GLUCOMETER NNP I-NP B-m
87 1 CD O B-do
87 EA NNP B-NP I-do
87 SC NNP I-NP B-mo
87 x1 NNP I-NP B-du
88 MAALOX-TABLETS NNP I-NP B-m
88 QUICK NNP I-NP I-m
88 DISSOLVE/CHEWABLE NNP I-NP I-m
88 1-2 JJ B-NP B-do
88 TAB NNP I-NP I-do
88 PO NNP I-NP B-mo
88 Q6H NNP I-NP B-f
89 PRN NNP I-NP O
89 Upset NNP I-NP B-r
89 Stomach NNP I-NP I-r
90 DIET: NNP I-NP O
90 House NNP I-NP O
90 / VBD B-VP O
90 Low NNP B-NP O
90 chol/low NN I-NP O
90 sat VBD B-VP O
90 fat JJ B-NP O
91 DIET: NNP I-NP O
91 House NNP I-NP O
91 / NNP I-NP O
91 ADA NNP I-NP O
91 1800 CD O O
91 cals/dy NN B-NP O
92 ACTIVITY: NNP I-NP O
92 Partial NNP I-NP O
92 weight-bearing: JJ O O
92 no DT B-NP O
92 weight NN I-NP O
92 on IN B-VP O
92 Lt NNP B-NP O
92 foot NN I-NP O
92 Use NNP I-NP O
92 air NN I-NP O
92 cast VBD B-VP O
93 FOLLOW NNP B-NP O
93 UP NNP I-NP O
93 APPOINTMENT( NNP I-NP O
93 S NNP I-NP O
93 ): NNP I-NP O
94 Orthopedics NNP I-NP O
94 , , O O
94 first JJ B-NP O
94 week NN I-NP O
94 February NNP I-NP O
94 768 CD O O
94 302-6808 JJ O O
94 , , O O
95 Dr NNP B-NP O
95 magouyrk NNP I-NP O
95 PCP NNP I-NP O
95 November NNP I-NP O
95 , , O O
96 Arrange NNP B-NP O
96 INR NNP I-NP O
96 to TO O O
96 be VB O O
96 drawn VBN O O
96 on IN B-VP O
96 1/5/04 CD O O
96 with IN B-VP O
96 f/u JJ B-NP O
96 INR's NNP I-NP O
96 to TO O O
96 be VB O O
96 drawn VBN O O
96 every DT O O
97 30 CD O O
97 days NNS B-NP O
97 INR's NNP I-NP O
97 will MD O O
97 be VB O O
97 followed VBN O O
97 by IN B-VP O
97 Dr NNP B-NP O
97 Morrin NNP I-NP O
98 ALLERGY: NNP I-NP O
98 NKA NNP I-NP O
99 ADMIT NNP I-NP O
99 DIAGNOSIS: NNP I-NP O
100 atrial JJ B-NP O
100 fibrillation' NN I-NP O
101 PRINCIPAL NNP I-NP O
101 DISCHARGE NNP I-NP O
101 DIAGNOSIS NNP I-NP O
101 ;Responsible JJ O O
101 After IN B-VP O
101 Study NNP B-NP O
101 for IN B-VP O
101 Causing NNP B-NP O
101 Admission NNP I-NP O
101 ) ) O O
102 atrial JJ B-NP O
102 fibrillation NN I-NP O
102 , , O O
102 calcaneous JJ B-NP O
102 fracture NN I-NP O
103 OTHER NNP I-NP O
103 DIAGNOSIS;Conditions NNP I-NP O
103 , , O O
103 Infections NNP B-NP O
103 , , O O
103 Complications NNP B-NP O
103 , , O O
103 affecting VBG O O
103 Treatment/Stay NNP B-NP O
104 diabetes NNS I-NP O
104 , , O O
104 HTN NNP B-NP O
104 , , O O
104 hypercholesterolemia NN B-NP O
104 , , O O
105 OPERATIONS NNP B-NP O
105 AND NNP I-NP O
105 PROCEDURES: NNP I-NP O
106 OTHER NNP I-NP O
106 TREATMENTS/PROCEDURES NNP I-NP O
106 ( ( O O
106 NOT NNP B-NP O
106 IN NNP I-NP O
106 O.R NNP I-NP O
106 ) ) O O
107 CT NNP B-NP O
107 foot NN I-NP O
107 , , O O
107 Plain NNP B-NP O
107 film NN I-NP O
107 foot NN I-NP O
107 3views CD O O
108 BRIEF NNP B-NP O
108 RESUME NNP I-NP O
108 OF NNP I-NP O
108 HOSPITAL NNP I-NP O
108 COURSE: NNP I-NP O
109 Mr NNP I-NP O
109 Schmider NNP I-NP O
109 is VBZ O O
109 a DT B-NP O
109 64yo JJ I-NP O
109 man NN I-NP O
109 with IN B-VP O
109 T2DM NNP B-NP O
109 , , O O
109 HTN NNP B-NP O
109 , , O O
109 chronic JJ B-NP O
110 afib NN I-NP O
110 , , O O
110 and CC O O
110 several JJ B-NP O
110 hospital NN I-NP O
110 admissions NNS I-NP O
110 for IN B-VP O
110 CHF NNP B-NP O
110 who WP O O
110 presents VBZ O O
110 after IN B-VP O
111 becoming VBG O O
111 dizzy NN B-NP O
111 while IN B-VP O
111 shovelling VBG O O
111 snow VBP O O
111 The DT B-NP O
111 pateint NN I-NP O
111 had VBD B-VP O
111 not RB O O
111 taken VBN O O
111 his PRP$ O O
112 rate NN B-NP O
112 control NN I-NP O
112 medications VBZ O O
112 this DT B-NP O
112 AM NNP I-NP O
112 , , O O
112 and CC O O
112 was VBD B-VP O
112 shovelling VBG O O
112 snow NN B-NP O
113 when WRB O O
113 he PRP O O
113 experienced VBD B-VP O
113 dizziness/lightheadedness NN B-NP O
113 and CC O O
114 fell VBD B-VP O
114 to TO O O
114 his PRP$ O O
114 kness NN B-NP O
114 No NNP I-NP O
114 loss NN I-NP O
114 of IN B-VP O
114 consciousness NN B-NP O
114 , , O O
114 no DT B-NP O
114 head NN I-NP O
114 trauma NN I-NP O
115 Did NNP I-NP O
115 expereince VB O O
115 generalized JJ B-NP O
115 weakness NN I-NP O
115 , , O O
115 but CC O O
115 no DT B-NP O
116 slurred JJ I-NP O
116 speech NN I-NP O
116 , , O O
116 focal JJ B-NP O
116 weakness NN I-NP O
116 , , O O
116 or CC O O
116 incontinence NN B-NP O
116 No RB O O
117 chest NN B-NP O
117 pain NN I-NP O
117 , , O O
117 no DT B-NP O
117 SOB NNP I-NP O
117 , , O O
117 no DT B-NP O
117 orthopnea NN I-NP O
117 , , O O
117 no DT B-NP O
117 PND NNP I-NP O
117 , , O O
117 no DT B-NP O
118 palpitation NN I-NP O
118 s VBD B-VP O
118 EMS-HR NNP B-NP O
118 140s-160s NNS I-NP O
118 , , O O
118 BP NNP B-NP O
118 190/90 CD O O
118 , , O O
118 in IN B-VP O
118 ED NNP B-NP O
119 rate NN I-NP B-r
119 rate NN I-NP B-r
119 controlled VBN O I-r
119 controlled VBN O I-r
119 with IN B-VP O
119 IV NNP B-NP B-mo
119 metoprolol NN I-NP B-m
119 and CC O O
119 diltiazem NN B-NP B-m
120 HR NNP I-NP O
120 100s CD O O
120 , , O O
120 SBP NNP B-NP O
120 100s CD O O
121 Exam NNP B-NP O
121 JVP NNP I-NP O
121 8-10 CD O O
121 , , O O
121 chest JJS B-NP O
121 CTA NNP I-NP O
121 , , O O
121 CV NNP B-NP O
121 irreg NN I-NP O
121 , , O O
121 no DT B-NP O
121 MRG NNP I-NP O
121 , , O O
121 Abd NNP B-NP O
121 obese UH O O
121 , , O O
121 LE NNP B-NP O
121 trace NN I-NP O
121 edema NN I-NP O
121 , , O O
122 possible JJ B-NP O
122 absent NN I-NP O
122 left VBD B-VP O
122 DP NNP B-NP O
122 Labs NNP I-NP O
122 creat NN I-NP O
122 2.1 CD O O
122 ( ( O O
122 base~1.7 NN B-NP O
122 ) ) O O
122 , , O O
122 dig JJ O O
122 0.8 CD O O
122 , , O O
122 trop NN B-NP O
122 0.1 CD O O
122 , , O O
123 ckmb NN B-NP O
123 10.5 CD O O
123 , , O O
123 ck VBD B-VP O
123 383 CD O O
124 ****HOSP NNP B-NP O
124 COURSE*** NNP I-NP O
125 1 CD O O
125 CV NNP B-NP O
125 Isch: NNP I-NP O
125 Most NNP I-NP O
125 c/w JJ B-NP O
125 demand NN I-NP O
125 ischemia NN I-NP B-r
125 Gave NNP I-NP O
126 ASA NNP I-NP B-m
126 , , O O
126 continue VBP O O
126 rate NN B-NP B-r
126 control NN I-NP I-r
126 with IN B-VP O
126 home NN B-NP B-m
126 meds NNS I-NP I-m
126 , , O O
127 continue VBP O O
127 lipitor/niacin NN B-NP B-m
127 ( ( O O
127 incr JJ B-NP O
127 lipitor NN I-NP B-m
127 40--&gt;80 JJ O B-do
127 ) ) O O
127 INR VBZ O O
127 3.3 CD O O
128 so RB O O
128 no RB O O
128 heparin JJ B-NP O
128 Enzymes NNP I-NP O
128 trended VBD B-VP O
128 down RB O O
128 from IN B-VP O
128 0/1-&gt;0.24-&gt;0.23 JJ B-NP O
129 Pump: NNP I-NP O
129 Mildly NNP I-NP O
129 incr JJ B-NP O
129 JVP NNP I-NP O
129 , , O O
129 trace NN B-NP B-r
129 trace NN I-NP B-r
129 edema; NN I-NP I-r
129 edema; NN I-NP I-r
130 continue VBP O O
130 lasix NN B-NP B-m
130 lasix NN I-NP B-m
130 , , O O
130 60 CD O B-do
130 bid NN B-NP B-f
130 ( ( O O
130 was VBD B-VP O
130 40po CD O B-do
130 40po CD O B-mo
130 TID NNP B-NP B-f
130 at IN B-VP O
131 home NN B-NP O
131 ) ) O O
131 Telemetry NN B-NP O
132 2 CD O O
132 Endo: NNP B-NP O
132 Continue NNP I-NP O
132 home NN I-NP O
132 insulin NN I-NP B-m
132 Provided NNP I-NP O
132 diabetes VBZ O O
132 education NN B-NP O
132 Provided VBD B-VP O
133 glucometer RB O O
133 3 CD O O
133 Renal: NNP B-NP O
133 CRI NNP I-NP O
133 , , O O
133 stable JJ O O
134 4 CD O O
134 Pulm: NNP B-NP O
134 Low NNP I-NP O
134 susp NN I-NP O
134 PE NNP I-NP O
134 , , O O
134 given VBN O O
134 INR NNP B-NP O
134 3.3 CD O O
134 and CC O O
134 no DT B-NP O
134 pain NN I-NP O
134 or CC O O
134 asym NN B-NP O
134 LE NNP I-NP O
135 swelling VBG O O
135 5.MSK:sustained CD O O
135 fall NN B-NP O
135 to TO O O
135 Lt NNP B-NP O
135 heel NN I-NP O
135 during IN B-VP O
135 presyncope NN B-NP O
135 Initially NNP I-NP O
135 p VBZ O O
136 ain NN B-NP O
136 with IN B-VP O
136 ambulation NN B-NP O
136 On IN B-VP O
136 HD NNP B-NP O
136 2 CD O O
136 difficulty NN B-NP O
136 with IN B-VP O
136 weight JJ O O
136 bearting VBG O O
137 Tenderness NN B-NP O
137 over IN B-VP O
137 tallus JJ B-NP O
137 Plain NNP I-NP O
137 films NNS I-NP O
137 showed VBD B-VP O
137 question NN B-NP O
137 of IN B-VP O
137 anterior JJ O O
137 cal JJ O O
138 caneous JJ O O
138 and CC O O
138 tallus JJ B-NP O
138 fracture NN I-NP O
138 Discussed VBN O O
138 with IN B-VP O
138 orthopedics NNS B-NP O
138 Provided NNP I-NP O
139 hard RB O O
139 boot VBZ O O
139 told VBD B-VP O
139 to TO O O
139 not RB O O
139 bear VB O O
139 full JJ B-NP O
139 weight NN I-NP O
139 on IN B-VP O
139 left JJ B-NP O
139 foot NN I-NP O
139 CT NNP I-NP O
139 performed VBD B-VP O
140 with IN B-VP O
140 reconstitutions NNS B-NP O
140 to TO O O
140 rule VB O O
140 out RP O O
140 avulsion NN B-NP O
140 Patient NNP I-NP O
140 was VBD B-VP O
140 stable JJ O O
140 to TO O O
140 be VB O O
141 discharged VBN O O
141 with IN B-VP O
141 outpatient JJ B-NP O
141 regimen NNS I-NP O
141 with IN B-VP O
141 follow VBP O O
141 up RP O O
141 one CD O O
141 week NN B-NP O
141 from IN B-VP O
142 discharge NN B-NP O
142 with IN B-VP O
142 orthopedics NNS B-NP O
142 ambulatory JJ B-NP O
142 clinic JJ I-NP O
142 Code: NNP I-NP O
142 FULL NNP I-NP O
142 CODE NNP I-NP O
143 ADDITIONAL NNP I-NP O
143 COMMENTS: NNP I-NP O
143 Please NNP I-NP O
143 take VB O O
143 all DT B-NP O
143 medications NNS I-NP O
143 as IN B-VP O
143 indicated JJ B-NP O
143 Please NNP I-NP O
143 call NN I-NP O
143 orthopedics NNS I-NP O
143 for IN B-VP O
144 your PRP$ O O
144 appointment NN B-NP O
144 You PRP O O
144 need VBP O O
144 to TO O O
144 be VB O O
144 seen VBN O O
144 next JJ B-NP O
144 week NN I-NP O
144 to TO O O
144 evaluate VB O O
144 your PRP$ O O
144 foot NN B-NP O
145 fracture NN I-NP O
145 242 CD O O
145 672 CD O O
145 4668 CD O O
145 Please NNP B-NP O
145 take VB O O
145 your PRP$ O O
145 blood NN B-NP O
145 sugar NN I-NP O
145 as IN B-VP O
145 you PRP O O
145 were VBD B-VP O
146 taught VBN O O
146 here RB O O
146 Please NNP B-NP O
146 follow VB O O
146 up RP O O
146 with IN B-VP O
146 yoru NNS B-NP O
146 cardiologist VBP O O
146 within IN B-VP O
146 2 CD O O
146 weeks NNS B-NP O
146 of IN B-VP O
147 discharge NN B-NP O
148 DISCHARGE NNP I-NP O
148 CONDITION: NNP I-NP O
148 Stable NNP I-NP O
149 TO NNP I-NP O
149 DO/PLAN: NNP I-NP O
150 No NNP I-NP O
150 dictated VBD B-VP O
150 summary JJ B-NP O
151 ENTERED NNP I-NP O
151 BY: NNP I-NP O
151 QUILLER NNP I-NP O
151 , , O O
151 ELBERT NNP B-NP O
151 J NNP I-NP O
151 , , O O
151 M.D NNP B-NP O
151 , , O O
151 M.PHIL NNP B-NP O
151 ( ( O O
151 NH177 NNP B-NP O
151 ) ) O O
151 4/14/04 CD O O
151 @ $ O O
151 05:27 CD O O
151 PM NNP B-NP O
152 ****** JJ B-NP O
152 END NNP I-NP O
152 OF NNP I-NP O
152 DISCHARGE NNP I-NP O
152 ORDERS NNP I-NP O
152 ****** NNP I-NP O
153 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #55056 VBZ O O
4 447820941 CD O O
4 TSH NNP B-NP O
4 87152485 CD O O
4 102781 CD O O
4 1/10/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 NSTE NNP I-NP O
4 MI NNP I-NP O
4 , , O O
4 refused VBD B-VP O
4 cath NN B-NP O
4 treated VBN O O
4 medically RB O O
4 with IN B-VP O
4 lovenox/integrilin JJ B-NP B-m
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/10/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/4/2001 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 BIGLER NNP I-NP O
8 , , O O
8 MANUEL NNP B-NP O
8 637-16-52-7 NNP I-NP O
9 Ca NNP I-NP O
9 Parkway NNP I-NP O
9 , , O O
9 Ale NNP B-NP O
9 Ph NNP I-NP O
9 Por NNP I-NP O
9 , , O O
9 Mississippi NNP B-NP O
9 02896 CD O O
10 Service: NNP B-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 7/18/01 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 SPANIER NNP I-NP O
14 , , O O
14 DOUGLAS NNP B-NP O
14 MOSE NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
14 , , O O
14 PH.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 ECASA NNP I-NP B-m
17 ( ( O I-m
17 ASPIRIN NNP B-NP I-m
17 ENTERIC NNP I-NP I-m
17 COATED NNP I-NP I-m
17 ) ) O I-m
17 325 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 MICRONASE NNP I-NP B-m
18 ( ( O I-m
18 GLYBURIDE NNP B-NP I-m
18 ) ) O I-m
18 5 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 HCTZ NNP I-NP B-m
19 ( ( O I-m
19 HYDROCHLOROTHIAZIDE NNP B-NP I-m
19 ) ) O I-m
19 25 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 NITROGLYCERIN NNP I-NP B-m
20 1/150 CD O I-m
20 ( ( O I-m
20 0.4 CD O I-m
20 MG NNP B-NP I-m
20 ) ) O I-m
20 1 CD O B-do
20 TAB NNP B-NP I-do
20 SL NNP I-NP B-mo
20 q5min VBD B-VP B-f
20 x $ O O
20 3 CD O O
21 PRN NNP B-NP O
21 chest NN I-NP B-r
21 pain NN I-NP I-r
21 HOLD NNP I-NP O
21 IF: NNP I-NP O
21 SBP NNP I-NP O
21 &lt; VBD B-VP O
21 100 CD O O
22 ZOCOR NNP B-NP B-m
22 ( ( O I-m
22 SIMVASTATIN NNP B-NP I-m
22 ) ) O I-m
22 20 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QHS NNP I-NP B-f
23 Food/Drug NNP I-NP O
23 Interaction NNP I-NP O
23 Instruction NNP I-NP O
24 Avoid NNP I-NP O
24 grapefruit NN I-NP O
24 unless IN B-VP O
24 MD NNP B-NP O
24 instructs NNS I-NP O
24 otherwise RB O O
25 LEVOFLOXACIN NNP B-NP B-m
25 250 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QD NNP I-NP B-f
25 X NNP I-NP B-du
25 4 CD O I-du
25 Days NNPS B-NP I-du
26 Starting VBG O O
26 Today NNP B-NP O
26 ( ( O O
26 10/16 CD O O
26 ) ) O O
26 Food/Drug NNP B-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 If IN B-VP O
27 on IN B-VP O
27 tube NN B-NP O
27 feeds NNS I-NP O
27 , , O O
27 please VB O O
27 cycle NN B-NP O
27 ( ( O O
27 hold VB O O
27 1 CD O O
27 hr NN B-NP O
27 before IN B-VP O
27 to TO O O
27 2 CD O O
27 hr NNS B-NP O
28 after IN B-VP O
28 ) ) O O
28 Take VBP O O
28 2 CD O O
28 hours NNS B-NP O
28 before IN B-VP O
28 or CC O O
28 2 CD O O
28 hours NNS B-NP O
28 after IN B-VP O
28 dairy NN B-NP O
28 products NNS I-NP O
29 ZESTRIL NNP I-NP B-m
29 ( ( O I-m
29 LISINOPRIL NNP B-NP I-m
29 ) ) O I-m
29 20 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QD NNP I-NP B-f
30 Alert NNP I-NP O
30 overridden: NNP I-NP O
30 Override NNP I-NP O
30 added VBD B-VP O
30 on IN B-VP O
30 2/18/01 CD O O
30 by IN B-VP O
30 : : O O
31 POTENTIALLY NNP B-NP O
31 SERIOUS NNP I-NP O
31 INTERACTION: NNP I-NP O
31 POTASSIUM NNP I-NP B-m
31 CHLORIDE NNP I-NP I-m
31 &amp; NNP I-NP O
32 LISINOPRIL NNP I-NP B-m
33 POTENTIALLY NNP I-NP O
33 SERIOUS NNP I-NP O
33 INTERACTION: NNP I-NP O
33 POTASSIUM NNP I-NP B-m
33 CHLORIDE NNP I-NP I-m
33 &amp; NNP I-NP O
34 LISINOPRIL NNP I-NP B-m
34 Reason NNP I-NP O
34 for IN B-VP O
34 override: NN B-NP O
34 ok JJ B-NP O
35 ATENOLOL NNP I-NP B-m
35 50 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 QD NNP I-NP O
35 Food/Drug NNP I-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
36 Take NNP I-NP O
36 consistently RB O O
36 with IN B-VP O
36 meals NNS B-NP O
36 or CC O O
36 on IN B-VP O
36 empty JJ B-NP O
36 stomach NN I-NP O
37 PRILOSEC NNP I-NP B-m
37 ( ( O I-m
37 OMEPRAZOLE NNP B-NP I-m
37 ) ) O I-m
37 20 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 Alert NNP I-NP O
38 overridden: NNP I-NP O
38 Override NNP I-NP O
38 added VBD B-VP O
38 on IN B-VP O
38 2/18/01 CD O O
38 by IN B-VP O
38 : : O O
39 POTENTIALLY NNP B-NP O
39 SERIOUS NNP I-NP O
39 INTERACTION: NNP I-NP O
39 HYDROCHLOROTHIAZIDE NNP I-NP B-m
39 &amp; NNP I-NP O
40 OMEPRAZOLE NNP I-NP B-m
41 POTENTIALLY NNP I-NP O
41 SERIOUS NNP I-NP O
41 INTERACTION: NNP I-NP O
41 HYDROCHLOROTHIAZIDE NNP I-NP B-m
41 &amp; NNP I-NP O
42 OMEPRAZOLE NNP I-NP B-m
42 Reason NNP I-NP O
42 for IN B-VP O
42 override: NN B-NP O
42 ok JJ B-NP O
43 RETURN NNP I-NP O
43 TO NNP I-NP O
43 WORK: NNP I-NP O
43 Not RB O O
43 Applicable NNP B-NP O
44 FOLLOW NNP I-NP O
44 UP NNP I-NP O
44 APPOINTMENT( NNP I-NP O
44 S NNP I-NP O
44 ): NNP I-NP O
45 Dr NNP I-NP O
45 Truman NNP I-NP O
45 Thro NNP I-NP O
45 1-2 JJ B-NP O
45 wks NN I-NP O
45 , , O O
46 Dr NNP B-NP O
46 Stevie NNP I-NP O
46 Gilani NNP I-NP O
46 , , O O
46 cardiology NN B-NP O
46 , , O O
46 Mon NNP B-NP O
46 , , O O
46 1/2/02 CD O O
46 1:00 CD O O
46 pm NN B-NP O
46 , , O O
46 Bock NNP B-NP O
46 0/12/02 CD O O
46 , , O O
47 No DT B-NP O
47 Known NNP I-NP O
47 Allergies NNP I-NP O
48 ADMIT NNP I-NP O
48 DIAGNOSIS: NNP I-NP O
49 chest JJS B-NP O
49 pain NN I-NP O
50 PRINCIPAL NNP I-NP O
50 DISCHARGE NNP I-NP O
50 DIAGNOSIS NNP I-NP O
50 ;Responsible JJ O O
50 After IN B-VP O
50 Study NNP B-NP O
50 for IN B-VP O
50 Causing NNP B-NP O
50 Admission NNP I-NP O
50 ) ) O O
51 NSTE NNP B-NP O
51 MI NNP I-NP O
51 , , O O
51 refused VBD B-VP O
51 cath NN B-NP O
51 treated VBN O O
51 medically RB O O
51 with IN B-VP O
51 lovenox/integrilin NN B-NP B-m
52 OTHER NNP I-NP O
52 DIAGNOSIS;Conditions NNP I-NP O
52 , , O O
52 Infections NNP B-NP O
52 , , O O
52 Complications NNP B-NP O
52 , , O O
52 affecting VBG O O
52 Treatment/Stay NNP B-NP O
53 LGIB NNP I-NP O
53 TOBACCO NNP I-NP O
53 PAF-no NNP I-NP O
53 anticoag NN I-NP O
53 for IN B-VP O
53 distant JJ B-NP O
53 h/o NN I-NP O
53 lgi NN I-NP O
53 bleed VBD B-VP O
53 htn JJ B-NP O
53 dm NN I-NP O
53 hyperchol NN I-NP O
54 periph NN I-NP O
54 neuropathy JJ B-NP O
54 h NN I-NP O
54 pylori JJ B-NP O
55 OPERATIONS NNP I-NP O
55 AND NNP I-NP O
55 PROCEDURES: NNP I-NP O
56 OTHER NNP I-NP O
56 TREATMENTS/PROCEDURES NNP I-NP O
56 ( ( O O
56 NOT NNP B-NP O
56 IN NNP I-NP O
56 O.R NNP I-NP O
56 ) ) O O
57 medical JJ B-NP O
57 treatment NN I-NP O
57 of IN B-VP O
57 NSTE NNP B-NP O
57 MI: NNP I-NP O
57 lovenox/integrilin NN I-NP B-m
57 ( ( O O
57 pt NN B-NP O
57 refused VBD B-VP O
57 cath NN B-NP O
57 ) ) O O
58 BRIEF NNP B-NP O
58 RESUME NNP I-NP O
58 OF NNP I-NP O
58 HOSPITAL NNP I-NP O
58 COURSE: NNP I-NP O
59 70 CD O O
59 yo NNP B-NP O
59 woman NN I-NP O
59 with IN B-VP O
59 no DT O O
59 known VBN O O
59 CAD NNP B-NP O
59 , , O O
59 cardiac JJ B-NP O
59 RF: NNP I-NP O
59 HTN NNP I-NP O
59 , , O O
60 DM NNP B-NP O
60 , , O O
60 hyperchol NN B-NP O
60 , , O O
60 current JJ B-NP O
60 tob NN I-NP O
60 , , O O
60 H/O NNP B-NP O
60 PAF NNP I-NP O
60 on IN B-VP O
60 no DT B-NP O
60 anticoag NN I-NP O
60 2/2 CD O O
60 distant JJ B-NP O
60 h/o NN I-NP O
61 LGIB NNP I-NP O
61 , , O O
61 a/w NN B-NP O
61 palpitations NNS I-NP O
61 followed VBN O O
61 by IN B-VP O
61 10 CD O O
61 hrs NN B-NP O
61 of IN B-VP O
61 chest NN B-NP O
62 tightness NN I-NP O
62 Pt NNP I-NP O
62 at IN B-VP O
62 baseline NN B-NP O
62 able JJ O O
62 to TO O O
62 do VB O O
62 1-2 JJ B-NP O
62 flights NNS I-NP O
62 of IN B-VP O
63 stairs NNS B-NP O
63 before IN B-VP O
63 SOB NNP B-NP O
63 No NNP I-NP O
63 sx NN I-NP O
63 of IN B-VP O
63 CHF NNP B-NP O
63 Pt NNP I-NP O
63 in IN B-VP O
63 her PRP$ O O
63 USOH NNP B-NP O
63 , , O O
64 eating VBG O O
64 potato JJ B-NP O
64 chips NNS I-NP O
64 at IN B-VP O
64 home NN B-NP O
64 , , O O
64 when WRB O O
64 she PRP O O
64 had VBD B-VP O
65 palpitations NNS B-NP O
65 for IN B-VP O
65 a DT B-NP O
65 couple NN I-NP O
65 of IN B-VP O
65 minutes NNS B-NP O
65 , , O O
65 +LH NNP B-NP O
65 , , O O
65 felt VBD B-VP O
65 weak JJ O O
65 , , O O
65 SOB NNP B-NP O
65 , , O O
66 then RB O O
66 had VBD B-VP O
66 tightness NN B-NP O
66 in IN B-VP O
66 chest NN B-NP O
66 which WDT O O
66 she PRP O O
66 has VBZ O O
66 never RB O O
67 had VBN O O
67 before IN B-VP O
67 with IN B-VP O
67 her PRP$ O O
67 palpitations NNS B-NP O
67 Palp NNP I-NP O
67 resolved VBD B-VP O
67 , , O O
68 but CC O O
68 CP NNP B-NP O
68 lingered VBD B-VP O
68 through IN B-VP O
68 night NN B-NP O
68 5/10 CD O O
68 SSCP NNP B-NP O
69 "squeezing" NNP I-NP O
69 , , O O
69 also RB O O
69 in IN B-VP O
69 back RB O O
69 , , O O
69 and CC O O
69 L NNP B-NP O
69 arm NN I-NP O
69 ?relief NN I-NP O
69 with IN B-VP O
69 burping VBG O O
70 Pt NNP B-NP O
70 last JJ O O
70 had VBD B-VP O
70 tachyarrhythmia JJ O O
70 2 CD O O
70 yrs NN B-NP O
70 ago RB O O
70 and CC O O
70 has VBZ O O
71 had VBN O O
71 none NN B-NP O
71 since IN B-VP O
71 IN NNP B-NP O
71 ED NNP I-NP O
71 , , O O
71 pt NN B-NP O
71 pain NN I-NP B-r
71 pain NN I-NP B-r
71 releived VBD B-VP O
71 with IN B-VP O
72 SLNG NNP B-NP B-m
72 , , O O
72 and CC O O
72 2" CD O B-do
72 NTP NNP B-NP B-m
72 EKG NNP I-NP O
72 with IN B-VP O
72 TWflattening NNP B-NP O
72 v5-6 NN I-NP O
72 but CC O O
72 no DT B-NP O
73 ST NNP I-NP O
73 elevations NNS I-NP O
73 , , O O
73 and CC O O
73 CK160 NNP B-NP O
73 , , O O
73 TnI NNP B-NP O
73 0.3 CD O O
73 Pt NNP B-NP O
73 started VBD B-VP O
74 on IN B-VP O
74 heparin NN B-NP B-m
74 , , O O
74 integrelin NN B-NP B-m
74 for IN B-VP O
74 NSTE NNP B-NP B-r
74 NSTE NNP I-NP B-r
74 MI NNP I-NP I-r
74 MI NNP I-NP I-r
74 , , O O
74 and CC O O
74 cont NN B-NP O
74 on IN B-VP O
75 ASA NNP B-NP B-m
75 , , O O
75 BB NNP B-NP B-m
75 , , O O
75 ACEI NNP B-NP B-m
75 , , O O
75 statin NN B-NP B-m
75 Exam NNP I-NP O
75 notable JJ O O
75 for IN B-VP O
75 VSS NNP B-NP O
75 , , O O
75 no DT B-NP O
76 JVD NNP I-NP O
76 , , O O
76 distant JJ B-NP O
76 heart NN I-NP O
76 sounds VBZ O O
76 I-II/VI JJ B-NP O
76 SEM NNP I-NP O
76 at IN B-VP O
76 USB NNP B-NP O
76 , , O O
76 nl JJ B-NP O
77 S2 NNP I-NP O
77 , , O O
77 clear JJ B-NP O
77 lungs NNS I-NP O
77 , , O O
77 neuro JJ B-NP O
77 intact NN I-NP O
77 Of IN B-VP O
77 note NN B-NP O
77 , , O O
77 in IN B-VP O
77 past JJ O O
77 , , O O
78 pt NN B-NP O
78 has VBZ O O
78 refused VBN O O
78 multiple RB O O
78 medical JJ B-NP O
78 procedures NNS I-NP O
79 ( ( O O
79 mammos NN B-NP O
79 , , O O
79 colonoscopy NN B-NP O
79 , , O O
79 EP NNP B-NP O
79 study NN I-NP O
79 ) ) O O
79 , , O O
79 and CC O O
79 at IN B-VP O
79 this DT B-NP O
79 point NN I-NP O
79 , , O O
80 does VBZ O O
80 not RB O O
80 want VB O O
80 to TO O O
80 have VB O O
80 a DT B-NP O
80 cardiac JJ I-NP O
80 cath NN I-NP O
80 Admit NNP I-NP O
80 to TO O O
81 Coness- NNP B-NP O
81 Ther NNP I-NP O
81 Hospital NNP I-NP O
81 for IN B-VP O
81 further JJ B-NP O
81 management/potential JJ I-NP O
81 cath NN I-NP O
81 if IN B-VP O
82 she PRP O O
82 changes VBZ O O
83 mind RB O O
83 1 CD O O
83 Cardiac--acute JJ B-NP O
83 NSTE NNP I-NP O
83 MI NNP I-NP O
83 vs POS O O
83 demand-induced JJ B-NP O
84 NSTE NNP I-NP O
84 MI NNP I-NP O
84 from IN B-VP O
84 tachyarrythmia NN B-NP O
84 Cont NNP I-NP O
84 ASA NNP I-NP B-m
84 , , O O
85 BB NNP B-NP B-m
85 , , O O
85 ACEinh NNP B-NP B-m
85 , , O O
85 statin NN B-NP B-m
85 , , O O
85 heparin NN B-NP B-m
85 , , O O
85 integrilin NN B-NP B-m
85 Was NNP I-NP O
86 discussed VBN O O
86 many JJ B-NP O
86 times NNS I-NP O
86 w/ VBP O O
86 pt JJ O O
86 by IN B-VP O
86 different JJ B-NP O
86 staff NN I-NP O
86 benefits NNS I-NP O
87 and CC O O
87 info VB O O
87 about IN B-VP O
87 cath NN B-NP O
87 , , O O
87 but CC O O
87 pt RB O O
87 deciced VBD B-VP O
87 on IN B-VP O
87 medical JJ B-NP O
87 rx NN I-NP O
88 Pt NNP I-NP O
88 switched VBD B-VP O
88 from IN B-VP O
88 heparin NN B-NP B-m
88 to TO O O
88 lovenox/integrilin VB O B-m
88 for IN B-VP O
88 proven JJ B-NP O
88 benefits NNS I-NP O
88 if IN B-VP O
89 noninvasive JJ B-NP O
89 managmemetn NN I-NP O
89 for IN B-VP B-du
89 total NN B-NP I-du
89 of IN B-VP I-du
89 72 CD O I-du
89 hr JJ B-NP I-du
89 course NN I-NP I-du
89 integ/hep NN I-NP B-m
90 ( ( O O
90 finished VBN O O
90 Wed NNP B-NP O
90 , , O O
90 monitor NN B-NP O
90 until IN B-VP O
90 Thurs NNP B-NP O
90 ) ) O O
90 Titrating VBG O B-do
90 BP NNP B-NP B-m
90 meds NNS I-NP I-m
90 for IN B-VP O
90 better JJR B-NP O
91 control NN I-NP O
91 ( ( O O
91 130-160 JJ B-NP O
91 )--because NN I-NP O
91 HR NNP I-NP O
91 has VBZ O O
91 been VBN O O
91 in IN B-VP O
91 50's CD O O
91 , , O O
91 added VBD B-VP O
91 HCTZ NNP B-NP B-m
91 for IN B-VP O
91 BP NNP B-NP B-r
92 control NN I-NP O
92 PUMP: NNP I-NP O
92 repeat NN I-NP O
92 echo NN I-NP O
92 ( ( O O
92 last JJ O O
92 one CD O O
92 '88 POS O O
92 ) ) O O
93 for IN B-VP O
93 change NN B-NP O
93 in IN B-VP O
93 fxn: JJ B-NP O
93 prelim: NN I-NP O
93 mild JJ B-NP O
93 hypokinesis NN I-NP O
93 in IN B-VP O
94 lat JJ B-NP O
94 wall NN I-NP O
94 , , O O
94 awaiting VBG O O
94 final JJ B-NP O
95 report NN I-NP O
95 RATE/RHYTHM: NNP I-NP O
95 cardiac JJ B-NP O
95 telemetry NN I-NP O
95 , , O O
95 HR's NNP B-NP O
95 tend VBP O O
95 to TO O O
96 be VB O O
96 low JJ O O
96 50's CD O O
96 in IN B-VP O
96 AM NNP B-NP O
96 asymptomatic JJ O O
96 , , O O
96 cont JJ B-NP O
96 regimen NNS I-NP O
96 First JJ B-NP O
96 time NN I-NP O
96 she PRP O O
96 has VBZ O O
96 had VBN O O
97 palpitations NNS B-NP O
97 in IN B-VP O
97 2 CD O O
97 yrs NN B-NP O
97 , , O O
97 will MD O O
97 need VB O O
97 f/u NN B-NP O
97 of IN B-VP O
97 this DT B-NP O
97 issue--no JJ I-NP O
97 arrythmias NN I-NP O
97 in IN B-VP O
97 ho NN B-NP O
98 use NN I-NP O
99 2 CD O O
99 Endo: NNP B-NP O
99 DM NNP I-NP B-r
99 II--CZI NNP I-NP B-m
99 ss NN I-NP O
99 , , O O
99 cont JJ B-NP O
99 micronase NN I-NP B-m
100 3 CD O O
100 GI: NNP B-NP O
100 nexium NN I-NP B-m
100 , , O O
100 colace NN B-NP B-m
101 4 CD O O
101 ID: NNP B-NP O
101 pt NN I-NP O
101 with IN B-VP O
101 UTI--rx NNP B-NP B-r
101 levoflox NN I-NP B-m
101 x VBZ O B-du
101 7 CD O I-du
101 days NNS B-NP I-du
102 4 CD O O
102 DVT NNP B-NP B-r
102 proph: NN I-NP I-r
102 on IN B-VP O
102 lovenox $ O B-m
103 5 CD O O
103 code NN B-NP O
103 status: NN I-NP O
103 FULL NNP I-NP O
104 6 CD O O
104 Dispo: NNP B-NP O
104 PT NNP I-NP O
104 eval NN I-NP O
104 , , O O
104 discharge NN B-NP O
104 Thursday NNP I-NP O
104 when WRB O O
104 72 CD O B-du
104 hr NN B-NP I-du
104 course NN I-NP I-du
105 lovenox/integrilin VBD B-VP B-m
105 complete JJ O O
105 for IN B-VP O
105 rx JJ B-NP B-r
105 NSTE NNP I-NP I-r
105 MI NNP I-NP I-r
105 Pt NNP I-NP O
105 in IN B-VP O
105 stable JJ B-NP O
105 condition NN I-NP O
105 a DT B-NP O
106 nd NN I-NP O
106 will MD O O
106 d/c VB O O
106 on IN B-VP O
106 new JJ B-NP O
106 meds: NN I-NP O
106 HCTZ NNP I-NP B-m
106 , , O O
106 nexium NN B-NP B-m
106 ( ( O O
106 LGIB NNP B-NP B-r
106 history NN I-NP I-r
106 ) ) O O
106 , , O O
106 SLNG NNP B-NP B-m
106 prn NN I-NP B-f
106 , , O O
107 levoflox JJ O B-m
107 x VBP O B-du
107 4 CD O I-du
107 more JJR B-NP I-du
107 days NNS I-NP I-du
107 Pt NNP I-NP O
107 f/u NN I-NP O
107 with IN B-VP O
107 Dr NNP B-NP O
107 Ezequiel NNP I-NP O
107 Drzewicki NNP I-NP O
107 in IN B-VP O
107 1-2 JJ B-NP O
107 wks NN I-NP O
107 , , O O
108 and CC O O
108 with IN B-VP O
108 a DT B-NP O
108 new JJ I-NP O
108 cardiologist NN I-NP O
108 in IN B-VP O
108 2-4 JJ B-NP O
108 wks JJ I-NP O
109 ADDITIONAL NNP I-NP O
109 COMMENTS: NNP I-NP O
109 You PRP O O
109 have VBP O O
109 had VBN O O
109 a DT B-NP O
109 heart NN I-NP O
109 attack NN I-NP O
109 and CC O O
109 because IN B-VP O
109 you PRP O O
109 did VBD B-VP O
109 not RB O O
109 want VB O O
109 to TO O O
109 have VB O O
109 a DT B-NP O
110 cardiac JJ I-NP O
110 catheterization NN I-NP O
110 to TO O O
110 fix VB O O
110 any DT B-NP O
110 blockages NNS I-NP O
110 that WDT O O
110 may MD O O
110 be VB O O
110 in IN B-VP O
110 your PRP$ O O
110 heart NN B-NP O
111 arteries VBZ O O
111 supplying VBG O O
111 your PRP$ O O
111 heart NN B-NP O
111 , , O O
111 we PRP O O
111 have VBP O O
111 treated VBN O O
111 you PRP O O
111 with IN B-VP O
111 medicines NNS B-NP O
111 Your PRP$ O O
112 blood NN B-NP O
112 pressure NN I-NP O
112 was VBD B-VP O
112 high JJ O O
112 in IN B-VP O
112 the DT B-NP O
112 hospital NN I-NP O
112 , , O O
112 so RB O O
112 we've RB O O
112 started VBN O O
112 you PRP O O
112 on IN B-VP O
112 a DT B-NP O
113 medicine NN I-NP O
113 HCTZ NNP I-NP B-m
113 , , O O
113 and CC O O
113 also RB O O
113 an DT O O
113 antibiotic JJ O B-m
113 , , O O
113 levofloxacin JJ O B-m
113 , , O O
113 for IN B-VP O
113 a DT O B-r
113 a DT B-NP B-r
113 urinary JJ I-NP O
114 tract NN I-NP O
114 infection NN I-NP O
114 which WDT O O
114 you PRP O O
114 should MD O O
114 take VB O O
114 for IN B-VP B-du
114 4 CD O I-du
114 more JJR B-NP I-du
114 days NNS I-NP I-du
114 See NNP I-NP O
114 Dr NNP I-NP O
115 Garhart NNP I-NP O
115 in IN B-VP O
115 1-2 JJ B-NP O
115 wks NN I-NP O
115 , , O O
115 and CC O O
115 a DT B-NP O
115 cardiologist NN I-NP O
115 in IN B-VP O
115 2-4 JJ B-NP O
115 wks NN I-NP O
115 Call NN I-NP O
115 if IN B-VP O
115 you PRP O O
115 have VBP O O
116 more JJR B-NP O
116 chest JJ I-NP O
116 pain NN I-NP O
116 , , O O
116 shortness NN B-NP O
116 of IN B-VP O
116 breath NN B-NP O
116 , , O O
116 palpitations NNS B-NP O
117 DISCHARGE NNP I-NP O
117 CONDITION: NNP I-NP O
117 Stable NNP I-NP O
118 TO NNP I-NP O
118 DO/PLAN: NNP I-NP O
119 No NNP I-NP O
119 dictated VBD B-VP O
119 summary JJ B-NP O
120 ENTERED NNP I-NP O
120 BY: NNP I-NP O
120 ANAYA NNP I-NP O
120 , , O O
120 EDUARDO NNP B-NP O
120 SAMMIE NNP I-NP O
120 , , O O
120 M.D NNP B-NP O
120 ( ( O O
120 NV48 NNP B-NP O
120 ) ) O O
120 7/18/01 CD O O
120 @ $ O O
120 11:46 CD O O
120 AM NNP B-NP O
121 ****** JJ B-NP O
121 END NN I-NP O
121 OF NNP I-NP O
121 DISCHARGE NNP I-NP O
121 ORDERS NNP I-NP O
121 ****** NNP I-NP O
122 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #64589 VBZ O O
2 220253841 CD O O
2 HH NNP B-NP O
2 55640268 CD O O
2 7682221 CD O O
2 9/7/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/28/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
4 ATTENDING: NNP I-NP O
4 KETTMANN NNP I-NP O
4 , , O O
4 QUENTIN NNP B-NP O
4 M.D NNP I-NP O
5 ADMISSION NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Cardiac NNP I-NP O
5 arrest NN I-NP O
6 DISCHARGE NNP I-NP O
6 DIAGNOSIS: NNP I-NP O
6 Sepsis/line NNP I-NP O
6 infection NN I-NP O
6 , , O O
6 end-stage JJ B-NP O
6 renal JJ I-NP O
7 disease NN I-NP O
7 on IN B-VP O
7 hemodialysis NN B-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT B-NP O
8 54-year-old JJ I-NP O
8 female NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 cardiomyopathy NN B-NP O
9 , , O O
9 hypertension NN B-NP O
9 , , O O
9 diabetes VBZ O O
9 type JJ O O
9 2 CD O O
9 , , O O
10 end-stage JJ B-NP O
10 renal JJ I-NP O
10 disease NN I-NP O
10 on IN B-VP O
10 hemodialysis NN B-NP O
10 who WP O O
10 had VBD B-VP O
10 a DT O O
10 reported VBN O O
11 cardiac JJ B-NP O
11 arrest NN I-NP O
11 while IN B-VP O
11 receiving VBG O O
11 dialysis NN B-NP O
11 on IN B-VP O
11 8/1/06 CD O O
11 in IN B-VP O
11 her PRP$ O O
12 outpatient JJ B-NP O
12 clinic NN I-NP O
12 at IN B-VP O
12 Richgo NNP B-NP O
12 Ster NNP I-NP O
12 Ha NNP I-NP O
12 She PRP O O
12 began VBD B-VP O
12 to TO O O
12 feel VB O O
12 nauseated JJ O O
12 and CC O O
13 then RB O O
13 vomited VBD B-VP O
13 The DT B-NP O
13 patient NN I-NP O
13 then RB O O
13 reportedly RB O O
13 went VBD B-VP O
13 into IN B-VP O
13 VFib NNP B-NP O
13 and CC O O
13 was VBD B-VP O
14 shocked VBN O O
14 once RB O O
14 by IN B-VP O
14 EMS NNP B-NP O
14 , , O O
14 resulting VBG O O
14 in IN B-VP O
14 a DT B-NP O
14 narrow JJ I-NP O
14 QRS NNP I-NP O
14 complex NN I-NP O
14 rhythm NN I-NP O
15 She PRP O O
15 was VBD B-VP O
15 intubated VBN O O
15 , , O O
15 received VBD B-VP O
15 amiodarone NN B-NP B-m
15 and CC O O
15 dopamine NN B-NP B-m
15 , , O O
15 as IN B-VP O
15 her PRP$ O B-r
15 her PRP$ O B-r
15 BP NNP B-NP I-r
15 BP NNP I-NP I-r
15 was VBD B-VP O
16 approximately RB O O
16 70s CD O O
16 systolic NN B-NP O
16 over IN B-VP O
16 palpable JJ B-NP O
16 diastolic NN I-NP O
16 In IN B-VP O
16 the DT B-NP O
16 ED NNP I-NP O
16 , , O O
16 a DT B-NP O
16 portable JJ I-NP O
17 chest NN I-NP O
17 x-ray NN I-NP O
17 revealed VBD B-VP O
17 diffuse RB O O
17 bilateral JJ B-NP O
17 opacities NNS I-NP O
17 , , O O
17 risk NN B-NP O
17 of IN B-VP O
17 pulmonary JJ B-NP O
17 edema NN I-NP O
17 and CC O O
18 ABG NNP B-NP O
18 showed VBD B-VP O
18 respiratory JJ B-NP O
18 acidosis NN I-NP O
18 Pt NNP I-NP O
18 was VBD B-VP O
18 transferred VBN O O
18 to TO O O
18 the DT B-NP O
18 ICU NNP I-NP O
18 for IN B-VP O
18 further JJ B-NP O
19 management NN I-NP O
20 Of IN B-VP O
20 note NN B-NP O
20 , , O O
20 she PRP O O
20 was VBD B-VP O
20 recently RB O O
20 hospitalized VBN O O
20 at IN B-VP O
20 Somver NNP B-NP O
20 Vasky NNP I-NP O
20 University NNP I-NP O
20 Of IN B-VP O
20 Medical NNP B-NP O
20 Center NNP I-NP O
20 on IN B-VP O
20 1/5/06 CD O O
21 through IN B-VP O
21 11/11/07 CD O O
21 for IN B-VP O
21 initiation NN B-NP O
21 of IN B-VP O
21 dialysis NN B-NP O
21 after IN B-VP O
21 her PRP$ O O
21 BUN NNP B-NP O
21 and CC O O
21 creatinine NN B-NP O
22 had VBD B-VP O
22 risen VBN O O
22 remarkably RB O O
22 from IN B-VP O
22 baseline NN B-NP O
22 She PRP O O
22 was VBD B-VP O
22 then RB O O
22 asymptomatic JJ O O
22 at IN B-VP O
23 that DT B-NP O
23 time NN I-NP O
23 A DT B-NP O
23 fistulogram NN I-NP O
23 and CC O O
23 angioplasty NN B-NP O
23 of IN B-VP O
23 her PRP$ O O
23 right JJ B-NP O
23 AV NNP I-NP O
23 fistula NN I-NP O
24 was VBD B-VP O
24 performed VBN O O
24 on IN B-VP O
24 9/14/06 CD O O
24 with IN B-VP O
24 prednisone NN B-NP B-m
24 premedication NN I-NP O
24 but CC O O
24 it PRP O O
25 was VBD B-VP O
25 unsuccessful JJ O O
25 and CC O O
25 therefore RB O O
25 a DT B-NP O
25 left NN I-NP O
25 IJ NNP I-NP O
25 tunneled VBD B-VP O
25 dialysis NN B-NP O
26 catheter NN I-NP O
26 was VBD B-VP O
26 inserted VBN O O
26 on IN B-VP O
26 10/18/06 CD O O
26 with IN B-VP O
26 the DT B-NP O
26 tip NN I-NP O
26 ending VBG O O
26 in IN B-VP O
26 the DT B-NP O
27 right JJ I-NP O
27 atrium NN I-NP O
27 She PRP O O
27 has VBZ O O
27 since IN B-VP O
27 received VBN O O
27 dialysis NN B-NP O
27 treatments NNS I-NP O
27 with IN B-VP O
27 no DT B-NP O
28 complication NN I-NP O
29 PAST NNP I-NP O
29 MEDICAL NNP I-NP O
29 HISTORY: NNP I-NP O
29 Coronary NNP I-NP O
29 artery NN I-NP O
29 disease NN I-NP O
29 , , O O
30 CHF NNP B-NP O
30 , , O O
30 echo NN B-NP O
30 in IN B-VP O
30 August NNP B-NP O
30 of IN B-VP O
30 1999 CD O O
30 shows NNS B-NP O
30 moderate VBP O O
30 left VBN O O
30 ventricular JJ B-NP O
31 hypertrophy NN I-NP O
31 of IN B-VP O
31 about IN B-VP O
31 65% CD O O
31 , , O O
31 diabetes VBZ O O
31 type VBP O O
31 2 CD O O
31 20 CD O O
31 years NNS B-NP O
31 including VBG O O
31 with IN B-VP O
32 retinopathy NN B-NP O
32 , , O O
32 nephropathy JJ O O
32 and CC O O
32 neuropathic JJ B-NP O
32 pain NN I-NP O
32 , , O O
32 hypertension NN B-NP O
32 for IN B-VP O
33 the DT O O
33 past JJ O O
33 20 CD O O
33 years NNS B-NP O
33 , , O O
33 hypercholesterolemia NN B-NP O
33 , , O O
33 status NN B-NP O
33 post NN I-NP O
33 medullary JJ B-NP O
34 CVA NNP I-NP O
34 August NNP I-NP O
34 1999 CD O O
34 , , O O
34 right RB O O
34 PICA NNP B-NP O
34 resulting VBG O O
34 Wallenberg's NNP B-NP O
34 syndrome NN I-NP O
34 , , O O
35 morbid NN B-NP O
35 obesity NN I-NP O
35 , , O O
35 left VBD B-VP O
35 knee JJ B-NP O
35 degenerative JJ I-NP O
35 joint NN I-NP O
35 disease NN I-NP O
35 , , O O
36 iron-deficiency NN B-NP O
36 anemia NN I-NP O
37 ALLERGIES: NNP I-NP O
37 IV NNP I-NP O
37 contrast NN I-NP O
37 , , O O
37 which WDT O O
37 gives VBZ O O
37 her PRP$ O O
37 anaphylaxis NN B-NP O
37 , , O O
38 tetracycline NN B-NP O
38 to TO O O
38 an DT B-NP O
38 unknown JJ I-NP O
38 reaction NN I-NP O
38 , , O O
38 lisinopril JJ B-NP O
39 HOME NNP I-NP O
39 MEDICATIONS: NNP I-NP O
39 At IN B-VP O
39 the DT B-NP O
39 time NN I-NP O
39 of IN B-VP O
39 admission NN B-NP O
39 include VBP O O
39 amitriptyline JJ O B-m
40 25 CD O B-do
40 mg NN B-NP I-do
40 p.o NN I-NP B-mo
40 bedtime NN I-NP B-f
40 , , O O
40 enteric-coated JJ B-NP B-m
40 aspirin NN I-NP I-m
40 325 CD O B-do
40 mg NN B-NP I-do
40 p.o JJ O B-mo
40 daily RB O B-f
40 , , O O
41 enalapril VBZ O B-m
41 20 CD O B-do
41 mg NN B-NP I-do
41 p.o NN I-NP B-mo
41 b.i.d NN I-NP B-f
41 , , O O
41 Lasix NNP B-NP B-m
41 200 CD O B-do
41 mg NN B-NP I-do
41 p.o NN I-NP B-mo
41 b.i.d NN I-NP B-f
41 , , O O
41 Losartan NNP B-NP B-m
42 50 CD O B-do
42 mg NN B-NP I-do
42 p.o JJ O B-mo
42 daily JJ O B-f
42 , , O O
42 Toprol-XL JJ O B-m
42 200 CD O B-do
42 mg NN B-NP I-do
42 p.o NN I-NP B-mo
42 b.i.d NN I-NP B-f
42 , , O O
42 Advair NNP B-NP B-m
42 Diskus NNP I-NP O
43 250/50 CD O O
43 one CD O B-do
43 puff NN B-NP I-do
43 inhaler NN I-NP B-mo
43 b.i.d NN I-NP B-f
43 , , O O
43 insulin JJ B-NP B-m
43 insulin NN I-NP B-m
43 NPH NNP I-NP I-m
43 NPH NNP I-NP I-m
43 50 CD O B-do
43 units NNS B-NP I-do
43 q.a.m JJ B-NP B-f
43 subcu NN I-NP B-mo
44 and CC O O
44 25 CD O B-do
44 units NNS B-NP I-do
44 q.p.m RB O B-f
44 subcu VBP O B-mo
44 , , O O
44 insulin JJ O B-m
44 lispro FW O I-m
44 18 CD O B-do
44 units NNS B-NP I-do
44 subcu VBP O B-mo
44 at IN B-VP O
45 dinner NN B-NP B-f
45 time NN I-NP I-f
45 , , O O
45 Protonix NNP B-NP B-m
45 40 CD O B-do
45 mg NN B-NP I-do
45 p.o JJ O B-mo
45 daily RB O B-f
45 , , O O
45 sevelamer JJ O B-m
45 1200 CD O B-do
45 mg NN B-NP I-do
45 p.o NN I-NP B-mo
46 t.i.d NN I-NP B-f
46 , , O O
46 tramadol VBZ O B-m
46 25 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 q.6 NN I-NP B-f
46 h NN I-NP I-f
46 p.r.n NN I-NP I-f
46 pain VBP O B-r
47 SOCIAL NNP B-NP O
47 HISTORY: NNP I-NP O
47 This DT B-NP O
47 patient NN I-NP O
47 is VBZ O O
47 single JJ O O
47 and CC O O
47 has VBZ O O
47 one CD O O
47 son NN B-NP O
47 and CC O O
47 one CD O O
48 grandson NN B-NP O
48 Arturo NNP I-NP O
48 Randklev NNP I-NP O
48 is VBZ O O
48 the DT B-NP O
48 healthcare NN I-NP O
48 proxy NN I-NP O
48 and CC O O
48 is VBZ O O
48 her PRP$ O O
48 son NN B-NP O
49 She PRP O O
49 worked VBD B-VP O
49 30 CD O O
49 years NNS B-NP O
49 for IN B-VP O
49 Wi NNP B-NP O
49 Co NNP I-NP O
49 Baya NNP I-NP O
49 and CC O O
49 is VBZ O O
49 currently RB O O
49 retired VBN O O
50 PHYSICAL NNP B-NP O
50 EXAMINATION NNP I-NP O
50 ON NNP I-NP O
50 ADMISSION: NNP I-NP O
50 Her NNP I-NP O
50 vital JJ B-NP O
50 signs NNS I-NP O
50 were VBD B-VP O
51 temperature JJ O O
51 97.6 CD O O
51 , , O O
51 heart NN B-NP O
51 rate NN I-NP O
51 72 CD O O
51 , , O O
51 BP NNP B-NP O
51 of IN B-VP O
51 115/66 CD O O
51 with IN B-VP O
51 mean JJ B-NP O
51 arterial JJ I-NP O
52 pressure NN I-NP O
52 of IN B-VP O
52 83 CD O O
52 , , O O
52 respiratory NN B-NP O
52 14 CD O O
52 , , O O
52 sating VBG O O
52 100% CD O O
52 on IN B-VP O
52 60% CD O O
52 inspired JJ B-NP O
52 FiO2 NNP I-NP O
53 Her NNP I-NP O
53 CVP NNP I-NP O
53 at IN B-VP O
53 admission NN B-NP O
53 was VBD B-VP O
53 17 CD O O
53 to TO O O
53 20 CD O O
53 The DT B-NP O
53 patient NN I-NP O
53 is VBZ O O
53 an DT B-NP O
53 obese JJ I-NP O
53 woman NN I-NP O
53 who WP O O
53 was VBD B-VP O
54 intubated VBN O O
54 and CC O O
54 responded VBN O O
54 to TO O O
54 voice VB O O
54 Her PRP$ O O
54 pupils NNS B-NP O
54 were VBD B-VP O
54 3 CD O O
54 to TO O O
54 2 CD O O
54 mm NNS B-NP O
55 bilaterally RB O O
55 Her NNP B-NP O
55 extraocular JJ B-NP O
55 movements NNS I-NP O
55 were VBD B-VP O
55 intact JJ B-NP O
55 Her NNP I-NP O
55 chest NN I-NP O
56 exam NN I-NP O
56 was VBD B-VP O
56 notable JJ O O
56 for IN B-VP O
56 diffuse NN B-NP O
56 crackles NNS I-NP O
56 throughout IN B-VP O
56 with IN B-VP O
56 good JJ B-NP O
56 air NN I-NP O
57 movement NN I-NP O
57 Cardiac NNP I-NP O
57 auscultation NN I-NP O
57 revealed VBD B-VP O
57 regular JJ B-NP O
57 rate NN I-NP O
57 and CC O O
57 rhythm NN B-NP O
58 with IN B-VP O
58 no DT B-NP O
58 murmurs NNS I-NP O
58 , , O O
58 rubs NNS B-NP O
58 or CC O O
58 gallops VBZ O O
58 Her PRP$ O O
58 abdomen NNS B-NP O
58 was VBD B-VP O
58 soft JJ O O
58 , , O O
59 nontender NN B-NP O
59 and CC O O
59 nondistended VBN O O
59 with IN B-VP O
59 normal JJ B-NP O
59 active JJ I-NP O
59 bowel NN I-NP O
59 sounds VBZ O O
60 Extremities NNS B-NP O
60 showed VBD B-VP O
60 no DT B-NP O
60 edema NN I-NP O
60 Distal NNP I-NP O
60 pulses NNS I-NP O
60 were VBD B-VP O
60 not RB O O
60 palpable JJ O O
61 bilaterally RB O O
61 She PRP O O
61 has VBZ O O
61 thickened VBN O O
61 hyperpigmented VBN O O
61 skin JJ B-NP O
62 changes NNS I-NP O
62 on IN B-VP O
62 both DT B-NP O
62 feet NNS I-NP O
63 LABORATORY NNP I-NP O
63 DATA: NNP I-NP O
63 Significant NNP I-NP O
63 labs NN I-NP O
63 on IN B-VP O
63 admission NN B-NP O
63 included VBD B-VP O
63 a DT B-NP O
63 sodium NN I-NP O
64 of IN B-VP O
64 141 CD O O
64 , , O O
64 potassium NN B-NP O
64 4.1 CD O O
64 , , O O
64 chloride NN B-NP O
64 of IN B-VP O
64 102 CD O O
64 , , O O
64 bicarb NN B-NP O
64 of IN B-VP O
64 31 CD O O
64 , , O O
64 BUN NNP B-NP O
64 33 CD O O
64 , , O O
65 creatinine NN B-NP O
65 4.2 CD O O
65 with IN B-VP O
65 a DT B-NP O
65 glucose NN I-NP O
65 of IN B-VP O
65 156 CD O O
65 Her NNP B-NP O
65 hematocrit NN I-NP O
65 was VBD B-VP O
65 32 CD O O
66 An DT B-NP O
66 ABG NNP I-NP O
66 at IN B-VP O
66 10 CD O O
66 p.m NN B-NP O
66 of IN B-VP O
66 admission NN B-NP O
66 on IN B-VP O
66 FiO2 NNP B-NP O
66 of IN B-VP O
66 60% CD O O
66 revealed VBD B-VP O
66 a DT B-NP O
66 pH NN I-NP O
66 of IN B-VP O
66 7.36 CD O O
66 , , O O
66 pCO2 NN B-NP O
66 of IN B-VP O
67 52 CD O O
67 , , O O
67 pO2 NN B-NP O
67 91 CD O O
67 Her NNP B-NP O
67 first JJ B-NP O
67 set NN I-NP O
67 of IN B-VP O
67 cardiac JJ B-NP O
67 enzyme NN I-NP O
67 revealed VBD B-VP O
67 a DT B-NP O
68 creatinine JJ I-NP O
68 kinase NN I-NP O
68 of IN B-VP O
68 116 CD O O
68 and CC O O
68 the DT B-NP O
68 MB NNP I-NP O
68 fraction NN I-NP O
68 of IN B-VP O
68 0.7 CD O O
68 and CC O O
68 troponin JJ B-NP O
69 T NNP I-NP O
69 of IN B-VP O
69 less JJR O O
69 than IN B-VP O
69 assay NN B-NP O
69 and CC O O
69 lactate NN B-NP O
69 of IN B-VP O
69 1.8 CD O O
69 Tox NNP B-NP O
69 screen NN I-NP O
69 was VBD B-VP O
70 negative JJ B-NP O
70 Urinalysis NNP I-NP O
70 was VBD B-VP O
70 remarkable JJ O O
70 for IN B-VP O
70 2+ CD O O
70 protein NN B-NP O
70 , , O O
70 3+ CD O O
70 blood NN B-NP O
70 and CC O O
71 positive JJ O O
71 for IN B-VP O
71 nitrates NNS B-NP O
71 , , O O
71 and CC O O
71 negative JJ O O
71 for IN B-VP O
71 leuks NN B-NP O
71 , , O O
71 4 CD O O
71 to TO O O
71 10 CD O O
71 white JJ B-NP O
72 blood NN I-NP O
72 cells NNS I-NP O
72 , , O O
72 15 CD O O
72 to TO O O
72 25 CD O O
72 red JJ B-NP O
72 blood NN I-NP O
72 cells NNS I-NP O
72 , , O O
72 2+ CD O O
72 bacteria NNS B-NP O
72 , , O O
72 1+ CD O O
72 squamous JJ B-NP O
73 epithelial JJ I-NP O
73 cells NNS I-NP O
74 IMAGING: NNP I-NP O
74 Significant NNP I-NP O
74 imaging VBG O O
74 at IN B-VP O
74 admission NN B-NP O
74 was VBD B-VP O
74 an DT O O
74 x-ray JJ O O
74 for IN B-VP O
74 chest JJS B-NP O
75 x-ray JJ I-NP O
75 revealing NN I-NP O
75 diffuse NN I-NP O
75 bilateral JJ B-NP O
75 opacities NNS I-NP O
75 , , O O
75 possible JJ B-NP O
75 pulmonary JJ I-NP O
76 edema NN I-NP O
76 versus NN I-NP O
76 aspiration NN I-NP O
76 pneumonia NN I-NP O
76 , , O O
76 an DT B-NP O
76 EKG NNP I-NP O
76 showing VBG O O
76 normal JJ B-NP O
76 sinus NN I-NP O
77 rhythm VBD B-VP O
77 100 CD O O
77 beats NNS B-NP O
77 per IN B-VP O
77 minute NN B-NP O
77 with IN B-VP O
77 no DT B-NP O
77 acute NN I-NP O
77 ST NNP I-NP O
77 changes NNS I-NP O
77 and CC O O
77 old JJ B-NP O
78 T-wave JJ I-NP O
78 inversion NN I-NP O
78 in IN B-VP O
78 V2 NNP B-NP O
79 ASSESSMENT: NNP I-NP O
79 This DT O O
79 is VBZ O O
79 a DT B-NP O
79 55-year-old JJ I-NP O
79 female NN I-NP O
79 with IN B-VP O
79 end-stage JJ B-NP O
79 renal JJ I-NP O
80 disease NN I-NP O
80 on IN B-VP O
80 hemodialysis NN B-NP O
80 secondary JJ O O
80 to TO O O
80 diabetes NNS B-NP O
80 who WP O O
80 had VBD B-VP O
80 an DT B-NP O
80 apparent JJ I-NP O
81 VFib NNP I-NP O
81 arrest NN I-NP O
81 at IN B-VP O
81 hemodialysis NN B-NP O
81 on IN B-VP O
81 0/9/06 CD O O
81 and CC O O
81 was VBD B-VP O
81 shocked VBN O O
81 and CC O O
82 admitted VBN O O
82 to TO O O
82 the DT B-NP O
82 CCU NNP I-NP O
82 after IN B-VP O
82 being VBG O O
82 intubated VBN O O
82 in IN B-VP O
82 the DT B-NP O
82 Vibay NNP I-NP O
82 General NNP I-NP O
82 Hospital NNP I-NP O
82 ED NNP I-NP O
82 The DT B-NP O
83 patient NN I-NP O
83 had VBD B-VP O
83 difficulty NN B-NP O
83 weaning VBG O O
83 from IN B-VP O
83 vent NN B-NP O
83 and CC O O
83 was VBD B-VP O
83 finally RB O O
84 extubated VBN O O
84 on IN B-VP O
84 0/22/06 CD O O
84 The DT B-NP O
84 CCU NNP I-NP O
84 course NN I-NP O
84 was VBD B-VP O
84 also RB O O
84 complicated VBN O O
84 by IN B-VP O
85 coag-negative JJ B-NP O
85 Staph NNP I-NP O
85 grown NN I-NP O
85 from IN B-VP O
85 a DT B-NP O
85 Quinton NNP I-NP O
85 catheter NN I-NP O
85 blood NN I-NP O
85 draw VB O O
86 The DT B-NP O
86 catheter NN I-NP O
86 was VBD B-VP O
86 changed VBN O O
86 to TO O O
86 over IN B-VP O
86 a DT B-NP O
86 wire NN I-NP O
86 on IN B-VP O
86 0/22/06 CD O O
86 Blood NNP B-NP O
87 cultures NNS I-NP O
87 on IN B-VP O
87 1/10/06 CD O O
87 revealed VBD B-VP O
87 likely JJ B-NP B-r
87 Staph NNP I-NP I-r
87 aureus NN I-NP I-r
87 growth NN I-NP I-r
87 for IN B-VP O
88 which WDT O O
88 the DT B-NP O
88 patient NN I-NP O
88 received VBD B-VP O
88 continuous JJ B-NP O
88 vancomycin JJ I-NP B-m
89 HOSPITAL NNP I-NP O
89 COURSE NNP I-NP O
89 BY NNP I-NP O
89 PROBLEMS: NNP I-NP O
90 1 CD O O
90 Question NNP B-NP O
90 of IN B-VP O
90 VFib NNP B-NP O
90 arrest VBP O O
90 Whether NNP B-NP O
90 or CC O O
90 not RB O O
90 the DT B-NP O
90 patient NN I-NP O
90 actually RB O O
91 had VBD B-VP O
91 a DT B-NP O
91 VFib NNP I-NP O
91 arrest NN I-NP O
91 seems VBZ O O
91 to TO O O
91 be VB O O
91 in IN B-VP O
91 some DT B-NP O
91 doubt NN I-NP O
91 as IN B-VP O
91 she PRP O O
91 never RB O O
91 had VBD B-VP O
91 an DT B-NP O
92 arrhythmia NN I-NP O
92 on IN B-VP O
92 tele NN B-NP O
92 here RB O O
92 by IN B-VP O
92 report NN B-NP O
92 and CC O O
92 her PRP$ O O
92 troponin NN B-NP O
92 when WRB O O
92 peaked VBN O O
92 at IN B-VP O
93 0.14 CD O O
93 on IN B-VP O
93 8/1/06 CD O O
93 after IN B-VP O
93 receiving VBG O O
93 one CD O O
93 external JJ B-NP O
93 defibrillator NN I-NP O
93 shock NN I-NP O
94 at IN B-VP O
94 hemodialysis NN B-NP O
94 We PRP O O
94 believe VBP O O
94 what WP O O
94 likely JJ O O
94 happened VBD B-VP O
94 was VBD B-VP O
94 a DT B-NP O
94 vagal JJ I-NP O
94 event NN I-NP O
94 during IN B-VP O
95 hemodialysis NN B-NP O
95 , , O O
95 possibly RB O O
95 including VBG O O
95 a DT B-NP O
95 pause NN I-NP O
95 misread NN I-NP O
95 at IN B-VP O
95 VF NNP B-NP O
95 by IN B-VP O
95 the DT B-NP O
95 defibrillator NN I-NP O
96 This DT B-NP O
96 explantation NN I-NP O
96 is VBZ O O
96 supported VBN O O
96 by IN B-VP O
96 the DT B-NP O
96 observation NN I-NP O
96 that IN B-VP O
96 she PRP O O
96 has VBZ O O
96 been VBN O O
97 continuously RB O O
97 having VBG O O
97 nausea NN B-NP O
97 with IN B-VP O
97 dialysis NN B-NP O
97 and CC O O
97 her PRP$ O O
97 known VBN O O
97 a DT B-NP O
97 history NN I-NP O
98 of IN B-VP O
98 vasovagal JJ B-NP O
98 episodes NNS I-NP O
98 in IN B-VP O
98 the DT B-NP O
98 past JJ I-NP O
98 Echo NNP I-NP O
98 on IN B-VP O
98 8/1/06 CD O O
98 shows NNS B-NP O
98 an DT B-NP O
98 EF NNP I-NP O
99 of IN B-VP O
99 60 CD O O
99 to TO O O
99 65% CD O O
99 with IN B-VP O
99 mild JJ O B-r
99 concentric JJ O I-r
99 left VBD B-VP I-r
99 ventricular JJ B-NP I-r
99 hypertrophy NN I-NP I-r
100 and CC O O
100 no DT B-NP O
100 wall NN I-NP O
100 motion NN I-NP O
100 abnormalities VBZ O O
100 The DT B-NP O
100 patient NN I-NP O
100 was VBD B-VP O
100 continued VBN O O
100 on IN B-VP O
101 telemetry NN B-NP O
101 and CC O O
101 treated VBD B-VP O
101 with IN B-VP O
101 her PRP$ O O
101 home NN B-NP B-do
101 dose NN I-NP I-do
101 of IN B-VP O
101 beta-blocker NN B-NP B-m
101 with IN B-VP O
102 good JJ B-NP O
102 response NN I-NP O
103 2 CD O O
103 Volume NN B-NP O
103 status NN I-NP O
103 The DT B-NP O
103 patient NN I-NP O
103 is VBZ O O
103 very RB O O
103 close JJ O O
103 to TO O O
103 her PRP$ O O
103 dry JJ B-NP O
103 weight NN I-NP O
104 upon IN B-VP O
104 discharge NN B-NP O
104 , , O O
104 which WDT O O
104 she PRP O O
104 gives VBZ O O
104 at IN B-VP O
104 354 CD O O
104 pounds NNS B-NP O
104 by IN B-VP O
104 wet NN B-NP O
104 scale NN I-NP O
104 She PRP O O
105 has VBZ O O
105 been VBN O O
105 continued VBN O O
105 on IN B-VP O
105 hemodialysis NN B-NP O
105 with IN B-VP O
105 good JJ B-NP O
105 results NNS I-NP O
106 3 CD O O
106 Possibly RB O O
106 infected VBN O O
106 hemodialysis NN B-NP O
106 catheter NN I-NP O
106 The DT B-NP O
106 patient NN I-NP O
106 had VBD B-VP O
106 a DT B-NP O
107 single JJ I-NP O
107 set NN I-NP O
107 of IN B-VP O
107 coag-negative JJ B-NP B-r
107 Staph NNP I-NP I-r
107 positive JJ B-NP I-r
107 blood NN I-NP I-r
107 cultures NNS I-NP I-r
107 from IN B-VP O
108 Quinton NNP B-NP O
108 catheter NN I-NP O
108 on IN B-VP O
108 8/8/06 CD O O
108 Line NNP B-NP O
108 was VBD B-VP O
108 changed VBN O O
108 over IN B-VP O
108 wire NN B-NP O
109 4/28/06 CD O O
109 and CC O O
109 was VBD B-VP O
109 treated VBN O O
109 with IN B-VP O
109 vancomycin NNS B-NP B-m
109 dose JJ O O
109 by IN B-VP O
109 renal JJ B-NP O
109 levels NNS I-NP O
110 The DT B-NP O
110 patient NN I-NP O
110 continued VBD B-VP O
110 to TO O O
110 grow VB O O
110 out RP O O
110 coag-negative JJ B-NP O
110 Staph NNP I-NP O
110 , , O O
110 positive JJ B-NP O
111 blood NN I-NP O
111 cultures NNS I-NP O
111 from IN B-VP O
111 2 CD O O
111 out IN B-VP O
111 of IN B-VP O
111 2 CD O O
111 sets NNS B-NP O
111 drawn VBN O O
111 on IN B-VP O
111 8/8/06 CD O O
112 4 CD O O
112 Anemia NNP B-NP O
112 In IN B-VP O
112 the DT B-NP O
112 setting NN I-NP O
112 of IN B-VP O
112 end-stage JJ B-NP O
112 renal JJ I-NP O
112 disease NN I-NP O
112 her PRP$ O O
113 baseline NN B-NP O
113 hematocrit NN I-NP O
113 is VBZ O O
113 about IN B-VP O
113 30 CD O O
113 and CC O O
113 stable JJ O O
114 5 CD O O
114 Diabetes NNPS B-NP O
114 type NN I-NP O
114 2 CD O O
114 She PRP O O
114 was VBD B-VP O
114 treated VBN O O
114 with IN B-VP O
114 a DT B-NP O
114 Portland NNP I-NP O
114 protocol NN I-NP O
115 during IN B-VP O
115 her PRP$ O O
115 ICU NNP B-NP O
115 course NN I-NP O
115 wand NN I-NP O
115 was VBD B-VP O
115 switched VBN O O
115 to TO O O
115 a DT O O
115 long JJ O O
115 and CC O O
116 short-acting JJ B-NP O
116 subcutaneous JJ I-NP B-mo
116 subcutaneous JJ I-NP B-mo
116 insulin NN I-NP O
116 approaching VBG O O
116 her PRP$ O O
116 home NN B-NP B-do
116 dose NN I-NP I-do
116 of IN B-VP O
116 NPH NNP B-NP B-m
116 BID NNP I-NP B-f
117 6 CD O O
117 FEN NNP B-NP O
117 The DT B-NP O
117 patient NN I-NP O
117 was VBD B-VP O
117 gradually RB O O
117 advanced JJ O O
117 to TO O O
117 an DT B-NP O
117 oral JJ I-NP O
117 diet NN I-NP O
117 with IN B-VP O
118 no DT B-NP O
118 signs NNS I-NP O
118 of IN B-VP O
118 aspiration NN B-NP O
118 status NN I-NP O
118 post NN I-NP O
118 extubation NN I-NP O
119 7 CD O O
119 Prophylaxis NNP B-NP O
119 The DT B-NP O
119 patient NN I-NP O
119 received VBD B-VP O
119 heparin JJ O B-m
119 subcutaneously RB O B-mo
119 and CC O O
120 Nexium NNP B-NP B-m
121 8 CD O O
121 Code NNP B-NP O
121 The DT B-NP O
121 patient NN I-NP O
121 is VBZ O O
121 full JJ B-NP O
121 code NN I-NP O
121 Her NNP I-NP O
121 healthcare NN I-NP O
121 proxy NN I-NP O
121 is VBZ O O
121 her PRP$ O O
122 son NN B-NP O
122 Noble JJ B-NP O
122 Schomberg NNP I-NP O
122 , , O O
122 030-855-6086 JJ B-NP O
123 DISPOSITION: NNP I-NP O
123 This DT B-NP O
123 patient NN I-NP O
123 will MD O O
123 likely RB O O
123 need VB O O
123 rehab NNS B-NP O
123 and CC O O
123 is VBZ O O
123 being VBG O O
124 screened VBN O O
124 by IN B-VP O
124 PT NNP B-NP O
124 and CC O O
124 OT NNP B-NP O
124 and CC O O
124 will MD O O
124 likely RB O O
124 be VB O O
124 discharged VBN O O
124 to TO O O
124 rehab VB O O
124 when WRB O O
125 bed NN B-NP O
125 is VBZ O O
125 available JJ B-NP O
126 eScription NN I-NP O
126 document: VBZ O O
126 5-2572147 JJ B-NP O
126 CSSten NNP I-NP O
126 Tel NNP I-NP O
127 Dictated NNP I-NP O
127 By: NNP I-NP O
127 ARTOLA NNP I-NP O
127 , , O O
127 GARY NNP B-NP O
128 Attending: NNP I-NP O
128 DIX NNP I-NP O
128 , , O O
128 REGGIE NNP B-NP O
129 Dictation NNP I-NP O
129 ID NNP I-NP O
129 5231801 CD O O
130 D: NNP B-NP O
130 4/18/06 CD O O
131 T: NNP B-NP O
131 4/18/06 CD O O
132 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #66947 VBZ O O
4 165924793 CD O O
4 ARCCH NNP B-NP O
4 42505562 CD O O
4 4965709 CD O O
4 1/30/2007 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 s/p JJ B-NP O
4 angioplasty NN I-NP O
4 and CC O O
4 stenting VBG O O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/8/2007 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/14/2007 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 COOLBAUGH NNP I-NP O
8 , , O O
8 OMAR NNP B-NP O
8 J NNP I-NP O
8 598-85-46-5 JJ B-NP O
9 South NNP I-NP O
9 Dakota NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 6/21/07 CD O O
11 AT NNP B-NP O
11 10:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 labs/ekg NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 KEASER NNP I-NP O
14 , , O O
14 JR NNP B-NP O
14 , , O O
14 OMER NNP B-NP O
14 R NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 MEDICATIONS NNP I-NP O
18 ON NNP I-NP O
18 ADMISSION: NNP I-NP O
19 1 CD O O
19 MYCOPHENOLATE NNP B-NP B-m
19 MOFETIL NNP I-NP I-m
19 1000 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 2 CD O O
20 OXYBUTYNIN NNP B-NP B-m
20 CHLORIDE NNP I-NP I-m
20 XL NNP I-NP I-m
20 10 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 3 CD O O
21 INSULIN NNP B-NP B-m
21 GLARGINE NNP I-NP I-m
21 20 CD O B-do
21 UNITS NNP B-NP I-do
21 SC NNP I-NP B-mo
21 QAM NNP I-NP B-f
22 4 CD O O
22 FUROSEMIDE NNP B-NP B-m
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 5 CD O O
23 CLOPIDOGREL NNP B-NP B-m
23 75 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QD NNP I-NP B-f
24 6 CD O O
24 PRAVASTATIN NNP B-NP B-m
24 40 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QHS NNP I-NP B-f
25 7 CD O O
25 PREDNISONE NNP B-NP B-m
25 5 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QD NNP I-NP B-f
26 8 CD O O
26 CYCLOSPORINE NNP B-NP B-m
26 ( ( O I-m
26 SANDIMMUNE NNP B-NP I-m
26 ) ) O I-m
26 75 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 BID NNP I-NP B-f
27 9 CD O O
27 METOPROLOL NNP B-NP B-m
27 SUCCINATE NNP I-NP I-m
27 EXTENDED NNP I-NP I-m
27 RELEASE NNP I-NP I-m
27 50 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 10 CD O O
28 FENOFIBRATE NNP B-NP B-m
28 ( ( O I-m
28 TRICOR NNP B-NP I-m
28 ) ) O I-m
28 48 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 MEDICATIONS NNP I-NP O
29 ON NNP I-NP O
29 DISCHARGE: NNP I-NP O
30 ENTERIC NNP I-NP B-m
30 COATED NNP I-NP I-m
30 ASA NNP I-NP I-m
30 325 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 DAILY NNP I-NP B-f
31 PLAVIX NNP I-NP B-m
31 ( ( O I-m
31 CLOPIDOGREL NNP B-NP I-m
31 ) ) O I-m
31 75 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 DAILY NNP I-NP B-f
32 Starting NNP I-NP O
32 Tomorrow NNP I-NP O
32 ( ( O O
32 5/25 CD O O
32 ) ) O O
33 CYCLOSPORINE NNP B-NP B-m
33 ( ( O I-m
33 SANDIMMUNE NNP B-NP I-m
33 ) ) O I-m
33 75 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 BID NNP I-NP B-f
34 Food/Drug NNP I-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Avoid NNP I-NP O
35 grapefruit NN I-NP O
35 unless IN B-VP O
35 MD NNP B-NP O
35 instructs NNS I-NP O
35 otherwise RB O O
36 Give VBP O O
36 with IN B-VP O
36 meals NNS B-NP O
37 Override NNP I-NP O
37 Notice: NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 1/17/07 CD O O
37 by IN B-VP O
37 REGES NNP B-NP O
37 , , O O
37 FAUSTO NNP B-NP O
37 T NNP I-NP O
37 BUCK NNP I-NP O
37 JERRY NNP I-NP O
37 , , O O
37 M.D NNP B-NP O
37 on IN B-VP O
37 order NN B-NP O
37 for IN B-VP O
37 TRICOR NNP B-NP B-m
37 PO NNP I-NP B-mo
37 ( ( O O
37 ref JJ O O
37 # # O O
37 438676570 CD O O
37 ) ) O O
38 POTENTIALLY NNP B-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 CYCLOSPORINE NNP I-NP B-m
38 &amp; NNP I-NP O
39 FENOFIBRATE NNP I-NP B-m
39 , , O I-m
39 MICRONIZED NNP B-NP I-m
39 MICRONIZED NNP I-NP B-m
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: JJ B-NP O
40 patient NN I-NP O
40 home NN I-NP B-m
40 meds NNS I-NP I-m
40 Previous NNP I-NP O
40 override IN B-VP O
40 information: JJ B-NP O
41 Override NNP I-NP O
41 added VBD B-VP O
41 on IN B-VP O
41 1/17/07 CD O O
41 by IN B-VP O
41 KELLETT NNP B-NP O
41 , , O O
41 WILTON NNP B-NP O
41 GAYLORD NNP I-NP O
41 MILO NNP I-NP O
41 , , O O
41 M.D NNP B-NP O
42 POTENTIALLY NNP I-NP O
42 SERIOUS NNP I-NP O
42 INTERACTION: NNP I-NP O
42 PRAVASTATIN NNP I-NP B-m
42 SODIUM NNP I-NP I-m
42 &amp; NNP I-NP O
43 CYCLOSPORINE NNP I-NP B-m
43 Reason NNP I-NP O
43 for IN B-VP O
43 override: JJ B-NP O
43 patient NN I-NP O
43 home NN I-NP B-m
43 meds NNS I-NP I-m
44 TRICOR NNP I-NP B-m
44 ( ( O I-m
44 FENOFIBRATE NNP B-NP I-m
44 ( ( O I-m
44 TRICOR NNP B-NP I-m
44 ) ) O I-m
44 ) ) O I-m
44 48 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 DAILY NNP I-NP B-f
45 Alert NNP I-NP O
45 overridden: NNP I-NP O
45 Override NNP I-NP O
45 added VBD B-VP O
45 on IN B-VP O
45 1/17/07 CD O O
45 by IN B-VP O
45 RAGONE NNP B-NP O
45 , , O O
45 JAMAL NNP B-NP O
45 F NNP I-NP O
45 BERNARD NNP I-NP O
45 HOUSTON NNP I-NP O
45 , , O O
45 M.D NNP B-NP O
46 POTENTIALLY NNP I-NP O
46 SERIOUS NNP I-NP O
46 INTERACTION: NNP I-NP O
46 PRAVASTATIN NNP I-NP B-m
46 SODIUM NNP I-NP I-m
46 &amp; NNP I-NP O
47 FENOFIBRATE NNP I-NP B-m
47 , , O I-m
47 MICRONIZED NNP B-NP I-m
48 POTENTIALLY NNP I-NP O
48 SERIOUS NNP I-NP O
48 INTERACTION: NNP I-NP O
48 CYCLOSPORINE NNP I-NP B-m
48 &amp; NNP I-NP O
49 FENOFIBRATE NNP I-NP B-m
49 , , O I-m
49 MICRONIZED NNP B-NP I-m
49 Reason NNP I-NP O
49 for IN B-VP O
49 override: JJ B-NP O
50 patient NN I-NP O
50 home NN I-NP O
50 meds NNS I-NP O
50 Number NNP I-NP B-du
50 of IN B-VP I-du
50 Doses NNP B-NP I-du
50 Required NNP I-NP I-du
50 ( ( O I-du
50 approximate JJ B-NP I-du
50 ): NN I-NP I-du
50 4 CD O I-du
51 LASIX NNP B-NP B-m
51 ( ( O I-m
51 FUROSEMIDE NNP B-NP I-m
51 ) ) O I-m
51 40 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 DAILY NNP I-NP B-f
52 INSULIN NNP I-NP B-m
52 GLARGINE NNP I-NP I-m
52 20 CD O B-do
52 UNITS NNP B-NP I-do
52 SC NNP I-NP B-mo
52 DAILY NNP I-NP B-f
53 TOPROL NNP I-NP B-m
53 XL NNP I-NP I-m
53 ( ( O I-m
53 METOPROLOL NNP B-NP I-m
53 SUCCINATE NNP I-NP I-m
53 EXTENDED NNP I-NP I-m
53 RELEASE NNP I-NP I-m
53 ) ) O I-m
54 50 CD O B-do
54 MG NNP B-NP I-do
54 PO NNP I-NP B-mo
54 DAILY NNP I-NP B-f
54 Food/Drug NNP I-NP O
54 Interaction NNP I-NP O
54 Instruction NNP I-NP O
55 Take NNP I-NP O
55 consistently RB O O
55 with IN B-VP O
55 meals NNS B-NP O
55 or CC O O
55 on IN B-VP O
55 empty JJ B-NP O
55 stomach NN I-NP O
56 Number NNP I-NP B-du
56 of IN B-VP I-du
56 Doses NNP B-NP I-du
56 Required NNP I-NP I-du
56 ( ( O I-du
56 approximate JJ B-NP I-du
56 ): NN I-NP I-du
56 3 CD O I-du
57 CELLCEPT NNP B-NP B-m
57 ( ( O I-m
57 MYCOPHENOLATE NNP B-NP I-m
57 MOFETIL NNP I-NP I-m
57 ) ) O I-m
57 1 CD O B-do
57 , , O I-do
57 000 CD O I-do
57 MG NNP B-NP I-do
57 PO NNP I-NP B-mo
57 BID NNP I-NP B-f
58 Food/Drug NNP I-NP O
58 Interaction NNP I-NP O
58 Instruction NNP I-NP O
59 Give NNP I-NP O
59 on IN B-VP O
59 an DT B-NP O
59 empty JJ I-NP O
59 stomach NN I-NP O
59 ( ( O O
59 give JJ O O
59 1hr CD O O
59 before IN B-VP O
59 or CC O O
59 2hr CD O O
59 after IN B-VP O
60 food NN B-NP O
60 ) ) O O
60 Food NN B-NP O
60 decreases NNS I-NP O
60 peak NN I-NP O
60 by IN B-VP O
60 up IN B-VP O
60 to TO O O
60 40% CD O O
61 TNG NNP B-NP B-m
61 0.4 CD O I-m
61 MG NNP B-NP I-m
61 ( ( O I-m
61 NITROGLYCERIN NNP B-NP I-m
61 1/150 CD O I-m
61 ( ( O I-m
61 0.4 CD O I-m
61 MG NNP B-NP I-m
61 ) ) O I-m
61 ) ) O I-m
62 1 CD O B-do
62 TAB NNP B-NP I-do
62 SL NNP I-NP B-mo
62 Q5MIN NNP I-NP B-f
62 X NNP I-NP I-f
62 3 CD O I-f
62 3 CD O B-do
62 doses NNS B-NP I-f
62 doses VBZ O I-do
62 PRN NNP B-NP I-f
62 PRN NNP I-NP B-f
62 Chest NNP I-NP B-r
62 Pain NNP I-NP I-r
63 DITROPAN NNP I-NP B-m
63 XL NNP I-NP I-m
63 ( ( O I-m
63 OXYBUTYNIN NNP B-NP I-m
63 CHLORIDE NNP I-NP I-m
63 XL NNP I-NP I-m
63 ) ) O I-m
63 10 CD O O
63 MG NNP B-NP O
63 PO NNP I-NP O
63 DAILY NNP I-NP O
64 Number NNP I-NP B-du
64 of IN B-VP I-du
64 Doses NNP B-NP I-du
64 Required NNP I-NP I-du
64 ( ( O I-du
64 approximate JJ B-NP I-du
64 ): NN I-NP I-du
64 3 CD O I-du
65 PRAVACHOL NNP B-NP B-m
65 ( ( O I-m
65 PRAVASTATIN NNP B-NP I-m
65 ) ) O I-m
65 40 CD O B-do
65 MG NNP B-NP I-do
65 PO NNP I-NP B-mo
65 BEDTIME NNP I-NP B-f
66 Food/Drug NNP I-NP O
66 Interaction NNP I-NP O
66 Instruction NNP I-NP O
67 Avoid NNP I-NP O
67 grapefruit NN I-NP O
67 unless IN B-VP O
67 MD NNP B-NP O
67 instructs NNS I-NP O
67 otherwise RB O O
68 Override NNP B-NP O
68 Notice: NNP I-NP O
68 Override NNP I-NP O
68 added VBD B-VP O
68 on IN B-VP O
68 1/17/07 CD O O
68 by IN B-VP O
68 KWAN NNP B-NP O
68 , , O O
68 JOHNSON NNP B-NP O
68 A NNP I-NP O
68 EDMUNDO NNP I-NP O
68 TAD NNP I-NP O
68 , , O O
68 M.D NNP B-NP O
68 on IN B-VP O
68 order NN B-NP O
68 for IN B-VP O
68 TRICOR NNP B-NP B-m
68 PO NNP I-NP B-mo
68 ( ( O O
68 ref JJ O O
68 # # O O
68 438676570 CD O O
68 ) ) O O
69 POTENTIALLY NNP B-NP O
69 SERIOUS NNP I-NP O
69 INTERACTION: NNP I-NP O
69 PRAVASTATIN NNP I-NP B-m
69 SODIUM NNP I-NP I-m
69 &amp; NNP I-NP O
70 FENOFIBRATE NNP I-NP B-m
70 , , O I-m
70 MICRONIZED NNP B-NP I-m
70 Reason NNP I-NP O
70 for IN B-VP O
70 override: JJ B-NP O
71 patient NN I-NP O
71 home NN I-NP B-m
71 meds NNS I-NP I-m
71 Previous NNP I-NP O
71 override IN B-VP O
71 information: JJ B-NP O
72 Override NNP I-NP O
72 added VBD B-VP O
72 on IN B-VP O
72 1/17/07 CD O O
72 by IN B-VP O
72 LAMOREE NNP B-NP O
72 , , O O
72 MARCELLUS NNP B-NP O
72 VICENTE NNP I-NP O
72 RONALD NNP I-NP O
72 , , O O
72 M.D NNP B-NP O
73 on IN B-VP O
73 order NN B-NP O
73 for IN B-VP O
73 CYCLOSPORINE NNP B-NP B-m
73 ( ( O I-m
73 SANDIMMUNE NNP B-NP I-m
73 ) ) O I-m
73 PO NNP B-NP B-mo
73 ( ( O O
73 ref JJ O O
73 # # O O
74 472656194 CD O O
74 ) ) O O
75 POTENTIALLY NNP B-NP O
75 SERIOUS NNP I-NP O
75 INTERACTION: NNP I-NP O
75 PRAVASTATIN NNP I-NP B-m
75 SODIUM NNP I-NP I-m
75 &amp; NNP I-NP O
76 CYCLOSPORINE NNP I-NP B-m
76 Reason NNP I-NP O
76 for IN B-VP O
76 override: JJ B-NP O
76 patient NN I-NP O
76 home NN I-NP B-m
76 meds NNS I-NP I-m
77 Previous NNP I-NP O
77 override IN B-VP O
77 information: JJ B-NP O
78 Override NNP I-NP O
78 added VBD B-VP O
78 on IN B-VP O
78 1/17/07 CD O O
78 by IN B-VP O
78 SLEIMAN NNP B-NP O
78 , , O O
78 CARTER NNP B-NP O
78 ERNESTO NNP I-NP O
78 BRUNO NNP I-NP O
78 , , O O
78 M.D NNP B-NP O
79 on IN B-VP O
79 order NN B-NP O
79 for IN B-VP O
79 PRAVACHOL NNP B-NP B-m
79 PO NNP I-NP B-mo
79 ( ( O O
79 ref JJ O O
79 # # O O
79 214437202 CD O O
79 ) ) O O
80 Pt NNP B-NP O
80 has VBZ O O
80 a DT B-NP O
80 PROBABLE NNP I-NP O
80 allergy NN I-NP O
80 to TO O O
80 SIMVASTATIN; NNP B-NP O
80 reaction NN I-NP O
80 is VBZ O O
81 muscle JJ B-NP O
81 aches NNS I-NP O
81 Reason NNP I-NP O
81 for IN B-VP O
81 override: JJ B-NP O
81 patient NN I-NP O
81 home NN I-NP O
81 meds NNS I-NP O
82 PREDNISOLONE NNP I-NP B-m
82 SODIUM NNP I-NP I-m
82 PHOSPHATE NNP I-NP I-m
82 5MG/5ML CD O I-m
82 5 CD O B-do
82 MG NNP B-NP I-do
82 PO NNP I-NP B-mo
82 DAILY NNP I-NP B-f
83 DIET: NNP I-NP O
83 House NNP I-NP O
83 / VBD B-VP O
83 Low NNP B-NP O
83 chol/low NN I-NP O
83 sat VBD B-VP O
83 fat JJ B-NP O
84 ACTIVITY: NNP I-NP O
84 light NN I-NP O
84 activity NN I-NP O
84 , , O O
84 no DT B-NP O
84 heavy JJ I-NP O
84 lifting NN I-NP O
84 or CC O O
84 driving VBG O O
84 x JJ O O
84 2 CD O O
84 days NNS B-NP O
84 ok RB O O
84 to TO O O
84 shower VB O O
84 , , O O
84 no DT B-NP O
84 swimming NN I-NP O
84 or CC O O
84 bathing VBG O O
84 x JJ O O
84 5 CD O O
84 days NNS B-NP O
85 Lift NNP I-NP O
85 restrictions: NN I-NP O
85 Do NNP I-NP O
85 not RB O O
85 lift VB O O
85 greater JJR O O
85 then RB O O
85 10-15 CD O O
85 pounds NNS B-NP O
86 FOLLOW NNP I-NP O
86 UP NNP I-NP O
86 APPOINTMENT( NNP I-NP O
86 S NNP I-NP O
86 ): NNP I-NP O
87 Heart NNP I-NP O
87 failure NN I-NP O
87 Clinic NNP I-NP O
87 2-4 JJ B-NP O
87 weeks NNS I-NP O
87 , , O O
88 ALLERGY: NNP B-NP O
88 SIMVASTATIN NNP I-NP O
89 ADMIT NNP I-NP O
89 DIAGNOSIS: NNP I-NP O
90 s/p VBD B-VP O
90 cardiac JJ B-NP O
90 transplant NN I-NP O
91 PRINCIPAL NNP I-NP O
91 DISCHARGE NNP I-NP O
91 DIAGNOSIS NNP I-NP O
91 ;Responsible JJ O O
91 After IN B-VP O
91 Study NNP B-NP O
91 for IN B-VP O
91 Causing NNP B-NP O
91 Admission NNP I-NP O
91 ) ) O O
92 s/p NN B-NP O
92 angioplasty NN I-NP O
92 and CC O O
92 stenting VBG O O
93 OTHER NNP B-NP O
93 DIAGNOSIS;Conditions NNP I-NP O
93 , , O O
93 Infections NNP B-NP O
93 , , O O
93 Complications NNP B-NP O
93 , , O O
93 affecting VBG O O
93 Treatment/Stay NNP B-NP O
94 s/p JJ B-NP O
94 cardiac NN I-NP O
94 transplant NN I-NP O
94 1992 CD O O
94 ( ( O O
94 S/P NNP B-NP O
94 cardiac VBP O O
94 transplant NN B-NP O
94 ) ) O O
94 Diabetes VBZ O O
94 mellitus JJ B-NP O
95 type NN I-NP O
95 II NNP I-NP O
95 ( ( O O
95 diabetes VBZ O O
95 mellitus VBP O O
95 type JJ O O
95 2 CD O O
95 ) ) O O
95 Trochanteric NNP B-NP O
95 bursitis NN I-NP O
95 ( ( O O
95 trochanteric JJ B-NP O
96 bursitis NN I-NP O
96 ) ) O O
96 Dyslipidemia NNP B-NP O
96 ( ( O O
96 dyslipidemia NN B-NP O
96 ) ) O O
96 DJD NNP B-NP O
96 spine NN I-NP O
96 ( ( O O
96 OA NNP B-NP O
96 of IN B-VP O
96 cervical JJ B-NP O
97 spine NN I-NP O
97 ) ) O O
97 Hx NNP B-NP O
97 vocal JJ B-NP O
97 cord NN I-NP O
97 injury NN I-NP O
97 postop NN I-NP O
97 Hx NNP I-NP O
97 gastritis NN I-NP O
97 with IN B-VP O
97 UGIB NNP B-NP O
97 ( ( O O
97 H/O NNP B-NP O
97 upper NNP I-NP O
98 GI NNP I-NP O
98 bleeding VBG O O
98 ) ) O O
98 Hx NNP B-NP O
98 postop JJ B-NP O
98 seizure NN I-NP O
99 OPERATIONS NNP I-NP O
99 AND NNP I-NP O
99 PROCEDURES: NNP I-NP O
100 OTHER NNP I-NP O
100 TREATMENTS/PROCEDURES NNP I-NP O
100 ( ( O O
100 NOT NNP B-NP O
100 IN NNP I-NP O
100 O.R NNP I-NP O
100 ) ) O O
101 s/p NN B-NP O
101 LAD NNP I-NP O
101 angioplasty NN I-NP O
101 and CC O O
101 stenting VBG O O
102 BRIEF NNP B-NP O
102 RESUME NNP I-NP O
102 OF NNP I-NP O
102 HOSPITAL NNP I-NP O
102 COURSE: NNP I-NP O
103 71 CD O O
103 year NN B-NP O
103 old JJ B-NP O
103 female NN I-NP O
103 that WDT O O
103 is VBZ O O
103 now RB O O
103 15 CD O O
103 years NNS B-NP O
103 following VBG O O
104 cardiac JJ B-NP O
104 transplantation NN I-NP O
104 , , O O
104 with IN B-VP O
104 a DT B-NP O
104 multiplicity NN I-NP O
104 of IN B-VP O
104 medical JJ B-NP O
104 issues NNS I-NP O
104 , , O O
105 including VBG O O
105 allograft NN B-NP O
105 coronary JJ B-NP O
105 artery NN I-NP O
105 disease NN I-NP O
105 , , O O
105 bilateral JJ B-NP O
105 carotid NN I-NP O
106 disease NN I-NP O
106 ( ( O O
106 underwent JJ B-NP O
106 carotid NN I-NP O
106 stenting NN I-NP O
106 in IN B-VP O
106 March NNP B-NP O
106 2006 CD O O
106 ) ) O O
106 , , O O
106 History NNP B-NP O
106 of IN B-VP O
106 TIA NNP B-NP O
106 , , O O
107 diabetes VBZ O O
107 and CC O O
107 significant JJ B-NP O
107 obesity.Her JJ I-NP O
107 baseline NN I-NP O
107 renal JJ B-NP O
107 cr NN I-NP O
107 was VBD B-VP O
108 1.7 CD O O
108 The DT B-NP O
108 LCX NNP I-NP O
108 was VBD B-VP O
108 stented VBN O O
108 in IN B-VP O
108 June NNP B-NP O
109 2006 CD O O
109 Current NNP B-NP O
109 meds NNS I-NP O
110 includes VBZ O O
110 CellCept IN B-VP B-m
110 1000 CD O B-do
110 mg NN B-NP I-do
110 p.o NN I-NP B-mo
110 b.i.d NN I-NP B-f
110 , , O O
110 prednisone NN B-NP B-m
110 5 CD O B-do
110 mg JJ O I-do
111 daily RB O B-f
111 , , O O
111 cyclosporine VB O B-m
111 75 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 b.i.d NN I-NP B-f
111 , , O O
111 Toprol-XL NNP B-NP B-m
111 50 CD O B-do
111 mg NN B-NP I-do
111 daily RB O B-f
111 , , O O
111 TriCor NNP B-NP B-m
111 , , O O
112 once RB O B-f
112 daily JJ O I-f
112 , , O O
112 Pravachol NNP B-NP B-m
112 40 CD O B-do
112 mg JJ O I-do
112 daily RB O B-f
112 , , O O
112 Plavix NNP B-NP B-m
112 75 CD O B-do
112 mg JJ O I-do
112 daily RB O B-f
112 , , O O
112 Lasix NNP B-NP B-m
112 , , O O
112 40 CD O B-do
112 mg JJ O I-do
113 daily RB O B-f
113 , , O O
113 insulin NN B-NP B-m
113 , , O O
113 aspirin NN B-NP B-m
113 , , O O
113 Ditropan NNP B-NP B-m
113 10 CD O B-do
113 mg JJ O I-do
113 daily JJ O B-f
113 and CC O O
114 vitamins NNS B-NP B-m
114 Elective NNP I-NP O
114 cardiac JJ B-NP O
114 catheterization NN I-NP O
114 Was NNP I-NP O
114 performed VBN O O
115 today NN B-NP O
115 for IN B-VP O
115 her PRP$ O O
115 annual JJ B-NP O
115 post NN I-NP O
115 cardiac JJ B-NP O
115 transplant NN I-NP O
115 evaluation NN I-NP O
115 revealed VBD B-VP O
116 double JJ B-NP O
116 vessel NN I-NP O
116 disease NN I-NP O
116 proximal JJ B-NP O
116 LAD NNP I-NP O
116 95% CD O O
116 lesion NN B-NP O
116 , , O O
116 LeftnCX NNP B-NP O
117 ( ( O O
117 Proximal NNP B-NP O
117 ) ) O O
117 , , O O
117 75% CD O O
117 lesion NN B-NP O
117 CX NNP I-NP O
117 ( ( O O
117 Mid NNP B-NP O
117 ) ) O O
117 , , O O
117 95% CD O O
117 lesion NN B-NP O
117 , , O O
117 MARG1 NNP B-NP O
117 ( ( O O
117 Ostial NNP B-NP O
117 ) ) O O
117 , , O O
117 95% CD O O
118 lesion NN B-NP O
118 Successful NNP I-NP O
118 PTCA/Stenting NNP I-NP O
118 - : O O
118 LAD NNP B-NP O
118 using VBG O O
118 XB3.5guide NNP B-NP O
118 , , O O
119 BMW NNP B-NP O
119 , , O O
119 which WDT O O
119 was VBD B-VP O
119 predilated VBN O O
119 with IN B-VP O
119 a DT O O
119 2mm CD O O
119 balloon NN B-NP O
119 , , O O
119 2 CD O O
119 DES NNP B-NP O
119 was VBD B-VP O
119 used VBN O O
119 ( ( O O
119 3 CD O O
119 by IN B-VP O
120 18 CD O O
120 ) ) O O
120 and( NN B-NP O
120 3 CD O O
120 by IN B-VP O
120 18 CD O O
120 ) ) O O
120 cypher NN B-NP O
120 stents NNS I-NP O
120 which WDT O O
120 was VBD B-VP O
120 subsequently RB O O
120 postdilated VBN O O
120 to TO O O
121 3.2 CD O O
121 , , O O
121 no DT B-NP O
121 residual JJ I-NP O
122 stenosis NN I-NP O
122 Right NNP I-NP O
122 groin NN I-NP O
122 access NN I-NP O
122 was VBD B-VP O
122 closed VBN O O
122 with IN B-VP O
123 Starclose NNP B-NP O
123 PCI NNP I-NP O
123 of IN B-VP O
123 the DT B-NP O
123 LAD NNP I-NP O
123 today NN I-NP O
123 and CC O O
123 possible JJ O O
123 planned VBN O O
123 PCI NNP B-NP O
123 of IN B-VP O
124 LCX NNP B-NP O
124 in IN B-VP O
124 1-3 JJ B-NP O
124 weeks NNS I-NP O
124 Check NNP I-NP O
124 renal JJ B-NP O
124 function NN I-NP O
124 over IN B-VP O
124 the DT O O
124 next JJ O O
124 2 CD O O
125 days NNS B-NP O
125 Plan: NNP I-NP O
126 PCI NNP I-NP O
126 of IN B-VP O
126 the DT B-NP O
126 LAD NNP I-NP O
126 today NN I-NP O
126 and CC O O
126 possible JJ O O
126 planned VBN O O
126 PCI NNP B-NP O
126 of IN B-VP O
126 LCX NNP B-NP O
126 in IN B-VP O
126 1-3 JJ B-NP O
127 weeks NNS I-NP O
127 Check NNP I-NP O
127 renal JJ B-NP O
127 function NN I-NP O
127 over IN B-VP O
127 the DT O O
127 next JJ O O
127 2 CD O O
128 days NNS B-NP O
129 0/7/07 CD O O
130 Up NNP B-NP O
130 , , O O
130 eating VBG O O
130 and CC O O
130 voiding VBG O O
130 well RB O O
130 Ambulating VBG O O
130 on IN B-VP O
130 POD NNP B-NP O
130 - : O O
130 "tired" NN B-NP O
130 but CC O O
130 no DT B-NP O
130 change NN I-NP O
131 from IN B-VP O
131 baseline NN B-NP O
132 No NNP I-NP O
132 Chest NNP I-NP O
132 pain NN I-NP O
132 , , O O
132 shortness NN B-NP O
132 of IN B-VP O
132 breath NN B-NP O
132 , , O O
132 groin NN B-NP O
132 or CC O O
132 flank NN B-NP O
132 pain VBP O O
132 No DT B-NP O
132 palpitations NNS I-NP O
133 Multiple NNP I-NP O
133 questions NNS I-NP O
133 regarding VBG O O
133 activity NN B-NP O
133 , , O O
133 medications NNS B-NP O
133 reviewed VBD B-VP O
133 with IN B-VP O
133 patient JJ B-NP O
134 PHYSICAL NNP I-NP O
134 EXAM: NNP I-NP O
134 96.4 CD O O
134 80-90s JJ O O
134 110/60 CD O O
134 97%ra CD O O
134 voiding NN B-NP O
134 to TO O O
134 BR NNP B-NP O
135 NAD NNP I-NP O
135 JVP NNP I-NP O
135 not RB O O
135 elevated VBD B-VP O
136 COR NNP B-NP O
136 RRR NNP I-NP O
136 , , O O
136 S1S2 NNP B-NP O
136 , , O O
136 no DT B-NP O
136 murmur NN I-NP O
136 appreciated VBD B-VP O
137 Lungs NNP B-NP O
137 - : O O
137 CTA NNP B-NP O
137 bilat NN I-NP O
137 , , O O
137 no DT B-NP O
137 RRW NNP I-NP O
138 EXT NNP I-NP O
138 - : O O
138 warm NN B-NP O
138 , , O O
138 no DT B-NP O
138 edema NN I-NP O
139 Right RB O O
139 Groin-soft NNP B-NP O
139 , , O O
139 no DT B-NP O
139 ecchymosis NN I-NP O
139 , , O O
139 no DT B-NP O
139 hematoma NN I-NP O
139 or CC O O
139 bruit NN B-NP O
139 Palpable JJ B-NP O
139 femoral JJ I-NP O
140 pulse NN I-NP O
141 EKG: NNP I-NP O
141 SR NNP I-NP O
141 at IN B-VP O
141 95 CD O O
141 wtih NN B-NP O
141 inc NN I-NP O
141 RBBB NNP I-NP O
141 , , O O
141 flat JJ B-NP O
141 T NNP I-NP O
141 1 CD O O
141 , , O O
141 L NNP B-NP O
141 , , O O
141 no DT B-NP O
141 change NN I-NP O
141 from IN B-VP O
141 prior JJ B-NP O
142 TELE: NNP I-NP O
142 no DT B-NP O
142 tele JJ I-NP O
142 events NNS I-NP O
143 A/P: NNP I-NP O
144 **CV:12 CD O O
144 years NNS B-NP O
144 post NN I-NP O
144 transplant NN I-NP O
144 , , O O
144 resume VB O O
144 meds NNS B-NP O
144 per IN B-VP O
144 transplant NN B-NP O
144 team NN I-NP O
145 *CAD: VBD B-VP O
145 1 CD O O
145 day NN B-NP O
145 post NN I-NP O
145 Cypher NNP I-NP O
145 DES NNP I-NP O
145 to TO O O
145 LAD VB O O
145 with IN B-VP O
145 significant JJ B-NP O
145 residual JJ I-NP O
145 disease NN I-NP O
145 , , O O
146 please VB O O
146 see VB O O
146 cath JJ B-NP O
146 report NN I-NP O
146 for IN B-VP O
146 full JJ B-NP O
146 details NNS I-NP O
146 Will MD O O
146 need VB O O
146 ASA NNP B-NP B-m
146 325 CD O B-do
146 daily JJ B-NP B-f
146 x NNP I-NP O
146 life NN I-NP O
146 , , O O
147 Plavix NNP B-NP B-m
147 75 CD O B-do
147 daily RB O B-f
147 for IN B-VP B-du
147 minimum NN B-NP I-du
147 of IN B-VP I-du
147 12 CD O I-du
147 months NNS B-NP I-du
147 and CC O O
147 should MD O O
147 continue VB O O
147 out RP O O
147 indef JJ B-NP O
148 Importance NN I-NP O
148 of IN B-VP O
148 both DT O O
148 stressed JJ O O
148 and CC O O
148 patient JJ B-NP O
148 understands! JJ I-NP O
148 SL NNP I-NP B-mo
148 TNG NNP I-NP B-m
148 prn NN I-NP B-f
148 chest NN I-NP B-r
149 pain NN I-NP O
149 AM NNP I-NP O
149 enzymes RB O O
149 pending VBG O O
150 *PUMP: NNP B-NP O
150 no DT B-NP O
150 evidence NN I-NP O
150 of IN B-VP O
150 volume NN B-NP O
150 overload NN I-NP O
150 , , O O
150 CHF NNP B-NP O
151 *RHYTHM: NNP I-NP O
151 no DT B-NP O
151 palps NN I-NP O
151 , , O O
151 no DT B-NP O
151 tachy/brady JJ I-NP O
151 tele NN I-NP O
151 events NNS I-NP O
152 *HTN: VBP O O
152 BP NNP B-NP B-r
152 BP NNP I-NP B-r
152 well RB O O
152 controlled VBD B-VP O
152 HR NNP B-NP O
152 up RP O O
152 some DT O O
152 on IN B-VP O
152 Toprol NNP B-NP B-m
152 XL NNP I-NP I-m
152 50 CD O B-do
152 , , O O
152 lasix VBD B-VP B-m
152 40 CD O B-do
153 *LIPIDS: NN B-NP O
153 will MD O O
153 cont VB O O
153 pravachol NN B-NP B-m
153 40 CD O B-do
153 , , O O
153 tricor VBD B-VP B-m
153 48 CD O B-do
154 **PULM: JJ O O
154 no DT B-NP O
154 issues NNS I-NP O
155 **RENAL: VBP O O
155 baseline NN B-NP O
155 1.5 CD O O
155 - : O O
155 1.7 CD O O
155 , , O O
155 AM NNP B-NP O
155 pending VBG O O
155 encouraged VBD B-VP O
155 increased VBN O O
155 PO NNP B-NP O
155 intake NN I-NP O
156 over IN B-VP O
156 next JJ B-NP O
156 several JJ I-NP O
156 days NNS I-NP O
156 , , O O
156 if IN B-VP O
156 urine JJ B-NP O
156 output NN I-NP O
156 falls VBZ O O
156 she PRP O O
156 will MD O O
156 call VB O O
156 , , O O
156 she PRP O O
156 should MD O O
157 have VB O O
157 renal JJ B-NP O
157 fx NN I-NP O
157 rechecked VBD B-VP O
157 on IN B-VP O
157 monday NN B-NP O
157 with IN B-VP O
157 local JJ B-NP O
157 MD NNP I-NP O
158 **ENDO: NNP I-NP O
158 check VB O O
158 hgb NN B-NP O
158 a1c NN I-NP O
158 as IN B-VP O
158 outpt JJ B-NP O
158 cont NN I-NP O
158 insulin NN I-NP B-m
159 **DISPO: NNP I-NP O
159 stable JJ O O
159 and CC O O
159 ready JJ O O
159 for IN B-VP O
159 DC NNP B-NP O
159 this DT O O
159 am VBP O O
159 pending VBG O O
159 labs NN B-NP O
159 , , O O
159 attending VBG O O
159 eval JJ B-NP O
160 FU NNP I-NP O
160 with IN B-VP O
160 Transplant NNP B-NP O
160 team NN I-NP O
160 , , O O
160 they PRP O O
160 will MD O O
160 be VB O O
160 in IN B-VP O
160 contact JJ O O
160 regarding VBG O O
160 date NN B-NP O
160 of IN B-VP O
160 staged JJ B-NP O
161 PCI NNP I-NP O
161 to TO O O
161 LCx VB O O
161 To TO O O
161 call VB O O
161 with IN B-VP O
161 any DT B-NP O
161 concerns NNS I-NP O
161 All DT B-NP O
161 Questions NNS I-NP O
161 answered VBD B-VP O
162 Addendum: NNP B-NP O
162 renal JJ B-NP O
162 fx NN I-NP O
162 fine NN I-NP O
162 but CC O O
162 asxatic JJ B-NP O
162 MB NNP I-NP O
162 bump NN I-NP O
162 to TO O O
162 25 CD O O
162 , , O O
162 rechecking VBG O O
162 and CC O O
162 dc VB O O
162 if IN B-VP O
163 stable JJ O O
163 , , O O
163 keep VB O O
163 until IN B-VP O
163 tomorrow NN B-NP O
163 if IN B-VP O
163 up IN B-VP O
164 ADDITIONAL NNP B-NP O
164 COMMENTS: NNP I-NP O
164 -you NNP I-NP O
164 must MD O O
164 take VB O O
164 aspirin NN B-NP B-m
164 for IN B-VP B-du
164 life NN B-NP I-du
165 -you NN I-NP O
165 must MD O O
165 take VB O O
165 plavix NN B-NP B-m
165 for IN B-VP B-du
165 a DT B-NP I-du
165 minimum NN I-NP I-du
165 of IN B-VP I-du
165 1 CD O I-du
165 year- NNS B-NP I-du
165 DO NNP I-NP O
165 NOT NNP I-NP O
165 STOP NNP I-NP O
165 ASPIRIN NNP I-NP B-m
165 OR NNP I-NP O
166 PLAVIX NNP I-NP B-m
166 FOR NNP I-NP O
166 ANY NNP I-NP O
166 REASON NNP I-NP O
166 UNLESS NNP I-NP O
166 SPEAK NNP I-NP O
166 WITH NNP I-NP O
166 YOUR NNP I-NP O
166 CARDIOLOGIST NNP I-NP O
166 FIRST!!! NNP I-NP O
167 -resume NNP I-NP O
167 other JJ B-NP B-m
167 medications NNS I-NP I-m
167 at IN B-VP O
167 usual JJ B-NP O
167 doses NNS I-NP O
168 -you VBP O O
168 will MD O O
168 need VB O O
168 your PRP$ O O
168 kidney NN B-NP O
168 function NN I-NP O
168 test NN I-NP O
168 on IN B-VP O
168 monday NN B-NP O
168 10/23 CD O O
168 after IN B-VP O
168 receiving VBG O O
169 contrast- NN B-NP O
169 this DT O O
169 should MD O O
169 be VB O O
169 followed VBN O O
169 by IN B-VP O
169 heart NN B-NP O
169 transplant NN I-NP O
169 clinic JJ B-NP O
170 -drink NNP I-NP O
170 plenty NN I-NP O
170 of IN B-VP O
170 fluids NNS B-NP O
170 over IN B-VP O
170 the DT B-NP O
170 next JJ I-NP O
170 several JJ I-NP O
170 days NNS I-NP O
170 , , O O
170 if IN B-VP O
170 your PRP$ O O
170 urine NN B-NP O
170 output NN I-NP O
171 falls VBZ O O
171 please VB O O
171 call VB O O
172 -you NNP B-NP O
172 will MD O O
172 need VB O O
172 to TO O O
172 return VB O O
172 for IN B-VP O
172 another DT B-NP O
172 intervention NN I-NP O
172 in IN B-VP O
172 the DT B-NP O
172 next JJ I-NP O
172 several JJ I-NP O
173 weeks- NN I-NP O
173 this DT O O
173 should MD O O
173 be VB O O
173 set VBN O O
173 up RP O O
173 through IN B-VP O
173 transplant NN B-NP O
173 clinic JJ B-NP O
174 -call NN I-NP O
174 with IN B-VP O
174 questions NNS B-NP O
174 or CC O O
174 concerns NNS B-NP O
175 DISCHARGE NNP I-NP O
175 CONDITION: NNP I-NP O
175 Stable NNP I-NP O
176 TO NNP I-NP O
176 DO/PLAN: NNP I-NP O
177 No NNP I-NP O
177 dictated VBD B-VP O
177 summary JJ B-NP O
178 ENTERED NNP I-NP O
178 BY: NNP I-NP O
178 DANES NNP I-NP O
178 , , O O
178 CRUZ NNP B-NP O
178 , , O O
178 M.D NNP B-NP O
178 ( ( O O
178 XO06 NNP B-NP O
178 ) ) O O
178 6/21/07 CD O O
178 @ $ O O
178 09:39 CD O O
178 AM NNP B-NP O
179 ****** JJ B-NP O
179 END NN I-NP O
179 OF NNP I-NP O
179 DISCHARGE NNP I-NP O
179 ORDERS NNP I-NP O
179 ****** NNP I-NP O
180 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #71200 VBZ O O
2 051009128 CD O O
2 GRHC NNP B-NP O
2 36066753 CD O O
2 457914 CD O O
2 3/11/1999 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 RT NNP I-NP O
2 LUNG NNP I-NP O
2 CARCINOMA NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/11/1999 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/29/1999 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 Seventy-year-old NNP I-NP O
4 woman NN I-NP O
4 with IN B-VP O
4 a DT B-NP O
5 complex JJ I-NP O
5 past NN I-NP O
5 medical JJ B-NP O
5 history NN I-NP O
5 which WDT O O
6 includes VBZ O O
6 cerebrovascular JJ B-NP O
6 accident NN I-NP O
6 x NN I-NP O
6 two CD O O
6 in IN B-VP O
6 1980s CD O O
6 without IN B-VP O
6 deficits NNS B-NP O
6 , , O O
7 seizure NN B-NP O
7 history NN I-NP O
7 probably RB O O
7 secondary JJ O O
7 to TO O O
7 ETOH NNP B-NP O
7 withdrawal NN I-NP O
7 ( ( O O
7 none NN B-NP O
7 since IN B-VP O
8 1993 CD O O
8 ) ) O O
8 , , O O
8 hypertension NN B-NP O
8 x VBD B-VP O
8 30 CD O O
8 years NNS B-NP O
8 , , O O
8 asthma RB O O
8 , , O O
8 gout NN B-NP O
8 , , O O
8 status NN B-NP O
8 post NN I-NP O
8 repair NN I-NP O
8 of IN B-VP O
9 subclavian JJ B-NP O
9 artery NN I-NP O
9 stenosis NN I-NP O
9 in IN B-VP O
9 1993 CD O O
9 The DT B-NP O
9 patient NN I-NP O
9 presented VBD B-VP O
9 to TO O O
9 the DT B-NP O
10 Dagha NNP I-NP O
10 Medical NNP I-NP O
10 Center NNP I-NP O
10 on IN B-VP O
10 10/5 CD O O
10 with IN B-VP O
10 severe JJ B-NP O
10 chest NN I-NP O
10 pain NN I-NP O
10 The DT B-NP O
11 patient NN I-NP O
11 ruled VBD B-VP O
11 out RP O O
11 for IN B-VP O
11 myocardial JJ B-NP O
11 infarction NN I-NP O
11 but CC O O
11 chest JJS O O
11 x-ray JJ O O
11 showed VBD B-VP O
12 a DT B-NP O
12 right JJ I-NP O
12 lung NN I-NP O
12 mass NN I-NP O
12 A NNP I-NP O
12 chest NN I-NP O
12 CT NNP I-NP O
12 on IN B-VP O
12 9/21 CD O O
12 revealed VBD B-VP O
12 a DT O O
12 2.3 CD O O
12 x NN B-NP O
12 2.8 CD O O
12 cm NN B-NP O
13 lobulated VBD B-VP O
13 mass NN B-NP O
13 in IN B-VP O
13 the DT B-NP O
13 right NN I-NP O
13 lower JJR B-NP O
13 lobe NN I-NP O
13 involving VBG O O
13 the DT B-NP O
13 pleura NN I-NP O
13 There EX O O
14 were VBD B-VP O
14 extensive JJ B-NP O
14 hilar NN I-NP O
14 and CC O O
14 mediastinal JJ B-NP O
14 constitutions NNS I-NP O
14 consistent JJ O O
14 with IN B-VP O
15 prior JJ B-NP O
15 granulomatous JJ I-NP O
15 disease NN I-NP O
15 Tests NNS I-NP O
15 were VBD B-VP O
15 positive JJ O O
15 for IN B-VP O
15 multiple JJ O O
16 precarinal JJ O O
16 and CC O O
16 right JJ B-NP O
16 peritracheal NN I-NP O
16 areas NNS I-NP O
16 of IN B-VP O
16 adenopathy JJ O O
16 recent JJ O O
16 from IN B-VP O
17 metastatic JJ B-NP O
17 disease NN I-NP O
18 PAST NNP I-NP O
18 MEDICAL NNP I-NP O
18 HISTORY: NNP I-NP O
18 Cerebrovascular NNP I-NP O
18 accident NN I-NP O
18 x NN I-NP O
18 without IN B-VP O
18 versus NN B-NP O
19 reversal NN I-NP O
19 ischemic JJ B-NP O
19 neurological JJ I-NP O
19 deficits NNS I-NP O
19 in IN B-VP O
20 1987 CD O O
20 , , O O
20 history NN B-NP O
20 of IN B-VP O
20 ETOH NNP B-NP O
20 withdrawal NN I-NP O
20 , , O O
20 B12 NNP B-NP O
20 deficiency NN I-NP O
20 , , O O
20 hypertension NN B-NP O
20 , , O O
21 gout NN B-NP O
21 , , O O
21 E NNP B-NP O
21 coli NNS I-NP O
21 , , O O
21 sepsis NN B-NP O
21 in IN B-VP O
21 1990 CD O O
21 , , O O
21 status NN B-NP O
21 post NN I-NP O
21 myocardial JJ B-NP O
21 infarction NN I-NP O
22 ( ( O O
22 per IN B-VP O
22 M.D NNP B-NP O
22 note NN I-NP O
22 , , O O
22 the DT B-NP O
22 patient NN I-NP O
22 denies NNS I-NP O
22 ) ) O O
22 , , O O
22 asthma JJ B-NP O
23 PAST NNP I-NP O
23 SURGICAL NNP I-NP O
23 HISTORY: NNP I-NP O
23 Right NNP I-NP O
23 total JJ B-NP O
23 knee NN I-NP O
23 replacement NN I-NP O
23 in IN B-VP O
23 1982 CD O O
23 , , O O
24 innominate NN B-NP O
24 and CC O O
24 left VBD B-VP O
24 subclavian JJ B-NP O
24 artery NN I-NP O
25 stenosis NN I-NP O
25 - : O O
25 bypassed VBN O O
25 ( ( O O
25 with IN B-VP O
25 re-op NN B-NP O
25 in IN B-VP O
25 1993 CD O O
25 ) ) O O
25 , , O O
25 left VBD B-VP O
25 total JJ B-NP O
25 knee JJ I-NP O
26 replacement NN I-NP O
26 in IN B-VP O
26 1994 CD O O
26 , , O O
26 ovarian JJ B-NP O
26 cyst NN I-NP O
26 excision NN I-NP O
27 ALLERGIES: NNP I-NP O
27 Aspirin NNP I-NP O
27 causes VBZ O O
27 epistaxis FW O O
27 ( ( O O
27 this DT O O
27 was VBD B-VP O
27 in IN B-VP O
27 combination NN B-NP O
28 with IN B-VP O
28 Motrin NNP B-NP O
28 ) ) O O
29 MEDICATIONS: NNP B-NP O
29 Adalat NNP I-NP B-m
29 200 CD O B-do
29 mg NN B-NP I-do
29 p.o NN I-NP B-mo
29 b.i.d NN I-NP B-f
29 , , O O
29 Zantac NNP B-NP B-m
29 150 CD O B-do
29 mg NN B-NP I-do
29 p.o NN I-NP B-mo
29 b.i.d NN I-NP B-f
29 , , O O
30 Magnesium NNP B-NP B-m
30 Oxide NNP I-NP I-m
30 40 CD O B-do
30 mg NN B-NP I-do
30 t.i.d NN I-NP B-f
30 , , O O
30 Ultram NNP B-NP B-m
30 300 CD O B-do
30 mg NN B-NP I-do
30 q.d NN I-NP B-f
30 , , O O
31 Trazodone NNP B-NP B-m
31 100 CD O B-do
31 mg NN B-NP I-do
31 q.h.s NN I-NP B-f
31 , , O O
31 Azmacort NNP B-NP B-m
31 80 CD O B-do
31 mg NN B-NP I-do
31 p.r.n NN I-NP B-f
31 , , O O
31 aspirin RB O B-m
31 81 CD O B-do
31 mg NN B-NP I-do
31 q.d NN I-NP B-f
31 , , O O
32 Dyazide NNP B-NP B-m
32 25 CD O B-do
32 mg NN B-NP I-do
32 q.d NN I-NP B-f
32 , , O O
32 nose JJ B-NP B-m
32 spray NN I-NP I-m
32 b.i.d NN I-NP B-f
32 , , O O
32 calcium NN B-NP B-m
32 chloride NN I-NP I-m
32 pills NNS I-NP I-m
32 q.d RB O B-f
32 , , O O
33 Colchicine NNP B-NP B-m
33 600 CD O B-do
33 mg NN B-NP I-do
33 q.d NN I-NP B-f
33 , , O O
33 cyproheptadine VB O B-m
33 hydrochloride RB O I-m
33 4 CD O B-do
33 mg NNS B-NP I-do
33 b.i.d JJ B-NP B-f
34 q.h.s NN I-NP O
34 , , O O
34 anticholesterol NN B-NP B-m
34 med VBD B-VP I-m
35 PHYSICAL NNP B-NP O
35 EXAMINATION: NNP I-NP O
35 Clinic NNP I-NP O
35 - : O O
35 Blood NN B-NP O
35 pressure NN I-NP O
35 146/78 CD O O
35 , , O O
35 pulse RB O O
35 76 CD O O
35 , , O O
36 respiratory NN B-NP O
36 rate NN I-NP O
36 16 CD O O
36 In IN B-VP O
36 general JJ O O
36 , , O O
36 the DT B-NP O
37 patient NN I-NP O
37 was VBD B-VP O
37 in IN B-VP O
37 no DT B-NP O
37 acute NN I-NP O
37 distress NN I-NP O
37 Normocephalic NNP I-NP O
37 , , O O
37 atraumatic VBZ O O
37 The DT B-NP O
38 patient's JJ I-NP O
38 emotions NNS I-NP O
38 were VBD B-VP O
38 intact JJ B-NP O
38 Heart NNP I-NP O
38 in IN B-VP O
38 regular JJ B-NP O
38 rate NN I-NP O
38 and CC O O
38 rhythm NN B-NP O
39 with IN B-VP O
39 no DT B-NP O
39 murmurs NNS I-NP O
39 , , O O
39 gallops NNS B-NP O
39 or CC O O
39 rubs VB O O
39 Lungs NNS B-NP O
39 had VBD B-VP O
39 fine JJ B-NP O
39 crackles NNS I-NP O
40 posterior RB O O
40 chest VBP O O
40 The DT B-NP O
40 bases NNS I-NP O
40 were VBD B-VP O
40 clear JJ O O
40 to TO O O
40 auscultation VB O O
40 The DT B-NP O
41 abdomen NNS I-NP O
41 was VBD B-VP O
41 obese JJ O O
41 , , O O
41 soft JJ O O
41 , , O O
41 non-tender JJ O O
41 without IN B-VP O
41 hepatosplenomegaly JJ B-NP O
41 No NNP I-NP O
42 costovertebral JJ O O
42 angle RB O O
42 tenderness JJ B-NP O
42 Extremities NNS I-NP O
42 were VBD B-VP O
42 without IN B-VP O
43 clubbing VBG O O
43 , , O O
43 cyanosis NN B-NP O
43 or CC O O
43 edema VB O O
43 The DT B-NP O
43 patient NN I-NP O
43 was VBD B-VP O
43 alert JJ O O
43 and CC O O
43 oriented VBD B-VP O
43 x NNP B-NP O
44 three CD O O
44 Non-focal JJ B-NP O
44 Speech NNP I-NP O
44 was VBD B-VP O
44 fluent JJ B-NP O
45 LABORATORY NNP I-NP O
45 DATA: NNP I-NP O
45 White NNP I-NP O
45 blood NN I-NP O
45 cell NN I-NP O
45 count NN I-NP O
45 9.03 CD O O
45 , , O O
45 hematocrit NN B-NP O
45 38.2 CD O O
45 , , O O
46 platelets NNS B-NP O
46 215 CD O O
46 Coagulation NNP B-NP O
46 status NN I-NP O
46 was VBD B-VP O
46 normal JJ O O
47 with IN B-VP O
47 INR NNP B-NP O
47 of IN B-VP O
47 1.2 CD O O
47 Sodium NNP B-NP O
47 of IN B-VP O
47 41 CD O O
47 , , O O
47 potassium NN B-NP O
47 3.8 CD O O
47 , , O O
47 BUN/creatinine NNP B-NP O
48 16/0.8 CD O O
48 , , O O
48 glucose VBD B-VP O
48 126 CD O O
49 HOSPITAL NNP B-NP O
49 COURSE: NNP I-NP O
49 The DT B-NP O
49 patient NN I-NP O
49 admitted VBD B-VP O
49 to TO O O
49 the DT B-NP O
49 Thoracic NNP I-NP O
49 Surgery NNP I-NP O
50 Service NNP I-NP O
50 on IN B-VP O
50 3/27/99 CD O O
50 and CC O O
50 taken VBN O O
50 to TO O O
50 the DT B-NP O
50 Operating NN I-NP O
51 Room NNP I-NP O
51 for IN B-VP O
51 a DT B-NP O
51 video NN I-NP O
51 assisted VBN O O
51 thorascopic RB O O
51 right JJ B-NP O
51 lower JJR I-NP O
51 lobe NN I-NP O
51 lobectomy NN I-NP O
51 by IN B-VP O
52 Dr NNP B-NP O
52 Minick NNP I-NP O
52 The DT B-NP O
52 procedure NN I-NP O
52 went VBD B-VP O
52 without IN B-VP O
52 complications NNS B-NP O
53 Postoperatively RB O O
53 , , O O
53 the DT B-NP O
53 patient NN I-NP O
53 did VBD B-VP O
53 well RB O O
53 The DT B-NP O
53 chest JJS I-NP O
53 tube NN I-NP O
53 that WDT O O
53 was VBD B-VP O
54 placed VBN O O
54 intraoperatively RB O O
54 did VBD B-VP O
54 not RB O O
54 have VB O O
54 a DT B-NP O
54 leak NN I-NP O
54 The DT B-NP O
54 patient NN I-NP O
54 was VBD B-VP O
55 followed VBN O O
55 by IN B-VP O
55 the DT B-NP O
55 Internal NNP I-NP O
55 Medicine NNP I-NP O
55 Service NNP I-NP O
55 The DT O O
55 patient JJ O O
55 went VBD B-VP O
55 into IN B-VP O
56 rapid JJ B-NP O
56 atrial JJ I-NP O
56 fibrillation NN I-NP O
56 postoperatively RB O O
56 She PRP O O
56 was VBD B-VP O
56 placed VBN O O
56 on IN B-VP O
56 a DT B-NP O
57 rule NN I-NP O
57 out IN B-VP O
57 myocardial JJ B-NP O
57 infarction NN I-NP O
57 and CC O O
57 seen VBN O O
57 by IN B-VP O
57 the DT B-NP O
57 Cardiology NNP I-NP O
57 Service NNP I-NP O
58 The DT B-NP O
58 patient NN I-NP O
58 was VBD B-VP O
58 successfully RB O O
58 converted VBN O O
58 into IN B-VP O
58 a DT B-NP O
58 normal JJ I-NP O
58 sinus NN I-NP O
58 rhythm NN I-NP O
59 using VBG O O
59 Diltiazem NNP B-NP B-m
59 IV NNP I-NP B-mo
59 This DT O O
59 was VBD B-VP O
59 converted VBN O O
59 to TO O O
59 p.o VB O B-mo
59 Diltiazem NNP B-NP B-m
59 The DT B-NP O
60 patient's JJ I-NP O
60 postoperative JJ I-NP O
60 course NN I-NP O
60 was VBD B-VP O
60 largely RB O O
60 unremarkable JJ O O
60 but CC O O
60 for IN B-VP O
61 dysrhythmia NN B-NP O
61 She PRP O O
61 was VBD B-VP O
61 on IN B-VP O
61 no DT B-NP O
61 antibiotics NNS I-NP O
61 She PRP O O
61 required VBD B-VP O
61 diuresis NN B-NP O
62 with IN B-VP O
62 Lasix NNP B-NP B-m
62 40 CD O B-do
62 q.d NN B-NP B-f
62 for IN B-VP O
62 home NN B-NP O
62 The DT B-NP B-r
62 patient's NN I-NP B-r
62 patient's NN I-NP I-r
62 pain NN I-NP I-r
62 pain NN I-NP I-r
62 was VBD B-VP O
62 well RB O O
63 controlled VBN O O
63 with IN B-VP O
63 p.o NN B-NP B-mo
63 pain NN I-NP B-m
63 medications NNS I-NP I-m
63 , , O O
63 Percocet NNP B-NP B-m
64 Final NNP I-NP O
64 pathology NN I-NP O
64 was VBD B-VP O
64 read VBN O O
64 as IN B-VP O
64 squamous JJ B-NP O
64 cell NN I-NP O
64 carcinoma NN I-NP O
64 , , O O
64 4.0 CD O O
64 cm NN B-NP O
64 , , O O
65 moderately RB O O
65 differentiated VBN O O
65 with IN B-VP O
65 focal JJ B-NP O
65 characterization NN I-NP O
65 with IN B-VP O
66 extensive JJ B-NP O
66 necrosis NN I-NP O
66 No NNP I-NP O
66 lymphatic NN I-NP O
66 or CC O O
66 vascularization NN B-NP O
66 was VBD B-VP O
67 identified VBN O O
67 Tumor NNP B-NP O
67 abuts NNS I-NP O
67 but CC O O
67 did VBD B-VP O
67 not RB O O
67 invade VB O O
67 the DT B-NP O
67 pleura NN I-NP O
68 DISPOSITION: NNP I-NP O
68 The DT B-NP O
68 patient NN I-NP O
68 was VBD B-VP O
68 discharged VBN O O
68 to TO O O
68 home VB O O
69 FOLLOW-UP: NNP B-NP O
69 With IN B-VP O
69 Thoracic NNP B-NP O
69 Surgery NNP I-NP O
69 Service NNP I-NP O
69 as IN B-VP O
69 has VBZ O O
69 been VBN O O
69 arranged VBN O O
70 as RB O O
70 well RB O O
70 as IN B-VP O
70 with IN B-VP O
70 primary JJ B-NP O
70 care NN I-NP O
70 physician NN I-NP O
70 and CC O O
70 Cardiology NNP B-NP O
71 as IN B-VP O
71 needed VBN O O
72 DISCHARGE NNP B-NP O
72 MEDICATIONS: NNP I-NP O
72 Albuterol NNP I-NP B-m
72 nebulizers VBZ O I-m
72 250 CD O B-do
72 mg NN B-NP I-do
72 q.4h NN I-NP B-f
72 , , O O
73 Allopurinol NNP B-NP B-m
73 300 CD O B-do
73 mg NN B-NP I-do
73 q.d NN I-NP B-f
73 , , O O
73 Colchicine NNP B-NP B-m
73 0.6 CD O B-do
73 mg NN B-NP I-do
74 q.d NN I-NP B-f
74 , , O O
74 cyproheptadine NN B-NP B-m
74 hydrochloride NN I-NP I-m
74 by IN B-VP B-mo
74 mouth NN B-NP I-mo
74 400 CD O B-do
74 mg NN B-NP I-do
74 q.d NN I-NP B-f
74 , , O O
74 Digoxin NNP B-NP B-m
75 0.125 CD O B-do
75 mg NN B-NP I-do
75 q.d NN I-NP B-f
75 , , O O
75 Diltiazem NNP B-NP B-m
75 30 CD O B-do
75 mg NN B-NP I-do
75 t.i.d NN I-NP B-f
75 , , O O
75 Colace NNP B-NP B-m
75 100 CD O B-do
75 mg NN B-NP I-do
75 t.i.d NN I-NP B-f
75 , , O O
75 Lasix NNP B-NP B-m
76 40 CD O B-do
76 mg NN B-NP I-do
76 p.o NN I-NP B-mo
76 q.d NN I-NP B-f
76 , , O O
76 Percocet NNP B-NP B-m
76 1-2 JJ B-NP B-do
76 tablets NNS I-NP I-do
76 p.o VBP O B-mo
76 q.4h JJ B-NP B-f
76 p.r.n NN I-NP I-f
76 , , O O
76 Dilantin NNP B-NP B-m
77 200 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
77 b.i.d NN I-NP B-f
77 , , O O
77 Trazodone NNP B-NP B-m
77 100 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
77 q.h.s NN I-NP B-f
78 DISCHARGE NNP I-NP O
78 DIAGNOSIS: NNP I-NP O
78 SQUAMOUS NNP I-NP O
78 CELL NNP I-NP O
78 CARCINOMA NNP I-NP O
78 OF IN B-VP O
78 THE NNP B-NP O
78 LUNG NNP I-NP O
79 Dictated NNP I-NP O
79 By: NNP I-NP O
80 Attending: NNP I-NP O
80 EFREN NNP I-NP O
80 B NNP I-NP O
80 MUSHETT NNP I-NP O
80 , , O O
80 M.D NNP B-NP O
80 OH8 NNP I-NP O
81 LW748/7644 NNP I-NP O
82 Batch: NNP I-NP O
82 21957 CD O O
82 Index NNP B-NP O
82 No NNP I-NP O
82 F8XZ8FXAE5 NNP I-NP O
82 D: NNP I-NP O
82 3/7/99 CD O O
83 T: NNP B-NP O
83 7/14/99 CD O O
84 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #72791 VBZ O O
4 447546077 CD O O
4 OH NNP B-NP O
4 06972217 CD O O
4 7590252 CD O O
4 4/21/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHRONIC NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 , , O O
4 PNEUMONIA NNP B-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/7/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/16/2005 CD O O
7 ATTENDING: NNP B-NP O
7 LEIFER NNP I-NP O
7 , , O O
7 JEFFEREY NNP B-NP O
7 GRAHAM NNP I-NP O
7 MD NNP I-NP O
8 PRINCIPAL NNP I-NP O
8 DIAGNOSES: NNP I-NP O
8 Endocarditis NNP I-NP O
8 , , O O
8 urinary JJ B-NP O
8 tract NN I-NP O
8 infection NN I-NP O
9 SECONDARY NNP I-NP O
9 DIAGNOSES: NNP I-NP O
9 Mitral NNP I-NP O
9 regurgitation NN I-NP O
9 , , O O
9 diabetes VBZ O O
9 , , O O
10 hypertension NN B-NP O
10 , , O O
10 congestive JJ B-NP O
10 heart NN I-NP O
10 failure NN I-NP O
10 , , O O
10 recurrent NN B-NP O
10 UTIs NNP I-NP O
10 , , O O
10 uterine JJ B-NP O
11 prolapse NN I-NP O
11 , , O O
11 hyperlipidemia NN B-NP O
11 , , O O
11 hiatal JJ B-NP O
11 hernia NN I-NP O
11 , , O O
11 right JJ B-NP O
11 breast NN I-NP O
11 nodule JJ B-NP O
12 HISTORY NNP I-NP O
12 OF NNP I-NP O
12 PRESENT NNP I-NP O
12 ILLNESS: NNP I-NP O
12 The DT B-NP O
12 patient NN I-NP O
12 is VBZ O O
12 a DT O O
12 76-year-old JJ O O
12 with IN B-VP O
12 a DT B-NP O
13 history NN I-NP O
13 of IN B-VP O
13 severe JJ B-NP O
13 mitral JJ I-NP O
13 regurgitation NN I-NP O
13 , , O O
13 history NN B-NP O
13 of IN B-VP O
13 congestive JJ B-NP O
14 heart NN I-NP O
14 failure NN I-NP O
14 with IN B-VP O
14 an DT B-NP O
14 ejection NN I-NP O
14 fraction NN I-NP O
14 of IN B-VP O
14 60% CD O O
14 in IN B-VP O
14 7/24 CD O O
14 , , O O
14 chronic JJ B-NP O
15 abdominal JJ I-NP O
15 discomfort NN I-NP O
15 , , O O
15 history NN B-NP O
15 of IN B-VP O
15 recurrent NN B-NP O
15 UTIs NNP I-NP O
15 , , O O
15 and CC O O
15 uterine JJ B-NP O
16 prolapse NN I-NP O
16 , , O O
16 who WP O O
16 one CD O O
16 week NN B-NP O
16 prior RB O O
16 to TO O O
16 admission NN B-NP O
16 developed NNS I-NP O
16 increased VBD B-VP O
17 nausea NN B-NP O
17 , , O O
17 decreased VBN O O
17 appetite NN B-NP O
17 , , O O
17 weakness NN B-NP O
17 , , O O
17 fatigue NN B-NP O
17 and CC O O
17 increased VBD B-VP O
17 low JJ O O
18 back RB O O
18 pain NN B-NP O
18 No NNP I-NP O
18 vomiting NN I-NP O
18 , , O O
18 diarrhea NN B-NP O
18 , , O O
18 cough NN B-NP O
18 , , O O
18 or CC O O
18 dysuria NNS B-NP O
18 On IN B-VP O
19 presentation NN B-NP O
19 , , O O
19 the DT B-NP O
19 patient NN I-NP O
19 was VBD B-VP O
19 found VBN O O
19 to TO O O
19 be VB O O
19 hypotensive JJ O O
19 , , O O
19 in IN B-VP O
19 septic JJ B-NP O
20 shock NN I-NP O
20 , , O O
20 with IN B-VP O
20 bacteremia NN B-NP O
20 in IN B-VP O
20 urinary JJ B-NP O
20 tract NN I-NP O
20 infection NN I-NP O
20 and CC O O
20 admitted VBN O O
20 to TO O O
21 the DT B-NP O
21 Medical NNP I-NP O
21 ICU NNP I-NP O
21 for IN B-VP O
21 pressure NN B-NP O
21 support NN I-NP O
22 ADMISSION NNP I-NP O
22 PHYSICAL NNP I-NP O
22 EXAMINATION: NNP I-NP O
22 Notable NNP I-NP O
22 for IN B-VP O
22 heart NN B-NP O
22 rate NN I-NP O
22 of IN B-VP O
22 94 CD O O
22 , , O O
23 blood NN B-NP O
23 pressure NN I-NP O
23 of IN B-VP O
23 80-90/50 JJ B-NP O
23 Notable NNP I-NP O
23 for IN B-VP O
23 heart NN B-NP O
23 exam NN I-NP O
23 with IN B-VP O
23 regular JJ B-NP O
24 rate NN I-NP O
24 and CC O O
24 rhythm NN B-NP O
24 , , O O
24 normal JJ B-NP O
24 S1 NNP I-NP O
24 and CC O O
24 S2 NNP B-NP O
24 , , O O
24 with IN B-VP O
24 3/6 CD O O
24 systolic JJ B-NP O
24 crescendo NN I-NP O
25 murmur NN I-NP O
25 and CC O O
25 decrescendo NN B-NP O
25 murmur NN I-NP O
25 at IN B-VP O
25 the DT B-NP O
25 right JJ I-NP O
25 upper JJ I-NP O
25 sternal JJ I-NP O
25 border NN I-NP O
26 radiating VBG O O
26 to TO O O
26 the DT B-NP O
26 clavicles NNS I-NP O
26 and CC O O
26 carotids NNS B-NP O
26 , , O O
26 and CC O O
26 3/6 CD O O
26 holosystolic JJ B-NP O
27 murmur NN I-NP O
27 at IN B-VP O
27 the DT B-NP O
27 apex NN I-NP O
27 radiating VBG O O
27 to TO O O
27 the DT B-NP O
27 axilla NN I-NP O
27 , , O O
27 and CC O O
27 an DT B-NP O
27 apical JJ I-NP O
27 heave NN I-NP O
28 JVP NNP I-NP O
28 flat JJ B-NP O
28 Chest NNP I-NP O
28 with IN B-VP O
28 crackles NNS B-NP O
28 in IN B-VP O
28 the DT B-NP O
28 right NN I-NP O
28 middle NN I-NP O
28 lung NN I-NP O
28 fields NNS I-NP O
28 and CC O O
29 leg VB O O
29 basilar JJ B-NP O
29 crackles NNS I-NP O
29 Abdominal NNP I-NP O
29 exam NN I-NP O
29 was VBD B-VP O
29 benign JJ B-NP O
29 Guaiac NNP I-NP O
30 negative JJ B-NP O
30 Extremities NNS I-NP O
30 with IN B-VP O
30 no DT B-NP O
30 clubbing NN I-NP O
30 , , O O
30 cyanosis NN B-NP O
30 , , O O
30 or CC O O
30 edema NN B-NP O
30 and CC O O
31 1+ CD O O
31 dorsalis NNS B-NP O
31 pedis JJ B-NP O
31 pulses NNS I-NP O
31 bilaterally RB O O
32 RELEVANT NNP B-NP O
32 STUDIES NNP I-NP O
32 AND NNP I-NP O
32 TESTS: NNP I-NP O
32 Blood NNP I-NP O
32 culture NN I-NP O
32 on IN B-VP O
32 9/10 CD O O
33 Streptococcus NNP B-NP O
33 viridans NNS I-NP O
33 , , O O
33 levofloxacin RB O O
33 sensitive JJ O O
33 , , O O
33 penicillin JJ B-NP O
33 MIC NNP I-NP O
34 0.19 CD O O
34 Urine NNP B-NP O
34 culture NN I-NP O
34 on IN B-VP O
34 9/10 CD O O
34 Greater NNP B-NP O
34 than IN B-VP O
34 100 CD O O
34 , , O O
34 000 CD O O
34 Klebsiella NNP B-NP O
35 pneumoniae NN I-NP O
35 , , O O
35 ampicillin NN B-NP O
35 resistant NN I-NP O
35 , , O O
35 gentamicin NN B-NP O
35 sensitive JJ O O
35 , , O O
35 and CC O O
36 levofloxacin RB O O
36 sensitive JJ B-NP O
36 TEE NNP I-NP O
36 on IN B-VP O
36 0/14 CD O O
36 Severe JJ B-NP O
36 mitral JJ I-NP O
37 regurgitation NN I-NP O
37 , , O O
37 posterior JJ B-NP O
37 leaflet NN I-NP O
37 with IN B-VP O
37 mitral JJ B-NP O
37 calcifications NNS I-NP O
37 and CC O O
38 linear JJ B-NP O
38 density NN I-NP O
38 concerning VBG O O
38 for IN B-VP O
38 endocarditis NN B-NP O
39 HOSPITAL NNP I-NP O
39 COURSE: NNP I-NP O
40 IMPRESSION: NNP I-NP O
40 A NNP I-NP O
40 76-year-old JJ B-NP O
40 female NN I-NP O
40 with IN B-VP O
40 mitral JJ B-NP O
40 regurgitation NN I-NP O
40 , , O O
41 history NN B-NP O
41 of IN B-VP O
41 CHF NNP B-NP O
41 , , O O
41 history NN B-NP O
41 of IN B-VP O
41 recurrent NN B-NP O
41 UTI NNP I-NP O
41 , , O O
41 who WP O O
41 presented VBD B-VP O
41 with IN B-VP O
42 nausea NN B-NP O
42 and CC O O
42 chills NNS B-NP O
42 , , O O
42 had VBD B-VP O
42 hypotension NN B-NP O
42 requiring VBG O O
42 a DT B-NP O
42 medical JJ I-NP O
42 ICU NNP I-NP O
42 stay NN I-NP O
42 x RB O O
43 2 CD O O
43 days NNS B-NP O
43 , , O O
43 with IN B-VP O
43 Streptococcus NNP B-NP O
43 viridans NNS I-NP O
43 bacteremia NN I-NP O
43 and CC O O
43 mitral JJ B-NP O
44 calcifications NNS I-NP O
44 in IN B-VP O
44 linear JJ B-NP O
44 density NN I-NP O
44 concerning VBG O O
44 for IN B-VP O
44 endocarditis NN B-NP O
44 plus CC O O
45 Klebsiella NNP B-NP O
45 UTI NNP I-NP O
46 1 CD O O
46 Infectious NNP B-NP O
46 disease: VBD B-VP O
46 The DT B-NP O
46 patient NN I-NP O
46 presented VBN O O
46 with IN B-VP O
46 chills NNS B-NP O
46 and CC O O
47 hypotension NN B-NP O
47 and CC O O
47 was VBD B-VP O
47 admitted VBN O O
47 to TO O O
47 the DT B-NP O
47 MICU NNP I-NP O
47 from IN B-VP O
47 the DT B-NP O
47 ED NNP I-NP O
47 for IN B-VP O
48 treatment NN B-NP O
48 of IN B-VP O
48 septic JJ B-NP O
48 shock NN I-NP O
48 Her PRP$ O O
48 mean JJ B-NP B-r
48 arterial JJ I-NP I-r
48 pressures NNS I-NP I-r
48 were VBD B-VP O
48 kept VBN O O
49 above IN B-VP O
49 65 CD O O
49 with IN B-VP O
49 Levophed NNP B-NP B-m
49 She PRP O O
49 initially RB O O
49 was VBD B-VP O
49 treated VBN O O
49 with IN B-VP O
50 levofloxacin JJ B-NP B-m
50 levofloxacin NN I-NP B-m
50 and CC O O
50 vancomycin NN B-NP B-m
50 vancomycin NN I-NP B-m
50 to TO O O
50 treat VB O O
50 Gram-positive JJ B-NP B-r
50 Gram-positive JJ I-NP B-r
50 cocci NN I-NP O
51 bacteremia NN I-NP O
51 and CC O O
51 UTI NNP B-NP B-r
51 UTI NNP I-NP B-r
51 Blood NNP I-NP O
51 culture NN I-NP O
51 from IN B-VP O
51 10/22 CD O O
51 , , O O
51 grew VBD B-VP O
51 out RP O O
52 Streptococcus NNP B-NP O
52 viridans NNS I-NP O
52 , , O O
52 levofloxacin RB O O
52 sensitive JJ O O
52 , , O O
52 penicillin JJ B-NP O
52 MIC NNP I-NP O
53 0.19 CD O O
53 Urine NNP B-NP O
53 culture NN I-NP O
53 was VBD B-VP O
53 positive JJ O O
53 for IN B-VP O
53 Klebsiella NNP B-NP O
53 , , O O
53 ampicillin NN B-NP O
54 resistant NN I-NP O
54 , , O O
54 gentamicin NN B-NP O
54 and CC O O
54 levofloxacin JJ O O
54 sensitive JJ O O
54 On IN B-VP O
54 3/18 CD O O
54 , , O O
55 antibiotics NNS B-NP B-m
55 were VBD B-VP O
55 changed VBN O O
55 to TO O O
55 penicillin VB O B-m
55 3 CD O B-do
55 million CD O I-do
55 units NNS B-NP I-do
55 IV NNP I-NP B-mo
55 q.4h NN I-NP B-f
56 and CC O O
56 gentamicin $ O B-m
56 50 CD O B-do
56 mg NN B-NP I-do
56 IV NNP I-NP B-mo
56 q.8h NNP I-NP B-f
56 ATEE NNP I-NP O
56 on IN B-VP O
56 10/19 CD O O
56 showed VBD B-VP O
56 severe JJ B-NP O
56 mitral JJ I-NP O
57 regurgitation NN I-NP O
57 with IN B-VP O
57 posterior JJ B-NP O
57 leaflet NN I-NP O
57 calcifications NNS I-NP O
57 and CC O O
57 linear JJ B-NP O
58 density NN I-NP O
58 concerning VBG O O
58 for IN B-VP O
58 endocarditis NN B-NP O
58 Therefore NNP I-NP O
58 , , O O
58 a DT B-NP O
58 PICC NNP I-NP O
58 line NN I-NP O
58 was VBD B-VP O
59 placed VBN O O
59 on IN B-VP O
59 1/19 CD O O
59 for IN B-VP O
59 continuation NN B-NP O
59 of IN B-VP O
59 a DT B-NP O
59 six-week JJ I-NP O
59 course NN I-NP O
59 of IN B-VP O
60 penicillin $ O B-m
60 3 CD O B-do
60 million CD O I-do
60 units NNS B-NP I-do
60 IV NNP I-NP B-mo
60 q.4h NN I-NP B-f
60 until IN B-VP O
60 0/12 CD O O
60 and CC O O
60 two-week JJ B-NP O
61 course NN I-NP O
61 of IN B-VP O
61 gentamicin JJ O B-m
61 50 CD O B-do
61 mg NN B-NP I-do
61 IV NNP I-NP B-mo
61 q.8h NN I-NP B-f
61 until IN B-VP O
61 2/25 CD O O
61 She PRP O O
61 will MD O O
61 follow VB O O
62 up RP O O
62 in IN B-VP O
62 the DT B-NP O
62 Infectious JJ I-NP O
62 Disease NNP I-NP O
62 Clinic NNP I-NP O
62 with IN B-VP O
62 Dr NNP B-NP O
62 Ramiro NNP I-NP O
62 Halcom NNP I-NP O
62 on IN B-VP O
63 0/9/05 CD O O
63 at IN B-VP O
63 8 CD O O
63 a.m JJ O O
64 2 CD O O
64 Cardiovascular: NNP B-NP O
64 Ischemia: NNP I-NP B-r
64 The DT B-NP O
64 patient NN I-NP O
64 was VBD B-VP O
64 maintained VBN O O
64 on IN B-VP O
65 aspirin NN B-NP B-m
65 Lipitor NNP I-NP B-m
65 was VBD B-VP O
65 initially RB O O
65 helped VBN O O
65 for IN B-VP O
65 an DT B-NP B-r
65 initial JJ I-NP O
66 transaminitis NN I-NP O
66 presumed VBD B-VP O
66 to TO O O
66 be VB O O
66 secondary JJ O O
66 to TO O O
66 shock VB O O
66 liver NN B-NP O
66 , , O O
66 that WDT O O
66 at IN B-VP O
67 the DT B-NP O
67 time NN I-NP O
67 of IN B-VP O
67 discharge NN B-NP O
67 her PRP$ O O
67 liver NN B-NP O
67 enzymes NNS I-NP O
67 had VBD B-VP O
67 normalized VBN O O
67 and CC O O
67 she PRP O O
68 was VBD B-VP O
68 restarted VBN O O
68 on IN B-VP O
68 her PRP$ O O
68 Lipitor NNP B-NP B-m
68 Pump: NNP I-NP O
68 The DT B-NP O
68 patient NN I-NP O
68 has VBZ O O
68 a DT B-NP O
68 history NN I-NP O
69 of IN B-VP O
69 congestive JJ B-NP O
69 heart NN I-NP O
69 failure NN I-NP O
69 , , O O
69 with IN B-VP O
69 an DT B-NP O
69 ejection NN I-NP O
69 fraction NN I-NP O
69 60% CD O O
69 in IN B-VP O
70 7/24 CD O O
70 She PRP O O
70 had VBD B-VP B-r
70 hypotension NN B-NP O
70 , , O O
70 requiring VBG O B-m
70 Levophed VBN O B-du
70 until IN B-VP I-du
70 11/0 CD O O
70 She PRP O O
71 had VBD B-VP O
71 an DT B-NP O
71 episode NN I-NP O
71 of IN B-VP O
71 flash JJ B-NP O
71 pulmonary JJ I-NP O
71 edema NN I-NP O
71 on IN B-VP O
71 11/9 CD O O
71 in IN B-VP O
71 the DT B-NP O
71 setting NN I-NP O
72 of IN B-VP O
72 fluid JJ B-NP O
72 bolus NN I-NP O
72 and CC O O
72 one CD O B-do
72 unit NN B-NP I-do
72 of IN B-VP O
72 packed JJ B-NP B-m
72 red JJ I-NP I-m
72 blood NN I-NP I-m
72 cells NNS I-NP I-m
72 She PRP O O
72 has VBZ O O
72 a DT O O
73 very RB O O
73 attenuatus JJ B-NP O
73 balance NN I-NP O
73 between IN B-VP O
73 preload NN B-NP O
73 dependence NN I-NP O
73 and CC O O
73 overload NN B-NP O
74 Her NNP I-NP O
74 Lasix NNP I-NP B-m
74 and CC O O
74 ACE-I NNP B-NP B-m
74 were VBD B-VP O
74 held VBN O O
74 while IN B-VP O
74 she PRP O O
74 was VBD B-VP O
74 hypotensive JJ O O
74 Because IN B-VP O
75 her PRP$ O O
75 systolic JJ B-NP O
75 blood NN I-NP O
75 pressure NN I-NP O
75 continued VBD B-VP O
75 to TO O O
75 be VB O O
75 low JJ O O
75 in IN B-VP O
75 the DT O O
75 90s CD O O
75 and CC O O
76 low JJ O O
76 100s CD O O
76 , , O O
76 attempt NN B-NP O
76 was VBD B-VP O
76 not RB O O
76 made VBN O O
76 to TO O O
76 re-add VB O O
76 the DT B-NP O
76 ACE NNP I-NP B-m
76 while IN B-VP O
76 in IN B-VP O
76 the DT B-NP O
77 hospital NN I-NP O
77 It PRP O O
77 is VBZ O O
77 anticipated JJ O O
77 that IN B-VP O
77 her PRP$ O O
77 cardiologist NN B-NP O
77 and CC O O
77 outpatient JJ B-NP O
78 physicians NNS I-NP O
78 will MD O O
78 attempt VB O O
78 to TO O O
78 add VB O O
78 the DT B-NP O
78 ACE NNP I-NP B-m
78 back RB O O
78 onto IN B-VP O
78 her PRP$ O O
78 medical JJ B-NP O
79 regimen NN I-NP O
79 for IN B-VP O
79 better JJR B-NP B-r
79 afterload NN I-NP I-r
79 reduction NN I-NP I-r
79 as IN B-VP O
79 her PRP$ O O
79 blood NN B-NP O
79 pressure NN I-NP O
80 tolerates VBZ O O
80 The DT B-NP O
80 patient NN I-NP O
80 also RB O O
80 has VBZ O O
80 a DT O B-r
80 very RB O O
80 severe JJ B-NP O
80 mitral JJ I-NP O
81 regurgitation NN I-NP O
81 , , O O
81 which WDT O O
81 would MD O O
81 be VB O O
81 one CD O O
81 of IN B-VP O
81 the DT B-NP O
81 reasons NNS I-NP O
81 that IN B-VP O
81 an DT B-NP O
81 ACE NNP I-NP B-m
81 on IN B-VP O
82 her PRP$ O B-m
82 medication NN B-NP I-m
82 regimen NNS I-NP O
82 would MD O O
82 be VB O O
82 beneficial JJ B-NP O
82 Rhythm: NNP I-NP O
82 The DT B-NP O
82 patient NN I-NP O
83 was VBD B-VP O
83 maintained VBN O O
83 on IN B-VP O
83 telemetry NN B-NP O
83 , , O O
83 and CC O O
83 was VBD B-VP O
83 found VBN O O
83 to TO O O
83 be VB O O
83 a DT B-NP O
83 normal JJ I-NP O
83 sinus NN I-NP O
84 rhythm NN I-NP O
84 with IN B-VP O
84 ectopy NN B-NP O
84 , , O O
84 including VBG O O
84 short JJ O O
84 once RB O O
84 of IN B-VP O
84 nonsustained VBN O B-r
84 nonsustained JJ B-NP B-r
85 ventricular JJ I-NP O
85 tachycardia NN I-NP O
85 She PRP O O
85 was VBD B-VP O
85 started VBN O O
85 on IN B-VP O
85 Lopressor NNP B-NP B-m
85 Lopressor NNP I-NP B-m
85 12.5 CD O B-do
85 mg NN B-NP I-do
86 t.i.d NN I-NP B-f
86 on IN B-VP O
86 3/18 CD O O
86 , , O O
86 and CC O O
86 this DT O O
86 was VBD B-VP O
86 increased VBN O O
86 to TO O O
86 25 CD O B-do
86 mg NNS B-NP I-do
86 b.i.d NN I-NP B-f
86 at IN B-VP O
87 discharge NN B-NP O
87 , , O O
87 with IN B-VP O
87 her PRP$ O O
87 heart NN B-NP O
87 rates NNS I-NP O
87 continuing VBG O O
87 to TO O O
87 be VB O O
87 between IN B-VP O
87 the DT O O
87 70s CD O O
88 and CC O O
88 the DT O O
88 90s CD O O
88 , , O O
88 however RB O O
88 , , O O
88 with IN B-VP O
88 less JJR B-NP O
88 episodes NNS I-NP O
88 of IN B-VP O
88 ectopy NN B-NP O
88 Her PRP$ O O
89 electrolytes NNS B-NP O
89 were VBD B-VP O
89 also RB O O
89 well RB O O
89 repleted VBD B-VP O
90 3 CD O O
90 Gastrointestinal: NNP B-NP O
90 The DT B-NP O
90 patient NN I-NP O
90 had VBD B-VP O
90 evidence NN B-NP O
90 of IN B-VP O
90 shock NN B-NP O
90 liver NN I-NP O
91 ( ( O O
91 0/24 CD O O
91 with IN B-VP O
91 an DT B-NP O
91 ALT NNP I-NP O
91 of IN B-VP O
91 135 CD O O
91 , , O O
91 AST NNP B-NP O
91 of IN B-VP O
91 177 CD O O
91 , , O O
91 alkaline JJ B-NP O
91 phosphatase NN I-NP O
91 of IN B-VP O
92 251 CD O O
92 , , O O
92 and CC O O
92 T NNP B-NP O
92 bili NN I-NP O
92 of IN B-VP O
92 1.7 CD O O
92 ) ) O O
92 that WDT O O
92 is VBZ O O
92 now RB O O
92 resolving VBG O O
92 Lipitor NNP B-NP B-m
92 was VBD B-VP O
92 held VBN O O
92 , , O O
93 and CC O O
93 was VBD B-VP O
93 started VBN O O
93 as IN B-VP O
93 a DT B-NP O
93 transaminitis NN I-NP O
93 resolved VBN O O
93 Non-contrast NNP B-NP O
93 CT NNP I-NP O
93 of IN B-VP O
94 the DT B-NP O
94 abdomen NNS I-NP O
94 showed VBD B-VP O
94 biliary JJ B-NP O
94 sludge NN I-NP O
94 and CC O O
94 gallstones NNS B-NP O
94 , , O O
94 no DT B-NP O
94 evidence NN I-NP O
94 of IN B-VP O
95 acute JJ B-NP O
95 cholecystitis NN I-NP O
95 Right NNP I-NP O
95 upper NN I-NP O
95 quadrant NN I-NP O
95 ultrasound NN I-NP O
95 confirmed VBD B-VP O
96 the DT B-NP O
96 CT NNP I-NP O
96 findings NNS I-NP O
96 Colon NNP I-NP O
96 cancer NN I-NP O
96 is VBZ O O
96 a DT B-NP O
96 concern NN I-NP O
96 with IN B-VP O
96 the DT B-NP O
96 patient's NN I-NP O
97 anemia NN I-NP O
97 being VBG O O
97 new JJ O O
97 since IN B-VP O
97 0/29 CD O O
97 Her NNP B-NP O
97 last JJ B-NP O
97 colonoscopy NN I-NP O
97 was VBD B-VP O
97 in IN B-VP O
97 2000 CD O O
97 , , O O
98 and CC O O
98 she PRP O O
98 will MD O O
98 benefit VB O O
98 from IN B-VP O
98 repeat NN B-NP O
98 colonoscopy NN I-NP O
98 as IN B-VP O
98 an DT B-NP O
98 outpatient NN I-NP O
99 She PRP O O
99 was VBD B-VP O
99 continued VBN O O
99 on IN B-VP O
99 Nexium NNP B-NP B-m
99 for IN B-VP O
99 prophylaxis NN B-NP B-r
99 Heme: NNP I-NP O
99 The DT B-NP O
99 patient NN I-NP O
100 had VBD B-VP O
100 guaiac JJ B-NP O
100 positive JJ I-NP O
100 stools NNS I-NP O
100 in IN B-VP O
100 the DT B-NP O
100 medical JJ I-NP O
100 ICU NNP I-NP O
100 , , O O
100 her PRP$ O O
100 hematocrit NN B-NP O
100 was VBD B-VP O
101 stable JJ O O
101 around IN B-VP O
101 33% CD O O
101 She PRP O O
101 has VBZ O O
101 a DT B-NP O
101 microcytic JJ I-NP O
101 anemia NN I-NP O
101 with IN B-VP O
101 an DT B-NP O
101 MCV NNP I-NP O
101 of IN B-VP O
102 79 CD O O
102 , , O O
102 her PRP$ O O
102 iron NN B-NP O
102 studies NNS I-NP O
102 ( ( O O
102 iron NN B-NP O
102 of IN B-VP O
102 10 CD O O
102 , , O O
102 TIBC NNP B-NP O
102 of IN B-VP O
102 191 CD O O
102 , , O O
102 ferritin NN B-NP O
102 is VBZ O O
102 744 CD O O
102 ) ) O O
103 suggesting VBG O O
103 anemia NN B-NP O
103 of IN B-VP O
103 chronic JJ B-NP O
103 disease NN I-NP O
103 with IN B-VP O
103 possibly RB O O
103 overlying VBG O O
103 iron NN B-NP O
104 deficiency NN I-NP O
105 4 CD O O
105 Endocrine: NNP B-NP O
105 The DT B-NP O
105 patient NN I-NP O
105 had VBD B-VP O
105 a DT B-NP O
105 normal JJ I-NP O
105 random NN I-NP O
105 cortisol JJ B-NP O
105 level NN I-NP O
105 of IN B-VP O
106 35.3 CD O O
106 She PRP O O
106 had VBD B-VP O
106 an DT B-NP O
106 uncertain JJ I-NP O
106 diagnosis NN I-NP O
106 of IN B-VP O
106 diabetes NNS B-NP O
106 and CC O O
106 was VBD B-VP O
106 on IN B-VP O
106 the DT B-NP O
107 Portland NNP I-NP O
107 protocol NN I-NP O
107 in IN B-VP O
107 the DT B-NP O
107 medical JJ I-NP O
107 ICU NNP I-NP O
107 Hemoglobin NNP I-NP O
107 A1c NNP I-NP O
107 , , O O
107 however RB O O
107 , , O O
108 was VBD B-VP O
108 6.5 CD O O
108 Therefore RB O O
108 , , O O
108 she PRP O O
108 was VBD B-VP O
108 maintained VBN O O
108 thereafter RB O O
108 only RB O O
108 on IN B-VP O
109 insulin NN B-NP B-m
109 sliding VBG O B-do
109 scale NN B-NP I-do
109 and CC O O
109 rarely RB O O
109 required JJ O O
109 any DT B-NP O
109 coverage NN I-NP O
110 5 CD O O
110 Prophylaxis: NNP B-NP B-r
110 Prophylaxis: NNP I-NP B-r
110 The DT B-NP O
110 patient NN I-NP O
110 was VBD B-VP O
110 kept VBN O O
110 on IN B-VP O
110 Lovenox NNP B-NP B-m
110 and CC O O
110 Protonix NNP B-NP B-m
111 DISCHARGE NNP I-NP O
111 MEDICATIONS: NNP I-NP O
111 Aspirin NNP I-NP B-m
111 81 CD O B-do
111 mg JJ O I-do
111 daily RB O B-f
111 , , O O
111 iron NN B-NP B-m
111 sulfate NN I-NP I-m
111 325 CD O B-do
111 mg JJ O I-do
112 daily RB O B-f
112 , , O O
112 gentamicin JJ B-NP B-m
112 sulfate NN I-NP I-m
112 50 CD O B-do
112 mg NN B-NP I-do
112 IV NNP I-NP B-mo
112 q.8h NN I-NP B-f
112 until IN B-VP B-du
112 2/25 CD O O
112 for IN B-VP O
112 a DT B-NP O
113 two-week JJ I-NP O
113 course NN I-NP O
113 , , O O
113 penicillin JJ B-NP B-m
113 G NNP I-NP I-m
113 potassium NN I-NP I-m
113 3 CD O B-do
113 million CD O I-do
113 units NNS B-NP I-do
113 IV NNP I-NP B-mo
113 q.4h NN I-NP B-f
114 until IN B-VP B-du
114 0/12 CD O I-du
114 for IN B-VP I-du
114 a DT B-NP I-du
114 six-week JJ I-NP I-du
114 course NN I-NP I-du
114 , , O O
114 Lopressor NNP B-NP B-m
114 25 CD O B-do
114 mg NN B-NP I-do
114 b.i.d NN I-NP B-f
114 , , O O
115 Caltrate NNP B-NP B-m
115 plus CC O I-m
115 D2 NNP B-NP I-m
115 tablets NNS I-NP I-m
115 p.o VBP O B-mo
115 daily RB O B-f
115 , , O O
115 Lipitor NNP B-NP B-m
115 10 CD O B-do
115 mg JJ O I-do
115 daily JJ O B-f
115 , , O O
115 and CC O O
116 Protonix NNP B-NP B-m
116 40 CD O B-do
116 mg NNS B-NP I-do
116 daily RB O B-f
116 The DT B-NP O
116 patient NN I-NP O
116 has VBZ O O
116 not RB O O
116 been VBN O O
116 restarted VBN O O
116 on IN B-VP O
116 her PRP$ O O
117 home NN B-NP O
117 Lasix NNP I-NP O
117 and CC O O
117 lisinopril JJ O O
117 secondary JJ O O
117 to TO O O
117 persistently RB O O
117 low JJ B-NP O
117 blood NN I-NP O
118 pressures NNS I-NP O
118 between IN B-VP O
118 the DT O O
118 90s CD O O
118 and CC O O
118 100s CD O O
118 It PRP O O
118 is VBZ O O
118 anticipated VBN O O
118 that IN B-VP O
119 especially RB O O
119 her PRP$ O O
119 Lisinopril NNP B-NP B-m
119 and CC O O
119 her PRP$ O O
119 Lasix NNP B-NP B-m
119 will MD O O
119 be VB O O
119 added VBN O O
119 back RB O O
119 on IN B-VP O
119 to TO O O
120 her PRP$ O O
120 medical JJ B-NP O
120 regimen NN I-NP O
120 as IN B-VP O
120 her PRP$ O O
120 blood NN B-NP O
120 pressure NN I-NP O
120 tolerates VBZ O O
120 Given VBN O O
120 that IN B-VP O
121 she PRP O O
121 was VBD B-VP O
121 no RB O O
121 longer JJR O O
121 on IN B-VP O
121 Lasix NNP B-NP B-m
121 , , O O
121 she PRP O O
121 was VBD B-VP O
121 also RB O O
121 taken VBN O O
121 potassium NN B-NP B-m
122 chloride NN I-NP O
123 DISPOSITION: NNP I-NP O
123 The DT B-NP O
123 patient NN I-NP O
123 is VBZ O O
123 to TO O O
123 be VB O O
123 discharged VBN O O
123 to TO O O
123 rehabilitation NN B-NP O
124 at IN B-VP O
124 Acanmingpeerra NNP B-NP O
124 Virg NNP I-NP O
124 Tantblu NNP I-NP O
124 Medical NNP I-NP O
124 Center NNP I-NP O
124 in IN B-VP O
124 order NN B-NP O
124 to TO O O
124 be VB O O
124 able JJ O O
124 to TO O O
124 get VB O O
124 her PRP$ O O
124 antibiotic JJ B-NP B-m
125 therapy NN I-NP O
125 She PRP O O
125 was VBD B-VP O
125 discharged VBN O O
125 on IN B-VP O
125 stable JJ B-NP O
125 condition NN I-NP O
126 PHYSICIANS NNP I-NP O
126 FOLLOW-UP: NNP I-NP O
126 The DT B-NP O
126 patient NN I-NP O
126 has VBZ O O
126 been VBN O O
126 following VBG O O
126 follow-up JJ O O
127 appointments: JJ O O
128 1 CD O O
128 Stress NNP B-NP O
128 test NN I-NP O
128 in IN B-VP O
128 7/27/05 CD O O
128 at IN B-VP O
128 3 CD O O
128 p.m RB O O
129 2 CD O O
129 Dr NNP B-NP O
129 Gale NNP I-NP O
129 Montante NNP I-NP O
129 ( ( O O
129 general JJ B-NP O
129 cardiology NN I-NP O
129 ) ) O O
129 on IN B-VP O
129 11/13/05 CD O O
129 at IN B-VP O
129 10 CD O O
129 a.m JJ O O
130 3 CD O O
130 Dr NNP B-NP O
130 Ed NNP I-NP O
130 Storti NNP I-NP O
130 3/15/05 CD O O
130 at IN B-VP O
130 12 CD O O
130 p.m RB O O
131 4 CD O O
131 Dr NNP B-NP O
131 Stacey NNP I-NP O
131 Koers NNP I-NP O
131 ( ( O O
131 infectious JJ B-NP O
131 disease NN I-NP O
131 ) ) O O
131 0/9/05 CD O O
131 at IN B-VP O
131 8 CD O O
131 a.m IN B-VP O
132 The DT B-NP O
132 patient NN I-NP O
132 will MD O O
132 follow VB O O
132 up RP O O
132 regarding VBG O O
132 the DT B-NP O
132 success NN I-NP O
132 of IN B-VP O
132 her PRP$ O O
133 antibiotic JJ B-NP B-m
133 therapy NN I-NP O
133 It PRP O O
133 is VBZ O O
133 also RB O O
133 anticipated JJ O O
133 that IN B-VP O
133 her PRP$ O O
133 cardiologist NN B-NP O
134 will MD O O
134 re-add VB O O
134 back RB O O
134 on IN B-VP O
134 her PRP$ O O
134 ACE NNP B-NP B-m
134 for IN B-VP O
134 better JJR B-NP B-r
134 better JJR I-NP B-r
134 afterload NN I-NP I-r
134 afterload NN I-NP I-r
134 reduction NN I-NP I-r
134 reduction NN I-NP I-r
134 as IN B-VP O
134 her PRP$ O O
135 blood NN B-NP O
135 pressures NNS I-NP O
135 tolerates VBZ O O
135 , , O O
135 and CC O O
135 potentially RB O O
135 we PRP O O
135 will MD O O
135 add VB O O
135 her PRP$ O O
135 back NN B-NP O
136 on IN B-VP O
136 to TO O O
136 the DT B-NP O
136 Lasix NNP I-NP B-m
136 as IN B-VP O
136 well RB O O
136 She PRP O O
136 will MD O O
136 require VB O O
136 weekly JJ B-NP O
136 lab NN I-NP O
136 draws NN I-NP O
136 to TO O O
137 check VB O O
137 her PRP$ O O
137 electrolytes NNS B-NP O
137 and CC O O
137 CBC NNP B-NP O
137 while IN B-VP O
137 she PRP O O
137 is VBZ O O
137 on IN B-VP O
137 the DT B-NP O
137 antibiotics NNS I-NP B-m
138 CONSULTANTS: NNP I-NP O
138 Infectious NNP I-NP O
138 disease NN I-NP O
138 , , O O
138 Dr NNP B-NP O
138 Rupert NNP I-NP O
138 Zenon NNP I-NP O
138 , , O O
138 pager NN B-NP O
139 number NN I-NP O
139 25215 CD O O
140 PRIMARY NNP B-NP O
140 CARE NNP I-NP O
140 PHYSICIAN: NNP I-NP O
140 Dr NNP I-NP O
140 Abel NNP I-NP O
140 Guignard NNP I-NP O
141 The DT B-NP O
141 patient NN I-NP O
141 is VBZ O O
141 full JJ B-NP O
141 code NN I-NP O
141 Her PRP$ O O
141 family NN B-NP O
141 is VBZ O O
141 aware JJ O O
141 of IN B-VP O
141 the DT B-NP O
141 situation NN I-NP O
142 eScription NN I-NP O
142 document: IN B-VP O
142 9-5297905 CD O O
142 CSSten NNP B-NP O
142 Tel NNP I-NP O
143 CC: NNP I-NP O
143 Xavier NNP I-NP O
143 Tapaha NNP I-NP O
143 M.D NNP I-NP O
144 BEAUKO NNP I-NP O
144 , , O O
144 Tanro NNP B-NP O
144 Hospital NNP I-NP O
144 Center NNP I-NP O
145 Bercop NNP I-NP O
145 Blvd NNP I-NP O
145 , , O O
145 Ca NNP B-NP O
145 , , O O
145 Texas NNP B-NP O
145 46829 CD O O
146 CC: NNP B-NP O
146 Moses NNP I-NP O
146 Ludtke NNP I-NP O
147 Hamnoy NNP I-NP O
147 Iclare NNP I-NP O
147 Memorial NNP I-NP O
147 Hospital NNP I-NP O
148 Leahlit NNP I-NP O
149 CC: NNP I-NP O
149 Bob NNP I-NP O
149 Penland NNP I-NP O
149 MD NNP I-NP O
150 S NNP I-NP O
150 Ra NNP I-NP O
150 Clevecra NNP I-NP O
151 Dictated NNP I-NP O
151 By: NNP I-NP O
151 BENAGE NNP I-NP O
151 , , O O
151 SONNY NNP B-NP O
151 WES NNP I-NP O
151 KEVIN NNP I-NP O
152 Attending: NNP I-NP O
152 JOO NNP I-NP O
152 , , O O
152 LUCAS NNP B-NP O
152 LINCOLN NNP I-NP O
153 Dictation NNP I-NP O
153 ID NNP I-NP O
153 6496241 CD O O
154 D: NNP B-NP O
154 8/24/05 CD O O
155 T: NNP B-NP O
155 7/0/05 CD O O
156 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #73301 VBZ O O
2 108580724 CD O O
2 MSH NNP B-NP O
2 40855000 CD O O
2 3134917 CD O O
2 5/15/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 SEPSIS NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/22/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/28/2006 CD O O
4 ATTENDING: NNP B-NP O
4 TAJIMA NNP I-NP O
4 , , O O
4 BURT NNP B-NP O
4 MD NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
6 Urosepsis NNP I-NP O
7 LIST NNP I-NP O
7 OF NNP I-NP O
7 PROBLEMS: NNP I-NP O
8 1 CD O O
8 Urosepsis NNP B-NP O
9 2 CD O O
9 Hypoxic NNP B-NP O
9 respiratory NN I-NP O
9 failure NN I-NP O
10 3 CD O O
10 Pneumonia NNP B-NP O
11 4 CD O O
11 Aspiration NNP B-NP O
12 5 CD O O
12 Pulmonary NNP B-NP O
12 embolism NN I-NP O
13 6 CD O O
13 Diabetes VBZ O O
14 7 CD O O
14 Obstructive JJ B-NP O
14 sleep NN I-NP O
14 apnea NN I-NP O
15 8 CD O O
15 Spinal JJ B-NP O
15 sarcoidosis NN I-NP O
16 HISTORY NNP I-NP O
16 OF NNP I-NP O
16 PRESENT NNP I-NP O
16 ILLNESS: NNP I-NP O
17 The DT B-NP O
17 patient NN I-NP O
17 is VBZ O O
17 a DT B-NP O
17 66-year-old JJ I-NP O
17 man NN I-NP O
17 with IN B-VP O
17 a DT B-NP O
17 history NN I-NP O
17 of IN B-VP O
17 spinal JJ B-NP O
18 sarcoidosis NN I-NP O
18 with IN B-VP O
18 secondary JJ B-NP O
18 paraplegia NNS I-NP O
18 who WP O O
18 presented VBD B-VP O
18 with IN B-VP O
18 altered JJ B-NP O
19 mental JJ I-NP O
19 status NN I-NP O
19 , , O O
19 hypoxemic JJ B-NP O
19 respiratory NN I-NP O
19 failure NN I-NP O
19 and CC O O
19 hypotension NN B-NP O
19 He PRP O O
20 was VBD B-VP O
20 doing VBG O O
20 well RB O O
20 until IN B-VP O
20 the DT B-NP O
20 morning NN I-NP O
20 of IN B-VP O
20 1/22/2006 CD O O
20 when WRB O O
20 he PRP O O
20 complained VBD B-VP O
21 of IN B-VP O
21 difficulty NN B-NP O
21 breathing NN I-NP O
21 and CC O O
21 his PRP$ O O
21 wife NN B-NP O
21 placed VBD B-VP O
21 him PRP O O
21 on IN B-VP O
21 home NN B-NP O
21 CPAP NNP I-NP O
22 machine NN I-NP O
22 that IN B-VP O
22 he PRP O O
22 usually RB O O
22 uses VBZ O O
22 at IN B-VP O
22 night NN B-NP O
22 Despite IN B-VP O
22 being VBG O O
22 placed VBN O O
22 on IN B-VP O
23 the DT B-NP O
23 machine NN I-NP O
23 , , O O
23 he PRP O O
23 was VBD B-VP O
23 still RB O O
23 having VBG O O
23 air NN B-NP O
23 hunger NN I-NP O
23 and CC O O
23 complaining NN B-NP O
23 of IN B-VP O
24 feeling VBG O O
24 unwell IN B-VP O
24 His PRP$ O O
24 wife NN B-NP O
24 also RB O O
24 noted VBD B-VP O
24 him PRP O O
24 to TO O O
24 have VB O O
24 increasing VBG O O
25 lethargy JJ O O
25 and CC O O
25 decreased JJ B-NP O
25 responsiveness NN I-NP O
25 and CC O O
25 called VBD B-VP O
25 EMS NNP B-NP O
25 to TO O O
25 have VB O O
25 him PRP O O
26 brought VBN O O
26 to TO O O
26 the DT B-NP O
26 emergency NN I-NP O
26 room NN I-NP O
26 He PRP O O
26 also RB O O
26 was VBD B-VP O
26 noted VBN O O
26 to TO O O
26 have VB O O
26 a DT B-NP O
27 decreased JJ I-NP O
27 urine NN I-NP O
27 output NN I-NP O
27 from IN B-VP O
27 his PRP$ O O
27 chronic JJ B-NP O
27 suprapubic JJ I-NP O
27 catheter NN I-NP O
27 x2 NNP I-NP O
28 days NNS I-NP O
28 In IN B-VP O
28 the DT B-NP O
28 emergency NN I-NP O
28 room NN I-NP O
28 , , O O
28 he PRP O O
28 was VBD B-VP O
28 found VBN O O
28 to TO O O
28 be VB O O
28 unresponsive JJ O O
28 , , O O
29 grunting NN B-NP O
29 , , O O
29 and CC O O
29 in IN B-VP O
29 respiratory NN B-NP O
29 distress NN I-NP O
29 His PRP$ O O
29 initial JJ B-NP O
29 room NN I-NP O
29 air NN I-NP O
30 saturation NN I-NP O
30 was VBD B-VP O
30 in IN B-VP O
30 the DT O O
30 high JJ O O
30 60's CD O O
30 to TO O O
30 low VB O O
30 70's CD O O
30 He PRP O O
30 was VBD B-VP O
30 placed VBN O O
30 on IN B-VP O
31 100% CD O O
31 nonrebreather NN B-NP O
31 with IN B-VP O
31 some DT B-NP O
31 improvement NN I-NP O
31 of IN B-VP O
31 his PRP$ O O
31 saturations NNS B-NP O
31 in IN B-VP O
32 the DT O O
32 low JJ O O
32 90's CD O O
32 and CC O O
32 an DT B-NP O
32 ABG NNP I-NP O
32 of IN B-VP O
32 7.37/43/77 CD O O
32 on IN B-VP O
32 100% CD O O
32 nonrebreather CC O O
32 He PRP O O
33 was VBD B-VP O
33 therefore RB O O
33 intubated VBN O O
33 for IN B-VP O
33 hypoxic JJ B-NP O
33 respiratory JJ I-NP O
33 failure NN I-NP O
33 He PRP O O
34 became VBD B-VP O
34 hypotensive JJ O O
34 with IN B-VP O
34 intubation NN B-NP O
34 despite IN B-VP O
34 using VBG O O
34 etomidate NN B-NP B-m
34 with IN B-VP O
35 blood NN B-NP O
35 pressures NNS I-NP O
35 in IN B-VP O
35 the DT O O
35 60's/40's CD O O
35 , , O O
35 and CC O O
35 an DT B-NP O
35 initial JJ I-NP O
35 CVP NNP I-NP O
35 of IN B-VP O
35 16 CD O O
35 , , O O
35 so RB O O
35 he PRP O O
36 was VBD B-VP O
36 started VBN O O
36 on IN B-VP O
36 Levophed NNP B-NP B-m
36 with IN B-VP O
36 a DT B-NP O
36 systolic JJ I-NP O
36 blood NN I-NP O
36 pressure NN I-NP O
36 in IN B-VP O
36 the DT O O
37 130's CD O O
37 on IN B-VP O
37 7 CD O B-do
37 to TO O I-do
37 10 CD O I-do
37 of IN B-VP O
37 Levophed NNP B-NP B-m
37 He PRP O O
37 received VBD B-VP O
37 1 CD O B-do
37 liter NN B-NP I-do
37 of IN B-VP O
37 IV NNP B-NP B-mo
37 fluid NN I-NP B-m
38 He PRP O O
38 received VBD B-VP O
38 a DT B-NP O
38 head NN I-NP O
38 CT NNP I-NP O
38 without IN B-VP O
38 contrast NN B-NP O
38 that WDT O O
38 showed VBD B-VP O
38 no DT B-NP O
38 acute JJ I-NP O
39 bleeding NN I-NP O
39 or CC O O
39 acute JJ B-NP O
39 infarction NN I-NP O
39 He PRP O O
39 had VBD B-VP O
39 a DT B-NP O
39 chest JJ I-NP O
39 x-ray NN I-NP O
39 that WDT O O
39 showed VBD B-VP O
40 no DT O O
40 obvious JJ O O
40 infiltrate VB O O
40 His PRP$ O O
40 INR NNP B-NP O
40 was VBD B-VP O
40 found VBN O O
40 to TO O O
40 be VB O O
40 elevated VBN O O
40 Given NNP B-NP O
41 the DT B-NP O
41 CT NNP I-NP O
41 of IN B-VP O
41 his PRP$ O O
41 abdomen NNS B-NP O
41 without IN B-VP O
41 contrast NN B-NP O
41 that WDT O O
41 showed VBD B-VP O
41 a DT B-NP O
41 suprapubic JJ I-NP O
42 catheter NN I-NP O
42 obstruction NN I-NP O
42 with IN B-VP O
42 bilateral JJ B-NP O
42 hydronephrosis NN I-NP O
42 and CC O O
42 distended VBD B-VP O
43 bladder VB O O
43 His PRP$ O O
43 creatinine NN B-NP O
43 was VBD B-VP O
43 2.9 CD O O
43 , , O O
43 elevated VBN O O
43 from IN B-VP O
43 his PRP$ O O
43 baseline NN B-NP O
43 of IN B-VP O
44 0.9 CD O O
44 Urology NNP B-NP O
44 was VBD B-VP O
44 consulted VBN O O
44 to TO O O
44 change VB O O
44 the DT B-NP O
44 suprapubic JJ I-NP O
44 catheter NN I-NP O
45 tube NN I-NP O
45 and CC O O
45 pus NN B-NP O
45 was VBD B-VP O
45 noted VBN O O
45 to TO O O
45 be VB O O
45 aspirated VBN O O
45 from IN B-VP O
45 the DT B-NP O
45 suprapubic JJ I-NP O
46 catheter NN I-NP O
46 He PRP O O
46 was VBD B-VP O
46 started VBN O O
46 on IN B-VP O
46 vancomycin NN B-NP B-m
46 , , O O
46 gentamicin NN B-NP B-m
46 , , O O
46 Flagyl NNP B-NP B-m
46 , , O O
46 and CC O O
47 stress NN B-NP O
47 dose NN I-NP O
47 steroids NNS I-NP B-m
47 , , O O
47 and CC O O
47 blood NN B-NP O
47 and CC O O
47 urine JJ B-NP O
47 cultures NNS I-NP O
47 were VBD B-VP O
47 sent VBN O O
47 in IN B-VP O
48 the DT B-NP O
48 emergency NN I-NP O
48 and CC O O
48 he PRP O O
48 was VBD B-VP O
48 transferred VBN O O
48 to TO O O
48 the DT B-NP O
48 MICU NNP I-NP O
49 PAST NNP I-NP O
49 MEDICAL NNP I-NP O
49 HISTORY: NNP I-NP O
50 Sarcoid NNP I-NP O
50 disease NN I-NP O
50 20 CD O O
50 years NNS B-NP O
50 ago RB O O
50 , , O O
50 paraplegia JJ O O
50 x18 CD O O
50 years NNS B-NP O
50 , , O O
50 chronic JJ B-NP O
51 suprapubic JJ I-NP O
51 catheter/ostomy NN I-NP O
51 for IN B-VP O
51 12 CD O O
51 years NNS B-NP O
51 , , O O
51 diabetes VBZ O O
51 type JJ B-NP O
51 II NNP I-NP O
51 , , O O
51 right JJ B-NP B-r
52 DVT NNP I-NP O
52 , , O O
52 on IN B-VP O
52 Coumadin NNP B-NP B-m
52 , , O O
52 status NN B-NP O
52 post NN I-NP O
52 chronic NN I-NP O
52 UTI NNP I-NP O
52 , , O O
52 and CC O O
52 CPAP NNP B-NP O
52 at IN B-VP O
52 night NN B-NP O
52 for IN B-VP O
53 obstructive JJ B-NP O
53 sleep JJ I-NP O
53 apnea NN I-NP O
54 HOME NNP I-NP O
54 MEDICATIONS: NNP I-NP O
55 Include NNP I-NP O
55 Regular NNP I-NP B-m
55 Regular NNP I-NP B-m
55 Insulin NNP I-NP I-m
55 Insulin NNP I-NP I-m
55 sliding VBG O B-do
55 sliding VBG O B-do
55 scale JJ B-NP I-do
55 scale NN I-NP I-do
55 a.c NN I-NP B-f
55 and CC O O
55 at IN B-VP O
55 bedtime NN B-NP B-f
55 , , O O
55 NPH NNP B-NP B-m
55 NPH NNP I-NP B-m
55 54 CD O B-do
56 units NNS B-NP O
56 in IN B-VP B-f
56 the DT B-NP I-f
56 morning NN I-NP I-f
56 and CC O O
56 68 CD O B-do
56 units NNS B-NP I-do
56 in IN B-VP B-f
56 the DT B-NP I-f
56 night NN I-NP I-f
56 , , O O
56 baclofen VBD B-VP B-m
56 10 CD O B-do
56 mg NN B-NP I-do
57 t.i.d NN I-NP B-f
57 , , O O
57 amitriptyline VBP O B-m
57 25 CD O B-do
57 mg NN B-NP I-do
57 at IN B-VP B-f
57 bedtime NN B-NP I-f
57 , , O O
57 oxybutynin VBZ O B-m
57 5 CD O B-do
57 mg NN B-NP I-do
57 t.i.d NN I-NP B-f
57 , , O O
58 gabapentin NN B-NP B-m
58 300 CD O B-do
58 mg NN B-NP I-do
58 t.i.d NN I-NP B-f
58 , , O O
58 iron NN B-NP B-m
58 sulfate NN I-NP I-m
58 325 CD O B-do
58 mg NN B-NP I-do
58 t.i.d NN I-NP B-f
58 , , O O
58 vitamin VBP O B-m
58 C NNP B-NP I-m
59 500 CD O B-do
59 mg JJ O I-do
59 daily RB O B-f
59 , , O O
59 magnesium NN B-NP B-m
59 420 CD O B-do
59 mg NN B-NP I-do
59 t.i.d NN I-NP B-f
59 , , O O
59 Coumadin NNP B-NP B-m
59 5 CD O B-do
59 mg JJ O I-do
59 daily RB O B-f
59 , , O O
60 ranitidine VB O B-m
60 150 CD O B-do
60 mg NN B-NP I-do
60 b.i.d NN I-NP B-f
60 , , O O
60 and CC O O
60 calcium NN B-NP B-m
60 950 CD O B-do
60 mg JJ B-NP I-do
60 daily JJ I-NP B-f
61 ALLERGIES: NNP I-NP O
62 No NNP I-NP O
62 known VBN O O
62 drug NN B-NP O
62 allergies NNS I-NP O
63 PHYSICAL NNP I-NP O
63 EXAMINATION NNP I-NP O
63 ON NNP I-NP O
63 ADMISSION: NNP I-NP O
64 His PRP$ O O
64 temperature NN B-NP O
64 was VBD B-VP O
64 97.4 CD O O
64 , , O O
64 heart NN B-NP O
64 rate NN I-NP O
64 105 CD O O
64 , , O O
64 blood NN B-NP O
64 pressure NN I-NP O
64 136/67 CD O O
64 , , O O
65 his PRP$ O O
65 O2 NNP B-NP O
65 saturation NN I-NP O
65 was VBD B-VP O
65 100% CD O O
65 on IN B-VP O
65 AC NNP B-NP O
65 700 CD O O
65 with IN B-VP O
65 PEEP NNP B-NP O
65 of IN B-VP O
65 5 CD O O
65 In IN B-VP O
65 general JJ O O
65 , , O O
66 he PRP O O
66 was VBD B-VP O
66 intubated VBN O O
66 and CC O O
66 responsive JJ O O
66 to TO O O
66 simple VB O O
66 commands NNS B-NP O
66 HEENT: NNP I-NP O
67 Sluggish NNP I-NP O
67 pupils VBZ O O
67 His PRP$ O O
67 lungs NNS B-NP O
67 were VBD B-VP O
67 clear JJ O O
67 anteriorly RB O O
67 His PRP$ O O
67 heart NN B-NP O
67 was VBD B-VP O
68 in IN B-VP O
68 regular JJ B-NP O
68 rate NN I-NP O
68 and CC O O
68 rhythm NN B-NP O
68 with IN B-VP O
68 no DT B-NP O
68 murmurs NNS I-NP O
68 , , O O
68 rubs NNS B-NP O
68 or CC O O
68 gallops VB O O
68 His PRP$ O O
69 abdomen NNS B-NP O
69 was VBD B-VP O
69 obese JJ O O
69 , , O O
69 large JJ O O
69 , , O O
69 soft JJ O O
69 , , O O
69 nondistended JJ O O
69 and CC O O
69 nontender NN B-NP O
69 , , O O
69 with IN B-VP O
70 positive JJ B-NP O
70 bowel NN I-NP O
70 sounds VBZ O O
70 His PRP$ O O
70 extremities NNS B-NP O
70 had VBD B-VP O
70 chronic JJ B-NP O
70 venous JJ I-NP O
70 stasis NN I-NP O
71 changes NNS I-NP O
71 of IN B-VP O
71 right NN B-NP O
71 and CC O O
71 lower JJR B-NP O
71 extremities NNS I-NP O
71 with IN B-VP O
71 areas NNS B-NP O
71 of IN B-VP O
71 no DT B-NP O
71 skin NN I-NP O
72 breakdown NN I-NP O
72 He PRP O O
72 had VBD B-VP O
72 a DT B-NP O
72 large JJ I-NP O
72 sacral JJ I-NP O
72 decubitus NN I-NP O
72 ulcer NN I-NP O
72 with IN B-VP O
72 bone NN B-NP O
73 exposed VBD B-VP O
73 that DT O O
73 was VBD B-VP O
73 foul JJ O O
73 smelling VBG O O
73 on IN B-VP O
73 his PRP$ O O
73 sacrum NN B-NP O
73 He PRP O O
73 was VBD B-VP O
74 neurologically RB O O
74 moving VBG O O
74 all DT O O
74 four CD O O
74 extremities NNS B-NP O
74 and CC O O
74 following VBG O O
75 commands NNS B-NP O
75 He PRP O O
75 had VBD B-VP O
75 an DT B-NP O
75 ostomy NN I-NP O
75 and CC O O
75 suprapubic JJ B-NP O
75 catheter NN I-NP O
75 in IN B-VP O
75 place NN B-NP O
76 LABORATORY NNP I-NP O
76 STUDIES: NNP I-NP O
77 Notable NNP I-NP O
77 for IN B-VP O
77 an DT B-NP O
77 elevated JJ I-NP O
77 creatinine NN I-NP O
77 of IN B-VP O
77 2.9 CD O O
77 , , O O
77 otherwise RB O O
77 , , O O
77 his PRP$ O O
77 Chem-7 NNP B-NP O
78 was VBD B-VP O
78 within IN B-VP O
78 normal JJ B-NP O
78 limits NNS I-NP O
78 His PRP$ O O
78 LFTs NNP B-NP O
78 were VBD B-VP O
78 within IN B-VP O
78 normal JJ B-NP O
78 limits NNS I-NP O
79 His PRP$ O O
79 hematocrit NN B-NP O
79 was VBD B-VP O
79 34.6 CD O O
79 , , O O
79 his PRP$ O O
79 white JJ B-NP O
79 count NN I-NP O
79 was VBD B-VP O
79 9.4 CD O O
79 , , O O
79 and CC O O
79 his PRP$ O O
80 platelets NNS B-NP O
80 were VBD B-VP O
80 343 CD O O
80 , , O O
80 000 CD O O
80 He PRP O O
80 had VBD B-VP O
80 negative JJ O O
80 cardiac JJ O O
80 enzymes VBZ O O
80 His PRP$ O O
81 urine JJ O O
81 and CC O O
81 blood NN B-NP O
81 tox NN I-NP O
81 screens NNS I-NP O
81 were VBD B-VP O
81 negative JJ O O
81 His PRP$ O O
81 UA NNP B-NP O
81 was VBD B-VP O
82 significant JJ O O
82 for IN B-VP O
82 3+ CD O O
82 protein NN B-NP O
82 , , O O
82 trace NN B-NP O
82 glucose NN I-NP O
82 , , O O
82 negative JJ B-NP O
82 ketones NNS I-NP O
82 , , O O
82 3+ CD O O
83 leukocyte NN B-NP O
83 esterase NN I-NP O
83 , , O O
83 negative JJ B-NP O
83 nitrites NNS I-NP O
83 , , O O
83 4-10 JJ B-NP O
83 red JJ I-NP O
83 blood NN I-NP O
83 cells NNS I-NP O
83 , , O O
83 4+ CD O O
84 bacteria NNS B-NP O
84 , , O O
84 and CC O O
84 3+ CD O O
84 triple JJ B-NP O
84 phosphate NN I-NP O
84 crystals NNS I-NP O
84 His PRP$ O O
84 EKG NNP B-NP O
84 was VBD B-VP O
84 in IN B-VP O
85 normal JJ B-NP O
85 sinus NNS I-NP O
85 rhythm VBP O O
85 with IN B-VP O
85 an DT B-NP O
85 old JJ I-NP O
85 right JJ I-NP O
85 bundle-branch NN I-NP O
85 block NN I-NP O
85 and CC O O
86 left VBD B-VP O
86 axis JJ B-NP O
86 deviation NN I-NP O
86 , , O O
86 first-degree JJ B-NP O
86 AV NNP I-NP O
86 block VB O O
86 His PRP$ O O
86 chest JJS O O
86 x-ray JJ O O
87 showed VBD B-VP O
87 retrocardiac JJ B-NP O
87 opacity NN I-NP O
87 that WDT O O
87 was VBD B-VP O
87 thought VBN O O
87 to TO O O
87 be VB O O
87 aspiration JJ B-NP O
88 versus NN I-NP O
88 pneumonia NN I-NP O
88 Abdominal NNP I-NP O
88 and CC O O
88 chest JJS B-NP O
88 CT NN I-NP O
88 showed VBD B-VP O
88 bibasilar JJ B-NP O
89 airspace NN I-NP O
89 opacities NNS I-NP O
89 , , O O
89 left VBD B-VP O
89 greater JJR O O
89 than IN B-VP O
89 right RB O O
89 , , O O
89 with IN B-VP O
89 aspiration NN B-NP O
90 versus NN I-NP O
90 pneumonia NN I-NP O
90 , , O O
90 bilateral JJ B-NP O
90 hydronephrosis NN I-NP O
90 , , O O
90 severe JJ B-NP O
90 decubitus NN I-NP O
91 ulcers NNS I-NP O
91 , , O O
91 and CC O O
91 large JJ B-NP O
91 gastrohepatic JJ I-NP O
91 lymph NN I-NP O
91 nodes NNS I-NP O
91 slightly RB O O
91 enlarged VBD B-VP O
91 and CC O O
92 calcified VBD B-VP O
93 ASSESSMENT: NNP B-NP O
94 This DT O O
94 is VBZ O O
94 a DT B-NP O
94 66-year-old JJ I-NP O
94 man NN I-NP O
94 with IN B-VP O
94 spinal JJ B-NP O
94 sarcoidosis NN I-NP O
94 and CC O O
94 secondary JJ B-NP O
95 paraplegia NN I-NP O
95 , , O O
95 who WP O O
95 presented VBD B-VP O
95 with IN B-VP O
95 altered JJ B-NP O
95 mental JJ I-NP O
95 status NN I-NP O
95 , , O O
95 hypoxemic JJ B-NP O
96 respiratory NN I-NP O
96 failure NN I-NP O
96 , , O O
96 and CC O O
96 hypotension NN B-NP O
96 , , O O
96 who WP O O
96 had VBD B-VP O
96 urosepsis NN B-NP O
96 and CC O O
97 pneumonia NN B-NP O
97 and CC O O
97 found VBN O O
97 later RB O O
97 on IN B-VP O
97 admission NN B-NP O
97 to TO O O
97 have VB O O
97 pulmonary JJ B-NP O
98 embolism NN I-NP O
99 HOSPITAL NNP I-NP O
99 COURSE NNP I-NP O
99 BY NNP I-NP O
99 PROBLEM: NNP I-NP O
100 1 CD O O
100 Hypoxemia: NNP B-NP O
100 He PRP O O
100 was VBD B-VP O
100 intubated VBN O O
100 at IN B-VP O
100 the DT B-NP O
100 time NN I-NP O
100 of IN B-VP O
100 admission NN B-NP O
100 and CC O O
101 extubated VBD B-VP O
101 a DT B-NP O
101 day NN I-NP O
101 later RB O O
101 on IN B-VP O
101 5/9/2006 CD O O
101 BiPAP NNP B-NP O
101 was VBD B-VP O
101 used VBN O O
101 at IN B-VP O
101 night NN B-NP O
101 as IN B-VP O
102 he PRP O O
102 had VBD B-VP O
102 used VBN O O
102 at IN B-VP O
102 home NN B-NP O
102 for IN B-VP O
102 a DT B-NP O
102 sleep JJ I-NP O
102 apnea NN I-NP O
102 with IN B-VP O
102 O2 NNP B-NP O
102 saturations NNS I-NP O
102 in IN B-VP O
102 the DT O O
103 high JJ O O
103 90's CD O O
103 on IN B-VP O
103 room NN B-NP O
103 air NN I-NP O
103 during IN B-VP O
103 the DT B-NP O
103 day NN I-NP O
103 He PRP O O
103 was VBD B-VP O
103 initially RB O O
103 treated VBN O O
104 for IN B-VP O
104 pneumonia NN B-NP B-r
104 pneumonia NN I-NP B-r
104 pneumonia NN I-NP B-r
104 with IN B-VP O
104 ceftazidime NN B-NP B-m
104 , , O O
104 levofloxacin NN B-NP B-m
104 , , O O
104 and CC O O
104 vancomycin VBZ O B-m
105 The DT B-NP O
105 vancomycin NN I-NP B-m
105 was VBD B-VP O
105 discontinued VBN O O
105 on IN B-VP O
105 4/3/2006 CD O O
105 , , O O
105 and CC O O
105 the DT B-NP O
106 ceftazidime NN I-NP B-m
106 was VBD B-VP O
106 discontinued VBN O O
106 on IN B-VP O
106 2/4/206 CD O O
106 His PRP$ O O
106 levofloxacin NN B-NP B-m
106 levofloxacin NN I-NP B-m
106 was VBD B-VP O
107 continued VBN O O
107 at IN B-VP O
107 500 CD O B-do
107 500 CD O B-do
107 mg NN B-NP I-do
107 mg NN I-NP I-do
107 per IN B-VP B-f
107 per IN B-VP B-f
107 day NN B-NP I-f
107 day NN I-NP I-f
107 for IN B-VP B-du
107 for IN B-VP B-du
107 a DT O I-du
107 a DT B-NP I-du
107 total JJ I-NP I-du
107 total JJ I-NP I-du
107 10-day JJ I-NP I-du
107 10-day JJ I-NP I-du
107 course NN I-NP I-du
107 course NN I-NP I-du
107 on IN B-VP O
108 6/10/2006 CD O O
108 This DT O O
108 is VBZ O O
108 to TO O O
108 be VB O O
108 used VBN O O
108 for IN B-VP O
108 a DT B-NP O
108 UTI NNP I-NP B-r
108 and CC O O
108 pneumonia NN B-NP B-r
108 On IN B-VP O
109 2/23/2006 CD O O
109 , , O O
109 the DT B-NP O
109 patient NN I-NP O
109 was VBD B-VP O
109 supposed VBN O O
109 to TO O O
109 go VB O O
109 home NN B-NP O
109 and CC O O
109 found VBN O O
109 to TO O O
109 have VB O O
110 a DT B-NP O
110 desaturation NN I-NP O
110 to TO O O
110 high JJ O O
110 80's CD O O
110 on IN B-VP O
110 room NN B-NP O
110 air NN I-NP O
110 He PRP O O
110 was VBD B-VP O
110 found VBN O O
110 to TO O O
110 have VB O O
110 a DT B-NP O
111 chest JJ I-NP O
111 x-ray NN I-NP O
111 within IN B-VP O
111 normal JJ B-NP O
111 limits NNS I-NP O
111 A DT B-NP O
111 pulmonary JJ I-NP O
111 embolism NN I-NP O
111 CT NNP I-NP O
111 was VBD B-VP O
112 done VBN O O
112 that IN B-VP O
112 demonstrated VBD B-VP O
112 a DT B-NP O
112 small JJ I-NP O
112 nonocclusive JJ I-NP O
112 pulmonary JJ I-NP O
112 embolism NN I-NP O
112 in IN B-VP O
113 the DT B-NP O
113 posterobasilar JJ I-NP O
113 segment NN I-NP O
113 of IN B-VP O
113 the DT B-NP O
113 right JJ I-NP O
113 lower JJR I-NP O
113 lobe NN I-NP O
113 with IN B-VP O
113 involving VBG O O
114 right JJ B-NP O
114 lower JJR I-NP O
114 lobe NN I-NP O
114 infarct NN I-NP O
114 suggestive NN I-NP O
114 that IN B-VP O
114 he PRP O O
114 had VBD B-VP O
114 had VBN O O
114 a DT B-NP O
114 PE NNP I-NP O
114 that WDT O O
114 was VBD B-VP O
115 resolving VBG O O
115 At IN B-VP O
115 this DT B-NP O
115 time NN I-NP O
115 , , O O
115 his PRP$ O O
115 INR NNP B-NP O
115 had VBD B-VP O
115 been VBN O O
115 subtherapeutic JJ O O
115 for IN B-VP O
116 three CD O O
116 days NNS B-NP O
116 at IN B-VP O
116 1.7 CD O O
116 to TO O O
116 1.9 CD O O
116 and CC O O
116 he PRP O O
116 was VBD B-VP O
116 continued VBN O O
116 on IN B-VP O
116 his PRP$ O O
116 Coumadin NNP B-NP B-m
117 The DT B-NP O
117 following JJ I-NP O
117 day NN I-NP O
117 , , O O
117 his PRP$ O O
117 INR NNP B-NP O
117 was VBD B-VP O
117 therapeutic JJ O O
117 at IN B-VP O
117 2 CD O O
117 , , O O
117 and CC O O
117 on IN B-VP O
117 the DT B-NP O
117 day NN I-NP O
118 of IN B-VP O
118 discharge NN B-NP O
118 , , O O
118 it PRP O O
118 was VBD B-VP O
118 2.2 CD O O
118 It PRP O O
118 was VBD B-VP O
118 thought VBN O O
118 that IN B-VP O
118 the DT B-NP O
118 PE NNP I-NP O
118 was VBD B-VP O
118 in IN B-VP O
118 the DT B-NP O
119 setting NN I-NP O
119 of IN B-VP O
119 a DT B-NP O
119 subtherapeutic JJ I-NP O
119 INR NNP I-NP O
119 His PRP$ O O
119 oxygen NN B-NP O
119 requirement NN I-NP O
119 was VBD B-VP O
119 back RB O O
120 to TO O O
120 baseline NN B-NP O
120 at IN B-VP O
120 the DT B-NP O
120 time NN I-NP O
120 of IN B-VP O
120 discharge NN B-NP O
120 , , O O
120 and CC O O
120 his PRP$ O O
120 goal NN B-NP O
120 INR NNP I-NP O
120 was VBD B-VP O
120 to TO O O
120 be VB O O
121 on IN B-VP O
121 the DT B-NP O
121 higher JJR I-NP O
121 end NN I-NP O
121 of IN B-VP O
121 the DT O O
121 2 CD O O
121 to TO O O
121 3 CD O O
121 range NN B-NP O
121 , , O O
121 which WDT O O
121 was VBD B-VP O
121 goal NN B-NP O
121 previously RB O O
122 He PRP O O
122 was VBD B-VP O
122 also RB O O
122 given VBN O O
122 nebulizer NN B-NP O
122 treatments NNS I-NP O
122 throughout IN B-VP O
122 his PRP$ O O
123 hospitalization NN B-NP O
124 2 CD O O
124 ID: NNP B-NP O
124 His PRP$ O O
124 urine NN B-NP O
124 was VBD B-VP O
124 found VBN O O
124 to TO O O
124 have VB O O
124 Proteus NNP B-NP O
124 , , O O
124 resistant NN B-NP O
124 to TO O O
125 Macrobid NNP B-NP O
125 , , O O
125 and CC O O
125 Klebsiella NNP B-NP O
125 , , O O
125 resistant NN B-NP O
125 to TO O O
125 ampicillin VB O O
125 Levofloxacin NNP B-NP B-m
126 was VBD B-VP O
126 started VBN O O
126 for IN B-VP O
126 this DT O O
126 and CC O O
126 for IN B-VP O
126 the DT B-NP B-r
126 presumed JJ I-NP I-r
126 pneumonia NN I-NP I-r
126 seen VBN O O
126 on IN B-VP O
126 chest JJS B-NP O
127 x-ray NN I-NP O
127 for IN B-VP O
127 a DT B-NP O
127 total NN I-NP O
127 of IN B-VP O
127 a DT B-NP B-du
127 10-day JJ I-NP I-du
127 course NN I-NP I-du
127 Sputum NNP I-NP O
127 and CC O O
127 blood NN B-NP O
127 cultures NNS I-NP O
128 have VBP O O
128 been VBN O O
128 no DT B-NP O
128 growth NN I-NP O
128 to TO O O
128 date NN B-NP O
128 He PRP O O
128 had VBD B-VP O
128 no DT B-NP O
128 fevers NNS I-NP O
128 and CC O O
128 no DT B-NP O
128 elevated JJ I-NP O
129 white JJ I-NP O
129 counts NNS I-NP O
130 3 CD O O
130 Cardiac: NNP B-NP O
130 He PRP O O
130 was VBD B-VP O
130 thought VBN O O
130 to TO O O
130 have VB O O
130 an DT B-NP O
130 element NN I-NP O
130 of IN B-VP O
130 autonomic JJ B-NP O
131 insufficiency NN I-NP O
131 secondary JJ O O
131 to TO O O
131 sarcoid VB O O
131 with IN B-VP O
131 episodes NNS B-NP O
131 of IN B-VP O
131 hypo NN B-NP O
131 and CC O O
132 hypertension NN B-NP O
132 in IN B-VP O
132 the DT B-NP O
132 MICU NNP I-NP O
132 His PRP$ O O
132 cortisol NN B-NP O
132 stim NN I-NP O
132 test NN I-NP O
132 was VBD B-VP O
132 within IN B-VP O
133 normal JJ B-NP O
133 limits NNS I-NP O
133 , , O O
133 it PRP O O
133 was VBD B-VP O
133 14.5 CD O O
133 before IN B-VP O
133 stim NN B-NP O
133 and CC O O
133 23.6 CD O O
133 after IN B-VP O
133 stim NN B-NP O
133 , , O O
133 so IN B-VP O
133 he PRP O O
134 was VBD B-VP O
134 not RB O O
134 treated VBN O O
134 with IN B-VP O
134 steroids NNS B-NP O
134 His PRP$ O O
134 blood NN B-NP O
134 pressure NN I-NP O
134 was VBD B-VP O
134 in IN B-VP O
134 the DT O O
135 30's CD O O
135 to TO O O
135 160's CD O O
135 with IN B-VP O
135 pauses NNS B-NP O
135 in IN B-VP O
135 the DT O O
135 100's CD O O
135 on IN B-VP O
135 the DT B-NP O
135 floor NN I-NP O
135 with IN B-VP O
135 frequent JJ B-NP O
136 bigeminy NN I-NP O
136 and CC O O
136 trigeminy NN B-NP O
136 and CC O O
136 many JJ B-NP O
136 PVCs NNP I-NP O
136 , , O O
136 so IN B-VP O
136 he PRP O O
136 was VBD B-VP O
136 started VBN O O
136 on IN B-VP O
136 12.5 CD O B-do
137 b.i.d NN B-NP B-f
137 metoprolol NN I-NP B-m
137 on IN B-VP O
137 0/14/2006 CD O O
137 with IN B-VP O
137 good JJ B-NP O
137 results NNS I-NP O
137 He PRP O O
137 continued VBD B-VP O
138 to TO O O
138 have VB O O
138 ectopy NN B-NP O
138 and CC O O
138 continued VBD B-VP O
138 to TO O O
138 be VB O O
138 hypertensive JJ O O
138 , , O O
138 and CC O O
138 given VBN O O
138 his PRP$ O O
139 diabetes NNS B-NP O
139 , , O O
139 he PRP O O
139 was VBD B-VP O
139 started VBN O O
139 on IN B-VP O
139 a DT B-NP O
139 low JJ I-NP B-do
139 dose NN I-NP I-do
139 of IN B-VP O
139 captopril NN B-NP B-m
139 on IN B-VP O
139 8/14/2006 CD O O
140 with IN B-VP O
140 no DT B-NP O
140 complications NNS I-NP O
140 and CC O O
140 was VBD B-VP O
140 able JJ O O
140 to TO O O
140 maintain VB O O
140 blood NN B-NP B-r
140 pressures NNS I-NP I-r
140 in IN B-VP O
141 ideal JJ B-NP O
141 ranges NNS I-NP O
142 4 CD O O
142 GU: NNP B-NP O
142 Urology NNP I-NP O
142 replaces VBZ O O
142 suprapubic JJ O O
142 catheter RB O O
142 early RB O O
142 on IN B-VP O
142 admission NN B-NP O
143 He PRP O O
143 was VBD B-VP O
143 continued VBN O O
143 to TO O O
143 have VB O O
143 bladder VBN O O
143 irrigation NN B-NP O
143 with IN B-VP O
143 good JJ B-NP O
143 effect NN I-NP O
143 , , O O
144 and CC O O
144 Urology NNP B-NP O
144 signed VBD B-VP O
144 off RP O O
144 on IN B-VP O
144 9/24/2007 CD O O
145 5 CD O O
145 Endocrine: NNP B-NP O
145 The DT B-NP O
145 patient NN I-NP O
145 was VBD B-VP O
145 given VBN O O
145 NPH NNP B-NP B-m
145 20 CD O B-do
145 b.i.d NN B-NP B-f
145 through IN B-VP B-du
145 his PRP$ O O
146 hospitalization NN B-NP O
146 and CC O O
146 Regular JJ B-NP B-m
146 Insulin NNP I-NP I-m
146 sliding VBG O B-do
146 scale NN B-NP I-do
146 His PRP$ O O
146 sugars NNS B-NP O
147 were VBD B-VP O
147 high JJ O O
147 on IN B-VP O
147 this DT O O
147 reduced VBN O O
147 regimen NNS B-NP O
147 and CC O O
147 so RB O O
147 he PRP O O
147 was VBD B-VP O
147 placed VBN O O
147 on IN B-VP O
147 his PRP$ O O
148 home NN B-NP O
148 NPH NNP I-NP B-m
148 doses VBZ O O
148 for IN B-VP O
148 discharge NN B-NP O
149 6 CD O O
149 Decubitus NNP B-NP O
149 ulcer: JJ B-NP O
149 Plastic NNP I-NP O
149 Surgery NNP I-NP O
149 was VBD B-VP O
149 consulted VBN O O
149 on IN B-VP O
149 1/22/2006 CD O O
150 and CC O O
150 the DT B-NP O
150 wound NN I-NP O
150 did VBD B-VP O
150 not RB O O
150 look VB O O
150 infected VBD B-VP O
150 It PRP O O
150 was VBD B-VP O
150 debrided VBN O O
150 and CC O O
151 wet-to-dry JJ B-NP O
151 t.i.d NN I-NP O
151 dressing NN I-NP O
151 changes NNS I-NP O
151 were VBD B-VP O
151 recommended VBN O O
151 as RB O O
151 well RB O O
151 as IN B-VP O
152 Panafil NNP B-NP B-m
152 t.i.d IN B-VP B-f
152 dressing VBG O O
152 changes NNS B-NP O
152 He PRP O O
152 was VBD B-VP O
152 prescribed VBN O O
152 Panafil NNP B-NP B-m
152 to TO O O
152 go VB O O
153 home NN B-NP O
153 on IN B-VP O
154 7 CD O O
154 Renal: NNP B-NP O
154 The DT B-NP O
154 creatinine NN I-NP O
154 was VBD B-VP O
154 initially RB O O
154 2.7 CD O O
154 , , O O
154 and CC O O
154 after IN B-VP O
154 receiving VBG O O
155 IV NNP B-NP B-mo
155 fluids NNS I-NP B-m
155 , , O O
155 it PRP O O
155 came VBD B-VP O
155 down RB O O
155 to TO O O
155 1.2 CD O O
155 He PRP O O
155 likely RB O O
155 had VBD B-VP O
155 acute JJ B-NP O
155 renal JJ I-NP O
156 failure NN I-NP O
156 secondary JJ O O
156 to TO O O
156 postrenal JJ B-NP O
156 obstructive JJ I-NP O
156 etiology NN I-NP O
156 His PRP$ O O
157 creatinine NN B-NP O
157 was VBD B-VP O
157 stable JJ O O
157 at IN B-VP O
157 around IN B-VP O
157 1 CD O O
157 for IN B-VP O
157 the DT B-NP O
157 remainder NN I-NP O
157 of IN B-VP O
157 his PRP$ O O
158 admission NN B-NP O
159 8 CD O O
159 Heme: NNP B-NP O
159 The DT B-NP O
159 patient NN I-NP O
159 has VBZ O O
159 a DT B-NP O
159 history NN I-NP O
159 of IN B-VP O
159 DVT NNP B-NP O
159 Initially NNP I-NP O
159 , , O O
159 his PRP$ O O
159 INR NNP B-NP O
160 was VBD B-VP O
160 found VBN O O
160 to TO O O
160 be VB O O
160 therapeutic JJ O O
160 and CC O O
160 he PRP O O
160 was VBD B-VP O
160 placed VBN O O
160 on IN B-VP O
160 levofloxacin NN B-NP B-m
160 , , O O
160 so IN B-VP O
161 the DT B-NP O
161 plan NN I-NP O
161 was VBD B-VP O
161 that IN B-VP O
161 he PRP O O
161 should MD O O
161 have VB O O
161 half NN B-NP O
161 of IN B-VP O
161 his PRP$ O O
161 home NN B-NP O
161 Coumadin NNP I-NP B-m
161 dose NN I-NP O
162 while IN B-VP O
162 he PRP O O
162 was VBD B-VP O
162 on IN B-VP O
162 levofloxacin NN B-NP B-m
162 , , O O
162 so IN B-VP O
162 he PRP O O
162 was VBD B-VP O
162 given VBN O O
162 half NN B-NP O
162 of IN B-VP O
162 dose NN B-NP O
162 and CC O O
163 his PRP$ O O
163 INRs NN B-NP O
163 came VBD B-VP O
163 down RB O O
163 to TO O O
163 a DT B-NP O
163 nadir NN I-NP O
163 of IN B-VP O
163 1.7 CD O O
163 His PRP$ O O
163 INR NNP B-NP O
163 was VBD B-VP O
163 subtherapeutic JJ O O
164 for IN B-VP O
164 three CD O O
164 days NNS B-NP O
164 , , O O
164 and CC O O
164 at IN B-VP O
164 that DT B-NP O
164 time NN I-NP O
164 , , O O
164 a DT B-NP O
164 PE NNP I-NP O
164 was VBD B-VP O
164 found VBN O O
164 , , O O
164 his PRP$ O O
164 INR NNP B-NP O
164 was VBD B-VP O
165 1.8 CD O O
165 The DT B-NP O
165 day NN I-NP O
165 after IN B-VP O
165 this DT O O
165 , , O O
165 his PRP$ O O
165 INR NNP B-NP O
165 was VBD B-VP O
165 2 CD O O
165 and CC O O
165 then RB O O
165 came VBD B-VP O
165 up RB O O
165 to TO O O
165 2.2 CD O O
166 on IN B-VP O
166 the DT B-NP O
166 day NN I-NP O
166 of IN B-VP O
166 discharge NN B-NP O
166 He PRP O O
166 was VBD B-VP O
166 discharged VBN O O
166 on IN B-VP O
166 Coumadin NNP B-NP B-m
166 5 CD O B-do
166 mg NN B-NP I-do
166 , , O O
167 which WDT O O
167 is VBZ O O
167 his PRP$ O O
167 home NN B-NP O
167 dose NN I-NP O
167 to TO O O
167 follow VB O O
167 up RP O O
167 at IN B-VP O
167 his PRP$ O O
167 Coumadin NNP B-NP O
167 Clinic NNP I-NP O
168 9 CD O O
168 FEN: NNP B-NP O
168 He PRP O O
168 was VBD B-VP O
168 placed VBN O O
168 on IN B-VP O
168 maintenance NN B-NP O
168 IV NNP I-NP B-mo
168 fluids NNS I-NP B-m
168 until IN B-VP B-du
168 cleared VBN O O
168 to TO O O
169 eat VB O O
169 by IN B-VP O
169 Speech NNP B-NP O
169 and CC O O
169 Swallow NNP B-NP O
169 Speech NNP I-NP O
169 and CC O O
169 Swallow NNP B-NP O
169 estimates NNS I-NP O
169 having VBG O O
170 baseline NN B-NP O
170 aspiration NN I-NP O
170 risk NN I-NP O
170 and CC O O
170 he PRP O O
170 was VBD B-VP O
170 known VBN O O
170 to TO O O
170 cough VB O O
170 and CC O O
170 aspirate VB O O
171 at IN B-VP O
171 home NN B-NP O
171 He PRP O O
171 had VBD B-VP O
171 been VBN O O
171 recently RB O O
171 worked VBN O O
171 up RP O O
171 at IN B-VP O
171 the DT B-NP O
171 A NNP I-NP O
171 County NNP I-NP O
171 Medical NNP I-NP O
171 Center NNP I-NP O
172 on IN B-VP O
172 a DT B-NP O
172 recent JJ I-NP O
172 admission NN I-NP O
172 for IN B-VP O
172 aspiration NN B-NP O
172 pneumonia NN I-NP O
172 They PRP O O
172 recommended VBD B-VP O
173 thickened VBN O O
173 puree JJ B-NP O
173 diets NNS I-NP O
173 and CC O O
173 felt VBD B-VP O
173 that IN B-VP O
173 even RB O O
173 this DT O O
173 he PRP O O
173 was VBD B-VP O
173 likely JJ O O
173 to TO O O
174 aspirate VB O O
174 The DT B-NP O
174 risks NNS I-NP O
174 and CC O O
174 benefits NNS B-NP O
174 of IN B-VP O
174 eating VBG O O
174 were VBD B-VP O
174 explained VBN O O
174 to TO O O
174 his PRP$ O O
175 wife NN B-NP O
175 and CC O O
175 him PRP O O
175 and CC O O
175 he PRP O O
175 decided VBD B-VP O
175 to TO O O
175 continue VB O O
175 to TO O O
175 eat VB O O
175 as IN B-VP O
175 there EX O O
175 was VBD B-VP O
175 no DT B-NP O
176 ideal JJ I-NP O
176 option NN I-NP O
177 10 CD O O
177 Pain: NN B-NP O
177 He PRP O O
177 continued VBD B-VP O
177 gabapentin NN B-NP B-m
177 , , O O
177 oxybutynin NN B-NP B-m
177 , , O O
177 and CC O O
178 amitriptyline NN B-NP B-m
178 as IN B-VP O
178 at IN B-VP O
178 home NN B-NP O
179 11 CD O O
179 Prophylaxis: NNP B-NP B-r
179 Prophylaxis: NNP I-NP B-r
179 He PRP O O
179 was VBD B-VP O
179 given VBN O O
179 Nexium NNP B-NP B-m
179 and CC O O
179 Coumadin NNP B-NP B-m
180 12 CD O O
180 Code NNP B-NP O
180 status: NN I-NP O
180 He PRP O O
180 was VBD B-VP O
180 full JJ B-NP O
180 code NN I-NP O
180 , , O O
180 which WDT O O
180 was VBD B-VP O
180 discussed VBN O O
180 with IN B-VP O
180 his PRP$ O O
181 wife NN B-NP O
182 PHYSICAL NNP I-NP O
182 EXAMINATION NNP I-NP O
182 AT NNP I-NP O
182 DISCHARGE: NNP I-NP O
183 The DT B-NP O
183 current JJ I-NP O
183 temperature NN I-NP O
183 was VBD B-VP O
183 98 CD O O
183 , , O O
183 the DT B-NP O
183 heart NN I-NP O
183 rate NN I-NP O
183 was VBD B-VP O
183 91 CD O O
183 to TO O O
183 114 CD O O
183 , , O O
184 blood NN B-NP O
184 pressure NN I-NP O
184 100-114/54-70 CD O O
184 , , O O
184 respiratory JJ B-NP O
184 rate NN I-NP O
184 of IN B-VP O
184 20 CD O O
184 , , O O
184 and CC O O
185 saturating VBG O O
185 97-100% JJ O O
185 on IN B-VP O
185 1-2 JJ B-NP O
185 liters NNS I-NP O
185 In IN B-VP O
185 general JJ O O
185 , , O O
185 he PRP O O
185 was VBD B-VP O
185 responsive JJ O O
185 , , O O
186 alert JJ O O
186 , , O O
186 and CC O O
186 appropriate VB O O
186 His PRP$ O O
186 lungs NNS B-NP O
186 were VBD B-VP O
186 clear JJ O O
186 to TO O O
186 auscultation VB O O
187 bilaterally RB O O
187 His PRP$ O O
187 heart NN B-NP O
187 had VBD B-VP O
187 normal JJ B-NP O
187 S1 NNP I-NP O
187 and CC O O
187 S2 NNP B-NP O
187 , , O O
187 soft JJ B-NP O
187 systolic JJ I-NP O
188 ejection NN I-NP O
188 murmur NN I-NP O
188 at IN B-VP O
188 the DT B-NP O
188 right JJ I-NP O
188 upper JJ I-NP O
188 sternal JJ I-NP O
188 border NN I-NP O
188 His PRP$ O O
188 abdomen NNS B-NP O
189 had VBD B-VP O
189 positive JJ B-NP O
189 bowel NN I-NP O
189 sounds NNS I-NP O
189 , , O O
189 distended VBD B-VP O
189 , , O O
189 soft JJ O O
189 and CC O O
189 nontender NN B-NP O
189 He PRP O O
189 had VBD B-VP O
190 a DT B-NP O
190 suprapubic JJ I-NP O
190 catheter NN I-NP O
190 as RB O O
190 well RB O O
190 as IN B-VP O
190 an DT B-NP O
190 ostomy NN I-NP O
190 that WDT O O
190 were VBD B-VP O
190 clean JJ O O
190 , , O O
190 dry JJ O O
191 and CC O O
191 intact JJ B-NP O
191 Extremities NNS I-NP O
191 , , O O
191 he PRP O O
191 had VBD B-VP O
191 2+ CD O O
191 peripheral JJ B-NP O
191 edema NN I-NP O
191 that WDT O O
191 was VBD B-VP O
192 stable JJ O O
192 with IN B-VP O
192 no DT B-NP O
192 skin NN I-NP O
192 breakdown RB O O
193 LABORATORY NNP B-NP O
193 VALUES: NNP I-NP O
194 His PRP$ O O
194 labs NN B-NP O
194 at IN B-VP O
194 the DT B-NP O
194 time NN I-NP O
194 of IN B-VP O
194 discharge NN B-NP O
194 were VBD B-VP O
194 stable JJ O O
194 His PRP$ O O
194 hematocrit NN B-NP O
195 was VBD B-VP O
195 27.2 CD O O
195 , , O O
195 down RB O O
195 from IN B-VP O
195 29 CD O O
195 , , O O
195 which WDT O O
195 was VBD B-VP O
195 closed VBN O O
195 to TO O O
195 his PRP$ O O
195 baseline NN B-NP O
195 of IN B-VP O
195 34 CD O O
196 His PRP$ O O
196 INR NNP B-NP O
196 was VBD B-VP O
196 2.1 CD O O
196 at IN B-VP O
196 the DT B-NP O
196 time NN I-NP O
196 discharge NN I-NP O
197 DISCHARGE NNP I-NP O
197 MEDICATIONS: NNP I-NP O
198 Amitriptyline NNP I-NP B-m
198 25 CD O B-do
198 mg NN B-NP I-do
198 p.o NN I-NP B-mo
198 at IN B-VP B-f
198 bedtime NN B-NP I-f
198 , , O O
198 vitamin VBP O B-m
198 C NNP B-NP I-m
198 500 CD O B-do
198 mg NN B-NP I-do
198 p.o JJ O B-mo
198 daily RB O B-f
198 , , O O
199 baclofen VBD B-VP B-m
199 10 CD O B-do
199 mg NN B-NP I-do
199 p.o NN I-NP B-mo
199 t.i.d NN I-NP B-f
199 , , O O
199 Caltrate NNP B-NP B-m
199 600 CD O I-m
199 Plus NNP B-NP I-m
199 D NNP I-NP I-m
199 one CD O B-do
199 tablet NN B-NP I-do
199 p.o NN I-NP B-mo
200 b.i.d NN I-NP B-f
200 , , O O
200 ferrous JJ B-NP B-m
200 sulfate NN I-NP I-m
200 325 CD O B-do
200 mg NN B-NP I-do
200 p.o NN I-NP B-mo
200 t.i.d NN I-NP B-f
200 , , O O
200 gabapentin NN B-NP B-m
200 300 CD O B-do
200 mg NN B-NP I-do
201 p.o NN I-NP B-mo
201 t.i.d NN I-NP B-f
201 , , O O
201 NPH NNP B-NP B-m
201 NPH NNP I-NP B-m
201 human JJ B-NP I-m
201 human JJ I-NP I-m
201 insulin NN I-NP I-m
201 insulin NN I-NP I-m
201 54 CD O B-do
201 units NNS B-NP I-do
201 in IN B-VP B-f
201 the DT B-NP I-f
201 morning NN I-NP I-f
201 , , O O
201 68 CD O B-do
201 units NNS B-NP I-do
202 in IN B-VP B-f
202 the DT B-NP I-f
202 evening NN I-NP I-f
202 , , O O
202 Regular JJ B-NP B-m
202 Insulin NNP I-NP I-m
202 sliding VBG O B-do
202 scale NN B-NP I-do
202 , , O O
202 levofloxacin VBZ O B-m
202 500 CD O B-do
203 mg NN B-NP O
203 p.o JJ O B-mo
203 daily RB O B-f
203 , , O O
203 to TO O O
203 end VB O O
203 on IN B-VP O
203 10/16/2006 CD O O
203 for IN B-VP B-du
203 a DT B-NP O
203 total JJ I-NP O
203 course NN I-NP O
203 of IN B-VP O
203 10 CD O O
204 days NNS B-NP O
204 , , O O
204 magnesium NN B-NP B-m
204 oxide RB O I-m
204 420 CD O B-do
204 mg NNS B-NP I-do
204 p.o JJ B-NP B-mo
204 t.i.d NN I-NP B-f
204 , , O O
204 metoprolol FW O B-m
204 12.5 CD O B-do
204 mg NN B-NP I-do
204 p.o NN I-NP B-mo
205 b.i.d NN I-NP B-f
205 , , O O
205 oxybutynin VBZ O B-m
205 5 CD O B-do
205 mg NN B-NP I-do
205 p.o NN I-NP B-mo
205 t.i.d NN I-NP B-f
205 , , O O
205 Panafil NNP B-NP B-m
205 ointment NN I-NP I-m
205 t.i.d NN I-NP B-f
205 , , O O
206 ranitidine VB O B-m
206 500 CD O B-do
206 mg NN B-NP I-do
206 p.o NN I-NP B-mo
206 b.i.d NN I-NP B-f
206 , , O O
206 and CC O O
206 Coumadin NNP B-NP B-m
206 5 CD O B-do
206 mg NN B-NP I-do
206 p.o JJ O B-mo
206 daily RB O B-f
207 FOLLOW NNP B-NP O
207 UP: NNP I-NP O
208 The DT B-NP O
208 patient NN I-NP O
208 will MD O O
208 follow VB O O
208 up RP O O
208 his PRP$ O O
208 PCP NNP B-NP O
208 , , O O
208 Dr NNP B-NP O
208 Dunstan NNP I-NP O
208 The DT B-NP O
208 appointment NN I-NP O
209 with IN B-VP O
209 Dr NNP B-NP O
209 Carros NNP I-NP O
209 will MD O O
209 be VB O O
209 within IN B-VP O
209 the DT B-NP O
209 next JJ I-NP O
209 week NN I-NP O
209 , , O O
209 and CC O O
209 the DT B-NP O
210 appointment NN I-NP O
210 with IN B-VP O
210 the DT B-NP O
210 Coumadin NNP I-NP O
210 Clinic NNP I-NP O
210 will MD O O
210 be VB O O
210 tomorrow NN B-NP O
210 or CC O O
210 the DT B-NP O
210 next JJ I-NP O
211 day NN I-NP O
212 ISSUES NNP I-NP O
212 FOR NNP I-NP O
212 FOLLOW NNP I-NP O
212 UP: NNP I-NP O
213 Include NNP I-NP O
213 following VBG O O
213 up RP O O
213 on IN B-VP O
213 his PRP$ O O
213 aspiration NN B-NP O
213 risk NN I-NP O
213 and CC O O
213 continuing VBG O O
213 to TO O O
214 discourage VB O O
214 thin JJ B-NP O
214 liquids NNS I-NP O
214 as RB O O
214 well RB O O
214 as IN B-VP O
214 encourage NN B-NP O
214 him PRP O O
214 sitting VBG O O
214 upright JJ O O
215 when WRB O O
215 eating NN B-NP O
215 and CC O O
215 being VBG O O
215 observed VBN O O
215 and CC O O
215 stopping VBG O O
215 when WRB O O
215 he PRP O O
215 coughs VBZ O O
215 He PRP O O
216 will MD O O
216 need VB O O
216 continuous JJ B-NP O
216 blood NN I-NP O
216 pressure NN I-NP O
216 and CC O O
216 heart NN B-NP O
216 rate NN I-NP O
216 monitoring NN I-NP O
217 given VBN O O
217 the DT B-NP O
217 new JJ I-NP O
217 beta-blocker NN I-NP B-m
217 and CC O O
217 the DT B-NP O
217 ACE NNP I-NP B-m
217 inhibitor NN I-NP I-m
217 as RB O O
217 well RB O O
217 as IN B-VP O
218 assessment NN B-NP O
218 of IN B-VP O
218 his PRP$ O O
218 frequent JJ B-NP O
218 PVCs NNP I-NP O
218 We PRP O O
218 will MD O O
218 continue VB O O
218 to TO O O
218 follow VB O O
218 his PRP$ O O
219 diabetes NNS B-NP O
219 and CC O O
219 continue VB O O
219 to TO O O
219 follow VB O O
219 his PRP$ O O
219 INR NNP B-NP O
219 with IN B-VP O
219 a DT B-NP O
219 goal NN I-NP O
219 being VBG O O
219 2 CD O O
219 to TO O O
219 3 CD O O
220 with IN B-VP O
220 ideal JJ B-NP O
220 goal NN I-NP O
220 on IN B-VP O
220 the DT B-NP O
220 higher JJR I-NP O
220 end NN I-NP O
220 8 CD O O
220 range NN B-NP O
221 eScription NN I-NP O
221 document: IN B-VP O
221 2-8481192 JJ B-NP O
221 EMSSten NNP I-NP O
221 Tel NNP I-NP O
222 Dictated NNP I-NP O
222 By: NNP I-NP O
222 PITTARI NNP I-NP O
222 , , O O
222 NIGEL NNP B-NP O
223 Attending: NNP I-NP O
223 SIFFERT NNP I-NP O
223 , , O O
223 TROY NNP B-NP O
224 Dictation NNP I-NP O
224 ID NNP I-NP O
224 1933790 CD O O
225 D: NNP B-NP O
225 7/1/06 CD O O
226 T: NNP B-NP O
226 7/1/06 CD O O
227 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #74976 VBZ O O
4 999570460 CD O O
4 NRH NNP B-NP O
4 64850592 CD O O
4 846474 CD O O
4 7/22/1992 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/28/1992 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/19/1992 CD O O
7 PRINCIPAL NNP B-NP O
7 DISCHARGE: NNP I-NP O
7 CORONARY NNP I-NP O
7 ARTERY NNP I-NP O
7 DISEASE NNP I-NP O
7 , , O O
7 STATUS NNP B-NP O
7 POST NNP I-NP O
8 MYOCARDIAL NNP I-NP O
8 INFARCTION NNP I-NP O
9 OTHER NNP I-NP O
9 DIAGNOSES: NNP I-NP O
9 1 CD O O
9 STATUS NNP B-NP O
9 POST NNP I-NP O
9 ATHERECTOMY NNP I-NP O
9 COMPLICATED NNP I-NP O
9 BY NNP I-NP O
10 REOCCLUSION NNP I-NP O
10 AND NNP I-NP O
10 MYOCARDIAL NNP I-NP O
10 INFARCTION NNP I-NP O
11 2 CD O O
11 INSULIN NNP B-NP O
11 DEPENDENT NNP I-NP O
11 DIABETES NNP I-NP O
11 MELLITUS NNP I-NP O
12 3 CD O O
12 ELEVATED NNP B-NP O
12 CHOLESTEROL NNP I-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 is VBZ O O
13 a DT O O
13 59 CD O O
13 year NN B-NP O
13 old JJ B-NP O
13 female NN I-NP O
14 with IN B-VP O
14 multiple JJ B-NP O
14 cardiac JJ I-NP O
14 risk NN I-NP O
14 factors NNS I-NP O
14 who WP O O
15 presents VBP O O
15 with IN B-VP O
15 exertional JJ B-NP O
15 chest NN I-NP O
15 discomfort NN I-NP O
15 and CC O O
15 early JJ B-NP O
15 positive JJ I-NP O
15 ETT NNP I-NP O
16 The DT B-NP O
16 patient NN I-NP O
16 has VBZ O O
16 a DT B-NP O
16 history NN I-NP O
16 of IN B-VP O
16 cardiac JJ B-NP O
16 risk NN I-NP O
16 factors NNS I-NP O
16 of IN B-VP O
16 obesity NN B-NP O
16 , , O O
17 diabetes VBZ O O
17 mellitus NN B-NP O
17 , , O O
17 and CC O O
17 cholesterol VB O O
17 The DT B-NP O
17 patient NN I-NP O
17 describes VBZ O O
17 a DT B-NP O
18 6-month JJ I-NP O
18 history NN I-NP O
18 of IN B-VP O
18 exertional JJ B-NP O
18 angina NN I-NP O
18 described VBD B-VP O
18 as IN B-VP O
18 chest NN B-NP O
18 heaviness NN I-NP O
19 with IN B-VP O
19 mild JJ B-NP O
19 shortness NN I-NP O
19 of IN B-VP O
19 breath NN B-NP O
19 whenever WRB O O
19 she PRP O O
19 walked VBD B-VP O
19 more JJR O O
19 than IN B-VP O
19 one CD O O
20 block NN B-NP O
20 or CC O O
20 climbed VBN O O
20 stairs IN B-VP O
20 The DT B-NP O
20 patient NN I-NP O
20 is VBZ O O
20 followed VBN O O
20 by IN B-VP O
20 Dr NNP B-NP O
20 Garrett NNP I-NP O
20 H NNP I-NP O
20 Lipkind NNP I-NP O
20 , , O O
20 LMD NNP B-NP O
20 at IN B-VP O
20 Skaemp NNP B-NP O
20 Center NNP I-NP O
20 She PRP O O
20 had VBD B-VP O
20 an DT B-NP O
20 ETT NNP I-NP O
20 on IN B-VP O
21 7/19/92 CD O O
21 , , O O
21 modified VBN O O
21 Bruce NNP B-NP O
21 protocol NN I-NP O
21 , , O O
21 in IN B-VP O
21 which WDT O O
21 she PRP O O
21 went VBD B-VP O
21 2 CD O O
21 minutes NNS B-NP O
21 and CC O O
21 2 CD O O
22 seconds NNS B-NP O
22 , , O O
22 stopped VBD B-VP O
22 secondary JJ O O
22 to TO O O
22 typical JJ B-NP O
22 anterior JJ I-NP O
22 chest NN I-NP O
22 discomfort NN I-NP O
23 The DT B-NP O
23 heart NN I-NP O
23 rate NN I-NP O
23 was VBD B-VP O
23 135 CD O O
23 , , O O
23 83% CD O O
23 predicted VBD B-VP O
23 EKG NNP B-NP O
23 changes NNS I-NP O
23 were VBD B-VP O
24 significant JJ O O
24 for IN B-VP O
24 20 CD O O
24 mm JJ B-NP O
24 horizontal JJ I-NP O
24 ST NNP I-NP O
24 depressions NNS I-NP O
24 in IN B-VP O
24 1 CD O O
24 , , O O
24 V4-5 NNP B-NP O
24 , , O O
24 1 CD O O
24 mm NN B-NP O
24 ST NNP I-NP O
25 depressions NNS I-NP O
25 in IN B-VP O
25 II NNP B-NP O
25 , , O O
25 III NNP B-NP O
25 and CC O O
25 F NNP B-NP O
25 The DT B-NP O
25 patient NN I-NP O
25 was VBD B-VP O
25 referred VBN O O
25 for IN B-VP O
25 cardiac JJ B-NP O
26 catheterization NN I-NP O
26 The DT B-NP O
26 patient NN I-NP O
26 denies VBZ O O
26 orthopnea NN B-NP O
26 , , O O
26 PND NNP B-NP O
26 , , O O
26 and CC O O
26 has VBZ O O
26 mild VBN O O
27 occasoinal JJ B-NP O
27 hypertension NN I-NP O
27 PAST NNP I-NP O
27 MEDICAL NNP I-NP O
27 HISTORY: NNP I-NP O
27 Noninsulin NNP I-NP O
28 dependent NN I-NP O
28 diabetes VBZ O O
28 mellitus RBS O O
28 , , O O
28 oral JJ B-NP O
28 agent NN I-NP O
28 times NNS I-NP O
28 six CD O O
28 months NNS B-NP O
28 Asthma NNP I-NP O
28 , , O O
29 no DT B-NP O
29 recent JJ I-NP O
29 symptoms NNS I-NP O
29 MEDICATIONS NNP I-NP O
29 ON NNP I-NP O
29 ADMISSION: NNP I-NP O
29 Glucotrol NNP I-NP B-m
29 7.5 CD O B-do
29 mg NN B-NP I-do
30 p.o NN I-NP B-mo
30 q-day JJ O B-f
30 , , O O
30 Mevacor NNP B-NP B-m
30 10 CD O B-do
30 mg NN B-NP I-do
30 p.o NN I-NP B-mo
30 q.d NN I-NP B-f
30 , , O O
30 Isoril NNP B-NP B-m
30 10 CD O B-do
30 mg NN B-NP I-do
30 p.o NN I-NP B-mo
30 t.i.d NN I-NP B-f
30 , , O O
31 Propranolol NNP B-NP B-m
31 20 CD O B-do
31 mg NN B-NP I-do
31 p.o NN I-NP B-mo
31 t.i.d NN I-NP B-f
31 , , O O
31 Nitroglycerin NNP B-NP B-m
31 sublingual JJ B-NP B-mo
31 p.r.n NN I-NP B-f
32 ALLERGIES: NNP I-NP O
32 ? . B-VP O
32 ALLERGY NNP B-NP O
32 TO NNP I-NP O
32 UNRECALLED NNP I-NP O
32 ANTIBIOTIC NNP I-NP O
32 FAMILY NNP I-NP O
32 HISTORY: NNP I-NP O
33 Brother NNP I-NP O
33 required VBD B-VP O
33 CABG NNP B-NP O
33 in IN B-VP O
33 his PRP$ O O
33 50's CD O O
33 , , O O
33 mother JJR O O
33 died VBD B-VP O
33 of IN B-VP O
33 heart NN B-NP O
33 disease NN I-NP O
33 , , O O
34 age NN B-NP O
34 unknown JJ B-NP O
35 PHYSICAL NNP I-NP O
35 EXAMINATION: NNP I-NP O
35 Blood NNP I-NP O
35 pressure NN I-NP O
35 140/70 CD O O
35 , , O O
35 pulse RB O O
35 70 CD O O
35 Neck: NNP B-NP O
36 negative JJ B-NP O
36 JVD NNP I-NP O
36 , , O O
36 2+ CD O O
36 carotids NNS B-NP O
36 , , O O
36 without IN B-VP O
36 bruits NNS B-NP O
37 Chest: NNP I-NP O
37 Clear NNP I-NP O
37 to TO O O
37 auscultation VB O O
37 Cardiac: NNP B-NP O
37 Regular NNP I-NP O
37 rate NN I-NP O
37 and CC O O
37 rhythm NN B-NP O
37 , , O O
38 S1 NNP B-NP O
38 and CC O O
38 S2 NNP B-NP O
38 , , O O
38 a DT B-NP O
38 I/IV NNP I-NP O
38 systolic JJ B-NP O
38 ejection NN I-NP O
38 murmur FW O O
38 heard NN B-NP O
38 best JJS O O
38 at IN B-VP O
38 the DT B-NP O
38 right JJ I-NP O
39 sternal JJ I-NP O
39 border NN I-NP O
39 Abdomen: NNP I-NP O
39 Plus NNP I-NP O
39 bowel NN I-NP O
39 sounds NNS I-NP O
39 , , O O
39 nontender FW O O
40 Extremities: NNP B-NP O
40 +2 NNP I-NP O
40 femorals NNS I-NP O
40 , , O O
40 no DT B-NP O
40 bruits NNS I-NP O
40 , , O O
40 positive JJ O O
40 left VBD B-VP O
40 DP NNP B-NP O
40 , , O O
40 trace NN B-NP O
40 PT NNP I-NP O
40 , , O O
41 right RB O O
41 positive JJ O O
41 2 CD O O
41 DP NNP B-NP O
41 and CC O O
41 plus CC O O
41 2 CD O O
41 PT NNP B-NP O
42 LABORATORY NNP I-NP O
42 EXAMINATION: NNP I-NP O
42 BUN/creatinine NNP I-NP O
42 12/1.2 CD O O
42 , , O O
42 glucose RB O O
42 318 CD O O
42 , , O O
43 hematocrit NN B-NP O
43 42.3 CD O O
43 , , O O
43 white JJ B-NP O
43 blood NN I-NP O
43 cell NN I-NP O
43 count NN I-NP O
44 8.38 CD O O
44 , , O O
44 cholesterol NN B-NP O
44 222 CD O O
44 , , O O
44 triglycerides NNS B-NP O
44 173 CD O O
45 HOSPITAL NNP B-NP O
45 COURSE: NNP I-NP O
45 The DT B-NP O
45 patient JJ I-NP O
45 underwent JJ I-NP O
45 catheterization NN I-NP O
45 on IN B-VP O
45 2/13/92 CD O O
46 She PRP O O
46 had VBD B-VP O
46 a DT O O
46 proximal JJ O O
46 95% CD O O
46 LAD NNP B-NP O
46 lesion NN I-NP O
46 and CC O O
46 diagonal JJ O O
46 1 CD O O
47 40% CD O O
47 stenosis NN B-NP O
47 She PRP O O
47 had VBD B-VP O
47 an DT B-NP O
47 anomalous JJ I-NP O
47 posterior NN I-NP O
47 circumflex NN I-NP O
47 with IN B-VP O
48 luminal JJ B-NP O
48 irregularities NNS I-NP O
48 Her PRP$ O O
48 mean JJ B-NP O
48 RA NNP I-NP O
48 was VBD B-VP O
48 5 CD O O
48 , , O O
48 and CC O O
48 her PRP$ O O
48 mean JJ B-NP O
48 capillary JJ I-NP O
49 wedge NN I-NP O
49 pressure NN I-NP O
49 was VBD B-VP O
49 11 CD O O
49 Her NNP B-NP O
49 cardiac NN I-NP O
49 output NN I-NP O
49 was VBD B-VP O
49 6.2 CD O O
49 , , O O
49 wifh VBD B-VP O
49 an DT B-NP O
49 FCR NNP I-NP O
49 of IN B-VP O
50 1226 CD O O
50 The DT B-NP O
50 patient NN I-NP O
50 underwent JJ B-NP O
50 athrectomy NN I-NP O
50 of IN B-VP O
50 her PRP$ O O
50 proximal JJ B-NP O
50 LAD NNP I-NP O
50 lesion NN I-NP O
51 through IN B-VP O
51 a DT O O
51 10 CD O O
51 French JJ B-NP O
51 arterial JJ I-NP O
51 sheath NN I-NP O
51 The DT B-NP O
51 stenosis NN I-NP O
51 was VBD B-VP O
51 reduced VBN O O
52 from IN B-VP O
52 an DT O O
52 80% CD O O
52 to TO O O
52 20% CD O O
52 residual JJ O O
52 The DT B-NP O
52 Heparin NNP I-NP B-m
52 was VBD B-VP O
52 shut VBN O O
52 off RP O O
52 , , O O
52 and CC O O
53 sheaths NNS B-NP O
53 were VBD B-VP O
53 pulled VBN O O
53 later RB O O
53 that DT B-NP O
53 afternoon NN I-NP O
53 Her PRP$ O O
53 post NN B-NP O
53 atherectomy JJ B-NP O
54 course NN I-NP O
54 was VBD B-VP O
54 complicated VBN O O
54 on IN B-VP O
54 the DT B-NP O
54 evening NN I-NP O
54 of IN B-VP O
54 10/9/92 CD O O
54 by IN B-VP O
54 the DT B-NP O
54 onset NN I-NP O
54 of IN B-VP O
55 severe JJ B-NP O
55 chest NN I-NP O
55 discomfort NN I-NP O
55 The DT B-NP O
55 patient NN I-NP O
55 had VBD B-VP O
55 significant JJ O O
55 flipped VBN O O
56 T-waves NNS B-NP O
56 in IN B-VP O
56 III NNP B-NP O
56 and CC O O
56 F NNP B-NP O
56 and CC O O
56 2 CD O O
56 mm NN B-NP O
56 ST NNP I-NP O
56 depressions NNS I-NP O
56 as RB O O
56 well RB O O
56 in IN B-VP O
56 III NNP B-NP O
56 and CC O O
56 F NNP B-NP O
57 The DT B-NP O
57 patient NN I-NP O
57 was VBD B-VP O
57 subsequently RB O O
57 brought VBN O O
57 to TO O O
57 the DT B-NP O
57 cath NN I-NP O
57 lab NN I-NP O
57 on IN B-VP O
57 10/9/92 CD O O
58 where WRB O O
58 the DT B-NP O
58 LAD NNP I-NP O
58 was VBD B-VP O
58 found VBN O O
58 to TO O O
58 be VB O O
58 100% CD O O
58 occluded JJ O O
58 and CC O O
58 was VBD B-VP O
58 dilated VBN O O
58 to TO O O
58 a DT O O
59 30% CD O O
59 residual JJ O O
59 with IN B-VP O
59 balloon NN B-NP O
59 PTCA NNP I-NP O
59 Thrombus NNP I-NP O
59 was VBD B-VP O
59 found VBN O O
59 at IN B-VP O
59 the DT B-NP O
59 prior JJ I-NP O
60 athrectomy NN I-NP O
60 site NN I-NP O
60 The DT B-NP O
60 patient NN I-NP O
60 was VBD B-VP O
60 transferred VBN O O
60 to TO O O
60 the DT B-NP O
60 Cardiac NNP I-NP O
60 Care NNP I-NP O
61 Unit NNP I-NP O
61 after IN B-VP O
61 the DT B-NP O
61 PTCA NNP I-NP O
61 which WDT O O
61 she PRP O O
61 proceeded VBD B-VP O
61 to TO O O
61 rule VB O O
61 in IN B-VP O
61 for IN B-VP O
61 a DT B-NP O
61 myocardial JJ I-NP O
62 infarction NN I-NP O
62 with IN B-VP O
62 peak JJ B-NP O
62 CPK's NNP I-NP O
62 of IN B-VP O
62 1390 CD O O
62 with IN B-VP O
62 MB's NNP B-NP O
62 of IN B-VP O
62 55 CD O O
62 The DT B-NP O
62 patient's NN I-NP O
63 post NN I-NP O
63 PTCA NNP I-NP O
63 course NN I-NP O
63 was VBD B-VP O
63 complicated VBN O O
63 by IN B-VP O
63 several JJ B-NP O
63 episodes NNS I-NP O
63 of IN B-VP O
63 transient JJ B-NP B-r
63 transient NN I-NP B-r
64 chest NN I-NP O
64 discomfort NN I-NP O
64 which WDT O O
64 was VBD B-VP O
64 relieved VBN O O
64 both DT O O
64 by IN B-VP O
64 Mylanta NNP B-NP B-m
64 and CC O O
64 sublingual JJ B-NP B-mo
65 TNG NNP I-NP B-m
65 These DT B-NP O
65 episodes NNS I-NP O
65 were VBD B-VP O
65 not RB O O
65 compared VBN O O
65 with IN B-VP O
65 EKG NNP B-NP O
65 nor CC O O
65 felt VBD B-VP O
65 to TO O O
65 be VB O O
66 secondary JJ O O
66 to TO O O
66 recurrent VB O O
66 dyspepsia VB O O
66 The DT B-NP O
66 patient NN I-NP O
66 on IN B-VP O
66 9/9/92 CD O O
66 , , O O
66 seven CD O O
67 days NNS B-NP O
67 post RB O O
67 MI NNP B-NP O
67 , , O O
67 had VBD B-VP O
67 a DT O O
67 modified VBN O O
67 Bruce NNP B-NP O
67 ETT NNP I-NP O
67 where WRB O O
67 she PRP O O
67 went VBD B-VP O
67 9 CD O O
67 minutes NNS B-NP O
68 without IN B-VP O
68 any DT B-NP O
68 ischemic JJ I-NP O
68 changes NNS I-NP O
68 The DT B-NP O
68 patient's NN I-NP O
68 blood NN I-NP O
68 sugars NNS I-NP O
68 remained VBD B-VP O
69 elevated JJ O O
69 throughout IN B-VP O
69 her PRP$ O O
69 hospital NN B-NP O
69 course NN I-NP O
69 She PRP O O
69 was VBD B-VP O
69 maintained VBN O O
69 on IN B-VP O
70 Glucotrol NNP B-NP B-m
70 with IN B-VP O
70 NPH NNP B-NP B-m
70 subcu NN I-NP B-mo
70 subcu NN I-NP B-mo
70 q.a.m NN I-NP B-f
70 q.a.m NN I-NP B-f
70 was VBD B-VP O
70 added VBN O O
70 with IN B-VP O
70 the DT B-NP O
70 hope NN I-NP O
70 that IN B-VP O
70 the DT B-NP O
71 patient NN I-NP O
71 would MD O O
71 eventually RB O O
71 after IN B-VP O
71 the DT B-NP O
71 stress NN I-NP O
71 of IN B-VP O
71 her PRP$ O O
71 MI NNP B-NP O
71 , , O O
71 her PRP$ O B-r
71 her PRP$ O B-r
71 blood NN B-NP O
72 sugars NNS I-NP O
72 would MD O O
72 return VB O O
72 to TO O O
72 prior JJ B-NP O
72 levels NNS I-NP O
72 The DT B-NP O
72 patient NN I-NP O
72 was VBD B-VP O
72 thus RB O O
72 treated VBN O O
73 with IN B-VP O
73 Mevacor NNP B-NP B-m
73 for IN B-VP O
73 hypercholesterolemia NN B-NP B-r
73 The DT B-NP O
73 patient NN I-NP O
73 was VBD B-VP O
73 discharged VBN O O
74 in IN B-VP O
74 good JJ B-NP O
74 condition NN I-NP O
74 on IN B-VP O
74 10/11/92 CD O O
74 with IN B-VP O
74 followup NN B-NP O
74 with IN B-VP O
74 Dr NNP B-NP O
74 Kneisel NNP I-NP O
74 in IN B-VP O
74 Frejames NNP B-NP O
74 Ny'smiss NNP I-NP O
74 Hospital NNP I-NP O
75 DISPOSITION: NNP I-NP O
75 MEDICATIONS NNP I-NP O
75 ON NNP I-NP O
75 DISCHARGE: NNP I-NP O
75 Mevacor NNP I-NP B-m
75 10 CD O B-do
75 mg NN B-NP I-do
75 p.o NN I-NP B-mo
75 q-day JJ O B-f
75 , , O O
76 Aspirin NNP B-NP B-m
76 one CD O B-do
76 p.o NN B-NP B-mo
76 q-day NN I-NP B-f
76 , , O O
76 Glucotrol NNP B-NP B-m
76 20 CD O B-do
76 mg NN B-NP I-do
76 p.o NN I-NP B-mo
76 b.i.d NN I-NP B-f
76 , , O O
77 Isordil NNP B-NP B-m
77 40 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
77 t.i.d NN I-NP B-f
77 , , O O
77 Lopressor NNP B-NP B-m
77 200 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
77 b.i.d NN I-NP B-f
77 , , O O
77 NPH NNP B-NP B-m
77 26 CD O B-do
78 units NNS B-NP O
78 subcutaneously RB O B-mo
78 each DT B-NP B-f
78 morning NN I-NP I-f
79 RT688/9972 NNP I-NP O
80 YONG NNP I-NP O
80 S NNP I-NP O
80 UGARTE NNP I-NP O
80 , , O O
80 M.D NNP B-NP O
80 ZE69 NNP I-NP O
80 D: NNP I-NP O
80 2/27/92 CD O O
81 Batch: NNP B-NP O
81 4948 CD O O
81 Report: NNP B-NP O
81 I2158Q2 NNP I-NP O
81 T: NNP I-NP O
81 6/29/92 CD O O
82 Dictated NNP B-NP O
82 By: NNP I-NP O
82 ANDREAS NNP I-NP O
82 D NNP I-NP O
82 DECONTI NNP I-NP O
82 , , O O
82 M.D NNP B-NP O
83 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #80815 VBZ O O
2 394520578 CD O O
2 GEMC NNP B-NP O
2 37110469 CD O O
2 7719852 CD O O
2 6/19/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 C-DIFF.COLITIS NNP I-NP O
2 Unsigned NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 10/2/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/16/2006 CD O O
4 ATTENDING: NNP B-NP O
4 TRENTHAM NNP I-NP O
4 , , O O
4 DEL NNP B-NP O
4 GUADALUPE NNP I-NP O
4 MD NNP I-NP O
5 HISTORY NNP I-NP O
5 OF NNP I-NP O
5 PRESENT NNP I-NP O
5 ILLNESS: NNP I-NP O
5 Mr NNP I-NP O
5 Klaja NNP I-NP O
5 is VBZ O O
5 an DT B-NP O
5 81-year-old JJ I-NP O
5 gentleman NN I-NP O
6 whose WP$ O O
6 chief JJ B-NP O
6 complaint NN I-NP O
6 was VBD B-VP O
6 abdominal JJ B-NP O
6 pain NN I-NP O
6 and CC O O
6 diarrhea NN B-NP O
6 He PRP O O
6 had VBD B-VP O
6 a DT B-NP O
7 past JJ I-NP O
7 medical JJ I-NP O
7 history NN I-NP O
7 of IN B-VP O
7 ischemic JJ B-NP O
7 cardiomyopathy NN I-NP O
7 and CC O O
7 recent JJ B-NP O
8 complex JJ I-NP O
8 medical JJ I-NP O
8 history NN I-NP O
8 including VBG O O
8 a DT B-NP O
8 septic JJ I-NP O
8 right NN I-NP O
8 knee NN I-NP O
8 arthritis NN I-NP O
9 with IN B-VP O
9 MRSA NNP B-NP O
9 complicated VBN O O
9 by IN B-VP O
9 a DT B-NP O
9 PICC NNP I-NP O
9 line-induced JJ B-NP O
9 right JJ I-NP O
9 upper JJ I-NP O
9 extremity NN I-NP O
10 DVT NNP I-NP O
10 followed VBN O O
10 by IN B-VP O
10 bacteremia NN B-NP B-r
10 with IN B-VP O
10 multi-resistant JJ B-NP O
10 Klebsiella NNP I-NP O
11 pneumoniae NN I-NP O
11 , , O O
11 treated VBN O O
11 with IN B-VP O
11 meropenem NN B-NP B-m
11 for IN B-VP B-du
11 14 CD O I-du
11 days NNS B-NP I-du
11 with IN B-VP O
11 the DT B-NP O
11 course NN I-NP O
12 ending VBG O O
12 on IN B-VP O
12 11/12/2006 CD O O
12 The DT B-NP O
12 patient NN I-NP O
12 presented VBN O O
12 with IN B-VP O
12 left JJ B-NP O
12 lower JJR I-NP O
12 quadrant JJ I-NP O
12 abdominal JJ I-NP O
13 pain NN I-NP O
13 during IN B-VP O
13 his PRP$ O O
13 last JJ B-NP O
13 admission NN I-NP O
13 2 CD O O
13 weeks NNS B-NP O
13 ago RB O O
13 associated VBN O O
13 with IN B-VP O
13 low-volume JJ B-NP O
13 mucus NN I-NP O
14 diarrhea NN I-NP O
14 , , O O
14 C NNP B-NP O
14 diff NN I-NP O
14 toxin NN I-NP O
14 assay NN I-NP O
14 was VBD B-VP O
14 at IN B-VP O
14 that DT B-NP O
14 time NN I-NP O
14 negative JJ O O
14 on IN B-VP O
14 6/11 CD O O
15 Abdominal NNP B-NP O
15 CT NNP I-NP O
15 showed VBD B-VP O
15 diverticulosis NN B-NP O
15 with IN B-VP O
15 stranding NN B-NP O
15 of IN B-VP O
15 the DT B-NP O
15 sigmoid JJ I-NP O
15 colon NN I-NP O
16 Blood NNP I-NP O
16 cultures NNS I-NP O
16 grew VBD B-VP O
16 klebsiella NN B-NP B-r
16 , , O O
16 treated VBN O O
16 with IN B-VP O
16 14 CD O B-du
16 days NNS B-NP I-du
16 of IN B-VP O
16 meropenem NN B-NP B-m
17 as IN B-VP O
17 previously RB O O
17 noted VBN O O
17 However RB O O
17 , , O O
17 since IN B-VP O
17 this DT B-NP O
17 discharge NN I-NP O
17 , , O O
17 the DT B-NP O
17 mild JJ I-NP O
18 abdominal JJ I-NP O
18 pain NN I-NP O
18 persisted VBD B-VP O
18 He PRP O O
18 continues VBZ O O
18 to TO O O
18 have VB O O
18 low-grade JJ B-NP O
18 mucus NN I-NP O
19 diarrhea NN I-NP O
19 about IN B-VP O
19 5 CD O O
19 times NNS B-NP O
19 a DT B-NP O
19 day NN I-NP O
19 , , O O
19 not RB O O
19 associated VBN O O
19 with IN B-VP O
19 fever NN B-NP O
19 , , O O
19 chills NNS B-NP O
20 or CC O O
20 anorexia NN B-NP O
20 Over IN B-VP O
20 the DT O O
20 last JJ O O
20 2 CD O O
20 days NNS B-NP O
20 prior RB O O
20 to TO O O
20 this DT B-NP O
20 admission NN I-NP O
20 , , O O
20 the DT B-NP O
21 diarrhea NN I-NP O
21 became VBD B-VP O
21 high JJ B-NP O
21 volume NN I-NP O
21 , , O O
21 still RB O O
21 nonbloody NN B-NP O
21 and CC O O
21 not RB O O
21 associated VBN O O
22 again RB O O
22 with IN B-VP O
22 fever NN B-NP O
22 or CC O O
22 chills NNS B-NP O
22 He PRP O O
22 was VBD B-VP O
22 brought VBN O O
22 into IN B-VP O
22 the DT B-NP O
22 emergency NN I-NP O
23 department NN I-NP O
23 at IN B-VP O
23 which WDT O O
23 time NN B-NP O
23 , , O O
23 he PRP O O
23 was VBD B-VP O
23 afebrile RB O O
23 with IN B-VP O
23 a DT B-NP O
23 blood NN I-NP O
23 pressure NN I-NP O
24 of IN B-VP O
24 85/49 CD O O
24 , , O O
24 heart NN B-NP O
24 rate NN I-NP O
24 in IN B-VP O
24 the DT O O
24 80s CD O O
24 , , O O
24 respiratory JJ B-NP O
24 rate NN I-NP O
24 of IN B-VP O
24 20 CD O O
24 , , O O
24 O2 NNP B-NP O
25 saturation NN I-NP O
25 93% CD O O
25 on IN B-VP O
25 room NN B-NP O
25 air NN I-NP O
25 At IN B-VP O
25 that DT B-NP O
25 time NN I-NP O
25 , , O O
25 he PRP O O
25 received VBD B-VP O
25 volume NN B-NP O
26 resuscitation NN I-NP O
26 with IN B-VP O
26 2 CD O B-do
26 liters NNS B-NP I-do
26 of IN B-VP O
26 IV NNP B-NP B-mo
26 fluids NNS I-NP B-m
26 , , O O
26 stool NN B-NP O
26 samples NNS I-NP O
26 for IN B-VP O
26 C NNP B-NP O
27 diff NN I-NP O
27 assay NN I-NP O
27 were VBD B-VP O
27 sent VBN O O
27 He PRP O O
27 received VBD B-VP O
27 empiric JJ B-NP O
27 therapy NN I-NP O
27 with IN B-VP O
27 p.o NN B-NP B-mo
28 vancomycin VBP O B-m
28 An DT B-NP O
28 abdominal JJ I-NP O
28 CT NNP I-NP O
28 in IN B-VP O
28 the DT B-NP O
28 emergency NN I-NP O
28 department NN I-NP O
28 showed VBD B-VP O
29 thickening NN B-NP O
29 of IN B-VP O
29 the DT B-NP O
29 sigmoid NN I-NP O
29 colon NN I-NP O
29 and CC O O
29 rectum NN B-NP O
30 PAST NNP I-NP O
30 MEDICAL NNP I-NP O
30 HISTORY: NNP I-NP O
30 Includes NNP I-NP O
30 coronary JJ B-NP O
30 artery NN I-NP O
30 disease NN I-NP O
30 as IN B-VP O
30 noted VBN O O
31 with IN B-VP O
31 an DT B-NP O
31 anterior JJ I-NP O
31 MI NNP I-NP O
31 in IN B-VP O
31 2003 CD O O
31 , , O O
31 that WDT O O
31 had VBD B-VP O
31 complicated VBN O O
31 to TO O O
31 VT NNP B-NP O
31 arrest NN I-NP O
31 , , O O
32 status NN B-NP O
32 post NN I-NP O
32 CABG NNP I-NP O
32 in IN B-VP O
32 2003 CD O O
32 that WDT O O
32 was VBD B-VP O
32 a DT B-NP O
32 left JJ I-NP O
32 internal JJ I-NP O
32 mammary JJ I-NP O
32 artery NN I-NP O
33 to TO O O
33 LAD NNP B-NP O
33 with IN B-VP O
33 saphenous JJ B-NP O
33 vein NN I-NP O
33 graft NN I-NP O
33 to TO O O
33 the DT B-NP O
33 PTA NNP I-NP O
33 and CC O O
33 obtuse RB O O
33 marginal JJ O O
34 He PRP O O
34 has VBZ O O
34 had VBD B-VP O
34 a DT B-NP O
34 catheterization NN I-NP O
34 in IN B-VP O
34 8/23 CD O O
34 that WDT O O
34 showed VBD B-VP O
34 patent JJ B-NP O
34 grafts NNS I-NP O
35 and CC O O
35 drug-eluting JJ B-NP B-m
35 stent NN I-NP I-m
35 to TO O O
35 the DT B-NP O
35 left NN I-NP O
35 circumflex NN I-NP O
35 He PRP O O
35 has VBZ O O
35 chronic JJ B-NP O
36 kidney NN I-NP O
36 disease NN I-NP O
36 , , O O
36 baseline JJ B-NP O
36 creatinine NN I-NP O
36 between IN B-VP O
36 1.3 CD O O
36 and CC O O
36 1.5 CD O O
36 , , O O
37 hypertension NN B-NP O
37 , , O O
37 hypercholesterolemia NN B-NP O
37 , , O O
37 C NNP B-NP O
37 diff NN I-NP O
37 colitis NN I-NP O
37 in IN B-VP O
37 2003 CD O O
37 , , O O
37 BPH NNP B-NP O
37 , , O O
38 asthma NN B-NP O
38 , , O O
38 GERD NNP B-NP O
38 , , O O
38 status NN B-NP O
38 post NN I-NP O
38 right RB O O
38 upper JJ B-NP O
38 extremity NN I-NP O
38 PICC-related NNP I-NP O
38 DVT NNP I-NP O
39 and CC O O
39 right JJ B-NP O
39 knee NN I-NP O
39 septic JJ B-NP O
39 arthritis NN I-NP O
40 MEDICATIONS: NNP I-NP O
40 aspirin VBZ O B-m
40 81 CD O B-do
40 mg NN B-NP I-do
40 , , O O
40 Plavix NNP B-NP B-m
40 75 CD O B-do
40 mg NN B-NP I-do
40 , , O O
40 Coumadin NNP B-NP B-m
40 5 CD O B-do
40 mg NN B-NP I-do
40 , , O O
40 digoxin NN B-NP B-m
40 0.125 CD O B-do
40 mg NN B-NP I-do
40 , , O O
41 Lasix NNP B-NP B-m
41 49 CD O B-do
41 mg JJ O I-do
41 daily RB O B-f
41 , , O O
41 lisinopril VBD B-VP B-m
41 10 CD O B-do
41 mg JJ O I-do
41 daily RB O B-f
41 , , O O
41 Lopressor NNP B-NP B-m
41 25 CD O B-do
41 mg NN B-NP I-do
41 b.i.d NN I-NP B-f
41 , , O O
41 Zocor NNP B-NP B-m
41 80 CD O B-do
41 mg JJ O I-do
42 daily RB O B-f
42 , , O O
42 Flomax NNP B-NP B-m
42 0.4 CD O B-do
42 mg JJ O I-do
42 daily JJ O B-f
42 and CC O O
42 Flovent JJ O B-m
42 110 CD O B-do
42 mcg NN B-NP I-do
42 b.i.d NN I-NP B-f
43 ALLERGIES: NNP I-NP O
43 penicillin NN I-NP O
43 which WDT O O
43 caused VBD B-VP O
43 hives NNS B-NP O
43 and CC O O
43 swelling VBG O O
44 SOCIAL NNP B-NP O
44 HISTORY: NNP I-NP O
44 He PRP O O
44 previously RB O O
44 a DT B-NP O
44 smoker NN I-NP O
44 He PRP O O
44 does VBZ O O
44 not RB O O
44 drink VB O O
44 He PRP O O
45 is VBZ O O
45 a DT B-NP O
45 nursing NN I-NP O
45 home NN I-NP O
45 resident NN I-NP O
46 FAMILY NNP I-NP O
46 HISTORY: NNP I-NP O
46 Significant NNP I-NP O
46 for IN B-VP O
46 coronary JJ B-NP O
46 artery NN I-NP O
46 disease NN I-NP O
46 , , O O
46 two CD O O
47 brothers NNS B-NP O
47 who WP O O
47 had VBD B-VP O
47 coronary JJ B-NP O
47 artery NN I-NP O
47 disease NN I-NP O
47 in IN B-VP O
47 their PRP$ O O
47 60s CD O O
47 No NNPS B-NP O
47 family NN I-NP O
48 history NN I-NP O
48 of IN B-VP O
48 cancer NN B-NP O
49 PHYSICAL NNP I-NP O
49 EXAMINATION: NNP I-NP O
49 Vitals NNP I-NP O
49 as IN B-VP O
49 previous JJ O O
49 noted VBD B-VP O
49 , , O O
49 blood NN B-NP O
49 pressure NN I-NP O
50 in IN B-VP O
50 the DT O O
50 80s/49 CD O O
50 , , O O
50 heart NN B-NP O
50 rate NN I-NP O
50 80 CD O O
50 , , O O
50 regular JJ O O
50 , , O O
50 respiratory JJ B-NP O
50 rate NN I-NP O
50 20 CD O O
50 , , O O
50 O2 NNP B-NP O
51 saturation NN I-NP O
51 93% CD O O
51 on IN B-VP O
51 room NN B-NP O
51 air NN I-NP O
51 Patient NNP I-NP O
51 was VBD B-VP O
51 afebrile JJ B-NP O
51 Pertinent NNP I-NP O
52 physical JJ B-NP O
52 findings NNS I-NP O
52 included: NN I-NP O
52 Pulmonary: NNP I-NP O
52 He PRP O O
52 had VBD B-VP O
52 a DT B-NP O
52 prolonged JJ I-NP O
53 expiratory NN I-NP O
53 phase NN I-NP O
53 , , O O
53 but CC O O
53 no DT B-NP O
53 crackles NNS I-NP O
53 Cardiovascular: NNP I-NP O
53 Distant NNP I-NP O
53 heart NN I-NP O
54 sounds VBZ O O
54 , , O O
54 regular JJ B-NP O
54 rate NN I-NP O
54 and CC O O
54 rhythm NN B-NP O
54 Normal NNP I-NP O
54 S1 NNP I-NP O
54 and CC O O
54 S2 NNP B-NP O
54 No NNP I-NP O
54 rubs NN I-NP O
54 or CC O O
55 gallops NNS B-NP O
55 Systolic JJ B-NP O
55 ejection NN I-NP O
55 or CC O O
55 murmur VB O O
55 3/6 CD O O
55 at IN B-VP O
55 the DT B-NP O
55 left NN I-NP O
55 lower RBR O O
56 sternal JJ B-NP O
56 border NN I-NP O
56 Abdomen: NNP I-NP O
56 Obese NNP I-NP O
56 , , O O
56 distended VBD B-VP O
56 abdomen NNS B-NP O
56 , , O O
56 left VBD B-VP O
56 lower JJR B-NP O
57 quadrant JJ I-NP O
57 tenderness NN I-NP O
57 to TO O O
57 palpation VB O O
57 No DT B-NP O
57 rebound NN I-NP O
57 at IN B-VP O
57 this DT B-NP O
57 time NN I-NP O
58 Extremities NNS I-NP O
58 are VBP O O
58 warm JJ O O
58 , , O O
58 2+ CD O O
58 pulses NNS B-NP O
58 with IN B-VP O
58 1+ CD O O
58 bilateral JJ B-NP O
58 lower JJR I-NP O
58 extremity NN I-NP O
59 edema NN I-NP O
59 to TO O O
59 the DT B-NP O
59 shins NNS I-NP O
59 Neurologic: NNP I-NP O
59 Alert NNP I-NP O
59 and CC O O
59 oriented VBN O O
59 x3 NN B-NP O
59 , , O O
59 cranial JJ B-NP O
60 nerves NNS I-NP O
60 grossly RB O O
60 intact JJ O O
60 , , O O
60 no DT B-NP O
60 abnormalities NNS I-NP O
61 admission VBP O O
61 abdominal JJ B-NP O
61 CT NNP I-NP O
61 showed VBD B-VP O
61 bowel IN B-VP O
61 wall NN B-NP O
61 thickening NN I-NP O
61 in IN B-VP O
62 the DT O O
62 descending VBG O O
62 sigmoid JJ B-NP O
62 colon NN I-NP O
62 and CC O O
62 rectum NN B-NP O
62 Chest NNP I-NP O
62 x-ray NN I-NP O
62 showed VBD B-VP O
63 left-sided JJ B-NP O
63 pleural JJ I-NP O
63 effusion NN I-NP O
63 , , O O
63 atelectasis NN B-NP O
63 in IN B-VP O
63 the DT B-NP O
63 left NN I-NP O
63 lower JJR B-NP O
63 lobe NN I-NP O
64 LABORATORY NNP I-NP O
64 DATA: NNP I-NP O
64 Labs NNP I-NP O
64 were VBD B-VP O
64 significant JJ O O
64 for IN B-VP O
64 a DT B-NP O
64 white JJ I-NP O
64 count NN I-NP O
64 of IN B-VP O
65 15.7 CD O O
65 , , O O
65 hematocrit NN B-NP O
65 of IN B-VP O
65 35.5 CD O O
65 and CC O O
65 INR NNP B-NP O
65 of IN B-VP O
65 3.2 CD O O
65 Electrolytes NNS B-NP O
65 were VBD B-VP O
66 normal JJ B-NP O
67 Patient NNP I-NP O
67 was VBD B-VP O
67 initially RB O O
67 admitted VBN O O
67 to TO O O
67 the DT B-NP O
67 MICU NNP I-NP O
67 for IN B-VP O
67 hypertension NN B-NP O
67 and CC O O
68 infectious JJ B-NP O
68 etiology NN I-NP O
68 He PRP O O
68 was VBD B-VP O
68 stabilized VBN O O
68 there RB O O
68 and CC O O
68 transferred VBD B-VP O
68 to TO O O
69 the DT B-NP O
69 floor NN I-NP O
69 within IN B-VP O
69 a DT B-NP O
69 few JJ I-NP O
69 days NNS I-NP O
70 HOSPITAL NNP I-NP O
70 COURSE: NNP I-NP O
71 1 CD O O
71 Colitis NNP B-NP O
71 , , O O
71 presumed VBD B-VP O
71 infectious JJ B-NP O
71 etiology NN I-NP O
71 , , O O
71 descending VBG O O
71 and CC O O
71 sigmoid JJ B-NP O
72 colon NN I-NP O
72 Colitis NNP I-NP O
72 was VBD B-VP O
72 worse JJR O O
72 over IN B-VP O
72 the DT B-NP O
72 last JJ I-NP O
72 month NN I-NP O
72 , , O O
72 associated VBN O O
72 with IN B-VP O
73 diarrhea JJ B-NP O
73 Abdominal NNP I-NP O
73 CT NNP I-NP O
73 is VBZ O O
73 consistent JJ O O
73 with IN B-VP O
73 an DT B-NP O
73 infectious JJ I-NP O
74 inflammatory NN I-NP O
74 bowel NN I-NP O
74 process NN I-NP O
74 Given NNP I-NP O
74 history NN I-NP O
74 of IN B-VP O
74 C NNP B-NP O
74 diff NN I-NP O
74 colitis NN I-NP O
74 , , O O
74 C NNP B-NP O
75 diff NN I-NP O
75 was VBD B-VP O
75 the DT O O
75 most RBS O O
75 likely JJ B-NP O
75 infectious JJ I-NP O
75 etiology NN I-NP O
75 , , O O
75 but CC O O
75 others NNS B-NP O
75 were VBD B-VP O
76 possible JJ B-NP O
76 Ischemic NNP I-NP O
76 colitis NN I-NP O
76 was VBD B-VP O
76 considered VBN O O
76 secondary JJ O O
76 to TO O O
76 low JJ O O
77 forward RB O O
77 flow NN B-NP O
77 , , O O
77 given VBN O O
77 patient's NN B-NP O
77 cardiomyopathy NN I-NP O
77 and CC O O
77 low JJ B-NP O
77 ejection NN I-NP O
78 fraction NN I-NP O
78 of IN B-VP O
78 20% CD O O
78 to TO O O
78 35% CD O O
78 and CC O O
78 he PRP O O
78 also RB O O
78 got VBD B-VP O
78 a DT B-NP O
78 pattern NN I-NP O
78 of IN B-VP O
78 inflammatory JJ B-NP O
79 colitis NN I-NP O
79 or CC O O
79 nonspecific JJ B-NP O
79 colitis NN I-NP O
79 Stool NNP I-NP O
79 samples NNS I-NP O
79 were VBD B-VP O
79 sent VBN O O
79 for IN B-VP O
79 a DT B-NP O
79 C NNP I-NP O
80 diff NN I-NP O
80 toxin NN I-NP O
80 and CC O O
80 assay NN B-NP O
80 and CC O O
80 all DT O O
80 were VBD B-VP O
80 negative JJ B-NP O
80 x NN I-NP O
80 at IN B-VP O
80 least JJS O O
80 3 CD O O
80 samples NNS B-NP O
81 Stool NNP I-NP O
81 cultures NNS I-NP O
81 were VBD B-VP O
81 sent VBN O O
81 and CC O O
81 did VBD B-VP O
81 not RB O O
81 grow VB O O
81 anything NN B-NP O
81 out RP O O
81 during IN B-VP O
82 admission NN B-NP O
82 Empiric NNP I-NP O
82 treatment NN I-NP O
82 was VBD B-VP O
82 started VBN O O
82 with IN B-VP O
82 p.o NN B-NP B-mo
82 vancomycin NN I-NP B-m
83 Patient's NNP I-NP O
83 abdominal NN I-NP O
83 pain NN I-NP O
83 continued VBD B-VP O
83 to TO O O
83 improve VB O O
83 and CC O O
83 completely RB O O
84 resolved VBN O O
84 By IN B-VP O
84 discharge NN B-NP O
84 , , O O
84 patient NN B-NP O
84 remained VBD B-VP O
84 afebrile JJ O O
84 and CC O O
84 white JJ B-NP O
85 blood NN I-NP O
85 cell NN I-NP O
85 count NN I-NP O
85 decreased VBD B-VP O
85 Advance NNP B-NP O
85 patient's NN I-NP O
85 diet NN I-NP O
85 as IN B-VP O
85 tolerated VBN O O
86 and CC O O
86 by IN B-VP O
86 discharge NN B-NP O
86 the DT B-NP O
86 patient NN I-NP O
86 was VBD B-VP O
86 up RB O O
86 to TO O O
86 soft JJ B-NP O
86 solids NNS I-NP O
86 We PRP O O
86 added VBD B-VP O
87 lactobacillus CC O B-m
87 p.o NN B-NP B-mo
87 for IN B-VP O
87 probiotics NNS B-NP O
87 and CC O O
87 patient NN B-NP O
87 also RB O O
87 had VBD B-VP O
87 flex VBN O O
87 sig RB O O
88 two CD O O
88 days NNS B-NP O
88 before IN B-VP O
88 discharge NN B-NP O
88 , , O O
88 showing VBG O O
88 resolving VBG O O
88 inflammation NN B-NP O
89 consistent NN I-NP O
89 with IN B-VP O
89 colitis NN B-NP O
89 of IN B-VP O
89 inflammatory JJ B-NP O
89 etiology NN I-NP O
89 The DT B-NP O
89 flex JJ I-NP O
89 sig NN I-NP O
90 did VBD B-VP O
90 not RB O O
90 change VB O O
90 his PRP$ O O
90 management NN B-NP O
90 We PRP O O
90 did VBD B-VP O
90 discharge VB O O
90 the DT B-NP O
90 patient NN I-NP O
90 on IN B-VP O
90 a DT B-NP O
91 2-week JJ I-NP B-du
91 course NN I-NP I-du
91 p.o NN I-NP B-mo
91 vancomycin VBP O B-m
91 alone RB O O
92 2 CD O O
92 Coronary JJ B-NP O
92 artery NN I-NP O
92 disease NN I-NP O
92 Patient NNP I-NP O
92 had VBD B-VP O
92 no DT B-NP O
92 evidence NN I-NP O
92 for IN B-VP O
92 acute JJ B-NP O
93 coronary JJ I-NP O
93 syndrome NN I-NP O
93 on IN B-VP O
93 admission NN B-NP O
93 We PRP O O
93 continued VBD B-VP O
93 his PRP$ O O
93 aspirin NN B-NP B-m
93 , , O O
94 Plavix NNP B-NP B-m
94 , , O O
94 statin NN B-NP B-m
94 and CC O O
94 beta-blocker NN B-NP B-m
94 Patient NNP I-NP O
94 had VBD B-VP O
94 no DT B-NP O
94 ischemic JJ I-NP O
94 issues NNS I-NP O
95 or CC O O
95 coronary JJ B-NP O
95 artery NN I-NP O
95 disease NN I-NP O
95 issues NNS I-NP O
95 during IN B-VP O
95 his PRP$ O O
95 admission NN B-NP O
96 3 CD O O
96 CHF NNP B-NP O
96 Patient NNP I-NP O
96 has VBZ O O
96 previous JJ B-NP O
96 EF NNP I-NP O
96 noted VBD B-VP O
96 at IN B-VP O
96 20% CD O O
96 to TO O O
96 35% CD O O
96 , , O O
96 so RB O O
96 a DT B-NP O
97 gentle JJ I-NP B-m
97 hydration NN I-NP I-m
97 therapy NN I-NP I-m
97 at IN B-VP O
97 first JJ O O
97 in IN B-VP O
97 the DT B-NP O
97 MICU NNP I-NP O
97 for IN B-VP O
97 hypertension NN B-NP B-r
98 and CC O O
98 then RB O O
98 as IN B-VP O
98 patient's NN B-NP O
98 blood NN I-NP O
98 pressure NN I-NP O
98 increased VBD B-VP O
98 , , O O
98 was VBD B-VP O
98 able JJ O O
98 to TO O O
99 restart VB O O
99 patient's NN B-NP O
99 Lasix NNP I-NP B-m
99 dose NN I-NP O
99 in IN B-VP O
99 order NN B-NP O
99 to TO O O
99 diurese VB O O
99 all DT O O
99 of IN B-VP O
99 the DT B-NP O
99 extra JJ I-NP B-r
100 fluid NN I-NP O
100 gained VBN O O
100 during IN B-VP O
100 the DT B-NP O
100 rehydration NN I-NP O
100 therapy NN I-NP O
100 , , O O
100 was VBD B-VP O
100 restarted VBN O O
100 on IN B-VP O
100 the DT B-NP O
101 Lasix NNP I-NP B-m
101 40 CD O B-do
101 mg NN B-NP I-do
101 p.o JJ O B-mo
101 daily RB O B-f
101 , , O O
101 his PRP$ O O
101 daily JJ B-NP O
101 dose NN I-NP O
101 at IN B-VP O
101 home NN B-NP O
101 Also RB O O
101 considered VBD B-VP O
102 restarting VBG O O
102 lisinopril NN B-NP B-m
102 , , O O
102 but CC O O
102 deferred VBD B-VP O
102 discharge NN B-NP O
102 to TO O O
102 outpatient VB O O
103 follow VB O O
103 up RP O O
103 with IN B-VP O
103 primary JJ B-NP O
103 care NN I-NP O
103 physician NN I-NP O
103 for IN B-VP O
103 restart NN B-NP O
103 of IN B-VP O
103 lisinopril NN B-NP B-m
103 , , O O
104 once RB O O
104 patient NN B-NP O
104 is VBZ O O
104 fully RB O O
104 recovered VBN O O
105 4 CD O O
105 Chronic NNP B-NP O
105 kidney NN I-NP O
105 disease NN I-NP O
105 Patient NNP I-NP O
105 had VBD B-VP O
105 a DT B-NP O
105 baseline NN I-NP O
105 of IN B-VP O
105 creatinine NN B-NP O
106 1.2 CD O O
106 to TO O O
106 1.5 CD O O
106 and CC O O
106 he PRP O O
106 came VBD B-VP O
106 into IN B-VP O
106 the DT B-NP O
106 hospital NN I-NP O
106 with IN B-VP O
106 a DT B-NP O
106 creatinine NN I-NP O
106 of IN B-VP O
106 1.0 CD O O
107 The DT B-NP O
107 patient NN I-NP O
107 was VBD B-VP O
107 below IN B-VP O
107 baseline NN B-NP O
107 and CC O O
107 remained VBD B-VP O
107 below IN B-VP O
107 baseline NN B-NP O
107 during IN B-VP O
108 admission NN B-NP O
108 He PRP O O
108 did VBD B-VP O
108 not RB O O
108 have VB O O
108 any DT B-NP O
108 renal JJ I-NP O
108 issues NNS I-NP O
109 5 CD O O
109 Hematology NNP B-NP O
109 Patient NNP I-NP O
109 has VBZ O O
109 a DT B-NP O
109 history NN I-NP O
109 a DT B-NP O
109 line-induced JJ I-NP O
109 DVT NNP I-NP O
109 , , O O
109 has VBZ O O
110 been VBN O O
110 treated VBN O O
110 with IN B-VP O
110 Coumadin NNP B-NP B-m
110 , , O O
110 with IN B-VP O
110 no DT B-NP O
110 definitive JJ I-NP O
110 evidence NN I-NP O
110 as IN B-VP O
110 to TO O O
110 how WRB O O
111 along JJ B-NP O
111 patient NN I-NP O
111 should MD O O
111 be VB O O
111 treated VBN O O
111 , , O O
111 given VBN O O
111 that IN B-VP O
111 the DT B-NP O
111 DVT NNP I-NP O
111 was VBD B-VP O
111 line NN B-NP O
112 induced VBN O O
112 Coumadin NNP B-NP B-m
112 was VBD B-VP O
112 therapeutic JJ O O
112 on IN B-VP O
112 admission NN B-NP O
112 , , O O
112 became VBD B-VP O
113 supertherapeutic JJ O O
113 in IN B-VP O
113 the DT B-NP O
113 MICU NNP I-NP O
113 Held NNP I-NP O
113 Coumadin NNP I-NP B-m
113 until IN B-VP B-du
113 INR NNP B-NP O
113 fell VBD B-VP O
113 below IN B-VP O
114 3 CD O O
114 , , O O
114 restarted VBN O O
114 Coumadin NNP B-NP B-m
114 afterwards NNS I-NP O
114 at IN B-VP O
114 6 CD O B-do
114 mg NNS B-NP I-do
114 p.o JJ O B-mo
114 daily RB O B-f
114 , , O O
114 patient's NN B-NP O
115 normal JJ B-NP O
115 dose JJ I-NP O
115 Patient NNP I-NP O
115 was VBD B-VP O
115 therapeutic JJ O O
115 on IN B-VP O
115 discharge NN B-NP O
115 Will NNP I-NP O
115 follow VB O O
116 up RP O O
116 with IN B-VP O
116 primary JJ B-NP O
116 care NN I-NP O
116 physician NN I-NP O
116 for IN B-VP O
116 Coumadin NNP B-NP B-m
116 monitoring VBG O O
117 6 CD O O
117 Nutrition NNP B-NP O
117 Patient NNP I-NP O
117 was VBD B-VP O
117 in IN B-VP O
117 the DT B-NP O
117 MICU NNP I-NP O
117 and CC O O
117 was VBD B-VP O
117 n.p.o RB O O
117 given VBN O O
118 abdominal JJ B-NP O
118 pain NN I-NP O
118 and CC O O
118 colitis NN B-NP O
118 When WRB O O
118 transferred VBN O O
118 to TO O O
118 floor NN B-NP O
118 , , O O
118 was VBD B-VP O
119 started VBN O O
119 on IN B-VP O
119 liquid NN B-NP O
119 diet NN I-NP O
119 and CC O O
119 advanced VBD B-VP O
119 to TO O O
119 soft JJ B-NP O
119 solid JJ I-NP O
119 diet NN I-NP O
119 By IN B-VP O
120 discharge NN B-NP O
120 , , O O
120 the DT B-NP O
120 patient NN I-NP O
120 did VBD B-VP O
120 not RB O O
120 have VB O O
120 abdominal JJ B-NP O
120 pain NN I-NP O
120 and CC O O
120 most JJS O O
120 of IN B-VP O
121 the DT B-NP O
121 diarrhea NN I-NP O
121 had VBD B-VP O
121 resolved VBN O O
122 PROCEDURES NNP B-NP O
122 PERFORMED: NNP I-NP O
122 The DT B-NP O
122 patient NN I-NP O
122 had VBD B-VP O
122 a DT B-NP O
122 flexible JJ I-NP O
122 sigmoidoscopy NN I-NP O
123 during IN B-VP O
123 the DT B-NP O
123 admission NN I-NP O
123 that WDT O O
123 showed VBD B-VP O
123 colitis NNS B-NP O
123 consistent JJ O O
123 with IN B-VP O
124 inflammatory JJ B-NP O
124 etiology NN I-NP O
125 DIAGNOSIS: NNP I-NP O
125 Patient NNP I-NP O
125 had VBD B-VP O
125 repeated VBN O O
125 negative JJ B-NP O
125 C NNP I-NP O
125 diff NN I-NP O
125 toxin NN I-NP O
125 assays NNS I-NP O
125 , , O O
126 but CC O O
126 colitis NN B-NP O
126 was VBD B-VP O
126 presumed VBN O O
126 to TO O O
126 be VB O O
126 C NNP B-NP O
126 diff NN I-NP O
126 and CC O O
126 given VBN O O
126 history NN B-NP O
126 , , O O
126 could MD O O
127 have VB O O
127 been VBN O O
127 other JJ O O
127 infectious JJ O O
127 or CC O O
127 inflammatory JJ B-NP O
127 etiologies NNS I-NP O
127 Patient NNP I-NP O
128 continued VBD B-VP O
128 to TO O O
128 improve VB O O
128 on IN B-VP O
128 vancomycin NN B-NP B-m
128 and CC O O
128 thus RB O O
128 was VBD B-VP O
128 discharged VBN O O
128 with IN B-VP O
129 presumed JJ B-NP O
129 C NNP I-NP O
129 diff NN I-NP O
129 colitis NN I-NP O
129 diagnosis NN I-NP O
130 DISCHARGE NNP I-NP O
130 MEDICATIONS: NNP I-NP O
130 Included NNP I-NP O
130 aspirin VBD B-VP B-m
130 81 CD O B-do
130 mg NNS B-NP I-do
130 p.o JJ O B-mo
130 daily RB O B-f
130 , , O O
130 Plavix NNP B-NP B-m
131 75 CD O B-do
131 mg NN B-NP I-do
131 p.o JJ O B-mo
131 daily RB O B-f
131 , , O O
131 digoxin NN B-NP B-m
131 0.125 CD O B-do
131 mg NN B-NP I-do
131 p.o JJ O B-mo
131 daily RB O B-f
131 , , O O
131 Nexium NNP B-NP B-m
131 20 CD O B-do
131 mg NN B-NP I-do
131 p.o JJ O B-mo
132 daily RB O B-f
132 , , O O
132 Flovent NNP B-NP B-m
132 110 CD O B-do
132 mcg NN B-NP I-do
132 inhale NN I-NP B-mo
132 b.i.d NN I-NP B-f
132 , , O O
132 Lasix NNP B-NP B-m
132 40 CD O B-do
132 mg NN B-NP I-do
132 p.o JJ O B-mo
132 daily RB O B-f
132 , , O O
133 lactobacillus CC O B-m
133 2 CD O B-do
133 tabs NNS B-NP I-do
133 p.o JJ B-NP B-mo
133 t.i.d NN I-NP B-f
133 , , O O
133 metoprolol FW O B-m
133 25 CD O B-do
133 mg NN B-NP I-do
133 p.o NN I-NP B-mo
133 b.i.d NN I-NP B-f
133 , , O O
134 simvastatin VBD B-VP B-m
134 80 CD O B-do
134 mg NN B-NP I-do
134 p.o NN I-NP B-mo
134 at IN B-VP B-f
134 bed NN B-NP I-f
134 time NN I-NP I-f
134 , , O O
134 Flomax NNP B-NP B-m
134 0.4 CD O B-do
134 mg NN B-NP I-do
134 p.o NN I-NP B-mo
134 every DT B-NP B-f
135 evening NN I-NP O
135 , , O O
135 vancomycin FW O B-m
135 250 CD O B-do
135 mg NN B-NP I-do
135 p.o NN I-NP B-mo
135 every DT O B-f
135 6 CD O I-f
135 hours NNS B-NP I-f
135 x8 JJ B-NP B-du
135 days NNS I-NP I-du
135 at IN B-VP O
136 discharge NN B-NP O
136 and CC O O
136 Coumadin NNP B-NP B-m
136 5 CD O B-do
136 mg NN B-NP I-do
136 p.o NN I-NP B-mo
136 every DT B-NP B-f
136 evening NN I-NP I-f
137 Patient NNP I-NP O
137 had VBD B-VP O
137 to TO O O
137 follow VB O O
137 up RP O O
137 with IN B-VP O
137 primary JJ B-NP O
137 care NN I-NP O
137 physician NN I-NP O
137 , , O O
137 setup NN B-NP O
137 for IN B-VP O
137 2 CD O O
138 to TO O O
138 3 CD O O
138 weeks NNS B-NP O
138 after IN B-VP O
138 discharge NN B-NP O
139 eScription NN I-NP O
139 document: VBZ O O
139 5-3515128 JJ B-NP O
139 HFFocus NNP I-NP O
140 Dictated NNP I-NP O
140 By: NNP I-NP O
140 SOLLOCK NNP I-NP O
140 , , O O
140 SHELTON NNP B-NP O
141 Attending: NNP I-NP O
141 VALLEJOS NNP I-NP O
141 , , O O
141 JAIME NNP B-NP O
141 TERRANCE NNP I-NP O
142 Dictation NNP I-NP O
142 ID NNP I-NP O
142 6974267 CD O O
143 D: NNP B-NP O
143 1/25/06 CD O O
144 T: NNP B-NP O
144 11/21/06 CD O O
145 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #87290 VBZ O O
4 280126400 CD O O
4 BHSH NNP B-NP O
4 01276695 CD O O
4 7973693 CD O O
4 7/15/2007 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 s/p JJ B-NP O
4 pacemaker NN I-NP O
4 placement NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/17/2007 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 0/17/2007 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 FRIGGE NNP I-NP O
8 , , O O
8 ELI NNP B-NP O
8 047-45-81-2 NNP I-NP O
9 S NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 5/2/07 CD O O
11 AT NNP B-NP O
11 03:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 PIEDRA NNP I-NP O
14 , , O O
14 AUGUSTINE NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 LIPITOR NNP I-NP B-m
20 ( ( O I-m
20 ATORVASTATIN NNP B-NP I-m
20 ) ) O I-m
20 80 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 DAILY NNP I-NP B-f
21 CLINDAMYCIN NNP I-NP B-m
21 HCL NNP I-NP I-m
21 300 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QID NNP I-NP B-f
21 X NNP I-NP B-du
21 12 CD O I-du
21 doses NNS B-NP I-du
22 Starting VBG O O
22 after IN B-VP O
22 IV NNP B-NP B-mo
22 ANTIBIOTICS NNP I-NP B-m
22 END NNP I-NP O
23 PLAVIX NNP I-NP B-m
23 ( ( O I-m
23 CLOPIDOGREL NNP B-NP I-m
23 ) ) O I-m
23 75 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 DAILY NNP I-NP B-f
24 COLACE NNP I-NP B-m
24 ( ( O I-m
24 DOCUSATE NNP B-NP I-m
24 SODIUM NNP I-NP I-m
24 ) ) O I-m
24 100 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 BID NNP I-NP B-f
25 NEXIUM NNP I-NP B-m
25 ( ( O I-m
25 ESOMEPRAZOLE NNP B-NP I-m
25 ) ) O I-m
25 40 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 DAILY NNP I-NP B-f
26 GLIPIZIDE NNP I-NP B-m
26 2.5 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 DAILY NNP I-NP B-f
27 LISINOPRIL NNP I-NP B-m
27 5 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 BID NNP I-NP B-f
27 HOLD NNP I-NP O
27 IF: NNP I-NP O
27 SBP NNP I-NP O
27 &lt; VBD B-VP O
27 120 CD O O
28 Alert NNP B-NP O
28 overridden: MD O O
28 Override NNP B-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 3/22/07 CD O O
28 by IN B-VP O
28 : : O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 POTASSIUM NNP I-NP B-m
29 CHLORIDE NNP I-NP I-m
29 &amp; NNP I-NP O
30 LISINOPRIL NNP I-NP B-m
31 POTENTIALLY NNP I-NP O
31 SERIOUS NNP I-NP O
31 INTERACTION: NNP I-NP O
31 POTASSIUM NNP I-NP B-m
31 CHLORIDE NNP I-NP I-m
31 &amp; NNP I-NP O
32 LISINOPRIL NNP I-NP B-m
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: NN B-NP O
32 md NN I-NP O
32 aware JJ B-NP O
33 Previous NNP I-NP O
33 Override NNP I-NP O
33 Notice NNP I-NP O
34 Override NNP I-NP O
34 added VBD B-VP O
34 on IN B-VP O
34 3/22/07 CD O O
34 by IN B-VP O
34 YANCE NNP B-NP O
34 , , O O
34 LAZARO NNP B-NP O
34 S NNP I-NP O
34 , , O O
34 M.D NNP B-NP O
34 , , O O
34 PH.D NNP B-NP O
35 on IN B-VP O
35 order NN B-NP O
35 for IN B-VP O
35 POTASSIUM NNP B-NP B-m
35 CHLORIDE NNP I-NP I-m
35 IV NNP I-NP B-mo
35 ( ( O O
35 ref JJ O O
35 # # O O
35 762756022 CD O O
35 ) ) O O
36 POTENTIALLY NNP B-NP O
36 SERIOUS NNP I-NP O
36 INTERACTION: NNP I-NP O
36 LISINOPRIL NNP I-NP B-m
36 &amp; NNP I-NP O
36 POTASSIUM NNP I-NP B-m
37 CHLORIDE NNP I-NP O
38 POTENTIALLY NNP I-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 LISINOPRIL NNP I-NP B-m
38 &amp; NNP I-NP O
38 POTASSIUM NNP I-NP B-m
39 CHLORIDE NNP I-NP O
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: NN B-NP O
39 md NN I-NP O
39 aware JJ B-NP O
40 REGLAN NNP I-NP B-m
40 ( ( O I-m
40 METOCLOPRAMIDE NNP B-NP I-m
40 HCL NNP I-NP I-m
40 ) ) O I-m
40 10 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 TID NNP I-NP B-f
41 TOPROL NNP I-NP B-m
41 XL NNP I-NP I-m
41 ( ( O I-m
41 METOPROLOL NNP B-NP I-m
41 SUCCINATE NNP I-NP I-m
41 EXTENDED NNP I-NP I-m
41 RELEASE NNP I-NP I-m
41 ) ) O I-m
42 50 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 DAILY NNP I-NP B-f
42 Food/Drug NNP I-NP O
42 Interaction NNP I-NP O
42 Instruction NNP I-NP O
43 Take NNP I-NP O
43 consistently RB O O
43 with IN B-VP O
43 meals NNS B-NP O
43 or CC O O
43 on IN B-VP O
43 empty JJ B-NP O
43 stomach NN I-NP O
44 SENNA NNP I-NP B-m
44 TABLETS NNP I-NP I-m
44 ( ( O I-m
44 SENNOSIDES NNP B-NP I-m
44 ) ) O I-m
44 2 CD O B-do
44 TAB NNP B-NP I-do
44 PO NNP I-NP B-mo
44 BID NNP I-NP B-f
45 DIET: NNP I-NP O
45 House NNP I-NP O
45 / VBD B-VP O
45 Low NNP B-NP O
45 chol/low NN I-NP O
45 sat VBD B-VP O
45 fat JJ B-NP O
46 RETURN NNP I-NP O
46 TO NNP I-NP O
46 WORK: NNP I-NP O
46 Not RB O O
46 Applicable NNP B-NP O
47 FOLLOW NNP I-NP O
47 UP NNP I-NP O
47 APPOINTMENT( NNP I-NP O
47 S NNP I-NP O
47 ): NNP I-NP O
48 Dr NNP I-NP O
48 Colonnese NNP I-NP O
48 ( ( O O
48 cardiac JJ B-NP O
48 cath NN I-NP O
48 ) ) O O
48 813.650-9721 CD O O
48 4/0/07 CD O O
48 @ NN B-NP O
48 11:20am CD O O
48 , , O O
49 Dr NNP B-NP O
49 Neville NNP I-NP O
49 Lemmen NNP I-NP O
49 ( ( O O
49 pcp NN B-NP O
49 ) ) O O
49 10/10/07 CD O O
49 @ $ O O
49 11:45am CD O O
49 , , O O
50 Dr NNP B-NP O
50 Randolph NNP I-NP O
50 Beren NNP I-NP O
50 ( ( O O
50 cardiology NN B-NP O
50 ) ) O O
50 1/15/07 CD O O
50 @ $ O O
50 4:30pm CD O O
50 , , O O
51 Dr NNP B-NP O
51 Woten NNP I-NP O
51 ( ( O O
51 EP-pacemaker NNP B-NP O
51 ) ) O O
51 813.650-9721 CD O O
51 6/9/07 CD O O
51 @ NN B-NP O
51 8:30am CD O O
51 , , O O
52 ALLERGY: NNP B-NP O
52 Penicillins NNP I-NP O
53 ADMIT NNP I-NP O
53 DIAGNOSIS: NNP I-NP O
54 lightheadedness NN I-NP O
54 , , O O
54 hypertension NN B-NP O
55 PRINCIPAL NNP I-NP O
55 DISCHARGE NNP I-NP O
55 DIAGNOSIS NNP I-NP O
55 ;Responsible JJ O O
55 After IN B-VP O
55 Study NNP B-NP O
55 for IN B-VP O
55 Causing NNP B-NP O
55 Admission NNP I-NP O
55 ) ) O O
56 s/p NN B-NP O
56 pacemaker NN I-NP O
56 placement NN I-NP O
57 OTHER NNP I-NP O
57 DIAGNOSIS;Conditions NNP I-NP O
57 , , O O
57 Infections NNP B-NP O
57 , , O O
57 Complications NNP B-NP O
57 , , O O
57 affecting VBG O O
57 Treatment/Stay NNP B-NP O
58 CAD NNP I-NP O
58 s/p VBD B-VP O
58 CABG NNP B-NP O
58 x NNP I-NP O
58 2 CD O O
58 ( ( O O
58 coronary JJ B-NP O
58 artery NN I-NP O
58 disease NN I-NP O
58 ) ) O O
58 , , O O
58 RAS NNP B-NP O
58 c VBZ O O
58 L NNP B-NP O
58 renal JJ B-NP O
58 stent NN I-NP O
58 , , O O
59 bilateral JJ B-NP O
59 common JJ I-NP O
59 iliac JJ I-NP O
59 artery NN I-NP O
59 stents NNS I-NP O
59 , , O O
59 PAF NNP B-NP O
59 ( ( O O
59 paroxysmal JJ B-NP O
59 atrial JJ I-NP O
60 fibrillation NN I-NP O
60 ) ) O O
60 , , O O
60 DM NNP B-NP O
60 ( ( O O
60 diabetes VBZ O O
60 mellitus NN B-NP O
60 ) ) O O
61 OPERATIONS NNP B-NP O
61 AND NNP I-NP O
61 PROCEDURES: NNP I-NP O
62 OTHER NNP I-NP O
62 TREATMENTS/PROCEDURES NNP I-NP O
62 ( ( O O
62 NOT NNP B-NP O
62 IN NNP I-NP O
62 O.R NNP I-NP O
62 ) ) O O
63 pacemaker NN B-NP O
63 placement NN I-NP O
64 BRIEF NNP I-NP O
64 RESUME NNP I-NP O
64 OF NNP I-NP O
64 HOSPITAL NNP I-NP O
64 COURSE: NNP I-NP O
65 CC: NNP I-NP O
65 lightheadedness NN I-NP O
65 , , O O
65 hypertension NN B-NP O
66 HPI: NNP I-NP O
66 83yo CD O O
66 W NNP B-NP O
66 c NN I-NP O
66 4 CD O O
66 recent JJ B-NP O
66 admits NNS I-NP O
66 for IN B-VP O
66 LH NNP B-NP O
66 and CC O O
66 elevated VBD B-VP O
66 BP NNP B-NP O
66 , , O O
66 with IN B-VP O
66 h/o JJ B-NP O
66 paroxysmal JJ I-NP O
67 rapid JJ I-NP O
67 afib NN I-NP O
67 and CC O O
67 tachy-brady JJ B-NP O
67 syndrome NN I-NP O
67 , , O O
67 admitted VBN O O
67 for IN B-VP O
67 LH NNP B-NP O
67 , , O O
67 SBP NNP B-NP O
67 in IN B-VP O
67 190s CD O O
67 No NNP B-NP O
67 CP NNP I-NP O
67 , , O O
68 no DT B-NP O
68 palps NN I-NP O
68 , , O O
68 no DT B-NP O
68 n/v NN I-NP O
68 In IN B-VP O
68 ED NNP B-NP O
68 SBP NNP I-NP O
68 to TO O O
68 170s CD O O
68 to TO O O
68 130s CD O O
68 without IN B-VP O
68 intervention NN B-NP O
68 On IN B-VP O
69 prior JJ B-NP O
69 admits NNS I-NP O
69 has VBZ O O
69 had VBN O O
69 intermittent JJ B-NP O
69 HTN NNP I-NP O
69 , , O O
69 a DT B-NP O
69 fib JJ I-NP O
69 c NN I-NP O
69 RVR NNP I-NP O
69 c NN I-NP O
69 bradycardia/pauses NNS I-NP O
69 c VBP O O
70 lopressor NN B-NP B-m
70 On IN B-VP O
70 last JJ B-NP O
70 admit NN I-NP O
70 , , O O
70 pt NN B-NP O
70 was VBD B-VP O
70 seen VBN O O
70 by IN B-VP O
70 EP NNP B-NP O
70 and CC O O
70 BB NNP B-NP O
70 and CC O O
70 amiodarone NN B-NP B-m
71 were VBD B-VP O
71 stopped VBN O O
71 2/2 CD O O
71 bradycardia/pauses NNS B-NP O
71 with IN B-VP O
71 plan NN B-NP O
71 for IN B-VP O
71 f/u NN B-NP O
71 with IN B-VP O
71 outpatient JJ B-NP O
72 cardiology NN I-NP O
72 Pt NNP I-NP O
72 represents VBZ O O
72 with IN B-VP O
72 similar JJ B-NP O
72 sxs NN I-NP O
72 ( ( O O
72 has VBZ O O
72 not RB O O
72 seen VBN O O
72 cardiologist NN B-NP O
73 yet RB O O
73 ) ) O O
74 PMH: NNP B-NP O
74 CAD NNP I-NP O
74 s/p NN I-NP O
74 CABG NNP I-NP O
74 , , O O
74 RAS NNP B-NP O
74 s/p VBD B-VP O
74 stenting VBG O O
74 x2 NN B-NP O
74 , , O O
74 atherosclerosis NN B-NP O
74 of IN B-VP O
74 abd JJ B-NP O
74 aorta NN I-NP O
74 and CC O O
75 celiac JJ B-NP O
75 artery NN I-NP O
75 , , O O
75 b/l JJ B-NP O
75 common JJ I-NP O
75 iliac NN I-NP O
75 stents NNS I-NP O
75 , , O O
75 afib NN B-NP O
75 , , O O
75 DM NNP B-NP O
76 Home NNP I-NP O
76 Meds: NNP I-NP O
76 ASA NNP I-NP B-m
76 325qd CD O B-do
76 , , O O
76 Lipitor NNP B-NP B-m
76 80qd CD O B-do
76 , , O O
76 plavix NN B-NP B-m
76 75qd CD O B-do
76 , , O O
76 colace NN B-NP B-m
76 100bid CD O B-do
76 , , O O
76 nexium NN B-NP B-m
77 40qd CD O B-do
77 , , O O
77 glipizide RB O B-m
77 2.5qd CD O B-do
77 , , O O
77 lisinopril VBD B-VP B-m
77 5 CD O B-do
77 bid NN B-NP B-f
77 , , O O
77 reglan NN B-NP B-m
77 10tid CD O B-do
77 , , O O
77 mom NN B-NP B-m
77 qhs NN I-NP B-f
78 All: NNP I-NP O
78 PCN--&gt;hives NNP I-NP O
79 SocHx: NNP I-NP O
79 retired; NN I-NP O
79 lives VBZ O O
79 w/son; JJ O O
79 no DT B-NP O
79 etoh/tob/illicits NNS I-NP O
80 STATUS: NNP I-NP O
80 afebrile NN I-NP O
80 , , O O
80 HR NNP B-NP O
80 NSR NNP I-NP O
80 70s CD O O
80 , , O O
80 130s/70s CD O O
81 PROC/STUDIES: NNP B-NP O
82 1/5 CD O O
82 EKG: NNP B-NP O
82 NSR NNP I-NP O
82 , , O O
82 lat JJ B-NP O
82 TW NNP I-NP O
82 flattening VBG O O
82 unchanged JJ O O
83 1/5 CD O O
83 CXR: NNP B-NP O
83 no DT B-NP O
83 acute JJ I-NP O
83 process NN I-NP O
84 1/5 CD O O
84 KUB: NNP B-NP O
84 nonspecific NN I-NP O
84 gas NN I-NP O
84 pattern NN I-NP O
85 1/8 CD O O
85 pacemaker NN B-NP O
85 placement NN I-NP O
86 CONSULTS: NNP I-NP O
86 EP NNP I-NP O
87 Hospital NNP I-NP O
87 course: VBD B-VP O
88 1 CD O O
88 ) ) O O
88 CV: NNP B-NP O
88 HTN: NNP I-NP O
88 Unclear NNP I-NP O
88 precipitant NN I-NP O
88 for IN B-VP O
88 intermittent NN B-NP O
88 HTN NNP I-NP O
88 - : O O
88 ?2/2 JJ O O
88 renal JJ O O
89 known VBN O O
89 renal JJ B-NP O
89 artery NN I-NP O
89 stenosis NN I-NP O
89 , , O O
89 HR NNP B-NP O
89 lability NN I-NP O
89 , , O O
89 autonomic JJ B-NP O
89 syndrome NN I-NP O
90 Given NNP I-NP O
90 h/o VBD B-VP O
90 tachy-brady JJ O O
90 and CC O O
90 difficult JJ O O
90 to TO O O
90 control VB O O
90 afib JJ B-NP O
90 w/bradycardia NN I-NP O
90 and CC O O
91 documented JJ B-NP O
91 pauses NNS I-NP O
91 , , O O
91 EP NNP B-NP O
91 was VBD B-VP O
91 consulted VBN O O
91 and CC O O
91 a DT B-NP O
91 dual JJ I-NP O
91 chamber NN I-NP O
91 GUIDANT NNP I-NP O
91 pacemaker NN I-NP O
92 inserted VBD B-VP O
92 without IN B-VP O
92 difficulty NN B-NP O
92 on IN B-VP O
92 10/13 CD O O
92 - : O O
92 programmed VBN O O
92 to TO O O
92 DDI NNP B-NP O
92 60 CD O O
92 mode NN B-NP O
92 BB NNP I-NP B-m
92 was VBD B-VP O
93 initiated VBN O O
93 and CC O O
93 plan NN B-NP O
93 to TO O O
93 continue VB O O
93 Toprol NNP B-NP B-m
93 XL NNP I-NP I-m
93 upon IN B-VP O
93 discharge NN B-NP O
93 Plan NN I-NP O
93 to TO O O
93 continue VB O O
94 clindamycin JJ B-NP B-m
94 qid NN I-NP B-f
94 to TO O O
94 complete VB O O
94 3 CD O B-du
94 day NN B-NP I-du
94 course NN I-NP I-du
94 and CC O O
94 to TO O O
94 f/u VB O O
94 with IN B-VP O
94 EP NNP B-NP O
94 in IN B-VP O
94 2wks CD O O
94 Upon IN B-VP O
95 discharge NN B-NP O
95 , , O O
95 pt's NN B-NP O
95 hr NN I-NP O
95 60 CD O O
95 , , O O
95 bp VBD B-VP O
95 130s/70s CD O O
96 Anticoagulation-discussion NN B-NP O
96 on IN B-VP O
96 previous JJ B-NP O
96 admit NN I-NP O
96 initiated VBN O O
96 with IN B-VP O
96 cardiology NN B-NP O
97 who WP O O
97 recommended VBD B-VP O
97 dc'ing VBG O O
97 Aspirin NNP B-NP B-m
97 and CC O O
97 adding VBG O O
97 Coumadin NNP B-NP B-m
97 with IN B-VP O
97 Plavix NNP B-NP B-m
97 for IN B-VP O
98 anticoagulation NN B-NP B-r
98 anticoagulation NN I-NP B-r
98 , , O O
98 but CC O O
98 deferred VBD B-VP O
98 decision NN B-NP O
98 to TO O O
98 pt's VB O O
98 outpatient JJ B-NP O
98 cardiologist NN I-NP O
99 Dr NNP I-NP O
99 Duenke NNP I-NP O
99 Plan NNP I-NP O
99 for IN B-VP O
99 this DT B-NP O
99 admission NN I-NP O
99 is VBZ O O
99 the DT B-NP O
99 same- JJ I-NP O
99 continue NN I-NP O
99 pt's NN I-NP O
99 home NN I-NP O
99 ASA NNP I-NP B-m
99 and CC O O
100 Plavix NNP B-NP B-m
100 now RB O O
100 , , O O
100 with IN B-VP O
100 plan NN B-NP O
100 to TO O O
100 f/u VB O O
100 with IN B-VP O
100 Dr NNP B-NP O
100 Breck NNP I-NP O
100 for IN B-VP O
100 discussion NN B-NP O
100 of IN B-VP O
100 risks/benefits NNS B-NP O
101 of IN B-VP O
101 initiating VBG O O
101 coumadin JJ O B-m
102 2 CD O O
102 ) ) O O
102 Heme+ NNP B-NP O
102 stool: JJ B-NP O
102 Trace NNP I-NP O
102 in IN B-VP O
102 ED NNP B-NP O
102 , , O O
102 HCT NNP B-NP O
102 stable JJ B-NP O
102 Got NNP I-NP O
102 IV NNP I-NP B-mo
102 nexium NN I-NP B-m
102 , , O O
102 IVF NNP B-NP O
102 , , O O
102 large JJ B-NP O
102 bore NN I-NP O
103 IVs NNP I-NP O
103 initially RB O O
103 but CC O O
103 no DT B-NP O
103 melena NN I-NP O
103 Hct NNP I-NP O
103 remained VBD B-VP O
103 stable JJ O O
103 throughout IN B-VP O
103 hospital JJ B-NP O
104 course NN I-NP O
104 Would NNP I-NP O
104 recommend VB O O
104 outpatient JJ B-NP O
104 colonoscopy NN I-NP O
104 for IN B-VP O
104 further JJ B-NP O
104 evaluation NN I-NP O
105 3 CD O O
105 ) ) O O
105 DM: NNP B-NP O
105 while IN B-VP B-du
105 in-house NN B-NP I-du
105 , , O O
105 pt NN B-NP O
105 was VBD B-VP O
105 started VBN O O
105 on IN B-VP O
105 NPH NNP B-NP B-m
105 and CC O O
105 RISS; NNP B-NP B-m
105 plan NN I-NP O
105 to TO O O
105 resume VB O O
106 home NN B-NP B-m
106 meds NNS I-NP I-m
106 upon IN B-VP O
106 discharge NN B-NP O
107 4 CD O O
107 ) ) O O
107 Renal JJ B-NP O
107 artery NN I-NP O
107 stenosis NN I-NP O
107 - : O O
107 s/p NN B-NP O
107 stenting VBG O O
107 x $ O O
107 2 CD O O
107 Cr NNP B-NP O
107 at IN B-VP O
107 baseline NN B-NP O
108 5 CD O O
108 ) ) O O
108 Constipation: NNP B-NP O
108 pt NN I-NP O
108 came VBD B-VP O
108 in IN B-VP O
108 with IN B-VP O
108 constipation NN B-NP B-r
108 constipation NN I-NP B-r
108 with IN B-VP O
108 no DT B-NP O
108 bm NN I-NP O
108 x1wk VBZ O O
108 pta JJ B-NP O
109 Dulcolax NNP I-NP B-m
109 and CC O O
109 stool JJ B-NP B-m
109 softeners NNS I-NP I-m
109 given VBN O O
109 with IN B-VP O
109 good JJ B-NP O
109 response NN I-NP O
109 Plan NN I-NP O
109 to TO O O
109 cont VB O O
109 stool NN B-NP B-m
110 softeners NNS I-NP O
110 upon IN B-VP O
110 discharge NN B-NP O
111 6 CD O O
111 ) ) O O
111 Code: NNP B-NP O
111 DNI NNP I-NP O
111 , , O O
111 not RB O O
111 DNR NNP B-NP O
112 ADDITIONAL NNP I-NP O
112 COMMENTS: NNP I-NP O
112 For IN B-VP O
112 VNA: NNP B-NP O
112 pls NN I-NP O
112 check NN I-NP O
112 pt's NN I-NP O
112 vital JJ B-NP O
112 signs NNS I-NP O
112 , , O O
112 cardiopulmonary JJ B-NP O
112 assessment NN I-NP O
112 , , O O
112 assist NN B-NP O
113 with IN B-VP O
113 medications NNS B-NP O
114 For IN B-VP O
114 Pt: NNP B-NP O
115 1 CD O O
115 Please NNP B-NP O
115 continue VB O O
115 to TO O O
115 take VB O O
115 the DT B-NP O
115 antibiotic JJ I-NP B-m
115 antibiotic JJ I-NP B-m
115 Clindamycin NNP I-NP I-m
115 Clindamycin NNP I-NP B-m
115 until IN B-VP B-du
115 until IN B-VP B-du
115 until IN B-VP B-du
115 you PRP O O
115 run VBP O O
115 out IN B-VP O
116 of IN B-VP O
116 pills NNS B-NP O
117 2 CD O O
117 Please NNP B-NP O
117 call VB O O
117 your PRP$ O O
117 doctor NN B-NP O
117 or CC O O
117 go VB O O
117 to TO O O
117 the DT B-NP O
117 nearest JJS I-NP O
117 ER NN I-NP O
117 if IN B-VP O
117 you PRP O O
117 have VBP O O
118 fever&gt;100.4 VBN O O
118 , , O O
118 chills NNS B-NP O
118 , , O O
118 nausea NN B-NP O
118 , , O O
118 vomiting VBG O O
118 , , O O
118 chest JJS B-NP O
118 pain NN I-NP O
118 , , O O
118 shortness NN B-NP O
118 of IN B-VP O
118 breath NN B-NP O
118 or CC O O
119 anything NN B-NP O
119 else RB O O
119 concerning VBG O O
119 to TO O O
119 you PRP O O
120 3 CD O O
120 Continue NNP B-NP O
120 stool NN I-NP B-m
120 softeners NNS I-NP I-m
120 for IN B-VP O
120 constipation NN B-NP B-r
120 Resume NNP I-NP O
120 all DT B-NP O
120 home NN I-NP B-m
120 meds NNS I-NP I-m
121 DISCHARGE NNP I-NP O
121 CONDITION: NNP I-NP O
121 Stable NNP I-NP O
122 TO NNP I-NP O
122 DO/PLAN: NNP I-NP O
123 No NNP I-NP O
123 dictated VBD B-VP O
123 summary JJ B-NP O
124 ENTERED NNP I-NP O
124 BY: NNP I-NP O
124 BRIDENBECKER NNP I-NP O
124 , , O O
124 PIERRE NNP B-NP O
124 J NNP I-NP O
124 , , O O
124 MD NNP B-NP O
124 ( ( O O
124 QN41 NNP B-NP O
124 ) ) O O
124 5/2/07 CD O O
124 @ $ O O
124 03:16 CD O O
124 PM NNP B-NP O
125 ****** JJ B-NP O
125 END NNP I-NP O
125 OF NNP I-NP O
125 DISCHARGE NNP I-NP O
125 ORDERS NNP I-NP O
125 ****** NNP I-NP O
126 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #89464 VBZ O O
4 555294245 CD O O
4 HMC NNP B-NP O
4 78160786 CD O O
4 533045 CD O O
4 8/20/1999 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 8/20/1999 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 8/20/1999 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 BILATERAL NNP I-NP O
7 LOWER NNP I-NP O
7 EXTREMITY NNP I-NP O
7 WEAKNESS NNP I-NP O
8 OTHER NNP I-NP O
8 PROBLEMS: NNP I-NP O
9 1 CD O O
9 HISTORY NNP B-NP O
9 OF NNP I-NP O
9 MORBID NNP I-NP O
9 OBESITY NNP I-NP O
10 2 CD O O
10 OBSTRUCTIVE NNP B-NP O
10 SLEEP NNP I-NP O
10 APNEA NNP I-NP O
11 3 CD O O
11 ATRIAL NNP B-NP O
11 FIBRILLATION NNP I-NP O
12 4 CD O O
12 HISTORY NNP B-NP O
12 OF NNP I-NP O
12 CELLULITIS NNP I-NP O
13 5 CD O O
13 EJECTION NNP B-NP O
13 FRACTION NNP I-NP O
13 OF IN B-VP O
13 40 CD O O
13 PERCENT NN B-NP O
13 WITH NNP I-NP O
13 LEFT NNP I-NP O
13 ATRIAL NNP I-NP O
13 ENLARGEMENT NNP I-NP O
14 6 CD O O
14 URINARY NNP B-NP O
14 TRACT NNP I-NP O
14 INFECTION NNP I-NP O
15 CHIEF NNP I-NP O
15 COMPLAINT: NNP I-NP O
15 Mr NNP I-NP O
15 Foller NNP I-NP O
15 is VBZ O O
15 a DT O O
15 very RB O O
15 pleasant JJ O O
15 59 CD O O
15 year-old JJ B-NP O
15 man NN I-NP O
15 who WP O O
16 presents VBZ O O
16 with IN B-VP O
16 a DT B-NP O
16 history NN I-NP O
16 of IN B-VP O
16 morbid NN B-NP O
16 obesity NN I-NP O
16 , , O O
17 paroxysmal JJ B-NP O
17 atrial JJ I-NP O
17 fibrillation NN I-NP O
17 and CC O O
17 ejection NN B-NP O
17 fraction NN I-NP O
17 of IN B-VP O
17 40 CD O O
17 percent NN B-NP O
18 who WP O O
18 presents VBZ O O
18 status NN B-NP O
18 post NN I-NP O
18 a DT B-NP O
18 fall NN I-NP O
18 and CC O O
18 with IN B-VP O
18 increasing VBG O O
18 urinary JJ B-NP O
19 frequency NN I-NP O
20 HISTORY NNP I-NP O
20 OF NNP I-NP O
20 PRESENT NNP I-NP O
20 ILLNESS: NNP I-NP O
20 Mr NNP I-NP O
20 Neilsen NNP I-NP O
20 has VBZ O O
20 morbid VBN O O
20 obesity NN B-NP O
20 and CC O O
20 is VBZ O O
21 currently RB O O
21 at IN B-VP O
21 a DT B-NP O
21 weight NN I-NP O
21 of IN B-VP O
21 450 CD O O
21 pounds NNS B-NP O
22 and CC O O
22 also RB O O
22 has VBZ O O
22 a DT B-NP O
22 history NN I-NP O
22 of IN B-VP O
22 fluctuating VBG O O
22 weight NN B-NP O
22 with IN B-VP O
22 decrease NN B-NP O
22 in IN B-VP O
23 weight NN B-NP O
23 to TO O O
23 200 CD O O
23 pounds NNS B-NP O
23 with IN B-VP O
23 dieting VBG O O
23 He PRP O O
23 also RB O O
23 has VBZ O O
23 obstructive JJ B-NP O
23 sleep JJ I-NP O
24 apnea NN I-NP O
24 on IN B-VP O
24 continuous JJ B-NP O
24 positive JJ I-NP O
24 airway NN I-NP O
24 pressure NN I-NP O
24 , , O O
24 history NN B-NP O
24 of IN B-VP O
24 atrial JJ B-NP O
25 fibrillation NN I-NP O
25 and CC O O
25 is VBZ O O
25 not RB O O
25 anticoagulated VBN O O
25 per IN B-VP O
25 his PRP$ O O
25 primary JJ B-NP O
25 care NN I-NP O
26 physician NN I-NP O
26 He PRP O O
26 has VBZ O O
26 a DT O O
26 mildly RB O O
26 decreased JJ B-NP O
26 ejection NN I-NP O
26 fraction NN I-NP O
26 with IN B-VP O
26 mitral JJ B-NP O
27 regurgitation NN I-NP O
27 and CC O O
27 a DT B-NP O
27 history NN I-NP O
27 of IN B-VP O
27 cellulitis NN B-NP O
27 He PRP O O
27 presented VBD B-VP O
27 in IN B-VP O
27 4/10 CD O O
28 for IN B-VP O
28 a DT B-NP O
28 short JJ I-NP O
28 stay NN I-NP O
28 unit NN I-NP O
28 admission NN I-NP O
28 with IN B-VP O
28 progressive JJ B-NP O
28 lower JJR I-NP O
28 extremity NN I-NP O
29 weakness NN I-NP O
29 bilaterally RB O O
29 and CC O O
29 urinary JJ B-NP O
29 incontinence NN I-NP O
29 It PRP O O
29 was VBD B-VP O
29 felt VBN O O
29 at IN B-VP O
29 that DT B-NP O
30 time NN I-NP O
30 by IN B-VP O
30 neurosurgery NN B-NP O
30 and CC O O
30 neurology NN B-NP O
30 to TO O O
30 be VB O O
30 multifactorial JJ O O
30 and CC O O
30 no DT O O
31 consistent JJ O O
31 with IN B-VP O
31 disk NN B-NP O
31 or CC O O
31 cord NN B-NP O
31 impingement NN I-NP O
31 There EX O O
31 was VBD B-VP O
31 a DT B-NP O
31 work NN I-NP O
31 up RB O O
31 at IN B-VP O
32 that DT B-NP O
32 time NN I-NP O
32 including VBG O O
32 B12 NNP B-NP O
32 , , O O
32 ANA NNP B-NP O
32 and CC O O
32 HIV NNP B-NP O
32 all DT O O
32 of IN B-VP O
32 which WDT O O
32 were VBD B-VP O
32 negative JJ B-NP O
33 EMG NNP I-NP O
33 showed VBD B-VP O
33 decreased JJ B-NP O
33 recruitment NN I-NP O
33 in IN B-VP O
33 the DT B-NP O
33 tibialis NN I-NP O
33 anterior NN I-NP O
33 and CC O O
34 gastrocnemius NN B-NP O
34 bilaterally RB O O
34 His PRP$ O O
34 rectus NN B-NP O
34 femoris NN I-NP O
34 were VBD B-VP O
34 normal JJ O O
35 bilaterally RB O O
35 He PRP O O
35 was VBD B-VP O
35 treated VBN O O
35 for IN B-VP O
35 a DT B-NP B-r
35 urinary JJ I-NP I-r
35 tract NN I-NP I-r
35 infection NN I-NP I-r
35 at IN B-VP O
35 that DT B-NP O
36 time NN I-NP O
36 with IN B-VP O
36 Bactrim NNP B-NP B-m
36 Bactrim NNP I-NP B-m
36 for IN B-VP O
36 resolution NN B-NP O
36 of IN B-VP O
36 his PRP$ O B-r
36 incontinence NN B-NP I-r
36 and CC O O
36 he PRP O O
36 was VBD B-VP O
36 not RB O O
37 anticoagulated VBN O O
37 by IN B-VP O
37 his PRP$ O O
37 primary JJ B-NP O
37 care NN I-NP O
37 physician NN I-NP O
37 Since IN B-VP O
37 discharge NN B-NP O
37 he PRP O O
38 noted VBD B-VP O
38 continued JJ O O
38 right RB O O
38 greater JJR O O
38 than IN B-VP O
38 left VBD B-VP O
38 lower JJR B-NP O
38 extremity NN I-NP O
38 weakness NN I-NP O
39 otherwise RB O O
39 at IN B-VP O
39 baseline NN B-NP O
39 health NN I-NP O
39 until IN B-VP O
39 two CD O O
39 weeks NNS B-NP O
39 prior RB O O
39 to TO O O
39 admission NN B-NP O
40 when WRB O O
40 he PRP O O
40 noted VBD B-VP O
40 some DT B-NP O
40 lumbar NN I-NP O
40 and CC O O
40 sacral JJ B-NP O
40 pain NN I-NP O
40 , , O O
40 nonradiating NN B-NP O
40 , , O O
40 worse JJR O O
41 while IN B-VP O
41 moving VBG O O
41 his PRP$ O O
41 right NN B-NP O
41 leg NN I-NP O
41 Over IN B-VP O
41 the DT B-NP O
41 past JJ I-NP O
41 few JJ I-NP O
41 days NNS I-NP O
41 he PRP O O
41 noted VBD B-VP O
41 also RB O O
42 increasing VBG O O
42 urinary JJ B-NP O
42 frequency NN I-NP O
42 without IN B-VP O
42 burning VBG O O
42 or CC O O
42 urinary JJ B-NP O
43 incontinence NN I-NP O
43 , , O O
43 no DT B-NP O
43 fever NN I-NP O
43 or CC O O
43 chills NNS B-NP O
43 and CC O O
43 no DT B-NP O
43 costovertebral JJ I-NP O
43 angle NN I-NP O
44 tenderness NN I-NP O
44 or CC O O
44 pain NN B-NP O
44 No DT B-NP O
44 bowel NN I-NP O
44 incontinence NN I-NP O
44 or CC O O
44 perianal JJ B-NP O
44 numbness NN I-NP O
44 or CC O O
45 pain VB O O
45 The DT B-NP O
45 night NN I-NP O
45 of IN B-VP O
45 admission NN B-NP O
45 , , O O
45 at IN B-VP O
45 7:30 CD O O
45 p.m NN B-NP O
45 while IN B-VP O
45 getting VBG O O
45 up RP O O
45 from IN B-VP O
45 a DT B-NP O
46 chair NN I-NP O
46 , , O O
46 his PRP$ O O
46 right JJ B-NP O
46 leg NN I-NP O
46 gave VBD B-VP O
46 out RB O O
46 and CC O O
46 he PRP O O
46 fell VBD B-VP O
46 to TO O O
46 the DT B-NP O
46 floor NN I-NP O
46 "gracefully" NN I-NP O
47 without IN B-VP O
47 injury NN B-NP O
47 or CC O O
47 head NN B-NP O
47 trauma NN I-NP O
47 , , O O
47 no DT B-NP O
47 loss NN I-NP O
47 of IN B-VP O
47 consciousness NN B-NP O
47 He PRP O O
47 had VBD B-VP O
47 no DT B-NP O
48 preceeding NN I-NP O
48 dizziness NN I-NP O
48 , , O O
48 chest NN B-NP O
48 pain NN I-NP O
48 , , O O
48 shortness NN B-NP O
48 of IN B-VP O
48 breath NN B-NP O
48 or CC O O
49 paresthesia NN B-NP O
49 and CC O O
49 presented VBN O O
49 to TO O O
49 the DT B-NP O
49 Emergency NNP I-NP O
49 Room NNP I-NP O
49 at IN B-VP O
49 the DT B-NP O
49 Onven NNP I-NP O
49 County NNP I-NP O
49 Hospital NNP I-NP O
50 PAST NNP I-NP O
50 MEDICAL NNP I-NP O
50 HISTORY: NNP I-NP O
50 As IN B-VP O
50 above IN B-VP O
51 ALLERGIES: NNP B-NP O
51 Penicillin NNP I-NP O
51 gives VBZ O O
51 him PRP O O
51 hives VBZ O O
52 SOCIAL NNP B-NP O
52 HISTORY: NNP I-NP O
52 He PRP O O
52 is VBZ O O
52 a DT B-NP O
52 psychology NN I-NP O
52 Professor NNP I-NP O
52 , , O O
52 therapist NN B-NP O
52 , , O O
52 former JJ B-NP O
53 illicit NNS I-NP O
53 drug NN I-NP O
53 use NN I-NP O
53 including VBG O O
53 LSD NNP B-NP O
53 No NNP I-NP O
53 history NN I-NP O
53 of IN B-VP O
54 tobacco NN B-NP O
54 use NN I-NP O
54 , , O O
54 currently RB O O
54 Rare NNP B-NP O
54 alcohol NN I-NP O
54 use NN I-NP O
54 and CC O O
54 lives NNS B-NP O
54 with IN B-VP O
54 his PRP$ O O
54 wife NN B-NP O
55 of IN B-VP O
55 15 CD O O
55 years NNS B-NP O
56 FAMILY NNP I-NP O
56 HISTORY: NNP I-NP O
56 Varicose NNP I-NP O
56 veins NNS I-NP O
56 , , O O
56 early JJ B-NP O
56 coronary JJ I-NP O
56 artery NN I-NP O
56 disease NN I-NP O
56 in IN B-VP O
56 a DT B-NP O
57 brother NN I-NP O
57 who WP O O
57 was VBD B-VP O
57 50 CD O O
57 years NNS B-NP O
57 old JJ O O
57 His PRP$ O O
57 parents NNS B-NP O
57 passed VBN O O
58 away RB O O
58 in IN B-VP O
58 a DT B-NP O
58 motor NN I-NP O
58 vehicle NN I-NP O
58 accident NN I-NP O
58 No NNP I-NP O
58 history NN I-NP O
58 of IN B-VP O
58 clots NNS B-NP O
59 PHYSICAL NNP I-NP O
59 EXAM: NNP I-NP O
59 The DT B-NP O
59 patient NN I-NP O
59 is VBZ O O
59 a DT O O
59 morbidly RB O O
59 obese JJ B-NP O
59 man NN I-NP O
59 in IN B-VP O
59 no DT B-NP O
59 acute NN I-NP O
60 distress NN I-NP O
60 , , O O
60 sitting VBG O O
60 in IN B-VP O
60 a DT B-NP O
60 chair NN I-NP O
60 Vital NNP I-NP O
60 signs NNS I-NP O
60 showed VBD B-VP O
61 temperature NN B-NP O
61 of IN B-VP O
61 97.1 CD O O
61 , , O O
61 pulse RB O O
61 80 CD O O
61 , , O O
61 blood NN B-NP O
61 pressure NN I-NP O
61 148/90 CD O O
61 , , O O
61 oxygen NN B-NP O
62 saturation NN I-NP O
62 96% CD O O
62 on IN B-VP O
62 room NN B-NP O
62 air NN I-NP O
62 with IN B-VP O
62 a DT B-NP O
62 respiratory JJ I-NP O
62 rate NN I-NP O
62 of IN B-VP O
62 20 CD O O
62 HEENT: NNP B-NP O
63 Obese NNP I-NP O
63 neck NN I-NP O
63 Pupils NNP I-NP O
63 equal JJ O O
63 , , O O
63 round NN B-NP O
63 and CC O O
63 reactive JJ O O
63 to TO O O
63 light JJ O O
63 and CC O O
64 accommodation NN B-NP O
64 No NNP I-NP O
64 conjunctivitis NN I-NP O
64 Oropharynx NNP I-NP O
64 is VBZ O O
64 clear JJ B-NP O
64 Mucous JJ I-NP O
65 membranes NNS I-NP O
65 were VBD B-VP O
65 moist JJ B-NP O
65 Jugular NNP I-NP O
65 venous JJ B-NP O
65 distention NN I-NP O
65 not RB O O
65 appreciated VBN O O
66 CHEST: NNP B-NP O
66 Clear NNP I-NP O
66 to TO O O
66 auscultation VB O O
66 bilaterally RB O O
66 HEART: NNP B-NP O
66 II/VI NNP I-NP O
66 systolic JJ B-NP O
67 ejection NN I-NP O
67 murmur NN I-NP O
67 at IN B-VP O
67 the DT B-NP O
67 apex NN I-NP O
67 radiating VBG O O
67 to TO O O
67 the DT B-NP O
67 axilla NN I-NP O
67 Irregular NNP I-NP O
67 , , O O
68 irregular JJ B-NP O
68 rhythm NN I-NP O
68 No NNP I-NP O
68 S3 NNP I-NP O
68 or CC O O
68 S4 NNP B-NP O
68 ABDOMEN: NNP I-NP O
68 Obese NNP I-NP O
68 , , O O
68 soft JJ O O
68 and CC O O
69 nontender JJ B-NP O
69 ABDOMEN: NNP I-NP O
69 Obese NNP I-NP O
69 , , O O
69 soft JJ O O
69 and CC O O
69 nontender NN B-NP O
69 Nondistended VBD B-VP O
69 with IN B-VP O
70 positive JJ B-NP O
70 bowel NN I-NP O
70 sounds NNS I-NP O
70 and CC O O
70 a DT B-NP O
70 significant JJ I-NP O
70 rash NN I-NP O
70 of IN B-VP O
70 his PRP$ O O
70 pannus NN B-NP O
71 RECTAL: NNP I-NP O
71 Strong NNP I-NP O
71 rectal JJ B-NP O
71 tone NN I-NP O
71 EXTREMITIES: NNP I-NP O
71 Right NNP I-NP O
71 calf NN I-NP O
71 was VBD B-VP O
71 with IN B-VP O
71 a DT B-NP O
72 shallow NN I-NP O
72 , , O O
72 erythematous JJ B-NP O
72 dry JJ I-NP O
72 ulcer NN I-NP O
72 which WDT O O
72 was VBD B-VP O
72 chronic JJ O O
72 with IN B-VP O
72 changes NNS B-NP O
73 consistent JJ O O
73 with IN B-VP O
73 venous JJ B-NP O
73 insufficiency NN I-NP O
73 and CC O O
73 varicose JJ B-NP O
73 veins NNS I-NP O
74 NEUROLOGICAL: NNP I-NP O
74 Nonfocal NNP I-NP O
74 Strength NNP I-NP O
74 in IN B-VP O
74 the DT B-NP O
74 right JJ I-NP O
74 hip NN I-NP O
74 flexor NN I-NP O
74 was VBD B-VP O
75 decreased VBN O O
75 to TO O O
75 4/5 CD O O
75 and CC O O
75 on IN B-VP O
75 the DT O O
75 right JJ O O
75 his PRP$ O O
75 plantar NN B-NP O
75 dorsiflexion NN I-NP O
75 strength NN I-NP O
76 was VBD B-VP O
76 4/5 CD O O
76 bilaterally RB O O
76 Sensation NNP B-NP O
76 was VBD B-VP O
76 grossly RB O O
76 intact JJ O O
76 to TO O O
76 touch VB O O
77 Finger-to-nose NNP B-NP O
77 was VBD B-VP O
77 normal JJ B-NP O
78 LABORATORY NNP I-NP O
78 DATA NNP I-NP O
78 ON NNP I-NP O
78 ADMISSION: NNP I-NP O
78 Sodium NNP I-NP O
78 140 CD O O
78 , , O O
78 potassium NN B-NP O
78 4.5 CD O O
78 , , O O
78 chloride RB O O
79 102 CD O O
79 , , O O
79 bicarbonate NN B-NP O
79 26 CD O O
79 , , O O
79 BUN NNP B-NP O
79 20 CD O O
79 , , O O
80 creatinine NN B-NP O
80 0.9 CD O O
80 , , O O
80 glucose RB O O
80 101 CD O O
80 He PRP O O
80 had VBD B-VP O
80 a DT B-NP O
80 white JJ I-NP O
80 blood NN I-NP O
80 cell NN I-NP O
80 count NN I-NP O
80 of IN B-VP O
80 9 CD O O
81 with IN B-VP O
81 76 CD O O
81 polys NNS B-NP O
81 , , O O
81 4 CD O O
81 bands NNS B-NP O
81 , , O O
81 hematocrit NN B-NP O
81 37.6 CD O O
81 and CC O O
81 a DT B-NP O
81 platelet NN I-NP O
81 count NN I-NP O
81 of IN B-VP O
82 236 CD O O
82 His PRP$ O O
82 urinalysis NN B-NP O
82 showed VBD B-VP O
82 3+ CD O O
82 blood NN B-NP O
82 and CC O O
82 positive JJ B-NP O
82 leukocyte NN I-NP O
83 esterase NN I-NP O
83 with IN B-VP O
83 15-20 JJ B-NP O
83 white JJ I-NP O
83 blood NN I-NP O
83 cells NNS I-NP O
83 , , O O
83 one CD O O
83 plus CC O O
83 bacteria NNS B-NP O
83 and CC O O
83 one CD O O
84 plus CC O O
84 squamous JJ B-NP O
84 cells NNS I-NP O
85 HOSPITAL NNP I-NP O
85 COURSE: NNP I-NP O
85 1 CD O O
85 Neurological: NNP B-NP O
85 The DT B-NP O
85 neurology NN I-NP O
85 service NN I-NP O
85 came VBD B-VP O
85 by IN B-VP O
86 to TO O O
86 see VB O O
86 the DT B-NP O
86 patient NN I-NP O
86 in IN B-VP O
86 the DT B-NP O
86 Emergency NNP I-NP O
86 Room NNP I-NP O
86 and CC O O
86 felt VBD B-VP O
87 that IN B-VP O
87 there EX O O
87 was VBD B-VP O
87 no DT B-NP O
87 acute JJ I-NP O
87 neurologic JJ I-NP O
87 change NN I-NP O
87 but CC O O
87 if IN B-VP O
87 the DT B-NP O
87 patient NN I-NP O
87 was VBD B-VP O
88 unable JJ O O
88 to TO O O
88 walk VB O O
88 he PRP O O
88 should MD O O
88 be VB O O
88 sent VBN O O
88 to TO O O
88 rehabilitation NN B-NP O
88 They PRP O O
88 saw VBD B-VP O
88 no DT B-NP O
89 new JJ I-NP O
89 acute NN I-NP O
89 change NN I-NP O
89 and CC O O
89 he PRP O O
89 should MD O O
89 continue VB O O
89 to TO O O
89 be VB O O
89 followed VBN O O
89 by IN B-VP O
89 neurology NN B-NP O
90 in IN B-VP O
90 clinic JJ O O
91 2 CD O O
91 Cardiac: NNPS B-NP O
91 He PRP O O
91 does VBZ O O
91 have VB O O
91 a DT B-NP O
91 history NN I-NP O
91 of IN B-VP O
91 paroxysmal JJ B-NP O
91 atrial JJ I-NP O
92 fibrillation NN I-NP O
92 and CC O O
92 echocardiogram NN B-NP O
92 with IN B-VP O
92 decreased JJ B-NP O
92 ejection NN I-NP O
92 fraction NN I-NP O
93 was VBD B-VP O
93 noted VBN O O
93 previously RB O O
93 He PRP O O
93 will MD O O
93 be VB O O
93 started VBN O O
93 on IN B-VP O
93 a DT B-NP O
93 trial NN I-NP O
93 of IN B-VP O
93 Lasix NNP B-NP B-m
93 p.o JJ O B-mo
94 q RB O B-f
94 day NN B-NP I-f
94 to TO O O
94 decrease VB O O
94 his PRP$ O B-r
94 peripheral JJ B-NP I-r
94 edema NN I-NP I-r
94 to TO O O
94 help VB O O
94 him PRP O O
94 with IN B-VP O
95 rehabilitation NN B-NP O
95 and CC O O
95 his PRP$ O O
95 primary JJ B-NP O
95 care NN I-NP O
95 physician NN I-NP O
95 will MD O O
95 continue VB O O
95 to TO O O
96 follow VB O O
96 him PRP O O
96 for IN B-VP O
96 his PRP$ O O
96 atrial JJ B-NP O
96 fibrillation NN I-NP O
96 and CC O O
96 he PRP O O
96 does VBZ O O
96 elect VB O O
96 not RB O O
96 to TO O O
97 anticoagulate VB O O
97 him PRP O O
97 at IN B-VP O
97 the DT B-NP O
97 moment NN I-NP O
97 though IN B-VP O
97 Coumadin NNP B-NP B-m
97 should MD O O
97 be VB O O
97 a DT B-NP O
98 consideration NN I-NP O
98 given VBN O O
98 his PRP$ O O
98 risk NN B-NP O
98 of IN B-VP O
98 stroke NN B-NP O
99 3 CD O O
99 Skin NNP B-NP O
99 care: NN I-NP O
99 Right NNP I-NP O
99 calf NN I-NP O
99 demonstrates VBZ O O
99 a DT B-NP O
99 pressure NN I-NP O
99 ulcer NN I-NP O
99 and CC O O
99 the DT B-NP O
100 patient NN I-NP O
100 should MD O O
100 apply VB O O
100 Nystatin NNP B-NP B-m
100 powder NN I-NP I-m
100 for IN B-VP O
100 his PRP$ O B-r
100 pannus NN B-NP I-r
100 rash NN I-NP I-r
101 4 CD O O
101 Infectious JJ B-NP O
101 disease: NN I-NP O
101 His PRP$ O B-r
101 urinary JJ B-NP I-r
101 tract NN I-NP I-r
101 infection NN I-NP I-r
101 will MD O O
101 be VB O O
102 treated VBN O O
102 with IN B-VP O
102 seven CD O B-du
102 days NNS B-NP I-du
102 of IN B-VP O
102 Bactrim NNP B-NP B-m
102 and CC O O
102 follow JJ B-NP O
102 urine NN I-NP O
102 cultures NNS I-NP O
103 DISPOSITION NNP I-NP O
103 ON NNP I-NP O
103 DISCHARGE: NNP I-NP O
103 The DT B-NP O
103 patient NN I-NP O
103 will MD O O
103 be VB O O
103 discharged VBN O O
103 to TO O O
104 rehabilitation VB O O
104 care NN B-NP O
104 for IN B-VP O
104 leg NN B-NP O
105 strengthening VBG O O
106 MEDICATIONS NNP B-NP O
106 ON NNP I-NP O
106 DISCHARGE: NNP I-NP O
106 Aspirin NNP I-NP B-m
106 325 CD O B-do
106 mg NN B-NP I-do
106 p.o NN I-NP B-mo
106 q JJ B-NP B-f
106 day NN I-NP I-f
106 , , O O
106 Colace NNP B-NP B-m
106 100 CD O B-do
107 mg NN B-NP O
107 p.o NN I-NP B-mo
107 b.i.d NN I-NP B-f
107 , , O O
107 Lasix NNP B-NP B-m
107 40 CD O B-do
107 mg NN B-NP I-do
107 p.o NN I-NP B-mo
107 q NN I-NP B-f
107 a.m NN I-NP I-f
107 , , O O
108 Indomethacin NNP B-NP B-m
108 25 CD O B-do
108 mg NN B-NP I-do
108 p.o NN I-NP B-mo
108 t.i.d NN I-NP B-f
108 p.r.n NN I-NP I-f
108 pain NN I-NP B-r
108 , , O O
108 Lisinopril NNP B-NP B-m
108 15 CD O B-do
108 mg NN B-NP I-do
108 p.o NN I-NP B-mo
108 q JJ B-NP B-f
109 day NN I-NP O
109 , , O O
109 multivitamin VB O B-m
109 one CD O B-do
109 tablet NN B-NP I-do
109 p.o NN I-NP B-mo
109 q JJ B-NP B-f
109 day NN I-NP I-f
109 , , O O
109 Bactrim NNP B-NP B-m
109 DS NNP I-NP I-m
109 one CD O B-do
109 tablet NN B-NP I-do
109 p.o NN I-NP B-mo
110 t.i.d NN I-NP B-f
110 , , O O
110 Tamsulosin NNP B-NP B-m
110 0.4 CD O B-do
110 mg NN B-NP I-do
110 p.o NN I-NP B-mo
110 q JJ B-NP B-f
110 day NN I-NP I-f
110 , , O O
110 Miconazole NNP B-NP B-m
110 2% CD O I-m
110 topical JJ B-NP I-m
110 powder NN I-NP I-m
111 b.i.d NN I-NP B-f
112 CONDITION NNP I-NP O
112 ON NNP I-NP O
112 DISCHARGE: NNP I-NP O
112 Stable NNP I-NP O
113 Dictated NNP I-NP O
113 By: NNP I-NP O
113 JOSE NNP I-NP O
113 FLICKNER NNP I-NP O
113 , , O O
113 M.D NNP B-NP O
113 EL24 NNP I-NP O
114 Attending: NNP I-NP O
114 ANTOINE NNP I-NP O
114 SCHWERTNER NNP I-NP O
114 , , O O
114 M.D NNP B-NP O
114 ZO12 NNP I-NP O
114 ZF589/3744 NNP I-NP O
115 Batch: NNP I-NP O
115 5136 CD O O
115 Index NNP B-NP O
115 No NNP I-NP O
115 L7GO4H06PR NNP I-NP O
115 D: NNP I-NP O
115 2/7/99 CD O O
116 T: NNP B-NP O
116 2/7/99 CD O O
117 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #90349 VBZ O O
2 819093619 CD O O
2 TTTMC NNP B-NP O
2 73833058 CD O O
2 9531316 CD O O
2 7/5/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 pre-syncope NN I-NP O
2 , , O O
2 non-cardiac JJ B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/23/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/1/2004 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 BONETTI NNP I-NP O
5 , , O O
5 RASHAD NNP B-NP O
5 520-60-47-1 CD O O
6 Ficonmipa NNP B-NP O
6 Ln NNP I-NP O
6 Room: NNP I-NP O
6 Southsterter NNP I-NP O
6 Tes NNP I-NP O
6 Ter NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/15/04 CD O O
8 AT NNP B-NP O
8 04:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Attending NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 PFLUGER NNP I-NP O
11 , , O O
11 CARY NNP B-NP O
11 K NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
11 , , O O
11 J.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 TYLENOL NNP I-NP B-m
16 ( ( O I-m
16 ACETAMINOPHEN NNP B-NP I-m
16 ) ) O I-m
16 650 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 Q4H NNP I-NP B-f
16 PRN NNP I-NP I-f
16 Headache NNP I-NP B-r
17 ALBUTEROL NNP I-NP B-m
17 INHALER NNP I-NP I-m
17 2 CD O B-do
17 PUFF NNP B-NP I-do
17 INH NNP I-NP B-mo
17 QID NNP I-NP B-f
17 Starting VBG O O
17 Today NNP B-NP O
17 ( ( O O
17 2/9 CD O O
17 ) ) O O
18 ECASA NNP B-NP B-m
18 ( ( O I-m
18 ASPIRIN NNP B-NP I-m
18 ENTERIC NNP I-NP I-m
18 COATED NNP I-NP I-m
18 ) ) O I-m
18 81 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 ATENOLOL NNP I-NP B-m
19 25 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 LEVOXYL NNP I-NP B-m
20 ( ( O I-m
20 LEVOTHYROXINE NNP B-NP I-m
20 SODIUM NNP I-NP I-m
20 ) ) O I-m
20 75 CD O B-do
20 MCG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 ZOCOR NNP I-NP B-m
21 ( ( O I-m
21 SIMVASTATIN NNP B-NP I-m
21 ) ) O I-m
21 40 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QHS NNP I-NP B-f
22 Food/Drug NNP I-NP O
22 Interaction NNP I-NP O
22 Instruction NNP I-NP O
23 Avoid NNP I-NP O
23 grapefruit NN I-NP O
23 unless IN B-VP O
23 MD NNP B-NP O
23 instructs NNS I-NP O
23 otherwise RB O O
24 Alert NNP B-NP O
24 overridden: NNP I-NP O
24 Override NNP I-NP O
24 added VBD B-VP O
24 on IN B-VP O
24 4/12/04 CD O O
24 by IN B-VP O
25 BINGGELI NNP B-NP O
25 , , O O
25 LONNIE NNP B-NP O
25 , , O O
25 M.D NNP B-NP O
26 on IN B-VP O
26 order NN B-NP O
26 for IN B-VP O
26 ZOCOR NNP B-NP B-m
26 PO NNP I-NP B-mo
26 ( ( O O
26 ref JJ O O
26 # # O O
26 63128567 CD O O
26 ) ) O O
27 Pt NNP B-NP O
27 has VBZ O O
27 a DT B-NP O
27 PROBABLE NNP I-NP O
27 allergy NN I-NP O
27 to TO O O
27 ATORVASTATIN; NNP B-NP O
27 reaction NN I-NP O
27 is VBZ O O
28 unknown JJ B-NP O
28 Reason NNP I-NP O
28 for IN B-VP O
28 override: NN B-NP O
28 aware JJ B-NP O
29 IMDUR NNP I-NP B-m
29 ( ( O I-m
29 ISOSORBIDE NNP B-NP I-m
29 MONONIT.( NNP I-NP I-m
29 SR NNP I-NP I-m
29 ) ) O I-m
29 ) ) O I-m
29 30 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QD NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 Give NNP I-NP O
31 on IN B-VP O
31 an DT B-NP O
31 empty JJ I-NP O
31 stomach NN I-NP O
31 ( ( O O
31 give JJ O O
31 1hr CD O O
31 before IN B-VP O
31 or CC O O
31 2hr CD O O
31 after IN B-VP O
32 food NN B-NP O
32 ) ) O O
33 ZANTAC NNP B-NP B-m
33 ( ( O I-m
33 RANITIDINE NNP B-NP I-m
33 HCL NNP I-NP I-m
33 ) ) O I-m
33 150 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 BID NNP I-NP B-f
34 CELEBREX NNP I-NP B-m
34 ( ( O I-m
34 CELECOXIB NNP B-NP I-m
34 ) ) O I-m
34 200 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QD NNP I-NP B-f
35 Food/Drug NNP I-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
35 Take NNP I-NP O
35 with IN B-VP O
35 food NN B-NP O
36 DIET: NNP I-NP O
36 House NNP I-NP O
36 / VBD B-VP O
36 Low NNP B-NP O
36 chol/low NN I-NP O
36 sat VBD B-VP O
36 fat JJ B-NP O
37 ACTIVITY: NNP I-NP O
37 Walking NNP I-NP O
37 as IN B-VP O
37 tolerated VBN O O
38 FOLLOW NNP B-NP O
38 UP NNP I-NP O
38 APPOINTMENT( NNP I-NP O
38 S NNP I-NP O
38 ): NNP I-NP O
39 Dr NNP I-NP O
39 Beeler NNP I-NP O
39 , , O O
39 pt NN B-NP O
39 to TO O O
39 call VB O O
39 for IN B-VP O
39 appt JJ B-NP O
39 1-2 JJ I-NP O
39 weeks NNS I-NP O
39 , , O O
40 ALLERGY: NNP B-NP O
40 ATORVASTATIN NNP I-NP O
41 ADMIT NNP I-NP O
41 DIAGNOSIS: NNP I-NP O
42 Pre-syncope NNP I-NP O
43 PRINCIPAL NNP I-NP O
43 DISCHARGE NNP I-NP O
43 DIAGNOSIS NNP I-NP O
43 ;Responsible JJ O O
43 After IN B-VP O
43 Study NNP B-NP O
43 for IN B-VP O
43 Causing NNP B-NP O
43 Admission NNP I-NP O
43 ) ) O O
44 pre-syncope NN B-NP O
44 , , O O
44 non-cardiac JJ B-NP O
45 OTHER NNP I-NP O
45 DIAGNOSIS;Conditions NNP I-NP O
45 , , O O
45 Infections NNP B-NP O
45 , , O O
45 Complications NNP B-NP O
45 , , O O
45 affecting VBG O O
45 Treatment/Stay NNP B-NP O
46 htn NN I-NP O
46 ( ( O O
46 hypertension NN B-NP O
46 ) ) O O
46 asthma NN B-NP O
46 ( ( O O
46 asthma NN B-NP O
46 ) ) O O
46 hypothyroidism NN B-NP O
47 ( ( O O
47 hypothyroidism NN B-NP O
47 ) ) O O
47 elevated VBD B-VP O
47 cholesterol NN B-NP O
47 ( ( O O
47 elevated VBN O O
47 cholesterol NN B-NP O
47 ) ) O O
47 varicose NN B-NP O
48 veins NNS I-NP O
48 ( ( O O
48 varicose JJ B-NP O
48 veins NNS I-NP O
48 ) ) O O
48 UTIs NNP B-NP O
48 ( ( O O
48 urinary JJ B-NP O
48 tract NN I-NP O
48 infection NN I-NP O
48 ) ) O O
49 OPERATIONS NNP B-NP O
49 AND NNP I-NP O
49 PROCEDURES: NNP I-NP O
50 OTHER NNP I-NP O
50 TREATMENTS/PROCEDURES NNP I-NP O
50 ( ( O O
50 NOT NNP B-NP O
50 IN NNP I-NP O
50 O.R NNP I-NP O
50 ) ) O O
51 none NN B-NP O
52 BRIEF NNP I-NP O
52 RESUME NNP I-NP O
52 OF NNP I-NP O
52 HOSPITAL NNP I-NP O
52 COURSE: NNP I-NP O
53 75 CD O O
53 yo NN B-NP O
53 Spanish JJ B-NP O
53 speaking NN I-NP O
53 F NNP I-NP O
53 w/ NN I-NP O
53 HTN NNP I-NP O
53 , , O O
53 high JJ B-NP O
53 cholesterol NN I-NP O
53 , , O O
54 hypothyroidism NN B-NP O
54 , , O O
54 asthma NN B-NP O
54 , , O O
54 presents NNS B-NP O
54 w/ VBP O O
54 pre-syncope JJ B-NP O
55 ********* NN I-NP O
56 Seen NNP I-NP O
56 by IN B-VP O
56 PCP NNP B-NP O
56 3d CD O O
56 PTA NNP B-NP O
56 for IN B-VP O
56 L NNP B-NP O
56 hip NN I-NP O
56 pain NN I-NP O
56 , , O O
56 HA NNP B-NP O
56 , , O O
56 polyarthralgias NN B-NP O
56 EKG NNP I-NP O
56 then RB O O
57 showed VBD B-VP O
57 sinus NNS B-NP O
57 brady JJ B-NP O
57 TSH NNP I-NP O
57 noted VBD B-VP O
57 to TO O O
57 be VB O O
57 mildly RB O O
57 elevated VBN O O
57 at IN B-VP O
57 that DT B-NP O
57 visit NN I-NP O
57 at IN B-VP O
58 5.3 CD O O
58 , , O O
58 RF NNP B-NP O
58 and CC O O
58 ANA NNP B-NP O
58 neg RB O O
58 Now RB O O
58 p/w VBZ O O
58 1-2 JJ B-NP O
58 days NNS I-NP O
59 presyncopal VBP O O
59 episodes JJ B-NP O
59 x2 NNP I-NP O
59 , , O O
59 one CD O O
59 while IN B-VP O
59 walking VBG O O
59 then RB O O
59 this DT O O
59 am VBP O O
60 at IN B-VP O
60 church NN B-NP O
60 while IN B-VP O
60 seated VBN O O
60 No NNP B-NP O
60 SOB NNP I-NP O
60 , , O O
60 CP NNP B-NP O
60 , , O O
60 palps NN B-NP O
60 , , O O
60 no DT B-NP O
60 LOC NNP I-NP O
60 , , O O
61 no DT B-NP O
61 f/s/c NN I-NP O
61 , , O O
61 wt JJ B-NP O
61 loss NN I-NP O
61 , , O O
61 + NNP B-NP O
61 dec VBZ O O
61 'd MD O O
61 po's VB O O
61 x2 NNP B-NP O
61 days NNS I-NP O
62 2/2 CD O O
62 n/dyspepsia NN B-NP O
62 , , O O
62 also RB O O
62 +BRBPR VBP O O
62 w/ JJ B-NP O
62 minimal JJ I-NP O
62 blood NN I-NP O
63 x1-2d JJ B-NP O
63 +chronic JJ I-NP O
63 L&gt;R NNP I-NP O
63 hip NN I-NP O
63 pain NN I-NP O
63 In IN B-VP O
63 ED: NNP B-NP O
63 afeb NN I-NP O
63 , , O O
64 normotensive JJ O O
64 , , O O
64 rec'd JJ B-NP O
64 CXR: NNP I-NP O
64 clear JJ B-NP O
64 EKG: NNP I-NP O
64 NSR NNP I-NP O
64 51 CD O O
64 Has NNP B-NP O
64 been VBN O O
65 taking VBG O O
65 meds NNS B-NP O
65 as IN B-VP O
66 directed JJ B-NP O
66 PE: NNP I-NP O
66 98.5 CD O O
66 65 CD O O
66 147/80 CD O O
66 12 CD O O
66 99%RA CD O O
66 , , O O
66 NAD NNP B-NP O
66 , , O O
66 mm NN B-NP O
66 dry NN I-NP O
66 , , O O
67 OP NNP B-NP O
67 clear JJ O O
67 , , O O
67 JVP NNP B-NP O
67 flat JJ O O
67 , , O O
67 CTAB NNP B-NP O
67 , , O O
67 rrr NN B-NP O
67 , , O O
67 no DT B-NP O
67 m/g/r NN I-NP O
67 , , O O
67 ABd NNP B-NP O
68 soft JJ O O
68 , , O O
68 NT/ND NNP B-NP O
68 , , O O
68 heme NN B-NP O
68 pos NN I-NP O
68 brown JJ B-NP O
68 stool NN I-NP O
68 , , O O
68 +ext JJ B-NP O
68 hemorrhoids NNS I-NP O
68 , , O O
69 TR NNP B-NP O
69 edema NN I-NP O
69 bilat NN I-NP O
69 , , O O
69 2+ CD O O
69 pulses NNS B-NP O
69 , , O O
69 +L&gt;R NNP B-NP O
69 trochanteric VBD B-VP O
70 bursa JJ B-NP O
70 point NN I-NP O
70 tenderness NN I-NP O
70 , , O O
70 neuro JJ B-NP O
71 non-focal JJ I-NP O
71 LABS: NNP I-NP O
71 cardiac NN I-NP O
71 enzymes NNS I-NP O
71 neg JJ B-NP O
71 x1 NNP I-NP O
71 , , O O
71 UA NNP B-NP O
71 neg NN I-NP O
71 , , O O
71 TSH NNP B-NP O
72 5.3 CD O O
72 , , O O
72 otherwise RB O O
72 unremarkable JJ O O
72 , , O O
72 Hct NNP B-NP O
72 40 CD O O
72 at IN B-VP O
73 baseline NN B-NP O
74 *****HOSP NNP I-NP O
74 COURSE******* NNP I-NP O
75 CV: NNP I-NP O
75 unlikely JJ B-NP O
75 cardiac JJ I-NP O
75 origin NN I-NP O
75 of IN B-VP O
75 presyncope NN B-NP O
75 , , O O
75 more RBR O O
75 likely JJ B-NP O
75 mild JJ I-NP O
76 hypovolemia NN I-NP O
76 R/R: NNP I-NP O
76 monitored VBD B-VP O
76 on IN B-VP O
76 tele NN B-NP O
76 , , O O
76 noted VBD B-VP O
76 to TO O O
76 brady VB O O
76 to TO O O
76 low VB O O
76 50s CD O O
76 after IN B-VP O
76 ta NN B-NP O
77 king NN I-NP O
77 atenolol NN I-NP B-m
77 , , O O
77 which WDT O O
77 could MD O O
77 be VB O O
77 a DT B-NP O
77 contributing JJ I-NP O
77 factor NN I-NP O
77 ISCHEMIA: NNP I-NP O
77 R/o'd NNP I-NP O
78 for IN B-VP O
78 MI NNP B-NP O
78 by IN B-VP O
78 enzymes NNS B-NP O
78 LDL NNP I-NP O
78 elevated VBD B-VP O
78 , , O O
78 vague JJ B-NP O
78 rxn NN I-NP O
78 to TO O O
78 lipitor NN B-NP B-m
78 Started NNP I-NP O
78 zocor NN I-NP B-m
78 , , O O
79 aspirin JJ B-NP B-m
79 Cont'd NNP I-NP O
79 BB NNP I-NP B-m
79 , , O O
79 imdur NN B-NP B-m
79 aMIBI VBD B-VP O
79 3/24 CD O O
79 showed: NN B-NP O
79 small JJ B-NP O
79 reversible JJ I-NP O
79 defect NN I-NP O
79 of IN B-VP O
80 mild JJ B-NP O
80 intensity NN I-NP O
80 in IN B-VP O
80 distal JJ B-NP O
80 ant NN I-NP O
80 wall NN I-NP O
80 and CC O O
80 apex JJ B-NP O
80 c/w NN I-NP O
80 small JJ B-NP O
80 area NN I-NP O
80 ischemia NN I-NP O
80 in IN B-VP O
81 distal JJ B-NP O
81 LAD NNP I-NP O
81 Pt NNP I-NP O
81 reports NNS I-NP O
81 prior RB O O
81 h/o VBP O O
81 blood NN B-NP O
81 in IN B-VP O
81 stool NN B-NP O
81 while IN B-VP O
81 on IN B-VP O
81 ASA NNP B-NP B-m
81 Advised NNP I-NP O
82 of IN B-VP O
82 benefits NNS B-NP O
82 of IN B-VP O
82 ASA NNP B-NP B-m
82 for IN B-VP O
82 her PRP$ O O
82 , , O O
82 and CC O O
82 started VBD B-VP O
82 on IN B-VP O
82 81mg CD O B-do
82 qd NN B-NP B-f
82 , , O O
82 advised VBD B-VP O
82 to TO O O
82 try VB O O
82 this DT O O
83 and CC O O
83 discuss VB O O
83 further JJ O O
83 with IN B-VP O
83 her PRP$ O O
83 primary JJ B-NP O
83 care NN I-NP O
83 physician JJ B-NP O
84 PUMP: NNP I-NP O
84 gave VBD B-VP O
84 500cc CD O O
84 NS NNP B-NP O
84 Pt NNP I-NP O
84 w/ VBZ O O
84 no DT B-NP O
84 further JJ I-NP O
84 episodes NNS I-NP O
84 on IN B-VP O
84 ambulation NN B-NP O
84 Unable JJ O O
84 to TO O O
85 perform VB O O
85 echo JJ O O
85 prior RB O O
85 to TO O O
85 discharge VB O O
85 but CC O O
85 may MD O O
85 pursue VB O O
85 this DT O O
85 as IN B-VP O
85 an DT B-NP O
85 outpatient JJ I-NP O
86 Pt NNP I-NP O
86 noted VBD B-VP O
86 to TO O O
86 be VB O O
86 hypertensive JJ O O
86 to TO O O
86 180 CD O O
86 SBP NNP B-NP O
86 20-24h JJ O O
86 after IN B-VP O
86 atenolol NN B-NP B-m
86 dose NN I-NP O
87 Therefore NNP I-NP O
87 switched VBD B-VP O
87 to TO O O
87 bid VB O B-f
87 frequency NN B-NP O
87 with IN B-VP O
87 1/2 CD O B-do
87 dose NN B-NP I-do
87 ( ( O I-do
87 25mg CD O I-do
87 ) ) O I-do
87 given VBN O O
88 bradycardia NN B-NP O
88 May NNP I-NP O
88 consider VB O O
88 increasing VBG O O
88 imdur NN B-NP B-m
88 if IN B-VP O
88 persistent JJ B-NP B-r
88 hypertension NN I-NP I-r
89 GI: NNP I-NP O
89 dyspepsia NN I-NP O
89 Started NNP I-NP O
89 PPI NNP I-NP B-m
89 , , O O
89 chk'd NN B-NP O
89 H.pylori NNP I-NP O
89 May NNP I-NP O
89 benefit NN I-NP O
89 from IN B-VP O
89 EGD NNP B-NP O
89 as IN B-VP O
90 outpt JJ B-NP O
90 D/c'd NNP I-NP O
90 on IN B-VP O
90 H2 NNP B-NP O
90 blker NN I-NP O
91 ENDO: NNP I-NP O
91 mildly RB O O
91 subtherapeutic JJ O O
91 on IN B-VP O
91 levoxyl NN B-NP B-m
91 levoxyl NN I-NP B-m
91 , , O O
91 increased VBD B-VP O
91 to TO O O
91 75mcg CD O B-do
91 qd NNS B-NP B-f
92 MSK: NNP I-NP O
92 trochanteric JJ B-NP B-r
92 bursitis NN I-NP I-r
92 Rx'd NNP I-NP O
92 w/ NN I-NP O
93 NSAIDS NNP I-NP B-m
93 , , O O
93 d/c'd NN B-NP O
93 on IN B-VP O
93 celebrex NN B-NP B-m
93 , , O O
93 but CC O O
93 may MD O O
93 consider VB O O
93 changing VBG O O
93 to TO O O
93 hi VB O O
93 dose JJ B-NP O
94 ibuprofen JJ I-NP B-m
95 PULM: NNP I-NP O
95 asthma NN I-NP B-r
95 , , O O
95 cont'd NN B-NP O
95 albuterol NN I-NP B-m
95 inh NN I-NP B-mo
95 prn NN I-NP B-f
96 PPX: NNP I-NP O
96 lovenox NN I-NP B-m
96 for IN B-VP O
96 DVT NNP B-NP B-r
96 ppx VBP O I-r
97 ADDITIONAL NNP B-NP O
97 COMMENTS: NNP I-NP O
97 It PRP O O
97 is VBZ O O
97 important JJ O O
97 that IN B-VP O
97 you PRP O O
97 call VBP O O
97 Dr NNP B-NP O
97 Mcquade NNP I-NP O
97 for IN B-VP O
97 a DT O O
97 follow JJ O O
97 up RP O O
97 appointment NN B-NP O
98 within IN B-VP O
98 the DT B-NP O
98 next JJ I-NP O
98 1-2 JJ I-NP O
98 weeks NNS I-NP O
98 You PRP O O
98 should MD O O
98 take VB O O
98 all DT B-NP O
98 medications NNS I-NP O
98 on IN B-VP O
98 the DT B-NP O
99 discharge NN I-NP O
99 list NN I-NP O
99 at IN B-VP O
99 the DT B-NP O
99 doses NNS I-NP O
99 specified VBD B-VP O
99 It PRP O O
99 is VBZ O O
99 important JJ O O
99 that IN B-VP O
99 you PRP O O
99 stay VBP O O
100 well RB O O
100 hydrated VBN O O
100 If IN B-VP O
100 you PRP O O
100 feel VBP O O
100 lightheaded VBN O O
100 , , O O
100 fall NN B-NP O
100 , , O O
100 or CC O O
100 lose VB O O
100 consciousness NN B-NP O
100 , , O O
101 call VB O O
101 your PRP$ O O
101 doctor NN B-NP O
101 or CC O O
101 seek JJ B-NP O
101 attention NN I-NP O
101 at IN B-VP O
101 the DT B-NP O
101 nearest JJS I-NP O
101 emergency NN I-NP O
101 room NN I-NP O
102 DISCHARGE NNP I-NP O
102 CONDITION: NNP I-NP O
102 Stable NNP I-NP O
103 TO NNP I-NP O
103 DO/PLAN: NNP I-NP O
104 No NNP I-NP O
104 dictated VBD B-VP O
104 summary JJ B-NP O
105 ENTERED NNP I-NP O
105 BY: NNP I-NP O
105 CASTILLIO NNP I-NP O
105 , , O O
105 GLENN NNP B-NP O
105 QUINTON NNP I-NP O
105 , , O O
105 M.D NNP B-NP O
105 ( ( O O
105 XS689 NNP B-NP O
105 ) ) O O
105 9/15/04 CD O O
105 @ $ O O
105 04 CD O O
106 ****** JJ B-NP O
106 END NN I-NP O
106 OF NNP I-NP O
106 DISCHARGE NNP I-NP O
106 ORDERS NNP I-NP O
106 ****** NNP I-NP O
107 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #91996 VBZ O O
2 150823816 CD O O
2 DMC NNP B-NP O
2 60956989 CD O O
2 948914 CD O O
2 1/29/1990 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Unsigned VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/26/1990 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 7/3/1990 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 This DT O O
4 is VBZ O O
4 a DT O O
4 22 CD O O
4 year NN B-NP O
4 old JJ O O
4 , , O O
4 gravida JJ B-NP O
4 V NNP I-NP O
4 para NN I-NP O
5 0314 CD O O
5 , , O O
5 at IN B-VP O
5 24 CD O O
5 weeks NNS B-NP O
5 , , O O
5 now RB O O
5 with IN B-VP O
5 severe JJ B-NP O
6 frontal JJ I-NP O
6 headache NN I-NP O
6 and CC O O
6 scintillations NNS B-NP O
6 Dating NNP I-NP O
6 is VBZ O O
6 by IN B-VP O
6 the DT B-NP O
6 last JJ I-NP O
7 menstrual JJ I-NP O
7 period NN I-NP O
7 and CC O O
7 an DT B-NP O
7 early JJ I-NP O
7 ultrasound NN I-NP O
7 which WDT O O
7 placed VBD B-VP O
7 her PRP O O
7 at IN B-VP O
8 approximately RB O O
8 24 CD O O
8 weeks NNS B-NP O
8 She PRP O O
8 presented VBD B-VP O
8 with IN B-VP O
8 a DT O O
8 three CD O O
8 and CC O O
8 a DT B-NP O
8 half JJ I-NP O
8 day NN I-NP O
9 history NN I-NP O
9 of IN B-VP O
9 severe JJ B-NP B-r
9 severe JJ I-NP B-r
9 severe JJ I-NP B-r
9 frontal JJ I-NP I-r
9 frontal JJ I-NP I-r
9 frontal JJ I-NP I-r
9 headaches NNS I-NP I-r
9 headaches NNS I-NP I-r
9 headaches NNS I-NP I-r
9 with IN B-VP I-r
9 with IN B-VP I-r
9 with IN B-VP I-r
9 scintillations NNS B-NP I-r
9 scintillations NNS I-NP I-r
9 scintillations NNS I-NP I-r
9 There EX O O
9 was VBD B-VP O
10 no DT B-NP O
10 relief NN I-NP O
10 with IN B-VP O
10 Tylenol NNP B-NP B-m
10 , , O O
10 aspirin NN B-NP B-m
10 or CC O O
10 Fioricet NNP B-NP B-m
10 She PRP O O
10 also RB O O
10 stated VBD B-VP O
10 she PRP O O
11 had VBD B-VP O
11 marked VBN O O
11 polydipsia NN B-NP O
11 for IN B-VP O
11 four CD O O
11 days NNS B-NP O
11 She PRP O O
11 denied VBD B-VP O
11 abdominal JJ B-NP O
11 pain NN I-NP O
11 or CC O O
12 swelling VBG O O
12 She PRP O O
12 has VBZ O O
12 a DT B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 preeclampsia NN B-NP O
12 with IN B-VP O
12 a DT B-NP O
12 previous JJ I-NP O
12 twin NN I-NP O
13 gestation NN I-NP O
13 She PRP O O
13 does VBZ O O
13 note JJ B-NP O
13 fetal JJ I-NP O
13 activity NN I-NP O
13 At IN B-VP O
13 this DT B-NP O
13 juncture NN I-NP O
13 , , O O
13 I PRP O O
14 should MD O O
14 note VB O O
14 that IN B-VP O
14 much RB O O
14 of IN B-VP O
14 this DT B-NP O
14 history NN I-NP O
14 is VBZ O O
14 as IN B-VP O
14 per IN B-VP O
14 patient NN B-NP O
14 and CC O O
14 is VBZ O O
15 somewhat RB O O
15 unreliable JJ B-NP O
15 PAST NNP I-NP O
15 OBSTETRICAL NNP I-NP O
15 HISTORY: NNP I-NP O
15 C-section NNP I-NP O
15 for IN B-VP O
16 twins; RB O O
16 previous JJ B-NP O
16 C-section NN I-NP O
16 for IN B-VP O
16 singleton; JJ B-NP O
16 history NN I-NP O
16 by IN B-VP O
16 patient NN B-NP O
16 of IN B-VP O
17 preeclampsia NN B-NP O
17 PAST NNP I-NP O
17 HISTORY: NNP I-NP O
17 Initially NNP I-NP O
17 she PRP O O
17 admitted VBD B-VP O
17 to TO O O
17 no DT B-NP O
17 past JJ I-NP O
18 medical JJ I-NP O
18 problems NNS I-NP O
18 , , O O
18 however RB O O
18 , , O O
18 upon IN B-VP O
18 reviewing VBG O O
18 her PRP$ O O
18 chart NN B-NP O
18 the DT B-NP O
18 following NN I-NP O
19 is VBZ O O
19 obvious: JJ B-NP O
19 chronic JJ I-NP O
19 hypertension; NN I-NP O
19 seizure NN I-NP B-r
19 disorder NN I-NP I-r
19 following VBG O O
19 motor NN B-NP O
20 vehicle NN I-NP O
20 accident NN I-NP O
20 for IN B-VP O
20 which WDT O O
20 she PRP O O
20 is VBZ O O
20 on IN B-VP O
20 valproic NN B-NP B-m
20 acid NN I-NP I-m
20 , , O O
20 no DT O O
20 clearly RB O O
21 documented VBN O O
21 recent JJ B-NP O
21 seizures; JJ I-NP O
21 history NN I-NP O
21 of IN B-VP O
21 asthma NN B-NP B-r
21 for IN B-VP O
21 which WDT O O
21 she PRP O O
21 takes VBZ O O
22 medicines NNS B-NP B-m
22 p.r.n.; JJ B-NP B-f
22 history NN I-NP O
22 of IN B-VP O
22 behavioral JJ B-NP O
22 disorders NNS I-NP O
22 with IN B-VP O
22 question NN B-NP O
22 of IN B-VP O
23 pseudoseizures NNS B-NP O
23 in IN B-VP O
23 the DT B-NP O
23 past; NN I-NP O
23 obesity; JJ B-NP O
23 multiple JJ I-NP O
23 drug NN I-NP O
23 allergies; NN I-NP O
24 cholecystectomy NN I-NP O
24 in IN B-VP O
24 1990; CD O O
24 appendectomy NN B-NP O
24 at IN B-VP O
24 age NN B-NP O
24 14; CD O O
24 motor NN B-NP O
24 vehicle NN I-NP O
25 accident NN I-NP O
25 with IN B-VP O
25 V-P NNP B-NP O
25 shunt NN I-NP O
25 placement NN I-NP O
25 in IN B-VP O
25 1980; CD O O
25 facial JJ B-NP O
25 reconstruction NN I-NP O
26 times NNS I-NP O
26 three CD O O
26 in IN B-VP O
26 1980; CD O O
26 superficial JJ B-NP O
26 vascular NN I-NP O
26 surgery NN I-NP O
26 in IN B-VP O
26 1989 CD O O
26 for IN B-VP O
27 varicosities NNS B-NP O
27 of IN B-VP O
27 the DT B-NP O
27 lower JJR I-NP O
27 extremities NNS I-NP O
27 SOCIAL NNP I-NP O
27 HISTORY: NNP I-NP O
27 She PRP O O
27 denies VBZ O O
28 tobacco NN B-NP O
28 , , O O
28 ethanol '' O O
28 or CC O O
28 drug NN B-NP O
28 use VBP O O
29 PHYSICAL NNP B-NP O
29 EXAMINATION: NNP I-NP O
29 Revealed VBD B-VP O
29 an DT B-NP O
29 obese JJ I-NP O
29 white JJ I-NP O
29 female NN I-NP O
29 in IN B-VP O
29 mild JJ B-NP O
30 distress NN I-NP O
30 The DT B-NP O
30 pupils NNS I-NP O
30 are VBP O O
30 equal JJ O O
30 , , O O
30 round NN B-NP O
30 and CC O O
31 reactive JJ O O
31 to TO O O
31 light JJ O O
31 and CC O O
31 accommodation; JJ B-NP O
31 fundi NN I-NP O
31 well RB O O
31 visualized VBN O O
31 , , O O
31 no DT B-NP O
32 papilledema NN I-NP O
32 Good NNP I-NP O
32 facial NN I-NP O
32 movements NNS I-NP O
32 No DT B-NP O
32 oral JJ I-NP O
32 lesions NNS I-NP O
32 The DT B-NP O
32 chest NN I-NP O
33 was VBD B-VP O
33 clear JJ O O
33 The DT B-NP O
33 heart NN I-NP O
33 showed VBD B-VP O
33 a DT B-NP O
33 regular JJ I-NP O
33 rate NN I-NP O
33 and CC O O
33 rhythm VB O O
33 The DT B-NP O
34 abdomen NNS I-NP O
34 was VBD B-VP O
34 soft JJ O O
34 and CC O O
34 nontender NN B-NP O
34 with IN B-VP O
34 a DT B-NP O
34 fetal JJ I-NP O
34 heart NN I-NP O
34 rate NN I-NP O
34 in IN B-VP O
34 the DT O O
35 140's CD O O
35 The DT B-NP O
35 extremities NNS I-NP O
35 showed VBD B-VP O
35 trace NN B-NP O
35 edema IN B-VP O
35 The DT B-NP O
35 neuro NN I-NP O
35 exam NN I-NP O
35 showed VBD B-VP O
36 cranial JJ B-NP O
36 nerves NNS I-NP O
36 II-XII NNP I-NP O
36 grossly RB O O
36 intact JJ B-NP O
36 Reflexes NNP I-NP O
36 were VBD B-VP O
36 1+ CD O O
36 without IN B-VP O
37 clonus NN B-NP O
37 The DT B-NP O
37 strength NN I-NP O
37 was VBD B-VP O
37 reduced VBN O O
37 to TO O O
37 4/5 CD O O
37 in IN B-VP O
37 the DT B-NP O
37 right JJ I-NP O
37 upper NN I-NP O
37 and CC O O
38 right JJ B-NP O
38 lower JJR I-NP O
38 extremities NNS I-NP O
38 , , O O
38 however RB O O
38 , , O O
38 the DT B-NP O
38 exam NN I-NP O
38 was VBD B-VP O
38 questionable JJ O O
38 as IN B-VP O
38 she PRP O O
39 seemed VBD B-VP O
39 to TO O O
39 have VB O O
39 a DT B-NP O
39 varying NN I-NP O
39 exam NN I-NP O
39 depending VBG O O
39 on IN B-VP O
39 the DT B-NP O
39 examiner NN I-NP O
39 and CC O O
39 time NN B-NP O
39 of IN B-VP O
40 exam NN B-NP O
40 She PRP O O
40 also RB O O
40 demonstrated VBD B-VP O
40 decreased JJ B-NP O
40 fine JJ I-NP O
40 finger NN I-NP O
40 movements NNS I-NP O
40 on IN B-VP O
40 the DT B-NP O
41 right JJ I-NP O
42 HOSPITAL NNP I-NP O
42 COURSE: NNP I-NP O
42 Problem NNP I-NP O
42 #1 NNP I-NP O
42 ) ) O O
42 Headache NNP B-NP O
42 The DT B-NP O
42 patient NN I-NP O
42 has VBZ O O
42 a DT B-NP O
42 history NN I-NP O
43 of IN B-VP O
43 chronic JJ B-NP B-r
43 headaches NNS I-NP I-r
43 for IN B-VP O
43 which WDT O O
43 she PRP O O
43 was VBD B-VP O
43 maintained VBN O O
44 on IN B-VP O
44 Fioricet NNP B-NP B-m
44 in IN B-VP O
44 the DT B-NP O
44 past NN I-NP O
44 Over IN B-VP O
44 the DT B-NP O
44 first JJ I-NP O
44 week NN I-NP O
44 of IN B-VP O
44 hospitalization NN B-NP O
44 , , O O
45 she PRP O O
45 complained VBD B-VP O
45 of IN B-VP O
45 increasing VBG O O
45 headache NN B-NP O
45 that WDT O O
45 prevented VBD B-VP O
45 her PRP O O
45 from IN B-VP O
46 looking VBG O O
46 into IN B-VP O
46 the DT B-NP O
46 light NN I-NP O
46 as RB O O
46 well RB O O
46 as IN B-VP O
46 prevented VBN O O
46 her PRP$ O O
46 from IN B-VP O
46 ambulating VBG O O
46 out IN B-VP O
47 of IN B-VP O
47 the DT B-NP O
47 bed NN I-NP O
47 At IN B-VP O
47 times NNS B-NP O
47 , , O O
47 she PRP O O
47 complained VBD B-VP O
47 of IN B-VP O
47 intermittent JJ B-NP O
47 visual JJ I-NP O
48 symptoms NNS I-NP O
48 These DT B-NP O
48 headaches NNS I-NP B-r
48 headaches NNS I-NP B-r
48 headaches NNS I-NP B-r
48 were VBD B-VP O
48 not RB O O
48 completely RB O O
48 relieved VBN O O
48 by IN B-VP O
48 Demerol NNP B-NP B-m
48 , , O O
49 Percocet NNP B-NP B-m
49 or CC O O
49 Tylenol NNP B-NP B-m
49 She PRP O O
49 was VBD B-VP O
49 eventually RB O O
49 tried VBN O O
49 on IN B-VP O
49 Fioricet NNP B-NP B-m
49 which WDT O O
50 apparently RB O O
50 produced VBD B-VP O
50 good JJ B-NP O
50 relief NN I-NP O
50 of IN B-VP O
50 the DT B-NP O
50 headaches NNS I-NP B-r
50 She PRP O O
50 was VBD B-VP O
50 seen VBN O O
50 by IN B-VP O
51 neurology NN B-NP O
51 and CC O O
51 noted VBD B-VP O
51 with IN B-VP O
51 a DT O O
51 questionably RB O O
51 abnormal JJ B-NP O
51 neuro NNS I-NP O
51 exam VBP O O
51 with IN B-VP O
52 findings NNS B-NP O
52 localized VBN O O
52 to TO O O
52 the DT B-NP O
52 right JJ I-NP O
52 side NN I-NP O
52 Apparently NNP I-NP O
52 she PRP O O
52 has VBZ O O
52 a DT B-NP O
52 history NN I-NP O
53 of IN B-VP O
53 this DT B-NP O
53 abnormality NN I-NP O
53 in IN B-VP O
53 the DT B-NP O
53 past NN I-NP O
53 A NNP I-NP O
53 CT NNP I-NP O
53 scan NN I-NP O
53 revealed VBD B-VP O
53 what WP O O
53 was VBD B-VP O
54 apparently RB O O
54 old JJ B-NP O
54 damage NN I-NP O
54 from IN B-VP O
54 the DT B-NP O
54 previous JJ I-NP O
54 motor NN I-NP O
54 vehicle NN I-NP O
54 accident VBD B-VP O
54 An DT B-NP O
55 MRI NNP I-NP O
55 was VBD B-VP O
55 entirely RB O O
55 within IN B-VP O
55 normal JJ B-NP O
55 limits NNS I-NP O
55 She PRP O O
55 refused VBD B-VP O
55 a DT B-NP O
55 lumbar NN I-NP O
56 puncture NN I-NP O
56 At IN B-VP O
56 this DT B-NP O
56 time NN I-NP O
56 , , O O
56 the DT B-NP O
56 headaches NNS I-NP B-r
56 are VBP O O
56 thought VBN O O
56 to TO O O
56 be VB O O
56 either RB O O
57 vascular JJ O O
57 in IN B-VP O
57 origin NN B-NP O
57 or CC O O
57 psychogenic JJ O O
57 She PRP O O
57 was VBD B-VP O
57 continued VBN O O
57 on IN B-VP O
57 Fioricet NNP B-NP B-m
58 at IN B-VP O
58 the DT B-NP O
58 time NN I-NP O
58 of IN B-VP O
58 discharge NN B-NP O
58 Problem NNP I-NP O
58 #2 NNP I-NP O
58 ) ) O O
58 Hypertension NNP B-NP O
58 She PRP O O
58 had VBD B-VP O
59 elevated VBN O O
59 blood NN B-NP O
59 pressures NNS I-NP O
59 of IN B-VP O
59 150-160 JJ O O
59 over IN B-VP O
59 as RB O O
59 high JJ O O
59 as IN B-VP O
59 110 CD O O
59 upon IN B-VP O
60 admission NN B-NP O
60 She PRP O O
60 has VBZ O O
60 a DT B-NP O
60 history NN I-NP O
60 of IN B-VP O
60 chronic JJ B-NP B-r
60 hypertension NN I-NP I-r
60 in IN B-VP O
60 the DT B-NP O
60 past NN I-NP O
61 and CC O O
61 was VBD B-VP O
61 at IN B-VP O
61 least JJS B-NP O
61 briefly NN I-NP O
61 maintained VBD B-VP O
61 on IN B-VP O
61 hydrochlorothiazide NN B-NP B-m
61 before IN B-VP O
62 She PRP O O
62 had VBD B-VP O
62 a DT B-NP O
62 negative JJ I-NP O
62 work NN I-NP O
62 up RB O O
62 for IN B-VP O
62 PET NNP B-NP O
62 , , O O
62 including VBG O O
62 repeat NN B-NP O
62 24 CD O O
62 hour NN B-NP O
62 urines NNS I-NP O
63 and CC O O
63 repeat NN B-NP O
63 PET NNP I-NP O
63 labs NN I-NP O
63 As NNP I-NP O
63 well RB O O
63 , , O O
63 she PRP O O
63 had VBD B-VP O
63 no DT B-NP O
63 physical JJ I-NP O
63 findings NNS I-NP O
64 consistent JJ O O
64 with IN B-VP O
64 PET NNP B-NP O
64 Given NNP I-NP O
64 her PRP$ O O
64 history NN B-NP O
64 of IN B-VP O
64 chronic JJ B-NP O
64 hypertension NN I-NP O
64 , , O O
64 we PRP O O
65 felt VBD B-VP O
65 this DT O O
65 was VBD B-VP O
65 most RBS O O
65 likely JJ B-NP O
65 chronic JJ I-NP B-r
65 chronic JJ I-NP B-r
65 hypertension NN I-NP I-r
65 hypertension NN I-NP I-r
65 aggravated VBN O O
65 by IN B-VP O
66 pregnancy NN B-NP O
66 She PRP O O
66 was VBD B-VP O
66 begun VBN O O
66 on IN B-VP O
66 a DT B-NP O
66 beta NN I-NP B-m
66 blocker NN I-NP I-m
66 , , O O
66 namely RB O O
66 labetolol JJ O B-m
66 , , O O
66 with IN B-VP O
67 good JJ B-NP O
67 control NN I-NP O
67 She PRP O O
67 was VBD B-VP O
67 discharged VBN O O
67 to TO O O
67 home NN B-NP O
67 on IN B-VP O
67 labetolol NN B-NP B-m
67 Problem NNP I-NP O
68 #3 NN I-NP O
68 ) ) O O
68 History NN B-NP O
68 of IN B-VP O
68 seizure NN B-NP O
68 disorder NN I-NP O
68 She PRP O O
68 carries VBZ O O
68 the DT B-NP O
68 diagnosis NN I-NP O
68 of IN B-VP O
68 a DT B-NP O
69 seizure NN I-NP B-r
69 disorder NN I-NP I-r
69 , , O O
69 although IN B-VP O
69 this DT O O
69 is VBZ O O
69 , , O O
69 at IN B-VP O
69 least JJS O O
69 recently RB O O
69 , , O O
69 poorly RB O O
70 documented VBN O O
70 She PRP O O
70 has VBZ O O
70 been VBN O O
70 on IN B-VP O
70 valproic JJ B-NP B-m
70 acid NN I-NP I-m
70 in IN B-VP O
70 the DT B-NP O
70 past NN I-NP O
70 and CC O O
70 has VBZ O O
70 been VBN O O
71 taking VBG O O
71 a DT B-NP O
71 small JJ I-NP B-do
71 dose NN I-NP I-do
71 of IN B-VP O
71 valproic NN B-NP B-m
71 valproic NN I-NP B-m
71 acid NN I-NP I-m
71 acid NN I-NP I-m
71 apparently RB O O
71 on IN B-VP O
71 her PRP$ O O
71 own JJ O O
72 throughout IN B-VP B-du
72 throughout IN B-VP B-du
72 this DT O I-du
72 this DT B-NP I-du
72 pregnancy NN I-NP I-du
72 pregnancy NN I-NP I-du
72 She PRP O O
72 has VBZ O O
72 been VBN O O
72 taking VBG O O
72 250 CD O B-do
72 mg NN B-NP I-do
72 a DT B-NP B-f
72 week NN I-NP I-f
72 She PRP O O
73 last JJ O O
73 noted VBD B-VP O
73 an DT B-NP O
73 obvious JJ I-NP O
73 seizure NN I-NP O
73 three CD O O
73 years NNS B-NP O
73 ago IN B-VP O
73 It PRP O O
73 is VBZ O O
73 not RB O O
73 clear JJ O O
74 that IN B-VP O
74 this DT O O
74 was VBD B-VP O
74 witnessed VBN O O
74 by IN B-VP O
74 anyone NN B-NP O
74 else RB O O
74 While IN B-VP O
74 in IN B-VP O
74 the DT B-NP O
74 hospital NN I-NP O
74 , , O O
74 she PRP O O
75 had VBD B-VP O
75 an DT B-NP O
75 EEG NNP I-NP O
75 which WDT O O
75 suggested VBD B-VP O
75 some DT B-NP O
75 slowing NN I-NP O
75 in IN B-VP O
75 the DT B-NP O
75 right JJ I-NP O
75 parietal JJ I-NP O
76 region NN I-NP O
76 There EX O O
76 was VBD B-VP O
76 no DT B-NP O
76 clear JJ I-NP O
76 seizure NN I-NP O
76 activity NN I-NP O
76 seen VBN O O
76 on IN B-VP O
76 EEG NNP B-NP O
76 She PRP O O
77 called VBD B-VP O
77 us PRP O O
77 to TO O O
77 her PRP$ O O
77 room NN B-NP O
77 on IN B-VP O
77 several JJ B-NP O
77 episodes NNS I-NP O
77 which WDT O O
77 she PRP O O
77 described VBD B-VP O
77 as IN B-VP O
78 seizures NNS B-NP O
78 These DT B-NP O
78 seizures NNS I-NP O
78 were VBD B-VP O
78 witnessed VBN O O
78 by IN B-VP O
78 several JJ B-NP O
78 physicians NNS I-NP O
78 and CC O O
79 were VBD B-VP O
79 remarkable JJ O O
79 for IN B-VP O
79 absence NN B-NP O
79 of IN B-VP O
79 a DT B-NP O
79 postictal JJ I-NP O
79 period NN I-NP O
79 as RB O O
79 well RB O O
79 as IN B-VP O
80 abnormal JJ B-NP O
80 idiosyncratic JJ I-NP O
80 behaviors NNS I-NP O
80 during IN B-VP O
80 the DT B-NP O
80 events NNS I-NP O
80 It PRP O O
80 was VBD B-VP O
80 our PRP$ O O
81 feeling NN B-NP O
81 that IN B-VP O
81 these DT O O
81 were VBD B-VP O
81 not RB O O
81 true JJ B-NP O
81 seizures NNS I-NP O
81 Indeed RB O O
81 , , O O
81 reviewing VBG O O
81 her PRP$ O O
82 chart NN B-NP O
82 , , O O
82 she PRP O O
82 has VBZ O O
82 had VBD B-VP O
82 episodes NNS B-NP O
82 of IN B-VP O
82 what WDT O O
82 have VBP O O
82 been VBN O O
82 called VBN O O
82 pseudoseizures NNS B-NP O
83 similar JJ O O
83 to TO O O
83 these DT O O
83 in IN B-VP O
83 the DT B-NP O
83 past JJ I-NP O
83 Given NNP I-NP O
83 her PRP$ O O
83 multiple JJ B-NP O
83 drug NN I-NP O
83 allergies NNS I-NP O
83 , , O O
84 including VBG O O
84 Dilantin NNP B-NP O
84 , , O O
84 phenobarb NN B-NP O
84 and CC O O
84 tegretol NN B-NP O
84 , , O O
84 we PRP O O
84 felt VBD B-VP O
84 limited VBN O O
84 in IN B-VP O
84 our PRP$ O O
85 therapeutic JJ B-NP O
85 options NNS I-NP O
85 We PRP O O
85 did VBD B-VP O
85 elect VB O O
85 to TO O O
85 increase VB O O
85 her PRP$ O O
85 dose NN B-NP O
85 of IN B-VP O
85 valproic JJ B-NP B-m
86 acid NN I-NP O
86 as IN B-VP O
86 this DT O O
86 has VBZ O O
86 apparently RB O O
86 been VBN O O
86 effective JJ O O
86 in IN B-VP O
86 the DT O O
86 past JJ O O
86 She PRP O O
86 will MD O O
87 continue VB O O
87 this DT O O
87 as IN B-VP O
87 an DT B-NP O
87 outpatient NN I-NP O
87 Problem NNP I-NP O
87 #4 NNP I-NP O
87 ) ) O O
87 Nausea NN B-NP O
87 and CC O O
87 vomiting VBG O O
88 She PRP O O
88 complained VBD B-VP O
88 of IN B-VP O
88 persistent JJ B-NP O
88 nausea NN I-NP O
88 and CC O O
88 vomiting NN B-NP O
88 during IN B-VP O
88 the DT B-NP O
88 latter JJ I-NP O
89 part NN I-NP O
89 of IN B-VP O
89 her PRP$ O O
89 hospitalization NN B-NP O
89 and CC O O
89 declined VBD B-VP O
89 to TO O O
89 take VB O O
89 anything NN B-NP O
89 p.o IN B-VP O
89 The DT B-NP O
90 etiology NN I-NP O
90 of IN B-VP O
90 this DT B-NP O
90 nausea NN I-NP O
90 and CC O O
90 vomiting NN B-NP O
90 was VBD B-VP O
90 unclear JJ O O
90 , , O O
90 although IN B-VP O
91 apparently RB O O
91 associated VBN O O
91 with IN B-VP O
91 some DT B-NP O
91 diarrhea NN I-NP O
91 As RB O O
91 much JJ O O
91 as IN B-VP O
91 was VBD B-VP O
91 possible JJ O O
91 , , O O
92 work VB O O
92 up RP O O
92 for IN B-VP O
92 an DT B-NP O
92 organic JJ I-NP O
92 cause NN I-NP O
92 of IN B-VP O
92 the DT B-NP O
92 problem NN I-NP O
92 was VBD B-VP O
92 negative JJ O O
92 We PRP O O
93 elected VBD B-VP O
93 initially RB O O
93 to TO O O
93 treat VB O O
93 her PRP O O
93 with IN B-VP O
93 intravenous JJ B-NP B-mo
93 hydration NN I-NP B-m
93 , , O O
93 however RB O O
93 , , O O
94 she PRP O O
94 declined VBD B-VP O
94 further JJ B-NP O
94 IV's NNP I-NP O
94 In IN B-VP O
94 fact NN B-NP O
94 , , O O
94 she PRP O O
94 became VBD B-VP O
94 quite RB O O
94 vocal JJ O O
94 in IN B-VP O
94 her PRP$ O O
95 demand NN B-NP O
95 to TO O O
95 go VB O O
95 home NN B-NP O
95 She PRP O O
95 understands VBZ O O
95 our PRP$ O O
95 concerns NNS B-NP O
95 as IN B-VP O
95 to TO O O
95 the DT B-NP O
95 risks NNS I-NP O
95 of IN B-VP O
96 poor JJ B-NP O
96 p.o NNS I-NP O
96 intake VBP O O
96 and CC O O
96 insists VBZ O O
96 she PRP O O
96 will MD O O
96 be VB O O
96 able JJ O O
96 to TO O O
96 take VB O O
96 in IN B-VP O
96 p.o.'s NN B-NP O
96 at IN B-VP O
97 home NN B-NP O
97 Given NNP I-NP O
97 her PRP$ O O
97 feelings NNS B-NP O
97 in IN B-VP O
97 this DT B-NP O
97 regard NN I-NP O
97 , , O O
97 we PRP O O
97 have VBP O O
97 elected VBN O O
97 to TO O O
98 discharge VB O O
98 her PRP$ O O
98 for IN B-VP O
98 a DT B-NP O
98 trial NN I-NP O
98 of IN B-VP O
98 outpatient JJ B-NP O
98 management NN I-NP O
98 Follow NNP I-NP O
98 up RP O O
98 will MD O O
99 be VB O O
99 in IN B-VP O
99 the DT B-NP O
99 clinic NN I-NP O
99 Should MD O O
99 she PRP O O
99 show VB O O
99 evidence NN B-NP O
99 of IN B-VP O
99 compromise NN B-NP O
99 or CC O O
100 dehydration NN B-NP O
100 , , O O
100 she PRP O O
100 will MD O O
100 be VB O O
100 readmitted VBN O O
100 Problem NNP B-NP O
100 #5 NNP I-NP O
100 ) ) O O
100 Psychosocial NNP B-NP O
101 The DT B-NP O
101 patient NN I-NP O
101 has VBZ O O
101 been VBN O O
101 seen VBN O O
101 several JJ B-NP O
101 times NNS I-NP O
101 in IN B-VP O
101 the DT B-NP O
101 past NN I-NP O
101 for IN B-VP O
101 behavioral JJ B-NP O
102 disorders NNS I-NP O
102 It PRP O O
102 is VBZ O O
102 difficult JJ O O
102 to TO O O
102 sort VB O O
102 out RP O O
102 what WP O O
102 part NN B-NP O
102 of IN B-VP O
102 her PRP$ O O
103 symptomatology NN B-NP O
103 is VBZ O O
103 organic JJ O O
103 and CC O O
103 what WP O O
103 , , O O
103 if IN B-VP O
103 any DT O O
103 , , O O
103 is VBZ O O
103 inorganic JJ O O
103 She PRP O O
103 was VBD B-VP O
104 seen VBN O O
104 by IN B-VP O
104 psychiatry NN B-NP O
104 during IN B-VP O
104 her PRP$ O O
104 stay NN B-NP O
104 here RB O O
104 who WP O O
104 felt VBD B-VP O
104 that IN B-VP O
104 she PRP O O
104 had VBD B-VP O
104 a DT B-NP O
105 significant JJ I-NP O
105 conflict NN I-NP O
105 in IN B-VP O
105 her PRP$ O O
105 home NN B-NP O
105 life NN I-NP O
105 We PRP O O
105 have VBP O O
105 counseled VBN O O
105 her PRP O O
105 as RB O O
106 much JJ O O
106 as IN B-VP O
106 possible JJ O O
106 throughout IN B-VP O
106 her PRP$ O O
106 stay NN B-NP O
106 She PRP O O
106 has VBZ O O
106 seen VBN O O
106 both DT B-NP O
106 social JJ I-NP O
107 services NNS I-NP O
107 and CC O O
107 psychiatry NN B-NP O
107 , , O O
107 however RB O O
107 , , O O
107 she PRP O O
107 is VBZ O O
107 at IN B-VP O
107 best RBS O O
107 reluctant JJ O O
107 to TO O O
107 avail VB O O
108 herself NN B-NP O
108 of IN B-VP O
108 these DT B-NP O
108 services NNS I-NP O
108 Our PRP$ O O
108 plan NN B-NP O
108 at IN B-VP O
108 the DT B-NP O
108 time NN I-NP O
108 of IN B-VP O
108 discharge NN B-NP O
108 is VBZ O O
109 for IN B-VP O
109 follow JJ O O
109 up RP O O
109 with IN B-VP O
109 DSS NNP B-NP O
109 As NNP I-NP O
109 well RB O O
109 , , O O
109 we PRP O O
109 have VBP O O
109 emphasized VBN O O
109 our PRP$ O O
110 availability NN B-NP O
110 to TO O O
110 the DT B-NP O
110 patient NN I-NP O
110 at IN B-VP O
110 all DT B-NP O
110 times NNS I-NP O
110 and CC O O
110 tried VBD B-VP O
110 to TO O O
110 be VB O O
110 as RB O O
111 supportive JJ O O
111 as IN B-VP O
111 possible JJ O O
111 in IN B-VP O
111 these DT B-NP O
111 circumstances NNS I-NP O
112 DISPOSITION: VBP O O
112 The DT B-NP O
112 patient NN I-NP O
112 was VBD B-VP O
112 discharged VBN O O
112 for IN B-VP O
112 a DT B-NP O
112 trial NN I-NP O
112 of IN B-VP O
112 management NN B-NP O
113 at IN B-VP O
113 home NN B-NP O
113 The DT B-NP O
113 etiology NN I-NP O
113 of IN B-VP O
113 her PRP$ O O
113 discomfort NN B-NP O
113 is VBZ O O
113 somewhat RB O O
114 obscure JJ O O
114 , , O O
114 however RB O O
114 , , O O
114 we PRP O O
114 have VBP O O
114 as RB O O
114 best RB O O
114 as IN B-VP O
114 possible JJ O O
114 ruled VBD B-VP O
114 out RP O O
114 obvious JJ B-NP O
115 major JJ I-NP O
115 organic JJ I-NP O
115 pathology NN I-NP O
115 , , O O
115 including VBG O O
115 PET NNP B-NP O
115 , , O O
115 central JJ B-NP O
115 CNS NNP I-NP O
115 processes NNS I-NP O
115 and CC O O
116 fulminant JJ B-NP O
116 hypertension NN I-NP O
117 DISCHARGE NNP I-NP O
117 DIAGNOSES: NNP I-NP O
117 1 CD O O
117 INTRAUTERINE NNP B-NP O
117 PREGNANCY NNP I-NP O
117 AT NNP I-NP O
117 24 CD O O
117 WEEKS NNP B-NP O
118 2 CD O O
118 HEADACHE NNP B-NP O
119 3 CD O O
119 SEIZURE NNP B-NP O
119 DISORDER NNP I-NP O
120 4 CD O O
120 CHRONIC NNP B-NP O
120 HYPERTENSION NNP I-NP O
121 5 CD O O
121 RULE NNP B-NP O
121 OUT NNP I-NP O
121 PRE-ECLAMPTIC NNP I-NP O
121 TOXEMIA NNP I-NP O
122 6 CD O O
122 NAUSEA NNP B-NP O
122 AND NNP I-NP O
122 VOMITING NNP I-NP O
123 OPERATIONS/PROCEDURES: NNP I-NP O
123 CT NNP I-NP O
124 MRI NNP I-NP O
125 EEG NNP I-NP O
125 TIMES NNP I-NP O
125 TWO NNP I-NP O
126 Batch: NNP I-NP O
126 4395 CD O O
126 Report: NNP B-NP O
126 N9695L1 NNP I-NP O
126 T: NNP I-NP O
127 ________________________________ NNP I-NP O
127 FI216/6976 NNP I-NP O
128 TYRONE NNP I-NP O
128 SNIDER NNP I-NP O
128 , , O O
128 M.D NNP B-NP O
128 PM91 NNP I-NP O
128 D: NNP I-NP O
128 6/12/90 CD O O
129 Batch: NNP B-NP O
129 9922 CD O O
129 Report: NNP B-NP O
129 B8548X7 NNP I-NP O
129 T: NNP I-NP O
129 7/21/90 CD O O
130 Dictated NNP B-NP O
130 By: NNP I-NP O
130 TRACY NNP I-NP O
130 MUNOZ NNP I-NP O
130 , , O O
130 M.D NNP B-NP O
131 cc: NN I-NP O
131 WENDELL NNP I-NP O
131 W NNP I-NP O
131 HEMM NNP I-NP O
131 , , O O
131 M.D NNP B-NP O
132 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #95821 VBZ O O
4 773007983 CD O O
4 SMUOMC NNP B-NP O
4 76581417 CD O O
4 046135 CD O O
4 11/14/2002 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 NON NNP I-NP O
4 Q NNP I-NP O
4 WAVE NNP I-NP O
4 MYOCARDIAL NNP I-NP O
4 INFARCTION NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 6/3/2002 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/7/2002 CD O O
7 DIAGNOSIS: NNP B-NP O
7 THE NNP I-NP O
7 PATIENT NNP I-NP O
7 IS NNP I-NP O
7 STATUS NNP I-NP O
7 POST NNP I-NP O
7 NON NNP I-NP O
7 ST NNP I-NP O
7 ELEVATION NNP I-NP O
7 MI NNP I-NP O
7 MEDICAL NNP I-NP O
8 MANAGEMENT NNP I-NP O
9 PROCEDURES: NNP I-NP O
9 Echocardiogram NNP I-NP O
10 CHIEF NNP I-NP O
10 COMPLAINT: NNP I-NP O
10 Syncope NNP I-NP O
11 HISTORY NNP I-NP O
11 OF NNP I-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
11 This DT O O
11 is VBZ O O
11 a DT O O
11 75 CD O O
11 year NN B-NP O
11 old JJ B-NP O
11 woman NN I-NP O
11 with IN B-VP O
12 history NN B-NP O
12 of IN B-VP O
12 hypertension NN B-NP O
12 , , O O
13 hyperlipidemia NN B-NP O
13 and CC O O
13 past JJ B-NP O
13 tobacco NN I-NP O
13 use NN I-NP O
13 and CC O O
13 a DT B-NP O
13 history NN I-NP O
13 of IN B-VP O
13 angina NN B-NP O
13 but CC O O
13 no DT O O
14 previously RB O O
14 known VBN O O
14 CAD NNP B-NP O
14 who WP O O
14 is VBZ O O
14 now RB O O
14 presenting VBG O O
14 with IN B-VP O
14 syncope NN B-NP O
14 at IN B-VP O
15 baseline NN B-NP O
15 She PRP O O
15 had VBD B-VP O
15 a DT B-NP O
15 history NN I-NP O
15 of IN B-VP O
15 angina NN B-NP O
15 with IN B-VP O
15 substernal JJ B-NP O
15 sharp JJ I-NP O
15 pain NN I-NP O
16 only RB O O
16 with IN B-VP O
16 exertion NN B-NP O
16 and CC O O
16 no DT B-NP O
16 radiation NN I-NP O
16 or CC O O
16 associated VBN O O
16 symptoms NNS B-NP O
16 and CC O O
16 with IN B-VP O
17 a DT B-NP O
17 frequency NN I-NP O
17 approximately RB O O
17 once RB O O
17 every DT B-NP O
17 several JJ I-NP O
17 months NNS I-NP O
17 She PRP O O
17 had VBD B-VP O
17 no DT B-NP O
18 baseline NN I-NP O
18 shortness NN I-NP O
18 of IN B-VP O
18 breath NN B-NP O
18 with IN B-VP O
18 one CD O O
18 flight NN B-NP O
18 of IN B-VP O
18 stairs NNS B-NP O
18 and CC O O
18 walking VBG O O
19 around IN B-VP O
19 the DT B-NP O
19 house NN I-NP O
19 nor CC O O
19 orthopnea NN B-NP O
19 , , O O
19 no DT B-NP O
19 paroxysmal JJ I-NP O
19 nocturnal JJ I-NP O
19 dyspnea NN I-NP O
19 or CC O O
20 leg NN B-NP O
20 edema NN I-NP O
20 She PRP O O
20 had VBD B-VP O
20 "a JJ B-NP O
20 couple NN I-NP O
20 of IN B-VP O
20 falls/syncope NN B-NP O
20 over IN B-VP O
20 the DT B-NP O
20 last JJ I-NP O
20 year" NN I-NP O
21 Most NNP I-NP O
21 recently RB O O
21 , , O O
21 about IN B-VP O
21 three CD O O
21 months NNS B-NP O
21 ago RB O O
21 , , O O
21 without IN B-VP O
21 symptoms NNS B-NP O
21 , , O O
21 the DT B-NP O
22 patient NN I-NP O
22 did VBD B-VP O
22 not RB O O
22 seek VB O O
22 medical JJ B-NP O
22 attention NN I-NP O
22 The DT B-NP O
22 night NN I-NP O
22 prior RB O O
22 to TO O O
23 admission NN B-NP O
23 , , O O
23 at IN B-VP O
23 approximately RB O O
23 11:30 CD O O
23 p.m VBD B-VP O
23 the DT B-NP O
23 patient NN I-NP O
23 was VBD B-VP O
23 hanging VBG O O
24 laundry NN B-NP O
24 and CC O O
24 had VBD B-VP O
24 a DT B-NP O
24 sudden JJ I-NP O
24 episode NN I-NP O
24 of IN B-VP O
24 syncope NN B-NP O
24 with IN B-VP O
24 likely JJ B-NP O
24 loss NN I-NP O
24 of IN B-VP O
25 consciousness NN B-NP O
25 of IN B-VP O
25 unclear JJ B-NP O
25 duration NN I-NP O
25 but CC O O
25 likely JJ O O
25 for IN B-VP O
25 minutes NNS B-NP O
25 The DT B-NP O
26 patient NN I-NP O
26 denied VBD B-VP O
26 any DT B-NP O
26 prodromal JJ I-NP O
26 symptoms NNS I-NP O
26 of IN B-VP O
26 chest NN B-NP O
26 pain NN I-NP O
26 , , O O
26 shortness NN B-NP O
26 of IN B-VP O
27 breath NN B-NP O
27 , , O O
27 palpitations NNS B-NP O
27 , , O O
27 light-headnessness JJ O O
27 , , O O
27 visual JJ B-NP O
27 changes NNS I-NP O
27 , , O O
27 balance NN B-NP O
27 , , O O
28 bowel NN B-NP O
28 or CC O O
28 bladder NN B-NP O
28 incontinence NN I-NP O
28 , , O O
28 tonoclonic JJ B-NP O
28 movements NNS I-NP O
28 She PRP O O
29 subsequently RB O O
29 felt VBD B-VP O
29 weak JJ O O
29 and CC O O
29 was VBD B-VP O
29 unable JJ O O
29 to TO O O
29 get VB O O
29 up RP O O
29 until IN B-VP O
29 on IN B-VP O
29 the DT B-NP O
30 afternoon NN I-NP O
30 admission NN I-NP O
30 where WRB O O
30 she PRP O O
30 was VBD B-VP O
30 found VBN O O
30 by IN B-VP O
30 her PRP$ O O
30 apartment NN B-NP O
30 manager NN I-NP O
31 REVIEW NNP I-NP O
31 OF NNP I-NP O
31 SYSTEMS: NNP I-NP O
31 Unremarkable NNP I-NP O
31 She PRP O O
31 denied VBD B-VP O
31 URI NNP B-NP O
31 symptoms NNS I-NP O
31 , , O O
31 UTI NNP B-NP O
32 symptoms NNS I-NP O
32 , , O O
32 bright JJ B-NP O
32 red JJ I-NP O
32 blood NN I-NP O
32 per IN B-VP O
32 rectum NN B-NP O
32 , , O O
32 melena NN B-NP O
32 , , O O
33 normal JJ B-NP O
33 appetite NN I-NP O
33 , , O O
33 stable JJ B-NP O
33 weight NN I-NP O
33 , , O O
33 arthralgias NN B-NP O
33 , , O O
33 except IN B-VP O
33 for IN B-VP O
33 mild JJ B-NP O
33 knee NN I-NP O
34 pain NN I-NP O
34 after IN B-VP O
34 the DT B-NP O
34 fall NN I-NP O
34 She PRP O O
34 did VBD B-VP O
34 note VB O O
34 right NN B-NP O
34 sided VBN O O
34 arm NN B-NP O
34 and CC O O
34 leg NN B-NP O
34 weakness NN I-NP O
35 for IN B-VP O
35 about IN B-VP O
35 a DT B-NP O
35 year NN I-NP O
35 that WDT O O
35 invoked VBD B-VP O
35 a DT B-NP O
35 question NN I-NP O
35 of IN B-VP O
35 CVA NNP B-NP O
36 PAST NNP I-NP O
36 MEDICAL NNP I-NP O
36 HISTORY: NNP I-NP O
36 Hypertension NNP I-NP O
36 , , O O
36 hypothymia NN B-NP O
36 , , O O
36 past JJ B-NP O
36 tobacco NN I-NP O
36 use NN I-NP O
36 , , O O
37 question NN B-NP O
37 of IN B-VP O
37 an DT B-NP O
37 old JJ I-NP O
37 CVA NNP I-NP O
37 , , O O
37 COPD NNP B-NP O
37 not RB O O
37 O2 NNP B-NP O
38 dependent NN I-NP O
38 , , O O
38 status NN B-NP O
38 post NN I-NP O
38 appendectomy NN I-NP O
39 MEDICATIONS: NNP I-NP O
39 The DT B-NP O
39 patient NN I-NP O
39 is VBZ O O
39 on IN B-VP O
39 aspirin NN B-NP B-m
39 , , O O
39 lisinopril NN B-NP B-m
39 , , O O
39 atenolol JJ B-NP B-m
40 ALLERGIES: NNP I-NP O
40 The DT B-NP O
40 patient NN I-NP O
40 had VBD B-VP O
40 no DT O O
40 known VBN O O
40 medical JJ B-NP O
40 allergies NNS I-NP O
41 SOCIAL NNP I-NP O
41 HISTORY: NNP I-NP O
41 The DT B-NP O
41 patient NN I-NP O
41 lives VBZ O O
41 alone RB O O
41 in IN B-VP O
41 none NN B-NP O
41 She PRP O O
41 has VBZ O O
41 two CD O O
42 daughters NNS B-NP O
42 who WP O O
42 live VBP O O
42 in IN B-VP O
42 In IN B-VP O
42 Na NNP B-NP O
42 The DT B-NP O
43 granddaughter NN I-NP O
43 lives VBZ O O
43 in IN B-VP O
43 Porttempe NNP B-NP O
43 His PRP$ O O
43 Coucla NNP B-NP O
43 Her NNP I-NP O
43 son NN I-NP O
43 is VBZ O O
43 in IN B-VP O
43 Font NNP B-NP O
43 She PRP O O
44 is VBZ O O
44 a DT B-NP O
44 smoker NN I-NP O
44 with IN B-VP O
44 one CD O O
44 cigarette NN B-NP O
44 every DT B-NP O
44 few JJ I-NP O
44 days NNS I-NP O
44 for IN B-VP O
44 about IN B-VP O
44 45 CD O O
44 years NNS B-NP O
45 The DT B-NP O
45 patient NN I-NP O
45 does VBZ O O
45 not RB O O
45 use VB O O
45 ethanol JJ B-NP O
46 FAMILY NNP I-NP O
46 HISTORY: NNP I-NP O
46 The DT B-NP O
46 patient's NN I-NP O
46 father NN I-NP O
46 died VBD B-VP O
46 of IN B-VP O
46 a DT B-NP O
46 myocardial JJ I-NP O
47 infarction NN I-NP O
47 at IN B-VP O
47 79 CD O O
47 and CC O O
47 mother RB O O
47 died VBD B-VP O
47 at IN B-VP O
47 27 CD O O
47 during IN B-VP O
48 pregnancy NN B-NP O
49 PHYSICAL NNP I-NP O
49 EXAMINATION: NNP I-NP O
49 In IN B-VP O
49 the DT B-NP O
49 Emergency NNP I-NP O
49 Department NNP I-NP O
49 the DT B-NP O
49 patient NN I-NP O
49 had VBD B-VP O
50 a DT B-NP O
50 temperature NN I-NP O
50 of IN B-VP O
50 97.3 CD O O
50 , , O O
50 heart NN B-NP O
50 rate NN I-NP O
50 of IN B-VP O
50 108 CD O O
50 , , O O
51 blood NN B-NP O
51 pressure NN I-NP O
51 of IN B-VP O
51 152/102 CD O O
51 satting VBG O O
51 96% CD O O
51 on IN B-VP O
51 room NN B-NP O
51 air NN I-NP O
51 Her PRP$ O O
51 examination NN B-NP O
52 is VBZ O O
52 notable JJ O O
52 for IN B-VP O
52 poor JJ B-NP O
52 hygiene NN I-NP O
52 , , O O
52 incontinence NN B-NP O
52 of IN B-VP O
52 urine NN B-NP O
52 , , O O
52 stool NN B-NP O
52 and CC O O
52 a DT B-NP O
53 tachycardia NN I-NP O
53 wheeze NN I-NP O
53 , , O O
53 poor JJ B-NP O
53 strength NN I-NP O
53 throughout IN B-VP O
53 On IN B-VP O
53 the DT B-NP O
53 floor NN I-NP O
53 her PRP$ O O
54 physical JJ B-NP O
54 examination NN I-NP O
54 showed VBD B-VP O
54 a DT B-NP O
54 heart NN I-NP O
54 rate NN I-NP O
54 in IN B-VP O
54 the DT O O
54 90s CD O O
54 , , O O
54 systolic JJ B-NP O
54 blood NN I-NP O
55 pressure NN I-NP O
55 of IN B-VP O
55 110 CD O O
55 She PRP O O
55 is VBZ O O
55 satting VBG O O
55 96% CD O O
55 on IN B-VP O
55 four CD O O
55 liters NNS B-NP O
55 In IN B-VP O
55 general JJ O O
56 she PRP O O
56 was VBD B-VP O
56 comfortable JJ O O
56 but CC O O
56 in IN B-VP O
56 mild JJ B-NP O
56 respiratory NN I-NP O
56 distress NN I-NP O
56 with IN B-VP O
56 a DT B-NP O
56 wheeze NN I-NP O
57 She PRP O O
57 was VBD B-VP O
57 using VBG O O
57 her PRP$ O O
57 respiratory NN B-NP O
57 muscles NNS I-NP O
57 HEENT NNP I-NP O
57 , , O O
57 extraocular JJ B-NP O
57 muscles NNS I-NP O
58 are VBP O O
58 intact JJ O O
58 , , O O
58 PERRL NNP B-NP O
58 Cranial NNP I-NP O
58 nerves NNS I-NP O
58 II NNP I-NP O
58 through IN B-VP O
58 XII NNP B-NP O
58 are VBP O O
58 intact JJ B-NP O
58 Neck NNP I-NP O
59 - : O O
59 she PRP O O
59 had VBD B-VP O
59 no DT B-NP O
59 adenopathy NN I-NP O
59 , , O O
59 thyromegaly NN B-NP O
59 or CC O O
59 GP6 NNP B-NP O
59 Cardiovascular NNP I-NP O
59 - : O O
60 regular JJ B-NP O
60 rate NN I-NP O
60 and CC O O
60 rhythm NN B-NP O
60 , , O O
60 normal JJ B-NP O
60 S1 NNP I-NP O
60 , , O O
60 S2 NNP B-NP O
60 , , O O
60 no DT B-NP O
60 murmurs NN I-NP O
60 , , O O
60 rubs NN B-NP O
60 or CC O O
61 gallops NNS B-NP O
61 , , O O
61 distant JJ B-NP O
61 heart NN I-NP O
61 sounds VBZ O O
61 Respirations NNPS B-NP O
61 - : O O
61 she PRP O O
61 had VBD B-VP O
61 some DT B-NP O
62 wheezes NNS I-NP O
62 , , O O
62 no DT B-NP O
62 crackles NNS I-NP O
62 She PRP O O
62 had VBD B-VP O
62 increased VBN O O
62 respiratory JJ B-NP O
62 phase NN I-NP O
63 Abdomen NNP I-NP O
63 - : O O
63 she PRP O O
63 was VBD B-VP O
63 obese JJ O O
63 , , O O
63 non-tender JJ O O
63 and CC O O
63 non-distended JJ O O
63 with IN B-VP O
63 left JJ B-NP O
64 groin NN I-NP O
64 erythematous JJ O O
64 and CC O O
64 scaling VBG O O
64 with IN B-VP O
64 a DT B-NP O
64 question NN I-NP O
64 of IN B-VP O
64 fungal JJ B-NP O
64 infection NN I-NP O
65 Extremities NNP I-NP O
65 - : O O
65 no DT B-NP O
65 edema NN I-NP O
65 She PRP O O
65 had VBD B-VP O
65 1+ CD O O
65 dorsalis NNS B-NP O
65 pedis JJ B-NP O
65 pulses NNS I-NP O
65 Neuro NNP I-NP O
66 examination NN I-NP O
66 - : O O
66 she PRP O O
66 was VBD B-VP O
66 alert JJ O O
66 She PRP O O
66 knew VBD B-VP O
66 she PRP O O
66 was VBD B-VP O
66 at IN B-VP O
66 the DT B-NP O
66 Dellsbrothers NNP I-NP O
66 Loitmette NNP I-NP O
66 Hospital NNP I-NP O
66 She PRP O O
66 said VBD B-VP O
66 it PRP O O
66 was VBD B-VP O
66 1982 CD O O
66 , , O O
66 July NNP B-NP O
66 , , O O
66 Thursday NNP B-NP O
66 Cranial NNP I-NP O
67 nerves NNS I-NP O
67 II NNP I-NP O
67 through IN B-VP O
67 XII NNP B-NP O
67 are VBP O O
67 intact JJ O O
67 as IN B-VP O
67 previously RB O O
67 noted VBN O O
67 She PRP O O
67 had VBD B-VP O
67 4/5 CD O O
68 bilateral JJ B-NP O
68 lower JJR I-NP O
68 extremity NN I-NP O
68 strength NN I-NP O
68 She PRP O O
68 had VBD B-VP O
68 1+ CD O O
68 deep JJ B-NP O
68 tendon NN I-NP O
69 reflexes NNS I-NP O
69 with IN B-VP O
69 toes NNS B-NP O
69 down RP O O
69 going VBG O O
69 She PRP O O
69 had VBD B-VP O
69 normal JJ B-NP O
69 sensation NN I-NP O
70 LABORATORY NNP I-NP O
70 DATA: NNP I-NP O
70 Sodium NNP I-NP O
70 134 CD O O
70 , , O O
70 potassium NN B-NP O
70 3.9 CD O O
70 , , O O
70 chloride RB O O
70 101 CD O O
70 , , O O
70 CO2 NNP B-NP O
70 26 CD O O
70 , , O O
71 BUN NNP B-NP O
71 14 CD O O
71 , , O O
71 creatinine NN B-NP O
71 1.1 CD O O
71 , , O O
71 glucose VBD B-VP O
71 139 CD O O
71 She PRP O O
71 had VBD B-VP O
71 an DT B-NP O
72 anion NN I-NP O
72 gap NN I-NP O
72 of IN B-VP O
72 12 CD O O
72 White NNP B-NP O
72 count NN I-NP O
72 was VBD B-VP O
72 15.7 CD O O
72 with IN B-VP O
72 71% CD O O
72 polys NNS B-NP O
72 , , O O
72 14% CD O O
72 bands NNS B-NP O
72 , , O O
73 8% CD O O
73 lymphs NN B-NP O
73 , , O O
73 2% CD O O
73 monos VBD B-VP O
73 Her NNP B-NP O
73 hematocrit NN I-NP O
73 was VBD B-VP O
73 47.0 CD O O
73 , , O O
73 her PRP$ O O
73 platelets NNS B-NP O
73 were VBD B-VP O
74 366 CD O O
74 , , O O
74 Troponin NNP B-NP O
74 was VBD B-VP O
74 3.99 CD O O
74 , , O O
74 CK NNP B-NP O
74 1161 CD O O
74 , , O O
74 MB NNP B-NP O
74 31.2 CD O O
74 Her NNP B-NP O
74 albumin NN I-NP O
74 was VBD B-VP O
74 4.1 CD O O
74 , , O O
75 total JJ B-NP O
75 bilirubin NN I-NP O
75 0.4 CD O O
75 , , O O
75 alkaline JJ B-NP O
75 phosphatase NN I-NP O
75 66 CD O O
75 , , O O
75 ALT NNP B-NP O
75 13 CD O O
75 , , O O
75 AST NNP B-NP O
75 51 CD O O
75 Her NNP B-NP O
76 lipids NNS I-NP O
76 - : O O
76 her PRP$ O O
76 LDLs NNP B-NP O
76 149 CD O O
76 , , O O
76 total JJ B-NP O
76 cholesterol NN I-NP O
76 232 CD O O
76 , , O O
76 HDL NNP B-NP O
76 49 CD O O
76 , , O O
76 coags SYM O O
76 - : O O
76 her PRP$ O O
77 PTT NNP B-NP O
77 is VBZ O O
77 30.1 CD O O
77 , , O O
77 INR NNP B-NP O
77 1.0 CD O O
77 Her NNP B-NP O
77 head NN I-NP O
77 CT NNP I-NP O
77 showed VBD B-VP O
77 no DT B-NP O
77 evidence NN I-NP O
77 of IN B-VP O
77 bleed NN B-NP O
78 She PRP O O
78 had VBD B-VP O
78 an DT B-NP O
78 old JJ I-NP O
78 lacunar NN I-NP O
78 in IN B-VP O
78 the DT B-NP O
78 thalamus NN I-NP O
78 She PRP O O
78 had VBD B-VP O
78 an DT B-NP O
78 old JJ I-NP O
78 infarct NN I-NP O
78 in IN B-VP O
79 her PRP$ O O
79 PTM NNP B-NP O
79 internal JJ B-NP O
79 capsule NN I-NP O
79 He PRP O O
79 EKG NNP B-NP O
79 showed VBD B-VP O
79 sinus JJ B-NP O
79 tachycardia NN I-NP O
79 at IN B-VP O
79 102 CD O O
80 normal JJ O O
80 axis RB O O
80 , , O O
80 normal JJ B-NP O
80 intervals NNS I-NP O
80 , , O O
80 diffuse NN B-NP O
80 T NNP I-NP O
80 wave VBP O O
80 inversions NNS B-NP O
80 in IN B-VP O
80 1 CD O O
80 , , O O
80 2 CD O O
80 , , O O
80 3 CD O O
81 AVF NNP B-NP O
81 , , O O
81 V2 NNP B-NP O
81 to TO O O
81 V6 NNP B-NP O
81 Her NNP I-NP O
81 chest NN I-NP O
81 x-ray NN I-NP O
81 showed VBD B-VP O
81 no DT B-NP O
81 active JJ I-NP O
81 process NN I-NP O
82 HOSPITAL NNP I-NP O
82 COURSE: NNP I-NP O
82 The DT B-NP O
82 patient NN I-NP O
82 was VBD B-VP O
82 found VBN O O
82 to TO O O
82 have VB O O
82 non JJ B-NP O
82 ST NNP I-NP O
82 elevation NN I-NP O
83 MRI NNP I-NP O
83 and CC O O
83 there EX O O
83 was VBD B-VP O
83 possible JJ B-NP O
83 cause NN I-NP O
83 of IN B-VP O
83 her PRP$ O O
83 syncope NN B-NP O
84 and CC O O
84 was VBD B-VP O
84 treated VBN O O
84 conservatively RB O O
84 with IN B-VP O
84 medical JJ B-NP O
84 management NN I-NP O
85 Cardiovascular NNP I-NP O
85 - : O O
85 ischemia NN B-NP B-r
85 ischemia NN I-NP B-r
85 ischemia NN I-NP B-r
85 ischemia NN I-NP B-r
85 ischemia NN I-NP B-r
85 , , O O
85 ST NNP B-NP B-r
85 ST NNP I-NP B-r
85 ST NNP I-NP B-r
85 ST NNP I-NP B-r
85 ST NNP I-NP B-r
85 elevation NN I-NP I-r
85 elevation NN I-NP I-r
85 elevation NN I-NP I-r
85 elevation NN I-NP I-r
85 elevation NN I-NP I-r
85 , , O O
85 myocardial JJ B-NP B-r
85 myocardial JJ I-NP B-r
85 myocardial JJ I-NP B-r
85 myocardial JJ I-NP B-r
85 myocardial JJ I-NP B-r
85 infarction NN I-NP I-r
85 infarction NN I-NP I-r
85 infarction NN I-NP I-r
85 infarction NN I-NP I-r
85 infarction NN I-NP I-r
86 The DT B-NP O
86 patient NN I-NP O
86 was VBD B-VP O
86 treated VBN O O
86 with IN B-VP O
86 aspirin JJ B-NP B-m
86 aspirin NN I-NP B-m
86 aspirin NN I-NP B-m
86 , , O O
86 heparin NN B-NP B-m
86 heparin NN I-NP B-m
86 heparin NN I-NP B-m
86 , , O O
86 Lopressor NNP B-NP B-m
86 Lopressor NNP I-NP B-m
86 Lopressor NNP I-NP B-m
86 , , O O
87 captopril NN B-NP B-m
87 captopril NN I-NP B-m
87 captopril NN I-NP B-m
87 , , O O
87 cozaar NN B-NP B-m
87 cozaar NN I-NP B-m
87 cozaar NN I-NP B-m
87 initially RB O O
87 with IN B-VP O
87 heart NN B-NP O
87 rate NN I-NP O
87 and CC O O
87 blood NN B-NP O
87 pressure NN I-NP O
88 controlled VBD B-VP O
88 An DT B-NP O
88 echocardiogram NN I-NP O
88 showed VBD B-VP O
88 an DT B-NP O
88 ejection NN I-NP O
88 fraction NN I-NP O
88 of IN B-VP O
88 30% CD O O
89 with IN B-VP O
89 apical JJ B-NP O
89 anterolateral JJ I-NP O
89 wall NN I-NP O
89 motion NN I-NP O
89 abnormality NN I-NP O
89 and CC O O
89 heparin NN B-NP B-m
89 was VBD B-VP O
90 discontinued VBN O O
90 The DT B-NP O
90 patient NN I-NP O
90 had VBD B-VP O
90 no DT B-NP O
90 further JJ I-NP O
90 chest NN I-NP O
90 pain NN I-NP O
91 Pulmonary NNP I-NP O
91 - : O O
91 the DT B-NP O
91 patient NN I-NP O
91 has VBZ O O
91 had VBN O O
91 some DT O B-r
91 wheezing VBG O I-r
91 on IN B-VP O
91 examination NN B-NP O
92 secondary JJ O O
92 to TO O O
92 COPD NNP B-NP O
92 and CC O O
92 the DT B-NP O
92 patient NN I-NP O
92 was VBD B-VP O
92 started VBN O O
92 on IN B-VP O
92 Atrovent NNP B-NP B-m
92 nebs NN I-NP B-mo
92 and CC O O
93 subsequently RB O O
93 had VBD B-VP O
93 no DT B-NP O
93 further JJ I-NP O
93 wheezing NN I-NP O
94 I.D NNP I-NP O
94 - : O O
94 the DT B-NP O
94 patient NN I-NP O
94 initially RB O O
94 had VBD B-VP O
94 an DT O O
94 increased VBN O O
94 white JJ B-NP O
94 count NN I-NP O
94 with IN B-VP O
95 bandemia NN B-NP O
95 of IN B-VP O
95 an DT B-NP O
95 unclear JJ I-NP O
95 cause NN I-NP O
95 Her NNP I-NP O
95 workup NN I-NP O
95 was VBD B-VP O
95 negative JJ B-NP O
95 Her NNP I-NP O
95 UA NNP I-NP O
96 and CC O O
96 chest JJS O O
96 x-ray JJ O O
96 were VBD B-VP O
96 negative JJ O O
96 She PRP O O
96 had VBD B-VP O
96 no DT B-NP O
96 fevers NNS I-NP O
96 Her NNP I-NP O
96 white JJ B-NP O
96 blood NN I-NP O
97 cell NN I-NP O
97 count NN I-NP O
97 ultimately RB O O
97 declined VBD B-VP O
97 to TO O O
97 normal JJ B-NP O
98 Renal NNP I-NP O
98 - : O O
98 the DT B-NP O
98 patient NN I-NP O
98 was VBD B-VP O
98 most RBS O B-r
98 most RBS O B-r
98 likely JJ O I-r
98 likely JJ O I-r
98 dehydrated VBN O I-r
98 dehydrated VBN O I-r
98 initially RB O O
98 and CC O O
98 was VBD B-VP O
99 given VBN O O
99 fluids NNS B-NP B-m
99 until IN B-VP B-du
99 she PRP O I-du
99 had VBD B-VP I-du
99 good JJ B-NP I-du
99 urine NN I-NP I-du
99 output NN I-NP I-du
99 Her NNP I-NP O
99 IV NNP I-NP B-mo
99 fluids VBZ O B-m
100 ultimately RB O O
100 discontinued VBN O O
100 Renal NNP B-NP O
100 ultrasound NN I-NP O
100 was VBD B-VP O
100 negative JJ O O
100 for IN B-VP O
101 hydronephrosis NN B-NP O
101 or CC O O
101 obstruction NN B-NP O
102 Neuro NNP I-NP O
102 - : O O
102 Although IN B-VP O
102 the DT B-NP O
102 patient's NN I-NP O
102 CT NNP I-NP O
102 was VBD B-VP O
102 negative JJ O O
102 for IN B-VP O
102 acute JJ B-NP O
102 stroke NN I-NP O
102 and CC O O
103 positive JJ O O
103 for IN B-VP O
103 possible JJ B-NP O
103 infarct NN I-NP O
103 the DT B-NP O
103 patient NN I-NP O
103 declined VBD B-VP O
103 MRI NNP B-NP O
103 of IN B-VP O
103 the DT B-NP O
103 brain NN I-NP O
104 to TO O O
104 workup VB O O
104 for IN B-VP O
104 a DT B-NP O
104 possible JJ I-NP O
104 TIA NNP I-NP O
105 PLAN NNP I-NP O
105 FOLLOWING NNP I-NP O
105 DISCHARGE: NNP I-NP O
105 The DT B-NP O
105 patient NN I-NP O
105 is VBZ O O
105 somewhat RB O O
105 debilitated JJ O O
106 following VBG O O
106 her PRP$ O O
106 hospitalization NN B-NP O
106 , , O O
106 requires VBZ O O
107 physical JJ B-NP O
107 therapy NN I-NP O
107 to TO O O
107 regain VB O O
107 her PRP$ O O
107 ability NN B-NP O
107 to TO O O
107 perform VB O O
107 activities NNS B-NP O
107 of IN B-VP O
108 daily JJ O O
108 living VBG O O
108 Additionally RB O O
108 the DT B-NP O
108 patient NN I-NP O
108 should MD O O
108 follow VB O O
108 with IN B-VP O
109 Gynecology NNP B-NP O
109 , , O O
109 is VBZ O O
109 scheduled VBN O O
109 for IN B-VP O
109 a DT B-NP O
109 workup NN I-NP O
109 for IN B-VP O
109 her PRP$ O O
109 incontinence NN B-NP O
109 which WDT O O
110 may MD O O
110 also RB O O
110 include VB O O
110 an DT B-NP O
110 issue NN I-NP O
110 of IN B-VP O
110 uterine JJ B-NP O
110 prolapse NN I-NP O
111 Dictated NNP I-NP O
111 By: NNP I-NP O
111 RICKIE NNP I-NP O
111 RILES NNP I-NP O
111 , , O O
111 M.D NNP B-NP O
111 AA89 NNP I-NP O
112 Attending: NNP I-NP O
112 GUY NNP I-NP O
112 G NNP I-NP O
112 DELFAVERO NNP I-NP O
112 , , O O
112 M.D NNP B-NP O
112 WV48 NNP I-NP O
112 DP536/960504 NNP I-NP O
113 Batch: NNP I-NP O
113 7826 CD O O
113 Index NNP B-NP O
113 No NNP I-NP O
113 L1GGAHHQR3 NNP I-NP O
113 D: NNP I-NP O
113 7/14/02 CD O O
114 T: NNP B-NP O
114 3/5/02 CD O O
115 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #97948 VBZ O O
4 212707884 CD O O
4 NUMC NNP B-NP O
4 02730170 CD O O
4 7874231 CD O O
4 5/12/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 , , O O
4 coronary JJ B-NP O
4 artery NN I-NP O
4 disease NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/4/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/3/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 PITPITAN NNP I-NP O
8 , , O O
8 CHAS NNP B-NP O
8 533-43-09-8 CD O O
9 Asssho NNP B-NP O
9 Dr NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 1/10/04 CD O O
11 AT NNP B-NP O
11 07:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 LANGBEIN NNP I-NP O
14 , , O O
14 GARLAND NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 VENTOLIN NNP I-NP B-m
19 NEBULIZER NNP I-NP I-m
19 ( ( O I-m
19 ALBUTEROL NNP B-NP I-m
19 NEBULIZER NNP I-NP I-m
19 ) ) O I-m
19 2.5 CD O B-do
19 MG NNP B-NP I-do
19 NEB NNP I-NP B-mo
19 Q4H NNP I-NP B-f
20 PRN NNP I-NP O
20 Shortness NNP I-NP B-r
20 of IN B-VP I-r
20 Breath NNP B-NP I-r
21 ATENOLOL NNP I-NP B-m
21 12.5 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
21 Starting NNP I-NP O
21 IN NNP I-NP O
21 AM NNP I-NP O
21 ( ( O O
21 8/7 CD O O
21 ) ) O O
22 NPH NNP B-NP B-m
22 NPH NNP I-NP B-m
22 NPH NNP I-NP B-m
22 NPH NNP I-NP B-m
22 HUMULIN NNP I-NP I-m
22 HUMULIN NNP I-NP I-m
22 HUMULIN NNP I-NP I-m
22 HUMULIN NNP I-NP I-m
22 INSULIN NNP I-NP I-m
22 INSULIN NNP I-NP I-m
22 INSULIN NNP I-NP I-m
22 INSULIN NNP I-NP I-m
22 ( ( O I-m
22 ( ( O I-m
22 ( ( O I-m
22 ( ( O I-m
22 INSULIN NNP B-NP I-m
22 INSULIN NNP I-NP I-m
22 INSULIN NNP I-NP I-m
22 INSULIN NNP I-NP I-m
22 NPH NNP I-NP I-m
22 NPH NNP I-NP I-m
22 NPH NNP I-NP I-m
22 NPH NNP I-NP I-m
22 HUMAN NNP I-NP I-m
22 HUMAN NNP I-NP I-m
22 HUMAN NNP I-NP I-m
22 HUMAN NNP I-NP I-m
22 ) ) O I-m
22 ) ) O I-m
22 ) ) O I-m
22 ) ) O I-m
23 60 CD O B-do
23 UNITS NNP B-NP I-do
23 QAM; NNP I-NP B-f
23 70 CD O B-do
23 UNITS NNP B-NP I-do
23 QPM NNP I-NP B-f
23 SC NNP I-NP B-mo
23 60 CD O B-do
23 UNITS NNP B-NP I-do
23 QAM NNP I-NP B-f
23 70 CD O B-do
23 UNITS NNP B-NP I-do
23 QPM NNP I-NP B-f
24 LISINOPRIL NNP I-NP B-m
24 5 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QD NNP I-NP B-f
25 Alert NNP I-NP O
25 overridden: NNP I-NP O
25 Override NNP I-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 1/10/04 CD O O
25 by IN B-VP O
26 VANABEL NNP B-NP O
26 , , O O
26 SAMUEL NNP B-NP O
26 , , O O
26 M.D NNP B-NP O
27 POTENTIALLY NNP I-NP O
27 SERIOUS NNP I-NP O
27 INTERACTION: NNP I-NP O
27 POTASSIUM NNP I-NP B-m
27 CHLORIDE NNP I-NP I-m
27 &amp; NNP I-NP O
28 LISINOPRIL NNP I-NP B-m
28 Reason NNP I-NP O
28 for IN B-VP O
28 override: NN B-NP O
28 aware JJ B-NP O
29 ZOCOR NNP I-NP B-m
29 ( ( O I-m
29 SIMVASTATIN NNP B-NP I-m
29 ) ) O I-m
29 20 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QHS NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 Avoid NNP I-NP O
31 grapefruit NN I-NP O
31 unless IN B-VP O
31 MD NNP B-NP O
31 instructs NNS I-NP O
31 otherwise RB O O
32 FLOVENT NNP B-NP B-m
32 ( ( O I-m
32 FLUTICASONE NNP B-NP I-m
32 PROPIONATE NNP I-NP I-m
32 ) ) O I-m
32 44 CD O B-do
32 MCG NNP B-NP I-do
32 INH NNP I-NP B-mo
32 BID NNP I-NP B-f
33 COMBIVENT NNP I-NP B-m
33 ( ( O I-m
33 IPRATROPIUM NNP B-NP I-m
33 AND NNP I-NP I-m
33 ALBUTEROL NNP I-NP I-m
33 SULFATE NNP I-NP I-m
33 ) ) O I-m
34 2 CD O B-do
34 PUFF NNP B-NP I-do
34 INH NNP I-NP B-mo
34 QID NNP I-NP B-f
35 DIET: NNP I-NP O
35 House NNP I-NP O
35 / VBD B-VP O
35 Low NNP B-NP O
35 chol/low NN I-NP O
35 sat VBD B-VP O
35 fat JJ B-NP O
36 DIET: NNP I-NP O
36 House NNP I-NP O
36 / NNP I-NP O
36 ADA NNP I-NP O
36 2100 CD O O
36 cals/dy NN B-NP O
37 DIET: NNP I-NP O
37 2 CD O O
37 gram NN B-NP O
37 Sodium NNP I-NP O
38 ACTIVITY: NNP I-NP O
38 Resume NNP I-NP O
38 regular JJ B-NP O
38 exercise NN I-NP O
39 FOLLOW NNP I-NP O
39 UP NNP I-NP O
39 APPOINTMENT( NNP I-NP O
39 S NNP I-NP O
39 ): NNP I-NP O
40 Dr NNP I-NP O
40 Nico NNP I-NP O
40 within IN B-VP O
40 4-6 JJ B-NP O
40 weeks NNS I-NP O
40 , , O O
40 please VB O O
40 call VB O O
40 079.422.5908 CD O O
40 4-6 JJ B-NP O
40 weeks NNS I-NP O
40 , , O O
41 Dr NNP B-NP O
41 Williams NNP I-NP O
41 Dulkis NNP I-NP O
41 , , O O
41 OTH NNP B-NP O
41 , , O O
41 317.160.9552 CD O O
41 , , O O
41 please NN B-NP O
41 see VB O O
41 Dr NNP B-NP O
41 Faulker NNP I-NP O
41 within IN B-VP O
41 the DT B-NP O
41 week NN I-NP O
41 within IN B-VP O
41 1 CD O O
41 week NN B-NP O
41 , , O O
42 ALLERGY: NNP B-NP O
42 Aspirin NNP I-NP O
42 , , O O
42 Sulfa NNP B-NP O
43 ADMIT NNP I-NP O
43 DIAGNOSIS: NNP I-NP O
44 chest JJS B-NP O
44 pain NN I-NP O
45 PRINCIPAL NNP I-NP O
45 DISCHARGE NNP I-NP O
45 DIAGNOSIS NNP I-NP O
45 ;Responsible JJ O O
45 After IN B-VP O
45 Study NNP B-NP O
45 for IN B-VP O
45 Causing NNP B-NP O
45 Admission NNP I-NP O
45 ) ) O O
46 chest JJS B-NP O
46 pain NN I-NP O
46 , , O O
46 coronary JJ B-NP O
46 artery NN I-NP O
46 disease NN I-NP O
47 OTHER NNP I-NP O
47 DIAGNOSIS;Conditions NNP I-NP O
47 , , O O
47 Infections NNP B-NP O
47 , , O O
47 Complications NNP B-NP O
47 , , O O
47 affecting VBG O O
47 Treatment/Stay NNP B-NP O
48 ASTHMA/COPD NNP I-NP O
48 FEV1 NNP I-NP O
48 .97 NNP I-NP O
48 , , O O
48 FEV1/FVC NNP B-NP O
48 .46 NNP I-NP O
48 INSULIN NNP I-NP O
48 REQ NNP I-NP O
48 TYPE NNP I-NP O
48 II NNP I-NP O
49 DM NNP I-NP O
49 SEASONAL NNP I-NP O
49 RHINITIS NNP I-NP O
49 DIVERTICULOSIS NNP I-NP O
49 NEPHROLITHIASIS NNP I-NP O
49 S/P NNP I-NP O
49 INTUBATION NNP I-NP O
49 1/8 CD O O
50 OPERATIONS NNP B-NP O
50 AND NNP I-NP O
50 PROCEDURES: NNP I-NP O
51 Cardiac NNP I-NP O
51 catheterization NN I-NP O
51 ( ( O O
51 0/0/04 CD O O
51 ): NNP B-NP O
51 LAD NNP I-NP O
51 prox VBD B-VP O
51 40% CD O O
51 , , O O
51 no DT B-NP O
51 LCX NNP I-NP O
51 lesions NNS I-NP O
51 , , O O
51 No NNP B-NP O
51 RCA NNP I-NP O
52 lesions NNS I-NP O
52 , , O O
52 R NNP B-NP O
52 PDA NNP I-NP O
52 mid VBD B-VP O
52 30% CD O O
52 lesion NN B-NP O
52 Conclusion: NNP I-NP O
52 non-obstructive JJ B-NP O
52 CAD NNP I-NP O
52 , , O O
53 normal JJ B-NP O
53 L NNP I-NP O
53 heart NN I-NP O
53 filling NN I-NP O
53 pressures VBZ O O
54 OTHER NNP B-NP O
54 TREATMENTS/PROCEDURES NNP I-NP O
54 ( ( O O
54 NOT NNP B-NP O
54 IN NNP I-NP O
54 O.R NNP I-NP O
54 ) ) O O
55 none NN B-NP O
56 BRIEF NNP I-NP O
56 RESUME NNP I-NP O
56 OF NNP I-NP O
56 HOSPITAL NNP I-NP O
56 COURSE: NNP I-NP O
57 Mr NNP I-NP O
57 Gerache NNP I-NP O
57 is VBZ O O
57 a DT B-NP O
57 59 JJ I-NP O
57 yo NN I-NP O
57 man NN I-NP O
57 with IN B-VP O
57 poorly RB O O
57 controlled VBN O O
57 diabetes NNS B-NP O
57 , , O O
57 asthma NNS B-NP O
58 who WP O O
58 presented VBD B-VP O
58 with IN B-VP O
58 chest NN B-NP O
58 pain NN I-NP O
58 Over IN B-VP O
58 the DT B-NP O
58 past JJ I-NP O
58 few JJ I-NP O
58 weeks NNS I-NP O
58 he PRP O O
58 has VBZ O O
58 had VBN O O
59 intermittent VBN O O
59 chest JJS B-NP O
59 pain NN I-NP O
59 with IN B-VP O
59 activity NN B-NP O
59 , , O O
59 lasting VBG O O
59 5 CD O O
59 minutes NNS B-NP O
59 , , O O
59 relieved VBN O O
60 with IN B-VP O
60 rest NN B-NP O
60 He PRP O O
60 also RB O O
60 has VBZ O O
60 shortness NN B-NP O
60 of IN B-VP O
60 breath NN B-NP O
60 when WRB O O
60 he PRP O O
61 climbs VBZ O O
61 stairs NNS B-NP O
61 , , O O
61 but CC O O
61 he PRP O O
61 said VBD B-VP O
61 that IN B-VP O
61 this DT O O
61 is VBZ O O
61 more RBR O O
61 from IN B-VP O
62 his PRP$ O O
62 asthma NN B-NP O
62 He PRP O O
62 presented VBD B-VP O
62 to TO O O
62 his PRP$ O O
62 PCP NNP B-NP O
62 because IN B-VP O
62 of IN B-VP O
63 a DT B-NP O
63 finger NN I-NP O
63 injury NN I-NP O
63 , , O O
63 and CC O O
63 then RB O O
63 told VBD B-VP O
63 him PRP O O
63 about IN B-VP O
63 the DT B-NP O
64 chest JJS I-NP O
64 pain NN I-NP O
64 Pt NNP I-NP O
64 was VBD B-VP O
64 sent VBN O O
64 to TO O O
64 the DT B-NP O
64 ED NNP I-NP O
64 He PRP O O
64 has VBZ O O
65 been VBN O O
65 chest JJS B-NP O
65 pain NN I-NP O
65 free JJ O O
65 since IN B-VP O
65 the DT B-NP O
65 day NN I-NP O
65 before IN B-VP O
65 admission NN B-NP O
66 His PRP$ O O
66 finger NN B-NP O
66 sticks NNS I-NP O
66 at IN B-VP O
66 home NN B-NP O
66 have VBP O O
66 been VBN O O
66 in IN B-VP O
66 the DT B-NP O
66 200-300 JJ I-NP O
66 range NN I-NP O
67 HOSPITAL NNP I-NP O
67 COURSE: NNP I-NP O
68 1 CD O O
68 CV NNP B-NP O
68 - : O O
68 ischemia: NN B-NP O
68 Mr NNP I-NP O
68 Wanzer NNP I-NP O
68 had VBD B-VP O
68 a DT B-NP O
68 cardiac JJ I-NP O
68 catheterization NN I-NP O
68 on IN B-VP O
68 the DT B-NP O
68 mor NN I-NP O
69 ning NN I-NP O
69 of IN B-VP O
69 5/13 CD O O
69 He PRP O O
69 has VBZ O O
69 had VBD B-VP O
69 3 CD O O
69 sets NNS B-NP O
69 of IN B-VP O
69 negative JJ B-NP O
69 enzymes NNS I-NP O
69 ( ( O O
69 elevated VBN O O
69 CKMB NNP B-NP O
69 but CC O O
70 negative JJ B-NP O
70 troponins NNS I-NP O
70 ) ) O O
70 EKG NNP B-NP O
70 significant JJ O O
70 only RB O O
70 for IN B-VP O
70 j NN B-NP O
70 point NN I-NP O
70 elevation NN I-NP O
71 diffusely RB O O
72 -beta JJ B-NP B-m
72 blocker NN I-NP I-m
72 was VBD B-VP O
72 started VBN O O
73 -cholesterol NN B-NP O
73 was VBD B-VP O
73 checked VBN O O
73 ( ( O O
73 elevated VBN O O
73 triglycerides NNS B-NP O
73 308 CD O O
73 , , O O
73 total JJ B-NP O
73 cholesterol NN I-NP O
74 146 CD O O
74 , , O O
74 HDL NNP B-NP O
74 29 CD O O
74 ) ) O O
74 Baseline NNP B-NP O
74 LFTs NNP I-NP O
74 checked VBD B-VP O
75 -statin NNP B-NP B-m
75 was VBD B-VP O
75 started VBN O O
76 -aspirin NNP B-NP B-m
76 was VBD B-VP O
76 held VBN O O
76 because IN B-VP O
76 of IN B-VP O
76 the DT B-NP O
76 patient's NN I-NP O
76 stated VBD B-VP O
76 allergy NN B-NP O
76 to TO O O
76 aspirin VB O O
77 ( ( O O
77 causes NNS B-NP O
77 asthma VBP O O
77 type NN B-NP O
77 symptoms NNS I-NP O
77 ) ) O O
78 -will VBP O O
78 start JJ B-NP O
78 patient NN I-NP O
78 on IN B-VP O
78 low-dose JJ B-NP B-do
78 lisinopril NN I-NP B-m
79 PUMP: NNP I-NP O
79 no DT B-NP O
79 prior JJ I-NP O
79 echo NN I-NP O
79 , , O O
79 consider VB O O
79 as IN B-VP O
79 outpatient NN B-NP O
79 appears VBZ O O
80 euvolemic JJ B-NP O
81 rhythm: NN I-NP O
81 no DT B-NP O
81 active JJ I-NP O
81 issues NNS I-NP O
82 2 CD O O
82 ENDO NNP B-NP O
82 - : O O
82 on IN B-VP O
82 insulin NN B-NP B-m
82 at IN B-VP O
82 home NN B-NP O
82 but CC O O
82 rarely RB O O
82 checks VBZ O O
82 his PRP$ O O
82 sugars NNS B-NP O
82 when WRB O O
82 he PRP O O
83 does VBZ O O
83 it's VB O O
83 usually RB O O
83 200-300s JJ B-NP O
83 Hemoglobin NNP I-NP O
83 A1c NNP I-NP O
83 is VBZ O O
83 10.7 CD O O
84 Patient NN B-NP O
84 was VBD B-VP O
84 continued VBN O O
84 on IN B-VP O
84 home NN B-NP O
84 regimen NNS I-NP O
84 of IN B-VP O
84 NPH NNP B-NP B-m
84 insulin NN I-NP I-m
84 but CC O O
84 clearly RB O O
84 needs VBZ O O
85 better RBR O O
85 control NN B-NP O
85 of IN B-VP O
85 his PRP$ O B-r
85 sugars NNS B-NP I-r
85 as IN B-VP O
85 outpatient JJ O O
86 3 CD O O
86 PULM: NNP B-NP O
87 pt NN I-NP O
87 says VBZ O O
87 he PRP O O
87 has VBZ O O
87 had VBN O O
87 asthma VBN O O
87 as IN B-VP O
87 a DT B-NP O
87 child NN I-NP O
87 no DT B-NP O
87 record NN I-NP O
87 of IN B-VP O
87 PFTs NNP B-NP O
87 but CC O O
87 should MD O O
88 obtain VB O O
88 as IN B-VP O
88 outpatient JJ B-NP O
88 Home NNP I-NP O
88 inhalers NNS I-NP O
88 continued VBD B-VP O
89 4 CD O O
89 RENAL: NNP B-NP O
89 Mr NNP I-NP O
89 Gaulding NNP I-NP O
89 currently RB O O
89 has VBZ O O
89 good JJ B-NP O
89 renal JJ I-NP O
89 function NN I-NP O
89 but CC O O
89 needs VBZ O O
89 to TO O O
90 have VB O O
90 his PRP$ O O
90 Cr NNP B-NP O
90 checked VBD B-VP O
90 after IN B-VP O
90 starting VBG O O
90 the DT B-NP O
90 lisinopril JJ I-NP B-m
91 ADDITIONAL NNP I-NP O
91 COMMENTS: NNP I-NP O
91 You PRP O O
91 must MD O O
91 have VB O O
91 your PRP$ O O
91 kidney NN B-NP O
91 function NN I-NP O
91 checked VBD B-VP O
91 within IN B-VP O
91 1 CD O O
91 week NN B-NP O
91 , , O O
91 please VB O O
91 make VB O O
92 an DT B-NP O
92 appointment NN I-NP O
92 with IN B-VP O
92 your PRP$ O O
92 primary JJ B-NP O
92 care NN I-NP O
92 doctor NN I-NP O
92 Please NNP I-NP O
92 take VB O O
92 your PRP$ O B-m
93 medications NNS B-NP O
93 as IN B-VP O
93 instructed JJ B-NP O
93 Please NNP I-NP O
93 follow VB O O
93 up RP O O
93 with IN B-VP O
93 Dr NNP B-NP O
93 Shiley NNP I-NP O
93 , , O O
93 your PRP$ O O
94 cardiologist NN B-NP O
94 within IN B-VP O
94 4-6 JJ B-NP O
94 weeks NNS I-NP O
95 DISCHARGE NNP I-NP O
95 CONDITION: NNP I-NP O
95 Stable NNP I-NP O
96 TO NNP I-NP O
96 DO/PLAN: NNP I-NP O
97 Please NNP I-NP O
97 consider VB O O
97 carefully RB O O
97 your PRP$ O O
97 lifestyle NN B-NP O
97 , , O O
97 including VBG O O
97 your PRP$ O O
97 diet NN B-NP O
97 and CC O O
98 exercise NN B-NP O
98 plans NNS I-NP O
98 Although IN B-VP O
98 you PRP O O
98 did VBD B-VP O
98 not RB O O
98 have VB O O
98 blockages NNS B-NP O
98 in IN B-VP O
98 your PRP$ O O
98 heart NN B-NP O
99 vessels NNS I-NP O
99 requiring VBG O O
99 stenting NN B-NP O
99 , , O O
99 you PRP O O
99 have VBP O O
99 started VBN O O
99 to TO O O
99 have VB O O
99 blockages NNS B-NP O
99 , , O O
99 so IN B-VP O
99 the DT B-NP O
100 best JJS I-NP O
100 thing NN I-NP O
100 you PRP O O
100 can MD O O
100 do VB O O
100 is VBZ O O
100 to TO O O
100 slow VB O O
100 this DT B-NP O
100 process NN I-NP O
100 down RP O O
100 This DT O O
100 includes VBZ O O
101 losing VBG O O
101 weight NN B-NP O
101 through IN B-VP O
101 diet JJ O O
101 and CC O O
101 exercise NN B-NP O
101 , , O O
101 taking VBG O O
101 medications NNS B-NP O
101 including VBG O O
102 statin NN B-NP B-m
102 , , O O
102 beta NN B-NP B-m
102 blocker NN I-NP I-m
102 ( ( O I-m
102 atenolol NN B-NP I-m
102 ) ) O I-m
102 and CC O O
102 ACE NNP B-NP B-m
102 inhibitor NN I-NP I-m
102 ( ( O I-m
102 lisinopril NN B-NP I-m
102 ) ) O I-m
103 No RB O O
103 dictated JJ B-NP O
103 summary NN I-NP O
104 ENTERED NNP I-NP O
104 BY: NNP I-NP O
104 KOZATEK NNP I-NP O
104 , , O O
104 EUSEBIO NNP B-NP O
104 , , O O
104 M.D NNP B-NP O
104 ( ( O O
104 GX5 NNP B-NP O
104 ) ) O O
104 1/10/04 CD O O
104 @ $ O O
104 06:39 CD O O
104 PM NNP B-NP O
105 ****** JJ B-NP O
105 END NNP I-NP O
105 OF NNP I-NP O
105 DISCHARGE NNP I-NP O
105 ORDERS NNP I-NP O
105 ****** NNP I-NP O
106 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #98358 VBZ O O
2 441230814 CD O O
2 PTHKMC NNP B-NP O
2 75713869 CD O O
2 8014229 CD O O
2 1/5/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 heart NN I-NP O
2 failure NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/4/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/24/2004 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 TABIOS NNP I-NP O
5 , , O O
5 MARLIN NNP B-NP O
5 196-97-89-3 CD O O
6 Road NNP B-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 6/30/04 CD O O
8 AT NNP B-NP O
8 02:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 HO NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 BOYSEN NNP I-NP O
11 , , O O
11 ANDREA NNP B-NP O
11 JORDAN NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ATENOLOL NNP I-NP B-m
16 100 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 LASIX NNP I-NP B-m
17 ( ( O I-m
17 FUROSEMIDE NNP B-NP I-m
17 ) ) O I-m
17 40 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 REGLAN NNP I-NP B-m
18 ( ( O I-m
18 METOCLOPRAMIDE NNP B-NP I-m
18 HCL NNP I-NP I-m
18 ) ) O I-m
18 10 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 TID NNP I-NP B-f
19 Instructions: NNP I-NP O
19 Give NNP I-NP O
19 with IN B-VP O
19 warm JJ B-NP O
19 water NN I-NP O
19 , , O O
19 separately RB O O
19 from IN B-VP O
19 other JJ B-NP O
20 pills NNS I-NP O
20 before IN B-VP O
20 meals NNS B-NP O
20 Thanks NNP I-NP O
20 , , O O
21 COUMADIN NNP B-NP B-m
21 ( ( O I-m
21 WARFARIN NNP B-NP I-m
21 SODIUM NNP I-NP I-m
21 ) ) O I-m
21 3.75 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QPM NNP I-NP B-f
22 Starting NNP I-NP O
22 ROUTINE NNP I-NP O
22 , , O O
22 20:00 CD O O
22 ( ( O O
22 Standard NNP B-NP O
22 Admin NNP I-NP O
22 Time NNP I-NP O
22 ) ) O O
22 ( ( O O
22 3/23 CD O O
22 ) ) O O
23 Food/Drug NNP B-NP O
23 Interaction NNP I-NP O
23 Instruction NNP I-NP O
24 No NNP I-NP O
24 high JJ B-NP O
24 Vitamin-K NNP I-NP O
24 containing VBG O O
24 foods NNS B-NP O
25 Alert NNP I-NP O
25 overridden: VBD B-VP O
25 Override NNP B-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 4/15/04 CD O O
25 by IN B-VP O
26 ROMANI NNP B-NP O
26 , , O O
26 LONG NNP B-NP O
26 , , O O
26 M.D NNP B-NP O
26 , , O O
26 PH.D NNP B-NP O
27 POTENTIALLY NNP I-NP O
27 SERIOUS NNP I-NP O
27 INTERACTION: NNP I-NP O
27 SIMVASTATIN NNP I-NP B-m
27 &amp; NNP I-NP O
27 WARFARIN NNP I-NP B-m
28 Reason NNP I-NP O
28 for IN B-VP O
28 override: NN B-NP O
28 aware JJ B-NP O
29 SIMVASTATIN NNP I-NP B-m
29 20 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QHS NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 Avoid NNP I-NP O
31 grapefruit NN I-NP O
31 unless IN B-VP O
31 MD NNP B-NP O
31 instructs NNS I-NP O
31 otherwise RB O O
32 Override NNP B-NP O
32 Notice: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 4/15/04 CD O O
32 by IN B-VP O
33 STUBBE NNP B-NP O
33 , , O O
33 SAMMIE NNP B-NP O
33 , , O O
33 M.D NNP B-NP O
33 , , O O
33 PH.D NNP B-NP O
34 on IN B-VP O
34 order NN B-NP O
34 for IN B-VP O
34 COUMADIN NNP B-NP B-m
34 PO NNP I-NP B-mo
34 ( ( O O
34 ref JJ O O
34 # # O O
34 09689542 CD O O
34 ) ) O O
35 POTENTIALLY NNP B-NP O
35 SERIOUS NNP I-NP O
35 INTERACTION: NNP I-NP O
35 SIMVASTATIN NNP I-NP B-m
35 &amp; NNP I-NP O
35 WARFARIN NNP I-NP B-m
36 Reason NNP I-NP O
36 for IN B-VP O
36 override: NN B-NP O
36 aware JJ B-NP O
36 Previous NNP I-NP O
36 override NN I-NP O
36 information: NN I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 4/14/04 CD O O
37 by IN B-VP O
37 SISEMORE NNP B-NP O
37 , , O O
37 AL NNP B-NP O
37 MANUAL NNP I-NP O
37 , , O O
37 M.D NNP B-NP O
38 POTENTIALLY NNP I-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 WARFARIN NNP I-NP B-m
38 &amp; NNP I-NP O
38 SIMVASTATIN NNP I-NP B-m
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: NN B-NP O
39 aware JJ B-NP O
40 INSULIN NNP I-NP B-m
40 INSULIN NNP I-NP B-m
40 INSULIN NNP I-NP B-m
40 INSULIN NNP I-NP B-m
40 70/30 CD O I-m
40 70/30 CD O I-m
40 70/30 CD O I-m
40 70/30 CD O I-m
40 ( ( O I-m
40 ( ( O I-m
40 ( ( O I-m
40 ( ( O I-m
40 HUMAN NNP B-NP I-m
40 HUMAN NNP I-NP I-m
40 HUMAN NNP I-NP I-m
40 HUMAN NNP I-NP I-m
40 ) ) O I-m
40 ) ) O I-m
40 ) ) O I-m
40 ) ) O I-m
40 10 CD O B-do
40 UNITS NNP B-NP I-do
40 QAM; NNP I-NP B-f
40 0 CD O B-do
40 UNITS NNP B-NP I-do
40 QPM NNP I-NP B-f
40 SC NNP I-NP B-mo
41 10 CD O B-do
41 UNITS NNP B-NP I-do
41 QAM NNP I-NP B-f
41 0 CD O B-do
41 UNITS NNP B-NP I-do
41 QPM NNP I-NP B-f
42 COZAAR NNP I-NP B-m
42 ( ( O I-m
42 LOSARTAN NNP B-NP I-m
42 ) ) O I-m
42 100 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 QD NNP I-NP B-f
43 Number NNP I-NP B-du
43 of IN B-VP I-du
43 Doses NNP B-NP I-du
43 Required NNP I-NP I-du
43 ( ( O I-du
43 approximate JJ B-NP I-du
43 ): NN I-NP I-du
43 10 CD O I-du
44 PROTONIX NNP B-NP B-m
44 ( ( O I-m
44 PANTOPRAZOLE NNP B-NP I-m
44 ) ) O I-m
44 40 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 QD NNP I-NP B-f
45 DIET: NNP I-NP O
45 Fluid NNP I-NP O
45 restriction: VBD B-VP O
45 2 CD O O
45 liters NNS B-NP O
46 DIET: NNP I-NP O
46 House NNP I-NP O
46 / VBD B-VP O
46 Low NNP B-NP O
46 chol/low NN I-NP O
46 sat VBD B-VP O
46 fat JJ B-NP O
47 DIET: NNP I-NP O
47 2 CD O O
47 gram NN B-NP O
47 Sodium NNP I-NP O
48 ACTIVITY: NNP I-NP O
48 Walking NNP I-NP O
48 as IN B-VP O
48 tolerated VBN O O
49 FOLLOW NNP B-NP O
49 UP NNP I-NP O
49 APPOINTMENT( NNP I-NP O
49 S NNP I-NP O
49 ): NNP I-NP O
50 asselmeier RB O O
50 1-2 JJ B-NP O
50 weeks NNS I-NP O
50 , , O O
51 Arrange NNP B-NP O
51 INR NNP I-NP O
51 to TO O O
51 be VB O O
51 drawn VBN O O
51 on IN B-VP O
51 8/16/04 CD O O
51 with IN B-VP O
51 f/u JJ B-NP O
51 INR's NNP I-NP O
51 to TO O O
51 be VB O O
51 drawn VBN O O
51 every DT O O
52 7 CD O O
52 days NNS B-NP O
52 INR's NNP I-NP O
52 will MD O O
52 be VB O O
52 followed VBN O O
52 by IN B-VP O
52 keiffer NN B-NP O
53 ALLERGY: NNP I-NP O
53 NKA NNP I-NP O
54 ADMIT NNP I-NP O
54 DIAGNOSIS: NNP I-NP O
55 congestive JJ B-NP O
55 heart NN I-NP O
55 failure NN I-NP O
56 PRINCIPAL NNP I-NP O
56 DISCHARGE NNP I-NP O
56 DIAGNOSIS NNP I-NP O
56 ;Responsible JJ O O
56 After IN B-VP O
56 Study NNP B-NP O
56 for IN B-VP O
56 Causing NNP B-NP O
56 Admission NNP I-NP O
56 ) ) O O
57 heart NN B-NP O
57 failure NN I-NP O
58 OTHER NNP I-NP O
58 DIAGNOSIS;Conditions NNP I-NP O
58 , , O O
58 Infections NNP B-NP O
58 , , O O
58 Complications NNP B-NP O
58 , , O O
58 affecting VBG O O
58 Treatment/Stay NNP B-NP O
59 idiopathic JJ O O
59 dilated VBD B-VP O
59 CM NNP B-NP O
59 hx NN I-NP O
59 asthma NN I-NP O
59 hx NN I-NP O
59 CVA NNP I-NP O
60 ( ( O O
60 hemorrhage NN B-NP O
60 ) ) O O
60 IDDM NNP B-NP O
60 ( ( O O
60 diabetes VBZ O O
60 mellitus NN B-NP O
60 ) ) O O
60 Nephrotic NNP B-NP O
60 Syndrome NNP I-NP O
60 2/2 CD O O
60 DM NNP B-NP O
61 ( ( O O
61 nephrotic JJ B-NP O
61 syndrome NN I-NP O
61 ) ) O O
61 AICD NNP B-NP O
61 ( ( O O
61 for IN B-VP O
61 h/o NN B-NP O
61 VT NNP I-NP O
61 ) ) O O
61 ( ( O O
61 ventricular JJ B-NP O
62 tachycardia NN I-NP O
62 ) ) O O
62 CAD NNP B-NP O
62 ( ( O O
62 coronary JJ B-NP O
62 artery NN I-NP O
62 disease NN I-NP O
62 ) ) O O
63 OPERATIONS NNP B-NP O
63 AND NNP I-NP O
63 PROCEDURES: NNP I-NP O
64 none NN I-NP O
65 OTHER NNP I-NP O
65 TREATMENTS/PROCEDURES NNP I-NP O
65 ( ( O O
65 NOT NNP B-NP O
65 IN NNP I-NP O
65 O.R NNP I-NP O
65 ) ) O O
66 none NN B-NP O
67 BRIEF NNP I-NP O
67 RESUME NNP I-NP O
67 OF NNP I-NP O
67 HOSPITAL NNP I-NP O
67 COURSE: NNP I-NP O
68 56F CD O O
68 with IN B-VP O
68 hx NN B-NP O
68 of IN B-VP O
68 idiopathic JJ B-NP O
68 cmp NN I-NP O
68 ( ( O O
68 ef JJ O O
68 25% CD O O
68 ) ) O O
68 , , O O
68 presents VBZ O O
68 with IN B-VP O
68 dyspnea NN B-NP O
68 on IN B-VP O
69 exertion NN B-NP O
69 , , O O
69 orthopnea NN B-NP O
69 , , O O
69 lower JJR B-NP O
69 extermity NN I-NP O
69 edema VBP O O
70 HPI: NNP B-NP O
70 reports NNS I-NP O
70 1 CD O O
70 wk JJ B-NP O
70 history NN I-NP O
70 of IN B-VP O
70 increasing VBG O O
70 lower JJR B-NP O
70 extermity NN I-NP O
70 edema NN I-NP O
70 , , O O
71 orthopnea NN B-NP O
71 Has NNP I-NP O
71 been VBN O O
71 taking VBG O O
71 all DT B-NP O
71 meds NNS I-NP O
71 but CC O O
71 has VBZ O O
71 recently RB O O
71 had VBN O O
71 multiple JJ B-NP O
72 dietary JJ I-NP O
72 indiscretions NNS I-NP O
72 including VBG O O
72 chicken NN B-NP O
72 noodle JJ B-NP O
72 soup NN I-NP O
72 and CC O O
72 grilled VBD B-VP O
72 ham NNS B-NP O
73 cheese JJ B-NP O
73 sandwich NN I-NP O
73 In IN B-VP O
73 addition NN B-NP O
73 patient NN I-NP O
73 has VBZ O O
73 episodes NNS B-NP O
73 of IN B-VP O
73 nausea NN B-NP O
73 and CC O O
73 also RB O O
74 hypoglycemia NN B-NP O
74 when WRB O O
74 she PRP O O
74 discontinues VBZ O O
74 her PRP$ O O
74 medications NNS B-NP O
74 No DT B-NP O
74 chest NN I-NP O
74 pain NN I-NP O
74 , , O O
74 no DT B-NP O
75 palpitations NNS I-NP O
75 , , O O
75 dyspnea NN B-NP O
75 on IN B-VP O
75 exertion NN B-NP O
75 with IN B-VP O
75 stairs NNS B-NP O
76 In IN B-VP O
76 emergency NN B-NP O
76 department NN I-NP O
76 d NN I-NP O
76 , , O O
76 70 CD O O
76 / VBD B-VP O
76 138/87/ CD O O
76 100% CD O O
77 CXR: NNP B-NP O
77 mod NN I-NP O
77 pulm NN I-NP O
77 edema NN I-NP O
77 , , O O
77 L NNP B-NP O
77 small JJ B-NP O
77 pleural JJ I-NP O
77 effusion NN I-NP O
77 and CC O O
77 LLL NNP B-NP O
77 opacity NN I-NP O
78 PE: NNP I-NP O
78 jvp NN I-NP O
78 10 CD O O
78 chest: NN B-NP O
78 crackles NNS I-NP O
78 1/4 CD O O
78 bases NNS B-NP O
78 b/l JJ B-NP O
78 cv: NNS I-NP O
78 enlarged VBD B-VP O
78 pmi NN B-NP O
78 , , O O
78 rv NN B-NP O
78 heave NN I-NP O
78 , , O O
79 3/6 CD O O
79 hsm NN B-NP O
79 lsb NN I-NP O
79 , , O O
79 apex NN B-NP O
79 , , O O
79 no DT B-NP O
79 gallops NNS I-NP O
79 abd: VBP O O
79 no DT B-NP O
79 organomegaly; NN I-NP O
79 ext: VBZ O O
79 warm JJ O O
79 3+ CD O O
79 LE NNP B-NP O
80 edema NN I-NP O
81 PMH: NNP I-NP O
81 cardiomyopathy NN I-NP O
81 , , O O
81 Asthma NNP B-NP O
81 , , O O
81 cva/brain NN B-NP O
81 aneurysm NN I-NP O
81 , , O O
81 AICD NNP B-NP O
81 for IN B-VP O
81 VT NNP B-NP O
81 , , O O
81 DM NNP B-NP O
81 , , O O
82 dvt NN B-NP O
82 R.leg NNP I-NP O
82 , , O O
82 gerd NN B-NP O
82 , , O O
82 chronic JJ B-NP O
82 leg NN I-NP O
82 swelling NN I-NP O
82 , , O O
82 Hypertension NNP B-NP O
83 SH: NNP I-NP O
83 lives VBZ O O
83 with IN B-VP O
83 son NN B-NP O
83 , , O O
83 1 CD O O
83 cig/day NN B-NP O
83 , , O O
83 no DT B-NP O
83 etoh NN I-NP O
84 EKG: NNP I-NP O
84 nsr CC O O
84 nl JJ B-NP O
84 axis NN I-NP O
84 , , O O
84 qtc RB O O
84 473 CD O O
84 lae NN B-NP O
84 , , O O
84 lvh NN B-NP O
84 , , O O
84 lat JJ B-NP O
84 twi NN I-NP O
84 , , O O
84 st NN B-NP O
84 elev NN I-NP O
84 , , O O
84 v1 NN B-NP O
84 , , O O
84 v2--old JJ B-NP O
85 LABS: NNP I-NP O
85 bnp: NN I-NP O
85 3726 CD O O
85 ck NN B-NP O
85 937 CD O O
85 mb NN B-NP O
85 7.3 CD O O
85 tn&lt;assay NN B-NP O
85 echo: NN I-NP O
86 ECHO: NNP I-NP O
86 1/23/03 CD O O
86 severe JJ B-NP O
86 global JJ I-NP O
86 lvhk NN I-NP O
86 20% CD O O
86 lae NN B-NP O
86 , , O O
86 decraesed VBD B-VP O
86 rv NN B-NP O
86 f( NN I-NP O
86 x NNP I-NP O
86 ) ) O O
86 , , O O
86 MR NNP B-NP O
86 , , O O
86 mild JJ B-NP O
87 tr NN I-NP O
87 , , O O
87 pasp VBP O O
87 28 CD O O
88 Assessment NNP B-NP O
88 56 CD O O
88 female JJ B-NP O
88 idiopathic JJ I-NP O
88 CMP NNP I-NP O
88 Presents NNPS I-NP O
88 with IN B-VP O
88 CHF NNP B-NP O
88 exacerbation NN I-NP O
88 2/2 CD O O
89 dietary JJ B-NP O
89 indiscretion NN I-NP O
90 *************************Hospital NNP I-NP O
90 Course******************** NNP I-NP O
91 1.CV CD O O
91 ISCH: NNP B-NP O
91 Elevated NNP I-NP O
91 ck NN I-NP O
91 , , O O
91 tni NN B-NP O
91 ( ( O O
91 - : O O
91 ) ) O O
91 , , O O
91 ckmb RB O O
91 low JJ O O
91 , , O O
91 ruled VBD B-VP O
91 out RP O O
91 X3 NNP B-NP O
91 cont NN I-NP O
92 Beta NNP I-NP B-m
92 Blocker NNP I-NP I-m
92 , , O O
92 ASA NNP B-NP B-m
92 , , O O
92 non-occlusive JJ O O
92 2vd CD O O
92 on IN B-VP O
92 cath NN B-NP O
93 PUMP: NNP I-NP O
93 warm NN I-NP O
93 and CC O O
93 wet; VB O O
93 the DT B-NP O
93 patient NN I-NP O
93 was VBD B-VP O
93 diresed VBN O O
93 approximately RB O O
93 6 CD O O
93 Liters NNS B-NP O
93 to TO O O
94 her PRP$ O O
94 dry JJ B-NP O
94 weight NN I-NP O
94 of IN B-VP O
94 149 CD O O
94 kilograms NNS B-NP O
94 At IN B-VP O
94 dry JJ B-NP O
94 weight NN I-NP O
94 patient NN I-NP O
94 had VBD B-VP O
94 a DT B-NP O
94 BNP NNP I-NP O
95 of IN B-VP O
95 3700 CD O O
95 In IN B-VP O
95 house NN B-NP O
95 her PRP$ O O
95 ACE NNP B-NP O
95 was VBD B-VP O
95 switched VBN O O
95 to TO O O
95 Cozaar NNP B-NP B-m
95 secondary JJ O O
95 to TO O O
95 cough VB O O
96 Beta NNP B-NP B-m
96 Blocker NNP I-NP I-m
96 was VBD B-VP O
96 changed VBN O O
96 to TO O O
96 once RB O B-f
96 once RB O B-f
96 a DT O I-f
96 a DT B-NP I-f
96 day NN I-NP I-f
96 day NN I-NP I-f
96 Atenolol NNP I-NP B-m
96 An DT B-NP O
96 echo NN I-NP O
96 on IN B-VP O
96 4/15 CD O O
97 revealed VBD B-VP O
97 EF NNP B-NP O
97 21% CD O O
97 mV NN B-NP O
97 moderate JJ B-NP O
97 mr NN I-NP O
97 , , O O
97 incomplete JJ B-NP O
97 closure NN I-NP O
97 , , O O
97 TV: NNP B-NP O
97 moderate NNP I-NP O
97 tr NN I-NP O
97 , , O O
98 incomplete JJ B-NP O
98 closure;LV NN I-NP O
98 globak NN I-NP O
98 HK NNP I-NP O
98 , , O O
98 rv VBZ O O
98 mildly RB O O
98 to TO O O
98 moderately RB O O
98 decreased JJ O O
98 , , O O
99 incomplete JJ B-NP O
99 study NN I-NP O
99 due JJ O O
99 to TO O O
99 patient VB O O
99 not RB O O
99 fully RB O O
99 cooperating VBG O O
99 On IN B-VP O
99 the DT B-NP O
99 patients NNS I-NP O
100 final JJ B-NP O
100 day NN I-NP O
100 in IN B-VP O
100 the DT B-NP O
100 hospital NN I-NP O
100 she PRP O O
100 was VBD B-VP O
100 noted VBN O O
100 to TO O O
100 have VB O O
100 symptomatic JJ B-NP O
100 dehydra NN I-NP O
101 tion NN I-NP O
101 and CC O O
101 was VBD B-VP O
101 orthostatic JJ O O
101 - : O O
101 symptoms NNS B-NP O
101 resoved VBN O O
101 with IN B-VP O
101 a DT O O
101 500 CD O O
101 cc NN B-NP O
101 NS NNP I-NP O
101 bolus CC O O
102 2.ENDO CD O O
102 : : O O
102 the DT B-NP O
102 patient's NN I-NP O
102 insulin NN I-NP B-m
102 regiment NN I-NP O
102 was VBD B-VP O
102 modified VBN O O
102 and CC O O
102 she PRP O O
102 was VBD B-VP O
102 dc'd VBN O O
103 on IN B-VP O
103 insulin NN B-NP B-m
103 70/30 CD O I-m
103 10 CD O O
103 am VBP O O
103 THe NNP B-NP O
103 patient's NN I-NP O
103 admission NN I-NP O
103 regimine NN I-NP O
103 of IN B-VP O
103 Lantus NNP B-NP B-m
103 40 CD O B-do
103 q NN B-NP B-f
104 d NN I-NP O
104 was VBD B-VP O
104 causing VBG O O
104 both DT O O
104 hyper JJR O O
104 and CC O O
104 hypoglycemia NN B-NP O
104 in IN B-VP O
104 house NN B-NP O
104 Her PRP$ O O
104 hospital JJ B-NP O
104 course NN I-NP O
105 was VBD B-VP O
105 notable JJ O O
105 for IN B-VP O
105 a DT B-NP O
105 few JJ I-NP O
105 episodes NNS I-NP O
105 of IN B-VP O
105 hypoglycemia NN B-NP O
105 resulting VBG O O
105 in IN B-VP O
105 down JJ B-NP B-do
106 titration NN I-NP O
106 of IN B-VP O
106 insulin NN B-NP B-m
106 AM NNP I-NP O
106 and CC O O
106 PM NNP B-NP O
106 doses VBZ O O
106 THe NNP B-NP O
106 patient NN I-NP O
106 was VBD B-VP O
106 noted VBN O O
106 to TO O O
106 be VB O O
107 extremely RB O O
107 hypoglycmeic JJ O O
107 on IN B-VP O
107 8 CD O B-do
107 units NNS B-NP I-do
107 of IN B-VP O
107 70/30 CD O O
107 in IN B-VP O
107 the DT B-NP O
107 PM NNP I-NP O
107 and CC O O
107 the DT B-NP O
107 PM NNP I-NP B-f
108 insulin NN I-NP B-m
108 was VBD B-VP O
108 discontinued VBN O O
108 for IN B-VP O
108 the DT B-NP O
108 time NN I-NP O
108 being VBG O O
108 It PRP O O
108 was VBD B-VP O
108 decided VBN O O
108 that IN B-VP O
108 the DT B-NP O
109 patient's NN I-NP O
109 diet NN I-NP O
109 at IN B-VP O
109 home NN B-NP O
109 would MD O O
109 have VB O O
109 higher JJR B-NP O
109 glucose NN I-NP O
109 and CC O O
109 carbohydrate NN B-NP O
110 content NN I-NP O
110 and CC O O
110 her PRP$ O O
110 Fs's NNP B-NP O
110 will MD O O
110 need VB O O
110 further RB O O
110 w/up VB O O
110 as IN B-VP O
110 outpatient NN B-NP O
110 We PRP O O
110 reccomend VBP O O
111 titrating VBG O B-do
111 the DT O O
111 70/30 CD O O
111 insulin NN B-NP B-m
111 up RB O O
111 as RB O B-f
111 needed VBN O I-f
112 3.GI: CD O O
112 she PRP O O
112 complained VBD B-VP O
112 of IN B-VP O
112 mild JJ B-NP O
112 epigastric JJ I-NP O
112 pain NN I-NP O
112 after IN B-VP O
112 meals NNS B-NP O
112 , , O O
112 and CC O O
112 said VBD B-VP O
112 it PRP O O
113 is VBZ O O
113 thought VBN O O
113 that IN B-VP O
113 this DT O O
113 represents VBZ O O
113 diabetic JJ B-NP B-r
113 gastroparesis NN I-NP I-r
113 Her NNP I-NP O
113 reglan NN I-NP B-m
114 dose NN I-NP O
114 was VBD B-VP O
114 increased VBN O O
114 to TO O O
114 10 CD O B-do
114 and CC O O
114 she PRP O O
114 tolerated VBD B-VP O
114 PO's NNP B-NP O
114 better RBR O O
114 subsequently RB O O
114 and CC O O
115 was VBD B-VP O
115 less RBR O O
115 symptomatic JJ O O
116 4.HEME: CD O O
116 cont NN B-NP O
116 coumadin NN I-NP B-m
117 5.PROPHYLAXIS: CD O O
117 coumadin NN B-NP B-m
117 , , O O
117 nexium NN B-NP B-m
118 6.CODE CD O O
118 full JJ B-NP O
119 ADDITIONAL NNP I-NP O
119 COMMENTS: NNP I-NP O
119 1 CD O O
119 Please NNP B-NP O
119 followup NN I-NP O
119 with IN B-VP O
119 Dr NNP B-NP O
119 Scarles NNP I-NP O
119 in IN B-VP O
119 1-2 JJ B-NP O
119 weeks NNS I-NP O
120 2 CD O O
120 Please NNP B-NP O
120 switch VB O O
120 your PRP$ O O
120 insulin NN B-NP B-m
120 to TO O O
120 10 CD O B-do
120 units NNS B-NP I-do
120 of IN B-VP O
120 70/30 CD O O
120 insulin NN B-NP B-m
120 the DT B-NP O
120 morning NN I-NP B-f
121 Your PRP$ O O
121 primary JJ B-NP O
121 doctor NN I-NP O
121 may MD O O
121 make VB O O
121 changes NNS B-NP O
121 in IN B-VP O
121 your PRP$ O O
121 insulin NN B-NP B-m
121 regimin NN I-NP O
122 based VBN O O
122 on IN B-VP O
122 your PRP$ O O
122 recorded VBN O O
122 blood NN B-NP B-r
122 sugars NNS I-NP I-r
123 3 CD O O
123 Please NNP B-NP O
123 stop VB O O
123 taking VBG O O
123 Metoprolol NNP B-NP B-m
123 and CC O O
123 Lisinopril NNP B-NP B-m
124 4 CD O O
124 Please NNP B-NP O
124 start VB O O
124 taking VBG O O
124 Cozaar NNP B-NP B-m
124 and CC O O
124 Atenolol NNP B-NP B-m
124 Your NNP I-NP O
124 Reglan NNP I-NP B-m
124 dose VBP O O
124 is VBZ O O
125 increased JJ O O
126 5 CD O O
126 VNA NNP B-NP O
126 for IN B-VP O
126 diabetes JJ B-NP O
126 management NN I-NP O
126 , , O O
126 CHF NNP B-NP O
126 management NN I-NP O
126 , , O O
126 and CC O O
126 medical JJ B-NP O
126 compliance NN I-NP O
127 DISCHARGE NNP I-NP O
127 CONDITION: NNP I-NP O
127 Stable NNP I-NP O
128 TO NNP I-NP O
128 DO/PLAN: NNP I-NP O
129 No NNP I-NP O
129 dictated VBD B-VP O
129 summary JJ B-NP O
130 ENTERED NNP I-NP O
130 BY: NNP I-NP O
130 WOHLWENDI NNP I-NP O
130 , , O O
130 BARRETT NNP B-NP O
130 , , O O
130 M.D NNP B-NP O
130 , , O O
130 PH.D NNP B-NP O
130 ( ( O O
130 RL81 NNP B-NP O
130 ) ) O O
130 6/30/04 CD O O
130 @ $ O O
130 03 CD O O
131 ****** JJ B-NP O
131 END NN I-NP O
131 OF NNP I-NP O
131 DISCHARGE NNP I-NP O
131 ORDERS NNP I-NP O
131 ****** NNP I-NP O
132 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #98718 VBZ O O
2 192629344 CD O O
2 VCH NNP B-NP O
2 68247963 CD O O
2 4374625 CD O O
2 4/13/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 LEFT NNP I-NP O
2 LEG NNP I-NP O
2 CELLULITIS NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/18/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/23/2006 CD O O
4 ATTENDING: NNP B-NP O
4 DIFABIO NNP I-NP O
4 III NNP I-NP O
4 , , O O
4 ARNOLD NNP B-NP O
4 IGNACIO NNP I-NP O
4 MD NNP I-NP O
5 SERVICE: NNP I-NP O
5 Cardiac NNP I-NP O
5 Surgery NNP I-NP O
5 Service NNP I-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 Mr NNP I-NP O
6 Slunaker NNP I-NP O
6 is VBZ O O
6 a DT B-NP O
6 56-year-old JJ I-NP O
7 gentleman NN I-NP O
7 who WP O O
7 underwent VBD B-VP O
7 coronary JJ B-NP O
7 artery NN I-NP O
7 bypass NN I-NP O
7 grafting VBG O O
7 x4 NN B-NP O
7 on IN B-VP O
8 0/16/06 CD O O
8 with IN B-VP O
8 left JJ B-NP O
8 internal JJ I-NP O
8 mammary JJ I-NP O
8 artery NN I-NP O
8 to TO O O
8 left VB O O
8 anterior RP O O
9 descending VBG O O
9 coronary JJ B-NP O
9 artery NN I-NP O
9 , , O O
9 a DT B-NP O
9 saphenous JJ I-NP O
9 vein NN I-NP O
9 graft NN I-NP O
9 to TO O O
9 the DT B-NP O
9 ramus NN I-NP O
10 coronary JJ B-NP O
10 artery NN I-NP O
10 , , O O
10 a DT B-NP O
10 saphenous JJ I-NP O
10 vein NN I-NP O
10 graft NN I-NP O
10 to TO O O
10 the DT B-NP O
10 second JJ I-NP O
10 obtuse NN I-NP O
11 marginal JJ B-NP O
11 coronary JJ I-NP O
11 artery NN I-NP O
11 , , O O
11 and CC O O
11 a DT B-NP O
11 left JJ I-NP O
11 radial JJ I-NP O
11 artery NN I-NP O
11 graft NN I-NP O
11 to TO O O
11 the DT O O
12 right JJ O O
12 coronary JJ O O
12 artery IN B-VP O
12 The DT B-NP O
12 patient NN I-NP O
12 did VBD B-VP O
12 well RB O O
12 postoperatively RB O O
12 He PRP O O
13 was VBD B-VP O
13 discharged VBN O O
13 to TO O O
13 home NN B-NP O
13 in IN B-VP O
13 stable JJ B-NP O
13 condition NN I-NP O
13 on IN B-VP O
13 10/20/06 CD O O
13 The DT B-NP O
14 patient NN I-NP O
14 noted VBD B-VP O
14 his PRP$ O O
14 left JJ B-NP O
14 lower JJR I-NP O
14 leg NN I-NP O
14 to TO O O
14 be VB O O
14 warm JJ O O
14 and CC O O
14 swollen JJ O O
14 with IN B-VP O
15 redness NN B-NP O
15 and CC O O
15 presented VBN O O
15 to TO O O
15 see VB O O
16 Dr NNP B-NP O
16 Emory NNP I-NP O
16 Bebeau NNP I-NP O
16 in IN B-VP O
16 clinic JJ B-NP O
16 Dr NNP I-NP O
16 Odor NNP I-NP O
16 placed VBD B-VP O
16 the DT B-NP O
16 patient NN I-NP O
16 on IN B-VP O
17 levofloxacin NN B-NP B-m
17 and CC O O
17 vancomycin NN B-NP B-m
17 and CC O O
17 had VBD B-VP O
17 him PRP O O
17 admitted VBN O O
17 for IN B-VP O
17 left NN B-NP B-r
17 left VBD B-VP B-r
17 lower JJR B-NP O
18 leg NN I-NP O
18 cellulitis NN I-NP O
19 PAST NNP I-NP O
19 MEDICAL NNP I-NP O
19 AND NNP I-NP O
19 SURGICAL NNP I-NP O
19 HISTORY: NNP I-NP O
19 Significant NNP I-NP O
19 for IN B-VP O
19 hypertension NN B-NP O
19 , , O O
20 dyslipidemia NN B-NP O
20 , , O O
20 lumbar NN B-NP O
20 disc NN I-NP O
20 disease NN I-NP O
20 , , O O
20 nephrolithiasis NN B-NP O
20 , , O O
20 status NN B-NP O
20 post NN I-NP O
21 cholecystectomy NN I-NP O
21 , , O O
21 status NN B-NP O
21 post NN I-NP O
21 coronary JJ B-NP O
21 artery NN I-NP O
21 bypass NN I-NP O
21 graft NN I-NP O
21 as IN B-VP O
22 stated VBN O O
22 above IN B-VP O
23 ALLERGIES: NNP B-NP O
23 The DT B-NP O
23 patient NN I-NP O
23 has VBZ O O
23 allergies NNS B-NP O
23 to TO O O
23 tetanus VB O O
23 , , O O
23 where WRB O O
23 he PRP O O
24 develops VBZ O O
24 swelling VBG O O
25 MEDICATIONS NNP B-NP O
25 ON NNP I-NP O
25 ADMISSION: NNP I-NP O
25 Toprol NNP I-NP B-m
25 25 CD O B-do
25 mg JJ O I-do
25 daily RB O B-f
25 , , O O
25 diltiazem VBZ O B-m
25 30 CD O B-do
25 mg NN B-NP I-do
26 t.i.d NN I-NP B-f
26 , , O O
26 aspirin RB O B-m
26 325 CD O B-do
26 mg JJ O I-do
26 daily RB O B-f
26 , , O O
26 Lasix NNP B-NP B-m
26 40 CD O B-do
26 mg JJ O I-do
26 daily RB O B-f
26 , , O O
26 atorvastatin VBD B-VP B-m
26 40 CD O B-do
27 mg JJ O O
27 daily RB O B-f
27 , , O O
27 Tricor NNP B-NP B-m
27 145 CD O B-do
27 mg JJ O I-do
27 daily RB O B-f
27 , , O O
27 Zetia NNP B-NP B-m
27 10 CD O B-do
27 mg JJ O I-do
27 daily RB O B-f
27 , , O O
27 metformin VBD B-VP B-m
27 500 CD O B-do
28 mg JJ O O
28 daily JJ O B-f
28 , , O O
28 and CC O O
28 potassium NN B-NP B-m
28 chloride NN I-NP I-m
28 slow JJ B-NP I-m
28 release NN I-NP I-m
28 20 CD O B-do
28 mEq JJ B-NP I-do
28 daily JJ I-NP B-f
29 PHYSICAL NNP I-NP O
29 EXAMINATION: NNP I-NP O
29 Five NNP I-NP O
29 feet NNS I-NP O
29 10 CD O O
29 inches NNS B-NP O
29 tall JJ O O
29 , , O O
29 temperature NN B-NP O
29 97 CD O O
29 , , O O
30 heart NN B-NP O
30 rate NN I-NP O
30 52 CD O O
30 and CC O O
30 regular JJ O O
30 , , O O
30 blood NN B-NP O
30 pressure NN I-NP O
30 right JJ B-NP O
30 arm NN I-NP O
30 142/76 CD O O
30 , , O O
30 left VBD B-VP O
31 arm NN B-NP O
31 148/76 CD O O
31 , , O O
31 oxygen NN B-NP O
31 saturation NN I-NP O
31 95% CD O O
31 on IN B-VP O
31 room NN B-NP O
31 air NN I-NP O
31 Cardiovascular: NNP I-NP O
32 Regular NNP I-NP O
32 rate NN I-NP O
32 and CC O O
32 rhythm NN B-NP O
32 with IN B-VP O
32 a DT O O
32 2/6 CD O O
32 systolic JJ B-NP O
32 murmur NN I-NP O
32 at IN B-VP O
32 the DT B-NP O
32 right JJ I-NP O
33 upper JJ I-NP O
33 sternal JJ I-NP O
33 border NN I-NP O
33 Peripheral NNP I-NP O
33 vascular NN I-NP O
33 2+ CD O O
33 pulses NNS B-NP O
33 bilaterally RB O O
34 throughout IN B-VP O
34 Extremities: NNP B-NP O
34 Left NNP I-NP O
34 anterior JJ B-NP O
34 tibial JJ I-NP O
34 cellulitis NN I-NP O
35 ADMISSION NNP I-NP O
35 LABORATORY NNP I-NP O
35 DATA: NNP I-NP O
35 Admission NNP I-NP O
35 labs NN I-NP O
35 , , O O
35 sodium NN B-NP O
35 135 CD O O
35 , , O O
35 potassium NN B-NP O
36 4.4 CD O O
36 , , O O
36 chloride NN B-NP O
36 of IN B-VP O
36 101 CD O O
36 , , O O
36 CO2 NNP B-NP O
36 27 CD O O
36 , , O O
36 BUN NNP B-NP O
36 of IN B-VP O
36 29 CD O O
36 , , O O
36 creatinine NN B-NP O
36 1.3 CD O O
36 , , O O
36 glucose NN B-NP O
37 of IN B-VP O
37 113 CD O O
37 , , O O
37 WBC NNP B-NP O
37 is VBZ O O
37 11.62 CD O O
37 , , O O
37 hemoglobin NN B-NP O
37 11.9 CD O O
37 , , O O
37 hematocrit NN B-NP O
37 34.1 CD O O
37 , , O O
37 and CC O O
38 platelets NNS B-NP O
38 of IN B-VP O
38 573 CD O O
38 PT NNP B-NP O
38 13.2 CD O O
38 , , O O
38 PTT NNP B-NP O
38 of IN B-VP O
38 31.5 CD O O
38 , , O O
38 and CC O O
38 PT/INR NNP B-NP O
38 of IN B-VP O
38 1.0 CD O O
39 Urinalysis NNP B-NP O
39 was VBD B-VP O
39 negative JJ O O
39 for IN B-VP O
39 urinary JJ B-NP O
39 tract NN I-NP O
39 infection NN I-NP O
40 HOSPITAL NNP I-NP O
40 COURSE: NNP I-NP O
40 The DT B-NP O
40 patient NN I-NP O
40 was VBD B-VP O
40 admitted VBN O O
40 for IN B-VP O
40 a DT O B-r
40 a DT B-NP B-r
40 left JJ I-NP O
40 lower JJR I-NP O
40 leg NN I-NP O
41 cellulitis NN I-NP O
41 and CC O O
41 was VBD B-VP O
41 placed VBN O O
41 on IN B-VP O
41 levofloxacin NN B-NP B-m
41 and CC O O
41 vancomycin NN B-NP B-m
42 Infectious NNP I-NP O
42 disease NN I-NP O
42 consult NN I-NP O
42 was VBD B-VP O
42 called VBN O O
42 , , O O
42 and CC O O
42 recommendations NNS B-NP O
42 were VBD B-VP O
43 followed VBN O O
43 , , O O
43 which WDT O O
43 were VBD B-VP O
43 to TO O O
43 discontinue VB O O
43 the DT B-NP O
43 vancomycin NN I-NP B-m
43 and CC O O
44 levofloxacin NN B-NP B-m
44 , , O O
44 and CC O O
44 change NN B-NP O
44 to TO O O
44 Ancef NNP B-NP B-m
44 1 CD O B-do
44 gm NN B-NP I-do
44 IV NNP I-NP B-mo
44 q.8h NN I-NP B-f
44 and CC O O
44 monitor VB O O
44 his PRP$ O O
45 wound NN B-NP O
45 The DT B-NP O
45 patient NN I-NP O
45 remained VBD B-VP O
45 afebrile JJ B-NP O
45 White NNP I-NP O
45 count NN I-NP O
45 trended VBD B-VP O
45 down RB O O
46 and CC O O
46 leg JJ B-NP O
46 wound NN I-NP O
46 improved VBD B-VP O
46 on IN B-VP O
46 exam NN B-NP O
46 On IN B-VP O
46 the DT B-NP O
46 day NN I-NP O
46 of IN B-VP O
46 discharge NN B-NP O
46 , , O O
46 the DT B-NP O
47 patient NN I-NP O
47 was VBD B-VP O
47 noted VBN O O
47 to TO O O
47 have VB O O
47 an DT O O
47 improved VBN O O
47 left VBD B-VP O
47 lower JJR B-NP O
47 leg NN I-NP O
47 wound NN I-NP O
47 , , O O
47 he PRP O O
48 remained VBD B-VP O
48 afebrile JJ O O
48 , , O O
48 and CC O O
48 was VBD B-VP O
48 evaluated VBN O O
48 by IN B-VP O
48 Dr NNP B-NP O
48 Manvelyan NNP I-NP O
48 , , O O
48 and CC O O
48 cleared VBD B-VP O
49 for IN B-VP O
49 discharge NN B-NP O
49 to TO O O
49 home NN B-NP O
49 Infectious NNP I-NP O
49 disease NN I-NP O
49 wanted VBD B-VP O
49 him PRP O O
49 to TO O O
49 continue VB O O
50 on IN B-VP O
50 an DT B-NP O
50 oral JJ I-NP B-mo
50 dose NN I-NP O
50 of IN B-VP O
50 Augmentin NNP B-NP B-m
50 875/125 CD O B-do
50 mg NN B-NP I-do
50 b.i.d NN I-NP B-f
50 for IN B-VP B-du
50 a DT B-NP O
50 total NN I-NP O
50 of IN B-VP O
50 10 CD O O
51 days NNS B-NP O
52 DISCHARGE NNP I-NP O
52 LABORATORY NNP I-NP O
52 DATA: NNP I-NP O
52 Discharge NNP I-NP O
52 labs NNS I-NP O
52 are VBP O O
52 as IN B-VP O
52 follows VBZ O O
52 , , O O
53 glucose JJ O O
53 137 CD O O
53 , , O O
53 BUN NNP B-NP O
53 of IN B-VP O
53 21 CD O O
53 , , O O
53 creatinine NN B-NP O
53 1.2 CD O O
53 , , O O
53 sodium NN B-NP O
53 136 CD O O
53 , , O O
53 potassium NN B-NP O
54 4.2 CD O O
54 , , O O
54 chloride NN B-NP O
54 of IN B-VP O
54 102 CD O O
54 , , O O
54 CO2 NNP B-NP O
54 of IN B-VP O
54 26 CD O O
54 , , O O
54 magnesium NN B-NP O
54 1.8 CD O O
54 , , O O
54 WBC NNP B-NP O
54 is VBZ O O
54 11.11 CD O O
54 , , O O
55 hemoglobin NN B-NP O
55 12.6 CD O O
55 , , O O
55 hematocrit NN B-NP O
55 36.9 CD O O
55 , , O O
55 and CC O O
55 platelets NNS B-NP O
55 of IN B-VP O
55 695 CD O O
56 DISCHARGE NNP B-NP O
56 MEDICATIONS: NNP I-NP O
56 Discharge NNP I-NP O
56 medications NNS I-NP O
56 are VBP O O
56 as IN B-VP O
56 follows VBZ O O
56 , , O O
57 Augmentin NNP B-NP B-m
57 875/125 CD O I-m
57 1 CD O B-do
57 tab NN B-NP I-do
57 b.i.d NN I-NP B-f
57 for IN B-VP B-du
57 10 CD O I-du
57 days NNS B-NP I-du
57 , , O O
57 enteric-coated JJ B-NP B-m
58 aspirin NN I-NP O
58 325 CD O B-do
58 mg JJ O I-do
58 daily RB O B-f
58 , , O O
58 Lipitor NNP B-NP B-m
58 40 CD O B-do
58 mg JJ O I-do
58 daily RB O B-f
58 , , O O
58 diltiazem VBZ O B-m
58 30 CD O B-do
58 mg NN B-NP I-do
59 t.i.d NN I-NP B-f
59 , , O O
59 Zetia NNP B-NP B-m
59 10 CD O B-do
59 mg JJ O I-do
59 daily RB O B-f
59 , , O O
59 Tricor NNP B-NP B-m
59 145 CD O B-do
59 mg NN B-NP I-do
59 nightly RB O B-f
59 , , O O
59 Diflucan NNP B-NP B-m
59 200 CD O B-do
59 mg NNS B-NP I-do
60 daily RB O B-f
60 for IN B-VP B-du
60 one CD O I-du
60 dose NN B-NP I-du
60 for IN B-VP O
60 a DT B-NP B-r
60 penile JJ I-NP I-r
60 yeast NN I-NP I-r
60 infection NN I-NP I-r
60 , , O O
60 due JJ O O
60 to TO O O
61 antibiotic JJ B-NP O
61 use NN I-NP O
61 Metformin NNP I-NP B-m
61 500 CD O B-do
61 mg NN B-NP I-do
61 q.p.m NN I-NP B-f
61 , , O O
61 Toprol-XL NNP B-NP B-m
61 25 CD O B-do
61 mg NN B-NP I-do
61 daily RB O B-f
61 , , O O
62 and CC O O
62 oxycodone RB O B-m
62 5-10 JJ B-NP B-do
62 mg NN I-NP I-do
62 q.4h NN I-NP B-f
62 p.r.n NN I-NP I-f
62 pain NN I-NP B-r
63 FOLLOWUP: NNP I-NP O
63 Mr NNP I-NP O
63 Ansari NNP I-NP O
63 will MD O O
63 follow VB O O
63 up RP O O
63 with IN B-VP O
63 Dr NNP B-NP O
63 Noah NNP I-NP O
63 Schaffhauser NNP I-NP O
63 on IN B-VP O
64 5/7/06 CD O O
64 at IN B-VP O
64 1 CD O O
64 o'clock NN B-NP O
64 , , O O
64 Dr NNP B-NP O
64 Aaron NNP I-NP O
64 Phung NNP I-NP O
64 in IN B-VP O
64 three-four JJ B-NP O
64 days NNS I-NP O
64 , , O O
64 his PRP$ O O
65 primary JJ B-NP O
65 care NN I-NP O
65 physician NN I-NP O
65 , , O O
65 and CC O O
65 his PRP$ O O
65 cardiologist NN B-NP O
65 , , O O
65 Dr NNP B-NP O
65 Jonathon NNP I-NP O
65 Sopata NNP I-NP O
66 in IN B-VP O
66 one CD O O
66 to TO O O
66 two CD O O
66 weeks NNS B-NP O
67 DISCHARGE NNP I-NP O
67 INSTRUCTIONS: NNP I-NP O
67 The DT B-NP O
67 patient NN I-NP O
67 was VBD B-VP O
67 instructed VBN O O
67 to TO O O
67 monitor VB O O
68 his PRP$ O O
68 leg NN B-NP O
68 wound NN I-NP O
68 and CC O O
68 call VB O O
68 if IN B-VP O
68 he PRP O O
68 had VBD B-VP O
68 any DT O O
68 increased VBN O O
68 weight NN B-NP O
68 , , O O
69 temperature NN B-NP O
69 greater JJR O O
69 than IN B-VP O
69 101 CD O O
69 degrees NNS B-NP O
69 , , O O
69 any DT B-NP O
69 drainage NN I-NP O
69 from IN B-VP O
69 the DT B-NP O
70 wound NN I-NP O
70 , , O O
70 redness NN B-NP O
70 , , O O
70 swelling VBG O O
70 or CC O O
70 change NN B-NP O
70 of IN B-VP O
70 any DT B-NP O
70 kind NN I-NP O
70 in IN B-VP O
70 his PRP$ O O
70 leg NN B-NP O
70 wound IN B-VP O
71 He PRP O O
71 was VBD B-VP O
71 cleared VBN O O
71 by IN B-VP O
71 Infectious NNP B-NP O
71 Disease NNP I-NP O
71 Service NNP I-NP O
71 and CC O O
71 discharged VBD B-VP O
71 to TO O O
72 home NN B-NP O
72 in IN B-VP O
72 stable JJ B-NP O
72 condition NN I-NP O
73 eScription NN I-NP O
73 document: VBZ O O
73 8-0219144 JJ B-NP O
73 CSSten NNP I-NP O
73 Tel NNP I-NP O
74 Dictated NNP I-NP O
74 By: NNP I-NP O
74 SHEAHAN NNP I-NP O
74 , , O O
74 WILMER NNP B-NP O
75 Attending: NNP I-NP O
75 KITTELMAN NNP I-NP O
75 III NNP I-NP O
75 , , O O
75 CARROL NNP B-NP O
75 JAMES NNP I-NP O
76 Dictation NNP I-NP O
76 ID NNP I-NP O
76 8010511 CD O O
77 D: NNP B-NP O
77 4/3/06 CD O O
78 T: NNP B-NP O
78 4/3/06 CD O O
79 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #106650 VBZ O O
2 912344838 CD O O
2 CDHMC NNP B-NP O
2 57611498 CD O O
2 246241 CD O O
2 1/1/1995 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/16/1995 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/24/1995 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 Ms NNP I-NP O
4 Loften NNP I-NP O
4 is VBZ O O
4 a DT O O
4 62 CD O O
4 year NN B-NP O
4 old JJ B-NP O
4 woman NN I-NP O
4 with IN B-VP O
5 cardiac JJ B-NP O
5 risk NN I-NP O
5 factors NNS I-NP O
5 including VBG O O
6 hypertension NN B-NP O
6 , , O O
6 diabetes VBZ O O
6 mellitus NN B-NP O
6 , , O O
6 postmenopausal NN B-NP O
6 , , O O
6 who WP O O
6 presents VBZ O O
6 with IN B-VP O
7 exertional JJ B-NP O
7 angina NNS I-NP O
7 x VBP O O
7 four CD O O
7 months NNS B-NP O
7 On IN B-VP O
7 the DT B-NP O
7 day NN I-NP O
7 prior RB O O
7 to TO O O
7 admission NN B-NP O
7 , , O O
8 she PRP O O
8 had VBD B-VP O
8 a DT B-NP O
8 nondiagnostic JJ I-NP O
8 exercise NN I-NP O
8 tolerance NN I-NP O
8 test NN I-NP O
8 , , O O
8 and CC O O
8 was VBD B-VP O
8 admitted VBN O O
9 for IN B-VP O
9 cardiac JJ B-NP O
9 catheterization NN I-NP O
9 on IN B-VP O
9 January NNP B-NP O
9 , , O O
9 1995 CD O O
9 Upon IN B-VP O
9 further JJ O O
10 questioning VBG O O
10 when WRB O O
10 the DT B-NP O
10 patient NN I-NP O
10 presented VBD B-VP O
10 for IN B-VP O
10 catheterization NN B-NP O
10 , , O O
10 it PRP O O
10 was VBD B-VP O
11 found VBN O O
11 that IN B-VP O
11 she PRP O O
11 had VBD B-VP O
11 a DT B-NP O
11 previous JJ I-NP O
11 allergic JJ I-NP O
11 reaction NN I-NP O
11 to TO O O
11 intravenous JJ B-NP B-mo
12 contrast NN I-NP B-m
12 dye NN I-NP I-m
12 that WDT O O
12 caused VBD B-VP O
12 laryngeal JJ B-NP O
12 edema NN I-NP O
12 For IN B-VP O
12 that DT B-NP O
12 reason NN I-NP O
12 , , O O
12 the DT B-NP O
13 patient NN I-NP O
13 was VBD B-VP O
13 admitted VBN O O
13 for IN B-VP O
13 premedication NN B-NP O
13 overnight JJ O O
13 prior RB O O
13 to TO O O
14 catheterization VB O O
15 The DT B-NP O
15 patient NN I-NP O
15 , , O O
15 again RB O O
15 , , O O
15 is VBZ O O
15 a DT O O
15 62 CD O O
15 year NN B-NP O
15 old JJ O O
15 , , O O
15 and CC O O
15 is VBZ O O
15 a DT B-NP O
15 patient NN I-NP O
15 of IN B-VP O
15 Dr NNP B-NP O
16 Mayer NNP I-NP O
16 , , O O
16 with IN B-VP O
16 multiple JJ B-NP O
16 cardiac JJ I-NP O
16 risk NN I-NP O
16 factors NNS I-NP O
16 including VBG O O
16 hypertension NN B-NP O
16 , , O O
17 diabetes VBZ O O
17 , , O O
17 elevated VBD B-VP O
17 cholesterol NN B-NP O
17 , , O O
17 a DT B-NP O
17 positive JJ I-NP O
17 family NN I-NP O
17 history NN I-NP O
17 , , O O
17 and CC O O
18 being VBG O O
18 a DT B-NP O
18 postmenopausal NN I-NP O
18 woman NN I-NP O
18 She PRP O O
18 first RB O O
18 noted VBD B-VP O
18 exertional JJ B-NP O
19 substernal JJ I-NP O
19 chest NN I-NP O
19 pain NN I-NP O
19 about IN B-VP O
19 four CD O O
19 months NNS B-NP O
19 prior RB O O
19 to TO O O
19 admission VB O O
19 The DT B-NP O
20 pain NN I-NP O
20 radiates VBZ O O
20 to TO O O
20 her PRP$ O O
20 left JJ B-NP O
20 arm NN I-NP O
20 , , O O
20 and CC O O
20 is VBZ O O
20 associated VBN O O
20 with IN B-VP O
20 shortness NN B-NP O
20 of IN B-VP O
21 breath NN B-NP O
21 , , O O
21 but CC O O
21 no DT B-NP O
21 diaphoresis NN I-NP O
21 or CC O O
21 nausea NN B-NP O
21 or CC O O
21 vomiting VBG O O
21 The DT B-NP B-r
21 pain NN I-NP I-r
21 is VBZ O O
22 relieved VBN O O
22 by IN B-VP O
22 rest NN B-NP O
22 within IN B-VP O
22 two CD O O
22 minutes NNS B-NP O
22 , , O O
22 or CC O O
22 by IN B-VP O
22 a DT B-NP O
22 sublingual JJ I-NP B-mo
23 Nitroglycerin NNP I-NP B-m
23 , , O O
23 which WDT O O
23 she PRP O O
23 has VBZ O O
23 used VBN O O
23 in IN B-VP B-du
23 the DT B-NP I-du
23 past JJ I-NP I-du
23 week NN I-NP I-du
23 x NN I-NP I-du
23 two CD O I-du
23 Her NNP B-NP O
24 exercise NN I-NP O
24 tolerance NN I-NP O
24 is VBZ O O
24 limited VBN O O
24 by IN B-VP O
24 this DT B-NP O
24 pain NN I-NP O
24 , , O O
24 and CC O O
24 is VBZ O O
24 diminished VBN O O
24 to TO O O
25 +/- JJ O O
25 50 CD O O
25 yards NNS B-NP O
25 on IN B-VP O
25 the DT B-NP O
25 flat JJ I-NP O
25 surface NN I-NP O
25 at IN B-VP O
25 present JJ O O
25 The DT B-NP O
25 patient NN I-NP O
25 had VBD B-VP O
25 one CD O O
26 episode NN B-NP O
26 of IN B-VP O
26 pain NN B-NP O
26 at IN B-VP O
26 rest NN B-NP O
26 three CD O O
26 nights NNS B-NP O
26 prior RB O O
26 to TO O O
26 admission VB O O
26 She PRP O O
27 denies VBZ O O
27 shortness NN B-NP O
27 of IN B-VP O
27 breath NN B-NP O
27 , , O O
27 orthopnea NN B-NP O
27 , , O O
27 paroxysmal JJ B-NP O
27 nocturnal JJ I-NP O
28 dyspnea NN I-NP O
29 She PRP O O
29 was VBD B-VP O
29 admitted VBN O O
29 for IN B-VP O
29 rule NN B-NP O
29 out IN B-VP O
29 myocardial JJ B-NP O
29 infarction NN I-NP O
29 on IN B-VP O
29 November NNP B-NP O
29 , , O O
30 1995 CD O O
30 , , O O
30 and CC O O
30 ruled VBD B-VP O
30 out RP O O
30 by IN B-VP O
30 enzymes NNS B-NP O
30 and CC O O
30 electrocardiogram VB O O
30 She PRP O O
30 had VBD B-VP O
30 an DT B-NP O
31 echocardiogram NN I-NP O
31 done VBN O O
31 which WDT O O
31 revealed VBD B-VP O
31 an DT B-NP O
31 ejection NN I-NP O
31 fraction NN I-NP O
31 of IN B-VP O
31 60 CD O O
32 percent NN B-NP O
32 , , O O
32 with IN B-VP O
32 no DT B-NP O
32 regional JJ I-NP O
32 wall NN I-NP O
32 motion NN I-NP O
32 abnormalities NNS I-NP O
32 She PRP O O
32 had VBD B-VP O
32 2+ CD O O
33 mitral JJ B-NP O
33 regurgitation NN I-NP O
33 , , O O
33 1+ CD O O
33 aortic JJ B-NP O
33 regurgitation NN I-NP O
33 , , O O
33 and CC O O
33 1+ CD O O
33 tricuspid JJ B-NP O
34 regurgitation NN I-NP O
34 The DT B-NP O
34 day NN I-NP O
34 prior RB O O
34 to TO O O
34 admission NN B-NP O
34 , , O O
34 she PRP O O
34 underwent VBD B-VP O
34 an DT B-NP O
35 exercise NN I-NP O
35 tolerance NN I-NP O
35 test NN I-NP O
35 She PRP O O
35 went VBD B-VP O
35 two CD O O
35 minutes NNS B-NP O
35 on IN B-VP O
35 standard JJ B-NP O
35 Bruce NNP I-NP O
36 protocol NN I-NP O
36 , , O O
36 stopped VBD B-VP O
36 secondary JJ O O
36 to TO O O
36 diaphoresis VB O O
36 and CC O O
36 shortness NN B-NP O
36 of IN B-VP O
36 breath NN B-NP O
37 without IN B-VP O
37 chest NN B-NP O
37 pain NN I-NP O
37 , , O O
37 and CC O O
37 she PRP O O
37 had VBD B-VP O
37 nondiagnostic JJ B-NP O
37 electrocardiogram NN I-NP O
38 changes VBZ O O
38 The DT B-NP O
38 patient NN I-NP O
38 was VBD B-VP O
38 admitted VBN O O
38 for IN B-VP O
38 premedication NN B-NP O
38 for IN B-VP O
38 her PRP$ O O
38 dye NN B-NP O
39 allergy NN I-NP O
39 and CC O O
39 subsequently RB O O
39 catheterization NN B-NP O
40 PAST NNP I-NP O
40 MEDICAL NNP I-NP O
40 HISTORY: NNP I-NP O
40 Her NNP I-NP O
40 past JJ B-NP O
40 medical JJ I-NP O
40 history NN I-NP O
40 is VBZ O O
40 significant JJ O O
40 for: JJ O O
41 1 CD O O
41 Hypertension NNP B-NP O
42 2 CD O O
42 Diabetes VBZ O O
43 3 CD O O
43 Hypercholesterolemia NN B-NP O
44 4 CD O O
44 She PRP O O
44 has VBZ O O
44 a DT B-NP O
44 history NN I-NP O
44 of IN B-VP O
44 a DT B-NP O
44 deep JJ I-NP O
44 venous JJ I-NP O
44 thrombosis NN I-NP O
44 in IN B-VP O
44 1994 CD O O
45 5 CD O O
45 She PRP O O
45 has VBZ O O
45 chronic JJ B-NP O
45 renal JJ I-NP O
45 insufficiency NN I-NP O
45 , , O O
45 with IN B-VP O
45 a DT B-NP O
45 GFR NNP I-NP O
45 of IN B-VP O
45 48 CD O O
45 , , O O
45 and CC O O
45 the DT B-NP O
46 twenty-four JJ I-NP O
46 hour NN I-NP O
46 urine NN I-NP O
46 shows VBZ O O
46 3.8 CD O O
46 grams NNS B-NP O
46 of IN B-VP O
46 protein NN B-NP O
47 6 CD O O
47 She PRP O O
47 is VBZ O O
47 status NN B-NP O
47 post NN I-NP O
47 cholecystectomy NN I-NP O
48 7 CD O O
48 She PRP O O
48 has VBZ O O
48 vitiligo JJ B-NP O
49 MEDICATIONS NNP I-NP O
49 ON NNP I-NP O
49 ADMISSION: NNP I-NP O
49 1 CD O O
49 Aspirin NNP B-NP B-m
49 q.d VBD B-VP B-f
50 2 CD O O
50 Enalapril NNP B-NP B-m
50 20 CD O B-do
50 mg NN B-NP I-do
50 b.i.d NN I-NP B-f
51 3 CD O O
51 Cardizem NNP B-NP B-m
51 300 CD O B-do
51 mg NN B-NP I-do
51 q.d NN I-NP B-f
52 4 CD O O
52 Insulin NNP B-NP B-m
52 Insulin NNP I-NP B-m
52 mixed VBD B-VP I-m
52 mixed JJ O I-m
52 70/30 CD O I-m
52 70/30 CD O I-m
52 with IN B-VP O
52 60 CD O B-do
52 units NNS B-NP I-do
52 in IN B-VP B-f
52 the DT B-NP I-f
52 morning NN I-NP I-f
52 and CC O O
52 30 CD O B-do
52 in IN B-VP B-f
52 the DT B-NP O
53 evening NN I-NP O
54 5 CD O O
54 Atenolol NNP B-NP B-m
54 50 CD O B-do
54 mg NN B-NP I-do
54 q.d NN I-NP B-f
55 ALLERGIES: NNP I-NP O
55 Her NNP I-NP O
55 allergies NNS I-NP O
55 include VBP O O
55 contrast NN B-NP O
55 dye NN I-NP O
55 which WDT O O
55 gives VBZ O O
55 her PRP O O
55 a DT B-NP O
56 rash NN I-NP O
56 and CC O O
56 laryngeal NN B-NP O
56 edema NN I-NP O
56 , , O O
56 Penicillin NNP B-NP O
56 which WDT O O
56 gives VBZ O O
56 her PRP$ O O
57 edema JJ B-NP O
58 SOCIAL NNP I-NP O
58 HISTORY: NNP I-NP O
58 The DT B-NP O
58 patient NN I-NP O
58 lives VBZ O O
58 alone RB O O
58 , , O O
58 but CC O O
58 has VBZ O O
58 two CD O O
58 very RB O O
59 supportive JJ B-NP O
59 daughters NNS I-NP O
59 She PRP O O
59 has VBZ O O
59 no DT B-NP O
59 smoking NN I-NP O
59 or CC O O
60 alcohol NN B-NP O
60 history NN I-NP O
61 FAMILY NNP I-NP O
61 HISTORY: NNP I-NP O
61 Her NNP I-NP O
61 family NN I-NP O
61 history NN I-NP O
61 is VBZ O O
61 significant JJ O O
61 for IN B-VP O
61 brothers NNS B-NP O
61 who WP O O
62 had VBD B-VP O
62 myocardial JJ B-NP O
62 infarctions NNS I-NP O
62 in IN B-VP O
62 their PRP$ O O
62 50's CD O O
62 and CC O O
62 60's CD O O
62 , , O O
63 and CC O O
63 a DT B-NP O
63 mother NN I-NP O
63 who WP O O
63 had VBD B-VP O
63 a DT B-NP O
63 myocardial JJ I-NP O
63 infarction NN I-NP O
63 when WRB O O
63 she PRP O O
63 was VBD B-VP O
63 69 CD O O
64 PHYSICAL NNP B-NP O
64 EXAMINATION: NNP I-NP O
64 On IN B-VP O
64 examination NN B-NP O
64 , , O O
64 this DT O O
64 is VBZ O O
64 a DT O O
64 very RB O O
64 pleasant JJ B-NP O
65 Clarkant NNP I-NP O
65 Prings NNP I-NP O
65 U NNP I-NP O
65 woman NN I-NP O
65 , , O O
65 who WP O O
65 speaks VBZ O O
65 predominantly RB O O
66 Spanish JJ O O
66 , , O O
66 who WP O O
66 is VBZ O O
66 in IN B-VP O
66 no DT B-NP O
66 acute NN I-NP O
66 distress NN I-NP O
66 Her NNP I-NP O
66 vital JJ B-NP O
66 signs NNS I-NP O
66 were VBD B-VP O
66 a DT B-NP O
67 temperature NN I-NP O
67 of IN B-VP O
67 98.6 CD O O
67 , , O O
67 heart NN B-NP O
67 rate NN I-NP O
67 71 CD O O
67 , , O O
67 blood NN B-NP O
67 pressure NN I-NP O
67 168/70 CD O O
67 , , O O
68 respiratory NN B-NP O
68 rate NN I-NP O
68 18 CD O O
68 The DT B-NP O
68 remainder NN I-NP O
68 of IN B-VP O
68 her PRP$ O O
68 examination NN B-NP O
68 was VBD B-VP O
69 significant JJ O O
69 for IN B-VP O
69 flat JJ B-NP O
69 jugular JJ I-NP O
69 venous JJ I-NP O
69 pressure NN I-NP O
69 , , O O
69 but CC O O
69 questionable JJ B-NP O
70 bruit NN I-NP O
70 in IN B-VP O
70 the DT B-NP O
70 left NN I-NP O
70 carotid NN I-NP O
70 Cardiac NNP I-NP O
70 examination NN I-NP O
70 was VBD B-VP O
70 significant JJ O O
70 for IN B-VP O
71 a DT B-NP O
71 normal JJ I-NP O
71 S1 NNP I-NP O
71 and CC O O
71 S2 NNP B-NP O
71 , , O O
71 with IN B-VP O
71 an DT B-NP O
71 S3 NNP I-NP O
71 noted VBD B-VP O
71 , , O O
71 no DT B-NP O
71 murmur NN I-NP O
71 Her PRP$ O O
71 extremities NNS B-NP O
72 showed VBD B-VP O
72 trace NN B-NP O
72 edema NN I-NP O
72 bilaterally RB O O
72 , , O O
72 2+ CD O O
72 pulse NN B-NP O
72 in IN B-VP O
72 the DT O O
72 left JJ O O
72 femoral JJ O O
72 , , O O
72 no DT B-NP O
73 pulses NNS I-NP O
73 palpated VBN O O
73 on IN B-VP O
73 the DT B-NP O
73 right NN I-NP O
73 , , O O
73 and CC O O
73 1+ CD O O
73 dorsalis NNS B-NP O
73 pedis JJ B-NP O
73 pulses NNS I-NP O
74 LABORATORY NNP I-NP O
74 DATA: NNP I-NP O
74 Her NNP I-NP O
74 labs NN I-NP O
74 are VBP O O
74 significant JJ O O
74 for IN B-VP O
74 a DT B-NP O
74 creatinine NN I-NP O
74 of IN B-VP O
74 1.7 CD O O
74 , , O O
75 an DT O O
75 elevated VBN O O
75 cholesterol NN B-NP O
75 at IN B-VP O
75 294 CD O O
75 Her PRP$ O O
75 urine NN B-NP O
75 showed VBD B-VP O
76 3+ CD O O
76 protein NN B-NP O
76 , , O O
76 1+ CD O O
76 glucose VBD B-VP O
76 Her NNP B-NP O
76 electrocardiogram NN I-NP O
76 was VBD B-VP O
76 normal JJ B-NP O
76 sinus JJ I-NP O
77 rhythm NN I-NP O
77 at IN B-VP O
77 78 CD O O
77 , , O O
77 with IN B-VP O
77 normal JJ B-NP O
77 axis NNS I-NP O
77 and CC O O
77 interval NN B-NP O
77 , , O O
77 and CC O O
77 lateral JJ B-NP O
77 V4 NNP I-NP O
77 through IN B-VP O
78 V6 NNP B-NP O
78 T NNP I-NP O
78 wave VBP O O
78 flattening VBG O O
79 HOSPITAL NNP B-NP O
79 COURSE: NNP I-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 was VBD B-VP O
79 catheterized VBN O O
79 on IN B-VP O
79 January NNP B-NP O
79 , , O O
80 1995 CD O O
80 , , O O
80 with IN B-VP O
80 results NNS B-NP O
80 showing VBG O O
80 proximal JJ O O
80 left JJ O O
80 anterior JJ O O
81 descending VBG O O
81 stenosis NN B-NP O
81 of IN B-VP O
81 50 CD O O
81 percent NN B-NP O
81 , , O O
81 mid NN B-NP O
81 left VBD B-VP O
81 anterior JJ O O
81 descending VBG O O
82 stenosis NN B-NP O
82 of IN B-VP O
82 70 CD O O
82 percent NN B-NP O
82 The DT B-NP O
82 distal NN I-NP O
82 left VBD B-VP O
82 anterior JJ B-NP O
82 descending NN I-NP O
82 was VBD B-VP O
83 diffusely RB O O
83 diseased VBN O O
83 , , O O
83 and CC O O
83 her PRP$ O O
83 first JJ O O
83 diagonal JJ O O
83 showed VBD B-VP O
83 a DT B-NP O
83 discrete JJ I-NP O
84 stenosis NN I-NP O
84 of IN B-VP O
84 80 CD O O
84 percent NN B-NP O
84 On IN B-VP O
84 the DT B-NP O
84 right NN I-NP O
84 , , O O
84 she PRP O O
84 had VBD B-VP O
84 in IN B-VP O
84 the DT B-NP O
84 proximal JJ I-NP O
85 right JJ I-NP O
85 coronary NN I-NP O
85 artery VBD B-VP O
85 a DT B-NP O
85 discrete JJ I-NP O
85 lesion NN I-NP O
85 of IN B-VP O
85 50 CD O O
85 percent NN B-NP O
85 , , O O
85 and CC O O
85 in IN B-VP O
85 the DT B-NP O
86 mid NN I-NP O
86 right JJ B-NP O
86 coronary JJ I-NP O
86 artery NN I-NP O
86 diffusely RB O O
86 diseased VBD B-VP O
86 at IN B-VP O
86 50 CD O O
86 percent NN B-NP O
86 The DT B-NP O
87 patient NN I-NP O
87 underwent JJ B-NP O
87 successful JJ I-NP O
87 balloon NN I-NP O
87 angioplasty NN I-NP O
87 of IN B-VP O
87 the DT B-NP O
87 mid NN I-NP O
87 left VBD B-VP O
88 anterior JJ O O
88 descending VBG O O
88 artery JJ B-NP O
88 stenosis NN I-NP O
88 from IN B-VP O
88 70 CD O O
88 percent NN B-NP O
88 to TO O O
88 10 CD O O
88 percent NN B-NP O
89 The DT B-NP O
89 patient's NN I-NP O
89 post NN I-NP O
89 catheterization NN I-NP O
89 course NN I-NP O
89 was VBD B-VP O
89 complicated VBN O O
89 by IN B-VP O
89 a DT B-NP O
89 loss NN I-NP O
90 of IN B-VP O
90 150 CD O O
90 cc NN B-NP O
90 of IN B-VP O
90 blood NN B-NP O
90 after IN B-VP O
90 her PRP$ O O
90 right JJ B-NP O
90 groin NN I-NP O
90 sheath NN I-NP O
90 was VBD B-VP O
90 removed VBN O O
90 , , O O
90 but CC O O
91 the DT B-NP O
91 bleeding NN I-NP O
91 was VBD B-VP O
91 stopped VBN O O
91 after IN B-VP O
91 90 CD O O
91 minutes NNS B-NP O
91 of IN B-VP O
91 compression NN B-NP O
91 Her NNP I-NP O
92 hematocrit NN I-NP O
92 on IN B-VP O
92 admission NN B-NP O
92 was VBD B-VP O
92 35.9 CD O O
92 , , O O
92 which WDT O O
92 dropped VBD B-VP O
92 to TO O O
92 30.1 CD O O
92 after IN B-VP O
92 the DT B-NP O
93 sheath NN I-NP O
93 removal NN I-NP O
93 , , O O
93 but CC O O
93 remained VBD B-VP O
93 stable JJ O O
93 and CC O O
93 she PRP O O
93 was VBD B-VP O
93 discharged VBN O O
93 with IN B-VP O
93 a DT B-NP O
94 hematocrit NN I-NP O
94 of IN B-VP O
94 30.8 CD O O
94 The DT B-NP O
94 patient NN I-NP O
94 also RB O O
94 had VBD B-VP O
94 one CD O O
94 mild JJ B-NP O
94 occurrence NN I-NP O
94 of IN B-VP O
95 chest NN B-NP O
95 pain NN I-NP O
95 post NN I-NP O
95 catheterization NN I-NP O
95 which WDT O O
95 was VBD B-VP O
95 relieved VBN O O
95 with IN B-VP O
95 two CD O O
96 sublinguals NNS B-NP O
96 , , O O
96 and CC O O
96 showed VBD B-VP O
96 no DT B-NP O
96 electrocardiogram NN I-NP O
96 changes VBZ O O
97 Upon NNP B-NP O
97 discharge NN I-NP O
97 , , O O
97 the DT B-NP O
97 patient NN I-NP O
97 was VBD B-VP O
97 noted VBN O O
97 to TO O O
97 have VB O O
97 elevated VBN O O
97 liver JJ B-NP O
98 function NN I-NP O
98 tests NNS I-NP O
98 , , O O
98 with IN B-VP O
98 an DT B-NP O
98 ALT NNP I-NP O
98 going VBG O O
98 from IN B-VP O
98 16 CD O O
98 to TO O O
98 156 CD O O
98 , , O O
98 an DT B-NP O
98 AST NNP I-NP O
98 going VBG O O
98 from IN B-VP O
99 16 CD O O
99 to TO O O
99 65 CD O O
99 , , O O
99 an DT B-NP O
99 alkaline JJ I-NP O
99 phosphatase NN I-NP O
99 going VBG O O
99 from IN B-VP O
99 87 CD O O
99 to TO O O
99 171 CD O O
99 The DT B-NP O
100 patient's NN I-NP O
100 primary JJ B-NP O
100 medical JJ I-NP O
100 doctor NN I-NP O
100 , , O O
100 Dr NNP B-NP O
100 Schummer NNP I-NP O
100 , , O O
100 was VBD B-VP O
100 notified VBN O O
100 and CC O O
101 agreed VBN O O
101 to TO O O
101 workup VB O O
101 the DT B-NP O
101 elevated JJ I-NP O
101 liver NN I-NP O
101 function NN I-NP O
101 tests VBZ O O
101 The DT B-NP O
101 patient NN I-NP O
102 was VBD B-VP O
102 discharged VBN O O
102 on IN B-VP O
102 her PRP O O
102 admitting VBG O O
102 medications NNS B-NP O
103 DISCHARGE NNP I-NP O
103 MEDICATIONS: NNP I-NP O
103 1 CD O O
103 Aspirin NNP B-NP B-m
103 325 CD O B-do
103 mg NN B-NP I-do
103 q.d NN I-NP B-f
104 2 CD O O
104 Enalapril NNP B-NP B-m
104 20 CD O B-do
104 mg NN B-NP I-do
104 b.i.d NN I-NP B-f
105 3 CD O O
105 Cardizem NNP B-NP B-m
105 300 CD O B-do
105 mg NN B-NP I-do
105 q.d NN I-NP B-f
106 4 CD O O
106 Atenolol NNP B-NP B-m
106 50 CD O B-do
106 mg NN B-NP I-do
106 b.i.d NN I-NP B-f
107 5 CD O O
107 Additionally RB O O
107 , , O O
107 she PRP O O
107 was VBD B-VP O
107 started VBN O O
107 on IN B-VP O
107 Simvastatin NNP B-NP B-m
107 10 CD O B-do
107 mg NN B-NP I-do
107 q.h.s JJ B-NP B-f
108 CONDITION NNP I-NP O
108 ON NNP I-NP O
108 DISCHARGE: NNP I-NP O
108 The DT B-NP O
108 patient NN I-NP O
108 was VBD B-VP O
108 discharged VBN O O
108 in IN B-VP O
108 stable JJ B-NP O
109 condition NN I-NP O
110 FOLLOW-UP: NNP I-NP O
110 The DT B-NP O
110 patient NN I-NP O
110 was VBD B-VP O
110 discharged VBN O O
110 with IN B-VP O
110 a DT B-NP O
110 scheduled JJ I-NP O
110 appointment NN I-NP O
111 the DT B-NP O
111 day NN I-NP O
111 after IN B-VP O
111 discharge NN B-NP O
111 with IN B-VP O
111 Dr NNP B-NP O
111 Mondone NNP I-NP O
112 Dictated NNP I-NP O
112 By: NNP I-NP O
112 IRA NNP I-NP O
112 ZARELLA NNP I-NP O
112 , , O O
112 DBE NNP B-NP O
113 Attending: NNP I-NP O
113 EMMETT NNP I-NP O
113 FARREL NNP I-NP O
113 , , O O
113 M.D NNP B-NP O
113 NY6 NNP I-NP O
114 DO451/1343 NNP I-NP O
115 Batch: NNP I-NP O
115 62407 CD O O
115 Index NNP B-NP O
115 No NNP I-NP O
115 D3WLB4259P NNP I-NP O
115 D: NNP I-NP O
115 6/25/95 CD O O
116 T: NNP B-NP O
116 6/25/95 CD O O
117 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #108014 VBZ O O
2 596789724 CD O O
2 JH NNP B-NP O
2 82413662 CD O O
2 3294450 CD O O
2 0/7/2003 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 RENAL NNP I-NP O
2 FAILURE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/7/2003 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/11/2003 CD O O
4 ATTENDING: NNP B-NP O
4 DALE NNP I-NP O
4 NED NNP I-NP O
4 SAVITCH NNP I-NP O
4 MD NNP I-NP O
5 ATTENDING NNP I-NP O
5 PHYSICIAN NNP I-NP O
5 ON NNP I-NP O
5 ADMISSION: NNP I-NP O
6 Emmitt NNP I-NP O
6 Marc NNP I-NP O
6 Guier NNP I-NP O
6 , , O O
6 M.D NNP B-NP O
7 ATTENDING NNP I-NP O
7 PHYSICIAN NNP I-NP O
7 ON NNP I-NP O
7 DISCHARGE: NNP I-NP O
8 Marco NNP I-NP O
8 Mccaster NNP I-NP O
8 , , O O
8 M.D NNP B-NP O
9 CHIEF NNP I-NP O
9 COMPLAINT: NNP I-NP O
10 Mr NNP I-NP O
10 Gramby NNP I-NP O
10 is VBZ O O
10 a DT B-NP O
10 43-year-old JJ I-NP O
10 man NN I-NP O
10 with IN B-VP O
10 morbid JJ B-NP O
10 obesity NN I-NP O
10 , , O O
10 type NN B-NP O
10 II NNP I-NP O
11 diabetes VBZ O O
11 , , O O
11 hypertension NN B-NP O
11 , , O O
11 hyperlipidemia NN B-NP O
11 , , O O
11 chronic JJ B-NP O
11 renal JJ I-NP O
12 insufficiency NN I-NP O
12 , , O O
12 and CC O O
12 severe JJ B-NP O
12 peripheral JJ I-NP O
12 arterial JJ I-NP O
12 disease NN I-NP O
12 status NN I-NP O
12 post NN I-NP O
13 femoral JJ B-NP O
13 popliteal NN I-NP O
13 bypass NN I-NP O
13 in IN B-VP O
13 July NNP B-NP O
13 which WDT O O
13 was VBD B-VP O
13 complicated VBN O O
13 by IN B-VP O
13 repeated JJ B-NP O
14 return NN I-NP O
14 of IN B-VP O
14 cellulitis NN B-NP O
14 x $ O O
14 2 CD O O
14 who WP O O
14 was VBD B-VP O
14 admitted VBN O O
14 with IN B-VP O
14 cellulitis NN B-NP O
14 and CC O O
15 volume NN B-NP O
15 overload JJ B-NP O
16 HISTORY NNP I-NP O
16 OF NNP I-NP O
16 PRESENT NNP I-NP O
16 ILLNESS: NNP I-NP O
17 The DT B-NP O
17 patient NN I-NP O
17 has VBZ O O
17 had VBN O O
17 two CD O O
17 wound JJ B-NP B-r
17 complications NNS I-NP I-r
17 after IN B-VP O
17 his PRP$ O O
17 femoral JJ B-NP O
18 popliteal NN I-NP O
18 bypass NN I-NP O
18 requiring VBG O O
18 two CD O O
18 separate JJ B-NP O
18 incisions NNS I-NP O
18 and CC O O
18 drainages NNS B-NP O
19 including VBG O O
19 courses NNS B-NP O
19 of IN B-VP O
19 intravenous JJ B-NP B-mo
19 nafcillin NNS I-NP B-m
19 x VBP O B-du
19 4 CD O I-du
19 weeks NNS B-NP I-du
19 and CC O O
19 with IN B-VP O
20 vancomycin JJ O B-m
20 x $ O B-du
20 4 CD O I-du
20 weeks NNS B-NP I-du
20 He PRP O O
20 had VBD B-VP O
20 been VBN O O
20 seen VBN O O
20 by IN B-VP O
20 Vascular JJ B-NP O
20 Surgery NNP I-NP O
20 five CD O O
21 days NNS B-NP O
21 prior RB O O
21 to TO O O
21 admission NN B-NP O
21 and CC O O
21 had VBD B-VP O
21 been VBN O O
21 started VBN O O
21 on IN B-VP O
21 dicloxacillin NN B-NP B-m
21 for IN B-VP O
22 a DT B-NP O
22 third JJ I-NP O
22 episode NN I-NP O
22 of IN B-VP O
22 cellulitis NN B-NP B-r
22 He PRP O O
22 had VBD B-VP O
22 also RB O O
22 presented VBN O O
22 with IN B-VP O
22 fluid JJ B-NP B-r
22 fluid NN I-NP B-r
23 overload NN I-NP O
23 and CC O O
23 spironolactone NN B-NP B-m
23 was VBD B-VP O
23 added VBN O O
23 to TO O O
23 his PRP$ O O
23 diuretic JJ B-NP B-m
23 regimen NNS I-NP I-m
24 His PRP$ O O
24 primary JJ B-NP O
24 care NN I-NP O
24 provider NN I-NP O
24 saw VBD B-VP O
24 him PRP O O
24 the DT B-NP O
24 day NN I-NP O
24 prior RB O O
24 to TO O O
24 admission NN B-NP O
24 , , O O
24 and CC O O
25 the DT B-NP O
25 patient NN I-NP O
25 reported VBD B-VP O
25 a DT B-NP O
25 recent JJ I-NP O
25 fall NN I-NP O
25 and CC O O
25 the DT B-NP O
25 primary JJ I-NP O
25 care NN I-NP O
25 physician NN I-NP O
26 recommended VBD B-VP O
26 admission NN B-NP O
26 to TO O O
26 the DT B-NP O
26 hospital NN I-NP O
26 The DT B-NP O
26 patient NN I-NP O
26 does VBZ O O
26 report VB O O
27 some DT B-NP O
27 fever NN I-NP O
27 and CC O O
27 shaking VBG O O
27 chills NNS B-NP O
27 and CC O O
27 decreased VBN O O
27 appetite NN B-NP O
27 Also RB O O
27 , , O O
28 reported VBD B-VP O
28 weakness NN B-NP O
28 in IN B-VP O
28 bilateral JJ B-NP O
28 lower JJR I-NP O
28 extremities NNS I-NP O
28 and CC O O
28 right JJ B-NP O
28 foot NN I-NP O
29 pain NN I-NP O
29 He PRP O O
29 has VBZ O O
29 chronic JJ B-NP O
29 loss NN I-NP O
29 of IN B-VP O
29 sensation NN B-NP O
29 in IN B-VP O
29 both DT B-NP O
29 feet NNS I-NP O
30 PAST NNP I-NP O
30 MEDICAL NNP I-NP O
30 HISTORY: NNP I-NP O
31 Morbid NNP I-NP O
31 obesity NN I-NP O
31 , , O O
31 type NN B-NP O
31 II NNP I-NP O
31 diabetes VBZ O O
31 , , O O
31 chronic JJ B-NP O
31 renal JJ I-NP O
31 insufficiency NN I-NP O
32 with IN B-VP O
32 a DT B-NP O
32 baseline JJ I-NP O
32 creatinine NN I-NP O
32 of IN B-VP O
32 2-2.5 JJ O O
32 , , O O
32 dyslipidemia NN B-NP O
32 , , O O
32 hypertension NN B-NP O
32 , , O O
33 coronary JJ B-NP O
33 artery NN I-NP O
33 disease NN I-NP O
33 , , O O
33 peripheral JJ B-NP O
33 vascular JJ I-NP O
33 disease NN I-NP O
33 , , O O
33 anemia NN B-NP O
33 , , O O
34 history NN B-NP O
34 of IN B-VP O
34 deep JJ B-NP O
34 vein NN I-NP O
34 thrombosis NN I-NP O
34 , , O O
34 obstructive JJ B-NP O
34 sleep NN I-NP O
34 apnea NN I-NP O
34 , , O O
34 anger NN B-NP O
35 disorder NN I-NP O
35 , , O O
35 peptic JJ B-NP O
35 ulcer NN I-NP O
35 disease NN I-NP O
35 , , O O
35 and CC O O
35 tinea NN B-NP O
35 pedis VBP O O
36 MEDICATIONS NNP B-NP O
36 ON NNP I-NP O
36 ADMISSION: NNP I-NP O
37 Atenolol NNP I-NP B-m
37 100 CD O B-do
37 mg NN B-NP I-do
37 q.d NN I-NP B-f
37 , , O O
37 spironolactone NN B-NP B-m
37 , , O O
37 torsemide RB O B-m
37 160 CD O B-do
37 mg NN B-NP I-do
37 b.i.d NN I-NP B-f
37 , , O O
38 Hyzaar NNP B-NP B-m
38 50/12.5 CD O I-m
38 q NN B-NP B-f
38 day NN I-NP I-f
38 , , O O
38 lisinopril VBZ O B-m
38 60 CD O B-do
38 mg NN B-NP I-do
38 q NN I-NP B-f
38 day NN I-NP I-f
38 , , O O
38 Neurontin NNP B-NP B-m
38 1200 CD O B-do
38 mg NN B-NP I-do
39 t.i.d NN I-NP B-f
39 , , O O
39 Norvasc NNP B-NP B-m
39 Norvasc NNP I-NP B-m
39 10 CD O B-do
39 mg NN B-NP I-do
39 q.a.m NN I-NP B-f
39 and CC O O
39 5 CD O B-do
39 mg NN B-NP I-do
39 q.p.m NN I-NP B-f
39 , , O O
39 Coumadin NNP B-NP B-m
39 8 CD O B-do
39 mg NN B-NP I-do
39 , , O O
40 aspirin NN B-NP B-m
40 , , O O
40 Humalog NNP B-NP B-m
40 sliding VBG O B-do
40 scale NN B-NP I-do
40 , , O O
40 Percocet NNP B-NP B-m
40 , , O O
40 Pletal NNP B-NP B-m
40 100 CD O B-do
40 mg NN B-NP I-do
40 b.i.d NN I-NP B-f
40 , , O O
41 Procrit NNP B-NP B-m
41 , , O O
41 Zantac NNP B-NP B-m
41 , , O O
41 nitroglycerin JJ B-NP B-m
41 p.r.n NN I-NP B-f
41 , , O O
41 and CC O O
41 NPH NNP B-NP B-m
41 80 CD O B-do
41 q.a.m NN B-NP B-f
41 and CC O O
42 q.p.m JJ B-NP O
43 PHYSICAL NNP I-NP O
43 EXAMINATION: NNP I-NP O
44 On IN B-VP O
44 physical JJ B-NP O
44 exam NN I-NP O
44 , , O O
44 the DT B-NP O
44 patient NN I-NP O
44 was VBD B-VP O
44 afebrile JJ O O
44 and CC O O
44 had VBD B-VP O
44 a DT B-NP O
44 temperature NN I-NP O
45 of IN B-VP O
45 99 CD O O
45 , , O O
45 a DT B-NP O
45 heart NN I-NP O
45 rate NN I-NP O
45 of IN B-VP O
45 70 CD O O
45 , , O O
45 blood NN B-NP O
45 pressure NN I-NP O
45 200/79 CD O O
45 possibly RB O O
45 taken VBN O O
46 with IN B-VP O
46 an DT B-NP O
46 undersized JJ I-NP O
46 cuff NN I-NP O
46 , , O O
46 18 CD O O
46 and CC O O
46 99% CD O O
46 on IN B-VP O
46 room NN B-NP O
46 air NN I-NP O
46 He PRP O O
46 is VBZ O O
46 obese JJ O O
46 and CC O O
47 comfortable JJ B-NP O
47 man NN I-NP O
47 in IN B-VP O
47 bed NN B-NP O
47 and CC O O
47 in IN B-VP O
47 no DT B-NP O
47 acute NN I-NP O
47 distress VB O O
47 His PRP$ O O
47 JVP NNP B-NP O
47 could MD O O
48 not RB O O
48 be VB O O
48 assessed VBN O O
48 from IN B-VP O
48 the DT B-NP O
48 size NN I-NP O
48 of IN B-VP O
48 his PRP$ O O
48 neck NN B-NP O
48 Heart NNP I-NP O
48 sounds VBZ O O
48 were VBD B-VP O
49 distant JJ B-NP O
49 Chest NNP I-NP O
49 was VBD B-VP O
49 clear JJ O O
49 His PRP$ O O
49 abdomen NNS B-NP O
49 is VBZ O O
49 obese JJ O O
49 with IN B-VP O
49 bowel NN B-NP O
50 sounds NNS I-NP O
50 , , O O
50 nontender NN B-NP O
50 , , O O
50 and CC O O
50 nondistended VBD B-VP O
50 Extremities: NNP B-NP O
50 Notable NNP I-NP O
50 for IN B-VP O
50 3+ CD O O
51 edema NN B-NP O
51 , , O O
51 and CC O O
51 including VBG O O
51 1+ CD O O
51 extending VBG O O
51 to TO O O
51 the DT B-NP O
51 groin NN I-NP O
51 His PRP$ O O
51 pulses NNS B-NP O
51 were VBD B-VP O
52 Dopplerable JJ O O
52 bilaterally RB O O
52 with IN B-VP O
52 a DT B-NP O
52 triphasic JJ I-NP O
52 wave NN I-NP O
52 on IN B-VP O
52 the DT B-NP O
52 right NN I-NP O
52 and CC O O
53 biphasic VB O O
53 on IN B-VP O
53 the DT O O
53 left VBN O O
53 The DT B-NP O
53 medial JJ I-NP O
53 aspect NN I-NP O
53 of IN B-VP O
53 his PRP$ O O
53 right JJ B-NP O
53 leg NN I-NP O
53 had VBD B-VP O
53 a DT B-NP O
54 surgical JJ I-NP O
54 scar NN I-NP O
54 A NNP I-NP O
54 healed VBD B-VP O
54 annular JJ B-NP O
54 burn NN I-NP O
54 wound NN I-NP O
54 in IN B-VP O
54 the DT B-NP O
54 medial JJ I-NP O
54 knee NN I-NP O
55 and CC O O
55 an DT B-NP O
55 area NN I-NP O
55 of IN B-VP O
55 erythema NN B-NP O
55 along IN B-VP O
55 the DT B-NP O
55 scar NN I-NP O
55 with IN B-VP O
55 warmth NN B-NP O
55 , , O O
55 moderate JJ B-NP O
56 tenderness NN I-NP O
56 , , O O
56 no DT B-NP O
56 fluctuance NN I-NP O
56 and CC O O
56 minimal JJ B-NP O
56 induration NN I-NP O
56 , , O O
56 no DT B-NP O
56 discharge NN I-NP O
57 The DT B-NP O
57 diameter NN I-NP O
57 of IN B-VP O
57 his PRP$ O O
57 right JJ B-NP O
57 leg NN I-NP O
57 was VBD B-VP O
57 greater JJR O O
57 than IN B-VP O
57 his PRP$ O O
57 left VBD B-VP O
57 His PRP$ O O
58 right JJ B-NP O
58 heel NN I-NP O
58 had VBD B-VP O
58 an DT B-NP O
58 intact JJ I-NP O
58 ??blough?? NN I-NP O
58 and CC O O
58 his PRP$ O O
58 left JJ B-NP O
58 heel NN I-NP O
58 had VBD B-VP O
58 a DT B-NP O
58 dry JJ I-NP O
59 pressure NN I-NP O
59 sore VBD B-VP O
59 His PRP$ O O
59 right JJ B-NP O
59 big JJ I-NP O
59 toe NN I-NP O
59 was VBD B-VP O
59 tender NN B-NP O
59 to TO O O
59 palpation VB O O
60 LABORATORY NNP B-NP O
60 STUDIES: NNP I-NP O
61 Labs NNP I-NP O
61 were VBD B-VP O
61 notable JJ O O
61 for IN B-VP O
61 a DT B-NP O
61 creatinine NN I-NP O
61 of IN B-VP O
61 3.4 CD O O
61 and CC O O
61 an DT B-NP O
61 INR NNP I-NP O
61 of IN B-VP O
61 7.1 CD O O
61 His PRP$ O O
62 EKG NN B-NP O
62 showed VBD B-VP O
62 normal JJ B-NP O
62 sinus NN I-NP O
62 rhythm NN I-NP O
62 at IN B-VP O
62 75 CD O O
63 HOSPITAL NNP B-NP O
63 COURSE NNP I-NP O
63 BY NNP I-NP O
63 PROBLEMS: NNP I-NP O
64 Problem NNP I-NP O
64 #1 NNP I-NP O
64 Infectious NNP I-NP O
64 Disease: NNP I-NP O
64 The DT B-NP O
64 patient NN I-NP O
64 was VBD B-VP O
64 started VBN O O
64 on IN B-VP O
65 vancomycin NN B-NP B-m
65 IV NNP I-NP B-mo
65 on IN B-VP O
65 admission NN B-NP O
65 for IN B-VP O
65 his PRP$ O B-r
65 right JJ B-NP I-r
65 medial JJ I-NP I-r
65 thigh JJ I-NP I-r
65 cellulitis NN I-NP I-r
66 at IN B-VP O
66 the DT B-NP O
66 site NN I-NP O
66 of IN B-VP O
66 the DT B-NP O
66 femoropopliteal JJ I-NP O
66 bypass NN I-NP O
66 with IN B-VP O
66 rapid JJ B-NP O
67 defervescence NN I-NP O
67 and CC O O
67 improvement NN B-NP O
67 No NNP I-NP O
67 drainage NN I-NP O
67 , , O O
67 no DT B-NP O
67 fluctuance NN I-NP O
68 Additional NNP I-NP O
68 antibiotic JJ B-NP B-m
68 coverage NN I-NP O
68 was VBD B-VP O
68 added VBN O O
68 specifically RB O O
68 of IN B-VP O
69 fluoroquinolone NN B-NP B-m
69 for IN B-VP O
69 anti-psuedomonal JJ B-NP B-r
69 anti-psuedomonal JJ I-NP B-r
69 coverage NN I-NP O
69 for IN B-VP O
69 his PRP$ O O
69 diabetic JJ B-NP O
70 foot NN I-NP O
70 ulcers NNS I-NP O
70 The DT B-NP O
70 right NN I-NP O
70 heel NN I-NP O
70 also RB O O
70 looked VBD B-VP O
70 increasingly RB O O
70 purulent JJ O O
71 during IN B-VP O
71 his PRP$ O O
71 hospitalization NN B-NP O
71 and CC O O
71 bilateral JJ B-NP O
71 foot NN I-NP O
71 plain NN I-NP O
71 films NNS I-NP O
71 were VBD B-VP O
72 done VBN O O
72 These DT O O
72 were VBD B-VP O
72 negative JJ O O
72 for IN B-VP O
72 osteomyelitis NN B-NP O
72 but CC O O
72 showed VBD B-VP O
72 a DT B-NP O
72 metal NN I-NP O
73 sliver NN I-NP O
73 in IN B-VP O
73 the DT B-NP O
73 right JJ I-NP O
73 foot NN I-NP O
73 and CC O O
73 an DT B-NP O
73 acute JJ I-NP O
73 fracture NN I-NP O
73 of IN B-VP O
73 the DT B-NP O
73 first JJ I-NP O
74 metatarsal NN I-NP O
74 Surgical NNP I-NP O
74 debridement NN I-NP O
74 was VBD B-VP O
74 done VBN O O
74 in IN B-VP O
74 the DT B-NP O
74 operating NN I-NP O
74 room NN I-NP O
75 with IN B-VP O
75 drainage NN B-NP O
75 of IN B-VP O
75 pus NN B-NP O
75 , , O O
75 but CC O O
75 the DT B-NP O
75 metal NN I-NP O
75 showed VBD B-VP O
75 could MD O O
75 not RB O O
75 be VB O O
75 located VBN O O
76 even RB O O
76 with IN B-VP O
76 fluoroscopy PDT O O
76 The DT B-NP O
76 patient NN I-NP O
76 will MD O O
76 complete VB O O
76 a DT B-NP B-du
76 14-day JJ I-NP B-du
76 14-day JJ I-NP I-du
76 course NN I-NP I-du
76 course NN I-NP I-du
77 of IN B-VP O
77 levofloxacin NN B-NP B-m
77 and CC O O
77 clindamycin NN B-NP B-m
77 for IN B-VP O
77 these DT O B-r
77 these DT B-NP B-r
77 foot NNS I-NP I-r
77 foot VBP O I-r
77 ulcers NNS B-NP I-r
77 ulcers NNS I-NP I-r
77 , , O O
77 and CC O O
77 will MD O O
78 be VB O O
78 discharged VBN O O
78 home NN B-NP O
78 with IN B-VP O
78 visiting VBG O O
78 nursing NN B-NP O
78 care NN I-NP O
78 for IN B-VP O
78 b.i.d JJ B-NP O
79 wet-to-dry JJ I-NP O
79 dressing NN I-NP O
79 changes NNS I-NP O
79 He PRP O O
79 will MD O O
79 follow VB O O
79 up RP O O
79 with IN B-VP O
79 Jerold NNP B-NP O
79 Cristopher NNP I-NP O
79 Blazon NNP I-NP O
79 , , O O
79 M.D NNP B-NP O
79 in IN B-VP O
79 one CD O O
79 to TO O O
79 two CD O O
79 weeks NNS B-NP O
80 Problem NNP I-NP O
80 #2 NNP I-NP O
80 Renal: NNP I-NP O
80 The DT B-NP O
80 patient NN I-NP O
80 was VBD B-VP O
80 volume NN B-NP O
80 overloaded VBN O O
80 on IN B-VP O
81 admission NN B-NP O
81 His PRP$ O O
81 torsemide NN B-NP B-m
81 was VBD B-VP O
81 changed VBN O O
81 to TO O O
81 IV NNP B-NP B-mo
81 and CC O O
81 metolazone NN B-NP B-m
81 was VBD B-VP O
82 added VBN O O
82 and CC O O
82 was VBD B-VP O
82 given VBN O O
82 30 CD O O
82 minutes NNS B-NP O
82 prior RB O O
82 to TO O O
82 his PRP$ O O
82 first JJ B-NP O
82 torsemide NN I-NP B-m
82 dose NN I-NP O
83 of IN B-VP O
83 the DT B-NP O
83 day NN I-NP O
83 A NNP I-NP O
83 diuresis NN I-NP O
83 of IN B-VP O
83 1.5-2 JJ B-NP O
83 liters NNS I-NP O
83 a DT B-NP O
83 day NN I-NP O
83 was VBD B-VP O
83 achieved VBN O O
83 with IN B-VP O
84 this DT B-NP O
84 regimen NNS I-NP O
84 with IN B-VP O
84 the DT B-NP O
84 exception NN I-NP O
84 of IN B-VP O
84 a DT O O
84 4 CD O O
84 liter NN B-NP O
84 diuresis NN I-NP O
84 overnight VBD B-VP O
85 on IN B-VP O
85 the DT B-NP O
85 first JJ I-NP O
85 day NN I-NP O
85 of IN B-VP O
85 admission NN B-NP O
85 His PRP$ O O
85 electrolytes NNS B-NP B-m
85 were VBD B-VP O
85 replaced VBN O O
85 as IN B-VP B-f
86 needed VBN O O
86 I PRP O O
86 have VBP O O
86 expected VBN O O
86 his PRP$ O O
86 creatinine JJ B-NP O
86 increase NN I-NP O
86 to TO O O
86 4.5 CD O O
86 by IN B-VP O
87 discharge NN B-NP O
87 He PRP O O
87 will MD O O
87 need VB O O
87 close JJ B-NP O
87 renal JJ I-NP O
87 follow NN I-NP O
87 ups NNS I-NP O
87 as IN B-VP O
87 he PRP O O
87 may MD O O
87 be VB O O
88 approaching VBG O O
88 need NN B-NP O
88 for IN B-VP O
88 dialysis NN B-NP O
88 The DT B-NP O
88 Renal NNP I-NP O
88 Service NNP I-NP O
88 followed VBD B-VP O
88 him PRP O O
89 during IN B-VP O
89 this DT B-NP O
89 hospitalization NN I-NP O
89 and CC O O
89 at IN B-VP O
89 their PRP$ O O
89 recommendation NN B-NP O
89 , , O O
90 spironolactone NN B-NP B-m
90 will MD O O
90 be VB O O
90 discontinued VBN O O
90 upon IN B-VP O
90 discharge NN B-NP O
90 since IN B-VP O
90 his PRP$ O O
91 diuresis NN B-NP O
91 will MD O O
91 be VB O O
91 slowed VBN O O
92 Problem NNP B-NP O
92 #3 NNP I-NP O
92 Vascular: NNP I-NP O
92 Diuresis NNP I-NP O
92 was VBD B-VP O
92 essential JJ O O
92 for IN B-VP O
92 resolution NN B-NP O
92 of IN B-VP O
93 his PRP$ O O
93 cellulitis NN B-NP O
93 Pletal NNP I-NP B-m
93 was VBD B-VP O
93 continued VBN O O
93 and CC O O
93 because IN B-VP O
93 of IN B-VP O
93 his PRP$ O O
93 severe JJ B-NP O
94 peripheral JJ I-NP O
94 arterial JJ I-NP O
94 disease NN I-NP O
94 , , O O
94 he PRP O O
94 will MD O O
94 require VB O O
94 excellent JJ B-NP O
94 wound NN I-NP O
94 care NN I-NP O
95 to TO O O
95 optimize VB O O
95 healing VBG O O
96 Problem NNP B-NP O
96 #4 NNP I-NP O
96 Heme: NNP I-NP O
96 Initially NNP I-NP O
96 , , O O
96 his PRP$ O O
96 Coumadin NNP B-NP B-m
96 was VBD B-VP O
96 held VBN O O
96 for IN B-VP O
96 a DT B-NP O
97 supratherapeutic JJ I-NP O
97 INR NNP I-NP O
97 This DT O O
97 was VBD B-VP O
97 restarted VBN O O
97 when WRB O O
97 his PRP$ O O
97 INR NNP B-NP O
97 was VBD B-VP O
97 2.2 CD O O
98 and CC O O
98 he PRP O O
98 his PRP$ O O
98 now RB O O
98 in IN B-VP O
98 the DT B-NP O
98 therapeutic JJ I-NP O
98 range NN I-NP O
98 and CC O O
98 will MD O O
98 need VB O O
98 to TO O O
98 be VB O O
99 followed VBN O O
100 Problem NNP B-NP O
100 #5 NNP I-NP O
100 Cardiovascular: NNP I-NP O
100 He PRP O O
100 was VBD B-VP O
100 hypertensive JJ O B-r
100 on IN B-VP O
100 arrival NN B-NP O
101 which WDT O O
101 was VBD B-VP O
101 treated VBN O O
101 with IN B-VP O
101 Hydralazine NNP B-NP B-m
101 initially RB O O
101 and CC O O
101 transitioned VBD B-VP O
101 to TO O O
102 his PRP$ O O
102 p.o NN B-NP B-mo
102 home NN I-NP B-m
102 medicines NNS I-NP I-m
102 Even RB O O
102 with IN B-VP O
102 a DT B-NP O
102 large JJ I-NP O
102 cuff NN I-NP O
102 , , O O
102 his PRP$ O O
102 blood NN B-NP O
103 pressure NN I-NP O
103 continued VBD B-VP O
103 to TO O O
103 run VB O O
103 high RB O O
103 in IN B-VP O
103 the DT B-NP O
103 150s-180s NNS I-NP O
103 On IN B-VP O
103 hospital JJ B-NP O
103 day NN I-NP O
104 #9 NNP I-NP O
104 , , O O
104 Hydralazine NNP B-NP B-m
104 p.o NN I-NP B-mo
104 was VBD B-VP O
104 added VBN O O
104 with IN B-VP O
104 good JJ B-NP O
104 effect NN I-NP O
104 which WDT O O
104 lowered VBD B-VP O
104 his PRP$ O B-r
105 systolic JJ B-NP O
105 blood NN I-NP O
105 pressure NN I-NP O
105 to TO O O
105 the DT B-NP O
105 range NN I-NP O
105 of IN B-VP O
105 the DT B-NP O
105 120s-130s JJ I-NP O
105 Goal NNP I-NP O
105 is VBZ O O
106 below IN B-VP O
106 130/80 CD O O
107 Problem NNP B-NP O
107 #6 NNP I-NP O
107 Endocrine: NNP I-NP O
107 The DT B-NP O
107 patient NN I-NP O
107 was VBD B-VP O
107 admitted VBN O O
107 with IN B-VP O
107 NPH NNP B-NP B-m
107 and CC O O
108 Humalog NNP B-NP B-m
108 The DT B-NP O
108 Diabetes NNP I-NP O
108 Service NNP I-NP O
108 saw VBD B-VP O
108 the DT B-NP O
108 patient NN I-NP O
108 and CC O O
108 at IN B-VP O
108 their PRP$ O O
109 recommendation NN B-NP O
109 NPH NNP I-NP B-m
109 NPH NNP I-NP B-m
109 doses NNS I-NP O
109 were VBD B-VP O
109 increased VBN O O
109 , , O O
109 and CC O O
109 he PRP O O
109 is VBZ O O
109 now RB O O
109 on IN B-VP O
109 90 CD O B-do
110 units NNS B-NP O
110 in IN B-VP B-f
110 the DT B-NP I-f
110 morning NN I-NP I-f
110 and CC O O
110 85 CD O B-do
110 units NNS B-NP I-do
110 at IN B-VP B-f
110 night NN B-NP I-f
110 The DT B-NP O
110 goal NN I-NP O
110 for IN B-VP O
110 this DT B-NP O
111 patient NN I-NP O
111 is VBZ O O
111 below IN B-VP O
111 150 CD O O
111 particularly RB O O
111 given VBN O O
111 the DT B-NP O
111 need NN I-NP O
111 for IN B-VP O
111 wound NN B-NP B-r
112 healing NN I-NP O
113 Problem NNP I-NP O
113 #7: NNP I-NP O
113 GI: NNP I-NP O
113 The DT B-NP O
113 patient NN I-NP O
113 was VBD B-VP O
113 seen VBN O O
113 by IN B-VP O
113 Nutrition NNP B-NP O
113 and CC O O
113 will MD O O
113 be VB O O
114 evaluated VBN O O
114 as IN B-VP O
114 an DT B-NP O
114 outpatient NN I-NP O
114 by IN B-VP O
114 Bariatric NNP B-NP O
114 Surgery NNP I-NP O
114 pending VBG O O
114 next JJ B-NP O
115 week NN I-NP O
115 This DT O O
115 is VBZ O O
115 of IN B-VP O
115 utmost JJ B-NP O
115 importance NN I-NP O
115 for IN B-VP O
115 this DT B-NP O
115 patient NN I-NP O
115 with IN B-VP O
116 life-threatening JJ B-NP O
116 morbid NN I-NP O
116 obesity NN I-NP O
116 who WP O O
116 already RB O O
116 has VBZ O O
116 severe JJ B-NP O
117 complications NNS I-NP O
117 of IN B-VP O
117 obesity-related JJ B-NP O
117 conditions NNS I-NP O
117 The DT B-NP O
117 patient NN I-NP O
117 has VBZ O O
118 obesity NN B-NP O
118 , , O O
118 hyperventilation NN B-NP O
118 syndrome NN I-NP O
119 Problem NNP I-NP O
119 #8 NNP I-NP O
119 Pulmonary: NNP I-NP O
119 The DT B-NP O
119 patient NN I-NP O
119 has VBZ O O
119 obstructive JJ B-NP O
119 sleep NN I-NP O
119 apnea NN I-NP O
120 A NNP I-NP O
120 CPAP NNP I-NP O
120 machine NN I-NP O
120 was VBD B-VP O
120 brought VBN O O
120 to TO O O
120 the DT B-NP O
120 patient NN I-NP O
120 bedside NN I-NP O
120 , , O O
120 but CC O O
120 the DT B-NP O
121 patient NN I-NP O
121 was VBD B-VP O
121 unable JJ O O
121 to TO O O
121 tolerate VB O O
121 the DT B-NP O
121 nose JJ I-NP O
121 mask NN I-NP O
121 He PRP O O
121 will MD O O
121 use VB O O
121 his PRP$ O O
122 own JJ B-NP O
122 device NN I-NP O
122 when WRB O O
122 he PRP O O
122 returns VBZ O O
122 home NN B-NP O
123 DISCHARGE NNP I-NP O
123 INSTRUCTIONS: NNP I-NP O
124 He PRP O O
124 will MD O O
124 go VB O O
124 home NN B-NP O
124 with IN B-VP O
124 visiting VBG O O
124 nurse JJ B-NP O
124 care NN I-NP O
124 and CC O O
124 will MD O O
124 need VB O O
124 to TO O O
124 see VB O O
124 his PRP$ O O
125 nephrologist NN B-NP O
125 , , O O
125 vascular JJ B-NP O
125 surgeons NNS I-NP O
125 , , O O
125 primary JJ B-NP O
125 care NN I-NP O
125 provider NN I-NP O
125 , , O O
125 and CC O O
126 Bariatric NNP B-NP O
126 Surgery NNP I-NP O
126 following VBG O O
126 discharge NN B-NP O
127 eScription NN I-NP O
127 document: VBZ O O
127 1-9252905 JJ B-NP O
127 EMSSten NNP I-NP O
127 Tel NNP I-NP O
128 Dictated NNP I-NP O
128 By: NNP I-NP O
128 GREIBER NNP I-NP O
128 , , O O
128 JORDON NNP B-NP O
129 Attending: NNP I-NP O
129 BARTOSIK NNP I-NP O
129 , , O O
129 RICK NNP B-NP O
129 ARMAND NNP I-NP O
130 Dictation NNP I-NP O
130 ID NNP I-NP O
130 4807831 CD O O
131 D: NNP B-NP O
131 2/2/03 CD O O
132 T: NNP B-NP O
132 2/2/03 CD O O
133 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #108881 VBZ O O
4 242314196 CD O O
4 RGH NNP B-NP O
4 69457618 CD O O
4 7356086 CD O O
4 7/17/2007 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 EXACERBATION NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/3/2007 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/4/2007 CD O O
7 ATTENDING: NNP B-NP O
7 LACINSKI NNP I-NP O
7 , , O O
7 OLLIE NNP B-NP O
7 WARNER NNP I-NP O
7 MD NNP I-NP O
8 CHIEF NNP I-NP O
8 COMPLAINT: NNP I-NP O
8 Status NNP I-NP O
8 post NN I-NP O
8 fall NN I-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 This DT O O
9 is VBZ O O
9 a DT B-NP O
9 61-year-old JJ I-NP O
9 gentleman NN I-NP O
9 with IN B-VP O
10 severe JJ B-NP O
10 pulmonary JJ I-NP O
10 hypertension NN I-NP O
10 secondary JJ O O
10 to TO O O
10 chronic JJ B-NP O
10 PEs NNP I-NP O
10 , , O O
10 OSA NNP B-NP O
10 , , O O
11 gout NN B-NP O
11 , , O O
11 bilateral JJ B-NP O
11 hip NN I-NP O
11 replacements NNS I-NP O
11 who WP O O
11 presents VBP O O
11 with IN B-VP O
11 two CD O O
11 falls NNS B-NP O
11 in IN B-VP O
12 the DT O O
12 past JJ O O
12 two CD O O
12 days NNS B-NP O
12 The DT B-NP O
12 day NN I-NP O
12 prior RB O O
12 to TO O O
12 admission NN B-NP O
12 , , O O
12 the DT B-NP O
12 patient NN I-NP O
12 fell VBD B-VP O
13 while IN B-VP O
13 he PRP O O
13 was VBD B-VP O
13 standing VBG O O
13 at IN B-VP O
13 the DT B-NP O
13 sink NN I-NP O
13 He PRP O O
13 has VBZ O O
13 poor JJ B-NP O
13 recall NN I-NP O
13 of IN B-VP O
13 events NNS B-NP O
14 but CC O O
14 thinks VBZ O O
14 he PRP O O
14 landed VBD B-VP O
14 on IN B-VP O
14 his PRP$ O O
14 leg NN B-NP O
14 On IN B-VP O
14 the DT B-NP O
14 day NN I-NP O
14 of IN B-VP O
14 admission NN B-NP O
14 , , O O
14 he PRP O O
15 fell VBD B-VP O
15 after IN B-VP O
15 getting VBG O O
15 out IN B-VP O
15 of IN B-VP O
15 the DT B-NP O
15 shower NN I-NP O
15 He PRP O O
15 grabbed VBD B-VP O
15 a DT B-NP O
15 chair NN I-NP O
15 , , O O
15 but CC O O
16 slipped VBD B-VP O
16 and CC O O
16 landed VBD B-VP O
16 on IN B-VP O
16 his PRP$ O O
16 buttocks NNS B-NP O
16 , , O O
16 then RB O O
16 he PRP O O
16 fell VBD B-VP O
16 backwards NNS B-NP O
16 and CC O O
17 hit VBD B-VP O
17 the DT B-NP O
17 back NN I-NP O
17 of IN B-VP O
17 his PRP$ O O
17 head NN B-NP O
17 He PRP O O
17 denies VBZ O O
17 any DT B-NP O
17 loss NN I-NP O
17 of IN B-VP O
17 consciousness NN B-NP O
18 EMS NNP I-NP O
18 was VBD B-VP O
18 called VBN O O
18 and CC O O
18 brought VBD B-VP O
18 him PRP O O
18 to TO O O
18 the DT B-NP O
18 Emergency NNP I-NP O
18 Department NNP I-NP O
18 He PRP O O
19 did VBD B-VP O
19 note VB O O
19 a DT B-NP O
19 brief JJ I-NP O
19 episode NN I-NP O
19 of IN B-VP O
19 chest NN B-NP O
19 pain NN I-NP O
19 after IN B-VP O
19 the DT B-NP O
19 fall NN I-NP O
19 He PRP O O
19 says VBZ O O
19 he PRP O O
19 is VBZ O O
19 compliant JJ O O
20 with IN B-VP O
20 his PRP$ O O
20 medication NN B-NP B-m
20 regimen NNS I-NP I-m
20 and CC O O
20 denies NNS B-NP O
20 dietary JJ B-NP O
20 indiscretion NN I-NP O
21 REVIEW NNP I-NP O
21 OF NNP I-NP O
21 SYSTEMS: NNP I-NP O
21 Review NNP I-NP O
21 of IN B-VP O
21 systems NNS B-NP O
21 also RB O O
21 notable JJ O O
21 for IN B-VP O
21 complaints NNS B-NP O
22 of IN B-VP O
22 more JJR B-NP O
22 labored JJ I-NP O
22 breathing NN I-NP O
22 , , O O
22 increased VBD B-VP O
22 swelling NN B-NP O
22 , , O O
22 especially RB O O
22 in IN B-VP O
22 the DT B-NP O
23 left NN I-NP O
23 lower JJR B-NP O
23 extremity NN I-NP O
23 as RB O O
23 well RB O O
23 as IN B-VP O
23 worsening VBG O O
23 orthopnea NN B-NP O
23 over IN B-VP O
23 the DT B-NP O
23 past JJ I-NP O
24 several JJ I-NP O
24 days NNS I-NP O
24 He PRP O O
24 uses VBZ O O
24 BiPAP NNP B-NP O
24 at IN B-VP O
24 home NN B-NP O
24 at IN B-VP O
24 baseline NN B-NP O
25 PAST NNP I-NP O
25 MEDICAL NNP I-NP O
25 HISTORY: NNP I-NP O
25 Significant NNP I-NP O
25 for IN B-VP O
25 pulmonary JJ B-NP O
25 hypertension NN I-NP O
25 , , O O
26 last JJ B-NP O
26 catheterization NN I-NP O
26 was VBD B-VP O
26 in IN B-VP O
26 July NNP B-NP O
26 2005 CD O O
26 , , O O
26 which WDT O O
26 showed VBD B-VP O
26 no DT B-NP O
27 obstructive JJ I-NP O
27 lesions NNS I-NP O
27 , , O O
27 PASP NNP B-NP O
27 of IN B-VP O
27 104 CD O O
27 He PRP O O
27 has VBZ O O
27 OSA VBN O O
27 and CC O O
27 is VBZ O O
27 on IN B-VP O
27 BiPAP NNP B-NP O
27 , , O O
27 he PRP O O
27 has VBZ O O
28 history NN B-NP O
28 of IN B-VP O
28 DVTs NNP B-NP O
28 , , O O
28 history NN B-NP O
28 of IN B-VP O
28 lower JJR B-NP O
28 extremity NN I-NP O
28 ulcers NNS I-NP O
28 and CC O O
28 cellulitis NN B-NP O
28 , , O O
29 hypertriglyceridemia NN B-NP O
29 , , O O
29 gout NN B-NP O
29 , , O O
29 hypertension NN B-NP O
29 , , O O
29 obesity NN B-NP O
29 He PRP O O
29 is VBZ O O
29 status NN B-NP O
30 post NN I-NP O
30 bilateral JJ B-NP O
30 hip NN I-NP O
30 replacement NN I-NP O
30 as RB O O
30 well RB O O
30 as IN B-VP O
30 knee NN B-NP O
31 replacement NN I-NP O
32 ALLERGIES: NNP I-NP O
32 He PRP O O
32 is VBZ O O
32 allergic JJ O O
32 to TO O O
32 Versed VBN O O
33 SOCIAL NNP B-NP O
33 HISTORY: NNP I-NP O
33 He PRP O O
33 lives VBZ O O
33 in IN B-VP O
33 Chuhern NNP B-NP O
33 Boulevard NNP I-NP O
33 , , O O
33 Tra NNP B-NP O
33 Berke NNP I-NP O
33 Call NNP I-NP O
33 , , O O
33 North NNP B-NP O
33 Dakota NNP I-NP O
33 02692 CD O O
33 part NN B-NP O
33 of IN B-VP O
33 the DT B-NP O
33 year NN I-NP O
33 and CC O O
33 owns VBZ O O
33 a DT B-NP O
33 car NN I-NP O
34 dealership NN I-NP O
34 No NNP I-NP O
34 tobacco NN I-NP O
35 PHYSICAL NNP I-NP O
35 EXAMINATION NNP I-NP O
35 ON NNP I-NP O
35 ADMISSION: NNP I-NP O
35 He PRP O O
35 was VBD B-VP O
35 afebrile RB O O
35 , , O O
35 heart NN B-NP O
35 rate NN I-NP O
36 94 CD O O
36 , , O O
36 blood NN B-NP O
36 pressure NN I-NP O
36 126/60 CD O O
36 , , O O
36 92% CD O O
36 on IN B-VP O
36 room NN B-NP O
36 air NN I-NP O
36 Head NNP I-NP O
36 atraumatic NN I-NP O
36 , , O O
36 no DT B-NP O
37 nuchal JJ I-NP O
37 rigidity NN I-NP O
37 JVP NNP I-NP O
37 was VBD B-VP O
37 10 CD O O
37 Lungs NNS B-NP O
37 were VBD B-VP O
37 clear JJ O O
37 with IN B-VP O
37 distant JJ B-NP O
38 breath NN I-NP O
38 sounds VBZ O O
38 Cardiovascular JJ B-NP O
38 exam: NNS I-NP O
38 Tachycardic VBP O O
38 with IN B-VP O
38 a DT B-NP O
38 loud JJ I-NP O
38 S2 NNP I-NP O
39 Extremities NNP I-NP O
39 showed VBD B-VP O
39 swelling VBG O O
39 over IN B-VP O
39 the DT B-NP O
39 right JJ I-NP O
39 wrist NN I-NP O
39 without IN B-VP O
39 warmth WP O O
40 Lower NNP B-NP O
40 extremities NNS I-NP O
40 had VBD B-VP O
40 brawny VBN O O
40 skin JJ B-NP O
40 changes NNS I-NP O
40 bilaterally RB O O
40 with IN B-VP O
41 2+ CD O O
41 edema NN B-NP O
41 in IN B-VP O
41 the DT B-NP O
41 legs NN I-NP O
41 to TO O O
41 the DT B-NP O
41 mid NN I-NP O
41 shin JJ B-NP O
41 Neuro NNP I-NP O
41 exam: NN I-NP O
41 cranial JJ B-NP O
41 nerves NNS I-NP O
42 II-XII NNP I-NP O
42 were VBD B-VP O
42 grossly RB O O
42 intact JJ O O
42 He PRP O O
42 had VBD B-VP O
42 4/5 CD O O
42 strength NN B-NP O
42 at IN B-VP O
42 the DT B-NP O
42 left JJ I-NP O
42 hip NN I-NP O
42 flexor NN I-NP O
42 , , O O
43 5/5 CD O O
43 otherwise RB O O
43 in IN B-VP O
43 the DT B-NP O
43 lower JJR I-NP O
43 extremities NNS I-NP O
44 LABORATORY NNP I-NP O
44 DATA NNP I-NP O
44 ON NNP I-NP O
44 ADMISSION: NNP I-NP O
44 Included VBD B-VP O
44 a DT B-NP O
44 hematocrit NN I-NP O
44 of IN B-VP O
44 58.7 CD O O
45 within IN B-VP O
45 the DT B-NP O
45 patient's JJ I-NP O
45 baseline NN I-NP O
45 of IN B-VP O
45 53 CD O O
45 to TO O O
45 58 CD O O
45 , , O O
45 creatinine NN B-NP O
45 of IN B-VP O
45 1 CD O O
45 , , O O
45 INR NNP B-NP O
46 4.4 CD O O
46 , , O O
46 troponin VBD B-VP O
46 0.04 CD O O
46 EKG NNP B-NP O
46 showed VBD B-VP O
46 normal JJ B-NP O
46 sinus NNS I-NP O
46 rhythm VBP O O
46 with IN B-VP O
46 left JJ B-NP O
47 atrial JJ I-NP O
47 enlargement NN I-NP O
47 and CC O O
47 right JJ B-NP O
47 atrial JJ I-NP O
47 enlargement NN I-NP O
47 Head NNP I-NP O
47 CT NNP I-NP O
47 was VBD B-VP O
48 negative JJ B-NP O
48 Plain NNP I-NP O
48 films NNS I-NP O
48 of IN B-VP O
48 the DT B-NP O
48 pelvis NN I-NP O
48 were VBD B-VP O
48 negative JJ O O
48 for IN B-VP O
48 fracture NN B-NP O
49 Hardware NNP I-NP O
49 was VBD B-VP O
49 in IN B-VP O
49 place NN B-NP O
49 Right NNP I-NP O
49 wrist NN I-NP O
49 showed VBD B-VP O
49 no DT B-NP O
49 fracture NN I-NP O
49 , , O O
49 but CC O O
49 did VBD B-VP O
50 show VB O O
50 erosive JJ B-NP O
50 changes NNS I-NP O
50 suggestive VBP O O
50 of IN B-VP O
50 crystal JJ B-NP O
50 deposition NN I-NP O
51 Chest NNP I-NP O
51 x-ray NN I-NP O
51 showed VBD B-VP O
51 no DT B-NP O
51 pulmonary JJ I-NP O
51 edema NN I-NP O
51 Additional NNP I-NP O
51 studies NNS I-NP O
52 included VBD B-VP O
52 a DT B-NP O
52 repeat NN I-NP O
52 head NN I-NP O
52 CT NNP I-NP O
52 , , O O
52 which WDT O O
52 was VBD B-VP O
52 again RB O O
52 negative JJ B-NP O
53 HOSPITAL NNP I-NP O
53 COURSE NNP I-NP O
53 BY NNP I-NP O
53 PROBLEM: NNP I-NP O
53 In IN B-VP O
53 summary JJ O O
53 , , O O
53 this DT O O
53 is VBZ O O
53 a DT B-NP O
53 61-year-old JJ I-NP O
54 gentleman NN I-NP O
54 with IN B-VP O
54 a DT B-NP O
54 history NN I-NP O
54 of IN B-VP O
54 pulmonary JJ B-NP O
54 history NN I-NP O
54 of IN B-VP O
54 hypertension NN B-NP O
54 and CC O O
55 chronic JJ B-NP O
55 PEs NNP I-NP O
55 on IN B-VP O
55 anticoagulation NN B-NP B-m
55 who WP O O
55 presents VBZ O O
55 after IN B-VP O
55 falls NNS B-NP O
55 in IN B-VP O
55 the DT B-NP O
56 setting NN I-NP O
56 of IN B-VP O
56 worsening VBG O O
56 lower JJR B-NP O
56 extremity NN I-NP O
56 edema NN I-NP O
56 as RB O O
56 well RB O O
56 as IN B-VP O
56 orthopnea NN B-NP O
57 CARDIAC: NNP I-NP O
57 ISCHEMIA: NNP I-NP O
57 he PRP O O
57 was VBD B-VP O
57 ruled VBN O O
57 out RP O O
57 for IN B-VP O
57 MI NNP B-NP O
57 His PRP$ O O
57 last JJ B-NP O
58 catheterization NN I-NP O
58 was VBD B-VP O
58 negative JJ O O
58 in IN B-VP O
58 July NNP B-NP O
58 2005 CD O O
58 He PRP O O
58 was VBD B-VP O
58 continued VBN O O
59 on IN B-VP O
59 his PRP$ O O
59 beta-blocker NN B-NP B-m
59 and CC O O
59 he PRP O O
59 was VBD B-VP O
59 anticoagulated VBN O O
59 on IN B-VP O
59 Coumadin NNP B-NP B-m
60 PUMP: NNP I-NP O
60 The DT B-NP O
60 patient NN I-NP O
60 has VBZ O O
60 severe JJ B-NP O
60 pulmonary JJ I-NP O
60 hypertension NN I-NP O
60 The DT B-NP O
61 PVMC NNP I-NP O
61 team NN I-NP O
61 followed VBD B-VP O
61 this DT B-NP O
61 patient NN I-NP O
61 carefully RB O O
61 He PRP O O
61 was VBD B-VP O
61 diuresed VBN O O
62 with IN B-VP O
62 a DT B-NP O
62 daily JJ I-NP O
62 goal NN I-NP O
62 of IN B-VP O
62 negative JJ O O
62 500 CD O O
62 to TO O O
62 1 CD O O
62 L NNP B-NP O
62 with IN B-VP O
62 IV NNP B-NP B-mo
62 Lasix NNP I-NP B-m
62 once RB O B-f
63 or CC O O
63 twice VB O O
63 a DT B-NP O
63 day NN I-NP O
63 as IN B-VP O
63 needed VBN O O
63 His PRP$ O O
63 home NN B-NP O
63 dose NN I-NP O
63 of IN B-VP O
63 Lasix NNP B-NP B-m
63 Lasix NNP I-NP B-m
63 Lasix NNP I-NP B-m
63 Lasix NNP I-NP B-m
63 is VBZ O O
63 160 CD O B-do
63 160 CD O B-do
63 mg NN B-NP I-do
63 mg NN I-NP I-do
63 p.o NN I-NP B-mo
63 p.o NN I-NP B-mo
63 He PRP O O
63 responded VBD B-VP O
64 very RB O O
64 well RB O O
64 to TO O O
64 two CD O B-du
64 doses NNS B-NP I-du
64 of IN B-VP O
64 160 CD O B-do
64 mg NNS B-NP I-do
64 IV NNP I-NP B-mo
64 twice RB O B-f
64 twice RB O B-f
64 per IN B-VP I-f
64 per IN B-VP I-f
64 day NN B-NP I-f
64 day NN I-NP I-f
64 , , O O
64 but CC O O
64 this DT O O
64 was VBD B-VP O
64 titrated VBN O O
64 down RB O O
65 to TO O O
65 160 CD O B-do
65 once RB O B-f
65 a DT B-NP I-f
65 day NN I-NP I-f
65 given VBN O O
65 the DT B-NP O
65 goal NN I-NP O
65 of IN B-VP O
65 keeping VBG O O
65 the DT B-NP O
65 patient NN I-NP O
65 approximately RB O O
65 500 CD O O
65 mL NNS B-NP O
65 to TO O O
66 1 CD O O
66 L NNP B-NP O
66 negative JJ O O
66 per IN B-VP O
66 day NN B-NP O
66 to TO O O
66 minimize VB O O
66 fluid NN B-NP O
66 and CC O O
66 electrolyte JJ B-NP O
66 shifts NNS I-NP O
66 His PRP$ O O
66 weight NN B-NP O
66 on IN B-VP O
67 admission NN B-NP O
67 was VBD B-VP O
67 440 CD O O
67 pounds NNS B-NP O
67 At IN B-VP O
67 discharge NN B-NP O
67 , , O O
68 his PRP$ O O
68 weight NN B-NP O
68 was VBD B-VP O
68 429 CD O O
68 His PRP$ O O
68 dry JJ B-NP O
68 weight NN I-NP O
68 according VBG O O
68 to TO O O
68 his PRP$ O O
68 primary JJ B-NP O
69 cardiologist's NN I-NP O
69 notes NNS I-NP O
69 suggest VBP O O
69 a DT B-NP O
69 dry JJ I-NP O
69 weight NN I-NP O
69 of IN B-VP O
69 419 CD O O
69 pounds NNS B-NP O
69 He PRP O O
69 was VBD B-VP O
70 otherwise RB O O
70 maintained VBN O O
70 on IN B-VP O
70 his PRP$ O O
70 home NN B-NP O
70 regimen NNS I-NP O
70 of IN B-VP O
70 Procardia NNP B-NP B-m
70 , , O O
71 hydrochlorothiazide NN B-NP B-m
71 , , O O
71 Revatio NNP B-NP B-m
71 , , O O
71 and CC O O
71 Toprol NNP B-NP B-m
71 He PRP O O
71 will MD O O
71 need VB O O
71 to TO O O
71 follow VB O O
72 up RP O O
72 with IN B-VP O
72 Dr NNP B-NP O
72 Santor NNP I-NP O
72 , , O O
72 his PRP$ O O
72 cardiologist NN B-NP O
72 , , O O
72 on IN B-VP O
72 5/11/07 CD O O
73 2 CD O O
73 Rhythm: NNPS B-NP O
73 The DT B-NP O
73 patient NN I-NP O
73 was VBD B-VP O
73 in IN B-VP O
73 normal JJ B-NP O
73 sinus NN I-NP O
73 rhythm NN I-NP O
73 He PRP O O
73 did VBD B-VP O
73 have VB O O
74 an DT B-NP O
74 episode NN I-NP O
74 of IN B-VP O
74 missed JJ B-NP O
74 beats NNS I-NP O
74 , , O O
74 likely RB O O
74 Wenckebach NNP B-NP O
74 on IN B-VP O
74 6/3/07 CD O O
74 as RB O O
74 well RB O O
75 as IN B-VP O
75 some DT O O
75 ectopy IN B-VP O
75 These DT O O
75 were VBD B-VP O
75 thought VBN O O
75 secondary JJ O O
75 to TO O O
75 fluid VB O O
75 shifts VB O O
76 His PRP$ O O
76 electrolytes NNS B-NP O
76 were VBD B-VP O
76 thus RB O O
76 repleted VBN O O
76 aggressively RB O O
76 and CC O O
76 he PRP O O
76 was VBD B-VP O
77 monitored VBN O O
77 on IN B-VP O
77 telemetry NN B-NP O
78 3 CD O O
78 Pulmonary: NNP B-NP O
78 His PRP$ O O
78 baseline NN B-NP O
78 room NN I-NP O
78 air NN I-NP O
78 oxygen IN B-VP O
78 saturation NN B-NP O
78 was VBD B-VP O
79 90-93% CD O O
79 He PRP O O
79 should MD O O
79 use VB O O
79 oxygen NN B-NP B-m
79 as IN B-VP O
79 treatment NN B-NP O
79 for IN B-VP O
79 his PRP$ O B-r
79 pulmonary JJ B-NP O
80 hypertension NN I-NP O
80 He PRP O O
80 should MD O O
80 also RB O O
80 be VB O O
80 provided VBN O O
80 with IN B-VP O
80 oxygen NN B-NP B-m
80 at IN B-VP O
80 home NN B-NP O
81 when WRB O O
81 he PRP O O
81 is VBZ O O
81 discharged VBN O O
81 Chest NNP B-NP O
81 x-ray NN I-NP O
81 was VBD B-VP O
81 clear JJ O O
81 In IN B-VP O
81 addition NN B-NP O
81 , , O O
81 he PRP O O
82 uses VBZ O O
82 BiPAP NNP B-NP O
82 at IN B-VP O
82 night NN B-NP O
82 and CC O O
82 this DT O O
82 should MD O O
82 be VB O O
82 continued VBN O O
82 while IN B-VP O
82 he PRP O O
82 is VBZ O O
82 at IN B-VP O
83 rehabilitation NN B-NP O
83 and CC O O
83 after IN B-VP O
83 he PRP O O
83 is VBZ O O
83 discharged VBN O O
84 4 CD O O
84 Heme: NNP B-NP O
84 The DT B-NP O
84 patient NN I-NP O
84 has VBZ O O
84 a DT B-NP O
84 history NN I-NP O
84 of IN B-VP O
84 DVT NNP B-NP O
84 with IN B-VP O
84 PEs NNP B-NP O
84 He PRP O O
84 is VBZ O O
84 on IN B-VP O
85 Coumadin NNP B-NP B-m
85 with IN B-VP O
85 an DT B-NP O
85 INR NNP I-NP B-r
85 goal NN I-NP I-r
85 of IN B-VP O
85 2.5 CD O O
85 Initially RB O O
85 , , O O
85 he PRP O O
85 was VBD B-VP O
86 supertherapeutic JJ O O
86 on IN B-VP O
86 admission NN B-NP O
86 , , O O
86 but CC O O
86 his PRP$ O O
86 regimen NN B-NP O
86 was VBD B-VP O
86 restarted VBN O O
86 after IN B-VP O
86 holding VBG O O
86 2 CD O O
87 doses NNS B-NP O
87 Of IN B-VP O
87 note NN B-NP O
87 , , O O
87 on IN B-VP O
87 11/6 CD O O
87 , , O O
87 he PRP O O
87 did VBD B-VP O
87 miss VB O O
87 a DT B-NP O
87 dose NN I-NP O
87 of IN B-VP O
87 Coumadin NNP B-NP B-m
87 Coumadin NNP I-NP B-m
87 Coumadin NNP I-NP B-m
87 inadvertently RB O O
87 , , O O
87 but CC O O
88 he PRP O O
88 should MD O O
88 be VB O O
88 continued VBN O O
88 on IN B-VP O
88 his PRP$ O O
88 home NN B-NP B-m
88 regimen NNS I-NP I-m
88 , , O O
88 which WDT O O
88 is VBZ O O
88 11 CD O B-do
88 11 CD O B-do
88 mg NN B-NP I-do
88 mg NN I-NP I-do
88 on IN B-VP B-f
88 on IN B-VP B-f
89 Monday NNP B-NP O
89 , , O O
89 Wednesday NNP B-NP O
89 and CC O O
89 Friday NNP B-NP O
89 and CC O O
89 12 CD O B-do
89 mg NN B-NP I-do
89 the DT B-NP B-f
89 other JJ I-NP O
89 days NNS I-NP O
89 of IN B-VP O
89 the DT B-NP O
90 week NN I-NP O
90 In IN B-VP O
90 addition NN B-NP O
90 , , O O
90 because IN B-VP O
90 of IN B-VP O
90 the DT B-NP O
90 patient's NN I-NP O
90 asymmetric JJ B-NP O
90 lower JJR I-NP O
91 extremity NN I-NP O
91 edema NN I-NP O
91 , , O O
91 LENIS NNP B-NP O
91 were VBD B-VP O
91 obtained VBN O O
91 and CC O O
91 were VBD B-VP O
91 negative JJ O O
91 The DT B-NP O
92 patient's NN I-NP O
92 elevated VBD B-VP O
92 hematocrit NN B-NP O
92 was VBD B-VP O
92 likely JJ O O
92 secondary JJ O O
92 to TO O O
92 pulmonary JJ B-NP O
93 hypertension NN I-NP O
93 and CC O O
93 hypoxia NN B-NP O
93 and CC O O
93 was VBD B-VP O
93 within IN B-VP O
93 his PRP$ O O
93 baseline NN B-NP O
94 5 CD O O
94 Fluids NNP B-NP O
94 , , O O
94 electrolytes VBZ O O
94 and CC O O
94 nutrition: VBZ O O
94 The DT B-NP O
94 patient NN I-NP O
94 was VBD B-VP O
95 maintained VBN O O
95 on IN B-VP O
95 K NNP B-NP O
95 and CC O O
95 mag NN B-NP O
95 scales NNS I-NP O
95 He PRP O O
95 was VBD B-VP O
95 also RB O O
95 on IN B-VP O
95 a DT O O
95 2 CD O O
95 L NNP B-NP O
95 fluid NN I-NP O
96 restriction NN I-NP O
96 The DT B-NP O
96 patient NN I-NP O
96 refused VBD B-VP O
96 a DT B-NP O
96 cardiac JJ I-NP O
96 diet; NN I-NP O
96 however RB O O
96 , , O O
96 he PRP O O
96 was VBD B-VP O
97 willing JJ O O
97 to TO O O
97 accept VB O O
97 a DT O O
97 diet JJ O O
97 that WDT O O
97 was VBD B-VP O
97 had VBN O O
97 no DT B-NP O
97 added JJ I-NP O
97 salt NN I-NP O
98 6 CD O O
98 Neurologic: NNP B-NP O
98 The DT B-NP O
98 patient's NN I-NP O
98 neuro JJ B-NP O
98 exam NN I-NP O
98 was VBD B-VP O
98 completely RB O O
99 nonfocal JJ O O
99 He PRP O O
99 had VBD B-VP O
99 a DT B-NP O
99 repeat NN I-NP O
99 head NN I-NP O
99 CT NNP I-NP O
99 , , O O
99 which WDT O O
99 was VBD B-VP O
99 also RB O O
99 negative JJ O O
100 This DT O O
100 was VBD B-VP O
100 on IN B-VP O
100 5/12/07 CD O O
101 7 CD O O
101 Musculoskeletal: NNP B-NP O
101 The DT B-NP O
101 patient NN I-NP O
101 was VBD B-VP O
101 seen VBN O O
101 by IN B-VP O
101 Physical JJ B-NP O
101 Therapy NN I-NP O
102 He PRP O O
102 was VBD B-VP O
102 treated VBN O O
102 for IN B-VP O
102 his PRP$ O B-r
102 hip NN B-NP I-r
102 pain NN I-NP I-r
102 initially RB O O
102 with IN B-VP O
102 oxycodone NN B-NP B-m
102 This DT O O
103 was VBD B-VP O
103 changed VBN O O
103 to TO O O
103 Dilaudid NNP B-NP B-m
103 for IN B-VP O
103 better JJR B-NP B-r
103 pain NN I-NP I-r
103 control NN I-NP I-r
103 He PRP O O
103 said VBD B-VP O
103 that IN B-VP O
103 he PRP O O
104 would MD O O
104 like VB O O
104 to TO O O
104 be VB O O
104 changed VBN O O
104 back RB O O
104 to TO O O
104 his PRP$ O O
104 home NN B-NP B-do
104 dose NN I-NP I-do
104 of IN B-VP O
104 oxycodone NN B-NP B-m
104 when WRB O O
105 he PRP O O
105 is VBZ O O
105 discharged VBN O O
105 , , O O
105 as IN B-VP O
105 he PRP O O
105 feels VBZ O O
105 the DT B-NP O
105 Dilaudid NNP I-NP B-m
105 is VBZ O O
105 fairly RB O O
105 strong JJ B-NP O
106 X-rays NNS I-NP O
106 were VBD B-VP O
106 negative JJ O O
106 for IN B-VP O
106 any DT B-NP O
106 fracture NN I-NP O
107 8 CD O O
107 Rheumatological: NNP B-NP O
107 The DT B-NP O
107 patient NN I-NP O
107 has VBZ O O
107 a DT B-NP O
107 history NN I-NP O
107 of IN B-VP O
107 gout NN B-NP O
107 This DT O O
108 appeared VBD B-VP O
108 to TO O O
108 be VB O O
108 exacerbated VBN O O
108 with IN B-VP O
108 diuresis NN B-NP O
108 His PRP$ O O
108 gouty NN B-NP O
108 pain NN I-NP O
108 was VBD B-VP O
109 initially RB O O
109 in IN B-VP O
109 his PRP$ O O
109 right JJ B-NP O
109 wrist NN I-NP O
109 He PRP O O
109 also RB O O
109 describes VBZ O O
109 pain NN B-NP O
109 in IN B-VP O
109 his PRP$ O O
110 right JJ B-NP O
110 knee NN I-NP O
110 He PRP O O
110 is VBZ O O
110 on IN B-VP O
110 his PRP$ O O
110 home NN B-NP B-do
110 home NN I-NP B-do
110 doses VBZ O I-do
110 doses NNS B-NP I-do
110 of IN B-VP O
110 allopurinol NN B-NP B-m
110 and CC O O
111 colchicine NN B-NP B-m
111 Indocin NNP I-NP B-m
111 was VBD B-VP O
111 added VBN O O
111 and CC O O
111 at IN B-VP O
111 discharge NN B-NP O
111 , , O O
111 the DT B-NP O
111 patient NN I-NP O
111 had VBD B-VP O
112 received VBN O O
112 two CD O B-du
112 two CD O B-du
112 days NNS B-NP I-du
112 days NNS I-NP I-du
112 of IN B-VP O
112 Indocin NNP B-NP B-m
112 We PRP O O
112 would MD O O
112 like VB O O
112 him PRP O O
112 to TO O O
112 receive VB O O
112 a DT B-NP B-du
113 total NN I-NP O
113 of IN B-VP O
113 three CD O O
113 days NNS B-NP O
113 of IN B-VP O
113 Indocin NNP B-NP B-m
113 Tylenol NNP I-NP B-m
113 and CC O O
113 narcotics NNS B-NP B-m
113 as IN B-VP O
114 previously RB O O
114 described VBN O O
114 can MD O O
114 be VB O O
114 used VBN O O
114 to TO O O
114 help VB O O
114 with IN B-VP O
114 his PRP$ O B-r
114 his PRP$ O B-r
114 gouty NN B-NP I-r
114 gouty NN I-NP I-r
114 pain NN I-NP I-r
114 pain VBP O I-r
115 9 CD O O
115 GI: NNP B-NP O
115 The DT B-NP O
115 patient NN I-NP O
115 takes VBZ O O
115 Nexium NNP B-NP B-m
115 at IN B-VP O
115 home NN B-NP O
115 and CC O O
115 he PRP O O
115 was VBD B-VP O
115 continued VBN O O
115 on IN B-VP O
116 Prilosec NNP B-NP B-m
116 while IN B-VP B-du
116 an DT B-NP I-du
116 inpatient NN I-NP I-du
116 He PRP O O
116 should MD O O
116 be VB O O
116 switched VBN O O
116 back RB O O
116 to TO O O
117 Nexium NN B-NP B-m
117 when WRB O O
117 he PRP O O
117 is VBZ O O
117 discharged VBN O O
117 from IN B-VP O
117 rehabilitation NN B-NP O
118 PHYSICAL NNP I-NP O
118 EXAMINATION NNP I-NP O
118 AT NNP I-NP O
118 DISCHARGE: NNP I-NP O
118 At IN B-VP O
118 discharge NN B-NP O
118 , , O O
118 the DT B-NP O
118 patient NN I-NP O
118 was VBD B-VP O
119 afebrile IN B-VP O
119 His PRP$ O O
119 blood NN B-NP O
119 pressure NN I-NP O
119 was VBD B-VP O
119 between IN B-VP O
119 110-140 JJ O O
119 over IN B-VP O
119 66-80 JJ O O
119 , , O O
120 heart NN B-NP O
120 rate NN I-NP O
120 is VBZ O O
120 between IN B-VP O
120 76 CD O O
120 and CC O O
120 87 CD O O
120 His PRP$ O O
120 room NN B-NP O
120 air NN I-NP O
120 saturation NN I-NP O
120 was VBD B-VP O
120 91% CD O O
121 on IN B-VP O
121 room NN B-NP O
121 air NN I-NP O
121 He PRP O O
121 was VBD B-VP O
121 breathing VBG O O
121 very RB O O
121 comfortably RB O O
121 and CC O O
121 complained VBD B-VP O
122 only RB O O
122 of IN B-VP O
122 right JJ B-NP O
122 wrist NN I-NP O
122 pain VB O O
122 His PRP$ O O
122 lungs NNS B-NP O
122 were VBD B-VP O
122 clear JJ B-NP O
122 JVP NNP I-NP O
122 is VBZ O O
122 less JJR O O
123 than IN B-VP O
123 10 CD O O
123 His PRP$ O O
123 cardiac JJ B-NP O
123 exam NN I-NP O
123 was VBD B-VP O
123 tachy VBN O O
123 with IN B-VP O
123 a DT B-NP O
123 regular JJ I-NP O
123 rhythm NN I-NP O
123 and CC O O
123 a DT B-NP O
124 loud JJ I-NP O
124 S2 NNP I-NP O
125 LABORATORY NNP I-NP O
125 DATA NNP I-NP O
125 ON NNP I-NP O
125 DISCHARGE: NNP I-NP O
125 Include NNP I-NP O
125 a DT B-NP O
125 creatinine NN I-NP O
125 of IN B-VP O
125 1 CD O O
125 and CC O O
126 include VBP O O
126 a DT B-NP O
126 hematocrit NN I-NP O
126 of IN B-VP O
126 53.1 CD O O
126 and CC O O
126 INR NNP B-NP O
126 of IN B-VP O
126 2.3 CD O O
126 Potassium NNP B-NP O
126 was VBD B-VP O
126 3.9 CD O O
127 and CC O O
127 magnesium NN B-NP O
127 was VBD B-VP O
127 2.0 CD O O
128 DISPOSITION: NNP B-NP O
128 The DT B-NP O
128 patient NN I-NP O
128 is VBZ O O
128 being VBG O O
128 discharged VBN O O
128 to TO O O
128 rehab VB O O
129 FOLLOWUP: NNP B-NP O
129 He PRP O O
129 should MD O O
129 follow VB O O
129 up RP O O
129 with IN B-VP O
129 his PRP$ O O
129 cardiologist NN B-NP O
129 , , O O
129 Dr NNP B-NP O
130 Insco NNP I-NP O
130 He PRP O O
130 also RB O O
130 has VBZ O O
130 an DT B-NP O
130 appointment NN I-NP O
130 scheduled VBN O O
130 with IN B-VP O
131 Endocrinology NNP B-NP O
131 in IN B-VP O
131 the DT B-NP O
131 near JJ I-NP O
131 future NN I-NP O
132 DISCHARGE NNP I-NP O
132 MEDICATIONS: NNP I-NP O
132 Coumadin NNP I-NP B-m
132 Coumadin NNP I-NP B-m
132 11 CD O B-do
132 mg NN B-NP I-do
132 Monday NNP I-NP B-f
132 , , O O
132 Wednesday NNP B-NP O
132 and CC O O
133 Friday NNP B-NP O
133 and CC O O
133 12 CD O B-do
133 mg NNS B-NP I-do
133 nightly RB O B-f
133 on IN B-VP O
133 Tuesdays NNP B-NP O
133 , , O O
133 Thursdays NNP B-NP O
133 , , O O
133 Saturday NNP B-NP O
133 and CC O O
134 Sunday NNP B-NP O
134 , , O O
134 Diovan NNP B-NP B-m
134 320 CD O B-do
134 a DT B-NP B-f
134 day NN I-NP I-f
134 , , O O
134 multivitamin RB O B-m
134 1 CD O B-do
134 tab JJ O I-do
134 daily RB O B-f
134 , , O O
134 Toprol-XL NNP B-NP B-m
134 50 CD O B-do
135 once RB O B-f
135 a DT B-NP I-f
135 day NN I-NP I-f
135 , , O O
135 nifedipine NN B-NP B-m
135 extended VBD B-VP I-m
135 release NN B-NP I-m
135 30 CD O B-do
135 once RB O B-f
135 a DT B-NP I-f
135 day NN I-NP I-f
135 , , O O
135 Revatio NNP B-NP B-m
135 20 CD O B-do
136 mg NN B-NP O
136 3 CD O B-f
136 times NNS B-NP I-f
136 a DT B-NP I-f
136 day NN I-NP I-f
136 , , O O
136 hydrochlorothiazide RB O B-m
136 25 CD O B-do
136 once RB O B-f
136 a DT B-NP I-f
136 day NN I-NP I-f
136 , , O O
136 Lasix NNP B-NP B-m
136 160 CD O B-do
136 IV NNP B-NP B-mo
137 once RB O B-f
137 per IN B-VP I-f
137 day NN B-NP I-f
137 , , O O
137 allopurinol RB O B-m
137 200 CD O B-do
137 once RB O B-f
137 per IN B-VP I-f
137 day NN B-NP I-f
137 , , O O
137 colchicine VB O B-m
137 0.6 CD O B-do
137 once RB O B-f
138 per IN B-VP O
138 day NN B-NP O
138 , , O O
138 Colace NNP B-NP B-m
138 , , O O
138 Prilosec NNP B-NP B-m
138 20 CD O B-do
138 once RB O B-f
138 a DT B-NP I-f
138 day NN I-NP I-f
138 , , O O
138 Dilaudid NNP B-NP B-m
138 2 CD O B-do
138 mg NN B-NP I-do
138 q.4 NN I-NP O
138 h NN I-NP O
139 p.o NN I-NP B-mo
139 p.r.n NN I-NP O
139 pain NN I-NP B-r
139 pain NN I-NP B-r
139 , , O O
139 Tylenol NNP B-NP B-m
139 500-1000 CD O B-do
139 mg NN B-NP I-do
139 p.o NN I-NP B-mo
139 q.6 NN I-NP B-f
139 h NN I-NP I-f
139 p.r.n NN I-NP I-f
139 pain NN I-NP B-r
139 not RB O O
140 to TO O O
140 exceed VB O O
140 4 CD O O
140 gm JJ B-NP O
140 total NN I-NP O
140 from IN B-VP O
140 all DT B-NP O
140 sources NNS I-NP O
140 in IN B-VP O
140 a DT B-NP O
140 24-hour JJ I-NP O
140 period NN I-NP O
140 , , O O
140 Ambien NNP B-NP B-m
141 10 CD O B-do
141 mg NN B-NP I-do
141 p.o NN I-NP B-mo
141 nightly RB O B-f
141 p.r.n VBZ O I-f
141 insomnia JJ B-NP B-r
142 eScription NN I-NP O
142 document: VBZ O O
142 9-7953231 CD O O
142 CSSten NNP B-NP O
142 Tel NNP I-NP O
143 Dictated NNP I-NP O
143 By: NNP I-NP O
143 TOPLK NNP I-NP O
143 , , O O
143 JEREMIAH NNP B-NP O
144 Attending: NNP I-NP O
144 OVIEDO NNP I-NP O
144 , , O O
144 RICK NNP B-NP O
144 ARNOLDO NNP I-NP O
145 Dictation NNP I-NP O
145 ID NNP I-NP O
145 0340302 CD O O
146 D: NNP B-NP O
146 5/18/07 CD O O
147 T: NNP B-NP O
147 5/18/07 CD O O
148 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #122190 VBZ O O
2 382610871 CD O O
2 SH NNP B-NP O
2 65942396 CD O O
2 484692 CD O O
2 10/1/1997 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 MYOCARDIAL NNP I-NP O
2 INFARCTION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 10/1/1997 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/4/1998 CD O O
4 ADMISSION NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 CHEST NNP I-NP O
4 PAIN NNP I-NP O
5 PROBLEM NNP I-NP O
5 LIST: NNP I-NP O
5 1 CD O O
5 ) ) O O
5 CORONARY NNPS B-NP O
5 ARTERY NNP I-NP O
5 DISEASE NNP I-NP O
6 2 CD O O
6 ) ) O O
6 HYPOTHYROIDISM NNP B-NP O
7 3 CD O O
7 ) ) O O
7 PEPTIC NNP B-NP O
7 ULCER NNP I-NP O
7 DISEASE NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 is VBZ O O
8 a DT O O
8 70 CD O O
8 year-old JJ B-NP O
8 woman NN I-NP O
8 who WP O O
9 had VBD B-VP O
9 coronary JJ B-NP O
9 artery NN I-NP O
9 bypass NN I-NP O
9 graft NN I-NP O
9 in IN B-VP O
10 1993 CD O O
10 who WP O O
10 presents VBZ O O
10 with IN B-VP O
10 ten JJ B-NP O
10 minutes NNS I-NP O
10 of IN B-VP O
10 acute JJ B-NP O
10 chest NN I-NP O
10 pain NN I-NP O
10 today NN I-NP O
10 In IN B-VP O
11 November NNP B-NP O
11 of IN B-VP O
11 1992 CD O O
11 , , O O
11 she PRP O O
11 had VBD B-VP O
11 quadruple JJ B-NP O
11 bypass NN I-NP O
11 surgery NN I-NP O
11 with IN B-VP O
11 LIMA NNP B-NP O
11 to TO O O
11 the DT B-NP O
12 LAD NNP I-NP O
12 and CC O O
12 saphenous JJ B-NP O
12 vein NN I-NP O
12 graft NN I-NP O
12 to TO O O
12 the DT B-NP O
12 PDA NNP I-NP O
12 , , O O
12 OM2 NNP B-NP O
12 and CC O O
12 diagonal JJ B-NP O
12 branch NN I-NP O
13 She PRP O O
13 was VBD B-VP O
13 feeling VBG O O
13 generally RB O O
13 well RB O O
13 until IN B-VP O
13 the DT B-NP O
13 beginning NN I-NP O
13 of IN B-VP O
13 May NNP B-NP O
13 at IN B-VP O
14 home NN B-NP O
14 From NNP I-NP O
14 November NNP I-NP O
14 , , O O
14 1997 CD O O
14 to TO O O
14 March NNP B-NP O
14 , , O O
14 1997 CD O O
14 , , O O
14 she PRP O O
14 was VBD B-VP O
14 in IN B-VP O
15 O NNP B-NP O
15 and CC O O
15 began VBD B-VP O
15 to TO O O
15 experience VB O O
15 intermittent JJ B-NP O
15 episodes NNS I-NP O
15 of IN B-VP O
15 diaphoresis NN B-NP O
16 These DT O O
16 tended VBD B-VP O
16 to TO O O
16 occur VB O O
16 with IN B-VP O
16 ambulation NN B-NP O
16 on IN B-VP O
16 a DT B-NP O
16 flat JJ I-NP O
16 surface NN I-NP O
16 , , O O
16 although IN B-VP O
17 she PRP O O
17 did VBD B-VP O
17 have VB O O
17 one CD O O
17 episode NN B-NP O
17 that WDT O O
17 awakened VBD B-VP O
17 her PRP O O
17 from IN B-VP O
17 sleep VBG O O
17 The DT B-NP O
17 second JJ I-NP O
18 time NN I-NP O
18 this DT O O
18 happened VBD B-VP O
18 , , O O
18 she PRP O O
18 went VBD B-VP O
18 to TO O O
18 the DT B-NP O
18 Faxtpaul NNP I-NP O
18 Dekan NNP I-NP O
18 Health NNP I-NP O
18 Care NNP I-NP O
18 there RB O O
18 in IN B-VP O
18 Ton NNP B-NP O
19 with IN B-VP O
19 the DT B-NP O
19 complaints NNS I-NP O
19 of IN B-VP O
19 diaphoresis NN B-NP O
19 and CC O O
19 some DT B-NP O
19 nausea NN I-NP O
19 , , O O
19 although IN B-VP O
19 she PRP O O
20 did VBD B-VP O
20 not RB O O
20 have VB O O
20 chest JJS B-NP O
20 pain NN I-NP O
20 , , O O
20 shortness NN B-NP O
20 of IN B-VP O
20 breath NN B-NP O
20 , , O O
20 vomiting VBG O O
20 or CC O O
21 palpitations NNS B-NP O
21 No DT B-NP O
21 EKG NNP I-NP O
21 was VBD B-VP O
21 done VBN O O
21 at IN B-VP O
21 the DT B-NP O
21 time NN I-NP O
21 She PRP O O
21 said VBD B-VP O
21 that IN B-VP O
21 she PRP O O
21 was VBD B-VP O
22 definitely RB O O
22 more RBR O O
22 comfortable JJ B-NP O
22 lying NN I-NP O
22 or CC O O
22 sitting VBG O O
22 than IN B-VP O
22 standing VBG O O
22 It PRP O O
22 is VBZ O O
23 of IN B-VP O
23 note NN B-NP O
23 that IN B-VP O
23 she PRP O O
23 had VBD B-VP O
23 had VBN O O
23 her PRP$ O O
23 Beta NNP B-NP B-m
23 blocker NN I-NP I-m
23 , , O O
23 Pendalol NNP B-NP B-m
23 Pendalol NNP I-NP B-m
23 decreased VBD B-VP O
23 from IN B-VP O
24 5 CD O B-do
24 mg NNS B-NP I-do
24 to TO O O
24 2.5 CD O B-do
24 mg NNS B-NP I-do
24 prior RB O O
24 to TO O O
24 this DT B-NP O
24 trip NN I-NP O
24 to TO O O
24 Glension NNP B-NP O
24 Street NNP I-NP O
24 On IN B-VP O
24 return NN B-NP O
24 to TO O O
24 the DT B-NP O
25 Gene NNP I-NP O
25 Er NNP I-NP O
25 Za NNP I-NP O
25 , , O O
25 she PRP O O
25 had VBD B-VP O
25 upper JJ B-NP B-r
25 respiratory NN I-NP I-r
25 and CC O I-r
25 pharyngeal NN B-NP I-r
25 symptoms NNS I-NP I-r
26 with IN B-VP O
26 low JJ B-NP B-r
26 grade NN I-NP I-r
26 fevers NNS I-NP I-r
26 and CC O O
26 a DT B-NP B-r
26 cough JJ I-NP I-r
26 productive NN I-NP O
26 of IN B-VP O
26 a DT B-NP O
26 green JJ I-NP O
26 sputum NN I-NP O
27 This DT O O
27 was VBD B-VP O
27 treated VBN O O
27 with IN B-VP O
27 Amoxicillin NNP B-NP B-m
27 Amoxicillin NNP I-NP B-m
27 Amoxicillin NNP I-NP B-m
27 given VBN O O
27 to TO O O
27 her PRP$ O O
27 by IN B-VP O
27 her PRP$ O O
27 son NN B-NP O
27 who WP O O
27 is VBZ O O
27 a DT O O
28 pharmacist JJ O O
28 These DT B-NP O
28 symptoms NNS I-NP O
28 gradually RB O O
28 resolved VBD B-VP O
28 and CC O O
28 she PRP O O
28 saw VBD B-VP O
28 Dr NNP B-NP O
29 Jessie NNP I-NP O
29 on IN B-VP O
29 January NNP B-NP O
29 , , O O
29 1997 CD O O
29 and CC O O
29 was VBD B-VP O
29 given VBN O O
29 a DT B-NP O
29 clean JJ I-NP O
29 bill NN I-NP O
29 of IN B-VP O
29 health NN B-NP O
30 At IN B-VP O
30 this DT B-NP O
30 visit NN I-NP O
30 , , O O
30 he PRP O O
30 did VBD B-VP O
30 start VB O O
30 her PRP$ O O
30 on IN B-VP O
30 Prinivil NNP B-NP B-m
30 Since IN B-VP O
30 she PRP O O
30 had VBD B-VP O
30 been VBN O O
31 home VBN O O
31 from IN B-VP O
31 Er NNP B-NP O
31 Dr NNP I-NP O
31 , , O O
31 Win NNP B-NP O
31 Ca NNP I-NP O
31 S NNP I-NP O
31 , , O O
31 she PRP O O
31 really RB O O
31 had VBD B-VP O
31 not RB O O
31 had VBN O O
31 repeat NN B-NP O
31 episodes NNS I-NP O
31 of IN B-VP O
32 diaphoresis NN B-NP O
32 Then RB O O
32 on IN B-VP O
32 the DT B-NP O
32 day NN I-NP O
32 of IN B-VP O
32 admission NN B-NP O
32 when WRB O O
32 she PRP O O
32 went VBD B-VP O
32 shopping NN B-NP O
33 and CC O O
33 had VBD B-VP O
33 a DT B-NP O
33 recurrent JJ I-NP O
33 episode NN I-NP O
33 of IN B-VP O
33 diaphoresis NN B-NP O
33 while IN B-VP O
33 carrying VBG O O
33 bags NNS B-NP O
33 , , O O
34 this DT B-NP O
34 time NN I-NP O
34 with IN B-VP O
34 substernal JJ B-NP B-r
34 chest NN I-NP I-r
34 pain NN I-NP I-r
34 that WDT O O
34 radiated VBD B-VP O
34 down IN B-VP O
34 both DT B-NP O
34 arms NNS I-NP O
35 She PRP O O
35 also RB O O
35 had VBD B-VP O
35 a DT B-NP O
35 general JJ I-NP O
35 sense NN I-NP O
35 of IN B-VP O
35 heaviness NN B-NP O
35 across IN B-VP O
35 her PRP$ O O
35 chest NN B-NP O
35 She PRP O O
36 drove VBD B-VP O
36 home NN B-NP O
36 and CC O O
36 took VBD B-VP O
36 a DT B-NP O
36 sublingual JJ I-NP B-mo
36 nitroglycerin NN I-NP B-m
36 that WDT O O
36 completely RB O O
37 resolved VBD B-VP O
37 her PRP O O
37 pain NN B-NP O
37 She PRP O O
37 describes VBZ O O
37 this DT B-NP O
37 pain NN I-NP O
37 as IN B-VP O
37 exactly RB O O
37 like IN B-VP O
37 the DT B-NP O
38 anginal JJ I-NP O
38 pain NN I-NP O
38 that IN B-VP O
38 she PRP O O
38 had VBD B-VP O
38 prior RB O O
38 to TO O O
38 her PRP$ O O
38 coronary JJ B-NP O
38 artery NN I-NP O
38 bypass NN I-NP O
39 graft VBD B-VP O
39 The DT B-NP O
39 total JJ I-NP O
39 duration NN I-NP O
39 of IN B-VP O
39 this DT B-NP O
39 episode NN I-NP O
39 was VBD B-VP O
39 approximately RB O O
39 ten JJ B-NP O
40 minutes NNS I-NP O
40 By IN B-VP O
40 the DT B-NP O
40 time NN I-NP O
40 she PRP O O
40 presented VBD B-VP O
40 to TO O O
40 the DT B-NP O
40 Emergency NNP I-NP O
40 Room NNP I-NP O
40 , , O O
40 she PRP O O
40 had VBD B-VP O
41 no DT B-NP O
41 diaphoresis NN I-NP O
41 and CC O O
41 no DT B-NP O
41 chest NN I-NP O
41 pain NN I-NP O
41 and CC O O
41 was VBD B-VP O
41 feeling VBG O O
41 perfectly RB O O
41 normal JJ O O
42 The DT B-NP O
42 latest JJS I-NP O
42 echocardiogram NN I-NP O
42 in IN B-VP O
42 May NNP B-NP O
42 of IN B-VP O
42 1997 CD O O
42 showed VBD B-VP O
42 an DT B-NP O
42 ejection NN I-NP O
43 fraction NN I-NP O
43 of IN B-VP O
43 35% CD O O
43 with IN B-VP O
43 mid NN B-NP O
43 to TO O O
43 distal VB O O
43 septal JJ O O
43 and CC O O
43 apical JJ B-NP O
43 akinesis NN I-NP O
43 and CC O O
44 inferior JJ B-NP O
44 akinesis NN I-NP O
44 with IN B-VP O
44 mild JJ B-NP O
44 mitral JJ I-NP O
44 regurgitation NN I-NP O
44 In IN B-VP O
44 August NNP B-NP O
44 of IN B-VP O
45 1997 CD O O
45 , , O O
45 she PRP O O
45 went VBD B-VP O
45 4 CD O O
45 minutes NNS B-NP O
45 and CC O O
45 18 CD O O
45 seconds NNS B-NP O
45 on IN B-VP O
45 an DT B-NP O
45 exercise NN I-NP O
45 tolerance NN I-NP O
46 test NN I-NP O
46 with IN B-VP O
46 Thallium NNP B-NP O
46 which WDT O O
46 showed VBD B-VP O
46 only RB O O
46 fixed VBN O O
46 defects NNS B-NP O
46 , , O O
46 no DT B-NP O
46 reversible JJ I-NP O
47 defects NNS I-NP O
48 PAST NNP I-NP O
48 MEDICAL NNP I-NP O
48 HISTORY: NNP I-NP O
48 Significant NNP I-NP O
48 for IN B-VP O
48 coronary JJ B-NP O
48 artery NN I-NP O
48 disease NN I-NP O
48 and CC O O
49 coronary JJ B-NP O
49 artery NN I-NP O
49 bypass NN I-NP O
49 graft NN I-NP O
49 with IN B-VP O
49 cardiac JJ B-NP O
50 risk NN I-NP O
50 factors NNS I-NP O
50 of IN B-VP O
50 hypertension NN B-NP O
50 , , O O
50 family NN B-NP O
50 history NN I-NP O
50 and CC O O
50 high JJ B-NP O
50 cholesterol NN I-NP O
50 , , O O
51 hypothyroidism NN B-NP O
51 and CC O O
51 remote VB O O
51 peptic JJ B-NP O
51 ulcer JJ I-NP O
51 disease NN I-NP O
51 with IN B-VP O
51 history NN B-NP O
51 of IN B-VP O
52 cholecystectomy NN B-NP O
52 and CC O O
52 appendectomy JJ B-NP O
53 MEDICATIONS NNP I-NP O
53 ON NNP I-NP O
53 ADMISSION: NNP I-NP O
53 1 CD O O
53 ) ) O O
53 Zocor NNP B-NP B-m
53 5 CD O B-do
53 mg NN B-NP I-do
53 p.o NN I-NP B-mo
53 q.h.s $ O B-f
53 2 CD O O
53 ) ) O O
53 Prinivil VBD B-VP B-m
54 5 CD O B-do
54 mg NN B-NP I-do
54 p.o NN I-NP B-mo
54 q JJ B-NP B-f
54 day NN I-NP I-f
54 3 CD O O
54 ) ) O O
54 Pendalol VBD B-VP B-m
54 2.5 CD O B-do
54 mg NN B-NP I-do
55 p.o NN I-NP B-mo
55 q JJ B-NP B-f
55 day NN I-NP I-f
55 4 CD O O
55 ) ) O O
55 Aspirin $ O B-m
55 325 CD O B-do
55 mg NN B-NP I-do
55 p.o NN I-NP B-mo
55 q JJ B-NP B-f
55 day NN I-NP I-f
55 5 CD O O
55 ) ) O O
55 Synthroid NNP B-NP B-m
55 Synthroid NNP I-NP B-m
55 0.100 CD O B-do
56 mg NN B-NP O
56 p.o NN I-NP B-mo
56 q NN I-NP B-f
56 Monday NNP I-NP I-f
56 , , O I-f
56 Wednesday NNP B-NP I-f
56 and CC O I-f
56 Friday NNP B-NP I-f
56 and CC O O
56 0.12 CD O B-do
56 mg NN B-NP I-do
56 p.o NN I-NP B-mo
56 Tuesday NNP I-NP B-f
56 , , O O
57 Thursday NNP B-NP O
57 , , O O
57 Saturday NNP B-NP O
57 and CC O O
57 Sunday NNP B-NP O
57 6 CD O O
57 ) ) O O
57 Pepcid NNP B-NP B-m
57 p.r.n NN I-NP B-f
58 ALLERGIES: NNP I-NP O
58 The DT B-NP O
58 patient NN I-NP O
58 had VBD B-VP O
58 no DT O O
58 known VBN O O
58 drug NN B-NP O
58 allergies NNS I-NP O
59 SOCIAL NNP I-NP O
59 HISTORY: NNP I-NP O
59 The DT B-NP O
59 patient NN I-NP O
59 lives VBZ O O
59 in IN B-VP O
59 Full NNP B-NP O
59 Quer NNP I-NP O
59 Dienson NNP I-NP O
59 with IN B-VP O
59 her PRP$ O O
59 husband NN B-NP O
59 and CC O O
60 has VBZ O O
60 two CD O O
60 married JJ B-NP O
60 sons NNS I-NP O
60 She PRP O O
60 does VBZ O O
60 not RB O O
60 smoke VB O O
60 and CC O O
61 drinks VB O O
61 wine NN B-NP O
61 occasionally RB O O
62 FAMILY NNP B-NP O
62 HISTORY: NNP I-NP O
62 Mother NNP I-NP O
62 died VBD B-VP O
62 of IN B-VP O
62 a DT B-NP O
62 myocardial JJ I-NP O
62 infarction NN I-NP O
62 at IN B-VP O
62 age NN B-NP O
62 58 CD O O
63 and CC O O
63 her PRP$ O O
63 brother NN B-NP O
63 had VBD B-VP O
63 a DT B-NP O
63 coronary JJ I-NP O
63 artery NN I-NP O
63 bypass NN I-NP O
63 graft NN I-NP O
64 at IN B-VP O
64 age NN B-NP O
64 79 CD O O
64 and CC O O
64 she PRP O O
64 has VBZ O O
64 a DT B-NP O
64 sister NN I-NP O
64 with IN B-VP O
64 Alzheimer's NNP B-NP O
64 disease NN I-NP O
65 PHYSICAL NNP I-NP O
65 EXAMINATION: NNP I-NP O
65 The DT B-NP O
65 patient NN I-NP O
65 is VBZ O O
65 a DT O O
65 pleasant JJ O O
65 , , O O
65 elderly JJ B-NP O
65 woman NN I-NP O
65 in IN B-VP O
66 no DT B-NP O
66 apparent JJ I-NP O
66 distress NN I-NP O
66 Vital NNP I-NP O
66 signs: NN I-NP O
67 Temperature NN I-NP O
67 99.4 CD O O
67 degrees NNS B-NP O
67 , , O O
67 heart NN B-NP O
67 rate NN I-NP O
67 87 CD O O
67 , , O O
67 blood NN B-NP O
67 pressure NN I-NP O
67 115/78 CD O O
67 , , O O
68 respiratory NN B-NP O
68 rate NN I-NP O
68 18 CD O O
68 , , O O
68 oxygen NN B-NP O
68 saturation NN I-NP O
68 98% CD O O
68 on IN B-VP O
68 room NN B-NP O
68 air NN I-NP O
68 The DT B-NP O
68 rest NN I-NP O
69 of IN B-VP O
69 the DT B-NP O
69 physical JJ I-NP O
69 examination NN I-NP O
69 was VBD B-VP O
69 significant JJ O O
69 for IN B-VP O
69 a DT B-NP O
69 clear JJ I-NP O
69 oropharynx JJ I-NP O
70 Lungs NNS I-NP O
70 were VBD B-VP O
70 clear JJ O O
70 to TO O O
70 auscultation VB O O
70 bilaterally RB O O
70 Cardiovascular JJ B-NP O
71 examination NN I-NP O
71 was VBD B-VP O
71 regular JJ B-NP O
71 rate NN I-NP O
71 and CC O O
71 rhythm NN B-NP O
71 , , O O
71 S1 NNP B-NP O
71 and CC O O
71 S2 NNP B-NP O
71 and CC O O
71 a DT O O
71 two CD O O
71 out IN B-VP O
71 of IN B-VP O
72 six CD O O
72 systolic JJ B-NP O
72 ejection NN I-NP O
72 murmur NN I-NP O
72 at IN B-VP O
72 the DT B-NP O
72 left JJ I-NP O
72 upper JJ I-NP O
72 sternal JJ I-NP O
72 border NN I-NP O
72 with IN B-VP O
73 no DT B-NP O
73 gallop NN I-NP O
73 or CC O O
73 rub VB O O
73 Abdomen NNP B-NP O
73 was VBD B-VP O
73 soft JJ O O
73 with IN B-VP O
73 good JJ B-NP O
73 bowel NN I-NP O
73 sounds VBZ O O
74 Extremities NNS B-NP O
74 revealed VBD B-VP O
74 no DT B-NP O
74 edema JJ I-NP O
74 Neurological NNP I-NP O
74 examination NN I-NP O
74 was VBD B-VP O
75 non-focal JJ B-NP O
75 Rectal NNP I-NP O
75 examination NN I-NP O
75 was VBD B-VP O
75 guaiac JJ O O
75 negative JJ O O
75 with IN B-VP O
75 no DT B-NP O
75 masses NNS I-NP O
76 LABORATORY: NNP I-NP O
76 Laboratory NNP I-NP O
76 studies NNS I-NP O
76 were VBD B-VP O
76 significant JJ O O
76 for IN B-VP O
76 a DT B-NP O
76 white JJ I-NP O
76 blood NN I-NP O
77 cell NN I-NP O
77 count NN I-NP O
77 of IN B-VP O
77 5.46 CD O O
77 , , O O
77 hematocrit NN B-NP O
77 40.1 CD O O
77 , , O O
77 platelets NNS B-NP O
77 190 CD O O
78 Cardiac NNP B-NP O
78 Troponin NNP I-NP O
78 I PRP O O
78 was VBD B-VP O
78 0.0 CD O O
78 CK NNP B-NP O
78 was VBD B-VP O
78 102 CD O O
78 Urinalysis NNP B-NP O
78 was VBD B-VP O
78 negative JJ B-NP O
79 Chest NNP I-NP O
79 x-ray NN I-NP O
79 was VBD B-VP O
79 clear JJ O O
79 with IN B-VP O
79 no DT B-NP O
79 infiltrates NNS I-NP O
79 EKG NNP I-NP O
79 was VBD B-VP O
79 normal JJ B-NP O
79 sinus JJ I-NP O
80 rhythm NN I-NP O
80 with IN B-VP O
80 normal JJ B-NP O
80 intervals NNS I-NP O
80 and CC O O
80 normal JJ B-NP O
80 axis NN I-NP O
80 with IN B-VP O
80 a DT B-NP O
80 left NN I-NP O
80 bundle NN I-NP O
81 branch NN I-NP O
81 block NN I-NP O
81 pattern NN I-NP O
81 and CC O O
81 first JJ B-NP O
81 degree NN I-NP O
81 atrioventricular JJ B-NP O
81 block NN I-NP O
81 with IN B-VP O
82 no DT B-NP O
82 change NN I-NP O
82 compared VBN O O
82 to TO O O
82 an DT B-NP O
82 EKG NNP I-NP O
82 done VBN O O
82 on IN B-VP O
82 January NNP B-NP O
82 , , O O
82 1997 CD O O
83 HOSPITAL NNP B-NP O
83 COURSE: NNP I-NP O
83 The DT B-NP O
83 impression NN I-NP O
83 on IN B-VP O
83 admission NN B-NP O
83 was VBD B-VP O
83 that IN B-VP O
83 this DT O O
83 is VBZ O O
83 a DT B-NP O
84 woman NN I-NP O
84 with IN B-VP O
84 known JJ B-NP O
84 coronary JJ I-NP O
84 artery NN I-NP O
84 disease NN I-NP O
84 status NN I-NP O
85 post NN I-NP O
85 coronary JJ B-NP O
85 artery NN I-NP O
85 bypass NN I-NP O
85 graft NN I-NP O
85 who WP O O
85 is VBZ O O
85 now RB O O
85 experiencing VBG O O
85 unstable JJ B-NP O
86 angina NN I-NP O
86 with IN B-VP O
86 diaphoretic JJ B-NP O
86 episodes NNS I-NP O
86 , , O O
86 both DT O O
86 at IN B-VP O
86 rest NN B-NP O
86 and CC O O
86 exertion NN B-NP O
86 and CC O O
86 now RB O O
87 substernal JJ B-NP O
87 chest NN I-NP O
87 pain NN I-NP O
87 She PRP O O
87 ruled VBD B-VP O
87 out RP O O
87 for IN B-VP O
87 a DT B-NP O
87 myocardial JJ I-NP O
87 infarction NN I-NP O
88 On IN B-VP O
88 May NNP B-NP O
88 , , O O
88 1998 CD O O
88 , , O O
88 she PRP O O
88 had VBD B-VP O
88 a DT B-NP O
88 standard JJ I-NP O
88 Bruce NNP I-NP O
88 exercise NN I-NP O
88 tolerance NN I-NP O
89 test NN I-NP O
89 in IN B-VP O
89 which WDT O O
89 she PRP O O
89 went VBD B-VP O
89 3 CD O O
89 minutes NNS B-NP O
89 , , O O
89 30 CD O O
89 seconds NNS B-NP O
89 and CC O O
89 stopped VBD B-VP O
89 because IN B-VP O
89 of IN B-VP O
90 chest NN B-NP O
90 pain NN I-NP O
90 This DT O O
90 was VBD B-VP O
90 typical JJ O O
90 of IN B-VP O
90 anginal JJ B-NP O
90 pain NN I-NP O
90 and CC O O
90 resolved VBD B-VP O
90 eight CD O O
91 minutes NNS B-NP O
91 into IN B-VP O
91 recovery NN B-NP O
91 The DT B-NP O
91 EKG NNP I-NP O
91 had VBD B-VP O
91 no DT B-NP O
91 changes NNS I-NP O
91 with IN B-VP O
91 a DT B-NP O
91 left NN I-NP O
91 bundle NN I-NP O
92 branch NN I-NP O
92 block NN I-NP O
92 at IN B-VP O
92 baseline NN B-NP O
92 and CC O O
92 this DT O O
92 was VBD B-VP O
92 considered VBN O O
92 to TO O O
92 be VB O O
92 consistent JJ O O
93 with IN B-VP O
93 but CC O O
93 not RB O O
93 diagnostic JJ O O
93 of IN B-VP O
93 ischemia NN B-NP O
93 She PRP O O
93 subsequently RB O O
93 underwent JJ B-NP O
94 cardiac JJ I-NP O
94 catheterization NN I-NP O
94 which WDT O O
94 revealed VBD B-VP O
94 patent NN B-NP O
94 grafts NNS I-NP O
94 with IN B-VP O
94 her PRP$ O O
94 known VBN O O
95 underlying JJ B-NP O
95 native JJ I-NP O
95 disease NN I-NP O
95 Her NNP I-NP O
95 right NN I-NP O
95 atrial JJ B-NP O
95 pressure NN I-NP O
95 was VBD B-VP O
95 4 CD O O
95 , , O O
95 right RB O O
96 ventricular JJ O O
96 46/8 CD O O
96 , , O O
96 PA NNP B-NP O
96 42/22 CD O O
96 , , O O
96 pulmonary JJ B-NP O
96 capillary JJ I-NP O
96 wedge NN I-NP O
96 pressure NN I-NP O
96 19 CD O O
97 From IN B-VP O
97 here RB O O
97 , , O O
97 she PRP O O
97 was VBD B-VP O
97 managed VBN O O
97 medically RB O O
97 with IN B-VP O
97 increases NNS B-NP O
97 in IN B-VP O
97 her PRP$ O O
97 ACE NNP B-NP B-m
98 inhibitor NN I-NP O
98 , , O O
98 Statin NNP B-NP B-m
98 and CC O O
98 the DT B-NP O
98 addition NN I-NP O
98 of IN B-VP O
98 nitrates NNS B-NP B-m
98 After IN B-VP O
98 the DT B-NP O
98 cardiac JJ I-NP B-r
99 catheterization NN I-NP O
99 , , O O
99 she PRP O O
99 developed VBD B-VP O
99 a DT B-NP O
99 large JJ I-NP O
99 right JJ I-NP O
99 groin NN I-NP O
99 hematoma NN I-NP O
99 at IN B-VP O
99 the DT B-NP O
100 puncture NN I-NP O
100 site NN I-NP O
100 and CC O O
100 a DT B-NP O
100 bruit NN I-NP O
100 was VBD B-VP O
100 noted VBN O O
100 An DT B-NP O
100 ultrasound NN I-NP O
100 was VBD B-VP O
100 done VBN O O
100 that WDT O O
101 revealed VBD B-VP O
101 a DT B-NP O
101 pseudoaneurysm NN I-NP O
101 of IN B-VP O
101 the DT B-NP O
101 common JJ I-NP O
101 femoral JJ I-NP O
101 artery NN I-NP O
101 She PRP O O
101 was VBD B-VP O
102 followed VBN O O
102 by IN B-VP O
102 Vascular NNP B-NP O
102 Surgery NNP I-NP O
102 and CC O O
102 on IN B-VP O
102 March NNP B-NP O
102 , , O O
102 1998 CD O O
102 , , O O
102 had VBD B-VP O
102 a DT B-NP O
103 follow-up JJ I-NP O
103 ultrasound NN I-NP O
103 which WDT O O
103 confirmed VBD B-VP O
103 the DT B-NP O
103 presence NN I-NP O
103 of IN B-VP O
103 a DT B-NP O
104 pseudoaneurysm NN I-NP O
104 in IN B-VP O
104 her PRP$ O O
104 common JJ B-NP O
104 femoral JJ I-NP O
104 artery NN I-NP O
104 measuring VBG O O
104 2 CD O O
104 X JJ O O
104 1.5 CD O O
104 cm NN B-NP O
105 surrounded VBN O O
105 by IN B-VP O
105 a DT B-NP O
105 large JJ I-NP O
105 hematoma NN I-NP O
105 On IN B-VP O
105 March NNP B-NP O
105 , , O O
105 1998 CD O O
105 , , O O
105 the DT B-NP O
105 patient JJ I-NP O
106 underwent JJ I-NP O
106 surgical JJ I-NP O
106 repair NN I-NP O
106 of IN B-VP O
106 the DT B-NP O
106 pseudoaneurysm NN I-NP O
106 without IN B-VP O
106 any DT B-NP O
107 complications NNS I-NP O
107 and CC O O
107 she PRP O O
107 was VBD B-VP O
107 discharged VBN O O
107 on IN B-VP O
107 January NNP B-NP O
107 , , O O
107 1998 CD O O
107 with IN B-VP O
108 follow-up JJ O O
108 with IN B-VP O
108 both DT B-NP O
108 Dr NNP I-NP O
108 Polito NNP I-NP O
108 of IN B-VP O
108 Vascular NNP B-NP O
108 Surgery NNP I-NP O
108 and CC O O
108 Dr NNP B-NP O
108 Khat NNP I-NP O
108 , , O O
109 her PRP$ O O
109 cardiologist JJ B-NP O
110 MEDICATIONS NNP I-NP O
110 ON NNP I-NP O
110 DISCHARGE: NNP I-NP O
110 1 CD O O
110 ) ) O O
110 Aspirin $ O B-m
110 325 CD O B-do
110 mg NN B-NP I-do
110 p.o NN I-NP B-mo
110 q JJ B-NP B-f
110 day NN I-NP I-f
110 2 CD O O
110 ) ) O O
111 Colace NN B-NP B-m
111 100 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 b.i.d IN B-VP B-f
111 3 CD O O
111 ) ) O O
111 Synthroid NNP B-NP B-m
111 Synthroid NNP I-NP B-m
112 100 CD O B-do
112 mcg NN B-NP I-do
112 p.o NN I-NP B-mo
112 q NN I-NP B-f
112 Monday NNP I-NP I-f
112 , , O I-f
112 Wednesday NNP B-NP I-f
112 and CC O I-f
112 Friday NNP B-NP I-f
112 , , O O
112 112 CD O B-do
112 mcg NN B-NP I-do
112 p.o NN I-NP B-mo
112 q NN I-NP B-f
113 Tuesday NNP I-NP O
113 , , O O
113 Thursday NNP B-NP O
113 , , O O
113 Saturday NNP B-NP O
113 and CC O O
113 Sunday NNP B-NP O
113 4 CD O O
113 ) ) O O
113 Lisinopril FW O B-m
113 10 CD O B-do
113 mg NN B-NP I-do
113 p.o NN I-NP B-mo
114 q JJ B-NP B-f
114 day NN I-NP I-f
114 5 CD O O
114 ) ) O O
114 Beclomethasone CD O B-m
114 diproprionate NN B-NP I-m
114 double JJ B-NP I-m
114 strength NN I-NP I-m
114 spray NN I-NP I-m
114 to TO O O
115 each DT B-NP B-mo
115 nostril NN I-NP I-mo
115 b.i.d RB O B-f
115 6 CD O O
115 ) ) O O
115 Zocor NNP B-NP B-m
115 20 CD O B-do
115 mg NN B-NP I-do
115 p.o NN I-NP B-mo
115 q.h.s $ O B-f
115 7 CD O O
115 ) ) O O
115 Toprol NNP B-NP B-m
115 XL $ O I-m
115 75 CD O B-do
116 mg NN B-NP O
116 p.o NN I-NP B-mo
116 q JJ B-NP B-f
116 day NN I-NP I-f
116 8 CD O O
116 ) ) O O
116 Imdur NNP B-NP B-m
116 30 CD O B-do
116 mg NN B-NP I-do
116 p.o NN I-NP B-mo
116 q JJ B-NP B-f
116 day NN I-NP I-f
116 9 CD O O
116 ) ) O O
116 Augmentin NNP B-NP B-m
116 one CD O B-do
117 tablet NN B-NP O
117 p.o NN I-NP B-mo
117 q JJ B-NP B-f
117 day NN I-NP I-f
117 for IN B-VP B-du
117 seven CD O I-du
117 additional JJ B-NP I-du
117 days NNS I-NP I-du
118 Dictated VBD B-VP O
118 By: NNP B-NP O
118 JEWELL NNP I-NP O
118 ROLFSEN NNP I-NP O
118 , , O O
118 M.D NNP B-NP O
118 YO53 NNP I-NP O
119 Attending: NNP I-NP O
119 OREN NNP I-NP O
119 STANOVICH NNP I-NP O
119 , , O O
119 M.D NNP B-NP O
119 MK60 NNP I-NP O
120 IL970/1869 NNP I-NP O
121 Batch: NNP I-NP O
121 91777 CD O O
121 Index NNP B-NP O
121 No NNP I-NP O
121 ZWEAXN002T NNP I-NP O
121 D: NNP I-NP O
121 8/21/98 CD O O
122 T: NNP B-NP O
122 8/21/98 CD O O
123 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #133198 VBZ O O
4 974726289 CD O O
4 SH NNP B-NP O
4 63436693 CD O O
4 9978052 CD O O
4 3/13/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHEST NNP I-NP O
4 PAIN NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/20/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/18/2005 CD O O
7 ATTENDING: NNP B-NP O
7 LANGLAIS NNP I-NP O
7 , , O O
7 EZEQUIEL NNP B-NP O
7 MD NNP I-NP O
8 PRINCIPAL NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
9 Coronary NNP I-NP O
9 artery NN I-NP O
9 disease NN I-NP O
10 HISTORY NNP I-NP O
10 OF NNP I-NP O
10 PRESENT NNP I-NP O
10 ILLNESS: NNP I-NP O
11 A NNP I-NP O
11 66-year-old JJ B-NP O
11 gentleman NN I-NP O
11 with IN B-VP O
11 a DT B-NP O
11 medical JJ I-NP O
11 history NN I-NP O
11 significant JJ O O
11 for IN B-VP O
12 coronary JJ B-NP O
12 artery NN I-NP O
12 disease NN I-NP O
12 and CC O O
12 two CD O O
12 prior JJ B-NP O
12 MIs NNP I-NP O
12 He PRP O O
12 is VBZ O O
12 also RB O O
12 status NN B-NP O
13 post NN I-NP O
13 angioplasty NN I-NP O
13 and CC O O
13 an DT B-NP O
13 LAD NNP I-NP O
13 stent NN I-NP O
13 , , O O
13 he PRP O O
13 has VBZ O O
13 hypertension NN B-NP O
13 , , O O
14 hyperlipidemia NN B-NP O
14 , , O O
14 and CC O O
14 diabetes VBZ O O
14 mellitus NN B-NP O
14 , , O O
14 and CC O O
14 presents NNS B-NP O
14 now RB O O
14 with IN B-VP O
15 chest NN B-NP O
15 pain VBP O O
15 The DT B-NP O
15 patient NN I-NP O
15 had VBD B-VP O
15 been VBN O O
15 in IN B-VP O
15 his PRP$ O O
15 usual JJ B-NP O
15 state NN I-NP O
15 of IN B-VP O
15 health NN B-NP O
16 when WRB O O
16 on IN B-VP O
16 the DT B-NP O
16 day NN I-NP O
16 prior RB O O
16 to TO O O
16 admission NN B-NP O
16 , , O O
16 he PRP O O
16 developed VBD B-VP O
16 substernal JJ B-NP B-r
16 chest NN I-NP O
17 pain NN I-NP O
17 while IN B-VP O
17 walking VBG O O
17 and CC O O
17 lasted VBD B-VP O
17 2-3 JJ B-NP O
17 hours NNS I-NP O
17 and CC O O
17 was VBD B-VP O
17 relieved VBN O O
17 by IN B-VP O
17 rest NN B-NP O
18 and CC O O
18 sublingual JJ B-NP B-mo
18 nitroglycerin NN I-NP B-m
18 He PRP O O
18 denies VBZ O O
18 shortness NN B-NP O
18 of IN B-VP O
18 breath NN B-NP O
18 , , O O
19 nausea NN B-NP O
19 , , O O
19 or CC O O
19 diaphoresis NN B-NP O
19 He PRP O O
19 presented VBD B-VP O
19 to TO O O
19 Renba NNP B-NP O
19 Memorial NNP I-NP O
19 Urgent NNP I-NP O
19 Care NNP I-NP O
19 where WRB O O
19 he PRP O O
19 was VBD B-VP O
19 evaluated VBN O O
19 and CC O O
19 sent VBN O O
19 to TO O O
19 the DT B-NP O
20 Crossdick NNP I-NP O
20 Hospital NNP I-NP O
20 Of IN B-VP O
20 emergency NN B-NP O
20 department NN I-NP O
20 , , O O
20 where WRB O O
20 he PRP O O
20 was VBD B-VP O
21 found VBN O O
21 to TO O O
21 have VB O O
21 a DT B-NP O
21 troponin NN I-NP O
21 of IN B-VP O
21 5.6 CD O O
21 , , O O
21 which WDT O O
21 peaked VBD B-VP O
21 at IN B-VP O
21 6.7 CD O O
21 He PRP O O
21 was VBD B-VP O
22 admitted VBN O O
22 , , O O
22 and CC O O
22 cardiac JJ B-NP O
22 catheterization NN I-NP O
22 revealed VBD B-VP O
22 diffuse NN B-NP O
22 disease NN I-NP O
23 He PRP O O
23 is VBZ O O
23 being VBG O O
23 evaluated VBN O O
23 for IN B-VP O
23 possible JJ B-NP O
23 surgical JJ I-NP O
23 intervention NN I-NP O
24 PAST NNP I-NP O
24 MEDICAL NNP I-NP O
24 HISTORY: NNP I-NP O
25 Hypertension NNP I-NP O
25 , , O O
25 insulin-dependent JJ B-NP O
25 diabetes NNS I-NP O
25 mellitus NN I-NP O
25 , , O O
26 hypothyroidism NN B-NP O
26 , , O O
26 hypercholesterolemia NN B-NP O
26 , , O O
26 B12 NNP B-NP O
26 deficiency NN I-NP O
26 sleep NN I-NP O
26 apnea NN I-NP O
26 , , O O
27 on IN B-VP O
27 home NN B-NP O
27 CPAP NNP I-NP O
27 , , O O
27 nephrolithiasis NN B-NP O
27 , , O O
27 restless JJ B-NP O
27 legs JJ I-NP O
27 syndrome NN I-NP O
27 , , O O
27 and CC O O
28 diabetic JJ B-NP O
28 retinopathy NN I-NP O
29 PAST NNP I-NP O
29 SURGICAL NNP I-NP O
29 HISTORY: NNP I-NP O
30 Congenital NNP I-NP O
30 Schatzki's NNP I-NP O
30 ring NN I-NP O
30 , , O O
30 status NN B-NP O
30 post NN I-NP O
30 dilation NN I-NP O
30 via IN B-VP O
30 EGD NNP B-NP O
31 SOCIAL NNP I-NP O
31 HISTORY: NNP I-NP O
32 Positive NNP I-NP O
32 for IN B-VP O
32 a DT B-NP O
32 rare JJ I-NP O
32 alcohol NN I-NP O
32 use IN B-VP O
32 The DT B-NP O
32 patient NN I-NP O
32 has VBZ O O
32 three CD O O
32 children NNS B-NP O
32 , , O O
33 and CC O O
33 is VBZ O O
33 semi-retired JJ O O
33 as IN B-VP O
33 an DT B-NP O
33 architect NN I-NP O
34 ALLERGIES: NNP I-NP O
35 Sulfa NNP I-NP O
35 causing VBG O O
35 rash NN B-NP O
35 and CC O O
35 joint JJ B-NP O
35 swelling NN I-NP O
35 , , O O
35 and CC O O
35 enalaprilat JJ B-NP O
35 causing NN I-NP O
36 cough NN I-NP O
37 MEDICATIONS NNP I-NP O
37 ON NNP I-NP O
37 ADMISSION: NNP I-NP O
38 Lopressor NNP I-NP B-m
38 50 CD O B-do
38 mg NN B-NP I-do
38 p.o NN I-NP B-mo
38 q.i.d NN I-NP B-f
38 , , O O
38 valsartan JJ O B-m
38 160 CD O B-do
38 mg JJ O I-do
38 p.o JJ O B-mo
38 daily JJ O B-f
38 , , O O
38 aspirin JJ O B-m
39 325 CD O B-do
39 mg JJ O I-do
39 p.o JJ O B-mo
39 daily JJ O B-f
39 , , O O
39 atorvastatin JJ O B-m
39 80 CD O B-do
39 mg JJ O I-do
39 p.o JJ O B-mo
39 daily JJ O B-f
39 , , O O
39 B12 NNP B-NP B-m
39 100 CD O B-do
39 mcg NN B-NP I-do
40 p.o JJ O B-mo
40 daily RB O B-f
40 , , O O
40 Colace NNP B-NP B-m
40 100 CD O B-do
40 mg NN B-NP I-do
40 p.o NN I-NP B-mo
40 b.i.d NN I-NP B-f
40 , , O O
40 folate NN B-NP B-m
40 , , O O
40 Levoxyl NNP B-NP B-m
40 , , O O
40 Nexium NNP B-NP B-m
40 , , O O
41 Lantus NNP B-NP B-m
41 , , O O
41 and CC O O
41 NovoLog NNP B-NP B-m
41 insulin VBP O I-m
42 PHYSICAL NNP B-NP O
42 EXAMINATION: NNP I-NP O
43 Height NNP I-NP O
43 5 CD O O
43 feet NNS B-NP O
43 7 CD O O
43 inches NNS B-NP O
43 tall JJ O O
43 , , O O
43 weight VBD B-VP O
43 67 CD O O
43 kg NNS B-NP O
43 Vital NNP I-NP O
43 signs: VBD B-VP O
43 Not RB O O
44 listed VBN O O
44 HEENT: NNP B-NP O
44 PERRL NNP I-NP O
44 Oropharynx NNP I-NP O
44 is VBZ O O
44 benign JJ B-NP O
44 Neck: NNP I-NP O
44 Without NNP I-NP O
45 carotid NN I-NP O
45 bruits NNS I-NP O
45 Chest: NNP I-NP O
45 Without IN B-VP O
45 incisions NNS B-NP O
45 Cardiovascular: NNP I-NP O
46 Regular NNP I-NP O
46 rate NN I-NP O
46 and CC O O
46 rhythm NN B-NP O
46 , , O O
46 no DT B-NP O
46 murmurs NNS I-NP O
46 Respiratory: NNP I-NP O
46 Breath NNP I-NP O
46 sounds NNS I-NP O
47 are VBP O O
47 clear JJ O O
47 bilaterally RB O O
47 Abdomen: NNP B-NP O
47 No NNP I-NP O
47 incisions NNS I-NP O
47 , , O O
47 soft JJ O O
47 , , O O
47 no DT B-NP O
47 masses NNS I-NP O
48 Rectal: NNP I-NP O
48 Normal NNP I-NP O
48 tone NN I-NP O
48 , , O O
48 no DT B-NP O
48 masses NNS I-NP O
48 , , O O
48 guaiac JJ B-NP O
48 negative JJ I-NP O
48 Extremities: NNP I-NP O
49 Without NNP I-NP O
49 scarring NN I-NP O
49 , , O O
49 varicosities NNS B-NP O
49 or CC O O
49 edema VB O O
49 Pedal NNP B-NP O
49 pulses NNS I-NP O
49 are VBP O O
49 1+ CD O O
50 bilaterally RB O O
50 Radial JJ B-NP O
50 pulses NNS I-NP O
50 are VBP O O
50 2+ CD O O
50 bilaterally RB O O
50 Allen's NNP B-NP O
50 test NN I-NP O
50 in IN B-VP O
51 the DT B-NP O
51 left JJ I-NP O
51 upper JJ I-NP O
51 extremity NN I-NP O
51 is VBZ O O
51 normal JJ O O
51 by IN B-VP O
51 pulse JJ B-NP O
51 oximeter NN I-NP O
51 Neuro: NNP I-NP O
52 Alert NNP I-NP O
52 and CC O O
52 oriented VBN O O
52 , , O O
52 grossly RB O O
52 nonfocal JJ B-NP O
52 exam NN I-NP O
52 , , O O
52 although IN B-VP O
52 there EX O O
52 is VBZ O O
53 slightly RB O O
53 decreased VBN O O
53 light JJ B-NP O
53 touch JJ I-NP O
53 sensation NN I-NP O
53 in IN B-VP O
53 the DT B-NP O
53 lower JJR I-NP O
53 extremities NNS I-NP O
54 around IN B-VP O
54 the DT B-NP O
54 great JJ I-NP O
54 toe NN I-NP O
54 bilaterally RB O O
55 LABORATORY NNP B-NP O
55 VALUES NNP I-NP O
55 ON NNP I-NP O
55 ADMISSION: NNP I-NP O
56 Include NNP I-NP O
56 sodium NN I-NP O
56 of IN B-VP O
56 139 CD O O
56 , , O O
56 potassium NN B-NP O
56 of IN B-VP O
56 4.3 CD O O
56 BUN NNP B-NP O
56 of IN B-VP O
56 12 CD O O
56 , , O O
56 creatinine NN B-NP O
57 of IN B-VP O
57 1.2 CD O O
57 , , O O
57 and CC O O
57 glucose NN B-NP O
57 of IN B-VP O
57 106 CD O O
57 Hematology NNP B-NP O
57 includes VBZ O O
57 white JJ B-NP O
57 blood NN I-NP O
57 cell NN I-NP O
58 count NN I-NP O
58 of IN B-VP O
58 7.4 CD O O
58 , , O O
58 hematocrit NN B-NP O
58 of IN B-VP O
58 33 CD O O
58 , , O O
58 INR NNP B-NP O
58 of IN B-VP O
58 1 CD O O
58 , , O O
58 PTT NNP B-NP O
58 of IN B-VP O
58 104 CD O O
58 Cardiac NNP B-NP O
59 catheterization NN I-NP O
59 data: NN I-NP O
59 EKG NNP I-NP O
59 , , O O
59 normal JJ B-NP O
59 sinus NN I-NP O
59 rhythm NN I-NP O
59 at IN B-VP O
59 67 CD O O
59 with IN B-VP O
59 a DT B-NP O
60 nonspecific JJ I-NP O
60 T-wave NNP I-NP O
60 abnormality NN I-NP O
60 in IN B-VP O
60 1 CD O O
60 , , O O
60 aVL NN B-NP O
60 , , O O
60 V5 NNP B-NP O
60 , , O O
60 and CC O O
60 V6 NNP B-NP O
60 Chest NNP I-NP O
61 x-ray NN I-NP O
61 is VBZ O O
61 without IN B-VP O
61 acute JJ B-NP O
61 disease NN I-NP O
62 HOSPITAL NNP I-NP O
62 COURSE: NNP I-NP O
63 The DT B-NP O
63 patient NN I-NP O
63 was VBD B-VP O
63 admitted VBN O O
63 on IN B-VP O
63 3/10/05 CD O O
63 and CC O O
63 underwent JJ B-NP O
63 cardiac JJ I-NP O
64 catheterization NN I-NP O
64 the DT B-NP O
64 following JJ I-NP O
64 day NN I-NP O
64 , , O O
64 which WDT O O
64 revealed VBD B-VP O
64 90% CD O O
64 proximal JJ B-NP O
65 LAD NNP I-NP O
65 stenosis NN I-NP O
65 , , O O
65 90% CD O O
65 mid NN B-NP O
65 LAD NNP I-NP O
65 and CC O O
65 100% CD O O
65 distal JJ B-NP O
65 LAD NNP I-NP O
65 stenosis NN I-NP O
65 , , O O
65 100% CD O O
65 mid NN B-NP O
66 LVB1 NNP I-NP O
66 , , O O
66 80% CD O O
66 mid NN B-NP O
66 circumflex NN I-NP O
66 , , O O
66 70% CD O O
66 proximal JJ B-NP O
66 D1 NNP I-NP O
66 , , O O
66 70% CD O O
66 proximal JJ B-NP O
66 PDA NNP I-NP O
66 , , O O
66 and CC O O
67 a DT B-NP O
67 right JJ I-NP O
67 dominant JJ I-NP O
67 circulation NN I-NP O
67 There EX O O
67 is VBZ O O
67 diffuse JJ B-NP O
67 coronary JJ I-NP O
68 calcification NN I-NP O
68 and CC O O
68 extensive JJ B-NP O
68 diffuse NN I-NP O
68 disease NN I-NP O
68 with IN B-VP O
68 small JJ B-NP O
68 distal JJ I-NP O
69 vessels NNS I-NP O
69 LAD NNP I-NP O
69 in IN B-VP O
69 stent JJ B-NP O
69 restenosis NN I-NP O
69 There EX O O
69 is VBZ O O
69 collateral JJ B-NP O
69 flow NN I-NP O
70 diffusely RB O O
70 small JJ O O
70 left VBD B-VP O
70 main JJ O O
70 The DT B-NP O
70 patient NN I-NP O
70 was VBD B-VP O
70 taken VBN O O
70 to TO O O
70 the DT B-NP O
71 operating NN I-NP O
71 room NN I-NP O
71 on IN B-VP O
71 4/15/05 CD O O
71 and CC O O
71 underwent JJ B-NP O
71 CABG NNP I-NP O
71 x4 NN I-NP O
71 with IN B-VP O
71 SVG1 NNP B-NP O
71 to TO O O
72 RCA NNP B-NP O
72 , , O O
72 and CC O O
72 sequential JJ B-NP O
72 graft NN I-NP O
72 of IN B-VP O
72 SVG2 NNP B-NP O
72 to TO O O
72 D1 NNP B-NP O
72 and CC O O
72 then RB O O
72 OM1 NNP B-NP O
72 The DT B-NP O
73 patient NN I-NP O
73 also RB O O
73 had VBD B-VP O
73 LIMA NNP B-NP O
73 to TO O O
73 LAD NNP B-NP O
73 and CC O O
73 an DT B-NP O
73 LAD NNP I-NP O
73 endarterectomy VBD B-VP O
73 The DT B-NP O
74 patient NN I-NP O
74 was VBD B-VP O
74 taken VBN O O
74 to TO O O
74 the DT B-NP O
74 Intensive NNP I-NP O
74 Care NNP I-NP O
74 Unit NNP I-NP O
74 following VBG O O
74 surgery NN B-NP O
74 in IN B-VP O
75 stable JJ B-NP O
75 condition NN I-NP O
75 He PRP O O
75 was VBD B-VP O
75 given VBN O O
75 150 CD O B-do
75 mg NN B-NP I-do
75 of IN B-VP O
75 Plavix NNP B-NP B-m
75 Plavix NNP I-NP B-m
75 on IN B-VP O
75 arrival NN B-NP O
75 to TO O O
76 the DT B-NP O
76 ICU NNP I-NP O
76 , , O O
76 and CC O O
76 a DT B-NP B-do
76 second JJ I-NP I-do
76 dose NN I-NP I-do
76 6 CD O O
76 hours NNS B-NP O
76 later RB O O
76 He PRP O O
76 was VBD B-VP O
76 also RB O O
76 started VBN O O
76 on IN B-VP O
77 heparin NN B-NP B-m
77 500 CD O B-do
77 units NNS B-NP I-do
77 for IN B-VP B-du
77 48 CD O I-du
77 hours NNS B-NP I-du
77 and CC O O
77 given VBN O O
77 aspirin NNS B-NP B-m
77 that WDT O O
77 same JJ B-NP O
77 night NN I-NP O
78 The DT B-NP O
78 patient NN I-NP O
78 was VBD B-VP O
78 extubated VBN O O
78 the DT B-NP O
78 following JJ I-NP O
78 day NN I-NP O
78 and CC O O
78 was VBD B-VP O
78 noted VBN O O
78 to TO O O
79 require VB O O
79 the DT B-NP O
79 transfusion NN I-NP B-mo
79 of IN B-VP O
79 a DT B-NP B-do
79 unit NN I-NP I-do
79 of IN B-VP O
79 packed JJ B-NP B-m
79 red JJ I-NP I-m
79 blood NN I-NP I-m
79 cells NNS I-NP I-m
79 He PRP O O
80 required VBD B-VP O
80 neosynephrine RB O B-m
80 transiently RB O B-du
80 , , O O
80 which WDT O O
80 was VBD B-VP O
80 weaned VBN O O
80 off RP O O
80 on IN B-VP O
81 postoperative JJ B-NP O
81 day NN I-NP O
81 #2 VBD B-VP O
81 That DT B-NP O
81 same JJ I-NP O
81 day NN I-NP O
81 , , O O
81 he PRP O O
81 transferred VBD B-VP O
81 to TO O O
81 the DT B-NP O
82 Step-Down JJ I-NP O
82 Unit NNP I-NP O
82 , , O O
82 neurologically RB O O
82 intact JJ O O
82 , , O O
82 with IN B-VP O
82 pain NN B-NP O
82 well RB O O
82 controlled VBN O O
82 , , O O
83 hemodynamically RB O O
83 stable JJ O O
83 , , O O
83 started VBD B-VP O
83 on IN B-VP O
83 aspirin NN B-NP B-m
83 , , O O
83 Lopressor NNP B-NP B-m
83 , , O O
83 and CC O O
84 Plavix NNP B-NP B-m
84 The DT B-NP O
84 patient NN I-NP O
84 was VBD B-VP O
84 also RB O O
84 on IN B-VP O
84 2 CD O B-do
84 liters NNS B-NP I-do
84 of IN B-VP O
84 oxygen NN B-NP B-m
84 at IN B-VP O
84 the DT B-NP O
84 time NN I-NP O
85 of IN B-VP O
85 transfer NN B-NP O
85 , , O O
85 and CC O O
85 had VBD B-VP O
85 chest JJS B-NP O
85 tube NN I-NP O
85 in IN B-VP O
85 that DT O O
85 still RB O O
85 had VBD B-VP O
85 output NN B-NP O
85 The DT B-NP O
86 patient's NN I-NP O
86 diet NN I-NP O
86 was VBD B-VP O
86 being VBG O O
86 advanced VBN O O
86 , , O O
86 and CC O O
86 he PRP O O
86 was VBD B-VP O
86 being VBG O O
86 diuresed VBN O O
86 with IN B-VP O
87 Lasix NNP B-NP B-m
87 with IN B-VP O
87 good JJ B-NP O
87 effect NN I-NP O
87 Perioperatively RB O O
87 , , O O
87 he PRP O O
87 was VBD B-VP O
87 also RB O O
87 followed VBN O O
87 by IN B-VP O
88 the DT B-NP O
88 Diabetes NNP I-NP O
88 Management NNP I-NP O
88 Service NNP I-NP O
88 for IN B-VP O
88 blood NN B-NP B-r
88 blood NN I-NP B-r
88 sugar NN I-NP I-r
88 sugar NN I-NP I-r
88 control NN I-NP I-r
88 control NN I-NP I-r
88 and CC O O
88 was VBD B-VP O
89 transitioned VBN O O
89 from IN B-VP O
89 IV NNP B-NP B-mo
89 insulin NN I-NP B-m
89 to TO O O
89 subcutaneous JJ B-NP B-mo
89 insulin NN I-NP B-m
90 postoperatively RB O O
90 The DT B-NP O
90 patient NN I-NP O
90 was VBD B-VP O
90 noted VBN O O
90 to TO O O
90 have VB O O
90 a DT B-NP B-r
90 preoperative JJ I-NP O
91 urinary JJ I-NP O
91 tract NN I-NP O
91 infection NN I-NP O
91 of IN B-VP O
91 E NNP B-NP O
91 coli NNS I-NP O
91 for IN B-VP O
91 which WDT O O
91 he PRP O O
91 was VBD B-VP O
91 started VBN O O
91 on IN B-VP O
92 levofloxacin NN B-NP B-m
92 on IN B-VP O
92 0/5/05 CD O O
92 and CC O O
92 treated VBD B-VP O
92 for IN B-VP B-du
92 five CD O I-du
92 days NNS B-NP I-du
92 On IN B-VP O
93 postoperative JJ B-NP O
93 day NN I-NP O
93 #3 NNP I-NP O
93 , , O O
93 his PRP$ O O
93 wires NNS B-NP O
93 , , O O
93 chest JJS B-NP O
93 tubes NNS I-NP O
93 and CC O O
93 Foley NNP B-NP O
93 were VBD B-VP O
94 removed VBN O O
94 He PRP O O
94 was VBD B-VP O
94 noted VBN O O
94 to TO O O
94 have VB O O
94 loose JJ B-NP O
94 lower JJR I-NP O
94 front NN I-NP O
94 teeth NNS I-NP O
94 following VBG O O
95 his PRP$ O O
95 difficult JJ B-NP O
95 intubation NN I-NP O
95 , , O O
95 and CC O O
95 the DT B-NP O
95 Dental NNP I-NP O
95 Service NNP I-NP O
95 was VBD B-VP O
95 called VBN O O
95 to TO O O
96 see VB O O
96 the DT B-NP O
96 patient NN I-NP O
96 The DT B-NP O
96 recommendation NN I-NP O
96 was VBD B-VP O
96 simply RB O O
96 to TO O O
96 avoid VB O O
96 putting VBG O O
97 pressure NN B-NP O
97 on IN B-VP O
97 those DT B-NP O
97 teeth NNS I-NP O
97 and CC O O
97 they PRP O O
97 advised VBD B-VP O
97 that IN B-VP O
97 this DT O O
97 would MD O O
97 allow VB O O
98 the DT B-NP O
98 teeth NN I-NP O
98 to TO O O
98 retighten VB O O
98 in IN B-VP O
98 the DT B-NP O
98 jaw NN I-NP O
98 over IN B-VP O
98 the DT B-NP O
98 next JJ I-NP O
98 couple NN I-NP O
98 of IN B-VP O
98 weeks NNS B-NP O
99 The DT B-NP O
99 patient NN I-NP O
99 continued VBD B-VP O
99 to TO O O
99 do VB O O
99 well RB O O
99 , , O O
99 remained VBD B-VP O
99 in IN B-VP O
99 sinus NN B-NP O
99 rhythm NN I-NP O
99 , , O O
99 and CC O O
100 was VBD B-VP O
100 weaned VBN O O
100 off RP O O
100 oxygen NN B-NP B-m
100 , , O O
100 saturating VBG O O
100 well RB O O
100 on IN B-VP O
100 room NN B-NP O
100 air NN I-NP O
100 He PRP O O
101 progressed VBD B-VP O
101 daily RB O O
101 and CC O O
101 walked VBD B-VP O
101 first RB O O
101 with IN B-VP O
101 assistance NN B-NP O
101 and CC O O
101 then RB O O
102 steadily RB O O
102 on IN B-VP O
102 his PRP$ O O
102 own JJ O O
102 He PRP O O
102 is VBZ O O
102 discharged VBN O O
102 to TO O O
102 home NN B-NP O
102 in IN B-VP O
102 good JJ B-NP O
102 condition NN I-NP O
103 on IN B-VP O
103 postoperative JJ B-NP O
103 day NN I-NP O
103 #7 VB O O
103 on IN B-VP O
103 the DT B-NP O
103 following JJ I-NP O
103 medications: NN I-NP O
104 Enteric-coated NNP I-NP B-m
104 aspirin NN I-NP I-m
104 325 CD O B-do
104 mg NN B-NP I-do
104 p.o JJ O B-mo
104 daily RB O B-f
104 , , O O
104 atenolol VBZ O B-m
104 75 CD O B-do
104 mg NN B-NP I-do
104 p.o JJ O B-mo
105 daily RB O B-f
105 , , O O
105 Colace NNP B-NP B-m
105 100 CD O B-do
105 mg NN B-NP I-do
105 p.o NN I-NP B-mo
105 t.i.d NN I-NP B-f
105 , , O O
105 oxycodone RB O B-m
105 5 CD O B-do
105 mg NNS B-NP I-do
105 to TO O I-do
105 10 CD O I-do
105 mg NNS B-NP I-do
105 p.o JJ B-NP B-mo
106 q.6h JJ I-NP B-f
106 p.r.n NN I-NP I-f
106 pain NN I-NP B-r
106 , , O O
106 Plavix NNP B-NP B-m
106 75 CD O B-do
106 mg NN B-NP I-do
106 p.o JJ O B-mo
106 daily RB O B-f
106 , , O O
106 Lantus NNP B-NP B-m
106 38 CD O B-do
106 units NNS B-NP I-do
107 subcutaneously RB O B-mo
107 at IN B-VP B-f
107 bedtime NN B-NP I-f
107 , , O O
107 NovoLog NNP B-NP B-m
107 18 CD O B-do
107 units NNS B-NP I-do
107 subcutaneous JJ B-NP B-mo
107 q.a.m NN I-NP B-f
107 , , O O
108 NovoLog NNP B-NP B-m
108 12 CD O B-do
108 units NNS B-NP I-do
108 subcutaneously RB O B-mo
108 with IN B-VP B-f
108 lunch NN B-NP I-f
108 and CC O I-f
108 supper NN B-NP I-f
108 , , O O
108 and CC O O
109 atorvastatin RB O B-m
109 80 CD O B-do
109 mg NNS B-NP I-do
109 p.o JJ O B-mo
109 daily RB O B-f
109 He PRP O O
109 is VBZ O O
109 to TO O O
109 have VB O O
109 a DT B-NP O
109 follow-up JJ I-NP O
110 appointment NN I-NP O
110 with IN B-VP O
110 his PRP$ O O
110 cardiologist NN B-NP O
110 , , O O
110 Dr NNP B-NP O
110 Abusufait NNP I-NP O
110 , , O O
110 in IN B-VP O
110 one CD O O
110 to TO O O
110 two CD O O
110 weeks NNS B-NP O
110 , , O O
111 and CC O O
111 with IN B-VP O
111 his PRP$ O O
111 cardiac NN B-NP O
111 surgeon NN I-NP O
111 , , O O
111 Dr NNP B-NP O
111 Cederberg NNP I-NP O
111 , , O O
111 in IN B-VP O
111 four CD O O
111 to TO O O
111 six CD O O
111 weeks NNS B-NP O
112 eScription NN I-NP O
112 document: IN B-VP O
112 7-8654026 JJ B-NP O
112 EMSFocus NNP I-NP O
112 transcriptionists NNS I-NP O
113 Dictated VBD B-VP O
113 By: NNP B-NP O
113 GOTTDENGER NNP I-NP O
113 , , O O
113 NEWTON NNP B-NP O
114 Attending: NNP I-NP O
114 ROTHERHAM NNP I-NP O
114 , , O O
114 KENT NNP B-NP O
115 Dictation NNP I-NP O
115 ID NNP I-NP O
115 1407522 CD O O
116 D: NNP B-NP O
116 5/18/05 CD O O
117 T: NNP B-NP O
117 5/18/05 CD O O
118 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #140999 VBZ O O
4 889331222 CD O O
4 CCMC NNP B-NP O
4 70201597 CD O O
4 486489 CD O O
4 2/5/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 STENOSIS NNP I-NP O
4 LEFT NNP I-NP O
4 BYPASS NNP I-NP O
4 GRAFT NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/5/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/9/2002 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 This DT O O
7 is VBZ O O
7 a DT B-NP O
7 63 JJ I-NP O
7 year-old JJ I-NP O
7 male NN I-NP O
7 with IN B-VP O
7 a DT B-NP O
8 history NN I-NP O
8 of IN B-VP O
8 peripheral JJ B-NP O
8 vascular JJ I-NP O
9 disease NN I-NP O
9 , , O O
9 hypertension NN B-NP O
9 , , O O
9 non-insulin JJ B-NP O
9 dependent NN I-NP O
9 diabetes VBZ O O
9 mellitus RBS O O
9 , , O O
10 coronary JJ B-NP O
10 artery NN I-NP O
10 disease NN I-NP O
10 , , O O
10 aortic JJ B-NP O
10 stenosis NN I-NP O
10 , , O O
10 and CC O O
10 status NN B-NP O
10 post NN I-NP O
10 bilateral JJ B-NP O
11 lower JJR I-NP O
11 extremity NN I-NP O
11 bypass NN I-NP O
11 grafts NNS I-NP O
11 who WP O O
11 presented VBD B-VP O
11 to TO O O
11 the DT B-NP O
11 hospital NN I-NP O
11 with IN B-VP O
12 increasing VBG O O
12 left VBD B-VP O
12 lower JJR B-NP O
12 extremity NN I-NP O
12 pain NN I-NP O
12 He PRP O O
12 was VBD B-VP O
12 taken VBN O O
12 to TO O O
12 angiography VB O O
13 at IN B-VP O
13 which WDT O O
13 time NN B-NP O
13 tPA NN I-NP B-m
13 infusion NN I-NP B-mo
13 was VBD B-VP O
13 commenced VBN O O
13 He PRP O O
13 is VBZ O O
13 most RBS O O
13 recently RB O O
14 status NN B-NP O
14 post NN I-NP O
14 a DT O O
14 left JJ O O
14 femoral JJ O O
14 to TO O O
14 peroneal VB O O
14 bypass NN B-NP O
14 graft NN I-NP O
14 in IN B-VP O
14 August NNP B-NP O
14 of IN B-VP O
15 2001 CD O O
15 and CC O O
15 has VBZ O O
15 noticed VBN O O
15 that IN B-VP O
15 , , O O
15 in IN B-VP O
15 the DT O O
15 past JJ O O
15 two CD O O
15 to TO O O
15 three CD O O
15 weeks NNS B-NP O
15 , , O O
15 has VBZ O O
15 been VBN O O
16 developing VBG O O
16 increasing VBG O O
16 rest NN B-NP O
16 pain NN I-NP O
16 and CC O O
16 coolness NN B-NP O
16 to TO O O
16 the DT B-NP O
16 left JJ I-NP O
16 foot NN I-NP O
16 to TO O O
17 the DT B-NP O
17 point NN I-NP O
17 where WRB O O
17 he PRP O O
17 was VBD B-VP O
17 not RB O O
17 able JJ O O
17 to TO O O
17 ambulate VB O O
17 In IN B-VP O
17 angiography NN B-NP O
17 , , O O
17 he PRP O O
18 was VBD B-VP O
18 found VBN O O
18 to TO O O
18 have VB O O
18 an DT B-NP O
18 occlusion NN I-NP O
18 of IN B-VP O
18 the DT B-NP O
18 left NN I-NP O
18 lower JJR B-NP O
18 extremity NN I-NP O
18 vein NN I-NP O
19 graft NN I-NP O
19 in IN B-VP O
19 the DT B-NP O
19 area NN I-NP O
19 of IN B-VP O
19 the DT O O
19 mid-thigh JJ O O
19 with IN B-VP O
19 no DT B-NP O
19 passage NN I-NP O
19 of IN B-VP O
19 contrast NN B-NP O
19 and CC O O
20 minimal JJ B-NP O
20 reconstitution NN I-NP O
20 of IN B-VP O
20 collaterals NNS B-NP O
20 to TO O O
20 his PRP$ O O
20 foot NN B-NP O
21 PAST NNP I-NP O
21 MEDICAL NNP I-NP O
21 HISTORY: NNP I-NP O
21 Peripheral NNP I-NP O
21 vascular JJ B-NP O
21 disease NN I-NP O
21 Myocardial NNP I-NP O
22 infarction NN I-NP O
22 Hypertension NNP I-NP O
22 Non-insulin NNP I-NP O
23 dependent NN I-NP O
23 diabetes VBZ O O
23 mellitus RBS O O
23 Aortic JJ B-NP O
23 stenosis NN I-NP O
23 He PRP O O
23 is VBZ O O
23 status NN B-NP O
23 post NN I-NP O
23 a DT O O
24 left JJ O O
24 femoral JJ O O
24 to TO O O
24 peroneal VB O O
24 bypass NN B-NP O
24 graft NN I-NP O
24 in IN B-VP O
24 August NNP B-NP O
24 of IN B-VP O
24 2001 CD O O
24 A DT B-NP O
24 revision NN I-NP O
25 with IN B-VP O
25 cephalic JJ B-NP O
25 vein NN I-NP O
25 to TO O O
25 dorsalis VB O O
25 pedis NN B-NP O
25 in IN B-VP O
25 August NNP B-NP O
25 of IN B-VP O
25 2001 CD O O
25 He PRP O O
25 is VBZ O O
26 status NN B-NP O
26 post NN I-NP O
26 a DT B-NP O
26 right JJ I-NP O
26 femoral NN I-NP O
26 to TO O O
26 peroneal VB O O
26 in IN B-VP O
26 July NNP B-NP O
26 of IN B-VP O
26 2000 CD O O
26 and CC O O
26 a DT B-NP O
26 right JJ I-NP O
27 fourth JJ I-NP O
27 toe NN I-NP O
27 amputation NN I-NP O
27 in IN B-VP O
27 July NNP B-NP O
27 of IN B-VP O
27 2000 CD O O
28 MEDICATIONS: NNP B-NP O
28 Glipizide NNP I-NP B-m
28 5 CD O B-do
28 mg NN B-NP I-do
28 b.i.d NN I-NP B-f
28 , , O O
28 Hydrochlorothiazide NNP B-NP B-m
28 50 CD O B-do
28 mg NN B-NP I-do
29 q.d NN I-NP B-f
29 , , O O
29 Lisinopril NNP B-NP B-m
29 20 CD O B-do
29 mg NN B-NP I-do
29 q.d NN I-NP B-f
29 , , O O
29 Simvastatin NNP B-NP B-m
29 20 CD O B-do
29 mg NN B-NP I-do
29 q.d NN I-NP B-f
29 , , O O
30 Amlodipine NNP B-NP B-m
30 5 CD O B-do
30 mg NN B-NP I-do
30 q.d NN I-NP B-f
30 , , O O
30 Imdur NNP B-NP B-m
30 30 CD O B-do
30 mg NN B-NP I-do
30 q.d NN I-NP B-f
30 , , O O
30 and CC O O
30 Toprol NNP B-NP B-m
30 100 CD O B-do
30 mg NN B-NP I-do
30 q.d NN I-NP B-f
30 and CC O O
31 enteric JJ O B-m
31 coated VBN O I-m
31 aspirin NN B-NP I-m
32 ALLERGIES: NNP I-NP O
32 No NNP I-NP O
32 known VBN O O
32 drug NN B-NP O
32 allergies NNS I-NP O
33 HOSPITAL NNP I-NP O
33 COURSE: NNP I-NP O
33 The DT B-NP O
33 patient NN I-NP O
33 first RB O O
33 underwent JJ B-NP O
33 angiography NN I-NP O
33 at IN B-VP O
33 which WDT O O
34 time NN B-NP O
34 they PRP O O
34 found VBD B-VP O
34 that IN B-VP O
34 the DT B-NP O
34 vein NN I-NP O
34 graft NN I-NP O
34 was VBD B-VP O
34 occluded VBN O O
35 He PRP O O
35 underwent JJ B-NP O
35 tPA JJ I-NP B-m
35 treatment NN I-NP O
35 and CC O O
35 was VBD B-VP O
35 brought VBN O O
35 back RB O O
35 to TO O O
35 angiography VB O O
36 This DT B-NP O
36 time NN I-NP O
36 they PRP O O
36 did VBD B-VP O
36 not RB O O
36 find VB O O
36 necessarily RB O O
36 any DT B-NP O
36 improvement NN I-NP O
36 The DT B-NP O
37 conduit NN I-NP O
37 actually RB O O
37 opened VBN O O
37 but CC O O
37 it PRP O O
37 was VBD B-VP O
37 found VBN O O
37 that IN B-VP O
37 he PRP O O
37 does VBZ O O
37 have VB O O
37 a DT B-NP O
37 high JJ I-NP O
38 grade NN I-NP O
38 anastomotic JJ B-NP O
38 stricture NN I-NP O
38 of IN B-VP O
38 the DT B-NP O
38 distal JJ I-NP O
38 anastomosis NN I-NP O
38 He PRP O O
38 was VBD B-VP O
39 taken VBN O O
39 to TO O O
39 the DT B-NP O
39 operating NN I-NP O
39 room NN I-NP O
39 on IN B-VP O
39 6/11/01 CD O O
39 for IN B-VP O
39 a DT B-NP O
39 left NN I-NP O
39 lower JJR B-NP O
39 extremity NN I-NP O
40 thrombectomy NN I-NP O
40 via IN B-VP O
40 groin NN B-NP O
40 and CC O O
40 foot NN B-NP O
40 cutdown NN I-NP O
40 Status NNP I-NP O
40 post NN I-NP O
40 that WDT O O
41 procedure NN B-NP O
41 he PRP O O
41 developed VBD B-VP O
41 symptoms NNS B-NP O
41 of IN B-VP O
41 acute JJ B-NP O
41 chest NN I-NP O
41 pain NN I-NP O
41 and CC O O
42 hypotension NN B-NP O
42 An DT B-NP O
42 ECG NNP I-NP O
42 was VBD B-VP O
42 performed VBN O O
42 , , O O
42 as RB O O
42 well RB O O
42 as IN B-VP O
42 troponin NN B-NP O
42 drawn NN I-NP O
42 , , O O
43 revealing VBG O O
43 that IN B-VP O
43 he PRP O O
43 has VBZ O O
43 an DT B-NP O
43 acute JJ I-NP O
43 myocardial JJ I-NP O
43 infarction NN I-NP O
43 The DT B-NP O
44 cardiology NN I-NP O
44 service NN I-NP O
44 was VBD B-VP O
44 called VBN O O
44 and CC O O
44 the DT B-NP O
44 patient NN I-NP O
44 was VBD B-VP O
44 admitted VBN O O
45 post-thrombectomy NN B-NP O
45 to TO O O
45 the DT B-NP O
45 cardiac JJ I-NP O
45 care NN I-NP O
45 unit NN I-NP O
45 At IN B-VP O
45 that DT B-NP O
45 time NN I-NP O
45 he PRP O O
45 was VBD B-VP O
46 managed VBN O O
46 medically RB O O
46 for IN B-VP O
46 a DT B-NP O
46 few JJ I-NP O
46 days NNS I-NP O
46 Based VBN O O
46 on IN B-VP O
46 his PRP$ O O
46 severe JJ B-NP O
46 aortic JJ I-NP O
47 stenosis NN I-NP O
47 and CC O O
47 difficulty NN B-NP O
47 in IN B-VP O
47 managing VBG O O
47 his PRP$ O O
47 blood NN B-NP O
47 pressure NN I-NP O
47 , , O O
47 the DT B-NP O
47 cardiac JJ I-NP O
48 surgery NN I-NP O
48 service NN I-NP O
48 was VBD B-VP O
48 consulted VBN O O
48 He PRP O O
48 was VBD B-VP O
48 scheduled VBN O O
48 to TO O O
48 see VB O O
48 cardiac JJ B-NP O
49 surgery NN I-NP O
49 in IN B-VP O
49 office NN B-NP O
49 setting NN I-NP O
49 but CC O O
49 , , O O
49 given VBN O O
49 his PRP$ O O
49 current JJ B-NP O
49 condition NN I-NP O
49 , , O O
49 we PRP O O
49 were VBD B-VP O
50 going VBG O O
50 to TO O O
50 perform VB O O
50 his PRP$ O O
50 surgery NN B-NP O
50 a DT B-NP O
50 little JJ I-NP O
50 bit NN I-NP O
50 sooner RBR O O
50 He PRP O O
50 did VBD B-VP O
50 have VB O O
50 a DT B-NP O
51 bout NN I-NP O
51 of IN B-VP O
51 pneumonia NN B-NP O
51 which WDT O O
51 mildly RB O O
51 delayed VBD B-VP O
51 his PRP$ O O
51 surgery NN B-NP O
52 On IN B-VP O
52 8/14/02 CD O O
52 he PRP O O
52 underwent JJ B-NP O
52 catheterization NN I-NP O
52 which WDT O O
52 revealed VBD B-VP O
52 a DT B-NP O
52 right JJ I-NP O
53 dominant NN I-NP O
53 system NN I-NP O
53 , , O O
53 a DT B-NP O
53 discreet NN I-NP O
53 40% CD O O
53 lesion NN B-NP O
53 in IN B-VP O
53 the DT B-NP O
53 proximal JJ I-NP O
53 left NN I-NP O
53 main JJ O O
53 , , O O
53 a DT B-NP O
54 discreet NN I-NP O
54 30% CD O O
54 lesion NN B-NP O
54 in IN B-VP O
54 the DT O O
54 proximal JJ O O
54 left VBD B-VP O
54 anterior JJ O O
54 descending VBG O O
55 artery NN B-NP O
55 , , O O
55 100% CD O O
55 lesion NN B-NP O
55 in IN B-VP O
55 the DT B-NP O
55 first JJ I-NP O
55 marginal JJ I-NP O
55 branch NN I-NP O
55 of IN B-VP O
55 the DT B-NP O
55 left NN I-NP O
56 circumflex JJ B-NP O
56 artery NN I-NP O
56 , , O O
56 as RB O O
56 well RB O O
56 as IN B-VP O
56 100% CD O O
56 lesion NN B-NP O
56 in IN B-VP O
56 the DT B-NP O
56 second JJ I-NP O
56 marginal JJ I-NP O
57 branch NN I-NP O
57 of IN B-VP O
57 the DT B-NP O
57 left NN I-NP O
57 circumflex JJ B-NP O
57 artery NN I-NP O
57 He PRP O O
57 has VBZ O O
57 a DT B-NP O
57 discreet NN I-NP O
57 80% CD O O
57 lesion NN B-NP O
58 in IN B-VP O
58 the DT B-NP O
58 proximal JJ I-NP O
58 right JJ I-NP O
58 coronary NN I-NP O
58 artery NN I-NP O
58 , , O O
58 as RB O O
58 well RB O O
58 as IN B-VP O
58 evidence NN B-NP O
58 of IN B-VP O
59 severe JJ B-NP O
59 aortic JJ I-NP O
59 stenosis NN I-NP O
59 During IN B-VP O
59 catheterization NN B-NP O
59 this DT O O
59 revealed VBD B-VP O
59 an DT B-NP O
59 RA NNP I-NP O
60 pressure NN I-NP O
60 of IN B-VP O
60 10 CD O O
60 , , O O
60 a DT B-NP O
60 pulmonary JJ I-NP O
60 artery NN I-NP O
60 pressure NN I-NP O
60 of IN B-VP O
60 49/20 CD O O
60 , , O O
60 with IN B-VP O
60 wedge NN B-NP O
60 of IN B-VP O
61 31 CD O O
61 He PRP O O
61 had VBD B-VP O
61 a DT B-NP O
61 thick JJ I-NP O
61 cardiac JJ I-NP O
61 output NN I-NP O
61 of IN B-VP O
61 4.77 CD O O
61 and CC O O
61 cardiac JJ B-NP O
61 index NN I-NP O
61 of IN B-VP O
62 2.1 CD O O
63 Based VBN O O
63 on IN B-VP O
63 the DT B-NP O
63 findings NNS I-NP O
63 of IN B-VP O
63 these DT B-NP O
63 catheterization NN I-NP O
63 results NNS I-NP O
63 , , O O
63 the DT B-NP O
63 patient NN I-NP O
64 was VBD B-VP O
64 taken VBN O O
64 to TO O O
64 the DT B-NP O
64 operating NN I-NP O
64 room NN I-NP O
64 on IN B-VP O
64 0/27/02 CD O O
64 with IN B-VP O
64 Dr NNP B-NP O
64 Opfer NNP I-NP O
64 and CC O O
64 Dr NNP B-NP O
65 Gack NNP I-NP O
65 for IN B-VP O
65 an DT B-NP O
65 aortic JJ I-NP O
65 valve NN I-NP O
65 replacement NN I-NP O
65 with IN B-VP O
65 a DT B-NP O
65 #23 JJ I-NP O
66 Carpentier-Edwards NNP I-NP O
66 pericardial NN I-NP O
66 valve NN I-NP O
66 and CC O O
66 mitral JJ B-NP O
66 valvuloplasty NN I-NP O
66 with IN B-VP O
67 an DT B-NP O
67 Alfieri NNP I-NP O
67 suture NN I-NP O
67 repair NN I-NP O
67 , , O O
67 as RB O O
67 well RB O O
67 as IN B-VP O
67 coronary JJ B-NP O
67 artery NN I-NP O
67 bypass NN I-NP O
67 graft NN I-NP O
68 times NNS I-NP O
68 three CD O O
68 with IN B-VP O
68 left VBN O O
68 internal JJ B-NP O
68 mammary JJ I-NP O
68 artery NN I-NP O
68 to TO O O
68 the DT O O
68 left VBN O O
68 anterior JJ O O
69 descending VBG O O
69 artery NN B-NP O
69 , , O O
69 left VBD B-VP O
69 radial JJ O O
69 to TO O O
69 obtuse VB O O
69 marginal JJ O O
69 one CD O O
69 , , O O
69 and CC O O
69 left VBD B-VP O
70 radial JJ O O
70 to TO O O
70 posterior VB O O
70 descending VBG O O
70 artery RB O O
70 Postoperatively RB O O
70 he PRP O O
71 underwent VBD B-VP O
71 our PRP$ O O
71 routine JJ B-NP O
71 care NN I-NP O
71 and CC O O
71 went VBD B-VP O
71 to TO O O
71 the DT B-NP O
71 Cardiac NNP I-NP O
71 Surgical NNP I-NP O
72 Intensive NNP I-NP O
72 Care NNP I-NP O
72 Unit NNP I-NP O
72 where WRB O O
72 he PRP O O
72 generally RB O O
72 did VBD B-VP O
72 well RB O O
73 He PRP O O
73 remained VBD B-VP O
73 on IN B-VP O
73 his PRP$ O O
73 aspirin NN B-NP B-m
73 and CC O O
73 Lopressor NNP B-NP B-m
73 , , O O
73 as RB O O
73 well RB O O
73 as IN B-VP O
73 Coumadin NNP B-NP B-m
73 He PRP O O
74 was VBD B-VP O
74 mildly RB O B-r
74 tachycardic JJ O I-r
74 and CC O O
74 his PRP$ O O
74 Lopressor NNP B-NP B-m
74 dose NN I-NP O
74 was VBD B-VP O
74 adjusted VBN O O
75 Because IN B-VP O
75 of IN B-VP O
75 his PRP$ O O
75 diabetes NNS B-NP O
75 mellitus RB O O
75 , , O O
75 he PRP O O
75 was VBD B-VP O
75 placed VBN O O
75 on IN B-VP O
75 the DT B-NP O
75 Portland NNP I-NP O
76 protocol NN I-NP O
76 and CC O O
76 remained VBD B-VP O
76 on IN B-VP O
76 a DT B-NP O
76 full JJ I-NP O
76 ten-day JJ I-NP B-du
76 ten-day JJ I-NP B-du
76 course NN I-NP I-du
76 course NN I-NP I-du
76 of IN B-VP O
76 Flagyl NNP B-NP B-m
76 and CC O O
77 Cefotaxime NNP B-NP B-m
77 for IN B-VP O
77 his PRP$ O B-r
77 his PRP$ O B-r
77 preoperative JJ B-NP I-r
77 preoperative JJ I-NP I-r
77 pneumonia NN I-NP I-r
77 pneumonia NN I-NP I-r
77 On IN B-VP O
77 postoperative JJ B-NP O
77 day NN I-NP O
77 #1 VBD B-VP O
78 he PRP O O
78 was VBD B-VP O
78 transferred VBN O O
78 to TO O O
78 the DT B-NP O
78 floor NN I-NP O
78 where WRB O O
78 he PRP O O
78 did VBD B-VP O
78 well RB O O
78 and CC O O
78 was VBD B-VP O
78 able JJ O O
78 to TO O O
79 ambulate VB O O
79 at IN B-VP O
79 least JJS O O
79 to TO O O
79 a DT B-NP O
79 chair NN I-NP O
79 and CC O O
79 was VBD B-VP O
79 deemed VBN O O
79 that IN B-VP O
79 he PRP O O
79 probably RB O O
79 is VBZ O O
79 not RB O O
80 a DT B-NP O
80 candidate NN I-NP O
80 to TO O O
80 go VB O O
80 home NN B-NP O
80 immediately RB O O
80 but CC O O
80 a DT B-NP O
80 candidate NN I-NP O
80 for IN B-VP O
81 rehabilitation NN B-NP O
81 He PRP O O
81 has VBZ O O
81 been VBN O O
81 taken VBN O O
81 off RP O O
81 his PRP$ O O
81 Portland NNP B-NP O
81 protocol NN I-NP O
81 and CC O O
82 his PRP$ O O
82 staples NNS B-NP O
82 have VBP O O
82 been VBN O O
82 discontinued VBN O O
83 On IN B-VP O
83 his PRP$ O O
83 pre-discharge NN B-NP O
83 examination NN I-NP O
83 he PRP O O
83 is VBZ O O
83 stable JJ O O
83 with IN B-VP O
83 clean JJ B-NP O
83 incisions NNS I-NP O
83 , , O O
84 as RB O O
84 well RB O O
84 as IN B-VP O
84 stable JJ B-NP O
84 sternum NN I-NP O
84 He PRP O O
84 is VBZ O O
84 now RB O O
84 currently RB O O
84 on IN B-VP O
84 room NN B-NP O
84 air NN I-NP O
84 and CC O O
85 will MD O O
85 be VB O O
85 discharged VBN O O
85 to TO O O
85 rehabilitation VB O O
86 DISPOSITION: NNP B-NP O
86 DISCHARGE NNP I-NP O
86 MEDICATIONS: NNP I-NP O
86 Coumadin NNP I-NP B-m
86 4 CD O B-do
86 mg NN B-NP I-do
86 p.o NN I-NP B-mo
86 q.hs NN I-NP B-f
86 to TO O O
87 maintain VB O O
87 INR NNP B-NP B-r
87 between IN B-VP O
87 2 CD O O
87 and CC O O
87 3 CD O O
87 , , O O
87 aspirin NN B-NP B-m
87 , , O O
87 Diltiazem NNP B-NP B-m
87 30 CD O B-do
88 mg NN B-NP O
88 t.i.d NN I-NP B-f
88 , , O O
88 Simvastatin NNP B-NP B-m
88 20 CD O B-do
88 mg NN B-NP I-do
88 q.d NN I-NP B-f
88 , , O O
88 Colace NNP B-NP B-m
88 100 CD O B-do
88 mg NN B-NP I-do
88 t.i.d NN I-NP B-f
88 , , O O
88 Nexium NNP B-NP B-m
88 20 CD O B-do
89 mg NN B-NP O
89 q.d NN I-NP B-f
89 , , O O
89 Niferex-150 NNP B-NP B-m
89 b.i.d NN I-NP B-f
89 , , O O
89 Glipizide NNP B-NP B-m
89 5 CD O B-do
89 mg NN B-NP I-do
89 b.i.d NN I-NP B-f
89 , , O O
89 Lasix NNP B-NP B-m
89 40 CD O B-do
89 mg NN B-NP I-do
90 b.i.d NN I-NP B-f
90 , , O O
90 and CC O O
90 Lopressor NNP B-NP B-m
90 50 CD O B-do
90 mg NN B-NP I-do
90 b.i.d NN I-NP B-f
90 with IN B-VP O
90 CZI NNP B-NP B-m
90 sliding VBG O B-do
90 scale NN B-NP I-do
91 Dictated NNP I-NP O
91 By: NNP I-NP O
91 MYRON NNP I-NP O
91 MANCUSI NNP I-NP O
91 , , O O
91 M.D NNP B-NP O
91 UQ80 NNP I-NP O
92 Attending: NNP I-NP O
92 HORACIO NNP I-NP O
92 D NNP I-NP O
92 RATCLIFF NNP I-NP O
92 , , O O
92 M.D NNP B-NP O
92 US4 NNP I-NP O
92 RZ720/557904 NNP I-NP O
93 Batch: NNP I-NP O
93 1811 CD O O
93 Index NNP B-NP O
93 No NNP I-NP O
93 VCGWLQER75 NNP I-NP O
93 D: NNP I-NP O
93 11/17/02 CD O O
94 T: NNP B-NP O
94 11/17/02 CD O O
95 CC: NNP B-NP O
95 1 CD O O
95 BURT NNP B-NP O
95 D NNP I-NP O
95 CROPSEY NNP I-NP O
95 , , O O
95 M.D NNP B-NP O
95 QM26 NNP I-NP O
96 2 CD O O
96 PORBON NNP B-NP O
96 HOSPITALS NNP I-NP O
96 AND NNP I-NP O
96 CLINICS NNP I-NP O
96 CARDIOLOGY NNP I-NP O
96 CLINIC NNP I-NP O
97 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #141408 VBZ O O
2 962087273 CD O O
2 TH NNP B-NP O
2 12854369 CD O O
2 6752923 CD O O
2 1/9/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 POST NNP I-NP O
2 OP NNP I-NP O
2 LOWER NNP I-NP O
2 EXTREMITY NNP I-NP O
2 EDEMA NNP I-NP O
2 Unsigned VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/9/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 1/22/2007 CD O O
4 ATTENDING: NNP B-NP O
4 MONTIETH NNP I-NP O
4 , , O O
4 LUCIANO NNP B-NP O
4 M.D NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Congestive NNP I-NP O
5 heart NN I-NP O
5 failure NN I-NP O
5 , , O O
5 question NN B-NP O
6 incisional JJ B-NP O
6 cellulitis NN I-NP O
7 HISTORY NNP I-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 68-year-old JJ B-NP O
7 woman NN I-NP O
7 who WP O O
7 underwent JJ B-NP O
8 mitral JJ I-NP O
8 valvuloplasty NN I-NP O
8 and CC O O
8 CABG NNP B-NP O
8 on IN B-VP O
8 8/26/06 CD O O
8 , , O O
8 postoperative JJ B-NP O
8 issues NNS I-NP O
9 included VBD B-VP O
9 atrial JJ B-NP O
9 fibrillation NN I-NP O
9 She PRP O O
9 was VBD B-VP O
10 discharged VBN O O
10 on IN B-VP O
10 5/15/06 CD O O
10 and CC O O
10 now RB O O
10 returns VBZ O O
10 to TO O O
10 the DT B-NP O
10 emergency NN I-NP O
10 room NN I-NP O
10 with IN B-VP O
11 lower JJR B-NP O
11 extremity NN I-NP O
11 swelling VBG O O
11 as RB O O
11 well RB O O
11 as IN B-VP O
11 erythema NN B-NP O
11 noted VBD B-VP O
11 at IN B-VP O
11 the DT B-NP O
11 lower JJR I-NP O
12 pole NN I-NP O
12 of IN B-VP O
12 her PRP$ O O
12 sternal JJ O O
12 wound IN B-VP O
12 The DT B-NP O
12 patient NN I-NP O
12 denies VBZ O O
12 purulent JJ B-NP O
12 drainage NN I-NP O
13 from IN B-VP O
13 wound NN B-NP O
13 , , O O
13 chills NNS B-NP O
13 or CC O O
13 nausea NN B-NP O
13 and CC O O
13 vomiting VBG O O
13 She PRP O O
13 reports VBZ O O
13 recent JJ B-NP O
14 low-grade JJ I-NP O
14 temperatures NNS I-NP O
14 of IN B-VP O
14 100 CD O O
15 PAST NNP B-NP O
15 MEDICAL NNP I-NP O
15 HISTORY: NNP I-NP O
15 Hypertension NNP I-NP O
15 , , O O
15 insulin-dependent JJ B-NP O
15 diabetes NNS I-NP O
16 mellitus NN I-NP O
16 , , O O
16 hypothyroidism NN B-NP O
16 , , O O
16 hypercholesterolemia NN B-NP O
16 , , O O
16 COPD NNP B-NP O
16 , , O O
16 GERD NNP B-NP O
16 , , O O
17 depression NN B-NP O
17 , , O O
17 history NN B-NP O
17 of IN B-VP O
17 GI NNP B-NP O
17 bleed NN I-NP O
17 on IN B-VP O
17 Coumadin NNP B-NP B-m
17 therapy NN I-NP O
17 and CC O O
17 pulmonary JJ B-NP O
18 hypertension NN I-NP O
19 PAST NNP I-NP O
19 SURGICAL NNP I-NP O
19 HISTORY: NNP I-NP O
19 Status NNP I-NP O
19 post NN I-NP O
19 appendectomy NN I-NP O
19 , , O O
19 status NN B-NP O
19 post NN I-NP O
20 cholecystectomy NN I-NP O
20 , , O O
20 status NN B-NP O
20 post NN I-NP O
20 tonsils NNS I-NP O
20 and CC O O
20 adenoids NNS B-NP O
20 , , O O
20 status NN B-NP O
20 post NN I-NP O
21 tubal JJ B-NP O
21 ligation NN I-NP O
21 and CC O O
21 removal NN B-NP O
21 of IN B-VP O
21 left JJ B-NP O
21 upper JJ I-NP O
21 extremity NN I-NP O
21 lipoma VBP O O
22 FAMILY NNP B-NP O
22 HISTORY: NNP I-NP O
22 Mother NNP I-NP O
22 died VBD B-VP O
22 of IN B-VP O
22 cervical JJ B-NP O
22 cancer NN I-NP O
23 SOCIAL NNP I-NP O
23 HISTORY: NNP I-NP O
23 The DT B-NP O
23 patient NN I-NP O
23 has VBZ O O
23 a DT B-NP O
23 remote JJ I-NP O
23 history NN I-NP O
23 of IN B-VP O
23 smoking NN B-NP O
23 , , O O
24 quit VBP O O
24 9 CD O O
24 years NNS B-NP O
24 ago RB O O
24 , , O O
24 no DT B-NP O
24 alcohol NN I-NP O
24 use IN B-VP O
24 The DT B-NP O
24 patient NN I-NP O
24 lives VBZ O O
24 with IN B-VP O
24 her PRP$ O O
25 husband NN B-NP O
25 on IN B-VP O
25 the DT B-NP O
25 Ard NNP I-NP O
25 Ont NNP I-NP O
25 Esnowi NNP I-NP O
25 She PRP O O
25 is VBZ O O
25 a DT B-NP O
25 retired JJ I-NP O
26 clothing NN I-NP O
26 company NN I-NP O
26 worker NN I-NP O
27 ALLERGIES: NNP I-NP O
27 Bactrim NNP I-NP O
27 causing VBG O O
27 hives NNS B-NP O
27 and CC O O
27 erythromycin VB O O
27 causing VBG O O
28 abdominal JJ B-NP O
28 cramps NNS I-NP O
29 MEDICATIONS NNP I-NP O
29 ON NNP I-NP O
29 ADMISSION: NNP I-NP O
30 1 CD O O
30 Toprol NNP B-NP B-m
30 25 CD O B-do
30 p.o JJ O B-mo
30 daily RB O B-f
31 2 CD O O
31 Valsartan NNP B-NP B-m
31 40 CD O B-do
31 mg NN B-NP I-do
31 p.o JJ O B-mo
31 daily JJ O B-f
32 3 CD O O
32 Aspirin NNP B-NP B-m
32 81 CD O B-do
32 mg NN B-NP I-do
32 p.o JJ O B-mo
32 daily JJ O B-f
33 4 CD O O
33 Plavix NNP B-NP B-m
33 75 CD O B-do
33 mg NN B-NP I-do
33 p.o JJ O B-mo
33 daily JJ O B-f
34 5 CD O O
34 Coumadin NNP B-NP B-m
34 variable JJ O B-do
34 dose JJ O I-do
34 daily JJ O B-f
35 6 CD O O
35 Lasix NNP B-NP B-m
35 40 CD O B-do
35 mg NN B-NP I-do
35 p.o NN I-NP B-mo
35 b.i.d VBD B-VP B-f
36 7 CD O O
36 Spironolactone NNP B-NP B-m
36 25 CD O B-do
36 mg NN B-NP I-do
36 p.o JJ O B-mo
36 daily JJ O B-f
37 8 CD O O
37 Simvastatin NNP B-NP B-m
37 20 CD O B-do
37 mg NN B-NP I-do
37 p.o JJ O B-mo
37 daily JJ O B-f
38 9 CD O O
38 Nortriptyline NNP B-NP B-m
38 50 CD O B-do
38 mg NN B-NP I-do
38 p.o JJ O B-mo
38 daily JJ O B-f
39 10 CD O O
39 Fluoxetine NNP B-NP B-m
39 20 CD O B-do
39 mg NN B-NP I-do
39 p.o JJ O B-mo
39 daily JJ O B-f
40 11 CD O O
40 Synthroid NNP B-NP B-m
40 88 CD O B-do
40 mcg NN B-NP I-do
40 p.o JJ B-NP B-mo
40 daily JJ I-NP B-f
41 PHYSICAL NNP I-NP O
41 EXAMINATION: NNP I-NP O
41 Height NNP I-NP O
41 5 CD O O
41 feet NNS B-NP O
41 2 CD O O
41 inches NNS B-NP O
41 tall JJ O O
41 and CC O O
41 weight VBD B-VP O
41 97 CD O O
42 kg NNS B-NP O
42 Vital NNP I-NP O
42 signs NNS I-NP O
42 , , O O
42 temperature NN B-NP O
42 98.8 CD O O
42 , , O O
42 heart NN B-NP O
42 rate NN I-NP O
42 90 CD O O
42 , , O O
42 blood NN B-NP O
42 pressure NN I-NP O
43 120/72 CD O O
43 and CC O O
43 oxygen JJ B-NP O
43 saturation NN I-NP O
43 98% CD O O
43 on IN B-VP O
43 room NN B-NP O
43 air NN I-NP O
43 HEENT NNP I-NP O
43 , , O O
43 PERRL NNP B-NP O
43 , , O O
44 oropharynx JJ B-NP O
44 benign NN I-NP O
44 Chest NNP I-NP O
44 with IN B-VP O
44 midline JJ B-NP O
44 incision NN I-NP O
44 Cardiovascular NNP I-NP O
44 , , O O
45 regular JJ B-NP O
45 rate NN I-NP O
45 and CC O O
45 rhythm NN B-NP O
45 , , O O
45 no DT B-NP O
45 murmurs NN I-NP O
45 , , O O
45 stable JJ B-NP O
45 sternum NN I-NP O
45 No NNP I-NP O
45 clicks VBZ O O
46 Respiratory NNP B-NP O
46 , , O O
46 breath NN B-NP O
46 sounds NNS I-NP O
46 are VBP O O
46 clear JJ O O
46 bilaterally RB O O
46 Abdomen NNP B-NP O
47 without IN B-VP O
47 incisions NNS B-NP O
47 , , O O
47 soft JJ O O
47 , , O O
47 no DT B-NP O
47 masses NNS I-NP O
47 Extremities NNS I-NP O
47 with IN B-VP O
47 2+ CD O O
48 bilateral JJ B-NP O
48 lower JJR I-NP O
48 extremity NN I-NP O
48 edema NN I-NP O
48 , , O O
48 erythema NN B-NP O
48 on IN B-VP O
48 the DT B-NP O
48 left NN I-NP O
48 Pedal NNP I-NP O
48 pulses NNS I-NP O
48 are VBP O O
48 1+ CD O O
49 bilaterally RB O O
49 Radial JJ B-NP O
49 pulses NNS I-NP O
49 2+ CD O O
50 bilaterally RB O O
50 Neuro NNP B-NP O
50 , , O O
50 alert NN B-NP O
50 and CC O O
50 oriented VBN O O
50 , , O O
50 grossly RB O O
50 nonfocal JJ B-NP O
50 exam NN I-NP O
51 LABORATORY NNP I-NP O
51 DATA: NNP I-NP O
51 Chemistries NNP I-NP O
51 include VBP O O
51 the DT O O
51 following JJ O O
51 , , O O
51 sodium NN B-NP O
51 of IN B-VP O
52 132 CD O O
52 , , O O
52 BUN NNP B-NP O
52 of IN B-VP O
52 15 CD O O
52 , , O O
52 creatinine NN B-NP O
52 of IN B-VP O
52 0.8 CD O O
52 and CC O O
52 BNP NNP B-NP O
52 of IN B-VP O
52 2520 CD O O
52 Hematology NNP B-NP O
53 includes VBZ O O
53 white JJ B-NP O
53 blood NN I-NP O
53 cell NN I-NP O
53 count NN I-NP O
53 of IN B-VP O
53 6.8 CD O O
53 and CC O O
53 hematocrit NN B-NP O
53 of IN B-VP O
53 24.6 CD O O
54 HOSPITAL NNP B-NP O
54 COURSE: NNP I-NP O
54 The DT B-NP O
54 patient NN I-NP O
54 was VBD B-VP O
54 admitted VBN O O
54 on IN B-VP O
54 2/28/06 CD O O
54 Her PRP$ O O
54 exam NN B-NP O
55 was VBD B-VP O
55 notable JJ O O
55 for IN B-VP O
55 significant JJ B-NP O
55 lower JJR I-NP O
55 extremity NN I-NP O
55 edema NN I-NP O
55 with IN B-VP O
55 probable JJ B-NP O
56 lower JJR I-NP O
56 extremity NN I-NP O
56 cellulitis NN I-NP O
56 on IN B-VP O
56 the DT B-NP O
56 left NN I-NP O
56 as RB O O
56 well RB O O
56 as IN B-VP O
56 pulmonary JJ O O
57 wheezing VBG O O
57 The DT B-NP O
57 patient NN I-NP O
57 was VBD B-VP O
57 admitted VBN O O
57 to TO O O
57 the DT B-NP O
57 Intensive NNP I-NP O
57 Care NNP I-NP O
57 Unit NNP I-NP O
58 for IN B-VP O
58 dyspnea NN B-NP O
58 and CC O O
58 underwent JJ B-NP O
58 transthoracic NN I-NP O
58 echocardiogram NN I-NP O
58 , , O O
58 which WDT O O
59 revealed VBD B-VP O
59 ejection NN B-NP O
59 fraction NN I-NP O
59 of IN B-VP O
59 40% CD O O
59 to TO O O
59 45% CD O O
59 and CC O O
59 a DT O O
59 stable JJ O O
59 mitral JJ O O
60 valve IN B-VP O
60 The DT B-NP O
60 patient NN I-NP O
60 was VBD B-VP O
60 started VBN O O
60 on IN B-VP O
60 a DT B-NP O
60 Lasix NNP I-NP B-m
60 drip NN I-NP B-mo
60 and CC O O
60 Diuril NNP B-NP B-m
60 with IN B-VP O
61 improvement NN B-NP O
61 of IN B-VP O
61 symptoms NNS B-NP O
61 She PRP O O
61 was VBD B-VP O
61 also RB O O
61 started VBN O O
61 on IN B-VP O
61 antibiotics NNS B-NP B-m
61 for IN B-VP O
62 coverage NN B-NP O
62 of IN B-VP O
62 possible JJ B-NP B-r
62 lower JJR I-NP I-r
62 extremity NN I-NP I-r
62 cellulitis VBP O I-r
62 The DT B-NP O
62 Pulmonary NNP I-NP O
63 team NN I-NP O
63 was VBD B-VP O
63 consulted VBN O O
63 , , O O
63 as IN B-VP O
63 the DT B-NP O
63 patient NN I-NP O
63 has VBZ O O
63 history NN B-NP O
63 of IN B-VP O
63 COPD NNP B-NP O
63 and CC O O
63 they PRP O O
64 recommended VBD B-VP O
64 regimen NNS B-NP O
64 of IN B-VP O
64 Advair NNP B-NP B-m
64 and CC O O
64 steroid JJ B-NP B-m
65 taper NN I-NP O
65 for IN B-VP O
65 her PRP$ O B-r
65 her PRP$ O B-r
65 COPD NNP B-NP I-r
65 COPD NNP I-NP I-r
65 She PRP O O
65 was VBD B-VP O
65 empirically RB O O
65 covered VBN O O
65 for IN B-VP O
65 pneumonia NN B-NP B-r
65 pneumonia NN I-NP B-r
66 with IN B-VP O
66 levofloxacin NN B-NP B-m
66 and CC O O
66 Flagyl NNP B-NP B-m
66 and CC O O
66 continued VBD B-VP O
66 to TO O O
66 diurese VB O O
66 well RB O O
66 on IN B-VP O
66 a DT B-NP O
67 Lasix NNP I-NP B-m
67 drip NN I-NP B-mo
67 She PRP O O
67 was VBD B-VP O
67 transferred VBN O O
67 to TO O O
67 the DT B-NP O
67 Step-Down JJ I-NP O
67 Unit NNP I-NP O
67 the DT B-NP O
68 following JJ I-NP O
68 day NN I-NP O
68 Her NNP I-NP O
68 preadmission NN I-NP O
68 cardiac NN I-NP B-m
68 meds NNS I-NP I-m
68 as RB O O
68 well RB O O
68 as IN B-VP O
68 her PRP$ O O
69 Coumadin NNP B-NP B-m
69 for IN B-VP O
69 atrial JJ B-NP B-r
69 atrial JJ I-NP B-r
69 fibrillation NN I-NP I-r
69 fibrillation NN I-NP I-r
69 were VBD B-VP O
69 restarted VBN O O
69 The DT B-NP O
69 patient NN I-NP O
69 required VBN O O
69 ongoing JJ B-NP O
70 aggressive JJ I-NP O
70 diuresis NN I-NP O
70 to TO O O
70 eventually RB O O
70 achieve VB O O
70 a DT B-NP O
70 fluid JJ I-NP O
70 balance NN I-NP O
70 of IN B-VP O
70 is VBZ O O
71 negative JJ O O
71 1 CD O O
71 liter JJ O O
71 daily JJ O O
71 With IN B-VP O
71 diuresis NN B-NP O
71 , , O O
71 the DT B-NP O
71 patient NN I-NP O
71 complained VBD B-VP O
71 of IN B-VP O
72 postural JJ B-NP O
72 dizziness NN I-NP O
72 , , O O
72 lightheadedness NN B-NP O
72 and CC O O
72 nausea NN B-NP O
72 Liver NNP I-NP O
72 function NN I-NP O
73 tests NNS I-NP O
73 as RB O O
73 well RB O O
73 as IN B-VP O
73 amylase NN B-NP O
73 and CC O O
73 lipase NN B-NP O
73 were VBD B-VP O
73 checked VBN O O
73 and CC O O
73 noted VBN O O
73 to TO O O
73 be VB O O
74 normal JJ B-NP O
74 KUB NNP I-NP O
74 was VBD B-VP O
74 without IN B-VP O
74 evidence NN B-NP O
74 of IN B-VP O
75 small-bowel JJ B-NP O
75 obstruction NN I-NP O
75 or CC O O
75 perforation NN B-NP O
75 , , O O
75 and CC O O
75 with IN B-VP O
75 stool NN B-NP O
75 throughout IN B-VP O
75 the DT B-NP O
75 colon NN I-NP O
76 The DT B-NP O
76 patient's NN I-NP O
76 nausea NN I-NP O
76 and CC O O
76 vomiting VBG O O
76 resolved VBD B-VP O
76 when WRB O O
76 her PRP$ O O
76 bowels NNS B-NP O
76 began VBD B-VP O
76 to TO O O
76 move VB O O
77 The DT B-NP O
77 patient NN I-NP O
77 continues VBZ O O
77 her PRP$ O O
77 course NN B-NP O
77 of IN B-VP O
77 antibiotics NNS B-NP B-m
77 antibiotics NNS I-NP B-m
77 both DT O O
77 to TO O O
77 cover VB O O
78 lower JJR B-NP B-r
78 extremity NN I-NP I-r
78 cellulitis NN I-NP I-r
78 and CC O O
78 pneumonia NN B-NP B-r
79 DISPOSITION: NNP I-NP O
79 She PRP O O
79 is VBZ O O
79 discharged VBN O O
79 to TO O O
79 home NN B-NP O
79 in IN B-VP O
79 good JJ B-NP O
79 condition NN I-NP O
79 on IN B-VP O
80 hospital JJ B-NP O
80 day NN I-NP O
80 #8 VB O O
80 on IN B-VP O
80 the DT B-NP O
80 following JJ I-NP O
80 medications: NN I-NP O
81 1 CD O O
81 Enteric-coated JJ B-NP B-m
81 aspirin NN I-NP I-m
81 81 CD O B-do
81 mg NN B-NP I-do
81 p.o JJ O B-mo
81 daily JJ O B-f
82 2 CD O O
82 Zetia NNP B-NP B-m
82 10 CD O B-do
82 mg NN B-NP I-do
82 p.o JJ O B-mo
82 daily JJ O B-f
83 3 CD O O
83 Fluoxetine NNP B-NP B-m
83 20 CD O B-do
83 mg NN B-NP I-do
83 p.o JJ O B-mo
83 daily JJ O B-f
84 4 CD O O
84 Advair NNP B-NP B-m
84 Diskus NNP I-NP I-m
84 one CD O B-do
84 puff NN B-NP I-do
84 nebulized VBD B-VP B-mo
84 b.i.d RB O B-f
85 5 CD O O
85 Lasix NNP B-NP B-m
85 60 CD O B-do
85 mg NN B-NP I-do
85 p.o NN I-NP B-mo
85 b.i.d VBD B-VP B-f
86 6 CD O O
86 NPH NNP B-NP B-m
86 insulin NN I-NP I-m
86 30 CD O B-do
86 units NNS B-NP I-do
86 subcutaneously RB O B-mo
86 q.p.m RB O B-f
87 7 CD O O
87 NPH NNP B-NP B-m
87 insulin NN I-NP I-m
87 20 CD O B-do
87 units NNS B-NP I-do
87 subcutaneously RB O B-mo
87 q.a.m VBP O B-f
88 8 CD O O
88 Potassium NNP B-NP B-m
88 slow JJ B-NP I-m
88 release NN I-NP I-m
88 30 CD O B-do
88 mEq NN B-NP I-do
88 p.o JJ O B-mo
88 daily JJ O B-f
89 9 CD O O
89 Levofloxacin NNP B-NP B-m
89 500 CD O B-do
89 mg NN B-NP I-do
89 p.o NN I-NP B-mo
89 q.24 NN I-NP B-f
89 h NN I-NP I-f
89 x4 NNP I-NP B-du
89 doses VBZ O I-du
90 10 CD O O
90 Levothyroxine NNP B-NP B-m
90 88 CD O B-do
90 mcg NN B-NP I-do
90 p.o JJ O B-mo
90 daily JJ O B-f
91 11 CD O O
91 Toprol-XL JJ O B-m
91 100 CD O B-do
91 mg JJ O I-do
91 p.o JJ O B-mo
91 daily JJ O B-f
92 12 CD O O
92 Nortriptyline NNP B-NP B-m
92 50 CD O B-do
92 mg NN B-NP I-do
92 p.o NN I-NP B-mo
92 nightly RB O B-f
93 13 CD O O
93 Prednisone NNP B-NP B-m
93 Prednisone NNP I-NP B-m
93 Prednisone NNP I-NP B-m
93 Prednisone NNP I-NP B-m
93 Prednisone NNP I-NP B-m
93 taper NN I-NP I-m
93 taper NN I-NP I-m
93 taper IN B-VP I-m
93 taper JJR B-NP I-m
93 taper NN I-NP I-m
93 30 CD O B-do
93 mg NN B-NP I-do
93 q.24 NN I-NP B-f
93 h NN I-NP I-f
93 x3 NN I-NP B-du
93 doses NNS I-NP I-du
93 , , O O
93 20 CD O B-do
93 mg NN B-NP I-do
93 q.24 NN I-NP B-f
93 h NN I-NP I-f
93 x3 NN I-NP B-du
94 doses NNS I-NP O
94 followed VBN O O
94 by IN B-VP O
94 a DT O O
94 10 CD O B-do
94 mg NN B-NP I-do
94 q.24 NN I-NP B-f
94 h NN I-NP I-f
94 x3 NN I-NP B-du
94 doses NNS I-NP I-du
94 , , O O
94 then RB O O
94 5 CD O B-do
94 5 CD O B-do
94 mg NN B-NP I-do
94 mg NN I-NP I-do
94 q.24 NN I-NP B-f
94 q.24 NN I-NP B-f
94 h NN I-NP I-f
94 h NN I-NP I-f
94 x3 NNP I-NP B-du
94 x3 NNP I-NP B-du
95 doses VBZ O O
96 14 CD O O
96 Simvastatin NNP B-NP B-m
96 40 CD O B-do
96 mg NN B-NP I-do
96 p.o NN I-NP B-mo
96 nightly RB O B-f
97 15 CD O O
97 Diovan NNP B-NP B-m
97 20 CD O B-do
97 mg NN B-NP I-do
97 p.o JJ O B-mo
97 daily JJ O B-f
98 16 CD O O
98 Coumadin NNP B-NP B-m
98 Coumadin NNP I-NP B-m
98 to TO O O
98 be VB O O
98 taken VBN O O
98 as RB O B-f
98 directed VBN O I-f
98 to TO O O
98 maintain VB O O
98 INR NNP B-NP O
98 2 CD O O
98 to TO O O
98 2.5 CD O O
99 for IN B-VP O
99 atrial JJ B-NP B-r
99 atrial JJ I-NP B-r
99 fibrillation NN I-NP I-r
99 fibrillation NN I-NP I-r
100 The DT B-NP O
100 patient NN I-NP O
100 is VBZ O O
100 to TO O O
100 have VB O O
100 followup JJ B-NP O
100 appointments NNS I-NP O
100 with IN B-VP O
100 her PRP$ O O
101 cardiologist NN B-NP O
101 , , O O
101 Dr NNP B-NP O
101 Schwarzkopf NNP I-NP O
101 in IN B-VP O
101 one CD O O
101 to TO O O
101 two CD O O
101 weeks NNS B-NP O
101 with IN B-VP O
101 her PRP$ O O
101 cardiac JJ B-NP O
102 surgeon NN I-NP O
102 , , O O
102 Dr NNP B-NP O
102 Carlough NNP I-NP O
102 in IN B-VP O
102 four CD O O
102 to TO O O
102 six CD O O
102 weeks NNS B-NP O
102 VNA NNP I-NP O
102 will MD O O
102 monitor VB O O
102 her PRP$ O O
103 vital JJ B-NP O
103 signs NNS I-NP O
103 , , O O
103 weight NN B-NP O
103 and CC O O
103 wounds NNS B-NP O
103 and CC O O
103 the DT B-NP O
103 patient's NN I-NP O
103 INR NNP I-NP O
103 and CC O O
103 Coumadin NNP B-NP B-m
104 dosing NN I-NP O
104 will MD O O
104 be VB O O
104 followed VBN O O
104 by IN B-VP O
104 S NNP B-NP O
104 Community NNP I-NP O
104 Hospital NNP I-NP O
105 Anticoagulation NNP I-NP O
105 Service NNP I-NP O
105 at IN B-VP O
105 300-135-5841 JJ B-NP O
106 eScription NN I-NP O
106 document: IN B-VP O
106 9-7182888 CD O O
106 CSSten NNP B-NP O
106 Tel NNP I-NP O
107 Dictated NNP I-NP O
107 By: NNP I-NP O
107 GOODNOE NNP I-NP O
107 , , O O
107 IAN NNP B-NP O
108 Attending: NNP I-NP O
108 LEDLOW NNP I-NP O
108 , , O O
108 JEROMY NNP B-NP O
109 Dictation NNP I-NP O
109 ID NNP I-NP O
109 3198633 CD O O
110 D: NNP B-NP O
110 6/21/07 CD O O
111 T: NNP B-NP O
111 6/21/07 CD O O
112 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #151931 VBZ O O
2 918306143 CD O O
2 DGH NNP B-NP O
2 12507329 CD O O
2 867015 CD O O
2 10/30/1997 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 DILATED NNP I-NP O
2 CARDIOMYOPATHY NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 8/24/1997 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/9/1997 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 CARDIOMYOPATHY NNP I-NP O
5 SIGNIFICANT NNP I-NP O
5 PROBLEM: NNP I-NP O
5 NON-INSULIN NNP I-NP O
5 DEPENDENT NNP I-NP O
5 DIABETES NNP I-NP O
5 MELLITUS NNP I-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 The DT B-NP O
6 patient NN I-NP O
6 is VBZ O O
6 a DT B-NP O
6 57 JJ I-NP O
6 year-old JJ I-NP O
6 female NN I-NP O
7 with IN B-VP O
7 dilated VBN O O
7 cardiomyopathy NN B-NP O
7 who WP O O
7 is VBZ O O
8 admitted VBN O O
8 for IN B-VP O
8 transplant JJ B-NP O
8 evaluation NN I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 initially RB O O
9 presented VBN O O
9 in IN B-VP O
9 1991 CD O O
9 with IN B-VP O
9 substernal JJ B-NP O
9 chest NN I-NP O
9 pain NN I-NP O
9 At IN B-VP O
9 that DT B-NP O
9 time NN I-NP O
9 , , O O
9 it PRP O O
9 was VBD B-VP O
10 thought VBN O O
10 that IN B-VP O
10 she PRP O O
10 was VBD B-VP O
10 having VBG O O
10 a DT B-NP O
10 myocardial JJ I-NP B-r
10 infarction NN I-NP I-r
10 and CC O O
11 Streptokinase NNP B-NP B-m
11 was VBD B-VP O
11 given; VBN O O
11 however RB O O
11 details NNS B-NP O
11 are VBP O O
11 not RB O O
11 known VBN O O
11 An DT B-NP O
12 echocardiogram NN I-NP O
12 at IN B-VP O
12 that DT B-NP O
12 time NN I-NP O
12 showed VBD B-VP O
12 that IN B-VP O
12 her PRP$ O O
12 ejection NN B-NP O
12 fraction NN I-NP O
12 was VBD B-VP O
13 35-40% JJ O O
13 with IN B-VP O
13 evidence NN B-NP O
13 an DT B-NP O
13 anteroseptal JJ I-NP O
13 myocardial JJ I-NP O
13 infarction NN I-NP O
13 An DT B-NP O
13 ETT NNP I-NP O
14 Thallium NN I-NP O
14 showed VBD B-VP O
14 fixed JJ O O
14 anteroseptal JJ O O
14 and CC O O
14 apical JJ B-NP O
14 defects NNS I-NP O
14 Cardiac NNP I-NP O
15 catheterization NN I-NP O
15 showed VBD B-VP O
15 clean JJ B-NP O
15 coronaries NNS I-NP O
15 The DT B-NP O
15 patient NN I-NP O
15 was VBD B-VP O
15 referred VBN O O
16 to TO O O
16 Terself NNP B-NP O
16 Health NNP I-NP O
16 where WRB O O
16 an DT B-NP O
16 exercise NN I-NP O
16 bicycle NN I-NP O
16 test NN I-NP O
17 showed VBD B-VP O
17 6 CD O O
17 minutes NNS B-NP O
17 and CC O O
17 22 CD O O
17 seconds NNS B-NP O
17 of IN B-VP O
17 exercise NN B-NP O
17 Her NNP I-NP O
17 peak JJ B-NP O
17 heart NN I-NP O
17 rate NN I-NP O
18 was VBD B-VP O
18 113 CD O O
18 with IN B-VP O
18 a DT B-NP O
18 peak JJ I-NP O
18 blood NN I-NP O
18 pressure NN I-NP O
18 of IN B-VP O
18 140/60 CD O O
18 and CC O O
18 a DT B-NP O
18 peak JJ I-NP O
18 VO2 NNP I-NP O
18 of IN B-VP O
18 11.6 CD O O
19 ml NNS B-NP O
19 per IN B-VP O
19 kg NN B-NP O
19 per IN B-VP O
19 minute NN B-NP O
19 The DT B-NP O
19 patient NN I-NP O
19 apparently RB O O
19 did VBD B-VP O
19 well RB O O
19 until IN B-VP O
19 about IN B-VP O
20 a DT B-NP O
20 year NN I-NP O
20 prior RB O O
20 to TO O O
20 admission NN B-NP O
20 when WRB O O
20 she PRP O O
20 noted VBD B-VP O
20 a DT B-NP O
20 gradual JJ I-NP O
20 decrease NN I-NP O
20 in IN B-VP O
20 her PRP$ O O
21 exercise NN B-NP O
21 tolerance NN I-NP O
21 At IN B-VP O
21 an DT B-NP O
21 outside NN I-NP O
21 , , O O
21 she PRP O O
21 was VBD B-VP O
21 hospitalized VBN O O
21 for IN B-VP O
22 congestive JJ B-NP O
22 heart NN I-NP O
22 failure NN I-NP O
22 symptoms NNS I-NP O
22 Lately RB O O
22 , , O O
22 the DT B-NP O
22 patient NN I-NP O
22 noticed VBD B-VP O
23 that IN B-VP O
23 she PRP O O
23 is VBZ O O
23 unable JJ O O
23 to TO O O
23 walk VB O O
23 without IN B-VP O
23 becoming VBG O O
23 short JJ O O
23 of IN B-VP O
23 breath NN B-NP O
23 In IN B-VP O
24 March NNP B-NP O
24 of IN B-VP O
24 1997 CD O O
24 , , O O
24 the DT B-NP O
24 patient NN I-NP O
24 was VBD B-VP O
24 able JJ O O
24 to TO O O
24 walk VB O O
24 one CD O O
24 mile NN B-NP O
24 , , O O
24 but CC O O
24 is VBZ O O
24 now RB O O
25 unable JJ O O
25 to TO O O
25 do VB O O
25 so RB O O
25 The DT B-NP O
25 patient NN I-NP O
25 reports NNS I-NP O
25 stopping VBG O O
25 several JJ B-NP O
25 times NNS I-NP O
25 while IN B-VP O
26 trying VBG O O
26 to TO O O
26 climb VB O O
26 one CD O O
26 flight NN B-NP O
26 of IN B-VP O
26 stairs NNS B-NP O
26 She PRP O O
26 does VBZ O O
26 report VB O O
26 orthopnea NN B-NP O
26 as RB O O
27 well RB O O
27 as IN B-VP O
27 paroxysmal JJ B-NP O
27 nocturnal JJ I-NP O
27 dyspnea NN I-NP O
27 , , O O
27 no DT B-NP O
27 light JJ I-NP O
27 headedness NN I-NP O
27 or CC O O
28 syncope NN B-NP O
28 She PRP O O
28 does VBZ O O
28 have VB O O
28 some DT B-NP O
28 palpitations NNS I-NP O
28 as RB O O
28 well RB O O
28 as IN B-VP O
28 complaints NNS B-NP O
28 of IN B-VP O
29 twinges NNS B-NP O
29 under IN B-VP O
29 left VBD B-VP O
29 breast NN B-NP O
29 that IN B-VP O
29 occur VBP O O
29 randomly RB O O
29 She PRP O O
29 does VBZ O O
29 not RB O O
30 experience VB O O
30 any DT B-NP O
30 leg NN I-NP O
30 swelling VBG O O
30 The DT B-NP O
30 patient NN I-NP O
30 saw VBD B-VP O
30 Dr NNP B-NP O
30 Ontiveros NNP I-NP O
30 on IN B-VP O
31 July NNP B-NP O
31 , , O O
31 1997 CD O O
31 at IN B-VP O
31 which WDT O O
31 time NN B-NP O
31 an DT B-NP O
31 echocardiogram NN I-NP O
31 showed VBD B-VP O
31 a DT O O
32 massively RB O O
32 dilated VBN O O
32 left JJ B-NP O
32 ventricle NN I-NP O
32 with IN B-VP O
32 severely RB O O
32 depressed JJ B-NP O
32 systolic JJ I-NP O
33 function NN I-NP O
33 and CC O O
33 an DT B-NP O
33 ejection NN I-NP O
33 fraction NN I-NP O
33 of IN B-VP O
33 15% CD O O
33 All DT B-NP O
33 walls NNS I-NP O
33 were VBD B-VP O
33 severely RB O O
34 hypokinetic JJ O O
34 There EX O O
34 was VBD B-VP O
34 moderate JJ O O
34 left VBD B-VP O
34 atrial JJ B-NP O
34 enlargement NN I-NP O
34 and CC O O
35 moderate JJ B-NP O
35 mitral JJ I-NP O
35 regurgitation NN I-NP O
35 There EX O O
35 was VBD B-VP O
35 normal JJ B-NP O
35 right JJ I-NP O
35 ventricular NN I-NP O
36 size NN I-NP O
36 and CC O O
36 function NN B-NP O
36 and CC O O
36 no DT B-NP O
36 thrombus NN I-NP O
36 or CC O O
36 pericardial JJ B-NP O
36 effusion NN I-NP O
36 The DT B-NP O
37 patient NN I-NP O
37 underwent NN I-NP O
37 a DT B-NP O
37 bicycle NN I-NP O
37 test NN I-NP O
37 for IN B-VP O
37 which WDT O O
37 achieved VBD B-VP O
37 5 CD O O
37 minutes NNS B-NP O
37 and CC O O
38 33 CD O O
38 seconds NNS B-NP O
38 with IN B-VP O
38 a DT B-NP O
38 maximal JJ I-NP O
38 heart NN I-NP O
38 rate NN I-NP O
38 of IN B-VP O
38 108 CD O O
38 and CC O O
38 a DT B-NP O
38 VO2 NNP I-NP O
38 of IN B-VP O
38 6.4 CD O O
38 ml NNS B-NP O
38 per IN B-VP O
39 kg NN B-NP O
39 per IN B-VP O
39 minute NN B-NP O
40 PAST NNP I-NP O
40 MEDICAL NNP I-NP O
40 HISTORY: NNP I-NP O
40 Significant NNP I-NP O
40 for IN B-VP O
40 1 CD O O
40 ) ) O O
40 History NN B-NP O
40 of IN B-VP O
40 bronchitis NN B-NP O
41 2 CD O O
41 ) ) O O
41 History NN B-NP O
41 of IN B-VP O
41 cardiomyopathy NN B-NP O
41 as IN B-VP O
41 above IN B-VP O
41 3 CD O O
41 ) ) O O
42 Non-insulin NNP B-NP O
42 dependent NN I-NP O
42 diabetes VBZ O O
42 mellitus RB O O
42 4 CD O O
42 ) ) O O
42 Status NNP B-NP O
42 post NN I-NP O
43 hysterectomy NN I-NP O
43 at IN B-VP O
43 age NN B-NP O
43 40 CD O O
43 5 CD O O
43 ) ) O O
43 Status NNP B-NP O
43 post NN I-NP O
43 cholecystectomy NN I-NP O
43 6 CD O O
43 ) ) O O
44 Status NNP B-NP O
44 post NN I-NP O
44 appendectomy RB O O
44 7 CD O O
44 ) ) O O
44 History NN B-NP O
44 of IN B-VP O
44 panic NN B-NP O
44 disorders NNS I-NP O
44 8 CD O O
44 ) ) O O
45 History NN B-NP O
45 of IN B-VP O
45 agoraphobia $ O O
45 9 CD O O
45 ) ) O O
45 History NN B-NP O
45 of IN B-VP O
45 alcohol NN B-NP O
45 use NN I-NP O
46 MEDICATIONS NNP I-NP O
46 ON NNP I-NP O
46 ADMISSION: NNP I-NP O
46 1 CD O O
46 ) ) O O
46 Coumadin NNP B-NP B-m
46 Coumadin NNP I-NP B-m
46 2.5 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 four CD O B-f
46 times NNS B-NP O
46 a DT B-NP O
47 week NN I-NP O
47 and CC O O
47 5 CD O B-do
47 mg NN B-NP I-do
47 p.o NN I-NP B-mo
47 three CD O B-f
47 times NNS B-NP I-f
47 a DT B-NP I-f
47 week NN I-NP I-f
48 2 CD O O
48 ) ) O O
48 Digoxin NN B-NP B-m
48 0.125 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 q JJ B-NP B-f
48 day NN I-NP I-f
48 3 CD O O
48 ) ) O O
48 Enalapril NNP B-NP B-m
48 10 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 b.i.d IN B-VP B-f
49 4 CD O O
49 ) ) O O
49 Micronase NNP B-NP B-m
49 2.5 CD O B-do
49 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 q JJ B-NP B-f
49 day NN I-NP I-f
49 5 CD O O
49 ) ) O O
49 Multivitamins VBZ O B-m
49 one CD O B-do
49 tablet NN B-NP I-do
50 p.o NN I-NP B-mo
50 q JJ B-NP B-f
50 day NN I-NP I-f
50 6 CD O O
50 ) ) O O
50 Lasix FW O B-m
50 40 CD O B-do
50 mg NN B-NP I-do
50 p.o NN I-NP B-mo
50 b.i.d IN B-VP B-f
50 7 CD O O
50 ) ) O O
50 Xanax VBD B-VP B-m
50 0.5 CD O B-do
50 mg NN B-NP I-do
50 p.o NN I-NP B-mo
51 q.i.d NN I-NP B-f
51 p.r.n NN I-NP I-f
52 ALLERGIES: NNP I-NP O
52 The DT B-NP O
52 patient NN I-NP O
52 had VBD B-VP O
52 no DT O O
52 known VBN O O
52 drug NN B-NP O
52 allergies NNS I-NP O
53 FAMILY NNP I-NP O
53 HISTORY: NNP I-NP O
53 Her PRP$ O O
53 parents NNS B-NP O
53 both DT O O
53 died VBD B-VP O
53 with IN B-VP O
53 cardiac JJ B-NP O
53 problems NNS I-NP O
53 with IN B-VP O
54 coronary JJ B-NP O
54 artery NN I-NP O
54 disease NN I-NP O
54 ( ( O O
54 father NN B-NP O
54 at IN B-VP O
54 age NN B-NP O
54 42 CD O O
54 , , O O
54 mother NN B-NP O
55 at IN B-VP O
55 age NN B-NP O
55 62 CD O O
55 ) ) O O
56 SOCIAL NNP B-NP O
56 HISTORY: NNP I-NP O
56 The DT B-NP O
56 patient NN I-NP O
56 lives VBZ O O
56 alone RB O O
56 with IN B-VP O
56 an DT B-NP O
56 apartment NN I-NP O
56 next JJ O O
56 to TO O O
57 her PRP$ O O
57 son NN B-NP O
57 She PRP O O
57 has VBZ O O
57 worked VBN O O
57 as IN B-VP O
57 a DT B-NP O
57 house NN I-NP O
57 cleaner NN I-NP O
57 She PRP O O
58 has VBZ O O
58 an DT O O
58 18 CD O O
58 pack NN B-NP O
58 year NN I-NP O
58 history NN I-NP O
58 of IN B-VP O
58 cigarette NN B-NP O
58 smoking; NN I-NP O
58 she PRP O O
58 quit VBD B-VP O
58 smoking VBG O O
59 30 CD O O
59 years NNS B-NP O
59 ago RB O O
59 She PRP O O
59 does VBZ O O
59 have VB O O
59 a DT B-NP O
59 history NN I-NP O
59 of IN B-VP O
59 heavy JJ B-NP O
59 alcohol NN I-NP O
59 use NN I-NP O
59 She PRP O O
60 is VBZ O O
60 recently RB O O
60 divorced VBN O O
61 PHYSICAL NNP B-NP O
61 EXAMINATION: NNP I-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 is VBZ O O
61 pleasant JJ O O
61 in IN B-VP O
61 no DT B-NP O
61 apparent JJ I-NP O
62 distress NN I-NP O
62 The DT B-NP O
62 patient NN I-NP O
62 is VBZ O O
62 afebrile JJ O O
62 with IN B-VP O
62 a DT B-NP O
63 blood NN I-NP O
63 pressure NN I-NP O
63 of IN B-VP O
63 110/76 CD O O
63 , , O O
63 heart NN B-NP O
63 rate NN I-NP O
63 70 CD O O
63 and CC O O
63 a DT B-NP O
63 respiratory JJ I-NP O
63 rate NN I-NP O
63 of IN B-VP O
64 20 CD O O
64 with IN B-VP O
64 oxygen JJ B-NP O
64 saturation NN I-NP O
64 of IN B-VP O
64 97% CD O O
64 on IN B-VP O
64 room NN B-NP O
64 air NN I-NP O
64 Her PRP$ O O
64 head NN B-NP O
64 examination NN I-NP O
65 is VBZ O O
65 remarkable JJ O O
65 for IN B-VP O
65 upper JJ B-NP O
65 dentures NNS I-NP O
65 Neck NNP I-NP O
65 shows VBZ O O
65 jugular NN B-NP O
65 venous JJ B-NP O
66 pressure NN I-NP O
66 of IN B-VP O
66 7 CD O O
66 cm NNS B-NP O
66 Carotid NNP I-NP O
66 upstrokes NNS I-NP O
66 are VBP O O
66 decreased VBN O O
66 and CC O O
66 without IN B-VP O
67 bruits NNS B-NP O
67 There EX O O
67 was VBD B-VP O
67 no DT B-NP O
67 lymphadenopathy JJ I-NP O
67 Lungs NNP I-NP O
67 show VBP O O
67 occasional JJ B-NP O
68 bibasilar JJ I-NP O
68 rales NNS I-NP O
68 Heart NNP I-NP O
68 shows VBZ O O
68 regular JJ B-NP O
68 rate NN I-NP O
68 and CC O O
68 rhythm NN B-NP O
68 with IN B-VP O
68 distant JJ B-NP O
69 heart NN I-NP O
69 sounds VBZ O O
69 There EX O O
69 is VBZ O O
69 a DT B-NP O
69 left JJ I-NP O
69 ventricular NN I-NP O
69 heave NN I-NP O
69 and CC O O
69 an DT B-NP O
69 S3 NNP I-NP O
69 present VBD B-VP O
70 The DT B-NP O
70 abdomen NNS I-NP O
70 is VBZ O O
70 obese JJ O O
70 with IN B-VP O
70 bowel NN B-NP O
70 sounds NNS I-NP O
70 present JJ O O
70 , , O O
70 soft JJ O O
70 , , O O
70 non-tender JJ O O
71 without IN B-VP O
71 masses VBZ O O
71 The DT B-NP O
71 extremities NNS I-NP O
71 show VBP O O
71 1+ CD O O
71 pitting VBG O O
71 edema NN B-NP O
71 bilaterally RB O O
72 Pulses NNP B-NP O
72 are VBP O O
72 intact JJ O O
72 bilaterally RB O O
72 and CC O O
72 the DT B-NP O
72 extremities NNS I-NP O
72 are VBP O O
72 warm JJ B-NP O
73 Neurological NNP I-NP O
73 examination NN I-NP O
73 is VBZ O O
73 non-focal JJ O O
73 with IN B-VP O
73 intact JJ B-NP O
73 sensation NN I-NP O
73 and CC O O
74 motor NN B-NP O
74 examination NN I-NP O
74 Deep NNP I-NP O
74 tendon NN I-NP O
74 reflexes NNS I-NP O
74 are VBP O O
74 symmetric JJ O O
74 and CC O O
74 2+ CD O O
75 bilaterally RB O O
75 with IN B-VP O
75 downgoing VBG O O
75 toes NNS B-NP O
75 bilaterally RB O O
76 HOSPITAL NNP B-NP O
76 COURSE: NNP I-NP O
76 The DT B-NP O
76 patient NN I-NP O
76 was VBD B-VP O
76 admitted VBN O O
76 for IN B-VP O
76 a DT B-NP O
76 transplantation NN I-NP O
77 work-up NN I-NP O
77 She PRP O O
77 was VBD B-VP O
77 catheterized VBN O O
77 on IN B-VP O
77 February NNP B-NP O
77 , , O O
78 1997 CD O O
78 The DT B-NP O
78 catheterization NN I-NP O
78 showed VBD B-VP O
78 no DT B-NP O
78 coronary JJ I-NP O
78 artery NN I-NP O
78 disease NN I-NP O
78 noted VBD B-VP O
79 The DT B-NP O
79 atrium NN I-NP O
79 showed VBD B-VP O
79 16 CD O O
79 mm NN B-NP O
79 of IN B-VP O
79 mercury NN B-NP O
79 mean JJ B-NP O
79 pressure NN I-NP O
79 The DT B-NP O
79 right JJ I-NP O
80 ventricle NN I-NP O
80 showed VBD B-VP O
80 48/18 CD O O
80 mm NN B-NP O
80 of IN B-VP O
80 mercury NN B-NP O
80 The DT B-NP O
80 PA NNP I-NP O
80 showed VBD B-VP O
80 48/34 CD O O
80 mm NN B-NP O
80 of IN B-VP O
81 mercury NN B-NP O
81 with IN B-VP O
81 a DT B-NP O
81 mean JJ I-NP O
81 pressure NN I-NP O
81 of IN B-VP O
81 39 CD O O
81 mm NN B-NP O
81 of IN B-VP O
81 mercury NN B-NP O
81 The DT B-NP O
81 pulmonary JJ I-NP O
82 capillary JJ I-NP O
82 wedge NN I-NP O
82 pressure NN I-NP O
82 showed VBD B-VP O
82 a DT B-NP O
82 mean NN I-NP O
82 of IN B-VP O
82 30 CD O O
82 mm NN B-NP O
82 of IN B-VP O
82 mercury NN B-NP O
83 Cardiac NNP I-NP O
83 output NN I-NP O
83 and CC O O
83 cardiac JJ B-NP O
83 index NN I-NP O
83 showed VBD B-VP O
83 4.4 CD O O
83 liters NNS B-NP O
83 per IN B-VP O
83 minute NN B-NP O
83 and CC O O
84 2.2 CD O O
84 liters NNS B-NP O
84 per IN B-VP O
84 minute NN B-NP O
84 per IN B-VP O
84 meter NN B-NP O
84 squared VBD B-VP O
84 The DT B-NP O
84 patient NN I-NP O
84 was VBD B-VP O
84 briefly RB O O
85 transferred VBN O O
85 to TO O O
85 the DT B-NP O
85 Coronary NNP I-NP O
85 Care NNP I-NP O
85 Unit NNP I-NP O
85 secondary JJ O O
85 to TO O O
85 her PRP$ O O
85 elevated JJ B-NP O
86 pulmonary JJ I-NP O
86 capillary JJ I-NP O
86 wedge NN I-NP O
86 pressure NN I-NP O
86 and CC O O
86 the DT B-NP O
86 presence NN I-NP O
86 of IN B-VP O
86 her PRP$ O O
87 Swan-Ganz JJ B-NP O
87 catheter NN I-NP O
87 The DT B-NP O
87 patient NN I-NP O
87 was VBD B-VP O
87 diuresed VBN O O
87 with IN B-VP O
87 good JJ B-NP O
87 response NN I-NP O
88 She PRP O O
88 was VBD B-VP O
88 transferred VBN O O
88 back RB O O
88 to TO O O
88 the DT B-NP O
88 General NNP I-NP O
88 Medicine NNP I-NP O
88 Team NNP I-NP O
88 where WRB O O
89 diuresis NN B-NP O
89 with IN B-VP O
89 intravenous JJ B-NP B-mo
89 Lasix NNP I-NP B-m
89 was VBD B-VP O
89 continued VBN O O
89 She PRP O O
89 tolerated VBD B-VP O
90 Enalapril NNP B-NP B-m
90 and CC O O
90 Lasix NNP B-NP B-m
90 well RB O O
90 By IN B-VP O
90 the DT B-NP O
90 end NN I-NP O
90 of IN B-VP O
90 her PRP$ O O
90 hospitalization NN B-NP O
90 , , O O
90 she PRP O O
91 was VBD B-VP O
91 taking VBG O O
91 12.5 CD O B-do
91 mg NN B-NP I-do
91 of IN B-VP O
91 Enalapril NNP B-NP B-m
91 b.i.d NN I-NP B-f
91 and CC O O
91 40 CD O B-do
91 mg NN B-NP I-do
91 of IN B-VP O
91 Lasix NNP B-NP B-m
91 p.o NN I-NP B-mo
92 b.i.d NN I-NP B-f
92 She PRP O O
92 had VBD B-VP O
92 been VBN O O
92 taken VBN O O
92 off RP O O
92 her PRP$ O O
92 Coumadin NNP B-NP B-m
92 and CC O O
92 had VBD B-VP O
92 been VBN O O
92 placed VBN O O
92 on IN B-VP O
93 Heparin NNP B-NP B-m
93 during IN B-VP B-du
93 this DT B-NP I-du
93 hospitalization NN I-NP I-du
93 The DT B-NP O
93 patient NN I-NP O
93 did VBD B-VP O
93 experience VB O O
94 some DT B-NP O
94 hematuria NNS I-NP O
94 toward IN B-VP O
94 the DT B-NP O
94 end NN I-NP O
94 of IN B-VP O
94 her PRP$ O O
94 hospitalization NN B-NP O
94 which WDT O O
94 was VBD B-VP O
94 felt VBN O O
95 to TO O O
95 be VB O O
95 secondary JJ O O
95 to TO O O
95 Foley NNP B-NP O
95 trauma NN I-NP O
95 while IN B-VP O
95 she PRP O O
95 was VBD B-VP O
95 in IN B-VP O
95 the DT B-NP O
95 Coronary NNP I-NP O
95 Care NNP I-NP O
96 Unit NNP I-NP O
97 As IN B-VP O
97 part NN B-NP O
97 of IN B-VP O
97 the DT B-NP O
97 patient's NN I-NP O
97 transplant JJ B-NP O
97 evaluation NN I-NP O
97 , , O O
97 she PRP O O
97 had VBD B-VP O
97 a DT B-NP O
97 PPD NNP I-NP O
97 with IN B-VP O
98 controls NNS B-NP O
98 placed VBD B-VP O
98 which WDT O O
98 showed VBD B-VP O
98 that IN B-VP O
98 her PRP$ O O
98 PPD NNP B-NP O
98 was VBD B-VP O
98 negative JJ O O
98 and CC O O
98 her PRP$ O O
99 controls NNS B-NP O
99 were VBD B-VP O
99 positive JJ O O
99 The DT B-NP O
99 patient JJ I-NP O
99 underwent NN I-NP O
99 a DT B-NP O
99 Dental NNP I-NP O
99 consult NN I-NP O
99 as RB O O
100 well RB O O
100 as IN B-VP O
100 a DT B-NP O
100 Psychiatric NNP I-NP O
100 consult NN I-NP O
100 The DT B-NP O
100 Psychiatric NNP I-NP O
100 evaluation NN I-NP O
100 was VBD B-VP O
101 favorable JJ O O
101 for IN B-VP O
101 transplantation NN B-NP O
101 The DT B-NP O
101 Dental NNP I-NP O
101 consult NN I-NP O
101 involved VBD B-VP O
101 the DT B-NP O
102 patient NN I-NP O
102 having VBG O O
102 panoramic JJ B-NP O
102 x-rays JJ I-NP O
102 Thyrology NN I-NP O
102 showed VBD B-VP O
102 a DT B-NP O
103 cytomegalovirus NN I-NP O
103 IgG NNP I-NP O
103 being VBG O O
103 positive JJ O O
103 , , O O
103 a DT B-NP O
103 cytomegalovirus NN I-NP O
103 IgM NNP I-NP O
103 being VBG O O
104 equivocal JJ O O
104 , , O O
104 and CC O O
104 Epstein-Barr NNP B-NP O
104 virus NN I-NP O
104 anti-VCA JJ B-NP O
104 IgG NNP I-NP O
104 at IN B-VP O
104 640 CD O O
104 , , O O
104 an DT B-NP O
105 Epstein-Barr JJ I-NP O
105 virus NN I-NP O
105 anti-VCA JJ B-NP O
105 IgM NNP I-NP O
105 being VBG O O
105 less JJR O O
105 than IN B-VP O
105 10 CD O O
105 and CC O O
105 a DT B-NP O
105 mucal JJ I-NP O
106 screen NN I-NP O
106 being VBG O O
106 greater JJR O O
106 than IN B-VP O
106 or CC O O
106 equal JJ O O
106 to TO O O
106 32 CD O O
106 , , O O
106 a DT B-NP O
106 varicella NN I-NP O
106 zoster NN I-NP O
106 titer NN I-NP O
107 of IN B-VP O
107 512 CD O O
107 , , O O
107 a DT B-NP O
107 Toxoplasma NNP I-NP O
107 IgG NNP I-NP O
107 being VBG O O
107 positive JJ O O
107 , , O O
107 a DT B-NP O
107 Toxoplasma NNP I-NP O
107 IgM NNP I-NP O
107 being VBG O O
108 negative JJ B-NP O
108 Abdominal NNP I-NP O
108 ultrasound NN I-NP O
108 showed VBD B-VP O
108 a DT O O
108 mildly RB O O
108 dilated JJ B-NP O
108 common JJ I-NP O
108 bile NN I-NP O
109 and CC O O
109 pancreatic JJ B-NP O
109 duct NN I-NP O
109 and CC O O
109 showed VBD B-VP O
109 that IN B-VP O
109 this DT B-NP O
109 patient NN I-NP O
109 was VBD B-VP O
109 status NN B-NP O
109 post NN I-NP O
110 cholecystectomy NN I-NP O
111 While IN B-VP O
111 the DT B-NP O
111 patient NN I-NP O
111 maybe RB O O
111 a DT B-NP O
111 good JJ I-NP O
111 transplant NN I-NP O
111 candidate NN I-NP O
111 , , O O
111 it PRP O O
111 was VBD B-VP O
111 felt VBN O O
112 that IN B-VP O
112 her PRP$ O O
112 weight NN B-NP O
112 was VBD B-VP O
112 a DT B-NP O
112 negative JJ I-NP O
112 factor NN I-NP O
112 in IN B-VP O
112 her PRP$ O O
112 potential JJ O O
112 for IN B-VP O
113 transplant NN B-NP O
113 The DT B-NP O
113 patient NN I-NP O
113 will MD O O
113 be VB O O
113 pursuing VBG O O
113 cardiac JJ B-NP O
113 rehabilitation NN I-NP O
114 and CC O O
114 weight JJ B-NP O
114 loss NN I-NP O
114 if IN B-VP O
114 she PRP O O
114 is VBZ O O
114 to TO O O
114 be VB O O
114 considered VBN O O
114 for IN B-VP O
114 transplant NN B-NP O
114 in IN B-VP O
114 the DT B-NP O
115 future NN I-NP O
115 The DT B-NP O
115 patient NN I-NP O
115 was VBD B-VP O
115 discharged VBN O O
116 MEDICATIONS NNP B-NP O
116 ON NNP I-NP O
116 DISCHARGE: NNP I-NP O
116 1 CD O O
116 ) ) O O
116 Tylenol $ O B-m
116 650 CD O B-do
116 mg NN B-NP I-do
116 p.o NN I-NP B-mo
116 q.4h NN I-NP B-f
116 p.r.n NN I-NP I-f
117 headache NN I-NP B-r
117 2 CD O O
117 ) ) O O
117 Xanax VBD B-VP B-m
117 0.5 CD O B-do
117 mg NN B-NP I-do
117 p.o NN I-NP B-mo
117 q.i.d $ O B-f
118 3 CD O O
118 ) ) O O
118 Digoxin NN B-NP B-m
118 0.125 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
118 q JJ B-NP B-f
118 day NN I-NP I-f
118 4 CD O O
118 ) ) O O
118 Enalapril NNP B-NP B-m
118 12.5 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
119 b.i.d IN B-VP B-f
119 5 CD O O
119 ) ) O O
119 Lasix FW O B-m
119 40 CD O B-do
119 mg NN B-NP I-do
119 p.o NN I-NP B-mo
119 b.i.d IN B-VP B-f
119 6 CD O O
119 ) ) O O
119 Micronase NNP B-NP B-m
119 1.25 CD O B-do
119 mg NN B-NP I-do
119 p.o NN I-NP B-mo
119 q JJ B-NP B-f
120 day NN I-NP O
120 7 CD O O
120 ) ) O O
120 Multivitamins VBZ O B-m
120 one CD O B-do
120 tablet NN B-NP I-do
120 p.o NN I-NP B-mo
120 q JJ B-NP B-f
120 day NN I-NP I-f
120 8 CD O O
120 ) ) O O
120 Coumadin NNP B-NP B-m
120 Coumadin NNP I-NP B-m
120 2.5 CD O B-do
121 mg NN B-NP O
121 p.o NN I-NP B-mo
121 p.o JJ B-NP B-mo
121 q JJ I-NP B-f
121 day NN I-NP I-f
121 on IN B-VP I-f
121 even JJ B-NP I-f
121 days NNS I-NP I-f
121 and CC O O
121 5 CD O B-do
121 mg NN B-NP I-do
121 p.o NN I-NP O
121 q JJ B-NP B-f
121 day NN I-NP I-f
121 on IN B-VP I-f
121 odd JJ B-NP I-f
121 days NNS I-NP I-f
122 INSTRUCTIONS: VBP O O
122 The DT B-NP O
122 patient NN I-NP O
122 was VBD B-VP O
122 instructed VBN O O
122 that IN B-VP O
122 she PRP O O
122 should MD O O
122 increase VB O O
123 her PRP$ O O
123 diuresis NN B-NP O
123 at IN B-VP O
123 home NN B-NP O
123 if IN B-VP O
123 she PRP O O
123 noticed VBD B-VP O
123 an DT B-NP O
123 increase NN I-NP O
123 in IN B-VP O
124 her PRP$ O O
124 weight NN B-NP O
124 and CC O O
124 was VBD B-VP O
124 instructed VBN O O
124 to TO O O
124 see VB O O
124 a DT B-NP O
124 physician NN I-NP O
124 for IN B-VP O
124 continued VBN O O
124 for IN B-VP O
125 weight NN B-NP O
125 increases NNS I-NP O
125 due JJ O O
125 to TO O O
125 fluid VB O O
125 accumulation NN B-NP O
126 Dictated NNP I-NP O
126 By: NNP I-NP O
126 WINFRED NNP I-NP O
126 WIECHMANN NNP I-NP O
126 , , O O
126 M.D NNP B-NP O
126 IP22 NNP I-NP O
127 Attending: NNP I-NP O
127 RUSSELL NNP I-NP O
127 SHUPERT NNP I-NP O
127 , , O O
127 M.D NNP B-NP O
127 SC8 NNP I-NP O
128 RG559/6002 NNP I-NP O
129 Batch: NNP I-NP O
129 10840 CD O O
129 Index NNP B-NP O
129 No NNP I-NP O
129 NFGMA3ZOO NNP I-NP O
129 D: NNP I-NP O
129 4/8/97 CD O O
130 T: NNP B-NP O
130 5/21/97 CD O O
131 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #155926 VBZ O O
2 740149689 CD O O
2 GMH NNP B-NP O
2 94560560 CD O O
2 356656 CD O O
2 10/17/1992 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/18/1992 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/19/1992 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 1 CD O O
4 CORONARY NNP B-NP O
4 ARTERY NNP I-NP O
4 DISEASE NNP I-NP O
5 SECONDARY NNP I-NP O
5 DIAGNOSES: NNP I-NP O
5 2 CD O O
5 HYPETENSION NNP B-NP O
6 3 CD O O
6 DYSPEPSIA NNP B-NP O
7 4 CD O O
7 ADJUSTMENT NNP B-NP O
7 DISORDER NNP I-NP O
7 WITH NNP I-NP O
7 ANXIETY NNP I-NP O
8 ID/CHIEF NNP I-NP O
8 COMPLAINT: NNP I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 is VBZ O O
8 a DT O O
8 70 CD O O
8 year NN B-NP O
8 old JJ B-NP O
8 white JJ I-NP O
8 female NN I-NP O
9 status NN I-NP O
9 post NN I-NP O
9 non NN I-NP O
9 Q NNP I-NP O
9 wave VBP O O
9 MI NNP B-NP O
9 in IN B-VP O
9 28 CD O O
9 of IN B-VP O
9 May NNP B-NP O
9 , , O O
9 with IN B-VP O
10 thrombolytic JJ B-NP O
10 therapy NN I-NP O
10 and CC O O
10 cardiac JJ B-NP O
10 risk NN I-NP O
10 factors NNS I-NP O
10 of IN B-VP O
10 long JJ O O
10 standing VBG O O
11 hypertension NN B-NP O
11 , , O O
11 hypercholesterolemia NN B-NP O
11 , , O O
11 and CC O O
11 history NN B-NP O
11 of IN B-VP O
11 tobacco NN B-NP O
11 use NN I-NP O
11 , , O O
11 who WP O O
12 presents VBZ O O
12 upon IN B-VP O
12 transfer NN B-NP O
12 from IN B-VP O
12 Ra NNP B-NP O
12 Memorial NNP I-NP O
12 Hospital NNP I-NP O
12 with IN B-VP O
12 chief JJ B-NP O
13 complaint NN I-NP O
13 of IN B-VP O
13 post NN B-NP O
13 MI NNP I-NP O
13 unstable JJ B-NP O
13 angina JJ I-NP O
14 HISTORY NNP I-NP O
14 OF NNP I-NP O
14 PRESENT NNP I-NP O
14 ILLNESS: NNP I-NP O
14 The DT B-NP O
14 patient NN I-NP O
14 has VBZ O O
14 the DT B-NP O
14 history NN I-NP O
14 of IN B-VP O
15 long JJ O O
15 standing VBG O O
15 hypertension NN B-NP O
15 and CC O O
15 has VBZ O O
15 had VBN O O
16 chest VBN O O
16 pain NN B-NP O
16 in IN B-VP O
16 the DT O O
16 past JJ O O
16 including VBG O O
16 at IN B-VP O
16 least JJS O O
16 one CD O O
16 previous JJ B-NP O
16 episode NN I-NP O
16 of IN B-VP O
17 rule NN B-NP O
17 out IN B-VP O
17 MI NNP B-NP O
17 She PRP O O
17 was VBD B-VP O
17 admitted VBN O O
17 on IN B-VP O
17 22 CD O O
17 of IN B-VP O
17 April NNP B-NP O
17 , , O O
17 to TO O O
17 Hen NNP B-NP O
17 Mo NNP I-NP O
17 Gardensworth NNP I-NP O
17 Sent NNP I-NP O
17 Hospital NNP I-NP O
17 with IN B-VP O
18 signs NNS B-NP O
18 and CC O O
18 symptoms NNS B-NP O
18 consistent JJ O O
18 with IN B-VP O
18 acute JJ B-NP O
18 MI NNP I-NP O
18 , , O O
18 and CC O O
18 apparently RB O O
19 received VBN O O
19 salvage NN B-NP O
19 therapy NN I-NP O
19 with IN B-VP O
19 IV NNP B-NP B-mo
19 Streptokinase NNP I-NP B-m
19 and CC O O
19 TPA NNP B-NP B-m
19 Limited NNP I-NP O
20 records NNS I-NP O
20 are VBP O O
20 available JJ O O
20 from IN B-VP O
20 this DT B-NP O
20 hospitalization NN I-NP O
20 The DT B-NP O
20 patient NN I-NP O
21 apparently RB O O
21 had VBD B-VP O
21 a DT B-NP O
21 submax JJ I-NP O
21 exercise NN I-NP O
21 tolerance NN I-NP O
21 test NN I-NP O
21 before IN B-VP O
21 discharge NN B-NP O
22 which WDT O O
22 is VBZ O O
22 reportedly RB O O
22 unremarkable JJ O O
22 Upon IN B-VP O
22 discharge NN B-NP O
22 from IN B-VP O
22 Woodgi NNP B-NP O
22 Hospital NNP I-NP O
22 the DT B-NP O
22 patient NN I-NP O
22 additionally RB O O
22 did VBD B-VP O
22 well RB O O
22 and CC O O
22 then RB O O
22 had VBD B-VP O
22 three CD O O
23 episodes NNS B-NP O
23 of IN B-VP O
23 typical JJ B-NP B-r
23 substernal JJ I-NP I-r
23 chest NN I-NP I-r
23 pain NN I-NP I-r
23 with IN B-VP O
23 minimal JJ B-NP O
23 exertion NN I-NP O
24 that WDT O O
24 were VBD B-VP O
24 relieved VBN O O
24 with IN B-VP O
24 SL NNP B-NP B-mo
24 Nitroglycerin NNP I-NP B-m
25 On IN B-VP O
25 0 CD O O
25 of IN B-VP O
25 August NNP B-NP O
25 , , O O
25 the DT B-NP O
25 patient NN I-NP O
25 presented VBD B-VP O
25 to TO O O
25 Cooker NNP B-NP O
25 View NNP I-NP O
25 Home NNP I-NP O
25 Hospital NNP I-NP O
25 with IN B-VP O
25 an DT B-NP O
26 episode NN I-NP O
26 of IN B-VP O
26 heavy JJ B-NP O
26 substernal JJ I-NP O
26 chest NN I-NP O
26 pressure NN I-NP O
26 that WDT O O
26 was VBD B-VP O
26 similar JJ O O
26 in IN B-VP O
27 quality NN B-NP O
27 to TO O O
27 her PRP$ O O
27 previous JJ B-NP O
27 MI NNP I-NP O
27 This DT B-NP O
27 pain NN I-NP B-r
27 was VBD B-VP O
27 not RB O O
27 relieved VBN O O
27 with IN B-VP O
27 SL NNP B-NP B-mo
28 Nitroglycerin NNP I-NP B-m
28 There EX O O
28 was VBD B-VP O
28 no DT B-NP O
28 associated JJ I-NP O
28 shortness NN I-NP O
28 of IN B-VP O
28 breath NN B-NP O
28 , , O O
29 nausea NN B-NP O
29 , , O O
29 vomiting VBG O O
29 or CC O O
29 diaphoresis NN B-NP O
29 In IN B-VP O
29 the DT B-NP O
29 Ist NNP I-NP O
29 Medical NNP I-NP O
29 Center NNP I-NP O
29 ER NNP I-NP O
29 , , O O
29 she PRP O O
29 was VBD B-VP O
30 treated VBN O O
30 with IN B-VP O
30 SL NNP B-NP B-mo
30 and CC O O
30 topical JJ B-NP B-mo
30 nitrates NNS I-NP B-m
30 nitrates NNS I-NP B-m
30 with IN B-VP O
30 subsequent JJ B-NP O
30 relief NN I-NP O
30 of IN B-VP O
30 her PRP$ O B-r
31 chest NN B-NP B-r
31 pain NN I-NP I-r
31 Her NNP I-NP O
31 presentation NN I-NP O
31 was VBD B-VP O
31 also RB O O
31 significant JJ O O
31 for IN B-VP O
31 a DT B-NP O
31 chest JJ I-NP O
32 x-ray JJ I-NP O
32 consistent NN I-NP O
32 with IN B-VP O
32 interstitial JJ B-NP O
32 edema NN I-NP O
32 Otherwise NNP I-NP O
32 , , O O
32 her PRP$ O O
33 examination NN B-NP O
33 was VBD B-VP O
33 unremarkable JJ O O
33 and CC O O
33 her PRP$ O O
33 EKG NNP B-NP O
33 showed VBD B-VP O
33 no DT B-NP O
33 worrisome JJ I-NP O
34 ischemic JJ I-NP O
34 changes NNS I-NP O
34 She PRP O O
34 ruled VBD B-VP O
34 out RP O O
34 for IN B-VP O
34 MI NNP B-NP O
34 and CC O O
34 on IN B-VP O
34 0 CD O O
34 of IN B-VP O
34 February NNP B-NP O
34 , , O O
34 was VBD B-VP O
35 transferred VBN O O
35 to TO O O
35 CNMC NNP B-NP O
35 on IN B-VP O
35 IV NNP B-NP B-mo
35 Heparin NNP I-NP B-m
35 , , O O
35 IV NNP B-NP B-mo
35 Nitroglycerin NNP I-NP B-m
35 , , O O
35 beta NN B-NP B-m
35 blockade NN I-NP I-m
36 and CC O O
36 aspirin NN B-NP B-m
36 At IN B-VP O
36 the DT B-NP O
36 time NN I-NP O
36 of IN B-VP O
36 her PRP$ O O
36 admission NN B-NP O
36 , , O O
36 the DT B-NP O
36 patient NN I-NP O
36 was VBD B-VP O
36 without IN B-VP O
37 chest NN B-NP O
37 pain NN I-NP O
37 and CC O O
37 denied VBD B-VP O
37 other JJ O O
37 associated VBN O O
37 symptoms NNS B-NP O
38 PAST NNP I-NP O
38 MEDICAL NNP I-NP O
38 HISTORY: NNP I-NP O
38 Coronary NNP I-NP O
38 artery NN I-NP O
38 disease NN I-NP O
38 status NN I-NP O
38 post NN I-NP O
38 MI NNP I-NP O
38 in IN B-VP O
39 28 CD O O
39 of IN B-VP O
39 May NNP B-NP O
39 , , O O
39 as IN B-VP O
39 above; NN B-NP O
39 long RB O O
39 standing VBG O O
39 hypertension NN B-NP O
39 , , O O
40 75 CD O O
40 pack NN B-NP O
40 year NN I-NP O
40 history NN I-NP O
40 of IN B-VP O
40 cigarette NN B-NP O
40 smoking NN I-NP O
40 , , O O
40 hypercholesterolemia NN B-NP O
40 , , O O
41 chronic JJ B-NP O
41 dyspepsia NN I-NP O
41 , , O O
41 history NN B-NP O
41 of IN B-VP O
41 positive JJ B-NP O
41 PPD NNP I-NP O
41 with IN B-VP O
41 normal JJ B-NP O
41 chest JJ I-NP O
41 x-ray NN I-NP O
41 , , O O
42 remote JJ B-NP O
42 history NN I-NP O
42 of IN B-VP O
42 breast NN B-NP O
42 cancer NN I-NP O
42 PAST NNP I-NP O
42 SURGICAL NNP I-NP O
42 HISTORY: NNP I-NP O
42 Status NNP I-NP O
43 post NN I-NP O
43 cholecystectomy NN I-NP O
43 , , O O
43 status NN B-NP O
43 post NN I-NP O
43 appendectomy NN I-NP O
43 , , O O
43 status NN B-NP O
43 post NN I-NP O
43 renal JJ B-NP O
44 stone NN I-NP O
44 removal NN I-NP O
44 , , O O
44 status NN B-NP O
44 post NN I-NP O
44 C NNP I-NP O
44 section NN I-NP O
44 x VBD B-VP O
44 3 CD O O
44 , , O O
44 status NN B-NP O
44 post NN I-NP O
44 breast NN I-NP O
45 lumpectomy JJ B-NP O
45 MEDICATIONS NNP I-NP O
45 ON NNP I-NP O
45 TRANSFER: NNP I-NP O
45 IV NNP I-NP B-mo
45 Nitroglycerin NNP I-NP B-m
45 at IN B-VP O
45 140 CD O B-do
46 micrograms NNS B-NP O
46 per IN B-VP B-f
46 minute NN B-NP I-f
46 , , O O
46 IV NNP B-NP B-mo
46 Heparin NNP I-NP B-m
46 drip NN I-NP I-m
46 , , O O
46 Lopressor NNP B-NP B-m
46 , , O O
46 aspirin VBZ O B-m
46 one CD O B-do
46 a DT B-NP B-f
47 day NN I-NP O
47 ALLERGIES: NNP I-NP O
47 Penicillin NNP I-NP O
47 which WDT O O
47 causes VBZ O O
47 anaphylaxis JJ B-NP O
47 FAMILY NNP I-NP O
48 HISTORY: NNP I-NP O
48 Negative NNP I-NP O
48 for IN B-VP O
48 premature NN B-NP O
48 cardiac JJ B-NP O
48 disease NN I-NP O
48 , , O O
48 negative JJ O O
48 for IN B-VP O
49 diabetes NNS B-NP O
49 mellitus VBP O O
49 SOCIAL NNP B-NP O
49 HISTORY: NNP I-NP O
49 Most NNP I-NP O
49 significant JJ O O
49 for IN B-VP O
49 her PRP$ O O
50 husband's JJ B-NP O
50 recent JJ I-NP O
50 diagnosis NN I-NP O
50 of IN B-VP O
50 GI NNP B-NP O
50 malignancy NN I-NP O
50 which WDT O O
50 will MD O O
50 require VB O O
51 inpatient JJ B-NP O
51 admission NN I-NP O
51 at IN B-VP O
51 ORMC NNP B-NP O
51 and CC O O
51 the DT B-NP O
51 recent JJ I-NP O
51 death NN I-NP O
51 of IN B-VP O
51 a DT B-NP O
51 brother-in-law NN I-NP O
52 at IN B-VP O
52 GH NNP B-NP O
53 PHYSICAL NNP I-NP O
53 EXAMINATION: NNP I-NP O
53 The DT B-NP O
53 patient NN I-NP O
53 is VBZ O O
53 an DT B-NP O
53 obese JJ I-NP O
53 white JJ I-NP O
53 female NN I-NP O
53 in IN B-VP O
53 no DT B-NP O
54 apparent JJ I-NP O
54 distress NN I-NP O
54 , , O O
54 pleasant JJ O O
54 and CC O O
54 cooperative JJ O O
55 The DT B-NP O
55 vital JJ I-NP O
55 signs NNS I-NP O
55 were VBD B-VP O
55 temp JJ O O
55 97.8 CD O O
55 , , O O
55 pulse RB O O
55 48 CD O O
55 , , O O
55 BP NNP B-NP O
55 140/60 CD O O
55 , , O O
55 respirations NNS B-NP O
56 16 CD O O
56 with IN B-VP O
56 O2 NNP B-NP O
56 sat NN I-NP O
56 of IN B-VP O
56 95% CD O O
56 on IN B-VP O
56 O2 NNP B-NP O
56 2 CD O O
56 liters NNS B-NP O
56 per IN B-VP O
56 minute NN B-NP O
56 HEENT NNP I-NP O
56 exam NN I-NP O
56 was VBD B-VP O
57 unremarkable JJ O O
57 There EX O O
57 were VBD B-VP O
57 normal JJ B-NP O
57 carotid JJ I-NP O
57 upstrokes NNS I-NP O
57 without IN B-VP O
57 bruit NN B-NP O
58 The DT B-NP O
58 chest JJS I-NP O
58 exam NN I-NP O
58 showed VBD B-VP O
58 bibasilar JJ B-NP O
58 rales NNS I-NP O
58 right RB O O
58 greater JJR O O
58 than IN B-VP O
58 left JJR O O
58 but CC O O
59 otherwise VBP O O
59 the DT B-NP O
59 lungs NNS I-NP O
59 were VBD B-VP O
59 clear JJ O O
59 to TO O O
59 auscultation VB O O
59 , , O O
59 no DT O O
59 wheezing VBG O O
59 CV NNP B-NP O
60 exam NN I-NP O
60 showed VBD B-VP O
60 a DT B-NP O
60 regular JJ I-NP O
60 rate NN I-NP O
60 and CC O O
60 rhythm NN B-NP O
60 with IN B-VP O
60 distant JJ B-NP O
60 heart NN I-NP O
60 sounds VBZ O O
60 , , O O
61 normal JJ B-NP O
61 S1 NNP I-NP O
61 and CC O O
61 S2 NNP B-NP O
61 , , O O
61 question NN B-NP O
61 of IN B-VP O
61 S4 NNP B-NP O
61 , , O O
61 no DT O O
61 appreciable JJ O O
61 murmurs VBZ O O
61 The DT B-NP O
62 abdomen NNS I-NP O
62 was VBD B-VP O
62 obese JJ O O
62 , , O O
62 soft JJ O O
62 with IN B-VP O
62 normoactive JJ B-NP O
62 bowel NN I-NP O
62 sounds NNS I-NP O
62 There EX O O
62 were VBD B-VP O
63 previous JJ B-NP O
63 surgical JJ I-NP O
63 scars NNS I-NP O
63 No DT B-NP O
63 masses NNS I-NP O
63 or CC O O
63 hepatosplenomegaly NN B-NP O
63 was VBD B-VP O
64 noted VBN O O
64 There EX O O
64 were VBD B-VP O
64 normal JJ O O
64 femoral JJ O O
64 and CC O O
64 distal JJ B-NP O
64 pulses NNS I-NP O
64 , , O O
64 no DT B-NP O
64 peripheral JJ I-NP O
65 edema NN I-NP O
65 , , O O
65 no DT B-NP O
65 peripheral JJ I-NP O
65 bruits NNS I-NP O
65 Neuro NNP I-NP O
65 exam NN I-NP O
65 was VBD B-VP O
65 unremarkable JJ B-NP O
66 LABORATORY NNP I-NP O
66 DATA: NNP I-NP O
66 The DT B-NP O
66 admission NN I-NP O
66 labs NN I-NP O
66 showed VBD B-VP O
66 hematocrit JJ O O
66 34.2 CD O O
66 , , O O
66 WBC NNP B-NP O
67 6.7 CD O O
67 , , O O
67 platelets NNS B-NP O
67 159 CD O O
67 , , O O
67 000 CD O O
67 , , O O
67 PTT NNP B-NP O
67 50.0 CD O O
67 on IN B-VP O
67 IV NNP B-NP B-mo
67 Heparin NNP I-NP B-m
68 Urinalysis NNP I-NP O
68 was VBD B-VP O
68 essentially RB O O
68 within IN B-VP O
68 normal JJ B-NP O
68 limits NNS I-NP O
68 Glucose NNP I-NP O
68 was VBD B-VP O
68 110 CD O O
68 , , O O
69 BUN NNP B-NP O
69 12 CD O O
69 , , O O
69 creatinine NN B-NP O
69 1.0 CD O O
69 , , O O
69 sodium NN B-NP O
69 142 CD O O
69 , , O O
69 potassium NN B-NP O
69 4.0 CD O O
69 , , O O
69 chloride RB O O
69 106 CD O O
69 and CC O O
70 bicarb $ O O
70 29 CD O O
70 LFT's NNP B-NP O
70 were VBD B-VP O
70 all DT O O
70 within IN B-VP O
70 normal JJ B-NP O
70 limits NNS I-NP O
70 Admission NNP I-NP O
70 CK NNP I-NP O
70 was VBD B-VP O
71 32 CD O O
71 , , O O
71 albumin RB O O
71 3.9 CD O O
71 , , O O
71 magnesium NN B-NP O
71 2.0 CD O O
71 , , O O
71 uric JJ B-NP O
71 acid NN I-NP O
71 6.2 CD O O
71 , , O O
71 cholesterol NN B-NP O
71 186 CD O O
71 The DT B-NP O
72 chest JJS I-NP O
72 x-ray NN I-NP O
72 was VBD B-VP O
72 unavailable JJ B-NP O
72 EKG NNP I-NP O
72 showed VBD B-VP O
72 sinus JJ B-NP O
72 bradycardia NN I-NP O
72 at IN B-VP O
72 a DT B-NP O
73 rate NN I-NP O
73 of IN B-VP O
73 50 CD O O
73 , , O O
73 first RB O O
73 degree JJ B-NP O
73 AV NNP I-NP O
73 block NN I-NP O
73 axis NN I-NP O
73 +60 NN I-NP O
73 , , O O
73 ST NNP B-NP O
73 elevation NN I-NP O
73 in IN B-VP O
73 leads VBZ O O
74 V2-V4 NNP B-NP O
74 , , O O
74 poor JJ B-NP O
74 R NNP I-NP O
74 wave NN I-NP O
74 progression NN I-NP O
74 leads VBZ O O
74 V1-V3 NNP B-NP O
75 HOSPITAL NNP I-NP O
75 COURSE: NNP I-NP O
75 The DT B-NP O
75 patient NN I-NP O
75 did VBD B-VP O
75 well RB O O
75 over IN B-VP O
75 the DT O O
75 first JJ O O
75 24 CD O O
75 hours NNS B-NP O
75 of IN B-VP O
76 admission NN B-NP O
76 On IN B-VP O
76 16 CD O O
76 of IN B-VP O
76 June NNP B-NP O
76 , , O O
76 the DT B-NP O
76 patient NN I-NP O
76 went VBD B-VP O
76 to TO O O
76 cardiac VB O O
77 cath NN B-NP O
77 Angiogram NNP I-NP O
77 showed VBD B-VP O
77 50% CD O O
77 mid NN B-NP O
77 circumflex NN I-NP O
77 , , O O
77 60% CD O O
77 mid NN B-NP O
77 left VBD B-VP O
77 anterior JJ B-NP O
78 descending NN I-NP O
78 and CC O O
78 only RB O O
78 luminal JJ B-NP O
78 irregularities NNS I-NP O
78 in IN B-VP O
78 the DT B-NP O
78 right JJ I-NP O
78 RCA NNP I-NP O
78 , , O O
79 anterior RB O O
79 wall JJ B-NP O
79 hypokinesis NN I-NP O
79 but CC O O
79 overall JJ B-NP O
79 good JJ I-NP O
79 LV NNP I-NP O
79 systolic JJ B-NP O
79 function NN I-NP O
80 with IN B-VP O
80 an DT B-NP O
80 EF NNP I-NP O
80 of IN B-VP O
80 approximately RB O O
80 72% CD O O
80 Average JJ B-NP O
80 pulmonary JJ I-NP O
80 capillary JJ I-NP O
80 wedge NN I-NP O
81 pressure NN I-NP O
81 was VBD B-VP O
81 20 CD O O
81 and CC O O
81 right JJ B-NP O
81 atrial JJ I-NP O
81 pressure NN I-NP O
81 9 CD O O
81 Cardiac NNP B-NP O
81 output NN I-NP O
81 was VBD B-VP O
82 4.5 CD O O
82 with IN B-VP O
82 cardiac JJ B-NP O
82 index NN I-NP O
82 of IN B-VP O
82 2.5 CD O O
82 Careful NNP B-NP O
82 review NN I-NP O
82 of IN B-VP O
82 the DT B-NP O
82 cath NN I-NP O
82 films NNS I-NP O
83 showed VBD B-VP O
83 no DT O O
83 hemodynamically RB O O
83 significant JJ B-NP O
83 lesions NNS I-NP O
83 felt VBD B-VP O
83 to TO O O
83 be VB O O
84 responsible JJ O O
84 for IN B-VP O
84 the DT B-NP O
84 patient's NN I-NP O
84 chest NN I-NP O
84 pain NN I-NP O
84 Echo NNP I-NP O
84 performed VBD B-VP O
84 on IN B-VP O
85 8 CD O O
85 of IN B-VP O
85 August NNP B-NP O
85 , , O O
85 showed VBD B-VP O
85 left JJ B-NP O
85 ventricular JJ I-NP O
85 hypertrophy NN I-NP O
85 with IN B-VP O
85 low JJ B-NP O
85 normal JJ I-NP O
85 LV NNP I-NP O
86 systolic NN I-NP O
86 function NN I-NP O
86 , , O O
86 estimated VBN O O
86 EF NNP B-NP O
86 of IN B-VP O
86 50-55% NNP B-NP O
86 , , O O
86 inferior JJ B-NP O
86 posterior JJ I-NP O
87 hypokinesis NN I-NP O
87 , , O O
87 and CC O O
87 trace NN B-NP O
87 of IN B-VP O
87 tricuspid JJ O O
87 and CC O O
87 mitral JJ B-NP O
87 regurgitation NN I-NP O
87 There EX O O
88 was VBD B-VP O
88 mild JJ B-NP O
88 right JJ I-NP O
88 ventricular NN I-NP O
88 hypertrophy NN I-NP O
88 and CC O O
88 normal JJ O O
88 estimated VBN O O
89 pulmonary JJ B-NP O
89 artery NN I-NP O
89 pressure NN I-NP O
90 Postcatheterization NNP I-NP O
90 , , O O
90 the DT B-NP O
90 patient NN I-NP O
90 showed VBD B-VP O
90 mild JJ B-NP B-r
90 hypertension NN I-NP I-r
90 which WDT O O
90 was VBD B-VP O
91 treated VBN O O
91 by IN B-VP O
91 the DT B-NP O
91 addition NN I-NP O
91 of IN B-VP O
91 a DT B-NP O
91 calcium NN I-NP B-m
91 channel NN I-NP I-m
91 blocker NN I-NP I-m
91 , , O O
91 and CC O O
91 she PRP O O
91 was VBD B-VP O
92 also RB O O
92 diuresed VBN O O
92 for IN B-VP O
92 fluid NN B-NP O
92 overload NN I-NP O
92 Prior NNP I-NP O
92 to TO O O
92 discharge VB O O
92 , , O O
92 she PRP O O
92 had VBD B-VP O
92 two CD O O
93 additional JJ B-NP O
93 episodes NNS I-NP O
93 of IN B-VP O
93 chest NN B-NP B-r
93 chest NN I-NP B-r
93 pain NN I-NP I-r
93 pain NN I-NP I-r
93 that WDT O O
93 were VBD B-VP O
93 low JJ O O
93 in IN B-VP O
93 intensity NN B-NP O
93 but CC O O
94 prolonged VBD B-VP O
94 Each DT O O
94 of IN B-VP O
94 these DT B-NP O
94 required JJ I-NP O
94 several JJ I-NP O
94 Nitroglycerins NNS I-NP B-m
94 and CC O O
95 antacids NNS B-NP B-m
95 to TO O O
95 be VB O O
95 relieved VBN O O
95 It PRP O O
95 was VBD B-VP O
95 felt VBN O O
95 that IN B-VP O
95 the DT B-NP O
95 chest JJS I-NP O
95 pain NN I-NP O
95 was VBD B-VP O
96 unlikely JJ O O
96 to TO O O
96 be VB O O
96 cardiac JJ O O
96 in IN B-VP O
96 origin NN B-NP O
96 and CC O O
96 more RBR O O
96 likely JJ O O
96 represented VBN O O
96 either RB O O
97 GI NNP B-NP O
97 symptomatology NN I-NP O
97 or CC O O
97 an DT B-NP O
97 anxiety NN I-NP O
97 reaction NN I-NP O
97 The DT B-NP O
97 patient NN I-NP O
97 repeatedly RB O O
98 expressed VBD B-VP O
98 great JJ B-NP O
98 concern NN I-NP O
98 over IN B-VP O
98 her PRP$ O O
98 husband's JJ B-NP O
98 illness NN I-NP O
98 and CC O O
98 understood VBD B-VP O
99 the DT B-NP O
99 possible JJ I-NP O
99 connection NN I-NP O
99 between IN B-VP O
99 this DT O O
99 and CC O O
99 her PRP$ O O
99 chest NN B-NP O
99 pain NN I-NP O
99 On IN B-VP O
99 13 CD O O
99 of IN B-VP O
99 August NNP B-NP O
99 , , O O
100 the DT B-NP O
100 patient JJ I-NP O
100 underwent JJ I-NP O
100 exercise NN I-NP O
100 treadmill NN I-NP O
100 test NN I-NP O
100 on IN B-VP O
100 the DT O O
100 modified VBN O O
100 Bruce NNP B-NP O
101 protocol NN I-NP O
101 She PRP O O
101 went VBD B-VP O
101 10 CD O O
101 minutes NNS B-NP O
101 and CC O O
101 30 CD O O
101 seconds NNS B-NP O
101 stopping VBG O O
101 secondary JJ O O
101 to TO O O
102 fatigue VB O O
102 Maximum NNP B-NP O
102 heart NN I-NP O
102 rate NN I-NP O
102 was VBD B-VP O
102 108 CD O O
102 , , O O
102 maximum JJ B-NP O
102 BP NNP I-NP O
102 164 CD O O
102 systolic NN B-NP O
102 , , O O
102 no DT B-NP O
103 symptoms NNS I-NP O
103 and CC O O
103 no DT B-NP O
103 EKG NNP I-NP O
103 changes NNS I-NP O
103 , , O O
103 and CC O O
103 the DT B-NP O
103 test NN I-NP O
103 was VBD B-VP O
103 interpreted VBN O O
103 as IN B-VP O
104 showing VBG O O
104 no DT B-NP O
104 evidence NN I-NP O
104 for IN B-VP O
104 ischemia NN B-NP O
104 The DT B-NP O
104 patient NN I-NP O
104 was VBD B-VP O
104 discharged VBN O O
104 to TO O O
105 home NN B-NP O
105 and CC O O
105 is VBZ O O
105 to TO O O
105 follow VB O O
105 up RP O O
105 at IN B-VP O
105 AMC NNP B-NP O
106 COMPLICATIONS: NNP I-NP O
106 None NNP I-NP O
106 MEDICATIONS NNP I-NP O
106 ON NNP I-NP O
106 DISCHARGE: NNP I-NP O
106 Nifedipine NNP I-NP B-m
106 XL NNP I-NP I-m
106 90 CD O B-do
107 mg NN B-NP O
107 po NN I-NP B-mo
107 q NN I-NP B-f
107 am VBP O I-f
107 , , O O
107 Lopressor NNP B-NP B-m
107 50 CD O B-do
107 mg NN B-NP I-do
107 po NN I-NP B-mo
107 b.i.d NN I-NP B-f
107 , , O O
107 Zantac NNP B-NP B-m
107 150 CD O B-do
107 mg NN B-NP I-do
107 po NN I-NP B-mo
107 q NN I-NP B-f
107 hs NN I-NP I-f
107 , , O O
108 aspirin RB O B-m
108 81 CD O B-do
108 mg NNS B-NP I-do
108 po JJ B-NP B-mo
108 q JJ I-NP B-f
108 d NN I-NP I-f
108 , , O O
108 Serax NNP B-NP B-m
108 Serax NNP I-NP B-m
108 15 CD O B-do
108 15 CD O B-do
108 mg NN B-NP I-do
108 mg NN I-NP I-do
108 po NN I-NP B-mo
108 po NN I-NP B-mo
108 q VBD B-VP B-f
108 6 CD O I-f
108 h NN B-NP I-f
108 or CC O O
108 q NN B-NP B-f
108 hs NN I-NP I-f
108 prn NN I-NP I-f
108 , , O O
109 Nitroglycerin NNP B-NP B-m
109 1/150 CD O B-do
109 grain NN B-NP I-do
109 q NN I-NP O
109 5 CD O O
109 minutes NNS B-NP O
109 x VBP O B-du
109 3 CD O I-du
109 SL NNP B-NP B-mo
109 prn NN I-NP O
109 chest NN I-NP B-r
109 pain NN I-NP I-r
110 CONDITION NNP I-NP O
110 ON NNP I-NP O
110 DISCHARGE: NNP I-NP O
110 Good NNP I-NP O
110 FOLLOW NNP I-NP O
110 UP NNP I-NP O
110 CARE: NNP I-NP O
110 With IN B-VP O
110 her PRP$ O O
110 primary JJ B-NP O
111 care NN I-NP O
111 physician NN I-NP O
111 , , O O
111 Dr NNP B-NP O
111 Gayle NNP I-NP O
111 Demeritt NNP I-NP O
111 , , O O
111 and CC O O
111 her PRP$ O O
111 cardiologist NN B-NP O
111 , , O O
111 Dr NNP B-NP O
111 Mark NNP I-NP O
111 Willians NNP I-NP O
111 , , O O
111 at IN B-VP O
111 ACSH NNP B-NP O
112 ZR634/9372 NNP I-NP O
113 LESLIE NNP I-NP O
113 F NNP I-NP O
113 BUZIS NNP I-NP O
113 , , O O
113 M.D NNP B-NP O
113 IK5 NNP I-NP O
113 D: NNP I-NP O
113 6/19/92 CD O O
114 Batch: NNP B-NP O
114 8454 CD O O
114 Report: NNP B-NP O
114 A0568G63 NNP I-NP O
114 T: NNP I-NP O
114 9/1/92 CD O O
115 Dictated NNP B-NP O
115 By: NNP I-NP O
115 IAN NNP I-NP O
115 WALER NNP I-NP O
115 , , O O
115 M.D NNP B-NP O
116 cc: VBZ O O
116 1 CD O O
116 RICARDO NNP B-NP O
116 R NNP I-NP O
116 HEALD NNP I-NP O
116 , , O O
116 M.D NNP B-NP O
117 2 CD O O
117 FREDDIE NNP B-NP O
117 L NNP I-NP O
117 ZIPPERER NNP I-NP O
117 , , O O
117 M.D NNP B-NP O
118 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #156908 VBZ O O
4 326844120 CD O O
4 R NNP B-NP O
4 21669179 CD O O
4 8491274 CD O O
4 5/12/2007 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 ROMI NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/18/2007 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/26/2007 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 BRENCHLEY NNP I-NP O
8 , , O O
8 BRENT NNP B-NP O
8 L NNP I-NP O
8 246-19-65-4 JJ B-NP O
9 Naside NNP I-NP O
9 Roche NNP I-NP O
9 Enron NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 7/10/07 CD O O
11 AT NNP B-NP O
11 09:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 AMA NNP I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 ACETO NNP I-NP O
14 , , O O
14 PABLO NNP B-NP O
14 F NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
14 , , O O
14 M.S NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 AMA NNP I-NP O
18 MEDICATIONS NNP I-NP O
18 ON NNP I-NP O
18 ADMISSION: NNP I-NP O
19 1 CD O O
19 ACETYLSALICYLIC NNP B-NP B-m
19 ACID NNP I-NP I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 2 CD O O
20 ATENOLOL NNP B-NP B-m
20 25 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 3 CD O O
21 ATORVASTATIN NNP B-NP B-m
21 80 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 4 CD O O
22 DOCUSATE NNP B-NP B-m
22 SODIUM NNP I-NP I-m
22 100 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 BID NNP I-NP B-f
23 5 CD O O
23 LOSARTAN NNP B-NP B-m
23 50 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QD NNP I-NP B-f
24 6 CD O O
24 METFORMIN NNP B-NP B-m
24 850 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 BID NNP I-NP B-f
25 7 CD O O
25 TERAZOSIN NNP B-NP B-m
25 HCL NNP I-NP I-m
25 1 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QD NNP I-NP B-f
26 8 CD O O
26 AMLODIPINE NNP B-NP B-m
26 10 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 QD NNP I-NP B-f
27 9 CD O O
27 LOSARTAN NNP B-NP B-m
27 50 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 10 CD O O
28 PANTOPRAZOLE NNP B-NP B-m
28 40 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 MEDICATIONS NNP I-NP O
29 ON NNP I-NP O
29 DISCHARGE: NNP I-NP O
30 ACETYLSALICYLIC NNP I-NP B-m
30 ACID NNP I-NP I-m
30 325 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 DAILY NNP I-NP B-f
31 Starting NNP I-NP O
31 IN NNP I-NP O
31 AM NNP I-NP O
31 ( ( O O
31 10/14 CD O O
31 ) ) O O
32 AMLODIPINE $ O B-m
32 10 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 DAILY NNP I-NP B-f
33 Food/Drug NNP I-NP O
33 Interaction NNP I-NP O
33 Instruction NNP I-NP O
34 Avoid NNP I-NP O
34 grapefruit NN I-NP O
34 unless IN B-VP O
34 MD NNP B-NP O
34 instructs NNS I-NP O
34 otherwise RB O O
35 ATENOLOL NNP B-NP B-m
35 25 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 DAILY NNP I-NP B-f
36 LIPITOR NNP I-NP B-m
36 ( ( O I-m
36 ATORVASTATIN NNP B-NP I-m
36 ) ) O I-m
36 80 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 DAILY NNP I-NP B-f
37 COLACE NNP I-NP B-m
37 ( ( O I-m
37 DOCUSATE NNP B-NP I-m
37 SODIUM NNP I-NP I-m
37 ) ) O I-m
37 100 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 BID NNP I-NP B-f
38 LOSARTAN NNP I-NP B-m
38 50 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 DAILY NNP I-NP B-f
38 HOLD NNP I-NP O
38 IF: NNP I-NP O
38 sbp VBD B-VP O
38 &lt; $ O O
38 100 CD O O
39 Override NNP B-NP O
39 Notice: NNP I-NP O
39 Override NNP I-NP O
39 added VBD B-VP O
39 on IN B-VP O
39 7/10/07 CD O O
39 by IN B-VP O
40 KETCHAM NNP B-NP O
40 , , O O
40 JAKE NNP B-NP O
40 WALDO NNP I-NP O
40 , , O O
40 M.D NNP B-NP O
40 , , O O
40 PH.D NNP B-NP O
41 on IN B-VP O
41 order NN B-NP O
41 for IN B-VP O
41 KCL NNP B-NP B-m
41 IV NNP I-NP B-mo
41 ( ( O O
41 ref JJ O O
41 # # O O
41 687673059 CD O O
41 ) ) O O
42 POTENTIALLY NNP B-NP O
42 SERIOUS NNP I-NP O
42 INTERACTION: NNP I-NP O
42 LOSARTAN NNP I-NP B-m
42 POTASSIUM NNP I-NP I-m
42 &amp; NNP I-NP O
43 POTASSIUM NNP I-NP B-m
43 CHLORIDE NNP I-NP I-m
43 Reason NNP I-NP O
43 for IN B-VP O
43 override: NN B-NP O
43 md NN I-NP O
43 aware JJ B-NP O
44 Previous NNP I-NP O
44 override NN I-NP O
44 information: NN I-NP O
45 Override NNP I-NP O
45 added VBD B-VP O
45 on IN B-VP O
45 11/8/07 CD O O
45 by IN B-VP O
45 DERNIER NNP B-NP O
45 , , O O
45 AUGUSTINE NNP B-NP O
45 A NNP I-NP O
45 , , O O
45 P.A.-C NNP B-NP O
46 on IN B-VP O
46 order NN B-NP O
46 for IN B-VP O
46 KCL NNP B-NP B-m
46 IMMEDIATE NNP I-NP I-m
46 RELEASE NNP I-NP I-m
46 PO NNP I-NP B-mo
46 ( ( O O
46 ref JJ O O
46 # # O O
47 856712835 CD O O
47 ) ) O O
48 POTENTIALLY NNP B-NP O
48 SERIOUS NNP I-NP O
48 INTERACTION: NNP I-NP O
48 LOSARTAN NNP I-NP B-m
48 POTASSIUM NNP I-NP I-m
48 &amp; NNP I-NP O
49 POTASSIUM NNP I-NP B-m
49 CHLORIDE NNP I-NP I-m
49 Reason NNP I-NP O
49 for IN B-VP O
49 override: NN B-NP O
49 will MD O O
49 monitor VB O O
50 Number NNP B-NP B-do
50 of IN B-VP I-do
50 Doses NNP B-NP I-do
50 Required NNP I-NP I-do
50 ( ( O I-do
50 approximate JJ B-NP I-do
50 ): NN I-NP I-do
50 3 CD O I-do
51 MG NNP B-NP B-m
51 GLUCONATE NNP I-NP I-m
51 ( ( O I-m
51 MAGNESIUM NNP B-NP I-m
51 GLUCONATE NNP I-NP I-m
51 ) ) O I-m
51 400 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 DAILY NNP I-NP B-f
52 Starting NNP I-NP O
52 IN NNP I-NP O
52 AM NNP I-NP O
52 ( ( O O
52 10/14 CD O O
52 ) ) O O
53 PROTONIX NNP B-NP B-m
53 ( ( O I-m
53 PANTOPRAZOLE NNP B-NP I-m
53 ) ) O I-m
53 40 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 DAILY NNP I-NP B-f
54 TERAZOSIN NNP I-NP B-m
54 HCL NNP I-NP I-m
54 1 CD O B-do
54 MG NNP B-NP I-do
54 PO NNP I-NP B-mo
54 DAILY NNP I-NP B-f
55 Number NNP I-NP B-du
55 of IN B-VP I-du
55 Doses NNP B-NP I-du
55 Required NNP I-NP I-du
55 ( ( O I-du
55 approximate JJ B-NP I-du
55 ): NN I-NP I-du
55 2 CD O I-du
56 DIET: NNP B-NP O
56 House NNP I-NP O
56 / VBD B-VP O
56 2 CD O O
56 gm NN B-NP O
56 Na NNP I-NP O
56 / NNP I-NP O
56 Carbohydrate NNP I-NP O
56 Controlled NNP I-NP O
56 / NNP I-NP O
56 Low NNP I-NP O
56 saturated VBD B-VP O
56 fat JJ B-NP O
57 low JJ I-NP O
57 cholesterol NN I-NP O
58 ACTIVITY: NNP I-NP O
58 Resume NNP I-NP O
58 regular JJ B-NP O
58 exercise NN I-NP O
59 FOLLOW NNP I-NP O
59 UP NNP I-NP O
59 APPOINTMENT( NNP I-NP O
59 S NNP I-NP O
59 ): NNP I-NP O
60 PCP NNP I-NP O
60 x VBD B-VP O
60 1 CD O O
60 week NN B-NP O
60 , , O O
61 ALLERGY: NNP B-NP O
61 HYDROCHLOROTHIAZIDE NNP I-NP O
62 ADMIT NNP I-NP O
62 DIAGNOSIS: NNP I-NP O
63 CP NNP I-NP O
64 PRINCIPAL NNP I-NP O
64 DISCHARGE NNP I-NP O
64 DIAGNOSIS NNP I-NP O
64 ;Responsible JJ O O
64 After IN B-VP O
64 Study NNP B-NP O
64 for IN B-VP O
64 Causing NNP B-NP O
64 Admission NNP I-NP O
64 ) ) O O
65 ROMI NNP B-NP O
66 OTHER NNP I-NP O
66 DIAGNOSIS;Conditions NNP I-NP O
66 , , O O
66 Infections NNP B-NP O
66 , , O O
66 Complications NNP B-NP O
66 , , O O
66 affecting VBG O O
66 Treatment/Stay NNP B-NP O
67 essential JJ B-NP O
67 HTN NNP I-NP O
67 , , O O
67 NIDDM NNP B-NP O
67 , , O O
67 CAD NNP B-NP O
67 , , O O
67 asystolic JJ B-NP O
67 arrest NN I-NP O
67 , , O O
67 Hypokalemia NNP B-NP O
67 , , O O
67 Chronic NNP B-NP O
68 right-sided VBD B-VP O
68 chest JJS B-NP O
68 wall NN I-NP O
68 pain NN I-NP O
68 : : O O
68 10/6 CD O O
68 ETT NNP B-NP O
68 6' CD O O
68 SBP NNP B-NP O
68 c VBD B-VP O
68 100%PHR CD O O
68 no DT B-NP O
68 isch NN I-NP O
68 , , O O
69 prostate NN B-NP O
69 nodules NNS I-NP O
69 , , O O
69 PUD/GERD NNP B-NP O
69 , , O O
69 headaches NNS B-NP O
69 , , O O
69 h/o JJ B-NP O
69 flash NN I-NP O
69 pulmonary JJ B-NP O
69 edema NN I-NP O
70 OPERATIONS NNP I-NP O
70 AND NNP I-NP O
70 PROCEDURES: NNP I-NP O
71 none NN I-NP O
72 OTHER NNP I-NP O
72 TREATMENTS/PROCEDURES NNP I-NP O
72 ( ( O O
72 NOT NNP B-NP O
72 IN NNP I-NP O
72 O.R NNP I-NP O
72 ) ) O O
73 none NN B-NP O
74 BRIEF NNP I-NP O
74 RESUME NNP I-NP O
74 OF NNP I-NP O
74 HOSPITAL NNP I-NP O
74 COURSE: NNP I-NP O
75 PCP: NNP I-NP O
75 Dr NNP I-NP O
75 Marco NNP I-NP O
75 Labat NNP I-NP O
75 ( ( O O
75 ING NNP B-NP O
75 SCEODE NNP I-NP O
75 HEALTHCARE NNP I-NP O
75 ) ) O O
76 Cards: NNP B-NP O
76 none NN I-NP O
76 active JJ B-NP O
76 senior JJ I-NP O
76 living NN I-NP O
76 center: NN I-NP O
76 564 CD O O
76 071 CD O O
76 7165 CD O O
77 --------------------------------------------------- NN B-NP O
78 CC: NNP I-NP O
78 chest NN I-NP O
78 pain NN I-NP O
79 *** NNP I-NP O
80 HPI: NNP I-NP O
80 76 CD O O
80 yo NN B-NP O
80 Spanish JJ O O
80 speaking VBG O O
80 male JJ B-NP O
80 w/ JJ I-NP O
80 NIDDM NNP I-NP O
80 , , O O
80 HTN NNP B-NP O
80 , , O O
80 w/ JJ B-NP O
80 recent JJ I-NP O
80 CCU NNP I-NP O
80 admission NN I-NP O
81 @ NNP I-NP O
81 TMC NNP I-NP O
81 for IN B-VP O
81 NSTEMI/asystole NNP B-NP O
81 arrest/pulm NN I-NP O
81 edema NN I-NP O
81 , , O O
81 left VBD B-VP O
81 AMA NNP B-NP O
81 before IN B-VP O
82 stress/cath NN B-NP O
82 Then RB O O
82 ED NNP B-NP O
82 visit NN I-NP O
82 on IN B-VP O
82 9/27 CD O O
82 for IN B-VP O
82 weakness NN B-NP O
82 , , O O
82 c/o NN B-NP O
82 of IN B-VP O
82 cp NN B-NP O
82 , , O O
82 left VBD B-VP O
82 AMA NNP B-NP O
82 , , O O
83 then RB O O
83 admission NN B-NP O
83 on IN B-VP O
83 0/2 CD O O
83 where WRB O O
83 he PRP O O
83 again RB O O
83 left VBD B-VP O
83 AMA NNP B-NP O
83 before IN B-VP O
83 evaluation NN B-NP O
84 Presented VBN O O
84 to TO O O
84 AH NNP B-NP O
84 ED NNP I-NP O
84 for IN B-VP O
84 similar JJ B-NP O
84 ongoing JJ I-NP O
84 complaints NNS I-NP O
84 including VBG O O
84 constant JJ B-NP O
84 CP NNP I-NP O
85 "burning/nauseous JJ B-NP O
85 feeling" NN I-NP O
85 x $ O O
85 3 CD O O
85 days NNS B-NP O
85 with IN B-VP O
85 some DT O O
85 associated VBN O O
85 palpitations NNS B-NP O
86 and CC O O
86 sob NN B-NP O
86 He PRP O O
86 states VBZ O O
86 that IN B-VP O
86 the DT B-NP O
86 pain NN I-NP O
86 started VBD B-VP O
86 3 CD O O
86 days NNS B-NP O
86 PTA NNP I-NP O
86 while IN B-VP O
86 walking VBG O O
86 around RB O O
87 house NN B-NP O
87 , , O O
87 approx VBP O O
87 6/10 CD O O
87 however RB O O
87 didn't JJ O O
87 call VB O O
87 EMS NNP B-NP O
87 until IN B-VP O
87 today NN B-NP O
87 - : O O
87 mostly RB O O
87 b/c IN B-VP O
87 he PRP O O
88 has VBZ O O
88 began VBD B-VP O
88 to TO O O
88 get VB O O
88 dizzier JJR O O
88 and CC O O
88 weaker JJR O O
88 since IN B-VP O
88 seen VBN O O
88 in IN B-VP O
88 CADA NNP B-NP O
88 HOSPITAL NNP I-NP O
88 Denies NNP I-NP O
89 radiation NN I-NP O
89 of IN B-VP O
89 pain/chills/fevers/cough/weight JJ B-NP O
89 changes/urinary/bowel NN I-NP O
89 sxs NN I-NP O
90 Per NNP I-NP O
90 MH NNP I-NP O
90 pt NN I-NP O
90 seen VBN O O
90 in IN B-VP O
90 SOUTHNEY NNP B-NP O
90 TROTEN NNP I-NP O
90 GENERAL NNP I-NP O
90 HOSPITAL NNP I-NP O
90 on IN B-VP O
90 11/19/07 CD O O
90 with IN B-VP O
90 c/o NN B-NP O
90 continued VBD B-VP O
90 lack NN B-NP O
90 of IN B-VP O
90 appetite NN B-NP O
90 , , O O
91 lack NN B-NP O
91 of IN B-VP O
91 energy NN B-NP O
91 , , O O
91 dizziness NN B-NP O
91 x VBD B-VP O
91 10 CD O O
91 days NNS B-NP O
91 Denies NNPS I-NP O
91 orthostatic JJ B-NP O
91 sxs NN I-NP O
91 , , O O
91 but CC O O
91 does VBZ O O
92 feel VB O O
92 weak JJ O O
92 when WRB O O
92 standing VBG O O
92 up RP O O
92 No DT B-NP O
92 change NN I-NP O
92 in IN B-VP O
92 exercise NN B-NP O
92 tolerance NN I-NP O
92 , , O O
92 can MD O O
92 walk VB O O
92 5 CD O O
93 blocks NNS B-NP O
93 w/o VBP O O
93 difficulty NN B-NP O
93 ( ( O O
93 unchanged JJ O O
93 ) ) O O
93 In IN B-VP O
93 CYSANDERS NNP B-NP O
93 HE NNP I-NP O
93 HOSPITAL NNP I-NP O
93 he PRP O O
93 had VBD B-VP O
93 c/o VBN O O
93 occ RB O O
93 sharp JJ B-NP O
93 cp NN I-NP O
93 , , O O
94 bilateral JJ O O
94 , , O O
94 not RB O O
94 associated VBN O O
94 with IN B-VP O
94 exercise/food NN B-NP O
94 He PRP O O
94 stated VBD B-VP O
94 sxs NN B-NP O
94 are VBP O O
95 different JJ O O
95 from IN B-VP O
95 when WRB O O
95 he PRP O O
95 had VBD B-VP O
95 the DT B-NP O
95 NSTEMI NNP I-NP O
95 In IN B-VP O
95 ED NNP B-NP O
95 , , O O
95 pt RB O O
95 currently RB O O
95 pain VBP O O
95 free JJ O O
95 - : O O
96 enzymes RB O O
96 flat JJ B-NP O
96 x NN I-NP O
96 1 CD O O
96 , , O O
96 EKG NNP B-NP O
96 unchanged JJ O O
96 per IN B-VP O
96 ED NNP B-NP O
96 ( ( O O
96 however RB O O
96 ? . B-VP O
96 &lt;1 JJ B-NP O
96 mm NN I-NP O
96 ST NNP I-NP O
96 depression NN I-NP O
96 in IN B-VP O
97 lateral JJ B-NP O
97 leads NNS I-NP O
97 Given VBN O O
97 ASA NNP B-NP B-m
97 325 CD O B-do
97 x NNP B-NP B-du
97 1 CD O I-du
97 , , O O
97 Ativan NNP B-NP B-m
97 0.5 CD O B-do
97 mg NN B-NP I-do
97 x NN I-NP B-du
97 1 CD O I-du
97 , , O O
97 Mg NNP B-NP B-m
97 chloride VBP O I-m
97 500 CD O B-do
97 mg NN B-NP I-do
98 x VBD B-VP B-du
98 1 CD O I-du
99 *Cardiac JJ B-NP O
99 Hx NNP I-NP O
99 per IN B-VP O
99 ACH NNP B-NP O
99 note: FW O O
100 CAD: NNP B-NP O
100 MI NNP I-NP O
100 January NNP I-NP O
100 likely JJ B-NP O
100 sx NN I-NP O
100 of IN B-VP O
100 stable JJ B-NP O
100 angina NN I-NP O
100 , , O O
100 bradycardic NN B-NP O
100 to TO O O
100 30's CD O O
100 on IN B-VP O
101 atenolol NN B-NP B-m
101 , , O O
101 MIBI NNP B-NP O
101 9/4 CD O O
101 mild NN B-NP O
101 LV NNP I-NP O
101 enlargement NN I-NP O
101 with IN B-VP O
101 fixed JJ B-NP O
101 inferior JJ I-NP O
101 defect NN I-NP O
101 and CC O O
102 no DT B-NP O
102 reversible JJ I-NP O
102 defects NNS I-NP O
103 Echo: NNP I-NP O
103 EF NNP I-NP O
103 35% CD O O
103 , , O O
103 LAE NNP B-NP O
103 , , O O
103 mod NN B-NP O
103 MR NNP I-NP O
103 , , O O
103 mild NN B-NP O
103 AI NNP I-NP O
103 , , O O
103 trace NN B-NP O
103 TR NNP I-NP O
103 with IN B-VP O
103 inferior JJ B-NP O
103 wall NN I-NP O
103 HK NNP I-NP O
103 6/10 CD O O
104 left VBD B-VP O
104 TH NNP B-NP O
104 AMA NNP I-NP O
104 prior RB O O
104 to TO O O
104 MIBI NNP B-NP O
104 , , O O
104 did VBD B-VP O
104 not RB O O
104 f/u VB O O
104 outpt NN B-NP O
104 , , O O
104 hx NN B-NP O
104 med VBD B-VP O
104 noncompliance NN B-NP O
104 Pt NNP I-NP O
105 reported VBD B-VP O
105 cardiac JJ B-NP O
105 cath NN I-NP O
105 in IN B-VP O
105 Ra NNP B-NP O
105 Corpho NNP I-NP O
105 Pa NNP I-NP O
105 Diagnostic NNP I-NP O
105 cath NN I-NP O
105 only RB O O
105 ( ( O O
105 no DT B-NP O
105 report NN I-NP O
106 available JJ O O
106 ) ) O O
106 per IN B-VP O
106 ALT NNP B-NP O
106 HOSPITALS NNP I-NP O
106 note VBP O O
106 0/28 CD O O
107 *** NN B-NP O
108 ROS: NNP I-NP O
108 recent JJ B-NP O
108 urgent JJ I-NP O
108 care NN I-NP O
108 visit NN I-NP O
108 for IN B-VP O
108 c/o NN B-NP O
108 weakness NN I-NP O
108 and CC O O
108 decreased VBD B-VP O
108 po NNS B-NP O
109 intake NN I-NP O
109 ( ( O O
109 per IN B-VP O
109 LMR NNP B-NP O
109 ) ) O O
109 , , O O
109 + JJ B-NP O
109 blurry NN I-NP O
109 vision NN I-NP O
109 , , O O
109 + NNP B-NP O
109 dizziness NN I-NP O
109 and CC O O
109 racing VBG O O
109 heart NN B-NP O
109 rate NN I-NP O
110 intermittently RB O O
110 at IN B-VP O
110 night NN B-NP O
110 ( ( O O
110 unclear JJ B-NP O
110 duration NN I-NP O
110 ) ) O O
110 , , O O
110 as IN B-VP O
110 above IN B-VP O
110 otherwise RB O O
111 unremarkable JJ B-NP O
112 *** NN I-NP O
113 PMH: NNP I-NP O
113 See NNP I-NP O
113 problem NN I-NP O
113 List NNP I-NP O
114 *** NNP I-NP O
115 HOME NNP I-NP O
115 MEDS: NNP I-NP O
115 ASA NNP I-NP B-m
115 325 CD O B-do
115 mg JJ O I-do
115 daily RB O B-f
115 , , O O
115 lipitor NN B-NP B-m
115 80 CD O B-do
115 mg JJ O I-do
115 daily RB O B-f
115 , , O O
115 amlodipine JJ O B-m
115 5 CD O B-do
115 mg JJ O I-do
116 daily RB O B-f
116 , , O O
116 protonix VBD B-VP B-m
116 40 CD O B-do
116 mg JJ O I-do
116 daily RB O B-f
116 , , O O
116 losartan VBD B-VP B-m
116 50 CD O B-do
116 mg JJ O I-do
116 daily RB O B-f
116 , , O O
116 terazosin VBD B-VP B-m
116 1 CD O B-do
116 mg JJ O I-do
117 daily RB O B-f
117 , , O O
117 atenolol VBZ O B-m
117 25 CD O B-do
117 mg JJ O I-do
117 daily RB O B-f
117 , , O O
117 metformin VBD B-VP B-m
117 850 CD O B-do
117 mg NN B-NP I-do
117 qam NN I-NP B-f
117 ( ( O O
117 Patient NNP B-NP O
118 states VBZ O O
118 compliance NN B-NP O
118 with IN B-VP O
118 all DT B-NP O
118 meds NNS I-NP O
118 ) ) O O
119 *** VBP O O
120 ALLERGIES: NNP B-NP O
120 HCTZ NNP I-NP O
120 - : O O
120 renal JJ B-NP O
120 failure NN I-NP O
120 , , O O
120 hypokalemia NN B-NP O
120 , , O O
121 *** NNP B-NP O
122 FH: NNP I-NP O
122 Mother NNP I-NP O
122 died VBD B-VP O
122 2/2 CD O O
122 heart NN B-NP O
122 disease NN I-NP O
122 , , O O
122 Father NNP B-NP O
122 had VBD B-VP O
122 a DT B-NP O
122 sudden JJ I-NP O
122 cardiac NN I-NP O
122 death; NN I-NP O
123 no DT B-NP O
123 FH NNP I-NP O
123 of IN B-VP O
123 CA NNP B-NP O
123 , , O O
123 DM NNP B-NP O
123 , , O O
123 HTN NNP B-NP O
124 *** NNP I-NP O
125 SH: NNP I-NP O
125 lives VBZ O O
125 alone RB O O
125 in IN B-VP O
125 assisted JJ B-NP O
125 living NN I-NP O
125 @ NNP I-NP O
125 Gocam NNP I-NP O
125 Trache NNP I-NP O
125 Boiseatl NNP I-NP O
125 no DT B-NP O
125 family NN I-NP O
125 member NN I-NP O
125 or CC O O
126 friends NNS B-NP O
126 former JJ B-NP O
126 heavy JJ I-NP O
126 smoker NN I-NP O
126 , , O O
126 no DT B-NP O
126 EtOH/IVDU NNP I-NP O
126 from IN B-VP O
126 Yonkers NNP B-NP O
126 Well NNP I-NP O
126 Westo NNP I-NP O
126 , , O O
126 immigrated VBD B-VP O
127 in IN B-VP O
127 70's CD O O
127 , , O O
127 previously RB O O
127 worked VBN O O
127 as IN B-VP O
127 janitor NN B-NP O
128 *** NNP I-NP O
129 PE NNP I-NP O
129 on IN B-VP O
129 ADMISSION: NNP B-NP O
129 VS: NNP I-NP O
129 Afeb NNP I-NP O
129 , , O O
129 Tc NNP B-NP O
129 96.6 CD O O
129 , , O O
129 HR NNP B-NP O
129 77 CD O O
129 , , O O
129 BP NNP B-NP O
129 147/72 CD O O
129 , , O O
129 RR NNP B-NP O
129 16 CD O O
129 , , O O
129 SaO2 NNP B-NP O
129 95% CD O O
129 2 CD O O
129 L NNP B-NP O
130 Gen: NNP I-NP O
130 NAD NNP I-NP O
130 , , O O
130 NARD NNP B-NP O
130 , , O O
130 sitting VBG O O
130 up RP O O
130 on IN B-VP O
130 stretcher NN B-NP O
130 , , O O
130 speaking VBG O O
130 Spanish JJ O O
130 in IN B-VP O
130 full JJ B-NP O
131 sentences NNS I-NP O
132 HEENT: NNP I-NP O
132 NCAT NNP I-NP O
132 , , O O
132 EOMI NNP B-NP O
132 , , O O
132 PERRL NNP B-NP O
132 , , O O
132 anicteric JJ O O
132 , , O O
132 mmm NN B-NP O
132 , , O O
132 OP NNP B-NP O
132 clear JJ B-NP O
133 NECK: NNP I-NP O
133 supple NN I-NP O
133 , , O O
133 no DT B-NP O
133 LAD NNP I-NP O
133 , , O O
133 no DT B-NP O
133 JVD NNP I-NP O
134 CHEST: NNP I-NP O
134 ctab VBZ O O
134 no DT B-NP O
134 w/r/c NN I-NP O
135 CV: NNP I-NP O
135 RRR NNP I-NP O
135 distant JJ B-NP O
135 S1S2 NNP I-NP O
136 ABD: NNP I-NP O
136 +BS NNP I-NP O
136 , , O O
136 soft JJ O O
136 , , O O
136 NTND NNP B-NP O
137 EXT: NNP I-NP O
137 no DT B-NP O
137 e/c/c; NN I-NP O
137 2+ CD O O
137 DP's NNP B-NP O
137 b/l NN I-NP O
138 SKIN: NNP I-NP O
138 intact NN I-NP O
138 , , O O
138 no DT B-NP O
138 rashes NNS I-NP O
139 NEURO: NNP I-NP O
139 A+O NNP I-NP O
139 x NNP I-NP O
139 3 CD O O
139 , , O O
139 nonfocal JJ B-NP O
139 exam NN I-NP O
140 *** NNP I-NP O
141 LABS: NNP I-NP O
141 Na NNP I-NP O
141 139 CD O O
141 K NNP B-NP O
141 3.3 CD O O
141 Mg NNP B-NP O
141 1.4 CD O O
141 CO2 NNP B-NP O
141 23 CD O O
141 BUN NNP B-NP O
141 23 CD O O
141 CRE NNP B-NP O
141 1.6 CD O O
141 ( ( O O
141 baseline NN B-NP O
141 ) ) O O
141 CBC NNP B-NP O
141 nrl JJ B-NP O
142 INR NNP I-NP O
142 1.1 CD O O
142 CKMB NNP B-NP O
142 + NNP I-NP O
142 Ti NNP I-NP O
142 flat JJ B-NP O
142 x NNP I-NP O
142 3 CD O O
143 *** NNP B-NP O
144 RADIOLOGY: NNP I-NP O
144 Chest NNP I-NP O
144 PA NNP I-NP O
144 &amp; NNP I-NP O
144 Lateral: NNP I-NP O
144 No NNP I-NP O
144 significant JJ B-NP O
144 interval NN I-NP O
144 change NN I-NP O
144 without IN B-VP O
145 acute JJ B-NP O
145 cardiopulmonary JJ I-NP O
145 disease NN I-NP O
146 *** NNP I-NP O
147 HOSPITAL NNP I-NP O
147 COURSE:76 NNP I-NP O
147 yo NNP I-NP O
147 M NNP I-NP O
147 w/ NN I-NP O
147 significant JJ B-NP O
147 cardiac JJ I-NP O
147 history NN I-NP O
147 , , O O
147 recent JJ B-NP O
148 NSTEMI/asystole NNP I-NP O
148 arrest NN I-NP O
148 a/w NN I-NP O
148 ongoing VBG O O
148 c/o NN B-NP O
148 weakness NN I-NP O
148 , , O O
148 dizziness NN B-NP O
148 and CC O O
148 CP NNP B-NP O
148 x NNP I-NP O
148 3 CD O O
149 days NNS B-NP O
149 , , O O
149 currently RB O O
149 CP NNP B-NP O
149 free JJ O O
149 however RB O O
149 multiple JJ B-NP O
149 RF's NNP I-NP O
149 for IN B-VP O
149 ACS NNP B-NP O
149 thus RB O O
149 admitted VBD B-VP O
150 to TO O O
150 Medicine NNP B-NP O
150 for IN B-VP O
150 ROMI NNP B-NP O
150 and CC O O
150 further JJ B-NP O
150 eval/management NN I-NP O
151 * NNP I-NP O
151 CV: NNP I-NP O
151 significant JJ B-NP O
151 cardiac JJ I-NP O
151 hx NN I-NP O
151 appears VBZ O O
151 euvolemic JJ O O
151 on IN B-VP O
151 exam NN B-NP O
151 ( ( O O
151 I PRP O O
151 ) ) O O
151 subtle VBD B-VP O
151 EKG NNP B-NP O
152 changes NNS I-NP O
152 on IN B-VP O
152 admit NN B-NP O
152 , , O O
152 however RB O O
152 ? . B-VP O
152 &lt; $ O O
152 1 CD O O
152 mm NN B-NP O
152 ST NNP I-NP O
152 depressions NNS I-NP O
152 in IN B-VP O
152 lateral JJ B-NP O
152 leads NNS I-NP O
152 ( ( O O
152 more RBR O O
153 prominent NN B-NP O
153 in IN B-VP O
153 V5 NNP B-NP O
153 isolated JJ B-NP O
153 lead NN I-NP O
153 ) ) O O
153 cycle NN B-NP O
153 enzymes VBZ O O
153 with IN B-VP O
153 repeat NN B-NP O
153 EKG NNP I-NP O
153 on IN B-VP O
153 admit NN B-NP O
154 ( ( O O
154 no DT B-NP O
154 acute NN I-NP O
154 changes NNS I-NP O
154 ) ) O O
154 and CC O O
154 serial JJ B-NP O
154 EKG's NNP I-NP O
154 with IN B-VP O
154 enzymes NNS B-NP O
154 R/O NNP I-NP O
154 complete VBP O O
154 on IN B-VP O
154 HD NNP B-NP O
154 #2 NNP I-NP O
155 Currently NNP I-NP O
155 CP NNP I-NP O
155 free JJ O O
155 however RB O O
155 will MD O O
155 continue VB O O
155 baseline VB O O
155 Statin/ASA/ARB NNP B-NP O
155 ETT NNP I-NP O
156 MIBI NNP I-NP O
156 ordered VBD B-VP O
156 continue VB O O
156 above IN B-VP B-m
156 meds NNS B-NP I-m
156 and CC O O
156 baseline NN B-NP O
156 BB/CCB NNP I-NP B-m
156 ( ( O O
156 P NNP B-NP O
156 ) ) O O
156 HD NNP B-NP O
156 stable JJ O O
156 yet RB O O
157 risk NN B-NP B-r
157 for IN B-VP O
157 cardiac JJ B-NP O
157 event NN I-NP O
157 thus RB O O
157 will MD O O
157 treat VB O O
157 with IN B-VP O
157 BB NNP B-NP B-m
157 and CC O O
157 titrate NN B-NP O
157 as IN B-VP O
157 tolerated JJ B-NP O
158 TTE NNP I-NP O
158 already RB O O
158 done VBN O O
158 on IN B-VP O
158 previous JJ B-NP O
158 admit NN I-NP O
158 ( ( O O
158 R NNP B-NP O
158 ) ) O O
158 tele VBD B-VP O
158 monitoring VBG O O
159 ***Pt NN B-NP O
159 became VBD B-VP O
159 extremely RB O O
159 aggitated VBN O O
159 and CC O O
159 refusing VBG O O
159 treatment/testing VBG O O
159 on IN B-VP O
159 HD NNP B-NP O
159 #2 NNP I-NP O
160 and CC O O
160 left VBD B-VP O
160 AMA NNP B-NP O
160 after IN B-VP O
160 lengthly RB O O
160 d/w JJ B-NP O
160 pt NN I-NP O
160 , , O O
160 interpreter NN B-NP O
160 , , O O
160 and CC O O
160 SW NNP B-NP O
160 - : O O
160 However RB O O
160 , , O O
161 unfortunately RB O O
161 this DT O O
161 is VBZ O O
161 what WP O O
161 happens VBZ O O
161 repeatedly RB O O
161 on IN B-VP O
161 all DT B-NP O
161 admissions NNS I-NP O
161 - : O O
161 he PRP O O
162 signs NNS B-NP O
162 out RP O O
162 AMA NNP B-NP O
162 prior RB O O
162 to TO O O
162 MIBI NNP B-NP O
162 being VBG O O
162 obtained**** JJ B-NP O
163 * NNP I-NP O
163 Endo: NNP I-NP O
163 h/o NN I-NP O
163 NIDDM NNP I-NP O
163 on IN B-VP O
163 Metformin NNP B-NP B-m
163 at IN B-VP O
163 baseline NN B-NP O
163 A1C NNP I-NP O
163 and CC O O
163 fasting VBG O O
163 lipids NNS B-NP O
164 ordered VBD B-VP O
164 Held NNP B-NP O
164 metformin NN I-NP B-m
164 and CC O O
164 instituted JJ B-NP O
164 DM NNP I-NP O
164 protocol NN I-NP O
164 while IN B-VP B-du
164 in IN B-VP I-du
164 house NN B-NP I-du
165 * NN I-NP O
165 Renal/ NNP I-NP O
165 FEN: NNP I-NP O
165 Known NNP I-NP O
165 CRI NNP I-NP O
165 ( ( O O
165 baseline JJ B-NP O
165 CRE NNP I-NP O
165 1.3-1.6 CD O O
165 ) ) O O
165 gentle NN B-NP O
165 hydration NN I-NP O
165 in IN B-VP O
165 ED NNP B-NP O
166 for IN B-VP O
166 now RB O O
166 , , O O
166 careful JJ O O
166 given VBN O O
166 EF NNP B-NP O
166 20% CD O O
166 hypoMg NN B-NP O
166 and CC O O
166 hypoK NN B-NP O
166 on IN B-VP O
166 admit NN B-NP O
166 -received VBN O O
167 repletion NN B-NP O
167 monitor NN I-NP O
167 lytes/replete JJ B-NP O
167 prn NN I-NP O
167 2 CD O O
167 g NN B-NP O
167 Na/low NNP I-NP O
167 fat/chol NN I-NP O
167 carbo NN I-NP O
168 controlled VBD B-VP O
168 diet JJ B-NP O
168 Nutrition NNP I-NP O
168 consult NN I-NP O
168 ordered VBD B-VP O
168 given VBN O O
168 recent JJ B-NP O
168 decrease NN I-NP O
168 in IN B-VP O
169 appetite NN B-NP O
169 and CC O O
169 FTT NNP B-NP O
169 picture NN I-NP O
170 * NNP I-NP O
170 PPx: NNP I-NP O
170 statin NN I-NP B-m
170 , , O O
170 ASA NNP B-NP B-m
170 , , O O
170 lovenox NN B-NP B-m
170 SC NNP I-NP B-mo
170 , , O O
170 PPi NNP B-NP B-m
170 * NNP I-NP O
170 Misc: NNP I-NP O
170 SW NNP I-NP O
170 consulted VBD B-VP O
170 d/w JJ B-NP O
170 pt NN I-NP O
170 at IN B-VP O
171 length NN B-NP O
171 if IN B-VP O
171 he PRP O O
171 would MD O O
171 benefit VB O O
171 from IN B-VP O
171 services NNS B-NP O
171 at IN B-VP O
171 home NN B-NP O
171 when WRB O O
171 d/c' NN B-NP O
171 d SYM O O
171 - : O O
171 he PRP O O
172 will MD O O
172 think VB O O
172 it PRP O O
172 over RP O O
172 and CC O O
172 get VB O O
172 back RB O O
172 to TO O O
172 team NN B-NP O
173 * NNP I-NP O
173 FULL NNP I-NP O
173 CODE NNP I-NP O
174 ADDITIONAL NNP I-NP O
174 COMMENTS: NNP I-NP O
174 UNFORTUNATELY NNP I-NP O
174 PATIENT NNP I-NP O
174 LEFT NNP I-NP O
174 AMA NNP I-NP O
174 DESPITE NNP I-NP O
174 LENGTHY NNP I-NP O
174 DISCUSSION NNP I-NP O
174 ABOUT NNP I-NP O
174 HIS NNP I-NP O
175 HEALTH NNP I-NP O
175 AND NNP I-NP O
175 RISK NNP I-NP O
175 FOR NNP I-NP O
175 MI/DEATH NNP I-NP O
176 DISCHARGE NNP I-NP O
176 CONDITION: NNP I-NP O
176 Stable NNP I-NP O
177 TO NNP I-NP O
177 DO/PLAN: NNP I-NP O
178 MIBI NNP I-NP O
178 as IN B-VP O
178 outpatient NN B-NP O
178 if IN B-VP O
178 pt JJ B-NP O
178 compliant NN I-NP O
179 No NNP I-NP O
179 dictated VBD B-VP O
179 summary JJ B-NP O
180 ENTERED NNP I-NP O
180 BY: NNP I-NP O
180 DUBOW NNP I-NP O
180 , , O O
180 ALVARO NNP B-NP O
180 G NNP I-NP O
180 , , O O
180 P.A.-C NNP B-NP O
180 ( ( O O
180 NM87 NNP B-NP O
180 ) ) O O
180 7/10/07 CD O O
180 @ $ O O
180 09:46 CD O O
180 AM NNP B-NP O
181 ****** JJ B-NP O
181 END NN I-NP O
181 OF NNP I-NP O
181 DISCHARGE NNP I-NP O
181 ORDERS NNP I-NP O
181 ****** NNP I-NP O
182 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #158995 VBZ O O
2 694173251 CD O O
2 PEMH NNP B-NP O
2 39011682 CD O O
2 572341 CD O O
2 9/19/1992 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 8/25/1992 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/19/1992 CD O O
4 DISCHARGE NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 1 CD O O
4 ) ) O O
4 DEGENERATIVE NNPS B-NP O
4 JOINT NNP I-NP O
4 DISEASE NNP I-NP O
4 , , O O
4 RIGHT NNP B-NP O
4 ANKLE NNP I-NP O
5 ( ( O O
5 RIGHT NNP B-NP O
5 TIBIOTALAR NNP I-NP O
5 JOINT NNP I-NP O
5 ) ) O O
5 SECONDARY NNP B-NP O
5 TO NNP I-NP O
6 TRAUMATIC NNP I-NP O
6 ARTHRITIS NNP I-NP O
7 2 CD O O
7 ) ) O O
7 INSULIN NNP B-NP O
7 DEPENDENT NNP I-NP O
7 DIABETES NNP I-NP O
8 3 CD O O
8 ) ) O O
8 HYPERTENSION NNP B-NP O
9 OPERATIONS NNP I-NP O
9 AND NNP I-NP O
9 PROCEDURES: NNP I-NP O
9 Tibiotalar NNP I-NP O
9 fusion NN I-NP O
9 with IN B-VP O
9 cross-cannulated JJ B-NP O
10 AO NNP I-NP O
10 screws NN I-NP O
10 times NNS I-NP O
10 three CD O O
10 and CC O O
10 local JJ B-NP O
10 bone NN I-NP O
11 graft NN I-NP O
11 performed VBD B-VP O
11 3/12/92 CD O O
11 by IN B-VP O
11 Dr NNP B-NP O
11 Tim NNP I-NP O
11 Fajen NNP I-NP O
12 HISTORY NNP I-NP O
12 OF NNP I-NP O
12 PRESENT NNP I-NP O
12 ILLNESS: NNP I-NP O
12 This DT O O
12 44 CD O O
12 year NN B-NP O
12 old JJ B-NP O
12 Phys NNP I-NP O
12 Ed NNP I-NP O
12 teacher NN I-NP O
12 had VBD B-VP O
13 a DT B-NP O
13 long JJ I-NP O
13 history NN I-NP O
13 of IN B-VP O
13 ankle NN B-NP O
13 pain NN I-NP O
13 on IN B-VP O
13 the DT B-NP O
14 right JJ I-NP O
14 side NN I-NP O
14 He PRP O O
14 had VBD B-VP O
14 a DT B-NP O
14 fracture NN I-NP O
14 as IN B-VP O
14 a DT B-NP O
14 child NN I-NP O
14 which WDT O O
14 was VBD B-VP O
14 fixed VBN O O
14 with IN B-VP O
14 an DT B-NP O
15 open JJ I-NP O
15 reduction NN I-NP O
15 and CC O O
15 internal JJ B-NP O
15 fixation NN I-NP O
15 He PRP O O
15 sustained VBD B-VP O
15 a DT B-NP O
15 second JJ I-NP O
15 ankle NN I-NP O
16 fracture NN I-NP O
16 a DT B-NP O
16 number NN I-NP O
16 of IN B-VP O
16 years NNS B-NP O
16 later RB O O
16 when WRB O O
16 he PRP O O
16 fell VBD B-VP O
16 off RP O O
16 a DT B-NP O
16 ladder NN I-NP O
16 and CC O O
17 refractured VBD B-VP O
17 his PRP$ O O
17 ankle NN B-NP O
17 Currently RB O O
17 , , O O
17 he PRP O O
17 has VBZ O O
17 pain VBN O O
17 on IN B-VP O
17 all DT B-NP O
17 movements NNS I-NP O
17 of IN B-VP O
18 the DT B-NP O
18 ankle NN I-NP O
18 while IN B-VP O
18 walking VBG O O
18 and CC O O
18 performing VBG O O
18 any DT B-NP O
18 activity NN I-NP O
18 The DT B-NP O
18 pain NN I-NP O
18 is VBZ O O
19 primarily RB O O
19 in IN B-VP O
19 the DT B-NP O
19 ankle JJ I-NP O
19 joint NN I-NP O
19 but CC O O
19 also RB O O
19 in IN B-VP O
19 his PRP$ O O
19 mid JJ B-NP O
19 foot NN I-NP O
19 He PRP O O
19 has VBZ O O
19 been VBN O O
20 controlling VBG O O
20 his PRP$ O B-r
20 his PRP$ O B-r
20 pain NN B-NP I-r
20 pain NN I-NP I-r
20 with IN B-VP O
20 Darvocet NNP B-NP B-m
20 as RB O O
20 well RB O O
20 as IN B-VP O
20 intramuscular JJ B-NP B-mo
20 Tordal NNP I-NP B-m
21 15 CD O B-do
21 to TO O I-do
21 30 CD O I-do
21 mg NNS B-NP I-do
21 four CD O B-f
21 times NNS B-NP I-f
21 a DT B-NP I-f
21 day NN I-NP I-f
21 He PRP O O
21 denies VBZ O O
21 any DT B-NP O
21 other JJ I-NP O
21 joint JJ I-NP O
22 involvement NN I-NP O
22 and CC O O
22 he PRP O O
22 denies VBZ O O
22 any DT B-NP O
22 motor NN I-NP O
22 or CC O O
22 sensory JJ B-NP O
22 changes NNS I-NP O
22 PAST NNP I-NP O
23 MEDICAL NNP I-NP O
23 HISTORY: NNP I-NP O
23 Significant NNP I-NP O
23 for IN B-VP O
23 Insulin NNP B-NP B-r
23 dependent JJ B-NP I-r
23 diabetes NNS I-NP I-r
24 currently RB O O
24 managed VBN O O
24 with IN B-VP O
24 32 CD O B-do
24 units NNS B-NP I-do
24 of IN B-VP O
24 NPH NNP B-NP B-m
24 Humulin NNP I-NP I-m
24 He PRP O O
24 also RB O O
24 has VBZ O O
24 a DT B-NP O
25 history NN I-NP O
25 significant JJ O O
25 for IN B-VP O
25 hypertension NN B-NP O
25 He PRP O O
25 denies VBZ O O
25 bowel NN B-NP O
25 or CC O O
25 bladder NN B-NP O
26 dysfunction NN I-NP O
26 , , O O
26 he PRP O O
26 denies VBZ O O
26 coronary JJ B-NP O
26 artery NN I-NP O
26 disease NN I-NP O
26 , , O O
26 dysrrhythmia NN B-NP O
26 , , O O
26 or CC O O
27 murmur NN B-NP O
27 , , O O
27 he PRP O O
27 denies VBZ O O
27 peptic JJ B-NP O
27 ulcer JJ I-NP O
27 disease NN I-NP O
27 , , O O
27 and CC O O
27 he PRP O O
27 denies VBZ O O
27 thyroid JJ B-NP O
27 gland NN I-NP O
28 abnormality NN I-NP O
28 PAST NNP I-NP O
28 SURGICAL NNP I-NP O
28 HISTORY: NNP I-NP O
28 Significant NNP I-NP O
28 for IN B-VP O
28 fracture NN B-NP O
29 times NNS I-NP O
29 two CD O O
29 of IN B-VP O
29 his PRP$ O O
29 right JJ B-NP O
29 ankle NN I-NP O
29 status NN I-NP O
29 post NN I-NP O
29 open JJ B-NP O
29 reduction NN I-NP O
29 and CC O O
30 internal JJ B-NP O
30 fixation NN I-NP O
30 first JJ B-NP O
30 time NN I-NP O
30 in IN B-VP O
30 1965 CD O O
30 and CC O O
30 second JJ B-NP O
30 time NN I-NP O
30 in IN B-VP O
30 1988 CD O O
30 , , O O
30 he PRP O O
31 had VBD B-VP O
31 herniorrhaphy NN B-NP O
31 in IN B-VP O
31 1978 CD O O
31 , , O O
31 he PRP O O
31 had VBD B-VP O
31 drainage NN B-NP O
31 of IN B-VP O
31 a DT B-NP O
31 right JJ I-NP O
31 thumb NN I-NP O
31 abscess NN I-NP O
32 in IN B-VP O
32 1988 CD O O
32 , , O O
32 and CC O O
32 he PRP O O
32 has VBZ O O
32 had VBN O O
32 septicemia VBN O O
32 treated VBN O O
32 at IN B-VP O
32 Vensperdon NNP B-NP O
32 Hospital NNP I-NP O
32 in IN B-VP O
33 February NNP B-NP O
33 and CC O O
33 July NNP B-NP O
33 of IN B-VP O
33 1991 CD O O
33 CURRENT NNP B-NP O
33 MEDICATIONS: NNP I-NP O
33 NPH NNP I-NP B-m
33 Insulin NNP I-NP I-m
34 32 CD O B-do
34 units NNS B-NP I-do
34 every DT B-NP B-f
34 morning NN I-NP I-f
34 , , O O
34 Procardia NNP B-NP B-m
34 XL NNP I-NP I-m
34 90 CD O B-do
34 mg NN B-NP I-do
34 q.a.m NN I-NP B-f
34 , , O O
34 Lotensin NNP B-NP B-m
34 40 CD O B-do
34 mg NN B-NP I-do
35 p.o NN I-NP B-mo
35 q.d NN I-NP B-f
35 , , O O
35 Lasix NNP B-NP B-m
35 40 CD O B-do
35 mg NN B-NP I-do
35 p.o NN I-NP B-mo
35 q.d NN I-NP B-f
35 , , O O
35 potassium NN B-NP B-m
35 supplement NN I-NP I-m
35 , , O O
35 and CC O O
35 then RB O O
36 Ketorolac NNP B-NP B-m
36 15-30 JJ B-NP B-do
36 mg NNS I-NP I-do
36 intramuscularly RB O B-mo
36 q.i.d RB O B-f
36 , , O O
36 and CC O O
36 Darvocet NNP B-NP B-m
36 N-100 NNP I-NP I-m
36 one CD O B-do
37 to TO O O
37 four CD O O
37 tablets NNS B-NP O
37 q.d RB O B-f
37 ALLERGIES: NNP B-NP O
37 He PRP O O
37 has VBZ O O
37 no DT O O
37 known VBN O O
37 drug NN B-NP O
37 allergies NNS I-NP O
38 He PRP O O
38 denies VBZ O O
38 smoking VBG O O
38 history NN B-NP O
38 and CC O O
38 he PRP O O
38 denies VBZ O O
38 ethanol JJ O O
38 abuse IN B-VP O
38 REVIEW NNP B-NP O
38 OF NNP I-NP O
39 SYSTEMS: NNP I-NP O
39 Negative NNP I-NP O
39 for IN B-VP O
39 dyspnea NN B-NP O
39 on IN B-VP O
39 exertion NN B-NP O
39 , , O O
39 shortness NN B-NP O
39 of IN B-VP O
39 breath NN B-NP O
39 , , O O
40 palpitations NNS B-NP O
40 , , O O
40 or CC O O
40 anginal JJ O O
40 like IN B-VP O
40 symptoms NNS B-NP O
40 He PRP O O
40 does VBZ O O
40 get VB O O
40 bilateral JJ B-NP O
40 leg NN I-NP O
41 edema NN I-NP O
41 He PRP O O
41 has VBZ O O
41 not RB O O
41 had VBN O O
41 any DT B-NP O
41 evidence NN I-NP O
41 of IN B-VP O
41 neuropathy JJ O O
41 , , O O
41 retinopathy JJ O O
41 , , O O
41 or CC O O
42 nephropathies NNS B-NP O
42 associated VBN O O
42 with IN B-VP O
42 his PRP$ O O
42 diabetes NNS B-NP O
43 PHYSICAL NNP I-NP O
43 EXAMINATION: NNP I-NP O
43 Well-developed VBD B-VP O
43 44 CD O O
43 year NN B-NP O
43 old JJ B-NP O
43 male NN I-NP O
43 who WP O O
43 appears VBZ O O
44 stated VBN O O
44 age NN B-NP O
44 HEENT: NNP I-NP O
44 Demonstrated NNP I-NP O
44 pupils VBZ O O
44 to TO O O
45 be VB O O
45 equal JJ O O
45 and CC O O
45 reactive JJ O O
45 , , O O
45 extraocular JJ B-NP O
45 muscles NNS I-NP O
45 intact JJ O O
45 , , O O
45 and CC O O
45 oropharynx NN B-NP O
46 was VBD B-VP O
46 clear JJ B-NP O
46 NECK: NNP I-NP O
46 Supple NNP I-NP O
46 with IN B-VP O
46 full JJ B-NP O
46 painless NN I-NP O
46 range NN I-NP O
46 of IN B-VP O
46 motion NN B-NP O
46 and CC O O
47 there EX O O
47 was VBD B-VP O
47 no DT B-NP O
47 goiter NN I-NP O
47 , , O O
47 adenopathy JJ O O
47 , , O O
47 or CC O O
47 jugular JJ B-NP O
47 venous JJ I-NP O
47 distention NN I-NP O
48 LUNGS: NNP I-NP O
48 Clear NNP I-NP O
48 to TO O O
48 auscultation VB O O
48 CARDIAC: NNP B-NP O
48 Demonstrated NNP I-NP O
48 a DT B-NP O
48 regular JJ I-NP O
49 rate NN I-NP O
49 and CC O O
49 rhythm NN B-NP O
49 without IN B-VP O
49 significant JJ B-NP O
49 murmur NN I-NP O
49 , , O O
49 rub NN B-NP O
49 , , O O
49 or CC O O
49 thrill VB O O
50 ABDOMEN: NNP B-NP O
50 Soft NNP I-NP O
50 , , O O
50 non-obese JJ O O
50 , , O O
50 and CC O O
50 non-tender NN B-NP O
50 without IN B-VP O
50 evidence NN B-NP O
50 of IN B-VP O
51 hepatosplenomegaly NN B-NP O
51 ORTHOPEDIC: NNP I-NP O
51 Demonstrated VBD B-VP O
51 that IN B-VP O
51 he PRP O O
51 had VBD B-VP O
52 approximately RB O O
52 10 CD O O
52 degrees NNS B-NP O
52 of IN B-VP O
52 dorsiflexion NN B-NP O
52 , , O O
52 10 CD O O
52 degrees NNS B-NP O
52 of IN B-VP O
52 plantar NN B-NP O
53 flexion NN I-NP O
53 with IN B-VP O
53 very RB O O
53 limited JJ B-NP O
53 subtalar JJ I-NP O
53 motion NN I-NP O
53 , , O O
53 good JJ B-NP O
53 mid NN I-NP O
53 foot NN I-NP O
53 motion NN I-NP O
53 but CC O O
54 with IN B-VP O
54 some DT B-NP O
54 pain NN I-NP O
54 on IN B-VP O
54 motion NN B-NP O
54 of IN B-VP O
54 the DT B-NP O
54 mid JJ I-NP O
54 foot NN I-NP O
54 There EX O O
54 was VBD B-VP O
54 pain NN B-NP O
54 during IN B-VP O
55 movement NN B-NP O
55 of IN B-VP O
55 his PRP$ O O
55 tibiotalar JJ B-NP O
55 joint NN I-NP O
55 Specifically RB O O
55 , , O O
55 there EX O O
55 was VBD B-VP O
55 little JJ B-NP O
56 pain NN I-NP O
56 with IN B-VP O
56 motion NN B-NP O
56 of IN B-VP O
56 the DT B-NP O
56 subtalar JJ I-NP O
56 joint NN I-NP O
56 or CC O O
56 the DT B-NP O
56 mid JJ I-NP O
56 foot NN I-NP O
56 He PRP O O
56 had VBD B-VP O
57 good JJ B-NP O
57 dorsalis NN I-NP O
57 pedis NN I-NP O
57 and CC O O
57 posterior JJ B-NP O
57 tibialis NN I-NP O
57 pulses NNS I-NP O
57 , , O O
57 he PRP O O
57 had VBD B-VP O
57 normal JJ B-NP O
58 sensation NN I-NP O
58 at IN B-VP O
58 the DT B-NP O
58 first JJ I-NP O
58 dorsal NN I-NP O
58 web NN I-NP O
58 space NN I-NP O
58 , , O O
58 dorsum NN B-NP O
58 , , O O
58 and CC O O
58 plantar NN B-NP O
59 aspects NNS I-NP O
59 of IN B-VP O
59 the DT B-NP O
59 foot NN I-NP O
59 , , O O
59 and CC O O
59 the DT B-NP O
59 hindfoot NN I-NP O
59 appeared VBD B-VP O
59 to TO O O
59 be VB O O
59 in IN B-VP O
59 neutral JJ B-NP O
60 position NN I-NP O
60 There EX O O
60 did VBD B-VP O
60 not RB O O
60 appear VB O O
60 to TO O O
60 be VB O O
60 any DT B-NP O
60 supination NN I-NP O
60 or CC O O
60 pronation NN B-NP O
61 deformities NNS I-NP O
61 He PRP O O
61 had VBD B-VP O
61 full JJ B-NP O
61 painless NN I-NP O
61 range NN I-NP O
61 of IN B-VP O
61 motion NN B-NP O
61 at IN B-VP O
61 the DT B-NP O
61 hip NN I-NP O
61 and CC O O
62 at IN B-VP O
62 the DT B-NP O
62 knee NN I-NP O
62 on IN B-VP O
62 the DT B-NP O
62 ipsilateral JJ I-NP O
62 side NN I-NP O
63 LABORATORY NNP I-NP O
63 EXAMINATION: NNP I-NP O
63 X-Rays NNP I-NP O
63 demonstrated VBD B-VP O
63 marked JJ B-NP O
63 degenerative JJ I-NP O
64 joint JJ I-NP O
64 disease NN I-NP O
64 with IN B-VP O
64 a DT B-NP O
64 complete JJ I-NP O
64 obliteration NN I-NP O
65 of IN B-VP O
65 the DT B-NP O
65 articular JJ I-NP O
65 joint JJ I-NP O
65 space NN I-NP O
65 in IN B-VP O
65 the DT B-NP O
65 lateral JJ I-NP O
65 half NN I-NP O
65 of IN B-VP O
65 the DT O O
65 joint JJ O O
66 There EX O O
66 were VBD B-VP O
66 also RB O O
66 some DT B-NP O
66 degenerative JJ I-NP O
66 changes NNS I-NP O
66 in IN B-VP O
66 the DT B-NP O
66 mid JJ I-NP O
66 foot NN I-NP O
66 His PRP$ O O
67 pre-operative JJ B-NP O
67 laboratory NN I-NP O
67 evaluation NN I-NP O
67 demonstrated VBD B-VP O
67 EKG NNP B-NP O
67 with IN B-VP O
67 normal JJ B-NP O
68 sinus NNS I-NP O
68 rhythm NN I-NP O
68 and CC O O
68 no DT B-NP O
68 evidence NN I-NP O
68 of IN B-VP O
68 ischemic JJ B-NP O
68 changes NNS I-NP O
68 , , O O
68 glucose NN B-NP O
68 was VBD B-VP O
68 133 CD O O
68 , , O O
69 BUN NNP B-NP O
69 was VBD B-VP O
69 35 CD O O
69 , , O O
69 creatinine NN B-NP O
69 1.2 CD O O
69 , , O O
69 potassium NN B-NP O
69 of IN B-VP O
69 4.2 CD O O
69 , , O O
69 liver JJR B-NP O
69 function NN I-NP O
69 tests NNS I-NP O
70 were VBD B-VP O
70 entirely RB O O
70 within IN B-VP O
70 normal JJ B-NP O
70 limits NNS I-NP O
70 , , O O
70 hematocrit NN B-NP O
70 was VBD B-VP O
70 42.8 CD O O
70 , , O O
70 white JJ B-NP O
71 blood NN I-NP O
71 cell NN I-NP O
71 count NN I-NP O
71 was VBD B-VP O
71 9 CD O O
71 , , O O
71 and CC O O
71 the DT B-NP O
71 PT NNP I-NP O
71 and CC O O
71 PTT NNP B-NP O
71 were VBD B-VP O
71 11.6 CD O O
71 and CC O O
71 28.2 CD O O
72 respectively RB O O
72 The DT B-NP O
72 patient's NN I-NP O
72 urinalysis NN I-NP O
72 was VBD B-VP O
72 entirely RB O O
72 clear JJ O O
72 for IN B-VP O
73 bacteria NNS B-NP O
73 and CC O O
73 negative JJ O O
73 for IN B-VP O
73 glucose NN B-NP O
73 and CC O O
73 ketones NNS B-NP O
74 HOSPITAL NNP I-NP O
74 COURSE: NNP I-NP O
74 The DT B-NP O
74 patient NN I-NP O
74 was VBD B-VP O
74 admitted VBN O O
74 as IN B-VP O
74 a DT B-NP O
74 same JJ I-NP O
74 day NN I-NP O
74 surgery NN I-NP O
75 candidate NN I-NP O
75 with IN B-VP O
75 traumatic JJ B-NP O
75 arthritis NN I-NP O
75 at IN B-VP O
75 the DT B-NP O
75 right JJ I-NP O
76 tibiotalar NN I-NP O
76 joint NN I-NP O
76 and CC O O
76 he PRP O O
76 underwent VBD B-VP O
76 tibiotalar JJ B-NP O
76 fusion NN I-NP O
76 with IN B-VP O
77 cross-cannulated JJ B-NP O
77 AO NNP I-NP O
77 screws NNS I-NP O
77 and CC O O
77 local JJ B-NP O
77 bone NN I-NP O
77 graft NN I-NP O
77 The DT B-NP O
77 procedure NN I-NP O
78 involved VBN O O
78 partial JJ B-NP O
78 fibulectomy NN I-NP O
78 as RB O O
78 well RB O O
78 as IN B-VP O
78 a DT B-NP O
78 partial JJ I-NP O
78 osteotomy NN I-NP O
78 of IN B-VP O
78 the DT B-NP O
79 medial JJ I-NP O
79 malleolus NN I-NP O
79 The DT B-NP O
79 position NN I-NP O
79 of IN B-VP O
79 the DT B-NP O
79 ankle NN I-NP O
79 at IN B-VP O
79 the DT B-NP O
79 end NN I-NP O
79 of IN B-VP O
79 the DT B-NP O
80 procedure NN I-NP O
80 was VBD B-VP O
80 neutral JJ B-NP O
80 dorsiflexion NN I-NP O
80 , , O O
80 plantar NN B-NP O
80 flexion NN I-NP O
80 , , O O
80 and CC O O
80 neutral JJ B-NP O
81 varus/valgus NN I-NP O
81 He PRP O O
81 had VBD B-VP O
81 a DT B-NP O
81 general JJ I-NP O
81 endotracheal NN I-NP O
81 anesthetic JJ O O
81 for IN B-VP O
81 failed JJ B-NP O
82 sciatic JJ I-NP O
82 nerve NN I-NP O
82 block NN I-NP O
82 , , O O
82 estimated VBN O O
82 blood NN B-NP O
82 loss NN I-NP O
82 was VBD B-VP O
82 200 CD O O
82 cc NN B-NP O
82 , , O O
82 and CC O O
82 total JJ B-NP O
83 tourniquet NN I-NP O
83 time NN I-NP O
83 was VBD B-VP O
83 1 CD O O
83 hour NN B-NP O
83 and CC O O
83 57 CD O O
83 minutes NNS B-NP O
83 He PRP O O
83 received VBD B-VP O
83 2500 CD O B-do
83 cc NN B-NP I-do
83 of IN B-VP O
84 crystalloid NN B-NP B-m
84 intraoperatively RB O O
84 and CC O O
84 he PRP O O
84 tolerated VBD B-VP O
84 the DT B-NP O
84 procedure NN I-NP O
84 well RB O O
85 Post-operatively RB O O
85 , , O O
85 his PRP$ O O
85 motor NN B-NP O
85 and CC O O
85 sensory JJ B-NP O
85 examinations NNS I-NP O
85 were VBD B-VP O
85 intact JJ O O
86 with IN B-VP O
86 regard NN B-NP O
86 to TO O O
86 deep VB O O
86 and CC O O
86 superficial JJ B-NP O
86 peroneal NN I-NP O
86 and CC O O
86 posterior JJ B-NP O
86 tibialis NN I-NP O
87 nerves NNS I-NP O
87 His PRP$ O O
87 Hemovac NNP B-NP O
87 put VBD B-VP O
87 out RP O O
87 a DT B-NP O
87 total NN I-NP O
87 of IN B-VP O
87 150 CD O O
87 cc NN B-NP O
87 and CC O O
87 was VBD B-VP O
87 removed VBN O O
87 on IN B-VP O
88 post-operative JJ B-NP O
88 day NN I-NP O
88 number NN I-NP O
88 one CD O O
88 He PRP O O
88 initially RB O O
88 was VBD B-VP O
88 kept VBN O O
88 in IN B-VP O
88 a DT B-NP O
89 posterior JJ I-NP O
89 splint NN I-NP O
89 with IN B-VP O
89 anterior JJ B-NP O
89 wings NNS I-NP O
89 This DT O O
89 was VBD B-VP O
89 changed VBN O O
89 on IN B-VP O
90 post-operative JJ B-NP O
90 day NN I-NP O
90 two CD O O
90 The DT B-NP O
90 wound NN I-NP O
90 appeared VBD B-VP O
90 to TO O O
90 be VB O O
90 clean JJ O O
90 and CC O O
90 dry JJ O O
90 and CC O O
91 he PRP O O
91 was VBD B-VP O
91 placed VBN O O
91 in IN B-VP O
91 a DT B-NP O
91 short-leg JJ I-NP O
91 fiberglass NN I-NP O
91 cast NN I-NP O
91 since IN B-VP O
91 there EX O O
91 was VBD B-VP O
91 little JJ B-NP O
92 swelling JJ I-NP O
92 apparent NN I-NP O
92 He PRP O O
92 had VBD B-VP O
92 an DT O O
92 X-Ray JJ O O
92 after IN B-VP O
92 placement NN B-NP O
92 of IN B-VP O
92 the DT B-NP O
92 cast NN I-NP O
92 and CC O O
93 the DT B-NP O
93 position NN I-NP O
93 of IN B-VP O
93 the DT B-NP O
93 ankle NN I-NP O
93 looked VBD B-VP O
93 to TO O O
93 be VB O O
93 in IN B-VP O
93 neutral JJ B-NP O
93 position NN I-NP O
93 and CC O O
94 neutral JJ B-NP O
94 varus/valgus NN I-NP O
94 He PRP O O
94 was VBD B-VP O
94 cleared VBN O O
94 by IN B-VP O
94 Physical NNP B-NP O
94 Therapy NNP I-NP O
95 ambulatory NN I-NP O
95 , , O O
95 non-weight JJ B-NP O
95 bearing NN I-NP O
95 , , O O
95 with IN B-VP O
95 use NN B-NP O
95 of IN B-VP O
95 crutches NNS B-NP O
95 He PRP O O
95 did VBD B-VP O
95 not RB O O
96 have VB O O
96 any DT B-NP O
96 difficulties NNS I-NP O
96 with IN B-VP O
96 the DT B-NP O
96 cast NN I-NP O
96 , , O O
96 no DT B-NP O
96 significant JJ I-NP O
96 swelling NN I-NP O
96 , , O O
96 and CC O O
97 was VBD B-VP O
97 discharged VBN O O
97 on IN B-VP O
97 post-operative JJ B-NP O
97 day NN I-NP O
97 three CD O O
97 The DT B-NP O
97 patient NN I-NP O
97 did VBD B-VP O
97 have VB O O
98 some DT O O
98 elevated VBN O O
98 temperatures NNS B-NP O
98 which WDT O O
98 were VBD B-VP O
98 attributed VBN O O
98 to TO O O
98 atelectasis NN B-NP O
98 and CC O O
99 was VBD B-VP O
99 encouraged VBN O O
99 to TO O O
99 cough VB O O
99 and CC O O
99 deep JJ B-NP O
99 breath NN I-NP O
100 DISPOSITION: NNP I-NP O
100 Patient NNP I-NP O
100 will MD O O
100 follow-up VB O O
100 with IN B-VP O
100 Dr NNP B-NP O
100 Norman NNP I-NP O
100 Dutko NNP I-NP O
100 in IN B-VP O
101 approximately RB O O
101 three CD O O
101 weeks NNS B-NP O
101 at IN B-VP O
101 which WDT O O
101 time NN B-NP O
101 the DT B-NP O
101 cast NN I-NP O
101 will MD O O
102 be VB O O
102 changed VBN O O
102 and CC O O
102 stitches NNS B-NP O
102 removed VBD B-VP O
102 DISCHARGE NNP B-NP O
102 MEDICATIONS: NNP I-NP O
102 The DT B-NP O
103 medications NNS I-NP O
103 that IN B-VP O
103 he PRP O O
103 was VBD B-VP O
103 admitted VBN O O
103 on IN B-VP O
103 with IN B-VP O
103 the DT B-NP O
103 addition NN I-NP O
103 of IN B-VP O
103 Vicodan NNP B-NP B-m
104 one CD O B-do
104 to TO O I-do
104 two CD O I-do
104 p.o NNS B-NP B-mo
104 q.3-4h JJ B-NP B-f
104 p.r.n NN I-NP I-f
104 , , O O
104 Naprosyn NNP B-NP B-m
104 500 CD O B-do
104 mg NN B-NP I-do
104 p.o NN I-NP B-mo
104 b.i.d NN I-NP B-f
104 as IN B-VP O
104 a DT B-NP O
105 substitute NN I-NP O
105 for IN B-VP O
105 the DT B-NP O
105 Tordal NNP I-NP B-m
105 , , O O
105 and CC O O
105 Halcion NNP B-NP B-m
105 0.125 CD O B-do
105 to TO O I-do
105 0.25 CD O I-do
105 mg NNS B-NP I-do
105 p.o JJ B-NP B-mo
105 q.h.s JJ I-NP B-f
106 p.r.n NN I-NP O
107 AS273/4278 NNP I-NP O
108 ISSAC NNP I-NP O
108 B NNP I-NP O
108 CHEAIRS NNP I-NP O
108 , , O O
108 M.D NNP B-NP O
108 VB69 NNP I-NP O
108 D: NNP I-NP O
108 0/14/92 CD O O
109 Batch: NNP B-NP O
109 2482 CD O O
109 Report: NNP B-NP O
109 O7557E8 NNP I-NP O
109 T: NNP I-NP O
109 6/2/92 CD O O
110 Dictated NNP B-NP O
110 By: NNP I-NP O
111 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #159637 VBZ O O
4 331676950 CD O O
4 GMC NNP B-NP O
4 88209373 CD O O
4 4083911 CD O O
4 4/28/2003 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 non-ischemic JJ B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/22/2003 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/4/2003 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 DISERENS NNP I-NP O
8 , , O O
8 JR NNP B-NP O
8 , , O O
8 GAYLE NNP B-NP O
8 034-41-95-4 CD O O
9 S NNP B-NP O
9 Mode NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 4/28/03 CD O O
11 AT NNP B-NP O
11 03:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 SCHMELZER NNP I-NP O
14 , , O O
14 ALLAN NNP B-NP O
14 RODOLFO NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ECASA NNP I-NP B-m
19 ( ( O I-m
19 ASPIRIN NNP B-NP I-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 ) ) O I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Starting VBG O O
20 Today NNP B-NP O
20 ( ( O O
20 0/12 CD O O
20 ) ) O O
21 FOLIC NNP B-NP B-m
21 ACID NNP I-NP I-m
21 1 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 ATIVAN NNP I-NP B-m
22 ( ( O I-m
22 LORAZEPAM NNP B-NP I-m
22 ) ) O I-m
22 1 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QHS NNP I-NP B-f
23 NITROGLYCERIN NNP I-NP B-m
23 1/150 CD O I-m
23 ( ( O I-m
23 0.4 CD O I-m
23 MG NNP B-NP I-m
23 ) ) O I-m
23 1 CD O B-do
23 TAB NNP B-NP I-do
23 SL NNP I-NP B-mo
23 q5min VBD B-VP B-f
23 x $ O O
23 3 CD O O
24 PRN NNP B-NP O
24 chest NN I-NP B-r
24 pain NN I-NP I-r
25 DARVOCET NNP I-NP B-m
25 N NNP I-NP I-m
25 100 CD O I-m
25 ( ( O I-m
25 PROPOXYPHENE NNP B-NP I-m
25 NAP./ACETAMINOPHEN NNP I-NP I-m
25 ) ) O I-m
26 1 CD O B-do
26 TAB NNP B-NP I-do
26 PO NNP I-NP B-mo
26 Q4H NNP I-NP B-f
26 PRN NNP I-NP I-f
26 Pain NNP I-NP B-r
27 ZOCOR NNP I-NP B-m
27 ( ( O I-m
27 SIMVASTATIN NNP B-NP I-m
27 ) ) O I-m
27 80 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QHS NNP I-NP B-f
28 Food/Drug NNP I-NP O
28 Interaction NNP I-NP O
28 Instruction NNP I-NP O
29 Avoid NNP I-NP O
29 grapefruit NN I-NP O
29 unless IN B-VP O
29 MD NNP B-NP O
29 instructs NNS I-NP O
29 otherwise RB O O
30 NORVASC NNP B-NP B-m
30 ( ( O I-m
30 AMLODIPINE NNP B-NP I-m
30 ) ) O I-m
30 2.5 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 BID NNP I-NP B-f
31 Food/Drug NNP I-NP O
31 Interaction NNP I-NP O
31 Instruction NNP I-NP O
32 Avoid NNP I-NP O
32 grapefruit NN I-NP O
32 unless IN B-VP O
32 MD NNP B-NP O
32 instructs NNS I-NP O
32 otherwise RB O O
33 TOPROL NNP B-NP B-m
33 XL NNP I-NP I-m
33 ( ( O I-m
33 METOPROLOL NNP B-NP I-m
33 ( ( O I-m
33 SUST NNP B-NP I-m
33 REL NNP I-NP I-m
33 ) ) O I-m
33 ) ) O I-m
33 50 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
34 Food/Drug NNP I-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Take NNP I-NP O
35 consistently RB O O
35 with IN B-VP O
35 meals NNS B-NP O
35 or CC O O
35 on IN B-VP O
35 empty JJ B-NP O
35 stomach NN I-NP O
36 Number NNP I-NP B-du
36 of IN B-VP I-du
36 Doses NNP B-NP I-du
36 Required NNP I-NP I-du
36 ( ( O I-du
36 approximate JJ B-NP I-du
36 ): NN I-NP I-du
36 3 CD O I-du
37 ALTACE NNP B-NP B-m
37 ( ( O I-m
37 RAMIPRIL NNP B-NP I-m
37 ) ) O I-m
37 2.5 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 Override NNP I-NP O
38 Notice: NNP I-NP O
38 Override NNP I-NP O
38 added VBD B-VP O
38 on IN B-VP O
38 4/28/03 CD O O
38 by IN B-VP O
38 RAMSDEN NNP B-NP O
38 , , O O
38 SAL NNP B-NP O
38 I PRP O O
38 MICHEAL NNP B-NP O
38 , , O O
38 M.D NNP B-NP O
39 on IN B-VP O
39 order NN B-NP O
39 for IN B-VP O
39 POTASSIUM NNP B-NP B-m
39 CHLORIDE NNP I-NP I-m
39 IV NNP I-NP B-mo
39 ( ( O O
39 ref JJ O O
39 # # O O
39 68076838 CD O O
39 ) ) O O
40 POTENTIALLY NNP B-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 RAMIPRIL NNP I-NP B-m
40 &amp; NNP I-NP O
40 POTASSIUM NNP I-NP B-m
41 CHLORIDE NNP I-NP O
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
41 md NN I-NP O
41 aware JJ B-NP O
42 Previous NNP I-NP O
42 override NN I-NP O
42 information: NN I-NP O
43 Override NNP I-NP O
43 added VBD B-VP O
43 on IN B-VP O
43 4/28/03 CD O O
43 by IN B-VP O
43 SCHWINGEL NNP B-NP O
43 , , O O
43 WALLY NNP B-NP O
43 PRINCE NNP I-NP O
43 , , O O
43 M.D NNP B-NP O
44 on IN B-VP O
44 order NN B-NP O
44 for IN B-VP O
44 POTASSIUM NNP B-NP B-m
44 CHLORIDE NNP I-NP I-m
44 IMMED NNP I-NP I-m
44 REL NNP I-NP I-m
44 PO NNP I-NP B-mo
44 ( ( O O
44 ref JJ O O
44 # # O O
45 59620667 CD O O
45 ) ) O O
46 POTENTIALLY NNP B-NP O
46 SERIOUS NNP I-NP O
46 INTERACTION: NNP I-NP O
46 RAMIPRIL NNP I-NP B-m
46 &amp; NNP I-NP O
46 POTASSIUM NNP I-NP B-m
47 CHLORIDE NNP I-NP O
47 Reason NNP I-NP O
47 for IN B-VP O
47 override: NN B-NP O
47 md NN I-NP O
47 awaer VBP O O
48 Previous NNP B-NP O
48 override IN B-VP O
48 information: JJ B-NP O
49 Override NNP I-NP O
49 added VBD B-VP O
49 on IN B-VP O
49 8/18/03 CD O O
49 by IN B-VP O
49 GOUGIS NNP B-NP O
49 , , O O
49 BLAKE NNP B-NP O
49 B NNP I-NP O
49 , , O O
49 M.D NNP B-NP O
50 POTENTIALLY NNP I-NP O
50 SERIOUS NNP I-NP O
50 INTERACTION: NNP I-NP O
50 POTASSIUM NNP I-NP B-m
50 CHLORIDE NNP I-NP I-m
50 &amp; NNP I-NP O
51 RAMIPRIL NNP I-NP B-m
52 POTENTIALLY NNP I-NP O
52 SERIOUS NNP I-NP O
52 INTERACTION: NNP I-NP O
52 POTASSIUM NNP I-NP B-m
52 CHLORIDE NNP I-NP I-m
52 &amp; NNP I-NP O
53 RAMIPRIL NNP I-NP B-m
53 Reason NNP I-NP O
53 for IN B-VP O
53 override: NN B-NP O
53 aware JJ O O
53 and CC O O
53 monitoring NN B-NP O
54 CLOPIDOGREL NNP I-NP B-m
54 75 CD O B-do
54 MG NNP B-NP I-do
54 PO NNP I-NP B-mo
54 QD NNP I-NP B-f
55 VIOXX NNP I-NP B-m
55 ( ( O I-m
55 ROFECOXIB NNP B-NP I-m
55 ) ) O I-m
55 25 CD O B-do
55 MG NNP B-NP I-do
55 PO NNP I-NP B-mo
55 BID NNP I-NP B-f
56 Food/Drug NNP I-NP O
56 Interaction NNP I-NP O
56 Instruction NNP I-NP O
56 Take NNP I-NP O
56 with IN B-VP O
56 food NN B-NP O
57 PROTONIX NNP I-NP B-m
57 ( ( O I-m
57 PANTOPRAZOLE NNP B-NP I-m
57 ) ) O I-m
57 40 CD O B-do
57 MG NNP B-NP I-do
57 PO NNP I-NP B-mo
57 QD NNP I-NP B-f
58 DIET: NNP I-NP O
58 House NNP I-NP O
58 / VBD B-VP O
58 Low NNP B-NP O
58 chol/low NN I-NP O
58 sat VBD B-VP O
58 fat JJ B-NP O
59 ACTIVITY: NNP I-NP O
59 Resume NNP I-NP O
59 regular JJ B-NP O
59 exercise NN I-NP O
60 FOLLOW NNP I-NP O
60 UP NNP I-NP O
60 APPOINTMENT( NNP I-NP O
60 S NNP I-NP O
60 ): NNP I-NP O
61 Dr NNP I-NP O
61 Damon NNP I-NP O
61 Krzeczkowski NNP I-NP O
61 , , O O
61 229-213-3224 JJ O O
61 , , O O
61 in IN B-VP O
61 about RB O O
61 1 CD O O
61 week NN B-NP O
61 1 CD O O
61 week NN B-NP O
61 , , O O
62 Dr NNP B-NP O
62 Lon NNP I-NP O
62 Willims NNP I-NP O
62 , , O O
62 792-273-6290 JJ O O
62 , , O O
62 in IN B-VP O
62 about RB O O
62 4 CD O O
62 weeks NNS B-NP O
62 4 CD O O
62 weeks NNS B-NP O
62 , , O O
63 ALLERGY: NNP B-NP O
63 Atarax NNP I-NP O
63 ( ( O O
63 hydroxyzine JJ B-NP O
63 hcl NN I-NP O
63 ) ) O O
63 , , O O
63 Sulfa NNP B-NP O
64 ADMIT NNP I-NP O
64 DIAGNOSIS: NNP I-NP O
65 chest JJS B-NP O
65 pain NN I-NP O
66 PRINCIPAL NNP I-NP O
66 DISCHARGE NNP I-NP O
66 DIAGNOSIS NNP I-NP O
66 ;Responsible JJ O O
66 After IN B-VP O
66 Study NNP B-NP O
66 for IN B-VP O
66 Causing NNP B-NP O
66 Admission NNP I-NP O
66 ) ) O O
67 non-ischemic JJ B-NP O
67 chest NN I-NP O
67 pain NN I-NP O
68 OTHER NNP I-NP O
68 DIAGNOSIS;Conditions NNP I-NP O
68 , , O O
68 Infections NNP B-NP O
68 , , O O
68 Complications NNP B-NP O
68 , , O O
68 affecting VBG O O
68 Treatment/Stay NNP B-NP O
69 HTN NNP I-NP O
69 , , O O
69 CAD NNP B-NP O
69 , , O O
69 high JJ B-NP O
69 cholesterol NN I-NP O
69 , , O O
69 OSA NNP B-NP O
69 , , O O
69 OA NNP B-NP O
69 , , O O
69 depression NN B-NP O
69 , , O O
69 anxiety NN B-NP O
70 OPERATIONS NNP I-NP O
70 AND NNP I-NP O
70 PROCEDURES: NNP I-NP O
71 OTHER NNP I-NP O
71 TREATMENTS/PROCEDURES NNP I-NP O
71 ( ( O O
71 NOT NNP B-NP O
71 IN NNP I-NP O
71 O.R NNP I-NP O
71 ) ) O O
72 exercise NN B-NP O
72 tolerance NN I-NP O
72 test NN I-NP O
73 BRIEF NNP I-NP O
73 RESUME NNP I-NP O
73 OF NNP I-NP O
73 HOSPITAL NNP I-NP O
73 COURSE: NNP I-NP O
74 45 CD O O
74 yo NN B-NP O
74 M NNP I-NP O
74 with IN B-VP O
74 multiple JJ B-NP O
74 cardiac JJ I-NP O
74 risk NN I-NP O
74 factors NNS I-NP O
74 , , O O
75 including VBG O O
75 known VBN O O
75 CAD NNP B-NP O
75 s/p NN I-NP O
75 MI NNP I-NP O
75 ( ( O O
75 4/14 CD O O
75 with IN B-VP O
75 PCI NNP B-NP O
75 to TO O O
75 LAD NNP B-NP O
75 , , O O
75 complicated VBN O O
75 by IN B-VP O
76 instent JJ B-NP O
76 thrombosis NN I-NP O
76 1 CD O O
76 week NN B-NP O
76 post-cath-&gt;successfully RB O O
76 restented VBN O O
76 ) ) O O
76 , , O O
77 HTN NNP B-NP O
77 , , O O
77 dyslipidemia NN B-NP O
77 , , O O
77 obesity NN B-NP O
77 , , O O
77 and CC O O
77 positive JJ B-NP O
77 FHx NNP I-NP O
78 presents NNS I-NP O
78 with IN B-VP O
78 acute JJ B-NP O
78 onset NN I-NP O
78 of IN B-VP O
78 chest NN B-NP O
78 pain NN I-NP O
78 The DT B-NP O
78 patient NN I-NP O
79 has VBZ O O
79 had VBN O O
79 several JJ B-NP O
79 episodes/admissions NNS I-NP O
79 for IN B-VP O
79 recurrent NN B-NP O
80 c/p NN I-NP O
80 since IN B-VP O
80 then RB O O
80 with IN B-VP O
80 caths NNS B-NP O
80 consistently RB O O
81 demonstrating VBG O O
81 non-significant JJ B-NP O
81 disease NN I-NP O
81 Last JJ B-NP O
81 cath NN I-NP O
81 in IN B-VP O
81 8/24 CD O O
82 showed VBD B-VP O
82 R NNP B-NP O
82 dominant JJ B-NP O
82 system NN I-NP O
82 with IN B-VP O
82 30% CD O O
82 proximal JJ B-NP O
82 LAD NNP I-NP O
82 lesion NN I-NP O
83 ETT-MIBI NNP I-NP O
83 in IN B-VP O
83 5/12 CD O O
83 ( ( O O
83 9:30 CD O O
83 , , O O
83 5.2 CD O O
83 METS NNP B-NP O
83 , , O O
83 HR NNP B-NP O
83 153 CD O O
83 , , O O
83 BP NNP B-NP O
83 130/80 CD O O
83 , , O O
83 was VBD B-VP O
83 non-ischemic JJ O O
84 but CC O O
84 terminated VBD B-VP O
84 2/2 CD O O
84 fatigue NN B-NP O
84 ) ) O O
84 showed VBD B-VP O
84 large JJ B-NP O
84 fixed JJ I-NP O
84 defect NN I-NP O
84 in IN B-VP O
85 anterior JJ O O
85 , , O O
85 anteroseptal JJ O O
85 , , O O
85 anterolateral JJ O O
85 , , O O
85 inferior JJ O O
85 , , O O
85 LV NNP B-NP O
86 apex VBZ O O
86 with IN B-VP O
86 EF NNP B-NP O
86 of IN B-VP O
86 35% CD O O
86 Seen JJ O O
86 11/1 CD O O
86 at IN B-VP O
86 GH NNP B-NP O
86 for IN B-VP O
87 syncope NN B-NP O
87 , , O O
87 dx NN B-NP O
87 with IN B-VP O
87 VT NNP B-NP O
87 and CC O O
87 had VBD B-VP O
87 AICD NNP B-NP O
88 placed VBN O O
89 On IN B-VP O
89 this DT B-NP O
89 occasion NN I-NP O
90 he PRP O O
90 noted VBD B-VP O
90 sudden JJ B-NP O
90 onset NN I-NP O
90 of IN B-VP O
90 8/10 CD O O
90 chest JJS B-NP O
90 pain NN I-NP O
90 while IN B-VP O
91 at IN B-VP O
91 rest NN B-NP O
91 at IN B-VP O
91 6:30 CD O O
91 pm NN B-NP O
91 on IN B-VP O
91 the DT B-NP O
91 evening NN I-NP O
91 of IN B-VP O
91 admission NN B-NP O
92 The DT B-NP O
92 pain NN I-NP O
92 was VBD B-VP O
92 sharp/stabbing VBG O O
92 and CC O O
92 was VBD B-VP O
92 bilateral JJ O O
93 with IN B-VP O
93 radiation NN B-NP O
93 to TO O O
93 the DT B-NP O
93 L NNP I-NP O
93 arm NN I-NP O
93 He PRP O O
93 also RB O O
93 had VBD B-VP O
94 diaphoresis NN B-NP O
94 , , O O
94 SOB NNP B-NP O
94 , , O O
94 and CC O O
94 nausea NN B-NP O
94 but CC O O
94 denies VBZ O O
94 vomitting VBG O O
94 , , O O
94 F/C NNP B-NP O
94 , , O O
95 LH NNP B-NP O
95 , , O O
95 dizziness NN B-NP O
95 He PRP O O
95 took VBD B-VP O
95 1 CD O B-do
95 TNG NNP B-NP B-m
95 SL NNP I-NP B-mo
95 with IN B-VP O
95 some DT B-NP O
95 relief NN I-NP O
96 EMS NNP I-NP O
96 transported VBD B-VP O
96 to TO O O
96 Greena NNP B-NP O
96 Hospital NNP I-NP O
96 where WRB O O
96 his PRP$ O O
96 vitals NNS B-NP O
96 were VBD B-VP O
96 98.2 CD O O
96 , , O O
96 73 CD O O
96 , , O O
96 92/62 CD O O
96 , , O O
97 15 CD O O
97 Rec'd NNP B-NP O
97 IV NNP I-NP B-mo
97 TNG NNP I-NP B-m
97 , , O O
97 heparin NN B-NP B-m
97 , , O O
97 MSO4 NNP B-NP B-m
97 , , O O
97 ASA NNP B-NP B-m
97 with IN B-VP O
97 pain VBP O O
97 down IN B-VP O
97 to TO O O
97 4/10 CD O O
98 Transfered NNP B-NP O
98 to TO O O
98 ITH NNP B-NP O
98 A: NNP I-NP O
98 45 CD O O
98 yo NN B-NP O
98 M NNP I-NP O
98 with IN B-VP O
98 known VBN O O
98 CAD NNP B-NP O
98 s/p NN I-NP O
98 MI NNP I-NP O
98 in IN B-VP O
98 4/14 CD O O
98 , , O O
99 s/p FW O O
99 recent JJ B-NP O
99 ICD NNP I-NP O
99 placement NN I-NP O
99 for IN B-VP O
99 syncope/VT NN B-NP O
99 at IN B-VP O
99 BMC NNP B-NP O
99 , , O O
100 now RB O O
100 with IN B-VP O
100 his PRP$ O O
100 angina NN B-NP O
100 at IN B-VP O
100 rest NN B-NP O
100 Given VBN O O
100 non-oclusive JJ B-NP O
101 CAD NNP I-NP O
101 on IN B-VP O
101 multiple JJ B-NP O
101 recent JJ I-NP O
101 caths NNS I-NP O
101 ( ( O O
101 including VBG O O
101 2 CD O O
101 mos NN B-NP O
101 ago RB O O
102 at IN B-VP O
102 EHC NNP B-NP O
102 per IN B-VP O
102 patient NN B-NP O
102 ) ) O O
102 , , O O
102 likelihood NN B-NP O
102 of IN B-VP O
102 ischemia NN B-NP O
102 now RB O O
103 is VBZ O O
103 low JJ B-NP O
104 P: NNP I-NP O
104 CV: NNP I-NP O
104 Ischemia-r/o NNP I-NP O
104 MI NNP I-NP O
104 , , O O
104 asa NN B-NP B-m
104 , , O O
104 toprol NN B-NP B-m
104 , , O O
104 heparin NN B-NP B-m
104 , , O O
104 plavix NN B-NP B-m
104 , , O O
104 zocor NN B-NP B-m
104 Ruled VBD B-VP O
104 out RP O O
105 by IN B-VP O
105 ensymes NNS B-NP O
105 , , O O
105 ETT NNP B-NP O
105 was VBD B-VP O
105 non-ischemic JJ B-NP O
105 Pump-euvolemic NNP I-NP O
105 , , O O
105 no DT B-NP O
105 h/o NN I-NP O
105 CHF NNP I-NP O
106 Rhythm-has NNP I-NP O
106 AICD NNP I-NP O
106 , , O O
106 on IN B-VP O
106 tele NN B-NP O
106 , , O O
106 replete JJ B-NP O
106 lytes NNS I-NP O
107 GI: NNP I-NP O
107 has VBZ O O
107 lost VBN O O
107 40 CD O O
107 lbs NN B-NP O
107 on IN B-VP O
107 liquid NN B-NP O
107 diet NN I-NP O
107 , , O O
107 consider VB O O
107 nutrition NN B-NP O
107 consult NN I-NP O
107 as IN B-VP O
108 outpatient JJ B-NP O
109 CODE: NNP I-NP O
109 FULL NNP I-NP O
109 CODE NNP I-NP O
110 ADDITIONAL NNP I-NP O
110 COMMENTS: NNP I-NP O
110 Please NNP I-NP O
110 be VB O O
110 sure JJ O O
110 to TO O O
110 contact VB O O
110 Dr NNP B-NP O
110 Klussmann NNP I-NP O
110 ( ( O O
110 229-213-3224 JJ O O
110 ) ) O O
110 to TO O O
110 set VB O O
110 up RP O O
110 an DT B-NP O
111 appointment NN I-NP O
111 to TO O O
111 be VB O O
111 seen VBN O O
111 in IN B-VP O
111 about RB O O
111 1 CD O O
111 week NN B-NP O
111 Also RB O O
111 , , O O
111 be VB O O
111 sure JJ O O
111 to TO O O
111 set VB O O
111 up RP O O
111 an DT B-NP O
112 appointment NN I-NP O
112 to TO O O
112 see VB O O
112 Dr NNP B-NP O
112 Helfgott NNP I-NP O
112 ( ( O O
112 792-273-6290 JJ O O
112 ) ) O O
112 in IN B-VP O
112 about RB O O
112 4 CD O O
112 weeks NNS B-NP O
113 You PRP O O
113 should MD O O
113 contact VB O O
113 your PRP$ O O
113 doctor NN B-NP O
113 or CC O O
113 return NN B-NP O
113 to TO O O
113 the DT B-NP O
113 emergency NN I-NP O
113 room NN I-NP O
113 if IN B-VP O
113 you PRP O O
114 experience VBP O O
114 any DT O O
114 of IN B-VP O
114 the DT B-NP O
114 following JJ I-NP O
114 symptoms: NN I-NP O
114 chest JJS B-NP O
114 pain NN I-NP O
114 , , O O
114 chest NN B-NP O
114 pressure NN I-NP O
114 , , O O
115 shortness NN B-NP O
115 of IN B-VP O
115 breath NN B-NP O
115 , , O O
115 dizziness NN B-NP O
115 , , O O
115 lightheadedness NN B-NP O
115 , , O O
115 nausea NN B-NP O
115 , , O O
115 vomitting NN B-NP O
115 , , O O
115 or CC O O
116 any DT B-NP O
116 other JJ I-NP O
116 concerning NN I-NP O
116 symptoms NNS I-NP O
117 DISCHARGE NNP I-NP O
117 CONDITION: NNP I-NP O
117 Stable NNP I-NP O
118 TO NNP I-NP O
118 DO/PLAN: NNP I-NP O
119 1 CD O O
119 Consider NNP B-NP O
119 increasing VBG O O
119 CCB NNP B-NP B-m
119 as IN B-VP O
119 patient NN B-NP O
119 seems VBZ O O
119 to TO O O
119 feel VB O O
119 it PRP O O
119 helps VBZ O O
119 his PRP$ O O
120 symptoms JJ O O
121 2 CD O O
121 Consider NNP B-NP O
121 adjusting VBG O O
121 HTN NNP B-NP B-m
121 meds NNS I-NP I-m
121 as IN B-VP O
121 patient NN B-NP O
121 was VBD B-VP O
121 relatively RB O O
121 hypotensive JJ O B-r
122 ( ( O O
122 SBP NNP B-NP O
122 90-110 CD O O
122 ) ) O O
122 in IN B-VP O
122 hospital NN B-NP O
122 ( ( O O
122 althought JJ B-NP O
122 asymptomatic NN I-NP O
122 ) ) O O
123 3 CD O O
123 Consider NNP B-NP O
123 outpatient JJ B-NP O
123 cardiac NN I-NP O
123 rehabillitation NN I-NP O
124 4 CD O O
124 Consider NNP B-NP O
124 nutrition NN I-NP O
124 consult NN I-NP O
124 as IN B-VP O
124 outpatient NN B-NP O
124 to TO O O
124 ensure VB O O
124 adequate JJ B-NP O
125 nutrition NN I-NP O
125 status NN I-NP O
125 on IN B-VP O
125 "liquid NNP B-NP O
125 diet" NN I-NP O
126 No NNP I-NP O
126 dictated VBD B-VP O
126 summary JJ B-NP O
127 ENTERED NNP I-NP O
127 BY: NNP I-NP O
127 BOATMAN NNP I-NP O
127 , , O O
127 JOAN NNP B-NP O
127 LOWELL NNP I-NP O
127 , , O O
127 M.D NNP B-NP O
127 ( ( O O
127 NZ69 NNP B-NP O
127 ) ) O O
127 4/28/03 CD O O
127 @ $ O O
127 02:37 CD O O
127 PM NNP B-NP O
128 ****** JJ B-NP O
128 END NNP I-NP O
128 OF NNP I-NP O
128 DISCHARGE NNP I-NP O
128 ORDERS NNP I-NP O
128 ****** NNP I-NP O
129 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #163611 VBZ O O
4 235043506 CD O O
4 HSPHAC NNP B-NP O
4 37252645 CD O O
4 4811259 CD O O
4 5/15/2007 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/22/2007 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
7 ATTENDING: NNP I-NP O
7 TELLES NNP I-NP O
7 , , O O
7 MARCELO NNP B-NP O
7 M.D NNP I-NP O
8 ADMITTING NNP I-NP O
8 INTERN: NNP I-NP O
9 Darrin NNP I-NP O
9 Strzyzewski NNP I-NP O
9 , , O O
9 M.D NNP B-NP O
10 ADMITTING NNP I-NP O
10 RESIDENT: NNP I-NP O
11 Rigoberto NNP I-NP O
11 Shuford NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 ESTIMATED NNP I-NP O
12 DATE NNP I-NP O
12 OF NNP I-NP O
12 DISCHARGE: NNP I-NP O
13 0/24/07 CD O O
14 PRINCIPAL NNP B-NP O
14 DIAGNOSIS: NNP I-NP O
15 Congestive NNP I-NP O
15 heart NN I-NP O
15 failure NN I-NP O
15 , , O O
15 amyloid NN B-NP O
15 , , O O
15 and CC O O
15 pneumonia NN B-NP O
16 SECONDARY NNP I-NP O
16 DIAGNOSES: NNP I-NP O
17 Include NNP I-NP O
17 hypertension NN I-NP O
17 , , O O
17 diabetes VBZ O O
17 , , O O
17 peripheral JJ B-NP O
17 vascular JJ I-NP O
17 disease NN I-NP O
18 status NN I-NP O
18 post NN I-NP O
18 left VBD B-VP O
18 BKA NNP B-NP O
18 , , O O
18 status NN B-NP O
18 post NN I-NP O
18 pacemaker NN I-NP O
18 for IN B-VP O
18 sick JJ B-NP O
18 sinus NN I-NP O
19 syndrome NN I-NP O
19 , , O O
19 hypercholesterolemia NN B-NP O
19 , , O O
19 pseudogout NN B-NP O
19 , , O O
19 spinal JJ B-NP O
19 stenosis NN I-NP O
20 HISTORY NNP I-NP O
20 OF NNP I-NP O
20 PRESENT NNP I-NP O
20 ILLNESS: NNP I-NP O
21 This DT O O
21 is VBZ O O
21 an DT B-NP O
21 88-year-old JJ I-NP O
21 Tere NNP I-NP O
21 All NNP I-NP O
21 War NNP I-NP O
21 male NN I-NP O
21 with IN B-VP O
21 a DT B-NP O
21 history NN I-NP O
21 of IN B-VP O
21 CHF NNP B-NP O
21 with IN B-VP O
22 an DT O O
22 estimated VBN O O
22 EF NNP B-NP O
22 of IN B-VP O
22 45-50% JJ O O
22 and CC O O
22 diastolic JJ B-NP O
22 dysfunction NN I-NP O
22 as RB O O
22 well RB O O
22 , , O O
22 also RB O O
23 with IN B-VP O
23 a DT B-NP O
23 history NN I-NP O
23 of IN B-VP O
23 hypertension NN B-NP O
23 , , O O
23 diabetes VBZ O O
23 , , O O
23 peripheral JJ B-NP O
23 vascular JJ I-NP O
24 disease NN I-NP O
24 , , O O
24 history NN B-NP O
24 of IN B-VP O
24 a DT B-NP O
24 CVA NNP I-NP O
24 , , O O
24 history NN B-NP O
24 of IN B-VP O
24 hypercholesterolemia NN B-NP O
24 , , O O
24 who WP O O
25 was VBD B-VP O
25 recently RB O O
25 admitted VBN O O
25 to TO O O
25 the DT B-NP O
25 Tiesville NNP I-NP O
25 Caing NNP I-NP O
25 Hospital NNP I-NP O
25 for IN B-VP O
25 a DT B-NP B-r
25 CHF NNP I-NP I-r
25 exacerbation NN I-NP I-r
26 During IN B-VP O
26 the DT B-NP O
26 recent JJ I-NP O
26 admission NN I-NP O
26 , , O O
26 his PRP$ O O
26 home NN B-NP O
26 Lasix NNP I-NP B-m
26 was VBD B-VP O
26 increased VBN O O
26 from IN B-VP O
26 20 CD O O
27 mg NNS B-NP O
27 p.o JJ O O
27 daily JJ O O
27 to TO O O
27 80 CD O B-do
27 mg NNS B-NP I-do
27 p.o JJ B-NP B-mo
27 b.i.d NN I-NP B-f
27 During IN B-VP O
27 the DT B-NP O
27 past JJ I-NP O
27 admission NN I-NP O
27 , , O O
27 he PRP O O
28 had VBD B-VP O
28 a DT B-NP O
28 negative JJ I-NP O
28 lower JJR I-NP O
28 extremity NN I-NP O
28 ultrasounds NNS I-NP O
28 for IN B-VP O
28 right JJ B-NP O
28 leg NN I-NP O
28 edema NN I-NP O
29 and CC O O
29 chronic JJ B-NP O
29 swelling NN I-NP O
29 and CC O O
29 during IN B-VP O
29 the DT B-NP O
29 last JJ I-NP O
29 admission NN I-NP O
29 , , O O
29 he PRP O O
29 was VBD B-VP O
30 diuresed VBN O O
30 with IN B-VP O
30 Lasix NNP B-NP B-m
30 and CC O O
30 discharged VBD B-VP O
30 home NN B-NP O
30 on IN B-VP O
30 5/23/07 CD O O
30 During IN B-VP O
30 the DT O O
31 two CD O O
31 days NNS B-NP O
31 prior RB O O
31 to TO O O
31 admission NN B-NP O
31 , , O O
31 the DT B-NP O
31 patient NN I-NP O
31 experienced VBD B-VP O
31 increasing VBG O O
32 shortness NN B-NP O
32 of IN B-VP O
32 breath NN B-NP O
32 , , O O
32 orthopnea NN B-NP O
32 , , O O
32 and CC O O
32 PND NNP B-NP O
32 The DT B-NP O
32 VNA NNP I-NP O
32 who WP O O
32 visited VBD B-VP O
32 the DT B-NP O
33 patient NN I-NP O
33 noted VBD B-VP O
33 a DT B-NP O
33 fever NN I-NP O
33 of IN B-VP O
33 101 CD O O
33 Fahrenheit NNP B-NP O
33 and CC O O
33 so RB O O
33 the DT B-NP O
33 patient NN I-NP O
33 went VBD B-VP O
34 to TO O O
34 the DT B-NP O
34 Emergency NNP I-NP O
34 Department NNP I-NP O
34 In IN B-VP O
34 the DT B-NP O
34 Emergency NNP I-NP O
34 Department NNP I-NP O
34 , , O O
34 the DT B-NP O
35 patient NN I-NP O
35 was VBD B-VP O
35 afebrile JJ O O
35 , , O O
35 had VBD B-VP O
35 a DT B-NP O
35 heart NN I-NP O
35 rate NN I-NP O
35 of IN B-VP O
35 80 CD O O
35 , , O O
35 blood NN B-NP O
35 pressure NN I-NP O
36 130/80s CD O O
36 , , O O
36 respirations NNS B-NP O
36 16 CD O O
36 satting VBG O O
36 95% CD O O
36 on IN B-VP O
36 2-4 JJ B-NP O
36 liters NNS I-NP O
36 Of IN B-VP O
36 note NN B-NP O
36 , , O O
36 the DT B-NP O
37 patient NN I-NP O
37 has VBZ O O
37 no DT B-NP O
37 oxygen NN I-NP O
37 requirement NN I-NP O
37 at IN B-VP O
37 home NN B-NP O
37 at IN B-VP O
37 baseline NN B-NP O
37 The DT B-NP O
38 patient NN I-NP O
38 had VBD B-VP O
38 crackles NNS B-NP O
38 on IN B-VP O
38 exam IN B-VP O
38 The DT O O
38 chest JJS O O
38 x-ray JJ O O
38 showed VBD B-VP O
38 improved JJ B-NP O
39 effusions NNS I-NP O
39 from IN B-VP O
39 prior JJ O O
39 but CC O O
39 did VBD B-VP O
39 not RB O O
39 rule VB O O
39 out RP O O
39 pneumonia IN B-VP O
39 His PRP$ O O
39 right JJ B-NP O
40 leg NN I-NP O
40 was VBD B-VP O
40 still RB O O
40 swollen VBN O O
40 but CC O O
40 unchanged JJ O O
40 from IN B-VP O
40 prior JJ O O
40 In IN B-VP O
40 the DT B-NP O
40 Emergency NNP I-NP O
41 Room NNP I-NP O
41 , , O O
41 he PRP O O
41 was VBD B-VP O
41 given VBN O O
41 IV NNP B-NP B-mo
41 Lasix NNP I-NP B-m
41 100 CD O B-do
41 mg NN B-NP I-do
41 and CC O O
41 750 CD O B-do
41 mg NN B-NP I-do
41 of IN B-VP O
41 levofloxacin NN B-NP B-m
41 x1 VBP O B-du
42 The DT B-NP O
42 patient NN I-NP O
42 was VBD B-VP O
42 admitted VBN O O
42 to TO O O
42 the DT B-NP O
42 Cardiology NNP I-NP O
42 Service NNP I-NP O
42 for IN B-VP O
42 volume NN B-NP O
43 overload NN I-NP O
43 and CC O O
43 the DT B-NP O
43 question NN I-NP O
43 of IN B-VP O
43 pneumonia NN B-NP O
44 HOME NNP I-NP O
44 MEDICATIONS: NNP I-NP O
45 Tylenol NNP I-NP B-m
45 p.r.n NN I-NP B-f
45 , , O O
45 aspirin RB O B-m
45 81 CD O B-do
45 mg NNS B-NP I-do
45 every DT O O
45 daily RB O B-f
45 , , O O
45 diltiazem NN B-NP B-m
45 extended VBD B-VP O
46 release NN B-NP O
46 120 CD O B-do
46 mg JJ O I-do
46 daily RB O B-f
46 , , O O
46 Colace NNP B-NP B-m
46 100 CD O B-do
46 mg NN B-NP I-do
46 twice RB O B-f
46 daily RB O I-f
46 , , O O
46 iron NN B-NP B-m
46 sulfate NN I-NP I-m
46 325 CD O B-do
47 mg NN B-NP O
47 three CD O B-f
47 times NNS B-NP I-f
47 daily RB O I-f
47 , , O O
47 folic JJ O B-m
47 acid VBP O I-m
47 1 CD O B-do
47 mg JJ O I-do
47 daily RB O B-f
47 , , O O
47 Lasix NNP B-NP B-m
47 80 CD O B-do
47 mg NN B-NP I-do
47 p.o NN I-NP B-mo
48 twice RB O B-f
48 daily RB O I-f
48 , , O O
48 gabapentin VBD B-VP B-m
48 100 CD O B-do
48 mg JJ O I-do
48 twice RB O B-f
48 daily RB O I-f
48 , , O O
48 NPH NNP B-NP B-m
48 insulin VBZ O I-m
48 20 CD O B-do
48 units NNS B-NP I-do
49 subcutaneously RB O B-mo
49 daily RB O B-f
49 , , O O
49 regular JJ B-NP B-m
49 insulin NN I-NP I-m
49 sliding VBG O B-do
49 scale NN B-NP I-do
49 , , O O
49 Xalatan NNP B-NP B-m
49 eye NN I-NP O
50 drops VBZ O O
50 one CD O B-do
50 drop NN B-NP I-do
50 each DT B-NP B-mo
50 eye NN I-NP I-mo
50 q.p.m NN I-NP B-f
50 , , O O
50 metoprolol FW O B-m
50 12.5 CD O B-do
50 mg NN B-NP I-do
50 twice RB O B-f
50 daily RB O I-f
50 , , O O
51 senna JJ B-NP B-m
51 tablets NNS I-NP I-m
51 twice RB O B-f
51 daily RB O I-f
51 , , O O
51 simvastatin VBD B-VP B-m
51 40 CD O B-do
51 mg NN B-NP I-do
51 once RB O B-f
51 daily JJ B-NP I-f
52 ALLERGIES: NNP I-NP O
53 IV NNP I-NP O
53 contrast NN I-NP O
53 and CC O O
53 latex JJ B-NP O
54 SOCIAL NNP I-NP O
54 HISTORY: NNP I-NP O
55 The DT B-NP O
55 patient NN I-NP O
55 is VBZ O O
55 a DT B-NP O
55 retired JJ I-NP O
55 cook NN I-NP O
55 He PRP O O
55 is VBZ O O
55 originally RB O O
55 from IN B-VP O
55 E NNP B-NP O
55 Vi NNP I-NP O
56 He PRP O O
56 has VBZ O O
56 a DT B-NP O
56 history NN I-NP O
56 of IN B-VP O
56 past JJ B-NP O
56 tobacco NN I-NP O
56 use NN I-NP O
56 , , O O
56 quit VBP O O
56 30 CD O O
56 years NNS B-NP O
56 ago RB O O
56 and CC O O
56 in IN B-VP O
57 the DT B-NP O
57 past JJ I-NP O
57 drank NN I-NP O
57 alcohol NN I-NP O
57 rarely RB O O
57 He PRP O O
57 is VBZ O O
57 wheelchair-bound JJ O O
57 at IN B-VP O
58 baseline NN B-NP O
58 He PRP O O
58 lives VBZ O O
58 alone RB O O
58 VNA NNP B-NP O
58 visits VBZ O O
58 him PRP O O
58 He PRP O O
58 has VBZ O O
58 three CD O O
59 daughters NNS B-NP O
59 in IN B-VP O
59 Vale NNP B-NP O
59 , , O O
59 Georgia NNP B-NP O
60 FAMILY NNP I-NP O
60 HISTORY: NNP I-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 notes NNS I-NP O
61 there RB O O
61 has VBZ O O
61 been VBN O O
61 no DT B-NP O
61 one NN I-NP O
61 in IN B-VP O
61 his PRP$ O O
61 immediate JJ B-NP O
61 family NN I-NP O
62 who WP O O
62 had VBD B-VP O
62 an DT B-NP O
62 MI NNP I-NP O
63 PHYSICAL NNP I-NP O
63 EXAMINATION NNP I-NP O
63 ON NNP I-NP O
63 ADMISSION: NNP I-NP O
64 VITAL NNP I-NP O
64 SIGNS: NNP I-NP O
64 Temperature NNP I-NP O
64 of IN B-VP O
64 100.0 CD O O
64 Fahrenheit NNP B-NP O
64 , , O O
64 heart NN B-NP O
64 rate NN I-NP O
64 71 CD O O
64 , , O O
65 blood NN B-NP O
65 pressure NN I-NP O
65 116/64 CD O O
65 satting VBG O O
65 100% CD O O
65 on IN B-VP O
65 2 CD O O
65 liters NNS B-NP O
65 His PRP$ O O
65 nasal JJ B-NP O
66 cannula NN I-NP O
66 oxygen NN I-NP O
66 respirations NNS I-NP O
66 16 CD O O
67 GENERAL: NNP B-NP O
67 In IN B-VP O
67 no DT B-NP O
67 acute NN I-NP O
67 distress NN I-NP O
67 , , O O
67 lying VBG O O
67 bed NN B-NP O
67 , , O O
67 speaking NN B-NP O
67 in IN B-VP O
67 full JJ B-NP O
68 sentences NNS I-NP O
69 HEENT: NNP I-NP O
69 OP NNP I-NP O
69 clear JJ O O
69 without IN B-VP O
69 erythema VBG O O
69 The DT B-NP O
69 patient NN I-NP O
69 has VBZ O O
69 dentures NNS B-NP O
70 Pupils NNP I-NP O
70 were VBD B-VP O
70 equal JJ O O
70 , , O O
70 round NN B-NP O
70 and CC O O
70 reactive JJ B-NP O
70 Extraocular NNP I-NP O
70 muscle NN I-NP O
70 was VBD B-VP O
71 intact JJ B-NP O
72 NECK: NNP I-NP O
72 No NNP I-NP O
72 lymphadenopathy JJ B-NP O
72 No NNP I-NP O
72 carotid NN I-NP O
72 bruits NNS I-NP O
72 Neck NNP I-NP O
72 was VBD B-VP O
72 supple JJ B-NP O
73 JVP NNP I-NP O
73 listed VBN O O
73 in IN B-VP O
73 chart NN B-NP O
73 as IN B-VP O
73 12 CD O O
73 cm NN B-NP O
74 CARDIOVASCULAR: NNP I-NP O
74 Regular NNP I-NP O
74 rate NN I-NP O
74 and CC O O
74 rhythm NN B-NP O
74 , , O O
74 II/VI NNP B-NP O
74 systolic JJ B-NP O
74 ejection NN I-NP O
75 murmur NN I-NP O
75 at IN B-VP O
75 the DT B-NP O
75 left NN I-NP O
75 lower RBR O O
75 sternal JJ B-NP O
75 border NN I-NP O
76 RESPIRATION: NNP I-NP O
76 The DT B-NP O
76 patient NN I-NP O
76 had VBD B-VP O
76 crackles NNS B-NP O
76 half NN I-NP O
76 way NN I-NP O
76 up IN B-VP O
76 each DT B-NP O
76 lung NN I-NP O
77 bilaterally RB O O
77 There EX O O
77 was VBD B-VP O
77 no DT B-NP O
77 egophony NN I-NP O
77 , , O O
77 there EX O O
77 was VBD B-VP O
77 no DT B-NP O
77 dullness NN I-NP O
77 to TO O O
78 percussion NN B-NP O
79 ABDOMEN: NNP I-NP O
79 Positive NNP I-NP O
79 bowel NN I-NP O
79 sounds NNS I-NP O
79 , , O O
79 soft JJ O O
79 and CC O O
79 nontender NN B-NP O
79 There EX O O
79 was VBD B-VP O
79 a DT B-NP O
80 mild JJ I-NP O
80 distention NN I-NP O
80 and CC O O
80 no DT B-NP O
80 masses NNS I-NP O
81 EXTREMITIES: VBP O O
81 The DT B-NP O
81 patient NN I-NP O
81 has VBZ O O
81 a DT O O
81 left VBN O O
81 BKA NNP B-NP O
81 The DT B-NP O
81 right NN I-NP O
81 leg NN I-NP O
81 showed VBD B-VP O
82 2+ CD O O
82 pitting VBG O O
82 edema NN B-NP O
82 halfway NN I-NP O
82 up IN B-VP O
82 his PRP$ O O
82 anterior NN B-NP O
82 shin VB O O
82 His PRP$ O O
82 left JJ B-NP O
82 leg NN I-NP O
82 had VBD B-VP O
83 no DT B-NP O
83 ulceration NN I-NP O
83 or CC O O
83 lacerations NNS B-NP O
83 and CC O O
83 no DT B-NP O
83 tenderness NN I-NP O
84 NEURO: NNP I-NP O
84 Alert NNP I-NP O
84 and CC O O
84 oriented VBN O O
84 x3 NNP B-NP O
84 Cranial NNP I-NP O
84 nerves NNS I-NP O
84 II NNP I-NP O
84 through IN B-VP O
84 XII NNP B-NP O
85 intact JJ B-NP O
85 Generally NNP I-NP O
85 , , O O
85 nonfocal JJ B-NP O
85 exam NN I-NP O
86 REVIEW NNP I-NP O
86 OF NNP I-NP O
86 SYSTEMS: NNP I-NP O
87 The DT B-NP O
87 patient NN I-NP O
87 has VBZ O O
87 a DT B-NP O
87 minimal JJ I-NP O
87 chest NN I-NP O
87 pain NN I-NP O
87 in IN B-VP O
87 the DT B-NP O
87 past JJ I-NP O
87 couple NN I-NP O
87 of IN B-VP O
87 days NNS B-NP O
88 only RB O O
88 with IN B-VP O
88 cough NN B-NP O
88 , , O O
88 otherwise RB O O
88 no DT B-NP O
88 chest NN I-NP O
88 pain VBZ O O
88 The DT B-NP O
88 patient NN I-NP O
88 was VBD B-VP O
88 chest JJ O O
89 pain-free JJ O O
89 in IN B-VP O
89 the DT B-NP O
89 Emergency NNP I-NP O
89 Room NNP I-NP O
89 and CC O O
89 there EX O O
89 was VBD B-VP O
89 no DT B-NP O
89 nausea NN I-NP O
89 , , O O
90 vomiting VBG O O
90 , , O O
90 diaphoresis NN B-NP O
90 , , O O
90 palpitations NNS B-NP O
90 , , O O
90 no DT B-NP O
90 rash NN I-NP O
90 , , O O
90 no DT B-NP O
90 diarrhea NN I-NP O
90 , , O O
91 positive JJ B-NP O
91 constipation NN I-NP O
91 , , O O
91 increased VBD B-VP O
91 leg NN B-NP O
91 swelling VBG O O
91 since IN B-VP O
91 the DT B-NP O
91 last JJ I-NP O
92 admission NN I-NP O
92 , , O O
92 no DT B-NP O
92 hematuria NN I-NP O
92 , , O O
92 no DT B-NP O
92 dysuria NN I-NP O
92 The DT B-NP O
92 patient NN I-NP O
92 had VBD B-VP O
92 a DT B-NP O
93 productive JJ I-NP O
93 cough NN I-NP O
93 of IN B-VP O
93 clear JJ B-NP O
93 phlegm NN I-NP O
93 and CC O O
93 no DT B-NP O
93 hemoptysis NN I-NP O
93 The DT B-NP O
93 patient NN I-NP O
94 had VBD B-VP O
94 a DT B-NP O
94 good JJ I-NP O
94 medication NN I-NP O
94 compliance NN I-NP O
95 ADMISSION NNP I-NP O
95 LABS: NNP I-NP O
96 Of IN B-VP O
96 note NN B-NP O
96 on IN B-VP O
96 admission NN B-NP O
96 , , O O
96 the DT B-NP O
96 patient NN I-NP O
96 had VBD B-VP O
96 a DT B-NP O
96 creatinine NN I-NP O
96 of IN B-VP O
96 1.1 CD O O
96 which WDT O O
97 was VBD B-VP O
97 at IN B-VP O
97 his PRP$ O O
97 baseline NN B-NP O
97 The DT B-NP O
97 patient NN I-NP O
97 had VBD B-VP O
97 a DT B-NP O
97 hematocrit NN I-NP O
97 of IN B-VP O
97 35.2 CD O O
97 Of IN B-VP O
98 note NN B-NP O
98 , , O O
98 his PRP$ O O
98 baseline NN B-NP O
98 hematocrit NN I-NP O
98 is VBZ O O
98 between IN B-VP O
98 31 CD O O
98 and CC O O
98 32 CD O O
98 BNP NNP B-NP O
98 was VBD B-VP O
98 570 CD O O
99 Troponin NNP B-NP O
99 was VBD B-VP O
99 0.78 CD O O
99 , , O O
99 AST NNP B-NP O
99 62 CD O O
99 , , O O
99 ALT NNP B-NP O
99 26 CD O O
99 , , O O
99 alkaline JJ B-NP O
99 phosphatase NN I-NP O
99 183 CD O O
99 , , O O
100 albumin RB O O
100 3.6 CD O O
101 Admission NNP B-NP O
101 EKG NNP I-NP O
101 was VBD B-VP O
101 V-paced JJ O O
101 with IN B-VP O
101 left JJ B-NP O
101 axis JJ I-NP O
101 deviation NN I-NP O
101 , , O O
101 no DT B-NP O
101 acute JJ I-NP O
101 ST-T NNP I-NP O
102 wave NN I-NP O
102 changes NNS I-NP O
102 It PRP O O
102 was VBD B-VP O
102 unchanged JJ O O
102 from IN B-VP O
102 prior JJ O O
102 The DT B-NP O
102 patient NN I-NP O
102 was VBD B-VP O
102 in IN B-VP O
103 atrial JJ B-NP O
103 fibrillation NN I-NP O
103 on IN B-VP O
103 the DT B-NP O
103 EKG NNP I-NP O
104 Admission NNP I-NP O
104 chest JJS B-NP O
104 x-ray NN I-NP O
104 from IN B-VP O
104 7/17/07 CD O O
104 , , O O
104 decreased VBD B-VP O
104 size NN B-NP O
104 small JJ B-NP O
105 bilateral JJ I-NP O
105 effusions NNS I-NP O
105 , , O O
105 associated VBN O O
105 with IN B-VP O
105 some DT B-NP O
105 segmental JJ I-NP O
105 bibasilar JJ I-NP O
106 atelectasis NN I-NP O
106 versus NN I-NP O
106 consolidation NN I-NP O
106 No NNP I-NP O
106 frank VBD B-VP O
106 evidence NN B-NP O
106 of IN B-VP O
106 CHF NNP B-NP O
107 CONSULTANTS: NNP I-NP O
108 Hematology NNP I-NP O
108 of IN B-VP O
108 BH NNP B-NP O
108 , , O O
108 Dr NNP B-NP O
108 Bradley NNP I-NP O
108 Ebanks NNP I-NP O
109 ASSESSMENT: NNP I-NP O
110 This DT O O
110 is VBZ O O
110 an DT B-NP O
110 88-year-old JJ I-NP O
110 Co NNP I-NP O
110 Louis NNP I-NP O
110 Awestinsde NNP I-NP O
110 male NN I-NP O
110 with IN B-VP O
110 a DT B-NP O
110 history NN I-NP O
110 of IN B-VP O
111 hypertension NN B-NP O
111 , , O O
111 diabetes VBZ O O
111 , , O O
111 CHF NNP B-NP O
111 who WP O O
111 presented VBD B-VP O
111 with IN B-VP O
111 increasing VBG O O
112 shortness NN B-NP O
112 of IN B-VP O
112 breath NN B-NP O
112 likely JJ O O
112 secondary JJ O O
112 to TO O O
112 CHF NNP B-NP O
112 and CC O O
112 also RB O O
112 presented VBN O O
113 with IN B-VP O
113 a DT B-NP O
113 fever NN I-NP O
113 concerning VBG O O
113 for IN B-VP O
113 pneumonia NN B-NP B-r
113 for IN B-VP O
113 which WDT O O
113 he PRP O O
113 was VBD B-VP O
113 treated VBN O O
114 with IN B-VP O
114 antibiotics NNS B-NP B-m
114 The DT B-NP O
114 patient NN I-NP O
114 also RB O O
114 had VBD B-VP O
114 a DT B-NP O
114 new JJ I-NP O
114 diagnosis NN I-NP O
114 of IN B-VP O
115 amyloid NN B-NP O
115 during IN B-VP O
115 this DT B-NP O
115 admission NN I-NP O
116 HOSPITAL NNP I-NP O
116 COURSE NNP I-NP O
116 BY NNP I-NP O
116 PROBLEM: NNP I-NP O
117 1 CD O O
117 Cardiovascular: NNP B-NP O
118 A NNP I-NP O
118 Ischemia: NNP I-NP O
118 The DT B-NP O
118 patient NN I-NP O
118 has VBZ O O
118 no DT O O
118 known VBN O O
118 diagnosis NN B-NP O
118 of IN B-VP O
118 CAD; NNP B-NP O
119 however RB O O
119 , , O O
119 he PRP O O
119 has VBZ O O
119 many JJ B-NP O
119 risk NN I-NP O
119 factors NNS I-NP O
119 The DT B-NP O
119 patient NN I-NP O
119 had VBD B-VP O
119 a DT B-NP O
119 troponin NN I-NP O
119 of IN B-VP O
120 0.7 CD O O
120 on IN B-VP O
120 admit NN B-NP O
120 which WDT O O
120 subsequently RB O O
120 trended VBD B-VP O
120 down RP O O
120 This DT B-NP O
120 troponin NN I-NP O
120 leak NN I-NP O
121 was VBD B-VP O
121 thought VBN O O
121 to TO O O
121 be VB O O
121 due JJ O O
121 to TO O O
121 demand VB O O
121 The DT B-NP O
121 patient NN I-NP O
121 remained VBD B-VP O
121 chest JJ O O
122 pain-free JJ O O
122 during IN B-VP O
122 his PRP$ O O
122 entire JJ B-NP O
122 hospital NN I-NP O
122 course NN I-NP O
122 , , O O
122 and CC O O
122 had VBD B-VP O
122 no DT B-NP O
122 acute JJ I-NP O
123 ischemic JJ I-NP O
123 issues NNS I-NP O
123 The DT B-NP O
123 patient NN I-NP O
123 was VBD B-VP O
123 continued VBN O O
123 on IN B-VP O
123 his PRP$ O O
123 aspirin NN B-NP B-m
123 , , O O
124 beta-blocker NN B-NP B-m
124 and CC O O
124 statin NN B-NP B-m
124 medications NNS I-NP I-m
125 B NNP I-NP O
125 Pump: NNP I-NP O
125 The DT B-NP O
125 patient NN I-NP O
125 has VBZ O O
125 a DT B-NP O
125 history NN I-NP O
125 of IN B-VP O
125 CHF NNP B-NP O
125 with IN B-VP O
125 an DT B-NP O
125 EF NNP I-NP O
125 of IN B-VP O
125 40-45% JJ O O
126 In IN B-VP O
126 the DT B-NP O
126 past NN I-NP O
126 , , O O
126 this DT B-NP O
126 congestive JJ I-NP O
126 heart NN I-NP O
126 failure NN I-NP O
126 had VBD B-VP O
126 been VBN O O
126 presumably RB O O
127 attributed VBN O O
127 to TO O O
127 ischemic VB O O
127 for IN B-VP O
127 hypertensive JJ B-NP O
127 etiology NN I-NP O
127 However RB O O
127 , , O O
128 during IN B-VP O
128 this DT B-NP O
128 admission NN I-NP O
128 , , O O
128 the DT B-NP O
128 patient NN I-NP O
128 had VBD B-VP O
128 a DT B-NP O
128 cardiac JJ I-NP O
128 biopsy NN I-NP O
128 that WDT O O
128 was VBD B-VP O
129 positive JJ O O
129 for IN B-VP O
129 amyloid JJ O O
129 suggesting VBG O O
129 that IN B-VP O
129 amyloid NN B-NP O
129 is VBZ O O
129 the DT B-NP O
129 cause NN I-NP O
130 underlying VBG O O
130 his PRP$ O O
130 CHF NNP B-NP O
130 The DT B-NP O
130 patient NN I-NP O
130 appeared VBD B-VP O
130 mildly RB O O
130 fluid JJ O O
130 overloaded VBN O O
131 on IN B-VP O
131 admission NN B-NP O
131 He PRP O O
131 was VBD B-VP O
131 successfully RB O O
131 diuresed VBN O O
131 with IN B-VP O
131 100 CD O B-do
131 IV NNP B-NP B-mo
131 Lasix NNP I-NP B-m
131 for IN B-VP B-du
132 several JJ B-NP O
132 days NNS I-NP O
132 The DT B-NP O
132 patient NN I-NP O
132 has VBZ O O
132 been VBN O O
132 switched VBN O O
132 to TO O O
132 his PRP$ O O
132 home NN B-NP O
132 dose NN I-NP O
132 of IN B-VP O
133 Lasix NNP B-NP B-m
133 of IN B-VP O
133 80 CD O B-do
133 mg NNS B-NP I-do
133 p.o JJ B-NP B-mo
133 b.i.d NN I-NP B-f
133 and CC O O
133 was VBD B-VP O
133 euvolemic VBN O O
133 for IN B-VP O
133 several JJ B-NP O
133 days NNS I-NP O
134 prior RB O O
134 to TO O O
134 his PRP$ O O
134 discharge NN B-NP O
134 His PRP$ O O
134 euvolemic JJ B-NP O
134 weight NN I-NP O
134 on IN B-VP O
134 8/18/07 CD O O
134 was VBD B-VP O
135 64.5 CD O O
135 kilograms NNS B-NP O
135 His PRP$ O O
135 discharge NN B-NP O
135 weight NN I-NP O
135 will MD O O
135 be VB O O
135 reported VBN O O
135 in IN B-VP O
135 an DT B-NP O
136 addendum NN I-NP O
136 During IN B-VP O
136 this DT B-NP O
136 admission NN I-NP O
136 , , O O
136 he PRP O O
136 was VBD B-VP O
136 continued VBN O O
136 on IN B-VP O
136 his PRP$ O O
137 beta-blocker NN B-NP B-m
137 His PRP$ O O
137 calcium NN B-NP B-m
137 channel NN I-NP I-m
137 blocker NN I-NP I-m
137 and CC O O
137 diltiazem NN B-NP B-m
137 was VBD B-VP O
138 discontinued VBN O O
138 during IN B-VP O
138 this DT B-NP O
138 admission NN I-NP O
138 given VBN O O
138 his PRP$ O O
138 likely JJ B-NP O
138 restrictive JJ I-NP O
139 heart NN I-NP O
139 physiology NN I-NP O
139 with IN B-VP O
139 his PRP$ O O
139 new JJ B-NP O
139 diagnosis NN I-NP O
139 of IN B-VP O
139 amyloid JJ O B-r
139 amyloid IN B-VP B-r
139 The DT B-NP O
139 patient NN I-NP O
140 was VBD B-VP O
140 started VBN O O
140 on IN B-VP O
140 a DT B-NP O
140 nitrate NN I-NP B-m
140 during IN B-VP B-du
140 this DT B-NP I-du
140 admission NN I-NP I-du
140 in IN B-VP O
140 order NN B-NP O
140 to TO O O
140 reduce VB O B-r
141 preload NN B-NP O
141 As IN B-VP O
141 mentioned VBN O O
141 above IN B-VP O
141 , , O O
141 the DT B-NP O
141 patient NN I-NP O
141 had VBD B-VP O
141 a DT B-NP O
141 catheterization NN I-NP O
142 with IN B-VP O
142 an DT B-NP O
142 endomyocardial JJ I-NP O
142 biopsy NN I-NP O
142 that WDT O O
142 was VBD B-VP O
142 positive JJ O O
142 for IN B-VP O
142 amyloid VBG O O
142 A NNP B-NP O
143 panel NN I-NP O
143 of IN B-VP O
143 other JJ B-NP O
143 amyloid-related JJ I-NP O
143 tests NNS I-NP O
143 were VBD B-VP O
143 also RB O O
143 sent VBN O O
143 out IN B-VP O
143 Of IN B-VP O
144 note NN B-NP O
144 , , O O
144 serum JJ B-NP O
144 genetic JJ I-NP O
144 amyloid NN I-NP O
144 testing NN I-NP O
144 was VBD B-VP O
144 pending VBG O O
144 at IN B-VP O
144 the DT B-NP O
144 time NN I-NP O
144 of IN B-VP O
145 discharge NN B-NP O
145 Of IN B-VP O
145 note NN B-NP O
145 , , O O
145 the DT B-NP O
145 patient NN I-NP O
145 had VBD B-VP O
145 a DT B-NP O
145 serum JJ I-NP O
145 immunofixation NN I-NP O
145 test NN I-NP O
146 that WDT O O
146 was VBD B-VP O
146 within IN B-VP O
146 normal JJ B-NP O
146 limits NNS I-NP O
146 The DT B-NP O
146 patient NN I-NP O
146 had VBD B-VP O
146 a DT B-NP O
146 urine JJ I-NP O
147 immunofixation NN I-NP O
147 test NN I-NP O
147 with IN B-VP O
147 a DT B-NP O
147 positive JJ I-NP O
147 monoclonal NN I-NP O
147 spike NN I-NP O
147 with IN B-VP O
147 Lambda NNP B-NP O
148 light NN I-NP O
148 chain NN I-NP O
148 The DT B-NP O
148 patient NN I-NP O
148 also RB O O
148 had VBD B-VP O
148 a DT B-NP O
148 serum-free JJ I-NP O
148 light NN I-NP O
148 chain NN I-NP O
148 assay VBP O O
149 that WDT O O
149 was VBD B-VP O
149 equivocal/positive JJ O O
149 The DT B-NP O
149 patient NN I-NP O
149 also RB O O
149 had VBD B-VP O
149 positive JJ B-NP O
150 proteinuria NNS I-NP O
150 on IN B-VP O
150 a DT B-NP O
150 spot NN I-NP O
150 urine IN B-VP O
150 The DT B-NP O
150 patient NN I-NP O
150 also RB O O
150 had VBD B-VP O
150 a DT B-NP O
150 bone NN I-NP O
150 marrow NN I-NP O
151 biopsy NN I-NP O
151 done VBN O O
151 by IN B-VP O
151 Dr NNP B-NP O
151 Jarred NNP I-NP O
151 Canner NNP I-NP O
151 of IN B-VP O
151 MOMH NNP B-NP O
151 in IN B-VP O
151 order NN B-NP O
151 to TO O O
151 further JJ B-NP O
152 define NN I-NP O
152 this DT B-NP O
152 subtype NN I-NP O
152 of IN B-VP O
152 amyloid NN B-NP O
152 that IN B-VP O
152 this DT B-NP O
152 patient NN I-NP O
152 has VBZ O O
152 and CC O O
152 in IN B-VP O
152 order NN B-NP O
153 to TO O O
153 facilitate VB O O
153 a DT B-NP O
153 screening NN I-NP O
153 of IN B-VP O
153 his PRP$ O O
153 family NN B-NP O
153 members NNS I-NP O
153 for IN B-VP O
153 amyloid NN B-NP O
153 He PRP O O
154 also RB O O
154 had VBD B-VP O
154 a DT B-NP O
154 bone NN I-NP O
154 marrow NN I-NP O
154 biopsy NN I-NP O
154 given VBN O O
154 the DT B-NP O
154 monoclonal JJ I-NP O
154 spike NN I-NP O
154 on IN B-VP O
154 his PRP$ O O
155 urine JJ B-NP O
155 immunofixation NN I-NP O
155 test NN I-NP O
156 C NNP I-NP O
156 Rhythm: NNP I-NP O
156 The DT B-NP O
156 patient NN I-NP O
156 has VBZ O O
156 a DT B-NP O
156 pacemaker NN I-NP O
156 originally RB O O
156 put VBD B-VP O
156 in IN B-VP O
156 for IN B-VP O
157 sick JJ B-NP O
157 sinus NN I-NP O
157 syndrome NN I-NP O
157 He PRP O O
157 is VBZ O O
157 V-paced JJ O O
157 The DT B-NP O
157 patient NN I-NP O
157 was VBD B-VP O
157 discovered VBN O O
158 to TO O O
158 be VB O O
158 in IN B-VP O
158 atrial JJ B-NP O
158 fibrillation NN I-NP O
158 on IN B-VP O
158 this DT B-NP O
158 admission NN I-NP O
158 On IN B-VP O
158 11/0/07 CD O O
158 , , O O
158 the DT B-NP O
159 EP NNP I-NP O
159 Service NNP I-NP O
159 changed VBD B-VP O
159 the DT B-NP O
159 pacemaker NN I-NP O
159 setting VBG O O
159 to TO O O
159 VVI NNP B-NP O
159 given VBN O O
159 that IN B-VP O
159 the DT B-NP O
160 patient NN I-NP O
160 was VBD B-VP O
160 in IN B-VP O
160 atrial JJ B-NP O
160 fibrillation NN I-NP O
160 and CC O O
160 decreased VBD B-VP O
160 the DT B-NP O
160 heart NN I-NP O
160 rate NN I-NP O
161 to TO O O
161 the DT O O
161 60s-70s JJ O O
161 The DT B-NP O
161 patient NN I-NP O
161 remained VBD B-VP O
161 on IN B-VP O
161 telemetry NN B-NP O
161 throughout IN B-VP O
161 his PRP$ O O
162 stay NN B-NP O
162 which WDT O O
162 was VBD B-VP O
162 uneventful JJ O O
162 The DT B-NP O
162 patient NN I-NP O
162 was VBD B-VP O
162 also RB O O
162 started VBN O O
162 on IN B-VP O
163 Coumadin NNP B-NP B-m
163 Coumadin NNP I-NP B-m
163 Coumadin NNP I-NP B-m
163 for IN B-VP O
163 anticoagulation NN B-NP B-r
163 given VBN O O
163 his PRP$ O O
163 atrial JJ B-NP B-r
163 fibrillation NN I-NP I-r
163 and CC O O
164 the DT B-NP O
164 diagnosis NN I-NP O
164 of IN B-VP O
164 amyloid JJ O B-r
164 The DT B-NP O
164 patient NN I-NP O
164 remained VBD B-VP O
164 subtherapeutic JJ O O
165 and CC O O
165 on IN B-VP O
165 3/14/07 CD O O
165 , , O O
165 his PRP$ O O
165 INR NNP B-NP O
165 was VBD B-VP O
165 still RB O O
165 subtherapeutic JJ O O
165 at IN B-VP O
165 1.5 CD O O
165 , , O O
165 and CC O O
165 he PRP O O
166 will MD O O
166 most VB O O
166 likely RB O O
166 be VB O O
166 discharged VBN O O
166 on IN B-VP O
166 Coumadin NNP B-NP B-m
166 3.5 CD O B-do
166 mg NN B-NP I-do
166 every DT B-NP B-f
166 evening NN I-NP I-f
167 which WDT O O
167 will MD O O
167 be VB O O
167 adjusted VBN O O
167 as IN B-VP O
167 necessary JJ O O
167 at IN B-VP O
167 the DT B-NP O
167 Rehabilitation NNP I-NP O
168 Facility NNP I-NP O
169 2 CD O O
169 Infectious NNP B-NP O
169 Disease: NNP I-NP O
169 The DT B-NP O
169 patient NN I-NP O
169 presented VBN O O
169 with IN B-VP O
169 a DT B-NP O
169 mild JJ I-NP O
169 cough NN I-NP O
170 The DT B-NP O
170 patient NN I-NP O
170 had VBD B-VP O
170 a DT B-NP O
170 fever NN I-NP O
170 on IN B-VP O
170 admit NN B-NP O
170 but CC O O
170 was VBD B-VP O
170 afebrile RB O O
170 after IN B-VP O
170 one CD O O
170 to TO O O
171 two CD O O
171 days NNS B-NP O
171 on IN B-VP O
171 antibiotics NNS B-NP O
171 The DT B-NP O
171 patient NN I-NP O
171 had VBD B-VP O
171 no DT B-NP O
171 leukocytosis NN I-NP O
172 Again RB O O
172 , , O O
172 there EX O O
172 was VBD B-VP O
172 a DT B-NP O
172 question NN I-NP O
172 of IN B-VP O
172 pneumonia NN B-NP O
172 on IN B-VP O
172 the DT O O
172 chest JJS O O
172 x-ray JJ O O
172 and CC O O
173 his PRP$ O O
173 clinical JJ B-NP O
173 findings NNS I-NP O
173 were VBD B-VP O
173 suspicious JJ O O
173 for IN B-VP O
173 pneumonia NN B-NP B-r
173 The DT B-NP O
173 patient NN I-NP O
174 received VBD B-VP O
174 a DT B-NP O
174 five-day JJ I-NP B-du
174 course NN I-NP I-du
174 of IN B-VP O
174 levofloxacin NN B-NP B-m
174 at IN B-VP O
174 750 CD O B-do
174 mg JJ O I-do
174 daily RB O B-f
174 The DT B-NP O
175 course NN I-NP O
175 of IN B-VP O
175 antibiotics NNS B-NP B-m
175 ended VBD B-VP O
175 on IN B-VP O
175 3/25/07 CD O O
175 The DT B-NP O
175 patient NN I-NP O
175 had VBD B-VP O
175 blood NN B-NP O
175 , , O O
176 urine JJ O O
176 and CC O O
176 sputum NN B-NP O
176 cultures NNS I-NP O
176 which WDT O O
176 were VBD B-VP O
176 negative JJ O O
177 3 CD O O
177 Heme: NNP B-NP O
177 The DT B-NP O
177 patient NN I-NP O
177 has VBZ O O
177 baseline VBN O O
177 anemia NN B-NP O
177 between IN B-VP O
177 hematocrit NN B-NP O
177 of IN B-VP O
178 31 CD O O
178 and CC O O
178 32 CD O O
178 which WDT O O
178 remained VBD B-VP O
178 stable JJ O O
178 during IN B-VP O
178 his PRP$ O O
178 hospitalization NN B-NP O
178 The DT B-NP O
179 patient NN I-NP O
179 also RB O O
179 has VBZ O O
179 a DT B-NP O
179 baseline NN I-NP O
179 thrombocytopenia NN I-NP O
179 with IN B-VP O
179 platelets NNS B-NP O
179 at IN B-VP O
180 approximately RB O O
180 170 CD O O
180 which WDT O O
180 remained VBD B-VP O
180 stable JJ O O
180 throughout IN B-VP O
180 his PRP$ O O
181 hospitalization NN B-NP O
181 and CC O O
181 again RB O O
181 the DT B-NP O
181 patient NN I-NP O
181 as IN B-VP O
181 stated VBN O O
181 above IN B-VP O
181 was VBD B-VP O
181 started VBN O O
182 on IN B-VP O
182 Coumadin NNP B-NP B-m
182 Coumadin NNP I-NP B-m
182 during IN B-VP B-du
182 during IN B-VP B-du
182 this DT O I-du
182 this DT B-NP I-du
182 admission NN I-NP I-du
182 admission NN I-NP I-du
182 for IN B-VP O
182 atrial JJ B-NP B-r
182 fibrillation NN I-NP I-r
182 and CC O O
182 for IN B-VP O
183 amyloid JJ O B-r
183 The DT B-NP O
183 Coumadin NNP I-NP B-m
183 Coumadin NNP I-NP B-m
183 was VBD B-VP O
183 slowly RB O O
183 increased VBN O O
183 up RP O O
183 to TO O O
183 3.5 CD O B-do
183 mg NNS B-NP I-do
183 given VBN O O
184 subtherapeutic JJ B-NP B-r
184 INR NNP I-NP I-r
184 The DT B-NP O
184 patient NN I-NP O
184 had VBD B-VP O
184 a DT B-NP O
184 bone NN I-NP O
184 marrow NN I-NP O
184 biopsy NN I-NP O
184 done VBN O O
184 on IN B-VP O
185 6/17/07 CD O O
185 as IN B-VP O
185 mentioned VBN O O
185 above IN B-VP O
185 in IN B-VP O
185 order NN B-NP O
185 to TO O O
185 further JJ O O
185 define VB O O
185 the DT B-NP O
186 amyloid JJ I-NP O
186 ??_?? NN I-NP O
186 and CC O O
186 because IN B-VP O
186 of IN B-VP O
186 the DT B-NP O
186 monoclonal JJ I-NP O
186 spike NN I-NP O
186 on IN B-VP O
186 the DT B-NP O
186 urine JJ I-NP O
187 immunofixation NN I-NP O
187 The DT B-NP O
187 final JJ I-NP O
187 results NNS I-NP O
187 of IN B-VP O
187 the DT B-NP O
187 bone NN I-NP O
187 marrow NN I-NP O
187 biopsy NN I-NP O
187 are VBP O O
188 pending VBG O O
189 4 CD O O
189 Endocrine: NNP B-NP O
189 The DT B-NP O
189 patient NN I-NP O
189 has VBZ O O
189 a DT B-NP O
189 history NN I-NP O
189 of IN B-VP O
189 diabetes NNS B-NP B-r
189 diabetes NNS I-NP B-r
189 At IN B-VP O
189 first JJ O O
189 , , O O
190 he PRP O O
190 was VBD B-VP O
190 on IN B-VP O
190 his PRP$ O O
190 home NN B-NP O
190 dose NN I-NP O
190 of IN B-VP O
190 NPH NNP B-NP B-m
190 insulin NN I-NP I-m
190 which WDT O O
190 was VBD B-VP O
190 20 CD O B-do
190 units NNS B-NP I-do
191 subcutaneous JJ O B-mo
191 daily RB O B-f
191 as RB O O
191 well RB O O
191 as IN B-VP O
191 an DT B-NP O
191 insulin NN I-NP B-m
191 sliding VBG O B-do
191 scale NN B-NP I-do
191 Because IN B-VP O
192 of IN B-VP O
192 persistent JJ B-NP B-r
192 persistent JJ I-NP B-r
192 hypoglycemia NN I-NP I-r
192 hypoglycemia NN I-NP I-r
192 , , O O
192 the DT B-NP O
192 patient's NN I-NP O
192 NPH NNP I-NP B-m
192 was VBD B-VP O
192 reduced VBN O O
192 to TO O O
192 10 CD O B-do
192 10 CD O B-do
193 units NNS B-NP O
193 of IN B-VP O
193 NPH NNP B-NP B-m
193 insulin VBP O I-m
193 subcutaneous JJ O B-mo
193 daily JJ O B-f
194 5 CD O O
194 FEN: NNP B-NP O
194 The DT B-NP O
194 patient NN I-NP O
194 had VBD B-VP O
194 a DT B-NP O
194 low-salt JJ I-NP O
194 diet NN I-NP O
194 and CC O O
194 a DT B-NP O
194 2-liter JJ I-NP O
194 fluid NN I-NP O
195 restriction NN I-NP O
195 and CC O O
195 was VBD B-VP O
195 seen VBN O O
195 by IN B-VP O
195 Nutrition NNP B-NP O
195 inhouse RB O O
196 6 CD O O
196 Renal: NNP B-NP O
196 The DT B-NP O
196 patient NN I-NP O
196 had VBD B-VP O
196 a DT B-NP O
196 creatinine NN I-NP O
196 of IN B-VP O
196 approximately RB O O
196 1.0 CD O O
197 which WDT O O
197 stayed VBD B-VP O
197 stable JJ O O
197 throughout IN B-VP O
197 his PRP$ O O
197 hospitalization NN B-NP O
198 7 CD O O
198 GI: NNP B-NP O
198 The DT B-NP O
198 patient NN I-NP O
198 has VBZ O O
198 chronic JJ B-NP O
198 LFT NNP I-NP O
198 abnormalities NNS I-NP O
198 likely RB O O
199 secondary JJ O O
199 to TO O O
199 CHF; NNP B-NP O
199 however RB O O
199 , , O O
199 the DT B-NP O
199 etiology NN I-NP O
199 is VBZ O O
199 uncertain JJ O O
200 8 CD O O
200 Question NNP B-NP O
200 restless NN I-NP O
200 leg NN I-NP O
200 syndrome: NN I-NP O
200 On IN B-VP O
200 5/10/07 CD O O
200 , , O O
200 the DT B-NP O
200 patient NN I-NP O
200 was VBD B-VP O
201 complaining VBG O O
201 of IN B-VP O
201 myoclonic JJ B-NP B-r
201 jerks NNS I-NP I-r
201 of IN B-VP O
201 his PRP$ O O
201 right NN B-NP O
201 leg NN I-NP O
201 which WDT O O
201 is VBZ O O
201 an DT B-NP O
201 old JJ I-NP O
202 problem NN I-NP O
202 His PRP$ O O
202 general JJ B-NP O
202 exam NN I-NP O
202 was VBD B-VP O
202 within IN B-VP O
202 normal JJ B-NP O
202 limits NNS I-NP O
202 He PRP O O
202 was VBD B-VP O
203 given VBN O O
203 a DT B-NP O
203 trial NN I-NP O
203 of IN B-VP O
203 magnesium NN B-NP B-m
203 supplementation NN I-NP I-m
203 inhouse NN I-NP O
203 for IN B-VP O
203 this DT O O
204 9 CD O O
204 Low NNP B-NP O
204 back RB O O
204 , , O O
204 sacral JJ O O
204 pain: IN B-VP O
204 His PRP$ O O
204 low JJ O B-r
204 back RB O I-r
204 pain NN B-NP I-r
204 appears VBZ O O
204 to TO O O
204 be VB O O
205 chronic JJ O O
205 and CC O O
205 it PRP O O
205 was VBD B-VP O
205 treated VBN O O
205 with IN B-VP O
205 oxycodone NN B-NP B-m
205 successfully RB O O
205 The DT B-NP O
206 patient NN I-NP O
206 also RB O O
206 was VBD B-VP O
206 noted VBN O O
206 to TO O O
206 have VB O O
206 a DT B-NP O
206 skin JJ I-NP O
206 tear NN I-NP O
206 on IN B-VP O
206 his PRP$ O O
206 right NN B-NP O
206 buttock NN I-NP O
207 which WDT O O
207 showed VBD B-VP O
207 no DT B-NP O
207 signs NNS I-NP O
207 of IN B-VP O
207 infection NN B-NP O
207 and CC O O
207 a DT B-NP O
207 DuoDERM NNP I-NP O
207 was VBD B-VP O
207 placed VBN O O
207 over IN B-VP O
208 it PRP O O
208 for IN B-VP O
208 wound NN B-NP O
208 care NN I-NP O
208 The DT B-NP O
208 patient NN I-NP O
208 also RB O O
208 had VBD B-VP O
208 a DT B-NP O
208 stage NN I-NP O
208 I PRP O O
208 sacral JJ B-NP O
209 decubitus NN I-NP O
209 ulcer NN I-NP O
209 and CC O O
209 a DT B-NP O
209 DuoDERM NNP I-NP O
209 was VBD B-VP O
209 placed VBN O O
209 on IN B-VP O
209 it PRP O O
209 for IN B-VP O
209 wound NN B-NP O
209 care NN I-NP O
209 and CC O O
210 for IN B-VP O
210 protection NN B-NP O
211 10 CD O O
211 Prophylaxis: NNP B-NP B-r
211 The DT B-NP O
211 patient NN I-NP O
211 was VBD B-VP O
211 on IN B-VP O
211 DVT NNP B-NP B-r
211 dose JJ B-NP O
211 Lovenox NNP I-NP B-m
211 inhouse NN I-NP O
212 and CC O O
212 was VBD B-VP O
212 also RB O O
212 on IN B-VP O
212 Coumadin NNP B-NP B-m
213 11 CD O O
213 Physical NNP B-NP O
213 Therapy: NNP I-NP O
213 Of IN B-VP O
213 note NN B-NP O
213 , , O O
213 the DT B-NP O
213 patient NN I-NP O
213 has VBZ O O
213 a DT O O
213 left VBN O O
213 BKA NNP B-NP O
213 The DT B-NP O
214 patient's NN I-NP O
214 family NN I-NP O
214 brought VBD B-VP O
214 in IN B-VP O
214 his PRP$ O O
214 prosthetic JJ B-NP O
214 leg NN I-NP O
214 as RB O O
214 well RB O O
214 as IN B-VP O
214 his PRP$ O O
215 walker NN B-NP O
215 Physical NNP I-NP O
215 Therapy NNP I-NP O
215 inhouse NN I-NP O
215 worked VBD B-VP O
215 with IN B-VP O
215 the DT B-NP O
215 patient NN I-NP O
215 , , O O
215 and CC O O
215 it PRP O O
216 was VBD B-VP O
216 determined VBN O O
216 that IN B-VP O
216 the DT B-NP O
216 patient NN I-NP O
216 was VBD B-VP O
216 unsafe JJ O O
216 to TO O O
216 go VB O O
216 home NN B-NP O
216 and CC O O
216 it PRP O O
216 was VBD B-VP O
217 recommended VBN O O
217 that IN B-VP O
217 he PRP O O
217 go VB O O
217 to TO O O
217 a DT B-NP O
217 rehabilitation NN I-NP O
217 facility NN I-NP O
217 to TO O O
217 which WDT O O
217 the DT B-NP O
218 patient NN I-NP O
218 finally RB O O
218 agreed VBD B-VP O
219 CODE NNP B-NP O
219 STATUS: NNP I-NP O
220 The DT B-NP O
220 patient NN I-NP O
220 is VBZ O O
220 full JJ B-NP O
220 code NN I-NP O
220 Healthcare NNP I-NP O
220 proxy NN I-NP O
220 is VBZ O O
220 daughter RB O O
220 , , O O
220 Wilford NNP B-NP O
220 A NNP I-NP O
220 Greaux NNP I-NP O
220 Home NNP I-NP O
220 phone NN I-NP O
220 number NN I-NP O
220 is VBZ O O
220 458-092-2461 JJ O O
220 , , O O
220 work VB O O
220 number NN B-NP O
221 727-352-1113 JJ B-NP O
222 DISCHARGE NNP I-NP O
222 MEDICATIONS: NNP I-NP O
223 1 CD O O
223 Tylenol NNP B-NP B-m
223 650 CD O B-do
223 mg NN B-NP I-do
223 p.o NN I-NP B-mo
223 q.4h NN I-NP B-f
223 p.r.n NN I-NP I-f
224 2 CD O O
224 Aspirin NNP B-NP B-m
224 81 CD O B-do
224 mg NN B-NP I-do
224 p.o JJ O B-mo
224 daily JJ O B-f
225 3 CD O O
225 Colace NNP B-NP B-m
225 100 CD O B-do
225 mg NN B-NP I-do
225 p.o NN I-NP B-mo
225 b.i.d VBD B-VP B-f
226 4 CD O O
226 Ferrous NNP B-NP B-m
226 sulfate NN I-NP I-m
226 325 CD O B-do
226 mg NN B-NP I-do
226 p.o NN I-NP B-mo
226 three CD O B-f
226 times NNS B-NP I-f
226 daily RB O I-f
227 5 CD O O
227 Folic NNP B-NP B-m
227 acid VBD B-VP I-m
227 1 CD O B-do
227 mg NN B-NP I-do
227 by IN B-VP B-mo
227 mouth NN B-NP I-mo
227 once RB O B-f
227 daily JJ O I-f
228 6 CD O O
228 Lasix NNP B-NP B-m
228 80 CD O B-do
228 mg NN B-NP I-do
228 p.o NN I-NP B-mo
228 twice RB O B-f
228 daily RB O I-f
229 7 CD O O
229 Gabapentin NNP B-NP B-m
229 100 CD O B-do
229 mg NN B-NP I-do
229 by IN B-VP B-mo
229 mouth NN B-NP I-mo
229 b.i.d NN I-NP B-f
230 8 CD O O
230 Insulin NNP B-NP B-m
230 NPH NNP I-NP I-m
230 10 CD O B-do
230 units NNS B-NP I-do
230 subcutaneous JJ O B-mo
230 daily JJ O B-f
231 9 CD O O
231 Combivent NNP B-NP B-m
231 Combivent NNP I-NP B-m
231 2 CD O B-do
231 2 CD O B-do
231 puffs NNS B-NP I-do
231 puffs NNS I-NP I-do
231 inhaled VBD B-VP B-mo
231 inhaled JJ O B-mo
231 four CD O B-f
231 four CD O B-f
231 times NNS B-NP I-f
231 times NNS I-NP I-f
231 daily JJ B-NP I-f
231 daily JJ I-NP I-f
231 p.r.n NN I-NP I-f
231 p.r.n NN I-NP I-f
231 shortness NN I-NP B-r
232 of IN B-VP O
232 breath NN B-NP O
232 or CC O O
232 wheezing VBG O B-r
232 while IN B-VP B-du
232 while IN B-VP B-du
232 the DT B-NP O
232 patient NN I-NP O
232 is VBZ O O
232 recovering VBG O O
232 from IN B-VP O
232 his PRP$ O O
233 pneumonia NN B-NP O
234 10 CD O O
234 Isosorbide NNP B-NP B-m
234 dinitrate NN I-NP I-m
234 20 CD O B-do
234 mg NN B-NP I-do
234 p.o NN I-NP B-mo
234 three CD O B-f
234 times NNS B-NP I-f
234 daily RB O I-f
235 11 CD O O
235 Xalatan NNP B-NP B-m
235 eye NN I-NP I-m
235 drops VBZ O I-m
235 one CD O B-do
235 drop NN B-NP I-do
235 each DT B-NP B-mo
235 eye NN I-NP I-mo
235 q.p.m RB O B-f
236 12 CD O O
236 Metoprolol NNP B-NP B-m
236 tartrate NN I-NP I-m
236 12.5 CD O B-do
236 mg NN B-NP I-do
236 by IN B-VP B-mo
236 mouth JJ O I-mo
236 twice JJ O B-f
236 daily RB O I-f
237 13 CD O O
237 Oxycodone NNP B-NP B-m
237 2.5 CD O B-do
237 mg NN B-NP I-do
237 by IN B-VP B-mo
237 mouth NN B-NP I-mo
237 every DT O B-f
237 six CD O I-f
237 hours NNS B-NP I-f
237 p.r.n VBP O I-f
237 pain VBP O B-r
238 14 CD O O
238 Senna NNP B-NP B-m
238 tablets NNS I-NP I-m
238 two CD O B-do
238 tablets NNS B-NP I-do
238 by IN B-VP B-mo
238 mouth JJ O I-mo
238 twice JJ O B-f
238 daily RB O I-f
239 15 CD O O
239 Simvastatin NNP B-NP B-m
239 40 CD O B-do
239 mg NN B-NP I-do
239 by IN B-VP B-mo
239 mouth NN B-NP I-mo
239 at IN B-VP B-f
239 bedtime JJ O I-f
240 16 CD O O
240 Multivitamin NNP B-NP B-m
240 one CD O B-do
240 tablet NN B-NP I-do
240 by IN B-VP B-mo
240 mouth JJ O I-mo
240 daily JJ O B-f
241 17 CD O O
241 Coumadin NNP B-NP B-m
241 3.5 CD O B-do
241 mg NN B-NP I-do
241 by IN B-VP B-mo
241 mouth NN B-NP I-mo
241 q.p.m JJ B-NP B-f
242 MEDICATION NNP I-NP O
242 CHANGES NNP I-NP O
242 MADE NNP I-NP O
242 DURING NNP I-NP O
242 THIS NNP I-NP O
242 ADMISSION: NNP I-NP O
243 Diltiazem NNP I-NP B-m
243 was VBD B-VP O
243 discontinued VBN O O
243 NPH NNP B-NP B-m
243 NPH NNP I-NP B-m
243 insulin NN I-NP I-m
243 insulin NN I-NP I-m
243 was VBD B-VP O
243 reduced VBN O O
243 from IN B-VP O
243 20 CD O O
244 units NNS B-NP O
244 daily RB O O
244 to TO O O
244 10 CD O B-do
244 10 CD O B-do
244 units NNS B-NP I-do
244 units NNS I-NP I-do
244 daily RB O B-f
244 daily RB O B-f
244 A NNP B-NP O
244 multivitamin NN I-NP B-m
244 was VBD B-VP O
244 added VBN O O
245 Isosorbide NNP B-NP B-m
245 dinitrate NN I-NP I-m
245 was VBD B-VP O
245 added VBN O O
245 Coumadin NNP B-NP B-m
245 was VBD B-VP O
245 added VBN O O
246 TO-DO NNP B-NP O
246 LIST NNP I-NP O
246 FOR NNP I-NP O
246 REHAB NNP I-NP O
246 AND NNP I-NP O
246 VNA: NNP I-NP O
247 1 CD O O
247 Monitor NNP B-NP O
247 blood NN I-NP O
247 pressure NN I-NP O
248 2 CD O O
248 Monitor NNP B-NP O
248 blood NN I-NP O
248 sugars NNS I-NP O
249 3 CD O O
249 Please NNP B-NP O
249 check VB O O
249 INR NNP B-NP O
249 on IN B-VP O
249 4/30/07 CD O O
249 and CC O O
249 every DT O O
249 two CD O O
249 to TO O O
249 three CD O O
249 days NNS B-NP O
250 thereafter RB O O
250 and CC O O
250 adjust VBP O O
250 the DT B-NP O
250 Coumadin NNP I-NP B-m
250 as IN B-VP B-f
250 necessary JJ O I-f
250 for IN B-VP O
250 target NN B-NP B-r
250 INR NNP I-NP I-r
250 of IN B-VP O
251 2-3 JJ O O
252 4 CD O O
252 Please NNP B-NP O
252 do VB O O
252 wound RB O O
252 care VB O O
252 on IN B-VP O
252 right JJ B-NP O
252 buttocks NNS I-NP O
252 and CC O O
252 sacrum NN B-NP O
252 ( ( O O
252 the DT B-NP O
253 patient NN I-NP O
253 has VBZ O O
253 a DT B-NP O
253 skin JJ I-NP O
253 tear NN I-NP O
253 on IN B-VP O
253 the DT B-NP O
253 right JJ I-NP O
253 buttocks NNS I-NP O
253 but CC O O
253 no DT B-NP O
253 signs NNS I-NP O
253 of IN B-VP O
254 infection NN B-NP O
254 , , O O
254 and CC O O
254 the DT B-NP O
254 patient NN I-NP O
254 has VBZ O O
254 a DT B-NP O
254 stage NN I-NP O
254 I PRP O O
254 decubitus VBP O O
254 ulcer JJ O O
254 on IN B-VP O
254 the DT B-NP O
255 sacrum NN I-NP O
255 ) ) O O
255 Please NNP B-NP O
255 apply VB O O
255 DuoDERM NNP B-NP O
255 and CC O O
255 do VBP O O
255 wound VB O O
255 care VB O O
256 5 CD O O
256 Please NNP B-NP O
256 have VBP O O
256 VNA NNP B-NP O
256 do VBP O O
256 home NN B-NP O
256 safety NN I-NP O
256 evaluation NN I-NP O
256 when WRB O O
256 the DT B-NP O
256 patient NN I-NP O
257 goes VBZ O O
257 home NN B-NP O
257 , , O O
257 and CC O O
257 please VB O O
257 continue VB O O
257 physical JJ B-NP O
257 therapy NN I-NP O
258 FOLLOW-UP NNP I-NP O
258 APPOINTMENTS: NNP I-NP O
259 The DT B-NP O
259 patient NN I-NP O
259 will MD O O
259 follow VB O O
259 up RP O O
259 with IN B-VP O
259 his PRP$ O O
259 cardiologist NN B-NP O
259 , , O O
259 Dr NNP B-NP O
259 Cedric NNP I-NP O
259 D NNP I-NP O
259 Laite NNP I-NP O
259 , , O O
259 of IN B-VP O
259 RDH NNP B-NP O
259 His PRP$ O O
259 office NN B-NP O
259 is VBZ O O
259 aware JJ O O
259 that IN B-VP O
259 he PRP O O
259 needs VBZ O O
259 an DT B-NP O
260 appointment NN I-NP O
260 in IN B-VP O
260 the DT O O
260 next JJ O O
260 one CD O O
260 to TO O O
260 two CD O O
260 weeks NNS B-NP O
260 and CC O O
260 his PRP$ O O
260 office NN B-NP O
260 will MD O O
260 call VB O O
261 the DT B-NP O
261 patient NN I-NP O
261 with IN B-VP O
261 confirmation NN B-NP O
261 of IN B-VP O
261 this DT B-NP O
261 appointment NN I-NP O
261 Dr NNP I-NP O
261 Petruso NNP I-NP O
262 office NN I-NP O
262 number NN I-NP O
262 is VBZ O O
262 852-385-4973 JJ B-NP O
263 CONTINUING NNP I-NP O
263 CARE NNP I-NP O
263 PLAN NNP I-NP O
263 FOR NNP I-NP O
263 M.D.s: NNP I-NP O
264 For IN B-VP O
264 cardiologist NN B-NP O
264 , , O O
265 1 CD O O
265 Follow NNP B-NP O
265 up RB O O
265 final JJ B-NP O
265 results NNS I-NP O
265 of IN B-VP O
265 amyloid JJ B-NP O
265 genetic JJ I-NP O
265 test NN I-NP O
266 2 CD O O
266 Follow NNP B-NP O
266 up RB O O
266 final JJ B-NP O
266 results NNS I-NP O
266 of IN B-VP O
266 bone NN B-NP O
266 marrow NN I-NP O
266 biopsy VBD B-VP O
267 3 CD O O
267 Follow NNP B-NP O
267 up RB O O
267 final JJ B-NP O
267 results NNS I-NP O
267 of IN B-VP O
267 the DT B-NP O
267 heart NN I-NP O
267 biopsy NN I-NP O
267 including VBG O O
267 special JJ B-NP O
268 stains NNS I-NP O
269 For IN B-VP O
269 Primary NNP B-NP O
269 Care NNP I-NP O
269 Physician NNP I-NP O
269 , , O O
270 1 CD O O
270 Manage NNP B-NP O
270 insulin NN I-NP B-m
270 regimen NNS I-NP O
271 2 CD O O
271 Follow NNP B-NP O
271 low JJ O O
271 back RB O O
271 pain NN B-NP O
271 which WDT O O
271 appears VBZ O O
271 to TO O O
271 be VB O O
271 chronic JJ O O
272 3 CD O O
272 Follow NNP B-NP O
272 decubitus NN I-NP O
272 ulcer NN I-NP O
272 stage NN I-NP O
272 I PRP O O
273 4 CD O O
273 Follow NNP B-NP O
273 INR NNP I-NP O
273 and CC O O
273 adjust RB O O
273 Coumadin NNP B-NP B-m
273 as IN B-VP B-f
273 needed VBN O I-f
274 5 CD O O
274 Monitor NNP B-NP O
274 LFT NNP I-NP O
274 which WDT O O
274 appear VBP O O
274 to TO O O
274 be VB O O
274 chronically RB O O
274 elevated VBN O O
274 and CC O O
275 workup NN B-NP O
275 as IN B-VP O
275 necessary JJ O O
276 6 CD O O
276 Question NN B-NP O
276 of IN B-VP O
276 restless NN B-NP O
276 leg NN I-NP O
276 syndrome JJ B-NP O
276 Please NNP I-NP O
276 reassess NN I-NP O
276 and CC O O
276 treat NN B-NP O
277 as IN B-VP O
277 needed VBN O O
278 7 CD O O
278 Monitor NNP B-NP O
278 hematocrit NN I-NP O
278 and CC O O
278 platelets NNS B-NP O
279 An DT B-NP O
279 addendum NN I-NP O
279 to TO O O
279 this DT B-NP O
279 stat JJ I-NP O
279 dictation NN I-NP O
279 will MD O O
279 follow VB O O
279 when WRB O O
279 the DT B-NP O
279 patient NN I-NP O
280 discharge NN I-NP O
280 is VBZ O O
280 confirmed VBN O O
280 including VBG O O
280 a DT B-NP O
280 finalized JJ I-NP O
280 medication NN I-NP O
280 list NN I-NP O
280 for IN B-VP O
281 discharge NN B-NP O
281 and CC O O
281 a DT B-NP O
281 final JJ I-NP O
281 discharge NN I-NP O
281 weight NN I-NP O
282 eScription NN I-NP O
282 document: VBZ O O
282 7-3368383 JJ B-NP O
282 EMSSten NNP I-NP O
282 Tel NNP I-NP O
283 CC: NNP I-NP O
283 Omar NNP I-NP O
283 Arnstein NNP I-NP O
283 M.D NNP I-NP O
284 Kaihend NNP I-NP O
284 Medical NNP I-NP O
284 Center NNP I-NP O
285 Tuc NNP I-NP O
286 Dictated NNP I-NP O
286 By: NNP I-NP O
286 BITTING NNP I-NP O
286 , , O O
286 JORDAN NNP B-NP O
287 Attending: NNP I-NP O
287 HARCOURT NNP I-NP O
287 , , O O
287 DALE NNP B-NP O
288 Dictation NNP I-NP O
288 ID NNP I-NP O
288 0097732 CD O O
289 D: NNP B-NP O
289 3/14/07 CD O O
290 T: NNP B-NP O
290 3/14/07 CD O O
291 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #163977 VBZ O O
4 072274871 CD O O
4 TH NNP B-NP O
4 93517091 CD O O
4 561631 CD O O
4 9/5/1990 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/20/1990 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/19/1990 CD O O
7 DISCHARGE NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 PERIPHERAL NNP I-NP O
7 VASCULAR NNP I-NP O
7 DISEASE NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT B-NP O
8 55-year-old JJ I-NP O
8 man NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 smoking NN B-NP O
9 and CC O O
9 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 a DT B-NP O
10 left NN I-NP O
10 sided VBN O O
10 hemisphere RB O O
10 stroke NN B-NP O
10 who WP O O
10 was VBD B-VP O
10 normotensive JJ O O
10 , , O O
10 nondiabetic JJ O O
10 and CC O O
11 does VBZ O O
11 not RB O O
11 have VB O O
11 known VBN O O
11 coronary JJ B-NP O
11 disease NN I-NP O
11 who WP O O
11 underwent VBD B-VP O
11 a DT O O
11 right-sided JJ O O
12 femoral JJ O O
12 to TO O O
12 popliteal VB O O
12 bypass NN B-NP O
12 graft NN I-NP O
12 in IN B-VP O
12 February NNP B-NP O
12 of IN B-VP O
12 1986 CD O O
12 for IN B-VP O
12 severe JJ B-NP O
13 claudication NN I-NP O
13 This DT O O
13 resulted VBD B-VP O
13 in IN B-VP O
13 relief NN B-NP O
13 He PRP O O
13 was VBD B-VP O
13 readmitted VBN O O
13 in IN B-VP O
13 March NNP B-NP O
14 of IN B-VP O
14 1988 CD O O
14 for IN B-VP O
14 increase NN B-NP O
14 in IN B-VP O
14 pain NN B-NP O
14 in IN B-VP O
14 the DT B-NP O
14 calves NNS I-NP O
14 which WDT O O
14 began VBD B-VP O
14 at IN B-VP O
15 ambulation NN B-NP O
15 of IN B-VP O
15 30 CD O O
15 feet NNS B-NP O
15 Angiographic JJ B-NP O
15 evaluation NN I-NP O
15 at IN B-VP O
15 that DT B-NP O
15 time NN I-NP O
15 showed VBD B-VP O
16 a DT B-NP O
16 thrombosed JJ I-NP O
16 graft NN I-NP O
16 and CC O O
16 he PRP O O
16 was VBD B-VP O
16 taken VBN O O
16 to TO O O
16 the DT B-NP O
16 Operating NN I-NP O
16 Room NNP I-NP O
16 for IN B-VP O
16 a DT B-NP O
17 saphenous JJ I-NP O
17 vein NN I-NP O
17 in IN B-VP O
17 situ NN B-NP O
17 right RB O O
17 femoral JJ O O
17 to TO O O
17 right JJ B-NP O
17 popliteal NN I-NP O
17 bypass NN I-NP O
18 graft NN I-NP O
18 This DT O O
18 was VBD B-VP O
18 complicated VBN O O
18 by IN B-VP O
18 wound NN B-NP O
18 cellulitis NN I-NP O
18 which WDT O O
18 was VBD B-VP O
19 medicated VBN O O
19 in IN B-VP O
19 the DT B-NP O
19 appropriate JJ I-NP O
19 manner NN I-NP O
19 and CC O O
19 he PRP O O
19 was VBD B-VP O
19 therefore RB O O
20 discharged VBD B-VP O
20 The DT B-NP O
20 patient NN I-NP O
20 was VBD B-VP O
20 readmitted VBN O O
20 in IN B-VP O
20 February NNP B-NP O
20 of IN B-VP O
20 1988 CD O O
20 with IN B-VP O
21 graft NN B-NP O
21 stenosis NN I-NP O
21 and CC O O
21 underwent JJ B-NP O
21 angioplasty NN I-NP O
21 After IN B-VP O
21 this DT B-NP O
21 procedure NN I-NP O
21 , , O O
21 he PRP O O
22 had VBD B-VP O
22 palpable JJ B-NP O
22 pulses NNS I-NP O
22 He PRP O O
22 was VBD B-VP O
22 readmitted VBN O O
22 in IN B-VP O
22 July NNP B-NP O
22 of IN B-VP O
22 1989 CD O O
22 for IN B-VP O
23 angioplasty NN B-NP O
23 He PRP O O
23 presented VBD B-VP O
23 at IN B-VP O
23 this DT B-NP O
23 time NN I-NP O
23 with IN B-VP O
23 progressive JJ B-NP O
23 pain NN I-NP O
23 and CC O O
24 three CD O O
24 months NNS B-NP O
24 of IN B-VP O
24 frank JJ B-NP O
24 rest NN I-NP O
24 pain NN I-NP O
24 in IN B-VP O
24 the DT B-NP O
24 right JJ I-NP O
24 calf NN I-NP O
24 and CC O O
24 claudication NN B-NP O
25 of IN B-VP O
25 the DT B-NP O
25 left JJ I-NP O
25 calf NN I-NP O
25 at IN B-VP O
25 400 CD O O
25 yards NNS B-NP O
25 He PRP O O
25 denied VBD B-VP O
25 dependent JJ B-NP O
25 rubor NN I-NP O
25 pallor NN I-NP O
25 or CC O O
26 coldness NN B-NP O
26 in IN B-VP O
26 the DT B-NP O
26 foot NN I-NP O
26 but CC O O
26 he PRP O O
26 does VBZ O O
26 have VB O O
26 pain NN B-NP O
26 paresthesias NN I-NP O
26 He PRP O O
26 has VBZ O O
26 a DT B-NP O
27 history NN I-NP O
27 of IN B-VP O
27 chest NN B-NP O
27 pain NN I-NP O
27 and CC O O
27 was VBD B-VP O
27 evaluated VBN O O
27 by IN B-VP O
27 an DT B-NP O
27 exercise NN I-NP O
27 tolerance NN I-NP O
28 test NN I-NP O
28 in IN B-VP O
28 the DT B-NP O
28 past NN I-NP O
28 and CC O O
28 was VBD B-VP O
28 found VBN O O
28 not RB O O
28 to TO O O
28 have VB O O
28 coronary JJ B-NP O
28 artery NN I-NP O
28 disease NN I-NP O
29 but CC O O
29 was VBD B-VP O
29 felt VBN O O
29 to TO O O
29 have VB O O
29 esophageal NN B-NP O
29 dismotility NN I-NP O
29 which WDT O O
29 was VBD B-VP O
29 demonstrated VBN O O
30 on IN B-VP O
30 the DT B-NP O
30 study NN I-NP O
30 PAST NNP I-NP O
30 MEDICAL NNP I-NP O
30 HISTORY: NNP I-NP O
30 1 CD O O
30 Esophageal NNP B-NP O
30 reflux NN I-NP O
30 2 CD O O
31 Left NNP B-NP O
31 hemisphere NN I-NP O
31 stroke VBD B-VP O
31 which WDT O O
31 resulted VBD B-VP O
31 in IN B-VP O
31 residual JJ B-NP O
31 right JJ I-NP O
32 hemiparesis NN I-NP O
32 3 CD O O
32 Anxiety NNP B-NP O
32 disorder NN I-NP O
32 4 CD O O
32 Chronic NNP B-NP O
32 low JJ O O
32 back RB O O
32 pain VBP O O
32 5 CD O O
33 Peptic JJ B-NP O
33 ulcer JJ I-NP O
33 disease NN I-NP O
33 6 CD O O
33 Herniated NNP B-NP O
33 nucleus JJ B-NP O
33 pulposus NN I-NP O
33 PAST NNP I-NP O
34 SURGICAL NNP I-NP O
34 HISTORY: NNP I-NP O
34 1 CD O O
34 Femoral NNP B-NP O
34 popliteal JJ B-NP O
34 bypass NN I-NP O
34 graft NN I-NP O
34 in IN B-VP O
34 1986 CD O O
34 2 CD O O
35 Femoral NNP B-NP O
35 popliteal NN I-NP O
35 saphenous JJ B-NP O
35 vein NN I-NP O
35 in IN B-VP O
35 situ NN B-NP O
35 graft NN I-NP O
35 in IN B-VP O
35 1988 CD O O
35 3 CD O O
36 Cholecystectomy NNP B-NP O
36 in IN B-VP O
36 1986 CD O O
36 4 CD O O
36 Lysis NN B-NP O
36 of IN B-VP O
36 adhesions NNS B-NP O
36 for IN B-VP O
36 small JJ B-NP O
36 bowel NN I-NP O
37 obstruction NN I-NP O
37 in IN B-VP O
37 1970 CD O O
37 , , O O
37 repeated VBN O O
37 in IN B-VP O
37 1970 CD O O
37 again RB O O
37 5 CD O O
37 Resection NNP B-NP O
37 of IN B-VP O
37 a DT O O
38 herniated VBN O O
38 nucleus NN B-NP O
38 pulposus NN I-NP O
38 in IN B-VP O
38 1985 CD O O
38 6 CD O O
38 Knee NNP B-NP O
38 operation NN I-NP O
38 in IN B-VP O
38 1974 CD O O
38 7 CD O O
39 Cystoscopy NNP B-NP O
39 in IN B-VP O
39 1986 CD O O
39 MEDICATIONS: NNP B-NP O
39 On IN B-VP O
39 admission NN B-NP O
39 included VBD B-VP O
39 Pepcid NNP B-NP B-m
39 , , O O
40 40 CD O B-do
40 mg NN B-NP I-do
40 at IN B-VP B-f
40 h.s.; NN B-NP I-f
40 trazodone NN I-NP B-m
40 , , O O
40 15 CD O B-do
40 mg NN B-NP I-do
40 at IN B-VP B-f
40 h.s.; NN B-NP I-f
40 Carafate NNP I-NP B-m
40 , , O O
40 one CD O B-do
40 q.i.d.; NN B-NP B-f
41 nitroglycerin CC O B-m
41 p.r.n NN B-NP B-f
41 and CC O O
41 Flexeril NNP B-NP B-m
41 , , O O
41 10 CD O B-do
41 mg NN B-NP I-do
41 q NN I-NP B-f
41 eight CD O I-f
41 hours NNS B-NP I-f
41 p.r.n VBP O I-f
41 back RB O B-r
42 pain VBP O O
42 ALLERGIES: NNP B-NP O
42 QUESTION NNP I-NP O
42 OF NNP I-NP O
42 PENICILLIN NNP I-NP O
42 AND NNP I-NP O
42 QUESTION NNP I-NP O
42 OF NNP I-NP O
42 DYE NNP I-NP O
43 HABITS: NNP I-NP O
43 The DT B-NP O
43 patient NN I-NP O
43 has VBZ O O
43 smoked VBN O O
43 one CD O O
43 pack NN B-NP O
43 per IN B-VP O
43 day NN B-NP O
43 for IN B-VP O
43 45 CD O O
43 years NNS B-NP O
44 Alcohol NNP I-NP O
44 was VBD B-VP O
44 none RB O O
44 REVIEW NNP B-NP O
44 OF NNP I-NP O
44 SYSTEMS: NNP I-NP O
44 Noteable NNP I-NP O
44 for IN B-VP O
44 five CD O O
44 episodes NNS B-NP O
45 of IN B-VP O
45 pneumonia NN B-NP O
45 Flaccid NNP I-NP O
45 urinary JJ B-NP O
45 bladder NN I-NP O
45 and CC O O
45 chronic JJ B-NP O
45 chest NN I-NP O
45 discomfort NN I-NP O
46 from IN B-VP O
46 esophageal JJ B-NP O
46 dismotility NN I-NP O
47 PHYSICAL NNP I-NP O
47 EXAMINATION: NNP I-NP O
47 On IN B-VP O
47 admission NN B-NP O
47 revealed VBD B-VP O
47 a DT B-NP O
47 robust JJ I-NP O
47 white JJ I-NP O
47 male NN I-NP O
48 in IN B-VP O
48 no DT B-NP O
48 acute NN I-NP O
48 distress NN I-NP O
48 He PRP O O
48 had VBD B-VP O
48 no DT O O
48 skin JJ O O
49 lesions VBZ O O
49 No DT B-NP O
49 lymphadenopathy JJ I-NP O
49 Head NNP I-NP O
49 and CC O O
49 neck JJ B-NP O
49 exams NNS I-NP O
49 were VBD B-VP O
49 noteable JJ O O
50 only RB O O
50 for IN B-VP O
50 partial JJ B-NP O
50 denture NN I-NP O
50 plates VBZ O O
50 The DT B-NP O
50 breasts NNS I-NP O
50 had VBD B-VP O
50 no DT B-NP O
50 masses NNS I-NP O
50 or CC O O
51 discharge NN B-NP O
51 Lungs NNS I-NP O
51 were VBD B-VP O
51 clear JJ O O
51 to TO O O
51 auscultation VB O O
51 Heart NNP B-NP O
51 had VBD B-VP O
51 a DT B-NP O
51 regular JJ I-NP O
52 rate NN I-NP O
52 and CC O O
52 rhythm NN B-NP O
52 without IN B-VP O
52 murmurs NNS B-NP O
52 , , O O
52 rubs NNS B-NP O
52 or CC O O
52 gallops VBZ O O
52 The DT B-NP O
52 pulses NNS I-NP O
52 were VBD B-VP O
53 palpable JJ O O
53 at IN B-VP O
53 the DT B-NP O
53 carotid NN I-NP O
53 and CC O O
53 radials NNS B-NP O
53 and CC O O
53 dopplerable JJ O O
53 at IN B-VP O
53 the DT B-NP O
54 popliteals NNS I-NP O
54 , , O O
54 dorsalis NN B-NP O
54 pedis NN I-NP O
54 and CC O O
54 posterior JJ B-NP O
54 tibials NNS I-NP O
54 bilaterally RB O O
55 Abdomen NNP B-NP O
55 was VBD B-VP O
55 soft JJ O O
55 and CC O O
55 nontender NN B-NP O
55 , , O O
55 nondistended VBD B-VP O
55 Bowel NNP B-NP O
55 sounds NNS I-NP O
55 were VBD B-VP O
56 present JJ O O
56 There EX O O
56 was VBD B-VP O
56 no DT B-NP O
56 hepatosplenomegaly NN I-NP O
56 or CC O O
56 masses NNS B-NP O
56 There EX O O
56 was VBD B-VP O
56 a DT B-NP O
57 right JJ I-NP O
57 paramedian NN I-NP O
57 scar NN I-NP O
57 Genital NNP I-NP O
57 examination NN I-NP O
57 revealed VBD B-VP O
57 a DT B-NP O
57 normal JJ I-NP O
58 uncircumcised JJ I-NP O
58 phallus NN I-NP O
58 with IN B-VP O
58 a DT B-NP O
58 redundant JJ I-NP O
58 prepuce NN I-NP O
58 Cord NNP I-NP O
58 , , O O
58 scrotum NN B-NP O
58 , , O O
59 testes NNS B-NP O
59 and CC O O
59 external JJ B-NP O
59 rings NNS I-NP O
59 were VBD B-VP O
59 unremarkable JJ B-NP O
59 Stool NNP I-NP O
59 was VBD B-VP O
59 guaiac JJ B-NP O
60 negative JJ I-NP O
60 Musculoskeletal NNP I-NP O
60 examination NN I-NP O
60 was VBD B-VP O
60 otherwise RB O O
60 noteable JJ O O
60 for IN B-VP O
61 scars NNS B-NP O
61 in IN B-VP O
61 the DT B-NP O
61 knees NNS I-NP O
61 and CC O O
61 lower JJR O O
61 back RB O O
61 Neurological JJ B-NP O
61 examination NN I-NP O
62 revealed VBD B-VP O
62 a DT B-NP O
62 numb JJ I-NP O
62 right NN I-NP O
62 lower RBR O O
62 extremity NN B-NP O
62 with IN B-VP O
62 a DT B-NP O
62 negative JJ I-NP O
62 pinprick NN I-NP O
63 examination NN I-NP O
64 HOSPITAL NNP I-NP O
64 COURSE: NNP I-NP O
64 The DT B-NP O
64 patient NN I-NP O
64 was VBD B-VP O
64 taken VBN O O
64 to TO O O
64 the DT B-NP O
64 Angiography NNP I-NP O
64 Suite NNP I-NP O
65 on IN B-VP O
65 3/5/90 CD O O
65 where WRB O O
65 multiple JJ B-NP O
65 segmental JJ I-NP O
65 narrowings NNS I-NP O
65 of IN B-VP O
66 the DT B-NP O
66 right NN I-NP O
66 graft NN I-NP O
66 and CC O O
66 complete JJ B-NP O
66 occlusion NN I-NP O
66 of IN B-VP O
66 the DT B-NP O
66 left JJ I-NP O
66 distal JJ I-NP O
66 SFA NNP I-NP O
66 with IN B-VP O
67 distal JJ B-NP O
67 reconstitution NN I-NP O
67 were VBD B-VP O
67 discovered VBN O O
67 He PRP O O
67 was VBD B-VP O
67 taken VBN O O
67 to TO O O
67 the DT B-NP O
68 Operating NN I-NP O
68 Room NN I-NP O
68 by IN B-VP O
68 Dr NNP B-NP O
68 Dougherty NNP I-NP O
68 on IN B-VP O
68 5/1/90 CD O O
68 where WRB O O
68 a DT B-NP O
68 right JJ I-NP O
68 reverse NN I-NP O
69 saphenous JJ B-NP O
69 bypass NN I-NP O
69 graft NN I-NP O
69 from IN B-VP O
69 the DT O O
69 in IN B-VP O
69 situ NN B-NP O
69 vein NN I-NP O
69 graft NN I-NP O
69 to TO O O
69 below IN B-VP O
69 the DT B-NP O
70 knee NN I-NP O
70 popliteal NN I-NP O
70 artery NN I-NP O
70 was VBD B-VP O
70 performed VBN O O
70 by IN B-VP O
70 Dr NNP B-NP O
70 Bayani NNP I-NP O
70 assisted VBN O O
70 by IN B-VP O
71 Dr NNP B-NP O
71 Macgowan NNP I-NP O
71 and CC O O
71 Dr NNP B-NP O
71 Horwath NNP I-NP O
71 Postoperatively NNP I-NP O
71 , , O O
71 the DT B-NP O
71 patient NN I-NP O
71 had VBD B-VP O
72 excellent JJ B-NP O
72 palpable JJ I-NP O
72 pulses NNS I-NP O
72 in IN B-VP O
72 the DT B-NP O
72 foot NN I-NP O
72 and CC O O
72 he PRP O O
72 enjoyed VBD B-VP O
72 an DT B-NP O
73 unremarkable JJ I-NP O
73 hospital NN I-NP O
73 course NN I-NP O
73 and CC O O
73 was VBD B-VP O
73 sent VBN O O
73 home NN B-NP O
73 on IN B-VP O
74 INCOMPLETE NNP B-NP O
74 DICTATION NNP I-NP O
75 ________________________________ NNP I-NP O
75 YO013/6073 NNP I-NP O
76 ELMER NNP I-NP O
76 P NNP I-NP O
76 KNEIFL NNP I-NP O
76 , , O O
76 M.D NNP B-NP O
76 QM26 NNP I-NP O
76 D: NNP I-NP O
76 11/28/90 CD O O
77 Batch: NNP B-NP O
77 9493 CD O O
77 Report: NNP B-NP O
77 Y0035C69 NNP I-NP O
77 T: NNP I-NP O
77 2/6/90 CD O O
78 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #172366 VBZ O O
2 805770489 CD O O
2 CNHAMC NNP B-NP O
2 29803992 CD O O
2 0399681 CD O O
2 5/2/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 INFECTED NNP I-NP O
2 MESH NNP I-NP O
2 IN NNP I-NP O
2 ABDOMINAL NNP I-NP O
2 Signed NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 4/17/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/22/2006 CD O O
4 ATTENDING: NNP B-NP O
4 SWEED NNP I-NP O
4 , , O O
4 ZANE NNP B-NP O
4 MD NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 MRSA-infected NNP I-NP O
5 abdominal JJ B-NP O
5 mesh JJ I-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 This DT O O
6 is VBZ O O
6 a DT B-NP O
6 90+-year-old JJ I-NP O
6 male NN I-NP O
6 with IN B-VP O
6 a DT B-NP O
7 complex JJ I-NP O
7 past NN I-NP O
7 medical JJ B-NP O
7 history NN I-NP O
7 including VBG O O
7 CAD NNP B-NP O
7 status NN I-NP O
7 post NN I-NP O
7 stent NN I-NP O
7 x2 NN I-NP O
7 , , O O
8 hypertension NN B-NP O
8 , , O O
8 CHF NNP B-NP O
8 with IN B-VP O
8 an DT B-NP O
8 EF NNP I-NP O
8 of IN B-VP O
8 10-20% JJ O O
8 , , O O
8 AF NNP B-NP O
8 , , O O
8 on IN B-VP O
8 chronic JJ B-NP O
9 anticoagulation NN I-NP O
9 , , O O
9 status NN B-NP O
9 post NN I-NP O
9 pacer NN I-NP O
9 placement NN I-NP O
9 , , O O
9 and CC O O
9 diabetes VBZ O O
10 mellitus NNS B-NP O
10 who WP O O
10 presented VBD B-VP O
10 to TO O O
10 the DT B-NP O
10 SICU NNP I-NP O
10 status NN I-NP O
10 post NN I-NP O
10 exploratory NN I-NP O
11 laparotomy NN I-NP O
11 for IN B-VP O
11 removal NN B-NP O
11 of IN B-VP O
11 chronically RB O O
11 MRSA-infected JJ B-NP O
11 mesh NN I-NP O
11 from IN B-VP O
12 prior JJ B-NP O
12 abdominal JJ I-NP O
12 surgery NN I-NP O
12 He PRP O O
12 was VBD B-VP O
12 admitted VBN O O
12 to TO O O
12 the DT B-NP O
12 ICU NNP I-NP O
12 for IN B-VP O
13 careful JJ B-NP O
13 monitoring NN I-NP O
13 and CC O O
13 fluid NN B-NP O
13 volume NN I-NP O
13 management NN I-NP O
14 postoperatively RB O O
14 He PRP O O
14 has VBZ O O
14 had VBN O O
14 multiple JJ B-NP O
14 abdominal JJ I-NP O
14 surgeries NNS I-NP O
14 The DT B-NP O
15 mesh NN I-NP O
15 was VBD B-VP O
15 originally RB O O
15 placed VBN O O
15 for IN B-VP O
15 ventral JJ B-NP O
15 hernia NN I-NP O
15 repair NN I-NP O
15 in IN B-VP O
15 2005 CD O O
15 He PRP O O
16 had VBD B-VP O
16 since IN B-VP O
16 developed VBN O O
16 draining VBG O O
16 sinus NN B-NP O
16 tracts NNS I-NP O
16 for IN B-VP O
16 which WDT O O
16 cultures NNS B-NP O
16 have VBP O O
17 grown VBN O O
17 out RP O O
17 MRSA NNP B-NP O
17 He PRP O O
17 was VBD B-VP O
17 admitted VBN O O
17 preoperatively RB O O
17 for IN B-VP O
17 reversal NN B-NP O
17 of IN B-VP O
18 anticoagulation NN B-NP O
18 and CC O O
18 semi-urgent JJ B-NP O
18 removal NN I-NP O
18 of IN B-VP O
18 the DT B-NP O
18 mesh NN I-NP O
18 In IN B-VP O
18 the DT B-NP O
19 operating NN I-NP O
19 room NN I-NP O
19 , , O O
19 he PRP O O
19 underwent VBD B-VP O
19 an DT B-NP O
19 exploratory JJ I-NP O
19 laparotomy NN I-NP O
19 , , O O
19 lysis NN B-NP O
19 of IN B-VP O
20 adhesions NNS B-NP O
20 and CC O O
20 removal NN B-NP O
20 of IN B-VP O
20 the DT B-NP O
20 abdominal JJ I-NP O
20 mesh NN I-NP O
20 He PRP O O
20 was VBD B-VP O
20 closed VBN O O
20 and CC O O
21 one CD O O
21 Jackson-Pratt NNP B-NP O
21 drain NN I-NP O
21 was VBD B-VP O
21 left VBN O O
21 in IN B-VP O
21 place NN B-NP O
21 During IN B-VP O
21 the DT B-NP O
21 procedure NN I-NP O
21 , , O O
22 he PRP O O
22 was VBD B-VP O
22 intubated VBN O O
22 with IN B-VP O
22 etomidate NN B-NP B-m
22 , , O O
22 succinylcholine NN B-NP B-m
22 and CC O O
22 kept VBD B-VP O
22 sedated VBN O B-r
22 sedated VBN O B-r
23 with IN B-VP O
23 Versed JJ O B-m
23 and CC O O
23 fentanyl NN B-NP B-m
23 He PRP O O
23 received VBD B-VP O
23 intraoperative JJ B-NP O
23 vancomycin NN I-NP B-m
24 and CC O O
24 levofloxacin NN B-NP B-m
24 as RB O O
24 well RB O O
24 as IN B-VP O
24 2200 CD O B-do
24 mL NN B-NP I-do
24 of IN B-VP O
24 lactated JJ B-NP B-m
24 Ringer's NNP I-NP I-m
24 In IN B-VP O
24 an DT B-NP B-r
25 attempt NN I-NP O
25 to TO O O
25 reverse VB O O
25 anticoagulation NN B-NP O
25 , , O O
25 one CD O B-do
25 unit NN B-NP I-do
25 of IN B-VP O
25 FFP NNP B-NP B-m
25 was VBD B-VP O
25 begun VBN O O
25 but CC O O
26 then RB O O
26 aborted VBD B-VP O
26 due JJ O O
26 to TO O O
26 hypotension NN B-NP B-r
26 , , O O
26 which WDT O O
26 resolved VBD B-VP O
26 with IN B-VP O
26 epinephrine JJ B-NP B-m
27 injection NN I-NP B-mo
27 , , O O
27 likely RB O O
27 due JJ O O
27 to TO O O
27 transfusion VB O O
27 reaction NN B-NP O
27 Another DT B-NP B-do
27 unit NN I-NP I-do
27 of IN B-VP O
28 FFP NNP B-NP B-m
28 was VBD B-VP O
28 hung VBN O O
28 and CC O O
28 tolerated VBN O O
28 well RB O O
28 EBL NNP B-NP O
28 was VBD B-VP O
28 300 CD O O
28 mL JJ B-NP O
28 Urine NNP I-NP O
28 output NN I-NP O
29 was VBD B-VP O
29 410 CD O O
29 mL NN B-NP O
29 for IN B-VP O
29 the DT B-NP O
29 four-hour JJ I-NP O
29 case NN I-NP O
29 He PRP O O
29 was VBD B-VP O
29 extubated VBN O O
29 uneventfully RB O O
30 and CC O O
30 transferred VBD B-VP O
30 to TO O O
30 the DT B-NP O
30 ICU NNP I-NP O
30 in IN B-VP O
30 stable JJ B-NP O
30 condition NN I-NP O
31 PAST NNP I-NP O
31 MEDICAL NNP I-NP O
31 HISTORY: NNP I-NP O
32 1 CD O O
32 Colon NNP B-NP O
32 cancer NN I-NP O
32 , , O O
32 status NN B-NP O
32 post NN I-NP O
32 colonoscopy NN I-NP O
32 in IN B-VP O
32 2005 CD O O
32 that WDT O O
32 was VBD B-VP O
33 negative JJ O O
34 2 CD O O
34 Prostate NNP B-NP O
34 cancer NN I-NP O
35 3 CD O O
35 History NNP B-NP O
35 of IN B-VP O
35 CVA NNP B-NP O
35 with IN B-VP O
35 a DT B-NP O
35 left JJ I-NP O
35 occipital JJ I-NP O
35 infarct NN I-NP O
35 thought VBD B-VP O
35 to TO O O
35 be VB O O
36 due JJ O O
36 to TO O O
36 embolic VB O O
36 phenomenon NN B-NP O
37 4 CD O O
37 History NNP B-NP O
37 of IN B-VP O
37 TIAs NNP B-NP O
38 5 CD O O
38 Osteoarthritis NNP B-NP O
38 of IN B-VP O
38 the DT B-NP O
38 cervical JJ I-NP O
38 spine NN I-NP O
39 6 CD O O
39 Chronic NNP B-NP O
39 atrial JJ B-NP O
39 fibrillation NN I-NP O
39 , , O O
39 on IN B-VP O
39 Coumadin NNP B-NP B-m
39 for IN B-VP O
39 anticoagulation NN B-NP B-r
40 7 CD O O
40 Sick NNP B-NP O
40 sinus NN I-NP O
40 syndrome NN I-NP O
40 , , O O
40 status NN B-NP O
40 post NN I-NP O
40 pacer NN I-NP O
40 placement NN I-NP O
41 8 CD O O
41 CAD NNP B-NP O
41 status NN I-NP O
41 post NN I-NP O
41 MI NNP I-NP O
41 in IN B-VP O
41 2005 CD O O
41 , , O O
41 status NN B-NP O
41 post NN I-NP O
41 stenting NN I-NP O
41 of IN B-VP O
41 LAD NNP B-NP O
41 and CC O O
42 RCA NNP B-NP O
43 9 CD O O
43 CHF NNP B-NP O
44 10 CD O O
44 Spindle-cell NNP B-NP O
44 tumors NNS I-NP O
44 from IN B-VP O
44 lung NN B-NP O
45 11 CD O O
45 Hypothyroidism NNP B-NP O
46 12 CD O O
46 MRSA NNP B-NP O
46 wound NN I-NP O
46 infection/mesh JJ B-NP O
46 infection NN I-NP O
47 13 CD O O
47 Status NNP B-NP O
47 post NN I-NP O
47 Mallory-Weiss NNP I-NP O
47 tear NN I-NP O
48 14 CD O O
48 Hiatal NNP B-NP O
48 hernia VBD B-VP O
49 15 CD O O
49 Status NNP B-NP O
49 post NN I-NP O
49 debridement NN I-NP O
49 of IN B-VP O
49 skin NN B-NP O
49 and CC O O
49 subcutaneous JJ B-NP O
49 tissue NN I-NP O
49 with IN B-VP O
50 partial JJ B-NP O
50 excision NN I-NP O
50 of IN B-VP O
50 mesh NN B-NP O
50 and CC O O
50 wound NN B-NP O
50 vac NN I-NP O
50 on IN B-VP O
50 3/25/05 CD O O
51 16 CD O O
51 Status NNP B-NP O
51 post NN I-NP O
51 ex NN I-NP O
51 lap VBZ O O
51 ventral JJ B-NP O
51 hernia NNS I-NP O
51 repair NN I-NP O
51 with IN B-VP O
51 Sepramesh NNP B-NP O
51 , , O O
52 3/28/05 CD O O
53 17 CD O O
53 Status NNP B-NP O
53 post NN I-NP O
53 right RB O O
53 colectomy NN B-NP O
53 in IN B-VP O
53 2002 CD O O
53 complicated VBN O O
53 by IN B-VP O
53 fascial JJ B-NP O
54 dehiscence NN I-NP O
54 requiring VBG O O
54 ex CC O O
54 lap JJ O O
54 and CC O O
54 repair NN B-NP O
54 of IN B-VP O
54 fascial JJ B-NP O
54 dehiscence NN I-NP O
55 18 CD O O
55 Status NNP B-NP O
55 post NN I-NP O
55 prostatectomy NN I-NP O
56 19 CD O O
56 Status NNP B-NP O
56 post NN I-NP O
56 right NN I-NP O
56 VATS NNP I-NP O
56 and CC O O
56 wedge VB O O
56 resection NN B-NP O
57 20 CD O O
57 Status NNP B-NP O
57 post NN I-NP O
57 fusion NN I-NP O
57 of IN B-VP O
57 cervical JJ B-NP O
57 spine NN I-NP O
58 21 CD O O
58 Status NNP B-NP O
58 post NN I-NP O
58 TNA NNP I-NP O
59 22 CD O O
59 Status NNP B-NP O
59 post NN I-NP O
59 appendectomy NN I-NP O
60 OUTPATIENT NNP I-NP O
60 MEDICATIONS: NNP I-NP O
61 1 CD O O
61 Amiodarone NNP B-NP B-m
61 200 CD O B-do
61 mg NN B-NP I-do
61 by IN B-VP B-mo
61 mouth JJ O I-mo
61 daily JJ O B-f
62 2 CD O O
62 Calcium NN B-NP B-m
63 3 CD O O
63 Colace NNP B-NP B-m
63 100 CD O B-do
63 mg NN B-NP I-do
63 by IN B-VP B-mo
63 mouth NN B-NP I-mo
63 t.i.d NN I-NP B-f
64 4 CD O O
64 Coumadin NNP B-NP B-m
64 alternating VBG O B-do
64 doses NNS B-NP I-do
64 of IN B-VP I-do
64 4 CD O I-do
64 mg NNS B-NP I-do
64 and CC O I-do
64 3 CD O I-do
64 mg NN B-NP I-do
65 5 CD O O
65 Diltiazem NNP B-NP B-m
65 CD NN I-NP I-m
65 360 CD O B-do
65 mg NN B-NP I-do
65 p.o JJ O B-mo
65 daily JJ O B-f
66 6 CD O O
66 Aspirin NNP B-NP B-m
66 81 CD O B-do
66 mg NN B-NP I-do
66 p.o JJ O B-mo
66 daily JJ O B-f
67 7 CD O O
67 Folate NNP B-NP B-m
67 1 CD O B-do
67 mg NN B-NP I-do
67 p.o JJ O B-mo
67 daily JJ O B-f
68 8 CD O O
68 Lisinopril NNP B-NP B-m
68 10 CD O B-do
68 mg NN B-NP I-do
68 p.o JJ O B-mo
68 daily JJ O B-f
69 9 CD O O
69 Metamucil NNP B-NP B-m
69 p.r.n VBD B-VP B-f
70 10 CD O O
70 Clopidogrel NNP B-NP B-m
70 75 CD O B-do
70 mg NN B-NP I-do
70 p.o JJ O B-mo
70 daily JJ O B-f
71 11 CD O O
71 Potassium NN B-NP B-m
72 12 CD O O
72 Protonix NNP B-NP B-m
72 40 CD O B-do
72 mg NN B-NP I-do
72 p.o JJ O B-mo
72 daily JJ O B-f
73 13 CD O O
73 Simvastatin NNP B-NP B-m
73 80 CD O B-do
73 mg NN B-NP I-do
73 p.o JJ O B-mo
73 daily JJ O B-f
74 14 CD O O
74 Synthroid NNP B-NP B-m
74 25 CD O B-do
74 mcg NN B-NP I-do
74 p.o JJ O B-mo
74 daily JJ O B-f
75 15 CD O O
75 Thiamine NNP B-NP B-m
75 100 CD O B-do
75 mg NN B-NP I-do
75 p.o JJ O B-mo
75 daily JJ O B-f
76 16 CD O O
76 Metoprolol NNP B-NP B-m
76 SR NNP I-NP I-m
76 100 CD O B-do
76 mg NN B-NP I-do
76 p.o NN I-NP B-mo
76 b.i.d VBD B-VP B-f
77 17 CD O O
77 Zyprexa NNP B-NP B-m
77 2.5 CD O B-do
77 mg NN B-NP I-do
77 at IN B-VP B-f
77 bedtime NN B-NP I-f
77 p.r.n NN I-NP I-f
78 ALLERGIES: NNP I-NP O
78 Ether NNP I-NP O
79 SOCIAL NNP I-NP O
79 HISTORY: NNP I-NP O
79 No NNP I-NP O
79 alcohol NN I-NP O
79 or CC O O
79 tobacco NN B-NP O
79 use NN I-NP O
79 Married NNP I-NP O
79 , , O O
79 lives VBZ O O
79 with IN B-VP O
80 wife NN B-NP O
80 , , O O
80 retired VBD B-VP O
80 25 CD O O
80 years NNS B-NP O
80 ago RB O O
81 ADMISSION NNP B-NP O
81 LABS: NNP I-NP O
81 Remarkable NNP I-NP O
81 for IN B-VP O
81 creatinine NN B-NP O
81 of IN B-VP O
81 1 CD O O
81 , , O O
81 hematocrit NN B-NP O
81 of IN B-VP O
82 30.1% CD O O
82 , , O O
82 INR NNP B-NP O
82 of IN B-VP O
82 1.7 CD O O
82 EKG NNP B-NP O
82 V-paced NNP I-NP O
82 at IN B-VP O
82 60 CD O O
82 , , O O
82 no DT B-NP O
82 ST-T NNP I-NP O
82 wave NN I-NP O
82 abnormalities NNS I-NP O
83 compared VBN O O
83 to TO O O
83 preop VB O O
84 PHYSICAL NNP B-NP O
84 EXAMINATION: NNP I-NP O
84 Vital NNP I-NP O
84 Signs: NNP I-NP O
84 On IN B-VP O
84 admission NN B-NP O
84 , , O O
84 temperature NN B-NP O
85 98 CD O O
85 , , O O
85 pulse RB O O
85 60 CD O O
85 and CC O O
85 V-paced NNP B-NP O
85 , , O O
85 blood NN B-NP O
85 pressure NN I-NP O
85 140/85 CD O O
85 , , O O
85 saturating VBG O O
85 96% CD O O
86 on IN B-VP O
86 3 CD O O
86 L NNP B-NP O
86 nasal JJ B-NP O
86 cannula NN I-NP O
86 Neuro: NNP I-NP O
86 Awake NNP I-NP O
86 , , O O
86 alert NN B-NP O
86 , , O O
86 appropriate JJ B-NP O
87 Pulmonary: NNP I-NP O
87 Clear NNP I-NP O
87 to TO O O
87 auscultation VB O O
87 bilaterally RB O O
87 , , O O
87 no DT B-NP O
87 rales NNS I-NP O
87 , , O O
87 no DT B-NP O
88 wheezes JJ I-NP O
88 Cardiovascular: NNP I-NP O
88 Regular NNP I-NP O
88 rate NN I-NP O
88 and CC O O
88 rhythm NN B-NP O
88 , , O O
88 no DT B-NP O
88 murmurs NN I-NP O
88 , , O O
89 rubs NN B-NP O
89 or CC O O
89 gallops NNS B-NP O
89 Abdomen: NNP I-NP O
89 Soft NNP I-NP O
89 , , O O
89 nondistended VBD B-VP O
89 , , O O
89 mildly RB O O
89 tender JJ B-NP O
90 midline NN I-NP O
90 incision NN I-NP O
90 with IN B-VP O
90 dressing VBG O O
90 clean JJ O O
90 , , O O
90 dry JJ O O
90 and CC O O
90 intact JJ B-NP O
90 JP NNP I-NP O
90 in IN B-VP O
91 midline NN B-NP O
91 with IN B-VP O
91 sanguinous JJ B-NP O
91 drainage NN I-NP O
91 Lax NNP I-NP O
91 abdominal VBZ O O
91 wall NN B-NP O
91 with IN B-VP O
92 protuberance NN B-NP O
92 but CC O O
92 soft JJ B-NP O
92 Extremities: NNP I-NP O
92 Warm NNP I-NP O
92 and CC O O
92 well RB O O
92 perfused JJ B-NP O
93 IMAGING: NNP I-NP O
93 Chest NNP I-NP O
93 x-ray JJ O O
93 negative JJ O O
93 for IN B-VP O
93 acute JJ B-NP O
93 disease NN I-NP O
93 and CC O O
94 cardiomegaly JJ B-NP O
95 HOSPITAL NNP I-NP O
95 COURSE: NNP I-NP O
95 This DT O O
95 is VBZ O O
95 a DT B-NP O
95 90+-year-old JJ I-NP O
95 gentleman NN I-NP O
95 with IN B-VP O
95 a DT B-NP O
95 complex JJ I-NP O
96 past NN I-NP O
96 medical JJ B-NP O
96 history NN I-NP O
96 including VBG O O
96 CAD NNP B-NP O
96 status NN I-NP O
96 post NN I-NP O
96 MI NNP I-NP O
96 and CC O O
96 stent JJ B-NP O
96 x2 NN I-NP O
96 , , O O
97 CHF NNP B-NP O
97 was VBD B-VP O
97 admitted VBN O O
97 to TO O O
97 the DT B-NP O
97 SICU NNP I-NP O
97 , , O O
97 status NN B-NP O
97 post NN I-NP O
97 ex NN I-NP O
97 lap NN I-NP O
97 for IN B-VP O
97 removal NN B-NP O
97 of IN B-VP O
98 MRSA-infected NNP B-NP O
98 mesh NN I-NP O
98 for IN B-VP O
98 careful JJ B-NP O
98 monitoring NN I-NP O
98 and CC O O
98 fluid JJ B-NP O
98 resuscitation NN I-NP O
99 in IN B-VP O
99 light NN B-NP O
99 of IN B-VP O
99 cardiac JJ B-NP O
99 status NN I-NP O
99 His PRP$ O O
99 postoperative JJ B-NP O
99 course NN I-NP O
99 was VBD B-VP O
100 remarkable JJ O O
100 for IN B-VP O
100 bleeding VBG O O
100 with IN B-VP O
100 sanguinous JJ B-NP O
100 output NN I-NP O
100 from IN B-VP O
100 the DT B-NP O
100 JP NNP I-NP O
100 drain NN I-NP O
100 , , O O
101 a DT B-NP O
101 question NN I-NP O
101 of IN B-VP O
101 an DT B-NP O
101 abdominal JJ I-NP O
101 hematoma NN I-NP O
101 and CC O O
101 a DT B-NP O
101 progressive JJ I-NP O
101 drop NN I-NP O
101 in IN B-VP O
101 his PRP$ O O
102 hematocrit NN B-NP O
102 The DT B-NP O
102 heparin NN I-NP B-m
102 drip NN I-NP B-mo
102 , , O O
102 which WDT O O
102 was VBD B-VP O
102 initiated VBN O O
102 given VBN O O
102 the DT B-NP B-r
103 patient's NN I-NP O
103 chronic JJ B-NP O
103 AF NNP I-NP O
103 , , O O
103 was VBD B-VP O
103 discontinued VBN O O
103 and CC O O
103 FFP NNP B-NP B-m
103 administered VBD B-VP O
104 Platelets NNS B-NP O
104 were VBD B-VP O
104 also RB O O
104 given VBN O O
104 at IN B-VP O
104 the DT B-NP O
104 request NN I-NP O
104 of IN B-VP O
104 the DT B-NP O
104 Plastic NNP I-NP O
104 Surgery NNP I-NP O
105 Team NNP I-NP O
105 in IN B-VP O
105 light NN B-NP O
105 of IN B-VP O
105 aspirin NN B-NP B-m
105 and CC O O
105 Plavix NNP B-NP B-m
105 , , O O
105 which WDT O O
105 were VBD B-VP O
105 continued VBN O O
105 due JJ O O
105 to TO O O
106 the DT O B-r
106 the DT B-NP B-r
106 patient's NN I-NP I-r
106 patient's NN I-NP I-r
106 cardiac JJ B-NP I-r
106 cardiac JJ I-NP I-r
106 stents NNS I-NP I-r
106 stents NNS I-NP I-r
106 Despite IN B-VP O
106 bolus JJ B-NP B-mo
106 Lasix NNP I-NP B-m
106 , , O O
106 the DT B-NP O
106 patient NN I-NP O
107 did VBD B-VP O
107 develop VB O O
107 CHF NNP B-NP O
107 with IN B-VP O
107 symptomatic JJ B-NP O
107 pulmonary JJ I-NP O
107 edema NN I-NP O
107 and CC O O
107 increased VBD B-VP O
108 oxygen NN B-NP O
108 requirement NN I-NP O
108 Concomitantly NNP I-NP O
108 , , O O
108 the DT B-NP O
108 patient NN I-NP O
108 also RB O O
108 became VBD B-VP O
109 delirious JJ O O
109 , , O O
109 as IN B-VP O
109 is VBZ O O
109 his PRP$ O O
109 historical JJ B-NP O
109 pattern NN I-NP O
109 with IN B-VP O
109 significant JJ B-NP O
109 agitation NN I-NP O
110 He PRP O O
110 developed VBD B-VP O
110 hypertension NN B-NP B-r
110 hypertension NN I-NP B-r
110 hypertension NN I-NP B-r
110 refractory NN I-NP O
110 to TO O O
110 beta-blockade NN B-NP B-m
110 , , O O
110 calcium NN B-NP B-m
111 channel NN I-NP O
111 blockers NNS I-NP O
111 and CC O O
111 IV NNP B-NP B-mo
111 ACE NNP I-NP B-m
111 inhibitors NNS I-NP I-m
111 in IN B-VP O
111 this DT O O
111 setting VBG O O
111 The DT B-NP O
112 patient NN I-NP O
112 was VBD B-VP O
112 thus RB O O
112 placed VBN O O
112 on IN B-VP O
112 a DT B-NP O
112 nitroglycerin JJ I-NP B-m
112 drip NN I-NP B-mo
112 , , O O
112 a DT B-NP O
112 furosemide JJ I-NP B-m
112 furosemide NN I-NP B-m
113 drip NN I-NP B-mo
113 drip NN I-NP B-mo
113 drip NN I-NP B-mo
113 drip NN I-NP B-mo
113 with IN B-VP O
113 ginger NN B-NP B-m
113 ginger NN I-NP B-m
113 blood NN I-NP I-m
113 blood NN I-NP I-m
113 product NN I-NP I-m
113 product NN I-NP I-m
113 resuscitation NN I-NP O
113 to TO O O
113 address VB O O
113 bleeding VBG O B-r
113 bleeding NN B-NP B-r
114 and CC O O
114 an DT O B-r
114 an DT B-NP B-r
114 elevated JJ I-NP I-r
114 elevated JJ I-NP I-r
114 INR NNP I-NP I-r
114 INR NNP I-NP I-r
114 He PRP O O
114 responded VBD B-VP O
114 well RB O O
114 to TO O O
114 this DT B-NP O
114 regimen NNS I-NP O
114 and CC O O
115 aggressive JJ B-NP O
115 pulmonary JJ I-NP O
115 toilet NN I-NP O
115 Both NNP I-NP O
115 the DT B-NP O
115 patient's NN I-NP O
115 PCP NNP I-NP O
115 , , O O
115 Dr NNP B-NP O
116 Gillice NNP I-NP O
116 , , O O
116 and CC O O
116 his PRP$ O O
116 cardiologist NN B-NP O
116 , , O O
116 Dr NNP B-NP O
116 Keks NNP I-NP O
116 , , O O
116 did VBD B-VP O
116 follow VB O O
116 the DT B-NP O
117 patient NN I-NP O
117 His PRP$ O O
117 oxygenation NN B-NP O
117 never RB O O
117 suffered VBD B-VP O
117 during IN B-VP O
117 this DT B-NP O
117 time NN I-NP O
117 and CC O O
117 he PRP O O
118 did VBD B-VP O
118 not RB O O
118 have VB O O
118 significant JJ B-NP O
118 hypercarbia NN I-NP O
118 He PRP O O
118 was VBD B-VP O
118 eventually RB O O
118 weaned VBN O O
119 back RB O O
119 to TO O O
119 nasal VB O O
119 cannula NN B-NP O
119 He PRP O O
119 did VBD B-VP O
119 have VB O O
119 a DT B-NP O
119 mild JJ I-NP O
119 transient JJ I-NP O
119 elevation NN I-NP O
119 in IN B-VP O
120 creatinine NN B-NP O
120 while IN B-VP O
120 on IN B-VP O
120 the DT B-NP O
120 Lasix NNP I-NP B-m
120 drip NN I-NP B-mo
120 but CC O O
120 has VBZ O O
120 since IN B-VP O
120 recovered VBN O O
120 back RB O O
121 to TO O O
121 baseline VB O O
121 off IN B-VP O
121 of IN B-VP O
121 the DT B-NP O
121 Lasix NNP I-NP B-m
121 drip VB O B-mo
121 His PRP$ O O
121 nasogastric JJ B-NP O
121 tube NN I-NP O
121 was VBD B-VP O
122 removed VBN O O
122 on IN B-VP O
122 9/2/06 CD O O
122 and CC O O
122 he PRP O O
122 tolerated VBD B-VP O
122 ice JJ B-NP O
122 chips NNS I-NP O
122 without IN B-VP O
123 difficulty NN B-NP O
123 His PRP$ O O
123 home NN B-NP O
123 cardiac NN I-NP B-m
123 medications NNS I-NP I-m
123 were VBD B-VP O
123 restarted VBN O O
123 on IN B-VP O
124 9/28/06 CD O O
124 The DT B-NP O
124 patient NN I-NP O
124 was VBD B-VP O
124 out IN B-VP O
124 of IN B-VP O
124 bed NN B-NP O
124 and CC O O
124 ambulating VBG O O
124 without IN B-VP O
125 difficulty NN B-NP O
125 At IN B-VP O
125 the DT B-NP O
125 time NN I-NP O
125 of IN B-VP O
125 dictation NN B-NP O
125 , , O O
125 his PRP$ O O
125 nitroglycerin JJ B-NP B-m
125 drip NN I-NP B-mo
125 was VBD B-VP O
126 being VBG O O
126 weaned VBN O O
126 with IN B-VP O
126 the DT B-NP O
126 assistance NN I-NP O
126 of IN B-VP O
126 nitro JJ B-NP B-m
126 paste NN I-NP I-m
126 He PRP O O
126 is VBZ O O
127 anticipated VBN O O
127 to TO O O
127 be VB O O
127 transferred VBN O O
127 to TO O O
127 the DT B-NP O
127 floor NN I-NP O
127 once RB O O
127 he PRP O O
127 receives VBZ O O
127 a DT B-NP O
127 red JJ I-NP B-m
128 blood NN I-NP O
128 cell NN I-NP O
128 transfusion NN I-NP B-mo
128 and CC O O
128 once RB O O
128 the DT B-NP O
128 nitroglycerin NN I-NP B-m
128 drip NN I-NP B-mo
128 is VBZ O O
128 off IN B-VP O
129 PLAN: NNP B-NP O
130 Neuro: NNP I-NP O
131 1 CD O O
131 The DT B-NP O
131 patient NN I-NP O
131 does VBZ O O
131 sundown VBN O O
131 at IN B-VP O
131 home NN B-NP O
131 and CC O O
131 has VBZ O O
131 done VBN O O
131 so RB O O
131 while IN B-VP O
131 in IN B-VP O
132 the DT B-NP O
132 ICU NNP I-NP O
132 He PRP O O
132 has VBZ O O
132 been VBN O O
132 much RB O O
132 more RBR O O
132 calm JJ O O
132 and CC O O
132 appropriate JJ O O
132 over IN B-VP O
132 the DT O O
133 past JJ O O
133 24 CD O O
133 to TO O O
133 36 CD O O
133 hours NNS B-NP O
134 2 CD O O
134 He PRP O O
134 does VBZ O O
134 experience VB O O
134 more RBR O O
134 significant JJ B-NP O
134 delirium NN I-NP O
134 with IN B-VP O
134 morphine NN B-NP B-m
135 and CC O O
135 less RBR O O
135 so RB O O
135 with IN B-VP O
135 sparing VBG O O
135 Dilaudid NNP B-NP B-m
135 p.r.n RB O B-f
136 3 CD O O
136 We PRP O O
136 will MD O O
136 continue VB O O
136 with IN B-VP O
136 sparing VBG O O
136 Dilaudid NNP B-NP B-m
136 p.r.n NN I-NP B-f
136 , , O O
136 and CC O O
136 Zyprexa NNP B-NP B-m
137 2.5 CD O B-do
137 at IN B-VP B-f
137 bedtime NN B-NP I-f
137 p.r.n NN I-NP I-f
137 per IN B-VP O
137 home NN B-NP O
137 regimen NNS I-NP O
137 Haldol NNP I-NP B-m
137 is VBZ O O
137 written VBN O O
137 p.r.n RB O B-f
138 as IN B-VP O
138 needed VBN O O
139 Cardiovascular: NNP B-NP O
140 1 CD O O
140 CAD NNP B-NP O
140 status NN I-NP O
140 post NN I-NP O
140 stent NN I-NP O
140 x2 NN I-NP O
140 , , O O
140 AF NNP B-NP O
140 on IN B-VP O
140 chronic JJ B-NP O
140 anticoagulation NN I-NP O
140 , , O O
140 CHF NNP B-NP O
140 , , O O
141 status NN B-NP O
141 post NN I-NP O
141 pacer NN I-NP O
141 for IN B-VP O
141 sick JJ B-NP O
141 sinus NN I-NP O
141 syndrome NN I-NP O
141 , , O O
141 currently RB O O
141 V NNP B-NP O
141 paced VBD B-VP O
142 2 CD O O
142 Outpatient NNP B-NP O
142 systolic JJ B-NP O
142 blood NN I-NP O
142 pressure NN I-NP O
142 150 CD O O
142 to TO O O
142 180 CD O O
142 , , O O
142 current JJ B-NP O
142 goal NN I-NP O
143 of IN B-VP O
143 SBP NNP B-NP O
143 140 CD O O
143 to TO O O
143 160 CD O O
144 3 CD O O
144 Weaning NNP B-NP O
144 off RP O O
144 nitroglycerin JJ B-NP B-m
144 drip NN I-NP B-mo
144 , , O O
144 nitro JJ B-NP B-m
144 paste NN I-NP I-m
144 added VBD B-VP O
145 4 CD O O
145 Diltiazem NNP B-NP B-m
145 CD NN I-NP I-m
145 360 CD O B-do
145 p.o JJ O B-mo
145 daily RB O B-f
145 , , O O
145 Lopressor NNP B-NP B-m
145 SR NNP I-NP I-m
145 100 CD O B-do
145 mg NN B-NP I-do
145 p.o NN I-NP B-mo
145 b.i.d NN I-NP B-f
145 , , O O
146 lisinopril VBZ O B-m
146 10 CD O B-do
146 mg NN B-NP I-do
146 p.o JJ O B-mo
146 daily RB O B-f
146 , , O O
146 amiodarone RB O B-m
146 200 CD O B-do
146 mg NNS B-NP I-do
146 p.o JJ O B-mo
146 daily RB O B-f
146 , , O O
147 restarted VBD B-VP O
147 per IN B-VP O
147 home NN B-NP O
147 regimen NNS I-NP O
148 5 CD O O
148 Aspirin NNP B-NP B-m
148 and CC O O
148 Plavix NNP B-NP B-m
148 to TO O O
148 continue VB O O
148 for IN B-VP O
148 cardiac JJ B-NP B-r
148 cardiac JJ I-NP B-r
148 stents NNS I-NP I-r
148 stents NNS I-NP I-r
149 6 CD O O
149 Watch NNP B-NP O
149 for IN B-VP O
149 overload NN B-NP O
150 Pulmonary: NNP I-NP O
151 1 CD O O
151 Pulmonary NNP B-NP O
151 edema NN I-NP O
151 with IN B-VP O
151 improving VBG O O
151 chest JJS O O
151 x-ray JJ O O
151 , , O O
151 currently RB O O
152 saturating VBG O O
152 well RB O O
152 on IN B-VP O
152 4 CD O O
152 L NNP B-NP O
152 of IN B-VP O
152 nasal JJ B-NP O
152 cannula NN I-NP O
153 2 CD O O
153 Aggressive NNP B-NP O
153 pulmonary JJ B-NP O
153 toilet NN I-NP O
153 , , O O
153 nebs RB O O
153 , , O O
153 out IN B-VP O
153 of IN B-VP O
153 bed NN B-NP O
153 and CC O O
153 ambulation NN B-NP O
154 3 CD O O
154 Lasix NNP B-NP B-m
154 with IN B-VP O
154 blood NN B-NP O
155 GI: NNP I-NP O
156 1 CD O O
156 Patient NNP B-NP O
156 advanced VBD B-VP O
156 to TO O O
156 clear VB O O
156 liquids NNS B-NP O
156 only RB O O
157 2 CD O O
157 All DT B-NP O
157 p.o NN I-NP O
157 meds VBZ O O
158 3 CD O O
158 Nexium NNP B-NP B-m
159 GU: NNP I-NP O
160 1 CD O O
160 Good NNP B-NP O
160 urine NN I-NP O
160 output NN I-NP O
160 off IN B-VP O
160 Lasix NNP B-NP B-m
161 2 CD O O
161 Creatinine NNP B-NP O
161 back RB O O
161 to TO O O
161 baseline NN B-NP O
161 of IN B-VP O
161 1 CD O O
162 3 CD O O
162 Lasix NNP B-NP B-m
162 to TO O O
162 be VB O O
162 given VBN O O
162 with IN B-VP O
162 blood NN B-NP O
162 as RB O O
162 well RB O O
162 as IN B-VP O
162 potassium NN B-NP B-m
163 4 CD O O
163 Slowly NNP B-NP O
163 trending VBG O O
163 back RB O O
163 to TO O O
163 preop VB O O
163 weight NN B-NP O
163 , , O O
163 would MD O O
163 recommend VB O O
163 gentle JJ B-NP O
164 diuresis NN I-NP O
164 p.r.n NN I-NP O
164 and CC O O
164 careful JJ B-NP O
164 observance NN I-NP O
164 of IN B-VP O
164 potassium NN B-NP O
165 Heme: NNP I-NP O
166 1 CD O O
166 Hematocrit NNP B-NP O
166 25% CD O O
166 today NN B-NP O
166 , , O O
166 we PRP O O
166 will MD O O
166 give VB O O
166 one CD O B-do
166 unit NN B-NP I-do
166 of IN B-VP O
166 packed JJ B-NP B-m
166 red JJ I-NP O
167 blood NN I-NP O
167 cells NNS I-NP O
167 with IN B-VP O
167 Lasix NNP B-NP B-m
167 and CC O O
167 potassium NN B-NP B-m
168 2 CD O O
168 Continue NNP B-NP O
168 with IN B-VP O
168 subcutaneous JJ B-NP B-mo
168 heparin NNS I-NP B-m
168 for IN B-VP O
168 now RB O O
168 and CC O O
168 Coumadin NNP B-NP B-m
168 to TO O O
168 restart VB O O
169 at IN B-VP O
169 discretion NN B-NP O
169 of IN B-VP O
169 primary JJ B-NP O
169 team NN I-NP O
170 ID: NNP I-NP O
171 1 CD O O
171 Vancomycin NNP B-NP B-m
171 for IN B-VP O
171 MRSA-infected NNP B-NP B-r
171 mesh JJ O I-r
172 2 CD O O
172 PICC NNP B-NP O
172 line NN I-NP O
172 consult NN I-NP O
172 ordered VBD B-VP O
172 for IN B-VP O
172 anticipated JJ B-NP O
172 long-term JJ I-NP B-du
173 vancomycin NN I-NP B-m
174 Endocrine: NNP I-NP O
175 1 CD O O
175 Synthroid NNP B-NP B-m
175 at IN B-VP O
175 home NN B-NP B-do
175 dose NN I-NP I-do
176 2 CD O O
176 RISS NNP B-NP B-m
177 SERVICES NNPS I-NP O
177 FOLLOWING NNP I-NP O
177 THE NNP I-NP O
177 PATIENT: NNP I-NP O
178 1 CD O O
178 Medicine NNP B-NP O
178 , , O O
178 Dr NNP B-NP O
178 Harcar NNP I-NP O
178 , , O O
178 patient's NN B-NP O
178 PCP NNP I-NP O
179 2 CD O O
179 Cardiology NNP B-NP O
179 , , O O
179 Dr NNP B-NP O
179 Pagliari NNP I-NP O
180 3 CD O O
180 Plastic NNP B-NP O
180 Surgery NNP I-NP O
180 , , O O
180 Dr NNP B-NP O
180 Dunshie NNP I-NP O
181 Patient NNP I-NP O
181 anticipated VBD B-VP O
181 to TO O O
181 be VB O O
181 transferred VBN O O
181 to TO O O
181 the DT B-NP O
181 floor NN I-NP O
181 on IN B-VP O
181 9/28/06 CD O O
182 eScription NN B-NP O
182 document: NN I-NP O
182 8-1765940 JJ B-NP O
182 CSSten NNP I-NP O
182 Tel NNP I-NP O
183 Dictated NNP I-NP O
183 By: NNP I-NP O
183 POSSINGER NNP I-NP O
183 , , O O
183 NICK NNP B-NP O
184 Attending: NNP I-NP O
184 BERKELEY NNP I-NP O
184 , , O O
184 MURRAY NNP B-NP O
185 Dictation NNP I-NP O
185 ID NNP I-NP O
185 7197007 CD O O
186 D: NNP B-NP O
186 11/29/06 CD O O
187 T: NNP B-NP O
187 11/29/06 CD O O
188 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #174046 VBZ O O
2 765192522 CD O O
2 SFH NNP B-NP O
2 79392868 CD O O
2 2175092 CD O O
2 5/17/2002 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 LOWER NNP I-NP O
2 GASTROINTESTINAL NNP I-NP O
2 BLEED NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/20/2002 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/13/2002 CD O O
4 PRINCIPLE NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 LOWER NNP I-NP O
4 GASTROINTESTINAL NNP I-NP O
4 BLEED NNP I-NP O
5 HISTORY NNP I-NP O
5 OF NNP I-NP O
5 PRESENT NNP I-NP O
5 ILLNESS: NNP I-NP O
5 The DT B-NP O
5 patient NN I-NP O
5 is VBZ O O
5 a DT B-NP O
5 75-year-old JJ I-NP O
5 male NN I-NP O
5 with IN B-VP O
6 a DT B-NP O
6 history NN I-NP O
6 of IN B-VP O
6 coronary JJ B-NP O
6 artery NN I-NP O
6 disease NN I-NP O
7 status NN I-NP O
7 post NN I-NP O
7 five CD O O
7 catheterization NN B-NP O
7 with IN B-VP O
7 a DT B-NP O
7 pacemaker NN I-NP O
7 in IN B-VP O
7 place NN B-NP O
7 , , O O
8 arthritis NN B-NP O
8 , , O O
8 gout NN B-NP O
8 , , O O
8 benign JJ B-NP O
8 prostatic JJ I-NP O
8 hypertrophy NN I-NP O
8 , , O O
8 hypertension NN B-NP O
8 and CC O O
9 myelodysplasia NN B-NP O
9 who WP O O
9 presents VBZ O O
9 with IN B-VP O
9 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 lower JJR B-NP O
10 gastrointestinal NN I-NP O
10 bleeds NNS I-NP O
10 He PRP O O
10 has VBZ O O
10 had VBD B-VP O
10 three CD O O
10 episodes NNS B-NP O
10 in IN B-VP O
10 the DT B-NP O
10 past NN I-NP O
11 He PRP O O
11 presented VBD B-VP O
11 to TO O O
11 an DT B-NP O
11 outside JJ I-NP O
11 hospital NN I-NP O
11 four CD O O
11 days NNS B-NP O
11 prior RB O O
11 to TO O O
11 admission NN B-NP O
12 with IN B-VP O
12 symptoms NNS B-NP O
12 of IN B-VP O
12 bright JJ B-NP O
12 red JJ I-NP O
12 blood NN I-NP O
12 per IN B-VP O
12 rectum NN B-NP O
12 His PRP$ O O
12 vital JJ B-NP O
12 signs NNS I-NP O
12 at IN B-VP O
13 that DT B-NP O
13 time NN I-NP O
13 were VBD B-VP O
13 normal JJ O O
13 and CC O O
13 stable JJ O O
13 with IN B-VP O
13 a DT B-NP O
13 hematocrit NN I-NP O
13 of IN B-VP O
13 33 CD O O
13 A NNP B-NP O
13 tagged VBD B-VP O
14 red JJ B-NP O
14 blood NN I-NP O
14 cell NN I-NP O
14 scan NN I-NP O
14 was VBD B-VP O
14 negative JJ O O
14 during IN B-VP O
14 that DT B-NP O
14 hospitalization NN I-NP O
14 as IN B-VP O
14 was VBD B-VP O
15 an DT B-NP O
15 upper JJ I-NP O
15 endoscopy NN I-NP O
15 Colonoscopy NNP I-NP O
15 revealed VBD B-VP O
15 diverticula NN B-NP O
15 throughout IN B-VP O
16 the DT B-NP O
16 large JJ I-NP O
16 colon NN I-NP O
16 with IN B-VP O
16 more RBR O O
16 on IN B-VP O
16 the DT B-NP O
16 right NN I-NP O
16 than IN B-VP O
16 on IN B-VP O
16 the DT B-NP O
16 left NN I-NP O
16 During IN B-VP B-du
17 that DT B-NP O
17 hospitalization NN I-NP O
17 at IN B-VP O
17 the DT B-NP O
17 outside JJ I-NP O
17 hospital NN I-NP O
17 , , O O
17 he PRP O O
17 was VBD B-VP O
17 transfused VBN O O
18 with IN B-VP O
18 four CD O B-do
18 units NNS B-NP I-do
18 of IN B-VP O
18 packed JJ B-NP B-m
18 red JJ I-NP I-m
18 blood NN I-NP I-m
18 cells NNS I-NP I-m
18 and CC O O
18 then RB O O
18 transferred VBD B-VP O
18 to TO O O
19 the DT B-NP O
19 Siter NNP I-NP O
19 Calvty NNP I-NP O
19 Valley NNP I-NP O
19 Hospital NNP I-NP O
19 for IN B-VP O
19 further JJ B-NP O
19 evaluation NN I-NP O
19 and CC O O
20 treatment NN B-NP O
21 HOSPITAL NNP I-NP O
21 COURSE: NNP I-NP O
21 On IN B-VP O
21 admission NN B-NP O
21 , , O O
21 his PRP$ O O
21 hematocrit NN B-NP O
21 was VBD B-VP O
21 32.9 CD O O
22 Subsequent JJ B-NP O
22 serial JJ I-NP O
22 hematocrits NNS I-NP O
22 over IN B-VP O
22 the DT O O
22 following JJ O O
23 two CD O O
23 days NNS B-NP O
23 were VBD B-VP O
23 stable JJ O O
23 During IN B-VP O
23 the DT B-NP O
23 first JJ I-NP O
23 hospital NN I-NP O
23 day NN I-NP O
23 , , O O
23 he PRP O O
23 had VBD B-VP O
23 two CD O O
24 grossly RB O O
24 heme-positive JJ B-NP O
24 bowel NN I-NP O
24 movements NNS I-NP O
24 and CC O O
24 , , O O
24 by IN B-VP O
24 the DT B-NP O
24 second JJ I-NP O
24 hospital NN I-NP O
25 day NN I-NP O
25 , , O O
25 he PRP O O
25 had VBD B-VP O
25 bowel NN B-NP O
25 movements NNS I-NP O
25 that WDT O O
25 were VBD B-VP O
25 brown VBN O O
25 and CC O O
25 formed VBN O O
25 but CC O O
25 guaiac JJ O O
26 positive JJ O O
26 still RB O O
26 His PRP$ O O
26 hematocrit NN B-NP O
26 remained VBD B-VP O
26 stable JJ O O
26 between IN B-VP O
26 30 CD O O
26 and CC O O
26 35 CD O O
27 throughout IN B-VP O
27 his PRP$ O O
27 earlier JJR B-NP O
27 hospitalization NN I-NP O
28 Given IN B-VP O
28 the DT B-NP O
28 patient's JJ I-NP O
28 history NN I-NP O
28 of IN B-VP O
28 multiple JJ B-NP O
28 gastrointestinal JJ I-NP O
28 bleeds NNS I-NP O
28 , , O O
29 the DT B-NP O
29 decision NN I-NP O
29 was VBD B-VP O
29 made VBN O O
29 to TO O O
29 perform VB O O
29 a DT B-NP O
29 right JJ I-NP O
29 hemicolectomy NN I-NP O
29 to TO O O
29 prevent VB O O
30 further RB O O
30 episodes NNS B-NP O
30 This DT O O
30 was VBD B-VP O
30 performed VBN O O
30 on IN B-VP O
30 hospital JJ B-NP O
30 day NN I-NP O
30 number NN I-NP O
30 three CD O O
31 See NNP B-NP O
31 Operative NNP I-NP O
31 Note NNP I-NP O
31 for IN B-VP O
31 details NNS B-NP O
32 The DT B-NP O
32 procedure NN I-NP O
32 and CC O O
32 recovery NN B-NP O
32 were VBD B-VP O
32 unremarkable JJ O O
32 He PRP O O
32 was VBD B-VP O
32 started VBN O O
32 on IN B-VP O
33 sips NNS B-NP O
33 on IN B-VP O
33 postoperative JJ B-NP O
33 day NN I-NP O
33 number NN I-NP O
33 one CD O O
33 and CC O O
33 clear JJ B-NP O
33 liquids NNS I-NP O
33 on IN B-VP O
34 postoperative JJ B-NP O
34 day NN I-NP O
34 number NN I-NP O
34 two CD O O
34 He PRP O O
34 tolerated VBD B-VP O
34 all DT O O
34 of IN B-VP O
34 this DT B-NP O
34 well NN I-NP O
34 His PRP$ O O
35 Foley NNP B-NP O
35 catheter NN I-NP O
35 was VBD B-VP O
35 removed VBN O O
35 on IN B-VP O
35 postoperative JJ B-NP O
35 day NN I-NP O
35 number NN I-NP O
35 two CD O O
35 His PRP$ O O
36 diet NN B-NP O
36 was VBD B-VP O
36 advanced VBN O O
36 On IN B-VP O
36 postoperative JJ B-NP O
36 day NN I-NP O
36 number NN I-NP O
36 three CD O O
36 , , O O
36 he PRP O O
36 had VBD B-VP O
37 passed VBN O O
37 flatus RB O O
37 He PRP O O
37 began VBD B-VP O
37 to TO O O
37 have VB O O
37 loose JJ B-NP O
37 bowel NN I-NP O
37 movements NNS I-NP O
37 His PRP$ O O
37 diet NN B-NP O
38 was VBD B-VP O
38 advanced JJ O O
38 and CC O O
38 , , O O
38 by IN B-VP O
38 postoperative JJ B-NP O
38 day NN I-NP O
38 number NN I-NP O
38 four CD O O
38 , , O O
38 he PRP O O
38 was VBD B-VP O
39 tolerating VBG O O
39 a DT B-NP O
39 regular JJ I-NP O
39 house NN I-NP O
39 diet NN I-NP O
40 On IN B-VP O
40 the DT B-NP O
40 day NN I-NP O
40 of IN B-VP O
40 discharge NN B-NP O
40 , , O O
40 the DT B-NP O
40 patient NN I-NP O
40 was VBD B-VP O
40 stable JJ O O
40 and CC O O
40 tolerating VBG O O
41 p.o.'s NN B-NP O
41 quite RB O O
41 well RB O O
41 His PRP$ O B-r
41 His PRP$ O B-r
41 pain NN B-NP I-r
41 pain NN I-NP I-r
41 was VBD B-VP O
41 well RB O O
41 controlled VBN O O
41 with IN B-VP O
41 p.o NN B-NP B-mo
41 p.o NN I-NP B-mo
41 pain NN I-NP B-m
42 medication NN I-NP O
42 of IN B-VP O
42 Percocet NNP B-NP B-m
42 and CC O O
42 he PRP O O
42 was VBD B-VP O
42 voiding VBG O O
42 freely RB O O
42 without IN B-VP O
43 difficulty NN B-NP O
43 He PRP O O
43 was VBD B-VP O
43 ambulating VBG O O
43 successfully RB O O
43 Therefore RB O O
43 , , O O
43 it PRP O O
43 was VBD B-VP O
44 deemed VBN O O
44 that IN B-VP O
44 he PRP O O
44 was VBD B-VP O
44 suitable JJ O O
44 for IN B-VP O
44 discharge NN B-NP O
45 The DT B-NP O
45 patient NN I-NP O
45 was VBD B-VP O
45 seen VBN O O
45 by IN B-VP O
45 his PRP$ O O
45 cardiologist NN B-NP O
45 , , O O
45 Dr NNP B-NP O
45 Poette NNP I-NP O
45 throughout IN B-VP O
45 his PRP$ O O
46 hospitalization NN B-NP O
46 Prior NNP I-NP O
46 to TO O O
46 surgery VB O O
46 , , O O
46 he PRP O O
46 was VBD B-VP O
46 deemed VBN O O
46 suitable JJ O O
46 for IN B-VP O
47 surgery NN B-NP O
47 without IN B-VP O
47 any DT B-NP O
47 serious JJ I-NP O
47 cardiac JJ I-NP O
47 risks NNS I-NP O
47 On IN B-VP O
47 postoperative JJ B-NP O
47 day NN I-NP O
48 #2 NNP I-NP O
48 , , O O
48 the DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 noted VBN O O
48 to TO O O
48 have VB O O
48 a DT B-NP O
48 run NN I-NP O
48 of IN B-VP O
48 V-tach NNP B-NP O
48 10 CD O O
48 beats NNS B-NP O
48 , , O O
49 asymptomatic JJ O O
49 , , O O
49 no DT B-NP O
49 chest NN I-NP O
49 pain NN I-NP O
49 or CC O O
49 discomfort NN B-NP O
49 , , O O
49 no DT B-NP O
49 shortness NN I-NP O
49 of IN B-VP O
49 breath NN B-NP O
50 He PRP O O
50 said VBD B-VP O
50 that IN B-VP O
50 he PRP O O
50 was VBD B-VP O
50 coughing VBG O O
50 at IN B-VP O
50 the DT B-NP O
50 time NN I-NP O
50 that IN B-VP O
50 that DT B-NP O
50 tracing NN I-NP O
50 came VBD B-VP O
50 up RP O O
51 A NNP B-NP O
51 CK NNP I-NP O
51 and CC O O
51 troponin NN B-NP O
51 were VBD B-VP O
51 sent VBN O O
51 which WDT O O
51 were VBD B-VP O
51 both DT O O
51 flat JJ O O
51 The DT B-NP O
51 patient NN I-NP O
51 had VBD B-VP O
52 previously RB O O
52 been VBN O O
52 ruled VBN O O
52 out RP O O
52 for IN B-VP O
52 MI NNP B-NP O
52 Postoperatively NNP I-NP O
52 , , O O
52 as IN B-VP O
52 a DT B-NP O
53 prophylactic JJ I-NP O
53 course NN I-NP O
53 , , O O
53 given VBN O O
53 that IN B-VP O
53 he PRP O O
53 has VBZ O O
53 a DT B-NP O
53 ventricular JJ I-NP O
53 pacemaker NN I-NP O
53 and CC O O
54 we PRP O O
54 could MD O O
54 not RB O O
54 follow VB O O
54 EKGs NNP B-NP O
54 based VBN O O
54 on IN B-VP O
54 that IN B-VP O
54 The DT B-NP O
54 patient NN I-NP O
54 did VBD B-VP O
54 well RB O O
55 thereafter RB O O
55 , , O O
55 and CC O O
55 had VBD B-VP O
55 no DT B-NP O
55 further JJ I-NP O
55 cardiac NN I-NP O
55 symptoms NNS I-NP O
55 or CC O O
55 issues NNS B-NP O
55 The DT B-NP O
56 patient NN I-NP O
56 was VBD B-VP O
56 seen VBN O O
56 by IN B-VP O
56 physical JJ B-NP O
56 therapy NN I-NP O
56 throughout IN B-VP O
56 his PRP$ O O
56 postoperative JJ B-NP O
57 course NN I-NP O
57 and CC O O
57 prior JJ O O
57 to TO O O
57 discharge VB O O
57 was VBD B-VP O
57 deemed VBN O O
57 suitable JJ O O
57 for IN B-VP O
57 discharge NN B-NP O
57 to TO O O
58 home NN B-NP O
58 , , O O
58 was VBD B-VP O
58 able JJ O O
58 to TO O O
58 do VB O O
58 all DT B-NP O
58 necessary JJ I-NP O
58 activities NNS I-NP O
58 to TO O O
58 go VB O O
58 home NN B-NP O
59 DISCHARGE NNP I-NP O
59 MEDICATIONS: NNP I-NP O
59 Allopurinol NNP I-NP B-m
59 300 CD O B-do
59 mg NN B-NP I-do
59 p.o NN I-NP B-mo
59 q.d NN I-NP B-f
59 , , O O
59 atenolol RB O B-m
60 25 CD O B-do
60 mg NNS B-NP I-do
60 p.o JJ B-NP B-mo
60 q.d NN I-NP B-f
60 , , O O
60 Colace NNP B-NP B-m
60 100 CD O B-do
60 mg NN B-NP I-do
60 p.o NN I-NP B-mo
60 b.i.d NN I-NP B-f
61 p.r.n NN I-NP O
61 constipation NN I-NP B-r
61 , , O O
61 Percocet NNP B-NP B-m
61 1-2 JJ B-NP B-do
61 tablets NNS I-NP I-do
61 p.o VBP O B-mo
61 q.4h JJ B-NP B-f
61 p.r.n NN I-NP I-f
61 pain NN I-NP B-r
61 , , O O
62 Zantac NNP B-NP B-m
62 150 CD O B-do
62 mg NN B-NP I-do
62 p.o NN I-NP B-mo
62 b.i.d NN I-NP B-f
62 , , O O
62 Flomax NNP B-NP B-m
62 0.8 CD O B-do
62 mg NN B-NP I-do
62 p.o NN I-NP B-mo
62 q.d NN I-NP B-f
63 He PRP O O
63 will MD O O
63 follow VB O O
63 up RP O O
63 with IN B-VP O
63 Dr NNP B-NP O
63 Weigold NNP I-NP O
63 , , O O
63 his PRP$ O O
63 hematologist NN B-NP O
63 , , O O
63 in IN B-VP O
63 2-4 JJ B-NP O
63 weeks NNS I-NP O
64 He PRP O O
64 will MD O O
64 follow VB O O
64 up RP O O
64 with IN B-VP O
64 Dr NNP B-NP O
64 Condiff NNP I-NP O
64 on IN B-VP O
64 8/28/02 CD O O
64 He PRP O O
64 was VBD B-VP O
64 stable JJ O O
64 at IN B-VP O
65 the DT B-NP O
65 time NN I-NP O
65 of IN B-VP O
65 discharge NN B-NP O
65 and CC O O
65 is VBZ O O
65 discharged VBN O O
65 to TO O O
65 home NN B-NP O
65 with IN B-VP O
65 services NNS B-NP O
66 Dictated VBN O O
66 By: NNP B-NP O
66 GUILLERMO NNP I-NP O
66 PICKINGS NNP I-NP O
66 , , O O
66 M.D NNP B-NP O
66 RZ88 NNP I-NP O
67 Attending: NNP I-NP O
67 LONNY NNP I-NP O
67 JURAS NNP I-NP O
67 , , O O
67 M.D NNP B-NP O
67 HU83 NNP I-NP O
68 GO568/513958 NNP I-NP O
69 Batch: NNP I-NP O
69 62628 CD O O
69 Index NNP B-NP O
69 No NNP I-NP O
69 XPBE4L64O2 NNP I-NP O
69 D: NNP I-NP O
69 7/25/02 CD O O
70 T: NNP B-NP O
70 7/25/02 CD O O
71 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #180337 VBZ O O
4 443003187 CD O O
4 W NNP B-NP O
4 67626522 CD O O
4 3713536 CD O O
4 6/19/2000 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 sleep JJ B-NP O
4 apnea NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 6/19/2000 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 9/10/2000 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 DAMBOISE NNP I-NP O
8 , , O O
8 GREGORIO NNP B-NP O
8 T NNP I-NP O
8 225-87-00-6 JJ B-NP O
9 Hend NNP I-NP O
9 Lake NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 8/7 CD O O
11 AT NNP B-NP O
11 08:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Attending NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 CALK NNP I-NP O
14 , , O O
14 JAY NNP B-NP O
14 A NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 TYLENOL NNP I-NP B-m
19 ( ( O I-m
19 ACETAMINOPHEN NNP B-NP I-m
19 ) ) O I-m
19 650-1 CD O B-do
19 , , O I-do
19 000 CD O I-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 Q4-6H NNP I-NP B-f
20 PRN NNP I-NP O
20 headache NN I-NP B-r
21 TYLENOL NNP I-NP B-m
21 LIQUID NNP I-NP I-m
21 ( ( O I-m
21 ACETAMINOPHEN NNP B-NP I-m
21 ELIXER NNP I-NP I-m
21 ) ) O I-m
22 650-1 CD O O
22 , , O O
22 300 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 Q4-6H NNP I-NP B-f
22 PRN NNP I-NP I-f
22 headache NN I-NP B-r
23 TYLENOL NNP I-NP B-m
23 #3 NNP I-NP I-m
23 ( ( O I-m
23 ACETAMINOPHEN NNP B-NP I-m
23 W/CODEINE NNP I-NP I-m
23 30MG CD O I-m
23 ) ) O I-m
23 1-2 CD O B-do
23 TAB NNP B-NP I-do
23 PO NNP I-NP B-mo
23 Q4H NNP I-NP B-f
24 PRN NNP I-NP O
24 pain NN I-NP B-r
24 Instructions: NNP I-NP O
24 max NN I-NP O
24 dose NN I-NP O
24 tylenol NN I-NP B-m
24 = VBD B-VP O
24 4gram/day CD O B-do
25 LAC-HYDRIN JJ O B-m
25 12% CD O I-m
25 ( ( O I-m
25 AMMONIUM NNP B-NP I-m
25 LACTATE NNP I-NP I-m
25 12% CD O I-m
25 ) ) O I-m
25 TOPICAL NNP B-NP B-mo
25 TP NNP I-NP I-mo
25 BID NNP I-NP B-f
26 Instructions: NNP I-NP O
26 to TO O O
26 lower VB O O
26 extremities NNS B-NP O
27 CEPACOL NNP I-NP B-m
27 1 CD O B-do
27 LOZENGE NNP B-NP I-do
27 PO NNP I-NP B-mo
27 Q4H NNP I-NP B-f
27 PRN NNP I-NP I-f
27 sore VBD B-VP B-r
27 throat NN B-NP I-r
28 FLAGYL NNP I-NP B-m
28 ( ( O I-m
28 METRONIDAZOLE NNP B-NP I-m
28 ) ) O I-m
28 500 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 BID NNP I-NP B-f
28 X NNP I-NP B-du
28 5 CD O I-du
28 Days NNPS B-NP I-du
29 Starting VBG O O
29 Today NNP B-NP O
29 ( ( O O
29 10/19 CD O O
29 ) ) O O
29 Food/Drug NNP B-NP O
29 Interaction NNP I-NP O
29 Instruction NNP I-NP O
30 Take NNP I-NP O
30 with IN B-VP O
30 food NN B-NP O
31 METAMUCIL NNP I-NP B-m
31 SUGAR NNP I-NP I-m
31 FREE NNP I-NP I-m
31 ( ( O I-m
31 PSYLLIUM NNP B-NP I-m
31 ( ( O I-m
31 METAMUCIL NNP B-NP I-m
31 ) ) O I-m
31 SU NNP B-NP I-m
31 ) ) O I-m
32 1 CD O B-do
32 PACKET NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
32 PRN NNP I-NP I-f
32 CONSTIPATION NNP I-NP B-r
33 DICLOXACILLIN NNP I-NP B-m
33 500 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QID NNP I-NP B-f
33 X NNP I-NP B-du
33 12 CD O I-du
33 Days NNP B-NP I-du
34 Food/Drug NNP I-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Give NNP I-NP O
35 on IN B-VP O
35 an DT B-NP O
35 empty JJ I-NP O
35 stomach NN I-NP O
35 ( ( O O
35 give JJ O O
35 1hr CD O O
35 before IN B-VP O
35 or CC O O
35 2hr CD O O
35 after IN B-VP O
36 food NN B-NP O
36 ) ) O O
37 LISINOPRIL NNP B-NP B-m
37 20 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 DIET: NNP I-NP O
38 House NNP I-NP O
38 / VBD B-VP O
38 Low NNP B-NP O
38 chol/low NN I-NP O
38 sat VBD B-VP O
38 fat JJ B-NP O
39 RETURN NNP I-NP O
39 TO NNP I-NP O
39 WORK: NNP I-NP O
39 Not RB O O
39 Applicable NNP B-NP O
40 FOLLOW NNP I-NP O
40 UP NNP I-NP O
40 APPOINTMENT( NNP I-NP O
40 S NNP I-NP O
40 ): NNP I-NP O
41 Dr NNP I-NP O
41 Schak NNP I-NP O
41 one CD O O
41 week NN B-NP O
41 , , O O
42 Dr NNP B-NP O
42 Hartis NNP I-NP O
42 next JJ B-NP O
42 week NN I-NP O
42 , , O O
43 Dr NNP B-NP O
43 Chionchio NNP I-NP O
43 nest JJS O O
43 available JJ O O
43 , , O O
44 ALLERGY: NNP B-NP O
44 Aspirin NNP I-NP O
44 , , O O
44 Iron NNP B-NP O
44 ( ( O O
44 ferrous JJ B-NP O
44 sulfate NN I-NP O
44 ) ) O O
44 , , O O
44 Nsaid's NNP B-NP O
45 ADMIT NNP I-NP O
45 DIAGNOSIS: NNP I-NP O
46 chf NN I-NP O
47 PRINCIPAL NNP I-NP O
47 DISCHARGE NNP I-NP O
47 DIAGNOSIS NNP I-NP O
47 ;Responsible JJ O O
47 After IN B-VP O
47 Study NNP B-NP O
47 for IN B-VP O
47 Causing NNP B-NP O
47 Admission NNP I-NP O
47 ) ) O O
48 sleep VBP O O
48 apnea IN B-VP O
49 OTHER NNP B-NP O
49 DIAGNOSIS;Conditions NNP I-NP O
49 , , O O
49 Infections NNP B-NP O
49 , , O O
49 Complications NNP B-NP O
49 , , O O
49 affecting VBG O O
49 Treatment/Stay NNP B-NP O
50 vonWillebrand NN I-NP O
50 factor NN I-NP O
50 disease NN I-NP O
50 iron NN I-NP O
50 deficiency NN I-NP O
50 anemia NN I-NP O
51 s/p NN I-NP O
51 TAH NNP I-NP O
51 for IN B-VP O
51 chronic JJ O O
51 bleeding VBG O O
51 obstructive JJ B-NP O
51 sleep JJ I-NP O
51 apnea NN I-NP O
51 morbid NN I-NP O
51 obesity NN I-NP O
52 pickwickian/restrictive JJ B-NP O
52 lung NN I-NP O
52 disease NN I-NP O
52 hypertension NN I-NP O
52 Bacterial NNP I-NP O
52 vaginosis NN I-NP O
53 OPERATIONS NNP I-NP O
53 AND NNP I-NP O
53 PROCEDURES: NNP I-NP O
54 OTHER NNP I-NP O
54 TREATMENTS/PROCEDURES NNP I-NP O
54 ( ( O O
54 NOT NNP B-NP O
54 IN NNP I-NP O
54 O.R NNP I-NP O
54 ) ) O O
55 BRIEF NNP B-NP O
55 RESUME NNP I-NP O
55 OF NNP I-NP O
55 HOSPITAL NNP I-NP O
55 COURSE: NNP I-NP O
56 *** VBZ O O
56 11/17 CD O O
56 *** NN B-NP O
57 43yo CD O O
57 morbidly RB O O
57 obese JJ B-NP O
57 F NNP I-NP O
57 c NN I-NP O
57 H/O NNP I-NP O
57 OSA NNP I-NP O
57 p/w NN I-NP O
57 fatigue NN I-NP O
57 , , O O
57 SOB NNP B-NP O
57 , , O O
57 orthopnea NN B-NP O
57 , , O O
57 cough NN B-NP O
57 , , O O
58 and CC O O
58 LEE NNP B-NP O
58 , , O O
58 thought VBD B-VP O
58 to TO O O
58 be VB O O
58 CHF NNP B-NP O
58 RA NNP I-NP O
58 sat VBD B-VP O
58 on IN B-VP O
58 adm NN B-NP O
58 was VBD B-VP O
58 85% CD O O
58 , , O O
58 up RB O O
58 to TO O O
58 91% CD O O
58 on IN B-VP O
58 5 CD O O
58 L NNP B-NP O
59 NC NNP I-NP O
59 Plan NNP I-NP O
59 is VBZ O O
59 to TO O O
59 get VB O O
59 echo JJ O O
59 , , O O
59 empirically RB O O
59 diurese JJ B-NP O
59 LEE NNP I-NP O
60 is VBZ O O
60 probably RB O O
60 venous JJ B-NP O
60 stasis: NN I-NP O
60 will MD O O
60 get VB O O
60 LENIs NNP B-NP O
60 , , O O
60 then RB O O
61 apply VB O O
61 compression NN B-NP O
61 stockings NNS I-NP O
61 if IN B-VP O
61 LENIs NNP B-NP O
61 neg FW O O
61 This DT O O
61 is VBZ O O
62 a DT O O
62 very RB O O
62 difficult JJ O O
62 and CC O O
62 demanding VBG O O
62 patient JJ O O
62 1/5 CD O O
63 sats NNS B-NP O
63 on IN B-VP O
63 4L CD O O
63 low JJ O O
63 90s CD O O
63 Pt NNP B-NP O
63 asking VBG O O
63 for IN B-VP O
63 tx NN B-NP O
63 for IN B-VP O
64 cellulitis NN B-NP O
64 , , O O
64 none NN B-NP O
64 seen VBN O O
64 clinically RB O O
64 only RB O O
64 longstanding VBG O O
65 venous JJ B-NP O
65 stasis NN I-NP O
65 Also RB O O
65 requesting VBG O O
65 coryza NN B-NP O
65 tx NN I-NP O
65 , , O O
65 refusing VBG O O
66 inh JJ B-NP B-mo
66 steroids NNS I-NP B-m
66 or CC O O
66 claritin VB O B-m
66 Spoke NNP B-NP O
66 w/ WRB O O
66 Dr NNP B-NP O
66 Loy NNP I-NP O
66 , , O O
67 outpt NN B-NP O
67 pulm NN I-NP O
67 , , O O
67 who WP O O
67 rec VBP O O
67 cpap JJ B-NP O
67 18-19 JJ I-NP O
67 cm NN I-NP O
67 H2O NNP I-NP O
67 for IN B-VP O
67 8 CD O O
67 w/ JJ B-NP O
67 O2 NNP I-NP O
68 Pt NNP I-NP O
68 refusing VBG O O
68 tx JJ B-NP O
68 LENIS NNP I-NP O
68 negative NN I-NP O
68 , , O O
68 limited JJ B-NP O
68 study NN I-NP O
69 Pt NNP I-NP O
69 refusing VBG O O
69 sc JJ B-NP O
69 hep NN I-NP O
69 4/29 CD O O
69 pt NN B-NP O
69 is VBZ O O
69 not RB O O
69 tolerating VBG O O
70 cpap NN B-NP O
70 at IN B-VP O
70 night NN B-NP O
70 second NN I-NP O
70 to TO O O
70 feeling NN B-NP O
70 of IN B-VP O
71 suffocating VBG O O
71 She PRP O O
71 is VBZ O O
71 also RB O O
71 refusing VBG O O
71 inpatient NN B-NP O
71 rehab NN I-NP O
72 despite IN B-VP O
72 social JJ B-NP O
72 work NN I-NP O
72 and CC O O
72 care NN B-NP O
72 coord NN I-NP O
72 assistance NN I-NP O
73 w/ NN I-NP O
73 home/bills NNS I-NP O
73 issues NNS I-NP O
73 Pt NNP I-NP O
73 has VBZ O O
73 definite VBN O O
73 IDA NNP B-NP O
73 and CC O O
74 would MD O O
74 benefit VB O O
74 from IN B-VP O
74 iron NN B-NP O
74 She PRP O O
74 doesn't VBZ O O
74 tolerate JJ B-NP O
74 po NN I-NP O
75 and CC O O
75 will MD O O
75 need VB O O
75 iv JJ B-NP O
75 Pt NNP I-NP O
75 was VBD B-VP O
75 consented VBN O O
75 Tolerated NNP B-NP O
75 iron NN I-NP B-m
75 iv NN I-NP B-mo
75 Gyn NNP I-NP O
75 appt NN I-NP O
76 rec NN I-NP O
76 flagyl NN I-NP B-m
76 for IN B-VP O
76 BV NNP B-NP B-r
76 Echo NNP I-NP O
76 showed VBD B-VP O
76 slightly RB O O
76 inc JJ B-NP O
76 ef NN I-NP O
77 and CC O O
77 lv/a JJ B-NP O
77 enlarg NN I-NP O
77 EKG NNP I-NP O
77 w/ VBZ O O
77 possible JJ B-NP O
77 lat JJ I-NP O
78 strain NN I-NP O
78 10/19 CD O O
78 Pt NNP B-NP O
78 is VBZ O O
78 still RB O O
78 not RB O O
78 compliant JJ B-NP O
78 w/ NN I-NP O
78 cpap NN I-NP O
78 because IN B-VP O
78 her PRP$ O O
78 nose JJ B-NP O
78 burns NNS I-NP O
79 w/ VBP O O
79 the DT B-NP O
79 oxygen NN I-NP O
79 despite IN B-VP O
79 humidification NN B-NP O
79 Exam NNP I-NP O
79 of IN B-VP O
79 nose NN B-NP O
79 is VBZ O O
79 unremarkable JJ O O
80 She PRP O O
80 is VBZ O O
80 also RB O O
80 refusing VBG O O
80 BP NNP B-NP B-m
80 medication NN I-NP I-m
80 because IN B-VP O
80 she PRP O O
80 claims VBZ O O
80 that IN B-VP O
80 she PRP O O
80 does VBZ O O
80 not RB O O
81 have VB O O
81 high JJ B-NP O
81 BP NNP I-NP O
81 She PRP O O
81 has VBZ O O
81 an DT O O
81 elevated VBN O O
81 wt NN B-NP O
81 ct NN I-NP O
81 and CC O O
81 some DT B-NP O
81 pain NN I-NP O
81 and CC O O
81 swelling NN B-NP O
81 of IN B-VP O
81 R NNP B-NP O
82 LE NNP I-NP O
82 Will NNP I-NP O
82 tx VB O O
82 w/ JJ B-NP O
82 diclox NN I-NP B-m
82 for IN B-VP O
82 cellulitis NN B-NP B-r
82 Pt NNP I-NP O
82 recd NN I-NP O
82 flu NN I-NP O
82 shot NN I-NP O
82 and CC O O
82 pneumovax NN B-NP B-m
83 She PRP O O
83 says VBZ O O
83 that IN B-VP O
83 she PRP O O
83 does VBZ O O
83 not RB O O
83 have VB O O
83 a DT B-NP O
83 fever NN I-NP O
83 , , O O
83 cough NN B-NP O
83 or CC O O
83 feels NNS B-NP O
83 ill VBP O O
83 at IN B-VP O
83 this DT B-NP O
84 time NN I-NP O
84 Pt NNP I-NP O
84 suffered VBD B-VP O
84 very RB O O
84 minor JJ B-NP O
84 trauma NN I-NP O
84 to TO O O
84 Right NNP B-NP O
84 first RB O O
84 toe VBZ O O
84 on IN B-VP O
84 her PRP$ O O
84 car NN B-NP O
85 Examination NN I-NP O
85 is VBZ O O
85 unremarkable JJ O O
85 This DT O O
85 can MD O O
85 be VB O O
85 followed VBN O O
85 up RP O O
85 w/ JJ B-NP O
85 PCP NNP I-NP O
85 Dr NNP I-NP O
86 Pavoni NNP I-NP O
86 ( ( O O
86 her PRP$ O O
86 hematologist NN B-NP O
86 ) ) O O
86 said VBD B-VP O
86 that IN B-VP O
86 she PRP O O
86 is VBZ O O
86 not RB O O
86 a DT B-NP O
86 candidate NN I-NP O
86 for IN B-VP O
86 dvt NN B-NP O
87 prophylaxis JJ O O
87 second JJ O O
87 to TO O O
87 bleeding; VB O O
87 she PRP O O
87 should MD O O
87 not RB O O
87 receive VB O O
87 any DT B-NP O
88 anticoagulants NNS I-NP O
88 unless IN B-VP O
88 strong JJ B-NP O
88 clinical JJ I-NP O
88 indication NN I-NP O
89 ADDITIONAL NNP I-NP O
89 COMMENTS: NNP I-NP O
89 Please NNP I-NP O
89 have VBP O O
89 appt VBN O O
89 w/ JJ B-NP O
89 Dr NNP I-NP O
89 Fridal NNP I-NP O
89 and CC O O
89 Dr NNP B-NP O
89 Trezza NNP I-NP O
89 in IN B-VP O
89 one CD O O
89 week NN B-NP O
89 See NNP I-NP O
89 Dr NNP I-NP O
90 Knipple NNP I-NP O
90 at IN B-VP O
90 next JJ B-NP O
90 available JJ I-NP O
90 appt NN I-NP O
90 Please NNP I-NP O
90 have VBP O O
90 VNA NNP B-NP O
90 for IN B-VP O
90 every DT B-NP O
90 other JJ I-NP O
90 day NN I-NP O
91 to TO O O
91 do VB O O
91 respiratory JJ B-NP O
91 eval NN I-NP O
91 and CC O O
91 assistance NN B-NP O
91 w/ NN I-NP O
91 medical JJ B-NP O
91 care NN I-NP O
91 Please NNP I-NP O
91 have VBP O O
92 PT/OT NNP B-NP O
92 to TO O O
92 see VB O O
92 pt JJ O O
92 twice RB O O
92 weekly JJ B-NP O
92 Pt NNP I-NP O
92 must MD O O
92 use VB O O
92 CPAP NNP B-NP O
92 at IN B-VP O
92 18-19 JJ B-NP O
92 cm NN I-NP O
92 H2O NNP I-NP O
92 for IN B-VP O
92 8hrs CD O O
93 night NN B-NP O
93 w/ NN I-NP O
93 O2 NNP I-NP O
93 at IN B-VP O
93 4-5 JJ B-NP O
93 L NNP I-NP O
93 &amp; NNP I-NP O
93 w/ POS O O
93 ambulation NN B-NP O
93 Sitz NNP I-NP O
93 bath NN I-NP O
93 to TO O O
93 vagina VB O O
93 twice/d JJ O O
93 Call VB O O
94 your PRP$ O O
94 doctor NN B-NP O
94 if IN B-VP O
94 short JJ O O
94 of IN B-VP O
94 breath NN B-NP O
94 , , O O
94 chest NN B-NP O
94 pain NN I-NP O
94 , , O O
94 nausea/vomiting NN B-NP O
94 , , O O
94 worsening VBG O O
95 leg NN B-NP O
95 pain NN I-NP O
95 , , O O
95 headaches NNS B-NP O
95 or CC O O
95 other JJ B-NP O
95 worrisome NN I-NP O
95 symptoms NNS I-NP O
95 Pt NNP I-NP O
95 is VBZ O O
95 to TO O O
95 go VB O O
95 to TO O O
95 Emjeaneser/ NNP B-NP O
95 Valley NNP I-NP O
95 Memorial NNP I-NP O
95 Hospital NNP I-NP O
95 as IN B-VP O
95 an DT B-NP O
95 outpatient JJ I-NP O
95 Home NNP I-NP O
95 health NN I-NP O
95 aid NN I-NP O
95 twice RB O O
95 per IN B-VP O
95 wk NN B-NP O
96 DISCHARGE NNP I-NP O
96 CONDITION: NNP I-NP O
96 Stable NNP I-NP O
97 TO NNP I-NP O
97 DO/PLAN: NNP I-NP O
98 No NNP I-NP O
98 dictated VBD B-VP O
98 summary JJ B-NP O
99 ENTERED NNP I-NP O
99 BY: NNP I-NP O
99 TESORO NNP I-NP O
99 , , O O
99 NATHAN NNP B-NP O
99 T NNP I-NP O
99 , , O O
99 M.D NNP B-NP O
99 ( ( O O
99 HE59 NNP B-NP O
99 ) ) O O
99 8/7 CD O O
99 @ $ O O
99 09:46 CD O O
99 AM NNP B-NP O
100 ****** JJ B-NP O
100 END NN I-NP O
100 OF NNP I-NP O
100 DISCHARGE NNP I-NP O
100 ORDERS NNP I-NP O
100 ****** NNP I-NP O
101 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #182634 VBZ O O
4 805705747 CD O O
4 PH NNP B-NP O
4 53859318 CD O O
4 4563124 CD O O
4 3/22/2003 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 colonic JJ B-NP O
4 microperforation NN I-NP O
4 , , O O
4 afib JJ B-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/11/2003 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/2/2003 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 GVERRERO NNP I-NP O
8 , , O O
8 STAN NNP B-NP O
8 O NNP I-NP O
8 346-21-49-8 JJ B-NP O
9 Irv NNP I-NP O
9 Lu NNP I-NP O
9 Spo NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 5/27/03 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 KERSON NNP I-NP O
14 , , O O
14 RODNEY NNP B-NP O
14 S NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 FESO4 NNP I-NP B-m
19 ( ( O I-m
19 FERROUS NNP B-NP I-m
19 SULFATE NNP I-NP I-m
19 ) ) O I-m
19 300 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 Starting NNP I-NP O
20 IN NNP I-NP O
20 AM NNP I-NP O
20 ( ( O O
20 6/1 CD O O
20 ) ) O O
20 Food/Drug NNP B-NP O
20 Interaction NNP I-NP O
20 Instruction NNP I-NP O
21 Avoid NNP I-NP O
21 milk NN I-NP O
21 and CC O O
21 antacid JJ B-NP O
22 FOLATE NNP I-NP B-m
22 ( ( O I-m
22 FOLIC NNP B-NP I-m
22 ACID NNP I-NP I-m
22 ) ) O I-m
22 1 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 SYNTHROID NNP I-NP B-m
23 ( ( O I-m
23 LEVOTHYROXINE NNP B-NP I-m
23 SODIUM NNP I-NP I-m
23 ) ) O I-m
23 100 CD O B-do
23 MCG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QD NNP I-NP B-f
24 PREDNISONE NNP I-NP B-m
24 5 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QAM NNP I-NP B-f
25 ZOCOR NNP I-NP B-m
25 ( ( O I-m
25 SIMVASTATIN NNP B-NP I-m
25 ) ) O I-m
25 20 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QHS NNP I-NP B-f
26 Food/Drug NNP I-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 Avoid NNP I-NP O
27 grapefruit NN I-NP O
27 unless IN B-VP O
27 MD NNP B-NP O
27 instructs NNS I-NP O
27 otherwise RB O O
28 Override NNP B-NP O
28 Notice: NNP I-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 11/0/03 CD O O
28 by IN B-VP O
29 LIU NNP B-NP O
29 , , O O
29 HERMAN NNP B-NP O
29 ANTONIO NNP I-NP O
29 , , O O
29 M.D NNP B-NP O
30 on IN B-VP O
30 order NN B-NP O
30 for IN B-VP O
30 NEORAL NNP B-NP B-m
30 PO NNP I-NP B-mo
30 ( ( O O
30 ref JJ O O
30 # # O O
30 55336954 CD O O
30 ) ) O O
31 POTENTIALLY NNP B-NP O
31 SERIOUS NNP I-NP O
31 INTERACTION: NNP I-NP O
31 SIMVASTATIN NNP I-NP B-m
31 &amp; NNP I-NP O
31 CYCLOSPORINE NNP I-NP B-m
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: NN B-NP O
32 will MD O O
32 monitor VB O O
33 NEORAL NNP B-NP B-m
33 ( ( O I-m
33 CYCLOSPORINE NNP B-NP I-m
33 MICRO NNP I-NP I-m
33 ( ( O I-m
33 NEORAL NNP B-NP I-m
33 ) ) O I-m
33 ) ) O I-m
33 100 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 BID NNP I-NP B-f
34 Food/Drug NNP I-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Avoid NNP I-NP O
35 grapefruit NN I-NP O
35 unless IN B-VP O
35 MD NNP B-NP O
35 instructs NNS I-NP O
35 otherwise RB O O
36 Give VBP O O
36 with IN B-VP O
36 meals NNS B-NP O
37 Override NNP I-NP O
37 Notice: NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 11/0/03 CD O O
37 by IN B-VP O
38 ELVEY NNP B-NP O
38 , , O O
38 EDMUND NNP B-NP O
38 LENNY NNP I-NP O
38 , , O O
38 M.D NNP B-NP O
39 on IN B-VP O
39 order NN B-NP O
39 for IN B-VP O
39 LOSARTAN NNP B-NP B-m
39 PO NNP I-NP B-mo
39 ( ( O O
39 ref JJ O O
39 # # O O
39 04133525 CD O O
39 ) ) O O
40 POTENTIALLY NNP B-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 CYCLOSPORINE NNP I-NP B-m
40 &amp; NNP I-NP O
40 LOSARTAN NNP I-NP B-m
41 POTASSIUM NNP I-NP O
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
41 will MD O O
41 monitor VB O O
42 Previous JJ O O
42 override IN B-VP O
42 information: JJ B-NP O
43 Override NNP I-NP O
43 added VBD B-VP O
43 on IN B-VP O
43 11/0/03 CD O O
43 by IN B-VP O
43 LYNADY NNP B-NP O
43 , , O O
43 LAMONT NNP B-NP O
43 LORENZO NNP I-NP O
43 , , O O
43 M.D NNP B-NP O
44 POTENTIALLY NNP I-NP O
44 SERIOUS NNP I-NP O
44 INTERACTION: NNP I-NP O
44 SIMVASTATIN NNP I-NP B-m
44 &amp; NNP I-NP O
44 CYCLOSPORINE NNP I-NP B-m
45 Reason NNP I-NP O
45 for IN B-VP O
45 override: NN B-NP O
45 will MD O O
45 monitor VB O O
46 LOSARTAN NNP B-NP B-m
46 50 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 QD NNP I-NP B-f
47 Alert NNP I-NP O
47 overridden: NNP I-NP O
47 Override NNP I-NP O
47 added VBD B-VP O
47 on IN B-VP O
47 11/0/03 CD O O
47 by IN B-VP O
48 CONOLEY NNP B-NP O
48 , , O O
48 KELLEY NNP B-NP O
48 OTHA NNP I-NP O
48 , , O O
48 M.D NNP B-NP O
49 POTENTIALLY NNP I-NP O
49 SERIOUS NNP I-NP O
49 INTERACTION: NNP I-NP O
49 CYCLOSPORINE NNP I-NP B-m
49 &amp; NNP I-NP O
49 LOSARTAN NNP I-NP B-m
50 POTASSIUM NNP I-NP O
50 Reason NNP I-NP O
50 for IN B-VP O
50 override: NN B-NP O
50 will MD O O
50 monitor VB O O
51 Number NNP B-NP O
51 of IN B-VP O
51 Doses NNP B-NP O
51 Required NNP I-NP O
51 ( ( O O
51 approximate JJ B-NP O
51 ): NN I-NP O
51 3 CD O O
52 ATENOLOL NNP B-NP B-m
52 25 CD O B-do
52 MG NNP B-NP I-do
52 PO NNP I-NP B-mo
52 QD NNP I-NP B-f
53 PRILOSEC NNP I-NP B-m
53 ( ( O I-m
53 OMEPRAZOLE NNP B-NP I-m
53 ) ) O I-m
53 20 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 QD NNP I-NP B-f
54 AMIODARONE NNP I-NP B-m
54 AMIODARONE NNP I-NP B-m
54 AMIODARONE NNP I-NP B-m
54 AMIODARONE NNP I-NP B-m
54 400 CD O B-do
54 MG NNP B-NP I-do
54 PO NNP I-NP B-mo
54 PO NNP I-NP B-mo
54 PO NNP I-NP B-mo
54 BID NNP I-NP B-f
55 Instructions: NNP I-NP O
55 400 CD O O
55 bid NN B-NP O
55 x VBD B-VP B-du
55 6 CD O I-du
55 days NNS B-NP I-du
55 , , O O
55 then RB O O
55 400 CD O B-do
55 400 CD O B-do
55 qd NN B-NP B-f
55 qd NN I-NP B-f
55 x VBD B-VP B-du
55 1 CD O B-du
55 1 CD O I-du
55 week NN B-NP I-du
55 week NN I-NP I-du
55 , , O O
55 then RB O O
56 200 CD O B-do
56 qd NNS B-NP B-f
56 Alert NNP I-NP O
56 overridden: VBD B-VP O
56 Override NNP B-NP O
56 added VBD B-VP O
56 on IN B-VP O
56 5/27/03 CD O O
56 by IN B-VP O
56 : : O O
57 POTENTIALLY NNP B-NP O
57 SERIOUS NNP I-NP O
57 INTERACTION: NNP I-NP O
57 LEVOFLOXACIN NNP I-NP B-m
57 &amp; NNP I-NP O
57 AMIODARONE NNP I-NP B-m
58 HCL NNP I-NP O
58 Reason NNP I-NP O
58 for IN B-VP O
58 override: NN B-NP O
58 aware JJ B-NP O
59 ECASA NNP I-NP B-m
59 ( ( O I-m
59 ASPIRIN NNP B-NP I-m
59 ENTERIC NNP I-NP I-m
59 COATED NNP I-NP I-m
59 ) ) O I-m
59 325 CD O B-do
59 MG NNP B-NP I-do
59 PO NNP I-NP B-mo
59 QD NNP I-NP B-f
60 Starting VBG O O
60 Today NNP B-NP O
60 ( ( O O
60 8/7 CD O O
60 ) ) O O
60 Instructions: NNP B-NP O
60 To TO O O
60 start VB O O
60 on IN B-VP O
60 0/12 CD O O
61 FLAGYL NNP B-NP B-m
61 ( ( O I-m
61 METRONIDAZOLE NNP B-NP I-m
61 ) ) O I-m
61 500 CD O B-do
61 MG NNP B-NP I-do
61 PO NNP I-NP B-mo
61 TID NNP I-NP B-f
61 X NNP I-NP B-du
61 2 CD O I-du
61 Days NNP B-NP I-du
62 Food/Drug NNP I-NP O
62 Interaction NNP I-NP O
62 Instruction NNP I-NP O
62 Take NNP I-NP O
62 with IN B-VP O
62 food NN B-NP O
63 LEVOFLOXACIN NNP I-NP B-m
63 500 CD O B-do
63 MG NNP B-NP I-do
63 PO NNP I-NP B-mo
63 QD NNP I-NP B-f
63 X NNP I-NP B-du
63 2 CD O I-du
63 Days NNPS B-NP I-du
64 Starting VBG O O
64 Today NNP B-NP O
64 ( ( O O
64 8/7 CD O O
64 ) ) O O
64 Food/Drug NNP B-NP O
64 Interaction NNP I-NP O
64 Instruction NNP I-NP O
65 Administer NNP I-NP O
65 iron NN I-NP B-m
65 products NNS I-NP I-m
65 a DT B-NP B-f
65 minimum NN I-NP O
65 of IN B-VP O
65 2 CD O O
65 hours NNS B-NP O
65 before IN B-VP O
65 or CC O O
66 after IN B-VP O
66 a DT B-NP O
66 levofloxacin NN I-NP B-m
66 or CC O O
66 ciprofloxacin NN B-NP B-m
66 dose VBP O O
66 dose JJ O O
67 If IN B-VP O
67 on IN B-VP O
67 tube NN B-NP O
67 feeds NNS I-NP O
67 , , O O
67 please VB O O
67 cycle NN B-NP O
67 ( ( O O
67 hold VB O O
67 1 CD O O
67 hr NN B-NP O
67 before IN B-VP O
67 to TO O O
67 2 CD O O
67 hr NNS B-NP O
68 after IN B-VP O
68 ) ) O O
68 Take VBP O O
68 2 CD O O
68 hours NNS B-NP O
68 before IN B-VP O
68 or CC O O
68 2 CD O O
68 hours NNS B-NP O
68 after IN B-VP O
68 dairy NN B-NP O
68 products NNS I-NP O
69 Alert NNP I-NP O
69 overridden: MD O O
69 Override NNP B-NP O
69 added VBD B-VP O
69 on IN B-VP O
69 5/27/03 CD O O
69 by IN B-VP O
69 : : O O
70 POTENTIALLY NNP B-NP O
70 SERIOUS NNP I-NP O
70 INTERACTION: NNP I-NP O
70 AMIODARONE NNP I-NP B-m
70 HCL NNP I-NP I-m
70 &amp; NNP I-NP O
71 LEVOFLOXACIN NNP I-NP B-m
71 Reason NNP I-NP O
71 for IN B-VP O
71 override: NN B-NP O
71 aware JJ B-NP O
72 DIET: NNP I-NP O
72 House NNP I-NP O
72 / VBD B-VP O
72 Low NNP B-NP O
72 chol/low NN I-NP O
72 sat VBD B-VP O
72 fat JJ B-NP O
73 ACTIVITY: NNP I-NP O
73 Resume NNP I-NP O
73 regular JJ B-NP O
73 exercise NN I-NP O
74 FOLLOW NNP I-NP O
74 UP NNP I-NP O
74 APPOINTMENT( NNP I-NP O
74 S NNP I-NP O
74 ): NNP I-NP O
75 Dr NNP I-NP O
75 Schultheiss NNP I-NP O
75 ( ( O O
75 cardiology NN B-NP O
75 ) ) O O
75 5/30/03 CD O O
75 scheduled VBN O O
75 , , O O
76 Gastroenterology- NNP B-NP O
76 Dr NNP I-NP O
76 Degener NNP I-NP O
76 , , O O
76 call NN B-NP O
76 for IN B-VP O
76 appointment NN B-NP O
76 , , O O
77 ALLERGY: NNP B-NP O
77 Iv NNP I-NP O
77 contrast NN I-NP O
77 dyes NNS I-NP O
77 , , O O
77 Codeine NNP B-NP O
77 , , O O
77 Penicillins NNP B-NP O
77 , , O O
77 Erythromycins NNP B-NP O
77 , , O O
78 Morphine NNP B-NP O
78 , , O O
78 Demerol NNP B-NP O
79 ADMIT NNP I-NP O
79 DIAGNOSIS: NNP I-NP O
80 Aspiration NNP I-NP O
80 PNA NNP I-NP O
81 PRINCIPAL NNP I-NP O
81 DISCHARGE NNP I-NP O
81 DIAGNOSIS NNP I-NP O
81 ;Responsible JJ O O
81 After IN B-VP O
81 Study NNP B-NP O
81 for IN B-VP O
81 Causing NNP B-NP O
81 Admission NNP I-NP O
81 ) ) O O
82 colonic NN B-NP O
82 microperforation NN I-NP O
82 , , O O
82 afib VBZ O O
83 OTHER NNP B-NP O
83 DIAGNOSIS;Conditions NNP I-NP O
83 , , O O
83 Infections NNP B-NP O
83 , , O O
83 Complications NNP B-NP O
83 , , O O
83 affecting VBG O O
83 Treatment/Stay NNP B-NP O
84 cad NN I-NP O
84 ( ( O O
84 coronary JJ B-NP O
84 artery NN I-NP O
84 disease NN I-NP O
84 ) ) O O
84 hodgkin NN B-NP O
84 ( ( O O
84 Hodgkins NNP B-NP O
84 disease NN I-NP O
84 ) ) O O
84 renal NN B-NP O
85 transplant NN I-NP O
85 ( ( O O
85 kidney VB O O
85 transplant NN B-NP O
85 ) ) O O
85 htn NN B-NP O
86 ( ( O O
86 hypertension NN B-NP O
86 ) ) O O
86 s/p NN B-NP O
86 appy JJ O O
86 ( ( O O
86 S/P NNP B-NP O
86 appendectomy RB O O
86 ) ) O O
86 h/o VBZ O O
86 A DT B-NP O
86 fib NN I-NP O
86 ( ( O O
86 H/O NNP B-NP O
86 atrial JJ B-NP O
87 fibrillation NN I-NP O
87 ) ) O O
87 hypothyroidism NN B-NP O
87 ( ( O O
87 hypothyroidism NN B-NP O
87 ) ) O O
87 polyarteritis NN B-NP O
88 OPERATIONS NNP I-NP O
88 AND NNP I-NP O
88 PROCEDURES: NNP I-NP O
89 Colonoscopy NNP I-NP O
89 under IN B-VP O
89 general JJ B-NP O
89 anesthesia NN I-NP O
90 OTHER NNP I-NP O
90 TREATMENTS/PROCEDURES NNP I-NP O
90 ( ( O O
90 NOT NNP B-NP O
90 IN NNP I-NP O
90 O.R NNP I-NP O
90 ) ) O O
91 none NN B-NP O
92 BRIEF NNP I-NP O
92 RESUME NNP I-NP O
92 OF NNP I-NP O
92 HOSPITAL NNP I-NP O
92 COURSE: NNP I-NP O
93 74 CD O O
93 yo NN B-NP O
93 woman NN I-NP O
93 in IN B-VP O
93 remission NN B-NP O
93 from IN B-VP O
93 Hodgkin's NNP B-NP O
93 Lymphoma NNP I-NP O
94 and CC O O
94 s/p JJ B-NP O
94 renal JJ I-NP O
94 transplant( NN I-NP O
94 11/12 CD O O
94 ) ) O O
94 who WP O O
94 p/w VBP O O
94 hypoxia NNS B-NP O
94 , , O O
94 low JJ B-NP O
94 grade NN I-NP O
94 fever NN I-NP O
94 in IN B-VP O
95 setting VBG O O
95 of IN B-VP O
95 colonoscopy NN B-NP O
95 under IN B-VP O
95 general JJ B-NP O
95 anesthesia NN I-NP O
95 Pt NNP I-NP O
95 had VBD B-VP O
95 PET NNP B-NP O
95 scan JJ O O
95 on IN B-VP O
96 1/29 CD O O
96 which WDT O O
96 showed VBD B-VP O
96 uptake NN B-NP O
96 in IN B-VP O
96 asc JJ B-NP O
96 colon NN I-NP O
96 and CC O O
96 hep JJ B-NP O
97 flexure NN I-NP O
97 concerning VBG O O
97 for IN B-VP O
97 malignancy NN B-NP O
97 CT NNP I-NP O
97 colonoscopy NN I-NP O
98 showed VBD B-VP O
98 1.6 CD O O
98 les NNS B-NP O
98 in IN B-VP O
98 desc NN B-NP O
98 colon NN I-NP O
98 and CC O O
98 colonoscopy NN B-NP O
98 under IN B-VP O
99 GA NNP B-NP O
99 performed VBD B-VP O
99 due JJ O O
99 to TO O O
99 difficulty NN B-NP O
99 of IN B-VP O
99 going VBG O O
99 beyond IN B-VP O
100 hep JJ B-NP O
100 flexure NN I-NP O
100 Pt NNP I-NP O
100 had VBD B-VP O
100 hypoxia VBN O O
100 to TO O O
100 80s CD O O
100 when WRB O O
101 awakening VBG O O
101 from IN B-VP O
101 anesthesia JJ B-NP O
101 Temp NNP I-NP O
101 to TO O O
101 101.1 CD O O
101 CXR NNP B-NP O
101 showed VBD B-VP O
102 ?LLL NNP B-NP O
102 opacity NN I-NP O
102 Thought NNP I-NP O
102 to TO O O
102 be VB O O
102 likely JJ B-NP O
102 Pneumonitis NNP I-NP O
102 vs NN I-NP O
102 asp NN I-NP O
102 PNA NNP I-NP O
102 In IN B-VP O
102 Pacu NNP B-NP O
103 Pt NNP I-NP O
103 also RB O O
103 had VBD B-VP O
103 EKG NNP B-NP O
103 changes NNS I-NP O
103 , , O O
103 TWIs NNP B-NP O
103 and CC O O
103 ? . B-VP O
103 BBB NNP B-NP O
103 assoc NN I-NP O
104 with IN B-VP O
104 HR70s-80s NNP B-NP O
104 EKGs NNP I-NP O
104 resolved VBD B-VP O
104 when WRB O O
104 rate NN B-NP O
104 in IN B-VP O
104 60s CD O O
105 Physical JJ B-NP O
105 Exam NNP I-NP O
105 revealed VBD B-VP O
105 AOOx3 NNP B-NP O
105 woman NN I-NP O
105 in IN B-VP O
105 NAD NNP B-NP O
105 PERRL NNP I-NP O
105 No NNP I-NP O
105 carotid NN I-NP O
105 bruits NNS I-NP O
106 Cardiac NNP I-NP O
106 exam NN I-NP O
106 remarkable NN I-NP O
106 for IN B-VP O
106 RRR NNP B-NP O
106 , , O O
106 2/6 CD O O
106 murmur NN B-NP O
106 at IN B-VP O
106 RUSB NNP B-NP O
106 There EX O O
106 are VBP O O
107 crackles NNS B-NP O
107 at IN B-VP O
107 LL NNP B-NP O
107 base NN I-NP O
107 to TO O O
107 mid VB O O
107 lung JJ B-NP O
107 field NN I-NP O
107 Abd NNP I-NP O
107 exam NN I-NP O
107 there EX O O
107 is VBZ O O
108 rebound NN B-NP O
108 and CC O O
108 invol NN B-NP O
108 guarding VBG O O
108 Tenderness NNP B-NP O
108 in IN B-VP O
108 epigastric JJ O O
109 and CC O O
109 suprapubic JJ B-NP O
109 area NN I-NP O
109 +BS VBZ O O
109 No DT B-NP O
109 hepatomegaly NN I-NP O
110 Labs NNP I-NP O
110 significant JJ O O
110 for IN B-VP O
110 HCt NNP B-NP O
110 24 CD O O
110 from IN B-VP O
110 baseline NN B-NP O
110 of IN B-VP O
110 30 CD O O
110 , , O O
110 Cr NNP B-NP O
111 1.9 CD O O
111 from IN B-VP O
111 baseline NN B-NP O
111 of IN B-VP O
111 1.6 CD O O
111 Cardiac NNP B-NP O
111 enzymes NNS I-NP O
111 were VBD B-VP O
111 flat JJ B-NP O
112 HOSPITAL NNP I-NP O
112 COURSE:**************** NNP I-NP O
113 1 CD O O
113 Pulm-On NNP B-NP O
113 floor NN I-NP O
113 pt's NN I-NP O
113 oxygenation NN I-NP O
113 improved VBD B-VP O
113 within IN B-VP O
113 one CD O O
113 day NN B-NP O
113 to TO O O
113 96% CD O O
113 on IN B-VP O
113 RA NNP B-NP O
114 Likely NNP I-NP O
114 aspiration NN I-NP O
114 , , O O
114 but CC O O
114 final JJ B-NP O
114 read NN I-NP O
114 on IN B-VP O
115 CXR NNP B-NP O
115 shows VBZ O O
115 no DT B-NP O
115 infiltrate/opacity NN I-NP O
115 Levo/Flagyl NNP I-NP B-m
115 given VBN O O
115 empirically RB O O
115 x JJ O B-du
115 5days CD O I-du
116 though IN B-VP O
116 she PRP O O
116 remained VBD B-VP O
116 afeb JJ O O
117 2 CD O O
117 CV-Pt NN B-NP O
117 has VBZ O O
117 h/o VBN O O
117 MI NNP B-NP O
117 , , O O
117 RCA NNP B-NP O
117 stent NN I-NP O
117 , , O O
117 mod RB O O
117 AS IN B-VP O
117 Low NNP B-NP O
117 Hct NNP I-NP O
117 and CC O O
117 EKG NNP B-NP O
117 changes NNS I-NP O
118 concerning VBG O O
118 for IN B-VP O
119 myocardial JJ B-NP O
119 injury NN I-NP O
119 Her NNP I-NP O
119 cardiac NN I-NP O
119 enzymes NNS I-NP O
119 were VBD B-VP O
119 negative JJ O O
119 after IN B-VP O
119 the DT B-NP O
119 initial JJ I-NP O
120 hypoxic NN I-NP O
120 episode NN I-NP O
120 , , O O
120 and CC O O
120 EKG NNP B-NP O
120 changes NNS I-NP O
120 resolved VBD B-VP O
120 Transfused JJ O O
120 2u CD O B-do
120 PRBCs NNP B-NP B-m
120 On IN B-VP O
121 1/16 CD O O
121 she PRP O O
121 had VBD B-VP O
121 Afib NNP B-NP O
121 with IN B-VP O
121 RVR NNP B-NP O
121 to TO O O
121 130s CD O O
121 with IN B-VP O
121 chest NN B-NP O
121 arm NN I-NP O
121 pain NN I-NP O
121 which WDT O O
121 is VBZ O O
121 her PRP$ O O
122 anginal JJ B-NP O
122 equivalent JJ I-NP O
122 ECG NNP I-NP O
122 with IN B-VP O
122 rate NN B-NP O
122 related VBN O O
122 ischemia NN B-NP O
122 ST NNP I-NP O
122 depression NN I-NP O
123 V5-6 NNP I-NP O
123 , , O O
123 L NNP B-NP O
123 +Minimal NNP I-NP O
123 troponin NN I-NP O
123 leak NN I-NP O
123 to TO O O
123 0.19 CD O O
123 , , O O
123 which WDT O O
123 subseq VBZ O O
123 downtrended VBN O O
124 with IN B-VP O
124 nl JJ B-NP O
124 CK NNP I-NP O
124 She PRP O O
124 was VBD B-VP O
124 init RB O O
124 treated VBN O O
124 with IN B-VP O
124 lopressor NN B-NP B-m
124 5mg CD O B-do
125 IV NNP B-NP B-mo
125 but CC O O
125 had VBD B-VP O
125 hypotension NN B-NP B-r
125 to TO O O
125 80's CD O O
125 which WDT O O
125 resolved VBD B-VP O
125 quickly RB O O
125 with IN B-VP O
125 IVF NNP B-NP B-m
125 She PRP O O
125 was VBD B-VP O
126 eventually RB O O
126 rate NN B-NP O
126 controlled VBN O O
126 with IN B-VP O
126 dilt NN B-NP B-m
126 drip NN I-NP B-mo
126 She PRP O O
126 returned VBD B-VP O
126 to TO O O
126 sinus VB O O
127 rhythm NN B-NP O
127 within IN B-VP O
127 the DT B-NP O
127 day NN I-NP O
127 Cards NNP I-NP O
127 c/s'd NN I-NP O
128 and CC O O
128 recommended VBD B-VP O
128 amio NN B-NP B-m
128 load NN I-NP O
128 She PRP O O
128 had VBD B-VP O
128 PFT's NNP B-NP O
128 , , O O
128 LFT's NNP B-NP O
128 and CC O O
128 TFT's NNP B-NP O
128 prior RB O O
128 to TO O O
129 d/c VB O O
129 Plan NNP B-NP O
129 to TO O O
129 follow VB O O
129 up RP O O
129 with IN B-VP O
129 Dr NNP B-NP O
129 Lenberg NNP I-NP O
129 Consider NNP I-NP O
129 anticoagulation NN I-NP B-m
129 for IN B-VP O
130 PAF NNP B-NP B-r
130 , , O O
130 this DT O O
130 is VBZ O O
130 at IN B-VP O
130 least JJS O O
130 2nd CD O O
130 episode NN B-NP O
130 Pt NNP I-NP O
130 to TO O O
130 restart VB O O
130 ecasa VB O B-m
130 ecasa JJ O B-m
130 5d CD O B-du
130 p NN B-NP O
130 colonosco NN I-NP O
131 py VBD B-VP O
132 2 CD O O
132 GI-Pt NNP B-NP O
132 had VBD B-VP O
132 abd VBN O O
132 exam RB O O
132 concerning VBG O O
132 for IN B-VP O
132 focal JJ B-NP O
132 peritoneal NN I-NP O
133 irritation NN I-NP O
133 It PRP O O
133 is VBZ O O
133 likely JJ O O
133 that IN B-VP O
133 she PRP O O
133 had VBD B-VP O
133 a DT B-NP O
133 microperforation NN I-NP O
133 during IN B-VP O
134 colonoscopy NN B-NP O
134 as IN B-VP O
134 CT NNP B-NP O
134 showed VBD B-VP O
134 fluid NN B-NP O
134 in IN B-VP O
134 pelvis NN B-NP O
134 and CC O O
134 she PRP O O
134 had VBD B-VP O
134 Hct NNP B-NP O
134 drop NN I-NP O
135 requiring VBG O O
135 2U CD O B-do
135 pRBC NN B-NP B-m
135 Her NNP I-NP O
135 exam NN I-NP O
135 improved VBD B-VP O
135 , , O O
135 and CC O O
135 she PRP O O
135 was VBD B-VP O
135 tolerating VBG O O
135 PO NNP B-NP O
135 well RB O O
136 at IN B-VP O
136 the DT B-NP O
136 time NN I-NP O
136 of IN B-VP O
136 discharge NN B-NP O
136 She PRP O O
136 has VBZ O O
136 been VBN O O
136 afeb VBN O O
136 and CC O O
136 well RB O O
136 appearing VBG O O
136 for IN B-VP O
137 several JJ B-NP O
137 days NNS I-NP O
137 prior RB O O
137 to TO O O
137 d/c VB O O
137 Plan NNP B-NP O
137 to TO O O
137 complete VB O O
137 5d CD O B-du
137 5d CD O B-du
137 abx NN B-NP B-m
137 As IN B-VP O
137 per IN B-VP O
137 Dr NNP B-NP O
137 Thorburn NNP I-NP O
138 her PRP$ O O
138 colonoscopy NN B-NP O
138 was VBD B-VP O
138 complex JJ O O
138 , , O O
138 and CC O O
138 she PRP O O
138 had VBD B-VP O
138 polypectomy NN B-NP O
138 of IN B-VP O
138 2.5 CD O O
138 cm NNS B-NP O
138 polyp JJ B-NP O
139 Path NNP I-NP O
139 is VBZ O O
139 pending VBG O O
139 If IN B-VP O
139 + VBN O O
139 for IN B-VP O
139 cancer NN B-NP O
139 , , O O
139 the DT B-NP O
139 base NN I-NP O
139 looked VBD B-VP O
139 "clean" NNP B-NP O
139 , , O O
139 so RB O O
139 may MD O O
139 be VB O O
140 feasible JJ O O
140 to TO O O
140 re-scope VB O O
140 her PRP$ O O
140 for IN B-VP O
140 surveillance NN B-NP O
140 at IN B-VP O
140 a DT B-NP O
140 later JJ I-NP O
140 time NN I-NP O
140 , , O O
140 as IN B-VP O
140 per IN B-VP O
140 GI NNP B-NP O
141 3 CD O O
141 HEME- NNP B-NP O
141 Hct NNP I-NP O
141 after IN B-VP O
141 colonoscopy NN B-NP O
141 went VBD B-VP O
141 to TO O O
142 24 CD O O
142 ( ( O O
142 baseline NN B-NP O
142 30 CD O O
142 ); JJ B-NP O
142 post-transfusion NN I-NP O
142 HCt NNP I-NP O
142 of IN B-VP O
142 30 CD O O
143 5 CD O O
143 s/p JJ B-NP O
143 Renal NNP I-NP O
143 transplant NN I-NP O
143 Continuing NNP I-NP O
143 meds VBZ O O
144 ADDITIONAL NNP B-NP O
144 COMMENTS: NNP I-NP O
145 DISCHARGE NNP I-NP O
145 CONDITION: NNP I-NP O
145 Stable NNP I-NP O
146 TO NNP I-NP O
146 DO/PLAN: NNP I-NP O
147 No NNP I-NP O
147 dictated VBD B-VP O
147 summary JJ B-NP O
148 ENTERED NNP I-NP O
148 BY: NNP I-NP O
148 HAJDUKIEWICZ NNP I-NP O
148 , , O O
148 CLIFFORD NNP B-NP O
148 NICHOLAS NNP I-NP O
148 , , O O
148 M.D NNP B-NP O
148 ( ( O O
148 ET412 NNP B-NP O
148 ) ) O O
148 5/27/03 CD O O
148 @ $ O O
148 05:24 CD O O
148 PM NNP B-NP O
149 ****** JJ B-NP O
149 END NNP I-NP O
149 OF NNP I-NP O
149 DISCHARGE NNP I-NP O
149 ORDERS NNP I-NP O
149 ****** NNP I-NP O
150 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #183745 VBZ O O
2 676331324 CD O O
2 TMH NNP B-NP O
2 12324822 CD O O
2 5221030 CD O O
2 4/1/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 same JJ B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/28/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/10/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 TAM NNP I-NP O
5 , , O O
5 MEL NNP B-NP O
5 506-68-15-3 CD O O
6 Ver NNP B-NP O
6 Ho NNP I-NP O
6 E NNP I-NP O
7 Service: NNP I-NP O
7 GGI NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/27/06 CD O O
8 AT NNP B-NP O
8 03:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 LEDAY NNP I-NP O
11 , , O O
11 EMERY NNP B-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ROCALTROL NNP I-NP B-m
16 ( ( O I-m
16 CALCITRIOL NNP B-NP I-m
16 ) ) O I-m
16 0.5 CD O B-do
16 MCG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 BID NNP I-NP B-f
17 CALCIUM NNP I-NP B-m
17 CARBONATE NNP I-NP I-m
17 ( ( O I-m
17 500 CD O I-m
17 MG NNP B-NP I-m
17 ELEMENTAL NNP I-NP I-m
17 CA++ NNP I-NP I-m
17 ) ) O I-m
18 1 CD O B-do
18 , , O I-do
18 000 CD O I-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 Q6H NNP I-NP B-f
19 Instructions: NNP I-NP O
19 500mg CD O O
19 elemental JJ B-NP O
19 calcium NN I-NP O
19 is VBZ O O
19 the DT B-NP O
19 equivalent NN I-NP O
19 of IN B-VP O
20 1250mg CD O O
20 of IN B-VP O
20 calcium NN B-NP O
20 carbonate NN I-NP O
21 HYDROCHLOROTHIAZIDE NNP I-NP B-m
21 25 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 DAILY NNP I-NP B-f
22 Starting NNP I-NP O
22 Tomorrow NNP I-NP O
22 ( ( O O
22 11/6 CD O O
22 ) ) O O
23 SYNTHROID NNP B-NP B-m
23 ( ( O I-m
23 LEVOTHYROXINE NNP B-NP I-m
23 SODIUM NNP I-NP I-m
23 ) ) O I-m
23 200 CD O B-do
23 MCG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 Instructions: NNP I-NP O
24 ( ( O O
24 typical JJ B-NP O
24 dose NN I-NP O
24 is VBZ O O
24 1 CD O O
24 mcg NN B-NP O
24 per IN B-VP O
24 lb NN B-NP O
24 ) ) O O
25 OXYCODONE NNP B-NP B-m
25 5-10 JJ B-NP B-do
25 MG NNP I-NP I-do
25 PO NNP I-NP B-mo
25 Q4H NNP I-NP B-f
25 PRN NNP I-NP I-f
25 Pain NNP I-NP B-r
26 ATENOLOL NNP I-NP B-m
26 100 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 DAILY NNP I-NP B-f
27 DIET: NNP I-NP O
27 House NNP I-NP O
27 / VBD B-VP O
27 Low NNP B-NP O
27 chol/low NN I-NP O
27 sat VBD B-VP O
27 fat JJ B-NP O
28 ACTIVITY: NNP I-NP O
28 Walking NNP I-NP O
28 as IN B-VP O
28 tolerated VBN O O
29 FOLLOW NNP B-NP O
29 UP NNP I-NP O
29 APPOINTMENT( NNP I-NP O
29 S NNP I-NP O
29 ): NNP I-NP O
30 Dr NNP I-NP O
30 Tooles NNP I-NP O
30 please VB O O
30 call NN B-NP O
30 to TO O O
30 schedule NN B-NP O
30 , , O O
31 Primary NNP B-NP O
31 Care NNP I-NP O
31 please VB O O
31 call NN B-NP O
31 to TO O O
31 schedule NN B-NP O
31 , , O O
32 ALLERGY: NNP B-NP O
32 Erythromycins NNP I-NP O
33 ADMIT NNP I-NP O
33 DIAGNOSIS: NNP I-NP O
34 metastatic JJ B-NP O
34 thyroid NN I-NP O
34 cancer NN I-NP O
35 PRINCIPAL NNP I-NP O
35 DISCHARGE NNP I-NP O
35 DIAGNOSIS NNP I-NP O
35 ;Responsible JJ O O
35 After IN B-VP O
35 Study NNP B-NP O
35 for IN B-VP O
35 Causing NNP B-NP O
35 Admission NNP I-NP O
35 ) ) O O
36 same JJ B-NP O
37 OTHER NNP I-NP O
37 DIAGNOSIS;Conditions NNP I-NP O
37 , , O O
37 Infections NNP B-NP O
37 , , O O
37 Complications NNP B-NP O
37 , , O O
37 affecting VBG O O
37 Treatment/Stay NNP B-NP O
38 OBESITY NNP I-NP O
38 SLEEP NNP I-NP O
38 APNEA NNP I-NP O
38 PNEUMONIA NNP I-NP O
39 OPERATIONS NNP I-NP O
39 AND NNP I-NP O
39 PROCEDURES: NNP I-NP O
40 LT NNP I-NP O
40 PARATRACHEAL NNP I-NP O
40 &amp; NNP I-NP O
40 MODIFIED NNP I-NP O
40 RADICAL NNP I-NP O
40 NECK NNP I-NP O
40 DISSECTION NNP I-NP O
40 DR NNP I-NP O
40 TROSPER NNP I-NP O
40 4/17/06 CD O O
41 OTHER NNP B-NP O
41 TREATMENTS/PROCEDURES NNP I-NP O
41 ( ( O O
41 NOT NNP B-NP O
41 IN NNP I-NP O
41 O.R NNP I-NP O
41 ) ) O O
42 none NN B-NP O
43 BRIEF NNP I-NP O
43 RESUME NNP I-NP O
43 OF NNP I-NP O
43 HOSPITAL NNP I-NP O
43 COURSE: NNP I-NP O
44 43 CD O O
44 yo NN B-NP O
44 F NNP I-NP O
44 with IN B-VP O
44 metastatic JJ B-NP O
44 tall NN I-NP O
44 cell NN I-NP O
44 papillary JJ O O
44 ca MD O O
44 to TO O O
44 bilateral VB O O
44 IJ NNP B-NP O
44 nodes NNS I-NP O
45 s/p VBP O O
45 RAI NNP B-NP O
46 s/p NN I-NP O
46 Left NNP I-NP O
46 paratracheal NN I-NP O
46 and CC O O
46 modified VBD B-VP O
46 radial JJ B-NP O
46 neck NN I-NP O
46 dissection NN I-NP O
47 Left NNP I-NP O
47 recurrent NN I-NP O
47 laryngeal NN I-NP O
47 nerve NN I-NP O
47 was VBD B-VP O
47 identified VBN O O
48 Left NNP B-NP O
48 parathyroids NNS I-NP O
48 were VBD B-VP O
48 not RB O O
48 identified VBN O O
48 , , O O
48 and CC O O
48 were VBD B-VP O
48 not RB O O
48 seen VBN O O
48 in IN B-VP O
48 the DT B-NP O
48 specimen NNS I-NP O
49 She PRP O O
49 is VBZ O O
49 already RB O O
49 moderately RB O O
49 hypoparathyroid JJ O O
49 from IN B-VP O
49 her PRP$ O O
49 total JJ B-NP O
49 thyroidectomy NN I-NP O
49 in IN B-VP O
50 1/24 CD O O
50 ( ( O O
50 pre NN B-NP O
50 op NN I-NP O
50 ca MD O O
50 7.6 CD O O
50 ) ) O O
51 The DT B-NP O
51 left JJ I-NP O
51 IJ NNP I-NP O
51 was VBD B-VP O
51 noted VBN O O
51 to TO O O
51 be VB O O
51 clotted VBN O O
51 at IN B-VP O
51 the DT B-NP O
51 end NN I-NP O
51 of IN B-VP O
51 the DT B-NP O
51 case NN I-NP O
51 and CC O O
51 was VBD B-VP O
52 ligated VBN O O
53 mild JJ O O
53 oozing VBG O O
53 in IN B-VP O
53 the DT B-NP O
53 upper JJ I-NP O
53 portion NN I-NP O
53 of IN B-VP O
53 the DT B-NP O
53 surgical JJ I-NP O
53 bed NN I-NP O
53 was VBD B-VP O
53 treated VBN O O
53 with IN B-VP O
54 fibrillar JJ O O
54 ( ( O O
54 cotton NN B-NP O
54 surgicel NN I-NP O
54 ) ) O O
55 The DT B-NP O
55 inferior JJ I-NP O
55 aspect NN I-NP O
55 of IN B-VP O
55 the DT B-NP O
55 wound NN I-NP O
55 was VBD B-VP O
55 quite RB O O
55 deep JJ O O
55 ( ( O O
55 thymus JJ O O
55 taken VBN O O
55 with IN B-VP O
55 the DT B-NP O
56 specimen NNS I-NP O
56 ) ) O O
57 7 CD O O
57 JP NNP B-NP O
57 drain NN I-NP O
57 placed VBD B-VP O
57 along IN B-VP O
57 the DT B-NP O
57 dissection NN I-NP O
57 bed VBD B-VP O
58 PMH: NNP B-NP O
58 asthma NN I-NP O
58 , , O O
58 PSVT NNP B-NP O
58 in IN B-VP O
58 2001 CD O O
58 , , O O
58 obesity NN B-NP O
58 , , O O
58 obstructive JJ B-NP O
58 sleep NN I-NP O
58 apnea NN I-NP O
58 , , O O
58 thalessemia JJ B-NP O
59 trait NN I-NP O
60 PSH: NNP I-NP O
60 gastric JJ B-NP O
60 bypass NN I-NP O
60 5 CD O O
60 of IN B-VP O
60 July NNP B-NP O
60 , , O O
60 s/p JJ B-NP O
60 cholecystectomy NN I-NP O
60 , , O O
60 bowel NN B-NP O
60 obstruction NN I-NP O
60 4/13 CD O O
61 total JJ B-NP O
61 thyroidectomy NN I-NP O
61 11/17 CD O O
62 Meds: NNP B-NP O
62 atenolol VBD B-VP B-m
62 100 CD O B-do
62 qd NN B-NP B-f
62 , , O O
62 hctz VBD B-VP B-m
62 25 CD O B-do
62 qd NN B-NP B-f
62 , , O O
62 levoxyl JJ O B-m
62 200 CD O B-do
62 bid NN B-NP B-f
62 , , O O
62 rocaltrol VB O B-m
62 0.5 CD O B-do
62 bid NN B-NP B-f
62 , , O O
63 calcium NN B-NP B-m
63 500 CD O B-do
63 mg NN B-NP I-do
63 elemental JJ O O
63 6 CD O B-f
63 times NNS B-NP I-f
63 per IN B-VP I-f
63 day NN B-NP I-f
64 All: NNP I-NP O
64 erythromycin VBZ O B-m
64 leads VBZ O O
64 to TO O O
64 GI NNP B-NP O
64 upset JJ B-NP O
65 pt NN I-NP O
65 underwent VBD B-VP O
65 the DT B-NP O
65 above JJ I-NP O
65 procedure NN I-NP O
65 , , O O
65 brief JJ B-NP O
65 desciption NN I-NP O
65 as IN B-VP O
65 above IN B-VP O
65 , , O O
65 please VB O O
65 see VB O O
66 operative JJ B-NP O
66 note NN I-NP O
66 for IN B-VP O
66 full JJ B-NP O
66 details NNS I-NP O
66 Pt NNP I-NP O
66 tolerated VBD B-VP O
66 the DT B-NP O
66 procedure NN I-NP O
66 well RB O O
66 Pt's NNP B-NP O
67 diet NN I-NP O
67 was VBD B-VP O
67 advanced VBN O O
67 , , O O
67 pain NN B-NP B-r
67 was VBD B-VP O
67 well RB O O
67 controlled VBN O O
67 on IN B-VP O
67 oral JJ B-NP B-m
67 oral JJ I-NP B-mo
67 medications NNS I-NP I-m
67 ON NNP I-NP O
68 pod#0 NN I-NP O
68 pt NN I-NP O
68 was VBD B-VP O
68 hypertensive JJ O B-r
68 requiring VBG O O
68 multiple JJ B-NP O
68 doses NNS I-NP O
68 of IN B-VP O
68 IV NNP B-NP B-mo
68 IV NNP I-NP B-mo
68 medication NN I-NP O
69 ( ( O O
69 labetalol JJ O B-m
69 and CC O O
69 hydralazine NN B-NP B-m
69 ) ) O O
69 in IN B-VP O
69 order NN B-NP O
69 to TO O O
69 control VB O O
69 pod#1 JJ O O
69 she PRP O O
69 was VBD B-VP O
70 restarted VBN O O
70 on IN B-VP O
70 all DT O O
70 her PRP$ O O
70 oral JJ B-NP B-m
70 oral JJ I-NP B-mo
70 medications NNS I-NP I-m
70 and CC O O
70 her PRP$ O O
70 pressure NN B-NP O
70 lowered VBD B-VP O
71 appropriately RB O O
71 pod#1 JJ O O
71 , , O O
71 she PRP O O
71 ate VBD B-VP O
71 a DT B-NP O
71 fatty JJ I-NP O
71 meal NN I-NP O
71 as IN B-VP O
71 instructed VBN O O
71 for IN B-VP O
71 lunch NN B-NP O
72 and CC O O
72 there EX O O
72 was VBD B-VP O
72 no DT B-NP O
72 evidence NN I-NP O
72 of IN B-VP O
72 a DT B-NP O
72 chyle JJ I-NP O
72 leak NN I-NP O
72 and CC O O
72 her PRP$ O O
72 JP NNP B-NP O
72 drain NN I-NP O
72 was VBD B-VP O
73 d/c'd JJ B-NP O
73 Her NNP I-NP O
73 serum NN I-NP O
73 calcium NN I-NP O
73 levels NNS I-NP O
73 were VBD B-VP O
73 7.5 CD O O
73 and CC O O
73 a DT B-NP O
73 recheck NN I-NP O
73 was VBD B-VP O
73 8.1 CD O O
73 the DT B-NP O
73 pt NN I-NP O
73 was VBD B-VP O
74 neurologically RB O O
74 intact JJ O O
74 , , O O
74 af JJ O O
74 , , O O
74 hd JJ O O
74 stable JJ O O
74 and CC O O
74 wound NN B-NP O
74 was VBD B-VP O
74 c/d/i JJ B-NP O
74 Pt NNP I-NP O
74 was VBD B-VP O
74 deemed VBN O O
75 ready JJ O O
75 for IN B-VP O
75 d/c NN B-NP O
75 to TO O O
75 f/u VB O O
75 c JJ B-NP O
75 dr NN I-NP O
75 macky JJ B-NP O
75 pt NN I-NP O
75 to TO O O
75 call VB O O
75 to TO O O
75 schedule VB O O
76 ADDITIONAL NNP B-NP O
76 COMMENTS: NNP I-NP O
76 1 CD O O
76 Please NNP B-NP O
76 call VB O O
76 if IN B-VP O
76 fever RB O O
76 greater JJR O O
76 than IN B-VP O
76 101.5 CD O O
76 , , O O
76 if IN B-VP O
76 increased VBN O O
76 redness NN B-NP O
76 around RB O O
77 wound RB O O
77 , , O O
77 if IN B-VP O
77 discharge NN B-NP O
77 from IN B-VP O
77 wound NN B-NP O
77 , , O O
77 if IN B-VP O
77 increased VBN O O
77 pain NN B-NP O
77 uncontrolled JJ O O
77 by IN B-VP O
77 pain NN B-NP B-m
78 medications NNS I-NP O
79 2 CD O O
79 Please NNP B-NP O
79 do VB O O
79 not RB O O
79 immerse VB O O
79 wound NN B-NP O
79 in IN B-VP O
79 bath NN B-NP O
79 , , O O
79 swimming NN B-NP O
79 , , O O
79 or CC O O
79 sauna NN B-NP O
79 for IN B-VP O
79 2 CD O O
79 weeks NNS B-NP O
80 3 CD O O
80 Please NNP B-NP O
80 do VB O O
80 not RB O O
80 drive VB O O
80 while IN B-VP O
80 taking VBG O O
80 narcotics NNS B-NP O
81 4 CD O O
81 Please NNP B-NP O
81 follow VB O O
81 up RP O O
81 with IN B-VP O
81 primary JJ B-NP O
81 care NN I-NP O
81 provider NN I-NP O
81 concerning VBG O O
82 hospitalization NN B-NP O
83 DISCHARGE NNP I-NP O
83 CONDITION: NNP I-NP O
83 Stable NNP I-NP O
84 TO NNP I-NP O
84 DO/PLAN: NNP I-NP O
85 No NNP I-NP O
85 dictated VBD B-VP O
85 summary JJ B-NP O
86 ENTERED NNP I-NP O
86 BY: NNP I-NP O
86 KORTRIGHT NNP I-NP O
86 , , O O
86 ANTONIA NNP B-NP O
86 JAMISON NNP I-NP O
86 , , O O
86 M.D NNP B-NP O
86 ( ( O O
86 XX29 NNP B-NP O
86 ) ) O O
86 9/27/06 CD O O
86 @ $ O O
86 03 CD O O
87 ****** JJ B-NP O
87 END NN I-NP O
87 OF NNP I-NP O
87 DISCHARGE NNP I-NP O
87 ORDERS NNP I-NP O
87 ****** NNP I-NP O
88 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #188924 VBZ O O
4 429472380 CD O O
4 EMCO NNP B-NP O
4 98607374 CD O O
4 2554367 CD O O
4 9/6/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Congestive NNP I-NP O
4 heart NN I-NP O
4 failure NN I-NP O
4 with IN B-VP O
4 dilated VBN O O
4 cardiomyopathy JJ B-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/22/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 9/6/2005 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 SOLTOW NNP I-NP O
8 , , O O
8 TERENCE NNP B-NP O
8 161-86-99-2 CD O O
9 Mo NNP B-NP O
9 Clasmentale NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 6/7/05 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 HO NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 BROGLEY NNP I-NP O
14 , , O O
14 WILBURN NNP B-NP O
14 MICHAEL NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Override NNP I-NP O
20 Notice: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 4/7/05 CD O O
20 by IN B-VP O
21 FELCH NNP B-NP O
21 , , O O
21 LEN NNP B-NP O
21 A NNP I-NP O
21 , , O O
21 M.D NNP B-NP O
22 on IN B-VP O
22 order NN B-NP O
22 for IN B-VP O
22 COUMADIN NNP B-NP B-m
22 PO NNP I-NP B-mo
22 ( ( O O
22 ref JJ O O
22 # # O O
22 55946845 CD O O
22 ) ) O O
23 POTENTIALLY NNP B-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 ASPIRIN NNP I-NP B-m
23 &amp; NNP I-NP O
23 WARFARIN NNP I-NP B-m
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 MD NNP I-NP O
24 aware JJ B-NP O
24 Previous NNP I-NP O
24 override NN I-NP O
24 information: NN I-NP O
25 Override NNP I-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 4/7/05 CD O O
25 by IN B-VP O
25 SUTKUS NNP B-NP O
25 , , O O
25 STUART NNP B-NP O
25 W NNP I-NP O
25 , , O O
25 M.D NNP B-NP O
26 POTENTIALLY NNP I-NP O
26 SERIOUS NNP I-NP O
26 INTERACTION: NNP I-NP O
26 WARFARIN NNP I-NP B-m
26 &amp; NNP I-NP O
26 ASPIRIN NNP I-NP B-m
27 Reason NNP I-NP O
27 for IN B-VP O
27 override: NN B-NP O
27 Patient NNP I-NP O
27 has VBZ O O
27 been VBN O O
27 stable JJ O O
27 on IN B-VP O
27 this DT B-NP O
28 regimen NN I-NP O
28 at IN B-VP O
28 home NN B-NP O
29 PHOSLO NNP I-NP B-m
29 ( ( O I-m
29 CALCIUM NNP B-NP I-m
29 ACETATE NNP I-NP I-m
29 ) ) O I-m
29 667 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 TID NNP I-NP B-f
30 FOLATE NNP I-NP B-m
30 ( ( O I-m
30 FOLIC NNP B-NP I-m
30 ACID NNP I-NP I-m
30 ) ) O I-m
30 1 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 QD NNP I-NP B-f
31 DIOVAN NNP I-NP B-m
31 ( ( O I-m
31 VALSARTAN NNP B-NP I-m
31 ) ) O I-m
31 160 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
31 his PRP$ O O
31 cardiologist NN B-NP O
32 Number NNP I-NP B-du
32 of IN B-VP I-du
32 Doses NNP B-NP I-du
32 Required NNP I-NP I-du
32 ( ( O I-du
32 approximate JJ B-NP I-du
32 ): NN I-NP I-du
32 4 CD O I-du
33 CARVEDILOL NNP B-NP B-m
33 6.25 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 BID NNP I-NP B-f
33 HOLD NNP I-NP O
33 IF: NNP I-NP O
33 HR NNP I-NP O
33 &lt; NNP I-NP O
33 60 CD O O
33 , , O O
33 or CC O O
33 SBP NNP B-NP O
33 &lt; VBP O O
33 100 CD O O
34 Food/Drug NNP B-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Take NNP I-NP O
35 consistently RB O O
35 with IN B-VP O
35 meals NNS B-NP O
35 or CC O O
35 on IN B-VP O
35 empty JJ B-NP O
35 stomach NN I-NP O
36 his PRP$ O O
36 cardiologist JJ B-NP O
36 Number NNP I-NP O
36 of IN B-VP O
36 Doses NNP B-NP O
36 Required NNP I-NP O
36 ( ( O O
36 approximate JJ B-NP O
36 ): NN I-NP O
36 8 CD O O
37 NEPHROCAPS NNP B-NP B-m
37 ( ( O I-m
37 NEPHRO-VIT NNP B-NP I-m
37 RX NNP I-NP I-m
37 ) ) O I-m
37 1 CD O B-do
37 TAB NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 Alert NNP I-NP O
38 overridden: NNP I-NP O
38 Override NNP I-NP O
38 added VBD B-VP O
38 on IN B-VP O
38 4/7/05 CD O O
38 by IN B-VP O
39 ALAMIN NNP B-NP O
39 , , O O
39 NORMAN NNP B-NP O
39 B NNP I-NP O
39 , , O O
39 M.D NNP B-NP O
40 POTENTIALLY NNP I-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 SIMVASTATIN NNP I-NP B-m
40 &amp; NNP I-NP O
40 NIACIN NNP I-NP B-m
40 , , O O
41 VIT NNP B-NP B-m
41 B-3 NNP I-NP I-m
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
41 MD NNP I-NP O
41 Aware NNP I-NP O
42 LIPITOR NNP I-NP B-m
42 ( ( O I-m
42 ATORVASTATIN NNP B-NP I-m
42 ) ) O I-m
42 20 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 QD NNP I-NP B-f
43 Alert NNP I-NP O
43 overridden: NNP I-NP O
43 Override NNP I-NP O
43 added VBD B-VP O
43 on IN B-VP O
43 6/7/05 CD O O
43 by IN B-VP O
43 : : O O
44 POTENTIALLY NNP B-NP O
44 SERIOUS NNP I-NP O
44 INTERACTION: NNP I-NP O
44 NIACIN NNP I-NP B-m
44 , , O O
44 VIT NNP B-NP B-m
44 B-3 NNP I-NP I-m
44 &amp; NNP I-NP O
45 ATORVASTATIN NNP I-NP B-m
45 CALCIUM NNP I-NP I-m
45 Reason NNP I-NP O
45 for IN B-VP O
45 override: NN B-NP O
45 home NN I-NP O
45 med VBN O O
46 LASIX NNP B-NP B-m
46 ( ( O I-m
46 FUROSEMIDE NNP B-NP I-m
46 ) ) O I-m
46 80 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 BID NNP I-NP B-f
47 DIET: NNP I-NP O
47 2 CD O O
47 gram NN B-NP O
47 Sodium NNP I-NP O
48 ACTIVITY: NNP I-NP O
48 Walking NNP I-NP O
48 as IN B-VP O
48 tolerated VBN O O
49 FOLLOW NNP B-NP O
49 UP NNP I-NP O
49 APPOINTMENT( NNP I-NP O
49 S NNP I-NP O
49 ): NNP I-NP O
50 Dr NNP I-NP O
50 Sackrider NNP I-NP O
50 at IN B-VP O
50 ACH NNP B-NP O
50 5/6/05 CD O O
50 at IN B-VP O
50 1:30 CD O O
50 PM NNP B-NP O
50 scheduled VBN O O
50 , , O O
51 Dr NNP B-NP O
51 Dauphin NNP I-NP O
51 at IN B-VP O
51 CMC NNP B-NP O
51 0/4/05 CD O O
51 at IN B-VP O
51 1:40 CD O O
51 PM NNP B-NP O
51 scheduled VBN O O
51 , , O O
52 Aaron NNP B-NP O
52 Searl NNP I-NP O
52 at IN B-VP O
52 MJH NNP B-NP O
52 , , O O
52 call NN B-NP O
52 to TO O O
52 schedule NN B-NP O
52 this DT O O
52 within IN B-VP O
52 2 CD O O
52 weeks NNS B-NP O
52 TBA NNP I-NP O
52 , , O O
53 ALLERGY: NNP B-NP O
53 Penicillins NNP I-NP O
53 , , O O
53 lisinopril NN B-NP O
53 , , O O
53 Hctz NNP B-NP O
53 , , O O
53 Advair NNP B-NP O
54 ADMIT NNP I-NP O
54 DIAGNOSIS: NNP I-NP O
55 Dyspnea NNP I-NP O
55 and CC O O
55 hypoxia NN B-NP O
55 on IN B-VP O
55 exertion NN B-NP O
56 PRINCIPAL NNP I-NP O
56 DISCHARGE NNP I-NP O
56 DIAGNOSIS NNP I-NP O
56 ;Responsible JJ O O
56 After IN B-VP O
56 Study NNP B-NP O
56 for IN B-VP O
56 Causing NNP B-NP O
56 Admission NNP I-NP O
56 ) ) O O
57 Congestive NNP B-NP O
57 heart NN I-NP O
57 failure NN I-NP O
57 with IN B-VP O
57 dilated VBN O O
57 cardiomyopathy NN B-NP O
58 OTHER NNP I-NP O
58 DIAGNOSIS;Conditions NNP I-NP O
58 , , O O
58 Infections NNP B-NP O
58 , , O O
58 Complications NNP B-NP O
58 , , O O
58 affecting VBG O O
58 Treatment/Stay NNP B-NP O
59 Asthma NNP I-NP O
59 , , O O
59 OSA NNP B-NP O
59 , , O O
59 CRF NNP B-NP O
59 , , O O
59 Recent NNP B-NP O
59 multifocal JJ B-NP O
59 PNA NNP I-NP O
59 , , O O
59 h/o NN B-NP O
59 DVT NNP I-NP O
59 , , O O
59 hypercholesterolemia NN B-NP O
59 , , O O
60 obesity NN B-NP O
61 OPERATIONS NNP I-NP O
61 AND NNP I-NP O
61 PROCEDURES: NNP I-NP O
62 Chest NNP I-NP O
62 CT NNP I-NP O
63 OTHER NNP I-NP O
63 TREATMENTS/PROCEDURES NNP I-NP O
63 ( ( O O
63 NOT NNP B-NP O
63 IN NNP I-NP O
63 O.R NNP I-NP O
63 ) ) O O
64 Pulmonary NNP B-NP O
64 consult NN I-NP O
65 BRIEF NNP I-NP O
65 RESUME NNP I-NP O
65 OF NNP I-NP O
65 HOSPITAL NNP I-NP O
65 COURSE: NNP I-NP O
66 ID: NNP I-NP O
66 42 CD O O
66 yo NN B-NP O
66 man NN I-NP O
66 dilated VBD B-VP O
66 non-ischemic JJ B-NP O
66 CM NNP I-NP O
66 ( ( O O
66 EF NNP B-NP O
66 23% CD O O
66 , , O O
67 cath NN B-NP O
67 4/13 CD O O
67 = NN B-NP O
67 no DT B-NP O
67 CAD NNP I-NP O
67 ) ) O O
67 , , O O
67 OSA NNP B-NP O
67 , , O O
67 CRF NNP B-NP O
67 almost RB O O
67 ESRD NNP B-NP O
67 ( ( O O
67 2/2 CD O O
67 HTN NNP B-NP O
67 vs NN I-NP O
67 obesity NN I-NP O
68 related VBN O O
68 GS NNP B-NP O
68 ) ) O O
68 , , O O
68 DVT NNP B-NP O
68 ( ( O O
68 4/30 CD O O
68 , , O O
68 on IN B-VP O
68 coumadin NN B-NP B-m
68 ) ) O O
68 , , O O
68 asthma RB O O
68 , , O O
68 HTN NNP B-NP O
68 , , O O
68 OSA NNP B-NP O
68 , , O O
68 mild JJ B-NP O
69 hyperhomocysteinemia NN I-NP O
69 --- NNP I-NP O
70 CC: NNP I-NP O
70 5 CD O O
70 weeks NNS B-NP O
70 worsening VBG O O
70 DOE NNP B-NP O
70 3 CD O O
70 miles NNS B-NP O
70 flat JJ B-NP O
70 ground NN I-NP O
70 --&gt; VBD B-VP O
70 50 CD O O
70 ft JJ B-NP O
70 flat JJ I-NP O
71 ground NN I-NP O
71 --- NNP I-NP O
72 DX: NNP I-NP O
72 CHF NNP I-NP O
72 exacerbation NN I-NP O
72 AND NNP I-NP O
72 ? . B-VP O
72 multifocal JJ B-NP O
72 PNA NNP I-NP O
72 vs NN I-NP O
72 other JJ B-NP O
72 primary JJ I-NP O
72 lung NN I-NP O
73 etiology NN I-NP O
73 , , O O
73 CRF NNP B-NP O
73 almost RB O O
73 ESRD NNP B-NP O
73 --- NNP I-NP O
74 HPI: NNP I-NP O
74 42 CD O O
74 yo NN B-NP O
74 man NN I-NP O
74 w NN I-NP O
74 above IN B-VP O
74 hx NN B-NP O
74 , , O O
74 admitted VBD B-VP O
74 4/30 CD O O
74 dx'd JJ B-NP O
74 multifocal JJ I-NP B-r
74 PNA NNP I-NP I-r
74 tx'd NN I-NP O
75 14d CD O B-du
75 levoflox NN B-NP B-m
75 , , O O
75 D/C'd NNP B-NP O
75 feeling VBG O O
75 well RB O O
75 , , O O
75 then RB O O
75 progressive JJ B-NP O
75 inc NNS I-NP O
75 DOE NNP I-NP O
75 now RB O O
76 hypoxia VBZ O O
76 on IN B-VP O
76 exertion NN B-NP O
76 No NNP I-NP O
76 cough/F/C NN I-NP O
76 Last JJ B-NP O
76 admit NN I-NP O
76 4/30 CD O O
76 CT: NNP B-NP O
77 multifocal JJ B-NP O
77 PNA NNP I-NP O
77 , , O O
77 CTA NNP B-NP O
77 no DT B-NP O
77 PE NNP I-NP O
77 , , O O
77 LENIS NNP B-NP B-r
77 L NNP I-NP I-r
77 peroneal NN I-NP I-r
77 DVT NNP I-NP I-r
77 Started NNP I-NP O
77 Heparin NNP I-NP B-m
77 , , O O
77 VQ NNP B-NP O
78 negative JJ O O
78 , , O O
78 converted VBN O O
78 to TO O O
78 coumadin VB O B-m
78 INR NNP B-NP O
78 2-3 CD O O
78 for IN B-VP O
78 DVT NNP B-NP B-r
78 ECHO: NNP I-NP O
78 EF NNP I-NP O
78 25% CD O O
78 , , O O
78 mod FW O O
79 RV NNP B-NP O
79 dsyfn NN I-NP O
79 , , O O
79 severe JJ B-NP O
79 TR NNP I-NP O
79 ( ( O O
79 then RB O O
79 F/U NNP B-NP O
79 cardiac VBD B-VP O
79 MRI NNP B-NP O
79 10/16 CD O O
79 EF NNP B-NP O
79 23% CD O O
79 , , O O
80 global JJ B-NP O
80 hypokinesis NN I-NP O
80 , , O O
80 no DT B-NP O
80 WMA NNP I-NP O
80 , , O O
80 nl JJ B-NP O
80 RV NNP I-NP O
80 , , O O
80 no DT B-NP O
80 valve NN I-NP O
80 dz NN I-NP O
80 ) ) O O
80 Renal NNP B-NP O
80 consult NN I-NP O
80 for IN B-VP O
81 stable JJ B-NP O
81 CRF NNP I-NP O
81 Cr NNP I-NP O
81 5.5-6.0 JJ O O
81 , , O O
81 F/U NNP B-NP O
81 in IN B-VP O
81 outpatient JJ B-NP O
81 clinic NN I-NP O
81 , , O O
81 have VBP O O
81 discussed VBN O O
82 vascular JJ B-NP O
82 access NN I-NP O
82 but CC O O
82 none NN B-NP O
82 placed VBD B-VP O
82 yet RB O O
82 4/30 CD O O
82 Ddimer NN B-NP O
82 1400 CD O O
82 , , O O
82 BNP NNP B-NP O
82 2009 CD O O
82 , , O O
83 Trop NNP B-NP O
83 0.84--&gt;0.54 CD O O
83 not RB O O
83 considered VBN O O
83 ischemic JJ O O
83 , , O O
83 no DT B-NP O
83 tx NN I-NP O
83 C/O NNP I-NP O
83 10lb CD O O
83 weight NN B-NP O
84 gain NN I-NP O
84 over IN B-VP O
84 last JJ B-NP O
84 month NN I-NP O
84 , , O O
84 ROS NNP B-NP O
84 O/W NNP I-NP O
84 negative JJ O O
84 ( ( O O
84 no DT B-NP O
84 F/C/CP NNP I-NP O
84 , , O O
84 etc FW O O
84 ) ) O O
84 Now RB O O
84 DDimer NNP B-NP O
85 1207 CD O O
85 , , O O
85 BNP NNP B-NP O
85 2917 CD O O
85 , , O O
85 Trop NNP B-NP O
85 not RB O O
86 sent VBD B-VP O
86 --- NNP B-NP O
87 STATUS: NNP I-NP O
87 T NNP I-NP O
87 97.2 CD O O
87 HR NNP B-NP O
87 98-104 CD O O
87 BP NNP B-NP O
87 160/114 CD O O
87 RR NNP B-NP O
87 18 CD O O
87 95% CD O O
88 RA NNP B-NP O
88 desat VBD B-VP O
88 85% CD O O
88 RA NNP B-NP O
88 walking VBG O O
88 50 CD O O
88 ft JJ B-NP O
89 comfortable JJ I-NP O
89 breathing NN I-NP O
89 at IN B-VP O
89 rest NN B-NP O
89 , , O O
89 nice JJ B-NP O
89 guy NN I-NP O
89 , , O O
89 JVP NNP B-NP O
89 to TO O O
89 earlobe VB O O
89 , , O O
89 bibasilar JJ B-NP O
90 rales NNS I-NP O
90 , , O O
90 no DT B-NP O
90 wheezes NN I-NP O
90 , , O O
90 obese JJ O O
90 , , O O
90 S3 NNP B-NP O
90 , , O O
90 1+ CD O O
90 pitting VBG O O
90 edema NN B-NP O
90 to TO O O
90 B NNP B-NP O
90 shins NNS I-NP O
90 , , O O
90 diffuse NN B-NP O
91 PIPA NNP I-NP O
91 --- NNP I-NP O
92 EVENTS NNP I-NP O
92 In IN B-VP O
92 ED: NNP B-NP O
92 Duonebs NNP I-NP B-m
92 , , O O
92 ASA NNP B-NP B-m
92 325 CD O B-do
92 , , O O
92 Lasix NNP B-NP B-m
92 80mg CD O B-do
93 PO NNP B-NP B-mo
93 CXR: NNP I-NP O
93 increased VBD B-VP O
93 bilat JJ B-NP O
93 LL NNP I-NP O
93 opacities NNS I-NP O
93 to TO O O
93 periphery VB O O
94 with IN B-VP O
94 some DT B-NP O
94 cephalization NN I-NP O
94 of IN B-VP O
94 vessels NNS B-NP O
94 , , O O
94 some DT B-NP O
94 opacification NN I-NP O
95 ECG: NNP I-NP O
95 98 CD O O
95 bpm NN B-NP O
95 , , O O
95 LAE NNP B-NP O
95 , , O O
95 strain NN B-NP O
95 --- JJ B-NP O
96 TESTS/PROCEDURES NNP I-NP O
96 Chest NNP I-NP O
96 CT NNP I-NP O
96 8/18 CD O O
96 ( ( O O
96 compare NN B-NP O
96 to TO O O
96 4/30 CD O O
96 ): NNS B-NP O
96 Per NNP I-NP O
96 pulm NN I-NP O
96 c/w NN I-NP O
97 scarring/persistent NN I-NP O
97 changes NNS I-NP O
97 after IN B-VP O
97 recent JJ B-NP O
97 multifocal JJ I-NP O
97 PNA NNP I-NP O
97 4/30 CD O O
97 , , O O
97 no DT B-NP O
97 e/o NN I-NP O
98 of IN B-VP O
98 new JJ B-NP O
98 primary JJ I-NP O
98 lung NN I-NP O
98 path NN I-NP O
98 , , O O
98 ground NN B-NP O
98 glass NN I-NP O
98 c/w NN I-NP O
98 pulmonary JJ B-NP O
99 edema NN I-NP O
99 --- NNP I-NP O
100 HOSPITAL NNP I-NP O
100 COURSE: NNP I-NP O
100 SOB NNP I-NP O
100 secondary JJ O O
100 to TO O O
100 CHF NNP B-NP O
100 exacerbation NN I-NP O
100 and CC O O
100 fluid NN B-NP O
100 overload NN I-NP O
100 No NNP I-NP O
101 evidence NN I-NP O
101 of IN B-VP O
101 infectious JJ B-NP O
101 pulmonary JJ I-NP O
101 process NN I-NP O
101 contributing VBG O O
101 to TO O O
101 present VB O O
102 symptoms NNS B-NP O
102 CXR NNP I-NP O
102 and CC O O
102 CT NNP B-NP O
102 changes NNS I-NP O
102 are VBP O O
102 c/w JJ B-NP O
102 scarring/changes NNS I-NP O
102 from IN B-VP O
102 recent JJ B-NP O
103 multifocal JJ I-NP O
103 PNA NNP I-NP O
103 4/30 CD O O
103 , , O O
103 with IN B-VP O
103 additional JJ B-NP O
103 ground NN I-NP O
103 glass NN I-NP O
103 c/w NN I-NP O
103 pulmonary JJ B-NP O
103 edema NN I-NP O
104 No NNP I-NP O
104 clinical JJ O O
104 or CC O O
104 radiologic JJ B-NP O
104 e/o NN I-NP O
104 primary JJ B-NP O
104 lung NN I-NP O
104 etiology NN I-NP O
104 for IN B-VP O
104 DOE NNP B-NP O
104 Pulmonary NNP I-NP O
105 team NN I-NP O
105 assessed VBD B-VP O
105 patient NN B-NP O
105 and CC O O
105 reviewed VBD B-VP O
105 non JJ B-NP O
105 contrast NN I-NP O
105 chest JJS B-NP O
105 CT NN I-NP O
105 from IN B-VP O
105 this DT B-NP O
106 admssion NN I-NP O
106 - : O O
106 they PRP O O
106 confirmed VBD B-VP O
106 that IN B-VP O
106 current JJ B-NP O
106 sx NN I-NP O
106 are VBP O O
106 likely JJ O O
106 2/2 CD O O
106 pulomonary JJ B-NP O
107 edema NN I-NP O
107 Patient NNP I-NP O
107 was VBD B-VP O
107 diuresed VBN O O
107 with IN B-VP O
107 Lasix NNP B-NP B-m
107 just RB O O
107 over IN B-VP O
107 3L CD O O
107 net JJ O O
107 negative JJ O O
107 with IN B-VP O
108 improvement NN B-NP O
108 in IN B-VP O
108 his PRP$ O O
108 oxygen NN B-NP O
108 saturations NNS I-NP O
108 ( ( O O
108 rest NN B-NP O
108 and CC O O
108 ambulation NN B-NP O
108 ) ) O O
108 At IN B-VP O
108 time NN B-NP O
108 of IN B-VP O
109 d/c NN B-NP O
109 JVP NNP I-NP O
109 10cm CD O O
109 Pt NNP B-NP O
109 will MD O O
109 diurese VB O O
109 further RBR O O
109 at IN B-VP O
109 home NN B-NP O
109 on IN B-VP O
109 Lasix NNP B-NP B-m
109 80 CD O B-do
109 BID NNP B-NP B-f
109 ( ( O O
109 he PRP O O
109 had VBD B-VP O
110 not RB O O
110 been VBN O O
110 taking VBG O O
110 his PRP$ O O
110 lasix NN B-NP B-m
110 for IN B-VP O
110 2d CD O B-du
110 prior JJ O O
110 to TO O O
110 d/c VB O O
110 HTN NNP B-NP B-r
110 HTN NNP I-NP B-r
110 was VBD B-VP O
111 another DT B-NP O
111 issue NN I-NP O
111 on IN B-VP O
111 admission NN B-NP O
111 but CC O O
111 is VBZ O O
111 most JJS O O
111 likely JJ O O
111 due JJ O O
111 to TO O O
111 patient VB O O
111 taking VBG O O
111 wrong JJ B-NP O
112 dose NN I-NP O
112 of IN B-VP O
112 Coreg NNP B-NP B-m
112 Coreg NNP I-NP B-m
112 ( ( O O
112 taking VBG O O
112 QOD NNP B-NP B-f
112 instead RB O O
112 of IN B-VP O
112 BID NNP B-NP B-f
112 ) ) O O
112 On IN B-VP O
112 a DT B-NP O
112 BID NNP I-NP B-f
112 Coreg NNP I-NP B-m
112 regiments NNS I-NP O
112 , , O O
112 BP NNP B-NP B-r
113 much RB O O
113 better JJR O O
113 controlled VBN O O
113 Etiology NN B-NP O
113 of IN B-VP O
113 his PRP$ O O
113 CMP NNP B-NP O
113 still RB O O
113 remains VBZ O O
113 unclear JJ O O
113 despite IN B-VP O
114 extensive JJ B-NP O
114 outpt NN I-NP O
114 W/U NNP I-NP O
114 Additionally NNP I-NP O
114 , , O O
114 discrepancy NN B-NP O
114 between IN B-VP O
114 Echo NNP B-NP O
114 and CC O O
115 Cardiac NNP B-NP O
115 MRI NNP I-NP O
115 is VBZ O O
115 puzzling VBG O O
115 No NNP B-NP O
115 concern NN I-NP O
115 for IN B-VP O
115 ischemia NN B-NP O
115 on IN B-VP O
115 this DT B-NP O
115 admission NN I-NP O
115 , , O O
116 clean JJ B-NP O
116 cath NN I-NP O
116 in IN B-VP O
116 2002 CD O O
116 Started VBD B-VP O
116 on IN B-VP O
116 ASA NNP B-NP B-m
116 and CC O O
116 continued VBN O O
116 on IN B-VP O
116 Lipitor NNP B-NP B-m
116 Renal NNP I-NP O
116 function NN I-NP O
117 remained VBD B-VP O
117 stable JJ O O
117 but CC O O
117 impaired JJ O O
117 He PRP O O
117 is VBZ O O
117 being VBG O O
117 evaluated VBN O O
117 for IN B-VP O
117 dialysis NN B-NP O
117 as IN B-VP O
117 an DT B-NP O
118 outpatient NN I-NP O
118 but CC O O
118 no DT B-NP O
118 vasc JJ I-NP O
118 access NN I-NP O
118 placed VBN O O
118 yet RB O O
118 Phoslo NNP B-NP B-m
118 , , O O
118 nephrocaps NNS B-NP B-m
118 continued VBD B-VP O
119 here RB O O
119 Finally RB O O
119 , , O O
119 pt FW O O
119 continued VBN O O
119 on IN B-VP O
119 coumadin NN B-NP B-m
119 for IN B-VP O
119 h/o JJ B-NP O
119 recent JJ I-NP B-r
119 DVT NNP I-NP I-r
119 ( ( O O
119 4/30 CD O O
119 ) ) O O
119 and CC O O
119 INR NNP B-NP O
120 remained VBD B-VP O
120 in IN B-VP O
120 therapeutic JJ B-NP O
120 range NN I-NP O
120 Low NNP I-NP O
120 suspicion NN I-NP O
120 for IN B-VP O
120 PE NNP B-NP O
120 on IN B-VP O
120 this DT B-NP O
120 admission NN I-NP O
120 He PRP O O
121 was VBD B-VP O
121 discharged VBN O O
121 in IN B-VP O
121 stable JJ B-NP O
121 condition NN I-NP O
121 with IN B-VP O
121 outpatient NN B-NP O
121 follow VBP O O
121 up RP O O
121 instructions NNS B-NP O
122 ADDITIONAL NNP I-NP O
122 COMMENTS: NNP I-NP O
122 1 CD O O
122 Be NNP B-NP O
122 sure JJ O O
122 to TO O O
122 take VB O O
122 your PRP$ O O
122 Coreg NNP B-NP B-m
122 as IN B-VP O
122 instructed JJ O O
123 2 CD O O
123 Call NNPS B-NP O
123 your PRP$ O O
123 doctor NN B-NP O
123 if IN B-VP O
123 your PRP$ O O
123 shortness NN B-NP O
123 of IN B-VP O
123 breath NN B-NP O
123 gets VBZ O O
123 worse JJR O O
123 or CC O O
123 if IN B-VP O
123 you PRP O O
123 have VBP O O
124 chest VBN O O
124 pain NN B-NP O
124 , , O O
124 fevers NNS B-NP O
124 or CC O O
124 dizziness NN B-NP O
125 3 CD O O
125 Take NNP B-NP O
125 your PRP$ O O
125 coumadin NN B-NP B-m
125 as IN B-VP O
125 regulated VBN O O
125 by IN B-VP O
125 the DT B-NP O
125 anticoagulation NN I-NP O
126 clinic JJ O O
127 4 CD O O
127 Check NNP B-NP O
127 your PRP$ O O
127 weight JJ O O
127 daily JJ O O
127 and CC O O
127 take VB O O
127 your PRP$ O O
127 lasix NN B-NP B-m
127 as IN B-VP O
127 prescribed JJ O O
128 5 CD O O
128 Call NNP B-NP O
128 you PRP O O
128 primary VBP O O
128 care VB O O
128 doctor NN B-NP O
128 and CC O O
128 cardiologist NN B-NP O
128 Monday NNP I-NP O
128 morning NN I-NP O
128 11/1 CD O O
129 Please NNP B-NP O
129 see VB O O
129 one CD O O
129 of IN B-VP O
129 them PRP O O
129 this DT O O
129 upcoming VBG O O
129 week NN B-NP O
130 DISCHARGE NNP I-NP O
130 CONDITION: NNP I-NP O
130 Fair NNP I-NP O
131 TO NNP I-NP O
131 DO/PLAN: NNP I-NP O
132 Follow NNP I-NP O
132 up RP O O
132 with IN B-VP O
132 your PRP$ O O
132 primary JJ B-NP O
132 care NN I-NP O
132 doctor NN I-NP O
132 , , O O
132 your PRP$ O O
132 cardiologist NN B-NP O
132 and CC O O
132 the DT B-NP O
132 renal JJ I-NP O
133 clinic NN I-NP O
134 No NNP I-NP O
134 dictated VBD B-VP O
134 summary JJ B-NP O
135 ENTERED NNP I-NP O
135 BY: NNP I-NP O
135 LAA NNP I-NP O
135 , , O O
135 TOM NNP B-NP O
135 J NNP I-NP O
135 , , O O
135 M.D NNP B-NP O
135 , , O O
135 M.B.A NNP B-NP O
135 ( ( O O
135 BQ30 NNP B-NP O
135 ) ) O O
135 6/7/05 CD O O
135 @ $ O O
135 10:25 CD O O
135 AM NNP B-NP O
136 ****** JJ B-NP O
136 END NN I-NP O
136 OF NNP I-NP O
136 DISCHARGE NNP I-NP O
136 ORDERS NNP I-NP O
136 ****** NNP I-NP O
137 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #191340 VBZ O O
4 853345880 CD O O
4 TLUMC NNP B-NP O
4 81063320 CD O O
4 450919 CD O O
4 4/22/1997 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CONGESTIBE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/22/1997 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/13/1997 CD O O
7 DISCHARGE NNP B-NP O
7 DIAGNOSES: NNP I-NP O
7 1 CD O O
7 SHORTNESS NNP B-NP O
7 OF NNP I-NP O
7 BREATH NNP I-NP O
8 2 CD O O
8 HYPERTENSION NNP B-NP O
9 3 CD O O
9 DIABETES NNP B-NP O
10 4 CD O O
10 HISTORY NNP B-NP O
10 OF NNP I-NP O
10 MITRAL NNP I-NP O
10 REGURGITATION NNP I-NP O
11 HISTORY NNP I-NP O
11 OF NNP I-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
11 The DT B-NP O
11 patient NN I-NP O
11 is VBZ O O
11 a DT O O
11 68 CD O O
11 year NN B-NP O
11 old JJ B-NP O
11 female NN I-NP O
12 with IN B-VP O
12 a DT B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 long JJ O O
12 standing VBG O O
13 hypertension NN B-NP O
13 and CC O O
13 diabetes NNS B-NP O
13 who WP O O
13 says VBZ O O
13 that IN B-VP O
13 she PRP O O
13 had VBD B-VP O
13 been VBN O O
13 doing VBG O O
13 well RB O O
14 until IN B-VP O
14 approximately RB O O
14 one CD O O
14 week NN B-NP O
14 prior RB O O
14 to TO O O
14 admission NN B-NP O
14 when WRB O O
14 she PRP O O
14 was VBD B-VP O
14 in IN B-VP O
14 Tempefayscot NNP B-NP O
14 , , O O
14 Michigan NNP B-NP O
14 76498 CD O O
14 for IN B-VP O
14 a DT B-NP O
14 wedding NN I-NP O
14 and CC O O
14 during IN B-VP O
14 that DT B-NP O
14 time NN I-NP O
14 she PRP O O
14 was VBD B-VP O
14 unable JJ O O
14 to TO O O
14 follow VB O O
15 her PRP$ O O
15 normal JJ B-NP O
15 strict JJ I-NP O
15 low JJ I-NP O
15 salt NN I-NP O
15 diet NN I-NP O
15 During IN B-VP O
15 that DT B-NP O
15 time NN I-NP O
15 and CC O O
15 since IN B-VP O
15 the DT B-NP O
16 time NN I-NP O
16 back RP O O
16 in IN B-VP O
16 Ette NNP B-NP O
16 Na NNP I-NP O
16 No NNP I-NP O
16 the DT B-NP O
16 patient NN I-NP O
16 began VBD B-VP O
16 having VBG O O
16 increasing VBG O O
16 shortness NN B-NP O
17 of IN B-VP O
17 breath NN B-NP O
17 , , O O
17 dyspnea NN B-NP O
17 on IN B-VP O
17 exertion NN B-NP O
17 and CC O O
17 paroxysmal JJ B-NP O
17 nocturnal JJ I-NP O
17 dyspnea NN I-NP O
18 The DT B-NP O
18 patient NN I-NP O
18 on IN B-VP O
18 the DT B-NP O
18 night NN I-NP O
18 prior RB O O
18 to TO O O
18 admission NN B-NP O
18 was VBD B-VP O
18 unable JJ O O
18 to TO O O
18 sleep VB O O
19 secondary JJ O O
19 to TO O O
19 shortness VB O O
19 of IN B-VP O
19 breath NN B-NP O
19 and CC O O
19 sitting VBG O O
19 up RP O O
19 most JJS O O
19 of IN B-VP O
19 the DT B-NP O
20 evening NN I-NP O
20 She PRP O O
20 went VBD B-VP O
20 to TO O O
20 see VB O O
20 her PRP$ O O
20 doctor NN B-NP O
20 , , O O
20 Dr NNP B-NP O
20 Sherbo NNP I-NP O
20 in IN B-VP O
20 Clinic NNP B-NP O
20 the DT B-NP O
21 next JJ I-NP O
21 morning NN I-NP O
21 who WP O O
21 found VBD B-VP O
21 her PRP O O
21 to TO O O
21 be VB O O
21 in IN B-VP O
21 congestive JJ B-NP O
21 heart NN I-NP O
21 failure NN I-NP O
21 and CC O O
22 recommended VBD B-VP O
22 her PRP O O
22 to TO O O
22 go VB O O
22 to TO O O
22 May NNP B-NP O
22 While IN B-VP O
22 in IN B-VP O
22 the DT B-NP O
23 Emergency NNP I-NP O
23 Room NNP I-NP O
23 the DT B-NP O
23 patient NN I-NP O
23 was VBD B-VP O
23 given VBN O O
23 Procardia NNP B-NP B-m
23 XL NNP I-NP I-m
23 20 CD O B-do
23 mg NN B-NP I-do
23 p.o NN I-NP B-mo
23 x VBZ O B-du
23 1 CD O I-du
24 for IN B-VP O
24 a DT B-NP B-r
24 systolic JJ I-NP I-r
24 blood NN I-NP I-r
24 pressure NN I-NP I-r
24 greater JJR O O
24 than IN B-VP O
24 200 CD O O
24 , , O O
24 Aspirin NNP B-NP B-m
24 , , O O
24 Nitropaste NNP B-NP B-m
25 and CC O O
25 IV NNP B-NP B-mo
25 Lasix NNP I-NP B-m
25 The DT B-NP O
25 patient NN I-NP O
25 had VBD B-VP O
25 significant JJ B-NP O
25 response NN I-NP O
25 to TO O O
25 the DT B-NP O
25 IV NNP I-NP B-mo
25 Lasix NNP I-NP B-m
26 with IN B-VP O
26 complete JJ B-NP O
26 resolution NN I-NP O
26 of IN B-VP O
26 her PRP$ O B-r
26 shortness NN B-NP I-r
26 of IN B-VP I-r
26 breath NN B-NP I-r
26 and CC O O
26 was VBD B-VP O
27 admitted VBN O O
27 to TO O O
27 the DT B-NP O
27 Short NNP I-NP O
27 Stay NNP I-NP O
27 Unit NNP I-NP O
27 for IN B-VP O
27 evaluation NN B-NP O
28 PAST NNP I-NP O
28 MEDICAL NNP I-NP O
28 HISTORY: NNP I-NP O
28 As NNP I-NP O
28 mentioned VBN O O
28 above IN B-VP O
28 and CC O O
28 included VBD B-VP O
28 a DT B-NP O
28 stress NN I-NP O
29 echocardiogram NN I-NP O
29 in IN B-VP O
29 the DT B-NP O
29 past NN I-NP O
29 which WDT O O
29 showed VBD B-VP O
30 mitral JJ B-NP O
30 regurgitation NN I-NP O
30 , , O O
30 hypokinesis NN B-NP O
30 of IN B-VP O
30 the DT B-NP O
30 septum NN I-NP O
30 and CC O O
30 AV NNP B-NP O
30 block NN I-NP O
30 on IN B-VP O
31 exertion NN B-NP O
31 with IN B-VP O
31 an DT B-NP O
31 ejection NN I-NP O
31 fraction NN I-NP O
31 of IN B-VP O
31 about IN B-VP O
31 40% CD O O
32 MEDICATIONS NNS B-NP O
32 ON NNP I-NP O
32 ADMISSION: NNP I-NP O
32 Cardura NNP I-NP B-m
32 , , O O
32 Vasotec NNP B-NP B-m
32 and CC O O
32 Metoprolol NNP B-NP B-m
33 SOCIAL NNP I-NP O
33 HISTORY: NNP I-NP O
33 Denies VBZ O O
33 any DT B-NP O
33 tobacco NN I-NP O
33 Lives VBZ O O
33 with IN B-VP O
33 her PRP$ O O
33 husband NN B-NP O
34 PHYSICAL NNP I-NP O
34 EXAMINATION: NNP I-NP O
34 Temperature NNP I-NP O
34 was VBD B-VP O
34 98.2 CD O O
34 , , O O
34 respirations NNS B-NP O
34 14 CD O O
34 Her NNP B-NP O
35 heart NN I-NP O
35 rate NN I-NP O
35 was VBD B-VP O
35 40 CD O O
35 , , O O
35 blood NN B-NP O
35 pressure NN I-NP O
35 148/70 CD O O
35 , , O O
36 saturation NN B-NP O
36 95% CD O O
36 on IN B-VP O
36 room NN B-NP O
36 air NN I-NP O
36 She PRP O O
36 was VBD B-VP O
36 a DT B-NP O
36 pleasant JJ I-NP O
36 woman NN I-NP O
36 , , O O
36 Spanish JJ O O
37 speaking VBG O O
37 only RB O O
37 and CC O O
37 was VBD B-VP O
37 able JJ O O
37 to TO O O
37 speak VB O O
37 in IN B-VP O
37 full JJ B-NP O
37 sentences NNS I-NP O
37 Neck NNP I-NP O
37 was VBD B-VP O
38 supple JJ O O
38 with IN B-VP O
38 no DT B-NP O
38 carotid NN I-NP O
38 bruits VBZ O O
38 Jugular NNP B-NP O
38 venous JJ B-NP O
38 pressure NN I-NP O
38 was VBD B-VP O
39 approximately RB O O
39 8 CD O O
39 cm JJ B-NP O
39 Lungs NNS I-NP O
39 clear JJ O O
39 to TO O O
39 auscultation VB O O
39 without IN B-VP O
39 any DT B-NP O
40 crackles NNS I-NP O
40 Heart NNP I-NP O
40 was VBD B-VP O
40 in IN B-VP O
40 regular JJ B-NP O
40 rate NN I-NP O
40 and CC O O
40 rhythm NN B-NP O
40 with IN B-VP O
40 a DT B-NP O
40 II/VI NNP I-NP O
41 systolic JJ B-NP O
41 murmur NN I-NP O
41 radiating VBG O O
41 out RP O O
41 to TO O O
41 the DT B-NP O
41 apex JJ I-NP O
41 Abdomen NNP I-NP O
41 was VBD B-VP O
41 soft JJ O O
41 and CC O O
42 nontender JJ B-NP O
42 Extremities NNS I-NP O
42 were VBD B-VP O
42 without IN B-VP O
42 any DT B-NP O
42 edema JJ I-NP O
43 LABORATORY NNP I-NP O
43 DATA: NNP I-NP O
43 Her NNP I-NP O
43 electrocardiogram NN I-NP O
43 showed VBD B-VP O
43 bradycardia NN B-NP O
43 at IN B-VP O
43 40 CD O O
44 with IN B-VP O
44 a DT B-NP O
44 left NN I-NP O
44 bundle NN I-NP O
44 branch NN I-NP O
44 pattern NN I-NP O
44 and CC O O
44 she PRP O O
44 had VBD B-VP O
44 2:1 CD O O
45 AV NNP B-NP O
45 block NN I-NP O
45 Her NNP I-NP O
45 chest NN I-NP O
45 x-ray NN I-NP O
45 showed VBD B-VP O
45 an DT B-NP O
45 enlarged JJ I-NP O
45 heart NN I-NP O
45 with IN B-VP O
45 pleural JJ B-NP O
46 effusions NNS I-NP O
46 and CC O O
46 cephalization NN B-NP O
46 which WDT O O
46 was VBD B-VP O
46 often RB O O
46 shown VBN O O
46 with IN B-VP O
46 congestive JJ B-NP O
47 heart NN I-NP O
47 failure NN I-NP O
47 Her NNP I-NP O
47 laboratory NN I-NP O
47 data NNS I-NP O
47 SMA-7 NNP I-NP O
47 was VBD B-VP O
47 within IN B-VP O
47 normal JJ B-NP O
47 limits NNS I-NP O
48 Her PRP$ O O
48 white JJ B-NP O
48 count NN I-NP O
48 was VBD B-VP O
48 3.8 CD O O
48 Her NNP B-NP O
48 Hematocrit NNP I-NP O
48 was VBD B-VP O
48 37.9 CD O O
48 , , O O
48 Platelet NNP B-NP O
48 Count NNP I-NP O
49 182 CD O O
49 Her NNP B-NP O
49 CPK NNP I-NP O
49 was VBD B-VP O
49 within IN B-VP O
49 normal JJ B-NP O
49 limits NNS I-NP O
49 as IN B-VP O
49 were VBD B-VP O
49 her PRP$ O O
49 coagulations NNS B-NP O
50 HOSPITAL NNP I-NP O
50 COURSE: NNP I-NP O
50 The DT B-NP O
50 patient NN I-NP O
50 was VBD B-VP O
50 admitted VBN O O
50 to TO O O
50 the DT B-NP O
50 Short NNP I-NP O
50 Stay NNP I-NP O
50 Unit NNP I-NP O
51 for IN B-VP O
51 further JJ B-NP O
51 evaluation NN I-NP O
51 and CC O O
51 was VBD B-VP O
51 ruled VBN O O
51 out RP O O
51 with IN B-VP O
52 serial JJ B-NP O
52 CPK's NNP I-NP O
52 She PRP O O
52 was VBD B-VP O
52 seen VBN O O
52 by IN B-VP O
52 the DT B-NP O
52 Cardiology NNP I-NP O
52 Group NNP I-NP O
52 who WP O O
52 on IN B-VP O
52 further JJ B-NP O
53 evaluation NN I-NP O
53 of IN B-VP O
53 her PRP$ O O
53 also RB O O
53 felt VBD B-VP O
53 that IN B-VP O
53 even RB O O
53 with IN B-VP O
53 the DT B-NP O
53 resolution NN I-NP O
53 of IN B-VP O
53 her PRP$ O O
54 congestive JJ B-NP O
54 heart NN I-NP O
54 failure NN I-NP O
54 she PRP O O
54 was VBD B-VP O
54 ready JJ O O
54 to TO O O
54 go VB O O
54 home NN B-NP O
54 with IN B-VP O
54 adjustment NN B-NP O
55 in IN B-VP O
55 her PRP$ O O
55 blood NN B-NP B-m
55 pressure NN I-NP I-m
55 medications NNS I-NP I-m
55 and CC O O
55 felt VBD B-VP O
55 that IN B-VP O
55 with IN B-VP O
55 her PRP$ O O
56 bradycardia NN B-NP O
56 she PRP O O
56 would MD O O
56 not RB O O
56 be VB O O
56 able JJ O O
56 to TO O O
56 tolerate VB O O
56 her PRP$ O O
56 Lopressor NNP B-NP B-m
56 It PRP O O
57 was VBD B-VP O
57 felt VBN O O
57 that IN B-VP O
57 the DT B-NP O
57 Lopressor NNP I-NP B-m
57 was VBD B-VP O
57 extremely RB O O
57 important JJ O O
57 in IN B-VP O
57 her PRP$ O O
58 anti-ischemic JJ B-NP O
58 regimen NNS I-NP O
58 and CC O O
58 in IN B-VP O
58 discussing VBG O O
58 with IN B-VP O
58 her PRP$ O O
58 outpatient JJ B-NP O
59 Cardiologist NNP I-NP O
59 , , O O
59 Dr NNP B-NP O
59 Konczak NNP I-NP O
59 , , O O
59 it PRP O O
59 was VBD B-VP O
59 felt VBN O O
59 that IN B-VP O
59 a DT B-NP O
59 pacemaker NN I-NP O
59 placement NN I-NP O
60 would MD O O
60 be VB O O
60 in IN B-VP O
60 her PRP$ O O
60 best JJS B-NP O
60 interest NN I-NP O
60 In IN B-VP O
60 that DT B-NP O
60 way NN I-NP O
60 she PRP O O
60 could MD O O
60 have VB O O
60 good JJ B-NP O
61 control NN I-NP O
61 of IN B-VP O
61 her PRP$ O B-r
61 heart NN B-NP I-r
61 rate NN I-NP I-r
61 and CC O O
61 maximization NN B-NP O
61 of IN B-VP O
61 her PRP$ O O
61 blood NN B-NP B-m
61 pressure NN I-NP O
62 medications NNS I-NP O
62 and CC O O
62 her PRP$ O O
62 increased JJ B-NP O
62 tolerance NN I-NP O
62 of IN B-VP O
62 beta NN B-NP B-m
62 blockers NNS I-NP I-m
62 The DT B-NP O
63 patient NN I-NP O
63 then RB O O
63 underwent JJ B-NP O
63 pacemaker NN I-NP O
63 placement NN I-NP O
63 without IN B-VP O
63 any DT B-NP O
63 difficulty NN I-NP O
64 and CC O O
64 it PRP O O
64 was VBD B-VP O
64 interrogated VBN O O
64 the DT B-NP O
64 day NN I-NP O
64 after IN B-VP O
64 placement NN B-NP O
64 without IN B-VP O
64 any DT B-NP O
65 problem NN I-NP O
65 The DT B-NP O
65 patient NN I-NP O
65 was VBD B-VP O
65 doing VBG O O
65 well RB O O
65 with IN B-VP O
65 only RB O O
65 minimal JJ B-NP O
65 pain NN I-NP O
65 at IN B-VP O
65 the DT B-NP O
66 incision NN I-NP O
66 site NN I-NP O
67 DISPOSITION: NNP I-NP O
67 The DT B-NP O
67 patient NN I-NP O
67 was VBD B-VP O
67 discharged VBN O O
67 in IN B-VP O
67 stable JJ B-NP O
67 condition NN I-NP O
67 with IN B-VP O
68 no DT B-NP O
68 reportable JJ I-NP O
68 disease NN I-NP O
68 and CC O O
68 no DT B-NP O
68 adverse JJ I-NP O
68 drug NN I-NP O
68 reactions NNS I-NP O
69 MEDICATIONS NNP I-NP O
69 ON NNP I-NP O
69 DISCHARGE: NNP I-NP O
69 Keflex NNP I-NP B-m
69 250 CD O B-do
69 mg NN B-NP I-do
69 p.o NN I-NP B-mo
69 q.i.d NN I-NP B-f
69 for IN B-VP B-du
69 5 CD O I-du
69 days; NN B-NP I-du
70 Norvasc NNP I-NP B-m
70 5 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 qd; VBD B-VP B-f
70 Hydrochlorothiazide NNP B-NP B-m
70 25 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 qd NN I-NP B-f
70 and CC O O
70 Vasotec NNP B-NP B-m
71 20 CD O B-do
71 mg NN B-NP I-do
71 p.o NN I-NP B-mo
71 b.i.d IN B-VP B-f
71 FOLLOW-UP NNP B-NP O
71 CARE: NNP I-NP O
71 The DT B-NP O
71 patient NN I-NP O
71 will MD O O
71 follow-up VB O O
71 with IN B-VP O
72 her PRP O O
72 Cardiologist NNP B-NP O
72 , , O O
72 Dr NNP B-NP O
72 Wes NNP I-NP O
72 Rounsville NNP I-NP O
72 in IN B-VP O
72 one CD O O
72 week NN B-NP O
72 and CC O O
72 will MD O O
72 probably RB O O
72 have VB O O
73 her PRP$ O O
73 blood NN B-NP B-m
73 pressure NN I-NP I-m
73 medications NNS I-NP I-m
73 further RBR O O
73 adjusted VBN O O
73 at IN B-VP O
73 that DT B-NP O
73 point NN I-NP O
74 Dictated VBD B-VP O
74 By: NNP B-NP O
74 JAMAL NNP I-NP O
74 GRANIERI NNP I-NP O
74 , , O O
74 M.D NNP B-NP O
74 HW45 NNP I-NP O
75 Attending: NNP I-NP O
75 KELLY NNP I-NP O
75 SHIRE NNP I-NP O
75 , , O O
75 M.D NNP B-NP O
75 UJ62 NNP I-NP O
75 XI621/7115 NNP I-NP O
76 Batch: NNP I-NP O
76 82857 CD O O
76 Index NNP B-NP O
76 No NNP I-NP O
76 P2DLM2571M NNP I-NP O
76 D: NNP I-NP O
76 0/29/97 CD O O
77 T: NNP B-NP O
77 3/8/97 CD O O
78 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #197385 VBZ O O
4 878638236 CD O O
4 KH NNP B-NP O
4 56828582 CD O O
4 8585103 CD O O
4 11/17/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 NSTEMI NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/17/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/29/2005 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 RUDLONG NNP I-NP O
8 , , O O
8 NUMBERS NNP B-NP O
8 288-16-61-4 CD O O
9 Chie NNP B-NP O
9 Sa NNP I-NP O
9 Sterlo NNP I-NP O
9 Van NNP I-NP O
9 S NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 8/28/05 CD O O
11 AT NNP B-NP O
11 08:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 7pm CD O B-f
12 dose NN B-NP O
12 of IN B-VP O
12 lovenox NN B-NP B-m
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 BRUNECZ NNP I-NP O
14 , , O O
14 JULIAN NNP B-NP O
14 G NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
15 w/ NN I-NP O
15 services NNS I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 ECASA NNP I-NP B-m
17 325 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 Override NNP I-NP O
18 Notice: NNP I-NP O
18 Override NNP I-NP O
18 added VBD B-VP O
18 on IN B-VP O
18 9/20/05 CD O O
18 by IN B-VP O
19 GANGLUFF NNP B-NP O
19 , , O O
19 CHONG NNP B-NP O
19 B NNP I-NP O
19 , , O O
19 M.D NNP B-NP O
19 , , O O
19 PH.D NNP B-NP O
20 on IN B-VP O
20 order NN B-NP O
20 for IN B-VP O
20 COUMADIN NNP B-NP B-m
20 PO NNP I-NP B-mo
20 ( ( O O
20 ref JJ O O
20 # # O O
20 758570817 CD O O
20 ) ) O O
21 POTENTIALLY NNP B-NP O
21 SERIOUS NNP I-NP O
21 INTERACTION: NNP I-NP O
21 ASPIRIN NNP I-NP B-m
21 &amp; NNP I-NP O
21 WARFARIN NNP I-NP B-m
22 Reason NNP I-NP O
22 for IN B-VP O
22 override: NN B-NP O
22 needs NNS I-NP O
22 Previous JJ O O
22 override IN B-VP O
22 information: JJ B-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 9/5/05 CD O O
23 by IN B-VP O
23 IMHOLTE NNP B-NP O
23 , , O O
23 RENE NNP B-NP O
23 , , O O
23 M.D NNP B-NP O
24 on IN B-VP O
24 order NN B-NP O
24 for IN B-VP O
24 COUMADIN NNP B-NP B-m
24 PO NNP I-NP B-mo
24 5 CD O B-do
24 MG NNP B-NP I-do
24 QPM NNP I-NP B-f
24 ( ( O O
24 ref JJ O O
24 # # O O
24 370510168 CD O O
24 ) ) O O
25 POTENTIALLY NNP B-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 ASPIRIN NNP I-NP B-m
25 &amp; NNP I-NP O
25 WARFARIN NNP I-NP B-m
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 ok VBP O O
26 Previous NNP B-NP O
26 override IN B-VP O
26 information: JJ B-NP O
27 Override NNP I-NP O
27 added VBD B-VP O
27 on IN B-VP O
27 9/5/05 CD O O
27 by IN B-VP O
27 BROGAN NNP B-NP O
27 , , O O
27 KARL NNP B-NP O
27 T NNP I-NP O
27 , , O O
27 M.D NNP B-NP O
28 on IN B-VP O
28 order NN B-NP O
28 for IN B-VP O
28 COUMADIN NNP B-NP B-m
28 PO NNP I-NP B-mo
28 ( ( O O
28 ref JJ O O
28 # # O O
28 895728054 CD O O
28 ) ) O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 ASPIRIN NNP I-NP B-m
29 &amp; NNP I-NP O
29 WARFARIN NNP I-NP B-m
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 aware JJ B-NP O
31 ATENOLOL NNP I-NP B-m
31 100 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 LASIX NNP I-NP B-m
32 ( ( O I-m
32 FUROSEMIDE NNP B-NP I-m
32 ) ) O I-m
32 40 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 LISINOPRIL NNP I-NP B-m
33 5 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
34 Alert NNP I-NP O
34 overridden: NNP I-NP O
34 Override NNP I-NP O
34 added VBD B-VP O
34 on IN B-VP O
34 0/10/05 CD O O
34 by IN B-VP O
35 FOOR NNP B-NP O
35 , , O O
35 RAY NNP B-NP O
35 F NNP I-NP O
35 , , O O
35 M.D NNP B-NP O
35 , , O O
35 PH.D NNP B-NP O
36 POTENTIALLY NNP I-NP O
36 SERIOUS NNP I-NP O
36 INTERACTION: NNP I-NP O
36 POTASSIUM NNP I-NP B-m
36 CHLORIDE NNP I-NP I-m
36 &amp; NNP I-NP O
37 LISINOPRIL NNP I-NP B-m
37 Reason NNP I-NP O
37 for IN B-VP O
37 override: NN B-NP O
37 needs NNS I-NP O
38 NITROGLYCERIN NNP I-NP B-m
38 1/150 CD O I-m
38 ( ( O I-m
38 0.4 CD O I-m
38 MG NNP B-NP I-m
38 ) ) O I-m
38 1 CD O B-do
38 TAB NNP B-NP I-do
38 SL NNP I-NP B-mo
38 q5min VBD B-VP B-f
38 x $ O O
38 3 CD O O
39 PRN NNP B-NP O
39 chest NN I-NP B-r
39 pain NN I-NP I-r
40 COUMADIN NNP I-NP B-m
40 ( ( O I-m
40 WARFARIN NNP B-NP I-m
40 SODIUM NNP I-NP I-m
40 ) ) O I-m
40 5 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QPM NNP I-NP B-f
41 Starting NNP I-NP O
41 ROUTINE NNP I-NP O
41 , , O O
41 20:00 CD O O
41 ( ( O O
41 Standard NNP B-NP O
41 Admin NNP I-NP O
41 Time NNP I-NP O
41 ) ) O O
42 Food/Drug NNP B-NP O
42 Interaction NNP I-NP O
42 Instruction NNP I-NP O
43 No NNP I-NP O
43 high JJ B-NP O
43 Vitamin-K NNP I-NP O
43 containing VBG O O
43 foods NNS B-NP O
44 Alert NNP I-NP O
44 overridden: VBD B-VP O
44 Override NNP B-NP O
44 added VBD B-VP O
44 on IN B-VP O
44 9/20/05 CD O O
44 by IN B-VP O
45 MCDUFFEY NNP B-NP O
45 , , O O
45 BRYANT NNP B-NP O
45 N NNP I-NP O
45 , , O O
45 M.D NNP B-NP O
45 , , O O
45 PH.D NNP B-NP O
46 POTENTIALLY NNP I-NP O
46 SERIOUS NNP I-NP O
46 INTERACTION: NNP I-NP O
46 ASPIRIN NNP I-NP B-m
46 &amp; NNP I-NP O
46 WARFARIN NNP I-NP B-m
47 POTENTIALLY NNP I-NP O
47 SERIOUS NNP I-NP O
47 INTERACTION: NNP I-NP O
47 ATORVASTATIN NNP I-NP B-m
47 CALCIUM NNP I-NP I-m
47 &amp; NNP I-NP O
48 WARFARIN NNP I-NP B-m
48 Reason NNP I-NP O
48 for IN B-VP O
48 override: NN B-NP O
48 needs NNS I-NP O
49 LOVENOX NNP I-NP B-m
49 ( ( O I-m
49 ENOXAPARIN NNP B-NP I-m
49 ) ) O I-m
49 90 CD O B-do
49 MG NNP B-NP I-do
49 SC NNP I-NP B-mo
49 BID NNP I-NP B-f
50 Alert NNP I-NP O
50 overridden: NNP I-NP O
50 Override NNP I-NP O
50 added VBD B-VP O
50 on IN B-VP O
50 8/28/05 CD O O
50 by IN B-VP O
51 GAUDIOSO NNP B-NP O
51 , , O O
51 SHAWN NNP B-NP O
51 V NNP I-NP O
51 , , O O
51 M.D NNP B-NP O
52 SERIOUS NNP I-NP O
52 INTERACTION: NNP I-NP O
52 HEPARIN NNP I-NP B-m
52 &amp; NNP I-NP O
52 ENOXAPARIN NNP I-NP B-m
52 SODIUM NNP I-NP I-m
53 Reason NNP I-NP O
53 for IN B-VP O
53 override: NN B-NP O
53 aware JJ B-NP O
54 FLOVENT NNP I-NP B-m
54 ( ( O I-m
54 FLUTICASONE NNP B-NP I-m
54 PROPIONATE NNP I-NP I-m
54 ) ) O I-m
54 110 CD O B-do
54 MCG NNP B-NP I-do
54 INH NNP I-NP B-mo
54 BID NNP I-NP B-f
55 LIPITOR NNP I-NP B-m
55 ( ( O I-m
55 ATORVASTATIN NNP B-NP I-m
55 ) ) O I-m
55 80 CD O B-do
55 MG NNP B-NP I-do
55 PO NNP I-NP B-mo
55 QD NNP I-NP B-f
56 Override NNP I-NP O
56 Notice: NNP I-NP O
56 Override NNP I-NP O
56 added VBD B-VP O
56 on IN B-VP O
56 9/20/05 CD O O
56 by IN B-VP O
57 HIPKINS NNP B-NP O
57 , , O O
57 TYRON NNP B-NP O
57 M NNP I-NP O
57 , , O O
57 M.D NNP B-NP O
57 , , O O
57 PH.D NNP B-NP O
58 on IN B-VP O
58 order NN B-NP O
58 for IN B-VP O
58 COUMADIN NNP B-NP B-m
58 PO NNP I-NP B-mo
58 ( ( O O
58 ref JJ O O
58 # # O O
58 758570817 CD O O
58 ) ) O O
59 POTENTIALLY NNP B-NP O
59 SERIOUS NNP I-NP O
59 INTERACTION: NNP I-NP O
59 ATORVASTATIN NNP I-NP B-m
59 CALCIUM NNP I-NP I-m
59 &amp; NNP I-NP O
60 WARFARIN NNP I-NP B-m
60 Reason NNP I-NP O
60 for IN B-VP O
60 override: NN B-NP O
60 needs NNS I-NP O
61 Previous JJ O O
61 override IN B-VP O
61 information: JJ B-NP O
62 Override NNP I-NP O
62 added VBD B-VP O
62 on IN B-VP O
62 9/5/05 CD O O
62 by IN B-VP O
62 KEMPT NNP B-NP O
62 , , O O
62 BORIS NNP B-NP O
62 , , O O
62 M.D NNP B-NP O
63 on IN B-VP O
63 order NN B-NP O
63 for IN B-VP O
63 COUMADIN NNP B-NP B-m
63 PO NNP I-NP B-mo
63 5 CD O B-do
63 MG NNP B-NP I-do
63 QPM NNP I-NP B-f
63 ( ( O O
63 ref JJ O O
63 # # O O
63 370510168 CD O O
63 ) ) O O
64 POTENTIALLY NNP B-NP O
64 SERIOUS NNP I-NP O
64 INTERACTION: NNP I-NP O
64 ATORVASTATIN NNP I-NP B-m
64 CALCIUM NNP I-NP I-m
64 &amp; NNP I-NP O
65 WARFARIN NNP I-NP B-m
65 Reason NNP I-NP O
65 for IN B-VP O
65 override: NN B-NP O
65 ok VBP O O
66 Previous NNP B-NP O
66 override IN B-VP O
66 information: JJ B-NP O
67 Override NNP I-NP O
67 added VBD B-VP O
67 on IN B-VP O
67 9/5/05 CD O O
67 by IN B-VP O
67 LAKIN NNP B-NP O
67 , , O O
67 IRWIN NNP B-NP O
67 N NNP I-NP O
67 , , O O
67 M.D NNP B-NP O
68 on IN B-VP O
68 order NN B-NP O
68 for IN B-VP O
68 COUMADIN NNP B-NP B-m
68 PO NNP I-NP B-mo
68 ( ( O O
68 ref JJ O O
68 # # O O
68 895728054 CD O O
68 ) ) O O
69 POTENTIALLY NNP B-NP O
69 SERIOUS NNP I-NP O
69 INTERACTION: NNP I-NP O
69 ATORVASTATIN NNP I-NP B-m
69 CALCIUM NNP I-NP I-m
69 &amp; NNP I-NP O
70 WARFARIN NNP I-NP B-m
70 Reason NNP I-NP O
70 for IN B-VP O
70 override: NN B-NP O
70 aware JJ B-NP O
71 PLAVIX NNP I-NP B-m
71 ( ( O I-m
71 CLOPIDOGREL NNP B-NP I-m
71 ) ) O I-m
71 75 CD O B-do
71 MG NNP B-NP I-do
71 PO NNP I-NP B-mo
71 QD NNP I-NP B-f
72 Starting NNP I-NP O
72 Tomorrow NNP I-NP O
72 March NNP I-NP O
73 MAGNESIUM NNP I-NP B-m
73 OXIDE NNP I-NP I-m
73 ( ( O I-m
73 241 CD O I-m
73 MG NNP B-NP I-m
73 ELEMENTAL NNP I-NP I-m
73 MG NNP I-NP I-m
73 ) ) O I-m
73 800 CD O B-do
73 MG NNP B-NP I-do
73 PO NNP I-NP B-mo
73 BID NNP I-NP B-f
74 DIET: NNP I-NP O
74 Patient NNP I-NP O
74 should MD O O
74 measure VB O O
74 weight JJ B-NP O
74 daily JJ I-NP O
75 DIET: NNP I-NP O
75 Fluid NNP I-NP O
75 restriction NN I-NP O
76 DIET: NNP I-NP O
76 House NNP I-NP O
76 / VBD B-VP O
76 Low NNP B-NP O
76 chol/low NN I-NP O
76 sat VBD B-VP O
76 fat JJ B-NP O
77 DIET: NNP I-NP O
77 4 CD O O
77 gram NN B-NP O
77 Sodium NNP I-NP O
78 RETURN NNP I-NP O
78 TO NNP I-NP O
78 WORK: NNP I-NP O
78 Not RB O O
78 Applicable NNP B-NP O
79 FOLLOW NNP I-NP O
79 UP NNP I-NP O
79 APPOINTMENT( NNP I-NP O
79 S NNP I-NP O
79 ): NNP I-NP O
80 Dr NNP I-NP O
80 Campolongo NNP I-NP O
80 within IN B-VP O
80 4 CD O O
80 weeks NNS B-NP O
80 , , O O
81 PCP NNP B-NP O
81 in IN B-VP O
81 2 CD O O
81 weeks NNS B-NP O
81 , , O O
82 Arrange NNP B-NP O
82 INR NNP I-NP O
82 to TO O O
82 be VB O O
82 drawn VBN O O
82 on IN B-VP O
82 6/10/05 CD O O
82 with IN B-VP O
82 f/u JJ B-NP O
82 INR's NNP I-NP O
82 to TO O O
82 be VB O O
82 drawn VBN O O
82 every DT O O
83 3 CD O O
83 days NNS B-NP O
83 INR's NNP I-NP O
83 will MD O O
83 be VB O O
83 followed VBN O O
83 by IN B-VP O
83 HWMH NNP B-NP O
83 anticoagulation NN I-NP O
83 service NN I-NP O
84 ALLERGY: NNP I-NP O
84 NKA NNP I-NP O
85 ADMIT NNP I-NP O
85 DIAGNOSIS: NNP I-NP O
86 acute JJ B-NP O
86 coronary JJ I-NP O
86 syndrome NN I-NP O
87 PRINCIPAL NNP I-NP O
87 DISCHARGE NNP I-NP O
87 DIAGNOSIS NNP I-NP O
87 ;Responsible JJ O O
87 After IN B-VP O
87 Study NNP B-NP O
87 for IN B-VP O
87 Causing NNP B-NP O
87 Admission NNP I-NP O
87 ) ) O O
88 NSTEMI NNP B-NP O
89 OTHER NNP I-NP O
89 DIAGNOSIS;Conditions NNP I-NP O
89 , , O O
89 Infections NNP B-NP O
89 , , O O
89 Complications NNP B-NP O
89 , , O O
89 affecting VBG O O
89 Treatment/Stay NNP B-NP O
90 CHF NNP I-NP O
90 CAD NNP I-NP O
91 OPERATIONS NNP I-NP O
91 AND NNP I-NP O
91 PROCEDURES: NNP I-NP O
92 Catheterization: NNP I-NP O
92 R NNP I-NP O
92 dominant NN I-NP O
92 , , O O
92 ostial JJ B-NP O
92 OM1 NNP I-NP O
92 95% CD O O
92 culprit NN B-NP O
92 lesion NN I-NP O
92 , , O O
92 stented VBN O O
92 with IN B-VP O
93 2.5x13-mm JJ B-NP O
93 DES; NNP I-NP O
93 diffuse NN I-NP O
93 OM2 NNP I-NP O
93 70% CD O O
93 lesion NN B-NP O
93 stented VBN O O
93 with IN B-VP O
93 2.5x13-mm JJ B-NP O
93 DES; NNP I-NP O
93 and CC O O
93 LCX NNP B-NP O
94 lesion NN I-NP O
94 stented VBD B-VP O
94 with IN B-VP O
94 3.5x13-mm JJ B-NP O
94 DES NNP I-NP O
94 , , O O
94 all RB O O
94 stented VBD B-VP O
94 to TO O O
94 0% CD O O
94 with IN B-VP O
94 TIMI NNP B-NP O
94 3 CD O O
94 flow NN B-NP O
95 OTHER NNP I-NP O
95 TREATMENTS/PROCEDURES NNP I-NP O
95 ( ( O O
95 NOT NNP B-NP O
95 IN NNP I-NP O
95 O.R NNP I-NP O
95 ) ) O O
96 none NN B-NP O
97 BRIEF NNP I-NP O
97 RESUME NNP I-NP O
97 OF NNP I-NP O
97 HOSPITAL NNP I-NP O
97 COURSE: NNP I-NP O
98 ID/CC: NNP I-NP O
98 68 CD O O
98 yo NN B-NP O
98 retired VBN O O
98 social JJ B-NP O
98 worker NN I-NP O
98 with IN B-VP O
98 cardiac JJ B-NP O
98 risk NN I-NP O
98 factors NNS I-NP O
98 of IN B-VP O
98 obesity NN B-NP O
98 , , O O
99 hypertension NN B-NP O
99 and CC O O
99 possible JJ B-NP O
99 family NN I-NP O
99 history NN I-NP O
99 admitted VBN O O
99 with IN B-VP O
99 atrial JJ B-NP O
99 flutter NN I-NP O
99 and CC O O
100 found VBN O O
100 to TO O O
100 have VB O O
100 ACS NNP B-NP O
101 HPI: NNP I-NP O
101 Pt NNP I-NP O
101 is VBZ O O
101 fairly RB O O
101 inactive JJ O O
101 at IN B-VP O
101 baseline NN B-NP O
101 but CC O O
101 over IN B-VP O
101 the DT O O
101 three CD O O
101 days NNS B-NP O
101 prior RB O O
101 to TO O O
102 admission NN B-NP O
102 had VBD B-VP O
102 noted VBN O O
102 shortness NN B-NP O
102 of IN B-VP O
102 breath NN B-NP O
102 with IN B-VP O
102 walking VBG O O
102 even RB O O
102 a DT B-NP O
102 few JJ I-NP O
102 steps NNS I-NP O
103 On IN B-VP O
103 night NN B-NP O
103 prior RB O O
103 to TO O O
103 admission NN B-NP O
103 , , O O
103 she PRP O O
103 had VBD B-VP O
103 severe JJ B-NP O
103 shortness NN I-NP O
103 of IN B-VP O
103 breath NN B-NP O
103 , , O O
103 unable JJ O O
104 to TO O O
104 breathe VB O O
104 in IN B-VP O
104 comfortably RB O O
104 even RB O O
104 sitting VBG O O
104 bolt NN B-NP O
104 upright; NN I-NP O
104 this DT O O
104 was VBD B-VP O
104 accompanied VBN O O
105 by IN B-VP O
105 substernal JJ B-NP O
105 chest NN I-NP O
105 pressure NN I-NP O
105 and CC O O
105 profuse NN B-NP O
105 diaphoresis NN I-NP O
105 She PRP O O
105 went VBD B-VP O
105 to TO O O
105 XMC VB O O
106 clinic JJ O O
106 the DT B-NP O
106 following JJ I-NP O
106 morning NN I-NP O
106 reporting VBG O O
106 the DT B-NP O
106 shortness NN I-NP O
106 of IN B-VP O
106 breath NN B-NP O
106 was VBD B-VP O
106 found VBN O O
107 to TO O O
107 be VB O O
107 in IN B-VP O
107 atrial JJ B-NP O
107 flutter NN I-NP O
107 with IN B-VP O
107 2:1 CD O O
107 block NN B-NP O
107 and CC O O
107 2-3mm JJ B-NP O
107 lateral JJ I-NP O
107 ST NNP I-NP O
107 depressions NNS I-NP O
108 in IN B-VP O
108 V4-V6 NNP B-NP O
108 The DT B-NP O
108 first JJ I-NP O
108 EKG NNP I-NP O
108 in IN B-VP O
108 the DT B-NP O
108 ED NNP I-NP O
108 showed VBD B-VP O
108 new JJ O O
108 deep JJ O O
108 , , O O
108 symmetrical JJ O O
108 T-wave CD O O
109 inversions NNS B-NP O
109 in IN B-VP O
109 V4-V6 NNP B-NP O
109 , , O O
109 1-mm JJ O O
109 concave VBP O O
109 down RP O O
109 ST NNP B-NP O
109 elevation NN I-NP O
109 in IN B-VP O
109 lead JJ B-NP O
109 III NNP I-NP O
109 and CC O O
110 similar JJ B-NP O
110 contour NN I-NP O
110 in IN B-VP O
110 II NNP B-NP O
110 and CC O O
110 aVF VB O O
110 although IN B-VP O
110 not RB O O
110 elevated VBN O O
110 First NNP B-NP O
110 TnI NNP I-NP O
110 7.39 CD O O
110 , , O O
111 MB NNP B-NP O
111 21.2 CD O O
111 Went NNP B-NP O
111 to TO O O
111 cath VB O O
111 lab NN B-NP O
111 and CC O O
111 found VBN O O
111 to TO O O
111 have VB O O
111 active JJ B-NP O
111 thrombus NN I-NP O
111 in IN B-VP O
111 the DT B-NP O
111 OM NNP I-NP O
112 distribution; NN I-NP O
112 received VBD B-VP O
112 drug-eluting JJ B-NP O
112 stents NNS I-NP O
112 to TO O O
112 OM1 NNP B-NP O
112 , , O O
112 OM2 NNP B-NP O
112 , , O O
112 and CC O O
112 LCX NNP B-NP O
112 and CC O O
113 monitored VBD B-VP O
113 overnight VBN O O
113 in IN B-VP O
113 the DT B-NP O
113 CCU NNP I-NP O
113 with IN B-VP O
113 18 CD O B-du
113 hours NNS B-NP I-du
113 of IN B-VP O
113 post-procedure JJ B-NP B-f
114 eptifibatide NN I-NP B-m
115 Home NNP I-NP O
115 meds: NN I-NP O
115 metoprolol NN I-NP B-m
115 , , O O
115 norvasc RB O B-m
115 , , O O
115 combivent JJ B-NP B-m
116 PEx: NNP I-NP O
116 On IN B-VP O
116 transfer NN B-NP O
116 to TO O O
116 floor NN B-NP O
116 , , O O
116 exam CC O O
116 notable JJ O O
116 for IN B-VP O
116 faint NN B-NP O
116 bibasilar NN I-NP O
116 crackles NNS I-NP O
116 , , O O
117 JVP NNP B-NP O
117 14 CD O O
117 , , O O
117 S1S2 NNP B-NP O
117 intermittent NN I-NP O
117 gallop NN I-NP O
117 , , O O
117 no DT B-NP O
117 LE NNP I-NP O
117 edema NN I-NP O
118 EKG: NNP I-NP O
118 atrial JJ B-NP O
118 flutter NN I-NP O
118 with IN B-VP O
118 variable JJ B-NP O
118 block NN I-NP O
118 , , O O
118 bifascicular JJ B-NP O
118 block NN I-NP O
118 ( ( O O
118 LAFB NNP B-NP O
118 and CC O O
119 RBBB NNP B-NP O
119 ) ) O O
120 Assessment NNP B-NP O
120 and CC O O
120 Hospital NNP B-NP O
120 Course: NNP I-NP O
121 68 CD O O
121 yo NNP B-NP O
121 woman NN I-NP O
121 with IN B-VP O
121 non-ST JJ B-NP O
121 elevation NN I-NP O
121 MI NNP I-NP O
121 and CC O O
121 atrial JJ B-NP O
121 flutter NN I-NP O
121 with IN B-VP O
121 variable JJ B-NP O
122 block NN I-NP O
122 , , O O
122 s/p NN B-NP O
122 facilitated VBD B-VP O
122 PCI NNP B-NP O
122 with IN B-VP O
122 3 CD O O
122 stents NNS B-NP O
122 in IN B-VP O
122 OM NNP B-NP O
122 and CC O O
122 LCX NNP B-NP O
122 distribution NN I-NP O
123 1 CD O O
123 ) ) O O
123 CV NNP B-NP O
123 Ischemia: NNP I-NP O
123 s/p VBD B-VP O
123 NSTEMI: NNP B-NP O
123 ASA NNP I-NP B-m
123 , , O O
123 clopidogrel NN B-NP B-m
123 , , O O
123 atorvastatin RB O B-m
123 80 CD O B-do
123 , , O O
123 atenolol RB O B-m
124 100 CD O B-do
124 , , O O
124 captopril RB O B-m
124 converted VBN O O
124 to TO O O
124 lisinopril VB O B-m
124 Pump: NNP B-NP O
124 CHF NNP I-NP O
124 , , O O
124 with IN B-VP O
124 atrial JJ B-NP O
124 flutter NN I-NP O
125 and CC O O
125 ACS NNP B-NP O
125 the DT B-NP O
125 likely JJ I-NP O
125 precipitants NNS I-NP O
125 Initially RB O O
125 required VBD B-VP O
125 O2 NNP B-NP B-m
125 to TO O O
126 maintain VB O O
126 sat JJ O O
126 &gt; JJ O O
126 90 CD O O
126 but CC O O
126 gradually RB O O
126 titrated VBD B-VP O
126 to TO O O
126 off IN B-VP O
126 Diuresed VBN O O
126 well RB O O
126 with IN B-VP O
126 Lasix NNP B-NP B-m
127 80 CD O B-do
127 IV NNP B-NP B-mo
127 bid NN I-NP B-f
127 , , O O
127 negative JJ O O
127 1 CD O O
127 L/day NNP B-NP O
127 for IN B-VP B-du
127 3 CD O I-du
127 days NNS B-NP I-du
127 and CC O O
127 then RB O O
127 converted VBD B-VP O
127 to TO O O
127 PO NNP B-NP B-mo
127 lasix VBZ O B-m
127 40 CD O B-do
128 TTE NNP B-NP O
128 showed VBD B-VP O
128 normal JJ B-NP O
128 LV NNP I-NP O
128 size NN I-NP O
128 , , O O
128 concentric JJ B-NP O
128 LVH NNP I-NP O
128 , , O O
128 EF NNP B-NP O
128 50% CD O O
128 , , O O
128 abnormal JJ B-NP O
128 septal JJ I-NP O
129 motion NN I-NP O
129 , , O O
129 mild JJ B-NP O
129 diffuse NN I-NP O
129 HK NNP I-NP O
129 Nl NNP I-NP O
129 RV NNP I-NP O
129 size/function NN I-NP O
129 , , O O
129 mild JJ B-NP O
129 LAE NNP I-NP O
129 , , O O
129 mild JJ B-NP O
129 RAE NNP I-NP O
129 No NNP I-NP O
129 AI NNP I-NP O
129 , , O O
130 mild-mod JJ B-NP O
130 MR NNP I-NP O
130 , , O O
130 mild JJ B-NP O
130 TR NNP I-NP O
130 PA NNP I-NP O
130 29 CD O O
130 + NNP B-NP O
130 RA NNP I-NP O
130 Trace NNP I-NP O
130 pulmonic JJ B-NP O
130 regurgitation NN I-NP O
130 Nutrition NNP I-NP O
131 was VBD B-VP O
131 consulted VBN O O
131 regarding VBG O O
131 low-fat JJ O O
131 and CC O O
131 low-salt JJ B-NP O
131 diets NNS I-NP O
131 , , O O
131 as RB O O
131 well RB O O
131 as IN B-VP O
131 fluid JJ B-NP O
132 restriction NN I-NP O
132 Rhythm: NNP I-NP O
132 Initially NNP I-NP O
132 rate-controlled VBD B-VP O
132 on IN B-VP O
132 beta-blocker NN B-NP B-m
132 and CC O O
133 diltiazem NN B-NP B-m
133 for IN B-VP O
133 goal NN B-NP B-r
133 goal NN I-NP B-r
133 rate NN I-NP I-r
133 rate NN I-NP I-r
133 in IN B-VP O
133 60s; CD O O
133 she PRP O O
133 will MD O O
133 be VB O O
133 discharged VBN O O
133 on IN B-VP O
133 atenolol NN B-NP B-m
133 100 CD O B-do
133 mg NN B-NP I-do
134 po NN I-NP B-mo
134 QD NNP I-NP B-f
134 She PRP O O
134 had VBD B-VP O
134 several JJ B-NP O
134 10-14-beat JJ I-NP O
134 runs NNS I-NP O
134 of IN B-VP O
134 NSVT NNP B-NP O
134 , , O O
134 treated VBD B-VP O
134 with IN B-VP O
134 aggressive JJ B-NP O
135 lyte JJ I-NP O
135 replacement NN I-NP O
135 particularly RB O O
135 in IN B-VP O
135 light NN B-NP O
135 of IN B-VP O
135 long JJ B-NP O
135 QTc NNP I-NP O
135 Initiated NNP I-NP O
135 heparin NN I-NP B-m
135 and CC O O
136 discharged VBN O O
136 on IN B-VP O
136 coumadin NN B-NP B-m
136 with IN B-VP O
136 a DT B-NP O
136 lovenox NN I-NP B-m
136 bridge NN I-NP O
136 She PRP O O
136 was VBD B-VP O
136 not RB O O
136 considered VBN O O
136 an DT B-NP O
136 ICD NNP I-NP O
137 candidate NN I-NP O
137 based VBN O O
137 on IN B-VP O
137 her PRP$ O O
137 EF NNP B-NP O
138 2 CD O O
138 ) ) O O
138 Endo: NNP B-NP O
138 PEHC NNP I-NP O
138 chart NN I-NP O
138 shows VBZ O O
138 a DT B-NP O
138 diagnosis NN I-NP O
138 of IN B-VP O
138 diabetes VBZ O O
138 No DT B-NP O
138 fingersticks NNS I-NP O
138 were VBD B-VP O
139 elevated VBN O O
139 this DT O O
139 admission; VBZ O O
139 a DT B-NP O
139 hemoglobin NN I-NP O
139 A1C NNP I-NP O
139 was VBD B-VP O
139 6.2% CD O O
139 Likely JJ O O
139 to TO O O
139 have VB O O
140 glucose JJ B-NP O
140 intolerance NN I-NP O
140 and CC O O
140 will MD O O
140 benefit VB O O
140 from IN B-VP O
140 weight JJ B-NP O
140 loss NN I-NP O
141 3 CD O O
141 ) ) O O
141 FEN: NNP B-NP O
141 Standing NNP I-NP O
141 Mg NNP I-NP B-m
141 oxide IN B-VP I-m
141 for IN B-VP O
141 long JJ B-NP B-r
141 QTc; NNP I-NP I-r
141 she PRP O O
141 will MD O O
141 be VB O O
141 discharged VBN O O
141 on IN B-VP O
141 800 CD O B-do
141 mg NNS B-NP I-do
141 po JJ B-NP B-mo
142 bid; NN I-NP B-f
142 &lt;2g NNP I-NP O
142 NaCl NNP I-NP O
142 , , O O
142 &lt;2L NNP B-NP O
142 Fluid NNP I-NP O
142 restriction NN I-NP O
143 restricted VBD B-VP O
143 , , O O
143 Cardiac NNP B-NP O
143 diet VBZ O O
144 4 CD O O
144 ) ) O O
144 Renal: NNP B-NP O
144 Because IN B-VP O
144 of IN B-VP O
144 history NN B-NP O
144 of IN B-VP O
144 HTN NNP B-NP O
144 , , O O
144 renal JJ B-NP O
144 arteries NNS I-NP O
144 were VBD B-VP O
144 visualized VBN O O
144 during IN B-VP O
145 catheterization; NN B-NP O
145 study NN I-NP O
145 revealed VBD B-VP O
145 3 CD O O
145 left VBD B-VP O
145 renal JJ B-NP O
145 arteries NNS I-NP O
145 , , O O
145 one CD O O
145 of IN B-VP O
145 which WDT O O
145 had VBD B-VP O
145 a DT O O
146 40% CD O O
146 lesion NN B-NP O
146 , , O O
146 and CC O O
146 2 CD O O
146 right JJ B-NP O
146 renal JJ I-NP O
146 arteries NNS I-NP O
146 No DT B-NP O
146 intervention NN I-NP O
146 was VBD B-VP O
146 done VBN O O
147 Pt NNP B-NP O
147 will MD O O
147 be VB O O
147 discharged VBN O O
147 home NN B-NP O
147 in IN B-VP O
147 good JJ B-NP O
147 condition NN I-NP O
147 and CC O O
147 will MD O O
147 be VB O O
147 followed VBN O O
147 by IN B-VP O
147 the DT B-NP O
148 NH NNP I-NP O
148 heart NN I-NP O
148 failure NN I-NP O
148 service NN I-NP O
149 ADDITIONAL NNP I-NP O
149 COMMENTS: NNP I-NP O
149 Take NNP I-NP O
149 all DT B-NP O
149 medicines NNS I-NP O
149 as IN B-VP O
149 directed VBN O O
149 DO NNP B-NP O
149 NOT NNP I-NP O
149 MISS NNP I-NP O
149 A NNP I-NP O
149 SINGLE NNP I-NP O
149 DOSE NNP I-NP O
149 OF NNP I-NP O
149 PLAVIX NNP I-NP B-m
149 THIS NNP I-NP O
150 MEDICINE NNP I-NP O
150 KEEPS NNP I-NP O
150 YOUR NNP I-NP O
150 NEW NNP I-NP O
150 STENTS NNP I-NP O
150 OPEN NNP I-NP O
150 AND NNP I-NP O
150 IS NNP I-NP O
150 VITALLY NNP I-NP O
150 IMPORTANT NNP I-NP O
150 TO NNP I-NP O
150 YOUR NNP I-NP O
151 HEALTH NNP I-NP O
152 DISCHARGE NNP I-NP O
152 CONDITION: NNP I-NP O
152 Stable NNP I-NP O
153 TO NNP I-NP O
153 DO/PLAN: NNP I-NP O
154 No NNP I-NP O
154 dictated VBD B-VP O
154 summary JJ B-NP O
155 ENTERED NNP I-NP O
155 BY: NNP I-NP O
155 GUM NNP I-NP O
155 , , O O
155 LAWRENCE NNP B-NP O
155 A NNP I-NP O
155 , , O O
155 M.D NNP B-NP O
155 , , O O
155 PH.D NNP B-NP O
155 ( ( O O
155 LP51 NNP B-NP O
155 ) ) O O
155 8/28/05 CD O O
155 @ $ O O
155 12:45 CD O O
155 PM NNP B-NP O
156 ****** JJ B-NP O
156 END NNP I-NP O
156 OF NNP I-NP O
156 DISCHARGE NNP I-NP O
156 ORDERS NNP I-NP O
156 ****** NNP I-NP O
157 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #197702 VBZ O O
2 091761834 CD O O
2 CMLMC NNP B-NP O
2 07592927 CD O O
2 3017067 CD O O
2 9/27/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 b NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 4/8/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/3/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 SCHEFFER NNP I-NP O
5 , , O O
5 FELTON NNP B-NP O
5 128-55-71-1 CD O O
6 Pend NNP B-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 2/22/06 CD O O
8 AT NNP B-NP O
8 06:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 TARKA NNP I-NP O
11 , , O O
11 FELTON NNP B-NP O
11 CHAD NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ACETYLSALICYLIC NNP I-NP B-m
16 ACID NNP I-NP I-m
16 81 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 DAILY NNP I-NP B-f
17 Starting VBG O O
17 Today NNP B-NP O
17 ( ( O O
17 6/17 CD O O
17 ) ) O O
18 ATENOLOL $ O B-m
18 100 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 BID NNP I-NP B-f
18 Starting VBG O O
18 Today NNP B-NP O
18 ( ( O O
18 6/17 CD O O
18 ) ) O O
19 LIPITOR NNP B-NP B-m
19 ( ( O I-m
19 ATORVASTATIN NNP B-NP I-m
19 ) ) O I-m
19 40 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 Starting VBG O O
20 Today NNP B-NP O
20 ( ( O O
20 6/17 CD O O
20 ) ) O O
21 Instructions: NNP B-NP O
21 Please NNP I-NP O
21 cut VB O O
21 your PRP$ O O
21 lipitor NN B-NP B-m
21 80mg CD O B-do
21 tablet NN B-NP I-do
21 in IN B-VP I-do
21 half JJ O I-do
22 using VBG O O
22 your PRP$ O O
22 pill NN B-NP O
22 cutter NN I-NP O
23 ZETIA NNP I-NP B-m
23 ( ( O I-m
23 EZETIMIBE NNP B-NP I-m
23 ) ) O I-m
23 10 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 DAILY NNP I-NP B-f
24 HYDROCHLOROTHIAZIDE NNP I-NP B-m
24 50 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 DAILY NNP I-NP B-f
25 IMDUR NNP I-NP B-m
25 ER NNP I-NP I-m
25 ( ( O I-m
25 ISOSORBIDE NNP B-NP I-m
25 MONONITRATE NNP I-NP I-m
25 ( ( O I-m
25 SR NNP B-NP I-m
25 ) ) O I-m
25 ) ) O I-m
25 120 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 DAILY NNP I-NP B-f
26 Food/Drug NNP I-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 Give NNP I-NP O
27 on IN B-VP O
27 an DT B-NP O
27 empty JJ I-NP O
27 stomach NN I-NP O
27 ( ( O O
27 give JJ O O
27 1hr CD O O
27 before IN B-VP O
27 or CC O O
27 2hr CD O O
27 after IN B-VP O
28 food NN B-NP O
28 ) ) O O
29 LISINOPRIL NNP B-NP B-m
29 LISINOPRIL NNP I-NP B-m
29 40 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 PO NNP I-NP B-mo
29 DAILY NNP I-NP B-f
29 Starting VBG O O
29 Today NNP B-NP O
29 ( ( O O
29 6/17 CD O O
29 ) ) O O
30 Instructions: NNP B-NP O
30 Please NNP I-NP O
30 take VB O O
30 one CD O B-do
30 40mg CD O I-do
30 tablet NN B-NP I-do
30 daily JJ B-NP B-f
31 Alert NNP I-NP O
31 overridden: NNP I-NP O
31 Override NNP I-NP O
31 added VBD B-VP O
31 on IN B-VP O
31 2/22/06 CD O O
31 by IN B-VP O
31 : : O O
32 POTENTIALLY NNP B-NP O
32 SERIOUS NNP I-NP O
32 INTERACTION: NNP I-NP O
32 POTASSIUM NNP I-NP B-m
32 CHLORIDE NNP I-NP I-m
32 &amp; NNP I-NP O
33 LISINOPRIL NNP I-NP B-m
34 POTENTIALLY NNP I-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 POTASSIUM NNP I-NP B-m
34 CHLORIDE NNP I-NP I-m
34 &amp; NNP I-NP O
35 LISINOPRIL NNP I-NP B-m
36 POTENTIALLY NNP I-NP O
36 SERIOUS NNP I-NP O
36 INTERACTION: NNP I-NP O
36 POTASSIUM NNP I-NP B-m
36 CHLORIDE NNP I-NP I-m
36 &amp; NNP I-NP O
37 LISINOPRIL NNP I-NP B-m
38 POTENTIALLY NNP I-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 POTASSIUM NNP I-NP B-m
38 CHLORIDE NNP I-NP I-m
38 &amp; NNP I-NP O
39 LISINOPRIL NNP I-NP B-m
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: NN B-NP O
40 NIFEDIPINE NNP I-NP B-m
40 ( ( O I-m
40 SUSTAINED NNP B-NP I-m
40 RELEASE NNP I-NP I-m
40 ) ) O I-m
40 ( ( O I-m
40 NIFEDIPINE NNP B-NP I-m
40 ( ( O I-m
40 S NNP B-NP I-m
40 ) ) O I-m
41 90 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 DAILY NNP I-NP B-f
41 Food/Drug NNP I-NP O
41 Interaction NNP I-NP O
41 Instruction NNP I-NP O
42 Avoid NNP I-NP O
42 grapefruit NN I-NP O
42 unless IN B-VP O
42 MD NNP B-NP O
42 instructs NNS I-NP O
42 otherwise RB O O
43 NITROGLYCERIN NNP B-NP B-m
43 1/150 CD O I-m
43 ( ( O I-m
43 0.4 CD O I-m
43 MG NNP B-NP I-m
43 ) ) O I-m
43 1 CD O B-do
43 TAB NNP B-NP I-do
43 SL NNP I-NP B-mo
43 Q5MIN NNP I-NP B-f
43 X NNP I-NP O
43 3 CD O O
43 doses NNS B-NP O
44 PRN NNP I-NP O
44 Chest NNP I-NP B-r
44 Pain NNP I-NP I-r
45 DIET: NNP I-NP O
45 House NNP I-NP O
45 / VBD B-VP O
45 Low NNP B-NP O
45 chol/low NN I-NP O
45 sat VBD B-VP O
45 fat JJ B-NP O
46 DIET: NNP I-NP O
46 House NNP I-NP O
46 / NNP I-NP O
46 ADA NNP I-NP O
46 2100 CD O O
46 cals/dy NN B-NP O
47 RETURN NNP I-NP O
47 TO NNP I-NP O
47 WORK: NNP I-NP O
47 After IN B-VP O
47 Appt NNP B-NP O
47 with IN B-VP O
47 local JJ B-NP O
47 physician NN I-NP O
48 FOLLOW NNP I-NP O
48 UP NNP I-NP O
48 APPOINTMENT( NNP I-NP O
48 S NNP I-NP O
48 ): NNP I-NP O
49 PCP NNP I-NP O
49 Dr NNP I-NP O
49 Deangelo NNP I-NP O
49 Shoobridge NNP I-NP O
49 Yshealt NNP I-NP O
49 Hill NNP I-NP O
49 Healthcare NNP I-NP O
49 Center NNP I-NP O
49 2/10 CD O O
49 at IN B-VP O
49 3pm CD O O
49 scheduled JJ O O
49 , , O O
50 Cardiologist NNP B-NP O
50 Dr NNP I-NP O
50 Kendrick NNP I-NP O
50 Lowin NNP I-NP O
50 230-881-8027 JJ B-NP O
50 Meaert NNP I-NP O
50 Mo NNP I-NP O
50 Rynei NNP I-NP O
50 Hospital NNP I-NP O
50 5/12 CD O O
50 at IN B-VP O
50 8: CD O O
50 scheduled JJ O O
50 , , O O
51 Cardiac JJ B-NP O
51 catheterization NN I-NP O
51 at IN B-VP O
51 AV NNP B-NP O
51 , , O O
51 please NN B-NP O
51 go VB O O
51 to TO O O
51 Admitting NNP B-NP O
51 in IN B-VP O
51 the DT B-NP O
51 lobby NN I-NP O
51 to TO O O
51 register VB O O
51 at IN B-VP O
51 7:30am CD O O
51 , , O O
51 do VBP O O
51 not RB O O
51 eat VB O O
51 breakfast NN B-NP O
51 7/21 CD O O
51 at IN B-VP O
51 7:30am CD O O
51 scheduled JJ O O
51 , , O O
52 ALLERGY: NNP B-NP O
52 GEMFIBROZIL NNP I-NP O
53 ADMIT NNP I-NP O
53 DIAGNOSIS: NNP I-NP O
54 chest JJS B-NP O
54 pain NN I-NP O
55 PRINCIPAL NNP I-NP O
55 DISCHARGE NNP I-NP O
55 DIAGNOSIS NNP I-NP O
55 ;Responsible JJ O O
55 After IN B-VP O
55 Study NNP B-NP O
55 for IN B-VP O
55 Causing NNP B-NP O
55 Admission NNP I-NP O
55 ) ) O O
56 b VBZ O O
57 OTHER NNP B-NP O
57 DIAGNOSIS;Conditions NNP I-NP O
57 , , O O
57 Infections NNP B-NP O
57 , , O O
57 Complications NNP B-NP O
57 , , O O
57 affecting VBG O O
57 Treatment/Stay NNP B-NP O
58 HTN NNP I-NP O
58 HYPERLIPIDEMIA NNP I-NP O
59 ATYPICAL NNP I-NP O
59 C.PAIN NNP I-NP O
59 STEMI NNP I-NP O
59 5/23 CD O O
59 Echo NNP B-NP O
59 5/23 CD O O
59 EF NNP B-NP O
59 60% CD O O
59 , , O O
59 mild JJ B-NP O
59 LVH NNP I-NP O
59 , , O O
59 RV NNP B-NP O
59 with IN B-VP O
60 HK NNP B-NP O
60 mi $ O O
60 3/6 CD O O
60 s/p NN B-NP O
60 RCA NNP I-NP O
60 stent VBD B-VP O
61 3/6 CD O O
61 DM NNP B-NP O
61 ( ( O O
61 diet-controlled JJ O O
61 ) ) O O
61 chronic JJ B-NP O
61 renal JJ I-NP O
61 insufficiency NN I-NP O
61 ( ( O O
61 chronic JJ B-NP O
61 renal JJ I-NP O
62 dysfunction NN I-NP O
62 ) ) O O
63 OPERATIONS NNP B-NP O
63 AND NNP I-NP O
63 PROCEDURES: NNP I-NP O
64 None NNP I-NP O
65 OTHER NNP I-NP O
65 TREATMENTS/PROCEDURES NNP I-NP O
65 ( ( O O
65 NOT NNP B-NP O
65 IN NNP I-NP O
65 O.R NNP I-NP O
65 ) ) O O
66 stress NN B-NP O
66 test NN I-NP O
67 BRIEF NNP I-NP O
67 RESUME NNP I-NP O
67 OF NNP I-NP O
67 HOSPITAL NNP I-NP O
67 COURSE: NNP I-NP O
68 ***CC: NNP I-NP O
68 Chest NNP I-NP O
68 pain NN I-NP O
69 ***HPI: VBD B-VP O
69 52M CD O O
69 pastor NN B-NP O
69 h/o NN I-NP O
69 NIDDM NNP I-NP O
69 , , O O
69 HTN NNP B-NP O
69 , , O O
69 hypercholesterolemia NN B-NP O
69 , , O O
69 and CC O O
69 known VBN O O
70 3-vessel JJ B-NP O
70 CAD NNP I-NP O
70 s/p NN I-NP O
70 NSTEMI NNP I-NP O
70 ( ( O O
70 2002 CD O O
70 ) ) O O
70 w/ NN B-NP O
70 failed VBD B-VP O
70 angioplasty JJ O O
70 to TO O O
70 Marg1 NNP B-NP O
70 occlusion NN I-NP O
70 , , O O
71 CYPHER NNP B-NP O
71 stent NN I-NP O
71 to TO O O
71 RCA NNP B-NP O
71 ( ( O O
71 2003 CD O O
71 ) ) O O
71 , , O O
71 recurrent JJ B-NP O
71 unstable JJ I-NP O
71 angina NN I-NP O
71 w/ NN I-NP O
71 last JJ B-NP O
71 cath NN I-NP O
71 ( ( O O
71 0/0 CD O O
71 ) ) O O
72 w/ NN B-NP O
72 diffuse NN I-NP O
72 CAD NNP I-NP O
72 precluding VBG O O
72 CABG/PTCA NNP B-NP O
72 but CC O O
72 w/ JJ B-NP O
72 patent NN I-NP O
72 RCA NNP I-NP O
72 stent NN I-NP O
72 , , O O
72 last JJ B-NP O
73 perfusion NN I-NP O
73 stress NN I-NP O
73 ( ( O O
73 0/0 CD O O
73 ) ) O O
73 w/ NN B-NP O
73 moderate JJ B-NP O
73 rev NN I-NP O
73 ischemia NN I-NP O
73 in IN B-VP O
73 Diag/PDA NNP B-NP O
73 territories NNS I-NP O
73 , , O O
74 ETT NNP B-NP O
74 ( ( O O
74 6/10 CD O O
74 ) ) O O
74 w/ NN B-NP O
74 CP NNP I-NP O
74 and CC O O
74 ST NNP B-NP O
74 depression NN I-NP O
74 in IN B-VP O
74 inferolateral JJ B-NP O
74 leads NNS I-NP O
74 , , O O
74 last JJ B-NP O
74 Echo NNP I-NP O
75 ( ( O O
75 0/0 CD O O
75 ) ) O O
75 w/ NN B-NP O
75 EF NNP I-NP O
75 55-60% JJ O O
75 no DT B-NP O
75 WMA NNP I-NP O
75 , , O O
75 physically RB O O
75 active JJ O O
75 at IN B-VP O
75 baseline NN B-NP O
75 p/w NN I-NP O
75 CP NNP I-NP O
75 At IN B-VP O
76 8:45am CD O O
76 pt NN B-NP O
76 first RB O O
76 noticed VBD B-VP O
76 left-sided JJ B-NP O
76 substernal JJ I-NP O
76 pain/pressure NN I-NP O
76 after IN B-VP O
77 breakfast NN B-NP O
77 and CC O O
77 coffee NN B-NP O
77 while IN B-VP O
77 walking VBG O O
77 to TO O O
77 living VBG O O
77 room NN B-NP O
77 , , O O
77 well-circumscribed JJ O O
77 , , O O
78 4/10 CD O O
78 intensity NN B-NP O
78 , , O O
78 constant JJ O O
78 , , O O
78 w/o JJ B-NP O
78 radiation NN I-NP O
78 to TO O O
78 jaw/arm/back NN B-NP O
78 , , O O
78 worse JJR O O
78 on IN B-VP O
78 deep JJ B-NP O
79 inspiration NN I-NP O
79 , , O O
79 w/ NN B-NP O
79 associated VBN O O
79 nausea NN B-NP O
79 and CC O O
79 dizziness NN B-NP O
79 Pt NNP I-NP O
79 sat VBD B-VP O
79 down RP O O
79 w/ NN B-NP O
79 pain NN I-NP O
80 2/10 CD O O
80 , , O O
80 administered VBN O O
80 nitro JJ B-NP B-m
80 spray NN I-NP I-m
80 x2 NNP I-NP B-f
80 w/o NN I-NP O
80 relief NN I-NP O
80 , , O O
80 wife NN B-NP O
80 measured VBD B-VP O
80 BP NNP B-NP O
80 158/90s CD O O
81 ( ( O O
81 usu JJ O O
81 140/85 CD O O
81 ) ) O O
81 No DT B-NP O
81 other JJ I-NP O
81 sx NN I-NP O
81 , , O O
81 but CC O O
81 pt VBP O O
81 describes NNS B-NP O
81 pain VBP O O
81 as IN B-VP O
81 similar JJ O O
81 but CC O O
81 less RBR O O
82 intense JJ O O
82 than IN B-VP O
82 that DT O O
82 experienced VBD B-VP O
82 in IN B-VP O
82 2002 CD O O
82 MI NNP B-NP O
82 Denies NNP I-NP O
82 h/o VBZ O O
82 CP NNP B-NP O
82 since IN B-VP O
82 then RB O O
83 despite IN B-VP O
83 recently RB O O
83 active JJ B-NP O
83 baseline NN I-NP O
83 ( ( O O
83 yesterday NN B-NP O
83 washing VBG O O
83 windows/ JJ O O
83 climbing VBG O O
84 ladders NNS B-NP O
84 , , O O
84 over IN B-VP O
84 last JJ B-NP O
84 months NNS I-NP O
84 doing VBG O O
84 cement JJ B-NP O
84 work NN I-NP O
84 in IN B-VP O
84 church NN B-NP O
84 ) ) O O
84 , , O O
84 but CC O O
84 notes NNS B-NP O
84 DOE NNP I-NP O
85 with IN B-VP O
85 walking VBG O O
85 2 CD O O
85 blocks NNS B-NP O
85 uphill JJ B-NP O
85 Pt NNP I-NP O
85 reports NNS I-NP O
85 frequent VBD B-VP O
85 prophylactic JJ B-NP O
85 use NN I-NP O
85 of IN B-VP O
86 nifedipine JJ B-NP B-m
86 sprays NNS I-NP I-m
86 immediately RB O O
86 prior RB O O
86 to TO O O
86 exertion/activity.On VB O O
86 6/1/06 CD O O
86 , , O O
86 pt NN B-NP O
87 was VBD B-VP O
87 evaluated VBN O O
87 for IN B-VP O
87 CABG NNP B-NP O
87 by IN B-VP O
87 surgeon NN B-NP O
87 Dr NNP I-NP O
87 Ashley NNP I-NP O
87 Starcher NNP I-NP O
87 , , O O
87 who WP O O
87 noted VBD B-VP O
87 possible JJ B-NP O
88 candidacy NN I-NP O
88 for IN B-VP O
88 combined VBN O O
88 CABG/TMLR NNP B-NP O
88 since IN B-VP O
88 diagonal JJ O O
88 likely JJ O O
88 too RB O O
88 small JJ O O
88 to TO O O
89 bypass VB O O
89 Since IN B-VP O
89 pt NN B-NP O
89 was VBD B-VP O
89 asymptomatic JJ B-NP O
89 w/ NN I-NP O
89 nlm NN I-NP O
89 LVEF NNP I-NP O
89 , , O O
89 he PRP O O
89 has VBZ O O
89 remained VBN O O
89 on IN B-VP O
89 medical JJ B-NP O
90 therapy NN I-NP O
90 Last JJ B-NP O
90 visit NN I-NP O
90 to TO O O
90 PCP NNP B-NP O
90 Dr NNP I-NP O
90 Rob NNP I-NP O
90 Holzinger NNP I-NP O
90 at IN B-VP O
90 Thbull NNP B-NP O
90 Carmonte NNP I-NP O
90 Medical NNP I-NP O
90 Center NNP I-NP O
91 on IN B-VP O
91 11/29/06 CD O O
91 was VBD B-VP O
91 routine JJ O O
91 , , O O
91 and CC O O
91 he PRP O O
91 is VBZ O O
91 followed VBN O O
91 by IN B-VP O
91 cardiologist NN B-NP O
91 Dr NNP I-NP O
91 Heath NNP I-NP O
91 Koerner NNP I-NP O
92 ****ED NNP I-NP O
92 Course: NNP I-NP O
92 CP NNP I-NP O
92 spontaneously RB O O
92 resolved VBD B-VP O
92 ( ( O O
92 total JJ B-NP O
92 duration NN I-NP O
92 1hr CD O O
92 ) ) O O
92 prior RB O O
92 to TO O O
93 arrival VB O O
93 by IN B-VP O
93 car NN B-NP O
93 at IN B-VP O
93 BMC NNP B-NP O
93 ED NNP I-NP O
93 where WRB O O
93 VS NNP B-NP O
93 Afebrile NNP I-NP O
93 HR118 NNP I-NP O
93 BP NNP I-NP O
93 150/68 CD O O
93 RR18 NNP B-NP O
94 98%RA CD O O
94 Received NNP B-NP O
94 lopressor NN I-NP B-m
94 5mg CD O B-do
94 IV NNP B-NP B-mo
94 x1` NNP I-NP B-du
94 HR NNP I-NP O
94 80s CD O O
94 , , O O
94 ASA NNP B-NP B-m
94 ECG NNP I-NP O
94 showed VBD B-VP O
94 NSR@95bpm NNP B-NP O
94 w/ NN I-NP O
95 ST NNP I-NP O
95 depression NN I-NP O
95 and CC O O
95 T NNP B-NP O
95 wave VBP O O
95 flattening VBG O O
95 in IN B-VP O
95 2 CD O O
95 , , O O
95 3 CD O O
95 , , O O
95 V5 NNP B-NP O
95 , , O O
95 V6 NNP B-NP O
95 different JJ O O
95 from IN B-VP O
95 prior JJ B-NP O
95 ECG NNP I-NP O
96 10/0/06 CD O O
96 , , O O
96 high JJ B-NP O
96 voltage NN I-NP O
96 and CC O O
96 LVH NNP B-NP O
96 also RB O O
96 present VBD B-VP O
96 Received NNP B-NP O
96 heparin NN I-NP B-m
96 heparin VBD B-VP B-m
96 5000U CD O B-do
96 bolus NN B-NP B-mo
97 x1 NN I-NP B-f
97 and CC O O
97 1500U/hr CD O B-do
97 infusion NN B-NP B-mo
97 Labs: NNP I-NP O
97 CK NNP I-NP O
97 647 CD O O
97 ( ( O O
97 h/o NN B-NP O
97 chronically RB O O
97 elev JJ B-NP O
97 CKs NNP I-NP O
98 400-1300s NN I-NP O
98 ) ) O O
98 , , O O
98 CK-MB JJ O O
98 3.8 CD O O
98 , , O O
98 TnI NNP B-NP O
98 &lt;0.10 NNP I-NP O
98 , , O O
98 WBC NNP B-NP O
98 6.41 CD O O
98 , , O O
98 Hct NNP B-NP O
98 44.2 CD O O
98 , , O O
98 Plt NNP B-NP O
98 228 CD O O
98 , , O O
98 Cre NNP B-NP O
98 1.3 CD O O
98 , , O O
99 PTT NNP B-NP O
99 33.6 CD O O
100 ****ROS: NNP B-NP O
100 Pt NNP I-NP O
100 notes NNS I-NP O
100 ( ( O O
100 intentional JJ O O
100 ) ) O O
100 20lb CD O O
100 weight JJ B-NP O
100 loss NN I-NP O
100 ( ( O O
100 215`195lb CD O O
100 ) ) O O
100 over IN B-VP O
100 last JJ B-NP O
101 month NN I-NP O
101 since IN B-VP O
101 starting VBG O O
101 metformin JJ B-NP B-m
101 Pertinent NNP I-NP O
101 negatives NNS I-NP O
101 include VBP O O
101 no DT B-NP O
101 systemic JJ I-NP O
102 complaints/ NN I-NP O
102 LOC/ NNP I-NP O
102 change NN I-NP O
102 in IN B-VP O
102 vision/ NN B-NP O
102 diaphoresis/ NN I-NP O
102 cough/ NN I-NP O
102 orthopnea/ NN I-NP O
102 edema/ NN I-NP O
103 leg NN I-NP O
103 pain NN I-NP O
103 or CC O O
103 claudication/ NN B-NP O
103 change NN I-NP O
103 in IN B-VP O
103 GU/GI NNP B-NP O
103 habits NNS I-NP O
104 ****PMH/PSH: NNP I-NP O
105 *CAD NNP I-NP O
105 ( ( O O
105 3-vessel JJ O O
105 as IN B-VP O
105 below IN B-VP O
105 ) ) O O
106 -s/p FW O O
106 NSTEMI NNP B-NP O
106 ( ( O O
106 2002 CD O O
106 ) ) O O
106 w/ FW O O
106 recurrent NN B-NP O
106 UA NNP I-NP O
107 -L NNP I-NP O
107 Cath NNP I-NP O
107 5/23 CD O O
107 "Diffuse NNP B-NP O
107 CAD NNP I-NP O
107 precludes VBZ O O
107 CABG/PTCA;" NNP B-NP O
107 RCA NNP I-NP O
107 stents NNS I-NP O
107 patent; VBP O O
108 Diag1 NNP B-NP O
108 ostial JJ O O
108 80% CD O O
108 , , O O
108 Diag2 NNP B-NP O
108 prox VBZ O O
108 80% CD O O
108 , , O O
108 LCx NNP B-NP O
108 prox VBZ O O
108 40% CD O O
108 , , O O
108 LCx NNP B-NP O
108 mid VBD B-VP O
108 50% CD O O
108 , , O O
108 Marg1 NNP B-NP O
108 ostial JJ O O
109 100% CD O O
109 ( ( O O
109 collat JJ B-NP O
109 LCx NNP I-NP O
109 ) ) O O
109 , , O O
109 Marg2 NNP B-NP O
109 ostial JJ O O
109 50% CD O O
109 , , O O
109 RCA NNP B-NP O
109 dist NN I-NP O
109 100% CD O O
109 ( ( O O
109 collat NN B-NP O
109 to TO O O
109 PDA NNP B-NP O
109 from IN B-VP O
110 RCA NNP B-NP O
110 intracoronary NN I-NP O
110 ) ) O O
110 , , O O
110 no DT B-NP O
110 sig NN I-NP O
110 LM/LAD NNP I-NP O
110 lesions NNS I-NP O
111 L NNP I-NP O
111 cath VBD B-VP O
111 1/11 CD O O
111 Failed NNP B-NP O
111 angioplasty JJ B-NP O
111 Marg1 NNP I-NP O
111 ostial JJ O O
111 100% CD O O
111 ( ( O O
111 inability NN B-NP O
111 to TO O O
112 cross VB O O
112 occlusion NN B-NP O
112 ) ) O O
112 , , O O
112 no DT B-NP O
112 sig NN I-NP O
112 LM/LCx/LAD/RCA NNP I-NP O
112 lesions NNS I-NP O
113 L NNP I-NP O
113 cath NN I-NP O
113 4/8 CD O O
113 Cypher NNP B-NP O
113 stent NN I-NP O
113 to TO O O
113 RCA; NNP B-NP O
113 RCA NNP I-NP O
113 distal JJ O O
113 100% CD O O
113 , , O O
113 RCA NNP B-NP O
113 prox VBZ O O
113 60% CD O O
113 , , O O
114 RCA NNP B-NP O
114 mid VBD B-VP O
114 85% CD O O
114 , , O O
114 RCA NNP B-NP O
114 mid VBD B-VP O
114 95% CD O O
114 , , O O
114 LCx NNP B-NP O
114 mid VBD B-VP O
114 35% CD O O
114 , , O O
114 Marg1 NNP B-NP O
114 ostial VBD B-VP O
114 100% CD O O
114 2/12 CD O O
115 Failed VBD B-VP O
115 angioplasty NN B-NP O
115 to TO O O
115 Marg1 NNP B-NP O
115 100%; CD O O
115 RCA NNP B-NP O
115 90% CD O O
115 , , O O
115 PDA NNP B-NP O
115 100% CD O O
116 - : O O
116 Stress: NN B-NP O
116 8/5 CD O O
116 ETT NNP B-NP O
116 , , O O
116 std NN B-NP O
116 Bruce NNP I-NP O
116 , , O O
116 6.0 CD O O
116 METS: NNP B-NP O
116 4/10 CD O O
116 CP NNP B-NP O
116 3min CD O O
116 , , O O
116 1mm CD O O
116 ST NNP B-NP O
116 dep NN I-NP O
117 in IN B-VP O
117 2 CD O O
117 , , O O
117 3 CD O O
117 , , O O
117 F NNP B-NP O
117 , , O O
117 V5-6 NNP B-NP O
117 , , O O
117 Duke NNP B-NP O
117 -7 NNP I-NP O
117 ( ( O O
117 mod NN B-NP O
117 ) ) O O
117 , , O O
117 HRR NNP B-NP O
117 13 CD O O
117 5/23 CD O O
117 Exercise NN B-NP O
117 MIBI NNP I-NP O
117 SPECT NNP I-NP O
117 , , O O
117 7.0 CD O O
118 METS: NNP B-NP O
118 CP NNP I-NP O
118 , , O O
118 1mm CD O O
118 ST NNP B-NP O
118 dep NN I-NP O
118 in IN B-VP O
118 2 CD O O
118 , , O O
118 3 CD O O
118 , , O O
118 F NNP B-NP O
118 , , O O
118 V5-6 NNP B-NP O
118 , , O O
118 65% CD O O
118 APHR NNP B-NP O
118 , , O O
118 rev NN B-NP O
118 ischemia NN I-NP O
118 in IN B-VP O
119 Diag NNP B-NP O
119 , , O O
119 PDA NNP B-NP O
119 territories NNS I-NP O
119 ( ( O O
119 sum VB O O
119 stress/diff NN B-NP O
119 7/7 CD O O
119 mild/mod NN B-NP O
119 ) ) O O
120 3/18 CD O O
120 Ex NNP B-NP O
120 MIBI NNP I-NP O
120 SPECT NNP I-NP O
120 , , O O
120 7.6 CD O O
120 METS NNP B-NP O
120 , , O O
120 CP NNP B-NP O
120 , , O O
120 no DT B-NP O
120 perf NN I-NP O
120 defect VBP O O
121 10/21 CD O O
121 Ex NNP B-NP O
121 MIBI NNP I-NP O
121 SPECT NNP I-NP O
121 , , O O
121 6.4 CD O O
121 METS NNP B-NP O
121 , , O O
121 CP NNP B-NP O
121 , , O O
121 rev NN B-NP O
121 isch NN I-NP O
121 LCx NNP I-NP O
121 territory NN I-NP O
121 , , O O
121 sum NN B-NP O
122 stress/diff NN I-NP O
122 7/5 CD O O
122 ) ) O O
123 8/11 CD O O
123 Ex NNP B-NP O
123 MIBI NNP I-NP O
123 SPECT NNP I-NP O
123 , , O O
123 7.6 CD O O
123 METS NNP B-NP O
123 , , O O
123 CP NNP B-NP O
123 , , O O
123 rev NN B-NP O
123 isch NN I-NP O
123 LCx NNP I-NP O
123 , , O O
123 PDA NNP B-NP O
123 territory NN I-NP O
124 scar NN I-NP O
124 , , O O
124 sum VB O O
124 stress/diff JJ O O
124 15/11 CD O O
124 ) ) O O
124 0/21 CD O O
124 Adeno NNP B-NP O
124 MIBI NNP I-NP O
124 SPECT NNP I-NP O
124 , , O O
124 no DT B-NP O
124 perf NN I-NP O
124 defect NN I-NP O
124 , , O O
125 sum JJ B-NP O
125 stress NN I-NP O
125 2 CD O O
126 11/17 CD O O
126 ETT NNP B-NP O
126 , , O O
126 std NN B-NP O
126 Bruce NNP I-NP O
126 56%APHR CD O O
126 , , O O
126 CP NNP B-NP O
126 4min CD O O
126 , , O O
126 1mm CD O O
126 ST NNP B-NP O
126 dep NN I-NP O
126 2 CD O O
126 , , O O
126 3 CD O O
126 , , O O
126 F NNP B-NP O
127 -Echo: VBZ O O
127 5/23 CD O O
127 LV NNP B-NP O
127 nlm JJ B-NP O
127 size NN I-NP O
127 , , O O
127 EF NNP B-NP O
127 55-60% CD O O
127 , , O O
127 no DT B-NP O
127 WMA NNP I-NP O
127 , , O O
127 thick JJ B-NP O
127 MV NNP I-NP O
127 , , O O
127 mild JJ B-NP O
128 RVE/RAE NNP I-NP O
128 , , O O
128 trace NN B-NP O
128 MR/PR NNP I-NP O
128 10/7 CD O O
128 ( ( O O
128 Stress NNP B-NP O
128 ): NNP I-NP O
128 EF NNP I-NP O
128 55-60% JJ O O
128 , , O O
128 nlm JJ B-NP O
128 ventricular JJ I-NP O
129 contractility NN I-NP O
129 2/12 CD O O
129 EF NNP B-NP O
129 55-60% CD O O
129 , , O O
129 mild FW O O
129 concentric JJ B-NP O
129 LV NNP I-NP O
129 hypertrophy NN I-NP O
129 , , O O
129 no DT B-NP O
130 WMA NNP I-NP O
130 , , O O
130 thick JJ B-NP O
130 MV NNP I-NP O
130 , , O O
130 trace NN B-NP O
130 MR/PR NNP I-NP O
131 -CT/A NNP I-NP O
131 Ch/Abd/Pel NNP I-NP O
131 ( ( O O
131 6/10 CD O O
131 ): NNP B-NP O
131 nlm JJ B-NP O
131 Ao NNP I-NP O
131 w/o NN I-NP O
131 dissection/aneurysm NN I-NP O
132 *NIDDM NNP I-NP O
132 ( ( O O
132 2005 CD O O
132 ) ) O O
132 , , O O
132 HgbA1c NNP B-NP O
132 7.1 CD O O
132 ` `` O O
132 Metformin RB O B-m
132 1mo CD O O
132 ago IN B-VP O
133 *Hypercholesterolemia NN B-NP O
133 ( ( O O
133 &lt;2000 CD O O
133 ) ) O O
133 -h/o FW O O
133 elev NN B-NP O
133 CKs NNP I-NP O
133 ( ( O O
133 400-1300s JJ O O
133 on IN B-VP O
133 gemfibrozil NN B-NP B-m
133 , , O O
134 statins NNS B-NP B-m
134 ) ) O O
135 *HTN VBP O O
135 ( ( O O
135 1996 CD O O
135 ) ) O O
136 *chronic JJ B-NP O
136 renal JJ I-NP O
136 insufficiency NN I-NP O
136 , , O O
136 bl JJ B-NP O
136 Cre NNP I-NP O
136 1.2 CD O O
137 refused VBD B-VP O
137 renal JJ B-NP O
137 MRA NNP I-NP O
137 11/11 CD O O
138 *Carotid NN B-NP O
138 stenoses NNS I-NP O
138 ( ( O O
138 2006 CD O O
138 ) ) O O
138 , , O O
138 R NNP B-NP O
138 ICA NNP I-NP O
138 55-60% JJ O O
138 , , O O
138 L NNP B-NP O
138 ICA NNP I-NP O
138 &gt;50% NNP I-NP O
138 asx NN I-NP O
139 *Erectile NNP I-NP O
139 dysfunction NN I-NP O
139 s/p NN I-NP O
139 penile JJ B-NP O
139 prosthesis NN I-NP O
139 placement NN I-NP O
140 ****MEDS NNP I-NP O
140 ( ( O O
140 pre- JJ B-NP O
140 admission NN I-NP O
140 ): NNP I-NP O
140 ASA NNP I-NP B-m
140 81mg CD O B-do
140 PO NNP B-NP B-mo
140 qdayAtenolol VBD B-VP B-f
140 100mg CD O O
140 PO NNP B-NP O
141 BIDLisinopril NNP I-NP O
141 80mg CD O O
141 PO NNP B-NP O
141 qdayImdur NN I-NP O
141 ER NNP I-NP B-m
141 ( ( O I-m
141 isosorbide NN B-NP I-m
141 ) ) O I-m
141 120mg CD O B-do
141 PO NNP B-NP B-mo
141 qdayLipitor NN I-NP B-f
141 80mg CD O O
142 PO NNP B-NP O
142 qdayZetia NN I-NP O
142 ( ( O B-m
142 ezetimibe NN B-NP I-m
142 ) ) O I-m
142 10mg CD O B-do
142 PO NNP B-NP B-mo
142 qdayHCTZ VBD B-VP B-f
142 50mg CD O O
142 PO NNP B-NP O
142 qdayMetformin VBD B-VP O
142 500mg CD O O
142 PO NNP B-NP O
143 qdayNifedipine NN I-NP O
143 ER NNP I-NP B-m
143 90mg CD O B-do
143 PO NNP B-NP B-mo
143 qdayNitroglycerin VBD B-VP B-f
143 0.4MG/SPRAY CD O O
143 PO NNP B-NP O
143 x1 NNP I-NP O
143 PRN NNP I-NP O
143 chest JJS B-NP O
144 pain NN I-NP O
145 ****ALLERGIES: JJ B-NP O
145 Gemfibrozil NNP I-NP O
145 ` `` O O
145 elev RB O O
145 CK NNP B-NP O
145 ( ( O O
145 400-1300s JJ O O
145 ) ) O O
146 ****SH: NN B-NP O
146 Denies NNPS I-NP O
146 h/o VBZ O O
146 tob/EtOH/drugs NNS B-NP O
146 Pt NNP I-NP O
146 lives VBZ O O
146 in IN B-VP O
146 Orlwoodank NNP B-NP O
146 w/ JJ B-NP O
146 wife NN I-NP O
146 of IN B-VP O
146 30yrs CD O O
146 , , O O
147 3 CD O O
147 grown JJ B-NP O
147 children NNS I-NP O
147 , , O O
147 5 CD O O
147 grandchildren NNS B-NP O
147 all DT B-NP O
147 healthy JJ I-NP O
147 Pastor NNP I-NP O
147 at IN B-VP O
147 Leighfay NNP B-NP O
147 Che NNP I-NP O
147 O NNP I-NP O
147 Broke NNP I-NP O
147 Lo NNP I-NP O
147 x30yrs NNP I-NP O
148 ****FH: NNP I-NP O
148 Significant NNP I-NP O
148 h/o NN I-NP O
148 DM NNP I-NP O
148 , , O O
148 HTN NNP B-NP O
148 Father NNP I-NP O
148 91yo CD O O
148 h/o NN B-NP O
148 MI NNP I-NP O
148 ( ( O O
148 62yo CD O O
148 ) ) O O
148 , , O O
148 CVA NNP B-NP O
148 ( ( O O
148 76yo CD O O
148 ) ) O O
148 , , O O
149 HTN NNP B-NP O
149 , , O O
149 DM NNP B-NP O
149 Mother NNP I-NP O
149 80yo CD O O
149 h/o NN B-NP O
149 HTN NNP I-NP O
149 , , O O
149 DM NNP B-NP O
149 , , O O
149 identical JJ B-NP O
149 twin NN I-NP O
149 h/o NN I-NP O
149 HTN NNP I-NP O
149 , , O O
149 DM NNP B-NP O
149 Denies NNP I-NP O
149 h/o NN I-NP O
150 cancer NN I-NP O
151 ****PHYSICAL NNP I-NP O
151 EXAM:VS: NNP I-NP O
151 T NNP I-NP O
151 98 CD O O
151 HR NNP B-NP O
151 63 CD O O
151 reg NN B-NP O
151 BP NNP I-NP O
151 126/67 CD O O
151 RR NNP B-NP O
151 18 CD O O
151 O2Sat NNP B-NP O
151 98% CD O O
152 RAGen: NNP B-NP O
152 black JJ B-NP O
152 male NN I-NP O
152 in IN B-VP O
152 NAD NNP B-NP O
152 , , O O
152 lying VBG O O
152 in IN B-VP O
152 bed NN B-NP O
152 , , O O
152 pleasantHEENT: NN B-NP O
152 PEERLA NNP I-NP O
152 , , O O
152 MMM NNP B-NP O
152 , , O O
153 oropharynx JJ B-NP O
153 clearCV: NN I-NP O
153 nlm NN I-NP O
153 S1 NNP I-NP O
153 , , O O
153 S2 NNP B-NP O
153 , , O O
153 no DT B-NP O
153 murmur NN I-NP O
153 JVP NNP I-NP O
153 ~8cm NNP I-NP O
153 , , O O
153 No NNP B-NP O
153 obvious JJ B-NP O
154 carotid NN I-NP O
154 bruits NNS I-NP O
154 bilat VBP O O
154 , , O O
154 symmetric JJ B-NP O
154 No NNP I-NP O
154 bruit NN I-NP O
154 at IN B-VP O
154 fem JJ B-NP O
154 groove NN I-NP O
154 bilat NN I-NP O
154 , , O O
154 DP NNP B-NP O
154 2+ CD O O
155 bilatResp: NN B-NP O
155 mild NN I-NP O
155 bibasilar JJ B-NP O
155 crackles NNS I-NP O
155 , , O O
155 no DT B-NP O
155 wheeze NN I-NP O
155 , , O O
155 no DT B-NP O
155 accessory JJ I-NP O
155 muscle NN I-NP O
156 useAbd: JJ B-NP O
156 Soft NNP I-NP O
156 , , O O
156 NT NNP B-NP O
156 , , O O
156 obeseSkin FW O O
156 &amp; FW O O
156 Ext: NNP B-NP O
156 WWP NNP I-NP O
156 , , O O
156 no DT B-NP O
156 edema NN I-NP O
156 , , O O
156 nails NNS B-NP O
156 unremarkable JJ O O
157 ( ( O O
157 remnant JJ B-NP O
157 red JJ I-NP O
157 paint NN I-NP O
157 )Neuro: NNP I-NP O
157 A&amp;Ox3 NNP I-NP O
157 , , O O
157 CN NNP B-NP O
157 II-XII NNP I-NP O
157 grossly RB O O
157 intact JJ B-NP O
158 ****ADMISSION NNP I-NP O
158 LABS: NNP I-NP O
158 WBC NNP I-NP O
158 6.4 CD O O
158 , , O O
158 hct NN B-NP O
158 44 CD O O
158 , , O O
158 Cr NNP B-NP O
158 1.3 CD O O
158 , , O O
158 enz FW O O
158 neg FW O O
158 , , O O
158 ddimer VBZ O O
158 530s CD O O
159 ****ADMISSION NN B-NP O
159 EKG NNP I-NP O
159 ( ( O O
159 8/10 CD O O
159 ): NNP B-NP O
159 NSR@95bpm NNP I-NP O
159 w/ VBD B-VP O
159 ST NNP B-NP O
159 depression NN I-NP O
159 and CC O O
159 T NNP B-NP O
159 wave VBP O O
160 flattening VBG O O
160 in IN B-VP O
160 2 CD O O
160 , , O O
160 3 CD O O
160 , , O O
160 V5 NNP B-NP O
160 , , O O
160 V6 NNP B-NP O
160 different JJ O O
160 from IN B-VP O
160 prior JJ B-NP O
160 ECG NNP I-NP O
160 10/0/06 CD O O
160 , , O O
160 high JJ B-NP O
160 voltage NN I-NP O
161 and CC O O
161 LVH NNP B-NP O
161 also RB O O
161 present.Radiology: VBZ O O
162 ****ADMISSION JJ B-NP O
162 CXR NNP I-NP O
162 ( ( O O
162 8/10 CD O O
162 ): NNP B-NP O
162 nlm JJ B-NP O
162 heart NN I-NP O
162 , , O O
162 clear JJ B-NP O
162 lungs NNS I-NP O
162 , , O O
162 no DT B-NP O
163 PTX/edemaMicrobiology:UA NNP I-NP O
163 , , O O
163 USed NNP B-NP O
163 ( ( O O
163 8/10 CD O O
163 ): NNP B-NP O
163 WNL NNP I-NP O
164 ****STUDIES: NNP I-NP O
165 -ETT NNP I-NP O
165 MIBI: NNP I-NP O
165 abnormal JJ O O
165 imaging VBG O O
165 - : O O
165 preliminary JJ B-NP O
165 results NNS I-NP O
165 showed VBD B-VP O
165 that IN B-VP O
165 he PRP O O
165 stopped VBD B-VP O
166 after IN B-VP O
166 5 CD O O
166 minutes NNS B-NP O
166 due JJ O O
166 to TO O O
166 chest VB O O
166 pain NN B-NP O
166 , , O O
166 1mm CD O O
166 ST NNP B-NP O
166 depressions NNS I-NP O
166 in IN B-VP O
166 inferior JJ O O
166 and CC O O
167 lateral JJ B-NP O
167 leads NNS I-NP O
167 , , O O
167 and CC O O
167 mild JJ B-NP O
167 ischemia NN I-NP O
167 in IN B-VP O
167 Diag1 NNP B-NP O
167 territory NN I-NP O
167 which WDT O O
167 raises VBZ O O
167 concern NN B-NP O
168 for IN B-VP O
168 balanced VBN O O
168 ischemia NN B-NP O
169 ****ASSESSMENT NN I-NP O
169 and CC O O
169 PLAN: NNP B-NP O
170 52M CD O O
170 pastor NN B-NP O
170 w/ NN I-NP O
170 unstable JJ B-NP O
170 angina NN I-NP O
170 in IN B-VP O
170 setting NN B-NP O
170 of IN B-VP O
170 known VBN O O
170 3-vessel JJ B-NP O
170 CAD NNP I-NP O
170 s/p NN I-NP O
170 stent NN I-NP O
171 to TO O O
171 RCA NNP B-NP O
171 '03 NNP I-NP O
171 last JJ B-NP O
171 cath NN I-NP O
171 3 CD O O
171 of IN B-VP O
171 May NNP B-NP O
171 w/ NN I-NP O
171 diffuse NN I-NP O
171 CAD NNP I-NP O
171 precluding NN I-NP O
171 CABG/PTCA NNP I-NP O
171 , , O O
171 medically RB O O
172 managed VBN O O
172 and CC O O
172 asymptomatic JJ O O
172 until IN B-VP O
172 present JJ B-NP O
172 Vitals NNS I-NP O
172 stable JJ O O
172 , , O O
172 enzymes RB O O
172 negative JJ O O
172 , , O O
173 stress JJ B-NP O
173 test NN I-NP O
173 with IN B-VP O
173 abnormal JJ B-NP O
173 perfusion NN I-NP O
174 CV NNP I-NP O
174 *ischemia* NNP I-NP O
174 Known NNP I-NP O
174 3vd CD O O
174 s/p NN B-NP O
174 stent NN I-NP O
174 Rest NNP I-NP O
174 chest NN I-NP O
174 pain NN I-NP O
174 NSSTT NNP I-NP O
175 inferolaterally RB O O
175 , , O O
175 Negative NNP B-NP O
175 enzymes VBZ O O
175 Stress NNP B-NP O
175 test NN I-NP O
175 prelim NN I-NP O
175 read NN I-NP O
175 shows VBZ O O
176 abnormal JJ B-NP O
176 perfusion: NN I-NP O
176 stopped VBD B-VP O
176 after IN B-VP O
176 5 CD O O
176 minutes NNS B-NP O
176 due JJ O O
176 to TO O O
176 chest VB O O
176 pain NN B-NP O
176 , , O O
176 1mm CD O O
176 ST NNP B-NP O
177 depressions NNS I-NP O
177 in IN B-VP O
177 inferior JJ O O
177 and CC O O
177 lateral JJ B-NP O
177 leads NNS I-NP O
177 , , O O
177 mild JJ O O
177 ischemic JJ O O
177 in IN B-VP O
177 Diag1 NNP B-NP O
178 territory NN I-NP O
178 which WDT O O
178 is VBZ O O
178 concerning VBG O O
178 for IN B-VP O
178 "balanced NNP B-NP O
178 ischemia" NN I-NP O
178 rather RB O O
178 than IN B-VP O
178 an DT B-NP O
179 improvement NN I-NP O
179 compared VBN O O
179 to TO O O
179 previous JJ B-NP O
179 nuclear JJ I-NP O
179 imaging NN I-NP O
179 in IN B-VP O
179 0/12 CD O O
179 Inpatient NNP B-NP O
179 cardiac JJ B-NP O
180 cathterization NN I-NP O
180 advised VBN O O
180 by IN B-VP O
180 medical JJ B-NP O
181 team NN I-NP O
181 but CC O O
181 refused VBN O O
181 by IN B-VP O
181 pt NN B-NP O
181 Pt NNP I-NP O
181 opts VBZ O O
181 to TO O O
181 be VB O O
181 discharged VBN O O
181 and CC O O
181 follow VB O O
181 up RP O O
181 for IN B-VP O
182 elective JJ B-NP O
182 cardiac JJ I-NP O
182 catheterization NN I-NP O
182 on IN B-VP O
182 Tue NNP B-NP O
182 4/10 CD O O
182 The DT B-NP O
182 risks NNS I-NP O
182 of IN B-VP O
182 this DT B-NP O
182 plan NN I-NP O
182 were VBD B-VP O
183 discussed VBN O O
183 with IN B-VP O
183 him PRP O O
183 by IN B-VP O
183 his PRP$ O O
183 outpatient JJ B-NP O
183 cardiologist NN I-NP O
183 , , O O
183 Dr NNP B-NP O
183 Marion NNP I-NP O
183 Brzostowski NNP I-NP O
184 While IN B-VP O
184 an DT B-NP O
184 inpatient NN I-NP O
184 , , O O
184 patient NN B-NP O
184 was VBD B-VP O
184 medically RB O O
184 managed VBN O O
184 w/ NN B-NP O
184 ASA NNP I-NP B-m
184 , , O O
184 hep NN B-NP B-m
184 gtt NN I-NP I-m
184 , , O O
184 statin NN B-NP B-m
184 , , O O
185 bb NN B-NP B-m
185 , , O O
185 acei JJ B-NP B-m
185 Lipid NNP I-NP O
185 panel NN I-NP O
185 checked VBD B-VP O
185 with IN B-VP O
185 TC NNP B-NP O
185 101 CD O O
185 , , O O
185 tri NN B-NP O
185 89 CD O O
185 , , O O
185 HDL NNP B-NP O
185 41 CD O O
185 , , O O
185 LDL NNP B-NP O
185 31 CD O O
185 Statin NNP B-NP B-m
186 dose NN I-NP O
186 lowered VBD B-VP O
186 for IN B-VP O
186 persistently RB O O
186 high JJ B-NP O
186 CK NNP I-NP O
186 Acei NNP I-NP B-m
186 dose RB O O
186 lowered VBD B-VP O
186 as IN B-VP O
186 marginal JJ B-NP O
186 BP NNP I-NP O
187 effect NN I-NP O
187 above IN B-VP O
187 ULN NNP B-NP O
187 dose VBP O O
187 Heparin NNP B-NP B-m
187 gtt NN I-NP I-m
187 was VBD B-VP O
187 discontinued VBN O O
187 prior RB O O
187 to TO O O
187 discharge VB O O
188 On IN B-VP O
188 discharge NN B-NP O
188 , , O O
188 pt RB O O
188 instructed VBN O O
188 to TO O O
188 take VB O O
188 ASA NNP B-NP B-m
188 , , O O
188 bb NN B-NP B-m
188 , , O O
188 acei NN B-NP B-m
188 , , O O
188 imdur NN B-NP B-m
188 , , O O
188 lipitor NN B-NP B-m
188 , , O O
188 zetia NN B-NP B-m
189 He PRP O O
189 was VBD B-VP O
189 advised VBN O O
189 to TO O O
189 discontinue VB O O
189 metformin NN B-NP B-m
189 for IN B-VP B-du
189 2 CD O O
189 days NNS B-NP O
189 before IN B-VP O
189 and CC O O
189 2 CD O O
189 days NNS B-NP O
190 after IN B-VP O
190 cardiac JJ B-NP O
190 catheterization NN I-NP O
190 He PRP O O
190 was VBD B-VP O
190 advised VBN O O
190 to TO O O
190 be VB O O
190 minimally RB O O
190 active JJ O O
191 and CC O O
191 to TO O O
191 call VB O O
191 his PRP$ O O
191 physician NN B-NP O
191 or CC O O
191 911 CD O O
191 if IN B-VP O
191 he PRP O O
191 experienced VBD B-VP O
191 any DT B-NP O
191 further JJ I-NP O
191 chest NN I-NP O
191 pain NN I-NP O
191 , , O O
192 shortness NN B-NP O
192 of IN B-VP O
192 breath NN B-NP O
192 , , O O
192 palpitations NNS B-NP O
192 , , O O
192 lightheadedness NN B-NP O
192 or CC O O
192 any DT B-NP O
192 other JJ I-NP O
192 symptoms NNS I-NP O
192 c VBP O O
193 concerning VBG O O
193 to TO O O
193 him PRP O O
194 *pump* VB O O
194 Appears NNP B-NP O
194 euvolemic JJ B-NP O
194 Nl NNP I-NP O
194 EF NNP I-NP O
194 HTN NNP I-NP B-r
194 HTN NNP I-NP B-r
194 controlled VBD B-VP O
194 as IN B-VP O
194 above IN B-VP O
194 with IN B-VP O
194 bb NN B-NP B-m
194 , , O O
194 acei JJ B-NP B-m
195 *rhythm* NNP I-NP O
195 Sinus NNP I-NP O
195 rhythm NN I-NP O
195 Pt NNP I-NP O
195 continued VBD B-VP O
195 on IN B-VP O
195 home NN B-NP O
195 atenolol NN I-NP B-m
196 RENAL: NNP I-NP O
196 *CRI* NNP I-NP O
196 Possibly RB O O
196 related VBD B-VP O
196 to TO O O
196 HTN/DM NNP B-NP O
196 Pt NNP I-NP O
196 w/ VBD B-VP O
196 Cr NNP B-NP O
196 1.3 CD O O
196 , , O O
196 within IN B-VP O
196 baseline NN B-NP O
197 ENDO: NNP I-NP O
197 *DM* NNP I-NP O
197 Metformin NNP I-NP B-m
197 held VBD B-VP O
197 Pt NNP B-NP O
197 rx'ed NN I-NP O
197 w/ NN I-NP O
197 SSI NNP I-NP B-m
197 HgA1c NNP I-NP O
197 checked VBD B-VP O
197 and CC O O
197 pending VBG O O
198 TSH NNP B-NP O
198 also RB O O
198 checked VBD B-VP O
198 and CC O O
198 pending VBG O O
199 PROPH: NNP B-NP O
199 nexium/heparin JJ B-NP B-m
199 gtt NN I-NP B-mo
200 CODE: NNP I-NP O
200 FULL NNP I-NP O
201 DISPOSITION: NNP I-NP O
201 Pt NNP I-NP O
201 discharged VBD B-VP O
201 to TO O O
201 home VB O O
201 with IN B-VP O
201 plans NNS B-NP O
201 for IN B-VP O
201 elective JJ B-NP O
201 outpatient NN I-NP O
202 cardiac JJ B-NP O
202 cathterization NN I-NP O
202 , , O O
202 cardiology NN B-NP O
202 , , O O
202 PCP NNP B-NP O
202 f/u VBP O O
203 DISCHARGE NNP B-NP O
203 STATUS: NNP I-NP O
203 afebrile IN B-VP O
203 P NNP B-NP O
203 50s-90s JJ B-NP O
203 SBP NNP I-NP O
203 120s/70s CD O O
203 sat VBD B-VP O
203 RA NNP B-NP O
204 Exam NNP I-NP O
204 w/o NN I-NP O
204 significant JJ B-NP O
204 change NN I-NP O
204 from IN B-VP O
204 admission NN B-NP O
204 Labs NNP I-NP O
204 w/ VBD B-VP O
204 Hct NNP B-NP O
204 40.2 CD O O
204 , , O O
204 Cr NNP B-NP O
204 1.2 CD O O
205 ADDITIONAL NNP B-NP O
205 COMMENTS: NNP I-NP O
205 You PRP O O
205 were VBD B-VP O
205 admitted VBN O O
205 with IN B-VP O
205 chest JJ B-NP O
205 pain NN I-NP O
205 Your PRP$ O O
205 blood NN B-NP O
205 tests NNS I-NP O
205 show VBP O O
205 that IN B-VP O
205 you PRP O O
205 did VBD B-VP O
205 not RB O O
206 have VB O O
206 a DT B-NP O
206 heart NN I-NP O
206 attack NN I-NP O
206 You PRP O O
206 had VBD B-VP O
206 a DT B-NP O
206 stress NN I-NP O
206 test NN I-NP O
206 which WDT O O
206 is VBZ O O
206 concerning VBG O O
206 for IN B-VP O
206 regions NNS B-NP O
207 of IN B-VP O
207 your PRP$ O O
207 heart NN B-NP O
207 not RB O O
207 receiving VBG O O
207 enough RB O O
207 blood NN B-NP O
207 flow VB O O
207 The DT B-NP O
207 medical JJ I-NP O
207 team NN I-NP O
208 advised VBD B-VP O
208 cardiac JJ B-NP O
208 catheterization NN I-NP O
208 during IN B-VP O
208 this DT B-NP O
208 admission NN I-NP O
208 , , O O
208 but CC O O
208 your PRP$ O O
208 plan NN B-NP O
208 is VBZ O O
208 to TO O O
209 go VB O O
209 home NN B-NP O
209 today NN I-NP O
209 and CC O O
209 return NN B-NP O
209 for IN B-VP O
209 an DT B-NP O
209 elective JJ I-NP O
209 outpatient NN I-NP O
209 cardiac JJ B-NP O
209 catherization NN I-NP O
210 on IN B-VP O
210 Tuesday NNP B-NP O
210 7/21 CD O O
210 at IN B-VP O
210 7:30am CD O O
210 Please NNP B-NP O
210 go VB O O
210 to TO O O
210 the DT B-NP O
210 Admitting NNP I-NP O
210 Office NNP I-NP O
210 on IN B-VP O
210 the DT B-NP O
210 Ins NNP I-NP O
210 to TO O O
210 register VB O O
210 Do NNP B-NP O
210 not RB O O
210 eat VB O O
210 anything NN B-NP O
210 after IN B-VP O
210 midnight NN B-NP O
210 Monday NNP I-NP O
211 night NN I-NP O
211 Do NNP I-NP O
211 not RB O O
211 eat VB O O
211 breakfast NN B-NP O
211 or CC O O
211 drink VB O O
211 liquids NNS B-NP O
211 after IN B-VP O
211 midnight NN B-NP O
211 Your PRP$ O B-m
212 medications NNS B-NP O
212 have VBP O O
212 been VBN O O
212 changed VBN O O
212 as IN B-VP O
212 follows: NN B-NP O
212 a DT O O
212 ) ) O O
212 stop NN B-NP O
213 taking VBG O O
213 metformin NN B-NP B-m
213 for IN B-VP B-du
213 2 CD O O
213 days NNS B-NP O
213 before IN B-VP O
213 and CC O O
213 2 CD O O
213 days NNS B-NP O
213 after IN B-VP O
213 your PRP$ O O
213 cardiac JJ B-NP O
214 catheterization NN I-NP O
214 b NN I-NP O
214 ) ) O O
214 take VB O O
214 lisinopril JJ B-NP B-m
214 lisinopril NN I-NP B-m
214 40 CD O B-do
214 mg JJ O I-do
214 daily JJ O B-f
214 instead RB O O
214 of IN B-VP O
214 80 CD O B-do
214 mg JJ B-NP I-do
214 daily JJ I-NP B-f
215 c NN I-NP O
215 ) ) O O
215 take VB O O
215 lipitor NN B-NP B-m
215 lipitor NN I-NP B-m
215 40 CD O B-do
215 mg JJ O I-do
215 daily JJ O B-f
215 instead RB O O
215 of IN B-VP O
215 80 CD O B-do
215 mg NNS B-NP I-do
215 daily RB O B-f
215 Do NNP B-NP O
215 not RB O O
215 do VB O O
215 any DT B-NP O
216 significant JJ I-NP O
216 exertion NN I-NP O
216 until IN B-VP O
216 your PRP$ O O
216 cardiac JJ B-NP O
216 catheterization NN I-NP O
216 Call VB O O
216 your PRP$ O O
216 doctor NN B-NP O
217 or CC O O
217 go VB O O
217 to TO O O
217 the DT B-NP O
217 ED NNP I-NP O
217 if IN B-VP O
217 you PRP O O
217 experience VBP O O
217 any DT B-NP O
217 further JJ I-NP O
217 chest NN I-NP O
217 pain NN I-NP O
217 , , O O
217 dizziness NN B-NP O
217 , , O O
218 palpitations NNS B-NP O
218 , , O O
218 shortness NN B-NP O
218 of IN B-VP O
218 breath NN B-NP O
218 , , O O
218 or CC O O
218 other JJ B-NP O
218 symptoms NNS I-NP O
218 concerning VBG O O
218 to TO O O
218 you PRP O O
219 DISCHARGE NNP B-NP O
219 CONDITION: NNP I-NP O
219 Fair NNP I-NP O
220 TO NNP I-NP O
220 DO/PLAN: NNP I-NP O
221 PCP/cards: NNP I-NP O
222 -f/u NNP I-NP O
222 official NN I-NP O
222 results NNS I-NP O
222 of IN B-VP O
222 stress JJ B-NP O
222 test NN I-NP O
223 -f/u NN I-NP O
223 results NNS I-NP O
223 of IN B-VP O
223 outpatient JJ B-NP O
223 cardiac JJ I-NP O
223 catheterization NN I-NP O
224 ( ( O O
224 prehydration/mucomyst IN B-VP O
224 peri-cath NN B-NP O
224 ) ) O O
225 -f/u VBZ O O
225 results NNS B-NP O
225 of IN B-VP O
225 HgA1c NNP B-NP O
225 and CC O O
225 TSH NNP B-NP O
226 No NNP I-NP O
226 dictated VBD B-VP O
226 summary JJ B-NP O
227 ENTERED NNP I-NP O
227 BY: NNP I-NP O
227 WEYKER NNP I-NP O
227 , , O O
227 MARCUS NNP B-NP O
227 A NNP I-NP O
227 , , O O
227 M.D NNP B-NP O
227 ( ( O O
227 LI54 NNP B-NP O
227 ) ) O O
227 2/22/06 CD O O
227 @ $ O O
227 05 CD O O
228 ****** JJ B-NP O
228 END NN I-NP O
228 OF NNP I-NP O
228 DISCHARGE NNP I-NP O
228 ORDERS NNP I-NP O
228 ****** NNP I-NP O
229 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #214865 VBZ O O
4 141207481 CD O O
4 MH NNP B-NP O
4 20518742 CD O O
4 4382552 CD O O
4 2/22/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 HIP NNP I-NP O
4 FRACTURE NNP I-NP O
4 , , O O
4 STATUS NNP B-NP O
4 POST NNP I-NP O
4 HEART NNP I-NP O
4 TRANSPLANT NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/15/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/28/2006 CD O O
7 ATTENDING: NNP B-NP O
7 HADDENHAM NNP I-NP O
7 , , O O
7 LONNIE NNP B-NP O
7 MD NNP I-NP O
8 CHIEF NNP I-NP O
8 COMPLAINT: NNP I-NP O
8 Right NNP I-NP O
8 Hip NNP I-NP O
8 fracture NN I-NP O
9 BRIEF NNP I-NP O
9 ADMISSION NNP I-NP O
9 HISTORY: NNP I-NP O
9 Ms NNP I-NP O
9 Heit NNP I-NP O
9 is VBZ O O
9 a DT B-NP O
9 67-year-old JJ I-NP O
9 lady NN I-NP O
9 who WP O O
10 received VBD B-VP O
10 a DT B-NP O
10 heart NN I-NP O
10 transplant NN I-NP O
10 in IN B-VP O
10 March NNP B-NP O
10 2006 CD O O
10 for IN B-VP O
10 idiopathic JJ O O
11 dilated VBN O O
11 cardiomyopathy NN B-NP O
11 and CC O O
11 who WP O O
11 was VBD B-VP O
11 transferred VBN O O
11 from IN B-VP O
11 an DT B-NP O
11 outside JJ I-NP O
11 hospital NN I-NP O
11 after IN B-VP O
12 sutaining VBG O O
12 a DT B-NP O
12 right JJ I-NP O
12 hip NN I-NP O
12 fracture NN I-NP O
12 She PRP O O
12 had VBD B-VP O
12 been VBN O O
12 in IN B-VP O
12 good JJ B-NP O
12 health NN I-NP O
13 until IN B-VP O
13 one CD O O
13 day NN B-NP O
13 prior RB O O
13 to TO O O
13 admission NN B-NP O
13 to TO O O
13 Storg NNP B-NP O
13 Hospital NNP I-NP O
14 when WRB O O
14 she PRP O O
14 tripped VBD B-VP O
14 over IN B-VP O
14 the DT B-NP O
14 carpet NN I-NP O
14 in IN B-VP O
14 her PRP$ O O
14 house NN B-NP O
14 and CC O O
14 fell VBD B-VP O
14 to TO O O
14 the DT B-NP O
15 ground NN I-NP O
15 and CC O O
15 fractured VBD B-VP O
15 her PRP$ O O
15 right JJ B-NP O
15 hip NN I-NP O
15 There EX O O
15 was VBD B-VP O
15 no DT B-NP O
15 loss NN I-NP O
15 of IN B-VP O
16 consciousness NN B-NP O
16 or CC O O
16 head NN B-NP O
16 trauma NNS I-NP O
16 nor CC O O
16 were VBD B-VP O
16 there EX O O
16 any DT O O
16 preceding VBG O O
17 symptoms NNS B-NP O
17 such JJ O O
17 as IN B-VP O
17 chest NN B-NP O
17 pain NN I-NP O
17 , , O O
17 shortness NN B-NP O
17 of IN B-VP O
17 breath NN B-NP O
17 , , O O
17 or CC O O
18 palpitations NNS B-NP O
18 She PRP O O
18 has VBZ O O
18 a DT B-NP O
18 history NN I-NP O
18 of IN B-VP O
18 osteoarthritis NN B-NP O
18 as RB O O
18 well RB O O
18 as IN B-VP O
19 known VBN O O
19 bilateral JJ B-NP O
19 hip NN I-NP O
19 insufficiency NN I-NP O
19 fractures NNS I-NP O
19 for IN B-VP O
19 which WDT O O
19 she PRP O O
19 has VBZ O O
20 been VBN O O
20 evaluated VBN O O
20 in IN B-VP O
20 the DT O O
20 past JJ O O
20 She PRP O O
20 was VBD B-VP O
20 transferred VBN O O
20 to TO O O
20 O'mead NNP B-NP O
20 Hospital NNP I-NP O
20 for IN B-VP O
20 orthopedic JJ B-NP O
20 surgery NN I-NP O
21 REVIEW NNP I-NP O
21 OF NNP I-NP O
21 SYSTEMS: NNP I-NP O
21 The DT B-NP O
21 patient NN I-NP O
21 has VBZ O O
21 felt VBN O O
21 in IN B-VP O
21 good JJ B-NP O
21 health NN I-NP O
21 with IN B-VP O
21 no DT B-NP O
22 recent JJ I-NP O
22 fevers NNS I-NP O
22 , , O O
22 chills NNS B-NP O
22 , , O O
22 or CC O O
22 night NN B-NP O
22 sweats NNS I-NP O
22 She PRP O O
22 is VBZ O O
22 able JJ O O
22 to TO O O
22 do VB O O
22 her PRP$ O O
23 daily JJ B-NP O
23 activities NNS I-NP O
23 as RB O O
23 well RB O O
23 as IN B-VP O
23 low JJ B-NP O
23 intensity NN I-NP O
23 aerobic JJ B-NP O
23 activities NNS I-NP O
24 without IN B-VP O
24 significant JJ B-NP O
24 dyspnea NN I-NP O
24 on IN B-VP O
24 exertion NN B-NP O
24 She PRP O O
24 notes VBZ O O
24 no DT B-NP O
24 recent JJ I-NP O
25 cough NN I-NP O
25 , , O O
25 nausea NN B-NP O
25 , , O O
25 vomiting VBG O O
25 , , O O
25 diarrhea NN B-NP O
25 , , O O
25 dysuria NN B-NP O
25 , , O O
25 or CC O O
25 lower JJR B-NP O
25 extremity NN I-NP O
26 swelling VBG O O
27 PAST NNP B-NP O
27 MEDICAL NNP I-NP O
27 HISTORY: NNP I-NP O
28 1 CD O O
28 Idiopathic NNP B-NP O
28 dilated VBD B-VP O
28 cardiomyopathy NN B-NP O
28 , , O O
28 status NN B-NP O
28 post NN I-NP O
28 heart NN I-NP O
29 transplant NN I-NP O
29 on IN B-VP O
29 7/16/2006 CD O O
29 She PRP O O
29 is VBZ O O
29 status NN B-NP O
29 post NN I-NP O
29 biventricular JJ B-NP O
30 assist NN I-NP O
30 device NN I-NP O
30 x6 NNP I-NP O
30 months NNS I-NP O
30 and CC O O
30 AICD NNP B-NP O
30 , , O O
30 now RB O O
30 both DT O O
30 removed VBD B-VP O
31 2 CD O O
31 Chronic NNP B-NP O
31 renal JJ B-NP O
31 insufficiency NN I-NP O
31 with IN B-VP O
31 a DT B-NP O
31 baseline JJ I-NP O
31 creatinine NN I-NP O
31 of IN B-VP O
32 1.1-1.2 JJ O O
33 3 CD O O
33 Osteoarthritis NN B-NP O
33 in IN B-VP O
33 both DT B-NP O
33 hips NNS I-NP O
34 4 CD O O
34 Osteoporosis NN B-NP O
34 with IN B-VP O
34 bilateral JJ B-NP O
34 femoral JJ I-NP O
34 neck NN I-NP O
34 insufficiency NN I-NP O
34 fractures VBZ O O
35 5 CD O O
35 Hypercholesterolemia NNP B-NP O
36 6 CD O O
36 History NNP B-NP O
36 of IN B-VP O
36 recurring VBG O O
36 C NNP B-NP O
36 difficile NN I-NP O
36 colitis NN I-NP O
37 MEDICATIONS NNP I-NP O
37 ON NNP I-NP O
37 ADMISSION: NNP I-NP O
37 Neoral NNP I-NP B-m
37 150 CD O B-do
37 mg NN B-NP I-do
37 b.i.d NN I-NP B-f
37 , , O O
37 prednisone NN B-NP B-m
37 8 CD O B-do
37 mg JJ O I-do
38 daily RB O B-f
38 , , O O
38 CellCept NNP B-NP B-m
38 1500 CD O B-do
38 mg NN B-NP I-do
38 b.i.d NN I-NP B-f
38 , , O O
38 Protonix NNP B-NP B-m
38 20 CD O B-do
38 mg JJ O I-do
38 daily RB O B-f
38 , , O O
38 Pravachol NNP B-NP B-m
39 40 CD O B-do
39 mg JJ O I-do
39 daily RB O B-f
39 , , O O
39 diltiazem VBZ O B-m
39 360 CD O B-do
39 mg JJ O I-do
39 daily RB O B-f
39 , , O O
39 multivitamin PRP O B-m
39 one CD O B-do
39 daily RB O B-f
39 , , O O
40 magnesium NN B-NP B-m
40 oxide RB O I-m
40 400 CD O B-do
40 mg JJ O I-do
40 daily RB O B-f
40 , , O O
40 calcium NN B-NP B-m
40 and CC O O
40 vitamin NN B-NP B-m
40 D NNP I-NP I-m
40 1800 CD O B-do
40 mg NN B-NP I-do
41 daily RB O B-f
41 , , O O
41 Fosamax NNP B-NP B-m
41 weekly RB O B-f
41 on IN B-VP I-f
41 Mondays NNS B-NP I-f
41 , , O O
41 Colace NNP B-NP B-m
41 100 CD O B-do
41 mg JJ O I-do
41 daily RB O B-f
41 , , O O
41 Zocor NNP B-NP B-m
41 20 CD O B-do
42 mg JJ O O
42 daily RB O B-f
42 , , O O
42 Dulcolax NNP B-NP B-m
42 10 CD O B-do
42 mg NN B-NP I-do
42 as IN B-VP B-f
42 needed VBN O I-f
42 for IN B-VP O
42 constipation NN B-NP B-r
42 , , O O
42 vitamin NN B-NP B-m
42 E NNP I-NP I-m
43 400 CD O B-do
43 units NNS B-NP I-do
43 daily RB O B-f
43 , , O O
43 and CC O O
43 vitamin JJ B-NP B-m
43 C NNP I-NP I-m
43 500 CD O B-do
43 mg NN B-NP I-do
43 b.i.d NN I-NP B-f
44 ALLERGIES: NNP I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 has VBZ O O
44 a DT B-NP O
44 history NN I-NP O
44 of IN B-VP O
44 heparin-induced JJ B-NP O
45 thrombocytopenia NN I-NP O
45 Penicillin NNP I-NP O
45 causes VBZ O O
45 a DT B-NP O
45 rash JJ I-NP O
46 ADMISSION NNP I-NP O
46 PHYSICAL NNP I-NP O
46 EXAMINATION: NNP I-NP O
46 She PRP O O
46 was VBD B-VP O
46 afebrile RB O O
46 , , O O
46 98.6 CD O O
46 , , O O
46 pulse RB O O
47 115 CD O O
47 , , O O
47 blood NN B-NP O
47 pressure NN I-NP O
47 118/80 CD O O
47 , , O O
47 respiratory NN B-NP O
47 rate NN I-NP O
47 18 CD O O
47 , , O O
47 and CC O O
47 oxygen NN B-NP O
48 saturation NN I-NP O
48 95% CD O O
48 on IN B-VP O
48 room NN B-NP O
48 air NN I-NP O
48 She PRP O O
48 was VBD B-VP O
48 a DT B-NP O
48 well-appearing JJ I-NP O
48 lady NN I-NP O
48 in IN B-VP O
48 no DT B-NP O
49 acute JJ I-NP O
49 distress NN I-NP O
49 who WP O O
49 rated VBD B-VP O
49 her PRP O O
49 pain NN B-NP O
49 as IN B-VP O
49 2/10 CD O O
49 at IN B-VP O
49 rest NN B-NP O
49 and CC O O
49 yet RB O O
49 8/10 CD O O
50 upon IN B-VP O
50 movement NN B-NP O
50 of IN B-VP O
50 her PRP$ O O
50 lower JJR B-NP O
50 extremities NNS I-NP O
50 On IN B-VP O
50 head NN B-NP O
50 and CC O O
50 neck NN B-NP O
50 exam NN I-NP O
50 , , O O
51 her PRP$ O O
51 JVP NNP B-NP O
51 was VBD B-VP O
51 flat JJ B-NP O
51 Her NNP I-NP O
51 oropharynx NN I-NP O
51 was VBD B-VP O
51 without IN B-VP O
51 erythema NN B-NP O
51 or CC O O
52 exudates VBZ O O
52 Her PRP$ O O
52 lungs NNS B-NP O
52 were VBD B-VP O
52 clear JJ O O
52 bilaterally RB O O
52 On IN B-VP O
52 examination NN B-NP O
52 of IN B-VP O
53 the DT B-NP O
53 heart NN I-NP O
53 , , O O
53 she PRP O O
53 had VBD B-VP O
53 a DT B-NP O
53 regular JJ I-NP O
53 rhythm NN I-NP O
53 and CC O O
53 was VBD B-VP O
53 tachycardic JJ B-NP O
53 S1 NNP I-NP O
53 and CC O O
54 S2 NNP B-NP O
54 were VBD B-VP O
54 clearly RB O O
54 audible JJ O O
54 There EX O O
54 was VBD B-VP O
54 no DT B-NP O
54 rub NN I-NP O
54 or CC O O
54 murmur NN B-NP O
54 or CC O O
54 gallop VB O O
55 Her PRP$ O O
55 abdominal JJ B-NP O
55 exam NN I-NP O
55 was VBD B-VP O
55 benign JJ O O
55 , , O O
55 and CC O O
55 her PRP$ O O
55 extremities NNS B-NP O
55 were VBD B-VP O
55 warm JJ O O
55 and CC O O
56 without IN B-VP O
56 edema FW O O
56 Her PRP$ O O
56 right JJ B-NP O
56 leg NN I-NP O
56 was VBD B-VP O
56 shortened VBN O O
56 and CC O O
56 externally RB O O
57 rotated JJ B-NP O
58 LABORATORIES NNP I-NP O
58 ON NNP I-NP O
58 ADMISSION: NNP I-NP O
58 Significant NNP I-NP O
58 for IN B-VP O
58 sodium NN B-NP O
58 of IN B-VP O
58 146 CD O O
58 , , O O
59 potassium NN B-NP O
59 of IN B-VP O
59 4.2 CD O O
59 , , O O
59 chloride NN B-NP O
59 of IN B-VP O
59 111 CD O O
59 , , O O
59 bicarbonates NNS B-NP O
59 of IN B-VP O
59 24 CD O O
59 , , O O
59 BUN NNP B-NP O
59 39 CD O O
59 , , O O
60 creatinine NN B-NP O
60 1.4 CD O O
60 , , O O
60 PTT NNP B-NP O
60 26.2 CD O O
60 , , O O
60 and CC O O
60 INR NNP B-NP O
60 1.1 CD O O
61 Plain NNP B-NP O
61 films NNS I-NP O
61 of IN B-VP O
61 the DT B-NP O
61 hip NN I-NP O
61 revealed VBD B-VP O
61 a DT B-NP O
61 nondisplaced JJ I-NP O
61 right JJ I-NP O
61 femoral JJ I-NP O
62 fracture NN I-NP O
63 EKG NNP I-NP O
63 showed VBD B-VP O
63 sinus JJ B-NP O
63 tachycardia NN I-NP O
63 Echocardiogram NNP I-NP O
63 performed VBD B-VP O
63 on IN B-VP O
64 7/10/2006 CD O O
64 revealed VBD B-VP O
64 LVEF NNP B-NP O
64 of IN B-VP O
64 55-60% CD O O
64 without IN B-VP O
64 wall NN B-NP O
64 motion NN I-NP O
65 abnormality NN I-NP O
65 and CC O O
65 no DT B-NP O
65 evidence NN I-NP O
65 of IN B-VP O
65 diastolic JJ B-NP O
65 dysfunction NN I-NP O
65 Her NNP I-NP O
65 RV NNP I-NP O
65 was VBD B-VP O
66 mildly RB O O
66 enlarged VBN O O
66 , , O O
66 mild JJ O O
66 left VBD B-VP O
66 atrial JJ B-NP O
66 enlargement NN I-NP O
66 , , O O
66 no DT B-NP O
66 AR NNP I-NP O
66 , , O O
66 and CC O O
66 mild JJ B-NP O
67 TR NNP I-NP O
67 There EX O O
67 was VBD B-VP O
67 no DT B-NP O
67 aortic JJ I-NP O
67 regurgitation NN I-NP O
67 , , O O
67 mild JJ B-NP O
67 mitral JJ I-NP O
68 regurgitation NN I-NP O
68 , , O O
68 and CC O O
68 trace NN B-NP O
68 tricuspid JJ B-NP O
68 regurgitation NN I-NP O
69 Most NNP I-NP O
69 recent JJ B-NP O
69 right JJ I-NP O
69 heart NN I-NP O
69 catheterization NN I-NP O
69 results NNS I-NP O
69 performed VBD B-VP O
69 in IN B-VP O
69 May NNP B-NP O
70 2006 CD O O
70 showed VBD B-VP O
70 normal JJ B-NP O
70 right-sided JJ I-NP O
70 filling NN I-NP O
70 pressures NNS I-NP O
70 with IN B-VP O
70 a DT B-NP O
70 right JJ I-NP O
71 atrial JJ I-NP O
71 pressure NN I-NP O
71 of IN B-VP O
71 3 CD O O
71 mmHg NNS B-NP O
71 , , O O
71 RV NNP B-NP O
71 4 CD O O
71 , , O O
71 PA NNP B-NP O
71 24 CD O O
71 , , O O
71 and CC O O
71 pulmonary JJ B-NP O
71 capillary JJ I-NP O
72 wedge NN I-NP O
72 pressure NN I-NP O
72 of IN B-VP O
72 9 CD O O
73 HOSPITAL NNP B-NP O
73 COURSE NNP I-NP O
73 BY NNP I-NP O
73 SYSTEMS: NNP I-NP O
73 In IN B-VP O
73 summary JJ O O
73 , , O O
73 Ms NNP B-NP O
73 Hilz NNP I-NP O
73 is VBZ O O
73 a DT B-NP O
74 67-year-old JJ I-NP O
74 female NN I-NP O
74 status NN I-NP O
74 post NN I-NP O
74 heart NN I-NP O
74 transplant NN I-NP O
74 in IN B-VP O
74 March NNP B-NP O
74 2006 CD O O
75 who WP O O
75 was VBD B-VP O
75 stable JJ O O
75 from IN B-VP O
75 a DT B-NP O
76 cardiac JJ I-NP O
76 standpoint NN I-NP O
76 when WRB O O
76 she PRP O O
76 tripped VBD B-VP O
76 and CC O O
76 sustained VBD B-VP O
76 a DT B-NP O
77 right JJ I-NP O
77 hip NN I-NP O
77 fracture NN I-NP O
77 She PRP O O
77 was VBD B-VP O
77 transferred VBN O O
77 from IN B-VP O
77 outside JJ B-NP O
77 hospital NN I-NP O
77 in IN B-VP O
77 Ing NNP B-NP O
77 Port NNP I-NP O
77 for IN B-VP O
78 surgical JJ B-NP O
78 evaluation NN I-NP O
79 Musculoskeletal: NNP I-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 is VBZ O O
79 status NN B-NP O
79 post NN I-NP O
79 right RB O O
79 hip NN B-NP O
79 fracture NN I-NP O
80 She PRP O O
80 went VBD B-VP O
80 to TO O O
80 the DT B-NP O
80 OR NNP I-NP O
80 on IN B-VP O
80 hospital JJ B-NP O
80 day NN I-NP O
80 #2 NNP I-NP O
80 and CC O O
80 received VBD B-VP O
80 a DT B-NP O
80 dynamic JJ I-NP O
80 hip NN I-NP O
81 screw VBD B-VP O
81 The DT B-NP O
81 procedure NN I-NP O
81 was VBD B-VP O
81 uncomplicated VBN O O
81 , , O O
81 and CC O O
81 the DT B-NP O
81 patient NN I-NP O
81 was VBD B-VP O
81 able JJ O O
82 to TO O O
82 begin VB O O
82 weightbearing VBG O O
82 on IN B-VP O
82 postoperative JJ B-NP O
82 day NN I-NP O
82 #1 NNP I-NP O
82 She PRP O O
82 worked VBD B-VP O
82 with IN B-VP O
83 physical JJ B-NP O
83 therapy NN I-NP O
83 and CC O O
83 upon IN B-VP O
83 discharge NN B-NP O
83 was VBD B-VP O
83 able JJ O O
83 to TO O O
83 ambulate VB O O
83 around IN B-VP O
84 the DT B-NP O
84 Angeles NNP I-NP O
84 with IN B-VP O
84 a DT B-NP O
84 walker NN I-NP O
84 She PRP O O
84 should MD O O
84 continue VB O O
84 aspirin VB O B-m
84 325 CD O B-do
84 mg JJ O I-do
84 daily RB O B-f
85 for IN B-VP B-du
85 four CD O I-du
85 weeks NNS B-NP I-du
85 after IN B-VP O
85 the DT B-NP O
85 surgery NN I-NP O
85 There EX O O
85 is VBZ O O
85 no DT B-NP O
85 indication NN I-NP O
85 for IN B-VP O
86 systemic JJ B-NP O
86 anticoagulation NN I-NP O
86 after IN B-VP O
86 this DT B-NP O
86 particular JJ I-NP O
86 procedure NN I-NP O
86 She PRP O O
87 will MD O O
87 receive VB O O
87 oxycodone NN B-NP B-m
87 as IN B-VP B-f
87 needed VBN O I-f
88 Cardiovascular: NNP B-NP O
88 She PRP O O
88 is VBZ O O
88 status NN B-NP O
88 post NN I-NP O
88 transplant NN I-NP O
88 with IN B-VP O
88 the DT B-NP O
88 last JJ I-NP O
89 echocardiogram NN I-NP O
89 revealing VBG O O
89 ejection NN B-NP O
89 fraction NN I-NP O
89 of IN B-VP O
89 60% CD O O
89 She PRP O O
89 was VBD B-VP O
90 continued VBN O O
90 on IN B-VP O
90 her PRP$ O O
90 standard JJ B-NP O
90 immunosuppressive JJ I-NP B-m
90 medications NNS I-NP I-m
90 There EX O O
91 was VBD B-VP O
91 no DT B-NP O
91 evidence NN I-NP O
91 of IN B-VP O
91 ischemia NN B-NP O
91 throughout IN B-VP O
91 the DT B-NP O
91 hospital NN I-NP O
91 stay NN I-NP O
91 She PRP O O
92 was VBD B-VP O
92 euvolemic JJ O O
92 with IN B-VP O
92 no DT B-NP O
92 evidence NN I-NP O
92 of IN B-VP O
92 congestive JJ B-NP O
92 heart NN I-NP O
92 failure NN I-NP O
92 She PRP O O
92 was VBD B-VP O
92 in IN B-VP O
92 sinus JJ B-NP O
93 rhythm NN I-NP O
93 on IN B-VP O
93 telemetry NN B-NP O
93 throughout IN B-VP O
93 her PRP$ O O
93 hospital NN B-NP O
93 stay NN I-NP O
94 Hematology: NNP I-NP O
94 The DT B-NP O
94 patient NN I-NP O
94 has VBZ O O
94 a DT B-NP O
94 history NN I-NP O
94 of IN B-VP O
94 heparin-induced JJ B-NP B-r
95 thrombocytopenia NN I-NP O
95 She PRP O O
95 was VBD B-VP O
95 treated VBN O O
95 with IN B-VP O
95 fondaparinux JJ O B-m
95 daily JJ O B-f
95 prior RB O O
96 to TO O O
96 the DT B-NP O
96 procedure NN I-NP O
96 and CC O O
96 then RB O O
96 discharged VBD B-VP O
96 on IN B-VP O
96 aspirin NN B-NP B-m
96 for IN B-VP B-du
96 four CD O O
96 weeks NNS B-NP O
97 postprocedure NN I-NP O
97 Her NNP I-NP O
97 hematocrit NN I-NP O
97 dropped VBD B-VP O
97 from IN B-VP O
97 33.5% CD O O
97 to TO O O
97 24.9% CD O O
97 after IN B-VP O
98 the DT B-NP O
98 surgery NN I-NP O
98 She PRP O O
98 was VBD B-VP O
98 transfused VBN O O
98 with IN B-VP O
98 2 CD O B-do
98 units NNS B-NP I-do
98 of IN B-VP O
98 packed JJ B-NP B-m
98 red JJ I-NP O
98 blood NN I-NP O
99 cells NNS I-NP O
99 on IN B-VP O
99 the DT B-NP O
99 day NN I-NP O
99 after IN B-VP O
99 surgery NN B-NP O
99 with IN B-VP O
99 appropriate JJ B-NP O
99 hematocrit NN I-NP B-r
99 rise NN I-NP O
100 She PRP O O
100 received VBD B-VP O
100 additional JJ O O
100 2 CD O B-do
100 units NNS B-NP I-do
100 of IN B-VP O
100 packed JJ B-NP B-m
100 red JJ I-NP I-m
100 blood NN I-NP I-m
100 cells NNS I-NP I-m
100 prior RB O O
101 to TO O O
101 discharge VB O O
101 , , O O
101 and CC O O
101 her PRP$ O O
101 hematocrit NN B-NP O
101 was VBD B-VP O
101 30.4% CD O O
101 on IN B-VP O
101 the DT B-NP O
101 day NN I-NP O
101 of IN B-VP O
102 discharge NN B-NP O
102 Stools NNP I-NP O
102 were VBD B-VP O
102 guaiac JJ O O
102 negative JJ O O
102 , , O O
102 and CC O O
102 it PRP O O
102 was VBD B-VP O
102 thought VBN O O
102 that IN B-VP O
103 his PRP$ O O
103 hematocrit NN B-NP O
103 drop NN I-NP O
103 was VBD B-VP O
103 due JJ O O
103 to TO O O
103 the DT B-NP O
103 postoperative JJ I-NP O
103 blood NN I-NP O
103 loss NN I-NP O
103 as RB O O
104 well RB O O
104 as IN B-VP O
104 potential JJ B-NP O
104 hematoma NN I-NP O
104 formation NN I-NP O
104 at IN B-VP O
104 the DT B-NP O
104 site NN I-NP O
104 of IN B-VP O
104 the DT B-NP O
104 surgery NN I-NP O
105 Her NNP I-NP O
105 hematocrit NN I-NP O
105 will MD O O
105 be VB O O
105 followed VBN O O
105 closely RB O O
105 as IN B-VP O
105 an DT B-NP O
105 outpatient JJ I-NP O
106 DISCHARGE NNP I-NP O
106 MEDICATIONS: NNP I-NP O
106 Tylenol NNP I-NP B-m
106 650 CD O B-do
106 mg NN B-NP I-do
106 every DT O B-f
106 four CD O I-f
106 hours NNS B-NP I-f
106 as IN B-VP I-f
106 needed VBN O I-f
107 for IN B-VP O
107 pain NN B-NP B-r
107 , , O O
107 aspirin RB O B-m
107 325 CD O B-do
107 mg NNS B-NP I-do
107 daily RB O B-f
107 for IN B-VP B-du
107 four CD O I-du
107 weeks NNS B-NP I-du
107 after IN B-VP O
107 the DT B-NP O
107 surgery NN I-NP O
107 , , O O
108 Fosamax NNP B-NP B-m
108 70 CD O B-do
108 mg NN B-NP I-do
108 weekly RB O B-f
108 , , O O
108 Dulcolax NNP B-NP B-m
108 p.r VBZ O B-mo
108 10 CD O B-do
108 mg NN B-NP I-do
108 as IN B-VP B-f
108 needed VBN O I-f
108 for IN B-VP O
109 constipation NN B-NP B-r
109 , , O O
109 Caltrate NNP B-NP B-m
109 plus CC O I-m
109 D NNP B-NP I-m
109 one CD O B-do
109 tablet NN B-NP I-do
109 daily RB O B-f
109 , , O O
109 Neoral NNP B-NP B-m
110 ( ( O O
110 cyclosporine NN B-NP O
110 ) ) O O
110 150 CD O B-do
110 mg NN B-NP I-do
110 b.i.d NN I-NP B-f
110 , , O O
110 diltiazem NN B-NP B-m
110 extended VBD B-VP I-m
110 release NN B-NP I-m
110 360 CD O B-do
110 mg JJ O I-do
111 daily RB O B-f
111 , , O O
111 Colace NNP B-NP B-m
111 100 CD O B-do
111 mg NN B-NP I-do
111 b.i.d NN I-NP B-f
111 , , O O
111 magnesium NN B-NP B-m
111 oxide RB O I-m
111 420 CD O B-do
111 mg JJ O I-do
111 daily RB O B-f
111 , , O O
112 CellCept NNP B-NP B-m
112 1500 CD O B-do
112 mg NN B-NP I-do
112 b.i.d NN I-NP B-f
112 , , O O
112 oxycodone CD O B-m
112 5-10 JJ B-NP B-do
112 mg NN I-NP I-do
112 every DT O B-f
112 six CD O O
112 hours NNS B-NP O
112 as IN B-VP O
113 needed VBN O O
113 for IN B-VP O
113 pain NN B-NP B-r
113 , , O O
113 Protonix NNP B-NP B-m
113 40 CD O B-do
113 mg JJ O I-do
113 daily RB O B-f
113 , , O O
113 Pravachol NNP B-NP B-m
113 40 CD O B-do
113 mg JJ O I-do
113 daily RB O B-f
113 , , O O
114 prednisone NN B-NP B-m
114 8 CD O B-do
114 mg NN B-NP I-do
114 every DT B-NP B-f
114 morning NN I-NP I-f
114 , , O O
114 and CC O O
114 multivitamin VB O B-m
114 one CD O B-do
114 tablet NN B-NP I-do
114 daily JJ B-NP B-f
115 FOLLOWUP NNP I-NP O
115 PLANS: NNP I-NP O
115 The DT B-NP O
115 patient NN I-NP O
115 will MD O O
115 continue VB O O
115 her PRP$ O O
115 home NN B-NP B-m
115 medication NN I-NP O
116 regimen NNS I-NP O
116 In IN B-VP O
116 addition NN B-NP O
116 , , O O
116 she PRP O O
116 should MD O O
116 be VB O O
116 maintained VBN O O
116 on IN B-VP O
116 aspirin NN B-NP B-m
116 325 CD O B-do
116 mg NN B-NP I-do
117 for IN B-VP B-du
117 four CD O I-du
117 weeks NNS B-NP I-du
117 to TO O O
117 prevent VB O O
117 clot NN B-NP B-r
117 formation NN I-NP O
117 postsurgery IN B-VP O
117 She PRP O O
117 should MD O O
118 take VB O O
118 oxycodone RP O B-m
118 as RB O B-f
118 needed VBN O I-f
118 for IN B-VP O
118 pain NN B-NP B-r
118 She PRP O O
118 has VBZ O O
118 a DT B-NP O
118 followup JJ I-NP O
119 appointment NN I-NP O
119 with IN B-VP O
119 orthopedic JJ B-NP O
119 surgery NN I-NP O
119 The DT B-NP O
119 attending NN I-NP O
119 who WP O O
119 performed VBD B-VP O
120 her PRP$ O O
120 procedure NN B-NP O
120 was VBD B-VP O
120 Dr NNP B-NP O
120 Firkey NNP I-NP O
120 Her NNP I-NP O
120 appointment NN I-NP O
120 is VBZ O O
120 scheduled VBN O O
120 for IN B-VP O
121 4/13/2006 CD O O
121 at IN B-VP O
121 09:15 CD O O
121 a.m NNS B-NP O
121 She PRP O O
121 should MD O O
121 followup VB O O
121 with IN B-VP O
121 her PRP O O
121 primary JJ B-NP O
122 care NN I-NP O
122 doctor NN I-NP O
122 within IN B-VP O
122 1-2 JJ B-NP O
122 weeks NNS I-NP O
122 of IN B-VP O
122 discharge NN B-NP O
122 and CC O O
122 will MD O O
122 also RB O O
122 be VB O O
123 closely RB O O
123 followed VBN O O
123 by IN B-VP O
123 transplant NN B-NP O
123 clinic NN I-NP O
123 She PRP O O
123 was VBD B-VP O
123 instructed VBN O O
123 to TO O O
124 have VB O O
124 her PRP$ O O
124 blood NN B-NP O
124 drawn NN I-NP O
124 on IN B-VP O
124 Monday NNP B-NP O
124 after IN B-VP O
124 discharge NN B-NP O
124 , , O O
124 9/24/2006 CD O O
124 , , O O
124 to TO O O
124 be VB O O
125 reviewed VBN O O
125 by IN B-VP O
125 her PRP$ O O
125 primary JJ B-NP O
125 care NN I-NP O
125 doctor NN I-NP O
126 eScription NN I-NP O
126 document: VBZ O O
126 7-0558379 JJ B-NP O
126 HFFocus NNP I-NP O
127 Dictated NNP I-NP O
127 By: NNP I-NP O
127 CARLEW NNP I-NP O
127 , , O O
127 AGUSTIN NNP B-NP O
128 Attending: NNP I-NP O
128 GAUGER NNP I-NP O
128 , , O O
128 FILIBERTO NNP B-NP O
129 Dictation NNP I-NP O
129 ID NNP I-NP O
129 0495038 CD O O
130 D: NNP B-NP O
130 1/10/06 CD O O
131 T: NNP B-NP O
131 0/27/06 CD O O
132 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #217805 VBZ O O
2 427263098 CD O O
2 VH NNP B-NP O
2 31474529 CD O O
2 2621953 CD O O
2 0/25/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CAD NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 7/0/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/0/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 PREHN NNP I-NP O
5 , , O O
5 DAMION NNP B-NP O
5 426-57-09-1 CD O O
6 A NNP B-NP O
6 S NNP I-NP O
6 Sadenabirm NNP I-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/23/06 CD O O
8 AT NNP B-NP O
8 01:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 MOREDOCK NNP I-NP O
11 , , O O
11 ROLAND NNP B-NP O
11 C NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ATENOLOL NNP I-NP B-m
16 125 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 DAILY NNP I-NP B-f
16 Starting VBG O O
16 Today NNP B-NP O
16 ( ( O O
16 11/9 CD O O
16 ) ) O O
17 LIPITOR NNP B-NP B-m
17 ( ( O I-m
17 ATORVASTATIN NNP B-NP I-m
17 ) ) O I-m
17 80 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 DAILY NNP I-NP B-f
18 Instructions: NNP I-NP O
18 p/w NN I-NP O
18 angina NN I-NP O
18 , , O O
18 s/p JJ B-NP O
18 PCI NNP I-NP O
19 Alert NNP I-NP O
19 overridden: NNP I-NP O
19 Override NNP I-NP O
19 added VBD B-VP O
19 on IN B-VP O
19 5/24/06 CD O O
19 by IN B-VP O
20 KOTH NNP B-NP O
20 , , O O
20 JEFFERSON NNP B-NP O
20 KEVIN NNP I-NP O
20 , , O O
20 M.D NNP B-NP O
21 SERIOUS NNP I-NP O
21 INTERACTION: NNP I-NP O
21 MICONAZOLE NNP I-NP B-m
21 NITRATE NNP I-NP I-m
21 &amp; NNP I-NP O
21 ATORVASTATIN NNP I-NP B-m
22 CALCIUM NNP I-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 MICONAZOLE NNP I-NP B-m
23 NITRATE NNP I-NP I-m
23 &amp; NNP I-NP O
23 ATORVASTATIN NNP I-NP B-m
24 CALCIUM NNP I-NP O
25 POTENTIALLY NNP I-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 NIACIN NNP I-NP B-m
25 , , O O
25 VIT NNP B-NP B-m
25 B-3 NNP I-NP I-m
25 &amp; NNP I-NP O
26 ATORVASTATIN NNP I-NP B-m
26 CALCIUM NNP I-NP I-m
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 aware JJ B-NP O
27 KEFLEX NNP I-NP B-m
27 ( ( O I-m
27 CEPHALEXIN NNP B-NP I-m
27 ) ) O I-m
27 500 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QID NNP I-NP B-f
28 Starting VBG O O
28 Today NNP B-NP O
28 ( ( O O
28 11/9 CD O O
28 ) ) O O
29 Instructions: NNP B-NP O
29 started VBD B-VP O
29 7/14 CD O O
29 , , O O
29 stop VBD B-VP O
29 10/21 CD O O
30 PLAVIX NNP B-NP B-m
30 ( ( O I-m
30 CLOPIDOGREL NNP B-NP I-m
30 ) ) O I-m
30 75 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 DAILY NNP I-NP B-f
31 Starting NNP I-NP O
31 Tomorrow NNP I-NP O
31 ( ( O O
31 2/14 CD O O
31 ) ) O O
32 ENTERIC NNP B-NP B-m
32 COATED NNP I-NP I-m
32 ASA NNP I-NP I-m
32 325 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 DAILY NNP I-NP B-f
33 LASIX NNP I-NP B-m
33 ( ( O I-m
33 FUROSEMIDE NNP B-NP I-m
33 ) ) O I-m
33 80 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 BID NNP I-NP B-f
33 Starting NNP I-NP I-f
33 IN NNP I-NP I-f
33 AM NNP I-NP I-f
33 ( ( O O
33 1/25 CD O O
33 ) ) O O
34 POTASSIUM NNP B-NP B-m
34 CHLORIDE NNP I-NP I-m
34 SLOW NNP I-NP I-m
34 REL NNP I-NP I-m
34 ( ( O I-m
34 KCL NNP B-NP I-m
34 SLOW NNP I-NP I-m
34 RELEASE NNP I-NP I-m
34 ) ) O I-m
35 10 CD O B-do
35 MEQ NNP B-NP I-do
35 PO NNP I-NP B-mo
35 DAILY NNP I-NP B-f
35 As IN B-VP O
35 per IN B-VP O
35 CGH NNP B-NP O
35 Potassium NNP I-NP O
35 Chloride NNP I-NP O
35 Policy: NNP I-NP O
36 each DT O O
36 20 CD O O
36 mEq NNS B-NP O
36 dose VB O O
36 to TO O O
36 be VB O O
36 given VBN O O
36 with IN B-VP O
36 4 CD O O
36 oz NNS B-NP O
36 of IN B-VP O
36 fluid NN B-NP O
37 Alert NNP I-NP O
37 overridden: NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 9/23/06 CD O O
37 by IN B-VP O
37 : : O O
38 POTENTIALLY NNP B-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 LISINOPRIL NNP I-NP B-m
38 &amp; NNP I-NP O
38 POTASSIUM NNP I-NP B-m
39 CHLORIDE NNP I-NP O
40 POTENTIALLY NNP I-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 LISINOPRIL NNP I-NP B-m
40 &amp; NNP I-NP O
40 POTASSIUM NNP I-NP B-m
41 CHLORIDE NNP I-NP O
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
41 aware JJ B-NP O
42 LISINOPRIL NNP I-NP B-m
42 5 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 DAILY NNP I-NP B-f
43 Override NNP I-NP O
43 Notice: NNP I-NP O
43 Override NNP I-NP O
43 added VBD B-VP O
43 on IN B-VP O
43 8/4/06 CD O O
43 by IN B-VP O
44 RAMSIER NNP B-NP O
44 , , O O
44 TRENTON NNP B-NP O
44 H NNP I-NP O
44 , , O O
44 M.D NNP B-NP O
45 on IN B-VP O
45 order NN B-NP O
45 for IN B-VP O
45 POTASSIUM NNP B-NP B-m
45 CHLORIDE NNP I-NP I-m
45 IMMED NNP I-NP I-m
45 REL NNP I-NP I-m
45 PO NNP I-NP B-mo
45 ( ( O O
45 ref JJ O O
45 # # O O
46 126584751 CD O O
46 ) ) O O
47 POTENTIALLY NNP B-NP O
47 SERIOUS NNP I-NP O
47 INTERACTION: NNP I-NP O
47 LISINOPRIL NNP I-NP B-m
47 &amp; NNP I-NP O
47 POTASSIUM NNP I-NP B-m
48 CHLORIDE NNP I-NP O
49 POTENTIALLY NNP I-NP O
49 SERIOUS NNP I-NP O
49 INTERACTION: NNP I-NP O
49 LISINOPRIL NNP I-NP B-m
49 &amp; NNP I-NP O
49 POTASSIUM NNP I-NP B-m
50 CHLORIDE NNP I-NP O
50 Reason NNP I-NP O
50 for IN B-VP O
50 override: NN B-NP O
50 will MD O O
50 monitor VB O O
51 Previous JJ O O
51 override IN B-VP O
51 information: JJ B-NP O
52 Override NNP I-NP O
52 added VBD B-VP O
52 on IN B-VP O
52 4/15/06 CD O O
52 by IN B-VP O
52 BI NNP B-NP O
52 , , O O
52 GLENN NNP B-NP O
52 N NNP I-NP O
52 , , O O
52 M.D NNP B-NP O
52 , , O O
52 PH.D NNP B-NP O
53 POTENTIALLY NNP I-NP O
53 SERIOUS NNP I-NP O
53 INTERACTION: NNP I-NP O
53 POTASSIUM NNP I-NP B-m
53 CHLORIDE NNP I-NP I-m
53 &amp; NNP I-NP O
54 LISINOPRIL NNP I-NP B-m
55 POTENTIALLY NNP I-NP O
55 SERIOUS NNP I-NP O
55 INTERACTION: NNP I-NP O
55 POTASSIUM NNP I-NP B-m
55 CHLORIDE NNP I-NP I-m
55 &amp; NNP I-NP O
56 LISINOPRIL NNP I-NP B-m
56 Reason NNP I-NP O
56 for IN B-VP O
56 override: NN B-NP O
56 monitering VBG O O
57 MICONAZOLE NNP B-NP B-m
57 NITRATE NNP I-NP I-m
57 2% CD O I-m
57 CREAM NNP B-NP I-m
57 TP NNP I-NP B-mo
57 BID NNP I-NP B-f
58 Instructions: NNP I-NP O
58 apply VB O O
58 in IN B-VP O
58 between IN B-VP O
58 toes NNS B-NP O
58 B/L NNP I-NP O
59 Override NNP I-NP O
59 Notice: NNP I-NP O
59 Override NNP I-NP O
59 added VBD B-VP O
59 on IN B-VP O
59 5/24/06 CD O O
59 by IN B-VP O
60 HESBY NNP B-NP O
60 , , O O
60 NICOLAS NNP B-NP O
60 DOMINICK NNP I-NP O
60 , , O O
60 M.D NNP B-NP O
61 on IN B-VP O
61 order NN B-NP O
61 for IN B-VP O
61 LIPITOR NNP B-NP B-m
61 PO NNP I-NP B-mo
61 ( ( O O
61 ref JJ O O
61 # # O O
61 146549249 CD O O
61 ) ) O O
62 SERIOUS NNP B-NP O
62 INTERACTION: NNP I-NP O
62 MICONAZOLE NNP I-NP B-m
62 NITRATE NNP I-NP I-m
62 &amp; NNP I-NP O
62 ATORVASTATIN NNP I-NP B-m
63 CALCIUM NNP I-NP O
63 Reason NNP I-NP O
63 for IN B-VP O
63 override: NN B-NP O
63 aware JJ B-NP O
64 Previous NNP I-NP O
64 override NN I-NP O
64 information: NN I-NP O
65 Override NNP I-NP O
65 added VBD B-VP O
65 on IN B-VP O
65 4/15/06 CD O O
65 by IN B-VP O
65 POCAI NNP B-NP O
65 , , O O
65 GARY NNP B-NP O
65 F NNP I-NP O
65 , , O O
65 M.D NNP B-NP O
65 , , O O
65 PH.D NNP B-NP O
66 SERIOUS NNP I-NP O
66 INTERACTION: NNP I-NP O
66 SIMVASTATIN NNP I-NP B-m
66 &amp; NNP I-NP O
66 MICONAZOLE NNP I-NP B-m
66 NITRATE NNP I-NP I-m
67 SERIOUS NNP I-NP O
67 INTERACTION: NNP I-NP O
67 SIMVASTATIN NNP I-NP B-m
67 &amp; NNP I-NP O
67 MICONAZOLE NNP I-NP B-m
67 NITRATE NNP I-NP I-m
68 Reason NNP I-NP O
68 for IN B-VP O
68 override: NN B-NP O
68 aware JJ B-NP O
69 MICONAZOLE NNP I-NP B-m
69 NITRATE NNP I-NP I-m
69 2% CD O I-m
69 POWDER NNP B-NP I-m
69 TOPICAL NNP I-NP B-mo
69 TP NNP I-NP I-mo
69 BID NNP I-NP B-f
70 Instructions: NNP I-NP O
70 apply VB O O
70 to TO O O
70 groin VB O O
71 Override NNP B-NP O
71 Notice: NNP I-NP O
71 Override NNP I-NP O
71 added VBD B-VP O
71 on IN B-VP O
71 5/24/06 CD O O
71 by IN B-VP O
72 MUEHL NNP B-NP O
72 , , O O
72 REID NNP B-NP O
72 GENE NNP I-NP O
72 , , O O
72 M.D NNP B-NP O
73 on IN B-VP O
73 order NN B-NP O
73 for IN B-VP O
73 LIPITOR NNP B-NP B-m
73 PO NNP I-NP B-mo
73 ( ( O O
73 ref JJ O O
73 # # O O
73 146549249 CD O O
73 ) ) O O
74 SERIOUS NNP B-NP O
74 INTERACTION: NNP I-NP O
74 MICONAZOLE NNP I-NP B-m
74 NITRATE NNP I-NP I-m
74 &amp; NNP I-NP O
74 ATORVASTATIN NNP I-NP B-m
75 CALCIUM NNP I-NP O
75 Reason NNP I-NP O
75 for IN B-VP O
75 override: NN B-NP O
75 aware JJ B-NP O
76 NIASPAN NNP I-NP B-m
76 ( ( O I-m
76 NICOTINIC NNP B-NP I-m
76 ACID NNP I-NP I-m
76 SUSTAINED NNP I-NP I-m
76 RELEASE NNP I-NP I-m
76 ) ) O I-m
76 0.5 CD O B-do
76 GM NNP B-NP I-do
76 PO NNP I-NP B-mo
76 QPM NNP I-NP B-f
77 Instructions: NNP I-NP O
77 Take NNP I-NP O
77 aspirin NN I-NP B-m
77 30 CD O O
77 minutes NNS B-NP O
77 before- JJ B-NP O
77 hand NN I-NP O
77 to TO O O
78 prevent VB O O
78 facial JJ O B-r
78 flushing VBG O I-r
79 Override NNP B-NP O
79 Notice: NNP I-NP O
79 Override NNP I-NP O
79 added VBD B-VP O
79 on IN B-VP O
79 5/24/06 CD O O
79 by IN B-VP O
80 HARTZFELD NNP B-NP O
80 , , O O
80 NICK NNP B-NP O
80 TIMMY NNP I-NP O
80 , , O O
80 M.D NNP B-NP O
81 on IN B-VP O
81 order NN B-NP O
81 for IN B-VP O
81 LIPITOR NNP B-NP B-m
81 PO NNP I-NP B-mo
81 ( ( O O
81 ref JJ O O
81 # # O O
81 146549249 CD O O
81 ) ) O O
82 POTENTIALLY NNP B-NP O
82 SERIOUS NNP I-NP O
82 INTERACTION: NNP I-NP O
82 NIACIN NNP I-NP B-m
82 , , O O
82 VIT NNP B-NP B-m
82 B-3 NNP I-NP I-m
82 &amp; NNP I-NP O
83 ATORVASTATIN NNP I-NP B-m
83 CALCIUM NNP I-NP I-m
83 Reason NNP I-NP O
83 for IN B-VP O
83 override: NN B-NP O
83 aware JJ B-NP O
84 Previous NNP I-NP O
84 override NN I-NP O
84 information: NN I-NP O
85 Override NNP I-NP O
85 added VBD B-VP O
85 on IN B-VP O
85 4/15/06 CD O O
85 by IN B-VP O
85 RAUHE NNP B-NP O
85 , , O O
85 WESTON NNP B-NP O
85 L NNP I-NP O
85 , , O O
85 M.D NNP B-NP O
85 , , O O
85 PH.D NNP B-NP O
86 POTENTIALLY NNP I-NP O
86 SERIOUS NNP I-NP O
86 INTERACTION: NNP I-NP O
86 SIMVASTATIN NNP I-NP B-m
86 &amp; NNP I-NP O
86 NIACIN NNP I-NP B-m
86 , , O O
87 VIT NNP B-NP B-m
87 B-3 NNP I-NP I-m
87 Reason NNP I-NP O
87 for IN B-VP O
87 override: NN B-NP O
87 aware JJ B-NP O
88 DIET: NNP I-NP O
88 Patient NNP I-NP O
88 should MD O O
88 measure VB O O
88 weight JJ B-NP O
88 daily JJ I-NP O
89 DIET: NNP I-NP O
89 House NNP I-NP O
89 / VBD B-VP O
89 Low NNP B-NP O
89 chol/low NN I-NP O
89 sat VBD B-VP O
89 fat JJ B-NP O
90 ACTIVITY: NNP I-NP O
90 Resume NNP I-NP O
90 regular JJ B-NP O
90 exercise NN I-NP O
91 FOLLOW NNP I-NP O
91 UP NNP I-NP O
91 APPOINTMENT( NNP I-NP O
91 S NNP I-NP O
91 ): NNP I-NP O
92 Dr NNP I-NP O
92 Weakland NNP I-NP O
92 , , O O
92 Primary NNP B-NP O
92 Care NNP I-NP O
92 1-2 JJ B-NP O
92 weeks NNS I-NP O
92 Please NNP I-NP O
92 call VB O O
92 the DT B-NP O
92 office NN I-NP O
92 if IN B-VP O
92 you PRP O O
92 do VBP O O
92 not RB O O
92 hear VB O O
92 from IN B-VP O
92 them PRP O O
92 in IN B-VP O
92 the DT O O
92 next JJ O O
92 2 CD O O
92 days NNS B-NP O
92 , , O O
93 Dr NNP B-NP O
93 Trouser NNP I-NP O
93 , , O O
93 Cardiology NNP B-NP O
93 571-491-1951 JJ B-NP O
93 Please NNP I-NP O
93 call NN I-NP O
93 in IN B-VP O
93 1-2 JJ B-NP O
93 days NNS I-NP O
93 if IN B-VP O
93 you PRP O O
93 do VBP O O
93 not RB O O
93 hear VB O O
93 from IN B-VP O
93 the DT B-NP O
93 office NN I-NP O
93 You PRP O O
93 must MD O O
93 be VB O O
93 seen VBN O O
93 in IN B-VP O
93 2-4 JJ B-NP O
93 weeks NNS I-NP O
93 , , O O
94 ALLERGY: NNP B-NP O
94 Shellfish NNP I-NP O
95 ADMIT NNP I-NP O
95 DIAGNOSIS: NNP I-NP O
96 angina NN I-NP O
97 PRINCIPAL NNP I-NP O
97 DISCHARGE NNP I-NP O
97 DIAGNOSIS NNP I-NP O
97 ;Responsible JJ O O
97 After IN B-VP O
97 Study NNP B-NP O
97 for IN B-VP O
97 Causing NNP B-NP O
97 Admission NNP I-NP O
97 ) ) O O
98 CAD NNP B-NP O
99 OTHER NNP I-NP O
99 DIAGNOSIS;Conditions NNP I-NP O
99 , , O O
99 Infections NNP B-NP O
99 , , O O
99 Complications NNP B-NP O
99 , , O O
99 affecting VBG O O
99 Treatment/Stay NNP B-NP O
100 2 CD O O
100 VESSEL NNP B-NP O
100 CAD NNP I-NP O
100 HTN NNP I-NP O
100 +ETT VBD B-VP O
100 4/7 CD O O
100 W/ NNP B-NP O
100 ST NNP I-NP O
100 DEPRESSION NNP I-NP O
100 ANGINA NNP I-NP O
100 , , O O
100 ? . B-VP O
100 UNSTABLE NNP B-NP O
101 CURRENTLY NNP I-NP O
101 STABLE NNP I-NP O
101 NO NNP I-NP O
101 CHEST NNP I-NP O
101 PAIN NNP I-NP O
101 SINCE NNP I-NP O
101 3/5 CD O O
101 S/P NNP B-NP O
101 CATH NNP I-NP O
101 5/24 CD O O
102 OPERATIONS NNP B-NP O
102 AND NNP I-NP O
102 PROCEDURES: NNP I-NP O
103 OTHER NNP I-NP O
103 TREATMENTS/PROCEDURES NNP I-NP O
103 ( ( O O
103 NOT NNP B-NP O
103 IN NNP I-NP O
103 O.R NNP I-NP O
103 ) ) O O
104 cardiac VBP O O
104 cath NN B-NP O
105 BRIEF NNP I-NP O
105 RESUME NNP I-NP O
105 OF NNP I-NP O
105 HOSPITAL NNP I-NP O
105 COURSE: NNP I-NP O
106 cc: NN I-NP O
106 SOB/DOE NNP I-NP O
106 x VBZ O O
106 9 CD O O
106 months NNS B-NP O
107 HPI: NNP I-NP O
107 60M CD O O
107 HTN NNP B-NP O
107 , , O O
107 obese JJ O O
107 , , O O
107 CAD NNP B-NP O
107 S/P NNP I-NP O
107 stent NN I-NP O
107 in IN B-VP O
107 '96 CD O O
107 to TO O O
107 LCx NNP B-NP O
107 , , O O
107 w/ NN B-NP O
107 DOE NNP I-NP O
107 and CC O O
108 substernal JJ B-NP O
108 chest NN I-NP O
108 tightness NN I-NP O
108 w/ NN I-NP O
108 walking VBG O O
108 approx JJ O O
108 200 CD O O
108 yards NNS B-NP O
108 Sx NNP I-NP O
108 resolve VBP O O
109 with IN B-VP O
109 rest NN B-NP O
109 Associated VBN O O
109 with IN B-VP O
109 SOB NNP B-NP O
109 and CC O O
109 periodic JJ B-NP O
109 radiation NN I-NP O
109 to TO O O
109 the DT B-NP O
109 R NNP I-NP O
109 chest NN I-NP O
110 Have VBP O O
110 been VBN O O
110 slowly RB O O
110 progressing VBG O O
110 over IN B-VP O
110 the DT B-NP O
110 past JJ I-NP O
110 months NNS I-NP O
110 Since IN B-VP O
111 last JJ B-NP O
111 cath NN I-NP O
111 in IN B-VP O
111 '96 NNP B-NP O
111 , , O O
111 has VBZ O O
111 had VBN O O
111 few JJ B-NP O
111 episodes NNS I-NP O
111 of IN B-VP O
111 chest NN B-NP B-r
111 pain NN I-NP I-r
111 releived VBD B-VP O
111 with IN B-VP O
111 sl JJ B-NP B-mo
112 nitro NNS I-NP B-m
112 On IN B-VP O
112 ROS NNP B-NP O
112 positive JJ B-NP O
112 orthopnea NN I-NP O
112 ( ( O O
112 3 CD O O
112 pillows NNS B-NP O
112 ) ) O O
112 , , O O
112 no DT B-NP O
112 PND NNP I-NP O
112 No NNP I-NP O
113 lightheadedness NN I-NP O
113 , , O O
113 dizziness NN B-NP O
113 , , O O
113 nausea NN B-NP O
113 , , O O
113 emesis NN B-NP O
113 , , O O
113 cough NN B-NP O
113 , , O O
113 abd RB O O
113 pain VBP O O
113 No DT B-NP O
113 fever NN I-NP O
114 or CC O O
114 chills NNS B-NP O
114 Recent JJ B-NP O
114 gain NN I-NP O
114 of IN B-VP O
114 100 CD O O
114 lb NNS B-NP O
114 in IN B-VP O
114 setting VBG O O
114 of IN B-VP O
114 family NN B-NP O
114 illnesses NNS I-NP O
115 In IN B-VP O
115 the DT B-NP O
115 last JJ I-NP O
115 week NN I-NP O
115 , , O O
115 got VBD B-VP O
115 PECT NNP B-NP O
115 ( ( O O
115 neg NN B-NP O
115 ) ) O O
115 , , O O
115 Stress NNP B-NP O
115 Echo NNP I-NP O
115 negative NN I-NP O
115 for IN B-VP O
115 ischimia NN B-NP O
116 w/ NN I-NP O
116 submax NN I-NP O
116 HR NNP I-NP O
116 , , O O
116 + NNP B-NP O
116 MIBI NNP I-NP O
116 Admitted NNP I-NP O
116 for IN B-VP O
116 further JJ B-NP O
116 evaluation NN I-NP O
117 In IN B-VP O
117 ED: NNP B-NP O
117 T98.6 NNP I-NP O
117 P70 NNP I-NP O
117 BP141/69 NNP I-NP O
117 Sat NNP I-NP O
117 94%RA CD O O
117 Given NNP B-NP O
117 ASA NNP I-NP B-m
117 and CC O O
117 Keflex NNP B-NP B-m
117 ( ( O O
117 for IN B-VP O
117 LE NNP B-NP B-r
117 LE NNP I-NP B-r
118 cellulitis NN I-NP O
118 ) ) O O
119 ******** VBZ O O
120 *PMHx: JJ B-NP O
120 CAD NNP I-NP O
120 ( ( O O
120 s/p JJ O O
120 2 CD O O
120 stents NNS B-NP O
120 to TO O O
120 LCx NNP B-NP O
120 '96 NNP I-NP O
120 ) ) O O
120 , , O O
120 HTN NNP B-NP O
120 , , O O
120 hyperlipidemia NN B-NP O
120 , , O O
120 hepatitis NN B-NP O
121 ( ( O O
121 resolved VBN O O
121 ) ) O O
121 , , O O
121 colonic JJ B-NP O
121 polyps NNS I-NP O
121 , , O O
121 osteoarthritis NN B-NP O
121 , , O O
121 s/p NN B-NP O
121 appy JJ O O
121 , , O O
121 s/p JJ B-NP O
121 R NNP I-NP O
122 THR NNP I-NP O
122 *ALL: NNP I-NP O
122 Shellfish NNP I-NP O
122 --&gt; NNP I-NP O
123 Rash NNP I-NP O
123 *Home NNP I-NP O
123 Meds: NNP I-NP O
123 norvasc RB O B-m
123 10mg CD O B-do
123 , , O O
123 lasix VBD B-VP B-m
123 40mg CD O B-do
123 qd NN B-NP B-f
123 , , O O
123 lipitor NN B-NP B-m
124 80mg CD O B-do
124 qd NN B-NP B-f
124 , , O O
124 atenolol RB O B-m
124 100mg CD O B-do
124 qd NN B-NP B-f
124 , , O O
124 isordil JJ O B-m
124 20mg CD O B-do
124 tid NN B-NP B-f
124 , , O O
124 ASA NNP B-NP B-m
124 325mg CD O B-do
125 qd NN B-NP B-f
125 *Social JJ B-NP O
125 Hx: NNP I-NP O
125 married VBD B-VP O
125 , , O O
125 wife NN B-NP O
125 in IN B-VP O
125 EMC NNP B-NP O
125 w/ NN I-NP O
125 Alzheimer's NNP I-NP O
126 Lives VBZ O O
126 alone RB O O
126 Mother NNP B-NP O
126 died VBD B-VP O
126 a DT B-NP O
126 year NN I-NP O
126 ago RB O O
126 from IN B-VP O
126 malignancy NN B-NP O
126 , , O O
126 used VBD B-VP O
126 to TO O O
126 take VB O O
127 care NN B-NP O
127 of IN B-VP O
127 her PRP$ O O
127 Past NNP B-NP O
127 tobacco NN I-NP O
127 ( ( O O
127 40pk CD O O
127 yrs NN B-NP O
127 ) ) O O
127 , , O O
127 no DT B-NP O
127 ETOH NNP I-NP O
127 or CC O O
128 drugs NNS B-NP O
128 *Fam VBP O O
128 Hx: NNP B-NP O
128 no DT B-NP O
129 CAD NNP I-NP O
130 ********* NNP I-NP O
131 **Stress NNP I-NP O
131 Echo NNP I-NP O
131 6/26 CD O O
131 EF NNP B-NP O
131 45% CD O O
131 , , O O
131 borderline NN B-NP O
131 LVE NNP I-NP O
131 , , O O
131 concentric JJ B-NP O
131 LVH NNP I-NP O
131 , , O O
131 post NN B-NP O
132 basilar JJ B-NP O
132 HK NNP I-NP O
132 and CC O O
132 mid-inf JJ B-NP O
132 HK NNP I-NP O
132 LAE NNP I-NP O
132 No NNP I-NP O
132 ischimia NN I-NP O
132 , , O O
132 but CC O O
132 submax JJ B-NP O
132 stress NN I-NP O
132 test NN I-NP O
133 ( ( O O
133 peak JJ B-NP O
133 HR NNP I-NP O
133 85bmp CD O O
133 ) ) O O
133 **MIVI NN B-NP O
133 ( ( O O
133 10/15/06 CD O O
133 ): RB O O
133 non-ischimic JJ B-NP O
133 Patchy NNP I-NP O
133 uptake NN I-NP O
134 diffusely RB O O
134 w/ VBD B-VP O
134 small JJ B-NP O
134 reversible JJ I-NP O
134 apical JJ I-NP O
134 defect NN I-NP O
134 -&gt; NNP I-NP O
134 ? . B-VP O
134 mild JJ B-NP O
134 ischimia NN I-NP O
134 in IN B-VP O
134 LAD NNP B-NP O
135 territory NN I-NP O
135 Small NNP I-NP O
135 defect NN I-NP O
135 of IN B-VP O
135 medium NN B-NP O
135 intensity NN I-NP O
135 in IN B-VP O
135 the DT B-NP O
135 basal NN I-NP O
136 inferolateral JJ B-NP O
136 wall NN I-NP O
136 that WDT O O
136 is VBZ O O
136 fixed VBN O O
136 c/w JJ B-NP O
136 LCx/OM NNP I-NP O
137 scar NN I-NP O
137 **PECT VBD B-VP O
137 6/26 CD O O
137 no DT B-NP O
137 evidence NN I-NP O
137 of IN B-VP O
138 PE NNP B-NP O
138 **CXR NNP I-NP O
138 ( ( O O
138 admission NN B-NP O
138 ): NNP I-NP O
138 R NNP I-NP O
138 hilar JJ B-NP O
139 opacity NN I-NP O
139 **EKG: NNP I-NP O
139 SR NNP I-NP O
139 75bmp CD O O
139 , , O O
139 RBBB NNP B-NP O
139 , , O O
139 LEA NNP B-NP O
139 , , O O
139 PVC NNP B-NP O
139 , , O O
139 strain NN B-NP O
140 pattern JJ B-NP O
141 Cath NNP I-NP O
141 11/4/06 CD O O
141 : : O O
141 Right JJ B-NP O
141 Dominant NNP I-NP O
141 , , O O
141 LAD NNP B-NP O
141 ( ( O O
141 Proximal NNP B-NP O
141 ) ) O O
141 , , O O
141 Discrete NNP B-NP O
141 55% CD O O
141 lesion NN B-NP O
141 , , O O
141 LCX NNP B-NP O
142 ( ( O O
142 Mid NNP B-NP O
142 ) ) O O
142 , , O O
142 Discrete NNP B-NP O
142 80% CD O O
142 lesion NN B-NP O
142 , , O O
142 RCA NNP B-NP O
142 ( ( O O
142 Proximal NNP B-NP O
142 ) ) O O
142 , , O O
142 Discrete NNP B-NP O
142 99% CD O O
142 lesion NN B-NP O
142 , , O O
142 RT NNP B-NP O
142 LV-BR NNP I-NP O
143 ( ( O O
143 Ostial NNP B-NP O
143 ) ) O O
143 , , O O
143 Discrete NNP B-NP O
143 55% CD O O
143 lesion NN B-NP O
143 , , O O
143 RT NNP B-NP O
143 PDA NNP I-NP O
143 ( ( O O
143 Proximal NNP B-NP O
143 ) ) O O
143 , , O O
143 Discrete NNP B-NP O
143 50% CD O O
143 lesion NN B-NP O
143 , , O O
144 Collateral NNP B-NP O
144 flow NN I-NP O
144 from IN B-VP O
144 LAD NNP B-NP O
144 to TO O O
144 RT NNP B-NP O
144 PDA NNP I-NP O
144 , , O O
144 Collateral NNP B-NP O
144 flow NN I-NP O
144 from IN B-VP O
144 CX NNP B-NP O
144 to TO O O
144 RT VB O O
144 LV-BR NNP B-NP O
145 Right NNP I-NP O
145 heart NN I-NP O
145 Cath NNP I-NP O
145 11/4/06 CD O O
145 : : O O
145 RA NNP B-NP O
145 13/13 CD O O
145 RV NNP B-NP O
145 41/-1 CD O O
145 , , O O
145 PA NNP B-NP O
145 47/16 CD O O
145 , , O O
145 PW NNP B-NP O
145 27/25 CD O O
145 PA:74% NNP B-NP O
146 Fick NNP I-NP O
146 CO:6.95 NNP I-NP O
146 Thermal NNP I-NP O
146 CO: NNP I-NP O
146 SVR:1163 NNP I-NP O
147 Fick NNP I-NP O
147 CI:2.76 NNP I-NP O
147 Thermal NNP I-NP O
147 CI: NNP I-NP O
147 PVR:69 NNP I-NP O
148 Cath NNP I-NP O
148 9/27/06 CD O O
148 : : O O
148 PCI NN B-NP O
148 and CC O O
148 stent NN B-NP O
148 to TO O O
148 LCx NNP B-NP O
149 ********** NNP I-NP O
150 *Daily RB O O
150 Status: NNP B-NP O
150 T98.3 NNP I-NP O
150 P94 NNP I-NP O
150 BP130/80 NNP I-NP O
150 Sat NNP I-NP O
150 96%RA CD O O
150 GEN: NNP B-NP O
150 NAD NNP I-NP O
150 , , O O
151 A&amp;Ox3 NNP B-NP O
151 HEENT: NNP I-NP O
151 mmm NN I-NP O
151 , , O O
151 PERRLA NNP B-NP O
151 , , O O
151 JVP NNP B-NP O
151 8cm CD O O
151 , , O O
151 CEA NNP B-NP O
151 scars VBZ O O
152 b/l JJ B-NP O
152 CV: NNP I-NP O
152 RRR NNP I-NP O
152 , , O O
152 1/6 CD O O
152 RUSB NNP B-NP O
152 ejection NN I-NP O
152 murmur; VBD B-VP O
152 non-displaced JJ B-NP O
152 PMI NNP I-NP O
153 , , O O
153 B/L NNP B-NP O
153 CEA NNP I-NP O
153 scars NNS I-NP O
153 , , O O
153 no DT B-NP O
153 bruits NNS I-NP O
153 ABD: NNP I-NP O
153 obese JJ O O
153 , , O O
153 NABS NNP B-NP O
153 , , O O
153 nt RB O O
153 , , O O
153 nd UH O O
153 , , O O
153 no DT B-NP O
153 HSM NNP I-NP O
153 , , O O
153 B/L NNP B-NP O
154 femoral JJ B-NP O
154 bruits NNS I-NP O
154 PULM: NNP I-NP O
154 CTA NNP I-NP O
155 b/l VBD B-VP O
155 EXTR: NNP B-NP O
155 3+ CD O O
155 b/l NN B-NP O
155 edema NN I-NP O
155 to TO O O
155 knees NNS B-NP O
155 , , O O
155 b/l NN B-NP O
155 ankle NN I-NP O
155 erythema NN I-NP O
155 and CC O O
156 warmth NN B-NP O
156 w/ NN I-NP O
156 exudation NN I-NP O
156 on IN B-VP O
156 L NNP B-NP O
156 , , O O
156 + NNP B-NP O
156 onchomycosis NN I-NP O
156 B/L NNP I-NP O
156 NEURO: NNP I-NP O
156 full JJ B-NP O
156 strength NN I-NP O
156 &amp; NNP I-NP O
157 sensation NN I-NP O
157 Limited NNP I-NP O
157 R NNP I-NP O
157 eye NN I-NP O
157 abduction NN I-NP O
157 ( ( O O
157 Lateral NNP B-NP O
157 Rectus NNP I-NP O
157 ) ) O O
158 PERRLA NNP B-NP O
159 *********** NNP I-NP O
160 A/P: NNP I-NP O
160 60 CD O O
160 yo NN B-NP O
160 M NNP I-NP O
160 with IN B-VP O
160 CAD NNP B-NP O
160 , , O O
160 HTN NNP B-NP O
160 and CC O O
160 Hyperlipidemia NNP B-NP O
160 admitted VBD B-VP O
160 with IN B-VP O
161 increasing VBG O O
161 DOE NNP B-NP O
161 and CC O O
161 intermidiate VB O O
161 MIBI NNP B-NP O
161 as IN B-VP O
161 out-pt NN B-NP O
161 in IN B-VP O
161 setting NN B-NP O
161 of IN B-VP O
162 significant JJ B-NP O
162 deconditioning NN I-NP O
162 and CC O O
162 multiple JJ B-NP O
162 cardiac JJ I-NP O
162 risk NN I-NP O
163 factors NNS I-NP O
163 1 CD O O
163 CV: NNP B-NP O
163 i- JJ O O
163 no DT B-NP O
163 evidence NN I-NP O
163 of IN B-VP O
163 active JJ B-NP O
163 ischemia NN I-NP O
163 Admission NNP I-NP O
164 cardiac VBZ O O
164 markers NNS B-NP O
164 negative JJ B-NP O
164 Continued NNP I-NP O
164 statin/high JJ B-NP B-do
164 statin/high NN I-NP B-m
164 dose NN I-NP I-do
164 ASA NNP I-NP B-m
164 ( ( O O
164 post FW O O
165 stent NN B-NP O
165 )/started VBN O O
165 Plavix NNP B-NP B-m
165 ( ( O O
165 post FW O O
165 stent NN B-NP O
165 )/increased VBD B-VP O
165 atenolol JJ B-NP B-m
165 atenolol NN I-NP B-m
165 from IN B-VP O
165 100mg CD O B-do
165 to TO O O
165 125 CD O B-do
166 mg NN B-NP O
166 Started VBD B-VP O
166 Niaspan NNP B-NP B-m
166 for IN B-VP O
166 low JJ B-NP B-r
166 HDL NNP I-NP I-r
166 ( ( O O
166 Trig NNP B-NP O
166 138 CD O O
166 , , O O
166 HDL NNP B-NP O
166 38 CD O O
166 , , O O
166 LDL NNP B-NP O
166 85 CD O O
166 ) ) O O
166 Subtotal NNP B-NP O
166 RCA NNP I-NP O
167 occlusion NN I-NP O
167 , , O O
167 80% CD O O
167 OM NNP B-NP O
167 , , O O
167 50% CD O O
167 mid NN B-NP O
167 LAD NNP I-NP O
167 Cypher NNP I-NP O
167 Stents NNP I-NP O
167 in IN B-VP O
167 mid NN B-NP O
167 RCA NNP I-NP O
167 to TO O O
167 os VB O O
167 Returned VBN O O
168 to TO O O
168 cath VB O O
168 lab NN B-NP O
168 for IN B-VP O
169 Lcx NNP B-NP O
169 PCI NNP I-NP O
169 1/8 CD O O
169 and CC O O
169 cypher JJR B-NP O
169 stent NN I-NP O
169 placed VBD B-VP O
169 Wedge NNP B-NP O
169 elevated VBD B-VP O
169 EF NNP B-NP O
169 45% CD O O
169 on IN B-VP O
169 stress NN B-NP O
170 echo NN I-NP O
170 Difficult NNP I-NP O
170 to TO O O
170 determine VB O O
170 volume NN B-NP O
170 status NN I-NP O
170 by IN B-VP O
170 clinical JJ B-NP O
170 exam NN I-NP O
170 alone RB O O
171 Increased VBD B-VP O
171 lasix JJ B-NP B-m
171 lasix NN I-NP B-m
171 from IN B-VP O
171 40 CD O B-do
171 mg NNS B-NP I-do
171 PO NNP I-NP B-mo
171 daily RB O B-f
171 to TO O O
171 80 CD O B-do
171 mg NNS B-NP I-do
171 PO NNP I-NP B-mo
171 BID NNP I-NP B-f
171 , , O O
171 increased VBD B-VP O
171 b-blocker NN B-NP B-m
171 , , O O
172 continued VBD B-VP O
172 norvasc JJ O B-m
172 and CC O O
172 stopped VBD B-VP O
172 isordil NNS B-NP B-m
172 Will NNP I-NP O
172 stop VB O O
172 norvasc NN B-NP B-m
172 to TO O O
172 allow VB O O
172 room NN B-NP O
173 for IN B-VP O
173 ACE-I JJ B-NP O
173 titration NN I-NP O
173 r-telemetry NN I-NP O
174 monitoring NN I-NP O
174 revealed VBD B-VP O
174 2 CD O O
174 episodes NNS B-NP O
174 of IN B-VP O
174 NSVT NNP B-NP O
174 post-PCI JJ B-NP O
174 Continue NNP I-NP O
174 ASA/Plavix NNP I-NP B-m
174 ASA/Plavix NNP I-NP B-m
174 at IN B-VP O
175 current JJ B-NP O
175 doses NNS I-NP O
175 x VBP O B-du
175 x JJ O B-du
175 1 CD O I-du
175 1 CD O I-du
175 year NN B-NP I-du
175 year NN I-NP I-du
175 2 CD O O
175 PULM: NNP B-NP O
175 likely RB O O
175 symptoms VBD B-VP O
176 related VBN O O
176 to TO O O
176 cardiac VB O O
176 etiology NN B-NP O
177 No NNP I-NP O
177 evidence NN I-NP O
177 of IN B-VP O
177 PE NNP B-NP O
177 per IN B-VP O
177 out-pt JJ B-NP O
177 scan NN I-NP O
177 within IN B-VP O
177 the DT B-NP O
177 last JJ I-NP O
177 week NN I-NP O
177 3 CD O O
177 ID: NNP B-NP O
177 lower JJR B-NP O
178 extremity NN I-NP O
178 cellulitis NN I-NP O
178 in IN B-VP O
178 setting VBG O O
178 of IN B-VP O
179 venous JJ B-NP O
179 stasis NN I-NP O
179 and CC O O
179 likely JJ B-NP O
179 peripheral JJ I-NP B-r
179 vascular JJ I-NP I-r
179 disease NN I-NP I-r
179 Treat NNP I-NP O
179 with IN B-VP O
180 keflex NNP B-NP B-m
180 x $ O B-du
180 2 CD O I-du
180 weeks NNS B-NP I-du
180 and CC O O
180 continue VB O O
180 longer JJR O O
180 if IN B-VP O
180 legs NNS B-NP O
180 still RB O O
180 erythematous JJ B-NP O
180 ABX NNP I-NP B-m
181 started VBD B-VP B-du
181 7/14 CD O I-du
181 , , O I-du
181 stop VBD B-VP I-du
181 9/22 CD O I-du
181 4 CD O O
181 FEN: NNP B-NP O
181 cardiac JJ B-NP O
181 diet NN I-NP O
181 Started VBD B-VP O
181 low JJ B-NP O
181 dose NN I-NP O
181 potassium NN I-NP B-m
182 10 CD O B-do
182 mEq JJ O I-do
182 daily JJ O B-f
182 as IN B-VP O
182 increased VBN O O
182 lasix NN B-NP B-m
182 Will NNP I-NP O
182 have VBP O O
182 patient JJ B-NP O
182 check NN I-NP O
182 lytes NNS I-NP O
182 in IN B-VP O
182 2 CD O O
182 days NNS B-NP O
183 FULL NNP I-NP O
183 CODE NNP I-NP O
184 ADDITIONAL NNP I-NP O
184 COMMENTS: NNP I-NP O
184 You PRP O O
184 have VBP O O
184 been VBN O O
184 diagnosed VBN O O
184 with IN B-VP O
184 coronary JJ B-NP O
184 artery NN I-NP O
184 disease NN I-NP O
184 You PRP O O
184 have VBP O O
184 new JJ B-NP O
184 stents NNS I-NP O
185 to TO O O
185 keep VB O O
185 blood NN B-NP O
185 flowing VBG O O
185 to TO O O
185 your PRP$ O O
185 heart NN B-NP O
185 You PRP O O
185 MUST NNP B-NP O
185 continue VB O O
185 your PRP$ O O
185 aspirin NN B-NP B-m
185 and CC O O
186 plavix NN B-NP B-m
186 Do NNP I-NP O
186 NOT NNP I-NP O
186 discontinue VB O O
186 these DT B-NP B-m
186 medications NNS I-NP I-m
186 without IN B-VP O
186 speaking VBG O O
186 to TO O O
186 your PRP$ O O
187 doctor NN B-NP O
187 We PRP O O
187 have VBP O O
187 increased VBN O O
187 your PRP$ O O
187 lasix NN B-NP B-m
187 and CC O O
187 your PRP$ O O
187 atenolol NN B-NP B-m
187 You PRP O O
187 are VBP O O
187 on IN B-VP O
188 antibiotics NNS B-NP B-m
188 for IN B-VP O
188 cellulitis NN B-NP B-r
188 ( ( O O
188 a DT B-NP O
188 skin NN I-NP O
188 infection NN I-NP O
188 ) ) O O
188 Continue VB O O
188 your PRP$ O O
188 toe NN B-NP B-m
189 cream NN I-NP O
189 Come NNP I-NP O
189 to TO O O
189 the DT B-NP O
189 ER NNP I-NP O
189 if IN B-VP O
189 you PRP O O
189 have VBP O O
189 any DT B-NP O
189 trouble NN I-NP O
189 breathing NN I-NP O
189 , , O O
189 chest NN B-NP O
189 pain NN I-NP O
189 , , O O
189 leg NN B-NP O
190 swelling NN I-NP O
190 , , O O
190 or CC O O
190 any DT B-NP O
190 other JJ I-NP O
190 concerning NN I-NP O
190 symptoms NNS I-NP O
191 DISCHARGE NNP I-NP O
191 CONDITION: NNP I-NP O
191 Satisfactory NNP I-NP O
192 TO NNP I-NP O
192 DO/PLAN: NNP I-NP O
193 1 CD O O
193 Follow NNP B-NP O
193 lytes NNS I-NP O
193 , , O O
193 LFTs NNP B-NP O
193 on IN B-VP O
193 meds NNS B-NP O
194 2 CD O O
194 Follow NNP B-NP O
194 LE NNP I-NP O
194 cellulitis NN I-NP O
194 to TO O O
194 resolution VB O O
195 3 CD O O
195 ECHO NNP B-NP O
195 as IN B-VP O
195 outpt JJ O O
196 4 CD O O
196 Encourage NNP B-NP O
196 weight VBD B-VP O
196 reduction NN B-NP O
197 No NNP I-NP O
197 dictated VBD B-VP O
197 summary JJ B-NP O
198 ENTERED NNP I-NP O
198 BY: NNP I-NP O
198 MUMBY NNP I-NP O
198 , , O O
198 FRANKLYN NNP B-NP O
198 R NNP I-NP O
198 , , O O
198 M.D NNP B-NP O
198 , , O O
198 PH.D NNP B-NP O
198 ( ( O O
198 PS482 NNP B-NP O
198 ) ) O O
198 9/23/06 CD O O
198 @ $ O O
198 12 CD O O
199 ****** JJ B-NP O
199 END NN I-NP O
199 OF NNP I-NP O
199 DISCHARGE NNP I-NP O
199 ORDERS NNP I-NP O
199 ****** NNP I-NP O
200 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #230210 VBZ O O
2 387873161 CD O O
2 RMC NNP B-NP O
2 91193823 CD O O
2 243791 CD O O
2 0/10/1995 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 5/28/1995 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/27/1995 CD O O
4 DIAGNOSIS: NNP B-NP O
4 MORBID NNP I-NP O
4 OBESITY NNP I-NP O
5 PROCEDURE: NNP I-NP O
5 Panniculectomy NNP I-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 This DT O O
6 is VBZ O O
6 a DT O O
6 42 CD O O
6 year NN B-NP O
6 old JJ B-NP O
6 female NN I-NP O
6 nurse NN I-NP O
7 chronically RB O O
7 obese JJ O O
7 , , O O
7 whose WP$ O O
7 last JJ O O
7 weight JJ O O
8 two CD O O
8 weeks NNS B-NP O
8 ago RB O O
8 was VBD B-VP O
8 430 CD O O
8 pounds NNS B-NP O
8 , , O O
8 after IN B-VP O
8 a DT B-NP O
8 loss NN I-NP O
8 of IN B-VP O
8 90 CD O O
8 pounds NNS B-NP O
8 since IN B-VP O
9 February NNP B-NP O
9 The DT B-NP O
9 patient's NN I-NP O
9 mobility NN I-NP O
9 is VBZ O O
9 limited VBN O O
9 to TO O O
9 short VB O O
9 walks NNS B-NP O
9 around IN B-VP O
10 the DT B-NP O
10 house NN I-NP O
10 and CC O O
10 she PRP O O
10 has VBZ O O
10 had VBD B-VP O
10 some DT B-NP O
10 shortness NN I-NP O
10 of IN B-VP O
10 breath NN B-NP O
10 with IN B-VP O
10 exertion NN B-NP O
11 PAST NNP I-NP O
11 MEDICAL NNP I-NP O
11 HISTORY: NNP I-NP O
11 Significant NNP I-NP O
11 for IN B-VP O
11 a DT B-NP O
11 congenital JJ I-NP O
11 heart NN I-NP O
11 murmur NN I-NP O
12 with IN B-VP O
12 major JJ B-NP O
12 depression NN I-NP O
12 , , O O
12 diagnosed VBN O O
12 in IN B-VP O
12 1990; CD O O
13 duodenal JJ B-NP O
13 ulcer NN I-NP O
13 in IN B-VP O
13 1972; CD O O
13 diabetes NNS B-NP O
13 mellitus RB O O
13 , , O O
13 type NN B-NP O
13 II NNP I-NP O
13 , , O O
13 diagnosed VBD B-VP O
13 in IN B-VP O
14 1995; CD O O
14 status NN B-NP O
14 post NN I-NP O
14 laparotomy NN I-NP O
14 in IN B-VP O
14 1974 CD O O
15 MEDICATIONS: NNP B-NP O
15 Paxil NNP I-NP B-m
15 , , O O
15 60 CD O B-do
15 mg NN B-NP I-do
15 P NNP I-NP B-mo
15 O NNP I-NP I-mo
15 q NN I-NP B-f
15 AM; NNP I-NP I-f
15 Diabeta NNP I-NP B-m
15 , , O O
15 5 CD O B-do
15 mg NN B-NP I-do
15 P NNP I-NP B-mo
15 O NNP I-NP I-mo
15 q NN I-NP B-f
15 AM; NNP I-NP I-f
16 Trazadone NNP I-NP B-m
16 , , O O
16 100 CD O B-do
16 mg NN B-NP I-do
16 q NN I-NP B-f
16 h.s.; NN I-NP I-f
16 Ultram NNP I-NP B-m
16 , , O O
16 100 CD O B-do
16 mg NN B-NP I-do
16 q JJ B-NP B-f
16 4-6 JJ I-NP O
16 hours NNS I-NP O
17 prn; NN I-NP O
17 Reglan NNP I-NP B-m
17 , , O O
17 10 CD O B-do
17 mg NN B-NP I-do
17 q NN I-NP B-f
17 6 CD O I-f
17 hours NNS B-NP I-f
17 prn JJ B-NP I-f
17 nausea; JJ I-NP B-r
17 Bactroban NNP I-NP B-m
17 ointment NN I-NP I-m
17 b.i.d.; NN I-NP B-f
18 Lotrisone NNP I-NP B-m
18 cream NN I-NP I-m
18 b.i.d NN I-NP B-f
18 topically; NN I-NP B-mo
18 Afrin NNP I-NP B-m
18 nasal NN I-NP I-m
18 spray NN I-NP I-m
18 q VBD B-VP B-f
18 12 CD O I-f
18 hours NNS B-NP I-f
18 PRN; NNP I-NP I-f
19 Proventil NNP I-NP B-m
19 inhalers NNS I-NP I-m
19 , , O O
19 two CD O B-do
19 puffs NNS B-NP I-do
19 PRN NNP I-NP B-f
20 ALLERGIES: NNP I-NP O
20 To TO O O
20 Penicillin NNP B-NP O
20 , , O O
20 which WDT O O
20 produces VBZ O O
20 a DT B-NP O
20 rash; NN I-NP O
20 Corticosteroids NNP I-NP O
21 Phenothiazine NNP I-NP O
21 and CC O O
21 aspirin RB O O
22 PHYSICAL NNP B-NP O
22 EXAM: NNP I-NP O
22 Vital NNP I-NP O
22 signs NNS I-NP O
22 on IN B-VP O
22 admission NN B-NP O
22 , , O O
22 temperature NN B-NP O
22 99 CD O O
22 , , O O
22 pulse RB O O
22 80 CD O O
22 , , O O
23 respirations NNS B-NP O
23 20 CD O O
23 , , O O
23 blood NN B-NP O
23 pressure NN I-NP O
23 102/70; CD O O
23 height VBD B-VP O
23 4 CD O O
24 feet NNS B-NP O
24 , , O O
24 11 CD O O
24 inches; NN B-NP O
24 weight VBD B-VP O
24 430 CD O O
24 pounds NNS B-NP O
24 Physical JJ B-NP O
24 exam NN I-NP O
24 in IN B-VP O
24 general JJ O O
24 - : O O
24 this DT O O
25 is VBZ O O
25 a DT O O
25 massively RB O O
25 obese JJ B-NP O
25 woman NN I-NP O
25 lying VBG O O
25 down RP O O
25 in IN B-VP O
25 no DT B-NP O
25 apparent JJ I-NP O
25 distress NN I-NP O
25 Her PRP$ O O
26 skin NN B-NP O
26 is VBZ O O
26 warm JJ O O
26 and CC O O
26 dry JJ B-NP O
26 Her NNP I-NP O
26 HEENT NNP I-NP O
26 is VBZ O O
26 benign JJ B-NP O
26 Lungs NNS I-NP O
26 were VBD B-VP O
26 clear JJ O O
26 to TO O O
27 auscultation VB O O
27 bilaterally RB O O
27 Heart NNP B-NP O
27 - : O O
27 normal JJ B-NP O
27 S1 NNP I-NP O
27 , , O O
27 normal JJ B-NP O
27 S2 NNP I-NP O
27 and CC O O
27 a DT B-NP O
28 regular JJ I-NP O
28 rate NN I-NP O
28 and CC O O
28 rhythm NN B-NP O
28 and CC O O
28 without IN B-VP O
28 any DT B-NP O
28 appreciable JJ I-NP O
28 murmur NN I-NP O
28 at IN B-VP O
28 this DT B-NP O
29 time NN I-NP O
29 Abdomen NNP I-NP O
29 - : O O
29 morbidly RB O O
29 obese JJ O O
29 , , O O
29 with IN B-VP O
29 a DT B-NP O
29 pannus NN I-NP O
29 hanging VBG O O
29 down RP O O
29 to TO O O
30 below IN B-VP O
30 the DT B-NP O
30 knee NN I-NP O
30 level NN I-NP O
30 , , O O
30 it PRP O O
30 is VBZ O O
30 soft JJ O O
30 , , O O
30 non JJ B-NP O
30 tender NN I-NP O
30 and CC O O
30 with IN B-VP O
30 difficulty NN B-NP O
31 auscultating VBG O O
31 bowel NN B-NP O
31 sounds VBZ O O
31 Neurologically RB O O
31 , , O O
31 she PRP O O
31 is VBZ O O
31 alert JJ O O
31 and CC O O
32 oriented VBD B-VP O
32 x $ O O
32 3 CD O O
32 with IN B-VP O
32 no DT B-NP O
32 focal JJ I-NP O
32 deficits NNS I-NP O
32 Extremities NNPS I-NP O
32 - : O O
32 she PRP O O
32 is VBZ O O
32 able JJ O O
32 to TO O O
33 stand VB O O
33 on IN B-VP O
33 her PRP$ O O
33 feet NNS B-NP O
33 with IN B-VP O
33 no DT B-NP O
33 motor NN I-NP O
33 or CC O O
33 sensory JJ B-NP O
33 deficits NNS I-NP O
34 HOSPITAL NNP I-NP O
34 COURSE: NNP I-NP O
34 The DT B-NP O
34 patient NN I-NP O
34 was VBD B-VP O
34 admitted VBN O O
34 on IN B-VP O
34 0/25/95 CD O O
34 with IN B-VP O
34 concern NN B-NP O
35 for IN B-VP O
35 her PRP$ O O
35 being VBG O O
35 at IN B-VP O
35 high JJ B-NP O
35 risk NN I-NP O
35 of IN B-VP O
35 skin JJ B-NP O
35 breakdown NN I-NP O
35 and CC O O
36 infection NN B-NP O
36 Plans NNS I-NP O
36 were VBD B-VP O
36 made VBN O O
36 for IN B-VP O
36 panniculectomy NN B-NP O
36 , , O O
36 however RB O O
36 , , O O
36 prior RB O O
36 to TO O O
37 this DT B-NP O
37 procedure NN I-NP O
37 , , O O
37 she PRP O O
37 was VBD B-VP O
37 admitted VBN O O
37 for IN B-VP O
37 IV NNP B-NP B-mo
37 Ancef NNP I-NP B-m
37 t.i.d.; NN I-NP B-f
37 Hibiclenz NNP I-NP B-m
38 showers NNS I-NP B-mo
38 and CC O O
38 sub-q JJ B-NP B-mo
38 Heparin NNP I-NP B-m
38 Preoperatively NNP I-NP O
38 , , O O
38 her PRP$ O O
38 pulmonary JJ B-NP O
38 function NN I-NP O
39 was VBD B-VP O
39 assessed VBN O O
39 and CC O O
39 found VBN O O
39 to TO O O
39 have VB O O
39 an DT B-NP O
39 FEV-1 NNP I-NP O
39 of IN B-VP O
39 53% CD O O
39 of IN B-VP O
39 predicted; JJ B-NP O
39 FVC NNP I-NP O
39 of IN B-VP O
40 57% CD O O
40 of IN B-VP O
40 predicted VBN O O
40 and CC O O
40 an DT B-NP O
40 FEV-1/FVC NNP I-NP O
40 of IN B-VP O
40 93% CD O O
40 of IN B-VP O
40 predicted VBN O O
40 Chest NNP B-NP O
40 x-ray NN I-NP O
41 showed VBD B-VP O
41 no DT B-NP O
41 active JJ I-NP O
41 cardiopulmonary JJ I-NP O
41 disease NN I-NP O
41 and CC O O
41 an DT B-NP O
41 EKG NNP I-NP O
41 showed VBD B-VP O
41 a DT B-NP O
41 normal JJ I-NP O
42 sinus NN I-NP O
42 rhythm NN I-NP O
42 with IN B-VP O
42 a DT B-NP O
42 non NN I-NP O
42 specific JJ B-NP O
42 T NNP I-NP O
42 wave VBP O O
42 abnormality NN B-NP O
42 without IN B-VP O
42 change NN B-NP O
43 since IN B-VP O
43 1994 CD O O
43 Her NNP B-NP O
43 hematocrit NN I-NP O
43 preoperatively RB O O
43 was VBD B-VP O
43 39.8 CD O O
43 and CC O O
43 her PRP$ O O
43 white JJ B-NP O
44 count NN I-NP O
44 was VBD B-VP O
44 9 CD O O
44 A NNP B-NP O
44 pulmonary JJ B-NP O
44 consultation NN I-NP O
44 was VBD B-VP O
44 also RB O O
44 obtained VBN O O
44 because IN B-VP O
44 of IN B-VP O
45 concern NN B-NP O
45 about IN B-VP O
45 her PRP$ O O
45 pulmonary JJ B-NP O
45 status NN I-NP O
45 for IN B-VP O
45 the DT B-NP O
45 operation NN I-NP O
45 On IN B-VP O
45 their PRP$ O O
46 recommendation NN B-NP O
46 , , O O
46 the DT B-NP O
46 patient NN I-NP O
46 was VBD B-VP O
46 treated VBN O O
46 with IN B-VP O
46 Azmacort NNP B-NP B-m
46 inhalers NNS I-NP I-m
46 , , O O
47 Albuterol NNP B-NP B-m
47 nebulizer NN I-NP I-m
47 , , O O
47 and CC O O
47 aggressive JJ B-NP O
47 chest NN I-NP O
47 PT NNP I-NP O
47 On IN B-VP O
47 0/13/95 CD O O
47 , , O O
47 the DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 taken VBN O O
48 to TO O O
48 the DT B-NP O
48 operating NN I-NP O
48 room NN I-NP O
48 where WRB O O
48 a DT B-NP O
48 panniculectomy NN I-NP O
48 was VBD B-VP O
49 performed VBN O O
49 by IN B-VP O
49 Dr NNP B-NP O
49 Stanczyk NNP I-NP O
49 , , O O
49 without IN B-VP O
49 any DT B-NP O
49 complications NNS I-NP O
50 Postoperatively RB O O
50 , , O O
50 the DT B-NP O
50 patient NN I-NP O
50 was VBD B-VP O
50 transferred VBN O O
50 to TO O O
50 the DT B-NP O
50 Co NNP I-NP O
50 Wauhendprings NNP I-NP O
50 Ton NNP I-NP O
50 ICU NNP I-NP O
50 , , O O
50 where WRB O O
51 she PRP O O
51 continued VBD B-VP O
51 to TO O O
51 be VB O O
51 intubated VBN O O
51 and CC O O
51 on IN B-VP O
51 ventilatory JJ B-NP O
51 support NN I-NP O
51 On IN B-VP O
52 postoperative JJ B-NP O
52 day NN I-NP O
52 one CD O O
52 , , O O
52 the DT B-NP O
52 patient NN I-NP O
52 was VBD B-VP O
52 successfully RB O O
52 extubated VBN O O
52 in IN B-VP O
53 the DT B-NP O
53 morning NN I-NP O
53 , , O O
53 had VBD B-VP O
53 100% CD O O
53 saturation NN B-NP O
53 on IN B-VP O
53 40% CD O O
53 face NN B-NP O
53 mask NN I-NP O
53 and CC O O
53 she PRP O O
53 was VBD B-VP O
54 mobilized VBN O O
54 early RB O O
54 with IN B-VP O
54 aggressive JJ B-NP O
54 chest NN I-NP O
54 PT NNP I-NP O
54 and CC O O
54 deep JJ B-NP O
54 breathing NN I-NP O
55 encouragement NN I-NP O
55 stopped VBD B-VP O
55 The DT O O
55 patient JJ O O
55 received VBN O O
55 two CD O B-do
55 ( ( O I-do
55 2 CD O I-do
55 ) ) O I-do
55 units NNS B-NP I-do
55 of IN B-VP O
56 autologous JJ B-NP B-m
56 red JJ I-NP I-m
56 blood NN I-NP I-m
56 cells; NN I-NP I-m
56 after IN B-VP O
56 which WDT O O
56 her PRP$ O O
56 hematocrit NN B-NP O
56 was VBD B-VP O
56 32% CD O O
57 Postoperative JJ B-NP O
57 day NN I-NP O
57 two CD O O
57 , , O O
57 the DT B-NP O
57 patient NN I-NP O
57 was VBD B-VP O
57 found VBN O O
57 to TO O O
57 have VB O O
57 a DT B-NP O
57 hematocrit NN I-NP O
58 down RB O O
58 to TO O O
58 25.2 CD O O
58 , , O O
58 likely RB O O
58 due JJ O O
58 to TO O O
58 re-equilibration NN B-NP O
58 and CC O O
58 over IN B-VP O
58 the DT O O
58 next JJ O O
58 two CD O O
59 days NNS B-NP O
59 received VBD B-VP O
59 two CD O B-do
59 ( ( O I-do
59 2 CD O I-do
59 ) ) O I-do
59 units NNS B-NP I-do
59 of IN B-VP O
59 blood NN B-NP B-m
59 with IN B-VP O
59 a DT B-NP O
59 hematocrit NN I-NP O
59 reaching VBG O O
60 29% CD O O
60 Though IN B-VP O
60 she PRP O O
60 complained VBD B-VP O
60 of IN B-VP O
60 light JJ B-NP O
60 headiness NN I-NP O
60 prior RB O O
60 to TO O O
60 the DT B-NP O
61 transfusion NN I-NP B-m
61 , , O O
61 afterwards IN B-VP O
61 she PRP O O
61 was VBD B-VP O
61 up RB O O
61 and CC O O
61 walking VBG O O
61 without IN B-VP O
61 difficulty NN B-NP O
62 From IN B-VP O
62 postoperative JJ B-NP O
62 day NN I-NP O
62 two CD O O
62 , , O O
62 the DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
62 saturating VBG O O
62 at IN B-VP O
62 greater JJR O O
63 than IN B-VP O
63 93% CD O O
63 on IN B-VP O
63 room NN B-NP O
63 air; NN I-NP O
63 had VBD B-VP O
63 a DT B-NP O
63 wound NN I-NP O
63 that WDT O O
63 was VBD B-VP O
63 clean JJ O O
63 and CC O O
63 dry JJ O O
63 and CC O O
63 intact JJ O O
64 with IN B-VP O
64 serosanguineous JJ B-NP O
64 drainage NN I-NP O
64 in IN B-VP O
64 the DT B-NP O
64 Jackson-Pratt NNP I-NP O
64 drains NNS I-NP O
64 and CC O O
65 showed VBD B-VP O
65 no DT B-NP O
65 evidence NN I-NP O
65 of IN B-VP O
65 cellulitis NN B-NP O
65 , , O O
65 purulent JJ B-NP O
65 drainage NN I-NP O
65 or CC O O
65 fever NN B-NP O
65 , , O O
65 on IN B-VP O
65 IV NNP B-NP B-mo
66 Ancef NNP I-NP B-m
66 On IN B-VP O
66 postoperative JJ B-NP O
66 day NN I-NP O
66 five CD O O
66 , , O O
66 two CD O O
66 of IN B-VP O
66 the DT O O
66 four CD O O
66 Jackson-Pratt JJ B-NP O
67 drains NNS I-NP O
67 were VBD B-VP O
67 removed VBN O O
67 after IN B-VP O
67 their PRP$ O O
67 output NN B-NP O
67 fell VBD B-VP O
67 below IN B-VP O
67 30 CD O O
67 ccs NNS B-NP O
67 per IN B-VP O
67 day NN B-NP O
68 and CC O O
68 the DT B-NP O
68 patient NN I-NP O
68 was VBD B-VP O
68 discharged VBN O O
68 in IN B-VP O
68 good JJ B-NP O
68 condition NN I-NP O
68 on IN B-VP O
68 postoperative JJ B-NP O
69 day NN I-NP O
69 six CD O O
69 with IN B-VP O
69 plans NNS B-NP O
69 for IN B-VP O
69 home NN B-NP O
69 visiting NN I-NP O
69 nurse NN I-NP O
69 for IN B-VP O
69 dressing VBG O O
69 changes NNS B-NP O
70 daily RB O O
70 and CC O O
70 P NNP B-NP B-mo
70 O NNP I-NP I-mo
70 Keflex NNP I-NP B-m
70 while IN B-VP B-du
70 two CD O I-du
70 Jackson-Pratt JJ B-NP I-du
70 drains NNS I-NP I-du
70 were VBD B-VP I-du
70 in IN B-VP I-du
70 The DT B-NP O
71 patient NN I-NP O
71 will MD O O
71 be VB O O
71 following VBG O O
71 up RP O O
71 in IN B-VP O
71 outpatient JJ B-NP O
71 clinic NN I-NP O
71 with IN B-VP O
71 Dr NNP B-NP O
71 Bartles NNP I-NP O
72 in IN B-VP O
72 one CD O O
72 ( ( O O
72 1 CD O O
72 ) ) O O
72 week NN B-NP O
73 DISCHARGE NNP I-NP O
73 MEDICATIONS: NNP I-NP O
73 1 CD O O
73 ) ) O O
73 Keflex NNP B-NP B-m
73 , , O O
73 500 CD O B-do
73 mg NN B-NP I-do
73 P NNP I-NP B-mo
73 O NNP I-NP I-mo
73 q.i.d.; RB O B-f
73 2 CD O O
73 ) ) O O
73 Percocet NNP B-NP B-m
74 one CD O B-do
74 to TO O I-do
74 two CD O I-do
74 P NNP B-NP B-mo
74 O NNP I-NP I-mo
74 q VBD B-VP B-f
74 4 CD O I-f
74 hours NNS B-NP I-f
74 prn VBP O I-f
74 pain; RB O B-r
74 3 CD O O
74 ) ) O O
75 Lotrisone NNP B-NP B-m
75 topically RB O B-mo
75 , , O I-mo
75 TP NNP B-NP I-mo
75 b.i.d.; VBZ O B-f
75 4 CD O O
75 ) ) O O
75 Paxil NNP B-NP B-m
75 , , O O
75 60 CD O B-do
75 mg NN B-NP I-do
75 P NNP I-NP B-mo
75 O NNP I-NP I-mo
75 q VBD B-VP B-f
75 AM; NNP B-NP I-f
75 5 CD O O
75 ) ) O O
76 Azmacort NNP B-NP B-m
76 , , O O
76 four CD O B-do
76 puffs NNS B-NP I-do
76 inhaled VBD B-VP B-mo
76 q.i.d.; RB O B-f
76 6 CD O O
76 ) ) O O
76 Bactroban NNP B-NP B-m
76 topically RB O B-mo
76 TP NNP B-NP I-mo
77 b.i.d.; VBD B-VP B-f
77 7 CD O O
77 ) ) O O
77 Diabeta NNP B-NP B-m
77 , , O O
77 5 CD O B-do
77 mg NN B-NP I-do
77 P NNP I-NP B-mo
77 O NNP I-NP I-mo
77 q VBD B-VP B-f
77 AM; NNP B-NP I-f
77 8 CD O O
77 ) ) O O
77 Ferrous JJ B-NP B-m
77 Sulfate NNP I-NP I-m
77 , , O O
77 300 CD O B-do
77 mg NN B-NP I-do
77 P NNP I-NP B-mo
77 O NNP I-NP I-mo
78 t.i.d.; VBD B-VP B-f
78 9 CD O O
78 ) ) O O
78 Proventil NNP B-NP B-m
78 inhaler NN I-NP I-m
78 , , O O
78 two CD O B-do
78 puffs NNS B-NP I-do
78 inhaled VBD B-VP B-mo
78 q.i.d RB O B-f
79 Dictated VBN O O
79 By: NNP B-NP O
79 QUINCY NNP I-NP O
79 BUESING NNP I-NP O
79 , , O O
79 M.D NNP B-NP O
79 HU21 NNP I-NP O
80 Attending: NNP I-NP O
80 CURTIS NNP I-NP O
80 J NNP I-NP O
80 BUKER NNP I-NP O
80 , , O O
80 M.D NNP B-NP O
80 NX4 NNP I-NP O
81 ZF318/1886 NNP I-NP O
82 Batch: NNP I-NP O
82 63728 CD O O
82 Index NNP B-NP O
82 No NNP I-NP O
82 NUNKMK7P0A NNP I-NP O
82 D: NNP I-NP O
82 8/13/95 CD O O
83 T: NNP B-NP O
83 8/13/95 CD O O
84 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #232166 VBZ O O
2 624809693 CD O O
2 NBC NNP B-NP O
2 86704114 CD O O
2 6671024 CD O O
2 0/12/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 morbid NN I-NP O
2 obesity NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/14/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/25/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 DABER NNP I-NP O
5 , , O O
5 MARVIN NNP B-NP O
5 017-27-50-5 CD O O
6 Na NNP B-NP O
7 Service: NNP I-NP O
7 GGI NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 10/1/06 CD O O
8 AT NNP B-NP O
8 05:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 HO NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 BAFFUTO NNP I-NP O
11 , , O O
11 JOSIAH NNP B-NP O
11 J NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 DISPOSITION: NNP I-NP O
12 Home NNP I-NP O
13 DISCHARGE NNP I-NP O
13 MEDICATIONS: NNP I-NP O
14 ROXICET NNP I-NP B-m
14 ELIXIR NNP I-NP I-m
14 ( ( O I-m
14 OXYCODONE+APAP NNP B-NP I-m
14 LIQUID NNP I-NP I-m
14 ) ) O I-m
15 5 CD O B-do
15 MILLILITERS NNP B-NP I-do
15 PO NNP I-NP B-mo
15 Q4H NNP I-NP B-f
15 PRN NNP I-NP I-f
15 Pain NNP I-NP B-r
16 PHENERGAN NNP I-NP B-m
16 ( ( O I-m
16 PROMETHAZINE NNP B-NP I-m
16 HCL NNP I-NP I-m
16 ) ) O I-m
16 25 CD O B-do
16 MG NNP B-NP I-do
16 PR NNP I-NP B-mo
16 Q6H NNP I-NP B-f
16 PRN NNP I-NP I-f
16 Nausea NNP I-NP B-r
17 MULTIVITAMIN NNP I-NP B-m
17 THERAPEUTIC NNP I-NP I-m
17 ( ( O I-m
17 THERAPEUTIC NNP B-NP I-m
17 MULTIVI NNP I-NP I-m
17 ) ) O I-m
18 1 CD O B-do
18 TAB NNP B-NP I-do
18 PO NNP I-NP B-mo
18 DAILY NNP I-NP B-f
18 Instructions: NNP I-NP O
18 chewable JJ B-NP O
19 DIET: NNP I-NP O
19 stage NN I-NP O
19 2 CD O O
19 gastric JJ B-NP O
19 band NN I-NP O
20 ACTIVITY: NNP I-NP O
20 Walking NNP I-NP O
20 as IN B-VP O
20 tolerated VBN O O
21 FOLLOW NNP B-NP O
21 UP NNP I-NP O
21 APPOINTMENT( NNP I-NP O
21 S NNP I-NP O
21 ): NNP I-NP O
22 Dr NNP I-NP O
22 Germano NNP I-NP O
22 2 CD O O
22 weeks NNS B-NP O
22 , , O O
23 ALLERGY: NNP B-NP O
23 NKA NNP I-NP O
24 ADMIT NNP I-NP O
24 DIAGNOSIS: NNP I-NP O
25 s/p VBD B-VP O
25 Lap NNP B-NP O
25 Band NNP I-NP O
26 PRINCIPAL NNP I-NP O
26 DISCHARGE NNP I-NP O
26 DIAGNOSIS NNP I-NP O
26 ;Responsible JJ O O
26 After IN B-VP O
26 Study NNP B-NP O
26 for IN B-VP O
26 Causing NNP B-NP O
26 Admission NNP I-NP O
26 ) ) O O
27 morbid NN B-NP O
27 obesity NN I-NP O
28 OTHER NNP I-NP O
28 DIAGNOSIS;Conditions NNP I-NP O
28 , , O O
28 Infections NNP B-NP O
28 , , O O
28 Complications NNP B-NP O
28 , , O O
28 affecting VBG O O
28 Treatment/Stay NNP B-NP O
29 s/p NN I-NP O
29 lap NN I-NP O
29 band NN I-NP O
30 OPERATIONS NNP I-NP O
30 AND NNP I-NP O
30 PROCEDURES: NNP I-NP O
31 11/10/06 CD O O
31 BETTIES NNP B-NP O
31 , , O O
31 HUNTER NNP B-NP O
31 E NNP I-NP O
31 , , O O
31 M.D NNP B-NP O
32 LAPARO NNP I-NP O
32 PLACEMENT NNP I-NP O
32 ADJUSTABLE NNP I-NP O
32 GASTRIC NNP I-NP O
32 BAND NNP I-NP O
32 LAPAROSCOPIC NNP I-NP O
32 HIATAL NNP I-NP O
32 HERNIA NNP I-NP O
33 REP NNP I-NP O
34 OTHER NNP I-NP O
34 TREATMENTS/PROCEDURES NNP I-NP O
34 ( ( O O
34 NOT NNP B-NP O
34 IN NNP I-NP O
34 O.R NNP I-NP O
34 ) ) O O
35 none NN B-NP O
36 BRIEF NNP I-NP O
36 RESUME NNP I-NP O
36 OF NNP I-NP O
36 HOSPITAL NNP I-NP O
36 COURSE: NNP I-NP O
37 Patient NNP I-NP O
37 was VBD B-VP O
37 admitted VBN O O
37 to TO O O
37 the DT B-NP O
37 All NNP I-NP O
37 Hospital NNP I-NP O
37 surgery NN I-NP O
37 service NN I-NP O
37 on IN B-VP O
37 0/12/2006 CD O O
37 after IN B-VP O
38 undergoing VBG O O
38 laparoscopic NN B-NP O
38 gastric JJ O O
38 banding VBG O O
38 No DT O O
38 concerning VBG O O
38 intraoperative JJ B-NP O
39 events NNS I-NP O
39 occurred; JJ B-NP O
39 please NN I-NP O
39 see VB O O
39 dictated JJ B-NP O
39 operative JJ I-NP O
39 note NN I-NP O
39 for IN B-VP O
39 details NNS B-NP O
39 The DT B-NP O
40 patient NN I-NP O
40 was VBD B-VP O
40 transferred VBN O O
40 to TO O O
40 the DT B-NP O
40 floor NN I-NP O
40 from IN B-VP O
40 the DT B-NP O
40 PACU NNP I-NP O
40 in IN B-VP O
40 stable JJ B-NP O
40 condition NN I-NP O
41 Patient NNP I-NP O
41 had VBD B-VP O
41 adequate JJ B-NP O
41 pain NN I-NP O
41 control NN I-NP O
41 and CC O O
41 no DT B-NP O
41 issues NNS I-NP O
41 overnight VBD B-VP O
41 into IN B-VP O
41 POD1 NNP B-NP O
41 and CC O O
42 that IN B-VP O
42 time NN B-NP O
42 the DT B-NP O
42 patient NN I-NP O
42 was VBD B-VP O
42 started VBN O O
42 on IN B-VP O
42 a DT B-NP O
42 Stage NN I-NP O
42 I PRP O O
42 diet VBP O O
42 which WDT O O
42 was VBD B-VP O
42 tolerated VBN O O
43 The DT B-NP O
43 patient NN I-NP O
43 was VBD B-VP O
43 then RB O O
43 advanced JJ O O
43 to TO O O
43 clears NNS B-NP O
43 and CC O O
43 discharged VBD B-VP O
43 to TO O O
43 home VB O O
43 a DT B-NP O
43 Stage NNP I-NP O
43 II NNP I-NP O
44 diet VBZ O O
44 The DT B-NP O
44 incision NN I-NP O
44 was VBD B-VP O
44 C/D/I NNP B-NP O
44 , , O O
44 with IN B-VP O
44 no DT B-NP O
44 evidence NN I-NP O
44 of IN B-VP O
44 hematoma NN B-NP O
44 collection NN I-NP O
44 or CC O O
45 infection NN B-NP O
45 The DT B-NP O
45 remainder NN I-NP O
45 of IN B-VP O
45 the DT B-NP O
45 hospital NN I-NP O
45 course NN I-NP O
45 was VBD B-VP O
45 relatively RB O O
46 unremarkable JJ O O
46 , , O O
46 and CC O O
46 the DT B-NP O
46 patient NN I-NP O
46 was VBD B-VP O
46 discharged VBN O O
46 in IN B-VP O
46 stable JJ B-NP O
46 condition NN I-NP O
46 , , O O
47 ambulating VBG O O
47 and CC O O
47 voiding VBG O O
47 independently RB O O
47 , , O O
47 and CC O O
47 with IN B-VP O
47 adequate JJ B-NP O
47 pain NN I-NP O
47 control NN I-NP O
48 The DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 given VBN O O
48 explicit JJ B-NP O
48 instructions NNS I-NP O
48 to TO O O
48 follow-up NN B-NP O
48 in IN B-VP O
48 clinic NN B-NP O
48 with IN B-VP O
49 Dr NNP B-NP O
49 Mcmenamy NNP I-NP O
49 in IN B-VP O
49 two CD O O
49 weeks NNS B-NP O
50 ADDITIONAL NNP I-NP O
50 COMMENTS: NNP I-NP O
50 May NNP I-NP O
50 shower VB O O
50 2 CD O O
50 days NNS B-NP O
50 after IN B-VP O
50 surgery NN B-NP O
50 , , O O
50 but CC O O
50 do VBP O O
50 not RB O O
50 tub VB O O
50 bathe NN B-NP O
50 , , O O
50 swim NN B-NP O
50 , , O O
50 soak NN B-NP O
50 , , O O
50 or CC O O
51 scrub JJ B-NP O
51 incision NN I-NP O
51 for IN B-VP O
51 2 CD O O
51 weeks NNS B-NP O
51 Bandage NNP I-NP O
51 strips NNS I-NP O
51 will MD O O
51 fall VB O O
51 off RP O O
51 over IN B-VP O
51 time NN B-NP O
52 Seek NNP I-NP O
52 medical JJ B-NP O
52 attention NN I-NP O
52 for IN B-VP O
52 fevers NNS B-NP O
52 ( ( O O
52 temp&gt;101.5 NN B-NP O
52 ) ) O O
52 , , O O
52 worsening VBG O O
52 pain NN B-NP O
52 , , O O
52 drainage NN B-NP O
53 or CC O O
53 excessive JJ B-NP O
53 bleeding NN I-NP O
53 from IN B-VP O
53 incision NN B-NP O
53 , , O O
53 chest NN B-NP O
53 pain NN I-NP O
53 , , O O
53 shortness NN B-NP O
53 of IN B-VP O
53 breath NN B-NP O
53 , , O O
53 or CC O O
54 any DT B-NP O
54 other JJ I-NP O
54 symptoms NNS I-NP O
54 of IN B-VP O
54 concern NN B-NP O
54 Follow NNP I-NP O
54 up RB O O
54 with IN B-VP O
54 your PRP$ O O
54 surgeon NN B-NP O
54 in IN B-VP O
54 1-2 JJ B-NP O
54 weeks NNS I-NP O
55 Please NNP I-NP O
55 do VBP O O
55 not RB O O
55 drive VB O O
55 or CC O O
55 consume VB O O
55 alcohol NN B-NP O
55 while IN B-VP O
55 taking VBG O O
55 pain JJ B-NP B-m
55 medications NNS I-NP I-m
56 Crush NNP I-NP O
56 pills NNS I-NP O
56 , , O O
56 open JJ B-NP O
56 capsules NNS I-NP O
56 , , O O
56 or CC O O
56 take VB O O
56 elixirs NNS B-NP O
57 DISCHARGE NNP I-NP O
57 CONDITION: NNP I-NP O
57 Stable NNP I-NP O
58 TO NNP I-NP O
58 DO/PLAN: NNP I-NP O
59 No NNP I-NP O
59 dictated VBD B-VP O
59 summary JJ B-NP O
60 ENTERED NNP I-NP O
60 BY: NNP I-NP O
60 CHANGO NNP I-NP O
60 , , O O
60 JUSTIN NNP B-NP O
60 J NNP I-NP O
60 , , O O
60 M.D NNP B-NP O
60 ( ( O O
60 DD20 NNP B-NP O
60 ) ) O O
60 11/10/06 CD O O
60 @ $ O O
60 07 CD O O
61 ****** JJ B-NP O
61 END NN I-NP O
61 OF NNP I-NP O
61 DISCHARGE NNP I-NP O
61 ORDERS NNP I-NP O
61 ****** NNP I-NP O
62 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #237715 VBZ O O
4 593111043 CD O O
4 SMH NNP B-NP O
4 01580237 CD O O
4 0277843 CD O O
4 7/9/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 UNSTABLE NNP I-NP O
4 ANGINA NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/9/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/8/2005 CD O O
7 ATTENDING: NNP B-NP O
7 BOENISCH NNP I-NP O
7 , , O O
7 RAUL NNP B-NP O
7 MD NNP I-NP O
8 DEATH NNP I-NP O
8 SUMMARY: NNP I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 was VBD B-VP O
8 a DT B-NP O
8 69-year-old JJ I-NP O
8 female NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 coronary JJ B-NP O
9 disease NN I-NP O
9 status NN I-NP O
9 post NN I-NP O
9 prior RB O O
9 myocardial JJ B-NP O
10 infarction NN I-NP O
10 and CC O O
10 surgery NN B-NP O
10 in IN B-VP O
10 2002 CD O O
10 who WP O O
10 presented VBD B-VP O
10 to TO O O
10 R.healt NNP B-NP O
10 Medical NNP I-NP O
10 Center NNP I-NP O
10 Emergency NNP I-NP O
10 Department NNP I-NP O
10 on IN B-VP O
10 10/9/05 CD O O
10 with IN B-VP O
10 three CD O O
10 days NNS B-NP O
11 of IN B-VP O
11 chest NN B-NP O
11 pain NN I-NP O
11 and CC O O
11 shortness NN B-NP O
11 of IN B-VP O
11 breath NN B-NP O
11 Of IN B-VP O
11 note NN B-NP O
11 she PRP O O
11 had VBD B-VP O
11 been VBN O O
12 noncompliant JJ O O
12 with IN B-VP O
12 prior JJ B-NP O
12 regimens NNS I-NP O
12 and CC O O
12 treatments NNS B-NP O
12 and CC O O
12 despite IN B-VP O
13 diuretics NNS B-NP B-m
13 started VBD B-VP O
13 three CD O B-du
13 days NNS B-NP I-du
13 by IN B-VP O
13 her PRP$ O O
13 primary JJ B-NP O
13 care NN I-NP O
13 physician NN I-NP O
13 she PRP O O
14 reported VBD B-VP O
14 new JJ B-NP O
14 shortness NN I-NP O
14 of IN B-VP O
14 breath NN B-NP O
14 and CC O O
14 chest JJS B-NP O
14 pain NN I-NP O
14 at IN B-VP O
14 rest NN B-NP O
14 An DT B-NP O
14 EKG NNP I-NP O
15 in IN B-VP O
15 the DT B-NP O
15 emergency NN I-NP O
15 department NN I-NP O
15 revealed VBD B-VP O
15 widespread JJ B-NP O
15 ST NNP I-NP O
15 depressions NNS I-NP O
16 She PRP O O
16 was VBD B-VP O
16 treated VBN O O
16 for IN B-VP O
16 pulmonary JJ B-NP B-r
16 pulmonary JJ I-NP B-r
16 pulmonary JJ I-NP B-r
16 pulmonary JJ I-NP B-r
16 pulmonary JJ I-NP B-r
16 edema NN I-NP I-r
16 edema NN I-NP I-r
16 edema NN I-NP I-r
16 edema NN I-NP I-r
16 edema NN I-NP I-r
16 with IN B-VP O
16 IV NNP B-NP B-mo
16 nitroglycerin NN I-NP B-m
16 , , O O
16 Lasix NNP B-NP B-m
16 , , O O
17 aspirin NN B-NP B-m
17 , , O O
17 heparin NN B-NP B-m
17 , , O O
17 beta-blockers NNS B-NP B-m
17 , , O O
17 and CC O O
17 then RB O O
17 she PRP O O
17 was VBD B-VP O
17 taken VBN O O
17 urgently RB O O
18 to TO O O
18 the DT B-NP O
18 cath NN I-NP O
18 lab NN I-NP O
18 where WRB O O
18 coronary JJ B-NP O
18 angiography NN I-NP O
18 revealed VBD B-VP O
18 a DT B-NP O
18 left NN I-NP O
18 main JJ B-NP O
19 coronary JJ I-NP O
19 artery NN I-NP O
19 thrombosis NN I-NP O
19 with IN B-VP O
19 proximal JJ O O
19 and CC O O
19 distal JJ B-NP O
19 stenoses NNS I-NP O
19 of IN B-VP O
20 about RB O O
20 70% CD O O
20 , , O O
20 50% CD O O
20 of IN B-VP O
20 her PRP$ O O
20 LAD NNP B-NP O
20 , , O O
20 and CC O O
20 60% CD O O
20 of IN B-VP O
20 her PRP$ O O
20 first JJ O O
20 diagonal JJ O O
20 The DT B-NP O
21 patient NN I-NP O
21 was VBD B-VP O
21 transferred VBN O O
21 to TO O O
21 the DT B-NP O
21 coronary JJ I-NP O
21 care NN I-NP O
21 unit NN I-NP O
21 after IN B-VP O
21 placement NN B-NP O
22 of IN B-VP O
22 an DT B-NP O
22 intraaortic JJ I-NP O
22 balloon NN I-NP O
22 pump NN I-NP O
22 for IN B-VP O
22 further JJ B-NP O
22 management NN I-NP O
22 and CC O O
23 evaluation NN B-NP O
24 PAST NNP I-NP O
24 MEDICAL NNP I-NP O
24 HISTORY: NNP I-NP O
25 CHF NNP I-NP O
25 , , O O
25 hypertension NN B-NP O
25 , , O O
25 hyperlipidemia NN B-NP O
25 , , O O
25 CAD NNP B-NP O
25 , , O O
25 prior RB O O
25 myocardial JJ B-NP O
26 infarction NN I-NP O
26 , , O O
26 restrictive JJ B-NP O
26 lung NN I-NP O
26 disease NN I-NP O
26 , , O O
26 diabetes VBZ O O
26 mellitus NN B-NP O
26 , , O O
26 chronic JJ B-NP O
27 renal JJ I-NP O
27 insufficiency NN I-NP O
27 , , O O
27 morbid NN B-NP O
27 obesity NN I-NP O
27 , , O O
27 and CC O O
27 iron NN B-NP O
27 deficiency NN I-NP O
27 anemia VBD B-VP O
28 HOME NNP B-NP O
28 MEDICATIONS: NNP I-NP O
29 Aspirin NNP I-NP B-m
29 , , O O
29 hydralazine NN B-NP B-m
29 , , O O
29 nitroglycerin RB O B-m
29 , , O O
29 quinine NN B-NP B-m
29 , , O O
29 Norvasc NNP B-NP B-m
29 , , O O
29 Lasix NNP B-NP B-m
29 , , O O
30 Toprol NNP B-NP B-m
30 , , O O
30 lisinopril NN B-NP B-m
30 , , O O
30 albuterol NN B-NP B-m
30 , , O O
30 and CC O O
30 famotidine NN B-NP B-m
31 ALLERGIES: NNP I-NP O
32 She PRP O O
32 was VBD B-VP O
32 allergic JJ O O
32 to TO O O
32 erythromycin VB O O
32 , , O O
32 Bactrim NNP B-NP O
32 , , O O
32 and CC O O
32 IV NNP B-NP O
32 contrast VBP O O
33 FAMILY NNP B-NP O
33 HISTORY: NNP I-NP O
34 Noncontributory NNP I-NP O
35 REVIEW NNP I-NP O
35 OF NNP I-NP O
35 SYSTEMS: NNP I-NP O
36 Noted NNP I-NP O
36 no DT B-NP O
36 fever NN I-NP O
36 , , O O
36 chills NNS B-NP O
36 , , O O
36 sweats NNS B-NP O
36 , , O O
36 coughs NNS B-NP O
36 , , O O
36 abdominal JJ B-NP O
36 pain NN I-NP O
36 , , O O
36 nausea NN B-NP O
36 , , O O
37 or CC O O
37 vomiting VBG O O
38 PHYSICAL JJ B-NP O
38 EXAMINATION: NNP I-NP O
39 She PRP O O
39 was VBD B-VP O
39 morbidly RB O O
39 obese JJ O O
39 with IN B-VP O
39 moderate JJ B-NP O
39 respiratory NN I-NP O
39 distress NN I-NP O
39 lying VBG O O
40 at IN B-VP O
40 about IN B-VP O
40 30-degree JJ B-NP O
40 angle NN I-NP O
40 Her NNP I-NP O
40 O2 NNP I-NP O
40 saturation NN I-NP O
40 was VBD B-VP O
40 97% CD O O
40 on IN B-VP O
40 3L CD O O
40 nasal JJ B-NP O
41 cannula NN I-NP O
41 Temperature NNP I-NP O
41 was VBD B-VP O
41 99 CD O O
41 degrees NNS B-NP O
41 , , O O
41 pulse NN B-NP O
41 was VBD B-VP O
41 80 CD O O
41 and CC O O
41 regular JJ O O
41 , , O O
42 BP NNP B-NP O
42 was VBD B-VP O
42 140/50 CD O O
42 , , O O
42 and CC O O
42 respirations NNS B-NP O
42 about IN B-VP O
42 20 CD O O
42 Mucous JJ B-NP O
42 membranes NNS I-NP O
42 were VBD B-VP O
43 moist JJ O O
43 and CC O O
43 intact JJ B-NP O
43 Pupils NNP I-NP O
43 were VBD B-VP O
43 equal JJ O O
43 , , O O
43 round NN B-NP O
43 , , O O
43 and CC O O
43 reactive JJ O O
43 to TO O O
44 light VB O O
44 Her PRP$ O O
44 sclerae NN B-NP O
44 were VBD B-VP O
44 anicteric JJ B-NP O
44 Her NNP I-NP O
44 conjunctivae NN I-NP O
44 were VBD B-VP O
44 pale JJ O O
45 She PRP O O
45 had VBD B-VP O
45 a DT O O
45 15-cm JJ O O
45 of IN B-VP O
45 JVD NNP B-NP O
45 with IN B-VP O
45 2+ CD O O
45 carotids NNS B-NP O
45 without IN B-VP O
45 bruits NNS B-NP O
45 Coarse NNP I-NP O
46 breath NN I-NP O
46 sounds VBZ O O
46 bilaterally RB O O
46 with IN B-VP O
46 crackles NNS B-NP O
46 two-thirds NNS I-NP O
46 of IN B-VP O
46 the DT B-NP O
46 way NN I-NP O
46 up IN B-VP O
47 the DT B-NP O
47 bases NNS I-NP O
47 Cardiac NNP I-NP O
47 exam NN I-NP O
47 was VBD B-VP O
47 regular JJ B-NP O
47 rate NN I-NP O
47 and CC O O
47 rhythm NN B-NP O
47 with IN B-VP O
47 2/6 CD O O
48 holosystolic JJ O O
48 murmur FW O O
48 Her PRP$ O O
48 abdomen NNS B-NP O
48 was VBD B-VP O
48 obese JJ O O
48 , , O O
48 soft JJ O O
48 , , O O
48 nontender NN B-NP O
48 , , O O
48 and CC O O
49 nondistended VBD B-VP O
49 She PRP O O
49 had VBD B-VP O
49 no DT B-NP O
49 clubbing NN I-NP O
49 , , O O
49 cyanosis NN B-NP O
49 , , O O
49 or CC O O
49 palpable JJ B-NP O
49 edema NN I-NP O
50 She PRP O O
50 has VBZ O O
50 1+ CD O O
50 distal JJ B-NP O
50 pulses NNS I-NP O
50 noted VBD B-VP O
51 Her NNP B-NP O
51 EKG NNP I-NP O
51 was VBD B-VP O
51 normal JJ B-NP O
51 sinus JJ I-NP O
51 rhythm NN I-NP O
51 with IN B-VP O
51 ST NNP B-NP O
51 depressions NNS I-NP O
51 in IN B-VP O
51 the DT B-NP O
52 inferolateral JJ I-NP O
52 leads NNS I-NP O
52 and CC O O
52 a DT B-NP O
52 right JJ I-NP O
52 bundle-branch NN I-NP O
52 block NN I-NP O
52 was VBD B-VP O
52 present JJ B-NP O
53 Her NNP I-NP O
53 chest NN I-NP O
53 x-ray NN I-NP O
53 revealed VBD B-VP O
53 bilateral JJ B-NP O
53 pulmonary JJ I-NP O
53 infiltrates NNS I-NP O
54 consistent JJ O O
54 with IN B-VP O
54 edema NN B-NP O
54 So IN B-VP O
54 the DT B-NP O
54 patient NN I-NP O
54 was VBD B-VP O
54 admitted VBN O O
54 to TO O O
54 the DT B-NP O
55 coronary JJ I-NP O
55 care NN I-NP O
55 unit NN I-NP O
55 and CC O O
55 a DT B-NP O
55 consult NN I-NP O
55 with IN B-VP O
55 Cardiovascular NNP B-NP O
55 Surgery NNP I-NP O
55 and CC O O
56 serial JJ B-NP O
56 crits NNS I-NP O
56 were VBD B-VP O
56 performed VBN O O
56 The DT B-NP O
56 patient's NN I-NP O
56 condition NN I-NP O
56 continued VBD B-VP O
57 to TO O O
57 deteriorate VB O O
57 She PRP O O
57 developed VBD B-VP O
57 respiratory NN B-NP O
57 distress NN I-NP O
57 Anesthesia NNP I-NP O
58 was VBD B-VP O
58 called VBN O O
58 and CC O O
58 her PRP$ O O
58 airway NN B-NP O
58 was VBD B-VP O
58 secured VBN O O
58 via IN B-VP O
58 an DT B-NP O
58 emergent JJ I-NP O
58 intubation NN I-NP O
59 The DT B-NP O
59 patient NN I-NP O
59 subsequently RB O O
59 developed VBD B-VP O
59 signs NNS B-NP O
59 of IN B-VP O
59 abdominal JJ B-NP O
59 pain NN I-NP O
59 and CC O O
60 presumed VBN O O
60 sepsis NN B-NP O
60 and CC O O
60 ischemic JJ B-NP O
60 bowel NN I-NP O
60 She PRP O O
60 was VBD B-VP O
60 brought VBN O O
60 to TO O O
60 the DT B-NP O
61 operating NN I-NP O
61 room NN I-NP O
61 for IN B-VP O
61 an DT B-NP O
61 exploratory JJ I-NP O
61 laparotomy NN I-NP O
61 Status NNP I-NP O
61 post NN I-NP O
61 an DT B-NP O
62 exploratory NN I-NP O
62 laparotomy VBZ O O
62 the DT B-NP O
62 patient NN I-NP O
62 had VBD B-VP O
62 a DT B-NP O
62 complex JJ I-NP O
62 course NN I-NP O
62 in IN B-VP O
62 the DT B-NP O
63 surgical JJ I-NP O
63 ICU NNP I-NP O
63 where WRB O O
63 she PRP O O
63 underwent VBD B-VP O
63 multi-organ JJ B-NP O
63 system NN I-NP O
63 dysfunction NN I-NP O
64 Her NNP I-NP O
64 prognosis NN I-NP O
64 was VBD B-VP O
64 very RB O O
64 dire JJ O O
64 This DT O O
64 was VBD B-VP O
64 explained VBN O O
64 to TO O O
64 the DT B-NP O
64 family NN I-NP O
65 and CC O O
65 on IN B-VP O
65 11/12/05 CD O O
65 at IN B-VP O
65 2:20 CD O O
65 a.m IN B-VP O
65 the DT B-NP O
65 family NN I-NP O
65 decided VBD B-VP O
65 to TO O O
65 withdraw VB O O
65 care NN B-NP O
65 , , O O
66 which WDT O O
66 will MD O O
66 be VB O O
66 consistent JJ O O
66 with IN B-VP O
66 both DT O O
66 the DT B-NP O
66 patient NN I-NP O
66 and CC O O
66 family's NN B-NP O
67 wishes NNS I-NP O
67 and CC O O
67 desires NNS B-NP O
67 , , O O
67 and CC O O
67 the DT B-NP O
67 patient NN I-NP O
67 was VBD B-VP O
67 pronounced VBN O O
67 dead JJ O O
67 at IN B-VP O
67 2:24 CD O O
68 a.m NN B-NP O
68 on IN B-VP O
68 11/12/05 CD O O
69 DATE NN B-NP O
69 OF NNP I-NP O
69 DEATH: NNP I-NP O
70 11/12/05 CD O O
71 TIME NNP B-NP O
71 OF NNP I-NP O
71 DEATH: NNP I-NP O
72 02:24 CD O O
72 a.m NN B-NP O
73 eScription NN I-NP O
73 document: VBZ O O
73 4-0472746 JJ B-NP O
73 EMSSten NNP I-NP O
73 Tel NNP I-NP O
74 Dictated NNP I-NP O
74 By: NNP I-NP O
74 GARZONE NNP I-NP O
74 , , O O
74 COREY NNP B-NP O
75 Attending: NNP I-NP O
75 AIKENS NNP I-NP O
75 , , O O
75 GIUSEPPE NNP B-NP O
76 Dictation NNP I-NP O
76 ID NNP I-NP O
76 5285156 CD O O
77 D: NNP B-NP O
77 7/15/06 CD O O
78 T: NNP B-NP O
78 7/15/06 CD O O
79 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #244891 VBZ O O
4 963169421 CD O O
4 OCH NNP B-NP O
4 32248360 CD O O
4 7735873 CD O O
4 10/8/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 atypical JJ B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/29/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 8/21/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 ORPEN NNP I-NP O
8 , , O O
8 SCOTTY NNP B-NP O
8 P NNP I-NP O
8 756-11-47-0 JJ B-NP O
9 Phh NNP I-NP O
9 Nacall NNP I-NP O
9 Franbirm NNP I-NP O
9 , , O O
9 KS NNP B-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 2/15/04 CD O O
11 AT NNP B-NP O
11 08:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Rib NNP I-NP O
12 film NN I-NP O
12 completion NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 WASER NNP I-NP O
14 , , O O
14 EMMETT NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 FAMOTIDINE NNP I-NP B-m
19 20 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 LASIX NNP I-NP B-m
20 ( ( O I-m
20 FUROSEMIDE NNP B-NP I-m
20 ) ) O I-m
20 80 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 Starting NNP I-NP O
21 at IN B-VP O
21 2:00 CD O O
21 pm NNS B-NP O
21 July NNP I-NP O
22 MOTRIN NNP I-NP B-m
22 ( ( O I-m
22 IBUPROFEN NNP B-NP I-m
22 ) ) O I-m
22 300 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 Q6H NNP I-NP B-f
23 Instructions: NNP I-NP O
23 syrup VBD B-VP O
23 form JJ O O
23 100mg/5ml CD O O
24 Food/Drug NNP B-NP O
24 Interaction NNP I-NP O
24 Instruction NNP I-NP O
24 Take NNP I-NP O
24 with IN B-VP O
24 food NN B-NP O
25 ZOCOR NNP I-NP B-m
25 ( ( O I-m
25 SIMVASTATIN NNP B-NP I-m
25 ) ) O I-m
25 20 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QHS NNP I-NP B-f
26 Food/Drug NNP I-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 Avoid NNP I-NP O
27 grapefruit NN I-NP O
27 unless IN B-VP O
27 MD NNP B-NP O
27 instructs NNS I-NP O
27 otherwise RB O O
28 MAALOX-TABLETS NNP B-NP B-m
28 QUICK NNP I-NP I-m
28 DISSOLVE/CHEWABLE NNP I-NP I-m
28 1-2 JJ B-NP B-do
28 TAB NNP I-NP I-do
28 PO NNP I-NP B-mo
28 Q6H NNP I-NP B-f
29 PRN NNP I-NP O
29 Upset NNP I-NP B-r
29 Stomach NNP I-NP I-r
30 ECASA NNP I-NP B-m
30 ( ( O I-m
30 ASPIRIN NNP B-NP I-m
30 ENTERIC NNP I-NP I-m
30 COATED NNP I-NP I-m
30 ) ) O I-m
30 325 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 QD NNP I-NP B-f
31 DIET: NNP I-NP O
31 House NNP I-NP O
31 / VBD B-VP O
31 Low NNP B-NP O
31 chol/low NN I-NP O
31 sat VBD B-VP O
31 fat JJ B-NP O
32 DIET: NNP I-NP O
32 2 CD O O
32 gram NN B-NP O
32 Sodium NNP I-NP O
33 ACTIVITY: NNP I-NP O
33 Resume NNP I-NP O
33 regular JJ B-NP O
33 exercise NN I-NP O
34 FOLLOW NNP I-NP O
34 UP NNP I-NP O
34 APPOINTMENT( NNP I-NP O
34 S NNP I-NP O
34 ): NNP I-NP O
35 Dr NNP I-NP O
35 Jericho NNP I-NP O
35 , , O O
35 one CD O O
35 week NN B-NP O
35 , , O O
35 pt NN B-NP O
35 to TO O O
35 call VB O O
35 for IN B-VP O
35 appointment NN B-NP O
35 , , O O
36 ALLERGY: NNP B-NP O
36 PROPOXYPHENE NNP I-NP O
36 NAPSYL NNP I-NP O
37 ADMIT NNP I-NP O
37 DIAGNOSIS: NNP I-NP O
38 chest JJS B-NP O
38 pain NN I-NP O
39 PRINCIPAL NNP I-NP O
39 DISCHARGE NNP I-NP O
39 DIAGNOSIS NNP I-NP O
39 ;Responsible JJ O O
39 After IN B-VP O
39 Study NNP B-NP O
39 for IN B-VP O
39 Causing NNP B-NP O
39 Admission NNP I-NP O
39 ) ) O O
40 atypical JJ B-NP O
40 chest NN I-NP O
40 pain NN I-NP O
41 OTHER NNP I-NP O
41 DIAGNOSIS;Conditions NNP I-NP O
41 , , O O
41 Infections NNP B-NP O
41 , , O O
41 Complications NNP B-NP O
41 , , O O
41 affecting VBG O O
41 Treatment/Stay NNP B-NP O
42 PVD NNP I-NP O
42 s/p NN I-NP O
42 surgery NN I-NP O
42 s/p NN I-NP O
42 MI NNP I-NP O
42 1984 CD O O
42 CHF NNP B-NP O
42 ( ( O O
42 congestive JJ B-NP O
42 heart NN I-NP O
43 failure NN I-NP O
43 ) ) O O
43 atypical JJ B-NP O
43 chest NN I-NP O
43 pain NN I-NP O
43 ( ( O O
43 atypical JJ B-NP O
43 chest NN I-NP O
43 pain NN I-NP O
43 ) ) O O
43 s/p NN B-NP O
43 brainstem NN I-NP O
44 CVA NNP I-NP O
44 congenital NN I-NP O
44 R NNP I-NP O
44 hemiparesis NN I-NP O
44 supraglottic JJ B-NP O
44 laryngeal NN I-NP O
44 SCC NNP I-NP O
44 s/p NN I-NP O
45 XRT NNP I-NP O
45 chronic JJ B-NP O
45 RLE NNP I-NP O
45 circumf NN I-NP O
45 &gt; NNP I-NP O
45 LLE NNP I-NP O
45 ( ( O O
45 ) ) O O
45 esophageal VBP O O
45 stricture JJ B-NP O
45 s/p NN I-NP O
45 lye NN I-NP O
46 ingestion NN I-NP O
46 OA NNP I-NP O
46 ( ( O O
46 osteoarthritis NN B-NP O
46 ) ) O O
46 s/p VBZ O O
46 bilateral JJ B-NP O
46 rotator NN I-NP O
46 cuff NN I-NP O
47 repair NN I-NP O
47 recurrent JJ B-NP O
47 UTI NNP I-NP O
47 ( ( O O
47 urinary JJ B-NP O
47 tract NN I-NP O
47 infection NN I-NP O
47 ) ) O O
47 anemia NN B-NP O
47 of IN B-VP O
47 chronic JJ B-NP O
48 disease NN I-NP O
48 ( ( O O
48 anemia NN B-NP O
48 ) ) O O
48 persistent JJ B-NP O
48 thrombocytosis NN I-NP O
48 diet-controlled JJ B-NP O
48 DM NNP I-NP O
48 current JJ B-NP O
49 smoker NN I-NP O
50 OPERATIONS NNP I-NP O
50 AND NNP I-NP O
50 PROCEDURES: NNP I-NP O
51 none NN I-NP O
52 OTHER NNP I-NP O
52 TREATMENTS/PROCEDURES NNP I-NP O
52 ( ( O O
52 NOT NNP B-NP O
52 IN NNP I-NP O
52 O.R NNP I-NP O
52 ) ) O O
53 none NN B-NP O
54 BRIEF NNP I-NP O
54 RESUME NNP I-NP O
54 OF NNP I-NP O
54 HOSPITAL NNP I-NP O
54 COURSE: NNP I-NP O
55 CC: NNP I-NP O
55 L-sided NNP I-NP O
55 CP NNP I-NP O
56 HPI: NNP I-NP O
56 76yoF CD O O
56 PMH NNP B-NP O
56 MI NNP I-NP O
56 ( ( O O
56 1984 CD O O
56 ) ) O O
56 , , O O
56 PVD NNP B-NP O
56 , , O O
56 CVA NNP B-NP O
56 , , O O
56 DVT NNP B-NP O
56 , , O O
56 supraglottic JJ B-NP O
56 laryngeal NN I-NP O
56 SCC NNP I-NP O
57 s/p NN I-NP O
57 XRT NNP I-NP O
57 ( ( O O
57 2002 CD O O
57 ) ) O O
57 , , O O
57 who WP O O
57 presents VBZ O O
57 from IN B-VP O
57 home NN B-NP O
57 c/o NN I-NP O
57 "stabbing VBG O O
57 pins" NN B-NP O
57 CP NNP I-NP O
58 that IN B-VP O
58 awoke VBD B-VP O
58 her PRP O O
58 from IN B-VP O
58 sleep NN B-NP O
58 at IN B-VP O
58 6 CD O O
58 am VBP O O
58 The DT B-NP O
58 pain NN I-NP O
59 initially RB O O
59 started VBD B-VP O
59 next JJ O O
59 to TO O O
59 the DT B-NP O
59 L NNP I-NP O
59 breast NN I-NP O
59 in IN B-VP O
59 the DT B-NP O
60 midaxillary JJ I-NP O
60 line NN I-NP O
60 , , O O
60 then RB O O
60 radiated VBD B-VP O
60 to TO O O
60 breast VB O O
60 , , O O
60 sternum NN B-NP O
60 , , O O
60 neck NN B-NP O
60 , , O O
61 and CC O O
61 back RB O O
61 around IN B-VP O
61 to TO O O
61 L NNP B-NP O
61 midaxillary JJ B-NP O
61 line NN I-NP O
61 After IN B-VP O
61 30 CD O O
61 min NN B-NP O
62 of IN B-VP O
62 pain NN B-NP O
62 , , O O
62 pt NN B-NP O
62 called VBD B-VP O
62 covering VBG O O
62 PCP NNP B-NP O
62 &amp; NN I-NP O
62 was VBD B-VP O
62 told VBN O O
62 to TO O O
62 come VB O O
63 to TO O O
63 ED VB O O
63 The DT B-NP O
63 "stabbing" NN I-NP O
63 has VBZ O O
63 faded VBN O O
63 to TO O O
63 a DT B-NP O
63 "soreness" NN I-NP O
64 that WDT O O
64 is VBZ O O
64 replicated VBN O O
64 with IN B-VP O
64 palpation NN B-NP O
64 The DT B-NP O
64 pain NN I-NP O
64 is VBZ O O
65 worse JJR O O
65 with IN B-VP O
65 mov't NN B-NP O
65 &amp; NNP I-NP O
65 inspiration; VBZ O O
65 not RB O O
65 assoc JJ O O
65 with IN B-VP O
66 n/v JJ O O
66 , , O O
66 diaphoresis NN B-NP O
66 , , O O
66 SOB NNP B-NP O
66 Basline NNP I-NP O
66 cough NN I-NP O
66 has VBZ O O
66 not RB O O
67 worsened; VBN O O
67 green JJ B-NP O
67 looser NN I-NP O
67 stools NNS I-NP O
67 x VBP O O
67 3 CD O O
67 wks; JJ B-NP O
67 denies NNS I-NP O
67 dysuria NN I-NP O
68 Has NNP I-NP O
68 perhaps RB O O
68 felt VBD B-VP O
68 more RBR O O
68 tired JJ O O
68 with IN B-VP O
68 walking NN B-NP O
68 in IN B-VP O
68 recent JJ B-NP O
69 weeks NNS I-NP O
69 Of IN B-VP O
69 note NN B-NP O
69 , , O O
69 1984 CD O O
69 MI NNP B-NP O
69 p/w NN I-NP O
69 "squeezing" NNP I-NP O
69 sensation NN I-NP O
69 distinct NN I-NP O
69 from IN B-VP O
69 this DT B-NP O
70 pain; NN I-NP O
70 adm VBZ O O
70 0/29/01 CD O O
70 with IN B-VP O
70 similar JJ B-NP O
70 complaints NNS I-NP O
70 &amp; JJ B-NP O
70 labs; JJ I-NP O
70 ETT NNP I-NP O
70 &amp; NNP I-NP O
71 echo VBD B-VP O
71 non-ischemic JJ O O
71 In IN B-VP O
71 ED NNP B-NP O
71 , , O O
71 T NNP B-NP O
71 97.9; CD O O
71 HR NNP B-NP O
71 71; CD O O
71 BP NNP B-NP O
71 126/60; CD O O
72 RR NNP B-NP O
72 20; CD O O
72 99% CD O O
72 on IN B-VP O
72 RA NNP B-NP O
72 Reg NNP I-NP O
72 S1 NNP I-NP O
72 S2 NNP I-NP O
72 distant NN I-NP O
72 , , O O
72 chest VBP O O
73 diffusely RB O O
73 tender NN B-NP O
73 to TO O O
73 palp VB O O
73 , , O O
73 fine JJ B-NP O
73 rales NNS I-NP O
73 1/2 CD O O
73 up RB O O
73 bilat JJ O O
73 , , O O
73 abd JJ O O
74 soft JJ O O
74 , , O O
74 RLE NNP B-NP O
74 circumf NN I-NP O
74 &gt; NNP I-NP O
74 LLE NNP I-NP O
74 ( ( O O
74 baseline NN B-NP O
74 ) ) O O
74 , , O O
74 s/p JJ B-NP O
74 amp NN I-NP O
74 of IN B-VP O
74 L NNP B-NP O
75 3rd CD O O
75 finger NN B-NP O
75 , , O O
75 R NNP B-NP O
75 1st CD O O
75 toe NN B-NP O
75 A NNP I-NP O
75 set NN I-NP O
75 enzymes NNS I-NP O
75 neg; VBP O O
75 WBC NNP B-NP O
75 6 CD O O
75 , , O O
76 HCT NNP B-NP O
76 38.9 CD O O
76 , , O O
76 DDimer NNP B-NP O
76 951 CD O O
76 EKG: NNP B-NP O
76 NSR NNP I-NP O
76 @ NNP I-NP O
76 65 CD O O
76 , , O O
76 nl RB O O
76 axis NN B-NP O
76 , , O O
76 TWI NNP B-NP O
77 I PRP O O
77 , , O O
77 L NNP B-NP O
77 , , O O
77 V1-4 NNP B-NP O
77 NEXT NNP I-NP O
77 EKG: NNP I-NP O
77 NSR NNP I-NP O
77 @ VBD B-VP O
77 61 CD O O
77 with IN B-VP O
77 1 CD O O
77 deg NNS B-NP O
77 AVB NNP I-NP O
78 ( ( O O
78 Both NNP B-NP O
78 these DT B-NP O
78 patterns NNS I-NP O
78 seen VBN O O
78 on IN B-VP O
78 old JJ B-NP O
78 EKGs NNP I-NP O
78 ) ) O O
78 CXR NNP B-NP O
78 clear JJ B-NP O
79 Given NNP I-NP O
79 ASA NNP I-NP B-m
79 , , O O
79 NTG NNP B-NP B-m
79 ( ( O O
79 partial JJ B-NP O
79 relief NN I-NP O
79 , , O O
79 but CC O O
79 dropped VBD B-VP O
79 BP NNP B-NP B-r
79 ) ) O O
79 , , O O
80 heparin JJ B-NP B-m
80 bolus NN I-NP I-m
80 &amp; NNP I-NP O
80 cont NN I-NP O
81 infusion NN I-NP O
82 ************* NNP I-NP O
82 PLAN NNP I-NP O
82 ************************* NNP I-NP O
83 IMP--L NNP I-NP O
83 CP NNP I-NP O
83 seems VBZ O O
83 MSK NNP B-NP O
83 , , O O
83 ? . B-VP O
83 rib NN B-NP O
83 fractures NNS I-NP O
83 , , O O
83 rib NN B-NP O
83 films NNS I-NP O
83 preliminary JJ O O
83 read VBD B-VP O
83 without IN B-VP O
84 fracture NN B-NP O
84 but CC O O
84 does VBZ O O
84 have VB O O
84 some DT B-NP O
84 loss NN I-NP O
84 of IN B-VP O
84 height NN B-NP O
84 of IN B-VP O
84 vertebral JJ B-NP O
84 bodies NNS I-NP O
85 suggestive VBP O O
85 of IN B-VP O
85 compression NN B-NP O
85 fractures NNS I-NP O
85 She PRP O O
85 was VBD B-VP O
85 treated VBN O O
85 with IN B-VP O
85 motrin NN B-NP B-m
85 for IN B-VP O
86 muscular JJ B-NP B-r
86 pain NN I-NP I-r
86 CV--ISCH--h/o NNP I-NP O
86 MI; NNP I-NP O
86 cont NN I-NP O
87 ASA NNP I-NP B-m
87 , , O O
87 statin NN B-NP B-m
87 , , O O
87 r/o'd VB O O
88 MI NNP B-NP O
88 Not RB O O
88 previously RB O O
88 on IN B-VP O
88 BB NNP B-NP O
88 , , O O
88 ACEI NNP B-NP O
88 PUMP--? NNP I-NP O
88 some DT B-NP O
88 CHF NNP I-NP O
88 I/O; NNP I-NP O
88 Lasix NNP I-NP B-m
88 80 CD O B-f
88 QD NNP B-NP I-f
89 RHYTHM--transient JJ O O
89 1 CD O O
89 deg NN B-NP O
89 AVB; NNP I-NP O
90 tele VBZ O O
90 PAIN--cont NNP B-NP O
90 Motrin NNP I-NP B-m
90 Motrin NNP I-NP B-m
90 Motrin NNP I-NP B-m
90 for IN B-VP O
90 chronic JJ B-NP B-r
90 throat NN I-NP I-r
90 pain NN I-NP I-r
90 , , O O
90 OA NNP B-NP B-r
90 , , O O
91 L NNP B-NP B-r
91 chest JJS B-NP O
92 pain NN I-NP O
92 GI--cont NNP I-NP O
92 famotidine NN I-NP B-m
92 , , O O
93 Colace NNP B-NP B-m
93 PULM--low NNP I-NP O
93 suspicion NN I-NP O
93 for IN B-VP O
93 PE; NNP B-NP O
93 has VBZ O O
93 a DT B-NP O
93 history NN I-NP O
93 of IN B-VP O
93 an DT B-NP O
93 elevated JJ I-NP O
93 d NN I-NP O
94 dimer NN I-NP O
94 in IN B-VP O
94 past JJ O O
94 no DT B-NP O
94 furtehr NN I-NP O
94 workup NN I-NP O
94 at IN B-VP O
94 this DT B-NP O
94 time; NN I-NP O
94 no DT B-NP O
94 anticoagulation NN I-NP O
94 for IN B-VP O
95 now RB O O
95 Pt NNP B-NP O
95 rule NN I-NP O
95 dout NN I-NP O
95 for IN B-VP O
95 MI NNP B-NP O
95 whil NN I-NP O
95 in IN B-VP O
95 house NN B-NP O
95 Her PRP$ O O
95 pain NN B-NP B-r
95 was VBD B-VP O
95 thought VBN O O
95 to TO O O
95 be VB O O
96 musculoskeletal JJ O O
96 in IN B-VP O
96 origin NN B-NP O
96 and CC O O
96 was VBD B-VP O
96 treated VBN O O
96 with IN B-VP O
96 NSAIDS NNP B-NP B-m
96 She PRP O O
96 will MD O O
96 need VB O O
96 to TO O O
97 follow VB O O
97 up RP O O
97 with IN B-VP O
97 Dr NNP B-NP O
97 Maccutcheon NNP I-NP O
97 as IN B-VP O
97 an DT B-NP O
97 outpt NN I-NP O
97 Her NNP I-NP O
97 rib NN I-NP O
97 film NN I-NP O
97 final JJ B-NP O
97 read NN I-NP O
97 was VBD B-VP O
98 pedning VBG O O
98 at IN B-VP O
98 the DT B-NP O
98 time NN I-NP O
98 of IN B-VP O
98 discharge NN B-NP O
98 and CC O O
98 will MD O O
98 need VB O O
98 to TO O O
98 be VB O O
98 followed VBN O O
98 up RP O O
98 on IN B-VP O
99 ADDITIONAL NNP B-NP O
99 COMMENTS: NNP I-NP O
99 1 CD O O
99 Please NNP B-NP O
99 follow VB O O
99 up RP O O
99 with IN B-VP O
99 Dr NNP B-NP O
99 Haddow NNP I-NP O
99 within IN B-VP O
99 1 CD O O
99 week NN B-NP O
99 of IN B-VP O
99 dsicharge NN B-NP O
100 2 CD O O
100 Please NNP B-NP O
100 continue VB O O
100 to TO O O
100 take VB O O
100 all DT O O
100 of IN B-VP O
100 your PRP$ O B-m
100 medications NNS B-NP I-m
100 as IN B-VP O
100 directed JJ B-NP O
101 DISCHARGE NNP I-NP O
101 CONDITION: NNP I-NP O
101 Satisfactory NNP I-NP O
102 TO NNP I-NP O
102 DO/PLAN: NNP I-NP O
103 1 CD O O
103 Follow NNP B-NP O
103 up RB O O
103 with IN B-VP O
103 Dr NNP B-NP O
103 Hogy NNP I-NP O
104 2 CD O O
104 Follow NNP B-NP O
104 up RB O O
104 on IN B-VP O
104 final JJ B-NP O
104 read NN I-NP O
104 of IN B-VP O
104 rib JJ B-NP O
104 films NNS I-NP O
105 No RB O O
105 dictated VBD B-VP O
105 summary JJ B-NP O
106 ENTERED NNP I-NP O
106 BY: NNP I-NP O
106 BOLTER NNP I-NP O
106 , , O O
106 CHARLIE NNP B-NP O
106 IRVING NNP I-NP O
106 , , O O
106 M.D NNP B-NP O
106 ( ( O O
106 RT74 NNP B-NP O
106 ) ) O O
106 2/15/04 CD O O
106 @ $ O O
106 07:09 CD O O
106 PM NNP B-NP O
107 ****** JJ B-NP O
107 END NNP I-NP O
107 OF NNP I-NP O
107 DISCHARGE NNP I-NP O
107 ORDERS NNP I-NP O
107 ****** NNP I-NP O
108 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #253290 VBZ O O
2 755494408 CD O O
2 NMC NNP B-NP O
2 20190911 CD O O
2 5782272 CD O O
2 6/30/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Asthma NNP I-NP O
2 exacerbation NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 7/6/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/15/2005 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 REINHOLTZ NNP I-NP O
5 , , O O
5 IVORY NNP B-NP O
5 261-40-05-7 JJ B-NP O
6 Minfran NNP I-NP O
6 Cin NNP I-NP O
6 Geneli NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 4/2/05 CD O O
8 AT NNP B-NP O
8 04:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 STRUVE NNP I-NP O
11 , , O O
11 FRANCISCO NNP B-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ECASA NNP I-NP B-m
16 ( ( O I-m
16 ASPIRIN NNP B-NP I-m
16 ENTERIC NNP I-NP I-m
16 COATED NNP I-NP I-m
16 ) ) O I-m
16 325 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 CARDIZEM NNP I-NP B-m
17 SR NNP I-NP I-m
17 ( ( O I-m
17 DILTIAZEM NNP B-NP I-m
17 SUSTAINED NNP I-NP I-m
17 RELEASE NNP I-NP I-m
17 ) ) O I-m
17 120 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 Food/Drug NNP I-NP O
18 Interaction NNP I-NP O
18 Instruction NNP I-NP O
19 Avoid NNP I-NP O
19 grapefruit NN I-NP O
19 unless IN B-VP O
19 MD NNP B-NP O
19 instructs NNS I-NP O
19 otherwise RB O O
20 Override NNP B-NP O
20 Notice: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 0/9/05 CD O O
20 by IN B-VP O
20 DUHART NNP B-NP O
20 , , O O
20 RANDY NNP B-NP O
20 M NNP I-NP O
20 , , O O
20 M.D NNP B-NP O
20 on IN B-VP O
20 order NN B-NP O
20 for IN B-VP O
20 LOPRESSOR NNP B-NP B-m
20 PO NNP I-NP B-mo
20 ( ( O O
20 ref JJ O O
20 # # O O
20 31219927 CD O O
20 ) ) O O
21 POTENTIALLY NNP B-NP O
21 SERIOUS NNP I-NP O
21 INTERACTION: NNP I-NP O
21 DILTIAZEM NNP I-NP B-m
21 HCL NNP I-NP I-m
21 &amp; NNP I-NP O
22 METOPROLOL NNP I-NP B-m
22 TARTRATE NNP I-NP I-m
22 Reason NNP I-NP O
22 for IN B-VP O
22 override: NN B-NP O
22 aware JJ B-NP O
23 Previous NNP I-NP O
23 override NN I-NP O
23 information: NN I-NP O
24 Override NNP I-NP O
24 added VBD B-VP O
24 on IN B-VP O
24 7/11/05 CD O O
24 by IN B-VP O
24 EHRHARD NNP B-NP O
24 , , O O
24 STANLEY NNP B-NP O
24 , , O O
24 M.D NNP B-NP O
25 POTENTIALLY NNP I-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 METOPROLOL NNP I-NP B-m
25 TARTRATE NNP I-NP I-m
25 &amp; NNP I-NP O
26 DILTIAZEM NNP I-NP B-m
26 HCL NNP I-NP I-m
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 ok JJ B-NP O
27 Number NNP I-NP O
27 of IN B-VP O
27 Doses NNP B-NP O
27 Required NNP I-NP O
27 ( ( O O
27 approximate JJ B-NP O
27 ): NN I-NP O
27 99 CD O O
28 HYDROCHLOROTHIAZIDE NNP B-NP B-m
28 25 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 LISINOPRIL NNP I-NP B-m
29 30 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QD NNP I-NP B-f
30 Override NNP I-NP O
30 Notice: NNP I-NP O
30 Override NNP I-NP O
30 added VBD B-VP O
30 on IN B-VP O
30 7/11/05 CD O O
30 by IN B-VP O
31 JACQUEMIN NNP B-NP O
31 , , O O
31 FOREST NNP B-NP O
31 G NNP I-NP O
31 , , O O
31 M.D NNP B-NP O
31 , , O O
31 PH.D NNP B-NP O
32 on IN B-VP O
32 order NN B-NP O
32 for IN B-VP O
32 POTASSIUM NNP B-NP B-m
32 CHLORIDE NNP I-NP I-m
32 IMMED NNP I-NP I-m
32 REL NNP I-NP I-m
32 PO NNP I-NP B-mo
32 ( ( O O
32 ref JJ O O
32 # # O O
33 73021085 CD O O
33 ) ) O O
34 POTENTIALLY NNP B-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 LISINOPRIL NNP I-NP B-m
34 &amp; NNP I-NP O
34 POTASSIUM NNP I-NP B-m
35 CHLORIDE NNP I-NP O
35 Reason NNP I-NP O
35 for IN B-VP O
35 override: NN B-NP O
35 aware JJ B-NP O
36 LORAZEPAM NNP I-NP B-m
36 0.5 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 BID NNP I-NP B-f
36 PRN NNP I-NP I-f
36 Anxiety NNP I-NP B-r
37 LOPRESSOR NNP I-NP B-m
37 ( ( O I-m
37 METOPROLOL NNP B-NP I-m
37 TARTRATE NNP I-NP I-m
37 ) ) O I-m
37 12.5 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 BID NNP I-NP B-f
38 Starting VBG O O
38 Today NNP B-NP O
38 ( ( O O
38 2/19 CD O O
38 ) ) O O
38 HOLD NNP B-NP O
38 IF: NNP I-NP O
38 HR&lt;50 NNP I-NP O
38 , , O O
38 SBP&lt;100 NNP B-NP O
39 Food/Drug NNP I-NP O
39 Interaction NNP I-NP O
39 Instruction NNP I-NP O
40 Take NNP I-NP O
40 consistently RB O O
40 with IN B-VP O
40 meals NNS B-NP O
40 or CC O O
40 on IN B-VP O
40 empty JJ B-NP O
40 stomach NN I-NP O
41 Reason: NNP I-NP O
41 Override NNP I-NP O
41 added VBD B-VP O
41 on IN B-VP O
41 7/11/05 CD O O
41 by IN B-VP O
42 BOILEAU NNP B-NP O
42 , , O O
42 RAYFORD NNP B-NP O
42 , , O O
42 M.D NNP B-NP O
43 on IN B-VP O
43 order NN B-NP O
43 for IN B-VP O
43 CARDIZEM NNP B-NP B-m
43 SR NNP I-NP I-m
43 PO NNP I-NP B-mo
43 ( ( O O
43 ref JJ O O
43 # # O O
43 76249027 CD O O
43 ) ) O O
44 POTENTIALLY NNP B-NP O
44 SERIOUS NNP I-NP O
44 INTERACTION: NNP I-NP O
44 METOPROLOL NNP I-NP B-m
44 TARTRATE NNP I-NP I-m
44 &amp; NNP I-NP O
45 DILTIAZEM NNP I-NP B-m
45 HCL NNP I-NP I-m
45 Reason NNP I-NP O
45 for IN B-VP O
45 override: NN B-NP O
45 ok VBP O O
46 Previous NNP B-NP O
46 override IN B-VP O
46 information: JJ B-NP O
47 Override NNP I-NP O
47 added VBD B-VP O
47 on IN B-VP O
47 7/11/05 CD O O
47 by IN B-VP O
47 UPHOLD NNP B-NP O
47 , , O O
47 DONNY NNP B-NP O
47 , , O O
47 M.D NNP B-NP O
48 on IN B-VP O
48 order NN B-NP O
48 for IN B-VP O
48 CARDIZEM NNP B-NP B-m
48 PO NNP I-NP B-mo
48 ( ( O O
48 ref JJ O O
48 # # O O
48 49626929 CD O O
48 ) ) O O
49 POTENTIALLY NNP B-NP O
49 SERIOUS NNP I-NP O
49 INTERACTION: NNP I-NP O
49 METOPROLOL NNP I-NP B-m
49 TARTRATE NNP I-NP I-m
49 &amp; NNP I-NP O
50 DILTIAZEM NNP I-NP B-m
50 HCL NNP I-NP I-m
50 Reason NNP I-NP O
50 for IN B-VP O
50 override: NN B-NP O
50 ok JJ B-NP O
51 PREDNISONE NNP I-NP B-m
51 PREDNISONE NNP I-NP B-m
51 PREDNISONE NNP I-NP B-m
51 PREDNISONE NNP I-NP B-m
51 PREDNISONE NNP I-NP B-m
51 PREDNISONE NNP I-NP B-m
51 PREDNISONE NNP I-NP B-m
51 40 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 QAM NNP I-NP B-f
51 X NNP I-NP B-du
51 10 CD O I-du
51 doses NNS B-NP I-du
52 Starting VBG O O
52 Today NNP B-NP O
52 ( ( O O
52 2/19 CD O O
52 ) ) O O
53 Instructions: NNP B-NP O
53 Taper: NNP I-NP O
53 40mg CD O B-do
53 40mg CD O B-do
53 for IN B-VP B-du
53 2 CD O B-du
53 2 CD O I-du
53 days NNS B-NP I-du
53 days NNS I-NP I-du
53 , , O O
53 then RB O O
53 35mg CD O B-do
53 for IN B-VP B-du
53 2days CD O I-du
53 , , O O
54 then RB O O
54 30mg CD O B-do
54 for IN B-VP B-du
54 2days CD O I-du
54 , , O O
54 then RB O O
54 25mg CD O B-do
54 for IN B-VP B-du
54 2days CD O I-du
54 , , O O
54 then RB O O
54 20mg CD O B-do
55 indefinitely RB O B-du
56 ZOCOR NNP B-NP B-m
56 ( ( O I-m
56 SIMVASTATIN NNP B-NP I-m
56 ) ) O I-m
56 40 CD O B-do
56 MG NNP B-NP I-do
56 PO NNP I-NP B-mo
56 QHS NNP I-NP B-f
57 Food/Drug NNP I-NP O
57 Interaction NNP I-NP O
57 Instruction NNP I-NP O
58 Avoid NNP I-NP O
58 grapefruit NN I-NP O
58 unless IN B-VP O
58 MD NNP B-NP O
58 instructs NNS I-NP O
58 otherwise RB O O
59 CLOPIDOGREL NNP B-NP B-m
59 75 CD O B-do
59 MG NNP B-NP I-do
59 PO NNP I-NP B-mo
59 QD NNP I-NP B-f
60 CALCIUM NNP I-NP B-m
60 CARB NNP I-NP I-m
60 + NNP I-NP I-m
60 D NNP I-NP I-m
60 ( ( O I-m
60 600MG CD O I-m
60 ELEM NNP B-NP I-m
60 CA NNP I-NP I-m
60 + NNP I-NP I-m
60 VIT NNP I-NP I-m
60 D/200 NNP I-NP I-m
60 IU NNP I-NP I-m
60 ) ) O I-m
61 1 CD O B-do
61 TAB NNP B-NP I-do
61 PO NNP I-NP B-mo
61 QD NNP I-NP B-f
62 COMBIVENT NNP I-NP B-m
62 ( ( O I-m
62 IPRATROPIUM NNP B-NP I-m
62 AND NNP I-NP I-m
62 ALBUTEROL NNP I-NP I-m
62 SULFATE NNP I-NP I-m
62 ) ) O I-m
63 2 CD O B-do
63 PUFF NNP B-NP I-do
63 INH NNP I-NP B-mo
63 QID NNP I-NP B-f
64 ATOVAQUONE NNP I-NP B-m
64 750 CD O B-do
64 MG NNP B-NP I-do
64 PO NNP I-NP B-mo
64 BID NNP I-NP B-f
65 Food/Drug NNP I-NP O
65 Interaction NNP I-NP O
65 Instruction NNP I-NP O
65 Give NNP I-NP O
65 with IN B-VP O
65 meals NNS B-NP O
66 NAPROSYN NNP I-NP B-m
66 ( ( O I-m
66 NAPROXEN NNP B-NP I-m
66 ) ) O I-m
66 250-500 CD O B-do
66 MG NNP B-NP I-do
66 PO NNP I-NP B-mo
66 BID NNP I-NP B-f
66 PRN NNP I-NP I-f
66 Pain NNP I-NP B-r
67 Food/Drug NNP I-NP O
67 Interaction NNP I-NP O
67 Instruction NNP I-NP O
67 Take NNP I-NP O
67 with IN B-VP O
67 food NN B-NP O
68 Alert NNP I-NP O
68 overridden: NNP I-NP O
68 Override NNP I-NP O
68 added VBD B-VP O
68 on IN B-VP O
68 4/2/05 CD O O
68 by IN B-VP O
68 : : O O
69 POTENTIALLY NNP B-NP O
69 SERIOUS NNP I-NP O
69 INTERACTION: NNP I-NP O
69 CLOPIDOGREL NNP I-NP B-m
69 BISULFATE NNP I-NP I-m
69 &amp; NNP I-NP O
70 NAPROXEN NNP I-NP B-m
70 Reason NNP I-NP O
70 for IN B-VP O
70 override: NN B-NP O
70 musculoskeletal NN I-NP O
70 pain NN I-NP O
71 ADVAIR NNP I-NP B-m
71 DISKUS NNP I-NP I-m
71 500/50 CD O I-m
71 ( ( O I-m
71 FLUTICASONE NNP B-NP I-m
71 PROPIONATE/ NNP I-NP I-m
71 ) ) O I-m
72 1 CD O B-do
72 PUFF NNP B-NP I-do
72 INH NNP I-NP B-mo
72 BID NNP I-NP B-f
73 DIET: NNP I-NP O
73 No NNP I-NP O
73 Restrictions NNP I-NP O
74 ACTIVITY: NNP I-NP O
74 Resume NNP I-NP O
74 regular JJ B-NP O
74 exercise NN I-NP O
75 FOLLOW NNP I-NP O
75 UP NNP I-NP O
75 APPOINTMENT( NNP I-NP O
75 S NNP I-NP O
75 ): NNP I-NP O
76 Dr NNP I-NP O
76 BALVANZ NNP I-NP O
76 , , O O
76 PCP NNP B-NP O
76 2 CD O O
76 weeks NNS B-NP O
76 , , O O
77 ALLERGY: NNP B-NP O
77 Penicillins NNP I-NP O
78 ADMIT NNP I-NP O
78 DIAGNOSIS: NNP I-NP O
79 asthma VBZ O O
79 exacerbation NN B-NP O
80 PRINCIPAL NNP I-NP O
80 DISCHARGE NNP I-NP O
80 DIAGNOSIS NNP I-NP O
80 ;Responsible JJ O O
80 After IN B-VP O
80 Study NNP B-NP O
80 for IN B-VP O
80 Causing NNP B-NP O
80 Admission NNP I-NP O
80 ) ) O O
81 Asthma NNP B-NP O
81 exacerbation NN I-NP O
82 OTHER NNP I-NP O
82 DIAGNOSIS;Conditions NNP I-NP O
82 , , O O
82 Infections NNP B-NP O
82 , , O O
82 Complications NNP B-NP O
82 , , O O
82 affecting VBG O O
82 Treatment/Stay NNP B-NP O
83 CAD NNP I-NP O
83 s/p NN I-NP O
83 NSTEMI NNP I-NP O
83 , , O O
83 stent NN B-NP O
83 to TO O O
83 LAD NNP B-NP O
83 OBESITY NNP I-NP O
83 OSA NNP I-NP O
83 HTN NNP I-NP O
84 diabetes VBZ O O
84 mellitus $ O O
84 2/2 CD O O
84 chronic JJ B-NP O
84 steroid NN I-NP B-m
84 use NN I-NP O
85 OPERATIONS NNP I-NP O
85 AND NNP I-NP O
85 PROCEDURES: NNP I-NP O
86 none NN I-NP O
87 OTHER NNP I-NP O
87 TREATMENTS/PROCEDURES NNP I-NP O
87 ( ( O O
87 NOT NNP B-NP O
87 IN NNP I-NP O
87 O.R NNP I-NP O
87 ) ) O O
88 ECHO NNP B-NP O
89 BRIEF NNP I-NP O
89 RESUME NNP I-NP O
89 OF NNP I-NP O
89 HOSPITAL NNP I-NP O
89 COURSE: NNP I-NP O
90 45 CD O O
90 Yo NNP B-NP O
90 obese JJ B-NP O
90 F NNP I-NP O
90 ho NN I-NP O
90 IDDM NNP I-NP O
90 , , O O
90 sleep JJ B-NP O
90 apnea NN I-NP O
90 , , O O
90 asthma NN B-NP B-r
90 on IN B-VP O
91 chronic JJ B-NP O
91 prednisone NN I-NP B-m
91 , , O O
91 HTN NNP B-NP O
91 , , O O
91 CAD NNP B-NP O
91 s/p VBD B-VP O
91 NSTEMI NNP B-NP O
91 in IN B-VP O
91 6/10 CD O O
91 w JJ B-NP O
91 stent NN I-NP O
91 to TO O O
91 LAD NNP B-NP O
92 presents NNS I-NP O
92 w VBP O O
92 SOB NNP B-NP O
92 x $ O O
92 3 CD O O
92 days NNS B-NP O
92 Pt NNP I-NP O
92 was VBD B-VP O
92 in IN B-VP O
92 USH NNP B-NP O
92 until IN B-VP O
92 2 CD O O
92 days NNS B-NP O
92 PTA NNP I-NP O
92 , , O O
92 when WRB O O
92 she PRP O O
93 noticed VBD B-VP O
93 sudden JJ B-NP O
93 onset NN I-NP O
93 of IN B-VP O
93 shortness NN B-NP O
93 of IN B-VP O
93 breath NN B-NP O
93 and CC O O
93 chest NN B-NP O
93 pressure NN I-NP O
93 She PRP O O
94 states VBZ O O
94 that IN B-VP O
94 her PRP$ O O
94 chest NN B-NP O
94 feels NNS I-NP O
94 heavy VBP O O
94 at IN B-VP O
94 times NNS B-NP O
94 , , O O
94 sometimes RB O O
94 worse JJR O O
94 when WRB O O
94 taking VBG O O
95 a DT B-NP O
95 deep JJ I-NP O
95 breath NN I-NP O
95 She PRP O O
95 states VBZ O O
95 that IN B-VP O
95 since IN B-VP O
95 onset NN B-NP O
95 of IN B-VP O
95 chest JJ B-NP O
95 pressure NN I-NP O
95 , , O O
95 her PRP$ O O
95 chest NN B-NP O
96 tightness NN I-NP O
96 has VBZ O O
96 become VBN O O
96 more RBR O O
96 severe JJ O O
96 and CC O O
96 worse JJ B-NP O
96 w NN I-NP O
96 exertion NN I-NP O
96 She PRP O O
96 also RB O O
96 states VBZ O O
97 that IN B-VP O
97 she PRP O O
97 occasionally RB O O
97 gets VBZ O O
97 palpitations NNS B-NP O
97 since IN B-VP O
97 her PRP$ O O
97 MI NNP B-NP O
97 , , O O
97 but CC O O
97 no DT B-NP O
98 N/V/diaphoresis NNP I-NP O
98 Pt NNP I-NP O
98 states VBZ O O
98 that IN B-VP O
98 she PRP O O
98 has VBZ O O
98 also RB O O
98 developed VBN O O
98 a DT B-NP O
98 dry JJ I-NP O
98 cough NN I-NP O
98 over IN B-VP O
99 past JJ B-NP O
99 few JJ I-NP O
99 days NNS I-NP O
99 , , O O
99 no DT B-NP O
99 fevers NNS I-NP O
99 , , O O
99 no DT O O
99 sick JJ O O
99 contacts VBZ O O
99 No DT B-NP O
99 lower JJR I-NP O
99 ext NN I-NP O
99 edema NN I-NP O
99 , , O O
99 but CC O O
99 has VBZ O O
100 had VBN O O
100 stable JJ B-NP O
100 3-pillow JJ I-NP O
100 orthopnea NN I-NP O
100 and CC O O
100 PND NNP B-NP O
101 PE: NNP I-NP O
101 BP NNP I-NP O
101 170/105 CD O O
101 HR NNP B-NP O
101 80 CD O O
101 100%RA CD O O
102 NAD NNP B-NP O
102 , , O O
102 AOx3 NNP B-NP O
102 , , O O
102 JVP NNP B-NP O
102 8cm CD O O
102 , , O O
102 sternum NN B-NP O
102 tender NN I-NP O
102 to TO O O
102 palpation NN B-NP O
102 , , O O
102 bilat JJ B-NP O
102 exp NN I-NP O
102 wheezes VBZ O O
103 throughout IN B-VP O
103 , , O O
103 prolonged VBD B-VP O
103 expiratory JJ B-NP O
103 phase NN I-NP O
103 , , O O
103 s1 NN B-NP O
103 s2 NN I-NP O
103 , , O O
103 abd JJ O O
103 soft JJ O O
103 , , O O
103 no DT B-NP O
104 c/c/e NN I-NP O
105 labs: RB O O
105 trop JJ O O
105 neg FW O O
105 x3 NN B-NP O
105 , , O O
105 D-dimer&lt;200 NNP B-NP O
105 , , O O
105 BNP NNP B-NP O
105 19 CD O O
106 EKG: NNP B-NP O
106 NSR NNP I-NP O
106 , , O O
106 nl JJ B-NP O
106 Axis NNP I-NP O
106 , , O O
106 no DT B-NP O
106 ST NNP I-NP O
106 changes NNS I-NP O
107 CXR: NNP I-NP O
107 lungs NNS I-NP O
107 clear JJ O O
107 bilaterally RB O O
107 , , O O
107 costophrenic JJ B-NP O
107 sulci NN I-NP O
107 sharp JJ B-NP O
107 bilat NN I-NP O
107 , , O O
107 no DT B-NP O
107 acute JJ I-NP O
108 pulm NN I-NP O
108 process NN I-NP O
109 45 CD O O
109 yo NN B-NP O
109 F NNP I-NP O
109 IDDM NNP I-NP O
109 , , O O
109 known VBN O O
109 CAD NNP B-NP O
109 s/p JJ B-NP O
109 recent JJ I-NP O
109 MI NNP I-NP O
109 w NN I-NP O
109 stent NN I-NP O
109 to TO O O
109 LAD NNP B-NP O
109 , , O O
109 asthma NN B-NP B-r
109 on IN B-VP O
109 chronic JJ B-NP O
110 prednisone NN I-NP B-m
110 , , O O
110 presents NNS B-NP O
110 w VBP O O
110 3 CD O O
110 days NNS B-NP O
110 worsening VBG O O
110 dyspnea NN B-NP O
110 and CC O O
110 chest JJ B-NP O
110 pressure NN I-NP O
110 Pt NNP I-NP O
111 treated VBD B-VP O
111 for IN B-VP O
111 asthma JJ B-NP B-r
111 exacerbation NN I-NP I-r
111 w NN I-NP O
111 prednisone NN I-NP B-m
111 and CC O O
111 no DT B-NP O
111 relief NN I-NP O
111 of IN B-VP O
111 symptoms NNS B-NP O
112 Given NNP I-NP O
112 known VBP O O
112 CAD NNP B-NP O
112 , , O O
112 recent JJ B-NP O
112 MI NNP I-NP O
112 , , O O
112 ho NN B-NP O
112 PND NNP I-NP O
112 and CC O O
112 orthopnea NN B-NP O
112 , , O O
112 considered VBN O O
112 both DT O O
112 cardiac JJ O O
113 and CC O O
113 pulmonary JJ B-NP O
113 etiologies NNS I-NP O
113 of IN B-VP O
113 symptoms NNS B-NP O
114 CV: NNP I-NP O
114 ROMI NNP I-NP O
114 with IN B-VP O
114 neg JJ B-NP O
114 cardiac JJ I-NP O
114 enzymes NNS I-NP O
114 x3 VBP O O
114 , , O O
114 no DT B-NP O
114 ischemic JJ I-NP O
114 changes NNS I-NP O
114 on IN B-VP O
114 ECG NNP B-NP O
114 ECHO NNP I-NP O
115 shows VBZ O O
115 concentric JJ B-NP O
115 LVH NNP I-NP O
115 but CC O O
115 EF NNP B-NP O
115 65% CD O O
115 , , O O
115 no DT B-NP O
115 evidence NN I-NP O
115 of IN B-VP O
115 wall NN B-NP O
115 motion NN I-NP O
115 abnormalities NNS I-NP O
116 or CC O O
116 systolic/diastolic JJ B-NP O
116 dysfunction NN I-NP O
116 BNP NNP I-NP O
116 , , O O
116 TnI NNP B-NP O
116 normal JJ B-NP O
116 JVP NNP I-NP O
116 8cm CD O O
116 One CD O O
116 episode NN B-NP O
117 of IN B-VP O
117 subjective JJ B-NP O
117 palpitations NNS I-NP O
117 during IN B-VP O
118 admission NN B-NP O
118 , , O O
118 with IN B-VP O
118 no DT B-NP O
118 evidence NN I-NP O
118 of IN B-VP O
118 arrhythmia NN B-NP O
118 on IN B-VP O
118 telemetry NN B-NP O
118 She PRP O O
118 did VBD B-VP O
118 have VB O O
118 one CD O O
119 brief JJ B-NP O
119 episode NN I-NP O
119 of IN B-VP O
119 apparent JJ B-NP O
119 broad-complex JJ I-NP O
119 tachycardia NN I-NP O
119 on IN B-VP O
119 telemetry NN B-NP O
119 which WDT O O
119 , , O O
119 on IN B-VP O
120 closer JJR B-NP O
120 inspection NN I-NP O
120 and CC O O
120 review NN B-NP O
120 by IN B-VP O
120 the DT B-NP O
120 EP NNP I-NP O
120 fellow NN I-NP O
120 , , O O
120 was VBD B-VP O
120 clearly RB O O
120 shown VBN O O
120 to TO O O
120 be VB O O
121 artefactual JJ O O
121 ( ( O O
121 normal JJ B-NP O
121 sinus NN I-NP O
121 rhythm NN I-NP O
121 observed VBD B-VP O
121 throughout IN B-VP O
121 in IN B-VP O
121 lead NN B-NP O
121 I PRP O O
121 ) ) O O
122 Ischemia: NNP B-NP O
122 continue VBP O O
122 zocor NN B-NP B-m
122 , , O O
122 clopidogrel NN B-NP B-m
122 , , O O
122 ECASA NNP B-NP B-m
122 nitrates VBZ O B-m
122 as IN B-VP B-f
122 needed VBN O I-f
123 Pump: NNP B-NP O
123 continue VBP O O
123 lisinopril NN B-NP B-m
123 , , O O
123 HCTZ NNP B-NP B-m
123 , , O O
123 cardizem NN B-NP B-m
123 Lopressor NNP I-NP B-m
123 12.5mg CD O B-do
123 PO NNP B-NP B-mo
123 BID NNP I-NP B-f
124 Rhythm: NNP I-NP O
124 NSR NNP I-NP O
124 stable JJ B-NP O
125 Pulm: NNP I-NP O
125 Dyspnea NNP I-NP O
125 and CC O O
125 wheezing VBG O O
125 w JJ B-NP O
125 ho NN I-NP O
125 multiple JJ B-NP O
125 asthma JJ I-NP O
125 exacerbations NNS I-NP O
125 on IN B-VP O
126 presentation NN B-NP O
126 Never NNP I-NP O
126 hospitalized VBD B-VP O
126 , , O O
126 chronic JJ B-NP O
126 prednisone NN I-NP B-m
126 therapy NN I-NP I-m
126 s/p NN I-NP O
126 gentle JJ B-NP O
127 diuresis NN I-NP O
127 , , O O
127 pred VBN O B-m
127 , , O O
127 nebs JJ B-NP O
127 w NN I-NP O
127 improvement NN I-NP O
127 of IN B-VP O
127 symptoms NNS B-NP O
127 D-dimer&lt;200 NNP I-NP O
128 Admission NNP I-NP O
128 peak NN I-NP O
128 flow NN I-NP O
128 150 CD O O
128 ( ( O O
128 baseline JJ O O
128 nl IN B-VP O
128 300-350 JJ O O
128 ) ) O O
128 , , O O
128 at IN B-VP O
128 discharge JJ B-NP O
128 275-300 JJ I-NP O
129 Ambulatory NNP I-NP O
129 O2 NNP I-NP O
129 sat VBD B-VP O
129 WNL NNP B-NP O
130 -Combivent NNP I-NP B-m
130 , , O O
130 Advair NNP B-NP B-m
130 , , O O
130 steroid JJ B-NP B-m
130 steroid NN I-NP B-m
130 taper NN I-NP O
130 ( ( O O
130 40mg CD O B-do
130 to TO O O
130 20mg CD O B-do
130 over IN B-VP B-du
130 over IN B-VP B-du
130 8 CD O I-du
130 8 CD O I-du
130 days NNS B-NP I-du
130 days NNS I-NP I-du
130 ) ) O O
130 , , O O
130 PCP NNP B-NP B-m
130 ppx NN I-NP I-m
131 with IN B-VP O
131 BID NNP B-NP B-f
131 Atovaquone NNP I-NP B-m
131 in IN B-VP O
131 setting VBG O O
131 of IN B-VP O
131 chronic JJ B-NP O
131 prednisone NN I-NP B-m
132 ENDO: NNP I-NP O
132 Chronic NNP I-NP O
132 steroid NN I-NP B-m
132 use NN I-NP O
132 , , O O
132 Insulin NNP B-NP B-m
132 SS NNP I-NP O
132 in-house NN I-NP O
132 -calcium/vit NNP I-NP B-m
132 D NNP I-NP O
133 supplement NN I-NP O
134 MUSC: NNP I-NP O
134 Reproducible NNP I-NP O
134 sternal JJ B-NP O
134 pain NN I-NP O
134 on IN B-VP O
134 palpation NN B-NP O
134 consistent NN I-NP O
134 with IN B-VP O
135 costochondritis NN B-NP O
135 Naprosyn NNP I-NP B-m
135 PRN NNP I-NP B-f
135 pain NN I-NP B-r
136 Psych: NNP I-NP O
136 Continue NNP I-NP O
136 Zoloft NNP I-NP B-m
136 for IN B-VP O
136 depression NN B-NP B-r
136 and CC O O
136 Lorazepam NNP B-NP B-m
136 for IN B-VP O
136 anxiety NN B-NP B-r
137 PPx: NNP I-NP O
137 PPI NNP I-NP O
138 FULL NNP I-NP O
138 CODE NNP I-NP O
139 ADDITIONAL NNP I-NP O
139 COMMENTS: NNP I-NP O
139 Please NNP I-NP O
139 call VB O O
139 your PRP$ O O
139 PCP NNP B-NP O
139 or CC O O
139 come VBN O O
139 to TO O O
139 the DT B-NP O
139 emergency NN I-NP O
139 room NN I-NP O
139 if IN B-VP O
139 you PRP O O
139 experience VBP O O
139 any DT O O
140 of IN B-VP O
140 the DT B-NP O
140 following: JJ I-NP O
140 loss NN I-NP O
140 of IN B-VP O
140 consciousness NN B-NP O
140 , , O O
140 chest NN B-NP O
140 pain NN I-NP O
140 , , O O
140 difficulty NN B-NP O
141 breathing NN I-NP O
141 , , O O
141 swelling VBG O O
141 in IN B-VP O
141 legs JJ B-NP O
142 DISCHARGE NNP I-NP O
142 CONDITION: NNP I-NP O
142 Stable NNP I-NP O
143 TO NNP I-NP O
143 DO/PLAN: NNP I-NP O
144 Assess: NNP I-NP O
145 -efficacy NN I-NP O
145 of IN B-VP O
145 prednisone NN B-NP B-m
145 20mg CD O B-do
145 upon IN B-VP O
145 completion NN B-NP O
145 of IN B-VP O
145 taper JJ B-NP O
146 -status NN I-NP O
146 of IN B-VP O
146 dyspnea/asthma NN B-NP O
146 symptoms NNS I-NP O
146 on IN B-VP O
146 low JJ B-NP B-do
146 dose JJ I-NP I-do
146 beta-blocker NN I-NP B-m
147 -chest NNP I-NP O
147 pain/costochondritis NN I-NP O
147 with IN B-VP O
147 PRN NNP B-NP B-f
147 NSAIDs NNP I-NP B-m
148 -compliance NN I-NP O
148 with IN B-VP O
148 atovaquone NN B-NP B-m
148 ppx NN I-NP O
149 No NNP I-NP O
149 dictated VBD B-VP O
149 summary JJ B-NP O
150 ENTERED NNP I-NP O
150 BY: NNP I-NP O
150 KEPNER NNP I-NP O
150 , , O O
150 KENDRICK NNP B-NP O
150 , , O O
150 M.D NNP B-NP O
150 ( ( O O
150 CB41 NNP B-NP O
150 ) ) O O
150 4/2/05 CD O O
150 @ $ O O
150 03 CD O O
151 ****** JJ B-NP O
151 END NN I-NP O
151 OF NNP I-NP O
151 DISCHARGE NNP I-NP O
151 ORDERS NNP I-NP O
151 ****** NNP I-NP O
152 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #269404 VBZ O O
2 211892555 CD O O
2 AGH NNP B-NP O
2 34558636 CD O O
2 1187944 CD O O
2 8/14/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CORONARY NNP I-NP O
2 ARTERY NNP I-NP O
2 DISEASE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/13/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 11/8/2006 CD O O
4 ATTENDING: NNP B-NP O
4 SHELOR NNP I-NP O
4 , , O O
4 KENDRICK NNP B-NP O
4 M.D NNP I-NP O
5 SERVICE: NNP I-NP O
6 Cardiac NNP I-NP O
6 Surgery NNP I-NP O
6 Service NNP I-NP O
7 ADMITTING NNP I-NP O
7 DIAGNOSES: NNP I-NP O
8 Coronary NNP I-NP O
8 artery NN I-NP O
8 disease NN I-NP O
8 and CC O O
8 aortic JJ B-NP O
8 stenosis NN I-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
10 This DT O O
10 is VBZ O O
10 a DT B-NP O
10 79-year-old JJ I-NP O
10 male NN I-NP O
10 status NN I-NP O
10 post NN I-NP O
10 stenting NN I-NP O
10 of IN B-VP O
10 the DT B-NP O
10 PDA NNP I-NP O
10 and CC O O
11 PTCA NNP B-NP O
11 , , O O
11 radioablation NN B-NP O
11 and CC O O
11 stenting NN B-NP O
11 of IN B-VP O
11 his PRP$ O O
11 LAD NNP B-NP O
11 in IN B-VP O
11 2000 CD O O
11 He PRP O O
11 had VBD B-VP O
12 recurrent JJ B-NP O
12 ischemic JJ I-NP O
12 symptoms NNS I-NP O
12 four CD O O
12 months NNS B-NP O
12 later RB O O
12 and CC O O
12 cardiac JJ B-NP O
13 catheterization NN I-NP O
13 showed VBD B-VP O
13 restenosis NN B-NP O
13 of IN B-VP O
13 his PRP$ O O
13 LAD NNP B-NP O
13 with IN B-VP O
13 an DT O O
13 80% CD O O
13 lesion NN B-NP O
14 at IN B-VP O
14 D3 NNP B-NP O
14 He PRP O O
14 had VBD B-VP O
14 brachytherapy NN B-NP O
14 and CC O O
14 repeat NN B-NP O
14 PTCA NNP I-NP O
14 Since IN B-VP O
14 then RB O O
14 , , O O
14 he PRP O O
14 has VBZ O O
15 done VBN O O
15 well RB O O
15 but CC O O
15 he PRP O O
15 had VBD B-VP O
15 increasing VBG O O
15 dyspnea NN B-NP O
15 from IN B-VP O
15 CR NNP B-NP O
15 Exercise NNP I-NP O
16 thallium NN I-NP O
16 test NN I-NP O
16 , , O O
16 which WDT O O
16 showed VBD B-VP O
16 increasing VBG O O
16 LV NNP B-NP O
16 filling NN I-NP O
16 pressures NNS I-NP O
17 during IN B-VP O
17 exercise NN B-NP O
17 and CC O O
17 inferior JJ B-NP O
17 apical JJ I-NP O
17 ischemia NN I-NP O
17 He PRP O O
17 was VBD B-VP O
17 admitted VBN O O
18 for IN B-VP O
18 cardiac JJ B-NP O
18 catheterization NN I-NP O
18 , , O O
18 which WDT O O
18 was VBD B-VP O
18 done VBN O O
18 on IN B-VP O
18 6/14/06 CD O O
18 and CC O O
18 the DT B-NP O
19 patient NN I-NP O
19 was VBD B-VP O
19 found VBN O O
19 to TO O O
19 have VB O O
19 a DT O O
19 45% CD O O
19 proximal JJ B-NP O
19 right JJ I-NP O
19 coronary JJ I-NP O
19 artery NN I-NP O
20 disease NN I-NP O
20 , , O O
20 50% CD O O
20 distal NN B-NP O
20 left VBD B-VP O
20 main JJ B-NP O
20 disease NN I-NP O
20 , , O O
20 and CC O O
20 95% CD O O
20 mid NN B-NP O
20 LAD NNP I-NP O
20 disease NN I-NP O
21 PAST NNP I-NP O
21 MEDICAL NNP I-NP O
21 HISTORY: NNP I-NP O
22 Significant NNP I-NP O
22 for IN B-VP O
22 hypertension NN B-NP O
22 , , O O
22 dyslipidemia NN B-NP O
22 , , O O
22 and CC O O
22 chest JJS B-NP O
22 radiation NN I-NP O
22 , , O O
23 prostate NN B-NP O
23 cancer NN I-NP O
23 , , O O
23 osteoporosis NN B-NP O
23 , , O O
23 and CC O O
23 urinary JJ B-NP O
23 incontinence NN I-NP O
24 HOSPITAL NNP I-NP O
24 COURSE: NNP I-NP O
25 He PRP O O
25 was VBD B-VP O
25 admitted VBN O O
25 , , O O
25 made VBN O O
25 ready NN B-NP O
25 for IN B-VP O
25 surgery NN B-NP O
25 He PRP O O
25 was VBD B-VP O
25 taken VBN O O
25 to TO O O
25 the DT B-NP O
26 operating NN I-NP O
26 room NN I-NP O
26 on IN B-VP O
26 10/3/06 CD O O
26 At IN B-VP O
26 which WDT O O
26 time NN B-NP O
26 , , O O
26 he PRP O O
26 underwent VBD B-VP O
26 a DT B-NP O
26 CABG NNP I-NP O
27 x3 NN I-NP O
27 with IN B-VP O
27 a DT B-NP O
27 LIMA NNP I-NP O
27 to TO O O
27 the DT B-NP O
27 LAD NNP I-NP O
27 , , O O
27 a DT B-NP O
27 saphenous JJ I-NP O
27 vein NN I-NP O
27 graft NN I-NP O
27 to TO O O
27 the DT B-NP O
27 PDA NNP I-NP O
27 and CC O O
28 a DT B-NP O
28 saphenous JJ I-NP O
28 vein NN I-NP O
28 graft NN I-NP O
28 to TO O O
28 the DT B-NP O
28 obtuse NN I-NP O
28 marginal VBZ O O
28 The DT B-NP O
28 patient's NN I-NP O
29 aortic JJ B-NP O
29 valve NN I-NP O
29 was VBD B-VP O
29 only RB O O
29 found VBN O O
29 to TO O O
29 be VB O O
29 mildly RB O O
29 stenotic JJ O O
29 with IN B-VP O
29 the DT B-NP O
29 valve JJ I-NP O
30 area NN I-NP O
30 of IN B-VP O
30 1.4 CD O O
30 and CC O O
30 a DT B-NP O
30 peak JJ I-NP O
30 gradient NN I-NP O
30 of IN B-VP O
30 30 CD O O
30 This DT O O
30 was VBD B-VP O
30 discussed VBN O O
30 with IN B-VP O
31 his PRP$ O O
31 cardiologist NN B-NP O
31 , , O O
31 Dr NNP B-NP O
31 Cletus NNP I-NP O
31 Columbres NNP I-NP O
31 and CC O O
31 a DT B-NP O
31 combined JJ I-NP O
31 decision NN I-NP O
31 was VBD B-VP O
31 made VBN O O
32 not RB O O
32 to TO O O
32 replace VB O O
32 the DT B-NP O
32 aortic JJ I-NP O
32 valve NN I-NP O
32 at IN B-VP O
32 this DT B-NP O
32 time NN I-NP O
32 The DT B-NP O
32 patient's NN I-NP O
33 immediate JJ B-NP O
33 postoperative JJ I-NP O
33 course NN I-NP O
33 was VBD B-VP O
33 uncomplicated JJ O O
33 He PRP O O
33 was VBD B-VP O
34 transferred VBN O O
34 to TO O O
34 the DT B-NP O
34 Intensive NNP I-NP O
34 Care NNP I-NP O
34 Unit NNP I-NP O
34 in IN B-VP O
34 a DT B-NP O
34 stable JJ I-NP O
34 fashion NN I-NP O
34 He PRP O O
35 was VBD B-VP O
35 found VBN O O
35 to TO O O
35 have VB O O
35 an DT B-NP O
35 inferior JJ I-NP O
35 lateral JJ I-NP O
35 ischemia NN I-NP O
35 on IN B-VP O
35 EKG NNP B-NP O
35 , , O O
35 therefore RB O O
35 , , O O
36 he PRP O O
36 was VBD B-VP O
36 taken VBN O O
36 to TO O O
36 the DT B-NP O
36 cath NN I-NP O
36 lab NN I-NP O
36 , , O O
36 all DT B-NP O
36 grafts NNS I-NP O
36 were VBD B-VP O
36 found VBN O O
36 to TO O O
36 be VB O O
36 patent JJ O O
37 and CC O O
37 there EX O O
37 was VBD B-VP O
37 resolution NN B-NP O
37 of IN B-VP O
37 ischemia NN B-NP O
37 He PRP O O
37 was VBD B-VP O
37 weaned VBN O O
37 off RP O O
37 his PRP$ O O
37 pressors NNS B-NP B-m
37 and CC O O
37 he PRP O O
38 was VBD B-VP O
38 extubated VBN O O
39 He PRP O O
39 was VBD B-VP O
39 found VBN O O
39 to TO O O
39 be VB O O
39 hemodynamically RB O O
40 stable JJ O O
40 He PRP O O
40 was VBD B-VP O
40 started VBN O O
40 on IN B-VP O
40 Lopressor NNP B-NP B-m
40 and CC O O
40 gentle JJ B-NP O
40 diuresis NN I-NP O
40 On IN B-VP O
41 postoperative JJ B-NP O
41 day NN I-NP O
41 #3 NNP I-NP O
41 , , O O
41 we PRP O O
41 titrated VBD B-VP B-do
41 up RP O I-do
41 his PRP$ O O
41 Lopressor NNP B-NP B-m
41 and CC O O
41 started VBD B-VP O
41 on IN B-VP O
42 his PRP$ O O
42 Norvasc NNP B-NP B-m
42 and CC O O
42 transferred VBD B-VP O
42 him PRP O O
42 to TO O O
42 the DT B-NP O
42 Step-Down JJ I-NP O
42 Unit NNP I-NP O
42 On IN B-VP O
43 postoperative JJ B-NP O
43 day NN I-NP O
43 #4 NNP I-NP O
43 , , O O
43 he PRP O O
43 was VBD B-VP O
43 slightly RB O B-r
43 tachycardic JJ O I-r
43 with IN B-VP O
43 ambulation NN B-NP O
44 and CC O O
44 we PRP O O
44 titrated VBD B-VP B-do
44 up RP O I-do
44 on IN B-VP O
44 his PRP$ O O
44 beta-blockers NNS B-NP B-m
44 PA NNP I-NP O
44 and CC O O
44 chest JJS B-NP O
44 x-ray JJ I-NP O
44 look NN I-NP O
45 good JJ B-NP O
45 Physical NNP I-NP O
45 therapy NN I-NP O
45 was VBD B-VP O
45 consulted VBN O O
45 to TO O O
45 decide VB O O
45 whether IN B-VP O
45 the DT B-NP O
46 patient NN I-NP O
46 would MD O O
46 benefit VB O O
46 from IN B-VP O
46 rehabilitation NN B-NP O
46 He PRP O O
46 was VBD B-VP O
46 started VBN O O
46 on IN B-VP O
47 empiric JJ B-NP O
47 levofloxacin NN I-NP B-m
47 for IN B-VP O
47 questionable JJ B-NP B-r
47 pneumonia NN I-NP I-r
47 He PRP O O
47 was VBD B-VP O
47 found VBN O O
48 suitable JJ O O
48 for IN B-VP O
48 discharge NN B-NP O
48 on IN B-VP O
48 postoperative JJ B-NP O
48 day NN I-NP O
48 #5 NNP I-NP O
48 , , O O
48 however RB O O
48 , , O O
48 the DT B-NP O
49 patient NN I-NP O
49 had VBD B-VP O
49 isolated VBN O O
49 temperature NN B-NP O
49 and CC O O
49 his PRP$ O O
49 white JJ B-NP O
49 count NN I-NP O
49 was VBD B-VP O
49 found VBN O O
49 to TO O O
50 be VB O O
50 trending VBG O O
50 and CC O O
50 he PRP O O
50 was VBD B-VP O
50 hypertensive JJ O O
50 The DT B-NP O
50 patient NN I-NP O
50 was VBD B-VP O
50 found VBN O O
50 to TO O O
51 have VB O O
51 a DT B-NP B-r
51 positive JJ I-NP I-r
51 blood NN I-NP I-r
51 culture NN I-NP I-r
51 from IN B-VP O
51 when WRB O O
51 he PRP O O
51 had VBD B-VP O
51 been VBN O O
51 in IN B-VP O
51 the DT B-NP O
52 Intensive NNP I-NP O
52 Care NNP I-NP O
52 Unit NNP I-NP O
52 and CC O O
52 he PRP O O
52 was VBD B-VP O
52 continued VBN O O
52 on IN B-VP O
52 levofloxacin PDT O B-m
52 The DT B-NP O
53 patient NN I-NP O
53 was VBD B-VP O
53 discovered VBN O O
53 to TO O O
53 have VB O O
53 left VBN O B-r
53 leg JJ B-NP I-r
53 cellulitis NN I-NP I-r
53 at IN B-VP O
53 the DT B-NP O
53 knee NN I-NP O
54 where WRB O O
54 his PRP$ O O
54 saphenous JJ B-NP O
54 vein NN I-NP O
54 graft NN I-NP O
54 was VBD B-VP O
54 harvested VBN O O
54 from IN B-VP O
54 He PRP O O
54 was VBD B-VP O
55 started VBN O O
55 on IN B-VP O
55 vancomycin NN B-NP B-m
55 This DT B-NP O
55 area NN I-NP O
55 continued VBD B-VP O
55 to TO O O
55 be VB O O
55 watched VBN O O
55 while IN B-VP O
56 the DT B-NP O
56 patient NN I-NP O
56 remained VBD B-VP O
56 on IN B-VP O
56 IV NNP B-NP B-mo
56 antibiotics NNS I-NP B-m
56 He PRP O O
56 was VBD B-VP O
56 afebrile IN B-VP O
56 His PRP$ O O
57 white JJ B-NP O
57 blood NN I-NP O
57 cell NN I-NP O
57 count NN I-NP O
57 was VBD B-VP O
57 12 CD O O
57 The DT B-NP O
57 patient NN I-NP O
57 remained VBD B-VP O
57 stable JJ O O
57 but CC O O
58 he PRP O O
58 continued VBD B-VP O
58 to TO O O
58 have VB O O
58 a DT B-NP O
58 white JJ I-NP O
58 count NN I-NP O
58 and CC O O
58 left VBD B-VP O
59 leg NN B-NP O
59 ultrasound NN I-NP O
59 finally RB O O
59 done VBN O O
59 on IN B-VP O
59 postoperative JJ B-NP O
59 day NN I-NP O
59 #10 NNP I-NP O
59 , , O O
59 revealed VBD B-VP O
59 a DT B-NP O
60 fluid JJ I-NP O
60 collection NN I-NP O
60 above IN B-VP O
60 the DT B-NP O
60 knee NN I-NP O
60 to TO O O
60 the DT B-NP O
60 mid NN I-NP O
60 calf NN I-NP O
60 mostly RB O O
60 behind IN B-VP O
60 his PRP$ O O
61 knee NN B-NP O
61 where WRB O O
61 the DT B-NP O
61 area NN I-NP O
61 of IN B-VP O
61 erythema NN B-NP O
61 was VBD B-VP O
61 and CC O O
61 his PRP$ O O
61 white JJ B-NP O
61 blood NN I-NP O
61 cell NN I-NP O
62 count NN I-NP O
62 went VBD B-VP O
62 up RB O O
62 to TO O O
62 15 CD O O
62 Therefore NNP B-NP O
62 , , O O
62 on IN B-VP O
62 10/28/06 CD O O
62 , , O O
62 the DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
63 taken VBN O O
63 to TO O O
63 the DT B-NP O
63 operating NN I-NP O
63 room NN I-NP O
63 , , O O
63 at IN B-VP O
63 which WDT O O
63 time NN B-NP O
63 , , O O
63 he PRP O O
63 underwent VBD B-VP O
63 a DT B-NP O
64 drainage NN I-NP O
64 and CC O O
64 irrigation NN B-NP O
64 of IN B-VP O
64 his PRP$ O O
64 left JJ B-NP O
64 lower JJR I-NP O
64 extremity NN I-NP O
64 saphenous JJ B-NP O
65 vein NNS I-NP O
65 donor JJ B-NP O
65 site NN I-NP O
65 , , O O
65 moderate JJ B-NP O
65 amount NN I-NP O
65 of IN B-VP O
65 fluid NN B-NP O
65 were VBD B-VP O
65 expressed VBN O O
65 , , O O
65 and CC O O
66 cultures NNS B-NP O
66 were VBD B-VP O
66 taken VBN O O
66 The DT B-NP O
66 patient NN I-NP O
66 was VBD B-VP O
66 transferred VBN O O
66 back RB O O
66 to TO O O
66 the DT B-NP O
67 Step-Down NNP I-NP O
67 Unit NNP I-NP O
67 after IN B-VP O
67 this DT B-NP O
67 procedure NN I-NP O
67 Please NNP I-NP O
67 see VB O O
67 the DT O O
67 continuing VBG O O
68 dictation NN B-NP O
68 done VBN O O
68 by IN B-VP O
68 Valentin NNP B-NP O
68 Krull NNP I-NP O
68 for IN B-VP O
68 the DT B-NP O
68 rest NN I-NP O
68 of IN B-VP O
68 the DT B-NP O
68 patient's JJ I-NP O
69 hospital NN I-NP O
69 course NN I-NP O
69 and CC O O
69 discharge NN B-NP O
69 status NN I-NP O
70 eScription NN I-NP O
70 document: VBZ O O
70 4-5978600 JJ B-NP O
70 EMSSten NNP I-NP O
70 Tel NNP I-NP O
71 Dictated NNP I-NP O
71 By: NNP I-NP O
71 FRENKEL NNP I-NP O
71 , , O O
71 EMIL NNP B-NP O
72 Attending: NNP I-NP O
72 FINLEY NNP I-NP O
72 , , O O
72 RYAN NNP B-NP O
73 Dictation NNP I-NP O
73 ID NNP I-NP O
73 5169133 CD O O
74 D: NNP B-NP O
74 10/5/06 CD O O
75 T: NNP B-NP O
75 10/5/06 CD O O
76 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #269991 VBZ O O
4 515955975 CD O O
4 OH NNP B-NP O
4 36437373 CD O O
4 166689 CD O O
4 0/25/1995 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/11/1995 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/18/1995 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 MYOCARDIAL NNP I-NP O
7 INFARCTION NNP I-NP O
8 LIST NNP I-NP O
8 OF NNP I-NP O
8 SIGNIFICANT NNP I-NP O
8 PROBLEMS: NNP I-NP O
8 DIABETES NNP I-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 The DT B-NP O
9 patient NN I-NP O
9 is VBZ O O
9 a DT O O
9 54 CD O O
9 year NN B-NP O
9 old JJ O O
9 , , O O
9 white JJ B-NP O
10 male NN I-NP O
10 with IN B-VP O
10 cardiac JJ B-NP O
10 risk NN I-NP O
10 factors NNS I-NP O
10 of IN B-VP O
11 diabetes NNS B-NP O
11 , , O O
11 borderline NN B-NP O
11 hypertension NN I-NP O
11 , , O O
11 male JJ B-NP O
11 gender NN I-NP O
11 , , O O
11 and CC O O
11 a DT B-NP O
11 positive JJ I-NP O
12 family NN I-NP O
12 history NN I-NP O
12 , , O O
12 who WP O O
12 has VBZ O O
12 no DT B-NP O
12 prior JJ I-NP O
12 cardiac JJ I-NP O
12 history NN I-NP O
12 , , O O
12 but CC O O
12 now RB O O
12 presents VBZ O O
13 to TO O O
13 Leyson NNP B-NP O
13 Memorial NNP I-NP O
13 Hospital NNP I-NP O
13 complaining NN I-NP O
13 of IN B-VP O
13 substernal JJ B-NP O
13 chest NN I-NP O
14 pain NN I-NP O
14 Approximately RB O O
14 six CD O O
14 weeks NNS B-NP O
14 ago RB O O
14 , , O O
14 the DT B-NP O
14 patient NN I-NP O
14 lifted VBD B-VP O
14 a DT B-NP O
14 100-pound JJ I-NP O
15 bag NN I-NP O
15 and CC O O
15 the DT B-NP O
15 next JJ I-NP O
15 a.m NN I-NP O
15 , , O O
15 noted VBD B-VP O
15 substernal JJ B-NP O
15 chest NN I-NP O
15 pressure NN I-NP O
15 without IN B-VP O
16 associated VBN O O
16 symptoms NNS B-NP O
16 This DT B-NP O
16 pressure NN I-NP O
16 lasted VBD B-VP O
16 approximately RB O O
16 three CD O O
16 to TO O O
17 five CD O O
17 minutes NNS B-NP O
17 and CC O O
17 resolved VBD B-VP O
17 spontaneously RB O O
17 Since IN B-VP O
17 then RB O O
17 , , O O
17 the DT B-NP O
17 patient NN I-NP O
18 has VBZ O O
18 had VBN O O
18 two CD O O
18 similar JJ B-NP O
18 episodes NNS I-NP O
18 of IN B-VP O
18 substernal JJ B-NP O
18 chest NN I-NP O
18 pressure NN I-NP O
18 that WDT O O
18 have VBP O O
19 occurred VBN O O
19 while IN B-VP O
19 he PRP O O
19 was VBD B-VP O
19 exerting VBG O O
19 himself PRP O O
19 , , O O
19 once RB O O
19 while IN B-VP O
19 running VBG O O
19 during IN B-VP O
19 a DT B-NP O
20 basketball NN I-NP O
20 game NN I-NP O
20 and CC O O
20 once RB O O
20 again RB O O
20 while IN B-VP O
20 running VBG O O
20 on IN B-VP O
20 the DT B-NP O
20 beach NN I-NP O
20 in IN B-VP O
21 Westtpo NNP B-NP O
21 Racecon NNP I-NP O
21 Nari NNP I-NP O
21 Neither NNP I-NP O
21 episode NN I-NP O
21 had VBD B-VP O
21 associated VBN O O
21 symptoms NNS B-NP O
21 ( ( O O
21 i.e NN B-NP O
21 , , O O
21 radiation NN B-NP O
21 , , O O
22 nausea NN B-NP O
22 , , O O
22 vomiting VBG O O
22 , , O O
22 diaphoresis NN B-NP O
22 , , O O
22 palpitations NNS B-NP O
22 ) ) O O
22 , , O O
22 and CC O O
22 both DT B-NP O
22 episodes NNS I-NP O
23 lasted VBD B-VP O
23 less JJR O O
23 than IN B-VP O
23 five CD O O
23 minutes NNS B-NP O
23 and CC O O
23 resolved VBN O O
23 with IN B-VP O
23 rest NN B-NP O
23 On IN B-VP O
23 the DT B-NP O
23 night NN I-NP O
24 prior RB O O
24 to TO O O
24 admission NN B-NP O
24 , , O O
24 the DT B-NP O
24 patient NN I-NP O
24 was VBD B-VP O
24 working VBG O O
24 regripping VBG O O
24 his PRP$ O O
24 golf NN B-NP O
25 clubs NNS I-NP O
25 and CC O O
25 noted VBD B-VP O
25 a DT O O
25 pulling VBG O O
25 sensation NN B-NP O
25 into IN B-VP O
25 his PRP$ O O
25 chest NN B-NP O
25 , , O O
25 which WDT O O
25 again RB O O
26 resolved VBD B-VP O
26 with IN B-VP O
26 rest NN B-NP O
26 On IN B-VP O
26 the DT B-NP O
26 morning NN I-NP O
26 of IN B-VP O
26 admission NN B-NP O
26 , , O O
26 the DT B-NP O
26 patient NN I-NP O
26 awoke VBD B-VP O
27 at IN B-VP O
27 4:00 CD O O
27 a.m NNS B-NP O
27 , , O O
27 noting VBG O O
27 a DT B-NP O
27 6-7/10 JJ I-NP O
27 substernal JJ I-NP O
27 chest NN I-NP O
27 pressure NN I-NP O
27 associated VBN O O
28 with IN B-VP O
28 diaphoresis NN B-NP O
28 The DT B-NP O
28 pain NN I-NP O
28 persisted VBD B-VP O
28 for IN B-VP O
28 five CD O O
28 hours NNS B-NP O
28 , , O O
28 at IN B-VP O
28 which WDT O O
28 time NN B-NP O
29 the DT B-NP O
29 patient NN I-NP O
29 presented VBD B-VP O
29 to TO O O
29 MLMC NNP B-NP O
29 At IN B-VP O
29 KGH NNP B-NP O
29 , , O O
29 the DT B-NP O
29 patient NN I-NP O
29 was VBD B-VP O
29 found VBN O O
29 to TO O O
30 have VB O O
30 a DT B-NP O
30 blood NN I-NP O
30 pressure NN I-NP O
30 of IN B-VP O
30 152/88 CD O O
30 and CC O O
30 a DT B-NP O
30 heart NN I-NP O
30 rate NN I-NP O
30 of IN B-VP O
30 76 CD O O
30 His PRP$ O O
31 physical JJ B-NP O
31 examination NN I-NP O
31 was VBD B-VP O
31 benign JJ O O
31 However RB O O
31 , , O O
31 the DT B-NP O
31 patient's NN I-NP O
32 electrocardiogram NN I-NP O
32 showed VBD B-VP O
32 new JJ B-NP O
32 ST NNP I-NP O
32 depressions NNS I-NP O
32 in IN B-VP O
32 V2-V5 NNP B-NP O
32 , , O O
32 T NNP B-NP O
32 wave VBP O O
33 inversions NNS B-NP O
33 in IN B-VP O
33 AVL NNP B-NP O
33 , , O O
33 and CC O O
33 flat JJ B-NP O
33 T's NNP I-NP O
33 in IN B-VP O
33 1 CD O O
33 and CC O O
33 V6 NNP B-NP O
33 The DT B-NP O
33 patient NN I-NP O
33 was VBD B-VP O
34 treated VBN O O
34 with IN B-VP O
34 two CD O B-do
34 sublingual JJ B-NP B-mo
34 nitroglycerins NNS I-NP B-m
34 and CC O O
34 sent VBD B-VP O
34 to TO O O
34 the DT B-NP O
34 Mendwood NNP I-NP O
34 Hospital NNP I-NP O
34 On IN B-VP O
34 route NN B-NP O
34 to TO O O
34 Icoson NNP B-NP O
34 Hospital NNP I-NP O
34 , , O O
34 the DT B-NP O
34 patient NN I-NP O
34 received VBD B-VP O
35 two CD O B-do
35 sublingual JJ B-NP B-mo
35 nitroglycerin NN I-NP B-m
35 sprays NNS I-NP I-m
35 On IN B-VP O
35 arrival NN B-NP O
35 , , O O
35 the DT B-NP O
35 patient's NN I-NP O
36 pain NN I-NP O
36 had VBD B-VP O
36 dwindled VBN O O
36 to TO O O
36 1/10 CD O O
36 , , O O
36 without IN B-VP O
36 associated VBN O O
36 symptoms NNS B-NP O
36 The DT B-NP O
37 patient's NN I-NP O
37 blood NN I-NP O
37 pressure NN I-NP O
37 was VBD B-VP O
37 126/80 CD O O
37 , , O O
37 with IN B-VP O
37 a DT B-NP O
37 heart NN I-NP O
37 rate NN I-NP O
37 of IN B-VP O
37 80 CD O O
37 The DT B-NP O
38 patient NN I-NP O
38 was VBD B-VP O
38 treated VBN O O
38 with IN B-VP O
38 an DT B-NP O
38 aspirin NN I-NP B-m
38 , , O O
38 a DT B-NP O
38 sublingual JJ I-NP B-mo
38 nitroglycerin NN I-NP B-m
38 , , O O
39 nitro JJ B-NP B-m
39 paste NN I-NP I-m
39 , , O O
39 Lopressor NNP B-NP B-m
39 5 CD O B-do
39 mg NN B-NP I-do
39 x VBD B-VP B-du
39 1 CD O I-du
39 intravenously RB O B-mo
39 , , O O
39 and CC O O
39 intravenous JJ B-NP B-mo
40 heparin NN I-NP B-m
40 Upon NNP I-NP O
40 transfer NN I-NP O
40 to TO O O
40 the DT B-NP O
40 CCU NNP I-NP O
40 , , O O
40 the DT B-NP O
40 patient NN I-NP O
40 was VBD B-VP O
40 pain RB O O
40 free JJ B-NP O
40 A NNP I-NP O
41 repeat NN I-NP O
41 electrocardiogram NN I-NP O
41 demonstrated VBD B-VP O
41 resolution NN B-NP O
41 of IN B-VP O
41 ST NNP B-NP O
41 depressions NNS I-NP O
42 and CC O O
42 flat JJ B-NP O
42 T NNP I-NP O
42 waves NNS I-NP O
42 , , O O
42 but CC O O
42 persistence NN B-NP O
42 of IN B-VP O
42 the DT B-NP O
42 T NNP I-NP O
42 wave VBP O O
42 inversion NN B-NP O
42 in IN B-VP O
42 AVL NNP B-NP O
43 The DT B-NP O
43 patient NN I-NP O
43 was VBD B-VP O
43 admitted VBN O O
43 for IN B-VP O
43 further JJ B-NP O
43 treatment NN I-NP O
43 and CC O O
43 to TO O O
43 rule VB O O
43 out RP O O
44 myocardial JJ B-NP O
44 infarction NN I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 gives VBZ O O
44 no DT B-NP O
44 history NN I-NP O
44 of IN B-VP O
44 edema NN B-NP O
44 , , O O
45 paroxysmal JJ B-NP O
45 nocturnal JJ I-NP O
45 dyspnea NN I-NP O
45 , , O O
45 or CC O O
45 orthopnea IN B-VP O
45 The DT B-NP O
45 patient NN I-NP O
45 denies VBZ O O
46 fevers NNS B-NP O
46 , , O O
46 upper JJ B-NP O
46 respiratory NN I-NP O
46 infection NN I-NP O
46 symptoms NNS I-NP O
46 , , O O
46 cough NN B-NP O
46 , , O O
46 abdominal JJ B-NP O
47 pain NN I-NP O
47 , , O O
47 nausea NN B-NP O
47 , , O O
47 vomiting VBG O O
47 , , O O
47 diarrhea NN B-NP O
47 , , O O
47 dysuria NN B-NP O
47 , , O O
47 or CC O O
47 weight JJ B-NP O
47 loss NN I-NP O
48 PAST NNP I-NP O
48 MEDICAL NNP I-NP O
48 HISTORY: NNP I-NP O
48 The DT B-NP O
48 patient's NN I-NP O
48 past JJ B-NP O
48 medical JJ I-NP O
48 history NN I-NP O
48 is VBZ O O
49 significant JJ O O
49 for IN B-VP O
49 diabetes VBZ O O
49 The DT B-NP O
49 patient NN I-NP O
49 has VBZ O O
50 kidney VBN O O
50 stones NNS B-NP O
50 , , O O
50 is VBZ O O
50 status NN B-NP O
50 post NN I-NP O
50 procedure NN I-NP O
50 three CD O O
50 to TO O O
50 four CD O O
50 years NNS B-NP O
50 ago RB O O
50 , , O O
51 and CC O O
51 a DT B-NP O
51 history NN I-NP O
51 of IN B-VP O
51 sinusitis NN B-NP O
52 ALLERGIES: NNP I-NP O
52 No NNP I-NP O
52 known VBN O O
52 drug NN B-NP O
52 allergies NNS I-NP O
53 MEDICATIONS NNP I-NP O
53 ON NNP I-NP O
53 ADMISSION: NNP I-NP O
53 The DT B-NP O
53 patient's NN I-NP O
53 medications NNS I-NP O
53 at IN B-VP O
53 the DT B-NP O
53 time NN I-NP O
53 of IN B-VP O
54 admission NN B-NP O
54 included VBD B-VP O
54 only RB O O
54 Glyburide NNP B-NP B-m
54 2.5 CD O B-do
54 mg NN B-NP I-do
55 p.o NN I-NP B-mo
55 q.d VBP O B-f
56 SOCIAL NNP B-NP O
56 HISTORY: NNP I-NP O
56 The DT B-NP O
56 patient NN I-NP O
56 is VBZ O O
56 unmarried JJ O O
56 He PRP O O
56 was VBD B-VP O
56 the DT B-NP O
56 part NN I-NP O
56 owner NN I-NP O
57 of IN B-VP O
57 a DT B-NP O
57 bar NN I-NP O
57 He PRP O O
57 does VBZ O O
57 not RB O O
57 smoke VB O O
57 , , O O
57 and CC O O
57 he PRP O O
57 does VBZ O O
57 not RB O O
58 drink VB O O
59 FAMILY NNP B-NP O
59 HISTORY: NNP I-NP O
59 The DT B-NP O
59 patient's NN I-NP O
59 mother NN I-NP O
59 had VBD B-VP O
59 a DT B-NP O
59 myocardial JJ I-NP O
59 infarction NN I-NP O
60 in IN B-VP O
60 her PRP$ O O
60 60's CD O O
61 PHYSICAL NNP B-NP O
61 EXAMINATION: NNP I-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 is VBZ O O
61 a DT O O
61 pleasant JJ O O
61 , , O O
61 tan JJ B-NP O
61 male NN I-NP O
61 in IN B-VP O
61 no DT B-NP O
62 acute JJ I-NP O
62 distress NN I-NP O
62 Blood NNP I-NP O
62 pressure NN I-NP O
62 , , O O
62 126/80 CD O O
63 Heart NNP B-NP O
63 rate NN I-NP O
63 , , O O
63 80 CD O O
63 Respiratory NNP B-NP O
63 rate NN I-NP O
63 , , O O
63 20 CD O O
63 Temperature NN B-NP O
63 , , O O
63 98 CD O O
63 Oxygen NNP B-NP O
64 saturation NN I-NP O
64 , , O O
64 100% CD O O
64 on IN B-VP O
64 two CD O O
64 liters NNS B-NP O
64 Head VBP O O
64 , , O O
64 eyes NNS B-NP O
64 , , O O
64 ears NNS B-NP O
64 , , O O
64 nose RB O O
64 , , O O
64 and CC O O
64 throat NN B-NP O
65 examination NN I-NP O
65 was VBD B-VP O
65 anicteric JJ O O
65 , , O O
65 with IN B-VP O
65 oropharynx JJ B-NP O
65 benign NN I-NP O
65 Neck NNP I-NP O
65 was VBD B-VP O
66 supple JJ O O
66 , , O O
66 with IN B-VP O
66 no DT B-NP O
66 lymphadenopathy JJ I-NP O
66 Carotids NNS I-NP O
66 were VBD B-VP O
66 2+ CD O O
66 , , O O
66 with IN B-VP O
66 no DT B-NP O
66 bruits NNS I-NP O
67 Lungs NNS I-NP O
67 were VBD B-VP O
67 clear JJ O O
67 to TO O O
67 auscultation VB O O
67 bilaterally RB O O
67 Back NNP B-NP O
67 examination NN I-NP O
68 demonstrated VBD B-VP O
68 no DT B-NP O
68 costovertebral JJ I-NP O
68 angle NN I-NP O
68 tenderness NN I-NP O
68 and CC O O
68 no DT B-NP O
68 spinal JJ I-NP O
69 tenderness NN I-NP O
69 Coronary NNP I-NP O
69 examination NN I-NP O
69 revealed VBD B-VP O
69 a DT B-NP O
69 regular JJ I-NP O
69 rate NN I-NP O
69 and CC O O
70 rhythm NN B-NP O
70 , , O O
70 distant JJ B-NP O
70 S1 NNP I-NP O
70 and CC O O
70 S2 NNP B-NP O
70 , , O O
70 and CC O O
70 no DT B-NP O
70 murmurs NN I-NP O
70 , , O O
70 rubs NN B-NP O
70 or CC O O
70 gallops NNS B-NP O
71 Abdominal NNP I-NP O
71 examination NN I-NP O
71 was VBD B-VP O
71 benign JJ B-NP O
71 Rectal NNP I-NP O
71 examination NN I-NP O
71 showed VBD B-VP O
71 guaiac JJ B-NP O
72 negative JJ I-NP O
72 stool NN I-NP O
72 Extremities NNS I-NP O
72 showed VBD B-VP O
72 no DT B-NP O
72 cyanosis NN I-NP O
72 , , O O
72 clubbing VBG O O
72 , , O O
72 or CC O O
73 edema NN B-NP O
73 , , O O
73 with IN B-VP O
73 pulses NNS B-NP O
73 2+ CD O O
73 throughout IN B-VP O
73 , , O O
73 and CC O O
73 no DT B-NP O
73 femoral JJ I-NP O
73 bruits NNS I-NP O
74 Neurologic NNP I-NP O
74 examination NN I-NP O
74 revealed VBD B-VP O
74 the DT B-NP O
74 patient NN I-NP O
74 to TO O O
74 be VB O O
74 alert JJ O O
74 and CC O O
75 oriented VBD B-VP O
75 x $ O O
75 3 CD O O
76 LABORATORY NNP B-NP O
76 DATA: NNP I-NP O
76 Laboratory NNP I-NP O
76 studies NNS I-NP O
76 on IN B-VP O
76 admission NN B-NP O
76 revealed VBD B-VP O
76 the DT B-NP O
77 patient's NN I-NP O
77 electrolytes VBZ O O
77 to TO O O
77 be VB O O
77 within IN B-VP O
77 normal JJ B-NP O
78 limits NNS I-NP O
78 , , O O
78 except IN B-VP O
78 for IN B-VP O
78 a DT B-NP O
78 glucose NN I-NP O
78 of IN B-VP O
78 293 CD O O
78 The DT B-NP O
78 first JJ I-NP O
78 CK NNP I-NP O
78 returned VBD B-VP O
78 970 CD O O
78 , , O O
79 with IN B-VP O
79 an DT B-NP O
79 MB NNP I-NP O
79 fraction NN I-NP O
79 of IN B-VP O
79 65.1 CD O O
79 Magnesium NNP B-NP O
79 was VBD B-VP O
79 1.6 CD O O
79 CBC NNP B-NP O
79 was VBD B-VP O
79 within IN B-VP O
80 normal JJ B-NP O
80 limits NNS I-NP O
80 , , O O
80 with IN B-VP O
80 a DT B-NP O
80 hematocrit NN I-NP O
80 of IN B-VP O
80 44.1 CD O O
80 Coag's NNP B-NP O
80 were VBD B-VP O
80 also RB O O
80 normal JJ O O
81 at IN B-VP O
81 12.7 CD O O
81 and CC O O
81 27.4 CD O O
81 Chest NNP B-NP O
81 x-ray NN I-NP O
81 showed VBD B-VP O
81 no DT B-NP O
81 enlarged JJ I-NP O
81 heart NN I-NP O
81 and CC O O
81 no DT B-NP O
82 infiltrate NN I-NP O
82 Electrocardiogram NNP I-NP O
82 showed VBD B-VP O
82 normal JJ B-NP O
82 sinus NN I-NP O
82 rhythm NN I-NP O
82 , , O O
82 with IN B-VP O
82 a DT B-NP O
83 rate NN I-NP O
83 of IN B-VP O
83 60 CD O O
83 , , O O
83 and CC O O
83 no DT B-NP O
83 ST-T NNP I-NP O
83 changes NNS I-NP O
83 on IN B-VP O
83 the DT O O
83 19 CD O O
83 of IN B-VP O
83 May NNP B-NP O
83 , , O O
83 1995 CD O O
84 However RB O O
84 , , O O
84 electrocardiogram VBP O O
84 at IN B-VP O
84 the DT B-NP O
84 Bertgrand NNP I-NP O
84 Hospital NNP I-NP O
84 , , O O
84 pain NN B-NP O
84 free JJ O O
84 , , O O
84 showed VBD B-VP O
84 normal JJ B-NP O
85 sinus NN I-NP O
85 rhythm NN I-NP O
85 , , O O
85 with IN B-VP O
85 a DT B-NP O
85 heart NN I-NP O
85 rate NN I-NP O
85 of IN B-VP O
85 82 CD O O
85 , , O O
85 T NNP B-NP O
85 wave VBP O O
85 inversions NNS B-NP O
85 , , O O
85 AVL NNP B-NP O
85 , , O O
85 and CC O O
86 flat JJ B-NP O
86 T's NNP I-NP O
86 in IN B-VP O
86 lead JJ O O
86 1 CD O O
87 HOSPITAL NNP B-NP O
87 COURSE: NNP I-NP O
87 The DT B-NP O
87 patient NN I-NP O
87 was VBD B-VP O
87 admitted VBN O O
87 with IN B-VP O
87 a DT B-NP O
87 diagnosis NN I-NP O
87 of IN B-VP O
88 acute JJ B-NP O
88 myocardial JJ I-NP O
88 infarction NN I-NP O
88 Electrocardiogram NNP I-NP O
89 changes NNS I-NP O
89 were VBD B-VP O
89 consistent JJ O O
89 with IN B-VP O
89 lateral JJ O O
89 or CC O O
89 anterolateral JJ B-NP O
89 ischemia NN I-NP O
90 His PRP$ O O
90 peak NN B-NP O
90 CK's NNP I-NP O
90 returned VBD B-VP O
90 at IN B-VP O
90 1 CD O O
90 , , O O
90 330 CD O O
90 , , O O
90 with IN B-VP O
90 54.5% CD O O
90 MB NNP B-NP O
90 fractions NNS I-NP O
90 The DT B-NP O
91 patient NN I-NP O
91 was VBD B-VP O
91 maintained VBN O O
91 on IN B-VP O
91 heparin NN B-NP B-m
91 and CC O O
91 intravenous JJ B-NP B-mo
91 nitroglycerin NN I-NP B-m
91 for IN B-VP B-du
92 72 CD O O
92 hours NNS B-NP O
92 after IN B-VP O
92 admission NN B-NP O
92 and CC O O
92 was VBD B-VP O
92 started VBN O O
92 on IN B-VP O
92 Lopressor NNP B-NP B-m
92 and CC O O
93 enteric-coated JJ B-NP B-m
93 aspirin NN I-NP I-m
93 at IN B-VP O
93 admission NN B-NP O
93 The DT B-NP O
93 patient NN I-NP O
93 remained VBD B-VP O
93 chest JJS B-NP O
94 pain NN I-NP O
94 free JJ O O
94 for IN B-VP O
94 the DT O O
94 five CD O O
94 days NNS B-NP O
94 post NN I-NP O
94 myocardial JJ B-NP O
94 infarction NN I-NP O
94 and CC O O
95 underwent NN B-NP O
95 a DT B-NP O
95 submax JJ I-NP O
95 ETT NNP I-NP O
95 on IN B-VP O
95 the DT O O
95 1 CD O O
95 of IN B-VP O
95 January NNP B-NP O
95 , , O O
95 1995 CD O O
95 In IN B-VP O
95 addition NN B-NP O
95 , , O O
95 an DT B-NP O
96 electrocardiogram NN I-NP O
96 was VBD B-VP O
96 performed VBN O O
96 , , O O
96 which WDT O O
96 showed VBD B-VP O
96 a DT B-NP O
96 left JJ I-NP O
96 ventricle NN I-NP O
96 with IN B-VP O
97 73% CD O O
97 ejection NN B-NP O
97 fraction NN I-NP O
97 , , O O
97 upper JJ B-NP O
97 limits NNS I-NP O
97 of IN B-VP O
97 normal JJ B-NP O
97 size NN I-NP O
97 , , O O
97 and CC O O
97 a DT B-NP O
97 question NN I-NP O
98 of IN B-VP O
98 inferior JJ B-NP O
98 wall NN I-NP O
98 hypokinesis NN I-NP O
98 On IN B-VP O
98 the DT O O
98 14 CD O O
98 of IN B-VP O
98 May NNP B-NP O
98 , , O O
98 the DT B-NP O
98 patient NN I-NP O
98 underwent NN I-NP O
98 a DT B-NP O
99 submax NN I-NP O
99 ETT NNP I-NP O
99 , , O O
99 which WDT O O
99 was VBD B-VP O
99 stopped VBN O O
99 secondary JJ O O
99 to TO O O
99 chest VB O O
99 tightness NN B-NP O
99 , , O O
99 with IN B-VP O
100 diagnostic JJ B-NP O
100 electrocardiogram NN I-NP O
100 changes NNS I-NP O
100 , , O O
100 maximal JJ B-NP O
100 heart NN I-NP O
100 rate NN I-NP O
100 of IN B-VP O
100 96 CD O O
100 , , O O
101 blood NN B-NP O
101 pressure NN I-NP O
101 of IN B-VP O
101 145/82 CD O O
101 , , O O
101 electrocardiogram NN B-NP O
101 with IN B-VP O
101 2 CD O O
101 mm NNS B-NP O
101 ST NNP I-NP O
102 depressions NNS I-NP O
102 , , O O
102 persisting VBG O O
102 into IN B-VP O
102 recovery NN B-NP O
102 Because IN B-VP O
102 of IN B-VP O
102 a DT B-NP O
102 positive JJ I-NP O
102 ETT NNP I-NP O
102 , , O O
103 the DT B-NP O
103 patient NN I-NP O
103 subsequently RB O O
103 underwent JJ B-NP O
103 cardiac JJ I-NP O
103 catheterization NN I-NP O
103 , , O O
103 which WDT O O
104 showed VBD B-VP O
104 a DT B-NP O
104 proximal JJ I-NP O
104 left NN I-NP O
104 circ NN I-NP O
104 lesion NN I-NP O
104 70% CD O O
104 stenosed VBN O O
104 , , O O
104 which WDT O O
104 was VBD B-VP O
105 percutaneous JJ B-NP O
105 transhepatic JJ I-NP O
105 coronary NN I-NP O
105 angioplastied VBD B-VP O
105 to TO O O
105 20% CD O O
105 residual JJ O O
105 , , O O
106 as RB O O
106 well RB O O
106 as IN B-VP O
106 a DT B-NP O
106 mid-left JJ I-NP O
106 circ NN I-NP O
106 lesion NN I-NP O
106 70% CD O O
106 stenosed VBN O O
106 , , O O
106 which WDT O O
106 was VBD B-VP O
107 percutaneous JJ B-NP O
107 transhepatic JJ I-NP O
107 coronary NN I-NP O
107 angioplastied VBD B-VP O
107 to TO O O
107 a DT O O
107 30% CD O O
107 residual JJ O O
108 The DT B-NP O
108 left JJ I-NP O
108 anterior JJ I-NP O
108 descending NN I-NP O
108 was VBD B-VP O
108 found VBN O O
108 to TO O O
108 be VB O O
108 diffusely RB O O
108 diseased VBN O O
108 , , O O
109 without IN B-VP O
109 focal JJ B-NP O
109 stenoses NNS I-NP O
109 , , O O
109 and CC O O
109 the DT B-NP O
109 proximal JJ I-NP O
109 right JJ I-NP O
109 coronary NN I-NP O
109 artery NN I-NP O
110 showed VBD B-VP O
110 a DT O O
110 60% CD O O
110 shelf-like JJ B-NP O
110 lesion NN I-NP O
110 The DT B-NP O
110 patient NN I-NP O
110 did VBD B-VP O
110 not RB O O
110 experience VB O O
111 chest JJS B-NP O
111 pain NN I-NP O
111 or CC O O
111 shortness NN B-NP O
111 of IN B-VP O
111 breath NN B-NP O
111 during IN B-VP O
111 the DT B-NP O
111 procedure NN I-NP O
111 Post NNP I-NP O
112 cardiac VBP O O
112 catheterization/percutaneous JJ B-NP O
112 transhepatic JJ I-NP O
112 coronary NN I-NP O
113 angioplasty NN I-NP O
113 , , O O
113 the DT B-NP O
113 patient NN I-NP O
113 was VBD B-VP O
113 maintained VBN O O
113 on IN B-VP O
113 his PRP$ O O
113 glipizide NN B-NP B-m
113 and CC O O
114 atenolol NN B-NP B-m
114 , , O O
114 50 CD O B-do
114 mg NN B-NP I-do
114 p.o NN I-NP B-mo
114 q.d NN I-NP B-f
114 , , O O
114 and CC O O
114 enteric-coated JJ B-NP B-m
114 aspirin NN I-NP I-m
114 , , O O
114 as RB O O
114 well RB O O
114 as IN B-VP O
115 heparin NNS B-NP B-m
115 overnight JJ O B-du
115 Two CD O O
115 days NNS B-NP O
115 after IN B-VP O
115 the DT B-NP O
115 cardiac JJ I-NP O
115 catheterization NN I-NP O
115 , , O O
115 the DT B-NP O
116 patient NN I-NP O
116 underwent VBD B-VP O
116 a DT B-NP O
116 second JJ I-NP O
116 submax NN I-NP O
116 ETT NNP I-NP O
116 This DT O O
116 he PRP O O
116 performed VBD B-VP O
116 without IN B-VP O
117 chest JJS B-NP O
117 discomfort NN I-NP O
117 or CC O O
117 electrocardiogram NN B-NP O
117 changes NNS I-NP O
118 DISPOSITION: VBP O O
118 The DT B-NP O
118 patient NN I-NP O
118 was VBD B-VP O
118 discharged VBN O O
118 to TO O O
118 home NN B-NP O
118 on IN B-VP O
118 the DT O O
118 30 CD O O
118 of IN B-VP O
118 November NNP B-NP O
119 CONDITION NNP I-NP O
119 ON NNP I-NP O
119 DISCHARGE: NNP I-NP O
119 The DT B-NP O
119 patient's JJ I-NP O
119 condition NN I-NP O
119 at IN B-VP O
119 the DT B-NP O
119 time NN I-NP O
119 of IN B-VP O
120 discharge NN B-NP O
120 was VBD B-VP O
120 stable JJ B-NP O
121 DISCHARGE NNP I-NP O
121 PLAN: NNP I-NP O
121 The DT B-NP O
121 patient NN I-NP O
121 will MD O O
121 receive VB O O
121 diabetic JJ B-NP O
121 teaching NN I-NP O
121 as IN B-VP O
122 an DT B-NP O
122 outpatient NN I-NP O
122 with IN B-VP O
122 CH NNP B-NP O
122 and CC O O
122 will MD O O
122 follow VB O O
122 up RP O O
122 with IN B-VP O
123 Dr NNP B-NP O
123 Kalert NNP I-NP O
124 DISCHARGE NNP I-NP O
124 MEDICATIONS: NNP I-NP O
124 Atenolol NNP I-NP B-m
124 50 CD O B-do
124 mg NN B-NP I-do
124 p.o NN I-NP B-mo
124 q.d NN I-NP B-f
124 , , O O
124 sublingual JJ B-NP B-mo
125 nitroglycerins NNS I-NP B-m
125 p.r.n VBP O B-f
125 chest JJS B-NP B-r
125 pain NN I-NP I-r
125 , , O O
125 and CC O O
126 Glucotrol NNP B-NP B-m
126 5 CD O B-do
126 mg NN B-NP I-do
126 p.o NN I-NP B-mo
126 q.d NN I-NP B-f
127 Dictated NNP I-NP O
127 By: NNP I-NP O
127 HARLAND NNP I-NP O
127 DELAUGHTER NNP I-NP O
127 , , O O
127 M.D NNP B-NP O
128 Attending: NNP I-NP O
128 GREG NNP I-NP O
128 B NNP I-NP O
128 ADAM NNP I-NP O
128 , , O O
128 M.D NNP B-NP O
128 IA7 NNP I-NP O
128 FA178/8091 NNP I-NP O
129 Batch: NNP I-NP O
129 4678 CD O O
129 Index NNP B-NP O
129 No NNP I-NP O
129 CIMAHR8WJA NNP I-NP O
129 D: NNP I-NP O
129 11/10/95 CD O O
130 T: NNP B-NP O
130 2/12/95 CD O O
131 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #275970 VBZ O O
2 550102522 CD O O
2 LHS NNP B-NP O
2 91830964 CD O O
2 513938 CD O O
2 8/3/1991 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/1/1991 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/23/1991 CD O O
4 CHIEF NNP B-NP O
4 COMPLAINT: NNP I-NP O
4 The DT B-NP O
4 patient NN I-NP O
4 is VBZ O O
4 a DT B-NP O
4 42-year-old JJ I-NP O
4 woman NN I-NP O
5 admitted VBD B-VP O
5 for IN B-VP O
5 treatment NN B-NP O
5 of IN B-VP O
5 two CD O O
5 pulmonary JJ B-NP O
6 embolisms NNS I-NP O
6 and CC O O
6 a DT B-NP O
6 urinary JJ I-NP O
6 tract NN I-NP O
6 infection NN I-NP O
7 PRINCIPAL NNP I-NP O
7 DIAGNOSIS: NNP I-NP O
7 1 CD O O
7 Pulmonary NNP B-NP O
7 embolisms NNS I-NP O
7 times NNS I-NP O
7 two CD O O
8 2 CD O O
8 Urinary JJ B-NP O
8 tract NN I-NP O
8 infection NN I-NP O
9 3 CD O O
9 Status NNP B-NP O
9 post NN I-NP O
9 total JJ B-NP O
9 abdominal JJ I-NP O
10 hysterectomy NN I-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
11 Twenty NNP I-NP O
11 years NNS I-NP O
11 ago RB O O
11 the DT B-NP O
11 patient NN I-NP O
11 suffered VBD B-VP O
11 a DT B-NP O
12 pulmonary JJ I-NP B-r
12 pulmonary JJ I-NP B-r
12 embolism NN I-NP I-r
12 embolism NN I-NP I-r
12 which WDT O O
12 was VBD B-VP O
12 poorly RB O O
13 documented VBN O O
13 after IN B-VP O
13 a DT B-NP O
13 tubal JJ I-NP O
13 ligation NN I-NP O
13 She PRP O O
13 was VBD B-VP O
13 treated VBN O O
13 with IN B-VP O
13 heparin NN B-NP B-m
14 and CC O O
14 Coumadin NNP B-NP B-m
14 Since IN B-VP O
14 that DT B-NP O
14 time NN I-NP O
14 she PRP O O
14 has VBZ O O
14 been VBN O O
14 well RB O O
14 On IN B-VP O
14 1 CD O O
14 of IN B-VP O
14 October NNP B-NP O
15 the DT B-NP O
15 patient JJ I-NP O
15 underwent JJ I-NP O
15 elective JJ I-NP O
15 total JJ I-NP O
15 abdominal JJ I-NP O
15 hysterectomy NN I-NP O
16 secondary JJ O O
16 to TO O O
16 fibroids NNS B-NP O
16 and CC O O
16 menorrhagia NN B-NP O
16 On IN B-VP O
16 6 CD O O
16 of IN B-VP O
16 March NNP B-NP O
16 , , O O
16 the DT B-NP O
16 night NN I-NP O
17 before IN B-VP O
17 discharge NN B-NP O
17 , , O O
17 the DT B-NP O
17 patient NN I-NP O
17 noted VBD B-VP O
17 the DT B-NP O
17 onset NN I-NP O
17 of IN B-VP O
17 sharp JJ B-NP O
17 pleuritic JJ I-NP O
18 chest NN I-NP O
18 pain NN I-NP O
18 upon IN B-VP O
18 movement NN B-NP O
18 in IN B-VP O
18 bed NN B-NP O
18 It PRP O O
18 was VBD B-VP O
18 felt VBN O O
18 this DT O O
18 was VBD B-VP O
18 musculo- JJ B-NP O
19 skeletal NN I-NP O
19 and CC O O
19 she PRP O O
19 was VBD B-VP O
19 discharged VBN O O
19 While IN B-VP O
19 at IN B-VP O
19 home NN B-NP O
19 before IN B-VP O
19 admission NN B-NP O
19 , , O O
20 the DT B-NP O
20 patient NN I-NP O
20 noted VBD B-VP O
20 some DT B-NP O
20 shortness NN I-NP O
20 of IN B-VP O
20 breath NN B-NP O
20 and CC O O
20 a DT B-NP O
20 temperature NN I-NP O
20 to TO O O
21 101 CD O O
21 She PRP O O
21 continued VBD B-VP O
21 to TO O O
21 have VB O O
21 a DT B-NP O
21 pleuritic JJ I-NP O
21 chest NN I-NP O
21 pain NN I-NP O
21 and CC O O
21 came VBD B-VP O
21 to TO O O
22 the DT B-NP O
22 emergency NN I-NP O
22 room NN I-NP O
22 She PRP O O
22 was VBD B-VP O
22 admitted VBN O O
22 on IN B-VP O
22 30 CD O O
22 of IN B-VP O
22 May NNP B-NP O
23 Past NNP I-NP O
23 medical JJ B-NP O
23 history: NN I-NP O
23 ( ( O O
23 1 CD O O
23 ) ) O O
23 Pulmonary JJ B-NP O
23 embolism NN I-NP O
23 ( ( O O
23 2 CD O O
23 ) ) O O
23 Cholecys- NNP B-NP O
24 tectomy NN I-NP O
24 ( ( O O
24 3 CD O O
24 ) ) O O
24 Costochondritis NNP B-NP O
24 ( ( O O
24 4 CD O O
24 ) ) O O
24 Status NNP B-NP O
24 post NN I-NP O
24 TAH NNP I-NP O
24 for IN B-VP O
25 fibroids NNS B-NP O
25 ( ( O O
25 5 CD O O
25 ) ) O O
25 Asthma VBP O O
26 The DT B-NP O
26 patient's JJ I-NP O
26 family NN I-NP O
26 history NN I-NP O
26 is VBZ O O
26 notable JJ O O
26 for IN B-VP O
26 a DT B-NP O
26 cousin NN I-NP O
26 with IN B-VP O
26 lupus PDT O O
27 The DT B-NP O
27 patient NN I-NP O
27 doesn't NN I-NP O
27 smoke VBD B-VP O
27 The DT B-NP O
27 patient JJ I-NP O
27 drinks NNS I-NP O
27 occasionally RB O O
28 PHYSICAL NNP B-NP O
28 EXAMINATION: NNP I-NP O
28 The DT B-NP O
28 patient NN I-NP O
28 was VBD B-VP O
28 an DT B-NP O
28 obese JJ I-NP O
28 women NNS I-NP O
28 who WP O O
29 appeared VBD B-VP O
29 tired JJ O O
29 and CC O O
29 was VBD B-VP O
29 having VBG O O
29 some DT B-NP O
30 discomfort NN I-NP O
30 breathing VBG O O
30 Her PRP$ O O
30 temperature NN B-NP O
30 in IN B-VP O
30 the DT B-NP O
30 emergency NN I-NP O
30 room NN I-NP O
30 was VBD B-VP O
31 102.5 CD O O
31 Her NNP B-NP O
31 blood NN I-NP O
31 pressure NN I-NP O
31 was VBD B-VP O
31 110/80 CD O O
31 Heart NNP B-NP O
31 rate NN I-NP O
31 was VBD B-VP O
31 120 CD O O
32 Respirations NNPS B-NP O
32 were VBD B-VP O
32 32 CD O O
32 which WDT O O
32 went VBD B-VP O
32 down IN B-VP O
32 to TO O O
32 24 CD O O
32 as IN B-VP O
32 she PRP O O
32 calmed VBD B-VP O
32 down RP O O
33 Her NNP B-NP O
33 O2 NNP I-NP O
33 saturation NN I-NP O
33 on IN B-VP O
33 room NN B-NP O
33 air NN I-NP O
33 was VBD B-VP O
33 99% CD O O
33 An DT B-NP O
33 ABG NNP I-NP O
33 was VBD B-VP O
33 not RB O O
33 done VBN O O
33 Head NNP B-NP O
34 was VBD B-VP O
34 unremarkable JJ B-NP O
34 Neck NNP I-NP O
34 was VBD B-VP O
34 supple JJ B-NP O
34 Lungs NNP I-NP O
34 were VBD B-VP O
34 clear JJ O O
34 without IN B-VP O
34 a DT B-NP O
35 rub NN I-NP O
35 Cardiac NNP I-NP O
35 exam NN I-NP O
35 shows VBZ O O
35 regular JJ B-NP O
35 rate NN I-NP O
35 and CC O O
35 rhythm NN B-NP O
35 without IN B-VP O
35 murmurs NNS B-NP O
36 appreciated VBD B-VP O
36 Abdomen NNP B-NP O
36 was VBD B-VP O
36 soft JJ O O
36 and CC O O
36 has VBZ O O
36 bowel VBN O O
36 sounds VBZ O O
36 The DT B-NP O
36 wound NN I-NP O
37 had VBD B-VP O
37 its PRP$ O O
37 dressing NN B-NP O
37 in IN B-VP O
37 place NN B-NP O
37 and CC O O
37 there EX O O
37 was VBD B-VP O
37 a DT B-NP O
37 small JJ I-NP O
37 amount NN I-NP O
37 of IN B-VP O
38 serosanguinous JJ B-NP O
38 drainage NN I-NP O
38 appreciated VBD B-VP O
38 It PRP O O
38 was VBD B-VP O
38 nontender JJ B-NP O
39 Neurologic NNP I-NP O
39 exam NN I-NP O
39 was VBD B-VP O
39 nonfocal JJ B-NP O
40 LABORATORY NNP I-NP O
40 DATA: NNP I-NP O
40 Electrolytes NNP I-NP O
40 were VBD B-VP O
40 within IN B-VP O
40 normal JJ B-NP O
40 limits NNS I-NP O
41 BUN NNP I-NP O
41 6 CD O O
41 , , O O
41 creatinine NN B-NP O
41 0.8 CD O O
41 , , O O
41 glucose RB O O
41 114 CD O O
41 , , O O
42 white JJ B-NP O
42 count NN I-NP O
42 12.2 CD O O
42 , , O O
42 hematocrit NN B-NP O
42 26 CD O O
42 , , O O
42 platelets NNS B-NP O
42 508 CD O O
42 , , O O
42 000 CD O O
42 PT NNP B-NP O
42 13.4 CD O O
42 , , O O
42 PTT NNP B-NP O
43 25.6 CD O O
43 Chest NNP B-NP O
43 x-ray NN I-NP O
43 showed VBD B-VP O
43 bilateral JJ B-NP O
43 basilar JJ I-NP O
43 atelectasis NN I-NP O
43 EKG NNP I-NP O
44 showed VBD B-VP O
44 sinus JJ B-NP O
44 tachycardia NN I-NP O
44 at IN B-VP O
44 104 CD O O
44 with IN B-VP O
44 normal JJ B-NP O
44 interval NN I-NP O
44 and CC O O
44 axis NN B-NP O
45 There EX O O
45 was VBD B-VP O
45 T-wave JJ B-NP O
45 inversion NN I-NP O
45 in IN B-VP O
45 3 CD O O
45 and CC O O
45 V1 NNP B-NP O
45 without IN B-VP O
45 other JJ B-NP O
45 ST-T JJ I-NP O
45 wave NN I-NP O
46 changes NNS I-NP O
46 VQ NNP I-NP O
46 scan NN I-NP O
46 obtained VBD B-VP O
46 prior RB O O
46 to TO O O
46 admission NN B-NP O
46 was VBD B-VP O
46 read VBN O O
46 as IN B-VP O
46 low JJ B-NP O
47 probability NN I-NP O
48 HOSPITAL NNP I-NP O
48 COURSE: NNP I-NP O
48 The DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 admitted VBN O O
48 and CC O O
48 started VBN O O
48 on IN B-VP O
49 heparin NN B-NP B-m
49 The DT B-NP O
49 PTT NNP I-NP O
49 was VBD B-VP O
49 quickly RB O O
49 thera- JJ O O
50 peutic JJ O O
50 The DT B-NP O
50 patient NN I-NP O
50 had VBD B-VP O
50 informal JJ B-NP O
50 noninvasive JJ I-NP O
50 studies NNS I-NP O
50 , , O O
50 mainly RB O O
51 ultrasound IN B-VP O
51 of IN B-VP O
51 the DT B-NP O
51 thighs NNS I-NP O
51 which WDT O O
51 failed VBD B-VP O
51 to TO O O
51 show VB O O
51 deep JJ B-NP O
51 venous JJ I-NP O
52 thrombosis NN I-NP O
52 She PRP O O
52 , , O O
52 therefore RB O O
52 , , O O
52 underwent NN B-NP O
52 on IN B-VP O
52 the DT B-NP O
52 second JJ I-NP O
52 hospital NN I-NP O
52 day NN I-NP O
53 pulmonary JJ B-NP O
53 angiography NN I-NP O
53 which WDT O O
53 showed VBD B-VP O
53 two CD O O
53 small JJ B-NP O
53 pulmonary JJ I-NP O
53 embolisms NNS I-NP O
54 on IN B-VP O
54 the DT B-NP O
54 left JJ I-NP O
54 side NN I-NP O
54 In IN B-VP O
54 the DT B-NP O
54 meantime NN I-NP O
54 , , O O
54 her PRP$ O O
54 VQ NNP B-NP O
54 scan NN I-NP O
54 had VBD B-VP O
54 been VBN O O
54 reinter- RB O O
55 preted VBN O O
55 as IN B-VP O
55 showing VBG O O
55 intermediate JJ B-NP O
55 probability NN I-NP O
55 with IN B-VP O
55 notch JJ B-NP O
55 defect NN I-NP O
55 on IN B-VP O
56 left NN B-NP O
56 and CC O O
56 right VBD B-VP O
56 The DT B-NP O
56 patient NN I-NP O
56 had VBD B-VP O
56 been VBN O O
56 started VBN O O
56 on IN B-VP O
56 Coumadin NNP B-NP B-m
57 In IN B-VP O
57 the DT B-NP O
57 meantime NN I-NP O
57 , , O O
57 after IN B-VP O
57 her PRP$ O O
57 procedure NN B-NP O
57 she PRP O O
57 developed VBD B-VP O
57 a DT B-NP O
57 procedure NN I-NP O
58 She PRP O O
58 had VBD B-VP O
58 some DT B-NP O
58 dysuria NNS I-NP O
58 Her PRP$ O O
58 urine JJ O O
58 had VBD B-VP O
58 white JJ B-NP O
58 cells NNS I-NP O
58 and CC O O
58 bacteria NNS B-NP O
58 and CC O O
59 eventually RB O O
59 grew VBD B-VP O
59 out RP O O
59 Enterobacter NNP B-NP O
59 aerogenes NNS I-NP O
59 In IN B-VP O
59 the DT B-NP O
59 meantime NN I-NP O
59 she PRP O O
60 was VBD B-VP O
60 treated VBN O O
60 with IN B-VP O
60 ceftizoxime NN B-NP B-m
60 and CC O O
60 defervesced VBD B-VP O
60 and CC O O
60 was VBD B-VP O
60 converted VBN O O
60 to TO O O
61 p.o VB O B-mo
61 Bactrim NNP B-NP B-m
61 and CC O O
61 remained VBD B-VP O
61 afebrile IN B-VP O
61 The DT B-NP O
61 Enterobacter NNP I-NP O
61 was VBD B-VP O
61 sensi- JJ O O
62 tive JJ O O
62 to TO O O
62 this DT O O
62 antibiotic JJ O B-m
62 The DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
62 discharged VBN O O
62 on IN B-VP O
62 1 CD O B-do
62 mg NNS B-NP I-do
63 p.o JJ B-NP B-mo
63 q JJ I-NP B-f
63 h.s NN I-NP I-f
63 of IN B-VP O
63 Coumadin NNP B-NP B-m
63 with IN B-VP O
63 a DT B-NP O
63 PT NNP I-NP O
63 the DT O O
63 preceding VBG O O
63 day NN B-NP O
63 of IN B-VP O
63 19 CD O O
64 CONDITION NNP B-NP O
64 ON NNP I-NP O
64 DISCHARGE: NNP I-NP O
64 The DT B-NP O
64 patient's JJ I-NP O
64 condition NN I-NP O
64 is VBZ O O
64 good JJ B-NP O
65 DISPOSITION: NNP I-NP O
65 The DT B-NP O
65 patient NN I-NP O
65 will MD O O
65 be VB O O
65 transferred VBN O O
65 to TO O O
65 the DT B-NP O
66 Critmi NNP I-NP O
66 Ganstown NNP I-NP O
66 Community NNP I-NP O
66 Medical NNP I-NP O
66 Center NNP I-NP O
66 under IN B-VP O
66 the DT B-NP O
66 care NN I-NP O
66 of IN B-VP O
67 Dr NNP B-NP O
67 Jamie NNP I-NP O
67 Perman NNP I-NP O
67 who WP O O
67 is VBZ O O
67 the DT B-NP O
67 patient's NN I-NP O
67 primary JJ B-NP O
67 care NN I-NP O
67 physician NN I-NP O
68 A NNP I-NP O
68 PT NNP I-NP O
68 will MD O O
68 need VB O O
68 to TO O O
68 be VB O O
68 checked VBN O O
68 on IN B-VP O
68 arrival NN B-NP O
68 Most NNP I-NP O
68 likely RB O O
68 the DT B-NP O
69 patient's NN I-NP O
69 PT NNP I-NP O
69 will MD O O
69 be VB O O
69 in IN B-VP O
69 the DT B-NP O
69 range NN I-NP O
69 of IN B-VP O
69 18 CD O O
69 to TO O O
69 20 CD O O
69 and CC O O
69 she PRP O O
69 will MD O O
69 need VB O O
70 approximately RB O O
70 1 CD O B-do
70 mg JJ B-NP I-do
70 p.o NN I-NP B-mo
70 of IN B-VP O
70 Coumadin NNP B-NP B-m
71 Discharge NNP I-NP O
71 medications: VBD B-VP O
71 Bactrim NNP B-NP B-m
71 one CD O B-do
71 double JJ B-NP I-do
71 strength NN I-NP I-do
71 tablet NN I-NP I-do
71 p.o NN I-NP B-mo
72 b.i.d.; NN I-NP B-f
72 iron NN I-NP B-m
72 sulfate NN I-NP I-m
72 325 CD O B-do
72 mg NN B-NP I-do
72 p.o NN I-NP B-mo
72 q.d.; NN I-NP B-f
72 Motrin NNP I-NP B-m
72 800 CD O B-do
72 mg NN B-NP I-do
72 p.o NN I-NP B-mo
72 t.i.d.; VBD B-VP B-f
73 Colace NNP B-NP B-m
73 100 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 t.i.d.; NN I-NP B-f
73 Coumadin NNP I-NP B-m
73 1 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 q NN I-NP B-f
73 h.s NN I-NP I-f
74 Dictated NNP I-NP O
74 By: NNP I-NP O
74 WILLIAMS NNP I-NP O
74 A NNP I-NP O
74 LOERZEL NNP I-NP O
74 , , O O
74 M.D NNP B-NP O
74 AC60 NNP I-NP O
75 YL709/0015 NNP I-NP O
76 LONG NNP I-NP O
76 J NNP I-NP O
76 VLASAK NNP I-NP O
76 , , O O
76 M.D NNP B-NP O
76 WC5 NNP I-NP O
76 D: NNP I-NP O
76 3/22/91 CD O O
77 T: NNP B-NP O
77 6/25/91 CD O O
78 Batch: NNP B-NP O
78 O270 NNP I-NP O
78 Report: NNP I-NP O
78 NS047H22 NNP I-NP O
78 T: NNP I-NP O
79 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #276413 VBZ O O
2 759240036 CD O O
2 TMC NNP B-NP O
2 42253959 CD O O
2 2554216 CD O O
2 1/18/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/18/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
4 ATTENDING: NNP I-NP O
4 LINAHAN NNP I-NP O
4 , , O O
4 OMER NNP B-NP O
4 M.D NNP I-NP O
5 PRINCIPLE NNP I-NP O
5 ADMISSION NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Bacteremia NNP I-NP O
5 , , O O
5 peri-sepsis NN B-NP O
5 and CC O O
6 apnea NN B-NP O
7 PRINCIPLE NNP I-NP O
7 DISCHARGE NNP I-NP O
7 DIAGNOSIS: NNP I-NP O
7 Bacteremia NNP I-NP O
7 , , O O
7 peri-sepsis NN B-NP O
7 and CC O O
8 apnea NN B-NP O
8 , , O O
8 as RB O O
8 well RB O O
8 as IN B-VP O
8 failure NN B-NP O
8 to TO O O
8 tolerate VB O O
8 p.o JJ B-NP O
8 diets NNS I-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 He PRP O O
9 is VBZ O O
9 an DT B-NP O
9 81-year-old JJ I-NP O
9 man NN I-NP O
9 primarily RB O O
10 Russian-speaking NNP B-NP O
10 , , O O
10 with IN B-VP O
10 a DT B-NP O
10 history NN I-NP O
10 of IN B-VP O
10 multiple JJ B-NP O
10 medical JJ I-NP O
10 problems NNS I-NP O
11 including VBG O O
11 coronary JJ B-NP O
11 artery NN I-NP O
11 disease NN I-NP O
11 status NN I-NP O
11 post NN I-NP O
11 an DT B-NP O
11 MI NNP I-NP O
11 in IN B-VP O
11 2004 CD O O
11 as RB O O
12 well RB O O
12 as IN B-VP O
12 a DT B-NP O
12 cath NN I-NP O
12 at IN B-VP O
12 the DT B-NP O
12 same JJ I-NP O
12 time NN I-NP O
12 with IN B-VP O
12 percutaneous JJ B-NP O
12 intervention NN I-NP O
12 , , O O
13 congestive JJ B-NP O
13 heart NN I-NP O
13 failure NN I-NP O
13 with IN B-VP O
13 an DT B-NP O
13 ejection NN I-NP O
13 fraction NN I-NP O
13 of IN B-VP O
13 45-50% JJ O O
13 , , O O
14 atrial JJ B-NP B-r
14 fibrillation NN I-NP I-r
14 on IN B-VP O
14 anticoagulation NN B-NP B-m
14 and CC O O
14 a DT B-NP O
14 partial JJ I-NP O
14 pacemaker NN I-NP O
15 for IN B-VP O
15 sick JJ B-NP O
15 sinus NN I-NP O
15 syndrome NN I-NP O
15 , , O O
15 multiple JJ B-NP O
15 strokes NNS I-NP O
15 x4 VBP O O
15 , , O O
15 diabetes VBZ O O
15 mellitus VBP O O
16 type JJ O O
16 2 CD O O
16 and CC O O
16 COPD NNP B-NP O
16 , , O O
16 who WP O O
16 was VBD B-VP O
16 recently RB O O
16 admitted VBN O O
16 to TO O O
16 the DT B-NP O
16 Ghampemaw NNP I-NP O
16 A NNP I-NP O
16 Hospital NNP I-NP O
16 for IN B-VP O
17 bacteremia NN B-NP O
17 with IN B-VP O
17 Streptococcus NNP B-NP O
17 oralis NNS I-NP O
17 without IN B-VP O
17 a DT B-NP O
17 clear JJ I-NP O
17 source NN I-NP O
17 His PRP$ O O
18 white JJ B-NP O
18 blood NN I-NP O
18 cell NN I-NP O
18 count NN I-NP O
18 had VBD B-VP O
18 increased VBN O O
18 to TO O O
18 20 CD O O
18 His PRP$ O O
18 INR NNP B-NP O
18 had VBD B-VP O
18 been VBN O O
19 supratherapeutic JJ O O
19 on IN B-VP O
19 admission NN B-NP O
19 at IN B-VP O
19 that DT B-NP O
19 time NN I-NP O
19 to TO O O
19 14 CD O O
19 At IN B-VP O
19 that DT B-NP O
19 time NN I-NP O
19 , , O O
20 he PRP O O
20 had VBD B-VP O
20 had VBN O O
20 a DT B-NP O
20 transesophageal NN I-NP O
20 echocardiogram NN I-NP O
20 which WDT O O
20 did VBD B-VP O
20 not RB O O
20 show VB O O
21 any DT B-NP O
21 vegetations NNS I-NP O
21 and CC O O
21 he PRP O O
21 was VBD B-VP O
21 discharged VBN O O
21 to TO O O
21 rehab VB O O
21 on IN B-VP O
21 3/14/06 CD O O
21 with IN B-VP O
21 a DT B-NP O
22 course NN I-NP O
22 of IN B-VP O
22 IV NNP B-NP B-mo
22 penicillin NN I-NP B-m
22 through IN B-VP O
22 a DT B-NP O
22 PICC NNP I-NP O
22 line NN I-NP O
22 , , O O
22 as RB O O
22 well RB O O
22 as IN B-VP O
22 oral JJ B-NP B-mo
23 Flagyl NNP I-NP B-m
23 empirically RB O O
23 for IN B-VP O
23 an DT B-NP B-r
23 elevated JJ I-NP I-r
23 white JJ I-NP I-r
23 count NN I-NP I-r
23 At IN B-VP O
23 the DT B-NP O
23 rehab NN I-NP O
24 facility NN I-NP O
24 where WRB O O
24 he PRP O O
24 was VBD B-VP O
24 placed VBN O O
24 , , O O
24 the DT B-NP O
24 patient NN I-NP O
24 was VBD B-VP O
24 found VBN O O
24 to TO O O
24 have VB O O
25 pulled VBN O O
25 his PRP$ O O
25 PICC NNP B-NP O
25 line NN I-NP O
25 and CC O O
25 the DT B-NP O
25 patient NN I-NP O
25 was VBD B-VP O
25 complaining VBG O O
25 of IN B-VP O
25 being VBG O O
26 short JJ O O
26 of IN B-VP O
26 breath NN B-NP O
26 and CC O O
26 having VBG O O
26 some DT B-NP O
26 mental JJ I-NP O
26 status NN I-NP O
26 changes NNS I-NP O
26 He PRP O O
26 was VBD B-VP O
27 treated VBN O O
27 with IN B-VP O
27 some DT B-NP O
27 sublingual JJ I-NP B-mo
27 nitroglycerin NN I-NP B-m
27 at IN B-VP O
27 the DT B-NP O
27 outside JJ I-NP O
28 facility NN I-NP O
28 and CC O O
28 brought VBD B-VP O
28 to TO O O
28 the DT B-NP O
28 Ellwis NNP I-NP O
28 Medical NNP I-NP O
28 Center NNP I-NP O
28 Emergency NNP I-NP O
28 Room NNP I-NP O
28 , , O O
28 where WRB O O
28 a DT B-NP O
28 chest NN I-NP O
29 x-ray NN I-NP O
29 showed VBD B-VP O
29 some DT B-NP O
29 lack NN I-NP O
29 of IN B-VP O
29 the DT B-NP O
29 PICC NNP I-NP O
29 line NN I-NP O
29 and CC O O
29 the DT O O
29 short JJ O O
29 of IN B-VP O
29 breath JJ O O
30 quickly RB O O
30 improved VBN O O
30 in IN B-VP O
30 the DT B-NP O
30 emergency NN I-NP O
30 room NN I-NP O
30 He PRP O O
30 was VBD B-VP O
30 , , O O
30 however RB O O
30 , , O O
31 lethargic JJ O O
31 and CC O O
31 then RB O O
31 at IN B-VP O
31 times NNS B-NP O
31 , , O O
31 apneic NN B-NP O
31 in IN B-VP O
31 the DT B-NP O
31 emergency NN I-NP O
31 room NN I-NP O
31 A NNP I-NP O
31 gas NN I-NP O
32 was VBD B-VP O
32 performed VBN O O
32 which WDT O O
32 showed VBD B-VP O
32 respiratory JJ B-NP O
32 alkalosis NN I-NP O
32 with IN B-VP O
32 a DT B-NP O
32 pH NN I-NP O
32 of IN B-VP O
33 7.5 CD O O
33 , , O O
33 a DT B-NP O
33 pCO2 NN I-NP O
33 of IN B-VP O
33 34 CD O O
33 and CC O O
33 a DT B-NP O
33 pAO2 NN I-NP O
33 of IN B-VP O
33 135 CD O O
33 The DT B-NP O
33 patient NN I-NP O
33 then RB O O
33 became VBD B-VP O
34 slightly RB O B-r
34 hypotensive JJ O I-r
34 with IN B-VP O
34 systolic JJ B-NP O
34 blood NN I-NP O
34 pressures NNS I-NP O
34 to TO O O
34 the DT O O
34 90s CD O O
34 , , O O
35 was VBD B-VP O
35 given VBN O O
35 IV NNP B-NP B-mo
35 fluid NN I-NP B-m
35 boluses NNS I-NP B-do
35 as RB O O
35 well RB O O
35 as IN B-VP O
35 treated VBN O O
35 empirically RB O O
35 with IN B-VP O
36 vancomycin NN B-NP B-m
36 and CC O O
36 ceftazidime NN B-NP B-m
36 , , O O
36 to TO O O
36 which WDT O O
36 his PRP$ O O
36 blood NN B-NP O
36 pressure NN I-NP O
36 responded VBN O O
37 by IN B-VP O
37 going VBG O O
37 up RP O O
37 to TO O O
37 around IN B-VP O
37 100-110/60 JJ B-NP O
37 Given NNP I-NP O
37 his PRP$ O O
37 apnea NN B-NP O
37 , , O O
37 a DT B-NP O
37 CPAP NNP I-NP O
37 was VBD B-VP O
38 initiated VBN O O
38 in IN B-VP O
38 the DT B-NP O
38 emergency NN I-NP O
38 department NN I-NP O
38 and CC O O
38 his PRP$ O O
38 oxygenation NN B-NP O
38 issues NNS I-NP O
39 quickly RB O O
39 resolved VBD B-VP O
39 A DT B-NP O
39 head NN I-NP O
39 CT NNP I-NP O
39 was VBD B-VP O
39 performed VBN O O
39 , , O O
39 which WDT O O
39 was VBD B-VP O
39 negative JJ B-NP O
40 A NNP I-NP O
40 right NN I-NP O
40 internal JJ B-NP O
40 jugular JJ I-NP O
40 line NN I-NP O
40 was VBD B-VP O
40 placed VBN O O
40 and CC O O
40 gentle JJ B-NP O
40 rehydration NN I-NP O
41 therapy NN I-NP O
41 according VBG O O
41 to TO O O
41 early JJ B-NP O
41 goal-directed JJ I-NP O
41 therapy NN I-NP O
41 for IN B-VP O
41 peri-sepsis NN B-NP O
42 was VBD B-VP O
42 initiated VBN O O
42 , , O O
42 given VBN O O
42 the DT B-NP O
42 presumption NN I-NP O
42 of IN B-VP O
42 repeat NN B-NP O
42 bacteremia NN I-NP O
42 and CC O O
43 early JJ B-NP O
43 sepsis NN I-NP O
43 He PRP O O
43 was VBD B-VP O
43 admitted VBN O O
43 to TO O O
43 medicine VB O O
43 for IN B-VP O
43 further JJ B-NP O
44 management NN I-NP O
45 PAST NNP I-NP O
45 MEDICAL NNP I-NP O
45 HISTORY: NNP I-NP O
45 Coronary NNP I-NP O
45 artery NN I-NP O
45 disease NN I-NP O
45 status NN I-NP O
45 post NN I-NP O
45 MI NNP I-NP O
45 in IN B-VP O
46 2004 CD O O
46 and CC O O
46 a DT B-NP O
46 cath NN I-NP O
46 in IN B-VP O
46 2005 CD O O
46 He PRP O O
46 is VBZ O O
46 status NN B-NP O
46 post NN I-NP O
46 a DT B-NP O
46 hip NN I-NP O
46 fracture NN I-NP O
46 in IN B-VP O
47 2005 CD O O
47 He PRP O O
47 has VBZ O O
47 peripheral JJ B-NP O
47 vascular JJ I-NP O
47 disease NN I-NP O
47 , , O O
47 diabetes VBZ O O
47 , , O O
47 COPD NNP B-NP O
47 but CC O O
47 not RB O O
48 reported VBD B-VP O
48 to TO O O
48 be VB O O
48 on IN B-VP O
48 any DT B-NP O
48 home NN I-NP O
48 oxygenation NN I-NP O
48 , , O O
48 dementia NN B-NP O
48 , , O O
48 Paget NNP B-NP O
48 disease NN I-NP O
48 , , O O
49 atrial JJ B-NP O
49 fibrillation NN I-NP O
49 , , O O
49 BPH NNP B-NP O
49 , , O O
49 congestive JJ B-NP O
49 heart NN I-NP O
49 failure NN I-NP O
49 , , O O
49 EF NNP B-NP O
49 of IN B-VP O
49 45-50% JJ O O
49 , , O O
50 hypertension NN B-NP O
50 , , O O
50 diabetes NNS B-NP O
50 and CC O O
50 hypercholesterolemia NN B-NP O
51 MEDICATIONS NNP I-NP O
51 ON NNP I-NP O
51 ADMISSION NNP I-NP O
51 included VBD B-VP O
51 the DT B-NP O
51 following: NN I-NP O
51 Glucotrol NNP I-NP B-m
51 10 CD O B-do
51 mg NN B-NP I-do
52 p.o NN I-NP B-mo
52 b.i.d NN I-NP B-f
52 and CC O O
52 lisinopril $ O B-m
52 5 CD O B-do
52 mg NN B-NP I-do
52 p.o NN I-NP B-mo
52 q JJ B-NP B-f
52 day NN I-NP I-f
52 , , O O
52 metformin RB O B-m
52 500 CD O B-do
52 mg NNS B-NP I-do
53 p.o JJ B-NP B-mo
53 t.i.d NN I-NP B-f
53 , , O O
53 Flagyl NNP B-NP B-m
53 500 CD O B-do
53 mg NN B-NP I-do
53 p.o NN I-NP B-mo
53 t.i.d NN I-NP B-f
53 x10 NNP I-NP B-du
53 days NNS I-NP I-du
53 which WDT O O
53 was VBD B-VP O
53 started VBN O O
54 on IN B-VP O
54 2/5/06 CD O O
54 , , O O
54 sublingual JJ B-NP B-mo
54 nitroglycerin NN I-NP B-m
54 p.r.n NN I-NP B-f
54 , , O O
54 nystatin JJ B-NP B-m
54 suspension NN I-NP I-m
55 q.i.d NN I-NP B-f
55 , , O O
55 Zyprexa NNP B-NP B-m
55 2.5 CD O B-do
55 mg NN B-NP I-do
55 p.o NN I-NP B-mo
55 q NN I-NP B-f
55 h.s NN I-NP I-f
55 , , O O
55 Penicillin NNP B-NP B-m
55 G NNP I-NP I-m
55 3 CD O B-do
55 million CD O I-do
55 units NNS B-NP I-do
56 IV NNP I-NP B-mo
56 q VBD B-VP B-f
56 4h CD O I-f
56 x7 NNP B-NP B-du
56 days NNS I-NP I-du
56 , , O O
56 Milk NNP B-NP B-m
56 of IN B-VP I-m
56 Magnesia NNP B-NP I-m
56 , , O O
56 Tylenol NNP B-NP B-m
56 p.r.n NN I-NP B-f
56 , , O O
56 Dulcolax NNP B-NP B-m
57 p.r.n NN I-NP B-f
57 , , O O
57 Colace NNP B-NP B-m
57 p.r.n NN I-NP B-f
57 , , O O
57 atenolol RB O B-m
57 50 CD O B-do
57 mg NNS B-NP I-do
57 q JJ B-NP B-f
57 day NN I-NP I-f
57 , , O O
57 Lipitor NNP B-NP B-m
57 20 CD O B-do
57 mg NN B-NP I-do
57 q NN I-NP B-f
58 day NN I-NP O
58 , , O O
58 Senna NNP B-NP B-m
58 liquid VBZ O I-m
58 q NN B-NP B-f
58 h.s NN I-NP I-f
58 , , O O
58 Flomax NNP B-NP B-m
58 0.4 CD O B-do
58 q NN B-NP B-f
58 day NN I-NP I-f
59 ALLERGIES: NNP I-NP O
59 He PRP O O
59 has VBZ O O
59 no DT O O
59 known VBN O O
59 drug NN B-NP O
59 allergies NNS I-NP O
60 SOCIAL NNP I-NP O
60 HISTORY: NNP I-NP O
60 He PRP O O
60 has VBZ O O
60 a DT B-NP O
60 history NN I-NP O
60 of IN B-VP O
60 heavy JJ B-NP O
60 tobacco NN I-NP O
60 use NN I-NP O
60 He PRP O O
60 quit VBD B-VP O
61 40 CD O O
61 years NNS B-NP O
61 ago RB O O
61 He PRP O O
61 lives VBZ O O
61 at IN B-VP O
61 home NN B-NP O
61 with IN B-VP O
61 a DT B-NP O
61 24-hour JJ I-NP O
61 attendant NN I-NP O
61 and CC O O
61 he PRP O O
62 rarely RB O O
62 uses VBZ O O
62 alcohol NN B-NP O
63 FAMILY NNP I-NP O
63 HISTORY: NNP I-NP O
63 Noncontributory NNP I-NP O
64 ADMISSION NNP I-NP O
64 PHYSICAL NNP I-NP O
64 EXAM NNP I-NP O
64 notable JJ O O
64 for IN B-VP O
64 the DT B-NP O
64 following: NN I-NP O
64 His PRP$ O O
65 temperature NN B-NP O
65 was VBD B-VP O
65 95.9 CD O O
65 , , O O
65 his PRP$ O O
65 heart NN B-NP O
65 rate NN I-NP O
65 was VBD B-VP O
65 60 CD O O
65 , , O O
65 his PRP$ O O
65 blood NN B-NP O
65 pressure NN I-NP O
66 was VBD B-VP O
66 110/62 CD O O
66 He PRP O O
66 is VBZ O O
66 satting VBG O O
66 98% CD O O
66 on IN B-VP O
66 a DT B-NP O
66 CPAP NNP I-NP O
66 machine NN I-NP O
66 In IN B-VP O
66 general JJ O O
66 , , O O
66 he PRP O O
67 was VBD B-VP O
67 in IN B-VP O
67 no DT B-NP O
67 acute NN I-NP O
67 distress NN I-NP O
67 in IN B-VP O
67 restraints NNS B-NP O
67 His PRP$ O O
67 head NN B-NP O
67 and CC O O
67 neck NN B-NP O
67 exam NN I-NP O
68 was VBD B-VP O
68 notable JJ O O
68 for IN B-VP O
68 a DT B-NP O
68 supple JJ I-NP O
68 neck NN I-NP O
68 Pupils NNS I-NP O
68 are VBP O O
68 equal JJ O O
68 , , O O
68 round NN B-NP O
68 and CC O O
69 reactive VB O O
69 His PRP$ O O
69 heart NN B-NP O
69 demonstrated VBD B-VP O
69 a DT B-NP O
69 regular JJ I-NP O
69 rate NN I-NP O
69 and CC O O
69 rhythm VB O O
69 His PRP$ O O
70 JVP NNP B-NP O
70 was VBD B-VP O
70 flat JJ O O
70 He PRP O O
70 did VBD B-VP O
70 not RB O O
70 demonstrate VB O O
70 any DT B-NP O
70 murmurs NNS I-NP O
70 , , O O
70 rubs NNS B-NP O
70 , , O O
70 or CC O O
71 gallops VB O O
71 His PRP$ O O
71 pulmonary JJ B-NP O
71 exam NN I-NP O
71 was VBD B-VP O
71 clear JJ O O
71 anteriorly RB O O
71 His PRP$ O O
71 abdominal JJ B-NP O
72 exam NN I-NP O
72 was VBD B-VP O
72 noted VBN O O
72 for IN B-VP O
72 being VBG O O
72 soft JJ O O
72 , , O O
72 nontender NN B-NP O
72 , , O O
72 and CC O O
72 nondistended VBD B-VP O
72 with IN B-VP O
73 positive JJ B-NP O
73 bowel NN I-NP O
73 sounds NNS I-NP O
73 and CC O O
73 mild JJ B-NP O
73 tympani NN I-NP O
73 He PRP O O
73 had VBD B-VP O
73 good JJ B-NP O
73 peripheral JJ I-NP O
74 pulses NNS I-NP O
74 with IN B-VP O
74 trace NN B-NP O
74 lower JJR B-NP O
74 extremity NN I-NP O
74 edema VB O O
74 His PRP$ O O
74 neuro JJ B-NP O
74 exam NN I-NP O
74 was VBD B-VP O
75 nonfocal JJ B-NP O
76 OPERATIONS: NNP I-NP O
76 During IN B-VP O
76 his PRP$ O O
76 hospital NN B-NP O
76 stay NN I-NP O
76 at IN B-VP O
76 this DT B-NP O
76 time NN I-NP O
76 included VBD B-VP O
76 a DT B-NP O
76 PEG NNP I-NP O
77 tube NN I-NP O
77 placement NN I-NP O
77 which WDT O O
77 happened VBD B-VP O
77 on IN B-VP O
77 4/2/06 CD O O
78 HOSPITAL NNP B-NP O
78 COURSE NNP I-NP O
78 BY NNP I-NP O
78 SYSTEM: NNP I-NP O
79 1 CD O O
79 ID: NNP B-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 has VBZ O O
79 a DT B-NP O
79 history NN I-NP O
79 of IN B-VP O
79 recent JJ B-NP O
79 strep NN I-NP O
79 oralis NN I-NP O
80 bacteremia NN I-NP O
80 and CC O O
80 leukocytosis NN B-NP O
80 He PRP O O
80 was VBD B-VP O
80 afebrile RB O O
80 at IN B-VP O
80 the DT B-NP O
80 time NN I-NP O
80 of IN B-VP O
81 admission; NN B-NP O
81 however RB O O
81 , , O O
81 given VBN O O
81 concern NN B-NP O
81 for IN B-VP O
81 possible JJ B-NP B-r
81 possible JJ I-NP B-r
81 possible JJ I-NP B-r
81 possible JJ I-NP B-r
81 early JJ I-NP I-r
81 early JJ I-NP I-r
81 early JJ I-NP I-r
81 early JJ I-NP I-r
81 sepsis NN I-NP I-r
81 sepsis NN I-NP I-r
81 sepsis NN I-NP I-r
81 sepsis NN I-NP I-r
81 given VBN O O
82 his PRP$ O O
82 blood NN B-NP O
82 pressure NN I-NP O
82 , , O O
82 he PRP O O
82 was VBD B-VP O
82 treated VBN O O
82 with IN B-VP O
82 empiric JJ B-NP O
82 IV NNP I-NP B-mo
82 IV NNP I-NP B-mo
82 fluids NNS I-NP B-m
82 and CC O O
83 antibiotics NNS B-NP B-m
83 with IN B-VP O
83 vancomycin NN B-NP B-m
83 and CC O O
83 ceftazidime VB O B-m
83 His PRP$ O O
83 chest JJS O O
83 x-ray JJ O O
84 looked VBD B-VP O
84 like IN B-VP O
84 it PRP O O
84 might MD O O
84 have VB O O
84 some DT B-NP O
84 aspiration NN I-NP O
84 and CC O O
84 he PRP O O
84 was VBD B-VP O
84 treated VBN O O
84 with IN B-VP O
85 an DT B-NP B-du
85 empiric JJ I-NP I-du
85 7-day JJ I-NP I-du
85 course NN I-NP I-du
85 of IN B-VP O
85 Ceptaz NNP B-NP B-m
85 and CC O O
85 Flagyl NNP B-NP B-m
85 for IN B-VP O
85 aspiration NN B-NP B-r
85 aspiration NN I-NP B-r
86 pneumonia NN I-NP O
86 This DT B-NP O
86 course NN I-NP O
86 was VBD B-VP O
86 completed VBN O O
86 earlier RBR O O
86 in IN B-VP O
86 his PRP$ O O
86 hospital NN B-NP O
87 stay NN I-NP O
87 He PRP O O
87 was VBD B-VP O
87 also RB O O
87 initially RB O O
87 treated VBN O O
87 with IN B-VP O
87 vancomycin NN B-NP B-m
87 A NNP I-NP O
87 PICC NNP I-NP O
87 was VBD B-VP O
88 placed VBN O O
88 on IN B-VP O
88 11/0/06 CD O O
88 for IN B-VP O
88 further JJ B-NP O
88 antibiotic JJ I-NP B-m
88 management NN I-NP O
88 of IN B-VP O
88 his PRP$ O B-r
89 bacteremia NN B-NP O
89 His PRP$ O O
89 vancomycin NN B-NP B-m
89 was VBD B-VP O
89 switched VBN O O
89 to TO O O
89 IV NNP B-NP B-mo
89 penicillin NN I-NP B-m
89 and CC O O
90 this DT O O
90 will MD O O
90 be VB O O
90 continued VBN O O
90 for IN B-VP B-du
90 a DT B-NP I-du
90 full JJ I-NP I-du
90 3-4 JJ I-NP I-du
90 week NN I-NP I-du
90 course NN I-NP I-du
90 on IN B-VP O
90 8/14/07 CD O O
90 A NNP B-NP O
91 TEE NNP I-NP O
91 was VBD B-VP O
91 considered VBN O O
91 unnecessary JJ O O
91 given VBN O O
91 the DT B-NP O
91 fact NN I-NP O
91 that IN B-VP O
91 he PRP O O
91 was VBD B-VP O
91 going VBG O O
92 to TO O O
92 be VB O O
92 treated VBN O O
92 anyway RB O O
92 with IN B-VP O
92 antibiotics NNS B-NP B-m
92 for IN B-VP B-du
92 4 CD O I-du
92 weeks NNS B-NP I-du
92 All DT B-NP O
92 blood NN I-NP O
92 , , O O
93 urine NN B-NP O
93 , , O O
93 sputum NN B-NP O
93 cultures NNS I-NP O
93 and CC O O
93 stool JJ B-NP O
93 cultures NNS I-NP O
93 remained VBD B-VP O
93 no DT B-NP O
93 growth NN I-NP O
93 to TO O O
94 date NN B-NP O
94 at IN B-VP O
94 the DT B-NP O
94 time NN I-NP O
94 of IN B-VP O
94 discharge NN B-NP O
95 2 CD O O
95 Pulmonary: NNP B-NP O
95 As NNP I-NP O
95 mentioned VBD B-VP O
95 above IN B-VP O
95 , , O O
95 the DT B-NP O
95 patient NN I-NP O
95 demonstrated VBD B-VP O
95 some DT B-NP O
96 apnea NN I-NP O
96 in IN B-VP O
96 the DT B-NP O
96 Emergency NNP I-NP O
96 Department NNP I-NP O
96 which WDT O O
96 resolved VBD B-VP O
96 with IN B-VP O
96 CPAP; NNP B-NP O
97 however RB O O
97 , , O O
97 given VBN O O
97 the DT B-NP O
97 fact NN I-NP O
97 that IN B-VP O
97 the DT B-NP O
97 patient NN I-NP O
97 was VBD B-VP O
97 a DT B-NP O
97 significant JJ I-NP O
98 aspiration NN I-NP O
98 risk NN I-NP O
98 , , O O
98 a DT B-NP O
98 CPAP NNP I-NP O
98 was VBD B-VP O
98 considered VBN O O
98 unnecessary JJ O O
98 and CC O O
98 possibly RB O O
99 would MD O O
99 increase VB O O
99 the DT B-NP O
99 risk NN I-NP O
99 of IN B-VP O
99 aspiration NN B-NP O
99 Pulmonary NNP I-NP O
99 was VBD B-VP O
99 consulted VBN O O
99 , , O O
100 who WP O O
100 felt VBD B-VP O
100 that IN B-VP O
100 the DT B-NP O
100 patient NN I-NP O
100 was VBD B-VP O
100 demonstrating VBG O O
100 Cheyne-Stokes JJ B-NP O
101 respirations NNS I-NP O
101 secondary JJ O O
101 to TO O O
101 possible JJ B-NP O
101 CHF NNP I-NP O
101 or CC O O
101 history NN B-NP O
101 of IN B-VP O
101 CVAs NNP B-NP O
101 that IN B-VP O
101 he PRP O O
102 has VBZ O O
102 had VBN O O
102 in IN B-VP O
102 the DT O O
102 past JJ O O
102 His PRP$ O O
102 ABG NNP B-NP O
102 , , O O
102 as IN B-VP O
102 I PRP O O
102 mentioned VBD B-VP O
102 above IN B-VP O
102 , , O O
102 demonstrated VBD B-VP O
103 respiratory JJ B-NP O
103 alkalosis NN I-NP O
103 with IN B-VP O
103 a DT B-NP O
103 mild JJ I-NP O
103 metabolic JJ I-NP O
103 alkalosis NN I-NP O
103 as RB O O
103 well RB O O
104 His PRP$ O O
104 repeat NN B-NP O
104 ABG NNP I-NP O
104 showed VBD B-VP O
104 no DT B-NP O
104 significant JJ I-NP O
104 change NN I-NP O
104 , , O O
104 which WDT O O
104 likely RB O O
105 indicates VBZ O O
105 a DT B-NP O
105 chronic JJ I-NP O
105 process NN I-NP O
105 He PRP O O
105 did VBD B-VP O
105 not RB O O
105 demonstrate VB O O
105 any DT B-NP O
105 PEs NNP I-NP O
105 on IN B-VP O
106 studies NNS B-NP O
106 that WDT O O
106 were VBD B-VP O
106 performed VBN O O
106 here RB O O
106 No NNP B-NP O
106 pneumonia NN I-NP O
106 was VBD B-VP O
106 noted VBN O O
106 and CC O O
106 the DT B-NP O
107 desaturations NNS I-NP O
107 that WDT O O
107 were VBD B-VP O
107 detected VBN O O
107 while IN B-VP O
107 the DT B-NP O
107 patient NN I-NP O
107 was VBD B-VP O
107 sleeping VBG O O
108 overnight RB O O
108 on IN B-VP O
108 15 CD O O
108 units NNS B-NP O
108 O2 NNP I-NP O
108 sat VBD B-VP O
108 monitor NN B-NP O
108 resolved VBD B-VP O
108 quickly RB O O
108 with IN B-VP O
108 2 CD O B-do
109 liters NNS B-NP O
109 of IN B-VP O
109 oxygen NN B-NP B-m
109 by IN B-VP B-mo
109 nasal JJ B-NP I-mo
109 cannula NN I-NP I-mo
109 A DT B-NP O
109 plan NN I-NP O
109 was VBD B-VP O
109 made VBN O O
109 to TO O O
109 not RB O O
110 reinitiate VB O O
110 CPAP NNP B-NP O
110 given VBN O O
110 the DT B-NP O
110 aspiration NN I-NP O
110 risk NN I-NP O
110 He PRP O O
110 was VBD B-VP O
110 initially RB O O
111 diuresed VBN O O
111 mildly RB O O
111 with IN B-VP O
111 Lasix NNP B-NP B-m
111 This DT O O
111 was VBD B-VP O
111 eventually RB O O
111 discontinued VBN O O
112 The DT B-NP O
112 patient NN I-NP O
112 should MD O O
112 receive VB O O
112 nighttime JJ B-NP O
112 supplemental JJ I-NP O
112 oxygen NN I-NP B-m
112 , , O O
113 particularly RB O O
113 if IN B-VP O
113 he PRP O O
113 desaturates VBZ O O
113 to TO O O
113 less JJR O O
113 than IN B-VP O
113 90% CD O O
114 3 CD O O
114 Cardiovascular: NNPS B-NP O
114 The DT B-NP O
114 patient NN I-NP O
114 is VBZ O O
114 status NN B-NP O
114 post NN I-NP O
114 an DT B-NP O
114 MI NNP I-NP O
114 , , O O
114 status NN B-NP O
115 post NN I-NP O
115 PCI NNP I-NP O
115 in IN B-VP O
115 2004 CD O O
115 His PRP$ O O
115 enzymes NNS B-NP O
115 were VBD B-VP O
115 negative JJ O O
115 on IN B-VP O
115 this DT B-NP O
115 admission NN I-NP O
116 and CC O O
116 a DT B-NP O
116 repeat NN I-NP O
116 EKG NNP I-NP O
116 was VBD B-VP O
116 unchanged JJ O O
116 from IN B-VP O
116 previous JJ O O
116 The DT B-NP O
116 patient NN I-NP O
116 was VBD B-VP O
117 restarted VBN O O
117 on IN B-VP O
117 his PRP$ O O
117 home NN B-NP B-do
117 doses NNS I-NP I-do
117 of IN B-VP O
117 aspirin NN B-NP B-m
117 , , O O
117 statin NN B-NP B-m
117 , , O O
117 beta NN B-NP B-m
117 blocker NN I-NP I-m
117 2 CD O B-do
118 pump NN B-NP O
118 The DT B-NP O
118 patient's NN I-NP O
118 ejection NN I-NP O
118 fraction NN I-NP O
118 was VBD B-VP O
118 45-50% JJ O O
118 with IN B-VP O
118 inferior JJ B-NP O
119 wall NN I-NP O
119 hypokinesis NN I-NP O
119 Hypotension NNP I-NP O
119 improved VBD B-VP O
119 on IN B-VP O
119 admission NN B-NP O
119 , , O O
119 restarted VBD B-VP O
120 his PRP$ O O
120 beta NN B-NP B-m
120 blocker NN I-NP I-m
120 and CC O O
120 his PRP$ O O
120 ACE NNP B-NP B-m
120 inhibitor NN I-NP I-m
120 and CC O O
120 IV NNP B-NP B-mo
120 fluids NNS I-NP B-m
120 at IN B-VP O
120 the DT B-NP O
120 time NN I-NP O
121 of IN B-VP O
121 discharge NN B-NP O
121 Re NNP I-NP O
121 the DT B-NP O
121 patient's JJ I-NP O
121 history NN I-NP O
121 of IN B-VP O
121 a-fib NN B-NP O
121 , , O O
121 he PRP O O
121 was VBD B-VP O
121 in IN B-VP O
122 normal JJ B-NP O
122 sinus NN I-NP O
122 rhythm NN I-NP O
122 for IN B-VP O
122 the DT B-NP O
122 majority NN I-NP O
122 of IN B-VP O
122 his PRP$ O O
122 hospital NN B-NP O
122 stay NN I-NP O
123 Coumadin NNP I-NP B-m
123 was VBD B-VP O
123 held VBN O O
123 peri-procedure NN B-NP O
123 when WRB O O
123 he PRP O O
123 was VBD B-VP O
123 getting VBG O O
123 his PRP$ O O
123 PEG NN B-NP O
124 placed VBD B-VP O
124 and CC O O
124 vitamin JJ B-NP B-m
124 K NNP I-NP I-m
124 had VBD B-VP O
124 been VBN O O
124 administered VBN O O
124 in IN B-VP O
124 view NN B-NP O
124 of IN B-VP O
124 his PRP$ O O
125 supratherapeutic JJ B-NP O
125 Coumadin NNP I-NP B-m
125 His PRP$ O O
125 Coumadin NNP B-NP B-m
125 should MD O O
125 be VB O O
125 restarted VBN O O
125 on IN B-VP O
126 0/30/07 CD O O
126 Of IN B-VP O
126 note NN B-NP O
126 as IN B-VP O
126 well RB O O
126 for IN B-VP O
126 rhythm NN B-NP O
126 issues NNS I-NP O
126 , , O O
126 the DT B-NP O
126 patient NN I-NP O
126 was VBD B-VP O
127 kept VBN O O
127 on IN B-VP O
127 potassium NN B-NP B-m
127 and CC O O
127 magnesium NN B-NP B-m
127 scales NNS I-NP O
127 while IN B-VP B-du
127 while IN B-VP B-du
127 in IN B-VP I-du
127 in IN B-VP I-du
127 hospital JJ B-NP I-du
127 hospital NN I-NP I-du
127 and CC O O
127 he PRP O O
128 has VBZ O O
128 a DT B-NP O
128 partial JJ I-NP O
128 pacemaker NN I-NP O
128 placed VBD B-VP O
128 for IN B-VP O
128 his PRP$ O O
128 sick JJ B-NP O
128 sinus NN I-NP O
128 syndrome VBD B-VP O
129 4 CD O O
129 GI: NNP B-NP O
129 The DT B-NP O
129 patient NN I-NP O
129 had VBD B-VP O
129 a DT B-NP O
129 history NN I-NP O
129 of IN B-VP O
129 constipation NN B-NP O
129 His PRP$ O O
129 abdomen NNS B-NP O
130 was VBD B-VP O
130 tympanitic JJ O O
130 when WRB O O
130 he PRP O O
130 first RB O O
130 presented VBD B-VP O
130 He PRP O O
130 was VBD B-VP O
130 given VBN O O
130 a DT B-NP O
130 bowel NN I-NP B-m
131 regimen NN I-NP O
131 and CC O O
131 has VBZ O O
131 subsequently RB O O
131 begun VBN O O
131 making VBG O O
131 good JJ B-NP O
131 solid JJ I-NP O
131 stool NN I-NP O
132 Midway NNP I-NP O
132 through IN B-VP O
132 his PRP$ O O
132 hospital NN B-NP O
132 course NN I-NP O
132 , , O O
132 the DT B-NP O
132 patient NN I-NP O
132 developed VBD B-VP O
132 trouble NN B-NP O
133 with IN B-VP O
133 eating NN B-NP O
133 He PRP O O
133 had VBD B-VP O
133 multiple JJ B-NP O
133 NG NNP I-NP O
133 tubes NN I-NP O
133 placed VBD B-VP O
133 which WDT O O
133 he PRP O O
133 was VBD B-VP O
134 self-discontinuing VBG O O
134 requiring VBG O O
134 urgent JJ B-NP O
134 reconsideration NN I-NP O
134 of IN B-VP O
134 more RBR O O
135 permanent JJ B-NP O
135 feeding NN I-NP O
135 tubes VBZ O O
135 A DT B-NP O
135 discussion NN I-NP O
135 was VBD B-VP O
135 held VBN O O
135 between IN B-VP O
135 our PRP$ O O
136 service NN B-NP O
136 and CC O O
136 the DT B-NP O
136 GI NNP I-NP O
136 team NN I-NP O
136 , , O O
136 who WP O O
136 felt VBD B-VP O
136 that IN B-VP O
136 a DT B-NP O
136 PEG NNP I-NP O
136 would MD O O
136 be VB O O
136 useful JJ O O
136 for IN B-VP O
137 managing VBG O O
137 this DT B-NP O
137 patient's NN I-NP O
137 feeding NN I-NP O
137 in IN B-VP O
137 the DT B-NP O
137 future NN I-NP O
137 On IN B-VP O
137 2/25/06 CD O O
137 , , O O
137 GI NNP B-NP O
138 endoscopically RB O O
138 placed VBD B-VP O
138 a DT B-NP O
138 PEG NNP I-NP O
138 tube NN I-NP O
138 for IN B-VP O
138 future JJ O O
138 feeding VBG O O
138 Nutrition NN B-NP O
139 was VBD B-VP O
139 consulted VBN O O
139 and CC O O
139 tube JJ B-NP O
139 feeds NNS I-NP O
139 were VBD B-VP O
139 re-initiated JJ O O
139 that IN B-VP O
139 evening VBG O O
140 Again NNP B-NP O
140 , , O O
140 his PRP$ O O
140 Coumadin NNP B-NP B-m
140 will MD O O
140 be VB O O
140 held VBN O O
140 until IN B-VP B-du
140 9/23/07 CD O I-du
140 so RB O O
140 as IN B-VP O
140 to TO O O
140 promote VB O O
141 appropriate JJ B-NP O
141 wound NN I-NP O
141 healing VBG O O
141 around IN B-VP O
141 the DT B-NP O
141 site NN I-NP O
141 of IN B-VP O
141 the DT B-NP O
141 PEG NNP I-NP O
141 placement NN I-NP O
142 5 CD O O
142 Heme: NNP B-NP O
142 The DT B-NP O
142 patient NN I-NP O
142 had VBD B-VP O
142 a DT B-NP O
142 history NN I-NP O
142 of IN B-VP O
142 anemia NN B-NP O
142 but CC O O
142 did VBD B-VP O
142 not RB O O
143 demonstrate VB O O
143 any DT B-NP O
143 acute JJ I-NP O
143 hematocrit NN I-NP O
143 drops VBZ O O
143 His PRP$ O O
143 INR NN B-NP O
143 on IN B-VP O
143 admission NN B-NP O
143 was VBD B-VP O
144 1.9 CD O O
144 We PRP O O
144 had VBD B-VP O
144 transiently RB O O
144 restarted VBN O O
144 Coumadin NNP B-NP B-m
144 but CC O O
144 he PRP O O
144 will MD O O
144 have VB O O
144 to TO O O
145 restart VB O O
145 that DT O O
145 again RB O O
145 on IN B-VP O
145 9/23/07 CD O O
145 , , O O
145 given VBN O O
145 the DT B-NP O
145 fact NN I-NP O
145 that IN B-VP O
145 it PRP O O
145 was VBD B-VP O
145 held VBN O O
146 for IN B-VP O
146 his PRP$ O O
146 PEG NNP B-NP O
146 placement NN I-NP O
146 He PRP O O
146 was VBD B-VP O
146 continued VBN O O
146 on IN B-VP O
146 iron NN B-NP B-m
146 supplements NNS I-NP I-m
147 during IN B-VP B-du
147 his PRP$ O I-du
147 hospital NN B-NP I-du
147 stay NN I-NP I-du
148 6 CD O O
148 Renal: NNP B-NP O
148 The DT B-NP O
148 patient NN I-NP O
148 , , O O
148 as IN B-VP O
148 discussed VBN O O
148 above IN B-VP O
148 , , O O
148 has VBZ O O
148 demonstrated VBN O O
148 a DT B-NP O
149 respiratory JJ I-NP O
149 alkalosis NN I-NP O
149 with IN B-VP O
149 a DT B-NP O
149 mild JJ I-NP O
149 metabolic JJ I-NP O
149 alkalosis NN I-NP O
149 as RB O O
149 well RB O O
150 His PRP$ O O
150 creatinine NN B-NP O
150 was VBD B-VP O
150 mildly RB O O
150 elevated JJ O O
150 which WDT O O
150 is VBZ O O
150 secondary JJ O O
150 to TO O O
150 chronic JJ B-NP O
151 renal JJ I-NP O
151 insufficiency NN I-NP O
151 for IN B-VP O
151 unclear JJ B-NP O
151 reasons NNS I-NP O
151 His PRP$ O O
151 creatinine NN B-NP O
151 by IN B-VP O
151 the DT B-NP O
152 time NN I-NP O
152 of IN B-VP O
152 discharge NN B-NP O
152 had VBD B-VP O
152 improved VBN O O
152 dramatically RB O O
152 to TO O O
152 0.7 CD O O
153 7 CD O O
153 Endocrine: NNP B-NP O
153 The DT B-NP O
153 patient's JJ I-NP O
153 oral JJ I-NP O
153 hypoglycemics NNS I-NP O
153 were VBD B-VP O
153 held VBN O O
153 during IN B-VP O
154 this DT B-NP O
154 hospital NN I-NP O
154 stay NN I-NP O
154 He PRP O O
154 was VBD B-VP O
154 started VBN O O
154 on IN B-VP O
154 insulin NN B-NP B-m
154 sliding-scale JJ O B-do
154 and CC O O
155 Lantus NNP B-NP B-m
155 As IN B-VP O
155 his PRP$ O O
155 feeding NN B-NP O
155 has VBZ O O
155 increased VBN O O
155 and CC O O
155 his PRP$ O O
155 tube NN B-NP O
155 feeds NNS I-NP O
155 have VBP O O
156 reached VBN O O
156 goal NN B-NP O
156 , , O O
156 his PRP$ O O
156 Lantus NNP B-NP B-m
156 has VBZ O O
156 had VBN O O
156 to TO O O
156 be VB O O
156 titrated VBN O O
156 up IN B-VP O
156 He PRP O O
156 is VBZ O O
157 currently RB O O
157 at IN B-VP O
157 15 CD O B-do
157 units NNS B-NP I-do
157 q RB O B-f
157 p.m IN B-VP I-f
157 He PRP O O
157 may MD O O
157 need VB O O
157 more JJR B-NP O
157 while NN I-NP O
157 at IN B-VP O
157 the DT B-NP O
158 facility NN I-NP O
158 that IN B-VP O
158 he PRP O O
158 is VBZ O O
158 going VBG O O
158 to TO O O
159 8 CD O O
159 GU: NNP B-NP O
159 The DT B-NP O
159 patient NN I-NP O
159 has VBZ O O
159 a DT B-NP O
159 history NN I-NP O
159 of IN B-VP O
159 vesiculous JJ B-NP O
159 spermatocele NNS I-NP O
159 or CC O O
160 hydrocele NN B-NP O
160 , , O O
160 which WDT O O
160 is VBZ O O
160 going VBG O O
160 to TO O O
160 be VB O O
160 followed VBN O O
160 by IN B-VP O
160 urology NN B-NP O
160 as IN B-VP O
160 an DT B-NP O
161 outpatient NN I-NP O
161 We PRP O O
161 had VBD B-VP O
161 held VBN O O
161 his PRP$ O O
161 Flomax NNP B-NP B-m
161 initially RB O O
161 given VBN O O
161 low JJ B-NP O
161 blood NN I-NP O
162 pressure NN I-NP O
162 but CC O O
162 we PRP O O
162 restarted VBD B-VP O
162 it PRP O O
162 during IN B-VP B-du
162 his PRP$ O I-du
162 hospital NN B-NP I-du
162 stay NN I-NP I-du
162 here RB O O
163 9 CD O O
163 FEN: NNP B-NP O
163 As NNP I-NP O
163 mentioned VBD B-VP O
163 above IN B-VP O
163 , , O O
163 the DT B-NP O
163 patient NN I-NP O
163 is VBZ O O
163 on IN B-VP O
163 aspiration NN B-NP O
164 precautions NNS I-NP O
164 secondary VBP O O
164 to TO O O
164 speech VB O O
164 and CC O O
164 swallow VB O O
164 evaluation NN B-NP O
164 that WDT O O
164 was VBD B-VP O
165 consistent JJ O O
165 with IN B-VP O
165 aspiration NN B-NP O
165 NG NNP I-NP O
165 tubes NNS I-NP O
165 were VBD B-VP O
165 placed VBN O O
165 multiple JJ B-NP O
165 times NNS I-NP O
166 but CC O O
166 were VBD B-VP O
166 self-discontinued VBN O O
166 by IN B-VP O
166 the DT B-NP O
166 patient NN I-NP O
166 Finally NNP I-NP O
166 , , O O
166 a DT B-NP O
166 PEG NNP I-NP O
166 tube NN I-NP O
167 was VBD B-VP O
167 placed VBN O O
167 on IN B-VP O
167 1/5 CD O O
167 and CC O O
167 tube JJ B-NP O
167 feeds NNS I-NP O
167 were VBD B-VP O
167 reinitiated VBN O O
167 that IN B-VP O
167 evening VBG O O
168 10: CD O O
168 Psych: NNP B-NP O
168 The DT B-NP O
168 patient NN I-NP O
168 has VBZ O O
168 a DT B-NP O
168 history NN I-NP O
168 of IN B-VP O
168 being VBG O O
168 mildly RB O B-r
168 mildly RB O B-r
168 agitated VBN O I-r
168 agitated JJ B-NP I-r
169 Zyprexa NNP I-NP B-m
169 Zyprexa NNP I-NP B-m
169 was VBD B-VP O
169 initiated VBN O O
169 here RB O O
169 at IN B-VP O
169 home NN B-NP O
169 doses NNS I-NP O
169 of IN B-VP O
169 2.5 CD O B-do
169 mg NNS B-NP I-do
169 q JJ B-NP B-f
169 day NN I-NP I-f
169 and CC O O
170 then RB O O
170 titrated VBD B-VP O
170 up RB O O
170 to TO O O
170 2.5 CD O B-do
170 mg NNS B-NP I-do
170 b.i.d VBD B-VP B-f
170 The DT B-NP O
170 patient NN I-NP O
170 has VBZ O O
170 responded VBN O O
170 very RB O O
171 nicely RB O O
171 to TO O O
171 this DT O O
171 and CC O O
171 is VBZ O O
171 no DT O O
171 longer RB O O
171 agitated VBN O O
172 11 CD O O
172 Prophylaxis: NNP B-NP B-r
172 He PRP O O
172 was VBD B-VP O
172 kept VBN O O
172 on IN B-VP O
172 TEDS NNP B-NP O
172 and CC O O
172 P-boots NNP B-NP O
172 Coumadin NNP I-NP B-m
172 as IN B-VP O
173 mentioned VBN O O
173 above IN B-VP O
173 will MD O O
173 need VB O O
173 to TO O O
173 be VB O O
173 restarted VBN O O
173 on IN B-VP O
173 9/23/07 CD O O
173 and CC O O
173 Nexium NNP B-NP B-m
174 was VBD B-VP O
174 to TO O O
174 continue VB O O
174 while IN B-VP B-du
174 he PRP O I-du
174 is VBZ O I-du
174 here RB O I-du
175 The DT B-NP O
175 patient NN I-NP O
175 is VBZ O O
175 full JJ B-NP O
175 code NN I-NP O
175 His PRP$ O O
175 contacts NNS B-NP O
175 include VBP O O
175 his PRP$ O O
175 son NN B-NP O
175 ( ( O O
175 053 CD O O
175 ) ) O O
175 471-4960 CD O O
175 and CC O O
175 Hillesheim NNP B-NP O
175 , , O O
175 his PRP$ O O
175 daughter NN B-NP O
175 ( ( O O
175 226 CD O O
175 ) ) O O
175 407-4962 CD O O
176 DISCHARGE NNP B-NP O
176 MEDICATIONS: NNP I-NP O
176 See NNP I-NP O
176 addendum JJ B-NP O
177 DISCHARGE NNP I-NP O
177 PHYSICAL NNP I-NP O
177 EXAM: NNP I-NP O
177 Notable NNP I-NP O
177 for IN B-VP O
177 a DT B-NP O
177 temperature NN I-NP O
177 of IN B-VP O
177 98.4 CD O O
177 T NNP B-NP O
178 max NN I-NP O
178 , , O O
178 his PRP$ O O
178 current JJ O O
178 is VBZ O O
178 96.6 CD O O
178 His PRP$ O O
178 heart NN B-NP O
178 rate NN I-NP O
178 is VBZ O O
178 in IN B-VP O
178 the DT O O
178 90s CD O O
178 His PRP$ O O
179 blood NN B-NP O
179 pressure NN I-NP O
179 has VBZ O O
179 been VBN O O
179 stable JJ O O
179 in IN B-VP O
179 the DT O O
179 110-120s/70-80s JJ O O
179 His PRP$ O O
180 respirations NNS B-NP O
180 have VBP O O
180 been VBN O O
180 18-20 JJ O O
180 , , O O
180 satting VBG O O
180 92-96% CD O O
180 on IN B-VP O
180 room NN B-NP O
180 air NN I-NP O
180 In IN B-VP O
181 general JJ O O
181 , , O O
181 he PRP O O
181 is VBZ O O
181 in IN B-VP O
181 no DT B-NP O
181 acute NN I-NP O
181 distress VB O O
181 His PRP$ O O
181 lungs NNS B-NP O
181 are VBP O O
181 with IN B-VP O
181 coarse JJ B-NP O
182 bilateral JJ I-NP O
182 breath NN I-NP O
182 sounds VBZ O O
182 His PRP$ O O
182 rate NN B-NP O
182 and CC O O
182 rhythm NN B-NP O
182 were VBD B-VP O
182 regular JJ O O
183 without IN B-VP O
183 murmurs NNS B-NP O
183 His PRP$ O O
183 abdomen NNS B-NP O
183 is VBZ O O
183 soft JJ O O
183 and CC O O
183 nontender NN B-NP O
183 with IN B-VP O
183 good JJ B-NP O
184 bowel NN I-NP O
184 sounds VBZ O O
184 His PRP$ O O
184 extremities NNS B-NP O
184 are VBP O O
184 without IN B-VP O
184 edema NN B-NP O
185 He PRP O O
185 is VBZ O O
185 to TO O O
185 be VB O O
185 discharged VBN O O
185 today NN B-NP O
185 , , O O
185 1/26/06 CD O O
185 , , O O
185 to TO O O
185 rehabilitation VB O O
185 where WRB O O
186 they PRP O O
186 will MD O O
186 focus VB O O
186 primarily RB O O
186 on IN B-VP O
186 his PRP$ O O
186 physical JJ B-NP O
186 therapy NN I-NP O
186 and CC O O
186 rehab NN B-NP O
187 needs NNS I-NP O
188 eScription NN I-NP O
188 document: IN B-VP O
188 9-2621164 CD O O
188 HSSten NNP B-NP O
188 Tel NNP I-NP O
189 Dictated NNP I-NP O
189 By: NNP I-NP O
189 MADONNA NNP I-NP O
189 , , O O
189 BRANDON NNP B-NP O
190 Attending: NNP I-NP O
190 EMMANUEL NNP I-NP O
190 CLEMENT NNP I-NP O
190 CRITTLE NNP I-NP O
190 , , O O
190 M.D NNP B-NP O
190 IO1 NNP I-NP O
191 Dictation NNP I-NP O
191 ID NNP I-NP O
191 3934773 CD O O
192 D: NNP B-NP O
192 1/26/06 CD O O
193 T: NNP B-NP O
193 1/26/06 CD O O
194 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #280639 VBZ O O
4 051654496 CD O O
4 TMCO NNP B-NP O
4 96217849 CD O O
4 292122 CD O O
4 3/8/1993 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/30/1993 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/25/1993 CD O O
7 DIAGNOSIS: NNP B-NP O
7 OSTEOARTHRITIS NNP I-NP O
7 LEFT NNP I-NP O
7 HIP NNP I-NP O
8 STATUS NNP I-NP O
8 POST NNP I-NP O
8 OSTEOTOMY NNP I-NP O
8 FOR NNP I-NP O
8 OSTEOARTHRITIS NNP I-NP O
9 OF IN B-VP O
9 THE NNP B-NP O
9 RIGHT NNP I-NP O
9 HIP NNP I-NP O
10 HISTORY NNP I-NP O
10 OF NNP I-NP O
10 SLEEP NNP I-NP O
10 APNEA NNP I-NP O
11 OPERATIONS/PROCEDURES: NNP I-NP O
11 LEFT NNP I-NP O
11 TOTAL NNP I-NP O
11 HIP NNP I-NP O
11 REPLACEMENT NNP I-NP O
11 BY NNP I-NP O
11 DR NNP I-NP O
11 KOBA NNP I-NP O
11 ON NNP I-NP O
12 0 CD O O
12 of IN B-VP O
12 May NNP B-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 is VBZ O O
13 a DT O O
13 46 CD O O
13 year NN B-NP O
13 old JJ B-NP O
13 male NN I-NP O
13 with IN B-VP O
14 left JJ B-NP O
14 hip NN I-NP O
14 pain NN I-NP O
14 , , O O
14 now RB O O
14 worsening VBG O O
14 over IN B-VP O
14 the DT B-NP O
15 past JJ I-NP O
15 year NN I-NP O
15 , , O O
15 unrelieved JJ O O
15 with IN B-VP O
15 conservative JJ B-NP O
15 therapy NN I-NP O
15 The DT B-NP O
15 patient NN I-NP O
15 has VBZ O O
15 a DT B-NP O
16 history NN I-NP O
16 of IN B-VP O
16 congenital JJ B-NP O
16 dysplasia NN I-NP O
16 of IN B-VP O
16 the DT B-NP O
16 hip NN I-NP O
16 , , O O
16 which WDT O O
16 was VBD B-VP O
16 treated VBN O O
16 with IN B-VP O
17 osteotomy NN B-NP O
17 of IN B-VP O
17 the DT B-NP O
17 right JJ I-NP O
17 hip NN I-NP O
17 in IN B-VP O
17 1988 CD O O
17 , , O O
17 with IN B-VP O
17 good JJ B-NP O
17 improvement NN I-NP O
17 PAST NNP I-NP O
18 MEDICAL NNP I-NP O
18 HISTORY NNP I-NP O
18 was VBD B-VP O
18 also RB O O
18 remarkable JJ O O
18 for IN B-VP O
18 sleep JJ B-NP O
18 apnea NN I-NP O
18 ALLERGIES NNP I-NP O
19 included VBD B-VP O
19 intravenous JJ B-NP O
19 pyelogram NN I-NP O
19 dye NN I-NP O
19 and CC O O
19 shrimp JJ B-NP O
19 MEDICATIONS NNP I-NP O
19 ON NNP I-NP O
20 ADMISSION NNP I-NP O
20 were VBD B-VP O
20 none RB O O
21 PHYSICAL NNP B-NP O
21 EXAMINATION: NNP I-NP O
21 The DT B-NP O
21 patient NN I-NP O
21 was VBD B-VP O
21 an DT B-NP O
21 obese JJ I-NP O
21 white JJ I-NP O
21 male NN I-NP O
21 in IN B-VP O
21 no DT B-NP O
22 acute NN I-NP O
22 distress NN I-NP O
22 He PRP O O
22 ambulated VBD B-VP O
22 with IN B-VP O
22 a DT B-NP O
22 truncal JJ I-NP O
23 lurch NN I-NP O
23 to TO O O
23 the DT O O
23 left VBN O O
23 Head NNP B-NP O
23 and CC O O
23 neck NN B-NP O
23 were VBD B-VP O
23 within IN B-VP O
23 normal JJ B-NP O
23 limits NNS I-NP O
23 Lungs NNS I-NP O
24 were VBD B-VP O
24 clear JJ B-NP O
24 Cardiac NNP I-NP O
24 examination NN I-NP O
24 was VBD B-VP O
24 regular JJ B-NP O
24 Abdomen NNP I-NP O
24 was VBD B-VP O
24 obese JJ O O
24 , , O O
25 but CC O O
25 benign VBZ O O
25 The DT B-NP O
25 left JJ I-NP O
25 hip NN I-NP O
25 was VBD B-VP O
25 remarkable JJ O O
25 for IN B-VP O
25 being VBG O O
25 3/4 CD O O
25 inch NN B-NP O
25 longer JJR O O
26 than IN B-VP O
26 the DT B-NP O
26 right JJ I-NP O
26 leg NN I-NP O
26 Flexion NNP I-NP O
26 was VBD B-VP O
26 limited VBN O O
26 to TO O O
26 90 CD O O
26 degrees NNS B-NP O
26 , , O O
26 with IN B-VP O
26 10 CD O O
27 degrees NNS B-NP O
27 lacking VBG O O
27 full JJ B-NP O
27 extension NN I-NP O
27 External NNP I-NP O
27 rotation NN I-NP O
27 was VBD B-VP O
27 30 CD O O
27 degrees NNS B-NP O
27 , , O O
28 internal JJ B-NP O
28 rotation NN I-NP O
28 0 CD O O
28 , , O O
28 abduction NN B-NP O
28 30 CD O O
28 degrees NNS B-NP O
28 with IN B-VP O
28 increased JJ B-NP O
28 pain NN I-NP O
28 , , O O
28 and CC O O
29 adduction NN B-NP O
29 20 CD O O
29 degrees VBZ O O
29 The DT B-NP O
29 patient's NN I-NP O
29 neurovascular JJ B-NP O
29 examination NN I-NP O
29 was VBD B-VP O
30 within IN B-VP O
30 normal JJ B-NP O
30 limits NNS I-NP O
31 HOSPITAL NNP I-NP O
31 COURSE: NNP I-NP O
31 The DT B-NP O
31 patient NN I-NP O
31 was VBD B-VP O
31 admitted VBN O O
31 on IN B-VP O
31 0 CD O O
31 of IN B-VP O
31 May NNP B-NP O
31 , , O O
31 and CC O O
32 underwent JJ O O
32 left VBD B-VP O
32 total JJ B-NP O
32 hip NN I-NP O
32 replacement NN I-NP O
32 which WDT O O
32 he PRP O O
33 tolerated VBD B-VP O
33 well RB O O
33 Estimated VBN O O
33 blood NN B-NP O
33 loss NN I-NP O
33 was VBD B-VP O
33 400 CD O O
33 cc NN B-NP O
33 The DT B-NP O
33 patient NN I-NP O
33 was VBD B-VP O
34 in IN B-VP O
34 stable JJ B-NP O
34 condition NN I-NP O
34 for IN B-VP O
34 the DT B-NP O
34 entire JJ I-NP O
34 hospital NN I-NP O
34 stay VB O O
34 His PRP$ O O
34 immediate JJ B-NP O
35 postoperative JJ I-NP O
35 hematocrit NN I-NP O
35 was VBD B-VP O
35 36.3 CD O O
35 The DT B-NP O
35 patient NN I-NP O
35 was VBD B-VP O
35 febrile JJ O O
35 for IN B-VP O
35 the DT B-NP O
36 first JJ I-NP O
36 postoperative JJ I-NP O
36 day NN I-NP O
36 , , O O
36 but CC O O
36 rapidly RB O O
36 defervesced VBD B-VP O
36 on IN B-VP O
36 perioperative JJ B-NP B-m
37 antibiotics NNS I-NP O
37 with IN B-VP O
37 Ancef NNP B-NP B-m
37 On IN B-VP O
37 postoperative JJ B-NP O
37 day NN I-NP O
37 #2 NNP I-NP O
37 , , O O
37 hematocrit NN B-NP B-r
37 had VBD B-VP O
38 dropped VBN O O
38 to TO O O
38 29 CD O O
38 and CC O O
38 the DT B-NP O
38 patient NN I-NP O
38 received VBD B-VP O
38 2 CD O B-do
38 units NNS B-NP I-do
38 of IN B-VP O
38 autologous JJ B-NP B-m
38 blood NN I-NP I-m
38 , , O O
39 which WDT O O
39 increased VBD B-VP O
39 his PRP$ O O
39 hematocrit NN B-NP O
39 to TO O O
39 36 CD O O
39 The DT B-NP O
39 patient NN I-NP O
39 remained VBD B-VP O
39 stable JJ O O
40 over IN B-VP O
40 30 CD O O
40 for IN B-VP O
40 the DT B-NP O
40 rest NN I-NP O
40 of IN B-VP O
40 his PRP$ O O
40 hospital NN B-NP O
40 course NN I-NP O
41 The DT B-NP O
41 incision NN I-NP O
41 was VBD B-VP O
41 examined VBN O O
41 on IN B-VP O
41 postoperative JJ B-NP O
41 day NN I-NP O
41 #1 NNP I-NP O
41 , , O O
41 and CC O O
41 was VBD B-VP O
41 found VBN O O
41 to TO O O
42 be VB O O
42 clean JJ O O
42 and CC O O
42 dry JJ O O
42 The DT B-NP O
42 patient NN I-NP O
42 started VBD B-VP O
42 physical JJ B-NP O
42 therapy NN I-NP O
42 on IN B-VP O
43 postoperative JJ B-NP O
43 day NN I-NP O
43 #1 NNP I-NP O
43 , , O O
43 and CC O O
43 made VBD B-VP O
43 rapid JJ O O
43 progress IN B-VP O
43 The DT B-NP O
43 patient NN I-NP O
43 was VBD B-VP O
44 anticoagulated VBN O O
44 with IN B-VP O
44 Coumadin NNP B-NP B-m
44 for IN B-VP O
44 a DT B-NP O
44 prothrombin JJ I-NP B-r
44 time NN I-NP I-r
44 in IN B-VP O
44 the DT B-NP O
44 range NN I-NP O
44 of IN B-VP O
45 14 CD O O
45 to TO O O
45 16 CD O O
45 , , O O
45 and CC O O
45 stabilized VBN O O
45 at IN B-VP O
45 a DT B-NP O
45 dose NN I-NP O
45 of IN B-VP O
45 8 CD O B-do
45 milligrams NNS B-NP I-do
45 per IN B-VP B-f
45 night NN B-NP I-f
45 At IN B-VP O
46 the DT B-NP O
46 last JJ I-NP O
46 dose NN I-NP O
46 , , O O
46 his PRP$ O O
46 prothrombin JJ B-NP O
46 time NN I-NP O
46 had VBD B-VP O
46 gone VBN O O
46 up RB O O
46 over IN B-VP O
46 16 CD O O
46 and CC O O
46 he PRP O O
46 was VBD B-VP O
47 changed VBN O O
47 to TO O O
47 Coumadin NNP B-NP B-m
47 5 CD O B-do
47 milligrams NNS B-NP I-do
47 by IN B-VP B-mo
47 mouth NN B-NP I-mo
47 at IN B-VP B-f
47 hour NN B-NP I-f
47 of IN B-VP I-f
47 sleep NN B-NP I-f
47 The DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 cleared VBN O O
48 by IN B-VP O
48 the DT B-NP O
48 Physical NNP I-NP O
48 Therapy NNP I-NP O
48 Service NNP I-NP O
48 and CC O O
48 cleared VBN O O
49 medically RB O O
49 for IN B-VP O
49 discharge NN B-NP O
49 home NN I-NP O
49 on IN B-VP O
49 postoperative JJ B-NP O
49 day NN I-NP O
49 #6 NNP I-NP O
50 DISPOSITION: NNP I-NP O
50 The DT B-NP O
50 patient NN I-NP O
50 will MD O O
50 be VB O O
50 discharged VBN O O
50 to TO O O
50 home VB O O
50 The DT B-NP O
50 patient NN I-NP O
51 is VBZ O O
51 to TO O O
51 FOLLOW-UP JJ O O
51 with IN B-VP O
51 Dr NNP B-NP O
51 Mcfadden NNP I-NP O
51 in IN B-VP O
51 5 CD O O
51 weeks NNS B-NP O
52 MEDICATIONS NNP I-NP O
52 ON NNP I-NP O
52 DISCHARGE NNP I-NP O
52 included VBD B-VP O
52 Coumadin NNP B-NP B-m
52 for IN B-VP B-du
52 a DT B-NP O
52 full JJ I-NP O
52 6-week JJ I-NP O
53 course NN I-NP O
53 , , O O
53 Percocet NNP B-NP B-m
53 as IN B-VP B-f
53 needed VBN O I-f
53 The DT B-NP O
53 patient NN I-NP O
53 will MD O O
53 FOLLOW-UP NNP B-NP O
53 with IN B-VP O
53 the DT B-NP O
54 Coumadin NNP I-NP O
54 Program NNP I-NP O
54 through IN B-VP O
54 this DT B-NP O
54 hospital NN I-NP O
54 The DT B-NP O
54 patient NN I-NP O
54 had VBD B-VP O
54 no DT B-NP O
55 problems NNS I-NP O
55 with IN B-VP O
55 his PRP$ O O
55 breathing NN B-NP O
55 and CC O O
55 will MD O O
55 require VB O O
55 no DT B-NP O
55 special JJ I-NP O
55 therapy NN I-NP O
55 at IN B-VP O
56 this DT B-NP O
56 time NN I-NP O
56 CONDITION NNP I-NP O
56 ON NNP I-NP O
56 DISCHARGE NNP I-NP O
56 was VBD B-VP O
56 good JJ B-NP O
57 Dictated NNP I-NP O
57 By: NNP I-NP O
57 LOUIS NNP I-NP O
57 VORSE NNP I-NP O
57 , , O O
57 M.D NNP B-NP O
57 NF33 NNP I-NP O
58 Attending: NNP I-NP O
58 JEWELL NNP I-NP O
58 HUFFSTUTTER NNP I-NP O
58 , , O O
58 M.D NNP B-NP O
58 YQ1 NNP I-NP O
58 YM787/1854 NNP I-NP O
59 Batch: NNP I-NP O
59 0196 CD O O
59 Index NNP B-NP O
59 No NNP I-NP O
59 SRKZDD3V2W NNP I-NP O
59 D: NNP I-NP O
59 3/15/93 CD O O
60 T: NNP B-NP O
60 3/5/93 CD O O
61 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #288166 VBZ O O
2 125371610 CD O O
2 GXMH NNP B-NP O
2 30499072 CD O O
2 300621 CD O O
2 2/16/2000 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 PNEUMONIA NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 4/22/2000 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/16/2000 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 LEGIONELLA NNP I-NP O
4 PNEUMONIA NNP I-NP O
4 , , O O
4 BILATERAL NNP B-NP O
4 PLEURAL NNP I-NP O
5 EFFUSIONS NNP I-NP O
6 HISTORY NNP I-NP O
6 OF IN B-VP O
6 THE NNP B-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 The DT B-NP O
6 patient NN I-NP O
6 is VBZ O O
6 a DT B-NP O
6 57-year-old JJ I-NP O
7 female NN I-NP O
7 with IN B-VP O
7 a DT B-NP O
7 distant JJ I-NP O
7 history NN I-NP O
7 of IN B-VP O
8 ovarian JJ B-NP O
8 cancer NN I-NP O
8 , , O O
8 rheumatoid VB O O
8 arthritis NN B-NP O
8 with IN B-VP O
8 systemic JJ B-NP O
8 lupus NN I-NP O
9 erythematosus NN I-NP O
9 features NNS I-NP O
9 , , O O
9 and CC O O
9 history NN B-NP O
9 of IN B-VP O
9 TTP NNP B-NP O
9 , , O O
9 status NN B-NP O
9 post NN I-NP O
10 splenectomy NN I-NP O
10 , , O O
10 who WP O O
10 was VBD B-VP O
10 admitted VBN O O
10 with IN B-VP O
10 fever NN B-NP O
10 , , O O
10 shortness NN B-NP O
10 of IN B-VP O
10 breath NN B-NP O
10 and CC O O
11 pleuritic JJ B-NP O
11 chest NN I-NP O
11 pain NN I-NP O
11 She PRP O O
11 was VBD B-VP O
11 in IN B-VP O
11 her PRP$ O O
11 usual JJ B-NP O
11 state NN I-NP O
11 of IN B-VP O
11 health NN B-NP O
11 until IN B-VP O
12 March NNP B-NP O
12 of IN B-VP O
12 this DT B-NP O
12 year NN I-NP O
12 , , O O
12 when WRB O O
12 she PRP O O
12 began VBD B-VP O
12 to TO O O
12 experience VB O O
12 dyspnea NN B-NP O
12 on IN B-VP O
13 exertion NN B-NP O
13 , , O O
13 shortness NN B-NP O
13 of IN B-VP O
13 breath NN B-NP O
13 one CD O O
13 week NN B-NP O
13 after IN B-VP O
13 her PRP$ O O
13 husband NN B-NP O
13 died VBD B-VP O
14 Initially NNP B-NP O
14 she PRP O O
14 thought VBD B-VP O
14 it PRP O O
14 was VBD B-VP O
14 anxiety NN B-NP O
14 secondary JJ O O
14 to TO O O
14 her PRP$ O O
14 husband's JJ B-NP O
15 death NN I-NP O
15 , , O O
15 but CC O O
15 this DT B-NP O
15 shortness NN I-NP O
15 of IN B-VP O
15 breath NN B-NP O
15 began VBD B-VP O
15 to TO O O
15 increase VB O O
15 and CC O O
15 occurred VBD B-VP O
16 on IN B-VP O
16 rest NN B-NP O
16 She PRP O O
16 also RB O O
16 reports VBZ O O
16 that IN B-VP O
16 she PRP O O
16 has VBZ O O
16 had VBD B-VP O
16 a DT B-NP O
16 recent JJ I-NP O
16 history NN I-NP O
16 of IN B-VP O
17 orthopnea NN B-NP O
17 and CC O O
17 says VBZ O O
17 that IN B-VP O
17 for IN B-VP O
17 the DT B-NP O
17 past JJ I-NP O
17 few JJ I-NP O
17 months NNS I-NP O
17 she PRP O O
17 has VBZ O O
17 had VBN O O
18 bilateral VBN O O
18 lower RBR O O
18 extremity NN B-NP O
18 edema NN I-NP O
18 with IN B-VP O
18 gradual JJ B-NP O
18 onset NN I-NP O
18 She PRP O O
18 also RB O O
18 has VBZ O O
19 had VBD B-VP O
19 a DT O O
19 dry JJ O O
19 , , O O
19 non JJ B-NP O
19 productive JJ I-NP O
19 cough NN I-NP O
19 for IN B-VP O
19 the DT B-NP O
19 past JJ I-NP O
19 month NN I-NP O
19 and CC O O
19 three CD O O
19 days NNS B-NP O
20 ago RB O O
20 began VBD B-VP O
20 to TO O O
20 have VB O O
20 fevers NNS B-NP O
20 up RB O O
20 to TO O O
20 102 CD O O
20 , , O O
20 chills NNS B-NP O
20 , , O O
20 nausea NN B-NP O
20 , , O O
20 dry JJ B-NP O
20 heaves NNS I-NP O
20 , , O O
21 headache NN B-NP O
21 and CC O O
21 diarrhea VB O O
21 The DT B-NP O
21 shortness NN I-NP O
21 of IN B-VP O
21 breath NN B-NP O
21 has VBZ O O
21 increased VBN O O
21 in IN B-VP O
22 intensity NN B-NP O
22 and CC O O
22 yesterday NN B-NP O
22 she PRP O O
22 began VBD B-VP O
22 to TO O O
22 experience VB O O
22 sharp JJ B-NP O
22 pleuritic JJ I-NP O
23 right NN I-NP O
23 chest NN I-NP O
23 pain NN I-NP O
23 She PRP O O
23 denied VBD B-VP O
23 productive JJ B-NP O
23 cough NN I-NP O
23 , , O O
23 neck NN B-NP O
23 stiffness NN I-NP O
23 , , O O
24 photophobia NN B-NP O
24 , , O O
24 sick JJ B-NP O
24 contacts NNS I-NP O
24 , , O O
24 chest JJS B-NP O
24 pain NN I-NP O
24 , , O O
24 palpitations NNS B-NP O
24 , , O O
24 or CC O O
24 recent JJ B-NP O
25 travel NN I-NP O
25 Of IN B-VP O
25 note NN B-NP O
25 , , O O
25 the DT B-NP O
25 patient NN I-NP O
25 had VBD B-VP O
25 been VBN O O
25 on IN B-VP O
25 Plaquenil NNP B-NP B-m
25 previously RB O O
25 but CC O O
26 she PRP O O
26 self VBD B-VP O
26 discontinued VBN O O
26 this DT O O
26 three CD O O
26 months NNS B-NP O
26 ago RB O O
26 because IN B-VP O
26 she PRP O O
26 has VBZ O O
26 been VBN O O
27 feeling VBG O O
27 well RB O O
27 She PRP O O
27 has VBZ O O
27 had VBD B-VP O
27 no DT B-NP O
27 recurrence NN I-NP O
27 of IN B-VP O
27 her PRP$ O O
27 rheumatoid JJ B-NP O
28 arthritis NN I-NP O
28 symptoms NNS I-NP O
28 , , O O
28 which WDT O O
28 for IN B-VP O
28 her PRP$ O O
28 include NN B-NP O
28 arthritis NN I-NP O
28 in IN B-VP O
28 her PRP$ O O
28 hands NNS B-NP O
29 PAST NNP I-NP O
29 MEDICAL NNP I-NP O
29 HISTORY: NNP I-NP O
29 Past NNP I-NP O
29 medical JJ B-NP O
29 history NN I-NP O
29 is VBZ O O
29 significant JJ O O
29 for IN B-VP O
30 diabetes NNS B-NP O
30 type JJ O O
30 2 CD O O
30 , , O O
30 hypertension NN B-NP O
30 , , O O
30 TTP NNP B-NP O
30 , , O O
30 history NN B-NP O
31 of IN B-VP O
31 splenectomy NN B-NP O
31 , , O O
31 history NN B-NP O
31 of IN B-VP O
31 Haemophilus NNP B-NP O
31 influenzae NN I-NP O
31 and CC O O
31 pneumococcal JJ B-NP O
32 sepsis NN I-NP O
32 , , O O
32 rheumatoid JJ B-NP O
32 arthritis NN I-NP O
32 with IN B-VP O
32 systemic JJ B-NP O
32 lupus NN I-NP O
32 erythematosus NN I-NP O
33 features NNS I-NP O
33 , , O O
33 history NN B-NP O
33 of IN B-VP O
33 osteomyelitis NN B-NP O
33 in IN B-VP O
33 the DT B-NP O
33 right JJ I-NP O
33 ankle NN I-NP O
33 , , O O
33 history NN B-NP O
33 of IN B-VP O
34 ovarian JJ B-NP O
34 cancer NN I-NP O
34 in IN B-VP O
34 1989 CD O O
34 , , O O
34 status NN B-NP O
34 post NN I-NP O
34 chemotherapy NN I-NP O
34 , , O O
34 total JJ B-NP O
34 abdominal JJ I-NP O
35 hysterectomy NN I-NP O
35 and CC O O
35 bilateral JJ B-NP O
35 salpingo-oophorectomy JJ I-NP O
36 ALLERGIES: NNP I-NP O
36 She PRP O O
36 has VBZ O O
36 no DT O O
36 known VBN O O
36 drug NN B-NP O
36 allergies NNS I-NP O
37 MEDICATIONS: NNP I-NP O
37 Her NNP I-NP O
37 medications NNS I-NP O
37 include VBP O O
37 diltiazem JJ O B-m
37 240 CD O B-do
37 mg NN B-NP I-do
37 a DT B-NP B-f
37 day NN I-NP I-f
37 , , O O
38 lisinopril VBZ O B-m
38 40 CD O B-do
38 mg NN B-NP I-do
38 a DT B-NP B-f
38 day NN I-NP I-f
38 , , O O
38 Naprosyn NNP B-NP B-m
38 500 CD O B-do
38 mg NN B-NP I-do
38 b.i.d NN I-NP B-f
38 , , O O
38 NPH NNP B-NP B-m
39 insulin VBZ O O
39 24 CD O B-do
39 units NNS B-NP I-do
39 subcutaneously RB O B-mo
39 q.a.m RB O B-f
39 , , O O
39 Entex-LA NNP B-NP B-m
40 SOCIAL NNP I-NP O
40 HISTORY: NNP I-NP O
40 She PRP O O
40 lives VBZ O O
40 with IN B-VP O
40 her PRP$ O O
40 son NN B-NP O
40 Her PRP$ O O
40 husband NN B-NP O
40 recently RB O O
41 died VBD B-VP O
41 in IN B-VP O
41 March NNP B-NP O
41 of IN B-VP O
41 this DT B-NP O
41 year NN I-NP O
41 with IN B-VP O
41 esophageal NN B-NP O
42 cancer NN I-NP O
42 She PRP O O
42 has VBZ O O
42 no DT B-NP O
42 alcohol NN I-NP O
42 or CC O O
42 tobacco NN B-NP O
42 use NN I-NP O
42 She PRP O O
42 is VBZ O O
42 an DT B-NP O
42 elementary JJ I-NP O
43 school NN I-NP O
43 teacher RB O O
44 FAMILY NNP B-NP O
44 HISTORY: NNP I-NP O
44 Family NNP I-NP O
44 history NN I-NP O
44 is VBZ O O
44 significant JJ O O
44 for IN B-VP O
44 coronary JJ B-NP O
44 artery NN I-NP O
45 disease NN I-NP O
45 as RB O O
45 well RB O O
45 as IN B-VP O
45 breast NN B-NP O
45 carcinoma NN I-NP O
46 PHYSICAL NNP I-NP O
46 EXAMINATION: NNP I-NP O
46 On IN B-VP O
46 physical JJ B-NP O
46 examination NN I-NP O
46 , , O O
46 the DT B-NP O
46 patient NN I-NP O
46 was VBD B-VP O
47 afebrile JJ O O
47 with IN B-VP O
47 a DT B-NP O
47 temperature NN I-NP O
47 of IN B-VP O
47 98 CD O O
47 , , O O
47 pulse NN B-NP O
47 in IN B-VP O
48 the DT O O
48 100s CD O O
48 , , O O
48 blood NN B-NP O
48 pressure NN I-NP O
48 182/99 CD O O
48 The DT B-NP O
48 patient's NN I-NP O
48 oxygen NN I-NP O
48 saturation NN I-NP O
49 was VBD B-VP O
49 92% CD O O
49 on IN B-VP O
49 5 CD O O
49 liters NNS B-NP O
49 She PRP O O
49 was VBD B-VP O
49 alert JJ O O
49 and CC O O
49 oriented VBN O O
49 , , O O
49 in IN B-VP O
49 mild JJ B-NP O
50 respiratory NN I-NP O
50 distress NN I-NP O
50 The DT B-NP O
50 skin NN I-NP O
50 was VBD B-VP O
50 without IN B-VP O
50 rash NN B-NP O
50 HEENT: NNP I-NP O
50 Not RB O O
51 significant JJ B-NP O
51 NECK: NNP I-NP O
51 The DT B-NP O
51 neck NN I-NP O
51 was VBD B-VP O
51 supple JJ O O
51 with IN B-VP O
51 no DT B-NP O
51 lymphadenopathy NN I-NP O
51 or CC O O
52 thyromegaly NN B-NP O
52 CARDIOVASCULAR: NNP I-NP O
52 Tachycardic NNP I-NP O
52 , , O O
52 regular JJ B-NP O
52 rhythm NN I-NP O
52 , , O O
52 without IN B-VP O
53 murmurs NNS B-NP O
53 , , O O
53 gallops NNS B-NP O
53 or CC O O
53 rubs VB O O
53 She PRP O O
53 had VBD B-VP O
53 no DT B-NP O
53 jugular JJ I-NP O
53 venous JJ I-NP O
53 distention NN I-NP O
54 LUNGS: NNP I-NP O
54 The DT B-NP O
54 lungs NNS I-NP O
54 revealed VBD B-VP O
54 markedly RB O O
54 decreased VBN O O
54 breath NN B-NP O
54 sounds NNS I-NP O
54 at IN B-VP O
54 the DT B-NP O
55 bases NNS I-NP O
55 and CC O O
55 faint NN B-NP O
55 crackles NNS I-NP O
55 at IN B-VP O
55 the DT B-NP O
55 bases NNS I-NP O
55 on IN B-VP O
55 the DT B-NP O
55 right JJ I-NP O
55 ABDOMEN: NNP I-NP O
56 Abdominal NNP I-NP O
56 examination NN I-NP O
56 was VBD B-VP O
56 completely RB O O
56 benign JJ B-NP O
56 No NNP I-NP O
56 hepatomegaly NN I-NP O
56 or CC O O
57 masses VBZ O O
57 She PRP O O
57 did VBD B-VP O
57 have VB O O
57 a DT B-NP O
57 scar NN I-NP O
57 from IN B-VP O
57 the DT B-NP O
57 splenectomy NN I-NP O
57 EXTREMITIES: NNP I-NP O
58 The DT B-NP O
58 extremities NNS I-NP O
58 showed VBD B-VP O
58 1+ CD O O
58 edema NN B-NP O
58 bilaterally RB O O
58 There EX O O
58 were VBD B-VP O
58 no DT B-NP O
58 cords NNS I-NP O
59 Negative NNP I-NP O
59 Homans' NNP I-NP O
59 sign NN I-NP O
59 There EX O O
59 was VBD B-VP O
59 no DT B-NP O
59 clubbing NN I-NP O
59 or CC O O
59 cyanosis NN B-NP O
60 NEUROLOGICAL: NNP I-NP O
60 The DT B-NP O
60 neurological JJ I-NP O
60 examination NN I-NP O
60 was VBD B-VP O
60 intact JJ B-NP O
61 LABORATORY NNP I-NP O
61 DATA: NNP I-NP O
61 Significant NNP I-NP O
61 laboratory NN I-NP O
61 studies NNS I-NP O
61 included VBD B-VP O
61 a DT B-NP O
62 sodium NN I-NP O
62 of IN B-VP O
62 137 CD O O
62 , , O O
62 white JJ B-NP O
62 blood NN I-NP O
62 cell NN I-NP O
62 count NN I-NP O
62 of IN B-VP O
62 19.5 CD O O
63 with IN B-VP O
63 2 CD O O
63 bands NNS B-NP O
63 and CC O O
63 86 CD O O
63 polys NN B-NP O
63 as RB O O
63 well RB O O
63 as IN B-VP O
63 Howell-Jolly NNP B-NP O
63 bodies NNS I-NP O
64 Hematocrit NNP I-NP O
64 was VBD B-VP O
64 38.6 CD O O
64 , , O O
64 platelets NNS B-NP O
64 495 CD O O
64 , , O O
64 000 CD O O
64 CK NNP B-NP O
64 was VBD B-VP O
64 50 CD O O
64 , , O O
64 troponin NN B-NP O
64 was VBD B-VP O
64 0 CD O O
65 D-dimer NN B-NP O
65 was VBD B-VP O
65 greater JJR O O
65 than IN B-VP O
65 1 CD O O
65 , , O O
65 000 CD O O
65 Chest NNP B-NP O
65 x-ray NN I-NP O
65 revealed VBD B-VP O
65 large JJ B-NP O
66 bilateral JJ I-NP O
66 pleural JJ I-NP O
66 effusions NNS I-NP O
66 , , O O
66 left VBD B-VP O
66 greater JJR O O
66 than IN B-VP O
66 right JJ O O
66 She PRP O O
66 had VBD B-VP O
66 a DT B-NP O
66 CT NNP I-NP O
67 scan NN I-NP O
67 which WDT O O
67 was VBD B-VP O
67 a DT B-NP O
67 limited JJ I-NP O
67 study NN I-NP O
67 that WDT O O
67 showed VBD B-VP O
67 no DT B-NP O
67 evidence NN I-NP O
67 of IN B-VP O
67 a DT B-NP O
68 pulmonary JJ I-NP O
68 embolism NN I-NP O
68 It PRP O O
68 showed VBD B-VP O
68 a DT B-NP O
68 questionable JJ I-NP O
68 infiltrate NN I-NP O
68 in IN B-VP O
68 the DT B-NP O
69 right JJ I-NP O
69 lung NN I-NP O
69 versus IN B-VP O
69 compressive JJ B-NP O
69 atelectasis NN I-NP O
70 HOSPITAL NNP I-NP O
70 COURSE: NNP I-NP O
70 In IN B-VP O
70 summary JJ O O
70 , , O O
70 this DT O O
70 is VBZ O O
70 a DT B-NP O
70 57-year-old JJ I-NP O
70 female NN I-NP O
70 with IN B-VP O
70 a DT B-NP O
71 distant JJ I-NP O
71 history NN I-NP O
71 of IN B-VP O
71 ovarian JJ B-NP O
71 cancer NN I-NP O
71 and CC O O
71 TTP NNP B-NP O
71 , , O O
71 who WP O O
72 was VBD B-VP O
72 admitted VBN O O
72 with IN B-VP O
72 likely JJ B-NP O
72 community NN I-NP O
72 acquired VBD B-VP O
72 pneumonia NN B-NP O
72 and CC O O
72 bilateral JJ B-NP O
73 moderate NN I-NP O
73 to TO O O
73 large JJ B-NP O
73 pleural JJ I-NP O
73 effusions NNS I-NP O
73 Initially RB O O
73 the DT B-NP O
73 patient NN I-NP O
73 was VBD B-VP O
74 given VBN O O
74 cefuroxime NN B-NP B-m
74 and CC O O
74 levofloxacin NN B-NP B-m
74 in IN B-VP O
74 the DT B-NP O
74 emergency NN I-NP O
74 department NN I-NP O
74 for IN B-VP O
74 a DT O B-r
74 a DT B-NP B-r
75 presumed JJ I-NP O
75 community NN I-NP O
75 acquired VBD B-VP O
75 pneumonia NN B-NP O
75 She PRP O O
75 also RB O O
75 was VBD B-VP O
75 given VBN O O
75 Lasix NNP B-NP B-m
76 for IN B-VP O
76 diuresis NN B-NP O
76 , , O O
76 given VBN O O
76 there EX O O
76 was VBD B-VP O
76 a DT B-NP O
76 question NN I-NP O
76 of IN B-VP O
76 whether IN B-VP O
76 or CC O O
76 not RB O O
76 she PRP O O
76 was VBD B-VP O
77 having VBG O O
77 any DT B-NP O
77 heart NN I-NP O
77 failure NN I-NP O
77 Given NNP I-NP O
77 her PRP$ O O
77 elevated JJ B-NP O
77 D-dimer NN I-NP O
77 , , O O
77 she PRP O O
77 had VBD B-VP O
77 a DT B-NP O
78 spiral JJ I-NP O
78 CT NNP I-NP O
78 scan NN I-NP O
78 of IN B-VP O
78 the DT O O
78 chest JJS O O
78 which WDT O O
78 did VBD B-VP O
78 not RB O O
78 reveal VB O O
78 any DT B-NP O
78 evidence NN I-NP O
78 of IN B-VP O
79 pulmonary JJ B-NP O
79 embolus NN I-NP O
79 and CC O O
79 also RB O O
79 had VBD B-VP O
79 lower JJR B-NP O
79 extremity NN I-NP O
79 Dopplers NNS I-NP O
79 which WDT O O
79 were VBD B-VP O
80 negative JJ O O
80 However RB O O
80 , , O O
80 there EX O O
80 was VBD B-VP O
80 a DT B-NP O
80 continuous JJ I-NP O
80 Doppler NNP I-NP O
80 wave VBP O O
80 form NN B-NP O
80 on IN B-VP O
80 the DT B-NP O
81 study NN I-NP O
81 which WDT O O
81 raised VBD B-VP O
81 the DT B-NP O
81 suspicion NN I-NP O
81 of IN B-VP O
81 a DT O O
81 more RBR O O
81 proximal JJ B-NP O
81 venous JJ I-NP O
82 compression NN I-NP O
82 Therefore NNP I-NP O
82 , , O O
82 she PRP O O
82 underwent VBD B-VP O
82 abdominal JJ B-NP O
82 CT NNP I-NP O
82 scan NN I-NP O
82 , , O O
82 which WDT O O
82 did VBD B-VP O
83 not RB O O
83 show VB O O
83 any DT B-NP O
83 evidence NN I-NP O
83 of IN B-VP O
83 venous JJ B-NP O
83 obstruction NN I-NP O
83 as RB O O
83 well RB O O
83 as IN B-VP O
83 lymphatic JJ B-NP O
84 obstruction NN I-NP O
85 1 CD O O
85 ) ) O O
85 INFECTIOUS NNP B-NP O
85 DISEASE: NNP I-NP O
85 The DT B-NP O
85 patient NN I-NP O
85 was VBD B-VP O
85 admitted VBN O O
85 and CC O O
85 treated VBN O O
85 for IN B-VP O
86 what WP O O
86 was VBD B-VP O
86 thought VBN O O
86 to TO O O
86 initially RB O O
86 be VB O O
86 just RB O O
86 a DT O B-r
86 a DT B-NP B-r
86 community NN I-NP O
86 acquired VBN O O
87 pneumonia NN B-NP O
87 with IN B-VP O
87 large JJ B-NP O
87 effusions NNS I-NP O
87 , , O O
87 likely JJ B-NP O
87 peripneumonic NN I-NP O
87 in IN B-VP O
87 nature NN B-NP O
88 She PRP O O
88 initially RB O O
88 was VBD B-VP O
88 started VBN O O
88 on IN B-VP O
88 cefuroxime NN B-NP B-m
88 and CC O O
88 azithromycin NN B-NP B-m
88 by IN B-VP O
88 the DT B-NP O
89 General NNP I-NP O
89 Medicine NNP I-NP O
89 team NN I-NP O
89 She PRP O O
89 was VBD B-VP O
89 pancultured VBN O O
89 as RB O O
89 well RB O O
89 as IN B-VP O
89 had VBD B-VP O
90 Legionella NNP B-NP O
90 urine JJ B-NP O
90 antigen NN I-NP O
90 sent VBD B-VP O
90 Subsequently NNP B-NP O
90 her PRP$ O O
90 Legionella NNP B-NP B-r
90 urine JJ B-NP O
91 antigen NN I-NP O
91 became VBD B-VP O
91 positive JJ O O
91 and CC O O
91 repeat JJ B-NP O
91 test NN I-NP O
91 again RB O O
91 revealed VBD B-VP O
91 that IN B-VP O
91 this DT O O
92 was VBD B-VP O
92 in IN B-VP O
92 fact NN B-NP O
92 positive JJ O O
92 At IN B-VP O
92 that DT B-NP O
92 time NN I-NP O
92 , , O O
92 levofloxacin NN B-NP B-m
92 was VBD B-VP O
92 added VBN O O
92 given VBN O O
93 recommendations NNS B-NP O
93 from IN B-VP O
93 the DT B-NP O
93 Infectious NNP I-NP O
93 Disease NNP I-NP O
93 Service NNP I-NP O
93 She PRP O O
93 was VBD B-VP O
94 continued VBN O O
94 on IN B-VP O
94 azithromycin; NN B-NP B-m
94 however RB O O
94 , , O O
94 cefuroxime NN B-NP B-m
94 was VBD B-VP O
94 discontinued VBN O O
94 as IN B-VP O
95 there EX O O
95 was VBD B-VP O
95 no DT B-NP O
95 evidence NN I-NP O
95 of IN B-VP O
95 other JJ B-NP O
95 etiology NN I-NP O
95 of IN B-VP O
95 her PRP$ O O
95 pneumonia NN B-NP O
95 She PRP O O
96 underwent JJ B-NP O
96 thoracentesis NN I-NP O
96 late RB O O
96 the DT B-NP O
96 evening NN I-NP O
96 of IN B-VP O
96 her PRP$ O O
96 admission NN B-NP O
96 , , O O
96 which WDT O O
97 revealed VBD B-VP O
97 a DT B-NP O
97 transudate NN I-NP O
97 Cytology NNP I-NP O
97 was VBD B-VP O
97 sent VBN O O
97 on IN B-VP O
97 this DT O O
97 and CC O O
97 was VBD B-VP O
97 negative JJ O O
98 as RB O O
98 well RB O O
98 as IN B-VP O
98 all DT B-NP O
98 cultures NNS I-NP O
98 were VBD B-VP O
98 negative JJ O O
98 from IN B-VP O
98 this DT O O
98 She PRP O O
98 underwent JJ B-NP O
99 multiple JJ I-NP O
99 bilateral JJ I-NP O
99 therapeutic JJ I-NP O
99 pleuracentesis NN I-NP O
99 , , O O
99 given VBN O O
99 that IN B-VP O
99 the DT B-NP O
100 effusions NNS I-NP O
100 were VBD B-VP O
100 quite RB O O
100 large JJ B-NP O
100 Ultrasound NNP I-NP O
100 revealed VBD B-VP O
100 multiple JJ B-NP O
101 loculations NNS I-NP O
101 on IN B-VP O
101 the DT B-NP O
101 right JJ I-NP O
101 side NN I-NP O
101 and CC O O
101 she PRP O O
101 had VBD B-VP O
101 to TO O O
101 undergo VB O O
101 right RB O O
101 sided VBN O O
102 ultrasound NN B-NP O
102 guided VBD B-VP O
102 thoracentesis NN B-NP O
102 to TO O O
102 remove VB O O
102 fluid NN B-NP O
102 In IN B-VP O
102 addition NN B-NP O
102 , , O O
102 the DT B-NP O
103 patient NN I-NP O
103 was VBD B-VP O
103 aggressively RB O O
103 diuresed VBN O O
103 with IN B-VP O
103 Lasix NNP B-NP B-m
103 to TO O O
103 help VB O O
103 with IN B-VP O
103 the DT B-NP O
104 effusions NNS I-NP O
105 The DT B-NP O
105 patient NN I-NP O
105 continued VBD B-VP O
105 to TO O O
105 have VB O O
105 a DT B-NP O
105 high JJ I-NP O
105 oxygen NN I-NP O
105 requirement NN I-NP O
105 throughout IN B-VP O
106 the DT B-NP O
106 hospitalization NN I-NP O
106 despite IN B-VP O
106 aggressive JJ B-NP O
106 thoracentesis NN I-NP O
106 However RB O O
106 , , O O
106 as IN B-VP O
107 she PRP O O
107 was VBD B-VP O
107 diuresed VBN O O
107 aggressively RB O O
107 , , O O
107 her PRP O O
107 oxygen VBP O B-m
107 requirement NN B-NP O
107 was VBD B-VP O
107 down RB O O
107 from IN B-VP O
108 initially RB O O
108 5 CD O B-do
108 to TO O I-do
108 6 CD O I-do
108 liters NNS B-NP I-do
108 per IN B-VP B-mo
108 nasal NN B-NP I-mo
108 cannula NN I-NP I-mo
108 Prior NNP I-NP O
108 to TO O O
108 discharge VB O O
108 , , O O
108 she PRP O O
109 was VBD B-VP O
109 off IN B-VP O
109 of IN B-VP O
109 O2 NNP B-NP B-m
109 except IN B-VP O
109 that IN B-VP O
109 she PRP O O
109 had VBD B-VP O
109 desaturations NNS B-NP O
109 to TO O O
109 86% CD O O
109 with IN B-VP O
110 ambulation NN B-NP O
110 Therefore NN I-NP O
110 , , O O
110 she PRP O O
110 was VBD B-VP O
110 discharged VBN O O
110 home NN B-NP O
110 with IN B-VP O
110 p.r.n NN B-NP B-f
110 oxygen NN I-NP B-m
111 She PRP O O
111 remained VBD B-VP O
111 afebrile RB O O
111 throughout IN B-VP O
111 the DT B-NP O
111 rest NN I-NP O
111 of IN B-VP O
111 the DT B-NP O
111 hospitalization NN I-NP O
112 and CC O O
112 her PRP$ O O
112 pulmonary JJ B-NP O
112 status NN I-NP O
112 continued VBD B-VP O
112 to TO O O
112 improve VB O O
112 prior RB O O
112 to TO O O
112 discharge VB O O
113 Other JJ B-NP O
113 complications NNS I-NP O
113 during IN B-VP O
113 the DT B-NP O
113 hospitalization NN I-NP O
113 included VBD B-VP O
113 an DT B-NP O
113 elevated JJ I-NP O
114 platelet NN I-NP O
114 count NN I-NP O
114 up RB O O
114 to TO O O
114 800 CD O O
114 This DT O O
114 was VBD B-VP O
114 thought VBN O O
114 likely RB O O
114 to TO O O
114 be VB O O
114 acute JJ B-NP O
115 phase NN I-NP O
115 reactant NN I-NP O
115 secondary JJ O O
115 to TO O O
115 infection NN B-NP O
115 and CC O O
115 fever NN B-NP O
115 and CC O O
115 this DT O O
115 will MD O O
115 be VB O O
116 followed VBN O O
116 as IN B-VP O
116 an DT B-NP O
116 outpatient NN I-NP O
116 In IN B-VP O
116 addition NN B-NP O
116 to TO O O
116 this DT O O
116 , , O O
116 she PRP O O
116 had VBD B-VP O
116 an DT O O
117 elevated VBN O O
117 CA-125 NNP B-NP O
117 level NN I-NP O
117 This DT O O
117 was VBD B-VP O
117 discussed VBN O O
117 with IN B-VP O
117 her PRP$ O O
117 GYN NNP B-NP O
117 oncologist NN I-NP O
118 and CC O O
118 he PRP O O
118 felt VBD B-VP O
118 that IN B-VP O
118 this DT O O
118 was VBD B-VP O
118 likely JJ O O
118 from IN B-VP O
118 the DT B-NP O
118 effusions NNS I-NP O
118 , , O O
118 but CC O O
118 again RB O O
119 should MD O O
119 be VB O O
119 followed VBN O O
119 as IN B-VP O
119 an DT B-NP O
119 outpatient NN I-NP O
119 to TO O O
119 make VB O O
119 sure JJ O O
119 that IN B-VP O
119 this DT O O
119 resolves VBZ O O
120 as IN B-VP O
120 the DT B-NP O
120 effusions NNS I-NP O
120 continue VBP O O
120 to TO O O
120 resolve VB O O
120 Abdominal NNP B-NP O
120 CT NNP I-NP O
120 scan NN I-NP O
120 , , O O
120 which WDT O O
120 was VBD B-VP O
121 done VBN O O
121 to TO O O
121 rule VB O O
121 out RB O O
121 more JJR B-NP O
121 proximal JJ I-NP O
121 venous JJ I-NP O
121 compression NN I-NP O
121 did VBD B-VP O
121 not RB O O
121 reveal VB O O
122 any DT B-NP O
122 recurrence NN I-NP O
122 of IN B-VP O
122 ovarian JJ B-NP O
122 cancer NN I-NP O
123 The DT B-NP O
123 patient NN I-NP O
123 was VBD B-VP O
123 discharged VBN O O
123 to TO O O
123 home NN B-NP O
123 on IN B-VP O
123 March NNP B-NP O
123 , , O O
123 2000 CD O O
123 , , O O
123 with IN B-VP O
123 services NNS B-NP O
124 as RB O O
124 well RB O O
124 as IN B-VP O
124 p.r.n NN B-NP B-f
124 oxygen IN B-VP B-m
124 She PRP O O
124 was VBD B-VP O
124 in IN B-VP O
124 stable JJ B-NP O
124 condition NN I-NP O
124 She PRP O O
124 had VBD B-VP O
124 no DT B-NP O
125 problems NNS I-NP O
125 with IN B-VP O
125 her PRP$ O O
125 diabetes NNS B-NP O
125 , , O O
125 hypertension NN B-NP O
125 , , O O
125 rheumatoid NN B-NP O
125 arthritis NN I-NP O
126 throughout IN B-VP O
126 the DT B-NP O
126 rest NN I-NP O
126 of IN B-VP O
126 her PRP$ O O
126 hospitalization NN B-NP O
127 DISCHARGE NNP I-NP O
127 MEDICATIONS: NNP I-NP O
127 Her NNP I-NP O
127 discharge NN I-NP O
127 medications NNS I-NP O
127 include VBP O O
127 Lasix NNP B-NP B-m
128 80 CD O B-do
128 mg NN B-NP I-do
128 b.i.d NN I-NP B-f
128 , , O O
128 insulin NN B-NP B-m
128 sliding VBG O B-do
128 scale NN B-NP I-do
128 , , O O
129 lisinopril VBZ O B-m
129 40 CD O B-do
129 mg NN B-NP I-do
129 a DT B-NP B-f
129 day NN I-NP I-f
129 , , O O
129 levofloxacin VBZ O B-m
129 500 CD O B-do
129 mg NN B-NP I-do
129 times NNS I-NP B-du
129 14 CD O I-du
129 days NNS B-NP I-du
129 , , O O
130 Cardizem-CD JJ O B-m
130 240 CD O B-do
130 mg NN B-NP I-do
130 p.o NN I-NP B-mo
130 q.d NN I-NP B-f
131 FOLLOW-UP: NNP I-NP O
131 She PRP O O
131 is VBZ O O
131 to TO O O
131 follow-up JJ O O
131 with IN B-VP O
131 Dr NNP B-NP O
131 Michalek NNP I-NP O
131 in IN B-VP O
131 one CD O O
131 week NN B-NP O
131 and CC O O
132 she PRP O O
132 is VBZ O O
132 to TO O O
132 have VB O O
132 her PRP$ O O
132 platelets NNS B-NP O
132 checked VBN O O
132 as RB O O
132 well RB O O
132 as IN B-VP O
132 a DT B-NP O
133 CA-125 NNP I-NP O
133 as IN B-VP O
133 her PRP$ O O
133 Legionella NNP B-NP O
133 pneumonia NN I-NP O
133 resolves NNS I-NP O
134 Dictated VBD B-VP O
134 By: NNP B-NP O
134 ANDREA NNP I-NP O
134 MADRUENO NNP I-NP O
134 , , O O
134 M.D NNP B-NP O
134 EH81 NNP I-NP O
135 Attending: NNP I-NP O
135 CORDELL NNP I-NP O
135 D NNP I-NP O
135 GETER NNP I-NP O
135 , , O O
135 M.D NNP B-NP O
135 AA78 NNP I-NP O
136 NT155/4887 NNP I-NP O
137 Batch: NNP I-NP O
137 93541 CD O O
137 Index NNP B-NP O
137 No NNP I-NP O
137 B2QX3B4MPD NNP I-NP O
137 D: NNP I-NP O
137 9/9 CD O O
138 T: NNP B-NP O
138 0/30 CD O O
139 CC: NNP B-NP O
139 1 CD O O
139 HARLAND NNP B-NP O
139 E NNP I-NP O
139 GOYNE NNP I-NP O
139 , , O O
139 M.D NNP B-NP O
139 EO01 NNP I-NP O
140 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #289431 VBZ O O
4 927243785 CD O O
4 RCHO NNP B-NP O
4 44245516 CD O O
4 4404996 CD O O
4 1/9/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 r/o NN I-NP O
4 MI NNP I-NP O
4 , , O O
4 SOB NNP B-NP O
4 multifactorial JJ B-NP O
4 deconditioning NN I-NP O
4 , , O O
4 pulmon JJ B-NP O
4 disease NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/9/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/29/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 REDRICK NNP I-NP O
8 , , O O
8 CRAIG NNP B-NP O
8 MATTHEW NNP I-NP O
8 639-51-79-1 JJ B-NP O
9 Arkansas NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 11/16/04 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 GIGGER NNP I-NP O
14 , , O O
14 JERALD NNP B-NP O
14 DARRYL NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 ACETYLSALICYLIC NNP I-NP B-m
17 ACID NNP I-NP I-m
17 81 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 AMITRIPTYLINE NNP I-NP B-m
18 HCL NNP I-NP I-m
18 25 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QHS NNP I-NP B-f
19 FUROSEMIDE NNP I-NP B-m
19 40 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Alert NNP I-NP O
20 overridden: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 6/23/04 CD O O
20 by IN B-VP O
21 ORMS NNP B-NP O
21 , , O O
21 EDDIE NNP B-NP O
21 , , O O
21 M.D NNP B-NP O
22 on IN B-VP O
22 order NN B-NP O
22 for IN B-VP O
22 FUROSEMIDE NNP B-NP B-m
22 PO NNP I-NP B-mo
22 ( ( O O
22 ref JJ O O
22 # # O O
22 73820170 CD O O
22 ) ) O O
23 Pt NNP B-NP O
23 has VBZ O O
23 a DT B-NP O
23 POSSIBLE NNP I-NP O
23 allergy NN I-NP O
23 to TO O O
23 Sulfa; NNP B-NP O
23 reaction NN I-NP O
23 is VBZ O O
23 renal JJ B-NP O
24 failure NN I-NP O
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 pt NN I-NP O
24 tol NN I-NP O
24 at IN B-VP O
24 home NN B-NP O
25 GLYBURIDE NNP I-NP B-m
25 10 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 BID NNP I-NP B-f
26 Alert NNP I-NP O
26 overridden: NNP I-NP O
26 Override NNP I-NP O
26 added VBD B-VP O
26 on IN B-VP O
26 6/23/04 CD O O
26 by IN B-VP O
27 OAKES NNP B-NP O
27 , , O O
27 ROOSEVELT NNP B-NP O
27 , , O O
27 M.D NNP B-NP O
28 on IN B-VP O
28 order NN B-NP O
28 for IN B-VP O
28 GLYBURIDE NNP B-NP B-m
28 PO NNP I-NP B-mo
28 ( ( O O
28 ref JJ O O
28 # # O O
28 43601169 CD O O
28 ) ) O O
29 Pt NNP B-NP O
29 has VBZ O O
29 a DT B-NP O
29 POSSIBLE NNP I-NP O
29 allergy NN I-NP O
29 to TO O O
29 Sulfa; NNP B-NP O
29 reaction NN I-NP O
29 is VBZ O O
29 renal JJ B-NP O
30 failure NN I-NP O
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 pt NN I-NP O
30 takes VBZ O O
30 at IN B-VP O
30 home NN B-NP O
31 NOVOLIN NNP I-NP B-m
31 INNOLET NNP I-NP I-m
31 70/30 CD O I-m
31 ( ( O I-m
31 INSULIN NNP B-NP I-m
31 70/30 CD O I-m
31 ( ( O I-m
31 HUMAN NNP B-NP I-m
31 ) ) O I-m
31 ) ) O I-m
32 100 CD O B-do
32 UNITS NNP B-NP I-do
32 SC NNP I-NP B-mo
32 BID NNP I-NP B-f
33 Number NNP I-NP B-du
33 of IN B-VP I-du
33 Doses NNP B-NP I-du
33 Required NNP I-NP I-du
33 ( ( O I-du
33 approximate JJ B-NP I-du
33 ): NN I-NP I-du
33 8 CD O I-du
34 NORVASC NNP B-NP B-m
34 ( ( O I-m
34 AMLODIPINE NNP B-NP I-m
34 ) ) O I-m
34 10 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QD NNP I-NP B-f
35 Food/Drug NNP I-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
36 Avoid NNP I-NP O
36 grapefruit NN I-NP O
36 unless IN B-VP O
36 MD NNP B-NP O
36 instructs NNS I-NP O
36 otherwise RB O O
37 LIPITOR NNP B-NP B-m
37 ( ( O I-m
37 ATORVASTATIN NNP B-NP I-m
37 ) ) O I-m
37 10 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 Override NNP I-NP O
38 Notice: NNP I-NP O
38 Override NNP I-NP O
38 added VBD B-VP O
38 on IN B-VP O
38 6/23/04 CD O O
38 by IN B-VP O
39 GASTINEAU NNP B-NP O
39 , , O O
39 RAMIRO NNP B-NP O
39 , , O O
39 M.D NNP B-NP O
40 on IN B-VP O
40 order NN B-NP O
40 for IN B-VP O
40 CLOTRIMAZOLE NNP B-NP B-m
40 1% CD O I-m
40 CREAM NNP B-NP I-m
40 TP NNP I-NP B-mo
40 ( ( O O
40 ref JJ O O
40 # # O O
40 17426481 CD O O
40 ) ) O O
41 SERIOUS NNP B-NP O
41 INTERACTION: NNP I-NP O
41 ATORVASTATIN NNP I-NP B-m
41 CALCIUM NNP I-NP I-m
41 &amp; NNP I-NP O
41 CLOTRIMAZOLE NNP I-NP B-m
42 Reason NNP I-NP O
42 for IN B-VP O
42 override: NN B-NP O
42 will MD O O
42 monitor VB O O
43 Previous JJ O O
43 override IN B-VP O
43 information: JJ B-NP O
44 Override NNP I-NP O
44 added VBD B-VP O
44 on IN B-VP O
44 6/23/04 CD O O
44 by IN B-VP O
44 ARDELEAN NNP B-NP O
44 , , O O
44 TRACY NNP B-NP O
44 , , O O
44 M.D NNP B-NP O
45 on IN B-VP O
45 order NN B-NP O
45 for IN B-VP O
45 LIPITOR NNP B-NP B-m
45 PO NNP I-NP B-mo
45 ( ( O O
45 ref JJ O O
45 # # O O
45 90735952 CD O O
45 ) ) O O
46 Pt NNP B-NP O
46 has VBZ O O
46 a DT B-NP O
46 PROBABLE NNP I-NP O
46 allergy NN I-NP O
46 to TO O O
46 SIMVASTATIN; NNP B-NP O
46 reaction NN I-NP O
46 is VBZ O O
47 myalgia JJ B-NP O
47 Reason NNP I-NP O
47 for IN B-VP O
47 override: NN B-NP O
47 pt NN I-NP O
47 tol NN I-NP O
47 lipitor NN I-NP B-m
47 at IN B-VP O
47 home NN B-NP O
48 DIET: NNP I-NP O
48 House NNP I-NP O
48 / NNP I-NP O
48 ADA NNP I-NP O
48 2100 CD O O
48 cals/dy NN B-NP O
49 ACTIVITY: NNP I-NP O
49 Walking NNP I-NP O
49 as IN B-VP O
49 tolerated VBN O O
50 FOLLOW NNP B-NP O
50 UP NNP I-NP O
50 APPOINTMENT( NNP I-NP O
50 S NNP I-NP O
50 ): NNP I-NP O
51 Dr NNP I-NP O
51 Giangrosso NNP I-NP O
51 SH NNP I-NP O
51 call NN I-NP O
51 to TO O O
51 schedule NN B-NP O
51 1wk CD O O
51 , , O O
52 ALLERGY: NNP B-NP O
52 Penicillins NNP I-NP O
52 , , O O
52 Sulfa NNP B-NP O
52 , , O O
52 ACE NNP B-NP O
52 Inhibitor NNP I-NP O
52 , , O O
52 METFORMIN NNP B-NP O
52 HCL NNP I-NP O
52 , , O O
53 SIMVASTATIN NNP B-NP O
53 , , O O
53 DRUG NNP B-NP O
53 ALLERGY NNP I-NP O
53 , , O O
53 ALLERGY NNP B-NP O
54 ADMIT NNP I-NP O
54 DIAGNOSIS: NNP I-NP O
55 SOB/Chest NNP I-NP O
55 pain NN I-NP O
56 PRINCIPAL NNP I-NP O
56 DISCHARGE NNP I-NP O
56 DIAGNOSIS NNP I-NP O
56 ;Responsible JJ O O
56 After IN B-VP O
56 Study NNP B-NP O
56 for IN B-VP O
56 Causing NNP B-NP O
56 Admission NNP I-NP O
56 ) ) O O
57 r/o NN B-NP O
57 MI NNP I-NP O
57 , , O O
57 SOB NNP B-NP O
57 multifactorial JJ B-NP O
57 deconditioning NN I-NP O
57 , , O O
57 pulmon JJ B-NP O
57 disease NN I-NP O
58 OTHER NNP I-NP O
58 DIAGNOSIS;Conditions NNP I-NP O
58 , , O O
58 Infections NNP B-NP O
58 , , O O
58 Complications NNP B-NP O
58 , , O O
58 affecting VBG O O
58 Treatment/Stay NNP B-NP O
59 HTN NNP I-NP O
59 , , O O
59 uncontrolled JJ B-NP O
59 DM NNP I-NP O
59 , , O O
59 Sleep NNP B-NP O
59 Apnea NNP I-NP O
59 , , O O
59 Asthma NNP B-NP O
60 OPERATIONS NNP I-NP O
60 AND NNP I-NP O
60 PROCEDURES: NNP I-NP O
61 OTHER NNP I-NP O
61 TREATMENTS/PROCEDURES NNP I-NP O
61 ( ( O O
61 NOT NNP B-NP O
61 IN NNP I-NP O
61 O.R NNP I-NP O
61 ) ) O O
62 none NN B-NP O
63 BRIEF NNP I-NP O
63 RESUME NNP I-NP O
63 OF NNP I-NP O
63 HOSPITAL NNP I-NP O
63 COURSE: NNP I-NP O
64 58 CD O O
64 yo NNP B-NP O
64 woman NN I-NP O
64 multiple NN I-NP O
64 cardiac JJ B-NP O
64 risk NN I-NP O
64 factors NNS I-NP O
65 ( ( O O
65 uncontrolled JJ B-NP O
65 DM2 NNP I-NP O
65 10.3 CD O O
65 HgbAIC NNP B-NP O
65 , , O O
65 HTN NNP B-NP O
65 , , O O
65 lipids NNS B-NP O
65 ) ) O O
65 , , O O
65 Asthma NNP B-NP O
65 , , O O
65 Sleep NNP B-NP O
65 Apnea NNP I-NP O
65 , , O O
66 with IN B-VP O
66 1 CD O O
66 week NN B-NP O
66 worsening VBG O O
66 DOE NNP B-NP O
66 Pt NNP I-NP O
66 c/o NN I-NP O
66 DOE NNP I-NP O
66 only RB O O
66 when WRB O O
67 walking VBG O O
67 up RP O O
67 an DT B-NP O
67 incline NN I-NP O
67 pt NN I-NP O
67 had VBD B-VP O
67 one CD O O
67 episode NN B-NP O
67 of IN B-VP O
68 diaphoresis NN B-NP O
68 with IN B-VP O
68 this DT B-NP O
68 SOB NNP I-NP O
68 but CC O O
68 denies VBZ O O
68 any DT B-NP O
68 cp NN I-NP O
68 , , O O
68 shoulder NN B-NP O
69 pain NN I-NP O
69 , , O O
69 backpain NN B-NP O
69 , , O O
69 jaw/neck NN B-NP O
69 pain NN I-NP O
69 pt JJ O O
69 denies VBZ O O
69 any DT B-NP O
69 n/v/d JJ I-NP O
70 Pt NNP I-NP O
70 went VBD B-VP O
70 to TO O O
70 PCP NNP B-NP O
70 and CC O O
70 due JJ O O
70 to TO O O
70 multiple JJ B-NP O
70 risk NN I-NP O
70 factors NNS I-NP O
70 was VBD B-VP O
71 told VBN O O
71 to TO O O
71 come VB O O
71 to TO O O
71 ED NNP B-NP O
71 for IN B-VP O
71 r/o NN B-NP O
71 MI NNP I-NP O
71 pt NN I-NP O
71 denies VBZ O O
71 SOB NNP B-NP O
71 at IN B-VP O
71 rest NN B-NP O
71 or CC O O
71 even RB O O
71 when WRB O O
72 walking VBG O O
72 on IN B-VP O
72 "flat JJ B-NP O
72 surface" NN I-NP O
72 pt NN I-NP O
72 says VBZ O O
72 been VBN O O
72 over IN B-VP O
72 all DT B-NP O
72 fatigue NN I-NP O
72 last JJ B-NP O
72 week NN I-NP O
72 also RB O O
73 known VBN O O
73 to TO O O
73 be VB O O
73 recovering VBG O O
73 from IN B-VP O
73 recent JJ B-NP O
73 renal JJ I-NP O
73 stone NN I-NP O
73 Pt NNP I-NP O
74 admit NN I-NP O
74 for IN B-VP O
74 r/o NN B-NP O
74 MI NNP I-NP O
74 In IN B-VP O
74 ED NNP B-NP O
74 pt NN I-NP O
74 BP NNP I-NP B-r
74 BP NNP I-NP B-r
74 elevated VBD B-VP I-r
74 elevated JJ O I-r
75 150-160's/80-90 JJ O O
75 given VBN O O
75 IV NNP B-NP B-mo
75 lopressor NN I-NP B-m
75 and CC O O
75 nitro JJ B-NP B-m
75 paste NN I-NP I-m
75 pt NN I-NP O
75 BP NNP I-NP O
76 stable JJ B-NP O
76 A/P NNP I-NP O
76 DOE NNP I-NP O
76 unlikely RB O O
76 due JJ O O
76 to TO O O
76 cardiac VB O O
76 problem NN B-NP O
76 , , O O
77 symptoms NNS B-NP O
77 more RBR O O
77 c/w JJ B-NP O
77 deconditioning NN I-NP O
77 in IN B-VP O
77 obese JJ O O
77 , , O O
77 DM NNP B-NP O
77 women NNS I-NP O
78 with IN B-VP O
78 underlying JJ B-NP O
78 pulmon JJ I-NP O
78 disease NN I-NP O
79 CV- NNP I-NP O
79 cardiac NN I-NP O
79 enz NN I-NP O
79 neg JJ B-NP O
79 x3- JJ I-NP O
79 ASA NNP I-NP B-m
79 , , O O
79 no DT B-NP O
79 BB NNP I-NP O
79 secondary JJ B-NP O
79 Asthma NNP I-NP O
80 Will NNP I-NP O
80 need VB O O
80 cardiac JJ B-NP O
80 mibi NN I-NP O
80 with IN B-VP O
80 adenosine NN B-NP B-m
80 as IN B-VP O
80 out RP O O
80 patient JJ B-NP O
81 hx NN I-NP O
81 diasystolic JJ B-NP O
81 dysfunc NN I-NP O
81 with IN B-VP O
81 nl JJ B-NP O
81 EF NNP I-NP O
81 Pt NNP I-NP O
81 on IN B-VP O
81 telemetry NN B-NP O
81 with IN B-VP O
81 no DT B-NP O
82 abnormalities NNS I-NP O
82 Serial NNP I-NP O
82 EKGs NNP I-NP O
82 unchanged JJ O O
82 with IN B-VP O
82 baseline JJ B-NP O
82 abnl NN I-NP O
82 poor JJ B-NP O
83 RWprogression NNP I-NP O
83 BP NNP I-NP O
83 initially RB O O
83 mildly RB O O
83 elevated VBD B-VP O
83 stable JJ O O
83 this DT O O
83 am VBP O O
83 can MD O O
83 rea VB O O
84 ddress JJ B-NP O
84 meds NNS I-NP O
84 as IN B-VP O
84 an DT B-NP O
84 outpt JJ I-NP O
85 Endo- JJ I-NP O
85 DM NNP I-NP B-r
85 DM NNP I-NP B-r
85 cont VBD B-VP O
85 home NN B-NP B-m
85 meds NNS I-NP I-m
85 SSI NNP I-NP B-m
86 Pulmon- NNP I-NP O
86 hx NN I-NP O
86 sleep NN I-NP O
86 apnea/Asthma NN I-NP O
86 on IN B-VP O
86 cpap NN B-NP O
86 /6lNC NNP I-NP O
87 ( ( O O
87 while IN B-VP O
87 in IN B-VP O
87 hosp NN B-NP O
87 ) ) O O
87 at IN B-VP O
87 night NN B-NP O
87 no DT B-NP O
87 baseline NN I-NP O
87 O2 NNP I-NP O
87 needed VBD B-VP O
88 Full NNP B-NP O
88 code NN I-NP O
89 ADDITIONAL NNP I-NP O
89 COMMENTS: NNP I-NP O
89 Please NNP I-NP O
89 call VB O O
89 your PRP$ O O
89 doctor NN B-NP O
89 if IN B-VP O
89 having VBG O O
89 chest JJS B-NP O
89 pain NN I-NP O
89 , , O O
89 worsening VBG O O
89 shortness NN B-NP O
89 of IN B-VP O
90 breath NN B-NP O
90 with IN B-VP O
90 exertion NN B-NP O
90 or CC O O
90 at IN B-VP O
90 rest JJS O O
90 , , O O
90 new JJ O O
90 onset VBN O O
90 back/shoulder NN B-NP O
90 pain NN I-NP O
90 , , O O
91 worsening VBG O O
91 fatigue NN B-NP O
91 or CC O O
91 any DT B-NP O
91 other JJ I-NP O
91 concerns NNS I-NP O
91 Please NNP I-NP O
91 call VB O O
91 your PRP$ O O
91 PCP NNP B-NP O
91 to TO O O
92 schedule VB O O
92 out RP O O
92 patient JJ B-NP O
92 Cardiac NNP I-NP O
92 MIBI NNP I-NP O
92 with IN B-VP O
92 adenosine JJ B-NP B-m
93 DISCHARGE NNP I-NP O
93 CONDITION: NNP I-NP O
93 Stable NNP I-NP O
94 TO NNP I-NP O
94 DO/PLAN: NNP I-NP O
95 No NNP I-NP O
95 dictated VBD B-VP O
95 summary JJ B-NP O
96 ENTERED NNP I-NP O
96 BY: NNP I-NP O
96 GUENIN NNP I-NP O
96 , , O O
96 DENVER NNP B-NP O
96 , , O O
96 M.D NNP B-NP O
96 ( ( O O
96 EM22 NNP B-NP O
96 ) ) O O
96 11/16/04 CD O O
96 @ $ O O
96 12:37 CD O O
96 PM NNP B-NP O
97 ****** JJ B-NP O
97 END NNP I-NP O
97 OF NNP I-NP O
97 DISCHARGE NNP I-NP O
97 ORDERS NNP I-NP O
97 ****** NNP I-NP O
98 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #293045 VBZ O O
4 859846912 CD O O
4 LMC NNP B-NP O
4 27937230 CD O O
4 2679773 CD O O
4 0/20/2002 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHF NNP I-NP O
4 exacerbation NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/20/2002 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/28/2002 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 WALTS NNP I-NP O
8 , , O O
8 MARCELO NNP B-NP O
8 573-58-18-1 JJ B-NP O
9 Vi NNP I-NP O
9 A NNP I-NP O
9 Ville NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 7/10/02 CD O O
11 AT NNP B-NP O
11 10:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Attending NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 MCCUTCHAN NNP I-NP O
14 , , O O
14 DARRIN NNP B-NP O
14 JOSH NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ECASA NNP I-NP B-m
19 ( ( O I-m
19 ASPIRIN NNP B-NP I-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 ) ) O I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 CAPTOPRIL NNP I-NP B-m
20 12.5 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 TID NNP I-NP B-f
20 HOLD NNP I-NP O
20 IF: NNP I-NP O
20 sbp&lt;95 JJ B-NP O
21 Food/Drug NNP I-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Give NNP I-NP O
22 on IN B-VP O
22 an DT B-NP O
22 empty JJ I-NP O
22 stomach NN I-NP O
22 ( ( O O
22 give JJ O O
22 1hr CD O O
22 before IN B-VP O
22 or CC O O
22 2hr CD O O
22 after IN B-VP O
23 food NN B-NP O
23 ) ) O O
24 Alert NNP B-NP O
24 overridden: NNP I-NP O
24 Override NNP I-NP O
24 added VBD B-VP O
24 on IN B-VP O
24 4/3/02 CD O O
24 by IN B-VP O
25 DIFRONZO NNP B-NP O
25 , , O O
25 ALVIN NNP B-NP O
25 , , O O
25 MD NNP B-NP O
25 , , O O
25 MPH NNP B-NP O
26 POTENTIALLY NNP I-NP O
26 SERIOUS NNP I-NP O
26 INTERACTION: NNP I-NP O
26 POTASSIUM NNP I-NP B-m
26 CHLORIDE NNP I-NP I-m
26 &amp; NNP I-NP O
27 CAPTOPRIL NNP I-NP B-m
27 Reason NNP I-NP O
27 for IN B-VP O
27 override: NN B-NP O
27 aware JJ B-NP O
28 LASIX NNP I-NP B-m
28 ( ( O I-m
28 FUROSEMIDE NNP B-NP I-m
28 ) ) O I-m
28 40 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 TID NNP I-NP B-f
29 LEVOXYL NNP I-NP B-m
29 ( ( O I-m
29 LEVOTHYROXINE NNP B-NP I-m
29 SODIUM NNP I-NP I-m
29 ) ) O I-m
29 100 CD O B-do
29 MCG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QD NNP I-NP B-f
30 NITROGLYCERIN NNP I-NP B-m
30 1/150 CD O B-do
30 ( ( O I-do
30 0.4 CD O I-do
30 MG NNP B-NP I-do
30 ) ) O I-do
30 1 CD O I-do
30 TAB NNP B-NP I-do
30 SL NNP I-NP B-mo
30 Q5 NNP I-NP B-f
30 MIN NNP I-NP O
30 X NNP I-NP O
30 3 CD O O
31 PRN NNP B-NP O
31 Chest NNP I-NP B-r
31 Pain NNP I-NP I-r
31 HOLD NNP I-NP O
31 IF: NNP I-NP O
31 SBP&lt;[ NNP I-NP O
31 ] NNP I-NP O
32 Instructions: NNP I-NP O
32 As IN B-VP O
32 per IN B-VP O
32 chest NN B-NP O
32 pain NN I-NP O
32 protocol NN I-NP O
33 ZOCOR NNP I-NP B-m
33 ( ( O I-m
33 SIMVASTATIN NNP B-NP I-m
33 ) ) O I-m
33 20 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QHS NNP I-NP B-f
34 Food/Drug NNP I-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Avoid NNP I-NP O
35 grapefruit NN I-NP O
35 unless IN B-VP O
35 MD NNP B-NP O
35 instructs NNS I-NP O
35 otherwise RB O O
36 Override NNP B-NP O
36 Notice: NNP I-NP O
36 Override NNP I-NP O
36 added VBD B-VP O
36 on IN B-VP O
36 4/3/02 CD O O
36 by IN B-VP O
37 FITZER NNP B-NP O
37 , , O O
37 BRENDON NNP B-NP O
37 , , O O
37 MD NNP B-NP O
37 , , O O
37 MPH NNP B-NP O
38 on IN B-VP O
38 order NN B-NP O
38 for IN B-VP O
38 MULTIVITAMIN NNP B-NP B-m
38 THERAPEUTIC NNP I-NP O
38 PO NNP I-NP B-mo
38 ( ( O O
38 ref JJ O O
38 # # O O
39 23182635 CD O O
39 ) ) O O
40 POTENTIALLY NNP B-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 SIMVASTATIN NNP I-NP B-m
40 &amp; NNP I-NP O
40 NIACIN NNP I-NP B-m
40 , , O O
41 VIT NNP B-NP B-m
41 B-3 NNP I-NP I-m
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
41 previously RB O O
41 overriden JJ B-NP O
42 PLAVIX NNP I-NP B-m
42 ( ( O I-m
42 CLOPIDOGREL NNP B-NP I-m
42 ) ) O I-m
42 75 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 QD NNP I-NP B-f
43 ATENOLOL NNP I-NP B-m
43 25 CD O B-do
43 MG NNP B-NP I-do
43 PO NNP I-NP B-mo
43 QD NNP I-NP B-f
44 NITROPATCH NNP I-NP B-m
44 ( ( O I-m
44 NITROGLYCERIN NNP B-NP I-m
44 PATCH NNP I-NP I-m
44 ) ) O I-m
44 0.2 CD O B-do
44 MG/HR NNP B-NP I-do
44 TP NNP I-NP B-mo
44 QHS NNP I-NP B-f
45 GLYBURIDE NNP I-NP B-m
45 5 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 BID NNP I-NP B-f
46 ISORDIL NNP I-NP B-m
46 ( ( O I-m
46 ISOSORBIDE NNP B-NP I-m
46 DINITRATE NNP I-NP I-m
46 ) ) O I-m
46 10 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 BID NNP I-NP B-f
47 DIET: NNP I-NP O
47 House NNP I-NP O
47 / VBD B-VP O
47 Low NNP B-NP O
47 chol/low NN I-NP O
47 sat VBD B-VP O
47 fat JJ B-NP O
48 DIET: NNP I-NP O
48 4 CD O O
48 gram NN B-NP O
48 Sodium NNP I-NP O
49 ACTIVITY: NNP I-NP O
49 Walking NNP I-NP O
49 as IN B-VP O
49 tolerated VBN O O
50 FOLLOW NNP B-NP O
50 UP NNP I-NP O
50 APPOINTMENT( NNP I-NP O
50 S NNP I-NP O
50 ): NNP I-NP O
51 Sandler NNP I-NP O
51 11/28/02 CD O O
51 scheduled VBN O O
51 , , O O
52 No DT B-NP O
52 Known NNP I-NP O
52 Allergies NNP I-NP O
53 ADMIT NNP I-NP O
53 DIAGNOSIS: NNP I-NP O
54 unstable JJ B-NP O
54 angina NN I-NP O
55 PRINCIPAL NNP I-NP O
55 DISCHARGE NNP I-NP O
55 DIAGNOSIS NNP I-NP O
55 ;Responsible JJ O O
55 After IN B-VP O
55 Study NNP B-NP O
55 for IN B-VP O
55 Causing NNP B-NP O
55 Admission NNP I-NP O
55 ) ) O O
56 CHF NNP B-NP O
56 exacerbation NN I-NP O
57 OTHER NNP I-NP O
57 DIAGNOSIS;Conditions NNP I-NP O
57 , , O O
57 Infections NNP B-NP O
57 , , O O
57 Complications NNP B-NP O
57 , , O O
57 affecting VBG O O
57 Treatment/Stay NNP B-NP O
58 CHF NNP I-NP O
58 ( ( O O
58 congestive JJ B-NP O
58 heart NN I-NP O
58 failure NN I-NP O
58 ) ) O O
58 cad NN B-NP O
58 ( ( O O
58 coronary JJ B-NP O
58 artery NN I-NP O
58 disease NN I-NP O
58 ) ) O O
58 htn NN B-NP O
59 ( ( O O
59 hypertension NN B-NP O
59 ) ) O O
59 dm NN B-NP O
59 ( ( O O
59 diabetes VBZ O O
59 mellitus NN B-NP O
59 ) ) O O
59 gerd NN B-NP O
59 ( ( O O
59 gastroesophageal JJ B-NP O
59 reflux NN I-NP O
60 disease NN I-NP O
60 ) ) O O
60 hypothyroidism NN B-NP O
60 ( ( O O
60 hypothyroidism NN B-NP O
60 ) ) O O
61 OPERATIONS NNP B-NP O
61 AND NNP I-NP O
61 PROCEDURES: NNP I-NP O
62 OTHER NNP I-NP O
62 TREATMENTS/PROCEDURES NNP I-NP O
62 ( ( O O
62 NOT NNP B-NP O
62 IN NNP I-NP O
62 O.R NNP I-NP O
62 ) ) O O
63 cardiac VBP O O
63 cath NN B-NP O
63 and CC O O
63 stent NN B-NP O
63 of IN B-VP O
63 RCA NNP B-NP O
63 , , O O
63 4/3/02 CD O O
64 BRIEF NNP B-NP O
64 RESUME NNP I-NP O
64 OF NNP I-NP O
64 HOSPITAL NNP I-NP O
64 COURSE: NNP I-NP O
65 71 CD O O
65 y.o NN B-NP O
65 F NNP I-NP O
65 w/ NN I-NP O
65 h/o NN I-NP O
65 CAD NNP I-NP O
65 , , O O
65 HTN NNP B-NP O
65 , , O O
65 CHF NNP B-NP O
65 , , O O
65 and CC O O
65 DM NNP B-NP O
65 w/ VBD B-VP O
65 several JJ B-NP O
66 recent JJ I-NP O
66 admissions NNS I-NP O
66 for IN B-VP O
66 flash NN B-NP O
66 pulm NN I-NP O
66 edema NN I-NP O
66 , , O O
66 most RBS O O
66 recently RB O O
66 at IN B-VP O
66 CH NNP B-NP O
66 1 CD O O
66 week NN B-NP O
67 ago RB O O
67 when WRB O O
67 she PRP O O
67 had VBD B-VP O
67 stent NN B-NP O
67 placed VBN O O
67 in IN B-VP O
67 L NNP B-NP O
67 renal JJ B-NP O
67 artery NN I-NP O
67 ( ( O O
67 cath NN B-NP O
67 showed VBD B-VP O
67 30% CD O O
67 LAD NNP B-NP O
67 , , O O
68 60% CD O O
68 and CC O O
68 70% CD O O
68 RCA NNP B-NP O
68 lesions NNS I-NP O
68 which WDT O O
68 were VBD B-VP O
68 not RB O O
69 intervened VBN O O
69 upon IN B-VP O
69 ) ) O O
69 Pt NNP B-NP O
69 well RB O O
69 until IN B-VP O
69 night NN B-NP O
69 of IN B-VP O
69 admission NN B-NP O
69 , , O O
69 when WRB O O
70 she PRP O O
70 developed VBD B-VP O
70 SOB NNP B-NP B-r
70 SOB NNP I-NP B-r
70 while IN B-VP O
70 watching VBG O O
70 TV NN B-NP O
70 Not RB O O
71 anginal JJ B-NP O
71 equivalent NN I-NP O
71 , , O O
71 no DT B-NP O
71 CP NNP I-NP O
71 Lasted VBD B-VP O
71 30 CD O O
71 minutes NNS B-NP O
71 , , O O
71 took VBD B-VP O
71 NTG NNP B-NP B-m
72 and CC O O
72 Lasix NNP B-NP B-m
72 120 CD O B-do
72 , , O O
72 called VBN O O
72 EMS NNP B-NP O
72 and CC O O
72 was VBD B-VP O
72 brought VBN O O
72 to TO O O
72 VMH NNP B-NP O
73 ER NNP I-NP O
73 In IN B-VP O
73 ER NNP B-NP O
73 , , O O
73 was VBD B-VP O
73 given VBN O O
73 ASA NNP B-NP B-m
73 , , O O
73 Lopressor NNP B-NP B-m
73 , , O O
73 and CC O O
74 Heparin NNP B-NP B-m
74 Admission NNP I-NP O
74 vitals: VBD B-VP O
74 T NNP B-NP O
74 98 CD O O
74 BP NNP B-NP O
74 119/46 CD O O
74 HR NNP B-NP O
74 81 CD O O
74 O2 NNP B-NP O
74 sat VBD B-VP O
75 97% CD O O
75 Exam NNP B-NP O
75 notable JJ O O
75 for: SYM O O
75 - : O O
75 m/r/g NN B-NP O
75 , , O O
75 decreased VBD B-VP O
76 BS/dullness NNP B-NP O
76 at IN B-VP O
76 R NNP B-NP O
76 base NN I-NP O
76 , , O O
76 guaiac JJ B-NP O
76 neg NN I-NP O
76 in IN B-VP O
76 ER NNP B-NP O
76 Labs NNP I-NP O
76 notable JJ O O
77 for IN B-VP O
77 Cr NNP B-NP O
77 2.0 CD O O
77 , , O O
77 Hct NNP B-NP O
77 30.5 CD O O
77 , , O O
77 neg JJ B-NP O
77 cardiac JJ I-NP O
77 enzymes NNS I-NP O
77 CXR NNP I-NP O
78 with IN B-VP O
78 bilat JJ B-NP O
78 pleural JJ I-NP O
78 effusions NNS I-NP O
78 EKG NNP I-NP O
78 w/ VBD B-VP O
78 downsloping VBG O O
79 ST NNP B-NP O
79 depressions NNS I-NP O
79 in IN B-VP O
79 II NNP B-NP O
79 , , O O
79 III NNP B-NP O
79 , , O O
79 F NNP B-NP O
79 , , O O
79 I PRP O O
79 , , O O
79 L NNP B-NP O
79 Impression: NNP I-NP O
80 71F CD O O
80 w/ NN B-NP O
80 recurrent NN I-NP O
80 CHF NNP I-NP O
80 and CC O O
80 flash JJ B-NP O
80 pulm NN I-NP O
80 edema NN I-NP O
80 , , O O
81 possibly RB O O
81 due JJ O O
81 to TO O O
81 coronary JJ B-NP O
81 artery NN I-NP O
81 lesions NNS I-NP O
81 or CC O O
82 HTN NNP B-NP O
83 #1 NNP I-NP O
83 CV- NNP I-NP O
83 r/o NN I-NP O
83 MI NNP I-NP O
83 On IN B-VP O
83 Heparin NNP B-NP B-m
83 , , O O
83 ASA NNP B-NP B-m
83 , , O O
83 Plavix NNP B-NP B-m
83 , , O O
83 Metoprolol NNP B-NP B-m
83 , , O O
83 nitrates VBZ O B-m
83 , , O O
83 ACE-I NNP B-NP B-m
83 , , O O
84 statin NN B-NP B-m
84 , , O O
84 lasix JJ B-NP B-m
84 Cardiac NNP I-NP O
84 catheterization NN I-NP O
84 and CC O O
84 stent NN B-NP O
84 placed VBN O O
84 in IN B-VP O
84 RCA NNP B-NP O
84 6/10 CD O O
84 , , O O
85 pt NN B-NP O
85 tolerated VBD B-VP O
85 procedure NN B-NP O
85 well RB O O
86 #2 NNP B-NP O
86 Pulm NNP I-NP O
86 - : O O
86 We PRP O O
86 continued VBD B-VP O
86 lasix JJ O B-m
86 , , O O
86 PRN NNP B-NP B-f
86 nebs NN I-NP B-m
86 for IN B-VP O
86 wheezing VBG O B-r
86 Pt NNP B-NP O
86 was VBD B-VP O
86 stable JJ O O
87 throughout IN B-VP O
87 hospitalization NN B-NP O
88 #3 NNP I-NP O
88 Endo NNP I-NP O
88 - : O O
88 We PRP O O
88 checked VBD B-VP O
88 finger NN B-NP O
88 sticks NNS I-NP O
88 and CC O O
88 covered VBD B-VP O
88 w/ NNS B-NP O
88 CZI NNP I-NP O
88 Continu NNP I-NP O
89 ed VBZ O O
89 synthroid JJ O B-m
89 Once RB O O
89 pt JJ B-NP O
89 re-started JJ I-NP O
89 PO NNP I-NP O
89 diet NN I-NP O
89 after IN B-VP O
89 cardiac JJ B-NP O
89 cath NN I-NP O
89 , , O O
89 we PRP O O
90 resumed VBD B-VP O
90 glyburide JJ B-NP B-m
91 #4 NNP I-NP O
91 Renal NNP I-NP O
91 - : O O
91 increased VBD B-VP O
91 Cr NNP B-NP O
91 slightly RB O O
91 above IN B-VP O
91 baseline NN B-NP O
91 Remained VBD B-VP O
91 stable JJ O O
92 during IN B-VP O
92 hospitalization NN B-NP O
93 #5 NNP I-NP O
93 F/E/N NNP I-NP O
93 - : O O
93 NPO NN B-NP O
93 in IN B-VP O
93 anticipation NN B-NP O
93 of IN B-VP O
93 cath NN B-NP O
93 Monitored NNP I-NP O
93 lytes VBZ O O
94 ADDITIONAL NNP B-NP O
94 COMMENTS: NNP I-NP O
94 1 CD O O
94 Please NNP B-NP O
94 f/u NN I-NP O
94 with IN B-VP O
94 Dr NNP B-NP O
94 Lidstone NNP I-NP O
94 on IN B-VP O
94 4/25/02 CD O O
94 , , O O
94 at IN B-VP O
94 3:15pm CD O O
95 DISCHARGE NNP B-NP O
95 CONDITION: NNP I-NP O
95 Stable NNP I-NP O
96 TO NNP I-NP O
96 DO/PLAN: NNP I-NP O
97 1 CD O O
97 F/u NNP B-NP O
97 with IN B-VP O
97 Dr NNP B-NP O
97 Darlin NNP I-NP O
97 to TO O O
97 discuss VB O O
97 results NNS B-NP O
97 of IN B-VP O
97 cardiac JJ B-NP O
97 cath NN I-NP O
97 , , O O
97 stenting VBG O O
97 , , O O
98 post-cath JJ B-NP O
98 management NN I-NP O
98 , , O O
98 and CC O O
98 overall JJ B-NP O
98 management NN I-NP O
98 of IN B-VP O
98 CHF NNP B-NP O
98 and CC O O
98 flash JJ B-NP O
98 pulmonary JJ I-NP O
99 edema NN I-NP O
100 No NNP I-NP O
100 dictated VBD B-VP O
100 summary JJ B-NP O
101 ENTERED NNP I-NP O
101 BY: NNP I-NP O
101 ORTEA NNP I-NP O
101 , , O O
101 ROLANDO NNP B-NP O
101 W NNP I-NP O
101 , , O O
101 M.D NNP B-NP O
101 ( ( O O
101 TQ46 NNP B-NP O
101 ) ) O O
101 7/10/02 CD O O
101 @ $ O O
101 10:14 CD O O
101 AM NNP B-NP O
102 ****** JJ B-NP O
102 END NN I-NP O
102 OF NNP I-NP O
102 DISCHARGE NNP I-NP O
102 ORDERS NNP I-NP O
102 ****** NNP I-NP O
103 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #293349 VBZ O O
2 252140420 CD O O
2 TCLH NNP B-NP O
2 97727998 CD O O
2 8788943 CD O O
2 11/3/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 congestive JJ B-NP O
2 heart NN I-NP O
2 failure NN I-NP O
2 , , O O
2 acute NN B-NP O
2 on IN B-VP O
2 chronic JJ B-NP O
2 renal JJ I-NP O
2 failure NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/28/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/20/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 DEAL NNP I-NP O
5 , , O O
5 ROMAN NNP B-NP O
5 479-30-32-1 CD O O
6 Derd NNP B-NP O
6 T NNP I-NP O
6 A NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 8/17/06 CD O O
8 AT NNP B-NP O
8 03:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 TOOTHACRE NNP I-NP O
11 , , O O
11 SHELBY NNP B-NP O
11 B NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 No NNP I-NP O
13 CPR NNP I-NP O
13 , , O O
13 Other JJ O O
13 - : O O
13 withhold JJ B-NP O
13 CPR NNP I-NP O
13 for IN B-VP O
13 sudden JJ B-NP O
13 death NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Rehabilitation NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ACETYLSALICYLIC NNP I-NP B-m
16 ACID NNP I-NP I-m
16 81 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 Override NNP I-NP O
17 Notice: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 10/2/06 CD O O
17 by IN B-VP O
18 KIRSCHBAUM NNP B-NP O
18 , , O O
18 JESSIE NNP B-NP O
18 A NNP I-NP O
18 , , O O
18 M.D NNP B-NP O
18 , , O O
18 PH.D NNP B-NP O
19 on IN B-VP O
19 order NN B-NP O
19 for IN B-VP O
19 COUMADIN NNP B-NP B-m
19 PO NNP I-NP B-mo
19 ( ( O O
19 ref JJ O O
19 # # O O
19 960263524 CD O O
19 ) ) O O
20 POTENTIALLY NNP B-NP O
20 SERIOUS NNP I-NP O
20 INTERACTION: NNP I-NP O
20 ASPIRIN NNP I-NP B-m
20 &amp; NNP I-NP O
20 WARFARIN NNP I-NP B-m
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: NN B-NP O
21 aware JJ O O
21 , , O O
21 reg JJ B-NP O
21 home NN I-NP O
21 meds NNS I-NP O
22 Previous NNP I-NP O
22 override IN B-VP O
22 information: JJ B-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 3/18/06 CD O O
23 by IN B-VP O
23 CAPES NNP B-NP O
23 , , O O
23 TITUS NNP B-NP O
23 N NNP I-NP O
23 , , O O
23 M.D NNP B-NP O
24 on IN B-VP O
24 order NN B-NP O
24 for IN B-VP O
24 COUMADIN NNP B-NP B-m
24 PO NNP I-NP B-mo
24 ( ( O O
24 ref JJ O O
24 # # O O
24 890243096 CD O O
24 ) ) O O
25 POTENTIALLY NNP B-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 ASPIRIN NNP I-NP B-m
25 &amp; NNP I-NP O
25 WARFARIN NNP I-NP B-m
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 aware JJ B-NP O
27 CALCIUM NNP I-NP B-m
27 CARBONATE NNP I-NP I-m
27 ( ( O I-m
27 500 CD O I-m
27 MG NNP B-NP I-m
27 ELEMENTAL NNP I-NP I-m
27 CA++ NNP I-NP I-m
27 ) ) O I-m
27 500 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 TID NNP I-NP B-f
28 COLACE NNP I-NP B-m
28 ( ( O I-m
28 DOCUSATE NNP B-NP I-m
28 SODIUM NNP I-NP I-m
28 ) ) O I-m
28 100 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 BID NNP I-NP B-f
29 IRON NNP I-NP B-m
29 SULFATE NNP I-NP I-m
29 ( ( O I-m
29 FERROUS NNP B-NP I-m
29 SULFATE NNP I-NP I-m
29 ) ) O I-m
29 325 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 TID NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
30 Avoid NNP I-NP O
30 milk NN I-NP O
30 and CC O O
30 antacid JJ B-NP O
31 FOLATE NNP I-NP B-m
31 ( ( O I-m
31 FOLIC NNP B-NP I-m
31 ACID NNP I-NP I-m
31 ) ) O I-m
31 1 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 LASIX NNP I-NP B-m
32 ( ( O I-m
32 FUROSEMIDE NNP B-NP I-m
32 ) ) O I-m
32 80 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
33 HYDRALAZINE NNP I-NP B-m
33 HCL NNP I-NP I-m
33 25 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 TID NNP I-NP B-f
33 HOLD NNP I-NP O
33 IF: NNP I-NP O
33 SBP&lt;90 NNP I-NP O
34 Food/Drug NNP I-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Take NNP I-NP O
35 consistently RB O O
35 with IN B-VP O
35 meals NNS B-NP O
35 or CC O O
35 on IN B-VP O
35 empty JJ B-NP O
35 stomach NN I-NP O
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 REGULAR NNP I-NP I-m
36 REGULAR NNP I-NP I-m
36 REGULAR NNP I-NP I-m
36 REGULAR NNP I-NP I-m
36 REGULAR NNP I-NP I-m
36 REGULAR NNP I-NP I-m
36 REGULAR NNP I-NP I-m
36 REGULAR NNP I-NP I-m
36 HUMAN NNP I-NP I-m
36 HUMAN NNP I-NP I-m
36 HUMAN NNP I-NP I-m
36 HUMAN NNP I-NP I-m
36 HUMAN NNP I-NP I-m
36 HUMAN NNP I-NP I-m
36 HUMAN NNP I-NP I-m
36 HUMAN NNP I-NP I-m
37 Sliding NNP I-NP B-do
37 Scale NNP I-NP I-do
37 ( ( O B-mo
37 subcutaneously RB O I-mo
37 ) ) O I-mo
37 SC NNP B-NP I-mo
37 AC NNP I-NP I-mo
38 If IN B-VP O
38 BS NNP B-NP B-r
38 is VBZ O O
38 less JJR O O
38 than IN B-VP O
38 125 CD O O
38 , , O O
38 then RB O O
38 give VB O O
38 0 CD O B-do
38 units NNS B-NP I-do
38 subcutaneously RB O B-mo
39 If IN B-VP O
39 BS NNP B-NP B-r
39 is VBZ O O
39 125-150 JJ O O
39 , , O O
39 then RB O O
39 give VB O O
39 2 CD O B-do
39 units NNS B-NP I-do
39 subcutaneously RB O B-mo
40 If IN B-VP O
40 BS NNP B-NP B-r
40 is VBZ O O
40 151-200 CD O O
40 , , O O
40 then RB O O
40 give VB O O
40 3 CD O B-do
40 units NNS B-NP I-do
40 subcutaneously RB O B-mo
41 If IN B-VP O
41 BS NNP B-NP B-r
41 is VBZ O O
41 201-250 JJ O O
41 , , O O
41 then RB O O
41 give VB O O
41 4 CD O B-do
41 units NNS B-NP I-do
41 subcutaneously RB O B-mo
42 If IN B-VP O
42 BS NNP B-NP B-r
42 is VBZ O O
42 251-300 JJ O O
42 , , O O
42 then RB O O
42 give VB O O
42 6 CD O B-do
42 units NNS B-NP I-do
42 subcutaneously RB O B-mo
43 If IN B-VP O
43 BS NNP B-NP B-r
43 is VBZ O O
43 301-350 JJ O O
43 , , O O
43 then RB O O
43 give VB O O
43 8 CD O B-do
43 units NNS B-NP I-do
43 subcutaneously RB O B-mo
44 If IN B-VP O
44 BS NNP B-NP B-r
44 is VBZ O O
44 351-400 CD O O
44 , , O O
44 then RB O O
44 give VB O O
44 10 CD O B-do
44 units NNS B-NP I-do
44 subcutaneously RB O B-mo
44 and CC O O
45 call VB O O
45 HO NNP B-NP O
45 Call NNP I-NP O
45 HO NNP I-NP O
45 if IN B-VP O
45 BS NNP B-NP O
45 is VBZ O O
45 greater JJR O O
45 than IN B-VP O
45 400 CD O O
46 ISORDIL NNP B-NP B-m
46 ( ( O I-m
46 ISOSORBIDE NNP B-NP I-m
46 DINITRATE NNP I-NP I-m
46 ) ) O I-m
46 20 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 TID NNP I-NP B-f
47 HOLD NNP I-NP O
47 IF: NNP I-NP O
47 SBP&lt;85 NNP I-NP O
48 LOPRESSOR NNP I-NP B-m
48 ( ( O I-m
48 METOPROLOL NNP B-NP I-m
48 TARTRATE NNP I-NP I-m
48 ) ) O I-m
48 12.5 CD O B-do
48 MG NNP B-NP I-do
48 PO NNP I-NP B-mo
48 TID NNP I-NP B-f
49 HOLD NNP I-NP O
49 IF: NNP I-NP O
49 sbp VBD B-VP O
49 &lt; JJ O O
49 100 CD O O
49 , , O O
49 hr NN B-NP O
49 &lt; VBD B-VP O
49 55 CD O O
50 Food/Drug NNP B-NP O
50 Interaction NNP I-NP O
50 Instruction NNP I-NP O
51 Take NNP I-NP O
51 consistently RB O O
51 with IN B-VP O
51 meals NNS B-NP O
51 or CC O O
51 on IN B-VP O
51 empty JJ B-NP O
51 stomach NN I-NP O
52 DILANTIN NNP I-NP B-m
52 ( ( O I-m
52 PHENYTOIN NNP B-NP I-m
52 ) ) O I-m
52 100 CD O B-do
52 MG NNP B-NP I-do
52 PO NNP I-NP B-mo
52 QID NNP I-NP B-f
53 Food/Drug NNP I-NP O
53 Interaction NNP I-NP O
53 Instruction NNP I-NP O
54 If IN B-VP O
54 on IN B-VP O
54 tube NN B-NP O
54 feeds NNS I-NP O
54 , , O O
54 please VB O O
54 cycle NN B-NP O
54 ( ( O O
54 hold VB O O
54 1 CD O O
54 hr NN B-NP O
54 before IN B-VP O
54 to TO O O
54 2 CD O O
54 hr NNS B-NP O
55 after IN B-VP O
55 ) ) O O
56 Override NNP B-NP O
56 Notice: NNP I-NP O
56 Override NNP I-NP O
56 added VBD B-VP O
56 on IN B-VP O
56 10/2/06 CD O O
56 by IN B-VP O
57 CUNNANE NNP B-NP O
57 , , O O
57 RALEIGH NNP B-NP O
57 I PRP O O
57 , , O O
57 M.D NNP B-NP O
57 , , O O
57 PH.D NNP B-NP O
58 on IN B-VP O
58 order NN B-NP O
58 for IN B-VP O
58 COUMADIN NNP B-NP B-m
58 PO NNP I-NP B-mo
58 ( ( O O
58 ref JJ O O
58 # # O O
58 960263524 CD O O
58 ) ) O O
59 POTENTIALLY NNP B-NP O
59 SERIOUS NNP I-NP O
59 INTERACTION: NNP I-NP O
59 PHENYTOIN NNP I-NP B-m
59 &amp; NNP I-NP O
59 WARFARIN NNP I-NP B-m
60 Reason NNP I-NP O
60 for IN B-VP O
60 override: NN B-NP O
60 aware JJ O O
60 , , O O
60 reg JJ B-NP O
60 home NN I-NP O
60 meds NNS I-NP O
61 Previous NNP I-NP O
61 override IN B-VP O
61 information: JJ B-NP O
62 Override NNP I-NP O
62 added VBD B-VP O
62 on IN B-VP O
62 3/18/06 CD O O
62 by IN B-VP O
62 GOICK NNP B-NP O
62 , , O O
62 KENNETH NNP B-NP O
62 M NNP I-NP O
62 , , O O
62 M.D NNP B-NP O
63 on IN B-VP O
63 order NN B-NP O
63 for IN B-VP O
63 COUMADIN NNP B-NP B-m
63 PO NNP I-NP B-mo
63 ( ( O O
63 ref JJ O O
63 # # O O
63 890243096 CD O O
63 ) ) O O
64 POTENTIALLY NNP B-NP O
64 SERIOUS NNP I-NP O
64 INTERACTION: NNP I-NP O
64 PHENYTOIN NNP I-NP B-m
64 &amp; NNP I-NP O
64 WARFARIN NNP I-NP B-m
65 Reason NNP I-NP O
65 for IN B-VP O
65 override: NN B-NP O
65 aware JJ B-NP O
66 PREDNISONE NNP I-NP B-m
66 10 CD O B-do
66 MG NNP B-NP I-do
66 PO NNP I-NP B-mo
66 QAM NNP I-NP B-f
67 SODIUM NNP I-NP B-m
67 BICARBONATE NNP I-NP I-m
67 325 CD O B-do
67 MG NNP B-NP I-do
67 PO NNP I-NP B-mo
67 TID NNP I-NP B-f
68 COUMADIN NNP I-NP B-m
68 ( ( O I-m
68 WARFARIN NNP B-NP I-m
68 SODIUM NNP I-NP I-m
68 ) ) O I-m
68 5 CD O B-do
68 MG NNP B-NP I-do
68 PO NNP I-NP B-mo
68 QPM NNP I-NP B-f
69 Starting NNP I-NP O
69 ROUTINE NNP I-NP O
69 , , O O
69 20:00 CD O O
69 ( ( O O
69 Standard NNP B-NP O
69 Admin NNP I-NP O
69 Time NNP I-NP O
69 ) ) O O
70 Food/Drug NNP B-NP O
70 Interaction NNP I-NP O
70 Instruction NNP I-NP O
71 No NNP I-NP O
71 high JJ B-NP O
71 Vitamin-K NNP I-NP O
71 containing VBG O O
71 foods NNS B-NP O
72 Alert NNP I-NP O
72 overridden: VBD B-VP O
72 Override NNP B-NP O
72 added VBD B-VP O
72 on IN B-VP O
72 10/2/06 CD O O
72 by IN B-VP O
73 SOLDAN NNP B-NP O
73 , , O O
73 TREVOR NNP B-NP O
73 E NNP I-NP O
73 , , O O
73 M.D NNP B-NP O
73 , , O O
73 PH.D NNP B-NP O
74 POTENTIALLY NNP I-NP O
74 SERIOUS NNP I-NP O
74 INTERACTION: NNP I-NP O
74 PHENYTOIN NNP I-NP B-m
74 &amp; NNP I-NP O
74 WARFARIN NNP I-NP B-m
75 POTENTIALLY NNP I-NP O
75 SERIOUS NNP I-NP O
75 INTERACTION: NNP I-NP O
75 SIMVASTATIN NNP I-NP B-m
75 &amp; NNP I-NP O
75 WARFARIN NNP I-NP B-m
76 POTENTIALLY NNP I-NP O
76 SERIOUS NNP I-NP O
76 INTERACTION: NNP I-NP O
76 ASPIRIN NNP I-NP B-m
76 &amp; NNP I-NP O
76 WARFARIN NNP I-NP B-m
77 SERIOUS NNP I-NP O
77 INTERACTION: NNP I-NP O
77 SULFAMETHOXAZOLE NNP I-NP B-m
77 &amp; NNP I-NP O
77 WARFARIN NNP I-NP B-m
78 Reason NNP I-NP O
78 for IN B-VP O
78 override: NN B-NP O
78 aware JJ O O
78 , , O O
78 reg JJ B-NP O
78 home NN I-NP O
78 meds NNS I-NP O
79 MVI NNP I-NP B-m
79 THERAPEUTIC NNP I-NP I-m
79 ( ( O I-m
79 THERAPEUTIC NNP B-NP I-m
79 MULTIVITAMINS NNP I-NP I-m
79 ) ) O I-m
79 1 CD O B-do
79 TAB NNP B-NP I-do
79 PO NNP I-NP B-mo
79 QD NNP I-NP B-f
80 Alert NNP I-NP O
80 overridden: NNP I-NP O
80 Override NNP I-NP O
80 added VBD B-VP O
80 on IN B-VP O
80 3/18/06 CD O O
80 by IN B-VP O
81 ARREZOLA NNP B-NP O
81 , , O O
81 CLINTON NNP B-NP O
81 J NNP I-NP O
81 , , O O
81 M.D NNP B-NP O
82 POTENTIALLY NNP I-NP O
82 SERIOUS NNP I-NP O
82 INTERACTION: NNP I-NP O
82 SIMVASTATIN NNP I-NP B-m
82 &amp; NNP I-NP O
82 NIACIN NNP I-NP B-m
82 , , O O
83 VIT NNP B-NP B-m
83 B-3 NNP I-NP I-m
83 Reason NNP I-NP O
83 for IN B-VP O
83 override: NN B-NP O
83 aware JJ B-NP O
84 LOVENOX NNP I-NP B-m
84 ( ( O I-m
84 ENOXAPARIN NNP B-NP I-m
84 ) ) O I-m
84 50 CD O B-do
84 MG NNP B-NP I-do
84 SC NNP I-NP B-mo
84 QD NNP I-NP B-f
84 Starting VBG O O
84 Today NNP B-NP O
84 ( ( O O
84 7/26 CD O O
84 ) ) O O
85 Instructions: NNP B-NP O
85 STOP NNP I-NP O
85 ONCE NNP I-NP O
85 INR&gt;2.0 NNP I-NP O
86 GLIPIZIDE NNP I-NP B-m
86 XL NNP I-NP I-m
86 2.5 CD O B-do
86 MG NNP B-NP I-do
86 PO NNP I-NP B-mo
86 QD NNP I-NP B-f
87 BACTRIM NNP I-NP B-m
87 DS NNP I-NP I-m
87 ( ( O I-m
87 TRIMETHOPRIM/SULFAMETHOXAZOLE NNP B-NP I-m
87 DOU NNP I-NP I-m
87 ) ) O I-m
88 1 CD O B-do
88 TAB NNP B-NP I-do
88 PO NNP I-NP B-mo
88 3x/Week CD O B-f
88 M-W-F NNP B-NP I-f
89 Override NNP I-NP O
89 Notice: NNP I-NP O
89 Override NNP I-NP O
89 added VBD B-VP O
89 on IN B-VP O
89 10/2/06 CD O O
89 by IN B-VP O
90 KAKEH NNP B-NP O
90 , , O O
90 BENTON NNP B-NP O
90 R NNP I-NP O
90 , , O O
90 M.D NNP B-NP O
90 , , O O
90 PH.D NNP B-NP O
91 on IN B-VP O
91 order NN B-NP O
91 for IN B-VP O
91 COUMADIN NNP B-NP B-m
91 PO NNP I-NP B-mo
91 ( ( O O
91 ref JJ O O
91 # # O O
91 960263524 CD O O
91 ) ) O O
92 SERIOUS NNP B-NP O
92 INTERACTION: NNP I-NP O
92 SULFAMETHOXAZOLE NNP I-NP B-m
92 &amp; NNP I-NP O
92 WARFARIN NNP I-NP B-m
93 Reason NNP I-NP O
93 for IN B-VP O
93 override: NN B-NP O
93 aware JJ O O
93 , , O O
93 reg JJ B-NP O
93 home NN I-NP O
93 meds NNS I-NP O
94 Previous NNP I-NP O
94 override IN B-VP O
94 information: JJ B-NP O
95 Override NNP I-NP O
95 added VBD B-VP O
95 on IN B-VP O
95 3/18/06 CD O O
95 by IN B-VP O
95 HINTON NNP B-NP O
95 , , O O
95 PETE NNP B-NP O
95 K NNP I-NP O
95 , , O O
95 M.D NNP B-NP O
96 SERIOUS NNP I-NP O
96 INTERACTION: NNP I-NP O
96 WARFARIN NNP I-NP B-m
96 &amp; NNP I-NP O
96 SULFAMETHOXAZOLE NNP I-NP B-m
97 Reason NNP I-NP O
97 for IN B-VP O
97 override: NN B-NP O
97 aware JJ B-NP O
98 FLOVENT NNP I-NP B-m
98 ( ( O I-m
98 FLUTICASONE NNP B-NP I-m
98 PROPIONATE NNP I-NP I-m
98 ) ) O I-m
98 220 CD O B-do
98 MCG NNP B-NP I-do
98 INH NNP I-NP B-mo
98 BID NNP I-NP B-f
99 PLAVIX NNP I-NP B-m
99 ( ( O I-m
99 CLOPIDOGREL NNP B-NP I-m
99 ) ) O I-m
99 75 CD O B-do
99 MG NNP B-NP I-do
99 PO NNP I-NP B-mo
99 QD NNP I-NP B-f
100 ESOMEPRAZOLE NNP I-NP B-m
100 40 CD O B-do
100 MG NNP B-NP I-do
100 PO NNP I-NP B-mo
100 QD NNP I-NP B-f
101 DUONEB NNP I-NP B-m
101 ( ( O I-m
101 ALBUTEROL NNP B-NP I-m
101 AND NNP I-NP I-m
101 IPRATROPIUM NNP I-NP I-m
101 NEBULIZER NNP I-NP I-m
101 ) ) O I-m
102 3/0.5 CD O B-do
102 MG NNP B-NP I-do
102 NEB NNP I-NP B-mo
102 Q6H NNP I-NP B-f
103 DARBEPOETIN NNP I-NP B-m
103 ALFA NNP I-NP I-m
103 25 CD O B-do
103 MCG NNP B-NP I-do
103 SC NNP I-NP B-mo
103 QWEEK NNP I-NP B-f
104 Reason NNP I-NP O
104 for IN B-VP O
104 ordering: JJ B-NP O
104 Renal NNP I-NP O
104 Disease NNP I-NP O
105 Last JJ B-NP O
105 known JJ I-NP O
105 Hgb NNP I-NP O
105 level NN I-NP O
105 at IN B-VP O
105 time NN B-NP O
105 of IN B-VP O
105 order: $ O O
105 9.2 CD O O
105 g/dL NN B-NP O
105 on IN B-VP O
106 8/25/06 CD O O
106 at IN B-VP O
106 HMH NNP B-NP O
107 Diagnosis: NNP I-NP O
107 Chronic NNP I-NP O
107 Renal NNP I-NP O
107 Failure NNP I-NP O
107 585 CD O O
108 Treatment NNP B-NP O
108 Cycle: NNP I-NP O
108 Initiation NNP I-NP O
109 LIPITOR NNP I-NP B-m
109 ( ( O I-m
109 ATORVASTATIN NNP B-NP I-m
109 ) ) O I-m
109 40 CD O B-do
109 MG NNP B-NP I-do
109 PO NNP I-NP B-mo
109 QD NNP I-NP B-f
110 Alert NNP I-NP O
110 overridden: NNP I-NP O
110 Override NNP I-NP O
110 added VBD B-VP O
110 on IN B-VP O
110 8/17/06 CD O O
110 by IN B-VP O
110 : : O O
111 POTENTIALLY NNP B-NP O
111 SERIOUS NNP I-NP O
111 INTERACTION: NNP I-NP O
111 NIACIN NNP I-NP B-m
111 , , O O
111 VIT NNP B-NP B-m
111 B-3 NNP I-NP I-m
111 &amp; NNP I-NP O
112 ATORVASTATIN NNP I-NP B-m
112 CALCIUM NNP I-NP I-m
113 POTENTIALLY NNP I-NP O
113 SERIOUS NNP I-NP O
113 INTERACTION: NNP I-NP O
113 WARFARIN NNP I-NP B-m
113 &amp; NNP I-NP O
113 ATORVASTATIN NNP I-NP B-m
114 CALCIUM NNP I-NP O
114 Reason NNP I-NP O
114 for IN B-VP O
114 override: NN B-NP O
114 reg NN I-NP O
114 home NN I-NP O
114 meds NNS I-NP O
115 DIET: NNP I-NP O
115 House NNP I-NP O
115 / NNP I-NP O
115 NAS NNP I-NP O
115 / NNP I-NP O
115 ADA NNP I-NP O
115 ADA NNP I-NP O
115 1600 CD O O
115 cals/daycals/dy NN B-NP O
115 / NNP I-NP O
115 Low NNP I-NP O
115 saturated VBD B-VP O
115 fat JJ B-NP O
116 low JJ I-NP O
116 cholesterol NN I-NP O
116 / NNP I-NP O
116 Renal NNP I-NP O
116 diet JJ B-NP O
116 / NNP I-NP O
116 LOW NNP I-NP O
116 POTASSIUM NNP I-NP O
116 (I) NNP I-NP O
116 (FDI) NNP I-NP O
117 ACTIVITY: NNP I-NP O
117 walking VBG O O
117 with IN B-VP O
117 walker NN B-NP O
117 and CC O O
117 2L CD O O
117 O2 NNP B-NP O
117 with IN B-VP O
117 assist NN B-NP O
118 FOLLOW NNP I-NP O
118 UP NNP I-NP O
118 APPOINTMENT( NNP I-NP O
118 S NNP I-NP O
118 ): NNP I-NP O
119 Dr NNP I-NP O
119 Rodney NNP I-NP O
119 Ahumada NNP I-NP O
119 6/9 CD O O
119 @ NNP B-NP O
119 3:30 CD O O
119 scheduled VBN O O
119 , , O O
120 Dr NNP B-NP O
120 Gustavo NNP I-NP O
120 Klecha NNP I-NP O
120 ( ( O O
120 renal JJ O O
120 ) ) O O
120 6/30 CD O O
120 @ $ O O
120 1:30 CD O O
120 scheduled VBN O O
120 , , O O
121 Dr NNP B-NP O
121 Pledger NNP I-NP O
121 ( ( O O
121 cardiology NN B-NP O
121 ) ) O O
121 7/4/06 CD O O
121 at IN B-VP O
121 1pm CD O O
121 scheduled JJ O O
121 , , O O
122 Arrange NNP B-NP O
122 INR NNP I-NP O
122 to TO O O
122 be VB O O
122 drawn VBN O O
122 on IN B-VP O
122 7/19/05 CD O O
122 with IN B-VP O
122 f/u JJ B-NP O
122 INR's NNP I-NP O
122 to TO O O
122 be VB O O
122 drawn VBN O O
122 every DT O O
123 1 CD O O
123 days NNS B-NP O
123 INR's NNP I-NP O
123 will MD O O
123 be VB O O
123 followed VBN O O
123 by IN B-VP O
123 Rehab NNP B-NP O
123 facility NN I-NP O
123 , , O O
123 then RB O O
123 Dr NNP B-NP O
123 Everette NNP I-NP O
123 Lambrakis NNP I-NP O
124 ALLERGY: NNP I-NP O
124 Penicillins NNP I-NP O
124 , , O O
124 ACE NNP B-NP O
124 Inhibitor NNP I-NP O
124 , , O O
124 DICLOXACILLIN NNP B-NP O
125 ADMIT NNP I-NP O
125 DIAGNOSIS: NNP I-NP O
126 acute NN I-NP O
126 on IN B-VP O
126 chronic JJ B-NP O
126 renal JJ I-NP O
126 failure NN I-NP O
126 , , O O
126 congestive JJ B-NP O
126 heart NN I-NP O
126 failure NN I-NP O
127 PRINCIPAL NNP I-NP O
127 DISCHARGE NNP I-NP O
127 DIAGNOSIS NNP I-NP O
127 ;Responsible JJ O O
127 After IN B-VP O
127 Study NNP B-NP O
127 for IN B-VP O
127 Causing NNP B-NP O
127 Admission NNP I-NP O
127 ) ) O O
128 congestive VBP O O
128 heart NN B-NP O
128 failure NN I-NP O
128 , , O O
128 acute NN B-NP O
128 on IN B-VP O
128 chronic JJ B-NP O
128 renal JJ I-NP O
128 failure NN I-NP O
129 OTHER NNP I-NP O
129 DIAGNOSIS;Conditions NNP I-NP O
129 , , O O
129 Infections NNP B-NP O
129 , , O O
129 Complications NNP B-NP O
129 , , O O
129 affecting VBG O O
129 Treatment/Stay NNP B-NP O
130 ANEMIA NNP I-NP O
130 CRI NNP I-NP O
130 ( ( O O
130 Cr NNP B-NP O
130 1.7 CD O O
130 ) ) O O
130 seizures NNS B-NP O
130 ( ( O O
130 partial JJ B-NP O
131 seizures NNS I-NP O
131 ) ) O O
131 dvt NN B-NP O
131 , , O O
131 left VBD B-VP O
131 calf NN B-NP O
131 ( ( O O
131 deep JJ B-NP O
131 venous JJ I-NP O
131 thrombosis NN I-NP O
131 ) ) O O
131 appendectomy NN B-NP O
132 ( ( O O
132 appendectomy JJ O O
132 ) ) O O
132 colon NN B-NP O
132 adenoma NN I-NP O
132 ( ( O O
132 colonic JJ B-NP O
132 polyps NNS I-NP O
132 ) ) O O
132 TAH NNP B-NP O
133 ( ( O O
133 hysterectomy NN B-NP O
133 ) ) O O
133 anemia NN B-NP O
133 ( ( O O
133 anemia NN B-NP O
133 ) ) O O
133 PPM VBZ O O
133 2/29 CD O O
133 for IN B-VP O
134 SSS NNP B-NP O
134 s/p NN I-NP O
134 MI NNP I-NP O
134 1997 CD O O
134 , , O O
134 9/11 CD O O
134 with IN B-VP O
134 stents NNS B-NP O
134 to TO O O
134 LAD NNP B-NP O
134 , , O O
134 D1 NNP B-NP O
134 , , O O
134 LCx NNP B-NP O
134 severe RB O O
134 pulmonary JJ B-NP O
135 sarcoidosis NN I-NP O
136 OPERATIONS NNP I-NP O
136 AND NNP I-NP O
136 PROCEDURES: NNP I-NP O
137 OTHER NNP I-NP O
137 TREATMENTS/PROCEDURES NNP I-NP O
137 ( ( O O
137 NOT NNP B-NP O
137 IN NNP I-NP O
137 O.R NNP I-NP O
137 ) ) O O
138 none NN B-NP O
139 BRIEF NNP I-NP O
139 RESUME NNP I-NP O
139 OF NNP I-NP O
139 HOSPITAL NNP I-NP O
139 COURSE: NNP I-NP O
140 CC: NNP I-NP O
140 SOB NNP I-NP O
140 , , O O
140 Increased VBD B-VP O
140 Cr NNP B-NP O
141 *** NNP I-NP O
142 HPI: NNP I-NP O
142 Ms NNP I-NP O
142 Commins NNP I-NP O
142 is VBZ O O
142 a DT O O
142 74 CD O O
142 yo JJ B-NP O
142 female NN I-NP O
142 with IN B-VP O
142 h/o JJ B-NP O
142 CAD NNP I-NP O
142 s/p NN I-NP O
142 LAD NNP I-NP O
142 stent NN I-NP O
142 9/11 CD O O
142 , , O O
142 CHF NNP B-NP O
142 w/ VBD B-VP O
142 EF NNP B-NP O
143 50% CD O O
143 , , O O
143 and CC O O
143 CRI NNP B-NP O
143 w/ VBP O O
143 Cr NNP B-NP O
143 ( ( O O
143 1.9-2.4 JJ O O
143 ) ) O O
143 who WP O O
143 presents VBZ O O
143 with IN B-VP O
143 elevated JJ B-NP O
143 K NNP I-NP O
143 and CC O O
143 Cr NNP B-NP O
143 and CC O O
144 increasing VBG O O
144 SOB NNP B-NP O
144 Pt NNP I-NP O
144 reports VBZ O O
144 1 CD O O
144 yr NN B-NP O
144 of IN B-VP O
144 weight JJ B-NP O
144 loss NN I-NP O
144 and CC O O
144 decreased VBD B-VP O
144 PO NNP B-NP O
144 more RBR O O
145 notable JJ O O
145 within IN B-VP O
145 past JJ B-NP O
145 1-2 JJ I-NP O
145 wks NN I-NP O
145 On IN B-VP O
145 ROS NNP B-NP O
145 +sweating VBG O O
145 @ JJ B-NP O
145 night NN I-NP O
145 o/w RB O O
145 negative JJ B-NP O
145 Pt NNP I-NP O
146 has VBZ O O
146 been VBN O O
146 off RP O O
146 her PRP$ O O
146 usual JJ B-NP B-do
146 dose NN I-NP I-do
146 of IN B-VP O
146 lasix JJ O B-m
146 per IN B-VP O
146 renal JJ B-NP O
146 input NN I-NP O
146 because IN B-VP O
146 on IN B-VP O
146 recent JJ B-NP O
147 admit NN I-NP O
147 ( ( O O
147 4/10 CD O O
147 ) ) O O
147 she PRP O O
147 had VBD B-VP O
147 elevated VBN O O
147 Cr NNP B-NP O
147 thought VBD B-VP O
147 to TO O O
147 be VB O O
147 prerenal JJ O O
147 , , O O
147 which WDT O O
147 is VBZ O O
147 when WRB O O
148 lasix NN B-NP B-m
148 was VBD B-VP O
148 stopped VBN O O
148 No RB O O
148 chest JJ B-NP O
148 pain NN I-NP O
148 , , O O
148 pressure NN B-NP O
148 or CC O O
148 palp NN B-NP O
148 No DT B-NP O
148 LE NNP I-NP O
148 edema NN I-NP O
148 , , O O
148 no DT B-NP O
148 PND NNP I-NP O
149 *** NNP I-NP O
150 PMH: NNP I-NP O
150 CHF NNP I-NP O
150 w/ VBD B-VP O
150 EF NNP B-NP O
150 50% CD O O
150 in IN B-VP O
150 8/15 CD O O
150 by IN B-VP O
150 TTE NNP B-NP O
150 showing VBG O O
150 LAE NNP B-NP O
150 , , O O
150 mild JJ B-NP O
150 MR/TR NNP I-NP O
150 , , O O
150 HK NNP B-NP O
150 inf VBP O O
151 septum NN B-NP O
151 &amp; NNP I-NP O
151 posterior NN I-NP O
151 basal NN I-NP O
151 , , O O
151 MI NNP B-NP O
151 1997 CD O O
151 , , O O
151 s/p NN B-NP O
151 LAD NNP I-NP O
151 , , O O
151 D1 NNP B-NP O
151 , , O O
151 LCx NNP B-NP O
151 stents NNS I-NP O
151 in IN B-VP O
151 2002 CD O O
151 , , O O
152 Anemia NNP B-NP O
152 , , O O
152 CRI NNP B-NP O
152 ( ( O O
152 baseline JJ B-NP O
152 Cr NNP I-NP O
152 1.9-2.4 NN I-NP O
152 ) ) O O
152 , , O O
152 H/o NNP B-NP O
152 partial JJ B-NP O
152 seizures NNS I-NP O
152 on IN B-VP O
153 dilantin NN B-NP B-m
153 , , O O
153 HTN NNP B-NP O
153 , , O O
153 h/o NN B-NP O
153 DVT NNP I-NP O
153 L NNP I-NP O
153 calf NN I-NP O
153 , , O O
153 s/p JJ B-NP O
153 TAH/ NNP I-NP O
153 appy NN I-NP O
153 , , O O
153 H/o NNP B-NP O
153 cervical JJ B-NP O
153 CA NNP I-NP O
153 , , O O
153 h/o VBD B-VP O
154 2-3 JJ B-NP O
154 mm NN I-NP O
154 polyp NN I-NP O
154 in IN B-VP O
154 1993 CD O O
154 , , O O
154 SSS NNP B-NP O
154 s/p VBD B-VP O
154 DDD NNP B-NP O
154 pacemaker NN I-NP O
154 in IN B-VP O
154 1997 CD O O
154 , , O O
154 Sarcoid NNP B-NP O
154 w/ NN I-NP O
155 severe JJ B-NP O
155 restrictive JJ I-NP O
155 pulmonary JJ I-NP O
155 dz NN I-NP O
155 , , O O
155 NIDDM NNP B-NP O
155 type NN I-NP O
155 II NNP I-NP O
155 , , O O
155 dyslipidemia NN B-NP O
156 *** NNP I-NP O
157 Admit NNP I-NP O
157 PE: NNP I-NP O
157 T NNP I-NP O
157 97.2 CD O O
157 BP NNP B-NP O
157 147/66 CD O O
157 P NNP B-NP O
157 52 CD O O
157 R NNP B-NP O
157 18 CD O O
157 100% CD O O
158 RA NNP B-NP O
158 Gen: NNP I-NP O
158 Frail NNP I-NP O
158 appearing VBG O O
158 elderly JJ B-NP O
159 female NN I-NP O
159 HEENT: NNP I-NP O
159 EOMI NNP I-NP O
159 , , O O
159 + NNP B-NP O
159 ?exopthalmos NNP I-NP O
159 , , O O
159 anicteric JJ O O
159 , , O O
160 mmm JJ B-NP O
160 Neck: NNP I-NP O
160 thyromegaly NN I-NP O
160 vs NN I-NP O
160 submandibular JJ B-NP O
160 fullness NN I-NP O
160 , , O O
160 no DT B-NP O
161 nodules NNS I-NP O
161 , , O O
161 non-painful JJ O O
161 , , O O
161 no DT B-NP O
161 cervical JJ I-NP O
161 LAD NNP I-NP O
161 Pulm: NNP I-NP O
161 bilateral JJ B-NP O
161 crackles NNS I-NP O
161 to TO O O
162 apeces NNS B-NP O
162 CV: NNP I-NP O
162 RRR NNP I-NP O
162 , , O O
162 II/VI NNP B-NP O
162 HSM NNP I-NP O
162 @ NNP I-NP O
162 LLSB NNP I-NP O
162 , , O O
162 JVP NNP B-NP O
162 @ NNP I-NP O
162 ear VBP O O
162 Abd: NNP B-NP O
162 nt NN I-NP O
162 , , O O
162 nd RB O O
162 , , O O
162 +hyperactive JJ B-NP O
162 BS NNP I-NP O
162 , , O O
163 no DT B-NP O
163 hsm NN I-NP O
163 Ext: NNP I-NP O
163 no DT B-NP O
163 c/c/e NN I-NP O
163 , , O O
164 ** NNP B-NP O
164 EKG: NNP I-NP O
164 atrial NN I-NP O
164 paced VBD B-VP O
164 , , O O
164 not RB O O
164 capturing VBG O O
164 SB NNP B-NP O
164 @ NNP I-NP O
164 56 CD O O
164 , , O O
164 nl RB O O
164 axis NN B-NP O
164 , , O O
165 nl JJ B-NP O
165 intervals NNS I-NP O
165 no DT B-NP O
165 st-t JJ I-NP O
165 wave NN I-NP O
165 changes NNS I-NP O
166 *** VBP O O
167 Consults: NNP B-NP O
167 Renal NNP I-NP O
167 , , O O
167 Cards NNP B-NP O
167 , , O O
167 EP NNP B-NP O
167 , , O O
167 Nutrition NNP B-NP O
167 , , O O
167 PT NNP B-NP O
168 **** NNP I-NP O
169 Imp: NNP I-NP O
169 74 CD O O
169 yo NNP B-NP O
169 woman NN I-NP O
169 with IN B-VP O
169 pulmonary JJ B-NP O
169 sarcoid NN I-NP O
169 and CC O O
169 CHF NNP B-NP O
169 and CC O O
169 CRI NNP B-NP O
169 here RB O O
169 with IN B-VP O
169 SOB NNP B-NP O
170 after IN B-VP O
170 stopping VBG O O
170 lasix JJ B-NP B-m
170 several JJ I-NP O
170 weeks NNS I-NP O
170 ago RB O O
170 Given NNP B-NP O
170 clinical JJ B-NP O
170 exam NN I-NP O
170 and CC O O
170 CXR NNP B-NP O
170 it PRP O O
171 appears VBZ O O
171 that IN B-VP O
171 she PRP O O
171 is VBZ O O
171 in IN B-VP O
171 decompensated JJ B-NP O
171 CHF NNP I-NP O
171 , , O O
171 and CC O O
171 in IN B-VP O
171 worse JJR B-NP O
171 renal JJ I-NP O
171 failure NN I-NP O
172 HOSPITAL NNP I-NP O
172 COURSE: NNP I-NP O
173 1 CD O O
173 ) ) O O
173 Cardiovascular: NNP B-NP O
173 She PRP O O
173 was VBD B-VP O
173 in IN B-VP O
173 mildly RB O O
173 decompensated VBN O O
173 CHF NNP B-NP O
173 , , O O
173 and CC O O
173 was VBD B-VP O
173 started VBN O O
174 on IN B-VP O
174 more RBR O O
174 aggressive JJ B-NP O
174 diuresis NN I-NP O
174 , , O O
174 starting VBG O O
174 with IN B-VP O
174 lasix JJ B-NP B-m
174 lasix NN I-NP B-m
174 40 CD O B-do
174 iv JJ B-NP B-mo
174 iv JJ I-NP B-mo
174 BID NNP I-NP B-f
174 increased VBD B-VP O
174 to TO O O
174 80 CD O B-do
175 bid NN B-NP B-f
175 on IN B-VP O
175 HD2 NNP B-NP O
175 as IN B-VP O
175 she PRP O O
175 was VBD B-VP O
175 not RB O O
175 meeting VBG O O
175 her PRP$ O O
175 diuresis NN B-NP O
175 goal NN I-NP O
175 With IN B-VP O
175 cardiology NN B-NP O
176 service NN I-NP O
176 consulting NN I-NP O
176 , , O O
176 she PRP O O
176 was VBD B-VP O
176 increase NN B-NP O
176 to TO O O
176 lasix VB O B-m
176 drip NN B-NP B-mo
176 at IN B-VP O
176 15/hr CD O B-do
176 on IN B-VP O
176 HD3 NNP B-NP O
176 , , O O
176 with IN B-VP O
177 i/o JJ B-NP O
177 goal NN I-NP O
177 1-2 JJ B-NP O
177 l NN I-NP O
177 neg IN B-VP O
177 She PRP O O
177 did VBD B-VP O
177 well RB O O
177 on IN B-VP O
177 this DT O O
177 and CC O O
177 by IN B-VP O
177 HD5 NNP B-NP O
177 was VBD B-VP O
177 near IN B-VP O
177 her PRP$ O O
177 dry JJ B-NP O
178 weight NN I-NP O
178 of IN B-VP O
178 49kg CD O O
178 and CC O O
178 her PRP$ O O
178 drip NN B-NP O
178 was VBD B-VP O
178 transitioned VBN O O
178 back RB O O
178 to TO O O
178 PO NNP B-NP B-mo
178 lasix NN I-NP B-m
178 She PRP O O
178 is VBZ O O
178 no DT O O
179 on IN B-VP O
179 lasix NN B-NP B-m
179 80 CD O B-do
179 po NN B-NP B-mo
179 bid NN I-NP B-f
179 , , O O
179 which WDT O O
179 is VBZ O O
179 felt VBN O O
179 to TO O O
179 be VB O O
179 adequate JJ O O
179 to TO O O
179 maintain VB O O
179 her PRP$ O O
179 dry JJ B-NP O
180 weight NN I-NP O
180 She PRP O O
180 was VBD B-VP O
180 continued VBN O O
180 on IN B-VP O
180 Hydralazine NNP B-NP B-m
180 , , O O
180 lopressol NN B-NP B-m
180 and CC O O
180 was VBD B-VP O
180 restarted VBN O O
180 on IN B-VP O
181 Isordil NNP B-NP B-m
181 on IN B-VP O
181 HD3 NNP B-NP O
181 , , O O
181 titrated VBD B-VP O
181 up RB O O
181 to TO O O
181 20 CD O B-do
181 tid NN B-NP B-f
181 She PRP O O
181 has VBZ O O
181 history NN B-NP O
181 of IN B-VP O
181 MI NNP B-NP O
181 with IN B-VP O
182 stents NNS B-NP O
182 and CC O O
182 was VBD B-VP O
182 continued VBN O O
182 on IN B-VP O
182 Asa NNP B-NP B-m
182 , , O O
182 Plavix NNP B-NP B-m
182 , , O O
182 Zocor NNP B-NP B-m
182 He PRP O O
182 cardiac VBD B-VP O
182 enzymes NNS B-NP O
182 were VBD B-VP O
183 negative JJ B-NP O
183 Her NNP I-NP O
183 BNP NNP I-NP O
183 fell VBD B-VP O
183 from IN B-VP O
183 3500 CD O O
183 on IN B-VP O
183 admit NN B-NP O
183 to TO O O
183 1500 CD O O
183 at IN B-VP O
183 her PRP$ O O
183 dry JJ B-NP O
183 wt NN I-NP O
183 on IN B-VP O
183 HD6 NNP B-NP O
184 She PRP O O
184 was VBD B-VP O
184 paced VBN O O
184 intermittent NN B-NP O
184 ( ( O O
184 pacer NN B-NP O
184 placed VBN O O
184 in IN B-VP O
184 past NN B-NP O
184 for IN B-VP O
184 sick JJ B-NP O
184 sinus NN I-NP O
184 , , O O
185 functioning VBG O O
185 properly RB O O
185 at IN B-VP O
185 a DT B-NP O
185 backup NN I-NP O
185 rate NN I-NP O
185 of IN B-VP O
185 50 CD O O
185 ) ) O O
186 2 CD O O
186 ) ) O O
186 Renal: NNP B-NP O
186 She PRP O O
186 presented VBD B-VP O
186 with IN B-VP O
186 acute NN B-NP O
186 on IN B-VP O
186 chronic JJ B-NP O
186 RF NNP I-NP O
186 possibly RB O O
186 due RB O O
186 to TO O O
186 poor JJ O O
186 for IN B-VP O
187 forward RB O O
187 flow NN B-NP O
187 in IN B-VP O
187 the DT B-NP O
187 setting NN I-NP O
187 of IN B-VP O
187 CHF NNP B-NP O
187 decompensation NN I-NP O
187 Cr NNP I-NP O
187 up RB O O
187 to TO O O
187 3.6 CD O O
187 on IN B-VP O
188 HD3 NNP B-NP O
188 , , O O
188 but CC O O
188 as IN B-VP O
188 she PRP O O
188 diuresed VBD B-VP O
188 , , O O
188 her PRP$ O O
188 Cr NNP B-NP O
188 stabilized VBD B-VP O
188 Renal NNP B-NP O
188 consult NN I-NP O
188 was VBD B-VP O
188 following VBG O O
189 and CC O O
189 recommended JJ B-NP O
189 diureses NNS I-NP O
189 , , O O
189 low JJ B-NP O
189 K NNP I-NP O
189 diet NN I-NP O
189 , , O O
189 good JJ B-NP O
189 glucose NN I-NP O
189 control NN I-NP O
189 , , O O
189 and CC O O
190 withholding VBG O O
190 ace NN B-NP B-m
190 inhibitor NN I-NP I-m
190 She PRP O O
190 is VBZ O O
190 discharge NN B-NP O
190 at IN B-VP O
190 her PRP$ O O
190 dry JJ B-NP O
190 weight NN I-NP O
190 with IN B-VP O
190 a DT B-NP O
190 Cr NNP I-NP O
191 stable NN I-NP O
191 at IN B-VP O
191 3.5 CD O O
191 She PRP O O
191 should MD O O
191 probably RB O O
191 not RB O O
191 go VB O O
191 on IN B-VP O
191 Ace NNP B-NP O
191 Inhibitor NNP I-NP O
191 again RB O O
192 3 CD O O
192 ) ) O O
192 FEN- NNP B-NP O
192 Hyperkalemia NNP I-NP B-r
192 w/o NN I-NP O
192 EKG NNP I-NP O
192 change NN I-NP O
192 Improved NNP I-NP O
192 w/ NN I-NP O
192 lasix NN I-NP B-m
192 Rec'd NNP I-NP O
192 Kayexylate NNP I-NP B-m
193 in IN B-VP O
193 ED NNP B-NP O
193 Now RB O O
193 improved VBZ O O
193 Follow NNP B-NP O
193 K/Mg NNP I-NP O
193 She PRP O O
193 should MD O O
193 not RB O O
193 be VB O O
193 on IN B-VP O
193 an DT B-NP O
193 Ace NNP I-NP O
193 inhibitor NN I-NP O
194 or CC O O
194 a DT O O
194 K-sparing JJ O O
194 diuretic JJ O O
195 4 CD O O
195 ) ) O O
195 ENDO- JJ B-NP O
195 glipizide NN I-NP B-m
195 at IN B-VP O
195 home NN B-NP O
195 which WDT O O
195 was VBD B-VP O
195 restarted VBN O O
195 on IN B-VP O
195 HD5 NNP B-NP O
195 Add NNP I-NP O
195 insulin NN I-NP B-m
195 SS NNP I-NP B-do
195 for IN B-VP O
196 tight JJ B-NP O
196 control NN I-NP O
196 TSH NNP I-NP O
196 high JJ B-NP O
196 T4 NNP I-NP O
196 low NN I-NP O
196 This DT O O
196 should MD O O
196 be VB O O
196 rechecked VBN O O
196 as IN B-VP O
196 an DT B-NP O
196 outpt NN I-NP O
197 before IN B-VP O
197 initiating VBG O O
197 therapy NN B-NP O
198 5 CD O O
198 ) ) O O
198 Heme- NN B-NP O
198 ON NNP I-NP O
198 coumadin NN I-NP B-m
198 for IN B-VP O
198 history NN B-NP B-r
198 DVT NNP I-NP I-r
198 Held NNP I-NP O
198 on IN B-VP O
198 HD3 NNP B-NP O
198 for IN B-VP O
198 an DT B-NP O
198 INR NNP I-NP O
199 3.1 CD O O
199 and CC O O
199 was VBD B-VP O
199 restarted VBN O O
199 shortly RB O O
199 after IN B-VP O
199 , , O O
199 but CC O O
199 her PRP$ O O
199 INR NNP B-NP O
199 is VBZ O O
199 1.4 CD O O
199 She PRP O O
200 received VBD B-VP O
200 1.5 CD O B-do
200 U NNP B-NP I-do
200 of IN B-VP O
200 PRBC NNP B-NP B-m
200 for IN B-VP O
200 goal NN B-NP O
200 HCT NNP I-NP O
200 &gt;30 NNP I-NP O
200 and CC O O
200 is VBZ O O
200 currently RB O O
200 30.8 CD O O
200 Her NNP B-NP O
201 anemia NN I-NP O
201 is VBZ O O
201 2/2 CD O O
201 chronic JJ B-NP O
201 renal JJ I-NP O
201 disease NN I-NP O
201 and CC O O
201 she PRP O O
201 was VBD B-VP O
201 started VBN O O
201 on IN B-VP O
202 darbopoetin NN B-NP B-m
202 25 CD O B-do
202 qwk NN B-NP B-f
202 She PRP O O
202 developed VBD B-VP O
202 a DT B-NP B-r
202 clot NN I-NP I-r
202 in IN B-VP O
202 her PRP$ O O
202 Right NNP B-NP O
202 external NN I-NP O
203 jugular NN I-NP O
203 ( ( O O
203 site NN B-NP O
203 of IN B-VP O
203 prior JJ B-NP O
203 IV NNP I-NP O
203 ) ) O O
203 and CC O O
203 was VBD B-VP O
203 place NN B-NP O
203 on IN B-VP O
203 renal JJ B-NP B-do
203 dose NN I-NP I-do
203 of IN B-VP O
203 lovenox NN B-NP B-m
204 until IN B-VP B-du
204 her PRP$ O I-du
204 INR&gt;2 NNP B-NP I-du
204 Lovenox NNP I-NP B-m
204 should MD O O
204 be VB O O
204 stopped VBN O O
204 once RB O O
204 her PRP$ O O
204 INR NNP B-NP O
204 is VBZ O O
204 &gt;2 JJ O O
205 6 CD O O
205 ) ) O O
205 Neuro- NN B-NP O
205 On IN B-VP O
205 dilantin NN B-NP B-m
205 for IN B-VP O
205 history NN B-NP O
205 of IN B-VP O
205 partial JJ B-NP B-r
205 seizures NNS I-NP I-r
206 7 CD O O
206 ) ) O O
206 Code- NNP B-NP O
206 no DT B-NP O
206 CPR NNP I-NP O
206 if IN B-VP O
206 sudden JJ B-NP O
206 death NN I-NP O
206 , , O O
206 but CC O O
206 intubation/defibrillation NN B-NP O
206 ok NN I-NP O
206 in IN B-VP O
206 the DT B-NP O
207 setting NN I-NP O
207 of IN B-VP O
207 instability NN B-NP O
208 Dispo: NNP I-NP O
208 She PRP O O
208 was VBD B-VP O
208 discharged VBN O O
208 to TO O O
208 Wadesdi NNP B-NP O
208 Ckgart NNP I-NP O
208 Community NNP I-NP O
208 Hospital NNP I-NP O
208 at IN B-VP O
208 a DT B-NP O
208 euvolemic JJ I-NP O
208 state NN I-NP O
208 with IN B-VP O
208 a DT B-NP O
208 dry JJ I-NP O
209 weight NN I-NP O
209 of IN B-VP O
209 49kg CD O O
209 She PRP O O
209 should MD O O
209 continue VB O O
209 on IN B-VP O
209 80 CD O B-do
209 po JJ B-NP B-mo
209 lasix NN I-NP B-m
209 bid NN I-NP B-f
209 unless IN B-VP O
209 her PRP$ O O
209 Cr NNP B-NP O
209 rises VBZ O O
210 above IN B-VP O
210 new JJ B-NP O
210 baseline NN I-NP O
210 of IN B-VP O
210 3.5 CD O O
210 or CC O O
210 if IN B-VP O
210 she PRP O O
210 gains NNS B-NP O
210 weight VBD B-VP O
210 or CC O O
210 shows VBZ O O
210 signs NNS B-NP O
210 of IN B-VP O
210 new JJ B-NP O
211 overload NN I-NP O
211 Lovenox NNP I-NP B-m
211 should MD O O
211 be VB O O
211 stopped VBN O O
211 once RB O O
211 her PRP$ O O
211 INR NNP B-NP O
211 is VBZ O O
211 &gt; JJ O O
211 2 CD O O
211 Coumadin NNP B-NP B-m
211 dose NN I-NP O
212 should MD O O
212 be VB O O
212 adjusted VBN O O
212 according VBG O O
212 to TO O O
212 INR NNP B-NP O
212 goal NN I-NP O
212 2-3 CD O O
212 She PRP O O
212 should MD O O
212 be VB O O
212 on IN B-VP O
212 a DT B-NP O
212 renal JJ I-NP O
213 diet NN I-NP O
213 with IN B-VP O
213 low JJ B-NP O
213 potassium NN I-NP O
213 and CC O O
213 low JJ B-NP O
213 glucose NN I-NP O
213 but CC O O
213 with IN B-VP O
213 diabetic JJ B-NP O
213 caloric JJ I-NP O
214 supplements NNS I-NP O
214 like IN B-VP O
214 GLUCERNA NNP B-NP O
214 She PRP O O
214 should MD O O
214 receive VB O O
214 a DT B-NP O
214 HOT NNP I-NP O
214 PACK NNP I-NP O
214 to TO O O
214 her PRP$ O O
214 neck NN B-NP O
214 2-3x JJ O O
215 per IN B-VP O
215 day NN B-NP O
215 and CC O O
215 to TO O O
215 her PRP$ O O
215 vein NN B-NP O
215 before IN B-VP O
215 blood NN B-NP O
215 draw NN I-NP O
215 for IN B-VP O
215 comfort NN B-NP O
216 She PRP O O
216 should MD O O
216 receive VB O O
216 physical JJ B-NP O
216 therapy NN I-NP O
216 daily RB O O
216 with IN B-VP O
216 the DT B-NP O
216 goal NN I-NP O
216 of IN B-VP O
216 gait NN B-NP O
216 stability NN I-NP O
216 , , O O
217 home NN B-NP O
217 safety NN I-NP O
217 , , O O
217 and CC O O
217 good JJ B-NP O
217 O2 NNP I-NP O
217 sats NNS I-NP O
217 on IN B-VP O
217 2L CD O O
217 O2 NNP B-NP O
217 She PRP O O
217 should MD O O
217 go VB O O
217 home NN B-NP O
217 with IN B-VP O
217 home NN B-NP O
217 O2 NNP I-NP B-m
217 at IN B-VP O
218 2L CD O B-do
218 and CC O O
218 with IN B-VP O
218 VNA NNP B-NP O
218 services NNS I-NP O
218 for IN B-VP O
218 meds NNS B-NP O
218 She PRP O O
218 lives VBZ O O
218 at IN B-VP O
218 home NN B-NP O
218 alone RB O O
218 and CC O O
218 it PRP O O
218 would MD O O
218 be VB O O
219 ideal JJ O O
219 if IN B-VP O
219 she PRP O O
219 had VBD B-VP O
219 a DT B-NP O
219 relative JJ I-NP O
219 stay NN I-NP O
219 with IN B-VP O
219 her PRP$ O O
219 for IN B-VP O
219 a DT B-NP O
219 few JJ I-NP O
219 days NNS I-NP O
219 to TO O O
219 a DT B-NP O
219 week NN I-NP O
219 after IN B-VP O
220 going VBG O O
220 home NN B-NP O
221 resume NN I-NP O
221 VNA NNP I-NP O
221 services NNS I-NP O
221 upon IN B-VP O
221 dc JJ B-NP O
222 contact: NN I-NP O
222 son NN I-NP O
222 Soulliere NNP I-NP O
222 in IN B-VP O
222 Ta NNP B-NP O
222 Broke NNP I-NP O
222 Ver NNP I-NP O
222 O NNP I-NP O
222 Arb NNP I-NP O
222 Ca NNP I-NP O
222 180-226-5150 JJ B-NP O
223 ADDITIONAL NNP I-NP O
223 COMMENTS: NNP I-NP O
223 Please NNP I-NP O
223 return VB O O
223 to TO O O
223 the DT B-NP O
223 hospital NN I-NP O
223 or CC O O
223 call VB O O
223 your PRP$ O O
223 doctor NN B-NP O
223 if IN B-VP O
223 you PRP O O
223 experience VBP O O
224 worsening VBG O O
224 shortness NN B-NP O
224 of IN B-VP O
224 breath NN B-NP O
224 , , O O
224 fever RB O O
224 over IN B-VP O
224 100.5 CD O O
224 , , O O
224 chest NN B-NP O
224 pain NN I-NP O
224 , , O O
224 decreased VBN O O
225 urine JJ B-NP O
225 output NN I-NP O
225 , , O O
225 weight VBD B-VP O
225 gain NN B-NP O
225 over IN B-VP O
225 5 CD O O
225 pounds NNS B-NP O
225 , , O O
225 or CC O O
225 any DT B-NP O
225 other JJ I-NP O
225 concerning NN I-NP O
226 symptoms NNS I-NP O
227 Please NNP I-NP O
227 keep VB O O
227 your PRP$ O O
227 follow-up JJ B-NP O
227 appts NNS I-NP O
228 DISCHARGE NNP I-NP O
228 CONDITION: NNP I-NP O
228 Stable NNP I-NP O
229 TO NNP I-NP O
229 DO/PLAN: NNP I-NP O
230 follow VB O O
230 up RP O O
230 with IN B-VP O
230 Dr NNP B-NP O
230 Zari NNP I-NP O
230 ( ( O O
230 PCP NNP B-NP O
230 ) ) O O
230 , , O O
230 Dr NNP B-NP O
230 Piquette NNP I-NP O
230 ( ( O O
230 renal JJ O O
230 ) ) O O
230 , , O O
230 and CC O O
230 cardiology NN B-NP O
230 as IN B-VP O
230 noted JJ O O
231 1 CD O O
231 ) ) O O
231 d/c NN B-NP O
231 Lovenox NNP I-NP B-m
231 once RB O O
231 INR NNP B-NP O
231 &gt; VBD B-VP O
231 2 CD O O
232 2 CD O O
232 ) ) O O
232 renal NN B-NP O
232 , , O O
232 diabetic JJ O O
232 , , O O
232 low JJ B-NP O
232 potassium NN I-NP O
232 , , O O
232 low JJ B-NP O
232 salt NN I-NP O
232 diet NN I-NP O
232 with IN B-VP O
232 glucerna JJ B-NP O
233 supplements NNS I-NP O
234 3 CD O O
234 ) ) O O
234 continue VBP O O
234 PT NNP B-NP O
234 for IN B-VP O
234 goal NN B-NP O
234 of IN B-VP O
234 safe JJ B-NP O
234 ambulation NN I-NP O
234 , , O O
234 home NN B-NP O
234 safety NN I-NP O
234 , , O O
234 and CC O O
234 good JJ B-NP O
234 O2 NNP I-NP O
234 sat VBD B-VP O
235 on IN B-VP O
235 2L CD O O
236 No NNP B-NP O
236 dictated VBD B-VP O
236 summary JJ B-NP O
237 ENTERED NNP I-NP O
237 BY: NNP I-NP O
237 COREY NNP I-NP O
237 , , O O
237 REYNALDO NNP B-NP O
237 D NNP I-NP O
237 , , O O
237 M.D NNP B-NP O
237 , , O O
237 PH.D NNP B-NP O
237 ( ( O O
237 ND42 NNP B-NP O
237 ) ) O O
237 8/17/06 CD O O
237 @ $ O O
237 03 CD O O
238 ****** JJ B-NP O
238 END NN I-NP O
238 OF NNP I-NP O
238 DISCHARGE NNP I-NP O
238 ORDERS NNP I-NP O
238 ****** NNP I-NP O
239 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #295212 VBZ O O
4 183042353 CD O O
4 PMC NNP B-NP O
4 62412226 CD O O
4 182679 CD O O
4 11/28/1991 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/28/1991 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 9/12/1991 CD O O
7 DIAGNOSIS: NNP B-NP O
7 1 CD O O
7 )CORONARY NNP B-NP O
7 ARTERY NNP I-NP O
7 DISEASE NNP I-NP O
8 2 CD O O
8 )ADULT NNP B-NP O
8 ONSET NNP I-NP O
8 DIABETES NNP I-NP O
8 MELLITUS NNP I-NP O
9 3 CD O O
9 )STATUS NNP B-NP O
9 POST NNP I-NP O
9 CORONARY NNP I-NP O
9 ARTERY NNP I-NP O
9 BYPASS NNP I-NP O
9 GRAFTING NNP I-NP O
10 4 CD O O
10 )HYPERTENSION NN B-NP O
11 5 CD O O
11 )STATUS NN B-NP O
11 POST NNP I-NP O
11 TOTAL NNP I-NP O
11 ABDOMINAL NNP I-NP O
11 HYSTERECTOMY NNP I-NP O
11 AND NNP I-NP O
12 BILATERAL NNP I-NP O
12 SALPINGO NNP I-NP O
12 OOPHORECTOMY NNP I-NP O
13 OPERATION: NNP I-NP O
13 Reoperation NNP I-NP O
13 coronary JJ B-NP O
13 artery NN I-NP O
13 bypass NN I-NP O
13 grafting NN I-NP O
13 by IN B-VP O
13 Dr NNP B-NP O
14 Errol NNP I-NP O
14 Mikhail NNP I-NP O
14 on IN B-VP O
14 13 CD O O
14 of IN B-VP O
14 July NNP B-NP O
15 HISTORY NNP I-NP O
15 OF NNP I-NP O
15 PRESENT NNP I-NP O
15 ILLNESS: NNP I-NP O
15 The DT B-NP O
15 patient NN I-NP O
15 is VBZ O O
15 a DT B-NP O
15 54-year-old JJ I-NP O
15 black JJ I-NP O
16 woman NN I-NP O
16 who WP O O
16 is VBZ O O
16 status NN B-NP O
16 post NN I-NP O
16 coronary JJ B-NP O
17 artery NN I-NP O
17 bypass NN I-NP O
17 grafting VBG O O
17 approximately RB O O
17 two CD O O
17 years NNS B-NP O
17 ago RB O O
17 by IN B-VP O
17 Dr NNP B-NP O
17 Micciche NNP I-NP O
18 who WP O O
18 had VBD B-VP O
18 developed VBN O O
18 recurrent JJ B-NP O
18 substernal JJ I-NP O
18 chest NN I-NP O
18 pain NN I-NP O
18 approximately RB O O
19 four CD O O
19 months NNS B-NP O
19 after IN B-VP O
19 her PRP$ O O
19 bypass NN B-NP O
19 surgery NN I-NP O
19 The DT B-NP O
19 patient NN I-NP O
19 underwent JJ B-NP O
20 exercise NN I-NP O
20 treadmill NN I-NP O
20 testing VBG O O
20 which WDT O O
20 showed VBD B-VP O
20 non-diagnostic JJ B-NP O
20 ST NNP I-NP O
20 segment NN I-NP O
21 changes NNS I-NP O
21 However RB O O
21 , , O O
21 thallium NN B-NP O
21 studies NNS I-NP O
21 revealed VBD B-VP O
21 decreased JJ B-NP O
21 perfusion NN I-NP O
21 to TO O O
22 the DT B-NP O
22 apex NN I-NP O
22 , , O O
22 superior JJ B-NP O
22 portion NN I-NP O
22 of IN B-VP O
22 the DT B-NP O
22 septum NN I-NP O
22 as RB O O
22 well RB O O
22 as IN B-VP O
22 the DT B-NP O
23 anterolateral JJ I-NP O
23 wall NN I-NP O
23 There EX O O
23 was VBD B-VP O
23 reperfusion NN B-NP O
23 of IN B-VP O
23 the DT B-NP O
23 high JJ I-NP O
23 septal NN I-NP O
23 and CC O O
24 anterolateral JJ B-NP O
24 wall NN I-NP O
24 The DT B-NP O
24 patient NN I-NP O
24 then RB O O
24 proceeded VBD B-VP O
24 to TO O O
24 cardiac VB O O
25 catheterization NN B-NP O
25 which WDT O O
25 revealed VBD B-VP O
25 100% CD O O
25 stenosis NN B-NP O
25 of IN B-VP O
25 her PRP$ O O
25 previous JJ B-NP O
25 graft NN I-NP O
26 Additionally RB O O
26 there EX O O
26 was VBD B-VP O
26 100% CD O O
26 mid JJ B-NP O
26 stenosis NN I-NP O
26 of IN B-VP O
26 the DT B-NP O
26 right JJ I-NP O
26 coronary JJ I-NP O
27 artery NN I-NP O
27 , , O O
27 80% CD O O
27 stenosis NN B-NP O
27 of IN B-VP O
27 the DT B-NP O
27 left JJ I-NP O
27 anterior JJ I-NP O
27 descending NN I-NP O
27 , , O O
27 90% CD O O
27 mid JJ B-NP O
28 stenosis NN I-NP O
28 of IN B-VP O
28 the DT B-NP O
28 first JJ I-NP O
28 diagonal NN I-NP O
28 , , O O
28 and CC O O
28 100% CD O O
28 stenosis NN B-NP O
28 of IN B-VP O
28 the DT B-NP O
28 circumflex NN I-NP O
29 after IN B-VP O
29 the DT B-NP O
29 first JJ I-NP O
29 obtuse NN I-NP O
29 marginal NN I-NP O
29 There EX O O
29 was VBD B-VP O
29 anterior JJ B-NP O
29 hypokinesis NN I-NP O
29 as RB O O
30 well RB O O
30 as IN B-VP O
30 apical JJ O O
30 and CC O O
30 inferior JJ B-NP O
30 akinesis NN I-NP O
30 There EX O O
30 was VBD B-VP O
30 severely RB O O
30 decreased JJ O O
31 left VBD B-VP O
31 ventricular JJ B-NP O
31 function NN I-NP O
31 The DT B-NP O
31 pulmonary JJ I-NP O
31 pressures NNS I-NP O
31 were VBD B-VP O
31 fairly RB O O
32 unremarkable JJ O O
32 Thus RB O O
32 , , O O
32 the DT B-NP O
32 patient NN I-NP O
32 presented VBD B-VP O
32 for IN B-VP O
32 reop NN B-NP O
32 coronary JJ B-NP O
32 artery NN I-NP O
33 bypass NN I-NP O
33 grafting VBG O O
34 HOSPITAL NNP B-NP O
34 COURSE: NNP I-NP O
34 The DT B-NP O
34 patient NN I-NP O
34 was VBD B-VP O
34 taken VBN O O
34 to TO O O
34 the DT B-NP O
34 Operating NN I-NP O
34 Room NNP I-NP O
34 on IN B-VP O
35 13 CD O O
35 of IN B-VP O
35 July NNP B-NP O
35 Under IN B-VP O
35 general JJ B-NP O
35 endotracheal NN I-NP O
35 anesthesia NN I-NP O
36 coronary JJ B-NP O
36 artery NN I-NP O
36 bypass NN I-NP O
36 grafting VBG O O
36 times NNS B-NP O
36 three CD O O
36 was VBD B-VP O
36 performed VBN O O
36 The DT B-NP O
37 right JJ I-NP O
37 internal JJ I-NP O
37 mammary JJ I-NP O
37 artery NN I-NP O
37 was VBD B-VP O
37 grafted VBN O O
37 to TO O O
37 the DT B-NP O
37 first JJ I-NP O
37 diagonal NN I-NP O
37 as RB O O
38 well RB O O
38 as IN B-VP O
38 saphenous JJ B-NP O
38 vein NN I-NP O
38 graft NN I-NP O
38 to TO O O
38 the DT O O
38 left VBN O O
38 anterior JJ B-NP O
38 descending NN I-NP O
38 , , O O
38 the DT B-NP O
39 old JJ I-NP O
39 obtuse NN I-NP O
39 marginal JJ B-NP O
39 graft NN I-NP O
39 , , O O
39 and CC O O
39 the DT O O
39 second JJ O O
39 diagonal JJ O O
39 The DT B-NP O
39 patient NN I-NP O
40 was VBD B-VP O
40 found VBN O O
40 to TO O O
40 have VB O O
40 dense JJ B-NP O
40 cardiac JJ I-NP O
40 adhesions NNS I-NP O
40 Her PRP$ O O
40 old JJ B-NP O
40 right JJ I-NP O
40 coronary NN I-NP O
41 artery NN I-NP O
41 graft NN I-NP O
41 was VBD B-VP O
41 occluded VBN O O
41 and CC O O
41 the DT B-NP O
41 old JJ I-NP O
41 obtuse NN I-NP O
41 marginal JJ B-NP O
41 graft NN I-NP O
41 was VBD B-VP O
42 tightly RB O O
42 stenotic JJ O O
42 at IN B-VP O
42 the DT B-NP O
42 origin NN I-NP O
42 The DT O O
42 left VBN O O
42 internal JJ B-NP O
42 mammary JJ I-NP O
42 artery NN I-NP O
43 was VBD B-VP O
43 subtotally RB O O
43 occluded VBN O O
43 distally RB O O
43 The DT B-NP O
43 patient NN I-NP O
43 spontaneously RB O O
44 defibrillated VBN O O
44 and CC O O
44 demonstrated VBN O O
44 modestly RB O O
44 decreased VBN O O
44 left VBD B-VP O
44 ventricular JJ B-NP O
45 function NN I-NP O
45 The DT B-NP O
45 patient NN I-NP O
45 was VBD B-VP O
45 taken VBN O O
45 to TO O O
45 the DT B-NP O
45 Cardiac NNP I-NP O
45 Intensive NNP I-NP O
45 Care NNP I-NP O
45 Unit NNP I-NP O
46 in IN B-VP O
46 stable JJ B-NP O
46 rhythm NN I-NP O
46 with IN B-VP O
46 stable JJ B-NP O
46 vital JJ I-NP O
46 signs NNS I-NP O
46 Postoperatively RB O O
46 the DT B-NP O
47 patient's NN I-NP O
47 course NN I-NP O
47 was VBD B-VP O
47 thoroughly RB O O
47 unremarkable JJ O O
47 The DT B-NP O
47 patient NN I-NP O
47 required VBN O O
48 sodium NN B-NP B-m
48 Nitroprusside NNP I-NP I-m
48 in IN B-VP O
48 the DT B-NP O
48 immediate JJ I-NP O
48 postoperative JJ I-NP O
48 period NN I-NP O
48 There EX O O
49 was VBD B-VP O
49 no DT B-NP O
49 evidence NN I-NP O
49 of IN B-VP O
49 postoperative JJ B-NP O
49 myocardial JJ I-NP O
49 infarction NN I-NP O
49 The DT B-NP O
50 patient NN I-NP O
50 was VBD B-VP O
50 successfully RB O O
50 extubated VBN O O
50 on IN B-VP O
50 the DT B-NP O
50 second JJ I-NP O
50 postoperative JJ I-NP O
50 day NN I-NP O
51 and CC O O
51 her PRP$ O O
51 mediastinal JJ O O
51 and CC O O
51 pleural JJ B-NP O
51 tubes NNS I-NP O
51 were VBD B-VP O
51 also RB O O
51 pulled VBN O O
51 without IN B-VP O
52 significant JJ B-NP O
52 incident NN I-NP O
52 The DT B-NP O
52 patient's NN I-NP O
52 diuresis NN I-NP O
52 was VBD B-VP O
52 initiated VBN O O
52 and CC O O
53 tolerated VBN O O
53 well RB O O
53 The DT B-NP O
53 rest NN I-NP O
53 of IN B-VP O
53 the DT B-NP O
53 patient's JJ I-NP O
53 postoperative JJ I-NP O
53 course NN I-NP O
53 was VBD B-VP O
54 unremarkable JJ O O
54 She PRP O O
54 remained VBD B-VP O
54 in IN B-VP O
54 normal JJ B-NP O
54 sinus NN I-NP O
54 rhythm NN I-NP O
54 without IN B-VP O
54 any DT B-NP O
55 evidence NN I-NP O
55 of IN B-VP O
55 arrhythmia NN B-NP O
55 She PRP O O
55 was VBD B-VP O
55 essentially RB O O
55 afebrile JJ O O
55 and CC O O
55 her PRP$ O O
56 wounds NNS B-NP O
56 were VBD B-VP O
56 all DT O O
56 healing VBG O O
56 well RB O O
56 However RB O O
56 , , O O
56 on IN B-VP O
56 chest JJS O O
56 x-ray JJ O O
56 it PRP O O
56 was VBD B-VP O
57 demonstrated VBN O O
57 that IN B-VP O
57 the DT B-NP O
57 patient NN I-NP O
57 had VBD B-VP O
57 right JJ B-NP O
57 lower JJR I-NP O
57 lobe NN I-NP O
57 collapse NN I-NP O
58 Because IN B-VP O
58 of IN B-VP O
58 her PRP$ O O
58 afebrile JJ B-NP O
58 state NN I-NP O
58 and CC O O
58 good JJ B-NP O
58 oxygenation NN I-NP O
58 on IN B-VP O
58 room NN B-NP O
58 air NN I-NP O
58 the DT B-NP O
59 patient NN I-NP O
59 was VBD B-VP O
59 not RB O O
59 bronch'd VBN O O
59 in IN B-VP O
59 order NN B-NP O
59 to TO O O
59 re-expand VB O O
59 her PRP$ O O
59 right JJ B-NP O
59 lower JJR I-NP O
60 lobe NN I-NP O
60 At IN B-VP O
60 the DT B-NP O
60 time NN I-NP O
60 of IN B-VP O
60 dictation NN B-NP O
60 , , O O
60 one CD O O
60 day NN B-NP O
60 prior RB O O
60 to TO O O
60 proposed VBN O O
61 discharge VB O O
61 the DT B-NP O
61 patient's NN I-NP O
61 chest JJS B-NP O
61 x-ray NN I-NP O
61 showed VBD B-VP O
61 some DT B-NP O
61 improved JJ I-NP O
61 aeration NN I-NP O
62 of IN B-VP O
62 that DT B-NP O
62 lower JJR I-NP O
62 lobe NN I-NP O
62 Thus NNP I-NP O
62 , , O O
62 the DT B-NP O
62 patient NN I-NP O
62 will MD O O
62 likely RB O O
62 be VB O O
62 discharged VBN O O
62 on IN B-VP O
63 29 CD O O
63 of IN B-VP O
63 March NNP B-NP O
64 DISPOSITION: NNP I-NP O
64 DISCHARGE NNP I-NP O
64 MEDICATIONS: NNP I-NP O
64 Atenolol NNP I-NP B-m
64 50 CD O B-do
64 mg NN B-NP I-do
64 po NN I-NP B-mo
64 q NN I-NP B-f
64 d NN I-NP I-f
64 , , O O
64 baby NN B-NP B-m
65 aspirin VBD B-VP O
65 one CD O B-do
65 po NN B-NP B-mo
65 q NN I-NP B-f
65 d NN I-NP I-f
65 , , O O
65 Diabinese JJ O B-m
65 500 CD O B-do
65 mg NN B-NP I-do
65 po NN I-NP B-mo
65 q NN I-NP B-f
65 d NN I-NP I-f
65 , , O O
65 iron NN B-NP B-m
66 sulfate NN I-NP O
66 325 CD O B-do
66 mg NN B-NP I-do
66 po NN I-NP B-mo
66 tid NN I-NP B-f
66 , , O O
66 Colace NNP B-NP B-m
66 , , O O
66 Percocet NNP B-NP B-m
66 The DT B-NP O
66 patient NN I-NP O
66 will MD O O
66 be VB O O
67 discharged VBN O O
67 to TO O O
67 home VB O O
67 FOLLOW-UP: NNP B-NP O
67 She PRP O O
67 will MD O O
67 follow-up VB O O
67 with IN B-VP O
67 Dr NNP B-NP O
68 Rory NNP I-NP O
68 Broadnax NNP I-NP O
68 in IN B-VP O
68 four CD O O
68 to TO O O
68 five CD O O
68 weeks NNS B-NP O
68 and CC O O
68 with IN B-VP O
68 private JJ B-NP O
68 medical JJ I-NP O
69 doctor NN I-NP O
69 and CC O O
69 cardiologist NN B-NP O
69 in IN B-VP O
69 one CD O O
69 to TO O O
69 two CD O O
69 weeks NNS B-NP O
69 The DT B-NP O
69 patient NN I-NP O
69 will MD O O
69 also RB O O
70 have VB O O
70 visiting VBG O O
70 nurse JJ O O
70 come VBN O O
70 in IN B-VP O
70 to TO O O
70 check VB O O
70 on IN B-VP O
70 her PRP O O
70 in IN B-VP O
70 the DT B-NP O
70 immediate JJ I-NP O
71 postoperative JJ I-NP O
71 period NN I-NP O
72 XU553/4112 NNP I-NP O
73 RAMON NNP I-NP O
73 H NNP I-NP O
73 LEPEZ NNP I-NP O
73 , , O O
73 M.D NNP B-NP O
73 LM2 NNP I-NP O
73 D: NNP I-NP O
73 11/15/91 CD O O
74 Batch: NNP B-NP O
74 2629 CD O O
74 Report: NNP B-NP O
74 H2454D50 NNP I-NP O
74 T: NNP I-NP O
74 9/25/91 CD O O
75 Dictated NNP B-NP O
75 By: NNP I-NP O
75 LEE NNP I-NP O
75 CATHOLIC NNP I-NP O
75 , , O O
75 M.D NNP B-NP O
75 VS71 NNP I-NP O
76 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #298021 VBZ O O
4 977738472 CD O O
4 CDH NNP B-NP O
4 18689855 CD O O
4 8020024 CD O O
4 7/24/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 angina RB O O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/24/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/30/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 DECICCO NNP I-NP O
8 , , O O
8 FAUSTINO NNP B-NP O
8 541-50-28-4 CD O O
9 Michigan NNP B-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 7/9/06 CD O O
11 AT NNP B-NP O
11 08:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 CUTLER NNP I-NP O
14 , , O O
14 CLAUDIO NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 DUONEB NNP I-NP B-m
19 ( ( O I-m
19 ALBUTEROL NNP B-NP I-m
19 AND NNP I-NP I-m
19 IPRATROPIUM NNP I-NP I-m
19 NEBULIZER NNP I-NP I-m
19 ) ) O I-m
20 3/0.5 CD O B-do
20 MG NNP B-NP I-do
20 INH NNP I-NP B-mo
20 Q6H NNP I-NP B-f
21 ALLOPURINOL NNP I-NP B-m
21 100 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 DAILY NNP I-NP B-f
22 AMOXICILLIN NNP I-NP B-m
22 250 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 TID NNP I-NP B-f
22 X NNP I-NP B-du
22 9 CD O I-du
22 doses NNS B-NP I-du
23 Food/Drug NNP I-NP O
23 Interaction NNP I-NP O
23 Instruction NNP I-NP O
24 May NNP I-NP O
24 be VB O O
24 taken VBN O O
24 without IN B-VP O
24 regard NN B-NP O
24 to TO O O
24 meals NNS B-NP O
25 ENTERIC NNP I-NP B-m
25 COATED NNP I-NP I-m
25 ASPIRIN NNP I-NP I-m
25 ( ( O I-m
25 ASPIRIN NNP B-NP I-m
25 ENTERIC NNP I-NP I-m
25 COATED NNP I-NP I-m
25 ) ) O I-m
26 81 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 DAILY NNP I-NP B-f
26 Starting VBG O O
26 Today NNP B-NP O
26 August NNP I-NP O
27 ATENOLOL NNP I-NP B-m
27 25 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 DAILY NNP I-NP B-f
28 PULMICORT NNP I-NP B-m
28 TURBUHALER NNP I-NP I-m
28 ( ( O I-m
28 BUDESONIDE NNP B-NP I-m
28 ORAL NNP I-NP I-m
28 INHALER NNP I-NP I-m
28 ) ) O I-m
29 1 CD O B-do
29 PUFF NNP B-NP I-do
29 INH NNP I-NP B-mo
29 BID NNP I-NP B-f
30 LASIX NNP I-NP B-m
30 ( ( O I-m
30 FUROSEMIDE NNP B-NP I-m
30 ) ) O I-m
30 40 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 DAILY NNP I-NP B-f
31 Starting VBG O O
31 Today NNP B-NP O
31 August NNP I-NP O
32 Alert NNP I-NP O
32 overridden: MD O O
32 Override NNP B-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 10/28/06 CD O O
32 by IN B-VP O
32 PINNELL NNP B-NP O
32 , , O O
32 JASON NNP B-NP O
32 E NNP I-NP O
32 S NNP I-NP O
32 , , O O
32 M.D NNP B-NP O
32 on IN B-VP O
32 order NN B-NP O
32 for IN B-VP O
32 LASIX NNP B-NP B-m
32 PO NNP I-NP B-mo
32 ( ( O O
32 ref JJ O O
32 # # O O
32 124703229 CD O O
32 ) ) O O
33 Pt NNP B-NP O
33 has VBZ O O
33 a DT B-NP O
33 POSSIBLE NNP I-NP O
33 allergy NN I-NP O
33 to TO O O
33 Sulfa; NNP B-NP O
33 reaction NN I-NP O
33 is VBZ O O
33 Unknown JJ B-NP O
34 Reason NNP I-NP O
34 for IN B-VP O
34 override: NNP B-NP O
34 home NN I-NP O
34 medication NN I-NP O
35 REGLAN NNP I-NP B-m
35 ( ( O I-m
35 METOCLOPRAMIDE NNP B-NP I-m
35 HCL NNP I-NP I-m
35 ) ) O I-m
35 10 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 QID NNP I-NP B-f
36 RANITIDINE NNP I-NP B-m
36 HCL NNP I-NP I-m
36 150 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 DAILY NNP I-NP B-f
37 SENNA NNP I-NP B-m
37 TABLETS NNP I-NP I-m
37 ( ( O I-m
37 SENNOSIDES NNP B-NP I-m
37 ) ) O I-m
37 2 CD O B-do
37 TAB NNP B-NP I-do
37 PO NNP I-NP B-mo
37 BID NNP I-NP B-f
37 PRN NNP I-NP I-f
37 Constipation NNP I-NP B-r
38 ZOCOR NNP I-NP B-m
38 ( ( O I-m
38 SIMVASTATIN NNP B-NP I-m
38 ) ) O I-m
38 40 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 BEDTIME NNP I-NP B-f
39 Food/Drug NNP I-NP O
39 Interaction NNP I-NP O
39 Instruction NNP I-NP O
40 Avoid NNP I-NP O
40 grapefruit NN I-NP O
40 unless IN B-VP O
40 MD NNP B-NP O
40 instructs NNS I-NP O
40 otherwise RB O O
41 Override NNP B-NP O
41 Notice: NNP I-NP O
41 Override NNP I-NP O
41 added VBD B-VP O
41 on IN B-VP O
41 10/28/06 CD O O
41 by IN B-VP O
42 CRANER NNP B-NP O
42 , , O O
42 LUCIEN NNP B-NP O
42 E NNP I-NP O
42 , , O O
42 M.D NNP B-NP O
43 on IN B-VP O
43 order NN B-NP O
43 for IN B-VP O
43 MULTIVITAMIN NNP B-NP B-m
43 THERAPEUTIC NNP I-NP O
43 PO NNP I-NP B-mo
43 ( ( O O
43 ref JJ O O
43 # # O O
44 269201277 CD O O
44 ) ) O O
45 POTENTIALLY NNP B-NP O
45 SERIOUS NNP I-NP O
45 INTERACTION: NNP I-NP O
45 SIMVASTATIN NNP I-NP B-m
45 &amp; NNP I-NP O
45 NIACIN NNP I-NP B-m
45 , , O O
46 VIT NNP B-NP B-m
46 B-3 NNP I-NP I-m
46 Reason NNP I-NP O
46 for IN B-VP O
46 override: NN B-NP O
47 MULTIVITAMIN NNP I-NP B-m
47 THERAPEUTIC NNP I-NP I-m
47 ( ( O I-m
47 THERAPEUTIC NNP B-NP I-m
47 MULTIVI NNP I-NP I-m
47 ) ) O I-m
48 1 CD O B-do
48 TAB NNP B-NP I-do
48 PO NNP I-NP B-mo
48 DAILY NNP I-NP B-f
49 Alert NNP I-NP O
49 overridden: NNP I-NP O
49 Override NNP I-NP O
49 added VBD B-VP O
49 on IN B-VP O
49 10/28/06 CD O O
49 by IN B-VP O
50 HAMAR NNP B-NP O
50 , , O O
50 ULYSSES NNP B-NP O
50 C NNP I-NP O
50 , , O O
50 M.D NNP B-NP O
51 POTENTIALLY NNP I-NP O
51 SERIOUS NNP I-NP O
51 INTERACTION: NNP I-NP O
51 SIMVASTATIN NNP I-NP B-m
51 &amp; NNP I-NP O
51 NIACIN NNP I-NP B-m
51 , , O O
52 VIT NNP B-NP B-m
52 B-3 NNP I-NP I-m
52 Reason NNP I-NP O
52 for IN B-VP O
52 override: NN B-NP O
53 DIET: NNP I-NP O
53 House NNP I-NP O
53 / VBD B-VP O
53 Low NNP B-NP O
53 chol/low NN I-NP O
53 sat VBD B-VP O
53 fat JJ B-NP O
54 DIET: NNP I-NP O
54 House NNP I-NP O
54 / NNP I-NP O
54 ADA NNP I-NP O
54 2100 CD O O
54 cals/dy NN B-NP O
55 DIET: NNP I-NP O
55 2 CD O O
55 gram NN B-NP O
55 Sodium NNP I-NP O
56 ACTIVITY: NNP I-NP O
56 Resume NNP I-NP O
56 regular JJ B-NP O
56 exercise NN I-NP O
57 FOLLOW NNP I-NP O
57 UP NNP I-NP O
57 APPOINTMENT( NNP I-NP O
57 S NNP I-NP O
57 ): NNP I-NP O
58 Please NNP I-NP O
58 call VB O O
58 your PRP$ O O
58 PCP NNP B-NP O
58 for IN B-VP O
58 f/u NN B-NP O
58 appt NN I-NP O
58 , , O O
59 ALLERGY: NNP B-NP O
59 IV NNP I-NP O
59 Contrast NNP I-NP O
59 , , O O
59 IRON NNP B-NP O
59 ANALOGUES NNP I-NP O
59 , , O O
59 Erythromycins NNP B-NP O
59 , , O O
60 LEVOFLOXACIN NNP B-NP O
60 , , O O
60 Sulfa NNP B-NP O
61 ADMIT NNP I-NP O
61 DIAGNOSIS: NNP I-NP O
62 angina NN I-NP O
63 PRINCIPAL NNP I-NP O
63 DISCHARGE NNP I-NP O
63 DIAGNOSIS NNP I-NP O
63 ;Responsible JJ O O
63 After IN B-VP O
63 Study NNP B-NP O
63 for IN B-VP O
63 Causing NNP B-NP O
63 Admission NNP I-NP O
63 ) ) O O
64 angina VBZ O O
65 OTHER NNP B-NP O
65 DIAGNOSIS;Conditions NNP I-NP O
65 , , O O
65 Infections NNP B-NP O
65 , , O O
65 Complications NNP B-NP O
65 , , O O
65 affecting VBG O O
65 Treatment/Stay NNP B-NP O
66 ASTHMA/COPD NNP I-NP O
66 aodm VBZ O O
66 S/P NNP B-NP O
66 MI NNP I-NP O
66 x VBD B-VP O
66 2 CD O O
66 S/P NNP B-NP O
66 V NNP I-NP O
66 FIB NNP I-NP O
66 ARREST NNP I-NP O
66 s/p VBD B-VP O
66 CABG NNP B-NP O
66 10/21 CD O O
66 sleep NN B-NP O
66 apnea NN I-NP O
67 obesity NN I-NP O
67 hypercholesterolemia NN I-NP O
67 s/p JJ B-NP O
67 chole NN I-NP O
67 s/p NN I-NP O
67 dvt NN I-NP O
67 -&gt; NNP I-NP O
68 greenfield VBD B-VP O
68 aaa JJ B-NP O
68 repair NN I-NP O
68 ( ( O O
68 abdominal JJ B-NP O
68 aortic JJ I-NP O
68 aneurysm NN I-NP O
68 ) ) O O
68 diverticular NN B-NP O
69 abscess NN I-NP O
69 ( ( O O
69 abscess NN B-NP O
69 ) ) O O
69 gerd NN B-NP O
69 ( ( O O
69 gastroesophageal JJ B-NP O
69 reflux NN I-NP O
70 disease NN I-NP O
70 ) ) O O
70 gout NN B-NP O
70 ( ( O O
70 gout NN B-NP O
70 ) ) O O
70 dm NN B-NP O
70 neuropathy JJ O O
71 ( ( O O
71 neuropathy JJ O O
71 ) ) O O
71 carpal JJ B-NP O
71 tunnel NN I-NP O
71 ( ( O O
71 carpal JJ B-NP O
71 tunnel NN I-NP O
71 syndrome NN I-NP O
71 ) ) O O
71 chf NN B-NP O
71 ( ( O O
71 congestive JJ B-NP O
72 heart NN I-NP O
72 failure NN I-NP O
72 ) ) O O
72 iron NN B-NP O
72 def NN I-NP O
72 anemia NN I-NP O
72 ( ( O O
72 baseline JJ O O
73 30 CD O O
73 ) ) O O
73 cri NN B-NP O
73 ( ( O O
73 1.4 CD O O
73 to TO O O
73 2 CD O O
73 ) ) O O
73 s/p NN B-NP O
73 sigmoid JJ B-NP O
73 colectomy NN I-NP O
73 4/13 CD O O
73 OSA NNP B-NP O
73 ( ( O O
73 sleep JJ B-NP O
73 apnea NN I-NP O
73 ) ) O O
73 s/p NN B-NP O
73 R NNP I-NP O
74 CEA NNP I-NP O
75 OPERATIONS NNP I-NP O
75 AND NNP I-NP O
75 PROCEDURES: NNP I-NP O
76 none NN I-NP O
77 OTHER NNP I-NP O
77 TREATMENTS/PROCEDURES NNP I-NP O
77 ( ( O O
77 NOT NNP B-NP O
77 IN NNP I-NP O
77 O.R NNP I-NP O
77 ) ) O O
78 none NN B-NP O
79 BRIEF NNP I-NP O
79 RESUME NNP I-NP O
79 OF NNP I-NP O
79 HOSPITAL NNP I-NP O
79 COURSE: NNP I-NP O
80 74F CD O O
80 hx/o NN B-NP O
80 CAD NNP I-NP O
80 s/p NN I-NP O
80 CABG NNP I-NP O
80 1996 CD O O
80 , , O O
80 DMII NNP B-NP O
80 , , O O
80 CHF NNP B-NP O
80 , , O O
80 hyperlipid NN B-NP O
80 , , O O
80 AAA NNP B-NP O
80 repair NN I-NP O
80 , , O O
80 GERD NNP B-NP O
80 , , O O
80 hx/o NN B-NP O
81 DVT NNP I-NP O
81 s/p VBD B-VP O
81 Greenfield NNP B-NP O
81 filter NN I-NP O
81 , , O O
81 anemia NN B-NP O
81 , , O O
81 who WP O O
81 p/w VBP O O
81 CP NNP B-NP O
81 c VBP O O
81 typical JJ O O
81 and CC O O
81 atypical JJ B-NP O
82 features NNS I-NP O
82 after IN B-VP O
82 recent JJ B-NP O
82 TKR NNP I-NP O
82 Pt NNP I-NP O
82 was VBD B-VP O
82 recently RB O O
82 seen VBN O O
82 by IN B-VP O
82 Dr NNP B-NP O
82 Ahlberg NNP I-NP O
82 and CC O O
82 sent VBD B-VP O
83 for IN B-VP O
83 dobutamine NN B-NP B-m
83 MIBI NNP I-NP O
83 to TO O O
83 risk VB O O
83 stratify NN B-NP O
83 in IN B-VP O
83 prep NN B-NP O
83 for IN B-VP O
83 R NNP B-NP O
83 TKR NNP I-NP O
83 Had NNP I-NP O
83 MIBI NNP I-NP O
83 on IN B-VP O
83 5/25 CD O O
84 which WDT O O
84 showed VBD B-VP O
84 86% CD O O
84 MPRH NNP B-NP O
84 , , O O
84 no DT B-NP O
84 clinical JJ I-NP O
84 ischemia NN I-NP O
84 , , O O
84 no DT B-NP O
84 diagnostic JJ I-NP O
84 EKG NNP I-NP O
84 chagnes NNS I-NP O
84 , , O O
85 MIBI NNP B-NP O
85 c VBP O O
85 small JJ B-NP O
85 reversible JJ I-NP O
85 defect NN I-NP O
85 of IN B-VP O
85 mod JJ B-NP O
85 intensity NN I-NP O
85 in IN B-VP O
85 mid NN B-NP O
85 and CC O O
85 basal NN B-NP O
85 inferior RB O O
86 wall PDT O O
86 This DT O O
86 was VBD B-VP O
86 not RB O O
86 deemed VBN O O
86 significant JJ O O
86 and CC O O
86 pt JJ B-NP O
86 underwent JJ I-NP O
86 TKR NNP I-NP O
86 on IN B-VP O
87 4/10 CD O O
87 without IN B-VP O
87 cardiac JJ B-NP O
87 complications NNS I-NP O
87 She PRP O O
87 was VBD B-VP O
87 sent VBN O O
87 to TO O O
87 rehab VB O O
87 where WRB O O
87 she PRP O O
87 was VBD B-VP O
88 stable JJ O O
88 until IN B-VP O
88 5/22 CD O O
88 when WRB O O
88 she PRP O O
88 was VBD B-VP O
88 discharged VBN O O
88 home NN B-NP O
88 Yesterday NN I-NP O
88 she PRP O O
88 had VBD B-VP O
88 3 CD O O
88 bouts NNS B-NP O
89 of IN B-VP O
89 chest JJS B-NP O
89 pain NN I-NP O
89 at IN B-VP O
89 rest NN B-NP O
89 , , O O
89 lasting VBG O O
89 5-10secs JJ O O
89 at IN B-VP O
89 a DT B-NP O
89 time NN I-NP O
89 , , O O
89 dull JJ B-NP O
89 SSCP NNP I-NP O
89 , , O O
89 rad NN B-NP O
89 to TO O O
89 jaw VB O O
89 , , O O
90 non-exertional JJ O O
90 , , O O
90 not RB O O
90 assc JJ B-NP O
90 c NNS I-NP O
90 SOB NNP I-NP O
90 , , O O
90 N NNP B-NP O
90 , , O O
90 V NNP B-NP O
90 , , O O
90 D NNP B-NP O
90 She PRP O O
90 does VBZ O O
90 however RB O O
90 report VB O O
91 intermittent NN B-NP O
91 nausea NN I-NP O
91 and CC O O
91 vomiting NN B-NP O
91 since IN B-VP O
91 her PRP$ O O
91 surgery NN B-NP O
91 SHe NNP I-NP O
91 was VBD B-VP O
91 admitted VBN O O
91 for IN B-VP O
92 a DT B-NP O
92 rule NN I-NP O
92 out IN B-VP O
92 and CC O O
92 possible JJ B-NP O
92 repeat NN I-NP O
92 catherization NN I-NP O
92 She PRP O O
92 ruled VBD B-VP O
92 out RP O O
92 on IN B-VP O
92 HD#1 NNP B-NP O
93 and CC O O
93 it PRP O O
93 was VBD B-VP O
93 not RB O O
93 felt VBN O O
93 that IN B-VP O
93 repeat NN B-NP O
93 stress NN I-NP O
93 imaging VBG O O
93 would MD O O
93 add VB O O
93 new JJ B-NP O
93 information NN I-NP O
94 given VBN O O
94 her PRP$ O O
94 recent JJ B-NP O
94 evaluation NN I-NP O
94 She PRP O O
94 refuses VBZ O O
94 further JJ B-NP O
94 coronary JJ I-NP O
94 intervention NN I-NP O
95 and CC O O
95 wishes NNS B-NP O
95 for IN B-VP O
95 medical JJ B-NP O
95 treatment NN I-NP O
95 Discussed VBN O O
95 c JJ B-NP O
95 attg NN I-NP O
95 who WP O O
95 felt VBD B-VP O
95 that IN B-VP O
95 med VBD B-VP O
96 mgmt NN B-NP O
96 was VBD B-VP O
96 appropriate JJ O O
96 She PRP O O
96 was VBD B-VP O
96 additionally RB O O
96 treated VBN O O
96 for IN B-VP O
96 nausea NN B-NP B-r
96 with IN B-VP O
97 reglan NN B-NP B-m
97 A NNP I-NP O
97 UTI NNP I-NP B-r
97 was VBD B-VP O
97 dx'd VBN O O
97 on IN B-VP O
97 U/A NNP B-NP O
97 and CC O O
97 she PRP O O
97 was VBD B-VP O
97 treated VBN O O
97 c JJ B-NP O
97 empiric JJ I-NP O
97 amox NN I-NP B-m
97 ( ( O O
97 she PRP O O
97 is VBZ O O
98 sulfa JJ O O
98 and CC O O
98 quinolone JJ B-NP O
98 allergic NN I-NP O
98 ) ) O O
98 for IN B-VP B-du
98 3 CD O I-du
98 days NNS B-NP I-du
98 She PRP O O
98 will MD O O
98 be VB O O
98 discharged VBN O O
98 home NN B-NP O
98 on IN B-VP O
99 her PRP$ O O
99 home NN B-NP B-m
99 medicines NNS I-NP I-m
99 including VBG O O
99 the DT B-NP O
99 amoxicillin NN I-NP B-m
99 and CC O O
99 reglan NN B-NP B-m
99 as IN B-VP O
99 discussed VBN O O
100 above IN B-VP O
101 ADDITIONAL NNP B-NP O
101 COMMENTS: NNP I-NP O
101 Please NNP I-NP O
101 have VBP O O
101 VNA NNP B-NP O
101 remove VB O O
101 staples NNS B-NP O
101 on IN B-VP O
101 0/28 CD O O
102 DISCHARGE NNP B-NP O
102 CONDITION: NNP I-NP O
102 Stable NNP I-NP O
103 TO NNP I-NP O
103 DO/PLAN: NNP I-NP O
104 - : O O
104 F/u NNP B-NP O
104 nausea SYM O O
105 - : O O
105 F/u NNP B-NP O
105 Cr NNP I-NP O
105 , , O O
105 INR NNP B-NP O
105 , , O O
105 HCT NNP B-NP O
106 - : O O
106 F/u NNP B-NP O
106 chest JJS B-NP O
106 pain NN I-NP O
106 sxs JJ O O
107 - : O O
107 VNA NN B-NP O
107 to TO O O
107 remove VB O O
107 staples NNS B-NP O
107 from IN B-VP O
107 knee JJ B-NP O
107 replacement NN I-NP O
107 on IN B-VP O
107 0/28 CD O O
108 No NNP B-NP O
108 dictated VBD B-VP O
108 summary JJ B-NP O
109 ENTERED NNP I-NP O
109 BY: NNP I-NP O
109 BUSUTTIL NNP I-NP O
109 , , O O
109 ANTONY NNP B-NP O
109 S NNP I-NP O
109 , , O O
109 M.D NNP B-NP O
109 ( ( O O
109 PN293 NNP B-NP O
109 ) ) O O
109 7/9/06 CD O O
109 @ $ O O
109 08:58 CD O O
109 AM NNP B-NP O
110 ****** JJ B-NP O
110 END NN I-NP O
110 OF NNP I-NP O
110 DISCHARGE NNP I-NP O
110 ORDERS NNP I-NP O
110 ****** NNP I-NP O
111 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #311514 VBZ O O
2 157011241 CD O O
2 SH NNP B-NP O
2 78994491 CD O O
2 114569 CD O O
2 2/5/1995 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 5/0/1995 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/21/1995 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 Patient NNP I-NP O
4 is VBZ O O
4 a DT O O
4 42 CD O O
4 year NN B-NP O
4 old JJ B-NP O
4 female NN I-NP O
4 with IN B-VP O
4 a DT B-NP O
5 history NN I-NP O
5 of IN B-VP O
5 variegate NN B-NP O
5 porphyria NNS I-NP O
5 , , O O
6 insulin NN B-NP O
6 dependent NN I-NP O
6 diabetes NNS I-NP O
6 , , O O
6 coronary JJ B-NP O
6 artery NN I-NP O
6 disease NN I-NP O
6 , , O O
6 status NN B-NP O
6 post NN I-NP O
7 coronary JJ B-NP O
7 artery NN I-NP O
7 bypass NN I-NP O
7 graft NN I-NP O
7 , , O O
7 and CC O O
7 hypercholesterolemia NN B-NP O
7 who WP O O
7 had VBD B-VP O
8 experienced VBN O O
8 five CD O O
8 days NNS B-NP O
8 of IN B-VP O
8 confusion NN B-NP O
8 , , O O
8 weakness NN B-NP O
8 , , O O
8 change NN B-NP O
8 in IN B-VP O
8 bowel NN B-NP O
9 habits NNS I-NP O
9 , , O O
9 and CC O O
9 fatigue NN B-NP O
9 with IN B-VP O
9 flashing JJ B-NP O
9 sensations NNS I-NP O
9 of IN B-VP O
9 anxiety NN B-NP O
9 with IN B-VP O
10 emotional JJ B-NP O
10 lability NN I-NP O
10 Patient NNP I-NP O
10 had VBD B-VP O
10 a DT B-NP O
10 history NN I-NP O
10 of IN B-VP O
10 variegate NN B-NP O
10 porphyria NNS I-NP O
11 for IN B-VP O
11 about IN B-VP O
11 fifteen JJ B-NP O
11 years NNS I-NP O
11 , , O O
11 was VBD B-VP O
11 followed VBN O O
11 by IN B-VP O
11 Dr NNP B-NP O
11 Nigel NNP I-NP O
11 Wickenhauser NNP I-NP O
11 , , O O
11 and CC O O
11 she PRP O O
12 had VBD B-VP O
12 been VBN O O
12 relatively RB O O
12 free JJ O O
12 of IN B-VP O
12 porphyria NN B-NP O
12 attacks NNS I-NP O
12 with IN B-VP O
12 the DT O O
12 last JJ O O
12 major JJ O O
13 one CD O O
13 approximately RB O O
13 twelve CD O O
13 years NNS B-NP O
13 ago RB O O
13 with IN B-VP O
13 symptoms NNS B-NP O
13 similar JJ O O
13 to TO O O
13 those DT O O
14 she PRP O O
14 was VBD B-VP O
14 experiencing VBG O O
14 at IN B-VP O
14 the DT B-NP O
14 time NN I-NP O
14 of IN B-VP O
14 this DT B-NP O
14 admission NN I-NP O
14 In IN B-VP O
14 May NNP B-NP O
15 1994 CD O O
15 , , O O
15 she PRP O O
15 had VBD B-VP O
15 a DT B-NP O
15 mild JJ I-NP O
15 porphyria NN I-NP O
15 attack NN I-NP O
15 which WDT O O
15 was VBD B-VP O
15 managed VBN O O
15 by IN B-VP O
15 stopping VBG O O
15 all DT O O
16 her PRP$ O O
16 medications NNS B-NP O
16 She PRP O O
16 intermittently RB O O
16 had VBD B-VP O
16 skin JJ B-NP O
16 lesions NNS I-NP O
16 , , O O
17 especially RB O O
17 with IN B-VP O
17 sun JJ B-NP O
17 exposure NN I-NP O
17 She PRP O O
17 had VBD B-VP O
17 never RB O O
17 been VBN O O
17 phlebotomized VBN O O
17 or CC O O
18 received VBN O O
18 other JJ B-NP O
18 treatments NNS I-NP O
18 In IN B-VP O
18 the DT O O
18 past JJ O O
18 two CD O B-du
18 months NNS B-NP I-du
18 , , O O
18 she PRP O O
18 had VBD B-VP O
18 been VBN O O
19 taking VBG O O
19 Ativan NNP B-NP B-m
19 of IN B-VP O
19 3-4 JJ B-NP B-do
19 mg NN I-NP I-do
19 q.d NN I-NP B-f
19 for IN B-VP O
19 anxiety NN B-NP B-r
19 She PRP O O
19 stopped VBD B-VP O
19 taking VBG O O
20 Ativan NNP B-NP B-m
20 on IN B-VP O
20 March NNP B-NP O
20 , , O O
20 1995 CD O O
20 and CC O O
20 after IN B-VP O
20 this DT B-NP O
20 abrupt JJ I-NP O
20 stopping NN I-NP O
20 of IN B-VP O
20 this DT B-NP B-m
21 medication NN I-NP O
21 , , O O
21 she PRP O O
21 started VBD B-VP O
21 to TO O O
21 have VB O O
21 feelings NNS B-NP O
21 of IN B-VP O
21 disorientation NN B-NP O
21 , , O O
22 confusion NN B-NP O
22 , , O O
22 and CC O O
22 fatigue NN B-NP O
22 with IN B-VP O
22 emotional JJ B-NP O
22 lability NN I-NP O
22 She PRP O O
22 also RB O O
22 was VBD B-VP O
22 in IN B-VP O
23 Idaho NNP B-NP O
23 with IN B-VP O
23 extensive JJ B-NP O
23 sun NN I-NP O
23 exposure NN I-NP O
23 in IN B-VP O
23 the DT O O
23 last JJ O O
23 two CD O O
23 weeks NNS B-NP O
23 She PRP O O
24 contacted VBD B-VP O
24 Dr NNP B-NP O
24 Furuya NNP I-NP O
24 who WP O O
24 advised VBD B-VP O
24 her PRP O O
24 to TO O O
24 increase VB O O
24 her PRP$ O O
24 carbohydrate JJ B-NP O
25 intake NN I-NP O
25 to TO O O
25 about IN B-VP O
25 400 CD O O
25 grams NNS B-NP O
25 a DT B-NP O
25 day NN I-NP O
25 , , O O
25 however RB O O
25 , , O O
25 her PRP O O
25 symptoms NNS B-NP O
25 progressed VBD B-VP O
26 Two CD O O
26 days NNS B-NP O
26 prior RB O O
26 to TO O O
26 admission NN B-NP O
26 , , O O
26 she PRP O O
26 felt VBD B-VP O
26 weak JJ O O
26 and CC O O
26 while IN B-VP O
26 standing VBG O O
26 , , O O
26 her PRP$ O O
27 legs NNS B-NP O
27 gave VBD B-VP O
27 way NN B-NP O
27 without IN B-VP O
27 losing VBG O O
27 consciousness NN B-NP O
27 She PRP O O
27 felt VBD B-VP O
27 weak JJ O O
28 throughout IN B-VP O
28 the DT B-NP O
28 week NN I-NP O
28 before IN B-VP O
28 admission NN B-NP O
28 with IN B-VP O
28 no DT B-NP O
28 vertigo NN I-NP O
28 , , O O
28 tinnitus NN B-NP O
28 , , O O
28 or CC O O
29 ataxia VB O O
29 She PRP O O
29 also RB O O
29 felt VBD B-VP O
29 paresthesias NNS B-NP O
29 of IN B-VP O
29 the DT B-NP O
29 hands NNS I-NP O
29 and CC O O
29 feet NNS B-NP O
29 but CC O O
29 not RB O O
30 perioral JJ O O
30 and CC O O
30 she PRP O O
30 also RB O O
30 experienced VBD B-VP O
30 episodes NNS B-NP O
30 of IN B-VP O
30 flushing NN B-NP O
30 and CC O O
31 tremulousness NN B-NP O
31 with IN B-VP O
31 a DT B-NP O
31 feeling NN I-NP O
31 of IN B-VP O
31 rushing VBG O O
31 sensation NN B-NP O
31 in IN B-VP O
31 the DT B-NP O
31 chest NN I-NP O
31 with IN B-VP O
32 no DT B-NP O
32 tachycardia NN I-NP O
32 associated VBN O O
32 at IN B-VP O
32 the DT B-NP O
32 time NN I-NP O
32 of IN B-VP O
32 this DT B-NP O
32 symptomatology NN I-NP O
32 She PRP O O
33 had VBD B-VP O
33 no DT B-NP O
33 fevers NNS I-NP O
33 with IN B-VP O
33 the DT B-NP O
33 sensation NN I-NP O
33 of IN B-VP O
33 flushing NN B-NP O
33 and CC O O
33 feeling NN B-NP O
33 of IN B-VP O
33 burning VBG O O
34 up RP O O
34 She PRP O O
34 had VBD B-VP O
34 several JJ B-NP O
34 bouts NNS I-NP O
34 of IN B-VP O
34 diarrhea NN B-NP O
34 intermingled VBN O O
34 with IN B-VP O
35 constipation NN B-NP O
35 On IN B-VP O
35 the DT B-NP O
35 day NN I-NP O
35 of IN B-VP O
35 admission NN B-NP O
35 , , O O
35 patient NN B-NP O
35 became VBD B-VP O
35 confused JJ O O
35 and CC O O
36 disoriented VBN O O
36 while IN B-VP O
36 driving VBG O O
36 and CC O O
36 she PRP O O
36 came VBD B-VP O
36 to TO O O
36 see VB O O
36 Dr NNP B-NP O
36 Heyn NNP I-NP O
36 in IN B-VP O
36 the DT B-NP O
37 VVH NNP I-NP O
37 Clinic NNP I-NP O
37 She PRP O O
37 was VBD B-VP O
37 admitted VBN O O
37 for IN B-VP O
37 evaluation NN B-NP O
37 of IN B-VP O
37 a DT B-NP O
37 possible JJ I-NP O
38 porphyria NN I-NP O
38 attack NN I-NP O
38 Of IN B-VP O
38 note NN B-NP O
38 , , O O
38 the DT B-NP O
38 only JJ I-NP O
38 new JJ I-NP O
38 medications NNS I-NP O
38 that IN B-VP O
38 she PRP O O
38 had VBD B-VP O
39 been VBN O O
39 taking VBG O O
39 was VBD B-VP O
39 chloral JJ B-NP B-m
39 hydrate NN I-NP I-m
39 for IN B-VP O
39 the DT O O
39 last JJ O O
39 five CD O B-du
39 days NNS B-NP I-du
39 and CC O O
40 Compazine NNP B-NP B-m
40 with IN B-VP O
40 one CD O B-do
40 dose NN B-NP I-do
41 PAST NNP I-NP O
41 MEDICAL NNP I-NP O
41 HISTORY: NNP I-NP O
41 1 CD O O
41 ) ) O O
41 Insulin NNP B-NP O
41 dependent NN I-NP O
41 diabetes VBZ O O
41 2 CD O O
41 ) ) O O
42 Coronary JJ B-NP O
42 artery NN I-NP O
42 disease NN I-NP O
42 status NN I-NP O
42 post NN I-NP O
42 PTCA NNP I-NP O
43 times NNS I-NP O
43 two CD O O
43 and CC O O
43 a DT B-NP O
43 coronary JJ I-NP O
43 artery NN I-NP O
43 bypass NN I-NP O
43 graft NN I-NP O
43 of IN B-VP O
43 the DT B-NP O
43 left JJ I-NP O
43 anterior JJ I-NP O
44 descending NN I-NP O
44 in IN B-VP O
44 3/21 CD O O
44 Exercise NN B-NP O
44 tolerance NN I-NP O
44 test NN I-NP O
44 was VBD B-VP O
44 noted VBN O O
44 before IN B-VP O
45 catheterization NN B-NP O
45 and CC O O
45 she PRP O O
45 had VBD B-VP O
45 a DT B-NP O
45 catheterization NN I-NP O
45 in IN B-VP O
45 7/14 CD O O
45 for IN B-VP O
45 angina NN B-NP O
46 She PRP O O
46 had VBD B-VP O
46 a DT B-NP O
46 patent NN I-NP O
46 LIMA NNP I-NP O
46 graft NN I-NP O
46 , , O O
46 60% CD O O
46 proximal NN B-NP O
46 left VBD B-VP O
46 anterior JJ O O
46 descending VBG O O
47 lesion NN B-NP O
47 , , O O
47 and CC O O
47 50% CD O O
47 right JJ B-NP O
47 coronary JJ I-NP O
47 artery NN I-NP O
47 stenosis NN I-NP O
47 3 CD O O
47 ) ) O O
48 Hypercholesterolemia NNP B-NP O
48 , , O O
48 did VBD B-VP O
48 not RB O O
48 tolerate VB O O
48 cholestyramine NN B-NP O
48 4 CD O O
48 ) ) O O
48 Status NNP B-NP O
49 post NN I-NP O
49 left VBD B-VP O
49 ulna JJ B-NP O
49 entrapment JJ I-NP O
49 release NN I-NP O
49 two CD O O
49 months NNS B-NP O
49 ago IN B-VP O
49 5 CD O O
49 ) ) O O
50 Hypertension NNP B-NP O
50 6 CD O O
50 ) ) O O
50 Status NNP B-NP O
50 post NN I-NP O
50 excisional JJ B-NP O
50 biopsy NN I-NP O
50 of IN B-VP O
50 the DT B-NP O
50 left NN I-NP O
50 breast; VBZ O O
50 the DT B-NP O
51 pathology NN I-NP O
51 of IN B-VP O
51 the DT B-NP O
51 lesion NN I-NP O
51 was VBD B-VP O
51 diabetic JJ B-NP O
51 mastopathy JJ I-NP O
52 ALLERGIES: NNP I-NP O
52 Morphine NNP I-NP O
52 which WDT O O
52 gave VBD B-VP O
52 her PRP O O
52 a DT B-NP O
52 rash NN I-NP O
52 and CC O O
52 patient NN B-NP O
52 avoided VBD B-VP O
53 multiple JJ B-NP O
53 medications NNS I-NP O
53 which WDT O O
53 were VBD B-VP O
53 known VBN O O
53 to TO O O
53 worsen VB O O
54 porphyria NNS B-NP O
54 such JJ O O
54 as IN B-VP O
54 sulfa NN B-NP O
54 drugs NNS I-NP O
54 ( ( O O
54 not RB O O
54 allgergies NNS B-NP O
54 ) ) O O
55 CURRENT NNP B-NP O
55 MEDICATIONS: NNP I-NP O
55 At IN B-VP O
55 home NN B-NP O
55 , , O O
55 patient JJ O O
55 took VBD B-VP O
55 insulin NN B-NP B-m
55 NPH NNP I-NP I-m
55 25 CD O B-do
55 units NNS B-NP I-do
55 in IN B-VP B-f
56 the DT B-NP O
56 morning NN I-NP O
56 with IN B-VP O
56 Regular JJ O B-m
56 10 CD O B-do
56 units NNS B-NP I-do
56 in IN B-VP B-f
56 the DT B-NP O
57 morning NN I-NP O
57 , , O O
57 aspirin RB O B-m
57 81 CD O B-do
57 mg NN B-NP I-do
57 q.d NN I-NP B-f
57 , , O O
57 Lopressor NNP B-NP B-m
57 25 CD O B-do
57 mg NN B-NP I-do
57 b.i.d NN I-NP B-f
57 , , O O
57 Compazine NNP B-NP B-m
57 5 CD O B-do
57 mg NN B-NP I-do
58 q.6h NN I-NP B-f
58 p.r.n JJ B-NP I-f
58 anxiety NN I-NP B-r
58 of IN B-VP O
58 which WDT O O
58 she PRP O O
58 took VBD B-VP O
58 only RB O O
58 one CD O O
58 dose NN B-NP O
58 , , O O
58 and CC O O
58 chloral JJ B-NP B-m
59 hydrate NN I-NP O
59 500 CD O B-do
59 to TO O I-do
59 1000 CD O I-do
59 mg NN B-NP I-do
59 q.h.s NN I-NP B-f
59 for IN B-VP B-du
59 five CD O I-du
59 days NNS B-NP I-du
60 SOCIAL NNP I-NP O
60 HISTORY: NNP I-NP O
60 Patient NNP I-NP O
60 was VBD B-VP O
60 married VBN O O
60 for IN B-VP O
60 fifteen JJ B-NP O
60 years NNS I-NP O
60 with IN B-VP O
60 one CD O O
61 son NN B-NP O
61 and CC O O
61 no DT B-NP O
61 history NN I-NP O
61 of IN B-VP O
61 smoking NN B-NP O
61 or CC O O
61 ethanol NN B-NP O
61 use NN I-NP O
62 PHYSICAL NNP I-NP O
62 EXAMINATION: NNP I-NP O
62 Patient NNP I-NP O
62 was VBD B-VP O
62 a DT B-NP O
62 pale NN I-NP O
62 and CC O O
62 anxious JJ B-NP O
62 white JJ I-NP O
62 female NN I-NP O
63 in IN B-VP O
63 no DT B-NP O
63 apparent JJ I-NP O
63 distress NN I-NP O
63 with IN B-VP O
63 a DT B-NP O
63 temperature NN I-NP O
64 of IN B-VP O
64 99.5 CD O O
64 , , O O
64 blood NN B-NP O
64 pressure NN I-NP O
64 134/70 CD O O
64 , , O O
64 heart NN B-NP O
64 rate NN I-NP O
64 of IN B-VP O
64 92 CD O O
64 , , O O
64 respiratory JJ B-NP O
64 rate NN I-NP O
65 of IN B-VP O
65 18 CD O O
65 , , O O
65 and CC O O
65 O2 NNP B-NP O
65 saturation NN I-NP O
65 of IN B-VP O
65 97% CD O O
65 on IN B-VP O
65 room NN B-NP O
65 air NN I-NP O
65 HEENT: NNP I-NP O
65 Examination NNP I-NP O
66 was VBD B-VP O
66 significant JJ O O
66 for IN B-VP O
66 oropharynx NN B-NP O
66 with IN B-VP O
66 upper JJ B-NP O
66 dentures NNS I-NP O
66 and CC O O
66 sclerae NNS B-NP O
66 were VBD B-VP O
67 anicteric JJ B-NP O
67 NECK: NNP I-NP O
67 Supple NNP I-NP O
67 with IN B-VP O
67 no DT B-NP O
67 jugular JJ I-NP O
67 venous JJ I-NP O
67 distention NN I-NP O
67 , , O O
67 no DT B-NP O
68 lymphadenopathy NN I-NP O
68 , , O O
68 and CC O O
68 thyroid NN B-NP O
68 was VBD B-VP O
68 not RB O O
68 palpable JJ B-NP O
68 CHEST: NNP I-NP O
68 Clear NNP I-NP O
68 to TO O O
69 auscultation VB O O
69 bilaterally RB O O
69 with IN B-VP O
69 no DT B-NP O
69 costovertebral JJ I-NP O
69 angle NN I-NP O
69 tenderness NN I-NP O
70 BREASTS: NNP I-NP O
70 Examination NNP I-NP O
70 was VBD B-VP O
70 notable JJ O O
70 for IN B-VP O
70 fully RB O O
70 healed VBN O O
70 scar NN B-NP O
70 of IN B-VP O
70 the DT B-NP O
70 left NN I-NP O
71 breast NN I-NP O
71 CARDIOVASCULAR: NNP I-NP O
71 Examination NNP I-NP O
71 showed VBD B-VP O
71 a DT B-NP O
71 regular JJ I-NP O
71 rate NN I-NP O
71 and CC O O
72 rhythm NN B-NP O
72 , , O O
72 normal JJ B-NP O
72 S1 NNP I-NP O
72 and CC O O
72 S2 NNP B-NP O
72 , , O O
72 and CC O O
72 2/6 CD O O
72 systolic JJ O O
72 murmur RB O O
72 heard RB O O
72 best JJS O O
72 at IN B-VP O
73 the DT B-NP O
73 apex NN I-NP O
73 ABDOMEN: NNP I-NP O
73 Soft NNP I-NP O
73 with IN B-VP O
73 good JJ B-NP O
73 bowel NN I-NP O
73 sounds NNS I-NP O
73 , , O O
73 non-tender NN B-NP O
73 , , O O
73 and CC O O
74 non-distended JJ B-NP O
74 EXTREMITIES: NNP I-NP O
74 1+ CD O O
74 pedal NN B-NP O
74 pulses NNS I-NP O
74 bilaterally RB O O
74 and CC O O
74 no DT B-NP O
75 clubbing NN I-NP O
75 , , O O
75 cyanosis NN B-NP O
75 , , O O
75 or CC O O
75 edema VB O O
75 SKIN: NNP B-NP O
75 Examination NNP I-NP O
75 showed VBD B-VP O
75 a DT B-NP O
75 blister NN I-NP O
76 of IN B-VP O
76 the DT B-NP O
76 left JJ I-NP O
76 hand NN I-NP O
76 fourth JJ O O
76 and CC O O
76 fifth JJ B-NP O
76 digit NN I-NP O
76 interspace NN I-NP O
76 and CC O O
76 healed VBD B-VP O
77 lesions NNS B-NP O
77 on IN B-VP O
77 the DT B-NP O
77 right JJ I-NP O
77 hand NN I-NP O
77 NEUROLOGICAL: NNP I-NP O
77 Examination NN I-NP O
77 showed VBD B-VP O
77 her PRP O O
78 to TO O O
78 be VB O O
78 alert JJ O O
78 and CC O O
78 oriented VBD B-VP O
78 times NNS B-NP O
78 three CD O O
78 with IN B-VP O
78 a DT B-NP O
78 normal JJ I-NP O
78 mental JJ I-NP O
78 status NN I-NP O
79 examination NN I-NP O
79 with IN B-VP O
79 no DT B-NP O
79 confusion NN I-NP O
79 noted VBD B-VP O
79 Cranial JJ B-NP O
79 nerves NNS I-NP O
79 were VBD B-VP O
79 intact JJ O O
79 , , O O
80 motor NN B-NP O
80 was VBD B-VP O
80 symmetric JJ O O
80 of IN B-VP O
80 3-4/5 JJ O O
80 on IN B-VP O
80 all DT B-NP O
80 muscle NN I-NP O
80 groups NNS I-NP O
80 , , O O
80 sensory JJ B-NP O
81 examination NN I-NP O
81 was VBD B-VP O
81 significant JJ O O
81 for IN B-VP O
81 decrease NN B-NP O
81 to TO O O
81 light JJ B-NP O
81 touch NN I-NP O
81 in IN B-VP O
81 the DT B-NP O
82 distal JJ I-NP O
82 feet NNS I-NP O
82 and CC O O
82 hands NNS B-NP O
82 , , O O
82 deep JJ B-NP O
82 tendon NN I-NP O
82 reflexes NNS I-NP O
82 were VBD B-VP O
82 symmetric JJ O O
82 and CC O O
82 1-2+ JJ O O
83 throughout IN B-VP O
83 , , O O
83 and CC O O
83 coordination NN B-NP O
83 showed VBD B-VP O
83 rapid JJ O O
83 alternating VBG O O
83 movements NNS B-NP O
83 and CC O O
84 finger-to-nose JJ O O
84 both DT O O
84 within IN B-VP O
84 normal JJ B-NP O
84 limits NNS I-NP O
84 Gait NNP I-NP O
84 was VBD B-VP O
84 mildly RB O O
84 wide JJ O O
85 based VBN O O
85 with IN B-VP O
85 normal JJ B-NP O
85 heel-to-toe JJ I-NP O
85 walk NN I-NP O
85 , , O O
85 she PRP O O
85 had VBD B-VP O
85 no DT B-NP O
85 pronator NN I-NP O
85 drift NN I-NP O
85 , , O O
85 and CC O O
86 Romberg NNP B-NP O
86 was VBD B-VP O
86 positive JJ B-NP O
87 LABORATORY NNP I-NP O
87 EXAMINATION: NNP I-NP O
87 On IN B-VP O
87 admission NN B-NP O
87 was VBD B-VP O
87 significant JJ O O
87 for IN B-VP O
87 a DT B-NP O
87 BUN NNP I-NP O
87 of IN B-VP O
88 17 CD O O
88 , , O O
88 creatinine NN B-NP O
88 of IN B-VP O
88 1.0 CD O O
88 , , O O
88 glucose NN B-NP O
88 was VBD B-VP O
88 364 CD O O
88 , , O O
89 liver JJR B-NP O
89 function NN I-NP O
89 tests NNS I-NP O
89 were VBD B-VP O
89 within IN B-VP O
89 normal JJ B-NP O
89 limits NNS I-NP O
89 , , O O
89 white JJ B-NP O
89 count NN I-NP O
89 was VBD B-VP O
90 7.2 CD O O
90 , , O O
90 hematocrit NN B-NP O
90 was VBD B-VP O
90 36 CD O O
90 , , O O
90 and CC O O
90 platelet NN B-NP O
90 count NN I-NP O
90 was VBD B-VP O
90 266 CD O O
91 HOSPITAL NNP B-NP O
91 COURSE: NNP I-NP O
91 Patient NNP I-NP O
91 was VBD B-VP O
91 admitted VBN O O
91 for IN B-VP O
91 possible JJ B-NP O
91 porphyria NN I-NP O
92 attack NN I-NP O
92 versus NN I-NP O
92 Ativan NNP I-NP B-m
92 withdrawal NN I-NP O
92 symptoms NNS I-NP O
92 versus IN B-VP O
93 anxiety NN B-NP B-r
93 attack NN I-NP I-r
93 Neurology NNP I-NP O
93 consultation NN I-NP O
93 was VBD B-VP O
93 obtained VBN O O
93 who WP O O
93 felt VBD B-VP O
93 that IN B-VP O
94 patient's JJ B-NP O
94 peripheral JJ I-NP O
94 neuropathy NN I-NP O
94 was VBD B-VP O
94 probably RB O O
94 secondary JJ O O
94 to TO O O
95 longstanding VBG O O
95 diabetes NNS B-NP O
95 but CC O O
95 felt VBD B-VP O
95 that IN B-VP O
95 some DT O O
95 of IN B-VP O
95 her PRP$ O O
95 symptomatology NN B-NP O
96 could MD O O
96 be VB O O
96 consistent JJ O O
96 with IN B-VP O
96 porphyria JJ B-NP O
96 Patient NNP I-NP O
96 was VBD B-VP O
96 also RB O O
96 seen VBN O O
96 by IN B-VP O
97 Psychiatry NNP B-NP O
97 who WP O O
97 felt VBD B-VP O
97 that IN B-VP O
97 this DT B-NP O
97 episode NN I-NP O
97 was VBD B-VP O
97 consistent JJ O O
97 with IN B-VP O
98 generalized JJ B-NP B-r
98 anxiety NN I-NP I-r
98 disorder NN I-NP I-r
98 separated VBN O O
98 by IN B-VP O
98 post NN B-NP O
98 dysthymia NN I-NP O
98 and CC O O
99 suggested VBD B-VP O
99 phenothiazines NNS B-NP B-m
99 which WDT O O
99 are VBP O O
99 proven VBN O O
99 to TO O O
99 be VB O O
99 safe JJ O O
99 in IN B-VP O
99 porphyria NN B-NP O
100 for IN B-VP O
100 treatment NN B-NP O
100 She PRP O O
100 was VBD B-VP O
100 started VBN O O
100 on IN B-VP O
100 Trilafon NNP B-NP B-m
100 2 CD O B-do
100 to TO O I-do
100 4 CD O I-do
100 mg NNS B-NP I-do
100 p.o JJ B-NP B-mo
100 p.r.n NN I-NP B-f
101 q.6h NN I-NP O
101 for IN B-VP O
101 anxiety NN B-NP B-r
101 The DT B-NP O
101 patient NN I-NP O
101 was VBD B-VP O
101 also RB O O
101 seen VBN O O
101 to TO O O
101 be VB O O
101 orthostatic JJ O O
102 which WDT O O
102 was VBD B-VP O
102 felt VBN O O
102 to TO O O
102 be VB O O
102 secondary JJ O O
102 to TO O O
102 dehydration VB O O
102 secondary JJ O O
102 to TO O O
102 poor JJ B-NP O
103 p.o NNS I-NP O
103 intake VBP O O
103 prior JJ O O
103 to TO O O
103 admission VB O O
103 She PRP O O
103 was VBD B-VP O
103 also RB O O
103 hyperglycemic JJ O O
103 on IN B-VP O
104 admission NN B-NP O
104 which WDT O O
104 may MD O O
104 have VB O O
104 contributed VBN O O
104 to TO O O
104 her PRP$ O O
104 dehydration NN B-NP O
104 She PRP O O
104 was VBD B-VP O
105 treated VBN O O
105 with IN B-VP O
105 normal JJ B-NP B-m
105 saline NN I-NP I-m
105 boluses NNS I-NP B-mo
105 and CC O O
105 her PRP$ O B-r
105 orthostasis NN B-NP I-r
105 improved VBD B-VP O
106 Her NNP B-NP O
106 Lopressor NNP I-NP B-m
106 was VBD B-VP O
106 also RB O O
106 held VBN O O
106 with IN B-VP O
106 this DT B-NP O
106 episode NN I-NP O
106 of IN B-VP O
106 orthostasis NN B-NP O
106 The DT B-NP O
107 Watson-Schwartz JJ I-NP O
107 test NN I-NP O
107 done VBN O O
107 by IN B-VP O
107 Dr NNP B-NP O
107 Mohar NNP I-NP O
107 on IN B-VP O
107 patient JJ O O
107 very RB O O
107 early RB O O
107 in IN B-VP O
107 the DT B-NP O
107 admission NN I-NP O
108 was VBD B-VP O
108 negative JJ O O
108 which WDT O O
108 made VBD B-VP O
108 an DT B-NP O
108 acute JJ I-NP O
108 porphyria NN I-NP O
108 attack NN I-NP O
108 very RB O O
109 unlikely JJ O O
109 These DT B-NP O
109 episodes NNS I-NP O
109 were VBD B-VP O
109 felt VBN O O
109 to TO O O
109 be VB O O
109 secondary JJ O O
109 to TO O O
109 a DT B-NP O
110 combination NN I-NP O
110 of IN B-VP O
110 anxiety NN B-NP O
110 attack NN I-NP O
110 and CC O O
110 rapid JJ B-NP O
110 taper NN I-NP O
110 of IN B-VP O
110 Ativan NNP B-NP B-m
110 which WDT O O
110 she PRP O O
111 had VBD B-VP O
111 been VBN O O
111 taking VBG O O
111 at IN B-VP O
111 moderately RB O O
111 high JJ B-NP B-do
111 doses NNS I-NP I-do
111 for IN B-VP O
111 the DT O O
111 last JJ O O
111 two CD O B-du
111 months NNS B-NP I-du
112 Patient NNP I-NP O
112 also RB O O
112 developed VBD B-VP O
112 urinary JJ B-NP B-r
112 tract NN I-NP I-r
112 infection NN I-NP I-r
112 symptoms NNS I-NP I-r
112 and CC O O
112 her PRP$ O O
113 urine JJ B-NP O
113 culture NN I-NP O
113 showed VBD B-VP O
113 greater JJR O O
113 than IN B-VP O
113 100 CD O O
113 , , O O
113 000 CD O O
113 colonies NNS B-NP O
113 of IN B-VP O
113 E NNP B-NP B-r
113 coli NNS I-NP I-r
113 which WDT O O
114 were VBD B-VP O
114 pansensitive JJ O O
114 She PRP O O
114 was VBD B-VP O
114 started VBN O O
114 on IN B-VP O
114 Keflex NNP B-NP B-m
114 Keflex NNP I-NP B-m
114 500 CD O B-do
114 500 CD O B-do
114 mg NN B-NP I-do
114 mg NN I-NP I-do
114 p.o NN I-NP B-mo
114 p.o NN I-NP B-mo
114 t.i.d NN I-NP B-f
114 t.i.d NN I-NP B-f
115 which WDT O O
115 is VBZ O O
115 shown VBN O O
115 to TO O O
115 be VB O O
115 safe JJ O O
115 in IN B-VP O
115 porphyria JJ B-NP O
116 DISPOSITION: NNP I-NP O
116 Patient NNP I-NP O
116 is VBZ O O
116 discharged VBN O O
116 to TO O O
116 home NN B-NP O
116 on IN B-VP O
116 August NNP B-NP O
116 in IN B-VP O
116 good JJ B-NP O
117 condition NN I-NP O
118 DISCHARGE NNP I-NP O
118 MEDICATIONS: NNP I-NP O
118 Aspirin NNP I-NP B-m
118 81 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
118 q.d NN I-NP B-f
118 , , O O
118 insulin NN B-NP B-m
118 NPH NNP I-NP I-m
118 25 CD O B-do
119 units NNS B-NP O
119 subcutaneously RB O B-mo
119 q.a.m RB O B-f
119 , , O O
119 insulin NN B-NP B-m
120 regular JJ O O
120 10 CD O B-do
120 units NNS B-NP I-do
120 subcutaneously RB O B-mo
120 q.a.m RB O B-f
120 , , O O
120 Trilafon NNP B-NP B-m
120 2 CD O B-do
120 mg NN B-NP I-do
120 p.o NN I-NP B-mo
120 q.6h NN I-NP B-f
120 , , O O
121 and CC O O
121 Keflex NNP B-NP B-m
121 500 CD O B-do
121 mg NN B-NP I-do
121 p.o NN I-NP B-mo
121 t.i.d JJ B-NP B-f
122 FOLLOW-UP: NNP I-NP O
122 Follow-up NNP I-NP O
122 will MD O O
122 be VB O O
122 with IN B-VP O
122 Dr NNP B-NP O
122 Dario NNP I-NP O
122 Rodriquz NNP I-NP O
123 Dictated NNP I-NP O
123 By: NNP I-NP O
123 BERNARD NNP I-NP O
123 SYPOLT NNP I-NP O
123 , , O O
123 M.D NNP B-NP O
123 UT0 NNP I-NP O
124 Attending: NNP I-NP O
124 JASPER NNP I-NP O
124 E NNP I-NP O
124 FIDO NNP I-NP O
124 , , O O
124 M.D NNP B-NP O
124 XK1 NNP I-NP O
125 SR568/7648 NNP I-NP O
125 Batch: NNP I-NP O
125 65143 CD O O
126 Index NNP B-NP O
126 No NNP I-NP O
126 ZIBANI61IH NNP I-NP O
126 D: NNP I-NP O
126 9/0/95 CD O O
127 T: NNP B-NP O
127 1/2/95 CD O O
128 addendum: VBD B-VP O
128 Her PRP O O
128 24 CD O O
128 hour NN B-NP O
128 urinary JJ B-NP O
128 porphobilinogen NN I-NP O
128 and CC O O
128 delta-aminolevulinic JJ B-NP O
128 acid NN I-NP O
129 were VBD B-VP O
129 both DT O O
129 normal JJ O O
129 , , O O
129 corroborating VBG O O
129 the DT B-NP O
129 Watson NNP I-NP O
129 Schwartz NNP I-NP O
129 test NN I-NP O
129 and CC O O
129 ruling VBG O O
129 out RP O O
129 an DT B-NP O
130 acute NN I-NP O
130 porphyric JJ B-NP O
130 attack NN I-NP O
131 ch97 NN I-NP O
132 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #311829 VBZ O O
2 650364230 CD O O
2 TH NNP B-NP O
2 92473563 CD O O
2 9014233 CD O O
2 0/21/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 RENAL NNP I-NP O
2 FAILURE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 5/19/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 7/14/2005 CD O O
4 ATTENDING: NNP B-NP O
4 SATERFIELD NNP I-NP O
4 , , O O
4 JAYSON NNP B-NP O
4 D NNP I-NP O
5 MEDICAL NNP I-NP O
5 SERVICE: NNP I-NP O
6 Milbrown NNP I-NP O
6 Ae NNP I-NP O
6 A NNP I-NP O
7 PRINCIPAL NNP I-NP O
7 DIAGNOSES: NNP I-NP O
8 Acute NNP I-NP O
8 renal JJ B-NP O
8 failure NN I-NP O
8 , , O O
8 anemia JJ B-NP O
9 LIST NNP I-NP O
9 OF NNP I-NP O
9 PROBLEMS/DIAGNOSES: NNP I-NP O
10 Hypertension NNP I-NP O
10 , , O O
10 family NN B-NP O
10 history NN I-NP O
10 of IN B-VP O
10 CAD NNP B-NP O
10 , , O O
10 degenerative JJ B-NP O
10 joint NN I-NP O
10 disease NN I-NP O
10 , , O O
11 depression NN B-NP O
11 , , O O
11 obstructive JJ B-NP O
11 sleep NN I-NP O
11 apnea NN I-NP O
11 , , O O
11 pulmonary JJ B-NP O
11 hypertension NN I-NP O
11 and CC O O
12 morbid JJ B-NP O
12 obesity NN I-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
14 A NNP I-NP O
14 60-year-old JJ O O
14 morbidly RB O O
14 obese JJ B-NP O
14 female NN I-NP O
14 with IN B-VP O
14 a DT B-NP O
14 history NN I-NP O
14 of IN B-VP O
15 hypertension NN B-NP O
15 , , O O
15 obstructive JJ B-NP O
15 sleep NN I-NP O
15 apnea NN I-NP O
15 , , O O
15 degenerative JJ B-NP O
15 joint NN I-NP O
16 disease NN I-NP O
16 , , O O
16 and CC O O
16 recent JJ B-NP O
16 falls NNS I-NP O
16 , , O O
16 now RB O O
16 in IN B-VP O
16 rehab NN B-NP O
16 since IN B-VP O
16 2/10 CD O O
16 , , O O
16 most RBS O O
17 recently RB O O
17 at IN B-VP O
17 Stusem NNP B-NP O
17 Memorial NNP I-NP O
17 Hospital NNP I-NP O
17 , , O O
17 who WP O O
17 presented VBD B-VP O
17 with IN B-VP O
17 acute JJ B-NP O
17 renal JJ I-NP O
17 failure NN I-NP O
18 found VBN O O
18 on IN B-VP O
18 routine JJ B-NP O
18 labs NN I-NP O
18 , , O O
18 the DT B-NP O
18 morning NN I-NP O
18 of IN B-VP O
18 admission NN B-NP O
18 The DT B-NP O
18 creatinine NN I-NP O
19 was VBD B-VP O
19 3.6 CD O O
19 on IN B-VP O
19 admission NN B-NP O
19 up IN B-VP O
19 from IN B-VP O
19 1 CD O O
19 in IN B-VP O
19 5/13 CD O O
19 and CC O O
19 up RB O O
19 from IN B-VP O
19 2.2 CD O O
19 in IN B-VP O
19 7/24 CD O O
20 BUN NNP B-NP O
20 was VBD B-VP O
20 elevated VBN O O
20 at IN B-VP O
20 96 CD O O
20 Labs NNS B-NP O
20 were VBD B-VP O
20 also RB O O
20 notable JJ O O
20 for IN B-VP O
20 hematocrit NN B-NP O
21 of IN B-VP O
21 24 CD O O
21 down IN B-VP O
21 from IN B-VP O
21 a DT B-NP O
21 baseline NN I-NP O
21 of IN B-VP O
21 44 CD O O
21 in IN B-VP O
21 2001 CD O O
21 The DT B-NP O
21 patient NN I-NP O
21 reports NNS I-NP O
22 being VBG O O
22 told VBD B-VP O
22 that IN B-VP O
22 she PRP O O
22 had VBD B-VP O
22 chronic JJ B-NP O
22 kidney NN I-NP O
22 disease NN I-NP O
22 during IN B-VP O
22 an DT B-NP O
23 admission NN I-NP O
23 to TO O O
23 SITMH NNP B-NP O
23 in IN B-VP O
23 2/10 CD O O
23 , , O O
23 attributed VBD B-VP O
23 to TO O O
23 heavy VB O O
23 NSAID NNP B-NP B-m
23 use NN I-NP O
23 in IN B-VP O
23 the DT B-NP O
24 setting NN I-NP O
24 of IN B-VP O
24 degenerative JJ B-NP B-r
24 joint JJ I-NP I-r
24 disease NN I-NP I-r
24 The DT B-NP O
24 patient NN I-NP O
24 stopped VBD B-VP O
24 using VBG O O
25 NSAIDs NNP B-NP B-m
25 in IN B-VP O
25 7/24 CD O O
25 Prior NNP B-NP O
25 to TO O O
25 July NNP B-NP O
25 , , O O
25 she PRP O O
25 reports VBZ O O
25 decreased VBD B-VP O
25 p.o NNS B-NP O
25 intake VB O O
26 in IN B-VP O
26 the DT B-NP O
26 setting NN I-NP O
26 of IN B-VP O
26 feeling VBG O O
26 like IN B-VP O
26 she PRP O O
26 was VBD B-VP O
26 retaining VBG O O
26 fluid NN B-NP O
26 Today NN I-NP O
26 , , O O
27 she PRP O O
27 complains VBZ O O
27 of IN B-VP O
27 diffuse NN B-NP O
27 swelling VBG O O
27 and CC O O
27 increased JJ B-NP O
27 shortness NN I-NP O
27 of IN B-VP O
28 breath JJ B-NP O
28 x2-3 JJ I-NP O
28 weeks NNS I-NP O
28 Denies VBZ O O
28 chest JJS B-NP O
28 pain NN I-NP O
28 , , O O
28 orthopnea NN B-NP O
28 or CC O O
28 PND NNP B-NP O
28 Also RB O O
28 , , O O
29 reports NNS B-NP O
29 dysuria NN I-NP O
29 in IN B-VP O
29 the DT B-NP O
29 setting NN I-NP O
29 of IN B-VP O
29 indwelling VBG O O
29 Foley NNP B-NP O
29 since IN B-VP O
29 7/24 CD O O
30 Denies NNPS B-NP O
30 fever NN I-NP O
30 , , O O
30 chills NNS B-NP O
30 , , O O
30 nausea NN B-NP O
30 , , O O
30 vomiting VBG O O
30 , , O O
30 abdominal JJ B-NP O
30 pain NN I-NP O
30 , , O O
30 no DT B-NP O
30 melena NN I-NP O
31 or CC O O
31 bright JJ B-NP O
31 red JJ I-NP O
31 blood NN I-NP O
31 per IN B-VP O
31 rectum NN B-NP O
31 in IN B-VP O
31 the DT O O
31 last JJ O O
31 six CD O O
31 months NNS B-NP O
31 but CC O O
31 reports NNS B-NP O
32 melena NN I-NP O
32 and CC O O
32 bright JJ B-NP O
32 red JJ I-NP O
32 blood NN I-NP O
32 per IN B-VP O
32 rectum NN B-NP O
32 intermittently RB O O
32 in IN B-VP O
32 2003 CD O O
32 in IN B-VP O
33 the DT B-NP O
33 setting NN I-NP O
33 of IN B-VP O
33 colonoscopy NN B-NP O
33 that WDT O O
33 was VBD B-VP O
33 positive JJ O O
33 for IN B-VP O
33 diverticula JJ B-NP O
34 ADMISSION NNP I-NP O
34 PHYSICAL NNP I-NP O
34 EXAM: NNP I-NP O
35 The DT B-NP O
35 patient NN I-NP O
35 was VBD B-VP O
35 afebrile JJ O O
35 with IN B-VP O
35 a DT B-NP O
35 heart NN I-NP O
35 rate NN I-NP O
35 ranging VBG O O
35 from IN B-VP O
35 60-90 JJ O O
35 , , O O
36 systolic JJ B-NP O
36 blood NN I-NP O
36 pressure NN I-NP O
36 of IN B-VP O
36 120-140 JJ O O
36 , , O O
36 respiratory JJ B-NP O
36 rate NN I-NP O
36 of IN B-VP O
36 18 CD O O
36 , , O O
36 she PRP O O
37 was VBD B-VP O
37 satting VBG O O
37 95% CD O O
37 on IN B-VP O
37 2-4 JJ B-NP O
37 liters NNS I-NP O
37 The DT B-NP O
37 patient NN I-NP O
37 was VBD B-VP O
37 obese JJ O O
37 nonmobile RB O O
37 , , O O
38 alert NN B-NP O
38 and CC O O
38 oriented VBN O O
38 x3 NN B-NP O
38 and CC O O
38 in IN B-VP O
38 no DT B-NP O
38 apparent JJ I-NP O
38 distress NN I-NP O
38 Pupils NNP I-NP O
38 were VBD B-VP O
39 equal JJ B-NP O
39 round NN I-NP O
39 and CC O O
39 reactive JJ O O
39 to TO O O
39 light JJ B-NP O
39 Sclerae NNP I-NP O
39 were VBD B-VP O
39 anicteric JJ O O
39 She PRP O O
40 had VBD B-VP O
40 no DT B-NP O
40 conjunctival JJ I-NP O
40 pallor NN I-NP O
40 JVP NNP I-NP O
40 could MD O O
40 not RB O O
40 be VB O O
40 assessed VBN O O
40 due JJ O O
40 to TO O O
41 body NN B-NP O
41 habitus VB O O
41 She PRP O O
41 had VBD B-VP O
41 a DT B-NP O
41 regular JJ I-NP O
41 rate NN I-NP O
41 and CC O O
41 rhythm NN B-NP O
41 , , O O
41 normal JJ B-NP O
41 S1 NNP I-NP O
41 and CC O O
42 S2 NNP B-NP O
42 She PRP O O
42 had VBD B-VP O
42 a DT B-NP O
42 II/VI NNP I-NP O
42 systolic JJ B-NP O
42 ejection NN I-NP O
42 murmur NN I-NP O
42 audible JJ O O
42 at IN B-VP O
42 the DT B-NP O
42 left JJ I-NP O
43 upper JJ I-NP O
43 sternal JJ I-NP O
43 border NN I-NP O
43 Lungs NNS I-NP O
43 were VBD B-VP O
43 notable JJ O O
43 for IN B-VP O
43 crackles NNS B-NP O
43 at IN B-VP O
43 the DT B-NP O
44 left JJ I-NP O
44 base NN I-NP O
44 on IN B-VP O
44 anterior JJ B-NP O
44 lung NN I-NP O
44 exam NN I-NP O
44 , , O O
44 they PRP O O
44 were VBD B-VP O
44 otherwise RB O O
44 clear JJ B-NP O
44 Her NNP I-NP O
45 abdomen NN I-NP O
45 was VBD B-VP O
45 obese JJ O O
45 , , O O
45 she PRP O O
45 had VBD B-VP O
45 positive JJ B-NP O
45 bowel NN I-NP O
45 sound VBD B-VP O
45 It PRP O O
45 was VBD B-VP O
45 soft JJ O O
45 , , O O
46 nondistended JJ O O
46 and CC O O
46 nontender JJ B-NP O
46 Extremities NNS I-NP O
46 were VBD B-VP O
46 warm JJ O O
46 and CC O O
46 well RB O O
47 perfused JJ O O
47 She PRP O O
47 had VBD B-VP O
47 2+ CD O O
47 pitting VBG O O
47 edema NN B-NP O
47 to TO O O
47 the DT B-NP O
47 knee NN I-NP O
47 bilaterally RB O O
48 Pertinent NNP B-NP O
48 lab NN I-NP O
48 results NNS I-NP O
48 as IN B-VP O
48 mentioned VBN O O
48 in IN B-VP O
48 the DT B-NP O
48 HPI NNP I-NP O
49 OPERATIONS NNP I-NP O
49 AND NNP I-NP O
49 PROCEDURES NNP I-NP O
49 DURING NNP I-NP O
49 THE NNP I-NP O
49 ADMISSION: NNP I-NP O
50 1/29/05 CD O O
50 creation NN B-NP O
50 of IN B-VP O
50 left JJ B-NP O
50 arm NN I-NP O
50 AV NNP I-NP O
50 fistula; VBD B-VP O
50 11/20/05 CD O O
50 EGD NNP B-NP O
51 HOSPITAL NNP I-NP O
51 COURSE NNP I-NP O
51 BY NNP I-NP O
51 PROBLEM: NNP I-NP O
52 In IN B-VP O
52 summary JJ O O
52 , , O O
52 this DT O O
52 is VBZ O O
52 a DT O O
52 60-year-old JJ O O
52 morbidly RB O O
52 obese JJ B-NP O
52 woman NN I-NP O
52 who WP O O
53 presented VBD B-VP O
53 with IN B-VP O
53 acute NN B-NP O
53 and CC O O
53 chronic JJ B-NP O
53 renal JJ I-NP O
53 failure NN I-NP O
53 and CC O O
53 anemia NN B-NP O
54 PROBLEM: NNP I-NP O
55 1 CD O O
55 Renal: NNP B-NP O
55 Renal NNP I-NP O
55 failure NN I-NP O
55 initially RB O O
55 thought VBD B-VP O
55 to TO O O
55 be VB O O
55 secondary JJ O O
55 to TO O O
56 prerenal JJ B-NP O
56 etiology NN I-NP O
56 in IN B-VP O
56 the DT B-NP O
56 setting NN I-NP O
56 of IN B-VP O
56 elevated JJ B-NP O
56 BUN/creatinine NNP I-NP O
56 ratio NN I-NP O
57 and CC O O
57 FENA NNP B-NP O
57 less JJR O O
57 than IN B-VP O
57 1% CD O O
57 in IN B-VP O
57 the DT B-NP O
57 setting NN I-NP O
57 of IN B-VP O
57 Lasix NNP B-NP B-m
57 and CC O O
57 FEBUN NNP B-NP O
57 of IN B-VP O
57 19% CD O O
58 and CC O O
58 because IN B-VP O
58 of IN B-VP O
58 the DT B-NP O
58 presence NN I-NP O
58 of IN B-VP O
58 abundant JJ B-NP O
58 granular JJ I-NP O
58 casts NNS I-NP O
58 ATN NNP I-NP O
58 also RB O O
59 possibility NN B-NP O
59 but CC O O
59 urine JJ B-NP O
59 sodium NN I-NP O
59 was VBD B-VP O
59 29 CD O O
59 Postrenal NNP B-NP O
59 etiology NN I-NP O
59 was VBD B-VP O
60 ruled VBN O O
60 out RP O O
60 with IN B-VP O
60 a DT B-NP O
60 renal JJ I-NP O
60 ultrasound NN I-NP O
60 without IN B-VP O
60 evidence NN B-NP O
60 of IN B-VP O
61 hydronephrosis NN B-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 was VBD B-VP O
61 aggressively RB O O
61 hydrated VBN O O
61 once RB O O
62 outside JJ B-NP O
62 hospital NN I-NP O
62 records NNS I-NP O
62 confirmed VBD B-VP O
62 an DT B-NP O
62 ejection NN I-NP O
62 fraction NN I-NP O
62 of IN B-VP O
62 60% CD O O
63 However RB O O
63 , , O O
63 the DT B-NP O
63 patient NN I-NP O
63 initially RB O O
63 appeared VBD B-VP O
63 to TO O O
63 fail VB O O
63 volume NN B-NP O
63 challenge NN I-NP O
64 with IN B-VP O
64 no DT B-NP O
64 acute JJ I-NP O
64 change NN I-NP O
64 in IN B-VP O
64 creatinine NN B-NP O
64 past IN B-VP O
64 3.2 CD O O
64 from IN B-VP O
64 2/16/05 CD O O
64 to TO O O
65 7/26/05 CD O O
65 At IN B-VP O
65 that DT B-NP O
65 time NN I-NP O
65 , , O O
65 Vascular NNP B-NP O
65 Surgery NNP I-NP O
65 was VBD B-VP O
65 consulted VBN O O
65 for IN B-VP O
65 AV NNP B-NP O
66 fistula NN I-NP O
66 placement NN I-NP O
66 in IN B-VP O
66 the DT B-NP O
66 setting NN I-NP O
66 of IN B-VP O
66 GFR NNP B-NP O
66 of IN B-VP O
66 approximately RB O O
66 17 CD O O
66 that WDT O O
67 was VBD B-VP O
67 not RB O O
67 improving VBG O O
67 AV NNP B-NP O
67 fistula NN I-NP O
67 was VBD B-VP O
67 placed VBN O O
67 on IN B-VP O
67 1/29/05 CD O O
67 in IN B-VP O
67 the DT B-NP O
67 left JJ I-NP O
68 arm NN I-NP O
68 without IN B-VP O
68 complication NN B-NP O
68 Renal NNP I-NP O
68 function NN I-NP O
68 was VBD B-VP O
68 waxing VBG O O
68 and CC O O
68 waning VBG O O
69 throughout IN B-VP O
69 hospital JJ B-NP O
69 course NN I-NP O
69 with IN B-VP O
69 creatinine NN B-NP O
69 at IN B-VP O
69 time NN B-NP O
69 of IN B-VP O
69 discharge NN B-NP O
70 of IN B-VP O
70 3.1 CD O O
70 Daily NNP B-NP O
70 urine JJ B-NP O
70 output NN I-NP O
70 usually RB O O
70 approximately RB O O
70 600-700 JJ B-NP O
70 mL NN I-NP O
71 All DT B-NP O
71 diuretics NNS I-NP B-m
71 and CC O O
71 ACE NNP B-NP B-m
71 inhibitor NN I-NP I-m
71 was VBD B-VP O
71 held VBN O O
71 throughout IN B-VP B-du
71 hospital JJ B-NP O
72 course NN I-NP O
72 and CC O O
72 blood NN B-NP O
72 pressure NN I-NP O
72 well RB O O
72 controlled VBD B-VP O
72 The DT B-NP O
72 patient NN I-NP O
72 should MD O O
73 not RB O O
73 be VB O O
73 restarted VBN O O
73 on IN B-VP O
73 these DT B-NP B-m
73 medications NNS I-NP I-m
73 because IN B-VP O
73 it PRP O O
73 will MD O O
73 precipitate VB O O
74 worsening VBG O O
74 kidney JJ B-NP O
74 failure NN I-NP O
75 2 CD O O
75 GI: NNP B-NP O
75 Colonoscopy NNP I-NP O
75 in IN B-VP O
75 2001/2003 CD O O
75 notable JJ O O
75 for IN B-VP O
75 diverticula JJ B-NP O
75 Stool NNP I-NP O
76 was VBD B-VP O
76 guaiac VBN O O
76 throughout IN B-VP O
76 hospital JJ B-NP O
76 course NN I-NP O
76 and CC O O
76 generally RB O O
76 guaiac JJ B-NP O
77 positive JJ I-NP O
77 brown JJ I-NP O
77 stool NN I-NP O
77 Hematocrit NNP I-NP O
77 did VBD B-VP O
77 not RB O O
77 bump VB O O
77 appropriately RB O O
78 after IN B-VP O
78 transfusion NN B-NP O
78 of IN B-VP O
78 4 CD O O
78 units NNS B-NP O
78 It PRP O O
78 went VBD B-VP O
78 from IN B-VP O
78 23.3-30 JJ B-NP O
78 GI NNP I-NP O
78 was VBD B-VP O
79 consulted VBN O O
79 in IN B-VP O
79 this DT B-NP O
79 setting NN I-NP O
79 and CC O O
79 plans NNS B-NP O
79 were VBD B-VP O
79 made VBN O O
79 for IN B-VP O
79 EGD NNP B-NP O
79 and CC O O
80 colonoscopy NN B-NP O
80 to TO O O
80 look VB O O
80 for IN B-VP O
80 a DT B-NP O
80 source NN I-NP O
80 of IN B-VP O
80 GI NNP B-NP O
80 bleed VBD B-VP O
80 Both DT B-NP O
80 procedures NNS I-NP O
81 were VBD B-VP O
81 scheduled VBN O O
81 in IN B-VP O
81 OR NNP B-NP O
81 and CC O O
81 attempted VBN O O
81 on IN B-VP O
81 5/3/05 CD O O
81 EGD NNP B-NP O
81 successfully RB O O
82 performed VBD B-VP O
82 with IN B-VP O
82 evidence NN B-NP O
82 of IN B-VP O
82 gastritis NN B-NP O
82 , , O O
82 nonbleeding VBG O O
82 ulcer NN B-NP O
82 , , O O
82 and CC O O
83 duodenal JJ B-NP O
83 mass NN I-NP O
83 with IN B-VP O
83 gastric JJ B-NP O
83 heterotopia NN I-NP O
83 H NNP I-NP O
83 pylori VBZ O O
83 stool JJ B-NP O
83 antigen NN I-NP O
84 and CC O O
84 H NNP B-NP O
84 pylori JJ B-NP O
84 biopsies NNS I-NP O
84 negative JJ B-NP O
84 Patient NNP I-NP O
84 continued VBD B-VP O
84 on IN B-VP O
84 Nexium NNP B-NP B-m
84 40 CD O B-do
85 mg JJ B-NP O
85 daily JJ I-NP B-f
85 Colonoscopy NNP I-NP O
85 not RB O O
85 obtained VBD B-VP O
85 unable JJ O O
85 to TO O O
85 get VB O O
85 past IN B-VP O
85 the DT B-NP O
85 rectum NN I-NP O
86 in IN B-VP O
86 the DT B-NP O
86 setting NN I-NP O
86 of IN B-VP O
86 required VBN O O
86 general JJ B-NP O
86 anesthesia/ETT NN I-NP O
86 in IN B-VP O
86 patient's NN B-NP O
87 thighs NNS I-NP O
88 3 CD O O
88 Cardiovascular/Pump NNP B-NP O
88 - : O O
88 ECHO NN B-NP O
88 with IN B-VP O
88 EF NNP B-NP O
88 equal JJ O O
88 to TO O O
88 65% CD O O
88 here RB O O
88 , , O O
89 moderate JJ B-NP O
89 diastolic JJ I-NP O
89 dysfunction NN I-NP O
89 and CC O O
89 moderate JJ B-NP O
89 pulmonary JJ I-NP O
90 hypertension NN I-NP O
90 No NNP I-NP O
90 rhythm NN I-NP O
90 or CC O O
90 ischemia NN B-NP O
90 issues NNS I-NP O
90 during IN B-VP O
90 hospital JJ B-NP O
91 course NN I-NP O
91 , , O O
91 low JJ B-NP O
91 HDL NNP I-NP O
91 , , O O
91 started VBD B-VP O
91 on IN B-VP O
91 statin NN B-NP B-m
92 4 CD O O
92 Heme/normocytic NNP B-NP O
92 anemia NN I-NP O
92 , , O O
92 likely RB O O
92 secondary JJ O O
92 to TO O O
92 GI NNP B-NP O
92 bleed NN I-NP O
92 with IN B-VP O
93 evidence NN B-NP O
93 of IN B-VP O
93 iron NN B-NP O
93 deficiency NN I-NP O
93 Iron NNP I-NP O
93 stores NNS I-NP O
93 repleted VBD B-VP O
93 with IN B-VP O
93 IV NNP B-NP B-mo
93 iron NN I-NP B-m
93 , , O O
94 also RB O O
94 possible JJ B-NP O
94 anemia NN I-NP O
94 in IN B-VP O
94 setting VBG O O
94 of IN B-VP O
94 low JJ B-NP O
94 EPO NNP I-NP O
94 EPO NNP I-NP O
94 level NN I-NP O
94 checked VBD B-VP O
95 low JJ O O
95 and CC O O
95 normal JJ O O
95 , , O O
95 may MD O O
95 ultimately RB O O
95 benefit VB O O
95 from IN B-VP O
95 Epogen NNP B-NP B-m
95 On IN B-VP O
95 Coumadin NNP B-NP B-m
96 for IN B-VP O
96 DVT NNP B-NP B-r
96 prophylaxis/paroxysmal JJ B-NP I-r
96 a-fib JJ I-NP I-r
96 prior NN I-NP O
96 to TO O O
96 arrival VB O O
97 Supratherapeutic NNP B-NP O
97 on IN B-VP O
97 admission NN B-NP O
97 , , O O
97 so RB O O
97 Coumadin JJ B-NP B-m
97 held NN I-NP O
97 in IN B-VP O
97 the DT B-NP O
97 setting NN I-NP O
97 of IN B-VP O
98 GI NNP B-NP O
98 bleed NN I-NP O
98 until IN B-VP B-du
98 INR NNP B-NP I-du
98 1.5 CD O I-du
98 , , O O
98 then RB O O
98 patient NN B-NP O
98 was VBD B-VP O
98 covered VBN O O
98 with IN B-VP O
99 subcutaneous JJ B-NP B-mo
99 heparin NN I-NP B-m
99 for IN B-VP O
99 DVT NNP B-NP B-r
99 prophylaxis NN I-NP I-r
99 However RB O O
99 , , O O
99 acute JJ B-NP O
99 drop NN I-NP O
99 in IN B-VP O
100 platelets NNS B-NP O
100 in IN B-VP O
100 the DT B-NP O
100 setting NN I-NP O
100 of IN B-VP O
100 heparin NN B-NP B-m
100 from IN B-VP O
100 the DT O O
100 200s CD O O
100 to TO O O
100 the DT O O
100 30s CD O O
100 , , O O
100 so RB O O
101 heparin JJ O B-m
101 stopped VBD B-VP O
101 PF4 NNP B-NP O
101 antibody NN I-NP O
101 negative JJ B-NP O
101 x1 NN I-NP O
101 and CC O O
101 borderline NN B-NP O
101 x1 NNP I-NP O
102 PF4 NNP I-NP O
102 antibody NN I-NP O
102 pending VBG O O
102 at IN B-VP O
102 the DT B-NP O
102 time NN I-NP O
102 of IN B-VP O
102 discharge NN B-NP O
102 , , O O
102 but CC O O
102 all DT B-NP O
102 heparin JJ I-NP B-m
103 products NNS I-NP O
103 including VBG O O
103 flush NN B-NP O
103 is VBZ O O
103 held VBN O O
103 The DT B-NP O
103 patient NN I-NP O
103 restarted VBN O O
103 on IN B-VP O
104 Coumadin NNP B-NP B-m
104 after IN B-VP O
104 EGD NNP B-NP O
104 at IN B-VP O
104 12.5 CD O B-do
104 mg NNS B-NP I-do
104 a DT B-NP B-f
104 day NN I-NP I-f
104 Status NNP I-NP O
104 post NN I-NP O
104 three CD O O
104 doses NNS B-NP O
104 , , O O
105 INR NNP B-NP O
105 was VBD B-VP O
105 2 CD O O
105 Target NNP B-NP O
105 INR NNP I-NP O
105 is VBZ O O
105 2-2.5 JJ O O
105 and CC O O
105 the DT B-NP O
105 patient NN I-NP O
105 will MD O O
105 be VB O O
105 followed VBN O O
106 at IN B-VP O
106 the DT B-NP O
106 Tarbripin NNP I-NP O
106 Of IN B-VP O
106 Anticoagulation NNP B-NP O
106 Clinic NNP I-NP O
106 , , O O
106 phone NN B-NP O
107 number NN I-NP O
107 is VBZ O O
107 300-135-5841 JJ B-NP O
107 INRs NNP I-NP O
107 can MD O O
107 be VB O O
107 faxed VBN O O
107 to TO O O
107 clinic VB O O
107 from IN B-VP O
107 rehab NN B-NP O
108 and CC O O
108 adjustments NNS B-NP O
108 in IN B-VP O
108 doses NNS B-NP O
108 can MD O O
108 be VB O O
108 made VBN O O
108 accordingly RB O O
109 5 CD O O
109 Endo: NNP B-NP O
109 TSH NNP I-NP O
109 within IN B-VP O
109 normal JJ B-NP O
109 limits NNS I-NP O
109 Hemoglobin NNP I-NP O
109 A1c NNP I-NP O
109 5.5 CD O O
109 , , O O
109 so RB O O
109 no DT B-NP O
110 evidence NN I-NP O
110 of IN B-VP O
110 diabetes NNS B-NP O
111 6 CD O O
111 ID: NNP B-NP O
111 UTI/proteus NNP I-NP O
111 , , O O
111 levofloxacin VBZ O B-m
111 renally RB O B-do
111 dosed VBN O I-do
111 Repeat NNP B-NP O
111 urine JJ B-NP O
112 dirty NN I-NP O
112 , , O O
112 so RB O O
112 p.o JJ B-NP B-mo
112 Cipro NNP I-NP B-m
112 started VBD B-VP O
112 for IN B-VP O
112 empiric JJ B-NP O
112 treatment NN I-NP O
112 of IN B-VP O
112 UTI NNP B-NP B-r
112 in IN B-VP O
113 setting VBG O O
113 of IN B-VP O
113 indwelling VBG O O
113 Foley NNP B-NP O
113 Two CD O O
113 days NNS B-NP O
113 prior RB O O
113 to TO O O
113 discharge VB O O
113 , , O O
113 the DT B-NP O
114 patient NN I-NP O
114 with IN B-VP O
114 low-grade JJ B-NP O
114 temp NN I-NP O
114 to TO O O
114 max VB O O
114 100.4 CD O O
114 Chest NNP B-NP O
114 x-ray NN I-NP O
114 unchanged JJ O O
115 but CC O O
115 only RB O O
115 portable JJ B-NP O
115 chest JJS I-NP O
115 x-ray NN I-NP O
115 was VBD B-VP O
115 obtained VBN O O
115 due JJ O O
115 to TO O O
115 patient's VB O O
116 immobility NN B-NP O
116 , , O O
116 blood NN B-NP O
116 cultures NNS I-NP O
116 and CC O O
116 urine JJ B-NP O
116 cultures NNS I-NP O
116 were VBD B-VP O
116 negative JJ B-NP O
117 Empirically NNP I-NP O
117 treating VBG O O
117 for IN B-VP O
117 nosocomial JJ B-NP B-r
117 pneumonia NN I-NP I-r
117 with IN B-VP O
117 p.o JJ B-NP B-mo
118 levo/cefpodox/azithro JJ I-NP B-m
118 x10 NNP I-NP B-du
118 days NNS I-NP I-du
118 , , O O
118 PICC NNP B-NP O
118 line NN I-NP O
118 in IN B-VP O
118 place NN B-NP O
118 at IN B-VP O
118 time NN B-NP O
118 of IN B-VP O
119 discharge NN B-NP O
119 However RB O O
119 , , O O
119 it PRP O O
119 should MD O O
119 be VB O O
119 discontinued VBN O O
119 by IN B-VP O
119 2/22/05 CD O O
119 to TO O O
120 prevent VB O O
120 infection NN B-NP O
121 7 CD O O
121 Allergy: NNP B-NP O
121 Postnasal NNP I-NP O
121 drip VBZ O O
121 Rhinorrhea NNP B-NP O
121 Continued NNP I-NP O
121 Claritin NNP I-NP B-m
122 and CC O O
122 Flonase NNP B-NP B-m
123 8 CD O O
123 Psyche: NNP B-NP O
123 Zoloft NNP I-NP B-m
123 continued VBD B-VP O
123 for IN B-VP O
123 depression NN B-NP B-r
124 9 CD O O
124 Pulmonary: NNP B-NP O
124 Intermittent NNP I-NP O
124 , , O O
124 the DT B-NP O
124 patient NN I-NP O
124 intermittently RB O O
125 desaturates VBZ O O
125 on IN B-VP O
125 room NN B-NP O
125 air NN I-NP O
125 to TO O O
125 80s CD O O
125 but CC O O
125 always RB O O
125 resolved VBD B-VP O
125 with IN B-VP O
126 repositioning NN B-NP O
126 and CC O O
126 O2 NNP B-NP O
126 Likely NNP I-NP O
126 secondary JJ O O
126 to TO O O
126 respiratory VB O O
126 muscle NN B-NP O
127 deconditioning VBG O O
127 and CC O O
127 to TO O O
127 restrictive VB O O
127 lung NN B-NP O
127 disease NN I-NP O
127 in IN B-VP O
127 the DT B-NP O
127 setting NN I-NP O
127 of IN B-VP O
128 morbid NN B-NP O
128 obesity NN I-NP O
128 Continuing NNP I-NP O
128 Flovent NNP I-NP B-m
128 for IN B-VP O
128 asthma NN B-NP B-r
128 and CC O O
128 albuterol NN B-NP B-m
128 nebs VBP O I-m
129 p.r.n NN B-NP B-f
129 for IN B-VP O
129 wheezing VBG O B-r
129 Continue NNP B-NP O
129 CPAP NNP I-NP O
129 at IN B-VP O
129 night NN B-NP O
129 for IN B-VP O
129 obstructive JJ B-NP O
130 sleep NN I-NP O
130 apnea NN I-NP O
131 10 CD O O
131 Oncology: NNP B-NP O
131 History NNP I-NP O
131 of IN B-VP O
131 breast NN B-NP O
131 mass NN I-NP O
131 last JJ O O
131 evaluated VBD B-VP O
131 in IN B-VP O
131 6/7 CD O O
131 at IN B-VP O
132 which WDT O O
132 time NN B-NP O
132 the DT B-NP O
132 risk NN I-NP O
132 of IN B-VP O
132 surgery NN B-NP O
132 would MD O O
132 determine VB O O
132 to TO O O
132 be VB O O
132 greater JJR O O
132 than IN B-VP O
133 the DT B-NP O
133 possible JJ I-NP O
133 risk NN I-NP O
133 of IN B-VP O
133 breast NN B-NP O
133 cancer NN I-NP O
133 Oncology NNP I-NP O
133 not RB O O
133 able JJ O O
133 to TO O O
133 see VB O O
134 patient JJ O O
134 during IN B-VP O
134 inpatient JJ B-NP O
134 stay NN I-NP O
134 but CC O O
134 will MD O O
134 schedule VB O O
134 outpatient JJ B-NP O
135 followup NN I-NP O
135 regarding VBG O O
135 the DT B-NP O
135 issue NN I-NP O
135 of IN B-VP O
135 possible JJ B-NP O
135 treatment NN I-NP O
135 with IN B-VP O
136 tamoxifen JJ O B-m
137 11 CD O O
137 FEN: NNP B-NP O
137 Gentle NNP I-NP O
137 bowel NN I-NP B-m
137 regimen NNS I-NP I-m
137 , , O O
137 renal JJ B-NP O
137 diet JJ I-NP O
138 CODE NNP I-NP O
138 STATUS: NNP I-NP O
139 Full NNP I-NP O
140 KEY NNP I-NP O
140 FEATURES NNP I-NP O
140 OF NNP I-NP O
140 PHYSICAL NNP I-NP O
140 EXAM NNP I-NP O
140 AT NNP I-NP O
140 THE NNP I-NP O
140 TIME NNP I-NP O
140 OF NNP I-NP O
140 DISCHARGE: NNP I-NP O
141 Essentially NNP I-NP O
141 unchanged JJ O O
141 from IN B-VP O
141 admission NN B-NP O
142 DISCHARGE NNP I-NP O
142 MEDICATIONS: NNP I-NP O
143 Include NNP I-NP O
143 Tylenol NNP I-NP B-m
143 650 CD O B-do
143 mg NN B-NP I-do
143 p.o NN I-NP B-mo
143 q.4h NN I-NP B-f
143 p.r.n NN I-NP I-f
143 , , O O
143 albuterol VB O B-m
143 albuterol JJ B-NP B-m
143 nebulizer JJ I-NP I-m
143 nebulizer NN I-NP I-m
143 2.5 CD O B-do
143 2.5 CD O B-do
144 mg NN B-NP O
144 inhaled VBD B-VP B-mo
144 inhaled JJ B-NP B-mo
144 q.6h NN I-NP B-f
144 q.6h NN I-NP B-f
144 p.r.n NN I-NP I-f
144 p.r.n NN I-NP I-f
144 for IN B-VP O
144 shortness NN B-NP B-r
144 of IN B-VP I-r
144 breath NN B-NP I-r
144 and CC O O
144 wheezing NN B-NP B-r
144 , , O O
145 ECASA NNP B-NP B-m
145 81 CD O B-do
145 mg NN B-NP I-do
145 p.o JJ O B-mo
145 daily RB O B-f
145 , , O O
145 PhosLo NNP B-NP B-m
145 667 CD O B-do
145 mg NN B-NP I-do
145 p.o NN I-NP B-mo
145 t.i.d NN I-NP B-f
145 , , O O
145 Catapres VBZ O B-m
145 0.1 CD O B-do
146 mg NN B-NP O
146 per IN B-VP B-f
146 day NN B-NP I-f
146 q JJ O I-f
146 weekly RB O I-f
146 , , O O
146 Colace NNP B-NP B-m
146 100 CD O B-do
146 mg NN B-NP I-do
146 p.o NN I-NP B-mo
146 b.i.d NN I-NP B-f
146 , , O O
146 metoprolol JJ B-NP B-m
147 tartarate NN I-NP O
147 25 CD O B-do
147 mg NN B-NP I-do
147 p.o NN I-NP B-mo
147 b.i.d NN I-NP B-f
147 , , O O
147 senna JJ B-NP B-m
147 tablets NNS I-NP I-m
147 two CD O B-do
147 tabs NNS B-NP I-do
147 p.o VBP O B-mo
147 b.i.d JJ B-NP B-f
148 p.r.n NN I-NP O
148 for IN B-VP O
148 constipation NN B-NP B-r
148 , , O O
148 ocean JJ B-NP B-m
148 spray NN I-NP I-m
148 two CD O B-do
148 sprays NNS B-NP I-do
148 inhaled VBD B-VP B-mo
148 q.i.d JJ B-NP B-f
149 p.r.n NN I-NP O
149 for IN B-VP O
149 dry JJ B-NP B-r
149 nose NN I-NP I-r
149 , , O O
149 Coumadin NNP B-NP B-m
149 12.5 CD O B-do
149 mg NN B-NP I-do
149 p.o NN I-NP B-mo
149 q.p.m NN I-NP B-f
149 , , O O
149 Zoloft NNP B-NP B-m
149 50 CD O B-do
149 mg NN B-NP I-do
150 p.o NN I-NP B-mo
150 q.a.m NN I-NP B-f
150 , , O O
150 azithromycin RB O B-m
150 250 CD O B-do
150 mg NNS B-NP I-do
150 p.o JJ B-NP B-mo
150 daily JJ I-NP B-f
150 x10 NNP I-NP B-du
150 days NNS I-NP I-du
150 , , O O
150 simvastatin JJ O B-m
151 20 CD O B-do
151 mg NN B-NP I-do
151 p.o NN I-NP B-mo
151 at IN B-VP B-f
151 bedtime NN B-NP I-f
151 , , O O
151 doxazosin VBZ O B-m
151 2 CD O B-do
151 mg NN B-NP I-do
151 p.o NN I-NP B-mo
151 b.i.d NN I-NP B-f
151 , , O O
151 Norvasc NNP B-NP B-m
151 5 CD O B-do
151 mg NN B-NP I-do
152 p.o JJ O B-mo
152 daily RB O B-f
152 , , O O
152 Claritin NNP B-NP B-m
152 10 CD O B-do
152 mg NN B-NP I-do
152 p.o JJ O B-mo
152 daily RB O B-f
152 , , O O
152 Flovent NNP B-NP B-m
152 110 CD O B-do
152 mcg NN B-NP I-do
152 inhaled VBD B-VP B-mo
153 b.i.d NN B-NP B-f
153 , , O O
153 cefpodoxime NN B-NP B-m
153 proxetil NN I-NP I-m
153 200 CD O B-do
153 mg NN B-NP I-do
153 p.o NN I-NP B-mo
153 b.i.d NN I-NP B-f
153 x10 NNP I-NP B-du
153 days NNS I-NP I-du
153 , , O O
153 Flonase NNP B-NP B-m
154 one CD O B-do
154 spray NN B-NP I-do
154 daily RB O B-f
154 , , O O
154 levofloxacin VBD B-VP B-m
154 250 CD O B-do
154 mg NN B-NP I-do
154 p.o NN I-NP B-mo
154 q.24 NN I-NP B-f
154 x10 NN I-NP B-du
154 doses NNS I-NP I-du
154 , , O O
154 and CC O O
155 Nexium NNP B-NP B-m
155 40 CD O B-do
155 mg NN B-NP I-do
155 p.o NN I-NP B-mo
155 b.i.d NN I-NP B-f
156 DISPOSITION: NNP I-NP O
157 To TO O O
157 rehab VB O O
157 facility NN B-NP O
158 FOLLOWUP: NNP I-NP O
159 Follow NNP I-NP O
159 up RP O O
159 with IN B-VP O
159 patient's NN B-NP O
159 primary JJ B-NP O
159 care NN I-NP O
159 doctor NN I-NP O
159 , , O O
159 Dr NNP B-NP O
159 Gleen NNP I-NP O
159 , , O O
159 and CC O O
160 oncologist NN B-NP O
160 to TO O O
160 be VB O O
160 arranged VBN O O
160 , , O O
160 dates NNS B-NP O
160 of IN B-VP O
160 appointments NNS B-NP O
160 will MD O O
160 be VB O O
161 forwarded VBN O O
161 to TO O O
161 rehab VB O O
161 facility NN B-NP O
162 eScription NN I-NP O
162 document: VBZ O O
162 3-0977712 JJ B-NP O
162 EMSSten NNP I-NP O
162 Tel NNP I-NP O
163 CC: NNP I-NP O
163 Carlton NNP I-NP O
163 Ahlstedt NNP I-NP O
163 M.D NNP I-NP O
164 Dictated NNP I-NP O
164 By: NNP I-NP O
164 LAURION NNP I-NP O
164 , , O O
164 ROBERT NNP B-NP O
165 Attending: NNP I-NP O
165 GOROVITZ NNP I-NP O
165 , , O O
165 EDGAR NNP B-NP O
166 Dictation NNP I-NP O
166 ID NNP I-NP O
166 9670631 CD O O
167 D: NNP B-NP O
167 9/20/05 CD O O
168 T: NNP B-NP O
168 9/20/05 CD O O
169 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #312736 VBZ O O
4 877940312 CD O O
4 NCMH NNP B-NP O
4 67382759 CD O O
4 732707 CD O O
4 6/17/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 AORTIC NNP I-NP O
4 STENOSIS NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/10/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/20/2001 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 The DT B-NP O
7 patient NN I-NP O
7 is VBZ O O
7 a DT O O
7 74 CD O O
7 year-old JJ B-NP O
7 gentleman NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
8 history NN I-NP O
8 of IN B-VP O
8 aortic JJ B-NP O
8 stenosis NN I-NP O
8 , , O O
9 non-insulin JJ B-NP O
9 dependent NN I-NP O
9 diabetes VBZ O O
9 mellitus RBS O O
9 , , O O
9 hypertension NN B-NP O
9 and CC O O
10 hypercholesterolemia NN B-NP O
10 who WP O O
10 is VBZ O O
10 preop NN B-NP O
10 for IN B-VP O
10 a DT B-NP O
10 cardiac JJ I-NP O
10 catheterization NN I-NP O
10 and CC O O
11 aortic JJ B-NP O
11 valve NN I-NP O
11 replacement NN I-NP O
11 to TO O O
11 be VB O O
11 admitted VBN O O
11 on IN B-VP O
11 July NNP B-NP O
11 , , O O
11 2001 CD O O
11 He PRP O O
12 has VBZ O O
12 had VBD B-VP O
12 an DT B-NP O
12 echocardiogram NN I-NP O
12 which WDT O O
12 demonstrates VBZ O O
12 severe JJ B-NP O
12 aortic JJ I-NP O
12 stenosis NN I-NP O
13 with IN B-VP O
13 mitral JJ B-NP O
13 annular JJ I-NP O
13 calcification NN I-NP O
13 , , O O
13 left VBD B-VP O
13 ventricular JJ B-NP O
13 hypertrophy NN I-NP O
13 and CC O O
14 1+ CD O O
14 aortic JJ B-NP O
14 insufficiency NN I-NP O
14 , , O O
14 also RB O O
14 mild JJ B-NP O
14 tricuspid JJ I-NP O
14 regurgitation NN I-NP O
14 and CC O O
15 ejection NN B-NP O
15 fraction NN I-NP O
15 of IN B-VP O
15 55% CD O O
16 PAST NNP B-NP O
16 MEDICAL NNP I-NP O
16 HISTORY: NNP I-NP O
16 Notable NNP I-NP O
16 for IN B-VP O
16 non-insulin JJ B-NP O
16 dependent NN I-NP O
16 diabetes VBZ O O
17 mellitus RBS O O
17 , , O O
17 depression NN B-NP O
17 , , O O
17 hypertension NN B-NP O
17 , , O O
18 hypercholesterolemia NN B-NP O
18 , , O O
18 and CC O O
18 gout NN B-NP O
19 ALLERGIES: NNP I-NP O
19 The DT B-NP O
19 patient NN I-NP O
19 had VBD B-VP O
19 no DT O O
19 known VBN O O
19 drug NN B-NP O
19 allergies NNS I-NP O
20 MEDICATIONS NNP I-NP O
20 ON NNP I-NP O
20 ADMISSION: NNP I-NP O
20 1 CD O O
20 ) ) O O
20 Simvastatin NNP B-NP B-m
20 2 CD O O
20 ) ) O O
20 Lopressor NNP B-NP B-m
20 50 CD O B-do
20 mg NN B-NP I-do
21 p.o NN I-NP B-mo
21 b.i.d IN B-VP B-f
21 3 CD O O
21 ) ) O O
21 Allopurinol $ O B-m
21 300 CD O B-do
21 mg NN B-NP I-do
21 once RB O B-f
22 a DT B-NP O
22 day NN I-NP O
22 4 CD O O
22 ) ) O O
22 Lasix FW O B-m
22 40 CD O B-do
22 mg NN B-NP I-do
22 three CD O B-f
22 times NNS B-NP I-f
22 a DT B-NP I-f
22 day NN I-NP I-f
22 5 CD O O
22 ) ) O O
22 Captopril NNP B-NP B-m
22 6 CD O O
22 ) ) O O
23 Potassium NNP B-NP B-m
23 replacement NN I-NP I-m
23 7 CD O O
23 ) ) O O
23 Multivitamin NNP B-NP B-m
24 PHYSICAL NNP I-NP O
24 EXAMINATION: NNP I-NP O
24 His PRP$ O O
24 examination NN B-NP O
24 is VBZ O O
24 unremarkable JJ O O
24 He PRP O O
24 has VBZ O O
24 a DT B-NP O
25 right JJ I-NP O
25 carotid NN I-NP O
25 bruit NN I-NP O
25 and CC O O
25 palpable JJ B-NP O
25 distal JJ I-NP O
26 pulses NNS I-NP O
26 CHEST: NNP I-NP O
26 Clear NNP I-NP O
26 ABDOMEN: NNP I-NP O
26 Soft NNP I-NP O
26 EXTREMITY: NNP I-NP O
26 No NNP I-NP O
26 lower JJR B-NP O
27 extremity NN I-NP O
27 edema VBP O O
28 HOSPITAL NNP B-NP O
28 COURSE: NNP I-NP O
28 He PRP O O
28 is VBZ O O
28 seen VBN O O
28 in IN B-VP O
28 consultation NN B-NP O
28 by IN B-VP O
28 Oral NNP B-NP O
28 Medicine NNP I-NP O
28 for IN B-VP O
29 carious JJ B-NP O
29 teeth NNS I-NP O
29 since IN B-VP O
29 he PRP O O
29 is VBZ O O
29 preopped VBN O O
29 for IN B-VP O
29 aortic JJ B-NP O
30 valve NN I-NP O
30 replacement NN I-NP O
30 and CC O O
30 he PRP O O
30 was VBD B-VP O
30 cleared VBN O O
30 by IN B-VP O
30 the DT B-NP O
30 dentist NN I-NP O
30 for IN B-VP O
30 this DT B-NP O
31 procedure NN I-NP O
31 He PRP O O
31 went VBD B-VP O
31 to TO O O
31 the DT B-NP O
31 cardiac JJ I-NP O
31 catheterization NN I-NP O
31 laboratory NN I-NP O
31 where WRB O O
32 he PRP O O
32 underwent JJ B-NP O
32 coronary JJ I-NP O
32 arteriography NN I-NP O
32 on IN B-VP O
32 June NNP B-NP O
32 , , O O
32 2001 CD O O
32 His PRP$ O O
33 aortic JJ B-NP O
33 valve NN I-NP O
33 area NN I-NP O
33 had VBD B-VP O
33 been VBN O O
33 calculated VBN O O
33 at IN B-VP O
33 echocardiogram NN B-NP O
33 at IN B-VP O
33 0.7 CD O O
33 cm NN B-NP O
34 squared VBD B-VP O
34 His PRP$ O O
34 coronary JJ B-NP O
34 arteriogram NN I-NP O
34 demonstrated VBD B-VP O
34 a DT O O
34 50% CD O O
34 lesion NN B-NP O
34 of IN B-VP O
34 his PRP$ O O
35 left JJ O O
35 anterior JJ O O
35 descending VBG O O
35 coronary JJ B-NP O
35 artery NN I-NP O
35 , , O O
35 60% CD O O
35 second JJ B-NP O
35 diagonal NN I-NP O
35 and CC O O
35 a DT O O
36 60% CD O O
36 lesion NN B-NP O
36 of IN B-VP O
36 the DT B-NP O
36 right JJ I-NP O
36 coronary JJ I-NP O
36 artery NN I-NP O
36 He PRP O O
36 underwent JJ B-NP O
36 preop JJ I-NP O
37 carotid NN I-NP O
37 ultrasound NN I-NP O
37 for IN B-VP O
37 the DT B-NP O
37 carotid NN I-NP O
37 bruit NN I-NP O
37 that WDT O O
37 was VBD B-VP O
37 noted VBN O O
37 and CC O O
37 he PRP O O
37 had VBD B-VP O
38 insignificant JJ B-NP O
38 carotid NN I-NP O
38 disease NN I-NP O
38 by IN B-VP O
38 doppler NN B-NP O
38 He PRP O O
38 went VBD B-VP O
38 to TO O O
38 the DT B-NP O
38 operating NN I-NP O
39 room NN I-NP O
39 on IN B-VP O
39 July NNP B-NP O
39 , , O O
39 2001 CD O O
39 where WRB O O
39 he PRP O O
39 underwent JJ B-NP O
39 aortic JJ I-NP O
39 valve NN I-NP O
40 replacement NN I-NP O
40 with IN B-VP O
40 a DT B-NP O
40 #23 JJ I-NP O
40 Carpentier-Edwards NNP I-NP O
40 bioprosthetic JJ B-NP O
40 valve NN I-NP O
40 and CC O O
41 coronary JJ B-NP O
41 artery NN I-NP O
41 bypass NN I-NP O
41 grafting VBG O O
41 times NNS B-NP O
41 two CD O O
41 with IN B-VP O
41 saphenous JJ B-NP O
41 vein NN I-NP O
41 graft NN I-NP O
42 to TO O O
42 the DT O O
42 left VBN O O
42 anterior JJ O O
42 descending VBG O O
42 coronary JJ B-NP O
42 artery NN I-NP O
42 and CC O O
42 the DT B-NP O
42 saphenous JJ I-NP O
43 vein NN I-NP O
43 graft NN I-NP O
43 to TO O O
43 the DT O O
43 posterior JJ O O
43 descending VBG O O
43 The DT B-NP O
43 intraoperative JJ I-NP O
43 course NN I-NP O
44 was VBD B-VP O
44 unremarkable JJ O O
44 His PRP$ O O
44 postoperative JJ B-NP O
44 course NN I-NP O
44 was VBD B-VP O
44 complicated VBN O O
44 only RB O O
44 by IN B-VP O
45 mild JJ B-NP O
45 confusion NN I-NP O
45 which WDT O O
45 has VBZ O O
45 cleared VBN O O
45 and CC O O
45 the DT B-NP O
45 patient NN I-NP O
45 is VBZ O O
45 alert JJ O O
45 and CC O O
46 oriented VBD B-VP O
46 He PRP O O
46 is VBZ O O
46 to TO O O
46 be VB O O
46 discharged VBN O O
46 to TO O O
46 rehabilitation VB O O
46 in IN B-VP O
46 good JJ B-NP O
47 condition NN I-NP O
47 on IN B-VP O
47 the DT B-NP O
47 following JJ I-NP O
47 medications NNS I-NP O
48 MEDICATIONS NNP I-NP O
48 ON NNP I-NP O
48 DISCHARGE: NNP I-NP O
48 1 CD O O
48 ) ) O O
48 Enteric NNP B-NP B-m
48 coated VBD B-VP I-m
48 aspirin RB O I-m
48 325 CD O B-do
48 mg NNS B-NP I-do
48 p.o JJ B-NP B-mo
49 q JJ I-NP B-f
49 day NN I-NP I-f
49 2 CD O O
49 ) ) O O
49 Lithium NN B-NP B-m
49 300 CD O B-do
49 mg NN B-NP I-do
49 twice RB O B-f
49 a DT B-NP I-f
49 day NN I-NP I-f
50 3 CD O O
50 ) ) O O
50 Potassium NN B-NP B-m
50 supplementation NN I-NP I-m
50 20 CD O B-do
50 mEq NN B-NP I-do
50 once RB O B-f
50 a DT B-NP I-f
50 day NN I-NP I-f
50 4 CD O O
50 ) ) O O
50 Pravachol VBD B-VP B-m
50 40 CD O B-do
51 mg NN B-NP O
51 once RB O B-f
51 a DT B-NP I-f
51 day NN I-NP I-f
51 5 CD O O
51 ) ) O O
51 Glyburide NNP B-NP B-m
51 1.25 CD O B-do
51 mg NN B-NP I-do
51 twice RB O B-f
51 a DT B-NP I-f
51 day NN I-NP I-f
51 6 CD O O
51 ) ) O O
51 Parnate VB O B-m
51 10 CD O B-do
52 mg NN B-NP O
52 twice RB O B-f
52 a DT B-NP I-f
52 day NN I-NP I-f
52 7 CD O O
52 ) ) O O
52 Lasix FW O B-m
52 20 CD O B-do
52 mg NN B-NP I-do
52 once RB O B-f
52 a DT B-NP I-f
52 day NN I-NP I-f
53 FOLLOW-UP: NNP I-NP O
53 The DT B-NP O
53 patient NN I-NP O
53 is VBZ O O
53 to TO O O
53 be VB O O
53 discharged VBN O O
53 to TO O O
53 the DT B-NP O
53 care NN I-NP O
53 of IN B-VP O
53 Dr NNP B-NP O
53 Kim NNP I-NP O
53 E NNP I-NP O
53 Scow NNP I-NP O
53 , , O O
53 Cardiovascular NNP B-NP O
53 Division NNP I-NP O
53 at IN B-VP O
53 Hany NNP B-NP O
53 Medical NNP I-NP O
53 Center NNP I-NP O
54 Dictated NNP I-NP O
54 By: NNP I-NP O
54 QUINN NNP I-NP O
54 WACHSMUTH NNP I-NP O
54 , , O O
54 M.D NNP B-NP O
55 Attending: NNP I-NP O
55 ERASMO NNP I-NP O
55 J NNP I-NP O
55 MURPHREE NNP I-NP O
55 , , O O
55 M.D NNP B-NP O
55 PI3 NNP I-NP O
55 DT105/7267 NNP I-NP O
56 Batch: NNP I-NP O
56 7705 CD O O
56 Index NNP B-NP O
56 No NNP I-NP O
56 HKLJAT69GJ NNP I-NP O
56 D: NNP I-NP O
56 8/1/01 CD O O
57 T: NNP B-NP O
57 8/1/01 CD O O
58 CC: NNP B-NP O
58 LEON NNP I-NP O
58 M NNP I-NP O
58 EVERTS NNP I-NP O
58 , , O O
58 M.D NNP B-NP O
58 WL7 NNP I-NP O
59 BOYD NNP I-NP O
59 LOVATO NNP I-NP O
59 , , O O
59 M.D NNP B-NP O
59 , , O O
59 Fallsu NNP B-NP O
60 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #312933 VBZ O O
2 441230814 CD O O
2 SMH NNP B-NP O
2 75713869 CD O O
2 8859203 CD O O
2 4/20/2007 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CARDIOGENIC NNP I-NP O
2 SHOCK NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/22/2007 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/24/2007 CD O O
4 ATTENDING: NNP B-NP O
4 STIVER NNP I-NP O
4 , , O O
4 CALVIN NNP B-NP O
4 MD NNP I-NP O
5 SERVICE: NNP I-NP O
5 Coronary NNP I-NP O
5 Care NNP I-NP O
5 Unit NNP I-NP O
6 BRIEF NNP I-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 Ms NNP I-NP O
6 Kolppa NNP I-NP O
6 was VBD B-VP O
6 a DT B-NP O
6 58-year-old JJ I-NP O
7 woman NN I-NP O
7 with IN B-VP O
7 a DT B-NP O
7 history NN I-NP O
7 of IN B-VP O
7 non-ischemic JJ B-NP O
7 cardiomyopathy NN I-NP O
7 and CC O O
7 ejection NN B-NP O
8 fraction NN I-NP O
8 of IN B-VP O
8 15% CD O O
8 who WP O O
8 was VBD B-VP O
8 initially RB O O
8 admitted VBN O O
8 to TO O O
8 the DT B-NP O
8 Faharb NNP I-NP O
8 Medical NNP I-NP O
8 Center NNP I-NP O
8 Of IN B-VP O
8 following VBG O O
8 a DT B-NP O
8 cardiac JJ I-NP O
8 arrest NN I-NP O
8 On IN B-VP O
8 arrival NN B-NP O
8 in IN B-VP O
8 the DT B-NP O
9 emergency NN I-NP O
9 department NN I-NP O
9 she PRP O O
9 was VBD B-VP O
9 found VBN O O
9 to TO O O
9 have VB O O
9 recurrent JJ B-NP O
9 ventricular JJ I-NP O
10 tachycardia NN I-NP O
10 and CC O O
10 was VBD B-VP O
10 defibrillated VBN O O
10 She PRP O O
10 required VBD B-VP O
10 an DT B-NP O
10 intraaortic JJ I-NP O
11 balloon NN I-NP O
11 pump NN I-NP O
11 to TO O O
11 maintain VB O O
11 her PRP$ O O
11 blood NN B-NP O
11 pressure NN I-NP O
12 PAST NNP I-NP O
12 MEDICAL NNP I-NP O
12 HISTORY: NNP I-NP O
12 Significant NNP I-NP O
12 for IN B-VP O
12 non-ischemic JJ B-NP O
13 cardiomyopathy NN I-NP O
13 She PRP O O
13 has VBZ O O
13 a DT B-NP O
13 pacemaker/ICD NN I-NP O
13 She PRP O O
13 has VBZ O O
13 a DT B-NP O
13 history NN I-NP O
13 of IN B-VP O
14 chronic JJ B-NP O
14 kidney NN I-NP O
14 disease NN I-NP O
14 , , O O
14 deep RB O O
14 venous JJ B-NP O
14 thrombosis NN I-NP O
14 , , O O
14 history NN B-NP O
14 of IN B-VP O
15 cerebrovascular JJ B-NP O
15 accident NN I-NP O
15 , , O O
15 history NN B-NP O
15 of IN B-VP O
15 hypercholesterolemia NN B-NP O
15 , , O O
16 history NN B-NP O
16 of IN B-VP O
16 coronary JJ B-NP O
16 artery NN I-NP O
16 disease NN I-NP O
16 , , O O
16 history NN B-NP O
16 of IN B-VP O
16 diabetes NNS B-NP O
16 , , O O
16 history NN B-NP O
17 of IN B-VP O
17 GI NNP B-NP O
17 bleed NN I-NP O
17 and CC O O
17 history NN B-NP O
17 of IN B-VP O
17 chronic JJ B-NP O
17 hepatitis NN I-NP O
17 C NNP I-NP O
18 HOSPITAL NNP I-NP O
18 COURSE NNP I-NP O
18 BY NNP I-NP O
18 PROBLEMS: NNP I-NP O
18 Ms NNP I-NP O
18 Rubins NNP I-NP O
18 had VBD B-VP O
18 a DT B-NP O
18 complicated JJ I-NP O
19 course NN I-NP O
19 in IN B-VP O
19 the DT B-NP O
19 hospital NN I-NP O
19 and CC O O
19 her PRP$ O O
19 care NN B-NP O
19 was VBD B-VP O
19 related VBN O O
19 primarily RB O O
19 to TO O O
20 recurrent VB O O
20 ventricular JJ B-NP O
20 tachycardia NN I-NP O
20 and CC O O
20 prolonged VBD B-VP O
20 anoxic JJ B-NP O
20 injury NN I-NP O
21 affecting VBG O O
21 multiple JJ B-NP O
21 organ JJ I-NP O
21 systems NNS I-NP O
21 During IN B-VP B-du
21 her PRP$ O I-du
21 hospital JJ B-NP I-du
21 course NN I-NP I-du
21 , , O O
22 she PRP O O
22 required VBD B-VP O
22 pressor NN B-NP B-m
22 medications NNS I-NP I-m
22 , , O O
22 an DT B-NP O
22 intraaortic JJ I-NP O
22 balloon NN I-NP O
22 pump NN I-NP O
22 , , O O
23 and CC O O
23 ventilator JJ B-NP O
23 support NN I-NP O
23 Of IN B-VP O
23 note NN B-NP O
23 , , O O
23 the DT B-NP O
23 patient NN I-NP O
23 had VBD B-VP O
23 noted VBN O O
23 , , O O
23 prior RB O O
23 to TO O O
23 her PRP$ O O
24 admission NN B-NP O
24 , , O O
24 that IN B-VP O
24 she PRP O O
24 would MD O O
24 never RB O O
24 want VB O O
24 to TO O O
24 be VB O O
24 dependent JJ O O
24 upon IN B-VP O
24 "machines." NNS B-NP O
24 Due NNP I-NP O
24 to TO O O
25 poor JJ B-NP O
25 neurological JJ I-NP O
25 status NN I-NP O
25 and CC O O
25 poor JJ B-NP O
26 prognosis NN I-NP O
26 , , O O
26 and CC O O
26 in IN B-VP O
26 conjunction NN B-NP O
26 with IN B-VP O
26 the DT B-NP O
26 patient's NN I-NP O
26 previously RB O O
26 expressed VBN O O
26 wishes NNS B-NP O
26 , , O O
27 medical JJ B-NP O
27 care NN I-NP O
27 was VBD B-VP O
27 withdrawn VBN O O
27 on IN B-VP O
27 6/14 CD O O
27 after IN B-VP O
27 many JJ B-NP O
27 discussions NNS I-NP O
27 with IN B-VP O
27 family NN B-NP O
27 The DT B-NP O
28 patient's NN I-NP O
28 primary JJ B-NP O
28 care NN I-NP O
28 physician NN I-NP O
28 , , O O
28 Dr NNP B-NP O
28 Sangh NNP I-NP O
28 , , O O
28 was VBD B-VP O
28 involved VBN O O
28 with IN B-VP O
28 these DT B-NP O
29 discussions NNS I-NP O
29 The DT B-NP O
29 intraaortic JJ I-NP O
29 balloon NN I-NP O
29 pump NN I-NP O
29 was VBD B-VP O
29 turned VBN O O
29 off RP O O
29 Pressure NN B-NP B-m
29 medications NNS I-NP I-m
30 were VBD B-VP O
30 held VBN O O
30 and CC O O
30 the DT B-NP O
30 mechanical JJ I-NP O
30 ventilator NN I-NP O
30 was VBD B-VP O
30 stopped VBN O O
30 The DT B-NP O
30 patient NN I-NP O
30 passed VBD B-VP O
30 away RB O O
31 on IN B-VP O
31 0/14/07 CD O O
31 shortly RB O O
31 after IN B-VP O
31 removal NN B-NP O
31 of IN B-VP O
31 mechanical JJ B-NP O
31 support NN I-NP O
32 eScription NN I-NP O
32 document: IN B-VP O
32 7-5741310 JJ B-NP O
32 CSSten NNP I-NP O
32 Tel NNP I-NP O
33 Dictated NNP I-NP O
33 By: NNP I-NP O
33 SUPPLEE NNP I-NP O
33 , , O O
33 GARTH NNP B-NP O
34 Attending: NNP I-NP O
34 UHYREK NNP I-NP O
34 , , O O
34 PARKER NNP B-NP O
35 Dictation NNP I-NP O
35 ID NNP I-NP O
35 0741981 CD O O
36 D: NNP B-NP O
36 0/14/07 CD O O
37 T: NNP B-NP O
37 11/28/07 CD O O
38 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #327289 VBZ O O
2 701267368 CD O O
2 ECH NNP B-NP O
2 49976759 CD O O
2 151133 CD O O
2 7/3/1995 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/29/1995 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 11/2/1995 CD O O
4 The DT B-NP O
4 patient NN I-NP O
4 received VBD B-VP O
4 care NN B-NP O
4 on IN B-VP O
4 the DT B-NP O
4 Stockvi NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Dilated NNP I-NP O
5 cardiomyopathy NN I-NP O
5 with IN B-VP O
5 associated JJ B-NP O
6 problems NNS I-NP O
6 of IN B-VP O
6 hypertension NN B-NP O
6 and CC O O
6 asthma NN B-NP O
7 CHIEF NNP I-NP O
7 COMPLAINT: NNP I-NP O
7 This DT O O
7 is VBZ O O
7 a DT O O
7 53 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 female NN I-NP O
7 with IN B-VP O
7 hypertension NN B-NP O
7 x NNP I-NP O
8 eight CD O O
8 years NNS B-NP O
8 , , O O
8 who WP O O
8 presents VBZ O O
8 with IN B-VP O
8 increased JJ B-NP O
8 dyspnea NN I-NP O
9 on IN B-VP O
9 exertion NN B-NP O
9 and CC O O
9 admitted VBN O O
9 for IN B-VP O
9 left NN B-NP O
9 and CC O O
9 right JJ B-NP O
9 heart NN I-NP O
9 catheterization NN I-NP O
9 , , O O
10 and CC O O
10 to TO O O
10 optimize VB O O
10 blood NN B-NP O
10 pressure NN I-NP O
10 control NN I-NP O
11 HISTORY NNP I-NP O
11 OF NNP I-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
11 This DT O O
11 is VBZ O O
11 a DT O O
11 53 CD O O
11 year NN B-NP O
11 old JJ B-NP O
11 Afro-American JJ I-NP O
12 female NN I-NP O
12 , , O O
12 first RB O O
12 diagnosed VBN O O
12 with IN B-VP O
13 hypertension NN B-NP O
13 in IN B-VP O
13 1987 CD O O
13 She PRP O O
13 presented VBD B-VP O
13 to TO O O
13 the DT B-NP O
13 Emergency NNP I-NP O
13 Room NNP I-NP O
13 in IN B-VP O
13 1987 CD O O
14 with IN B-VP O
14 acute JJ B-NP O
14 atypical JJ I-NP O
14 chest NN I-NP O
14 pain NN I-NP O
14 , , O O
14 and CC O O
14 was VBD B-VP O
14 ruled VBN O O
14 out RP O O
14 for IN B-VP O
14 a DT B-NP O
14 myocardial JJ I-NP O
15 infarction NN I-NP O
15 ETT NNP I-NP O
15 in IN B-VP O
15 1987 CD O O
15 demonstrated VBD B-VP O
15 chest JJS B-NP O
15 pain NN I-NP O
15 during IN B-VP O
15 exercise NN B-NP O
16 and CC O O
16 suggestive JJ B-NP O
16 ST NNP I-NP O
16 T NNP I-NP O
16 wave VBP O O
16 changes NNS B-NP O
16 in IN B-VP O
16 the DT B-NP O
16 inferolateral JJ I-NP O
16 leads NNS I-NP O
16 during IN B-VP O
17 exercise NN B-NP O
17 The DT B-NP O
17 patient NN I-NP O
17 was VBD B-VP O
17 discharged VBN O O
17 from IN B-VP O
17 the DT B-NP O
17 hospital NN I-NP O
17 , , O O
17 and CC O O
17 did VBD B-VP O
18 relatively RB O O
18 well RB O O
18 with IN B-VP O
18 intermittent JJ B-NP O
18 chest NN I-NP O
18 pain NN I-NP O
18 on IN B-VP O
18 exertion NN B-NP O
19 Exercise NNP I-NP O
19 tolerance NN I-NP O
19 test NN I-NP O
19 in IN B-VP O
19 1991 CD O O
19 demonstrated JJ O O
19 consistent JJ O O
19 , , O O
19 but CC O O
19 not RB O O
20 diagnostic JJ O O
20 of IN B-VP O
20 ischemia NN B-NP O
20 No NNP I-NP O
20 chest NN I-NP O
20 pain NN I-NP O
20 Echocardiogram NNP I-NP O
20 in IN B-VP O
20 1992 CD O O
21 demonstrated VBD B-VP O
21 inferior JJ O O
21 , , O O
21 posterior JJ O O
21 , , O O
21 and CC O O
21 apical JJ B-NP O
21 hyperkinesis NN I-NP O
21 , , O O
21 low JJ O O
21 to TO O O
22 normal JJ B-NP O
22 global JJ I-NP O
22 pattern NN I-NP O
22 of IN B-VP O
22 systolic JJ B-NP O
22 contractile NN I-NP O
22 function NN I-NP O
22 , , O O
22 and CC O O
22 a DT B-NP O
23 celionous JJ I-NP O
23 redundancy NN I-NP O
23 of IN B-VP O
23 the DT B-NP O
23 mitral JJ I-NP O
23 anterior JJ I-NP O
23 leaflet NN I-NP O
23 , , O O
23 with IN B-VP O
23 only JJ B-NP O
24 trace NN I-NP O
24 mitral JJ B-NP O
24 regurgitation NN I-NP O
25 Since IN B-VP O
25 1992 CD O O
25 , , O O
25 the DT B-NP O
25 patient NN I-NP O
25 has VBZ O O
25 developed VBN O O
25 severe JJ B-NP O
25 shortness NN I-NP O
25 of IN B-VP O
25 breath NN B-NP O
26 with IN B-VP O
26 positive JJ B-NP O
26 chest NN I-NP O
26 discomfort NN I-NP O
26 of IN B-VP O
26 pin NN B-NP O
26 and CC O O
26 needles NNS B-NP O
26 in IN B-VP O
26 the DT B-NP O
26 left NN I-NP O
27 chest NN I-NP O
27 , , O O
27 which WDT O O
27 radiates VBZ O O
27 down RP O O
27 her PRP$ O O
27 left JJ B-NP O
27 arm NN I-NP O
27 She PRP O O
27 notes VBZ O O
27 positive JJ B-NP O
28 paroxysmal JJ I-NP O
28 nocturnal JJ I-NP O
28 dyspnea NN I-NP O
28 with IN B-VP O
28 the DT B-NP O
28 need NN I-NP O
28 of IN B-VP O
28 sleeping VBG O O
28 elevated VBN O O
28 at IN B-VP O
29 45 CD O O
29 degrees NNS B-NP O
29 at IN B-VP O
29 some DT B-NP O
29 times NNS I-NP O
30 Echocardiogram NNP I-NP O
30 in IN B-VP O
30 1994 CD O O
30 demonstrated VBD B-VP O
30 moderately RB O O
30 dilated VBN O O
30 left JJ B-NP O
31 ventricle NN I-NP O
31 with IN B-VP O
31 severely RB O O
31 depressed JJ B-NP O
31 systolic JJ I-NP O
31 function NN I-NP O
31 Ejection NNP I-NP O
32 fraction NN I-NP O
32 equals NNS I-NP O
32 26% CD O O
32 There EX O O
32 was VBD B-VP O
32 2+ CD O O
32 mitral JJ B-NP O
32 regurgitation NN I-NP O
32 and CC O O
32 mild NN B-NP O
33 left VBD B-VP O
33 atrial JJ B-NP O
33 enlargement NN I-NP O
33 also RB O O
33 noted VBD B-VP O
33 Mild NNP B-NP O
33 tricuspid JJ B-NP O
33 regurgitation NN I-NP O
34 with IN B-VP O
34 pulmonary JJ B-NP O
34 artery NN I-NP O
34 pressure NN I-NP O
34 estimated VBN O O
34 at IN B-VP O
34 approximately RB O O
34 25 CD O O
35 Due JJ O O
35 to TO O O
35 her PRP$ O O
35 hypertension NN B-NP O
35 and CC O O
35 decreased JJ O O
35 left VBD B-VP O
35 ventricular JJ B-NP O
35 function NN I-NP O
35 , , O O
36 the DT B-NP O
36 patient NN I-NP O
36 presents VBZ O O
36 to TO O O
36 the DT B-NP O
36 Ton NNP I-NP O
36 Medical NNP I-NP O
36 Center NNP I-NP O
36 for IN B-VP O
36 a DT B-NP O
36 left NN I-NP O
37 and CC O O
37 right JJ B-NP O
37 side NN I-NP O
37 catheterization NN I-NP O
37 , , O O
37 and CC O O
37 also RB O O
37 for IN B-VP O
37 monitoring NN B-NP O
37 of IN B-VP O
37 her PRP$ O O
38 blood NN B-NP O
38 pressure NN I-NP O
38 Her NNP I-NP O
38 blood NN I-NP O
38 pressure NN I-NP O
38 ranged VBD B-VP O
38 , , O O
38 as IN B-VP O
38 an DT B-NP O
38 outpatient NN I-NP O
38 , , O O
39 between IN B-VP O
39 170 CD O O
39 to TO O O
39 180/100 CD O O
39 to TO O O
39 110 CD O O
40 PAST NNP B-NP O
40 MEDICAL NNP I-NP O
40 HISTORY: NNP I-NP O
40 1 CD O O
40 As IN B-VP O
40 above IN B-VP O
41 2 CD O O
41 Asthma NNP B-NP O
42 MEDICATIONS NNP I-NP O
42 ON NNP I-NP O
42 ADMISSION: NNP I-NP O
42 1 CD O O
42 Beclovent NNP B-NP B-m
42 4 CD O B-do
42 puffs NNS B-NP I-do
42 b.i.d VBD B-VP B-f
43 2 CD O O
43 Enalapril NNP B-NP B-m
43 4 CD O B-do
43 mg NN B-NP I-do
43 q.d NN I-NP B-f
44 3 CD O O
44 Diltiazem NNP B-NP B-m
44 360 CD O B-do
44 mg NN B-NP I-do
44 q.d NN I-NP B-f
45 4 CD O O
45 Lasix NNP B-NP B-m
45 40 CD O B-do
45 mg NN B-NP I-do
45 b.i.d NN I-NP B-f
46 ALLERGIES: NNP I-NP O
46 The DT B-NP O
46 patient NN I-NP O
46 has VBZ O O
46 no DT O O
46 known VBN O O
46 drug NN B-NP O
46 allergies NNS I-NP O
47 HABITS: VBP O O
47 The DT B-NP O
47 patient NN I-NP O
47 smokes VBZ O O
47 one-half JJ O O
47 per IN B-VP O
47 day NN B-NP O
47 to TO O O
47 one CD O O
47 pack NN B-NP O
47 per IN B-VP O
47 day NN B-NP O
48 for IN B-VP O
48 the DT B-NP O
48 last JJ I-NP O
48 twenty-five JJ I-NP O
48 years NNS I-NP O
48 Alcohol NNP I-NP O
48 , , O O
48 occasional JJ B-NP O
49 FAMILY NNP I-NP O
49 HISTORY: NNP I-NP O
49 The DT B-NP O
49 patient's NN I-NP O
49 mother NN I-NP O
49 died VBD B-VP O
49 in IN B-VP O
49 her PRP$ O O
49 sleep NN B-NP O
49 at IN B-VP O
49 age NN B-NP O
49 50 CD O O
50 of IN B-VP O
50 unknown JJ B-NP O
50 reasons NNS I-NP O
50 Her PRP$ O O
50 father NN B-NP O
50 died VBD B-VP O
50 due JJ O O
50 to TO O O
50 a DT B-NP O
51 motor NN I-NP O
51 vehicle NN I-NP O
51 accident NN I-NP O
51 Two CD O O
51 brothers NNS B-NP O
51 and CC O O
51 one CD O O
51 sister NN B-NP O
51 all DT O O
51 died VBD B-VP O
51 at IN B-VP O
52 age NN B-NP O
52 30 CD O O
52 to TO O O
52 40 CD O O
52 , , O O
52 the DT B-NP O
52 patient NN I-NP O
52 does VBZ O O
52 not RB O O
52 know VB O O
52 cause NN B-NP O
53 SOCIAL NNP I-NP O
53 HISTORY: NNP I-NP O
53 The DT B-NP O
53 patient NN I-NP O
53 has VBZ O O
53 not RB O O
53 worked VBN O O
53 since IN B-VP O
53 1995 CD O O
53 due JJ O O
53 to TO O O
53 what WP O O
54 she PRP O O
54 states VBZ O O
54 as IN B-VP O
54 shortness NN B-NP O
54 of IN B-VP O
54 breath NN B-NP O
54 and CC O O
54 chest NN B-NP O
54 pain NN I-NP O
55 She PRP O O
55 has VBZ O O
55 three CD O O
55 daughters NNS B-NP O
55 , , O O
55 all DT O O
55 in IN B-VP O
55 good JJ B-NP O
55 health NN I-NP O
55 , , O O
55 and CC O O
55 four CD O O
56 grandchildren NNS B-NP O
57 PHYSICAL NNP I-NP O
57 EXAMINATION: NNP I-NP O
57 On IN B-VP O
57 physical JJ B-NP O
57 examination NN I-NP O
57 , , O O
57 this DT O O
57 is VBZ O O
57 a DT O O
57 53 CD O O
57 year NN B-NP O
58 old JJ B-NP O
58 female NN I-NP O
58 , , O O
58 Afro-American JJ O O
58 , , O O
58 in IN B-VP O
58 no DT B-NP O
58 apparent JJ I-NP O
59 distress NN I-NP O
59 Vital NNP I-NP O
59 signs: NN I-NP O
59 Temperature NNP I-NP O
59 97.6 CD O O
59 , , O O
59 blood NN B-NP O
59 pressure NN I-NP O
59 134/72 CD O O
60 after IN B-VP O
60 Hydralazine NNP B-NP B-m
60 , , O O
60 heart NN B-NP O
60 rate NN I-NP O
60 75 CD O O
60 , , O O
60 respiratory JJ B-NP O
60 rate NN I-NP O
60 of IN B-VP O
60 12 CD O O
60 HEENT NNP B-NP O
61 examination: NN I-NP O
61 Extraocular NNP I-NP O
61 movements NNS I-NP O
61 are VBP O O
61 intact JJ B-NP O
61 Pupils NNP I-NP O
61 are VBP O O
61 equal JJ O O
61 , , O O
62 round NN B-NP O
62 , , O O
62 reactive JJ O O
62 to TO O O
62 light JJ B-NP O
62 Nasal NNP I-NP O
62 oral JJ B-NP O
62 pharynx NN I-NP O
62 had VBD B-VP O
62 no DT B-NP O
62 discharge NN I-NP O
62 , , O O
62 and CC O O
63 was VBD B-VP O
63 clear JJ O O
63 with IN B-VP O
63 no DT B-NP O
63 exudates NNS I-NP O
63 Neck: NNP I-NP O
63 No NNP I-NP O
63 adenopathy NN I-NP O
63 , , O O
63 no DT B-NP O
63 jugular JJ I-NP O
64 venous JJ I-NP O
64 distention NN I-NP O
64 , , O O
64 no DT B-NP O
64 thyromegaly NN I-NP O
64 Carotids NNP I-NP O
64 are VBP O O
64 2+ CD O O
64 with IN B-VP O
64 no DT B-NP O
64 bruits NNS I-NP O
65 Lungs NNP I-NP O
65 revealed VBD B-VP O
65 diffuse RB O O
65 expiratory JJ B-NP O
65 wheezes NNS I-NP O
65 , , O O
65 prolonged VBD B-VP O
65 expiratory JJ B-NP O
66 phase NN I-NP O
66 , , O O
66 no DT B-NP O
66 rhonchi NN I-NP O
66 or CC O O
66 rales NNS B-NP O
66 Cardiovascular NNP I-NP O
66 revealed VBD B-VP O
66 a DT B-NP O
66 regular JJ I-NP O
66 rate NN I-NP O
67 and CC O O
67 rhythm NN B-NP O
67 , , O O
67 normal JJ B-NP O
67 S1 NNP I-NP O
67 and CC O O
67 S2 NNP B-NP O
67 , , O O
67 positive JJ B-NP O
67 S4 NNP I-NP O
67 , , O O
67 with IN B-VP O
67 a DT O O
67 2/6 CD O O
67 systolic JJ B-NP O
68 murmur NN I-NP O
68 at IN B-VP O
68 the DT B-NP O
68 apex NN I-NP O
68 The DT B-NP O
68 abdomen NNS I-NP O
68 was VBD B-VP O
68 obese JJ O O
68 , , O O
68 soft JJ O O
68 , , O O
68 non-tender JJ O O
68 , , O O
69 non-distended JJ O O
69 , , O O
69 with IN B-VP O
69 no DT B-NP O
69 obvious JJ I-NP O
69 hepatosplenomegaly NN I-NP O
69 Extremities NNS I-NP O
70 revealed VBD B-VP O
70 no DT B-NP O
70 clubbing NN I-NP O
70 , , O O
70 cyanosis NN B-NP O
70 , , O O
70 or CC O O
70 edema NN B-NP O
70 , , O O
70 and CC O O
70 no DT B-NP O
70 bruits NNS I-NP O
70 Pulses NNS I-NP O
71 were VBD B-VP O
71 2+ CD O O
71 throughout IN B-VP O
71 Neurological NNP B-NP O
71 examination: NN I-NP O
71 Alert NNP I-NP O
71 and CC O O
71 oriented VBD B-VP O
72 x NNP B-NP O
72 three CD O O
72 , , O O
72 nonfocal JJ B-NP O
72 examination NN I-NP O
73 LABORATORY NNP I-NP O
73 EXAMINATION: NNP I-NP O
73 Labs NNP I-NP O
73 upon IN B-VP O
73 admission NN B-NP O
73 revealed VBD B-VP O
73 an DT B-NP O
73 SMA-7 NNP I-NP O
73 of IN B-VP O
74 143 CD O O
74 , , O O
74 4.1 CD O O
74 , , O O
74 102 CD O O
74 , , O O
74 28 CD O O
74 , , O O
74 20 CD O O
74 , , O O
74 1.2 CD O O
74 , , O O
74 and CC O O
74 93 CD O O
74 CBC NNP B-NP O
75 of IN B-VP O
75 6.3 CD O O
75 , , O O
75 46.1 CD O O
75 , , O O
75 and CC O O
75 280 CD O O
75 PT NNP B-NP O
75 and CC O O
75 PTT NNP B-NP O
75 of IN B-VP O
75 12.5 CD O O
75 and CC O O
75 28.4 CD O O
75 ALT NNP B-NP O
75 of IN B-VP O
75 14 CD O O
75 , , O O
76 AST NNP B-NP O
76 of IN B-VP O
76 19 CD O O
76 , , O O
76 LDH NNP B-NP O
76 of IN B-VP O
76 197 CD O O
76 , , O O
76 alkaline JJ B-NP O
76 phosphatase NN I-NP O
76 of IN B-VP O
76 77 CD O O
76 , , O O
76 total JJ B-NP O
76 bilirubin NN I-NP O
77 of IN B-VP O
77 .3 NNP B-NP O
77 , , O O
77 total JJ B-NP O
77 protein NN I-NP O
77 of IN B-VP O
77 7.9 CD O O
77 , , O O
77 albumin NN B-NP O
77 of IN B-VP O
77 4.2 CD O O
77 Globulins NNS B-NP O
77 of IN B-VP O
77 3.7 CD O O
77 , , O O
78 calcium NN B-NP O
78 of IN B-VP O
78 9.4 CD O O
78 , , O O
78 phosphate NN B-NP O
78 of IN B-VP O
78 4.4 CD O O
78 , , O O
78 cholesterol NN B-NP O
78 of IN B-VP O
78 210 CD O O
78 , , O O
78 and CC O O
79 triglyceride NN B-NP O
79 of IN B-VP O
79 67 CD O O
80 HOSPITAL NNP B-NP O
80 COURSE: NNP I-NP O
80 The DT B-NP O
80 patient JJ I-NP O
80 underwent JJ I-NP O
80 cardiac JJ I-NP O
80 catheterization NN I-NP O
80 on IN B-VP O
81 hospital JJ B-NP O
81 day NN I-NP O
81 number NN I-NP O
81 one CD O O
81 which WDT O O
81 demonstrated VBD B-VP O
81 no DT B-NP O
82 coronary JJ I-NP O
82 artery NN I-NP O
82 disease NN I-NP O
82 disease NN I-NP O
82 , , O O
82 right JJ B-NP O
82 atrium NN I-NP O
82 pressure NN I-NP O
82 of IN B-VP O
82 12 CD O O
82 , , O O
82 PA NNP B-NP O
83 pressure NN I-NP O
83 of IN B-VP O
83 56/32 CD O O
83 with IN B-VP O
83 a DT B-NP O
83 mean NN I-NP O
83 of IN B-VP O
83 38 CD O O
83 and CC O O
83 pulmonary JJ B-NP O
83 capillary JJ I-NP O
83 wedge NN I-NP O
84 pressure NN I-NP O
84 of IN B-VP O
84 20 CD O O
84 Cardiac NNP B-NP O
84 output NN I-NP O
84 was VBD B-VP O
84 5.1 CD O O
84 , , O O
84 SVR NNP B-NP O
84 of IN B-VP O
84 1459 CD O O
84 , , O O
84 and CC O O
84 PVR NNP B-NP O
84 of IN B-VP O
85 282 CD O O
85 The DT B-NP O
85 patient NN I-NP O
85 was VBD B-VP O
85 then RB O O
85 admitted VBN O O
85 to TO O O
85 the DT B-NP O
85 Floor NNP I-NP O
85 for IN B-VP O
85 workup NN B-NP O
85 of IN B-VP O
85 her PRP$ O O
86 hypertension NN B-NP O
86 Urine NNP I-NP O
86 metanephrine NN I-NP O
86 and CC O O
86 urine JJ B-NP O
86 VMA NNP I-NP O
86 were VBD B-VP O
86 sent VBN O O
86 The DT B-NP O
87 patient's NN I-NP O
87 Enalapril NNP I-NP B-m
87 was VBD B-VP O
87 discontinued VBN O O
87 in IN B-VP O
87 order NN B-NP O
87 to TO O O
87 perform VB O O
87 the DT B-NP O
88 Captopril NNP I-NP O
88 Renogram NNP I-NP O
88 Test NNP I-NP O
88 The DT B-NP O
88 patient NN I-NP O
88 was VBD B-VP O
88 started VBN O O
88 on IN B-VP O
88 Diltiazem NNP B-NP B-m
88 180 CD O B-do
89 mg NN B-NP O
89 q.d NN I-NP B-f
89 , , O O
89 Lasix NNP B-NP B-m
89 80 CD O B-do
89 mg NN B-NP I-do
89 b.i.d NN I-NP B-f
89 , , O O
89 and CC O O
89 Hydralazine NNP B-NP B-m
89 10 CD O B-do
89 mg NN B-NP I-do
89 t.i.d VBD B-VP B-f
90 The DT B-NP O
90 patient's NN I-NP O
90 blood NN I-NP O
90 pressure NN I-NP O
90 , , O O
90 on IN B-VP O
90 hospital JJ B-NP O
90 day NN I-NP O
90 number NN I-NP O
90 three CD O O
90 , , O O
90 was VBD B-VP O
91 130/70 CD O O
91 and CC O O
91 well-controlled JJ B-NP O
91 Her NNP I-NP O
91 heart NN I-NP O
91 rate NN I-NP O
91 was VBD B-VP O
91 70 CD O O
91 to TO O O
91 80 CD O O
91 On IN B-VP O
92 hospital JJ B-NP O
92 day NN I-NP O
92 number NN I-NP O
92 four CD O O
92 , , O O
92 the DT B-NP O
92 patient NN I-NP O
92 underwent NN I-NP O
92 a DT B-NP O
92 Captopril NNP I-NP O
93 Renogram NNP I-NP O
93 Test NNP I-NP O
93 which WDT O O
93 was VBD B-VP O
93 negative JJ O O
93 for IN B-VP O
93 renal JJ B-NP O
93 artery NN I-NP O
93 stenosis NN I-NP O
93 Other JJ B-NP O
94 hypertension NN I-NP O
94 workup NN I-NP O
94 Epinephrine NNP I-NP O
94 , , O O
94 Dopamine NNP B-NP O
94 , , O O
94 Metanephrine NNP B-NP O
94 , , O O
94 VMA NNP B-NP O
94 and CC O O
95 ANA NNP B-NP O
95 are VBP O O
95 still RB O O
95 pending VBG O O
96 The DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 discharged VBN O O
96 home NN B-NP O
96 on IN B-VP O
96 hospital JJ B-NP O
96 day NN I-NP O
96 number NN I-NP O
96 five CD O O
96 , , O O
96 with IN B-VP O
97 blood NN B-NP O
97 pressure NN I-NP O
97 being VBG O O
97 well-controlled JJ O O
97 throughout IN B-VP O
97 her PRP$ O O
97 hospital JJ B-NP O
97 visit NN I-NP O
98 in IN B-VP O
98 the DT O O
98 130/70's CD O O
99 The DT B-NP O
99 patient's JJ I-NP O
99 hypertension NN I-NP O
99 control NN I-NP O
99 was VBD B-VP O
99 attributed VBN O O
99 to TO O O
99 the DT B-NP O
99 fact NN I-NP O
99 that IN B-VP O
100 number NN B-NP O
100 one CD O O
100 , , O O
100 she PRP O O
100 stopped VBD B-VP O
100 smoking VBG O O
100 during IN B-VP O
100 her PRP$ O O
100 hospital JJ B-NP O
100 stay; NN I-NP O
100 two CD O O
100 , , O O
100 she PRP O O
101 was VBD B-VP O
101 inactive JJ O O
101 and CC O O
101 was VBD B-VP O
101 on IN B-VP O
101 bed NN B-NP O
101 rest; NN I-NP O
101 and CC O O
101 three CD O O
101 , , O O
101 the DT B-NP O
101 possibility NN I-NP O
101 of IN B-VP O
102 strict JJ B-NP O
102 compliance NN I-NP O
102 with IN B-VP O
102 medications NNS B-NP O
102 while IN B-VP O
102 in IN B-VP O
102 the DT B-NP O
102 hospital NN I-NP O
103 DISCHARGE NNP I-NP O
103 MEDICATIONS: NNP I-NP O
103 1 CD O O
103 Diltiazem NNP B-NP B-m
103 180 CD O B-do
103 mg NN B-NP I-do
103 po NN I-NP B-mo
103 q.d VBD B-VP B-f
104 2 CD O O
104 Enalapril NNP B-NP B-m
104 10 CD O B-do
104 mg NN B-NP I-do
104 po NN I-NP B-mo
104 q.d VBD B-VP B-f
105 3 CD O O
105 Lasix NNP B-NP B-m
105 80 CD O B-do
105 mg NN B-NP I-do
105 po NN I-NP B-mo
105 b.i.d VBD B-VP B-f
106 4 CD O O
106 One CD O B-do
106 aspirin NN B-NP B-m
106 per IN B-VP B-f
106 day NN B-NP I-f
107 CONDITION NNP I-NP O
107 ON NNP I-NP O
107 DISCHARGE: NNP I-NP O
107 The DT B-NP O
107 patient NN I-NP O
107 was VBD B-VP O
107 discharged VBN O O
107 home NN B-NP O
107 in IN B-VP O
107 stable JJ O O
108 and CC O O
108 good JJ B-NP O
108 condition NN I-NP O
109 FOLLOW-UP: NNP I-NP O
109 The DT B-NP O
109 patient NN I-NP O
109 will MD O O
109 have VB O O
109 follow-up JJ O O
109 with IN B-VP O
109 PACKMA NNP B-NP O
109 TEDET NNP I-NP O
109 UNIVERSITY NNP I-NP O
109 OF NNP I-NP O
109 MEDICAL NNP I-NP O
109 CENTER NNP I-NP O
109 on IN B-VP O
109 Thursday NNP B-NP O
109 , , O O
110 May NNP B-NP O
110 , , O O
110 1995 CD O O
110 for IN B-VP O
110 check NN B-NP O
110 of IN B-VP O
110 blood NN B-NP O
110 pressure NN I-NP O
110 and CC O O
111 frequent JJ B-NP O
111 blood NN I-NP O
111 follow-up NN I-NP O
111 with IN B-VP O
111 Dr NNP B-NP O
111 Pillon NNP I-NP O
111 on IN B-VP O
111 Monday NNP B-NP O
111 , , O O
111 July NNP B-NP O
111 , , O O
112 1995 CD O O
113 Dictated NNP B-NP O
113 By: NNP I-NP O
113 EMIL NNP I-NP O
113 LANDING NNP I-NP O
113 , , O O
113 M.D NNP B-NP O
114 Attending: NNP I-NP O
114 BLAIR NNP I-NP O
114 AUJLA NNP I-NP O
114 , , O O
114 M.D NNP B-NP O
114 MT83 NNP I-NP O
115 HO786/2561 NNP I-NP O
116 Batch: NNP I-NP O
116 2699 CD O O
116 Index NNP B-NP O
116 No NNP I-NP O
116 A6KVGF44QE NNP I-NP O
116 D: NNP I-NP O
116 3/17/95 CD O O
117 T: NNP B-NP O
117 0/13/95 CD O O
118 CC: NNP B-NP O
118 1 CD O O
118 MORGAN NNP B-NP O
118 GROSSEN NNP I-NP O
118 , , O O
118 M.D NNP B-NP O
118 MT83 NNP I-NP O
118 CARDIOLOGY NNP I-NP O
119 2 CD O O
119 BRITT NNP B-NP O
119 GUDE NNP I-NP O
119 , , O O
119 M.D NNP B-NP O
119 DI49 NNP I-NP O
120 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #329376 VBZ O O
3 183820439 CD O O
3 LHC NNP B-NP O
3 70360567 CD O O
3 775030 CD O O
3 0/19/2001 CD O O
3 12:00:00 CD O O
3 AM NNP B-NP O
3 non-cardiac JJ B-NP O
3 chest NN I-NP O
3 pain NN I-NP O
3 DIS NNP I-NP O
3 Admission NNP I-NP O
3 Date: NNP I-NP O
3 10/4/2001 CD O O
3 Report NNP B-NP O
3 Status: NNP I-NP O
4 Discharge NNP I-NP O
4 Date: NNP I-NP O
4 7/14/2001 CD O O
5 ****** NNP B-NP O
5 DISCHARGE NNP I-NP O
5 ORDERS NNP I-NP O
5 ****** NNP I-NP O
6 CODE NNP I-NP O
6 , , O O
6 AUGUSTINE NNP B-NP O
6 689-97-29-0 CD O O
7 Waynetpidsran NNP B-NP O
7 Ri NNP I-NP O
8 Service: NNP I-NP O
8 CAR NNP I-NP O
9 DISCHARGE NNP I-NP O
9 PATIENT NNP I-NP O
9 ON: NNP I-NP O
9 11/1/01 CD O O
9 AT NNP B-NP O
9 05:00 CD O O
9 PM NNP B-NP O
10 CONTINGENT NNP I-NP O
10 UPON NNP I-NP O
10 HO NNP I-NP O
10 evaluation NN I-NP O
11 WILL NNP I-NP O
11 D/C NNP I-NP O
11 ORDER NNP I-NP O
11 BE NNP I-NP O
11 USED NNP I-NP O
11 AS IN B-VP O
11 THE NNP B-NP O
11 D/C NNP I-NP O
11 SUMMARY: NNP I-NP O
11 YES NNP I-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ECASA NNP I-NP B-m
16 ( ( O I-m
16 ASPIRIN NNP B-NP I-m
16 ENTERIC NNP I-NP I-m
16 COATED NNP I-NP I-m
16 ) ) O I-m
16 325 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 Override NNP I-NP O
17 Notice: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 11/1/01 CD O O
17 by IN B-VP O
18 FRIEHAUF NNP B-NP O
18 , , O O
18 LUTHER NNP B-NP O
18 G NNP I-NP O
18 , , O O
18 M.D NNP B-NP O
19 on IN B-VP O
19 order NN B-NP O
19 for IN B-VP O
19 COUMADIN NNP B-NP B-m
19 PO NNP I-NP B-mo
19 ( ( O O
19 ref JJ O O
19 # # O O
19 44750239 CD O O
19 ) ) O O
20 POTENTIALLY NNP B-NP O
20 SERIOUS NNP I-NP O
20 INTERACTION: NNP I-NP O
20 ASPIRIN NNP I-NP B-m
20 &amp; NNP I-NP O
20 WARFARIN NNP I-NP B-m
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: NN B-NP O
21 will MD O O
21 monitor VB O O
22 CAPTOPRIL NNP B-NP B-m
22 12.5 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 TID NNP I-NP B-f
22 HOLD NNP I-NP O
22 IF: NNP I-NP O
22 SBP NNP I-NP O
22 &lt; NNP I-NP O
22 100 CD O O
22 AND NNP B-NP O
22 CALL NNP I-NP O
22 HO NNP I-NP O
23 Food/Drug NNP I-NP O
23 Interaction NNP I-NP O
23 Instruction NNP I-NP O
24 Give NNP I-NP O
24 on IN B-VP O
24 an DT B-NP O
24 empty JJ I-NP O
24 stomach NN I-NP O
24 ( ( O O
24 give JJ O O
24 1hr CD O O
24 before IN B-VP O
24 or CC O O
24 2hr CD O O
24 after IN B-VP O
25 food NN B-NP O
25 ) ) O O
26 Override NNP B-NP O
26 Notice: NNP I-NP O
26 Override NNP I-NP O
26 added VBD B-VP O
26 on IN B-VP O
26 10/24/01 CD O O
26 by IN B-VP O
27 HOOTMAN NNP B-NP O
27 , , O O
27 STUART NNP B-NP O
27 R NNP I-NP O
27 , , O O
27 M.D NNP B-NP O
28 on IN B-VP O
28 order NN B-NP O
28 for IN B-VP O
28 ALDACTONE NNP B-NP B-m
28 PO NNP I-NP B-mo
28 ( ( O O
28 ref JJ O O
28 # # O O
28 94240639 CD O O
28 ) ) O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 CAPTOPRIL NNP I-NP B-m
29 &amp; NNP I-NP O
29 SPIRONOLACTONE NNP I-NP B-m
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 AWARE NNP I-NP O
30 Previous NNP I-NP O
30 override IN B-VP O
30 information: JJ B-NP O
31 Override NNP I-NP O
31 added VBD B-VP O
31 on IN B-VP O
31 10/24/01 CD O O
31 by IN B-VP O
31 POUNDERS NNS B-NP O
31 , , O O
31 PHIL NNP B-NP O
31 E NNP I-NP O
31 , , O O
31 M.D NNP B-NP O
32 POTENTIALLY NNP I-NP O
32 SERIOUS NNP I-NP O
32 INTERACTION: NNP I-NP O
32 POTASSIUM NNP I-NP B-m
32 CHLORIDE NNP I-NP I-m
32 &amp; NNP I-NP O
33 CAPTOPRIL NNP I-NP B-m
33 Reason NNP I-NP O
33 for IN B-VP O
33 override: NN B-NP O
33 AWARE NNP I-NP O
34 DIGOXIN NNP I-NP B-m
34 0.125 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QOD NNP I-NP B-f
35 LASIX NNP I-NP B-m
35 ( ( O I-m
35 FUROSEMIDE NNP B-NP I-m
35 ) ) O I-m
35 80 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 BID NNP I-NP B-f
36 NIFEREX-150 NNP I-NP B-m
36 150 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 BID NNP I-NP B-f
37 NITROGLYCERIN NNP I-NP B-m
37 1/150 CD O I-m
37 ( ( O I-m
37 0.4 CD O I-m
37 MG NNP B-NP I-m
37 ) ) O I-m
37 1 CD O B-do
37 TAB NNP B-NP I-do
37 SL NNP I-NP B-mo
37 q5min VBD B-VP B-f
37 x $ O O
37 3 CD O O
38 PRN NNP B-NP O
38 chest NN I-NP B-r
38 pain NN I-NP I-r
38 HOLD NNP I-NP O
38 IF: NNP I-NP O
38 SBP NNP I-NP O
38 &lt; VBD B-VP O
38 100 CD O O
39 ALDACTONE NNP B-NP B-m
39 ( ( O I-m
39 SPIRONOLACTONE NNP B-NP I-m
39 ) ) O I-m
39 25 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 QD NNP I-NP B-f
40 Food/Drug NNP I-NP O
40 Interaction NNP I-NP O
40 Instruction NNP I-NP O
40 Give NNP I-NP O
40 with IN B-VP O
40 meals NNS B-NP O
41 Alert NNP I-NP O
41 overridden: VBD B-VP O
41 Override NNP B-NP O
41 added VBD B-VP O
41 on IN B-VP O
41 10/24/01 CD O O
41 by IN B-VP O
42 STEURY NNP B-NP O
42 , , O O
42 JERROD NNP B-NP O
42 J NNP I-NP O
42 , , O O
42 M.D NNP B-NP O
43 SERIOUS NNP I-NP O
43 INTERACTION: NNP I-NP O
43 POTASSIUM NNP I-NP B-m
43 CHLORIDE NNP I-NP I-m
43 &amp; NNP I-NP O
43 SPIRONOLACTONE NNP I-NP B-m
44 POTENTIALLY NNP I-NP O
44 SERIOUS NNP I-NP O
44 INTERACTION: NNP I-NP O
44 CAPTOPRIL NNP I-NP B-m
44 &amp; NNP I-NP O
44 SPIRONOLACTONE NNP I-NP B-m
45 Reason NNP I-NP O
45 for IN B-VP O
45 override: NN B-NP O
45 AWARE NNP I-NP O
46 COUMADIN NNP I-NP B-m
46 ( ( O I-m
46 WARFARIN NNP B-NP I-m
46 SODIUM NNP I-NP I-m
46 ) ) O I-m
46 6 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 QD NNP I-NP B-f
47 Food/Drug NNP I-NP O
47 Interaction NNP I-NP O
47 Instruction NNP I-NP O
48 No NNP I-NP O
48 high JJ B-NP O
48 Vitamin-K NNP I-NP O
48 containing VBG O O
48 foods NNS B-NP O
49 Alert NNP I-NP O
49 overridden: VBD B-VP O
49 Override NNP B-NP O
49 added VBD B-VP O
49 on IN B-VP O
49 11/1/01 CD O O
49 by IN B-VP O
50 JANCZEWSKI NNP B-NP O
50 , , O O
50 BRADFORD NNP B-NP O
50 L NNP I-NP O
50 , , O O
50 M.D NNP B-NP O
51 POTENTIALLY NNP I-NP O
51 SERIOUS NNP I-NP O
51 INTERACTION: NNP I-NP O
51 ASPIRIN NNP I-NP B-m
51 &amp; NNP I-NP O
51 WARFARIN NNP I-NP B-m
52 Reason NNP I-NP O
52 for IN B-VP O
52 override: NN B-NP O
52 will MD O O
52 monitor VB O O
53 CARVEDILOL NNP B-NP B-m
53 3.125 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 BID NNP I-NP B-f
53 HOLD NNP I-NP O
53 IF: NNP I-NP O
53 SBP NNP I-NP O
53 &lt; VBD B-VP O
53 100 CD O O
54 Food/Drug NNP B-NP O
54 Interaction NNP I-NP O
54 Instruction NNP I-NP O
55 Take NNP I-NP O
55 consistently RB O O
55 with IN B-VP O
55 meals NNS B-NP O
55 or CC O O
55 on IN B-VP O
55 empty JJ B-NP O
55 stomach NN I-NP O
56 Number NNP I-NP O
56 of IN B-VP O
56 Doses NNP B-NP O
56 Required NNP I-NP O
56 ( ( O O
56 approximate JJ B-NP O
56 ): NN I-NP O
56 5 CD O B-du
57 CELEXA NNP B-NP B-m
57 ( ( O I-m
57 CITALOPRAM NNP B-NP I-m
57 ) ) O I-m
57 20 CD O B-do
57 MG NNP B-NP I-do
57 PO NNP I-NP B-mo
57 QD NNP I-NP B-f
58 DIET: NNP I-NP O
58 House NNP I-NP O
58 / VBD B-VP O
58 Low NNP B-NP O
58 chol/low NN I-NP O
58 sat VBD B-VP O
58 fat JJ B-NP O
59 Activity NNP I-NP O
59 - : O O
59 As IN B-VP O
59 tolerated JJ B-NP O
60 RETURN NNP I-NP O
60 TO NNP I-NP O
60 WORK: NNP I-NP O
60 After IN B-VP O
60 Appt NNP B-NP O
60 with IN B-VP O
60 local JJ B-NP O
60 physician NN I-NP O
61 FOLLOW NNP I-NP O
61 UP NNP I-NP O
61 APPOINTMENT( NNP I-NP O
61 S NNP I-NP O
61 ): NNP I-NP O
62 Dr NNP I-NP O
62 Denny NNP I-NP O
62 Wolfard NNP I-NP O
62 within IN B-VP O
62 1-2 JJ B-NP O
62 weeks NNS I-NP O
62 , , O O
63 Dr NNP B-NP O
63 Highbaugh NNP I-NP O
63 within IN B-VP O
63 one CD O O
63 week NN B-NP O
63 , , O O
64 ALLERGY: NNP B-NP O
64 Iv NNP I-NP O
64 contrast VBD B-VP O
64 dyes JJ B-NP O
65 ADMIT NNP I-NP O
65 DIAGNOSIS: NNP I-NP O
66 chest JJS B-NP O
66 pain NN I-NP O
66 , , O O
66 R/O NNP B-NP O
66 MI NNP I-NP O
67 PRINCIPAL NNP I-NP O
67 DISCHARGE NNP I-NP O
67 DIAGNOSIS NNP I-NP O
67 ;Responsible JJ O O
67 After IN B-VP O
67 Study NNP B-NP O
67 for IN B-VP O
67 Causing NNP B-NP O
67 Admission NNP I-NP O
67 ) ) O O
68 non-cardiac JJ B-NP O
68 chest NN I-NP O
68 pain NN I-NP O
69 OTHER NNP I-NP O
69 DIAGNOSIS;Conditions NNP I-NP O
69 , , O O
69 Infections NNP B-NP O
69 , , O O
69 Complications NNP B-NP O
69 , , O O
69 affecting VBG O O
69 Treatment/Stay NNP B-NP O
70 Chronic NNP I-NP O
70 AF NNP I-NP O
70 since IN B-VP O
70 1/10 CD O O
70 , , O O
70 HTN NNP B-NP O
70 , , O O
70 BPH NNP B-NP O
70 , , O O
70 ventricular JJ B-NP O
70 pacemaker NN I-NP O
70 , , O O
70 h/o NN B-NP O
70 CHF NNP I-NP O
70 , , O O
70 left VBD B-VP O
71 buttock NN B-NP O
71 hematoma NN I-NP O
71 , , O O
71 S/P NNP B-NP O
71 TURP NNP I-NP O
71 , , O O
71 s/p JJ B-NP O
71 TV NN I-NP O
71 , , O O
71 MV NNP B-NP O
71 repair NN I-NP O
71 10/23 CD O O
71 , , O O
71 ischemic JJ B-NP O
72 cardiomyopathy NN I-NP O
73 OPERATIONS NNP I-NP O
73 AND NNP I-NP O
73 PROCEDURES: NNP I-NP O
74 OTHER NNP I-NP O
74 TREATMENTS/PROCEDURES NNP I-NP O
74 ( ( O O
74 NOT NNP B-NP O
74 IN NNP I-NP O
74 O.R NNP I-NP O
74 ) ) O O
75 none NN B-NP O
76 BRIEF NNP I-NP O
76 RESUME NNP I-NP O
76 OF NNP I-NP O
76 HOSPITAL NNP I-NP O
76 COURSE: NNP I-NP O
77 78 CD O O
77 yo NN B-NP O
77 man NN I-NP O
77 who WP O O
77 presents VBZ O O
77 with IN B-VP O
77 2 CD O O
77 episodes NNS B-NP O
77 of IN B-VP O
77 SSCP NNP B-NP O
77 Recently NNP I-NP O
77 had VBD B-VP O
77 MV NNP B-NP O
77 and CC O O
77 TV NNP B-NP O
78 repair NN I-NP O
78 with IN B-VP O
78 SVG NNP B-NP O
78 to TO O O
78 OM1 NNP B-NP O
78 Reported NNP I-NP O
78 to TO O O
78 have VB O O
78 80% CD O O
78 diag NNS B-NP O
78 , , O O
78 70% CD O O
78 LCX NNP B-NP O
78 from IN B-VP O
78 a DT B-NP O
78 cath NN I-NP O
79 in IN B-VP O
79 Ohio NNP B-NP O
79 in IN B-VP O
79 10/25 CD O O
79 Also RB O O
79 h/o JJ B-NP O
79 HTN NNP I-NP O
79 , , O O
79 DM NNP B-NP O
79 2 CD O O
79 ( ( O O
79 diet JJ O O
79 controlled VBN O O
79 ) ) O O
79 , , O O
79 AF NNP B-NP O
79 , , O O
80 ventricular JJ B-NP O
80 pacemaker NN I-NP O
80 , , O O
80 ischemic JJ B-NP O
80 CMP NNP I-NP O
80 , , O O
80 EF NNP B-NP O
80 30% CD O O
80 CP NNP B-NP O
80 occurred VBD B-VP O
80 while IN B-VP O
80 at IN B-VP O
81 rest NN B-NP O
81 , , O O
81 no DT B-NP O
81 radiation NN I-NP O
81 and CC O O
81 no DT O O
81 associated VBN O O
81 symptoms NNS B-NP O
81 1st CD O O
81 episode NN B-NP O
81 was VBD B-VP O
81 5/25 CD O O
81 , , O O
82 resolved VBD B-VP O
82 spontaneously RB O O
82 Came NNP B-NP O
82 to TO O O
82 ED NNP B-NP O
82 , , O O
82 EKG NNP B-NP O
82 was VBD B-VP O
82 paced VBN O O
82 , , O O
82 CK NNP B-NP O
82 flat JJ O O
82 , , O O
82 TnI NNP B-NP O
83 elevated VBD B-VP O
83 at IN B-VP O
83 0.17 CD O O
83 , , O O
83 similar JJ O O
83 to TO O O
83 value NN B-NP O
83 on IN B-VP O
83 0/12 CD O O
83 when WRB O O
83 pt NN B-NP O
83 came VBD B-VP O
83 in IN B-VP O
83 for IN B-VP O
83 a DT B-NP O
83 TIA NNP I-NP O
84 Mr NNP I-NP O
84 Faiella NNP I-NP O
84 was VBD B-VP O
84 sent VBN O O
84 home NN B-NP O
84 with IN B-VP O
84 sl JJ B-NP B-mo
84 nitro NNS I-NP B-m
84 Pain NNP I-NP B-r
84 occurred VBD B-VP O
84 again RB O O
84 while IN B-VP O
85 watching VBG O O
85 TV NN B-NP O
85 , , O O
85 resolved VBD B-VP O
85 with IN B-VP O
85 one CD O O
85 sl NN B-NP B-mo
85 nitro NN I-NP B-m
85 Was NNP I-NP O
85 admitted VBN O O
85 for IN B-VP O
85 workup NN B-NP O
85 of IN B-VP O
86 possible JJ B-NP O
86 ischemia NN I-NP O
86 Currently NNP I-NP O
86 CP NNP I-NP O
86 free JJ O O
87 1 CD O O
87 CV: NNP B-NP O
87 Ischemia: NNP I-NP O
87 ruled VBD B-VP O
87 out RP O O
87 for IN B-VP O
87 MI NNP B-NP O
87 , , O O
87 added VBD B-VP O
87 isordil NN B-NP B-m
87 to TO O O
87 regimen VB O O
87 , , O O
87 ASA NNP B-NP B-m
88 Continue NNP I-NP O
88 carvedilol NN I-NP B-m
88 , , O O
88 captopril VBP O B-m
88 Likely JJ O O
88 to TO O O
88 have VB O O
88 CAD NNP B-NP O
88 , , O O
88 Adenosine NNP B-NP O
88 MIBI NNP I-NP O
89 revealed VBD B-VP O
89 fixed VBN O O
89 inf/lat JJ B-NP O
89 defect NN I-NP O
89 , , O O
89 consistent JJ O O
89 with IN B-VP O
89 LCX NNP B-NP O
89 disease NN I-NP O
89 No NNP I-NP O
90 reversible NN I-NP O
90 defects NNS I-NP O
90 Since IN B-VP O
90 chest NN B-NP O
90 pain NN I-NP O
90 is VBZ O O
90 unlikely JJ O O
90 to TO O O
90 be VB O O
90 cardiac JJ O O
90 in IN B-VP O
91 origin NN B-NP O
91 , , O O
91 will MD O O
91 stop VB O O
91 nitrates NNS B-NP B-m
91 Pt NNP I-NP O
91 was VBD B-VP O
91 able JJ O O
91 to TO O O
91 amubulate VB O O
91 w/o JJ B-NP O
91 SOB NNP I-NP O
91 or CC O O
91 CP NNP B-NP O
92 CHF: NNP I-NP O
92 euvolemic JJ B-NP O
92 continue NN I-NP O
92 lasix NN I-NP B-m
92 , , O O
92 aldactone NN B-NP B-m
92 , , O O
92 digoxin NN B-NP B-m
93 2 CD O O
93 Endo: NNP B-NP O
93 DM NNP I-NP O
93 2 CD O O
93 , , O O
93 diet NN B-NP O
93 controlled VBD B-VP O
93 HbA1C NNP B-NP O
93 5.8% CD O O
94 3 CD O O
94 Renal: NNP B-NP O
94 baseline NN I-NP O
94 Cr NNP I-NP O
94 2.0 CD O O
95 4 CD O O
95 Neuro: NNPS B-NP O
95 recent JJ B-NP O
95 history NN I-NP O
95 of IN B-VP O
95 TIA NNP B-NP B-r
95 , , O O
95 on IN B-VP O
95 coumadin NN B-NP B-m
95 , , O O
95 may MD O O
95 not RB O O
95 want VB O O
95 to TO O O
95 reverse VB O O
96 anticoagulation NN B-NP O
96 for IN B-VP O
96 possibility NN B-NP O
96 of IN B-VP O
96 cath NN B-NP O
97 5 CD O O
97 Heme: NNP B-NP O
97 coumadin NN I-NP B-m
97 was VBD B-VP O
97 held VBN O O
97 for IN B-VP O
97 possible JJ B-NP O
97 cath NN I-NP O
97 , , O O
97 but CC O O
97 was VBD B-VP O
97 restarted VBN O O
97 on IN B-VP O
97 day NN B-NP O
98 of IN B-VP O
98 discharge NN B-NP O
99 ADDITIONAL NNP I-NP O
99 COMMENTS: NNP I-NP O
99 You PRP O O
99 were VBD B-VP O
99 admitted VBN O O
99 to TO O O
99 the DT B-NP O
99 hospital NN I-NP O
99 for IN B-VP O
99 chest NN B-NP O
99 pain NN I-NP O
99 , , O O
99 and CC O O
99 we PRP O O
99 have VBP O O
99 made VBN O O
99 sure JJ O O
100 that IN B-VP O
100 you PRP O O
100 are VBP O O
100 not RB O O
100 and CC O O
100 did VBD B-VP O
100 not RB O O
100 have VB O O
100 a DT B-NP O
100 heart NN I-NP O
100 attack NN I-NP O
100 We PRP O O
100 also RB O O
100 did VBD B-VP O
100 a DT B-NP O
101 perfusion NN I-NP O
101 test NN I-NP O
101 to TO O O
101 make VB O O
101 sure JJ O O
101 that IN B-VP O
101 your PRP$ O O
101 heart NN B-NP O
101 muscle NN I-NP O
101 is VBZ O O
101 receiving VBG O O
102 adequate JJ B-NP O
102 amounts NNS I-NP O
102 of IN B-VP O
102 blood NN B-NP O
102 flow NN I-NP O
102 If IN B-VP O
102 your PRP$ O O
102 chest JJS B-NP O
102 pain NN I-NP O
102 recurrs NN I-NP O
102 , , O O
102 gets VBZ O O
103 worse JJR O O
103 , , O O
103 or CC O O
103 you PRP O O
103 become VBP O O
103 short JJ O O
103 of IN B-VP O
103 breath NN B-NP O
103 , , O O
103 please VB O O
103 call VB O O
103 you PRP O O
103 cardiologist JJ O O
103 and CC O O
104 return NN B-NP O
104 to TO O O
104 the DT B-NP O
104 emergency NN I-NP O
104 department NN I-NP O
105 DISCHARGE NNP I-NP O
105 CONDITION: NNP I-NP O
105 Stable NNP I-NP O
106 TO NNP I-NP O
106 DO/PLAN: NNP I-NP O
107 Make NNP I-NP O
107 appointment NN I-NP O
107 with IN B-VP O
107 Dr NNP B-NP O
107 Moxness NNP I-NP O
107 within IN B-VP O
107 the DT B-NP O
107 next JJ I-NP O
107 1-2 JJ I-NP O
107 weeks NNS I-NP O
108 VNA: NNP I-NP O
108 Please NNP I-NP O
108 oversee VB O O
108 medications NNS B-NP O
108 , , O O
108 check NN B-NP O
108 vitals NNS I-NP O
108 , , O O
108 and CC O O
108 draw VB O O
108 PT/INR NNP B-NP O
108 once RB O O
108 a DT B-NP O
109 week NN I-NP O
109 , , O O
109 starting VBG O O
109 Thrusday JJ O O
109 0/22/01 CD O O
110 PT: NNP B-NP O
110 Please NNP I-NP O
110 help VB O O
110 Mr NNP B-NP O
110 Muskett NNP I-NP O
110 regain NN I-NP O
110 strength NN I-NP O
110 , , O O
110 flexibility NN B-NP O
110 and CC O O
110 range NN B-NP O
110 of IN B-VP O
111 motion NN B-NP O
112 No NNP I-NP O
112 dictated VBD B-VP O
112 summary JJ B-NP O
113 ENTERED NNP I-NP O
113 BY: NNP I-NP O
113 NINKE NNP I-NP O
113 , , O O
113 GARY NNP B-NP O
113 H NNP I-NP O
113 , , O O
113 M.D NNP B-NP O
113 ( ( O O
113 YK88 NNP B-NP O
113 ) ) O O
113 11/1/01 CD O O
113 @ $ O O
113 12 CD O O
114 ****** JJ B-NP O
114 END NN I-NP O
114 OF NNP I-NP O
114 DISCHARGE NNP I-NP O
114 ORDERS NNP I-NP O
114 ****** NNP I-NP O
115 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #333193 VBZ O O
2 783724033 CD O O
2 SCMH NNP B-NP O
2 69750620 CD O O
2 7272147 CD O O
2 11/24/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ischemic JJ B-NP O
2 foot NN I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/12/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/17/2006 CD O O
4 ATTENDING: NNP B-NP O
4 KATO NNP I-NP O
4 , , O O
4 WHITNEY NNP B-NP O
4 CRISTOPHER NNP I-NP O
5 VASCULAR NNP I-NP O
5 SURGERY NNP I-NP O
6 PRINCIPAL NNP I-NP O
6 DIAGNOSIS: NNP I-NP O
6 Right NNP I-NP O
6 foot NN I-NP O
6 gangrene NN I-NP O
7 DISCHARGE NNP I-NP O
7 DIAGNOSIS: NNP I-NP O
7 Right NNP I-NP O
7 foot NN I-NP O
7 gangrene NN I-NP O
8 OTHER NNP I-NP O
8 MEDICAL NNP I-NP O
8 ISSUES NNP I-NP O
8 CONSIDERED NNP I-NP O
8 AT NNP I-NP O
8 THIS NNP I-NP O
8 TIME: NNP I-NP O
8 Diabetes NNP I-NP O
8 type VBD B-VP O
8 2 CD O O
8 , , O O
9 peripheral JJ B-NP O
9 vascular JJ I-NP O
9 occlusive JJ I-NP O
9 disease NN I-NP O
9 , , O O
9 congestive JJ B-NP O
9 heart NN I-NP O
9 failure NN I-NP O
9 , , O O
10 coronary JJ B-NP O
10 artery NN I-NP O
10 disease NN I-NP O
10 , , O O
10 status NN B-NP O
10 post NN I-NP O
10 left VBD B-VP O
10 knee JJ B-NP O
10 amputation NN I-NP O
10 , , O O
11 depression NN B-NP O
11 , , O O
11 and CC O O
11 dementia JJ B-NP O
12 BRIEF NNP I-NP O
12 HISTORY NNP I-NP O
12 OF NNP I-NP O
12 PHYSICAL NNP I-NP O
12 ILLNESS: NNP I-NP O
12 The DT B-NP O
12 patient NN I-NP O
12 is VBZ O O
12 a DT B-NP O
12 90+-year-old JJ I-NP O
13 female NN I-NP O
13 with IN B-VP O
13 multiple JJ B-NP O
13 medical JJ I-NP O
13 problems NNS I-NP O
13 including VBG O O
13 dementia NN B-NP O
13 , , O O
14 coronary JJ B-NP O
14 artery NN I-NP O
14 disease NN I-NP O
14 , , O O
14 diabetes VBZ O O
14 , , O O
14 and CC O O
14 PVOD NNP B-NP O
14 , , O O
14 who WP O O
14 presented VBD B-VP O
14 to TO O O
14 the DT B-NP O
15 Trinmo NNP I-NP O
15 Rybay NNP I-NP O
15 Bethmorgreene NNP I-NP O
15 Burgstern NNP I-NP O
15 Medical NNP I-NP O
15 University NNP I-NP O
15 Of IN B-VP O
15 Medical NNP B-NP O
15 Center NNP I-NP O
15 Department NNP I-NP O
15 on IN B-VP O
15 5/1/06 CD O O
15 for IN B-VP O
16 an DT O O
16 intermittently RB O O
16 cold JJ O O
16 and CC O O
16 blue JJ B-NP O
16 foot NN I-NP O
16 Gangrene NNP I-NP O
16 was VBD B-VP O
16 noticed VBN O O
16 in IN B-VP O
16 the DT O O
16 second JJ O O
17 and CC O O
17 third JJ B-NP O
17 right JJ I-NP O
17 lower JJR I-NP O
17 extremity NN I-NP O
17 toes NNS I-NP O
17 She PRP O O
17 was VBD B-VP O
17 admitted VBN O O
17 for IN B-VP O
18 possible JJ B-NP O
18 amputation NN I-NP O
19 PAST NNP I-NP O
19 MEDICAL NNP I-NP O
19 HISTORY: NNP I-NP O
19 Significant NNP I-NP O
19 for IN B-VP O
19 diabetes NNS B-NP O
19 type JJ O O
19 2 CD O O
19 , , O O
19 coronary JJ B-NP O
20 artery NN I-NP O
20 disease NN I-NP O
20 status NN I-NP O
20 post NN I-NP O
20 myocardial JJ B-NP O
20 infarction NN I-NP O
20 , , O O
20 anemia NN B-NP O
20 , , O O
21 congestive JJ B-NP O
21 heart NN I-NP O
21 failure NN I-NP O
21 , , O O
21 asthma NN B-NP O
21 , , O O
21 depression NN B-NP O
21 , , O O
21 neurogenic JJ B-NP O
21 bladder NN I-NP O
21 , , O O
22 and CC O O
22 dementia NN B-NP O
23 PAST NNP I-NP O
23 SURGICAL NNP I-NP O
23 HISTORY: NNP I-NP O
23 Significant NNP I-NP O
23 for IN B-VP O
23 left VBD B-VP O
23 above-knee JJ B-NP O
24 amputation NN I-NP O
24 in IN B-VP O
24 4/10 CD O O
24 , , O O
24 left VBD B-VP O
24 superficial JJ B-NP O
24 femoral JJ I-NP O
24 artery NN I-NP O
24 to TO O O
24 peroneal VB O O
25 artery JJ B-NP O
25 bypass NN I-NP O
25 with IN B-VP O
25 graft NN B-NP O
25 on IN B-VP O
25 3/22 CD O O
25 , , O O
25 a DT B-NP O
25 right JJ I-NP O
25 hip NN I-NP O
25 arthroplasty NN I-NP O
25 in IN B-VP O
26 7/26 CD O O
26 , , O O
26 and CC O O
26 a DT B-NP O
26 remote JJ I-NP O
26 history NN I-NP O
26 of IN B-VP O
26 cholecystectomy NN B-NP O
26 and CC O O
26 appendectomy JJ B-NP O
27 HOME NNP I-NP O
27 MEDICATIONS: NNP I-NP O
28 1 CD O O
28 Trazodone NNP B-NP B-m
28 50 CD O B-do
28 mg NN B-NP I-do
28 nightly RB O B-f
29 2 CD O O
29 Celexa NNP B-NP B-m
29 20 CD O B-do
29 mg VBD B-VP I-do
29 daily RB O B-f
30 3 CD O O
30 Lactulose JJ O B-m
30 30 CD O B-do
30 mg NN B-NP I-do
30 q.a.m NN I-NP B-f
31 4 CD O O
31 FiberCon NNP B-NP B-m
31 one CD O B-do
31 tablet NN B-NP I-do
32 5 CD O O
32 Hydrochlorothiazide NNP B-NP B-m
32 25 CD O B-do
32 mg VBD B-VP I-do
32 daily RB O B-f
33 6 CD O O
33 MVI NNP B-NP B-m
33 daily RB O B-f
34 7 CD O O
34 Synthroid NNP B-NP B-m
34 25 CD O B-do
34 mcg VBD B-VP I-do
34 daily RB O B-f
35 8 CD O O
35 Colace NNP B-NP B-m
35 100 CD O B-do
35 mg NN B-NP I-do
35 b.i.d NN I-NP B-f
36 9 CD O O
36 Novolin NNP B-NP B-m
36 Novolin NNP I-NP B-m
36 30 CD O B-do
36 units NNS B-NP I-do
36 q.a.m RB O B-f
36 , , O O
36 7 CD O B-do
36 units NNS B-NP I-do
36 q.p.m RB O B-f
37 10 CD O O
37 Novolin NNP B-NP B-m
37 sliding VBG O B-do
37 scale JJ O I-do
38 11 CD O O
38 Hydrochlorothiazide NNP B-NP B-m
38 25 CD O B-do
38 mg VBD B-VP I-do
38 daily RB O B-f
39 12 CD O O
39 Zyprexa NNP B-NP B-m
39 2.5 CD O B-do
39 mg NN B-NP I-do
39 nightly RB O B-f
40 ALLERGIES: NNP B-NP O
40 She PRP O O
40 has VBZ O O
40 an DT B-NP O
40 allergy NN I-NP O
40 to TO O O
40 penicillin VB O O
40 and CC O O
41 fluoroquinolones VB O O
42 SOCIAL NNP B-NP O
42 HISTORY: NNP I-NP O
42 She PRP O O
42 lives VBZ O O
42 in IN B-VP O
42 a DT B-NP O
42 nursing NN I-NP O
42 home NN I-NP O
42 She PRP O O
42 has VBZ O O
42 not RB O O
42 been VBN O O
43 ambulatory VBN O O
43 at IN B-VP O
43 baseline NN B-NP O
43 status NN I-NP O
43 post NN I-NP O
43 her PRP$ O O
43 left JJ B-NP O
43 AKA NNP I-NP O
43 She PRP O O
43 is VBZ O O
44 wheelchair JJ O O
44 bound RB O O
45 PHYSICAL NNP B-NP O
45 EXAMINATION: NNP I-NP O
45 At IN B-VP O
45 the DT B-NP O
45 time NN I-NP O
45 of IN B-VP O
45 admission NN B-NP O
45 , , O O
45 she PRP O O
45 was VBD B-VP O
46 bradycardic JJ O O
46 to TO O O
46 47 CD O O
46 , , O O
46 otherwise RB O O
46 blood NN B-NP O
46 pressure NN I-NP O
46 and CC O O
46 vital JJ B-NP O
46 signs NNS I-NP O
46 were VBD B-VP O
47 stable JJ O O
47 In IN B-VP O
47 general JJ O O
47 , , O O
47 she PRP O O
47 was VBD B-VP O
47 confused VBN O O
47 , , O O
47 alert JJ O O
47 and CC O O
47 oriented JJ B-NP O
47 x0 NN I-NP O
47 but CC O O
48 in IN B-VP O
48 no DT B-NP O
48 acute JJ I-NP O
48 distress NN I-NP O
48 On IN B-VP O
48 her PRP$ O O
48 extremities NNS B-NP O
48 , , O O
48 on IN B-VP O
48 the DT B-NP O
48 left NN I-NP O
48 she PRP O O
48 had VBD B-VP O
48 an DT B-NP O
49 above-knee JJ I-NP O
49 amputation NN I-NP O
49 with IN B-VP O
49 stump JJ B-NP O
49 intact NN I-NP O
49 without IN B-VP O
49 ulcers NNS B-NP O
49 Her PRP$ O O
50 right JJ B-NP O
50 foot NN I-NP O
50 was VBD B-VP O
50 cool JJ O O
50 to TO O O
50 the DT B-NP O
50 mid JJ I-NP O
50 foot NN I-NP O
50 proximally RB O O
50 There EX O O
50 was VBD B-VP O
50 bluish JJ B-NP O
51 discoloration NN I-NP O
51 of IN B-VP O
51 toes NNS B-NP O
51 one CD O O
51 , , O O
51 two CD O O
51 , , O O
51 and CC O O
51 three CD O O
51 Pulses NNS B-NP O
51 , , O O
51 there EX O O
51 was VBD B-VP O
51 2+ CD O O
52 femoral JJ B-NP O
52 pulses NNS I-NP O
52 bilaterally RB O O
52 and CC O O
52 monophasic JJ B-NP O
52 PT NNP I-NP O
52 on IN B-VP O
52 the DT B-NP O
52 right NN I-NP O
52 The DT B-NP O
53 DP NNP I-NP O
53 was VBD B-VP O
53 not RB O O
53 dopplerable JJ B-NP O
54 HOSPITAL NNP I-NP O
54 COURSE: NNP I-NP O
54 The DT B-NP O
54 patient JJ I-NP O
54 underwent NN I-NP O
54 and CC O O
54 tolerated VBD B-VP O
54 a DT B-NP O
54 right JJ I-NP O
54 AKA NNP I-NP O
54 on IN B-VP O
54 7/8/06 CD O O
55 without IN B-VP O
55 any DT B-NP O
55 complications NNS I-NP O
55 , , O O
55 and CC O O
55 after IN B-VP O
55 recovery NN B-NP O
55 from IN B-VP O
55 anesthesia NN B-NP O
55 was VBD B-VP O
56 admitted VBN O O
56 to TO O O
56 the DT B-NP O
56 general JJ I-NP O
56 care NN I-NP O
56 floor NN I-NP O
56 Diet NNP I-NP O
56 was VBD B-VP O
56 advanced VBN O O
56 as IN B-VP O
57 tolerated VBN O O
57 The DT B-NP B-r
57 pain NN I-NP I-r
57 was VBD B-VP O
57 well RB O O
57 controlled VBN O O
57 with IN B-VP O
57 oral JJ B-NP B-m
57 pain NN I-NP O
58 medications NNS I-NP O
58 The DT B-NP O
58 patient NN I-NP O
58 was VBD B-VP O
58 evaluated VBN O O
58 by IN B-VP O
58 physical JJ B-NP O
58 therapy NN I-NP O
58 Her NNP I-NP O
59 stump NN I-NP O
59 wound NN I-NP O
59 was VBD B-VP O
59 healing VBG O O
59 with IN B-VP O
59 mild JJ B-NP O
59 erythema NN I-NP O
59 around IN B-VP O
59 the DT B-NP O
59 drainage NN I-NP O
60 site NN I-NP O
60 for IN B-VP O
60 which WDT O O
60 she PRP O O
60 was VBD B-VP O
60 treated VBN O O
60 with IN B-VP O
60 perioperative JJ B-NP B-du
60 ancef NN I-NP B-m
60 and CC O O
61 switched VBD B-VP O
61 to TO O O
61 one CD O B-du
61 week NN B-NP I-du
61 of IN B-VP O
61 p.o NN B-NP B-mo
61 linezolid NN I-NP B-m
61 just RB O O
61 prior RB O O
61 to TO O O
61 discharge VB O O
62 At IN B-VP O
62 the DT B-NP O
62 time NN I-NP O
62 of IN B-VP O
62 the DT B-NP O
62 discharge NN I-NP O
62 , , O O
62 the DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
62 discharged VBN O O
62 afebrile RB O O
63 with IN B-VP O
63 vital JJ B-NP O
63 signs NNS I-NP O
63 stable JJ O O
63 and CC O O
63 the DT B-NP O
63 wound NN I-NP O
63 , , O O
63 clean JJ O O
63 , , O O
63 dry JJ O O
63 and CC O O
63 intact JJ O O
64 There EX O O
64 were VBD B-VP O
64 no DT B-NP O
64 complications NNS I-NP O
64 encountered VBD B-VP O
64 in IN B-VP O
64 this DT B-NP O
64 hospital NN I-NP O
64 stay NN I-NP O
65 At IN B-VP O
65 the DT B-NP O
65 time NN I-NP O
65 of IN B-VP O
65 discharge NN B-NP O
65 , , O O
65 the DT B-NP O
65 patient NN I-NP O
65 was VBD B-VP O
65 afebrile RB O O
65 , , O O
65 vital JJ B-NP O
65 signs NNS I-NP O
66 stable JJ O O
66 , , O O
66 with IN B-VP O
66 the DT B-NP O
66 right JJ I-NP O
66 AKA NNP I-NP O
66 stump NN I-NP O
66 well RB O O
66 healed VBN O O
66 and CC O O
66 with IN B-VP O
66 mild JJ B-NP O
67 erythema NN I-NP O
67 inferior NN I-NP O
67 to TO O O
67 the DT B-NP O
67 incision NN I-NP O
68 DISCHARGE NNP I-NP O
68 MEDICATIONS: NNP I-NP O
69 1 CD O O
69 Tylenol NNP B-NP B-m
69 Elixir NNP I-NP I-m
69 1000 CD O B-do
69 mg NN B-NP I-do
69 p.o NN I-NP B-mo
69 q.6h NN I-NP B-f
69 p.r.n NN I-NP I-f
69 pain VBP O B-r
70 2 CD O O
70 Citalopram NNP B-NP B-m
70 20 CD O B-do
70 mg NN B-NP I-do
70 p.o JJ O B-mo
70 daily JJ O B-f
71 3 CD O O
71 Colace NNP B-NP B-m
71 100 CD O B-do
71 mg NN B-NP I-do
71 p.o NN I-NP B-mo
71 b.i.d VBD B-VP B-f
72 4 CD O O
72 Hydrochlorothiazide NNP B-NP B-m
72 25 CD O B-do
72 mg NN B-NP I-do
72 p.o JJ O B-mo
72 daily JJ O B-f
73 5 CD O O
73 Novolog NNP B-NP B-m
73 sliding VBG O B-do
73 scale JJ B-NP I-do
73 Please NNP I-NP O
73 see VB O O
73 the DT B-NP O
73 discharge NN I-NP O
73 summary NN I-NP O
73 for IN B-VP O
74 the DT B-NP O
74 scale NN I-NP O
74 doses VBZ O O
75 6 CD O O
75 Lantus NNP B-NP B-m
75 20 CD O B-do
75 units NNS B-NP I-do
75 subcutaneously RB O B-mo
75 q.a.m VBP O B-f
76 7 CD O O
76 Lactulose NNP B-NP B-m
76 30 CD O B-do
76 mL NN B-NP I-do
76 p.o JJ B-NP B-mo
76 daily JJ I-NP B-f
76 p.r.n NN I-NP I-f
76 constipation NN I-NP B-r
77 8 CD O O
77 Synthroid NNP B-NP B-m
77 25 CD O B-do
77 mcg NN B-NP I-do
77 p.o JJ O B-mo
77 daily JJ O B-f
78 9 CD O O
78 Linezolid JJ O B-m
78 600 CD O B-do
78 mg NN B-NP I-do
78 p.o NN I-NP B-mo
78 q.12h NN I-NP B-f
78 x10 NN I-NP B-du
78 doses VBZ O I-du
78 starting VBG O O
78 today NN B-NP O
78 , , O O
79 9/27/06 CD O O
80 10 CD O O
80 Zyprexa NNP B-NP B-m
80 2.5 CD O B-do
80 mg NN B-NP I-do
80 p.o NN I-NP B-mo
80 q.p.m NN I-NP B-f
81 DISPOSITION: NNP I-NP O
81 The DT B-NP O
81 patient NN I-NP O
81 is VBZ O O
81 to TO O O
81 be VB O O
81 discharged VBN O O
81 to TO O O
81 her PRP$ O O
81 skilled JJ B-NP O
82 nursing NN I-NP O
82 facility NN I-NP O
82 Plan NN I-NP O
82 is VBZ O O
82 for IN B-VP O
82 her PRP$ O O
82 to TO O O
82 follow VB O O
82 up RP O O
82 with IN B-VP O
82 Dr NNP B-NP O
82 Wynder NNP I-NP O
83 in IN B-VP O
83 one CD O O
83 to TO O O
83 two CD O O
83 weeks NNS B-NP O
83 and CC O O
83 with IN B-VP O
83 her PRP$ O O
83 primary JJ B-NP O
83 care NN I-NP O
83 physician NN I-NP O
83 in IN B-VP O
83 one CD O O
83 to TO O O
84 two CD O O
84 weeks NNS B-NP O
85 ADVANCED NNP I-NP O
85 DIRECTIVES: NNP I-NP O
85 The DT B-NP O
85 patient NN I-NP O
85 is VBZ O O
85 DNR/DNI NNP B-NP O
86 eScription NN I-NP O
86 document: VBD B-VP O
86 4-1720087 JJ B-NP O
86 CSSten NNP I-NP O
86 Tel NNP I-NP O
87 CC: NNP I-NP O
87 Jesse NNP I-NP O
87 Cravatta NNP I-NP O
87 MD NNP I-NP O
88 Twin NNP I-NP O
88 Nacomp NNP I-NP O
88 Blu NNP I-NP O
88 Health NNP I-NP O
89 Pring NNP I-NP O
89 Full NNP I-NP O
90 Ver NNP I-NP O
90 Dale NNP I-NP O
90 A NNP I-NP O
90 Pit NNP I-NP O
91 Dictated NNP I-NP O
91 By: NNP I-NP O
91 BONING NNP I-NP O
91 , , O O
91 FREEMAN NNP B-NP O
92 Attending: NNP I-NP O
92 VEROEVEN NNP I-NP O
92 , , O O
92 KELLEY NNP B-NP O
93 Dictation NNP I-NP O
93 ID NNP I-NP O
93 3032658 CD O O
94 D: NNP B-NP O
94 8/27/06 CD O O
95 T: NNP B-NP O
95 8/27/06 CD O O
96 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #343900 VBZ O O
4 543168539 CD O O
4 CMH NNP B-NP O
4 07809715 CD O O
4 970606 CD O O
4 11/26/1990 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/20/1990 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 8/4/1990 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 This DT O O
7 is VBZ O O
7 a DT O O
7 40 CD O O
7 year NN B-NP O
7 old JJ O O
7 , , O O
7 gravida JJ B-NP O
7 VI NNP I-NP O
7 para NN I-NP O
8 V NNP I-NP O
8 , , O O
8 black JJ B-NP O
8 female NN I-NP O
8 with IN B-VP O
8 an DT B-NP O
8 EDC NNP I-NP O
8 of IN B-VP O
8 3/18/90 CD O O
9 at IN B-VP O
9 29 CD O O
9 weeks NNS B-NP O
9 gestation NN I-NP O
9 She PRP O O
9 was VBD B-VP O
9 admitted VBN O O
9 for IN B-VP O
9 blood NN B-NP O
9 sugar NN I-NP O
9 control NN I-NP O
10 for IN B-VP O
10 gestational JJ B-NP O
10 diabetes NNS I-NP O
10 She PRP O O
10 had VBD B-VP O
10 a DT B-NP O
10 fasting JJ I-NP O
10 blood NN I-NP O
10 sugar NN I-NP O
10 of IN B-VP O
10 150 CD O O
10 and CC O O
11 had VBD B-VP O
11 not RB O O
11 been VBN O O
11 by IN B-VP O
11 an DT B-NP O
11 endocrinologist NN I-NP O
11 at IN B-VP O
11 TMC NNP B-NP O
11 She PRP O O
11 had VBD B-VP O
11 gained VBN O O
12 approximately RB O O
12 40 CD O O
12 pounds NNS B-NP O
12 to TO O O
12 date NN B-NP O
12 during IN B-VP O
12 this DT B-NP O
12 pregnancy NN I-NP O
12 She PRP O O
12 had VBD B-VP O
12 a DT B-NP O
13 previous JJ I-NP O
13 history NN I-NP O
13 of IN B-VP O
13 greater JJR O O
13 than IN B-VP O
13 eight CD O O
13 pound NN B-NP O
13 infants NNS I-NP O
13 delivered VBN O O
14 vaginally RB O O
14 without IN B-VP O
14 difficulty NN B-NP O
14 She PRP O O
14 had VBD B-VP O
14 no DT B-NP O
14 other JJ I-NP O
14 complaints NNS I-NP O
14 during IN B-VP O
15 this DT B-NP O
15 pregnancy NN I-NP O
15 She PRP O O
15 was VBD B-VP O
15 seen VBN O O
15 at IN B-VP O
15 her PRP$ O O
15 first JJ B-NP O
15 prenatal JJ I-NP O
15 visit NN I-NP O
15 at IN B-VP O
15 24 CD O O
16 weeks NNS B-NP O
16 She PRP O O
16 is VBZ O O
16 RH-negative JJ O O
16 and CC O O
16 received VBD B-VP O
16 RhoGAM NNP B-NP B-m
16 4/15/90 CD O O
16 The DT B-NP O
17 hematocrit NN I-NP O
17 on IN B-VP O
17 8/16/90 CD O O
17 was VBD B-VP O
17 31.8; CD O O
17 RPR NNP B-NP O
17 nonreactive; JJ B-NP O
17 rubella NN I-NP O
17 non-immune; JJ B-NP O
18 Pap NNP I-NP O
18 negative; NN I-NP O
18 hepatitis NN I-NP O
18 negative; JJ B-NP O
18 OB NNP I-NP O
18 GLT NNP I-NP O
18 196 CD O O
18 She PRP O O
18 had VBD B-VP O
19 amniocentesis NN B-NP O
19 for IN B-VP O
19 genetic JJ B-NP O
19 reasons NNS I-NP O
19 which WDT O O
19 was VBD B-VP O
19 46-XY JJ B-NP O
19 PAST NNP I-NP O
19 HISTORY: NNP I-NP O
20 Hyperthyroidism NNP I-NP B-r
20 , , O O
20 status NN B-NP O
20 post NN I-NP O
20 partial JJ B-NP O
20 thyroidectomy NN I-NP O
20 in IN B-VP O
20 1976 CD O O
20 , , O O
20 on IN B-VP O
21 Synthroid NNP B-NP B-m
21 0.015 CD O B-do
21 mg NN B-NP I-do
21 daily; NN I-NP B-f
21 endometriosis NN I-NP O
21 with IN B-VP O
21 right JJ B-NP O
22 salpingo-oophorectomy NN I-NP O
22 in IN B-VP O
22 1976; CD O O
22 tonsillectomy NN B-NP O
22 at IN B-VP O
22 age NN B-NP O
22 nine; JJ B-NP O
22 menarche NN I-NP O
23 at IN B-VP O
23 age NN B-NP O
23 13 CD O O
23 with IN B-VP O
23 regular JJ B-NP O
23 cycles NNS I-NP O
23 lasting VBG O O
23 approximately RB O O
23 three CD O O
23 days; JJ O O
23 no DT B-NP O
24 history NN I-NP O
24 of IN B-VP O
24 abnormal JJ B-NP O
24 Pap NNP I-NP O
24 smears; NN I-NP O
24 1972 CD O O
24 , , O O
24 spontaneous JJ B-NP O
24 abortion NN I-NP O
24 and CC O O
25 subsequent JJ B-NP O
25 D&amp;C; NNP I-NP O
25 1974 CD O O
25 , , O O
25 normal JJ B-NP O
25 spontaneous JJ I-NP O
25 vaginal JJ I-NP O
25 delivery NN I-NP O
25 of IN B-VP O
25 a DT B-NP O
25 male NN I-NP O
26 infant NN I-NP O
26 , , O O
26 8 CD O O
26 pounds NNS B-NP O
26 11 CD O O
26 ounces; NN B-NP O
26 1978 CD O O
26 , , O O
26 normal JJ B-NP O
26 spontaneous JJ I-NP O
26 vaginal JJ I-NP O
27 delivery NN I-NP O
27 of IN B-VP O
27 a DT B-NP O
27 male NN I-NP O
27 infant NN I-NP O
27 , , O O
27 nine CD O O
27 pounds NNS B-NP O
27 , , O O
27 with IN B-VP O
27 jaundice NN B-NP O
27 neonatally; NN I-NP O
28 1979 CD O O
28 , , O O
28 normal JJ B-NP O
28 spontaneous JJ I-NP O
28 vaginal JJ I-NP O
28 delivery; NN I-NP O
28 1982 CD O O
28 , , O O
28 normal JJ B-NP O
28 spontaneous JJ I-NP O
29 vaginal JJ I-NP O
29 delivery NN I-NP O
29 , , O O
29 8+ CD O O
29 pounds NNS B-NP O
29 , , O O
29 no DT B-NP O
29 complications; NN I-NP O
29 1984 CD O O
29 , , O O
29 normal JJ B-NP O
30 spontaneous JJ I-NP O
30 vaginal JJ I-NP O
30 delivery NN I-NP O
30 , , O O
30 six CD O O
30 pounds NNS B-NP O
30 SOCIAL NNP I-NP O
30 HISTORY: NNP I-NP O
30 She PRP O O
30 has VBZ O O
31 smoked VBN O O
31 3-4 JJ B-NP O
31 packs NNS I-NP O
31 of IN B-VP O
31 cigarettes NNS B-NP O
31 per IN B-VP O
31 day NN B-NP O
31 for IN B-VP O
31 the DT O O
31 past JJ O O
31 25 CD O O
31 years NNS B-NP O
32 MEDICATIONS NNP I-NP O
32 ON NNP I-NP O
32 ADMISSION: NNP I-NP O
32 Synthroid NNP I-NP B-m
32 and CC O O
32 vitamins VBZ O B-m
33 PHYSICAL NNP B-NP O
33 EXAMINATION: NNP I-NP O
33 Vital NNP I-NP O
33 signs NNS I-NP O
33 stable JJ O O
33 She PRP O O
33 presented VBD B-VP O
33 as IN B-VP O
33 a DT B-NP O
34 pleasant NN I-NP O
34 , , O O
34 obese JJ O O
34 , , O O
34 black JJ B-NP O
34 female NN I-NP O
34 in IN B-VP O
34 no DT B-NP O
34 acute NN I-NP O
35 distress VBZ O O
35 The DT B-NP O
35 HEENT NNP I-NP O
35 exam NN I-NP O
35 was VBD B-VP O
35 normal JJ O O
35 The DT B-NP O
35 neck NN I-NP O
35 was VBD B-VP O
35 supple; JJ O O
35 no DT B-NP O
36 adenopathy; NN I-NP O
36 thyroid VBZ O O
36 full JJ O O
36 , , O O
36 scar JJ B-NP O
36 present NN I-NP O
36 from IN B-VP O
36 partial JJ B-NP O
36 thyroidectomy NN I-NP O
37 The DT B-NP O
37 lungs NNS I-NP O
37 were VBD B-VP O
37 clear JJ O O
37 The DT B-NP O
37 cardiac JJ I-NP O
37 exam NN I-NP O
37 revealed VBD B-VP O
37 a DT B-NP O
37 normal JJ I-NP O
37 S1 NNP I-NP O
37 and CC O O
38 S2; NNP B-NP O
38 no DT B-NP O
38 murmurs NN I-NP O
38 or CC O O
38 gallops VBZ O O
38 The DT B-NP O
38 breasts NNS I-NP O
38 were VBD B-VP O
38 without IN B-VP O
38 masses NNS B-NP O
38 The DT B-NP O
39 abdomen NNS I-NP O
39 was VBD B-VP O
39 obese JJ O O
39 and CC O O
39 gravid JJ B-NP O
39 NST NNP I-NP O
39 was VBD B-VP O
39 reactive JJ O O
39 with IN B-VP O
39 a DT B-NP O
39 baseline NN I-NP O
39 of IN B-VP O
40 145 CD O O
40 The DT B-NP O
40 cervix NN I-NP O
40 was VBD B-VP O
40 long RB O O
40 , , O O
40 thick NN B-NP O
40 and CC O O
40 closed VBD B-VP O
40 The DT B-NP O
40 extremities NNS I-NP O
40 were VBD B-VP O
41 without IN B-VP O
41 edema IN B-VP O
41 The DT B-NP O
41 deep JJ I-NP O
41 tendon NN I-NP O
41 reflexes NNS I-NP O
41 were VBD B-VP O
41 1-2+ JJ B-NP O
42 LABORATORY NNP I-NP O
42 EXAMINATION: NNP I-NP O
42 A NNP I-NP O
42 finger NN I-NP O
42 stick NN I-NP O
42 blood NN I-NP O
42 sugar NN I-NP O
42 was VBD B-VP O
42 115 CD O O
42 with IN B-VP O
43 her PRP$ O O
43 last JJ B-NP O
43 meal NN I-NP O
43 being VBG O O
43 at IN B-VP O
43 noon NN B-NP O
44 HOSPITAL NNP I-NP O
44 COURSE: NNP I-NP O
44 The DT B-NP O
44 impression NN I-NP O
44 was VBD B-VP O
44 29 CD O O
44 weeks NNS B-NP O
44 gestation NN I-NP O
44 with IN B-VP O
45 gestational JJ B-NP O
45 diabetes NNS I-NP O
45 admitted VBD B-VP O
45 for IN B-VP O
45 glucose JJ B-NP O
46 control NN I-NP O
46 , , O O
46 status NN B-NP O
46 post NN I-NP O
46 partial JJ B-NP O
46 thyroidectomy NN I-NP O
46 and CC O O
46 anemia VB O O
46 The DT B-NP O
46 plan NN I-NP O
47 was VBD B-VP O
47 to TO O O
47 admit VB O O
47 her PRP$ O O
47 and CC O O
47 check VB O O
47 q4h JJ B-NP O
47 blood NN I-NP B-r
47 sugars NNS I-NP I-r
47 , , O O
47 begin VBP O O
47 an DT B-NP O
47 ADA NNP I-NP O
47 diet NN I-NP O
47 and CC O O
48 possible JJ B-NP O
48 insulin NN I-NP B-m
48 The DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 seen VBN O O
48 by IN B-VP O
48 the DT B-NP O
48 endocrinology NN I-NP O
49 service NN I-NP O
49 on IN B-VP O
49 admission NN B-NP O
49 and CC O O
49 begun VBN O O
49 on IN B-VP O
49 a DT B-NP O
49 diet JJ I-NP O
49 Her NNP I-NP O
49 blood NN I-NP B-r
49 sugars NNS I-NP I-r
50 continued VBD B-VP O
50 to TO O O
50 be VB O O
50 high JJ O O
50 with IN B-VP O
50 a DT B-NP O
50 fasting NN I-NP O
50 in IN B-VP O
50 the DT B-NP O
50 120-150 JJ I-NP O
50 range NN I-NP O
50 She PRP O O
50 was VBD B-VP O
51 begun VBN O O
51 on IN B-VP O
51 insulin NN B-NP B-m
51 and CC O O
51 was VBD B-VP O
51 managed VBN O O
51 by IN B-VP O
51 the DT B-NP O
51 endocrinology NN I-NP O
51 service NN I-NP O
51 and CC O O
52 controlled VBN O O
52 well RB O O
52 on IN B-VP O
52 the DT B-NP O
52 insulin NN I-NP B-m
52 over IN B-VP O
52 the DT B-NP O
52 next JJ I-NP O
52 several JJ I-NP B-du
52 days NNS I-NP I-du
52 Her PRP$ O B-r
53 fasting JJ B-NP O
53 blood NN I-NP O
53 sugar NN I-NP O
53 came VBD B-VP O
53 down RB O O
53 to TO O O
53 eventually RB O O
53 100-95 VB O O
53 on IN B-VP O
53 9/30/90 CD O O
54 DISPOSITION: NNP B-NP O
54 The DT B-NP O
54 patient NN I-NP O
54 was VBD B-VP O
54 discharged VBN O O
54 home NN B-NP O
54 MEDICATIONS NNP I-NP O
54 ON NNP I-NP O
55 DISCHARGE: NNP I-NP O
55 Insulin NNP I-NP B-m
55 ten VBD B-VP B-do
55 units NNS B-NP I-do
55 of IN B-VP O
55 regular JJ B-NP O
55 qAM NN I-NP B-f
55 and CC O O
55 16 CD O O
56 units NNS B-NP O
56 of IN B-VP O
56 regular JJ O O
56 and CC O O
56 16 CD O B-do
56 16 CD O B-do
56 units NNS B-NP I-do
56 units NNS I-NP I-do
56 NPH NNP I-NP B-m
56 qPM NN I-NP B-f
56 qPM NN I-NP B-f
56 FOLLOW NNP I-NP O
56 UP NNP I-NP O
56 will MD O O
56 be VB O O
56 with IN B-VP O
56 Dr NNP B-NP O
57 Gorneault NNP I-NP O
57 of IN B-VP O
57 the DT B-NP O
57 endocrinology NN I-NP O
57 service NN I-NP O
58 ________________________________ NNP I-NP O
58 TP137/7400 NNP I-NP O
59 LAWRENCE NNP I-NP O
59 SHUCK NNP I-NP O
59 , , O O
59 M.D NNP B-NP O
59 FH62 NNP I-NP O
59 D: NNP I-NP O
59 1/10/90 CD O O
60 Batch: NNP B-NP O
60 3241 CD O O
60 Report: NNP B-NP O
60 R0718Y8 NNP I-NP O
60 T: NNP I-NP O
60 2/17/90 CD O O
61 Dictated NNP B-NP O
61 By: NNP I-NP O
61 PORFIRIO NNP I-NP O
61 KRUML NNP I-NP O
61 , , O O
61 M.D NNP B-NP O
61 FH62 NNP I-NP O
62 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #348094 VBZ O O
2 765192522 CD O O
2 EMH NNP B-NP O
2 79392868 CD O O
2 6068847 CD O O
2 8/25/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Unsigned VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/1/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/18/2006 CD O O
4 ATTENDING: NNP B-NP O
4 WIGDOR NNP I-NP O
4 , , O O
4 SHELTON NNP B-NP O
4 MD NNP I-NP O
5 DISPOSITION: NNP I-NP O
5 To TO O O
5 rehabilitation VB O O
6 PRINCIPAL NNP B-NP O
6 DISCHARGE NNP I-NP O
6 DIAGNOSIS: NNP I-NP O
6 Status NNP I-NP O
6 post NN I-NP O
6 CABG NNP I-NP O
6 x3/LIMA NNP I-NP O
7 OTHER NNP I-NP O
7 DIAGNOSES: NNP I-NP O
7 Excessive NNP I-NP O
7 bleeding NN I-NP O
7 , , O O
7 history NN B-NP O
7 of IN B-VP O
7 GI NNP B-NP O
7 bleeding VBG O O
7 from IN B-VP O
8 diverticulosis NN B-NP O
8 which WDT O O
8 resulted VBD B-VP O
8 in IN B-VP O
8 colectomy NN B-NP O
8 , , O O
8 history NN B-NP O
8 of IN B-VP O
9 myelofibrosis NN B-NP O
9 followed VBN O O
9 by IN B-VP O
9 a DT B-NP O
9 hematologist JJ I-NP O
10 HISTORY NNP I-NP O
10 OF NNP I-NP O
10 PRESENT NNP I-NP O
10 ILLNESS: NNP I-NP O
10 Mr NNP I-NP O
10 Royce NNP I-NP O
10 Meidlinger NNP I-NP O
10 is VBZ O O
10 a DT B-NP O
10 78-year-old JJ I-NP O
10 male NN I-NP O
11 with IN B-VP O
11 a DT B-NP O
11 history NN I-NP O
11 of IN B-VP O
11 CAD NNP B-NP O
11 and CC O O
11 previous JJ B-NP O
11 MI NNP I-NP O
11 , , O O
11 angioplasty NN B-NP O
11 in IN B-VP O
11 1995 CD O O
11 and CC O O
12 stent JJ B-NP O
12 placement NN I-NP O
12 in IN B-VP O
12 2001 CD O O
12 , , O O
12 complained VBD B-VP O
12 about IN B-VP O
12 episodes NNS B-NP O
12 of IN B-VP O
12 shortness NN B-NP B-r
13 of IN B-VP O
13 breath NN B-NP O
13 and CC O O
13 increasing VBG O O
13 intolerance NN B-NP O
13 of IN B-VP O
13 physical JJ B-NP O
13 activity NN I-NP O
13 He PRP O O
14 was VBD B-VP O
14 using VBG O O
14 nitroglycerin JJ O B-m
14 and CC O O
14 rest NN B-NP O
14 during IN B-VP B-du
14 such PDT O I-du
14 an DT B-NP I-du
14 episode NN I-NP I-du
14 with IN B-VP O
15 obvious JJ B-NP O
15 success NN I-NP O
15 His PRP$ O O
15 cardiac JJ B-NP O
15 catheterization NN I-NP O
15 was VBD B-VP O
15 done VBN O O
15 at IN B-VP O
15 WLH NNP B-NP O
16 which WDT O O
16 revealed VBD B-VP O
16 three-vessel JJ B-NP O
16 coronary JJ I-NP O
16 artery NN I-NP O
16 disease NN I-NP O
16 with IN B-VP O
16 EF NNP B-NP O
16 of IN B-VP O
17 55% CD O O
17 He PRP O O
17 has VBZ O O
17 a DT B-NP O
17 permanent JJ I-NP O
17 pacemaker NN I-NP O
17 installed VBD B-VP O
17 4/20 CD O O
17 due JJ O O
17 to TO O O
17 sick VB O O
18 sinus NN B-NP O
18 syndrome NN I-NP O
18 and CC O O
18 an DT B-NP O
18 intermittent JJ I-NP O
18 AV NNP I-NP O
18 block NN I-NP O
18 , , O O
18 second-degree JJ B-NP O
19 Latest NNP I-NP O
19 echo NN I-NP O
19 reported VBD B-VP O
19 presence NN B-NP O
19 of IN B-VP O
19 mild-to-moderate JJ B-NP O
19 mitral JJ I-NP O
20 regurgitation NN I-NP O
21 PREOPERATIVE NNP I-NP O
21 CARDIAC NNP I-NP O
21 STATUS: NNP I-NP O
21 Urgent NNP I-NP O
21 The DT B-NP O
21 patient NN I-NP O
21 presented VBN O O
21 with IN B-VP O
22 critical JJ B-NP O
22 coronary JJ I-NP O
22 anatomy/myocardial JJ I-NP O
22 infarction NN I-NP O
22 in IN B-VP O
22 1987 CD O O
22 requiring VBG O O
23 hospitalization NN B-NP O
23 The DT B-NP O
23 patient NN I-NP O
23 has VBZ O O
23 a DT B-NP O
23 history NN I-NP O
23 of IN B-VP O
23 class NN B-NP O
23 III NNP I-NP O
23 angina NN I-NP O
24 There EX O O
24 has VBZ O O
24 been VBN O O
24 recent JJ B-NP O
24 stable JJ I-NP O
24 angina NN I-NP O
24 There EX O O
24 is VBZ O O
24 a DT B-NP O
24 history NN I-NP O
24 of IN B-VP O
24 class NN B-NP O
25 II NNP I-NP O
25 heart NN I-NP O
25 failure NN I-NP O
25 Recent NNP I-NP O
25 signs NNS I-NP O
25 and CC O O
25 symptoms NNS B-NP O
25 of IN B-VP O
25 congestive JJ B-NP O
25 heart NN I-NP O
26 failure NN I-NP O
26 include VBP O O
26 dyspnea NN B-NP O
26 on IN B-VP O
26 exertion NN B-NP O
26 The DT B-NP O
26 patient NN I-NP O
26 is VBZ O O
26 in IN B-VP O
26 normal JJ B-NP O
27 sinus NN I-NP O
27 rhythm VBP O O
28 PREVIOUS NNP B-NP O
28 CARDIOVASCULAR NNP I-NP O
28 INTERVENTIONS: NNP I-NP O
28 4/20 CD O O
28 off IN B-VP O
28 pump NN B-NP O
29 biventricular JJ B-NP O
29 permanent JJ I-NP O
29 pacemaker NN I-NP O
29 PTCAS/atherectomy NNP I-NP O
29 in IN B-VP O
29 1995 CD O O
29 and CC O O
30 stent NN B-NP O
30 in IN B-VP O
30 2001 CD O O
31 PAST NNP B-NP O
31 SURGICAL NNP I-NP O
31 HISTORY: NNP I-NP O
31 Colectomy NNP I-NP O
31 due JJ O O
31 to TO O O
31 bleeding VBG O O
31 from IN B-VP O
32 diverticulosis NN B-NP O
32 , , O O
32 THR NNP B-NP O
32 , , O O
32 right JJ B-NP O
32 inguinal JJ I-NP O
32 hernia NN I-NP O
33 FAMILY NNP I-NP O
33 HISTORY: NNP I-NP O
33 Coronary NNP I-NP O
33 artery NN I-NP O
33 disease NN I-NP O
33 Father NNP I-NP O
33 with IN B-VP O
33 MI NNP B-NP O
33 , , O O
33 died VBD B-VP O
34 at IN B-VP O
34 age NN B-NP O
34 46 CD O O
34 from IN B-VP O
34 MI NNP B-NP O
35 SOCIAL NNP I-NP O
35 HISTORY: NNP I-NP O
35 No NNP I-NP O
35 history NN I-NP O
35 of IN B-VP O
35 tobacco NN B-NP O
35 use IN B-VP O
35 The DT B-NP O
35 patient NN I-NP O
35 is VBZ O O
35 a DT B-NP O
36 retired JJ I-NP O
36 judge NN I-NP O
37 ALLERGIES: NNP I-NP O
37 To TO O O
37 penicillin VB O O
37 , , O O
37 which WDT O O
37 results NNS B-NP O
37 in IN B-VP O
37 rash NN B-NP O
37 and CC O O
37 heparin JJ B-NP O
38 ADMISSION NNP I-NP O
38 MEDICATIONS: NNP I-NP O
38 Atenolol NNP I-NP B-m
38 25 CD O B-do
38 mg JJ O I-do
38 daily RB O B-f
38 , , O O
38 allopurinol VBZ O B-m
38 300 CD O B-do
38 mg JJ O I-do
39 daily JJ O B-f
39 , , O O
39 and CC O O
39 Flomax NNP B-NP B-m
39 0.8 CD O B-do
39 mg JJ B-NP I-do
39 daily JJ I-NP B-f
40 PHYSICAL NNP I-NP O
40 EXAMINATION: NNP I-NP O
40 Height NNP I-NP O
40 and CC O O
40 weight VBD B-VP O
40 6 CD O O
40 feet NNS B-NP O
40 and CC O O
40 76 CD O O
40 kilos NNS B-NP O
41 Vital NNP I-NP O
41 signs: VBD B-VP O
41 Temperature NNP B-NP O
41 98 CD O O
41 , , O O
41 heart NN B-NP O
41 rate NN I-NP O
41 65 CD O O
41 , , O O
41 BP NNP B-NP O
41 right VBD B-VP O
41 arm NN B-NP O
41 118/60 CD O O
41 , , O O
42 left VBD B-VP O
42 arm NN B-NP O
42 120/58 CD O O
42 , , O O
42 oxygen NN B-NP O
42 saturation NN I-NP O
42 97% CD O O
42 room NN B-NP O
42 air NN I-NP O
42 HEENT: NNP I-NP O
43 PERRLA/dentition NNP I-NP O
43 without IN B-VP O
43 evidence NN B-NP O
43 of IN B-VP O
43 infection/no JJ B-NP O
43 carotid NN I-NP O
43 bruits NNS I-NP O
44 Chest: NNP I-NP O
44 No NNP I-NP O
44 incisions NNS I-NP O
44 Cardiovascular: NNP I-NP O
44 Regular NNP I-NP O
44 rate NN I-NP O
44 and CC O O
44 rhythm VB O O
45 All DT B-NP O
45 distal JJ I-NP O
45 pulses NNS I-NP O
45 intact JJ B-NP O
45 Allen's NNP I-NP O
45 test: NN I-NP O
45 Left NNP I-NP O
45 upper JJ B-NP O
45 extremity NN I-NP O
46 normal JJ O O
46 , , O O
46 right JJ B-NP O
46 upper JJ I-NP O
46 extremity NN I-NP O
46 normal JJ B-NP O
46 Respiratory: NNP I-NP O
46 Breath NNP I-NP O
47 sounds VBZ O O
47 clear JJ O O
47 bilaterally RB O O
47 Abdomen: NNP B-NP O
47 Laparotomy NNP I-NP O
47 scar NN I-NP O
47 , , O O
47 soft JJ O O
47 , , O O
47 no DT B-NP O
48 masses NNS I-NP O
48 Extremities: NNP I-NP O
48 Without IN B-VP O
48 scarring VBG O O
48 , , O O
48 varicosities NNS B-NP O
48 , , O O
48 or CC O O
48 edema VB O O
49 Neuro: NNP B-NP O
49 Alert NNP I-NP O
49 and CC O O
49 oriented VBN O O
49 , , O O
49 no DT B-NP O
49 focal JJ I-NP O
49 deficits NNS I-NP O
50 LABORATORY NNP I-NP O
50 DATA: NNP I-NP O
50 Chemistry: NNP I-NP O
50 Sodium NNP I-NP O
50 of IN B-VP O
50 138 CD O O
50 , , O O
50 potassium NN B-NP O
50 3.9 CD O O
50 , , O O
51 chloride RB O O
51 108 CD O O
51 , , O O
51 CO2 NNP B-NP O
51 24 CD O O
51 , , O O
51 BUN NNP B-NP O
51 19 CD O O
51 , , O O
51 creatinine NN B-NP O
51 1 CD O O
51 , , O O
51 glucose RB O O
51 98 CD O O
51 , , O O
51 and CC O O
52 magnesium NN B-NP O
52 2.1 CD O O
52 Hematology: NNP B-NP O
52 WBC NNP I-NP O
52 19.78 CD O O
52 , , O O
52 hematocrit NN B-NP O
52 30.4 CD O O
52 , , O O
53 hemoglobin NN B-NP O
53 10.2 CD O O
53 , , O O
53 platelets NNS B-NP O
53 525 CD O O
53 , , O O
53 PT NNP B-NP O
53 17.3 CD O O
53 , , O O
53 INR NNP B-NP O
53 1.4 CD O O
53 , , O O
53 PTT NNP B-NP O
53 51 CD O O
53 UA NNP B-NP O
53 was VBD B-VP O
54 normal JJ B-NP O
54 Cardiac NNP I-NP O
54 catheterization NN I-NP O
54 data NNS I-NP O
54 from IN B-VP O
54 11/0/05 CD O O
54 performed VBN O O
54 at IN B-VP O
55 HMH NNP B-NP O
55 showed VBD B-VP O
55 coronary JJ O O
55 anatomy RB O O
55 60% CD O O
55 distal JJ O O
55 left VBD B-VP O
55 main JJ O O
55 , , O O
55 60% CD O O
55 ostial JJ B-NP O
55 LAD NNP I-NP O
55 , , O O
56 70% CD O O
56 proximal JJ B-NP O
56 circumflex NN I-NP O
56 , , O O
56 80% CD O O
56 proximal JJ B-NP O
56 RCA NNP I-NP O
56 , , O O
56 60% CD O O
56 distal JJ B-NP O
56 RCA NNP I-NP O
56 , , O O
56 right JJ B-NP O
57 dominant JJ I-NP O
57 circulation NN I-NP O
57 EKG NNP I-NP O
57 from IN B-VP O
57 11/0/05 CD O O
57 showed VBD B-VP O
57 paced JJ B-NP O
57 rhythm NN I-NP O
57 , , O O
58 rate NN B-NP O
58 of IN B-VP O
58 64 CD O O
58 Chest JJS B-NP O
58 x-ray NN I-NP O
58 from IN B-VP O
58 11/0/05 CD O O
58 consistent JJ O O
58 with IN B-VP O
58 COPD NNP B-NP O
58 , , O O
58 left VBD B-VP O
59 pacemaker NN B-NP O
59 permanent NN I-NP O
59 , , O O
59 cardiomegaly NN B-NP O
59 , , O O
59 thoracic JJ B-NP O
59 vertebral JJ I-NP O
60 degeneration NN I-NP O
60 Patient NNP I-NP O
60 was VBD B-VP O
60 admitted VBN O O
60 to TO O O
60 TCH NNP B-NP O
60 CSS NNP I-NP O
60 and CC O O
60 stabilized VBN O O
60 for IN B-VP O
61 surgery NN B-NP O
61 Date NNP I-NP O
61 of IN B-VP O
61 surgery NN B-NP O
61 2/10/05 CD O O
62 PREOPERATIVE NNP B-NP O
62 DIAGNOSIS: NNP I-NP O
62 CAD NNP I-NP O
63 PROCEDURE: NNP I-NP O
63 CABG NNP I-NP O
63 x3 NNP I-NP O
63 with IN B-VP O
63 LIMA NNP B-NP O
63 to TO O O
63 LAD NNP B-NP O
63 , , O O
63 sequential JJ B-NP O
63 graft NN I-NP O
63 , , O O
63 SVG1 NNP B-NP O
64 connects VBZ O O
64 aorta NN B-NP O
64 to TO O O
64 VK7 NNP B-NP O
64 then RB O O
64 PDA NNP B-NP O
64 Bypass NNP I-NP O
64 time NN I-NP O
64 97 CD O O
64 minutes NNS B-NP O
64 Circa NNP I-NP O
65 arrest NN I-NP O
65 for IN B-VP O
65 5 CD O O
65 minutes NNS B-NP O
65 There EX O O
65 were VBD B-VP O
65 no DT B-NP O
65 complications NNS I-NP O
65 The DT B-NP O
65 patient NN I-NP O
66 was VBD B-VP O
66 transferred VBN O O
66 to TO O O
66 the DT B-NP O
66 unit NN I-NP O
66 in IN B-VP O
66 stable JJ B-NP O
66 fashion NN I-NP O
66 with IN B-VP O
66 lines NNS B-NP O
66 and CC O O
67 tubes NNS B-NP O
67 intact JJ B-NP O
68 ICU NNP I-NP O
68 PROGRESS NNP I-NP O
68 EVENT NNP I-NP O
68 SUMMARY: NNP I-NP O
68 4/25/05 CD O O
68 , , O O
68 postop JJ B-NP O
68 day NN I-NP O
68 #1 NNP I-NP O
68 , , O O
68 hypotensive JJ B-NP O
69 low JJ I-NP O
69 SVR NNP I-NP O
69 , , O O
69 vasopressin NN B-NP B-m
69 started VBD B-VP O
69 , , O O
69 rising VBG O O
69 creatinine NN B-NP O
69 3/3/05 CD O O
69 , , O O
70 postoperative JJ B-NP O
70 day NN I-NP O
70 #2 NNP I-NP O
70 , , O O
70 started VBD B-VP O
70 on IN B-VP O
70 dopamine NN B-NP B-m
70 for IN B-VP O
70 oliguria NN B-NP B-r
70 and CC O O
70 rising VBG O O
71 creatinine NN B-NP O
71 11/12/05 CD O O
71 , , O O
71 postop JJ B-NP O
71 day NN I-NP O
71 #3 NNP I-NP O
71 , , O O
71 creatinine VBP O O
71 down IN B-VP O
71 to TO O O
71 1.4 CD O O
71 , , O O
72 episode NN B-NP O
72 of IN B-VP O
72 bradycardia JJ B-NP O
72 Postop NNP I-NP O
72 day NN I-NP O
72 #4 NNP I-NP O
72 , , O O
72 continued VBD B-VP O
72 on IN B-VP O
72 dopamine NN B-NP B-m
72 at IN B-VP O
73 2 CD O B-do
73 mcg NN B-NP I-do
73 , , O O
73 continued VBD B-VP O
73 high JJ B-NP O
73 chest NN I-NP O
73 tube NN I-NP O
73 output NN I-NP O
73 Official NNP I-NP O
73 echo JJ B-NP O
73 report NN I-NP O
74 essentially RB O O
74 unchanged JJ B-NP O
74 Postop NNP I-NP O
74 day NN I-NP O
74 #5 NNP I-NP O
74 , , O O
74 weaned VBD B-VP O
74 off RP O O
74 dopamine NN B-NP B-m
74 , , O O
74 left VBD B-VP O
75 chest JJS B-NP O
75 tube NN I-NP O
75 discontinued VBN O O
75 , , O O
75 persistent JJ B-NP O
75 SVG NNP I-NP O
75 harvesting VBG O O
75 site NN B-NP O
75 bleed VBD B-VP O
76 Postop NNP B-NP O
76 day NN I-NP O
76 #6 NNP I-NP O
76 , , O O
76 11/29/05 CD O O
76 , , O O
76 no DT B-NP O
76 significant JJ I-NP O
76 events NNS I-NP O
76 , , O O
76 medial JJ B-NP O
76 chest NN I-NP O
77 tubes NNS I-NP O
77 were VBD B-VP O
77 discontinued VBN O O
77 without IN B-VP O
77 complications NNS B-NP O
77 The DT B-NP O
77 patient NN I-NP O
77 was VBD B-VP O
78 transferred VBN O O
78 to TO O O
78 the DT B-NP O
78 Step-Down JJ I-NP O
78 Unit NNP I-NP O
78 on IN B-VP O
78 11/29/05 CD O O
78 , , O O
78 postop JJ B-NP O
78 day NN I-NP O
78 #6 NNP I-NP O
79 SUMMARY NNP I-NP O
79 BY NNP I-NP O
79 SYSTEM: NNP I-NP O
80 Neurologically: NNP I-NP O
80 Intact NNP I-NP O
81 Cardiovascular: NNP I-NP O
81 On IN B-VP O
81 aspirin NN B-NP B-m
81 , , O O
81 has VBZ O O
81 pacemaker NN B-NP O
81 for IN B-VP O
81 sick JJ B-NP B-r
81 sinus NN I-NP I-r
82 Battery NNP I-NP O
82 is VBZ O O
82 low JJ O O
82 , , O O
82 cannot JJ B-NP O
82 pace NN I-NP O
82 above IN B-VP O
82 65 CD O O
82 beats NNS B-NP O
82 per IN B-VP O
82 minute NN B-NP O
82 with IN B-VP O
82 plans NNS B-NP O
83 to TO O O
83 exchange VB O O
83 generator NN B-NP O
83 Pressure NN I-NP O
83 is VBZ O O
83 better RBR O O
83 , , O O
83 paced VBD B-VP O
83 externally RB O O
83 at IN B-VP O
84 90 CD O O
84 BPM NNP B-NP O
85 Respiratory: NNP I-NP O
85 Saturating NNP I-NP O
85 well RB O O
85 on IN B-VP O
85 2 CD O B-do
85 liters NNS B-NP I-do
85 of IN B-VP O
85 oxygen NN B-NP B-m
85 delivered VBN O O
85 by IN B-VP O
86 nasal JJ B-NP B-mo
86 cannula NNS I-NP I-mo
86 so RB O O
86 was VBD B-VP O
86 moderate JJ B-NP O
86 chest NN I-NP O
86 tube NN I-NP O
86 output NN I-NP O
87 Diet: NNP I-NP O
87 Advanced NNP I-NP O
87 as IN B-VP O
87 tolerated VBN O O
88 Renal: NNP B-NP O
88 Postop NNP I-NP O
88 increase NN I-NP O
88 in IN B-VP O
88 creatinine JJ O B-r
88 requiring VBG O O
88 dopamine NN B-NP B-m
88 , , O O
89 creatinine NN B-NP O
89 now RB O O
89 down RB O O
89 to TO O O
89 1.5 CD O O
89 P.o NNP B-NP B-mo
89 Lasix NNP I-NP B-m
89 started VBD B-VP O
90 Endocrine: NNP B-NP O
90 No NNP I-NP O
90 issues NNS I-NP O
91 Hematology: NNP I-NP O
91 Anticoagulation NNP I-NP B-r
91 with IN B-VP O
91 aspirin JJ B-NP B-m
92 ID: NNP I-NP O
92 Antibiotics NNPS I-NP B-m
92 are VBP O O
92 off IN B-VP O
92 Afebrile NNP B-NP O
93 Elevated NNP I-NP O
93 white JJ B-NP O
93 count NN I-NP O
93 secondary JJ O O
93 to TO O O
93 myelofibrosis VB O O
93 Transferred NNP B-NP O
93 to TO O O
94 Step-Down NNP B-NP O
94 Unit NNP I-NP O
94 on IN B-VP O
94 postoperative JJ B-NP O
94 day NN I-NP O
94 #6 NNP I-NP O
94 Postop NNP I-NP O
94 day NN I-NP O
94 #7 NNP I-NP O
94 , , O O
94 8/3/05 CD O O
94 , , O O
95 last JJ O O
95 remaining VBG O O
95 chest JJS B-NP O
95 tube NN I-NP O
95 removed VBD B-VP O
95 Patient NNP B-NP O
95 still RB O O
95 complains VBZ O O
95 of IN B-VP O
96 shortness NN B-NP O
96 of IN B-VP O
96 breath NN B-NP O
96 , , O O
96 saturating VBG O O
96 well RB O O
96 on IN B-VP O
96 room NN B-NP O
96 air NN I-NP O
96 Chest NNP I-NP O
96 x-ray NN I-NP O
97 looked VBD B-VP O
97 slightly RB O O
97 wet JJ O O
97 but CC O O
97 nothing NN B-NP O
97 significant JJ O O
97 noted VBD B-VP O
97 Echo NNP B-NP O
97 showed VBD B-VP O
98 moderate JJ B-NP O
98 TR NNP I-NP O
98 No NNP I-NP O
98 changes NNS I-NP O
98 from IN B-VP O
98 prior JJ B-NP O
98 echos JJ I-NP O
98 Send NNP I-NP O
98 troponin NN I-NP B-m
98 , , O O
98 BNP NNP B-NP O
98 to TO O O
99 help VB O O
99 rule VB O O
99 out RP O O
99 PE NNP B-NP O
99 per IN B-VP O
99 cards NNS B-NP O
99 , , O O
99 very RB O O
99 slow JJ O O
99 to TO O O
99 ambulate VB O O
99 , , O O
99 needs VBZ O O
99 PT NNP B-NP O
99 , , O O
100 probably RB O O
100 rehab NN B-NP O
100 , , O O
100 is VBZ O O
100 being VBG O O
100 paced VBN O O
100 to TO O O
100 70 CD O O
100 BPM NNP B-NP O
100 with IN B-VP O
100 external JJ B-NP O
100 V NNP I-NP O
100 wire NN I-NP O
100 , , O O
101 has VBZ O O
101 internal JJ B-NP O
101 pacer NN I-NP O
101 working VBG O O
101 at IN B-VP O
101 60 CD O O
101 beats NNS B-NP O
101 per IN B-VP O
101 minute NN B-NP O
101 but CC O O
101 needs VBZ O O
102 battery NN B-NP O
102 change NN I-NP O
102 by IN B-VP O
102 EPS NNP B-NP O
103 FOLLOW-UP NNP I-NP O
103 APPOINTMENTS: NNP I-NP O
103 Dr NNP I-NP O
103 Clam NNP I-NP O
103 wants VBZ O O
103 him PRP O O
103 on IN B-VP O
103 low JJ B-NP O
103 flow NN I-NP O
103 O2 NNP I-NP O
103 for IN B-VP O
104 time NN B-NP O
104 being VBG O O
104 1/14/05 CD O O
104 , , O O
104 postop JJ B-NP O
104 day NN I-NP O
104 #8 NNP I-NP O
104 , , O O
104 sinus VBD B-VP O
104 rhythm JJ O O
104 2 CD O O
104 liters NNS B-NP O
104 , , O O
105 patient NN B-NP O
105 with IN B-VP O
105 bilateral JJ B-NP O
105 lower JJR I-NP O
105 extremity NN I-NP O
105 DVT's NNP I-NP O
105 , , O O
105 right JJ B-NP O
105 IJ NNP I-NP O
105 clot NN I-NP O
105 , , O O
105 and CC O O
106 left VBD B-VP O
106 upper JJ B-NP B-r
106 extremity NN I-NP I-r
106 DVT NNP I-NP I-r
106 as RB O O
106 well RB O O
106 , , O O
106 started VBD B-VP O
106 on IN B-VP O
106 argatroban NN B-NP B-m
106 , , O O
106 PTT NNP B-NP O
106 to TO O O
107 titrate VB O O
107 the DT B-NP O
107 goal NN I-NP O
107 of IN B-VP O
107 50/70 CD O O
107 HIT NNP B-NP O
107 screen NN I-NP O
107 came VBD B-VP O
107 back RB O O
107 positive JJ B-NP O
108 Hematology NNP I-NP O
108 , , O O
108 following VBG O O
108 recommended VBD B-VP O
108 vascular JJ B-NP O
108 consult NN I-NP O
108 for IN B-VP O
108 blue JJ B-NP O
109 fingers NNS I-NP O
109 and CC O O
109 toes NNS B-NP O
109 If IN B-VP O
109 color NN B-NP O
109 on IN B-VP O
109 extremities NNS B-NP O
109 does VBZ O O
109 not RB O O
109 improve VB O O
109 on IN B-VP O
110 argatroban NN B-NP B-m
110 , , O O
110 will MD O O
110 get VB O O
110 vascular JJ O O
110 to TO O O
110 see VB O O
110 So RB O O
110 far RB O O
110 color NN B-NP O
110 in IN B-VP O
110 right JJ B-NP O
110 hand NN I-NP O
111 looks VBZ O O
111 better RBR O O
111 Left NNP B-NP O
111 fingers NNS I-NP O
111 and CC O O
111 toes NNS B-NP O
111 bilaterally RB O O
111 , , O O
111 no DT O O
111 worse JJR O O
111 , , O O
111 no DT B-NP O
112 better JJR I-NP O
112 Respiratory NN I-NP O
112 status NN I-NP O
112 worsens NNS I-NP O
112 , , O O
112 consider VB O O
112 CT NNP B-NP O
112 angiogram NN I-NP O
112 with IN B-VP O
113 contrast NN B-NP O
113 to TO O O
113 rule VB O O
113 out RP O O
113 PE NNP B-NP O
113 with IN B-VP O
113 Mucomyst NNP B-NP B-m
113 given VBN O O
113 creatinine NN B-NP O
113 of IN B-VP O
113 2.1 CD O O
114 Blood NNP B-NP O
114 cultures NNS I-NP O
114 sent VBD B-VP O
114 for IN B-VP O
114 white JJ B-NP O
114 count NN I-NP O
114 The DT B-NP O
114 patient NN I-NP O
114 with IN B-VP O
114 left JJ B-NP O
114 chest NN I-NP O
115 effusion NN I-NP O
115 , , O O
115 will MD O O
115 get VB O O
115 chest JJS B-NP O
115 ultrasound NN I-NP O
115 once RB O O
115 stable JJ O O
115 , , O O
115 still RB O O
115 has VBZ O O
115 wires NNS B-NP O
116 in IN B-VP O
116 and CC O O
116 being VBG O O
116 externally RB O O
116 paced VBN O O
116 at IN B-VP O
116 70 CD O O
116 until IN B-VP O
116 internal JJ B-NP O
116 PPM NNP I-NP O
116 can MD O O
116 have VB O O
117 battery NN B-NP O
117 change NN I-NP O
117 9/15/05 CD O O
117 , , O O
117 postop JJ B-NP O
117 day NN I-NP O
117 #9 NNP I-NP O
117 , , O O
117 HIT NNP B-NP O
117 positive JJ O O
117 with IN B-VP O
118 worsening VBG O O
118 clinical JJ B-NP O
118 syndrome NN I-NP O
118 Positive NNP I-NP O
118 DVT's NNP I-NP O
118 in IN B-VP O
118 all DT B-NP O
118 extremities NNS I-NP O
118 , , O O
119 started VBD B-VP O
119 on IN B-VP O
119 argatroban NN B-NP B-m
119 , , O O
119 transferred VBN O O
119 to TO O O
119 ICU NNP B-NP O
119 for IN B-VP O
119 further JJ B-NP O
119 monitoring NN I-NP O
119 , , O O
120 intubated VBN O O
120 in IN B-VP O
120 early JJ B-NP O
120 a.m NN I-NP O
120 for IN B-VP O
120 respiratory NN B-NP O
120 distress NN I-NP O
120 0/4/05 CD O O
120 , , O O
121 postop JJ B-NP O
121 day NN I-NP O
121 #10 NNP I-NP O
121 , , O O
121 echo NN B-NP O
121 obtained VBD B-VP O
121 RV NNP B-NP O
121 strain NN I-NP O
121 , , O O
121 moderate-to-severe JJ B-NP O
121 TR NNP I-NP O
122 Renal NNP I-NP O
122 ultrasound NN I-NP O
122 with IN B-VP O
122 Doppler NNP B-NP O
122 obtained VBD B-VP O
122 , , O O
122 no DT B-NP O
122 evidence NN I-NP O
122 of IN B-VP O
122 portal JJ B-NP O
123 venous JJ I-NP O
123 vascular JJ I-NP O
123 thrombosis NN I-NP O
123 Argatroban NNP I-NP B-m
123 continued VBD B-VP O
123 , , O O
123 persistently RB O O
124 high JJ B-NP O
124 minute NN I-NP O
124 ventilatory NN I-NP O
124 requirement JJ B-NP O
124 Postop NNP I-NP O
124 day NN I-NP O
124 #11 NNP I-NP O
124 , , O O
124 transfused VBD B-VP O
125 2 CD O B-do
125 units NNS B-NP I-do
125 packed VBD B-VP B-m
125 red JJ B-NP I-m
125 blood NN I-NP I-m
125 cells NNS I-NP I-m
125 with IN B-VP O
125 improvement NN B-NP O
125 in IN B-VP O
125 hematocrit NN B-NP O
125 , , O O
126 creatinine NN B-NP O
126 , , O O
126 and CC O O
126 BP NNP B-NP O
126 after IN B-VP O
126 second JJ B-NP O
126 unit NN I-NP O
126 , , O O
126 required VBN O O
126 left VBD B-VP O
126 femoral JJ B-NP O
126 CVL NNP I-NP O
127 placement NN I-NP O
127 for IN B-VP O
127 poor JJ B-NP O
127 peripheral JJ I-NP O
127 access NN I-NP O
127 and CC O O
127 concern NN B-NP O
127 for IN B-VP O
127 worsening NN B-NP O
127 of IN B-VP O
128 right JJ B-NP O
128 arm NN I-NP O
128 swelling NN I-NP O
128 after IN B-VP O
128 blood NN B-NP O
128 administration NN I-NP O
128 in IN B-VP O
128 the DT B-NP O
128 ipsilateral JJ I-NP O
129 arm NN I-NP O
129 Postop NNP I-NP O
129 day NN I-NP O
129 #12 NNP I-NP O
129 , , O O
129 right JJ B-NP O
129 hand NN I-NP O
129 cyanosis NN I-NP O
129 worsening VBG O O
130 Ortho/plastic/vascular NNP B-NP O
130 service NN I-NP O
130 following VBG O O
130 , , O O
130 thrombolytic JJ B-NP O
130 therapy NN I-NP O
130 at IN B-VP O
131 this DT B-NP O
131 time NN I-NP O
131 given VBN O O
131 current JJ B-NP O
131 anticoagulation NN I-NP O
131 on IN B-VP O
131 argatroban NN B-NP B-m
131 on IN B-VP O
132 propofol NN B-NP B-m
132 , , O O
132 went VBD B-VP O
132 weaned VBN O O
132 to TO O O
132 PSV NNP B-NP O
132 Total NNP I-NP O
132 bilirubin NN I-NP O
132 elevated VBD B-VP O
132 at IN B-VP O
132 4.1 CD O O
132 , , O O
133 direct JJ B-NP O
133 bilirubin NN I-NP O
133 at IN B-VP O
133 1.5 CD O O
133 0/18/05 CD O O
133 , , O O
133 postop JJ B-NP O
133 day NN I-NP O
133 #13 NNP I-NP O
133 , , O O
133 left VBD B-VP O
133 hand NN B-NP O
134 ischemia NN I-NP O
134 continues VBZ O O
134 to TO O O
134 progress VB O O
134 , , O O
134 too RB O O
134 agitated VBN O O
134 to TO O O
134 be VB O O
134 extubated VBN O O
134 , , O O
135 continues VBZ O O
135 to TO O O
135 be VB O O
135 therapeutic JJ O O
135 on IN B-VP O
135 argatroban JJ B-NP B-m
135 Microthrombi NNP I-NP O
135 , , O O
136 conservative JJ B-NP O
136 management NN I-NP O
136 planned VBN O O
136 Tube NNP B-NP O
136 feeds NNS I-NP O
136 started VBD B-VP O
136 , , O O
136 bronched VBD B-VP O
137 moderate JJ B-NP O
137 amount NN I-NP O
137 of IN B-VP O
137 seropurulent JJ B-NP O
137 secretions NNS I-NP O
137 Postop NNP I-NP O
137 day NN I-NP O
137 #14 NNP I-NP O
137 , , O O
138 11/0/05 CD O O
138 , , O O
138 left VBD B-VP O
138 hand NN B-NP O
138 ischemia NN I-NP O
138 showed VBD B-VP O
138 signs NNS B-NP O
138 of IN B-VP O
138 demarcation NN B-NP O
138 , , O O
138 PTT NNP B-NP O
139 therapeutic NN I-NP O
139 on IN B-VP O
139 argatroban NN B-NP B-m
139 , , O O
139 plastic JJ B-NP O
139 C NNP I-NP O
139 valve NN I-NP O
139 patient NN I-NP O
139 , , O O
139 suggested VBD B-VP O
140 conservative JJ B-NP O
140 therapy NN I-NP O
140 , , O O
140 low JJ B-NP O
140 urine NN I-NP O
140 output NN I-NP O
140 which WDT O O
140 resolved VBD B-VP O
140 with IN B-VP O
141 albumin JJ B-NP O
141 bolus NN I-NP O
141 , , O O
141 CK NNP B-NP O
141 is VBZ O O
141 trending VBG O O
141 down RP O O
141 , , O O
141 GI NNP B-NP O
141 consult NN I-NP O
141 was VBD B-VP O
141 obtained VBN O O
141 for IN B-VP O
142 melena NN B-NP O
142 10/0/05 CD O O
142 , , O O
142 postop JJ B-NP O
142 day NN I-NP O
142 #15 NNP I-NP O
142 , , O O
142 increase NN B-NP O
142 sodium NN I-NP B-m
142 , , O O
142 free JJ B-NP O
142 water NN I-NP O
143 added VBD B-VP O
143 , , O O
143 left VBD B-VP O
143 hand NN B-NP O
143 continues VBZ O O
143 to TO O O
143 demarcate VB O O
143 , , O O
143 argatroban JJ B-NP B-m
143 dose NN I-NP O
144 increased VBD B-VP O
144 to TO O O
144 get VB O O
144 PTT NNP B-NP B-r
144 therapeutic JJ O O
144 9/4/05 CD O O
144 , , O O
144 postop JJ B-NP O
144 day NN I-NP O
144 #16 NNP I-NP O
144 , , O O
145 thick JJ B-NP O
145 secretions NNS I-NP O
145 plugged VBD B-VP O
145 to TO O O
145 desaturated VBN O O
145 , , O O
145 cup JJ B-NP O
145 leak NN I-NP O
145 and CC O O
145 poor JJ B-NP O
145 TVs NNP I-NP O
145 , , O O
146 prompted VBD B-VP O
146 increasing VBG O O
146 FIO2 NNP B-NP O
146 , , O O
146 temperature NN B-NP O
146 spike NN I-NP O
146 , , O O
146 blood NN B-NP O
146 glucose RB O O
146 high JJ O O
146 , , O O
147 pancultured VBD B-VP O
147 for IN B-VP O
147 question NN B-NP O
147 of IN B-VP O
147 sepsis NN B-NP O
147 4/17/05 CD O O
147 , , O O
147 postop JJ B-NP O
147 day NN I-NP O
147 #17 NNP I-NP O
147 , , O O
148 Serratia NNP B-NP O
148 marcescens VBZ O O
148 in IN B-VP O
148 sputum JJ B-NP B-r
148 culture NN I-NP I-r
148 , , O O
148 started VBD B-VP O
148 on IN B-VP O
148 ceftazidime NN B-NP B-m
148 , , O O
149 awaiting VBG O O
149 sensitivities NNS B-NP O
149 , , O O
149 GI NNP B-NP O
149 bleed NN I-NP O
149 , , O O
149 hematocrit NN B-NP O
149 dropped VBD B-VP O
149 from IN B-VP O
149 28-23 JJ O O
149 , , O O
150 2 CD O B-do
150 units NNS B-NP I-do
150 packed VBD B-VP B-m
150 red JJ B-NP I-m
150 blood NN I-NP I-m
150 cells NNS I-NP I-m
150 given VBN O O
150 , , O O
150 NG-tube JJ B-NP O
150 aspiration NN I-NP O
150 with IN B-VP O
151 bilious JJ B-NP O
151 fluid NN I-NP O
151 , , O O
151 presumed VBD B-VP O
151 lower JJR B-NP O
151 GI NNP I-NP O
151 bleed NN I-NP O
151 , , O O
151 argatroban NN B-NP B-m
151 reduced VBD B-VP O
151 to TO O O
152 lower VB O O
152 end NN B-NP O
152 of IN B-VP O
152 therapeutic JJ B-NP O
152 window NN I-NP O
152 4/25/05 CD O O
152 , , O O
152 postop JJ B-NP O
152 day NN I-NP O
152 #18 NNP I-NP O
152 , , O O
152 GI NNP B-NP O
153 bleed NN I-NP O
153 continues VBZ O O
153 , , O O
153 hematocrit NN B-NP O
153 dropped VBD B-VP O
153 having VBG O O
153 1 CD O O
153 unit NN B-NP O
153 transfusion NN I-NP O
153 , , O O
154 bilirubin NN B-NP O
154 increased VBD B-VP O
154 from IN B-VP O
154 1.7-3.3 JJ O O
154 , , O O
154 echo NN B-NP O
154 was VBD B-VP O
154 essentially RB O O
154 unchanged JJ O O
155 showing VBG O O
155 RV NNP B-NP O
155 strain NN I-NP O
155 Postop NNP I-NP O
155 day NN I-NP O
155 #19 NNP I-NP O
155 , , O O
155 persistent JJ B-NP O
155 respiratory NN I-NP O
156 alkalosis NN I-NP O
156 with IN B-VP O
156 improvement NN B-NP O
156 of IN B-VP O
156 blood NN B-NP O
156 gas NN I-NP O
156 with IN B-VP O
156 adequate JJ B-NP O
156 sedation NN I-NP O
156 , , O O
157 decreased VBD B-VP O
157 minute NN B-NP O
157 ventilation NN I-NP O
157 6/29/05 CD O O
157 , , O O
157 postop JJ B-NP O
157 day NN I-NP O
157 #20 NNP I-NP O
157 , , O O
157 became VBD B-VP O
158 hypotensive JJ O O
158 , , O O
158 oliguric JJ O O
158 , , O O
158 profound JJ B-NP O
158 metabolic JJ I-NP O
158 acidosis NN I-NP O
158 septic JJ O O
158 , , O O
158 source NN B-NP O
159 likely JJ B-NP O
159 chest NN I-NP O
159 , , O O
159 lines NNS B-NP O
159 rewired VBD B-VP O
159 , , O O
159 pressors NNS B-NP O
159 started VBD B-VP O
159 , , O O
159 resedated VBN O O
159 and CC O O
159 put VBN O O
160 on IN B-VP O
160 a DT B-NP O
160 rate NN I-NP O
160 , , O O
160 also RB O O
160 further JJ O O
160 per IN B-VP O
160 bleeding VBG O O
160 requiring VBG O O
160 1 CD O O
160 unit NN B-NP O
161 transfusion NN I-NP O
161 7/4/05 CD O O
161 , , O O
161 postop JJ B-NP O
161 day NN I-NP O
161 #21 NNP I-NP O
161 , , O O
161 general JJ B-NP O
161 surgery NN I-NP O
161 consult NN I-NP O
161 , , O O
162 no DT B-NP O
162 surgical JJ I-NP O
162 etiology NN I-NP O
162 at IN B-VP O
162 the DT B-NP O
162 current JJ I-NP O
162 point NN I-NP O
162 , , O O
162 ultrasound NN B-NP O
162 showed VBD B-VP O
162 no DT B-NP O
163 pericholecystic JJ I-NP O
163 fluid NN I-NP O
163 , , O O
163 positively RB O O
163 distended VBD B-VP O
163 gallbladder NN B-NP O
163 , , O O
163 add VB O O
164 fluconazole JJ O B-m
164 and CC O O
164 Flagyl NNP B-NP B-m
164 prophylactically RB O O
164 , , O O
164 argatroban JJ O B-m
164 held VBD B-VP O
164 given VBN O O
165 profuse NN B-NP B-r
165 GI NNP I-NP I-r
165 bleeding VBG O I-r
165 requiring VBG O O
165 3 CD O B-do
165 units NNS B-NP I-do
165 of IN B-VP O
165 packed JJ B-NP B-m
165 red JJ I-NP I-m
165 blood NN I-NP I-m
165 cells NNS I-NP I-m
165 , , O O
166 hematocrit NN B-NP O
166 currently RB O O
166 stable JJ B-NP O
166 Postop NNP I-NP O
166 day NN I-NP O
166 #22 NNP I-NP O
166 , , O O
166 no DT B-NP O
166 further JJ I-NP O
166 GI NNP I-NP O
167 bleed NN I-NP O
167 , , O O
167 argatroban NN B-NP B-m
167 remains VBZ O O
167 off RP O O
167 , , O O
167 continues VBZ O O
167 on IN B-VP O
167 vasopressin NN B-NP B-m
167 and CC O O
168 dopamine JJ B-NP B-m
168 Postop NNP I-NP O
168 day NN I-NP O
168 #23 NNP I-NP O
168 , , O O
168 no DT B-NP O
168 GI NNP I-NP O
168 bleed NN I-NP O
168 , , O O
168 off RB O O
168 vasopressin NN B-NP B-m
168 , , O O
168 dopamine NN B-NP B-m
169 weaned VBD B-VP O
169 too RB O O
169 , , O O
169 left VBD B-VP O
169 hand NN B-NP O
169 looks VBZ O O
169 a DT O O
169 little JJ O O
169 better JJR O O
169 , , O O
169 trial NN B-NP O
169 of IN B-VP O
169 extubation NN B-NP O
169 , , O O
170 now RB O O
170 tachypneic VBZ O O
170 2/1/05 CD O O
170 , , O O
170 postop JJ B-NP O
170 day NN I-NP O
170 #24 NNP I-NP O
170 , , O O
170 extubated VBD B-VP O
170 , , O O
170 tolerating VBG O O
171 BiPAP NNP B-NP O
171 10/29/05 CD O O
171 , , O O
171 postop JJ B-NP O
171 day NN I-NP O
171 #25 NNP I-NP O
171 , , O O
171 tachypneic NN B-NP O
171 on IN B-VP O
171 BiPAP NNP B-NP O
171 , , O O
172 hypotensive NN B-NP O
172 , , O O
172 bolus NN B-NP O
172 with IN B-VP O
172 albumin JJ O O
172 4/7/05 CD O O
172 , , O O
172 postop JJ B-NP O
172 day NN I-NP O
172 #26 NNP I-NP O
172 , , O O
173 tolerating VBG O O
173 facemask NN B-NP O
173 , , O O
173 overnight RB O O
173 started VBD B-VP O
173 tube NN B-NP O
173 feeds NNS I-NP O
173 , , O O
173 sugars NNS B-NP O
174 controlled VBD B-VP O
174 on IN B-VP O
174 no DT B-NP O
174 insulin NN I-NP O
174 and CC O O
174 possibly RB O O
174 improving VBG O O
174 , , O O
174 we PRP O O
174 will MD O O
174 allow VB O O
174 to TO O O
175 further JJ B-NP O
175 demarcate NN I-NP O
175 for IN B-VP O
175 further JJ O O
175 two CD O O
175 weeks NNS B-NP O
175 3/0/05 CD O O
175 , , O O
175 postop JJ B-NP O
175 day NN I-NP O
176 #27 NNP I-NP O
176 , , O O
176 GI NNP B-NP O
176 bleed NN I-NP O
176 , , O O
176 hematocrit NN B-NP O
176 stable JJ O O
176 , , O O
176 tachypneic JJ O O
176 , , O O
176 intolerant NN B-NP O
176 of IN B-VP O
176 BiPAP NNP B-NP O
177 requiring VBG O O
177 suctioning VBG O O
177 Postop NNP B-NP O
177 day NN I-NP O
177 #28 NNP I-NP O
177 , , O O
177 GI NNP B-NP O
177 bleed NN I-NP O
177 , , O O
177 hematocrit NN B-NP O
178 dropped VBD B-VP O
178 from IN B-VP O
178 30-27 JJ O O
178 , , O O
178 back RB O O
178 to TO O O
178 29 CD O O
178 appears VBZ O O
178 stable JJ O O
178 , , O O
178 remains VBZ O O
178 on IN B-VP O
179 argatroban NN B-NP B-m
179 , , O O
179 bronched VBN O O
179 yesterday NN B-NP O
179 with IN B-VP O
179 serous JJ B-NP O
179 secretions NNS I-NP O
179 8/11/05 CD O O
179 , , O O
180 postop JJ B-NP O
180 day NN I-NP O
180 #29 NNP I-NP O
180 , , O O
180 no DT B-NP O
180 GI NNP I-NP O
180 bleeds NNS I-NP O
180 bleed NN I-NP O
180 , , O O
180 transfused VBD B-VP O
180 1 CD O O
180 unit NN B-NP O
180 for IN B-VP O
181 hematocrit NN B-NP O
181 of IN B-VP O
181 26 CD O O
181 , , O O
181 intermittent NN B-NP O
181 problems NNS I-NP O
181 with IN B-VP O
181 external JJ B-NP O
181 pacer NN I-NP O
182 capture NN I-NP O
182 and CC O O
182 internal JJ B-NP O
182 pacer NN I-NP O
182 not RB O O
182 firing VBG O O
182 , , O O
182 neurologically RB O O
182 continues VBZ O O
183 to TO O O
183 improve VB O O
183 10/12/05 CD O O
183 , , O O
183 postop JJ B-NP O
183 day NN I-NP O
183 #30 NNP I-NP O
183 , , O O
183 EPS NNP B-NP O
183 interrogated VBD B-VP O
183 pacer NN B-NP O
183 and CC O O
184 backup NN B-NP O
184 , , O O
184 pacing VBG O O
184 appears VBZ O O
184 to TO O O
184 be VB O O
184 intact JJ O O
184 , , O O
184 internal JJ B-NP O
184 pacer NN I-NP O
184 set VBN O O
184 backup NN B-NP O
185 rate NN I-NP O
185 at IN B-VP O
185 65 CD O O
185 , , O O
185 currently RB O O
185 patient JJ B-NP O
185 overdrive NN I-NP O
185 paced VBN O O
185 at IN B-VP O
185 rate NN B-NP O
185 of IN B-VP O
185 100 CD O O
185 , , O O
186 external JJ B-NP O
186 wires NNS I-NP O
186 working VBG O O
186 10/30/05 CD O O
186 , , O O
186 postop JJ B-NP O
186 day NN I-NP O
186 #31 NNP I-NP O
186 , , O O
186 venous JJ B-NP O
186 blood NN I-NP O
187 gas NN I-NP O
187 overnight VBD B-VP O
187 revealed VBD B-VP O
187 pH NN B-NP O
187 7.28 CD O O
187 , , O O
187 BiPAP NNP B-NP O
187 initiated VBD B-VP O
187 resulting VBG O O
187 in IN B-VP O
188 decreased JJ B-NP O
188 BP NNP I-NP O
188 , , O O
188 held VBD B-VP O
188 Lasix NNP B-NP B-m
188 drip NN I-NP B-mo
188 with IN B-VP O
188 decreased JJ B-NP O
188 BP NNP I-NP O
188 , , O O
188 patient JJ O O
188 much RB O O
189 more JJR O O
189 alert JJ O O
189 and CC O O
189 oriented VBN O O
189 after IN B-VP O
189 2 CD O O
189 hours NNS B-NP O
189 on IN B-VP O
189 BiPAP NNP B-NP O
189 Postop NNP I-NP O
189 day NN I-NP O
189 #32 NNP I-NP O
189 , , O O
190 right JJ B-NP O
190 upper JJ I-NP O
190 extremity NN I-NP O
190 swelling VBG O O
190 continues VBZ O O
190 to TO O O
190 worsen VB O O
190 , , O O
190 positive JJ B-NP O
191 pressure NN I-NP O
191 mask NN I-NP O
191 ventilation NN I-NP O
191 Postop NNP I-NP O
191 day NN I-NP O
191 #33 NNP I-NP O
191 , , O O
191 more RBR O O
191 communicative JJ B-NP O
192 overnight JJ I-NP O
192 Postop NNP I-NP O
192 day NN I-NP O
192 #34 NNP I-NP O
192 , , O O
192 more RBR O O
192 communicative JJ B-NP O
192 overnight JJ I-NP O
192 Postop NNP I-NP O
193 day NN I-NP O
193 #35 NNP I-NP O
193 , , O O
193 increased VBD B-VP O
193 pacemaker NN B-NP O
193 threshold NN I-NP O
193 overnight NN I-NP O
193 from IN B-VP O
193 2-7 JJ B-NP O
194 Postop NNP I-NP O
194 day NN I-NP O
194 #36 NNP I-NP O
194 , , O O
194 2/23/05 CD O O
194 , , O O
194 increased VBN O O
194 pacemaker NN B-NP O
194 threshold NN I-NP O
194 overnight NN I-NP O
195 from IN B-VP O
195 2-7 JJ O O
195 6/17/05 CD O O
195 , , O O
195 postop JJ B-NP O
195 day NN I-NP O
195 #36 NNP I-NP O
195 , , O O
195 continues VBZ O O
195 to TO O O
195 improve VB O O
195 for IN B-VP O
196 speech NN B-NP O
196 and CC O O
196 swallow NN B-NP O
196 and CC O O
196 EP NNP B-NP O
196 assessment VBD B-VP O
196 2/4/05 CD O O
196 , , O O
196 postop JJ B-NP O
196 day NN I-NP O
196 #37 NNP I-NP O
196 , , O O
197 plans VBZ O O
197 for IN B-VP O
197 pacemaker NN B-NP O
197 battery NN I-NP O
197 changed VBD B-VP O
197 , , O O
197 external JJ B-NP O
197 wire NN I-NP O
197 threshold NN I-NP O
197 at IN B-VP O
197 7 CD O O
198 milliamps NNS B-NP O
198 , , O O
198 argatroban NN B-NP B-m
198 , , O O
198 off RB O O
198 diuresis NN B-NP O
198 , , O O
198 IV NNP B-NP B-mo
198 Lasix NNP I-NP B-m
198 restarted VBD B-VP O
198 , , O O
198 Dobbhoff NNP B-NP O
199 tube NN I-NP O
199 pulled VBD B-VP O
199 out RP O O
199 by IN B-VP O
199 patient JJ B-NP O
199 Postop NNP I-NP O
199 day NN I-NP O
199 #38 NNP I-NP O
199 , , O O
199 had VBD B-VP O
199 pacing VBG O O
199 generator NN B-NP O
200 changed VBD B-VP O
200 , , O O
200 off RB O O
200 argatroban NN B-NP B-m
200 at IN B-VP O
200 present JJ B-NP O
200 Postop NNP I-NP O
200 day NN I-NP O
200 #39 NNP I-NP O
200 , , O O
200 failed VBD B-VP O
200 video NN B-NP O
201 swallow NN I-NP O
201 , , O O
201 tube NN B-NP O
201 feed NN I-NP O
201 to TO O O
201 continue VB O O
201 , , O O
201 argatroban RB O B-m
201 restarted VBN O O
201 , , O O
201 Lopressor NNP B-NP B-m
202 started VBD B-VP O
202 , , O O
202 pacemaker NN B-NP O
202 working VBG O O
202 well RB O O
202 , , O O
202 wires NNS B-NP O
202 discontinued VBD B-VP O
202 0/21/05 CD O O
202 , , O O
203 postop JJ B-NP O
203 day NN I-NP O
203 #40 NNP I-NP O
203 , , O O
203 argatroban NN B-NP B-m
203 dose NN I-NP O
203 reduced VBN O O
203 to TO O O
203 maintain VB O O
203 PTT NNP B-NP B-r
203 of IN B-VP O
203 50 CD O O
204 Postop NNP B-NP O
204 day NN I-NP O
204 #41 NNP I-NP O
204 , , O O
204 INR NNP B-NP O
204 2.3 CD O O
204 , , O O
204 will MD O O
204 check VB O O
204 INR NNP B-NP O
204 off IN B-VP O
204 argatroban NN B-NP B-m
204 , , O O
204 large JJ B-NP O
205 number NN I-NP O
205 of IN B-VP O
205 loose JJ B-NP O
205 stools NNS I-NP O
205 Postop NNP I-NP O
205 day NN I-NP O
205 #42 NNP I-NP O
205 , , O O
205 C NNP B-NP O
205 diff NN I-NP O
205 pending VBG O O
205 , , O O
206 argatroban RB O B-m
206 restarted VBN O O
206 Postop NNP B-NP O
206 day NN I-NP O
206 #43 NNP I-NP O
206 , , O O
206 nausea NN B-NP O
206 , , O O
206 no DT B-NP O
206 vomiting NN I-NP O
207 yesterday NN I-NP O
207 , , O O
207 tube NN B-NP O
207 feeds NNS I-NP O
207 turned VBD B-VP O
207 off RP O O
207 temporarily RB O O
207 , , O O
207 more JJR B-NP O
207 tachypneic JJ I-NP O
208 Postop NNP I-NP O
208 day NN I-NP O
208 #44 NNP I-NP O
208 , , O O
208 GNR NNP B-NP O
208 from IN B-VP O
208 A NNP B-NP O
208 line NN I-NP O
208 , , O O
208 sputum NN B-NP O
208 Gram NNP I-NP O
208 stain NN I-NP O
208 , , O O
208 gram-positive JJ B-NP O
209 cocci NN I-NP O
209 , , O O
209 and CC O O
209 gram-positive JJ B-NP O
209 rods NNS I-NP O
209 , , O O
209 febrile NN B-NP O
209 to TO O O
209 101.8 CD O O
209 Postop NNP B-NP O
209 day NN I-NP O
209 #45 NNP I-NP O
209 , , O O
210 A NNP B-NP O
210 line NN I-NP O
210 removed VBN O O
210 , , O O
210 argatroban VB O B-m
210 off RP O O
210 , , O O
210 sputum JJ B-NP O
210 culture NN I-NP O
210 grew VBD B-VP O
210 Staph NNP B-NP O
210 aureus NN I-NP O
211 and CC O O
211 pseudomonas NN B-NP O
211 , , O O
211 afebrile JJ B-NP O
211 Foley NNP I-NP O
211 removed VBD B-VP O
211 , , O O
211 patient JJ B-NP O
211 voiding NN I-NP O
211 , , O O
212 transferred VBD B-VP O
212 back RB O O
212 to TO O O
212 Step-Down NNP B-NP O
212 Unit NNP I-NP O
212 on IN B-VP O
212 10/5/05 CD O O
212 , , O O
212 postop JJ B-NP O
212 day NN I-NP O
212 #46 NNP I-NP O
212 , , O O
213 PTT NNP B-NP O
213 therapeutic NN I-NP O
213 on IN B-VP O
213 argatroban NN B-NP B-m
213 , , O O
213 INR NNP B-NP O
213 tending VBG O O
213 up RP O O
213 , , O O
213 fingers NNS B-NP O
213 and CC O O
213 toes NNS B-NP O
214 still RB O O
214 discolored VBD B-VP O
214 , , O O
214 continue VBP O O
214 to TO O O
214 follow VB O O
214 Foley NNP B-NP O
214 in IN B-VP O
214 place NN B-NP O
214 secondary JJ O O
215 to TO O O
215 retention NN B-NP O
215 , , O O
215 continues VBZ O O
215 on IN B-VP O
215 tube NN B-NP O
215 feeds NNS I-NP O
215 , , O O
215 continues VBZ O O
215 on IN B-VP O
215 triple JJ B-NP B-m
216 antibiotic JJ I-NP O
216 therapy NN I-NP O
216 for IN B-VP O
216 sputum/blood JJ B-NP B-r
216 culture NN I-NP I-r
216 , , O O
216 rehabilitation NN B-NP O
216 when WRB O O
217 ready JJ O O
217 0/7/05 CD O O
217 , , O O
217 postop JJ B-NP O
217 day NN I-NP O
217 #47 NNP I-NP O
217 , , O O
217 V NNP B-NP O
217 paced/room NN I-NP O
217 air NN I-NP O
217 , , O O
217 family NN B-NP O
218 meeting NN I-NP O
218 , , O O
218 patient NN B-NP O
218 to TO O O
218 have VB O O
218 video NN B-NP O
218 swallow NN I-NP O
218 on IN B-VP O
218 Tuesday NNP B-NP O
218 , , O O
218 plastics NNS B-NP O
218 came VBD B-VP O
219 up RB O O
219 today NN B-NP O
219 , , O O
219 planned VBD B-VP O
219 to TO O O
219 take VB O O
219 to TO O O
219 OR NNP B-NP O
219 next JJ B-NP O
219 week NN I-NP O
219 for IN B-VP O
219 amputation NN B-NP O
219 of IN B-VP O
219 left JJ B-NP O
220 fingers NNS I-NP O
220 and CC O O
220 some DT B-NP O
220 toes NNS I-NP O
220 , , O O
220 patient JJ O O
220 doing VBG O O
220 much JJ O O
220 better RBR O O
220 with IN B-VP O
220 PT NNP B-NP O
220 , , O O
220 goal NN B-NP O
221 PTT NNP I-NP O
221 is VBZ O O
221 50 CD O O
221 , , O O
221 argatroban NN B-NP B-m
221 to TO O O
221 come VB O O
221 off RP O O
221 once RB O O
221 INR NNP B-NP O
221 is VBZ O O
221 over IN B-VP O
221 2 CD O O
221 , , O O
221 starting VBG O O
222 Flomax NNP B-NP B-m
222 since IN B-VP O
222 he PRP O O
222 had VBD B-VP O
222 urinary JJ B-NP B-r
222 retention NN I-NP I-r
222 and CC O O
222 Foley NNP B-NP O
222 had VBD B-VP O
222 to TO O O
222 be VB O O
223 reinserted VBN O O
223 , , O O
223 we PRP O O
223 will MD O O
223 do VB O O
223 another DT O O
223 voiding VBG O O
223 trial NN B-NP O
223 48 CD O O
223 hours NNS B-NP O
223 Postop NNP I-NP O
224 day NN I-NP O
224 #48 NNP I-NP O
224 , , O O
224 on IN B-VP O
224 Flomax NNP B-NP B-m
224 , , O O
224 to TO O O
224 do VB O O
224 voiding VBG O O
224 trial NN B-NP O
224 at IN B-VP O
224 midnight NN B-NP O
224 tonight NN I-NP O
224 , , O O
224 on IN B-VP O
225 Coumadin NNP B-NP B-m
225 and CC O O
225 argatroban NN B-NP B-m
225 for IN B-VP O
225 HIT NNP B-NP B-r
225 HIT NNP I-NP B-r
225 , , O O
225 goal NN B-NP O
225 PTT NNP I-NP O
225 is VBZ O O
225 50-70 JJ O O
225 , , O O
225 plans VBZ O O
225 to TO O O
226 discontinue VB O O
226 argatroban NN B-NP B-m
226 when WRB O O
226 INR NNP B-NP O
226 greater JJR O O
226 than IN B-VP O
226 2 CD O O
226 Plastics NNPS B-NP O
226 most RBS O O
227 likely JJ O O
227 to TO O O
227 take VB O O
227 to TO O O
227 OR NNP B-NP O
227 next JJ B-NP O
227 week NN I-NP O
227 for IN B-VP O
227 removal NN B-NP O
227 of IN B-VP O
227 left JJ B-NP O
227 fingers/hand NN I-NP O
228 Patient NNP I-NP O
228 under IN B-VP O
228 impression NN B-NP O
228 that IN B-VP O
228 it PRP O O
228 is VBZ O O
228 just RB O O
228 fingertips NNS B-NP O
228 , , O O
228 family NN B-NP O
228 are VBP O O
229 aware JJ O O
229 and CC O O
229 may MD O O
229 be VB O O
229 more JJR O O
229 once RB O O
229 Dr NNP B-NP O
229 Vonseeger NNP I-NP O
229 makes VBZ O O
229 final JJ B-NP O
229 decision NN I-NP O
229 as IN B-VP O
229 to TO O O
230 what WP O O
230 he PRP O O
230 will MD O O
230 do VB O O
230 , , O O
230 will MD O O
230 need VB O O
230 to TO O O
230 make VB O O
230 patient NN B-NP O
230 aware JJ O O
230 , , O O
230 toes NNS B-NP O
230 are VBP O O
230 also RB O O
231 to TO O O
231 be VB O O
231 amputated VBN O O
231 , , O O
231 most RBS O O
231 likely RB O O
231 will MD O O
231 not RB O O
231 do VB O O
231 all DT O O
231 at IN B-VP O
231 once RB O O
231 , , O O
231 physical JJ B-NP O
232 therapy NN I-NP O
232 has VBZ O O
232 been VBN O O
232 working VBG O O
232 with IN B-VP O
232 him PRP O O
232 , , O O
232 very RB O O
232 happy JJ O O
232 with IN B-VP O
232 the DT B-NP O
232 progress NN I-NP O
233 he PRP O O
233 has VBZ O O
233 been VBN O O
233 making VBG O O
233 , , O O
233 speech NN B-NP O
233 and CC O O
233 swallow NN B-NP O
233 to TO O O
233 video VB O O
233 swallow NN B-NP O
233 on IN B-VP O
234 Tuesday NNP B-NP O
234 11/8/05 CD O O
234 , , O O
234 postop JJ B-NP O
234 day NN I-NP O
234 #49 NNP I-NP O
234 , , O O
234 V NNP B-NP O
234 paced VBD B-VP O
234 room NN B-NP O
234 air NN I-NP O
234 , , O O
234 argatroban NN B-NP B-m
235 and CC O O
235 Coumadin NNP B-NP B-m
235 for IN B-VP O
235 HIT NNP B-NP B-r
235 HIT NNP I-NP B-r
235 , , O O
235 status NN B-NP O
235 unchanged JJ O O
235 , , O O
235 awaiting VBG O O
235 plastics NNS B-NP O
235 input JJ B-NP O
236 Postop NNP I-NP O
236 day NN I-NP O
236 #50 NNP I-NP O
236 , , O O
236 paced VBD B-VP O
236 room NN B-NP O
236 air NN I-NP O
236 , , O O
236 plastics NNS B-NP O
236 talked VBD B-VP O
236 at IN B-VP O
236 length NN B-NP O
236 to TO O O
236 the DT B-NP O
237 patient NN I-NP O
237 to TO O O
237 take VB O O
237 him PRP O O
237 to TO O O
237 OR NNP B-NP O
237 later RB O O
237 this DT B-NP O
237 week NN I-NP O
237 , , O O
237 continue VBP O O
237 argatroban NN B-NP B-m
237 , , O O
238 Coumadin NNP B-NP B-m
238 held VBD B-VP O
238 , , O O
238 PT NNP B-NP O
238 working VBG O O
238 closely RB O O
238 with IN B-VP O
238 patient NN B-NP O
238 , , O O
238 hemodynamically RB O O
239 stable JJ O O
239 and CC O O
239 afebrile JJ O O
239 , , O O
239 high JJ B-NP O
239 white JJ I-NP O
239 blood NN I-NP O
239 cell NN I-NP O
239 count NN I-NP O
239 unchanged JJ B-NP O
240 Postop NNP I-NP O
240 day NN I-NP O
240 #51 NNP I-NP O
240 , , O O
240 V NNP B-NP O
240 paced VBD B-VP O
240 room NN B-NP O
240 air NN I-NP O
240 , , O O
240 failed VBD B-VP O
240 video NN B-NP O
240 swallow NN I-NP O
240 , , O O
240 keep VB O O
241 n.p.o NN B-NP O
241 , , O O
241 patient NN B-NP O
241 and CC O O
241 family NN B-NP O
241 will MD O O
241 decide VB O O
241 by IN B-VP O
241 the DT B-NP O
241 a.m NN I-NP O
241 if IN B-VP O
241 they PRP O O
241 will MD O O
242 proceed VB O O
242 with IN B-VP O
242 surgery NN B-NP O
242 on IN B-VP O
242 Thursday NNP B-NP O
242 , , O O
242 wound VBD B-VP O
242 looking VBG O O
242 better JJR O O
242 per IN B-VP O
242 RN NNP B-NP O
242 , , O O
243 otherwise RB O O
243 status NN B-NP O
243 quo JJ B-NP O
243 Postop NNP I-NP O
243 day NN I-NP O
243 #52 NNP I-NP O
243 , , O O
243 V NNP B-NP O
243 paced VBD B-VP O
243 room NN B-NP O
243 air NN I-NP O
243 , , O O
243 patient NN B-NP O
244 going VBG O O
244 to TO O O
244 OR NNP B-NP O
244 with IN B-VP O
244 plastics NNS B-NP O
244 for IN B-VP O
244 toe NN B-NP O
244 finger NN I-NP O
244 amputations/left VBD B-VP O
244 hand NN B-NP O
245 debridement NN I-NP O
245 , , O O
245 holding VBG O O
245 tube NN B-NP O
245 feeds NNS I-NP O
245 and CC O O
245 argatroban NN B-NP B-m
245 after IN B-VP O
245 midnight NN B-NP O
245 , , O O
246 patient NN B-NP O
246 on IN B-VP O
246 day NN B-NP O
246 #9 NNP I-NP O
246 of IN B-VP O
246 #14 NNP B-NP O
246 of IN B-VP O
246 levofloxacin NN B-NP B-m
246 for IN B-VP O
246 EC NNP B-NP B-r
246 bacteremia NN I-NP I-r
246 and CC O O
247 day NN B-NP O
247 #9 NNP I-NP O
247 of IN B-VP O
247 #21 NNP B-NP O
247 off IN B-VP O
247 linezolid NN B-NP B-m
247 for IN B-VP O
247 pseudomonas JJ B-NP B-r
247 pneumonia NN I-NP I-r
247 Postop NNP I-NP O
248 day NN I-NP O
248 #53 NNP I-NP O
248 , , O O
248 V NNP B-NP O
248 paced VBD B-VP O
248 room NN B-NP O
248 air NN I-NP O
248 , , O O
248 went VBD B-VP O
248 to TO O O
248 OR NNP B-NP O
248 today NN I-NP O
248 , , O O
248 had VBD B-VP O
248 complete JJ B-NP O
249 amputation NN I-NP O
249 of IN B-VP O
249 left JJ B-NP O
249 hand NN I-NP O
249 and CC O O
249 most JJS O O
249 of IN B-VP O
249 toes NNS B-NP O
249 bilateral JJ O O
249 , , O O
249 toes NNS B-NP O
249 were VBD B-VP O
250 left VBN O O
250 open JJ O O
250 , , O O
250 left VBD B-VP O
250 arm NN B-NP O
250 was VBD B-VP O
250 closed VBN O O
250 with IN B-VP O
250 a DT B-NP O
250 large JJ I-NP O
250 skin NN I-NP O
250 flap NN I-NP O
250 , , O O
250 JP NNP B-NP O
250 drain NN I-NP O
251 left VBD B-VP O
251 in IN B-VP O
251 place NN B-NP O
251 at IN B-VP O
251 left JJ B-NP O
251 wrist NN I-NP O
251 , , O O
251 about RB O O
251 2 CD O B-do
251 unit NN B-NP I-do
251 units NNS I-NP O
251 of IN B-VP O
251 packed JJ B-NP B-m
251 red JJ I-NP O
252 blood NN I-NP O
252 cells NNS I-NP O
252 postop JJ B-NP O
252 Psych NNP I-NP O
252 consulted VBD B-VP O
252 to TO O O
252 help VB O O
252 patient NN B-NP O
252 coping VBG O O
252 , , O O
252 they PRP O O
253 will MD O O
253 see VB O O
253 him PRP O O
253 tomorrow NN B-NP O
253 , , O O
253 restarted VBD B-VP O
253 argatroban NN B-NP B-m
253 at IN B-VP O
253 05:00 CD O O
253 p.m NN B-NP O
253 , , O O
254 restarting VBG O O
254 Coumadin NNP B-NP B-m
254 Postop NNP I-NP O
254 day NN I-NP O
254 #54 NNP I-NP O
254 , , O O
254 8/28/05 CD O O
254 , , O O
254 plastics NNS B-NP O
255 following VBG O O
255 , , O O
255 patient NN B-NP O
255 has VBZ O O
255 JP VBN O O
255 drain NN B-NP O
255 in IN B-VP O
255 wrist NN B-NP O
255 , , O O
255 status NN B-NP O
255 post NN I-NP O
255 left VBD B-VP O
255 hand NN B-NP O
256 amputation NN I-NP O
256 , , O O
256 bilateral JJ B-NP O
256 toe NN I-NP O
256 amputation NN I-NP O
256 , , O O
256 psych NN B-NP O
256 consulted VBN O O
256 for IN B-VP O
256 further JJ B-NP O
257 eval NN I-NP O
257 , , O O
257 patient NN B-NP O
257 not RB O O
257 depressed VBN O O
257 , , O O
257 coping VBG O O
257 well RB O O
257 , , O O
257 remains VBZ O O
257 on IN B-VP O
257 tube NN B-NP O
257 feeds NNS I-NP O
257 , , O O
258 followed VBN O O
258 by IN B-VP O
258 speech NN B-NP O
258 and CC O O
258 swallow NN B-NP O
258 with IN B-VP O
258 no DT B-NP O
258 records NNS I-NP O
258 for IN B-VP O
258 p.o NN B-NP O
258 feeds NNS I-NP O
258 at IN B-VP O
259 this DT B-NP O
259 point NN I-NP O
259 , , O O
259 PT NNP B-NP O
259 following VBG O O
259 , , O O
259 will MD O O
259 continue VB O O
259 to TO O O
259 advance VB O O
259 mobilization NN B-NP O
260 as IN B-VP O
260 wounds NNS B-NP O
260 heal JJ O O
260 , , O O
260 stable JJ O O
260 hemodynamically RB O O
260 6/13/05 CD O O
260 , , O O
260 postop JJ B-NP O
260 day NN I-NP O
261 #55 NNP I-NP O
261 , , O O
261 plastics NNS B-NP O
261 following VBG O O
261 , , O O
261 patient JJ O O
261 remains VBZ O O
261 on IN B-VP O
261 tube NN B-NP O
261 feeds NNS I-NP O
261 , , O O
261 pending VBG O O
262 speech NN B-NP O
262 and CC O O
262 swallow JJ B-NP O
262 advancement NN I-NP O
262 , , O O
262 stable JJ O O
262 hemodynamically RB O O
262 , , O O
262 repeat NN B-NP O
263 blood NN I-NP O
263 cultures NNS I-NP O
263 drawn VBP O O
263 , , O O
263 white JJ B-NP O
263 count NN I-NP O
263 still RB O O
263 elevated VBN O O
263 , , O O
263 currently RB O O
264 remaining VBG O O
264 on IN B-VP O
264 argatroban NN B-NP B-m
264 or CC O O
264 INR NNP B-NP O
264 subtherapeutic JJ O O
264 1/25/06 CD O O
264 , , O O
264 postop JJ B-NP O
265 day NN I-NP O
265 #56 NNP I-NP O
265 , , O O
265 plastic NN B-NP O
265 following NN I-NP O
265 , , O O
265 removed VBD B-VP O
265 left JJ B-NP O
265 wrist NN I-NP O
265 JP NNP I-NP O
265 drain NN I-NP O
265 , , O O
265 white JJ B-NP O
266 count NN I-NP O
266 remains NNS I-NP O
266 elevated VBD B-VP O
266 , , O O
266 remains VBZ O O
266 on IN B-VP O
266 tube NN B-NP O
266 feeds NNS I-NP O
266 , , O O
266 speech NN B-NP O
266 and CC O O
266 swallow NN B-NP O
267 following NN I-NP O
267 , , O O
267 PTT NNP B-NP O
267 therapeutic JJ O O
267 , , O O
267 INR NNP B-NP O
267 not RB O O
267 yet RB O O
267 therapeutic JJ O O
267 , , O O
267 started VBD B-VP O
268 low-dose JJ B-NP B-do
268 Neurontin NNP I-NP B-m
268 per IN B-VP O
268 plastics NNS B-NP O
268 , , O O
268 stable JJ O O
268 11/29/06 CD O O
268 , , O O
268 postop JJ B-NP O
268 day NN I-NP O
269 #57 NNP I-NP O
269 , , O O
269 white JJ B-NP O
269 count NN I-NP O
269 up RP O O
269 a DT B-NP O
269 bit NN I-NP O
269 , , O O
269 cultures NNS B-NP O
269 remain VBP O O
269 negative JJ O O
269 at IN B-VP O
269 baseline NN B-NP O
269 , , O O
270 white JJ B-NP O
270 blood NN I-NP O
270 cell NN I-NP O
270 elevation NN I-NP O
270 upon IN B-VP O
270 admit NN B-NP O
270 , , O O
270 patient JJ O O
270 very RB O O
270 concerned JJ O O
271 about IN B-VP O
271 being VBG O O
271 tube JJ O O
271 fed VBN O O
271 , , O O
271 planned VBN O O
271 speech NN B-NP O
271 and CC O O
271 swallow JJ B-NP O
271 reevaluation NN I-NP O
272 scheduled VBN O O
272 for IN B-VP O
272 tomorrow NN B-NP O
272 , , O O
272 ambulate VBP O O
272 out IN B-VP O
272 of IN B-VP O
272 bed NN B-NP O
272 to TO O O
272 chair VB O O
272 with IN B-VP O
272 lift NN B-NP O
273 team NN I-NP O
273 and CC O O
273 may MD O O
273 weight VB O O
273 bear NN B-NP O
273 with IN B-VP O
273 PT NNP B-NP O
273 , , O O
273 plastics NNS B-NP O
273 following VBG O O
273 , , O O
273 PTT NNP B-NP O
274 therapeutic NN I-NP O
274 on IN B-VP O
274 argatroban JJ O B-m
274 3/18/06 CD O O
274 , , O O
274 postop JJ B-NP O
274 day NN I-NP O
274 #58 NNP I-NP O
274 , , O O
274 V NNP B-NP O
274 paced VBD B-VP O
274 via IN B-VP O
275 internal JJ B-NP O
275 PPM NNP I-NP O
275 , , O O
275 BP NNP B-NP O
275 stable JJ O O
275 , , O O
275 satting VBG O O
275 well RB O O
275 on IN B-VP O
275 room NN B-NP O
275 air NN I-NP O
275 , , O O
275 out IN B-VP O
275 of IN B-VP O
275 bed NN B-NP O
276 with IN B-VP O
276 PT NNP B-NP O
276 , , O O
276 ambulated VBD B-VP O
276 a DT O O
276 little JJ O O
276 , , O O
276 plastics/vascular JJ B-NP O
276 following NN I-NP O
276 , , O O
276 left VBD B-VP O
277 upper JJ B-NP O
277 extremity NN I-NP O
277 and CC O O
277 bilateral JJ B-NP O
277 toe NN I-NP O
277 amputation NN I-NP O
277 site NN I-NP O
277 healing VBG O O
277 well RB O O
277 , , O O
278 argatroban JJ B-NP B-m
278 argatroban NN I-NP B-m
278 dose NN I-NP O
278 increased VBD B-VP O
278 from IN B-VP O
278 0.1 CD O B-do
278 to TO O O
278 0.2 CD O B-do
278 , , O O
278 bridging VBG O O
278 to TO O O
278 Coumadin NNP B-NP B-m
278 , , O O
279 speech NN B-NP O
279 and CC O O
279 swallow JJ B-NP O
279 reevaluate NN I-NP O
279 at IN B-VP O
279 bedside NN B-NP O
279 , , O O
279 may MD O O
279 repeat VB O O
279 video NN B-NP O
280 swallow NN I-NP O
280 study NN I-NP O
280 later RB O O
280 this DT B-NP O
280 week NN I-NP O
280 as IN B-VP O
280 patient NN B-NP O
280 continues VBZ O O
280 to TO O O
280 work VB O O
280 with IN B-VP O
281 PT NNP B-NP O
281 and CC O O
281 increase VB O O
281 strength NN B-NP O
281 , , O O
281 remains VBZ O O
281 on IN B-VP O
281 Dobbhoff NNP B-NP O
281 tube NN I-NP O
281 feeds NNS I-NP O
281 , , O O
281 patient NN B-NP O
282 has VBZ O O
282 baseline VBN O O
282 neutrophilia NNS B-NP O
282 but CC O O
282 mildly RB O O
282 above IN B-VP O
282 baseline NN B-NP O
282 , , O O
282 afebrile RB O O
282 , , O O
283 following VBG O O
283 pancultures NNS B-NP O
283 including VBG O O
283 C NNP B-NP O
283 diff NN I-NP O
283 for IN B-VP O
283 loose JJ B-NP O
283 stools NNS I-NP O
283 , , O O
283 dosing VBG O O
284 Lasix NNP B-NP B-m
284 for IN B-VP O
284 reduced JJ B-NP B-r
284 urine JJ I-NP I-r
284 output NN I-NP I-r
284 Foley NNP I-NP O
284 in IN B-VP O
284 place NN B-NP O
284 , , O O
284 discontinued VBN O O
285 PCA NNP B-NP O
285 , , O O
285 rehabilitation NN B-NP O
285 screen NN I-NP O
285 initiated VBD B-VP O
285 8/25/06 CD O O
285 , , O O
285 postop JJ B-NP O
285 day NN I-NP O
285 #59 NNP I-NP O
285 , , O O
286 V NNP B-NP O
286 paced VBD B-VP O
286 via IN B-VP O
286 internal JJ B-NP O
286 pacemaker NN I-NP O
286 , , O O
286 BP NNP B-NP O
286 stable JJ O O
286 , , O O
286 remains VBZ O O
286 afebrile JJ O O
286 , , O O
287 remains VBZ O O
287 on IN B-VP O
287 linezolid NN B-NP B-m
287 for IN B-VP O
287 EC NNP B-NP B-r
287 bacteremia NN I-NP I-r
287 , , O O
287 chest VB O O
287 x-ray JJ O O
287 continues VBZ O O
287 to TO O O
288 demonstrate VB O O
288 persistent JJ B-NP O
288 opacifications NNS I-NP O
288 and CC O O
288 left VBD B-VP O
288 mid NN B-NP O
288 , , O O
288 left VBD B-VP O
288 lower JJR O O
288 , , O O
289 and CC O O
289 right JJ B-NP O
289 base NN I-NP O
289 , , O O
289 had VBD B-VP O
289 been VBN O O
289 on IN B-VP O
289 levofloxacin JJ B-NP B-m
289 levofloxacin NN I-NP B-m
289 1/29/05 CD O B-du
289 through IN B-VP O
290 10/29/05 CD O O
290 and CC O O
290 8/4/05 CD O B-du
290 through IN B-VP I-du
290 3/18/06 CD O I-du
290 , , O O
290 satting VBG O O
290 well RB O O
290 on IN B-VP O
290 room NN B-NP O
290 air NN I-NP O
290 , , O O
291 strictly RB O O
291 n.p.o JJ O O
291 , , O O
291 all DT B-NP O
291 nutrition NN I-NP O
291 via IN B-VP O
291 Dobbhoff NNP B-NP O
291 , , O O
291 patient NN B-NP O
291 has VBZ O O
291 been VBN O O
292 working VBG O O
292 diligently RB O O
292 with IN B-VP O
292 PT NNP B-NP O
292 , , O O
292 speech NN B-NP O
292 and CC O O
292 swallow NN B-NP O
292 to TO O O
292 reassess VB O O
292 again RB O O
293 Thursday NNP B-NP O
293 and CC O O
293 Friday NNP B-NP O
293 , , O O
293 remains VBZ O O
293 on IN B-VP O
293 argatroban NN B-NP B-m
293 with IN B-VP O
293 subtherapeutic JJ B-NP O
294 INR NNP I-NP O
294 , , O O
294 titrating VBG O B-do
294 Coumadin NNP B-NP B-m
294 dose NN I-NP O
294 , , O O
294 plastics NNS B-NP O
294 following VBG O O
294 left JJ B-NP O
294 hand NN I-NP O
294 and CC O O
295 bilateral JJ B-NP O
295 toe NN I-NP O
295 amputation NN I-NP O
295 sites NNS I-NP O
295 which WDT O O
295 are VBP O O
295 clean JJ O O
295 and CC O O
295 healing VBG O O
295 well RB O O
296 10/28/06 CD O O
296 , , O O
296 postop JJ B-NP O
296 day NN I-NP O
296 #60 NNP I-NP O
296 , , O O
296 remains VBZ O O
296 ventricularly RB O O
296 paced VBN O O
296 via IN B-VP O
297 internal JJ B-NP O
297 PPM NNP I-NP O
297 , , O O
297 BP NNP B-NP O
297 stable JJ O O
297 , , O O
297 ambulated VBD B-VP O
297 out IN B-VP O
297 of IN B-VP O
297 room NN B-NP O
297 today NN I-NP O
297 with IN B-VP O
297 PT NNP B-NP O
297 , , O O
298 Speech NNP B-NP O
298 and CC O O
298 Swallow NNP B-NP O
298 Service NNP I-NP O
298 encouraged VBN O O
298 by IN B-VP O
298 recent JJ B-NP O
298 PT NNP I-NP O
298 gains NNS I-NP O
298 , , O O
298 felt VBD B-VP O
299 bedside JJ B-NP O
299 exam NN I-NP O
299 today NN I-NP O
299 indicated VBD B-VP O
299 potential JJ O O
299 for IN B-VP O
299 advancement NN B-NP O
299 , , O O
299 scheduled VBN O O
300 for IN B-VP O
300 repeat NN B-NP O
300 video NN I-NP O
300 swallow NN I-NP O
300 , , O O
300 remains VBZ O O
300 strictly RB O O
300 n.p.o JJ O O
300 , , O O
300 fed JJ O O
300 via IN B-VP O
301 Dobbhoff NNP B-NP O
301 , , O O
301 white JJ B-NP O
301 count NN I-NP O
301 at IN B-VP O
301 preop JJ B-NP O
301 baseline NN I-NP O
301 , , O O
301 afebrile IN B-VP O
301 completing VBG O O
301 21 CD O B-du
302 day NN B-NP O
302 course NN I-NP O
302 of IN B-VP O
302 linezolid JJ O B-m
302 for IN B-VP O
302 EC NNP B-NP B-r
302 bacteremia NN I-NP I-r
302 , , O O
302 chest VB O O
302 x-ray JJ O O
302 continues VBZ O O
303 to TO O O
303 demonstrate VB O O
303 persistent JJ O O
303 although IN B-VP O
303 mildly RB O O
303 improved VBN O O
303 opacifications NNS B-NP O
304 in IN B-VP O
304 the DT B-NP O
304 left NN I-NP O
304 mid NN I-NP O
304 , , O O
304 left VBD B-VP O
304 lower JJR O O
304 , , O O
304 and CC O O
304 right JJ B-NP O
304 base NN I-NP O
304 , , O O
304 has VBZ O O
304 been VBN O O
304 on IN B-VP O
305 levofloxacin NN B-NP B-m
305 , , O O
305 saturating VBG O O
305 well RB O O
305 on IN B-VP O
305 room NN B-NP O
305 air NN I-NP O
305 , , O O
305 urine JJ B-NP O
305 output NN I-NP O
305 , , O O
305 JVD NNP B-NP O
305 , , O O
305 and CC O O
306 chest JJS O O
306 x-ray JJ O O
306 improved VBN O O
306 after IN B-VP O
306 adding VBG O O
306 low-dose JJ B-NP B-do
306 Lasix NNP I-NP B-m
306 , , O O
306 remains VBZ O O
306 on IN B-VP O
307 argatroban NN B-NP B-m
307 with IN B-VP O
307 subtherapeutic JJ B-NP O
307 INR NNP I-NP O
307 Plastics NNPS I-NP O
307 following VBG O O
307 Postop NNP B-NP O
308 day NN I-NP O
308 #61 NNP I-NP O
308 , , O O
308 10/2/06 CD O O
308 , , O O
308 long RB O O
308 postop JJ B-NP O
308 course NN I-NP O
308 complicated VBN O O
308 by IN B-VP O
308 HIT NNP B-NP O
309 positive JJ O O
309 , , O O
309 Speech NNP B-NP O
309 and CC O O
309 Swallow NNP B-NP O
309 Service NNP I-NP O
309 were VBD B-VP O
309 encouraged VBN O O
309 enough RB O O
309 by IN B-VP O
310 recent JJ B-NP O
310 PT NNP I-NP O
310 gains NNS I-NP O
310 to TO O O
310 reassess VB O O
310 video NN B-NP O
310 swallow NN I-NP O
310 but CC O O
310 again RB O O
310 was VBD B-VP O
310 seen VBN O O
310 to TO O O
311 aspirate VB O O
311 with IN B-VP O
311 all DT B-NP O
311 consistencies NNS I-NP O
311 , , O O
311 keeping VBG O O
311 strictly RB O O
311 n.p.o VBN O O
311 , , O O
311 all DT B-NP O
312 nutrition NN I-NP O
312 and CC O O
312 meds NNS B-NP O
312 via IN B-VP O
312 Dobbhoff NNP B-NP O
312 NGT NNP I-NP O
312 , , O O
312 no DT B-NP O
312 PEG NNP I-NP O
312 planned VBD B-VP O
312 at IN B-VP O
312 this DT B-NP O
313 point NN I-NP O
313 , , O O
313 the DT B-NP O
313 patient NN I-NP O
313 is VBZ O O
313 afebrile JJ O O
313 , , O O
313 completing VBG O O
313 21 CD O B-du
313 day NN B-NP I-du
313 course NN I-NP I-du
314 linezolid NN I-NP B-m
314 for IN B-VP O
314 EC NNP B-NP B-r
314 bacteremia NN I-NP I-r
314 Chest NNP I-NP O
314 x-ray NN I-NP O
314 continues VBZ O O
314 to TO O O
315 demonstrate VB O O
315 persistent JJ O O
315 although IN B-VP O
315 improved JJ B-NP O
315 calcifications NNS I-NP O
315 in IN B-VP O
315 the DT B-NP O
316 left NN I-NP O
316 mid NN I-NP O
316 , , O O
316 left VBD B-VP O
316 lower JJR O O
316 , , O O
316 and CC O O
316 right JJ B-NP O
316 base NN I-NP O
316 0/20/06 CD O O
316 , , O O
316 postop JJ B-NP O
316 day NN I-NP O
316 #62 NNP I-NP O
316 , , O O
317 remains VBZ O O
317 on IN B-VP O
317 argatroban NN B-NP B-m
317 drip NN I-NP B-mo
317 for IN B-VP O
317 HIT NNP B-NP B-r
317 , , O O
317 INR NNP B-NP O
317 trending VBG O O
317 up RP O O
317 , , O O
317 n.p.o RB O O
317 tube JJ B-NP O
318 feeds NNS I-NP O
318 via IN B-VP O
318 Dobbhoff NNP B-NP O
318 , , O O
318 three CD O B-du
318 more JJR B-NP I-du
318 days NNS I-NP I-du
318 of IN B-VP O
318 Linezolid NNP B-NP B-m
318 for IN B-VP O
318 EC NNP B-NP B-r
319 bacteremia NN I-NP O
319 2/29/06 CD O O
319 , , O O
319 postop JJ B-NP O
319 day NN I-NP O
319 63# CD O O
319 , , O O
319 VP NNP B-NP O
319 room NN I-NP O
319 air NN I-NP O
319 , , O O
319 remains VBZ O O
319 on IN B-VP O
320 argatroban NN B-NP B-m
320 for IN B-VP O
320 HIT NNP B-NP B-r
320 , , O O
320 INR NNP B-NP O
320 2.5 CD O O
320 , , O O
320 rising VBG O O
320 slowly RB O O
320 Order NNP B-NP O
320 for IN B-VP O
320 portable JJ B-NP O
321 chest JJ I-NP O
321 x-ray NN I-NP O
321 , , O O
321 20 CD O B-do
321 20 CD O B-do
321 mg NN B-NP I-do
321 mg NN I-NP I-do
321 IV NNP I-NP B-mo
321 IV NNP I-NP B-mo
321 Lasix NNP I-NP B-m
321 Lasix NNP I-NP B-m
321 for IN B-VP O
321 increased VBN O B-r
321 increased VBN O B-r
321 labored VBN O I-r
321 labored RBR O I-r
321 breathing VBG O I-r
321 breathing VBG O I-r
322 today NN B-NP O
322 , , O O
322 weight NN B-NP O
322 has VBZ O O
322 been VBN O O
322 stable JJ O O
322 past IN B-VP O
322 few JJ B-NP O
322 days NNS I-NP O
322 , , O O
322 positive JJ O O
322 on IN B-VP O
322 I's/O's NNP B-NP O
322 , , O O
323 white JJ B-NP O
323 count NN I-NP O
323 high JJ O O
323 but CC O O
323 at IN B-VP O
323 baseline JJ O O
323 secondary JJ O O
323 to TO O O
323 his PRP$ O O
323 history NN B-NP O
323 of IN B-VP O
324 myeloproliferative JJ B-NP O
324 disorder NN I-NP O
324 , , O O
324 patient NN B-NP O
324 remained VBD B-VP O
324 afebrile JJ O O
325 8/17/06 CD O O
325 , , O O
325 postop JJ B-NP O
325 day NN I-NP O
325 #64 NNP I-NP O
325 , , O O
325 V NNP B-NP O
325 paced VBD B-VP O
325 room NN B-NP O
325 air NN I-NP O
325 , , O O
325 decreased VBD B-VP O
325 argatroban JJ O B-m
326 4/0/06 CD O O
326 , , O O
326 postop JJ B-NP O
326 day NN I-NP O
326 #65 NNP I-NP O
326 , , O O
326 V NNP B-NP O
326 paced VBD B-VP O
326 , , O O
326 argatroban JJ O B-m
326 discontinued VBN O O
326 as IN B-VP O
327 INR NNP B-NP O
327 now RB O O
327 therapeutic JJ O O
327 , , O O
327 working VBG O O
327 with IN B-VP O
327 PT NNP B-NP O
327 doing VBG O O
327 well RB O O
327 , , O O
327 patient NN B-NP O
327 was VBD B-VP O
328 evaluated VBN O O
328 by IN B-VP O
328 Cardiac NNP B-NP O
328 Surgery NNP I-NP O
328 Service NNP I-NP O
328 to TO O O
328 be VB O O
328 stable JJ O O
328 to TO O O
328 discharge VB O O
328 to TO O O
329 rehabilitation VB O O
329 on IN B-VP O
329 7/24/06 CD O O
329 with IN B-VP O
329 the DT O O
329 following VBG O O
329 discharge NN B-NP O
330 instructions NNS I-NP O
331 DIET: NNP I-NP O
331 Osmolite NNP I-NP B-m
331 1.2 CD O O
331 tube NN B-NP O
331 feeds NNS I-NP O
331 at IN B-VP O
331 80 CD O B-do
331 cc NN B-NP I-do
331 an DT B-NP O
331 hour NN I-NP O
331 with IN B-VP O
331 plans NNS B-NP O
331 to TO O O
332 advance VB O O
332 p.o NN B-NP B-mo
332 as IN B-VP O
332 swallow JJ B-NP O
332 function NN I-NP O
332 improved VBD B-VP O
333 FOLLOW NNP B-NP O
333 UP NNP I-NP O
333 APPOINTMENTS: NNP I-NP O
333 Dr NNP I-NP O
333 Leaird NNP I-NP O
333 , , O O
333 282-008-4347 JJ O O
333 in IN B-VP O
333 5-6 JJ B-NP O
333 weeks NNS I-NP O
333 , , O O
334 Dr NNP B-NP O
334 Tanaka NNP I-NP O
334 , , O O
334 5324-517-0379 JJ O O
334 in IN B-VP O
334 1-2 JJ B-NP O
334 weeks NNS I-NP O
334 , , O O
334 Dr NNP B-NP O
334 Suriel NNP I-NP O
334 465-337-2375 JJ O O
334 in IN B-VP O
335 1-2 JJ B-NP O
335 weeks NNS I-NP O
335 , , O O
335 Dr NNP B-NP O
335 Peshek NNP I-NP O
335 OOGMCAGHC NNP I-NP O
335 Plastics NNS I-NP O
335 at IN B-VP O
335 305-235-4279 JJ O O
335 in IN B-VP O
335 7-10 JJ B-NP O
335 days NNS I-NP O
336 ADDITIONAL NNP I-NP O
336 COMMENTS: NNP I-NP O
336 The DT B-NP O
336 patient NN I-NP O
336 should MD O O
336 have VB O O
336 speech NN B-NP O
336 and CC O O
336 swallow NN B-NP O
337 follow VBP O O
337 up RP O O
337 while NN B-NP O
337 at IN B-VP O
337 rehab NN B-NP O
337 for IN B-VP O
337 ongoing VBG O O
337 evaluation NN B-NP O
337 of IN B-VP O
337 swallow JJ B-NP O
338 function NN I-NP O
338 He PRP O O
338 is VBZ O O
338 going VBG O O
338 to TO O O
338 rehabilitation VB O O
338 with IN B-VP O
338 Dobbhoff NNP B-NP O
338 tube NN I-NP O
338 in IN B-VP O
339 place NN B-NP O
339 for IN B-VP O
339 feeding VBG O O
339 with IN B-VP O
339 plans NNS B-NP O
339 to TO O O
339 advance VB O O
339 diet JJ O O
339 to TO O O
339 p.o VB O O
339 intake VB O O
339 once RB O O
340 swallow JJ B-NP O
340 function NN I-NP O
340 improves VBZ O O
340 Mr NNP B-NP O
340 Lesley NNP I-NP O
340 Cusmano NNP I-NP O
340 should MD O O
340 not RB O O
340 receive VB O O
340 any DT B-NP O
341 heparin NN I-NP O
341 products NNS I-NP O
341 , , O O
341 he PRP O O
341 has VBZ O O
341 HIT VBN O O
341 and CC O O
341 has VBZ O O
341 required VBN O O
341 anticoagulation NN B-NP O
342 therapy/surgical JJ B-NP O
342 amputation NN I-NP O
342 as IN B-VP O
342 a DT B-NP O
342 result NN I-NP O
343 TO NNP I-NP O
343 DO NNP I-NP O
343 PLAN: NNP I-NP O
343 Make NNP I-NP O
343 all DT B-NP O
343 follow-up JJ I-NP O
343 appointments NNS I-NP O
343 , , O O
343 local JJ B-NP O
343 wound NN I-NP O
343 care NN I-NP O
343 , , O O
344 wash JJ B-NP O
344 wounds NNS I-NP O
344 daily JJ O O
344 with IN B-VP O
344 soap NN B-NP O
344 and CC O O
344 water NN B-NP O
344 , , O O
344 shower JJR B-NP O
344 patient JJ I-NP O
344 daily JJ I-NP O
345 Please NNP I-NP O
345 follow VB O O
345 HH NNP B-NP O
345 Plastic NNP I-NP O
345 Surgery NNP I-NP O
345 Service NNP I-NP O
345 records NNS I-NP O
345 for IN B-VP O
345 dressing VBG O O
346 changes NNS B-NP O
346 , , O O
346 bilateral JJ B-NP O
346 lower JJR I-NP O
346 extremities NNS I-NP O
346 and CC O O
346 left JJ B-NP O
346 wrist NN I-NP O
346 Watch NNP I-NP O
347 wounds VBZ O O
347 for IN B-VP O
347 signs NNS B-NP O
347 of IN B-VP O
347 infection NN B-NP O
347 , , O O
347 redness NN B-NP O
347 , , O O
347 swelling VBG O O
347 , , O O
347 fever NN B-NP O
347 , , O O
347 pain NN B-NP O
347 , , O O
348 discharge NN B-NP O
348 Call NNP I-NP O
348 PCP/cardiologist NNP I-NP O
348 or CC O O
348 JH NNP B-NP O
348 Cardiac NNP I-NP O
348 Surgery NNP I-NP O
348 Service NNP I-NP O
349 at IN B-VP O
349 282-008-4347 JJ O O
349 with IN B-VP O
349 any DT B-NP O
349 questions NNS I-NP O
349 or CC O O
349 Dr NNP B-NP O
349 Boldenow NNP I-NP O
349 at IN B-VP O
349 305-235-4279 JJ O O
350 with IN B-VP O
350 any DT B-NP O
350 questions NNS I-NP O
350 regarding VBG O O
350 amputation NN B-NP O
350 sites NNS I-NP O
351 DISCHARGE NNP I-NP O
351 CONDITION: NNP I-NP O
351 Stable NNP I-NP O
352 DISCHARGE NNP I-NP O
352 MEDICATIONS: NNP I-NP O
352 Tylenol NNP I-NP B-m
352 325-650 JJ B-NP B-do
352 mg NN I-NP I-do
352 PNGT NNP I-NP O
352 q.4h NN I-NP B-f
352 p.r.n NN I-NP I-f
353 pain NN I-NP B-r
353 , , O O
353 atenolol RB O B-m
353 12.5 CD O B-do
353 mg JJ O I-do
353 daily RB O B-f
353 , , O O
353 Dulcolax NNP B-NP B-m
353 10 CD O B-do
353 mg NN B-NP I-do
353 PR NNP I-NP B-mo
353 daily RB O B-f
353 p.r.n VBZ O I-f
354 constipation NN B-NP B-r
354 , , O O
354 Chloraseptic NNP B-NP B-m
354 spray NN I-NP I-m
354 one CD O B-do
354 spray NN B-NP I-do
354 q.2h NN I-NP B-f
354 p.r.n NN I-NP I-f
354 pain NN I-NP O
355 instructions NNS I-NP O
355 for IN B-VP O
355 throat NN B-NP B-r
355 pain NN I-NP I-r
355 due JJ O O
355 to TO O O
355 NG NNP B-NP O
355 tube NN I-NP O
355 , , O O
355 Colace NNP B-NP B-m
355 100 CD O B-do
355 mg NN B-NP I-do
355 t.i.d NN I-NP B-f
356 p.r.n NN I-NP O
356 constipation NN I-NP B-r
356 , , O O
356 ferrous JJ B-NP B-m
356 sulfate NN I-NP I-m
356 300 CD O B-do
356 mg NN B-NP I-do
356 PNGT NNP I-NP O
356 t.i.d NN I-NP B-f
356 , , O O
356 Lasix NNP B-NP B-m
356 40 CD O B-do
357 mg NN B-NP O
357 PNGT NNP I-NP O
357 b.i.d NN I-NP B-f
357 , , O O
357 gentamicin JJ B-NP B-m
357 sulfate NN I-NP I-m
357 two CD O B-do
357 drops NNS B-NP I-do
357 OU NNP I-NP B-mo
357 q.8h NN I-NP B-f
357 , , O O
357 regular JJ B-NP B-m
358 insulin NN I-NP O
358 sliding VBG O B-do
358 scale NN B-NP I-do
358 , , O O
358 regular JJ B-NP B-m
358 insulin NN I-NP I-m
358 8 CD O B-do
358 units NNS B-NP I-do
358 subq VBD B-VP B-mo
358 q.6h NN B-NP B-f
358 with IN B-VP O
359 instructions NNS B-NP O
359 to TO O O
359 hold VB O O
359 if IN B-VP O
359 tube JJ B-NP O
359 feeds NNS I-NP O
359 off RP O O
359 or CC O O
359 n.p.o RB O O
359 , , O O
359 milk NN B-NP B-m
359 of IN B-VP O
360 magnesia NN B-NP O
360 30 CD O B-do
360 mL JJ B-NP I-do
360 daily JJ I-NP B-f
360 p.r.n NN I-NP I-f
360 constipation NN I-NP B-r
360 , , O O
360 nystatin JJ B-NP B-m
360 suspension NN I-NP I-m
360 1 CD O B-do
361 million CD O O
361 units NNS B-NP O
361 q.i.d JJ O B-f
361 swish JJ O O
361 and CC O O
361 spit NN B-NP O
361 , , O O
361 multivitamin FW O B-m
361 therapeutic JJ O O
362 with IN B-VP O
362 minerals NNS B-NP O
362 15 CD O B-do
362 mL NNS B-NP I-do
362 PNGT NNP I-NP O
362 daily RB O B-f
362 , , O O
362 simvastatin VBD B-VP B-m
362 20 CD O B-do
362 mg NN B-NP I-do
362 PNGT NNP I-NP O
362 q.h.s NN I-NP B-f
362 , , O O
363 Atrovent NNP B-NP B-m
363 nebulizers VBZ O I-m
363 0.5 CD O B-do
363 mg NN B-NP I-do
363 q.i.d NN I-NP B-f
363 , , O O
363 Neurontin NNP B-NP B-m
363 100 CD O B-do
363 mg NN B-NP I-do
363 t.i.d NN I-NP B-f
363 , , O O
364 Ambien NNP B-NP B-m
364 10 CD O B-do
364 mg NN B-NP I-do
364 q.h.s NN I-NP B-f
364 p.r.n NN I-NP I-f
364 insomnia NN I-NP B-r
364 , , O O
364 K-Dur NNP B-NP B-m
364 20 CD O B-do
364 mEq NN B-NP I-do
364 PNGT NNP I-NP O
364 b.i.d NN I-NP B-f
364 , , O O
365 Flomax NNP B-NP B-m
365 0.8 CD O B-do
365 mg JJ O I-do
365 daily RB O B-f
365 , , O O
365 miconazole JJ B-NP B-m
365 nitrate NN I-NP I-m
365 2% CD O I-m
365 powder NN B-NP I-m
365 topical JJ B-NP B-mo
365 b.i.d NN I-NP B-f
365 , , O O
366 Nexium NNP B-NP B-m
366 40 CD O B-do
366 mg JJ O I-do
366 daily RB O B-f
366 , , O O
366 Coumadin NNP B-NP B-m
366 with IN B-VP O
366 variable JJ B-NP B-do
366 dosage NN I-NP I-do
366 to TO O O
366 be VB O O
367 determined VBN O O
367 based VBN O O
367 on IN B-VP O
367 INR NNP B-NP O
367 , , O O
367 and CC O O
367 Prochlorperazine NNP B-NP B-m
367 20 CD O B-do
367 mg NN B-NP I-do
367 PR NNP I-NP B-mo
367 q.12h NN I-NP B-f
368 p.r.n NN I-NP O
368 emesis NN I-NP B-r
369 eScription NN I-NP O
369 document: VBZ O O
369 0-8526852 JJ B-NP O
369 EMSSten NNP I-NP O
369 Tel NNP I-NP O
370 CC: NNP I-NP O
370 Don NNP I-NP O
370 Lashutva NNP I-NP O
370 MD NNP I-NP O
371 DIVISION NNP I-NP O
371 OF NNP I-NP O
371 CARDIAC NNP I-NP O
371 SURGERY NNP I-NP O
372 Louissi NNP I-NP O
372 Salt NNP I-NP O
372 Balt NNP I-NP O
372 Go NNP I-NP O
372 E NNP I-NP O
372 Worce NNP I-NP O
373 Dictated NNP I-NP O
373 By: NNP I-NP O
373 CUMOLETTI NNP I-NP O
373 , , O O
373 JOSE NNP B-NP O
373 BRANDON NNP I-NP O
374 Attending: NNP I-NP O
374 HUHTA NNP I-NP O
374 , , O O
374 ODIS NNP B-NP O
375 Dictation NNP I-NP O
375 ID NNP I-NP O
375 1341159 CD O O
376 D: NNP B-NP O
376 7/24/06 CD O O
377 T: NNP B-NP O
377 7/24/06 CD O O
378 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #351554 VBZ O O
2 889265558 CD O O
2 TRCHC NNP B-NP O
2 80689098 CD O O
2 3425450 CD O O
2 6/7/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CHEST NNP I-NP O
2 PAIN NNP I-NP O
2 , , O O
2 RULE NNP B-NP O
2 OUT NNP I-NP O
2 MYOCARDIAL NNP I-NP O
2 INFARCTION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/8/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/28/2005 CD O O
4 ATTENDING: NNP B-NP O
4 LOBUR NNP I-NP O
4 , , O O
4 RENALDO NNP B-NP O
4 MD NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Coronary NNP I-NP O
5 artery NN I-NP O
5 disease NN I-NP O
5 with IN B-VP O
5 myocardial JJ B-NP O
6 infarction NN I-NP O
7 OTHER NNP I-NP O
7 DIAGNOSES: NNP I-NP O
8 1 CD O O
8 CAD NNP B-NP O
9 2 CD O O
9 Hypertension NNP B-NP O
10 3 CD O O
10 Congestive NNP B-NP O
10 heart NN I-NP O
10 failure NN I-NP O
11 4 CD O O
11 Diabetes VBZ O O
12 5 CD O O
12 Hypercholesterolemia NNP B-NP O
13 6 CD O O
13 Peripheral NNP B-NP O
13 vascular JJ B-NP O
13 disease NN I-NP O
14 7 CD O O
14 Smoking NNP B-NP O
14 history NN I-NP O
15 8 CD O O
15 History NN B-NP O
15 of IN B-VP O
15 alcohol NN B-NP O
15 abuse NN I-NP O
16 9 CD O O
16 History NNP B-NP O
16 of IN B-VP O
16 seizure NN B-NP O
16 disorder NN I-NP O
17 10 CD O O
17 Atrial NNP B-NP O
17 fibrillation NN I-NP O
17 with IN B-VP O
17 rapid JJ B-NP O
17 ventricular JJ I-NP O
17 response NN I-NP O
18 HISTORY NNP I-NP O
18 OF NNP I-NP O
18 PRESENT NNP I-NP O
18 ILLNESS: NNP I-NP O
18 Mr NNP I-NP O
18 Mauras NNP I-NP O
18 is VBZ O O
18 a DT B-NP O
18 72-year-old JJ I-NP O
18 man NN I-NP O
18 with IN B-VP O
19 history NN B-NP O
19 of IN B-VP O
19 CAD NNP B-NP O
19 status NN I-NP O
19 post NN I-NP O
19 CABG NNP I-NP O
19 , , O O
19 PCI NNP B-NP O
19 with IN B-VP O
19 history NN B-NP O
19 of IN B-VP O
19 stable JJ B-NP O
20 angina NN I-NP O
20 , , O O
20 type NN B-NP O
20 2 CD O O
20 diabetes NNS B-NP O
20 , , O O
20 peripheral JJ B-NP O
20 vascular JJ I-NP O
20 disease NN I-NP O
20 , , O O
20 former JJ B-NP O
21 smoking NN I-NP O
21 history NN I-NP O
21 and CC O O
21 also RB O O
21 history NN B-NP O
21 of IN B-VP O
21 seizure NN B-NP O
21 disorder NN I-NP O
21 with IN B-VP O
22 cataracts NNS B-NP O
22 and CC O O
22 recently RB O O
22 discharged VBD B-VP O
22 after IN B-VP O
22 an DT B-NP O
22 admission NN I-NP O
22 for IN B-VP O
22 atrial JJ B-NP O
23 fibrillation NN I-NP O
23 with IN B-VP O
23 rapid JJ B-NP O
23 ventricular JJ I-NP O
23 response NN I-NP O
23 He PRP O O
23 had VBD B-VP O
23 occasional JJ B-NP O
24 anginal JJ I-NP O
24 symptoms NNS I-NP O
24 prior RB O O
24 to TO O O
24 discharge VB O O
24 He PRP O O
24 took VBD B-VP O
24 about RB O O
24 two CD O B-do
25 nitroglycerins NNS B-NP B-m
25 per IN B-VP B-f
25 week NN B-NP I-f
25 Over IN B-VP O
25 the DT B-NP O
25 past JJ I-NP O
25 week NN I-NP O
25 , , O O
25 he PRP O O
25 had VBD B-VP O
25 escalating VBG O B-r
26 chest JJS B-NP O
26 pain NN I-NP O
26 requiring VBG O O
26 one CD O B-do
26 nitroglycerin JJ O B-m
26 per IN B-VP B-f
26 day NN B-NP I-f
26 The DT B-NP O
26 pain NN I-NP B-r
26 was VBD B-VP O
27 relieved VBN O O
27 by IN B-VP O
27 rest NN B-NP O
27 and CC O O
27 nitroglycerin RB O B-m
27 One CD O O
27 week NN B-NP O
27 prior RB O O
27 to TO O O
27 admission NN B-NP O
27 , , O O
28 his PRP$ O O
28 digoxin NN B-NP B-m
28 was VBD B-VP O
28 stopped VBN O O
28 and CC O O
28 his PRP$ O O
28 amiodarone NN B-NP B-m
28 was VBD B-VP O
28 decreased VBN O O
28 His PRP$ O O
29 Plavix NNP B-NP B-m
29 was VBD B-VP O
29 stopped VBN O O
29 and CC O O
29 his PRP$ O O
29 Coumadin NNP B-NP B-m
29 was VBD B-VP O
29 held VBN O O
29 On IN B-VP O
29 the DT B-NP O
29 morning NN I-NP O
29 of IN B-VP O
30 admission NN B-NP O
30 , , O O
30 he PRP O O
30 had VBD B-VP O
30 chest JJS B-NP O
30 pain NN I-NP O
30 He PRP O O
30 had VBD B-VP O
30 two CD O B-do
30 nitroglycerins NNS B-NP B-m
30 and CC O O
31 rested VBN O O
31 but CC O O
31 the DT B-NP O
31 pain NN I-NP O
31 persisted VBD B-VP O
31 He PRP O O
31 was VBD B-VP O
31 taken VBN O O
31 to TO O O
31 the DT B-NP O
31 ED NNP I-NP O
31 In IN B-VP O
31 the DT B-NP O
32 ED NNP I-NP O
32 , , O O
32 he PRP O O
32 received VBD B-VP O
32 Lopressor NNP B-NP B-m
32 , , O O
32 Enalapril NNP B-NP B-m
32 , , O O
32 Lovenox NNP B-NP B-m
32 treatment NN I-NP O
32 dose NN I-NP O
32 and CC O O
33 a DT B-NP O
33 Plavix NNP I-NP B-m
33 load NN I-NP O
34 PAST NNP I-NP O
34 MEDICAL NNP I-NP O
34 HISTORY: NNP I-NP O
34 Includes NNP I-NP O
34 CAD NNP I-NP O
34 , , O O
34 hypertension NN B-NP O
34 , , O O
34 CHF NNP B-NP O
34 , , O O
34 diabetes VBZ O O
34 , , O O
35 hypercholesterolemia NN B-NP O
35 , , O O
35 peripheral JJ B-NP O
35 vascular JJ I-NP O
35 disease NN I-NP O
35 and CC O O
35 past JJ B-NP O
36 smoking NN I-NP O
36 history NN I-NP O
37 ALLERGIES: NNP I-NP O
37 To TO O O
37 penicillin VB O O
38 SOCIAL NNP B-NP O
38 HISTORY: NNP I-NP O
38 Significant NNP I-NP O
38 for IN B-VP O
38 past JJ B-NP O
38 alcohol NN I-NP O
38 and CC O O
38 smoking NN B-NP O
39 history NN I-NP O
39 He PRP O O
39 quit VBD B-VP O
39 alcohol RB O O
39 25 CD O O
39 years NNS B-NP O
39 ago RB O O
40 PHYSICAL NNP B-NP O
40 EXAMINATION: NNP I-NP O
40 Significant NNP I-NP O
40 for IN B-VP O
40 afebrile NN B-NP O
40 , , O O
40 heart NN B-NP O
40 rate NN I-NP O
40 45 CD O O
41 and CC O O
41 blood NN B-NP O
41 pressure NN I-NP O
41 95/50 CD O O
41 He PRP O O
41 had VBD B-VP O
41 a DT B-NP O
41 left JJ I-NP O
41 surgical JJ I-NP O
41 pupil NN I-NP O
41 , , O O
41 left VBD B-VP O
41 eye NN B-NP O
42 ptosis NN I-NP O
42 at IN B-VP O
42 baseline NN B-NP O
42 His PRP$ O O
42 heart NN B-NP O
42 had VBD B-VP O
42 no DT B-NP O
42 murmurs NNS I-NP O
42 , , O O
42 rubs NNS B-NP O
42 or CC O O
42 gallops VB O O
43 His PRP$ O O
43 lungs NNS B-NP O
43 were VBD B-VP O
43 clear JJ O O
43 His PRP$ O O
43 abdomen NNS B-NP O
43 was VBD B-VP O
43 soft JJ O O
43 , , O O
43 nontender NN B-NP O
43 and CC O O
44 nondistended VBD B-VP O
44 He PRP O O
44 had VBD B-VP O
44 bilateral JJ B-NP O
44 femoral JJ I-NP O
44 bruits NNS I-NP O
44 , , O O
44 2+ CD O O
44 distal JJ O O
44 pulses VBZ O O
45 No DT B-NP O
45 pronator NN I-NP O
45 drift NN I-NP O
46 LABS: NNP I-NP O
46 Significant NNP I-NP O
46 for IN B-VP O
46 hematocrit NN B-NP O
46 baseline NN I-NP O
46 at IN B-VP O
46 30 CD O O
46 to TO O O
46 32 CD O O
46 , , O O
46 white JJ B-NP O
47 count NN I-NP O
47 of IN B-VP O
47 13 CD O O
47 His PRP$ O O
47 troponin NN B-NP O
47 peaked VBD B-VP O
47 at IN B-VP O
47 6.4 CD O O
48 EKG NNP B-NP O
48 showed VBD B-VP O
48 ST NNP B-NP O
48 depressions NNS I-NP O
48 in IN B-VP O
48 V3 NNP B-NP O
48 through IN B-VP O
48 V6 NNP B-NP O
48 that WDT O O
48 were VBD B-VP O
48 new JJ B-NP O
49 Echocardiogram NNP I-NP O
49 on IN B-VP O
49 8/11/05 CD O O
49 showed VBD B-VP O
49 an DT B-NP O
49 EF NNP I-NP O
49 of IN B-VP O
49 25 CD O O
49 to TO O O
49 30% CD O O
49 with IN B-VP O
49 septal JJ B-NP O
50 akinesis NN I-NP O
50 lateral JJ O O
50 and CC O O
50 posterior JJ B-NP O
50 hypokinesis NN I-NP O
50 and CC O O
50 mild JJ B-NP O
50 tricuspid JJ I-NP O
51 regurgitation NN I-NP O
52 Chest NNP I-NP O
52 x-ray NN I-NP O
52 showed VBD B-VP O
52 mild JJ B-NP O
52 pulmonary JJ I-NP O
52 edema NN I-NP O
53 HOSPITAL NNP I-NP O
53 COURSE: NNP I-NP O
53 Hospital NNP I-NP O
53 course NN I-NP O
53 for IN B-VP O
53 this DT B-NP O
53 72-year-old JJ I-NP O
53 man NN I-NP O
53 with IN B-VP O
54 non-ST-elevation JJ B-NP O
54 MI NNP I-NP O
55 1 CD O O
55 Cardiovascular: NNP B-NP O
55 A NNP I-NP O
55 catheterization NN I-NP O
55 on IN B-VP O
55 hospital JJ B-NP O
55 day NN I-NP O
55 1 CD O O
55 showed VBD B-VP O
56 four-vessel JJ B-NP O
56 disease NN I-NP O
56 No NNP I-NP O
56 intervention NN I-NP O
56 was VBD B-VP O
56 taken VBN O O
56 at IN B-VP O
56 that DT B-NP O
56 point NN I-NP O
56 , , O O
56 as IN B-VP O
57 it PRP O O
57 was VBD B-VP O
57 unclear JJ O O
57 which WDT O O
57 region NN B-NP O
57 was VBD B-VP O
57 the DT B-NP O
57 culprit NN I-NP O
57 Afterwards NNP I-NP O
57 , , O O
57 he PRP O O
57 was VBD B-VP O
58 in IN B-VP O
58 hypotensive JJ B-NP B-r
58 respiratory NN I-NP I-r
58 distress NN I-NP I-r
58 , , O O
58 likely RB O O
58 secondary JJ O O
58 to TO O O
58 flash VB O O
59 pulmonary JJ B-NP O
59 edema NN I-NP O
59 He PRP O O
59 received VBD B-VP O
59 Lasix NNP B-NP B-m
59 and CC O O
59 morphine NN B-NP B-m
59 and CC O O
59 he PRP O O
59 was VBD B-VP O
60 started VBN O O
60 on IN B-VP O
60 a DT B-NP O
60 nitro JJ I-NP B-m
60 drip NN I-NP B-mo
60 with IN B-VP O
60 improvement NN B-NP O
60 in IN B-VP O
60 symptoms NNS B-NP O
60 He PRP O O
60 was VBD B-VP O
61 found VBN O O
61 to TO O O
61 have VB O O
61 flash JJ B-NP O
61 pulmonary JJ I-NP O
61 edema NN I-NP O
61 and CC O O
61 in IN B-VP O
61 atrial JJ B-NP O
61 fibrillation NN I-NP O
62 with IN B-VP O
62 rapid JJ B-NP O
62 ventricular JJ I-NP O
62 response NN I-NP O
62 He PRP O O
62 was VBD B-VP O
62 taken VBN O O
62 back RB O O
62 to TO O O
62 the DT B-NP O
63 catheterization NN I-NP O
63 lab NN I-NP O
63 and CC O O
63 given VBN O O
63 four CD O O
63 stents NNS B-NP O
63 to TO O O
63 his PRP$ O O
63 saphenous JJ B-NP O
63 vein NN I-NP O
64 graft NN I-NP O
64 , , O O
64 OM1 NNP B-NP O
64 with IN B-VP O
64 good JJ B-NP O
64 resolution NN I-NP O
64 of IN B-VP O
64 his PRP$ O O
64 symptoms NNS B-NP O
64 and CC O O
64 he PRP O O
64 went VBD B-VP O
64 to TO O O
65 the DT B-NP O
65 CCU NNP I-NP O
65 afterwards NNS I-NP O
65 On IN B-VP O
65 hospital JJ B-NP O
65 day NN I-NP O
65 3 CD O O
65 , , O O
65 he PRP O O
65 was VBD B-VP O
65 transferred VBN O O
65 to TO O O
65 the DT B-NP O
66 floor NN I-NP O
66 and CC O O
66 was VBD B-VP O
66 given VBN O O
66 an DT B-NP O
66 amiodarone NN I-NP B-m
66 load NN I-NP O
66 given VBN O O
66 his PRP$ O O
66 ejection NN B-NP O
67 fraction NN I-NP O
67 and CC O O
67 increased VBD B-VP O
67 ectopy NN B-NP O
67 on IN B-VP O
67 telemetry NN B-NP O
67 His PRP$ O O
67 troponin NN B-NP O
67 had VBD B-VP O
68 been VBN O O
68 trended VBN O O
68 down RB O O
68 to TO O O
68 the DT O O
68 0.2s CD O O
68 by IN B-VP O
68 discharge NN B-NP O
68 His PRP$ O O
68 beta-blocker NN B-NP B-m
68 and CC O O
69 ACE NNP B-NP B-m
69 inhibitor NN I-NP I-m
69 were VBD B-VP O
69 titrated VBN O B-do
69 to TO O O
69 heart NN B-NP O
69 rate NN I-NP O
69 and CC O O
69 blood NN B-NP O
69 pressure NN I-NP O
70 Prior NNP I-NP O
70 to TO O O
70 anticipated VB O O
70 discharge NN B-NP O
70 , , O O
70 he PRP O O
70 re-developed VBD B-VP O
70 flash JJ B-NP O
70 pulmonary JJ I-NP O
71 edema NN I-NP O
71 secondary JJ O O
71 to TO O O
71 atrial JJ B-NP O
71 fibrillation NN I-NP O
71 with IN B-VP O
71 rapid JJ B-NP O
71 ventricular JJ I-NP O
72 response NN I-NP O
72 Electrophysiology NNP I-NP O
72 consult NN I-NP O
72 evaluated VBD B-VP O
72 him PRP O O
72 and CC O O
72 based VBN O O
72 on IN B-VP O
73 his PRP$ O O
73 prior JJ B-NP O
73 ejection NN I-NP O
73 fraction NN I-NP O
73 symptoms NNS I-NP O
73 , , O O
73 it PRP O O
73 was VBD B-VP O
73 decided VBN O O
73 to TO O O
73 place VB O O
73 a DT B-NP O
74 dual-chamber JJ I-NP O
74 pacemaker NN I-NP O
74 with IN B-VP O
74 AICD NNP B-NP O
74 He PRP O O
74 has VBZ O O
74 had VBN O O
74 no DT B-NP O
74 respiratory NN I-NP O
75 events NNS I-NP O
75 since IN B-VP O
75 that DT B-NP O
75 placement NN I-NP O
75 He PRP O O
75 has VBZ O O
75 remained VBN O O
75 in IN B-VP O
75 atrial JJ B-NP B-r
76 fibrillation NN I-NP O
76 and CC O O
76 was VBD B-VP O
76 re-loaded VBN O O
76 with IN B-VP O
76 digoxin NN B-NP B-m
76 He PRP O O
76 was VBD B-VP O
76 started VBN O O
76 on IN B-VP O
77 his PRP$ O O
77 Coumadin NNP B-NP B-m
77 two CD O O
77 days NNS B-NP O
77 prior RB O O
77 to TO O O
77 discharge VB O O
77 and CC O O
77 was VBD B-VP O
77 not RB O O
77 yet RB O O
78 therapeutic JJ O O
78 His PRP$ O O
78 repeat NN B-NP O
78 echo NN I-NP O
78 did VBD B-VP O
78 show VB O O
78 an DT B-NP O
78 EF NNP I-NP O
78 of IN B-VP O
78 55% CD O O
78 This DT O O
78 was VBD B-VP O
79 after IN B-VP O
79 the DT B-NP O
79 pacemaker NN I-NP O
79 was VBD B-VP O
79 placed VBN O O
80 2 CD O O
80 Renal: NNP B-NP O
80 He PRP O O
80 has VBZ O O
80 chronic JJ B-NP B-r
80 renal JJ I-NP I-r
80 insufficiency NN I-NP I-r
80 He PRP O O
80 was VBD B-VP O
80 given VBN O O
81 Mucomyst NNP B-NP B-m
81 precath NN I-NP B-mo
81 with IN B-VP O
81 good JJ B-NP O
81 effect NN I-NP O
81 His PRP$ O O
81 creatinine NN B-NP O
81 on IN B-VP O
81 discharge NN B-NP O
82 was VBD B-VP O
82 1.1 CD O O
82 and CC O O
82 he PRP O O
82 was VBD B-VP O
82 making VBG O O
82 urine JJ O O
83 3 CD O O
83 GU: NNP B-NP O
83 He PRP O O
83 has VBZ O O
83 had VBD B-VP O
83 some DT B-NP O
83 symptoms NNS I-NP O
83 of IN B-VP O
83 urinary JJ B-NP B-r
83 retention NN I-NP I-r
83 with IN B-VP O
84 difficult-to-place NN B-NP O
84 Foley NNP I-NP O
84 He PRP O O
84 was VBD B-VP O
84 started VBN O O
84 on IN B-VP O
84 Flomax NNP B-NP B-m
84 with IN B-VP O
84 good JJ B-NP O
85 effect NN I-NP O
85 His PRP$ O O
85 prostate NN B-NP O
85 was VBD B-VP O
85 not RB O O
85 overtly RB O O
85 large JJ O O
85 on IN B-VP O
85 exam IN B-VP O
85 His PRP$ O O
85 PSA NNP B-NP O
85 was VBD B-VP O
86 within IN B-VP O
86 normal JJ B-NP O
86 limits NNS I-NP O
87 4 CD O O
87 Endocrine: NNP B-NP O
87 He PRP O O
87 is VBZ O O
87 a DT B-NP O
87 type NN I-NP O
87 2 CD O O
87 diabetic JJ O O
87 His PRP$ O O
87 home NN B-NP B-do
87 dose NN I-NP I-do
87 of IN B-VP O
88 metformin NN B-NP B-m
88 was VBD B-VP O
88 held VBN O O
88 He PRP O O
88 was VBD B-VP O
88 continued VBN O O
88 on IN B-VP O
88 Lantus NNP B-NP B-m
88 with IN B-VP O
88 sliding VBG O B-do
89 scale JJ B-NP O
89 insulin NN I-NP B-m
90 5 CD O O
90 Hematology: NNP B-NP O
90 His PRP$ O O
90 hematocrit NN B-NP O
90 was VBD B-VP O
90 transiently RB O O
90 down RB O O
90 to TO O O
90 24 CD O O
90 When WRB O O
91 transferred VBN O O
91 out IN B-VP O
91 of IN B-VP O
91 the DT B-NP O
91 CCU NNP I-NP O
91 , , O O
91 he PRP O O
91 was VBD B-VP O
91 given VBN O O
91 three CD O B-do
91 units NNS B-NP I-do
91 of IN B-VP O
91 packed JJ B-NP B-m
92 red JJ I-NP O
92 blood NN I-NP O
92 cells NNS I-NP O
92 given VBN O O
92 his PRP$ O O
92 history NN B-NP O
92 of IN B-VP O
92 CAD NNP B-NP O
92 Since IN B-VP O
92 this DT O O
92 , , O O
92 his PRP$ O O
93 hematocrit NN B-NP O
93 has VBZ O O
93 been VBN O O
93 stable JJ O O
93 in IN B-VP O
93 the DT B-NP O
93 30-to-32 JJ I-NP O
93 range NN I-NP O
93 An DT B-NP O
93 abdominal JJ I-NP O
94 CT NNP I-NP O
94 did VBD B-VP O
94 not RB O O
94 show VB O O
94 any DT B-NP O
94 evidence NN I-NP O
94 of IN B-VP O
94 retroperitoneal NN B-NP O
94 bleed VB O O
94 His PRP$ O O
94 groin NN B-NP O
95 had VBD B-VP O
95 only RB O O
95 a DT O O
95 very RB O O
95 small JJ O O
95 hematoma VB O O
95 His PRP$ O O
95 stool NN B-NP O
95 guaiac NN I-NP O
95 was VBD B-VP O
95 only RB O O
95 trace JJ B-NP O
96 positive JJ I-NP O
97 DISPOSITION: NNP I-NP O
97 He PRP O O
97 was VBD B-VP O
97 discharged VBN O O
97 home NN B-NP O
97 in IN B-VP O
97 stable JJ B-NP O
97 condition NN I-NP O
97 with IN B-VP O
97 VNA NNP B-NP O
98 services NNS I-NP O
98 He PRP O O
98 will MD O O
98 follow VB O O
98 up RP O O
98 with IN B-VP O
98 his PRP$ O O
98 PCP NNP B-NP O
98 on IN B-VP O
98 4/7/05 CD O O
98 , , O O
98 with IN B-VP O
98 Dr NNP B-NP O
99 Wicinsky NNP I-NP O
99 on IN B-VP O
99 7/8/05 CD O O
99 , , O O
99 and CC O O
99 he PRP O O
99 should MD O O
99 have VB O O
99 his PRP$ O O
99 INR NNP B-NP O
99 checked VBD B-VP O
99 on IN B-VP O
100 8/4/05 CD O O
100 or CC O O
100 7/8/05 CD O O
100 and CC O O
100 Coumadin NNP B-NP B-m
100 adjusted VBD B-VP O
100 accordingly RB O O
101 PHYSICAL NNP B-NP O
101 EXAMINATION NNP I-NP O
101 ON NNP I-NP O
101 DISCHARGE: NNP I-NP O
101 His PRP$ O O
101 physical JJ B-NP O
101 exam NN I-NP O
101 on IN B-VP O
102 discharge NN B-NP O
102 was VBD B-VP O
102 largely RB O O
102 unchanged JJ O O
102 , , O O
102 afebrile JJ O O
102 and CC O O
102 hemodynamically RB O O
103 stable JJ O O
103 He PRP O O
103 had VBD B-VP O
103 now RB O O
103 a DT B-NP O
103 pacemaker NN I-NP O
103 placed VBN O O
103 over IN B-VP O
103 the DT B-NP O
103 left JJ I-NP O
103 chest NN I-NP O
104 Incision NN I-NP O
104 looked VBD B-VP O
104 clean JJ O O
104 , , O O
104 slightly RB O O
104 tender NN B-NP O
104 to TO O O
104 palpation NN B-NP O
104 He PRP O O
104 had VBD B-VP O
104 no DT B-NP O
105 murmurs NNS I-NP O
105 or CC O O
105 rubs NNS B-NP O
105 , , O O
105 no DT B-NP O
105 pedal NN I-NP O
105 edema VBZ O O
105 His PRP$ O O
105 chest NN B-NP O
105 was VBD B-VP O
105 clear JJ B-NP O
106 DISCHARGE NNP I-NP O
106 MEDICATIONS: NNP I-NP O
107 1 CD O O
107 Amiodarone NNP B-NP B-m
107 200 CD O B-do
107 mg NN B-NP I-do
107 p.o JJ O B-mo
107 daily JJ O B-f
108 2 CD O O
108 Enteric-coated JJ B-NP B-m
108 aspirin NN I-NP I-m
108 325 CD O B-do
108 mg NN B-NP I-do
108 p.o JJ O B-mo
108 daily JJ O B-f
109 3 CD O O
109 Librium NNP B-NP B-m
109 10 CD O B-do
109 mg NN B-NP I-do
109 p.o NN I-NP B-mo
109 b.i.d VBD B-VP B-f
110 4 CD O O
110 Colace NNP B-NP B-m
110 200 CD O B-do
110 mg NN B-NP I-do
110 p.o NN I-NP B-mo
110 b.i.d VBD B-VP B-f
111 5 CD O O
111 Ferrous NNP B-NP B-m
111 gluconate NN I-NP I-m
111 324 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 t.i.d VBD B-VP B-f
112 6 CD O O
112 Lasix NNP B-NP B-m
112 40 CD O B-do
112 mg NN B-NP I-do
112 p.o NN I-NP B-mo
112 b.i.d VBD B-VP B-f
113 7 CD O O
113 Nitroglycerin NNP B-NP B-m
113 one CD O B-do
113 tab NN B-NP I-do
113 p.o NN I-NP B-mo
113 q.5 NN I-NP B-f
113 minutes NNS I-NP I-f
113 p.r.n VBP O I-f
113 chest JJS B-NP B-r
113 pain NN I-NP I-r
114 8 CD O O
114 Dilantin NNP B-NP B-m
114 100 CD O B-do
114 mg NN B-NP I-do
114 p.o NN I-NP B-mo
114 b.i.d VBD B-VP B-f
115 9 CD O O
115 Senna NNP B-NP B-m
115 two CD O B-do
115 tabs NNS B-NP I-do
115 p.o VBP O B-mo
115 b.i.d RB O B-f
116 10 CD O O
116 Coumadin NNP B-NP B-m
116 3 CD O B-do
116 mg NN B-NP I-do
116 p.o NN I-NP B-mo
116 q.p.m VBD B-VP B-f
117 11 CD O O
117 Lipitor NNP B-NP B-m
117 80 CD O B-do
117 mg NN B-NP I-do
117 p.o JJ O B-mo
117 daily JJ O B-f
118 12 CD O O
118 Flomax NNP B-NP B-m
118 0.4 CD O B-do
118 mg NN B-NP I-do
118 p.o JJ O B-mo
118 daily JJ O B-f
119 13 CD O O
119 Plavix NNP B-NP B-m
119 75 CD O B-do
119 mg NN B-NP I-do
119 p.o JJ O B-mo
119 daily JJ O B-f
120 14 CD O O
120 Lantus NNP B-NP B-m
120 14 CD O B-do
120 units NNS B-NP I-do
120 subcutaneous JJ O B-mo
120 at IN B-VP B-f
120 nighttime RB O I-f
121 15 CD O O
121 Metformin NNP B-NP B-m
121 500 CD O B-do
121 mg NN B-NP I-do
121 p.o NN I-NP B-mo
121 b.i.d VBD B-VP B-f
122 16 CD O O
122 Ranitidine NNP B-NP B-m
122 150 CD O B-do
122 mg NN B-NP I-do
122 b.i.d NN I-NP B-f
123 17 CD O O
123 Digoxin NNP B-NP B-m
123 0.125 CD O B-do
123 mg NN B-NP I-do
123 p.o JJ O B-mo
123 daily JJ O B-f
124 18 CD O O
124 Enalapril NNP B-NP B-m
124 10 CD O B-do
124 mg NN B-NP I-do
124 p.o JJ O B-mo
124 daily JJ O B-f
125 19 CD O O
125 Atenolol NNP B-NP B-m
125 50 CD O B-do
125 mg NN B-NP I-do
125 p.o NN I-NP B-mo
125 b.i.d NN I-NP B-f
126 He PRP O O
126 was VBD B-VP O
126 discharged VBN O O
126 home NN B-NP O
126 with IN B-VP O
126 VNA NNP B-NP O
126 services NNS I-NP O
127 FOLLOW-UP: NNP I-NP O
127 He PRP O O
127 has VBZ O O
127 follow-up JJ B-NP O
127 appointments NNS I-NP O
127 with IN B-VP O
127 his PRP$ O O
127 PCP NNP B-NP O
127 , , O O
127 Dr NNP B-NP O
127 Santos NNP I-NP O
127 Ciliberto NNP I-NP O
127 at IN B-VP O
127 Mira NNP B-NP O
127 Health NNP I-NP O
127 on IN B-VP O
127 11/8/05 CD O O
127 , , O O
127 with IN B-VP O
127 Dr NNP B-NP O
127 Kelley NNP I-NP O
127 Hernon NNP I-NP O
127 of IN B-VP O
128 Electrophysiology NNP B-NP O
128 0/7/05 CD O O
128 at IN B-VP O
128 3 CD O O
128 p.m NN B-NP O
128 and CC O O
128 Dr NNP B-NP O
128 Daft NNP I-NP O
128 9/20/05 CD O O
129 scheduled VBD B-VP O
130 He PRP O O
130 will MD O O
130 have VB O O
130 his PRP$ O O
130 INR NNP B-NP O
130 drawn NN I-NP O
130 on IN B-VP O
130 8/4/05 CD O O
130 with IN B-VP O
130 follow-up JJ B-NP O
130 INRs NNP I-NP O
130 to TO O O
130 be VB O O
131 drawn VBN O O
131 every DT O O
131 seven CD O O
131 days NNS B-NP O
131 and CC O O
131 Coumadin NNP B-NP B-m
131 adjusted VBD B-VP O
131 accordingly RB O O
132 eScription JJ O O
132 document: IN B-VP O
132 9-8335570 JJ B-NP O
132 CSSten NNP I-NP O
132 Tel NNP I-NP O
133 CC: NNP I-NP O
133 Mark NNP I-NP O
133 Lyman NNP I-NP O
133 Bly NNP I-NP O
133 MD NNP I-NP O
134 Pa NNP I-NP O
134 A NNP I-NP O
134 Moines NNP I-NP O
135 OK NNP I-NP O
136 Xing NNP I-NP O
137 Dictated NNP I-NP O
137 By: NNP I-NP O
137 GEDNEY NNP I-NP O
137 , , O O
137 VICTOR NNP B-NP O
138 Attending: NNP I-NP O
138 GRANAHAN NNP I-NP O
138 , , O O
138 TYSON NNP B-NP O
139 Dictation NNP I-NP O
139 ID NNP I-NP O
139 5879600 CD O O
140 D: NNP B-NP O
140 7/8/05 CD O O
141 T: NNP B-NP O
141 7/8/05 CD O O
142 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #359997 VBZ O O
2 046900020 CD O O
2 RH NNP B-NP O
2 74123072 CD O O
2 834335 CD O O
2 8/20/1999 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CORONARY NNP I-NP O
2 ARTERY NNP I-NP O
2 DISEASE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 8/20/1999 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/8/1999 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 The DT B-NP O
4 patient NN I-NP O
4 is VBZ O O
4 a DT B-NP O
4 64 JJ I-NP O
4 year-old JJ I-NP O
4 gentleman NN I-NP O
5 with IN B-VP O
5 a DT B-NP O
5 history NN I-NP O
5 of IN B-VP O
5 chest NN B-NP O
5 discomfort NN I-NP O
5 , , O O
6 dyspnea NN B-NP O
6 on IN B-VP O
6 exertion NN B-NP O
6 and CC O O
6 fatigue NN B-NP O
6 who WP O O
6 was VBD B-VP O
6 scheduled VBN O O
6 for IN B-VP O
6 a DT B-NP O
6 coronary JJ I-NP O
7 artery NN I-NP O
7 bypass NN I-NP O
7 grafting NN I-NP O
7 He PRP O O
7 had VBD B-VP O
7 cardiac JJ B-NP O
7 catheterization NN I-NP O
7 at IN B-VP O
7 Ryhoagberg NNP B-NP O
7 Spisus NNP I-NP O
7 Community NNP I-NP O
7 Hospital NNP I-NP O
7 on IN B-VP O
7 November NNP B-NP O
7 , , O O
7 1999 CD O O
7 which WDT O O
7 demonstrated VBD B-VP O
7 a DT O O
7 30% CD O O
8 tapering VBG O O
8 lesion NN B-NP O
8 of IN B-VP O
8 the DT B-NP O
8 left NN I-NP O
8 main JJ B-NP O
8 coronary JJ I-NP O
8 artery NN I-NP O
8 , , O O
8 70% CD O O
8 proximal JJ B-NP O
9 lesion NN I-NP O
9 of IN B-VP O
9 the DT O O
9 left JJ O O
9 anterior JJ O O
9 descending VBG O O
9 coronary JJ B-NP O
9 artery NN I-NP O
9 , , O O
9 80% CD O O
9 lesion NN B-NP O
10 distal NN I-NP O
10 to TO O O
10 D1 NNP B-NP O
10 , , O O
10 100% CD O O
10 occlusion NN B-NP O
10 of IN B-VP O
10 his PRP$ O O
10 left JJ B-NP O
10 circumflex NN I-NP O
10 and CC O O
10 a DT O O
10 100% CD O O
11 occlusion NN B-NP O
11 of IN B-VP O
11 his PRP$ O O
11 right JJ B-NP O
11 coronary JJ I-NP O
11 artery NN I-NP O
11 He PRP O O
11 is VBZ O O
11 admitted VBN O O
11 on IN B-VP O
11 January NNP B-NP O
11 , , O O
11 1999 CD O O
11 for IN B-VP O
11 coronary JJ B-NP O
11 artery NN I-NP O
11 bypass NN I-NP O
11 grafting VBG O O
12 PAST NNP B-NP O
12 MEDICAL NNP I-NP O
12 HISTORY: NNP I-NP O
12 Psoriasis NNP I-NP O
12 and CC O O
12 polymyalgia NN B-NP O
12 rheumatica NN I-NP O
12 , , O O
13 coronary JJ B-NP O
13 artery NN I-NP O
13 disease NN I-NP O
13 and CC O O
13 wide JJ B-NP O
13 eye NN I-NP O
14 glaucoma VBD B-VP O
14 His PRP$ O O
14 echocardiogram NN B-NP O
14 demonstrated VBD B-VP O
14 left VBD B-VP O
14 ventricular JJ B-NP O
15 hypertrophy NN I-NP O
15 with IN B-VP O
15 a DT B-NP O
15 normal JJ I-NP O
15 ejection NN I-NP O
15 fraction NN I-NP O
15 He PRP O O
15 has VBZ O O
15 a DT O O
15 45 CD O O
15 year NN B-NP O
16 history NN I-NP O
16 of IN B-VP O
16 smoking VBG O O
17 MEDICATIONS NNP B-NP O
17 ON NNP I-NP O
17 ADMISSION: NNP I-NP O
17 1 CD O O
17 ) ) O O
17 Prednisone NN B-NP B-m
17 5 CD O B-do
17 mg NN B-NP I-do
17 p.o NN I-NP B-mo
17 b.i.d IN B-VP B-f
17 2 CD O O
17 ) ) O O
18 Lasix FW O B-m
18 40 CD O B-do
18 mg NN B-NP I-do
18 p.o NN I-NP B-mo
18 q JJ B-NP B-f
18 day NN I-NP I-f
18 3 CD O O
18 ) ) O O
18 Zocor NNP B-NP B-m
18 40 CD O B-do
19 mg NN B-NP O
19 p.o NN I-NP B-mo
19 q JJ B-NP B-f
19 day NN I-NP I-f
19 4 CD O O
19 ) ) O O
19 Atenolol $ O B-m
19 25 CD O B-do
19 mg NN B-NP I-do
19 p.o NN I-NP B-mo
19 q JJ B-NP B-f
19 day NN I-NP I-f
19 5 CD O O
19 ) ) O O
19 Nitropatch NNP B-NP B-m
20 6 CD O O
20 ) ) O O
20 Enteric NNP B-NP B-m
20 coated VBD B-VP I-m
20 aspirin JJ B-NP I-m
20 p.o JJ I-NP B-mo
20 q NN I-NP B-f
20 day NN I-NP I-f
20 7 CD O O
20 ) ) O O
20 Timolol NNP B-NP B-m
20 eye NN I-NP I-m
20 drops NNS I-NP I-m
20 to TO O O
21 his PRP$ O O
21 left JJ B-NP O
21 eye NN I-NP O
21 8 CD O O
21 ) ) O O
21 Captopril NNP B-NP B-m
21 18.75 CD O B-do
21 mg NN B-NP I-do
21 p.o NN I-NP B-mo
21 three CD O B-f
21 times NNS B-NP I-f
21 a DT B-NP I-f
21 day NN I-NP I-f
21 9 CD O O
21 ) ) O O
22 Tagamet VBD B-VP B-m
22 50 CD O B-do
22 mg NN B-NP I-do
22 p.o NN I-NP B-mo
22 twice RB O B-f
22 a DT B-NP I-f
22 day NN I-NP I-f
22 10 CD O O
22 ) ) O O
22 Calcium NN B-NP B-m
22 supplementation NN I-NP I-m
23 LABORATORY: NNP I-NP O
23 Laboratory NNP I-NP O
23 studies NNS I-NP O
23 on IN B-VP O
23 admission NN B-NP O
23 revealed VBD B-VP O
23 a DT B-NP O
23 BUN NNP I-NP O
23 of IN B-VP O
23 20 CD O O
23 , , O O
24 creatinine NN B-NP O
24 1.2 CD O O
24 , , O O
24 white JJ B-NP O
24 blood NN I-NP O
24 cell NN I-NP O
24 count NN I-NP O
24 8.8 CD O O
24 , , O O
24 hematocrit NN B-NP O
25 40.2 CD O O
25 Chest NNP B-NP O
25 x-ray NN I-NP O
25 revealed VBD B-VP O
25 no DT B-NP O
25 acute JJ I-NP O
25 disease NN I-NP O
26 HOSPITAL NNP I-NP O
26 COURSE: NNP I-NP O
26 On IN B-VP O
26 March NNP B-NP O
26 , , O O
26 1999 CD O O
26 , , O O
26 he PRP O O
26 underwent VBD B-VP O
26 coronary JJ B-NP O
27 artery NN I-NP O
27 bypass NN I-NP O
27 grafting VBG O O
27 times NNS B-NP O
27 three CD O O
27 with IN B-VP O
27 a DT B-NP O
27 left JJ I-NP O
28 internal JJ I-NP O
28 mammary JJ I-NP O
28 artery NN I-NP O
28 to TO O O
28 the DT O O
28 left VBN O O
28 anterior JJ B-NP O
28 coronary JJ I-NP O
28 artery NN I-NP O
28 , , O O
29 saphenous JJ B-NP O
29 vein NN I-NP O
29 graft NN I-NP O
29 to TO O O
29 the DT B-NP O
29 aorta NN I-NP O
29 and CC O O
29 a DT B-NP O
29 saphenous JJ I-NP O
29 vein NN I-NP O
29 graft NN I-NP O
29 from IN B-VP O
30 the DT B-NP O
30 obtuse NN I-NP O
30 marginal NN I-NP O
30 to TO O O
30 the DT B-NP O
30 aorta NN I-NP O
30 His PRP$ O O
30 intraoperative JJ B-NP O
30 course NN I-NP O
30 was VBD B-VP O
31 uncomplicated VBN O O
31 On IN B-VP O
31 postoperative JJ B-NP O
31 day NN I-NP O
31 number NN I-NP O
31 one CD O O
31 , , O O
31 he PRP O O
31 was VBD B-VP O
31 weaned VBN O O
31 to TO O O
32 extubation NN B-NP O
32 and CC O O
32 he PRP O O
32 was VBD B-VP O
32 treated VBN O O
32 with IN B-VP O
32 stress JJ B-NP B-do
32 steroids NNS I-NP B-m
32 to TO O O
32 prevent VB O O
33 steroid JJ B-NP B-r
33 withdrawal NN I-NP I-r
33 On IN B-VP O
33 postoperative JJ B-NP O
33 day NN I-NP O
33 number NN I-NP O
33 one CD O O
33 , , O O
33 he PRP O O
33 was VBD B-VP O
33 taken VBN O O
34 back RB O O
34 to TO O O
34 the DT B-NP O
34 operating NN I-NP O
34 room NN I-NP O
34 for IN B-VP O
34 bleeding NN B-NP O
34 After IN B-VP O
34 he PRP O O
34 was VBD B-VP O
34 extubated VBN O O
34 , , O O
35 he PRP O O
35 was VBD B-VP O
35 reintubated VBN O O
35 and CC O O
35 was VBD B-VP O
35 returned VBN O O
35 in IN B-VP O
35 good JJ O O
35 and CC O O
35 stable JJ B-NP O
35 condition NN I-NP O
35 to TO O O
36 the DT B-NP O
36 intensive JJ I-NP O
36 care NN I-NP O
36 unit NN I-NP O
36 on IN B-VP O
36 renal JJ B-NP O
36 Dopamine NNP I-NP B-m
36 He PRP O O
36 was VBD B-VP O
36 again RB O O
36 extubated JJ O O
37 and CC O O
37 was VBD B-VP O
37 seen VBN O O
37 in IN B-VP O
37 consultation NN B-NP O
37 by IN B-VP O
37 the DT B-NP O
37 Gastrointestinal NNP I-NP O
37 Service NNP I-NP O
37 for IN B-VP O
37 a DT B-NP O
38 question NN I-NP O
38 of IN B-VP O
38 gastrointestinal JJ B-NP O
38 bleed NN I-NP O
38 since IN B-VP O
38 there EX O O
38 was VBD B-VP O
38 a DT B-NP O
38 clot NN I-NP O
38 seen VBN O O
38 on IN B-VP O
39 the DT B-NP O
39 transesophageal NN I-NP O
39 echocardiogram VBZ O O
39 probe NN B-NP O
39 at IN B-VP O
39 its PRP$ O O
39 withdrawal NN B-NP O
39 from IN B-VP O
39 his PRP$ O O
40 first JJ B-NP O
40 surgery NN I-NP O
40 The DT B-NP O
40 Gastrointestinal NNP I-NP O
40 Service NNP I-NP O
40 saw VBD B-VP O
40 any DT B-NP O
40 evidence NN I-NP O
40 of IN B-VP O
41 any DT B-NP O
41 upper JJ I-NP O
41 gastrointestinal JJ I-NP O
41 bleed NN I-NP O
41 and CC O O
41 he PRP O O
41 was VBD B-VP O
41 maintained VBN O O
41 on IN B-VP O
41 H2 NNP B-NP B-m
42 blockers NNS I-NP O
42 He PRP O O
42 was VBD B-VP O
42 sent VBN O O
42 to TO O O
42 the DT B-NP O
42 step NN I-NP O
42 down RP O O
42 unit NN B-NP O
42 on IN B-VP O
42 routine JJ B-NP O
43 postoperative JJ I-NP O
43 day NN I-NP O
43 number NN I-NP O
43 two CD O O
43 and CC O O
43 his PRP$ O O
43 Captopril NNP B-NP B-m
43 was VBD B-VP O
43 increased VBN O O
43 for IN B-VP O
44 afterload NN B-NP B-r
44 reduction NN I-NP I-r
44 His PRP$ O O
44 course NN B-NP O
44 improved VBD B-VP O
44 and CC O O
44 he PRP O O
44 was VBD B-VP O
44 diuresed VBN O O
44 for IN B-VP O
44 a DT B-NP O
45 volume NN I-NP O
45 overload NN I-NP O
45 still RB O O
45 requiring VBG O O
45 oxygen PRP O B-m
45 supplementation NN B-NP I-m
45 on IN B-VP O
45 two CD O B-do
46 liters NNS B-NP O
46 His PRP$ O O
46 oxygen NN B-NP O
46 saturation NN I-NP O
46 was VBD B-VP O
46 only RB O O
46 91% CD O O
46 on IN B-VP O
46 postoperative JJ B-NP O
46 day NN I-NP O
47 number NN I-NP O
47 three CD O O
47 He PRP O O
47 continued VBD B-VP O
47 to TO O O
47 improve VB O O
47 and CC O O
47 continued VBN O O
47 to TO O O
47 have VB O O
47 care NN B-NP O
48 for IN B-VP O
48 his PRP$ O O
48 respiratory NN B-NP O
48 situation NN I-NP O
48 with IN B-VP O
48 continued JJ B-NP O
48 diuresis NN I-NP O
48 and CC O O
48 nebulizer NN B-NP O
49 treatments NNS I-NP O
49 and CC O O
49 ambulation NN B-NP O
49 He PRP O O
49 was VBD B-VP O
49 screened VBN O O
49 by IN B-VP O
49 rehabilitation NN B-NP O
49 and CC O O
50 awaited JJ B-NP O
50 rehabilitation NN I-NP O
50 placement NN I-NP O
50 He PRP O O
50 did VBD B-VP O
50 acquire VB O O
50 a DT B-NP O
50 rehabilitation NN I-NP O
51 bed NN I-NP O
51 on IN B-VP O
51 postoperative JJ B-NP O
51 day NN I-NP O
51 number NN I-NP O
51 six CD O O
51 and CC O O
51 he PRP O O
51 is VBZ O O
51 being VBG O O
51 transferred VBN O O
51 to TO O O
52 rehabilitation VB O O
52 on IN B-VP O
52 the DT B-NP O
52 following JJ I-NP O
52 medications NNS I-NP O
53 MEDICATIONS NNP I-NP O
53 ON NNP I-NP O
53 DISCHARGE: NNP I-NP O
53 1 CD O O
53 ) ) O O
53 Prednisone NN B-NP B-m
53 5 CD O B-do
53 mg NN B-NP I-do
53 p.o NN I-NP B-mo
53 twice RB O B-f
53 a DT B-NP I-f
53 day NN I-NP I-f
54 2 CD O O
54 ) ) O O
54 Enteric NNP B-NP B-m
54 coated VBD B-VP I-m
54 aspirin RB O I-m
54 325 CD O B-do
54 mg NNS B-NP I-do
54 p.o JJ B-NP B-mo
55 q JJ I-NP B-f
55 day NN I-NP I-f
55 3 CD O O
55 ) ) O O
55 Zantac VBD B-VP B-m
55 150 CD O B-do
55 mg NN B-NP I-do
55 p.o NN I-NP B-mo
55 twice RB O B-f
55 a DT B-NP I-f
55 day NN I-NP I-f
55 4 CD O O
55 ) ) O O
55 Niferex NNP B-NP B-m
55 150 CD O B-do
55 mg NN B-NP I-do
56 p.o NN I-NP B-mo
56 twice RB O B-f
56 a DT B-NP I-f
56 day NN I-NP I-f
56 5 CD O O
56 ) ) O O
56 Atrovent NNP B-NP B-m
56 nebulizer $ O I-m
56 0.5 CD O B-do
56 mg NN B-NP I-do
56 four CD O B-f
56 times NNS B-NP I-f
56 a DT B-NP I-f
56 day NN I-NP I-f
57 6 CD O O
57 ) ) O O
57 Timolol NNP B-NP B-m
57 eye NN I-NP I-m
57 drops VBZ O I-m
57 0.5% CD O I-m
57 one CD O B-do
57 drop NN B-NP I-do
57 in IN B-VP I-do
57 both DT B-NP I-do
57 eyes NNS I-NP I-do
57 twice RB O B-f
57 a DT B-NP I-f
57 day NN I-NP I-f
57 7 CD O O
57 ) ) O O
58 Atenolol $ O B-m
58 25 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 twice RB O B-f
58 a DT B-NP I-f
58 day NN I-NP I-f
58 8 CD O O
58 ) ) O O
58 Captopril NNP B-NP B-m
58 12.5 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 three CD O B-f
59 times NNS B-NP O
59 a DT B-NP O
59 day NN I-NP O
59 9 CD O O
59 ) ) O O
59 Lasix FW O B-m
59 40 CD O B-do
59 mg NN B-NP I-do
59 p.o NN I-NP B-mo
59 q JJ B-NP B-f
59 day NN I-NP I-f
59 10 CD O O
59 ) ) O O
59 Potassium NN B-NP B-m
59 SR NNP I-NP I-m
59 20 CD O B-do
60 mEq NN B-NP O
60 p.o NN I-NP B-mo
60 q JJ B-NP B-f
60 day NN I-NP I-f
60 11 CD O O
60 ) ) O O
60 Simvastatin NNP B-NP B-m
60 40 CD O B-do
60 mg NN B-NP I-do
60 p.o NN I-NP B-mo
60 q JJ B-NP B-f
60 day NN I-NP I-f
60 12 CD O O
60 ) ) O O
61 Ibuprofen NNP B-NP B-m
61 200-800 JJ B-NP B-do
61 mg NN I-NP I-do
61 as IN B-VP O
61 needed VBN O O
61 for IN B-VP O
61 pain JJ B-NP B-r
61 q.4-6h JJ I-NP O
62 FOLLOW-UP: NNP I-NP O
62 The DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
62 discharged VBN O O
62 to TO O O
62 the DT B-NP O
62 care NN I-NP O
62 of IN B-VP O
62 Dr NNP B-NP O
62 Lou NNP I-NP O
62 Pineault NNP I-NP O
62 at IN B-VP O
62 Potmend NNP B-NP O
62 Rehabilitation NNP I-NP O
62 Hospital NNP I-NP O
62 , , O O
63 Moorlberl NNP B-NP O
63 Street NNP I-NP O
64 Dictated NNP I-NP O
64 By: NNP I-NP O
64 RENE NNP I-NP O
64 CASTLEMAN NNP I-NP O
64 , , O O
64 M.D NNP B-NP O
65 Attending: NNP I-NP O
65 ERIN NNP I-NP O
65 D NNP I-NP O
65 CURTISS NNP I-NP O
65 , , O O
65 M.D NNP B-NP O
65 BF88 NNP I-NP O
66 WX064/8299 NNP I-NP O
67 Batch: NNP I-NP O
67 4551 CD O O
67 Index NNP B-NP O
67 No NNP I-NP O
67 XFBG746F4F NNP I-NP O
67 D: NNP I-NP O
67 9/19/99 CD O O
68 T: NNP B-NP O
68 9/19/99 CD O O
69 CC: NNP B-NP O
69 STEPHEN NNP I-NP O
69 T NNP I-NP O
69 SHIMANUKI NNP I-NP O
69 , , O O
69 M.D NNP B-NP O
69 MT3 NNP I-NP O
70 DUSTY NNP I-NP O
70 BJORGEN NNP I-NP O
70 , , O O
70 MD NNP B-NP O
70 , , O O
70 ON-TONFORN NNP B-NP O
71 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #367173 VBZ O O
2 435445425 CD O O
2 HTZMC NNP B-NP O
2 28920937 CD O O
2 0445406 CD O O
2 9/27/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 MYOCARDIAL NNP I-NP O
2 INFARCTION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 4/8/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/3/2006 CD O O
4 ATTENDING: NNP B-NP O
4 MANCINELLI NNP I-NP O
4 , , O O
4 MAURICE NNP B-NP O
4 A NNP I-NP O
4 MD NNP I-NP O
5 The DT B-NP O
5 patient NN I-NP O
5 is VBZ O O
5 a DT B-NP O
5 76-year-old JJ I-NP O
5 male NN I-NP O
5 with IN B-VP O
5 a DT B-NP O
5 history NN I-NP O
5 of IN B-VP O
5 diabetes NNS B-NP O
5 , , O O
6 hypertension NN B-NP O
6 , , O O
6 CAD NNP B-NP O
6 status NN I-NP O
6 post NN I-NP O
6 MI NNP I-NP O
6 in IN B-VP O
6 2000 CD O O
6 who WP O O
6 presented VBD B-VP O
6 with IN B-VP O
6 an DT B-NP O
6 ST NNP I-NP O
7 elevation NN I-NP O
7 MI NNP I-NP O
7 to TO O O
7 the DT B-NP O
7 Emergency NNP I-NP O
7 Room NNP I-NP O
7 on IN B-VP O
7 0/0/06 CD O O
7 He PRP O O
7 was VBD B-VP O
7 brought VBN O O
8 to TO O O
8 Cath VB O O
8 where WRB O O
8 he PRP O O
8 was VBD B-VP O
8 found VBN O O
8 to TO O O
8 have VB O O
8 in-stent JJ B-NP O
8 thrombosis NN I-NP O
8 in IN B-VP O
8 his PRP$ O O
8 LAD NNP B-NP O
9 which WDT O O
9 was VBD B-VP O
9 aspirated VBN O O
9 and CC O O
9 bare-metal JJ B-NP O
9 stent NN I-NP O
9 was VBD B-VP O
9 placed VBN O O
9 in IN B-VP O
9 his PRP$ O O
9 LAD NNP B-NP O
10 and CC O O
10 another DT B-NP O
10 stent NN I-NP O
10 was VBD B-VP O
10 placed VBN O O
10 in IN B-VP O
10 his PRP$ O O
10 diag-2 NN B-NP O
10 He PRP O O
10 had VBD B-VP O
10 been VBN O O
10 arrested VBN O O
11 multiple JJ B-NP O
11 times NNS I-NP O
11 in IN B-VP O
11 V-Tach NNP B-NP O
11 requiring VBG O O
11 CPR NNP B-NP O
11 and CC O O
11 cardioversion NN B-NP O
11 In IN B-VP O
11 the DT B-NP O
12 Cath NNP I-NP O
12 Lab NNP I-NP O
12 , , O O
12 he PRP O O
12 was VBD B-VP O
12 given VBN O O
12 bicarb NN B-NP B-m
12 , , O O
12 placed VBN O O
12 on IN B-VP O
12 the DT B-NP O
12 epi NN I-NP B-m
12 drip NN I-NP B-mo
12 , , O O
12 given VBN O O
13 Lasix NNP B-NP B-m
13 and CC O O
13 was VBD B-VP O
13 intubated VBN O O
13 He PRP O O
13 was VBD B-VP O
13 thought VBN O O
13 to TO O O
13 aspirate VB O O
13 at IN B-VP O
13 the DT B-NP O
13 time NN I-NP O
14 of IN B-VP O
14 intubation NN B-NP O
14 secondary JJ O O
14 to TO O O
14 vomiting VBG O O
14 A NNP B-NP O
14 bedside NN I-NP O
14 echo NN I-NP O
14 revealed VBD B-VP O
15 global JJ B-NP B-r
15 hypokinesis NN I-NP I-r
15 with IN B-VP O
15 an DT B-NP O
15 EF NNP I-NP O
15 of IN B-VP O
15 35% CD O O
15 He PRP O O
15 , , O O
15 at IN B-VP O
15 that DT B-NP O
15 time NN I-NP O
15 , , O O
15 was VBD B-VP O
16 placed VBN O O
16 on IN B-VP O
16 a DT B-NP O
16 balloon NN I-NP O
16 pump NN I-NP O
16 , , O O
16 dopamine NN B-NP B-m
16 16 CD O B-do
16 , , O O
16 amio RB O B-m
16 1 CD O B-do
16 , , O O
16 propofol NN B-NP B-m
16 1 CD O B-do
16 , , O O
16 and CC O O
17 Integrilin NNP B-NP B-m
17 and CC O O
17 brought VBD B-VP O
17 to TO O O
17 the DT B-NP O
17 floor NN I-NP O
17 On IN B-VP O
17 the DT B-NP O
17 floor NN I-NP O
17 , , O O
17 his PRP$ O O
17 blood NN B-NP O
18 pressures NNS I-NP O
18 were VBD B-VP O
18 difficult JJ O O
18 to TO O O
18 control VB O O
18 and CC O O
18 his PRP$ O O
18 ??___?? JJ B-NP O
18 readings NNS I-NP O
19 indicated VBD B-VP O
19 a DT B-NP O
19 wedge NN I-NP O
19 pressure NN I-NP O
19 of IN B-VP O
19 47 CD O O
19 His PRP$ O B-r
19 His PRP$ O B-r
19 His PRP$ O B-r
19 His PRP$ O B-r
19 MAPs NNP B-NP I-r
19 MAPs NNP I-NP I-r
19 MAPs NNP I-NP I-r
19 MAPs NNP I-NP I-r
19 to TO O O
19 keep VB O O
19 them PRP O O
19 over RP O O
19 60 CD O O
20 required VBN O O
20 max NN B-NP B-do
20 dopamine NN I-NP B-m
20 , , O O
20 max NN B-NP B-do
20 Levophed NNP I-NP B-m
20 , , O O
20 epinephrine NN B-NP B-m
20 and CC O O
20 dobutamine VB O B-m
21 His PRP$ O O
21 family NN B-NP O
21 was VBD B-VP O
21 aware JJ O O
21 of IN B-VP O
21 his PRP$ O O
21 prognosis NN B-NP O
21 and CC O O
21 was VBD B-VP O
21 there RB O O
21 at IN B-VP O
21 the DT B-NP O
21 time NN I-NP O
22 of IN B-VP O
22 his PRP$ O O
22 arrest NN B-NP O
22 at IN B-VP O
22 3:30 CD O O
22 in IN B-VP O
22 the DT B-NP O
22 morning NN I-NP O
22 CPR NNP I-NP O
22 was VBD B-VP O
22 initiated VBN O O
22 , , O O
22 and CC O O
23 ACLS NNP B-NP O
23 was VBD B-VP O
23 done VBN O O
23 until IN B-VP O
23 the DT B-NP O
23 family NN I-NP O
23 decided VBD B-VP O
23 to TO O O
23 terminate VB O O
23 the DT B-NP O
23 ACLS NNP I-NP O
23 and CC O O
24 the DT B-NP O
24 time NN I-NP O
24 of IN B-VP O
24 death NN B-NP O
24 was VBD B-VP O
24 3:47 CD O O
24 a.m NN B-NP O
24 on IN B-VP O
24 0/0/06 CD O O
24 At IN B-VP O
24 that DT B-NP O
24 time NN I-NP O
24 , , O O
24 exam RB O O
25 revealed VBD B-VP O
25 no DT B-NP O
25 breath NN I-NP O
25 sounds VBZ O O
25 , , O O
25 no DT B-NP O
25 heart NN I-NP O
25 sounds VBZ O O
25 , , O O
25 and CC O O
25 nonreactive JJ B-NP O
26 pupils NNS I-NP O
26 The DT B-NP O
26 cause NN I-NP O
26 of IN B-VP O
26 death NN B-NP O
26 was VBD B-VP O
26 thought VBN O O
26 to TO O O
26 be VB O O
26 cardiogenic JJ B-NP O
26 shock NN I-NP O
27 secondary JJ O O
27 to TO O O
27 ST NNP B-NP O
27 elevation NN I-NP O
27 MI NNP I-NP O
28 eScription NN I-NP O
28 document: VBD B-VP O
28 1-6435521 JJ B-NP O
28 EMSSten NNP I-NP O
28 Tel NNP I-NP O
29 Dictated NNP I-NP O
29 By: NNP I-NP O
29 LADNER NNP I-NP O
29 , , O O
29 JASPER NNP B-NP O
30 Attending: NNP I-NP O
30 HUXHOLD NNP I-NP O
30 , , O O
30 DAREN NNP B-NP O
30 T NNP I-NP O
31 Dictation NNP I-NP O
31 ID NNP I-NP O
31 6785315 CD O O
32 D: NNP B-NP O
32 2/22/06 CD O O
33 T: NNP B-NP O
33 2/22/06 CD O O
34 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #367177 VBZ O O
2 063867932 CD O O
2 CMC NNP B-NP O
2 69702188 CD O O
2 9378300 CD O O
2 3/9/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 hyperglycemia NN I-NP O
2 , , O O
2 urinary JJ B-NP O
2 tract NN I-NP O
2 infection NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/27/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/14/2005 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 KROPFELDER NNP I-NP O
5 , , O O
5 ART NNP B-NP O
5 378-97-31-8 CD O O
6 Ge NNP B-NP O
6 Topemodeport NNP I-NP O
6 Room: NNP I-NP O
6 Ver NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/19/05 CD O O
8 AT NNP B-NP O
8 04:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 ROBIDEAU NNP I-NP O
11 , , O O
11 ROBIN NNP B-NP O
11 QUINCY NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 LISINOPRIL NNP I-NP B-m
16 5 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 Alert NNP I-NP O
17 overridden: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 1/24/05 CD O O
17 by IN B-VP O
18 PAGLIO NNP B-NP O
18 , , O O
18 NOAH NNP B-NP O
18 A NNP I-NP O
18 , , O O
18 M.D NNP B-NP O
19 POTENTIALLY NNP I-NP O
19 SERIOUS NNP I-NP O
19 INTERACTION: NNP I-NP O
19 POTASSIUM NNP I-NP B-m
19 CHLORIDE NNP I-NP I-m
19 &amp; NNP I-NP O
20 LISINOPRIL NNP I-NP B-m
20 Reason NNP I-NP O
20 for IN B-VP O
20 override: NN B-NP O
20 aware JJ B-NP O
21 METFORMIN NNP I-NP B-m
21 1 CD O B-do
21 , , O I-do
21 000 CD O I-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 BID NNP I-NP B-f
22 LEVOFLOXACIN NNP I-NP B-m
22 250 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
22 X NNP I-NP B-du
22 1 CD O I-du
22 doses NNS B-NP I-du
23 Starting VBG O O
23 Today NNP B-NP O
23 ( ( O O
23 9/14 CD O O
23 ) ) O O
23 Food/Drug NNP B-NP O
23 Interaction NNP I-NP O
23 Instruction NNP I-NP O
24 Administer NNP I-NP O
24 iron NN I-NP B-m
24 products NNS I-NP I-m
24 a DT B-NP O
24 minimum NN I-NP O
24 of IN B-VP O
24 2 CD O O
24 hours NNS B-NP O
24 before IN B-VP O
24 or CC O O
25 after IN B-VP O
25 a DT B-NP O
25 levofloxacin NN I-NP B-m
25 or CC O O
25 ciprofloxacin NN B-NP B-m
25 dose VBP O O
25 dose JJ O O
26 If IN B-VP O
26 on IN B-VP O
26 tube NN B-NP O
26 feeds NNS I-NP O
26 , , O O
26 please VB O O
26 cycle NN B-NP O
26 ( ( O O
26 hold VB O O
26 1 CD O O
26 hr NN B-NP O
26 before IN B-VP O
26 to TO O O
26 2 CD O O
26 hr NNS B-NP O
27 after IN B-VP O
27 ) ) O O
27 Take VBP O O
27 2 CD O O
27 hours NNS B-NP O
27 before IN B-VP O
27 or CC O O
27 2 CD O O
27 hours NNS B-NP O
27 after IN B-VP O
27 dairy NN B-NP O
27 products NNS I-NP O
28 LANTUS NNP I-NP B-m
28 ( ( O I-m
28 INSULIN NNP B-NP I-m
28 GLARGINE NNP I-NP I-m
28 ) ) O I-m
28 20 CD O B-do
28 UNITS NNP B-NP I-do
28 SC NNP I-NP B-mo
28 QD NNP I-NP B-f
29 Starting VBG O O
29 Today NNP B-NP O
29 ( ( O O
29 9/14 CD O O
29 ) ) O O
30 DIET: NNP B-NP O
30 House NNP I-NP O
30 / NNP I-NP O
30 ADA NNP I-NP O
30 1800 CD O O
30 cals/dy NN B-NP O
31 ACTIVITY: NNP I-NP O
31 Resume NNP I-NP O
31 regular JJ B-NP O
31 exercise NN I-NP O
32 FOLLOW NNP I-NP O
32 UP NNP I-NP O
32 APPOINTMENT( NNP I-NP O
32 S NNP I-NP O
32 ): NNP I-NP O
33 Dr NNP I-NP O
33 Hal NNP I-NP O
33 Marlett NNP I-NP O
33 , , O O
33 Tarise NNP B-NP O
33 Hospital NNP I-NP O
33 Endocrine NNP I-NP O
33 and CC O O
33 Diabetes NNP B-NP O
33 Clinic NNP I-NP O
33 , , O O
33 Notland NNP B-NP O
33 Ave NNP I-NP O
33 , , O O
33 Dar NNP B-NP O
33 , , O O
33 Iowa NNP B-NP O
33 74499 CD O O
33 7/20/05 CD O O
33 , , O O
33 1:00 CD O O
33 PM NNP B-NP O
33 scheduled VBN O O
33 , , O O
34 Please NNP B-NP O
34 call VB O O
34 Kidane NNP B-NP O
34 at IN B-VP O
34 CDGH NNP B-NP O
34 Physician NNP I-NP O
34 Referral NNP I-NP O
34 for IN B-VP O
34 a DT B-NP O
34 primary JJ I-NP O
34 care NN I-NP O
34 physician NN I-NP O
34 , , O O
34 1- JJ O O
34 402-945-7732 JJ O O
34 , , O O
35 ALLERGY: NNP B-NP O
35 NKA NNP I-NP O
36 ADMIT NNP I-NP O
36 DIAGNOSIS: NNP I-NP O
37 hyperglycemia NN I-NP O
38 PRINCIPAL NNP I-NP O
38 DISCHARGE NNP I-NP O
38 DIAGNOSIS NNP I-NP O
38 ;Responsible JJ O O
38 After IN B-VP O
38 Study NNP B-NP O
38 for IN B-VP O
38 Causing NNP B-NP O
38 Admission NNP I-NP O
38 ) ) O O
39 hyperglycemia NN B-NP O
39 , , O O
39 urinary JJ B-NP O
39 tract NN I-NP O
39 infection NN I-NP O
40 OTHER NNP I-NP O
40 DIAGNOSIS;Conditions NNP I-NP O
40 , , O O
40 Infections NNP B-NP O
40 , , O O
40 Complications NNP B-NP O
40 , , O O
40 affecting VBG O O
40 Treatment/Stay NNP B-NP O
41 urinary JJ B-NP O
41 tract NN I-NP O
41 infection NN I-NP O
41 obesity NN I-NP O
41 ( ( O O
41 obesity NN B-NP O
41 ) ) O O
41 type NN B-NP O
41 2 CD O O
41 DM NNP B-NP O
41 ( ( O O
41 diabetes VBZ O O
41 mellitus NN B-NP O
41 ) ) O O
42 ?OSA NN B-NP O
42 ( ( O O
42 ? . B-VP O
42 sleep VB O O
42 apnea NN B-NP O
42 ) ) O O
43 OPERATIONS NNP B-NP O
43 AND NNP I-NP O
43 PROCEDURES: NNP I-NP O
44 None NNP I-NP O
45 OTHER NNP I-NP O
45 TREATMENTS/PROCEDURES NNP I-NP O
45 ( ( O O
45 NOT NNP B-NP O
45 IN NNP I-NP O
45 O.R NNP I-NP O
45 ) ) O O
46 None NN B-NP O
47 BRIEF NNP I-NP O
47 RESUME NNP I-NP O
47 OF NNP I-NP O
47 HOSPITAL NNP I-NP O
47 COURSE: NNP I-NP O
48 CC: NNP I-NP O
48 Hyperglycemia NNP I-NP O
48 ( ( O O
48 400s CD O O
48 ) ) O O
48 , , O O
48 not RB O O
48 in IN B-VP O
48 DKA NNP B-NP O
49 HPI: NNP I-NP O
49 31 CD O O
49 F NNP B-NP O
49 with IN B-VP O
49 a DT B-NP O
49 h/o NN I-NP O
49 Type NNP I-NP O
49 2 CD O O
49 DM NNP B-NP O
49 ( ( O O
49 diagnosed VBN O O
49 6 CD O O
49 years NNS B-NP O
49 ago RB O O
49 ) ) O O
49 , , O O
49 morbid JJ B-NP O
50 obesity NN I-NP O
50 , , O O
50 and CC O O
50 borderline JJ B-NP O
50 HTN NNP I-NP O
50 who WP O O
50 was VBD B-VP O
50 referred VBN O O
50 to TO O O
50 CH NNP B-NP O
50 ED NNP I-NP O
50 after IN B-VP O
50 being VBG O O
51 found VBN O O
51 to TO O O
51 be VB O O
51 hyperglylcemic JJ O O
51 ( ( O O
51 440 CD O O
51 mg/dl NN B-NP O
51 ) ) O O
51 at IN B-VP O
51 Nishing VBG O O
51 O NNP B-NP O
51 Chela NNP I-NP O
51 Center NNP I-NP O
51 And CC O O
51 She PRP O O
51 has VBZ O O
51 not RB O O
51 checked VBN O O
51 her PRP$ O O
51 blood NN B-NP O
51 sugar NN I-NP O
51 or CC O O
51 taken VBN O O
51 any DT B-NP O
51 medications NNS I-NP O
52 for IN B-VP O
52 diabetes NNS B-NP O
52 for IN B-VP O
52 an DT B-NP O
52 entire JJ I-NP O
52 year NN I-NP O
52 , , O O
52 secondary JJ O O
52 to TO O O
52 being VBG O O
52 very RB O O
52 involved VBN O O
53 with IN B-VP O
53 the DT B-NP O
53 care NN I-NP O
53 of IN B-VP O
53 her PRP$ O O
53 handicapped JJ B-NP O
53 mother NN I-NP O
53 ( ( O O
53 who WP O O
53 passed VBD B-VP O
53 away RB O O
54 this DT B-NP O
54 year NN I-NP O
54 at IN B-VP O
54 50 CD O O
54 years NNS B-NP O
54 old JJ O O
54 of IN B-VP O
54 complications NNS B-NP O
54 from IN B-VP O
54 diabetes NNS B-NP O
54 ) ) O O
54 She PRP O O
54 has VBZ O O
55 had VBD B-VP O
55 symptoms NNS B-NP O
55 of IN B-VP O
55 polydipsia NN B-NP O
55 and CC O O
55 polyuria NN B-NP O
55 , , O O
55 tingling VBG O O
55 in IN B-VP O
55 her PRP$ O O
55 fingers NNS B-NP O
55 and CC O O
56 toes NNS B-NP O
56 , , O O
56 and CC O O
56 worsening VBG O O
56 vision NN B-NP O
56 Also RB O O
56 has VBZ O O
56 had VBN O O
56 several JJ B-NP O
56 days NNS I-NP O
56 of IN B-VP O
56 UTI NNP B-NP O
57 symptoms NNS I-NP O
57 In IN B-VP O
57 MTCH NNP B-NP O
57 ED NNP I-NP O
57 , , O O
57 her PRP$ O B-r
57 her PRP$ O B-r
57 her PRP$ O B-r
57 blood NN B-NP I-r
57 blood NN I-NP I-r
57 blood NN I-NP I-r
57 sugar NN I-NP I-r
57 sugar NN I-NP I-r
57 sugar NN I-NP I-r
57 remained VBD B-VP O
57 in IN B-VP O
57 the DT O O
57 400s CD O O
57 despite IN B-VP O
58 Regular JJ B-NP B-m
58 insulin NN I-NP I-m
58 18 CD O B-do
58 units NNS B-NP I-do
58 , , O O
58 Lantus NNP B-NP B-m
58 20 CD O B-do
58 units NNS B-NP I-do
58 , , O O
58 and CC O O
58 Novolog NNP B-NP B-m
58 6 CD O B-do
58 units NNS B-NP I-do
59 Admitted VBN O O
59 for IN B-VP O
59 treatment NN B-NP O
59 of IN B-VP O
59 hyperglycemia NN B-NP O
59 and CC O O
59 optimizing VBG O O
59 her PRP$ O O
60 diabetes NNS B-NP B-m
60 medication NN I-NP I-m
60 regimen NNS I-NP O
60 -- : O O
61 PMH: NNP B-NP O
62 Type NNP I-NP O
62 2 CD O O
62 DM NNP B-NP O
62 - : O O
62 diagnosed VBD B-VP O
62 6 CD O O
62 years NNS B-NP O
62 ago RB O O
62 Was NNP B-NP O
62 previously RB O O
63 on IN B-VP O
63 insulin NN B-NP B-m
63 and CC O O
63 checking VBG O O
63 sugars NNS B-NP O
63 TID NNP I-NP O
63 No NNP I-NP O
63 self-FSBG JJ B-NP O
63 checks NNS I-NP O
63 or CC O O
63 diabetes NNS B-NP O
64 medications NNS I-NP O
64 for IN B-VP O
64 1 CD O O
64 year NN B-NP O
65 Morbid NNP I-NP O
65 obesity NN I-NP O
66 Borderline NNP I-NP O
66 HTN NNP I-NP O
67 HOME NNP I-NP O
67 MEDS: NNP I-NP O
67 None NNP I-NP O
68 ALL: NNP I-NP O
68 None NNP I-NP O
68 -- : O O
69 EXAM: NNP B-NP O
69 T98.1 NNP I-NP O
69 P84 NNP I-NP O
69 BP130/57 NNP I-NP O
69 R18 NNP I-NP O
69 O2sat96%RA NNP I-NP O
69 General: NNP I-NP O
69 Pleasant NNP I-NP O
69 , , O O
69 morbidly RB O O
70 obese JJ B-NP O
70 woman NN I-NP O
70 in IN B-VP O
70 NAD NNP B-NP O
70 HEENT: NNP I-NP O
70 EOMI NNP I-NP O
70 , , O O
70 PERRL NNP B-NP O
70 Fundus NNP I-NP O
70 exam RB O O
70 limited VBD B-VP O
70 Dry NNP B-NP O
71 O/P NNP I-NP O
71 Neck: NNP I-NP O
71 Acanthosis NNP I-NP O
71 nigricans NNS I-NP O
71 , , O O
71 no DT B-NP O
71 LAN NNP I-NP O
72 CV: NNP I-NP O
72 RRR NNP I-NP O
72 , , O O
72 II/VI NNP B-NP O
72 HSM NNP I-NP O
72 @ NNP I-NP O
72 LLSB NNP I-NP O
72 No NNP I-NP O
72 m/r/g NNP I-NP O
72 Apical NNP I-NP O
72 auscultation NN I-NP O
72 limited VBN O O
72 by IN B-VP O
73 intervening VBG O O
73 tissue NN B-NP O
74 Lungs: NNP I-NP O
74 CTAB NNP I-NP O
75 Abdomen: NNP I-NP O
75 S NNP I-NP O
75 , , O O
75 obese JJ O O
75 , , O O
75 NT NNP B-NP O
75 , , O O
75 ND NNP B-NP O
75 , , O O
75 NABS NNP B-NP O
76 Extremities: NNP I-NP O
76 No NNP I-NP O
76 C/C/E NNP I-NP O
76 No NNP I-NP O
76 wounds VBZ O O
76 on IN B-VP O
77 feet NNS B-NP O
77 Neuro: NNP I-NP O
77 Decreased VBD B-VP O
77 pinprick JJ B-NP O
77 medial JJ I-NP O
77 feet NNS I-NP O
77 b/l NN I-NP O
77 and CC O O
78 hands NNS B-NP O
78 ( ( O O
78 esp JJ B-NP O
78 ulnar JJ I-NP O
78 distribution NN I-NP O
78 ) ) O O
78 -- : O O
79 CHEM: $ O O
79 138 CD O O
79 / $ O O
79 4.0 CD O O
79 / $ O O
79 104 CD O O
79 / $ O O
79 29 CD O O
79 / $ O O
79 14 CD O O
79 / $ O O
79 0.9 CD O O
79 &lt; $ O O
79 331 CD O O
79 Anion NNP B-NP O
79 gap NN I-NP O
79 5 CD O O
79 , , O O
79 pH VBD B-VP O
80 7.41 CD O O
80 Blood NNP B-NP O
80 glucose: NN I-NP O
80 473 CD O O
80 , , O O
80 427 CD O O
80 , , O O
80 331 CD O O
80 , , O O
81 421 CD O O
81 CBC: NNP B-NP O
81 12.2 CD O O
81 &gt; VBD B-VP O
81 38.8 CD O O
81 &lt; JJ O O
81 428 CD O O
82 EKG: NNP B-NP O
82 NSR NNP I-NP O
82 @96 NNP I-NP O
82 Normal NNP I-NP O
82 intervals NNS I-NP O
82 , , O O
82 axis RB O O
82 Deep NNP B-NP O
82 pathologic NN I-NP O
82 Q NNP I-NP O
82 waves VBZ O O
82 in IN B-VP O
83 III NNP B-NP O
83 , , O O
83 aVF NN B-NP O
83 that WDT O O
83 are VBP O O
83 present JJ O O
83 in IN B-VP O
83 EKG NNP B-NP O
83 from IN B-VP O
83 2000 CD O O
83 No NNP B-NP O
83 ST/T NNP I-NP O
83 waves VBZ O O
83 changes NNS B-NP O
84 suggestive NN I-NP O
84 of IN B-VP O
84 ischemia NN B-NP O
85 ************HOSPITAL NNP I-NP O
85 COURSE************* NNP I-NP O
86 31 CD O O
86 F NNP B-NP O
86 with IN B-VP O
86 a DT B-NP O
86 h/o NN I-NP O
86 Type NNP I-NP O
86 2 CD O O
86 DM NNP B-NP O
86 ( ( O O
86 diagnosed VBN O O
86 6 CD O O
86 years NNS B-NP O
86 ago RB O O
86 ) ) O O
86 , , O O
86 morbid JJ B-NP O
86 obesity NN I-NP O
86 , , O O
86 and CC O O
87 borderline JJ B-NP O
87 HTN NNP I-NP O
87 who WP O O
87 presents VBZ O O
87 with IN B-VP O
87 hyperglycemia NN B-NP O
87 in IN B-VP O
87 400s CD O O
87 with IN B-VP O
88 hyperglycemia NN B-NP O
88 , , O O
88 ~1 JJ B-NP O
88 year NN I-NP O
88 of IN B-VP O
88 poor JJ B-NP O
88 diabetes NNS I-NP O
88 management NN I-NP O
88 , , O O
88 symptoms NNS B-NP O
88 of IN B-VP O
89 microvascular JJ B-NP O
89 damage NN I-NP O
89 , , O O
89 and CC O O
89 EKG NNP B-NP O
89 suggestive NN I-NP O
89 of IN B-VP O
89 old JJ B-NP O
89 inferior JJ I-NP O
89 MI NNP I-NP O
89 , , O O
89 not RB O O
89 in IN B-VP O
89 DKA NNP B-NP O
90 Also RB O O
90 has VBZ O O
90 had VBN O O
90 several JJ B-NP O
90 days NNS I-NP O
90 of IN B-VP O
90 UTI NNP B-NP O
90 symptoms NNS I-NP O
91 ENDO: NNP I-NP O
91 Primary NNP I-NP O
91 goals NNS I-NP O
91 of IN B-VP O
91 admission NN B-NP O
91 are VBP O O
91 blood NN B-NP O
91 glucose JJ B-NP O
91 &lt;200 NNP I-NP O
91 mg/dl NN I-NP O
91 , , O O
91 diabetes VBZ O O
92 education NN B-NP O
92 , , O O
92 diabetes VBZ O B-m
92 home NN B-NP I-m
92 medication NN I-NP I-m
92 regimen NNS I-NP I-m
92 / VBP O O
92 glucometer NN B-NP O
92 / JJ B-NP O
92 test NN I-NP O
92 strips NNS I-NP O
92 , , O O
93 and CC O O
93 setting VBG O O
93 the DT B-NP O
93 patient NN I-NP O
93 up RP O O
93 with IN B-VP O
93 a DT B-NP O
93 PCP NNP I-NP O
93 Check NNP I-NP O
93 HgA1c NNP I-NP O
93 Check NNP I-NP O
93 FSBG NNP I-NP O
93 QAC NNP I-NP O
94 Blood NNP I-NP B-r
94 sugar NN I-NP I-r
94 was VBD B-VP O
94 308 CD O O
94 at IN B-VP O
94 6 CD O O
94 pm NN B-NP O
94 last JJ B-NP O
94 night NN I-NP O
94 , , O O
94 340 CD O O
94 at IN B-VP O
94 7 CD O O
94 am VBP O O
94 this DT B-NP O
94 morning NN I-NP O
95 Increase NNP I-NP O
95 Lantus NNP I-NP B-m
95 to TO O O
95 25 CD O B-do
95 mg NNS B-NP I-do
95 SC NNP I-NP B-mo
95 QD NNP I-NP B-f
95 Increase NNP I-NP O
95 Metformin NNP I-NP B-m
95 to TO O O
95 1000 CD O B-do
95 mg NN B-NP I-do
95 PO NNP I-NP B-mo
95 BID NNP I-NP B-f
96 Consult NNP I-NP O
96 Diabetes NNP I-NP O
96 teaching VBG O O
96 program NN B-NP O
96 in IN B-VP O
96 AM NNP B-NP O
96 Set NNP I-NP O
96 up RP O O
96 follow-up NN B-NP O
96 with IN B-VP O
96 PCP NNP B-NP O
96 , , O O
96 +/- JJ B-NP O
97 ophthalmology NN I-NP O
98 ISCHEMIA: NNP I-NP O
98 Admission NNP I-NP O
98 EKG NNP I-NP O
98 and CC O O
98 EKG NNP B-NP O
98 in IN B-VP O
98 2000 CD O O
98 with IN B-VP O
98 Q-waves NNS B-NP O
98 in IN B-VP O
98 III NNP B-NP O
98 , , O O
98 F NNP B-NP O
98 suggesting VBG O O
99 old JJ B-NP O
99 inferior JJ I-NP O
99 infarct NN I-NP O
99 No NNP I-NP O
99 CP/SOB NNP I-NP O
99 Lipid NNP I-NP O
99 profile: NN I-NP O
99 Chol NNP I-NP O
99 160 CD O O
99 , , O O
99 Tri NNP B-NP O
99 187 CD O O
99 , , O O
99 HDL NNP B-NP O
100 38 CD O O
100 , , O O
100 LDL NNP B-NP O
100 94 CD O O
101 HTN: NNP B-NP B-r
101 Lisinopril NNP I-NP B-m
101 5 CD O B-do
101 mg NN B-NP I-do
101 PO NNP I-NP B-mo
101 QD NNP I-NP B-f
102 ID: NNP I-NP O
102 UTI NNP I-NP B-r
102 Levofloxacin NNP I-NP B-m
102 250 CD O B-do
102 mg NN B-NP I-do
102 PO NNP I-NP B-mo
102 QD NNP I-NP B-f
102 x VBD B-VP B-du
102 2 CD O I-du
102 doses NNS B-NP I-du
102 ( ( O O
102 already RB O O
102 treated VBN O O
102 for IN B-VP O
102 2 CD O O
103 days NNS B-NP O
103 ) ) O O
103 F/u NNP B-NP O
103 Urine NNP I-NP O
103 cultureHEME: NN I-NP O
103 Microcytic NNP I-NP O
103 anemia NN I-NP O
103 , , O O
103 likely JJ B-NP O
103 iron NN I-NP O
104 deficiency NN I-NP O
104 Fe NNP I-NP O
104 43 CD O O
104 , , O O
104 TIBC NNP B-NP O
104 300 CD O O
104 , , O O
104 Ferr NNP B-NP O
104 pending VBG O O
105 F/E/N: NNP B-NP O
105 KCl NNP I-NP B-m
105 PO NNP I-NP B-mo
105 replacement NN I-NP B-do
105 scale NN I-NP I-do
105 MgSulfate NNP I-NP B-m
105 sliding NN I-NP B-do
105 scale.GI: NN I-NP I-do
105 Colace NNP I-NP B-m
106 prn NN I-NP B-f
106 , , O O
106 MOM NNP B-NP B-m
106 prnDISPO: VBP O B-f
106 Goal NNP B-NP O
106 blood NN I-NP O
106 glucose NN I-NP O
106 is VBZ O O
106 &lt;200 JJ B-NP O
106 mg/dl JJ I-NP O
107 ADDITIONAL NNP I-NP O
107 COMMENTS: NNP I-NP O
108 DISCHARGE NNP I-NP O
108 CONDITION: NNP I-NP O
108 Stable NNP I-NP O
109 TO NNP I-NP O
109 DO/PLAN: NNP I-NP O
110 Follow NNP I-NP O
110 up RP O O
110 with IN B-VP O
110 Endocrinologist/Diabetes NNS B-NP O
110 doctor VBP O O
110 at IN B-VP O
110 Thomin NNP B-NP O
110 Emptroit NNP I-NP O
110 General NNP I-NP O
110 Hospital NNP I-NP O
111 Test NNP I-NP O
111 fingerstick NN I-NP O
111 blood NN I-NP O
111 glucose VBD B-VP O
111 3 CD O O
111 times NNS B-NP O
111 daily JJ O O
111 ( ( O O
111 including VBG O O
111 in IN B-VP O
111 the DT B-NP O
111 morning NN I-NP O
112 before IN B-VP O
112 eating VBG O O
112 ) ) O O
112 , , O O
112 and CC O O
112 keep VB O O
112 a DT B-NP O
112 log/record NN I-NP O
112 of IN B-VP O
112 the DT B-NP O
112 values NNS I-NP O
113 Take VB O O
113 your PRP$ O O
113 insulin NN B-NP B-m
113 and CC O O
113 metformin NN B-NP B-m
113 as IN B-VP O
113 prescribed JJ B-NP O
114 Decrease NNP I-NP O
114 your PRP$ O O
114 intake NN B-NP O
114 of IN B-VP O
114 food NN B-NP O
114 with IN B-VP O
114 high JJ O O
114 saturated VBN O O
114 fat NN B-NP O
114 and CC O O
114 cholesterol NN B-NP O
115 Take VBP O O
115 a DT B-NP O
115 30-45 JJ I-NP O
115 min NN I-NP O
115 walk NN I-NP O
115 at IN B-VP O
115 least JJS O O
115 5 CD O O
115 times NNS B-NP O
115 per IN B-VP O
115 week NN B-NP O
116 No RB O O
116 dictated VBD B-VP O
116 summary JJ B-NP O
117 ENTERED NNP I-NP O
117 BY: NNP I-NP O
117 CHARLEBOIS NNP I-NP O
117 , , O O
117 DWIGHT NNP B-NP O
117 L NNP I-NP O
117 , , O O
117 M.D NNP B-NP O
117 ( ( O O
117 JS05 NNP B-NP O
117 ) ) O O
117 9/19/05 CD O O
117 @ $ O O
117 02 CD O O
118 ****** JJ B-NP O
118 END NN I-NP O
118 OF NNP I-NP O
118 DISCHARGE NNP I-NP O
118 ORDERS NNP I-NP O
118 ****** NNP I-NP O
119 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #370707 VBZ O O
2 341782812 CD O O
2 IMC NNP B-NP O
2 82129084 CD O O
2 075826 CD O O
2 8/27/1992 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 8/27/1992 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/26/1993 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 The DT B-NP O
4 patient NN I-NP O
4 is VBZ O O
4 a DT B-NP O
4 53-year-old JJ I-NP O
4 right NN I-NP O
5 handed VBN O O
5 man NN B-NP O
5 who WP O O
5 was VBD B-VP O
5 admitted VBN O O
5 to TO O O
5 the DT B-NP O
6 neurology NN I-NP O
6 service NN I-NP O
6 on IN B-VP O
6 11/6/92 CD O O
6 He PRP O O
6 has VBZ O O
6 a DT O O
6 two CD O O
6 week NN B-NP O
6 history NN I-NP O
6 of IN B-VP O
6 right NN B-NP O
7 sided VBN O O
7 slowly RB O O
7 improving VBG O O
7 The DT B-NP O
7 neurology NN I-NP O
7 service NN I-NP O
7 felt VBD B-VP O
7 that IN B-VP O
7 the DT B-NP O
8 findings NNS I-NP O
8 on IN B-VP O
8 exam NN B-NP O
8 was VBD B-VP O
8 most RBS O O
8 consistent JJ O O
8 with IN B-VP O
8 cervical JJ B-NP O
8 disc NN I-NP O
8 disease NN I-NP O
8 and CC O O
9 they PRP O O
9 asked VBD B-VP O
9 neurosurgery NN B-NP O
9 to TO O O
9 consult VB O O
9 In IN B-VP O
9 brief NN B-NP O
9 , , O O
9 the DT B-NP O
9 patient's NN I-NP O
9 chief NN I-NP O
10 complaint NN I-NP O
10 is VBZ O O
10 right JJ B-NP O
10 sided JJ I-NP O
10 weakness NN I-NP O
10 The DT B-NP O
10 patient NN I-NP O
10 was VBD B-VP O
10 in IN B-VP O
10 his PRP$ O O
10 usual JJ B-NP O
11 state NN I-NP O
11 of IN B-VP O
11 health NN B-NP O
11 until IN B-VP O
11 approximately RB O O
11 three CD O O
11 and CC O O
11 a DT B-NP O
11 half JJ I-NP O
11 weeks NNS I-NP O
11 prior RB O O
11 to TO O O
12 admission NN B-NP O
12 He PRP O O
12 noted VBD B-VP O
12 pain NN B-NP O
12 in IN B-VP O
12 his PRP$ O O
12 right JJ B-NP O
12 shoulder NN I-NP O
12 over IN B-VP O
12 four CD O O
12 to TO O O
12 five CD O O
13 hours NNS B-NP O
13 , , O O
13 the DT B-NP O
13 pain NN I-NP O
13 increased VBD B-VP O
13 He PRP O O
13 also RB O O
13 noted VBD B-VP O
13 numbness NN B-NP O
13 in IN B-VP O
13 his PRP$ O O
13 right NN B-NP O
14 toes VBZ O O
14 His PRP$ O O
14 right JJ B-NP O
14 hand NN I-NP O
14 was VBD B-VP O
14 weak JJ O O
14 as IN B-VP O
14 well RB O O
14 and CC O O
14 he PRP O O
14 had VBD B-VP O
14 difficulty NN B-NP O
15 holding VBG O O
15 a DT B-NP O
15 cup NN I-NP O
15 Conservative NNP I-NP O
15 management NN I-NP O
15 failed VBD B-VP O
15 , , O O
15 i.e NN B-NP O
15 , , O O
15 bedrest IN B-VP O
15 He PRP O O
16 came VBD B-VP O
16 to TO O O
16 the DT B-NP O
16 emergency NN I-NP O
16 room NN I-NP O
16 at IN B-VP O
16 the DT B-NP O
16 request NN I-NP O
16 of IN B-VP O
16 his PRP$ O O
16 local JJ B-NP O
16 doctor NN I-NP O
16 and CC O O
17 was VBD B-VP O
17 admitted VBN O O
17 to TO O O
17 the DT B-NP O
17 neurology NN I-NP O
17 service NN I-NP O
17 While IN B-VP O
17 here RB O O
17 , , O O
17 on IN B-VP O
17 Decadron NNP B-NP B-m
17 , , O O
18 Motrin NNP B-NP B-m
18 and CC O O
18 Flexeril NNP B-NP B-m
18 , , O O
18 he PRP O O
18 noted VBD B-VP O
18 some DT B-NP O
18 improvement NN I-NP O
18 Of IN B-VP O
18 note NN B-NP O
18 , , O O
18 he PRP O O
18 fell VBD B-VP O
19 flat JJ O O
19 on IN B-VP O
19 his PRP$ O O
19 face NN B-NP O
19 first RB O O
19 on IN B-VP O
19 3/16/92 CD O O
19 and CC O O
19 sustained VBD B-VP O
19 a DT B-NP O
19 sprained JJ I-NP O
19 ankle NN I-NP O
20 At IN B-VP O
20 that DT B-NP O
20 time NN I-NP O
20 , , O O
20 he PRP O O
20 had VBD B-VP O
20 no DT B-NP O
20 back NN I-NP O
20 or CC O O
20 neck NN B-NP O
20 pain NN I-NP O
20 While IN B-VP O
20 in IN B-VP O
20 house NN B-NP O
20 , , O O
20 he PRP O O
20 felt VBD B-VP O
21 that IN B-VP O
21 he PRP O O
21 could MD O O
21 walk VB O O
21 three CD O O
21 times NNS B-NP O
21 around IN B-VP O
21 the DT B-NP O
21 Ingnorf NNP I-NP O
21 At IN B-VP O
21 that DT B-NP O
21 point NN I-NP O
21 , , O O
21 he PRP O O
22 experienced VBD B-VP O
22 weakness NN B-NP O
22 and CC O O
22 numbness NN B-NP O
22 on IN B-VP O
22 the DT B-NP O
22 fourth JJ I-NP O
22 trip NN I-NP O
22 around IN B-VP O
22 He PRP O O
23 has VBZ O O
23 also RB O O
23 noted VBN O O
23 some DT B-NP O
23 urgency NN I-NP O
23 since IN B-VP O
23 the DT B-NP O
23 onset NN I-NP O
23 of IN B-VP O
23 his PRP$ O O
23 neck NN B-NP O
23 pain NN I-NP O
23 He PRP O O
24 has VBZ O O
24 normal JJ B-NP O
24 peroneal JJ I-NP O
24 sensation NN I-NP O
24 except IN B-VP O
24 for IN B-VP O
24 the DT B-NP O
24 transient JJ I-NP O
24 occurrences NNS I-NP O
25 of IN B-VP O
25 some DT B-NP O
25 saddle JJ I-NP O
25 distribution NN I-NP O
25 of IN B-VP O
25 abnormal JJ B-NP O
25 sensation NN I-NP O
25 He PRP O O
25 has VBZ O O
26 constipation NN B-NP O
26 which WDT O O
26 has VBZ O O
26 now RB O O
26 improved VBN O O
26 PAST NNP B-NP O
26 MEDICAL NNP I-NP O
26 HISTORY: NNP I-NP O
26 L4-5 NNP I-NP O
27 laminectomy NN I-NP O
27 in IN B-VP O
27 1970 CD O O
27 and CC O O
27 1982 CD O O
27 In IN B-VP O
27 1980 CD O O
27 , , O O
27 he PRP O O
27 had VBD B-VP O
27 a DT B-NP O
27 perforated JJ I-NP O
27 ulcer NN I-NP O
28 In IN B-VP O
28 1982 CD O O
28 , , O O
28 he PRP O O
28 had VBD B-VP O
28 surgery NN B-NP O
28 for IN B-VP O
28 a DT B-NP O
28 hiatal JJ I-NP O
28 hernia NN I-NP O
28 In IN B-VP O
28 1983 CD O O
28 , , O O
28 he PRP O O
28 had VBD B-VP O
28 a DT B-NP O
29 cholecystectomy NN I-NP O
29 In IN B-VP O
29 1984 CD O O
29 , , O O
29 he PRP O O
29 had VBD B-VP O
29 a DT B-NP O
29 partial JJ I-NP O
29 gastrectomy NN I-NP O
29 and CC O O
30 colectomy NN B-NP O
30 for IN B-VP O
30 swallowing VBG O O
30 a DT B-NP O
30 toothpick NN I-NP O
30 He PRP O O
30 has VBZ O O
30 a DT B-NP O
30 history NN I-NP O
30 of IN B-VP O
30 anxiety NN B-NP O
31 attacks NNS I-NP O
31 related VBN O O
31 to TO O O
31 highway VB O O
31 driving VBG O O
31 He PRP O O
31 is VBZ O O
31 a DT B-NP O
31 past JJ I-NP O
31 smoker NN I-NP O
31 , , O O
31 stopped VBD B-VP O
32 seven CD O O
32 years NNS B-NP O
32 ago RB O O
32 after IN B-VP O
32 three CD O O
32 packs NNS B-NP O
32 per IN B-VP O
32 day NN B-NP O
32 times NNS I-NP O
32 40 CD O O
32 years NNS B-NP O
32 History NNP I-NP O
33 of IN B-VP O
33 alcohol NN B-NP O
33 abuse NN I-NP O
33 but CC O O
33 does VBZ O O
33 not RB O O
33 drink VB O O
33 now RB O O
33 He PRP O O
33 has VBZ O O
33 no DT B-NP O
33 cardiac NN I-NP O
33 , , O O
34 respiratory NN B-NP O
34 or CC O O
34 GI NNP B-NP O
34 disturbances NNS I-NP O
35 PHYSICAL NNP I-NP O
35 EXAMINATION: NNP I-NP O
35 On IN B-VP O
35 admission NN B-NP O
35 revealed VBD B-VP O
35 the DT B-NP O
35 patient NN I-NP O
35 to TO O O
35 be VB O O
36 afebrile JJ B-NP O
36 Vital JJ I-NP O
36 signs NNS I-NP O
36 were VBD B-VP O
36 stable JJ B-NP O
36 General NNP I-NP O
37 exam NN I-NP O
37 was VBD B-VP O
37 within IN B-VP O
37 normal JJ B-NP O
37 limits NNS I-NP O
37 He PRP O O
37 had VBD B-VP O
37 full JJ B-NP O
37 range NN I-NP O
37 of IN B-VP O
37 motion NN B-NP O
37 with IN B-VP O
38 increased JJ B-NP O
38 pain NN I-NP O
38 with IN B-VP O
38 extension NN B-NP O
38 of IN B-VP O
38 his PRP$ O O
38 neck NN B-NP O
38 He PRP O O
38 was VBD B-VP O
38 alert JJ O O
38 and CC O O
39 oriented VBN O O
39 with IN B-VP O
39 a DT B-NP O
39 normal JJ I-NP O
39 mental JJ I-NP O
39 status NN I-NP O
39 Speech NNP I-NP O
39 was VBD B-VP O
39 fluent JJ O O
39 with IN B-VP O
39 no DT B-NP O
40 dysarthria NN I-NP O
40 Cranial JJ B-NP O
40 nerves NNS I-NP O
40 were VBD B-VP O
40 entirely RB O O
40 within IN B-VP O
40 normal JJ B-NP O
40 limits NNS I-NP O
40 He PRP O O
41 had VBD B-VP O
41 no DT B-NP O
41 pronator NN I-NP O
41 drift NN I-NP O
41 On IN B-VP O
41 the DT B-NP O
41 left NN I-NP O
41 he PRP O O
41 was VBD B-VP O
41 5/5 CD O O
41 throughout IN B-VP O
41 On IN B-VP O
41 the DT B-NP O
42 right NN I-NP O
42 he PRP O O
42 had VBD B-VP O
42 5- JJ B-NP O
42 strength NN I-NP O
42 in IN B-VP O
42 his PRP$ O O
42 biceps NNS B-NP O
42 , , O O
42 triceps NNS B-NP O
42 , , O O
42 wrist JJ B-NP O
42 extensors NNS I-NP O
43 and CC O O
43 intrinsics NNS B-NP O
43 Hip NNP I-NP O
43 flexors NNS I-NP O
43 were VBD B-VP O
43 4/5 CD O O
43 Knee NNP B-NP O
43 flexors NNS I-NP O
43 and CC O O
43 knee NN B-NP O
44 extensors NNS I-NP O
44 were VBD B-VP O
44 4/5 CD O O
44 He PRP O O
44 was VBD B-VP O
44 essentially RB O O
44 5/5 CD O O
44 throughout IN B-VP O
44 the DT B-NP O
44 rest NN I-NP O
44 of IN B-VP O
45 his PRP$ O O
45 lower JJR O O
45 extremities VBZ O O
45 His PRP$ O O
45 reflexes NNS B-NP O
45 were VBD B-VP O
45 1-2+ JJ O O
45 in IN B-VP O
45 his PRP$ O O
45 upper JJ B-NP O
46 extremities NNS I-NP O
46 and CC O O
46 approximately RB O O
46 3+ CD O O
46 at IN B-VP O
46 the DT B-NP O
46 knees NNS I-NP O
46 with IN B-VP O
46 downgoing NN B-NP O
46 toes NNS I-NP O
47 He PRP O O
47 had VBD B-VP O
47 3-4 JJ B-NP O
47 beat NN I-NP O
47 clonus NN I-NP O
47 on IN B-VP O
47 the DT B-NP O
47 right JJ I-NP O
47 Coordination NNP I-NP O
47 was VBD B-VP O
47 okay VBN O O
48 bilaterally RB O O
48 Gait NNP B-NP O
48 tested VBD B-VP O
48 revealed VBD B-VP O
48 a DT B-NP O
48 tendency NN I-NP O
48 to TO O O
48 fall VB O O
48 with IN B-VP O
49 decreased JJ B-NP O
49 ability NN I-NP O
49 to TO O O
49 weight VB O O
49 bear NN B-NP O
49 on IN B-VP O
49 the DT B-NP O
49 right JJ I-NP O
49 Sensory NNP I-NP O
49 exam NN I-NP O
50 revealed VBD B-VP O
50 decreased JJ B-NP O
50 sensation NN I-NP O
50 in IN B-VP O
50 the DT B-NP O
50 right JJ I-NP O
50 hand NN I-NP O
50 and CC O O
50 the DT O O
50 last JJ O O
50 three CD O O
51 digits NNS B-NP O
51 of IN B-VP O
51 the DT B-NP O
51 left JJ I-NP O
51 hand NN I-NP O
51 He PRP O O
51 had VBD B-VP O
51 no DT B-NP O
51 subjective JJ I-NP O
51 numbness NN I-NP O
51 in IN B-VP O
51 his PRP$ O O
52 right NN B-NP O
52 leg NN I-NP O
52 , , O O
52 on IN B-VP O
52 the DT B-NP O
52 dorsum NN I-NP O
52 of IN B-VP O
52 his PRP$ O O
52 left JJ B-NP O
52 foot NN I-NP O
52 , , O O
52 he PRP O O
52 had VBD B-VP O
52 decreased VBN O O
53 sensation NN B-NP O
53 with IN B-VP O
53 a DT B-NP O
53 cut NN I-NP O
53 off RP O O
53 before IN B-VP O
53 the DT B-NP O
53 toes NNS I-NP O
54 MRI NNP I-NP O
54 was VBD B-VP O
54 a DT B-NP O
54 poor JJ I-NP O
54 quality NN I-NP O
54 study NN I-NP O
54 which WDT O O
54 showed VBD B-VP O
54 C5-6 NNP B-NP O
54 and CC O O
54 C6-7 NNP B-NP O
54 disc NN I-NP O
54 bulge NN I-NP O
55 CAT NNP I-NP O
55 scan NN I-NP O
55 showed VBD B-VP O
55 severe JJ B-NP O
55 stenosis NN I-NP O
55 of IN B-VP O
55 C6-7 NNP B-NP O
55 with IN B-VP O
55 osteophyte NN B-NP O
55 , , O O
55 moderate JJ B-NP O
56 stenosis NN I-NP O
56 at IN B-VP O
56 C5-6 NNP B-NP O
57 HOSPITAL NNP I-NP O
57 COURSE: NNP I-NP O
57 The DT B-NP O
57 patient NN I-NP O
57 was VBD B-VP O
57 seen VBN O O
57 by IN B-VP O
57 Dr NNP B-NP O
57 Dubey NNP I-NP O
57 who WP O O
57 agreed VBD B-VP O
58 with IN B-VP O
58 the DT B-NP O
58 plan NN I-NP O
58 for IN B-VP O
58 C5-6 NNP B-NP O
58 and CC O O
58 C6-7 NNP B-NP O
58 laminectomies NNS I-NP O
59 He PRP O O
59 was VBD B-VP O
59 taken VBN O O
59 to TO O O
59 the DT B-NP O
59 operating NN I-NP O
59 room NN I-NP O
59 on IN B-VP O
59 0/8/93 CD O O
59 Preoperative JJ B-NP O
60 diagnosis NN I-NP O
60 with IN B-VP O
60 cervical JJ B-NP O
60 stenosis NN I-NP O
60 with IN B-VP O
60 myelopathy JJ B-NP O
60 Postoperative NNP I-NP O
61 diagnosis NN I-NP O
61 was VBD B-VP O
61 the DT O O
61 same JJ O O
61 The DT B-NP O
61 procedure NN I-NP O
61 was VBD B-VP O
61 C4-5 NNP B-NP O
61 , , O O
61 C5-6 NNP B-NP O
61 , , O O
61 C6-7 NNP B-NP O
62 laminectomy NN I-NP O
62 He PRP O O
62 had VBD B-VP O
62 a DT B-NP O
62 Hemovac NNP I-NP O
62 placed VBN O O
62 postoperatively RB O O
62 The DT O O
63 estimated VBN O O
63 blood NN B-NP O
63 loss NN I-NP O
63 was VBD B-VP O
63 less JJR O O
63 than IN B-VP O
63 100 CD O O
63 cc NN B-NP O
63 Postoperatively RB O O
63 , , O O
63 he PRP O O
63 did VBD B-VP O
64 very RB O O
64 well RB O O
64 He PRP O O
64 had VBD B-VP O
64 good JJ B-NP O
64 upper JJ I-NP O
64 extremity NN I-NP O
64 strength NN I-NP O
64 which WDT O O
64 seemed VBD B-VP O
64 to TO O O
65 improve VB O O
65 He PRP O O
65 was VBD B-VP O
65 seen VBN O O
65 by IN B-VP O
65 physical JJ B-NP O
65 therapy NN I-NP O
65 He PRP O O
65 had VBD B-VP O
65 a DT O O
65 slightly RB O O
66 swollen VBN O O
66 calf NN B-NP O
66 and CC O O
66 had VBD B-VP O
66 noninvasive JJ B-NP O
66 vascular JJ I-NP O
66 studies NNS I-NP O
66 of IN B-VP O
66 his PRP$ O O
66 lower JJR B-NP O
67 extremities NNS I-NP O
67 which WDT O O
67 were VBD B-VP O
67 negative JJ O O
67 He PRP O O
67 did VBD B-VP O
67 , , O O
67 however RB O O
67 , , O O
67 note VBP O O
67 some DT O O
68 shooting VBG O O
68 pain NN B-NP O
68 in IN B-VP O
68 his PRP$ O O
68 left JJ B-NP O
68 lower JJR I-NP O
68 extremity NN I-NP O
68 His PRP$ O O
68 wound NN B-NP O
68 was VBD B-VP O
68 clean JJ O O
68 and CC O O
69 healing VBG O O
69 well RB O O
69 He PRP O O
69 was VBD B-VP O
69 out IN B-VP O
69 of IN B-VP O
69 bed NN B-NP O
69 with IN B-VP O
69 a DT B-NP O
69 walker NN I-NP O
69 The DT B-NP O
69 plan NN I-NP O
69 was VBD B-VP O
69 for IN B-VP O
70 discharge NN B-NP O
70 home NN I-NP O
70 He PRP O O
70 may MD O O
70 need VB O O
70 further JJ B-NP O
70 evaluation NN I-NP O
70 of IN B-VP O
70 his PRP$ O O
70 lumbar NN B-NP O
70 spine NN I-NP O
71 at IN B-VP O
71 some DT B-NP O
71 point NN I-NP O
71 but CC O O
71 he PRP O O
71 seems VBZ O O
71 to TO O O
71 be VB O O
71 doing VBG O O
71 well RB O O
71 with IN B-VP O
71 Percocet NNP B-NP B-m
71 only RB O O
72 PRINCIPAL NNP B-NP O
72 DIAGNOSIS: NNP I-NP O
72 CERVICAL NNP I-NP O
72 SPONDYLOSIS NNP I-NP O
72 STATUS NNP I-NP O
72 POST NNP I-NP O
72 MULTIPLE NNP I-NP O
73 LEVEL NNP I-NP O
73 CERVICAL NNP I-NP O
73 LAMINECTOMIES NNP I-NP O
74 HISTORY NNP I-NP O
74 OF NNP I-NP O
74 LUMBAR NNP I-NP O
74 DISC NNP I-NP O
74 DISEASE NNP I-NP O
75 HISTORY NNP I-NP O
75 OF NNP I-NP O
75 ALCOHOL NNP I-NP O
75 AND NNP I-NP O
75 TOBACCO NNP I-NP O
75 ABUSE NNP I-NP O
75 , , O O
76 NONE NNP B-NP O
76 CURRENTLY NNP I-NP O
77 PERFORATED NNP I-NP O
77 ULCER NNP I-NP O
78 HIATAL NNP I-NP O
78 HERNIA NNP I-NP O
79 STATUS NNP I-NP O
79 POST NNP I-NP O
79 CHOLECYSTECTOMY NNP I-NP O
79 , , O O
79 GASTRECTOMY NNP B-NP O
80 AND NNP I-NP O
80 COLECTOMY NNP I-NP O
81 ANXIETY NNP I-NP O
81 ATTACKS NNP I-NP O
82 DISPOSITION: NNP I-NP O
82 MEDICATIONS: NNP I-NP O
82 On IN B-VP O
82 discharge NN B-NP O
82 included VBD B-VP O
82 Colace NNP B-NP B-m
82 , , O O
83 klonopin NN B-NP B-m
83 , , O O
83 Flexeril NNP B-NP B-m
83 and CC O O
83 Percocet NNP B-NP B-m
83 He PRP O O
83 will MD O O
83 follow-up VB O O
84 with IN B-VP O
84 Dr NNP B-NP O
84 Mcnail NNP I-NP O
84 in IN B-VP O
84 one CD O O
84 to TO O O
84 two CD O O
84 weeks NNS B-NP O
85 Dictated VBD B-VP O
85 By: NNP B-NP O
85 ROCCO NNP I-NP O
85 TANDON NNP I-NP O
85 , , O O
85 M.D NNP B-NP O
85 ZH67 NNP I-NP O
86 Attending: NNP I-NP O
86 PEDRO NNP I-NP O
86 BADOUR NNP I-NP O
86 , , O O
86 M.D NNP B-NP O
86 QY35 NNP I-NP O
87 VP775/4731 NNP I-NP O
88 Batch: NNP I-NP O
88 4920 CD O O
88 Index NNP B-NP O
88 No NNP I-NP O
88 TQZQOXVFE NNP I-NP O
88 D: NNP I-NP O
88 6/21/93 CD O O
89 T: NNP B-NP O
89 0/16/93 CD O O
90 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #403481 VBZ O O
4 079025012 CD O O
4 PH NNP B-NP O
4 73514712 CD O O
4 2364381 CD O O
4 9/13/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 OSTEOMYELITIS NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 6/1/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/4/2004 CD O O
7 ATTENDING: NNP B-NP O
7 CORTEZ NNP I-NP O
7 DERICK NNP I-NP O
7 SADLIER NNP I-NP O
7 MD NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 was VBD B-VP O
8 admitted VBN O O
8 on IN B-VP O
8 4/12/04 CD O O
9 for IN B-VP O
9 a DT B-NP O
9 right JJ I-NP O
9 plantar NN I-NP O
9 surface NN I-NP O
9 neurotrophic JJ O O
9 ulcer JJ O O
9 secondary JJ O O
9 to TO O O
10 diabetes NNS B-NP O
10 mellitus IN B-VP O
10 The DT B-NP O
10 patient NN I-NP O
10 has VBZ O O
10 a DT B-NP O
10 long-standing JJ I-NP O
10 history NN I-NP O
10 of IN B-VP O
11 peripheral JJ B-NP O
11 neuropathy NNS I-NP O
11 and CC O O
11 slight JJ B-NP O
11 history NN I-NP O
11 of IN B-VP O
11 peripheral JJ B-NP O
11 vascular JJ I-NP O
12 disease NN I-NP O
12 This DT O O
12 has VBZ O O
12 been VBN O O
12 treated VBN O O
12 thus RB O O
12 far RB O O
12 by IN B-VP O
12 podiatric JJ B-NP O
13 debridements NNS I-NP O
13 until IN B-VP O
13 the DT B-NP O
13 day NN I-NP O
13 of IN B-VP O
13 admission NN B-NP O
13 when WRB O O
13 the DT B-NP O
13 patient NN I-NP O
14 presented VBD B-VP O
14 low-grade JJ B-NP O
14 fevers NNS I-NP O
14 and CC O O
14 chills VBZ O O
14 The DT B-NP O
14 patient NN I-NP O
14 also RB O O
14 has VBZ O O
14 a DT B-NP O
15 history NN I-NP O
15 of IN B-VP O
15 diabetes NNS B-NP O
15 mellitus NNS I-NP O
15 , , O O
15 hypertension NN B-NP O
15 , , O O
15 distant JJ B-NP O
15 past NN I-NP O
15 of IN B-VP O
16 pancreatitis NN B-NP O
16 , , O O
16 gout NN B-NP O
16 , , O O
16 neuropathy JJ O O
16 , , O O
16 high JJ B-NP O
16 cholesterol NN I-NP O
16 , , O O
16 and CC O O
16 chronic JJ B-NP O
17 renal JJ I-NP O
17 insufficiency NN I-NP O
17 He PRP O O
17 has VBZ O O
17 had VBD B-VP O
17 a DT O O
17 left JJ O O
17 fourth JJ O O
17 and CC O O
17 fifth JJ B-NP O
17 toe NN I-NP O
18 amputation NN I-NP O
18 before IN B-VP O
18 He PRP O O
18 has VBZ O O
18 also RB O O
18 undergone JJ B-NP O
18 recent JJ I-NP O
18 eye NN I-NP O
18 surgery NN I-NP O
18 of IN B-VP O
19 unknown JJ B-NP O
19 origin NN I-NP O
19 and CC O O
19 had VBD B-VP O
19 some DT B-NP O
19 unknown JJ I-NP O
19 pancreatic JJ I-NP O
19 surgery NN I-NP O
19 in IN B-VP O
19 1968 CD O O
20 most JJS O O
20 likely JJ O O
20 for IN B-VP O
20 phlegmon NN B-NP O
20 or CC O O
20 some DT B-NP O
20 sort NN I-NP O
20 of IN B-VP O
20 pancreatic JJ B-NP O
20 condition NN I-NP O
21 The DT B-NP O
21 patient NN I-NP O
21 was VBD B-VP O
21 admitted VBN O O
21 on IN B-VP O
21 4/12/04 CD O O
21 with IN B-VP O
21 a DT B-NP O
21 right JJ I-NP O
21 plantar NN I-NP O
21 surface NN I-NP O
22 neurotrophic JJ B-NP O
22 ulcer NN I-NP O
22 as RB O O
22 well RB O O
22 as IN B-VP O
22 recent JJ B-NP O
22 history NN I-NP O
22 of IN B-VP O
22 low-grade JJ B-NP O
22 fevers NNS I-NP O
23 and CC O O
23 chills VBZ O O
24 The DT B-NP O
24 patient NN I-NP O
24 notes VBZ O O
24 that IN B-VP O
24 the DT B-NP O
24 ulcer NN I-NP O
24 came VBD B-VP O
24 about RB O O
24 after IN B-VP O
24 some DT B-NP O
24 unknown JJ I-NP O
25 trauma NN I-NP O
25 to TO O O
25 the DT B-NP O
25 foot NN I-NP O
25 He PRP O O
25 had VBD B-VP O
25 been VBN O O
25 followed VBN O O
25 by IN B-VP O
25 podiatrist NN B-NP O
25 and CC O O
25 had VBD B-VP O
26 outpatient VBN O O
26 MRI NNP B-NP O
26 revealing VBG O O
26 osteo NN B-NP O
26 at IN B-VP O
26 the DT B-NP O
26 fifth NN I-NP O
26 metatarsal NN I-NP O
26 head NN I-NP O
26 and CC O O
27 the DT B-NP O
27 fourth JJ I-NP O
27 metatarsal NN I-NP O
27 shaft NN I-NP O
27 , , O O
27 presented VBN O O
27 to TO O O
27 the DT B-NP O
27 Egan NNP I-NP O
27 Healthcare NNP I-NP O
28 emergency NN I-NP O
28 department NN I-NP O
28 after IN B-VP O
28 having VBG O O
28 a DT B-NP O
28 fever NN I-NP O
28 of IN B-VP O
28 101.3 CD O O
28 degrees NNS B-NP O
28 On IN B-VP O
29 admission NN B-NP O
29 , , O O
29 the DT B-NP O
29 patient NN I-NP O
29 had VBD B-VP O
29 a DT B-NP O
29 low-grade JJ I-NP O
29 fever NN I-NP O
29 of IN B-VP O
29 99.7 CD O O
29 degrees NNS B-NP O
29 , , O O
30 pulse NN B-NP O
30 in IN B-VP O
30 the DT O O
30 90s CD O O
30 , , O O
30 respiratory NN B-NP O
30 rate NN I-NP O
30 16 CD O O
30 , , O O
30 and CC O O
30 blood NN B-NP O
30 pressure NN I-NP O
30 144/67 CD O O
31 He PRP O O
31 was VBD B-VP O
31 saturating VBG O O
31 95% CD O O
31 on IN B-VP O
31 room NN B-NP O
31 air NN I-NP O
32 MEDICATIONS: NNP I-NP O
33 At IN B-VP O
33 the DT B-NP O
33 time NN I-NP O
33 of IN B-VP O
33 admission NN B-NP O
33 were VBD B-VP O
33 as IN B-VP O
33 follows: JJ O O
34 1 CD O O
34 Lantus NNP B-NP B-m
34 100 CD O B-do
34 mg NN B-NP I-do
34 q.p.m NN I-NP B-f
35 2 CD O O
35 Humalog NNP B-NP B-m
35 20 CD O B-do
35 units NNS B-NP I-do
35 q.p.m RB O B-f
36 3 CD O O
36 Humalog NNP B-NP B-m
36 sliding VBG O B-do
36 scale JJ O I-do
37 4 CD O O
37 Neurontin NNP B-NP B-m
37 300 CD O B-do
37 mg NN B-NP I-do
37 t.i.d NN I-NP B-f
38 5 CD O O
38 Lisinopril NNP B-NP B-m
38 40 CD O B-do
38 mg NN B-NP I-do
38 q.d NN I-NP B-f
39 6 CD O O
39 Allopurinol NNP B-NP B-m
39 300 CD O B-do
39 mg NN B-NP I-do
39 q.d NN I-NP B-f
40 7 CD O O
40 Hydrochlorothiazide NNP B-NP B-m
40 25 CD O B-do
40 mg NN B-NP I-do
40 q.d NN I-NP B-f
41 8 CD O O
41 Zocor NNP B-NP B-m
41 20 CD O B-do
41 mg NN B-NP I-do
41 q.d NN I-NP B-f
42 9 CD O O
42 TriCor NNP B-NP B-m
42 50 CD O B-do
42 mg NN B-NP I-do
42 b.i.d NN I-NP B-f
43 10 CD O O
43 Atenolol NNP B-NP B-m
43 25 CD O B-do
43 mg NN B-NP I-do
43 q.d NN I-NP B-f
44 11 CD O O
44 Eyedrops NNP B-NP B-mo
44 prednisolone NN I-NP B-m
44 and CC O O
44 atropine NN B-NP B-m
45 12 CD O O
45 The DT B-NP O
45 patient NN I-NP O
45 was VBD B-VP O
45 on IN B-VP O
45 iron NN B-NP B-m
45 supplementation NN I-NP I-m
46 PHYSICAL NNP I-NP O
46 EXAMINATION: NNP I-NP O
46 Notable NNP I-NP O
46 findings NNS I-NP O
46 and/or VBP O O
46 that IN B-VP O
46 the DT B-NP O
46 patient NN I-NP O
47 had VBD B-VP O
47 clear JJ B-NP O
47 breath NN I-NP O
47 sounds NNS I-NP O
47 and CC O O
47 regular JJ B-NP O
47 rate NN I-NP O
47 and CC O O
47 rhythm NN B-NP O
47 On IN B-VP O
47 cardiac JJ B-NP O
48 examination NN I-NP O
48 had VBD B-VP O
48 a DT B-NP O
48 slight JJ I-NP O
48 murmur NN I-NP O
48 2/6 CD O O
48 along IN B-VP O
48 the DT B-NP O
48 left JJ I-NP O
48 sternal JJ I-NP O
48 border NN I-NP O
49 and CC O O
49 otherwise RB O O
49 had VBD B-VP O
49 a DT B-NP O
49 obese JJ I-NP O
49 abdomen NNS I-NP O
49 The DT B-NP O
49 extremities NNS I-NP O
49 and CC O O
49 back RB O O
50 revealed VBD B-VP O
50 no DT B-NP O
50 abnormalities NNS I-NP O
50 except IN B-VP O
50 for IN B-VP O
50 a DT B-NP O
50 right JJ I-NP O
50 foot NN I-NP O
50 ulcer NN I-NP O
50 along IN B-VP O
50 the DT O O
51 fourth JJ O O
51 and CC O O
51 fifth JJ B-NP O
51 metatarsal NN I-NP O
51 distal JJ O O
51 heads VBZ O O
51 The DT B-NP O
51 patient NN I-NP O
51 also RB O O
51 had VBD B-VP O
51 a DT O O
52 somewhat RB O O
52 cyanotic JJ O O
52 appearing VBG O O
52 and CC O O
52 somewhat RB O O
52 edematous JJ O O
52 and CC O O
52 swollen JJ B-NP O
53 fifth NN I-NP O
53 right RB O O
53 toe VBZ O O
53 The DT B-NP O
53 patient NN I-NP O
53 had VBD B-VP O
53 decreased VBN O O
53 sensation NN B-NP O
53 bilaterally RB O O
54 in IN B-VP O
54 the DT B-NP O
54 feet NNS I-NP O
54 up IN B-VP O
54 to TO O O
54 mid VB O O
54 shin PDT O O
54 The DT B-NP O
54 patient NN I-NP O
54 also RB O O
54 had VBD B-VP O
54 a DT B-NP O
54 known JJ I-NP O
54 history NN I-NP O
55 of IN B-VP O
55 drug NN B-NP O
55 allergies NNS I-NP O
56 LABORATORY NNP I-NP O
56 DATA: NNP I-NP O
57 At IN B-VP O
57 the DT B-NP O
57 time NN I-NP O
57 of IN B-VP O
57 admission NN B-NP O
57 , , O O
57 the DT B-NP O
57 patient's NN I-NP O
57 significant JJ B-NP O
57 labs NNS I-NP O
57 were VBD B-VP O
57 as IN B-VP O
58 follows VBZ O O
58 , , O O
58 his PRP$ O O
58 potassium NN B-NP O
58 was VBD B-VP O
58 4.3 CD O O
58 , , O O
58 BUN NNP B-NP O
58 was VBD B-VP O
58 38 CD O O
58 , , O O
58 creatinine NN B-NP O
58 was VBD B-VP O
58 3.2 CD O O
58 , , O O
59 and CC O O
59 his PRP$ O O
59 blood NN B-NP O
59 glucose NN I-NP O
59 was VBD B-VP O
59 187 CD O O
59 His PRP$ O O
59 white JJ B-NP O
59 blood NN I-NP O
59 cell NN I-NP O
59 count NN I-NP O
59 was VBD B-VP O
60 12.6 CD O O
60 and CC O O
60 hematocrit NN B-NP O
60 was VBD B-VP O
60 27.8 CD O O
61 HOSPITAL NNP B-NP O
61 COURSE: NNP I-NP O
62 The DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
62 admitted VBN O O
62 to TO O O
62 the DT B-NP O
62 vascular JJ I-NP O
62 surgery NN I-NP O
62 service NN I-NP O
62 under IN B-VP O
63 Dr NNP B-NP O
63 Tosco NNP I-NP O
63 and CC O O
63 was VBD B-VP O
63 started VBN O O
63 on IN B-VP O
63 vancomycin NN B-NP B-m
63 , , O O
63 levofloxacin NN B-NP B-m
63 , , O O
63 and CC O O
64 Flagyl NNP B-NP B-m
64 He PRP O O
64 continued VBD B-VP O
64 to TO O O
64 have VB O O
64 low-grade JJ B-NP O
64 fevers NNS I-NP O
64 over IN B-VP O
64 the DT B-NP O
64 course NN I-NP O
64 of IN B-VP O
65 the DT O O
65 next JJ O O
65 three CD O O
65 days NNS B-NP O
65 Finally RB O O
65 , , O O
65 on IN B-VP O
65 hospital JJ B-NP O
65 day NN I-NP O
65 3 CD O O
65 , , O O
65 had VBD B-VP O
65 a DT B-NP O
65 fever NN I-NP O
65 of IN B-VP O
66 103.2 CD O O
66 It PRP O O
66 was VBD B-VP O
66 decided VBN O O
66 that IN B-VP O
66 at IN B-VP O
66 the DT B-NP O
66 time NN I-NP O
66 of IN B-VP O
66 admission NN B-NP O
66 , , O O
66 the DT B-NP O
66 patient NN I-NP O
67 would MD O O
67 need VB O O
67 to TO O O
67 undergo VB O O
67 an DT B-NP O
67 amputation NN I-NP O
67 of IN B-VP O
67 the DT O O
67 third JJ O O
67 and CC O O
67 fourth JJ B-NP O
67 toe NN I-NP O
68 as RB O O
68 well RB O O
68 as IN B-VP O
68 metatarsal NN B-NP O
68 heads NNS I-NP O
68 to TO O O
68 remove VB O O
68 the DT B-NP O
68 infected JJ I-NP O
68 bone NN I-NP O
68 and CC O O
69 source NN B-NP O
69 of IN B-VP O
69 osteomyelitis NN B-NP O
69 On IN B-VP O
69 hospital JJ B-NP O
69 day NN I-NP O
69 3 CD O O
69 , , O O
69 the DT B-NP O
69 patient NN I-NP O
69 was VBD B-VP O
70 taken VBN O O
70 to TO O O
70 the DT B-NP O
70 operating NN I-NP O
70 room NN I-NP O
70 It PRP O O
70 should MD O O
70 be VB O O
70 noted VBN O O
70 at IN B-VP O
70 that DT B-NP O
70 time NN I-NP O
71 that IN B-VP O
71 the DT B-NP O
71 patient's NN I-NP O
71 creatinine NN I-NP O
71 bumped VBD B-VP O
71 before IN B-VP O
71 his PRP$ O O
71 operation NN B-NP O
71 from IN B-VP O
71 a DT B-NP O
72 BUN NNP I-NP O
72 of IN B-VP O
72 39 CD O O
72 and CC O O
72 a DT B-NP O
72 creatinine NN I-NP O
72 of IN B-VP O
72 2.1 CD O O
72 to TO O O
72 a DT B-NP O
72 BUN NNP I-NP O
72 of IN B-VP O
72 59 CD O O
72 on IN B-VP O
72 hospital JJ B-NP O
72 day NN I-NP O
73 3 CD O O
73 and CC O O
73 a DT B-NP O
73 creatinine NN I-NP O
73 of IN B-VP O
73 3.9 CD O O
73 This DT O O
73 occurred VBD B-VP O
73 coincidentally RB O O
73 the DT B-NP O
73 day NN I-NP O
74 after IN B-VP O
74 the DT B-NP O
74 patient NN I-NP O
74 had VBD B-VP O
74 several JJ B-NP O
74 MRIs NNP I-NP O
74 of IN B-VP O
74 is VBZ O O
74 lower JJR B-NP O
74 extremities NNS I-NP O
74 to TO O O
75 better RBR O O
75 understand VB O O
75 the DT B-NP O
75 vascular JJ I-NP O
75 supply NN I-NP O
75 to TO O O
75 his PRP$ O O
75 lower JJR B-NP O
75 extremities NNS I-NP O
76 Therefore RBR O O
76 , , O O
76 the DT B-NP O
76 patient NN I-NP O
76 had VBD B-VP O
76 contrast VBN O B-m
76 dye JJ O I-m
76 Although IN B-VP O
76 , , O O
76 this DT B-NP O
76 dye NN I-NP O
76 was VBD B-VP O
77 gadolinium NN B-NP B-m
77 , , O O
77 which WDT O O
77 is VBZ O O
77 sued VBN O O
77 commonly RB O O
77 for IN B-VP O
77 MRA NNP B-NP O
77 and CC O O
77 is VBZ O O
77 not RB O O
77 usually RB O O
78 associated VBN O O
78 with IN B-VP O
78 any DT O O
78 soft JJ O O
78 of IN B-VP O
78 renal JJ B-NP O
78 toxicities NNS I-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 was VBD B-VP O
79 taken VBN O O
79 to TO O O
79 the DT B-NP O
79 operating NN I-NP O
79 room NN I-NP O
79 on IN B-VP O
79 hospital JJ B-NP O
79 day NN I-NP O
79 3 CD O O
79 for IN B-VP O
80 a DT O O
80 right JJ O O
80 fourth JJ O O
80 and CC O O
80 fifth JJ B-NP O
80 toe NN I-NP O
80 amputation NN I-NP O
80 and CC O O
80 nonhealing JJ B-NP O
80 ulcer JJ I-NP O
81 debridement NN I-NP O
81 Please NNP I-NP O
81 refer NN I-NP O
81 to TO O O
81 the DT B-NP O
81 operative JJ I-NP O
81 note NN I-NP O
81 by IN B-VP O
81 Dr NNP B-NP O
82 Guemmer NNP I-NP O
82 for IN B-VP O
82 further RB O O
82 details NNS B-NP O
82 The DT B-NP O
82 patient NN I-NP O
82 tolerated VBD B-VP O
82 the DT B-NP O
83 procedure NN I-NP O
83 without IN B-VP O
83 any DT B-NP O
83 problems NNS I-NP O
83 and CC O O
83 the DT B-NP O
83 patient NN I-NP O
83 control NN I-NP O
83 was VBD B-VP O
84 adequate JJ O O
84 by IN B-VP O
84 postoperative JJ B-NP O
84 day NN I-NP O
84 1 CD O O
84 However RB O O
84 on IN B-VP O
84 postoperative JJ B-NP O
84 lab NN I-NP O
85 checkup NN I-NP O
85 , , O O
85 it PRP O O
85 was VBD B-VP O
85 see VB O O
85 that IN B-VP O
85 the DT B-NP O
85 patient's NN I-NP O
85 creatinine NN I-NP O
85 bumped VBD B-VP O
85 to TO O O
85 4.9 CD O O
86 with IN B-VP O
86 a DT B-NP O
86 BUN NNP I-NP O
86 of IN B-VP O
86 61 CD O O
86 This DT O O
86 was VBD B-VP O
86 viewed VBN O O
86 and CC O O
86 was VBD B-VP O
86 monitored VBN O O
86 by IN B-VP O
86 serial JJ B-NP O
87 BUN NNP I-NP O
87 and CC O O
87 creatinine NN B-NP O
87 checks NNS I-NP O
87 The DT B-NP O
87 following NN I-NP O
87 , , O O
87 BUN NNP B-NP O
87 and CC O O
87 creatinine NN B-NP O
88 came VBD B-VP O
88 back RB O O
88 at IN B-VP O
88 69 CD O O
88 for IN B-VP O
88 BUN NNP B-NP O
88 and CC O O
88 5.2 CD O O
88 for IN B-VP O
88 creatinine NN B-NP O
88 On IN B-VP O
88 postoperative JJ B-NP O
89 day NN I-NP O
89 #1 NNP I-NP O
89 , , O O
89 the DT B-NP O
89 patient's NN I-NP O
89 creatinine NN I-NP O
89 continued VBD B-VP O
89 to TO O O
89 rise VB O O
89 and CC O O
89 was VBD B-VP O
89 found VBN O O
90 to TO O O
90 be VB O O
90 6.5 CD O O
90 with IN B-VP O
90 a DT B-NP O
90 BUN NNP I-NP O
90 of IN B-VP O
90 81 CD O O
90 At IN B-VP O
90 this DT B-NP O
90 point NN I-NP O
90 , , O O
90 the DT B-NP O
90 renal JJ I-NP O
90 service NN I-NP O
90 was VBD B-VP O
91 consulted VBN O O
91 for IN B-VP O
91 further JJ B-NP O
91 input NN I-NP O
91 as RB O O
91 far RB O O
91 as IN B-VP O
91 possible JJ B-NP O
91 causes NNS I-NP O
91 of IN B-VP O
91 acute JJ B-NP O
92 renal JJ I-NP O
92 failure NN I-NP O
92 in IN B-VP O
92 the DT B-NP O
92 phase NN I-NP O
92 of IN B-VP O
92 chronic JJ B-NP O
92 renal JJ I-NP O
92 insufficiency NN I-NP O
92 and CC O O
93 postoperative JJ B-NP O
93 period NN I-NP O
93 The DT B-NP O
93 patient's NN I-NP O
93 vancomycin NN I-NP B-m
93 level NN I-NP O
93 came VBD B-VP O
93 to TO O O
93 be VB O O
94 in IN B-VP O
94 the DT B-NP O
94 therapeutic JJ I-NP O
94 range NN I-NP O
94 of IN B-VP O
94 30.8 CD O O
94 FENa NNP B-NP O
94 was VBD B-VP O
94 checked VBN O O
94 which WDT O O
95 revealed VBD B-VP O
95 0.74% CD O O
95 FENa NNP B-NP O
95 This DT O O
95 was VBD B-VP O
95 rechecked VBN O O
95 and CC O O
95 revealed VBD B-VP O
95 a DT B-NP O
95 FENa NNP I-NP O
95 of IN B-VP O
96 0.97% CD O O
96 both DT O O
96 , , O O
96 which WDT O O
96 indicated VBD B-VP O
96 prerenal JJ B-NP O
96 failure NN I-NP O
96 Renal NNP I-NP O
96 team NN I-NP O
96 also RB O O
97 advised VBD B-VP O
97 checking VBG O O
97 for IN B-VP O
97 other JJ B-NP O
97 causes NNS I-NP O
97 of IN B-VP O
97 the DT B-NP O
97 patient's NN I-NP O
97 anemia NN I-NP O
97 as RB O O
97 well RB O O
98 as IN B-VP O
98 other JJ B-NP O
98 causes NNS I-NP O
98 of IN B-VP O
98 the DT B-NP O
98 renal JJ I-NP O
98 failure NN I-NP O
98 Labs NNP I-NP O
98 have VBP O O
98 been VBN O O
98 sent VBN O O
98 and CC O O
99 some DT O O
99 are VBP O O
99 currently RB O O
99 pending VBG O O
99 regarding VBG O O
99 the DT B-NP O
99 C3-C4 NNP I-NP O
99 and CC O O
99 anti-GMB JJ B-NP O
100 antibodies NNS I-NP O
101 The DT B-NP O
101 patient's NN I-NP O
101 creatinine NN I-NP O
101 continued VBD B-VP O
101 to TO O O
101 rise VB O O
101 despite IN B-VP O
101 advanced JJ B-NP O
102 management NN I-NP O
102 including VBG O O
102 with IN B-VP O
102 IV NNP B-NP B-mo
102 resuscitation NN I-NP B-m
102 , , O O
102 fluid NN B-NP O
102 volume NN I-NP O
102 boluses NNS I-NP O
102 , , O O
103 and CC O O
103 occasional JJ B-NP O
103 boluses NNS I-NP O
103 of IN B-VP O
103 Lasix NNP B-NP B-m
103 Eventually NNP I-NP O
103 , , O O
103 the DT B-NP O
103 patient's NN I-NP O
103 BUN NNP I-NP O
104 and CC O O
104 creatinine NN B-NP O
104 rose VBD B-VP O
104 to TO O O
104 94 CD O O
104 and CC O O
104 8.3 CD O O
104 by IN B-VP O
104 postoperative JJ B-NP O
104 day NN I-NP O
104 2 CD O O
104 By IN B-VP O
104 the DT B-NP O
105 following JJ I-NP O
105 day NN I-NP O
105 , , O O
105 however RB O O
105 postoperative JJ B-NP O
105 day NN I-NP O
105 3 CD O O
105 , , O O
105 the DT B-NP O
105 patient's NN I-NP O
106 creatinine NN I-NP O
106 and CC O O
106 BUN NNP B-NP O
106 began VBD B-VP O
106 resolving VBG O O
106 that IN B-VP O
106 BUN NNP B-NP O
106 of IN B-VP O
106 95 CD O O
106 and CC O O
106 a DT B-NP O
107 creatinine NN I-NP O
107 7.8 CD O O
107 However RB O O
107 , , O O
107 at IN B-VP O
107 the DT B-NP O
107 same JJ I-NP O
107 time NN I-NP O
107 , , O O
107 the DT B-NP O
107 patient NN I-NP O
107 began VBD B-VP O
108 having VBG O O
108 hypoglycemic JJ B-NP O
108 episodes NNS I-NP O
108 in IN B-VP O
108 response NN B-NP O
108 to TO O O
108 the DT B-NP O
108 Lantus NNP I-NP B-m
108 dose NN I-NP O
108 that IN B-VP O
109 he PRP O O
109 was VBD B-VP O
109 getting VBG O O
109 at IN B-VP O
109 home NN B-NP O
109 and CC O O
109 continue VB O O
109 to TO O O
109 get VB O O
109 here RB O O
109 in IN B-VP O
109 hospital NN B-NP O
109 It PRP O O
110 was VBD B-VP O
110 summarized VBN O O
110 by IN B-VP O
110 the DT B-NP O
110 renal JJ I-NP O
110 team NN I-NP O
110 as RB O O
110 well RB O O
110 as IN B-VP O
110 by IN B-VP O
110 the DT B-NP O
110 surgical JJ I-NP O
111 service NN I-NP O
111 and CC O O
111 that IN B-VP O
111 the DT B-NP O
111 patient NN I-NP O
111 may MD O O
111 have VB O O
111 not RB O O
111 been VBN O O
111 taking VBG O O
111 his PRP$ O O
112 medication NN B-NP O
112 at IN B-VP O
112 home NN B-NP O
112 and CC O O
112 now RB O O
112 was VBD B-VP O
112 being VBG O O
112 his PRP$ O O
112 medications NNS B-NP O
112 , , O O
112 while IN B-VP O
112 here RB O O
113 in IN B-VP O
113 the DT B-NP O
113 hospital NN I-NP O
113 By IN B-VP O
113 postoperative JJ B-NP O
113 day NN I-NP O
113 4 CD O O
113 , , O O
113 the DT B-NP O
113 patient NN I-NP O
113 continued VBD B-VP O
114 to TO O O
114 have VB O O
114 dysregulation NN B-NP O
114 of IN B-VP O
114 his PRP$ O O
114 fingerstick JJ B-NP O
114 blood NN I-NP O
114 glucoses NNS I-NP O
114 ranging VBG O O
115 from IN B-VP O
115 a DT O O
115 high JJ O O
115 of IN B-VP O
115 367 CD O O
115 to TO O O
115 a DT B-NP O
115 low NN I-NP O
115 of IN B-VP O
115 52 CD O O
115 where WRB O O
115 she PRP O O
115 began VBD B-VP O
115 to TO O O
115 be VB O O
116 symptomatic JJ O O
116 , , O O
116 somewhat RB O O
116 somnolent JJ O O
116 , , O O
116 and CC O O
116 groggy VB O O
117 This DT B-NP O
117 patient's NN I-NP O
117 blood NN I-NP O
117 glucose VB O O
117 control NN B-NP O
117 was VBD B-VP O
117 evaluated VBN O O
117 by IN B-VP O
117 the DT B-NP O
118 diabetes NNS I-NP O
118 management NN I-NP O
118 service NN I-NP O
118 and CC O O
118 it PRP O O
118 was VBD B-VP O
118 summarized VBN O O
118 by IN B-VP O
118 them PRP O O
118 that IN B-VP O
119 the DT B-NP O
119 patient's JJ I-NP O
119 renal JJ I-NP O
119 insufficiency NN I-NP O
119 had VBD B-VP O
119 a DT B-NP O
119 significant JJ I-NP O
119 role NN I-NP O
119 in IN B-VP O
119 the DT B-NP O
120 patient's NN I-NP O
120 hypoglycemic JJ B-NP O
120 episodes NNS I-NP O
120 and CC O O
120 that IN B-VP O
120 he PRP O O
120 ended VBD B-VP O
120 up RP O O
120 having VBG O O
121 insulin NN B-NP O
121 toxicity NN I-NP O
121 due JJ O O
121 to TO O O
121 poor JJ B-NP O
121 creatinine JJ I-NP O
121 clearance NN I-NP O
121 and CC O O
121 renal JJ B-NP O
122 functioning NN I-NP O
122 level NN I-NP O
122 It PRP O O
122 should MD O O
122 be VB O O
122 noted VBN O O
122 that IN B-VP O
122 in IN B-VP O
122 light NN B-NP O
122 of IN B-VP O
122 this DT B-NP O
123 patient's JJ I-NP O
123 postoperative JJ I-NP O
123 complications NNS I-NP O
123 of IN B-VP O
123 acute JJ B-NP O
123 renal JJ I-NP O
123 failure NN I-NP O
123 in IN B-VP O
124 the DT B-NP O
124 phase NN I-NP O
124 of IN B-VP O
124 chronic JJ B-NP O
124 renal JJ I-NP O
124 failure NN I-NP O
124 and CC O O
124 chronic JJ B-NP O
124 renal JJ I-NP O
125 insufficiency NN I-NP O
125 , , O O
125 the DT B-NP O
125 patient NN I-NP O
125 never RB O O
125 required VBD B-VP O
125 a DT B-NP O
125 hemodialysis NN I-NP O
125 because IN B-VP O
126 the DT B-NP O
126 potassium NN I-NP O
126 levels NNS I-NP O
126 remained VBD B-VP O
126 stable JJ O O
126 The DT O O
126 high JJ O O
126 that IN B-VP O
126 the DT B-NP O
126 patient NN I-NP O
127 reached VBD B-VP O
127 was VBD B-VP O
127 5.6 CD O O
127 of IN B-VP O
127 potassium NN B-NP B-r
127 on IN B-VP O
127 the DT B-NP O
127 same JJ I-NP O
127 day NN I-NP O
127 that IN B-VP O
127 he PRP O O
127 had VBD B-VP O
127 a DT B-NP O
128 creatine NN I-NP O
128 of IN B-VP O
128 8.3 CD O O
128 , , O O
128 which WDT O O
128 was VBD B-VP O
128 on IN B-VP O
128 postoperative JJ B-NP O
128 day NN I-NP O
128 #2 NNP I-NP O
128 , , O O
128 This DT O O
128 was VBD B-VP O
129 treated VBN O O
129 with IN B-VP O
129 kayexalate NN B-NP B-m
129 and CC O O
129 along IN B-VP O
129 the DT B-NP O
129 same JJ I-NP O
129 lines NNS I-NP O
129 , , O O
129 the DT B-NP O
129 patient's NN I-NP O
130 medications NNS I-NP O
130 were VBD B-VP O
130 evaluated VBN O O
130 and CC O O
130 it PRP O O
130 was VBD B-VP O
130 decided VBN O O
130 to TO O O
130 decrease VB O O
130 it PRP O O
130 to TO O O
131 b.i.d VB O B-f
131 dosing NN B-NP O
131 and CC O O
131 to TO O O
131 start VB O O
131 holding VBG O O
131 lisinopril NN B-NP B-m
131 , , O O
131 Neurontin NNP B-NP B-m
131 , , O O
131 and CC O O
132 vancomycin NN B-NP B-m
132 for IN B-VP O
132 their PRP$ O O
132 possible JJ B-NP O
132 renal JJ I-NP O
132 toxic NN I-NP O
132 effects NNS I-NP O
132 A DT B-NP O
132 renal JJ I-NP O
133 ultrasound NN I-NP O
133 was VBD B-VP O
133 obtained VBN O O
133 on IN B-VP O
133 postoperative JJ B-NP O
133 day NN I-NP O
133 #1 NNP I-NP O
133 as RB O O
133 well RB O O
133 as IN B-VP O
134 Doppler NNP B-NP O
134 flow NN I-NP O
134 studies NNS I-NP O
134 The DT B-NP O
134 renal JJ I-NP O
134 ultrasound NN I-NP O
134 revealed VBD B-VP O
134 normal JJ B-NP O
135 parenchyma NN I-NP O
135 with IN B-VP O
135 somewhat WP O O
135 decreased VBD B-VP O
135 renal JJ B-NP O
135 indices NNS I-NP O
135 indicating VBG O O
135 some DT B-NP O
136 decreased JJ I-NP O
136 amount NN I-NP O
136 of IN B-VP O
136 blood NN B-NP O
136 flow NN I-NP O
136 to TO O O
136 their PRP$ O O
136 kidneys NNS B-NP O
136 At IN B-VP O
136 the DT B-NP O
136 same JJ I-NP O
137 time NN I-NP O
137 , , O O
137 an DT B-NP O
137 MRA NNP I-NP O
137 of IN B-VP O
137 the DT B-NP O
137 renal JJ I-NP O
137 arteries NNS I-NP O
137 was VBD B-VP O
137 obtained VBN O O
137 which WDT O O
137 revealed VBD B-VP O
137 no DT B-NP O
138 stenosis NN I-NP O
138 lesions NNS I-NP O
138 of IN B-VP O
138 the DT B-NP O
138 kidneys NNS I-NP O
139 The DT B-NP O
139 patient NN I-NP O
139 was VBD B-VP O
139 eventually RB O O
139 started VBN O O
139 on IN B-VP O
139 PhosLo NNP B-NP B-m
139 and CC O O
139 Ferrlecit NNP B-NP B-m
139 as RB O O
140 well RB O O
140 as IN B-VP O
140 Epogen NNP B-NP B-m
140 10 CD O I-m
140 10 CD O B-do
140 , , O I-do
140 000 CD O I-do
140 units NNS B-NP I-do
140 q JJ B-NP B-f
140 week NN I-NP I-f
140 at IN B-VP O
140 the DT B-NP O
140 recommendation NN I-NP O
140 of IN B-VP O
140 the DT B-NP O
141 renal JJ I-NP O
141 service NN I-NP O
141 This DT O O
141 was VBD B-VP O
141 continued VBN O O
141 during IN B-VP O
141 the DT B-NP O
141 duration NN I-NP B-du
141 of IN B-VP O
141 the DT B-NP O
142 patient's NN I-NP O
142 stay NN I-NP O
142 and CC O O
142 should MD O O
142 continue VB O O
142 in IN B-VP O
142 the DT B-NP O
142 postoperative JJ I-NP O
143 hospitalization NN I-NP O
143 In IN B-VP O
143 light NN B-NP O
143 of IN B-VP O
143 this DT B-NP O
143 postoperative JJ I-NP B-r
143 complications NNS I-NP I-r
143 , , O O
144 the DT B-NP O
144 creatinine NN I-NP O
144 became VBD B-VP O
144 stable JJ O O
144 by IN B-VP O
144 postoperative JJ B-NP O
144 day NN I-NP O
144 3 CD O O
144 and CC O O
144 blood NN B-NP B-m
145 pressure NN I-NP O
145 medications NNS I-NP O
145 were VBD B-VP O
145 restarted VBN O O
145 at IN B-VP O
145 previous JJ B-NP O
145 doses NNS I-NP O
145 and CC O O
145 were VBD B-VP O
146 titrated VBN O O
146 to TO O O
146 the DT B-NP O
146 need NN I-NP O
146 that IN B-VP O
146 the DT B-NP O
146 patient NN I-NP O
146 demonstrated VBN O O
146 by IN B-VP O
146 his PRP$ O O
146 blood NN B-NP B-r
147 pressure NN I-NP O
147 control NN I-NP O
147 This DT O O
147 was VBD B-VP O
147 eventually RB O O
147 attained VBN O O
147 on IN B-VP O
147 atenolol NN B-NP B-m
147 at IN B-VP O
148 150 CD O B-do
148 mg NN B-NP I-do
148 q.d NN I-NP B-f
148 However RB O O
148 , , O O
148 renal JJ B-NP O
148 service NN I-NP O
148 recommended VBD B-VP O
148 that IN B-VP O
148 the DT B-NP O
148 patient NN I-NP O
149 be VB O O
149 given VBN O O
149 Lopressor NNP B-NP B-m
149 100 CD O B-do
149 mg NN B-NP I-do
149 b.i.d NN I-NP B-f
149 This DT O O
149 seems VBZ O O
149 to TO O O
149 have VB O O
149 controlled VBN O O
150 the DT B-NP B-r
150 patient's NN I-NP I-r
150 blood NN I-NP I-r
150 pressure NN I-NP I-r
150 for IN B-VP O
150 the DT B-NP O
150 time NN I-NP O
150 being VBG O O
150 Physical JJ B-NP O
151 therapy NN I-NP O
151 was VBD B-VP O
151 also RB O O
151 involved VBN O O
151 in IN B-VP O
151 evaluating VBG O O
151 the DT B-NP O
151 patient NN I-NP O
151 and CC O O
151 assisted VBN O O
152 in IN B-VP O
152 the DT B-NP O
152 management NN I-NP O
152 of IN B-VP O
152 this DT B-NP O
152 patient's NN I-NP O
152 care NN I-NP O
153 It PRP O O
153 should MD O O
153 also RB O O
153 be VB O O
153 noted VBN O O
153 that IN B-VP O
153 a DT B-NP O
153 wax JJ I-NP O
153 sponge NN I-NP O
153 was VBD B-VP O
153 placed VBN O O
153 on IN B-VP O
153 the DT B-NP O
154 patient's NN I-NP O
154 right RB O O
154 open JJ O O
154 wound IN B-VP O
154 This DT O O
154 was VBD B-VP O
154 placed VBN O O
154 on IN B-VP O
154 postoperative JJ B-NP O
154 day NN I-NP O
155 #3 NNP I-NP O
155 , , O O
155 5/19/04 CD O O
155 The DT B-NP O
155 patient NN I-NP O
155 seems VBZ O O
155 to TO O O
155 be VB O O
155 tolerating VBG O O
155 this DT B-NP O
155 well NN I-NP O
155 The DT B-NP O
156 diabetes NNS I-NP O
156 management NN I-NP O
156 service NN I-NP O
156 , , O O
156 the DT B-NP O
156 physical JJ I-NP O
156 therapy NN I-NP O
156 , , O O
156 and CC O O
156 the DT B-NP O
156 renal JJ I-NP O
157 teams NNS I-NP O
157 continued VBD B-VP O
157 to TO O O
157 follow VB O O
157 the DT B-NP O
157 patient NN I-NP O
157 closely RB O O
157 during IN B-VP O
157 the DT B-NP O
157 duration NN I-NP O
158 of IN B-VP O
158 his PRP$ O O
158 stay NN B-NP O
158 until IN B-VP O
158 it PRP O O
158 was VBD B-VP O
158 felt VBN O O
158 that IN B-VP O
158 the DT B-NP O
158 patient's NN I-NP O
158 postoperative JJ B-NP O
159 complications NNS I-NP O
159 and CC O O
159 issues NNS B-NP O
159 including VBG O O
159 blood NN B-NP O
159 glucose NN I-NP O
159 control NN I-NP O
159 as RB O O
159 well RB O O
160 as IN B-VP O
160 renal JJ B-NP O
160 insufficiency NN I-NP O
160 were VBD B-VP O
160 under IN B-VP O
160 control NN B-NP O
160 From IN B-VP O
160 an DT B-NP O
160 operative JJ I-NP O
161 standpoint NN I-NP O
161 , , O O
161 the DT B-NP O
161 patient NN I-NP O
161 tolerated VBD B-VP O
161 the DT B-NP O
161 procedure NN I-NP O
161 well RB O O
161 and CC O O
161 it PRP O O
161 was VBD B-VP O
162 decided VBN O O
162 to TO O O
162 continue VB O O
162 the DT B-NP O
162 patient NN I-NP O
162 on IN B-VP O
162 levofloxacin NN B-NP B-m
162 for IN B-VP B-du
162 a DT O O
162 one CD O O
162 week NN B-NP O
163 course NN I-NP O
163 and CC O O
163 the DT B-NP O
163 patient NN I-NP O
163 is VBZ O O
163 to TO O O
163 be VB O O
163 discharged VBN O O
163 to TO O O
163 the DT B-NP O
163 rehab NN I-NP O
163 facility NN I-NP O
163 , , O O
164 which WDT O O
164 is VBZ O O
164 the DT O O
164 Still RB O O
164 Freedral NNP B-NP O
164 Hospital NNP I-NP O
164 for IN B-VP O
164 their PRP$ O O
164 ability NN B-NP O
164 to TO O O
165 care VB O O
165 for IN B-VP O
165 wax JJ B-NP O
165 sponge NN I-NP O
165 excellently RB O O
166 The DT B-NP O
166 patient NN I-NP O
166 was VBD B-VP O
166 seen VBN O O
166 by IN B-VP O
166 Dr NNP B-NP O
166 Ulvan NNP I-NP O
166 in IN B-VP O
166 the DT B-NP O
166 renal JJ I-NP O
166 staff NN I-NP O
166 and CC O O
166 by IN B-VP O
166 the DT B-NP O
167 diabetes NNS I-NP O
167 management NN I-NP O
167 service NN I-NP O
167 by IN B-VP O
167 Dr NNP B-NP O
167 Clint NNP I-NP O
167 Holets NNP I-NP O
167 , , O O
167 pager JJR O O
167 #050-61 JJ O O
167 The DT B-NP O
168 physical JJ I-NP O
168 examination NN I-NP O
168 at IN B-VP O
168 the DT B-NP O
168 time NN I-NP O
168 of IN B-VP O
168 discharge NN B-NP O
168 was VBD B-VP O
168 unchanged JJ O O
168 from IN B-VP O
169 the DT B-NP O
169 previous JJ I-NP O
169 few JJ I-NP O
169 days NNS I-NP O
169 where WRB O O
169 the DT B-NP O
169 patient NN I-NP O
169 was VBD B-VP O
169 seen VBN O O
169 to TO O O
169 have VB O O
169 adequate JJ B-NP O
170 Doppler NNP I-NP O
170 signal NN I-NP O
170 in IN B-VP O
170 all DT O O
170 his PRP$ O O
170 pedal NN B-NP O
170 pulses NNS I-NP O
170 , , O O
170 DPs NNP B-NP O
170 as RB O O
170 well RB O O
170 as IN B-VP O
170 PTs NNP B-NP O
170 and CC O O
170 a DT O O
171 faintly RB O O
171 palpable JJ B-NP O
171 right JJ I-NP O
171 DP NNP I-NP O
171 and CC O O
171 as RB O O
171 well RB O O
171 as IN B-VP O
171 faintly RB O O
171 palpable JJ O O
171 left VBD B-VP O
172 DP NNP B-NP O
173 DISCHARGE NNP I-NP O
173 MEDICATIONS: NNP I-NP O
174 The DT B-NP O
174 patient NN I-NP O
174 is VBZ O O
174 to TO O O
174 be VB O O
174 discharged VBN O O
174 on IN B-VP O
174 the DT B-NP O
174 following JJ I-NP O
174 medications NNS I-NP O
174 , , O O
175 Tylenol NNP B-NP B-m
175 650 CD O B-do
175 to TO O I-do
175 1000 CD O I-do
175 mg NN B-NP I-do
175 p.o NN I-NP B-mo
175 q.4h NN I-NP B-f
175 p.r.n NN I-NP I-f
175 for IN B-VP O
175 temperature NN B-NP B-r
175 greater JJR O O
176 than IN B-VP O
176 101 CD O O
176 , , O O
176 allopurinol RB O B-m
176 100 CD O B-do
176 mg NNS B-NP I-do
176 p.o JJ B-NP B-mo
176 q.d NN I-NP B-f
176 , , O O
176 enteric-coated JJ B-NP B-m
176 aspirin NN I-NP I-m
176 81 CD O B-do
177 mg NN B-NP O
177 p.o NN I-NP B-mo
177 q.d NN I-NP B-f
177 , , O O
177 Lopressor NNP B-NP B-m
177 100 CD O B-do
177 mg NN B-NP I-do
177 p.o NN I-NP B-mo
177 b.i.d NN I-NP B-f
177 , , O O
177 PhosLo NNP B-NP B-m
177 1334 CD O B-do
177 mg NN B-NP I-do
177 p.o NN I-NP B-mo
178 q.a.c NN I-NP O
178 , , O O
178 please VB O O
178 give VB O O
178 with IN B-VP O
178 meals NNS B-NP O
178 , , O O
178 Colace NNP B-NP B-m
178 100 CD O B-do
178 mg NN B-NP I-do
178 p.o NN I-NP B-mo
178 b.i.d NN I-NP B-f
178 , , O O
178 Epogen NNP B-NP B-m
179 10 CD O B-do
179 , , O I-do
179 000 CD O I-do
179 units NNS B-NP I-do
179 delivered VBN O O
179 subcuticularly RB O B-mo
179 q JJ B-NP B-f
179 week NN I-NP I-f
179 starting VBG O I-f
179 on IN B-VP I-f
179 Monday NNP B-NP I-f
179 , , O O
180 already RB O O
180 given VBN O O
180 one CD O O
180 dose JJ B-NP O
180 intra JJ I-NP O
180 hospital NN I-NP O
180 stay NN I-NP O
180 Please NNP I-NP O
180 give VB O O
180 the DT B-NP O
180 next JJ I-NP O
181 dose NN I-NP O
181 on IN B-VP O
181 0/0/04 CD O O
181 or CC O O
181 07 CD O O
181 , , O O
181 iron NN B-NP B-m
181 325 CD O B-do
181 mg NN B-NP I-do
181 p.o NN I-NP B-mo
181 t.i.d NN I-NP B-f
181 , , O O
181 Percocet NNP B-NP B-m
181 1 CD O B-do
182 to TO O O
182 2 CD O O
182 tablets NNS B-NP O
182 p.o JJ B-NP B-mo
182 q.4h JJ I-NP B-f
182 p.r.n NN I-NP I-f
182 pain NN I-NP B-r
182 , , O O
182 prednisolone NN B-NP B-m
182 1% CD O I-m
182 one CD O B-do
182 drop NN B-NP I-do
182 in IN B-VP B-mo
183 the DT B-NP O
183 effected JJ I-NP O
183 eye NN I-NP O
183 b.i.d NN I-NP B-f
183 , , O O
183 Zocor NNP B-NP B-m
183 20 CD O B-do
183 mg NN B-NP I-do
183 p.o NN I-NP B-mo
183 q.h.s NN I-NP B-f
183 , , O O
183 Neurontin NNP B-NP B-m
183 300 CD O B-do
184 mg NN B-NP O
184 p.o NN I-NP B-mo
184 b.i.d NN I-NP B-f
184 , , O O
184 atropine VBP O B-m
184 1 CD O B-do
184 mg NN B-NP I-do
184 one CD O I-do
184 drop NN B-NP I-do
184 in IN B-VP B-mo
184 the DT B-NP I-mo
184 affected JJ I-NP I-mo
184 eye NN I-NP I-mo
184 , , O O
185 levofloxacin JJ O B-m
185 250 CD O B-do
185 mg NN B-NP I-do
185 p.o NN I-NP B-mo
185 every DT B-NP B-f
185 morning NN I-NP I-f
185 starting VBG O O
185 on IN B-VP O
185 the DT O O
185 0/0/04 CD O O
186 and CC O O
186 continuing VBG O O
186 for IN B-VP B-du
186 one CD O I-du
186 week NN B-NP I-du
186 , , O O
186 Lispro NNP B-NP B-m
186 6 CD O B-do
186 units NNS B-NP I-do
186 subcuticularly RB O B-mo
187 q.a.c RB O B-f
187 , , O O
187 hold VB O O
187 if IN B-VP O
187 the DT B-NP O
187 patient NN I-NP O
187 is VBZ O O
187 not RB O O
187 eating VBG O O
187 much RB O O
187 or CC O O
187 if IN B-VP O
187 the DT B-NP O
187 patient NN I-NP O
188 does VBZ O O
188 not RB O O
188 have VB O O
188 a DT B-NP O
188 meal NN I-NP O
188 sitting VBG O O
188 right RB O O
188 in IN B-VP O
188 front NN B-NP O
188 of IN B-VP O
188 him PRP O O
188 at IN B-VP O
188 the DT B-NP O
188 time NN I-NP O
188 of IN B-VP O
189 dosage NN B-NP O
189 and CC O O
189 also RB O O
189 Lispro NNP B-NP B-m
189 Lispro NNP I-NP B-m
189 Lispro NNP I-NP B-m
189 sliding VBG O B-do
189 scale NN B-NP I-do
189 as IN B-VP O
189 per IN B-VP O
189 the DT B-NP O
189 discharge NN I-NP O
189 paper NN I-NP O
190 work NN I-NP O
190 in IN B-VP O
190 which WDT O O
190 the DT B-NP O
190 patient NN I-NP O
190 receives VBZ O O
190 two CD O B-do
190 units NNS B-NP I-do
190 if IN B-VP O
190 the DT B-NP O
190 blood NN I-NP O
190 glucose NN I-NP O
191 is VBZ O O
191 between IN B-VP O
191 125 CD O O
191 to TO O O
191 150 CD O O
191 and CC O O
191 onwards NNS B-NP O
191 from IN B-VP O
191 there RB O O
191 3 CD O B-do
191 units NNS B-NP I-do
191 for IN B-VP O
191 150 CD O O
191 to TO O O
192 200 CD O O
192 , , O O
192 and CC O O
192 so RB O O
192 forth JJ B-NP O
192 Please NNP I-NP O
192 also RB O O
192 give VBP O O
192 the DT B-NP O
192 patient NN I-NP O
192 half PDT O O
192 his PRP$ O O
192 sliding VBG O O
193 scale NN B-NP O
193 dose NN I-NP O
193 at IN B-VP O
193 the DT B-NP O
193 bedtime NN I-NP O
193 if IN B-VP O
193 his PRP$ O O
193 blood NN B-NP O
193 glucose NN I-NP O
193 is VBZ O O
193 greater JJR O O
193 than IN B-VP O
194 200 CD O O
194 and CC O O
194 recheck VB O O
194 his PRP$ O O
194 blood NN B-NP O
194 glucose RB O O
194 1 CD O O
194 to TO O O
194 2 CD O O
194 hours NNS B-NP O
194 later RB O O
194 , , O O
194 TriCor NNP B-NP B-m
194 54 CD O B-do
195 mg NN B-NP O
195 p.o NN I-NP B-mo
195 q.d NN I-NP B-f
195 , , O O
195 Lantus NNP B-NP B-m
195 25 CD O B-do
195 units NNS B-NP I-do
195 subcutaneous JJ B-NP B-mo
195 q.d NN I-NP B-f
195 , , O O
195 and CC O O
195 DuoNeb NNP B-NP B-m
195 3/0.5 CD O B-do
196 mg NN B-NP O
196 nebulizer NN I-NP B-mo
196 q.6h NN I-NP B-f
196 p.r.n NN I-NP I-f
196 wheezing VBG O B-r
197 The DT B-NP O
197 patient NN I-NP O
197 is VBZ O O
197 to TO O O
197 be VB O O
197 followed VBN O O
197 up RP O O
197 at IN B-VP O
197 the DT B-NP O
197 rehab NN I-NP O
197 facility NN I-NP O
197 at IN B-VP O
197 Ing NNP B-NP O
197 Mansy NNP I-NP O
197 General NNP I-NP O
197 Hospital NNP I-NP O
197 Please NNP I-NP O
197 also RB O O
197 note VBP O O
197 , , O O
197 the DT B-NP O
197 patient NN I-NP O
197 should MD O O
197 follow VB O O
197 up RP O O
197 with IN B-VP O
197 the DT B-NP O
198 renal JJ I-NP O
198 service NN I-NP O
198 as IN B-VP O
198 per IN B-VP O
198 the DT B-NP O
198 discharge NN I-NP O
198 report NN I-NP O
198 in IN B-VP O
198 two CD O O
198 to TO O O
198 three CD O O
198 weeks NNS B-NP O
199 as RB O O
199 well RB O O
199 as IN B-VP O
199 Dr NNP B-NP O
199 Knaub NNP I-NP O
199 as IN B-VP O
199 per IN B-VP O
199 the DT B-NP O
199 paper NN I-NP O
199 work NN I-NP O
199 in IN B-VP O
199 one CD O O
199 to TO O O
199 two CD O O
200 weeks NNS B-NP O
200 The DT B-NP O
200 wax JJ I-NP O
200 sponge NN I-NP O
200 should MD O O
200 be VB O O
200 change NN B-NP O
200 every DT O O
200 three CD O O
200 days NNS B-NP O
200 and CC O O
201 please NN B-NP O
201 follow VB O O
201 up RP O O
201 with IN B-VP O
201 Dr NNP B-NP O
201 Zaxas NNP I-NP O
201 regarding VBG O O
201 the DT B-NP O
201 longevity NN I-NP O
201 of IN B-VP O
202 the DT B-NP O
202 wax NN I-NP O
202 sponge NN I-NP O
203 He PRP O O
203 should MD O O
203 follow VB O O
203 up RP O O
203 with IN B-VP O
203 Dr NNP B-NP O
203 Amos NNP I-NP O
203 as RB O O
203 well RB O O
203 as IN B-VP O
203 the DT B-NP O
203 attending NN I-NP O
204 in IN B-VP O
204 the DT B-NP O
204 renal JJ I-NP O
204 service NN I-NP O
204 Dr NNP I-NP O
204 Riech NNP I-NP O
204 The DT B-NP O
204 clinic JJ I-NP O
204 number NN I-NP O
204 for IN B-VP O
204 the DT B-NP O
204 renal JJ I-NP O
205 service NN I-NP O
205 is VBZ O O
205 9057822 CD O O
206 eScription NN B-NP O
206 document: NN I-NP O
206 9-6956226 CD O O
206 EMSSten NNP B-NP O
206 Tel NNP I-NP O
207 Dictated NNP I-NP O
207 By: NNP I-NP O
207 WUERZ NNP I-NP O
207 , , O O
207 SANDY NNP B-NP O
208 Attending: NNP I-NP O
208 COWAN NNP I-NP O
208 , , O O
208 WILBUR NNP B-NP O
208 MIQUEL NNP I-NP O
209 Dictation NNP I-NP O
209 ID NNP I-NP O
209 6436301 CD O O
210 D: NNP B-NP O
210 2/12/04 CD O O
211 T: NNP B-NP O
211 2/12/04 CD O O
212 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #408381 VBZ O O
2 288978562 CD O O
2 HSH NNP B-NP O
2 40164507 CD O O
2 9863389 CD O O
2 8/17/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 s/p JJ B-NP O
2 panniculectomy NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/22/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/17/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 VANDERLOO NNP I-NP O
5 , , O O
5 BROOKS NNP B-NP O
5 940-78-98-8 CD O O
6 Aro NNP B-NP O
6 Ryen NNP I-NP O
6 Wotarg NNP I-NP O
6 St NNP I-NP O
7 Service: NNP I-NP O
7 PLA NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 7/1/06 CD O O
8 AT NNP B-NP O
8 12:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 SNF/rehab NNP I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 JAKIELA NNP I-NP O
11 , , O O
11 JEFFERSON NNP B-NP O
11 LLOYD NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Rehabilitation NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 TYLENOL NNP I-NP B-m
16 ( ( O I-m
16 ACETAMINOPHEN NNP B-NP I-m
16 ) ) O I-m
16 1 CD O B-do
16 , , O I-do
16 000 CD O I-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 Q6H NNP I-NP B-f
17 KEFLEX NNP I-NP B-m
17 ( ( O I-m
17 CEPHALEXIN NNP B-NP I-m
17 ) ) O I-m
17 500 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QID NNP I-NP B-f
18 COLACE NNP I-NP B-m
18 ( ( O I-m
18 DOCUSATE NNP B-NP I-m
18 SODIUM NNP I-NP I-m
18 ) ) O I-m
18 100 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 BID NNP I-NP B-f
19 PEPCID NNP I-NP B-m
19 ( ( O I-m
19 FAMOTIDINE NNP B-NP I-m
19 ) ) O I-m
19 20 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 DILAUDID NNP I-NP B-m
20 ( ( O I-m
20 HYDROMORPHONE NNP B-NP I-m
20 HCL NNP I-NP I-m
20 ) ) O I-m
20 2-4 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 Q4H NNP I-NP B-f
20 PRN NNP I-NP I-f
20 Pain NNP I-NP B-r
21 Alert NNP I-NP O
21 overridden: NNP I-NP O
21 Override NNP I-NP O
21 added VBD B-VP O
21 on IN B-VP O
21 0/10/06 CD O O
21 by IN B-VP O
22 SHOGREN NNP B-NP O
22 , , O O
22 DON NNP B-NP O
22 , , O O
22 M.D NNP B-NP O
23 on IN B-VP O
23 order NN B-NP O
23 for IN B-VP O
23 DILAUDID NNP B-NP B-m
23 PO NNP I-NP B-mo
23 ( ( O O
23 ref JJ O O
23 # # O O
23 693815861 CD O O
23 ) ) O O
24 Pt NNP B-NP O
24 has VBZ O O
24 a DT B-NP O
24 PROBABLE NNP I-NP O
24 allergy NN I-NP O
24 to TO O O
24 Morphine; NNP B-NP O
24 reaction NN I-NP O
24 is VBZ O O
24 GI NNP B-NP O
25 Intolerance NNP I-NP O
25 Reason NNP I-NP O
25 for IN B-VP O
25 override: NN B-NP O
25 will MD O O
25 watch VB O O
26 INSULIN NNP B-NP B-m
26 REGULAR NNP I-NP I-m
26 HUMAN NNP I-NP I-m
27 Sliding NNP I-NP O
27 Scale NNP I-NP O
27 ( ( O B-mo
27 subcutaneously RB O I-mo
27 ) ) O I-mo
27 SC NNP B-NP I-mo
27 Q4H NNP I-NP B-f
27 Low NNP I-NP O
27 Scale NNP I-NP O
28 Call NNP I-NP O
28 HO NNP I-NP O
28 if IN B-VP O
28 BS NNP B-NP O
28 less JJR O O
28 than IN B-VP O
28 60 CD O O
29 If IN B-VP O
29 BS NNP B-NP O
29 is VBZ O O
29 less JJR O O
29 than IN B-VP O
29 125 CD O O
29 , , O O
29 then RB O O
29 DO NNP B-NP O
29 NOT NNP I-NP O
29 Administer NNP I-NP O
30 supplemental NN I-NP O
30 ( ( O O
30 sliding VBG O O
30 scale NN B-NP O
30 ) ) O O
30 insulin NN B-NP B-m
30 insulin NN I-NP B-m
30 insulin NN I-NP B-m
30 insulin NN I-NP B-m
30 insulin NN I-NP B-m
31 If IN B-VP O
31 BS NNP B-NP O
31 is VBZ O O
31 125-150 JJ O O
31 , , O O
31 then RB O O
31 give VB O O
31 0 CD O O
31 units NNS B-NP O
31 subcutaneously RB O O
32 If IN B-VP O
32 BS NNP B-NP O
32 is VBZ O O
32 151-200 CD O O
32 , , O O
32 then RB O O
32 give VB O O
32 1 CD O B-do
32 units NNS B-NP I-do
32 subcutaneously RB O B-mo
33 If IN B-VP O
33 BS NNP B-NP O
33 is VBZ O O
33 201-250 JJ O O
33 , , O O
33 then RB O O
33 give VB O O
33 2 CD O B-do
33 units NNS B-NP I-do
33 subcutaneously RB O B-mo
34 If IN B-VP O
34 BS NNP B-NP O
34 is VBZ O O
34 251-300 JJ O O
34 , , O O
34 then RB O O
34 give VB O O
34 3 CD O B-do
34 units NNS B-NP I-do
34 subcutaneously RB O B-mo
35 If IN B-VP O
35 BS NNP B-NP O
35 is VBZ O O
35 301-350 JJ O O
35 , , O O
35 then RB O O
35 give VB O O
35 4 CD O B-do
35 units NNS B-NP I-do
35 subcutaneously RB O B-mo
36 If IN B-VP O
36 BS NNP B-NP O
36 is VBZ O O
36 351-400 CD O O
36 , , O O
36 then RB O O
36 give VB O O
36 5 CD O B-do
36 units NNS B-NP I-do
36 subcutaneously RB O B-mo
37 Call NNP B-NP O
37 HO NNP I-NP O
37 if IN B-VP O
37 BS NNP B-NP O
37 is VBZ O O
37 greater JJR O O
37 than IN B-VP O
37 350 CD O O
38 Please NNP B-NP O
38 give VB O O
38 at IN B-VP O
38 the DT B-NP O
38 same JJ I-NP O
38 time NN I-NP O
38 and CC O O
38 in IN B-VP O
38 addition NN B-NP O
38 to TO O O
38 standing VBG O O
39 mealtime JJ B-NP O
39 insulin NN I-NP B-m
40 LEVOTHYROXINE NNP I-NP B-m
40 SODIUM NNP I-NP I-m
40 75 CD O B-do
40 MCG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 DAILY NNP I-NP B-f
41 MAALOX-TABLETS NNP I-NP B-m
41 QUICK NNP I-NP I-m
41 DISSOLVE/CHEWABLE NNP I-NP I-m
41 1-2 JJ B-NP B-do
41 TAB NNP I-NP I-do
41 PO NNP I-NP B-mo
41 Q6H NNP I-NP B-f
42 PRN NNP I-NP O
42 Upset NNP I-NP B-r
42 Stomach NNP I-NP I-r
43 MILK NNP I-NP B-m
43 OF NNP I-NP I-m
43 MAGNESIA NNP I-NP I-m
43 ( ( O I-m
43 MAGNESIUM NNP B-NP I-m
43 HYDROXIDE NNP I-NP I-m
43 ) ) O I-m
44 30 CD O B-do
44 MILLILITERS NNP B-NP I-do
44 PO NNP I-NP B-mo
44 DAILY NNP I-NP B-f
44 PRN NNP I-NP I-f
44 Constipation NNP I-NP B-r
45 METOCLOPRAMIDE NNP I-NP B-m
45 HCL NNP I-NP I-m
45 10 CD O B-do
45 MG NNP B-NP I-do
45 IV NNP I-NP B-mo
45 Q8H NNP I-NP B-f
45 PRN NNP I-NP I-f
45 Nausea NNP I-NP B-r
46 QUINAPRIL NNP I-NP B-m
46 20 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 DAILY NNP I-NP B-f
47 Number NNP I-NP B-du
47 of IN B-VP I-du
47 Doses NNP B-NP I-du
47 Required NNP I-NP I-du
47 ( ( O I-du
47 approximate JJ B-NP I-du
47 ): NN I-NP I-du
47 5 CD O I-du
48 SIMETHICONE NNP B-NP B-m
48 SIMETHICONE NNP I-NP B-m
48 40 CD O B-do
48 40 CD O B-do
48 MG NNP B-NP I-do
48 MG NNP I-NP I-do
48 PO NNP I-NP B-mo
48 PO NNP I-NP B-mo
48 QID NNP I-NP B-f
48 QID NNP I-NP B-f
48 PRN NNP I-NP I-f
48 PRN NNP I-NP I-f
48 Upset NNP I-NP B-r
48 Stomach NNP I-NP I-r
48 , , O O
48 Other:gas NNP B-NP B-r
49 STYKER NNP I-NP B-m
49 PAIN NNP I-NP I-m
49 PUMP NNP I-NP I-m
49 ( ( O I-m
49 BUPIVACAINE NNP B-NP I-m
49 0.5% CD O I-m
49 ) ) O I-m
50 400 CD O O
50 MILLILITERS NNP B-NP O
50 IV NNP I-NP B-mo
50 Q24H NNP I-NP B-f
50 Instructions: NNP I-NP O
50 Rate NNP I-NP O
50 = VBD B-VP O
50 4ml/hr CD O O
51 Bolus NNP B-NP O
51 dose JJ B-NP O
51 = NNP I-NP O
51 4ml CD O O
51 Lockout NNP B-NP O
51 interval NN I-NP O
51 = VBD B-VP O
51 60 CD O O
51 minutes NNS B-NP O
52 DIET: NNP I-NP O
52 No NNP I-NP O
52 Restrictions NNP I-NP O
53 ACTIVITY: NNP I-NP O
53 Walking NNP I-NP O
53 as IN B-VP O
53 tolerated JJ B-NP O
54 Lift NNP I-NP O
54 restrictions: NN I-NP O
54 Do NNP I-NP O
54 not RB O O
54 lift VB O O
54 greater JJR O O
54 then RB O O
54 10 CD O O
54 pounds NNS B-NP O
55 FOLLOW NNP I-NP O
55 UP NNP I-NP O
55 APPOINTMENT( NNP I-NP O
55 S NNP I-NP O
55 ): NNP I-NP O
56 Dr NNP I-NP O
56 Donovan NNP I-NP O
56 Dike NNP I-NP O
56 446-414-3709 JJ B-NP O
56 5-7 JJ I-NP O
56 days NNS I-NP O
56 , , O O
57 ALLERGY: NNP B-NP O
57 Morphine NNP I-NP O
58 ADMIT NNP I-NP O
58 DIAGNOSIS: NNP I-NP O
59 abdominal JJ B-NP O
59 laxity NN I-NP O
60 PRINCIPAL NNP I-NP O
60 DISCHARGE NNP I-NP O
60 DIAGNOSIS NNP I-NP O
60 ;Responsible JJ O O
60 After IN B-VP O
60 Study NNP B-NP O
60 for IN B-VP O
60 Causing NNP B-NP O
60 Admission NNP I-NP O
60 ) ) O O
61 s/p VBP O O
61 panniculectomy IN B-VP O
62 OTHER NNP B-NP O
62 DIAGNOSIS;Conditions NNP I-NP O
62 , , O O
62 Infections NNP B-NP O
62 , , O O
62 Complications NNP B-NP O
62 , , O O
62 affecting VBG O O
62 Treatment/Stay NNP B-NP O
63 none NN I-NP O
64 OPERATIONS NNP I-NP O
64 AND NNP I-NP O
64 PROCEDURES: NNP I-NP O
65 0/10/06 CD O O
65 EADE NNP B-NP O
65 , , O O
65 CONNIE NNP B-NP O
65 EUGENE NNP I-NP O
65 , , O O
65 M.D NNP B-NP O
66 PANNICULECTOMY NNP I-NP O
67 OTHER NNP I-NP O
67 TREATMENTS/PROCEDURES NNP I-NP O
67 ( ( O O
67 NOT NNP B-NP O
67 IN NNP I-NP O
67 O.R NNP I-NP O
67 ) ) O O
68 Drain NNP B-NP O
68 care NN I-NP O
68 - : O O
68 monitor/record NN B-NP O
68 drain NN I-NP O
68 output NN I-NP O
68 , , O O
68 when WRB O O
68 less JJR O O
68 than IN B-VP O
68 30 CD O O
68 cc NN B-NP O
68 in IN B-VP O
68 24 CD O O
69 hours NNS B-NP O
69 pt NN I-NP O
69 may MD O O
69 call VB O O
69 for IN B-VP O
69 appointment NN B-NP O
69 for IN B-VP O
69 removal JJ B-NP O
69 Change NNP I-NP O
69 drain NN I-NP O
69 sponges NNS I-NP O
70 daily RB O O
70 Strip NNP B-NP O
70 drains VBZ O O
70 twice JJ O O
70 daily RB O O
71 Wound NNP B-NP O
71 check NN I-NP O
71 QD NNP I-NP O
71 - : O O
71 DSD NN B-NP O
71 to TO O O
71 incision VB O O
71 if IN B-VP O
71 spotting JJ B-NP O
72 BRIEF NNP I-NP O
72 RESUME NNP I-NP O
72 OF NNP I-NP O
72 HOSPITAL NNP I-NP O
72 COURSE: NNP I-NP O
73 56 CD O O
73 y.o NN B-NP O
73 morbidly RB O O
73 obese JJ B-NP O
73 female NN I-NP O
73 with IN B-VP O
73 abdominal JJ B-NP O
73 skin NN I-NP O
73 laxity NN I-NP O
73 2/2 CD O O
73 massive JJ B-NP O
74 weight NN I-NP O
74 loss NN I-NP O
74 after IN B-VP O
74 gastric JJ B-NP O
74 bypass NN I-NP O
74 , , O O
74 admitted VBN O O
74 to TO O O
74 plastics NNS B-NP O
74 on IN B-VP O
74 3/5/05 CD O O
74 for IN B-VP O
75 panniculectomy NN B-NP O
75 pt NN I-NP O
75 tolerated VBD B-VP O
75 all DT B-NP O
75 procedures NNS I-NP O
75 without IN B-VP O
75 difficulty NN B-NP O
75 post-op JJ B-NP O
76 period NN I-NP O
76 has VBZ O O
76 been VBN O O
76 uneventful JJ O O
76 at IN B-VP O
76 discharge NN B-NP O
76 pt NN I-NP O
76 is VBZ O O
76 afebrile JJ O O
76 with IN B-VP O
76 stable JJ B-NP O
77 vitals NNS I-NP O
77 , , O O
77 taking VBG O O
77 po's/voiding VBG O O
77 q NN B-NP O
77 shift NN I-NP O
77 has VBZ O O
77 ambulated VBN O O
77 independently RB O O
77 but CC O O
78 with IN B-VP O
78 some DT B-NP O
78 difficulty NN I-NP O
78 given VBN O O
78 body NN B-NP O
78 habitus NN I-NP O
78 pain NN I-NP O
78 generally RB O O
79 has VBZ O O
79 been VBN O O
79 well RB O O
79 managed VBN O O
79 Incisions NNS B-NP O
79 are VBP O O
79 clean JJ O O
79 , , O O
79 dry JJ O O
79 and CC O O
79 intact JJ B-NP O
79 Jp's NNP I-NP O
79 with IN B-VP O
80 moderate JJ B-NP O
80 serosanguinous JJ I-NP O
80 output NN I-NP O
80 remain VBP O O
80 in IN B-VP O
80 place NN B-NP O
80 Pt NNP I-NP O
80 is VBZ O O
80 discharged VBN O O
80 to TO O O
80 rehab VB O O
81 in IN B-VP O
81 stable JJ B-NP O
81 condition NN I-NP O
81 instructions NNS I-NP O
81 given VBN O O
81 Services NNS B-NP O
81 arranged VBD B-VP O
82 ADDITIONAL NNP B-NP O
82 COMMENTS: NNP I-NP O
83 DISCHARGE NNP I-NP O
83 CONDITION: NNP I-NP O
83 Stable NNP I-NP O
84 TO NNP I-NP O
84 DO/PLAN: NNP I-NP O
85 Continue NNP I-NP O
85 your PRP$ O O
85 antibiotics NNS B-NP B-m
85 as RB O B-du
85 long RB O I-du
85 as IN B-VP I-du
85 you PRP O I-du
85 have VBP O I-du
85 drain/s VBN O I-du
85 in IN B-VP I-du
85 place NN B-NP I-du
86 Drain NNP I-NP O
86 care NN I-NP O
86 - : O O
86 monitor/record NN B-NP O
86 drain NN I-NP O
86 output NN I-NP O
86 , , O O
86 when WRB O O
86 less JJR O O
86 than IN B-VP O
86 30 CD O O
86 cc NN B-NP O
86 in IN B-VP O
86 24 CD O O
87 hours NNS B-NP O
87 , , O O
87 call NN B-NP O
87 for IN B-VP O
87 appointment NN B-NP O
87 for IN B-VP O
87 removal JJ B-NP O
87 Change NNP I-NP O
87 drain NN I-NP O
87 sponges NNS I-NP O
87 daily RB O O
88 Strip NNP B-NP O
88 drains VBZ O O
88 twice JJ B-NP O
88 daily JJ I-NP O
89 Activity NNP I-NP O
89 - : O O
89 sponge NN B-NP O
89 baths NNS I-NP O
89 only RB O O
89 while IN B-VP O
89 drains NNS B-NP O
89 are VBP O O
89 in IN B-VP O
89 place NN B-NP O
89 Walking NNP I-NP O
89 as IN B-VP O
90 tolerated VBN O O
90 No NNP B-NP O
90 lifting VBG O O
90 more JJR O O
90 than IN B-VP O
90 10 CD O O
90 pounds NNS B-NP O
90 No DT B-NP O
90 jogging NN I-NP O
90 , , O O
90 swimming NN B-NP O
90 , , O O
90 or CC O O
91 aerobics NNS B-NP O
91 x JJ B-NP O
91 4-6 JJ I-NP O
91 weeks NNS I-NP O
91 Monitor/return NNP I-NP O
91 for IN B-VP O
91 signs NNS B-NP O
91 of IN B-VP O
91 infection NN B-NP O
91 which WDT O O
91 may MD O O
92 include: VB O O
92 increased VBD B-VP O
92 pain NN B-NP O
92 , , O O
92 swelling VBG O O
92 , , O O
92 redness NN B-NP O
92 , , O O
92 fever NN B-NP O
92 , , O O
92 drainage NN B-NP O
92 , , O O
92 problems NNS B-NP O
93 with IN B-VP O
93 incisions NNS B-NP O
93 , , O O
93 or CC O O
93 other JJ B-NP O
93 concerns NNS I-NP O
93 If IN B-VP O
93 you PRP O O
93 have VBP O O
93 any DT B-NP O
93 questions NNS I-NP O
93 , , O O
93 please VB O O
94 call VB O O
94 Dr NNP B-NP O
94 Nicky NNP I-NP O
94 Yamauchi NNP I-NP O
94 446-414-3709 CD O O
94 or CC O O
94 Benny NNP B-NP O
94 Demicco NNP I-NP O
94 NP NNP I-NP O
94 at IN B-VP O
94 525 CD O O
94 503-3214 JJ B-NP O
95 pager NN I-NP O
95 92813 CD O O
95 or CC O O
95 pager JJR O O
95 58806 CD O O
96 No NNP B-NP O
96 dictated VBD B-VP O
96 summary JJ B-NP O
97 ENTERED NNP I-NP O
97 BY: NNP I-NP O
97 BORKOSKI NNP I-NP O
97 , , O O
97 ALVIN NNP B-NP O
97 B NNP I-NP O
97 , , O O
97 N.P NNP B-NP O
97 ( ( O O
97 ) ) O O
97 7/1/06 CD O O
97 @ $ O O
97 11:28 CD O O
97 AM NNP B-NP O
98 ****** JJ B-NP O
98 END NN I-NP O
98 OF NNP I-NP O
98 DISCHARGE NNP I-NP O
98 ORDERS NNP I-NP O
98 ****** NNP I-NP O
99 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #410277 VBZ O O
4 785289682 CD O O
4 RM NNP B-NP O
4 34916218 CD O O
4 9502354 CD O O
4 10/16/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 NEW NNP I-NP O
4 ONSET NNP I-NP O
4 DIABETES NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/10/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 8/17/2006 CD O O
7 ATTENDING: NNP B-NP O
7 SPIESS NNP I-NP O
7 , , O O
7 RAFAEL NNP B-NP O
7 M.D NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
8 New-onset NNP I-NP O
8 diabetes VBZ O O
9 HISTORY NNP B-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 A NNP I-NP O
9 45-year-old JJ B-NP O
9 man NN I-NP O
9 with IN B-VP O
9 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
10 familial JJ B-NP O
10 cardiomyopathy NN I-NP O
10 and CC O O
10 status NN B-NP O
10 post NN I-NP O
10 cardiac NN I-NP O
10 transplant NN I-NP O
10 in IN B-VP O
11 2002 CD O O
11 , , O O
11 and CC O O
11 chronic JJ B-NP O
11 renal JJ I-NP O
11 insufficiency NN I-NP O
11 presented VBN O O
11 with IN B-VP O
11 greater JJR O O
11 than IN B-VP O
12 two CD O O
12 weeks NNS B-NP O
12 of IN B-VP O
12 polyuria NN B-NP O
12 , , O O
12 polydipsia NN B-NP O
12 , , O O
12 blurry JJ B-NP O
12 vision NN I-NP O
12 , , O O
12 muscle NN B-NP O
12 cramps NNS I-NP O
12 , , O O
13 and CC O O
13 myalgias NN B-NP O
13 and CC O O
13 reported VBD B-VP O
13 approximately RB O O
13 a DT B-NP O
13 15-pound JJ I-NP O
13 weight NN I-NP O
13 loss NN I-NP O
14 over IN B-VP O
14 three CD O O
14 weeks NNS B-NP O
14 with IN B-VP O
14 decrease NN B-NP O
14 in IN B-VP O
14 usual JJ B-NP O
14 lower JJR I-NP O
14 extremity NN I-NP O
14 edema NN I-NP O
15 Was NNP I-NP O
15 seen VBN O O
15 by IN B-VP O
15 his PRP$ O O
15 PCP NN B-NP O
15 on IN B-VP O
15 the DT B-NP O
15 day NN I-NP O
15 of IN B-VP O
15 admission NN B-NP O
15 and CC O O
15 found VBN O O
15 to TO O O
15 have VB O O
15 a DT B-NP O
16 fingerstick NN I-NP O
16 of IN B-VP O
16 1000 CD O O
16 The DT B-NP O
16 patient NN I-NP O
16 also RB O O
16 reported VBD B-VP O
16 sore RB O O
16 throat NN B-NP O
16 and CC O O
17 cough NN B-NP O
17 times NNS I-NP O
17 several JJ B-NP O
17 days NNS I-NP O
17 , , O O
17 but CC O O
17 otherwise RB O O
17 review NN B-NP O
17 of IN B-VP O
17 systems NNS B-NP O
17 is VBZ O O
18 negative JJ B-NP O
19 PAST NNP I-NP O
19 MEDICAL NNP I-NP O
19 HISTORY: NNP I-NP O
20 1 CD O O
20 Cardiomyopathy NNP B-NP O
20 , , O O
20 status NN B-NP O
20 post NN I-NP O
20 transplant NN I-NP O
20 and CC O O
20 AICD NNP B-NP O
20 placement VBD B-VP O
21 2 CD O O
21 Chronic NNP B-NP O
21 renal JJ B-NP O
21 insufficiency NN I-NP O
22 3 CD O O
22 Hypothyroidism NNP B-NP O
23 4 CD O O
23 Tricuspid NNP B-NP O
23 regurgitation NN I-NP O
24 5 CD O O
24 History NNP B-NP O
24 of IN B-VP O
24 pancreatitis NN B-NP O
25 6 CD O O
25 Gout NNP B-NP O
26 MEDICATIONS NNP I-NP O
26 ON NNP I-NP O
26 ADMISSION: NNP I-NP O
26 Calcium NNP I-NP B-m
26 carbonate NN I-NP I-m
26 1250 CD O B-do
26 mg NN B-NP I-do
26 t.i.d NN I-NP B-f
26 , , O O
27 Cartia NNP B-NP B-m
27 XT NNP I-NP I-m
27 300 CD O B-do
27 mg JJ O I-do
27 daily RB O B-f
27 , , O O
27 CellCept NNP B-NP B-m
27 1500 CD O B-do
27 mg NN B-NP I-do
27 b.i.d NN I-NP B-f
27 , , O O
27 colchicine VBP O B-m
27 0.6 CD O B-do
28 mg JJ B-NP O
28 daily JJ I-NP B-f
28 p.r.n NN I-NP I-f
28 , , O O
28 Neoral NNP B-NP B-m
28 150 CD O B-do
28 mg NN B-NP I-do
28 b.i.d NN I-NP B-f
28 , , O O
28 folate VBP O B-m
28 1 CD O B-do
28 mg JJ O I-do
28 daily JJ O B-f
28 , , O O
28 K-dur NNP B-NP B-m
29 20 CD O B-do
29 mg NN B-NP I-do
29 daily RB O B-f
29 , , O O
29 magnesium NN B-NP B-m
29 oxide RB O I-m
29 400 CD O B-do
29 mg NN B-NP I-do
29 b.i.d NN I-NP B-f
29 , , O O
29 methotrexate VB O B-m
29 2.5 CD O B-do
29 mg JJ O I-do
30 daily RB O B-f
30 , , O O
30 Pravastatin NNP B-NP B-m
30 20 CD O B-do
30 mg JJ O I-do
30 daily RB O B-f
30 , , O O
30 prednisone NN B-NP B-m
30 7 CD O B-do
30 mg JJ O I-do
30 daily RB O B-f
30 , , O O
30 Rocaltrol NNP B-NP B-m
31 0.25 CD O B-do
31 mg JJ O I-do
31 daily RB O B-f
31 , , O O
31 Synthroid NNP B-NP B-m
31 150 CD O B-do
31 mcg JJ O I-do
31 daily RB O B-f
31 , , O O
31 Torsemide NNP B-NP B-m
31 40 CD O B-do
31 mg JJ O I-do
31 daily RB O B-f
31 , , O O
32 Vitamin NNP B-NP B-m
32 C NNP I-NP I-m
32 , , O O
32 Vitamin NNP B-NP B-m
32 E NNP I-NP I-m
32 , , O O
32 and CC O O
32 cyclosporin VBZ O B-m
32 150 CD O B-do
32 mg NN B-NP I-do
32 b.i.d NN I-NP B-f
33 ALLERGIES: NNP I-NP O
33 Penicillin NNP I-NP O
33 leads VBZ O O
33 to TO O O
33 "shaking." VB O O
34 PHYSICAL NNP B-NP O
34 EXAMINATION NNP I-NP O
34 ON NNP I-NP O
34 ADMISSION: NNP I-NP O
34 Notable NNP I-NP O
34 for IN B-VP O
34 temperature NN B-NP O
34 98.8 CD O O
35 Blood NNP B-NP O
35 pressure NN I-NP O
35 140/82 CD O O
35 , , O O
35 heart NN B-NP O
35 rate NN I-NP O
35 92 CD O O
35 , , O O
35 saturation NN B-NP O
35 is VBZ O O
35 97% CD O O
35 on IN B-VP O
35 room NN B-NP O
36 air NN I-NP O
36 The DT B-NP O
36 patient NN I-NP O
36 is VBZ O O
36 obese JJ O O
36 , , O O
36 but CC O O
36 well RB O O
36 appearing VBG O O
36 Weight NNP B-NP O
36 117.7 CD O O
37 kilograms NNS B-NP O
37 Cardiovascular JJ B-NP O
37 examination: JJ I-NP O
37 Regular JJ I-NP O
37 rate NN I-NP O
37 and CC O O
37 rhythm NN B-NP O
38 Soft NNP I-NP O
38 , , O O
38 2/6 CD O O
38 systolic JJ O O
38 murmur RB O O
38 heard RB O O
38 best JJS O O
38 at IN B-VP O
38 the DT B-NP O
38 left JJ I-NP O
38 sternal JJ I-NP O
38 border NN I-NP O
39 No NNP I-NP O
39 lower JJR B-NP O
39 extremity NN I-NP O
39 edema NN I-NP O
40 ADMISSIONS NNP I-NP O
40 LABORATORIES: NNP I-NP O
40 Notable NNP I-NP O
40 for IN B-VP O
40 a DT B-NP O
40 blood NN I-NP O
40 glucose NN I-NP O
40 of IN B-VP O
40 1064 CD O O
40 , , O O
41 creatinine VBP O O
41 2.2 CD O O
41 from IN B-VP O
41 a DT B-NP O
41 baseline NN I-NP O
41 of IN B-VP O
41 1.8 CD O O
41 , , O O
41 sodium NN B-NP O
41 130 CD O O
41 , , O O
41 potassium NN B-NP O
41 4.9 CD O O
42 EKG NNP B-NP O
42 normal JJ B-NP O
42 sinus NN I-NP O
42 rhythm NN I-NP O
42 at IN B-VP O
42 87 CD O O
42 beats NNS B-NP O
42 per IN B-VP O
42 minute NN B-NP O
42 , , O O
42 evidence NN B-NP O
42 of IN B-VP O
42 left JJ B-NP O
43 atrial JJ I-NP O
43 enlargement NN I-NP O
43 , , O O
43 incomplete JJ B-NP O
43 right JJ I-NP O
43 bundle-branch NN I-NP O
43 block NN I-NP O
43 , , O O
43 and CC O O
44 anterior JJ B-NP O
44 T NNP I-NP O
44 wave NN I-NP O
44 changes NNS I-NP O
44 that WDT O O
44 are VBP O O
44 unchanged JJ O O
44 from IN B-VP O
44 prior JJ B-NP O
44 EKGs NNP I-NP O
45 HOSPITAL NNP I-NP O
45 COURSE NNP I-NP O
45 BY NNP I-NP O
45 ISSUE: NNP I-NP O
46 1 CD O O
46 Endocrine: NNP B-NP O
46 The DT B-NP O
46 patient NN I-NP O
46 with IN B-VP O
46 new-onset JJ B-NP B-r
46 new-onset JJ I-NP B-r
46 diabetes NNS I-NP I-r
46 diabetes VBZ O I-r
46 Endocrine NNP B-NP O
47 service NN I-NP O
47 was VBD B-VP O
47 consulted VBN O O
47 and CC O O
47 the DT B-NP O
47 patient NN I-NP O
47 was VBD B-VP O
47 controlled VBN O O
47 with IN B-VP O
47 a DT B-NP O
48 combination NN I-NP O
48 regimen NN I-NP O
48 of IN B-VP O
48 Lantus NNP B-NP B-m
48 , , O O
48 Novolog NNP B-NP B-m
48 q VBZ O B-f
48 q JJ B-NP B-f
48 a.c NN I-NP I-f
48 a.c NN I-NP I-f
48 , , O O
48 combined VBN O O
48 with IN B-VP O
48 a DT B-NP O
49 Novolog NNP I-NP B-m
49 sliding VBG O B-do
49 scale NN B-NP I-do
49 The DT B-NP O
49 patient NN I-NP O
49 was VBD B-VP O
49 discharged VBN O O
49 with IN B-VP O
49 followup NN B-NP O
50 with IN B-VP O
50 Napoleon NNP B-NP O
50 Mettee NNP I-NP O
50 , , O O
50 the DT B-NP O
50 diabetic JJ I-NP O
50 teaching NN I-NP O
50 nurse NN I-NP O
50 and CC O O
50 with IN B-VP O
50 Dr NNP B-NP O
50 Jonson NNP I-NP O
51 in IN B-VP O
51 the DT B-NP O
51 diabetes NNS I-NP O
51 clinic JJ O O
51 and CC O O
51 with IN B-VP O
51 VNA NNP B-NP O
51 services NNS I-NP O
51 to TO O O
51 assist VB O O
51 with IN B-VP O
51 home NN B-NP O
52 medications NNS I-NP O
52 The DT B-NP O
52 patient NN I-NP O
52 demonstrated VBD B-VP O
52 proper JJ B-NP O
52 understanding NN I-NP O
52 of IN B-VP O
53 blood NN B-NP O
53 glucose JJ B-NP O
53 testing NN I-NP O
53 and CC O O
53 insulin NN B-NP B-m
53 administration NN I-NP O
53 prior RB O O
53 to TO O O
54 discharge VB O O
55 2 CD O O
55 Cardiovascular: NNP B-NP O
55 The DT B-NP O
55 patient NN I-NP O
55 was VBD B-VP O
55 intravascularly RB O O
55 dry JJ O O
55 At IN B-VP O
55 the DT B-NP O
56 time NN I-NP O
56 of IN B-VP O
56 admission NN B-NP O
56 , , O O
56 he PRP O O
56 was VBD B-VP O
56 aggressively RB O O
56 hydrated VBN O O
56 and CC O O
56 euvolemic JJ B-NP O
57 prior NN I-NP O
57 to TO O O
57 discharge VB O O
58 3 CD O O
58 Rheumatology: NNP B-NP O
58 The DT B-NP O
58 patient NN I-NP O
58 had VBD B-VP O
58 mild VBN O B-r
58 acute JJ B-NP I-r
58 gout NN I-NP I-r
58 flare NN I-NP I-r
58 during IN B-VP O
59 admission NN B-NP O
59 for IN B-VP O
59 which WDT O O
59 he PRP O O
59 was VBD B-VP O
59 started VBN O O
59 on IN B-VP O
59 colchicine NN B-NP B-m
60 4 CD O O
60 Renal: NNP B-NP O
60 The DT B-NP O
60 patient NN I-NP O
60 with IN B-VP O
60 chronic JJ B-NP O
60 renal JJ I-NP O
60 insufficiency NN I-NP O
60 , , O O
60 likely JJ B-NP O
61 transplant NN I-NP O
61 , , O O
61 immunosuppression NN B-NP O
61 medication NN I-NP O
61 related VBN O O
61 Baseline NNP B-NP O
62 creatinine NN I-NP O
62 is VBZ O O
62 1.8 CD O O
62 Creatinine NN B-NP O
62 at IN B-VP O
62 admission NN B-NP O
62 of IN B-VP O
62 2.2 CD O O
62 likely RB O O
62 related VBN O O
63 to TO O O
63 prerenal JJ B-NP O
63 acute JJ I-NP O
63 renal JJ I-NP O
63 failure NN I-NP O
63 Creatinine NNP I-NP O
63 at IN B-VP O
63 discharge NN B-NP O
63 had VBD B-VP O
64 normalized VBN O O
64 to TO O O
64 1.6 CD O O
65 DISCHARGE NNP B-NP O
65 MEDICATIONS: NNP I-NP O
65 Vitamin NNP I-NP B-m
65 C NNP I-NP I-m
65 500 CD O B-do
65 mg NN B-NP I-do
65 b.i.d NN I-NP B-f
65 , , O O
65 Rocaltrol NNP B-NP B-m
65 0.25 CD O B-do
66 mcg JJ O O
66 daily RB O B-f
66 , , O O
66 calcium NN B-NP B-m
66 carbonate NN I-NP I-m
66 500 CD O B-do
66 mg NN B-NP I-do
66 t.i.d NN I-NP B-f
66 , , O O
66 colchicine VBP O B-m
66 0.3 CD O B-do
66 mg NN B-NP I-do
67 p.o NN I-NP B-mo
67 b.i.d NN I-NP B-f
67 , , O O
67 cyclosporin VBP O B-m
67 150 CD O B-do
67 mg NN B-NP I-do
67 b.i.d NN I-NP B-f
67 , , O O
67 folic JJ O B-m
67 acid VBP O I-m
67 1 CD O B-do
67 mg JJ O I-do
67 daily RB O B-f
67 , , O O
68 Synthroid NNP B-NP B-m
68 150 CD O B-do
68 mcg JJ O I-do
68 daily RB O B-f
68 , , O O
68 magnesium NN B-NP B-m
68 oxide RB O I-m
68 420 CD O B-do
68 mg NN B-NP I-do
68 b.i.d NN I-NP B-f
68 , , O O
69 prednisone NN B-NP B-m
69 7.5 CD O B-do
69 mg NN B-NP I-do
69 q.a.m NN I-NP B-f
69 , , O O
69 Vitamin NNP B-NP B-m
69 E NNP I-NP I-m
69 400 CD O B-do
69 units NNS B-NP I-do
69 daily RB O B-f
69 , , O O
69 Pravachol NNP B-NP B-m
69 20 CD O B-do
70 mg NN B-NP O
70 at IN B-VP B-f
70 night NN B-NP I-f
70 , , O O
70 Cartia NNP B-NP B-m
70 XT NNP I-NP I-m
70 that WDT O O
70 is VBZ O O
70 diltiazem RB O B-m
70 extended JJ B-NP I-m
70 release NN I-NP I-m
70 300 CD O B-do
70 300 CD O B-do
70 mg NNS B-NP I-do
70 mg JJ O I-do
71 daily JJ O B-f
71 daily RB O B-f
71 , , O O
71 CellCept NNP B-NP B-m
71 1500 CD O B-do
71 mg NN B-NP I-do
71 b.i.d NN I-NP B-f
71 , , O O
71 Lantus NNP B-NP B-m
71 insulin NN I-NP I-m
71 ( ( O I-m
71 Glargine NNP B-NP I-m
71 ) ) O I-m
71 40 CD O B-do
72 units NNS B-NP O
72 subcutaneous JJ B-NP B-mo
72 q.a.m NN I-NP B-f
72 , , O O
72 Novolog NNP B-NP B-m
72 12 CD O B-do
72 units NNS B-NP I-do
72 before IN B-VP B-f
72 breakfast NN B-NP I-f
72 , , O O
73 Novolog NNP B-NP B-m
73 12 CD O B-do
73 units NNS B-NP I-do
73 before IN B-VP B-f
73 lunch NN B-NP I-f
73 , , O O
73 Novolog NNP B-NP B-m
73 14 CD O B-do
73 units NNS B-NP I-do
73 before IN B-VP B-f
73 dinner NN B-NP I-f
73 , , O O
74 and CC O O
74 Novolog NNP B-NP B-m
74 Novolog NNP I-NP B-m
74 Novolog NNP I-NP B-m
74 Novolog NNP I-NP B-m
74 Novolog NNP I-NP B-m
74 Novolog NNP I-NP B-m
74 sliding VBG O B-do
74 scale JJ B-NP I-do
74 q NN I-NP B-f
74 a.c IN B-VP I-f
74 The DT O O
74 sliding VBG O O
74 scale NN B-NP O
74 is VBZ O O
74 as IN B-VP O
75 follows: NN B-NP O
75 If IN B-VP O
75 blood NN B-NP O
75 sugar NN I-NP O
75 is VBZ O O
75 150-200 JJ B-NP O
75 take NN I-NP O
75 4 CD O B-do
75 units NNS B-NP I-do
75 , , O O
75 if IN B-VP O
75 blood NN B-NP O
75 sugar NN I-NP O
76 is VBZ O O
76 201-250 JJ B-NP O
76 mg NNS I-NP O
76 take VBP O O
76 6 CD O B-do
76 units NNS B-NP I-do
76 , , O O
76 if IN B-VP O
76 blood NN B-NP O
76 sugar NN I-NP O
76 is VBZ O O
76 251-300 JJ B-NP O
76 take NN I-NP O
76 8 CD O B-do
77 units NNS B-NP O
77 , , O O
77 if IN B-VP O
77 blood NN B-NP O
77 sugar NN I-NP O
77 is VBZ O O
77 301-350 JJ B-NP O
77 take NN I-NP O
77 10 CD O B-do
77 units NNS B-NP I-do
77 , , O O
77 if IN B-VP O
77 blood NN B-NP O
77 sugar NN I-NP O
77 is VBZ O O
78 350-400 JJ B-NP O
78 take NN I-NP O
78 12 CD O B-do
78 units NNS B-NP I-do
78 , , O O
78 if IN B-VP O
78 it PRP O O
78 is VBZ O O
78 greater JJR O O
78 than IN B-VP O
78 400 CD O O
78 , , O O
78 the DT B-NP O
78 patient NN I-NP O
78 is VBZ O O
79 instructed VBN O O
79 to TO O O
79 call VB O O
79 his PRP$ O O
79 doctor NN B-NP O
80 eScription NN I-NP O
80 document: VBZ O O
80 2-8832408 JJ B-NP O
80 HFFocus NNP I-NP O
81 Dictated NNP I-NP O
81 By: NNP I-NP O
81 BRAYE NNP I-NP O
81 , , O O
81 DAMION NNP B-NP O
82 Attending: NNP I-NP O
82 VIDA NNP I-NP O
82 , , O O
82 JUSTIN NNP B-NP O
83 Dictation NNP I-NP O
83 ID NNP I-NP O
83 4581635 CD O O
84 D: NNP B-NP O
84 3/25/06 CD O O
85 T: NNP B-NP O
85 3/25/06 CD O O
86 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #413813 VBZ O O
2 965041836 CD O O
2 EVH NNP B-NP O
2 94253387 CD O O
2 7657131 CD O O
2 6/29/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Chest NNP I-NP O
2 pressure NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/29/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/7/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 MURPHEY NNP I-NP O
5 , , O O
5 CRUZ NNP B-NP O
5 001-14-30-0 NNP I-NP O
6 Range NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 8/25/06 CD O O
8 AT NNP B-NP O
8 11:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Attending NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 HEATLY NNP I-NP O
11 , , O O
11 SOLOMON NNP B-NP O
11 O NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 TYLENOL NNP I-NP B-m
16 ( ( O I-m
16 ACETAMINOPHEN NNP B-NP I-m
16 ) ) O I-m
16 650 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 Q4H NNP I-NP B-f
16 PRN NNP I-NP I-f
16 Headache NNP I-NP B-r
17 PERSANTINE NNP I-NP B-m
17 ( ( O I-m
17 DIPYRIDAMOLE NNP B-NP I-m
17 ) ) O I-m
17 50 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 BID NNP I-NP B-f
18 LASIX NNP I-NP B-m
18 ( ( O I-m
18 FUROSEMIDE NNP B-NP I-m
18 ) ) O I-m
18 10 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 ATIVAN NNP I-NP B-m
19 ( ( O I-m
19 LORAZEPAM NNP B-NP I-m
19 ) ) O I-m
19 3.5 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QHS NNP I-NP B-f
20 HOLD NNP I-NP O
20 IF: NNP I-NP O
20 RR&lt;12 NNP I-NP O
20 or CC O O
20 oversedation NN B-NP O
21 ATIVAN NNP I-NP B-m
21 ( ( O I-m
21 LORAZEPAM NNP B-NP I-m
21 ) ) O I-m
21 2 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QID NNP I-NP B-f
21 PRN NNP I-NP I-f
21 Anxiety NNP I-NP B-r
22 HOLD NNP I-NP O
22 IF: NNP I-NP O
22 RR&lt;12 NNP I-NP O
22 or CC O O
22 oversedation NN B-NP O
23 NTG NNP I-NP B-m
23 1/150 CD O I-m
23 ( ( O I-m
23 NITROGLYCERIN NNP B-NP I-m
23 1/150 CD O I-m
23 ( ( O I-m
23 0.4 CD O I-m
23 MG NNP B-NP I-m
23 ) ) O I-m
23 ) ) O I-m
24 1 CD O B-do
24 TAB NNP B-NP I-do
24 SL NNP I-NP B-mo
24 Q5MIN NNP I-NP B-f
24 X NNP I-NP B-du
24 3 CD O I-du
24 doses NNS B-NP I-du
24 PRN NNP I-NP I-du
24 Chest NNP I-NP B-r
24 Pain NNP I-NP I-r
25 NITROGLYCERIN NNP I-NP B-m
25 PASTE NNP I-NP I-m
25 2% CD O I-m
25 1 CD O B-do
25 INCHES NNP B-NP I-do
25 TP NNP I-NP B-mo
25 BID NNP I-NP B-f
26 HOLD NNP I-NP O
26 IF: NNP I-NP O
26 SBP&lt;100 NNP I-NP O
26 and CC O O
26 call VB O O
26 HO NNP B-NP O
27 INDERAL NNP I-NP B-m
27 ( ( O I-m
27 PROPRANOLOL NNP B-NP I-m
27 HCL NNP I-NP I-m
27 ) ) O I-m
27 10 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QID NNP I-NP B-f
28 HOLD NNP I-NP O
28 IF: NNP I-NP O
28 sbp&lt;100 VBD B-VP O
28 or CC O O
28 HR&lt;55 NNP B-NP O
28 and CC O O
28 call VB O O
28 HO NNP B-NP O
29 Food/Drug NNP I-NP O
29 Interaction NNP I-NP O
29 Instruction NNP I-NP O
30 Take NNP I-NP O
30 consistently RB O O
30 with IN B-VP O
30 meals NNS B-NP O
30 or CC O O
30 on IN B-VP O
30 empty JJ B-NP O
30 stomach NN I-NP O
31 SUCRALFATE NNP I-NP B-m
31 1 CD O B-do
31 GM NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QID NNP I-NP B-f
31 Food/Drug NNP I-NP O
31 Interaction NNP I-NP O
31 Instruction NNP I-NP O
32 Give NNP I-NP O
32 on IN B-VP O
32 an DT B-NP O
32 empty JJ I-NP O
32 stomach NN I-NP O
32 ( ( O O
32 give JJ O O
32 1hr CD O O
32 before IN B-VP O
32 or CC O O
32 2hr CD O O
32 after IN B-VP O
33 food NN B-NP O
33 ) ) O O
34 PAXIL NNP B-NP B-m
34 ( ( O I-m
34 PAROXETINE NNP B-NP I-m
34 ) ) O I-m
34 10 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QD NNP I-NP B-f
35 NORVASC NNP I-NP B-m
35 ( ( O I-m
35 AMLODIPINE NNP B-NP I-m
35 ) ) O I-m
35 2.5 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 QD NNP I-NP B-f
36 HOLD NNP I-NP O
36 IF: NNP I-NP O
36 SBP&lt;100 NNP I-NP O
36 and CC O O
36 call VB O O
36 HO NNP B-NP O
37 Food/Drug NNP I-NP O
37 Interaction NNP I-NP O
37 Instruction NNP I-NP O
38 Avoid NNP I-NP O
38 grapefruit NN I-NP O
38 unless IN B-VP O
38 MD NNP B-NP O
38 instructs NNS I-NP O
38 otherwise RB O O
39 Alert NNP B-NP O
39 overridden: NNP I-NP O
39 Override NNP I-NP O
39 added VBD B-VP O
39 on IN B-VP O
39 6/13/05 CD O O
39 by IN B-VP O
40 HERZFELD NNP B-NP O
40 , , O O
40 NORBERTO NNP B-NP O
40 W NNP I-NP O
40 , , O O
40 M.D NNP B-NP O
40 , , O O
40 PH.D NNP B-NP O
41 on IN B-VP O
41 order NN B-NP O
41 for IN B-VP O
41 NORVASC NNP B-NP B-m
41 PO NNP I-NP B-mo
41 5 CD O B-do
41 MG NNP B-NP I-do
41 QD NNP I-NP B-f
41 ( ( O O
41 ref JJ O O
41 # # O O
41 913242331 CD O O
41 ) ) O O
42 Pt NNP B-NP O
42 has VBZ O O
42 a DT B-NP O
42 PROBABLE NNP I-NP O
42 allergy NN I-NP O
42 to TO O O
42 DILTIAZEM NNP B-NP O
42 ; : O O
42 reaction NN B-NP O
42 is VBZ O O
43 Mental JJ B-NP O
43 Status NNP I-NP O
43 Change NNP I-NP O
43 Reason NNP I-NP O
43 for IN B-VP O
43 override: NN B-NP O
43 Pt NNP I-NP O
43 tolerates VBZ O O
44 IMDUR NNP B-NP B-m
44 ER NNP I-NP I-m
44 ( ( O I-m
44 ISOSORBIDE NNP B-NP I-m
44 MONONITRATE NNP I-NP I-m
44 ( ( O I-m
44 SR NNP B-NP I-m
44 ) ) O I-m
44 ) ) O I-m
44 30 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 BID NNP I-NP B-f
45 HOLD NNP I-NP O
45 IF: NNP I-NP O
45 SBP&lt;100 NNP I-NP O
45 and CC O O
45 call VB O O
45 HO NNP B-NP O
46 Food/Drug NNP I-NP O
46 Interaction NNP I-NP O
46 Instruction NNP I-NP O
47 Give NNP I-NP O
47 on IN B-VP O
47 an DT B-NP O
47 empty JJ I-NP O
47 stomach NN I-NP O
47 ( ( O O
47 give JJ O O
47 1hr CD O O
47 before IN B-VP O
47 or CC O O
47 2hr CD O O
47 after IN B-VP O
48 food NN B-NP O
48 ) ) O O
49 COZAAR NNP B-NP B-m
49 ( ( O I-m
49 LOSARTAN NNP B-NP I-m
49 ) ) O I-m
49 50 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 QD NNP I-NP B-f
50 HOLD NNP I-NP O
50 IF: NNP I-NP O
50 SBP&lt;100 NNP I-NP O
50 and CC O O
50 call VB O O
50 HO NNP B-NP O
51 Number NNP I-NP B-du
51 of IN B-VP I-du
51 Doses NNP B-NP I-du
51 Required NNP I-NP I-du
51 ( ( O I-du
51 approximate JJ B-NP I-du
51 ): NN I-NP I-du
51 3 CD O I-du
52 PROTONIX NNP B-NP B-m
52 ( ( O I-m
52 PANTOPRAZOLE NNP B-NP I-m
52 ) ) O I-m
52 40 CD O B-do
52 MG NNP B-NP I-do
52 PO NNP I-NP B-mo
52 QD NNP I-NP B-f
53 GLYBURIDE NNP I-NP B-m
53 2.5 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 QD NNP I-NP B-f
54 ZETIA NNP I-NP B-m
54 ( ( O I-m
54 EZETIMIBE NNP B-NP I-m
54 ) ) O I-m
54 10 CD O B-do
54 MG NNP B-NP I-do
54 PO NNP I-NP B-mo
54 QD NNP I-NP B-f
55 DIET: NNP I-NP O
55 House NNP I-NP O
55 / VBD B-VP O
55 Low NNP B-NP O
55 chol/low NN I-NP O
55 sat VBD B-VP O
55 fat JJ B-NP O
56 DIET: NNP I-NP O
56 House NNP I-NP O
56 / NNP I-NP O
56 ADA NNP I-NP O
56 1800 CD O O
56 cals/dy NN B-NP O
57 ACTIVITY: NNP I-NP O
57 Walking NNP I-NP O
57 as IN B-VP O
57 tolerated VBN O O
58 FOLLOW NNP B-NP O
58 UP NNP I-NP O
58 APPOINTMENT( NNP I-NP O
58 S NNP I-NP O
58 ): NNP I-NP O
59 Dr NNP I-NP O
59 Widowski NNP I-NP O
59 March NNP I-NP O
59 at IN B-VP O
59 3:30 CD O O
59 PM NNP B-NP O
59 , , O O
60 Dr NNP B-NP O
60 Caris NNP I-NP O
60 11/10/06 CD O O
60 , , O O
61 ALLERGY: NNP B-NP O
61 Penicillins NNP I-NP O
61 , , O O
61 Aspirin NNP B-NP O
61 , , O O
61 DILTIAZEM NNP B-NP O
61 , , O O
61 ATORVASTATIN NNP B-NP O
62 ADMIT NNP I-NP O
62 DIAGNOSIS: NNP I-NP O
63 Chest NNP I-NP O
63 pressure NN I-NP O
64 PRINCIPAL NNP I-NP O
64 DISCHARGE NNP I-NP O
64 DIAGNOSIS NNP I-NP O
64 ;Responsible JJ O O
64 After IN B-VP O
64 Study NNP B-NP O
64 for IN B-VP O
64 Causing NNP B-NP O
64 Admission NNP I-NP O
64 ) ) O O
65 Chest NNP B-NP O
65 pressure NN I-NP O
66 OTHER NNP I-NP O
66 DIAGNOSIS;Conditions NNP I-NP O
66 , , O O
66 Infections NNP B-NP O
66 , , O O
66 Complications NNP B-NP O
66 , , O O
66 affecting VBG O O
66 Treatment/Stay NNP B-NP O
67 htn NN I-NP O
67 elev NN I-NP O
67 chol NN I-NP O
67 bph NN I-NP O
67 , , O O
67 s/p JJ B-NP O
67 turp NN I-NP O
67 x4 NNP I-NP O
67 s/p VBZ O O
67 partial JJ B-NP O
67 gastrectomy NN I-NP O
67 IMI NNP I-NP O
67 '73 POS O O
67 CAD NNP B-NP O
68 s/p NN I-NP O
68 CABG NNP I-NP O
68 x3 NNP I-NP O
68 ( ( O O
68 S/P NNP B-NP O
68 cardiac JJ B-NP O
68 bypass NN I-NP O
68 graft NN I-NP O
68 surgery NN I-NP O
68 ) ) O O
69 OPERATIONS NNP B-NP O
69 AND NNP I-NP O
69 PROCEDURES: NNP I-NP O
70 None NNP I-NP O
71 OTHER NNP I-NP O
71 TREATMENTS/PROCEDURES NNP I-NP O
71 ( ( O O
71 NOT NNP B-NP O
71 IN NNP I-NP O
71 O.R NNP I-NP O
71 ) ) O O
72 None NN B-NP O
73 BRIEF NNP I-NP O
73 RESUME NNP I-NP O
73 OF NNP I-NP O
73 HOSPITAL NNP I-NP O
73 COURSE: NNP I-NP O
74 CC: NNP I-NP O
74 "Feeling VBG O O
74 sick" JJ B-NP O
75 HPI: NNP I-NP O
75 History NNP I-NP O
75 was VBD B-VP O
75 obtained VBN O O
75 from IN B-VP O
75 patient NN B-NP O
75 , , O O
75 who WP O O
75 is VBZ O O
75 a DT B-NP O
75 poor JJ I-NP O
75 historian NN I-NP O
75 He PRP O O
75 is VBZ O O
76 an DT O O
76 83 CD O O
76 yo NN B-NP O
76 man NN I-NP O
76 with IN B-VP O
76 a DT B-NP O
76 history NN I-NP O
76 of IN B-VP O
76 CAD NNP B-NP O
76 s/p NN I-NP O
76 MI NNP I-NP O
76 in IN B-VP O
76 1973 CD O O
76 , , O O
76 s/p VBD B-VP O
76 CABG NNP B-NP O
76 x3 NNP I-NP O
76 , , O O
76 T2DM NNP B-NP O
76 , , O O
77 hypertension NN B-NP O
77 who WP O O
77 presents VBZ O O
77 "feeling VBG O O
77 sick" NN B-NP O
77 since IN B-VP O
77 last JJ B-NP O
77 night NN I-NP O
77 He PRP O O
77 states VBZ O O
78 that IN B-VP O
78 he PRP O O
78 took VBD B-VP O
78 a DT B-NP O
78 Percocet NNP I-NP B-m
78 for IN B-VP O
78 back RB O B-r
78 pain NN B-NP I-r
78 and CC O O
78 that IN B-VP O
78 after IN B-VP O
78 that IN B-VP O
78 he PRP O O
78 began VBD B-VP O
78 to TO O O
79 feel VB O O
79 numb RB O O
79 in IN B-VP O
79 his PRP$ O O
79 arms NNS B-NP O
79 and CC O O
79 legs NNS B-NP O
79 and CC O O
79 around IN B-VP O
79 his PRP$ O O
79 head NN B-NP O
79 He PRP O O
79 also RB O O
79 had VBD B-VP O
79 some DT B-NP B-r
80 chest JJS I-NP O
80 pressure NN I-NP O
80 He PRP O O
80 took VBD B-VP O
80 some DT B-NP O
80 SL NNP I-NP B-mo
80 nitro NN I-NP B-m
80 and CC O O
80 doesn't JJ O O
80 remember VB O O
80 if IN B-VP O
80 it PRP O O
80 helped VBD B-VP O
81 Says VB O O
81 it PRP O O
81 also RB O O
81 wasn't VBZ O O
81 relieved VBN O O
81 by IN B-VP O
81 positional JJ B-NP O
81 change NN I-NP O
81 or CC O O
81 rest NN B-NP O
81 He PRP O O
81 denies VBZ O O
82 shortness NN B-NP O
82 of IN B-VP O
82 breath NN B-NP O
82 He PRP O O
82 was VBD B-VP O
82 having VBG O O
82 some DT B-NP O
82 nausea NN I-NP O
82 but CC O O
82 no DT B-NP O
82 vomiting NN I-NP O
82 He PRP O O
82 does VBZ O O
83 have VB O O
83 some DT B-NP O
83 blurry JJ I-NP O
83 vision NN I-NP O
83 at IN B-VP O
83 baseline NN B-NP O
83 , , O O
83 unchanged JJ O O
83 He PRP O O
83 awoke VBD B-VP O
83 this DT B-NP O
83 morning NN I-NP O
84 and CC O O
84 took VBD B-VP O
84 his PRP$ O O
84 blood NN B-NP O
84 pressure NN I-NP O
84 When WRB O O
84 he PRP O O
84 found VBD B-VP O
84 his PRP$ O O
84 systolic NN B-NP O
84 was VBD B-VP O
84 190 CD O O
84 , , O O
84 he PRP O O
85 called VBD B-VP O
85 EMS NNP B-NP O
85 He PRP O O
85 said VBD B-VP O
85 he PRP O O
85 felt VBD B-VP O
85 dizzy NN B-NP O
85 , , O O
85 "like IN B-VP O
85 I PRP O O
85 have VBP O O
85 pressure NN B-NP O
85 in IN B-VP O
85 my PRP$ O O
85 head NN B-NP O
85 , , O O
85 " NN B-NP O
86 and CC O O
86 could MD O O
86 not RB O O
86 describe VB O O
86 it PRP O O
86 beyond IN B-VP O
86 that IN B-VP O
86 He PRP O O
86 states VBZ O O
86 that IN B-VP O
86 when WRB O O
86 his PRP$ O O
86 BP NNP B-NP O
86 is VBZ O O
87 elevated VBN O O
87 his PRP$ O O
87 head NN B-NP O
87 feels NNS I-NP O
87 like IN B-VP O
87 this DT O O
87 and CC O O
87 he PRP O O
87 gets VBZ O O
87 flushed VBN O O
87 in IN B-VP O
87 the DT B-NP O
87 face.----- JJ I-NP O
88 PMH: NNP I-NP O
88 CAD NNP I-NP O
88 ( ( O O
88 Donny NNP B-NP O
88 Lopilato NNP I-NP O
88 is VBZ O O
88 outpt JJ B-NP O
88 cards NNS I-NP O
88 ) ) O O
88 , , O O
88 s/p $ O O
88 3V CD O O
88 CABG NNP B-NP O
88 , , O O
88 s/p NN B-NP O
88 UGIB NNP I-NP O
88 and CC O O
89 partial JJ B-NP O
89 gastrectomy NN I-NP O
89 for IN B-VP O
89 PUD NNP B-NP O
89 , , O O
89 chronic JJ O O
89 back RB O O
89 pain NN B-NP O
89 , , O O
89 s/p NN B-NP O
89 TURP NNP I-NP O
89 , , O O
89 DM NNP B-NP O
90 ------- NNP I-NP O
91 MEDS:Protonix NNP I-NP B-m
91 40 CD O B-do
91 mg NN B-NP I-do
91 po NN I-NP B-mo
91 qam NN I-NP B-f
91 , , O O
91 Sucralfate NNP B-NP B-m
91 1g CD O B-do
91 po NN B-NP B-mo
91 qid NN I-NP B-f
91 , , O O
91 Lasix NNP B-NP B-m
91 10 CD O B-do
91 mg NN B-NP I-do
91 po NN I-NP B-mo
91 qd NN I-NP B-f
91 , , O O
92 Lescol NNP B-NP B-m
92 20 CD O B-do
92 mg NN B-NP I-do
92 po NN I-NP B-mo
92 qd NN I-NP B-f
92 , , O O
92 Cozaar NNP B-NP B-m
92 50 CD O B-do
92 mg NN B-NP I-do
92 po NN I-NP B-mo
92 qd NN I-NP B-f
92 , , O O
92 Glyburide NNP B-NP B-m
92 2.5 CD O B-do
92 po NN B-NP B-mo
92 qd NN I-NP B-f
92 , , O O
92 Paxil NNP B-NP B-m
92 10 CD O B-do
93 mg NN B-NP O
93 po NN I-NP B-mo
93 qd NN I-NP B-f
93 , , O O
93 Ativan NNP B-NP B-m
93 2 CD O B-do
93 mg NN B-NP I-do
93 po NN I-NP B-mo
93 qid NN I-NP B-f
93 , , O O
93 Norvasc NNP B-NP B-m
93 5 CD O B-do
93 mg NN B-NP I-do
93 po NN I-NP B-mo
93 qd NN I-NP B-f
93 , , O O
93 Inderal NNP B-NP B-m
94 10 CD O B-do
94 mg NN B-NP I-do
94 po NN I-NP B-mo
94 qid NN I-NP B-f
94 , , O O
94 Persantine NNP B-NP B-m
94 50 CD O B-do
94 mg NN B-NP I-do
94 bid NN I-NP B-f
94 , , O O
94 Imdur NNP B-NP B-m
94 SR NNP I-NP I-m
94 30 CD O B-do
94 mg NN B-NP I-do
94 po NN I-NP B-mo
95 bid NN I-NP B-f
96 -------- NNP I-NP O
97 Exam NNP I-NP O
97 on IN B-VP O
97 admit:T NN B-NP O
97 96.5 CD O O
97 P: NNP B-NP O
97 64 CD O O
97 BP: NNP B-NP O
97 140/60 CD O O
97 RR: NNP B-NP O
97 20 CD O O
97 O2 NNP B-NP O
97 Sat: NNP I-NP O
97 100% CD O O
97 on IN B-VP O
98 2L CD O O
98 No NNP B-NP O
98 significant JJ B-NP O
98 findings NNS I-NP O
98 CN NNP I-NP O
98 2-12 JJ B-NP O
98 intact JJ I-NP O
98 AAOx3 NNP I-NP O
98 but CC O O
98 a DT B-NP O
98 bit NN I-NP O
99 circular JJ O O
99 in IN B-VP O
99 speech NN B-NP O
100 Labs: NNP I-NP O
100 cardiac NN I-NP O
100 enzymes NNS I-NP O
100 neg RB O O
100 , , O O
100 UA NNP B-NP O
100 clean JJ B-NP O
101 EKG: NNP I-NP O
101 A-paced NNP I-NP O
101 , , O O
101 unchanged JJ O O
101 from IN B-VP O
101 March NNP B-NP O
102 CXR: NNP I-NP O
102 no DT B-NP O
102 acute JJ I-NP O
102 process NN I-NP O
103 Stress NNP I-NP O
103 test NN I-NP O
103 March NNP I-NP O
103 2005:A CD O O
103 small JJ O O
103 to TO O O
103 medium VB O O
103 sized JJ B-NP O
104 region NN I-NP O
104 of IN B-VP O
104 myocardialscar/hibernation NN B-NP O
104 in IN B-VP O
104 the DT B-NP O
104 distribution NN I-NP O
104 of IN B-VP O
105 the DT B-NP O
105 PDA NNP I-NP O
105 coronary JJ B-NP O
105 artery NN I-NP O
105 No DT B-NP O
105 evidence NN I-NP O
105 of IN B-VP O
105 stress NN B-NP O
105 induced VBN O O
106 ischemia NN B-NP O
106 at IN B-VP O
106 a DT B-NP O
106 low JJ I-NP O
106 cardiac JJ I-NP O
106 workload NN I-NP O
107 Dobutamine NNP I-NP B-m
107 MIBI NNP I-NP O
107 4/9 CD O O
107 EF NNP B-NP O
107 48% CD O O
107 , , O O
107 no DT B-NP O
107 reversible JJ I-NP O
107 ischemia NN I-NP O
107 , , O O
107 fixed VBN O O
107 inferior JJ B-NP O
108 defect NN I-NP O
108 ( ( O O
108 old JJ O O
108 ) ) O O
108 Basoinferolateral NNP B-NP O
108 wall NN I-NP O
108 not RB O O
108 interpretale JJ O O
108 due JJ O O
108 to TO O O
108 bowel VB O O
109 activity NN B-NP O
109 When WRB O O
109 given VBN O O
109 dobutamine NN B-NP B-m
109 he PRP O O
109 went VBD B-VP O
109 in IN B-VP O
109 to TO O O
109 a DT B-NP O
109 V-paced JJ I-NP O
109 rhythm--&gt;? JJ I-NP O
110 paroxysmal JJ I-NP O
110 Afib NNP I-NP O
110 Test NNP I-NP O
110 was VBD B-VP O
110 submaximal JJ O O
110 with IN B-VP O
110 max JJ B-NP O
110 HR NNP I-NP O
110 98 CD O O
110 ( ( O O
110 77% CD O O
110 predicted VBN O O
110 ) ) O O
111 HOSPITAL NNP B-NP O
111 COURSE: NNP I-NP O
112 1 CD O O
112 CV: NNP B-NP O
112 Ischemia: NNP I-NP O
112 History NNP I-NP O
112 of IN B-VP O
112 CAD NNP B-NP B-r
112 CAD NNP I-NP B-r
112 CAD NNP I-NP B-r
112 but CC O O
112 no DT B-NP O
112 signs NNS I-NP O
112 of IN B-VP O
112 ischemia NN B-NP O
112 at IN B-VP O
112 present NN B-NP O
113 Ruled VBN O O
113 out RP O O
113 for IN B-VP O
113 MI NNP B-NP O
113 with IN B-VP O
113 3 CD O O
113 sets NNS B-NP O
113 of IN B-VP O
113 cardiac JJ B-NP O
113 enzymes NNS I-NP O
113 and CC O O
113 serial JJ B-NP O
113 EKGs NNP I-NP O
114 Continued NNP I-NP O
114 B-blocker NNP I-NP B-m
114 , , O O
114 statin NN B-NP B-m
114 , , O O
114 and CC O O
114 persantine VB O B-m
114 No NNP B-NP O
114 ASA NNP I-NP O
115 since IN B-VP O
115 history NN B-NP O
115 of IN B-VP O
115 GIB NNP B-NP O
115 with IN B-VP O
115 it PRP O O
115 Monitored VBD B-VP O
115 on IN B-VP O
115 telemetry NN B-NP O
115 without IN B-VP O
115 any DT B-NP O
116 events NNS I-NP O
116 Had VBD B-VP O
116 an DT B-NP O
116 adenosine JJ I-NP B-m
116 MIBI NNP I-NP O
116 on IN B-VP O
116 2/8/05 CD O O
116 with IN B-VP O
116 results NNS B-NP O
116 as IN B-VP O
116 above RB O O
116 Because IN B-VP O
117 he PRP O O
117 went VBD B-VP O
117 into IN B-VP O
117 brief NN B-NP O
117 VT NNP I-NP O
117 , , O O
117 his PRP$ O O
117 PM NNP B-NP O
117 was VBD B-VP O
117 evaluated VBN O O
117 by IN B-VP O
117 EP NNP B-NP O
117 to TO O O
117 r/o VB O O
117 pAF JJ B-NP O
117 EP NNP I-NP O
118 interoogation NN I-NP O
118 revealed VBD B-VP O
118 no DT B-NP O
118 mode NN I-NP O
118 shifts VBZ O O
118 Pt NNP B-NP O
118 continued VBD B-VP O
118 to TO O O
118 do VB O O
118 well RB O O
118 post VB O O
118 MIBI NNP B-NP O
119 Pump: NNP I-NP O
119 HTN: NNP I-NP B-r
119 HTN: NNP I-NP B-r
119 HTN: NNP I-NP B-r
119 HTN: NNP I-NP B-r
119 Continued NNP I-NP O
119 cozaar NN I-NP B-m
119 , , O O
119 ideral JJ O B-m
119 , , O O
119 imdur JJ O B-m
119 , , O O
119 lasix JJ B-NP B-m
120 Rhythm: NNP I-NP O
120 Has NNP I-NP O
120 pacemaker NN I-NP O
120 , , O O
120 no DT B-NP O
120 change NN I-NP O
120 on IN B-VP O
120 EKG NNP B-NP O
120 Monitored NNP I-NP O
120 on IN B-VP O
120 telemetry NN B-NP O
121 2 CD O O
121 PULM: NNP B-NP O
121 No NNP I-NP O
121 active JJ B-NP O
121 issues NNS I-NP O
121 Weaned VBD B-VP O
121 O2 NNP B-NP B-m
121 to TO O O
121 sat&gt;93% VB O B-do
122 3 CD O O
122 RENAL: NNP B-NP O
122 Creatinine NNP I-NP O
122 at IN B-VP O
122 baseline NN B-NP O
122 and CC O O
122 UA NNP B-NP O
122 clean VBP O O
122 Monitored NNP B-NP O
122 Cr NNP I-NP O
122 qd NN I-NP O
122 and CC O O
122 it PRP O O
123 remained VBD B-VP O
123 at IN B-VP O
123 baseline NN B-NP O
124 4 CD O O
124 GI: NNP B-NP O
124 History NNP I-NP O
124 of IN B-VP O
124 GIB NNP B-NP O
124 and CC O O
124 partial JJ B-NP O
124 gastrectomy NN I-NP O
124 for IN B-VP O
124 ulcer NN B-NP O
124 Avoided NNP I-NP O
125 aspirin NN I-NP O
125 , , O O
125 continued VBD B-VP O
125 PPI NNP B-NP B-m
126 5 CD O O
126 ENDO: NNP B-NP O
126 T2DM NNP I-NP B-r
126 Held NNP I-NP O
126 oral JJ B-NP O
126 hypoglycemic NN I-NP O
126 while IN B-VP O
126 in IN B-VP O
126 house NN B-NP O
126 Covered VBN O O
126 with IN B-VP O
127 SSI NNP B-NP B-m
127 regular JJ B-NP I-m
127 qac NN I-NP B-f
128 6 CD O O
128 NEURO: NNP B-NP O
128 "Dizziness" NNP I-NP O
128 unclear JJ O O
128 , , O O
128 does VBZ O O
128 not RB O O
128 give VB O O
128 history NN B-NP O
128 of IN B-VP O
128 room NN B-NP O
128 spinning NN I-NP O
128 or CC O O
129 lightheadedness NN B-NP O
129 It PRP O O
129 is VBZ O O
129 probably RB O O
129 a DT B-NP O
129 symptom NN I-NP O
129 of IN B-VP O
129 his PRP$ O O
129 hypertension NN B-NP O
129 since IN B-VP O
129 he PRP O O
130 has VBZ O O
130 had VBN O O
130 this DT O O
130 in IN B-VP O
130 the DT O O
130 past JJ O O
131 7 CD O O
131 FEN: NNP B-NP O
131 Low-fat NNP I-NP O
131 , , O O
131 low JJ B-NP O
131 salt NN I-NP O
131 diet JJ B-NP O
131 No NNP I-NP O
131 further JJ B-NP O
131 fluids NNS I-NP O
131 after IN B-VP O
131 what WP O O
131 he PRP O O
131 got VBD B-VP O
132 in IN B-VP O
132 ED NNP B-NP O
132 Taking NNP I-NP O
132 good JJ B-NP O
132 POs NNP I-NP O
133 8 CD O O
133 PPX: NNP B-NP O
133 Sc NNP I-NP B-mo
133 lovenox NN I-NP B-m
133 , , O O
133 PPI NNP B-NP B-m
134 9 CD O O
134 DISPO: NNP B-NP O
134 PT NNP I-NP O
134 consult NN I-NP O
134 placed VBD B-VP O
134 Discharged NNP B-NP O
134 home NN I-NP O
134 with IN B-VP O
134 VNA NNP B-NP O
135 10 CD O O
135 Full NNP B-NP O
135 code NN I-NP O
136 ADDITIONAL NNP I-NP O
136 COMMENTS: NNP I-NP O
136 Please NNP I-NP O
136 call VB O O
136 physician NN B-NP O
136 if IN B-VP O
136 you PRP O O
136 develop VBP O O
136 fevers NNS B-NP O
136 , , O O
136 chills NNS B-NP O
136 , , O O
136 shortness NN B-NP O
136 of IN B-VP O
136 breath NN B-NP O
136 , , O O
137 or CC O O
137 any DT B-NP O
137 other JJ I-NP O
137 symptoms NNS I-NP O
137 you PRP O O
137 find VBP O O
137 concerning VBG O O
137 Please NNP B-NP O
137 continue VB O O
137 taking VBG O O
137 your PRP$ O O
138 home NN B-NP B-m
138 medications NNS I-NP I-m
138 as IN B-VP O
138 before; NN B-NP O
138 there EX O O
138 have VBP O O
138 been VBN O O
138 no DT B-NP O
138 changes NNS I-NP O
139 DISCHARGE NNP I-NP O
139 CONDITION: NNP I-NP O
139 Satisfactory NNP I-NP O
140 TO NNP I-NP O
140 DO/PLAN: NNP I-NP O
141 Pacemaker NNP I-NP O
141 interrogation NN I-NP O
142 No NNP I-NP O
142 dictated VBD B-VP O
142 summary JJ B-NP O
143 ENTERED NNP I-NP O
143 BY: NNP I-NP O
143 SLOVINSKY NNP I-NP O
143 , , O O
143 JORGE NNP B-NP O
143 , , O O
143 M.D NNP B-NP O
143 ( ( O O
143 FS29 NNP B-NP O
143 ) ) O O
143 8/25/06 CD O O
143 @ $ O O
143 10 CD O O
144 ****** JJ B-NP O
144 END NN I-NP O
144 OF NNP I-NP O
144 DISCHARGE NNP I-NP O
144 ORDERS NNP I-NP O
144 ****** NNP I-NP O
145 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #416584 VBZ O O
4 490679245 CD O O
4 BMC NNP B-NP O
4 46490049 CD O O
4 5286761 CD O O
4 7/18/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/18/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/28/2005 CD O O
7 ATTENDING: NNP B-NP O
7 QUINCY NNP I-NP O
7 BRIDENBAUGH NNP I-NP O
7 MD NNP I-NP O
8 PRINCIPAL NNP I-NP O
8 DIAGNOSES: NNP I-NP O
9 1 CD O O
9 Hypoglycemia NNP B-NP O
10 2 CD O O
10 Altered NNP B-NP O
10 mental JJ B-NP O
10 status NN I-NP O
11 OTHER NNP I-NP O
11 DIAGNOSES: NNP I-NP O
12 1 CD O O
12 Volume NN B-NP O
12 overload NN I-NP O
12 likely JJ O O
12 secondary JJ O O
12 to TO O O
12 CHF VB O O
13 2 CD O O
13 Possible NNP B-NP O
13 pneumonia NN I-NP O
14 PAST NNP I-NP O
14 MEDICAL NNP I-NP O
14 HISTORY: NNP I-NP O
15 Significant NNP I-NP O
15 for: VBD B-VP O
16 1 CD O O
16 Bilateral NNP B-NP O
16 occipital JJ B-NP O
16 CVAs NNP I-NP O
17 2 CD O O
17 Diabetes NNP B-NP B-r
17 , , O O
17 on IN B-VP O
17 insulin NN B-NP B-m
18 3 CD O O
18 Hypertension NNP B-NP O
19 4 CD O O
19 Chronic NNP B-NP O
19 renal JJ B-NP O
19 insufficiency NN I-NP O
20 5 CD O O
20 Coronary JJ B-NP O
20 artery NN I-NP O
20 disease NN I-NP O
21 6 CD O O
21 Visual NNP B-NP O
21 impair NN I-NP O
21 with IN B-VP O
21 tunnel JJ B-NP O
21 vision NN I-NP O
22 7 CD O O
22 Monoclonal NNP B-NP O
22 gammopathy NN I-NP O
23 8 CD O O
23 Bilateral NNP B-NP O
23 occipital JJ B-NP O
23 CVAs NNP I-NP O
24 9 CD O O
24 History NNP B-NP O
24 of IN B-VP O
24 left JJ B-NP O
24 upper JJ I-NP O
24 extremity NN I-NP O
24 thrombophlebitis NN I-NP O
25 10 CD O O
25 Microcytic JJ B-NP O
25 anemia NN I-NP O
26 HISTORY NNP I-NP O
26 OF NNP I-NP O
26 PRESENT NNP I-NP O
26 ILLNESS: NNP I-NP O
27 The DT B-NP O
27 patient NN I-NP O
27 is VBZ O O
27 a DT B-NP O
27 75-year-old JJ I-NP O
27 woman NN I-NP O
27 who WP O O
27 was VBD B-VP O
27 found VBN O O
27 at IN B-VP O
27 home NN B-NP O
27 with IN B-VP O
28 altered JJ B-NP O
28 mental JJ I-NP O
28 status NN I-NP O
28 by IN B-VP O
28 home NN B-NP O
28 services NNS I-NP O
28 and CC O O
28 home NN B-NP O
28 nursing NN I-NP O
28 with IN B-VP O
29 confusion NN B-NP O
29 Her NNP I-NP O
29 fingerstick NN I-NP O
29 was VBD B-VP O
29 37 CD O O
29 , , O O
29 which WDT O O
29 increased VBD B-VP O
29 to TO O O
29 42 CD O O
29 with IN B-VP O
30 orange NN B-NP O
30 juice NN I-NP O
30 with IN B-VP O
30 improvement NN B-NP O
30 of IN B-VP O
30 her PRP$ O O
30 mental JJ B-NP O
30 status NN I-NP O
30 Her NNP I-NP O
30 insulin NN I-NP B-m
31 regimen NN I-NP O
31 has VBZ O O
31 been VBN O O
31 stable JJ O O
31 for IN B-VP O
31 quite RB O O
31 some DT B-NP O
31 time NN I-NP O
31 She PRP O O
31 had VBD B-VP O
31 taken VBN O O
31 her PRP$ O O
32 regular JJ B-NP O
32 dose NN I-NP O
32 of IN B-VP O
32 Novolin NNP B-NP B-m
32 40 CD O B-do
32 units NNS B-NP I-do
32 on IN B-VP O
32 the DT B-NP O
32 morning NN I-NP O
32 of IN B-VP O
32 admission NN B-NP O
33 She PRP O O
33 was VBD B-VP O
33 sent VBN O O
33 to TO O O
33 the DT B-NP O
33 emergency NN I-NP O
33 department NN I-NP O
33 She PRP O O
33 has VBZ O O
33 noted VBN O O
34 increasing VBG O O
34 bilateral JJ B-NP O
34 lower JJR I-NP O
34 extremity NN I-NP O
34 edema NN I-NP O
34 over IN B-VP O
34 one CD O O
34 or CC O O
34 two CD O O
35 months NNS B-NP O
35 , , O O
35 increased VBD B-VP O
35 dyspnea NN B-NP O
35 on IN B-VP O
35 exertion NN B-NP O
35 , , O O
35 nocturia NN B-NP O
35 In IN B-VP O
35 the DT B-NP O
35 ED NNP I-NP O
35 , , O O
35 her PRP$ O O
36 ambulatory JJ B-NP O
36 sat NN I-NP O
36 was VBD B-VP O
36 91% CD O O
36 on IN B-VP O
36 room NN B-NP O
36 air NN I-NP O
36 Glucose NNP I-NP O
36 was VBD B-VP O
36 still RB O O
36 low JJ O O
36 and CC O O
36 on IN B-VP O
37 chest JJS B-NP O
37 x-ray NN I-NP O
37 there EX O O
37 was VBD B-VP O
37 evidence NN B-NP O
37 of IN B-VP O
37 a DT B-NP O
37 right JJ I-NP O
37 pleural JJ I-NP O
37 effusion NN I-NP O
37 and CC O O
38 right JJ B-NP O
38 lower JJR I-NP O
38 lobe NN I-NP O
38 consolidation NN I-NP O
38 versus IN B-VP O
38 atelectasis NN B-NP O
38 She PRP O O
38 was VBD B-VP O
38 given VBN O O
39 Lasix NNP B-NP B-m
39 , , O O
39 glucose NN B-NP B-m
39 , , O O
39 Levaquin NNP B-NP B-m
39 , , O O
39 and CC O O
39 blood NN B-NP O
39 cultures NNS I-NP O
39 were VBD B-VP O
39 drawn VBN O O
39 She PRP O O
39 was VBD B-VP O
40 admitted VBN O O
40 for IN B-VP O
40 treatment NN B-NP O
40 of IN B-VP O
40 pneumonia NN B-NP O
41 She PRP O O
41 has VBZ O O
41 an DT B-NP O
41 allergy NN I-NP O
41 to TO O O
41 propoxyphene VB O O
42 MEDICATIONS: NNP B-NP O
43 1 CD O O
43 Lasix NNP B-NP B-m
43 Lasix NNP I-NP B-m
43 80 CD O B-do
43 mg NN B-NP I-do
43 p.o NN I-NP B-mo
43 q.d NN I-NP B-f
43 in IN B-VP I-f
43 the DT B-NP I-f
43 morning NN I-NP I-f
43 , , O O
43 40 CD O B-do
43 mg NN B-NP I-do
43 p.o NN I-NP B-mo
43 q.d NN I-NP B-f
43 in IN B-VP O
43 the DT B-NP O
44 evening NN I-NP O
45 2 CD O O
45 Atenolol NNP B-NP B-m
45 75 CD O B-do
45 mg NN B-NP I-do
45 p.o NN I-NP B-mo
45 q.d VBD B-VP B-f
46 3 CD O O
46 Lipitor NNP B-NP B-m
46 10 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 q.d VBD B-VP B-f
47 4 CD O O
47 Amitriptyline NNP B-NP B-m
47 25 CD O B-do
47 to TO O I-do
47 50 CD O I-do
47 mg NNS B-NP I-do
47 p.o JJ B-NP B-mo
47 q.h.s JJ I-NP B-f
47 p.r.n NN I-NP I-f
48 5 CD O O
48 Multivitamins NNP B-NP B-m
49 6 CD O O
49 Aspirin NNP B-NP B-m
49 325 CD O B-do
49 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 q.d VBD B-VP B-f
50 7 CD O O
50 Folate NNP B-NP B-m
50 100 CD O B-do
50 mg NN B-NP I-do
50 p.o NN I-NP B-mo
50 q.d VBD B-VP B-f
51 8 CD O O
51 Lisinopril NNP B-NP B-m
51 20 CD O B-do
51 mg NN B-NP I-do
51 p.o NN I-NP B-mo
51 q.d $ O B-f
52 9 CD O O
52 Iron NNP B-NP B-m
52 gluconate NN I-NP I-m
52 325 CD O B-do
52 mg NN B-NP I-do
52 p.o NN I-NP B-mo
52 t.i.d VBD B-VP B-f
53 10 CD O O
53 Novolin NNP B-NP B-m
53 34 CD O B-do
53 to TO O I-do
53 40 CD O I-do
53 units NNS B-NP I-do
53 subcu VBD B-VP B-mo
53 q.d RB O B-f
54 11 CD O O
54 Epogen NN B-NP B-m
54 5000 CD O B-do
54 units NNS B-NP I-do
54 subcu VBD B-VP B-mo
54 q JJ B-NP B-f
54 week NN I-NP I-f
55 FAMILY NNP I-NP O
55 HISTORY: NNP I-NP O
56 Father NNP I-NP O
56 died VBD B-VP O
56 of IN B-VP O
56 an DT B-NP O
56 MI NNP I-NP O
56 in IN B-VP O
56 his PRP$ O O
56 70s CD O O
56 , , O O
56 mother JJR O O
56 died VBD B-VP O
56 of IN B-VP O
56 leukemia NN B-NP O
56 No NNP I-NP O
57 history NN I-NP O
57 of IN B-VP O
57 hematologic NN B-NP O
57 disorders NNS I-NP O
57 in IN B-VP O
57 her PRP$ O O
57 family NN B-NP O
57 No NNP I-NP O
57 history NN I-NP O
57 of IN B-VP O
58 thalassemia NN B-NP O
58 that IN B-VP O
58 the DT B-NP O
58 patient NN I-NP O
58 knows VBZ O O
58 of IN B-VP O
59 SOCIAL NNP B-NP O
59 HISTORY: NNP I-NP O
60 She PRP O O
60 lives VBZ O O
60 in IN B-VP O
60 an DT B-NP O
60 assisted JJ I-NP O
60 living NN I-NP O
60 facility NN I-NP O
60 and CC O O
60 has VBZ O O
60 extensive JJ B-NP O
60 home NN I-NP O
61 care NN I-NP O
61 services NNS I-NP O
61 and CC O O
61 lives VBZ O O
61 alone RB O O
61 She PRP O O
61 was VBD B-VP O
61 previously RB O O
61 a DT B-NP O
61 nurse NN I-NP O
61 She PRP O O
62 has VBZ O O
62 children NNS B-NP O
62 who WP O O
62 live VBP O O
62 nearby RB O O
63 PHYSICAL NNP B-NP O
63 EXAM: NNP I-NP O
64 Vital NNP I-NP O
64 signs: VBD B-VP O
64 Temperature NNP B-NP O
64 was VBD B-VP O
64 95.2 CD O O
64 , , O O
64 blood NN B-NP O
64 pressure NN I-NP O
64 111/69 CD O O
64 , , O O
64 heart NN B-NP O
65 rate NN I-NP O
65 73 CD O O
65 , , O O
65 sating VBG O O
65 97% CD O O
65 on IN B-VP O
65 room NN B-NP O
65 air NN I-NP O
65 She PRP O O
65 was VBD B-VP O
65 alert JJ O O
65 and CC O O
65 oriented JJ B-NP O
65 x3 NNP I-NP O
66 Speech NNP I-NP O
66 and CC O O
66 mentation NN B-NP O
66 were VBD B-VP O
66 normal JJ B-NP O
66 No NNP I-NP O
66 lymphadenopathy NN I-NP O
66 2/6 CD O O
67 systolic JJ B-NP O
67 murmur NN I-NP O
67 at IN B-VP O
67 the DT B-NP O
67 base NN I-NP O
67 radiating NN I-NP O
67 to TO O O
67 across IN B-VP O
67 her PRP$ O O
67 precordium NN B-NP O
68 Distant NNP I-NP O
68 heart NN I-NP O
68 sounds VBZ O O
68 Right JJ B-NP O
68 lower JJR I-NP O
68 lobe NN I-NP O
68 with IN B-VP O
68 decreased JJ B-NP O
68 breath NN I-NP O
69 sounds NNS I-NP O
69 and CC O O
69 decreased JJ B-NP O
69 phrenitis NN I-NP O
69 , , O O
69 wheezing VBG O O
69 throughout IN B-VP O
69 her PRP$ O O
69 right JJ B-NP O
70 lung NN I-NP O
70 Abdomen: NNP I-NP O
70 Obese NNP I-NP O
70 , , O O
70 soft JJ O O
70 , , O O
70 nondistended JJ O O
70 , , O O
70 nontender NN B-NP O
70 , , O O
70 benign JJ B-NP O
71 Extremities: NNP I-NP O
71 2 CD O O
71 to TO O O
71 3+ CD O O
71 pitting VBG O O
71 edema JJ O O
71 bilateral JJ O O
71 and CC O O
71 symmetric JJ B-NP O
72 Neurologic: NNP I-NP O
72 She PRP O O
72 was VBD B-VP O
72 moving VBG O O
72 all DT B-NP O
72 extremities NNS I-NP O
72 well RB O O
72 Left NNP B-NP O
72 eye NN I-NP O
72 with IN B-VP O
73 slight JJ B-NP O
73 lateral JJ I-NP O
73 deviation NN I-NP O
73 Extraocular NNP I-NP O
73 movements NNS I-NP O
73 intact JJ B-NP O
73 Pupils NNP I-NP O
74 equally RB O O
74 round VBD B-VP O
74 and CC O O
74 reactive JJ O O
74 to TO O O
74 light JJ B-NP O
74 Evidence NNP I-NP O
74 of IN B-VP O
74 an DT B-NP O
74 old JJ I-NP O
75 cataract NN I-NP O
76 ADMISSION NNP I-NP O
76 DATA: NNP I-NP O
77 BNP NNP I-NP O
77 of IN B-VP O
77 1111 CD O O
77 , , O O
77 creatinine NN B-NP O
77 was VBD B-VP O
77 2.4 CD O O
77 which WDT O O
77 was VBD B-VP O
77 below IN B-VP O
77 her PRP$ O O
77 baseline NN B-NP O
77 of IN B-VP O
78 2.6 CD O O
78 to TO O O
78 2.8 CD O O
78 , , O O
78 white JJ B-NP O
78 count NN I-NP O
78 was VBD B-VP O
78 6.6 CD O O
78 with IN B-VP O
78 no DT B-NP O
78 left NN I-NP O
78 shift NN I-NP O
78 , , O O
78 hematocrit NN B-NP O
79 was VBD B-VP O
79 35.7 CD O O
79 which WDT O O
79 is VBZ O O
79 up RP O O
79 from IN B-VP O
79 her PRP$ O O
79 baseline NN B-NP O
79 of IN B-VP O
79 27 CD O O
79 to TO O O
79 33 CD O O
79 MCV NNP B-NP O
79 was VBD B-VP O
79 67.4 CD O O
80 which WDT O O
80 is VBZ O O
80 stable JJ O O
80 and CC O O
80 it PRP O O
80 has VBZ O O
80 been VBN O O
80 in IN B-VP O
80 this DT B-NP O
80 range NN I-NP O
80 and CC O O
80 she PRP O O
80 was VBD B-VP O
80 found VBN O O
81 to TO O O
81 have VB O O
81 in IN B-VP O
81 4/27 CD O O
81 a DT B-NP O
81 monoclonal JJ I-NP O
81 gammopathy NN I-NP O
81 on IN B-VP O
81 SPEP NNP B-NP O
81 EKG NNP I-NP O
81 showed VBD B-VP O
82 an DT B-NP O
82 inferoseptal JJ I-NP O
82 Q NNP I-NP O
82 wave NN I-NP O
82 , , O O
82 poor JJ B-NP O
82 R NNP I-NP O
82 wave NN I-NP O
82 progression NN I-NP O
82 , , O O
82 low JJ B-NP O
82 voltage NN I-NP O
82 left VBD B-VP O
83 axis JJ B-NP O
83 deviation NN I-NP O
83 Echo NNP I-NP O
83 in IN B-VP O
83 4/27 CD O O
83 showed VBD B-VP O
83 an DT B-NP O
83 EF NNP I-NP O
83 of IN B-VP O
83 50 CD O O
83 to TO O O
83 55% CD O O
83 with IN B-VP O
84 moderate-to-severe JJ B-NP O
84 MR NNP I-NP O
84 and CC O O
84 TR NNP B-NP O
84 , , O O
84 septal JJ B-NP O
84 hypokinesis NN I-NP O
84 and CC O O
84 a DT B-NP O
84 MIBI NNP I-NP O
84 at IN B-VP O
85 that DT B-NP O
85 time NN I-NP O
85 showed VBD B-VP O
85 no DT B-NP O
85 reversible JJ I-NP O
85 ischemia NN I-NP O
85 Chest NNP I-NP O
85 x-ray NN I-NP O
85 as IN B-VP O
86 describes NNS B-NP O
86 above IN B-VP O
86 UA NNP B-NP O
86 negative JJ O O
86 for IN B-VP O
86 UTI NNP B-NP O
87 IMPRESSION: NNP I-NP O
88 The DT B-NP O
88 patient NN I-NP O
88 was VBD B-VP O
88 evaluated VBN O O
88 to TO O O
88 be VB O O
88 low JJ B-NP O
88 likelihood NN I-NP O
88 for IN B-VP O
88 having VBG O O
89 pneumonia NN B-NP O
89 She PRP O O
89 was VBD B-VP O
89 thought VBN O O
89 to TO O O
89 more RBR O O
89 likely JJ O O
89 have VBP O O
89 volume NN B-NP O
89 overload NN I-NP O
90 secondary JJ O O
90 to TO O O
90 CHF NNP B-NP O
90 Because IN B-VP O
90 of IN B-VP O
90 her PRP$ O O
90 visual JJ B-NP O
90 problems NNS I-NP O
90 and CC O O
90 declining VBG O O
91 physical JJ B-NP O
91 condition NN I-NP O
91 and CC O O
91 deconditioning NN B-NP O
91 , , O O
91 patient's JJ B-NP O
91 current JJ I-NP O
91 living NN I-NP O
92 situation NN I-NP O
92 and CC O O
92 arrangements NNS B-NP O
92 are VBP O O
92 possibly RB O O
92 insufficient JJ O O
92 for IN B-VP O
92 her PRP$ O O
93 increasing VBG O O
93 needs NNS B-NP O
93 and CC O O
93 error NN B-NP O
93 in IN B-VP O
93 self JJ B-NP O
93 administration NN I-NP O
93 of IN B-VP O
93 medications NNS B-NP O
94 or CC O O
94 increasing VBG O O
94 renal JJ B-NP O
94 insufficiency NN I-NP O
94 or CC O O
94 poor JJ B-NP O
94 p.o NNS I-NP O
94 intake VBP O O
94 may MD O O
94 have VB O O
95 precipitated VBN O O
95 her PRP$ O O
95 hypoglycemic JJ B-NP O
95 episode NN I-NP O
95 and CC O O
95 altered VBD B-VP O
95 mental JJ B-NP O
95 status NN I-NP O
96 HOSPITAL NNP I-NP O
96 COURSE: NNP I-NP O
97 ID/Pulmonary: NNP I-NP O
97 Right NNP I-NP O
97 lower JJR B-NP O
97 lobe NN I-NP O
97 pneumonia NN I-NP O
97 versus NN I-NP O
97 CHF NNP I-NP O
97 , , O O
97 pleural JJ B-NP O
98 effusion NN I-NP O
98 This DT O O
98 was VBD B-VP O
98 treated VBN O O
98 initially RB O O
98 with IN B-VP O
98 levofloxacin JJ O B-m
98 although IN B-VP O
99 it PRP O O
99 is VBZ O O
99 unlikely JJ B-NP O
99 consolidated JJ I-NP O
99 lobar NN I-NP B-r
99 pneumonia NN I-NP I-r
99 because IN B-VP O
99 of IN B-VP O
99 the DT B-NP O
100 patient's NN I-NP O
100 good JJ B-NP O
100 clinical JJ I-NP O
100 status NN I-NP O
100 , , O O
100 lack NN B-NP O
100 of IN B-VP O
100 fever NN B-NP O
100 and CC O O
100 white JJ B-NP O
100 count NN I-NP O
100 and CC O O
101 lack NN B-NP O
101 of IN B-VP O
101 toxicity NN B-NP O
101 Sputum NNP I-NP O
101 culture NN I-NP O
101 and CC O O
101 gram NN B-NP O
101 stein NNS I-NP O
101 were VBD B-VP O
102 unremarkable JJ B-NP O
102 Pleural NNP I-NP O
102 effusion NN I-NP O
102 on IN B-VP O
102 the DT B-NP O
102 right NN I-NP O
102 decreased VBD B-VP O
102 only RB O O
103 minimally RB O O
103 with IN B-VP O
103 diuresis NN B-NP O
103 of IN B-VP O
103 1 CD O O
103 to TO O O
103 2 CD O O
103 liters NNS B-NP O
103 overnight JJ O O
103 and CC O O
103 for IN B-VP O
104 diagnostic JJ O O
104 and CC O O
104 therapeutic JJ B-NP O
104 purposes NNS I-NP O
104 , , O O
104 the DT B-NP O
104 patient NN I-NP O
104 underwent NN I-NP O
104 a DT B-NP O
105 thoracentesis NN I-NP O
105 on IN B-VP O
105 2/11/05 CD O O
105 and CC O O
105 had VBD B-VP O
105 withdraw VBN O O
105 800 CD O O
105 cc NN B-NP O
105 of IN B-VP O
105 clear JJ B-NP O
105 yellow JJ I-NP O
106 fluid NN I-NP O
106 whose WP$ O O
106 chemistries NNS B-NP O
106 and CC O O
106 cell NN B-NP O
106 count NN I-NP O
106 were VBD B-VP O
106 consistent JJ O O
106 with IN B-VP O
106 a DT B-NP O
107 sterile JJ I-NP O
107 transudative JJ I-NP O
107 effusion NN I-NP O
107 Gram NNP I-NP O
107 stein NN I-NP O
107 was VBD B-VP O
107 negative JJ B-NP O
108 Cultures NNS I-NP O
108 are VBP O O
108 pending VBG O O
108 at IN B-VP O
108 this DT B-NP O
108 time NN I-NP O
108 and CC O O
108 a DT B-NP O
108 chest JJ I-NP O
108 x-ray NN I-NP O
108 may MD O O
108 be VB O O
109 repeated VBN O O
109 to TO O O
109 rule VB O O
109 out RP O O
109 underlying VBG O O
109 pneumonia NN B-NP O
109 revealed VBN O O
109 by IN B-VP O
109 draining VBG O O
109 of IN B-VP O
110 the DT B-NP O
110 effusion NN I-NP O
110 Urine NNP I-NP O
110 legionella NN I-NP O
110 was VBD B-VP O
110 negative JJ B-NP O
111 Renal: NNP I-NP O
111 Chronic NNP I-NP O
111 renal JJ B-NP O
111 insufficiency NN I-NP O
111 Creatinine NNP I-NP O
111 is VBZ O O
111 at IN B-VP O
111 a DT B-NP O
111 baseline NN I-NP O
112 of IN B-VP O
112 2.6 CD O O
112 and CC O O
112 it PRP O O
112 decreased VBD B-VP O
112 significantly RB O O
112 on IN B-VP O
112 this DT B-NP O
112 admission NN I-NP O
112 possibly RB O O
113 because IN B-VP O
113 of IN B-VP O
113 improved JJ O O
113 forward RB O O
113 flow VBP O O
113 from IN B-VP O
113 discontinuation NN B-NP O
113 of IN B-VP O
113 her PRP$ O O
113 ACE NNP B-NP B-m
114 inhibitor NN I-NP O
115 Endocrinology: NNP I-NP O
115 The DT B-NP O
115 patient NN I-NP O
115 was VBD B-VP O
115 admitted VBN O O
115 with IN B-VP O
115 hypoglycemic JJ B-NP O
116 diabetes NNS I-NP O
116 possibly RB O O
116 secondary JJ O O
116 to TO O O
116 infection NN B-NP O
116 or CC O O
116 logistical JJ O O
116 and CC O O
116 social JJ B-NP O
117 barriers NNS I-NP O
117 Her PRP$ O O
117 NPH NNP B-NP B-m
117 dose NN I-NP O
117 was VBD B-VP O
117 cut VBN O O
117 to TO O O
117 20 CD O B-do
117 units NNS B-NP I-do
117 subcu VBD B-VP B-mo
117 q.d NN B-NP B-f
117 with IN B-VP O
118 lispro JJ O B-m
118 lispro JJ O B-m
118 lispro FW O B-m
118 sliding VBG O B-do
118 sliding VBG O B-do
118 scale JJ B-NP I-do
118 scale NN I-NP I-do
118 q.a.c NN I-NP B-f
118 and CC O O
118 q.h.s NN B-NP B-f
118 which WDT O O
118 she PRP O O
118 needed VBD B-VP O
118 only RB O O
119 minimally RB O O
119 about IN B-VP O
119 5 CD O B-do
119 units NNS B-NP I-do
119 a DT B-NP B-f
119 day NN I-NP I-f
119 and CC O O
119 her PRP$ O O
119 sugars NNS B-NP O
119 were VBD B-VP O
119 well RB O O
119 controlled VBN O O
120 on IN B-VP O
120 this DT B-NP O
120 regimen NN I-NP O
120 which WDT O O
120 supports VBZ O O
120 the DT B-NP O
120 hypothesis NN I-NP O
120 that IN B-VP O
120 her PRP$ O O
120 NPH NNP B-NP B-m
120 dose NN I-NP O
121 of IN B-VP O
121 34 CD O B-do
121 units NNS B-NP I-do
121 a DT B-NP B-f
121 day NN I-NP I-f
121 was VBD B-VP O
121 too RB O O
121 high JJ O O
121 beyond IN B-VP O
121 a DT B-NP O
121 certain JJ I-NP O
121 point NN I-NP O
122 Cardiac: NNP I-NP O
123 A NNP I-NP O
123 Pump: NNP I-NP O
123 The DT B-NP O
123 patient NN I-NP O
123 with IN B-VP O
123 CHF NNP B-NP O
123 , , O O
123 known VBN O O
123 valvular JJ B-NP O
123 dysfunction NN I-NP O
123 , , O O
124 exhibiting VBG O O
124 pulmonary JJ B-NP O
124 edema NN I-NP O
124 , , O O
124 lower JJR B-NP O
124 extremity NN I-NP O
124 edema NN I-NP O
124 and CC O O
124 orthopnea NN B-NP O
125 She PRP O O
125 was VBD B-VP O
125 initially RB O O
125 diuresed VBN O O
125 with IN B-VP O
125 IV NNP B-NP B-mo
125 Lasix NNP I-NP B-m
125 and CC O O
125 it PRP O O
125 was VBD B-VP O
125 noted VBN O O
125 that IN B-VP O
126 her PRP$ O O
126 weight NN B-NP O
126 was VBD B-VP O
126 up RB O O
126 10 CD O O
126 pounds NNS B-NP O
126 from IN B-VP O
126 her PRP$ O O
126 prior JJ B-NP O
126 admission NN I-NP O
126 She PRP O O
126 was VBD B-VP O
127 transitioned VBN O O
127 to TO O O
127 p.o VB O B-mo
127 Lasix NNP B-NP B-m
127 after IN B-VP O
127 diuresing VBG O O
127 very RB O O
127 well RB O O
127 on IN B-VP O
127 this DT B-NP O
128 regimen NN I-NP O
128 She PRP O O
128 continued VBD B-VP O
128 her PRP O O
128 Lipitor NNP B-NP B-m
128 and CC O O
128 aspirin NN B-NP B-m
128 , , O O
128 atenolol NN B-NP B-m
128 was VBD B-VP O
129 changed VBN O O
129 metoprolol RB O B-m
129 given VBN O O
129 her PRP$ O O
129 renal JJ B-NP B-r
129 insufficiency NN I-NP I-r
129 Lisinopril NNP I-NP B-m
129 was VBD B-VP O
130 switched VBN O O
130 to TO O O
130 captopril VB O B-m
130 , , O O
130 then RB O O
130 discontinued VBD B-VP O
130 given VBN O O
130 her PRP$ O O
130 bumping VBG O O
131 creatinine NN B-NP O
131 while IN B-VP O
131 diuresing VBG O O
131 on IN B-VP O
131 the DT B-NP O
131 ACE NNP I-NP B-m
131 inhibitor NN I-NP I-m
131 She PRP O O
131 was VBD B-VP O
132 slightly RB O O
132 hypotensive JJ O O
132 with IN B-VP O
132 systolic JJ B-NP O
132 blood NN I-NP O
132 pressures NNS I-NP O
132 in IN B-VP O
132 the DT O O
132 90s CD O O
132 to TO O O
133 100s CD O O
133 at IN B-VP O
133 one CD O O
133 point NN B-NP O
133 and CC O O
133 responded VBD B-VP O
133 to TO O O
133 a DT B-NP O
133 bolus NN I-NP O
133 of IN B-VP O
133 fluid NN B-NP O
133 , , O O
133 decrease NN B-NP O
133 in IN B-VP O
134 the DT B-NP O
134 captopril NN I-NP B-m
134 and CC O O
134 holding VBG O O
134 the DT B-NP O
134 Lasix NNP I-NP B-m
134 , , O O
134 unclear JJ B-NP O
134 etiology NN I-NP O
134 , , O O
134 looks VBZ O O
135 otherwise RB O O
135 low JJ B-NP O
135 Lasix NNP I-NP B-m
135 Lasix NNP I-NP B-m
135 was VBD B-VP O
135 decreased VBN O O
135 to TO O O
135 80 CD O B-do
135 mg NNS B-NP I-do
135 p.o JJ B-NP B-mo
135 b.i.d NN I-NP B-f
135 and CC O O
135 the DT B-NP O
136 patient NN I-NP O
136 should MD O O
136 have VB O O
136 daily JJ B-NP O
136 weights NNS I-NP O
136 and CC O O
136 electrolytes VBZ O O
136 checked VBN O O
136 and CC O O
137 repleted VBN O O
137 to TO O O
137 ensure VB O O
137 that IN B-VP O
137 her PRP$ O O
137 diuresis NN B-NP O
137 is VBZ O O
137 only RB O O
137 moderate JJ O O
137 everyday JJ O O
137 no DT O O
138 more JJR O O
138 than IN B-VP O
138 one CD O O
138 liter NN B-NP O
138 a DT B-NP O
138 day NN I-NP O
138 but CC O O
138 is VBZ O O
138 consistent JJ O O
138 such JJ O O
138 that IN B-VP O
138 she PRP O O
138 is VBZ O O
138 able JJ O O
139 to TO O O
139 maintain VB O O
139 her PRP$ O O
139 electrolytes NNS B-NP O
139 and CC O O
139 loose JJ B-NP O
139 fluid NN I-NP O
139 overtime NN I-NP O
140 Heme: NNP I-NP O
140 The DT B-NP O
140 patient NN I-NP O
140 has VBZ O O
140 a DT B-NP O
140 monoclonal JJ I-NP O
140 gammopathy NN I-NP O
140 and CC O O
140 a DT B-NP O
140 microcytosis NN I-NP O
141 which WDT O O
141 might MD O O
141 suggest VB O O
141 thalassemia NN B-NP O
141 She PRP O O
141 is VBZ O O
141 on IN B-VP O
141 iron NN B-NP B-m
141 and CC O O
141 Epogen NNP B-NP B-m
141 with IN B-VP O
142 an DT B-NP O
142 improved JJ I-NP O
142 hematocrit NN I-NP O
142 from IN B-VP O
142 the DT B-NP O
142 prior JJ I-NP O
142 admission NN I-NP O
142 but CC O O
142 no DT B-NP O
142 change NN I-NP O
142 in IN B-VP O
143 her PRP$ O O
143 MCV NNP B-NP O
143 , , O O
143 which WDT O O
143 suggests VBZ O O
143 that IN B-VP O
143 she PRP O O
143 has VBZ O O
143 more JJR O O
143 than IN B-VP O
143 renal JJ B-NP O
143 disease NN I-NP O
144 causing VBG O O
144 her PRP$ O O
144 microcytosis NN B-NP O
144 Further NNP I-NP O
144 workup NN I-NP O
144 of IN B-VP O
144 her PRP$ O O
144 monoclonal JJ B-NP O
145 gammopathy NN I-NP O
145 will MD O O
145 be VB O O
145 deferred VBN O O
145 to TO O O
145 her PRP$ O O
145 primary JJ B-NP O
145 care NN I-NP O
145 physician JJ B-NP O
146 Diabetic NNP I-NP O
146 diet: NN I-NP O
146 Low NNP I-NP O
146 sodium NN I-NP O
146 , , O O
146 low JJ B-NP O
146 fat NN I-NP O
146 , , O O
146 low JJ B-NP O
146 cholesterol NN I-NP O
147 Prophylaxis: NNP I-NP B-r
147 Prophylaxis: NNP I-NP B-r
147 Heparin NNP I-NP B-m
147 and CC O O
147 H2 NNP B-NP B-m
147 blocker NN I-NP I-m
148 DISPOSITION: NNP I-NP O
149 The DT B-NP O
149 patient NN I-NP O
149 has VBZ O O
149 been VBN O O
149 screened VBN O O
149 for IN B-VP O
149 admission NN B-NP O
149 to TO O O
149 Jack NNP B-NP O
149 Nor NNP I-NP O
149 Medical NNP I-NP O
149 Center NNP I-NP O
149 Of IN B-VP O
149 where WRB O O
150 she PRP O O
150 will MD O O
150 go VB O O
150 today NN B-NP O
150 Her NNP I-NP O
150 goal NN I-NP O
150 is VBZ O O
150 intense JJ B-NP O
150 physical JJ I-NP O
150 therapy NN I-NP O
150 and CC O O
151 learning VBG O O
151 greater JJR B-NP O
151 independence NN I-NP O
151 in IN B-VP O
151 her PRP$ O O
151 daily JJ O O
151 functioning VBG O O
151 Her PRP$ O O
152 pelvic JJ B-NP O
152 films NNS I-NP O
152 were VBD B-VP O
152 negative JJ O O
152 for IN B-VP O
152 fracture NN B-NP O
152 She PRP O O
152 should MD O O
152 be VB O O
152 ambulated VBN O O
153 t.i.d JJ B-NP O
154 DISCHARGE NNP I-NP O
154 MEDICATIONS: NNP I-NP O
155 1 CD O O
155 Lasix NNP B-NP B-m
155 80 CD O B-do
155 mg NN B-NP I-do
155 p.o NN I-NP B-mo
155 b.i.d VBD B-VP B-f
156 2 CD O O
156 Metoprolol NNP B-NP B-m
156 12.5 CD O B-do
156 mg NN B-NP I-do
156 p.o NN I-NP B-mo
156 b.i.d VBD B-VP B-f
157 3 CD O O
157 Lipitor NNP B-NP B-m
157 10 CD O B-do
157 mg NN B-NP I-do
157 p.o NN I-NP B-mo
157 q.d VBD B-VP B-f
158 4 CD O O
158 Amitriptyline NNP B-NP B-m
158 25 CD O B-do
158 to TO O I-do
158 50 CD O I-do
158 mg NNS B-NP I-do
158 p.o JJ B-NP B-mo
158 q.h.s JJ I-NP B-f
158 p.r.n NN I-NP I-f
159 5 CD O O
159 Multivitamins NNP B-NP B-m
160 6 CD O O
160 Aspirin325 NNP B-NP B-m
160 Aspirin325 NNP I-NP B-do
160 mg NN I-NP I-do
160 p.o NN I-NP B-mo
160 q.d VBD B-VP B-f
161 7 CD O O
161 Colace NNP B-NP B-m
161 100 CD O B-do
161 mg NN B-NP I-do
161 p.o NN I-NP B-mo
161 b.i.d VBD B-VP B-f
162 8 CD O O
162 Lisinopril NNP B-NP B-m
162 should MD O O
162 be VB O O
162 held VBN O O
162 for IN B-VP O
162 the DT B-NP O
162 moment NN I-NP O
163 9 CD O O
163 Iron NNP B-NP B-m
163 gluconate NN I-NP I-m
163 325 CD O B-do
163 mg NN B-NP I-do
163 p.o NN I-NP B-mo
163 q.i.d VBD B-VP B-f
164 10 CD O O
164 NPH NNP B-NP B-m
164 20 CD O B-do
164 units NNS B-NP I-do
164 subcu VBD B-VP B-mo
164 q.h.s RB O B-f
165 11 CD O O
165 Lispro NNP B-NP B-m
165 Lispro NNP I-NP B-m
165 sliding VBG O B-do
165 sliding VBG O B-do
165 scale JJ B-NP I-do
165 scale NN I-NP I-do
165 q.a.c NN I-NP B-f
165 and CC O O
165 q.h.s $ O B-f
166 12 CD O O
166 Epogen NNP B-NP B-m
166 5000 CD O B-do
166 units NNS B-NP I-do
166 subcu VBD B-VP B-mo
166 q JJ B-NP B-f
166 week NN I-NP I-f
167 Ms NNP I-NP O
167 Mengel NNP I-NP O
167 should MD O O
167 follow VB O O
167 up RP O O
167 with IN B-VP O
167 Dr NNP B-NP O
167 Rufener NNP I-NP O
167 when WRB O O
167 she PRP O O
167 is VBZ O O
167 able JJ O O
167 to TO O O
168 within IN B-VP O
168 the DT B-NP O
168 next JJ I-NP O
168 week NN I-NP O
168 or CC O O
168 two CD O O
168 Ellington NNP B-NP O
168 is VBZ O O
168 her PRP$ O O
168 primary JJ B-NP O
168 care NN I-NP O
169 physician NN I-NP O
169 , , O O
169 Jarrett NNP B-NP O
169 Sandlan NNP I-NP O
169 her PRP$ O O
169 PCP NNP B-NP O
169 number NN I-NP O
169 is VBZ O O
169 287-274-1873 JJ O O
169 She PRP O O
170 should MD O O
170 b VB O O
170 switched VBD B-VP O
170 to TO O O
170 Toprol NNP B-NP B-m
170 as IN B-VP O
170 her PRP$ O O
170 blood NN B-NP O
170 pressure NN I-NP O
170 tolerates NNS I-NP O
170 and CC O O
171 to TO O O
171 lisinopril VB O B-m
171 as IN B-VP O
171 her PRP$ O O
171 creatinine NN B-NP O
171 tolerates NNS I-NP O
171 after IN B-VP O
171 low-level JJ B-NP O
172 diuresis NN I-NP O
172 of IN B-VP O
172 about IN B-VP O
172 50 CD O O
172 cc NN B-NP O
172 to TO O O
172 one CD O O
172 liter NN B-NP O
172 a DT B-NP O
172 day NN I-NP O
172 Studies NNPS I-NP O
172 pending VBG O O
173 include VBP O O
173 cytology NN B-NP O
173 and CC O O
173 culture NN B-NP O
173 of IN B-VP O
173 pleural JJ B-NP O
173 fluid NN I-NP O
173 and CC O O
173 follow-up JJ B-NP O
173 chest NN I-NP O
174 x-ray NN I-NP O
174 on IN B-VP O
174 the DT B-NP O
174 day NN I-NP O
174 of IN B-VP O
174 her PRP$ O O
174 discharge NN B-NP O
174 Lasix NNP I-NP B-m
174 dose NN I-NP O
174 can MD O O
174 be VB O O
174 increased VBN O O
174 as IN B-VP O
175 needed VBN O O
175 for IN B-VP O
175 better JJR B-NP B-r
175 diuresis NN I-NP I-r
176 eScription NN I-NP O
176 document: VBZ O O
176 2-7752992 JJ B-NP O
176 EMSSten NNP I-NP O
176 Tel NNP I-NP O
177 Dictated NNP I-NP O
177 By: NNP I-NP O
177 KUFFEL NNP I-NP O
177 , , O O
177 CARLOS NNP B-NP O
178 Attending: NNP I-NP O
178 KRESHA NNP I-NP O
178 , , O O
178 OTIS NNP B-NP O
179 Dictation NNP I-NP O
179 ID NNP I-NP O
179 5039114 CD O O
180 D: NNP B-NP O
180 2/8/05 CD O O
181 T: NNP B-NP O
181 2/8/05 CD O O
182 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #417096 VBZ O O
4 524479939 CD O O
4 HH NNP B-NP O
4 47162946 CD O O
4 1620623 CD O O
4 6/14/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 chronic JJ B-NP O
4 diarrhea NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/29/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/17/2005 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 BURGOS NNP I-NP O
8 , , O O
8 REGINALD NNP B-NP O
8 399-26-72-6 CD O O
9 I PRP O O
9 Grand NNP B-NP O
9 Range NNP I-NP O
9 Ton NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 6/13/05 CD O O
11 AT NNP B-NP O
11 01:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 KRISHNA NNP I-NP O
14 , , O O
14 MAURO NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 ATENOLOL NNP I-NP B-m
20 50 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
20 HOLD NNP I-NP O
20 IF: NNP I-NP O
20 sbp VBD B-VP O
20 &lt; JJ O O
20 100 CD O O
20 , , O O
20 hr NN B-NP O
20 &lt; VBD B-VP O
20 60 CD O O
21 ENALAPRIL NNP B-NP B-m
21 MALEATE NNP I-NP I-m
21 20 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 BID NNP I-NP B-f
21 HOLD NNP I-NP O
21 IF: NNP I-NP O
21 sbp VBD B-VP O
21 &lt; $ O O
21 100 CD O O
22 Override NNP B-NP O
22 Notice: NNP I-NP O
22 Override NNP I-NP O
22 added VBD B-VP O
22 on IN B-VP O
22 4/7/05 CD O O
22 by IN B-VP O
23 ZINGLER NNP B-NP O
23 , , O O
23 MOHAMMAD NNP B-NP O
23 , , O O
23 M.D NNP B-NP O
23 , , O O
23 PH.D NNP B-NP O
24 on IN B-VP O
24 order NN B-NP O
24 for IN B-VP O
24 KCL NNP B-NP B-m
24 IMMEDIATE NNP I-NP I-m
24 RELEASE NNP I-NP I-m
24 PO NNP I-NP B-mo
24 ( ( O O
24 ref JJ O O
24 # # O O
24 61864355 CD O O
24 ) ) O O
25 POTENTIALLY NNP B-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 ENALAPRIL NNP I-NP B-m
25 MALEATE NNP I-NP I-m
25 &amp; NNP I-NP O
26 POTASSIUM NNP I-NP B-m
26 CHLORIDE NNP I-NP I-m
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 aware JJ B-NP O
27 Previous NNP I-NP O
27 override NN I-NP O
27 information: NN I-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 4/7/05 CD O O
28 by IN B-VP O
28 CONNAUGHTON NNP B-NP O
28 , , O O
28 DON NNP B-NP O
28 , , O O
28 M.D NNP B-NP O
28 , , O O
28 PH.D NNP B-NP O
29 on IN B-VP O
29 order NN B-NP O
29 for IN B-VP O
29 KCL NNP B-NP B-m
29 IMMEDIATE NNP I-NP I-m
29 RELEASE NNP I-NP I-m
29 PO NNP I-NP B-mo
29 ( ( O O
29 ref JJ O O
29 # # O O
29 38155122 CD O O
29 ) ) O O
30 POTENTIALLY NNP B-NP O
30 SERIOUS NNP I-NP O
30 INTERACTION: NNP I-NP O
30 ENALAPRIL NNP I-NP B-m
30 MALEATE NNP I-NP I-m
30 &amp; NNP I-NP O
31 POTASSIUM NNP I-NP B-m
31 CHLORIDE NNP I-NP I-m
31 Reason NNP I-NP O
31 for IN B-VP O
31 override: NN B-NP O
31 aware JJ B-NP O
32 NIFEDIPINE NNP I-NP B-m
32 ( ( O I-m
32 EXTENDED NNP B-NP I-m
32 RELEASE NNP I-NP I-m
32 ) ) O I-m
32 ( ( O I-m
32 NIFEDIPINE NNP B-NP I-m
32 ( ( O I-m
32 SL NNP B-NP I-m
32 ) ) O I-m
33 60 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
33 HOLD NNP I-NP O
33 IF: NNP I-NP O
33 sbp VBD B-VP O
33 &lt; JJ O O
33 100 CD O O
33 , , O O
33 hr NN B-NP O
33 &lt; VBD B-VP O
33 60 CD O O
34 Food/Drug NNP B-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Avoid NNP I-NP O
35 grapefruit NN I-NP O
35 unless IN B-VP O
35 MD NNP B-NP O
35 instructs NNS I-NP O
35 otherwise RB O O
36 LIPITOR NNP B-NP B-m
36 ( ( O I-m
36 ATORVASTATIN NNP B-NP I-m
36 ) ) O I-m
36 20 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 QHS NNP I-NP B-f
37 ZANTAC NNP I-NP B-m
37 ( ( O I-m
37 RANITIDINE NNP B-NP I-m
37 HCL NNP I-NP I-m
37 ) ) O I-m
37 150 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 BID NNP I-NP B-f
38 METFORMIN NNP I-NP B-m
38 500 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 BID NNP I-NP B-f
39 IMODIUM NNP I-NP B-m
39 ( ( O I-m
39 LOPERAMIDE NNP B-NP I-m
39 HCL NNP I-NP I-m
39 ) ) O I-m
39 2-4 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 Q6H NNP I-NP B-f
39 PRN NNP I-NP I-f
39 Diarrhea NNP I-NP B-r
40 PROTONIX NNP I-NP B-m
40 ( ( O I-m
40 PANTOPRAZOLE NNP B-NP I-m
40 ) ) O I-m
40 40 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 DIET: NNP I-NP O
41 House NNP I-NP O
41 / NNP I-NP O
41 Anti NNP I-NP O
41 Diarrhea NNP I-NP O
41 , , O O
41 Lactose NNP B-NP O
41 Restricted NNP I-NP O
42 ACTIVITY: NNP I-NP O
42 Resume NNP I-NP O
42 regular JJ B-NP O
42 exercise NN I-NP O
43 FOLLOW NNP I-NP O
43 UP NNP I-NP O
43 APPOINTMENT( NNP I-NP O
43 S NNP I-NP O
43 ): NNP I-NP O
44 Dr NNP I-NP O
44 Detillier NNP I-NP O
44 ( ( O O
44 GI NNP B-NP O
44 ) ) O O
44 3/5 CD O O
44 2pm CD O O
44 3/5 CD O O
44 2pm CD O O
44 scheduled VBN O O
44 , , O O
45 Colonoscopy NNP B-NP O
45 6/18 CD O O
45 9:30am CD O O
45 6/18 CD O O
45 9:30am CD O O
45 scheduled VBN O O
45 , , O O
46 Dr NNP B-NP O
46 Gaboriault NNP I-NP O
46 ( ( O O
46 PCP NNP B-NP O
46 ) ) O O
46 0/8 CD O O
46 1:30pm CD O O
46 0/8 CD O O
46 1:30pm CD O O
46 scheduled VBN O O
46 , , O O
47 ALLERGY: NNP B-NP O
47 CLOPIDOGREL NNP I-NP O
47 , , O O
47 Penicillins NNP B-NP O
48 ADMIT NNP I-NP O
48 DIAGNOSIS: NNP I-NP O
49 chronic JJ B-NP O
49 diarrhea NN I-NP O
50 PRINCIPAL NNP I-NP O
50 DISCHARGE NNP I-NP O
50 DIAGNOSIS NNP I-NP O
50 ;Responsible JJ O O
50 After IN B-VP O
50 Study NNP B-NP O
50 for IN B-VP O
50 Causing NNP B-NP O
50 Admission NNP I-NP O
50 ) ) O O
51 chronic VBP O O
51 diarrhea NN B-NP O
52 OTHER NNP I-NP O
52 DIAGNOSIS;Conditions NNP I-NP O
52 , , O O
52 Infections NNP B-NP O
52 , , O O
52 Complications NNP B-NP O
52 , , O O
52 affecting VBG O O
52 Treatment/Stay NNP B-NP O
53 htn NN I-NP O
53 ( ( O O
53 hypertension NN B-NP O
53 ) ) O O
53 hyperchol NN B-NP O
53 ( ( O O
53 elevated VBN O O
53 cholesterol NN B-NP O
53 ) ) O O
53 tobacco NN B-NP O
53 use NN I-NP O
54 ( ( O O
54 smoking VBG O O
54 ) ) O O
54 etoh NN B-NP O
54 use NN I-NP O
54 h/o NN I-NP O
54 +PPD NN I-NP O
54 '93 NNP I-NP O
54 ( ( O O
54 ) ) O O
55 OPERATIONS NNP B-NP O
55 AND NNP I-NP O
55 PROCEDURES: NNP I-NP O
56 OTHER NNP I-NP O
56 TREATMENTS/PROCEDURES NNP I-NP O
56 ( ( O O
56 NOT NNP B-NP O
56 IN NNP I-NP O
56 O.R NNP I-NP O
56 ) ) O O
57 N/A NNP B-NP O
58 BRIEF NNP I-NP O
58 RESUME NNP I-NP O
58 OF NNP I-NP O
58 HOSPITAL NNP I-NP O
58 COURSE: NNP I-NP O
59 76M CD O O
59 w NN B-NP O
59 MMP NNP I-NP O
59 incl VBZ O O
59 small JJ B-NP O
59 cell NN I-NP O
59 lung NN I-NP O
59 CA NNP I-NP O
59 tx'd NN I-NP O
59 w NN I-NP O
59 chemo NN I-NP O
59 and CC O O
59 XRT NN B-NP O
59 in IN B-VP O
59 remission NN B-NP O
59 X NNP I-NP O
59 18 CD O O
60 mo NN B-NP O
60 p/w NN I-NP O
60 LLQ NNP I-NP O
60 + NNP I-NP O
60 diarrhea VBZ O O
60 orignially RB O O
60 on IN B-VP O
60 10/28/05 CD O O
60 , , O O
60 CT NNP B-NP O
60 scan JJ B-NP O
60 w NN I-NP O
60 diverticulitis NN I-NP O
60 , , O O
61 tx'd JJ B-NP O
61 w NN I-NP O
61 cipro/flagyl NN I-NP B-m
61 Diarrhea NNP I-NP O
61 persisted VBD B-VP O
61 after IN B-VP O
61 course NN B-NP O
61 completed VBN O O
61 , , O O
61 PCP NNP B-NP O
61 gave VBD B-VP O
62 a DT B-NP O
62 second JJ I-NP O
62 course NN I-NP O
62 , , O O
62 but CC O O
62 diarrhea JJ B-NP O
62 persists NNS I-NP O
62 Diarrhea NNP I-NP O
62 is VBZ O O
62 watery JJ O O
62 , , O O
62 sometiems VBZ O O
63 black/bloody NN B-NP O
63 , , O O
63 occurs VBZ O O
63 throughout IN B-VP O
63 the DT B-NP O
63 day NN I-NP O
63 , , O O
63 not RB O O
63 a/w JJ B-NP O
63 meals NNS I-NP O
63 No DT B-NP O
63 cramping/abd NN I-NP O
64 pain NN I-NP O
64 , , O O
64 notes VBZ O O
64 occasional JJ B-NP O
64 burning NN I-NP O
64 in IN B-VP O
64 stomach NN B-NP O
64 No NNP I-NP O
64 recent JJ B-NP O
64 travels NNS I-NP O
64 , , O O
64 no DT B-NP O
64 h/o NN I-NP O
64 food NN I-NP O
65 allergies NNS I-NP O
65 , , O O
65 no DT B-NP O
65 fever/nausea/vomiting/LH NN I-NP O
65 No RB O O
65 new JJ B-NP O
65 meds NNS I-NP O
65 , , O O
65 no DT B-NP O
65 recent JJ I-NP O
65 weight NN I-NP O
66 loss NN I-NP O
66 Appetite NNP I-NP O
66 good JJ O O
66 In IN B-VP O
66 ED NNP B-NP O
66 , , O O
66 got VBD B-VP O
66 protonix RB O B-m
66 , , O O
66 guaiac NN B-NP O
66 was VBD B-VP O
66 positive JJ B-NP O
67 ALL: NNP I-NP O
67 Plavix/PCN NNP I-NP O
67 gives VBZ O O
67 GI NNP B-NP O
67 upset JJ B-NP O
68 MEDS: NNP I-NP O
68 ASA NNP I-NP B-m
68 , , O O
68 atenolol NN B-NP B-m
68 , , O O
68 lipitor NN B-NP B-m
68 , , O O
68 enalapril NN B-NP B-m
68 , , O O
68 nifedipine JJ B-NP B-m
68 xl NN I-NP I-m
68 , , O O
68 zantac NN B-NP B-m
68 , , O O
69 metformin FW O B-m
70 PE NNP B-NP O
70 T97.8 NNP I-NP O
70 HR55 NNP I-NP O
70 RR20 NNP I-NP O
70 BP186/92 NNP I-NP O
70 99% CD O O
70 RA NNP B-NP O
70 NAD NNP I-NP O
70 , , O O
70 reading VBG O O
70 paper NN B-NP O
70 Disconj NNP I-NP O
70 gaze NN I-NP O
70 , , O O
70 L NNP B-NP O
71 pupil VBP O O
71 lat JJ B-NP O
71 dev NN I-NP O
71 Lungs NNP I-NP O
71 w NN I-NP O
71 sl NN I-NP O
71 wheeze NN I-NP O
71 CV NNP I-NP O
71 Dist NNP I-NP O
71 S1/S2 NNP I-NP O
71 Abd NNP I-NP O
71 obese JJ O O
71 , , O O
71 + JJ B-NP O
71 BS NNP I-NP O
71 , , O O
72 S/NT/ND NNP B-NP O
72 Ext NNP I-NP O
72 no DT B-NP O
72 C/C/E NNP I-NP O
72 Neuro NNP I-NP O
72 Nonfocal NNP I-NP O
73 LABS: NNP I-NP O
73 Lytes NNP I-NP O
73 WNL NNP I-NP O
73 , , O O
73 CBC NNP B-NP O
73 WNL NNP I-NP O
73 ( ( O O
73 HCT NNP B-NP O
73 41.9 CD O O
73 ) ) O O
73 , , O O
73 Coags NNP B-NP O
73 WNL NNP I-NP O
74 *********************** NNP I-NP O
75 IMPRESSION: NNP I-NP O
75 76 CD O O
75 yo NN B-NP O
75 M NNP I-NP O
75 with IN B-VP O
75 MMP NNP B-NP O
75 p/w NN I-NP O
75 chronic NN I-NP O
75 bloody NN I-NP O
75 diarrhea VBZ O O
75 x $ O O
75 3 CD O O
75 wks NN B-NP O
75 , , O O
75 unclear JJ B-NP O
76 etiology NN I-NP O
76 , , O O
76 ? . B-VP O
76 malabsorption NN B-NP O
76 , , O O
76 but CC O O
76 clinically RB O O
76 very RB O O
76 stable JJ O O
76 , , O O
76 and CC O O
76 per IN B-VP O
76 GI NNP B-NP O
77 curbside NN I-NP O
77 , , O O
77 most JJS O O
77 of IN B-VP O
77 the DT B-NP O
77 work-up NN I-NP O
77 can MD O O
77 be VB O O
77 done VBN O O
77 as IN B-VP O
77 outpatient JJ B-NP O
78 *********************** NNP I-NP O
79 GI: NNP I-NP O
79 Chronic NNP I-NP O
79 diarrhea NN I-NP O
79 , , O O
79 possible JJ O O
79 due JJ O O
79 to TO O O
79 malabsorption VB O O
79 vs JJ B-NP O
79 infection NN I-NP O
80 Pt NNP I-NP O
80 was VBD B-VP O
80 made VBN O O
80 NPO NNP B-NP O
80 on IN B-VP O
80 night NN B-NP O
80 of IN B-VP O
80 admission NN B-NP O
80 , , O O
80 and CC O O
80 had VBD B-VP O
80 no DT B-NP O
80 bowel NN I-NP O
80 movements NNS I-NP O
80 , , O O
81 suggesting VBG O O
81 malabsorption NN B-NP O
81 as IN B-VP O
81 a DT B-NP O
81 possible JJ I-NP O
81 etiology NN I-NP O
81 Celiac NNP I-NP O
81 sprue NN I-NP O
82 studies NNS I-NP O
82 are VBP O O
82 pending VBG O O
82 Patient NNP B-NP O
82 was VBD B-VP O
82 also RB O O
82 empirically RB O O
82 put VBN O O
82 on IN B-VP O
82 a DT B-NP O
82 lactose JJ I-NP O
83 free JJ I-NP O
83 diet JJ I-NP O
83 Stool NNP I-NP O
83 cultures NNS I-NP O
83 ( ( O O
83 including VBG O O
83 parasites NNS B-NP O
83 , , O O
83 SSYCE NNP B-NP O
83 , , O O
83 stool NN B-NP O
83 osms/lytes NNS I-NP O
83 ) ) O O
84 were VBD B-VP O
84 ordered VBN O O
84 , , O O
84 but CC O O
84 could MD O O
84 not RB O O
84 be VB O O
84 sent VBN O O
84 , , O O
84 as IN B-VP O
84 patient NN B-NP O
84 had VBD B-VP O
84 no DT B-NP O
84 stool NN I-NP O
84 overnight VBD B-VP O
85 Patient NNP B-NP O
85 started VBD B-VP O
85 on IN B-VP O
85 immodium NN B-NP B-m
85 as IN B-VP O
85 diarrhea NN B-NP B-r
85 not RB O O
85 thought VBN O O
85 to TO O O
85 be VB O O
85 due JJ O O
85 to TO O O
85 an DT B-NP O
85 acute JJ I-NP O
86 infectious JJ I-NP O
86 process NN I-NP O
86 , , O O
86 with IN B-VP O
86 low JJ B-NP O
86 risk NN I-NP O
86 for IN B-VP O
86 toxic JJ B-NP O
86 megacolon NN I-NP O
86 Patient NNP I-NP O
87 also RB O O
87 scheduled VBD B-VP O
87 for IN B-VP O
87 an DT B-NP O
87 outpatient JJ I-NP O
87 colonoscopy NN I-NP O
87 Protonix NNP I-NP B-m
87 for IN B-VP O
87 heartburn NN B-NP B-r
88 HEME: NNP I-NP O
88 HCT NNP I-NP O
88 stable JJ B-NP O
89 ID: NNP I-NP O
89 Hold NNP I-NP O
89 off RP O O
89 further JJ B-NP O
89 abx NN I-NP B-m
89 at IN B-VP O
89 this DT B-NP O
89 point NN I-NP O
89 , , O O
89 as IN B-VP O
89 there EX O O
89 was VBD B-VP O
89 no DT B-NP O
89 response NN I-NP O
89 to TO O O
89 2 CD O O
90 course NN B-NP O
90 of IN B-VP O
90 cipro/flagyl JJ B-NP B-m
91 CV: NNP I-NP O
91 No NNP I-NP O
91 acute NN I-NP O
91 issues NNS I-NP O
91 , , O O
91 we PRP O O
91 continued VBD B-VP O
91 asa/bb/statin/acei/ccb JJ B-NP B-m
92 ENDO: NNP I-NP O
92 RISS NNP I-NP B-m
92 TSH NNP I-NP O
92 was VBD B-VP O
92 WNL NNP B-NP O
93 *********************** NNP I-NP O
94 DISPO: NNP I-NP O
94 Will NNP I-NP O
94 follow VB O O
94 up RP O O
94 with IN B-VP O
94 Dr NNP B-NP O
94 Haymans NNPS I-NP O
94 on IN B-VP O
94 3/5 CD O O
94 at IN B-VP O
94 2pm CD O O
94 Consider NNP B-NP O
94 outpatient NN I-NP O
95 small JJ B-NP O
95 intestinal JJ I-NP O
95 biopsy NN I-NP O
95 , , O O
95 ERCP NNP B-NP O
95 Follow NNP I-NP O
95 up RP O O
95 on IN B-VP O
95 celiac NNS B-NP O
95 sprue JJ B-NP O
95 studies NNS I-NP O
96 Patient NNP I-NP O
96 scheduled VBD B-VP O
96 for IN B-VP O
96 an DT B-NP O
96 outpatient JJ I-NP O
96 colonoscoyp NN I-NP O
96 on IN B-VP O
96 6/18 CD O O
96 at IN B-VP O
96 9:30am CD O O
97 ADDITIONAL NNP B-NP O
97 COMMENTS: NNP I-NP O
97 1 CD O O
97 You PRP O O
97 are VBP O O
97 scheduled VBN O O
97 for IN B-VP O
97 a DT B-NP O
97 colonoscopy NN I-NP O
97 on IN B-VP O
97 6/18 CD O O
97 at IN B-VP O
97 9:30am CD O O
97 No DT B-NP O
97 food NN I-NP O
97 or CC O O
98 drinks VBZ O O
98 the DT B-NP O
98 night NN I-NP O
98 before IN B-VP O
98 On IN B-VP O
98 8/7 CD O O
98 , , O O
98 only RB O O
98 clear JJ B-NP O
98 liquids NNS I-NP O
98 Please NNP I-NP O
98 drink VB O O
98 Oral NNP B-NP O
99 Phosphate NNP I-NP B-m
99 Soda NNP I-NP O
99 ( ( O O
99 you PRP O O
99 can MD O O
99 pick VB O O
99 up RP O O
99 over-the-counter JJ O O
99 at IN B-VP O
99 any DT B-NP O
99 pharmacy NN I-NP O
99 ) ) O O
99 the DT B-NP O
100 night NN I-NP B-f
100 before IN B-VP I-f
100 the DT B-NP I-f
100 colonoscopy NN I-NP I-f
100 Pls NNP I-NP O
100 call VB O O
100 522-750-9060 JJ O O
100 for IN B-VP O
100 more JJR B-NP O
100 directions NNS I-NP O
101 2 CD O O
101 Please NNP B-NP O
101 do VB O O
101 not RB O O
101 take VB O O
101 any DT B-NP O
101 dairy NN I-NP O
101 products NNS I-NP O
102 3 CD O O
102 Please NNP B-NP O
102 resume VB O O
102 all DT O O
102 of IN B-VP O
102 your PRP$ O O
102 regular JJ B-NP O
102 medications NNS I-NP O
102 No DT B-NP O
102 changes NNS I-NP O
102 were VBD B-VP O
102 made VBN O O
103 If IN B-VP O
103 the DT B-NP O
103 list NN I-NP O
103 above IN B-VP O
103 does VBZ O O
103 not RB O O
103 match VB O O
103 your PRP$ O O
103 regular JJ B-NP O
103 meds NNS I-NP O
103 , , O O
103 please VB O O
103 resume VB O O
103 your PRP$ O O
104 regular JJ B-NP O
104 meds NNS I-NP O
105 DISCHARGE NNP I-NP O
105 CONDITION: NNP I-NP O
105 Stable NNP I-NP O
106 TO NNP I-NP O
106 DO/PLAN: NNP I-NP O
107 1 CD O O
107 Outpatient NNP B-NP O
107 colonoscopy NN I-NP O
107 on IN B-VP O
107 6/18 CD O O
107 , , O O
107 follow-up JJ B-NP O
107 results NNS I-NP O
108 2 CD O O
108 Consider NNP B-NP O
108 outpatient NN I-NP O
108 small JJ B-NP O
108 intest NN I-NP O
108 bx/secretin NN I-NP O
108 test/ERCP VBZ O O
109 No DT B-NP O
109 dictated JJ I-NP O
109 summary NN I-NP O
110 ENTERED NNP I-NP O
110 BY: NNP I-NP O
110 SKOUSEN NNP I-NP O
110 , , O O
110 HERIBERTO NNP B-NP O
110 , , O O
110 M.D NNP B-NP O
110 , , O O
110 PH.D NNP B-NP O
110 ( ( O O
110 FG35 NNP B-NP O
110 ) ) O O
110 6/13/05 CD O O
110 @ $ O O
110 01:23 CD O O
110 PM NNP B-NP O
111 ****** JJ B-NP O
111 END NNP I-NP O
111 OF NNP I-NP O
111 DISCHARGE NNP I-NP O
111 ORDERS NNP I-NP O
111 ****** NNP I-NP O
112 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #423034 VBZ O O
4 227724958 CD O O
4 RLH NNP B-NP O
4 53008525 CD O O
4 669665 CD O O
4 1/19/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 GANGRENOUS NNP I-NP O
4 RIGHT NNP I-NP O
4 FIRST NNP I-NP O
4 TOE NNP I-NP O
4 Signed NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/3/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/12/2001 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 STATUS NNP I-NP O
7 POST NNP I-NP O
7 RIGHT NNP I-NP O
7 TIBIAL NNP I-NP O
7 ARTERIAL NNP I-NP O
7 BYPASS NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT O O
8 57 CD O O
8 year NN B-NP O
8 old JJ B-NP O
8 female NN I-NP O
8 who WP O O
8 is VBZ O O
9 status NN B-NP O
9 post NN I-NP O
9 a DT B-NP O
9 right JJ I-NP O
9 femoral JJ I-NP O
9 posterior JJ I-NP O
10 tibial JJ I-NP O
10 artery NN I-NP O
10 bypass NN I-NP O
10 in IN B-VP O
10 1997 CD O O
10 who WP O O
10 presented VBD B-VP O
10 with IN B-VP O
10 progressive JJ B-NP O
10 right NN I-NP O
11 first RB O O
11 toe VBZ O O
11 wound NN B-NP O
11 for IN B-VP O
11 two CD O O
11 months NNS B-NP O
11 She PRP O O
11 denied VBD B-VP O
11 any DT B-NP O
11 fevers NNS I-NP O
11 or CC O O
11 chills NNS B-NP O
11 or CC O O
12 any DT B-NP O
12 erythema NN I-NP O
12 around IN B-VP O
12 the DT B-NP O
12 toe NN I-NP O
12 site NN I-NP O
12 She PRP O O
12 also RB O O
12 denied VBD B-VP O
12 any DT B-NP O
12 rest NN I-NP O
12 pain NN I-NP O
13 PAST NNP I-NP O
13 MEDICAL NNP I-NP O
13 HISTORY: NNP I-NP O
13 Significant NNP I-NP O
13 for IN B-VP O
13 peripheral JJ B-NP O
13 vascular JJ I-NP O
13 disease NN I-NP O
13 , , O O
14 non JJ B-NP O
14 insulin NN I-NP O
14 dependent NN I-NP O
14 diabetes VBZ O O
14 mellitus RBS O O
14 , , O O
15 hypertension NN B-NP O
15 , , O O
15 high JJ B-NP O
15 cholesterol NN I-NP O
16 PAST NNP I-NP O
16 SURGICAL NNP I-NP O
16 HISTORY: NNP I-NP O
16 As IN B-VP O
16 above NN B-NP O
16 Also RB O O
16 is VBZ O O
16 status NN B-NP O
16 post NN I-NP O
16 right RB O O
17 carotid NN B-NP O
17 endarterectomy NN I-NP O
17 in IN B-VP O
17 '96 CD O O
17 , , O O
17 C-section NNP B-NP O
18 and CC O O
18 appendectomy NN B-NP O
18 and CC O O
18 bilateral JJ B-NP O
18 cataracts NNS I-NP O
19 MEDICATIONS NNP I-NP O
19 ON NNP I-NP O
19 ADMISSION: NNP I-NP O
19 Aspirin NNP I-NP B-m
19 325 CD O B-do
19 mg NN B-NP I-do
19 p.o NN I-NP B-mo
19 q NN I-NP B-f
19 d NN I-NP I-f
19 , , O O
19 Pravachol NNP B-NP B-m
19 60 CD O B-do
19 mg NN B-NP I-do
20 p.o NN I-NP B-mo
20 q NN I-NP B-f
20 d NN I-NP I-f
20 , , O O
20 metoprolol FW O B-m
20 60 CD O B-do
20 mg NN B-NP I-do
20 p.o NN I-NP B-mo
20 b.i.d NN I-NP B-f
20 , , O O
21 Glyburide NNP B-NP B-m
21 10 CD O B-do
21 mg NN B-NP I-do
21 p.o NN I-NP B-mo
21 b.i.d NN I-NP B-f
21 , , O O
21 Glucophage NNP B-NP B-m
21 1000 CD O B-do
21 mg NN B-NP I-do
21 p.o NN I-NP B-mo
21 b.i.d NN I-NP B-f
21 , , O O
22 Vasotec NNP B-NP B-m
22 20 CD O B-do
22 mg NN B-NP I-do
22 p.o NN I-NP B-mo
22 q NN I-NP B-f
22 d NN I-NP I-f
22 , , O O
22 vitamin NN B-NP B-m
22 B NNP I-NP I-m
22 multivitamin NN I-NP I-m
22 one CD O B-do
22 tablet NN B-NP I-do
22 p.o NN I-NP B-mo
22 q NN I-NP B-f
22 d NN I-NP I-f
22 , , O O
23 and CC O O
23 Plavix NNP B-NP B-m
23 75 CD O B-do
23 mg NN B-NP I-do
23 p.o NN I-NP B-mo
23 q NN I-NP B-f
23 d NN I-NP I-f
24 ALLERGIES: NNP I-NP O
24 No NNP I-NP O
24 known VBN O O
24 drug NN B-NP O
24 allergies NNS I-NP O
25 SURGICAL NNP I-NP O
25 EXAMINATION NNP I-NP O
25 ON NNP I-NP O
25 ADMISSION: NNP I-NP O
25 She PRP O O
25 was VBD B-VP O
25 afebrile JJ O O
25 with IN B-VP O
25 stable JJ B-NP O
26 vital JJ I-NP O
26 signs NNS I-NP O
26 She PRP O O
26 was VBD B-VP O
26 a DT O O
27 pleasant JJ O O
27 , , O O
27 mildly RB O O
27 obese JJ B-NP O
27 woman NN I-NP O
27 in IN B-VP O
27 no DT B-NP O
27 apparent JJ I-NP O
27 distress NN I-NP O
27 She PRP O O
27 had VBD B-VP O
27 no DT B-NP O
28 carotid NN I-NP O
28 bruits NNS I-NP O
28 and CC O O
28 no DT B-NP O
28 jugular JJ I-NP O
28 venous JJ I-NP O
28 distention NN I-NP O
28 NECK: NNP I-NP O
28 Supple NNP I-NP O
29 CHEST: NNP I-NP O
29 Clear NNP I-NP O
29 to TO O O
29 auscultation VB O O
29 bilaterally RB O O
29 HEART: NNP B-NP O
29 Regular NNP I-NP O
29 rate NN I-NP O
30 and CC O O
30 rhythm NN B-NP O
30 ABDOMEN: NNP I-NP O
30 Soft NNP I-NP O
30 , , O O
30 obese JJ O O
30 , , O O
30 non-tender JJ O O
30 , , O O
30 nondistended VBD B-VP O
31 RIGHT NNP B-NP O
31 LOWER NNP I-NP O
31 EXTREMITY: NNP I-NP O
31 Had VBD B-VP O
31 a DT B-NP O
31 non JJ I-NP O
31 healing NN I-NP O
31 wound NN I-NP O
31 of IN B-VP O
31 the DT B-NP O
31 right JJ I-NP O
31 great JJ I-NP O
32 toe NN I-NP O
32 with IN B-VP O
32 minimal JJ O O
32 surrounding VBG O O
32 erythema NN B-NP O
32 Pulse NNP I-NP O
32 examination NN I-NP O
32 was VBD B-VP O
33 significant JJ O O
33 for IN B-VP O
33 palpable JJ B-NP O
33 femoral JJ I-NP O
33 pulses NNS I-NP O
33 bilaterally RB O O
33 and CC O O
33 Dopplerable JJ B-NP O
34 DP NNP I-NP O
34 and CC O O
34 PT NNP B-NP O
34 on IN B-VP O
34 the DT B-NP O
34 left NN I-NP O
34 with IN B-VP O
34 a DT O O
34 faintly RB O O
34 dopplerable JJ B-NP O
34 posterior JJ I-NP O
34 tibial JJ I-NP O
35 pulse NN I-NP O
35 on IN B-VP O
35 the DT B-NP O
35 right NN I-NP O
35 and CC O O
35 no DT B-NP O
35 dopplerable JJ I-NP O
35 dorsalis NN I-NP O
35 pedis NN I-NP O
36 LABORATORY NNP I-NP O
36 EXAM: NNP I-NP O
36 Was NNP I-NP O
36 significant JJ O O
36 for IN B-VP O
36 AVI NNP B-NP O
36 of IN B-VP O
36 0.60 CD O O
36 and CC O O
36 0.59 CD O O
36 at IN B-VP O
36 the DT B-NP O
37 PT NNP I-NP O
37 , , O O
37 and CC O O
37 PTT NNP B-NP O
37 respectively RB O O
37 on IN B-VP O
37 the DT B-NP O
37 way NN I-NP O
37 with IN B-VP O
37 mildly RB O O
38 decreased JJ B-NP O
38 PVRs NNP I-NP O
38 Her NNP I-NP O
38 EKG NNP I-NP O
38 was VBD B-VP O
38 normal JJ B-NP O
38 sinus JJ I-NP O
38 rhythm NN I-NP O
38 Laboratory NNP I-NP O
38 exams NNS I-NP O
39 were VBD B-VP O
39 within IN B-VP O
39 normal JJ B-NP O
39 limits NNS I-NP O
40 HOSPITAL NNP I-NP O
40 COURSE: NNP I-NP O
40 The DT B-NP O
40 patient NN I-NP O
40 was VBD B-VP O
40 admitted VBN O O
40 to TO O O
40 the DT B-NP O
40 vascular JJ I-NP O
40 surgical JJ I-NP O
41 service NN I-NP O
41 and CC O O
41 placed VBN O O
41 on IN B-VP O
41 triple JJ B-NP B-m
41 antibiotics NNS I-NP I-m
41 and CC O O
42 dressing VBG O O
42 changes NNS B-NP O
42 She PRP O O
42 had VBD B-VP O
42 no DT B-NP O
42 resolution NN I-NP O
42 of IN B-VP O
42 her PRP$ O O
42 symptoms NNS B-NP O
42 of IN B-VP O
42 her PRP$ O O
42 non JJ B-NP O
43 healing NN I-NP O
43 ulcer NN I-NP O
43 and CC O O
43 as IN B-VP O
43 a DT B-NP O
43 result NN I-NP O
43 , , O O
43 she PRP O O
43 was VBD B-VP O
43 taken VBN O O
43 to TO O O
43 the DT B-NP O
43 operating NN I-NP O
43 room NN I-NP O
44 on IN B-VP O
44 6/30/2001 CD O O
44 by IN B-VP O
44 Dr NNP B-NP O
44 Viteo NNP I-NP O
44 where WRB O O
44 she PRP O O
44 had VBD B-VP O
44 a DT B-NP O
44 right JJ I-NP O
44 femoral JJ I-NP O
44 tibial JJ I-NP O
45 bypass NN I-NP O
45 graft NN I-NP O
45 and CC O O
45 first JJ B-NP O
45 toe NN I-NP O
45 amputation NN I-NP O
45 of IN B-VP O
45 the DT B-NP O
45 right JJ I-NP O
45 foot NN I-NP O
46 Postoperatively RB O O
46 , , O O
46 the DT B-NP O
46 patient NN I-NP O
46 was VBD B-VP O
46 transferred VBN O O
46 to TO O O
46 the DT B-NP O
46 regular JJ I-NP O
47 hospital NN I-NP O
47 floor NN I-NP O
47 She PRP O O
47 initially RB O O
47 had VBD B-VP O
47 a DT B-NP O
47 PCA NNP I-NP B-m
47 for IN B-VP O
47 pain NN B-NP B-r
47 She PRP O O
47 began VBD B-VP O
48 ambulating VBG O O
48 on IN B-VP O
48 postoperative JJ B-NP O
48 day NN I-NP O
48 two CD O O
48 She PRP O O
48 has VBZ O O
48 converted VBN O O
48 to TO O O
48 regular JJ B-NP O
49 diet NN I-NP O
49 and CC O O
49 her PRP$ O B-r
49 pain NN B-NP I-r
49 was VBD B-VP O
49 well RB O O
49 controlled VBN O O
49 on IN B-VP O
49 pain NN B-NP B-m
49 medications NNS I-NP I-m
49 She PRP O O
49 was VBD B-VP O
50 seen VBN O O
50 in IN B-VP O
50 consultation NN B-NP O
50 by IN B-VP O
50 the DT B-NP O
50 cardiology NN I-NP O
50 service NN I-NP O
50 and CC O O
50 made VBD B-VP O
50 some DT B-NP O
51 adjustments NNS I-NP O
51 to TO O O
51 her PRP$ O O
51 beta NN B-NP B-m
51 blockers NNS I-NP I-m
51 She PRP O O
51 was VBD B-VP O
51 seen VBN O O
51 by IN B-VP O
51 physical JJ B-NP O
51 therapy NN I-NP O
52 and CC O O
52 her PRP$ O O
52 functional JJ B-NP O
52 status NN I-NP O
52 has VBZ O O
52 improved VBN O O
52 to TO O O
52 the DT B-NP O
52 point NN I-NP O
52 where WRB O O
52 the DT B-NP O
52 day NN I-NP O
53 before IN B-VP O
53 discharge NN B-NP O
53 , , O O
53 she PRP O O
53 was VBD B-VP O
53 able JJ O O
53 to TO O O
53 ambulate VB O O
53 three CD O O
53 flights NNS B-NP O
53 of IN B-VP O
53 stairs NNS B-NP O
54 without IN B-VP O
54 difficulty NN B-NP O
54 She PRP O O
54 had VBD B-VP O
54 no DT B-NP O
54 signs NNS I-NP O
54 of IN B-VP O
54 infection NN B-NP O
54 on IN B-VP O
54 her PRP$ O O
54 leg NN B-NP O
55 wounds NNS I-NP O
55 and CC O O
55 she PRP O O
55 did VBD B-VP O
55 have VB O O
55 some DT B-NP O
55 mild JJ I-NP O
55 erythema NN I-NP B-r
55 around IN B-VP O
55 her PRP$ O O
55 right JJ B-NP O
55 great JJ I-NP O
56 toe NN I-NP O
56 which WDT O O
56 was VBD B-VP O
56 improved VBN O O
56 after IN B-VP O
56 the DT B-NP O
56 patient NN I-NP O
56 was VBD B-VP O
56 restarted VBN O O
56 on IN B-VP O
56 Ancef NNP B-NP B-m
56 on IN B-VP O
57 postoperative JJ B-NP O
57 day NN I-NP O
57 three CD O O
57 This DT B-NP O
57 erythema NN I-NP O
57 continued VBD B-VP O
57 to TO O O
57 improve VB O O
57 and CC O O
58 was VBD B-VP O
58 much RB O O
58 improved VBN O O
58 by IN B-VP O
58 the DT B-NP O
58 time NN I-NP O
58 of IN B-VP O
58 discharge NN B-NP O
59 DISPOSITION: NNP I-NP O
59 The DT B-NP O
59 patient NN I-NP O
59 was VBD B-VP O
59 discharged VBN O O
59 to TO O O
59 home NN B-NP O
59 with IN B-VP O
59 services NNS B-NP O
59 and CC O O
60 home NN B-NP O
60 physical JJ B-NP O
60 therapy NN I-NP O
60 and CC O O
60 home NN B-NP O
60 visiting NN I-NP O
60 nurses NNS I-NP O
61 DISCHARGE NNP I-NP O
61 INSTRUCTIONS: NNP I-NP O
61 Her NNP I-NP O
61 diet NN I-NP O
61 is VBZ O O
61 ADA NNP B-NP O
61 2100; CD O O
61 her PRP$ O O
61 activity NN B-NP O
61 is VBZ O O
61 as RB O O
62 tolerated JJ O O
62 She PRP O O
62 is VBZ O O
62 to TO O O
62 follow-up JJ O O
62 with IN B-VP O
62 Dr NNP B-NP O
63 Goldsby NNP I-NP O
63 on IN B-VP O
63 Friday NNP B-NP O
63 , , O O
63 2/29 CD O O
63 She PRP O O
63 should MD O O
63 call VB O O
63 to TO O O
63 schedule VB O O
63 her PRP$ O O
64 medications NNS B-NP O
65 DISCHARGE NNP I-NP O
65 MEDICATIONS: NNP I-NP O
65 Enteric NNP I-NP B-m
65 coated VBD B-VP I-m
65 aspirin RB O I-m
65 325 CD O B-do
65 mg NNS B-NP I-do
65 p.o JJ B-NP B-mo
65 q JJ I-NP B-f
65 d NN I-NP I-f
65 , , O O
66 Atenolol NNP B-NP B-m
66 50 CD O B-do
66 mg NN B-NP I-do
66 p.o NN I-NP B-mo
66 q NN I-NP B-f
66 d NN I-NP I-f
66 , , O O
66 Atenolol NNP B-NP B-m
66 50 CD O B-do
66 mg NN B-NP I-do
67 p.o NN I-NP B-mo
67 baid NN I-NP O
67 , , O O
67 Vasotec NNP B-NP B-m
67 20 CD O B-do
67 mg NN B-NP I-do
67 p.o NN I-NP B-mo
67 q NN I-NP B-f
67 d NN I-NP I-f
67 , , O O
67 Glyburide NNP B-NP B-m
67 10 CD O B-do
67 mg NN B-NP I-do
67 p.o NN I-NP B-mo
67 b.i.d NN I-NP B-f
67 , , O O
68 Percocet NNP B-NP B-m
68 one CD O B-do
68 to TO O I-do
68 two CD O I-do
68 tablets NNS B-NP I-do
68 p.o VBP O B-mo
68 q RB O B-f
68 4 CD O I-f
68 h NN B-NP I-f
68 p.r.n NN I-NP I-f
68 pain NN I-NP B-r
68 , , O O
68 vitamin NN B-NP B-m
68 B NNP I-NP I-m
68 100 CD O B-do
69 mg NN B-NP O
69 p.o NN I-NP B-mo
69 b.i.d NN I-NP B-f
69 , , O O
69 multivitamin VB O B-m
69 one CD O B-do
69 tablet NN B-NP I-do
69 p.o NN I-NP B-mo
69 q NN I-NP B-f
69 d NN I-NP I-f
69 , , O O
69 Pravachol NNP B-NP B-m
69 60 CD O B-do
69 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 q NN I-NP B-f
70 h.s NN I-NP I-f
70 , , O O
70 Glucophage NNP B-NP B-m
70 1000 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 t.i.d NN I-NP B-f
70 and CC O O
70 Keflex NNP B-NP B-m
70 500 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
71 q.i.d NN I-NP B-f
71 x NNP I-NP B-du
71 x VBD B-VP B-du
71 7 CD O I-du
71 7 CD O I-du
71 days NNS B-NP I-du
71 days NNS I-NP I-du
72 Dictated VBD B-VP O
72 By: NNP B-NP O
72 GERARD NNP I-NP O
72 OVERDICK NNP I-NP O
72 , , O O
72 M.D NNP B-NP O
72 MQ830 NNP I-NP O
73 Attending: NNP I-NP O
73 EDWARD NNP I-NP O
73 O NNP I-NP O
73 OWERS NNP I-NP O
73 , , O O
73 M.D NNP B-NP O
73 XY27 NNP I-NP O
73 MS888/7629 NNP I-NP O
74 Batch: NNP I-NP O
74 98881 CD O O
74 Index NNP B-NP O
74 No NNP I-NP O
74 K8RWGI1S99 NNP I-NP O
74 D: NNP I-NP O
74 9/17/01 CD O O
75 T: NNP B-NP O
75 9/17/01 CD O O
76 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #426134 VBZ O O
4 358237520 CD O O
4 IOH NNP B-NP O
4 45549347 CD O O
4 620218 CD O O
4 10/16/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 atypical JJ B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/16/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/4/2001 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 HEINZLE NNP I-NP O
8 , , O O
8 IAN NNP B-NP O
8 412-44-02-5 CD O O
9 Land NNP B-NP O
9 Jack NNP I-NP O
9 O NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 10/24/01 CD O O
11 AT NNP B-NP O
11 03:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 PHAREL NNP I-NP O
14 , , O O
14 ROOSEVELT NNP B-NP O
14 J NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ECASA NNP I-NP B-m
19 ( ( O I-m
19 ASPIRIN NNP B-NP I-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 ) ) O I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Alert NNP I-NP O
20 overridden: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 6/2/01 CD O O
20 by IN B-VP O
21 TRIANO NNP B-NP O
21 , , O O
21 ALFREDO NNP B-NP O
21 , , O O
21 M.D NNP B-NP O
22 DEFINITE NNP I-NP O
22 ALLERGY NNP I-NP O
22 ( ( O O
22 OR NNP B-NP O
22 SENSITIVITY NNP I-NP O
22 ) ) O O
22 to TO O O
22 G6PD NNP B-NP O
22 DEFICIENCY NNP I-NP O
23 Reason NNP I-NP O
23 for IN B-VP O
23 override: JJ B-NP O
23 patient NN I-NP O
23 taking VBG O O
23 as IN B-VP O
23 outpt JJ B-NP O
24 WELLBUTRIN NNP I-NP B-m
24 ( ( O I-m
24 BUPROPION NNP B-NP I-m
24 HCL NNP I-NP I-m
24 ) ) O I-m
24 200 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QD NNP I-NP B-f
25 COLACE NNP I-NP B-m
25 ( ( O I-m
25 DOCUSATE NNP B-NP I-m
25 SODIUM NNP I-NP I-m
25 ) ) O I-m
25 100 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 BID NNP I-NP B-f
26 FESO4 NNP I-NP B-m
26 ( ( O I-m
26 FERROUS NNP B-NP I-m
26 SULFATE NNP I-NP I-m
26 ) ) O I-m
26 300 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 BID NNP I-NP B-f
27 NITROGLYCERIN NNP I-NP B-m
27 1/150 CD O I-m
27 ( ( O I-m
27 0.4 CD O I-m
27 MG NNP B-NP I-m
27 ) ) O I-m
27 1 CD O B-do
27 TAB NNP B-NP I-do
27 SL NNP I-NP B-mo
27 q5min VBD B-VP B-f
27 x $ O O
27 3 CD O O
28 PRN NNP B-NP O
28 chest NN I-NP B-r
28 pain NN I-NP I-r
28 HOLD NNP I-NP O
28 IF: NNP I-NP O
28 SBP NNP I-NP O
28 &lt; VBD B-VP O
28 100 CD O O
29 ZOCOR NNP B-NP B-m
29 ( ( O I-m
29 SIMVASTATIN NNP B-NP I-m
29 ) ) O I-m
29 40 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QHS NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 Avoid NNP I-NP O
31 grapefruit NN I-NP O
31 unless IN B-VP O
31 MD NNP B-NP O
31 instructs NNS I-NP O
31 otherwise RB O O
32 ZESTRIL NNP B-NP B-m
32 ( ( O I-m
32 LISINOPRIL NNP B-NP I-m
32 ) ) O I-m
32 10 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 Alert NNP I-NP O
33 overridden: NNP I-NP O
33 Override NNP I-NP O
33 added VBD B-VP O
33 on IN B-VP O
33 10/24/01 CD O O
33 by IN B-VP O
33 : : O O
34 POTENTIALLY NNP B-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 POTASSIUM NNP I-NP B-m
34 CHLORIDE NNP I-NP I-m
34 &amp; NNP I-NP O
35 LISINOPRIL NNP I-NP B-m
36 POTENTIALLY NNP I-NP O
36 SERIOUS NNP I-NP O
36 INTERACTION: NNP I-NP O
36 POTASSIUM NNP I-NP B-m
36 CHLORIDE NNP I-NP I-m
36 &amp; NNP I-NP O
37 LISINOPRIL NNP I-NP B-m
37 Reason NNP I-NP O
37 for IN B-VP O
37 override: NN B-NP O
37 aware JJ B-NP O
38 ATENOLOL NNP I-NP B-m
38 50 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 BID NNP I-NP B-f
38 Food/Drug NNP I-NP O
38 Interaction NNP I-NP O
38 Instruction NNP I-NP O
39 Take NNP I-NP O
39 consistently RB O O
39 with IN B-VP O
39 meals NNS B-NP O
39 or CC O O
39 on IN B-VP O
39 empty JJ B-NP O
39 stomach NN I-NP O
40 PRILOSEC NNP I-NP B-m
40 ( ( O I-m
40 OMEPRAZOLE NNP B-NP I-m
40 ) ) O I-m
40 20 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 DIET: NNP I-NP O
41 House NNP I-NP O
41 / VBD B-VP O
41 Low NNP B-NP O
41 chol/low NN I-NP O
41 sat VBD B-VP O
41 fat JJ B-NP O
42 RETURN NNP I-NP O
42 TO NNP I-NP O
42 WORK: NNP I-NP O
42 Immediately RB O O
43 FOLLOW NNP B-NP O
43 UP NNP I-NP O
43 APPOINTMENT( NNP I-NP O
43 S NNP I-NP O
43 ): NNP I-NP O
44 Dr NNP I-NP O
44 Lindsay NNP I-NP O
44 Wontor NNP I-NP O
44 1-2 JJ B-NP O
44 weeks NNS I-NP O
44 , , O O
45 ALLERGY: NNP B-NP O
45 Quinine NNP I-NP O
45 ( ( O O
45 quinine JJ B-NP O
45 sulfate NN I-NP O
45 ) ) O O
45 , , O O
45 Tegretol NNP B-NP O
45 ( ( O O
45 carbamazepine NN B-NP O
45 ) ) O O
46 ADMIT NNP B-NP O
46 DIAGNOSIS: NNP I-NP O
47 chest JJS B-NP O
47 pain NN I-NP O
48 PRINCIPAL NNP I-NP O
48 DISCHARGE NNP I-NP O
48 DIAGNOSIS NNP I-NP O
48 ;Responsible JJ O O
48 After IN B-VP O
48 Study NNP B-NP O
48 for IN B-VP O
48 Causing NNP B-NP O
48 Admission NNP I-NP O
48 ) ) O O
49 atypical JJ B-NP O
49 chest NN I-NP O
49 pain NN I-NP O
50 OTHER NNP I-NP O
50 DIAGNOSIS;Conditions NNP I-NP O
50 , , O O
50 Infections NNP B-NP O
50 , , O O
50 Complications NNP B-NP O
50 , , O O
50 affecting VBG O O
50 Treatment/Stay NNP B-NP O
51 vitilago RB O O
51 NIDDM NNP B-NP O
51 ( ( O O
51 diabetes VBZ O O
51 mellitus NN B-NP O
51 ) ) O O
51 depression NN B-NP O
52 ( ( O O
52 depression NN B-NP O
52 ) ) O O
52 hypercholesterolemia NN B-NP O
52 ( ( O O
52 elevated VBN O O
52 cholesterol NN B-NP O
52 ) ) O O
52 esophagitis NN B-NP O
53 CAD NNP I-NP O
53 2/29 CD O O
53 , , O O
53 PTCA NNP B-NP O
53 htn NN I-NP O
53 ( ( O O
53 hypertension NN B-NP O
53 ) ) O O
53 ana NN B-NP O
53 ( ( O O
53 positive JJ B-NP O
53 ANA NNP I-NP O
53 ) ) O O
54 OPERATIONS NNP B-NP O
54 AND NNP I-NP O
54 PROCEDURES: NNP I-NP O
55 OTHER NNP I-NP O
55 TREATMENTS/PROCEDURES NNP I-NP O
55 ( ( O O
55 NOT NNP B-NP O
55 IN NNP I-NP O
55 O.R NNP I-NP O
55 ) ) O O
56 none NN B-NP O
57 BRIEF NNP I-NP O
57 RESUME NNP I-NP O
57 OF NNP I-NP O
57 HOSPITAL NNP I-NP O
57 COURSE: NNP I-NP O
58 63 CD O O
58 yo NN B-NP O
58 male NN I-NP O
58 , , O O
58 h/o JJ B-NP O
58 CAD NNP I-NP O
58 s/p NN I-NP O
58 MI NNP I-NP O
58 x2 NNP I-NP O
58 , , O O
58 s/p VBD B-VP O
58 cath NN B-NP O
58 11/12 CD O O
58 which WDT O O
59 showed VBD B-VP O
59 100% CD O O
59 LCfx NNP B-NP O
59 lesion NN I-NP O
59 unable JJ O O
59 to TO O O
59 be VB O O
59 stented VBN O O
59 At IN B-VP O
59 baseline NN B-NP O
59 , , O O
59 has VBZ O O
60 stable JJ B-NP O
60 angina NNS I-NP O
60 with IN B-VP O
60 exertion NN B-NP O
60 Has NNP I-NP O
60 been VBN O O
60 on IN B-VP O
60 medical JJ B-NP O
60 management NN I-NP O
60 on IN B-VP O
61 atenolol NN B-NP B-m
61 , , O O
61 ace-i JJ O B-m
61 , , O O
61 asa JJ O B-m
61 until IN B-VP B-du
61 day NN B-NP I-du
61 of IN B-VP I-du
61 adm NN B-NP I-du
61 when WRB O O
61 he PRP O O
61 woke VBD B-VP O
61 up RP O O
61 with IN B-VP O
61 L NNP B-NP O
62 arm NN I-NP O
62 and CC O O
62 shoulder NN B-NP B-r
62 pain NN I-NP I-r
62 reminiscent NN I-NP O
62 of IN B-VP O
62 old JJ B-NP O
62 MI NNP I-NP O
63 Tried NNP I-NP O
63 NTG NNP I-NP B-m
63 sl NN I-NP B-mo
63 x3 NN I-NP B-f
63 without IN B-VP O
63 full JJ B-NP O
63 relief NN I-NP O
63 , , O O
63 called VBN O O
63 EMS NNP B-NP O
63 In IN B-VP O
64 ED NNP B-NP O
64 , , O O
64 EKG NNP B-NP O
64 without IN B-VP O
64 significant JJ B-NP O
64 change NN I-NP O
64 , , O O
64 TnI NNP B-NP O
64 flat NN I-NP O
65 Started VBD B-VP O
65 on IN B-VP O
65 heparin NN B-NP B-m
65 for IN B-VP O
65 unstable JJ B-NP B-r
65 angina NNS I-NP I-r
65 Continued VBN O O
65 to TO O O
65 have VB O O
65 L NNP B-NP B-r
65 shoulder VB O O
66 discomfort NN B-NP O
66 intermittently RB O O
66 , , O O
66 which WDT O O
66 seemed VBD B-VP O
66 best RBS O O
66 relieved VBN O O
66 by IN B-VP O
66 tylenol NN B-NP B-m
66 and CC O O
67 hot JJ B-NP O
67 compresses NNS I-NP O
67 Serial JJ B-NP O
67 CK's NNP I-NP O
67 were VBD B-VP O
67 flat JJ O O
67 , , O O
67 and CC O O
67 while IN B-VP O
67 in IN B-VP O
67 hospital NN B-NP O
67 , , O O
67 had VBD B-VP O
67 no DT B-NP O
68 recurrence NN I-NP O
68 of IN B-VP O
68 chest NN B-NP O
68 pain NN I-NP O
68 He PRP O O
68 is VBZ O O
68 to TO O O
68 follow-up JJ O O
68 with IN B-VP O
68 Dr NNP B-NP O
68 Tollner NNP I-NP O
68 , , O O
68 with IN B-VP O
69 possibility NN B-NP O
69 of IN B-VP O
69 ETT-MIBI NNP B-NP O
69 as IN B-VP O
69 outpatient NN B-NP O
69 to TO O O
69 better JJR O O
69 define VB O O
69 his PRP$ O O
69 coronary JJ B-NP O
70 disease NN I-NP O
71 ADDITIONAL NNP I-NP O
71 COMMENTS: NNP I-NP O
71 1 CD O O
71 ) ) O O
71 Please NNP B-NP O
71 remember VB O O
71 to TO O O
71 take VB O O
71 the DT O O
71 increased VBN O O
71 dose NN B-NP O
71 of IN B-VP O
71 zestril $ O B-m
71 10 CD O B-do
71 mg NN B-NP I-do
71 by IN B-VP B-mo
71 mouth NN B-NP I-mo
72 once RB O B-f
72 a DT B-NP I-f
72 day NN I-NP I-f
72 Take NNP I-NP O
72 all DT O O
72 of IN B-VP O
72 your PRP$ O O
72 other JJ B-NP O
72 medicines NNS I-NP B-m
72 as IN B-VP O
72 you PRP O O
72 were VBD B-VP O
72 before IN B-VP O
73 2 CD O O
73 ) ) O O
73 Please NNP B-NP O
73 make VB O O
73 a DT B-NP O
73 follow-up JJ I-NP O
73 appointment NN I-NP O
73 with IN B-VP O
73 Dr NNP B-NP O
73 Cyrus NNP I-NP O
73 for IN B-VP O
73 the DT B-NP O
73 next JJ I-NP O
74 week NN I-NP O
74 or CC O O
74 two CD O O
75 3 CD O O
75 ) ) O O
75 If IN B-VP O
75 you PRP O O
75 experience VBP O O
75 chest JJS B-NP B-r
75 pain NN I-NP I-r
75 with IN B-VP O
75 activity NN B-NP O
75 , , O O
75 rest NN B-NP O
75 , , O O
75 take VB O O
75 a DT B-NP O
76 nitroglycerin NN I-NP B-m
76 once RB O B-f
76 every DT O I-f
76 5 CD O I-f
76 minutes NNS B-NP I-f
76 up RB O I-f
76 to TO O I-f
76 three CD O I-f
76 times; NN B-NP I-f
76 if IN B-VP O
76 the DT B-NP O
76 pain NN I-NP O
76 does VBZ O O
77 not RB O O
77 go VB O O
77 away RB O O
77 , , O O
77 call VB O O
77 911 CD O O
77 immediately RB O O
77 If IN B-VP O
77 you PRP O O
77 experience VBP O O
77 an DT B-NP O
77 increase NN I-NP O
77 in IN B-VP O
78 chest JJ B-NP O
78 pain NN I-NP O
78 or CC O O
78 shortness NN B-NP O
78 of IN B-VP O
78 breath NN B-NP O
78 at IN B-VP O
78 rest NN B-NP O
78 , , O O
78 return NN B-NP O
78 to TO O O
78 the DT B-NP O
78 hospital NN I-NP O
79 DISCHARGE NNP I-NP O
79 CONDITION: NNP I-NP O
79 Stable NNP I-NP O
80 TO NNP I-NP O
80 DO/PLAN: NNP I-NP O
81 1 CD O O
81 ) ) O O
81 ETT-MIBI NN B-NP O
81 as IN B-VP O
81 outpatient JJ O O
82 2 CD O O
82 ) ) O O
82 Check NNP B-NP O
82 K NNP I-NP O
82 , , O O
82 Cr NNP B-NP O
82 within IN B-VP O
82 1-2 JJ B-NP O
82 weeks NNS I-NP O
82 s/p VBP O O
82 change NN B-NP O
82 in IN B-VP O
82 zestril NN B-NP B-m
82 dose VBP O O
83 3 CD O O
83 ) ) O O
83 Given VBN O O
83 h/o JJ B-NP O
83 heartburn NN I-NP O
83 , , O O
83 not RB O O
83 responsive JJ O O
83 to TO O O
83 zantac VB O B-m
83 and CC O O
83 guaiac VB O O
83 pos NN B-NP O
83 stool NN I-NP O
83 , , O O
84 should MD O O
84 have VB O O
84 referral JJ O O
84 to TO O O
84 GI NNP B-NP O
84 and CC O O
84 EGD NNP B-NP O
84 as IN B-VP O
84 outpatient JJ B-NP O
85 No NNP I-NP O
85 dictated VBD B-VP O
85 summary JJ B-NP O
86 ENTERED NNP I-NP O
86 BY: NNP I-NP O
86 FODERA NNP I-NP O
86 , , O O
86 MYRON NNP B-NP O
86 , , O O
86 M.D NNP B-NP O
86 ( ( O O
86 AR68 NNP B-NP O
86 ) ) O O
86 10/24/01 CD O O
86 @ $ O O
86 02:12 CD O O
86 PM NNP B-NP O
87 ****** JJ B-NP O
87 END NNP I-NP O
87 OF NNP I-NP O
87 DISCHARGE NNP I-NP O
87 ORDERS NNP I-NP O
87 ****** NNP I-NP O
88 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #435683 VBZ O O
2 261209550 CD O O
2 ICH NNP B-NP O
2 74936279 CD O O
2 5609579 CD O O
2 7/6/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 SEPSIS NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 2/21/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/0/2006 CD O O
4 ATTENDING: NNP B-NP O
4 RAMINEZ NNP I-NP O
4 , , O O
4 ISRAEL NNP B-NP O
4 M.D NNP I-NP O
5 CHIEF NNP I-NP O
5 COMPLAINT: NNP I-NP O
6 Weakness NNP I-NP O
6 , , O O
6 shortness NN B-NP O
6 of IN B-VP O
6 breath NN B-NP O
6 , , O O
6 and CC O O
6 dizziness JJ B-NP O
7 HISTORY NNP I-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT B-NP O
8 48-year-old JJ I-NP O
8 female NN I-NP O
8 who WP O O
8 was VBD B-VP O
8 discharged VBN O O
8 to TO O O
8 home VB O O
8 on IN B-VP O
9 6/13/06 CD O O
9 from IN B-VP O
9 Nixma NNP B-NP O
9 County NNP I-NP O
9 Hospital NNP I-NP O
9 after IN B-VP O
9 an DT B-NP O
9 ICU NNP I-NP O
9 admission NN I-NP O
9 for IN B-VP O
10 pneumonia NN B-NP O
10 and CC O O
10 Klonopin NNP B-NP B-m
10 overdose VBP O O
10 Two CD O O
10 days NNS B-NP O
10 prior RB O O
10 to TO O O
10 admission NN B-NP O
11 here RB O O
11 , , O O
11 she PRP O O
11 experienced VBD B-VP O
11 shortness NN B-NP O
11 of IN B-VP O
11 breath NN B-NP O
11 at IN B-VP O
11 rest NN B-NP O
11 and CC O O
11 some DT B-NP O
12 lightheadedness NN I-NP O
12 At IN B-VP O
12 baseline NN B-NP O
12 , , O O
12 she PRP O O
12 becomes VBZ O O
12 dyspneic RB O O
12 after IN B-VP O
12 walking VBG O O
13 20 CD O O
13 feet NNS B-NP O
13 secondary JJ O O
13 to TO O O
13 obesity NN B-NP O
13 and CC O O
13 many JJ B-NP O
13 years NNS I-NP O
13 of IN B-VP O
13 smoking NN B-NP O
13 She PRP O O
13 also RB O O
14 notes VBZ O O
14 several JJ B-NP O
14 days NNS I-NP O
14 of IN B-VP O
14 headache NN B-NP O
14 and CC O O
14 some DT B-NP O
14 questionable JJ I-NP O
14 darkening NN I-NP O
14 in IN B-VP O
15 her PRP$ O O
15 visual JJ B-NP O
15 fields NNS I-NP O
15 bilaterally RB O O
15 She PRP O O
15 admits VBZ O O
15 that IN B-VP O
15 her PRP$ O O
15 p.o NN B-NP O
15 intake NN I-NP O
16 has VBZ O O
16 been VBN O O
16 rather RB O O
16 poor JJ O O
16 since IN B-VP O
16 coming VBG O O
16 home RB O O
16 secondary JJ O O
16 to TO O O
16 anorexia VB O O
16 and CC O O
17 that IN B-VP O
17 she PRP O O
17 has VBZ O O
17 felt VBN O O
17 dehydrated VBN O O
17 On IN B-VP O
17 review NN B-NP O
17 of IN B-VP O
17 systems NNS B-NP O
17 , , O O
17 she PRP O O
17 also RB O O
18 notes VBZ O O
18 chronic JJ B-NP O
18 waxing NN I-NP O
18 and CC O O
18 waning VBG O O
18 erythema NN B-NP O
18 of IN B-VP O
18 the DT B-NP O
18 right JJ I-NP O
18 lower JJR I-NP O
19 extremity NN I-NP O
19 which WDT O O
19 in IN B-VP O
19 recent JJ B-NP O
19 days NNS I-NP O
19 has VBZ O O
19 worsened VBN O O
19 with IN B-VP O
19 accompanying VBG O O
20 swelling VBG O O
20 and CC O O
20 mild JJ B-NP O
20 tenderness NN I-NP O
20 , , O O
20 although IN B-VP O
20 her PRP$ O O
20 son NN B-NP O
20 says VBZ O O
20 that IN B-VP O
20 it PRP O O
20 has VBZ O O
21 been VBN O O
21 worse VBN O O
21 in IN B-VP O
21 the DT B-NP O
21 past NN I-NP O
21 Also RB O O
21 , , O O
21 she PRP O O
21 has VBZ O O
21 noted VBN O O
21 loose JJ B-NP O
21 stools NNS I-NP O
21 since IN B-VP O
22 6/2/06 CD O O
22 She PRP O O
22 denies VBZ O O
22 chest JJS B-NP O
22 pain NN I-NP O
22 , , O O
22 pleurisy NN B-NP O
22 , , O O
22 abdominal JJ B-NP O
22 pain NN I-NP O
22 , , O O
22 blood NN B-NP O
23 in IN B-VP O
23 her PRP$ O O
23 stool NN B-NP O
23 or CC O O
23 urine NN B-NP O
23 , , O O
23 dysuria NN B-NP O
23 , , O O
23 change NN B-NP O
23 in IN B-VP O
23 frequency NN B-NP O
23 , , O O
23 character NN B-NP O
23 or CC O O
24 urination NN B-NP O
24 , , O O
24 or CC O O
24 focal JJ B-NP O
24 weakness NN I-NP O
24 No NNP I-NP O
24 new JJ B-NP O
24 medications NNS I-NP O
24 other JJ O O
24 than IN B-VP O
24 a DT B-NP O
25 recent JJ I-NP O
25 antibiotic JJ I-NP B-m
25 course NN I-NP O
25 at IN B-VP O
25 Dale NNP B-NP O
25 Skin NNP I-NP O
25 Sonmu NNP I-NP O
25 Medical NNP I-NP O
25 Center NNP I-NP O
25 completed VBD B-VP O
25 there EX O O
25 for IN B-VP O
26 pneumonia NN B-NP B-r
26 She PRP O O
26 has VBZ O O
26 not RB O O
26 taken VBN O O
26 her PRP$ O O
26 lisinopril NN B-NP B-m
26 or CC O O
26 methadone NN B-NP B-m
26 in IN B-VP O
26 the DT O O
27 last JJ O O
27 two CD O O
27 days NNS B-NP O
27 She PRP O O
27 has VBZ O O
27 no DT B-NP O
27 sick JJ I-NP O
27 contact NN I-NP O
27 She PRP O O
27 saw VBD B-VP O
27 her PRP O O
27 PCP NNP B-NP O
27 on IN B-VP O
28 0/10/06 CD O O
28 who WP O O
28 found VBD B-VP O
28 her PRP O O
28 to TO O O
28 be VB O O
28 hypotensive JJ O O
28 and CC O O
28 hypoxic NN B-NP O
28 and CC O O
28 then RB O O
29 sent VBD B-VP O
29 her PRP O O
29 to TO O O
29 Ma NNP B-NP O
29 County NNP I-NP O
29 Hospital NNP I-NP O
29 ED NNP I-NP O
29 Her NNP I-NP O
29 family NN I-NP O
29 is VBZ O O
29 not RB O O
29 clear JJ O O
29 on IN B-VP O
29 her PRP$ O O
30 discharge NN B-NP O
30 diagnosis NN I-NP O
30 , , O O
30 but CC O O
30 they PRP O O
30 report VBP O O
30 that IN B-VP O
30 her PRP$ O O
30 kidney NN B-NP O
30 function NN I-NP O
30 was VBD B-VP O
31 abnormal JJ O O
31 and CC O O
31 she PRP O O
31 was VBD B-VP O
31 dehydrated VBN O O
31 She PRP O O
31 was VBD B-VP O
31 not RB O O
31 admitted VBN O O
31 She PRP O O
31 then RB O O
32 came VBD B-VP O
32 to TO O O
32 the DT B-NP O
32 ED NNP I-NP O
32 at IN B-VP O
32 Town NNP B-NP O
32 Medical NNP I-NP O
32 Center NNP I-NP O
32 And CC O O
32 Clinics NNP B-NP O
32 for IN B-VP O
32 persistent JJ B-NP O
32 shortness NN I-NP O
32 of IN B-VP O
33 breath NN B-NP O
33 and CC O O
33 dizziness NN B-NP O
33 In IN B-VP O
33 the DT B-NP O
33 ED NNP I-NP O
33 , , O O
33 her PRP$ O O
33 vital JJ B-NP O
33 signs NNS I-NP O
33 were VBD B-VP O
33 that IN B-VP O
33 she PRP O O
34 was VBD B-VP O
34 afebrile RB O O
34 , , O O
34 her PRP O O
34 systolic JJ B-NP O
34 blood NN I-NP O
34 pressure NN I-NP O
34 was VBD B-VP O
34 in IN B-VP O
34 the DT O O
34 high JJ O O
34 60's CD O O
34 , , O O
35 her PRP$ O O
35 heart NN B-NP O
35 rate NN I-NP O
35 was VBD B-VP O
35 110 CD O O
35 , , O O
35 respiratory NN B-NP O
35 rate NN I-NP O
35 in IN B-VP O
35 the DT O O
35 30's CD O O
35 , , O O
35 and CC O O
35 O2 NNP B-NP O
36 saturations NNS I-NP O
36 were VBD B-VP O
36 in IN B-VP O
36 the DT O O
36 high JJ O O
36 80's CD O O
36 She PRP O O
36 was VBD B-VP O
36 given VBN O O
36 vancomycin NN B-NP B-m
36 , , O O
37 Levaquin NNP B-NP B-m
37 and CC O O
37 gentamicin NN B-NP B-m
37 and CC O O
37 3 CD O B-do
37 liters NNS B-NP I-do
37 of IN B-VP O
37 normal JJ B-NP B-m
37 saline NN I-NP I-m
37 She PRP O O
37 was VBD B-VP O
38 aggressively RB O O
38 given VBN O O
38 fluids NNS B-NP B-m
38 and CC O O
38 was VBD B-VP O
38 started VBN O O
38 on IN B-VP O
38 Levophed NNP B-NP B-m
38 for IN B-VP O
38 blood NN B-NP B-r
39 pressure NN I-NP O
39 support NN I-NP O
39 Her NNP I-NP O
39 EKG NNP I-NP O
39 was VBD B-VP O
39 notable JJ O O
39 for IN B-VP O
39 low JJ B-NP O
39 voltage NN I-NP O
39 on IN B-VP O
40 precordial JJ B-NP O
40 leads NNS I-NP O
40 and CC O O
40 borderline NN B-NP O
40 right RB O O
40 axis JJ B-NP O
40 deviation NN I-NP O
40 Chest NNP I-NP O
41 x-ray NN I-NP O
41 showed VBD B-VP O
41 cardiomegaly JJ O O
41 , , O O
41 but CC O O
41 otherwise RB O O
41 clear JJ O O
41 In IN B-VP O
41 the DT B-NP O
41 MICU NNP I-NP O
41 , , O O
41 her PRP$ O O
42 blood NN B-NP O
42 pressure NN I-NP O
42 was VBD B-VP O
42 stabilized VBN O O
42 on IN B-VP O
42 Levophed NNP B-NP B-m
42 , , O O
42 but CC O O
42 she PRP O O
42 was VBD B-VP O
42 also RB O O
42 noted VBN O O
43 to TO O O
43 drop VB O O
43 her PRP$ O O
43 blood NN B-NP O
43 pressure NN I-NP O
43 to TO O O
43 the DT O O
43 70's CD O O
43 when WRB O O
43 initiated VBN O O
43 on IN B-VP O
43 her PRP$ O O
43 home NN B-NP O
44 BiPAP NNP I-NP O
44 settings NNS I-NP O
45 PAST NNP I-NP O
45 MEDICAL NNP I-NP O
45 HISTORY: NNP I-NP O
46 She PRP O O
46 had VBD B-VP O
46 endocarditis VBN O O
46 20 CD O O
46 years NNS B-NP O
46 ago RB O O
46 She PRP O O
46 has VBZ O O
46 obstructive JJ B-NP O
46 sleep NN I-NP O
47 apnea NN I-NP O
47 , , O O
47 on IN B-VP O
47 her PRP$ O O
47 home NN B-NP O
47 BiPAP NNP I-NP O
47 , , O O
47 morbid NN B-NP O
47 obesity NN I-NP O
47 , , O O
47 and CC O O
47 hypertension NN B-NP O
47 She PRP O O
48 had VBD B-VP O
48 a DT B-NP O
48 right JJ I-NP O
48 ankle NN I-NP O
48 injury NN I-NP O
48 more JJR O O
48 than IN B-VP O
48 20 CD O O
48 years NNS B-NP O
48 ago RB O O
48 during IN B-VP O
48 the DT B-NP O
48 motor NN I-NP O
49 vehicle NN I-NP O
49 accident NN I-NP O
49 , , O O
49 which WDT O O
49 was VBD B-VP O
49 complicated VBN O O
49 by IN B-VP O
49 an DT B-NP O
49 ankle JJ I-NP O
49 infection NN I-NP O
50 She PRP O O
50 has VBZ O O
50 chronic JJ O B-r
50 right RB O I-r
50 lower JJR B-NP I-r
50 extremity NN I-NP I-r
50 pain NN I-NP I-r
50 and CC O O
50 she PRP O O
50 is VBZ O O
50 on IN B-VP O
51 methadone NN B-NP B-m
51 She PRP O O
51 had VBD B-VP O
51 a DT B-NP O
51 Klonopin NNP I-NP B-m
51 overdose NN I-NP O
51 She PRP O O
51 had VBD B-VP O
51 Enterobacter NNP B-NP O
52 pneumonia NN I-NP O
52 She PRP O O
52 was VBD B-VP O
52 treated VBN O O
52 with IN B-VP O
52 cefepime NN B-NP B-m
52 at IN B-VP O
52 that DT B-NP O
52 time NN I-NP O
52 , , O O
53 questionable JJ O O
53 the DT B-NP O
53 vancomycin NN I-NP B-m
53 She PRP O O
53 has VBZ O O
53 a DT B-NP O
53 questionable JJ I-NP O
53 diagnosis NN I-NP O
53 of IN B-VP O
54 COPD NNP B-NP O
54 with IN B-VP O
54 her PRP$ O O
54 extensive JJ B-NP O
54 smoking NN I-NP O
54 history NN I-NP O
54 In IN B-VP O
54 a DT B-NP O
54 well NN I-NP O
54 state NN I-NP O
54 , , O O
54 her PRP$ O O
55 PCO2 NNP B-NP O
55 was VBD B-VP O
55 49 CD O O
55 , , O O
55 her PRP$ O O
55 O2 NNP B-NP O
55 saturation NN I-NP O
55 is VBZ O O
55 89% CD O O
55 , , O O
55 and CC O O
55 she PRP O O
55 has VBZ O O
55 also RB O O
55 history NN B-NP O
56 of IN B-VP O
56 depression NN B-NP O
57 MEDICATIONS NNP I-NP O
57 AT NNP I-NP O
57 HOME: NNP I-NP O
58 Lisinopril NNP I-NP B-m
58 and CC O O
58 methadone NN B-NP B-m
58 She PRP O O
58 is VBZ O O
58 not RB O O
58 taking VBG O O
58 her PRP$ O O
58 lisinopril NN B-NP B-m
58 She PRP O O
59 has VBZ O O
59 in IN B-VP O
59 the DT O O
59 past JJ O O
59 taken VBN O O
59 lisinopril NN B-NP B-m
59 with IN B-VP O
59 hydrochlorothiazide NN B-NP B-m
60 ALLERGIES: NNP I-NP O
61 She PRP O O
61 is VBZ O O
61 allergic JJ O O
61 to TO O O
61 penicillin VB O O
61 and CC O O
61 sulfa VB O O
61 drugs NNS B-NP O
62 SOCIAL NNP I-NP O
62 HISTORY: NNP I-NP O
63 She PRP O O
63 smoked VBD B-VP O
63 half PDT O O
63 a DT B-NP O
63 pack NN I-NP O
63 a DT B-NP O
63 day NN I-NP O
63 for IN B-VP O
63 30 CD O O
63 years NNS B-NP O
63 No DT B-NP O
63 alcohol NN I-NP O
63 for IN B-VP O
63 three CD O O
64 years NNS B-NP O
64 No DT B-NP O
64 illicit NN I-NP O
64 drugs NNS I-NP O
64 She PRP O O
64 lives VBZ O O
64 at IN B-VP O
64 home NN B-NP O
64 , , O O
64 but CC O O
64 does VBZ O O
64 not RB O O
64 work VB O O
65 She PRP O O
65 is VBZ O O
65 on IN B-VP O
65 disability NN B-NP O
66 PHYSICAL NNP I-NP O
66 EXAMINATION: NNP I-NP O
67 She PRP O O
67 was VBD B-VP O
67 afebrile RB O O
67 , , O O
67 heart NN B-NP O
67 rate NN I-NP O
67 in IN B-VP O
67 the DT O O
67 100's CD O O
67 , , O O
67 blood NN B-NP O
67 pressure NN I-NP O
67 130/80 CD O O
67 , , O O
68 respiratory NN B-NP O
68 of IN B-VP O
68 18 CD O O
68 , , O O
68 and CC O O
68 O2 NNP B-NP O
68 saturation NN I-NP O
68 95% CD O O
68 on IN B-VP O
68 8 CD O B-do
68 liters NNS B-NP I-do
68 of IN B-VP O
68 oxygen NN B-NP B-m
69 She PRP O O
69 was VBD B-VP O
69 awake JJ O O
69 and CC O O
69 alert JJ O O
69 and CC O O
69 in IN B-VP O
69 no DT B-NP O
69 acute NN I-NP O
69 distress NN I-NP O
69 She PRP O O
69 is VBZ O O
70 anicteric JJ O O
70 , , O O
70 without IN B-VP O
70 pallor NN B-NP O
70 She PRP O O
70 had VBD B-VP O
70 a DT B-NP O
70 thick JJ I-NP O
70 neck NN I-NP O
70 Pulmonary: NNP I-NP O
71 She PRP O O
71 had VBD B-VP O
71 decreased VBN O O
71 breath NN B-NP O
71 sounds NNS I-NP O
71 and CC O O
71 crackles NNS B-NP O
71 at IN B-VP O
71 the DT B-NP O
71 bases NNS I-NP O
72 bilaterally RB O O
72 Cardiovascular: NNP B-NP O
72 She PRP O O
72 was VBD B-VP O
72 tachy JJ O O
72 , , O O
72 regular JJ O O
72 , , O O
72 but CC O O
73 distant JJ B-NP O
73 S4 NNP I-NP O
73 JVP NNP I-NP O
73 was VBD B-VP O
73 difficulty NN B-NP O
73 to TO O O
73 ascertain VB O O
73 secondary JJ O O
73 to TO O O
73 neck VB O O
74 habitus NN B-NP O
74 Her NNP I-NP O
74 abdomen NN I-NP O
74 was VBD B-VP O
74 obese JJ O O
74 , , O O
74 + JJ B-NP O
74 bowel NN I-NP O
74 sounds NNS I-NP O
74 , , O O
74 nontender NN B-NP O
74 and CC O O
75 nondistended JJ B-NP O
75 Extremities NNS I-NP O
75 were VBD B-VP O
75 without IN B-VP O
75 erythema NN B-NP O
75 of IN B-VP O
75 her PRP$ O O
75 legs NNS B-NP O
75 , , O O
75 but CC O O
76 with IN B-VP O
76 mild JJ O O
76 swelling VBG O O
76 of IN B-VP O
76 the DT O O
76 right JJ O O
76 lower JJR O O
76 ankle IN B-VP O
76 The DT B-NP O
76 ankles NNS I-NP O
76 were VBD B-VP O
77 without IN B-VP O
77 swelling VBG O O
77 and CC O O
77 with IN B-VP O
77 full JJ B-NP O
77 range NN I-NP O
77 of IN B-VP O
77 motion NN B-NP O
77 Neurologically NNP I-NP O
77 , , O O
78 she PRP O O
78 was VBD B-VP O
78 alert JJ O O
78 and CC O O
78 oriented JJ O O
78 , , O O
78 but CC O O
78 unfocused VBD B-VP O
78 in IN B-VP O
78 conversation NN B-NP O
78 , , O O
78 moving VBG O O
79 all DT O O
79 her PRP$ O O
79 extremities NNS B-NP O
79 Her NNP I-NP O
79 strength NN I-NP O
79 was VBD B-VP O
79 intact JJ B-NP O
80 LABORATORY NNP I-NP O
80 STUDIES NNP I-NP O
80 ON NNP I-NP O
80 ADMISSION: NNP I-NP O
81 Please NNP I-NP O
81 see VB O O
81 LMR NNP B-NP O
82 ASSESSMENT NNP I-NP O
82 AND NNP I-NP O
82 PLAN: NNP I-NP O
83 This DT O O
83 is VBZ O O
83 a DT B-NP O
83 49-year-old JJ I-NP O
83 woman NN I-NP O
83 with IN B-VP O
83 a DT B-NP O
83 recent JJ I-NP O
83 ICU NNP I-NP O
83 stay NN I-NP O
83 at IN B-VP O
83 an DT B-NP O
83 outside JJ I-NP O
84 hospital NN I-NP O
84 who WP O O
84 presented VBD B-VP O
84 with IN B-VP O
84 hypotension NN B-NP O
84 , , O O
84 tachycardia NN B-NP O
84 , , O O
84 and CC O O
84 acute JJ B-NP O
85 renal JJ I-NP O
85 failure NN I-NP O
85 Presentation NNP I-NP O
85 was VBD B-VP O
85 most RBS O O
85 consistent JJ O O
85 with IN B-VP O
85 right JJ B-NP O
86 pulmonary JJ I-NP O
86 embolus NN I-NP O
86 and CC O O
86 right JJ B-NP O
86 ventricular NN I-NP O
86 failure NN I-NP O
87 HOSPITAL NNP I-NP O
87 COURSE NNP I-NP O
87 BY NNP I-NP O
87 SYSTEM: NNP I-NP O
88 1 CD O O
88 Pulmonary/Vascular: NNP B-NP O
88 There EX O O
88 was VBD B-VP O
88 initial JJ B-NP O
88 concern NN I-NP O
88 for IN B-VP O
88 a DT B-NP O
88 PE NNP I-NP O
88 given VBN O O
89 the DT B-NP O
89 presentation NN I-NP O
89 of IN B-VP O
89 severe JJ B-NP O
89 hypotension NN I-NP O
89 , , O O
89 tachycardia NN B-NP O
89 , , O O
89 and CC O O
89 Aa NNP B-NP O
90 gradient NN I-NP O
90 without IN B-VP O
90 evidence NN B-NP O
90 of IN B-VP O
90 infection NN B-NP O
90 or CC O O
90 primary JJ B-NP O
90 cardiac JJ I-NP O
91 disease NN I-NP O
91 An DT B-NP O
91 echo NN I-NP O
91 showed VBD B-VP O
91 a DT B-NP O
91 dilated JJ I-NP O
91 RV NNP I-NP O
91 with IN B-VP O
91 depressed JJ B-NP O
91 RV NNP I-NP O
91 function NN I-NP O
92 suggestive NN I-NP O
92 of IN B-VP O
92 PE NNP B-NP O
92 Her NNP I-NP O
92 initial JJ B-NP O
92 PE NNP I-NP O
92 scan NN I-NP O
92 was VBD B-VP O
92 nondiagnostic JJ O O
93 secondary JJ O O
93 to TO O O
93 poorly RB O O
93 timed VBN O O
93 contrast NN B-NP O
93 and CC O O
93 motion NN B-NP O
93 of IN B-VP O
93 the DT B-NP O
93 patient NN I-NP O
93 A NNP I-NP O
94 VQ NNP I-NP O
94 scan JJ O O
94 showed VBD B-VP O
94 intermediate JJ B-NP O
94 probability NN I-NP O
94 She PRP O O
94 was VBD B-VP O
94 started VBN O O
94 on IN B-VP O
95 heparin NN B-NP B-m
95 drip NN I-NP B-mo
95 with IN B-VP O
95 a DT B-NP O
95 goal NN I-NP O
95 of IN B-VP O
95 60 CD O O
95 to TO O O
95 80 CD O O
95 Her PRP$ O O
95 second JJ B-NP O
95 PECT NNP I-NP O
95 showed VBD B-VP O
95 a DT B-NP O
96 small JJ I-NP O
96 PE NNP I-NP O
96 to TO O O
96 the DT B-NP O
96 right JJ I-NP O
96 upper JJ I-NP O
96 lobe NN I-NP O
96 , , O O
96 but CC O O
96 it PRP O O
96 was VBD B-VP O
96 not RB O O
96 large JJ O O
96 enough RB O O
96 to TO O O
97 explain VB O O
97 her PRP$ O O
97 dramatic JJ B-NP O
97 presentation NN I-NP O
97 The DT B-NP O
97 working JJ I-NP O
97 hypothesis NN I-NP O
97 is VBZ O O
98 that IN B-VP O
98 there EX O O
98 was VBD B-VP O
98 a DT B-NP O
98 significant JJ I-NP O
98 recanalization NN I-NP O
98 prior RB O O
98 to TO O O
98 this DT B-NP O
98 repeat NN I-NP O
99 CT NNP I-NP O
99 which WDT O O
99 took VBD B-VP O
99 place NN B-NP O
99 two CD O O
99 days NNS B-NP O
99 after IN B-VP O
99 the DT B-NP O
99 first JJ I-NP O
99 CT NNP I-NP O
99 She PRP O O
99 was VBD B-VP O
100 initially RB O O
100 on IN B-VP O
100 oxygen NN B-NP B-m
100 in IN B-VP O
100 the DT B-NP O
100 ICU NNP I-NP O
100 She PRP O O
100 was VBD B-VP O
100 never RB O O
100 intubated VBN O O
100 She PRP O O
101 was VBD B-VP O
101 on IN B-VP O
101 face NN B-NP O
101 mask NN I-NP O
101 , , O O
101 and CC O O
101 upon RB O O
101 transfer VB O O
101 to TO O O
101 the DT B-NP O
101 floor NN I-NP O
101 , , O O
101 she PRP O O
101 was VBD B-VP O
101 on IN B-VP O
102 nasal JJ B-NP O
102 cannula NN I-NP O
102 4 CD O O
102 liters NNS B-NP O
102 Her PRP$ O O
102 O2 JJ B-NP O
102 saturations NNS I-NP O
102 were VBD B-VP O
102 acceptable JJ B-NP O
103 in-house NN I-NP O
103 , , O O
103 although IN B-VP O
103 she PRP O O
103 did VBD B-VP O
103 desaturate VB O O
103 to TO O O
103 90% CD O O
103 when WRB O O
103 she PRP O O
103 took VBD B-VP O
103 her PRP O O
104 oxygen NN B-NP B-m
104 off RP O O
104 a DT B-NP O
104 night NN I-NP O
104 She PRP O O
104 multiple VBD B-VP O
104 times NNS B-NP O
104 refused VBD B-VP O
104 BiPAP NNP B-NP O
104 while IN B-VP O
104 in IN B-VP O
105 the DT B-NP O
105 hospital NN I-NP O
105 , , O O
105 but CC O O
105 she PRP O O
105 will MD O O
105 go VB O O
105 back RB O O
105 on IN B-VP O
105 it PRP O O
105 when WRB O O
105 she PRP O O
105 returns VBZ O O
105 home NN B-NP O
106 2 CD O O
106 Cardiovascular: NNP B-NP O
106 She PRP O O
106 had VBD B-VP O
106 a DT B-NP O
106 mild JJ I-NP O
106 troponin NN I-NP O
106 elevation NN I-NP O
106 on IN B-VP O
107 admission NN B-NP O
107 , , O O
107 likely RB O O
107 secondary JJ O O
107 to TO O O
107 RV VB O O
107 strain NN B-NP O
107 She PRP O O
107 had VBD B-VP O
107 severe JJ B-NP O
108 hypotension NN I-NP O
108 and CC O O
108 was VBD B-VP O
108 on IN B-VP O
108 two CD O O
108 pressors NNS B-NP O
108 She PRP O O
108 was VBD B-VP O
108 weaned VBN O O
108 off IN B-VP O
108 of IN B-VP O
108 these DT O O
109 on IN B-VP O
109 4/15/06 CD O O
109 , , O O
109 but CC O O
109 did VBD B-VP O
109 have VB O O
109 an DT B-NP O
109 episode NN I-NP O
109 of IN B-VP O
109 hypotension NN B-NP B-r
109 when WRB O O
109 her PRP$ O O
110 BiPAP NNP B-NP O
110 was VBD B-VP O
110 started VBN O O
110 She PRP O O
110 was VBD B-VP O
110 given VBN O O
110 a DT B-NP O
110 little JJ I-NP O
110 bit NN I-NP O
110 of IN B-VP O
110 low JJ B-NP B-do
110 dose JJ I-NP I-do
111 dobutamine NN I-NP B-m
111 and CC O O
111 then RB O O
111 she PRP O O
111 was VBD B-VP O
111 weaned VBN O O
111 off IN B-VP O
111 of IN B-VP O
111 that DT O O
111 on IN B-VP O
111 3/6/06 CD O O
112 Rhythm: NNP B-NP O
112 She PRP O O
112 has VBZ O O
112 no DT B-NP O
112 active JJ I-NP O
112 issues NNS I-NP O
112 We PRP O O
112 continued VBD B-VP O
112 to TO O O
112 hold VB O O
112 her PRP$ O O
113 lisinopril NN B-NP B-m
113 while IN B-VP B-du
113 in-house NN B-NP I-du
113 Her NNP I-NP O
113 blood NN I-NP O
113 pressures NNS I-NP O
113 were VBD B-VP O
113 stable JJ O O
113 , , O O
113 but CC O O
114 not RB O O
114 high JJ O O
114 enough RB O O
114 to TO O O
114 withstand VB O O
114 on IN B-VP O
114 additional JJ B-NP O
114 blood NN I-NP O
114 pressure NN I-NP O
115 lowering VBG O O
115 medication NN B-NP O
115 It PRP O O
115 was VBD B-VP O
115 discussed VBN O O
115 with IN B-VP O
115 her PRP$ O O
115 PCP NN B-NP O
115 that IN B-VP O
115 she PRP O O
116 perhaps RB O O
116 will MD O O
116 need VB O O
116 this DT B-NP B-m
116 medication NN I-NP I-m
116 restarted VBD B-VP O
116 as IN B-VP O
116 an DT O O
116 outpatient JJ O O
117 She PRP O O
117 does VBZ O O
117 have VB O O
117 a DT B-NP O
117 history NN I-NP O
117 of IN B-VP O
117 severe JJ B-NP O
117 hypertension NN I-NP O
118 3 CD O O
118 Renal: NNP B-NP O
118 As IN B-VP O
118 she PRP O O
118 was VBD B-VP O
118 in IN B-VP O
118 acute JJ B-NP O
118 failure NN I-NP O
118 on IN B-VP O
118 admission NN B-NP O
118 with IN B-VP O
118 a DT B-NP O
119 creatinine NN I-NP O
119 of IN B-VP O
119 6.9 CD O O
119 , , O O
119 it PRP O O
119 dropped VBD B-VP O
119 to TO O O
119 0.5 CD O O
119 , , O O
119 most RBS O O
119 likely JJ O O
119 this DT O O
119 was VBD B-VP O
119 due JJ O O
119 to TO O O
120 prerenal JJ B-NP O
120 azotemia NN I-NP O
120 and CC O O
120 decreased VBD B-VP O
120 renal JJ B-NP O
120 perfusion NN I-NP O
120 in IN B-VP O
120 the DT B-NP O
120 setting NN I-NP O
120 of IN B-VP O
121 hypotension NN B-NP O
121 Hypoperfusion NNP I-NP O
121 of IN B-VP O
121 the DT B-NP O
121 kidneys NNS I-NP O
121 in IN B-VP O
121 setting NN B-NP O
121 of IN B-VP O
122 hypovolemia NN B-NP O
122 and CC O O
122 right JJ B-NP O
122 heart NN I-NP O
122 failure NN I-NP O
122 resulting VBG O O
122 in IN B-VP O
122 decreased JJ O O
122 left VBD B-VP O
123 ventricular JJ B-NP O
123 preload NN I-NP O
123 Mucomyst NNP I-NP B-m
123 and CC O O
123 bicarb NN B-NP B-m
123 were VBD B-VP O
123 given VBN O O
123 prior RB O O
123 to TO O O
123 the DT B-NP O
124 PECTs NNP I-NP O
124 of IN B-VP O
124 her PRP$ O O
124 renal JJ B-NP O
124 protection NN I-NP O
124 She PRP O O
124 did VBD B-VP O
124 not RB O O
124 develop VB O O
124 any DT B-NP O
125 additional JJ I-NP O
125 contrast NN I-NP O
125 nephropathy NN I-NP O
125 after IN B-VP O
125 her PRP$ O O
125 CT NNP B-NP O
125 scans VBZ O O
125 Her PRP$ O O
126 creatinine NN B-NP O
126 on IN B-VP O
126 discharge NN B-NP O
126 was VBD B-VP O
126 0.6 CD O O
127 4 CD O O
127 Endocrine: NNP B-NP O
127 She PRP O O
127 had VBD B-VP O
127 a DT B-NP O
127 normal JJ I-NP O
127 increase NN I-NP O
127 in IN B-VP O
127 her PRP$ O O
127 cortisol JJ B-NP O
127 level NN I-NP O
128 with IN B-VP O
128 ACTH NNP B-NP O
128 stimulation NN I-NP O
128 Her PRP$ O O
128 fingersticks NNS B-NP O
128 were VBD B-VP O
128 monitored VBN O O
128 while IN B-VP O
128 she PRP O O
129 was VBD B-VP O
129 in-house NN B-NP O
129 and CC O O
129 she PRP O O
129 never RB O O
129 had VBD B-VP O
129 any DT B-NP O
129 need NN I-NP O
129 for IN B-VP O
129 supplemental JJ B-NP O
129 insulin NN I-NP O
130 5 CD O O
130 FEN: NNP B-NP O
130 She PRP O O
130 was VBD B-VP O
130 on IN B-VP O
130 a DT B-NP O
130 house NN I-NP O
130 diet JJ O O
131 6 CD O O
131 ID: NNP B-NP O
131 She PRP O O
131 was VBD B-VP O
131 empirically RB O O
131 covered VBN O O
131 on IN B-VP O
131 admission NN B-NP O
131 with IN B-VP O
132 vancomycin NN B-NP B-m
132 , , O O
132 levofloxacin NN B-NP B-m
132 and CC O O
132 gentamicin VB O B-m
132 Her PRP$ O O
132 antibiotics NNS B-NP B-m
132 were VBD B-VP O
133 given VBN O O
133 again RB O O
133 on IN B-VP O
133 10/16/06 CD O O
133 and CC O O
133 on IN B-VP O
133 11/13/06 CD O O
133 There EX O O
133 was VBD B-VP O
133 no DT B-NP O
133 evidence NN I-NP O
134 of IN B-VP O
134 an DT B-NP O
134 infection NN I-NP O
134 found VBD B-VP O
134 , , O O
134 no DT B-NP O
134 fever NN I-NP O
134 , , O O
134 normal JJ B-NP O
134 white JJ I-NP O
134 count NN I-NP O
134 , , O O
134 with IN B-VP O
134 a DT O O
135 normal JJ O O
135 differential JJ O O
135 , , O O
135 normal JJ B-NP O
135 UA NNP I-NP O
135 , , O O
135 chest JJS B-NP O
135 x-ray NN I-NP O
135 is VBZ O O
135 without IN B-VP O
136 infiltrate NN B-NP O
136 , , O O
136 and CC O O
136 antibiotics NNS B-NP B-m
136 were VBD B-VP O
136 discontinued VBN O O
136 on IN B-VP O
136 4/21/06 CD O O
136 She PRP O O
137 continued VBD B-VP O
137 to TO O O
137 remain VB O O
137 afebrile JJ B-NP O
137 in-house NN I-NP O
137 without IN B-VP O
137 any DT B-NP O
137 evidence NN I-NP O
137 of IN B-VP O
138 infection NN B-NP O
139 7 CD O O
139 Urology: NNP B-NP O
139 She PRP O O
139 did VBD B-VP O
139 complain NN B-NP O
139 of IN B-VP O
139 bladder NN B-NP O
139 spasms NNS I-NP O
139 while IN B-VP O
139 having VBG O O
139 the DT B-NP O
140 Foley NNP I-NP O
140 in IN B-VP O
140 place NN B-NP O
140 She PRP O O
140 was VBD B-VP O
140 started VBN O O
140 on IN B-VP O
140 Ditropan NNP B-NP B-m
140 She PRP O O
140 had VBD B-VP O
140 multiple JJ B-NP O
141 negative JJ I-NP O
141 urinalysis NN I-NP O
141 and CC O O
141 urine JJ B-NP O
141 cultures NNS I-NP O
141 Once IN B-VP O
141 the DT B-NP O
141 Foley NNP I-NP O
141 was VBD B-VP O
142 discontinued VBN O O
142 , , O O
142 she PRP O O
142 was VBD B-VP O
142 able JJ O O
142 to TO O O
142 void VB O O
142 and CC O O
142 she PRP O O
142 stopped VBD B-VP O
142 having VBG O O
142 bladder NN B-NP O
143 spasms NNS I-NP O
143 She PRP O O
143 was VBD B-VP O
143 started VBN O O
143 on IN B-VP O
143 Monistat NNP B-NP B-m
143 for IN B-VP O
143 a DT B-NP B-r
143 yeast JJ I-NP I-r
143 infection NN I-NP I-r
144 8 CD O O
144 Allergy: NNP B-NP O
144 She PRP O O
144 did VBD B-VP O
144 have VB O O
144 an DT O O
144 elevated VBN O O
144 eosinophilia NN B-NP O
144 on IN B-VP O
145 presentation NN B-NP O
145 and CC O O
145 it PRP O O
145 was VBD B-VP O
145 4% CD O O
145 on IN B-VP O
145 admission NN B-NP O
145 and CC O O
145 increased VBD B-VP O
145 to TO O O
145 8% CD O O
145 on IN B-VP O
146 4/21/06 CD O O
146 On IN B-VP O
146 the DT B-NP O
146 day NN I-NP O
146 of IN B-VP O
146 discharge NN B-NP O
146 , , O O
146 it PRP O O
146 was VBD B-VP O
146 7.5 CD O O
146 There EX O O
146 is VBZ O O
146 no DT B-NP O
147 clinical JJ I-NP O
147 evidence NN I-NP O
147 of IN B-VP O
147 allergy NN B-NP O
147 , , O O
147 rheumatic JJ B-NP O
147 disease NN I-NP O
147 or CC O O
147 parasitic JJ B-NP O
148 infection NN I-NP O
148 Her NNP I-NP O
148 obstructive JJ B-NP O
148 lung NN I-NP O
148 disease NN I-NP O
148 may MD O O
148 be VB O O
148 of IN B-VP O
148 an DT B-NP O
148 asthma NN I-NP O
149 variant NN I-NP O
149 , , O O
149 and CC O O
149 there EX O O
149 is VBZ O O
149 the DT B-NP O
149 possibility NN I-NP O
149 she PRP O O
149 may MD O O
149 need VB O O
149 inhaled JJ B-NP B-mo
150 corticosteroids NNS I-NP B-m
150 as IN B-VP O
150 an DT O O
150 outpatient JJ O O
151 9 CD O O
151 Heme: NNP B-NP O
151 She PRP O O
151 was VBD B-VP O
151 on IN B-VP O
151 unfractionated JJ B-NP B-m
151 heparin NN I-NP I-m
151 for IN B-VP O
151 her PRP$ O B-r
151 her PRP$ O B-r
151 presumed NN B-NP I-r
151 presumed JJ B-NP I-r
151 PE NNP I-NP I-r
151 PE NNP I-NP I-r
152 until IN B-VP B-du
152 6/15/06 CD O I-du
152 and CC O O
152 then RB O O
152 she PRP O O
152 was VBD B-VP O
152 changed VBN O O
152 to TO O O
152 Lovenox NNP B-NP B-m
152 in IN B-VP O
152 the DT B-NP O
152 morning NN I-NP O
153 of IN B-VP O
153 that DT B-NP O
153 day NN I-NP O
153 on IN B-VP O
153 120 CD O B-do
153 mg NN B-NP I-do
153 subq VBD B-VP B-mo
153 Her NNP B-NP O
153 weight NN I-NP O
153 at IN B-VP O
153 that DT B-NP O
153 time NN I-NP O
153 was VBD B-VP O
153 157 CD O O
153 kg NN B-NP O
154 Her NNP I-NP O
154 Coumadin NNP I-NP B-m
154 Coumadin NNP I-NP B-m
154 , , O O
154 her PRP$ O O
154 initially RB O O
154 given VBN O O
154 10 CD O O
154 , , O O
154 then RB O O
154 a DT B-NP O
154 dose NN I-NP O
154 of IN B-VP O
154 5 CD O B-do
154 and CC O O
154 then RB O O
154 2 CD O O
155 dose NN B-NP O
155 of IN B-VP O
155 7.5 CD O O
155 Her NNP B-NP O
155 INR NNP I-NP O
155 was VBD B-VP O
155 therapeutic JJ O O
155 on IN B-VP O
155 the DT B-NP O
155 day NN I-NP O
155 of IN B-VP O
155 discharge NN B-NP O
155 at IN B-VP O
156 2.5 CD O O
156 She PRP O O
156 will MD O O
156 continue VB O O
156 on IN B-VP O
156 the DT B-NP O
156 Lovenox NNP I-NP B-m
156 for IN B-VP B-du
156 two CD O I-du
156 additional JJ B-NP I-du
156 days NNS I-NP I-du
157 Her PRP$ O O
157 INR NNP B-NP O
157 will MD O O
157 be VB O O
157 monitored VBN O O
157 by IN B-VP O
157 Dr NNP B-NP O
157 Kid NNP I-NP O
157 , , O O
157 her PRP$ O O
157 PCP NNP B-NP O
158 10 CD O O
158 Psych/Addiction: NNP B-NP O
158 We PRP O O
158 are VBP O O
158 continuing VBG O O
158 her PRP$ O O
158 methadone NN B-NP B-m
158 methadone NN I-NP B-m
158 methadone NN I-NP B-m
158 It PRP O O
158 has VBZ O O
159 been VBN O O
159 switched VBN O O
159 from IN B-VP O
159 20 CD O B-do
159 20 CD O B-do
159 mg NN B-NP I-do
159 mg NN I-NP I-do
159 p.o NN I-NP B-mo
159 p.o JJ O B-mo
159 daily JJ O B-f
159 daily RB O B-f
159 to TO O O
159 10 CD O B-do
159 mg NNS B-NP I-do
159 p.o JJ O B-mo
159 b.i.d IN B-VP B-f
159 She PRP O O
159 was VBD B-VP O
160 also RB O O
160 given VBN O O
160 a DT B-NP O
160 little JJ I-NP O
160 bit NN I-NP O
160 of IN B-VP O
160 Ativan NNP B-NP B-m
160 Ativan NNP I-NP B-m
160 while IN B-VP B-du
160 while IN B-VP B-du
160 in-house JJ B-NP I-du
160 in-house NN I-NP I-du
160 to TO O O
160 help VB O O
160 with IN B-VP O
160 her PRP$ O B-r
161 agitation NN B-NP O
161 and CC O O
161 anxiety NN B-NP B-r
161 She PRP O O
161 was VBD B-VP O
161 initially RB O O
161 given VBN O O
161 a DT B-NP O
161 little JJ I-NP O
161 bit NN I-NP O
161 of IN B-VP O
162 Haldol NNP B-NP B-m
162 , , O O
162 but CC O O
162 that DT O O
162 was VBD B-VP O
162 discontinued VBN O O
162 on IN B-VP O
162 8/4/06 CD O O
162 and CC O O
162 there EX O O
162 was VBD B-VP O
162 no DT B-NP O
163 additional JJ I-NP O
163 need NN I-NP O
163 for IN B-VP O
163 that DT O O
163 She PRP O O
163 did VBD B-VP O
163 have VB O O
163 a DT B-NP O
163 central JJ I-NP O
163 line NN I-NP O
163 placed VBN O O
163 on IN B-VP O
164 4/18/06 CD O O
164 , , O O
164 which WDT O O
164 was VBD B-VP O
164 discontinued VBN O O
164 on IN B-VP O
164 6/15/06 CD O O
164 without IN B-VP O
164 any DT B-NP O
164 evidence NN I-NP O
165 of IN B-VP O
165 any DT B-NP O
165 line NN I-NP O
165 infection NN I-NP O
165 and CC O O
165 without IN B-VP O
165 any DT B-NP O
165 problems NNS I-NP O
165 She PRP O O
165 was VBD B-VP O
165 seen VBN O O
165 by IN B-VP O
166 Social NNP B-NP O
166 Work NNP I-NP O
166 and CC O O
166 PT NNP B-NP O
166 The DT B-NP O
166 patient NN I-NP O
166 refused VBD B-VP O
166 to TO O O
166 go VB O O
166 to TO O O
166 any DT B-NP O
166 sort NN I-NP O
166 of IN B-VP O
167 rehab NN B-NP O
167 or CC O O
167 nursing NN B-NP O
167 home NN I-NP O
167 It PRP O O
167 was VBD B-VP O
167 decided VBN O O
167 that IN B-VP O
167 the DT B-NP O
167 patient NN I-NP O
167 would MD O O
168 return VB O O
168 home NN B-NP O
168 with IN B-VP O
168 skilled JJ B-NP O
168 nursing NN I-NP O
168 and CC O O
168 with IN B-VP O
168 PT NNP B-NP O
168 as IN B-VP O
168 needed VBN O O
169 eScription NN B-NP O
169 document: VBZ O O
169 1-3509519 JJ B-NP O
169 EMSSten NNP I-NP O
169 Tel NNP I-NP O
170 Dictated NNP I-NP O
170 By: NNP I-NP O
170 MCMAIN NNP I-NP O
170 , , O O
170 MITCHELL NNP B-NP O
171 Attending: NNP I-NP O
171 MCDUGLE NNP I-NP O
171 , , O O
171 VINCENZO NNP B-NP O
172 Dictation NNP I-NP O
172 ID NNP I-NP O
172 6997683 CD O O
173 D: NNP B-NP O
173 2/21/06 CD O O
174 T: NNP B-NP O
174 2/21/06 CD O O
175 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #436461 VBZ O O
4 819083955 CD O O
4 LYWCH NNP B-NP O
4 98905634 CD O O
4 4508452 CD O O
4 0/21/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Atypical NNP I-NP O
4 Angina NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/9/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/9/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 GOMEY NNP I-NP O
8 , , O O
8 REGGIE NNP B-NP O
8 802-36-83-4 CD O O
9 Jo NNP B-NP O
9 Morejose NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 9/14/06 CD O O
11 AT NNP B-NP O
11 04:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 HO NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 GOETTMAN NNP I-NP O
14 , , O O
14 NELSON NNP B-NP O
14 PHIL NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 Starting NNP I-NP O
20 IN NNP I-NP O
20 AM NNP I-NP O
20 ( ( O O
20 4/20 CD O O
20 ) ) O O
21 ATENOLOL $ O B-m
21 12.5 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QAM NNP I-NP B-f
21 HOLD NNP I-NP O
21 IF: NNP I-NP O
21 SBP&lt;100 NNP I-NP O
21 or CC O O
21 HR&lt;50 NNP B-NP O
22 LIPITOR NNP I-NP B-m
22 ( ( O I-m
22 ATORVASTATIN NNP B-NP I-m
22 ) ) O I-m
22 80 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 DAILY NNP I-NP B-f
23 COGENTIN NNP I-NP B-m
23 ( ( O I-m
23 BENZTROPINE NNP B-NP I-m
23 MESYLATE NNP I-NP I-m
23 ) ) O I-m
23 1 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QAM NNP I-NP B-f
24 Override NNP I-NP O
24 Notice: NNP I-NP O
24 Override NNP I-NP O
24 added VBD B-VP O
24 on IN B-VP O
24 9/14/06 CD O O
24 by IN B-VP O
25 SIZELOVE NNP B-NP O
25 , , O O
25 RAYMOND NNP B-NP O
25 F NNP I-NP O
25 , , O O
25 M.D NNP B-NP O
26 on IN B-VP O
26 order NN B-NP O
26 for IN B-VP O
26 THORAZINE NNP B-NP B-m
26 PO NNP I-NP B-mo
26 ( ( O O
26 ref JJ O O
26 # # O O
26 417100958 CD O O
26 ) ) O O
27 POTENTIALLY NNP B-NP O
27 SERIOUS NNP I-NP O
27 INTERACTION: NNP I-NP O
27 BENZTROPINE NNP I-NP B-m
27 MESYLATE NNP I-NP I-m
27 &amp; NNP I-NP O
28 CHLORPROMAZINE NNP I-NP B-m
28 HCL NNP I-NP I-m
29 POTENTIALLY NNP I-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 BENZTROPINE NNP I-NP B-m
29 MESYLATE NNP I-NP I-m
29 &amp; NNP I-NP O
30 CHLORPROMAZINE NNP I-NP B-m
30 HCL NNP I-NP I-m
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 aware JJ B-NP O
31 THORAZINE NNP I-NP B-m
31 ( ( O I-m
31 CHLORPROMAZINE NNP B-NP I-m
31 HCL NNP I-NP I-m
31 ) ) O I-m
31 400 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QAM NNP I-NP B-f
32 Alert NNP I-NP O
32 overridden: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 9/14/06 CD O O
32 by IN B-VP O
33 BRACAMONTE NNP B-NP O
33 , , O O
33 WALLACE NNP B-NP O
33 B NNP I-NP O
33 , , O O
33 M.D NNP B-NP O
34 POTENTIALLY NNP I-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 BENZTROPINE NNP I-NP B-m
34 MESYLATE NNP I-NP I-m
34 &amp; NNP I-NP O
35 CHLORPROMAZINE NNP I-NP B-m
35 HCL NNP I-NP I-m
36 POTENTIALLY NNP I-NP O
36 SERIOUS NNP I-NP O
36 INTERACTION: NNP I-NP O
36 BENZTROPINE NNP I-NP B-m
36 MESYLATE NNP I-NP I-m
36 &amp; NNP I-NP O
37 CHLORPROMAZINE NNP I-NP B-m
37 HCL NNP I-NP I-m
37 Reason NNP I-NP O
37 for IN B-VP O
37 override: NN B-NP O
37 aware JJ B-NP O
38 ECASA NNP I-NP B-m
38 325 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 DAILY NNP I-NP B-f
39 GLIPIZIDE NNP I-NP B-m
39 XL NNP I-NP I-m
39 10 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 DAILY NNP I-NP B-f
40 SYNTHROID NNP I-NP B-m
40 ( ( O I-m
40 LEVOTHYROXINE NNP B-NP I-m
40 SODIUM NNP I-NP I-m
40 ) ) O I-m
40 100 CD O B-do
40 MCG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 DAILY NNP I-NP B-f
41 LISINOPRIL NNP I-NP B-m
41 20 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 DAILY NNP I-NP B-f
41 HOLD NNP I-NP O
41 IF: NNP I-NP O
41 SBP&lt;100 NNP I-NP O
42 METFORMIN NNP I-NP B-m
42 1 CD O B-do
42 , , O I-do
42 000 CD O I-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 BID NNP I-NP B-f
42 HOLD NNP I-NP O
42 IF: NNP I-NP O
42 NPO NNP I-NP O
43 TRAZODONE NNP I-NP B-m
43 50 CD O B-do
43 MG NNP B-NP I-do
43 PO NNP I-NP B-mo
43 BEDTIME NNP I-NP B-f
43 PRN NNP I-NP I-f
43 Insomnia NNP I-NP B-r
44 DIET: NNP I-NP O
44 House NNP I-NP O
44 / VBD B-VP O
44 Low NNP B-NP O
44 chol/low NN I-NP O
44 sat VBD B-VP O
44 fat JJ B-NP O
45 DIET: NNP I-NP O
45 2 CD O O
45 gram NN B-NP O
45 Sodium NNP I-NP O
46 ACTIVITY: NNP I-NP O
46 Walking NNP I-NP O
46 as IN B-VP O
46 tolerated VBN O O
47 FOLLOW NNP B-NP O
47 UP NNP I-NP O
47 APPOINTMENT( NNP I-NP O
47 S NNP I-NP O
47 ): NNP I-NP O
48 Dr NNP I-NP O
48 Mike NNP I-NP O
48 Kalafarski NNP I-NP O
48 10/1/06 CD O O
48 , , O O
49 ALLERGY: NNP B-NP O
49 NKA NNP I-NP O
50 ADMIT NNP I-NP O
50 DIAGNOSIS: NNP I-NP O
51 Atypical NNP I-NP O
51 Angina NNP I-NP O
52 PRINCIPAL NNP I-NP O
52 DISCHARGE NNP I-NP O
52 DIAGNOSIS NNP I-NP O
52 ;Responsible JJ O O
52 After IN B-VP O
52 Study NNP B-NP O
52 for IN B-VP O
52 Causing NNP B-NP O
52 Admission NNP I-NP O
52 ) ) O O
53 Atypical NNP B-NP O
53 Angina NNP I-NP O
54 OTHER NNP I-NP O
54 DIAGNOSIS;Conditions NNP I-NP O
54 , , O O
54 Infections NNP B-NP O
54 , , O O
54 Complications NNP B-NP O
54 , , O O
54 affecting VBG O O
54 Treatment/Stay NNP B-NP O
55 Diabetes NNP I-NP O
55 Type NNP I-NP O
55 II NNP I-NP O
55 HYPOTHYROID NNP I-NP O
55 HTN NNP I-NP O
55 schizophrenia NN I-NP O
56 OPERATIONS NNP I-NP O
56 AND NNP I-NP O
56 PROCEDURES: NNP I-NP O
57 NONE NNP I-NP O
58 OTHER NNP I-NP O
58 TREATMENTS/PROCEDURES NNP I-NP O
58 ( ( O O
58 NOT NNP B-NP O
58 IN NNP I-NP O
58 O.R NNP I-NP O
58 ) ) O O
59 pt NN B-NP O
59 got VBD B-VP O
59 2 CD O O
59 sets NNS B-NP O
59 of IN B-VP O
59 enzymes NNS B-NP O
59 and CC O O
59 they PRP O O
59 were VBD B-VP O
59 12 CD O O
59 hours NNS B-NP O
59 apart RB O O
59 and CC O O
59 both DT O O
59 were VBD B-VP O
60 negative JJ B-NP O
61 BRIEF NNP I-NP O
61 RESUME NNP I-NP O
61 OF NNP I-NP O
61 HOSPITAL NNP I-NP O
61 COURSE: NNP I-NP O
62 70 CD O O
62 y/o NN B-NP O
62 with IN B-VP O
62 known JJ B-NP O
62 CAD NNP I-NP O
62 , , O O
62 DM NNP B-NP O
62 , , O O
62 schzioaffective JJ B-NP O
62 disorder NN I-NP O
63 p/w NN I-NP O
63 intermittent NN I-NP O
63 chest NN I-NP O
63 pain NN I-NP O
63 x12 NNP I-NP O
63 hours NNS I-NP O
63 Poor NNP I-NP O
63 historian JJ B-NP O
63 Reports NNP I-NP O
64 episode NN I-NP O
64 of IN B-VP O
64 Left NNP B-NP O
64 sided VBD B-VP O
64 chest JJS B-NP O
64 pressure NN I-NP O
64 radiating VBG O O
64 up RP O O
64 to TO O O
64 shoulder/arm VB O O
65 while IN B-VP O
65 in IN B-VP O
65 bed NN B-NP O
65 lasting JJ B-NP O
65 couple NN I-NP O
65 of IN B-VP O
65 minutes NNS B-NP O
65 Diaphoresis NNP I-NP O
65 with IN B-VP O
65 no DT B-NP O
66 n/v/fever/cough/SOB NN I-NP O
66 Had VBD B-VP O
66 repeat NN B-NP O
66 episode NN I-NP O
66 lasting VBG O O
66 couple NN B-NP O
66 of IN B-VP O
66 seconds NNS B-NP O
67 since IN B-VP O
67 this DT O O
67 am VBP O O
67 No DT B-NP O
67 similar JJ I-NP O
67 episodes NNS I-NP O
67 of IN B-VP O
67 CP NNP B-NP O
67 in IN B-VP O
67 the DT B-NP O
67 past NN I-NP O
67 Had NNP I-NP O
67 recent JJ B-NP O
68 cardiac JJ I-NP O
68 w/u NN I-NP O
68 and CC O O
68 MIBI NNP B-NP O
68 showing VBG O O
68 mod JJ B-NP O
68 defect NN I-NP O
68 at IN B-VP O
68 the DT B-NP O
68 circumflex NN I-NP O
68 but CC O O
68 decided VBD B-VP O
69 no DT B-NP O
69 medical JJ I-NP O
69 trt NN I-NP O
69 at IN B-VP O
69 this DT B-NP O
69 point NN I-NP O
69 in IN B-VP O
69 time NN B-NP O
70 PMHx: NNP I-NP O
71 HTN NNP I-NP O
72 DM NNP I-NP O
73 CAD NNP I-NP O
73 s/p VBD B-VP O
73 MI NNP B-NP O
73 10/5 CD O O
73 schziophrenic/depression NN B-NP O
74 Hypothyroidism NNP I-NP O
74 ECHO: NNP I-NP O
74 EF NNP I-NP O
75 65% CD O O
75 PET NNP B-NP O
75 10/5 CD O O
75 with IN B-VP O
75 moderate JJ B-NP O
75 defect NN I-NP O
75 of IN B-VP O
75 the DT B-NP O
75 cx NN I-NP O
75 but CC O O
75 did VBD B-VP O
76 not RB O O
76 want VB O O
76 any DT B-NP O
76 medical JJ I-NP O
76 trt NN I-NP O
77 Meds: NNP I-NP O
78 Metformin NNP I-NP B-m
78 1000 CD O B-do
78 BID NNP B-NP B-f
78 Glipizide NNP I-NP B-m
78 10 CD O B-do
78 PO NNP B-NP B-mo
78 QD NNP I-NP B-f
78 , , O O
78 Synthroid NNP B-NP B-m
78 0.1 CD O B-do
78 QD NNP B-NP B-f
78 , , O O
78 Lisinipril NNP B-NP B-m
78 20mg CD O B-do
79 QD NNP B-NP B-f
79 , , O O
79 ASA NNP B-NP B-m
79 81 CD O B-do
79 QD NNP B-NP B-f
79 , , O O
79 Atenolol NNP B-NP B-m
79 12.5 CD O B-do
79 QD NNP B-NP B-f
80 All: NNP I-NP O
80 NKDA NNP I-NP O
81 SH:No NNP I-NP O
81 TOB/no NNP I-NP O
81 ETOH NNP I-NP O
82 ETOH NNP I-NP O
82 FH: NNP I-NP O
82 CAD NNP I-NP O
82 of IN B-VP O
82 mother NN B-NP O
82 and CC O O
83 sister NN B-NP O
84 PExam: NNP I-NP O
84 T97.7 NNP I-NP O
84 HR64-85 NNP I-NP O
84 BP110-165/62-78 NNP I-NP O
84 RR20 NNP I-NP O
84 96% CD O O
84 on IN B-VP O
84 RA NNP B-NP O
85 FS NNP I-NP O
85 89 CD O O
85 and CC O O
85 FS NNP B-NP O
85 149 CD O O
86 CVD: NNP B-NP O
86 RRR NNP I-NP O
86 No NNP I-NP O
86 M/R/G NNP I-NP O
87 A/P: NNP I-NP O
87 70 CD O O
87 y/o NNS B-NP O
87 female JJ O O
87 with IN B-VP O
87 DM NNP B-NP O
87 , , O O
87 HTN NNP B-NP O
87 , , O O
87 CAD NNP B-NP O
87 s/p VBD B-VP O
87 MI NNP B-NP O
87 10/5 CD O O
87 , , O O
87 s/p RB O O
87 Right NNP B-NP O
87 hip NN I-NP O
87 surgery NN I-NP O
88 came VBD B-VP O
88 in IN B-VP O
88 with IN B-VP O
88 intermittent JJ B-NP O
88 chest NN I-NP O
88 pain NN I-NP O
88 x12 JJ B-NP O
88 hours NNS I-NP O
88 likley VBP O O
88 secondary JJ O O
88 to TO O O
89 atypical JJ B-NP O
89 angina NN I-NP O
90 CVD: NNP I-NP O
90 ROMI NNP I-NP O
90 x2 NNP I-NP O
90 with IN B-VP O
90 troponin NN B-NP O
90 and CC O O
90 ck NN B-NP O
90 and CC O O
90 CKMB NNP B-NP O
90 nl NN I-NP O
90 and CC O O
90 cont NN B-NP O
90 pt's NN I-NP O
90 cardiac JJ B-NP B-m
91 medications NNS I-NP O
91 for IN B-VP O
91 BP NNP B-NP B-r
91 control NN I-NP I-r
91 and CC O O
91 ECG NNP B-NP O
91 early RB O O
91 R NNP B-NP O
91 wave VBP O O
91 but CC O O
91 no DT B-NP O
91 ST NNP I-NP O
91 changes NNS I-NP O
91 PT NNP I-NP O
92 denies VBZ O O
92 any DT B-NP O
92 chest NN I-NP O
92 pain NN I-NP O
92 and CC O O
92 SOB NNP B-NP O
92 No NNP I-NP O
92 evidence NN I-NP O
92 of IN B-VP O
92 active JJ B-NP O
92 cardiac JJ I-NP O
92 ishemia NN I-NP O
93 Known NNP I-NP O
93 defective JJ B-NP O
93 circumflex NN I-NP O
93 artery NN I-NP O
93 but CC O O
93 pt NN B-NP O
93 refused VBD B-VP O
93 any DT B-NP O
93 medical JJ I-NP O
93 intervention NN I-NP O
94 at IN B-VP O
94 this DT B-NP O
94 point NN I-NP O
94 in IN B-VP O
94 time NN B-NP O
94 Would MD O O
94 like VB O O
94 to TO O O
94 follow VB O O
94 up RP O O
94 with IN B-VP O
94 a DT B-NP O
94 PCP NNP I-NP O
94 as IN B-VP O
94 an DT B-NP O
95 outpatient NN I-NP O
96 DM: NNP I-NP O
96 cont NN I-NP O
96 pt NN I-NP O
96 oral JJ B-NP B-mo
96 hypoglycemics NNS I-NP B-m
97 Normocytic JJ B-NP O
97 anemia: NN I-NP O
97 ?anemia NN I-NP O
97 will MD O O
97 follow VB O O
97 up RP O O
97 with IN B-VP O
97 PCP NNP B-NP O
97 as IN B-VP O
97 an DT B-NP O
97 outpatient NN I-NP O
97 , , O O
97 the DT B-NP O
98 work NN I-NP O
98 up RB O O
98 is VBZ O O
98 so RB O O
98 far RB O O
98 normal JJ B-NP O
99 PPX: NNP I-NP O
99 Heparin NNP I-NP B-m
100 Full NNP I-NP O
100 Code NNP I-NP O
101 ADDITIONAL NNP I-NP O
101 COMMENTS: NNP I-NP O
101 Please NNP I-NP O
101 Call NNP I-NP O
101 if IN B-VP O
101 pt NN B-NP O
101 has VBZ O O
101 any DT B-NP O
101 chest JJS I-NP O
101 discomfort NN I-NP O
101 , , O O
101 shortness NN B-NP O
101 of IN B-VP O
101 breath NN B-NP O
101 , , O O
101 or CC O O
101 any DT B-NP O
102 increase NN I-NP O
102 fatigue NN I-NP O
102 or CC O O
102 weakness NN B-NP O
102 or CC O O
102 any DT B-NP O
102 other JJ I-NP O
102 concerns NNS I-NP O
103 DISCHARGE NNP I-NP O
103 CONDITION: NNP I-NP O
103 Stable NNP I-NP O
104 TO NNP I-NP O
104 DO/PLAN: NNP I-NP O
105 1 CD O O
105 Please NNP B-NP O
105 go VB O O
105 to TO O O
105 your PRP$ O O
105 follow VB O O
105 up RP O O
105 appt RB O O
106 2 CD O O
106 Please NNP B-NP O
106 come VB O O
106 to TO O O
106 the DT B-NP O
106 ER NNP I-NP O
106 for IN B-VP O
106 evaluation NN B-NP O
106 if IN B-VP O
106 you PRP O O
106 have VBP O O
106 any DT B-NP O
106 recurrent JJ I-NP O
106 chest NN I-NP O
107 pain NN I-NP O
107 or CC O O
107 any DT B-NP O
107 shortness NN I-NP O
107 of IN B-VP O
107 breath NN B-NP O
108 No NNP I-NP O
108 dictated VBD B-VP O
108 summary JJ B-NP O
109 ENTERED NNP I-NP O
109 BY: NNP I-NP O
109 SEREDA NNP I-NP O
109 , , O O
109 AHMED NNP B-NP O
109 , , O O
109 M.D NNP B-NP O
109 ( ( O O
109 UF337 NNP B-NP O
109 ) ) O O
109 9/14/06 CD O O
109 @ $ O O
109 04:38 CD O O
109 PM NNP B-NP O
110 ****** JJ B-NP O
110 END NNP I-NP O
110 OF NNP I-NP O
110 DISCHARGE NNP I-NP O
110 ORDERS NNP I-NP O
110 ****** NNP I-NP O
111 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #439236 VBZ O O
2 832383007 CD O O
2 ICMC NNP B-NP O
2 89731700 CD O O
2 826735 CD O O
2 0/4/2001 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 GERD NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/6/2001 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/18/2001 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 LLOPIS NNP I-NP O
5 , , O O
5 EVERETTE NNP B-NP O
5 086-70-24-3 NNP I-NP O
6 Tl NNP I-NP O
6 Room: NNP I-NP O
6 Leahstock NNP I-NP O
6 Ra NNP I-NP O
6 Fay NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 2/19/01 CD O O
8 AT NNP B-NP O
8 11:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 SOSNOWSKI NNP I-NP O
11 , , O O
11 WESLEY NNP B-NP O
11 NICOLAS NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ASA NNP I-NP B-m
16 ( ( O I-m
16 ACETYLSALICYLIC NNP B-NP I-m
16 ACID NNP I-NP I-m
16 ) ) O I-m
16 81 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 GEMFIBROZIL NNP I-NP B-m
17 600 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 BID NNP I-NP B-f
18 Override NNP I-NP O
18 Notice: NNP I-NP O
18 Override NNP I-NP O
18 added VBD B-VP O
18 on IN B-VP O
18 6/4/01 CD O O
18 by IN B-VP O
19 REGALADO NNP B-NP O
19 , , O O
19 ANDREA NNP B-NP O
19 G NNP I-NP O
19 , , O O
19 M.D NNP B-NP O
19 , , O O
19 PH.D NNP B-NP O
20 on IN B-VP O
20 order NN B-NP O
20 for IN B-VP O
20 ZOCOR NNP B-NP B-m
20 PO NNP I-NP B-mo
20 ( ( O O
20 ref JJ O O
20 # # O O
20 66826896 CD O O
20 ) ) O O
21 SERIOUS NNP B-NP O
21 INTERACTION: NNP I-NP O
21 GEMFIBROZIL NNP I-NP B-m
21 &amp; NNP I-NP O
21 SIMVASTATIN NNP I-NP B-m
22 Reason NNP I-NP O
22 for IN B-VP O
22 override: NN B-NP O
22 pt NN I-NP O
22 req VBD B-VP O
23 GLYBURIDE NNP B-NP B-m
23 10 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 MAALOX NNP I-NP B-m
24 PLUS NNP I-NP I-m
24 EXTRA NNP I-NP I-m
24 STRENGTH NNP I-NP I-m
24 15 CD O B-do
24 ML NNP B-NP I-do
24 PO NNP I-NP B-mo
24 Q6H NNP I-NP B-f
24 PRN NNP I-NP I-f
24 Indigestion NNP I-NP B-r
25 ZOCOR NNP I-NP B-m
25 ( ( O I-m
25 SIMVASTATIN NNP B-NP I-m
25 ) ) O I-m
25 20 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QHS NNP I-NP B-f
26 Food/Drug NNP I-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 Avoid NNP I-NP O
27 grapefruit NN I-NP O
27 unless IN B-VP O
27 MD NNP B-NP O
27 instructs NNS I-NP O
27 otherwise RB O O
28 Alert NNP B-NP O
28 overridden: NNP I-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 6/4/01 CD O O
28 by IN B-VP O
29 IBACH NNP B-NP O
29 , , O O
29 RUBEN NNP B-NP O
29 T NNP I-NP O
29 , , O O
29 M.D NNP B-NP O
29 , , O O
29 PH.D NNP B-NP O
30 SERIOUS NNP I-NP O
30 INTERACTION: NNP I-NP O
30 GEMFIBROZIL NNP I-NP B-m
30 &amp; NNP I-NP O
30 SIMVASTATIN NNP I-NP B-m
31 Reason NNP I-NP O
31 for IN B-VP O
31 override: NN B-NP O
31 pt NN I-NP O
31 req NN I-NP O
32 AVANDIA NNP I-NP B-m
32 ( ( O I-m
32 ROSIGLITAZONE NNP B-NP I-m
32 ) ) O I-m
32 4 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
33 OCUFLOX NNP I-NP B-m
33 ( ( O I-m
33 OFLOXACIN NNP B-NP I-m
33 0.3% CD O I-m
33 OPH NNP B-NP I-m
33 SOLUTION NNP I-NP I-m
33 ) ) O I-m
33 1 CD O B-do
33 DROP NNP B-NP I-do
33 OS NNP I-NP B-mo
33 QID NNP I-NP B-f
34 Number NNP I-NP B-du
34 of IN B-VP I-du
34 Doses NNP B-NP I-du
34 Required NNP I-NP I-du
34 ( ( O I-du
34 approximate JJ B-NP I-du
34 ): NN I-NP I-du
34 4 CD O I-du
35 ATENOLOL NNP B-NP B-m
35 50 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 QD NNP I-NP B-f
35 Food/Drug NNP I-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
36 Take NNP I-NP O
36 consistently RB O O
36 with IN B-VP O
36 meals NNS B-NP O
36 or CC O O
36 on IN B-VP O
36 empty JJ B-NP O
36 stomach NN I-NP O
37 PRILOSEC NNP I-NP B-m
37 ( ( O I-m
37 OMEPRAZOLE NNP B-NP I-m
37 ) ) O I-m
37 20 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 GLUCOPHAGE NNP I-NP B-m
38 ( ( O I-m
38 METFORMIN NNP B-NP I-m
38 ) ) O I-m
38 1 CD O B-do
38 , , O I-do
38 000 CD O I-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 BID NNP I-NP B-f
39 ALTACE NNP I-NP B-m
39 ( ( O I-m
39 RAMIPRIL NNP B-NP I-m
39 ) ) O I-m
39 2.5 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 QD NNP I-NP B-f
40 Alert NNP I-NP O
40 overridden: NNP I-NP O
40 Override NNP I-NP O
40 added VBD B-VP O
40 on IN B-VP O
40 2/19/01 CD O O
40 by IN B-VP O
40 : : O O
41 POTENTIALLY NNP B-NP O
41 SERIOUS NNP I-NP O
41 INTERACTION: NNP I-NP O
41 POTASSIUM NNP I-NP B-m
41 CHLORIDE NNP I-NP I-m
41 &amp; NNP I-NP O
42 RAMIPRIL NNP I-NP B-m
42 Reason NNP I-NP O
42 for IN B-VP O
42 override: NN B-NP O
42 aware JJ B-NP O
43 LOVENOX NNP I-NP B-m
43 ( ( O I-m
43 ENOXAPARIN NNP B-NP I-m
43 ) ) O I-m
43 40 CD O B-do
43 MG NNP B-NP I-do
43 SC NNP I-NP B-mo
43 Q12H NNP I-NP B-f
43 X NNP I-NP B-du
43 14 CD O I-du
43 Days NNPS B-NP I-du
44 Starting VBG O O
44 Today NNP B-NP O
44 ( ( O O
44 7/20 CD O O
44 ) ) O O
45 LOVENOX NNP B-NP B-m
45 ( ( O I-m
45 ENOXAPARIN NNP B-NP I-m
45 ) ) O I-m
45 40 CD O B-do
45 MG NNP B-NP I-do
45 SC NNP I-NP B-mo
45 QD NNP I-NP B-f
45 X NNP I-NP B-du
45 90 CD O I-du
45 Days NNP B-NP I-du
46 Starting VBG O O
46 2 CD O O
46 WEEKS NNP B-NP O
47 DIET: NNP I-NP O
47 House NNP I-NP O
47 / NNP I-NP O
47 ADA NNP I-NP O
47 2100 CD O O
47 cals/dy NN B-NP O
48 RETURN NNP I-NP O
48 TO NNP I-NP O
48 WORK: NNP I-NP O
48 Immediately RB O O
49 FOLLOW NNP B-NP O
49 UP NNP I-NP O
49 APPOINTMENT( NNP I-NP O
49 S NNP I-NP O
49 ): NNP I-NP O
50 Dr NNP I-NP O
50 Shad NNP I-NP O
50 Palovick NNP I-NP O
50 1 CD O O
50 week NN B-NP O
50 , , O O
51 Dr NNP B-NP O
51 Emmitt NNP I-NP O
51 Quire NNP I-NP O
51 0/1/01 CD O O
51 scheduled VBN O O
51 , , O O
52 ALLERGY: NNP B-NP O
52 Procardia NNP I-NP O
52 ( ( O O
52 nifedipine NN B-NP O
52 ( ( O O
52 immed JJ B-NP O
52 release NN I-NP O
52 ) ) O O
52 ) ) O O
52 , , O O
52 Isordil NNP B-NP O
52 , , O O
53 Benadryl NNP B-NP O
53 ( ( O O
53 diphenhydramine VB O O
53 hcl NN B-NP O
53 ) ) O O
54 ADMIT NNP B-NP O
54 DIAGNOSIS: NNP I-NP O
55 abdominal JJ B-NP O
55 pain NN I-NP O
56 PRINCIPAL NNP I-NP O
56 DISCHARGE NNP I-NP O
56 DIAGNOSIS NNP I-NP O
56 ;Responsible JJ O O
56 After IN B-VP O
56 Study NNP B-NP O
56 for IN B-VP O
56 Causing NNP B-NP O
56 Admission NNP I-NP O
56 ) ) O O
57 GERD NNP B-NP O
58 OTHER NNP I-NP O
58 DIAGNOSIS;Conditions NNP I-NP O
58 , , O O
58 Infections NNP B-NP O
58 , , O O
58 Complications NNP B-NP O
58 , , O O
58 affecting VBG O O
58 Treatment/Stay NNP B-NP O
59 CAD NNP I-NP O
59 , , O O
59 NIDDM NNP B-NP O
59 , , O O
59 Hypercholesterolemia NNP B-NP O
59 , , O O
59 h/o NN B-NP O
59 DVT/PE NNP I-NP O
59 , , O O
59 h/o NN B-NP O
59 RLL NNP I-NP O
59 pneumonia NN I-NP O
59 , , O O
59 GERD NNP B-NP O
59 , , O O
60 cva NN B-NP O
60 ( ( O O
60 cerebrovascular JJ B-NP O
60 accident NN I-NP O
60 ) ) O O
60 , , O O
60 cabg NN B-NP O
60 ( ( O O
60 cardiac JJ B-NP O
60 bypass NN I-NP O
60 graft NN I-NP O
60 surgery NN I-NP O
60 ) ) O O
61 pvd NN B-NP O
61 ( ( O O
61 peripheral JJ B-NP O
61 vascular JJ I-NP O
61 disease NN I-NP O
61 ) ) O O
62 OPERATIONS NNP B-NP O
62 AND NNP I-NP O
62 PROCEDURES: NNP I-NP O
63 OTHER NNP I-NP O
63 TREATMENTS/PROCEDURES NNP I-NP O
63 ( ( O O
63 NOT NNP B-NP O
63 IN NNP I-NP O
63 O.R NNP I-NP O
63 ) ) O O
64 BRIEF NNP B-NP O
64 RESUME NNP I-NP O
64 OF NNP I-NP O
64 HOSPITAL NNP I-NP O
64 COURSE: NNP I-NP O
65 This DT O O
65 is VBZ O O
65 a DT O O
65 63 CD O O
65 year NN B-NP O
65 old JJ B-NP O
65 M NNP I-NP O
65 with IN B-VP O
65 h/o NN B-NP O
65 CAD NNP I-NP O
65 , , O O
65 MI NNP B-NP O
65 , , O O
65 s/p NN B-NP O
65 CABGx4 NNP I-NP O
65 , , O O
65 h/o NN B-NP O
65 PE NNP I-NP O
65 , , O O
65 h/o NN B-NP O
65 CVA NNP I-NP O
66 on IN B-VP O
66 coumadin NN B-NP B-m
66 , , O O
66 NIDDM NNP B-NP O
66 and CC O O
66 h/o JJ B-NP O
66 recent JJ I-NP O
66 pneumonia NN I-NP O
66 ( ( O O
66 6/14 CD O O
66 ) ) O O
66 who WP O O
66 now RB O O
66 presents VBZ O O
67 with IN B-VP O
67 intermittent JJ B-NP O
67 epigastric JJ I-NP O
67 pain NN I-NP O
67 associated VBN O O
67 with IN B-VP O
67 nausea NN B-NP O
67 , , O O
67 diaphoresis NN B-NP O
68 and CC O O
68 SOB NNP B-NP O
68 x NNP I-NP O
68 2 CD O O
68 days NNS B-NP O
68 which WDT O O
68 he PRP O O
68 notes VBZ O O
68 is VBZ O O
68 his PRP$ O O
68 anginal JJ B-NP O
68 equivalent NN I-NP O
68 He PRP O O
69 denied VBD B-VP O
69 any DT B-NP O
69 associated JJ I-NP O
69 CP NNP I-NP O
69 , , O O
69 fevers/chills/sweats NNS B-NP O
69 , , O O
70 diarrhea/constipation NN B-NP O
70 Exam NNP I-NP O
70 was VBD B-VP O
70 notable JJ O O
70 only RB O O
70 for IN B-VP O
70 mild JJ B-NP O
70 epigastric JJ I-NP O
71 tenderness NN I-NP O
71 Labs NNP I-NP O
71 were VBD B-VP O
71 notable JJ O O
71 for IN B-VP O
71 Na NNP B-NP O
71 133 CD O O
71 and CC O O
71 Cr NNP B-NP O
71 1.7 CD O O
71 , , O O
71 negative JJ B-NP O
72 tropnin NN I-NP O
72 ( ( O O
72 0.00 CD O O
72 ) ) O O
72 and CC O O
72 CK NNP B-NP O
72 53 CD O O
72 , , O O
72 LFTs NNP B-NP O
72 normal JJ B-NP O
72 RUQ NNP I-NP O
72 ultrasound NN I-NP O
72 was VBD B-VP O
72 notable JJ O O
72 for IN B-VP O
73 normal JJ B-NP O
73 gall JJ I-NP O
73 bladder NN I-NP O
73 with IN B-VP O
73 a DT B-NP O
73 fatty JJ I-NP O
73 liver NN I-NP O
73 and CC O O
73 gallstones NNS B-NP O
73 and CC O O
73 no DT B-NP O
74 sonographic JJ I-NP O
74 Murphy's NNP I-NP O
74 ECG NNP I-NP O
74 showed VBD B-VP O
74 NSR NNP B-NP O
74 at IN B-VP O
74 80 CD O O
74 with IN B-VP O
74 flat JJ B-NP O
74 T NNP I-NP O
74 in IN B-VP O
74 I PRP O O
74 and CC O O
75 flipped VBD B-VP O
75 T NNP B-NP O
75 waves NNS I-NP O
75 in IN B-VP O
75 2 CD O O
75 , , O O
75 3 CD O O
75 ( ( O O
75 all DT O O
75 old JJ O O
75 ) ) O O
75 and CC O O
75 new JJ B-NP O
75 T NNP I-NP O
75 wave NN I-NP O
75 inversions NNS I-NP O
75 V5/V6 NNP I-NP O
75 V/Q NNP I-NP O
76 scan NN I-NP O
76 was VBD B-VP O
76 intermediate JJ B-NP O
76 probability NN I-NP O
76 likely RB O O
76 secondary JJ O O
76 to TO O O
76 recent JJ B-NP O
76 pne NN I-NP O
77 umonia NN I-NP O
77 , , O O
77 but CC O O
77 d-dimer JJ O O
77 800 CD O O
77 Pt NNP B-NP O
77 had VBD B-VP O
77 +LENI's VBN O O
77 Given VBN O O
77 his PRP$ O O
77 history NN B-NP O
77 of IN B-VP O
77 CVA NNP B-NP O
77 on IN B-VP O
78 anticoagulation NN B-NP B-r
78 anticoagulation NN I-NP B-r
78 , , O O
78 Dr NNP B-NP O
78 Yuenger NNP I-NP O
78 was VBD B-VP O
78 consulted VBN O O
78 and CC O O
78 reccomended VBN O O
79 starting VBG O O
79 the DT B-NP O
79 patient NN I-NP O
79 on IN B-VP O
79 reduced VBN O O
79 dose JJ B-NP O
79 lovenox NN I-NP B-m
79 lovenox NN I-NP B-m
79 ( ( O O
79 50mg CD O B-do
79 sc RB O B-mo
79 bid NN B-NP B-f
79 x VBZ O B-du
79 2 CD O I-du
79 wk NN B-NP I-du
79 and CC O O
80 40mg CD O B-do
80 sc NN B-NP B-mo
80 x VBD B-VP B-du
80 3 CD O I-du
80 mo NN B-NP I-du
80 ) ) O O
80 Checked VBD B-VP O
80 heparin JJ B-NP O
80 level NN I-NP O
80 ( ( O O
80 0.9 CD O O
80 ) ) O O
80 so RB O O
80 reduced JJ B-NP O
80 dose NN I-NP O
80 of IN B-VP O
81 lovenox NN B-NP B-m
81 to TO O O
81 lovenox VB O B-m
81 40mg CD O B-do
81 sc JJ B-NP B-mo
81 bid NN I-NP B-f
81 LENIS NNP I-NP O
81 to TO O O
81 be VB O O
81 repeated VBN O O
81 in IN B-VP O
81 3 CD O O
81 months NNS B-NP O
81 prior RB O O
82 to TO O O
82 d/c VB O O
83 lovenox JJ B-NP B-m
83 MI NNP I-NP O
83 and CC O O
83 was VBD B-VP O
83 ruled VBN O O
83 out RP O O
83 He PRP O O
83 underwent JJ O O
83 adenosine-MIBI JJ O O
83 which WDT O O
83 was VBD B-VP O
84 without IN B-VP O
84 change NN B-NP O
84 vs IN B-VP O
84 his PRP$ O O
84 dobutamine-MIBI JJ B-NP B-m
84 '00 NN I-NP O
84 He PRP O O
84 was VBD B-VP O
84 felt VBN O O
84 to TO O O
84 have VB O O
84 mild VBN O O
85 gastritis/GERD NNS B-NP O
85 and CC O O
85 was VBD B-VP O
85 discharged VBN O O
85 on IN B-VP O
85 his PRP$ O B-m
85 regular JJ B-NP I-m
85 medications NNS I-NP I-m
85 as RB O O
85 well RB O O
85 as IN B-VP O
86 Prilosec NNP B-NP B-m
86 20 CD O B-do
86 BID NNP B-NP B-f
86 and CC O O
86 Lovenox NNP B-NP B-m
86 as IN B-VP O
86 above IN B-VP O
86 He PRP O O
86 was VBD B-VP O
86 discharged VBN O O
86 in IN B-VP O
86 stable JJ B-NP O
87 condition NN I-NP O
87 and CC O O
87 will MD O O
87 follow-up VB O O
87 with IN B-VP O
87 Dr NNP B-NP O
87 Chadwick NNP I-NP O
87 Lafone NNP I-NP O
87 and CC O O
87 his PRP$ O O
87 primary JJ B-NP O
87 care NN I-NP O
88 doctor NN I-NP O
89 ADDITIONAL NNP I-NP O
89 COMMENTS: NNP I-NP O
89 1 CD O O
89 Please NNP B-NP O
89 set VBD B-VP O
89 up RP O O
89 a DT B-NP O
89 follow-up JJ I-NP O
89 appointment NN I-NP O
89 with IN B-VP O
89 your PRP$ O O
89 primary JJ B-NP O
89 care NN I-NP O
89 doctor NN I-NP O
90 within IN B-VP O
90 1-2 JJ B-NP O
90 weeks NNS I-NP O
90 for IN B-VP O
90 re-assessment NN B-NP O
90 of IN B-VP O
90 GI NNP B-NP O
90 distress NN I-NP O
91 2 CD O O
91 Follow-up NN B-NP O
91 with IN B-VP O
91 Dr NNP B-NP O
91 Frank NNP I-NP O
91 Trigleth NNP I-NP O
91 within IN B-VP O
91 1 CD O O
91 week NN B-NP O
92 3 CD O O
92 Take NNP B-NP O
92 lovenox NN I-NP B-m
92 as IN B-VP O
92 directed JJ O O
93 4 CD O O
93 Please NNP B-NP O
93 return NN I-NP O
93 to TO O O
93 the DT B-NP O
93 emergency NN I-NP O
93 department NN I-NP O
93 with IN B-VP O
93 worsening VBG O O
93 symptoms NNS B-NP O
93 or CC O O
94 new JJ B-NP O
94 fevers/chills/sweats NNS I-NP O
94 , , O O
94 chest JJS B-NP O
94 pain NN I-NP O
94 , , O O
94 difficulty NN B-NP O
94 breathing VBG O O
95 5 CD O O
95 VNA NNP B-NP O
95 for IN B-VP O
95 lovenox JJ B-NP B-m
95 teaching/compliance NN I-NP O
95 Medication NNP I-NP O
95 compliance NN I-NP O
96 6 CD O O
96 VNA NNP B-NP O
96 to TO O O
96 draw VB O O
96 serum JJ B-NP O
96 potassium NN I-NP O
96 7/21 CD O O
96 and CC O O
96 send VB O O
96 result NN B-NP O
96 into IN B-VP O
96 Dr NNP B-NP O
96 Ambrose NNP I-NP O
96 Rumple NNP I-NP O
97 DISCHARGE NNP I-NP O
97 CONDITION: NNP I-NP O
97 Stable NNP I-NP O
98 TO NNP I-NP O
98 DO/PLAN: NNP I-NP O
99 1 CD O O
99 Continue NNP B-NP O
99 home NN I-NP B-m
99 meds NNS I-NP I-m
100 2 CD O O
100 VNA NNP B-NP O
100 for IN B-VP O
100 assistance NN B-NP O
100 with IN B-VP O
100 Lovenox NNP B-NP B-m
100 and CC O O
100 meds NNS B-NP B-m
101 3 CD O O
101 Lovenox NNP B-NP B-m
101 as IN B-VP O
101 directed JJ O O
102 4 CD O O
102 Follow-up JJ B-NP O
102 LENIS NNP I-NP O
102 in IN B-VP O
102 3 CD O O
102 months NNS B-NP O
102 before IN B-VP O
102 d/c JJ O O
102 lovenox JJ O B-m
103 5 CD O O
103 Follow-up JJ O O
103 with IN B-VP O
103 Dr NNP B-NP O
103 Dean NNP I-NP O
103 Cooke NNP I-NP O
103 AND NNP I-NP O
103 pcp VBZ O O
104 No NNP B-NP O
104 dictated VBD B-VP O
104 summary JJ B-NP O
105 ENTERED NNP I-NP O
105 BY: NNP I-NP O
105 GETTO NNP I-NP O
105 , , O O
105 LEO NNP B-NP O
105 J NNP I-NP O
105 , , O O
105 M.D NNP B-NP O
105 , , O O
105 PH.D NNP B-NP O
105 ( ( O O
105 WH9 NNP B-NP O
105 ) ) O O
105 2/19/01 CD O O
105 @ $ O O
105 03 CD O O
106 ****** JJ B-NP O
106 END NN I-NP O
106 OF NNP I-NP O
106 DISCHARGE NNP I-NP O
106 ORDERS NNP I-NP O
106 ****** NNP I-NP O
107 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #439766 VBZ O O
2 761109598 CD O O
2 NNMC NNP B-NP O
2 78121632 CD O O
2 525450 CD O O
2 4/5/2001 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ? . B-VP O
2 MYOCAEDIAL NNP B-NP O
2 INFARCTION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/28/2001 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/16/2001 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 Mr NNP I-NP O
4 Almon NNP I-NP O
4 is VBZ O O
4 a DT O O
4 51 CD O O
4 year NN B-NP O
4 old JJ B-NP O
4 gentleman NN I-NP O
5 with IN B-VP O
5 history NN B-NP O
5 of IN B-VP O
5 insulin NN B-NP O
5 dependent NN I-NP O
6 diabetes VBZ O O
6 mellitus NNS B-NP O
6 and CC O O
6 unstable JJ B-NP O
6 angina NN I-NP O
6 The DT B-NP O
6 patient NN I-NP O
6 was VBD B-VP O
6 doing VBG O O
6 yard JJ B-NP O
7 work NN I-NP O
7 in IN B-VP O
7 the DT B-NP O
7 afternoon NN I-NP O
7 when WRB O O
7 he PRP O O
7 experienced VBD B-VP O
7 an DT B-NP O
7 episode NN I-NP O
7 of IN B-VP O
7 nausea NN B-NP O
7 and CC O O
8 vomiting VBG O O
8 along RB O O
8 with IN B-VP O
8 chest NN B-NP O
8 discomfort NN I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 presented VBD B-VP O
8 to TO O O
8 his PRP$ O O
9 primary JJ B-NP O
9 care NN I-NP O
9 physician NN I-NP O
9 who WP O O
9 noted VBD B-VP O
9 EKG NNP B-NP O
9 changes NNS I-NP O
9 with IN B-VP O
9 ST NNP B-NP O
9 depressions NNS I-NP O
9 in IN B-VP O
10 V3 NNP B-NP O
10 to TO O O
10 V6 NNP B-NP O
10 and CC O O
10 was VBD B-VP O
10 sent VBN O O
10 to TO O O
10 the DT B-NP O
10 emergency NN I-NP O
10 room NN I-NP O
10 which WDT O O
10 was VBD B-VP O
10 noted VBN O O
10 to TO O O
10 have VB O O
11 an DT B-NP O
11 old JJ I-NP O
11 T NNP I-NP O
11 wave NN I-NP O
11 inversion NN I-NP O
11 in IN B-VP O
11 lead NN B-NP O
11 3 CD O O
11 which WDT O O
11 was VBD B-VP O
11 now RB O O
11 upright JJ O O
11 and CC O O
11 ST NNP B-NP O
12 depressions NNS I-NP O
12 that WDT O O
12 were VBD B-VP O
12 normalizing VBG O O
12 CKs NNP B-NP O
12 at IN B-VP O
12 that DT B-NP O
12 time NN I-NP O
12 were VBD B-VP O
12 974 CD O O
12 , , O O
12 MB NNP B-NP O
13 24.3 CD O O
13 , , O O
13 Troponin NNP B-NP O
13 level NN I-NP O
13 was VBD B-VP O
13 1.77 CD O O
13 The DT B-NP O
13 patient NN I-NP O
13 received VBD B-VP O
13 aspirin JJ O B-m
13 5 CD O B-do
13 mg NN B-NP I-do
14 of IN B-VP O
14 intravenous JJ B-NP B-mo
14 Lopressor NNP I-NP B-m
14 , , O O
14 Heparin NNP B-NP B-m
14 drip NN I-NP B-mo
14 and CC O O
14 Adenosine NNP B-NP B-m
14 MIBI NNP I-NP O
14 which WDT O O
14 was VBD B-VP O
15 performed VBN O O
15 back RB O O
15 in IN B-VP O
15 May NNP B-NP O
15 of IN B-VP O
15 1999 CD O O
15 revealed VBD B-VP O
15 inferior JJ B-NP O
15 ischemia NN I-NP O
15 The DT B-NP O
16 patient JJ I-NP O
16 underwent JJ I-NP O
16 cardiac JJ I-NP O
16 catheterization NN I-NP O
16 on IN B-VP O
16 November NNP B-NP O
16 , , O O
16 2001 CD O O
16 which WDT O O
17 revealed VBD B-VP O
17 the DT B-NP O
17 following: NN I-NP O
17 Right NNP I-NP O
17 dominant NN I-NP O
17 system NN I-NP O
17 , , O O
17 no DT O O
17 significant JJ O O
17 left VBD B-VP O
18 main JJ B-NP O
18 lesions NNS I-NP O
18 identified VBN O O
18 , , O O
18 left VBD B-VP O
18 anterior RP O O
18 descending VBG O O
18 coronary JJ B-NP O
18 artery NN I-NP O
19 with IN B-VP O
19 a DT B-NP O
19 discreet NN I-NP O
19 mid NN I-NP O
19 65% CD O O
19 lesion NN B-NP O
19 , , O O
19 distal JJ O O
19 99% CD O O
19 lesion NN B-NP O
19 and CC O O
19 first JJ B-NP O
20 diagonal JJ I-NP O
20 coronary JJ I-NP O
20 artery NN I-NP O
20 with IN B-VP O
20 a DT O O
20 proximal JJ O O
20 discrete JJ O O
20 70% CD O O
20 lesion NN B-NP O
20 , , O O
20 left VBD B-VP O
21 circumflex JJ B-NP O
21 coronary JJ I-NP O
21 artery NN I-NP O
21 with IN B-VP O
21 a DT B-NP O
21 distal NN I-NP O
21 after IN B-VP O
21 the DT B-NP O
21 second JJ I-NP O
21 obtuse NN I-NP O
22 marginal JJ O O
22 discrete JJ O O
22 60% CD O O
22 lesion NN B-NP O
22 , , O O
22 supplying VBG O O
22 the DT B-NP O
22 second JJ I-NP O
22 obtuse NN I-NP O
22 marginal JJ B-NP O
23 First NNP I-NP O
23 marginal JJ B-NP O
23 coronary JJ I-NP O
23 artery NN I-NP O
23 had VBD B-VP O
23 an DT B-NP O
23 ostial JJ I-NP O
23 discrete NN I-NP O
23 90% CD O O
23 lesion NN B-NP O
24 and CC O O
24 a DT B-NP O
24 second JJ I-NP O
24 obtuse NN I-NP O
24 marginal NN I-NP O
24 had VBD B-VP O
24 an DT B-NP O
24 ostial JJ I-NP O
24 discrete NN I-NP O
24 100% CD O O
24 lesion NN B-NP O
25 Right NNP I-NP O
25 coronary NN I-NP O
25 artery NN I-NP O
25 had VBD B-VP O
25 a DT O O
25 mid JJ O O
25 discrete JJ O O
25 95% CD O O
25 lesion NN B-NP O
25 supplying VBG O O
25 the DT B-NP O
26 right JJ I-NP O
26 posterior NN I-NP O
26 descending VBG O O
26 coronary JJ B-NP O
26 artery NN I-NP O
26 He PRP O O
26 was VBD B-VP O
26 also RB O O
26 noted VBN O O
26 to TO O O
27 have VB O O
27 collateral JJ B-NP O
27 flow NN I-NP O
27 from IN B-VP O
27 left JJ O O
27 anterior JJ O O
27 descending VBG O O
27 artery NN B-NP O
27 to TO O O
27 the DT B-NP O
28 right JJ I-NP O
28 posterior NN I-NP O
28 descending VBG O O
28 artery IN B-VP O
28 The DT B-NP O
28 patient JJ I-NP O
28 underwent JJ I-NP O
29 echocardiogram NN I-NP O
29 on IN B-VP O
29 November NNP B-NP O
29 , , O O
29 2001 CD O O
29 which WDT O O
29 revealed VBD B-VP O
29 the DT B-NP O
29 following: NN I-NP O
29 1 CD O O
30 There EX O O
30 was VBD B-VP O
30 mild JJ O O
30 concentric JJ O O
30 left VBD B-VP O
30 ventricular JJ B-NP O
30 hypertrophy NN I-NP O
30 with IN B-VP O
30 normal JJ B-NP O
31 cavity NN I-NP O
31 size NN I-NP O
31 Left NNP I-NP O
31 ventricular VBZ O O
31 systolic JJ B-NP O
31 function NN I-NP O
31 is VBZ O O
31 mildly RB O O
31 reduced VBN O O
32 with IN B-VP O
32 an DT O O
32 estimated VBN O O
32 ejection NN B-NP O
32 fraction NN I-NP O
32 of IN B-VP O
32 45% CD O O
32 There EX O O
32 is VBZ O O
32 severe JJ B-NP O
33 hypokinesis NN I-NP O
33 of IN B-VP O
33 the DT B-NP O
33 basal NN I-NP O
33 and CC O O
33 mid JJ B-NP O
33 segments NNS I-NP O
33 of IN B-VP O
33 the DT B-NP O
33 inferior JJ I-NP O
33 wall NN I-NP O
33 and CC O O
34 inferior JJ B-NP O
34 septum NN I-NP O
34 In IN B-VP O
34 addition NN B-NP O
34 , , O O
34 there EX O O
34 is VBZ O O
34 severe JJ B-NP O
34 hypokinesis NN I-NP O
34 of IN B-VP O
34 the DT B-NP O
35 posterior NN I-NP O
35 wall NN I-NP O
35 , , O O
35 apex NN B-NP O
35 and CC O O
35 distal JJ O O
35 anterior RB O O
35 wall NN B-NP O
35 THis NNP I-NP O
35 is VBZ O O
35 suggestive JJ O O
36 of IN B-VP O
36 multiple JJ B-NP O
36 coronary JJ I-NP O
36 artery NN I-NP O
36 disease NN I-NP O
36 2 CD O O
36 The DT B-NP O
36 right JJ I-NP O
36 ventricle NN I-NP O
37 appears VBZ O O
37 normal JJ O O
37 in IN B-VP O
37 size NN B-NP O
37 and CC O O
37 systolic JJ B-NP O
37 function NN I-NP O
37 3 CD O O
37 The DT B-NP O
37 mitral JJ I-NP O
37 valve NN I-NP O
38 appears VBZ O O
38 mildly RB O O
38 thickened VBD B-VP O
38 The DT B-NP O
38 anterior JJ I-NP O
38 mitral JJ I-NP O
38 leaflet NN I-NP O
38 is VBZ O O
38 mildly RB O O
39 elongated JJ O O
39 and CC O O
39 there EX O O
39 might MD O O
39 be VB O O
39 mild JJ B-NP O
39 systolic JJ I-NP O
39 prolapse NN I-NP O
39 of IN B-VP O
39 the DT B-NP O
39 anterior JJ I-NP O
40 leaflet NN I-NP O
40 Mild NNP I-NP O
40 mitral JJ B-NP O
40 regurgitation NN I-NP O
40 is VBZ O O
40 seen VBN O O
40 4 CD O O
40 The DT B-NP O
40 aortic JJ I-NP O
40 valve NN I-NP O
41 is VBZ O O
41 trileaflet VBN O O
41 and CC O O
41 appears VBZ O O
41 mildly RB O O
41 thickened VBN O O
41 There EX O O
41 is VBZ O O
41 no DT B-NP O
41 aortic JJ I-NP O
42 stenosis NN I-NP O
42 or CC O O
42 regurgitation NN B-NP O
42 5 CD O O
42 The DT B-NP O
42 tricuspid JJ I-NP O
42 valve NN I-NP O
42 appears VBZ O O
43 structurally RB O O
43 normal JJ B-NP O
43 No NNP I-NP O
43 significant JJ B-NP O
43 tricuspid JJ I-NP O
43 regurgitation NN I-NP O
43 is VBZ O O
44 seen VBN O O
44 6 CD O O
44 There EX O O
44 is VBZ O O
44 no DT B-NP O
44 pericardial JJ I-NP O
44 effusion NN I-NP O
45 PAST NNP I-NP O
45 MEDICAL NNP I-NP O
45 HISTORY/ NNP I-NP O
45 PAST NNP I-NP O
45 SURGICAL NNP I-NP O
45 HISTORY: NNP I-NP O
45 Significant NNP I-NP O
45 for IN B-VP O
46 insulin NN B-NP O
46 dependent NN I-NP O
47 diabetes VBZ O O
47 mellitus RBS O O
47 , , O O
47 hypertension NN B-NP O
47 , , O O
47 hypercholesterolemia NN B-NP O
47 , , O O
47 peripheral JJ B-NP O
48 vascular JJ I-NP O
48 disease NN I-NP O
49 ALLERGIES: NNP I-NP O
49 The DT B-NP O
49 patient NN I-NP O
49 has VBZ O O
49 no DT O O
49 known VBN O O
49 drug NN B-NP O
49 allergies NNS I-NP O
50 MEDICATIONS: NNP I-NP O
50 On IN B-VP O
50 admission NN B-NP O
50 are VBP O O
50 Lisinopril NNP B-NP B-m
50 10 CD O B-do
50 mg NN B-NP I-do
50 once RB O B-f
50 a DT B-NP I-f
50 day NN I-NP I-f
50 , , O O
50 Zocor NNP B-NP B-m
51 40 CD O B-do
51 mg NN B-NP I-do
51 once RB O B-f
51 a DT B-NP I-f
51 day NN I-NP I-f
51 , , O O
51 vitamin NN B-NP B-m
51 E NNP I-NP I-m
51 , , O O
51 enteric RB O B-m
51 coated VBD B-VP I-m
51 aspirin JJ O I-m
52 325 CD O B-do
52 mg NN B-NP I-do
52 every DT B-NP B-f
52 other JJ I-NP I-f
52 day NN I-NP I-f
52 , , O O
52 NPH NNP B-NP B-m
52 NPH NNP I-NP B-m
52 Humulin NNP I-NP I-m
52 Humulin NNP I-NP I-m
52 insulin NN I-NP I-m
52 insulin NN I-NP I-m
52 40 CD O B-do
52 units NNS B-NP I-do
52 in IN B-VP B-f
52 the DT B-NP I-f
52 morning NN I-NP I-f
53 and CC O O
53 10 CD O B-do
53 in IN B-VP B-f
53 the DT B-NP I-f
53 evening NN I-NP I-f
53 , , O O
53 regular JJ B-NP B-m
53 insulin NN I-NP I-m
53 6 CD O B-do
53 units NNS B-NP I-do
53 twice RB O B-f
53 a DT B-NP I-f
53 day NN I-NP I-f
53 and CC O O
54 multivitamin VB O B-m
55 PHYSICAL NNP B-NP O
55 EXAMINATION: NNP I-NP O
55 Noncontributory NNP I-NP O
56 HOSPITAL NNP I-NP O
56 COURSE: NNP I-NP O
56 Mr NNP I-NP O
56 Bingamon NNP I-NP O
56 was VBD B-VP O
56 rushed VBN O O
56 to TO O O
56 the DT B-NP O
56 operating NN I-NP O
56 room NN I-NP O
56 on IN B-VP O
57 March NNP B-NP O
57 , , O O
57 2001 CD O O
57 where WRB O O
57 he PRP O O
57 underwent VBD B-VP O
57 a DT B-NP O
57 coronary JJ I-NP O
58 artery NN I-NP O
58 bypass NN I-NP O
58 graft NN I-NP O
58 x VBD B-VP O
58 3 CD O O
58 with IN B-VP O
58 a DT B-NP O
58 left JJ I-NP O
58 internal JJ I-NP O
58 mammary JJ I-NP O
58 artery NN I-NP O
58 to TO O O
58 left VB O O
59 anterior RP O O
59 descending VBG O O
59 artery NN B-NP O
59 , , O O
59 saphenous JJ B-NP O
59 vein NN I-NP O
59 graft NN I-NP O
59 to TO O O
59 the DT B-NP O
59 obtuse NN I-NP O
60 marginal JJ B-NP O
60 coronary JJ I-NP O
60 artery NN I-NP O
60 and CC O O
60 saphenous JJ B-NP O
60 vein NN I-NP O
60 graft NN I-NP O
60 to TO O O
60 the DT B-NP O
61 intermediate JJ I-NP O
61 coronary JJ I-NP O
61 artery NN I-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 did VBD B-VP O
61 well RB O O
62 intraoperatively RB O O
62 , , O O
62 came VBD B-VP O
62 off RP O O
62 bypass NN B-NP O
62 without IN B-VP O
62 incident NN B-NP O
62 , , O O
62 was VBD B-VP O
62 brought VBN O O
62 up RP O O
63 to TO O O
63 the DT B-NP O
63 intensive JJ I-NP O
63 care NN I-NP O
63 unit NN I-NP O
63 in IN B-VP O
63 normal JJ B-NP O
63 sinus NN I-NP O
63 rhythm NN I-NP O
63 and CC O O
63 in IN B-VP O
63 stable JJ B-NP O
64 condition NN I-NP O
64 Postoperatively RB O O
64 , , O O
64 Mr NNP B-NP O
64 Bown NNP I-NP O
64 did VBD B-VP O
64 very RB O O
64 well RB O O
64 He PRP O O
64 was VBD B-VP O
65 extubated VBN O O
65 on IN B-VP O
65 postoperative JJ B-NP O
65 day NN I-NP O
65 number NN I-NP O
65 one CD O O
65 and CC O O
65 transferred VBD B-VP O
65 to TO O O
65 the DT B-NP O
66 step NN I-NP O
66 down RB O O
66 unit NN B-NP O
66 He PRP O O
66 had VBD B-VP O
66 an DT B-NP O
66 unremarkable JJ I-NP O
66 postoperative JJ I-NP O
66 course NN I-NP O
66 until IN B-VP O
67 the DT B-NP O
67 night NN I-NP O
67 prior RB O O
67 to TO O O
67 discharge VB O O
67 when WRB O O
67 he PRP O O
67 was VBD B-VP O
67 noted VBN O O
67 to TO O O
67 have VB O O
67 serous JJ B-NP O
68 drainage NN I-NP O
68 from IN B-VP O
68 the DT B-NP O
68 inferior JJ I-NP O
68 aspect NN I-NP O
68 of IN B-VP O
68 his PRP$ O O
68 sternal JJ B-NP O
68 incision NN I-NP O
68 On IN B-VP O
69 physical JJ B-NP O
69 examination NN I-NP O
69 , , O O
69 he PRP O O
69 was VBD B-VP O
69 noted VBN O O
69 to TO O O
69 have VB O O
69 no DT B-NP O
69 sternal JJ I-NP O
69 click NN I-NP O
69 and CC O O
69 his PRP$ O O
70 white JJ B-NP O
70 count NN I-NP O
70 did VBD B-VP O
70 go VB O O
70 from IN B-VP O
70 9.2 CD O O
70 on IN B-VP O
70 May NNP B-NP O
70 to TO O O
70 11.26 CD O O
70 on IN B-VP O
70 February NNP B-NP O
70 The DT B-NP O
71 patient NN I-NP O
71 had VBD B-VP O
71 a DT B-NP O
71 T.max NNP I-NP O
71 of IN B-VP O
71 99 CD O O
71 We PRP O O
71 did VBD B-VP O
71 start VB O O
71 him PRP O O
71 on IN B-VP O
71 Keflex NNP B-NP B-m
71 500 CD O B-do
71 mg NN B-NP I-do
71 four CD O B-f
72 times NNS B-NP O
72 a DT B-NP O
72 day NN I-NP O
72 for IN B-VP B-du
72 10 CD O I-du
72 days NNS B-NP I-du
72 and CC O O
72 he PRP O O
72 will MD O O
72 have VB O O
72 a DT B-NP O
72 follow-up JJ I-NP O
72 white JJ I-NP O
72 blood NN I-NP O
73 cell NN I-NP O
73 count NN I-NP O
73 on IN B-VP O
73 November NNP B-NP O
73 , , O O
73 2001 CD O O
73 which WDT O O
73 shall MD O O
73 be VB O O
73 called VBN O O
73 into IN B-VP O
73 his PRP$ O O
73 primary JJ B-NP O
74 care NN I-NP O
74 physician JJ B-NP O
74 Mr NNP I-NP O
74 Piotrowski NNP I-NP O
74 other JJ B-NP O
74 labs NN I-NP O
74 for IN B-VP O
74 February NNP B-NP O
74 , , O O
74 2001 CD O O
74 are VBP O O
74 as IN B-VP O
75 follows: NNS B-NP O
75 Glucose NNP I-NP O
75 291 CD O O
75 , , O O
75 BUN NNP B-NP O
75 20 CD O O
75 , , O O
75 creatinine NN B-NP O
75 of IN B-VP O
75 0.9 CD O O
75 , , O O
75 sodium NN B-NP O
75 136 CD O O
75 , , O O
76 potassium NN B-NP O
76 5 CD O O
76 , , O O
76 chloride NN B-NP O
76 of IN B-VP O
76 97 CD O O
76 , , O O
76 CO2 NNP B-NP O
76 of IN B-VP O
76 31 CD O O
76 , , O O
76 magnesium NN B-NP O
76 of IN B-VP O
76 1.5 CD O O
76 WBC NNP B-NP O
76 was VBD B-VP O
77 11.26 CD O O
77 , , O O
77 hemoglobin NN B-NP O
77 9.2 CD O O
77 , , O O
77 hematocrit NN B-NP O
77 28.2 CD O O
77 , , O O
77 platelets NNS B-NP O
77 438 CD O O
77 PT NNP B-NP O
77 was VBD B-VP O
78 12.7 CD O O
78 , , O O
78 PT/INR NNP B-NP O
78 of IN B-VP O
78 1.1 CD O O
79 DISCHARGE NNP B-NP O
79 MEDICATIONS: NNP I-NP O
79 For IN B-VP O
79 Mr NNP B-NP O
79 Eide NNP I-NP O
79 are VBP O O
79 as IN B-VP O
79 follows: JJ B-NP O
79 Enteric NNP I-NP B-m
80 coated VBD B-VP O
80 aspirin RB O O
80 325 CD O B-do
80 mg NN B-NP I-do
80 once RB O B-f
80 a DT B-NP I-f
80 day NN I-NP I-f
80 , , O O
80 ibuprofen RB O B-m
81 200 CD O B-do
81 to TO O I-do
81 800 CD O I-do
81 mg NN B-NP I-do
81 every DT O B-f
81 4 CD O I-f
81 to TO O I-f
81 6 CD O I-f
81 h NN B-NP I-f
81 p.r.n NN I-NP I-f
81 pain NN I-NP B-r
81 , , O O
81 NPH NNP B-NP B-m
81 NPH NNP I-NP B-m
81 Humulin NNP I-NP I-m
81 Humulin NNP I-NP I-m
81 insulin NN I-NP I-m
81 insulin NN I-NP I-m
81 44 CD O B-do
82 units NNS B-NP O
82 in IN B-VP B-f
82 the DT B-NP I-f
82 morning NN I-NP I-f
82 , , O O
82 14 CD O B-do
82 units NNS B-NP I-do
82 in IN B-VP B-f
82 the DT B-NP I-f
82 evening NN I-NP I-f
82 , , O O
82 regular JJ B-NP B-m
82 insulin NN I-NP I-m
82 6 CD O B-do
83 units NNS B-NP O
83 twice RB O B-f
83 a DT B-NP I-f
83 day NN I-NP I-f
83 , , O O
83 Niferex NNP B-NP B-m
83 150 CD O B-do
83 mg NN B-NP I-do
83 twice RB O B-f
83 a DT B-NP I-f
83 day NN I-NP I-f
83 , , O O
83 potassium NN B-NP B-m
83 chloride NN I-NP I-m
84 20 CD O B-do
84 mEq NN B-NP I-do
84 once RB O B-f
84 a DT B-NP I-f
84 day NN I-NP I-f
84 , , O O
84 Zocor NNP B-NP B-m
84 40 CD O B-do
84 mg NN B-NP I-do
84 once RB O B-f
84 in IN B-VP I-f
84 the DT B-NP I-f
84 evening NN I-NP I-f
84 , , O O
84 Atenolol NNP B-NP B-m
84 50 CD O B-do
84 mg NN B-NP I-do
85 once RB O B-f
85 a DT B-NP I-f
85 day NN I-NP I-f
85 , , O O
85 Lisinopril NNP B-NP B-m
85 10 CD O B-do
85 mg NN B-NP I-do
85 once RB O B-f
85 a DT B-NP I-f
85 day NN I-NP I-f
85 , , O O
85 Keflex NNP B-NP B-m
85 500 CD O B-do
85 mg NN B-NP I-do
85 four CD O B-f
85 times NNS B-NP O
85 a DT B-NP O
86 day NN I-NP O
86 for IN B-VP B-du
86 10 CD O I-du
86 days NNS B-NP I-du
86 for IN B-VP O
86 his PRP$ O B-r
86 superficial JJ B-NP I-r
86 sternal JJ I-NP I-r
86 wound NN I-NP I-r
86 infection NN I-NP I-r
86 and CC O O
87 torsemide VB O B-m
87 60 CD O B-do
87 mg NN B-NP I-do
87 twice RB O B-f
87 a DT B-NP I-f
87 day NN I-NP I-f
88 DISPOSITION: NNP I-NP O
88 Mr NNP I-NP O
88 Geronimo NNP I-NP O
88 will MD O O
88 be VB O O
88 discharged VBN O O
88 to TO O O
88 home NN B-NP O
88 in IN B-VP O
88 stable JJ B-NP O
89 condition NN I-NP O
89 He PRP O O
89 will MD O O
89 follow-up VB O O
89 with IN B-VP O
89 Dr NNP B-NP O
89 Vern NNP I-NP O
89 Meehan NNP I-NP O
89 in IN B-VP O
90 six CD O O
90 weeks NNS B-NP O
90 , , O O
90 Dr NNP B-NP O
90 Tyrone NNP I-NP O
90 Younis NNP I-NP O
90 in IN B-VP O
90 two CD O O
90 weeks NNS B-NP O
90 and CC O O
90 his PRP$ O O
90 primary JJ B-NP O
90 care NN I-NP O
91 doctor NN I-NP O
91 , , O O
91 Dr NNP B-NP O
91 Waldie NNP I-NP O
91 in IN B-VP O
91 one CD O O
91 week NN B-NP O
91 He PRP O O
91 is VBZ O O
91 discharged VBN O O
91 in IN B-VP O
91 stable JJ B-NP O
91 condition NN I-NP O
92 Dictated NNP I-NP O
92 By: NNP I-NP O
92 MICHALE NNP I-NP O
92 SCHMIEL NNP I-NP O
92 , , O O
92 P.A NNP B-NP O
93 Attending: NNP I-NP O
93 CARROLL NNP I-NP O
93 F NNP I-NP O
93 YABLONSKY NNP I-NP O
93 , , O O
93 M.D NNP B-NP O
93 BF88 NNP I-NP O
94 QI057/9707 NNP I-NP O
95 Batch: NNP I-NP O
95 04367 CD O O
95 Index NNP B-NP O
95 No NNP I-NP O
95 D9XLM86A6X NNP I-NP O
95 D: NNP I-NP O
95 3/1/01 CD O O
96 T: NNP B-NP O
96 7/18/01 CD O O
97 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #442126 VBZ O O
4 840157437 CD O O
4 CBZMC NNP B-NP O
4 29175143 CD O O
4 019871 CD O O
4 10/23/1999 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/30/1999 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/27/1999 CD O O
7 FINAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 CORONARY NNP I-NP O
7 ARTERY NNP I-NP O
7 DISEASE NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT O O
8 70 CD O O
8 year NN B-NP O
8 old JJ B-NP O
8 female NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 coronary JJ B-NP O
9 artery NN I-NP O
9 disease NN I-NP O
9 , , O O
10 hypertension NN B-NP O
10 , , O O
10 type NN B-NP O
10 II NNP I-NP O
10 diabetes VBZ O O
10 mellitus NN B-NP O
10 , , O O
10 and CC O O
10 peripheral JJ B-NP O
10 vascular JJ I-NP O
11 disease NN I-NP O
11 who WP O O
11 is VBZ O O
11 status NN B-NP O
11 post NN I-NP O
11 a DT B-NP O
11 PTCA/stent NN I-NP O
11 of IN B-VP O
11 obtuse NN B-NP O
11 marginal JJ O O
11 1 CD O O
11 in IN B-VP O
12 August NNP B-NP O
12 of IN B-VP O
12 1990 CD O O
12 which WDT O O
12 restenosed VBD B-VP O
12 and CC O O
12 required JJ B-NP O
12 rotablation NN I-NP O
12 and CC O O
13 restenting NN B-NP O
13 in IN B-VP O
13 March NNP B-NP O
13 of IN B-VP O
13 1998 CD O O
13 who WP O O
13 presents VBZ O O
13 now RB O O
13 with IN B-VP O
13 unstable JJ O O
13 angina VBP O O
14 The DT B-NP O
14 patient NN I-NP O
14 had VBD B-VP O
14 increasing VBG O O
14 chest JJS B-NP O
14 pain NN I-NP O
14 over IN B-VP O
14 the DT B-NP O
14 past JJ I-NP O
14 month NN I-NP O
15 progressing VBG O O
15 to TO O O
15 pain VB O O
15 at IN B-VP O
15 rest NN B-NP O
15 The DT B-NP O
15 patient NN I-NP O
15 presented VBN O O
15 with IN B-VP O
15 substernal JJ B-NP O
16 chest NN I-NP O
16 pain NN I-NP O
16 to TO O O
16 the DT B-NP O
16 emergency NN I-NP O
16 room NN I-NP O
16 department NN I-NP O
16 with IN B-VP O
16 a DT B-NP O
16 blood NN I-NP O
16 pressure NN I-NP O
17 of IN B-VP O
17 230/90 CD O O
17 The DT B-NP B-r
17 patient's NN I-NP I-r
17 blood NN I-NP I-r
17 pressure NN I-NP I-r
17 was VBD B-VP O
17 controlled VBN O O
17 with IN B-VP O
17 IV NNP B-NP B-mo
18 Lopressor NNP I-NP B-m
18 and CC O O
18 the DT B-NP O
18 patient NN I-NP O
18 was VBD B-VP O
18 admitted VBN O O
18 for IN B-VP O
18 rule NN B-NP O
18 out IN B-VP O
18 myocardial JJ B-NP O
19 infarction NN I-NP O
19 The DT B-NP O
19 patient JJ I-NP O
19 underwent JJ I-NP O
19 cardiac JJ I-NP O
19 catheterization NN I-NP O
19 on IN B-VP O
20 2/25/99 CD O O
20 which WDT O O
20 revealed VBD B-VP O
20 the DT B-NP O
20 following: NN I-NP O
20 A NNP I-NP O
20 stent JJ B-NP O
20 restenosis NN I-NP O
20 of IN B-VP O
20 left JJ B-NP O
21 circumflex JJ I-NP O
21 artery NN I-NP O
21 , , O O
21 a DT O O
21 60 CD O O
21 percent NN B-NP O
21 left VBD B-VP O
21 anterior JJ O O
21 descending VBG O O
21 artery JJ B-NP O
22 stenosis NN I-NP O
22 , , O O
22 a DT O O
22 70 CD O O
22 percent NN B-NP O
22 diagonal JJ B-NP O
22 ostial JJ I-NP O
22 stenosis NN I-NP O
22 , , O O
22 a DT O O
22 40 CD O O
22 percent NN B-NP O
23 ostial JJ B-NP O
23 right JJ I-NP O
23 coronary JJ I-NP O
23 artery NN I-NP O
23 stenosis NN I-NP O
23 , , O O
23 and CC O O
23 95 CD O O
23 percent NN B-NP O
23 ostial JJ O O
24 posterior JJ O O
24 descending VBG O O
24 artery JJ B-NP O
24 stenosis NN I-NP O
24 No NNP I-NP O
24 myocardial JJ B-NP O
24 infarction NN I-NP O
24 was VBD B-VP O
25 noted VBN O O
25 and CC O O
25 ejection JJ B-NP O
25 fraction NN I-NP O
25 was VBD B-VP O
25 approximately RB O O
25 50 CD O O
25 percent NN B-NP O
26 calculated VBD B-VP O
26 The DT B-NP O
26 patient NN I-NP O
26 was VBD B-VP O
26 subsequently RB O O
26 scheduled VBN O O
26 for IN B-VP O
26 coronary JJ B-NP O
27 artery NN I-NP O
27 bypass NN I-NP O
27 graft NN I-NP O
28 PAST NNP I-NP O
28 MEDICAL NNP I-NP O
28 HISTORY: NNP I-NP O
28 Coronary NNP I-NP O
28 artery NN I-NP O
28 disease NN I-NP O
28 Hypertension NNP I-NP O
29 Congestive NNP I-NP O
29 heart NN I-NP O
29 failure NN I-NP O
29 Type NNP I-NP B-r
29 II NNP I-NP O
29 diabetes VBZ O O
30 mellitus FW O O
30 requiring VBG O O
30 insulin JJ B-NP B-m
30 Peripheral NNP I-NP O
30 vascular NN I-NP O
30 disease NN I-NP O
31 Gastroesophageal NNP I-NP O
31 reflux VBZ O O
31 disease NN B-NP O
32 PAST NNP I-NP O
32 SURGICAL NNP I-NP O
32 HISTORY: NNP I-NP O
32 Left NNP I-NP O
32 lower JJR B-NP O
32 extremity NN I-NP O
32 revascularization NN I-NP O
33 PHYSICAL NNP I-NP O
33 EXAMINATION: NNP I-NP O
33 Spanish-speaking NNP I-NP O
33 female JJ B-NP O
33 HEENT: NNP I-NP O
34 Unremarkable NNP I-NP O
34 Carotid NNP I-NP O
34 pulses VBZ O O
34 1 CD O O
34 plus CC O O
35 bilaterally RB O O
35 with IN B-VP O
35 no DT B-NP O
35 bruits NNS I-NP O
35 Lungs NNS I-NP O
35 clear VBP O O
35 to TO O O
35 auscultation VB O O
36 bilaterally RB O O
36 Heart: NNP B-NP O
36 Regular NNP I-NP O
36 rate NN I-NP O
36 and CC O O
36 rhythm NN B-NP O
36 No NNP I-NP O
36 murmurs NN I-NP O
37 Abdomen: NNP I-NP O
37 Soft NNP I-NP O
37 , , O O
37 nontender NN B-NP O
37 , , O O
37 nondistended VBD B-VP O
37 Firm NN B-NP O
37 to TO O O
37 palpation NN B-NP O
37 in IN B-VP O
37 both DT B-NP O
38 lower JJR I-NP O
38 quadrants NNS I-NP O
38 in IN B-VP O
38 area NN B-NP O
38 of IN B-VP O
38 lower JJR B-NP O
38 midline NN I-NP O
38 scar NN I-NP O
38 Extremities: NNP I-NP O
39 Tenderness NNP I-NP O
39 to TO O O
39 palpation NN B-NP O
39 in IN B-VP O
39 bilateral JJ B-NP O
39 lower JJR I-NP O
39 extremities NNS I-NP O
39 which WDT O O
39 was VBD B-VP O
40 diffuse NN B-NP O
40 and CC O O
40 nonspecific JJ B-NP O
40 Peripheral NNP I-NP O
40 pulses NNS I-NP O
40 revealed VBD B-VP O
40 1 CD O O
40 plus CC O O
41 dorsalis JJ B-NP O
41 pedis NN I-NP O
41 pulse NN I-NP O
41 and CC O O
41 1 CD O O
41 plus CC O O
41 posterior JJ B-NP O
41 tibial JJ I-NP O
41 pulse NN I-NP O
41 on IN B-VP O
41 right JJ B-NP O
42 lower JJR I-NP O
42 extremity NN I-NP O
42 and CC O O
42 2 CD O O
42 plus CC O O
42 dorsalis JJ B-NP O
42 pedis NN I-NP O
42 pulse NN I-NP O
42 and CC O O
42 2 CD O O
42 plus CC O O
43 posterior JJ B-NP O
43 tibial JJ I-NP O
43 pulse NN I-NP O
43 on IN B-VP O
43 left NNS B-NP O
43 lower JJR B-NP O
43 extremity NN I-NP O
43 with IN B-VP O
43 1 CD O O
43 plus CC O O
43 edema VB O O
44 bilaterally RB O O
44 Neurologic: NNP B-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 was VBD B-VP O
44 conscious JJ O O
44 and CC O O
44 alert JJ O O
44 and CC O O
45 oriented VBD B-VP O
45 times NNS B-NP O
45 three CD O O
45 with IN B-VP O
45 no DT B-NP O
45 deficits NNS I-NP O
46 LABORATORY NNP I-NP O
46 DATA: NNP I-NP O
46 Sodium NNP I-NP O
46 140 CD O O
46 , , O O
46 potassium NN B-NP O
46 4.7 CD O O
46 , , O O
46 BUN NNP B-NP O
46 18 CD O O
46 , , O O
46 creatinine NN B-NP O
47 1.0 CD O O
47 , , O O
47 glucose VBD B-VP O
47 205 CD O O
47 WBC NNP B-NP O
47 12 CD O O
47 , , O O
47 hematocrit NN B-NP O
47 37 CD O O
47 , , O O
47 INR NNP B-NP O
48 0.1 CD O O
48 ECG NNP B-NP O
48 revealed VBD B-VP O
48 normal JJ B-NP O
48 sinus NNS I-NP O
48 rhythm VBP O O
48 with IN B-VP O
48 nonspecific JJ B-NP O
48 ST-T NNP I-NP O
48 wave NN I-NP O
49 changes NNS I-NP O
50 MEDICATIONS: NNP I-NP O
50 Aspirin NNP I-NP B-m
50 325 CD O B-do
50 mg NN B-NP I-do
50 q.d NN I-NP B-f
50 , , O O
50 Atenolol NNP B-NP B-m
50 125 CD O B-do
50 mg NN B-NP I-do
50 p.o NN I-NP B-mo
50 b.i.d NN I-NP B-f
50 , , O O
51 Captopril NNP B-NP B-m
51 100 CD O B-do
51 mg NN B-NP I-do
51 p.o NN I-NP B-mo
51 t.i.d NN I-NP B-f
51 , , O O
51 Colace NNP B-NP B-m
51 , , O O
51 Axid NNP B-NP B-m
51 150 CD O B-do
51 mg NN B-NP I-do
52 p.o NN I-NP B-mo
52 b.i.d NN I-NP B-f
52 , , O O
52 Amlodipine NNP B-NP B-m
52 10 CD O B-do
52 mg NN B-NP I-do
52 p.o NN I-NP B-mo
52 q.d NN I-NP B-f
52 , , O O
52 Imdur NNP B-NP B-m
52 120 CD O B-do
52 mg NN B-NP I-do
52 p.o NN I-NP B-mo
52 b.i.d NN I-NP B-f
52 , , O O
53 and CC O O
53 insulin NN B-NP B-m
53 NPH NNP I-NP I-m
53 22 CD O B-do
53 units NNS B-NP I-do
53 q.a.m RB O B-f
53 and CC O O
53 regular JJ O O
53 10 CD O B-do
53 units NNS B-NP I-do
53 q.a.m JJ B-NP B-f
54 ALLERGIES: NNP I-NP O
54 Penicillin- NNP I-NP O
54 rash NN I-NP O
55 HOSPITAL NNP I-NP O
55 COURSE: NNP I-NP O
55 On IN B-VP O
55 1/30/99 CD O O
55 the DT B-NP O
55 patient NN I-NP O
55 was VBD B-VP O
55 brought VBN O O
55 to TO O O
55 the DT B-NP O
56 operating NN I-NP O
56 room NN I-NP O
56 and CC O O
56 underwent NN B-NP O
56 a DT B-NP O
56 coronary JJ I-NP O
56 artery NN I-NP O
57 bypass NN I-NP O
57 graft NN I-NP O
57 times NNS I-NP O
57 three CD O O
57 with IN B-VP O
57 a DT B-NP O
57 left JJ I-NP O
57 internal JJ I-NP O
57 mammary JJ I-NP O
57 artery NN I-NP O
57 to TO O O
57 the DT O O
58 left VBN O O
58 anterior JJ O O
58 descending VBG O O
58 artery NN B-NP O
58 and CC O O
58 saphenous JJ B-NP O
58 vein NN I-NP O
58 graft NN I-NP O
58 to TO O O
58 obtuse VB O O
59 marginal JJ O O
59 and CC O O
59 saphenous JJ B-NP O
59 vein NN I-NP O
59 graft NN I-NP O
59 to TO O O
59 posterior VB O O
59 descending VBG O O
59 artery RB O O
60 After IN B-VP O
60 surgery NN B-NP O
60 the DT B-NP O
60 patient NN I-NP O
60 was VBD B-VP O
60 transferred VBN O O
60 to TO O O
60 the DT B-NP O
60 Intensive NNP I-NP O
60 Care NNP I-NP O
61 Unit NNP I-NP O
61 in IN B-VP O
61 stable JJ B-NP O
61 condition NN I-NP O
61 On IN B-VP O
61 postoperative JJ B-NP O
61 day NN I-NP O
61 #1 VBD B-VP O
61 the DT B-NP O
61 patient NN I-NP O
61 was VBD B-VP O
62 extubated VBN O O
62 without IN B-VP O
62 incident NN B-NP O
63 On IN B-VP O
63 postoperative JJ B-NP O
63 day NN I-NP O
63 #2 VBD B-VP O
63 the DT B-NP O
63 patient NN I-NP O
63 experienced VBD B-VP O
63 a DT B-NP O
63 period NN I-NP O
63 of IN B-VP O
63 atrial JJ B-NP O
64 fibrillation NN I-NP O
64 with IN B-VP O
64 a DT B-NP O
64 rapid JJ I-NP O
64 ventricular JJ I-NP O
64 response NN I-NP O
64 and CC O O
64 rates NNS B-NP O
64 in IN B-VP O
64 the DT O O
65 150s CD O O
65 The DT B-NP O
65 patient NN I-NP O
65 was VBD B-VP O
65 treated VBN O O
65 with IN B-VP O
65 IV NNP B-NP B-mo
65 Lopressor NNP I-NP B-m
65 and CC O O
65 Diltiazem NNP B-NP B-m
65 drip NN I-NP O
66 at IN B-VP O
66 10 CD O B-do
66 mg/hr FW O I-do
66 The DT B-NP O
66 patient NN I-NP O
66 subsequently RB O O
66 converted VBD B-VP O
66 spontaneously RB O O
66 to TO O O
67 normal JJ B-NP O
67 sinus NN I-NP O
67 rhythm NN I-NP O
67 Postoperatively RB O O
67 the DT B-NP O
67 patient NN I-NP O
67 continued VBD B-VP O
67 to TO O O
68 experience VB O O
68 hypertension NN B-NP B-r
68 hypertension NN I-NP B-r
68 with IN B-VP O
68 systolic JJ B-NP O
68 blood NN I-NP O
68 pressures NNS I-NP O
68 ranging VBG O O
68 from IN B-VP O
69 160s CD O O
69 to TO O O
69 190s CD O O
69 The DT B-NP O
69 patient NN I-NP O
69 was VBD B-VP O
69 started VBN O O
69 back RB O O
69 on IN B-VP O
69 Lopressor NNP B-NP B-m
69 and CC O O
70 Captopril NNP B-NP B-m
70 and CC O O
70 gradually RB O O
70 increased VBD B-VP O
70 to TO O O
70 preoperative JJ B-NP O
70 doses NNS I-NP O
70 The DT B-NP O
71 patient NN I-NP O
71 was VBD B-VP O
71 also RB O O
71 started VBN O O
71 back RP O O
71 on IN B-VP O
71 Amlodipine NNP B-NP B-m
71 for IN B-VP O
71 further JJ B-NP B-r
71 blood NN I-NP O
72 pressure NN I-NP O
72 control VB O O
72 The DT B-NP O
72 patient NN I-NP O
72 continued VBD B-VP O
72 to TO O O
72 experience VB O O
72 brief JJ B-NP O
73 episodes NNS I-NP O
73 of IN B-VP O
73 atrial JJ B-NP O
73 fibrillation NN I-NP O
73 with IN B-VP O
73 spontaneous JJ B-NP O
73 conversion NN I-NP O
73 to TO O O
74 normal JJ B-NP O
74 sinus NN I-NP O
74 rhythm VBD B-VP O
74 The DT B-NP O
74 patient NN I-NP O
74 was VBD B-VP O
74 followed VBN O O
74 by IN B-VP O
74 her PRP$ O O
74 cardiologist NN B-NP O
75 postoperatively RB O O
75 , , O O
75 Dr NNP B-NP O
75 Grunow NNP I-NP O
75 The DT B-NP O
75 patient NN I-NP O
75 was VBD B-VP O
75 started VBN O O
75 on IN B-VP O
76 anticoagulation NN B-NP B-r
76 with IN B-VP O
76 Coumadin NNP B-NP B-m
76 The DT B-NP O
76 patient's NN I-NP O
76 atrial JJ B-NP O
76 fibrillation NN I-NP O
77 continued VBD B-VP O
77 to TO O O
77 decrease VB O O
77 in IN B-VP O
77 frequency NN B-NP O
77 and CC O O
77 duration NN B-NP O
77 and CC O O
77 , , O O
77 at IN B-VP O
77 the DT B-NP O
77 time NN I-NP O
77 of IN B-VP O
78 discharge NN B-NP O
78 , , O O
78 the DT B-NP O
78 patient NN I-NP O
78 had VBD B-VP O
78 been VBN O O
78 in IN B-VP O
78 normal JJ B-NP O
78 sinus NN I-NP O
78 rhythm NN I-NP O
78 for IN B-VP O
78 greater JJR O O
79 than IN B-VP O
79 24 CD O O
79 hours NNS B-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 was VBD B-VP O
79 seen VBN O O
79 by IN B-VP O
79 physical JJ B-NP O
79 therapy NN I-NP O
79 service NN I-NP O
80 and CC O O
80 it PRP O O
80 was VBD B-VP O
80 felt VBN O O
80 that IN B-VP O
80 the DT B-NP O
80 patient NN I-NP O
80 would MD O O
80 benefit VB O O
80 from IN B-VP O
80 rehabilitation NN B-NP O
81 The DT B-NP O
81 patient NN I-NP O
81 is VBZ O O
81 scheduled VBN O O
81 to TO O O
81 be VB O O
81 discharged VBN O O
81 on IN B-VP O
81 postoperative JJ B-NP O
81 day NN I-NP O
81 #8 NNP I-NP O
82 to TO O O
82 rehabilitation VB O O
82 facility NN B-NP O
82 in IN B-VP O
82 stable JJ B-NP O
82 condition NN I-NP O
82 with IN B-VP O
82 all DT B-NP O
82 wounds NNS I-NP O
83 clean JJ O O
83 and CC O O
83 dry JJ O O
84 On IN B-VP O
84 day NN B-NP O
84 of IN B-VP O
84 discharge NN B-NP O
84 her PRP$ O O
84 sodium NN B-NP O
84 is VBZ O O
84 137 CD O O
84 , , O O
84 potassium NN B-NP O
84 3.9 CD O O
84 , , O O
84 BUN NNP B-NP O
84 16 CD O O
84 , , O O
85 creatinine NN B-NP O
85 0.9 CD O O
85 , , O O
85 glucose VBD B-VP O
85 163 CD O O
85 WBC NNP B-NP O
85 16.7 CD O O
85 , , O O
85 hematocrit NN B-NP O
85 31 CD O O
85 , , O O
85 platelet NN B-NP O
86 count NN I-NP O
86 340 CD O O
86 , , O O
86 INR NNP B-NP O
86 2.3 CD O O
87 DISPOSITION: NNP B-NP O
87 DISCHARGE NNP I-NP O
87 MEDICATIONS: NNP I-NP O
87 Atenolol NNP I-NP B-m
87 125 CD O B-do
87 mg NN B-NP I-do
87 p.o NN I-NP B-mo
87 b.i.d NN I-NP B-f
87 , , O O
88 Captopril NNP B-NP B-m
88 100 CD O B-do
88 mg NN B-NP I-do
88 p.o NN I-NP B-mo
88 t.i.d NN I-NP B-f
88 , , O O
88 Colace NNP B-NP B-m
88 100 CD O B-do
88 mg NN B-NP I-do
88 p.o NN I-NP B-mo
89 t.i.d NN I-NP B-f
89 , , O O
89 Lasix NNP B-NP B-m
89 40 CD O B-do
89 mg NN B-NP I-do
89 p.o NN I-NP B-mo
89 q.d NN I-NP B-f
89 , , O O
89 insulin NN B-NP O
89 22 CD O B-do
89 units NNS B-NP I-do
89 NPH NNP I-NP O
89 subcu NN I-NP B-mo
89 q.a.m NN I-NP B-f
90 and CC O O
90 10 CD O B-do
90 units NNS B-NP I-do
90 regular JJ B-NP O
90 subcu NN I-NP B-mo
90 q.a.m NN I-NP B-f
90 , , O O
90 CZI NNP B-NP B-m
90 regular JJ B-NP I-m
90 insulin NN I-NP I-m
90 sliding VBG O B-do
91 scale NN B-NP O
91 , , O O
91 Percocet NNP B-NP B-m
91 1 CD O B-do
91 to TO O I-do
91 2 CD O I-do
91 tablets NNS B-NP I-do
91 p.o VBP O B-mo
91 q3 SYM O B-f
91 - : O I-f
91 4h CD O I-f
91 p.r.n NN B-NP I-f
91 pain NN I-NP B-r
91 , , O O
91 Zantac NNP B-NP B-m
91 150 CD O B-do
92 mg NN B-NP O
92 p.o NN I-NP B-mo
92 b.i.d NN I-NP B-f
92 , , O O
92 Coumadin NNP B-NP B-m
92 dosed VBD B-VP O
92 to TO O O
92 INR NNP B-NP O
92 of IN B-VP O
92 2 CD O O
92 to TO O O
92 2.5 CD O O
92 , , O O
92 and CC O O
92 Amlodipine NNP B-NP B-m
92 5 CD O B-do
93 mg NN B-NP O
93 p.o NN I-NP B-mo
93 q.d NN I-NP B-f
93 FOLLOWUP: NNP I-NP O
93 The DT B-NP O
93 patient NN I-NP O
93 is VBZ O O
93 to TO O O
93 follow-up JJ O O
93 in IN B-VP O
93 six CD O O
93 weeks NNS B-NP O
94 with IN B-VP O
94 cardiac JJ B-NP O
94 surgeon NN I-NP O
94 , , O O
94 Dr NNP B-NP O
94 Standrew NNP I-NP O
94 , , O O
94 with IN B-VP O
94 primary JJ B-NP O
94 care NN I-NP O
94 physician NN I-NP O
94 , , O O
94 Dr NNP B-NP O
95 Birdsong NNP I-NP O
95 , , O O
95 in IN B-VP O
95 one CD O O
95 to TO O O
95 two CD O O
95 weeks NNS B-NP O
95 , , O O
95 and CC O O
95 with IN B-VP O
95 cardiologist NN B-NP O
95 , , O O
95 Dr NNP B-NP O
95 Shelko NNP I-NP O
95 , , O O
96 in IN B-VP O
96 one CD O O
96 to TO O O
96 two CD O O
96 weeks NNS B-NP O
96 The DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 discharged VBN O O
96 to TO O O
96 the DT B-NP O
96 Faithhugh NNP I-NP O
96 Lowe NNP I-NP O
96 County NNP I-NP O
96 Memorial NNP I-NP O
96 Hospital NNP I-NP O
97 Dictated NNP I-NP O
97 By: NNP I-NP O
97 MARCEL NNP I-NP O
97 SHABOT NNP I-NP O
97 , , O O
97 P.A NNP B-NP O
98 Attending: NNP I-NP O
98 DOYLE NNP I-NP O
98 S NNP I-NP O
98 VARAKUTA NNP I-NP O
98 , , O O
98 M.D NNP B-NP O
98 HK45 NNP I-NP O
98 RY675/7835 NNP I-NP O
99 Batch: NNP I-NP O
99 3215 CD O O
99 Index NNP B-NP O
99 No NNP I-NP O
99 AFKJ4311BM NNP I-NP O
99 D: NNP I-NP O
99 9/19/99 CD O O
100 T: NNP B-NP O
100 9/19/99 CD O O
101 UZ5 NNP B-NP O
102 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #449738 VBZ O O
4 789989806 CD O O
4 HMC NNP B-NP O
4 20775881 CD O O
4 9405886 CD O O
4 7/0/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/10/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/1/2005 CD O O
7 ATTENDING: NNP B-NP O
7 KEMERER NNP I-NP O
7 , , O O
7 DEAN NNP B-NP O
7 OMAR NNP I-NP O
7 MD NNP I-NP O
8 SERVICE: NNP I-NP O
8 Cardiology NNP I-NP O
8 Usoslee NNP I-NP O
8 Avenue NNP I-NP O
8 , , O O
8 Ri NNP B-NP O
8 Dar NNP I-NP O
8 Cincogarlstock NNP I-NP O
8 , , O O
8 22451 CD O O
9 PRINCIPAL NNP B-NP O
9 DIAGNOSIS: NNP I-NP O
9 Acute NNP I-NP O
9 renal JJ B-NP O
9 failure NN I-NP O
10 PROBLEMS NNP I-NP O
10 AND NNP I-NP O
10 DIAGNOSIS: NNP I-NP O
10 Ischemic NNP I-NP O
10 cardiomyopathy NN I-NP O
10 , , O O
10 coronary JJ B-NP O
10 artery NN I-NP O
11 disease NN I-NP O
11 , , O O
11 insulin-dependent JJ B-NP O
11 diabetes NNS I-NP O
11 mellitus VBP O O
11 with IN B-VP O
11 neuropathy JJ O O
11 , , O O
12 hypercholesterolemia NN B-NP O
12 , , O O
12 hypertension NN B-NP O
12 , , O O
12 polyarticular JJ B-NP O
12 gout NN I-NP O
12 , , O O
12 elevated VBD B-VP O
13 CK NNP B-NP O
13 , , O O
13 and CC O O
13 osteoarthritis NN B-NP O
13 left VBD B-VP O
13 hip JJ B-NP O
14 HISTORY NNP I-NP O
14 OF NNP I-NP O
14 PRESENT NNP I-NP O
14 ILLNESS: NNP I-NP O
14 Mr NNP I-NP O
14 Sheumaker NNP I-NP O
14 is VBZ O O
14 a DT B-NP O
14 65-year-old JJ I-NP O
14 gentleman NN I-NP O
15 with IN B-VP O
15 known VBN O O
15 cardiomyopathy NN B-NP O
15 , , O O
15 coronary JJ B-NP O
15 artery NN I-NP O
15 disease NN I-NP O
15 , , O O
16 osteoarthritis NN B-NP O
16 , , O O
16 insulin-dependent JJ B-NP O
16 diabetes NNS I-NP O
16 mellitus NNS I-NP O
16 , , O O
16 who WP O O
17 presented VBD B-VP O
17 with IN B-VP O
17 a DT O O
17 1 CD O O
17 week NN B-NP O
17 of IN B-VP O
17 progressive JJ B-NP O
17 fatigue NN I-NP O
17 and CC O O
17 shortness NN B-NP O
17 of IN B-VP O
18 breath NN B-NP O
18 In IN B-VP O
18 the DT O O
18 prior JJ O O
18 2 CD O B-du
18 weeks NNS B-NP I-du
18 , , O O
18 he PRP O O
18 had VBD B-VP O
18 been VBN O O
18 started VBN O O
18 on IN B-VP O
19 hydrochlorothiazide NN B-NP B-m
19 He PRP O O
19 had VBD B-VP O
19 been VBN O O
19 nauseated VBN O O
19 and CC O O
19 vomiting VBG O O
19 as IN B-VP O
19 a DT B-NP O
20 result NN I-NP O
20 of IN B-VP O
20 Percocet NNP B-NP B-m
20 taken VBN O O
20 for IN B-VP O
20 his PRP$ O B-r
20 left JJ B-NP I-r
20 hip NN I-NP I-r
20 pain NN I-NP I-r
20 with IN B-VP O
20 resulting VBG O O
21 decreased VBN O O
21 p.o NNS B-NP O
21 intake VB O O
21 He PRP O O
21 was VBD B-VP O
21 evaluated VBN O O
21 in IN B-VP O
21 his PRP$ O O
21 primary JJ B-NP O
21 care NN I-NP O
22 clinic NN I-NP O
22 and CC O O
22 felt VBD B-VP O
22 to TO O O
22 be VB O O
22 in IN B-VP O
22 decompensated JJ B-NP O
22 heart NN I-NP O
22 failure NN I-NP O
23 In IN B-VP O
23 the DT B-NP O
23 Emergency NNP I-NP O
23 Department NNP I-NP O
23 , , O O
23 he PRP O O
23 was VBD B-VP O
23 dehydrated VBN O O
23 and CC O O
23 found VBN O O
23 to TO O O
23 be VB O O
23 in IN B-VP O
24 acute JJ B-NP O
24 renal JJ I-NP O
24 failure NN I-NP O
24 , , O O
24 hyperkalemic JJ O O
24 , , O O
24 and CC O O
24 uremic JJ O O
24 He PRP O O
24 complained VBD B-VP O
24 of IN B-VP O
25 joint JJ B-NP O
25 soreness NN I-NP O
25 , , O O
25 particularly RB O O
25 in IN B-VP O
25 his PRP$ O O
25 third JJ B-NP O
25 proximal JJ I-NP O
26 interphalangeal NN I-NP O
26 joints NNS I-NP O
26 bilaterally RB O O
26 His PRP$ O O
26 BUN NNP B-NP O
26 and CC O O
26 creatinine NN B-NP O
26 were VBD B-VP O
27 182 CD O O
27 and CC O O
27 4.8 CD O O
27 respectively RB O O
27 His PRP$ O O
27 potassium NN B-NP O
27 6.4 CD O O
27 , , O O
27 his PRP$ O O
27 sodium NN B-NP O
27 128 CD O O
27 , , O O
27 and CC O O
28 his PRP$ O O
28 CPK NN B-NP O
28 1356 CD O O
28 , , O O
28 and CC O O
28 his PRP$ O O
28 uric JJ B-NP O
28 acid NN I-NP O
28 level NN I-NP O
28 11.6 CD O O
28 Issues NNP B-NP O
28 in IN B-VP O
28 the DT B-NP O
29 hospital NN I-NP O
29 included VBD B-VP O
29 hyperkalemia NN B-NP O
29 , , O O
29 acute JJ B-NP O
29 renal JJ I-NP O
29 failure NN I-NP O
29 secondary JJ O O
29 to TO O O
30 dehydration NN B-NP O
30 , , O O
30 polyarticular JJ B-NP O
30 joint NN I-NP O
30 soreness NN I-NP O
30 and CC O O
30 left VBD B-VP O
30 hip NN B-NP O
30 pain NN I-NP O
30 For IN B-VP O
31 his PRP$ O B-r
31 his PRP$ O B-r
31 his PRP$ O B-r
31 his PRP$ O B-r
31 hyperkalemia NN B-NP I-r
31 hyperkalemia NN I-NP I-r
31 hyperkalemia NN I-NP I-r
31 hyperkalemia NN I-NP I-r
31 , , O O
31 the DT B-NP O
31 patient NN I-NP O
31 was VBD B-VP O
31 treated VBN O O
31 with IN B-VP O
31 calcium NN B-NP B-m
31 , , O O
32 gluconate NN B-NP B-m
32 , , O O
32 insulin NN B-NP B-m
32 , , O O
32 Kayexalate NNP B-NP B-m
32 and CC O O
32 his PRP$ O O
32 potassium NN B-NP O
32 level NN I-NP O
32 returned VBD B-VP O
33 to TO O O
33 normal JJ B-NP O
33 levels NNS I-NP O
33 by IN B-VP O
33 hospital JJ B-NP O
33 day NN I-NP O
33 #2 VB O O
33 For IN B-VP O
33 his PRP$ O B-r
33 acute JJ B-NP O
33 renal JJ I-NP O
34 failure NN I-NP O
34 , , O O
34 the DT B-NP O
34 patient NN I-NP O
34 was VBD B-VP O
34 hydrated VBN O O
34 gently RB O O
34 with IN B-VP O
34 60 CD O B-do
34 cc NNS B-NP I-do
34 of IN B-VP O
34 normal JJ O B-m
35 saline VBP O O
35 The DT B-NP O
35 renal JJ I-NP O
35 service NN I-NP O
35 was VBD B-VP O
35 consulted VBN O O
35 and CC O O
35 assisted VBN O O
35 with IN B-VP O
36 management NN B-NP O
36 The DT B-NP O
36 patient NN I-NP O
36 was VBD B-VP O
36 urinating JJ B-NP O
36 Renal NNP I-NP O
36 ultrasound NN I-NP O
36 was VBD B-VP O
37 normal JJ B-NP O
37 Renal NNP I-NP O
37 function NN I-NP O
37 returned VBD B-VP O
37 to TO O O
37 baseline VB O O
37 and CC O O
37 his PRP$ O O
37 creatinine NN B-NP O
38 at IN B-VP O
38 discharge NN B-NP O
38 was VBD B-VP O
38 1.4 CD O O
38 His PRP$ O O
38 baseline NN B-NP O
38 is VBZ O O
38 1.6 CD O O
38 With IN B-VP O
38 correction NN B-NP O
38 of IN B-VP O
39 his PRP$ O O
39 renal JJ B-NP O
39 function NN I-NP O
39 , , O O
39 the DT B-NP O
39 patient NN I-NP O
39 regained VBD B-VP O
39 strength NN B-NP O
39 For IN B-VP O
39 his PRP$ O O
39 joint NN B-NP O
40 symptoms NNS I-NP O
40 , , O O
40 Rheumatology NNP B-NP O
40 was VBD B-VP O
40 consulted VBN O O
40 who WP O O
40 performed VBD B-VP O
40 arthrocentesis NN B-NP O
41 of IN B-VP O
41 the DT B-NP O
41 left JJ I-NP O
41 knee NN I-NP O
41 and CC O O
41 diagnosed VBD B-VP O
41 polyarticular NN B-NP O
41 gout NN I-NP O
41 No NNP I-NP O
41 treatment NN I-NP O
42 was VBD B-VP O
42 initiated VBN O O
42 in IN B-VP O
42 the DT B-NP O
42 setting NN I-NP O
42 of IN B-VP O
42 impaired JJ B-NP O
42 renal JJ I-NP O
42 function NN I-NP O
42 and CC O O
42 a DT B-NP O
43 concern NN I-NP O
43 for IN B-VP O
43 fluid NN B-NP O
43 retention NN I-NP O
43 He PRP O O
43 has VBZ O O
43 a DT B-NP O
43 followup JJ I-NP O
43 appointment NN I-NP O
43 with IN B-VP O
44 Rheumatology NNP B-NP O
44 in IN B-VP O
44 July NNP B-NP O
44 2005 CD O O
44 For IN B-VP O
44 his PRP$ O O
44 hip NN B-NP O
44 pain NN I-NP O
44 , , O O
44 his PRP$ O O
44 orthopedist NN B-NP O
44 , , O O
45 Dr NNP B-NP O
45 Schuchmann NNP I-NP O
45 , , O O
45 evaluated VBD B-VP O
45 him PRP O O
45 for IN B-VP O
45 possible JJ B-NP O
45 future JJ I-NP O
45 hip NN I-NP O
45 surgery NN I-NP O
46 Neurology NNP I-NP O
46 was VBD B-VP O
46 consulted VBN O O
46 regarding VBG O O
46 atrophy NN B-NP O
46 of IN B-VP O
46 thenar NN B-NP O
46 muscles NNS I-NP O
46 and CC O O
47 elevated VBN O O
47 CPK NNP B-NP O
47 They PRP O O
47 did VBD B-VP O
47 not RB O O
47 feel VB O O
47 a DT B-NP O
47 secure NN I-NP O
47 diagnosis NN I-NP O
47 could MD O O
47 be VB O O
47 made VBN O O
48 and CC O O
48 recommended VBN O O
48 following VBG O O
48 daily JJ B-NP O
48 CPK NNP I-NP O
48 , , O O
48 which WDT O O
48 trended VBD B-VP O
48 down RB O O
48 over IN B-VP O
48 the DT B-NP O
49 course NN I-NP O
49 of IN B-VP O
49 hospitalization NN B-NP O
49 Followup NNP I-NP O
49 appointment NN I-NP O
49 in IN B-VP O
49 Neurology NNP B-NP O
49 was VBD B-VP O
50 scheduled VBN O O
50 to TO O O
50 discuss VB O O
50 essential JJ B-NP O
50 tremor NN I-NP O
50 and CC O O
50 further JJ O O
50 investigate VB O O
50 the DT B-NP O
51 muscle NN I-NP O
51 wasting VBG O O
51 with IN B-VP O
51 nerve NN B-NP O
51 conduction NN I-NP O
51 studies NNS I-NP O
51 and CC O O
51 EMG NNP B-NP O
51 if IN B-VP O
51 necessary JJ O O
52 based VBN O O
52 on IN B-VP O
52 CPK NNP B-NP O
52 levels NNS I-NP O
52 The DT B-NP O
52 patient NN I-NP O
52 had VBD B-VP O
52 an DT B-NP O
52 echocardiogram NN I-NP O
52 on IN B-VP O
53 hospital JJ B-NP O
53 day NN I-NP O
53 #2 NNP I-NP O
53 , , O O
53 which WDT O O
53 showed VBD B-VP O
53 an DT B-NP O
53 ejection NN I-NP O
53 fraction NN I-NP O
53 of IN B-VP O
53 40 CD O O
53 to TO O O
53 45% CD O O
53 , , O O
54 no DT B-NP O
54 pericardial JJ I-NP O
54 effusion NN I-NP O
54 , , O O
54 and CC O O
54 hypokinesis NN B-NP O
54 of IN B-VP O
54 the DT B-NP O
54 mid NN I-NP O
54 and CC O O
54 distal JJ B-NP O
55 septum NN I-NP O
55 , , O O
55 mid NN B-NP O
55 and CC O O
55 distal JJ B-NP O
55 inferior NN I-NP O
55 wall NN I-NP O
55 and CC O O
55 decreased VBD B-VP O
55 global JJ B-NP O
55 right NN I-NP O
56 ventricular NN I-NP O
56 function NN I-NP O
56 The DT B-NP O
56 patent NN I-NP O
56 foramen NNS I-NP O
56 ovale NN I-NP O
56 was VBD B-VP O
56 visualized VBN O O
57 At IN B-VP O
57 discharge NN B-NP O
57 , , O O
57 the DT B-NP O
57 patient NN I-NP O
57 was VBD B-VP O
57 afebrile RB O O
57 , , O O
57 hemodynamically RB O O
57 stable JJ O O
57 , , O O
58 euvolemic JJ O O
58 , , O O
58 ambulating VBG O O
58 , , O O
58 and CC O O
58 saturating VBG O O
58 on IN B-VP O
58 room NN B-NP O
58 air NN I-NP O
58 , , O O
58 and CC O O
58 on IN B-VP O
58 a DT B-NP O
59 stable JJ I-NP O
59 medical JJ I-NP O
59 regimen NNS I-NP O
59 He PRP O O
59 was VBD B-VP O
59 followed VBN O O
59 by IN B-VP O
59 VNA NNP B-NP O
59 at IN B-VP O
59 home NN B-NP O
59 starting VBG O O
60 February NNP B-NP O
60 , , O O
60 2005 CD O O
60 , , O O
60 for IN B-VP O
60 INR NNP B-NP O
60 checks NNS I-NP O
61 Followup NNP I-NP O
61 appointments NNS I-NP O
61 for IN B-VP O
61 Cardiology NNP B-NP O
61 , , O O
61 Neurology NNP B-NP O
61 , , O O
61 and CC O O
61 Rheumatology NNP B-NP O
62 were VBD B-VP O
62 put VBN O O
62 in IN B-VP O
62 place NN B-NP O
62 The DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
62 asked VBN O O
62 to TO O O
62 contact VB O O
62 his PRP$ O O
62 primary JJ B-NP O
63 care NN I-NP O
63 physician NN I-NP O
63 to TO O O
63 schedule VB O O
63 a DT B-NP O
63 followup JJ I-NP O
63 appointment NN I-NP O
64 On IN B-VP O
64 admission NN B-NP O
64 , , O O
64 the DT B-NP O
64 patient NN I-NP O
64 was VBD B-VP O
64 afebrile JJ O O
64 and CC O O
64 hemodynamically RB O O
65 stable JJ B-NP O
66 eScription NN I-NP O
66 document: VBZ O O
66 6-5164249 JJ B-NP O
66 SSSten NNP I-NP O
66 Tel NNP I-NP O
67 Dictated NNP I-NP O
67 By: NNP I-NP O
67 PIERMONT NNP I-NP O
67 , , O O
67 FLOYD NNP B-NP O
68 Attending: NNP I-NP O
68 SULESKI NNP I-NP O
68 , , O O
68 CHADWICK NNP B-NP O
68 ANTONIO NNP I-NP O
69 Dictation NNP I-NP O
69 ID NNP I-NP O
69 0550727 CD O O
70 D: NNP B-NP O
70 8/24/05 CD O O
71 T: NNP B-NP O
71 8/24/05 CD O O
72 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #451911 VBZ O O
4 610002579 CD O O
4 OHMC NNP B-NP O
4 73726819 CD O O
4 6004894 CD O O
4 4/11/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHF NNP I-NP O
4 EXACERBATION NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 8/17/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 0/21/2006 CD O O
7 ATTENDING: NNP B-NP O
7 DEMARTINO NNP I-NP O
7 , , O O
7 HARRIS NNP B-NP O
7 MD NNP I-NP O
8 DISCHARGE NNP I-NP O
8 DISPOSITION: NNP I-NP O
9 To TO O O
9 Rehabilitation NNP B-NP O
9 Hospital NNP I-NP O
10 DISCHARGE NNP I-NP O
10 MEDICATIONS: NNP I-NP O
11 Enteric-coated NNP I-NP B-m
11 aspirin VBZ O I-m
11 325 CD O B-do
11 mg NN B-NP I-do
11 p.o JJ O B-mo
11 daily RB O B-f
11 , , O O
11 amiodarone RB O B-m
11 200 CD O B-do
11 mg NNS B-NP I-do
11 p.o JJ O B-mo
12 daily RB O B-f
12 , , O O
12 Colace NNP B-NP B-m
12 100 CD O B-do
12 mg NN B-NP I-do
12 p.o NN I-NP B-mo
12 b.i.d NN I-NP B-f
12 , , O O
12 insulin JJ B-NP B-m
12 insulin NN I-NP B-m
12 NPH NNP I-NP I-m
12 NPH NNP I-NP I-m
12 7 CD O B-do
12 units NNS B-NP I-do
12 q.a.m RB O B-f
12 and CC O O
13 3 CD O B-do
13 units NNS B-NP I-do
13 q.p.m RB O B-f
13 subcutaneously RB O B-mo
13 subcutaneously RB O B-mo
13 , , O O
13 Atrovent NNP B-NP B-m
13 HFA NNP I-NP I-m
13 inhaler NN I-NP I-m
13 2 CD O B-do
13 puffs NNS B-NP I-do
14 inhaled VBD B-VP B-mo
14 q.i.d JJ B-NP B-f
14 p.r.n NN I-NP I-f
14 for IN B-VP O
14 wheezing VBG O B-r
14 , , O O
14 magnesium NN B-NP B-m
14 gluconate NN I-NP I-m
14 sliding VBG O B-do
15 scale JJ O O
15 p.o JJ O B-mo
15 daily JJ O B-f
15 , , O O
15 oxycodone JJ B-NP B-m
15 5-10 JJ I-NP B-do
15 mg NN I-NP I-do
15 p.o NN I-NP B-mo
15 q VBD B-VP B-f
15 4h CD O I-f
15 p.r.n NN B-NP I-f
15 pain NN I-NP B-r
15 , , O O
16 senna JJ B-NP B-m
16 tablets NNS I-NP I-m
16 one CD O B-do
16 to TO O I-do
16 two CD O I-do
16 tablets NNS B-NP I-do
16 p.o VBP O B-mo
16 b.i.d JJ B-NP B-f
16 p.r.n NN I-NP I-f
16 constipation NN I-NP B-r
16 , , O O
17 spironolactone NN B-NP B-m
17 25 CD O B-do
17 mg NN B-NP I-do
17 p.o JJ O B-mo
17 daily RB O B-f
17 , , O O
17 Coumadin NNP B-NP B-m
17 1 CD O B-do
17 mg NN B-NP I-do
17 p.o NN I-NP B-mo
17 every DT B-NP B-f
17 other JJ I-NP O
18 day NN I-NP O
18 , , O O
18 multivitamin CC O B-m
18 therapeutic JJ O I-m
18 one CD O B-do
18 tablet NN B-NP I-do
18 p.o NN I-NP B-mo
18 daily RB O B-f
18 , , O O
18 Zocor NNP B-NP B-m
18 40 CD O B-do
18 mg NN B-NP I-do
19 p.o JJ O B-mo
19 daily RB O B-f
19 , , O O
19 torsemide RB O B-m
19 100 CD O B-do
19 mg NNS B-NP I-do
19 p.o JJ O B-mo
19 daily RB O B-f
19 , , O O
19 OxyContin NNP B-NP B-m
19 10 CD O B-do
19 mg NN B-NP I-do
19 p.o NN I-NP B-mo
20 b.i.d NN I-NP B-f
20 , , O O
20 Cozaar NNP B-NP B-m
20 25 CD O B-do
20 mg NN B-NP I-do
20 p.o JJ O B-mo
20 daily RB O B-f
20 , , O O
20 Remeron NNP B-NP B-m
20 7.5 CD O B-do
20 mg NN B-NP I-do
20 p.o NN I-NP B-mo
20 q.h.s NN I-NP B-f
20 , , O O
20 and CC O O
21 aspartate JJ B-NP B-m
21 insulin NN I-NP I-m
21 sliding VBG O B-do
21 scale JJ B-NP I-do
22 DISCHARGE NNP I-NP O
22 DIET: NNP I-NP O
23 Discharge NNP I-NP O
23 diet NN I-NP O
23 is VBZ O O
23 2 CD O O
23 liters NNS B-NP O
23 fluid JJ B-NP O
23 restrict JJ I-NP O
23 Liberal NNP I-NP O
23 house NN I-NP O
23 diet JJ B-NP O
24 ADMISSION NNP I-NP O
24 DIAGNOSIS: NNP I-NP O
25 Foot NNP I-NP O
25 infection NN I-NP O
26 PRINCIPAL NNP I-NP O
26 DISCHARGE NNP I-NP O
26 DIAGNOSIS: NNP I-NP O
27 Decompensated NNP I-NP O
27 congestive JJ B-NP O
27 heart NN I-NP O
27 failure NN I-NP O
27 , , O O
27 status NN B-NP O
27 post NN I-NP O
27 bilateral JJ B-NP O
28 knee NN I-NP O
28 amputation NN I-NP O
28 , , O O
28 status NN B-NP O
28 post NN I-NP O
28 BKA NNP I-NP O
29 RETURN NNP I-NP O
29 TO NNP I-NP O
29 WORK: NNP I-NP O
30 Not RB O O
30 applicable JJ B-NP O
31 FOLLOW-UP JJ I-NP O
31 APPOINTMENTS: NNP I-NP O
32 Please NNP I-NP O
32 follow VB O O
32 up RP O O
32 with IN B-VP O
32 primary JJ B-NP O
32 care NN I-NP O
32 physician NN I-NP O
32 , , O O
32 Dr NNP B-NP O
32 Ricardo NNP I-NP O
32 Dzierzanowski NNP I-NP O
32 , , O O
32 at IN B-VP O
33 Pipe NNP B-NP O
33 Shanm NNP I-NP O
33 Hasb NNP I-NP O
33 Nota NNP I-NP O
33 Medical NNP I-NP O
33 Center NNP I-NP O
33 within IN B-VP O
33 one CD O O
33 to TO O O
33 two CD O O
33 weeks NNS B-NP O
34 Please NNP I-NP O
34 follow VB O O
34 up RP O O
34 with IN B-VP O
34 primary JJ B-NP O
34 cardiologist NN I-NP O
34 , , O O
34 Dr NNP B-NP O
34 Edwin NNP I-NP O
34 Mellor NNP I-NP O
35 within IN B-VP O
35 one CD O O
35 month NN B-NP O
36 OPERATIONS NNP I-NP O
36 AND NNP I-NP O
36 PROCEDURES: NNP I-NP O
37 None NNP I-NP O
38 OTHER NNP I-NP O
38 TREATMENTS NNP I-NP O
38 AND NNP I-NP O
38 PROCEDURES: NNP I-NP O
39 None NNP I-NP O
40 BRIEF NNP I-NP O
40 RESUME NNP I-NP O
40 OF NNP I-NP O
40 HOSPITAL NNP I-NP O
40 COURSE: NNP I-NP O
41 CHIEF NNP I-NP O
41 COMPLAINT: NNP I-NP O
42 Shortness NNP I-NP O
42 of IN B-VP O
42 breath JJ B-NP O
43 HISTORY NNP I-NP O
43 OF NNP I-NP O
43 PRESENT NNP I-NP O
43 ILLNESS: NNP I-NP O
44 A NNP I-NP O
44 73-year-old JJ B-NP O
44 man NN I-NP O
44 with IN B-VP O
44 a DT B-NP O
44 history NN I-NP O
44 of IN B-VP O
44 coronary JJ B-NP O
44 artery NN I-NP O
44 disease NN I-NP O
45 status NN I-NP O
45 post NN I-NP O
45 coronary JJ B-NP O
45 artery NN I-NP O
45 bypass NN I-NP O
45 graft NN I-NP O
45 , , O O
45 ischemic JJ B-NP O
46 cardiomyopathy NN I-NP O
46 , , O O
46 valvular JJ B-NP O
46 heart NN I-NP O
46 disease NN I-NP O
46 , , O O
46 known VBN O O
46 EF NNP B-NP O
46 of IN B-VP O
46 15-20% JJ O O
46 as IN B-VP O
46 of IN B-VP O
47 6/25 CD O O
47 , , O O
47 was VBD B-VP O
47 admitted VBN O O
47 to TO O O
47 the DT B-NP O
47 Rose-le NNP I-NP O
47 Medical NNP I-NP O
47 Center NNP I-NP O
47 from IN B-VP O
48 No NNP B-NP O
48 Memorial NNP I-NP O
48 with IN B-VP O
48 signs NNS B-NP O
48 and CC O O
48 symptoms NNS B-NP O
48 of IN B-VP O
49 decompensated JJ B-NP O
49 heart NN I-NP O
49 failure NN I-NP O
49 , , O O
49 and CC O O
49 acute NN B-NP O
49 on IN B-VP O
49 chronic JJ B-NP O
49 renal JJ I-NP O
49 failure NN I-NP O
50 On IN B-VP O
50 11/0/06 CD O O
50 , , O O
50 he PRP O O
50 was VBD B-VP O
50 admitted VBN O O
50 with IN B-VP O
50 a DT B-NP O
50 large JJ I-NP O
50 left JJ I-NP O
50 foot NN I-NP O
50 toe NN I-NP O
50 ulcer NN I-NP O
51 that WDT O O
51 was VBD B-VP O
51 nonhealing VBG O O
51 Multiple JJ B-NP O
51 surgeries NNS I-NP O
51 were VBD B-VP O
51 performed VBN O O
51 with IN B-VP O
52 persistent JJ O O
52 nonhealing VBG O O
52 wounds: NN B-NP O
52 Left NNP I-NP O
52 great JJ B-NP O
52 toe JJ I-NP O
52 amputation NN I-NP O
52 on IN B-VP O
53 6/10/06 CD O O
53 , , O O
53 which WDT O O
53 failed VBD B-VP O
53 to TO O O
53 heal VB O O
53 despite IN B-VP O
53 SFA NNP B-NP O
53 to TO O O
53 perineal VB O O
53 artery RB O O
54 bypassing VBG O O
54 the DT B-NP O
54 composite JJ I-NP O
54 vein NN I-NP O
54 Had VBD B-VP O
54 a DT B-NP O
54 short JJ I-NP O
54 CICU NNP I-NP O
54 stay NN I-NP O
54 for IN B-VP O
55 hypotension NN B-NP B-r
55 postoperatively RB O O
55 , , O O
55 maintained VBD B-VP O
55 on IN B-VP O
55 dobutamine NN B-NP B-m
55 On IN B-VP O
56 0/9/06 CD O O
56 underwent JJ B-NP O
56 debridement NN I-NP O
56 of IN B-VP O
56 left JJ B-NP O
56 medial JJ I-NP O
56 ulcer NN I-NP O
56 On IN B-VP O
56 10/12/06 CD O O
57 transmetatarsal JJ B-NP O
57 amputation NN I-NP O
57 , , O O
57 on IN B-VP O
57 7/3/06 CD O O
57 , , O O
57 debridement NN B-NP O
57 of IN B-VP O
58 transmetatarsal JJ B-NP O
58 amputation NN I-NP O
58 On IN B-VP O
58 11/29/06 CD O O
58 received VBD B-VP O
58 a DT O O
58 left VBN O O
58 below IN B-VP O
59 the DT B-NP O
59 knee NN I-NP O
59 amputation NN I-NP O
59 His PRP$ O O
59 renal JJ B-NP O
59 function NN I-NP O
59 had VBD B-VP O
59 been VBN O O
59 normal JJ O O
59 prior RB O O
59 to TO O O
60 the DT B-NP O
60 final JJ I-NP O
60 surgery NN I-NP O
60 until IN B-VP O
60 6/21/06 CD O O
60 to TO O O
60 3/25/06 CD O O
60 when WRB O O
60 his PRP$ O O
60 creatinine NN B-NP O
61 rose VBD B-VP O
61 from IN B-VP O
61 1.3 CD O O
61 to TO O O
61 2.2 CD O O
61 He PRP O O
61 was VBD B-VP O
61 discharged VBN O O
61 to TO O O
61 acute VB O O
61 rehabilitation NN B-NP O
62 and CC O O
62 was VBD B-VP O
62 there RB O O
62 noted VBN O O
62 to TO O O
62 have VB O O
62 this DT B-NP O
62 acute JJ I-NP O
62 renal JJ I-NP O
62 failure NN I-NP O
62 , , O O
62 which WDT O O
62 was VBD B-VP O
63 thought VBN O O
63 to TO O O
63 be VB O O
63 due JJ O O
63 to TO O O
63 prerenal JJ B-NP O
63 azotemia NN I-NP O
63 , , O O
63 but CC O O
63 his PRP$ O O
63 creatinine NN B-NP O
63 at IN B-VP O
64 this DT B-NP O
64 point NN I-NP O
64 had VBD B-VP O
64 not RB O O
64 changed VBN O O
64 much RB O O
64 from IN B-VP O
64 2.2 CD O O
64 to TO O O
64 2.5 CD O O
64 during IN B-VP O
64 his PRP$ O O
64 stay NN B-NP O
65 Diuretics NNPS I-NP O
65 were VBD B-VP O
65 held VBN O O
65 at IN B-VP O
65 rehabilitation NN B-NP O
65 facility NN I-NP O
65 until IN B-VP O
65 two CD O O
65 days NNS B-NP O
66 prior RB O O
66 to TO O O
66 admission NN B-NP O
66 He PRP O O
66 was VBD B-VP O
66 noted VBN O O
66 to TO O O
66 have VB O O
66 increased VBN O O
66 shortness NN B-NP O
66 of IN B-VP O
67 breath NN B-NP O
67 Patient NNP I-NP O
67 denies VBZ O O
67 any DT B-NP O
67 other JJ I-NP O
67 symptoms NNS I-NP O
67 up IN B-VP O
67 to TO O O
67 that DT B-NP O
67 point NN I-NP O
68 except IN B-VP O
68 occasional JJ B-NP O
68 lightheadedness NN I-NP O
68 , , O O
68 depressed VBD B-VP O
68 mood NN B-NP O
68 , , O O
68 and CC O O
68 lack NN B-NP O
68 of IN B-VP O
69 motivation NN B-NP O
69 No NNP I-NP O
69 orthopnea NN I-NP O
69 , , O O
69 uses VBZ O O
69 1 CD O O
69 pillow NN B-NP O
69 regularly RB O O
69 , , O O
69 denies VBZ O O
70 paroxysmal JJ B-NP O
70 nocturnal JJ I-NP O
70 dyspnea NN I-NP O
70 , , O O
70 and CC O O
70 denies VBZ O O
70 dyspnea NN B-NP O
70 on IN B-VP O
70 exertion NN B-NP O
70 , , O O
70 but CC O O
71 very RB O O
71 limited JJ B-NP O
71 movement NN I-NP O
72 PAST NNP I-NP O
72 MEDICAL NNP I-NP O
72 HISTORY: NNP I-NP O
73 Significant NNP I-NP O
73 for IN B-VP O
73 hypertension NN B-NP O
73 , , O O
73 GERD NNP B-NP O
73 , , O O
73 hypercholesterolemia NN B-NP O
73 , , O O
73 CAD NNP B-NP O
74 status NN I-NP O
74 post NN I-NP O
74 MI NNP I-NP O
74 in IN B-VP O
74 1996 CD O O
74 , , O O
74 received VBD B-VP O
74 a DT B-NP O
74 CABG NNP I-NP O
74 in IN B-VP O
74 0/26 CD O O
74 with IN B-VP O
74 a DT B-NP O
74 LIMA NNP I-NP O
74 to TO O O
75 LAD NNP B-NP O
75 , , O O
75 SVG NNP B-NP O
75 to TO O O
75 PDA NNP B-NP O
75 , , O O
75 SVG NNP B-NP O
75 to TO O O
75 OM1 NNP B-NP O
75 , , O O
75 and CC O O
75 mitral JJ B-NP O
75 valve NN I-NP O
75 annuloplasty NN I-NP O
76 Diabetes NNP I-NP O
76 mellitus NN I-NP O
76 , , O O
76 insulin-dependent JJ O O
76 , , O O
76 status NN B-NP O
76 post NN I-NP O
76 bilateral JJ O O
76 below IN B-VP O
77 the DT B-NP O
77 knee NN I-NP O
77 amputation NN I-NP O
77 , , O O
77 likely RB O O
77 from IN B-VP O
77 diabetes NNS B-NP O
77 related JJ B-NP O
77 foot NN I-NP O
77 ulcers NNS I-NP O
77 , , O O
78 history NN B-NP O
78 of IN B-VP O
78 atrial JJ B-NP O
78 fibrillation NN I-NP O
78 and CC O O
78 atrial JJ B-NP O
78 flutter NN I-NP O
78 , , O O
78 history NN B-NP O
78 of IN B-VP O
79 sick JJ B-NP O
79 sinus NN I-NP O
79 syndrome NN I-NP O
79 , , O O
79 history NN B-NP O
79 of IN B-VP O
79 second-degree JJ B-NP O
79 heart NN I-NP O
79 block NN I-NP O
79 , , O O
79 AICD NNP B-NP O
80 placed VBD B-VP O
80 2/10 CD O O
80 complicated VBN O O
80 by IN B-VP O
80 hematoma JJ B-NP O
80 History NNP I-NP O
80 of IN B-VP O
80 admissions NNS B-NP O
80 for IN B-VP O
81 hyponatremia NN B-NP O
81 Status NNP I-NP O
81 post NN I-NP O
81 left VBD B-VP O
81 SFA NNP B-NP O
81 to TO O O
81 perineal VB O O
81 artery JJ B-NP O
81 bypass NN I-NP O
81 to TO O O
82 incompetent VB O O
82 pain NN B-NP O
82 in IN B-VP O
82 0/2 CD O O
83 MEDICATIONS NNP B-NP O
83 ON NNP I-NP O
83 ADMISSION: NNP I-NP O
84 Amiodarone NNP I-NP B-m
84 200 CD O B-do
84 mg NN B-NP I-do
84 p.o JJ B-NP B-mo
84 daily JJ I-NP B-f
84 Atrovent NNP I-NP B-m
84 one CD O B-do
84 to TO O I-do
84 two CD O I-do
84 puffs NNS B-NP I-do
84 inhaled VBD B-VP B-mo
85 q.i.d JJ B-NP B-f
85 p.r.n NN I-NP I-f
85 for IN B-VP O
85 wheezing VBG O B-r
85 , , O O
85 Celexa NNP B-NP B-m
85 20 CD O B-do
85 mg NN B-NP I-do
85 p.o JJ O B-mo
85 daily RB O B-f
85 , , O O
85 Coumadin NNP B-NP B-m
85 2.5 CD O B-do
86 mg NN B-NP O
86 p.o JJ O B-mo
86 daily RB O B-f
86 , , O O
86 Diovan NNP B-NP B-m
86 80 CD O B-do
86 mg NN B-NP I-do
86 p.o JJ O B-mo
86 daily JJ O B-f
86 , , O O
86 enteric-coated JJ B-NP B-m
86 aspirin NN I-NP I-m
87 325 CD O B-do
87 mg NN B-NP I-do
87 p.o JJ O B-mo
87 daily RB O B-f
87 , , O O
87 Lantus NNP B-NP B-m
87 25 CD O B-do
87 units NNS B-NP I-do
87 every DT B-NP B-f
87 day NN I-NP I-f
87 subcutaneous JJ O B-mo
87 , , O O
87 Lasix NNP B-NP B-m
88 160 CD O B-do
88 mg NN B-NP I-do
88 p.o NN I-NP B-mo
88 b.i.d NN I-NP B-f
88 , , O O
88 Lipitor NNP B-NP B-m
88 20 CD O B-do
88 mg NN B-NP I-do
88 p.o NN I-NP B-mo
88 q.h.s NN I-NP B-f
88 , , O O
88 Lopressor NNP B-NP B-m
88 50 CD O B-do
88 mg NN B-NP I-do
89 p.o NN I-NP B-mo
89 b.i.d NN I-NP B-f
89 , , O O
89 therapeutic JJ B-NP B-m
89 multivitamin NN I-NP I-m
89 one CD O B-do
89 tablet NN B-NP I-do
89 p.o NN I-NP B-mo
89 daily RB O B-f
89 , , O O
90 solsite JJ B-NP B-m
90 topical JJ I-NP B-mo
91 IMPRESSION: NNP I-NP O
92 On IN B-VP O
92 admission NN B-NP O
92 , , O O
92 a DT B-NP O
92 73-year-old JJ I-NP O
92 male NN I-NP O
92 with IN B-VP O
92 severe JJ B-NP O
92 cardiomyopathy NN I-NP O
92 and CC O O
93 ejection NN B-NP O
93 fraction NN I-NP O
93 of IN B-VP O
93 15% CD O O
93 admitted VBN O O
93 for IN B-VP O
93 decompensated JJ B-NP O
93 heart NN I-NP O
93 failure NN I-NP O
94 in IN B-VP O
94 the DT B-NP O
94 setting NN I-NP O
94 of IN B-VP O
94 his PRP$ O O
94 diuretics NNS B-NP O
94 being VBG O O
94 held VBN O O
94 due JJ O O
94 to TO O O
94 an DT B-NP O
94 acute JJ I-NP O
94 renal JJ I-NP O
95 failure NN I-NP O
95 Review NNP I-NP O
95 of IN B-VP O
95 chart NN B-NP O
95 at IN B-VP O
95 the DT B-NP O
95 time NN I-NP O
95 of IN B-VP O
95 admission NN B-NP O
95 showed VBD B-VP O
95 renal JJ B-NP O
96 failure NN I-NP O
96 is VBZ O O
96 actually RB O O
96 present JJ O O
96 since IN B-VP O
96 the DT B-NP O
96 perioperative JJ I-NP O
96 period NN I-NP O
96 of IN B-VP O
96 his PRP$ O O
97 BKA NNP B-NP O
97 After IN B-VP O
97 being VBG O O
97 admitted VBN O O
97 to TO O O
97 the DT B-NP O
97 cardiology NN I-NP O
97 service NN I-NP O
97 , , O O
97 he PRP O O
97 was VBD B-VP O
98 diuresed VBN O O
98 successfully RB O O
98 to TO O O
98 his PRP$ O O
98 dry JJ B-NP O
98 weight NN I-NP O
98 , , O O
98 with IN B-VP O
98 a DT B-NP O
98 significant JJ I-NP O
99 improvement NN I-NP O
99 in IN B-VP O
99 his PRP$ O O
99 oxygen NN B-NP O
99 saturation NN I-NP O
99 , , O O
99 his PRP$ O O
99 creatinine NN B-NP O
99 , , O O
99 and CC O O
99 venous JJ B-NP O
100 congestion NN I-NP O
101 Other JJ B-NP O
101 active JJ I-NP O
101 issues NNS I-NP O
101 he PRP O O
101 was VBD B-VP O
101 treated VBN O O
101 for IN B-VP O
101 include NN B-NP O
101 urinary JJ B-NP O
101 tract JJ I-NP O
102 infection NN I-NP O
102 , , O O
102 diabetes VBZ O O
102 mellitus NN B-NP O
102 , , O O
102 acute NN B-NP O
102 on IN B-VP O
102 chronic JJ B-NP O
102 renal JJ I-NP O
102 failure NN I-NP O
102 , , O O
103 depression NN B-NP O
104 HOSPITAL NNP I-NP O
104 COURSE NNP I-NP O
104 BY NNP I-NP O
104 SYSTEMS: NNP I-NP O
105 1 CD O O
105 Cardiovascular: NNP B-NP O
105 Ischemia: NNP I-NP O
105 Known NNP I-NP O
105 coronary JJ B-NP O
105 artery NN I-NP O
105 disease NN I-NP O
106 status NN I-NP O
106 post NN I-NP O
106 CABG NNP I-NP O
106 x3 NNP I-NP O
106 , , O O
106 admitted VBD B-VP O
106 with IN B-VP O
106 troponin NN B-NP O
106 elevation NN I-NP O
106 likely RB O O
106 due JJ O O
107 to TO O O
107 demand VB O O
107 in IN B-VP O
107 the DT B-NP O
107 setting NN I-NP O
107 of IN B-VP O
107 heart NN B-NP O
107 failure NN I-NP O
107 for IN B-VP O
107 having VBG O O
107 his PRP$ O O
108 diuretics NNS B-NP O
108 held VBD B-VP O
108 This DT O O
108 was VBD B-VP O
108 noted VBN O O
108 to TO O O
108 trend NN B-NP O
108 down RP O O
108 post-diuresis NN B-NP O
108 We PRP O O
109 continued VBD B-VP O
109 aspirin JJ B-NP B-m
109 Initially NNP I-NP O
109 , , O O
109 we PRP O O
109 held VBD B-VP O
109 his PRP$ O O
109 ACE NNP B-NP B-m
109 inhibitor NN I-NP I-m
109 given VBN O O
110 history NN B-NP O
110 of IN B-VP O
110 cough NN B-NP O
110 and CC O O
110 his PRP$ O O
110 ARF NNP B-NP O
110 , , O O
110 and CC O O
110 ultimately RB O O
110 restarted VBD B-VP O
110 the DT B-NP O
111 patient NN I-NP O
111 on IN B-VP O
111 ARB NNP B-NP B-m
111 , , O O
111 after IN B-VP O
111 his PRP$ O O
111 creatinine NN B-NP O
111 had VBD B-VP O
111 normalized VBN O O
111 Statins NNP B-NP O
111 had VBD B-VP O
112 been VBN O O
112 held VBN O O
112 until IN B-VP O
112 we PRP O O
112 were VBD B-VP O
112 certain JJ O O
112 his PRP$ O O
112 liver JJ B-NP O
112 function NN I-NP O
112 tests NNS I-NP O
112 were VBD B-VP O
113 decreasing VBG O O
114 2 CD O O
114 Cardiovascular JJ B-NP O
114 pump: NN I-NP O
114 The DT B-NP O
114 patient NN I-NP O
114 remained VBD B-VP O
114 in IN B-VP O
114 floor NN B-NP O
114 volume NN I-NP O
115 overload NN I-NP O
115 on IN B-VP O
115 presentation NN B-NP O
115 , , O O
115 maintained VBD B-VP O
115 on IN B-VP O
115 2 CD O O
115 grams NNS B-NP O
115 salt JJ O O
115 daily RB O O
115 , , O O
115 2 CD O O
116 liters NNS B-NP O
116 fluid JJ B-NP O
116 restriction NN I-NP O
116 diet NN I-NP O
116 with IN B-VP O
116 1-2 JJ B-NP O
116 liters NNS I-NP O
116 per IN B-VP O
116 day NN B-NP O
116 goal NN I-NP O
117 diuresis NN I-NP O
117 attained VBN O O
117 by IN B-VP O
117 using VBG O O
117 100 CD O B-do
117 mg JJ B-NP I-do
117 IV NNP I-NP B-mo
117 torsemide NN I-NP B-m
117 b.i.d NN I-NP B-f
117 with IN B-VP O
117 the DT B-NP O
118 addition NN I-NP O
118 of IN B-VP O
118 25 CD O B-do
118 mg NN B-NP I-do
118 of IN B-VP O
118 hydrochlorothiazide NN B-NP B-m
118 b.i.d NN I-NP B-f
118 30 CD O O
118 minutes NNS B-NP O
118 prior RB O O
119 to TO O O
119 each DT B-NP O
119 torsemide NN I-NP B-m
119 dose NN I-NP O
119 , , O O
119 an DT B-NP O
119 average NN I-NP O
119 of IN B-VP O
119 two CD O O
119 liter NN B-NP O
119 fluid NN I-NP O
119 negative JJ B-NP O
120 Diuresis NNP I-NP O
120 was VBD B-VP O
120 affected VBN O O
120 over IN B-VP O
120 the DT B-NP O
120 course NN I-NP O
120 of IN B-VP O
120 a DT B-NP O
120 week NN I-NP O
120 , , O O
120 and CC O O
120 his PRP$ O O
120 status NN B-NP O
121 gradually RB O O
121 improved VBD B-VP O
121 Spironolactone NNP B-NP B-m
121 was VBD B-VP O
121 initially RB O O
121 held VBN O O
121 due JJ O O
121 to TO O O
122 high JJ B-NP O
122 K NNP I-NP O
122 but CC O O
122 was VBD B-VP O
122 re-added VBN O O
122 on IN B-VP O
122 1/30/06 CD O O
122 His PRP$ O O
122 jugular NN B-NP O
122 venous JJ B-NP O
123 distention NN I-NP O
123 dropped VBD B-VP O
123 from IN B-VP O
123 initial JJ B-NP O
123 presentation NN I-NP O
123 above IN B-VP O
123 the DT B-NP O
123 earlobes NNS I-NP O
124 at IN B-VP O
124 a DT B-NP O
124 30-degree JJ I-NP O
124 angle NN I-NP O
124 to TO O O
124 a DT B-NP O
124 JVP NNP I-NP O
124 of IN B-VP O
124 6-7 JJ B-NP O
124 cm NN I-NP O
124 at IN B-VP O
124 30 CD O O
124 degree JJ B-NP O
124 angle NN I-NP O
124 on IN B-VP O
124 the DT B-NP O
125 day NN I-NP O
125 of IN B-VP O
125 discharge NN B-NP O
125 Two CD O O
125 days NNS B-NP O
125 prior RB O O
125 to TO O O
125 discharge VB O O
125 , , O O
125 his PRP$ O O
125 creatinine NN B-NP O
126 began VBD B-VP O
126 to TO O O
126 rise VB O O
126 , , O O
126 suggesting VBG O O
126 prerenal JJ B-NP O
126 azotemia NN I-NP O
126 secondary JJ O O
126 to TO O O
126 over IN B-VP O
127 diuresis NN B-NP B-r
127 and CC O O
127 when WRB O O
127 his PRP$ O O
127 torsemide NN B-NP B-m
127 was VBD B-VP O
127 reduced VBN O O
127 to TO O O
127 100 CD O B-do
127 mg NNS B-NP I-do
127 p.o JJ O B-mo
127 daily RB O B-f
127 , , O O
128 hydrochlorothiazide NN B-NP B-m
128 was VBD B-VP O
128 dropped VBN O O
128 from IN B-VP O
128 his PRP$ O O
128 regimen NNS B-NP O
128 , , O O
128 patient's FW O O
129 creatinine NN B-NP O
129 began VBD B-VP O
129 to TO O O
129 drop VB O O
129 again RB O O
129 , , O O
129 and CC O O
129 patient NN B-NP O
129 was VBD B-VP O
129 able JJ O O
129 to TO O O
129 maintain VB O O
130 even RB O O
130 Ins NNP B-NP O
130 and CC O O
130 Outs NNP B-NP O
130 of IN B-VP O
130 fluid NN B-NP O
130 for IN B-VP O
130 two CD O O
130 days NNS B-NP O
130 prior RB O O
130 to TO O O
130 discharge VB O O
131 3 CD O O
131 Cardiovascular NNP B-NP O
131 rhythm: NN I-NP O
131 Patient NNP I-NP O
131 is VBZ O O
131 ventricularly RB O O
131 paced VBN O O
131 on IN B-VP O
132 symmetry NN B-NP O
132 for IN B-VP O
132 duration NN B-NP O
132 of IN B-VP O
132 hospitalization NN B-NP O
132 , , O O
132 history NN B-NP O
132 of IN B-VP O
132 atrial JJ B-NP B-r
132 atrial JJ I-NP B-r
133 fibrillation NN I-NP O
133 on IN B-VP O
133 Coumadin NNP B-NP B-m
133 , , O O
133 was VBD B-VP O
133 maintained VBN O O
133 on IN B-VP O
133 amiodarone NN B-NP B-m
133 during IN B-VP B-du
134 this DT B-NP O
134 hospitalization NN I-NP O
135 4 CD O O
135 Pulmonary: NNP B-NP O
135 The DT B-NP O
135 patient NN I-NP O
135 with IN B-VP O
135 initial JJ B-NP O
135 O2 NNP I-NP O
135 dependence NN I-NP O
136 Continued NNP I-NP O
136 inhaled VBD B-VP B-mo
136 ipratropium VB O B-m
136 his PRP$ O O
136 home NN B-NP O
136 medication NN I-NP O
136 After IN B-VP O
137 diuresis NN B-NP O
137 , , O O
137 the DT B-NP O
137 patient NN I-NP O
137 was VBD B-VP O
137 able JJ O O
137 to TO O O
137 achieve VB O O
137 oxygen NN B-NP O
137 saturation NN I-NP O
137 of IN B-VP O
138 100% CD O O
138 on IN B-VP O
138 room NN B-NP O
138 air NN I-NP O
139 5 CD O O
139 Renal: NNP B-NP O
139 Initial NNP I-NP O
139 acute NN I-NP O
139 on IN B-VP O
139 chronic JJ B-NP O
139 renal JJ I-NP O
139 failure NN I-NP O
139 thought VBD B-VP O
140 secondary JJ O O
140 to TO O O
140 volume NN B-NP O
140 overload NN I-NP O
140 and CC O O
140 forward RB O O
140 flow NN B-NP O
140 in IN B-VP O
140 the DT B-NP O
140 context NN I-NP O
140 of IN B-VP O
141 decompensated JJ B-NP O
141 congestive JJ I-NP O
141 heart NN I-NP O
141 failure NN I-NP O
141 His PRP$ O O
141 renal JJ B-NP O
141 function NN I-NP O
142 improved VBD B-VP O
142 , , O O
142 as IN B-VP O
142 he PRP O O
142 was VBD B-VP O
142 diuresed VBN O O
142 and CC O O
142 his PRP$ O O
142 heart NN B-NP O
142 likely RB O O
142 moved VBD B-VP O
142 to TO O O
142 more RBR O O
143 useful JJ B-NP O
143 part NN I-NP O
143 of IN B-VP O
143 the DT O O
143 starling VBG O O
143 curve NN B-NP O
143 Renal NNP I-NP O
143 ultrasound NN I-NP O
143 was VBD B-VP O
143 negative JJ O O
144 for IN B-VP O
144 hydronephrosis NN B-NP O
144 as IN B-VP O
144 was VBD B-VP O
144 test NN B-NP O
144 for IN B-VP O
144 urine NN B-NP O
144 eosinophils NNS I-NP O
145 Hyponatremia NNP I-NP O
145 was VBD B-VP O
145 likely JJ O O
145 due JJ O O
145 to TO O O
145 heart NN B-NP O
145 failure NN I-NP O
145 improved VBN O O
145 with IN B-VP O
146 diuresis NN B-NP O
147 6 CD O O
147 Heme: NNP B-NP O
147 The DT B-NP O
147 patient NN I-NP O
147 maintained VBD B-VP O
147 on IN B-VP O
147 Coumadin NNP B-NP B-m
147 with IN B-VP O
147 an DT B-NP O
147 INR NNP I-NP O
147 goal NN I-NP O
147 of IN B-VP O
148 2-3 JJ O O
148 In IN B-VP O
148 order NN B-NP O
148 to TO O O
148 achieve VB O O
148 this DT B-NP O
148 goal NN I-NP O
148 , , O O
148 his PRP$ O O
148 Coumadin NNP B-NP B-m
148 dose NN I-NP O
148 was VBD B-VP O
149 adjusted VBN O O
149 to TO O O
149 mg VB O O
149 p.o NN B-NP B-mo
149 every DT B-NP B-f
149 other JJ I-NP I-f
149 day NN I-NP I-f
149 He PRP O O
149 will MD O O
149 be VB O O
149 followed VBN O O
149 by IN B-VP O
150 chemo NN B-NP O
150 and CC O O
150 Coumadin NNP B-NP B-m
150 service NN I-NP O
150 after IN B-VP O
150 discharge NN B-NP O
150 with IN B-VP O
150 weekly JJ B-NP O
150 tests NNS I-NP O
150 to TO O O
151 make VB O O
151 sure JJ O O
151 that IN B-VP O
151 his PRP$ O O
151 INR NNP B-NP O
151 is VBZ O O
151 maintained VBN O O
151 within IN B-VP O
151 this DT B-NP O
151 range NN I-NP O
152 7 CD O O
152 Endocrine NNP B-NP O
152 Diabetes NNP I-NP B-r
152 Diabetes NNP I-NP B-r
152 mellitus NN I-NP I-r
152 mellitus NN I-NP I-r
152 , , O O
152 insulin-dependent JJ O O
152 , , O O
152 covered VBN O O
152 on IN B-VP O
153 NPH NNP B-NP B-m
153 NPH NNP I-NP B-m
153 q.a.m NN I-NP B-f
153 and CC O O
153 q.p.m NN B-NP B-f
153 with IN B-VP O
153 aspartate JJ O B-m
153 sliding VBG O B-do
153 scale NN B-NP I-do
153 for IN B-VP B-du
153 duration NN B-NP O
154 of IN B-VP O
154 hospitalization NN B-NP O
155 8 CD O O
155 Psych: NNP B-NP O
155 The DT B-NP O
155 patient NN I-NP O
155 was VBD B-VP O
155 restarted VBN O O
155 on IN B-VP O
155 Celexa NNP B-NP B-m
155 per IN B-VP O
155 PCP NNP B-NP O
155 for IN B-VP O
156 likely JJ B-NP B-r
156 depressive JJ I-NP I-r
156 mood NN I-NP I-r
156 response NN I-NP O
156 to TO O O
156 recent JJ B-NP O
156 bilateral JJ I-NP O
156 knee NN I-NP O
157 amputation NN I-NP O
157 It PRP O O
157 is VBZ O O
157 what WP O O
157 is VBZ O O
157 quite RB O O
157 possible JJ O O
157 that IN B-VP O
157 patient's JJ B-NP O
158 depression NN I-NP O
158 precedes VBZ O O
158 the DT B-NP O
158 bilateral JJ I-NP O
158 knee NN I-NP O
158 amputation NN I-NP O
158 and CC O O
158 informs NNS B-NP O
159 much RB O O
159 of IN B-VP O
159 his PRP$ O O
159 overall JJ B-NP O
159 care NN I-NP O
159 The DT B-NP O
159 patient's NN I-NP O
159 PCP NNP I-NP O
159 , , O O
159 Dr NNP B-NP O
159 Micheal NNP I-NP O
159 L NNP I-NP O
159 Davirro NNP I-NP O
159 , , O O
159 aware NN B-NP O
159 of IN B-VP O
159 the DT B-NP O
159 situation NN I-NP O
159 and CC O O
159 managing NN B-NP O
159 as IN B-VP O
159 outpatient NN B-NP O
159 The DT B-NP O
160 patient NN I-NP O
160 was VBD B-VP O
160 also RB O O
160 seen VBN O O
160 by IN B-VP O
160 the DT B-NP O
160 inpatient JJ I-NP O
160 psychiatry NN I-NP O
160 consultation NN I-NP O
160 , , O O
161 and CC O O
161 started VBD B-VP O
161 on IN B-VP O
161 Remeron NNP B-NP B-m
161 7.5 CD O B-do
161 7.5 CD O B-do
161 mg NN B-NP I-do
161 mg NN I-NP I-do
161 p.o JJ O B-mo
161 daily RB O B-f
161 in IN B-VP O
161 place NN B-NP O
161 of IN B-VP O
161 Celexa NNP B-NP B-m
161 He PRP O O
162 is VBZ O O
162 discharged VBN O O
162 on IN B-VP O
162 this DT B-NP B-m
162 medication NN I-NP I-m
162 The DT B-NP O
162 patient NN I-NP O
162 is VBZ O O
162 status NN B-NP O
162 post NN I-NP O
162 one CD O O
163 fall NN B-NP O
163 from IN B-VP O
163 the DT B-NP O
163 bed NN I-NP O
163 during IN B-VP O
163 the DT B-NP O
163 hospitalization NN I-NP O
163 Head NNP I-NP O
163 CT NNP I-NP O
163 at IN B-VP O
163 that DT B-NP O
164 time NN I-NP O
164 showed VBD B-VP O
164 no DT B-NP O
164 evidence NN I-NP O
164 of IN B-VP O
164 bleed NN B-NP O
164 or CC O O
164 trauma NN B-NP O
164 to TO O O
164 the DT B-NP O
164 head NN I-NP O
164 to TO O O
164 head VB O O
165 Examination NNP B-NP O
165 of IN B-VP O
165 back RB O O
165 and CC O O
165 extremities NNS B-NP O
165 reveals VBZ O O
165 no DT B-NP O
165 focal JJ I-NP O
165 tenderness NN I-NP O
166 or CC O O
166 ecchymoses VBZ O O
167 9 CD O O
167 Infectious JJ B-NP O
167 disease NN I-NP O
167 The DT B-NP O
167 patient NN I-NP O
167 initially RB O O
167 treated VBD B-VP O
167 for IN B-VP O
168 urinary JJ B-NP B-r
168 tract NN I-NP I-r
168 infection NN I-NP I-r
168 with IN B-VP O
168 uncomplicated JJ B-NP O
168 course NN I-NP O
168 with IN B-VP O
169 ciprofloxacin JJ O B-m
170 10 CD O O
170 Wound: NNP B-NP O
170 Wound NNP I-NP O
170 care NN I-NP O
170 nurse NN I-NP O
170 consulted VBN O O
170 for IN B-VP O
170 BKA NNP B-NP O
170 wound NN I-NP O
170 and CC O O
170 small JJ B-NP O
171 decubitus NN I-NP O
171 on IN B-VP O
171 his PRP$ O O
171 back NN B-NP O
171 , , O O
171 was VBD B-VP O
171 treated VBN O O
171 with IN B-VP O
171 DuoDERM NNP B-NP B-m
171 , , O O
171 BKA NNP B-NP O
171 site NN I-NP O
171 healing VBG O O
172 well RB O O
173 11 CD O O
173 Fluids NNS B-NP O
173 , , O O
173 electrolytes NNS B-NP O
173 and CC O O
173 nutrition: VBZ O O
173 The DT B-NP O
173 patient NN I-NP O
173 remained VBD B-VP O
173 on IN B-VP O
174 cardiac NN B-NP O
174 , , O O
174 2000 CD O O
174 calorie NN B-NP O
174 diabetic JJ B-NP O
174 diet NN I-NP O
174 , , O O
174 however RB O O
174 , , O O
174 as IN B-VP O
174 it PRP O O
174 became VBD B-VP O
175 apparent JJ O O
175 that IN B-VP O
175 he PRP O O
175 was VBD B-VP O
175 severely RB O O
175 malnourished VBN O O
175 , , O O
175 his PRP$ O O
175 diet NN B-NP O
175 was VBD B-VP O
176 liberalized VBN O O
176 to TO O O
176 allow VB O O
176 for IN B-VP O
176 nutritional JJ B-NP O
176 supplementation NN I-NP O
177 12 CD O O
177 PPX: NNP B-NP O
177 The DT B-NP O
177 patient NN I-NP O
177 maintained VBD B-VP O
177 on IN B-VP O
177 subcutaneous JJ B-NP B-mo
177 subcutaneous JJ I-NP B-mo
177 heparin NN I-NP B-m
177 heparin NN I-NP B-m
177 and CC O O
178 Nexium NNP B-NP B-m
178 Nexium NNP I-NP B-m
178 as IN B-VP O
178 DVT NNP B-NP O
178 and CC O O
178 GI NNP B-NP B-r
178 GI NNP I-NP B-r
178 prophylaxis NN I-NP I-r
178 prophylaxis NN I-NP I-r
178 during IN B-VP B-du
178 this DT B-NP I-du
178 hospitalization NN I-NP I-du
179 13 CD O O
179 Code NNP B-NP O
179 status NN I-NP O
179 , , O O
179 full JJ B-NP O
179 code NN I-NP O
180 TO NNP I-NP O
180 DO NNP I-NP O
180 PLAN NNP I-NP O
181 1 CD O O
181 Discharge NNP B-NP O
181 the DT B-NP O
181 patient NN I-NP O
181 to TO O O
181 rehab VB O O
181 on IN B-VP O
181 current JJ B-NP O
181 regimen NNS I-NP O
181 Patient NNP I-NP O
182 has VBZ O O
182 been VBN O O
182 working VBG O O
182 with IN B-VP O
182 PT NNP B-NP O
182 and CC O O
182 OT NNP B-NP O
182 during IN B-VP O
182 this DT B-NP O
182 hospitalization NN I-NP O
182 and CC O O
183 appears VBZ O O
183 well RB O O
183 positioned VBN O O
183 to TO O O
183 take VB O O
183 advantage NN B-NP O
183 of IN B-VP O
183 rehabilitation NN B-NP O
184 facilities NNS I-NP O
184 services NNS I-NP O
185 2 CD O O
185 Maintain NNP B-NP O
185 new JJ B-NP O
185 prescription NN I-NP O
185 of IN B-VP O
185 Remeron NNP B-NP B-m
185 , , O O
185 follow VB O O
185 up RP O O
185 with IN B-VP O
186 psychiatry NN B-NP O
186 to TO O O
186 assess VB O O
186 depressive JJ B-NP B-r
186 disorder/adjustment NN I-NP I-r
186 disorder NN I-NP I-r
187 3 CD O O
187 The DT B-NP O
187 patient NN I-NP O
187 has VBZ O O
187 been VBN O O
187 off RP O O
187 beta-blocker NN B-NP B-m
187 PCP NNP I-NP O
187 may MD O O
187 choose VB O O
187 to TO O O
188 start VB O O
188 beta-blocker NN B-NP B-m
188 at IN B-VP O
188 a DT O B-do
188 low-dose JJ O I-do
188 in IN B-VP O
188 the DT B-NP O
188 outpatient NN I-NP O
188 setting VBG O O
189 4 CD O O
189 Fasciculations NNS B-NP O
189 noted VBD B-VP O
189 during IN B-VP O
189 hospitalization NN B-NP O
189 fine JJ B-NP O
190 fasciculations NNS I-NP O
190 at IN B-VP O
190 hands NNS B-NP O
190 in IN B-VP O
190 Surga NNP B-NP O
190 Hospital NNP I-NP O
190 Maybe RB O O
190 secondary JJ O O
190 to TO O O
191 malnutrition NN B-NP O
191 and CC O O
191 diaries NNS B-NP O
191 is VBZ O O
191 , , O O
191 but CC O O
191 may MD O O
191 merit VB O O
191 further JJ B-NP O
191 workup NN I-NP O
191 in IN B-VP O
191 an DT B-NP O
192 outpatient JJ I-NP O
192 context NN I-NP O
193 5 CD O O
193 The DT B-NP O
193 patient NN I-NP O
193 had VBD B-VP O
193 rising VBG O O
193 alkaline NN B-NP O
193 phosphatase NN I-NP O
193 during IN B-VP O
194 hospitalization NN B-NP O
194 , , O O
194 CT NNP B-NP O
194 of IN B-VP O
194 chest JJS O O
194 incidentally RB O O
194 showed VBD B-VP O
194 gallstone JJ B-NP O
195 present NN I-NP O
195 within IN B-VP O
195 the DT B-NP O
195 gallbladder NN I-NP O
195 , , O O
195 follow VB O O
195 up RP O O
195 LFTs NNP B-NP O
195 in IN B-VP O
195 the DT B-NP O
195 outpatient NN I-NP O
196 context NN I-NP O
196 and CC O O
196 possible JJ B-NP O
196 right JJ I-NP O
196 upper NN I-NP O
196 quadrant NN I-NP O
196 ultrasound NN I-NP O
196 may MD O O
196 merit VB O O
197 consideration NN B-NP O
197 and CC O O
197 further JJ B-NP O
197 outpatient NN I-NP O
197 workup NN I-NP O
197 of IN B-VP O
197 this DT B-NP O
197 patient NN I-NP O
197 The DT B-NP O
198 patient NN I-NP O
198 will MD O O
198 follow VB O O
198 up RP O O
198 with IN B-VP O
198 Coumadin NNP B-NP O
198 clinic JJ O O
198 given VBN O O
198 goal NN B-NP O
198 INR NNP I-NP O
198 of IN B-VP O
199 2.0-3.0 JJ O O
199 The DT B-NP O
199 patient's NN I-NP O
199 creatinine NN I-NP O
199 and CC O O
199 BUN NNP B-NP O
199 should MD O O
199 be VB O O
199 checked VBN O O
200 along IN B-VP O
200 with IN B-VP O
200 electrolytes NNS B-NP O
200 to TO O O
200 make VB O O
200 sure JJ B-NP O
200 patient NN I-NP O
200 is VBZ O O
200 doing VBG O O
200 well RB O O
200 on IN B-VP O
201 current JJ B-NP O
201 maintenance NN I-NP O
201 diuretic JJ B-NP O
201 schedule NN I-NP O
201 of IN B-VP O
201 100 CD O B-do
201 mg NNS B-NP I-do
201 torsemide JJ O B-m
201 p.o JJ O B-mo
202 daily JJ O B-f
202 and CC O O
202 spironolactone JJ B-NP B-m
203 CODE NNP I-NP O
203 STATUS: NNP I-NP O
204 Full NNP I-NP O
204 code NN I-NP O
205 DISCHARGE NNP I-NP O
205 CONDITION: NNP I-NP O
206 Stable NNP I-NP O
206 Discharged NNP I-NP O
206 to TO O O
206 rehabilitation VB O O
207 eScription NN B-NP O
207 document: IN B-VP O
207 2-3432980 JJ B-NP O
207 EMSSten NNP I-NP O
207 Tel NNP I-NP O
208 CC: NNP I-NP O
208 Noe NNP I-NP O
208 W NNP I-NP O
208 Mcgoldrick NNP I-NP O
208 M.D NNP I-NP O
209 Ton NNP I-NP O
210 CC: NNP I-NP O
210 Keneth NNP I-NP O
210 Bartuska NNP I-NP O
210 M.D NNP I-NP O
211 NUTRISOCHI NNP I-NP O
211 ZIE-BRI NNP I-NP O
211 MEMORIAL NNP I-NP O
212 Jose NNP I-NP O
212 Mi NNP I-NP O
212 Ant NNP I-NP O
213 Dictated NNP I-NP O
213 By: NNP I-NP O
213 DOULANI NNP I-NP O
213 , , O O
213 DEVIN NNP B-NP O
214 Attending: NNP I-NP O
214 LEEDER NNP I-NP O
214 , , O O
214 BRENDON NNP B-NP O
215 Dictation NNP I-NP O
215 ID NNP I-NP O
215 7465299 CD O O
216 D: NNP B-NP O
216 7/14/06 CD O O
217 T: NNP B-NP O
217 7/14/06 CD O O
218 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #451973 VBZ O O
2 036050725 CD O O
2 WR NNP B-NP O
2 53380160 CD O O
2 093316 CD O O
2 1/3/1997 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CORONARY NNP I-NP O
2 ARTERY NNP I-NP O
2 DISEASE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 5/21/1997 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/12/1997 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
5 SIGNIFICANT NNP I-NP O
5 PROBLEMS: NNP I-NP O
6 1 CD O O
6 CORONARY NNP B-NP O
6 ARTERY NNP I-NP O
6 DISEASE NNP I-NP O
7 2 CD O O
7 HYPERCHOLESTEROLEMIA NNP B-NP O
8 3 CD O O
8 HYPERTENSION NNP B-NP O
9 4 CD O O
9 HISTORY NNP B-NP O
9 OF NNP I-NP O
9 CONGESTIVE NNP I-NP O
9 HEART NNP I-NP O
9 FAILURE NNP I-NP O
9 WITH NNP I-NP O
9 FLASH NNP I-NP O
9 PULMONARY NNP I-NP O
9 EDEMA NNP I-NP O
10 5 CD O O
10 HISTORY NNP B-NP O
10 OF NNP I-NP O
10 DEPRESSION NNP I-NP O
11 6 CD O O
11 GLAUCOMA NNP B-NP O
12 7 CD O O
12 NON-INSULIN-DEPENDENT NNP B-NP O
12 DIABETES NNP I-NP O
12 MELLITUS NNP I-NP O
13 8 CD O O
13 MITRAL NNP B-NP O
13 REGURGITATION NNP I-NP O
14 9 CD O O
14 CHRONIC NNP B-NP O
14 RENAL NNP I-NP O
14 INSUFFICIENCY NNP I-NP O
15 10 CD O O
15 HISTORY NNP B-NP O
15 OF NNP I-NP O
15 BREAST NNP I-NP O
15 CANCER NNP I-NP O
15 STATUS NNP I-NP O
15 POST NNP I-NP O
15 LEFT NNP I-NP O
15 MASTECTOMY NNP I-NP O
15 AND NNP I-NP O
16 TAMOXIFEN NNP I-NP B-m
16 TREATMENT NNP I-NP O
17 HISTORY NNP I-NP O
17 OF NNP I-NP O
17 PRESENT NNP I-NP O
17 ILLNESS: NNP I-NP O
17 The DT B-NP O
17 patient NN I-NP O
17 is VBZ O O
17 a DT B-NP O
17 69-year-old JJ I-NP O
17 female NN I-NP O
18 with IN B-VP O
18 known JJ B-NP O
18 coronary JJ I-NP O
18 artery NN I-NP O
18 disease NN I-NP O
18 , , O O
19 CRF NNP B-NP O
19 , , O O
19 and CC O O
19 history NN B-NP O
19 of IN B-VP O
19 flash JJ B-NP O
19 pulmonary JJ I-NP O
19 edema NN I-NP O
19 , , O O
19 recently RB O O
19 admitted VBN O O
19 to TO O O
20 Darnbo NNP B-NP O
20 Hospital NNP I-NP O
20 on IN B-VP O
20 7/29/97 CD O O
20 after IN B-VP O
20 sudden JJ B-NP O
20 onset NN I-NP O
20 of IN B-VP O
20 shortness NN B-NP B-r
20 of IN B-VP I-r
20 breath NN B-NP I-r
21 unrelieved VBN O O
21 by IN B-VP O
21 one CD O B-do
21 sublingual JJ B-NP B-mo
21 nitroglycerin NN I-NP B-m
21 This DT B-NP O
21 shortness NN I-NP O
21 of IN B-VP O
22 breath NN B-NP O
22 awakened VBD B-VP O
22 her PRP O O
22 from IN B-VP O
22 sleep NN B-NP O
22 Her NNP I-NP O
22 blood NN I-NP O
22 pressure NN I-NP O
22 in IN B-VP O
22 the DT B-NP O
23 Emergency NNP I-NP O
23 Room NNP I-NP O
23 was VBD B-VP O
23 230/110 CD O O
23 without IN B-VP O
23 EKG NNP B-NP O
23 changes NNS I-NP O
23 She PRP O O
23 responded VBD B-VP O
23 well RB O O
24 to TO O O
24 IV NNP B-NP B-mo
24 Lasix NNP I-NP B-m
24 and CC O O
24 IV NNP B-NP B-mo
24 nitroglycerin RB O B-m
24 , , O O
24 saturating VBG O O
24 at IN B-VP O
24 99% CD O O
24 on IN B-VP O
24 100% CD O O
25 nonrebreather CC O O
25 mask JJ B-NP O
25 Chest NNP I-NP O
25 x-ray NN I-NP O
25 was VBD B-VP O
25 consistent JJ O O
25 with IN B-VP O
25 pulmonary JJ B-NP O
26 edema NN I-NP O
26 Her NNP I-NP B-r
26 blood NN I-NP I-r
26 pressure NN I-NP I-r
26 was VBD B-VP O
26 stabilized VBN O O
26 on IN B-VP O
26 IV NNP B-NP B-mo
26 nitroglycerin NN I-NP B-m
26 with IN B-VP O
27 resolution NN B-NP O
27 of IN B-VP O
27 her PRP$ O O
27 shortness NN B-NP O
27 of IN B-VP O
27 breath NN B-NP O
27 She PRP O O
27 was VBD B-VP O
27 ruled VBN O O
27 out RP O O
27 for IN B-VP O
28 myocardial JJ B-NP O
28 infarction NN I-NP O
28 The DT B-NP O
28 patient NN I-NP O
28 was VBD B-VP O
28 also RB O O
28 recently RB O O
28 admitted VBD B-VP O
28 one CD O O
29 month NN B-NP O
29 ago RB O O
29 to TO O O
29 Stonemep NNP B-NP O
29 Medical NNP I-NP O
29 Center NNP I-NP O
29 for IN B-VP O
29 flash JJ B-NP O
29 pulmonary JJ I-NP O
29 edema NN I-NP O
29 without IN B-VP O
30 evidence NN B-NP O
30 of IN B-VP O
30 myocardial JJ B-NP O
30 infarction NN I-NP O
30 Echo NNP I-NP O
30 on IN B-VP O
30 admission NN B-NP O
30 showed VBD B-VP O
30 30% CD O O
31 ejection NN B-NP O
31 fraction NN I-NP O
31 with IN B-VP O
31 anteroapical JJ O O
31 and CC O O
31 posterobasal JJ B-NP O
31 hypokinesis NN I-NP O
32 Cardiac NNP I-NP O
32 catheterization NN I-NP O
32 in IN B-VP O
32 March NNP B-NP O
32 1997 CD O O
32 showed VBD B-VP O
32 a DT O O
32 90% CD O O
32 proximal JJ B-NP O
32 RCA NNP I-NP O
33 lesion NN I-NP O
33 and CC O O
33 diffuse NN B-NP O
33 distal JJ B-NP O
33 LAD NNP I-NP O
33 disease NN I-NP O
33 During IN B-VP O
33 vigorous JJ B-NP O
33 rehydration NN I-NP O
34 following VBG O O
34 that IN B-VP O
34 cardiac JJ B-NP O
34 catheterization NN I-NP O
34 , , O O
34 she PRP O O
34 developed VBD B-VP O
34 recurrent JJ B-NP O
35 pulmonary JJ I-NP O
35 edema NN I-NP O
35 requiring VBG O O
35 intubation NN B-NP O
35 from IN B-VP O
35 which WDT O O
35 she PRP O O
35 was VBD B-VP O
35 weaned VBN O O
36 following VBG O O
36 diuresis NN B-NP O
36 Because IN B-VP O
36 her PRP$ O O
36 pulmonary JJ B-NP O
36 edema NN I-NP O
36 was VBD B-VP O
36 believed VBN O O
36 to TO O O
36 be VB O O
37 ischemia RB O O
37 related VBN O O
37 , , O O
37 she PRP O O
37 was VBD B-VP O
37 transferred VBN O O
37 to TO O O
37 the DT B-NP O
37 Ha NNP I-NP O
37 Hospital NNP I-NP O
37 for IN B-VP O
37 RCA NNP B-NP O
37 angioplasty NN I-NP O
37 On IN B-VP O
37 this DT B-NP O
37 admission NN I-NP O
37 , , O O
37 she PRP O O
37 denies VBZ O O
37 any DT B-NP O
38 chest NN I-NP O
38 pain NN I-NP O
38 , , O O
38 shortness NN B-NP O
38 of IN B-VP O
38 breath NN B-NP O
38 , , O O
38 or CC O O
38 dizziness NN B-NP O
38 She PRP O O
38 has VBZ O O
38 three CD O O
39 pillow NN B-NP O
39 orthopnea NN I-NP O
39 , , O O
39 ankle NN B-NP O
39 edema NN I-NP O
39 She PRP O O
39 denies VBZ O O
39 any DT B-NP O
39 paroxysmal JJ I-NP O
39 nocturnal JJ I-NP O
40 dyspnea NN I-NP O
40 with IN B-VP O
40 the DT B-NP O
40 exception NN I-NP O
40 of IN B-VP O
40 her PRP$ O O
40 current JJ B-NP O
40 presentation NN I-NP O
40 The DT B-NP O
41 patient's NN I-NP O
41 coronary JJ B-NP O
41 risk NN I-NP O
41 factors NNS I-NP O
41 include VBP O O
41 diabetes NNS B-NP O
41 mellitus NNS I-NP O
41 , , O O
42 hypertension NN B-NP O
42 , , O O
42 hypercholesterolemia NN B-NP O
42 , , O O
42 post NN B-NP O
42 menopausal NN I-NP O
42 status NN I-NP O
42 without IN B-VP O
43 hormone NN B-NP O
43 replacement NN I-NP O
43 therapy NN I-NP O
43 , , O O
43 and CC O O
43 history NN B-NP O
43 of IN B-VP O
43 tobacco NN B-NP O
43 use IN B-VP O
43 Her PRP$ O O
44 exercise NN B-NP O
44 tolerance NN I-NP O
44 is VBZ O O
44 such JJ O O
44 that IN B-VP O
44 she PRP O O
44 develops VBZ O O
44 shortness NN B-NP O
44 of IN B-VP O
44 breath NN B-NP O
45 with IN B-VP O
45 walking VBG O O
45 one CD O O
45 block NN B-NP O
45 or CC O O
45 one CD O O
45 flight NN B-NP O
45 of IN B-VP O
45 stairs NNS B-NP O
45 She PRP O O
45 reports VBZ O O
45 having VBG O O
46 to TO O O
46 sit VB O O
46 down RP O O
46 at IN B-VP O
46 every DT B-NP O
46 other JJ I-NP O
46 bench NN I-NP O
46 in IN B-VP O
46 the DT B-NP O
46 mall NN I-NP O
47 PAST NNP I-NP O
47 MEDICAL NNP I-NP O
47 HISTORY: NNP I-NP O
47 1 CD O O
47 Hypercholesterolemia NNP B-NP O
47 Total NNP I-NP O
47 cholesterol NN I-NP O
48 266 CD O O
48 down RB O O
48 to TO O O
48 193 CD O O
48 2 CD O O
48 Hypertension NN B-NP O
48 3 CD O O
49 Breast NNP B-NP O
49 cancer NN I-NP O
49 status NN I-NP O
49 post NN I-NP O
49 left VBD B-VP O
49 mastectomy JJ O O
49 seven CD O O
49 years NNS B-NP O
49 ago RB O O
49 and CC O O
50 status NN B-NP O
50 post NN I-NP O
50 five CD O B-du
50 years NNS B-NP I-du
50 of IN B-VP O
50 Tamoxifen NNP B-NP B-m
50 therapy NN I-NP O
50 She PRP O O
50 has VBZ O O
50 had VBN O O
50 no DT B-NP O
50 other JJ I-NP O
51 chemo NN I-NP O
51 or CC O O
51 radiation NN B-NP O
51 treatment NN I-NP O
51 4 CD O O
51 Depression NNP B-NP O
51 5 CD O O
51 Hypercalcemia NNP B-NP O
51 ( ( O O
51 no DT O O
52 alkalized VBN O O
52 syndrome NN B-NP O
52 ) ) O O
52 1/11 CD O O
52 6 CD O O
52 History NN B-NP O
52 of IN B-VP O
52 recurrent NN B-NP O
52 pneumonia NN I-NP O
52 7 CD O O
53 History NNP B-NP O
53 of IN B-VP O
53 diverticulitis NN B-NP O
53 8 CD O O
53 Glaucoma NNP B-NP O
53 9 CD O O
53 Non-insulin-dependent JJ B-NP O
54 diabetes NNS I-NP O
54 mellitus VBP O O
54 diagnosed VBN O O
54 one CD O O
54 year NN B-NP O
54 ago RB O O
54 , , O O
54 diet VB O O
54 controlled VBD B-VP O
54 10 CD O O
55 Chronic NNP B-NP O
55 renal JJ B-NP O
55 insufficiency NN I-NP O
55 with IN B-VP O
55 a DT B-NP O
55 history NN I-NP O
55 of IN B-VP O
55 pyelonephritis NN B-NP O
55 at IN B-VP O
55 age NN B-NP O
56 three CD O O
56 11 CD O O
56 Mitral NNP B-NP O
56 regurgitation NN I-NP O
56 12 CD O O
56 Status NNP B-NP O
56 post NN I-NP O
56 total JJ B-NP O
56 abdominal JJ I-NP O
57 hysterectomy NN I-NP O
57 , , O O
57 bilateral JJ B-NP O
57 salpingo-oophorectomy NN I-NP O
57 at IN B-VP O
57 age NN B-NP O
57 40 CD O O
57 , , O O
57 hormone CD O O
58 replacement NN B-NP O
58 therapy NN I-NP O
58 for IN B-VP O
58 five CD O O
58 years NNS B-NP O
58 which WDT O O
58 was VBD B-VP O
58 then RB O O
58 discontinued VBN O O
59 secondary JJ O O
59 to TO O O
59 her PRP$ O O
59 breast NN B-NP O
59 cancer NN I-NP O
59 13 CD O O
59 Status NNP B-NP O
59 post NN I-NP O
59 bilateral JJ B-NP O
59 knee NN I-NP O
60 replacement NN I-NP O
61 TRANSFER NNP I-NP O
61 MEDICATIONS: NNP I-NP O
61 Lopressor NNP I-NP B-m
61 25 CD O B-do
61 mg NN B-NP I-do
61 p.o NN I-NP B-mo
61 b.i.d NN I-NP B-f
61 started VBD B-VP O
61 three CD O B-du
62 weeks NNS B-NP O
62 ago RB O O
62 , , O O
62 Axid NNP B-NP B-m
62 150 CD O B-do
62 mg NN B-NP I-do
62 p.o NN I-NP B-mo
62 b.i.d NN I-NP B-f
62 , , O O
62 enteric RB O B-m
63 coated VBD B-VP O
63 aspirin JJ O O
63 325 CD O B-do
63 mg NN B-NP I-do
63 p.o NN I-NP B-mo
63 q.day NN I-NP B-f
63 , , O O
63 Isordil NNP B-NP B-m
63 30 CD O B-do
63 mg NN B-NP I-do
63 p.o NN I-NP B-mo
63 q.i.d NN I-NP B-f
63 , , O O
64 hydralazine VBP O B-m
64 50 CD O B-do
64 mg NN B-NP I-do
64 p.o NN I-NP B-mo
64 q.i.d NN I-NP B-f
64 , , O O
64 Lasix NNP B-NP B-m
64 40 CD O B-do
64 mg NN B-NP I-do
64 p.o NN I-NP B-mo
64 q.day NN I-NP B-f
64 , , O O
64 Timoptic JJ O B-m
65 0.25% CD O O
65 one CD O B-do
65 GTT NNP B-NP I-do
65 OU NNP I-NP B-mo
65 b.i.d NN I-NP B-f
65 , , O O
65 Serax NNP B-NP B-m
65 30 CD O B-do
65 mg NN B-NP I-do
65 p.o NN I-NP B-mo
65 q.h.s NN I-NP B-f
65 p.r.n NN I-NP I-f
65 insomnia NN I-NP B-r
65 , , O O
66 and CC O O
66 IV NNP B-NP B-mo
66 heparin NN I-NP B-m
66 at IN B-VP O
66 1 CD O B-do
66 , , O I-do
66 300 CD O I-do
66 units NNS B-NP I-do
66 per IN B-VP B-f
66 hour NN B-NP I-f
67 ALLERGIES: NNP I-NP O
67 Tagamet NNP I-NP O
67 causes VBZ O O
67 a DT B-NP O
67 rash NN I-NP O
67 and CC O O
67 adhesive JJ B-NP O
67 tape NN I-NP O
68 SOCIAL NNP I-NP O
68 HISTORY: NNP I-NP O
68 Notable NNP I-NP O
68 for IN B-VP O
68 a DT B-NP O
68 history NN I-NP O
68 of IN B-VP O
68 tobacco NN B-NP O
68 She PRP O O
68 quit VBD B-VP O
68 17 CD O O
69 years NNS B-NP O
69 ago RB O O
69 She PRP O O
69 uses VBZ O O
69 no DT B-NP O
69 alcohol NN I-NP O
69 and CC O O
69 no DT B-NP O
69 IV NNP I-NP O
69 drug NN I-NP O
70 use NN I-NP O
70 She PRP O O
70 lives VBZ O O
70 with IN B-VP O
70 her PRP$ O O
70 husband NN B-NP O
70 in IN B-VP O
70 Lau NNP B-NP O
70 and CC O O
70 has VBZ O O
70 six CD O O
70 children NNS B-NP O
71 FAMILY NNP I-NP O
71 HISTORY: NNP I-NP O
71 Her NNP I-NP O
71 father NN I-NP O
71 died VBD B-VP O
71 of IN B-VP O
71 stomach NN B-NP O
71 cancer NN I-NP O
71 Mother NNP I-NP O
71 , , O O
71 two CD O O
72 aunts NNS B-NP O
72 , , O O
72 and CC O O
72 sister RB O O
72 have VBP O O
72 history NN B-NP O
72 of IN B-VP O
72 myocardial JJ B-NP O
73 infarction NN I-NP O
73 at IN B-VP O
73 ages NNS B-NP O
73 greater JJR O O
73 than IN B-VP O
73 60 CD O O
74 REVIEW NNP B-NP O
74 OF NNP I-NP O
74 SYSTEMS: NNP I-NP O
74 The DT B-NP O
74 patient NN I-NP O
74 has VBZ O O
74 been VBN O O
74 following VBG O O
74 her PRP$ O O
74 weight NN B-NP O
74 since IN B-VP O
75 her PRP$ O O
75 last JJ B-NP O
75 discharge NN I-NP O
75 ( ( O O
75 pulmonary JJ B-NP O
75 edema NN I-NP O
75 ) ) O O
75 She PRP O O
76 reports VBZ O O
76 a DT B-NP O
76 weight JJ I-NP O
76 loss NN I-NP O
76 from IN B-VP O
76 177 CD O O
76 to TO O O
76 175 CD O O
76 lb NN B-NP O
76 over IN B-VP O
76 the DT B-NP O
76 last JJ I-NP O
76 couple NN I-NP O
76 of IN B-VP O
77 days NNS B-NP O
77 She PRP O O
77 reports VBZ O O
77 a DT O O
77 12 CD O O
77 lb JJ B-NP O
77 weight JJ I-NP O
77 loss NN I-NP O
77 in IN B-VP O
77 the DT B-NP O
77 last JJ I-NP O
77 month NN I-NP O
77 She PRP O O
77 has VBZ O O
78 no DT B-NP O
78 complaints NNS I-NP O
78 of IN B-VP O
78 dysuria NN B-NP O
78 or CC O O
78 cough JJ B-NP O
79 PHYSICAL NNP I-NP O
79 EXAMINATION: NNP I-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 is VBZ O O
79 a DT B-NP O
79 pleasant JJ I-NP O
79 female NN I-NP O
79 , , O O
79 resting VBG O O
80 comfortably RB O O
80 in IN B-VP O
80 bed NN B-NP O
80 Her PRP$ O O
80 temperature NN B-NP O
80 was VBD B-VP O
81 98.5 CD O O
81 , , O O
81 blood NN B-NP O
81 pressure NN I-NP O
81 156/68 CD O O
81 , , O O
81 pulse RB O O
81 78 CD O O
81 , , O O
81 respirations NNS B-NP O
81 20 CD O O
81 , , O O
81 and CC O O
81 95% CD O O
81 on IN B-VP O
82 two CD O O
82 liters NNS B-NP O
82 There EX O O
82 was VBD B-VP O
82 no DT B-NP O
82 JVD NNP I-NP O
82 Carotids NNP I-NP O
82 were VBD B-VP O
82 1+ CD O O
82 without IN B-VP O
82 bruits NNS B-NP O
82 , , O O
82 no DT B-NP O
83 thyromegaly NN I-NP O
83 , , O O
83 and CC O O
83 no DT B-NP O
83 lymphadenopathy JJ I-NP O
83 Lungs NNS I-NP O
83 revealed VBD B-VP O
83 right JJ B-NP O
83 basilar NN I-NP O
84 crackles NNS I-NP O
84 She PRP O O
84 was VBD B-VP O
84 using VBG O O
84 accessory JJ B-NP O
84 muscles NNS I-NP O
84 for IN B-VP O
84 respirations NNS B-NP O
84 Heart NNP I-NP O
85 revealed VBD B-VP O
85 regular JJ B-NP O
85 rate NN I-NP O
85 and CC O O
85 rhythm NN B-NP O
85 , , O O
85 normal JJ B-NP O
85 S1 NNP I-NP O
85 and CC O O
85 S2 NNP B-NP O
85 There EX O O
85 was VBD B-VP O
85 a DT B-NP O
86 II-III/VI JJ I-NP O
86 systolic JJ I-NP O
86 ejection NN I-NP O
86 murmur NN I-NP O
86 at IN B-VP O
86 the DT B-NP O
86 LSB NNP I-NP O
86 There EX O O
86 was VBD B-VP O
86 a DT B-NP O
86 III/VI NNP I-NP O
87 holosystolic JJ B-NP O
87 murmur NN I-NP O
87 at IN B-VP O
87 the DT B-NP O
87 apex NN I-NP O
87 radiating VBG O O
87 to TO O O
87 the DT B-NP O
87 axilla NN I-NP O
87 There EX O O
87 was VBD B-VP O
88 no DT B-NP O
88 S3 NNP I-NP O
88 or CC O O
88 S4 NNP B-NP O
88 Her NNP I-NP O
88 abdomen NN I-NP O
88 was VBD B-VP O
88 slightly RB O O
88 distended VBN O O
88 with IN B-VP O
88 no DT B-NP O
89 hepatosplenomegaly NN I-NP O
89 She PRP O O
89 was VBD B-VP O
89 guaiac JJ O O
89 negative JJ O O
89 She PRP O O
89 had VBD B-VP O
89 2+ CD O O
89 femoral JJ B-NP O
90 pulses NNS I-NP O
90 bilaterally RB O O
90 without IN B-VP O
90 bruits NNS B-NP O
90 and CC O O
90 2+ CD O O
90 DP NNP B-NP O
90 pulses NNS I-NP O
90 bilaterally RB O O
91 There EX O O
91 was VBD B-VP O
91 no DT O O
91 ankle JJ O O
91 edema RB O O
91 Neurological JJ B-NP O
91 examination NN I-NP O
91 was VBD B-VP O
91 grossly RB O O
92 intact JJ B-NP O
93 LABORATORY NNP I-NP O
93 DATA: NNP I-NP O
93 BUN NNP I-NP O
93 was VBD B-VP O
93 59 CD O O
93 , , O O
93 creatinine NN B-NP O
93 3.9 CD O O
93 , , O O
93 hematocrit NN B-NP O
93 28.9 CD O O
93 , , O O
93 and CC O O
94 MCV NNP B-NP O
94 82.3 CD O O
94 Magnesium NNP B-NP O
94 was VBD B-VP O
94 2.4 CD O O
94 Chest NNP B-NP O
94 x-ray NN I-NP O
94 from IN B-VP O
95 outside JJ B-NP O
95 hospital NN I-NP O
95 was VBD B-VP O
95 consistent JJ O O
95 with IN B-VP O
95 pulmonary JJ B-NP O
95 edema NN I-NP O
95 EKG NNP I-NP O
95 revealed VBD B-VP O
96 normal JJ B-NP O
96 sinus NN I-NP O
96 rhythm NN I-NP O
96 at IN B-VP O
96 81 CD O O
96 , , O O
96 normal JJ B-NP O
96 axis NN I-NP O
96 and CC O O
96 intervals NNS B-NP O
96 ( ( O O
96 QT NNP B-NP O
96 slightly RB O O
97 increased VBD B-VP O
97 at IN B-VP O
97 0.46 CD O O
97 ) ) O O
97 , , O O
97 LVH NNP B-NP O
97 , , O O
97 LAE NNP B-NP O
97 There EX O O
97 was VBD B-VP O
97 T NNP B-NP O
97 flattening VBG O O
97 in IN B-VP O
97 AVL NNP B-NP O
98 There EX O O
98 were VBD B-VP O
98 no DT B-NP O
98 acute JJ I-NP O
98 ST NNP I-NP O
98 or CC O O
98 T NNP B-NP O
98 wave VBP O O
98 changes NNS B-NP O
99 HOSPITAL NNP I-NP O
99 COURSE: NNP I-NP O
100 1 CD O O
100 CONGESTIVE NNP B-NP O
100 HEART NNP I-NP O
100 FAILURE: NNP I-NP O
100 The DT B-NP O
100 patient NN I-NP O
100 was VBD B-VP O
100 much RB O O
100 improved VBN O O
100 after IN B-VP O
101 successful JJ B-NP O
101 diuresis NN I-NP O
101 with IN B-VP O
101 improvement NN B-NP O
102 of IN B-VP O
102 her PRP$ O O
102 pulmonary JJ B-NP O
102 examination NN I-NP O
102 and CC O O
102 no DT B-NP O
102 evidence NN I-NP O
102 of IN B-VP O
102 right NN B-NP O
102 sided VBN O O
103 failure NN B-NP O
103 She PRP O O
103 was VBD B-VP O
103 saturating VBG O O
103 well RB O O
103 on IN B-VP O
103 room NN B-NP O
103 air NN I-NP O
103 Care NNP I-NP O
103 was VBD B-VP O
103 taken VBN O O
103 to TO O O
104 diurese JJ O O
104 slowly RB O O
104 in IN B-VP O
104 order NN B-NP O
104 to TO O O
104 present VB O O
104 a DT B-NP O
104 prerenal JJ I-NP O
104 insult NN I-NP O
104 She PRP O O
104 remained VBD B-VP O
105 symptom JJ O O
105 free JJ O O
105 for IN B-VP O
105 the DT B-NP O
105 duration NN I-NP O
105 of IN B-VP O
105 her PRP$ O O
105 hospital JJ B-NP O
105 course NN I-NP O
106 2 CD O O
106 CORONARY NNP B-NP O
106 ARTERY NNP I-NP O
106 DISEASE: NNP I-NP O
106 The DT B-NP O
106 patient NN I-NP O
106 denies VBZ O O
106 ever RB O O
106 having VBG O O
106 had VBD B-VP O
106 any DT B-NP O
107 chest JJS I-NP O
107 pain NN I-NP O
107 , , O O
107 but CC O O
107 had VBD B-VP O
107 known VBN O O
107 anatomy NN B-NP O
107 with IN B-VP O
107 single JJ B-NP O
107 vessel NN I-NP O
107 disease NN I-NP O
107 ( ( O O
107 RCA NNP B-NP O
107 ) ) O O
108 Her PRP$ O O
108 history NN B-NP O
108 is VBZ O O
108 suggestive JJ O O
108 of IN B-VP O
108 possible JJ B-NP O
108 silent JJ I-NP O
108 ischemia NN I-NP O
108 consistent NN I-NP O
109 with IN B-VP O
109 her PRP$ O O
109 diabetic JJ B-NP O
109 status NN I-NP O
109 Her NNP I-NP O
109 anginal JJ B-NP O
109 equivalent NN I-NP O
109 appears VBZ O O
109 to TO O O
109 be VB O O
110 shortness NN B-NP O
110 of IN B-VP O
110 breath NN B-NP O
110 The DT B-NP O
110 patient JJ I-NP O
110 underwent JJ I-NP O
110 cardiac JJ I-NP O
110 catheterization NN I-NP O
111 on IN B-VP O
111 11/4/97 CD O O
111 with IN B-VP O
111 PTCA NNP B-NP O
111 plus CC O O
111 stent JJ B-NP O
111 placement NN I-NP O
111 to TO O O
111 her PRP$ O O
111 RCA NNP B-NP O
111 with IN B-VP O
111 a DT B-NP O
111 good JJ I-NP O
112 result NN I-NP O
112 She PRP O O
112 is VBZ O O
112 on IN B-VP O
112 Ticlid NNP B-NP B-m
112 for IN B-VP B-du
112 two CD O I-du
112 weeks NNS B-NP I-du
112 Her PRP$ O O
112 blood NN B-NP O
112 pressure NN I-NP O
112 was VBD B-VP O
113 well RB O O
113 controlled VBN O O
113 in IN B-VP O
113 her PRP$ O O
113 target NN B-NP O
113 range NN I-NP O
113 of IN B-VP O
113 140-160 JJ B-NP O
113 systolic JJ I-NP B-r
113 systolic JJ I-NP B-r
113 systolic JJ I-NP B-r
113 blood NN I-NP O
114 pressure NN I-NP O
114 on IN B-VP O
114 hydralazine NN B-NP B-m
114 , , O O
114 Lasix NNP B-NP B-m
114 , , O O
114 and CC O O
114 Lopressor NNP B-NP B-m
114 The DT B-NP O
114 day NN I-NP O
114 following VBG O O
115 cardiac JJ B-NP O
115 catheterization NN I-NP O
115 , , O O
115 her PRP$ O O
115 hematocrit NN B-NP O
115 and CC O O
115 creatinine NN B-NP O
115 remained VBD B-VP O
116 stable JJ O O
116 at IN B-VP O
116 30.9 CD O O
116 and CC O O
116 3.7 CD O O
116 , , O O
116 respectively RB O O
116 On IN B-VP O
116 0/9/97 CD O O
116 , , O O
116 her PRP$ O O
116 creatinine NN B-NP O
117 increased VBD B-VP O
117 to TO O O
117 4.2 CD O O
117 This DT B-NP O
117 increase NN I-NP O
117 was VBD B-VP O
117 thought VBN O O
117 to TO O O
117 be VB O O
117 due JJ O O
117 to TO O O
117 a DT B-NP O
118 combination NN I-NP O
118 of IN B-VP O
118 prerenal JJ B-NP O
118 insult NN I-NP O
118 in IN B-VP O
118 addition NN B-NP O
118 to TO O O
118 possible JJ O O
119 dinephropathy JJ O O
119 She PRP O O
119 was VBD B-VP O
119 hydrated VBN O O
119 gently RB O O
119 and CC O O
119 her PRP$ O O
119 creatinine NN B-NP O
119 was VBD B-VP O
120 watched VBN O O
120 for IN B-VP O
120 the DT O O
120 next JJ O O
120 two CD O O
120 days NNS B-NP O
120 , , O O
120 stabilizing VBG O O
120 in IN B-VP O
120 the DT O O
120 4.4 CD O O
120 to TO O O
120 4.5 CD O O
120 range NN B-NP O
121 3 CD O O
121 CHRONIC NNP B-NP O
121 RENAL NNP I-NP O
121 INSUFFICIENCY: NNP I-NP O
121 Etiology NNP I-NP O
121 was VBD B-VP O
121 unknown JJ O O
121 , , O O
121 possibly RB O O
122 secondary JJ O O
122 to TO O O
122 diabetes VB O O
122 mellitus NN B-NP O
122 or CC O O
122 hypertensive JJ O O
122 nephropathy JJ O O
122 She PRP O O
123 has VBZ O O
123 history NN B-NP O
123 of IN B-VP O
123 creatinine NN B-NP O
123 rises NNS I-NP O
123 to TO O O
123 high JJ O O
123 3s CD O O
123 and CC O O
123 4s CD O O
123 during IN B-VP O
123 recent JJ B-NP O
124 hospitalizations NNS I-NP O
124 Hospital NNP I-NP O
124 course NN I-NP O
124 is VBZ O O
124 as IN B-VP O
124 described VBN O O
124 above IN B-VP O
124 In IN B-VP O
125 addition NN B-NP O
125 , , O O
125 Axid NNP B-NP B-m
125 was VBD B-VP O
125 changed VBN O O
125 to TO O O
125 renal VB O B-do
125 dosing NN B-NP I-do
125 ( ( O O
125 q.day JJ O B-f
125 ) ) O O
125 and CC O O
125 the DT B-NP O
125 patient NN I-NP O
126 was VBD B-VP O
126 treated VBN O O
126 for IN B-VP O
126 a DT B-NP O
126 urinary JJ I-NP O
126 tract NN I-NP O
126 infection NN I-NP O
126 In IN B-VP O
126 reviewing VBG O O
126 the DT B-NP O
127 hospital NN I-NP O
127 records NNS I-NP O
127 , , O O
127 there EX O O
127 is VBZ O O
127 no DT B-NP O
127 evidence NN I-NP O
127 of IN B-VP O
127 previous JJ B-NP O
127 work NN I-NP O
127 up RB O O
127 for IN B-VP O
128 renal JJ B-NP O
128 artery NN I-NP O
128 stenosis NN I-NP O
128 This DT B-NP O
128 patient NN I-NP O
128 with IN B-VP O
128 history NN B-NP O
128 and CC O O
128 physical JJ O O
128 to TO O O
129 control VB O O
129 blood NN B-NP O
129 pressures NNS I-NP O
129 and CC O O
129 flash JJ B-NP O
129 pulmonary JJ I-NP O
129 edema NN I-NP O
129 in IN B-VP O
129 the DT B-NP O
129 setting NN I-NP O
129 of IN B-VP O
130 hypertension NN B-NP O
130 may MD O O
130 benefit VB O O
130 from IN B-VP O
130 further JJ B-NP O
130 evaluation NN I-NP O
130 of IN B-VP O
130 possible JJ B-NP O
130 renal JJ I-NP O
131 artery NN I-NP O
131 stenosis NN I-NP O
131 This DT B-NP O
131 work NN I-NP O
131 up RB O O
131 was VBD B-VP O
131 deferred VBN O O
131 during IN B-VP O
131 this DT B-NP O
132 hospitalization NN I-NP O
132 due JJ O O
132 to TO O O
132 management NN B-NP O
132 of IN B-VP O
132 acute NN B-NP O
132 issues NNS I-NP O
133 4 CD O O
133 DIABETES NNP B-NP O
133 MELLITUS: NNP I-NP O
133 This DT O O
133 was VBD B-VP O
133 stable JJ O O
133 , , O O
133 diet JJ O O
133 controlled VBD B-VP O
134 5 CD O O
134 ANEMIA: NNP B-NP O
134 The DT B-NP O
134 patient NN I-NP O
134 was VBD B-VP O
134 worked VBN O O
134 up RP O O
134 for IN B-VP O
134 her PRP$ O O
134 baseline NN B-NP O
134 low JJ B-NP O
135 hematocrit NN I-NP O
135 , , O O
135 found VBN O O
135 to TO O O
135 have VB O O
135 an DT B-NP B-r
135 iron NN I-NP I-r
135 deficiency NN I-NP I-r
135 anemia NN I-NP I-r
135 treated VBN O O
135 with IN B-VP O
136 Niferex NNP B-NP B-m
136 150 CD O B-do
136 mg NN B-NP I-do
136 p.o NN I-NP B-mo
136 b.i.d NN I-NP B-f
136 Given NNP I-NP O
136 her PRP$ O O
136 underlying JJ B-NP O
136 renal JJ I-NP O
136 failure NN I-NP O
136 , , O O
137 there EX O O
137 may MD O O
137 also RB O O
137 be VB O O
137 a DT O O
137 renally RB O O
137 driven JJ B-NP O
137 component NN I-NP O
137 to TO O O
137 her PRP$ O B-r
137 anemia NN B-NP I-r
137 and CC O O
137 she PRP O O
138 may MD O O
138 benefit VB O O
138 from IN B-VP O
138 Epogen NNP B-NP B-m
138 as IN B-VP O
138 an DT B-NP O
138 outpatient NN I-NP O
139 The DT B-NP O
139 patient NN I-NP O
139 was VBD B-VP O
139 discharged VBN O O
139 to TO O O
139 home NN B-NP O
139 in IN B-VP O
139 stable JJ B-NP O
139 condition NN I-NP O
139 to TO O O
139 follow VB O O
139 up RP O O
140 with IN B-VP O
140 Dr NNP B-NP O
140 Andre NNP I-NP O
140 Smithe NNP I-NP O
140 , , O O
140 her PRP$ O O
140 cardiologist NN B-NP O
140 , , O O
140 in IN B-VP O
140 two CD O O
140 weeks NNS B-NP O
140 , , O O
140 and CC O O
140 her PRP$ O O
141 primary JJ B-NP O
141 care NN I-NP O
141 physician NN I-NP O
141 in IN B-VP O
141 one CD O O
141 week NN B-NP O
141 based VBN O O
141 on IN B-VP O
141 previously RB O O
141 scheduled VBN O O
142 appointment NN B-NP O
143 DISCHARGE NNP I-NP O
143 MEDICATIONS: NNP I-NP O
143 Enteric NNP I-NP B-m
143 coated VBD B-VP I-m
143 aspirin RB O I-m
143 325 CD O B-do
143 mg NNS B-NP I-do
143 p.o JJ B-NP B-mo
143 q.day NN I-NP B-f
143 , , O O
144 Lasix NNP B-NP B-m
144 40 CD O B-do
144 mg NN B-NP I-do
144 p.o NN I-NP B-mo
144 q.day NN I-NP B-f
144 , , O O
144 hydralazine VBP O B-m
144 50 CD O B-do
144 mg NN B-NP I-do
145 p.o NN I-NP B-mo
145 q.i.d NN I-NP B-f
145 , , O O
145 Isordil NNP B-NP B-m
145 30 CD O B-do
145 mg NN B-NP I-do
145 p.o NN I-NP B-mo
145 t.i.d NN I-NP B-f
145 , , O O
145 Lopressor NNP B-NP B-m
145 25 CD O B-do
145 mg NN B-NP I-do
145 p.o NN I-NP B-mo
146 b.i.d NN I-NP B-f
146 , , O O
146 nitroglycerin RB O B-m
146 1/150 CD O I-m
146 one CD O B-do
146 tablet NN B-NP I-do
146 sublingual JJ B-NP B-mo
146 q NN I-NP B-f
146 5 CD O O
146 minutes NNS B-NP O
147 times NNS I-NP O
147 three CD O O
147 p.r.n NN B-NP O
147 chest NN I-NP B-r
147 pain NN I-NP I-r
147 , , O O
147 Timoptic NNP B-NP B-m
147 0.25% CD O I-m
147 one CD O B-do
147 drop NN B-NP I-do
147 OU NNP I-NP B-mo
147 b.i.d NN I-NP B-f
147 , , O O
148 Axid NNP B-NP B-m
148 150 CD O B-do
148 mg NN B-NP I-do
148 p.o NN I-NP B-mo
148 q.day NN I-NP B-f
148 , , O O
148 and CC O O
148 Ticlid NNP B-NP B-m
148 250 CD O B-do
148 mg NN B-NP I-do
148 p.o NN I-NP B-mo
148 b.i.d NN I-NP B-f
148 for IN B-VP B-du
148 two CD O O
149 weeks NNS B-NP O
149 Also RB O O
149 , , O O
149 Niferex NNP B-NP B-m
149 tablet VBD B-VP I-m
149 150 CD O B-do
149 mg NN B-NP I-do
149 p.o NN I-NP B-mo
149 b.i.d NN I-NP B-f
150 DISCHARGE NNP I-NP O
150 INSTRUCTIONS: NNP I-NP O
150 The DT B-NP O
150 patient NN I-NP O
150 was VBD B-VP O
150 instructed VBN O O
150 to TO O O
150 have VB O O
150 her PRP$ O O
151 CBC NNP B-NP O
151 checked VBN O O
151 at IN B-VP O
151 two CD O O
151 weeks NNS B-NP O
151 and CC O O
151 four CD O B-du
151 weeks NNS B-NP I-du
152 given VBN O O
152 her PRP$ O O
152 Ticlid NNP B-NP B-m
152 therapy NN I-NP O
153 Dictated NNP I-NP O
153 By: NNP I-NP O
153 LOUIS NNP I-NP O
153 LIEBOLD NNP I-NP O
153 , , O O
153 M.D NNP B-NP O
153 GS15 NNP I-NP O
154 Attending: NNP I-NP O
154 REFUGIO NNP I-NP O
154 J NNP I-NP O
154 HASSELL NNP I-NP O
154 , , O O
154 M.D NNP B-NP O
154 HA40 NNP I-NP O
155 MR501/7465 NNP I-NP O
156 Batch: NNP I-NP O
156 37548 CD O O
156 Index NNP B-NP O
156 No NNP I-NP O
156 O1EZ468S7B NNP I-NP O
156 D: NNP I-NP O
156 2/5/97 CD O O
157 T: NNP B-NP O
157 10/24/97 CD O O
158 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #456469 VBZ O O
4 608189475 CD O O
4 BMH NNP B-NP O
4 63257078 CD O O
4 0048321 CD O O
4 1/21/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CORONARY NNP I-NP O
4 ARTERY NNP I-NP O
4 DISEASE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/24/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/8/2006 CD O O
7 Date NNP B-NP O
7 of IN B-VP O
7 Admission: NNP B-NP O
7 7/24/2006 CD O O
8 ATTENDING: NNP B-NP O
8 LUY NNP I-NP O
8 , , O O
8 GENE NNP B-NP O
8 MD NNP I-NP O
9 SERVICE: NNP I-NP O
9 Cardiac NNP I-NP O
9 Surgery NNP I-NP O
9 Service NNP I-NP O
10 This DT O O
10 is VBZ O O
10 a DT B-NP O
10 discharge NN I-NP O
10 summary JJ B-NP O
10 addendum NN I-NP O
10 to TO O O
10 the DT O O
10 previously RB O O
10 dictated VBN O O
11 note NN B-NP O
11 by IN B-VP O
11 Neville NNP B-NP O
11 Mastenbrook NNP I-NP O
11 , , O O
11 dictated VBD B-VP O
11 on IN B-VP O
11 7/20/06 CD O O
12 HOSPITAL NNP B-NP O
12 COURSE: NNP I-NP O
12 Mr NNP I-NP O
12 Timbers NNP I-NP O
12 had VBD B-VP O
12 been VBN O O
12 prepared VBN O O
12 for IN B-VP O
12 discharge NN B-NP O
13 on IN B-VP O
13 postoperative JJ B-NP O
13 day NN I-NP O
13 five CD O O
13 , , O O
13 10/28/06 CD O O
13 , , O O
13 however RB O O
13 , , O O
13 was VBD B-VP O
13 noted VBN O O
13 to TO O O
14 complain VB O O
14 of IN B-VP O
14 left JJ B-NP O
14 lower JJR I-NP O
14 extremity NN I-NP O
14 tenderness NN I-NP O
14 and CC O O
14 erythema JJ B-NP O
14 White NNP I-NP O
15 blood NN I-NP O
15 cell NN I-NP O
15 count NN I-NP O
15 at IN B-VP O
15 that DT B-NP O
15 time NN I-NP O
15 was VBD B-VP O
15 noted VBN O O
15 to TO O O
15 be VB O O
15 8.9 CD O O
15 with IN B-VP O
15 the DT B-NP O
16 patient NN I-NP O
16 afebrile IN B-VP O
16 He PRP O O
16 otherwise RB O O
16 remained VBD B-VP O
16 hemodynamically RB O O
16 stable JJ O O
17 in IN B-VP O
17 normal JJ B-NP O
17 sinus NN I-NP O
17 with IN B-VP O
17 stable JJ B-NP O
17 blood NN I-NP O
17 pressure NN I-NP O
17 and CC O O
17 creatinine NN B-NP O
17 of IN B-VP O
17 1.1 CD O O
18 On IN B-VP O
18 postoperative JJ B-NP O
18 day NN I-NP O
18 6 CD O O
18 , , O O
18 7/9/06 CD O O
18 , , O O
18 white JJ B-NP O
18 blood NN I-NP O
18 count NN I-NP O
18 was VBD B-VP O
19 increased VBN O O
19 at IN B-VP O
19 11.7 CD O O
19 with IN B-VP O
19 the DT B-NP O
19 left NN I-NP O
19 lower JJR B-NP O
19 extremity NN I-NP O
19 increasingly RB O O
20 erythematous JJ O O
20 and CC O O
20 tender NN B-NP O
20 SVG NNP I-NP O
20 tract NN I-NP O
20 was VBD B-VP O
20 noted VBN O O
20 to TO O O
20 contain VB O O
20 only RB O O
21 minimal JJ B-NP O
21 fluid NN I-NP O
21 Negative NNP I-NP O
21 Homans' NNP I-NP O
21 sign NN I-NP O
21 was VBD B-VP O
21 observed VBN O O
21 with IN B-VP O
21 the DT B-NP O
22 patient NN I-NP O
22 demonstrating VBG O O
22 no DT B-NP O
22 calf NN I-NP O
22 tenderness NN I-NP O
22 on IN B-VP O
22 palpation NN B-NP O
22 The DT B-NP O
23 patient NN I-NP O
23 continued VBD B-VP O
23 to TO O O
23 remain VB O O
23 afebrile IN B-VP O
23 A DT B-NP O
23 course NN I-NP O
23 of IN B-VP O
23 Keflex NNP B-NP B-m
23 was VBD B-VP O
24 commenced VBN O O
24 on IN B-VP O
24 postoperative JJ B-NP O
24 day NN I-NP O
24 seven CD O O
24 , , O O
24 with IN B-VP O
24 the DT B-NP O
24 patient's JJ I-NP O
24 white JJ I-NP O
25 count NN I-NP O
25 increasing VBG O O
25 to TO O O
25 12.1 CD O O
25 with IN B-VP O
25 the DT B-NP O
25 patient NN I-NP O
25 now RB O O
25 demonstrating VBG O O
26 continued VBN O O
26 increase NN B-NP O
26 in IN B-VP O
26 erythema NN B-NP O
26 and CC O O
26 warmth NN B-NP O
26 along IN B-VP O
26 the DT B-NP O
26 left NN I-NP O
26 lower JJR B-NP O
27 extremity NN I-NP O
27 at IN B-VP O
27 SVG NNP B-NP O
27 harvest JJS B-NP O
27 site NN I-NP O
27 incision NN I-NP O
27 , , O O
27 particularly RB O O
27 distal JJ O O
27 to TO O O
28 the DT B-NP O
28 knee NN I-NP O
28 Additionally NNP I-NP O
28 , , O O
28 of IN B-VP O
28 note NN B-NP O
28 , , O O
28 Mr NNP B-NP O
28 Hovenga NNP I-NP O
28 's POS O O
28 Toprol NNP B-NP B-m
28 was VBD B-VP O
29 increased VBN O O
29 to TO O O
29 150 CD O B-do
29 mg NNS B-NP I-do
29 p.o JJ O B-mo
29 daily RB O B-f
29 with IN B-VP O
29 an DT O O
29 extra JJ O O
29 2 CD O B-do
29 mg NN B-NP I-do
29 of IN B-VP O
29 magnesium NN B-NP B-m
30 administered VBN O O
30 on IN B-VP O
30 postoperative JJ B-NP O
30 day NN I-NP O
30 seven CD O O
30 for IN B-VP O
30 sinus NN B-NP O
30 rhythm NN I-NP O
30 in IN B-VP O
30 the DT O O
31 high JJ O O
31 90s CD O O
31 with IN B-VP O
31 blood NN B-NP B-r
31 pressure NN I-NP I-r
31 mildly RB O O
31 hypertensive JJ O O
31 , , O O
31 additionally RB O O
32 with IN B-VP O
32 frequent JJ B-NP O
32 PVCs NNP I-NP O
32 noted VBD B-VP O
32 on IN B-VP O
32 telemetry NN B-NP O
32 Mr NNP I-NP O
32 Notarnicola NNP I-NP O
32 continued VBD B-VP O
32 to TO O O
33 ambulate VB O O
33 well RB O O
33 on IN B-VP O
33 room NN B-NP O
33 air NN I-NP O
33 and CC O O
33 remained VBD B-VP O
33 afebrile JJ B-NP O
33 Leukocytosis NNP I-NP O
34 was VBD B-VP O
34 additionally RB O O
34 worked VBN O O
34 up RP O O
34 with IN B-VP O
34 urinalysis NN B-NP O
34 and CC O O
34 chest JJS B-NP O
34 X-Ray NN I-NP O
34 , , O O
35 which WDT O O
35 subsequently RB O O
35 demonstrated VBD B-VP O
35 no DT B-NP O
35 infection NN I-NP O
35 or CC O O
35 infiltrate VB O O
35 Mr NNP B-NP O
36 Sermersheim NNP I-NP O
36 is VBZ O O
36 discharged VBN O O
36 to TO O O
36 rehabilitation VB O O
36 today NN B-NP O
36 , , O O
36 postoperative JJ B-NP O
36 day NN I-NP O
37 eight CD O O
37 , , O O
37 having VBG O O
37 recovered VBN O O
37 well RB O O
37 following VBG O O
37 his PRP$ O O
37 elective JJ B-NP O
37 coronary JJ I-NP O
38 artery NN I-NP O
38 bypass NN I-NP O
38 graft NN I-NP O
38 procedure NN I-NP O
38 , , O O
38 hemodynamically RB O O
38 stable JJ O O
38 with IN B-VP O
38 left JJ B-NP B-r
39 lower JJR I-NP O
39 extremity NN I-NP O
39 erythema NN I-NP O
39 and CC O O
39 tenderness NN B-NP O
39 significantly RB O O
39 improved VBD B-VP O
40 24 CD O O
40 hours NNS B-NP O
40 following VBG O O
40 initiation NN B-NP O
40 of IN B-VP O
40 Keflex NNP B-NP B-m
40 course NN I-NP O
40 White NNP I-NP O
40 blood NN I-NP O
40 cell NN I-NP O
41 count NN I-NP O
41 on IN B-VP O
41 the DT B-NP O
41 day NN I-NP O
41 of IN B-VP O
41 discharge NN B-NP O
41 has VBZ O O
41 improved VBN O O
41 to TO O O
41 11.2 CD O O
41 with IN B-VP O
41 the DT B-NP O
41 patient NN I-NP O
42 remaining VBG O O
42 afebrile JJ B-NP O
43 PHYSICAL NNP I-NP O
43 EXAMINATION: NNP I-NP O
43 On IN B-VP O
43 day NN B-NP O
43 of IN B-VP O
43 discharge NN B-NP O
43 , , O O
43 the DT B-NP O
43 patient NN I-NP O
43 is VBZ O O
43 a DT B-NP O
44 pleasant JJ I-NP O
44 male NN I-NP O
44 , , O O
44 appearing VBG O O
44 younger JJR O O
44 than IN B-VP O
44 stated VBN O O
44 age NN B-NP O
44 , , O O
44 alert NN B-NP O
44 and CC O O
45 oriented VBN O O
45 x3 NN B-NP O
45 in IN B-VP O
45 no DT B-NP O
45 acute NN I-NP O
45 distress NN I-NP O
45 Vital NNP I-NP O
45 signs NNS I-NP O
45 are VBP O O
45 as IN B-VP O
45 follows: JJ B-NP O
46 temperature NN I-NP O
46 99.5 CD O O
46 degrees NNS B-NP O
46 Fahrenheit NNP I-NP O
46 , , O O
46 heart NN B-NP O
46 rate NN I-NP O
46 80 CD O O
46 , , O O
46 sinus NN B-NP O
46 rhythm NN I-NP O
46 , , O O
47 blood NN B-NP O
47 pressure NN I-NP O
47 118/60 CD O O
47 , , O O
47 and CC O O
47 oxygen NN B-NP O
47 saturation NN I-NP O
47 100% CD O O
47 on IN B-VP O
47 room NN B-NP O
47 air NN I-NP O
48 Today's NNP I-NP O
48 weight NN I-NP O
48 listed VBD B-VP O
48 as IN B-VP O
48 0.7 CD O O
48 kilograms NNS B-NP O
48 above IN B-VP O
48 his PRP$ O O
48 preoperative JJ B-NP O
49 weight NN I-NP O
49 ( ( O O
49 preoperative JJ B-NP O
49 weight NN I-NP O
49 listed VBN O O
49 as IN B-VP O
49 87.3 CD O O
49 kilograms NNS B-NP O
49 ) ) O O
49 HEENT: VBP O O
49 no DT B-NP O
50 carotid NN I-NP O
50 bruits VBZ O O
50 or CC O O
50 JVD NNP B-NP O
50 is VBZ O O
50 appreciated VBN O O
50 Pulmonary: NNP B-NP O
50 lungs NNS I-NP O
50 are VBP O O
50 clear JJ O O
51 to TO O O
51 auscultation VB O O
51 bilaterally RB O O
51 with IN B-VP O
51 slightly RB O O
51 diminished VBN O O
51 breath NN B-NP O
52 sounds NNS I-NP O
52 at IN B-VP O
52 left JJ B-NP O
52 base NN I-NP O
52 Coronary: NNP I-NP O
52 regular JJ B-NP O
52 rate NN I-NP O
52 and CC O O
52 rhythm NN B-NP O
52 , , O O
52 normal JJ B-NP O
53 S1 NNP I-NP O
53 and CC O O
53 S2 NNP B-NP O
53 , , O O
53 no DT B-NP O
53 murmurs NN I-NP O
53 , , O O
53 rubs NN B-NP O
53 , , O O
53 or CC O O
53 gallops NNS B-NP O
53 are VBP O O
53 appreciated VBN O O
53 Abdomen: NNP B-NP O
54 slightly RB O O
54 distended VBD B-VP O
54 , , O O
54 mildly RB O O
54 obese JJ O O
54 , , O O
54 soft JJ O O
54 , , O O
54 nontender NN B-NP O
54 , , O O
54 and CC O O
55 nondistended VBD B-VP O
55 , , O O
55 positive JJ B-NP O
55 bowel NN I-NP O
55 sounds VBZ O O
55 Extremities: NNP B-NP O
55 trace NN I-NP O
56 bilateral JJ B-NP O
56 lower JJR I-NP O
56 extremity NN I-NP O
56 edema NN I-NP O
56 Skin: NNP I-NP O
56 midline NN I-NP O
56 sternotomy NN I-NP O
57 incision NN I-NP O
57 , , O O
57 well RB O O
57 approximated VBN O O
57 and CC O O
57 healing VBG O O
57 well RB O O
57 , , O O
57 with IN B-VP O
57 no DT B-NP O
57 erythema NN I-NP O
57 or CC O O
58 drainage VB O O
58 present JJ B-NP O
58 No NNP I-NP O
58 sternal NN I-NP O
58 click NN I-NP O
58 is VBZ O O
58 elicited VBN O O
58 on IN B-VP O
58 examination NN B-NP O
59 Left NNP I-NP O
59 lower JJR B-NP O
59 extremity NN I-NP O
59 thigh NN I-NP O
59 is VBZ O O
59 ecchymotic JJ O O
59 and CC O O
59 tender NN B-NP O
59 , , O O
59 no DT B-NP O
59 drainage NN I-NP O
60 present NN I-NP O
60 from IN B-VP O
60 proximal JJ B-NP O
60 SVG NNP I-NP O
60 harvest JJS B-NP O
60 site NN I-NP O
60 incision NN I-NP O
60 Left NNP I-NP O
60 lower JJR B-NP O
61 extremity NN I-NP O
61 distal NN I-NP O
61 to TO O O
61 SVG NNP B-NP O
61 incision NN I-NP O
61 and CC O O
61 knee NN B-NP O
61 erythematous JJ O O
61 although IN B-VP O
62 improved VBN O O
62 from IN B-VP O
62 prior JJ B-NP O
62 examinations NNS I-NP O
62 with IN B-VP O
62 decreased JJ B-NP O
62 erythema NN I-NP O
62 , , O O
63 warmth NN B-NP O
63 , , O O
63 and CC O O
63 tenderness NN B-NP O
63 along IN B-VP O
63 prior JJ B-NP O
63 SVG NNP I-NP O
63 tract NN I-NP O
63 No NNP I-NP O
63 calf NN I-NP O
63 tenderness NN I-NP O
64 is VBZ O O
64 present JJ O O
64 2+ CD O O
64 pulses NNS B-NP O
64 at IN B-VP O
64 all DT B-NP O
64 extremities NNS I-NP O
64 bilaterally RB O O
64 Neuro: NNP B-NP O
65 intact JJ O O
65 , , O O
65 nonfocal JJ B-NP O
65 examination NN I-NP O
66 LAB NNP I-NP O
66 VALUES NNP I-NP O
66 ON NNP I-NP O
66 DAY NNP I-NP O
66 OF NNP I-NP O
66 DISCHARGE: NNP I-NP O
66 ( ( O O
66 8/1/06 CD O O
66 ) ) O O
66 Sodium NN B-NP O
66 135 CD O O
66 , , O O
66 Potassium NNP B-NP O
67 4.1 CD O O
67 , , O O
67 BUN NNP B-NP O
67 33 CD O O
67 , , O O
67 Creatinine NNP B-NP O
67 1.5 CD O O
67 , , O O
67 Glucose NNP B-NP O
67 79 CD O O
67 , , O O
67 Calcium NNP B-NP O
67 9.0 CD O O
67 , , O O
67 Magnesium NNP B-NP O
68 1.6 CD O O
68 ( ( O O
68 replaced VBN O O
68 ) ) O O
68 , , O O
68 White NNP B-NP O
68 Blood NNP I-NP O
68 Cell NNP I-NP O
68 Count NNP I-NP O
68 11.2 CD O O
68 , , O O
68 Hematocrit NNP B-NP O
68 28.0 CD O O
68 , , O O
69 Platelet NNP B-NP O
69 Count: NNP I-NP O
69 380 CD O O
69 , , O O
69 000 CD O O
69 Microbiology: NNP B-NP O
69 negative JJ O O
69 for IN B-VP O
69 VRE NNP B-NP O
69 and CC O O
69 MRSA NNP B-NP O
70 and CC O O
70 routine JJ B-NP O
70 screening NN I-NP O
70 sent VBD B-VP O
70 on IN B-VP O
70 8/15/06 CD O O
70 Sputum JJ B-NP O
70 culture NN I-NP O
70 was VBD B-VP O
70 negative JJ O O
71 for IN B-VP O
71 growth NN B-NP O
71 ( ( O O
71 sent JJ O O
71 7/9/06 CD O O
71 ) ) O O
71 Repeat NNP B-NP O
71 sputum NN I-NP O
71 and CC O O
71 urine JJ B-NP O
71 cultures NNS I-NP O
72 negative JJ O O
72 for IN B-VP O
72 growth NN B-NP O
72 ( ( O O
72 sent JJ O O
72 1/22/06 CD O O
72 ) ) O O
73 DIAGNOSTIC NNP B-NP O
73 IMAGING: NNP I-NP O
73 Chest NNP I-NP O
73 x-ray JJ B-NP O
73 PA NNP I-NP O
73 and CC O O
73 lateral JJ B-NP O
73 view NN I-NP O
73 obtained VBN O O
73 day NN B-NP O
74 prior RB O O
74 to TO O O
74 discharge VB O O
74 , , O O
74 1/22/06 CD O O
74 , , O O
74 demonstrates VBZ O O
74 bilateral JJ B-NP O
74 small JJ I-NP O
74 pleural JJ I-NP O
75 effusions NNS I-NP O
75 , , O O
75 no DT B-NP O
75 pulmonary JJ I-NP O
75 edema NN I-NP O
75 present NN I-NP O
75 , , O O
75 and CC O O
75 calcified VBD B-VP O
75 granuloma NN B-NP O
76 present NN I-NP O
76 left VBD B-VP O
76 upper JJ B-NP O
76 lobe NN I-NP O
76 unchanged JJ O O
76 from IN B-VP O
76 prior JJ B-NP O
76 postoperative NN I-NP O
76 and CC O O
77 preoperative JJ B-NP O
77 films NNS I-NP O
77 , , O O
77 no DT B-NP O
77 pneumothorax NN I-NP O
77 or CC O O
77 infiltrate VB O O
77 present JJ B-NP O
78 Stable JJ I-NP O
78 cardiomediastinal JJ I-NP O
78 silhouette NN I-NP O
78 and CC O O
78 no DT B-NP O
78 infiltrate JJ I-NP O
78 present JJ I-NP O
79 DISPOSITION: NNP I-NP O
79 Mr NNP I-NP O
79 Neth NNP I-NP O
79 is VBZ O O
79 discharged VBN O O
79 to TO O O
79 rehabilitation VB O O
79 today NN B-NP O
80 having VBG O O
80 recovered VBN O O
80 well RB O O
80 following VBG O O
80 his PRP$ O O
80 elective JJ B-NP O
80 CABG NNP I-NP O
80 procedure NN I-NP O
80 Mr NNP I-NP O
81 Marcusen NNP I-NP O
81 is VBZ O O
81 discharged VBN O O
81 to TO O O
81 rehabilitation VB O O
81 today NN B-NP O
81 , , O O
81 postoperative JJ B-NP O
81 day NN I-NP O
82 eight CD O O
82 , , O O
82 hemodynamically RB O O
82 stable JJ O O
82 , , O O
82 to TO O O
82 continue VB O O
82 a DT B-NP O
82 course NN I-NP O
82 of IN B-VP O
82 Keflex NNP B-NP B-m
82 for IN B-VP O
83 left VBD B-VP B-r
83 lower JJR B-NP I-r
83 extremity NN I-NP I-r
83 erythema NN I-NP I-r
83 and CC O O
83 additionally RB O O
83 to TO O O
83 continue VB O O
83 one CD O B-du
84 week NN B-NP O
84 of IN B-VP O
84 diuresis NN B-NP O
84 in IN B-VP O
84 the DT B-NP O
84 form NN I-NP O
84 of IN B-VP O
84 low JJ B-NP B-do
84 dose JJ I-NP I-do
84 Lasix NNP I-NP B-m
84 for IN B-VP O
84 mild JJ B-NP B-r
84 persistent JJ I-NP O
85 postoperative JJ I-NP O
85 pulmonary JJ I-NP O
85 effusions NNS I-NP O
85 Mr NNP I-NP O
85 Brannigan NNP I-NP O
85 has VBZ O O
85 been VBN O O
86 instructed VBN O O
86 to TO O O
86 shower VB O O
86 and CC O O
86 monitor VB O O
86 incisions NNS B-NP O
86 for IN B-VP O
86 signs NNS B-NP O
86 of IN B-VP O
86 increasing VBG O O
87 infection NN B-NP O
87 such JJ O O
87 as IN B-VP O
87 fever NN B-NP O
87 , , O O
87 drainage NN B-NP O
87 , , O O
87 worsening VBG O O
87 pain NN B-NP O
87 or CC O O
87 increase NN B-NP O
87 in IN B-VP O
88 redness NN B-NP O
88 He PRP O O
88 is VBZ O O
88 to TO O O
88 follow VB O O
88 up RP O O
88 with IN B-VP O
88 his PRP$ O O
88 primary JJ B-NP O
88 care NN I-NP O
88 physician NN I-NP O
88 for IN B-VP O
89 continued JJ B-NP O
89 evaluation NN I-NP O
89 and CC O O
89 management NN B-NP O
89 of IN B-VP O
89 hypertension NN B-NP O
89 , , O O
89 dyslipidemia NN B-NP O
89 , , O O
90 obesity NN B-NP O
90 , , O O
90 obstructive JJ B-NP O
90 sleep NN I-NP O
90 apnea NN I-NP O
90 , , O O
90 and CC O O
90 uncontrolled VBD B-VP O
90 Type NNP B-NP O
90 II NNP I-NP O
90 diabetes VBZ O O
91 mellitus FW O O
91 Additionally RB O O
91 , , O O
91 the DT B-NP O
91 patient NN I-NP O
91 will MD O O
91 follow VB O O
91 up RP O O
91 with IN B-VP O
91 his PRP$ O O
92 cardiologist NN B-NP O
92 for IN B-VP O
92 continued JJ B-NP O
92 evaluation NN I-NP O
92 and CC O O
92 management NN B-NP O
92 of IN B-VP O
92 blood NN B-NP O
93 pressure NN I-NP O
93 , , O O
93 heart NN B-NP O
93 rate NN I-NP O
93 , , O O
93 heart NN B-NP O
93 rhythm NN I-NP O
93 , , O O
93 lipid JJ B-NP O
93 levels NNS I-NP O
93 , , O O
93 and CC O O
93 for IN B-VP O
93 possible JJ B-NP O
94 future JJ I-NP O
94 adjustment NN I-NP O
94 in IN B-VP O
94 medication NN B-NP B-m
94 Mr NNP I-NP O
94 Connin NNP I-NP O
94 will MD O O
94 follow VB O O
94 up RP O O
94 with IN B-VP O
95 his PRP$ O O
95 cardiac NN B-NP O
95 surgeon NN I-NP O
95 , , O O
95 Dr NNP B-NP O
95 Quinn NNP I-NP O
95 Dalio NNP I-NP O
95 , , O O
95 in IN B-VP O
95 six CD O O
95 to TO O O
95 eight CD O O
95 weeks NNS B-NP O
96 Additionally RB O O
96 , , O O
96 he PRP O O
96 will MD O O
96 follow VB O O
96 up RP O O
96 with IN B-VP O
96 his PRP$ O O
96 cardiologist NN B-NP O
96 , , O O
96 Dr NNP B-NP O
97 Octavio NNP I-NP O
97 Wulffraat NNP I-NP O
97 , , O O
97 in IN B-VP O
97 two CD O O
97 to TO O O
97 four CD O O
97 weeks NNS B-NP O
97 and CC O O
97 with IN B-VP O
97 his PRP$ O O
97 primary JJ B-NP O
97 care NN I-NP O
98 physician NN I-NP O
98 , , O O
98 Dr NNP B-NP O
98 Barrett NNP I-NP O
98 Mittleman NNP I-NP O
98 , , O O
98 in IN B-VP O
98 one CD O O
98 to TO O O
98 two CD O O
98 weeks NNS B-NP O
99 DISCHARGE NNP I-NP O
99 CONDITION: NNP I-NP O
99 Stable NNP I-NP O
100 DISCHARGE NNP I-NP O
100 MEDICATIONS: NNP I-NP O
100 Include NNP I-NP O
100 the DT B-NP O
100 following JJ I-NP O
100 Tylenol NNP I-NP B-m
100 Tylenol NNP I-NP B-m
100 325 CD O B-do
100 325 CD O B-do
100 mg NN B-NP I-do
100 mg NN I-NP I-do
101 p.o NN I-NP B-mo
101 p.o NN I-NP B-mo
101 q.6h NN I-NP B-f
101 q.6h NN I-NP B-f
101 p.r.n NN I-NP I-f
101 p.r.n NN I-NP I-f
101 pain NN I-NP B-r
101 for IN B-VP O
101 temperature NN B-NP B-r
101 greater JJR O O
101 than IN B-VP O
101 101 CD O O
101 degrees NNS B-NP O
102 Fahrenheit NNP I-NP O
102 , , O O
102 amlodipine VBP O B-m
102 5 CD O B-do
102 mg NNS B-NP I-do
102 p.o JJ O B-mo
102 daily RB O B-f
102 , , O O
102 atorvastatin VBD B-VP B-m
102 10 CD O B-do
102 mg NNS B-NP I-do
102 p.o JJ O B-mo
103 daily RB O B-f
103 , , O O
103 captopril VBD B-VP B-m
103 6.25 CD O B-do
103 mg NN B-NP I-do
103 p.o NN I-NP B-mo
103 t.i.d NN I-NP B-f
103 , , O O
103 Keflex NNP B-NP B-m
103 500 CD O B-do
103 mg NN B-NP I-do
103 p.o NN I-NP B-mo
103 q.i.d NN I-NP B-f
104 times NNS I-NP B-du
104 total JJ O I-du
104 of IN B-VP I-du
104 seven CD O I-du
104 days NNS B-NP I-du
104 , , O O
104 last JJ B-NP O
104 dose NN I-NP O
104 on IN B-VP O
104 9/15/06 CD O O
104 , , O O
104 Colace NNP B-NP B-m
104 100 CD O B-do
104 mg NN B-NP I-do
105 p.o NN I-NP B-mo
105 b.i.d NN I-NP B-f
105 p.r.n NN I-NP I-f
105 constipation NN I-NP B-r
105 , , O O
105 enteric-coated JJ B-NP B-m
105 aspirin NN I-NP I-m
105 325 CD O B-do
105 mg NN B-NP I-do
106 p.o JJ O B-mo
106 daily RB O B-f
106 , , O O
106 Lasix NNP B-NP B-m
106 40 CD O B-do
106 mg NN B-NP I-do
106 p.o JJ B-NP B-mo
106 daily JJ I-NP B-f
106 x7 NNP I-NP B-du
106 days NNS I-NP I-du
106 , , O O
106 hydrochlorothiazide JJ O B-m
107 12.5 CD O B-do
107 mg JJ O I-do
107 p.o JJ O B-mo
107 daily JJ O B-f
107 , , O O
107 NovoLog NNP B-NP B-m
107 3 CD O B-do
107 units NNS B-NP I-do
107 subcu JJ B-NP B-mo
107 AC NNP I-NP B-f
107 , , O O
107 Lantus NNP B-NP B-m
107 24 CD O B-do
107 units NNS B-NP I-do
108 subcu VBD B-VP B-mo
108 q RB O B-f
108 10 CD O I-f
108 p.m NN B-NP I-f
108 , , O O
108 hold VBP O O
108 if IN B-VP O
108 n.p.o NNS B-NP O
108 , , O O
108 potassium NN B-NP B-m
108 slow JJ B-NP I-m
108 release NN I-NP I-m
108 20 CD O B-do
108 mEq NN B-NP I-do
109 p.o JJ B-NP B-mo
109 daily JJ I-NP B-f
109 x7 NNP I-NP B-du
109 days NNS I-NP I-du
109 , , O O
109 Toprol-XL JJ O B-m
109 150 CD O B-do
109 mg JJ O I-do
109 p.o JJ O B-mo
109 daily JJ O B-f
109 , , O O
109 Niferex NNP B-NP B-m
109 150 CD O B-do
109 mg NN B-NP I-do
110 p.o NN I-NP B-mo
110 b.i.d NN I-NP B-f
110 , , O O
110 oxycodone RB O B-m
110 5 CD O B-do
110 to TO O I-do
110 10 CD O I-do
110 mg NNS B-NP I-do
110 p.o JJ B-NP B-mo
110 q.4h JJ I-NP B-f
110 p.r.n NN I-NP I-f
110 pain NN I-NP B-r
110 , , O O
110 Ambien NNP B-NP B-m
111 5 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 nightly RB O B-f
111 p.r.n VBZ O I-f
111 insomnia NN B-NP B-r
111 , , O O
111 NovoLog NNP B-NP B-m
111 6 CD O B-do
111 units NNS B-NP I-do
111 subcu VBP O B-mo
111 with IN B-VP B-f
112 breakfast NN B-NP O
112 , , O O
112 hold VBP O O
112 if IN B-VP O
112 n.p.o NNS B-NP O
112 , , O O
112 NovoLog NNP B-NP B-m
112 4 CD O B-do
112 units NNS B-NP I-do
112 subcu VBN O B-mo
112 with IN B-VP B-f
112 lunch NN B-NP I-f
112 , , O O
112 hold VBP O O
113 if IN B-VP O
113 n.p.o NNS B-NP O
113 , , O O
113 NovoLog NNP B-NP B-m
113 4 CD O B-do
113 units NNS B-NP I-do
113 subcu VBN O B-mo
113 with IN B-VP B-f
113 dinner NN B-NP I-f
113 , , O O
113 hold VBP O O
113 if IN B-VP O
113 n.p.o NNS B-NP O
113 , , O O
114 NovoLog NNP B-NP B-m
114 NovoLog NNP I-NP B-m
114 NovoLog NNP I-NP B-m
114 NovoLog NNP I-NP B-m
114 NovoLog NNP I-NP B-m
114 NovoLog NNP I-NP B-m
114 NovoLog NNP I-NP B-m
114 NovoLog NNP I-NP B-m
114 sliding VBG O B-do
114 scale JJ B-NP I-do
114 subcu NN I-NP B-mo
114 AC NNP I-NP B-f
114 , , O O
114 blood NN B-NP B-r
114 sugar NN I-NP I-r
114 less JJR O O
114 than IN B-VP O
114 125 CD O O
114 , , O O
114 give VBP O O
114 0 CD O B-do
115 units NNS B-NP O
115 subcu RB O B-mo
115 , , O O
115 blood NN B-NP B-r
115 sugar NN I-NP I-r
115 125 CD O O
115 to TO O O
115 150 CD O O
115 , , O O
115 give VBP O O
115 2 CD O B-do
115 units NNS B-NP I-do
115 subcu RB O B-mo
115 , , O O
115 blood NN B-NP B-r
116 sugar NN I-NP O
116 151 CD O O
116 to TO O O
116 200 CD O O
116 , , O O
116 give VBP O O
116 3 CD O B-do
116 units NNS B-NP I-do
116 subcu RB O B-mo
116 , , O O
116 blood NN B-NP B-r
116 sugar NN I-NP I-r
116 201 CD O O
116 to TO O O
116 250 CD O O
116 , , O O
117 give VBP O O
117 4 CD O B-do
117 units NNS B-NP I-do
117 subcu RB O B-mo
117 , , O O
117 blood NN B-NP B-r
117 sugar NN I-NP I-r
117 251 CD O O
117 to TO O O
117 300 CD O O
117 , , O O
117 give VBP O O
117 6 CD O B-do
117 units NNS B-NP I-do
117 subcu RB O B-mo
117 , , O O
118 blood NN B-NP B-r
118 sugar NN I-NP I-r
118 301 CD O O
118 to TO O O
118 350 CD O O
118 , , O O
118 give VBP O O
118 8 CD O B-do
118 units NNS B-NP I-do
118 subcu RB O B-mo
118 , , O O
118 if IN B-VP O
118 blood NN B-NP O
118 sugar NN I-NP O
118 351 CD O O
118 to TO O O
119 400 CD O O
119 , , O O
119 give VBP O O
119 10 CD O B-do
119 units NNS B-NP I-do
119 subcu RB O B-mo
119 , , O O
119 call VB O O
119 physician NN B-NP O
119 if IN B-VP O
119 blood NN B-NP O
119 sugar NN I-NP O
119 greater JJR O O
120 than IN B-VP O
120 400 CD O O
120 , , O O
120 NovoLog NNP B-NP B-m
120 sliding VBG O B-do
120 scale JJ B-NP I-do
120 subcu NN I-NP B-mo
120 q.h.s NN I-NP B-f
120 Please NNP I-NP O
120 recheck VB O O
121 fingerstick NN B-NP O
121 in IN B-VP O
121 1 CD O O
121 hour NN B-NP O
121 if IN B-VP O
121 administering VBG O O
121 NovoLog NNP B-NP B-m
121 NovoLog NNP I-NP B-m
121 NovoLog NNP I-NP B-m
121 NovoLog NNP I-NP B-m
121 NovoLog NNP I-NP B-m
121 at IN B-VP B-f
121 at IN B-VP B-f
121 at IN B-VP B-f
121 at IN B-VP B-f
121 at IN B-VP B-f
121 bedtime NN B-NP I-f
121 bedtime NN I-NP I-f
121 bedtime NN I-NP I-f
121 bedtime NN I-NP I-f
121 bedtime NN I-NP I-f
121 , , O O
121 if IN B-VP O
122 blood NN B-NP O
122 sugar NN I-NP O
122 less JJR O O
122 than IN B-VP O
122 200 CD O O
122 , , O O
122 give VBP O O
122 0 CD O B-do
122 units NNS B-NP I-do
122 subcu JJ B-NP B-mo
122 subcu NN I-NP B-mo
122 , , O O
122 if IN B-VP O
122 blood NN B-NP O
122 sugar NN I-NP O
122 201 CD O O
123 to TO O O
123 250 CD O O
123 , , O O
123 give VBP O O
123 2 CD O B-do
123 units NNS B-NP I-do
123 subcu RB O B-mo
123 , , O O
123 blood NN B-NP O
123 sugar NN I-NP O
123 251 CD O O
123 to TO O O
123 300 CD O O
123 , , O O
123 give VBP O O
123 3 CD O B-do
123 units NNS B-NP I-do
124 subcu RB O B-mo
124 , , O O
124 blood NN B-NP O
124 sugar NN I-NP O
124 301 CD O O
124 to TO O O
124 350 CD O O
124 , , O O
124 give VBP O O
124 4 CD O B-do
124 units NNS B-NP I-do
124 subcu RB O B-mo
124 , , O O
124 blood NN B-NP O
124 sugar NN I-NP O
125 351 CD O O
125 to TO O O
125 400 CD O O
125 , , O O
125 give VBP O O
125 5 CD O O
125 units NNS B-NP O
125 subcu RB O O
125 , , O O
125 blood NN B-NP O
125 sugar NN I-NP O
125 greater JJR O O
125 than IN B-VP O
125 400 CD O O
125 , , O O
126 call NN B-NP O
126 physician JJ B-NP O
127 Mr NNP I-NP O
127 Forde NNP I-NP O
127 has VBZ O O
127 recovered VBN O O
127 very RB O O
127 well RB O O
127 following VBG O O
127 his PRP$ O O
127 elective JJ B-NP O
127 coronary JJ I-NP O
128 artery NN I-NP O
128 bypass NN I-NP O
128 graft NN I-NP O
128 procedure NN I-NP O
128 and CC O O
128 is VBZ O O
128 anticipated VBN O O
128 to TO O O
128 continue VB O O
128 to TO O O
128 make VB O O
129 excellent JJ B-NP O
129 recovery NN I-NP O
129 with IN B-VP O
129 continued JJ B-NP O
129 close JJ I-NP O
129 followup NN I-NP O
129 with IN B-VP O
129 his PRP$ O O
129 primary JJ B-NP O
130 care NN I-NP O
130 physician NN I-NP O
130 and CC O O
130 cardiologist NN B-NP O
130 Thank NNP I-NP O
130 you PRP O O
130 for IN B-VP O
130 referring VBG O O
130 this DT B-NP O
131 patient NN I-NP O
131 to TO O O
131 our PRP$ O O
131 service NN B-NP O
131 Please NNP I-NP O
131 do VB O O
131 not RB O O
131 hesitate VB O O
131 to TO O O
131 call VB O O
131 with IN B-VP O
131 further JJ B-NP O
132 questions NNS I-NP O
132 or CC O O
132 concerns NNS B-NP O
133 eScription NN I-NP O
133 document: IN B-VP O
133 5-8522470 JJ B-NP O
133 CSSten NNP I-NP O
133 Tel NNP I-NP O
134 CC: NNP I-NP O
134 Jasper NNP I-NP O
134 Rojo NNP I-NP O
134 MD NNP I-NP O
135 DIVISION NNP I-NP O
135 OF NNP I-NP O
135 CARDIAC NNP I-NP O
135 SURGERY NNP I-NP O
136 Reve NNP I-NP O
136 U NNP I-NP O
136 Rill NNP I-NP O
136 Di NNP I-NP O
137 CC: NNP I-NP O
137 Max NNP I-NP O
137 Lattig NNP I-NP O
137 MD NNP I-NP O
138 Porteju NNP I-NP O
138 Surn NNP I-NP O
138 Anra NNP I-NP O
138 Hospital NNP I-NP O
139 A NNP I-NP O
139 Rance NNP I-NP O
139 En NNP I-NP O
140 CC: NNP I-NP O
140 Emil NNP I-NP O
140 Dee NNP I-NP O
140 Spatafora NNP I-NP O
140 MD NNP I-NP O
141 Terbsa NNP I-NP O
141 Hireve NNP I-NP O
142 Dictated NNP I-NP O
142 By: NNP I-NP O
142 CHAPDELAINE NNP I-NP O
142 , , O O
142 ALFRED NNP B-NP O
143 Attending: NNP I-NP O
143 KANETA NNP I-NP O
143 , , O O
143 RUSTY NNP B-NP O
144 Dictation NNP I-NP O
144 ID NNP I-NP O
144 6108486 CD O O
145 D: NNP B-NP O
145 8/1/06 CD O O
146 T: NNP B-NP O
146 1/30/06 CD O O
147 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #457094 VBZ O O
2 356821645 CD O O
2 TSH NNP B-NP O
2 20926128 CD O O
2 8585430 CD O O
2 4/3/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 atypical JJ B-NP O
2 chest NN I-NP O
2 pain NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 4/3/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/29/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 PADGET NNP I-NP O
5 , , O O
5 CHRISTOPER NNP B-NP O
5 A NNP I-NP O
5 434-60-76-2 JJ B-NP O
6 Bernand NNP I-NP O
6 Terfordpeocasterl NNP I-NP O
6 Ca NNP I-NP O
6 Room: NNP I-NP O
6 Virg NNP I-NP O
6 Hamlene NNP I-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 0/10/05 CD O O
8 AT NNP B-NP O
8 12:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 CIDRE NNP I-NP O
11 , , O O
11 CALVIN NNP B-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 No NNP I-NP O
13 CPR NNP I-NP O
13 , , O O
13 No NNP B-NP O
13 defib NN I-NP O
13 , , O O
13 No DT B-NP O
13 intubation NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Assisted NNP I-NP O
14 living VBG O O
15 DISCHARGE NNP B-NP O
15 MEDICATIONS: NNP I-NP O
16 ECOTRIN NNP I-NP B-m
16 ( ( O I-m
16 ASPIRIN NNP B-NP I-m
16 ENTERIC NNP I-NP I-m
16 COATED NNP I-NP I-m
16 ) ) O I-m
16 325 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 ATENOLOL NNP I-NP B-m
17 50 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 FERRO-SEQUELS NNP I-NP B-m
18 1 CD O B-do
18 TAB NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 LISINOPRIL NNP I-NP B-m
19 30 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 PRAVACHOL NNP I-NP B-m
20 ( ( O I-m
20 PRAVASTATIN NNP B-NP I-m
20 ) ) O I-m
20 80 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QHS NNP I-NP B-f
21 Food/Drug NNP I-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Avoid NNP I-NP O
22 grapefruit NN I-NP O
22 unless IN B-VP O
22 MD NNP B-NP O
22 instructs NNS I-NP O
22 otherwise RB O O
23 NORVASC NNP B-NP B-m
23 ( ( O I-m
23 AMLODIPINE NNP B-NP I-m
23 ) ) O I-m
23 5 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QD NNP I-NP B-f
24 Food/Drug NNP I-NP O
24 Interaction NNP I-NP O
24 Instruction NNP I-NP O
25 Avoid NNP I-NP O
25 grapefruit NN I-NP O
25 unless IN B-VP O
25 MD NNP B-NP O
25 instructs NNS I-NP O
25 otherwise RB O O
26 IMDUR NNP B-NP B-m
26 ER NNP I-NP I-m
26 ( ( O I-m
26 ISOSORBIDE NNP B-NP I-m
26 MONONITRATE NNP I-NP I-m
26 ( ( O I-m
26 SR NNP B-NP I-m
26 ) ) O I-m
26 ) ) O I-m
26 120 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 QD NNP I-NP B-f
27 Food/Drug NNP I-NP O
27 Interaction NNP I-NP O
27 Instruction NNP I-NP O
28 Give NNP I-NP O
28 on IN B-VP O
28 an DT B-NP O
28 empty JJ I-NP O
28 stomach NN I-NP O
28 ( ( O O
28 give JJ O O
28 1hr CD O O
28 before IN B-VP O
28 or CC O O
28 2hr CD O O
28 after IN B-VP O
29 food NN B-NP O
29 ) ) O O
30 PILOCARPINE VBD B-VP B-m
30 2% CD O I-m
30 1 CD O B-do
30 DROP NNP B-NP I-do
30 OU NNP I-NP B-mo
30 BID NNP I-NP B-f
31 BACTRIM NNP I-NP B-m
31 DS NNP I-NP I-m
31 ( ( O I-m
31 TRIMETHOPRIM/SULFAMETHOXAZOLE NNP B-NP I-m
31 DOU NNP I-NP I-m
31 ) ) O I-m
32 1 CD O B-do
32 TAB NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
32 X NNP I-NP B-du
32 12 CD O I-du
32 doses NNS B-NP I-du
32 Starting VBG O O
32 Today NNP B-NP O
32 ( ( O O
32 10/19 CD O O
32 ) ) O O
33 Instructions: NNP B-NP O
33 started VBD B-VP O
33 on IN B-VP O
33 4/14 CD O O
33 , , O O
33 continue VBP O O
33 until IN B-VP O
33 10/25 CD O O
33 AM NNP B-NP O
34 CLOBETASOL NNP I-NP B-m
34 PROPIONATE NNP I-NP I-m
34 0.05% CD O I-m
34 CREAM NNP B-NP I-m
34 TP NNP I-NP B-mo
34 BID NNP I-NP B-f
35 Instructions: NNP I-NP O
35 please VB O O
35 apply VB O O
35 to TO O O
35 affected JJ B-NP O
35 areas NNS I-NP O
36 Number NNP I-NP B-du
36 of IN B-VP I-du
36 Doses NNP B-NP I-du
36 Required NNP I-NP I-du
36 ( ( O I-du
36 approximate JJ B-NP I-du
36 ): NN I-NP I-du
36 10 CD O I-du
37 ALLEGRA NNP B-NP B-m
37 ( ( O I-m
37 FEXOFENADINE NNP B-NP I-m
37 HCL NNP I-NP I-m
37 ) ) O I-m
37 60 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 Food/Drug NNP I-NP O
38 Interaction NNP I-NP O
38 Instruction NNP I-NP O
39 Avoid NNP I-NP O
39 grapefruit NN I-NP O
39 unless IN B-VP O
39 MD NNP B-NP O
39 instructs NNS I-NP O
39 otherwise RB O O
40 Alert NNP B-NP O
40 overridden: NNP I-NP O
40 Override NNP I-NP O
40 added VBD B-VP O
40 on IN B-VP O
40 9/20/05 CD O O
40 by IN B-VP O
40 HADESTY NNP B-NP O
40 , , O O
40 MARSHALL NNP B-NP O
40 NED NNP I-NP O
40 GERARD NNP I-NP O
40 , , O O
40 M.D NNP B-NP O
41 on IN B-VP O
41 order NN B-NP O
41 for IN B-VP O
41 ALLEGRA NNP B-NP B-m
41 PO NNP I-NP B-mo
41 ( ( O O
41 ref JJ O O
41 # # O O
41 483093734 CD O O
41 ) ) O O
42 Pt NNP B-NP O
42 has VBZ O O
42 a DT B-NP O
42 PROBABLE NNP I-NP O
42 allergy NN I-NP O
42 to TO O O
42 DIPHENHYDRAMINE NNP B-NP O
42 ; : O O
42 reaction NN B-NP O
43 is VBZ O O
43 agitation JJ B-NP O
43 Reason NNP I-NP O
43 for IN B-VP O
43 override: NN B-NP O
43 pt NN I-NP O
43 takes VBZ O O
43 at IN B-VP O
43 home NN B-NP O
44 ALPHAGAN NNP I-NP B-m
44 ( ( O I-m
44 BRIMONIDINE NNP B-NP I-m
44 TARTRATE NNP I-NP I-m
44 ) ) O I-m
44 1 CD O B-do
44 DROP NNP B-NP I-do
44 OU NNP I-NP B-mo
44 BID NNP I-NP B-f
45 Number NNP I-NP B-du
45 of IN B-VP I-du
45 Doses NNP B-NP I-du
45 Required NNP I-NP I-du
45 ( ( O I-du
45 approximate JJ B-NP I-du
45 ): NN I-NP I-du
45 10 CD O I-du
46 PLAVIX NNP B-NP B-m
46 ( ( O I-m
46 CLOPIDOGREL NNP B-NP I-m
46 ) ) O I-m
46 75 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 QD NNP I-NP B-f
47 CALCIUM NNP I-NP B-m
47 CARBONATE NNP I-NP I-m
47 1 CD O B-do
47 , , O I-do
47 500 CD O I-do
47 MG NNP B-NP I-do
47 ( ( O O
47 600 CD O O
47 MG NNP B-NP O
47 ELEM NNP I-NP O
47 CA NNP I-NP O
47 )/ NNP I-NP O
47 VIT NNP I-NP B-m
47 D NNP I-NP I-m
47 200 CD O B-do
47 IU NNP B-NP O
48 1 CD O O
48 TAB NNP B-NP O
48 PO NNP I-NP B-mo
48 QD NNP I-NP B-f
49 ZETIA NNP I-NP B-m
49 ( ( O I-m
49 EZETIMIBE NNP B-NP I-m
49 ) ) O I-m
49 10 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 QD NNP I-NP B-f
50 METFORMIN NNP I-NP B-m
50 250 CD O B-do
50 MG NNP B-NP I-do
50 PO NNP I-NP B-mo
50 BID NNP I-NP B-f
51 ACIPHEX NNP I-NP B-m
51 ( ( O I-m
51 RABEPRAZOLE NNP B-NP I-m
51 ) ) O I-m
51 20 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 QD NNP I-NP B-f
52 DIET: NNP I-NP O
52 House NNP I-NP O
52 / VBD B-VP O
52 Low NNP B-NP O
52 chol/low NN I-NP O
52 sat VBD B-VP O
52 fat JJ B-NP O
53 DIET: NNP I-NP O
53 House NNP I-NP O
53 / NNP I-NP O
53 ADA NNP I-NP O
53 1800 CD O O
53 cals/dy NN B-NP O
54 DIET: NNP I-NP O
54 2 CD O O
54 gram NN B-NP O
54 Sodium NNP I-NP O
55 ACTIVITY: NNP I-NP O
55 Walking NNP I-NP O
55 as IN B-VP O
55 tolerated VBN O O
56 FOLLOW NNP B-NP O
56 UP NNP I-NP O
56 APPOINTMENT( NNP I-NP O
56 S NNP I-NP O
56 ): NNP I-NP O
57 Dr NNP I-NP O
57 Root NNP I-NP O
57 in IN B-VP O
57 March NNP B-NP O
57 scheduled VBD B-VP O
57 , , O O
58 ALLERGY: NNP B-NP O
58 epinephrine VBP O O
58 eye NN B-NP O
58 drops NNS I-NP O
58 , , O O
58 LEVOFLOXACIN NNP B-NP O
58 , , O O
58 IV NNP B-NP O
58 Contrast NNP I-NP O
58 , , O O
59 DIPHENHYDRAMINE NNP B-NP O
59 , , O O
59 Penicillins NNP B-NP O
59 , , O O
59 BACITRICIN NNP B-NP O
59 OINTMENT NNP I-NP O
59 , , O O
60 OXYBUTININ NNP B-NP O
61 ADMIT NNP I-NP O
61 DIAGNOSIS: NNP I-NP O
62 atypical JJ B-NP O
62 chest NN I-NP O
62 pain NN I-NP O
63 PRINCIPAL NNP I-NP O
63 DISCHARGE NNP I-NP O
63 DIAGNOSIS NNP I-NP O
63 ;Responsible JJ O O
63 After IN B-VP O
63 Study NNP B-NP O
63 for IN B-VP O
63 Causing NNP B-NP O
63 Admission NNP I-NP O
63 ) ) O O
64 atypical JJ B-NP O
64 chest NN I-NP O
64 pain NN I-NP O
65 OTHER NNP I-NP O
65 DIAGNOSIS;Conditions NNP I-NP O
65 , , O O
65 Infections NNP B-NP O
65 , , O O
65 Complications NNP B-NP O
65 , , O O
65 affecting VBG O O
65 Treatment/Stay NNP B-NP O
66 '93LIMA-LAD;SVGs-PDA CD O O
66 , , O O
66 D1 NNP B-NP O
66 , , O O
66 OM1 NNP B-NP O
66 ?USA NNP I-NP O
66 glaucoma NN I-NP O
66 esophageal NN I-NP O
66 spasm NN I-NP O
66 NIDDM NNP I-NP O
66 , , O O
66 diet JJ O O
67 controlled VBD B-VP O
67 fibrocystic JJ B-NP O
67 mastitis NN I-NP O
67 peripheral JJ B-NP O
68 neuropathy JJ I-NP O
68 OA NNP I-NP O
68 , , O O
68 DJD NNP B-NP O
68 h/o VBD B-VP O
68 duodenal JJ B-NP O
68 ulcer JJ I-NP O
68 lumbar NN I-NP O
68 spinal JJ B-NP O
68 stenosis NN I-NP O
68 HTN NNP I-NP O
69 hypercholesterolemia NN I-NP O
69 s/p NN I-NP O
69 carpal JJ B-NP O
69 tunnel NN I-NP O
69 release NN I-NP O
69 hyponatremia NN I-NP O
70 ( ( O O
70 hyponatremia NN B-NP O
70 ) ) O O
70 MI NNP B-NP O
70 ( ( O O
70 myocardial JJ B-NP O
70 infarction NN I-NP O
70 ) ) O O
70 ?cauda NN B-NP O
70 equina JJ B-NP O
71 OPERATIONS NNP I-NP O
71 AND NNP I-NP O
71 PROCEDURES: NNP I-NP O
72 OTHER NNP I-NP O
72 TREATMENTS/PROCEDURES NNP I-NP O
72 ( ( O O
72 NOT NNP B-NP O
72 IN NNP I-NP O
72 O.R NNP I-NP O
72 ) ) O O
73 none NN B-NP O
74 BRIEF NNP I-NP O
74 RESUME NNP I-NP O
74 OF NNP I-NP O
74 HOSPITAL NNP I-NP O
74 COURSE: NNP I-NP O
75 REASON NNP I-NP O
75 FOR NNP I-NP O
75 ADMIT: NNP I-NP O
75 substernal JJ B-NP O
75 CP NNP I-NP O
76 HPI: NNP I-NP O
76 83yoF CD O O
76 w/ NN B-NP O
76 CAD NNP I-NP O
76 s/p VBD B-VP O
76 4 CD O O
76 vessel NN B-NP O
76 CABG NNP I-NP O
76 1993 CD O O
76 s/p NN B-NP O
76 L NNP I-NP O
76 main JJ O O
76 and CC O O
76 diagonal JJ B-NP O
76 PTCA NNP I-NP O
77 w/ NN I-NP O
77 cypher NN I-NP O
77 stent NN I-NP O
77 0/4 CD O O
77 followed VBN O O
77 by IN B-VP O
77 bare NN B-NP O
77 metal NN I-NP O
77 stent NN I-NP O
77 in IN B-VP O
77 diagonal JJ O O
77 for IN B-VP O
78 recurrent NN B-NP O
78 CP NNP I-NP O
78 , , O O
78 p/w JJ B-NP O
78 substernal JJ I-NP O
78 epigastric NN I-NP O
78 pain NN I-NP O
78 Has NNP I-NP O
78 had VBD B-VP O
78 multiple VBN O O
79 admissions NNS B-NP O
79 for IN B-VP O
79 chest NN B-NP O
79 pain NN I-NP O
79 , , O O
79 last JJ O O
79 in IN B-VP O
79 4/30 CD O O
79 w/ NN B-NP O
79 MIBI NNP I-NP O
79 that WDT O O
79 was VBD B-VP O
79 improved VBN O O
80 from IN B-VP O
80 prior RB O O
80 Woke NNP B-NP O
80 up RB O O
80 at IN B-VP O
80 5am CD O O
80 w/ JJ B-NP O
80 substernal JJ I-NP B-r
80 epigastric NN I-NP I-r
80 pain NN I-NP I-r
80 , , O O
80 unclear JJ O O
80 if IN B-VP O
81 angina NNS B-NP O
81 or CC O O
81 esophageal JJ B-NP O
81 spasm NN I-NP O
81 Took NNP I-NP O
81 maalox NN I-NP B-m
81 and CC O O
81 3 CD O B-do
81 ntg JJ B-NP B-m
81 w/ NN I-NP O
81 pain NN I-NP B-r
82 relief NN I-NP O
82 Then RB O O
82 CP NNP B-NP O
82 radiated VBD B-VP O
82 to TO O O
82 left VB O O
82 arm NN B-NP O
82 which WDT O O
82 is VBZ O O
82 more RBR O O
82 typical JJ O O
82 of IN B-VP O
83 anginal JJ B-NP O
83 pain NN I-NP O
83 Called VBN O O
83 elkca NN B-NP O
83 rospi NN I-NP O
83 valley NN I-NP O
83 hospital NN I-NP O
83 and CC O O
83 came VBD B-VP O
83 in IN B-VP O
83 Had NNP B-NP O
83 some DT B-NP O
83 vague JJ I-NP B-r
83 symptoms NNS I-NP I-r
83 in IN B-VP O
83 ED NNP B-NP O
84 that WDT O O
84 responded VBD B-VP O
84 to TO O O
84 nitro VB O B-m
84 , , O O
84 BP NNP B-NP O
84 dropped VBD B-VP O
84 140s CD O O
84 to TO O O
84 90s CD O O
84 but CC O O
84 came VBD B-VP O
84 right RB O O
84 back RB O O
85 up IN B-VP O
85 First NNP B-NP O
85 set VBD B-VP O
85 neg RB O O
85 EKG NNP B-NP O
85 no DT B-NP O
85 changes NNS I-NP O
85 PE NNP I-NP O
85 unremarkable JJ B-NP O
86 *********************** NNP I-NP O
87 PMH: NNP I-NP O
87 CAD NNP I-NP O
87 s/p VBD B-VP O
87 4v CD O O
87 CABG NNP B-NP O
87 s/p NN I-NP O
87 Lmain NNP I-NP O
87 and CC O O
87 diagonal JJ B-NP O
87 cypher NN I-NP O
87 stent NN I-NP O
87 and CC O O
87 diagonal JJ B-NP O
87 BMT NNP I-NP O
88 0/4 CD O O
88 , , O O
88 htn NN B-NP O
88 , , O O
88 hyperchol NN B-NP O
88 , , O O
88 fibrocystic JJ B-NP O
88 mastitis NN I-NP O
88 , , O O
88 h/o NN B-NP O
88 type NN I-NP O
88 IV NNP I-NP O
88 RTADM NNP I-NP O
88 , , O O
88 eophageal NN B-NP O
89 spasm NN I-NP O
89 , , O O
89 glaucoma NN B-NP O
89 , , O O
89 peripheral JJ B-NP O
89 neuropathy NN I-NP O
89 , , O O
89 OA NNP B-NP O
89 , , O O
89 DJD NNP B-NP O
89 , , O O
89 h/o VBD B-VP O
89 duodenal JJ B-NP O
89 ulcer NN I-NP O
89 , , O O
90 lumbar JJ B-NP O
90 spinal JJ I-NP O
90 stenosis NN I-NP O
90 , , O O
90 s/p NN B-NP O
90 carpal JJ B-NP O
90 tunnel NN I-NP O
90 releaseplease NN I-NP O
90 see VBP O O
90 problem NN B-NP O
90 list NN I-NP O
91 *********************** NNP I-NP O
92 Cardiac NNP I-NP O
92 studies NNS I-NP O
93 -Cath VBP O O
93 0/4 CD O O
93 LM NNP B-NP O
93 stent JJ B-NP O
93 patent NN I-NP O
93 LAD NNP I-NP O
93 100% CD O O
93 lesion NN B-NP O
93 w/ NN I-NP O
93 patent NN I-NP O
93 LIMA NNP I-NP O
93 diagonal JJ O O
93 80% CD O O
94 lesion NN B-NP O
94 w/ NN I-NP O
94 cypher NN I-NP O
94 stent NN I-NP O
94 , , O O
94 another DT B-NP O
94 bare NN I-NP O
94 metal NN I-NP O
94 stent NN I-NP O
94 placed VBD B-VP O
94 distally RB O O
94 , , O O
94 LCx NNP B-NP O
95 100% CD O O
95 RCA NNP B-NP O
95 100% CD O O
95 w/ JJ B-NP O
95 patent NN I-NP O
95 SVG-&gt;RAMUS NNP I-NP O
95 , , O O
95 LIMA-&gt;LAD NNP B-NP O
95 , , O O
95 SVG-&gt;D2 NNP B-NP O
95 , , O O
95 SVG-&gt;PDA NNP B-NP O
96 -MIBI NNP I-NP O
96 4/30 CD O O
96 mod NN B-NP O
96 sized VBN O O
96 severe JJ B-NP O
96 perfusion NN I-NP O
96 defect NN I-NP O
96 in IN B-VP O
96 LCx/OM! NNP B-NP O
96 territory NN I-NP O
97 throughout IN B-VP O
97 inferolateral JJ O O
97 and CC O O
97 basal JJ B-NP O
97 inferior JJ I-NP O
97 wall NN I-NP O
97 w/ NN I-NP O
97 mild JJ B-NP O
97 reversibility NN I-NP O
97 , , O O
98 improved VBN O O
98 since IN B-VP O
98 3/24 CD O O
99 ************************ JJ B-NP O
100 ADMISSION NNP I-NP O
100 MEDS: NNP I-NP O
100 lisinopril VBD B-VP B-m
100 20mg CD O B-do
100 daily RB O B-f
100 , , O O
100 calcium NN B-NP B-m
100 600+D CD O I-m
100 daily RB O B-f
100 , , O O
100 isosorbide JJ O B-m
101 120mg CD O B-do
101 daily RB O B-f
101 , , O O
101 metformin VBD B-VP B-m
101 250mg CD O B-do
101 bid NN B-NP B-f
101 , , O O
101 allegra VBP O B-m
101 60mg CD O B-do
101 daily RB O B-f
101 , , O O
101 asa JJ O B-m
101 325mg CD O B-do
101 daily RB O B-f
101 , , O O
102 alphagam JJ B-NP B-m
102 gtts NN I-NP I-m
102 bid NN I-NP B-f
102 , , O O
102 pilocarpine VBP O B-m
102 2% CD O I-m
102 bid NN B-NP B-f
102 , , O O
102 clobetizol NN B-NP B-m
102 cream NN I-NP I-m
102 0.5mg CD O B-do
102 bid NN B-NP B-f
102 , , O O
103 pravachol NN B-NP B-m
103 80mg CD O B-do
103 qhs NN B-NP B-f
103 , , O O
103 zetia NN B-NP B-m
103 10mg CD O B-do
103 qhs NN B-NP B-f
103 , , O O
103 norvasc RB O B-m
103 5mg CD O B-do
103 daily JJ O B-f
103 , , O O
103 atenolol JJ O B-m
103 50mg CD O B-do
104 daily RB O B-f
104 , , O O
104 ferrex JJ O B-m
104 1/day CD O B-f
104 , , O O
104 acephex RB O B-m
104 20mg CD O B-do
104 daily JJ O B-f
104 , , O O
104 plavix JJ O B-m
104 75mg CD O B-do
104 qhs NN B-NP B-f
104 , , O O
104 ntg JJ B-NP B-m
104 prn NN I-NP B-f
105 ALLERGIES: NNP I-NP O
105 epi NN I-NP O
105 eyedrops NNS I-NP O
105 , , O O
105 IV NNP B-NP O
105 contrast NN I-NP O
105 , , O O
105 levo NN B-NP O
105 , , O O
106 penicillin NN B-NP O
106 , , O O
106 bacitracin JJ B-NP O
106 ointment NN I-NP O
106 , , O O
106 oxybutinin JJ B-NP O
106 SH: NNP I-NP O
106 lives VBZ O O
106 at IN B-VP O
106 Ran NNP B-NP O
106 O NNP I-NP O
107 assisted VBD B-VP O
107 living VBG O O
107 HCP NNP B-NP O
107 is VBZ O O
107 niece JJ B-NP O
107 Lucio NNP I-NP O
107 Fritzman NNP I-NP O
107 638 CD O O
107 826 CD O O
107 7097 CD O O
107 no DT B-NP O
108 tob/etoh/ivdu NN I-NP O
109 ************************* VBZ O O
110 ADMISSION NNP B-NP O
110 PE: NNP I-NP O
110 VS NNP I-NP O
110 afeb VBD B-VP O
110 61 CD O O
110 146/67 CD O O
110 16 CD O O
110 100%2L CD O O
111 HEENT: NNP B-NP O
111 anicteric NN I-NP O
111 , , O O
111 eomi NN B-NP O
111 , , O O
111 surgical JJ B-NP O
111 pupils NNS I-NP O
111 b/l NN I-NP O
111 , , O O
111 op JJ B-NP O
111 clear JJ I-NP O
111 NECK: NNP I-NP O
111 supple NN I-NP O
111 , , O O
112 carotid VBP O O
112 2+ CD O O
112 w/o JJ B-NP O
112 bruits NNS I-NP O
112 , , O O
112 no DT B-NP O
112 lan NN I-NP O
112 , , O O
112 jvp NN B-NP O
112 7 CD O O
112 LUNGS: NNP B-NP O
112 ctab NN I-NP O
112 , , O O
112 occ JJ B-NP O
112 wheezes NNS I-NP O
112 CV: NNP I-NP O
112 rr NN I-NP O
112 , , O O
112 nl JJ B-NP O
113 s1 NN I-NP O
113 s2 NN I-NP O
113 , , O O
113 no DT B-NP O
113 m/r/g NN I-NP O
113 ABD: NNP I-NP O
113 nl NN I-NP O
113 bs NN I-NP O
113 , , O O
113 soft JJ O O
113 , , O O
113 mild JJ B-NP O
113 tender NN I-NP O
113 in IN B-VP O
113 LLQ NNP B-NP O
113 to TO O O
113 deep VB O O
113 palpation NN B-NP O
113 , , O O
114 no DT B-NP O
114 masses NNS I-NP O
114 , , O O
114 no DT B-NP O
114 hsm NN I-NP O
114 EXT: NNP I-NP O
114 trace NN I-NP O
114 edema NN I-NP O
114 , , O O
114 warm JJ O O
114 , , O O
114 dp/pt JJ O O
114 1+ CD O O
114 b/l NN B-NP O
114 SKIN: NNP I-NP O
114 diffuse RB O O
115 erythematous JJ B-NP O
115 nodular JJ I-NP O
115 skin NN I-NP O
115 lesions NNS I-NP O
115 left VBD B-VP O
115 elbow JJ B-NP O
115 w/ JJ I-NP O
115 abrasion NN I-NP O
115 NEURO: NNP I-NP O
115 a&amp;ox3 NN I-NP O
115 , , O O
116 moves VBZ O O
116 all DT B-NP O
116 extremities NNS I-NP O
117 ************************* NNP I-NP O
118 LABS/STUDIES NNP I-NP O
119 --labs NNP I-NP O
119 on IN B-VP O
119 admission: NN B-NP O
119 Ca NNP I-NP O
119 10.9 CD O O
120 --cardiac NNP B-NP O
120 enzymes NNS I-NP O
120 x VBP O O
120 3 CD O O
120 neg JJ O O
121 --UA $ O O
121 1+ CD O O
121 LE NNP B-NP O
121 , , O O
121 neg JJ O O
121 nitrite RB O O
121 , , O O
121 10-15 JJ B-NP O
121 WBC NNP I-NP O
121 , , O O
121 4+ CD O O
121 bact NN B-NP O
122 --UCx NNP I-NP O
122 &gt;100 NNP I-NP O
122 , , O O
122 000 CD O O
122 enteric JJ B-NP O
122 gram NN I-NP O
122 neg NN I-NP O
122 rods NNS I-NP O
122 , , O O
122 mucoid NN B-NP O
122 , , O O
122 sens VBZ O O
122 pnding VBG O O
123 --EKG NNP B-NP O
123 sinus NN I-NP O
123 @55 NNP I-NP O
123 , , O O
123 LAD NNP B-NP O
123 , , O O
123 TWI NNP B-NP O
123 III NNP I-NP O
123 ( ( O O
123 new JJ O O
123 ) ) O O
123 , , O O
123 TW NNP B-NP O
123 flattening VBG O O
123 I/avF NNP B-NP O
123 ( ( O O
123 old JJ O O
123 ) ) O O
123 , , O O
123 V5-V6 JJ B-NP O
124 lateral JJ I-NP O
124 flattening NN I-NP O
124 ( ( O O
124 old JJ O O
124 ) ) O O
124 no DT B-NP O
124 ST NNP I-NP O
124 changes NNS I-NP O
124 , , O O
124 poor JJ B-NP O
124 RWP NNP I-NP O
125 --CXR NNP I-NP O
125 ( ( O O
125 portable JJ B-NP O
125 ): NN I-NP O
125 clear JJ B-NP O
126 ************************* NNP I-NP O
127 A/P NNP I-NP O
127 CV: NNP I-NP O
128 --ischemia: NNP I-NP O
128 Given NNP I-NP O
128 cardiac JJ B-NP O
128 history NN I-NP O
128 patient NN I-NP O
128 admitted VBN O O
128 for IN B-VP O
128 r/o NN B-NP O
128 MI NNP I-NP O
128 , , O O
128 although IN B-VP O
129 from IN B-VP O
129 story NN B-NP O
129 discomfort NN I-NP O
129 could MD O O
129 also RB O O
129 have VB O O
129 been VBN O O
129 2/2 CD O O
129 esophageal JJ B-NP O
129 spasm NN I-NP O
129 Patient NNP I-NP O
130 ruled VBD B-VP O
130 out RP O O
130 for IN B-VP O
130 MI NNP B-NP O
130 w/ VBD B-VP O
130 3 CD O O
130 sets NNS B-NP O
130 of IN B-VP O
130 neg JJ B-NP O
130 cardiac JJ I-NP O
130 enzymes NNS I-NP O
130 and CC O O
130 no DT B-NP O
130 EKG NNP I-NP O
130 changes NNS I-NP O
131 Did NNP I-NP O
131 not RB O O
131 have VB O O
131 recurrence NN B-NP O
131 of IN B-VP O
131 her PRP$ O O
131 chest JJS B-NP O
131 discomfort NN I-NP O
131 or CC O O
131 left VBD B-VP O
131 arm RP O O
131 tingling NN B-NP O
131 at IN B-VP O
132 rest NN B-NP O
132 or CC O O
132 with IN B-VP O
132 ambulation NN B-NP O
132 On IN B-VP O
132 good JJ B-NP O
132 cardiac JJ I-NP O
132 regimen NNS I-NP O
132 , , O O
132 and CC O O
132 continued VBD B-VP O
132 on IN B-VP O
132 ASA NNP B-NP B-m
132 , , O O
133 plavix NN B-NP B-m
133 , , O O
133 BB NNP B-NP B-m
133 , , O O
133 ACE NNP B-NP B-m
133 , , O O
133 statin NN B-NP B-m
133 , , O O
133 zetia NN B-NP B-m
133 lipid JJ B-NP O
133 panel NN I-NP O
133 good JJ B-NP O
133 w/ NN I-NP O
133 total JJ B-NP O
133 chol NN I-NP O
134 163 CD O O
134 and CC O O
134 ldl $ O O
134 86 CD O O
134 hdl NN B-NP O
134 43 CD O O
134 uptitrated JJ B-NP O
134 ACE NNP I-NP B-m
134 to TO O O
134 optimize VB O O
134 BP NNP B-NP B-r
134 , , O O
134 increased VBD B-VP O
134 to TO O O
134 30mg CD O B-do
135 daily JJ B-NP B-f
135 w/ NNS I-NP O
135 improved VBN O O
135 BP NNP B-NP O
135 w/ JJ B-NP O
135 SBP NNP I-NP O
135 in IN B-VP O
135 110s CD O O
136 --pump: JJ O O
136 no DT B-NP O
136 e/o JJ I-NP O
136 overload NN I-NP O
136 cont NN I-NP O
136 on IN B-VP O
136 home NN B-NP O
136 BP NNP I-NP B-m
136 meds VBZ O I-m
137 --rhythm: NNP B-NP O
137 tele NN I-NP O
137 w/out NN I-NP O
137 events NNS I-NP O
138 GI: NNP I-NP O
138 h/o NN I-NP O
138 esophageal NN I-NP B-r
138 spasm NN I-NP I-r
138 , , O O
138 cont NN B-NP O
138 PPI NNP I-NP B-m
138 likely JJ B-NP O
138 source NN I-NP O
138 of IN B-VP O
138 chest NN B-NP O
138 discomfort NN I-NP O
139 NEURO: NNP I-NP O
139 left VBD B-VP O
139 arm RP O O
139 tingling NN B-NP O
139 did VBD B-VP O
139 not RB O O
139 recur VB O O
139 but CC O O
139 if IN B-VP O
139 recurs NNS B-NP O
139 in IN B-VP O
139 the DT B-NP O
139 future NN I-NP O
139 may MD O O
140 consider VB O O
140 carotid NN B-NP O
140 ultrasound NN I-NP O
140 or CC O O
140 neck NN B-NP O
140 imaging VBG O O
141 HEME: NNP B-NP O
141 h/o NN I-NP O
141 Fed NNP I-NP B-r
141 anemia NN I-NP I-r
141 , , O O
141 cont NN B-NP O
141 iron NN I-NP B-m
141 Hct NNP I-NP O
141 stable JJ O O
141 in IN B-VP O
141 low JJ O O
141 30s CD O O
141 , , O O
141 32.6 CD O O
141 at IN B-VP O
141 d/c NN B-NP O
142 ENDO: NNP I-NP O
142 on IN B-VP O
142 lantus NN B-NP B-m
142 , , O O
142 novolog JJ B-NP B-m
142 prandial NN I-NP O
142 , , O O
142 and CC O O
142 novolog RB O B-m
142 sliding VBG O B-do
142 scale NN B-NP I-do
142 here RB O O
142 , , O O
143 restarted VBN O O
143 on IN B-VP O
143 home NN B-NP O
143 metformin NN I-NP B-m
143 at IN B-VP O
143 d/c JJ B-NP O
144 ID: NNP I-NP O
144 UTI NNP I-NP O
144 Started VBD B-VP O
144 on IN B-VP O
144 Bactrim NNP B-NP B-m
144 for IN B-VP B-du
144 7 CD O I-du
144 day NN B-NP I-du
144 course NN I-NP I-du
145 DERM: NNP I-NP O
145 cont NN I-NP O
145 steroid NN I-NP B-m
145 ointment NN I-NP I-m
146 HEENT: NNP I-NP O
146 cont NN I-NP O
146 eyedrops VBZ O B-m
147 FEN: NNP B-NP O
147 cardiac NN I-NP O
147 , , O O
147 diabetic JJ B-NP O
147 diet NN I-NP O
147 watch NN I-NP O
147 Ca NNP I-NP O
148 PPx: NNP I-NP O
148 lovenox NN I-NP B-m
148 , , O O
148 PPI NNP B-NP B-m
149 CODE: NNP I-NP O
149 DNR/DNI NNP I-NP O
149 ----- NNP I-NP O
149 > NNP I-NP O
150 HCP NNP I-NP O
150 niece RB O O
150 Andrea NNP B-NP O
150 Cocanougher NNP I-NP O
150 139 CD O O
150 049 CD O O
150 2689 CD O O
151 ADDITIONAL NNP B-NP O
151 COMMENTS: NNP I-NP O
151 *Please NNP I-NP O
151 call VB O O
151 our PRP$ O O
151 Dr NNP B-NP O
151 or CC O O
151 return VB O O
151 to TO O O
151 the DT B-NP O
151 ED NNP I-NP O
151 if IN B-VP O
151 you PRP O O
151 have VBP O O
151 any DT B-NP O
151 more JJR I-NP O
151 episodes NNS I-NP O
151 of IN B-VP O
152 chest JJS B-NP O
152 discomfort NN I-NP O
153 *Your NN I-NP O
153 lisinopril NN I-NP B-m
153 lisinopril NN I-NP B-m
153 has VBZ O O
153 been VBN O O
153 increased VBN O O
153 to TO O O
153 30mg CD O B-do
153 daily RB O B-f
153 You PRP O O
153 have VBP O O
153 been VBN O O
153 started VBN O O
154 on IN B-VP O
154 Bactrim NNP B-NP B-m
154 for IN B-VP B-du
154 7 CD O I-du
154 days NNS B-NP I-du
154 for IN B-VP O
154 a DT B-NP B-r
154 urinary JJ I-NP I-r
154 tract NN I-NP I-r
154 infection NN I-NP I-r
154 All DT B-NP O
154 other JJ I-NP B-m
155 medications NNS I-NP O
155 are VBP O O
155 the DT B-NP O
155 same JJ I-NP O
156 DISCHARGE NNP I-NP O
156 CONDITION: NNP I-NP O
156 Stable NNP I-NP O
157 TO NNP I-NP O
157 DO/PLAN: NNP I-NP O
158 *monitor NNP I-NP O
158 BP NNP I-NP O
158 w/ POS O O
158 uptitration NN B-NP O
158 of IN B-VP O
158 ACE NNP B-NP B-m
159 No NNP I-NP O
159 dictated VBD B-VP O
159 summary JJ B-NP O
160 ENTERED NNP I-NP O
160 BY: NNP I-NP O
160 SCHRENK NNP I-NP O
160 , , O O
160 ALLAN NNP B-NP O
160 HIRAM NNP I-NP O
160 JAE NNP I-NP O
160 , , O O
160 M.D NNP B-NP O
160 ( ( O O
160 DL79 NNP B-NP O
160 ) ) O O
160 0/10/05 CD O O
160 @ $ O O
160 11 CD O O
161 ****** JJ B-NP O
161 END NN I-NP O
161 OF NNP I-NP O
161 DISCHARGE NNP I-NP O
161 ORDERS NNP I-NP O
161 ****** NNP I-NP O
162 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #471540 VBZ O O
4 342590615 CD O O
4 CCHO NNP B-NP O
4 47454253 CD O O
4 0272677 CD O O
4 3/14/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 s/p JJ B-NP O
4 mechanical JJ I-NP O
4 fall NN I-NP O
4 , , O O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/5/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/20/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 HEMRICH NNP I-NP O
8 , , O O
8 NOBLE NNP B-NP O
8 223-66-98-9 JJ B-NP O
9 Por NNP I-NP O
9 Olu NNP I-NP O
9 Naeans NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 10/2/06 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 BOLSTAD NNP I-NP O
14 , , O O
14 CLEMENTE NNP B-NP O
14 ARMAND NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Rehabilitation NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 TYLENOL NNP I-NP B-m
19 TYLENOL NNP I-NP B-m
19 ( ( O I-m
19 ( ( O I-m
19 ACETAMINOPHEN NNP B-NP I-m
19 ACETAMINOPHEN NNP I-NP I-m
19 ) ) O I-m
19 ) ) O I-m
19 650 CD O B-do
19 650 CD O B-do
19 MG NNP B-NP I-do
19 MG NNP I-NP I-do
19 PO NNP I-NP B-mo
19 PO NNP I-NP B-mo
19 Q4H NNP I-NP B-f
19 Q4H NNP I-NP B-f
19 PRN NNP I-NP I-f
19 PRN NNP I-NP I-f
19 Pain NNP I-NP B-r
19 , , O O
19 Headache NNP B-NP B-r
20 AMIODARONE NNP I-NP B-m
20 100 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 DAILY NNP I-NP B-f
21 Override NNP I-NP O
21 Notice: NNP I-NP O
21 Override NNP I-NP O
21 added VBD B-VP O
21 on IN B-VP O
21 10/2/06 CD O O
21 by IN B-VP O
22 GREINKE NNP B-NP O
22 , , O O
22 LAMONT NNP B-NP O
22 M NNP I-NP O
22 , , O O
22 PA NNP B-NP O
23 on IN B-VP O
23 order NN B-NP O
23 for IN B-VP O
23 COUMADIN NNP B-NP B-m
23 PO NNP I-NP B-mo
23 ( ( O O
23 ref JJ O O
23 # # O O
23 901447890 CD O O
23 ) ) O O
24 POTENTIALLY NNP B-NP O
24 SERIOUS NNP I-NP O
24 INTERACTION: NNP I-NP O
24 AMIODARONE NNP I-NP B-m
24 HCL NNP I-NP I-m
24 &amp; NNP I-NP O
24 WARFARIN NNP I-NP B-m
25 Reason NNP I-NP O
25 for IN B-VP O
25 override: NN B-NP O
25 monitoring NN I-NP O
26 Previous NNP I-NP O
26 override IN B-VP O
26 information: JJ B-NP O
27 Override NNP I-NP O
27 added VBD B-VP O
27 on IN B-VP O
27 2/29/06 CD O O
27 by IN B-VP O
27 RELYEA NNP B-NP O
27 , , O O
27 ROCKY NNP B-NP O
27 B NNP I-NP O
27 , , O O
27 PA NNP B-NP O
28 on IN B-VP O
28 order NN B-NP O
28 for IN B-VP O
28 COUMADIN NNP B-NP B-m
28 PO NNP I-NP B-mo
28 ( ( O O
28 ref JJ O O
28 # # O O
28 766358178 CD O O
28 ) ) O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 AMIODARONE NNP I-NP B-m
29 HCL NNP I-NP I-m
29 &amp; NNP I-NP O
29 WARFARIN NNP I-NP B-m
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 monitor NN I-NP O
30 Previous NNP I-NP O
30 override IN B-VP O
30 information: JJ B-NP O
31 Override NNP I-NP O
31 added VBD B-VP O
31 on IN B-VP O
31 11/11/06 CD O O
31 by IN B-VP O
31 RODGERS NNP B-NP O
31 , , O O
31 CLARENCE NNP B-NP O
31 CARMINE NNP I-NP O
31 , , O O
31 M.D NNP B-NP O
32 on IN B-VP O
32 order NN B-NP O
32 for IN B-VP O
32 COUMADIN NNP B-NP B-m
32 PO NNP I-NP B-mo
32 ( ( O O
32 ref JJ O O
32 # # O O
32 699369105 CD O O
32 ) ) O O
33 POTENTIALLY NNP B-NP O
33 SERIOUS NNP I-NP O
33 INTERACTION: NNP I-NP O
33 AMIODARONE NNP I-NP B-m
33 HCL NNP I-NP I-m
33 &amp; NNP I-NP O
33 WARFARIN NNP I-NP B-m
34 Reason NNP I-NP O
34 for IN B-VP O
34 override: NN B-NP O
34 aware JJ B-NP O
34 Previous NNP I-NP O
34 override NN I-NP O
34 information: NN I-NP O
35 Override NNP I-NP O
35 added VBD B-VP O
35 on IN B-VP O
35 9/11/06 CD O O
35 by IN B-VP O
35 PETRONE NNP B-NP O
35 , , O O
35 EDDY NNP B-NP O
35 DALTON NNP I-NP O
35 , , O O
35 M.D NNP B-NP O
36 on IN B-VP O
36 order NN B-NP O
36 for IN B-VP O
36 COUMADIN NNP B-NP B-m
36 PO NNP I-NP B-mo
36 ( ( O O
36 ref JJ O O
36 # # O O
36 275187370 CD O O
36 ) ) O O
37 POTENTIALLY NNP B-NP O
37 SERIOUS NNP I-NP O
37 INTERACTION: NNP I-NP O
37 AMIODARONE NNP I-NP B-m
37 HCL NNP I-NP I-m
37 &amp; NNP I-NP O
37 WARFARIN NNP I-NP B-m
38 Reason NNP I-NP O
38 for IN B-VP O
38 override: NN B-NP O
38 aware JJ B-NP O
38 Previous NNP I-NP O
38 override NN I-NP O
38 information: NN I-NP O
39 Override NNP I-NP O
39 added VBD B-VP O
39 on IN B-VP O
39 9/11/06 CD O O
39 by IN B-VP O
39 FRANDEEN NNP B-NP O
39 , , O O
39 FRANKIE NNP B-NP O
39 PETER NNP I-NP O
39 , , O O
39 M.D NNP B-NP O
40 on IN B-VP O
40 order NN B-NP O
40 for IN B-VP O
40 COUMADIN NNP B-NP B-m
40 PO NNP I-NP B-mo
40 ( ( O O
40 ref JJ O O
40 # # O O
40 451868012 CD O O
40 ) ) O O
41 POTENTIALLY NNP B-NP O
41 SERIOUS NNP I-NP O
41 INTERACTION: NNP I-NP O
41 AMIODARONE NNP I-NP B-m
41 HCL NNP I-NP I-m
41 &amp; NNP I-NP O
41 WARFARIN NNP I-NP B-m
42 Reason NNP I-NP O
42 for IN B-VP O
42 override: NN B-NP O
42 aware JJ B-NP O
42 Previous NNP I-NP O
42 override NN I-NP O
42 information: NN I-NP O
43 Override NNP I-NP O
43 added VBD B-VP O
43 on IN B-VP O
43 1/30/06 CD O O
43 by IN B-VP O
43 MONNERJAHN NNP B-NP O
43 , , O O
43 VANCE NNP B-NP O
43 , , O O
43 PA-C NNP B-NP O
44 on IN B-VP O
44 order NN B-NP O
44 for IN B-VP O
44 COUMADIN NNP B-NP B-m
44 PO NNP I-NP B-mo
44 ( ( O O
44 ref JJ O O
44 # # O O
44 582207144 CD O O
44 ) ) O O
45 POTENTIALLY NNP B-NP O
45 SERIOUS NNP I-NP O
45 INTERACTION: NNP I-NP O
45 AMIODARONE NNP I-NP B-m
45 HCL NNP I-NP I-m
45 &amp; NNP I-NP O
45 WARFARIN NNP I-NP B-m
46 Reason NNP I-NP O
46 for IN B-VP O
46 override: NN B-NP O
46 monitor NN I-NP O
46 INR NNP I-NP O
47 NATURAL NNP I-NP B-m
47 TEARS NNP I-NP I-m
47 ( ( O I-m
47 ARTIFICIAL NNP B-NP I-m
47 TEARS NNP I-NP I-m
47 ) ) O I-m
47 2 CD O B-do
47 DROP NNP B-NP I-do
47 OU NNP I-NP B-mo
47 BID NNP I-NP B-f
48 COLACE NNP I-NP B-m
48 ( ( O I-m
48 DOCUSATE NNP B-NP I-m
48 SODIUM NNP I-NP I-m
48 ) ) O I-m
48 100 CD O B-do
48 MG NNP B-NP I-do
48 PO NNP I-NP B-mo
48 BID NNP I-NP B-f
49 PLAQUENIL NNP I-NP B-m
49 SULFATE NNP I-NP I-m
49 ( ( O I-m
49 HYDROXYCHLOROQUINE NNP B-NP I-m
49 ) ) O I-m
49 200 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 BID NNP I-NP B-f
50 Food/Drug NNP I-NP O
50 Interaction NNP I-NP O
50 Instruction NNP I-NP O
50 Take NNP I-NP O
50 with IN B-VP O
50 food NN B-NP O
51 ISORDIL NNP I-NP B-m
51 ( ( O I-m
51 ISOSORBIDE NNP B-NP I-m
51 DINITRATE NNP I-NP I-m
51 ) ) O I-m
51 20 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 TID NNP I-NP B-f
52 HOLD NNP I-NP O
52 IF: NNP I-NP O
52 SBP NNP I-NP O
52 &lt;110 NNP I-NP O
53 LISINOPRIL NNP I-NP B-m
53 20 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 DAILY NNP I-NP B-f
53 HOLD NNP I-NP O
53 IF: NNP I-NP O
53 SBP NNP I-NP O
53 &lt;110 NNP I-NP O
54 MILK NNP I-NP B-m
54 OF NNP I-NP I-m
54 MAGNESIA NNP I-NP I-m
54 ( ( O I-m
54 MAGNESIUM NNP B-NP I-m
54 HYDROXIDE NNP I-NP I-m
54 ) ) O I-m
55 30 CD O B-do
55 MILLILITERS NNP B-NP I-do
55 PO NNP I-NP B-mo
55 DAILY NNP I-NP B-f
55 PRN NNP I-NP I-f
55 Constipation NNP I-NP B-r
56 COUMADIN NNP I-NP B-m
56 ( ( O I-m
56 WARFARIN NNP B-NP I-m
56 SODIUM NNP I-NP I-m
56 ) ) O I-m
56 2.5 CD O B-do
56 MG NNP B-NP I-do
56 PO NNP I-NP B-mo
56 QPM NNP I-NP B-f
57 Starting NNP I-NP O
57 ROUTINE NNP I-NP O
57 , , O O
57 20:00 CD O O
57 ( ( O O
57 Standard NNP B-NP O
57 Admin NNP I-NP O
57 Time NNP I-NP O
57 ) ) O O
58 Instructions: NNP B-NP O
58 Pt NNP I-NP O
58 takes VBZ O O
58 coumadin VBP O B-m
58 2.5 CD O B-do
58 mg/ NNS B-NP I-do
58 5mg CD O I-do
58 once RB O B-f
58 daily JJ O I-f
58 , , O O
59 alternating JJ B-NP O
59 days NNS I-NP O
59 ( ( O O
59 5mg CD O O
59 3d/wk; CD O O
59 2.5mg CD O O
59 4d/wk CD O O
59 ) ) O O
60 Food/Drug NNP B-NP O
60 Interaction NNP I-NP O
60 Instruction NNP I-NP O
61 No NNP I-NP O
61 high JJ B-NP O
61 Vitamin-K NNP I-NP O
61 containing VBG O O
61 foods NNS B-NP O
62 Alert NNP I-NP O
62 overridden: VBD B-VP O
62 Override NNP B-NP O
62 added VBD B-VP O
62 on IN B-VP O
62 10/2/06 CD O O
62 by IN B-VP O
63 DANCY NNP B-NP O
63 , , O O
63 GERARD NNP B-NP O
63 E NNP I-NP O
63 , , O O
63 PA NNP B-NP O
64 POTENTIALLY NNP I-NP O
64 SERIOUS NNP I-NP O
64 INTERACTION: NNP I-NP O
64 AMIODARONE NNP I-NP B-m
64 HCL NNP I-NP I-m
64 &amp; NNP I-NP O
64 WARFARIN NNP I-NP B-m
65 Reason NNP I-NP O
65 for IN B-VP O
65 override: NN B-NP O
65 monitoring NN I-NP O
66 NORVASC NNP I-NP B-m
66 ( ( O I-m
66 AMLODIPINE NNP B-NP I-m
66 ) ) O I-m
66 10 CD O B-do
66 MG NNP B-NP I-do
66 PO NNP I-NP B-mo
66 DAILY NNP I-NP B-f
66 HOLD NNP I-NP O
66 IF: NNP I-NP O
66 SBP NNP I-NP O
66 &lt;110 NNP I-NP O
67 Food/Drug NNP I-NP O
67 Interaction NNP I-NP O
67 Instruction NNP I-NP O
68 Avoid NNP I-NP O
68 grapefruit NN I-NP O
68 unless IN B-VP O
68 MD NNP B-NP O
68 instructs NNS I-NP O
68 otherwise RB O O
69 NEURONTIN NNP B-NP B-m
69 ( ( O I-m
69 GABAPENTIN NNP B-NP I-m
69 ) ) O I-m
69 300 CD O B-do
69 MG NNP B-NP I-do
69 PO NNP I-NP B-mo
69 TID NNP I-NP B-f
70 NEXIUM NNP I-NP B-m
70 ( ( O I-m
70 ESOMEPRAZOLE NNP B-NP I-m
70 ) ) O I-m
70 20 CD O B-do
70 MG NNP B-NP I-do
70 PO NNP I-NP B-mo
70 DAILY NNP I-NP B-f
71 MAALOX-TABLETS NNP I-NP B-m
71 QUICK NNP I-NP I-m
71 DISSOLVE/CHEWABLE NNP I-NP I-m
71 1-2 JJ B-NP B-do
71 TAB NNP I-NP I-do
71 PO NNP I-NP B-mo
71 Q6H NNP I-NP B-f
72 PRN NNP I-NP O
72 Upset NNP I-NP B-r
72 Stomach NNP I-NP I-r
73 DULCOLAX NNP I-NP B-m
73 RECTAL NNP I-NP I-m
73 ( ( O I-m
73 BISACODYL NNP B-NP I-m
73 RECTAL NNP I-NP I-m
73 ) ) O I-m
73 10 CD O B-do
73 MG NNP B-NP I-do
73 PR NNP I-NP B-mo
73 DAILY NNP I-NP B-f
74 PRN NNP I-NP O
74 Constipation NNP I-NP B-r
75 CLOTRIMAZOLE NNP I-NP B-m
75 1% CD O I-m
75 TOPICAL NNP B-NP I-m
75 TOPICAL NNP I-NP B-mo
75 TP NNP I-NP I-mo
75 BID NNP I-NP B-f
76 Instructions: NNP I-NP O
76 apply VBP O O
76 to TO O O
76 feet NNS B-NP O
76 bilat JJ B-NP O
77 GLYBURIDE NNP I-NP B-m
77 5 CD O B-do
77 MG NNP B-NP I-do
77 PO NNP I-NP B-mo
77 BID NNP I-NP B-f
78 Alert NNP I-NP O
78 overridden: NNP I-NP O
78 Override NNP I-NP O
78 added VBD B-VP O
78 on IN B-VP O
78 10/2/06 CD O O
78 by IN B-VP O
78 : : O O
79 on IN B-VP O
79 order NN B-NP O
79 for IN B-VP O
79 GLYBURIDE NNP B-NP B-m
79 PO NNP I-NP B-mo
79 ( ( O O
79 ref JJ O O
79 # # O O
79 086901876 CD O O
79 ) ) O O
80 Pt NNP B-NP O
80 has VBZ O O
80 a DT B-NP O
80 POSSIBLE NNP I-NP O
80 allergy NN I-NP O
80 to TO O O
80 Sulfa; NNP B-NP O
80 reaction NN I-NP O
80 is VBZ O O
80 Unknown JJ B-NP O
81 Reason NNP I-NP O
81 for IN B-VP O
81 override: NN B-NP O
81 pt NN I-NP O
81 takes VBZ O O
81 regularly RB O O
81 at IN B-VP O
81 baseline NN B-NP O
82 LASIX NNP I-NP B-m
82 ( ( O I-m
82 FUROSEMIDE NNP B-NP I-m
82 ) ) O I-m
82 20 CD O B-do
82 MG NNP B-NP I-do
82 PO NNP I-NP B-mo
82 DAILY NNP I-NP B-f
83 Starting VBG O O
83 Today NNP B-NP O
83 February NNP I-NP O
84 Instructions: NNP I-NP O
84 Of IN B-VP O
84 note: JJ B-NP O
84 pt NN I-NP O
84 was VBD B-VP O
84 on IN B-VP O
84 40 CD O O
84 daily JJ O O
84 at IN B-VP O
84 baseline NN B-NP O
84 yet RB O O
85 was VBD B-VP O
85 held VBN O O
85 during IN B-VP O
85 admission NN B-NP O
85 for IN B-VP O
85 renal JJ B-NP O
85 insuff NN I-NP O
85 , , O O
85 since IN B-VP O
85 renal JJ B-NP O
85 fx NN I-NP O
86 corrected VBD B-VP O
86 pt NN B-NP O
86 restarted VBN O O
86 on IN B-VP O
86 lasix NN B-NP B-m
86 20 CD O B-do
86 qd NN B-NP B-f
86 on IN B-VP O
86 d/c NN B-NP O
87 Alert NNP I-NP O
87 overridden: NNP I-NP O
87 Override NNP I-NP O
87 added VBD B-VP O
87 on IN B-VP O
87 10/2/06 CD O O
87 by IN B-VP O
87 : : O O
88 on IN B-VP O
88 order NN B-NP O
88 for IN B-VP O
88 LASIX NNP B-NP B-m
88 PO NNP I-NP B-mo
88 ( ( O O
88 ref JJ O O
88 # # O O
88 684783802 CD O O
88 ) ) O O
89 Pt NNP B-NP O
89 has VBZ O O
89 a DT B-NP O
89 POSSIBLE NNP I-NP O
89 allergy NN I-NP O
89 to TO O O
89 Sulfa; NNP B-NP O
89 reaction NN I-NP O
89 is VBZ O O
89 Unknown JJ B-NP O
90 Reason NNP I-NP O
90 for IN B-VP O
90 override: NN B-NP O
90 monitored VBD B-VP O
91 DIET: NNP B-NP O
91 House NNP I-NP O
91 / NNP I-NP O
91 NAS NNP I-NP O
91 / NNP I-NP O
91 Carbohydrate NNP I-NP O
91 Controlled NNP I-NP O
91 / NNP I-NP O
91 Low NNP I-NP O
91 saturated VBD B-VP O
91 fat JJ B-NP O
92 low JJ I-NP O
92 cholesterol NN I-NP O
93 ACTIVITY: NNP I-NP O
93 Walking NNP I-NP O
93 as IN B-VP O
93 tolerated VBN O O
94 per IN B-VP O
94 physical JJ B-NP O
94 therapy NN I-NP O
94 recs NN I-NP O
95 FOLLOW NNP I-NP O
95 UP NNP I-NP O
95 APPOINTMENT( NNP I-NP O
95 S NNP I-NP O
95 ): NNP I-NP O
96 Dr NNP I-NP O
96 Mcnichol NNP I-NP O
96 ( ( O O
96 MH NNP B-NP O
96 MD NNP I-NP O
96 ) ) O O
96 724-105-6354 CD O O
96 2/10 CD O O
96 @ NN B-NP O
96 8:30am CD O O
96 , , O O
97 Dr NNP B-NP O
97 Jacob NNP I-NP O
97 Hainer NNP I-NP O
97 in IN B-VP O
97 SONMEN'S NNP B-NP O
97 COMMUNITY NNP I-NP O
97 MEMORIAL NNP I-NP O
97 HOSPITAL NNP I-NP O
97 ( ( O O
97 Dr NNP B-NP O
97 Krag NNP I-NP O
97 is VBZ O O
97 away RB O O
97 ) ) O O
97 291-538-5457 JJ O O
97 2/10 CD O O
97 @ JJ O O
97 9:15 CD O O
97 , , O O
98 psych NN B-NP O
98 will MD O O
98 call VB O O
98 the DT B-NP O
98 patient NN I-NP O
98 within IN B-VP O
98 24-48hrs JJ O O
98 780-484-6591 JJ O O
98 , , O O
99 Dr NNP B-NP O
99 Harty NNP I-NP O
99 - : O O
99 in IN B-VP O
99 the DT B-NP O
99 arthritis NN I-NP O
99 center NN I-NP O
99 Cean NNP I-NP O
99 Rockca NNP I-NP O
99 506-776-0600 JJ O O
99 0/8 CD O O
99 @ JJ O O
99 3:30 CD O O
99 , , O O
100 Arrange NNP B-NP O
100 INR NNP I-NP O
100 to TO O O
100 be VB O O
100 drawn VBN O O
100 on IN B-VP O
100 9/11/06 CD O O
100 with IN B-VP O
100 f/u JJ B-NP O
100 INR's NNP I-NP O
100 to TO O O
100 be VB O O
100 drawn VBN O O
100 every DT O O
101 3 CD O O
101 days NNS B-NP O
101 INR's NNP I-NP O
101 will MD O O
101 be VB O O
101 followed VBN O O
101 by IN B-VP O
101 Dr NNP B-NP O
101 Stanko NNP I-NP O
101 ( ( O O
101 PCP NNP B-NP O
101 ) ) O O
102 ALLERGY: NNP B-NP O
102 QUININE NNP I-NP O
102 , , O O
102 Aspirin NNP B-NP O
102 , , O O
102 Sulfa NNP B-NP O
102 , , O O
102 Penicillins NNP B-NP O
103 ADMIT NNP I-NP O
103 DIAGNOSIS: NNP I-NP O
104 s/p VBD B-VP O
104 mech JJ B-NP O
104 fall NN I-NP O
105 PRINCIPAL NNP I-NP O
105 DISCHARGE NNP I-NP O
105 DIAGNOSIS NNP I-NP O
105 ;Responsible JJ O O
105 After IN B-VP O
105 Study NNP B-NP O
105 for IN B-VP O
105 Causing NNP B-NP O
105 Admission NNP I-NP O
105 ) ) O O
106 s/p VBD B-VP O
106 mechanical JJ B-NP O
106 fall NN I-NP O
106 , , O O
107 OTHER NNP B-NP O
107 DIAGNOSIS;Conditions NNP I-NP O
107 , , O O
107 Infections NNP B-NP O
107 , , O O
107 Complications NNP B-NP O
107 , , O O
107 affecting VBG O O
107 Treatment/Stay NNP B-NP O
108 HTN NNP I-NP O
108 , , O O
108 CHF NNP B-NP O
108 , , O O
108 s/p NN B-NP O
108 St NNP I-NP O
108 Jude NNP I-NP O
108 MVR NNP I-NP O
108 for IN B-VP O
108 MS NNP B-NP O
108 , , O O
108 Hx NNP B-NP O
108 AFib/flutter NNP I-NP O
108 , , O O
108 s/p NN B-NP O
108 IMI NNP I-NP O
108 , , O O
108 NIDDM NNP B-NP O
108 , , O O
108 gout NN B-NP O
109 Hx NNP I-NP O
109 DVT NNP I-NP O
109 '70 NNP I-NP O
109 , , O O
109 s/p NN B-NP O
109 appy JJ O O
109 , , O O
109 s/p JJ B-NP O
109 umbilical JJ I-NP O
109 hernia NN I-NP O
109 repair NN I-NP O
109 , , O O
109 s/p JJ B-NP O
109 sigmoidectomy NN I-NP O
109 for IN B-VP O
110 diverticulitis NN B-NP O
110 s/p NN I-NP O
110 L NNP I-NP O
110 hip NN I-NP O
110 # # O O
110 '95 CD O O
110 , , O O
110 PE NNP B-NP O
110 , , O O
110 heart NN B-NP O
110 block NN I-NP O
110 ( ( O O
110 third JJ O O
110 degree VBP O O
110 heart NN B-NP O
111 block NN I-NP O
111 ) ) O O
111 , , O O
111 s/p JJ B-NP O
111 DDD NNP I-NP O
111 pacer NN I-NP O
112 OPERATIONS NNP I-NP O
112 AND NNP I-NP O
112 PROCEDURES: NNP I-NP O
113 none NN I-NP O
114 OTHER NNP I-NP O
114 TREATMENTS/PROCEDURES NNP I-NP O
114 ( ( O O
114 NOT NNP B-NP O
114 IN NNP I-NP O
114 O.R NNP I-NP O
114 ) ) O O
115 none NN B-NP O
116 BRIEF NNP I-NP O
116 RESUME NNP I-NP O
116 OF NNP I-NP O
116 HOSPITAL NNP I-NP O
116 COURSE: NNP I-NP O
117 CC: NNP I-NP O
117 fall NN I-NP O
118 --- NNP I-NP O
119 HPI: NNP I-NP O
119 83 CD O O
119 year NN B-NP O
119 old JJ B-NP O
119 F NNP I-NP O
119 with IN B-VP O
119 hx JJ B-NP O
119 CAD NNP I-NP O
119 s/p NN I-NP O
119 MI NNP I-NP O
119 , , O O
119 CHF NNP B-NP O
119 , , O O
119 Afib/aflutter NNP B-NP O
119 , , O O
119 heart NN B-NP O
119 block NN I-NP O
120 s/p NN I-NP O
120 pacer NN I-NP O
120 , , O O
120 s/p JJ B-NP O
120 St NNP I-NP O
120 Judes NNP I-NP O
120 MVR NNP I-NP O
120 , , O O
120 NIDDM NNP B-NP O
120 , , O O
120 hx NN B-NP O
120 PE NNP I-NP O
120 , , O O
120 hx NN B-NP O
120 L NNP I-NP O
120 hip NN I-NP O
120 fx NN I-NP O
120 s/p NN I-NP O
120 screws NNS I-NP O
120 since IN B-VP O
121 removed VBN O O
121 who WP O O
121 presents VBZ O O
121 with IN B-VP O
121 fall NN B-NP O
121 She PRP O O
121 was VBD B-VP O
121 reportedly RB O O
121 trying VBG O O
121 to TO O O
121 open VB O O
121 her PRP$ O O
122 closet NN B-NP O
122 door NN I-NP O
122 when WRB O O
122 she PRP O O
122 was VBD B-VP O
122 suprised VBN O O
122 to TO O O
122 realize VB O O
122 the DT B-NP O
122 door NN I-NP O
122 was VBD B-VP O
122 already RB O O
122 ajar JJ O O
123 and CC O O
123 this DT O O
123 resulted VBD B-VP O
123 in IN B-VP O
123 her PRP$ O O
123 falling VBG O O
123 into IN B-VP O
123 the DT B-NP O
123 closet NN I-NP O
123 She PRP O O
123 could MD O O
123 not RB O O
123 get VB O O
123 up RP O O
124 She PRP O O
124 reported VBD B-VP O
124 that IN B-VP O
124 she PRP O O
124 hit VBD B-VP O
124 her PRP O O
124 "whole JJ B-NP O
124 body" NN I-NP O
124 when WRB O O
124 she PRP O O
124 fell VBD B-VP O
124 She PRP O O
124 lay VBD B-VP O
124 there EX O O
125 through IN B-VP O
125 the DT B-NP O
125 entire JJ I-NP O
125 night NN I-NP O
125 The DT B-NP O
125 following JJ I-NP O
125 day NN I-NP O
125 she PRP O O
125 was VBD B-VP O
125 able JJ O O
125 to TO O O
125 crawl VB O O
125 out IN B-VP O
125 of IN B-VP O
126 the DT B-NP O
126 closet NN I-NP O
126 Her NNP I-NP O
126 son NN I-NP O
126 was VBD B-VP O
126 concerned VBN O O
126 when WRB O O
126 she PRP O O
126 didn't VBD B-VP O
126 answer VB O O
126 the DT B-NP O
126 phone NN I-NP O
126 and CC O O
127 called VBD B-VP O
127 the DT B-NP O
127 police NN I-NP O
127 who WP O O
127 found VBD B-VP O
127 her PRP O O
127 lying VBG O O
127 on IN B-VP O
127 the DT B-NP O
127 floor NN I-NP O
127 She PRP O O
127 complained VBD B-VP O
127 on IN B-VP O
128 admission NN B-NP O
128 of IN B-VP O
128 L NNP B-NP O
128 shoulder NN I-NP O
128 pain NN I-NP O
128 , , O O
128 bilat JJ B-NP O
128 Knee NNP I-NP O
128 pain NN I-NP O
128 , , O O
128 and CC O O
128 L NNP B-NP O
128 pubic/pelvis VBP O O
128 pain NN B-NP O
129 ROS NNP I-NP O
129 otherwise RB O O
129 negative JJ O O
129 for IN B-VP O
129 syncope NN B-NP O
129 , , O O
129 LOC NNP B-NP O
129 , , O O
129 CP NNP B-NP O
129 , , O O
129 SOB NNP B-NP O
129 , , O O
129 F/C NNP B-NP O
129 , , O O
129 cough NN B-NP O
129 , , O O
129 diarrhea NN B-NP O
129 , , O O
130 vomiting VBG O O
131 In IN B-VP O
131 ED: NNP B-NP O
131 Pt NNP I-NP O
131 was VBD B-VP O
131 found VBN O O
131 to TO O O
131 have VB O O
131 troponin JJ B-NP O
131 leak NN I-NP O
131 of IN B-VP O
131 0.23 CD O O
131 Her PRP$ O O
131 films NNS B-NP O
131 were VBD B-VP O
132 negative JJ O O
132 except IN B-VP O
132 pelvis NN B-NP O
132 XRY NNP I-NP O
132 which WDT O O
132 showed VBD B-VP O
132 question NN B-NP O
132 of IN B-VP O
132 pubic JJ B-NP O
132 ramus JJ I-NP O
133 fracture NN I-NP O
134 --- NNP I-NP O
135 Data: NNP I-NP O
136 EKG: NNP I-NP O
136 Prolonged NNP I-NP O
136 QT NNP I-NP O
136 interval NN I-NP O
136 , , O O
136 otherwise RB O O
136 unchanged JJ B-NP O
137 CXR: NNP I-NP O
137 neg NN I-NP O
137 for IN B-VP O
137 acute JJ B-NP O
137 cardiopulm NN I-NP O
137 dz NN I-NP O
138 Head NNP I-NP O
138 CT: NNP I-NP O
138 neg JJ B-NP O
139 Cspine NNP I-NP O
139 CT: NNP I-NP O
139 neg MD O O
140 L NNP B-NP O
140 shoulder VB O O
140 film: JJ B-NP O
140 neg JJ I-NP O
141 Bilat NNP I-NP O
141 knee NN I-NP O
141 film: NN I-NP O
141 neg JJ B-NP O
142 Pelvis NNP I-NP O
142 XRY: NNP I-NP O
142 ?pubic NNP I-NP O
142 ramus VBZ O O
142 fracture NN B-NP O
143 Labs: NNP I-NP O
143 *Na NNP I-NP O
143 146 CD O O
143 , , O O
143 *CK NN B-NP O
143 3320 CD O O
143 , , O O
143 *CKMB VBD B-VP O
143 12.9 CD O O
143 , , O O
143 *Trop FW O O
143 0.23--&gt;0.10 JJ B-NP O
143 *AST NN I-NP O
143 107 CD O O
144 Cr: NNP B-NP O
144 1.2-&gt;1.6 JJ B-NP O
145 --- NNP I-NP O
146 Medications NNP I-NP O
146 on IN B-VP O
146 Admission: NNP B-NP O
146 Amiodarone NNP I-NP B-m
146 100 CD O B-do
146 QD NNP B-NP B-f
146 , , O O
146 Colace NNP B-NP B-m
146 100 CD O B-do
146 bid NN B-NP B-f
146 , , O O
146 lasix VBZ O B-m
146 40mg CD O B-do
147 QD NNP B-NP B-f
147 , , O O
147 Glyburide NNP B-NP B-m
147 5mg CD O B-do
147 bid NN B-NP B-f
147 , , O O
147 Plaquenil NNP B-NP B-m
147 200mg CD O B-do
147 bid NN B-NP B-f
147 , , O O
147 Isordil NNP B-NP B-m
147 20mg CD O B-do
147 tid NN B-NP B-f
147 , , O O
147 Lisinopril NNP B-NP B-m
148 20mg CD O B-do
148 QD NNP B-NP B-f
148 , , O O
148 Coumadin NNP B-NP B-m
148 Coumadin NNP I-NP B-m
148 5mg CD O B-do
148 3dys/week CD O B-f
148 , , O O
148 2.5mg CD O B-do
148 4dys/week CD O B-f
148 , , O O
148 Norvasc NNP B-NP B-m
148 10mg CD O B-do
148 QD NNP B-NP B-f
148 , , O O
149 Neurontin NNP B-NP B-m
149 300mg CD O B-do
149 TID NNP B-NP B-f
150 --- NNP I-NP O
151 ALL: NNP I-NP O
151 Quinine-hypotension NNP I-NP O
151 &amp; NNP I-NP O
151 syncope NN I-NP O
151 , , O O
151 PCN-rash NNP B-NP O
151 , , O O
151 Sulfa NNP B-NP O
151 , , O O
151 Asa-rash NNP B-NP O
152 --- NNP I-NP O
153 PMH: NNP I-NP O
153 See NNP I-NP O
153 list NN I-NP O
154 --- NNP I-NP O
155 Exam NNP I-NP O
155 on IN B-VP O
155 Admit: NNP B-NP O
156 T NNP I-NP O
156 98.5 CD O O
156 , , O O
156 HR NNP B-NP O
156 60-64 CD O O
156 , , O O
156 RR NNP B-NP O
156 16-18 CD O O
156 , , O O
156 BP NNP B-NP O
156 149-155/58-81 CD O O
156 , , O O
156 O2 NNP B-NP O
156 99% CD O O
156 on IN B-VP O
156 2L CD O O
157 GEN: NNP B-NP O
157 NAD NNP I-NP O
157 , , O O
157 of IN B-VP O
157 stated VBN O O
157 age NN B-NP O
158 HEENT: NNP I-NP O
158 L NNP I-NP O
158 eye NN I-NP O
158 not RB O O
158 opening VBG O O
158 all PDT O O
158 the DT B-NP O
158 way NN I-NP O
158 L NNP I-NP O
158 eye NN I-NP O
158 slightly RB O O
158 tender VBZ O O
158 to TO O O
158 palpation VB O O
158 , , O O
159 EOMI NNP B-NP O
159 , , O O
159 PERRLA NNP B-NP O
159 B NNP I-NP O
159 , , O O
159 Dry NNP B-NP O
159 MM NNP I-NP O
160 NECK: NNP I-NP O
160 no DT B-NP O
160 LAD NNP I-NP O
160 , , O O
160 No NNP B-NP O
160 JVD NNP I-NP O
161 LUNGS: NNP I-NP O
161 CTA NNP I-NP O
161 B NNP I-NP O
162 HEART: NNP I-NP O
162 RRR NNP I-NP O
162 nrml MD O O
162 S1 NNP B-NP O
162 , , O O
162 mechanical JJ B-NP O
162 S2 NNP I-NP O
163 ABD: NNP I-NP O
163 soft JJ O O
163 , , O O
163 NT NNP B-NP O
163 , , O O
163 ND NNP B-NP O
164 EXT: NNP I-NP O
164 L NNP I-NP O
164 shoulder NN I-NP O
164 pain NN I-NP O
164 to TO O O
164 palpation NN B-NP O
164 and CC O O
164 with IN B-VP O
164 extension JJ B-NP O
164 Hyperkeratosis NNP I-NP O
164 of IN B-VP O
164 LE NNP B-NP O
165 to TO O O
165 below VB O O
165 knees NNS B-NP O
165 bilaterally RB O O
165 L NNP B-NP O
165 pelvis NN I-NP O
165 tender NN I-NP O
165 to TO O O
165 palpation VB O O
165 L NNP B-NP O
165 leg NN I-NP O
165 SAR NNP I-NP O
166 limited VBN O O
166 by IN B-VP O
166 pain NN B-NP O
166 in IN B-VP O
166 L NNP B-NP O
166 pubic JJ B-NP O
166 area NN I-NP O
166 Strength NNP I-NP O
166 5/5 CD O O
166 otherwise RB O O
166 No DT B-NP O
166 cyanosis NN I-NP O
167 --- NNP I-NP O
168 Hospital NNP I-NP O
168 Course: NNP I-NP O
169 1 CD O O
169 ) ) O O
169 ORTHO: IN B-VP O
169 The DT B-NP O
169 patient NN I-NP O
169 was VBD B-VP O
169 admitted VBN O O
169 s/p JJ B-NP O
169 fall NN I-NP O
169 with IN B-VP O
169 concern NN B-NP O
169 for IN B-VP O
169 pelvic JJ B-NP O
170 fracture NN I-NP O
170 from IN B-VP O
170 XRY NNP B-NP O
170 Shoulder NNP I-NP O
170 , , O O
170 hip NN B-NP O
170 , , O O
170 pelvic JJ B-NP O
170 films NNS I-NP O
170 negative JJ O O
170 for IN B-VP O
170 fx NN B-NP O
170 or CC O O
171 dislocation NN B-NP O
171 except IN B-VP O
171 abnl NN B-NP O
171 finding VBG O O
171 R NNP B-NP O
171 pelvic JJ B-NP O
171 ramus NN I-NP O
171 Unable JJ O O
171 to TO O O
171 perform VB O O
171 MRI NNP B-NP O
172 2/2 CD O O
172 valve NN B-NP O
172 and CC O O
172 pacer NN B-NP O
172 CT NNP I-NP O
172 pelvis NN I-NP O
172 negative NN I-NP O
172 for IN B-VP O
172 pelvic JJ B-NP O
172 fx NN I-NP O
172 Pain NNP I-NP B-r
172 controlled VBD B-VP O
173 with IN B-VP O
173 APAP NNP B-NP B-m
173 prn NN I-NP B-f
173 PT NNP I-NP O
173 consult NN I-NP O
173 obtained VBD B-VP O
173 3/21 CD O O
173 and CC O O
173 to TO O O
173 follow VB O O
173 daily RB O O
173 at IN B-VP O
173 rehab NN B-NP O
174 --- NNP I-NP O
175 2 CD O O
175 ) ) O O
175 GYN: NNP B-NP O
175 CT NNP I-NP O
175 pelvis NN I-NP O
175 did VBD B-VP O
175 show VB O O
175 R NNP B-NP O
175 adnexal JJ B-NP O
175 cyst NN I-NP O
175 on IN B-VP O
175 prelim NN B-NP O
175 read NN I-NP O
175 which WDT O O
175 will MD O O
175 need VB O O
176 further JJ B-NP O
176 characterization NN I-NP O
176 by IN B-VP O
176 US NNP B-NP O
176 and CC O O
176 outpt RB O O
176 follow VB O O
176 up RP O O
177 --- RB O O
178 3 CD O O
178 ) ) O O
178 CV: NNP B-NP O
178 She PRP O O
178 has VBZ O O
178 extensive JJ B-NP O
178 cardiac JJ I-NP O
178 history NN I-NP O
178 as IN B-VP O
178 above IN B-VP O
178 Her NNP B-NP O
178 fall NN I-NP O
178 is VBZ O O
178 not RB O O
179 likely JJ O O
179 related VBN O O
179 to TO O O
179 cardiac JJ B-NP O
179 issue NN I-NP O
179 as IN B-VP O
179 it PRP O O
179 appears VBZ O O
179 mechanical JJ O O
179 , , O O
179 no DT B-NP O
179 syncope NN I-NP O
179 , , O O
180 chest NN B-NP O
180 pain NN I-NP O
180 , , O O
180 etc FW O O
180 ISCHEMIA: NNP B-NP O
180 NSTEMI NNP I-NP O
180 w/ VBD B-VP O
180 small JJ B-NP O
180 TnI NNP I-NP O
180 leak NN I-NP O
180 , , O O
180 likely JJ B-NP O
180 demand NN I-NP O
181 related VBN O O
181 in IN B-VP O
181 setting NN B-NP O
181 of IN B-VP O
181 hypovolemia NN B-NP O
181 , , O O
181 fall NN B-NP O
181 Enzymes NNP I-NP O
181 trended VBD B-VP O
181 down RP O O
181 PUMP: NNP B-NP O
181 Dry NNP I-NP O
182 on IN B-VP O
182 admission NN B-NP O
182 Rehydrated VBN O O
182 with IN B-VP O
182 IVF NNP B-NP B-m
182 , , O O
182 po's NN B-NP O
182 encouraged VBD B-VP O
182 Euvolemic NNP B-NP O
182 by IN B-VP O
182 1/2 CD O O
183 JVP NNP B-NP O
183 up RB O O
183 to TO O O
183 12cm CD O O
183 , , O O
183 but CC O O
183 difficult JJ O O
183 to TO O O
183 gauge VB O O
183 volume NN B-NP O
183 status NN I-NP O
183 2/2 CD O O
183 TR NNP B-NP O
183 To TO O O
184 recommence VB O O
184 lasix NN B-NP B-m
184 at IN B-VP O
184 half PDT O B-do
184 dose JJ O I-do
184 1/28 CD O O
184 PCP NNP B-NP O
184 to TO O O
184 monitor VB O O
184 and CC O O
184 titrate VB O O
184 back RB O O
184 to TO O O
185 40 CD O O
185 mg NNS B-NP O
185 daily JJ O O
185 baseline VBP O O
185 dose JJ O O
185 if IN B-VP O
185 tolerated VBN O O
185 IVF NNP B-NP O
185 d/c'd NN I-NP O
185 RHYTHM: NNP I-NP O
185 She PRP O O
185 has VBZ O O
186 prolonged VBN O O
186 QT NNP B-NP O
186 on IN B-VP O
186 admission NN B-NP O
186 , , O O
186 on IN B-VP O
186 telemetry NN B-NP O
186 Unclear NNP I-NP O
186 etiology NN I-NP O
186 ?starvation NN I-NP O
187 Monitored NNP I-NP O
187 on IN B-VP O
187 tele NN B-NP O
187 until IN B-VP O
187 ROMI NNP B-NP O
187 Avoided NNP I-NP O
187 drugs NNS I-NP O
187 that WDT O O
187 confound VBP O O
187 Resolved VBN O O
187 to TO O O
188 QTc NNP B-NP O
188 in IN B-VP O
188 low JJ O O
188 500s CD O O
188 DDD NNP B-NP O
188 pacer NN I-NP O
188 functioning VBG O O
188 with IN B-VP O
188 V-pacing NNP B-NP O
188 at IN B-VP O
188 60bpm CD O O
189 --- $ O O
190 4 CD O O
190 )ENDO: NNP B-NP O
190 Holding NNP I-NP O
190 Glypizide NNP I-NP B-m
190 while IN B-VP B-du
190 in IN B-VP I-du
190 house NN B-NP I-du
190 Novolog NNP I-NP B-m
190 sliding VBG O B-do
190 scale JJ O I-do
191 Starting VBG O O
191 low JJ B-NP O
191 dose JJ I-NP O
191 NPH NNP I-NP B-m
191 6 CD O B-do
191 units NNS B-NP I-do
191 BID NNP I-NP B-f
191 on IN B-VP O
191 1/2 CD O O
191 Monitored NNP B-NP O
191 FS NNP I-NP O
191 daily RB O O
191 and CC O O
192 adjusted VBN O O
192 scale NN B-NP O
192 prn NN I-NP O
193 --- NNP I-NP O
194 5 CD O O
194 ) ) O O
194 HEME: NNP B-NP O
194 She PRP O O
194 is VBZ O O
194 on IN B-VP O
194 Coumadin NNP B-NP B-m
194 for IN B-VP O
194 St NNP B-NP O
194 Judes NNP I-NP O
194 Valve NNP I-NP O
194 , , O O
194 afib/flutter NN B-NP O
194 and CC O O
194 hx NN B-NP O
195 PEs NNP I-NP O
195 She PRP O O
195 did VBD B-VP O
195 not RB O O
195 take VB O O
195 coumadin NN B-NP O
195 the DT O O
195 last JJ O O
195 two CD O O
195 nights NNS B-NP O
195 before IN B-VP O
195 admission NN B-NP O
196 because IN B-VP O
196 of IN B-VP O
196 lying VBG O O
196 on IN B-VP O
196 the DT B-NP O
196 floor NN I-NP O
196 s/p NN I-NP O
196 fall NN I-NP O
196 Her NNP I-NP O
196 INR NNP I-NP O
196 was VBD B-VP O
196 subtherapeutic JJ O O
196 on IN B-VP O
197 admission NN B-NP O
197 Bridged NNP I-NP O
197 w/ NN I-NP O
197 lovenox NN I-NP B-m
197 and CC O O
197 INR NNP B-NP O
197 therapeutic JJ O O
197 1/2 CD O O
197 and CC O O
197 restarted VBN O O
197 on IN B-VP O
198 home NN B-NP B-m
198 regimen NNS I-NP I-m
198 of IN B-VP O
198 5/2.5mg CD O B-do
198 5/2.5mg CD O B-do
198 variable JJ B-NP I-do
198 dose JJ I-NP I-do
199 ***Needs NNS I-NP O
199 to TO O O
199 be VB O O
199 dosed VBN O O
199 daily RB O O
199 because IN B-VP O
199 of IN B-VP O
199 variable JJ B-NP O
199 dose JJ I-NP O
200 --- NNP I-NP O
201 6 CD O O
201 ) ) O O
201 FEN: NNP B-NP O
201 of IN B-VP O
201 note NN B-NP O
201 pt NN I-NP O
201 on IN B-VP O
201 80mg CD O B-do
201 lasix JJ O B-m
201 daily RB O B-f
201 at IN B-VP O
201 home NN B-NP O
201 yet RB O O
201 dry JJ O O
201 on IN B-VP O
201 admission NN B-NP O
201 with IN B-VP O
202 worsening VBG O O
202 renal JJ B-NP O
202 fx NN I-NP O
202 , , O O
202 thus RB O O
202 lasix JJ O B-m
202 held VBD B-VP O
202 Restarted VBN O O
202 on IN B-VP O
202 lasix NN B-NP B-m
202 20 CD O B-do
202 qd NN B-NP B-f
202 on IN B-VP O
202 day NN B-NP O
203 of IN B-VP O
203 d/c NN B-NP O
203 - : O O
203 to TO O O
203 be VB O O
203 monitored VBN O O
203 by IN B-VP O
203 PCP NNP B-NP O
204 --- NNP I-NP O
205 7 CD O O
205 ) ) O O
205 PPX NNP B-NP O
205 Lovenox/coumadin NNP I-NP B-m
206 --- NNP I-NP O
207 FULL NNP I-NP O
207 CODE NNP I-NP O
208 ADDITIONAL NNP I-NP O
208 COMMENTS: NNP I-NP O
208 1 CD O O
208 VNA NNP B-NP O
208 to TO O O
208 draw VB O O
208 INR NNP B-NP O
208 Q3 NNP I-NP O
208 days NNS I-NP O
208 and CC O O
208 call VB O O
208 PCP NNP B-NP O
208 with IN B-VP O
208 result NN B-NP O
208 for IN B-VP O
208 coumadin NN B-NP B-m
208 dosing VBG O O
209 management/adjustments NNS B-NP O
210 2 CD O O
210 PCP NNP B-NP O
210 to TO O O
210 follow-up NN B-NP O
210 with IN B-VP O
210 HgA1C NNP B-NP O
210 and CC O O
210 manage VB O O
210 DM NNP B-NP O
210 medications NNS I-NP O
210 Recommend NNP I-NP O
210 pt NN I-NP O
211 be VB O O
211 started VBN O O
211 on IN B-VP O
211 STATIN NNP B-NP B-m
211 and CC O O
211 LFTs NNP B-NP O
211 followed VBD B-VP O
212 3 CD O O
212 Physical NNP B-NP O
212 Therapy NNP I-NP O
212 to TO O O
212 follow VB O O
212 daily RB O O
212 at IN B-VP O
212 rehab NN B-NP O
212 for IN B-VP O
212 strength/conditioning/ JJ B-NP O
213 ambulatory/ JJ I-NP O
213 safety NN I-NP O
213 needs NNS I-NP O
214 DISCHARGE NNP I-NP O
214 CONDITION: NNP I-NP O
214 Stable NNP I-NP O
215 TO NNP I-NP O
215 DO/PLAN: NNP I-NP O
216 No NNP I-NP O
216 dictated VBD B-VP O
216 summary JJ B-NP O
217 ENTERED NNP I-NP O
217 BY: NNP I-NP O
217 ROCKAFELLOW NNP I-NP O
217 , , O O
217 CARMEN NNP B-NP O
217 B NNP I-NP O
217 , , O O
217 PA NNP B-NP O
217 ( ( O O
217 NM87 NNP B-NP O
217 ) ) O O
217 10/2/06 CD O O
217 @ $ O O
217 11:11 CD O O
217 AM NNP B-NP O
218 ****** JJ B-NP O
218 END NN I-NP O
218 OF NNP I-NP O
218 DISCHARGE NNP I-NP O
218 ORDERS NNP I-NP O
218 ****** NNP I-NP O
219 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #471570 VBZ O O
4 837820887 CD O O
4 SMMC NNP B-NP O
4 73429706 CD O O
4 888579 CD O O
4 0/22/1998 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 RENAL NNP I-NP O
4 FAILURE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/7/1998 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/19/1998 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 RIGHT NNP I-NP O
7 GROIN NNP I-NP O
7 ABSCESS NNP I-NP O
8 PROBLEM NNP I-NP O
8 LIST: NNP I-NP O
8 ( ( O O
8 1 CD O O
8 ) ) O O
8 Status NNP B-NP O
8 post NN I-NP O
8 renal JJ B-NP O
8 transplantation NN I-NP O
8 , , O O
8 living VBG O O
9 related VBN O O
9 donor NN B-NP O
9 May NNP I-NP O
9 1997 CD O O
9 , , O O
9 ( ( O O
9 2 CD O O
9 ) ) O O
9 hypertension NN B-NP O
9 , , O O
9 ( ( O O
9 3 CD O O
9 ) ) O O
10 insulin-dependent NN B-NP O
10 diabetes NNS I-NP O
10 mellitus NN I-NP O
10 , , O O
10 ( ( O O
10 4 CD O O
10 ) ) O O
10 pulmonary JJ B-NP O
10 hypertension NN I-NP O
10 , , O O
11 ( ( O O
11 5 CD O O
11 ) ) O O
11 hyperthyroidism NN B-NP O
11 , , O O
11 ( ( O O
11 6 CD O O
11 ) ) O O
11 hyperparathyroidism NN B-NP O
11 , , O O
11 ( ( O O
11 7 CD O O
11 ) ) O O
12 hypertriglyceridemia NN B-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 is VBZ O O
13 a DT B-NP O
13 42-year-old JJ I-NP O
13 white JJ I-NP O
14 man NN I-NP O
14 who WP O O
14 presents VBZ O O
14 with IN B-VP O
14 complaints NNS B-NP O
14 of IN B-VP O
15 fever NN B-NP O
15 to TO O O
15 103 CD O O
15 and CC O O
15 chills NNS B-NP O
15 , , O O
15 a DT B-NP O
15 productive JJ I-NP O
15 cough NN I-NP O
15 and CC O O
15 groin NN B-NP O
15 pain NN I-NP O
15 lasting JJ O O
16 three CD O O
16 days NNS B-NP O
16 At IN B-VP O
16 age NN B-NP O
16 three CD O O
16 , , O O
16 the DT B-NP O
16 patient NN I-NP O
16 was VBD B-VP O
16 diagnosed VBN O O
16 with IN B-VP O
16 Wilms' NNP B-NP O
17 tumor NN I-NP O
17 on IN B-VP O
17 the DT B-NP O
17 left NN I-NP O
17 , , O O
17 which WDT O O
17 was VBD B-VP O
17 resected VBN O O
17 and CC O O
17 subsequently RB O O
17 treated VBN O O
17 with IN B-VP O
18 wide JJ B-NP O
18 field NN I-NP O
18 radiation NN I-NP O
18 The DT B-NP O
18 patient NN I-NP O
18 , , O O
18 thereafter RB O O
18 developed VBD B-VP O
19 radiation-induced JJ B-NP O
19 tyroid NN I-NP O
19 cancer NN I-NP O
19 , , O O
19 at IN B-VP O
19 which WDT O O
19 time NN B-NP O
19 he PRP O O
19 underwent JJ B-NP O
20 subtotal JJ I-NP O
20 thyroidectomy NN I-NP O
20 In IN B-VP O
20 addition NN B-NP O
20 , , O O
20 the DT B-NP O
20 patient NN I-NP O
20 developed VBD B-VP O
21 radiation NN B-NP O
21 nephritis NN I-NP O
21 in IN B-VP O
21 his PRP$ O O
21 remaining VBG O O
21 right JJ B-NP O
21 kidney NN I-NP O
21 and CC O O
21 pulmonary JJ B-NP O
22 fibrosis NN I-NP O
22 In IN B-VP O
22 May NNP B-NP O
22 of IN B-VP O
22 1997 CD O O
22 , , O O
22 the DT B-NP O
22 patient NN I-NP O
22 underwent JJ B-NP O
22 living NN I-NP O
22 related VBN O O
23 donor JJ B-NP O
23 renal JJ I-NP O
23 transplantation NN I-NP O
23 for IN B-VP O
23 chronic JJ B-NP O
23 renal JJ I-NP O
23 failure NN I-NP O
23 The DT B-NP O
23 patient NN I-NP O
24 was VBD B-VP O
24 at IN B-VP O
24 that DT B-NP O
24 point NN I-NP O
24 CMV NNP I-NP O
24 antigen NN I-NP O
24 negative NN I-NP O
24 , , O O
24 however RB O O
24 , , O O
24 the DT B-NP O
24 donor NN I-NP O
24 kidney NN I-NP O
25 was VBD B-VP O
25 CMV NNP B-NP O
25 antigen NN I-NP O
25 positive JJ O O
25 The DT B-NP O
25 patient JJ I-NP O
25 underwent NN I-NP O
25 an DT B-NP O
25 uncomplicated JJ I-NP O
26 transplantation NN I-NP O
26 , , O O
26 however RB O O
26 , , O O
26 the DT B-NP O
26 postoperative JJ I-NP O
26 course NN I-NP O
26 was VBD B-VP O
26 complicated VBN O O
27 by IN B-VP O
27 cytomegalovirus NN B-NP B-r
27 infection NN I-NP I-r
27 , , O O
27 presenting VBG O O
27 with IN B-VP O
27 diarrhea NN B-NP O
27 and CC O O
28 requiring VBG O O
28 hospitalization NN B-NP O
28 in IN B-VP O
28 February NNP B-NP O
28 1997 CD O O
28 The DT B-NP O
28 patient NN I-NP O
28 was VBD B-VP O
28 treated VBN O O
29 with IN B-VP O
29 ganciclovir NN B-NP B-m
29 and CC O O
29 subsequently RB O O
29 maintained VBN O O
29 on IN B-VP O
29 Cytovene NNP B-NP B-m
29 The DT B-NP O
30 patient NN I-NP O
30 remained VBD B-VP O
30 healthy JJ O O
30 until IN B-VP O
30 November NNP B-NP O
30 1997 CD O O
30 , , O O
30 at IN B-VP O
30 which WDT O O
30 time NN B-NP O
30 he PRP O O
30 was VBD B-VP O
31 again RB O O
31 admitted VBN O O
31 for IN B-VP O
31 a DT B-NP O
31 recrudescence NN I-NP O
31 of IN B-VP O
31 his PRP$ O O
31 cytomegalovirus NN B-NP O
32 infection NN I-NP O
32 In IN B-VP O
32 November NNP B-NP O
32 1997 CD O O
32 , , O O
32 the DT B-NP O
32 patient NN I-NP O
32 presented VBN O O
32 with IN B-VP O
32 a DT B-NP O
33 three-day JJ I-NP O
33 history NN I-NP O
33 of IN B-VP O
33 fever NN B-NP O
33 to TO O O
33 approximately RB O O
33 105 CD O O
33 , , O O
33 anorexia NN B-NP O
33 , , O O
33 dry JJ B-NP O
34 cough NN I-NP B-r
34 , , O O
34 fatigue NN B-NP B-r
34 , , O O
34 headache NN B-NP B-r
34 , , O O
34 dizziness NN B-NP B-r
34 , , O O
34 sweats NNS B-NP B-r
34 , , O O
34 nausea NN B-NP O
34 and CC O O
34 dyspnea NN B-NP B-r
34 on IN B-VP O
35 exertion NN B-NP O
35 The DT B-NP O
35 patient NN I-NP O
35 was VBD B-VP O
35 , , O O
35 at IN B-VP O
35 that DT B-NP O
35 point NN I-NP O
35 , , O O
35 treated VBN O O
35 with IN B-VP O
36 ganciclovir JJ B-NP B-m
36 ganciclovir NN I-NP B-m
36 ganciclovir NN I-NP B-m
36 ganciclovir NN I-NP B-m
36 ganciclovir NN I-NP B-m
36 ganciclovir NN I-NP B-m
36 ganciclovir NN I-NP B-m
36 , , O O
36 however RB O O
36 his PRP$ O O
36 fevers NNS B-NP O
36 persisted VBD B-VP O
36 and CC O O
36 he PRP O O
36 was VBD B-VP O
36 discharged VBN O O
37 after IN B-VP O
37 five CD O B-du
37 five CD O B-du
37 five CD O B-du
37 five CD O B-du
37 five CD O B-du
37 five CD O B-du
37 five CD O B-du
37 days NNS B-NP I-du
37 days NNS I-NP I-du
37 days NNS I-NP I-du
37 days NNS I-NP I-du
37 days NNS I-NP I-du
37 days NNS I-NP I-du
37 days NNS I-NP I-du
37 of IN B-VP O
37 therapy NN B-NP O
37 At IN B-VP O
37 that DT B-NP O
37 time NN I-NP O
37 , , O O
37 the DT B-NP O
37 patient's NN I-NP O
37 CMV NNP I-NP O
38 antigen NN I-NP O
38 test NN I-NP O
38 was VBD B-VP O
38 negative JJ O O
38 , , O O
38 however RB O O
38 , , O O
38 his PRP$ O O
38 shell NN B-NP O
38 vial JJ B-NP O
38 cultures NNS I-NP O
38 , , O O
38 both DT O O
39 returned VBD B-VP O
39 as IN B-VP O
39 positive JJ O O
39 The DT B-NP O
39 patient NN I-NP O
39 was VBD B-VP O
39 maintained VBN O O
39 on IN B-VP O
39 ganciclovir NN B-NP B-m
40 therapy NN I-NP O
40 in IN B-VP O
40 the DT B-NP O
40 post NN I-NP O
40 hospital NN I-NP O
40 course NN I-NP O
40 until IN B-VP B-du
40 May NNP B-NP I-du
40 , , O I-du
40 1997 CD O I-du
40 , , O O
40 at IN B-VP O
41 which WDT O O
41 time NN B-NP O
41 his PRP$ O O
41 peripherally RB O O
41 inserted VBN O O
41 catheter NN B-NP O
41 was VBD B-VP O
41 removed VBN O O
42 Subsequently RB O O
42 , , O O
42 the DT B-NP O
42 patient NN I-NP O
42 has VBZ O O
42 been VBN O O
42 healthy JJ O O
42 for IN B-VP O
42 approximately RB O O
42 four CD O O
43 weeks NNS B-NP O
43 , , O O
43 then RB O O
43 on IN B-VP O
43 November NNP B-NP O
43 , , O O
43 1998 CD O O
43 , , O O
43 he PRP O O
43 noted VBD B-VP O
43 a DT B-NP O
43 groin JJ I-NP O
43 lump NN I-NP O
43 on IN B-VP O
43 the DT B-NP O
44 right NN I-NP O
44 From IN B-VP O
44 November NNP B-NP O
44 , , O O
44 1998 CD O O
44 , , O O
44 he PRP O O
44 noted VBD B-VP O
44 feeling VBG O O
45 worse NN B-NP O
45 with IN B-VP O
45 fevers NNS B-NP O
45 and CC O O
45 chills NNS B-NP O
45 , , O O
45 and CC O O
45 a DT B-NP O
45 productive JJ I-NP O
45 cough NN I-NP O
45 beginning NN I-NP O
45 on IN B-VP O
46 July NNP B-NP O
46 , , O O
46 1998 CD O O
46 The DT B-NP O
46 patient's NN I-NP O
46 groin NN I-NP O
46 lump NN I-NP O
46 , , O O
46 subsequently RB O O
46 , , O O
46 became VBD B-VP O
47 painful JJ O O
47 , , O O
47 and CC O O
47 he PRP O O
47 passed VBD B-VP O
47 several JJ B-NP O
47 loose JJ I-NP O
47 bowel NN I-NP O
47 movements NNS I-NP O
48 PAST NNP I-NP O
48 MEDICAL NNP I-NP O
48 HISTORY: NNP I-NP O
48 ( ( O O
48 1 CD O O
48 ) ) O O
48 Wilms' NNP B-NP O
48 tumor NN I-NP O
48 , , O O
48 ( ( O O
48 2 CD O O
48 ) ) O O
48 status NN B-NP O
48 post NN I-NP O
48 left VBD B-VP O
49 nephrectomy JJ O O
49 with IN B-VP O
49 wide JJ B-NP O
49 field NN I-NP O
49 radiation NN I-NP O
50 therapy NN I-NP O
50 , , O O
50 ( ( O O
50 3 CD O O
50 ) ) O O
50 NCH NNP B-NP O
50 renal JJ B-NP O
50 disease NN I-NP O
50 status NN I-NP O
50 post NN I-NP O
50 living NN I-NP O
50 related VBN O O
50 donor JJ B-NP O
51 renal JJ I-NP O
51 transplant NN I-NP O
51 from IN B-VP O
51 father NN B-NP O
51 in IN B-VP O
51 May NNP B-NP O
51 1997 CD O O
51 , , O O
51 ( ( O O
51 4 CD O O
51 ) ) O O
51 hypertension NN B-NP O
51 , , O O
51 ( ( O O
51 5 CD O O
51 ) ) O O
52 insulin-dependent NN B-NP O
52 diabetes NNS I-NP O
52 mellitus NN I-NP O
52 , , O O
52 ( ( O O
52 6 CD O O
52 ) ) O O
52 pulmonary JJ B-NP O
52 hypertension NN I-NP O
52 , , O O
53 ( ( O O
53 7 CD O O
53 ) ) O O
53 hyperthyroid NN B-NP O
53 , , O O
53 ( ( O O
53 8 CD O O
53 ) ) O O
53 hyperparathyroid NN B-NP O
53 , , O O
53 ( ( O O
53 9 CD O O
53 ) ) O O
53 hypertriglyceridemia NN B-NP O
53 , , O O
54 ( ( O O
54 10 CD O O
54 ) ) O O
54 gout NN B-NP O
54 , , O O
54 ( ( O O
54 11 CD O O
54 ) ) O O
54 CMV NNP B-NP O
54 infection NN I-NP O
54 in IN B-VP O
54 February NNP B-NP O
54 1997 CD O O
54 and CC O O
54 November NNP B-NP O
54 1997 CD O O
54 , , O O
55 ( ( O O
55 12 CD O O
55 ) ) O O
55 history NN B-NP O
55 of IN B-VP O
55 perirectal JJ B-NP O
55 abscess NN I-NP O
55 , , O O
55 ( ( O O
55 13 CD O O
55 ) ) O O
55 history NN B-NP O
55 of IN B-VP O
55 atrial JJ B-NP O
56 fibrillation NN I-NP O
56 spontaneously RB O O
56 converted VBN O O
56 in IN B-VP O
56 March NNP B-NP O
56 1998 CD O O
57 ALLERGIES: NNP B-NP O
57 NO NNP I-NP O
57 KNOWN NNP I-NP O
57 DRUG NNP I-NP O
57 ALLERGIES NNP I-NP O
58 ADMISSION NNP I-NP O
58 MEDICATIONS: NNP I-NP O
58 Synthroid NNP I-NP B-m
58 150 CD O B-do
58 mcg NN B-NP I-do
58 q.d NN I-NP B-f
58 , , O O
58 NPH NNP B-NP B-m
58 insulin VBZ O I-m
58 14 CD O B-do
59 units NNS B-NP O
59 q.a.m RB O B-f
59 , , O O
59 regular JJ B-NP B-m
59 insulin NN I-NP I-m
59 p.r.n NN I-NP B-f
59 , , O O
60 nadolol RB O B-m
60 80 CD O B-do
60 mg NN B-NP I-do
60 q.d NN I-NP B-f
60 , , O O
60 Prednisone NNP B-NP B-m
60 10 CD O B-do
60 mg NN B-NP I-do
60 q.d NN I-NP B-f
60 , , O O
60 Neoral NNP B-NP B-m
60 100 CD O B-do
60 mg NN B-NP I-do
60 b.i.d NN I-NP B-f
60 , , O O
61 CellCept NNP B-NP B-m
61 1 CD O B-do
61 g NN B-NP I-do
61 b.i.d NN I-NP B-f
61 , , O O
61 Axid NNP B-NP B-m
61 150 CD O B-do
61 mg NN B-NP I-do
61 q.d NN I-NP B-f
61 , , O O
61 Lasix NNP B-NP B-m
61 80 CD O B-do
61 mg NN B-NP I-do
61 p.o NN I-NP B-mo
61 p.r.n NN I-NP B-f
61 , , O O
62 Coumadin NNP B-NP B-m
62 4 CD O B-do
62 mg NN B-NP I-do
62 q.d JJ B-NP B-f
63 SOCIAL NNP I-NP O
63 HISTORY: NNP I-NP O
63 The DT B-NP O
63 patient NN I-NP O
63 lives VBZ O O
63 at IN B-VP O
63 home NN B-NP O
63 with IN B-VP O
63 his PRP$ O O
63 wife NN B-NP O
63 and CC O O
63 has VBZ O O
64 four CD O O
64 children NNS B-NP O
64 He PRP O O
64 denies VBZ O O
64 alcohol NN B-NP O
64 or CC O O
64 tobacco NN B-NP O
64 use VBP O O
65 FAMILY NNP B-NP O
65 HISTORY: NNP I-NP O
65 No NNP I-NP O
65 coronary JJ B-NP O
65 artery NN I-NP O
65 disease NN I-NP O
65 No NNP I-NP O
65 history NN I-NP O
65 of IN B-VP O
65 cancer NN B-NP O
66 PHYSICAL NNP I-NP O
66 EXAMINATION: NNP I-NP O
66 The DT B-NP O
66 patient NN I-NP O
66 is VBZ O O
66 a DT O O
66 pleasant JJ O O
66 , , O O
66 but CC O O
66 ill-appearing JJ B-NP O
67 man NN I-NP O
67 in IN B-VP O
67 some DT B-NP O
67 respiratory NN I-NP O
67 distress NN I-NP O
67 , , O O
67 lying VBG O O
67 in IN B-VP O
68 bed NN B-NP O
68 Temperature NN I-NP O
68 is VBZ O O
68 103 CD O O
68 , , O O
68 heart NN B-NP O
68 rate NN I-NP O
68 70 CD O O
68 , , O O
68 blood NN B-NP O
68 pressure NN I-NP O
68 160/80 CD O O
68 , , O O
69 respirations NNS B-NP O
69 26 CD O O
69 , , O O
69 oxygen NN B-NP O
69 saturation NN I-NP O
69 90% CD O O
69 on IN B-VP O
69 4 CD O B-do
69 L NNP B-NP I-do
69 oxygen NN I-NP B-m
69 HEENT NNP I-NP O
70 examination NN I-NP O
70 was VBD B-VP O
70 notable JJ O O
70 for IN B-VP O
70 cushingoid JJ B-NP O
70 facies NNS I-NP O
70 and CC O O
70 flushing NN B-NP O
70 was VBD B-VP O
71 evident JJ B-NP O
71 No NNP I-NP O
71 lymphadenopathy NN I-NP O
71 The DT B-NP O
71 neck NN I-NP O
71 was VBD B-VP O
71 supple JJ O O
71 , , O O
71 mucous JJ B-NP O
72 membranes NNS I-NP O
72 moist NN I-NP O
72 and CC O O
72 sclera NN B-NP O
72 were VBD B-VP O
72 anicteric JJ B-NP O
72 Chest NNP I-NP O
72 examination NN I-NP O
73 revealed VBD B-VP O
73 crackles NNS B-NP O
73 on IN B-VP O
73 the DT B-NP O
73 right NN I-NP O
73 to TO O O
73 half DT B-NP O
73 way NN I-NP O
73 up RP O O
73 Heart NNP B-NP O
73 examination NN I-NP O
74 revealed VBD B-VP O
74 a DT B-NP O
74 noisy JJ I-NP O
74 precordium NN I-NP O
74 with IN B-VP O
74 a DT B-NP O
74 prominent JJ I-NP O
74 T2 NNP I-NP O
74 and CC O O
74 a DT O O
74 2/6 CD O O
74 systolic JJ B-NP O
75 ejection NN I-NP O
75 murmur VBD B-VP O
75 Abdominal NNP B-NP O
75 examination NN I-NP O
75 was VBD B-VP O
75 negative JJ B-NP O
75 Extremity NNP I-NP O
76 examination NN I-NP O
76 revealed VBD B-VP O
76 some DT B-NP O
76 slight JJ I-NP O
76 swelling NN I-NP O
76 of IN B-VP O
76 the DT B-NP O
76 lower JJR I-NP O
76 extremities NNS I-NP O
77 Cutaneous NNP I-NP O
77 examination NN I-NP O
77 was VBD B-VP O
77 notable JJ O O
77 for IN B-VP O
77 evidence NN B-NP O
77 of IN B-VP O
77 thin JJ B-NP O
77 subcutaneous JJ I-NP O
78 tissues NNS I-NP O
78 and CC O O
78 development NN B-NP O
78 of IN B-VP O
78 a DT B-NP O
78 buffalo JJ I-NP O
78 hump NN I-NP O
79 LABORATORY NNP I-NP O
79 DATA: NNP I-NP O
79 White NNP I-NP O
79 count NN I-NP O
79 of IN B-VP O
79 11.3 CD O O
79 with IN B-VP O
79 46 CD O O
79 polys NNS B-NP O
79 , , O O
79 36 CD O O
80 lymphocytes NNS B-NP O
80 and CC O O
80 7 CD O O
80 bands NNS B-NP O
80 , , O O
80 hematocrit NN B-NP O
80 was VBD B-VP O
80 32.4 CD O O
80 and CC O O
81 platelets NNS B-NP O
81 were VBD B-VP O
81 143 CD O O
81 , , O O
81 000 CD O O
81 Coagulation NNP B-NP O
81 studies NNS I-NP O
81 revealed VBD B-VP O
81 a DT B-NP O
81 prothrombin JJ I-NP O
82 time NN I-NP O
82 of IN B-VP O
82 15.8 CD O O
82 and CC O O
82 an DT B-NP O
82 INR NNP I-NP O
82 of IN B-VP O
82 1.8 CD O O
82 Electrolytes NNS B-NP O
82 were VBD B-VP O
82 within IN B-VP O
82 normal JJ B-NP O
83 limits NNS I-NP O
83 , , O O
83 blood NN B-NP O
83 urea JJ B-NP O
83 nitrogen NN I-NP O
83 was VBD B-VP O
83 39 CD O O
83 , , O O
83 creatinine NN B-NP O
83 was VBD B-VP O
83 2.5 CD O O
83 , , O O
83 glucose NN B-NP O
83 was VBD B-VP O
84 85 CD O O
84 , , O O
84 calcium NN B-NP O
84 10.2 CD O O
84 Liver NNP B-NP O
84 function NN I-NP O
84 tests NNS I-NP O
84 revealed VBD B-VP O
84 an DT B-NP O
84 alkaline JJ I-NP O
85 phosphatase NN I-NP O
85 of IN B-VP O
85 342 CD O O
85 , , O O
85 total JJ B-NP O
85 protein NN I-NP O
85 was VBD B-VP O
85 7.9 CD O O
85 with IN B-VP O
85 an DT B-NP O
85 albumin NN I-NP O
85 of IN B-VP O
85 3.9 CD O O
86 Cholesterol NNP B-NP O
86 was VBD B-VP O
86 194 CD O O
86 , , O O
86 triglycerides NNS B-NP O
86 were VBD B-VP O
86 249 CD O O
86 Cyclosporine NNP B-NP O
86 level NN I-NP O
87 was VBD B-VP O
87 303 CD O O
88 HOSPITAL NNP B-NP O
88 COURSE: NNP I-NP O
89 1 CD O O
89 INFECTIOUS NNP B-NP O
89 DISEASES: NNP I-NP O
89 Surgery NNP I-NP O
89 was VBD B-VP O
89 consulted VBN O O
89 and CC O O
89 the DT B-NP O
89 right JJ I-NP O
89 groin NN I-NP O
90 abscess NN I-NP O
90 was VBD B-VP O
90 drained VBN O O
90 and CC O O
90 a DT B-NP O
90 wick NN I-NP O
90 was VBD B-VP O
90 inserted VBN O O
90 This DT B-NP O
90 wound NN I-NP O
90 was VBD B-VP O
91 dressed VBN O O
91 and CC O O
91 continued VBN O O
91 care NN B-NP O
91 was VBD B-VP O
91 preformed VBN O O
91 by IN B-VP O
91 nursing VBG O O
91 staff NN B-NP O
91 Blood NNP I-NP O
92 cultures NNS I-NP O
92 on IN B-VP O
92 admission NN B-NP O
92 revealed VBD B-VP O
92 no DT B-NP O
92 growth NN I-NP O
92 and CC O O
92 on IN B-VP O
92 hospital JJ B-NP O
92 day NN I-NP O
92 two CD O O
93 revealed VBD B-VP O
93 no DT B-NP O
93 growth NN I-NP O
93 Wound NNP I-NP O
93 cultures VBZ O O
93 revealed VBN O O
93 few JJ B-NP O
93 coagulase NN I-NP O
93 , , O O
94 negative JJ B-NP O
94 staph NN I-NP O
94 Antibiotics NNS I-NP B-m
94 were VBD B-VP O
94 initiated VBN O O
94 , , O O
94 first JJ B-NP O
94 vancomycin NN I-NP B-m
94 , , O O
95 gentamicin NN B-NP B-m
95 and CC O O
95 Flagyl NNP B-NP B-m
95 were VBD B-VP O
95 initiated VBN O O
95 , , O O
95 however RB O O
95 gentamycin NN B-NP B-m
95 was VBD B-VP O
96 subsequently RB O O
96 discontinued VBN O O
96 and CC O O
96 ceftazidime NN B-NP B-m
96 was VBD B-VP O
96 initiated VBN O O
96 The DT B-NP O
97 patient NN I-NP O
97 had VBD B-VP O
97 one CD O O
97 fever NN B-NP O
97 spike NN I-NP O
97 on IN B-VP O
97 hospital JJ B-NP O
97 day NN I-NP O
97 one CD O O
97 to TO O O
97 101.9 CD O O
97 The DT B-NP O
98 patient NN I-NP O
98 subsequently RB O O
98 had VBD B-VP O
98 no DT B-NP O
98 fever NN I-NP O
98 spikes NNS I-NP O
98 , , O O
98 however RB O O
98 , , O O
98 on IN B-VP O
98 hospital NN B-NP O
98 day NN I-NP O
99 three CD O O
99 Levaquin NNP B-NP B-m
99 was VBD B-VP O
99 initiated VBN O O
99 and CC O O
99 intravenous JJ B-NP B-mo
99 antibiotics NNS I-NP B-m
99 were VBD B-VP O
100 continued VBN O O
100 until IN B-VP B-du
100 hospital JJ B-NP I-du
100 day NN I-NP I-du
100 four CD O I-du
100 At IN B-VP O
100 that DT B-NP O
100 point NN I-NP O
100 , , O O
100 the DT B-NP O
100 patient NN I-NP O
100 had VBD B-VP O
101 been VBN O O
101 afebrile RB O O
101 for IN B-VP O
101 48 CD O O
101 hours NNS B-NP O
101 and CC O O
101 the DT B-NP O
101 decision NN I-NP O
101 was VBD B-VP O
101 made VBN O O
101 to TO O O
101 switch VB O O
101 the DT B-NP O
102 patient NN I-NP O
102 to TO O O
102 oral JJ B-NP B-mo
102 antibiotics NNS I-NP B-m
102 , , O O
102 including VBG O O
102 Levaquin NNP B-NP B-m
102 and CC O O
102 Augmentin NNP B-NP B-m
102 The DT B-NP O
103 patient NN I-NP O
103 continued VBD B-VP O
103 to TO O O
103 defervesce VB O O
103 , , O O
103 his PRP$ O O
103 breathing VBG O O
103 improved VBN O O
103 , , O O
103 the DT B-NP O
103 pain NN I-NP O
104 in IN B-VP O
104 his PRP$ O O
104 right JJ B-NP O
104 groin NN I-NP O
104 improved VBD B-VP O
104 , , O O
104 dressing VBG O O
104 changes NNS B-NP O
104 were VBD B-VP O
104 continued VBN O O
104 and CC O O
105 the DT B-NP O
105 patient NN I-NP O
105 remained VBD B-VP O
105 afebrile JJ O O
105 for IN B-VP O
105 more JJR O O
105 than IN B-VP O
105 24 CD O O
105 hours NNS B-NP O
105 after IN B-VP O
106 initiating VBG O O
106 oral JJ B-NP B-mo
106 antibiotics NNS I-NP B-m
107 2 CD O O
107 CARDIOVASCULAR: NNP B-NP O
107 The DT B-NP O
107 patient NN I-NP O
107 has VBZ O O
107 a DT B-NP O
107 history NN I-NP O
107 of IN B-VP O
107 hypertension NN B-NP B-r
107 hypertension NN I-NP B-r
107 and CC O O
108 has VBZ O O
108 been VBN O O
108 maintained VBN O O
108 on IN B-VP O
108 nadolol JJ B-NP B-m
108 nadolol NN I-NP B-m
108 , , O O
108 recently RB O O
108 requiring VBG O O
108 a DT O O
108 doubling VBG O O
108 in IN B-VP O
109 his PRP$ O O
109 dose NN B-NP O
109 from IN B-VP O
109 40 CD O B-do
109 mg NNS B-NP I-do
109 q.d RB O B-f
109 to TO O O
109 80 CD O B-do
109 mg NNS B-NP I-do
109 q.d RB O B-f
109 He PRP O O
109 was VBD B-VP O
109 admitted VBN O O
109 and CC O O
109 placed VBN O O
110 on IN B-VP O
110 80 CD O B-do
110 mg JJ B-NP I-do
110 q.d NN I-NP B-f
110 of IN B-VP O
110 nadolol NN B-NP B-m
110 , , O O
110 however RB O O
110 , , O O
110 his PRP$ O B-r
110 blood NN B-NP I-r
110 pressures NNS I-NP I-r
110 continued VBD B-VP O
110 to TO O O
111 run VB O O
111 up RB O O
111 to TO O O
111 170 CD O O
111 systolic NN B-NP O
111 and CC O O
111 up RB O O
111 to TO O O
111 110 CD O O
111 diastolic NN B-NP O
111 At IN B-VP O
111 that DT B-NP O
111 time NN I-NP O
111 , , O O
111 the DT B-NP O
112 decision NN I-NP O
112 was VBD B-VP O
112 made VBN O O
112 to TO O O
112 initiate VB O O
112 a DT B-NP O
112 second JJ I-NP O
112 antihypertensive JJ I-NP B-m
112 medication NN I-NP I-m
113 and CC O O
113 nifedipine JJ B-NP B-m
113 XL NNP I-NP I-m
113 was VBD B-VP O
113 chosen VBN O O
113 He PRP O O
113 was VBD B-VP O
113 maintained VBN O O
113 for IN B-VP B-du
113 for IN B-VP B-du
113 two CD O I-du
113 two CD O I-du
113 days NNS B-NP I-du
113 days NNS I-NP I-du
113 at IN B-VP O
113 30 CD O B-do
113 30 CD O B-do
114 mg NN B-NP O
114 on IN B-VP O
114 this DT B-NP B-m
114 medication NN I-NP I-m
114 and CC O O
114 his PRP$ O B-r
114 blood NN B-NP I-r
114 pressures NNS I-NP I-r
114 subsequently RB O O
115 stabilized VBN O O
115 at IN B-VP O
115 130/80 CD O O
115 The DT B-NP O
115 patient NN I-NP O
115 also RB O O
115 carries VBZ O O
115 a DT B-NP O
115 diagnosis NN I-NP O
115 of IN B-VP O
116 pulmonary JJ B-NP O
116 hypertension NN I-NP O
116 , , O O
116 presumed VBN O O
116 from IN B-VP O
116 the DT B-NP O
116 February NNP I-NP O
116 1997 CD O O
116 , , O O
116 results NNS B-NP O
117 of IN B-VP O
117 his PRP$ O O
117 echocardiogram NN B-NP O
117 These DT B-NP O
117 results NNS I-NP O
117 revealed VBD B-VP O
117 a DT B-NP O
117 pressure NN I-NP O
117 gradient NN I-NP O
118 in IN B-VP O
118 the DT B-NP O
118 pulmonary JJ I-NP O
118 arterial NN I-NP O
118 system NN I-NP O
118 , , O O
118 and CC O O
118 on IN B-VP O
118 this DT B-NP O
118 admission NN I-NP O
118 a DT B-NP O
119 subsequent JJ I-NP O
119 echocardiogram NN I-NP O
119 was VBD B-VP O
119 obtained VBN O O
119 to TO O O
119 assess VB O O
119 left JJ B-NP O
119 ventricular JJ I-NP O
120 function NN I-NP O
120 and CC O O
120 his PRP$ O O
120 pulmonary JJ B-NP O
120 vascular NN I-NP O
120 status NN I-NP O
120 The DT B-NP O
120 results NNS I-NP O
120 of IN B-VP O
120 this DT B-NP O
121 study NN I-NP O
121 revealed VBD B-VP O
121 2+ CD O O
121 tricuspid JJ B-NP O
121 regurgitation NN I-NP O
121 and CC O O
121 1+ CD O O
121 mitral JJ B-NP O
122 regurgitation NN I-NP O
122 , , O O
122 unchanged JJ O O
122 from IN B-VP O
122 prior JJ B-NP O
122 studies NNS I-NP O
122 and CC O O
122 a DT B-NP O
122 pulmonary JJ I-NP O
123 arterial JJ I-NP O
123 pressure NN I-NP O
123 of IN B-VP O
123 approximately RB O O
123 45 CD O O
123 mmHg NN B-NP O
123 , , O O
123 also RB O O
123 not RB O O
123 notably RB O O
124 changed VBD B-VP O
125 3 CD O O
125 PULMONARY: NNP B-NP O
125 On IN B-VP O
125 admission NN B-NP O
125 , , O O
125 the DT B-NP O
125 patient NN I-NP O
125 reported VBD B-VP O
125 a DT B-NP O
125 productive JJ I-NP O
126 cough NN I-NP O
126 , , O O
126 in IN B-VP O
126 addition NN B-NP O
126 to TO O O
126 difficulty VB O O
126 breathing VBG O O
126 This DT O O
126 was VBD B-VP O
126 evaluated VBN O O
127 with IN B-VP O
127 a DT B-NP O
127 chest NN I-NP O
127 radiogram NN I-NP O
127 , , O O
127 which WDT O O
127 revealed VBD B-VP O
127 possibility NN B-NP O
127 of IN B-VP O
127 a DT B-NP O
127 right NN I-NP O
127 sided VBD B-VP O
128 pulmonary JJ B-NP O
128 process NN I-NP O
128 , , O O
128 corroborated VBN O O
128 on IN B-VP O
128 examination NN B-NP O
128 by IN B-VP O
128 evidence NN B-NP O
128 of IN B-VP O
129 crackles NNS B-NP O
129 half DT B-NP O
129 way NN I-NP O
129 up RP O O
129 The DT B-NP O
129 decision NN I-NP O
129 was VBD B-VP O
129 made VBN O O
129 to TO O O
129 rule VB O O
129 the DT B-NP O
129 patient NN I-NP O
130 out RP O O
130 for IN B-VP O
130 another DT B-NP O
130 flare NN I-NP O
130 of IN B-VP O
130 his PRP$ O O
130 CMV NNP B-NP O
130 infection NN I-NP O
130 Studies NNP I-NP O
130 for IN B-VP O
130 CMV NNP B-NP O
131 antigen NN I-NP O
131 and CC O O
131 CMV NNP B-NP O
131 from IN B-VP O
131 the DT B-NP O
131 buffy NN I-NP O
131 coat NN I-NP O
131 were VBD B-VP O
131 sent VBN O O
131 and CC O O
131 the DT B-NP O
131 final JJ I-NP O
131 results NNS I-NP O
132 revealed VBD B-VP O
132 a DT B-NP O
132 positive JJ I-NP O
132 CMV NNP I-NP O
132 antigen NN I-NP O
132 , , O O
132 but CC O O
132 a DT B-NP O
132 negative JJ I-NP O
132 buffy NN I-NP O
132 coat NN I-NP O
132 The DT B-NP O
133 patient's NN I-NP O
133 pulmonary JJ B-NP O
133 status NN I-NP O
133 improved VBN O O
133 on IN B-VP O
133 oxygen NN B-NP B-m
133 and CC O O
133 on IN B-VP O
133 intravenous JJ B-NP B-mo
134 antibiotics NNS I-NP B-m
134 A DT B-NP O
134 induced JJ I-NP O
134 sputum NN I-NP O
134 sample NN I-NP O
134 was VBD B-VP O
134 obtained VBN O O
134 and CC O O
134 studies NNS B-NP O
134 were VBD B-VP O
135 sent VBN O O
135 for IN B-VP O
135 atypical JJ B-NP O
135 organisms NNS I-NP O
135 including VBG O O
135 CPT NNP B-NP O
135 , , O O
135 fungi NN B-NP O
135 , , O O
135 in IN B-VP O
135 addition NN B-NP O
135 to TO O O
136 bacteria VB O O
136 All PDT O O
136 these DT B-NP O
136 studies NNS I-NP O
136 were VBD B-VP O
136 negative JJ O O
136 In IN B-VP O
136 addition NN B-NP O
136 , , O O
137 Legionella NNP B-NP O
137 antigen NN I-NP O
137 was VBD B-VP O
137 also RB O O
137 negative JJ B-NP O
137 Prior NNP I-NP O
137 to TO O O
137 discharge VB O O
137 , , O O
137 the DT B-NP O
138 patient's NN I-NP O
138 pulmonary JJ B-NP O
138 status NN I-NP O
138 had VBD B-VP O
138 returned VBN O O
138 to TO O O
138 baseline VB O O
138 and CC O O
138 had VBD B-VP O
139 entirely RB O O
139 resolved VBN O O
140 4 CD O O
140 GASTROINTESTINAL: NNP B-NP O
140 On IN B-VP O
140 admission NN B-NP O
140 , , O O
140 the DT B-NP O
140 patient NN I-NP O
140 reported VBD B-VP O
140 multiple JJ B-NP O
141 loose JJ I-NP O
141 bowel NN I-NP O
141 movements NNS I-NP O
141 However RB O O
141 , , O O
141 in IN B-VP O
141 his PRP$ O O
141 hospital NN B-NP O
141 course NN I-NP O
141 this DT O O
141 did VBD B-VP O
142 not RB O O
142 continue VB O O
142 to TO O O
142 be VB O O
142 an DT B-NP O
142 issue NN I-NP O
142 The DT B-NP O
142 patient NN I-NP O
142 also RB O O
142 regained VBD B-VP O
142 his PRP$ O O
143 appetite NN B-NP O
143 during IN B-VP O
143 the DT B-NP O
143 hospital JJ I-NP O
143 course NN I-NP O
144 5 CD O O
144 HEMATOLOGIC: NNP B-NP O
144 The DT B-NP O
144 patient NN I-NP O
144 was VBD B-VP O
144 continued VBN O O
144 on IN B-VP O
144 his PRP$ O O
144 anticoagulation NN B-NP B-m
145 for IN B-VP O
145 history NN B-NP O
145 of IN B-VP O
145 atrial JJ B-NP B-r
145 fibrillation NN I-NP I-r
145 at IN B-VP O
145 4 CD O B-do
145 mg NNS B-NP I-do
145 daily RB O B-f
145 with IN B-VP O
145 an DT B-NP O
145 INR NNP I-NP O
146 remaining VBG O O
146 in IN B-VP O
146 his PRP$ O O
146 goal NN B-NP O
146 parameters NNS I-NP O
146 , , O O
146 which WDT O O
146 were VBD B-VP O
146 set VBN O O
146 at IN B-VP O
146 1.6-2.0 JJ O O
146 The DT B-NP O
147 patient NN I-NP O
147 however RB O O
147 , , O O
147 has VBZ O O
147 recently RB O O
147 spontaneously RB O O
147 converted VBN O O
147 to TO O O
147 sinus VB O O
148 rhythm NN B-NP O
148 and CC O O
148 throughout IN B-VP O
148 his PRP$ O O
148 hospital NN B-NP O
148 course NN I-NP O
148 remained VBD B-VP O
148 in IN B-VP O
148 sinus NN B-NP O
148 rhythm NN I-NP O
149 with IN B-VP O
149 continuous JJ O O
149 monitoring VBG O O
150 6 CD O O
150 RENAL: NNP B-NP O
150 On IN B-VP O
150 admission NN B-NP O
150 , , O O
150 the DT B-NP O
150 patient's JJ I-NP O
150 creatinine NN I-NP O
150 level NN I-NP O
150 was VBD B-VP O
150 2.5 CD O O
151 and CC O O
151 remained VBD B-VP O
151 stable JJ O O
151 throughout IN B-VP O
151 his PRP$ O O
151 hospital NN B-NP O
151 course NN I-NP O
151 His PRP$ O O
152 cyclosporine JJ B-NP B-m
152 level NN I-NP O
152 was VBD B-VP O
152 303 CD O O
152 on IN B-VP O
152 admission NN B-NP O
152 , , O O
152 on IN B-VP O
152 hospital JJ B-NP O
152 day NN I-NP O
152 four CD O O
152 , , O O
152 a DT B-NP O
153 level NN I-NP O
153 of IN B-VP O
153 700 CD O O
153 was VBD B-VP O
153 obtained VBN O O
153 , , O O
153 however RB O O
153 , , O O
153 this DT O O
153 determined VBN O O
153 from IN B-VP O
153 a DT B-NP O
153 history NN I-NP O
154 that IN B-VP O
154 this DT B-NP O
154 level NN I-NP O
154 had VBD B-VP O
154 been VBN O O
154 drawn VBN O O
154 shortly RB O O
154 after IN B-VP O
154 the DT B-NP O
154 patient NN I-NP O
154 had VBD B-VP O
154 taken VBN O O
155 the DT B-NP O
155 cyclosporine NN I-NP B-m
155 During IN B-VP O
155 his PRP$ O O
155 hospital JJ B-NP O
155 course NN I-NP O
155 , , O O
155 vancomycin NN B-NP B-m
155 levels NNS I-NP O
156 were VBD B-VP O
156 followed VBN O O
156 These DT B-NP O
156 levels NNS I-NP O
156 reached VBD B-VP O
156 a DT B-NP O
156 maximum NN I-NP O
156 of IN B-VP O
156 19.8 CD O O
156 on IN B-VP O
156 hospital JJ B-NP O
157 day NN I-NP O
157 four CD O O
157 , , O O
157 at IN B-VP O
157 which WDT O O
157 time NN B-NP O
157 intravenous JJ B-NP B-mo
157 antibiotics NNS I-NP B-m
157 were VBD B-VP O
157 discontinued VBN O O
158 7 CD O O
158 ENDOCRINE NNP B-NP O
158 The DT B-NP O
158 patient NN I-NP O
158 carries VBZ O O
158 a DT B-NP O
158 history NN I-NP O
158 of IN B-VP O
158 multiple JJ B-NP O
158 endocrine JJ I-NP O
159 issues NNS I-NP O
159 including VBG O O
159 hypercalcemia NN B-NP O
159 and CC O O
159 hyperparathyroidism NN B-NP O
159 , , O O
159 diabetes VBZ O O
160 mellitus NN B-NP O
160 , , O O
160 hyperthyroidism NN B-NP B-r
160 on IN B-VP O
160 thyroid JJ B-NP B-m
160 replacement NN I-NP O
160 therapy NN I-NP O
160 following VBG O O
161 subtotal JJ B-NP O
161 thyroidectomy NN I-NP O
161 , , O O
161 and CC O O
161 possibility NN B-NP O
161 of IN B-VP O
161 mineral JJ B-NP O
161 corticoid NN I-NP O
162 deficiency NN I-NP O
162 The DT B-NP O
162 Endocrine NNP I-NP O
162 Team NNP I-NP O
162 was VBD B-VP O
162 consulted VBN O O
162 Thyroid NNP B-NP O
162 studies NNS I-NP O
162 and CC O O
163 parathyroid JJ B-NP O
163 studies NNS I-NP O
163 were VBD B-VP O
163 sent VBN O O
163 and CC O O
163 revealed VBD B-VP O
163 a DT B-NP O
163 TSH NNP I-NP O
163 of IN B-VP O
163 0.02 CD O O
163 , , O O
163 a DT B-NP O
163 T4 NNP I-NP O
163 of IN B-VP O
164 6.0 CD O O
164 , , O O
164 a DT B-NP O
164 THPR NNP I-NP O
164 of IN B-VP O
164 1.47 CD O O
164 On IN B-VP O
164 discharge NN B-NP O
164 , , O O
164 the DT B-NP O
164 patient's NN I-NP O
164 parathyroid NN I-NP O
164 1 CD O O
164 , , O O
164 25 CD O O
165 vitamin NN B-NP O
165 D NNP I-NP O
165 and CC O O
165 25 CD O O
165 vitamin NN B-NP O
165 D NNP I-NP O
165 were VBD B-VP O
165 still RB O O
165 pending VBG O O
165 The DT B-NP O
165 Endocrine NNP I-NP O
165 Team NNP I-NP O
166 recommended VBD B-VP O
166 decreasing VBG O O
166 his PRP$ O O
166 Synthroid NNP B-NP B-m
166 dose NN I-NP O
166 to TO O O
166 a DT B-NP O
166 level NN I-NP O
166 of IN B-VP O
166 125 CD O B-do
166 mcg JJ O I-do
167 daily RB O B-f
167 In IN B-VP O
167 addition NN B-NP O
167 , , O O
167 they PRP O O
167 recommended VBD B-VP O
167 a DT B-NP O
167 bone NN I-NP O
167 densitometry NN I-NP O
167 study NN I-NP O
167 for IN B-VP O
168 evaluation NN B-NP O
168 of IN B-VP O
168 his PRP$ O O
168 bone NN B-NP O
168 mass NN I-NP O
168 following VBG O O
168 chronic JJ B-NP O
168 maintenance NN I-NP O
168 on IN B-VP O
168 the DT B-NP O
169 steroid JJ I-NP B-m
169 therapy NN I-NP O
169 and CC O O
169 a DT B-NP O
169 history NN I-NP O
169 of IN B-VP O
169 hyperparathyroidism NN B-NP O
169 The DT B-NP O
169 team NN I-NP O
170 thought VBD B-VP O
170 that IN B-VP O
170 the DT B-NP O
170 patient's NN I-NP O
170 previous JJ B-NP O
170 question NN I-NP O
170 of IN B-VP O
170 a DT B-NP O
170 mineral JJ I-NP O
170 corticoid NN I-NP O
171 deficiency NN I-NP O
171 was VBD B-VP O
171 likely JJ O O
171 due JJ O O
171 to TO O O
171 his PRP$ O O
171 prior JJ B-NP O
171 Cozaar NNP I-NP B-m
171 therapy NN I-NP O
171 They PRP O O
171 did VBD B-VP O
172 not RB O O
172 fell VBD B-VP O
172 it PRP O O
172 was VBD B-VP O
172 necessary JJ O O
172 at IN B-VP O
172 this DT B-NP O
172 point NN I-NP O
172 to TO O O
172 preform VB O O
172 a DT B-NP O
172 cortizone NN I-NP B-m
173 stimulation NN I-NP O
173 study NN I-NP O
173 or CC O O
173 to TO O O
173 further RB O O
173 assess VB O O
173 this DT B-NP O
173 possibility NN I-NP O
173 of IN B-VP O
173 a DT B-NP O
174 mineral JJ I-NP O
174 corticoid NN I-NP O
174 deficiency NN I-NP O
175 DISCHARGE NNP I-NP O
175 MEDICATIONS: NNP I-NP O
175 Augmentin NNP I-NP B-m
175 250/125 CD O B-do
175 mg NN B-NP I-do
175 t.i.d NN I-NP B-f
175 , , O O
175 Levaquin NNP B-NP B-m
175 250 CD O B-do
176 mg NN B-NP O
176 q.d NN I-NP B-f
176 , , O O
176 CellCept NNP B-NP B-m
176 500 CD O B-do
176 mg NN B-NP I-do
176 b.i.d NN I-NP B-f
176 , , O O
176 Neoral NNP B-NP B-m
176 100 CD O B-do
177 mg NN B-NP O
177 b.i.d NN I-NP B-f
177 , , O O
177 Prednisone NNP B-NP B-m
177 10 CD O B-do
177 mg NN B-NP I-do
177 q.d NN I-NP B-f
177 , , O O
177 Synthroid NNP B-NP B-m
177 125 CD O B-do
177 mcg NN B-NP I-do
177 q.d NN I-NP B-f
177 , , O O
177 INP NNP B-NP B-m
178 insulin VBZ O O
178 14 CD O B-do
178 units NNS B-NP I-do
178 subcu JJ B-NP B-mo
178 q.a.m NN I-NP B-f
178 , , O O
178 regular JJ B-NP B-m
178 insulin NN I-NP I-m
178 subcu NN I-NP B-mo
178 p.r.n NN I-NP B-f
178 , , O O
178 Axid NNP B-NP B-m
179 150 CD O B-do
179 mg NN B-NP I-do
179 q.d NN I-NP B-f
179 , , O O
179 nadolol RB O B-m
179 80 CD O B-do
179 mg NN B-NP I-do
179 q.d NN I-NP B-f
179 , , O O
179 nifedipine JJ B-NP B-m
179 XL NNP I-NP I-m
179 30 CD O B-do
179 mg NN B-NP I-do
179 q.d NN I-NP B-f
179 , , O O
179 Coumadin NNP B-NP B-m
180 4 CD O B-do
180 mg NN B-NP I-do
180 q.d NN I-NP B-f
180 , , O O
180 iron NN B-NP B-m
180 sulfate NN I-NP I-m
180 300 CD O B-do
180 mg NN B-NP I-do
180 q.d JJ B-NP B-f
181 CONDITION NNP I-NP O
181 ON NNP I-NP O
181 DISCHARGE: NNP I-NP O
181 Stable NNP I-NP O
182 DISPOSITION: NNP I-NP O
182 To TO O O
182 home VB O O
183 FOLLOW-UP: NNP B-NP O
183 1 CD O O
183 Bone NNP B-NP O
183 densitometry NN I-NP O
183 July NNP I-NP O
183 , , O O
183 1998 CD O O
184 2 CD O O
184 Dr NNP B-NP O
184 Clinton NNP I-NP O
184 Ardizone NNP I-NP O
184 January NNP I-NP O
184 , , O O
184 1998 CD O O
185 3 CD O O
185 Dr NNP B-NP O
185 Win NNP I-NP O
185 in IN B-VP O
185 March NNP B-NP O
186 Dictated NNP I-NP O
186 By: NNP I-NP O
186 MOHAMMAD NNP I-NP O
186 CLEARK NNP I-NP O
186 , , O O
186 M.D NNP B-NP O
187 Attending: NNP I-NP O
187 FABIAN NNP I-NP O
187 V NNP I-NP O
187 POMPONI NNP I-NP O
187 , , O O
187 M.D NNP B-NP O
187 MK1 NNP I-NP O
187 XA067/4603 NNP I-NP O
188 Batch: NNP I-NP O
188 59411 CD O O
188 Index NNP B-NP O
188 No NNP I-NP O
188 Y9BVVA9CXG NNP I-NP O
188 D: NNP I-NP O
188 0/18/98 CD O O
189 T: NNP B-NP O
189 0/18/98 CD O O
190 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #472947 VBZ O O
2 965041836 CD O O
2 RTH NNP B-NP O
2 94253387 CD O O
2 5833170 CD O O
2 1/7/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Viral NNP I-NP O
2 syndrome NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/7/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/16/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 REDFEARN NNP I-NP O
5 , , O O
5 SHAUN NNP B-NP O
5 001-14-30-0 NNP I-NP O
6 Lake NNP I-NP O
6 Woodcho NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 5/18/05 CD O O
8 AT NNP B-NP O
8 05:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 SCHEINER NNP I-NP O
11 , , O O
11 WILLIAMS NNP B-NP O
11 MAYNARD NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 TYLENOL NNP I-NP B-m
16 ( ( O I-m
16 ACETAMINOPHEN NNP B-NP I-m
16 ) ) O I-m
16 650 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 Q4H NNP I-NP B-f
16 PRN NNP I-NP I-f
16 Headache NNP I-NP B-r
17 CEPACOL NNP I-NP B-m
17 1-2 JJ B-NP B-do
17 LOZENGE NNP I-NP I-do
17 PO NNP I-NP B-mo
17 Q4H NNP I-NP B-f
17 PRN NNP I-NP I-f
17 Other:sore NNP I-NP B-r
17 throat NN I-NP I-r
18 VITAMIN NNP I-NP B-m
18 B12 NNP I-NP I-m
18 ( ( O I-m
18 CYANOCOBALAMIN NNP B-NP I-m
18 ) ) O I-m
18 1 CD O B-do
18 , , O I-do
18 000 CD O I-do
18 MCG NNP B-NP I-do
18 IM NNP I-NP B-mo
18 QD NNP I-NP B-f
18 X NNP I-NP B-du
18 3 CD O I-du
18 doses NNS B-NP I-du
19 DIPYRIDAMOLE NNP I-NP B-m
19 25 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QPM NNP I-NP B-f
20 LASIX NNP I-NP B-m
20 ( ( O I-m
20 FUROSEMIDE NNP B-NP I-m
20 ) ) O I-m
20 10 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 ISORDIL NNP I-NP B-m
21 ( ( O I-m
21 ISOSORBIDE NNP B-NP I-m
21 DINITRATE NNP I-NP I-m
21 ) ) O I-m
21 30 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 TID NNP I-NP B-f
22 ATIVAN NNP I-NP B-m
22 ( ( O I-m
22 LORAZEPAM NNP B-NP I-m
22 ) ) O I-m
22 3.5 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QHS NNP I-NP B-f
22 PRN NNP I-NP I-f
22 Insomnia NNP I-NP B-r
23 INDERAL NNP I-NP B-m
23 ( ( O I-m
23 PROPRANOLOL NNP B-NP I-m
23 HCL NNP I-NP I-m
23 ) ) O I-m
23 10 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QID NNP I-NP B-f
24 Food/Drug NNP I-NP O
24 Interaction NNP I-NP O
24 Instruction NNP I-NP O
25 Take NNP I-NP O
25 consistently RB O O
25 with IN B-VP O
25 meals NNS B-NP O
25 or CC O O
25 on IN B-VP O
25 empty JJ B-NP O
25 stomach NN I-NP O
26 NORVASC NNP I-NP B-m
26 ( ( O I-m
26 AMLODIPINE NNP B-NP I-m
26 ) ) O I-m
26 2.5 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 QD NNP I-NP B-f
27 Food/Drug NNP I-NP O
27 Interaction NNP I-NP O
27 Instruction NNP I-NP O
28 Avoid NNP I-NP O
28 grapefruit NN I-NP O
28 unless IN B-VP O
28 MD NNP B-NP O
28 instructs NNS I-NP O
28 otherwise RB O O
29 NITROGLYCERIN NNP B-NP B-m
29 0.2% CD O B-do
29 TOPICAL NNP B-NP B-mo
29 TP NNP I-NP I-mo
29 BID NNP I-NP B-f
29 Instructions: NNP I-NP O
29 1 CD O O
29 inch NN B-NP O
29 , , O O
30 ZETIA NNP B-NP B-m
30 ( ( O I-m
30 EZETIMIBE NNP B-NP I-m
30 ) ) O I-m
30 10 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 QD NNP I-NP B-f
31 AZITHROMYCIN NNP I-NP B-m
31 500 CD O I-m
31 MG NNP B-NP I-m
31 PACK NNP I-NP I-m
31 500 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
31 X NNP I-NP B-du
31 4 CD O I-du
31 doses NNS B-NP I-du
32 Alert NNP I-NP O
32 overridden: VBD B-VP O
32 Override NNP B-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 5/18/05 CD O O
32 by IN B-VP O
32 : : O O
33 POTENTIALLY NNP B-NP O
33 SERIOUS NNP I-NP O
33 INTERACTION: NNP I-NP O
33 LORAZEPAM NNP I-NP B-m
33 &amp; NNP I-NP O
33 AZITHROMYCIN NNP I-NP B-m
34 POTENTIALLY NNP I-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 AMLODIPINE NNP I-NP B-m
34 BESYLATE NNP I-NP I-m
34 &amp; NNP I-NP O
35 CALCIUM NNP I-NP B-m
35 PHOSPHATE NNP I-NP I-m
35 , , O O
35 ORAL NNP B-NP B-mo
35 Reason NNP I-NP O
35 for IN B-VP O
35 override: NN B-NP O
35 aware JJ B-NP O
36 DIET: NNP I-NP O
36 No NNP I-NP O
36 Restrictions NNP I-NP O
37 ACTIVITY: NNP I-NP O
37 Resume NNP I-NP O
37 regular JJ B-NP O
37 exercise NN I-NP O
38 FOLLOW NNP I-NP O
38 UP NNP I-NP O
38 APPOINTMENT( NNP I-NP O
38 S NNP I-NP O
38 ): NNP I-NP O
39 Dr NNP I-NP O
39 Tatlock NNP I-NP O
39 within IN B-VP O
39 2 CD O O
39 wks NNS B-NP O
39 , , O O
40 Dr NNP B-NP O
40 Ausherman NNP I-NP O
40 , , O O
41 ALLERGY: NNP B-NP O
41 Penicillins NNP I-NP O
41 , , O O
41 Aspirin NNP B-NP O
42 ADMIT NNP I-NP O
42 DIAGNOSIS: NNP I-NP O
43 Viral NNP I-NP O
43 syndrome NN I-NP O
44 PRINCIPAL NNP I-NP O
44 DISCHARGE NNP I-NP O
44 DIAGNOSIS NNP I-NP O
44 ;Responsible JJ O O
44 After IN B-VP O
44 Study NNP B-NP O
44 for IN B-VP O
44 Causing NNP B-NP O
44 Admission NNP I-NP O
44 ) ) O O
45 Viral NNP B-NP O
45 syndrome NN I-NP O
46 OTHER NNP I-NP O
46 DIAGNOSIS;Conditions NNP I-NP O
46 , , O O
46 Infections NNP B-NP O
46 , , O O
46 Complications NNP B-NP O
46 , , O O
46 affecting VBG O O
46 Treatment/Stay NNP B-NP O
47 htn NN I-NP O
47 elev NN I-NP O
47 chol NN I-NP O
47 bph NN I-NP O
47 , , O O
47 s/p JJ B-NP O
47 turp NN I-NP O
47 x4 NNP I-NP O
47 s/p VBZ O O
47 partial JJ B-NP O
47 gastrectomy NN I-NP O
47 IMI NNP I-NP O
47 '73 POS O O
47 CAD NNP B-NP O
48 s/p NN I-NP O
48 CABG NNP I-NP O
48 x3 NNP I-NP O
48 ( ( O O
48 S/P NNP B-NP O
48 cardiac JJ B-NP O
48 bypass NN I-NP O
48 graft NN I-NP O
48 surgery NN I-NP O
48 ) ) O O
49 OPERATIONS NNP B-NP O
49 AND NNP I-NP O
49 PROCEDURES: NNP I-NP O
50 None NNP I-NP O
51 OTHER NNP I-NP O
51 TREATMENTS/PROCEDURES NNP I-NP O
51 ( ( O O
51 NOT NNP B-NP O
51 IN NNP I-NP O
51 O.R NNP I-NP O
51 ) ) O O
52 None NN B-NP O
53 BRIEF NNP I-NP O
53 RESUME NNP I-NP O
53 OF NNP I-NP O
53 HOSPITAL NNP I-NP O
53 COURSE: NNP I-NP O
54 CC: NNP I-NP O
54 Sore NNP I-NP O
54 throat NN I-NP O
54 , , O O
54 cough NN B-NP O
54 , , O O
54 weakness NN B-NP O
55 --------------- NNP I-NP O
56 DDX: NNP I-NP O
56 83yo CD O O
56 man NN B-NP O
56 w/ NN I-NP O
56 ho NN I-NP O
56 CAD NNP I-NP O
56 , , O O
56 IMI NNP B-NP O
56 , , O O
56 CABG NNP B-NP O
56 ( ( O O
56 2000 CD O O
56 ) ) O O
56 , , O O
56 HTN NNP B-NP O
56 , , O O
57 hyperlipidemia NN B-NP O
57 , , O O
57 stable JJ B-NP O
57 angina NN I-NP O
57 , , O O
57 recently RB O O
57 d/c'd VBZ O O
57 from IN B-VP O
57 BDBH NNP B-NP O
57 10/7 CD O O
57 after IN B-VP O
58 being VBG O O
58 r/o'd NN B-NP O
58 for IN B-VP O
58 MI NNP B-NP O
58 with IN B-VP O
58 negative JJ B-NP O
58 MIBI NNP I-NP O
58 p/w NN I-NP O
58 2 CD O O
58 days NNS B-NP O
58 viral JJ B-NP O
58 syndrome JJ I-NP O
58 w NN I-NP O
59 sore NN I-NP O
59 throat NN I-NP O
59 , , O O
59 cough NN B-NP O
59 , , O O
59 weakness NN B-NP O
59 , , O O
59 sweats NNS B-NP O
60 --------------- VBP O O
61 HPI: NNP B-NP O
61 Pt NNP I-NP O
61 came VBD B-VP O
61 to TO O O
61 BMC NNP B-NP O
61 ED NNP I-NP O
61 with IN B-VP O
61 2 CD O O
61 days NNS B-NP O
61 weakness NN I-NP O
61 , , O O
61 fatigue NN B-NP O
61 , , O O
61 diziness NN B-NP O
61 , , O O
61 sore NN B-NP O
62 throat NN I-NP O
62 and CC O O
62 cough NN B-NP O
62 No NNP I-NP O
62 CP NNP I-NP O
62 , , O O
62 SOB NNP B-NP O
62 Appetite NNP I-NP O
62 ok NN I-NP O
62 , , O O
62 drinking VBG O O
62 plenty NN B-NP O
62 of IN B-VP O
63 fluids NNS B-NP O
63 No NNP I-NP O
63 weight NN I-NP O
63 loss NN I-NP O
63 Has NNP I-NP O
63 several JJ B-NP O
63 month NN I-NP O
63 h/o VBD B-VP O
63 weight JJ B-NP O
63 loss NN I-NP O
63 In IN B-VP O
64 ED NNP B-NP O
64 , , O O
64 given VBN O O
64 500 CD O B-do
64 azithro IN B-VP B-m
64 He PRP O O
64 was VBD B-VP O
64 observed VBN O O
64 O/N NNP B-NP O
64 and CC O O
64 then RB O O
64 admitted VBD B-VP O
64 to TO O O
65 medicine VB O O
65 because IN B-VP O
65 of IN B-VP O
65 FTT NNP B-NP O
65 Of IN B-VP O
65 note NN B-NP O
65 , , O O
65 pt NN B-NP O
65 c/o NN I-NP O
65 very RB O O
65 depressed JJ B-NP O
65 mood NN I-NP O
65 Had VBD B-VP O
65 a DT B-NP O
66 break NN I-NP O
66 in IN B-VP O
66 at IN B-VP O
66 his PRP$ O O
66 apartment NN B-NP O
66 10/7 CD O O
66 , , O O
66 everythign NN B-NP O
66 stolen VBN O O
66 Son NNP B-NP O
66 also RB O O
67 recently RB O O
67 dx'd VBZ O O
67 with IN B-VP O
67 metastatic JJ B-NP O
67 prostate NN I-NP O
67 ca MD O O
68 ---------------- VB O O
69 STATUS: NNP B-NP O
69 Afebrile NNP I-NP O
69 ( ( O O
69 though IN B-VP O
69 101.9 CD O O
69 O/N NNP B-NP O
69 in IN B-VP O
69 ED NNP B-NP O
69 ) ) O O
69 VSS NNP B-NP O
69 , , O O
69 NAD NNP B-NP O
69 , , O O
69 no DT B-NP O
70 cough NN I-NP O
70 CTAB NNP I-NP O
70 , , O O
70 RRR NNP B-NP O
70 , , O O
70 normal JJ B-NP O
70 S1/S2 NNP I-NP O
70 , , O O
70 no DT B-NP O
70 murmurs NN I-NP O
70 , , O O
70 Abd NNP B-NP O
70 benign NN I-NP O
70 , , O O
70 no DT B-NP O
70 edema NN I-NP O
71 AOx3 NNP I-NP O
71 - : O O
71 EKG:A-paced JJ O O
71 at IN B-VP O
71 69 CD O O
71 , , O O
71 IMI NNP B-NP O
71 , , O O
71 normal JJ B-NP O
71 axis NN I-NP O
71 , , O O
71 no DT B-NP O
71 acute NN I-NP O
72 iscmeic NN I-NP O
72 changes NNS I-NP O
73 ---------------- VBP O O
74 STUDIES: NNP B-NP O
75 - : O O
75 MIBI NNP B-NP O
75 ( ( O O
75 10/5 CD O O
75 ): NNP B-NP O
75 EF NNP I-NP O
75 45% CD O O
75 , , O O
75 noted VBD B-VP O
75 to TO O O
75 have VB O O
75 multiple JJ B-NP O
75 pulmonary JJ I-NP O
75 nodules NNS I-NP O
76 - : O O
76 CXR NNP B-NP O
76 ( ( O O
76 2/14 CD O O
76 ): RB O O
76 negative JJ O O
77 - : O O
77 CT NN B-NP O
77 Chest NNP I-NP O
77 ( ( O O
77 0/17 CD O O
77 ): RB O O
77 several JJ B-NP O
77 pulmonary JJ I-NP O
77 nodules NNS I-NP O
77 in IN B-VP O
77 RUL NNP B-NP O
78 inferiorly RB O O
78 , , O O
78 largest JJS O O
78 0.6cm CD O O
78 Also RB O O
78 tiny JJ B-NP O
78 nodules NNS I-NP O
78 in IN B-VP O
78 upper JJ B-NP O
79 lobes NNS I-NP O
79 bilaterally RB O O
79 , , O O
79 2-3mm JJ B-NP O
79 Several NNP I-NP O
79 small JJ B-NP O
79 nodes NNS I-NP O
79 in IN B-VP O
80 mediastinum NN B-NP O
80 No NNP I-NP O
80 LAD NNP I-NP O
80 C/W NNP I-NP O
80 inflammatory NN I-NP O
80 changes NNS I-NP O
80 , , O O
81 including VBG O O
81 possible JJ B-NP O
81 TB NN I-NP O
81 or CC O O
81 atypical JJ B-NP O
81 mycobacterium NN I-NP O
82 ---------------- NNP I-NP O
83 HOSPITAL NNP I-NP O
83 COURSE NNP I-NP O
83 BY NNP I-NP O
83 PROBLEMS: NNP I-NP O
84 ---------------- NNP I-NP O
85 1 CD O O
85 ) ) O O
85 ID NNP B-NP O
85 - : O O
85 No DT B-NP O
85 significant JJ I-NP O
85 fever NN I-NP O
85 or CC O O
85 WBC NNP B-NP O
85 Symptoms NNP I-NP O
85 were VBD B-VP O
85 already RB O O
85 improved VBN O O
85 on IN B-VP O
86 admission; NN B-NP O
86 no DT B-NP O
86 cough NN I-NP O
86 Pt NNP I-NP O
86 was VBD B-VP O
86 observed VBN O O
86 O/N NNP B-NP O
86 with IN B-VP O
86 IVF NNP B-NP B-m
86 Improved NNP I-NP O
86 in IN B-VP O
86 the DT B-NP O
87 morning NN I-NP O
87 Will MD O O
87 be VB O O
87 D/C'd NNP B-NP O
87 on IN B-VP O
87 azithromycin NN B-NP B-m
87 x $ O B-du
87 5 CD O I-du
87 days NNS B-NP I-du
88 ---------------- RB O O
89 2 CD O O
89 ) ) O O
89 PULMONARY NNP B-NP O
89 NODULES: NNP I-NP O
89 Had NNP I-NP O
89 been VBN O O
89 seen VBN O O
89 on IN B-VP O
89 prior JJ B-NP O
89 MIBI NNP I-NP O
89 CT NNP I-NP O
89 c/w NN I-NP O
89 pulmonary JJ O O
90 nodules VBZ O O
90 No DT B-NP O
90 clinical JJ I-NP O
90 signs NNS I-NP O
90 of IN B-VP O
90 TB NNP B-NP O
90 , , O O
90 but CC O O
90 did VBD B-VP O
90 have VB O O
90 night NN B-NP O
90 sweats NNS I-NP O
90 for IN B-VP O
91 several JJ B-NP O
91 months NNS I-NP O
91 Will MD O O
91 f/u VB O O
91 with IN B-VP O
91 Dr NNP B-NP O
91 Muether NNP I-NP O
91 as IN B-VP O
91 outpatient NN B-NP O
91 for IN B-VP O
91 w/u NN B-NP O
92 ----------------- NNP I-NP O
93 3 CD O O
93 ) ) O O
93 HEME: NNP B-NP O
93 Given NNP I-NP O
93 anemia NN I-NP O
93 , , O O
93 iron NN B-NP O
93 studies NNS I-NP O
93 , , O O
93 B12 NNP B-NP O
93 , , O O
93 folate NN B-NP O
93 sent VBD B-VP O
93 Got NNP B-NP O
93 B12 NNP I-NP B-m
93 1000ug CD O B-do
93 IM NNP B-NP B-mo
94 x VBD B-VP B-f
94 1 CD O I-f
94 Pt NNP B-NP O
94 refuses VBZ O O
94 all DT B-NP O
94 VNA NNP I-NP O
94 services NNS I-NP O
94 , , O O
94 so RB O O
94 patient JJ O O
94 was VBD B-VP O
94 instructed VBN O O
94 to TO O O
94 f/u VB O O
94 with IN B-VP O
95 doctors NNS B-NP O
95 office NN I-NP O
95 to TO O O
95 get VB O O
95 injectiosn NN B-NP O
95 for IN B-VP O
95 2 CD O O
95 more JJR B-NP O
95 days NNS I-NP O
95 , , O O
95 then RB O O
95 monthly RB O O
95 Likely JJ O O
96 2/2 CD O O
96 gastrectomy NN B-NP O
97 ----------------- NNP I-NP O
98 4 CD O O
98 ) ) O O
98 DEPRESSION: NNP B-NP O
98 Pt NNP I-NP O
98 seems VBZ O O
98 severely RB O O
98 depressed VBN O O
98 , , O O
98 admits VBZ O O
98 to TO O O
98 depressed VB O O
99 mood NN B-NP O
99 patient JJ B-NP O
99 declines NNS I-NP O
99 psych RB O O
99 consult VBP O O
99 at IN B-VP O
99 this DT B-NP O
99 time NN I-NP O
100 --------------- VBZ O O
101 FULL NNP B-NP O
101 CODE NNP I-NP O
102 ADDITIONAL NNP I-NP O
102 COMMENTS: NNP I-NP O
102 Please NNP I-NP O
102 call VB O O
102 your PRP$ O O
102 doctor NN B-NP O
102 if IN B-VP O
102 you PRP O O
102 continue VBP O O
102 to TO O O
102 feel VB O O
102 unwell RB O O
102 , , O O
102 or CC O O
102 return NN B-NP O
102 to TO O O
102 the DT O O
103 hosptial JJ O O
103 If IN B-VP O
103 you PRP O O
103 would MD O O
103 like VB O O
103 to TO O O
103 receive VB O O
103 your PRP$ O O
103 B12 NNP B-NP B-m
103 injections NNS I-NP B-mo
103 , , O O
103 please NN B-NP O
103 go VB O O
103 to TO O O
104 the DT B-NP O
104 doctors NNS I-NP O
104 office NN I-NP O
104 on IN B-VP O
104 Thursday NNP B-NP O
104 and CC O O
104 Friday NNP B-NP O
104 to TO O O
104 receive VB O O
104 the DT B-NP O
104 injections NNS I-NP O
105 DISCHARGE NNP I-NP O
105 CONDITION: NNP I-NP O
105 Stable NNP I-NP O
106 TO NNP I-NP O
106 DO/PLAN: NNP I-NP O
107 - : O O
107 continue NN B-NP O
107 azithro VBZ O B-m
107 x $ O B-du
107 4 CD O I-du
107 days NNS B-NP I-du
108 - : O O
108 B12 NNP B-NP B-m
108 1000ug CD O B-do
108 QD NNP B-NP B-f
108 for IN B-VP B-du
108 2 CD O I-du
108 more JJR B-NP I-du
108 days NNS I-NP I-du
108 , , O O
108 the DT B-NP O
108 qmonth JJ I-NP O
109 No NNP I-NP O
109 dictated VBD B-VP O
109 summary JJ B-NP O
110 ENTERED NNP I-NP O
110 BY: NNP I-NP O
110 SMELSER NNP I-NP O
110 , , O O
110 KOREY NNP B-NP O
110 , , O O
110 M.D NNP B-NP O
110 ( ( O O
110 RJ68 NNP B-NP O
110 ) ) O O
110 5/18/05 CD O O
110 @ $ O O
110 05 CD O O
111 ****** JJ B-NP O
111 END NN I-NP O
111 OF NNP I-NP O
111 DISCHARGE NNP I-NP O
111 ORDERS NNP I-NP O
111 ****** NNP I-NP O
112 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #483034 VBZ O O
4 590977812 CD O O
4 FFACH NNP B-NP O
4 63114914 CD O O
4 1131190 CD O O
4 5/13/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/30/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
7 ATTENDING: NNP I-NP O
7 ZOGG NNP I-NP O
7 , , O O
7 RAYMOND NNP B-NP O
7 RANDALL NNP I-NP O
7 MD NNP I-NP O
8 DISCHARGE NNP I-NP O
8 DATE: NNP I-NP O
9 Presumed NNP I-NP O
9 to TO O O
9 be VB O O
9 5/1/05 CD O O
10 PRIMARY NNP B-NP O
10 ONCOLOGIST: NNP I-NP O
11 Antoine NNP I-NP O
11 Petchulis NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 PRINCIPAL NNP I-NP O
12 DIAGNOSIS: NNP I-NP O
13 Pain NNP I-NP O
13 secondary JJ O O
13 to TO O O
13 a DT B-NP O
13 lytic JJ I-NP O
13 lesion NN I-NP O
13 in IN B-VP O
13 the DT B-NP O
13 right JJ I-NP O
13 hip NN I-NP O
14 SECONDARY NNP I-NP O
14 DIAGNOSES: NNP I-NP O
15 Recurrent NNP I-NP O
15 lymphoma NN I-NP O
15 , , O O
15 pulmonary JJ B-NP O
15 dysfunction NN I-NP O
15 secondary JJ O O
15 to TO O O
16 chemotherapy VB O B-m
16 and CC O O
16 obesity JJ B-NP O
17 HISTORY NNP I-NP O
17 OF NNP I-NP O
17 PRESENT NNP I-NP O
17 ILLNESS: NNP I-NP O
18 In IN B-VP O
18 brief NN B-NP O
18 , , O O
18 this DT O O
18 is VBZ O O
18 a DT B-NP O
18 57-year-old JJ I-NP O
18 female NN I-NP O
18 with IN B-VP O
18 follicular JJ B-NP O
18 lymphoma NN I-NP O
19 diagnosed VBD B-VP O
19 approximately RB O O
19 eight CD O O
19 years NNS B-NP O
19 ago RB O O
19 who WP O O
19 has VBZ O O
19 been VBN O O
19 treated VBN O O
19 in IN B-VP O
20 the DT O O
20 past JJ O O
20 with IN B-VP O
20 CVP NNP B-NP B-m
20 and CC O O
20 CHOP/Rituxan NNP B-NP B-m
20 She PRP O O
20 underwent VBD B-VP O
20 high-dose JJ B-NP O
21 chemotherapy NN I-NP O
21 and CC O O
21 autologous JJ B-NP O
21 stem NN I-NP O
21 cell NN I-NP O
21 rescue NN I-NP O
21 in IN B-VP O
21 10/6 CD O O
21 Her PRP$ O O
22 transplant NN B-NP O
22 was VBD B-VP O
22 complicated VBN O O
22 by IN B-VP O
22 worsening VBG O O
22 of IN B-VP O
22 her PRP$ O O
22 baseline NN B-NP O
22 impaired JJ B-NP O
23 lung NN I-NP O
23 function NN I-NP O
23 , , O O
23 and CC O O
23 she PRP O O
23 has VBZ O O
23 been VBN O O
23 oxygen VBN O O
23 dependent JJ O O
23 since IN B-VP O
23 the DT B-NP O
23 time NN I-NP O
24 of IN B-VP O
24 transplant NN B-NP O
24 In IN B-VP O
24 3/24 CD O O
24 , , O O
24 she PRP O O
24 began VBD B-VP O
24 to TO O O
24 have VB O O
24 back RB O O
24 pain NN B-NP O
24 and CC O O
25 eventually RB O O
25 was VBD B-VP O
25 shown VBN O O
25 to TO O O
25 have VB O O
25 recurrent NN B-NP O
25 or CC O O
25 increasing VBG O O
25 disease NN B-NP O
25 in IN B-VP O
26 the DT B-NP O
26 retroperitoneum NN I-NP O
26 by IN B-VP O
26 abdominal JJ B-NP O
26 CT NNP I-NP O
26 ( ( O O
26 paraaortic JJ O O
26 at IN B-VP O
26 the DT B-NP O
26 level NN I-NP O
26 of IN B-VP O
27 L2 NNP B-NP O
27 ) ) O O
27 The DT B-NP O
27 decision NN I-NP O
27 was VBD B-VP O
27 made VBN O O
27 to TO O O
27 pursue VB O O
27 radiation NN B-NP O
27 therapy NN I-NP O
27 to TO O O
27 this DT B-NP O
28 area NN I-NP O
28 , , O O
28 which WDT O O
28 she PRP O O
28 completed VBD B-VP O
28 on IN B-VP O
28 4/7/05 CD O O
28 The DT B-NP O
28 patient NN I-NP O
28 presented VBN O O
29 with IN B-VP O
29 complaints NNS B-NP O
29 of IN B-VP O
29 pain NN B-NP O
29 in IN B-VP O
29 the DT B-NP O
29 mid NN I-NP O
29 lower RBR O O
29 back RB O O
29 radiating VBG O O
29 in IN B-VP O
29 a DT B-NP O
30 band-like JJ I-NP O
30 distribution NN I-NP O
30 around IN B-VP O
30 the DT B-NP O
30 waist NN I-NP O
30 to TO O O
30 the DT B-NP O
30 abdomen NNS I-NP O
30 as RB O O
30 well RB O O
30 as IN B-VP O
31 into IN B-VP O
31 the DT B-NP O
31 right JJ I-NP O
31 hip NN I-NP O
31 and CC O O
31 buttock NN B-NP O
31 area NN I-NP O
31 The DT B-NP O
31 pain NN I-NP O
31 also RB O O
31 radiated VBD B-VP O
31 into IN B-VP O
32 the DT B-NP O
32 right JJ I-NP O
32 thigh NN I-NP O
32 with IN B-VP O
32 movement NN B-NP O
32 for IN B-VP O
32 weightbearing VBG O O
32 The DT B-NP O
32 patient NN I-NP O
33 reports VBZ O O
33 the DT B-NP O
33 pain NN I-NP O
33 was VBD B-VP O
33 occasionally RB O O
33 associated VBN O O
33 with IN B-VP O
33 numbness NN B-NP O
33 in IN B-VP O
33 the DT B-NP O
34 right JJ I-NP O
34 lateral JJ I-NP O
34 thigh NN I-NP O
34 She PRP O O
34 denied VBD B-VP O
34 any DT B-NP O
34 radiation NN I-NP O
34 of IN B-VP O
34 the DT B-NP O
34 pain NN I-NP O
34 to TO O O
35 below IN B-VP O
35 the DT B-NP O
35 knee NN I-NP O
35 She PRP O O
35 denied VBD B-VP O
35 any DT B-NP O
35 numbness NN I-NP O
35 in IN B-VP O
35 the DT B-NP O
35 lower JJR I-NP O
35 legs NN I-NP O
35 , , O O
35 back RB O O
36 or CC O O
36 saddle JJ B-NP O
36 area NN I-NP O
36 She PRP O O
36 denied VBD B-VP O
36 any DT B-NP O
36 change NN I-NP O
36 in IN B-VP O
36 bowel NN B-NP O
36 or CC O O
36 bladder NN B-NP O
37 function NN I-NP O
38 The DT B-NP O
38 patient NN I-NP O
38 had VBD B-VP O
38 fluoroscopic VBN O O
38 LP NNP B-NP O
38 on IN B-VP O
38 10/19/05 CD O O
38 with IN B-VP O
38 a DT B-NP O
38 glucose NN I-NP O
38 of IN B-VP O
38 69 CD O O
38 , , O O
39 a DT B-NP O
39 total JJ I-NP O
39 protein NN I-NP O
39 of IN B-VP O
39 49.3 CD O O
39 , , O O
39 and CC O O
39 cytology NN B-NP O
39 which WDT O O
39 was VBD B-VP O
39 negative JJ B-NP O
39 Plain NNP I-NP O
40 films NNS I-NP O
40 of IN B-VP O
40 her PRP$ O O
40 hip NN B-NP O
40 showed VBD B-VP O
40 enthesopathy NN B-NP O
40 of IN B-VP O
40 the DT B-NP O
40 superior JJ I-NP O
40 pelvis NN I-NP O
41 bilaterally RB O O
41 , , O O
41 lower JJR B-NP O
41 lumbar NN I-NP O
41 spine NN I-NP O
41 degeneration NN I-NP O
41 , , O O
41 and CC O O
41 sclerotic JJ B-NP O
41 focus NN I-NP O
42 in IN B-VP O
42 the DT B-NP O
42 proximal JJ I-NP O
42 region NN I-NP O
42 of IN B-VP O
42 the DT B-NP O
42 right JJ I-NP O
42 femur NN I-NP O
42 MRI NNP I-NP O
42 of IN B-VP O
42 the DT B-NP O
42 lumbar NN I-NP O
43 spine NN I-NP O
43 on IN B-VP O
43 4/7/05 CD O O
43 showed VBD B-VP O
43 an DT B-NP O
43 irregular JJ I-NP O
43 soft JJ I-NP O
43 tissue NN I-NP O
43 mass NN I-NP O
43 within IN B-VP O
43 the DT B-NP O
44 retroperitoneum NN I-NP O
44 centered VBD B-VP O
44 anterior RB O O
44 to TO O O
44 the DT B-NP O
44 spine NN I-NP O
44 at IN B-VP O
44 the DT B-NP O
44 level NN I-NP O
44 of IN B-VP O
45 L2 NNP B-NP O
45 , , O O
45 position NN B-NP O
45 posterior NN I-NP O
45 to TO O O
45 the DT B-NP O
45 IVC NNP I-NP O
45 and CC O O
45 right JJ B-NP O
45 lateral JJ I-NP O
45 aorta NN I-NP O
46 measuring VBG O O
46 4.5 CD O O
46 x JJ O O
46 2.7 CD O O
46 x JJ O O
46 3.4 CD O O
46 cm; NN B-NP O
46 there EX O O
46 is VBZ O O
46 a DT B-NP O
46 lesion NN I-NP O
46 involving VBG O O
46 the DT B-NP O
47 anterior JJ I-NP O
47 superior JJ I-NP O
47 aspect NN I-NP O
47 to TO O O
47 the DT B-NP O
47 L2 NNP I-NP O
47 vertebral JJ B-NP O
47 body NN I-NP O
47 continuous JJ O O
47 with IN B-VP O
48 the DT B-NP O
48 anterior JJ I-NP O
48 paraspinal JJ I-NP O
48 mass NN I-NP O
48 with IN B-VP O
48 wedging NN B-NP O
48 and CC O O
48 probable JJ B-NP O
48 pathologic JJ I-NP O
49 compression NN I-NP O
49 fracture NN I-NP O
49 No NNP I-NP O
49 epidural JJ B-NP O
49 mass NN I-NP O
50 PAST NNP I-NP O
50 MEDICAL NNP I-NP O
50 HISTORY: NNP I-NP O
51 1 CD O O
51 Recurrent NNP B-NP O
51 lymphoma NN I-NP O
52 2 CD O O
52 Pulmonary NNP B-NP O
52 function NN I-NP O
52 thought VBD B-VP O
52 to TO O O
52 be VB O O
52 due JJ O O
52 in IN B-VP O
52 part NN B-NP O
52 to TO O O
52 BCNU NNP B-NP B-m
53 chemotherapy NN I-NP O
53 , , O O
53 currently RB O O
53 on IN B-VP O
53 5 CD O B-do
53 liters NNS B-NP I-do
53 home VBP O O
53 O2 NNP B-NP B-m
54 3 CD O O
54 Status NNP B-NP O
54 post NN I-NP O
54 cholecystectomy NN I-NP O
55 4 CD O O
55 Obesity NNP B-NP O
56 MEDICATIONS NNP I-NP O
56 AT NNP I-NP O
56 THE NNP I-NP O
56 TIME NNP I-NP O
56 OF NNP I-NP O
56 ADMISSION: NNP I-NP O
57 1 CD O O
57 Prednisone NNP B-NP B-m
57 10 CD O B-do
57 mg NN B-NP I-do
57 p.o JJ O B-mo
57 daily JJ O B-f
58 2 CD O O
58 Imuran NNP B-NP B-m
58 Imuran NNP I-NP B-m
58 100 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 q.a.m NN I-NP B-f
58 , , O O
58 50 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 q.p.m VBD B-VP B-f
59 3 CD O O
59 Coumadin NNP B-NP B-m
59 6 CD O B-do
59 mg NN B-NP I-do
59 p.o NN I-NP B-mo
59 q.h.s VBD B-VP B-f
60 4 CD O O
60 Lasix NNP B-NP B-m
60 60 CD O B-do
60 mg NN B-NP I-do
60 p.o JJ O B-mo
60 daily JJ O B-f
61 5 CD O O
61 Potassium NNP B-NP B-m
61 t.i.d NN I-NP B-f
62 6 CD O O
62 Folic NNP B-NP B-m
62 acid VBD B-VP I-m
63 7 CD O O
63 Multivitamin NNP B-NP B-m
64 8 CD O O
64 Colace NNP B-NP B-m
64 100 CD O B-do
64 mg NN B-NP I-do
64 p.o NN I-NP B-mo
64 b.i.d VBD B-VP B-f
65 9 CD O O
65 MiraLax NNP B-NP B-m
66 10 CD O O
66 Paxil NNP B-NP B-m
66 10 CD O B-do
66 mg NN B-NP I-do
66 p.o JJ O B-mo
66 daily JJ O B-f
67 11 CD O O
67 MS-Contin JJ O B-m
67 60 CD O B-do
67 mg NN B-NP I-do
67 p.o NN I-NP B-mo
67 t.i.d VBD B-VP B-f
68 12 CD O O
68 Flexeril NNP B-NP B-m
68 one CD O B-do
68 tab NN B-NP I-do
68 p.o NN I-NP B-mo
68 t.i.d NN I-NP B-f
69 ALLERGIES: NNP I-NP O
70 Sulfa NNP I-NP O
70 , , O O
70 latex VBD B-VP O
71 FAMILY NNP B-NP O
71 HISTORY: NNP I-NP O
72 Father NNP I-NP O
72 died VBD B-VP O
72 at IN B-VP O
72 the DT B-NP O
72 age NN I-NP O
72 of IN B-VP O
72 50 CD O O
72 from IN B-VP O
72 a DT B-NP O
72 brain NN I-NP O
72 tumor NN I-NP O
72 Mother NNP I-NP O
72 was VBD B-VP O
73 diagnosed VBN O O
73 with IN B-VP O
73 uterine JJ B-NP O
73 cancer NN I-NP O
73 , , O O
73 coronary JJ B-NP O
73 artery NN I-NP O
73 disease NN I-NP O
73 , , O O
73 and CC O O
74 diabetes VBZ O O
75 SOCIAL NNP B-NP O
75 HISTORY: NNP I-NP O
76 The DT B-NP O
76 patient NN I-NP O
76 lives VBZ O O
76 with IN B-VP O
76 her PRP$ O O
76 husband NN B-NP O
76 in IN B-VP O
76 Holl NNP B-NP O
76 Cho NNP I-NP O
76 Shing NNP I-NP O
76 She PRP O O
76 denies VBZ O O
76 tobacco NN B-NP O
76 and CC O O
76 alcohol NN B-NP O
76 She PRP O O
76 has VBZ O O
76 four CD O O
76 grown JJ B-NP O
77 children NNS I-NP O
78 PHYSICAL JJ B-NP O
78 EXAMINATION NNP I-NP O
78 AT NNP I-NP O
78 THE NNP I-NP O
78 TIME NNP I-NP O
78 OF NNP I-NP O
78 ADMISSION: NNP I-NP O
79 Vitals: NNP I-NP O
79 Temperature NNP I-NP O
79 97.6 CD O O
79 , , O O
79 heart NN B-NP O
79 rate NN I-NP O
79 91 CD O O
79 , , O O
79 blood NN B-NP O
79 pressure NN I-NP O
79 140/90 CD O O
79 , , O O
80 respiratory NN B-NP O
80 rate NN I-NP O
80 22 CD O O
80 , , O O
80 oxygen NN B-NP O
80 saturation NN I-NP O
80 97% CD O O
80 on IN B-VP O
80 5 CD O O
80 liters NNS B-NP O
80 In IN B-VP O
81 general JJ O O
81 , , O O
81 the DT B-NP O
81 patient NN I-NP O
81 was VBD B-VP O
81 found VBN O O
81 to TO O O
81 be VB O O
81 alert JJ O O
81 and CC O O
81 oriented JJ B-NP O
81 x3 NN I-NP O
81 with IN B-VP O
82 difficulty NN B-NP O
82 standing VBG O O
82 secondary JJ O O
82 to TO O O
82 pain VB O O
82 and CC O O
82 habitus VB O O
82 HEENT: NNP B-NP O
83 Pupils NNP I-NP O
83 were VBD B-VP O
83 equally RB O O
83 round JJ O O
83 and CC O O
83 reactive JJ O O
83 to TO O O
83 light JJ B-NP O
83 Normal NNP I-NP O
83 sclerae NN I-NP O
83 , , O O
84 normal JJ B-NP O
84 conjunctivae NN I-NP O
84 Extraocular JJ B-NP O
84 movements NNS I-NP O
84 were VBD B-VP O
84 intact JJ B-NP O
84 Moist NNP I-NP O
85 mucous JJ B-NP O
85 membranes NNS I-NP O
85 and CC O O
85 clear JJ B-NP O
85 oropharynx NN I-NP O
85 Neck: NNP I-NP O
85 No NNP I-NP O
86 lymphadenopathy NN I-NP O
86 , , O O
86 no DT B-NP O
86 thyromegaly NN I-NP O
86 Pulmonary: NNP I-NP O
86 Clear NNP I-NP O
86 to TO O O
87 auscultation VB O O
87 bilaterally RB O O
87 with IN B-VP O
87 some DT B-NP O
87 wheeze NN I-NP O
87 at IN B-VP O
87 the DT B-NP O
87 right JJ I-NP O
87 base NN I-NP O
88 Cardiovascular: NNP I-NP O
88 Regular NNP I-NP O
88 rate NN I-NP O
88 and CC O O
88 rhythm NN B-NP O
88 , , O O
88 normal JJ B-NP O
88 S1 NNP I-NP O
88 and CC O O
88 S2 NNP B-NP O
88 , , O O
88 no DT B-NP O
89 murmurs NN I-NP O
89 , , O O
89 rubs NN B-NP O
89 , , O O
89 or CC O O
89 gallops NNS B-NP O
89 Abdomen: NNP I-NP O
89 Morbid NNP I-NP O
89 obesity NN I-NP O
89 , , O O
89 nontender NN B-NP O
89 , , O O
90 normoactive JJ B-NP O
90 bowel NN I-NP O
90 sounds NNS I-NP O
90 , , O O
90 no DT B-NP O
90 hepatosplenomegaly NN I-NP O
90 Back: NNP I-NP O
90 Mild NNP I-NP O
91 paraspinal JJ B-NP O
91 tenderness NN I-NP O
91 bilaterally RB O O
91 Extremities: NNP B-NP O
91 Bilateral NNP I-NP O
91 lower JJR B-NP O
92 extremity NN I-NP O
92 edema VBP O O
92 Neuro: NNP B-NP O
92 2/5 CD O O
92 hip NN B-NP O
92 flexion NN I-NP O
92 and CC O O
92 knee VB O O
92 extension NN B-NP O
92 and CC O O
93 flexion NN B-NP O
93 on IN B-VP O
93 the DT B-NP O
93 right; NN I-NP O
93 5/5 CD O O
93 hip NN B-NP O
93 flexion NN I-NP O
93 and CC O O
93 knee VB O O
93 extension NN B-NP O
93 and CC O O
94 flexion NN B-NP O
94 on IN B-VP O
94 the DT B-NP O
94 right; NN I-NP O
94 5/5 CD O O
94 hip NN B-NP O
94 flexion NN I-NP O
94 and CC O O
94 knee VB O O
94 extension NN B-NP O
94 and CC O O
95 flexion NN B-NP O
95 on IN B-VP O
95 the DT B-NP O
95 left; JJ I-NP O
95 distal JJ I-NP O
95 neuropathy JJ I-NP O
96 LABORATORY NNP I-NP O
96 STUDIES: NNP I-NP O
97 At IN B-VP O
97 the DT B-NP O
97 time NN I-NP O
97 of IN B-VP O
97 admission NN B-NP O
97 , , O O
97 white JJ B-NP O
97 cell NN I-NP O
97 count NN I-NP O
97 9.8 CD O O
97 , , O O
97 hematocrit NN B-NP O
97 35.5 CD O O
97 , , O O
98 platelets NNS B-NP O
98 249 CD O O
98 INR NNP B-NP O
98 2.1 CD O O
98 , , O O
98 PTT NNP B-NP O
98 45.8 CD O O
98 BMP NNP B-NP O
98 showed VBD B-VP O
98 a DT B-NP O
98 sodium NN I-NP O
98 of IN B-VP O
98 139 CD O O
98 , , O O
99 potassium NN B-NP O
99 4.2 CD O O
99 , , O O
99 chloride RB O O
99 99 CD O O
99 , , O O
99 bicarbonate NN B-NP O
99 36 CD O O
99 , , O O
99 BUN NNP B-NP O
99 19 CD O O
99 , , O O
99 creatinine NN B-NP O
100 0.6 CD O O
100 , , O O
100 glucose VBD B-VP O
100 126 CD O O
100 LFTs NNP B-NP O
100 were VBD B-VP O
100 within IN B-VP O
100 normal JJ B-NP O
100 limits NNS I-NP O
100 UA NNP I-NP O
100 showed VBD B-VP O
100 2+ CD O O
101 bacteria NNS B-NP O
101 but CC O O
101 no DT B-NP O
101 white JJ I-NP O
101 cells NNS I-NP O
102 In IN B-VP O
102 general JJ O O
102 , , O O
102 this DT O O
102 is VBZ O O
102 a DT B-NP O
102 57-year-old JJ I-NP O
102 female NN I-NP O
102 with IN B-VP O
102 follicular JJ B-NP O
102 lymphoma NN I-NP O
103 who WP O O
103 presented VBD B-VP O
103 for IN B-VP O
103 workup NN B-NP O
103 of IN B-VP O
103 lower JJR B-NP O
103 back NN I-NP O
103 pain NN I-NP O
103 recurring VBG O O
103 status NN B-NP O
103 post NN I-NP O
104 XRT NN I-NP O
104 to TO O O
104 the DT B-NP O
104 lumbar NN I-NP O
104 spine NN I-NP O
104 region NN I-NP O
105 HOSPITAL NNP I-NP O
105 COURSE: NNP I-NP O
106 1 CD O O
106 Oncology: NNP B-NP O
106 CT NNP I-NP O
106 of IN B-VP O
106 the DT B-NP O
106 thoracic NN I-NP O
106 , , O O
106 lumbar NN B-NP O
106 , , O O
106 and CC O O
106 sacral JJ B-NP O
106 spine NN I-NP O
106 on IN B-VP O
107 2/10/05 CD O O
107 showed VBD B-VP O
107 no DT B-NP O
107 evidence NN I-NP O
107 of IN B-VP O
107 cord NN B-NP O
107 compression NN I-NP O
107 but CC O O
107 did VBD B-VP O
107 show VB O O
107 a DT B-NP O
108 compression NN I-NP O
108 fracture NN I-NP O
108 at IN B-VP O
108 L2 NNP B-NP O
108 IR NNP I-NP O
108 was VBD B-VP O
108 consulted VBN O O
108 on IN B-VP O
108 11/24/05 CD O O
109 regarding VBG O O
109 the DT B-NP O
109 possibility NN I-NP O
109 of IN B-VP O
109 kyphoplasty NN B-NP O
109 to TO O O
109 this DT B-NP O
109 area; NN I-NP O
109 however RB O O
109 , , O O
110 they PRP O O
110 deferred VBD B-VP O
110 further RBR O O
110 treatment NN B-NP O
110 , , O O
110 as IN B-VP O
110 the DT B-NP O
110 pain NN I-NP O
110 was VBD B-VP O
110 thought VBN O O
110 to TO O O
110 be VB O O
111 secondary JJ O O
111 to TO O O
111 hip VB O O
111 pathology NN B-NP O
111 rather RB O O
111 than IN B-VP O
111 lumbar VB O O
111 spine JJ B-NP O
111 pathology NN I-NP O
112 CT NNP I-NP O
112 of IN B-VP O
112 the DT B-NP O
112 right JJ I-NP O
112 hip NN I-NP O
112 on IN B-VP O
112 11/24/05 CD O O
112 showed VBD B-VP O
112 a DT B-NP O
112 lytic JJ I-NP O
112 lesion NN I-NP O
112 in IN B-VP O
112 the DT B-NP O
113 posterior JJ I-NP O
113 acetabulum NN I-NP O
113 with IN B-VP O
113 an DT B-NP O
113 associated JJ I-NP O
113 fracture NN I-NP O
113 The DT B-NP O
113 patient NN I-NP O
114 was VBD B-VP O
114 evaluated VBN O O
114 by IN B-VP O
114 Orthopedic NNP B-NP O
114 Oncology NNP I-NP O
114 as RB O O
114 well RB O O
114 as IN B-VP O
114 Radiation NNP B-NP O
115 Oncology NNP I-NP O
115 Dr NNP I-NP O
115 Cestia NNP I-NP O
115 with IN B-VP O
115 Orthopedic NNP B-NP O
115 Oncology NNP I-NP O
115 deferred VBD B-VP O
115 any DT B-NP O
116 surgical JJ I-NP O
116 intervention NN I-NP O
116 until IN B-VP O
116 the DT B-NP O
116 completion NN I-NP O
116 of IN B-VP O
116 radiation NN B-NP O
116 therapy IN B-VP O
117 The DT B-NP O
117 patient NN I-NP O
117 started VBD B-VP O
117 radiation NN B-NP O
117 therapy NN I-NP O
117 to TO O O
117 the DT B-NP O
117 right JJ I-NP O
117 hip NN I-NP O
117 on IN B-VP O
118 5/18/05 CD O O
118 The DT B-NP O
118 contact NN I-NP O
118 in IN B-VP O
118 Radiation NNP B-NP O
118 Oncology NNP I-NP O
118 is VBZ O O
118 Britt NNP B-NP O
118 L NNP I-NP O
118 Redden NNP I-NP O
118 , , O O
118 M.D NNP B-NP O
118 , , O O
118 pager NN B-NP O
118 number NN I-NP O
118 93376 CD O O
118 The DT B-NP O
118 plan NN I-NP O
118 is VBZ O O
118 for IN B-VP O
118 the DT B-NP O
119 patient NN I-NP O
119 to TO O O
119 complete VB O O
119 a DT B-NP O
119 course NN I-NP O
119 of IN B-VP O
119 18 CD O O
119 treatments NNS B-NP O
119 of IN B-VP O
119 radiation NN B-NP O
119 to TO O O
119 the DT B-NP O
120 right JJ I-NP O
120 hip NN I-NP O
120 The DT B-NP O
120 patient NN I-NP O
120 will MD O O
120 then RB O O
120 have VB O O
120 a DT B-NP O
120 repeat NN I-NP O
120 CT NNP I-NP O
120 of IN B-VP O
120 the DT B-NP O
120 right JJ I-NP O
121 hip NN I-NP O
121 in IN B-VP O
121 one CD O O
121 month's NN B-NP O
121 time NN I-NP O
121 and CC O O
121 follow VB O O
121 up RP O O
121 with IN B-VP O
121 Dr NNP B-NP O
121 Saralegui NNP I-NP O
121 She PRP O O
121 has VBZ O O
121 an DT B-NP O
122 appointment NN I-NP O
122 to TO O O
122 meet VB O O
122 with IN B-VP O
122 Dr NNP B-NP O
122 Strief NNP I-NP O
122 on IN B-VP O
122 6/13/05 CD O O
122 at IN B-VP O
122 2:45 CD O O
122 p.m NN B-NP O
122 Per NNP I-NP O
123 recommendations NNS I-NP O
123 of IN B-VP O
123 Orthopedic NNP B-NP O
123 Oncology NNP I-NP O
123 and CC O O
123 Physical NNP B-NP O
123 Therapy NNP I-NP O
123 , , O O
123 the DT B-NP O
124 patient NN I-NP O
124 is VBZ O O
124 to TO O O
124 be VB O O
124 touched VBN O O
124 down RP O O
124 weightbearing VBG O O
124 on IN B-VP O
124 the DT B-NP O
124 right JJ I-NP O
124 leg NN I-NP O
125 ( ( O O
125 toes IN B-VP O
125 only RB O O
125 ) ) O O
125 and CC O O
125 full JJ B-NP O
125 weightbearing NN I-NP O
125 on IN B-VP O
125 the DT B-NP O
125 left NN I-NP O
125 leg NN I-NP O
125 It PRP O O
125 is VBZ O O
126 expected VBN O O
126 that IN B-VP O
126 she PRP O O
126 should MD O O
126 be VB O O
126 able JJ O O
126 to TO O O
126 undergo VB O O
126 physical JJ B-NP O
126 therapy NN I-NP O
126 with IN B-VP O
127 the DT B-NP O
127 use NN I-NP O
127 of IN B-VP O
127 a DT B-NP O
127 walker NN I-NP O
127 She PRP O O
127 should MD O O
127 be VB O O
127 kept VBN O O
127 on IN B-VP O
127 posterior JJ B-NP O
127 hip NN I-NP O
128 precaution NN I-NP O
128 with IN B-VP O
128 limitation NN B-NP O
128 of IN B-VP O
128 hip NN B-NP O
128 flexion NN I-NP O
128 and CC O O
128 internal JJ B-NP O
128 rotation NN I-NP O
129 of IN B-VP O
129 the DT B-NP O
129 right JJ I-NP O
129 hip NN I-NP O
130 2 CD O O
130 Pain: NNP B-NP O
130 The DT B-NP O
130 patient NN I-NP O
130 was VBD B-VP O
130 seen VBN O O
130 by IN B-VP O
130 the DT B-NP O
130 Pain NNP I-NP O
130 Service NNP I-NP O
130 during IN B-VP O
130 this DT B-NP O
131 hospitalization NN I-NP O
131 Her NNP I-NP O
131 current JJ B-NP O
131 pain NN I-NP B-m
131 pain NN I-NP B-r
131 regimen NNS I-NP I-m
131 includes VBZ O O
131 methadone NN B-NP B-m
131 5 CD O B-do
132 mg NN B-NP O
132 p.o NN I-NP B-mo
132 t.i.d NN I-NP B-f
132 , , O O
132 Neurontin NNP B-NP B-m
132 Neurontin NNP I-NP B-m
132 300 CD O B-do
132 mg NN B-NP I-do
132 p.o NN I-NP B-mo
132 q.h.s NN I-NP B-f
132 , , O O
132 and CC O O
132 100 CD O B-do
132 mg NN B-NP I-do
132 p.o NN I-NP B-mo
133 q.8 NN I-NP O
133 a.m NN I-NP O
133 and CC O O
133 q NN B-NP O
133 noon NN I-NP O
133 , , O O
133 MSIR NNP B-NP B-m
133 MSIR NNP I-NP B-m
133 30 CD O B-do
133 mg NN B-NP I-do
133 p.o NN I-NP B-mo
133 q.h.s NN I-NP B-f
133 as RB O O
133 well RB O O
133 as IN B-VP O
133 15-30 JJ B-NP B-do
133 mg NN I-NP I-do
134 q.2h NN I-NP B-f
134 as IN B-VP I-f
134 needed VBN O I-f
134 The DT B-NP O
134 patient NN I-NP O
134 was VBD B-VP O
134 also RB O O
134 started VBN O O
134 on IN B-VP O
134 Decadron NNP B-NP B-m
134 10 CD O B-do
134 mg NN B-NP I-do
135 p.o NN I-NP B-mo
135 q.a.m NN I-NP B-f
135 given VBN O O
135 her PRP$ O O
135 initial JJ B-NP O
135 concern NN I-NP O
135 for IN B-VP O
135 spinal JJ B-NP B-r
135 cord NN I-NP O
136 compression NN I-NP O
136 She PRP O O
136 has VBZ O O
136 been VBN O O
136 tapering VBG O O
136 off IN B-VP O
136 of IN B-VP O
136 the DT B-NP O
136 Decadron NNP I-NP B-m
136 and CC O O
136 will MD O O
137 be VB O O
137 discharged VBN O O
137 on IN B-VP O
137 4 CD O B-do
137 mg NNS B-NP I-do
137 p.o JJ B-NP B-mo
137 q.a.m NN I-NP B-f
137 with IN B-VP O
137 taper NN B-NP O
137 as IN B-VP O
137 listed VBN O O
137 in IN B-VP O
137 the DT B-NP O
138 discharge NN I-NP O
138 instructions NNS I-NP O
138 Once IN B-VP O
138 the DT B-NP O
138 patient NN I-NP O
138 has VBZ O O
138 completed VBN O O
138 Decadron NNP B-NP B-m
139 2 CD O B-do
139 mg NN B-NP I-do
139 p.o NN I-NP B-mo
139 q.a.m NN I-NP B-f
139 x3 NN I-NP B-du
139 doses NNS I-NP I-du
139 , , O O
139 she PRP O O
139 should MD O O
139 then RB O O
139 be VB O O
139 started VBN O O
139 on IN B-VP O
140 prednisone NN B-NP B-m
140 10 CD O B-do
140 mg NN B-NP I-do
140 p.o JJ O B-mo
140 daily JJ O B-f
140 per IN B-VP O
140 her PRP$ O O
140 home NN B-NP O
140 dosing NN I-NP O
140 for IN B-VP O
140 pulmonary JJ B-NP B-r
141 disease NN I-NP O
141 The DT B-NP O
141 patient NN I-NP O
141 did VBD B-VP O
141 receive JJ B-NP O
141 pamidronate NN I-NP B-m
141 90 CD O B-do
141 mg NN B-NP I-do
141 IV NNP I-NP B-mo
141 x1 NNP I-NP B-f
141 during IN B-VP B-du
142 this DT B-NP O
142 hospitalization NN I-NP O
143 3 CD O O
143 ID: NNP B-NP O
143 UA NNP I-NP O
143 on IN B-VP O
143 admission NN B-NP O
143 was VBD B-VP O
143 more RBR O O
143 or CC O O
143 less RBR O O
143 benign JJ O O
143 , , O O
143 and CC O O
143 urine JJ B-NP O
144 culture NN I-NP O
144 remained VBD B-VP O
144 negative JJ O O
144 The DT B-NP O
144 patient NN I-NP O
144 was VBD B-VP O
144 afebrile JJ O O
144 throughout IN B-VP O
145 her PRP$ O O
145 hospitalization NN B-NP O
145 She PRP O O
145 was VBD B-VP O
145 given VBN O O
145 a DT B-NP B-du
145 five-day JJ I-NP I-du
145 course NN I-NP I-du
145 of IN B-VP O
146 acyclovir JJ O B-m
146 200 CD O B-do
146 mg NN B-NP I-do
146 p.o NN I-NP B-mo
146 five CD O B-f
146 times NNS B-NP I-f
146 per IN B-VP I-f
146 day NN B-NP I-f
146 for IN B-VP O
146 concern NN B-NP O
146 of IN B-VP O
146 recurrent NN B-NP O
147 genital JJ B-NP B-r
147 herpes NNS I-NP I-r
147 Given VBN O O
147 continued VBD B-VP O
147 complaints NNS B-NP O
147 of IN B-VP O
147 vaginal JJ B-NP O
147 itching NN I-NP O
147 , , O O
148 the DT B-NP O
148 patient NN I-NP O
148 was VBD B-VP O
148 given VBN O O
148 fluconazole JJ O B-m
148 150 CD O B-do
148 mg NN B-NP I-do
148 x1 NN I-NP B-du
148 on IN B-VP O
148 9/29/05 CD O O
148 to TO O O
148 treat VB O O
149 a DT B-NP B-r
149 presumed JJ I-NP I-r
149 yeast NN I-NP I-r
149 infection NN I-NP I-r
150 4 CD O O
150 GI: NNP B-NP O
150 The DT B-NP O
150 patient NN I-NP O
150 has VBZ O O
150 a DT B-NP O
150 history NN I-NP O
150 of IN B-VP O
150 constipation NN B-NP O
150 secondary NN I-NP O
150 to TO O O
151 use VB O O
151 of IN B-VP O
151 pain NN B-NP O
151 medication NN I-NP O
151 She PRP O O
151 has VBZ O O
151 been VBN O O
151 having VBG O O
151 good JJ B-NP O
151 bowel NN I-NP O
151 movement NN I-NP O
152 on IN B-VP O
152 MiraLax NNP B-NP B-m
152 , , O O
152 Senna NNP B-NP B-m
152 , , O O
152 Colace NNP B-NP B-m
152 She PRP O O
152 has VBZ O O
152 also RB O O
152 writing VBG O O
152 for IN B-VP O
152 Dulcolax NNP B-NP B-m
153 p.r.n NN I-NP B-f
153 for IN B-VP O
153 constipation NN B-NP B-r
154 5 CD O O
154 Heme: NNP B-NP O
154 The DT B-NP O
154 patient NN I-NP O
154 is VBZ O O
154 on IN B-VP O
154 Coumadin NNP B-NP B-m
154 given VBN O O
154 a DT B-NP O
154 recent JJ I-NP O
154 history NN I-NP O
154 of IN B-VP O
155 DVT NNP B-NP B-r
155 She PRP O O
155 had VBD B-VP O
155 an DT B-NP O
155 INR NNP I-NP O
155 of IN B-VP O
155 3.7 CD O O
155 two CD O O
155 days NNS B-NP O
155 prior RB O O
155 to TO O O
155 admission NN B-NP O
155 , , O O
155 so IN B-VP O
155 her PRP$ O O
156 dosing NN B-NP O
156 was VBD B-VP O
156 reduced VBN O O
156 during IN B-VP O
156 this DT B-NP O
156 hospitalization NN I-NP O
156 Her NNP I-NP O
156 INR NNP I-NP O
156 has VBZ O O
156 been VBN O O
157 stable JJ O O
157 and CC O O
157 is VBZ O O
157 at IN B-VP O
157 2.3 CD O O
157 at IN B-VP O
157 the DT B-NP O
157 time NN I-NP O
157 of IN B-VP O
157 discharge NN B-NP O
157 on IN B-VP O
157 dosing NN B-NP O
157 of IN B-VP O
157 4.5 CD O O
157 mg NNS B-NP O
158 p.o JJ O O
158 q.h.s RB O O
159 6 CD O O
159 Pulmonary: NNP B-NP O
159 As NNP I-NP O
159 mentioned VBD B-VP O
159 above IN B-VP O
159 , , O O
159 the DT B-NP O
159 patient NN I-NP O
159 has VBZ O O
159 a DT B-NP O
159 pulmonary JJ I-NP B-r
160 dysfunction NN I-NP O
160 with IN B-VP O
160 a DT B-NP O
160 home NN I-NP O
160 O2 NNP I-NP B-m
160 requirement NN I-NP O
160 of IN B-VP O
160 5 CD O B-do
160 liters NNS B-NP I-do
160 She PRP O O
160 has VBZ O O
160 been VBN O O
161 stable JJ O O
161 on IN B-VP O
161 this DT B-NP O
161 home NN I-NP O
161 O2 NNP I-NP B-m
161 requirement NN I-NP O
161 throughout IN B-VP B-du
161 this DT B-NP O
162 hospitalization NN I-NP O
162 She PRP O O
162 does VBZ O O
162 require VB O O
162 CPAP NNP B-NP O
162 at IN B-VP O
162 night NN B-NP O
162 for IN B-VP O
162 obstructive JJ B-NP O
163 sleep NN I-NP O
163 apnea NN I-NP O
164 7 CD O O
164 Cardiovascular: NNP B-NP O
164 No NNP I-NP O
164 known JJ B-NP O
164 history NN I-NP O
164 of IN B-VP O
164 cardiovascular JJ B-NP O
164 disease NN I-NP O
165 Echo NNP I-NP O
165 on IN B-VP O
165 11/28/04 CD O O
165 showed VBD B-VP O
165 an DT B-NP O
165 EF NNP I-NP O
165 of IN B-VP O
165 55% CD O O
166 8 CD O O
166 Endo: NNP B-NP O
166 The DT B-NP O
166 patient NN I-NP O
166 is VBZ O O
166 on IN B-VP O
166 a DT O O
166 sliding VBG O B-do
166 scale NN B-NP I-do
166 of IN B-VP O
166 regular JJ B-NP B-m
166 insulin NN I-NP I-m
167 while IN B-VP O
167 on IN B-VP O
167 Decadron NNP B-NP B-m
167 It PRP O O
167 is VBZ O O
167 intended VBN O O
167 that IN B-VP O
167 this DT O O
167 should MD O O
167 be VB O O
167 stopped VBN O O
168 when WRB O O
168 the DT B-NP O
168 Decadron NNP I-NP B-m
168 taper NN I-NP O
168 has VBZ O O
168 finished VBN O O
169 9 CD O O
169 Fluids NNP B-NP O
169 , , O O
169 Electrolytes NNP B-NP O
169 , , O O
169 Nutrition: NNP B-NP O
169 The DT B-NP O
169 patient NN I-NP O
169 had VBD B-VP O
169 some DT B-NP B-r
170 hypocalcemia NN I-NP O
170 during IN B-VP O
170 this DT B-NP O
170 hospitalization NN I-NP O
170 She PRP O O
170 was VBD B-VP O
170 started VBN O O
170 on IN B-VP O
171 Tums NNP B-NP B-m
171 500 CD O B-do
171 mg NN B-NP I-do
171 p.o NN I-NP B-mo
171 t.i.d NN I-NP B-f
171 , , O O
171 with IN B-VP O
171 good JJ B-NP O
171 response NN I-NP O
171 She PRP O O
171 was VBD B-VP O
171 also RB O O
171 given VBN O O
172 pamidronate NN B-NP B-m
172 x1 NN I-NP B-f
172 as IN B-VP O
172 listed VBN O O
172 above IN B-VP O
173 CODE: NNP B-NP O
174 Full NNP I-NP O
174 code NN I-NP O
175 DISPOSITION: NNP I-NP O
176 The DT B-NP O
176 patient NN I-NP O
176 is VBZ O O
176 being VBG O O
176 discharged VBN O O
176 to TO O O
176 the DT B-NP O
176 Ensers NNS I-NP O
176 1 CD O O
176 for IN B-VP O
176 further JJ B-NP O
177 rehabilitation NN I-NP O
177 She PRP O O
177 has VBZ O O
177 a DT B-NP O
177 lytic JJ I-NP O
177 lesion NN I-NP O
177 in IN B-VP O
177 the DT B-NP O
177 right JJ I-NP O
177 hip NN I-NP O
177 with IN B-VP O
178 evidence NN B-NP O
178 of IN B-VP O
178 fracture NN B-NP O
178 Per NNP I-NP O
178 recommendations NNS I-NP O
178 of IN B-VP O
178 Orthopedic NNP B-NP O
178 Oncology NNP I-NP O
179 as RB O O
179 well RB O O
179 as IN B-VP O
179 physical JJ B-NP O
179 therapy NN I-NP O
179 , , O O
179 please VB O O
179 limit NN B-NP O
179 right RB O O
179 leg VBZ O O
179 to TO O O
179 touchdown VB O O
180 weightbearing VBG O O
180 only RB O O
180 The DT B-NP O
180 patient NN I-NP O
180 should MD O O
180 be VB O O
180 full JJ O O
180 weightbearing VBG O O
180 on IN B-VP O
181 the DT B-NP O
181 left NN I-NP O
181 leg NN I-NP O
181 with IN B-VP O
181 physical JJ B-NP O
181 therapy NN I-NP O
181 involving VBG O O
181 use NN B-NP O
181 of IN B-VP O
181 a DT B-NP O
181 walker NN I-NP O
182 The DT B-NP O
182 patient NN I-NP O
182 was VBD B-VP O
182 stable JJ O O
182 at IN B-VP O
182 the DT B-NP O
182 time NN I-NP O
182 of IN B-VP O
182 discharge NN B-NP O
182 She PRP O O
182 should MD O O
183 continue VB O O
183 with IN B-VP O
183 her PRP$ O O
183 radiation NN B-NP O
183 therapy NN I-NP O
183 to TO O O
183 completion NN B-NP O
183 and CC O O
183 then RB O O
183 follow VB O O
184 up RP O O
184 with IN B-VP O
184 Dr NNP B-NP O
184 Kelvin NNP I-NP O
184 Lang NNP I-NP O
184 , , O O
184 in IN B-VP O
184 Orthopedic NNP B-NP O
184 Oncology NNP I-NP O
184 on IN B-VP O
184 6/13/05 CD O O
185 MEDICATIONS NNP B-NP O
185 AT NNP I-NP O
185 THE NNP I-NP O
185 TIME NNP I-NP O
185 OF NNP I-NP O
185 DISCHARGE: NNP I-NP O
185 Include NNP I-NP O
185 , , O O
186 Imuran NNP B-NP B-m
186 Imuran NNP I-NP B-m
186 100 CD O B-do
186 mg NN B-NP I-do
186 p.o NN I-NP B-mo
186 q.a.m NN I-NP B-f
186 , , O O
186 50 CD O B-do
186 mg NN B-NP I-do
186 p.o NN I-NP B-mo
186 q.p.m.; NN I-NP B-f
186 Dulcolax NNP I-NP B-m
186 5 CD O B-do
186 mg NN B-NP I-do
186 p.o JJ B-NP B-mo
187 daily JJ I-NP B-f
187 p.r.n NN I-NP I-f
187 for IN B-VP O
187 constipation; NN B-NP B-r
187 calcium NN I-NP B-m
187 carbonate NN I-NP I-m
187 500 CD O B-do
187 mg NN B-NP I-do
187 p.o NN I-NP B-mo
188 t.i.d.; NN I-NP B-f
188 Flexeril NNP I-NP B-m
188 10 CD O B-do
188 mg NN B-NP I-do
188 p.o NN I-NP B-mo
188 t.i.d.; NN I-NP B-f
188 dexamethasone NN I-NP B-m
188 dexamethasone NN I-NP B-m
188 4 CD O B-do
188 mg NN B-NP I-do
188 p.o JJ B-NP B-mo
188 daily JJ I-NP B-f
189 x2 NN I-NP B-du
189 doses NNS I-NP I-du
189 then RB O O
189 2 CD O B-do
189 mg NNS B-NP I-do
189 p.o JJ B-NP B-mo
189 daily JJ I-NP B-f
189 x3 NN I-NP B-du
189 doses NNS I-NP I-du
189 then RB O O
189 start VB O O
189 prednisone NN B-NP B-m
189 10 CD O B-do
190 mg NN B-NP O
190 p.o JJ B-NP B-mo
190 daily JJ I-NP B-f
190 Colace NNP I-NP B-m
190 100 CD O B-do
190 mg NN B-NP I-do
190 p.o NN I-NP B-mo
190 b.i.d NN I-NP B-f
190 , , O O
190 Lasix NNP B-NP B-m
190 60 CD O B-do
190 mg NN B-NP I-do
190 p.o JJ O B-mo
191 daily JJ O B-f
191 , , O O
191 Regular JJ B-NP B-m
191 Insulin NNP I-NP I-m
191 sliding VBG O B-do
191 scale NN B-NP I-do
191 , , O O
191 methadone NN B-NP B-m
191 5 CD O B-do
191 mg NN B-NP I-do
191 p.o NN I-NP B-mo
191 t.i.d NN I-NP B-f
191 , , O O
192 Sennosides NNP B-NP B-m
192 two CD O B-do
192 tables NNS B-NP I-do
192 p.o VBP O B-mo
192 b.i.d NN B-NP B-f
192 , , O O
192 Coumadin NNP B-NP B-m
192 4.5 CD O B-do
192 mg NN B-NP I-do
192 p.o NN I-NP B-mo
192 q.p.m NN I-NP B-f
192 , , O O
193 MSIR NNP B-NP B-m
193 30 CD O B-do
193 mg NN B-NP I-do
193 p.o NN I-NP B-mo
193 q.h.s NN I-NP B-f
193 , , O O
193 MSIR NNP B-NP B-m
193 50-30 JJ B-NP B-do
193 mg NN I-NP I-do
193 p.o NN I-NP B-mo
193 q.2h NN I-NP B-f
193 as IN B-VP I-f
193 needed VBN O I-f
193 for IN B-VP O
194 pain NN B-NP B-r
194 , , O O
194 Paxil NNP B-NP B-m
194 10 CD O B-do
194 mg NN B-NP I-do
194 p.o JJ O B-mo
194 daily RB O B-f
194 , , O O
194 Mepron NNP B-NP B-m
194 750 CD O B-do
194 mg NN B-NP I-do
194 p.o NN I-NP B-mo
194 b.i.d NN I-NP B-f
194 , , O O
195 Neurontin NNP B-NP B-m
195 300 CD O B-do
195 mg NN B-NP I-do
195 p.o NN I-NP B-mo
195 q.h.s NN I-NP B-f
195 , , O O
195 Neurontin NNP B-NP B-m
195 100 CD O B-do
195 mg NN B-NP I-do
195 p.o NN I-NP B-mo
195 q.8 NN I-NP O
195 a.m NN I-NP O
195 and CC O O
196 q NN B-NP O
196 noon NN I-NP O
196 , , O O
196 MiraLax NNP B-NP B-m
196 17 CD O B-do
196 g NN B-NP I-do
196 p.o JJ B-NP B-mo
196 daily JJ I-NP B-f
197 eScription NN I-NP O
197 document: VBZ O O
197 6-6674736 JJ B-NP O
197 EMSSten NNP I-NP O
197 Tel NNP I-NP O
198 CC: NNP I-NP O
198 Chadwick NNP I-NP O
198 Kaua NNP I-NP O
198 MD NNP I-NP O
199 Chocollmiho NNP I-NP O
199 Valedelp NNP I-NP O
200 CC: NNP I-NP O
200 Melvin NNP I-NP O
200 Norris NNP I-NP O
200 Bernacki NNP I-NP O
200 MD NNP I-NP O
201 Arl NNP I-NP O
201 Wayne NNP I-NP O
202 Dictated NNP I-NP O
202 By: NNP I-NP O
202 WEINZINGER NNP I-NP O
202 , , O O
202 DONTE NNP B-NP O
203 Attending: NNP I-NP O
203 WAUTERS NNP I-NP O
203 , , O O
203 GAYLE NNP B-NP O
203 KENDALL NNP I-NP O
204 Dictation NNP I-NP O
204 ID NNP I-NP O
204 4360670 CD O O
205 D: NNP B-NP O
205 5/1/05 CD O O
206 T: NNP B-NP O
206 5/1/05 CD O O
207 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #496398 VBZ O O
4 079220999 CD O O
4 SHH NNP B-NP O
4 92547244 CD O O
4 5799826 CD O O
4 5/29/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 dizziness NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/29/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/17/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 CORKILL NNP I-NP O
8 , , O O
8 MICKEY NNP B-NP O
8 625-13-08-7 CD O O
9 Rhamcastaleah NNP B-NP O
9 Nono NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 9/0/04 CD O O
11 AT NNP B-NP O
11 06:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 HO NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 DEWYSE NNP I-NP O
14 , , O O
14 KENDALL NNP B-NP O
14 J NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
19 Starting NNP I-NP O
19 STAT NNP I-NP O
19 ( ( O O
19 0/17 CD O O
19 ) ) O O
20 Alert NNP B-NP O
20 overridden: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 8/6/04 CD O O
20 by IN B-VP O
21 LAHUE NNP B-NP O
21 , , O O
21 HENRY NNP B-NP O
21 , , O O
21 M.D NNP B-NP O
22 POTENTIALLY NNP I-NP O
22 SERIOUS NNP I-NP O
22 INTERACTION: NNP I-NP O
22 WARFARIN NNP I-NP B-m
22 &amp; NNP I-NP O
22 ASPIRIN NNP I-NP B-m
23 Reason NNP I-NP O
23 for IN B-VP O
23 override: NN B-NP O
23 MD NNP I-NP O
23 aware NN I-NP O
23 , , O O
23 pt NN B-NP O
23 on IN B-VP O
23 this DT B-NP O
23 regimen NN I-NP O
23 at IN B-VP O
23 home NN B-NP O
24 AMIODARONE NNP I-NP B-m
24 200 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QD NNP I-NP B-f
25 Alert NNP I-NP O
25 overridden: NNP I-NP O
25 Override NNP I-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 8/6/04 CD O O
25 by IN B-VP O
26 DYMENT NNP B-NP O
26 , , O O
26 ISAAC NNP B-NP O
26 , , O O
26 M.D NNP B-NP O
27 POTENTIALLY NNP I-NP O
27 SERIOUS NNP I-NP O
27 INTERACTION: NNP I-NP O
27 WARFARIN NNP I-NP B-m
27 &amp; NNP I-NP O
27 AMIODARONE NNP I-NP B-m
27 HCL NNP I-NP I-m
28 SERIOUS NNP I-NP O
28 INTERACTION: NNP I-NP O
28 DIGOXIN NNP I-NP B-m
28 &amp; NNP I-NP O
28 AMIODARONE NNP I-NP B-m
28 HCL NNP I-NP I-m
29 Reason NNP I-NP O
29 for IN B-VP O
29 override: NN B-NP O
29 MD NNP I-NP O
29 aware JJ B-NP O
29 pt NN I-NP O
29 on IN B-VP O
29 this DT B-NP O
29 regimen NN I-NP O
29 at IN B-VP O
29 home NN B-NP O
30 DIGOXIN NNP I-NP B-m
30 0.125 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 QD NNP I-NP B-f
31 Override NNP I-NP O
31 Notice: NNP I-NP O
31 Override NNP I-NP O
31 added VBD B-VP O
31 on IN B-VP O
31 8/6/04 CD O O
31 by IN B-VP O
32 MURIE NNP B-NP O
32 , , O O
32 ELLIOTT NNP B-NP O
32 , , O O
32 M.D NNP B-NP O
33 on IN B-VP O
33 order NN B-NP O
33 for IN B-VP O
33 AMIODARONE NNP B-NP B-m
33 PO NNP I-NP B-mo
33 ( ( O O
33 ref JJ O O
33 # # O O
33 75986840 CD O O
33 ) ) O O
34 SERIOUS NNP B-NP O
34 INTERACTION: NNP I-NP O
34 DIGOXIN NNP I-NP B-m
34 &amp; NNP I-NP O
34 AMIODARONE NNP I-NP B-m
34 HCL NNP I-NP I-m
35 Reason NNP I-NP O
35 for IN B-VP O
35 override: NN B-NP O
35 MD NNP I-NP O
35 aware JJ B-NP O
35 pt NN I-NP O
35 on IN B-VP O
35 this DT B-NP O
35 regimen NN I-NP O
35 at IN B-VP O
35 home NN B-NP O
36 COLACE NNP I-NP B-m
36 ( ( O I-m
36 DOCUSATE NNP B-NP I-m
36 SODIUM NNP I-NP I-m
36 ) ) O I-m
36 100 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 BID NNP I-NP B-f
37 LASIX NNP I-NP B-m
37 ( ( O I-m
37 FUROSEMIDE NNP B-NP I-m
37 ) ) O I-m
37 120 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 BID NNP I-NP B-f
38 NPH NNP I-NP B-m
38 HUMULIN NNP I-NP I-m
38 INSULIN NNP I-NP I-m
38 ( ( O I-m
38 INSULIN NNP B-NP I-m
38 NPH NNP I-NP I-m
38 HUMAN NNP I-NP I-m
38 ) ) O I-m
38 47 CD O B-do
38 UNITS NNP B-NP I-do
38 SC NNP I-NP B-mo
38 QAM NNP I-NP B-f
39 INSULIN NNP I-NP B-m
39 INSULIN NNP I-NP B-m
39 INSULIN NNP I-NP B-m
39 INSULIN NNP I-NP B-m
39 INSULIN NNP I-NP B-m
39 INSULIN NNP I-NP B-m
39 INSULIN NNP I-NP B-m
39 INSULIN NNP I-NP B-m
39 REGULAR NNP I-NP I-m
39 REGULAR NNP I-NP I-m
39 REGULAR NNP I-NP I-m
39 REGULAR NNP I-NP I-m
39 REGULAR NNP I-NP I-m
39 REGULAR NNP I-NP I-m
39 REGULAR NNP I-NP I-m
39 REGULAR NNP I-NP I-m
39 HUMAN NNP I-NP I-m
39 HUMAN NNP I-NP I-m
39 HUMAN NNP I-NP I-m
39 HUMAN NNP I-NP I-m
39 HUMAN NNP I-NP I-m
39 HUMAN NNP I-NP I-m
39 HUMAN NNP I-NP I-m
39 HUMAN NNP I-NP I-m
40 Sliding NNP I-NP B-do
40 Scale NNP I-NP I-do
40 ( ( O B-mo
40 subcutaneously RB O I-mo
40 ) ) O I-mo
40 SC NNP B-NP I-mo
40 AC+HS NNP I-NP B-f
41 If IN B-VP O
41 BS NNP B-NP O
41 is VBZ O O
41 less JJR O O
41 than IN B-VP O
41 125 CD O O
41 , , O O
41 then RB O O
41 give VB O O
41 0 CD O B-do
41 units NNS B-NP I-do
41 subcutaneously RB O B-mo
42 If IN B-VP O
42 BS NNP B-NP O
42 is VBZ O O
42 125-150 JJ O O
42 , , O O
42 then RB O O
42 give VB O O
42 2 CD O B-do
42 units NNS B-NP I-do
42 subcutaneously RB O B-mo
43 If IN B-VP O
43 BS NNP B-NP O
43 is VBZ O O
43 151-200 CD O O
43 , , O O
43 then RB O O
43 give VB O O
43 3 CD O B-do
43 units NNS B-NP I-do
43 subcutaneously RB O B-mo
44 If IN B-VP O
44 BS NNP B-NP O
44 is VBZ O O
44 201-250 JJ O O
44 , , O O
44 then RB O O
44 give VB O O
44 4 CD O B-do
44 units NNS B-NP I-do
44 subcutaneously RB O B-mo
45 If IN B-VP O
45 BS NNP B-NP O
45 is VBZ O O
45 251-300 JJ O O
45 , , O O
45 then RB O O
45 give VB O O
45 6 CD O B-do
45 units NNS B-NP I-do
45 subcutaneously RB O B-mo
46 If IN B-VP O
46 BS NNP B-NP O
46 is VBZ O O
46 301-350 JJ O O
46 , , O O
46 then RB O O
46 give VB O O
46 8 CD O B-do
46 units NNS B-NP I-do
46 subcutaneously RB O B-mo
47 If IN B-VP O
47 BS NNP B-NP O
47 is VBZ O O
47 351-400 CD O O
47 , , O O
47 then RB O O
47 give VB O O
47 10 CD O B-do
47 units NNS B-NP I-do
47 subcutaneously RB O B-mo
47 and CC O O
48 call VB O O
48 HO NNP B-NP O
48 Call NNP I-NP O
48 HO NNP I-NP O
48 if IN B-VP O
48 BS NNP B-NP O
48 is VBZ O O
48 greater JJR O O
48 than IN B-VP O
48 400 CD O O
49 MILK NNP B-NP B-m
49 OF NNP I-NP I-m
49 MAGNESIA NNP I-NP I-m
49 ( ( O I-m
49 MAGNESIUM NNP B-NP I-m
49 HYDROXIDE NNP I-NP I-m
49 ) ) O I-m
50 30 CD O B-do
50 MILLILITERS NNP B-NP I-do
50 PO NNP I-NP B-mo
50 QD NNP I-NP B-f
50 PRN NNP I-NP I-f
50 Constipation NNP I-NP B-r
51 COUMADIN NNP I-NP B-m
51 ( ( O I-m
51 WARFARIN NNP B-NP I-m
51 SODIUM NNP I-NP I-m
51 ) ) O I-m
51 2 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 QPM NNP I-NP B-f
52 Starting NNP I-NP O
52 NOW NNP I-NP O
52 , , O O
52 Within NNP B-NP O
52 Hour NNP I-NP O
52 of IN B-VP O
52 Pharmacy NNP B-NP O
52 Approval NNP I-NP O
52 ( ( O O
52 0/17 CD O O
52 ) ) O O
53 Food/Drug NNP B-NP O
53 Interaction NNP I-NP O
53 Instruction NNP I-NP O
54 No NNP I-NP O
54 high JJ B-NP O
54 Vitamin-K NNP I-NP O
54 containing VBG O O
54 foods NNS B-NP O
55 Override NNP I-NP O
55 Notice: NNP I-NP O
55 Override NNP I-NP O
55 added VBD B-VP O
55 on IN B-VP O
55 8/6/04 CD O O
55 by IN B-VP O
56 PALEN NNP B-NP O
56 , , O O
56 EVERETTE NNP B-NP O
56 , , O O
56 M.D NNP B-NP O
57 on IN B-VP O
57 order NN B-NP O
57 for IN B-VP O
57 ACETYLSALICYLIC NNP B-NP B-m
57 ACID NNP I-NP I-m
57 PO NNP I-NP B-mo
57 ( ( O O
57 ref JJ O O
57 # # O O
57 44957141 CD O O
57 ) ) O O
58 POTENTIALLY NNP B-NP O
58 SERIOUS NNP I-NP O
58 INTERACTION: NNP I-NP O
58 WARFARIN NNP I-NP B-m
58 &amp; NNP I-NP O
58 ASPIRIN NNP I-NP B-m
59 Reason NNP I-NP O
59 for IN B-VP O
59 override: NN B-NP O
59 MD NNP I-NP O
59 aware NN I-NP O
59 , , O O
59 pt NN B-NP O
59 on IN B-VP O
59 this DT B-NP O
59 regimen NN I-NP O
59 at IN B-VP O
59 home NN B-NP O
60 Previous NNP I-NP O
60 override IN B-VP O
60 information: JJ B-NP O
61 Override NNP I-NP O
61 added VBD B-VP O
61 on IN B-VP O
61 8/6/04 CD O O
61 by IN B-VP O
61 LOTERBAUER NNP B-NP O
61 , , O O
61 PORTER NNP B-NP O
61 , , O O
61 M.D NNP B-NP O
62 on IN B-VP O
62 order NN B-NP O
62 for IN B-VP O
62 AMIODARONE NNP B-NP B-m
62 PO NNP I-NP B-mo
62 ( ( O O
62 ref JJ O O
62 # # O O
62 75986840 CD O O
62 ) ) O O
63 POTENTIALLY NNP B-NP O
63 SERIOUS NNP I-NP O
63 INTERACTION: NNP I-NP O
63 WARFARIN NNP I-NP B-m
63 &amp; NNP I-NP O
63 AMIODARONE NNP I-NP B-m
63 HCL NNP I-NP I-m
64 Reason NNP I-NP O
64 for IN B-VP O
64 override: NN B-NP O
64 MD NNP I-NP O
64 aware JJ B-NP O
64 pt NN I-NP O
64 on IN B-VP O
64 this DT B-NP O
64 regimen NN I-NP O
64 at IN B-VP O
64 home NN B-NP O
65 Previous NNP I-NP O
65 override IN B-VP O
65 information: JJ B-NP O
66 Override NNP I-NP O
66 added VBD B-VP O
66 on IN B-VP O
66 9/23/04 CD O O
66 by IN B-VP O
66 ODONALD NNP B-NP O
66 , , O O
66 EMANUEL NNP B-NP O
66 , , O O
66 M.D NNP B-NP O
67 POTENTIALLY NNP I-NP O
67 SERIOUS NNP I-NP O
67 INTERACTION: NNP I-NP O
67 SIMVASTATIN NNP I-NP B-m
67 &amp; NNP I-NP O
67 WARFARIN NNP I-NP B-m
68 Reason NNP I-NP O
68 for IN B-VP O
68 override: NN B-NP O
68 MD NNP I-NP O
68 aware JJ B-NP O
69 SIMVASTATIN NNP I-NP B-m
69 80 CD O B-do
69 MG NNP B-NP I-do
69 PO NNP I-NP B-mo
69 QHS NNP I-NP B-f
69 Starting NNP I-NP O
69 STAT NNP I-NP O
69 ( ( O O
69 4/13 CD O O
69 ) ) O O
70 Food/Drug NNP B-NP O
70 Interaction NNP I-NP O
70 Instruction NNP I-NP O
71 Avoid NNP I-NP O
71 grapefruit NN I-NP O
71 unless IN B-VP O
71 MD NNP B-NP O
71 instructs NNS I-NP O
71 otherwise RB O O
72 Override NNP B-NP O
72 Notice: NNP I-NP O
72 Override NNP I-NP O
72 added VBD B-VP O
72 on IN B-VP O
72 9/23/04 CD O O
72 by IN B-VP O
73 KIDWELL NNP B-NP O
73 , , O O
73 RICHIE NNP B-NP O
73 , , O O
73 M.D NNP B-NP O
74 on IN B-VP O
74 order NN B-NP O
74 for IN B-VP O
74 COUMADIN NNP B-NP B-m
74 PO NNP I-NP B-mo
74 ( ( O O
74 ref JJ O O
74 # # O O
74 55008411 CD O O
74 ) ) O O
75 POTENTIALLY NNP B-NP O
75 SERIOUS NNP I-NP O
75 INTERACTION: NNP I-NP O
75 SIMVASTATIN NNP I-NP B-m
75 &amp; NNP I-NP O
75 WARFARIN NNP I-NP B-m
76 Reason NNP I-NP O
76 for IN B-VP O
76 override: NN B-NP O
76 MD NNP I-NP O
76 aware JJ B-NP O
77 NORVASC NNP I-NP B-m
77 ( ( O I-m
77 AMLODIPINE NNP B-NP I-m
77 ) ) O I-m
77 10 CD O B-do
77 MG NNP B-NP I-do
77 PO NNP I-NP B-mo
77 QD NNP I-NP B-f
77 HOLD NNP I-NP O
77 IF: NNP I-NP O
77 SBP NNP I-NP O
77 &lt; VBD B-VP O
77 95 CD O O
78 Food/Drug NNP B-NP O
78 Interaction NNP I-NP O
78 Instruction NNP I-NP O
79 Avoid NNP I-NP O
79 grapefruit NN I-NP O
79 unless IN B-VP O
79 MD NNP B-NP O
79 instructs NNS I-NP O
79 otherwise RB O O
80 IMDUR NNP B-NP B-m
80 ( ( O I-m
80 ISOSORBIDE NNP B-NP I-m
80 MONONIT.( NNP I-NP I-m
80 SR NNP I-NP I-m
80 ) ) O I-m
80 ) ) O I-m
80 60 CD O B-do
80 MG NNP B-NP I-do
80 PO NNP I-NP B-mo
80 QD NNP I-NP B-f
81 Food/Drug NNP I-NP O
81 Interaction NNP I-NP O
81 Instruction NNP I-NP O
82 Give NNP I-NP O
82 on IN B-VP O
82 an DT B-NP O
82 empty JJ I-NP O
82 stomach NN I-NP O
82 ( ( O O
82 give JJ O O
82 1hr CD O O
82 before IN B-VP O
82 or CC O O
82 2hr CD O O
82 after IN B-VP O
83 food NN B-NP O
83 ) ) O O
84 KCL NNP B-NP B-m
84 IMMEDIATE NNP I-NP I-m
84 RELEASE NNP I-NP I-m
84 40 CD O B-do
84 MEQ NNP B-NP I-do
84 PO NNP I-NP B-mo
84 BID NNP I-NP B-f
85 HOLD NNP I-NP O
85 IF: NNP I-NP O
85 potassium NN I-NP O
85 &gt; VBZ O O
85 4.5 CD O O
86 As IN B-VP O
86 per NN B-NP O
86 ICH NNP I-NP O
86 Potassium NNP I-NP O
86 Chloride NNP I-NP O
86 Policy: NNP I-NP O
87 each DT O O
87 20 CD O O
87 mEq NNS B-NP O
87 dose VB O O
87 to TO O O
87 be VB O O
87 given VBN O O
87 with IN B-VP O
87 4 CD O O
87 oz NNS B-NP O
87 of IN B-VP O
87 fluid NN B-NP O
88 COZAAR NNP I-NP B-m
88 ( ( O I-m
88 LOSARTAN NNP B-NP I-m
88 ) ) O I-m
88 100 CD O B-do
88 MG NNP B-NP I-do
88 PO NNP I-NP B-mo
88 QHS NNP I-NP B-f
88 Starting NNP I-NP O
88 STAT NNP I-NP O
88 ( ( O O
88 4/13 CD O O
88 ) ) O O
89 HOLD NNP B-NP O
89 IF: NNP I-NP O
89 SBP NNP I-NP O
89 &lt; VBZ O O
89 95 CD O O
89 Number NNP B-NP B-du
89 of IN B-VP I-du
89 Doses NNP B-NP I-du
89 Required NNP I-NP I-du
89 ( ( O I-du
89 approximate JJ B-NP I-du
89 ): NN I-NP I-du
89 3 CD O I-du
90 PLAVIX NNP B-NP B-m
90 ( ( O I-m
90 CLOPIDOGREL NNP B-NP I-m
90 ) ) O I-m
90 75 CD O B-do
90 MG NNP B-NP I-do
90 PO NNP I-NP B-mo
90 QD NNP I-NP B-f
90 Starting NNP I-NP O
90 STAT NNP I-NP O
90 ( ( O O
90 0/17 CD O O
90 ) ) O O
91 NEXIUM NNP B-NP B-m
91 ( ( O I-m
91 ESOMEPRAZOLE NNP B-NP I-m
91 ) ) O I-m
91 20 CD O B-do
91 MG NNP B-NP I-do
91 PO NNP I-NP B-mo
91 QD NNP I-NP B-f
92 LEVOTHYROXINE NNP I-NP B-m
92 SODIUM NNP I-NP I-m
92 50 CD O B-do
92 MCG NNP B-NP I-do
92 PO NNP I-NP B-mo
92 QD NNP I-NP B-f
93 Alert NNP I-NP O
93 overridden: NNP I-NP O
93 Override NNP I-NP O
93 added VBD B-VP O
93 on IN B-VP O
93 9/0/04 CD O O
93 by IN B-VP O
93 : : O O
94 POTENTIALLY NNP B-NP O
94 SERIOUS NNP I-NP O
94 INTERACTION: NNP I-NP O
94 DIGOXIN NNP I-NP B-m
94 &amp; NNP I-NP O
94 LEVOTHYROXINE NNP I-NP B-m
95 SODIUM NNP I-NP O
95 Reason NNP I-NP O
95 for IN B-VP O
95 override: NN B-NP O
95 aware JJ B-NP O
96 DIET: NNP I-NP O
96 House NNP I-NP O
96 / VBD B-VP O
96 2 CD O O
96 gm NN B-NP O
96 Na NNP I-NP O
96 / NNP I-NP O
96 ADA NNP I-NP O
96 2100 CD O O
96 cals/day NN B-NP O
96 / NNP I-NP O
96 Low NNP I-NP O
96 saturated VBD B-VP O
96 fat JJ B-NP O
97 low JJ I-NP O
97 cholesterol NN I-NP O
98 ACTIVITY: NNP I-NP O
98 Resume NNP I-NP O
98 regular JJ B-NP O
98 exercise NN I-NP O
99 FOLLOW NNP I-NP O
99 UP NNP I-NP O
99 APPOINTMENT( NNP I-NP O
99 S NNP I-NP O
99 ): NNP I-NP O
100 Dr NNP I-NP O
100 Kirkconnell NNP I-NP O
100 ( ( O O
100 cardiology VB O O
100 521-540-0293 NNS B-NP O
100 ) ) O O
100 at IN B-VP O
100 11:00am CD O O
100 9/22/04 CD O O
100 , , O O
101 Dr NNP B-NP O
101 Mccaffrey NNP I-NP O
101 ( ( O O
101 PCP NNP B-NP O
101 221-764-2384 CD O O
101 ) ) O O
101 at IN B-VP O
101 10:45am CD O O
101 5/8/04 CD O O
101 , , O O
102 Dr NNP B-NP O
102 Ziebol NNP I-NP O
102 ( ( O O
102 endocrinology IN B-VP O
102 091-018-1923 NN B-NP O
102 ) ) O O
102 at IN B-VP O
102 3:00pm CD O O
102 10/11/04 CD O O
102 , , O O
103 Arrange NNP B-NP O
103 INR NNP I-NP O
103 to TO O O
103 be VB O O
103 drawn VBN O O
103 on IN B-VP O
103 9/22/04 CD O O
103 with IN B-VP O
103 f/u JJ B-NP O
103 INR's NNP I-NP O
103 to TO O O
103 be VB O O
103 drawn VBN O O
103 every DT O O
104 7 CD O O
104 days NNS B-NP O
104 INR's NNP I-NP O
104 will MD O O
104 be VB O O
104 followed VBN O O
104 by IN B-VP O
104 Dr NNP B-NP O
104 Mac NNP I-NP O
104 Strogen NNP I-NP O
105 ALLERGY: NNP I-NP O
105 Cephalosporins NNP I-NP O
105 , , O O
105 ERYTHROMYCIN NNP B-NP O
105 , , O O
105 Penicillins NNP B-NP O
106 ADMIT NNP I-NP O
106 DIAGNOSIS: NNP I-NP O
107 dizziness NN I-NP O
107 , , O O
107 ataxia NN B-NP O
108 PRINCIPAL NNP I-NP O
108 DISCHARGE NNP I-NP O
108 DIAGNOSIS NNP I-NP O
108 ;Responsible JJ O O
108 After IN B-VP O
108 Study NNP B-NP O
108 for IN B-VP O
108 Causing NNP B-NP O
108 Admission NNP I-NP O
108 ) ) O O
109 dizziness NN B-NP O
110 OTHER NNP I-NP O
110 DIAGNOSIS;Conditions NNP I-NP O
110 , , O O
110 Infections NNP B-NP O
110 , , O O
110 Complications NNP B-NP O
110 , , O O
110 affecting VBG O O
110 Treatment/Stay NNP B-NP O
111 s/p RB O O
111 right RB O O
111 CEA NNP B-NP O
111 LBBB NNP I-NP O
111 on IN B-VP O
111 EKG NNP B-NP O
111 hypertension NN I-NP O
112 diabetes VBZ O O
112 EF NNP B-NP O
112 25-30% JJ B-NP O
112 CHF NNP I-NP O
112 ( ( O O
112 congestive JJ B-NP O
112 heart NN I-NP O
113 failure NN I-NP O
113 ) ) O O
113 Ischemic NNP B-NP O
113 Cardiomyopathy NNP I-NP O
113 ( ( O O
113 cardiomyopathy NN B-NP O
113 ) ) O O
113 Atrial NNP B-NP O
113 Fibrillation NNP I-NP O
114 ( ( O O
114 atrial JJ B-NP O
114 fibrillation NN I-NP O
114 ) ) O O
114 , , O O
114 symptomatic JJ B-NP O
114 bradycardia NN I-NP O
114 s/p NN I-NP O
114 AICD/pacer NNP I-NP O
115 placement NN I-NP O
115 , , O O
115 ?TIA JJ B-NP O
116 OPERATIONS NNP I-NP O
116 AND NNP I-NP O
116 PROCEDURES: NNP I-NP O
117 none NN I-NP O
118 OTHER NNP I-NP O
118 TREATMENTS/PROCEDURES NNP I-NP O
118 ( ( O O
118 NOT NNP B-NP O
118 IN NNP I-NP O
118 O.R NNP I-NP O
118 ) ) O O
119 Chest NNP B-NP O
119 PA NNP I-NP O
119 and CC O O
119 Lateral NNP B-NP O
120 AICD NNP I-NP O
120 Interrogation NNP I-NP O
120 ( ( O O
120 Dr NNP B-NP O
120 Kurt NNP I-NP O
120 Morring NNP I-NP O
120 ) ) O O
121 BRIEF NNP B-NP O
121 RESUME NNP I-NP O
121 OF NNP I-NP O
121 HOSPITAL NNP I-NP O
121 COURSE: NNP I-NP O
122 Ms NNP I-NP O
122 Galabeas NNP I-NP O
122 is VBZ O O
122 a DT O O
122 71F JJ O O
122 with IN B-VP O
122 DM NNP B-NP O
122 , , O O
122 CAD NNP B-NP O
122 , , O O
122 s/p VBD B-VP O
122 3vCABG CD O O
122 , , O O
122 s/p NN B-NP O
122 RCA NNP I-NP O
122 stent NN I-NP O
122 in IN B-VP O
122 1/2 CD O O
122 , , O O
123 CHF( NNP B-NP O
123 EF=45% NNP I-NP O
123 in IN B-VP O
123 1/2 CD O O
123 ) ) O O
123 , , O O
123 h/o JJ B-NP O
123 bradycardia NN I-NP O
123 now RB O O
123 with IN B-VP O
123 AICD/Pacer NNP B-NP O
123 , , O O
123 s/p JJ B-NP O
123 R-CEA NNP I-NP O
123 , , O O
124 s/p NN B-NP O
124 ? . B-VP O
124 TIA NNP B-NP O
124 , , O O
124 who WP O O
124 presents VBZ O O
124 with IN B-VP O
124 dizziness NN B-NP O
124 , , O O
124 ataxia JJ O O
124 x FW O O
124 24H CD O O
125 Pt NNP B-NP O
125 denies NNS I-NP O
125 CP NNP I-NP O
125 , , O O
125 SOB NNP B-NP O
125 , , O O
125 palpitations NNS B-NP O
125 Pt NNP I-NP O
125 denies VBZ O O
125 melana; FW O O
125 BRBPR NNP B-NP O
125 NO NNP I-NP O
125 new JJ B-NP O
125 meds NNS I-NP O
125 , , O O
126 no DT B-NP O
126 N/V/F/C NNP I-NP O
126 This DT O O
126 is VBZ O O
126 unlike IN B-VP O
126 anything NN B-NP O
126 she PRP O O
126 has VBZ O O
126 had VBN O O
126 in IN B-VP O
126 the DT B-NP O
126 past NN I-NP O
127 In IN B-VP O
127 the DT B-NP O
127 ED NNP I-NP O
127 , , O O
127 labs NNS B-NP O
127 were VBD B-VP O
127 all DT O O
127 within IN B-VP O
127 normal JJ B-NP O
127 limits NNS I-NP O
127 While IN B-VP O
127 on IN B-VP O
127 a DT B-NP O
127 monitor NN I-NP O
127 she PRP O O
128 had VBD B-VP O
128 an DT B-NP O
128 episode NN I-NP O
128 of IN B-VP O
128 bradycardia NN B-NP O
128 to TO O O
128 the DT O O
128 40s CD O O
128 Dr NNP B-NP O
128 Hilmer NNP I-NP O
128 of IN B-VP O
129 the DT B-NP O
129 EP NNP I-NP O
129 service NN I-NP O
129 interogated VBD B-VP O
129 the DT B-NP O
129 device NN I-NP O
129 and CC O O
129 indicated VBD B-VP O
129 that IN B-VP O
129 it PRP O O
129 was VBD B-VP O
130 working VBG O O
130 properly RB O O
130 with IN B-VP O
130 no DT B-NP O
130 arrhythmias JJ I-NP O
130 Telemetry NN I-NP O
130 in IN B-VP O
130 the DT B-NP O
130 ED NNP I-NP O
130 also RB O O
130 did VBD B-VP O
131 not RB O O
131 record VB O O
131 the DT B-NP O
131 bradycardic JJ I-NP O
131 episode NN I-NP O
131 , , O O
131 suggesting VBG O O
131 that IN B-VP O
131 perhaps RB O O
131 it PRP O O
131 was VBD B-VP O
131 an DT B-NP O
132 artifact JJ I-NP O
132 Pt's NNP I-NP O
132 toxicology NN I-NP O
132 screen NN I-NP O
132 was VBD B-VP O
132 negative JJ B-NP O
132 Her NNP I-NP O
132 vitals NNS I-NP O
132 in IN B-VP O
132 the DT B-NP O
132 ED NNP I-NP O
132 w NN I-NP O
133 ere RB O O
133 98.0 CD O O
133 , , O O
133 55 CD O O
133 , , O O
133 176/60 CD O O
133 , , O O
133 18 CD O O
133 , , O O
133 98%RA CD O O
133 No NNP B-NP O
133 dysmetria; NN I-NP O
133 no RB O O
133 dysdiadocokinesia; JJ O O
134 negativ RB O O
134 e VBP O O
134 Romberg's NNP B-NP O
134 sign NN I-NP O
135 Hospital NNP I-NP O
135 Course: NNP I-NP O
136 1 CD O O
136 CV: NNP B-NP O
136 pt NN I-NP O
136 ruled VBD B-VP O
136 out RP O O
136 for IN B-VP O
136 MI; NNP B-NP O
136 24H CD O O
136 telemetry NN B-NP O
136 showed VBD B-VP O
136 no DT B-NP O
136 arrhythmias JJ I-NP O
137 Pt's NNP I-NP O
137 BB NNP I-NP B-m
137 BB NNP I-NP B-m
137 was VBD B-VP O
137 held VBN O O
137 while IN B-VP O
137 in IN B-VP O
137 house NN B-NP O
137 because IN B-VP O
137 of IN B-VP O
137 worry NN B-NP O
137 about IN B-VP O
138 bradyarrhythmia NN B-NP B-r
138 , , O O
138 hypotension NN B-NP B-r
138 Continued VBD B-VP O
138 antihypertensive JJ B-NP B-m
138 antihypertensive JJ I-NP B-r
138 antihypertensive JJ I-NP B-r
138 antihypertensive JJ I-NP B-r
138 antihypertensive JJ I-NP B-r
138 antihypertensive JJ I-NP B-r
138 antihypertensive NN I-NP B-r
138 and CC O O
138 CAD NNP B-NP B-r
138 CAD NNP I-NP B-r
138 CAD NNP I-NP B-r
138 CAD NNP I-NP B-r
138 CAD NNP I-NP B-r
138 CAD NNP I-NP B-r
139 treatment NN I-NP O
139 with IN B-VP O
139 with IN B-VP O
139 Cozaar NNP B-NP B-m
139 Cozaar NNP I-NP B-m
139 , , O O
139 Lasix NNP B-NP B-m
139 Lasix NNP I-NP B-m
139 , , O O
139 Norvasc NNP B-NP B-m
139 Norvasc NNP I-NP B-m
139 , , O O
139 Isosorbide NNP B-NP B-m
139 Isosorbide NNP I-NP B-m
139 , , O O
139 Digoxin NNP B-NP B-m
139 Digoxin NNP I-NP B-m
139 , , O O
140 Amiodarone NNP B-NP B-m
140 Amiodarone NNP I-NP B-m
140 Pt NNP I-NP O
140 is VBZ O O
140 also RB O O
140 on IN B-VP O
140 Coumadin NNP B-NP B-m
140 , , O O
140 Plavix NNP B-NP B-m
140 , , O O
140 and CC O O
140 ASA NNP B-NP B-m
140 , , O O
140 which WDT O O
140 was VBD B-VP O
141 continued VBN O O
141 in IN B-VP O
141 house NN B-NP O
141 Pt NNP I-NP O
141 was VBD B-VP O
141 discussed VBN O O
141 w/ JJ B-NP O
141 pt's NN I-NP O
141 cardiologist NN I-NP O
141 , , O O
141 Dr NNP B-NP O
142 Kallio NNP I-NP O
142 who WP O O
142 indicated VBD B-VP O
142 this DT O O
142 was VBD B-VP O
142 not RB O O
142 a DT B-NP O
142 new JJ I-NP O
142 complaint NN I-NP O
142 in IN B-VP O
142 the DT B-NP O
142 patient NN I-NP O
142 and CC O O
143 also RB O O
143 that IN B-VP O
143 she PRP O O
143 has VBZ O O
143 been VBN O O
143 non-compliant JJ O O
143 in IN B-VP O
143 the DT B-NP O
143 past JJ I-NP O
143 PT NNP I-NP O
143 was VBD B-VP O
143 on IN B-VP O
143 Coreg NNP B-NP B-m
143 but CC O O
144 this DT O O
144 was VBD B-VP O
144 held VBN O O
144 prior RB O O
144 to TO O O
144 admit VB O O
144 for IN B-VP O
144 low JJ B-NP O
144 BP's NNP I-NP O
144 Pt NNP I-NP O
144 was VBD B-VP O
144 hypertensive JJ B-NP B-r
144 w/ NN I-NP O
144 SB NNP I-NP O
145 P NNP I-NP O
145 150's CD O O
145 while IN B-VP O
145 inpt NNS B-NP O
145 but CC O O
145 we PRP O O
145 will MD O O
145 d/c VB O O
145 pt VB O O
145 off RP O O
145 Coreg NNP B-NP B-m
145 and CC O O
145 defer VB O O
145 to TO O O
145 Dr NNP B-NP O
146 Doniel NNP I-NP O
146 for IN B-VP O
146 reinstitution NN B-NP O
146 of IN B-VP O
146 beta NN B-NP O
146 blockade NN I-NP O
147 2 CD O O
147 NEURO: NNP B-NP O
147 pt's NN I-NP O
147 neuro NN I-NP O
147 exam NN I-NP O
147 was VBD B-VP O
147 normal JJ O O
147 with IN B-VP O
147 no DT B-NP O
147 focal JJ I-NP O
147 signs NNS I-NP O
147 , , O O
147 and CC O O
147 no DT B-NP O
147 signs NNS I-NP O
148 of IN B-VP O
148 cerebellar JJ B-NP O
148 dysfunction NN I-NP O
148 Nevertheless NNP I-NP O
148 given VBN O O
148 her PRP$ O O
148 significant JJ B-NP O
148 vascular JJ I-NP O
149 risk NN I-NP O
149 factors NNS I-NP O
149 there RB O O
149 was VBD B-VP O
149 concern NN B-NP O
149 for IN B-VP O
149 vertebral-basilar JJ B-NP O
149 insufficiency NN I-NP O
150 MRI/MRA NNP I-NP O
150 was VBD B-VP O
150 not RB O O
150 possible JJ O O
150 given VBN O O
150 pt's JJ B-NP O
150 AICD/pacer NNP I-NP O
150 Upon NNP I-NP O
150 discussion NN I-NP O
150 w/ NN I-NP O
151 team NN I-NP O
151 CT/CTA NNP I-NP O
151 were VBD B-VP O
151 deferred VBN O O
151 given VBN O O
151 pt's JJ B-NP O
151 renal JJ I-NP O
151 insufficiency NN I-NP O
151 and CC O O
151 risk NN B-NP O
151 of IN B-VP O
152 contrast NN B-NP O
152 nephropathy NN I-NP O
152 coupled VBN O O
152 with IN B-VP O
152 our PRP$ O O
152 feeling NN B-NP O
152 that IN B-VP O
152 any DT B-NP O
152 findings NNS I-NP O
152 would MD O O
153 not RB O O
153 change VB O O
153 pt JJ B-NP O
153 management NN I-NP O
153 This DT O O
153 will MD O O
153 be VB O O
153 discussed VBN O O
153 with IN B-VP O
153 pt's NN B-NP O
153 PCP NNP I-NP O
153 , , O O
153 Dr NNP B-NP O
154 Benedict NNP I-NP O
154 Wichern NNP I-NP O
155 3 CD O O
155 ENDO: NNP B-NP O
155 pt NN I-NP O
155 was VBD B-VP O
155 continued VBN O O
155 on IN B-VP O
155 home NN B-NP O
155 insulin NN I-NP B-m
155 regimen NNS I-NP I-m
155 with IN B-VP O
155 coverage NN B-NP O
155 with IN B-VP O
156 insulin NN B-NP B-m
156 sliding VBG O B-do
156 scale JJ B-NP I-do
156 Pt NNP I-NP O
156 was VBD B-VP O
156 found VBN O O
156 have VBP O O
156 a DT B-NP O
156 TSH NNP I-NP O
156 of IN B-VP O
156 158 CD O O
156 FT4 NNP B-NP O
156 1.8 CD O O
156 , , O O
156 FT3 NNP B-NP O
156 56 CD O O
157 Upon NNP B-NP O
157 discussion NN I-NP O
157 w/ NN I-NP O
157 pt NN I-NP O
157 , , O O
157 she PRP O O
157 revealed VBD B-VP O
157 that IN B-VP O
157 she PRP O O
157 had VBD B-VP O
157 previously RB O O
157 been VBN O O
158 diagnosed VBN O O
158 and CC O O
158 begun VBN O O
158 on IN B-VP O
158 replacement NN B-NP O
158 but CC O O
158 did VBD B-VP O
158 not RB O O
158 know VB O O
158 what WP O O
158 it PRP O O
158 was VBD B-VP O
158 for IN B-VP O
158 and CC O O
159 subsequently RB O O
159 stopped VBD B-VP O
159 it PRP O O
159 on IN B-VP O
159 her PRP O O
159 own JJ B-NP O
159 Pt NNP I-NP O
159 started VBD B-VP O
159 on IN B-VP O
159 synthroid NN B-NP B-m
159 to TO O O
159 be VB O O
159 f/u JJ B-NP O
160 w/endocrine NN I-NP O
160 This DT O O
160 may MD O O
160 be VB O O
160 the DT B-NP O
160 etiology NN I-NP O
160 of IN B-VP O
160 her PRP$ O O
160 symptoms NNS B-NP O
161 4 CD O O
161 Prophylaxis: NNP B-NP O
161 Nexium; NNP I-NP B-m
161 pt NN I-NP O
161 was VBD B-VP O
161 already RB O O
161 anticoagulated VBN O O
161 with IN B-VP O
161 ASA NNP B-NP B-m
161 , , O O
161 plavix NN B-NP B-m
162 and CC O O
162 Coumadin NNP B-NP B-m
163 5 CD O O
163 Disp: NNP B-NP O
163 Pt NNP I-NP O
163 to TO O O
163 follow-up JJ B-NP O
163 w/ NN I-NP O
163 Dr NNP I-NP O
163 Kishaba NNP I-NP O
163 for IN B-VP O
163 managment NN B-NP O
163 of IN B-VP O
163 CHF/BP NNP B-NP O
163 , , O O
163 and CC O O
164 with IN B-VP O
164 Dr NNP B-NP O
164 Blagg NNP I-NP O
164 for IN B-VP O
164 f/u NN B-NP O
164 of IN B-VP O
164 potential JJ B-NP O
164 neurovascular JJ I-NP O
164 etiology NN I-NP O
164 of IN B-VP O
164 symptoms NNS B-NP O
165 Pt NNP I-NP O
165 to TO O O
165 f/u VB O O
165 with IN B-VP O
165 endocrinology NN B-NP O
165 for IN B-VP O
165 managment NN B-NP O
165 of IN B-VP O
165 hypothyroidism NN B-NP O
166 ADDITIONAL NNP I-NP O
166 COMMENTS: NNP I-NP O
167 DISCHARGE NNP I-NP O
167 CONDITION: NNP I-NP O
167 Stable NNP I-NP O
168 TO NNP I-NP O
168 DO/PLAN: NNP I-NP O
169 1 CD O O
169 continue NN B-NP O
169 levothyroxine NN I-NP B-m
169 for IN B-VP O
169 hypothyroidism NN B-NP B-r
169 f/u NN I-NP O
169 endo NN I-NP O
169 for IN B-VP O
169 management NN B-NP O
170 2 CD O O
170 f/u NN B-NP O
170 w/ NN I-NP O
170 Dr NNP I-NP O
170 Schryer NNP I-NP O
170 for IN B-VP O
170 possible JJ B-NP O
170 reinstitution NN I-NP O
170 of IN B-VP O
170 beta NN B-NP O
170 blockade NN I-NP O
170 and CC O O
171 CHF/BP NNP B-NP O
171 management NN I-NP O
172 3 CD O O
172 f/u NN B-NP O
172 Dr NNP I-NP O
172 Hackborn NNP I-NP O
172 for IN B-VP O
172 w/u JJ B-NP O
172 potential JJ I-NP O
172 vertebral-basilar JJ I-NP O
172 insufficieny NN I-NP O
172 with IN B-VP O
173 recognition NN B-NP O
173 of IN B-VP O
173 risk NN B-NP O
173 of IN B-VP O
173 iv JJ B-NP O
173 contrast NN I-NP O
173 nephropathy JJ B-NP O
173 vs JJ I-NP O
173 utility NN I-NP O
173 of IN B-VP O
174 information NN B-NP O
175 No NNP I-NP O
175 dictated VBD B-VP O
175 summary JJ B-NP O
176 ENTERED NNP I-NP O
176 BY: NNP I-NP O
176 CRAMM NNP I-NP O
176 , , O O
176 ALAN NNP B-NP O
176 , , O O
176 M.D NNP B-NP O
176 ( ( O O
176 JX65 NNP B-NP O
176 ) ) O O
176 9/0/04 CD O O
176 @ $ O O
176 06:12 CD O O
176 PM NNP B-NP O
177 ****** JJ B-NP O
177 END NNP I-NP O
177 OF NNP I-NP O
177 DISCHARGE NNP I-NP O
177 ORDERS NNP I-NP O
177 ****** NNP I-NP O
178 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #497131 VBZ O O
2 089633078 CD O O
2 SMC NNP B-NP O
2 47778883 CD O O
2 4598548 CD O O
2 1/12/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 back RB O O
2 pain NN B-NP O
2 , , O O
2 UTI NNP B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 7/9/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/12/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 EADDY NNP I-NP O
5 , , O O
5 DEAN NNP B-NP O
5 708-09-45-0 CD O O
6 Tl NNP B-NP O
6 I PRP O O
7 Service: NNP B-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 3/15/05 CD O O
8 AT NNP B-NP O
8 12:30 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 ekg NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 RULLMAN NNP I-NP O
11 , , O O
11 JARRETT NNP B-NP O
11 Q NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
11 , , O O
11 J.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ACETYLSALICYLIC NNP I-NP B-m
16 ACID NNP I-NP I-m
16 325 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
16 Starting VBG O O
16 Today NNP B-NP O
16 ( ( O O
16 5/28 CD O O
16 ) ) O O
17 Instructions: NNP B-NP O
17 FOR NNP I-NP O
17 YOUR NNP I-NP B-r
17 HEART NNP I-NP I-r
18 Alert NNP I-NP O
18 overridden: NNP I-NP O
18 Override NNP I-NP O
18 added VBD B-VP O
18 on IN B-VP O
18 7/4/05 CD O O
18 by IN B-VP O
18 DAGDAG NNP B-NP O
18 , , O O
18 DION NNP B-NP O
18 EMMETT NNP I-NP O
18 , , O O
18 M.D NNP B-NP O
18 , , O O
18 PH.D NNP B-NP O
19 on IN B-VP O
19 order NN B-NP O
19 for IN B-VP O
19 ACETYLSALICYLIC NNP B-NP B-m
19 ACID NNP I-NP I-m
19 PO NNP I-NP B-mo
19 ( ( O O
19 ref JJ O O
19 # # O O
19 262695316 CD O O
19 ) ) O O
20 Pt NNP B-NP O
20 has VBZ O O
20 a DT B-NP O
20 POSSIBLE NNP I-NP O
20 allergy NN I-NP O
20 to TO O O
20 IBUPROFEN; NNP B-NP O
20 reaction NN I-NP O
20 is VBZ O O
20 Hives NNP B-NP O
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: NN B-NP O
21 md NN I-NP O
21 aware JJ B-NP O
22 CIPROFLOXACIN NNP I-NP B-m
22 250 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 Q12H NNP I-NP B-f
22 X NNP I-NP B-du
22 5 CD O I-du
22 Days NNPS B-NP I-du
23 Starting VBG O O
23 Today NNP B-NP O
23 ( ( O O
23 5/28 CD O O
23 ) ) O O
24 Instructions: NNP B-NP O
24 FINISH NNP I-NP O
24 ANTIBIOTICS NNP I-NP B-m
24 TO NNP I-NP O
24 TREAT NNP I-NP O
24 YOUR NNP I-NP B-r
24 URINARY NNP I-NP O
25 TRACT NNP I-NP O
25 INFECTION NNP I-NP O
25 Food/Drug NNP I-NP O
25 Interaction NNP I-NP O
25 Instruction NNP I-NP O
26 Administer NNP I-NP O
26 iron NN I-NP B-m
26 products NNS I-NP I-m
26 a DT B-NP B-f
26 minimum NN I-NP O
26 of IN B-VP O
26 2 CD O O
26 hours NNS B-NP O
26 before IN B-VP O
26 or CC O O
27 after IN B-VP O
27 a DT B-NP O
27 levofloxacin NN I-NP B-m
27 or CC O O
27 ciprofloxacin NN B-NP B-m
27 dose VBP O O
27 dose JJ O O
28 If IN B-VP O
28 on IN B-VP O
28 tube NN B-NP O
28 feeds NNS I-NP O
28 , , O O
28 please VB O O
28 cycle NN B-NP O
28 ( ( O O
28 hold VB O O
28 1 CD O O
28 hr NN B-NP O
28 before IN B-VP O
28 to TO O O
28 2 CD O O
28 hr NNS B-NP O
29 after IN B-VP O
29 ) ) O O
29 Take VBP O O
29 2 CD O O
29 hours NNS B-NP O
29 before IN B-VP O
29 or CC O O
29 2 CD O O
29 hours NNS B-NP O
29 after IN B-VP O
29 dairy NN B-NP O
29 products NNS I-NP O
30 COLACE NNP I-NP B-m
30 ( ( O I-m
30 DOCUSATE NNP B-NP I-m
30 SODIUM NNP I-NP I-m
30 ) ) O I-m
30 100 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 BID NNP I-NP B-f
31 Starting VBG O O
31 Today NNP B-NP O
31 ( ( O O
31 5/28 CD O O
31 ) ) O O
31 Instructions: NNP B-NP O
31 STOOL NNP I-NP B-r
31 SOFTNER NNP I-NP I-r
32 FOLATE NNP I-NP B-m
32 ( ( O I-m
32 FOLIC NNP B-NP I-m
32 ACID NNP I-NP I-m
32 ) ) O I-m
32 1 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 GLIPIZIDE NNP I-NP B-m
33 5 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 Q12H NNP I-NP B-f
34 Starting NNP I-NP O
34 AT NNP I-NP O
34 9:00 CD O O
34 PM NNP B-NP O
34 ON NNP I-NP O
34 0/16 CD O O
34 ( ( O O
34 5/28 CD O O
34 ) ) O O
35 Instructions: NNP B-NP O
35 for IN B-VP O
35 your PRP$ O B-r
35 diabetes NNS B-NP I-r
36 LISINOPRIL VBP O B-m
36 20 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 Q12H NNP I-NP B-f
37 Override NNP I-NP O
37 Notice: NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 7/4/05 CD O O
37 by IN B-VP O
38 BOWERY NNP B-NP O
38 , , O O
38 TOM NNP B-NP O
38 J NNP I-NP O
38 , , O O
38 M.D NNP B-NP O
39 on IN B-VP O
39 order NN B-NP O
39 for IN B-VP O
39 KCL NNP B-NP B-m
39 IMMEDIATE NNP I-NP I-m
39 RELEASE NNP I-NP I-m
39 PO NNP I-NP B-mo
39 ( ( O O
39 ref JJ O O
39 # # O O
40 876350117 CD O O
40 ) ) O O
41 POTENTIALLY NNP B-NP O
41 SERIOUS NNP I-NP O
41 INTERACTION: NNP I-NP O
41 LISINOPRIL NNP I-NP B-m
41 &amp; NNP I-NP O
41 POTASSIUM NNP I-NP B-m
42 CHLORIDE NNP I-NP O
42 Reason NNP I-NP O
42 for IN B-VP O
42 override: NN B-NP O
42 monitoring NN I-NP O
43 Previous NNP I-NP O
43 override IN B-VP O
43 information: JJ B-NP O
44 Override NNP I-NP O
44 added VBD B-VP O
44 on IN B-VP O
44 7/4/05 CD O O
44 by IN B-VP O
44 FULBRIGHT NNP B-NP O
44 , , O O
44 JEWELL NNP B-NP O
44 R NNP I-NP O
44 , , O O
44 M.D NNP B-NP O
45 on IN B-VP O
45 order NN B-NP O
45 for IN B-VP O
45 KCL NNP B-NP B-m
45 IV NNP I-NP B-mo
45 ( ( O O
45 ref JJ O O
45 # # O O
45 739034101 CD O O
45 ) ) O O
46 POTENTIALLY NNP B-NP O
46 SERIOUS NNP I-NP O
46 INTERACTION: NNP I-NP O
46 LISINOPRIL NNP I-NP B-m
46 &amp; NNP I-NP O
46 POTASSIUM NNP I-NP B-m
47 CHLORIDE NNP I-NP O
47 Reason NNP I-NP O
47 for IN B-VP O
47 override: NN B-NP O
47 monitoring NN I-NP O
48 Previous NNP I-NP O
48 override IN B-VP O
48 information: JJ B-NP O
49 Override NNP I-NP O
49 added VBD B-VP O
49 on IN B-VP O
49 7/4/05 CD O O
49 by IN B-VP O
49 ANADIO NNP B-NP O
49 , , O O
49 SHAWN NNP B-NP O
49 E NNP I-NP O
49 , , O O
49 M.D NNP B-NP O
50 on IN B-VP O
50 order NN B-NP O
50 for IN B-VP O
50 KCL NNP B-NP B-m
50 SLOW NNP I-NP I-m
50 RELEASE NNP I-NP I-m
50 PO NNP I-NP B-mo
50 ( ( O O
50 ref JJ O O
50 # # O O
50 898030992 CD O O
50 ) ) O O
51 POTENTIALLY NNP B-NP O
51 SERIOUS NNP I-NP O
51 INTERACTION: NNP I-NP O
51 LISINOPRIL NNP I-NP B-m
51 &amp; NNP I-NP O
51 POTASSIUM NNP I-NP B-m
52 CHLORIDE NNP I-NP O
52 Reason NNP I-NP O
52 for IN B-VP O
52 override: NN B-NP O
52 aware JJ B-NP O
53 Previous NNP I-NP O
53 override NN I-NP O
53 information: NN I-NP O
54 Override NNP I-NP O
54 added VBD B-VP O
54 on IN B-VP O
54 7/4/05 CD O O
54 by IN B-VP O
54 RANDLES NNP B-NP O
54 , , O O
54 COLEMAN NNP B-NP O
54 KELLEY NNP I-NP O
54 , , O O
54 M.D NNP B-NP O
54 , , O O
54 PH.D NNP B-NP O
55 on IN B-VP O
55 order NN B-NP O
55 for IN B-VP O
55 K-LOR NNP B-NP B-m
55 PO NNP I-NP B-mo
55 ( ( O O
55 ref JJ O O
55 # # O O
55 887251597 CD O O
55 ) ) O O
56 POTENTIALLY NNP B-NP O
56 SERIOUS NNP I-NP O
56 INTERACTION: NNP I-NP O
56 LISINOPRIL NNP I-NP B-m
56 &amp; NNP I-NP O
56 POTASSIUM NNP I-NP B-m
57 CHLORIDE NNP I-NP O
57 Reason NNP I-NP O
57 for IN B-VP O
57 override: NN B-NP O
57 md NN I-NP O
57 aware JJ B-NP O
58 Previous NNP I-NP O
58 override NN I-NP O
58 information: NN I-NP O
59 Override NNP I-NP O
59 added VBD B-VP O
59 on IN B-VP O
59 7/4/05 CD O O
59 by IN B-VP O
59 KLINGLESMITH NNP B-NP O
59 , , O O
59 EFREN NNP B-NP O
59 O NNP I-NP O
59 , , O O
59 M.D NNP B-NP O
60 POTENTIALLY NNP I-NP O
60 SERIOUS NNP I-NP O
60 INTERACTION: NNP I-NP O
60 POTASSIUM NNP I-NP B-m
60 CHLORIDE NNP I-NP I-m
60 &amp; NNP I-NP O
61 LISINOPRIL NNP I-NP B-m
61 Reason NNP I-NP O
61 for IN B-VP O
61 override: NN B-NP O
61 md NN I-NP O
61 aware JJ O O
62 NIFEREX-150 JJ O B-m
62 150 CD O B-do
62 MG NNP B-NP I-do
62 PO NNP I-NP B-mo
62 BID NNP I-NP B-f
63 MVI NNP I-NP B-m
63 THERAPEUTIC NNP I-NP I-m
63 ( ( O I-m
63 THERAPEUTIC NNP B-NP I-m
63 MULTIVITAMINS NNP I-NP I-m
63 ) ) O I-m
63 1 CD O B-do
63 TAB NNP B-NP I-do
63 PO NNP I-NP B-mo
63 QD NNP I-NP B-f
64 Alert NNP I-NP O
64 overridden: NNP I-NP O
64 Override NNP I-NP O
64 added VBD B-VP O
64 on IN B-VP O
64 7/4/05 CD O O
64 by IN B-VP O
64 CAPPAERT NNP B-NP O
64 , , O O
64 BASIL NNP B-NP O
64 R NNP I-NP O
64 , , O O
64 M.D NNP B-NP O
65 POTENTIALLY NNP I-NP O
65 SERIOUS NNP I-NP O
65 INTERACTION: NNP I-NP O
65 ATORVASTATIN NNP I-NP B-m
65 CALCIUM NNP I-NP I-m
65 &amp; NNP I-NP O
66 NIACIN NNP I-NP B-m
66 , , O O
66 VIT NNP B-NP B-m
66 B-3 NNP I-NP I-m
66 Reason NNP I-NP O
66 for IN B-VP O
66 override: NN B-NP O
66 requires VBZ O O
67 TOPROL NNP B-NP B-m
67 XL NNP I-NP I-m
67 ( ( O I-m
67 METOPROLOL NNP B-NP I-m
67 SUCCINATE NNP I-NP I-m
67 EXTENDED NNP I-NP I-m
67 RELEASE NNP I-NP I-m
67 ) ) O I-m
68 100 CD O B-do
68 MG NNP B-NP I-do
68 PO NNP I-NP B-mo
68 Q24H NNP I-NP B-f
68 Food/Drug NNP I-NP O
68 Interaction NNP I-NP O
68 Instruction NNP I-NP O
69 Take NNP I-NP O
69 consistently RB O O
69 with IN B-VP O
69 meals NNS B-NP O
69 or CC O O
69 on IN B-VP O
69 empty JJ B-NP O
69 stomach NN I-NP O
70 Number NNP I-NP O
70 of IN B-VP O
70 Doses NNP B-NP O
70 Required NNP I-NP O
70 ( ( O O
70 approximate JJ B-NP O
70 ): NN I-NP O
70 3 CD O O
71 AMBIEN NNP B-NP B-m
71 ( ( O I-m
71 ZOLPIDEM NNP B-NP I-m
71 TARTRATE NNP I-NP I-m
71 ) ) O I-m
71 10 CD O B-do
71 MG NNP B-NP I-do
71 PO NNP I-NP B-mo
71 QHS NNP I-NP B-f
71 PRN NNP I-NP I-f
71 Insomnia NNP I-NP B-r
72 Food/Drug NNP I-NP O
72 Interaction NNP I-NP O
72 Instruction NNP I-NP O
73 Give NNP I-NP O
73 on IN B-VP O
73 an DT B-NP O
73 empty JJ I-NP O
73 stomach NN I-NP O
73 ( ( O O
73 give JJ O O
73 1hr CD O O
73 before IN B-VP O
73 or CC O O
73 2hr CD O O
73 after IN B-VP O
74 food NN B-NP O
74 ) ) O O
75 KCL NNP B-NP B-m
75 SLOW NNP I-NP I-m
75 RELEASE NNP I-NP I-m
75 20 CD O B-do
75 MEQ NNP B-NP I-do
75 PO NNP I-NP B-mo
75 QD NNP I-NP B-f
76 As IN B-VP O
76 per IN B-VP O
76 WRH NNP B-NP O
76 Potassium NNP I-NP B-m
76 Chloride NNP I-NP I-m
76 Policy: NNP I-NP O
77 each DT O O
77 20 CD O B-do
77 mEq NNS B-NP I-do
77 dose VB O O
77 to TO O O
77 be VB O O
77 given VBN O O
77 with IN B-VP O
77 4 CD O O
77 oz NNS B-NP O
77 of IN B-VP O
77 fluid NN B-NP O
78 Override NNP I-NP O
78 Notice: NNP I-NP O
78 Override NNP I-NP O
78 added VBD B-VP O
78 on IN B-VP O
78 7/4/05 CD O O
78 by IN B-VP O
78 WAYT NNP B-NP O
78 , , O O
78 FERDINAND NNP B-NP O
78 W NNP I-NP O
78 , , O O
78 M.D NNP B-NP O
78 on IN B-VP O
78 order NN B-NP O
78 for IN B-VP O
78 LISINOPRIL NNP B-NP B-m
78 PO NNP I-NP B-mo
78 ( ( O O
78 ref JJ O O
78 # # O O
78 700978620 CD O O
78 ) ) O O
79 POTENTIALLY NNP B-NP O
79 SERIOUS NNP I-NP O
79 INTERACTION: NNP I-NP O
79 POTASSIUM NNP I-NP B-m
79 CHLORIDE NNP I-NP I-m
79 &amp; NNP I-NP O
80 LISINOPRIL NNP I-NP B-m
80 Reason NNP I-NP O
80 for IN B-VP O
80 override: NN B-NP O
80 md NN I-NP O
80 aware JJ B-NP O
81 LIPITOR NNP I-NP B-m
81 ( ( O I-m
81 ATORVASTATIN NNP B-NP I-m
81 ) ) O I-m
81 40 CD O B-do
81 MG NNP B-NP I-do
81 PO NNP I-NP B-mo
81 QHS NNP I-NP B-f
82 Starting VBG O O
82 Today NNP B-NP O
82 ( ( O O
82 5/28 CD O O
82 ) ) O O
82 Instructions: NNP B-NP O
82 for IN B-VP O
82 your PRP$ O B-r
82 cholesterol NN B-NP I-r
83 Override NNP I-NP O
83 Notice: NNP I-NP O
83 Override NNP I-NP O
83 added VBD B-VP O
83 on IN B-VP O
83 7/4/05 CD O O
83 by IN B-VP O
83 HALSELL NNP B-NP O
83 , , O O
83 FIDEL NNP B-NP O
83 J NNP I-NP O
83 , , O O
83 M.D NNP B-NP O
84 on IN B-VP O
84 order NN B-NP O
84 for IN B-VP O
84 MVI NNP B-NP B-m
84 THERAPEUTIC NNP I-NP I-m
84 PO NNP I-NP B-mo
84 ( ( O O
84 ref JJ O O
84 # # O O
84 537040946 CD O O
84 ) ) O O
85 POTENTIALLY NNP B-NP O
85 SERIOUS NNP I-NP O
85 INTERACTION: NNP I-NP O
85 ATORVASTATIN NNP I-NP B-m
85 CALCIUM NNP I-NP I-m
85 &amp; NNP I-NP O
86 NIACIN NNP I-NP B-m
86 , , O O
86 VIT NNP B-NP B-m
86 B-3 NNP I-NP I-m
86 Reason NNP I-NP O
86 for IN B-VP O
86 override: NN B-NP O
86 requires VBZ O O
87 PLAVIX NNP B-NP B-m
87 ( ( O I-m
87 CLOPIDOGREL NNP B-NP I-m
87 ) ) O I-m
87 75 CD O B-do
87 MG NNP B-NP I-do
87 PO NNP I-NP B-mo
87 QD NNP I-NP B-f
87 Starting NNP I-NP O
87 IN NNP I-NP O
87 AM NNP I-NP O
87 ( ( O O
87 3/28 CD O O
87 ) ) O O
88 Instructions: NN B-NP O
88 to TO O O
88 prevent VB O O
88 blood NN B-NP B-r
88 clots NNS I-NP I-r
89 CANDESARTAN NNP I-NP B-m
89 16 CD O B-do
89 MG NNP B-NP I-do
89 PO NNP I-NP B-mo
89 QD NNP I-NP B-f
89 Starting VBG O O
89 Today NNP B-NP O
89 ( ( O O
89 5/28 CD O O
89 ) ) O O
90 Instructions: NNP B-NP O
90 for IN B-VP O
90 your PRP$ O B-r
90 blood NN B-NP I-r
90 pressure NN I-NP I-r
91 ADVAIR NNP I-NP B-m
91 DISKUS NNP I-NP I-m
91 250/50 CD O I-m
91 ( ( O I-m
91 FLUTICASONE NNP B-NP I-m
91 PROPIONATE/ NNP I-NP I-m
91 ) ) O I-m
92 1 CD O B-do
92 PUFF NNP B-NP I-do
92 INH NNP I-NP B-mo
92 BID NNP I-NP B-f
92 Starting VBG O O
92 Today NNP B-NP O
92 ( ( O O
92 5/28 CD O O
92 ) ) O O
93 Instructions: NNP B-NP O
93 for IN B-VP O
93 your PRP$ O B-r
93 breathing NN B-NP I-r
94 LASIX NNP I-NP B-m
94 ( ( O I-m
94 FUROSEMIDE NNP B-NP I-m
94 ) ) O I-m
94 40 CD O B-do
94 MG NNP B-NP I-do
94 PO NNP I-NP B-mo
94 BID NNP I-NP B-f
95 Instructions: NNP I-NP O
95 FOR NNP I-NP O
95 LEG NNP I-NP B-r
95 SWELLING NNP I-NP I-r
96 OXYCONTIN NNP I-NP B-m
96 ( ( O I-m
96 OXYCODONE NNP B-NP I-m
96 CONTROLLED NNP I-NP I-m
96 RELEASE NNP I-NP I-m
96 ) ) O I-m
96 45 CD O B-do
96 MG NNP B-NP I-do
96 PO NNP I-NP B-mo
96 Q12H NNP I-NP B-f
97 Starting NNP I-NP O
97 AT NNP I-NP O
97 5:00 CD O O
97 PM NNP B-NP O
97 ON NNP I-NP O
97 10/9/05 CD O O
97 ( ( O O
97 5/28 CD O O
97 ) ) O O
98 Instructions: NNP B-NP O
98 for IN B-VP O
98 pain NN B-NP B-r
99 PERCOCET NNP I-NP B-m
99 PERCOCET NNP I-NP B-m
99 1 CD O B-do
99 1 CD O B-do
99 TAB NNP B-NP I-do
99 TAB NNP I-NP I-do
99 PO NNP I-NP B-mo
99 PO NNP I-NP B-mo
99 Q4-6 NNP I-NP B-f
99 Q4-6 NNP I-NP B-f
99 hours NNS I-NP I-f
99 hours NNS I-NP I-f
99 PRN NNP I-NP I-f
99 PRN NNP I-NP I-f
99 Pain NNP I-NP B-r
100 Instructions: NNP I-NP O
100 for IN B-VP O
100 breakthrough NN B-NP B-r
100 pain NN I-NP I-r
100 not RB O O
100 managed VBN O O
100 by IN B-VP O
101 oxycontin JJ B-NP B-m
102 ALBUTEROL NNP I-NP B-m
102 INHALER NNP I-NP I-m
102 2 CD O B-do
102 PUFF NNP B-NP I-do
102 INH NNP I-NP B-mo
102 QID NNP I-NP B-f
102 PRN NNP I-NP I-f
102 Wheezing NNP I-NP B-r
103 Instructions: NNP I-NP O
103 for IN B-VP O
103 your PRP$ O O
103 breathing VBG O O
104 ALBUTEROL NNP B-NP B-m
104 NEBULIZER NNP I-NP I-m
104 2.5 CD O B-do
104 MG NNP B-NP I-do
104 NEB NNP I-NP B-mo
104 Q4H NNP I-NP B-f
104 PRN NNP I-NP I-f
104 Wheezing NNP I-NP B-r
105 Instructions: NNP I-NP O
105 for IN B-VP O
105 your PRP$ O O
105 breathing NN B-NP O
106 METAMUCIL NNP I-NP B-m
106 SUGAR NNP I-NP I-m
106 FREE NNP I-NP I-m
106 ( ( O I-m
106 PSYLLIUM NNP B-NP I-m
106 ( ( O I-m
106 METAMUCIL NNP B-NP I-m
106 ) ) O I-m
106 SU NNP B-NP I-m
106 ) ) O I-m
107 1-2 CD O B-do
107 PACKET NNP B-NP I-do
107 PO NNP I-NP B-mo
107 QD NNP I-NP B-f
107 PRN NNP I-NP I-f
107 Constipation NNP I-NP B-r
108 NITROGLYCERIN NNP I-NP B-m
108 1/150 CD O I-m
108 ( ( O I-m
108 0.4 CD O I-m
108 MG NNP B-NP I-m
108 ) ) O I-m
108 1 CD O B-do
108 TAB NNP B-NP I-do
108 SL NNP I-NP B-mo
108 Q5MIN NNP I-NP B-f
108 X NNP I-NP O
108 3 CD O O
108 doses NNS B-NP O
109 PRN NNP I-NP O
109 Chest NNP I-NP B-r
109 Pain NNP I-NP I-r
110 Instructions: NNP I-NP O
110 if IN B-VP O
110 pain NN B-NP B-r
110 is VBZ O O
110 not RB O O
110 relieved VBN O O
110 by IN B-VP O
110 nitro NN B-NP B-m
110 , , O O
110 call VB O O
110 911 CD O O
111 DIET: NNP B-NP O
111 Patient NNP I-NP O
111 should MD O O
111 measure VB O O
111 weight JJ B-NP O
111 daily JJ I-NP O
112 DIET: NNP I-NP O
112 House NNP I-NP O
112 / VBD B-VP O
112 Low NNP B-NP O
112 chol/low NN I-NP O
112 sat VBD B-VP O
112 fat JJ B-NP O
113 DIET: NNP I-NP O
113 House NNP I-NP O
113 / NNP I-NP O
113 ADA NNP I-NP O
113 1800 CD O O
113 cals/dy NN B-NP O
114 DIET: NNP I-NP O
114 2 CD O O
114 gram NN B-NP O
114 Sodium NNP I-NP O
115 ACTIVITY: NNP I-NP O
115 Resume NNP I-NP O
115 regular JJ B-NP O
115 exercise NN I-NP O
116 FOLLOW NNP I-NP O
116 UP NNP I-NP O
116 APPOINTMENT( NNP I-NP O
116 S NNP I-NP O
116 ): NNP I-NP O
117 Brentkii NNP I-NP O
117 Hospital NNP I-NP O
117 office NN I-NP O
117 will MD O O
117 call VB O O
117 you PRP O O
117 If IN B-VP O
117 you PRP O O
117 do VBP O O
117 not RB O O
117 hear VB O O
117 from IN B-VP O
117 the DT B-NP O
117 office NN I-NP O
117 , , O O
117 call: VBP O O
117 701-815-0965 CD O O
117 , , O O
118 Dr NNP B-NP O
118 Kleinke NNP I-NP O
118 , , O O
118 Renal NNP B-NP O
118 10/16 CD O O
118 at IN B-VP O
118 3PM CD O O
118 scheduled JJ O O
118 , , O O
119 Dr NNP B-NP O
119 Romine NNP I-NP O
119 , , O O
119 Cardiology NNP B-NP O
119 2/7 CD O O
119 at IN B-VP O
119 12:30 CD O O
119 PM NNP B-NP O
119 scheduled VBN O O
119 , , O O
120 ALLERGY: NNP B-NP O
120 Erythromycins NNP I-NP O
120 , , O O
120 Penicillins NNP B-NP O
120 , , O O
120 CLINDAMYCIN NNP B-NP O
120 , , O O
120 IBUPROFEN NNP B-NP O
121 ADMIT NNP I-NP O
121 DIAGNOSIS: NNP I-NP O
122 nephrolithiasis NN I-NP O
123 PRINCIPAL NNP I-NP O
123 DISCHARGE NNP I-NP O
123 DIAGNOSIS NNP I-NP O
123 ;Responsible JJ O O
123 After IN B-VP O
123 Study NNP B-NP O
123 for IN B-VP O
123 Causing NNP B-NP O
123 Admission NNP I-NP O
123 ) ) O O
124 back RB O O
124 pain NN B-NP O
124 , , O O
124 UTI NNP B-NP O
125 OTHER NNP I-NP O
125 DIAGNOSIS;Conditions NNP I-NP O
125 , , O O
125 Infections NNP B-NP O
125 , , O O
125 Complications NNP B-NP O
125 , , O O
125 affecting VBG O O
125 Treatment/Stay NNP B-NP O
126 h/o JJ B-NP O
126 IMI NNP I-NP O
126 Non-cardiac NNP I-NP O
126 chest NN I-NP O
126 pain NN I-NP O
126 , , O O
126 Lumbosacral NNP B-NP O
126 disc VBZ O O
126 dz NN B-NP O
126 Chronic NNP I-NP O
126 pain NN I-NP O
126 syndrome NN I-NP O
127 Migraines NNP I-NP O
127 , , O O
127 HTN NNP B-NP O
127 , , O O
127 Anxiety NNP B-NP O
127 Depression NNP I-NP O
127 ALLERG:PCN NNP I-NP O
127 , , O O
127 Erythro NNP B-NP O
127 , , O O
127 Tetracy NNP B-NP O
128 S/P NNP I-NP O
128 PTCA NNP I-NP O
128 3/18 CD O O
128 FOR NNP B-NP O
128 OCC NNP I-NP O
128 RCA NNP I-NP O
128 POSITIVE NNP I-NP O
128 ETT/MIBI NNP I-NP O
128 93: CD O O
128 ANT/LAT NNP B-NP O
128 WALL NNP I-NP O
128 ISCHEMIA NNP I-NP O
129 OPERATIONS NNP I-NP O
129 AND NNP I-NP O
129 PROCEDURES: NNP I-NP O
130 OTHER NNP I-NP O
130 TREATMENTS/PROCEDURES NNP I-NP O
130 ( ( O O
130 NOT NNP B-NP O
130 IN NNP I-NP O
130 O.R NNP I-NP O
130 ) ) O O
131 CT NNP B-NP O
131 abd VBP O O
132 BRIEF NNP B-NP O
132 RESUME NNP I-NP O
132 OF NNP I-NP O
132 HOSPITAL NNP I-NP O
132 COURSE: NNP I-NP O
133 CC: NNP I-NP O
133 59F CD O O
133 w/ NN B-NP O
133 CAD NNP I-NP O
133 recently RB O O
133 RCA/OM1 NNP B-NP O
133 stent NN I-NP O
133 admitted VBD B-VP O
133 with IN B-VP O
134 nephrolithiasis NN B-NP O
134 for IN B-VP O
134 pain NN B-NP O
134 control NN I-NP O
134 HPI: NNP I-NP O
134 hx NN I-NP O
134 chronic NN I-NP B-r
134 pain NN I-NP I-r
134 syndrome NN I-NP I-r
134 on IN B-VP O
135 percocet NN B-NP B-m
135 and CC O O
135 morphine NN B-NP B-m
135 ( ( O O
135 also RB O O
135 for IN B-VP O
135 OA NNP B-NP O
135 ) ) O O
135 , , O O
135 who WP O O
135 recently RB O O
135 had VBD B-VP O
135 R NNP B-NP O
135 heart NN I-NP O
136 cath NN I-NP O
136 and CC O O
136 PCI NNP B-NP O
136 1 CD O O
136 wks NN B-NP O
136 ago RB O O
136 During IN B-VP O
136 that DT B-NP O
136 admission NN I-NP O
136 , , O O
136 was VBD B-VP O
136 noted VBN O O
136 to TO O O
136 have VB O O
137 hematuria NNS B-NP O
137 --&gt; NNP I-NP O
137 renal JJ B-NP O
137 f/u NN I-NP O
137 C/O NNP I-NP O
137 L NNP I-NP O
137 flank VBD B-VP O
137 pain NN B-NP O
137 x JJ O O
137 2 CD O O
137 days NNS B-NP O
137 , , O O
137 planned VBN O O
137 for IN B-VP O
137 CT NNP B-NP O
138 In IN B-VP O
138 Cards NNP B-NP O
138 clinic NN I-NP O
138 on IN B-VP O
138 DOA NNP B-NP O
138 , , O O
138 noted VBD B-VP O
138 poor JJ B-NP O
138 pain NN I-NP O
138 control NN I-NP O
138 admitted VBN O O
138 by IN B-VP O
138 ED NNP B-NP O
138 for IN B-VP O
139 pain NN B-NP O
139 control NN I-NP O
139 Got NNP I-NP O
139 ASA NNP I-NP B-m
139 , , O O
139 no DT B-NP O
139 IVF NNP I-NP O
139 morphine NN I-NP O
139 PMH: NNP I-NP O
139 chronic NN I-NP O
139 pain NN I-NP O
139 syndrome NN I-NP O
139 , , O O
140 FM NNP B-NP O
140 on IN B-VP O
140 mscontin NN B-NP B-m
140 tid NN I-NP B-f
140 CHF NNP I-NP O
140 , , O O
140 diastolic JJ B-NP O
140 dysfunction NN I-NP O
140 OSA NNP I-NP O
140 , , O O
140 CPAP NNP B-NP O
140 HTN NNP I-NP O
140 , , O O
140 CAD NNP B-NP O
140 , , O O
141 chol NN B-NP O
141 , , O O
141 mult NN B-NP O
141 MI NNP I-NP O
141 , , O O
141 stent NN B-NP O
141 x VBD B-VP O
141 3 CD O O
141 1 CD O O
141 wk NN B-NP O
141 ---------- NNP I-NP O
142 EVENTS: NNP I-NP O
142 in IN B-VP O
142 ED NNP B-NP O
142 OBS NNP I-NP O
142 appeared VBD B-VP O
142 comfortable JJ O O
142 on IN B-VP O
142 dilaudid NN B-NP B-m
142 and CC O O
143 morphine NN B-NP B-m
143 ---------- NNP I-NP O
144 STATUS: NNP I-NP O
144 resumed VBD B-VP O
144 on IN B-VP O
144 home NN B-NP O
144 pain NN I-NP O
144 regimen NNS I-NP O
144 , , O O
144 required VBD B-VP O
144 additional JJ O O
144 25 CD O B-do
144 mg NN B-NP I-do
144 oxycodone NN I-NP B-m
145 overnight VBD B-VP B-du
146 --------- JJ B-NP O
146 STUDIES: NNP I-NP O
147 I- NNP I-NP O
147 CT NNP I-NP O
147 showed: VBD B-VP O
147 kidney NNP B-NP O
147 stones NNS I-NP O
147 on IN B-VP O
147 R NNP B-NP O
147 , , O O
147 by IN B-VP O
147 CT NNP B-NP O
147 ureter NN I-NP O
147 in IN B-VP O
147 ED NNP B-NP O
147 , , O O
147 no DT B-NP O
147 hydro NN I-NP O
148 stones NNS I-NP O
148 are VBP O O
148 old JJ O O
148 , , O O
148 not RB O O
148 clear JJ O O
148 that IN B-VP O
148 this DT O O
148 is VBZ O O
148 causing VBG O O
148 her PRP$ O O
148 current JJ B-NP O
148 pain NN I-NP O
149 -------- NNP I-NP O
149 IMP: NNP I-NP O
149 59F CD O O
149 with IN B-VP O
149 CAD NNP B-NP O
149 and CC O O
149 recent JJ B-NP O
149 PCI NNP I-NP O
149 now RB O O
149 with IN B-VP O
150 nephrolithiasis NN B-NP O
150 and CC O O
150 pain NN B-NP O
150 control NN I-NP O
150 problems NNS I-NP O
150 PLAN: NNP I-NP O
151 1 CD O O
151 CV: NNP B-NP O
151 gave VBD B-VP O
151 lasix JJ B-NP B-m
151 lasix NN I-NP B-m
151 to TO O O
151 increase VB O O
151 filtration NN B-NP B-r
151 and CC O O
151 UOP NNP B-NP B-r
151 , , O O
151 while IN B-VP O
152 increasing VBG O O
152 IVF NNP B-NP B-m
152 to TO O O
152 keep VB O O
152 up RP O O
152 w/ JJ B-NP O
152 euvolemic JJ I-NP B-r
152 state NN I-NP I-r
153 - : O O
153 cont NN B-NP O
153 outpt JJ B-NP O
153 regimen NNS I-NP O
153 - : O O
153 asa NN B-NP B-m
153 , , O O
153 statin NN B-NP B-m
153 , , O O
153 bb NN B-NP B-m
153 , , O O
153 acei RB O B-m
153 2 CD O O
153 GU/RENAL: NNP B-NP O
153 increase NN I-NP O
154 UOP NNP I-NP B-r
154 UOP NNP I-NP B-r
154 w/ NN I-NP O
154 IVF NNP I-NP B-m
154 and CC O O
154 Lasix NNP B-NP B-m
154 3 CD O O
154 ID: NNP B-NP O
154 does VBZ O O
154 not RB O O
154 appear VB O O
154 to TO O O
154 have VB O O
154 systemic JJ B-NP O
155 infection NN I-NP O
155 Inflammation NNP I-NP B-r
155 of IN B-VP O
155 ureter JJ B-NP O
155 tx NN I-NP O
155 UTI NNP I-NP O
155 ( ( O O
155 UA+ NNP B-NP O
155 ) ) O O
155 with IN B-VP O
155 cipro JJ O B-m
155 250 CD O B-do
155 mg NN B-NP I-do
155 PO NNP I-NP B-mo
155 x VBZ O B-du
155 7 CD O O
156 days NNS B-NP O
156 Started VBD B-VP O
156 1/16 CD O O
156 , , O O
156 ending VBG O O
156 2/12 CD O O
157 4 CD O O
157 FEN: NNP B-NP O
157 Diabetic NNP I-NP O
157 , , O O
157 low JJ B-NP O
157 salt NN I-NP O
157 , , O O
157 low JJ B-NP O
157 fat/cholesterol NN I-NP O
157 diet JJ O O
157 5 CD O O
157 Pain NNP B-NP B-r
157 Pain NNP I-NP B-r
157 Pain NNP I-NP B-r
157 control VB O I-r
157 control NN B-NP I-r
157 control NN I-NP I-r
157 with IN B-VP O
158 home NN B-NP O
158 regimen NNS I-NP O
158 of IN B-VP O
158 MScontin NNP B-NP B-m
158 and CC O O
159 oxycodone RB O B-m
159 Switched VBD B-VP O
159 to TO O O
159 45 CD O B-do
159 mg NN B-NP I-do
159 oxycontin NN I-NP B-m
159 PO NNP I-NP B-mo
159 q12h NN I-NP B-f
159 instead RB O O
159 of IN B-VP O
159 MS NNP B-NP B-m
159 contin NN I-NP I-m
159 upon RB O O
160 discharge NN B-NP O
160 as IN B-VP O
160 patient JJ O O
160 requiring VBG O O
160 frequent JJ B-NP O
160 PRN NNP I-NP O
160 for IN B-VP O
160 breakthrough NN B-NP O
160 Of IN B-VP O
160 note NN B-NP O
160 , , O O
161 back RB O O
161 pain NN B-NP O
161 crosses NNS I-NP O
161 lumbosacrum VBP O O
161 , , O O
161 radiates VBZ O O
161 down RP O O
161 legs NNS B-NP O
161 bilaterally RB O O
161 , , O O
161 and CC O O
161 to TO O O
162 groin VB O O
162 bilaterally RB O O
162 This DT B-NP O
162 distribution NN I-NP O
162 is VBZ O O
162 consistent JJ O O
162 with IN B-VP O
162 a DT O O
163 more RBR O O
163 mucskuloskeletal JJ B-NP O
163 etiology NN I-NP O
163 of IN B-VP O
163 pain NN B-NP O
163 , , O O
163 rather RB O O
163 than IN B-VP O
163 R-sided JJ B-NP O
164 nephrolithiasis JJ I-NP O
165 ADDITIONAL NNP I-NP O
165 COMMENTS: NNP I-NP O
165 You PRP O O
165 must MD O O
165 continue VB O O
165 your PRP$ O B-m
165 medications NNS B-NP I-m
165 , , O O
165 especially RB O O
165 aspirin JJ O B-m
165 and CC O O
165 plavix NN B-NP B-m
165 to TO O O
166 protect VB O O
166 your PRP$ O B-r
166 your PRP$ O B-r
166 stent JJ B-NP I-r
166 stent NN I-NP I-r
166 Continue NNP I-NP O
166 the DT B-NP O
166 Ciprrfloxacin NNP I-NP B-m
166 for IN B-VP O
166 your PRP$ O B-r
166 UTI NNP B-NP I-r
166 Follow NNP I-NP O
166 up RP O O
167 with IN B-VP O
167 your PRP$ O O
167 doctors NNS B-NP O
167 or CC O O
167 call VB O O
167 to TO O O
167 reschedule VB O O
167 the DT B-NP O
167 appointments NNS I-NP O
167 Call VB O O
167 your PRP$ O O
168 doctor NN B-NP O
168 or CC O O
168 return NN B-NP O
168 to TO O O
168 the DT B-NP O
168 ER NNP I-NP O
168 if IN B-VP O
168 you PRP O O
168 have VBP O O
168 fever VBN O O
168 , , O O
168 chills NNS B-NP O
168 , , O O
168 sweats NNS B-NP O
168 , , O O
168 worsening VBG O O
169 shortness NN B-NP O
169 of IN B-VP O
169 breath NN B-NP O
169 , , O O
169 chest NN B-NP O
169 pain NN I-NP O
169 , , O O
169 or CC O O
169 any DT B-NP O
169 other JJ I-NP O
169 problems NNS I-NP O
170 DISCHARGE NNP I-NP O
170 CONDITION: NNP I-NP O
170 Stable NNP I-NP O
171 TO NNP I-NP O
171 DO/PLAN: NNP I-NP O
172 1 CD O O
172 Follow-up NNP B-NP O
172 U/A NNP I-NP O
173 2 CD O O
173 Consider NNP B-NP O
173 CT NNP I-NP O
173 scan NN I-NP O
173 to TO O O
173 R/O NNP B-NP O
173 renal JJ B-NP O
173 CA NNP I-NP O
173 given VBN O O
173 hx NN B-NP O
173 of IN B-VP O
173 microscopic NN B-NP O
173 hematuria NN I-NP O
174 3 CD O O
174 Consider NNP B-NP O
174 cystoscopy NN I-NP O
174 to TO O O
174 R/O NNP B-NP O
174 bladder NN I-NP O
174 CA NNP I-NP O
174 given VBN O O
174 above IN B-VP O
175 4 CD O O
175 Med NNP B-NP O
175 check NN I-NP O
176 No NNP I-NP O
176 dictated VBD B-VP O
176 summary JJ B-NP O
177 ENTERED NNP I-NP O
177 BY: NNP I-NP O
177 HEMBRE NNP I-NP O
177 , , O O
177 MARCELINO NNP B-NP O
177 J NNP I-NP O
177 , , O O
177 M.D NNP B-NP O
177 , , O O
177 PH.D NNP B-NP O
177 ( ( O O
177 PS482 NNP B-NP O
177 ) ) O O
177 3/15/05 CD O O
177 @ $ O O
177 01 CD O O
178 ****** JJ B-NP O
178 END NN I-NP O
178 OF NNP I-NP O
178 DISCHARGE NNP I-NP O
178 ORDERS NNP I-NP O
178 ****** NNP I-NP O
179 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #497321 VBZ O O
4 078554939 CD O O
4 LRH NNP B-NP O
4 62413233 CD O O
4 7368393 CD O O
4 6/24/2007 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 INCACERATED NNP I-NP O
4 HERNIA NNP I-NP O
4 , , O O
4 SEPSIS NNP B-NP O
4 , , O O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/26/2007 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/25/2007 CD O O
7 ATTENDING: NNP B-NP O
7 CELLAR NNP I-NP O
7 , , O O
7 DONN NNP B-NP O
7 WILL NNP I-NP O
7 M.D NNP I-NP O
8 DISCHARGE NNP I-NP O
8 MEDICATIONS: NNP I-NP O
8 Include NNP I-NP O
8 Tylenol NNP I-NP B-m
8 325 CD O B-do
8 to TO O I-do
8 650 CD O I-do
8 mg NNS B-NP I-do
8 p.o JJ B-NP B-mo
8 q.4 JJ I-NP B-f
8 h NN I-NP O
9 p.r.n NN I-NP O
9 pain NN I-NP B-r
9 , , O O
9 DuoNeb NNP B-NP B-m
9 3/0.5 CD O B-do
9 mg NN B-NP I-do
9 q.6 NN I-NP B-f
9 h NN I-NP I-f
9 p.r.n NN I-NP I-f
9 , , O O
9 amiodarone VBP O B-m
9 amiodarone RB O B-m
9 400 CD O B-do
9 mg NNS B-NP I-do
10 p.o JJ B-NP B-mo
10 b.i.d NN I-NP B-f
10 for IN B-VP B-du
10 six CD O I-du
10 more JJR B-NP I-du
10 days NNS I-NP I-du
10 and CC O O
10 then RB O O
10 400 CD O B-do
10 mg NNS B-NP I-do
10 p.o JJ O B-mo
10 daily RB O B-f
10 , , O O
10 hold NN B-NP O
11 for IN B-VP O
11 systolic JJ O O
11 less JJR O O
11 than IN B-VP O
11 90 CD O O
11 , , O O
11 heart NN B-NP O
11 rate NN I-NP O
11 less JJR O O
11 than IN B-VP O
11 55 CD O O
11 , , O O
11 econazole JJ B-NP B-m
12 nitrate JJ I-NP O
12 topical JJ I-NP B-mo
12 daily NN I-NP B-f
12 , , O O
12 heparin JJ O B-m
12 5000 CD O B-do
12 units NNS B-NP I-do
12 subcutaneously RB O B-mo
12 q.12 JJ B-NP B-f
12 h NN I-NP I-f
12 , , O O
13 Regular NNP B-NP B-m
13 Insulin NNP I-NP I-m
13 sliding VBG O B-do
13 scale NN B-NP I-do
13 subcutaneously RB O B-mo
13 q.6 JJ B-NP B-f
13 h NN I-NP I-f
13 , , O O
13 Imodium NNP B-NP B-m
13 A-D NNP I-NP I-m
14 2 CD O B-do
14 mg NN B-NP I-do
14 p.o NN I-NP B-mo
14 b.i.d NN I-NP B-f
14 , , O O
14 metoclopramide RB O B-m
14 10 CD O B-do
14 mg NNS B-NP I-do
14 p.o JJ B-NP B-mo
14 q.i.d NN I-NP B-f
14 , , O O
14 Lopressor NNP B-NP B-m
14 50 CD O B-do
15 mg NN B-NP O
15 p.o NN I-NP B-mo
15 q.6 NN I-NP B-f
15 h NN I-NP I-f
15 , , O O
15 hold NN B-NP O
15 for IN B-VP O
15 systolic JJ O O
15 less JJR O O
15 than IN B-VP O
15 90 CD O O
15 , , O O
15 heart NN B-NP O
15 rate NN I-NP O
15 less JJR O O
16 than IN B-VP O
16 55 CD O O
16 , , O O
16 omeprazole VBD B-VP B-m
16 40 CD O B-do
16 mg NN B-NP I-do
16 p.o NN I-NP B-mo
16 b.i.d NN I-NP B-f
16 , , O O
16 oxycodone RB O B-m
16 1 CD O O
16 mg NNS B-NP O
16 per IN B-VP O
16 1 CD O O
16 mL JJ B-NP O
17 solution NN I-NP O
17 for IN B-VP O
17 a DT B-NP O
17 total NN I-NP O
17 of IN B-VP O
17 5 CD O B-do
17 mg NNS B-NP I-do
17 p.o JJ B-NP B-mo
17 q.4 JJ I-NP B-f
17 h NN I-NP I-f
17 p.r.n NN I-NP I-f
17 pain NN I-NP B-r
17 , , O O
17 Carafate NNP B-NP B-m
17 1 CD O B-do
18 gm NN B-NP O
18 p.o NN I-NP B-mo
18 q.i.d NN I-NP B-f
18 , , O O
18 and CC O O
18 Ambien NNP B-NP B-m
18 2.5 CD O B-do
18 mg NN B-NP I-do
18 p.o NN I-NP B-mo
18 nightly RB O B-f
19 DIET: NNP B-NP O
19 The DT B-NP O
19 patient NN I-NP O
19 is VBZ O O
19 currently RB O O
19 on IN B-VP O
19 a DT B-NP O
19 house NN I-NP O
19 diet JJ B-NP O
19 TPN NNP I-NP B-m
19 was VBD B-VP O
19 d/c'ed VBN O O
19 on IN B-VP O
19 the DT B-NP O
19 day NN I-NP O
19 of IN B-VP O
20 discharge NN B-NP O
21 ACTIVITY: NNP I-NP O
21 He PRP O O
21 may MD O O
21 walk VB O O
21 as IN B-VP O
21 tolerated JJ B-NP O
22 ADMISSION NNP I-NP O
22 DIAGNOSIS: NNP I-NP O
22 Incarcerated NNP I-NP O
22 chronic JJ B-NP O
22 ventral JJ I-NP O
22 hernia NN I-NP O
22 status NN I-NP O
23 post NN I-NP O
23 sigmoid NN I-NP O
23 colectomy NN I-NP O
23 , , O O
23 colostomy NN B-NP O
23 , , O O
23 and CC O O
23 Hartmann's NNP B-NP O
23 operation NN I-NP O
24 The DT B-NP O
24 patient NN I-NP O
24 is VBZ O O
24 to TO O O
24 follow VB O O
24 up RP O O
24 with IN B-VP O
24 Dr NNP B-NP O
24 Galla NNP I-NP O
24 in IN B-VP O
24 two CD O O
24 weeks NNS B-NP O
24 and CC O O
25 Dr NNP B-NP O
25 Caracciolo NNP I-NP O
25 who WP O O
25 is VBZ O O
25 the DT O O
25 attending VBG O O
25 in IN B-VP O
25 two CD O O
25 weeks NNS B-NP O
25 He PRP O O
25 should MD O O
25 also RB O O
25 follow VB O O
25 up RP O O
25 with IN B-VP O
25 Dr NNP B-NP O
26 Smutzler NNP I-NP O
26 , , O O
26 cardiology NN B-NP O
26 in IN B-VP O
26 2 CD O O
26 months NNS B-NP O
26 , , O O
26 and CC O O
26 Dr NNP B-NP O
26 Parramore NNP I-NP O
26 , , O O
26 GI NNP B-NP O
26 in IN B-VP O
26 2-4 JJ B-NP O
26 weeks NNS I-NP O
27 HOSPITAL NNP I-NP O
27 COURSE: NNP I-NP O
27 This DT O O
27 is VBZ O O
27 a DT B-NP O
27 72-year-old JJ I-NP O
27 male NN I-NP O
27 admitted VBN O O
27 for IN B-VP O
27 an DT B-NP O
28 incarcerated JJ I-NP O
28 chronic JJ I-NP O
28 ventral JJ I-NP O
28 hernia NN I-NP O
28 , , O O
28 postoperative JJ B-NP O
28 day NN I-NP O
28 6 CD O O
28 , , O O
28 status NN B-NP O
29 post NN I-NP O
29 sigmoid NN I-NP O
29 colectomy NN I-NP O
29 , , O O
29 colostomy NN B-NP O
29 , , O O
29 and CC O O
29 Hartmann's NNP B-NP O
29 operation NN I-NP O
30 Hospital NNP I-NP O
30 course NN I-NP O
30 was VBD B-VP O
30 complicated VBN O O
30 by IN B-VP O
30 postoperative JJ B-NP O
30 acute NN I-NP O
31 respiratory NN I-NP O
31 failure NN I-NP O
31 , , O O
31 respiratory JJ B-NP O
31 acidosis NN I-NP O
31 with IN B-VP O
31 metabolic JJ B-NP O
32 acidosis NN I-NP O
32 , , O O
32 pleural JJ B-NP O
32 effusion NN I-NP O
32 , , O O
32 hypokalemia NN B-NP O
32 , , O O
32 myocardial JJ B-NP O
32 infarction NN I-NP O
32 , , O O
33 thrombocytopenia NN B-NP O
33 , , O O
33 and CC O O
33 delirium NN B-NP O
33 He PRP O O
33 has VBZ O O
33 a DT O O
33 known VBN O O
33 history NN B-NP O
33 of IN B-VP O
33 penile NN B-NP O
34 cancer NN I-NP O
34 status NN I-NP O
34 post NN I-NP O
34 penectomy NN I-NP O
34 complicated VBN O O
34 by IN B-VP O
34 perineal NN B-NP O
35 urethrocutaneous JJ B-NP O
35 fistula NN I-NP O
35 , , O O
35 chronic JJ B-NP O
35 anemia NN I-NP O
35 requiring VBG O O
35 transfusions NNS B-NP O
35 , , O O
36 non-insulin-dependant JJ B-NP O
36 diabetes NNS I-NP O
36 , , O O
36 hypertension NN B-NP O
36 , , O O
37 hypercholesterolemia NN B-NP O
37 , , O O
37 obesity NN B-NP O
37 , , O O
37 and CC O O
37 recurrent NN B-NP O
37 UTIs NNP I-NP O
37 The DT B-NP O
37 patient NN I-NP O
38 had VBD B-VP O
38 a DT B-NP O
38 suprapubic JJ I-NP O
38 catheter NN I-NP O
38 placed VBN O O
38 by IN B-VP O
38 Urology NNP B-NP O
38 His PRP$ O O
38 postoperative JJ B-NP O
39 course NN I-NP O
39 otherwise NN I-NP O
39 was VBD B-VP O
39 alright RB O O
39 He PRP O O
39 started VBD B-VP O
39 having VBG O O
39 atrial JJ B-NP O
40 fibrillation NN I-NP O
40 on IN B-VP O
40 10/30/07 CD O O
40 , , O O
40 initially RB O O
40 remained VBD B-VP O
40 stable JJ O O
40 with IN B-VP O
40 normal JJ B-NP O
41 blood NN I-NP O
41 pressures NNS I-NP O
41 He PRP O O
41 was VBD B-VP O
41 transferred VBN O O
41 to TO O O
41 the DT B-NP O
41 floor NN I-NP O
41 on IN B-VP O
41 10/30/07 CD O O
41 , , O O
42 wherein NN B-NP O
42 he PRP O O
42 developed VBD B-VP O
42 rapid JJ B-NP O
42 ventricular JJ I-NP O
42 response NN I-NP O
42 to TO O O
42 120 CD O O
42 On IN B-VP O
43 11/21/07 CD O O
43 , , O O
43 he PRP O O
43 began VBD B-VP O
43 hypotensive JJ O O
43 with IN B-VP O
43 systolics NNS B-NP O
43 of IN B-VP O
43 70 CD O O
43 Cardiology NNP B-NP O
44 was VBD B-VP O
44 consulted VBN O O
44 He PRP O O
44 was VBD B-VP O
44 initially RB O O
44 treated VBN O O
44 with IN B-VP O
44 Lopressor NNP B-NP B-m
44 and CC O O
45 diltiazem VB O B-m
45 drip NN B-NP B-mo
45 He PRP O O
45 remained VBD B-VP O
45 hypotensive JJ O O
45 despite IN B-VP O
45 IV JJ B-NP O
45 boluses NNS I-NP O
45 He PRP O O
46 was VBD B-VP O
46 switched VBN O O
46 to TO O O
46 amiodarone VB O B-m
46 mode NN B-NP O
46 and CC O O
46 drip NN B-NP B-mo
46 , , O O
46 but CC O O
46 again RB O O
46 he PRP O O
46 became VBD B-VP O
47 hypotensive JJ O O
47 Therefore IN B-VP O
47 he PRP O O
47 was VBD B-VP O
47 transferred VBN O O
47 to TO O O
47 the DT B-NP O
47 unit NN I-NP O
47 and CC O O
47 given VBN O O
48 a DT B-NP O
48 digoxin NN I-NP B-m
48 load NN I-NP O
48 and CC O O
48 was VBD B-VP O
48 transferred VBN O O
48 for IN B-VP O
48 a DT B-NP O
48 possible JJ I-NP O
49 electrocardioversion NN I-NP O
49 He PRP O O
49 remained VBD B-VP O
49 asymptomatic JJ O O
49 throughout IN B-VP O
49 the DT B-NP O
50 day NN I-NP O
50 with IN B-VP O
50 low JJ B-NP O
50 blood NN I-NP O
50 pressures NNS I-NP O
50 In IN B-VP O
50 the DT B-NP O
50 ICU NNP I-NP O
50 , , O O
50 he PRP O O
50 was VBD B-VP O
50 again RB O O
50 started JJ O O
51 and CC O O
51 maintained VBD B-VP O
51 on IN B-VP O
51 amiodarone NN B-NP B-m
51 IV NNP I-NP B-mo
51 He PRP O O
51 tolerated VBD B-VP O
51 it PRP O O
51 without IN B-VP O
51 a DT B-NP O
52 problem NN I-NP O
52 He PRP O O
52 did VBD B-VP O
52 have VB O O
52 an DT B-NP O
52 episode NN I-NP O
52 of IN B-VP O
52 bright JJ B-NP O
52 red JJ I-NP O
52 blood NN I-NP O
52 from IN B-VP O
52 his PRP$ O O
52 NG NNP B-NP O
53 tube NN I-NP O
53 in IN B-VP O
53 the DT B-NP O
53 ICU NNP I-NP O
53 and CC O O
53 GI NNP B-NP O
53 was VBD B-VP O
53 consulted VBN O O
53 They PRP O O
53 felt VBD B-VP O
53 given VBN O O
53 that IN B-VP O
53 his PRP$ O O
54 hematocrits NNS B-NP B-r
54 have VBP O O
54 stabilized VBN O O
54 after IN B-VP O
54 two CD O B-do
54 units NNS B-NP I-do
54 of IN B-VP O
54 packed JJ B-NP B-m
54 cells NNS I-NP I-m
54 , , O O
54 he PRP O O
55 did VBD B-VP O
55 not RB O O
55 need VB O O
55 to TO O O
55 be VB O O
55 urgently RB O O
55 scoped VBN O O
55 He PRP O O
55 was VBD B-VP O
55 started VBN O O
55 on IN B-VP O
55 Pepcid NNP B-NP B-m
55 IV NNP I-NP B-mo
56 and CC O O
56 a DT B-NP O
56 Nexium NNP I-NP B-m
56 drip NN I-NP B-mo
56 , , O O
56 and CC O O
56 had VBD B-VP O
56 hematocrit VBN O O
56 measured VBN O O
56 q.6 RBR O O
56 h NN B-NP O
56 , , O O
56 which WDT O O
57 remains VBZ O O
57 normal JJ O O
57 He PRP O O
57 was VBD B-VP O
57 transferred VBN O O
57 back RB O O
57 to TO O O
57 the DT B-NP O
57 floor NN I-NP O
57 on IN B-VP O
57 these DT B-NP B-m
58 medications NNS I-NP O
58 and CC O O
58 was VBD B-VP O
58 started VBN O O
58 on IN B-VP O
58 TPN NNP B-NP B-m
58 after IN B-VP O
58 a DT B-NP O
58 PICC NNP I-NP O
58 line NN I-NP O
58 was VBD B-VP O
58 placed VBN O O
59 and CC O O
59 continued VBN O O
59 to TO O O
59 do VB O O
59 well RB O O
59 He PRP O O
59 was VBD B-VP O
59 scoped VBN O O
59 by IN B-VP O
59 GI NNP B-NP O
59 on IN B-VP O
59 6/20/07 CD O O
59 , , O O
59 which WDT O O
60 showed VBD B-VP O
60 diffuse IN B-VP O
60 gastritis NN B-NP O
60 thought VBN O O
60 to TO O O
60 be VB O O
60 due JJ O O
60 to TO O O
60 the DT B-NP O
60 NG NNP I-NP O
60 tube NN I-NP O
60 , , O O
60 and CC O O
61 two CD O O
61 ulcers NNS B-NP O
61 turned VBD B-VP O
61 out RP O O
61 bleeding JJ B-NP O
61 Postprocedure NN I-NP O
61 , , O O
61 he PRP O O
61 was VBD B-VP O
61 started VBN O O
61 on IN B-VP O
62 Carafate NNP B-NP B-m
62 and CC O O
62 was VBD B-VP O
62 transferred VBN O O
62 to TO O O
62 Nexium NNP B-NP B-m
62 p.o NN I-NP B-mo
62 after IN B-VP O
62 he PRP O O
62 was VBD B-VP O
62 taking VBG O O
62 a DT B-NP O
63 diet NN I-NP O
63 Again NNP I-NP O
63 , , O O
63 his PRP$ O O
63 PICC NNP B-NP O
63 line NN I-NP O
63 was VBD B-VP O
63 safe JJ O O
63 on IN B-VP O
63 11/8/07 CD O O
63 and CC O O
63 he PRP O O
63 was VBD B-VP O
64 started VBN O O
64 on IN B-VP O
64 TPN NNP B-NP B-m
64 on IN B-VP O
64 8/25/07 CD O O
64 The DT B-NP O
64 NG NNP I-NP O
64 tube NN I-NP O
64 was VBD B-VP O
64 removed VBN O O
64 on IN B-VP O
64 6/20/07 CD O O
65 and CC O O
65 his PRP$ O O
65 diet NN B-NP O
65 has VBZ O O
65 been VBN O O
65 slowly RB O O
65 advanced JJ O O
65 He PRP O O
65 is VBZ O O
65 being VBG O O
65 discharged VBN O O
65 on IN B-VP O
66 TPN NNP B-NP B-m
66 as IN B-VP O
66 his PRP$ O O
66 total JJ B-NP O
66 caloric JJ I-NP O
66 needs NNS I-NP O
66 are VBP O O
66 still RB O O
66 not RB O O
66 being VBG O O
66 met VBN O O
66 by IN B-VP O
66 p.o JJ B-NP O
67 nutrition NN I-NP O
67 and CC O O
67 he PRP O O
67 is VBZ O O
67 in IN B-VP O
67 good JJ B-NP O
67 condition NN I-NP O
67 on IN B-VP O
67 discharge NN B-NP O
68 He PRP O O
68 was VBD B-VP O
68 not RB O O
68 anti-coagulated JJ O O
68 for IN B-VP O
68 his PRP$ O O
68 Atrial JJ B-NP O
68 Fibrillation NNP I-NP O
68 due NN I-NP O
68 to TO O O
68 his PRP$ O O
68 risk NN B-NP O
68 of IN B-VP O
68 GI NNP B-NP O
69 bleeding NN I-NP O
69 , , O O
69 as IN B-VP O
69 decided VBN O O
69 by IN B-VP O
69 GI NNP B-NP O
70 eScription NN I-NP O
70 document: VBD B-VP O
70 5-6745409 JJ B-NP O
70 CSSten NNP I-NP O
70 Tel NNP I-NP O
71 Dictated NNP I-NP O
71 By: NNP I-NP O
71 VOCK NNP I-NP O
71 , , O O
71 RODOLFO NNP B-NP O
72 Attending: NNP I-NP O
72 REGINALDO NNP I-NP O
72 , , O O
72 EARLE NNP B-NP O
72 CHANCE NNP I-NP O
73 Dictation NNP I-NP O
73 ID NNP I-NP O
73 6112785 CD O O
74 D: NNP B-NP O
74 8/26/07 CD O O
75 T: NNP B-NP O
75 8/26/07 CD O O
76 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #498500 VBZ O O
4 407488014 CD O O
4 VEHH NNP B-NP O
4 39523841 CD O O
4 3178895 CD O O
4 3/17/2003 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Pancreatitis NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/17/2003 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/1/2003 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 EMILE NNP I-NP O
8 , , O O
8 DARON NNP B-NP O
8 493-31-10-1 CD O O
9 Ert NNP B-NP O
9 Deownside NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 4/15/03 CD O O
11 AT NNP B-NP O
11 04:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 SALEHI NNP I-NP O
14 , , O O
14 ALVIN NNP B-NP O
14 H NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 AMITRIPTYLINE NNP I-NP B-m
20 HCL NNP I-NP I-m
20 30 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QHS NNP I-NP B-f
21 PREMARIN NNP I-NP B-m
21 ( ( O I-m
21 CONJUGATED NNP B-NP I-m
21 ESTROGENS NNP I-NP I-m
21 ) ) O I-m
21 0.625 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 FLEXERIL NNP I-NP B-m
22 ( ( O I-m
22 CYCLOBENZAPRINE NNP B-NP I-m
22 HCL NNP I-NP I-m
22 ) ) O I-m
22 10 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 TID NNP I-NP B-f
22 PRN NNP I-NP I-f
22 Pain NNP I-NP B-r
23 Alert NNP I-NP O
23 overridden: NNP I-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 8/10/03 CD O O
23 by IN B-VP O
24 NICKLESS NNP B-NP O
24 , , O O
24 JAMES NNP B-NP O
24 , , O O
24 M.D NNP B-NP O
25 on IN B-VP O
25 order NN B-NP O
25 for IN B-VP O
25 FLEXERIL NNP B-NP B-m
25 PO NNP I-NP B-mo
25 10 CD O B-do
25 MG NNP B-NP I-do
25 TID NNP I-NP B-f
25 ( ( O O
25 ref JJ O O
25 # # O O
25 75816429 CD O O
25 ) ) O O
26 DEFINITE NNP B-NP O
26 ALLERGY NNP I-NP O
26 ( ( O O
26 OR NNP B-NP O
26 SENSITIVITY NNP I-NP O
26 ) ) O O
26 to TO O O
26 MUSCLE NNP B-NP O
26 RELAXANTS NNP I-NP O
26 , , O O
27 SKELETAL NNP B-NP O
27 Reason NNP I-NP O
27 for IN B-VP O
27 override: NN B-NP O
27 aware JJ B-NP O
27 meds NNS I-NP O
28 Number NNP I-NP O
28 of IN B-VP O
28 Doses NNP B-NP O
28 Required NNP I-NP O
28 ( ( O O
28 approximate JJ B-NP O
28 ): NN I-NP O
28 4 CD O O
29 COLACE NNP B-NP B-m
29 ( ( O I-m
29 DOCUSATE NNP B-NP I-m
29 SODIUM NNP I-NP I-m
29 ) ) O I-m
29 100 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 BID NNP I-NP B-f
30 FLUOXETINE NNP I-NP B-m
30 ( ( O I-m
30 FLUOXETINE NNP B-NP I-m
30 HCL NNP I-NP I-m
30 ) ) O I-m
30 40 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 QD NNP I-NP B-f
31 GEMFIBROZIL NNP I-NP B-m
31 600 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 BID NNP I-NP B-f
32 Alert NNP I-NP O
32 overridden: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 4/15/03 CD O O
32 by IN B-VP O
33 HOKKANEN NNP B-NP O
33 , , O O
33 WALTER NNP B-NP O
33 M NNP I-NP O
33 , , O O
33 M.D NNP B-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 SIMVASTATIN NNP I-NP B-m
34 &amp; NNP I-NP O
34 GEMFIBROZIL NNP I-NP B-m
35 POTENTIALLY NNP I-NP O
35 SERIOUS NNP I-NP O
35 INTERACTION: NNP I-NP O
35 SIMVASTATIN NNP I-NP B-m
35 &amp; NNP I-NP O
35 GEMFIBROZIL NNP I-NP B-m
36 Reason NNP I-NP O
36 for IN B-VP O
36 override: NN B-NP O
36 aware JJ B-NP O
37 NPH NNP I-NP B-m
37 HUMULIN NNP I-NP I-m
37 INSULIN NNP I-NP I-m
37 ( ( O I-m
37 INSULIN NNP B-NP I-m
37 NPH NNP I-NP I-m
37 HUMAN NNP I-NP I-m
37 ) ) O I-m
37 10 CD O B-do
37 UNITS NNP B-NP I-do
37 SC NNP I-NP B-mo
37 QAM NNP I-NP B-f
38 Starting VBG O O
38 Today NNP B-NP O
38 ( ( O O
38 5/19 CD O O
38 ) ) O O
39 NPH NNP B-NP B-m
39 HUMULIN NNP I-NP I-m
39 INSULIN NNP I-NP I-m
39 ( ( O I-m
39 INSULIN NNP B-NP I-m
39 NPH NNP I-NP I-m
39 HUMAN NNP I-NP I-m
39 ) ) O I-m
39 50 CD O B-do
39 UNITS NNP B-NP I-do
39 SC NNP I-NP B-mo
39 QHS NNP I-NP B-f
40 LORAZEPAM NNP I-NP B-m
40 1 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 AMLODIPINE NNP I-NP B-m
41 10 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 QD NNP I-NP B-f
41 Food/Drug NNP I-NP O
41 Interaction NNP I-NP O
41 Instruction NNP I-NP O
42 Avoid NNP I-NP O
42 grapefruit NN I-NP O
42 unless IN B-VP O
42 MD NNP B-NP O
42 instructs NNS I-NP O
42 otherwise RB O O
43 TOPROL NNP B-NP B-m
43 XL NNP I-NP I-m
43 ( ( O I-m
43 METOPROLOL NNP B-NP I-m
43 ( ( O I-m
43 SUST NNP B-NP I-m
43 REL NNP I-NP I-m
43 ) ) O I-m
43 ) ) O I-m
43 100 CD O B-do
43 MG NNP B-NP I-do
43 PO NNP I-NP B-mo
43 QD NNP I-NP B-f
44 Food/Drug NNP I-NP O
44 Interaction NNP I-NP O
44 Instruction NNP I-NP O
45 Take NNP I-NP O
45 consistently RB O O
45 with IN B-VP O
45 meals NNS B-NP O
45 or CC O O
45 on IN B-VP O
45 empty JJ B-NP O
45 stomach NN I-NP O
46 Number NNP I-NP O
46 of IN B-VP O
46 Doses NNP B-NP O
46 Required NNP I-NP O
46 ( ( O O
46 approximate JJ B-NP O
46 ): NN I-NP O
46 10 CD O O
47 IRBESARTAN NNP B-NP B-m
47 300 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QD NNP I-NP B-f
48 Number NNP I-NP B-du
48 of IN B-VP I-du
48 Doses NNP B-NP I-du
48 Required NNP I-NP I-du
48 ( ( O I-du
48 approximate JJ B-NP I-du
48 ): NN I-NP I-du
48 5 CD O I-du
49 LASIX NNP B-NP B-m
49 ( ( O I-m
49 FUROSEMIDE NNP B-NP I-m
49 ) ) O I-m
49 40 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 QD NNP I-NP B-f
50 Alert NNP I-NP O
50 overridden: NNP I-NP O
50 Override NNP I-NP O
50 added VBD B-VP O
50 on IN B-VP O
50 4/15/03 CD O O
50 by IN B-VP O
50 : : O O
51 POSSIBLE NNP B-NP O
51 ALLERGY NNP I-NP O
51 ( ( O O
51 OR NNP B-NP O
51 SENSITIVITY NNP I-NP O
51 ) ) O O
51 to TO O O
51 SULFA NNP B-NP O
52 Reason NNP I-NP O
52 for IN B-VP O
52 override: NN B-NP O
52 aware JJ B-NP O
53 LIPITOR NNP I-NP B-m
53 ( ( O I-m
53 ATORVASTATIN NNP B-NP I-m
53 ) ) O I-m
53 80 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 QD NNP I-NP B-f
54 Alert NNP I-NP O
54 overridden: NNP I-NP O
54 Override NNP I-NP O
54 added VBD B-VP O
54 on IN B-VP O
54 4/15/03 CD O O
54 by IN B-VP O
54 : : O O
55 SERIOUS NNP B-NP O
55 INTERACTION: NNP I-NP O
55 GEMFIBROZIL NNP I-NP B-m
55 &amp; NNP I-NP O
55 ATORVASTATIN NNP I-NP B-m
55 CALCIUM NNP I-NP I-m
56 POTENTIALLY NNP I-NP O
56 SERIOUS NNP I-NP O
56 INTERACTION: NNP I-NP O
56 GEMFIBROZIL NNP I-NP B-m
56 &amp; NNP I-NP O
57 ATORVASTATIN NNP I-NP B-m
57 CALCIUM NNP I-NP I-m
57 Reason NNP I-NP O
57 for IN B-VP O
57 override: NN B-NP O
57 aware JJ B-NP O
58 DIET: NNP I-NP O
58 House NNP I-NP O
58 / NNP I-NP O
58 Adv NNP I-NP O
58 as IN B-VP O
58 tol NN B-NP O
58 / IN B-VP O
58 ADA NNP B-NP O
58 1800 CD O O
58 cals/day NN B-NP O
58 / VB O O
58 Very RB O O
58 low JJ B-NP O
58 fat NN I-NP O
58 ( ( O O
58 20gms/day CD O O
58 ) ) O O
59 ACTIVITY: NNP B-NP O
59 Resume NNP I-NP O
59 regular JJ B-NP O
59 exercise NN I-NP O
60 FOLLOW NNP I-NP O
60 UP NNP I-NP O
60 APPOINTMENT( NNP I-NP O
60 S NNP I-NP O
60 ): NNP I-NP O
61 Dr NNP I-NP O
61 Bouy NNP I-NP O
61 , , O O
61 vascular JJ B-NP O
61 surgery NN I-NP O
61 , , O O
61 U NNP B-NP O
61 Daylis NNP I-NP O
61 Ont NNP I-NP O
61 , , O O
61 12:50 CD O O
61 pm NN B-NP O
61 , , O O
61 you PRP O O
61 need VBP O O
61 to TO O O
61 ask VB O O
61 Dr NNP B-NP O
61 Master NNP I-NP O
61 for IN B-VP O
61 a DT O O
61 referral JJ O O
61 for IN B-VP O
61 this DT B-NP O
61 appointment NN I-NP O
61 1/14/03 CD O O
61 scheduled VBN O O
61 , , O O
62 Dr NNP B-NP O
62 Blaine NNP I-NP O
62 Wehrley NNP I-NP O
62 , , O O
62 11:30 CD O O
62 AM NNP B-NP O
62 5/14/03 CD O O
62 scheduled VBN O O
62 , , O O
63 MRI/A NNP B-NP O
63 of IN B-VP O
63 abdomen NNS B-NP O
63 , , O O
63 SHS NNP B-NP O
63 Re NNP I-NP O
63 Na NNP I-NP O
63 , , O O
63 New NNP B-NP O
63 Hampshire NNP I-NP O
63 59460 CD O O
63 , , O O
63 11:20 CD O O
63 AM NNP B-NP O
63 , , O O
63 please NN B-NP O
63 arrive JJ O O
63 30 CD O O
63 min NN B-NP O
63 prior RB O O
63 to TO O O
63 appt VB O O
63 and CC O O
63 have VB O O
63 only RB O O
63 clear JJ B-NP O
63 liquids NNS I-NP O
63 that IN B-VP O
63 morning NN B-NP O
63 0/9/03 CD O O
63 scheduled VBN O O
63 , , O O
64 ALLERGY: NNP B-NP O
64 Amoxicillin NNP I-NP O
64 , , O O
64 Sulfa NNP B-NP O
64 , , O O
64 Ciprofloxacin NNP B-NP O
64 , , O O
65 Orphenadrine NNP B-NP O
65 citrate NN I-NP O
65 , , O O
66 Angiotensin NNP B-NP O
66 converting VBG O O
66 enzyme JJ B-NP O
66 inhibitor NN I-NP O
67 ADMIT NNP I-NP O
67 DIAGNOSIS: NNP I-NP O
68 Pancreatitis NNP I-NP O
69 PRINCIPAL NNP I-NP O
69 DISCHARGE NNP I-NP O
69 DIAGNOSIS NNP I-NP O
69 ;Responsible JJ O O
69 After IN B-VP O
69 Study NNP B-NP O
69 for IN B-VP O
69 Causing NNP B-NP O
69 Admission NNP I-NP O
69 ) ) O O
70 Pancreatitis NNP B-NP O
71 OTHER NNP I-NP O
71 DIAGNOSIS;Conditions NNP I-NP O
71 , , O O
71 Infections NNP B-NP O
71 , , O O
71 Complications NNP B-NP O
71 , , O O
71 affecting VBG O O
71 Treatment/Stay NNP B-NP O
72 ?CARDIOMYOPATHY NNP I-NP O
72 EF=39% NNP I-NP O
72 , , O O
72 HTN NNP B-NP O
72 , , O O
72 SEVERE NNP B-NP O
72 HYPERCHOL/HYPER NNP I-NP O
72 TG NNP I-NP O
72 POORLY NNP I-NP O
73 CONTROLLED NNP I-NP O
73 DM NNP I-NP O
73 S/P NNP I-NP O
73 CHOLE/APPY/TAH NNP I-NP O
73 DIFFUSE NNP I-NP O
73 ABDOMINAL NNP I-NP O
73 PAIN NNP I-NP O
74 ALLG: NNP I-NP O
74 SULFA/AMOXICILLIN NNP I-NP O
75 OPERATIONS NNP I-NP O
75 AND NNP I-NP O
75 PROCEDURES: NNP I-NP O
76 OTHER NNP I-NP O
76 TREATMENTS/PROCEDURES NNP I-NP O
76 ( ( O O
76 NOT NNP B-NP O
76 IN NNP I-NP O
76 O.R NNP I-NP O
76 ) ) O O
77 none NN B-NP O
78 BRIEF NNP I-NP O
78 RESUME NNP I-NP O
78 OF NNP I-NP O
78 HOSPITAL NNP I-NP O
78 COURSE: NNP I-NP O
79 The DT B-NP O
79 patient NN I-NP O
79 is VBZ O O
79 a DT O O
79 64-year-old JJ O O
79 with IN B-VP O
79 known JJ B-NP O
79 CAD NNP I-NP O
79 , , O O
79 atherosclerotic JJ B-NP O
79 peripheral JJ I-NP O
80 vascular JJ I-NP O
80 disease NN I-NP O
80 , , O O
80 and CC O O
80 type $ O O
80 2 CD O O
80 diabetes NNS B-NP O
80 presented VBN O O
80 with IN B-VP O
80 back JJ B-NP O
80 pain NN I-NP O
80 She PRP O O
81 describes VBZ O O
81 a DT B-NP O
81 sudden JJ I-NP O
81 onset NN I-NP O
81 of IN B-VP O
81 8/10 CD O O
81 stabbing VBG O O
81 back RB O O
81 pain RB O O
81 4 CD O O
81 days NNS B-NP O
81 ago RB O O
81 without IN B-VP O
82 a DT B-NP O
82 clear JJ I-NP O
82 precipitant NN I-NP O
82 The DT B-NP O
82 pain NN I-NP B-r
82 was VBD B-VP O
82 non JJ B-NP O
82 raditating NN I-NP O
82 and CC O O
82 partially RB O O
82 releived VBN O O
83 with IN B-VP O
83 analgesics.She NNS B-NP B-m
83 denied VBD B-VP O
83 any DT B-NP O
83 bowel NN I-NP O
83 or CC O O
83 bladder NN B-NP O
83 incontinence NN I-NP O
83 or CC O O
83 saddle JJ B-NP O
84 anesthes NNS I-NP O
84 ia VBP O O
84 She PRP O O
84 denied VBD B-VP O
84 any DT B-NP O
84 fevers NNS I-NP O
84 , , O O
84 chills NNS B-NP O
84 , , O O
84 nausea NN B-NP O
84 , , O O
84 vomiting VBG O O
84 , , O O
84 or CC O O
85 diarrhea VB O O
85 She PRP O O
85 does VBZ O O
85 however RB O O
85 complain VB O O
85 of IN B-VP O
85 some DT B-NP O
85 urinary JJ I-NP O
85 frequency NN I-NP O
85 ( ( O O
85 on IN B-VP O
86 lasix NN B-NP B-m
86 ) ) O O
86 in IN B-VP O
86 the DT B-NP O
86 last JJ I-NP O
86 few JJ I-NP O
86 days NNS I-NP O
86 with IN B-VP O
86 out RP O O
86 any DT B-NP O
86 dysuria NN I-NP O
86 or CC O O
86 urgency NN B-NP O
86 Of IN B-VP O
86 note NN B-NP O
87 over IN B-VP O
87 the DT B-NP O
87 past JJ I-NP O
87 month NN I-NP O
87 she PRP O O
87 has VBZ O O
87 had VBD B-VP O
87 increasing VBG O O
87 had VBD B-VP O
87 shortness NN B-NP O
87 of IN B-VP O
87 breath NN B-NP O
88 however RB O O
88 she PRP O O
88 denies VBZ O O
88 any DT B-NP O
88 orthopnea NN I-NP O
88 or CC O O
88 PND VB O O
88 The DT B-NP O
88 patient NN I-NP O
88 has VBZ O O
88 long RB O O
88 standing VBG O O
89 pedal NN B-NP O
89 edema NN I-NP O
89 and CC O O
89 has VBZ O O
89 increasing VBG O O
89 abdominal JJ B-NP O
89 distension NN I-NP O
89 over IN B-VP O
89 the DT B-NP O
89 last JJ I-NP O
89 month NN I-NP O
90 but CC O O
90 has VBZ O O
90 not RB O O
90 noticed VBN O O
90 any DT B-NP O
90 change NN I-NP O
90 in IN B-VP O
90 her PRP$ O O
90 weight NN B-NP O
90 The DT B-NP O
90 patient NN I-NP O
90 has VBZ O O
90 CAD NNP B-NP O
90 and CC O O
91 her PRP$ O O
91 angina JJ B-NP O
91 equivalent NN I-NP O
91 is VBZ O O
91 jaw JJ B-NP O
91 pain.However NN I-NP O
91 in IN B-VP O
91 the DT O O
91 last JJ O O
91 6 CD O O
91 months NNS B-NP O
91 she PRP O O
91 has VBZ O O
92 had VBN O O
92 intermittent NN B-NP O
92 left VBN O O
92 sided VBD B-VP O
92 chest JJS B-NP O
92 pain NN I-NP O
92 that WDT O O
92 radiates VBZ O O
92 to TO O O
92 her PRP$ O O
92 left JJ B-NP O
92 arm NN I-NP O
93 In IN B-VP O
93 the DT B-NP O
93 ED NNP I-NP O
93 the DT B-NP O
93 patient NN I-NP O
93 was VBD B-VP O
93 ruled VBN O O
93 out RP O O
93 for IN B-VP O
93 an DT B-NP O
93 aortic JJ I-NP O
93 dissection NN I-NP O
93 , , O O
93 MI NNP B-NP O
93 and CC O O
94 had VBD B-VP O
94 a DT B-NP O
94 negative JJ I-NP O
94 D-Dimer NNP I-NP O
94 However RB O O
94 lipase NN B-NP O
94 levels NNS I-NP O
94 have VBP O O
94 been VBN O O
94 elevated VBN O O
94 with IN B-VP O
95 norm JJ B-NP O
95 al NN I-NP O
95 LFTs NNP I-NP O
95 She PRP O O
95 was VBD B-VP O
95 admitted VBN O O
95 with IN B-VP O
95 a DT B-NP O
95 diagnosis NN I-NP O
95 of IN B-VP O
95 pancreatitis NN B-NP O
96 Hospital NNP I-NP O
96 course: VBD B-VP O
97 1.GI- JJ B-NP O
97 S/P NNP I-NP O
97 cholecystectomy NN I-NP O
97 Her PRP$ O O
97 lipase NN B-NP O
97 was VBD B-VP O
97 mildly RB O O
97 elevated VBN O O
97 on IN B-VP O
98 admission NN B-NP O
98 to TO O O
98 200 CD O O
98 , , O O
98 fell VBD B-VP O
98 to TO O O
98 60 CD O O
98 with IN B-VP O
98 NPO NNP B-NP O
98 and CC O O
98 IVF NNP B-NP B-m
98 However RB O O
98 , , O O
98 MRA NNP B-NP O
98 read VBP O O
98 with IN B-VP O
99 radiology NN B-NP O
99 2/11 CD O O
99 shows NNS B-NP O
99 diffuse VBP O O
99 atherosclerotic JJ B-NP O
99 disease NN I-NP O
99 including VBG O O
100 stenosis NN B-NP O
100 of IN B-VP O
100 celiac JJ B-NP O
100 artery NN I-NP O
100 , , O O
100 vascular JJ B-NP O
100 surgery NN I-NP O
100 was VBD B-VP O
100 consulted VBN O O
100 for IN B-VP O
100 concer NN B-NP O
101 about IN B-VP O
101 mesenteric JJ B-NP O
101 ischemia NN I-NP O
101 They PRP O O
101 do VBP O O
101 not RB O O
101 think VB O O
101 she PRP O O
101 is VBZ O O
101 having VBG O O
101 symptoms NNS B-NP O
101 of IN B-VP O
102 ischemia NN B-NP O
102 , , O O
102 would MD O O
102 like VB O O
102 abdominal JJ B-NP O
102 MRA NNP I-NP O
102 to TO O O
102 further VB O O
102 assess JJ B-NP O
102 abdominal JJ I-NP O
103 vasculature NN I-NP O
103 Triglycerides NNP I-NP B-r
103 very RB O O
103 high JJ O O
103 , , O O
103 could MD O O
103 be VB O O
103 cause NN B-NP O
103 of IN B-VP O
103 her PRP$ O O
104 pancreatitis NN B-NP O
104 , , O O
104 starting VBG O O
104 gemfibrozil JJ B-NP B-m
104 LDL NNP I-NP O
104 was VBD B-VP O
104 151 CD O O
105 2.Cardivascular- JJ B-NP O
105 Ischemia-On NNP I-NP O
105 a DT B-NP O
105 beta NN I-NP B-m
105 blocker NN I-NP I-m
105 , , O O
105 statin NN B-NP B-m
105 , , O O
105 ARB NNP B-NP B-m
105 , , O O
105 ruled VBD B-VP O
105 out RP O O
106 for IN B-VP O
106 an DT B-NP O
106 MI NNP I-NP O
106 , , O O
106 but CC O O
106 has VBZ O O
106 6 CD O O
106 month NN B-NP O
106 history NN I-NP O
106 of IN B-VP O
106 chest NN B-NP O
106 pain NN I-NP O
106 Adenosine NNP I-NP O
106 MIBI NNP I-NP O
107 negative JJ B-NP O
107 Started NNP I-NP O
107 gemfibrozil VBD B-VP B-m
107 Pump-We NNP B-NP O
107 changed VBD B-VP O
107 atenolol NN B-NP B-m
107 to TO O O
107 toprol VB O B-m
107 XL NNP B-NP I-m
108 and CC O O
108 amlodipine JJ B-NP B-m
109 3.Endocrine- NN I-NP O
109 Has NNP I-NP O
109 had VBD B-VP O
109 poor JJ B-NP B-r
109 poor JJ I-NP B-r
109 glucose JJ I-NP I-r
109 glucose JJ I-NP I-r
109 control NN I-NP I-r
109 control NN I-NP I-r
109 HbA1c NNP I-NP O
109 13 CD O O
109 We PRP O O
109 continued VBD B-VP O
110 NPH NNP B-NP B-m
110 qhs NN I-NP B-f
110 and CC O O
110 started VBD B-VP O
110 AM NNP B-NP B-f
110 NPH NNP I-NP B-m
110 as IN B-VP O
110 well RB O O
111 4.Renal-Chronic JJ B-NP O
111 renal JJ I-NP O
111 insufficiency NN I-NP O
111 , , O O
111 Cr NNP B-NP O
111 stable JJ O O
112 5 CD O O
112 ID NNP B-NP O
112 - : O O
112 Patient NN B-NP O
112 c/o NN I-NP O
112 urinary JJ B-NP O
112 frequency NN I-NP O
112 U/A NNP I-NP O
112 negative JJ B-NP O
113 6.Psych-On JJ I-NP O
113 amitryptilline NN I-NP B-m
113 and CC O O
113 fluoxetine JJ B-NP B-m
114 ADDITIONAL NNP I-NP O
114 COMMENTS: NNP I-NP O
114 Please NNP I-NP O
114 take VB O O
114 all DT B-NP O
114 medications NNS I-NP O
114 as IN B-VP O
114 described VBN O O
114 You PRP O O
114 will MD O O
114 need VB O O
114 to TO O O
114 follow VB O O
114 a DT B-NP O
115 low JJ I-NP O
115 fat NN I-NP O
115 and CC O O
115 low JJ B-NP O
115 carbohydrate NN I-NP O
115 diet NN I-NP O
115 to TO O O
115 control VB O O
115 your PRP$ O O
115 cholesterol NN B-NP O
115 and CC O O
116 diabetes VBZ O O
116 Please NNP B-NP O
116 take VB O O
116 insulin NN B-NP B-m
116 in IN B-VP B-f
116 the DT B-NP I-f
116 morning NN I-NP I-f
116 as RB O I-f
116 well RB O I-f
116 as IN B-VP I-f
116 the DT B-NP I-f
116 night NN I-NP I-f
116 , , O O
117 check VB O O
117 your PRP$ O O
117 fingersticks NNS B-NP O
117 twice RB O O
117 a DT B-NP O
117 day NN I-NP O
117 and CC O O
117 record VB O O
117 them PRP O O
117 Please NNP B-NP O
117 see VB O O
118 Dr NNP B-NP O
118 Colleen NNP I-NP O
118 on IN B-VP O
118 10/2 CD O O
118 and CC O O
118 ask VB O O
118 him PRP O O
118 to TO O O
118 help VB O O
118 with IN B-VP O
118 your PRP$ O O
118 insulin NN B-NP B-m
118 regimen NNS I-NP I-m
119 Please NNP I-NP O
119 go VB O O
119 to TO O O
119 your PRP$ O O
119 MRI NNP B-NP O
119 appointment NN I-NP O
119 0/12 CD O O
119 and CC O O
119 see VB O O
119 Dr NNP B-NP O
119 Cicerchia NNP I-NP O
119 4/8 CD O O
120 Call NNP B-NP O
120 your PRP$ O O
120 doctor NN B-NP O
120 or CC O O
120 go VB O O
120 to TO O O
120 the DT B-NP O
120 emergency NN I-NP O
120 room NN I-NP O
120 if IN B-VP O
120 you PRP O O
120 develop VBP O O
120 severe JJ B-NP O
120 chest NN I-NP O
121 pain NN I-NP O
121 , , O O
121 shortness NN B-NP O
121 of IN B-VP O
121 breath NN B-NP O
121 , , O O
121 or CC O O
121 abdominal JJ B-NP O
121 pain NN I-NP O
122 DISCHARGE NNP I-NP O
122 CONDITION: NNP I-NP O
122 Stable NNP I-NP O
123 TO NNP I-NP O
123 DO/PLAN: NNP I-NP O
124 No NNP I-NP O
124 dictated VBD B-VP O
124 summary JJ B-NP O
125 ENTERED NNP I-NP O
125 BY: NNP I-NP O
125 HUNEYCUTT NNP I-NP O
125 , , O O
125 IRVING NNP B-NP O
125 , , O O
125 M.D NNP B-NP O
125 ( ( O O
125 VS38 NNP B-NP O
125 ) ) O O
125 4/15/03 CD O O
125 @ $ O O
125 02:03 CD O O
125 PM NNP B-NP O
126 ****** JJ B-NP O
126 END NNP I-NP O
126 OF NNP I-NP O
126 DISCHARGE NNP I-NP O
126 ORDERS NNP I-NP O
126 ****** NNP I-NP O
127 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #499301 VBZ O O
2 697377829 CD O O
2 JC NNP B-NP O
2 38527267 CD O O
2 8331308 CD O O
2 10/26/2007 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ABDOMINAL NNP I-NP O
2 PAIN; NNP I-NP O
2 RENAL NNP I-NP O
2 FAILURE NNP I-NP O
2 , , O O
2 PULIMONARY NNP B-NP O
2 EDEMA NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 8/13/2007 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/16/2007 CD O O
4 ATTENDING: NNP B-NP O
4 ARBOLEDA NNP I-NP O
4 , , O O
4 CORNELL NNP B-NP O
4 MD NNP I-NP O
5 ADMISSION NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Abdominal NNP I-NP O
5 pain NN I-NP O
6 DISCHARGE NNP I-NP O
6 DIAGNOSIS: NNP I-NP O
6 Pneumonia NNP I-NP O
7 HISTORY NNP I-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 An DT B-NP O
7 86-year-old JJ I-NP O
7 female NN I-NP O
7 with IN B-VP O
7 past JJ B-NP O
8 medical JJ I-NP O
8 history NN I-NP O
8 significant JJ O O
8 for IN B-VP O
8 atrial JJ B-NP O
8 fibrillation NN I-NP O
8 , , O O
8 diastolic JJ B-NP O
9 CHF NNP I-NP O
9 , , O O
9 rheumatic JJ B-NP O
9 heart NN I-NP O
9 disease NN I-NP O
9 status NN I-NP O
9 post NN I-NP O
9 mitral JJ B-NP O
9 valve NN I-NP O
10 replacement NN I-NP O
10 and CC O O
10 tricuspid JJ B-NP O
10 repair NN I-NP O
10 , , O O
10 chronic JJ B-NP O
10 renal JJ I-NP O
10 insufficiency NN I-NP O
10 , , O O
10 prior JJ B-NP O
10 small-bowel JJ I-NP O
11 obstruction NN I-NP O
11 and CC O O
11 GI NNP B-NP O
11 bleeding NN I-NP O
11 who WP O O
11 presented VBD B-VP O
11 with IN B-VP O
11 abdominal JJ B-NP O
11 pain NN I-NP O
12 The DT B-NP O
12 patient NN I-NP O
12 reports NNS I-NP O
12 sudden JJ B-NP O
12 onset NN I-NP O
12 of IN B-VP O
12 abdominal JJ B-NP O
12 pain NN I-NP O
12 approximately RB O O
13 one CD O O
13 day NN B-NP O
13 prior RB O O
13 to TO O O
13 admission NN B-NP O
13 , , O O
13 which WDT O O
13 became VBD B-VP O
13 progressively RB O O
13 worse JJR O O
14 The DT B-NP O
14 patient NN I-NP O
14 was VBD B-VP O
14 noted VBN O O
14 to TO O O
14 have VB O O
14 nausea NN B-NP O
14 and CC O O
14 vomiting NN B-NP O
14 at IN B-VP O
14 home NN B-NP O
14 with IN B-VP O
15 green/yellow JJ B-NP O
15 fluid NN I-NP O
15 The DT B-NP O
15 patient NN I-NP O
15 was VBD B-VP O
15 suspected VBN O O
15 to TO O O
15 have VB O O
15 an DT B-NP O
16 aspiration NN I-NP O
16 event NN I-NP O
16 per IN B-VP O
16 the DT B-NP O
16 patient's NN I-NP O
16 daughter NN I-NP O
16 The DT B-NP O
16 patient NN I-NP O
16 denies VBZ O O
17 fever RB O O
17 or CC O O
17 chills VB O O
17 Denies NNPS B-NP O
17 dysuria NN I-NP O
17 Denies NNP I-NP O
17 shortness NN I-NP O
17 of IN B-VP O
17 breath NN B-NP O
17 or CC O O
18 cough NN B-NP O
18 No DT B-NP O
18 recent JJ I-NP O
18 antibiotics NNS I-NP O
18 No DT B-NP O
18 sick JJ I-NP O
18 contacts NNS I-NP O
19 EMERGENCY NNP I-NP O
19 DEPARTMENT NNP I-NP O
19 COURSE: NNP I-NP O
19 Temperature NNP I-NP O
19 97.5 CD O O
19 , , O O
19 heart NN B-NP O
19 rate NN I-NP O
19 74 CD O O
19 , , O O
20 blood NN B-NP O
20 pressure NN I-NP O
20 183/65 CD O O
20 improved VBN O O
20 to TO O O
20 128/56 CD O O
20 , , O O
20 respiratory NN B-NP O
20 rate NN I-NP O
20 16 CD O O
20 , , O O
21 oxygen NN B-NP O
21 saturation NN I-NP O
21 96% CD O O
21 on IN B-VP O
21 room NN B-NP O
21 air NN I-NP O
21 , , O O
21 subsequently RB O O
21 decreased VBN O O
21 to TO O O
21 92% CD O O
22 on IN B-VP O
22 room NN B-NP O
22 air NN I-NP O
22 and CC O O
22 improved VBN O O
22 to TO O O
22 96% CD O O
22 on IN B-VP O
22 2 CD O O
22 L NNP B-NP O
22 nasal JJ B-NP O
22 cannula NN I-NP O
22 On IN B-VP O
22 exam NN B-NP O
22 , , O O
23 patient NN B-NP O
23 was VBD B-VP O
23 noted VBN O O
23 to TO O O
23 have VB O O
23 positive JJ B-NP O
23 jugular NN I-NP O
23 venous JJ B-NP O
23 distension NN I-NP O
23 , , O O
23 3/6 CD O O
24 systolic JJ B-NP O
24 murmur NN I-NP O
24 at IN B-VP O
24 the DT B-NP O
24 left JJ I-NP O
24 upper JJ I-NP O
24 sternal JJ I-NP O
24 border NN I-NP O
24 , , O O
24 right JJ B-NP O
24 lower JJR I-NP O
25 quadrant JJ I-NP O
25 tenderness NN I-NP O
25 to TO O O
25 palpation NN B-NP O
25 , , O O
25 abdomen NNS B-NP O
25 soft JJ O O
25 and CC O O
25 without IN B-VP O
26 rebound NN B-NP O
26 tenderness NN I-NP O
26 A DT B-NP O
26 chest JJ I-NP O
26 x-ray NN I-NP O
26 was VBD B-VP O
26 performed VBN O O
26 and CC O O
26 a DT B-NP O
26 right JJ I-NP O
27 lower JJR I-NP O
27 lobe NN I-NP O
27 infiltrate NN I-NP O
27 and CC O O
27 moderate JJ B-NP O
27 pulmonary JJ I-NP O
27 edema NN I-NP O
27 was VBD B-VP O
27 noted VBN O O
27 A NNP B-NP O
28 KUB NNP I-NP O
28 was VBD B-VP O
28 also RB O O
28 performed VBN O O
28 , , O O
28 which WDT O O
28 did VBD B-VP O
28 not RB O O
28 show VB O O
28 any DT B-NP O
28 evidence NN I-NP O
28 of IN B-VP O
29 obstruction NN B-NP O
29 An DT B-NP O
29 abdominal JJ I-NP O
29 CT NNP I-NP O
29 demonstrated VBD B-VP O
29 mild JJ O O
29 diffuse IN B-VP O
29 small JJ B-NP O
30 bowel NN I-NP O
30 thickening VBG O O
30 concerning VBG O O
30 for IN B-VP O
30 infection NN B-NP O
30 versus NN I-NP O
30 ischemia VBZ O O
30 The DT B-NP O
31 patient NN I-NP O
31 was VBD B-VP O
31 given VBN O O
31 ceftriaxone NN B-NP B-m
31 , , O O
31 azithromycin NN B-NP B-m
31 and CC O O
31 Flagyl NNP B-NP B-m
31 IV NNP I-NP B-mo
31 as RB O O
31 well RB O O
32 as IN B-VP O
32 Lasix NNP B-NP B-m
32 40 CD O B-do
32 mg NN B-NP I-do
32 IV NNP I-NP B-mo
32 x1 NNP I-NP B-du
33 PAST NNP I-NP O
33 MEDICAL NNP I-NP O
33 HISTORY: NNP I-NP O
33 Hypertension NNP I-NP O
33 , , O O
33 atrial JJ B-NP B-r
33 fibrillation NN I-NP I-r
33 on IN B-VP O
34 Coumadin NNP B-NP B-m
34 , , O O
34 rheumatic JJ B-NP O
34 heart NN I-NP O
34 disease NN I-NP O
34 status NN I-NP O
34 post NN I-NP O
34 bioprosthetic JJ B-NP O
35 mitral JJ I-NP O
35 valve NN I-NP O
35 replacement NN I-NP O
35 and CC O O
35 tricuspid JJ B-NP O
35 valve NN I-NP O
35 repair NN I-NP O
35 ( ( O O
35 2000 CD O O
35 ) ) O O
35 , , O O
35 mild JJ B-NP O
36 aortic JJ I-NP O
36 stenosis NN I-NP O
36 , , O O
36 diastolic JJ B-NP O
36 heart NN I-NP O
36 failure NN I-NP O
36 , , O O
36 chronic JJ B-NP O
36 renal JJ I-NP O
37 insufficiency NN I-NP O
37 with IN B-VP O
37 baseline NN B-NP O
37 creatinine=2.6 NN I-NP O
37 , , O O
37 history NN B-NP O
37 of IN B-VP O
38 small-bowel JJ B-NP O
38 obstruction NN I-NP O
38 , , O O
38 history NN B-NP O
38 of IN B-VP O
38 GI NNP B-NP O
38 bleed NN I-NP O
38 ( ( O O
38 No-jack NNP B-NP O
38 Hospital NNP I-NP O
38 admission NN I-NP O
38 in IN B-VP O
38 3/28 CD O O
38 with IN B-VP O
38 capsule NN B-NP O
38 study NN I-NP O
38 demonstrating VBG O O
38 small JJ B-NP O
39 bowel NN I-NP O
39 lymphangiectasias NN I-NP O
39 and CC O O
39 angiectasis NN B-NP O
39 , , O O
39 colonoscopy NN B-NP O
40 demonstrating VBG O O
40 sessile JJ B-NP O
40 polyps NNS I-NP O
40 and CC O O
40 diverticulitis NN B-NP O
40 , , O O
40 questionable JJ B-NP O
41 history NN I-NP O
41 of IN B-VP O
41 mesenteric JJ B-NP O
41 ischemia NN I-NP O
41 , , O O
41 status NN B-NP O
41 post NN I-NP O
41 right RB O O
41 total JJ B-NP O
41 hip NN I-NP O
42 replacement NN I-NP O
42 , , O O
42 status NN B-NP O
42 post NN I-NP O
42 CVA NNP I-NP O
42 at IN B-VP O
42 age NN B-NP O
42 55 CD O O
42 , , O O
42 no DT B-NP O
42 history NN I-NP O
42 of IN B-VP O
42 MI NNP B-NP O
43 ADMISSION NNP I-NP O
43 MEDICATIONS: NNP I-NP O
44 1 CD O O
44 Renagel NNP B-NP B-m
44 one CD O B-do
44 tablet NN B-NP I-do
44 with IN B-VP B-f
44 dinner NN B-NP I-f
45 2 CD O O
45 Diovan NNP B-NP B-m
45 120 CD O B-do
45 mg VBD B-VP I-do
45 daily RB O B-f
46 3 CD O O
46 Procrit NNP B-NP B-m
46 5000 CD O B-do
46 units NNS B-NP I-do
46 subcutaneous JJ B-NP B-mo
46 q JJ I-NP B-f
46 week NN I-NP I-f
47 4 CD O O
47 Norvasc NNP B-NP B-m
47 5 CD O B-do
47 mg NN B-NP I-do
47 q.a.m NN I-NP B-f
48 5 CD O O
48 Norvasc NNP B-NP B-m
48 2.5 CD O B-do
48 mg NN B-NP I-do
48 q.p.m NN I-NP B-f
49 6 CD O O
49 Imdur NNP B-NP B-m
49 30 CD O B-do
49 mg NN B-NP I-do
49 twice RB O B-f
49 daily RB O I-f
50 7 CD O O
50 NovoLog NNP B-NP B-m
50 4/4/5 CD O B-do
50 plus CC O O
50 sliding VBG O B-do
50 scale JJ B-NP I-do
50 insulin NN I-NP B-m
51 8 CD O O
51 Lantus NNP B-NP B-m
51 8 CD O B-do
51 units NNS B-NP I-do
51 nightly RB O B-f
52 9 CD O O
52 Nexium NNP B-NP B-m
52 40 CD O B-do
52 mg NN B-NP I-do
52 twice RB O B-f
52 daily RB O I-f
53 10 CD O O
53 Coumadin NNP B-NP B-m
53 4 CD O B-do
53 mg NN B-NP I-do
53 p.o NN I-NP B-mo
53 q.p.m VBD B-VP B-f
54 11 CD O O
54 Caltrate NNP B-NP B-m
54 plus CC O I-m
54 D NNP B-NP I-m
54 one CD O B-do
54 tab NN B-NP I-do
54 twice RB O B-f
54 daily RB O I-f
55 12 CD O O
55 Iron NNP B-NP B-m
55 sulfate NN I-NP I-m
55 325 CD O B-do
55 mg NN B-NP I-do
55 twice RB O B-f
55 daily RB O I-f
56 13 CD O O
56 Lasix NNP B-NP B-m
56 Lasix NNP I-NP B-m
56 80 CD O B-do
56 mg NN B-NP I-do
56 p.o NN I-NP B-mo
56 q.a.m NN I-NP B-f
56 plus CC O O
56 40 CD O B-do
56 mg NN B-NP I-do
56 p.o NN I-NP B-mo
56 q.p.m NN I-NP B-f
57 ALLERGIES: NNP I-NP O
57 Codeine NNP I-NP O
57 and CC O O
57 Benadryl NNP B-NP O
58 ADMISSION NNP I-NP O
58 PHYSICAL NNP I-NP O
58 EXAMINATION: NNP I-NP O
58 Temperature NNP I-NP O
58 96.6 CD O O
58 , , O O
58 heart NN B-NP O
58 rate NN I-NP O
58 62 CD O O
58 , , O O
59 blood NN B-NP O
59 pressure NN I-NP O
59 108/60 CD O O
59 , , O O
59 respiratory NN B-NP O
59 rate NN I-NP O
59 20 CD O O
59 and CC O O
59 oxygen JJ B-NP O
59 saturation NN I-NP O
60 95% CD O O
60 on IN B-VP O
60 2 CD O O
60 l NN B-NP O
60 Chest NNP I-NP O
60 with IN B-VP O
60 bilateral JJ B-NP O
60 dullness NN I-NP O
60 and CC O O
60 right JJ B-NP O
60 basilar NN I-NP O
61 rales NNS I-NP O
61 Positive NNP I-NP O
61 egophony NN I-NP O
61 at IN B-VP O
61 right JJ B-NP O
61 base NN I-NP O
61 Heart NNP I-NP O
61 with IN B-VP O
61 regular JJ B-NP O
61 rate NN I-NP O
62 and CC O O
62 rhythm NN B-NP O
62 , , O O
62 and CC O O
62 a DT O O
62 3/6 CD O O
62 systolic JJ B-NP O
62 mid NN I-NP O
62 peaking VBG O O
62 murmur NN B-NP O
62 at IN B-VP O
62 left JJ B-NP O
62 upper JJ I-NP O
63 sternal JJ I-NP O
63 border NN I-NP O
63 heard NN I-NP O
63 throughout IN B-VP O
63 Normal NNP B-NP O
63 S1 NNP I-NP O
63 and CC O O
63 S2 NNP B-NP O
63 Abdomen NNP I-NP O
63 is VBZ O O
64 soft JJ O O
64 , , O O
64 nontender NN B-NP O
64 and CC O O
64 nondistended VBD B-VP O
64 Positive NNP B-NP O
64 bowel NN I-NP O
64 sounds VBZ O O
64 Guaiac NNP B-NP O
65 negative JJ B-NP O
66 ADMISSION NNP I-NP O
66 LABORATORY NNP I-NP O
66 DATA: NNP I-NP O
66 Sodium NNP I-NP O
66 141 CD O O
66 , , O O
66 potassium NN B-NP O
66 4.5 CD O O
66 , , O O
66 chloride RB O O
67 101 CD O O
67 , , O O
67 bicarbonate NN B-NP O
67 25 CD O O
67 , , O O
67 BUN NNP B-NP O
67 111 CD O O
67 , , O O
67 creatinine NN B-NP O
67 2.7 CD O O
67 and CC O O
67 glucose VB O O
67 206 CD O O
68 WBC NNP B-NP O
68 6.29 CD O O
68 , , O O
68 hematocrit NN B-NP O
68 37.7 CD O O
68 ( ( O O
68 38.5 CD O O
68 at IN B-VP O
68 last JJ B-NP O
68 check NN I-NP O
68 ) ) O O
68 , , O O
68 platelets VBZ O O
69 260 CD O O
69 , , O O
69 000 CD O O
69 , , O O
69 INR NNP B-NP O
69 2.8 CD O O
69 LFTs NNP B-NP O
69 normal JJ O O
69 , , O O
69 amylase JJ O O
69 80 CD O O
69 , , O O
69 lipase NN B-NP O
69 18 CD O O
69 , , O O
69 total JJ B-NP O
70 bilirubin NN I-NP O
70 0.8 CD O O
70 , , O O
70 albumin RB O O
70 3.7 CD O O
70 , , O O
70 lactate VBP O O
70 1.7 CD O O
70 Urinalysis NNP B-NP O
70 1+ CD O O
70 protein NN B-NP O
70 , , O O
71 WBC NNP B-NP O
71 2 CD O O
71 , , O O
71 RBC NNP B-NP O
71 0 CD O O
72 STUDIES: NNP B-NP O
73 1 CD O O
73 Chest NNP B-NP O
73 x-ray NN I-NP O
73 ( ( O O
73 5/30/07 CD O O
73 ): NNP B-NP O
73 Cardiomegaly NNP I-NP O
73 , , O O
73 mediastinal JJ B-NP O
73 wires NNS I-NP O
73 , , O O
74 positive JJ B-NP O
74 cephalization NN I-NP O
74 and CC O O
74 Kerley NNP B-NP O
74 B NNP I-NP O
74 lines NNS I-NP O
74 consistent NN I-NP O
74 with IN B-VP O
75 moderate JJ B-NP O
75 pulmonary JJ I-NP O
75 edema NN I-NP O
75 , , O O
75 right JJ B-NP O
75 lower JJR I-NP O
75 lobe NN I-NP O
75 opacification NN I-NP O
76 2 CD O O
76 KUB NNP B-NP O
76 ( ( O O
76 5/30/07 CD O O
76 ): NNP B-NP O
76 Nonspecific NNP I-NP O
76 gas NN I-NP O
76 pattern NN I-NP O
76 without IN B-VP O
76 evidence NN B-NP O
76 of IN B-VP O
77 obstruction NN B-NP O
77 or CC O O
77 free JJ B-NP O
77 air NN I-NP O
77 Calcified NNP I-NP O
77 aorta NN I-NP O
77 and CC O O
77 iliac JJ O O
78 3 CD O O
78 CT NNP B-NP O
78 abdomen NNS I-NP O
78 ( ( O O
78 2/17/070 CD O O
78 : : O O
78 1bilateral CD O O
78 infiltrates NNS B-NP O
78 consistent JJ O O
79 with IN B-VP O
79 pneumonia NN B-NP O
79 , , O O
79 questionable JJ O O
79 mild JJ O O
79 diffuse IN B-VP O
79 small-bowel JJ B-NP O
79 thickening NN I-NP O
79 , , O O
80 no DT B-NP O
80 appendicitis NN I-NP O
80 , , O O
80 no DT B-NP O
80 obstruction NN I-NP O
80 , , O O
80 no DT B-NP O
80 perforation NN I-NP O
80 , , O O
80 positive JJ B-NP O
81 gallstones NNS I-NP O
81 , , O O
81 positive JJ B-NP O
81 gallbladder NN I-NP O
81 distension NN I-NP O
81 without IN B-VP O
81 wall NN B-NP O
82 thickening NN I-NP O
82 or CC O O
82 pericholecystic JJ B-NP O
82 fluid NN I-NP O
83 4 CD O O
83 EKG NNP B-NP O
83 ( ( O O
83 5/30/07 CD O O
83 ): NNP B-NP O
83 Atrial NNP I-NP O
83 fibrillation NN I-NP O
83 at IN B-VP O
83 71 CD O O
83 beats NNS B-NP O
83 per IN B-VP O
83 minute NN B-NP O
83 , , O O
84 pseudonormalized VBD B-VP O
85 CONSULTING NNP B-NP O
85 SERVICES: NNP I-NP O
86 1 CD O O
86 Gastroenterology NNP B-NP O
87 2 CD O O
87 Surgery NNP B-NP O
88 HOSPITAL NNP I-NP O
88 COURSE NNP I-NP O
88 BY NNP I-NP O
88 PROBLEM: NNP I-NP O
89 1 CD O O
89 Abdominal NNP B-NP O
89 pain: NN I-NP O
89 Unclear NNP I-NP O
89 etiology NN I-NP O
89 of IN B-VP O
89 abdominal JJ B-NP O
89 pain NN I-NP O
89 on IN B-VP O
90 presentation NN B-NP O
90 , , O O
90 but CC O O
90 given VBN O O
90 history NN B-NP O
90 of IN B-VP O
90 mesenteric JJ B-NP O
90 ischemia NN I-NP O
90 and CC O O
91 questionable JJ B-NP O
91 small-bowel JJ I-NP O
91 thickening NN I-NP O
91 on IN B-VP O
91 CT NNP B-NP O
91 , , O O
91 the DT B-NP O
91 initial JJ I-NP O
91 concern NN I-NP O
92 GI NNP I-NP O
92 and CC O O
92 Surgical NNP B-NP O
92 Services NNPS I-NP O
92 were VBD B-VP O
92 consulted VBN O O
92 and CC O O
92 followed VBD B-VP O
92 the DT B-NP O
92 patient NN I-NP O
92 over IN B-VP O
93 Hospital NNP B-NP O
93 day NN I-NP O
93 #1 NNP I-NP O
93 Serial NNP I-NP O
93 CBC NNP I-NP O
93 , , O O
93 lactate NN B-NP O
93 and CC O O
93 anion NN B-NP O
93 gaps NNS I-NP O
93 were VBD B-VP O
94 followed VBN O O
94 and CC O O
94 showed VBD B-VP O
94 no DT B-NP O
94 evidence NN I-NP O
94 of IN B-VP O
94 ischemia NN B-NP O
94 By IN B-VP O
94 the DT B-NP O
94 evening NN I-NP O
94 of IN B-VP O
95 hospital JJ B-NP O
95 day NN I-NP O
95 #1 NNP I-NP O
95 , , O O
95 the DT B-NP O
95 patient's JJ I-NP O
95 abdominal JJ I-NP O
95 pain NN I-NP O
95 had VBD B-VP O
95 fully RB O O
95 resolved VBN O O
96 and CC O O
96 the DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 initiated VBN O O
96 on IN B-VP O
96 clears NNS B-NP O
96 By IN B-VP O
96 the DT B-NP O
96 morning NN I-NP O
96 of IN B-VP O
97 hospital NN B-NP O
97 day NN I-NP O
97 #2 NNP I-NP O
97 , , O O
97 the DT B-NP O
97 patient NN I-NP O
97 was VBD B-VP O
97 tolerating VBG O O
97 a DT O O
97 regular JJ O O
97 diet JJ O O
98 Although IN B-VP O
98 no DT B-NP O
98 clear JJ I-NP O
98 diagnosis NN I-NP O
98 could MD O O
98 be VB O O
98 made VBN O O
98 , , O O
98 the DT B-NP O
98 rapid JJ I-NP O
98 resolution NN I-NP O
99 of IN B-VP O
99 the DT B-NP O
99 patient's JJ I-NP O
99 abdominal JJ I-NP O
99 pain NN I-NP O
99 was VBD B-VP O
99 thought VBN O O
99 to TO O O
99 be VB O O
99 most RBS O O
99 consistent JJ O O
100 with IN B-VP O
100 viral JJ B-NP O
100 enteritis NN I-NP O
100 Given NNP I-NP O
100 the DT B-NP O
100 patient's JJ I-NP O
100 history NN I-NP O
100 of IN B-VP O
101 atherosclerosis NN B-NP O
101 , , O O
101 further JJ B-NP O
101 imaging NN I-NP O
101 of IN B-VP O
101 the DT B-NP O
101 abdominal JJ I-NP O
101 vessels NNS I-NP O
101 by IN B-VP O
101 MRA NNP B-NP O
102 during IN B-VP O
102 followup NN B-NP O
102 was VBD B-VP O
102 recommended VBN O O
102 by IN B-VP O
102 the DT B-NP O
102 GI NNP I-NP O
102 Service NNP I-NP O
103 2 CD O O
103 Pneumonia: NNP B-NP O
103 Bilateral NNP I-NP O
103 infiltrates VBZ O O
103 consistent JJ O O
103 with IN B-VP O
103 aspiration NN B-NP B-r
103 aspiration NN I-NP B-r
103 aspiration NN I-NP B-r
103 aspiration NN I-NP B-r
103 aspiration NN I-NP B-r
104 pneumonia IN B-VP O
104 The DT B-NP O
104 patient NN I-NP O
104 was VBD B-VP O
104 initially RB O O
104 treated VBN O O
104 empirically RB O O
104 with IN B-VP O
105 ceftriaxone NN B-NP B-m
105 , , O O
105 azithromycin NN B-NP B-m
105 and CC O O
105 Flagyl NNP B-NP B-m
105 IV NNP I-NP B-mo
105 , , O O
105 which WDT O O
105 was VBD B-VP O
105 switched VBN O O
105 to TO O O
106 cefpodoxime VB O B-m
106 plus CC O O
106 Flagyl NNP B-NP B-m
106 p.o NN I-NP B-mo
106 on IN B-VP O
106 hospital JJ B-NP O
106 day NN I-NP O
106 #2 VBD B-VP O
106 The DT B-NP O
106 patient NN I-NP O
107 became VBD B-VP O
107 febrile JJ B-NP B-r
107 febrile NN I-NP B-r
107 on IN B-VP O
107 HD#4 NNP B-NP O
107 ( ( O O
107 11/22/07 CD O O
107 ) ) O O
107 up RB O O
107 to TO O O
107 101.9 CD O O
107 and CC O O
107 as IN B-VP O
107 such JJ O O
107 was VBD B-VP O
107 switched VBN O O
108 back RB O O
108 to TO O O
108 ceftriaxone NN B-NP B-m
108 , , O O
108 Flagyl NNP B-NP B-m
108 and CC O O
108 azithromycin VB O B-m
108 IV NNP B-NP B-mo
108 after IN B-VP O
109 which WDT O O
109 the DT B-NP O
109 patient NN I-NP O
109 remained VBD B-VP O
109 afebrile JJ O O
109 throughout IN B-VP O
109 the DT B-NP O
109 remainder NN I-NP O
109 of IN B-VP O
110 her PRP$ O O
110 admission NN B-NP O
110 The DT B-NP O
110 patient NN I-NP O
110 was VBD B-VP O
110 discharged VBN O O
110 on IN B-VP O
110 2/11/07 CD O O
110 with IN B-VP O
111 instructions NNS B-NP O
111 to TO O O
111 complete VB O O
111 an DT O B-du
111 an DT O B-du
111 an DT O B-du
111 additional JJ O I-du
111 additional JJ O I-du
111 additional JJ O I-du
111 six CD O I-du
111 six CD O I-du
111 six CD O I-du
111 days NNS B-NP I-du
111 days NNS I-NP I-du
111 days NNS I-NP I-du
111 of IN B-VP O
111 cefpodoxime NN B-NP B-m
111 , , O O
112 Flagyl NNP B-NP B-m
112 and CC O O
112 azithromycin JJ B-NP B-m
112 p.o NN I-NP B-mo
112 p.o NN I-NP B-mo
112 for IN B-VP O
112 a DT B-NP O
112 total NN I-NP O
112 of IN B-VP O
112 14 CD O O
112 days NNS B-NP O
112 of IN B-VP O
112 antibiotic JJ B-NP O
113 therapy NN I-NP O
113 The DT B-NP O
113 patient NN I-NP O
113 was VBD B-VP O
113 also RB O O
113 given VBN O O
113 lactobacillus CC O B-m
113 as IN B-VP O
113 a DT B-NP B-r
113 probiotic JJ I-NP O
114 agent NN I-NP O
115 3 CD O O
115 Hypoxemia: NNP B-NP O
115 The DT B-NP O
115 patient NN I-NP O
115 was VBD B-VP O
115 noted VBN O O
115 in IN B-VP O
115 the DT B-NP O
115 ED NNP I-NP O
115 to TO O O
115 have VB O O
115 a DT B-NP O
115 mild JJ I-NP O
116 oxygen NN I-NP O
116 requirement NN I-NP O
116 with IN B-VP O
116 an DT B-NP O
116 oxygen NN I-NP O
116 saturation NN I-NP O
116 of IN B-VP O
116 92% CD O O
116 on IN B-VP O
116 room NN B-NP O
116 air NN I-NP O
116 , , O O
117 which WDT O O
117 improved VBD B-VP O
117 to TO O O
117 97% CD O O
117 on IN B-VP O
117 2 CD O O
117 L NNP B-NP O
117 nasal NN I-NP O
117 cannula VBZ O O
117 The DT B-NP O
117 differential JJ I-NP O
118 diagnosis NN I-NP O
118 for IN B-VP O
118 the DT B-NP O
118 patient's NN I-NP O
118 hypoxemia NN I-NP O
118 included VBD B-VP O
118 pulmonary JJ B-NP O
118 edema NN I-NP O
119 ( ( O O
119 seen VBN O O
119 on IN B-VP O
119 chest JJS B-NP O
119 x-ray NN I-NP O
119 ) ) O O
119 and CC O O
119 pneumonia VBZ O B-r
119 The DT B-NP O
119 patient NN I-NP O
119 was VBD B-VP O
119 given VBN O O
119 40 CD O B-do
119 mg JJ B-NP I-do
120 IV NNP I-NP B-mo
120 Lasix NNP I-NP B-m
120 in IN B-VP O
120 the DT B-NP O
120 Emergency NNP I-NP O
120 Department NNP I-NP O
120 and CC O O
120 was VBD B-VP O
120 treated VBN O O
120 for IN B-VP O
121 pneumonia NN B-NP O
121 as IN B-VP O
121 above IN B-VP O
121 On IN B-VP O
121 Hospital NNP B-NP O
121 day NN I-NP O
121 #2 NNP I-NP O
121 , , O O
121 the DT B-NP O
121 patient's NN I-NP O
121 at IN B-VP O
121 rest NN B-NP O
122 room NN I-NP O
122 air NN I-NP O
122 oxygen IN B-VP O
122 saturation NN B-NP O
122 was VBD B-VP O
122 noted VBN O O
122 to TO O O
122 be VB O O
122 95-97% JJ O O
122 , , O O
122 but CC O O
122 decreased VBD B-VP O
123 to TO O O
123 85% CD O O
123 with IN B-VP O
123 ambulation NN B-NP O
123 on IN B-VP O
123 room NN B-NP O
123 air NN I-NP O
123 The DT B-NP O
123 patient NN I-NP O
123 was VBD B-VP O
123 still RB O O
124 thought VBN O O
124 to TO O O
124 be VB O O
124 mildly RB O O
124 hypervolemic JJ O O
124 and CC O O
124 was VBD B-VP O
124 gently RB O O
124 diuresed VBN O O
124 On IN B-VP O
125 the DT B-NP O
125 day NN I-NP O
125 of IN B-VP O
125 discharge NN B-NP O
125 , , O O
125 the DT B-NP O
125 patient NN I-NP O
125 was VBD B-VP O
125 noted VBN O O
125 to TO O O
125 have VB O O
125 a DT B-NP O
125 room NN I-NP O
125 air NN I-NP O
126 saturation NN I-NP O
126 of IN B-VP O
126 100% CD O O
126 at IN B-VP O
126 rest NN B-NP O
126 and CC O O
126 95% CD O O
126 with IN B-VP O
126 ambulation NN B-NP O
126 The DT B-NP O
126 patient NN I-NP O
127 was VBD B-VP O
127 instructed VBN O O
127 to TO O O
127 continue VB O O
127 gentle JJ B-NP O
127 oral JJ I-NP O
127 diuresis NN I-NP O
127 at IN B-VP O
127 home NN B-NP O
127 and CC O O
127 VNA NNP B-NP O
128 services NNS I-NP O
128 were VBD B-VP O
128 arranged VBN O O
128 to TO O O
128 monitor VB O O
128 her PRP$ O O
128 oxygen NN B-NP O
128 saturations NNS I-NP O
128 and CC O O
128 daily JJ B-NP O
128 weight NN I-NP O
129 4 CD O O
129 Anemia: NNP B-NP O
129 History NNP I-NP O
129 of IN B-VP O
129 GI NNP B-NP O
129 bleeding NN I-NP O
129 , , O O
129 chronic JJ B-NP O
129 renal JJ I-NP O
129 insufficiency NN I-NP O
130 The DT B-NP O
130 patient's NN I-NP O
130 hematocrit NN I-NP O
130 was VBD B-VP O
130 stable JJ O O
130 at IN B-VP O
130 baseline JJ O O
130 33-36 JJ O O
130 throughout IN B-VP O
131 her PRP$ O O
131 hospital JJ B-NP O
131 admission NN I-NP O
131 The DT B-NP O
131 patient NN I-NP O
131 was VBD B-VP O
131 guaiac JJ O O
131 negative JJ O O
131 on IN B-VP O
132 admission NN B-NP O
132 An DT B-NP O
132 active JJ I-NP O
132 type NN I-NP O
132 and CC O O
132 screen NN B-NP O
132 was VBD B-VP O
132 maintained VBN O O
132 throughout IN B-VP O
133 admission NN B-NP O
133 No NNP I-NP O
133 evidence NN I-NP O
133 of IN B-VP O
133 GI NNP B-NP O
133 bleeding VBG O O
133 throughout IN B-VP O
134 hospitalization NN B-NP O
134 The DT B-NP O
134 patient's NN I-NP O
134 hematocrit NN I-NP O
134 was VBD B-VP O
134 37.7 CD O O
134 on IN B-VP O
134 admission NN B-NP O
135 and CC O O
135 33.5 CD O O
135 at IN B-VP O
135 discharge NN B-NP O
135 The DT B-NP O
135 patient NN I-NP O
135 was VBD B-VP O
135 given VBN O O
135 her PRP$ O O
135 weekly JJ B-NP B-f
135 Procrit NN I-NP B-m
136 5000 CD O B-do
136 units NNS B-NP I-do
136 subcutaneous JJ B-NP B-mo
136 injection NN I-NP I-mo
136 on IN B-VP O
136 2/11/07 CD O O
136 prior JJ O O
136 to TO O O
136 discharge VB O O
137 The DT B-NP O
137 patient NN I-NP O
137 was VBD B-VP O
137 instructed VBN O O
137 to TO O O
137 resume VB O O
137 iron NN B-NP B-m
137 supplementation NN I-NP I-m
137 after IN B-VP O
138 discharge NN B-NP O
139 5 CD O O
139 CHF: NNP B-NP O
139 The DT B-NP O
139 patient's NN I-NP O
139 admission NN I-NP O
139 chest JJS B-NP O
139 x-ray NN I-NP O
139 was VBD B-VP O
139 suggestive JJ O O
139 of IN B-VP O
140 pulmonary JJ B-NP O
140 edema NN I-NP O
140 , , O O
140 possibly RB O O
140 secondary JJ O O
140 to TO O O
140 elevated VB O O
140 blood NN B-NP O
140 pressure NN I-NP O
140 in IN B-VP O
141 the DT B-NP O
141 setting NN I-NP O
141 of IN B-VP O
141 abdominal JJ B-NP O
141 pain NN I-NP O
141 versus NN I-NP O
141 insufficient JJ B-NP O
141 diuresis NN I-NP O
141 at IN B-VP O
142 home NN B-NP O
142 There EX O O
142 was VBD B-VP O
142 no DT B-NP O
142 evidence NN I-NP O
142 of IN B-VP O
142 acute JJ B-NP O
142 ischemia NN I-NP O
142 on IN B-VP O
142 EKG NNP B-NP O
142 The DT B-NP O
143 patient NN I-NP O
143 was VBD B-VP O
143 gently RB O O
143 diuresed VBN O O
143 during IN B-VP O
143 her PRP$ O O
143 admission NN B-NP O
143 The DT B-NP O
143 patient's NN I-NP O
144 dry JJ B-NP O
144 weight NN I-NP O
144 is VBZ O O
144 57 CD O O
144 kg NN B-NP O
144 The DT B-NP O
144 patient's NN I-NP O
144 weight NN I-NP O
144 at IN B-VP O
144 discharge NN B-NP O
144 was VBD B-VP O
144 61 CD O O
145 kg JJ B-NP O
145 Repeat NNP I-NP O
145 chest JJS B-NP O
145 x-ray NN I-NP O
145 on IN B-VP O
145 the DT B-NP O
145 morning NN I-NP O
145 of IN B-VP O
145 discharge NN B-NP O
145 still RB O O
145 showed VBD B-VP O
146 evidence NN B-NP O
146 of IN B-VP O
146 pulmonary JJ B-NP O
146 congestion NN I-NP O
146 and CC O O
146 interstitial JJ B-NP O
146 edema NN I-NP O
146 As IN B-VP O
147 such JJ O O
147 , , O O
147 the DT B-NP O
147 patient NN I-NP O
147 was VBD B-VP O
147 thought VBN O O
147 to TO O O
147 be VB O O
147 still RB O O
147 mildly RB O O
147 hypervolemic JJ O O
147 at IN B-VP O
148 the DT B-NP O
148 time NN I-NP O
148 of IN B-VP O
148 her PRP$ O O
148 discharge NN B-NP O
148 and CC O O
148 was VBD B-VP O
148 instructed VBN O O
148 to TO O O
148 continue VB O O
148 gentle JJ B-NP B-r
148 gentle JJ I-NP B-r
148 gentle JJ I-NP B-r
149 diuresis NN I-NP O
149 at IN B-VP O
149 home NN B-NP O
149 The DT B-NP O
149 patient NN I-NP O
149 was VBD B-VP O
149 discharged VBN O O
149 on IN B-VP O
149 Lasix NNP B-NP B-m
149 Lasix NNP I-NP B-m
149 Lasix NNP I-NP B-m
149 80 CD O B-do
149 mg NN B-NP I-do
149 p.o NN I-NP B-mo
150 twice RB O B-f
150 daily RB O I-f
150 , , O O
150 which WDT O O
150 is VBZ O O
150 a DT B-NP O
150 slight JJ I-NP O
150 increase NN I-NP O
150 from IN B-VP O
150 her PRP$ O O
150 home NN B-NP O
150 dose NN I-NP O
150 of IN B-VP O
150 80 CD O B-do
151 mg NNS B-NP O
151 q.a.m RB O B-f
151 and CC O O
151 40 CD O B-do
151 mg NN B-NP I-do
151 q.p.m VBD B-VP B-f
151 The DT B-NP O
151 patient NN I-NP O
151 was VBD B-VP O
151 instructed VBN O O
151 to TO O O
151 measure VB O O
152 her PRP$ O O
152 weights NNS B-NP O
152 daily RB O O
152 and CC O O
152 to TO O O
152 follow VB O O
152 up RP O O
152 with IN B-VP O
152 her PRP$ O O
152 cardiologist NN B-NP O
152 , , O O
152 Dr NNP B-NP O
153 Michele NNP I-NP O
153 , , O O
153 for IN B-VP O
153 further JJ B-NP O
153 titration NN I-NP O
153 of IN B-VP O
153 her PRP$ O O
153 diuretic JJ B-NP O
153 dose NN I-NP O
154 6 CD O O
154 Hypertension: NNP B-NP O
154 The DT B-NP O
154 patient's NN I-NP O
154 blood NN I-NP O
154 pressure NN I-NP O
154 was VBD B-VP O
154 elevated VBN O O
154 in IN B-VP O
155 the DT B-NP O
155 ED NNP I-NP O
155 up RB O O
155 to TO O O
155 183/65 CD O O
155 in IN B-VP O
155 the DT B-NP O
155 setting NN I-NP O
155 of IN B-VP O
155 abdominal JJ B-NP O
155 pain NN I-NP O
155 and CC O O
155 improved VBN O O
156 over IN B-VP O
156 several JJ B-NP O
156 hours NNS I-NP O
156 to TO O O
156 the DT B-NP O
156 110-120s/60s-70s NNS I-NP O
156 On IN B-VP O
156 hospital JJ B-NP O
156 day NN I-NP O
156 #2 NNP I-NP O
156 , , O O
157 the DT O B-r
157 the DT B-NP B-r
157 patient's NN I-NP I-r
157 patient's NN I-NP I-r
157 blood NN I-NP I-r
157 blood NN I-NP I-r
157 pressure NN I-NP I-r
157 pressure NN I-NP I-r
157 was VBD B-VP O
157 noted VBN O O
157 to TO O O
157 be VB O O
157 slightly RB O O
157 elevated VBN O O
158 from IN B-VP O
158 130s-150s/70s JJ O O
158 As IN B-VP O
158 such JJ O O
158 , , O O
158 the DT B-NP O
158 patient's NN I-NP O
158 valsartan NN I-NP B-m
158 and CC O O
158 Norvasc NNP B-NP B-m
159 were VBD B-VP O
159 restarted VBN O O
159 on IN B-VP O
159 hospital JJ B-NP O
159 day NN I-NP O
159 #2 VBD B-VP O
159 The DT B-NP O
159 patient's NN I-NP O
159 Imdur NNP I-NP B-m
159 was VBD B-VP O
160 restarted VBN O O
160 on IN B-VP O
160 hospital JJ B-NP O
160 day NN I-NP O
160 #4 VBD B-VP O
160 The DT B-NP O
160 patient's NN I-NP O
160 blood NN I-NP O
160 pressure NN I-NP O
161 remained VBD B-VP O
161 well RB O O
161 controlled VBN O O
161 during IN B-VP O
161 the DT B-NP O
161 remainder NN I-NP O
161 of IN B-VP O
161 her PRP$ O O
161 admission NN B-NP O
162 ranging VBG O O
162 from IN B-VP O
162 100-122/46-71 JJ O O
162 on IN B-VP O
162 her PRP$ O O
162 home NN B-NP B-m
162 regimen NNS I-NP I-m
163 7 CD O O
163 Atrial NNP B-NP O
163 fibrillation: NN I-NP O
163 With IN B-VP O
163 pseudoregularization NN B-NP O
163 The DT B-NP O
164 patient's NN I-NP O
164 rate NN I-NP O
164 was VBD B-VP O
164 noted VBN O O
164 to TO O O
164 be VB O O
164 well RB O O
164 controlled VBN O O
164 The DT B-NP O
164 patient's NN I-NP O
165 Coumadin NNP I-NP B-m
165 was VBD B-VP O
165 held VBN O O
165 in IN B-VP O
165 the DT B-NP O
165 setting NN I-NP O
165 of IN B-VP O
165 a DT B-NP O
165 supratherapeutic JJ I-NP O
165 INR NNP I-NP O
165 likely RB O O
166 secondary JJ O O
166 to TO O O
166 concurrent VB O O
166 antibiotic JJ B-NP B-m
166 use NN I-NP O
166 The DT B-NP O
167 patient's NN I-NP O
167 INR NNP I-NP O
167 trended VBD B-VP O
167 down RB O O
167 to TO O O
167 2.1 CD O O
167 on IN B-VP O
167 hospital JJ B-NP O
167 day NN I-NP O
167 #4 NN I-NP O
167 and CC O O
167 she PRP O O
167 was VBD B-VP O
168 restarted VBN O O
168 on IN B-VP O
168 a DT O B-do
168 reduced VBN O I-do
168 dose NN B-NP I-do
168 of IN B-VP O
168 Coumadin NNP B-NP B-m
168 The DT B-NP O
168 patient's NN I-NP O
168 INR NNP I-NP O
168 was VBD B-VP O
169 2.7 CD O O
169 on IN B-VP O
169 the DT B-NP O
169 a.m NN I-NP O
169 of IN B-VP O
169 discharge NN B-NP O
169 on IN B-VP O
169 Coumadin NNP B-NP B-m
169 1 CD O B-do
169 mg NNS B-NP I-do
169 nightly RB O B-f
169 while IN B-VP B-du
169 still RB O O
170 on IN B-VP O
170 antibiotics NNS B-NP B-m
170 as IN B-VP O
170 above IN B-VP O
170 VNA NNP B-NP O
170 Services NNPS I-NP O
170 were VBD B-VP O
170 arranged VBN O O
170 to TO O O
170 measure VB O O
171 her PRP$ O O
171 INR NNP B-NP O
171 on IN B-VP O
171 3/14/07 CD O O
171 and CC O O
171 to TO O O
171 send VB O O
171 the DT B-NP O
171 results NNS I-NP O
171 to TO O O
171 the DT B-NP O
171 WSMH NNP I-NP O
171 Coumadin NNP I-NP O
171 Clinic NNP I-NP O
171 , , O O
172 300-135-5841 JJ O O
173 7 CD O O
173 Chronic NNP B-NP O
173 renal JJ B-NP O
173 insufficiency: NN I-NP O
173 The DT B-NP O
173 patient's NN I-NP O
173 creatinine NN I-NP O
173 was VBD B-VP O
174 noted VBN O O
174 to TO O O
174 be VB O O
174 at IN B-VP O
174 baseline JJ O O
174 2.7 CD O O
174 on IN B-VP O
174 admission NN B-NP O
174 and CC O O
174 slightly RB O O
175 increased VBD B-VP O
175 creatinine NN B-NP O
175 to TO O O
175 3.2 CD O O
175 at IN B-VP O
175 the DT B-NP O
175 time NN I-NP O
175 of IN B-VP O
175 discharge NN B-NP O
175 In IN B-VP O
176 contrast NN B-NP O
176 , , O O
176 the DT B-NP O
176 patient's NN I-NP O
176 BUN NNP I-NP O
176 was VBD B-VP O
176 83 CD O O
176 at IN B-VP O
176 discharge NN B-NP O
176 , , O O
176 down RB O O
176 from IN B-VP O
176 111 CD O O
176 on IN B-VP O
177 admission NN B-NP O
177 The DT B-NP O
177 patient NN I-NP O
177 did VBD B-VP O
177 not RB O O
177 show VB O O
177 evidence NN B-NP O
177 of IN B-VP O
177 contraction NN B-NP O
178 alkalosis NN I-NP O
178 with IN B-VP O
178 bicarbonate=22 NN B-NP O
178 on IN B-VP O
178 a.m NN B-NP O
178 of IN B-VP O
178 discharge NN B-NP O
178 The DT B-NP O
179 patient's NN I-NP O
179 BUN NNP I-NP O
179 , , O O
179 creatinine NN B-NP O
179 and CC O O
179 bicarbonate NN B-NP O
179 were VBD B-VP O
179 to TO O O
179 be VB O O
179 rechecked VBN O O
179 on IN B-VP O
180 3/14/07 CD O O
180 with IN B-VP O
180 the DT B-NP O
180 results NNS I-NP O
180 sent VBD B-VP O
180 to TO O O
180 Dr NNP B-NP O
180 Banana NNP I-NP O
180 ( ( O O
180 Cardiology NNP B-NP O
180 ) ) O O
180 and CC O O
181 Dr NNP B-NP O
181 Bechman NNP I-NP O
181 ( ( O O
181 nephrology NN B-NP O
181 ) ) O O
181 for IN B-VP O
181 further JJ B-NP O
181 titration NN I-NP O
181 of IN B-VP O
181 her PRP$ O O
181 medications NNS B-NP O
182 as IN B-VP O
182 needed JJ O O
183 8 CD O O
183 Diabetes: NNP B-NP B-r
183 The DT B-NP O
183 patient NN I-NP O
183 was VBD B-VP O
183 initially RB O O
183 continued VBN O O
183 on IN B-VP O
183 home NN B-NP B-do
183 dose NN I-NP I-do
184 Lantus NNP I-NP B-m
184 and CC O O
184 sliding VBG O B-do
184 scale JJ B-NP I-do
184 insulin NN I-NP B-m
184 Standing VBG O O
184 NovoLog NNP B-NP B-m
184 insulin NN I-NP I-m
185 q.a.c NN I-NP B-f
185 was VBD B-VP O
185 reinitiated VBN O O
185 as IN B-VP O
185 the DT B-NP O
185 patient's NN I-NP O
185 p.o NN I-NP O
185 intake NN I-NP O
185 improved VBD B-VP O
186 The DT B-NP O
186 patient's NN I-NP O
186 Lantus NNP I-NP B-m
186 dose NN I-NP O
186 was VBD B-VP O
186 titrated VBN O B-do
186 up RP O I-do
186 to TO O O
186 improve VB O O
186 glucose JJ B-NP B-r
187 control NN I-NP O
187 during IN B-VP O
187 admission NN B-NP O
187 However RB O O
187 , , O O
187 the DT B-NP O
187 patient NN I-NP O
187 experienced VBD B-VP O
188 intermittent JJ B-NP O
188 hypoglycemia NN I-NP O
188 at IN B-VP O
188 increased JJ B-NP B-do
188 doses NNS I-NP I-do
188 of IN B-VP O
188 Lantus NNP B-NP B-m
188 Lantus NNP I-NP B-m
188 and CC O O
188 was VBD B-VP O
189 returned VBN O O
189 to TO O O
189 her PRP$ O O
189 home NN B-NP O
189 dose NN I-NP O
189 of IN B-VP O
189 8 CD O B-do
189 units NNS B-NP I-do
189 subcu RB O B-mo
189 nightly RB O B-f
189 At IN B-VP O
189 the DT B-NP O
189 time NN I-NP O
190 of IN B-VP O
190 discharge NN B-NP O
190 , , O O
190 the DT B-NP O
190 patient NN I-NP O
190 was VBD B-VP O
190 returned VBN O O
190 to TO O O
190 her PRP$ O O
190 home NN B-NP O
190 insulin NN I-NP B-m
191 regimen NNS I-NP O
191 of IN B-VP O
191 Lantus NNP B-NP B-m
191 8 CD O B-do
191 units NNS B-NP I-do
191 nightly RB O B-f
191 plus CC O O
191 NovoLog NNP B-NP B-m
191 NovoLog NNP I-NP B-m
191 NovoLog NNP I-NP B-m
191 4 CD O B-do
191 units NNS B-NP I-do
191 with IN B-VP B-f
192 breakfast NN B-NP O
192 , , O O
192 4 CD O B-do
192 units NNS B-NP I-do
192 with IN B-VP B-f
192 lunch NN B-NP I-f
192 and CC O O
192 5 CD O B-do
192 units NNS B-NP I-do
192 with IN B-VP B-f
192 dinner NN B-NP I-f
192 plus CC O O
193 sliding VBG O B-do
193 scale JJ B-NP I-do
193 insulin NN I-NP B-m
193 The DT B-NP O
193 patient NN I-NP O
193 was VBD B-VP O
193 instructed VBN O O
193 to TO O O
193 continue VB O O
193 to TO O O
194 monitor VB O O
194 her PRP$ O O
194 blood NN B-NP O
194 glucose NN I-NP O
194 with IN B-VP O
194 meals NNS B-NP O
195 PROPHYLAXIS: NNP I-NP O
195 TEDs/Coumadin NNP I-NP B-m
195 , , O O
195 PPI NNP B-NP B-m
196 CODE NNP I-NP O
196 STATUS: NNP I-NP O
196 Full NNP I-NP O
196 code NN I-NP O
197 CONTACT: NNP I-NP O
197 Florencio NNP I-NP O
197 Kisto NNP I-NP O
197 , , O O
197 daughter/healthcare NN B-NP O
197 proxy NN I-NP O
197 , , O O
197 cell NN B-NP O
198 618-098-0834 CD O O
198 , , O O
198 home NN B-NP O
198 649-549-0700 JJ B-NP O
199 DISCHARGE NNP I-NP O
199 PHYSICAL NNP I-NP O
199 EXAMINATION: NNP I-NP O
199 Vital NNP I-NP O
199 signs: NN I-NP O
199 Afebrile NNP I-NP O
199 , , O O
199 heart NN B-NP O
200 rate NN I-NP O
200 65 CD O O
200 , , O O
200 blood NN B-NP O
200 pressure NN I-NP O
200 122/46 CD O O
200 , , O O
200 oxygen NN B-NP O
200 saturation NN I-NP O
200 96% CD O O
200 room NN B-NP O
200 air NN I-NP O
201 General: NNP I-NP O
201 Breathing NNP I-NP O
201 comfortably RB O O
201 on IN B-VP O
201 room NN B-NP O
201 air NN I-NP O
201 in IN B-VP O
201 no DT B-NP O
201 acute NN I-NP O
201 distress NN I-NP O
202 Chest: NNP I-NP O
202 Bilateral NNP I-NP O
202 BASILAR NNP I-NP O
202 Rales NNP I-NP O
202 right RB O O
202 greater JJR O O
202 than IN B-VP O
202 left VBD B-VP O
202 Heart: NNP B-NP O
203 Regular NNP I-NP O
203 rate NN I-NP O
203 and CC O O
203 rhythm NN B-NP O
203 , , O O
203 3/6 CD O O
203 mid NN B-NP O
203 peaking VBG O O
203 murmur NN B-NP O
203 at IN B-VP O
203 left JJ B-NP O
203 upper JJ I-NP O
204 sternal JJ I-NP O
204 border NN I-NP O
204 heard NN I-NP O
204 throughout IN B-VP O
204 , , O O
204 external JJ B-NP O
204 jugular NN I-NP O
204 venous JJ B-NP O
205 distention NN I-NP O
205 Abdomen: NNP I-NP O
205 Soft NNP I-NP O
205 , , O O
205 nontender NN B-NP O
205 and CC O O
205 nondistended VBD B-VP O
206 Positive NNP B-NP O
206 bowel NN I-NP O
206 sounds VBZ O O
206 Extremities: NNP B-NP O
206 Trace NNP I-NP O
206 bilateral JJ B-NP O
206 pedal NN I-NP O
207 edema NN I-NP O
207 , , O O
207 positive JJ B-NP O
207 pigmentation NN I-NP O
207 changes NNS I-NP O
207 of IN B-VP O
207 shins NNS B-NP O
207 consistent JJ O O
207 with IN B-VP O
208 venous JJ B-NP O
208 stasis NN I-NP O
209 DISCHARGE NNP I-NP O
209 MEDICATIONS: NNP I-NP O
210 1 CD O O
210 Norvasc NNP B-NP B-m
210 5 CD O B-do
210 mg NN B-NP I-do
210 p.o NN I-NP B-mo
210 q.a.m VBD B-VP B-f
211 2 CD O O
211 Norvasc NNP B-NP B-m
211 2.5 CD O B-do
211 mg NN B-NP I-do
211 q.p.m NN I-NP B-f
212 3 CD O O
212 Azithromycin NNP B-NP B-m
212 250 CD O B-do
212 mg NN B-NP I-do
212 p.o JJ B-NP B-mo
212 daily JJ I-NP B-f
212 x6 NN I-NP B-du
212 doses VBZ O I-du
213 4 CD O O
213 Caltrate NNP B-NP B-m
213 600 CD O I-m
213 plus CC O I-m
213 D NNP B-NP I-m
213 one CD O B-do
213 tablet NN B-NP I-do
213 p.o VB O B-mo
213 twice RB O B-f
213 daily RB O I-f
214 5 CD O O
214 Cefpodoxime NNP B-NP B-m
214 200 CD O B-do
214 mg NN B-NP I-do
214 p.o JJ B-NP B-mo
214 daily JJ I-NP B-f
214 x6 NN I-NP B-du
214 doses VBZ O I-du
215 6 CD O O
215 Colace NNP B-NP B-m
215 100 CD O B-do
215 mg NN B-NP I-do
215 p.o NN I-NP B-mo
215 twice RB O B-f
215 daily RB O I-f
215 as IN B-VP I-f
215 needed VBN O I-f
215 , , O O
215 constipation NN B-NP B-r
216 7 CD O O
216 Procrit NNP B-NP B-m
216 5000 CD O B-do
216 units NNS B-NP I-do
216 subcutaneous JJ B-NP B-mo
216 q JJ I-NP B-f
216 week NN I-NP I-f
217 8 CD O O
217 Nexium NN B-NP B-m
217 40 CD O B-do
217 mg NN B-NP I-do
217 p.o JJ O B-mo
217 daily JJ O B-f
218 9 CD O O
218 Ferrous JJ B-NP B-m
218 sulfate NN I-NP I-m
218 325 CD O B-do
218 mg NN B-NP I-do
218 p.o NN I-NP B-mo
218 b.i.d VBD B-VP B-f
219 10 CD O O
219 Lasix NNP B-NP B-m
219 80 CD O B-do
219 mg NN B-NP I-do
219 twice RB O B-f
219 daily RB O I-f
220 11 CD O O
220 NovoLog NNP B-NP B-m
220 sliding VBG O B-do
220 scale JJ O I-do
220 subcutaneous JJ O B-mo
220 with IN B-VP B-f
220 meals NNS B-NP I-f
221 12 CD O O
221 NovoLog NNP B-NP B-m
221 NovoLog NNP I-NP B-m
221 4 CD O B-do
221 units NNS B-NP I-do
221 subcutaneous JJ O B-mo
221 subcutaneous JJ O B-mo
221 with IN B-VP O
221 breakfast NN B-NP O
221 and CC O O
221 with IN B-VP O
221 lunch NN B-NP O
221 , , O O
222 5 CD O B-do
222 units NNS B-NP I-do
222 with IN B-VP B-f
222 dinner NN B-NP I-f
223 13 CD O O
223 Insulin NNP B-NP B-m
223 , , O O
223 glargine NN B-NP B-m
223 8 CD O B-do
223 units NNS B-NP I-do
223 subcutaneous JJ O B-mo
223 daily JJ O B-f
224 14 CD O O
224 Isosorbide NNP B-NP B-m
224 mononitrate NN I-NP I-m
224 30 CD O B-do
224 mg NN B-NP I-do
224 p.o NN I-NP B-mo
224 twice RB O B-f
224 daily RB O I-f
225 15 CD O O
225 Lactobacillus NNP B-NP B-m
225 two CD O B-do
225 tablets NNS B-NP I-do
225 p.o VBP O B-mo
225 three CD O B-f
225 times NNS B-NP I-f
225 daily JJ B-NP I-f
225 x25 NNP I-NP B-du
225 doses VBZ O I-du
226 16 CD O O
226 Flagyl NNP B-NP B-m
226 500 CD O B-do
226 mg NN B-NP I-do
226 p.o NN I-NP B-mo
226 q.8 NN I-NP B-f
226 h NN I-NP I-f
226 x19 NNP I-NP B-du
226 doses VBZ O I-du
227 17 CD O O
227 Senna NNP B-NP B-m
227 tablets NNS I-NP I-m
227 one CD O B-do
227 tablet NN B-NP I-do
227 p.o VB O B-mo
227 twice RB O B-f
227 daily RB O I-f
227 as IN B-VP I-f
227 needed VBN O I-f
227 for IN B-VP O
228 constipation NN B-NP B-r
229 18 CD O O
229 Sevelamer NNP B-NP B-m
229 400 CD O B-do
229 mg NN B-NP I-do
229 p.o NN I-NP B-mo
229 q.p.m VBD B-VP B-f
230 19 CD O O
230 Diovan NNP B-NP B-m
230 120 CD O B-do
230 mg NN B-NP I-do
230 p.o JJ O B-mo
230 daily JJ O B-f
231 20 CD O O
231 Coumadin NNP B-NP B-m
231 1 CD O B-do
231 mg NN B-NP I-do
231 p.o NN I-NP B-mo
231 q.p.m NN I-NP B-f
231 ( ( O O
231 levels NNS B-NP O
231 to TO O O
231 be VB O O
231 followed VBN O O
231 by IN B-VP O
231 the DT B-NP O
231 HCVMC NNP I-NP O
232 Coumadin NNP I-NP O
232 Clinic NNP I-NP O
232 ) ) O O
233 DISCHARGE NNP B-NP O
233 CONDITION: NNP I-NP O
233 Stable NNP I-NP O
234 eScription NN I-NP O
234 document: VBD B-VP O
234 6-7041125 JJ B-NP O
234 CSSten NNP I-NP O
234 Tel NNP I-NP O
235 Dictated NNP I-NP O
235 By: NNP I-NP O
235 MILANI NNP I-NP O
235 , , O O
235 HARLAND NNP B-NP O
236 Attending: NNP I-NP O
236 NALDER NNP I-NP O
236 , , O O
236 MATHEW NNP B-NP O
237 Dictation NNP I-NP O
237 ID NNP I-NP O
237 5063364 CD O O
238 D: NNP B-NP O
238 4/26/07 CD O O
239 T: NNP B-NP O
239 4/26/07 CD O O
240 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #505217 VBZ O O
2 275113133 CD O O
2 HNOH NNP B-NP O
2 67641761 CD O O
2 146738 CD O O
2 6/11/1995 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 5/16/1995 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/25/1995 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 RULE NNP I-NP O
4 OUT NNP I-NP O
4 MYOCARDIAL NNP I-NP O
4 INFARCTION NNP I-NP O
5 SECONDARY NNP I-NP O
5 DIAGNOSES: NNP I-NP O
5 1 CD O O
5 HISTORY NNP B-NP O
5 OF NNP I-NP O
5 NONINSULIN NNP I-NP O
5 DEPENDENT NNP I-NP O
6 DIABETES NNP I-NP O
7 2 CD O O
7 RIGHT NNP B-NP O
7 GREAT NNP I-NP O
7 TOE NNP I-NP O
7 ULCERATION NNP I-NP O
7 WITH NNP I-NP O
8 LYMPHANGITIS NNP I-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 The DT B-NP O
9 patient NN I-NP O
9 is VBZ O O
9 a DT O O
9 55 CD O O
9 year NN B-NP O
9 old JJ B-NP O
9 male NN I-NP O
9 with IN B-VP O
10 a DT B-NP O
10 history NN I-NP O
10 of IN B-VP O
10 noninsulin JJ B-NP O
10 dependent JJ I-NP O
11 diabetes NNS I-NP O
11 mellitus VBP O O
11 , , O O
11 a DT B-NP O
11 significant JJ I-NP O
11 heavy JJ I-NP O
11 smoking NN I-NP O
11 history NN I-NP O
11 , , O O
11 and CC O O
11 he PRP O O
11 has VBZ O O
12 a DT B-NP O
12 family NN I-NP O
12 history NN I-NP O
12 of IN B-VP O
12 cardiac JJ B-NP O
12 disease NN I-NP O
12 who WP O O
12 was VBD B-VP O
12 admitted VBN O O
12 with IN B-VP O
12 chest NN B-NP O
13 pain NN I-NP O
13 and CC O O
13 worsening VBG O O
13 right RB O O
13 great JJ B-NP O
13 toe JJ I-NP O
13 ulceration NN I-NP O
13 with IN B-VP O
13 lymphangitis NN B-NP O
14 In IN B-VP O
14 March NNP B-NP O
14 , , O O
14 Mr NNP B-NP O
14 Shroyer NNP I-NP O
14 stubbed VBD B-VP O
14 his PRP$ O O
14 right JJ B-NP O
14 great JJ I-NP O
14 toe NN I-NP O
14 and CC O O
15 subsequently RB O O
15 developed JJ B-NP O
15 ulceration NN I-NP O
15 He PRP O O
15 was VBD B-VP O
15 first RB O O
15 seen VBN O O
15 for IN B-VP O
15 this DT B-NP O
16 ulceration NN I-NP O
16 when WRB O O
16 it PRP O O
16 began VBD B-VP O
16 to TO O O
16 have VB O O
16 serosanguineous JJ B-NP O
16 fluid NN I-NP O
16 leakage NN I-NP O
17 Over IN B-VP O
17 the DT B-NP O
17 past JJ I-NP O
17 month NN I-NP O
17 he PRP O O
17 has VBZ O O
17 received VBN O O
17 several JJ B-NP O
17 debridements NNS I-NP O
17 and CC O O
18 completed VBD B-VP O
18 a DT B-NP B-du
18 course NN I-NP I-du
18 of IN B-VP O
18 Cipro NNP B-NP B-m
18 yesterday NN I-NP O
18 A NNP I-NP O
18 few JJ B-NP O
18 days NNS I-NP O
18 prior RB O O
18 to TO O O
19 admission VB O O
19 he PRP O O
19 began VBD B-VP O
19 to TO O O
19 have VB O O
19 left-sided JJ B-NP O
19 chest NN I-NP O
19 pressure NN I-NP O
19 on IN B-VP O
19 exertion NN B-NP O
20 with IN B-VP O
20 the DT B-NP O
20 pain NN I-NP O
20 resolving VBG O O
20 with IN B-VP O
20 rest NN B-NP O
20 The DT B-NP O
20 episode NN I-NP O
20 lasted VBD B-VP O
20 30 CD O O
20 seconds NNS B-NP O
21 to TO O O
21 two CD O O
21 minutes NNS B-NP O
21 and CC O O
21 were VBD B-VP O
21 accompanied VBN O O
21 by IN B-VP O
21 posterior JJ B-NP O
21 neck NN I-NP O
21 pain NN I-NP O
21 and CC O O
22 dizziness NN B-NP O
23 On IN B-VP O
23 the DT B-NP O
23 day NN I-NP O
23 of IN B-VP O
23 admission NN B-NP O
23 he PRP O O
23 developed VBD B-VP O
23 chills NNS B-NP O
23 with IN B-VP O
23 rigors NNS B-NP O
23 , , O O
23 nausea NN B-NP O
23 and CC O O
24 vomiting NN B-NP O
24 of IN B-VP O
24 food NN B-NP O
24 without IN B-VP O
24 blood NN B-NP O
24 He PRP O O
24 has VBZ O O
24 had VBN O O
24 2-3 JJ B-NP O
24 episodes NNS I-NP O
24 of IN B-VP O
24 soaking VBG O O
25 night NN B-NP O
25 sweats NNS I-NP O
25 in IN B-VP O
25 the DT O O
25 past JJ O O
25 two CD O O
25 weeks NNS B-NP O
25 For IN B-VP O
25 the DT O O
25 past JJ O O
25 two CD O O
25 days NNS B-NP O
25 he PRP O O
25 has VBZ O O
26 noted VBN O O
26 redness NN B-NP O
26 and CC O O
26 swelling NN B-NP O
26 of IN B-VP O
26 his PRP$ O O
26 right JJ B-NP O
26 foot NN I-NP O
26 The DT B-NP O
26 patient NN I-NP O
26 denies VBZ O O
27 shortness NN B-NP O
27 of IN B-VP O
27 breath NN B-NP O
27 , , O O
27 dyspnea NN B-NP O
27 on IN B-VP O
27 exertion NN B-NP O
27 , , O O
27 paroxysmal JJ B-NP O
27 nocturnal JJ I-NP O
28 dyspnea NN I-NP O
28 , , O O
28 palpitations NNS B-NP O
28 , , O O
28 weight JJ B-NP O
28 loss NN I-NP O
28 , , O O
28 abdominal JJ B-NP O
28 pain NN I-NP O
28 , , O O
28 diarrhea NN B-NP O
28 , , O O
29 melena NN B-NP O
29 , , O O
29 or CC O O
29 hematochezia VB O O
30 An DT B-NP O
30 exercise NN I-NP O
30 tolerance NN I-NP O
30 test NN I-NP O
30 in IN B-VP O
30 March NNP B-NP O
30 of IN B-VP O
30 1995 CD O O
30 , , O O
30 was VBD B-VP O
30 limited VBN O O
30 by IN B-VP O
30 back RB O O
31 pain NN B-NP O
31 , , O O
31 a DT B-NP O
31 blood NN I-NP O
31 pressure NN I-NP O
31 in IN B-VP O
31 the DT O O
31 220 CD O O
31 range NN B-NP O
31 , , O O
31 heart NN B-NP O
31 rate NN I-NP O
31 in IN B-VP O
31 150 CD O O
31 range NN B-NP O
31 , , O O
32 and CC O O
32 frequent JJ B-NP O
32 premature NN I-NP O
32 ventricular JJ B-NP O
32 beats NNS I-NP O
32 , , O O
32 but CC O O
32 was VBD B-VP O
32 felt VBN O O
32 to TO O O
32 be VB O O
33 negative JJ O O
33 for IN B-VP O
33 ischemia NN B-NP O
34 The DT B-NP O
34 patient NN I-NP O
34 was VBD B-VP O
34 seen VBN O O
34 at IN B-VP O
34 VRBCMH NNP B-NP O
34 on IN B-VP O
34 the DT B-NP O
34 day NN I-NP O
34 of IN B-VP O
34 admission NN B-NP O
34 and CC O O
34 was VBD B-VP O
34 given VBN O O
35 a DT B-NP B-du
35 dose NN I-NP I-du
35 of IN B-VP O
35 oxacillin NN B-NP B-m
35 and CC O O
35 sent VBD B-VP O
35 to TO O O
35 the DT O O
35 the DT B-NP O
35 Sidecrestso NNP I-NP O
35 Community NNP I-NP O
35 Hospital NNP I-NP O
36 for IN B-VP O
36 IV NNP B-NP B-mo
36 antibiotics NNS I-NP B-m
36 and CC O O
36 work-up JJ B-NP O
37 PAST NNP I-NP O
37 MEDICAL NNP I-NP O
37 HISTORY: NNP I-NP O
37 ( ( O O
37 1 CD O O
37 ) ) O O
37 Back NNP B-NP O
37 trauma NN I-NP O
37 with IN B-VP O
37 sciatica NN B-NP O
37 following VBG O O
37 back RB O O
38 surgery NN B-NP O
38 ( ( O O
38 2 CD O O
38 ) ) O O
38 Noninsulin NNP B-NP O
38 dependent NN I-NP O
38 diabetes NNS I-NP O
39 ( ( O O
39 3 CD O O
39 ) ) O O
39 Peripheral NNP B-NP O
39 neuropathy NN I-NP O
39 ( ( O O
39 4 CD O O
39 ) ) O O
39 Status NNP B-NP O
39 post NN I-NP O
39 colon NN I-NP O
39 carcinoma NN I-NP O
39 with IN B-VP O
40 resection NN B-NP O
40 in IN B-VP O
40 1981 CD O O
40 ( ( O O
40 5 CD O O
40 ) ) O O
40 Status NNP B-NP O
40 post NN I-NP O
40 appendectomy NN I-NP O
40 ( ( O O
40 6 CD O O
40 ) ) O O
40 Hearing NNP B-NP O
40 loss NN I-NP O
41 in IN B-VP O
41 his PRP$ O O
41 left JJ B-NP O
41 ear JJ I-NP O
42 MEDICATIONS NNP I-NP O
42 ON NNP I-NP O
42 ADMISSION: NNP I-NP O
42 Tylenol NNP I-NP B-m
42 #3 NNP I-NP I-m
42 and CC O O
42 glyburide RB O B-m
42 10 CD O B-do
42 mg NNS B-NP I-do
42 p.o JJ B-NP B-mo
42 q JJ I-NP B-f
43 day NN I-NP O
43 No NNP I-NP O
43 known VBN O O
43 drug NN B-NP O
43 allergies NNS I-NP O
44 SOCIAL NNP I-NP O
44 &amp; NNP I-NP O
44 FAMILY NNP I-NP O
44 HISTORY: NNP I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 has VBZ O O
44 a DT O O
44 40 CD O O
44 year NN B-NP O
44 history NN I-NP O
44 of IN B-VP O
45 smoking VBG O O
45 four CD O O
45 packs NNS B-NP O
45 per IN B-VP O
45 day NN B-NP O
45 , , O O
45 currently RB O O
46 smoking VBG O O
46 1-1/2 JJ B-NP O
46 packs NNS I-NP O
46 per IN B-VP O
46 day NN B-NP O
46 No NNP I-NP O
46 alcohol NN I-NP O
46 use NN I-NP O
46 No NNP I-NP O
46 IV NNP I-NP O
46 drugs NNS I-NP O
46 He PRP O O
46 is VBZ O O
47 a DT B-NP O
47 retired JJ I-NP O
47 shift NN I-NP O
47 chief NN I-NP O
47 for IN B-VP O
47 a DT B-NP O
47 local JJ I-NP O
47 prison NN I-NP O
47 on IN B-VP O
47 disability NN B-NP O
47 due JJ O O
47 to TO O O
47 back VB O O
48 pain NN B-NP O
48 The DT B-NP O
48 patient NN I-NP O
48 is VBZ O O
48 married JJ O O
48 and CC O O
48 lives VBZ O O
48 with IN B-VP O
48 his PRP$ O O
48 wife NN B-NP O
48 and CC O O
48 a DT O O
48 two CD O O
49 year NN B-NP O
49 old JJ B-NP O
49 son NN I-NP O
49 He PRP O O
49 is VBZ O O
49 active JJ O O
49 around IN B-VP O
49 the DT B-NP O
49 house NN I-NP O
49 and CC O O
49 does VBZ O O
49 seasonal JJ B-NP O
49 work NN I-NP O
50 with IN B-VP O
50 plant NN B-NP O
50 care NN I-NP O
50 He PRP O O
50 has VBZ O O
50 two CD O O
50 adult NN B-NP O
50 children NNS I-NP O
50 He PRP O O
50 has VBZ O O
50 a DT B-NP O
50 brother NN I-NP O
50 who WP O O
51 died VBD B-VP O
51 of IN B-VP O
51 a DT B-NP O
51 myocardial JJ I-NP O
51 infarction NN I-NP O
51 at IN B-VP O
51 the DT B-NP O
51 age NN I-NP O
51 of IN B-VP O
51 48 CD O O
51 A NNP B-NP O
51 cousin NN I-NP O
51 died VBD B-VP O
51 of IN B-VP O
52 a DT B-NP O
52 myocardial JJ I-NP O
52 infarction NN I-NP O
52 in IN B-VP O
52 his PRP$ O O
52 mid NN B-NP O
52 40s CD O O
52 A NNP B-NP O
52 sister NN I-NP O
52 died NN I-NP O
52 of IN B-VP O
52 breast NN B-NP O
53 cancer NN I-NP O
54 PHYSICAL NNP I-NP O
54 EXAMINATION: NNP I-NP O
54 Temperature NNP I-NP O
54 100.6 CD O O
54 , , O O
54 blood NN B-NP O
54 pressure NN I-NP O
54 130/80 CD O O
54 , , O O
55 and CC O O
55 pulse RB O O
55 68 CD O O
55 NECK: NNP B-NP O
55 No NNP I-NP O
55 jugular NN I-NP O
55 venous JJ B-NP O
56 distention NN I-NP O
56 , , O O
56 no DT B-NP O
56 bruits NNS I-NP O
56 , , O O
56 no DT B-NP O
56 masses NNS I-NP O
56 , , O O
56 no DT B-NP O
56 lymphadenopathy JJ I-NP O
56 LUNGS: NNP I-NP O
56 Clear NNP I-NP O
57 to TO O O
57 auscultation NN B-NP O
57 and CC O O
57 percussion NN B-NP O
57 CARDIAC: NNP I-NP O
57 Regular NNP I-NP O
57 rate NN I-NP O
57 and CC O O
57 rhythm NN B-NP O
58 Normal NNP I-NP O
58 S1 NNP I-NP O
58 and CC O O
58 S2 NNP B-NP O
58 A NNP I-NP O
58 1/6 CD O O
58 systolic JJ B-NP O
58 ejection NN I-NP O
58 murmur NN I-NP O
58 at IN B-VP O
58 the DT B-NP O
58 left NN I-NP O
58 lower RBR O O
59 sternal JJ B-NP O
59 base NN I-NP O
59 No NNP I-NP O
59 changes NNS I-NP O
59 with IN B-VP O
59 maneuvers NNS B-NP O
59 No DT B-NP O
59 radiation NN I-NP O
59 No RB O O
59 S3 NNP B-NP O
59 or CC O O
60 S4 NNP B-NP O
60 auscultated VBD B-VP O
60 ABDOMEN: NNP B-NP O
60 Benign NNP I-NP O
60 EXTREMITIES: NNP I-NP O
60 Trigger NNP I-NP O
60 finger NN I-NP O
60 of IN B-VP O
61 the DT O O
61 left JJ O O
61 fourth JJ O O
61 digit VB O O
61 A DT O O
61 1 CD O O
61 cm NN B-NP O
61 deep JJ B-NP O
61 ulcer NN I-NP O
61 with IN B-VP O
61 surrounding VBG O O
61 collar JJ O O
62 callous JJ O O
62 at IN B-VP O
62 the DT B-NP O
62 tip NN I-NP O
62 of IN B-VP O
62 the DT B-NP O
62 right JJ I-NP O
62 great JJ I-NP O
62 toe NN I-NP O
62 with IN B-VP O
62 erythema PDT O O
62 The DT B-NP O
62 ulcer JJ I-NP O
63 base NN I-NP O
63 is VBZ O O
63 red JJ O O
63 , , O O
63 nonpurulent JJ O O
63 , , O O
63 and CC O O
63 there EX O O
63 is VBZ O O
63 trace JJ B-NP O
63 edema NN I-NP O
63 NEURO: NNP I-NP O
63 Left VBD B-VP O
64 ear JJ O O
64 with IN B-VP O
64 decreased JJ B-NP O
64 hearing NN I-NP O
64 compared VBN O O
64 to TO O O
64 the DT B-NP O
64 right JJ I-NP O
64 Cranial NNP I-NP O
64 nerves NNS I-NP O
65 II-XII NNP I-NP O
65 otherwise RB O O
65 grossly RB O O
65 intact JJ O O
65 No DT B-NP O
65 sensation NN I-NP O
65 to TO O O
65 touch VB O O
65 below IN B-VP O
65 the DT B-NP O
66 knees NNS I-NP O
66 DTRs NNP I-NP O
66 are VBP O O
66 2+ CD O O
66 and CC O O
66 bilaterally RB O O
66 symmetric JJ O O
66 in IN B-VP O
66 the DT B-NP O
66 upper JJ I-NP O
67 extremities NNS I-NP O
67 DTRs NNP I-NP O
67 are VBP O O
67 zero CD O O
67 in IN B-VP O
67 the DT B-NP O
67 right NN I-NP O
67 and CC O O
67 left VBD B-VP O
67 lower JJR B-NP O
68 extremities NNS I-NP O
69 LABORATORY NNP I-NP O
69 DATA: NNP I-NP O
69 Sodium NNP I-NP O
69 135 CD O O
69 , , O O
69 potassium NN B-NP O
69 4.0 CD O O
69 , , O O
69 chloride RB O O
69 98 CD O O
69 , , O O
69 bicarb NN B-NP O
70 22 CD O O
70 , , O O
70 BUN NNP B-NP O
70 16 CD O O
70 , , O O
70 creatinine NN B-NP O
70 1.3 CD O O
70 , , O O
70 and CC O O
70 glucose VB O O
70 304 CD O O
71 White NNP B-NP O
71 count NN I-NP O
71 16.14 CD O O
71 , , O O
71 25 CD O O
71 bands NNS B-NP O
71 , , O O
71 68 CD O O
71 polys NN B-NP O
71 , , O O
71 and CC O O
71 2 CD O O
71 lymphs NN B-NP O
71 Hematocrit NNP I-NP O
72 43.2 CD O O
72 and CC O O
72 platelet NN B-NP O
72 count NN I-NP O
72 was VBD B-VP O
72 180 CD O O
72 CK NNP B-NP O
72 is VBZ O O
72 486 CD O O
72 , , O O
72 MB NNP B-NP O
72 5.1 CD O O
72 PT/PTT NNP B-NP O
72 11.6 CD O O
73 and CC O O
73 27.6 CD O O
73 INR NNP B-NP O
73 0.9 CD O O
74 Chest NNP B-NP O
74 x-ray NN I-NP O
74 was VBD B-VP O
74 within IN B-VP O
74 normal JJ B-NP O
74 limits NNS I-NP O
74 Right JJ B-NP O
74 foot NN I-NP O
74 x-ray NN I-NP O
74 shows NNS I-NP O
74 soft JJ B-NP O
75 tissue NN I-NP O
75 swelling VBG O O
75 in IN B-VP O
75 the DT B-NP O
75 first JJ I-NP O
75 toe NN I-NP O
75 No NNP I-NP O
75 bony NN I-NP O
75 changes NNS I-NP O
75 EKG NNP I-NP O
75 on IN B-VP O
76 admission NN B-NP O
76 showed VBD B-VP O
76 no DT B-NP O
76 ischemic JJ I-NP O
76 changes NNS I-NP O
77 HOSPITAL NNP I-NP O
77 COURSE: NNP I-NP O
77 The DT B-NP O
77 patient NN I-NP O
77 ruled VBD B-VP O
77 out RP O O
77 for IN B-VP O
77 a DT B-NP O
77 myocardial JJ I-NP O
77 infarction NN I-NP O
78 and CC O O
78 was VBD B-VP O
78 treated VBN O O
78 for IN B-VP O
78 right RB O B-r
78 right JJ O B-r
78 right RB O B-r
78 toe NN B-NP I-r
78 toe NN I-NP I-r
78 toe NN I-NP I-r
78 cellulitis NN I-NP I-r
78 cellulitis NN I-NP I-r
78 cellulitis NN I-NP I-r
78 with IN B-VP O
78 IV NNP B-NP B-mo
78 IV NNP I-NP B-mo
78 IV NNP I-NP B-mo
79 antibiotics NNS I-NP B-m
79 of IN B-VP O
79 gentamicin NN B-NP B-m
79 and CC O O
79 Clindamycin NNP B-NP B-m
79 The DT B-NP O
79 patient NN I-NP O
79 was VBD B-VP O
79 also RB O O
80 placed VBN O O
80 on IN B-VP O
80 atenolol JJ B-NP B-m
80 atenolol NN I-NP B-m
80 with IN B-VP O
80 the DT B-NP O
80 dose NN I-NP O
80 increased VBD B-VP O
80 to TO O O
80 75 CD O B-do
80 mg NNS B-NP I-do
80 p.o JJ B-NP B-mo
80 q JJ I-NP B-f
80 day NN I-NP I-f
81 On IN B-VP O
81 discharge NN B-NP O
81 , , O O
81 the DT B-NP O
81 patient NN I-NP O
81 was VBD B-VP O
81 switched VBN O O
81 from IN B-VP O
81 Nitropaste NNP B-NP B-m
81 to TO O O
81 Isordil NNP B-NP B-m
82 10 CD O B-do
82 mg NN B-NP I-do
82 p.o NN I-NP B-mo
82 t.i.d IN B-VP B-f
82 The DT B-NP O
82 patient's NN I-NP O
82 glyburide NN I-NP B-m
82 glyburide NN I-NP B-m
82 was VBD B-VP O
82 also RB O O
82 increased VBN O O
82 to TO O O
83 20 CD O B-do
83 mg NNS B-NP I-do
83 p.o JJ B-NP B-mo
83 q JJ I-NP B-f
83 day NN I-NP I-f
84 The DT B-NP O
84 patient NN I-NP O
84 underwent NN I-NP O
84 MIBI NNP I-NP O
84 which WDT O O
84 showed VBD B-VP O
84 a DT O O
84 large JJ O O
84 fixed VBN O O
84 posterior JJ B-NP O
85 lesion NN I-NP O
85 with IN B-VP O
85 peri-infarct JJ B-NP O
85 ischemia NN I-NP O
85 The DT B-NP O
85 patient NN I-NP O
85 was VBD B-VP O
85 felt VBN O O
85 to TO O O
85 be VB O O
86 medically RB O O
86 stable JJ O O
86 and CC O O
86 capable JJ O O
86 of IN B-VP O
86 being VBG O O
86 managed VBN O O
86 as IN B-VP O
86 an DT B-NP O
86 outpatient NN I-NP O
86 He PRP O O
87 was VBD B-VP O
87 discharged VBN O O
87 to TO O O
87 home VB O O
87 on IN B-VP O
87 2/5/95 CD O O
88 MEDICATIONS: NNP B-NP O
88 On IN B-VP O
88 discharge NN B-NP O
88 included VBD B-VP O
88 atenolol NN B-NP B-m
88 , , O O
88 75 CD O B-do
88 mg NN B-NP I-do
88 po NN I-NP B-mo
88 q JJ B-NP B-f
88 day NN I-NP I-f
88 , , O O
89 aspirin NN B-NP B-m
89 , , O O
89 325 CD O B-do
89 mg NN B-NP I-do
89 po NN I-NP B-mo
89 q JJ B-NP B-f
89 day NN I-NP I-f
89 , , O O
89 Glyburide NNP B-NP B-m
89 , , O O
89 20 CD O B-do
89 mg NN B-NP I-do
89 po NN I-NP B-mo
89 q JJ B-NP B-f
89 day NN I-NP I-f
89 , , O O
89 Tylenol NNP B-NP B-m
89 #3 NNP I-NP I-m
89 , , O O
90 two CD O B-do
90 tablets NNS B-NP I-do
90 po VBP O B-mo
90 x JJ O B-f
90 one CD O I-f
90 p.r.n NN B-NP I-f
90 for IN B-VP O
90 pain NN B-NP O
90 , , O O
90 sublingual JJ B-NP B-mo
90 nitroglycerin NN I-NP B-m
90 , , O O
91 p.r.n VBP O B-f
92 The DT B-NP O
92 patient NN I-NP O
92 is VBZ O O
92 to TO O O
92 follow-up JJ O O
92 with IN B-VP O
92 Dr NNP B-NP O
92 Netti NNP I-NP O
92 as IN B-VP O
92 an DT B-NP O
92 outpatient NN I-NP O
92 and CC O O
93 with IN B-VP O
93 Dr NNP B-NP O
93 Frasso NNP I-NP O
93 of IN B-VP O
93 AMH NNP B-NP O
93 Cardiology NNP I-NP O
94 DISPOSITION: NNP I-NP O
94 The DT B-NP O
94 patient NN I-NP O
94 was VBD B-VP O
94 discharged VBN O O
94 to TO O O
94 home NN B-NP O
95 Dictated NNP I-NP O
95 By: NNP I-NP O
95 EDWARDO NNP I-NP O
95 J NNP I-NP O
95 KNORI NNP I-NP O
95 , , O O
95 M.D NNP B-NP O
95 IF98 NNP I-NP O
96 Attending: NNP I-NP O
96 LUTHER NNP I-NP O
96 C NNP I-NP O
96 YAMAKI NNP I-NP O
96 , , O O
96 M.D NNP B-NP O
96 JW06 NNP I-NP O
97 YN997/9798 NNP I-NP O
98 Batch: NNP I-NP O
98 91184 CD O O
98 Index NNP B-NP O
98 No NNP I-NP O
98 UURKGW1LHR NNP I-NP O
98 D: NNP I-NP O
98 8/1/95 CD O O
99 T: NNP B-NP O
99 8/1/95 CD O O
100 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #506934 VBZ O O
2 222107294 CD O O
2 TSMC NNP B-NP O
2 86070162 CD O O
2 7180054 CD O O
2 5/29/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 HO NNP I-NP O
2 evaluation NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/8/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/27/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 ORBIN NNP I-NP O
5 , , O O
5 EARLE NNP B-NP O
5 B NNP I-NP O
5 460-45-53-2 JJ B-NP O
6 Bend NNP I-NP O
6 Uxcallcon NNP I-NP O
7 Service: NNP I-NP O
7 GGI NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/15/06 CD O O
8 AT NNP B-NP O
8 09:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 BLANDO NNP I-NP O
11 , , O O
11 BRUCE NNP B-NP O
11 N NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 DISPOSITION: NNP I-NP O
12 Home NNP I-NP O
12 w/ NN I-NP O
12 services NNS I-NP O
13 DISCHARGE NNP I-NP O
13 MEDICATIONS: NNP I-NP O
14 ALBUTEROL NNP I-NP B-m
14 ALBUTEROL NNP I-NP B-m
14 INHALER NNP I-NP I-m
14 INHALER NNP I-NP I-m
14 2 CD O B-do
14 2 CD O B-do
14 PUFF NNP B-NP I-do
14 PUFF NNP I-NP I-do
14 INH NNP I-NP B-mo
14 INH NNP I-NP B-mo
14 QID NNP I-NP B-f
14 QID NNP I-NP B-f
15 PRN NNP I-NP O
15 Shortness NNP I-NP B-r
15 of IN B-VP I-r
15 Breath NNP B-NP I-r
15 , , O O
15 Wheezing NNP B-NP B-r
16 LANTUS NNP I-NP B-m
16 ( ( O I-m
16 INSULIN NNP B-NP I-m
16 GLARGINE NNP I-NP I-m
16 ) ) O I-m
16 60 CD O B-do
16 UNITS NNP B-NP I-do
16 SC NNP I-NP B-mo
16 DAILY NNP I-NP B-f
17 Starting VBG O O
17 Today NNP B-NP O
17 ( ( O O
17 10/21 CD O O
17 ) ) O O
17 HOLD NNP B-NP O
17 IF: NNP I-NP O
17 npo JJ B-NP O
18 ROXICET NNP I-NP B-m
18 ORAL NNP I-NP I-m
18 SOLUTION NNP I-NP I-m
18 ( ( O I-m
18 OXYCODONE+APAP NNP B-NP I-m
18 LIQUID NNP I-NP I-m
18 ) ) O I-m
19 5-10 JJ B-NP B-do
19 MILLILITERS NNP I-NP I-do
19 PO NNP I-NP B-mo
19 Q4H NNP I-NP B-f
19 PRN NNP I-NP I-f
19 Pain NNP I-NP B-r
20 ZANTAC NNP I-NP B-m
20 SYRUP NNP I-NP I-m
20 ( ( O I-m
20 RANITIDINE NNP B-NP I-m
20 HCL NNP I-NP I-m
20 SYRUP NNP I-NP I-m
20 ) ) O I-m
20 150 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 BID NNP I-NP B-f
21 ACTIGALL NNP I-NP B-m
21 ( ( O I-m
21 URSODIOL NNP B-NP I-m
21 ) ) O I-m
21 300 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 BID NNP I-NP B-f
22 Instructions: NNP I-NP O
22 if IN B-VP O
22 gallbladder NN B-NP O
22 still RB O O
22 in- JJ B-NP O
22 start NN I-NP O
22 taking VBG O O
22 2 CD O O
23 weeks NNS B-NP O
23 after IN B-VP O
23 discharge NN B-NP O
24 LEVAQUIN NNP I-NP B-m
24 ( ( O I-m
24 LEVOFLOXACIN NNP B-NP I-m
24 ) ) O I-m
24 500 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 DAILY NNP I-NP B-f
25 Food/Drug NNP I-NP O
25 Interaction NNP I-NP O
25 Instruction NNP I-NP O
26 Administer NNP I-NP O
26 iron NN I-NP O
26 products NNS I-NP O
26 a DT B-NP O
26 minimum NN I-NP O
26 of IN B-VP O
26 2 CD O O
26 hours NNS B-NP O
26 before IN B-VP O
26 or CC O O
27 after IN B-VP O
27 a DT B-NP O
27 levofloxacin NN I-NP B-m
27 or CC O O
27 ciprofloxacin NN B-NP B-m
27 dose VBP O O
27 dose JJ O O
28 If IN B-VP O
28 on IN B-VP O
28 tube NN B-NP O
28 feeds NNS I-NP O
28 , , O O
28 please VB O O
28 cycle NN B-NP O
28 ( ( O O
28 hold VB O O
28 1 CD O O
28 hr NN B-NP O
28 before IN B-VP O
28 to TO O O
28 2 CD O O
28 hr NNS B-NP O
29 after IN B-VP O
29 ) ) O O
29 Take VBP O O
29 2 CD O O
29 hours NNS B-NP O
29 before IN B-VP O
29 or CC O O
29 2 CD O O
29 hours NNS B-NP O
29 after IN B-VP O
29 dairy NN B-NP O
29 products NNS I-NP O
30 Alert NNP I-NP O
30 overridden: MD O O
30 Override NNP B-NP O
30 added VBD B-VP O
30 on IN B-VP O
30 9/15/06 CD O O
30 by IN B-VP O
30 : : O O
31 POTENTIALLY NNP B-NP O
31 SERIOUS NNP I-NP O
31 INTERACTION: NNP I-NP O
31 PROCHLORPERAZINE NNP I-NP B-m
31 &amp; NNP I-NP O
32 LEVOFLOXACIN NNP I-NP B-m
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: NN B-NP O
32 aware JJ B-NP O
33 DIET: NNP I-NP O
33 stage NN I-NP O
33 II NNP I-NP O
33 bypass NN I-NP O
33 diet JJ B-NP O
34 ACTIVITY: NNP I-NP O
34 Walking NNP I-NP O
34 as IN B-VP O
34 tolerated VBN O O
35 FOLLOW NNP B-NP O
35 UP NNP I-NP O
35 APPOINTMENT( NNP I-NP O
35 S NNP I-NP O
35 ): NNP I-NP O
36 Please NNP I-NP O
36 call VB O O
36 Dr NNP B-NP O
36 Machesky NNP I-NP O
36 immediately RB O O
36 to TO O O
36 schedule VB O O
36 follow-up JJ B-NP O
36 appiontment NN I-NP O
36 , , O O
37 Please NNP B-NP O
37 follow-up NN I-NP O
37 with IN B-VP O
37 primary JJ B-NP O
37 care NN I-NP O
37 doctor NN I-NP O
37 for IN B-VP O
37 blood NN B-NP O
37 sugar NN I-NP O
37 check NN I-NP O
37 , , O O
38 ALLERGY: NNP B-NP O
38 NKA NNP I-NP O
39 ADMIT NNP I-NP O
39 DIAGNOSIS: NNP I-NP O
40 morbid NN I-NP O
40 obesity NN I-NP O
41 PRINCIPAL NNP I-NP O
41 DISCHARGE NNP I-NP O
41 DIAGNOSIS NNP I-NP O
41 ;Responsible JJ O O
41 After IN B-VP O
41 Study NNP B-NP O
41 for IN B-VP O
41 Causing NNP B-NP O
41 Admission NNP I-NP O
41 ) ) O O
42 HO NNP B-NP O
42 evaluation NN I-NP O
43 OTHER NNP I-NP O
43 DIAGNOSIS;Conditions NNP I-NP O
43 , , O O
43 Infections NNP B-NP O
43 , , O O
43 Complications NNP B-NP O
43 , , O O
43 affecting VBG O O
43 Treatment/Stay NNP B-NP O
44 none NN I-NP O
45 OPERATIONS NNP I-NP O
45 AND NNP I-NP O
45 PROCEDURES: NNP I-NP O
46 laparoscopic VBD B-VP O
46 roux-en-y JJ B-NP O
46 gastric JJ I-NP O
46 bypass NN I-NP O
47 OTHER NNP I-NP O
47 TREATMENTS/PROCEDURES NNP I-NP O
47 ( ( O O
47 NOT NNP B-NP O
47 IN NNP I-NP O
47 O.R NNP I-NP O
47 ) ) O O
48 none NN B-NP O
49 BRIEF NNP I-NP O
49 RESUME NNP I-NP O
49 OF NNP I-NP O
49 HOSPITAL NNP I-NP O
49 COURSE: NNP I-NP O
50 Patient NNP I-NP O
50 was VBD B-VP O
50 admitted VBN O O
50 to TO O O
50 the DT B-NP O
50 Toott NNP I-NP O
50 Hospital NNP I-NP O
50 surgery NN I-NP O
50 service NN I-NP O
50 after IN B-VP O
50 undergoing VBG O O
51 LRYGB NNP B-NP O
51 No NNP I-NP O
51 concerning VBG O O
51 intraoperative JJ B-NP O
51 events NNS I-NP O
51 occurred; JJ B-NP O
51 please NN I-NP O
51 see VB O O
51 dictated JJ B-NP O
52 operative JJ I-NP O
52 note NN I-NP O
52 for IN B-VP O
52 details NNS B-NP O
52 Patient NNP I-NP O
52 was VBD B-VP O
52 transferred VBN O O
52 to TO O O
52 the DT B-NP O
52 floor NN I-NP O
52 from IN B-VP O
53 the DT B-NP O
53 PACU NNP I-NP O
53 in IN B-VP O
53 stable JJ B-NP O
53 condition NN I-NP O
53 Patient NNP I-NP O
53 had VBD B-VP O
53 adequate JJ B-NP O
53 pain NN I-NP O
53 control NN I-NP O
53 and CC O O
53 no DT B-NP O
54 issues NNS I-NP O
54 overnight VBD B-VP O
54 into IN B-VP O
54 POD1 NNP B-NP O
54 The DT B-NP O
54 patient NN I-NP O
54 had VBD B-VP O
54 an DT B-NP O
54 UGI NNP I-NP O
54 on IN B-VP O
54 POD1 NNP B-NP O
54 that WDT O O
54 was VBD B-VP O
55 negative JJ O O
55 for IN B-VP O
55 obstruction NN B-NP O
55 or CC O O
55 leak NN B-NP O
55 , , O O
55 at IN B-VP O
55 that DT B-NP O
55 time NN I-NP O
55 was VBD B-VP O
55 started VBN O O
55 on IN B-VP O
55 a DT B-NP O
55 Stage NN I-NP O
55 I PRP O O
56 diet VBP O O
56 which WDT O O
56 was VBD B-VP O
56 tolerated VBN O O
56 well RB O O
56 The DT B-NP O
56 following JJ I-NP O
56 day NN I-NP O
56 the DT B-NP O
56 patient NN I-NP O
56 was VBD B-VP O
56 started VBN O O
57 on IN B-VP O
57 a DT B-NP O
57 Stage NNP I-NP O
57 II NNP I-NP O
57 diet VBD B-VP O
57 that DT O O
57 was VBD B-VP O
57 tolerated VBN O O
57 as RB O O
57 well RB O O
57 , , O O
57 but CC O O
57 patient JJ O O
58 initially RB O O
58 struggled VBN O O
58 to TO O O
58 have VB O O
58 adequate JJ B-NP O
58 intake NN I-NP O
58 Incision NNP I-NP O
58 erytematous JJ O O
58 , , O O
58 with IN B-VP O
59 serous JJ B-NP O
59 discharge NN I-NP O
59 by IN B-VP O
59 POD NNP B-NP O
59 2 CD O O
59 requiring VBG O O
59 multiple NNS B-NP O
59 but CC O O
59 decreasing VBG O O
59 dressing NN B-NP O
60 changes NNS I-NP O
60 Continued VBD B-VP O
61 dressing VBG O O
61 wound NN B-NP O
61 , , O O
61 DSD NNP B-NP O
61 with IN B-VP O
61 improvement NN B-NP O
61 Sugars NNP I-NP O
61 remained VBD B-VP O
61 high JJ O O
61 in IN B-VP O
61 200's CD O O
62 during IN B-VP O
62 admission NN B-NP O
62 Pt NNP I-NP O
62 seen VBN O O
62 by IN B-VP O
62 Endocrine NNP B-NP O
62 service NN I-NP O
62 and CC O O
62 sugars NNS B-NP O
62 finally RB O O
63 improving VBG O O
63 with IN B-VP O
63 lantus JJ O B-m
63 60 CD O B-do
63 sc NN B-NP B-mo
63 hs NN I-NP B-f
63 She PRP O O
63 also RB O O
63 had VBD B-VP O
63 some DT B-NP O
63 difficulties NNS I-NP O
64 with IN B-VP O
64 urination NN B-NP O
64 on IN B-VP O
64 POD4 NNP B-NP O
64 and CC O O
64 required VBD B-VP O
64 a DT B-NP O
64 foley JJ I-NP O
64 catheter NN I-NP O
64 for IN B-VP O
64 about IN B-VP O
64 a DT B-NP O
64 day NN I-NP O
64 Her NNP I-NP O
65 foley NN I-NP O
65 was VBD B-VP O
65 d/c'd VBN O O
65 the DT B-NP O
65 AM NNP I-NP O
65 before IN B-VP O
65 she PRP O O
65 was VBD B-VP O
65 d/c'd NN B-NP O
65 and CC O O
65 she PRP O O
65 urinated VBD B-VP O
65 without IN B-VP O
66 incident JJ B-NP O
66 Patient NNP I-NP O
66 was VBD B-VP O
66 noted VBN O O
66 to TO O O
66 have VB O O
66 a DT B-NP O
66 UTI NNP I-NP O
66 at IN B-VP O
66 discharge NN B-NP O
66 and CC O O
66 was VBD B-VP O
66 started VBN O O
66 on IN B-VP O
67 three CD O B-du
67 day NN B-NP I-du
67 course NN I-NP I-du
67 of IN B-VP O
67 levaquin JJ B-NP B-m
67 Remainder NNP I-NP O
67 of IN B-VP O
67 hospital JJ B-NP O
67 course NN I-NP O
68 unremarkable JJ O O
68 , , O O
68 and CC O O
68 the DT B-NP O
69 pateint NN I-NP O
69 was VBD B-VP O
69 discharged VBN O O
69 in IN B-VP O
69 stable JJ B-NP O
69 condition NN I-NP O
69 , , O O
69 tolerating VBG O O
69 stage NN B-NP O
69 II NNP I-NP O
69 diet RB O O
69 well RB O O
69 , , O O
70 ambulating VBG O O
70 , , O O
70 voiding VBG O O
71 independently RB O O
71 , , O O
71 and CC O O
71 with IN B-VP O
71 adequate JJ B-NP O
71 pain NN I-NP O
71 control NN I-NP O
71 The DT B-NP O
71 patient NN I-NP O
71 was VBD B-VP O
71 given VBN O O
72 explicit JJ B-NP O
72 instructions NNS I-NP O
72 to TO O O
72 follow-up NN B-NP O
72 in IN B-VP O
72 clinic NN B-NP O
72 with IN B-VP O
72 Dr NNP B-NP O
72 Truglia NNP I-NP O
72 in IN B-VP O
72 1-2 JJ B-NP O
72 weeks NNS I-NP O
73 Pt NNP I-NP O
73 sent VBD B-VP O
73 home NN B-NP O
73 with IN B-VP O
73 VNA NNP B-NP O
73 for IN B-VP O
73 wound NN B-NP O
73 checks NNS I-NP O
73 and CC O O
73 close JJ B-NP O
73 sugar NN I-NP O
73 control NN I-NP O
73 with IN B-VP O
74 instructions NNS B-NP O
74 to TO O O
74 f/u VB O O
74 with IN B-VP O
74 Leland NNP B-NP O
74 Bredeson NNP I-NP O
74 by IN B-VP O
74 phone NN B-NP O
74 and CC O O
74 record NN B-NP O
74 fingersticks NNS I-NP O
75 She PRP O O
75 should MD O O
75 f/u VB O O
75 with IN B-VP O
75 her PRP O O
75 PCP NNP B-NP O
75 if IN B-VP O
75 she PRP O O
75 has VBZ O O
75 further JJ B-NP O
75 probelms NNS I-NP O
75 with IN B-VP O
75 urination JJ B-NP O
76 ADDITIONAL NNP I-NP O
76 COMMENTS: NNP I-NP O
76 -You NNP I-NP O
76 may MD O O
76 shower VB O O
76 , , O O
76 but CC O O
76 do VBP O O
76 not RB O O
76 bathe VB O O
76 , , O O
76 swim VB O O
76 or CC O O
76 otherwise VB O O
76 immerse JJ O O
76 your PRP$ O O
77 incision NN B-NP O
78 -Do IN B-VP O
78 not RB O O
78 lift VB O O
78 anything NN B-NP O
78 heavier JJR O O
78 than IN B-VP O
78 a DT B-NP O
78 phone NN I-NP O
78 book NN I-NP O
79 -Do NNP I-NP O
79 not RB O O
79 drive VB O O
79 or CC O O
79 drink VB O O
79 alcohol NN B-NP O
79 while IN B-VP O
79 taking VBG O O
79 narcotic JJ B-NP B-m
79 pain NN I-NP I-m
79 medication NN I-NP I-m
80 -Resume IN B-VP O
80 all DT O O
80 of IN B-VP O
80 your PRP$ O B-m
80 home NN B-NP I-m
80 medications NNS I-NP I-m
81 -If VBP O O
81 you PRP O O
81 have VBP O O
81 fevers NNS B-NP O
81 &gt; VBP O O
81 101.5 CD O O
81 F NNP B-NP O
81 , , O O
81 vomiting VBG O O
81 , , O O
81 or CC O O
81 increased VBD B-VP O
81 redness NN B-NP O
81 , , O O
81 swelling VBG O O
81 , , O O
82 or CC O O
82 discharge NN B-NP O
82 from IN B-VP O
82 your PRP$ O O
82 incision NN B-NP O
82 , , O O
82 call VB O O
82 your PRP$ O O
82 doctor NN B-NP O
82 or CC O O
82 go VB O O
82 to TO O O
82 the DT B-NP O
82 nearest JJS I-NP O
83 emergency NN I-NP O
83 room NN I-NP O
84 -VNA: NNP I-NP O
84 please NN I-NP O
84 check VB O O
84 blood NN B-NP O
84 sugar NN I-NP O
84 daily RB O O
84 and CC O O
84 call VB O O
84 results NNS B-NP O
84 into IN B-VP O
84 MD NNP B-NP O
85 DISCHARGE NNP I-NP O
85 CONDITION: NNP I-NP O
85 Stable NNP I-NP O
86 TO NNP I-NP O
86 DO/PLAN: NNP I-NP O
87 No NNP I-NP O
87 dictated VBD B-VP O
87 summary JJ B-NP O
88 ENTERED NNP I-NP O
88 BY: NNP I-NP O
88 LEMME NNP I-NP O
88 , , O O
88 CRISTOBAL NNP B-NP O
88 R NNP I-NP O
88 , , O O
88 M.D NNP B-NP O
88 ( ( O O
88 XU023 NNP B-NP O
88 ) ) O O
88 9/15/06 CD O O
88 @ $ O O
88 10 CD O O
89 ****** JJ B-NP O
89 END NN I-NP O
89 OF NNP I-NP O
89 DISCHARGE NNP I-NP O
89 ORDERS NNP I-NP O
89 ****** NNP I-NP O
90 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #508921 VBZ O O
4 515984806 CD O O
4 JMH NNP B-NP O
4 10446912 CD O O
4 917465 CD O O
4 5/1/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Infected NNP I-NP O
4 R NNP I-NP O
4 THR NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/1/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/15/2001 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 FOSSELMAN NNP I-NP O
8 , , O O
8 JONAS NNP B-NP O
8 G NNP I-NP O
8 312-34-40-6 JJ B-NP O
9 Dier NNP I-NP O
9 Drive NNP I-NP O
9 , , O O
9 Villevo NNP B-NP O
9 Ttawi NNP I-NP O
9 Tlloa NNP I-NP O
9 Belle NNP I-NP O
9 , , O O
9 North NNP B-NP O
9 Dakota NNP I-NP O
9 03596 CD O O
10 Service: NNP B-NP O
10 ORT NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 6/6/01 CD O O
11 AT NNP B-NP O
11 03:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Eval NNP I-NP O
12 by IN B-VP O
12 Cardiology NNP B-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 BRINIUS NNP I-NP O
14 , , O O
14 MIKEL NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
15 w/ NN I-NP O
15 services NNS I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 TYLENOL NNP I-NP B-m
17 ( ( O I-m
17 ACETAMINOPHEN NNP B-NP I-m
17 ) ) O I-m
17 650 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 Q4H NNP I-NP B-f
17 PRN NNP I-NP I-f
17 headache NN I-NP B-r
18 VENTOLIN NNP I-NP B-m
18 ( ( O I-m
18 ALBUTEROL NNP B-NP I-m
18 INHALER NNP I-NP I-m
18 ) ) O I-m
18 1-2 CD O B-do
18 PUFF NNP B-NP I-do
18 INH NNP I-NP B-mo
18 QID NNP I-NP B-f
19 PRN NNP I-NP O
19 sob/wheeze NN I-NP B-r
20 ECASA NNP I-NP B-m
20 ( ( O I-m
20 ASPIRIN NNP B-NP I-m
20 ENTERIC NNP I-NP I-m
20 COATED NNP I-NP I-m
20 ) ) O I-m
20 325 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 ATENOLOL NNP I-NP B-m
21 25 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP O
21 Food/Drug NNP I-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Take NNP I-NP O
22 consistently RB O O
22 with IN B-VP O
22 meals NNS B-NP O
22 or CC O O
22 on IN B-VP O
22 empty JJ B-NP O
22 stomach NN I-NP O
23 CEFTRIAXONE NNP I-NP B-m
23 2 CD O B-do
23 , , O I-do
23 000 CD O I-do
23 MG NNP B-NP I-do
23 IV NNP I-NP B-mo
23 QD NNP I-NP B-f
24 Number NNP I-NP B-du
24 of IN B-VP I-du
24 Doses NNP B-NP I-du
24 Required NNP I-NP I-du
24 ( ( O I-du
24 approximate JJ B-NP I-du
24 ): NN I-NP I-du
24 2 CD O I-du
25 COLACE NNP B-NP B-m
25 ( ( O I-m
25 DOCUSATE NNP B-NP I-m
25 SODIUM NNP I-NP I-m
25 ) ) O I-m
25 100 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 BID NNP I-NP B-f
26 ENALAPRIL NNP I-NP B-m
26 ( ( O I-m
26 ENALAPRIL NNP B-NP I-m
26 MALEATE NNP I-NP I-m
26 ) ) O I-m
26 2.5 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 QD NNP I-NP B-f
27 PERCOCET NNP I-NP B-m
27 1-2 JJ B-NP B-do
27 TAB NNP I-NP I-do
27 PO NNP I-NP B-mo
27 Q4H NNP I-NP B-f
27 PRN NNP I-NP I-f
27 pain NN I-NP B-r
28 ZOCOR NNP I-NP B-m
28 ( ( O I-m
28 SIMVASTATIN NNP B-NP I-m
28 ) ) O I-m
28 5 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QHS NNP I-NP B-f
29 Food/Drug NNP I-NP O
29 Interaction NNP I-NP O
29 Instruction NNP I-NP O
30 Avoid NNP I-NP O
30 grapefruit NN I-NP O
30 unless IN B-VP O
30 MD NNP B-NP O
30 instructs NNS I-NP O
30 otherwise RB O O
31 ISOSORBIDE NNP B-NP B-m
31 MONONITRATE NNP I-NP I-m
31 30 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 Food/Drug NNP I-NP O
32 Interaction NNP I-NP O
32 Instruction NNP I-NP O
33 Give NNP I-NP O
33 on IN B-VP O
33 an DT B-NP O
33 empty JJ I-NP O
33 stomach NN I-NP O
33 ( ( O O
33 give JJ O O
33 1hr CD O O
33 before IN B-VP O
33 or CC O O
33 2hr CD O O
33 after IN B-VP O
34 food NN B-NP O
34 ) ) O O
34 Number NNP B-NP O
34 of IN B-VP O
34 Doses NNP B-NP O
34 Required NNP I-NP O
34 ( ( O O
34 approximate JJ B-NP O
34 ): NN I-NP O
34 15 CD O O
35 NEXIUM NNP B-NP B-m
35 ( ( O I-m
35 ESOMEPRAZOLE NNP B-NP I-m
35 ) ) O I-m
35 20 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 QD NNP I-NP B-f
36 DIET: NNP I-NP O
36 No NNP I-NP O
36 Restrictions NNP I-NP O
37 RETURN NNP I-NP O
37 TO NNP I-NP O
37 WORK: NNP I-NP O
37 after IN B-VP O
37 eval NN B-NP O
37 by IN B-VP O
37 Dr NNP B-NP O
37 Ashurst NNP I-NP O
38 FOLLOW NNP I-NP O
38 UP NNP I-NP O
38 APPOINTMENT( NNP I-NP O
38 S NNP I-NP O
38 ): NNP I-NP O
39 Dr NNP I-NP O
39 Lobato NNP I-NP O
39 9/24/01 CD O O
39 , , O O
39 VH NNP B-NP O
39 pre-admit NN I-NP O
39 for IN B-VP O
39 OR NNP B-NP O
39 I&amp;D/removal NNP I-NP O
39 hardware NN I-NP O
39 9/24/01 CD O O
39 scheduled VBN O O
39 , , O O
40 ALLERGY: NNP B-NP O
40 Shellfish NNP I-NP O
40 , , O O
40 Morphine NNP B-NP O
41 ADMIT NNP I-NP O
41 DIAGNOSIS: NNP I-NP O
42 Infected NNP I-NP O
42 R NNP I-NP O
42 THR NNP I-NP O
43 PRINCIPAL NNP I-NP O
43 DISCHARGE NNP I-NP O
43 DIAGNOSIS NNP I-NP O
43 ;Responsible JJ O O
43 After IN B-VP O
43 Study NNP B-NP O
43 for IN B-VP O
43 Causing NNP B-NP O
43 Admission NNP I-NP O
43 ) ) O O
44 Infected VBD B-VP O
44 R NNP B-NP O
44 THR NNP I-NP O
45 OTHER NNP I-NP O
45 DIAGNOSIS;Conditions NNP I-NP O
45 , , O O
45 Infections NNP B-NP O
45 , , O O
45 Complications NNP B-NP O
45 , , O O
45 affecting VBG O O
45 Treatment/Stay NNP B-NP O
46 hodgkins VBZ O O
46 lymphoma FW O O
46 ( ( O O
46 Hodgkins NNP B-NP O
46 disease NN I-NP O
46 ) ) O O
46 Asthma NNP B-NP O
46 ( ( O O
46 asthma NN B-NP O
46 ) ) O O
46 R NNP B-NP O
46 total JJ B-NP O
46 hip NN I-NP O
47 replacement NN I-NP O
47 ( ( O O
47 total JJ B-NP O
47 hip NN I-NP O
47 replacement NN I-NP O
47 ) ) O O
47 septic JJ B-NP O
47 joint NN I-NP O
47 ( ( O O
47 total JJ B-NP O
47 hip NN I-NP O
48 replacement NN I-NP O
48 ) ) O O
48 non NN B-NP O
48 Q NNP I-NP O
48 wave VBP O O
48 MI; NNP B-NP O
48 Extensive NNP I-NP O
48 CAD NNP I-NP O
49 OPERATIONS NNP I-NP O
49 AND NNP I-NP O
49 PROCEDURES: NNP I-NP O
50 CT-guided NNP I-NP O
50 aspiration NN I-NP O
50 R NNP I-NP O
50 hip NN I-NP O
50 per IN B-VP O
50 Radiology NNP B-NP O
50 4/1/01 CD O O
51 OTHER NNP B-NP O
51 TREATMENTS/PROCEDURES NNP I-NP O
51 ( ( O O
51 NOT NNP B-NP O
51 IN NNP I-NP O
51 O.R NNP I-NP O
51 ) ) O O
52 IV NNP B-NP B-mo
52 Abx NNP I-NP B-m
53 BRIEF NNP I-NP O
53 RESUME NNP I-NP O
53 OF NNP I-NP O
53 HOSPITAL NNP I-NP O
53 COURSE: NNP I-NP O
54 Admitted NNP I-NP O
54 from IN B-VP O
54 office NN B-NP O
54 4/1/01 CD O O
54 for IN B-VP O
54 infected VBN O O
54 L NNP B-NP O
54 THR NNP I-NP O
54 Aspiration NNP I-NP B-r
55 demonstrated VBD B-VP O
55 purulent JJ B-NP O
55 material NN I-NP O
55 Started VBD B-VP O
55 on IN B-VP O
55 Ceftriaxone NNP B-NP B-m
55 per IN B-VP O
55 ID NNP B-NP O
55 consult NN I-NP O
56 recs NN I-NP O
56 MIC NNP I-NP O
56 to TO O O
56 both DT B-NP O
56 PCN NNP I-NP B-m
56 and CC O O
56 Ceftriaxone NNP B-NP B-m
56 pending VBG O O
56 MRI NNP B-NP O
56 of IN B-VP O
56 pelvis NN B-NP O
56 completed VBN O O
57 10/10/01 CD O O
57 as IN B-VP O
57 pre-op JJ B-NP O
57 eval NN I-NP O
57 TU NNP I-NP O
57 Cardiology NNP I-NP O
57 was VBD B-VP O
57 consulted VBN O O
57 for IN B-VP O
57 pre-op JJ B-NP O
58 clearance NN I-NP O
58 given VBN O O
58 extensive JJ B-NP O
58 H/O NNP I-NP O
58 cardiomyopathy NN I-NP O
58 and CC O O
58 unstentable JJ B-NP O
58 CAD NNP I-NP O
58 per IN B-VP O
59 last JJ B-NP O
59 cardiac JJ I-NP O
59 cath NN I-NP O
59 8/7 CD O O
59 On IN B-VP O
59 further JJ B-NP O
59 d/w NN I-NP O
59 PT NNP I-NP O
59 , , O O
59 he PRP O O
59 was VBD B-VP O
59 adament JJ O O
59 about IN B-VP O
59 being VBG O O
60 allowed VBN O O
60 to TO O O
60 be VB O O
60 D/C NNP B-NP O
60 home NN I-NP O
60 on IN B-VP O
60 Abx NNP B-NP B-m
60 for IN B-VP O
60 August NNP B-NP O
60 holiday NN I-NP O
60 Given NNP I-NP O
60 that IN B-VP O
60 his PRP$ O O
61 clinical JJ B-NP O
61 picture NN I-NP O
61 was VBD B-VP O
61 much RB O O
61 improved VBN O O
61 on IN B-VP O
61 antibiotics NNS B-NP B-m
61 , , O O
61 both DT B-NP O
61 Dr NNP I-NP O
61 Salkeld NNP I-NP O
61 and CC O O
61 ID NNP B-NP O
62 MD NNP I-NP O
62 agreed VBD B-VP O
62 to TO O O
62 this DT O O
62 on IN B-VP O
62 provision NN B-NP O
62 that IN B-VP O
62 he PRP O O
62 return VB O O
62 immediately RB O O
62 for IN B-VP O
62 any DT B-NP O
63 evidence NN I-NP O
63 of IN B-VP O
63 progressing VBG O O
63 infection NN B-NP O
63 His PRP$ O O
63 R NNP B-NP O
63 hip NN I-NP O
63 pain NN I-NP O
63 and CC O O
63 exam NN B-NP O
63 were VBD B-VP O
63 much RB O O
64 improved VBN O O
64 by IN B-VP O
64 time NN B-NP O
64 of IN B-VP O
64 discharge NN B-NP O
64 Will NNP I-NP O
64 plan NN I-NP O
64 for IN B-VP O
64 IV NNP B-NP B-mo
64 lon NN I-NP O
64 line NN I-NP O
64 to TO O O
64 be VB O O
64 placed VBN O O
65 prior RB O O
65 to TO O O
65 D/C NNP B-NP O
65 for IN B-VP O
65 home NN B-NP B-do
65 dosing NN I-NP I-do
65 of IN B-VP O
65 QD NNP B-NP B-f
65 Ceftriaxone NNP I-NP B-m
65 ID NNP I-NP O
65 to TO O O
65 be VB O O
65 re-consulted JJ O O
66 on IN B-VP O
66 admission NN B-NP O
66 post-op NN I-NP O
66 10/5 CD O O
66 for IN B-VP O
66 re-eval NN B-NP O
66 of IN B-VP O
66 abx JJ B-NP B-m
66 choice NN I-NP O
66 By IN B-VP O
66 that DT B-NP O
66 time NN I-NP O
66 it PRP O O
67 is VBZ O O
67 presumed VBN O O
67 that IN B-VP O
67 the DT B-NP O
67 MIC NNP I-NP O
67 for IN B-VP O
67 PCN/CTX NNP B-NP B-m
67 will MD O O
67 be VB O O
67 available JJ O O
67 for IN B-VP O
67 ascertation NN B-NP O
68 of IN B-VP O
68 proper JJ B-NP O
68 long-term JJ I-NP O
68 Abx NNP I-NP B-m
68 care NN I-NP O
69 ADDITIONAL NNP I-NP O
69 COMMENTS: NNP I-NP O
69 Return NNP I-NP O
69 immediately RB O O
69 for IN B-VP O
69 increasing VBG O O
69 temps/shaking VBG O O
69 chills/pain NN B-NP O
69 at IN B-VP O
69 R NNP B-NP O
69 hip NN I-NP O
70 DISCHARGE NNP I-NP O
70 CONDITION: NNP I-NP O
70 Stable NNP I-NP O
71 TO NNP I-NP O
71 DO/PLAN: NNP I-NP O
72 1 CD O O
72 D/C NNP B-NP O
72 home NN I-NP O
72 with IN B-VP O
72 services NNS B-NP O
72 for IN B-VP O
72 QD NNP B-NP B-f
72 CTX NNP I-NP B-m
72 dosing VBG O O
73 2 CD O O
73 IV NNP B-NP O
73 long JJ B-NP O
73 line NN I-NP O
73 placement NN I-NP O
74 3 CD O O
74 Re-admission NN B-NP O
74 for IN B-VP O
74 removal NN B-NP O
74 of IN B-VP O
74 infected JJ B-NP O
74 hardware NN I-NP O
74 and CC O O
74 spacer NN B-NP O
74 placement NN I-NP O
75 9/24/01 CD O O
76 4 CD O O
76 IV NNP B-NP B-mo
76 Ceftriaxone NNP I-NP B-m
76 per IN B-VP O
76 VNA NNP B-NP O
76 2 CD O B-do
76 Gr NNP B-NP I-do
76 IV NNP I-NP O
76 QD NNP I-NP B-f
76 for IN B-VP O
76 10/9/01 CD O O
77 No NNP B-NP O
77 dictated VBD B-VP O
77 summary JJ B-NP O
78 ENTERED NNP I-NP O
78 BY: NNP I-NP O
78 BURKHARDT NNP I-NP O
78 , , O O
78 GIL NNP B-NP O
78 W NNP I-NP O
78 , , O O
78 M.D NNP B-NP O
78 ( ( O O
78 JT50 NNP B-NP O
78 ) ) O O
78 6/6/01 CD O O
78 @ $ O O
78 09:20 CD O O
78 AM NNP B-NP O
79 ****** JJ B-NP O
79 END NN I-NP O
79 OF NNP I-NP O
79 DISCHARGE NNP I-NP O
79 ORDERS NNP I-NP O
79 ****** NNP I-NP O
80 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #523663 VBZ O O
4 022965881 CD O O
4 CCHO NNP B-NP O
4 06363622 CD O O
4 5189032 CD O O
4 9/9/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/9/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/30/2005 CD O O
7 ATTENDING: NNP B-NP O
7 MANCHE NNP I-NP O
7 , , O O
7 EARLE NNP B-NP O
7 MD NNP I-NP O
8 ADMISSION NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
9 Dyspnea NNP I-NP O
9 on IN B-VP O
9 exertion NN B-NP O
10 DISCHARGE NNP I-NP O
10 DIAGNOSES: NNP I-NP O
11 1 CD O O
11 CHF NNP B-NP O
12 2 CD O O
12 Stage NNP B-NP O
12 IV NNP I-NP O
12 esophageal JJ B-NP O
12 cancer NN I-NP O
13 PRESENTING NNP I-NP O
13 SYMPTOMS: NNP I-NP O
14 Mr NNP I-NP O
14 Kanaan NNP I-NP O
14 is VBZ O O
14 a DT B-NP O
14 68-year-old JJ I-NP O
14 gentleman NN I-NP O
14 with IN B-VP O
14 stage NN B-NP O
14 IV NNP I-NP O
14 esophageal NN I-NP O
15 cancer NN I-NP O
15 who WP O O
15 was VBD B-VP O
15 two CD O O
15 weeks NNS B-NP O
15 status NN I-NP O
15 post VBD B-VP O
15 his PRP$ O O
15 third JJ B-NP O
15 cycle NN I-NP O
15 of IN B-VP O
16 chemotherapy NN B-NP O
16 for IN B-VP O
16 his PRP$ O O
16 cancer NN B-NP O
16 He PRP O O
16 also RB O O
16 had VBD B-VP O
16 ischemic JJ B-NP O
16 cardiomyopathy NN I-NP O
17 with IN B-VP O
17 a DT B-NP O
17 known JJ I-NP O
17 ejection NN I-NP O
17 of IN B-VP O
17 20% CD O O
17 and CC O O
17 coronary JJ B-NP O
17 artery NN I-NP O
17 disease NN I-NP O
17 status NN I-NP O
18 post NN I-NP O
18 CABG NNP I-NP O
18 in IN B-VP O
18 1993 CD O O
18 He PRP O O
18 presented VBD B-VP O
18 with IN B-VP O
18 progressive JJ B-NP O
18 shortness NN I-NP O
18 of IN B-VP O
19 breath NN B-NP O
19 over IN B-VP O
19 the DT O O
19 three CD O O
19 days NNS B-NP O
19 prior RB O O
19 to TO O O
19 admission NN B-NP O
19 He PRP O O
19 denied VBD B-VP O
19 any DT B-NP O
20 fever NN I-NP O
20 However RB O O
20 , , O O
20 he PRP O O
20 did VBD B-VP O
20 note VB O O
20 increase NN B-NP O
20 in IN B-VP O
20 his PRP$ O O
20 weight NN B-NP O
20 and CC O O
20 increased VBD B-VP O
21 lower JJR B-NP O
21 extremity NN I-NP O
21 edema NN I-NP O
21 over IN B-VP O
21 the DT B-NP O
21 last JJ I-NP O
21 week NN I-NP O
21 He PRP O O
21 has VBZ O O
21 three-pillow JJ B-NP O
22 orthopnea NN I-NP O
22 at IN B-VP O
22 baseline NN B-NP O
22 , , O O
22 but CC O O
22 has VBZ O O
22 been VBN O O
22 sleeping VBG O O
22 both DT O O
22 upright JJ O O
22 for IN B-VP O
22 the DT O O
23 three CD O O
23 days NNS B-NP O
23 prior RB O O
23 to TO O O
23 admission VB O O
23 Two CD O O
23 weeks NNS B-NP O
23 prior RB O O
23 to TO O O
23 admission NN B-NP O
23 , , O O
23 he PRP O O
24 was VBD B-VP O
24 walking VBG O O
24 in IN B-VP O
24 the DT B-NP O
24 mall NN I-NP O
24 and CC O O
24 was VBD B-VP O
24 able JJ O O
24 to TO O O
24 accomplish VB O O
24 all DT O O
24 of IN B-VP O
24 his PRP$ O O
25 ADLs NNP B-NP O
25 without IN B-VP O
25 difficulty NN B-NP O
25 On IN B-VP O
25 admission NN B-NP O
25 , , O O
25 he PRP O O
25 was VBD B-VP O
25 unable JJ O O
25 to TO O O
25 walk VB O O
26 more JJR O O
26 than IN B-VP O
26 20 CD O O
26 feet NNS B-NP O
26 without IN B-VP O
26 becoming VBG O O
26 severely RB O O
26 dyspneic IN B-VP O
26 He PRP O O
26 does VBZ O O
27 describe VB O O
27 having VBG O O
27 diminished VBN O O
27 appetite JJ O O
27 , , O O
27 increased JJ B-NP O
27 fatigue NN I-NP O
27 , , O O
27 and CC O O
27 three CD O O
28 days NNS B-NP O
28 of IN B-VP O
28 copious JJ B-NP O
28 watery NN I-NP O
28 stool NN I-NP O
28 , , O O
28 possibly RB O O
28 related VBN O O
28 to TO O O
28 his PRP$ O O
29 chemotherapy NN B-NP O
30 PAST NNP I-NP O
30 MEDICAL NNP I-NP O
30 HISTORY: NNP I-NP O
31 Significant NNP I-NP O
31 for IN B-VP O
31 pneumonia RB O O
31 two CD O O
31 weeks NNS B-NP O
31 ago RB O O
31 treated VBD B-VP O
31 as IN B-VP O
31 an DT B-NP O
31 outpatient NN I-NP O
31 , , O O
32 esophageal JJ B-NP O
32 cancer NN I-NP O
32 stage NN I-NP O
32 IV NNP I-NP O
32 status NN I-NP O
32 post NN I-NP O
32 chemo NN I-NP O
32 x3 NN I-NP O
32 cycles NNS I-NP O
32 , , O O
33 obstructive JJ B-NP O
33 sleep NN I-NP O
33 apnea NN I-NP O
33 , , O O
33 ischemic JJ B-NP O
33 cardiomyopathy NN I-NP O
33 , , O O
33 COPD NNP B-NP O
33 , , O O
33 atrial JJ B-NP O
34 fibrillation NN I-NP O
34 status NN I-NP O
34 post NN I-NP O
34 pacemaker NN I-NP O
34 and CC O O
34 AICD NNP B-NP O
34 placement NN I-NP O
34 , , O O
34 gout NN B-NP O
34 , , O O
35 pulmonary JJ B-NP O
35 vasculitis NN I-NP O
35 , , O O
35 and CC O O
35 also RB O O
35 CAD NNP B-NP O
36 OUTPATIENT NNP I-NP O
36 MEDICATIONS: NNP I-NP O
37 Include NNP I-NP O
37 amiodarone NN I-NP B-m
37 , , O O
37 digoxin NN B-NP B-m
37 , , O O
37 colchicine NN B-NP B-m
37 , , O O
37 Atrovent NNP B-NP B-m
37 , , O O
37 lisinopril NN B-NP B-m
37 , , O O
38 spironolactone NN B-NP B-m
38 , , O O
38 torsemide NN B-NP B-m
38 , , O O
38 Ativan NNP B-NP B-m
38 , , O O
38 Zocor NNP B-NP B-m
38 , , O O
38 and CC O O
38 Prilosec NNP B-NP B-m
39 ALLERGIES: NNP I-NP O
40 He PRP O O
40 has VBZ O O
40 no DT O O
40 known VBN O O
40 drug NN B-NP O
40 allergies NNS I-NP O
41 SOCIAL NNP I-NP O
41 HISTORY: NNP I-NP O
42 He PRP O O
42 lives VBZ O O
42 at IN B-VP O
42 home NN B-NP O
42 and CC O O
42 denies NNS B-NP O
42 alcohol VBP O O
42 use JJ B-NP O
43 PHYSICAL NNP I-NP O
43 EXAMINATION NNP I-NP O
43 ON NNP I-NP O
43 ADMISSION: NNP I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 was VBD B-VP O
44 afebrile JJ O O
44 with IN B-VP O
44 the DT B-NP O
44 temperature NN I-NP O
44 of IN B-VP O
44 95.8 CD O O
44 His PRP$ O O
44 heart NN B-NP O
45 rate NN I-NP O
45 was VBD B-VP O
45 in IN B-VP O
45 the DT O O
45 90s CD O O
45 His PRP$ O O
45 blood NN B-NP O
45 pressure NN I-NP O
45 was VBD B-VP O
45 90/60 CD O O
45 breathing NN B-NP O
45 at IN B-VP O
45 a DT B-NP O
46 rate NN I-NP O
46 of IN B-VP O
46 22 CD O O
46 His PRP$ O O
46 room NN B-NP O
46 air NN I-NP O
46 oxygenation NN I-NP O
46 was VBD B-VP O
46 82% CD O O
46 , , O O
46 but CC O O
46 increased VBD B-VP O
46 to TO O O
47 98% CD O O
47 on IN B-VP O
47 3 CD O O
47 liters NNS B-NP O
47 nasal JJ B-NP O
47 cannula NN I-NP O
47 He PRP O O
47 was VBD B-VP O
47 slightly RB O O
47 uncomfortable JJ O O
48 sitting VBG O O
48 straight VBD B-VP O
48 up RP O O
48 in IN B-VP O
48 bed NN B-NP O
48 and CC O O
48 visibly RB O O
48 tachypnic VB O O
48 His PRP$ O O
48 lung NN B-NP O
48 exam NN I-NP O
49 demonstrated VBD B-VP O
49 bilateral JJ B-NP O
49 scattered JJ I-NP O
49 wheezes NNS I-NP O
49 throughout IN B-VP O
49 the DT B-NP O
49 lung NN I-NP O
50 fields NNS I-NP O
50 and CC O O
50 bibasilar JJ B-NP O
50 crackles NNS I-NP O
50 His PRP$ O O
50 JVP NNP B-NP O
50 was VBD B-VP O
50 approximately RB O O
50 15 CD O O
50 cm JJ B-NP O
51 Heart NNP I-NP O
51 exam NN I-NP O
51 reveled VBD B-VP O
51 regular JJ B-NP O
51 rate NN I-NP O
51 and CC O O
51 rhythm NN B-NP O
51 with IN B-VP O
51 prominent JJ B-NP O
51 S3 NNP I-NP O
52 Abdominal NNP I-NP O
52 exam NN I-NP O
52 was VBD B-VP O
52 nontender JJR O O
52 His PRP$ O O
52 extremities NNS B-NP O
52 had VBD B-VP O
52 2+ CD O O
52 pitting VBG O O
53 edema NN B-NP O
53 to TO O O
53 the DT B-NP O
53 knees NNS I-NP O
54 PERTINENT NNP I-NP O
54 LABS: NNP I-NP O
55 On IN B-VP O
55 admission NN B-NP O
55 , , O O
55 he PRP O O
55 had VBD B-VP O
55 a DT B-NP O
55 creatinine NN I-NP O
55 of IN B-VP O
55 1.7 CD O O
55 , , O O
55 which WDT O O
55 is VBZ O O
55 at IN B-VP O
55 his PRP$ O O
56 baseline NN B-NP O
56 and CC O O
56 BUN NNP B-NP O
56 of IN B-VP O
56 46 CD O O
56 His PRP$ O O
56 BNP NNP B-NP O
56 was VBD B-VP O
56 2960 CD O O
56 , , O O
56 CK NNP B-NP O
56 48 CD O O
56 , , O O
56 CK-MB NNP B-NP O
56 1.0 CD O O
56 , , O O
56 and CC O O
57 troponin $ O O
57 0.1 CD O O
57 Hematocrit NNP B-NP O
57 44.5 CD O O
57 , , O O
57 white JJ B-NP O
57 count NN I-NP O
57 7.8 CD O O
57 , , O O
57 and CC O O
57 D-dimer NNP B-NP O
57 was VBD B-VP O
58 150 CD O O
58 His PRP$ O O
58 INR NNP B-NP O
58 was VBD B-VP O
58 1.3 CD O O
59 OPERATIONS NNP B-NP O
59 AND NNP I-NP O
59 PROCEDURES: NNP I-NP O
60 The DT B-NP O
60 patient NN I-NP O
60 had VBD B-VP O
60 a DT B-NP O
60 palliative JJ I-NP O
60 esophageal NN I-NP O
60 stent NN I-NP O
60 placed VBD B-VP O
60 on IN B-VP O
60 2/8/05 CD O O
61 HOSPITAL NNP B-NP O
61 COURSE NNP I-NP O
61 BY NNP I-NP O
61 SYSTEMS: NNP I-NP O
62 1 CD O O
62 Cardiovascular: NNP B-NP O
62 The DT B-NP O
62 patient NN I-NP O
62 presented VBN O O
62 with IN B-VP O
62 exam NN B-NP O
62 and CC O O
62 labs JJ B-NP O
63 findings NNS I-NP O
63 consistent JJ O O
63 with IN B-VP O
63 decompensated JJ B-NP O
63 heart NN I-NP O
63 failure NN I-NP O
63 For IN B-VP O
63 this DT O O
63 , , O O
64 he PRP O O
64 had VBD B-VP O
64 a DT O O
64 known VBN O O
64 ejection NN B-NP O
64 fraction NN I-NP O
64 of IN B-VP O
64 20% CD O O
64 While IN B-VP O
64 he PRP O O
64 was VBD B-VP O
64 in IN B-VP O
64 the DT B-NP O
65 hospital NN I-NP O
65 , , O O
65 he PRP O O
65 had VBD B-VP O
65 strict JJ B-NP O
65 I's NNP I-NP O
65 and CC O O
65 O's NNP B-NP O
65 and CC O O
65 was VBD B-VP O
65 diuresed VBN O O
65 with IN B-VP O
65 Lasix NNP B-NP B-m
66 and CC O O
66 torsemide VB O B-m
66 His PRP$ O O
66 diureses NNS B-NP O
66 was VBD B-VP O
66 somewhat RB O O
66 limited JJ O O
66 by IN B-VP O
66 systolic JJ B-NP O
67 blood NN I-NP O
67 pressure NN I-NP O
67 with IN B-VP O
67 a DT B-NP O
67 range NN I-NP O
67 of IN B-VP O
67 85 CD O O
67 to TO O O
67 110 CD O O
67 during IN B-VP O
67 his PRP$ O O
68 hospitalization NN B-NP O
68 On IN B-VP O
68 discharge NN B-NP O
68 , , O O
68 his PRP$ O O
68 weight NN B-NP O
68 was VBD B-VP O
68 down RB O O
68 to TO O O
68 82.1 CD O O
68 kg NNS B-NP O
69 and CC O O
69 was VBD B-VP O
69 down RB O O
69 from IN B-VP O
69 87.5 CD O O
69 on IN B-VP O
69 admission NN B-NP O
69 The DT B-NP O
69 patient NN I-NP O
69 did VBD B-VP O
69 have VB O O
69 slight VBN O O
70 leak NN B-NP O
70 in IN B-VP O
70 his PRP$ O O
70 troponin NN B-NP O
70 of IN B-VP O
70 0.1 CD O O
70 on IN B-VP O
70 admission NN B-NP O
70 , , O O
70 but CC O O
70 his PRP$ O O
70 EKG NNP B-NP O
70 was VBD B-VP O
71 unchanged JJ O O
71 and CC O O
71 his PRP$ O O
71 enzymes NNS B-NP O
71 x3 VBP O O
71 were VBD B-VP O
71 negative JJ O O
71 except IN B-VP O
71 for IN B-VP O
71 the DT B-NP O
72 troponin NN I-NP O
72 , , O O
72 which WDT O O
72 did VBD B-VP O
72 not RB O O
72 trend NN B-NP O
72 to TO O O
72 higher JJR O O
72 His PRP$ O O
72 cardiac JJ B-NP O
72 medical JJ I-NP O
73 regimen NN I-NP O
73 was VBD B-VP O
73 maximized VBN O O
73 with IN B-VP O
73 an DT B-NP O
73 ACE NNP I-NP B-m
73 inhibitor NN I-NP I-m
73 or CC O O
73 statin NN B-NP B-m
73 and CC O O
73 baby NN B-NP B-m
74 aspirin NN I-NP O
74 was VBD B-VP O
74 started VBN O O
74 on IN B-VP O
74 him PRP O O
74 He PRP O O
74 was VBD B-VP O
74 discharged VBN O O
74 home NN B-NP O
74 on IN B-VP O
74 torsemide JJ O B-m
75 100 CD O B-do
75 mg JJ O I-do
75 daily RB O B-f
75 in IN B-VP O
75 addition NN B-NP O
75 to TO O O
75 his PRP$ O O
75 spironolactone NN B-NP B-m
75 dose VBD B-VP O
76 2 CD O O
76 Pulmonary: NNP B-NP O
76 The DT B-NP O
76 patient NN I-NP O
76 received VBD B-VP O
76 Atrovent JJ B-NP B-m
76 nebulizers NNS I-NP I-m
76 in-house VBP O O
77 to TO O O
77 help VB O O
77 with IN B-VP O
77 his PRP$ O O
77 shortness NN B-NP B-r
77 of IN B-VP I-r
77 breath NN B-NP I-r
77 His PRP$ O O
77 primary JJ B-NP O
77 etiology NN I-NP O
77 , , O O
78 however RB O O
78 , , O O
78 was VBD B-VP O
78 pulmonary JJ O O
78 edema RB O O
78 secondary JJ O O
78 to TO O O
78 decompensated VB O O
78 heart NN B-NP O
79 failure NN I-NP O
79 His PRP$ O B-r
79 His PRP$ O B-r
79 His PRP$ O B-r
79 diuresis NN B-NP I-r
79 diuresis NN I-NP I-r
79 diuresis NN I-NP I-r
79 goal NN I-NP O
79 of IN B-VP O
79 1.5 CD O O
79 liter NN B-NP O
79 a DT B-NP O
79 day NN I-NP O
79 was VBD B-VP O
79 achieved VBN O O
79 with IN B-VP O
80 the DT B-NP O
80 combination NN I-NP O
80 of IN B-VP O
80 dopamine NN B-NP B-m
80 , , O O
80 nesiritide RB O B-m
80 , , O O
80 and CC O O
80 Lasix NNP B-NP B-m
80 drips NNS I-NP B-mo
80 He PRP O O
80 was VBD B-VP O
81 most RBS O O
81 responsive JJ O O
81 to TO O O
81 combination NN B-NP O
81 of IN B-VP O
81 nesiritide JJ O B-m
81 and CC O O
81 dopamine NN B-NP B-m
81 At IN B-VP O
82 the DT B-NP O
82 time NN I-NP O
82 of IN B-VP O
82 discharge NN B-NP O
82 , , O O
82 the DT B-NP O
82 patient's NN I-NP O
82 room NN I-NP O
82 air NN I-NP O
82 saturations NNS I-NP O
82 were VBD B-VP O
83 94% CD O O
83 with IN B-VP O
83 ambulatory JJ B-NP O
83 saturations NNS I-NP O
83 of IN B-VP O
83 86% CD O O
83 He PRP O O
83 was VBD B-VP O
83 therefore RB O O
84 discharged JJ B-NP O
84 home NN I-NP O
84 with IN B-VP O
84 oxygen NN B-NP B-m
84 to TO O O
84 use VB O O
84 overnight JJ O B-du
84 and CC O O
84 when WRB O O
85 symptomatic JJ O O
86 3 CD O O
86 Gastrointestinal: NNP B-NP O
86 The DT B-NP O
86 patient NN I-NP O
86 was VBD B-VP O
86 admitted VBN O O
86 with IN B-VP O
86 diarrhea NN B-NP O
87 that WDT O O
87 was VBD B-VP O
87 felt VBN O O
87 to TO O O
87 be VB O O
87 related VBN O O
87 to TO O O
87 his PRP$ O O
87 chemotherapy NN B-NP O
87 , , O O
87 which WDT O O
87 has VBZ O O
87 been VBN O O
88 completed VBN O O
88 two CD O O
88 weeks NNS B-NP O
88 earlier RBR O O
88 Stool NNP B-NP O
88 was VBD B-VP O
88 sent VBN O O
88 out RP O O
88 for IN B-VP O
88 C NNP B-NP O
89 difficile NN I-NP O
89 , , O O
89 which WDT O O
89 was VBD B-VP O
89 negative JJ O O
89 His PRP$ O O
89 colchicine NN B-NP B-m
89 was VBD B-VP O
89 initially RB O O
89 held VBN O O
90 because IN B-VP O
90 of IN B-VP O
90 his PRP$ O O
90 diarrhea NN B-NP O
90 , , O O
90 but CC O O
90 the DT B-NP O
90 patient NN I-NP O
90 then RB O O
90 developed VBD B-VP O
90 a DT B-NP O
90 flare NN I-NP O
91 of IN B-VP O
91 his PRP$ O O
91 gout NN B-NP O
91 in IN B-VP O
91 his PRP$ O O
91 right JJ B-NP O
91 great JJ I-NP O
91 toe JJ I-NP O
91 Colchicine NNP I-NP B-m
91 was VBD B-VP O
91 resumed VBN O O
91 to TO O O
92 treat VB O O
92 this DT O O
92 with IN B-VP O
92 good JJ B-NP O
92 results NNS I-NP O
92 The DT B-NP O
92 patient NN I-NP O
92 received VBD B-VP O
92 palliative JJ B-NP O
93 stent NN I-NP O
93 to TO O O
93 his PRP$ O O
93 esophagus NN B-NP O
93 on IN B-VP O
93 2/8/05 CD O O
93 that WDT O O
93 is VBZ O O
93 placed VBN O O
93 by IN B-VP O
93 Dr NNP B-NP O
93 Cap NNP I-NP O
94 without IN B-VP O
94 complications NNS B-NP O
94 The DT B-NP O
94 patient NN I-NP O
94 had VBD B-VP O
94 plans NNS B-NP O
94 to TO O O
94 follow VB O O
94 up RP O O
94 with IN B-VP O
95 is VBZ O O
95 outpatient JJ B-NP O
95 oncologist NN I-NP O
95 for IN B-VP O
95 ongoing VBG O O
95 care NN B-NP O
95 of IN B-VP O
95 his PRP$ O O
95 esophageal NN B-NP O
96 cancer NN I-NP O
96 after IN B-VP O
96 discharge NN B-NP O
97 4 CD O O
97 Renal: NNP B-NP O
97 The DT B-NP O
97 patient's NN I-NP O
97 creatinine NN I-NP O
97 was VBD B-VP O
97 1.7 CD O O
97 His PRP$ O O
97 baseline NN B-NP O
98 chronic JJ B-NP O
98 renal JJ I-NP O
98 insufficiency NN I-NP O
98 was VBD B-VP O
98 with IN B-VP O
98 the DT B-NP O
98 creatinine NN I-NP O
98 of IN B-VP O
99 approximately RB O O
99 1.3 CD O O
99 to TO O O
99 1.5 CD O O
99 At IN B-VP O
99 discharge NN B-NP O
99 , , O O
99 his PRP$ O O
99 creatinine NN B-NP O
99 was VBD B-VP O
99 1.6 CD O O
99 , , O O
100 which WDT O O
100 has VBZ O O
100 been VBN O O
100 stable JJ O O
100 throughout IN B-VP O
100 his PRP$ O O
100 entire JJ B-NP O
100 stay NN I-NP O
100 He PRP O O
100 briefly VBZ O O
101 required VBN O O
101 having VBG O O
101 a DT B-NP O
101 Foley NNP I-NP O
101 catheter NN I-NP O
101 placed VBD B-VP O
101 on IN B-VP O
101 8/28/05 CD O O
101 because IN B-VP O
101 of IN B-VP O
102 urinary JJ B-NP O
102 retention NN I-NP O
102 , , O O
102 but CC O O
102 it PRP O O
102 was VBD B-VP O
102 removed VBN O O
102 the DT B-NP O
102 next JJ I-NP O
102 day NN I-NP O
102 without IN B-VP O
103 difficulty NN B-NP O
103 and CC O O
103 did VBD B-VP O
103 not RB O O
103 have VB O O
103 problems NNS B-NP O
103 with IN B-VP O
103 voiding VBG O O
103 prior RB O O
103 to TO O O
104 discharge VB O O
105 5 CD O O
105 Hematology: NNP B-NP O
105 The DT B-NP O
105 patient NN I-NP O
105 was VBD B-VP O
105 placed VBN O O
105 on IN B-VP O
105 DVT NNP B-NP B-r
105 prophylaxis NN I-NP I-r
105 with IN B-VP O
106 Lovenox NNP B-NP B-m
106 He PRP O O
106 did VBD B-VP O
106 exhibit VB O O
106 some DT B-NP O
106 right JJ I-NP O
106 leg NN I-NP O
106 edema RB O O
106 more RBR O O
106 pronounced JJ O O
107 than IN B-VP O
107 his PRP$ O O
107 left JJ B-NP O
107 leg NN I-NP O
107 edema NN I-NP O
107 , , O O
107 but CC O O
107 this DT O O
107 is VBZ O O
107 felt VBN O O
107 to TO O O
107 be VB O O
107 due JJ O O
107 to TO O O
107 his PRP$ O O
107 gout NN B-NP O
108 in IN B-VP O
108 his PRP$ O O
108 right JJ O O
108 great JJ O O
108 toe IN B-VP O
109 The DT B-NP O
109 patient NN I-NP O
109 was VBD B-VP O
109 discharged VBN O O
109 to TO O O
109 home NN B-NP O
109 with IN B-VP O
109 services NNS B-NP O
109 and CC O O
109 PT NNP B-NP O
109 was VBD B-VP O
110 arranged VBN O O
110 to TO O O
110 go VB O O
110 and CC O O
110 do VB O O
110 a DT B-NP O
110 home NN I-NP O
110 safety NN I-NP O
110 evaluation NN I-NP O
111 PHYSICAL NNP I-NP O
111 EXAMINATION NNP I-NP O
111 ON NNP I-NP O
111 DISCHARGE: NNP I-NP O
112 The DT B-NP O
112 patient's NN I-NP O
112 vital JJ B-NP O
112 signs NNS I-NP O
112 were VBD B-VP O
112 stable JJ O O
112 He PRP O O
112 was VBD B-VP O
112 resting VBG O O
113 comfortably RB O O
113 in IN B-VP O
113 bed NN B-NP O
113 Crackles NNS I-NP O
113 in IN B-VP O
113 his PRP$ O O
113 lungs NNS B-NP O
113 were VBD B-VP O
113 notably RB O O
114 diminished VBN O O
114 from IN B-VP O
114 admission NN B-NP O
114 He PRP O O
114 no RB O O
114 longer RBR O O
114 was VBD B-VP O
114 tachypnic JJ O O
114 His PRP$ O O
115 heart NN B-NP O
115 had VBD B-VP O
115 a DT B-NP O
115 regular JJ I-NP O
115 rate NN I-NP O
115 and CC O O
115 rhythm NN B-NP O
115 , , O O
115 S1 NNP B-NP O
115 , , O O
115 S2 NNP B-NP O
115 , , O O
115 occasional JJ B-NP O
115 S3 NNP I-NP O
115 No NNP I-NP O
116 murmurs FW O O
116 Abdomen NNP B-NP O
116 was VBD B-VP O
116 soft JJ O O
116 and CC O O
116 nontender VB O O
116 His PRP$ O O
116 extremities NNS B-NP O
116 had VBD B-VP O
117 trace NN B-NP O
117 pitting VBG O O
117 edema JJ B-NP O
118 DISCHARGE NNP I-NP O
118 MEDICATIONS: NNP I-NP O
119 1 CD O O
119 Amiodarone NNP B-NP B-m
119 300 CD O B-do
119 mg VBD B-VP I-do
119 daily RB O B-f
120 2 CD O O
120 Colchicine NNP B-NP B-m
120 0.6 CD O B-do
120 mg NN B-NP I-do
120 every DT B-NP B-f
120 other JJ I-NP I-f
120 day NN I-NP I-f
121 3 CD O O
121 Digoxin NNP B-NP B-m
121 0.125 CD O B-do
121 mg NN B-NP I-do
121 every DT B-NP B-f
121 other JJ I-NP I-f
121 day NN I-NP I-f
122 4 CD O O
122 Ferrous NNP B-NP B-m
122 sulfate NN I-NP I-m
122 325 CD O B-do
122 mg JJ O I-do
122 daily RB O B-f
123 5 CD O O
123 Lisinopril NNP B-NP B-m
123 5 CD O B-do
123 mg VBD B-VP I-do
123 daily RB O B-f
124 6 CD O O
124 Ativan NNP B-NP B-m
124 0.5 CD O B-do
124 mg NN B-NP I-do
124 b.i.d NN I-NP B-f
125 7 CD O O
125 Spironolactone NNP B-NP B-m
125 12.5 CD O B-do
125 mg VBD B-VP I-do
125 daily RB O B-f
126 8 CD O O
126 Trazodone CD O B-m
126 50 CD O B-do
126 mg NN B-NP I-do
126 at IN B-VP B-f
126 night NN B-NP I-f
127 9 CD O O
127 Multivitamins NNP B-NP B-m
127 one CD O B-do
127 tablet NN B-NP I-do
127 daily RB O B-f
128 10 CD O O
128 Torsemide NNP B-NP B-m
128 100 CD O B-do
128 mg VBD B-VP I-do
128 daily RB O B-f
129 11 CD O O
129 Prilosec NNP B-NP B-m
129 20 CD O B-do
129 mg NN B-NP I-do
129 b.i.d NN I-NP B-f
130 12 CD O O
130 Simvastatin NNP B-NP B-m
130 80 CD O B-do
130 mg NN B-NP I-do
130 at IN B-VP B-f
130 night NN B-NP I-f
131 DISPOSITION: NNP I-NP O
132 The DT B-NP O
132 patient NN I-NP O
132 was VBD B-VP O
132 discharged VBN O O
132 to TO O O
132 home NN B-NP O
132 with IN B-VP O
132 services NNS B-NP O
132 He PRP O O
132 had VBD B-VP O
133 instructions NNS B-NP O
133 to TO O O
133 follow VB O O
133 up RP O O
133 with IN B-VP O
133 his PRP$ O O
133 primary JJ B-NP O
133 care NN I-NP O
133 doctor NN I-NP O
133 , , O O
133 Dr NNP B-NP O
134 Keltt NNP I-NP O
134 in IN B-VP O
134 one CD O O
134 weeks' NN B-NP O
134 time NN I-NP O
135 eScription NN I-NP O
135 document: IN B-VP O
135 1-0883572 JJ B-NP O
135 EMS NNP I-NP O
136 Dictated NNP I-NP O
136 By: NNP I-NP O
136 RENEAU NNP I-NP O
136 , , O O
136 DEVON NNP B-NP O
137 Attending: NNP I-NP O
137 SASHINGTON NNP I-NP O
137 , , O O
137 KENT NNP B-NP O
138 Dictation NNP I-NP O
138 ID NNP I-NP O
138 7154601 CD O O
139 D: NNP B-NP O
139 7/3/05 CD O O
140 T: NNP B-NP O
140 7/3/05 CD O O
141 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #544162 VBZ O O
2 044020768 CD O O
2 SHMC NNP B-NP O
2 29970772 CD O O
2 006624 CD O O
2 8/0/2002 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 SYNCOPE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/13/2002 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/9/2002 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 SYNCOPE NNP I-NP O
5 PROBLEMS: NNP I-NP O
5 1 CD O O
5 SYNCOPE NNP B-NP O
6 2 CD O O
6 ORTHOSTATIC NNP B-NP O
6 HYPOTENSION NNP I-NP O
7 3 CD O O
7 ISCHEMIC NNP B-NP O
7 CARDIOMYOPATHY NNP I-NP O
8 4 CD O O
8 DIABETES NNP B-NP O
8 MELLITUS NNP I-NP O
9 5 CD O O
9 CORONARY NNP B-NP O
9 ARTERY NNP I-NP O
9 DISEASE NNP I-NP O
10 HISTORY NNP I-NP O
10 OF NNP I-NP O
10 PRESENT NNP I-NP O
10 ILLNESS: NNP I-NP O
10 This DT O O
10 is VBZ O O
10 a DT B-NP O
10 62-year-old JJ I-NP O
10 white JJ I-NP O
10 male NN I-NP O
10 with IN B-VP O
11 insulin JJ B-NP O
11 dependent NN I-NP O
11 diabetes VBZ O O
11 mellitus RBS O O
11 , , O O
12 coronary JJ B-NP O
12 artery NN I-NP O
12 disease NN I-NP O
12 and CC O O
12 ischemic JJ B-NP O
12 cardiomyopathy NN I-NP O
12 who WP O O
12 was VBD B-VP O
13 admitted VBN O O
13 with IN B-VP O
13 syncope NN B-NP O
13 He PRP O O
13 is VBZ O O
13 status NN B-NP O
13 post NN I-NP O
13 myocardial JJ B-NP O
13 infarction NN I-NP O
13 in IN B-VP O
14 1979 CD O O
14 and CC O O
14 1985 CD O O
14 as RB O O
14 well RB O O
14 as IN B-VP O
14 a DT B-NP O
14 coronary JJ I-NP O
14 artery NN I-NP O
14 bypass NN I-NP O
14 graft NN I-NP O
14 in IN B-VP O
14 1987 CD O O
15 with IN B-VP O
15 a DT B-NP O
15 LIMA NNP I-NP O
15 to TO O O
15 LAD NNP B-NP O
15 , , O O
15 SVG NNP B-NP O
15 to TO O O
15 RCA NNP B-NP O
15 , , O O
15 SVG NNP B-NP O
15 to TO O O
15 OMB NNP B-NP O
15 Over IN B-VP O
15 the DT B-NP O
15 past JJ I-NP O
15 ten NN I-NP O
16 years NNS I-NP O
16 he PRP O O
16 has VBZ O O
16 complained VBN O O
16 of IN B-VP O
16 increasing VBG O O
16 CHF NNP B-NP O
16 symptoms NNS I-NP O
16 including VBG O O
17 dyspnea NN B-NP O
17 on IN B-VP O
17 exertion NN B-NP O
17 , , O O
17 fatigue NN B-NP O
17 , , O O
17 chest NN B-NP O
17 tightness NN I-NP O
17 and CC O O
17 has VBZ O O
17 had VBN O O
17 multiple JJ B-NP O
18 admits NNS I-NP O
18 for IN B-VP O
18 exacerbations NNS B-NP O
18 , , O O
18 the DT O O
18 most RBS O O
18 recent JJ O O
18 from IN B-VP O
18 June NNP B-NP O
18 to TO O O
19 January NNP B-NP O
19 , , O O
19 2001 CD O O
19 for IN B-VP O
19 progressive JJ B-NP O
19 fatigue NN I-NP O
19 At IN B-VP O
19 that DT B-NP O
19 time NN I-NP O
19 a DT B-NP O
19 right JJ I-NP O
20 heart NN I-NP O
20 catheterization NN I-NP O
20 revealed VBD B-VP O
20 high JJ B-NP O
20 filling NN I-NP O
20 pressures NNS I-NP O
20 and CC O O
20 he PRP O O
20 was VBD B-VP O
21 treated VBN O O
21 with IN B-VP O
21 aggressive JJ B-NP O
21 diuresis NN I-NP O
21 Angiography NNP I-NP O
21 revealed VBD B-VP O
21 occluded VBN O O
22 SVGs NNP B-NP O
22 and CC O O
22 a DT B-NP O
22 patent NN I-NP O
22 LIMA NNP I-NP O
22 Dobutamine NNP I-NP B-m
22 radionuclide NN I-NP O
22 study NN I-NP O
22 revealed VBD B-VP O
23 inferior JJ O O
23 and CC O O
23 inferolateral JJ B-NP O
23 infarct NN I-NP O
23 There EX O O
23 was VBD B-VP O
23 no DT B-NP O
23 evidence NN I-NP O
23 of IN B-VP O
24 revascularization NN B-NP O
24 Evaluation NNP I-NP O
24 for IN B-VP O
24 heart NN B-NP O
24 transplant NN I-NP O
24 found VBD B-VP O
24 cirrhosis NN B-NP O
25 by IN B-VP O
25 liver NN B-NP O
25 spleen NN I-NP O
25 scan JJ O O
25 which WDT O O
25 ruled VBD B-VP O
25 out RP O O
25 the DT B-NP O
25 possibility NN I-NP O
25 of IN B-VP O
25 transplant NN B-NP O
26 He PRP O O
26 reported VBD B-VP O
26 light-headedness JJ O O
26 and CC O O
26 dizziness NN B-NP O
26 and CC O O
26 was VBD B-VP O
26 seen VBN O O
26 by IN B-VP O
26 the DT B-NP O
27 Electrophysiology NNP I-NP O
27 Service NNP I-NP O
27 who WP O O
27 performed VBD B-VP O
27 an DT B-NP O
27 EP NNP I-NP O
27 study NN I-NP O
27 which WDT O O
27 was VBD B-VP O
28 negative JJ O O
28 for IN B-VP O
28 provokable JJ B-NP O
28 VT NNP I-NP O
28 and CC O O
28 since IN B-VP O
28 he PRP O O
28 is VBZ O O
28 not RB O O
28 a DT B-NP O
28 transplant JJ I-NP O
29 candidate NN I-NP O
29 it PRP O O
29 was VBD B-VP O
29 felt VBN O O
29 that IN B-VP O
29 empiric JJ B-NP O
29 ICD NNP I-NP O
29 placement NN I-NP O
29 would MD O O
29 not RB O O
29 be VB O O
29 in IN B-VP O
30 his PRP$ O O
30 best JJS B-NP O
30 interest NN I-NP O
30 His PRP$ O O
30 light-headedness JJ O O
30 and CC O O
30 presyncope NN B-NP O
30 worsened VBD B-VP O
31 His PRP$ O O
31 captopril NN B-NP B-m
31 captopril NN I-NP B-m
31 dose NN I-NP O
31 was VBD B-VP O
31 reduced VBN O O
31 from IN B-VP O
31 37.5 CD O B-do
31 mg NNS B-NP I-do
31 to TO O O
31 25 CD O B-do
31 mg NNS B-NP I-do
31 t.i.d JJ B-NP B-f
31 t.i.d NN I-NP B-f
31 with IN B-VP O
32 marked JJ B-NP O
32 improvement NN I-NP O
32 in IN B-VP O
32 his PRP$ O O
32 energy NN B-NP O
32 and CC O O
32 less JJR B-NP O
32 dizziness NN I-NP O
32 Over IN B-VP O
32 the DT B-NP O
32 past JJ I-NP O
33 weeks NNS I-NP O
33 his PRP$ O O
33 dizziness NN B-NP O
33 and CC O O
33 light-headedness NN B-NP O
33 recurred NN I-NP O
33 and CC O O
33 worsened VBD B-VP O
33 with IN B-VP O
34 episodes NNS B-NP O
34 of IN B-VP O
34 presyncope NN B-NP O
34 and CC O O
34 frank JJ B-NP O
34 syncope NN I-NP O
34 On IN B-VP O
34 the DT B-NP O
34 day NN I-NP O
34 of IN B-VP O
34 admission NN B-NP O
35 he PRP O O
35 was VBD B-VP O
35 scheduled VBN O O
35 for IN B-VP O
35 a DT B-NP O
35 clinic JJ I-NP O
35 appointment NN I-NP O
35 On IN B-VP O
35 arrival NN B-NP O
35 he PRP O O
35 felt VBD B-VP O
36 dizzy JJ O O
36 and CC O O
36 "crumpled" JJ O O
36 with IN B-VP O
36 loss NN B-NP O
36 of IN B-VP O
36 consciousness NN B-NP O
36 and CC O O
36 therefore NN B-NP O
36 was VBD B-VP O
37 admitted VBN O O
37 for IN B-VP O
37 further JJ B-NP O
37 evaluation NN I-NP O
38 PAST NNP I-NP O
38 MEDICAL NNP I-NP O
38 HISTORY: NNP I-NP O
38 Ischemic NNP I-NP O
38 cardiomyopathy NN I-NP O
38 with IN B-VP O
38 an DT B-NP O
38 ejection NN I-NP O
39 fraction NN I-NP O
39 of IN B-VP O
39 15% CD O O
39 to TO O O
39 20% CD O O
39 in IN B-VP O
39 February NNP B-NP O
39 of IN B-VP O
39 2001 CD O O
39 , , O O
40 status NN B-NP O
40 post NN I-NP O
40 anterior JJ B-NP O
40 MI NNP I-NP O
40 in IN B-VP O
40 1980 CD O O
40 and CC O O
40 1986 CD O O
40 , , O O
40 three CD O O
40 vessel NN B-NP O
40 CABG NNP I-NP O
40 in IN B-VP O
40 1987 CD O O
41 with IN B-VP O
41 LIMA NNP B-NP O
41 to TO O O
41 LAD NNP B-NP O
41 , , O O
41 SVG NNP B-NP O
41 to TO O O
41 OM NNP B-NP O
41 and CC O O
41 SVG NNP B-NP O
41 to TO O O
41 PDA NNP B-NP O
41 , , O O
41 type NN B-NP O
41 2 CD O O
41 diabetes NNS B-NP O
42 mellitus RB O O
42 , , O O
42 insulin JJ B-NP O
42 dependent NN I-NP O
42 , , O O
42 hypothyroidism NN B-NP O
42 , , O O
42 nephrolithiasis NN B-NP O
42 , , O O
43 gallstones NNS B-NP O
43 , , O O
43 cardiac JJ B-NP O
43 cirrhosis NN I-NP O
43 which WDT O O
43 is VBZ O O
43 mild JJ O O
43 and CC O O
43 was VBD B-VP O
43 diagnosed VBN O O
43 in IN B-VP O
44 February NNP B-NP O
44 2001 CD O O
44 by IN B-VP O
44 abdominal JJ B-NP O
44 ultrasound NN I-NP O
44 and CC O O
44 liver NN B-NP O
44 scan JJ O O
44 , , O O
44 IBS NNP B-NP O
44 , , O O
44 psoriasis NN B-NP O
45 ADMISSION NNP I-NP O
45 MEDICATIONS: NNP I-NP O
45 Captopril NNP I-NP B-m
45 25 CD O B-do
45 mg NN B-NP I-do
45 p.o NN I-NP B-mo
45 t.i.d NN I-NP B-f
45 , , O O
45 Isordil NNP B-NP B-m
45 40 CD O B-do
45 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 t.i.d NN I-NP B-f
46 , , O O
46 Lipitor NNP B-NP B-m
46 20 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 q.d NN I-NP B-f
46 , , O O
46 NPH NNP B-NP B-m
47 insulin VBZ O O
47 65 CD O B-do
47 units NNS B-NP I-do
47 subcu JJ B-NP B-mo
47 b.i.d NN I-NP B-f
47 , , O O
47 Xanax NNP B-NP B-m
47 p.r.n NN I-NP B-f
47 , , O O
47 torsemide RB O B-m
47 120 CD O B-do
47 mg NNS B-NP I-do
47 p.o JJ B-NP B-mo
48 q.a.m NN I-NP B-f
48 , , O O
48 torsemide RB O B-m
48 80 CD O B-do
48 mg NNS B-NP I-do
48 p.o JJ O B-mo
48 q.p.m RB O B-f
48 , , O O
48 digoxin VBZ O B-m
48 0.125 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 q.d NN I-NP B-f
48 , , O O
49 Synthroid NNP B-NP B-m
49 250 CD O B-do
49 mcg NN B-NP I-do
49 p.o NN I-NP B-mo
49 q.d NN I-NP B-f
49 , , O O
49 Prozac NNP B-NP B-m
49 20 CD O B-do
49 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 q.d NN I-NP B-f
50 ALLERGIES: NNP I-NP O
50 No NNP I-NP O
50 known VBN O O
50 drug NN B-NP O
50 allergies NNS I-NP O
51 ADMISSION NNP I-NP O
51 PHYSICAL NNP I-NP O
51 EXAMINATION: NNP I-NP O
51 Vital NNP I-NP O
51 signs: VBD B-VP O
51 Lying VBG O O
51 blood NN B-NP O
51 pressure NN I-NP O
52 94/58 CD O O
52 , , O O
52 heart NN B-NP O
52 rate NN I-NP O
52 70 CD O O
52 , , O O
52 oxygen NN B-NP O
53 saturation NN I-NP O
53 97% CD O O
53 on IN B-VP O
53 room NN B-NP O
53 air NN I-NP O
53 Sitting VBG O O
53 blood NN B-NP O
53 pressure NN I-NP O
53 78/54 CD O O
53 Patient NNP B-NP O
54 could MD O O
54 not RB O O
54 stand VB O O
54 secondary JJ O O
54 to TO O O
54 light-headedness JJ O O
54 to TO O O
54 complete VB O O
55 orthostatic JJ B-NP O
55 vital JJ I-NP O
55 signs NNS I-NP O
55 Afebrile NNP I-NP O
55 General: NNP I-NP O
55 Appearing NNP I-NP O
56 comfortable JJ O O
56 in IN B-VP O
56 a DT B-NP O
56 supine JJ I-NP O
56 position NN I-NP O
56 No NNP I-NP O
56 acute NN I-NP O
56 distress NN I-NP O
57 Cardiovascular: NNP I-NP O
57 Regular NNP I-NP O
57 Normal NNP I-NP O
57 S1 NNP I-NP O
57 , , O O
57 S2 NNP B-NP O
57 No NNP I-NP O
57 S3 NNP I-NP O
57 JVP NNP I-NP O
58 approximately RB O O
58 5 CD O O
58 cm NN B-NP O
58 A NNP I-NP O
58 II/VI NNP I-NP O
58 holosystolic JJ B-NP O
58 murmur NN I-NP O
58 at IN B-VP O
58 apex JJ B-NP O
58 Lungs: NNP I-NP O
59 Clear NNP I-NP O
59 to TO O O
59 auscultation VB O O
59 bilaterally RB O O
59 Abdomen: NNP B-NP O
59 Soft NNP I-NP O
59 , , O O
59 non-tender NN B-NP O
59 , , O O
60 nondistended VBD B-VP O
60 No DT B-NP O
60 hepatosplenomegaly NN I-NP O
60 Extremities: NNP I-NP O
60 No NNP I-NP O
60 edema NN I-NP O
61 ADMISSION NNP I-NP O
61 LABORATORY NNP I-NP O
61 DATA: NNP I-NP O
61 Sodium NNP I-NP O
61 128 CD O O
61 , , O O
61 potassium NN B-NP O
61 4.2 CD O O
61 , , O O
61 chloride RB O O
61 91 CD O O
61 , , O O
62 bicarbonate NN B-NP O
62 22 CD O O
62 , , O O
62 BUN NNP B-NP O
62 64 CD O O
62 , , O O
62 creatinine NN B-NP O
62 2.6 CD O O
62 , , O O
63 glucose VBD B-VP O
63 348 CD O O
63 White NNP B-NP O
63 blood NN I-NP O
63 cell NN I-NP O
63 count NN I-NP O
63 17.9 CD O O
63 , , O O
63 hematocrit NN B-NP O
63 37.6 CD O O
63 , , O O
64 platelets NNS B-NP O
64 286 CD O O
65 OPERATIONS NNP B-NP O
65 AND NNP I-NP O
65 PROCEDURES: NNP I-NP O
65 None NNP I-NP O
66 HOSPITAL NNP I-NP O
66 COURSE: NNP I-NP O
66 This DT O O
66 is VBZ O O
66 a DT B-NP O
66 62-year-old JJ I-NP O
66 white JJ I-NP O
66 male NN I-NP O
66 with IN B-VP O
66 history NN B-NP O
66 of IN B-VP O
67 insulin NN B-NP O
67 dependent NN I-NP O
67 diabetes VBZ O O
67 mellitus RBS O O
67 , , O O
67 coronary JJ B-NP O
68 artery NN I-NP O
68 disease NN I-NP O
68 and CC O O
68 ischemic JJ B-NP O
68 cardiomyopathy NN I-NP O
68 and CC O O
68 probably RB O O
68 cardiac JJ B-NP O
69 cirrhosis NN I-NP O
69 who WP O O
69 presents VBZ O O
69 with IN B-VP O
69 presyncope NN B-NP O
69 and CC O O
69 syncope VB O O
69 The DT B-NP O
69 arrhythmia NN I-NP O
70 was VBD B-VP O
70 considered VBN O O
70 possible JJ O O
70 and CC O O
70 there EX O O
70 has VBZ O O
70 been VBN O O
70 none RB O O
70 documented VBN O O
70 and CC O O
70 he PRP O O
71 was VBD B-VP O
71 not RB O O
71 inducible JJ O O
71 two CD O O
71 years NNS B-NP O
71 prior RB O O
71 to TO O O
71 admission VB O O
71 Given NNP B-NP O
71 his PRP$ O O
72 orthostatic JJ B-NP O
72 vital JJ I-NP O
72 signs NNS I-NP O
72 it PRP O O
72 was VBD B-VP O
72 felt VBN O O
72 that IN B-VP O
72 his PRP$ O O
72 volume NN B-NP O
72 status NN I-NP O
72 and CC O O
73 medications NNS B-NP O
73 were VBD B-VP O
73 responsible JJ O O
73 for IN B-VP O
73 his PRP$ O O
73 symptoms NNS B-NP O
73 In IN B-VP O
73 addition NN B-NP O
73 his PRP$ O O
74 elevated JJ B-NP O
74 BUN NNP I-NP O
74 and CC O O
74 creatinine NN B-NP O
74 were VBD B-VP O
74 consistent JJ O O
74 with IN B-VP O
74 volume NN B-NP O
74 depletion NN I-NP O
75 He PRP O O
75 improved VBD B-VP O
75 off RP O O
75 diuretics NNS B-NP B-m
75 , , O O
75 nitrates NNS B-NP B-m
75 and CC O O
75 ACE NNP B-NP B-m
75 inhibitor NN I-NP I-m
75 as RB O O
75 well RB O O
75 as IN B-VP O
76 liberalization NN B-NP O
76 of IN B-VP O
76 his PRP$ O O
76 diet JJ O O
76 regarding VBG O O
76 salt NN B-NP O
76 and CC O O
76 fluid JJ B-NP O
76 intake NN I-NP O
76 There EX O O
77 were VBD B-VP O
77 no DT B-NP O
77 arrhythmias NN I-NP O
77 noted VBD B-VP O
77 on IN B-VP O
77 his PRP$ O O
77 telemetry NN B-NP O
77 monitor NN I-NP O
77 An DT B-NP O
77 endocrine NN I-NP O
78 consult NN I-NP O
78 was VBD B-VP O
78 called VBN O O
78 to TO O O
78 evaluate VB O O
78 for IN B-VP O
78 possible JJ B-NP O
78 contribution NN I-NP O
78 of IN B-VP O
79 autonomic JJ B-NP O
79 insufficiency NN I-NP O
79 secondary JJ O O
79 to TO O O
79 his PRP$ O O
79 diabetes NNS B-NP O
79 mellitus VBP O O
79 They PRP O O
80 recommended VBD B-VP O
80 decreasing VBG O O
80 his PRP$ O O
80 Synthroid NNP B-NP B-m
80 dose NN I-NP O
80 due JJ O O
80 to TO O O
80 a DT B-NP O
80 suppressed JJ I-NP O
80 TSH NN I-NP O
81 as RB O O
81 well RB O O
81 as IN B-VP O
81 more RBR O O
81 aggressive JJ B-NP O
81 blood NN I-NP O
81 sugar NN I-NP O
81 control NN I-NP O
81 , , O O
81 however RB O O
81 , , O O
81 they PRP O O
81 were VBD B-VP O
82 unable JJ O O
82 to TO O O
82 document VB O O
82 orthostatic JJ B-NP O
82 hypotension NN I-NP O
82 and CC O O
82 felt VBD B-VP O
82 that IN B-VP O
82 his PRP$ O O
83 episodes NNS B-NP O
83 of IN B-VP O
83 presyncope NN B-NP O
83 and CC O O
83 syncope NN B-NP O
83 were VBD B-VP O
83 related VBN O O
83 to TO O O
83 his PRP$ O O
83 volume NN B-NP O
84 status NN I-NP O
84 and CC O O
84 medications NNS B-NP O
84 rather RB O O
84 than IN B-VP O
84 autonomic JJ B-NP O
84 insufficiency NN I-NP O
85 DISCHARGE NNP I-NP O
85 MEDICATIONS: NNP I-NP O
85 To TO O O
85 be VB O O
85 dictated VBN O O
85 on IN B-VP O
85 the DT B-NP O
85 actual JJ I-NP O
85 day NN I-NP O
85 of IN B-VP O
86 discharge NN B-NP O
87 CONDITION NNP I-NP O
87 ON NNP I-NP O
87 DISCHARGE: NNP I-NP O
87 Satisfactory NNP I-NP O
88 DISPOSITION: NNP I-NP O
88 Home NNP I-NP O
88 with IN B-VP O
88 services NNS B-NP O
89 FOLLOW-UP: NNP I-NP O
89 Primary NNP I-NP O
89 care NN I-NP O
89 provider NN I-NP O
89 and CC O O
89 cardiologist NN B-NP O
89 , , O O
89 Dr NNP B-NP O
89 Edgar NNP I-NP O
89 Der NNP I-NP O
90 Dictated NNP I-NP O
90 By: NNP I-NP O
90 JEFFERSON NNP I-NP O
90 PARIDO NNP I-NP O
90 , , O O
90 M.D NNP B-NP O
90 PC23 NNP I-NP O
91 Attending: NNP I-NP O
91 OMER NNP I-NP O
91 A NNP I-NP O
91 CALICO NNP I-NP O
91 , , O O
91 M.D NNP B-NP O
91 YS72 NNP I-NP O
92 LI346/023810 NNP I-NP O
93 Batch: NNP I-NP O
93 6827 CD O O
93 Index NNP B-NP O
93 No NNP I-NP O
93 G7HNXU3HHX NNP I-NP O
93 D: NNP I-NP O
93 7/18/02 CD O O
94 T: NNP B-NP O
94 7/18/02 CD O O
95 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #549067 VBZ O O
4 384866461 CD O O
4 WVHO NNP B-NP O
4 24092986 CD O O
4 3081628 CD O O
4 7/13/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/7/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/24/2004 CD O O
7 ATTENDING: NNP B-NP O
7 DUDLEY NNP I-NP O
7 SPERL NNP I-NP O
7 MD NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
9 This DT O O
9 is VBZ O O
9 a DT B-NP O
9 66-year-old JJ I-NP O
9 female NN I-NP O
9 who WP O O
9 presented VBD B-VP O
9 with IN B-VP O
9 one CD O O
9 day NN B-NP O
9 of IN B-VP O
10 abdominal JJ B-NP O
10 pain NN I-NP O
10 She PRP O O
10 was VBD B-VP O
10 constipated VBN O O
10 for IN B-VP O
10 seven CD O O
10 days NNS B-NP O
10 and CC O O
10 presented VBN O O
11 with IN B-VP O
11 abdominal JJ B-NP O
11 pain NN I-NP O
11 on IN B-VP O
11 0/5/04 CD O O
12 PAST NNP B-NP O
12 MEDICAL NNP I-NP O
12 HISTORY: NNP I-NP O
13 Significant NNP I-NP O
13 for IN B-VP O
13 hypertension NN B-NP O
13 , , O O
13 atrial JJ B-NP B-r
13 fibrillation NN I-NP I-r
13 on IN B-VP O
13 Coumadin NNP B-NP B-m
13 , , O O
14 diabetes VBZ O O
14 mellitus NN B-NP O
14 , , O O
14 high JJ B-NP O
14 cholesterol NN I-NP O
14 , , O O
14 coronary JJ B-NP O
14 artery NN I-NP O
14 disease NN I-NP O
14 , , O O
15 gallstones NNS B-NP O
15 and CC O O
15 diverticuli VB O O
16 PAST NNP B-NP O
16 SURGICAL NNP I-NP O
16 HISTORY: NNP I-NP O
17 Nonsignificant NNP I-NP O
18 ADMISSION NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 Avandia NNP I-NP B-m
19 4 CD O B-do
19 mg NN B-NP I-do
19 b.i.d NN I-NP B-f
19 , , O O
19 lisinopril VBZ O B-m
19 20 CD O B-do
19 mg NN B-NP I-do
19 b.i.d NN I-NP B-f
19 , , O O
19 Hytrin NNP B-NP B-m
19 one CD O B-do
19 q.h.s NN B-NP B-f
19 , , O O
20 Lasix NNP B-NP B-m
20 80 CD O B-do
20 mg NN B-NP I-do
20 x1 NN I-NP B-f
20 , , O O
20 spironolactone NN B-NP B-m
20 25 CD O B-do
20 mg NN B-NP I-do
20 x3 NN I-NP B-f
20 , , O O
20 atenolol RB O B-m
20 50 CD O B-do
20 mg NN B-NP I-do
20 b.i.d NN I-NP B-f
20 , , O O
21 Lipitor NNP B-NP B-m
21 10 CD O B-do
21 mg NN B-NP I-do
21 x1 NN I-NP B-f
21 , , O O
21 Flovent NNP B-NP B-m
21 , , O O
21 Bextra NNP B-NP B-m
21 10 CD O B-do
21 mg NN B-NP I-do
21 x1 NN I-NP B-f
21 , , O O
21 Nexium NNP B-NP B-m
21 20 CD O B-do
21 mg NN B-NP I-do
21 x1 NN I-NP B-f
21 , , O O
22 Humulin NNP B-NP B-m
22 22 CD O B-do
22 units NNS B-NP I-do
22 q.a.m RB O B-f
22 , , O O
22 Coumadin NNP B-NP B-m
22 5 CD O B-do
22 mg NN B-NP I-do
22 , , O O
22 and CC O O
22 baby NN B-NP B-m
22 aspirin VBP O I-m
22 81 CD O B-do
22 mg NN B-NP I-do
23 For IN B-VP O
23 this DT B-NP O
23 reason NN I-NP O
23 , , O O
23 the DT B-NP O
23 patient NN I-NP O
23 was VBD B-VP O
23 admitted VBN O O
23 to TO O O
23 the DT B-NP O
23 ED NNP I-NP O
23 and CC O O
23 the DT B-NP O
23 chest JJS I-NP O
24 x-ray NN I-NP O
24 at IN B-VP O
24 that DT B-NP O
24 time NN I-NP O
24 showed VBD B-VP O
24 free JJ B-NP O
24 air NN I-NP O
24 below IN B-VP O
24 the DT B-NP O
24 diaphragm NN I-NP O
24 The DT B-NP O
24 KUB NNP I-NP O
25 showed VBD B-VP O
25 dilated VBN O O
25 small JJ B-NP O
25 bowel NN I-NP O
25 and CC O O
25 the DT B-NP O
25 abdominal JJ I-NP O
25 CT NNP I-NP O
25 showed VBD B-VP O
25 multiple JJ B-NP O
26 free JJ I-NP O
26 air NN I-NP O
26 For IN B-VP O
26 this DT B-NP O
26 reason NN I-NP O
26 , , O O
26 the DT B-NP O
26 patient NN I-NP O
26 was VBD B-VP O
26 brought VBN O O
26 to TO O O
26 the DT B-NP O
26 OR NNP I-NP O
26 on IN B-VP O
27 0/5/04 CD O O
27 , , O O
27 the DT B-NP O
27 same JJ I-NP O
27 day NN I-NP O
27 and CC O O
27 she PRP O O
27 underwent JJ B-NP O
27 exploratory JJ I-NP O
27 laparotomy NN I-NP O
28 and CC O O
28 appendectomy NN B-NP O
28 as RB O O
28 well RB O O
28 The DT B-NP O
28 patient NN I-NP O
28 had VBD B-VP O
28 been VBN O O
28 diagnosed VBN O O
28 at IN B-VP O
28 that DT B-NP O
29 time NN I-NP O
29 of IN B-VP O
29 perforated JJ O O
29 appendicitis IN B-VP O
29 The DT B-NP O
29 surgery NN I-NP O
29 was VBD B-VP O
29 uncomplicated VBN O O
30 and CC O O
30 the DT B-NP O
30 patient NN I-NP O
30 afterwards NNS I-NP O
30 was VBD B-VP O
30 transferred VBN O O
30 to TO O O
30 the DT B-NP O
30 SICU NNP I-NP O
30 Please NNP I-NP O
31 refer VB O O
31 to TO O O
31 the DT B-NP O
31 interim JJ I-NP O
31 dictation NN I-NP O
31 for IN B-VP O
31 the DT B-NP O
31 patient NN I-NP O
31 for IN B-VP O
31 the DT B-NP O
31 SICU NNP I-NP O
32 course NN I-NP O
32 In IN B-VP O
32 the DT B-NP O
32 SICU NNP I-NP O
32 , , O O
32 mainly RB O O
32 she PRP O O
32 had VBD B-VP O
32 three CD O O
32 problems NNS B-NP O
32 and CC O O
32 for IN B-VP O
32 this DT B-NP O
33 reason NN I-NP O
33 , , O O
33 she PRP O O
33 was VBD B-VP O
33 kept VBN O O
33 in IN B-VP O
33 the DT B-NP O
33 unit NN I-NP O
33 She PRP O O
33 had VBD B-VP O
33 rapid JJ B-NP O
33 atrial JJ I-NP O
34 fibrillation NN I-NP O
34 , , O O
34 oliguria NN B-NP O
34 , , O O
34 and CC O O
34 confusion NN B-NP O
34 The DT B-NP O
34 patient NN I-NP O
34 was VBD B-VP O
35 transferred VBN O O
35 back RB O O
35 on IN B-VP O
35 the DT B-NP O
35 floor NN I-NP O
35 on IN B-VP O
35 3/20/04 CD O O
35 on IN B-VP O
35 no DT B-NP O
35 antibiotics NNS I-NP O
35 and CC O O
36 was VBD B-VP O
36 stable JJ O O
36 with IN B-VP O
36 NG NNP B-NP O
36 tube NN I-NP O
36 in IN B-VP O
36 place NN B-NP O
36 and CC O O
36 through IN B-VP O
36 this DT B-NP O
36 NG NNP I-NP O
36 tube NN I-NP O
36 , , O O
36 the DT B-NP O
37 patient NN I-NP O
37 was VBD B-VP O
37 fed VBN O O
37 The DT B-NP O
37 patient NN I-NP O
37 underwent JJ B-NP O
37 speech NN I-NP O
37 and CC O O
37 swallow JJ B-NP O
38 evaluation NN I-NP O
38 at IN B-VP O
38 that DT B-NP O
38 time NN I-NP O
38 and CC O O
38 the DT B-NP O
38 Speech NNP I-NP O
38 &amp; NNP I-NP O
38 Swallow NNP I-NP O
38 cleared VBD B-VP O
38 her PRP$ O O
38 for IN B-VP O
39 mechanical JJ B-NP O
39 soft JJ I-NP O
39 diet NN I-NP O
39 and CC O O
39 the DT B-NP O
39 NG NNP I-NP O
39 tube NN I-NP O
39 was VBD B-VP O
39 discontinued VBN O O
40 The DT B-NP O
40 postoperative JJ I-NP O
40 course NN I-NP O
40 mainly RB O O
40 has VBZ O O
40 been VBN O O
40 characterized VBN O O
40 by IN B-VP O
40 slow JJ B-NP O
41 recovery NN I-NP O
41 and CC O O
41 decrease NN B-NP O
41 in IN B-VP O
41 mental JJ B-NP O
41 confusion NN I-NP O
41 , , O O
41 for IN B-VP O
41 presence NN B-NP O
41 of IN B-VP O
42 flatus NN B-NP O
42 , , O O
42 bowel NN B-NP O
42 movement NN I-NP O
42 and CC O O
42 advanced VBD B-VP O
42 diet NNS B-NP O
42 to TO O O
42 mechanical JJ O O
42 soft JJ O O
42 diet VBZ O O
43 The DT B-NP O
43 patient NN I-NP O
43 also RB O O
43 was VBD B-VP O
43 restarted VBN O O
43 on IN B-VP O
43 Coumadin NNP B-NP B-m
43 on IN B-VP O
43 postop JJ B-NP O
43 day NN I-NP O
43 9 CD O O
43 , , O O
43 and CC O O
44 on IN B-VP O
44 postop JJ B-NP O
44 day NN I-NP O
44 13 CD O O
44 , , O O
44 she PRP O O
44 was VBD B-VP O
44 started VBN O O
44 also RB O O
44 on IN B-VP O
44 baby NN B-NP B-m
44 aspirin IN B-VP I-m
44 The DT B-NP O
45 patient NN I-NP O
45 is VBZ O O
45 discharged VBN O O
45 in IN B-VP O
45 stable JJ B-NP O
45 condition NN I-NP O
46 On IN B-VP O
46 physical JJ B-NP O
46 examination NN I-NP O
46 , , O O
46 she PRP O O
46 is VBZ O O
46 alert JJ O O
46 and CC O O
46 oriented JJ B-NP O
46 x3 NN I-NP O
47 Respiratory: NNP I-NP O
47 She PRP O O
47 is VBZ O O
47 clear JJ O O
47 in IN B-VP O
47 both DT B-NP O
47 lungs NNS I-NP O
47 She PRP O O
47 is VBZ O O
47 saturating VBG O O
47 on IN B-VP O
48 room NN B-NP O
48 air NN I-NP O
48 92% CD O O
48 during IN B-VP O
48 the DT B-NP O
48 day NN I-NP O
48 However RB O O
48 during IN B-VP O
48 the DT B-NP O
48 night NN I-NP O
48 and CC O O
48 most RBS O O
49 likely JJ O O
49 due JJ O O
49 to TO O O
49 her PRP$ O O
49 position NN B-NP O
49 in IN B-VP O
49 the DT B-NP O
49 bed NN I-NP O
49 , , O O
49 she PRP O O
49 requires VBZ O O
49 sometimes RB O O
50 oxygen JJ O B-m
50 2 CD O B-do
50 liters NNS B-NP I-do
50 nasal JJ B-NP B-mo
50 cannula NN I-NP I-mo
50 for IN B-VP O
50 saturation NN B-NP O
50 97% CD O O
50 Cardiac: NNP B-NP O
50 The DT B-NP O
51 patient NN I-NP O
51 is VBZ O O
51 in IN B-VP O
51 atrial JJ B-NP O
51 fibrillation NN I-NP O
51 , , O O
51 stable JJ B-NP O
51 condition NN I-NP O
51 Heart NNP I-NP O
51 rate NN I-NP O
52 is VBZ O O
52 controlled VBN O O
52 at IN B-VP O
52 93 CD O O
52 She PRP O O
52 is VBZ O O
52 on IN B-VP O
52 atenolol JJ O B-m
52 50 CD O B-do
52 mg NN B-NP I-do
52 b.i.d NN I-NP B-f
52 GI: NNP I-NP O
52 The DT B-NP O
53 patient NN I-NP O
53 is VBZ O O
53 on IN B-VP O
53 mechanical JJ O O
53 soft JJ O O
53 diet VBZ O O
53 The DT B-NP O
53 abdomen NNS I-NP O
53 is VBZ O O
53 nonpainful JJ B-NP O
54 Nondistended NNP I-NP O
54 Bowels NNP I-NP O
54 sounds NNS I-NP O
54 are VBP O O
54 present JJ O O
54 The DT B-NP O
54 patient NN I-NP O
54 had VBD B-VP O
55 already RB O O
55 bowel VBN O O
55 movement NN B-NP O
55 and CC O O
55 she PRP O O
55 is VBZ O O
55 passing VBG O O
55 flatus NN B-NP O
55 because IN B-VP O
55 she PRP O O
55 had VBD B-VP O
56 in IN B-VP O
56 the DT O O
56 last JJ O O
56 two CD O O
56 days NNS B-NP O
56 three CD O O
56 bowel NN B-NP O
56 movements NNS I-NP O
56 in IN B-VP O
56 one CD O O
56 day NN B-NP O
56 C NNP I-NP O
56 diff NN I-NP O
57 and CC O O
57 leucocytes NNS B-NP O
57 were VBD B-VP O
57 sent VBN O O
57 that WDT O O
57 are VBP O O
57 so RB O O
57 far RB O O
57 negative JJ B-NP O
57 GU: NNP I-NP O
57 The DT B-NP O
58 patient NN I-NP O
58 is VBZ O O
58 back RB O O
58 on IN B-VP O
58 home NN B-NP O
58 Lasix NNP I-NP B-m
58 80 CD O B-do
58 mg NN B-NP I-do
58 x1 NNP I-NP B-f
58 plus CC O O
58 spironolactone JJ O B-m
58 25 CD O B-do
58 mg NN B-NP I-do
59 b.i.d VBD B-VP B-f
59 The DT B-NP O
59 patient NN I-NP O
59 has VBZ O O
59 been VBN O O
59 voiding VBG O O
59 fine JJ O O
59 and CC O O
59 with IN B-VP O
59 no DT B-NP O
59 problem NN I-NP O
59 in IN B-VP O
60 urinating NN B-NP O
60 and CC O O
60 the DT B-NP O
60 Foley NNP I-NP O
60 was VBD B-VP O
60 discontinued VBN O O
60 on IN B-VP O
60 postoperative JJ B-NP O
60 day NN I-NP O
61 #12 NNP I-NP O
61 ID: NNP I-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 is VBZ O O
61 on IN B-VP O
61 no DT B-NP O
61 antibiotics NNS I-NP O
61 Heme: VBP O O
61 The DT B-NP O
61 patient NN I-NP O
61 is VBZ O O
62 back RB O O
62 on IN B-VP O
62 Coumadin NNP B-NP B-m
62 and CC O O
62 her PRP$ O O
62 INR NNP B-NP O
62 is VBZ O O
62 3.5 CD O O
62 She PRP O O
62 received VBD B-VP O
62 yesterday NN B-NP O
62 a DT B-NP O
63 dose NN I-NP O
63 of IN B-VP O
63 Coumadin NNP B-NP B-m
63 2.5 CD O B-do
63 mg NN B-NP I-do
63 She PRP O O
63 is VBZ O O
63 back RB O O
63 on IN B-VP O
63 baby NN B-NP B-m
63 aspirin NN I-NP I-m
63 also RB O O
63 at IN B-VP O
63 81 CD O B-do
64 mg NN B-NP O
64 She PRP O O
64 is VBZ O O
64 also RB O O
64 on IN B-VP O
64 subcutaneous JJ B-NP B-mo
64 heparin NN I-NP B-m
64 b.i.d NN I-NP B-f
64 as IN B-VP O
64 prophylaxis NN B-NP O
65 for IN B-VP O
65 DVT NNP B-NP B-r
65 and CC O O
65 she PRP O O
65 is VBZ O O
65 also RB O O
65 on IN B-VP O
65 pneumo JJ B-NP O
65 boots NNS I-NP O
66 The DT B-NP O
66 recent JJ I-NP O
66 labs NN I-NP O
66 on IN B-VP O
66 discharge NN B-NP O
66 are VBP O O
66 glucose JJ O O
66 100 CD O O
66 , , O O
66 BUN NNP B-NP O
66 of IN B-VP O
66 6 CD O O
66 , , O O
67 creatinine NN B-NP O
67 0.8 CD O O
67 , , O O
67 sodium NN B-NP O
67 144 CD O O
67 , , O O
67 potassium NN B-NP O
67 3.3 CD O O
67 She PRP O O
67 received VBD B-VP O
67 a DT B-NP O
67 dose NN I-NP O
68 of IN B-VP O
68 20 CD O B-do
68 mg NNS B-NP I-do
68 p.o JJ B-NP B-mo
68 potassium NN I-NP B-m
68 today NN I-NP O
68 Chloride NNP I-NP O
68 is VBZ O O
68 104 CD O O
68 , , O O
68 CO2 NNP B-NP O
68 32 CD O O
68 , , O O
68 anion NN B-NP O
69 gap NN I-NP O
69 8 CD O O
69 , , O O
69 calcium NN B-NP O
69 8 CD O O
69 , , O O
69 magnesium NN B-NP O
69 1.8 CD O O
69 PTT NNP B-NP O
69 34.7 CD O O
69 , , O O
69 PTT NNP B-NP O
69 6.3 CD O O
69 , , O O
69 INR NNP B-NP O
69 is VBZ O O
69 3.5 CD O O
70 The DT B-NP O
70 patient NN I-NP O
70 is VBZ O O
70 discharged VBN O O
70 with IN B-VP O
70 the DT O O
70 following VBG O O
70 medications: NN B-NP O
70 Flovent NNP I-NP B-m
71 220 CD O B-do
71 , , O O
71 INH NNP B-NP B-mo
71 x2 NNP I-NP B-f
71 , , O O
71 Pepcid NNP B-NP B-m
71 p.o VBZ O B-mo
71 20 CD O B-do
71 mg NN B-NP I-do
71 b.i.d NN I-NP B-f
71 , , O O
71 subcutaneous JJ B-NP B-mo
71 heparin NN I-NP B-m
71 5000 CD O B-do
72 units NNS B-NP O
72 b.i.d RB O B-f
72 , , O O
72 atenolol VBZ O B-m
72 50 CD O B-do
72 x2 NN B-NP B-f
72 She PRP O O
72 is VBZ O O
72 on IN B-VP O
72 Seroquel NNP B-NP B-m
72 25 CD O B-do
72 mg NN B-NP I-do
72 x1 NNP I-NP B-f
72 p.o NN I-NP B-mo
72 , , O O
73 insulin NN B-NP B-m
73 scale NN I-NP B-do
73 , , O O
73 Lasix NNP B-NP B-m
73 80 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 q.d NN I-NP B-f
73 , , O O
73 spironolactone NN B-NP B-m
73 25 CD O B-do
73 mg NN B-NP I-do
74 b.i.d NN I-NP B-f
74 , , O O
74 Simvastatin NNP B-NP B-m
74 10 CD O B-do
74 mg NN B-NP I-do
74 x1 NN I-NP B-f
74 , , O O
74 baby NN B-NP B-m
74 aspirin VBD B-VP I-m
74 80 CD O B-do
74 mg NN B-NP I-do
74 p.o NN I-NP B-mo
74 p.r.n NN I-NP B-f
74 She PRP O O
75 is VBZ O O
75 on IN B-VP O
75 albuterol NN B-NP B-m
75 at IN B-VP O
75 2.5 CD O B-do
75 mg NN B-NP I-do
75 q.12h NN I-NP B-f
75 and CC O O
75 she PRP O O
75 is VBZ O O
75 on IN B-VP O
75 Zofran NNP B-NP B-m
75 for IN B-VP O
75 nausea NN B-NP B-r
76 She PRP O O
76 is VBZ O O
76 on IN B-VP O
76 no DT B-NP O
76 pain NN I-NP O
76 medication NN I-NP O
76 and CC O O
76 she PRP O O
76 does VBZ O O
76 not RB O O
76 have VB O O
76 any DT O O
76 pain VB O O
77 The DT B-NP O
77 patient NN I-NP O
77 is VBZ O O
77 discharged VBN O O
77 in IN B-VP O
77 stable JJ B-NP O
77 condition NN I-NP O
77 and CC O O
77 she PRP O O
77 will MD O O
77 need VB O O
78 follow VB O O
78 up RP O O
78 with IN B-VP O
78 Dr NNP B-NP O
78 Ulysses NNP I-NP O
78 Gunnett NNP I-NP O
78 in IN B-VP O
78 three CD O O
78 weeks NNS B-NP O
78 and CC O O
78 the DT B-NP O
78 patient NN I-NP O
79 also RB O O
79 will MD O O
79 need VB O O
79 to TO O O
79 restart VB O O
79 her PRP$ O O
79 Humulin NNP B-NP B-m
79 dose NN I-NP O
79 for IN B-VP O
79 glucose JJ B-NP B-r
79 control NN I-NP I-r
80 and CC O O
80 the DT B-NP O
80 patient NN I-NP O
80 will MD O O
80 need VB O O
80 to TO O O
80 have VB O O
80 anticoagulation NN B-NP B-r
80 and CC O O
80 therefore RB O O
81 begin VB O O
81 Coumadin NNP B-NP B-m
81 for IN B-VP O
81 INR NNP B-NP O
81 range NN I-NP O
81 between IN B-VP O
81 2 CD O O
81 and CC O O
81 3 CD O O
82 eScription NN B-NP O
82 document: NN I-NP O
82 8-3090492 JJ B-NP O
82 EMSSten NNP I-NP O
82 Tel NNP I-NP O
83 Dictated NNP I-NP O
83 By: NNP I-NP O
83 RADEN NNP I-NP O
83 , , O O
83 WILBERT NNP B-NP O
84 Attending: NNP I-NP O
84 BRANTINGHAM NNP I-NP O
84 , , O O
84 QUINTON NNP B-NP O
85 Dictation NNP I-NP O
85 ID NNP I-NP O
85 9642896 CD O O
86 D: NNP B-NP O
86 5/24/04 CD O O
87 T: NNP B-NP O
87 5/24/04 CD O O
88 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #553121 VBZ O O
2 253394750 CD O O
2 R NNP B-NP O
2 76252492 CD O O
2 3915170 CD O O
2 0/3/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ? . B-VP O
2 MYOCARDIAL NNP B-NP O
2 INFARCTION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/25/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/23/2006 CD O O
4 ATTENDING: NNP B-NP O
4 PUSSER NNP I-NP O
4 , , O O
4 ROLLAND NNP B-NP O
4 M.D NNP I-NP O
5 CHIEF NNP I-NP O
5 COMPLAINT: NNP I-NP O
6 Chest NNP I-NP O
6 and CC O O
6 left VBD B-VP O
6 arm NN B-NP O
6 pain NN I-NP O
6 , , O O
6 and CC O O
6 left VBD B-VP O
6 arm NN B-NP O
6 paresthesias NN I-NP O
7 HISTORY NNP I-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT B-NP O
8 47-year-old JJ I-NP O
8 female NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
8 past JJ I-NP O
8 medical JJ I-NP O
8 history NN I-NP O
8 , , O O
8 which WDT O O
9 includes VBZ O O
9 HIV NNP B-NP O
9 positive JJ O O
9 , , O O
9 hepatitis JJ B-NP O
9 C NNP I-NP O
9 positive JJ O O
9 , , O O
9 seizures NNS B-NP O
9 , , O O
9 and CC O O
10 neuropathy JJ O O
10 , , O O
10 who WP O O
10 presented VBD B-VP O
10 complaining NN B-NP O
10 of IN B-VP O
10 left JJ B-NP O
10 hand NN I-NP O
10 paresthesias NN I-NP O
11 followed VBN O O
11 by IN B-VP O
11 left JJ B-NP O
11 hand NN I-NP O
11 pain NN I-NP O
11 that IN B-VP O
11 marches NNS B-NP O
11 proximally RB O O
11 up IN B-VP O
11 her PRP$ O O
11 left JJ B-NP O
12 arm NN I-NP O
12 and CC O O
12 affecting VBG O O
12 her PRP$ O O
12 left JJ B-NP O
12 shoulder NN I-NP O
12 and CC O O
12 chest NN B-NP O
12 Along IN B-VP O
12 with IN B-VP O
12 these DT B-NP O
13 symptoms NNS I-NP O
13 , , O O
13 she PRP O O
13 has VBZ O O
13 associated VBN O O
13 shortness NN B-NP O
13 of IN B-VP O
13 breath NN B-NP O
13 , , O O
13 palpitations NNS B-NP O
13 , , O O
14 lightheadedness NN B-NP O
14 , , O O
14 diaphoresis NN B-NP O
14 , , O O
14 and CC O O
14 nausea VBZ O O
14 The DT B-NP O
14 patient NN I-NP O
14 notes VBZ O O
14 that IN B-VP O
15 these DT B-NP O
15 symptoms NNS I-NP O
15 have VBP O O
15 been VBN O O
15 occurring VBG O O
15 approximately RB O O
15 five CD O O
15 times NNS B-NP O
15 per IN B-VP O
16 week NN B-NP O
16 over IN B-VP O
16 the DT O O
16 past JJ O O
16 two CD O O
16 months NNS B-NP O
16 She PRP O O
16 has VBZ O O
16 notified VBN O O
16 her PRP$ O O
16 PCP NNP B-NP O
16 of IN B-VP O
16 these DT B-NP O
17 events NNS I-NP O
17 , , O O
17 however RB O O
17 , , O O
17 the DT B-NP O
17 etiology NN I-NP O
17 has VBZ O O
17 never RB O O
17 been VBN O O
17 identified VBN O O
17 Of IN B-VP O
18 note NN B-NP O
18 , , O O
18 the DT B-NP O
18 patient NN I-NP O
18 states VBZ O O
18 that IN B-VP O
18 these DT B-NP O
18 symptoms NNS I-NP O
18 have VBP O O
18 increased VBN O O
18 in IN B-VP O
19 frequency NN B-NP O
19 since IN B-VP O
19 having VBG O O
19 two CD O O
19 syncopal JJ B-NP O
19 events NNS I-NP O
19 , , O O
19 which WDT O O
19 occurred VBD B-VP O
19 three CD O O
20 days NNS B-NP O
20 prior RB O O
20 to TO O O
20 admission NN B-NP O
21 Regarding NNP I-NP O
21 syncope NN I-NP O
21 , , O O
21 the DT B-NP O
21 patient NN I-NP O
21 recalls VBZ O O
21 her PRP$ O O
21 first JJ B-NP O
21 loss NN I-NP O
21 of IN B-VP O
22 consciousness JJ B-NP O
22 episode NN I-NP O
22 occurring VBG O O
22 three CD O O
22 days NNS B-NP O
22 ago RB O O
22 in IN B-VP O
22 her PRP$ O O
22 bedroom NN B-NP O
23 There EX O O
23 were VBD B-VP O
23 no DT B-NP O
23 antecedent NN I-NP O
23 symptoms VBZ O O
23 She PRP O O
23 came VBD B-VP O
23 back RB O O
23 to TO O O
24 consciousness NN B-NP O
24 while IN B-VP O
24 on IN B-VP O
24 the DT B-NP O
24 ground NN I-NP O
24 , , O O
24 called VBN O O
24 out RP O O
24 for IN B-VP O
24 help NN B-NP O
24 and CC O O
24 her PRP$ O O
25 daughter NN B-NP O
25 came VBD B-VP O
25 immediately RB O O
25 There EX O O
25 was VBD B-VP O
25 no DT B-NP O
25 witnessed JJ I-NP O
25 seizure NN I-NP O
26 activity NN I-NP O
26 , , O O
26 no DT B-NP O
26 postictal JJ I-NP O
26 confusion NN I-NP O
26 , , O O
26 no DT B-NP O
26 tongue NN I-NP O
26 trauma NN I-NP O
26 nor CC O O
26 was VBD B-VP O
26 there EX O O
27 any DT B-NP O
27 incontinence NN I-NP O
27 A NNP I-NP O
27 second JJ B-NP O
27 episode NN I-NP O
27 of IN B-VP O
27 syncope NN B-NP O
27 occurred VBD B-VP O
27 two CD O O
27 days NNS B-NP O
28 prior RB O O
28 to TO O O
28 arrival VB O O
28 while IN B-VP O
28 the DT B-NP O
28 patient NN I-NP O
28 was VBD B-VP O
28 standing VBG O O
28 in IN B-VP O
28 the DT B-NP O
28 bathroom NN I-NP O
29 There EX O O
29 was VBD B-VP O
29 some DT O O
29 preceding VBG O O
29 lightheadedness RBR O O
29 this DT B-NP O
29 time NN I-NP O
29 The DT B-NP O
30 post-event JJ I-NP O
30 characteristics NNS I-NP O
30 were VBD B-VP O
30 the DT B-NP O
30 same JJ I-NP O
30 Again NNP I-NP O
30 , , O O
30 the DT B-NP O
30 patient NN I-NP O
30 was VBD B-VP O
31 found VBN O O
31 by IN B-VP O
31 her PRP$ O O
31 son NN B-NP O
31 when WRB O O
31 she PRP O O
31 called VBD B-VP O
31 out RP O O
31 for IN B-VP O
31 help NN B-NP O
32 The DT B-NP O
32 patient NN I-NP O
32 denies VBZ O O
32 prior JJ B-NP O
32 history NN I-NP O
32 of IN B-VP O
32 syncopal JJ B-NP O
32 events NNS I-NP O
32 , , O O
32 however RB O O
32 , , O O
32 she PRP O O
33 does VBZ O O
33 have VB O O
33 a DT B-NP O
33 lifelong JJ I-NP O
33 history NN I-NP O
33 of IN B-VP O
33 seizures NNS B-NP O
33 and CC O O
33 has VBZ O O
33 not RB O O
33 been VBN O O
33 taking VBG O O
34 her PRP$ O O
34 Keppra NNP B-NP B-m
34 for IN B-VP B-du
34 approximately RB O I-du
34 a DT B-NP I-du
34 year NN I-NP I-du
34 , , O O
34 as IN B-VP O
34 her PRP$ O O
34 prescription NN B-NP O
34 has VBZ O O
34 ran VBN O O
35 out RP O O
35 and CC O O
35 she PRP O O
35 has VBZ O O
35 failed VBN O O
35 to TO O O
35 keep VB O O
35 follow-up JJ B-NP O
35 appointments NNS I-NP O
35 with IN B-VP O
35 her PRP$ O O
36 primary JJ B-NP O
36 neurologist NN I-NP O
36 , , O O
36 Dr NNP B-NP O
36 Loock NNP I-NP O
36 Both NNP I-NP O
36 the DT B-NP O
36 patient NN I-NP O
36 and CC O O
36 her PRP$ O O
37 daughter NN B-NP O
37 note NN I-NP O
37 that IN B-VP O
37 she PRP O O
37 usually RB O O
37 has VBZ O O
37 postictal JJ B-NP O
37 confusion NN I-NP O
37 and CC O O
37 that IN B-VP O
38 these DT B-NP O
38 syncopal JJ I-NP O
38 events NNS I-NP O
38 did VBD B-VP O
38 not RB O O
38 fit VB O O
38 that IN B-VP O
38 description NN B-NP O
38 Furthermore NNP I-NP O
38 , , O O
39 these DT B-NP O
39 episodes NNS I-NP O
39 did VBD B-VP O
39 not RB O O
39 feel VB O O
39 like IN B-VP O
39 her PRP$ O O
39 occasional JJ B-NP O
39 hypoglycemic JJ I-NP O
40 episodes NNS I-NP O
40 Unfortunately RB O O
40 , , O O
40 the DT B-NP O
40 patient's NN I-NP O
40 blood NN I-NP O
40 sugars NNS I-NP O
40 were VBD B-VP O
40 not RB O O
41 obtained VBN O O
41 during IN B-VP O
41 these DT B-NP O
41 syncopal JJ I-NP O
41 events NNS I-NP O
42 Of IN B-VP O
42 note NN B-NP O
42 , , O O
42 the DT B-NP O
42 patient NN I-NP O
42 recently RB O O
42 started VBD B-VP O
42 Flexeril NNP B-NP B-m
42 to TO O O
42 treat VB O O
42 chronic JJ O B-r
43 low JJ O O
43 back RB O O
43 pain NN B-NP O
44 REVIEW NNP I-NP O
44 OF NNP I-NP O
44 SYSTEMS: NNP I-NP O
45 The DT B-NP O
45 patient NN I-NP O
45 admits VBZ O O
45 stable JJ B-NP O
45 three-pillow JJ I-NP O
45 orthopnea NN I-NP O
45 , , O O
45 but CC O O
45 new JJ B-NP O
46 paroxysmal JJ I-NP O
46 nocturnal JJ I-NP O
46 dyspnea NN I-NP O
46 , , O O
46 no DT B-NP O
46 lower JJR I-NP O
46 extremity NN I-NP O
46 edema NN I-NP O
46 , , O O
46 weight JJ B-NP O
47 loss NN I-NP O
47 or CC O O
47 increased VBN O O
47 abdominal JJ B-NP O
47 girth NN I-NP O
47 The DT B-NP O
47 patient NN I-NP O
47 has VBZ O O
47 stable JJ B-NP O
48 four-block JJ I-NP O
48 ambulation NN I-NP O
48 limited VBN O O
48 by IN B-VP O
48 dyspnea NN B-NP O
48 She PRP O O
48 has VBZ O O
48 had VBN O O
48 notable JJ B-NP O
49 weight JJ I-NP O
49 loss NN I-NP O
49 as IN B-VP O
49 she PRP O O
49 has VBZ O O
49 decreased VBN O O
49 in IN B-VP O
49 dress NN B-NP O
49 size NN I-NP O
49 from IN B-VP O
49 18-14 CD O O
49 over IN B-VP O
50 the DT O O
50 past JJ O O
50 nine CD O O
50 months NNS B-NP O
50 She PRP O O
50 denies VBZ O O
50 fevers NNS B-NP O
50 or CC O O
50 chills NNS B-NP O
51 PAST NNP I-NP O
51 MEDICAL NNP I-NP O
51 HISTORY: NNP I-NP O
52 HIV NNP I-NP O
52 positive JJ O O
52 , , O O
52 drug-seeking JJ B-NP O
52 behavior NN I-NP O
52 , , O O
52 parotitis NN B-NP O
52 , , O O
52 migraine NN B-NP O
53 headaches NNS I-NP O
53 , , O O
53 anxiety NN B-NP O
53 and CC O O
53 panic NN B-NP O
53 , , O O
53 depression NN B-NP O
53 , , O O
53 hepatitis NN B-NP O
53 C NNP I-NP O
53 , , O O
53 seizures VBZ O O
53 , , O O
54 neuropathy JJ O O
54 , , O O
54 pancreatitis NN B-NP O
54 , , O O
54 abnormal JJ B-NP O
54 Pap NNP I-NP O
54 smear NN I-NP O
54 , , O O
54 diabetes VBZ O O
54 mellitus NN B-NP O
54 , , O O
55 cerebral JJ B-NP O
55 aneurysm NN I-NP O
55 , , O O
55 herpes VBZ O O
55 simplex JJ B-NP O
55 type NN I-NP O
55 1 CD O O
55 , , O O
55 and CC O O
55 chronic JJ O O
55 low JJ O O
55 back RB O O
56 pain NN B-NP O
57 ADMISSION NNP I-NP O
57 MEDICATIONS: NNP I-NP O
58 Flexeril NNP I-NP B-m
58 5 CD O B-do
58 mg JJ O I-do
58 daily RB O B-f
58 , , O O
58 clonazepam VBD B-VP B-m
58 1 CD O B-do
58 mg NN B-NP I-do
58 q.i.d NN I-NP B-f
58 , , O O
58 Truvada NNP B-NP B-m
58 one CD O B-do
58 tablet NN B-NP I-do
59 daily RB O B-f
59 , , O O
59 Norvir NNP B-NP B-m
59 1400 CD O B-do
59 mg NN B-NP I-do
59 b.i.d NN I-NP B-f
59 , , O O
59 glyburide JJ B-NP B-m
59 glyburide NN I-NP B-m
59 5 CD O B-do
59 mg NN B-NP I-do
59 q.a.m NN I-NP B-f
59 and CC O O
59 2.5 CD O B-do
59 mg NN B-NP I-do
60 q.p.m NN I-NP B-f
60 , , O O
60 Lomotil NNP B-NP B-m
60 one CD O B-do
60 tablet NN B-NP I-do
60 q.i.d NN I-NP B-f
60 p.r.n NN I-NP I-f
60 , , O O
60 methadone NN B-NP B-m
60 150 CD O B-do
60 mg JJ O I-do
60 daily RB O B-f
60 , , O O
61 Zofran NNP B-NP B-m
61 4 CD O B-do
61 mg JJ B-NP I-do
61 daily JJ I-NP B-f
61 p.r.n NN I-NP I-f
61 , , O O
61 Percocet NNP B-NP B-m
61 325 CD O B-do
61 mg/5 NN B-NP I-do
61 mg NN I-NP I-do
61 tablets VBZ O I-do
61 one CD O I-do
61 tablet NN B-NP I-do
62 q.6 NN I-NP B-f
62 h NN I-NP I-f
62 p.r.n NN I-NP I-f
62 , , O O
62 Zantac NNP B-NP B-m
62 150 CD O B-do
62 mg NN B-NP I-do
62 b.i.d NN I-NP B-f
62 , , O O
62 Zoloft NNP B-NP B-m
62 100 CD O B-do
62 mg NN B-NP I-do
62 q.a.m NN I-NP B-f
62 , , O O
62 and CC O O
63 trazodone RB O B-m
63 100 CD O B-do
63 mg NNS B-NP I-do
63 nightly RB O B-f
64 ALLERGIES: NNP B-NP O
65 Compazine NNP I-NP O
65 , , O O
65 Bactrim NNP B-NP O
65 , , O O
65 didanosine NN B-NP O
65 , , O O
65 gabapentin NN B-NP O
65 , , O O
65 cephalosporins NNS B-NP O
65 , , O O
66 penicillin NN B-NP O
66 , , O O
66 clindamycin NN B-NP O
66 , , O O
66 stavudine NN B-NP O
66 , , O O
66 Tylenol NNP B-NP O
66 No.3 NNP I-NP O
66 , , O O
66 levofloxacin NN B-NP O
66 , , O O
67 clindamycin NN B-NP O
67 , , O O
67 tetanus NN B-NP O
67 , , O O
67 IV NNP B-NP O
67 contrast NN I-NP O
67 , , O O
67 ibuprofen NN B-NP O
67 , , O O
67 abacavir NN B-NP O
67 and CC O O
68 ritonavir VB O O
69 SOCIAL NNP B-NP O
69 HISTORY: NNP I-NP O
70 The DT B-NP O
70 patient NN I-NP O
70 is VBZ O O
70 from IN B-VP O
70 Reve NNP B-NP O
70 Abilester NNP I-NP O
70 She PRP O O
70 is VBZ O O
70 living VBG O O
70 with IN B-VP O
70 her PRP$ O O
70 daughter NN B-NP O
71 and CC O O
71 son NN B-NP O
71 No NNP I-NP O
71 prior RB O O
71 tobacco NN B-NP O
71 or CC O O
71 smoking NN B-NP O
71 history NN I-NP O
71 She PRP O O
71 has VBZ O O
71 a DT B-NP O
71 prior JJ I-NP O
72 history NN I-NP O
72 of IN B-VP O
72 drinking NN B-NP O
72 alcohol NN I-NP O
72 and CC O O
72 IV NNP B-NP O
72 drug NN I-NP O
72 use NN I-NP O
73 FAMILY NNP I-NP O
73 HISTORY: NNP I-NP O
74 Negative NNP I-NP O
74 for IN B-VP O
74 early RB O O
74 coronary JJ B-NP O
74 artery NN I-NP O
74 disease NN I-NP O
74 Her NNP I-NP O
74 father NN I-NP O
74 had VBD B-VP O
74 an DT B-NP O
74 MI NNP I-NP O
75 at IN B-VP O
75 age NN B-NP O
75 74 CD O O
75 Her NNP B-NP O
75 mother NN I-NP O
75 had VBD B-VP O
75 coronary JJ B-NP O
75 artery NN I-NP O
75 disease NN I-NP O
75 at IN B-VP O
75 age NN B-NP O
75 76 CD O O
76 ADMISSION NNP B-NP O
76 PHYSICAL NNP I-NP O
76 EXAMINATION: NNP I-NP O
77 Temperature NNP I-NP O
77 97.8 CD O O
77 , , O O
77 blood NN B-NP O
77 pressure NN I-NP O
77 172/80 CD O O
77 , , O O
77 heart NN B-NP O
77 rate NN I-NP O
77 82 CD O O
77 , , O O
78 respiratory NN B-NP O
78 rate NN I-NP O
78 20 CD O O
78 , , O O
78 and CC O O
78 saturating VBG O O
78 100% CD O O
78 on IN B-VP O
78 room NN B-NP O
78 air NN I-NP O
78 This DT O O
78 is VBZ O O
78 a DT B-NP O
79 middle-aged JJ I-NP O
79 woman NN I-NP O
79 appearing VBG O O
79 older JJR O O
79 than IN B-VP O
79 stated VBN O O
79 age NN B-NP O
79 , , O O
79 complaining NN B-NP O
79 of IN B-VP O
80 left JJ B-NP O
80 hand NN I-NP O
80 pain NN I-NP O
80 , , O O
80 but CC O O
80 otherwise RB O O
80 appears VBZ O O
80 comfortable JJ O O
80 She PRP O O
80 has VBZ O O
80 a DT B-NP O
81 disconjugate NN I-NP O
81 gaze NN I-NP O
81 , , O O
81 has VBZ O O
81 only RB O O
81 light JJ B-NP O
81 vision NN I-NP O
81 in IN B-VP O
81 her PRP$ O O
81 left JJ B-NP O
81 eye NN I-NP O
82 Sclerae NNP I-NP O
82 are VBP O O
82 anicteric JJ B-NP O
82 Oropharynx NNP I-NP O
82 is VBZ O O
82 benign JJ O O
82 She PRP O O
82 had VBD B-VP O
82 no DT B-NP O
82 oral JJ I-NP O
83 ulcers NNS I-NP O
83 or CC O O
83 thrush NN B-NP O
83 Neck NN I-NP O
83 is VBZ O O
83 supple JJ O O
83 , , O O
83 without IN B-VP O
83 cervical JJ B-NP O
84 lymphadenopathy NN I-NP O
84 , , O O
84 no DT B-NP O
84 JVD NNP I-NP O
84 , , O O
84 and CC O O
84 no DT B-NP O
84 carotid NN I-NP O
84 bruits VBZ O O
84 Lungs NNS B-NP O
84 are VBP O O
84 clear JJ O O
85 to TO O O
85 auscultation VB O O
85 Regular JJ B-NP O
85 rate NN I-NP O
85 and CC O O
85 rhythm NN B-NP O
85 , , O O
85 S1 NNP B-NP O
85 and CC O O
85 S2 NNP B-NP O
85 , , O O
85 no DT B-NP O
85 murmurs NN I-NP O
85 , , O O
86 rubs NN B-NP O
86 or CC O O
86 gallops NNS B-NP O
86 Abdomen NNP I-NP O
86 was VBD B-VP O
86 obese JJ O O
86 , , O O
86 soft JJ O O
86 , , O O
86 nondistended JJ O O
86 , , O O
86 and CC O O
87 nontender NN B-NP O
87 with IN B-VP O
87 questionable JJ B-NP O
87 splenic JJ I-NP O
87 fullness NN I-NP O
87 , , O O
87 no DT B-NP O
87 clubbing NN I-NP O
87 , , O O
88 cyanosis NN B-NP O
88 or CC O O
88 edema VB O O
88 She PRP O O
88 had VBD B-VP O
88 a DT O O
88 4 CD O O
88 x NN B-NP O
88 4 CD O O
88 ecchymosis NN B-NP O
88 on IN B-VP O
88 her PRP$ O O
88 left JJ B-NP O
89 shoulder NN I-NP O
89 and CC O O
89 a DT O O
89 2 CD O O
89 x NN B-NP O
89 2 CD O O
89 scab NN B-NP O
89 over IN B-VP O
89 her PRP$ O O
89 left JJ B-NP O
89 elbow NN I-NP O
89 The DT B-NP O
89 soft JJ I-NP O
89 tissue NN I-NP O
90 extending VBG O O
90 from IN B-VP O
90 the DT B-NP O
90 left JJ I-NP O
90 shoulder NN I-NP O
90 to TO O O
90 left VB O O
90 elbow NN B-NP O
90 was VBD B-VP O
90 tender NN B-NP O
90 to TO O O
91 palpation NN B-NP O
91 as IN B-VP O
91 was VBD B-VP O
91 the DT B-NP O
91 left NN I-NP O
91 chest NN I-NP O
91 She PRP O O
91 had VBD B-VP O
91 decreased VBN O O
91 sensation NN B-NP O
91 of IN B-VP O
92 bilateral JJ B-NP O
92 lower JJR I-NP O
92 extremities NNS I-NP O
92 and CC O O
92 left VBD B-VP O
92 Aside NNP B-NP O
92 from IN B-VP O
92 a DT B-NP O
92 disconjugate NN I-NP O
93 gaze NN I-NP O
93 , , O O
93 cranial JJ B-NP O
93 nerves NNS I-NP O
93 were VBD B-VP O
93 intact JJ B-NP O
93 Motor NNP I-NP O
93 exam NN I-NP O
93 was VBD B-VP O
93 intact JJ B-NP O
93 Gait NNP I-NP O
94 was VBD B-VP O
94 slightly RB O O
94 wide-based JJ O O
94 , , O O
94 but CC O O
94 sufficient JJ O O
94 without IN B-VP O
94 cane NN B-NP O
94 Negative NNP I-NP O
95 Romberg NNP I-NP O
95 , , O O
95 negative JJ B-NP O
95 pronator NN I-NP O
95 drift NN I-NP O
95 , , O O
95 and CC O O
95 no DT B-NP O
95 dysmetria NN I-NP O
95 on IN B-VP O
96 finger-to-nose JJ B-NP O
96 bilateral NN I-NP O
96 , , O O
96 and CC O O
96 deep JJ B-NP O
96 tendon NN I-NP O
96 reflexes NNS I-NP O
96 were VBD B-VP O
96 2+ CD O O
97 throughout IN B-VP O
98 ADMISSION NNP B-NP O
98 LABORATORY NNP I-NP O
98 VALUES: NNP I-NP O
99 Sodium NNP I-NP O
99 138 CD O O
99 , , O O
99 potassium NN B-NP O
99 3.9 CD O O
99 , , O O
99 chloride RB O O
99 103 CD O O
99 , , O O
99 CO2 NNP B-NP O
99 28 CD O O
99 , , O O
99 BUN NNP B-NP O
99 13 CD O O
99 , , O O
100 creatinine NN B-NP O
100 0.7 CD O O
100 , , O O
100 glucose RB O O
100 179 CD O O
100 , , O O
100 calcium NN B-NP O
100 9.2 CD O O
100 , , O O
100 magnesium NN B-NP O
100 1.6 CD O O
100 , , O O
100 ALT NNP B-NP O
100 35 CD O O
100 , , O O
101 AST NNP B-NP O
101 34 CD O O
101 , , O O
101 alkaline JJ B-NP O
101 phosphatase NN I-NP O
101 57 CD O O
101 , , O O
101 CK NNP B-NP O
101 51 CD O O
101 , , O O
101 CK-MB NNP B-NP O
101 1.4 CD O O
101 , , O O
101 troponin NN B-NP O
101 less JJR O O
102 than IN B-VP O
102 assay NN B-NP O
102 , , O O
102 white JJ B-NP O
102 count NN I-NP O
102 of IN B-VP O
102 3.35 CD O O
102 , , O O
102 hemoglobin NN B-NP O
102 12.6 CD O O
102 , , O O
102 hematocrit NN B-NP O
103 36.7 CD O O
103 , , O O
103 PT NNP B-NP O
103 14.4 CD O O
103 , , O O
103 INR NNP B-NP O
103 1.1 CD O O
103 , , O O
103 and CC O O
103 PTT NNP B-NP O
103 29.5 CD O O
104 ADMISSION NNP B-NP O
104 DATA: NNP I-NP O
105 Chest NNP I-NP O
105 x-ray NN I-NP O
105 was VBD B-VP O
105 within IN B-VP O
105 normal JJ B-NP O
105 limits NNS I-NP O
105 EKG NNP I-NP O
105 was VBD B-VP O
105 normal JJ B-NP O
105 sinus JJ I-NP O
106 rhythm NN I-NP O
106 without IN B-VP O
106 ischemic JJ B-NP O
106 change NN I-NP O
106 CAT NNP I-NP O
106 scan NN I-NP O
106 of IN B-VP O
106 the DT B-NP O
106 head NN I-NP O
106 was VBD B-VP O
106 within IN B-VP O
107 normal JJ B-NP O
107 limits NNS I-NP O
107 Left VBN O O
107 shoulder NN B-NP O
107 and CC O O
107 arm NN B-NP O
107 plain NN I-NP O
107 films NNS I-NP O
107 were VBD B-VP O
107 negative JJ O O
108 for IN B-VP O
108 fracture NN B-NP O
108 or CC O O
108 dislocation NN B-NP O
109 IMPRESSION: NNP I-NP O
110 This DT O O
110 is VBZ O O
110 a DT B-NP O
110 47-year-old JJ I-NP O
110 female NN I-NP O
110 with IN B-VP O
110 a DT B-NP O
110 history NN I-NP O
110 significant JJ O O
110 for IN B-VP O
110 HIV NNP B-NP O
110 , , O O
111 diabetes VBZ O O
111 , , O O
111 questionable JJ B-NP O
111 cerebral JJ I-NP O
111 aneurysm NN I-NP O
111 , , O O
111 and CC O O
111 seizure NN B-NP O
111 disorder NN I-NP O
112 ( ( O O
112 not RB O O
112 taking VBG O O
112 Keppra NNP B-NP B-m
112 for IN B-VP B-du
112 the DT B-NP I-du
112 past JJ I-NP I-du
112 year NN I-NP I-du
112 ) ) O O
112 , , O O
112 who WP O O
112 recently RB O O
112 had VBD B-VP O
112 two CD O O
113 syncopal JJ B-NP O
113 events NNS I-NP O
113 without IN B-VP O
113 prodrome NN B-NP O
113 and CC O O
113 without IN B-VP O
113 postictal JJ B-NP O
113 state NN I-NP O
114 ( ( O O
114 thus RB O O
114 unlikely RB O O
114 a DT B-NP O
114 seizure NN I-NP O
114 in IN B-VP O
114 etiology NN B-NP O
114 ) ) O O
114 , , O O
114 who WP O O
114 presented VBD B-VP O
114 for IN B-VP O
115 evaluation NN B-NP O
115 of IN B-VP O
115 left JJ B-NP O
115 arm NN I-NP O
115 paresthesias NN I-NP O
115 and CC O O
115 chest NN B-NP O
115 pain NN I-NP O
115 , , O O
115 with IN B-VP O
116 associated JJ B-NP O
116 diaphoresis NN I-NP O
116 , , O O
116 shortness NN B-NP O
116 of IN B-VP O
116 breath NN B-NP O
116 and CC O O
116 nausea NN B-NP O
116 , , O O
116 which WDT O O
116 has VBZ O O
117 been VBN O O
117 intermittently RB O O
117 occurring VBG O O
117 over IN B-VP O
117 the DT O O
117 past JJ O O
117 two CD O O
117 months NNS B-NP O
118 During IN B-VP O
118 this DT B-NP O
118 admission NN I-NP O
118 , , O O
118 the DT B-NP O
118 patient NN I-NP O
118 had VBD B-VP O
118 frequent JJ B-NP O
118 recurrences NNS I-NP O
118 of IN B-VP O
119 her PRP$ O O
119 left JJ B-NP O
119 arm NN I-NP O
119 and CC O O
119 chest NN B-NP O
119 pain NN I-NP O
119 symptoms NNS I-NP O
119 , , O O
119 which WDT O O
119 were VBD B-VP O
119 related VBN O O
119 to TO O O
120 syncopal JJ B-NP O
120 events NNS I-NP O
120 Thus RB O O
120 , , O O
120 the DT B-NP O
120 medical JJ I-NP O
120 team NN I-NP O
120 does VBZ O O
120 not RB O O
120 think VB O O
120 that IN B-VP O
121 these DT O O
121 two CD O O
121 issues NNS B-NP O
121 are VBP O O
121 related VBN O O
121 The DT B-NP O
121 patient NN I-NP O
121 underwent NN I-NP O
121 an DT B-NP O
121 extensive JJ I-NP O
122 syncopal JJ I-NP O
122 evaluation NN I-NP O
122 , , O O
122 however RB O O
122 , , O O
122 the DT B-NP O
122 etiology NN I-NP O
122 was VBD B-VP O
122 never RB O O
122 identified VBN O O
123 The DT B-NP O
123 etiology NN I-NP O
123 of IN B-VP O
123 the DT B-NP O
123 patient's NN I-NP O
123 left VBD B-VP O
123 arm NN B-NP O
123 and CC O O
123 chest NN B-NP O
123 symptoms NNS I-NP O
123 and CC O O
124 syndromes NNS B-NP O
124 also RB O O
124 was VBD B-VP O
124 not RB O O
124 identified VBN O O
124 during IN B-VP O
124 this DT B-NP O
124 admission NN I-NP O
124 , , O O
124 however RB O O
124 , , O O
125 the DT B-NP O
125 medical JJ I-NP O
125 team NN I-NP O
125 suspects VBZ O O
125 it PRP O O
125 may MD O O
125 be VB O O
125 related VBN O O
125 to TO O O
125 a DT B-NP O
125 cervical JJ I-NP O
125 spinous JJ I-NP O
126 process NN I-NP O
126 , , O O
126 potentially RB O O
126 arthritis NN B-NP O
126 , , O O
126 disc JJ B-NP O
126 herniation NN I-NP O
126 or CC O O
126 nerve NN B-NP O
126 root NN I-NP O
127 impingement JJ B-NP O
127 Please NNP I-NP O
127 see VB O O
127 below IN B-VP O
127 for IN B-VP O
127 more JJR B-NP O
127 details NNS I-NP O
127 The DT B-NP O
127 remainder NN I-NP O
128 of IN B-VP O
128 the DT B-NP O
128 dictation NN I-NP O
128 will MD O O
128 be VB O O
128 divided VBN O O
128 into IN B-VP O
128 system: JJ O O
129 1 CD O O
129 Cardiovascular: NNP B-NP O
129 The DT B-NP O
129 patient NN I-NP O
129 underwent NN I-NP O
129 an DT B-NP O
129 extensive JJ I-NP O
130 cardiovascular JJ I-NP O
130 evaluation NN I-NP O
130 , , O O
130 all DT O O
130 of IN B-VP O
130 which WDT O O
130 was VBD B-VP O
130 negative JJ O O
131 a DT B-NP O
131 Pump: NNP I-NP O
131 Given NNP I-NP O
131 the DT B-NP O
131 patient's JJ I-NP O
131 history NN I-NP O
131 of IN B-VP O
131 HIV NNP B-NP O
131 and CC O O
131 taking VBG O O
132 antiretroviral JJ O O
132 , , O O
132 there EX O O
132 was VBD B-VP O
132 a DT B-NP O
132 concern NN I-NP O
132 about IN B-VP O
132 associated VBN O O
133 cardiomyopathy JJ B-NP O
133 Echocardiogram NNP I-NP O
133 that WDT O O
133 was VBD B-VP O
133 performed VBN O O
133 was VBD B-VP O
133 completely RB O O
134 within IN B-VP O
134 normal JJ B-NP O
134 limits NNS I-NP O
134 The DT B-NP O
134 patient NN I-NP O
134 did VBD B-VP O
134 not RB O O
134 exhibit VB O O
134 signs NNS B-NP O
134 of IN B-VP O
135 paroxysmal JJ B-NP O
135 nocturnal JJ I-NP O
135 dyspnea NN I-NP O
135 or CC O O
135 orthopnea NN B-NP O
135 during IN B-VP O
135 this DT B-NP O
135 admission NN I-NP O
136 Dyspnea NNP I-NP O
136 on IN B-VP O
136 exertion NN B-NP O
136 could MD O O
136 be VB O O
136 related VBN O O
136 to TO O O
136 decondition NN B-NP O
137 b NN I-NP O
137 Rhythm: NNP I-NP O
137 The DT B-NP O
137 patient's JJ I-NP O
137 telemetry NN I-NP O
137 history NN I-NP O
137 on IN B-VP O
137 2/23/2006 CD O O
137 was VBD B-VP O
138 notable JJ O O
138 for IN B-VP O
138 a DT B-NP O
138 nonsustained JJ I-NP O
138 5-beat JJ I-NP O
138 run NN I-NP O
138 of IN B-VP O
138 wide JJ B-NP O
138 complex JJ I-NP O
138 tachycardia NN I-NP O
139 with IN B-VP O
139 rates NNS B-NP O
139 in IN B-VP O
139 the DT O O
139 150's CD O O
139 This DT O O
139 was VBD B-VP O
139 immediately RB O O
139 followed VBN O O
139 by IN B-VP O
139 a DT B-NP O
140 nonsustained JJ I-NP O
140 4-beat JJ I-NP O
140 run NN I-NP O
140 of IN B-VP O
140 narrow JJ B-NP O
140 complex JJ I-NP O
140 tachycardia NN I-NP O
141 Cardiology NNP I-NP O
141 consult NN I-NP O
141 was VBD B-VP O
141 placed VBN O O
141 to TO O O
141 review VB O O
141 the DT B-NP O
141 telemetry NN I-NP O
141 strip NN I-NP O
141 and CC O O
142 to TO O O
142 assess VB O O
142 for IN B-VP O
142 referral JJ O O
142 to TO O O
142 EP NNP B-NP O
142 Service NNP I-NP O
142 for IN B-VP O
142 potential JJ B-NP O
142 AICD NNP I-NP O
142 Given NNP I-NP O
143 the DT B-NP O
143 negative JJ I-NP O
143 echocardiogram NN I-NP O
143 , , O O
143 the DT B-NP O
143 Card NNP I-NP O
143 Service NNP I-NP O
143 wanted VBD B-VP O
143 to TO O O
143 rule VB O O
143 out IN B-VP O
144 ischemia-induced JJ B-NP O
144 arrhythmia NN I-NP O
144 , , O O
144 so IN B-VP O
144 a DT B-NP O
144 MIBI NNP I-NP O
144 was VBD B-VP O
144 performed VBN O O
144 , , O O
144 and CC O O
144 the DT B-NP O
145 patient NN I-NP O
145 was VBD B-VP O
145 started VBN O O
145 on IN B-VP O
145 low-dose JJ B-NP B-do
145 beta-blocker NN I-NP B-m
145 and CC O O
145 aspirin VB O B-m
145 The DT B-NP O
146 adenosine NN I-NP O
146 MIBI NNP I-NP O
146 was VBD B-VP O
146 within IN B-VP O
146 normal JJ B-NP O
146 limits NNS I-NP O
146 The DT B-NP O
146 telemetry NN I-NP O
146 strip NN I-NP O
146 was VBD B-VP O
147 reviewed VBN O O
147 by IN B-VP O
147 the DT B-NP O
147 EP NNP I-NP O
147 Service NNP I-NP O
147 and CC O O
147 diagnosed VBD B-VP O
147 the DT B-NP O
147 patient NN I-NP O
147 with IN B-VP O
148 nonsustained JJ B-NP O
148 SVT NNP I-NP O
148 with IN B-VP O
148 aberrancy NN B-NP O
148 The DT B-NP O
148 Card NNP I-NP O
148 Service NNP I-NP O
148 then RB O O
148 advised VBD B-VP O
149 that IN B-VP O
149 there EX O O
149 was VBD B-VP O
149 no DT B-NP O
149 need NN I-NP O
149 for IN B-VP O
149 AICD NNP B-NP O
149 They PRP O O
149 stated VBD B-VP O
149 that IN B-VP O
149 if IN B-VP O
149 tolerated VBN O O
149 , , O O
150 the DT B-NP O
150 beta-blocker NN I-NP B-m
150 could MD O O
150 be VB O O
150 continued VBN O O
150 and CC O O
150 that IN B-VP O
150 the DT B-NP O
150 patient NN I-NP O
150 should MD O O
151 be VB O O
151 set VBN O O
151 up RP O O
151 as IN B-VP O
151 an DT B-NP O
151 outpatient NN I-NP O
151 for IN B-VP O
151 a DT B-NP O
151 loop JJ I-NP O
151 recorder NN I-NP O
151 This DT O O
151 will MD O O
151 be VB O O
152 coordinated VBN O O
152 through IN B-VP O
152 the DT B-NP O
152 patient's JJ I-NP O
152 PCP NNP I-NP O
152 Of IN B-VP O
152 note NN B-NP O
152 , , O O
152 after IN B-VP O
152 starting VBG O O
153 metoprolol JJ O B-m
153 12.5 CD O B-do
153 b.i.d NN B-NP B-f
153 , , O O
153 the DT B-NP O
153 patient NN I-NP O
153 had VBD B-VP O
153 occasional JJ B-NP O
153 bradycardia NN I-NP O
153 to TO O O
154 the DT O O
154 high JJ O O
154 40's CD O O
154 Thus RB O O
154 , , O O
154 it PRP O O
154 was VBD B-VP O
154 determined VBN O O
154 that IN B-VP O
154 this DT B-NP B-m
154 medication NN I-NP I-m
155 should MD O O
155 be VB O O
155 discontinued VBN O O
155 as IN B-VP O
155 it PRP O O
155 may MD O O
155 be VB O O
155 impairing VBG O O
155 the DT B-NP O
155 patient's NN I-NP O
156 exercise NN I-NP O
156 tolerance NN I-NP O
157 c NN I-NP O
157 Ischemia: NNP I-NP O
157 Coronary NNP I-NP O
157 disease NN I-NP O
157 risk NN I-NP O
157 factors NNS I-NP O
157 include VBP O O
157 diabetes NNS B-NP O
157 and CC O O
158 family NN B-NP O
158 history NN I-NP O
158 She PRP O O
158 ruled VBD B-VP O
158 out RP O O
158 for IN B-VP O
158 a DT B-NP O
158 myocardial JJ I-NP O
158 infarction NN I-NP O
158 , , O O
158 had VBD B-VP O
159 no DT B-NP O
159 ischemic JJ I-NP O
159 change NN I-NP O
159 on IN B-VP O
159 her PRP$ O O
159 EKG NNP B-NP O
159 , , O O
159 and CC O O
159 had VBD B-VP O
159 a DT B-NP O
159 negative JJ I-NP O
159 MIBI NNP I-NP O
159 No NNP I-NP O
160 further RB O O
160 workup NN B-NP O
160 for IN B-VP O
160 coronary JJ B-NP O
160 artery NN I-NP O
160 disease NN I-NP O
160 was VBD B-VP O
160 indicated VBN O O
160 A NNP B-NP O
161 lipid JJ B-NP O
161 panel NN I-NP O
161 was VBD B-VP O
161 completely RB O O
161 within IN B-VP O
161 normal JJ B-NP O
161 limits NNS I-NP O
161 and CC O O
161 suggesting VBG O O
162 treatment NN B-NP O
162 was VBD B-VP O
162 not RB O O
162 indicated VBN O O
163 d NN B-NP O
163 Miscellaneous: NNP I-NP O
163 On IN B-VP O
163 8/12/2006 CD O O
163 , , O O
163 the DT B-NP O
163 patient NN I-NP O
163 was VBD B-VP O
163 evaluated VBN O O
163 for IN B-VP O
164 one CD O O
164 of IN B-VP O
164 her PRP$ O O
164 left JJ B-NP O
164 arm NN I-NP O
164 and CC O O
164 chest NN B-NP O
164 pain NN I-NP O
164 events NNS I-NP O
164 The DT B-NP O
164 patient NN I-NP O
164 was VBD B-VP O
164 noted VBN O O
165 to TO O O
165 be VB O O
165 diaphoretic JJ O O
165 and CC O O
165 complained VBD B-VP O
165 of IN B-VP O
165 nausea NN B-NP O
165 and CC O O
165 shortness NN B-NP O
165 of IN B-VP O
166 breath NN B-NP O
166 The DT B-NP O
166 symptoms NNS I-NP O
166 occurred VBD B-VP O
166 while IN B-VP O
166 the DT B-NP O
166 patient NN I-NP O
166 was VBD B-VP O
166 lying VBG O O
166 in IN B-VP O
167 bed NN B-NP O
167 Upon IN B-VP O
167 arrival NN B-NP O
167 by IN B-VP O
167 the DT B-NP O
167 team NN I-NP O
167 , , O O
167 her PRP$ O O
167 blood NN B-NP O
167 pressure NN I-NP O
167 was VBD B-VP O
167 90/56 CD O O
167 , , O O
168 heart NN B-NP O
168 rate NN I-NP O
168 was VBD B-VP O
168 56 CD O O
168 , , O O
168 she PRP O O
168 had VBD B-VP O
168 poor JJ B-NP O
168 pallor NN I-NP O
168 , , O O
168 was VBD B-VP O
168 diaphoretic JJ O O
168 , , O O
168 and CC O O
169 described VBD B-VP O
169 chest JJS B-NP O
169 pain NN I-NP O
169 radiating VBG O O
169 up RP O O
169 and CC O O
169 down IN B-VP O
169 her PRP$ O O
169 arm NN B-NP O
169 EKG NN I-NP O
169 in IN B-VP O
170 telemetry NN B-NP O
170 during IN B-VP O
170 the DT B-NP O
170 event NN I-NP O
170 was VBD B-VP O
170 normal JJ B-NP O
170 sinus JJ I-NP O
170 rhythm NN I-NP O
170 with IN B-VP O
170 any DT B-NP O
170 acute JJ I-NP O
171 ST NNP I-NP O
171 or CC O O
171 T-wave NNP B-NP O
171 changes VBZ O O
171 The DT B-NP O
171 event NN I-NP O
171 spontaneously RB O O
171 resolved VBN O O
171 in IN B-VP O
171 less JJR O O
172 than IN B-VP O
172 15 CD O O
172 minutes NNS B-NP O
172 without IN B-VP O
172 medical JJ B-NP O
172 intervention NN I-NP O
173 2 CD O O
173 Neuro: NNP B-NP O
173 The DT B-NP O
173 patient NN I-NP O
173 has VBZ O O
173 a DT B-NP O
173 history NN I-NP O
173 of IN B-VP O
173 convulsive JJ B-NP B-r
173 seizures NNS I-NP I-r
173 and CC O O
174 has VBZ O O
174 been VBN O O
174 noncompliant JJ O O
174 with IN B-VP O
174 Keppra NNP B-NP B-m
174 for IN B-VP B-du
174 the DT O I-du
174 past JJ O I-du
174 12 CD O I-du
174 months NNS B-NP I-du
174 because IN B-VP O
175 she PRP O O
175 failed VBD B-VP O
175 to TO O O
175 keep VB O O
175 neuro JJ B-NP O
175 appointment NN I-NP O
175 with IN B-VP O
175 Dr NNP B-NP O
175 Sconiers NNP I-NP O
175 and CC O O
175 has VBZ O O
176 been VBN O O
176 unable JJ O O
176 to TO O O
176 obtain VB O O
176 refills NNS B-NP O
176 Per IN B-VP O
176 the DT B-NP O
176 patient NN I-NP O
176 , , O O
176 her PRP$ O O
176 recent JJ B-NP O
177 syncopal JJ I-NP O
177 events NNS I-NP O
177 were VBD B-VP O
177 without IN B-VP O
177 prodrome NN B-NP O
177 and CC O O
177 without IN B-VP O
177 postictal JJ B-NP O
178 state NN I-NP O
178 Thus NNP I-NP O
178 , , O O
178 were VBD B-VP O
178 unlikely JJ B-NP O
178 prior JJ I-NP O
178 seizures NNS I-NP O
178 and CC O O
178 unlikely JJ B-NP O
178 seizure NN I-NP O
179 in IN B-VP O
179 focus NN B-NP O
179 An DT B-NP O
179 EEG NNP I-NP O
179 was VBD B-VP O
179 performed VBN O O
179 during IN B-VP O
179 this DT B-NP O
179 admission NN I-NP O
179 and CC O O
180 demonstrated VBD B-VP O
180 no DT O O
180 definite JJ O O
180 focal JJ O O
180 or CC O O
180 epileptiform JJ B-NP O
180 features NNS I-NP O
180 Keppra NNP I-NP B-m
180 Keppra NNP I-NP B-m
180 Keppra NNP I-NP B-m
181 was VBD B-VP O
181 restarted VBN O O
181 at IN B-VP O
181 250 CD O B-do
181 mg NNS B-NP I-do
181 b.i.d NN I-NP B-f
181 with IN B-VP O
181 a DT B-NP O
181 goal NN I-NP O
181 to TO O O
181 increase VB O O
181 to TO O O
181 500 CD O B-do
181 mg NNS B-NP I-do
182 b.i.d RB O B-f
182 after IN B-VP O
182 7 CD O B-du
182 days NNS B-NP I-du
182 and CC O O
182 to TO O O
182 750 CD O B-do
182 mg NN B-NP I-do
182 after IN B-VP O
182 another DT B-NP O
182 week NN I-NP O
182 There EX O O
182 was VBD B-VP O
183 a DT B-NP O
183 question NN I-NP O
183 of IN B-VP O
183 a DT B-NP O
183 history NN I-NP O
183 of IN B-VP O
183 cerebral JJ B-NP O
183 aneurysm NN I-NP O
183 , , O O
183 diagnosed VBN O O
183 at IN B-VP O
183 an DT B-NP O
184 outside JJ I-NP O
184 facility NN I-NP O
184 , , O O
184 which WDT O O
184 was VBD B-VP O
184 never RB O O
184 confirmed VBN O O
184 by IN B-VP O
184 Tonfay NNP B-NP O
184 Medical NNP I-NP O
184 Center NNP I-NP O
184 imaging VBG O O
184 MRI NNP B-NP O
184 of IN B-VP O
184 the DT B-NP O
184 brain NN I-NP O
184 and CC O O
184 MRA NNP B-NP O
184 of IN B-VP O
184 the DT B-NP O
184 head NN I-NP O
184 and CC O O
184 neck NN B-NP O
185 obtained VBD B-VP O
185 this DT B-NP O
185 admission NN I-NP O
185 was VBD B-VP O
185 negative JJ O O
185 for IN B-VP O
185 hemorrhage NN B-NP O
185 , , O O
185 mass NN B-NP O
185 , , O O
185 edema NN B-NP O
185 , , O O
186 hydrocephalus NN B-NP O
186 , , O O
186 infarction NN B-NP O
186 , , O O
186 and CC O O
186 negative JJ O O
186 for IN B-VP O
186 abnormal JJ B-NP O
186 enhancement NN I-NP O
187 There EX O O
187 was VBD B-VP O
187 no DT B-NP O
187 aneurysm JJ I-NP O
187 high-flow JJ I-NP O
187 AVM NNP I-NP O
187 or CC O O
187 stenosis NN B-NP O
187 found VBN O O
187 , , O O
187 and CC O O
187 MRA NNP B-NP O
188 of IN B-VP O
188 the DT B-NP O
188 neck NN I-NP O
188 had VBD B-VP O
188 no DT B-NP O
188 significant JJ I-NP O
188 abnormality NN I-NP O
188 The DT B-NP O
188 patient's JJ I-NP O
189 neurologist NN I-NP O
189 , , O O
189 Dr NNP B-NP O
189 Klez NNP I-NP O
189 , , O O
189 was VBD B-VP O
189 aware JJ O O
189 of IN B-VP O
189 this DT B-NP O
189 admission NN I-NP O
189 A DT B-NP O
190 follow-up JJ I-NP O
190 appointment NN I-NP O
190 has VBZ O O
190 been VBN O O
190 made VBN O O
191 3 CD O O
191 Endocrine: NNP B-NP O
191 History NNP I-NP O
191 of IN B-VP O
191 diabetes NNS B-NP O
191 type JJ B-NP O
191 II NNP I-NP O
191 , , O O
191 hemoglobin JJ B-NP O
191 A1c NNP I-NP O
191 of IN B-VP O
192 6.1 CD O O
192 , , O O
192 reflects VBZ O O
192 excellent JJ B-NP O
192 outpatient JJ I-NP O
192 glycemic JJ I-NP O
192 control NN I-NP O
192 , , O O
192 however RB O O
192 , , O O
192 the DT B-NP O
193 patient NN I-NP O
193 reports NNS I-NP O
193 becoming VBG O O
193 diaphoretic JJ O O
193 with IN B-VP O
193 normal JJ B-NP O
193 glycemic JJ I-NP O
193 levels NNS I-NP O
194 between IN B-VP O
194 80 CD O O
194 and CC O O
194 100 CD O O
194 Given NNP B-NP O
194 recent JJ B-NP O
194 weight NN I-NP O
194 loss NN I-NP O
194 without IN B-VP O
194 glyburide NN B-NP B-m
195 dose NN I-NP O
195 adjustment NN I-NP O
195 , , O O
195 the DT B-NP O
195 medical JJ I-NP O
195 team NN I-NP O
195 decreased VBD B-VP O
195 glyburide JJ B-NP B-m
195 glyburide NN I-NP B-m
195 to TO O O
195 2.5 CD O B-do
195 mg NNS B-NP I-do
196 daily RB O B-f
196 for IN B-VP O
196 the DT B-NP O
196 patient NN I-NP O
196 to TO O O
196 begin VB O O
196 upon IN B-VP O
196 discharge NN B-NP O
196 During IN B-VP O
196 this DT B-NP O
197 admission NN I-NP O
197 , , O O
197 the DT O O
197 all DT B-NP O
197 oral JJ I-NP O
197 agents NNS I-NP O
197 were VBD B-VP O
197 held VBN O O
197 and CC O O
197 the DT B-NP O
197 patient NN I-NP O
197 was VBD B-VP O
198 treated VBN O O
198 with IN B-VP O
198 the DT B-NP O
198 Ryo NNP I-NP O
198 Hospital NNP I-NP O
198 Medical NNP I-NP O
198 Center NNP I-NP O
198 insulin NN I-NP B-m
198 protocol NN I-NP O
199 4 CD O O
199 Infectious NNP B-NP O
199 disease: VBD B-VP O
199 The DT B-NP O
199 patient NN I-NP O
199 has VBZ O O
199 a DT B-NP O
199 history NN I-NP O
199 of IN B-VP O
199 HIV NNP B-NP O
200 positive JJ O O
200 , , O O
200 CD4 NNP B-NP O
200 count NN I-NP O
200 on IN B-VP O
200 1/21/2006 CD O O
200 was VBD B-VP O
200 217 CD O O
200 The DT B-NP O
200 viral JJ I-NP O
200 load NN I-NP O
200 was VBD B-VP O
201 less JJR O O
201 than IN B-VP O
201 assay VB O O
201 The DT B-NP O
201 patient NN I-NP O
201 continued VBD B-VP O
201 on IN B-VP O
201 Truvada NNP B-NP B-m
201 and CC O O
201 Lexiva NNP B-NP B-m
202 The DT B-NP O
202 patient NN I-NP O
202 complained VBD B-VP O
202 of IN B-VP O
202 dysuria NN B-NP O
202 on IN B-VP O
202 2/6/2006 CD O O
202 Urinalysis NN B-NP O
202 was VBD B-VP O
203 ordered VBN O O
203 , , O O
203 but CC O O
203 symptoms NNS B-NP O
203 resolved VBD B-VP O
203 before IN B-VP O
203 specimen NNS B-NP O
203 could MD O O
203 be VB O O
203 sent VBN O O
203 the DT B-NP O
204 lab NN I-NP O
205 5 CD O O
205 Pain: NNP B-NP O
205 History NNP I-NP O
205 of IN B-VP O
205 chronic JJ B-NP B-r
205 pain NN I-NP I-r
205 and CC O O
205 lumbar NN B-NP B-r
205 spine NN I-NP I-r
205 herniations VBZ O I-r
206 The DT B-NP O
206 methadone NN I-NP B-m
206 methadone NN I-NP B-m
206 dose NN I-NP O
206 of IN B-VP O
206 155 CD O B-do
206 155 CD O B-do
206 mg NN B-NP I-do
206 mg NN I-NP I-do
206 was VBD B-VP O
206 confirmed VBN O O
206 with IN B-VP O
206 the DT B-NP O
206 outpatient NN I-NP O
207 clinic NN I-NP O
207 No NNP I-NP O
207 additional JJ B-NP O
207 regular NN I-NP O
207 narcotics NNS I-NP O
207 were VBD B-VP O
207 given VBN O O
207 during IN B-VP O
207 this DT B-NP O
208 admission NN I-NP O
209 6 CD O O
209 Heme: NNP B-NP O
209 The DT B-NP O
209 patient NN I-NP O
209 has VBZ O O
209 chronic VBN O O
209 pancytopenia NN B-NP O
209 She PRP O O
209 has VBZ O O
209 a DT B-NP O
210 normocytic JJ I-NP O
210 normochromic JJ I-NP O
210 anemia NN I-NP O
210 with IN B-VP O
210 normal JJ B-NP O
210 iron NN I-NP O
210 studies NNS I-NP O
210 , , O O
210 B12 NNP B-NP B-m
210 and CC O O
211 folate NN B-NP B-m
211 , , O O
211 and CC O O
211 a DT B-NP O
211 low JJ I-NP O
211 reticulocyte NN I-NP O
211 index NN I-NP O
211 consistent JJ O O
211 with IN B-VP O
211 anemia NN B-NP O
211 of IN B-VP O
212 chronic JJ B-NP O
212 disease NN I-NP O
212 , , O O
212 likely RB O O
212 from IN B-VP O
212 HIV NNP B-NP O
212 immunosuppression NN I-NP O
213 7 CD O O
213 Miscellaneous: NNP B-NP O
213 The DT B-NP O
213 patient NN I-NP O
213 was VBD B-VP O
213 screened VBN O O
213 by IN B-VP O
213 the DT B-NP O
213 Physical NNP I-NP O
214 Therapy NNP I-NP O
214 Service NNP I-NP O
214 who WP O O
214 recommended VBD B-VP O
214 a DT B-NP O
214 home NN I-NP O
214 safety NN I-NP O
214 evaluation NN I-NP O
214 This DT O O
215 will MD O O
215 be VB O O
215 coordinated VBN O O
215 to TO O O
215 the DT B-NP O
215 Tlandgilb NNP I-NP O
215 O NNP I-NP O
215 Visiting NNP I-NP O
215 Nurses NNP I-NP O
215 Association NNP I-NP O
216 Given NNP I-NP O
216 the DT B-NP O
216 liability NN I-NP O
216 and CC O O
216 predictability NN B-NP O
216 of IN B-VP O
216 events NNS B-NP O
216 , , O O
216 the DT B-NP O
216 team NN I-NP O
217 implemented VBD B-VP O
217 a DT B-NP O
217 24-hour JJ I-NP O
217 urine JJ I-NP O
217 collection NN I-NP O
217 to TO O O
217 assess VB O O
217 for IN B-VP O
218 pheochromocytoma NN B-NP O
218 The DT B-NP O
218 results NNS I-NP O
218 of IN B-VP O
218 the DT B-NP O
218 studies NNS I-NP O
218 are VBP O O
218 pending VBG O O
218 at IN B-VP O
218 the DT B-NP O
219 time NN I-NP O
219 of IN B-VP O
219 this DT B-NP O
219 discharge NN I-NP O
219 The DT B-NP O
219 patient NN I-NP O
219 may MD O O
219 have VB O O
219 autonomic JJ B-NP O
220 dysregulation NN I-NP O
220 as IN B-VP O
220 part NN B-NP O
220 of IN B-VP O
220 her PRP$ O O
220 diabetes NNS B-NP O
220 Alternatively RB O O
220 , , O O
220 the DT B-NP O
221 medical JJ I-NP O
221 team NN I-NP O
221 speculates VBZ O O
221 that IN B-VP O
221 the DT B-NP O
221 patient NN I-NP O
221 may MD O O
221 have VB O O
221 cervical JJ B-NP O
221 spinal JJ I-NP O
222 arthritis NN I-NP O
222 , , O O
222 lumbar JJ B-NP O
222 herniation NN I-NP O
222 or CC O O
222 nerve NN B-NP O
222 root NN I-NP O
222 impingement NN I-NP O
223 contributing VBG O O
223 to TO O O
223 these DT B-NP O
223 symptoms NNS I-NP O
223 Of IN B-VP O
223 note NN B-NP O
223 , , O O
223 the DT B-NP O
223 patient NN I-NP O
223 states VBZ O O
223 that IN B-VP O
224 these DT B-NP O
224 episodes NNS I-NP O
224 had VBD B-VP O
224 occurred VBN O O
224 more RBR O O
224 frequently RB O O
224 inpatient JJ O O
224 and CC O O
224 they PRP O O
225 were VBD B-VP O
225 at IN B-VP O
225 home NN B-NP O
225 It PRP O O
225 was VBD B-VP O
225 until IN B-VP O
225 the DT B-NP O
225 day NN I-NP O
225 of IN B-VP O
225 discharge NN B-NP O
225 that IN B-VP O
225 it PRP O O
225 was VBD B-VP O
226 noted VBN O O
226 that IN B-VP O
226 the DT B-NP O
226 patient NN I-NP O
226 was VBD B-VP O
226 not RB O O
226 receiving VBG O O
226 her PRP$ O O
226 Klonopin NNP B-NP B-m
226 1 CD O B-do
226 mg NN B-NP I-do
226 q.i.d NN I-NP B-f
227 as IN B-VP O
227 she PRP O O
227 had VBD B-VP O
227 prior RB O O
227 to TO O O
227 admission NN B-NP O
227 In IN B-VP O
227 fact NN B-NP O
227 , , O O
227 she PRP O O
227 has VBZ O O
227 only RB O O
227 received VBN O O
228 three CD O B-do
228 doses NNS B-NP I-do
228 of IN B-VP O
228 Klonopin NNP B-NP B-m
228 over IN B-VP B-du
228 a DT B-NP I-du
228 six-day JJ I-NP I-du
228 period NN I-NP I-du
228 It PRP O O
228 is VBZ O O
228 unclear JJ O O
229 what WP O O
229 role NN B-NP O
229 anxiety NN I-NP O
229 is VBZ O O
229 playing VBG O O
229 into IN B-VP O
229 these DT B-NP O
229 events NNS I-NP O
229 On IN B-VP O
229 the DT B-NP O
229 day NN I-NP O
229 of IN B-VP O
230 discharge NN B-NP O
230 , , O O
230 the DT B-NP O
230 patient NN I-NP O
230 stated VBD B-VP O
230 that IN B-VP O
230 she PRP O O
230 was VBD B-VP O
230 making VBG O O
230 arrangements NNS B-NP O
230 to TO O O
231 see VB O O
231 an DT B-NP O
231 orthopedic JJ I-NP O
231 specialist NN I-NP O
231 at IN B-VP O
231 Laly NNP B-NP O
231 County NNP I-NP O
231 Health NNP I-NP O
231 for IN B-VP O
232 evaluation NN B-NP O
232 of IN B-VP O
232 her PRP$ O O
232 cervical JJ B-NP O
232 spine NN I-NP O
233 FINAL NNP I-NP O
233 DIAGNOSES: NNP I-NP O
234 1 CD O O
234 Syncope NNP B-NP O
234 , , O O
234 not RB O O
234 otherwise RB O O
234 specified VBN O O
235 2 CD O O
235 Left NNP B-NP O
235 arm NN I-NP O
235 pain/left NN I-NP O
235 chest NN I-NP O
235 pain/left NN I-NP O
235 arm NN I-NP O
235 paresthesias NN I-NP O
235 ( ( O O
235 not RB O O
236 otherwise RB O O
236 specified VBN O O
236 ) ) O O
237 DISCHARGE NNP B-NP O
237 MEDICATIONS: NNP I-NP O
238 Ecotrin NNP I-NP B-m
238 81 CD O B-do
238 mg JJ O I-do
238 daily RB O B-f
238 , , O O
238 clonazepam VBD B-VP B-m
238 1 CD O B-do
238 mg NN B-NP I-do
238 q.6 NN I-NP B-f
238 h NN I-NP I-f
238 p.r.n NN I-NP I-f
238 , , O O
238 Imodium NNP B-NP B-m
238 one CD O B-do
239 to TO O O
239 two CD O O
239 tablets NNS B-NP O
239 q.i.d VBP O B-f
239 p.r.n NN B-NP I-f
239 for IN B-VP O
239 diarrhea NN B-NP B-r
239 , , O O
239 Truvada NNP B-NP B-m
239 one CD O B-do
239 tablet NN B-NP I-do
240 p.o NN I-NP B-mo
240 daily RB O B-f
240 , , O O
240 Lexiva NNP B-NP B-m
240 1400 CD O B-do
240 mg NN B-NP I-do
240 p.o NN I-NP B-mo
240 b.i.d NN I-NP B-f
240 , , O O
240 glyburide RB O B-m
240 2.5 CD O B-do
240 mg JJ O I-do
240 daily RB O B-f
240 , , O O
241 Keppra NNP B-NP B-m
241 Keppra NNP I-NP B-m
241 500 CD O B-do
241 mg NN B-NP I-do
241 b.i.d NN I-NP B-f
241 for IN B-VP B-du
241 14 CD O I-du
241 doses NNS B-NP I-du
241 and CC O O
241 then RB O O
241 750 CD O B-do
241 mg NNS B-NP I-do
241 b.i.d RBR O B-f
242 indefinitely RB O B-du
242 , , O O
242 methadone PRP O B-m
242 155 CD O B-do
242 mg JJ O I-do
242 daily RB O B-f
242 , , O O
242 Zantac NNP B-NP B-m
242 150 CD O B-do
242 mg NN B-NP I-do
242 b.i.d NN I-NP B-f
242 , , O O
243 Zoloft NNP B-NP B-m
243 300 CD O B-do
243 mg JJ O I-do
243 daily RB O B-f
243 , , O O
243 trazodone NN B-NP B-m
243 100 CD O B-do
243 mg NN B-NP I-do
243 at IN B-VP B-f
243 bedtime NN B-NP I-f
243 p.r.n NN I-NP I-f
243 , , O O
243 and CC O O
244 Zofran NNP B-NP B-m
244 4 CD O B-do
244 mg JJ B-NP I-do
244 daily JJ I-NP B-f
244 p.r.n NN I-NP I-f
244 for IN B-VP O
244 nausea NN B-NP B-r
245 MEDICAL NNP I-NP O
245 FOLLOW NNP I-NP O
245 UP: NNP I-NP O
246 On IN B-VP O
246 2/25/2006 CD O O
246 , , O O
246 the DT B-NP O
246 patient NN I-NP O
246 is VBZ O O
246 scheduled VBN O O
246 to TO O O
246 see VB O O
246 her PRP$ O O
246 PCP NNP B-NP O
246 , , O O
246 Dr NNP B-NP O
246 Les NNP I-NP O
246 Orosco NNP I-NP O
246 On IN B-VP O
246 7/10/2006 CD O O
246 , , O O
246 she PRP O O
246 is VBZ O O
246 scheduled VBN O O
246 to TO O O
246 see VB O O
246 her PRP$ O O
246 psychiatrist NN B-NP O
246 , , O O
247 Dr NNP B-NP O
247 Damien NNP I-NP O
247 Scherzer NNP I-NP O
247 On IN B-VP O
247 9/18/2006 CD O O
247 , , O O
247 she PRP O O
247 is VBZ O O
247 scheduled VBN O O
247 to TO O O
247 see VB O O
248 her PRP$ O O
248 Infectious JJ B-NP O
248 Disease NNP I-NP O
248 , , O O
248 Dr NNP B-NP O
248 Marion NNP I-NP O
248 Callais NNP I-NP O
248 On IN B-VP O
248 0/14/2006 CD O O
248 , , O O
248 she PRP O O
248 is VBZ O O
249 scheduled VBN O O
249 to TO O O
249 see VB O O
249 her PRP$ O O
249 neurologist NN B-NP O
249 , , O O
249 Dr NNP B-NP O
249 Shane NNP I-NP O
249 Bemberry NNP I-NP O
249 In IN B-VP O
250 addition NN B-NP O
250 , , O O
250 the DT B-NP O
250 patient NN I-NP O
250 is VBZ O O
250 going VBG O O
250 to TO O O
250 be VB O O
250 followed VBN O O
250 by IN B-VP O
250 the DT B-NP O
250 Na NNP I-NP O
250 Riventtortonlis NNP I-NP O
250 Jo NNP I-NP O
250 VNA NNP I-NP O
251 who WP O O
251 will MD O O
251 do VB O O
251 a DT B-NP O
251 medication NN I-NP O
251 reconciliation NN I-NP O
251 and CC O O
251 home NN B-NP O
251 safety NN I-NP O
252 evaluation NN I-NP O
253 SPECIFIC NNP I-NP O
253 INSTRUCTIONS: NNP I-NP O
254 1 CD O O
254 Take NNP B-NP O
254 medications NNS I-NP O
254 as IN B-VP O
254 listed VBN O O
254 , , O O
254 clarify VB O O
254 discrepancies NNS B-NP O
254 with IN B-VP O
254 your PRP$ O O
255 PCP NNP B-NP O
255 This DT O O
255 means VBZ O O
255 stop JJ O O
255 taking VBG O O
255 Flexeril NNP B-NP B-m
255 , , O O
255 ____ NNP B-NP O
255 glyburide NN I-NP B-m
255 has VBZ O O
255 been VBN O O
256 changed VBN O O
256 to TO O O
256 2.5 CD O B-do
256 mg NN B-NP I-do
256 , , O O
256 and CC O O
256 low-dose JJ B-NP B-do
256 aspirin NN I-NP B-m
256 has VBZ O O
256 been VBN O O
256 started VBN O O
257 2 CD O O
257 If IN B-VP O
257 you PRP O O
257 faint VBP O O
257 again RB O O
257 , , O O
257 you PRP O O
257 should MD O O
257 return VB O O
257 to TO O O
257 the DT B-NP O
257 ER NNP I-NP O
257 for IN B-VP O
258 evaluation NN B-NP O
259 3 CD O O
259 If IN B-VP O
259 your PRP$ O O
259 chest JJS B-NP O
259 pain NN I-NP O
259 symptoms NNS I-NP O
259 recur NN I-NP O
259 and CC O O
259 persist NN B-NP O
259 longer JJR O O
259 than IN B-VP O
259 the DT B-NP O
260 typical JJ I-NP O
260 course NN I-NP O
260 , , O O
260 call VB O O
260 your PRP$ O O
260 PCP NNP B-NP O
260 and/or NN I-NP O
260 return NN I-NP O
260 to TO O O
260 the DT B-NP O
260 emergency NN I-NP O
261 room NN I-NP O
262 4 CD O O
262 Make NNP B-NP O
262 an DT B-NP O
262 appointment NN I-NP O
262 with IN B-VP O
262 the DT B-NP O
262 Smill NNP I-NP O
262 Memorial NNP I-NP O
262 Hospital NNP I-NP O
262 to TO O O
262 evaluate VB O O
263 the DT B-NP O
263 cause NN I-NP O
263 of IN B-VP O
263 her PRP$ O O
263 left JJ B-NP O
263 arm NN I-NP O
263 symptoms NNS I-NP O
264 5 CD O O
264 Check NNP B-NP O
264 your PRP$ O O
264 blood NN B-NP O
264 sugars NNS I-NP O
264 before IN B-VP O
264 meals NNS B-NP O
264 and CC O O
264 at IN B-VP O
264 bedtime NN B-NP O
264 , , O O
264 record NN B-NP O
265 and CC O O
265 bring VB O O
265 your PRP$ O O
265 results NNS B-NP O
265 to TO O O
265 your PRP$ O O
265 follow-up JJ B-NP O
265 appointment NN I-NP O
266 SPECIFIC NNP I-NP O
266 INSTRUCTIONS NNP I-NP O
266 FOR IN B-VP O
266 THE NNP B-NP O
266 PCP: NNP I-NP O
267 1 CD O O
267 Please NNP B-NP O
267 arrange NN I-NP O
267 for IN B-VP O
267 a DT B-NP O
267 loop JJ I-NP O
267 monitor NN I-NP O
268 2 CD O O
268 Follow NNP B-NP O
268 up RB O O
268 on IN B-VP O
268 a DT B-NP O
268 24-hour JJ I-NP O
268 urine JJ I-NP O
268 studies NNS I-NP O
268 assessing VBG O O
268 for IN B-VP O
269 pheochromocytoma NN B-NP O
270 3 CD O O
270 Adjust NNP B-NP O
270 the DT B-NP O
270 patient's NN I-NP O
270 diabetes VBZ O O
270 management NN B-NP O
270 as IN B-VP O
270 needed VBN O O
271 eScription NN B-NP O
271 document: VBZ O O
271 1-2481939 JJ B-NP O
271 EMSSten NNP I-NP O
271 Tel NNP I-NP O
272 Dictated NNP I-NP O
272 By: NNP I-NP O
272 MARTYN NNP I-NP O
272 , , O O
272 BRUNO NNP B-NP O
273 Attending: NNP I-NP O
273 TOTI NNP I-NP O
273 , , O O
273 JEREMY NNP B-NP O
274 Dictation NNP I-NP O
274 ID NNP I-NP O
274 1865427 CD O O
275 D: NNP B-NP O
275 9/4/06 CD O O
276 T: NNP B-NP O
276 9/4/06 CD O O
277 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #555996 VBZ O O
2 708486546 CD O O
2 WRH NNP B-NP O
2 96067621 CD O O
2 9079561 CD O O
2 5/13/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 same JJ B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 5/13/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/13/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 COLAFRANCESCO NNP I-NP O
5 , , O O
5 VANCE NNP B-NP O
5 J NNP I-NP O
5 324-27-48-7 JJ B-NP O
6 Inero NNP I-NP O
6 Lane NNP I-NP O
6 Room: NNP I-NP O
6 Ster NNP I-NP O
6 Mar NNP I-NP O
6 1 CD O O
7 Service: NNP B-NP O
7 URO NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/20/05 CD O O
8 AT NNP B-NP O
8 11:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 ISHERWOOD NNP I-NP O
11 , , O O
11 REYES NNP B-NP O
11 GAVIN NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 DISPOSITION: NNP I-NP O
12 Home NNP I-NP O
13 DISCHARGE NNP I-NP O
13 MEDICATIONS: NNP I-NP O
14 CAPSAICIN NNP I-NP B-m
14 0.025 CD O I-m
14 % NN B-NP I-m
14 TP NNP I-NP B-mo
14 BID NNP I-NP B-f
14 Instructions: NNP I-NP O
14 apply VB O O
14 to TO O O
14 legs VB O O
15 LASIX NNP B-NP B-m
15 ( ( O I-m
15 FUROSEMIDE NNP B-NP I-m
15 ) ) O I-m
15 40 CD O B-do
15 MG NNP B-NP I-do
15 PO NNP I-NP B-mo
15 QD NNP I-NP B-f
16 MICRONASE NNP I-NP B-m
16 ( ( O I-m
16 GLYBURIDE NNP B-NP I-m
16 ) ) O I-m
16 2.5 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 L-THYROXINE NNP I-NP B-m
17 ( ( O I-m
17 LEVOTHYROXINE NNP B-NP I-m
17 SODIUM NNP I-NP I-m
17 ) ) O I-m
17 50 CD O B-do
17 MCG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 Alert NNP I-NP O
18 overridden: NNP I-NP O
18 Override NNP I-NP O
18 added VBD B-VP O
18 on IN B-VP O
18 8/3/05 CD O O
18 by IN B-VP O
19 MURRI NNP B-NP O
19 , , O O
19 CRISTOPHER NNP B-NP O
19 STEPHEN NNP I-NP O
19 , , O O
19 M.D NNP B-NP O
20 POTENTIALLY NNP I-NP O
20 SERIOUS NNP I-NP O
20 INTERACTION: NNP I-NP O
20 DIGOXIN NNP I-NP B-m
20 &amp; NNP I-NP O
20 LEVOTHYROXINE NNP I-NP B-m
21 SODIUM NNP I-NP O
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: NN B-NP O
21 home NN I-NP O
22 PYRIDIUM NNP I-NP B-m
22 ( ( O I-m
22 PHENAZOPYRIDINE NNP B-NP I-m
22 HCL NNP I-NP I-m
22 ) ) O I-m
22 100 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 TID NNP I-NP B-f
23 PRN NNP I-NP O
23 Other:bladder/stent NNP I-NP O
23 pain NN I-NP B-r
24 PROBENECID NNP I-NP B-m
24 1 CD O B-do
24 , , O I-do
24 500 CD O I-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 BID NNP I-NP B-f
25 COZAAR NNP I-NP B-m
25 ( ( O I-m
25 LOSARTAN NNP B-NP I-m
25 ) ) O I-m
25 75 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QD NNP I-NP B-f
25 HOLD NNP I-NP O
25 IF: NNP I-NP O
25 sbp VBD B-VP O
25 &lt;100 NNP B-NP O
26 Number NNP I-NP B-du
26 of IN B-VP I-du
26 Doses NNP B-NP I-du
26 Required NNP I-NP I-du
26 ( ( O I-du
26 approximate JJ B-NP I-du
26 ): NN I-NP I-du
26 5 CD O I-du
27 FLOMAX NNP B-NP B-m
27 ( ( O I-m
27 TAMSULOSIN NNP B-NP I-m
27 ) ) O I-m
27 0.4 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 NEXIUM NNP I-NP B-m
28 ( ( O I-m
28 ESOMEPRAZOLE NNP B-NP I-m
28 ) ) O I-m
28 40 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 BACTRIM NNP I-NP B-m
29 DS NNP I-NP I-m
29 ( ( O I-m
29 TRIMETHOPRIM/SULFAMETHOXAZOLE NNP B-NP I-m
29 DOU NNP I-NP I-m
29 ) ) O I-m
30 1 CD O B-do
30 TAB NNP B-NP I-do
30 PO NNP I-NP B-mo
30 Q24H NNP I-NP B-f
31 DIET: NNP I-NP O
31 House NNP I-NP O
31 / NNP I-NP O
31 ADA NNP I-NP O
31 2100 CD O O
31 cals/dy NN B-NP O
32 ACTIVITY: NNP I-NP O
32 Walking NNP I-NP O
32 as IN B-VP O
32 tolerated VBN O O
33 FOLLOW NNP B-NP O
33 UP NNP I-NP O
33 APPOINTMENT( NNP I-NP O
33 S NNP I-NP O
33 ): NNP I-NP O
34 Dr NNP I-NP O
34 Lyvers NNP I-NP O
34 at IN B-VP O
34 865-655-3733 JJ B-NP O
34 Please NNP I-NP O
34 call NN I-NP O
34 office NN I-NP O
34 for IN B-VP O
34 follow-up JJ B-NP O
34 appointment NN I-NP O
34 , , O O
35 ALLERGY: NNP B-NP O
35 Aspirin NNP I-NP O
35 , , O O
35 Morphine NNP B-NP O
35 , , O O
35 ALLOPURINOL NNP B-NP O
35 , , O O
35 ALENDRONATE NNP B-NP O
35 , , O O
36 FOSINOPRIL NNP B-NP O
36 , , O O
36 Codeine NNP B-NP O
36 , , O O
36 CARBAMAZEPINE NNP B-NP O
37 ADMIT NNP I-NP O
37 DIAGNOSIS: NNP I-NP O
38 nephrolithiasis NN I-NP O
39 PRINCIPAL NNP I-NP O
39 DISCHARGE NNP I-NP O
39 DIAGNOSIS NNP I-NP O
39 ;Responsible JJ O O
39 After IN B-VP O
39 Study NNP B-NP O
39 for IN B-VP O
39 Causing NNP B-NP O
39 Admission NNP I-NP O
39 ) ) O O
40 same JJ B-NP O
41 OTHER NNP I-NP O
41 DIAGNOSIS;Conditions NNP I-NP O
41 , , O O
41 Infections NNP B-NP O
41 , , O O
41 Complications NNP B-NP O
41 , , O O
41 affecting VBG O O
41 Treatment/Stay NNP B-NP O
42 DM NNP I-NP O
42 , , O O
42 gout NN B-NP O
42 , , O O
42 OA NNP B-NP O
42 , , O O
42 Afib NNP B-NP O
42 , , O O
42 Diverticulitis NNP B-NP O
42 , , O O
42 nephrolithiasis NN B-NP O
42 , , O O
42 CRI NNP B-NP O
42 , , O O
42 sleep JJ B-NP O
42 apnea NN I-NP O
43 OPERATIONS NNP I-NP O
43 AND NNP I-NP O
43 PROCEDURES: NNP I-NP O
44 cystoscopy NN I-NP O
44 , , O O
44 L NNP B-NP O
44 ureteroscopy NN I-NP O
44 , , O O
44 L NNP B-NP O
44 retrograde VBD B-VP O
44 pyelogram NN B-NP O
44 , , O O
44 Laser NNP B-NP O
44 lithotripsy NN I-NP O
44 and CC O O
45 L NNP B-NP O
45 stent JJ B-NP O
45 placement NN I-NP O
46 OTHER NNP I-NP O
46 TREATMENTS/PROCEDURES NNP I-NP O
46 ( ( O O
46 NOT NNP B-NP O
46 IN NNP I-NP O
46 O.R NNP I-NP O
46 ) ) O O
47 none NN B-NP O
48 BRIEF NNP I-NP O
48 RESUME NNP I-NP O
48 OF NNP I-NP O
48 HOSPITAL NNP I-NP O
48 COURSE: NNP I-NP O
49 This DT O O
49 is VBZ O O
49 a DT O O
49 79 CD O O
49 yoM NN B-NP O
49 with IN B-VP O
49 a DT O O
49 1 CD O O
49 cm NN B-NP O
49 L NNP I-NP O
49 renal VBZ O O
49 stone NN B-NP O
49 that WDT O O
49 was VBD B-VP O
49 stable JJ O O
49 for IN B-VP O
49 years NNS B-NP O
49 but CC O O
50 caused VBD B-VP O
50 left VBN O O
50 hip NN B-NP O
50 and CC O O
50 flank NN B-NP O
50 pain NN I-NP O
50 with IN B-VP O
50 nausea NN B-NP O
50 and CC O O
50 vomiting VBG O O
50 Patient NNP B-NP O
50 was VBD B-VP O
51 admitted VBN O O
51 to TO O O
51 OCMC NNP B-NP O
51 on IN B-VP O
51 8/9/05 CD O O
51 With IN B-VP O
51 hx NN B-NP O
51 of IN B-VP O
51 Afib NNP B-NP B-r
51 , , O O
51 patient's JJ B-NP O
51 cardiologist NN I-NP O
51 Dr NNP I-NP O
52 Cannizzo NNP I-NP O
52 was VBD B-VP O
52 consulted VBN O O
52 and CC O O
52 coumadin NN B-NP B-m
52 was VBD B-VP O
52 helf PRP O O
52 for IN B-VP O
52 operation NN B-NP O
52 It PRP O O
52 was VBD B-VP O
53 orginally RB O O
53 planned VBN O O
53 to TO O O
53 reverse VB O O
53 INR NNP B-NP B-r
53 with IN B-VP O
53 FFP NNP B-NP B-m
53 but CC O O
53 patient JJ O O
53 felt VBD B-VP O
53 throat NN B-NP O
54 tightness NN I-NP O
54 after IN B-VP O
54 5 CD O O
54 min NN B-NP O
54 of IN B-VP O
54 FFP NNP B-NP B-m
54 transfusion NN I-NP B-mo
54 and CC O O
54 FFP NNP B-NP B-m
54 was VBD B-VP O
54 stopped VBN O O
54 Patient NNP B-NP O
55 underwent JJ B-NP O
55 laser NN I-NP O
55 lithotripsy NN I-NP O
55 and CC O O
55 stent JJ B-NP O
55 placement NN I-NP O
55 on IN B-VP O
55 8/0/50 CD O O
55 and CC O O
55 he PRP O O
56 tolerated VBD B-VP O
56 the DT B-NP O
56 procedure NN I-NP O
56 well RB O O
56 Immediate NNP B-NP O
56 post-op NN I-NP O
56 , , O O
56 patient NN B-NP O
56 had VBD B-VP O
56 frequent JJ B-NP O
56 PVC NNP I-NP O
57 but CC O O
57 cardiac JJ B-NP O
57 enzyme NN I-NP O
57 was VBD B-VP O
57 negative JJ B-NP O
57 Foley NNP I-NP O
57 was VBD B-VP O
57 removed VBN O O
57 on IN B-VP O
57 POD1 NNP B-NP O
57 midnight NN I-NP O
57 and CC O O
58 patient NN B-NP O
58 voided VBD B-VP O
58 without IN B-VP O
58 difficulties NNS B-NP O
58 with IN B-VP O
58 post NN B-NP O
58 void NN I-NP O
58 residue JJ O O
58 120 CD O O
58 cc NN B-NP O
59 Patient NNP I-NP O
59 was VBD B-VP O
59 noticed VBN O O
59 to TO O O
59 have VB O O
59 an DT B-NP O
59 enlarged JJ I-NP O
59 prostate NN I-NP O
59 during IN B-VP O
59 procedure NN B-NP O
59 and CC O O
60 need NN B-NP O
60 to TO O O
60 follow VB O O
60 up RP O O
60 with IN B-VP O
60 Dr NNP B-NP O
60 Domebo NNP I-NP O
60 for IN B-VP O
60 further JJ B-NP O
60 management NN I-NP O
60 On IN B-VP O
60 POD2 NNP B-NP O
60 , , O O
60 patient NN B-NP O
61 tolerated VBD B-VP O
61 regular JJ B-NP O
61 diet NN I-NP O
61 , , O O
61 and CC O O
61 was VBD B-VP O
61 ready JJ O O
61 to TO O O
61 be VB O O
61 discharged VBN O O
61 home NN B-NP O
61 with IN B-VP O
61 Bactrim NNP B-NP B-m
62 and CC O O
62 low JJ B-NP B-do
62 dose NN I-NP I-do
62 Coumadin NNP I-NP B-m
62 He PRP O O
62 is VBZ O O
62 to TO O O
62 follow VB O O
62 up RP O O
62 with IN B-VP O
62 his PRP$ O O
62 PCP NNP B-NP O
62 for IN B-VP O
62 INR NNP B-NP O
62 check NN I-NP O
62 and CC O O
63 Coumadin NNP B-NP B-m
63 dose VBP O O
63 adjustment JJ B-NP O
64 ADDITIONAL NNP I-NP O
64 COMMENTS: NNP I-NP O
64 Please NNP I-NP O
64 start VB O O
64 taking VBG O O
64 Coumadin NNP B-NP B-m
64 at IN B-VP O
64 3 CD O B-do
64 mg NN B-NP I-do
64 for IN B-VP O
64 tonight NN B-NP B-du
64 and CC O I-du
64 tomorrow NN B-NP I-du
64 night NN I-NP I-du
64 and CC O O
65 resume VB O O
65 your PRP$ O O
65 regular JJ B-NP O
65 coumadine NN I-NP B-m
65 dose NN I-NP O
65 schedule NN I-NP O
65 Call NNP I-NP O
65 your PRP$ O O
65 Coumadin NNP B-NP B-m
65 clinic NN I-NP O
65 on IN B-VP O
66 Monday NNP B-NP O
66 for IN B-VP O
66 follow VBP O O
66 up RP O O
66 regarding VBG O O
66 to TO O O
66 blood VB O O
66 check NN B-NP O
66 and CC O O
66 coumadin JJ B-NP B-m
66 dosage NN I-NP O
67 adjustment NN I-NP O
67 No NNP I-NP O
67 lifting VBG O O
67 more JJR O O
67 that IN B-VP O
67 10 CD O O
67 lbs JJ B-NP O
67 No NNP I-NP O
67 driving VBG O O
67 while IN B-VP O
67 on IN B-VP O
67 narcotics NNS B-NP B-m
68 Please NNP I-NP O
68 call NN I-NP O
68 for IN B-VP O
68 fever NN B-NP O
68 &gt; NN I-NP O
68 101.5 CD O O
68 , , O O
68 unable JJ O O
68 to TO O O
68 urinate VB O O
68 , , O O
68 shortness NN B-NP O
68 of IN B-VP O
68 breath NN B-NP O
68 or CC O O
69 any DT B-NP O
69 other JJ I-NP O
69 concerning NN I-NP O
69 symptoms NNS I-NP O
69 Call NNP I-NP O
69 Urology NNP I-NP O
69 office NN I-NP O
69 865-655-3733 NN I-NP O
69 for IN B-VP O
70 appointment NN B-NP O
70 and CC O O
70 questions NNS B-NP O
71 DISCHARGE NNP I-NP O
71 CONDITION: NNP I-NP O
71 Stable NNP I-NP O
72 TO NNP I-NP O
72 DO/PLAN: NNP I-NP O
73 No NNP I-NP O
73 dictated VBD B-VP O
73 summary JJ B-NP O
74 ENTERED NNP I-NP O
74 BY: NNP I-NP O
74 JEZ NNP I-NP O
74 , , O O
74 JAMEY NNP B-NP O
74 , , O O
74 M.D NNP B-NP O
74 , , O O
74 PH.D NNP B-NP O
74 ( ( O O
74 PI87 NNP B-NP O
74 ) ) O O
74 9/20/05 CD O O
74 @ $ O O
74 12 CD O O
75 ****** JJ B-NP O
75 END NN I-NP O
75 OF NNP I-NP O
75 DISCHARGE NNP I-NP O
75 ORDERS NNP I-NP O
75 ****** NNP I-NP O
76 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #560453 VBZ O O
2 748470127 CD O O
2 CBMC NNP B-NP O
2 32700120 CD O O
2 8249855 CD O O
2 1/30/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 RIGHT NNP I-NP O
2 KNEE NNP I-NP O
2 EFFUSION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/27/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/21/2005 CD O O
4 ATTENDING: NNP B-NP O
4 REDWINE NNP I-NP O
4 , , O O
4 KENNY NNP B-NP O
4 M.D NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSES: NNP I-NP O
6 1 CD O O
6 Knee NNP B-NP O
6 pain NN I-NP O
7 2 CD O O
7 Chronic NNP B-NP O
7 venous JJ B-NP O
7 stasis NN I-NP O
8 3 CD O O
8 Lithium NNP B-NP O
8 toxicity NN I-NP O
9 4 CD O O
9 Obesity NNP B-NP O
10 HISTORY NNP I-NP O
10 OF NNP I-NP O
10 PRESENT NNP I-NP O
10 ILLNESS: NNP I-NP O
11 This DT O O
11 is VBZ O O
11 a DT B-NP O
11 50-year-old JJ I-NP O
11 female NN I-NP O
11 with IN B-VP O
11 a DT B-NP O
11 history NN I-NP O
11 of IN B-VP O
11 hypertension NN B-NP O
11 , , O O
12 diabetes VBZ O O
12 , , O O
12 obesity NN B-NP O
12 , , O O
12 as RB O O
12 well RB O O
12 as IN B-VP O
12 a DT B-NP O
12 schizophrenia NN I-NP O
12 and CC O O
12 bipolar JJ B-NP O
13 disorder NN I-NP O
13 , , O O
13 presents NNS B-NP O
13 with IN B-VP O
13 right JJ B-NP O
13 knee NN I-NP O
13 swelling VBG O O
13 , , O O
13 redness NN B-NP O
13 and CC O O
13 pain NN B-NP O
13 for IN B-VP O
14 one CD O O
14 week NN B-NP O
14 The DT B-NP O
14 patient NN I-NP O
14 lives VBZ O O
14 alone RB O O
14 at IN B-VP O
14 home NN B-NP O
14 and CC O O
14 has VBZ O O
14 two CD O O
14 brothers NNS B-NP O
15 who WP O O
15 periodically RB O O
15 check VBP O O
15 in IN B-VP O
15 on IN B-VP O
15 her PRP$ O O
15 She PRP O O
15 was VBD B-VP O
15 visited VBN O O
15 by IN B-VP O
15 her PRP$ O O
15 brother NN B-NP O
16 yesterday NN I-NP O
16 and CC O O
16 found VBD B-VP O
16 that IN B-VP O
16 her PRP$ O O
16 right JJ B-NP O
16 knee NN I-NP O
16 had VBD B-VP O
16 been VBN O O
16 swollen VBN O O
16 red JJ O O
16 and CC O O
17 tender NN B-NP O
17 for IN B-VP O
17 about IN B-VP O
17 a DT B-NP O
17 week NN I-NP O
17 After IN B-VP O
17 he PRP O O
17 noted VBD B-VP O
17 this DT O O
17 , , O O
17 he PRP O O
17 brought VBD B-VP O
17 her PRP O O
17 to TO O O
18 the DT B-NP O
18 emergency NN I-NP O
18 department NN I-NP O
18 The DT B-NP O
18 patient NN I-NP O
18 states VBZ O O
18 that IN B-VP O
18 the DT B-NP O
18 leg NN I-NP O
18 has VBZ O O
19 made VBN O O
19 it PRP O O
19 impossible JJ O O
19 for IN B-VP O
19 her PRP$ O O
19 to TO O O
19 ambulate VB O O
19 She PRP O O
19 denies VBZ O O
19 trauma NN B-NP O
19 to TO O O
19 the DT B-NP O
20 area NN I-NP O
20 recently RB O O
20 She PRP O O
20 also RB O O
20 denies VBZ O O
20 fevers NNS B-NP O
20 , , O O
20 chills NNS B-NP O
20 , , O O
20 shortness NN B-NP O
20 of IN B-VP O
21 breath NN B-NP O
21 or CC O O
21 chest JJS B-NP O
21 pain NN I-NP O
21 There EX O O
21 is VBZ O O
21 no DT B-NP O
21 nausea NN I-NP O
21 , , O O
21 vomiting VBG O O
21 , , O O
21 constipation NN B-NP O
22 or CC O O
22 diarrhea NN B-NP O
23 PAST NNP I-NP O
23 MEDICAL NNP I-NP O
23 HISTORY: NNP I-NP O
24 1 CD O O
24 Ovarian NNP B-NP O
24 cystadenofibroma NN I-NP O
24 , , O O
24 status NN B-NP O
24 post NN I-NP O
24 TAH-BSO NNP I-NP O
24 in IN B-VP O
24 1/24 CD O O
25 2 CD O O
25 Obesity NN B-NP O
26 3 CD O O
26 Hypertension NNP B-NP O
27 4 CD O O
27 Diabetes VBZ O O
28 5 CD O O
28 Hyperlipidemia NNP B-NP O
29 6 CD O O
29 Schizophrenia NNP B-NP O
30 7 CD O O
30 Bipolar NNP B-NP O
30 disorder NN I-NP O
31 8 CD O O
31 Obstructive JJ B-NP O
31 sleep NN I-NP O
31 apnea NN I-NP O
31 , , O O
31 on IN B-VP O
31 home NN B-NP O
31 BiPAP NNP I-NP O
32 9 CD O O
32 History NNP B-NP O
32 of IN B-VP O
32 laparoscopy NN B-NP O
32 for IN B-VP O
32 infertility NN B-NP O
33 ALLERGIES: NNP I-NP O
34 No NNP I-NP O
34 known VBN O O
34 drug NN B-NP O
34 allergies NNS I-NP O
35 MEDICATIONS NNP I-NP O
35 ON NNP I-NP O
35 ADMISSION: NNP I-NP O
36 1 CD O O
36 Lisinopril NNP B-NP B-m
36 10 CD O B-do
36 mg VBD B-VP I-do
36 daily RB O B-f
37 2 CD O O
37 Lipitor NNP B-NP B-m
37 40 CD O B-do
37 mg VBD B-VP I-do
37 daily RB O B-f
38 3 CD O O
38 Klonopin NNP B-NP B-m
39 4 CD O O
39 MetroGel NNP B-NP B-m
39 p.o NN I-NP B-mo
39 at IN B-VP B-f
39 bedtime JJ O I-f
40 5 CD O O
40 Lithium NNP B-NP B-m
40 900 CD O B-do
40 mg NN B-NP I-do
40 at IN B-VP B-f
40 bedtime JJ O I-f
41 6 CD O O
41 Acebutolol NNP B-NP B-m
41 200 CD O B-do
41 mg VBD B-VP I-do
41 daily RB O B-f
42 7 CD O O
42 Risperdal NNP B-NP B-m
42 0.5 CD O B-do
42 mg NN B-NP I-do
42 at IN B-VP B-f
42 bedtime JJ B-NP I-f
43 SOCIAL NNP I-NP O
43 HISTORY: NNP I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 lives VBZ O O
44 at IN B-VP O
44 home NN B-NP O
44 alone RB O O
44 She PRP O O
44 smokes VBZ O O
44 tobacco NN B-NP O
44 , , O O
44 but CC O O
44 denies VBZ O O
45 ethanol FW O O
45 She PRP O O
45 does VBZ O O
45 drink VB O O
45 several JJ B-NP O
45 bottles NNS I-NP O
45 of IN B-VP O
45 soda JJ O O
45 per IN B-VP O
45 day NN B-NP O
45 Her PRP$ O O
46 brother NN B-NP O
46 , , O O
46 Willard NNP B-NP O
46 Kloock NNP I-NP O
46 , , O O
46 did VBD B-VP O
46 involve VB O O
46 in IN B-VP O
46 her PRP O O
46 care; VB O O
46 his PRP$ O O
46 phone NN B-NP O
46 number NN I-NP O
47 is VBZ O O
47 427-986-1973 JJ O O
47 , , O O
47 he PRP O O
47 can MD O O
47 also RB O O
47 be VB O O
47 reached VBN O O
47 at IN B-VP O
47 243-754-1828 JJ B-NP O
47 Her NNP I-NP O
48 other JJ B-NP O
48 brother NN I-NP O
48 , , O O
48 Merrill NNP B-NP O
48 Luersen NNP I-NP O
48 , , O O
48 is VBZ O O
48 also RB O O
48 involved VBN O O
48 in IN B-VP O
48 her PRP$ O O
48 care NN B-NP O
48 and CC O O
48 can MD O O
49 be VB O O
49 reached VBN O O
49 at IN B-VP O
49 938-506-7946 JJ B-NP O
50 PHYSICAL NNP I-NP O
50 EXAMINATION: NNP I-NP O
51 Temperature NNP I-NP O
51 97.5 CD O O
51 , , O O
51 pulse RB O O
51 42 CD O O
51 , , O O
51 blood NN B-NP O
51 pressure NN I-NP O
51 107/58 CD O O
51 , , O O
51 respirations NNS B-NP O
52 20 CD O O
52 , , O O
52 and CC O O
52 oxygen NN B-NP O
52 saturation NN I-NP O
52 97% CD O O
52 In IN B-VP O
52 general JJ O O
52 , , O O
52 this DT O O
52 is VBZ O O
52 an DT B-NP O
52 obese JJ I-NP O
53 female NN I-NP O
53 , , O O
53 she PRP O O
53 is VBZ O O
53 Spanish-speaking VBG O O
53 mostly RB O O
53 She PRP O O
53 appears VBZ O O
53 unkempt JJ O O
53 and CC O O
54 in IN B-VP O
54 discomfort NN B-NP O
54 somewhat RB O O
54 because IN B-VP O
54 of IN B-VP O
54 her PRP$ O O
54 right JJ B-NP O
54 knee NN I-NP O
54 pain NN I-NP O
54 She PRP O O
54 is VBZ O O
54 no DT B-NP O
55 acute JJ I-NP O
55 distress NN I-NP O
55 Cardiovascular NNP I-NP O
55 exam NN I-NP O
55 shows NNS I-NP O
55 bradycardia VBP O O
55 , , O O
55 with IN B-VP O
56 normal JJ B-NP O
56 S1 NNP I-NP O
56 and CC O O
56 S2 NNP B-NP O
56 , , O O
56 and CC O O
56 2/6 CD O O
56 systolic JJ B-NP O
56 ejection NN I-NP O
56 murmur FW O O
56 heard NN B-NP O
56 best JJS O O
56 at IN B-VP O
57 the DT B-NP O
57 left JJ I-NP O
57 upper JJ I-NP O
57 sternal JJ I-NP O
57 border NN I-NP O
57 Her NNP I-NP O
57 chest NN I-NP O
57 exam NN I-NP O
57 showed VBD B-VP O
57 some DT O O
57 low JJ O O
58 soft JJ O O
58 rumbling VBG O O
58 sounds NNS B-NP O
58 with IN B-VP O
58 inspiration NN B-NP O
58 and CC O O
58 expiration NN B-NP O
58 , , O O
58 otherwise RB O O
58 , , O O
59 clear JJ O O
59 to TO O O
59 auscultation VB O O
59 bilaterally RB O O
59 Abdomen NNP B-NP O
59 was VBD B-VP O
59 distended VBN O O
59 and CC O O
60 obese JJ O O
60 There EX O O
60 are VBP O O
60 positive JJ B-NP O
60 bowel NN I-NP O
60 sounds NNS I-NP O
60 , , O O
60 and CC O O
60 no DT B-NP O
60 palpable JJ I-NP O
60 liver NN I-NP O
61 and CC O O
61 spleen JJ B-NP O
61 Extremity NNP I-NP O
61 exam NN I-NP O
61 showed VBD B-VP O
61 uncut JJ B-NP O
61 nails NNS I-NP O
61 on IN B-VP O
61 upper JJ O O
61 and CC O O
61 lower JJR B-NP O
62 extremities NNS I-NP O
62 bilaterally RB O O
62 Her PRP$ O O
62 right JJ B-NP O
62 leg NN I-NP O
62 was VBD B-VP O
62 greater JJR O O
62 in IN B-VP O
62 size NN B-NP O
62 than IN B-VP O
63 her PRP$ O O
63 left NN B-NP O
63 , , O O
63 however RB O O
63 , , O O
63 both DT O O
63 show VBP O O
63 significant JJ B-NP O
63 2-3+ JJ I-NP O
63 pitting NN I-NP O
63 edema NN I-NP O
63 On IN B-VP O
64 the DT B-NP O
64 right JJ I-NP O
64 ankle NN I-NP O
64 area NN I-NP O
64 , , O O
64 there EX O O
64 appears VBZ O O
64 to TO O O
64 be VB O O
64 chronic JJ B-NP O
64 venous JJ I-NP O
64 stasis NN I-NP O
65 changes NNS I-NP O
65 with IN B-VP O
65 hyperpigmented JJ B-NP O
65 patch NN I-NP O
65 on IN B-VP O
65 the DT B-NP O
65 lower JJR I-NP O
65 extremity NN I-NP O
65 There EX O O
66 are VBP O O
66 less JJR B-NP O
66 chronic JJ I-NP O
66 venous JJ I-NP O
66 stasis NN I-NP O
66 changes NNS I-NP O
66 on IN B-VP O
66 the DT B-NP O
66 left NN I-NP O
66 lower JJR B-NP O
67 extremity NN I-NP O
67 There EX O O
67 was VBD B-VP O
67 some DT B-NP O
67 mild JJ I-NP O
67 erythema NN I-NP O
67 around IN B-VP O
67 the DT B-NP O
67 right JJ I-NP O
67 knee NN I-NP O
68 This DT B-NP O
68 area NN I-NP O
68 of IN B-VP O
68 redness NN B-NP O
68 was VBD B-VP O
68 poorly RB O O
68 demarcated VBN O O
68 and CC O O
68 mildly RB O O
68 blanching VBG O O
69 There EX O O
69 was VBD B-VP O
69 painful JJ B-NP O
69 passive JJ I-NP O
69 motion NN I-NP O
69 on IN B-VP O
69 her PRP$ O O
69 right JJ B-NP O
69 knee NN I-NP O
69 Neuro NNP I-NP O
69 exam NN I-NP O
70 was VBD B-VP O
70 grossly RB O O
70 intact JJ O O
70 and CC O O
70 nonfocal JJ O O
70 She PRP O O
70 did VBD B-VP O
70 have VB O O
70 a DT B-NP O
70 coarse JJ I-NP O
70 tremor NN I-NP O
70 in IN B-VP O
71 her PRP$ O O
71 upper JJ O O
71 and CC O O
71 lower JJR B-NP O
71 extremities NNS I-NP O
71 when WRB O O
71 asked VBD B-VP O
71 to TO O O
71 use VB O O
71 these DT B-NP O
72 extremities NNS I-NP O
72 for IN B-VP O
72 motion NN B-NP O
73 DIAGNOSTIC NNP I-NP O
73 DATA: NNP I-NP O
74 Electrolytes NNP I-NP O
74 were VBD B-VP O
74 significant JJ O O
74 for IN B-VP O
74 a DT B-NP O
74 potassium NN I-NP O
74 of IN B-VP O
74 5.8 CD O O
74 and CC O O
74 a DT B-NP O
75 creatinine NN I-NP O
75 of IN B-VP O
75 1.6 CD O O
75 that WDT O O
75 was VBD B-VP O
75 raised VBN O O
75 from IN B-VP O
75 previous JJ B-NP O
75 creatinine NN I-NP O
75 in IN B-VP O
76 2004 CD O O
76 of IN B-VP O
76 1.0 CD O O
76 Her PRP$ O O
76 liver NN B-NP O
76 enzymes NNS I-NP O
76 were VBD B-VP O
76 unremarkable JJ B-NP O
76 Her NNP I-NP O
77 hematocrit NN I-NP O
77 was VBD B-VP O
77 45.5 CD O O
77 A NNP B-NP O
77 UA NNP I-NP O
77 done VBN O O
77 on IN B-VP O
77 admission NN B-NP O
77 was VBD B-VP O
77 bland NN B-NP O
77 , , O O
77 however RB O O
77 , , O O
78 urine JJ B-NP O
78 cultures NNS I-NP O
78 grew VBD B-VP O
78 greater JJR O O
78 than IN B-VP O
78 a DT O O
78 1000 CD O O
78 CFU/mL NNP B-NP O
78 of IN B-VP O
78 coag-negative JJ B-NP O
79 Staphylococcus NNP I-NP O
79 Her NNP I-NP O
79 right NN I-NP O
79 knee NN I-NP O
79 film NN I-NP O
79 showed VBD B-VP O
79 mild JJ B-NP O
79 effusion NN I-NP O
79 , , O O
79 no DT B-NP O
80 fracture NN I-NP O
80 This DT B-NP O
80 effusion NN I-NP O
80 was VBD B-VP O
80 tapped VBN O O
80 and CC O O
80 showed VBD B-VP O
80 20 CD O O
80 white JJ B-NP O
80 blood NN I-NP O
81 cells NNS I-NP O
81 , , O O
81 810 CD O O
81 red JJ B-NP O
81 blood NN I-NP O
81 cells NNS I-NP O
81 Of IN B-VP O
81 the DT B-NP O
81 white JJ I-NP O
81 blood NN I-NP O
81 cells NNS I-NP O
81 , , O O
81 21% CD O O
81 were VBD B-VP O
82 PMNs NNP B-NP O
82 and CC O O
82 75% CD O O
82 were VBD B-VP O
82 lymphocytes NNS B-NP O
82 There EX O O
82 were VBD B-VP O
82 no DT B-NP O
82 crystals NNS I-NP O
82 seen VBN O O
83 There EX O O
83 were VBD B-VP O
83 no DT O O
83 organisms JJ O O
83 seen VBN O O
84 ASSESSMENT: NNP B-NP O
85 Ms NNP I-NP O
85 Fought NNP I-NP O
85 is VBZ O O
85 a DT B-NP O
85 50-year-old JJ I-NP O
85 female NN I-NP O
85 with IN B-VP O
85 a DT B-NP O
85 history NN I-NP O
85 of IN B-VP O
85 bipolar JJ B-NP O
86 disorder NN I-NP O
86 , , O O
86 schizophrenia NN B-NP O
86 , , O O
86 obstructive JJ B-NP O
86 sleep NN I-NP O
86 apnea NN I-NP O
86 , , O O
86 hypertension NN B-NP O
86 , , O O
87 and CC O O
87 diabetes NNS B-NP O
87 , , O O
87 was VBD B-VP O
87 admitted VBN O O
87 for IN B-VP O
87 one CD O O
87 week NN B-NP O
87 of IN B-VP O
87 worsening VBG O O
87 right JJ B-NP O
87 knee NN I-NP O
88 redness NN I-NP O
88 , , O O
88 swelling VBG O O
88 and CC O O
88 pain NN B-NP O
88 causing NN I-NP O
88 immobility NN I-NP O
89 HOSPITAL NNP I-NP O
89 COURSE NNP I-NP O
89 BY NNP I-NP O
89 SYSTEM/PROBLEM: NNP I-NP O
90 1 CD O O
90 Leg NNP B-NP O
90 swelling: VBD B-VP O
90 The DT B-NP O
90 differential JJ I-NP O
90 diagnosis NN I-NP O
90 that WDT O O
90 was VBD B-VP O
90 considered VBN O O
91 for IN B-VP O
91 her PRP$ O O
91 leg NN B-NP O
91 swelling VBG O O
91 included VBD B-VP O
91 deep JJ B-NP O
91 venous JJ I-NP O
91 thrombosis NN I-NP O
91 versus NN I-NP O
92 cellulitis NN I-NP O
92 versus IN B-VP O
92 septic JJ B-NP O
92 joints NNS I-NP O
92 versus VBP O O
92 gout NN B-NP O
92 versus NN I-NP O
92 chronic JJ B-NP O
93 lymphedema NN I-NP O
93 with IN B-VP O
93 an DT B-NP O
93 acute NN I-NP O
93 worsening VBG O O
93 Infectious JJ B-NP O
93 causes NNS I-NP O
93 were VBD B-VP O
94 considered VBN O O
94 less RBR O O
94 likely JJ O O
94 given VBN O O
94 the DT B-NP O
94 fact NN I-NP O
94 that IN B-VP O
94 the DT B-NP O
94 patient's JJ I-NP O
94 white JJ I-NP O
95 count NN I-NP O
95 was VBD B-VP O
95 not RB O O
95 significantly RB O O
95 elevated VBN O O
95 , , O O
95 ( ( O O
95 it PRP O O
95 was VBD B-VP O
95 10.5 CD O O
95 with IN B-VP O
95 75% CD O O
96 polys NN B-NP O
96 , , O O
96 and CC O O
96 80% CD O O
96 lymphs NN B-NP O
96 ) ) O O
96 , , O O
96 and CC O O
96 in IN B-VP O
96 fact NN B-NP O
96 that IN B-VP O
96 she PRP O O
96 has VBZ O O
96 not RB O O
96 had VBN O O
96 any DT O O
97 fever RB O O
97 The DT B-NP O
97 patient NN I-NP O
97 was VBD B-VP O
97 treated VBN O O
97 empirically RB O O
97 , , O O
97 however RB O O
97 , , O O
97 as IN B-VP O
97 this DT B-NP O
98 diagnosis NN I-NP O
98 was VBD B-VP O
98 unable JJ O O
98 to TO O O
98 be VB O O
98 ruled VBN O O
98 out RP O O
98 initially RB O O
98 with IN B-VP O
98 vancomycin NN B-NP B-m
99 and CC O O
99 Unasyn NNP B-NP B-m
99 and CC O O
99 then RB O O
99 with IN B-VP O
99 levofloxacin PDT O B-m
99 The DT B-NP O
99 patient NN I-NP O
99 was VBD B-VP O
99 treated VBN O O
100 with IN B-VP O
100 therapeutic JJ B-NP B-do
100 therapeutic JJ I-NP B-do
100 doses NNS I-NP I-do
100 doses NNS I-NP I-do
100 of IN B-VP O
100 heparin NN B-NP B-m
100 heparin NN I-NP B-m
100 because IN B-VP O
100 of IN B-VP O
100 the DT B-NP O
100 concern NN I-NP O
100 of IN B-VP O
100 pain NN B-NP B-r
101 and CC O O
101 swelling VBG O B-r
101 asymmetrically RB O O
101 of IN B-VP O
101 the DT B-NP O
101 lower JJR I-NP O
101 extremities NNS I-NP O
101 This DT O O
102 continued VBN O O
102 until IN B-VP O
102 lower JJR B-NP O
102 extremity NN I-NP O
102 Doppler NNP I-NP O
102 studies NNS I-NP O
102 showed VBD B-VP O
102 no DT B-NP O
102 deep JJ I-NP O
103 venous JJ I-NP O
103 thrombosis NN I-NP O
103 in IN B-VP O
103 the DT B-NP O
103 right JJ I-NP O
103 femoral NN I-NP O
103 or CC O O
103 left VBD B-VP O
103 popliteal JJ B-NP O
103 veins NNS I-NP O
104 Uric JJ B-NP O
104 acid NN I-NP O
104 levels NNS I-NP O
104 were VBD B-VP O
104 checked VBN O O
104 and CC O O
104 shown VBN O O
104 to TO O O
104 be VB O O
104 elevated VBN O O
104 at IN B-VP O
104 8.6 CD O O
104 and CC O O
105 again RB O O
105 at IN B-VP O
105 8.0 CD O O
105 These DT B-NP O
105 values NNS I-NP O
105 suggest VBP O O
105 that IN B-VP O
105 gout NN B-NP O
105 may MD O O
105 be VB O O
105 involved VBN O O
105 in IN B-VP O
106 this DT B-NP O
106 problem NN I-NP O
106 , , O O
106 however RB O O
106 , , O O
106 there EX O O
106 are VBP O O
106 no DT B-NP O
106 crystals NNS I-NP O
106 and CC O O
106 the DT B-NP O
106 synovial JJ I-NP O
107 fluid NN I-NP O
107 making VBG O O
107 this DT B-NP O
107 diagnosis NN I-NP O
107 also RB O O
107 less RBR O O
107 likely RB O O
107 Over IN B-VP O
107 her PRP$ O O
107 hospital JJ B-NP O
108 course NN I-NP O
108 , , O O
108 the DT B-NP O
108 swelling NN I-NP O
108 , , O O
108 tenderness NN B-NP O
108 and CC O O
108 redness NN B-NP O
108 of IN B-VP O
108 the DT B-NP O
108 right JJ I-NP O
108 knee NN I-NP O
109 decreased VBD B-VP O
109 significantly RB O O
109 However RB O O
109 , , O O
109 the DT B-NP O
109 patient's NN I-NP O
109 left VBD B-VP O
109 knee NN B-NP O
109 began VBD B-VP O
110 to TO O O
110 cause VB O O
110 her PRP$ O O
110 significant JJ B-NP O
110 pain NN I-NP O
110 , , O O
110 requiring VBG O O
110 oxycodone NN B-NP B-m
110 , , O O
110 Tylenol NNP B-NP B-m
110 and CC O O
111 lidocaine JJ B-NP B-m
111 patch NN I-NP I-m
111 Because IN B-VP O
111 of IN B-VP O
111 concerning VBG O O
111 renal JJ B-NP O
111 function NN I-NP O
111 with IN B-VP O
111 a DT B-NP O
112 creatinine NN I-NP O
112 of IN B-VP O
112 1.6 CD O O
112 from IN B-VP O
112 1.0 CD O O
112 , , O O
112 NSAIDs NNP B-NP B-m
112 were VBD B-VP O
112 held VBN O O
112 initially RB O O
112 , , O O
112 however RB O O
112 , , O O
113 her PRP O O
113 creatinine NN B-NP O
113 trended VBD B-VP O
113 down RB O O
113 to TO O O
113 1.2 CD O O
113 on IN B-VP O
113 the DT B-NP O
113 day NN I-NP O
113 of IN B-VP O
113 discharge NN B-NP O
113 , , O O
113 and CC O O
114 so RB O O
114 she PRP O O
114 will MD O O
114 be VB O O
114 discharged VBN O O
114 with IN B-VP O
114 NSAIDs NNP B-NP B-m
114 , , O O
114 which WDT O O
114 are VBP O O
114 expected VBN O O
114 to TO O O
114 help VB O O
115 her PRP$ O B-r
115 musculoskeletal JJ B-NP I-r
115 pain NN I-NP I-r
115 While IN B-VP O
115 in IN B-VP O
115 the DT B-NP O
115 hospital NN I-NP O
115 , , O O
115 she PRP O O
115 received VBD B-VP O
116 Physical JJ B-NP O
116 Therapy NNP I-NP O
116 who WP O O
116 evaluated VBD B-VP O
116 the DT B-NP O
116 patient NN I-NP O
116 and CC O O
116 suggested VBD B-VP O
116 that IN B-VP O
116 the DT B-NP O
117 patient NN I-NP O
117 would MD O O
117 benefit VB O O
117 from IN B-VP O
117 continued JJ B-NP O
117 direct JJ I-NP O
117 physical JJ I-NP O
117 therapy NN I-NP O
117 to TO O O
118 address VB O O
118 functional JJ B-NP O
118 mobility NN I-NP O
118 retraining VBG O O
118 Short-terms JJ B-NP O
118 goals NNS I-NP O
119 included VBD B-VP O
119 ambulate JJ O O
119 50 CD O O
119 feet NNS B-NP O
119 with IN B-VP O
119 minimal JJ B-NP O
119 assistance NN I-NP O
119 with IN B-VP O
120 restrictive JJ B-NP O
120 device NN I-NP O
120 , , O O
120 and CC O O
120 to TO O O
120 tolerate VB O O
120 out IN B-VP O
120 of IN B-VP O
120 bed NN B-NP O
120 to TO O O
120 chair VB O O
120 for IN B-VP O
120 30 CD O O
121 minutes NNS B-NP O
121 with IN B-VP O
121 reports NNS B-NP O
121 of IN B-VP O
121 fatigue JJ O O
122 2 CD O O
122 Lithium NN B-NP O
122 toxicity: NN I-NP O
122 Because IN B-VP O
122 of IN B-VP O
122 the DT B-NP O
122 patient's NN I-NP O
122 coarse NN I-NP O
122 tremor NN I-NP O
122 , , O O
123 bradycardia NN B-NP O
123 , , O O
123 hypotension NN B-NP O
123 , , O O
123 and CC O O
123 the DT B-NP O
123 fact NN I-NP O
123 that IN B-VP O
123 she PRP O O
123 was VBD B-VP O
123 taking VBG O O
124 lithium NN B-NP B-m
124 , , O O
124 encouraged VBD B-VP O
124 her PRP O O
124 lithium NN B-NP B-m
124 level NN I-NP O
124 to TO O O
124 be VB O O
124 checked VBN O O
124 which WDT O O
124 came VBD B-VP O
125 back RB O O
125 elevated VBN O O
125 at IN B-VP O
125 2.7 CD O O
125 , , O O
125 ( ( O O
125 normal JJ B-NP O
125 levels NNS I-NP O
125 between IN B-VP O
125 0.5 CD O O
125 and CC O O
125 1.3 CD O O
125 ) ) O O
125 This DT B-NP O
126 level NN I-NP O
126 was VBD B-VP O
126 concerning VBG O O
126 because IN B-VP O
126 lithium NN B-NP O
126 has VBZ O O
126 a DT O O
126 very RB O O
126 narrow JJ B-NP O
127 therapeutic JJ I-NP O
127 window NN I-NP O
127 Her NNP I-NP O
127 lithium NN I-NP B-m
127 was VBD B-VP O
127 held VBN O O
127 and CC O O
127 she PRP O O
127 was VBD B-VP O
127 treated VBN O O
128 with IN B-VP O
128 IV NNP B-NP B-mo
128 fluids NNS I-NP B-m
128 , , O O
128 which WDT O O
128 allowed VBD B-VP O
128 her PRP$ O O
128 creatinine NN B-NP O
128 to TO O O
128 decrease VB O O
128 It PRP O O
128 was VBD B-VP O
129 thought VBN O O
129 that IN B-VP O
129 she PRP O O
129 was VBD B-VP O
129 also RB O O
129 somewhat RB O O
129 dehydrated VBD B-VP O
129 on IN B-VP O
129 presentation NN B-NP O
129 to TO O O
130 the DT B-NP O
130 emergency NN I-NP O
130 department NN I-NP O
130 Her NNP I-NP O
130 lithium NN I-NP O
130 toxicity NN I-NP O
130 could MD O O
130 in IN B-VP O
130 part NN B-NP O
131 explain NN I-NP O
131 for IN B-VP O
131 her PRP$ O O
131 bradycardia NN B-NP O
131 and CC O O
131 hypotension NN B-NP O
131 as RB O O
131 well RB O O
131 as IN B-VP O
131 her PRP$ O O
132 hypokalemia NN B-NP O
132 and CC O O
132 renal JJ B-NP O
132 failure NN I-NP O
132 A NNP I-NP O
132 psych NN I-NP O
132 consult NN I-NP O
132 was VBD B-VP O
132 obtained VBN O O
132 to TO O O
133 address VB O O
133 the DT B-NP O
133 question NN I-NP O
133 of IN B-VP O
133 when WRB O O
133 and CC O O
133 how WRB O O
133 to TO O O
133 restart VB O O
133 the DT B-NP O
133 lithium NN I-NP B-m
133 The DT B-NP O
134 psych NN I-NP O
134 consultant NN I-NP O
134 suggested VBD B-VP O
134 to TO O O
134 check VB O O
134 lithium NN B-NP B-m
134 levels NNS I-NP O
134 daily RB O O
134 until IN B-VP O
135 they PRP O O
135 fell VBD B-VP O
135 below IN B-VP O
135 0.5 CD O O
135 and CC O O
135 then RB O O
135 should MD O O
135 restart VB O O
135 the DT B-NP O
135 lithium NN I-NP B-m
135 at IN B-VP O
135 300 CD O B-do
135 mg NN B-NP I-do
136 at IN B-VP B-f
136 bedtime NN B-NP I-f
136 On IN B-VP O
136 the DT B-NP O
136 day NN I-NP O
136 of IN B-VP O
136 discharge NN B-NP O
136 , , O O
136 her PRP$ O O
136 lithium JJ B-NP B-m
136 level NN I-NP O
136 was VBD B-VP O
136 at IN B-VP O
137 1.12 CD O O
137 This DT B-NP O
137 level NN I-NP O
137 should MD O O
137 be VB O O
137 checked VBN O O
137 at IN B-VP O
137 the DT B-NP O
137 nursing NN I-NP O
137 facility NN I-NP O
137 and CC O O
138 lithium NN B-NP B-m
138 should MD O O
138 be VB O O
138 restarted VBN O O
138 at IN B-VP O
138 300 CD O B-do
138 mg NN B-NP I-do
138 at IN B-VP B-f
138 bedtime NN B-NP I-f
138 when WRB O O
138 the DT B-NP O
138 level NN I-NP O
139 is VBZ O O
139 0.5 CD O O
139 or CC O O
139 below IN B-VP O
140 3 CD O O
140 Cardiovascular: NNP B-NP O
140 From IN B-VP O
140 a DT B-NP O
140 pump NN I-NP O
140 standpoint NN I-NP O
140 , , O O
140 the DT B-NP O
140 patient NN I-NP O
140 was VBD B-VP O
141 hypovolemic JJ O O
141 and CC O O
141 hypotensive JJ O O
141 on IN B-VP O
141 presentation NN B-NP O
141 to TO O O
141 the DT B-NP O
141 emergency NN I-NP O
142 department NN I-NP O
142 She PRP O O
142 responded VBD B-VP O
142 well RB O O
142 to TO O O
142 normal JJ B-NP B-m
142 saline JJ I-NP I-m
142 fluid NN I-NP I-m
142 boluses NNS I-NP I-m
143 and CC O O
143 given VBN O O
143 a DT B-NP O
143 total NN I-NP O
143 of IN B-VP O
143 3 CD O B-do
143 liters NNS B-NP I-do
143 over IN B-VP O
143 her PRP$ O O
143 hospital JJ B-NP O
143 course NN I-NP O
143 From IN B-VP O
143 a DT B-NP O
144 rhythm NN I-NP O
144 standpoint NN I-NP O
144 , , O O
144 the DT B-NP O
144 patient's NN I-NP O
144 bradycardia NN I-NP O
144 was VBD B-VP O
144 resolved VBN O O
144 of IN B-VP O
145 either DT O O
145 over IN B-VP O
145 beta NN B-NP B-m
145 blockade NN I-NP I-m
145 or CC O O
145 lithium NN B-NP O
145 toxicity NN I-NP O
145 Her NNP I-NP O
145 beta-blocker NN I-NP B-m
146 was VBD B-VP O
146 held VBN O O
146 as RB O O
146 well RB O O
146 as IN B-VP O
146 her PRP$ O O
146 lithium NN B-NP B-m
146 and CC O O
146 her PRP$ O O
146 heart NN B-NP O
146 rate NN I-NP O
146 improved VBN O O
146 to TO O O
147 the DT O O
147 50 CD O O
147 and CC O O
147 60s CD O O
147 We PRP O O
147 would MD O O
147 recommend VB O O
147 holding VBG O O
147 the DT B-NP O
147 beta-blocker NN I-NP B-m
148 until IN B-VP B-du
148 follow VB O O
148 up RP O O
148 at IN B-VP O
148 her PRP$ O O
148 primary JJ B-NP O
148 care NN I-NP O
148 physician's NN I-NP O
148 office NN I-NP O
148 for IN B-VP O
148 her PRP$ O O
149 next JJ B-NP O
149 appointment NN I-NP O
149 From IN B-VP O
149 an DT B-NP O
149 ischemia NN I-NP O
149 standpoint NN I-NP O
149 , , O O
149 EKG NNP B-NP O
149 was VBD B-VP O
149 performed VBN O O
150 which WDT O O
150 was VBD B-VP O
150 a DT B-NP O
150 poor JJ I-NP O
150 study NN I-NP O
150 that WDT O O
150 showed VBD B-VP O
150 perhaps RB O O
150 some DT B-NP O
150 T-wave JJ I-NP O
150 inversions NNS I-NP O
151 in IN B-VP O
151 aVL NN B-NP O
151 However RB O O
151 , , O O
151 ACS NNP B-NP O
151 is VBZ O O
151 unlikely JJ O O
151 at IN B-VP O
151 this DT B-NP O
151 time NN I-NP O
151 The DT B-NP O
151 patient NN I-NP O
151 had VBD B-VP O
152 no DT B-NP O
152 chest NN I-NP O
152 pain NN I-NP O
153 4 CD O O
153 Renal: NNP B-NP O
153 Acute NNP I-NP O
153 renal JJ B-NP O
153 failure NN I-NP O
153 on IN B-VP O
153 presentation NN B-NP O
153 with IN B-VP O
153 a DT B-NP O
153 creatinine NN I-NP O
154 of IN B-VP O
154 1.6 CD O O
154 and CC O O
154 1.0 CD O O
154 is VBZ O O
154 likely JJ B-NP O
154 prerenal JJ I-NP O
154 versus NN I-NP O
154 lithium NN I-NP O
154 toxicity NN I-NP O
154 versus IN B-VP O
155 a DT B-NP O
155 combination NN I-NP O
155 of IN B-VP O
155 these DT B-NP O
155 A NNP I-NP O
155 creatinine NN I-NP O
155 improved VBN O O
155 to TO O O
155 1.2 CD O O
155 on IN B-VP O
155 the DT B-NP O
155 day NN I-NP O
156 of IN B-VP O
156 discharge NN B-NP O
157 5 CD O O
157 Endocrinology: NNP B-NP O
157 The DT B-NP O
157 patient NN I-NP O
157 had VBD B-VP O
157 a DT B-NP O
157 history NN I-NP O
157 of IN B-VP O
157 diabetes NNS B-NP O
158 according VBG O O
158 to TO O O
158 her PRP$ O O
158 medical JJ B-NP O
158 records NNS I-NP O
158 Her PRP$ O O
158 glucose NN B-NP O
158 while IN B-VP O
158 admitted VBN O O
159 here RB O O
159 was VBD B-VP O
159 in IN B-VP O
159 between IN B-VP O
159 90 CD O O
159 and CC O O
159 132 CD O O
159 These DT O O
159 were VBD B-VP O
159 random RB O O
159 glucose JJ B-NP O
159 draws NNS I-NP O
160 Hemoglobin NNP I-NP O
160 A1c NNP I-NP O
160 was VBD B-VP O
160 checked VBN O O
160 which WDT O O
160 came VBD B-VP O
160 back RB O O
160 at IN B-VP O
160 6.2 CD O O
160 At IN B-VP O
160 this DT B-NP O
161 time NN I-NP O
161 , , O O
161 diabetes NNS B-NP O
161 may MD O O
161 or CC O O
161 may MD O O
161 not RB O O
161 be VB O O
161 an DT B-NP O
161 appropriate JJ I-NP O
161 diagnosis NN I-NP O
161 for IN B-VP O
161 her PRP$ O O
162 and CC O O
162 she PRP O O
162 should MD O O
162 follow VB O O
162 up RP O O
162 with IN B-VP O
162 her PRP$ O O
162 primary JJ B-NP O
162 care NN I-NP O
162 physician NN I-NP O
162 with IN B-VP O
162 a DT O O
163 fasting VBG O O
163 blood NN B-NP O
163 glucose JJ B-NP O
163 test NN I-NP O
164 6 CD O O
164 Infectious NNP B-NP O
164 disease: NN I-NP O
164 On IN B-VP O
164 initial JJ B-NP O
164 presentation NN I-NP O
164 , , O O
164 the DT B-NP O
164 patient NN I-NP O
165 presented VBN O O
165 with IN B-VP O
165 hypotension NN B-NP O
165 in IN B-VP O
165 the DT B-NP O
165 setting NN I-NP O
165 of IN B-VP O
165 bradycardia NN B-NP O
165 and CC O O
165 beta NN B-NP B-m
166 blockade NN I-NP O
166 with IN B-VP O
166 decreased JJ B-NP O
166 volume NN I-NP O
166 status NN I-NP O
166 There EX O O
166 was VBD B-VP O
166 a DT B-NP O
166 concern NN I-NP O
167 initially RB O O
167 that IN B-VP O
167 this DT O O
167 may MD O O
167 be VB O O
167 cellulitis NN B-NP O
167 and CC O O
167 she PRP O O
167 was VBD B-VP O
167 covered VBN O O
167 broadly RB O O
168 with IN B-VP O
168 Unasyn NNP B-NP B-m
168 and CC O O
168 vancomycin NN B-NP B-m
168 However RB O O
168 , , O O
168 as IN B-VP O
168 she PRP O O
168 improved VBD B-VP O
168 , , O O
168 and CC O O
168 the DT B-NP O
169 redness NN I-NP O
169 and CC O O
169 swelling VBG O O
169 decreased VBN O O
169 , , O O
169 she PRP O O
169 was VBD B-VP O
169 switched VBN O O
169 to TO O O
169 levofloxacin VB O B-m
170 and CC O O
170 committed VBN O O
170 to TO O O
170 complete VB O O
170 a DT B-NP B-du
170 seven-day JJ I-NP I-du
170 course NN I-NP I-du
170 She PRP O O
170 will MD O O
170 complete VB O O
171 six CD O B-du
171 more JJR B-NP I-du
171 days NNS I-NP I-du
171 after IN B-VP O
171 discharge NN B-NP O
171 from IN B-VP O
171 the DT B-NP O
171 hospital NN I-NP O
171 of IN B-VP O
171 levofloxacin $ O B-m
172 7 CD O O
172 Deconditioning: NNP B-NP O
172 As NNP I-NP O
172 mentioned VBD B-VP O
172 above IN B-VP O
172 , , O O
172 Physical NNP B-NP O
172 Therapy NNP I-NP O
172 was VBD B-VP O
173 consulted VBN O O
173 and CC O O
173 the DT B-NP O
173 patient NN I-NP O
173 will MD O O
173 go VB O O
173 to TO O O
173 nursing VBG O O
173 facility NN B-NP O
173 for IN B-VP O
173 a DT B-NP O
174 temporary JJ I-NP O
174 rehabilitation NN I-NP O
174 Upon NNP I-NP O
174 discharge NN I-NP O
174 to TO O O
174 her PRP$ O O
174 home NN B-NP O
174 from IN B-VP O
174 rehab NN B-NP O
174 , , O O
175 home NN B-NP O
175 safety NN I-NP O
175 evaluation NN I-NP O
175 should MD O O
175 take VB O O
175 place NN B-NP O
175 to TO O O
175 make VB O O
175 sure JJ O O
175 that IN B-VP O
175 the DT B-NP O
176 patient NN I-NP O
176 is VBZ O O
176 okay JJ O O
176 to TO O O
176 go VB O O
176 back RB O O
176 home NN B-NP O
176 and CC O O
176 can MD O O
176 give VB O O
176 the DT B-NP O
176 services NNS I-NP O
176 that IN B-VP O
177 she PRP O O
177 needs VBZ O O
178 MEDICATIONS NNP B-NP O
178 ON NNP I-NP O
178 DISCHARGE: NNP I-NP O
179 1 CD O O
179 Tylenol NNP B-NP B-m
179 650 CD O B-do
179 mg NN B-NP I-do
179 p.o NN I-NP B-mo
179 q.4h NN I-NP B-f
179 p.r.n NN I-NP I-f
179 pain VBP O B-r
180 2 CD O O
180 Klonopin NNP B-NP B-m
180 1 CD O B-do
180 mg NN B-NP I-do
180 p.o NN I-NP B-mo
180 at IN B-VP B-f
180 bedtime JJ O I-f
181 3 CD O O
181 Oxycodone NN B-NP B-m
181 5 CD O B-do
181 mg NN B-NP I-do
181 to TO O I-do
181 10 CD O I-do
181 mg NNS B-NP I-do
181 p.o JJ B-NP B-mo
181 q.4h JJ I-NP B-f
181 p.r.n NN I-NP I-f
181 pain NN I-NP B-r
181 , , O O
181 please NN B-NP O
181 hold VB O O
182 if IN B-VP O
182 respiration NN B-NP O
182 rate NN I-NP O
182 is VBZ O O
182 less JJR O O
182 than IN B-VP O
182 12 CD O O
183 4 CD O O
183 Risperdal NNP B-NP B-m
183 0.5 CD O B-do
183 mg NN B-NP I-do
183 p.o NN I-NP B-mo
183 at IN B-VP B-f
183 bedtime JJ O I-f
184 5 CD O O
184 Levofloxacin NNP B-NP B-m
184 500 CD O B-do
184 mg NN B-NP I-do
184 p.o JJ O B-mo
184 daily JJ O B-f
184 for IN B-VP B-du
184 six CD O I-du
184 days NNS B-NP I-du
184 after IN B-VP O
184 the DT B-NP O
184 day NN I-NP O
184 of IN B-VP O
185 discharge NN B-NP O
185 from IN B-VP O
185 Wilgeimante NNP B-NP O
185 Eycis NNP I-NP O
185 Health NNP I-NP O
185 on IN B-VP O
185 0/19/05 CD O O
186 6 CD O O
186 Ibuprofen NNP B-NP B-m
186 600 CD O B-do
186 mg NN B-NP I-do
186 q.6h NN I-NP B-f
186 p.r.n NN I-NP I-f
186 pain NN I-NP B-r
187 DISCHARGE NNP I-NP O
187 DISPOSITION: NNP I-NP O
188 The DT B-NP O
188 patient NN I-NP O
188 was VBD B-VP O
188 discharged VBN O O
188 in IN B-VP O
188 stable JJ B-NP O
188 condition NN I-NP O
188 to TO O O
188 a DT B-NP O
188 nursing NN I-NP O
189 facility NN I-NP O
189 Please NNP I-NP O
189 draw VB O O
189 blood NN B-NP O
189 for IN B-VP O
189 lithium JJ B-NP O
189 level NN I-NP O
189 checks NNS I-NP O
189 daily RB O O
189 until IN B-VP O
190 it PRP O O
190 is VBZ O O
190 below IN B-VP O
190 0.5 CD O O
190 , , O O
190 at IN B-VP O
190 which WDT O O
190 time NN B-NP O
190 , , O O
190 she PRP O O
190 should MD O O
190 be VB O O
190 restarted VBN O O
190 on IN B-VP O
191 lithium NN B-NP B-m
191 300 CD O B-do
191 mg NN B-NP I-do
191 p.o NN I-NP B-mo
191 at IN B-VP B-f
191 bedtime NN B-NP I-f
191 She PRP O O
191 will MD O O
191 follow VB O O
191 up RP O O
191 with IN B-VP O
191 her PRP$ O O
192 primary JJ B-NP O
192 care NN I-NP O
192 physician NN I-NP O
192 , , O O
192 Dr NNP B-NP O
192 Aurelio NNP I-NP O
192 Gilberto NNP I-NP O
192 Hencheck NNP I-NP O
192 at IN B-VP O
192 Li NNP B-NP O
192 County NNP I-NP O
192 Hospital NNP I-NP O
192 , , O O
192 phone NN B-NP O
192 number NN I-NP O
192 is VBZ O O
192 156-903-7650 JJ B-NP O
192 A NNP I-NP O
192 message NN I-NP O
193 was VBD B-VP O
193 left VBN O O
193 in IN B-VP O
193 the DT B-NP O
193 voice NN I-NP O
193 mail NN I-NP O
193 of IN B-VP O
193 her PRP$ O O
193 physician's JJ B-NP O
193 office NN I-NP O
193 to TO O O
193 schedule VB O O
194 her PRP$ O O
194 an DT B-NP O
194 appointment NN I-NP O
194 and CC O O
194 to TO O O
194 contact VB O O
194 her PRP$ O O
194 brother NN B-NP O
194 , , O O
194 Oren NNP B-NP O
194 Dad NNP I-NP O
194 , , O O
194 at IN B-VP O
195 phone NN B-NP O
195 number NN I-NP O
195 427-986-1973 CD O O
195 or CC O O
195 683-173-8613 JJ O O
195 , , O O
195 or CC O O
195 Daren NNP B-NP O
195 Perella NNP I-NP O
195 at IN B-VP O
196 990-786-9092 CD O O
196 to TO O O
196 inform VB O O
196 them PRP O O
196 at IN B-VP O
196 when WRB O O
196 the DT B-NP O
196 appointment NN I-NP O
196 will MD O O
196 be VB O O
196 It PRP O O
197 was VBD B-VP O
197 requested VBN O O
197 that IN B-VP O
197 she PRP O O
197 be VB O O
197 seen VBN O O
197 within IN B-VP O
197 two CD O O
197 to TO O O
197 three CD O O
197 weeks NNS B-NP O
198 eScription NN I-NP O
198 document: IN B-VP O
198 3-9332178 JJ B-NP O
198 EMSSten NNP I-NP O
198 Tel NNP I-NP O
199 CC: NNP I-NP O
199 Colby NNP I-NP O
199 Kopan NNP I-NP O
199 M.D NNP I-NP O
200 Comho NNP I-NP O
200 Street NNP I-NP O
200 , , O O
200 Sas NNP B-NP O
200 Co NNP I-NP O
200 Lareox NNP I-NP O
200 , , O O
200 Utah NNP B-NP O
200 34863 CD O O
201 Ana NNP B-NP O
202 CC: NNP I-NP O
202 Raul NNP I-NP O
202 Nagelschmidt NNP I-NP O
202 MD NNP I-NP O
203 Lem NNP I-NP O
203 Ca NNP I-NP O
203 Chi NNP I-NP O
204 Son NNP I-NP O
204 Oak NNP I-NP O
205 Dictated NNP I-NP O
205 By: NNP I-NP O
205 BEKER NNP I-NP O
205 , , O O
205 ANIBAL NNP B-NP O
206 Attending: NNP I-NP O
206 BEIL NNP I-NP O
206 , , O O
206 LYMAN NNP B-NP O
207 Dictation NNP I-NP O
207 ID NNP I-NP O
207 1150769 CD O O
208 D: NNP B-NP O
208 6/17/05 CD O O
209 T: NNP B-NP O
209 6/17/05 CD O O
210 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #565443 VBZ O O
2 982004989 CD O O
2 C NNP B-NP O
2 70419019 CD O O
2 9147032 CD O O
2 0/7/2003 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 hypertensive JJ B-NP O
2 encephalopathy NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/7/2003 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/20/2003 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 CHOW NNP I-NP O
5 , , O O
5 MIKEL NNP B-NP O
5 R NNP I-NP O
5 943-98-90-2 CD O O
6 Co NNP B-NP O
6 Stobelle NNP I-NP O
6 Ey NNP I-NP O
7 Service: NNP I-NP O
7 NEU NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 7/9/03 CD O O
8 AT NNP B-NP O
8 05:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 STAIRES NNP I-NP O
11 , , O O
11 KIRBY NNP B-NP O
11 SANDY NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 DISPOSITION: NNP I-NP O
12 Home NNP I-NP O
12 w/ NN I-NP O
12 services NNS I-NP O
13 DISCHARGE NNP I-NP O
13 MEDICATIONS: NNP I-NP O
14 ACETYLSALICYLIC NNP I-NP B-m
14 ACID NNP I-NP I-m
14 325 CD O B-do
14 MG NNP B-NP I-do
14 PO NNP I-NP B-mo
14 QD NNP I-NP B-f
15 ATENOLOL NNP I-NP B-m
15 50 CD O B-do
15 MG NNP B-NP I-do
15 PO NNP I-NP B-mo
15 QD NNP I-NP B-f
15 Starting NNP I-NP O
15 IN NNP I-NP O
15 AM NNP I-NP O
15 ( ( O O
15 2/11 CD O O
15 ) ) O O
16 HOLD NNP B-NP O
16 IF: NNP I-NP O
16 SBP&lt;120 NNP I-NP O
16 , , O O
16 HR&lt;55 NNP B-NP O
17 ATORVASTATIN NNP I-NP B-m
17 40 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 HYDROCHLOROTHIAZIDE NNP I-NP B-m
18 25 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 AMLODIPINE NNP I-NP B-m
19 10 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
19 Food/Drug NNP I-NP O
19 Interaction NNP I-NP O
19 Instruction NNP I-NP O
20 Avoid NNP I-NP O
20 grapefruit NN I-NP O
20 unless IN B-VP O
20 MD NNP B-NP O
20 instructs NNS I-NP O
20 otherwise RB O O
21 FOLATE NNP B-NP B-m
21 ( ( O I-m
21 FOLIC NNP B-NP I-m
21 ACID NNP I-NP I-m
21 ) ) O I-m
21 1 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 DIET: NNP I-NP O
22 House NNP I-NP O
22 / VBD B-VP O
22 Low NNP B-NP O
22 chol/low NN I-NP O
22 sat VBD B-VP O
22 fat JJ B-NP O
23 DIET: NNP I-NP O
23 4 CD O O
23 gram NN B-NP O
23 Sodium NNP I-NP O
24 ACTIVITY: NNP I-NP O
24 Resume NNP I-NP O
24 regular JJ B-NP O
24 exercise NN I-NP O
25 FOLLOW NNP I-NP O
25 UP NNP I-NP O
25 APPOINTMENT( NNP I-NP O
25 S NNP I-NP O
25 ): NNP I-NP O
26 PCP NNP I-NP O
26 Dr NNP I-NP O
26 Burdzel NNP I-NP O
26 3-4 JJ B-NP O
26 weeks NNS I-NP O
26 , , O O
27 carotid VBP O O
27 ultrasound JJ O O
27 4/12/03 CD O O
27 scheduled VBN O O
27 , , O O
28 ALLERGY: NNP B-NP O
28 Losartan NNP I-NP O
28 , , O O
28 Perfume NNP B-NP O
29 ADMIT NNP I-NP O
29 DIAGNOSIS: NNP I-NP O
30 stroke VBD B-VP O
31 PRINCIPAL NNP B-NP O
31 DISCHARGE NNP I-NP O
31 DIAGNOSIS NNP I-NP O
31 ;Responsible JJ O O
31 After IN B-VP O
31 Study NNP B-NP O
31 for IN B-VP O
31 Causing NNP B-NP O
31 Admission NNP I-NP O
31 ) ) O O
32 hypertensive VBP O O
32 encephalopathy JJ B-NP O
33 OTHER NNP I-NP O
33 DIAGNOSIS;Conditions NNP I-NP O
33 , , O O
33 Infections NNP B-NP O
33 , , O O
33 Complications NNP B-NP O
33 , , O O
33 affecting VBG O O
33 Treatment/Stay NNP B-NP O
34 HYPERCHOLESTEROLEMIA NNP I-NP O
34 HTN NNP I-NP O
34 DEPRESSION NNP I-NP O
34 CAD NNP I-NP O
34 s/p VBD B-VP O
34 MI NNP B-NP O
34 '84 NNP I-NP O
34 ( ( O O
34 coronary JJ B-NP O
34 artery NN I-NP O
35 disease NN I-NP O
35 ) ) O O
35 , , O O
35 recurrent JJ O O
35 left VBD B-VP O
35 Bell's NNP B-NP O
35 palsy NN I-NP O
35 , , O O
35 obesity NN B-NP O
35 ( ( O O
35 obesity NN B-NP O
35 ) ) O O
35 allergic NN B-NP O
36 rhinitis NN I-NP O
36 ( ( O O
36 allergic JJ B-NP O
36 rhinitis NN I-NP O
36 ) ) O O
36 , , O O
36 history NN B-NP O
36 of IN B-VP O
36 TIA NNP B-NP O
36 vs FW O O
36 stroke NN B-NP O
36 , , O O
36 obstructive JJ B-NP O
37 sleep NN I-NP O
37 apnea NN I-NP O
37 , , O O
37 chronic JJ B-NP O
37 renal JJ I-NP O
37 insufficiency NN I-NP O
38 OPERATIONS NNP I-NP O
38 AND NNP I-NP O
38 PROCEDURES: NNP I-NP O
39 none NN I-NP O
40 OTHER NNP I-NP O
40 TREATMENTS/PROCEDURES NNP I-NP O
40 ( ( O O
40 NOT NNP B-NP O
40 IN NNP I-NP O
40 O.R NNP I-NP O
40 ) ) O O
41 CT NNP B-NP O
41 head NN I-NP O
41 without IN B-VP O
41 contrast NN B-NP O
42 BRIEF NNP I-NP O
42 RESUME NNP I-NP O
42 OF NNP I-NP O
42 HOSPITAL NNP I-NP O
42 COURSE: NNP I-NP O
43 59 CD O O
43 year-old JJ B-NP O
43 right-handed JJ I-NP O
43 woman NN I-NP O
43 admitted VBD B-VP O
43 for IN B-VP O
43 suspected VBN O O
43 acute JJ O O
43 stroke VBD B-VP O
43 Her NNP B-NP O
44 PMH NNP I-NP O
44 includes VBZ O O
44 HTN NNP B-NP O
44 , , O O
44 hypercholesterolemia NN B-NP O
44 , , O O
44 prior JJ B-NP O
44 TIA NNP I-NP O
44 vs NN I-NP O
44 stroke VBD B-VP O
44 3/23 CD O O
45 ( ( O O
45 manifest RBS O O
45 as IN B-VP O
45 slurred JJ B-NP O
45 speech NN I-NP O
45 , , O O
45 left VBD B-VP O
45 arm NN B-NP O
45 and CC O O
45 leg NN B-NP O
45 weakness NN I-NP O
45 ) ) O O
45 prior RB O O
46 myocardial JJ B-NP O
46 infarction NN I-NP O
46 ( ( O O
46 1984 CD O O
46 ) ) O O
46 , , O O
46 and CC O O
46 history NN B-NP O
46 of IN B-VP O
46 left JJ B-NP O
46 Bell's NNP I-NP O
46 palsy NN I-NP O
46 x VBD B-VP O
46 3 CD O O
46 with IN B-VP O
47 chronic JJ B-NP O
47 weakness NN I-NP O
47 of IN B-VP O
47 facial JJ B-NP O
47 expression NN I-NP O
47 muscles NNS I-NP O
47 on IN B-VP O
47 the DT B-NP O
47 left NN I-NP O
47 She PRP O O
47 had VBD B-VP O
47 a DT B-NP O
48 possible JJ I-NP O
48 patent NN I-NP O
48 foramen NNS I-NP O
48 ovale VBP O O
48 with IN B-VP O
48 agitated JJ B-NP O
48 saline NN I-NP O
48 contrast NN I-NP O
48 passage NN I-NP O
48 on IN B-VP O
49 valsalva NN B-NP O
49 maneuver NN I-NP O
49 TTE NNP I-NP O
49 when WRB O O
49 she PRP O O
49 was VBD B-VP O
49 admitted VBN O O
49 7/21 CD O O
49 for IN B-VP O
49 stroke NN B-NP O
49 work-up NN I-NP O
50 Recently RB O O
50 , , O O
50 this DT B-NP O
50 woman NN I-NP O
50 has VBZ O O
50 had VBN O O
50 2-weeks CD O O
50 of IN B-VP O
50 general JJ B-NP O
50 fatigue NN I-NP O
50 , , O O
50 exertional JJ B-NP O
50 dys NN I-NP O
51 pnea NN I-NP O
51 , , O O
51 frequent JJ B-NP O
51 headaches NNS I-NP O
51 , , O O
51 and CC O O
51 intermittent NN B-NP O
51 blurred VBN O O
51 vision NN B-NP O
51 while IN B-VP O
51 driving VBG O O
52 followed VBN O O
52 by IN B-VP O
52 a DT B-NP O
52 2-3 JJ I-NP O
52 second JJ I-NP O
52 episode NN I-NP O
52 of IN B-VP O
52 binocular JJ B-NP O
52 visual JJ I-NP O
52 loss NN I-NP O
52 7/17/03 CD O O
53 Notably RB O O
53 , , O O
53 she PRP O O
53 ran VBD B-VP O
53 out IN B-VP O
53 of IN B-VP O
53 amlodipine NN B-NP B-m
53 and CC O O
53 reports NNS B-NP O
53 obtaining VBG O O
53 a DT B-NP O
53 level NN I-NP O
53 of IN B-VP O
54 240/150 CD O O
54 on IN B-VP O
54 self-monitoring JJ O O
54 One CD O O
54 day NN B-NP O
54 prior RB O O
54 to TO O O
54 admission VB O O
54 she PRP O O
54 saw VBD B-VP O
54 her PRP O O
54 PCP NNP B-NP O
55 who WP O O
55 noted VBD B-VP O
55 hypertension NN B-NP O
55 and CC O O
55 referred VBD B-VP O
55 her PRP O O
55 to TO O O
55 an DT B-NP O
55 ophthalmologist NN I-NP O
55 , , O O
55 who WP O O
56 obtained VBD B-VP O
56 a DT B-NP O
56 normal JJ I-NP O
56 exam NN I-NP O
56 by IN B-VP O
56 report NN B-NP O
57 She PRP O O
57 awoke VBD B-VP O
57 this DT B-NP O
57 morning NN I-NP O
57 with IN B-VP O
57 a DT O O
57 more RBR O O
57 severe JJ B-NP O
57 right JJ I-NP O
57 frontal NN I-NP O
57 headache NN I-NP O
57 with IN B-VP O
58 pain NN B-NP O
58 radiating VBG O O
58 to TO O O
58 the DT B-NP O
58 right JJ I-NP O
58 shoulder NN I-NP O
58 She PRP O O
58 also RB O O
58 experienced VBD B-VP O
58 a DT B-NP O
58 problem NN I-NP O
59 with IN B-VP O
59 gait NN B-NP O
59 , , O O
59 leaning VBG O O
59 to TO O O
59 the DT B-NP O
59 right NN I-NP O
59 Her NNP I-NP O
59 husband NN I-NP O
59 phoned VBD B-VP O
59 EMS NNP B-NP O
59 because IN B-VP O
59 she PRP O O
59 had VBD B-VP O
60 a DT B-NP O
60 severe JJ I-NP O
60 headache NN I-NP O
60 and CC O O
60 seemed VBD B-VP O
60 "confused." NNS B-NP O
60 At IN B-VP O
60 present JJ O O
60 , , O O
60 the DT B-NP O
60 patient NN I-NP O
60 denies VBZ O O
61 headache NN B-NP O
61 and CC O O
61 confusion NN B-NP O
61 , , O O
61 as RB O O
61 well RB O O
61 as IN B-VP O
61 diplopia NN B-NP O
61 , , O O
61 vertigo NN B-NP O
61 , , O O
61 dysphagia NN B-NP O
61 , , O O
61 and CC O O
62 dysarthria VBZ O O
62 She PRP O O
62 denies VBZ O O
62 recent JJ B-NP O
62 chest NN I-NP O
62 pain NN I-NP O
62 , , O O
62 but CC O O
62 has VBZ O O
62 had VBN O O
62 orthopnea VBN O O
63 PMHx: NNP B-NP O
63 hypertension NN I-NP O
63 , , O O
63 hypercholesterolemia NN B-NP O
63 , , O O
63 prior JJ B-NP O
63 TIA NNP I-NP O
63 versus NN I-NP O
63 stroke NN I-NP O
63 , , O O
64 prior JJ B-NP O
64 myocardial JJ I-NP O
64 infarction NN I-NP O
64 ( ( O O
64 1984 CD O O
64 ) ) O O
64 , , O O
64 obstructive JJ B-NP O
64 sleep NN I-NP O
64 apnea NN I-NP O
64 , , O O
64 recurrent NN B-NP O
65 left VBD B-VP O
65 Bell's NNP B-NP O
65 palsy NN I-NP O
65 , , O O
65 allergic JJ B-NP O
65 rhinitis NN I-NP O
65 , , O O
65 chronic JJ B-NP O
65 renal JJ I-NP O
65 insufficiency NN I-NP O
66 ( ( O O
66 baseline JJ B-NP O
66 creatinine NN I-NP O
66 around IN B-VP O
66 1.5 CD O O
66 ) ) O O
67 Meds: NNP B-NP O
67 ASA NNP I-NP B-m
67 81 CD O B-do
67 , , O O
67 HCTZ NNP B-NP B-m
67 , , O O
67 atenolol NN B-NP B-m
67 , , O O
67 amlodipine NN B-NP B-m
67 , , O O
67 atorvastatin NN B-NP B-m
67 , , O O
67 loratadine NN B-NP B-m
67 , , O O
67 PRN NNP B-NP B-f
68 albuterol NN I-NP B-m
69 All: NNP I-NP O
69 iodinated VBD B-VP O
69 contrast NN B-NP O
69 , , O O
69 losartan JJ B-NP O
70 VS: NNP I-NP O
70 T NNP I-NP O
70 97.2 CD O O
70 HR NNP B-NP O
70 57 CD O O
70 BP NNP B-NP O
70 150/90 CD O O
71 GEN NNP B-NP O
71 obese JJ B-NP O
71 woman NN I-NP O
71 , , O O
71 comfortable JJ B-NP O
71 HEENT NNP I-NP O
71 sclerae NN I-NP O
71 anicteric NN I-NP O
71 , , O O
71 oral JJ B-NP O
71 mucosa NN I-NP O
71 moist NN I-NP O
72 NECK: NNP I-NP O
72 no DT B-NP O
72 bruits NNS I-NP O
73 HEART NNP I-NP O
73 mild NN I-NP O
73 bradycardia NN I-NP O
73 , , O O
73 regular JJ B-NP O
73 rhythm NN I-NP O
73 , , O O
73 II/VI NNP B-NP O
73 SEM NNP I-NP O
73 at IN B-VP O
73 USB NNP B-NP O
73 ABD NNP I-NP O
73 soft JJ O O
73 , , O O
74 nontender NN B-NP O
74 , , O O
74 nondistended VBD B-VP O
74 EXT: NNP B-NP O
74 no DT B-NP O
74 cyanosis NN I-NP O
74 , , O O
74 clubbing VBG O O
74 , , O O
74 or CC O O
74 edema; VB O O
74 radial JJ O O
75 and CC O O
75 dorsalis JJ B-NP O
75 pedis NN I-NP O
75 pulses VBZ O O
75 2+ CD O O
76 NEURO: NNP B-NP O
76 MS NNP I-NP O
76 significant JJ O O
76 for IN B-VP O
76 no DT B-NP O
76 deficits NNS I-NP O
76 on IN B-VP O
76 orientation NN B-NP O
76 , , O O
76 attention NN B-NP O
76 , , O O
76 langua JJ B-NP O
77 ge NN I-NP O
77 , , O O
77 memory NN B-NP O
77 , , O O
77 and CC O O
77 praxis NN B-NP O
77 CN NNP I-NP O
77 exam NN I-NP O
77 significant JJ O O
77 for IN B-VP O
77 right JJ B-NP O
77 hypertropic NN I-NP O
77 skew NN I-NP O
77 , , O O
78 left VBD B-VP O
78 facial JJ B-NP O
78 droop NN I-NP O
78 , , O O
78 mostly RB O O
78 lower JJR B-NP O
78 face NN I-NP O
78 but CC O O
78 with IN B-VP O
78 weak JJ B-NP O
78 eyebrow NN I-NP O
78 raise NN I-NP O
78 as RB O O
79 well RB O O
79 Motor NNP B-NP O
79 exam NN I-NP O
79 with IN B-VP O
79 normal JJ B-NP O
79 tone NN I-NP O
79 , , O O
79 no DT B-NP O
79 pronator NN I-NP O
79 drift NN I-NP O
79 , , O O
79 strength NN B-NP O
79 5/5 CD O O
79 in IN B-VP O
80 all DT B-NP O
80 muscle NN I-NP O
80 groups NNS I-NP O
80 in IN B-VP O
80 upper JJ O O
80 and CC O O
80 lower JJR B-NP O
80 extremities NNS I-NP O
80 Coordination NNP I-NP O
80 exam NN I-NP O
81 with IN B-VP O
81 slightly RB O O
81 slowed VBN O O
81 fine JJ B-NP O
81 finger NN I-NP O
81 movements NNS I-NP O
81 , , O O
81 right JJ B-NP O
81 hand NN I-NP O
81 , , O O
81 normal JJ B-NP O
82 performance NN I-NP O
82 on IN B-VP O
82 finger-nose-finger NN B-NP O
82 and CC O O
82 heel-knee-shin NN B-NP O
82 , , O O
82 sensory JJ B-NP O
82 exam NN I-NP O
83 without IN B-VP O
83 deficits NNS B-NP O
83 in IN B-VP O
83 light JJ B-NP O
83 touch NN I-NP O
83 , , O O
83 temperature NN B-NP O
83 , , O O
83 vibratory JJ B-NP O
83 sensation NN I-NP O
83 , , O O
84 reflexes VBZ O O
84 2 CD O O
84 throughout IN B-VP O
84 except IN B-VP O
84 for IN B-VP O
84 1 CD O O
84 in IN B-VP O
84 the DT B-NP O
84 ankles NNS I-NP O
84 , , O O
84 toes NNS B-NP O
84 downgoing VBG O O
85 bilaterally RB O O
85 GAIT NNP B-NP O
85 slightly RB O O
85 wided VBD B-VP O
85 based VBN O O
85 but CC O O
85 stable JJ B-NP O
85 gait NN I-NP O
85 with IN B-VP O
85 upright JJ B-NP O
86 posture NN I-NP O
86 , , O O
86 normal JJ B-NP O
86 arm-swing JJ I-NP O
86 No NNP I-NP O
86 difficulty NN I-NP O
86 with IN B-VP O
86 heel NN B-NP O
86 , , O O
86 or CC O O
86 toe NN B-NP O
86 walk VBP O O
86 Falls NNP B-NP O
87 to TO O O
87 left VB O O
87 on IN B-VP O
87 tandem JJ B-NP O
87 gait NN I-NP O
88 Non-contrast NNP I-NP O
88 head NN I-NP O
88 CT NNP I-NP O
88 negative JJ O O
88 for IN B-VP O
88 evidence NN B-NP O
88 of IN B-VP O
88 stroke NN B-NP O
88 or CC O O
88 hemorrhage NN B-NP O
89 Hospital NNP I-NP O
89 course: VBD B-VP O
89 the DT B-NP O
89 pt NN I-NP O
89 was VBD B-VP O
89 admitted VBN O O
89 with IN B-VP O
89 hypertension NN B-NP O
89 and CC O O
89 recent JJ B-NP O
90 headaches NNS I-NP O
90 , , O O
90 visual JJ B-NP O
90 changes NNS I-NP O
90 ( ( O O
90 blurred JJ B-NP O
90 vision NN I-NP O
90 ) ) O O
90 , , O O
90 change NN B-NP O
90 in IN B-VP O
90 gait NN B-NP O
90 ( ( O O
90 inability NN B-NP O
91 to TO O O
91 walk VB O O
91 in IN B-VP O
91 heels NNS B-NP O
91 ) ) O O
91 , , O O
91 and CC O O
91 recent JJ B-NP O
91 confusion NN I-NP O
91 Neurologic NNP I-NP O
91 exam NN I-NP O
91 was VBD B-VP O
92 significant JJ O O
92 for IN B-VP O
92 right JJ B-NP O
92 hypertropic NN I-NP O
92 skew NN I-NP O
92 without IN B-VP O
92 diplopia NN B-NP O
92 , , O O
92 left VBD B-VP O
92 facial JJ B-NP O
93 weakness NN I-NP O
93 that WDT O O
93 is VBZ O O
93 old JJ O O
93 per IN B-VP O
93 pt NN B-NP O
93 and CC O O
93 LMR NNP B-NP O
93 notes NNS I-NP O
93 , , O O
93 mild JJ B-NP O
93 slowing NN I-NP O
93 of IN B-VP O
93 right JJ B-NP O
93 fine JJ I-NP O
94 finger NN I-NP O
94 movements NNS I-NP O
94 , , O O
94 and CC O O
94 tendency NN B-NP O
94 to TO O O
94 fall VB O O
94 towards IN B-VP O
94 the DT B-NP O
94 left NN I-NP O
94 on IN B-VP O
94 tandem JJ B-NP O
94 gait NN I-NP O
95 These DT B-NP O
95 findings NNS I-NP O
95 do VBP O O
95 not RB O O
95 localize VB O O
95 well RB O O
95 and CC O O
95 the DT B-NP O
95 differential JJ I-NP O
95 diagnosis NN I-NP O
96 was VBD B-VP O
96 felt VBN O O
96 to TO O O
96 include VB O O
96 cerebral JJ B-NP O
96 ischemia/infarction NN I-NP O
96 and CC O O
96 hypertensive JJ B-NP O
97 encephalopathy NN I-NP O
97 The DT B-NP O
97 patient NN I-NP O
97 had VBD B-VP O
97 recent JJ B-NP O
97 poorly-controlled JJ I-NP O
98 hypertension NN I-NP O
98 as RB O O
98 well RB O O
98 as IN B-VP O
98 symptoms NNS B-NP O
98 of IN B-VP O
98 possible JJ B-NP O
98 heart NN I-NP O
98 failure NN I-NP O
98 including VBG O O
99 exertional JJ B-NP O
99 dyspnea NN I-NP O
99 and CC O O
99 orthopnea VB O O
100 An DT B-NP O
100 MRI NNP I-NP O
100 was VBD B-VP O
100 ordered VBN O O
100 to TO O O
100 evaluate VB O O
100 for IN B-VP O
100 possible JJ B-NP O
100 stroke NN I-NP O
100 or CC O O
100 hypertensive JJ B-NP O
101 encephalopathy NN I-NP O
101 Unfortunately RB O O
101 , , O O
101 the DT B-NP O
101 pt NN I-NP O
101 was VBD B-VP O
101 not RB O O
101 able JJ O O
101 to TO O O
101 tolerate VB O O
101 the DT B-NP O
102 procedure NN I-NP O
102 , , O O
102 citing VBG O O
102 claustrophobia NN B-NP O
102 from IN B-VP O
102 a DT B-NP O
102 traumatic JJ I-NP O
102 childhood NN I-NP O
102 experience NN I-NP O
103 as IN B-VP O
103 a DT B-NP O
103 prohibitive JJ I-NP O
103 factor NN I-NP O
103 Her PRP$ O O
103 atenolol NN B-NP B-m
103 was VBD B-VP O
103 continued VBN O O
103 and CC O O
103 she PRP O O
103 was VBD B-VP O
103 placed VBN O O
104 on IN B-VP O
104 aspirin NN B-NP B-m
104 aspirin NN I-NP B-m
104 325 CD O B-do
104 325 CD O B-do
104 mg NN B-NP I-do
104 mg NN I-NP I-do
104 qd NN I-NP B-f
104 qd NN I-NP B-f
104 for IN B-VP O
104 stroke NN B-NP B-r
104 and CC O O
104 heart NN B-NP B-r
104 prophylaxis VBP O I-r
104 Her PRP$ O O
104 blood NN B-NP O
105 pressures NNS I-NP O
105 remained VBD B-VP O
105 well-controlled JJ O O
105 throughout IN B-VP O
105 admission NN B-NP O
105 and CC O O
105 she PRP O O
106 remained VBD B-VP O
106 asymptomatic JJ O O
106 , , O O
106 without IN B-VP O
106 recurrent NN B-NP O
106 headache NN I-NP O
106 , , O O
106 confusion NN B-NP O
106 , , O O
106 and CC O O
107 weakness NN B-NP O
107 Her NNP I-NP O
107 fine NN I-NP O
107 finger NN I-NP O
107 movements NNS I-NP O
107 with IN B-VP O
107 the DT B-NP O
107 right JJ I-NP O
107 hand NN I-NP O
107 were VBD B-VP O
107 improved VBN O O
108 by IN B-VP O
108 hospital JJ B-NP O
108 day NN I-NP O
108 2 CD O O
108 She PRP O O
108 continued VBD B-VP O
108 to TO O O
108 have VB O O
108 difficulty NN B-NP O
108 with IN B-VP O
108 tandem JJ B-NP O
108 gait NN I-NP O
108 , , O O
109 falling VBG O O
109 to TO O O
109 the DT B-NP O
109 left NN I-NP O
109 Her NNP I-NP O
109 lipid NN I-NP O
109 profile NN I-NP O
109 revealed VBD B-VP O
109 elevated JJ B-NP O
109 total JJ I-NP O
110 cholesterol NN I-NP O
110 and CC O O
110 LDL NNP B-NP O
110 Her NNP I-NP O
110 homocysteine NN I-NP O
110 level NN I-NP O
110 was VBD B-VP O
110 slightly RB O O
110 elevated VBN O O
110 at IN B-VP O
111 14 CD O O
111 She PRP O O
111 was VBD B-VP O
111 instructed VBN O O
111 to TO O O
111 raise VB O O
111 her PRP$ O O
111 dose NN B-NP O
111 of IN B-VP O
111 atorvastatin NN B-NP B-m
111 as RB O O
111 well RB O O
111 as IN B-VP O
112 supplement NN B-NP O
112 her PRP$ O O
112 diet JJ O O
112 with IN B-VP O
112 folic JJ B-NP B-m
112 acid NN I-NP I-m
112 She PRP O O
112 has VBZ O O
112 an DT B-NP O
112 outpt JJ I-NP O
112 appointment NN I-NP O
112 for IN B-VP O
113 carotid JJ B-NP O
113 non-invasive JJ I-NP O
113 studies NNS I-NP O
113 4/0/03 CD O O
114 ADDITIONAL NNP B-NP O
114 COMMENTS: NNP I-NP O
115 DISCHARGE NNP I-NP O
115 CONDITION: NNP I-NP O
115 Fair NNP I-NP O
116 TO NNP I-NP O
116 DO/PLAN: NNP I-NP O
117 The DT B-NP O
117 pt NN I-NP O
117 should MD O O
117 take VB O O
117 a DT B-NP O
117 full JJ I-NP O
117 dose NN I-NP O
117 of IN B-VP O
117 aspirin NN B-NP B-m
117 ( ( O O
117 325 CD O B-do
117 mg NN B-NP I-do
117 ) ) O O
117 She PRP O O
117 should MD O O
117 take VB O O
118 folate NN B-NP B-m
118 supplementation NN I-NP I-m
118 She PRP O O
118 should MD O O
118 also RB O O
118 discuss VB O O
118 raising VBG O O
118 her PRP$ O O
118 dose NN B-NP O
118 of IN B-VP O
119 atorvastatin NN B-NP B-m
119 atorvastatin NN I-NP B-m
119 ( ( O I-m
119 ( ( O I-m
119 Lipitor NNP B-NP I-m
119 Lipitor NNP I-NP I-m
119 ) ) O I-m
119 ) ) O I-m
119 with IN B-VP O
119 her PRP$ O O
119 PCP NNP B-NP O
119 , , O O
119 because IN B-VP O
119 her PRP$ O O
119 cholesterol NN B-NP B-r
119 and CC O O
119 LDL NNP B-NP B-r
120 were VBD B-VP O
120 elevated VBN O O
120 this DT B-NP O
120 admission NN I-NP O
121 No RB O O
121 dictated VBD B-VP O
121 summary JJ B-NP O
122 ENTERED NNP I-NP O
122 BY: NNP I-NP O
122 LIDDER NNP I-NP O
122 , , O O
122 LENARD NNP B-NP O
122 JEFFERSON NNP I-NP O
122 , , O O
122 M.D NNP B-NP O
122 ( ( O O
122 FR22 NNP B-NP O
122 ) ) O O
122 7/9/03 CD O O
122 @ $ O O
122 05 CD O O
123 ****** JJ B-NP O
123 END NN I-NP O
123 OF NNP I-NP O
123 DISCHARGE NNP I-NP O
123 ORDERS NNP I-NP O
123 ****** NNP I-NP O
124 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #565922 VBZ O O
4 784638933 CD O O
4 ABOHS NNP B-NP O
4 85258264 CD O O
4 595041 CD O O
4 8/13/1998 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CEREBRO NNP I-NP O
4 VASCULAR NNP I-NP O
4 ACCIDENT NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/23/1998 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/7/1998 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 LEFT NNP I-NP O
7 SUBCORTICAL NNP I-NP O
7 STROKE NNP I-NP O
8 PROBLEM NNP I-NP O
8 LIST: NNP I-NP O
8 1 CD O O
8 ) ) O O
8 DIABETES NNPS B-NP O
8 MELLITUS NNP I-NP O
8 2 CD O O
8 ) ) O O
8 MULTINODULAR NNP B-NP O
8 GOITER NNP I-NP O
9 3 CD O O
9 ) ) O O
9 HYPERTENSION NNP B-NP O
9 4 CD O O
9 ) ) O O
9 ANEMIA NNP B-NP O
9 , , O O
9 SICKLE NNP B-NP O
9 CELL NNP I-NP O
9 TRAIT NNP I-NP O
10 5 CD O O
10 ) ) O O
10 STATUS NNP B-NP O
10 POST NNP I-NP O
10 TOTAL NNP I-NP O
10 ABDOMINAL NNP I-NP O
10 HYSTERECTOMY NNP I-NP O
10 , , O O
11 CERVICAL NNP B-NP O
11 DYSPLASIA NNP I-NP O
11 6 CD O O
11 ) ) O O
11 BURSITIS NNP B-NP O
11 AND NNP I-NP O
11 MULTIPLE NNP I-NP O
12 SITES NNP I-NP O
12 OF NNP I-NP O
12 ARTHRITIS NNP I-NP O
12 7 CD O O
12 ) ) O O
12 HISTORY NN B-NP O
12 OF NNP I-NP O
12 PHYSICAL NNP I-NP O
12 ABUSE NNP I-NP O
13 8 CD O O
13 ) ) O O
13 VITILIGO NNP B-NP O
13 9 CD O O
13 ) ) O O
13 HEMORRHOIDS NNP B-NP O
14 HISTORY NNP I-NP O
14 OF NNP I-NP O
14 PRESENT NNP I-NP O
14 ILLNESS: NNP I-NP O
14 Approximately RB O O
14 two CD O O
14 days NNS B-NP O
14 prior RB O O
14 to TO O O
15 presentation NN B-NP O
15 , , O O
15 while IN B-VP O
15 preparing VBG O O
15 to TO O O
16 return VB O O
16 to TO O O
16 bed VB O O
16 , , O O
16 the DT B-NP O
16 patient NN I-NP O
16 noted VBD B-VP O
16 decrease NN B-NP O
16 feeling NN I-NP O
16 in IN B-VP O
16 her PRP$ O O
16 right JJ B-NP O
16 leg NN I-NP O
17 and CC O O
17 right JJ B-NP O
17 arm NN I-NP O
17 clumsiness NN I-NP O
17 She PRP O O
17 returned VBD B-VP O
17 to TO O O
17 bed NN B-NP O
17 and CC O O
17 remained VBD B-VP O
17 there EX O O
18 all DT B-NP O
18 day NN I-NP O
18 long IN B-VP O
18 She PRP O O
18 fell VBD B-VP O
18 onto IN B-VP O
18 her PRP$ O O
18 bottom JJ O O
18 secondary JJ O O
18 to TO O O
18 unsteadiness VB O O
19 She PRP O O
19 has VBZ O O
19 remained VBN O O
19 on IN B-VP O
19 the DT B-NP O
19 couch NN I-NP O
19 , , O O
19 except IN B-VP O
19 to TO O O
19 get VB O O
19 water NN B-NP O
19 since IN B-VP O
19 one CD O O
19 day NN B-NP O
20 prior RB O O
20 to TO O O
20 admission VB O O
20 She PRP O O
20 was VBD B-VP O
20 unable JJ O O
20 to TO O O
20 stand VB O O
20 up RP O O
20 on IN B-VP O
20 the DT B-NP O
20 day NN I-NP O
20 of IN B-VP O
21 admission NN B-NP O
21 This DT B-NP O
21 event NN I-NP O
21 was VBD B-VP O
21 felt VBN O O
21 to TO O O
21 be VB O O
21 different JJ O O
21 from IN B-VP O
21 her PRP$ O O
21 usual JJ B-NP O
22 paralysis NN I-NP O
22 ( ( O O
22 she PRP O O
22 had VBD B-VP O
22 had VBN O O
22 similar JJ B-NP O
22 symptoms NNS I-NP O
22 of IN B-VP O
22 this DT B-NP O
22 before NN I-NP O
22 and CC O O
22 had VBD B-VP O
23 waited VBN O O
23 for IN B-VP O
23 it PRP O O
23 to TO O O
23 resolve VB O O
23 ) ) O O
23 , , O O
23 except IN B-VP O
23 that IN B-VP O
23 this DT B-NP O
23 event NN I-NP O
23 had VBD B-VP O
23 lasted VBN O O
24 greater JJR O O
24 than IN B-VP O
24 24 CD O O
24 hours NNS B-NP O
24 and CC O O
24 she PRP O O
24 also RB O O
24 began VBD B-VP O
24 to TO O O
24 notice VB O O
24 dysarthria NN B-NP O
24 She PRP O O
25 had VBD B-VP O
25 not RB O O
25 taken VBN O O
25 insulin NN B-NP B-m
25 for IN B-VP B-du
25 several JJ B-NP I-du
25 days NNS I-NP I-du
25 , , O O
25 but CC O O
25 has VBZ O O
25 had VBN O O
25 decreased VBN O O
25 p.o NNS B-NP O
26 intake VBP O O
26 secondary JJ O O
26 to TO O O
26 her PRP$ O O
26 inability NN B-NP O
26 to TO O O
26 move VB O O
26 Of IN B-VP O
26 note NN B-NP O
26 , , O O
26 she PRP O O
26 had VBD B-VP O
27 difficulty NN B-NP O
27 swallowing VBG O O
27 on IN B-VP O
27 the DT B-NP O
27 morning NN I-NP O
27 of IN B-VP O
27 admission NN B-NP O
28 REVIEW NNP I-NP O
28 OF NNP I-NP O
28 SYSTEMS: NNP I-NP O
28 She PRP O O
28 had VBD B-VP O
28 no DT B-NP O
28 fevers NNS I-NP O
28 , , O O
28 chills NNS B-NP O
28 , , O O
28 vomiting VBG O O
28 or CC O O
28 loss NN B-NP O
29 of IN B-VP O
29 consciousness NN B-NP O
29 No NNP I-NP O
29 seizure NN I-NP O
29 activity NN I-NP O
29 No NNP I-NP O
30 head NN I-NP O
30 or CC O O
30 neck NN B-NP O
30 trauma NN I-NP O
30 No NNP I-NP O
30 vertigo NN I-NP O
30 or CC O O
30 tenderness NN B-NP O
30 No DT B-NP O
30 recent JJ I-NP O
30 change NN I-NP O
31 in IN B-VP O
31 medications NNS B-NP O
31 No DT B-NP O
31 chest NN I-NP O
31 pain NN I-NP O
31 or CC O O
31 shortness NN B-NP O
31 of IN B-VP O
31 breath NN B-NP O
31 , , O O
31 no DT B-NP O
32 photophobia NN I-NP O
32 or CC O O
32 neck NN B-NP O
32 stiffness NN I-NP O
33 PAST NNP I-NP O
33 MEDICAL NNP I-NP O
33 HISTORY: NNP I-NP O
33 History NNP I-NP O
33 of IN B-VP O
33 diabetes NNS B-NP O
33 mellitus NNS I-NP O
33 , , O O
33 multinodular JJ B-NP O
34 goiter NN I-NP O
34 , , O O
34 hypertension NN B-NP O
34 , , O O
34 anemia NN B-NP O
34 and CC O O
34 sickle NN B-NP O
34 cell NN I-NP O
35 trait NN I-NP O
35 , , O O
35 status NN B-NP O
35 post NN I-NP O
35 total JJ B-NP O
35 abdominal JJ I-NP O
35 hysterectomy NN I-NP O
35 , , O O
35 history NN B-NP O
35 of IN B-VP O
36 cervical JJ B-NP O
36 dysplasia NN I-NP O
36 , , O O
36 bursitis NN B-NP O
36 and CC O O
36 multiple JJ B-NP O
36 musculoskeletal JJ I-NP O
37 complaints NNS I-NP O
37 , , O O
37 just RB O O
37 a DT B-NP O
37 history NN I-NP O
37 of IN B-VP O
37 physical JJ B-NP O
37 abuse NN I-NP O
37 and CC O O
37 vitiligo NN B-NP O
37 , , O O
38 hemorrhoids NNS B-NP O
39 MEDICATIONS: NNP I-NP O
39 Hydrochlorothiazide NNP I-NP B-m
39 12.5 CD O B-do
39 milligrams NNS B-NP I-do
39 once RB O B-f
39 a DT B-NP I-f
39 day NN I-NP I-f
39 , , O O
40 Norvasc NNP B-NP B-m
40 5 CD O B-do
40 milligrams NNS B-NP I-do
40 once RB O B-f
40 a DT B-NP I-f
40 day NN I-NP I-f
40 , , O O
40 Taxol NNP B-NP B-m
40 28 CD O B-do
40 milligrams NNS B-NP I-do
41 once RB O B-f
41 a DT B-NP I-f
41 day NN I-NP I-f
41 , , O O
41 Premarin NNP B-NP B-m
41 0.625 CD O B-do
41 milligrams NNS B-NP I-do
41 once RB O B-f
41 a DT B-NP I-f
41 day NN I-NP I-f
41 , , O O
41 Trazodone NNP B-NP B-m
41 , , O O
42 insulin NN B-NP O
42 12 CD O B-do
42 units NNS B-NP I-do
42 of IN B-VP O
42 regular JJ O B-m
42 and CC O O
42 50 CD O B-do
42 units NNS B-NP I-do
42 of IN B-VP O
42 NPH NNP B-NP B-m
42 in IN B-VP B-f
42 in IN B-VP B-f
42 the DT O I-f
42 the DT B-NP I-f
42 morning NN I-NP I-f
42 morning NN I-NP I-f
42 and CC O O
43 14 CD O B-do
43 units NNS B-NP I-do
43 of IN B-VP O
43 regular JJ O B-m
43 and CC O O
43 10 CD O B-do
43 units NNS B-NP I-do
43 of IN B-VP O
43 NPH NNP B-NP B-m
43 in IN B-VP B-f
43 in IN B-VP B-f
43 the DT O I-f
43 the DT B-NP I-f
43 evening NN I-NP I-f
43 evening NN I-NP I-f
43 She PRP O O
43 had VBD B-VP O
44 also RB O O
44 been VBN O O
44 taking VBG O O
44 Ansaid NNP B-NP B-m
44 100 CD O B-do
44 milligrams NNS B-NP I-do
44 p.o VBP O B-mo
44 b.i.d JJ B-NP B-f
44 p.r.n NN I-NP I-f
44 joint NN I-NP B-r
45 pain NN I-NP O
45 She PRP O O
45 is VBZ O O
45 also RB O O
45 reportedly RB O O
45 taking VBG O O
45 a DT B-NP O
45 baby NN I-NP B-m
45 aspirin RB O I-m
45 81 CD O B-do
45 milligrams NNS B-NP I-do
46 once RB O B-f
46 a DT B-NP I-f
46 day NN I-NP I-f
47 SOCIAL NNP I-NP O
47 HISTORY: NNP I-NP O
47 The DT B-NP O
47 patient NN I-NP O
47 is VBZ O O
47 on IN B-VP O
47 disability NN B-NP O
47 She PRP O O
47 lives VBZ O O
47 alone RB O O
47 as IN B-VP O
48 a DT B-NP O
48 widow NN I-NP O
48 No DT B-NP O
48 clear JJ I-NP O
48 history NN I-NP O
48 of IN B-VP O
48 tobacco NN B-NP O
48 or CC O O
48 ethanol NN B-NP O
49 use NN I-NP O
49 She PRP O O
49 has VBZ O O
49 two CD O O
49 children NNS B-NP O
49 She PRP O O
49 is VBZ O O
49 independent JJ O O
49 with IN B-VP O
49 ADLs NNP B-NP O
49 and CC O O
50 mobility NNP B-NP O
51 FAMILY NNP I-NP O
51 HISTORY: NNP I-NP O
51 Familial NNP I-NP O
51 intermittent NN I-NP O
51 paralytic JJ B-NP O
51 syndrome JJ I-NP O
52 PHYSICAL NNP I-NP O
52 EXAMINATION: NNP I-NP O
52 Temperature NNP I-NP O
52 was VBD B-VP O
52 97.1 CD O O
52 , , O O
52 heart NN B-NP O
52 rate NN I-NP O
52 110 CD O O
52 , , O O
53 respirations NNS B-NP O
53 20 CD O O
53 , , O O
53 blood NN B-NP O
53 pressure NN I-NP O
53 130/70 CD O O
53 , , O O
54 oxygen NN B-NP O
54 saturation NN I-NP O
54 100% CD O O
54 on IN B-VP O
54 room NN B-NP O
54 air NN I-NP O
54 Glucose NNP I-NP O
54 is VBZ O O
54 388 CD O O
54 Mental JJ B-NP O
54 status NN I-NP O
55 examination: VBZ O O
55 The DT B-NP O
55 patient NN I-NP O
55 was VBD B-VP O
55 alert JJ O O
55 and CC O O
55 oriented VBD B-VP O
55 times NNS B-NP O
55 three CD O O
56 following VBG O O
56 three CD O O
56 step NN B-NP O
56 command NN I-NP O
56 across IN B-VP O
56 the DT B-NP O
56 midline NN I-NP O
56 No NNP I-NP O
56 apraxia RB O O
57 Positive NNP B-NP O
57 dysarthria NN I-NP O
57 Repetition NNP I-NP O
57 intact JJ B-NP O
57 Memory NNP I-NP O
57 3/3 CD O O
57 immediately RB O O
58 and CC O O
58 3/3 CD O O
58 at IN B-VP O
58 5 CD O O
58 minutes NNS B-NP O
58 Cranial JJ B-NP O
58 nerves: JJ I-NP O
58 Pupils NNP I-NP O
58 3-2 CD O O
58 bilaterally RB O O
59 Right JJ B-NP O
59 central JJ I-NP O
59 facial JJ I-NP O
59 paralysis NN I-NP O
59 No NNP I-NP O
59 pallor NN I-NP O
59 or CC O O
59 droop NN B-NP O
59 Decreased VBN O O
60 sensation NN B-NP O
60 to TO O O
60 light JJ B-NP O
60 touch NN I-NP O
60 , , O O
60 pinprick NN B-NP O
60 and CC O O
60 temperature NN B-NP O
60 on IN B-VP O
60 the DT B-NP O
60 right JJ I-NP O
61 Tears NNP I-NP O
61 well RB O O
61 bilaterally RB O O
61 She PRP O O
61 cannot VBZ O O
61 shrug JJ O O
61 her PRP$ O O
61 right JJ B-NP O
61 shoulder NN I-NP O
62 Motor NNP I-NP O
62 and CC O O
62 tone NN B-NP O
62 flaccid NN I-NP O
62 on IN B-VP O
62 the DT B-NP O
62 right JJ I-NP O
62 Strength: NNP I-NP O
62 Right NNP I-NP O
62 hemiplegia NN I-NP O
63 ( ( O O
63 can MD O O
63 only RB O O
63 wiggle VB O O
63 toes NNS B-NP O
63 ) ) O O
63 , , O O
63 left VBD B-VP O
63 strength NN B-NP O
63 4-5/5 JJ O O
63 ( ( O O
63 poor JJ B-NP O
63 effort NN I-NP O
63 ) ) O O
63 Deep NNP B-NP O
64 tendon NN I-NP O
64 reflexes NNS I-NP O
64 are VBP O O
64 2+ CD O O
64 at IN B-VP O
64 the DT B-NP O
64 biceps NNS I-NP O
64 , , O O
64 1+ CD O O
64 at IN B-VP O
64 the DT B-NP O
64 knees NNS I-NP O
64 , , O O
64 0-1 NN B-NP O
64 at IN B-VP O
64 the DT B-NP O
65 ankle NN I-NP O
65 with IN B-VP O
65 an DT B-NP O
65 upgoing JJ I-NP O
65 right NN I-NP O
65 toe NN I-NP O
65 Sensation: NNP I-NP O
65 Decreased VBD B-VP O
65 sensation NN B-NP O
66 to TO O O
66 light JJ B-NP O
66 touch NN I-NP O
66 , , O O
66 pinprick NN B-NP O
66 and CC O O
66 vibration NN B-NP O
66 Temperature NN I-NP O
66 on IN B-VP O
66 the DT O O
66 right JJ O O
67 including VBG O O
67 trunk NN B-NP O
67 Gait NNP I-NP O
67 not RB O O
67 assessed VBD B-VP O
67 HEENT: NNP B-NP O
67 Atraumatic NNP I-NP O
67 Neck NNP I-NP O
68 supple JJ B-NP O
68 Lungs NNP I-NP O
68 clear NN I-NP O
68 to TO O O
68 auscultation VB O O
68 bilaterally RB O O
68 Cardiovascular: NNP B-NP O
69 Regular NNP I-NP O
69 rate NN I-NP O
69 and CC O O
69 rhythm NN B-NP O
69 Abdomen: NNP I-NP O
69 Soft NNP I-NP O
69 and CC O O
69 nontender RB O O
69 Positive NNP B-NP O
70 bowel NN I-NP O
70 sounds VBZ O O
70 Extremities: NNP B-NP O
70 No NNP I-NP O
70 edema NN I-NP O
71 EKG: NNP I-NP O
71 Sinus NNP I-NP O
71 tachycardia NN I-NP O
71 at IN B-VP O
71 104 CD O O
71 per IN B-VP O
71 report NN B-NP O
71 when WRB O O
71 compared VBN O O
71 with IN B-VP O
71 EKG NNP B-NP O
72 of IN B-VP O
72 March NNP B-NP O
72 , , O O
72 no DT B-NP O
72 significant JJ I-NP O
72 change NN I-NP O
72 Chest NNP I-NP O
72 x-ray: NN I-NP O
72 No NNP I-NP O
73 evidence NN I-NP O
73 of IN B-VP O
73 active JJ B-NP O
73 cardiopulmonary JJ I-NP O
73 disease NN I-NP O
73 CT NNP I-NP O
73 scan NN I-NP O
73 of IN B-VP O
73 the DT B-NP O
73 head NN I-NP O
73 on IN B-VP O
74 10/6/98 CD O O
74 showed VBD B-VP O
74 low JJ B-NP O
74 density NN I-NP O
74 area NN I-NP O
74 present NN I-NP O
74 in IN B-VP O
74 the DT B-NP O
74 posterior JJ I-NP O
74 limb NN I-NP O
74 of IN B-VP O
75 the DT B-NP O
75 left NN I-NP O
75 intracapsular JJ B-NP O
75 capsule NN I-NP O
75 consistent NN I-NP O
75 with IN B-VP O
75 an DT B-NP O
75 infarct JJ I-NP O
76 Otherwise NNP I-NP O
76 , , O O
76 no DT B-NP O
76 significant JJ I-NP O
76 abnormality NN I-NP O
76 was VBD B-VP O
76 seen VBN O O
76 Mild NNP B-NP O
76 age NN I-NP O
77 appropriate JJ B-NP O
77 involutional JJ I-NP O
77 changes NNS I-NP O
77 were VBD B-VP O
77 present JJ B-NP O
78 LABORATORY: NNP I-NP O
78 Showed VBD B-VP O
78 a DT B-NP O
78 glucose NN I-NP O
78 of IN B-VP O
78 353 CD O O
78 , , O O
78 sodium NN B-NP O
78 138 CD O O
78 , , O O
78 potassium NN B-NP O
78 4.9 CD O O
78 , , O O
79 chloride RB O O
79 98 CD O O
79 , , O O
79 CO2 NNP B-NP O
79 28 CD O O
79 , , O O
79 BUN NNP B-NP O
79 33 CD O O
79 , , O O
79 creatinine NN B-NP O
79 1.1 CD O O
79 , , O O
79 calcium NN B-NP O
80 10.3 CD O O
80 , , O O
80 magnesium NN B-NP O
80 2.0 CD O O
80 , , O O
80 troponin VBD B-VP O
80 0.09 CD O O
80 White NNP B-NP O
80 count NN I-NP O
80 8.4 CD O O
80 , , O O
80 hematocrit NN B-NP O
81 39.8 CD O O
81 , , O O
81 platelet NN B-NP O
81 count NN I-NP O
81 367 CD O O
81 , , O O
81 000 CD O O
81 PT NNP B-NP O
81 12.1 CD O O
81 , , O O
81 PTT NNP B-NP O
81 19.5 CD O O
81 INR NNP B-NP O
81 1.0 CD O O
82 ASSESSMENT NNP B-NP O
82 AND NNP I-NP O
82 PLAN: NNP I-NP O
82 Ms NNP I-NP O
82 Lofstrom NNP I-NP O
82 is VBZ O O
82 a DT B-NP O
82 57-year-old JJ I-NP O
82 female NN I-NP O
82 with IN B-VP O
82 a DT B-NP O
83 past JJ I-NP O
83 medical JJ I-NP O
83 history NN I-NP O
83 of IN B-VP O
83 hypertension NN B-NP O
83 , , O O
84 diabetes VBZ O O
84 mellitus NN B-NP O
84 , , O O
84 multinodular JJ B-NP O
84 goiter NN I-NP O
84 , , O O
84 arthritis NN B-NP O
84 and CC O O
84 questionable JJ B-NP O
85 recurrent NN I-NP O
85 bouts NNS I-NP O
85 of IN B-VP O
85 generalized JJ B-NP O
85 weakness NN I-NP O
85 who WP O O
85 was VBD B-VP O
85 admitted VBN O O
85 for IN B-VP O
85 new JJ B-NP O
86 onset NN I-NP O
86 of IN B-VP O
86 right NN B-NP O
86 sided VBN O O
86 weakness NN B-NP O
86 ( ( O O
86 three CD O O
86 days NNS B-NP O
86 prior RB O O
86 to TO O O
86 admission NN B-NP O
86 ) ) O O
86 , , O O
87 right JJ B-NP O
87 leg NN I-NP O
87 numbness NN I-NP O
87 and CC O O
87 weakness NN B-NP O
87 , , O O
87 right JJ B-NP O
87 arm NN I-NP O
87 clumsiness NN I-NP O
87 followed VBN O O
87 by IN B-VP O
88 dysarthria NNS B-NP O
89 HOSPITAL NNP I-NP O
89 COURSE NNP I-NP O
89 BY NNP I-NP O
89 SYSTEMS: NNP I-NP O
90 1 CD O O
90 NEUROLOGY: NNP B-NP O
90 The DT B-NP O
90 patient NN I-NP O
90 was VBD B-VP O
90 felt VBN O O
90 to TO O O
90 have VB O O
90 a DT B-NP O
90 probable JJ I-NP O
90 subcortical JJ I-NP O
91 stroke NN I-NP O
91 of IN B-VP O
91 the DT B-NP O
91 left NN I-NP O
91 hemisphere NN I-NP O
91 with IN B-VP O
91 preservation NN B-NP O
91 of IN B-VP O
91 the DT B-NP O
91 speech NN I-NP O
92 processing NN I-NP O
92 abilities NNS I-NP O
92 with IN B-VP O
92 dense JJ B-NP O
92 motor NN I-NP O
92 and CC O O
92 sensory JJ B-NP O
92 involvement NN I-NP O
93 This DT O O
93 was VBD B-VP O
93 felt VBN O O
93 to TO O O
93 potentially RB O O
93 represent VB O O
93 an DT B-NP O
93 MCA NNP I-NP O
93 branch NN I-NP O
93 occlusion NN I-NP O
93 with IN B-VP O
94 increased JJ B-NP O
94 edema NN I-NP O
94 versus IN B-VP O
94 a DT B-NP O
94 large JJ I-NP O
94 lacuna NN I-NP O
94 In IN B-VP O
94 addition NN B-NP O
94 , , O O
94 given VBN O O
94 her PRP$ O O
95 history NN B-NP O
95 , , O O
95 the DT B-NP O
95 team NN I-NP O
95 was VBD B-VP O
95 unable JJ O O
95 to TO O O
95 rule VB O O
95 out RP O O
95 the DT B-NP O
95 possibility NN I-NP O
95 of IN B-VP O
95 an DT B-NP O
96 embolic JJ I-NP O
96 event NN I-NP O
96 Therefore NNP I-NP O
96 , , O O
96 the DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 admitted VBN O O
96 and CC O O
96 ruled VBN O O
96 out RP O O
97 for IN B-VP O
97 a DT B-NP O
97 myocardial JJ I-NP O
97 infarction NN I-NP O
97 Her PRP$ O O
97 CKs NNP B-NP O
97 were VBD B-VP O
97 25 CD O O
97 , , O O
97 37 CD O O
97 , , O O
97 37 CD O O
97 and CC O O
97 32 CD O O
97 She PRP O O
98 was VBD B-VP O
98 placed VBN O O
98 on IN B-VP O
98 a DT B-NP O
98 cardiac JJ I-NP O
98 monitor NN I-NP O
98 with IN B-VP O
98 no DT B-NP O
98 evidence NN I-NP O
98 of IN B-VP O
98 arrhythmia NN B-NP O
99 she PRP O O
99 was VBD B-VP O
99 placed VBN O O
99 on IN B-VP O
99 subcu NN B-NP B-mo
99 heparin NN I-NP B-m
99 and CC O O
99 started VBD B-VP O
99 on IN B-VP O
99 full JJ B-NP O
99 dose NN I-NP O
99 aspirin IN B-VP B-m
100 325 CD O B-do
100 milligrams NNS B-NP I-do
100 p.o VBP O B-mo
100 q.d NN B-NP B-f
101 In IN B-VP O
101 order NN B-NP O
101 to TO O O
101 further RBR O O
101 work VB O O
101 up RP O O
101 the DT B-NP O
101 etiology NN I-NP O
101 for IN B-VP O
101 stroke NN B-NP O
101 , , O O
101 the DT B-NP O
101 patient NN I-NP O
102 had VBD B-VP O
102 an DT B-NP O
102 echocardiogram NN I-NP O
102 done VBN O O
102 which WDT O O
102 revealed VBD B-VP O
102 evidence NN B-NP O
102 of IN B-VP O
102 concentric JJ B-NP O
103 LVH NNP I-NP O
103 with IN B-VP O
103 preserved VBN O O
103 systolic JJ B-NP O
103 function NN I-NP O
103 , , O O
103 calculated VBN O O
103 ejection NN B-NP O
103 fraction NN I-NP O
104 of IN B-VP O
104 55% CD O O
104 Other JJ O O
104 than IN B-VP O
104 nonspecific JJ B-NP O
104 septal JJ I-NP O
104 abnormality NN I-NP O
104 , , O O
104 there EX O O
104 was VBD B-VP O
104 no DT B-NP O
105 evidence NN I-NP O
105 of IN B-VP O
105 regional JJ B-NP O
105 wall NN I-NP O
105 motion NN I-NP O
105 dysfunction NN I-NP O
105 There EX O O
105 were VBD B-VP O
105 early JJ B-NP O
106 changes NNS I-NP O
106 of IN B-VP O
106 mitral JJ B-NP O
106 annular JJ I-NP O
106 calcification NN I-NP O
106 present NN I-NP O
106 , , O O
106 some DT O O
106 increased VBN O O
107 excursion NN B-NP O
107 of IN B-VP O
107 the DT B-NP O
107 mitral JJ I-NP O
107 leaflet NN I-NP O
107 , , O O
107 but CC O O
107 this DT O O
107 is VBZ O O
107 associated VBN O O
107 with IN B-VP O
107 only RB O O
108 trivial JJ B-NP O
108 regurgitation NN I-NP O
108 Trileaflet NNP I-NP O
108 aortic JJ B-NP O
108 valve NN I-NP O
108 without IN B-VP O
109 dysfunction NN B-NP O
109 One CD O O
109 plus CC O O
109 tricuspid JJ B-NP O
109 regurgitation NN I-NP O
109 Peak NNP I-NP O
109 doppler NN I-NP O
109 flow NN I-NP O
110 velocity NN I-NP O
110 across IN B-VP O
110 the DT B-NP O
110 tricuspid JJ I-NP O
110 valve NN I-NP O
110 reached VBD B-VP O
110 2.5 CD O O
110 meters NNS B-NP O
110 per IN B-VP O
110 second JJ O O
111 consistent JJ O O
111 with IN B-VP O
111 normal JJ B-NP O
111 right JJ I-NP O
111 heart NN I-NP O
111 systolic JJ B-NP O
111 pressures NNS I-NP O
111 There EX O O
111 was VBD B-VP O
112 no DT B-NP O
112 evidence NN I-NP O
112 of IN B-VP O
112 effusion NN B-NP O
112 In IN B-VP O
112 addition NN B-NP O
112 , , O O
112 the DT B-NP O
112 patient JJ I-NP O
112 underwent JJ I-NP O
113 carotid NN I-NP O
113 noninvasive JJ B-NP O
113 studies NNS I-NP O
113 which WDT O O
113 revealed VBD B-VP O
113 no DT B-NP O
113 evidence NN I-NP O
113 of IN B-VP O
114 hemodynamically RB O O
114 significant JJ B-NP O
114 disease NN I-NP O
114 in IN B-VP O
114 either DT B-NP O
114 carotid JJ I-NP O
114 artery NN I-NP O
114 with IN B-VP O
115 those DT B-NP O
115 arteries NNS I-NP O
115 having VBG O O
115 minimal JJ B-NP O
115 plaque NN I-NP O
115 and CC O O
115 1-25% JJ B-NP O
115 stenosis NN I-NP O
115 In IN B-VP O
116 addition NN B-NP O
116 , , O O
116 the DT B-NP O
116 patient NN I-NP O
116 had VBD B-VP O
116 an DT B-NP O
116 MRI/MRA NNP I-NP O
116 to TO O O
116 further VB O O
116 evaluate VB O O
116 potential JJ B-NP O
117 lesions NNS I-NP O
117 On IN B-VP O
117 MRI NNP B-NP O
117 there EX O O
117 was VBD B-VP O
117 a DT B-NP O
117 focal JJ I-NP O
117 area NN I-NP O
117 of IN B-VP O
117 increased VBN O O
117 T2 NNP B-NP O
117 signal NN I-NP O
117 in IN B-VP O
118 the DT B-NP O
118 posterior JJ I-NP O
118 limb NN I-NP O
118 of IN B-VP O
118 the DT B-NP O
118 left JJ I-NP O
118 internal JJ I-NP O
118 capsule NN I-NP O
118 , , O O
118 close VB O O
118 the DT B-NP O
118 genu NN I-NP O
119 This DT B-NP O
119 area NN I-NP O
119 demonstrated VBD B-VP O
119 restricted JJ B-NP O
119 diffusion NN I-NP O
119 on IN B-VP O
119 EPI NNP B-NP O
119 diffusion NN I-NP O
119 , , O O
120 weighted VBD B-VP O
120 sequence NN B-NP O
120 A NNP I-NP O
120 similar JJ B-NP O
120 smaller JJR I-NP O
120 area NN I-NP O
120 of IN B-VP O
120 signal JJ B-NP O
120 abnormality NN I-NP O
121 was VBD B-VP O
121 noted VBN O O
121 in IN B-VP O
121 the DT B-NP O
121 left NN I-NP O
121 globus NN I-NP O
121 pallidus NN I-NP O
121 adjacent NN I-NP O
121 to TO O O
121 the DT O O
121 left VBN O O
121 internal JJ B-NP O
122 capsule NN I-NP O
122 abnormality NN I-NP O
122 These DT B-NP O
122 areas NNS I-NP O
122 represent VBP O O
122 subacute JJ B-NP O
122 infarctions NNS I-NP O
123 The DT B-NP O
123 ventricles NNS I-NP O
123 and CC O O
123 sulci NNS B-NP O
123 were VBD B-VP O
123 minimally RB O O
123 prominent JJ O O
123 , , O O
123 consistent JJ O O
123 with IN B-VP O
124 the DT B-NP O
124 patient's NN I-NP O
124 age NN I-NP O
124 There EX O O
124 was VBD B-VP O
124 no DT B-NP O
124 other JJ I-NP O
124 signal JJ I-NP O
124 abnormality NN I-NP O
124 noted VBD B-VP O
125 Major NNP B-NP O
125 vascular JJ B-NP O
125 flow NN I-NP O
125 voids NNS I-NP O
125 were VBD B-VP O
125 normal JJ O O
125 There EX O O
125 was VBD B-VP O
125 no DT B-NP O
125 mass NN I-NP O
125 or CC O O
125 mass NN B-NP O
126 effect NN I-NP O
126 Three NNP I-NP O
126 D NNP I-NP O
126 , , O O
126 TOF NNP B-NP O
126 MRN NNP I-NP O
126 angiogram NN I-NP O
126 on IN B-VP O
126 the DT B-NP O
126 circle NN I-NP O
126 of IN B-VP O
126 Willis NNP B-NP O
126 and CC O O
126 its PRP$ O O
127 major JJ B-NP O
127 tributaries NNS I-NP O
127 did VBD B-VP O
127 not RB O O
127 demonstrate VB O O
127 any DT B-NP O
127 abnormality NN I-NP O
127 Incidental NNP I-NP O
128 note NN I-NP O
128 was VBD B-VP O
128 made VBN O O
128 of IN B-VP O
128 a DT O O
128 dominant JJ O O
128 right JJ O O
128 vertebral JJ O O
128 artery IN B-VP O
128 The DT B-NP O
128 formal JJ I-NP O
129 impression NN I-NP O
129 revealed VBD B-VP O
129 subacute JJ B-NP O
129 infarcts NNS I-NP O
129 involving VBG O O
129 the DT B-NP O
129 posterior JJ I-NP O
129 limb NN I-NP O
130 of IN B-VP O
130 the DT B-NP O
130 internal JJ I-NP O
130 capsule NN I-NP O
130 on IN B-VP O
130 the DT B-NP O
130 left NN I-NP O
130 as RB O O
130 well RB O O
130 as IN B-VP O
130 the DT B-NP O
130 left NN I-NP O
130 globus NN I-NP O
131 pallidus NN I-NP O
131 Unremarkable NNP I-NP O
131 MR NNP I-NP O
131 angiogram NN I-NP O
131 on IN B-VP O
131 the DT B-NP O
131 circle NN I-NP O
131 of IN B-VP O
131 Willis NNP B-NP O
132 In IN B-VP O
132 addition NN B-NP O
132 , , O O
132 given VBN O O
132 the DT B-NP O
132 patient's JJ I-NP O
132 history NN I-NP O
132 of IN B-VP O
132 polymyalgias NN B-NP O
132 , , O O
132 an DT B-NP O
132 ESR NNP I-NP O
133 and CC O O
133 C-reactive JJ B-NP O
133 protein NN I-NP O
133 were VBD B-VP O
133 obtained VBN O O
133 The DT B-NP O
133 ESR NNP I-NP O
133 was VBD B-VP O
133 46 CD O O
133 The DT B-NP O
134 C-reactive JJ I-NP O
134 protein NN I-NP O
134 was VBD B-VP O
134 1.13 CD O O
134 The DT B-NP O
134 stroke NN I-NP O
134 service NN I-NP O
134 was VBD B-VP O
134 asked VBN O O
134 to TO O O
135 comment VB O O
135 on IN B-VP O
135 the DT B-NP O
135 possibility NN I-NP O
135 of IN B-VP O
135 a DT B-NP O
135 vasculitic JJ I-NP O
135 process NN I-NP O
135 In IN B-VP O
135 addition NN B-NP O
135 , , O O
136 the DT B-NP O
136 patient's NN I-NP O
136 primary JJ B-NP O
136 rheumatologist NN I-NP O
136 was VBD B-VP O
136 consulted VBN O O
136 as RB O O
136 well RB O O
136 The DT B-NP O
137 patient's NN I-NP O
137 primary JJ B-NP O
137 rheumatologist NN I-NP O
137 felt VBD B-VP O
137 that IN B-VP O
137 the DT B-NP O
137 patient's NN I-NP O
137 stroke NN I-NP O
137 was VBD B-VP O
138 most RBS O O
138 likely JJ O O
138 due JJ O O
138 to TO O O
138 small JJ B-NP O
138 vessel JJ I-NP O
138 disease NN I-NP O
138 associated VBN O O
138 with IN B-VP O
138 diabetes NNS B-NP O
139 and CC O O
139 hypertension NN B-NP O
139 He PRP O O
139 felt VBD B-VP O
139 there EX O O
139 was VBD B-VP O
139 no DT B-NP O
139 evidence NN I-NP O
139 for IN B-VP O
139 a DT B-NP O
139 vasculitis NN I-NP O
140 He PRP O O
140 therefore RB O O
140 suggested VBD B-VP O
140 to TO O O
140 continue VB O O
140 aspirin NN B-NP B-m
140 , , O O
140 but CC O O
140 in IN B-VP O
140 higher JJR B-NP B-do
140 doses NNS I-NP I-do
140 to TO O O
141 alleviate VB O O
141 her PRP$ O B-r
141 left JJ B-NP I-r
141 shoulder NN I-NP I-r
141 pain VBP O I-r
141 The DT B-NP O
141 patient NN I-NP O
141 did VBD B-VP O
141 not RB O O
141 feel VB O O
141 that IN B-VP O
142 she PRP O O
142 had VBD B-VP O
142 any DT B-NP O
142 vasculitic JJ I-NP O
142 process NN I-NP O
142 They PRP O O
142 therefore RB O O
142 recommended VBD B-VP O
143 continuing VBG O O
143 aspirin RB O B-m
143 325 CD O B-do
143 milligrams NNS B-NP I-do
143 p.o JJ B-NP B-mo
143 q.d NN I-NP B-f
143 , , O O
143 checking VBG O O
143 a DT B-NP O
143 serum NN I-NP O
144 homocystine NN I-NP O
144 which WDT O O
144 remains VBZ O O
144 pending VBG O O
144 at IN B-VP O
144 the DT B-NP O
144 time NN I-NP O
144 of IN B-VP O
144 this DT B-NP O
144 dictation NN I-NP O
144 , , O O
145 reviewing VBG O O
145 her PRP$ O O
145 carotid NN B-NP O
145 studies NNS I-NP O
145 ( ( O O
145 mentioned VBN O O
145 above IN B-VP O
145 ) ) O O
145 , , O O
145 and CC O O
145 continue VB O O
145 with IN B-VP O
146 physical JJ B-NP O
146 therapy NN I-NP O
146 occupational JJ B-NP O
146 therapy NN I-NP O
146 and CC O O
146 speech NN B-NP O
146 therapy NN I-NP O
147 PT NNP I-NP O
147 and CC O O
147 OT NNP B-NP O
147 were VBD B-VP O
147 consulted VBN O O
147 as RB O O
147 well RB O O
147 as IN B-VP O
147 Speech NNP B-NP O
147 Therapy NNP I-NP O
148 In IN B-VP O
148 addition NN B-NP O
148 to TO O O
148 continuing VBG O O
148 the DT B-NP O
148 patient NN I-NP O
148 on IN B-VP O
148 aspirin NN B-NP B-m
148 , , O O
148 continuing VBG O O
148 subcu JJ B-NP B-mo
149 heparin NN I-NP B-m
149 while IN B-VP B-du
149 the DT B-NP I-du
149 patient NN I-NP I-du
149 was VBD B-VP I-du
149 immobile JJ O I-du
149 , , O O
149 the DT B-NP O
149 patient's NN I-NP O
150 antihypertensives NNS I-NP B-m
150 were VBD B-VP O
150 held VBN O O
150 in IN B-VP O
150 order NN B-NP O
150 to TO O O
150 maintain VB O O
150 a DT B-NP O
150 systolic JJ I-NP O
150 blood NN I-NP O
151 pressure NN I-NP O
151 between IN B-VP O
151 140-160 JJ O O
151 and CC O O
151 a DT B-NP O
151 diastolic JJ I-NP O
151 blood NN I-NP O
151 pressure NN I-NP O
151 between IN B-VP O
152 85-90 JJ O O
152 for IN B-VP O
152 the DT B-NP O
152 first JJ I-NP O
152 ten JJ I-NP O
152 days NNS I-NP O
152 following VBG O O
152 her PRP$ O O
152 stroke NN B-NP O
152 For IN B-VP O
152 the DT B-NP O
152 first JJ I-NP O
153 few JJ I-NP O
153 days NNS I-NP O
153 , , O O
153 the DT B-NP O
153 patient NN I-NP O
153 was VBD B-VP O
153 kept VBN O O
153 in IN B-VP O
153 a DT B-NP O
153 lying JJ I-NP O
153 position NN I-NP O
153 as RB O O
153 much JJ O O
153 as IN B-VP O
154 possible JJ O O
154 and CC O O
154 her PRP$ O O
154 activity NN B-NP O
154 level NN I-NP O
154 was VBD B-VP O
154 gradually RB O O
154 increased VBN O O
154 to TO O O
154 the DT B-NP O
155 point NN I-NP O
155 where WRB O O
155 she PRP O O
155 was VBD B-VP O
155 participating VBG O O
155 in IN B-VP O
155 full JJ B-NP O
155 PT/OT NNP I-NP O
155 At IN B-VP O
155 the DT B-NP O
155 time NN I-NP O
155 of IN B-VP O
156 this DT B-NP O
156 dictation NN I-NP O
156 , , O O
156 the DT B-NP O
156 patient's NN I-NP O
156 Norvasc NNP I-NP B-m
156 continued VBD B-VP O
156 to TO O O
156 be VB O O
156 held VBN O O
156 with IN B-VP O
157 excellent JJ B-NP O
157 control NN I-NP O
157 of IN B-VP O
157 her PRP$ O B-r
157 blood NN B-NP I-r
157 pressure NN I-NP I-r
157 between IN B-VP O
157 systolic NN B-NP O
157 of IN B-VP O
158 140-160 JJ O O
158 It PRP O O
158 should MD O O
158 not RB O O
158 be VB O O
158 reinitiated VBN O O
158 until IN B-VP O
158 roughly RB O O
158 ten JJ B-NP O
158 days NNS I-NP O
158 after IN B-VP O
159 her PRP$ O O
159 stroke VBD B-VP O
160 The DT B-NP O
160 patient NN I-NP O
160 had VBD B-VP O
160 relatively RB O O
160 poor JJ B-NP O
160 return NN I-NP O
160 of IN B-VP O
160 function NN B-NP O
160 during IN B-VP O
160 her PRP$ O O
161 hospital NN B-NP O
161 stay NN I-NP O
161 , , O O
161 but CC O O
161 was VBD B-VP O
161 felt VBN O O
161 to TO O O
161 be VB O O
161 a DT B-NP O
161 good JJ I-NP O
161 candidate NN I-NP O
161 for IN B-VP O
161 potential JJ B-NP O
162 rehabilitation NN I-NP O
162 Therefore RB O O
162 when WRB O O
162 her PRP$ O O
162 medical JJ B-NP O
162 issues NNS I-NP O
162 were VBD B-VP O
162 stable JJ O O
162 , , O O
162 she PRP O O
163 was VBD B-VP O
163 considered VBN O O
163 ready JJ O O
163 for IN B-VP O
163 transfer NN B-NP O
163 to TO O O
163 a DT B-NP O
163 rehabilitation NN I-NP O
163 facility NN I-NP O
163 in IN B-VP O
164 an DT B-NP O
164 attempt NN I-NP O
164 to TO O O
164 further RB O O
164 improve VB O O
164 her PRP$ O O
164 neurologic JJ B-NP O
164 function NN I-NP O
164 As IN B-VP O
164 noted JJ O O
165 previously RB O O
165 , , O O
165 the DT B-NP O
165 patient's NN I-NP O
165 antihypertensives NNS I-NP B-m
165 should MD O O
165 be VB O O
165 reinitiated VBN O O
166 gradually RB O O
166 with IN B-VP O
166 a DT B-NP O
166 goal NN I-NP O
166 systolic JJ B-NP O
166 blood NN I-NP O
166 pressure NN I-NP O
166 between IN B-VP O
166 140-160 JJ O O
166 with IN B-VP O
167 a DT B-NP O
167 diastolic JJ I-NP O
167 blood NN I-NP O
167 pressure NN I-NP O
167 of IN B-VP O
167 85-90 JJ O O
167 to TO O O
167 be VB O O
167 initiated VBN O O
167 roughly RB O O
167 ten JJ B-NP O
168 days NNS I-NP O
168 from IN B-VP O
168 the DT B-NP O
168 time NN I-NP O
168 of IN B-VP O
168 her PRP$ O O
168 stroke NN B-NP O
168 ( ( O O
168 presented VBN O O
168 on IN B-VP O
168 10/6/98 CD O O
168 ) ) O O
168 As IN B-VP O
168 noted VBN O O
169 by IN B-VP O
169 the DT B-NP O
169 work NN I-NP O
169 up RB O O
169 , , O O
169 the DT B-NP O
169 patient NN I-NP O
169 had VBD B-VP O
169 no DT B-NP O
169 evidence NN I-NP O
169 of IN B-VP O
169 an DT B-NP O
169 embolic JJ I-NP O
169 source NN I-NP O
170 for IN B-VP O
170 her PRP$ O O
170 stroke NN B-NP O
170 and CC O O
170 her PRP$ O O
170 carotid NN B-NP O
170 studies NNS I-NP O
170 were VBD B-VP O
170 unremarkable JJ O O
171 2 CD O O
171 RHEUMATOLOGIC: NNP B-NP O
171 As IN B-VP O
171 noted VBN O O
171 , , O O
171 the DT B-NP O
171 patient NN I-NP O
171 has VBZ O O
171 a DT B-NP O
171 long JJ I-NP O
171 history NN I-NP O
171 of IN B-VP O
172 diffuse NN B-NP O
172 arthritic JJ B-NP O
172 complaints NNS I-NP O
172 She PRP O O
172 had VBD B-VP O
172 her PRP O O
172 sed JJ B-NP O
172 rate NN I-NP O
172 and CC O O
172 C-reactive JJ B-NP O
173 protein NN I-NP O
173 checked VBD B-VP O
173 Rheumatology NNP B-NP O
173 was VBD B-VP O
173 consulted VBN O O
173 who WP O O
173 felt VBD B-VP O
173 that IN B-VP O
173 her PRP$ O O
174 stroke NN B-NP O
174 was VBD B-VP O
174 not RB O O
174 consistent JJ O O
174 with IN B-VP O
174 a DT B-NP O
174 vascular JJ I-NP O
174 process NN I-NP O
174 They PRP O O
174 did VBD B-VP O
175 recommend VB O O
175 checking VBG O O
175 a DT B-NP O
175 urinalysis NN I-NP O
175 to TO O O
175 check VB O O
175 for IN B-VP O
175 red JJ B-NP O
175 blood NN I-NP O
175 cells NNS I-NP O
175 and CC O O
176 casts VBZ O O
176 Her PRP$ O O
176 urinalysis NN B-NP O
176 showed VBD B-VP O
176 no DT B-NP O
176 protein NN I-NP O
176 , , O O
176 no DT B-NP O
176 blood NN I-NP O
176 , , O O
176 0-2 JJ B-NP O
176 red JJ I-NP O
176 blood NN I-NP O
177 cells NNS I-NP O
177 , , O O
177 no DT B-NP O
177 casts NNS I-NP O
177 Only RB O O
177 other JJ B-NP O
177 recommendation NN I-NP O
177 was VBD B-VP O
177 to TO O O
177 continue VB O O
177 aspirin NN B-NP B-m
178 and CC O O
178 consider VB O O
178 higher JJR B-NP B-do
178 doses NNS I-NP I-do
178 to TO O O
178 alleviate VB O O
178 left JJ B-NP B-r
178 shoulder NN I-NP I-r
178 pain NN I-NP I-r
178 In IN B-VP O
179 addition NN B-NP O
179 , , O O
179 recommended VBD B-VP O
179 avoiding VBG O O
179 nonsteroidals NNS B-NP O
179 while IN B-VP O
179 the DT B-NP O
179 patient NN I-NP O
179 was VBD B-VP O
180 on IN B-VP O
180 aspirin JJ O B-m
181 3 CD O O
181 ENDOCRINE: NNP B-NP O
181 The DT B-NP O
181 patient NN I-NP O
181 has VBZ O O
181 a DT B-NP O
181 history NN I-NP O
181 of IN B-VP O
181 diabetes NNS B-NP B-r
181 diabetes NNS I-NP B-r
181 mellitus VBP O I-r
181 mellitus NN B-NP I-r
181 and CC O O
182 had VBD B-VP O
182 not RB O O
182 taken VBN O O
182 her PRP$ O O
182 insulin NN B-NP B-m
182 for IN B-VP B-du
182 several JJ B-NP I-du
182 days NNS I-NP I-du
182 prior RB O O
182 to TO O O
182 admission VB O O
182 The DT B-NP O
183 patient NN I-NP O
183 was VBD B-VP O
183 placed VBN O O
183 on IN B-VP O
183 her PRP$ O O
183 regular JJ B-NP B-m
183 insulin NN I-NP I-m
183 schedule NN I-NP O
183 as RB O O
183 well RB O O
183 as IN B-VP O
183 a DT O O
184 sliding VBG O B-do
184 scale NN B-NP I-do
184 The DT B-NP O
184 patient's NN I-NP O
184 blood NN I-NP O
184 sugar NN I-NP O
184 has VBZ O O
184 ranged VBN O O
184 from IN B-VP O
184 the DT O O
184 150 CD O O
185 to TO O O
185 the DT O O
185 high JJ O O
185 200s CD O O
185 As IN B-VP O
185 the DT B-NP O
185 patient's NN I-NP O
185 diet JJ B-NP O
185 returns NNS I-NP O
185 to TO O O
185 baseline VB O O
185 , , O O
185 she PRP O O
186 may MD O O
186 require VB O O
186 adjustments NNS B-NP O
186 of IN B-VP O
186 her PRP$ O O
186 NPH NNP B-NP B-m
186 and CC O O
186 regular JJ B-NP B-m
186 insulin NN I-NP I-m
186 doses NNS I-NP O
186 In IN B-VP O
187 addition NN B-NP O
187 , , O O
187 the DT B-NP O
187 patient's NN I-NP O
187 Premarin NNP I-NP B-m
187 was VBD B-VP O
187 held VBN O O
187 during IN B-VP B-du
187 this DT B-NP I-du
187 admission NN I-NP I-du
187 and CC O O
188 further JJ B-NP O
188 therapy NN I-NP O
188 should MD O O
188 be VB O O
188 decided VBN O O
188 by IN B-VP O
188 the DT B-NP O
188 patient's NN I-NP O
188 follow VBP O O
188 up RB O O
189 neurologist RB O O
190 4 CD O O
190 FLUIDS NNP B-NP O
190 , , O O
190 ELECTROLYTES NNP B-NP O
190 AND NNP I-NP O
190 NUTRITION: NNP I-NP O
190 The DT B-NP O
190 patient NN I-NP O
190 initially RB O O
191 appeared VBD B-VP O
191 somewhat RB O O
191 dehydrated VBN O O
191 on IN B-VP O
191 admission NN B-NP O
191 and CC O O
191 was VBD B-VP O
191 therefore RB O O
192 rehydrated VBN O O
192 with IN B-VP O
192 IV NNP B-NP B-mo
192 fluids NNS I-NP B-m
192 She PRP O O
192 had VBD B-VP O
192 good JJ B-NP O
192 resolution NN I-NP O
192 and CC O O
192 returned VBN O O
192 to TO O O
193 baseline NN B-NP O
193 of IN B-VP O
193 her PRP$ O O
193 BUN NNP B-NP O
193 and CC O O
193 creatinine VB O O
193 She PRP O O
193 was VBD B-VP O
193 eating VBG O O
193 well RB O O
193 at IN B-VP O
193 the DT B-NP O
194 time NN I-NP O
194 of IN B-VP O
194 discharge NN B-NP O
194 Close NNP I-NP O
194 observation NN I-NP O
194 was VBD B-VP O
194 paid VBN O O
194 to TO O O
194 her PRP$ O O
194 electrolytes NNS B-NP O
195 including VBG O O
195 her PRP$ O O
195 potassium NN B-NP O
195 Her PRP$ O O
195 electrolytes NNS B-NP O
195 should MD O O
195 be VB O O
195 periodically RB O O
196 monitored VBN O O
196 at IN B-VP O
196 least JJS O O
196 once RB O O
196 a DT B-NP O
196 week NN I-NP O
196 at IN B-VP O
196 rehabilitation NN B-NP O
196 She PRP O O
196 does VBZ O O
196 have VB O O
196 a DT B-NP O
197 history NN I-NP O
197 of IN B-VP O
197 hyperkalemia NN B-NP O
197 and CC O O
197 should MD O O
197 be VB O O
197 watched VBN O O
197 carefully RB O O
197 for IN B-VP O
197 this DT O O
198 5 CD O O
198 SOCIAL NNP B-NP O
198 WORK: NNP I-NP O
198 The DT B-NP O
198 patient NN I-NP O
198 initially RB O O
198 made VBD B-VP O
198 a DT B-NP O
198 comment NN I-NP O
198 to TO O O
198 the DT B-NP O
199 Medical NNP I-NP O
199 Team NN I-NP O
199 that IN B-VP O
199 she PRP O O
199 had VBD B-VP O
199 been VBN O O
199 abused VBN O O
199 by IN B-VP O
199 her PRP$ O O
199 husband NN B-NP O
199 The DT B-NP O
199 social JJ I-NP O
200 worker NN I-NP O
200 was VBD B-VP O
200 consulted VBN O O
200 and CC O O
200 asked VBN O O
200 to TO O O
200 see VB O O
200 her PRP$ O O
200 regarding VBG O O
200 this DT B-NP O
200 issue NN I-NP O
200 of IN B-VP O
201 spouse NN B-NP O
201 abuse IN B-VP O
201 It PRP O O
201 is VBZ O O
201 true JJ O O
201 that IN B-VP O
201 her PRP$ O O
201 husband NN B-NP O
201 had VBD B-VP O
201 hit VBN O O
201 her PRP O O
201 in IN B-VP O
201 the DT B-NP O
202 forehead NN I-NP O
202 with IN B-VP O
202 a DT B-NP O
202 baseball NN I-NP O
202 bat NN I-NP O
202 in IN B-VP O
202 the DT B-NP O
202 past NN I-NP O
202 He PRP O O
202 died VBD B-VP O
202 several JJ B-NP O
202 years NNS I-NP O
203 ago RB O O
203 and CC O O
203 no DT B-NP O
203 further JJ I-NP O
203 abuse NN I-NP O
203 history NN I-NP O
203 could MD O O
203 be VB O O
203 elicited VBN O O
203 since IN B-VP O
203 his PRP$ O O
203 death NN B-NP O
204 She PRP O O
204 currently RB O O
204 has VBZ O O
204 two CD O O
204 supportive JJ B-NP O
204 children NNS I-NP O
205 The DT B-NP O
205 patient NN I-NP O
205 was VBD B-VP O
205 considered VBN O O
205 stable JJ O O
205 and CC O O
205 ready JJ O O
205 for IN B-VP O
205 discharge NN B-NP O
205 to TO O O
205 a DT B-NP O
206 rehabilitation NN I-NP O
206 facility NN I-NP O
206 When WRB O O
206 the DT B-NP O
206 date NN I-NP O
206 of IN B-VP O
206 her PRP$ O O
206 transfer NN B-NP O
206 is VBZ O O
206 made VBN O O
207 available JJ O O
207 , , O O
207 her PRP$ O O
207 discharge NN B-NP O
207 medications NNS I-NP O
207 will MD O O
207 be VB O O
207 dictated VBN O O
207 along IN B-VP O
207 with IN B-VP O
208 follow JJ O O
208 up RP O O
209 Dictated NNP B-NP O
209 By: NNP I-NP O
209 RODGER NNP I-NP O
209 FALIS NNP I-NP O
209 , , O O
209 M.D NNP B-NP O
209 JL81 NNP I-NP O
210 Attending: NNP I-NP O
210 JUAN NNP I-NP O
210 AMISANO NNP I-NP O
210 , , O O
210 M.D NNP B-NP O
210 RW2 NNP I-NP O
210 CK149/6034 NNP I-NP O
211 Batch: NNP I-NP O
211 5491 CD O O
211 Index NNP B-NP O
211 No NNP I-NP O
211 PGONI565Z NNP I-NP O
211 D: NNP I-NP O
211 3/29/98 CD O O
212 T: NNP B-NP O
212 6/16/98 CD O O
213 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #569323 VBZ O O
4 185076505 CD O O
4 BMC NNP B-NP O
4 25759757 CD O O
4 6146391 CD O O
4 1/20/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHRONIC NNP I-NP O
4 OBSTRUCTIVE NNP I-NP O
4 PULMONARY NNP I-NP O
4 DISEASE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/30/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/7/2005 CD O O
7 ATTENDING: NNP B-NP O
7 REOPELL NNP I-NP O
7 , , O O
7 ROLF NNP B-NP O
7 M.D NNP I-NP O
8 PRINCIPAL NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
9 This DT O O
9 is VBZ O O
9 the DT B-NP O
9 diagnosis NN I-NP O
9 responsible JJ O O
9 for IN B-VP O
9 causing VBG O O
9 the DT B-NP O
9 admission NN I-NP O
9 is VBZ O O
10 sinus JJ B-NP O
10 arrest NN I-NP O
10 with IN B-VP O
10 apnea JJ B-NP O
11 HISTORY NNP I-NP O
11 OF NNP I-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
12 The DT B-NP O
12 patient NN I-NP O
12 is VBZ O O
12 a DT B-NP O
12 71-year-old JJ I-NP O
12 male NN I-NP O
12 with IN B-VP O
12 a DT B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 nonischemic JJ O O
13 dilated VBN O O
13 cardiomyopathy NN B-NP O
13 ( ( O O
13 EF NNP B-NP O
13 of IN B-VP O
13 55% CD O O
13 on IN B-VP O
13 this DT B-NP O
13 admission NN I-NP O
13 , , O O
13 although IN B-VP O
14 prior JJ B-NP O
14 admission NN I-NP O
14 indicating VBG O O
14 an DT B-NP O
14 EF NNP I-NP O
14 of IN B-VP O
14 35% CD O O
14 ) ) O O
14 , , O O
14 diabetes VBZ O O
14 , , O O
14 obstructive JJ B-NP O
15 sleep NN I-NP O
15 apnea NN I-NP O
15 , , O O
15 obesity NN B-NP O
15 hypoventilation NN I-NP O
15 syndrome NN I-NP O
15 , , O O
15 atrial JJ B-NP O
15 flutter NN I-NP O
16 status NN I-NP O
16 post NN I-NP O
16 ablation NN I-NP O
16 On IN B-VP O
16 7/28/05 CD O O
16 , , O O
16 he PRP O O
16 presented VBD B-VP O
16 with IN B-VP O
16 shortness NN B-NP O
17 of IN B-VP O
17 breath NN B-NP O
17 as RB O O
17 well RB O O
17 as IN B-VP O
17 a DT B-NP O
17 witnessed JJ I-NP O
17 apneic NN I-NP O
17 episode VB O O
17 His PRP$ O O
17 recent JJ B-NP O
18 history NN I-NP O
18 is VBZ O O
18 significant JJ O O
18 for IN B-VP O
18 having VBG O O
18 stopped VBD B-VP O
18 his PRP$ O O
18 Lasix NNP B-NP B-m
18 dose NN I-NP O
18 one CD O O
18 week NN B-NP O
19 prior RB O O
19 to TO O O
19 admission NN B-NP O
19 due JJ O O
19 to TO O O
19 increased VBN O O
19 frustration NN B-NP O
19 with IN B-VP O
20 incontinence NN B-NP O
20 Since IN B-VP O
20 then RB O O
20 , , O O
20 he PRP O O
20 has VBZ O O
20 had VBD B-VP O
20 increasing VBG O O
20 shortness NN B-NP O
20 of IN B-VP O
21 breath NN B-NP O
21 , , O O
21 orthopnea NN B-NP O
21 , , O O
21 bilateral JJ B-NP O
21 lower JJR I-NP O
21 edema NN I-NP O
21 , , O O
21 and CC O O
21 dyspnea NN B-NP O
21 on IN B-VP O
21 exertion NN B-NP O
22 to TO O O
22 the DT B-NP O
22 point NN I-NP O
22 of IN B-VP O
22 symptoms NNS B-NP O
22 upon IN B-VP O
22 walking VBG O O
22 10 CD O O
22 feet NNS B-NP O
22 In IN B-VP O
22 the DT B-NP O
22 Centsshealt NNP I-NP O
22 Careman NNP I-NP O
22 Inerist NNP I-NP O
22 Medical NNP I-NP O
22 Center NNP I-NP O
22 Emergency NNP I-NP O
22 Department NNP I-NP O
22 , , O O
22 he PRP O O
22 was VBD B-VP O
22 found VBN O O
22 to TO O O
22 be VB O O
23 saturating VBG O O
23 91% CD O O
23 on IN B-VP O
23 room NN B-NP O
23 air NN I-NP O
23 and CC O O
23 99% CD O O
23 on IN B-VP O
23 a DT O O
23 nonrebreather DT O O
23 An DT B-NP O
23 ABG NNP I-NP O
24 showed VBD B-VP O
24 a DT B-NP O
24 pH NN I-NP O
24 of IN B-VP O
24 7.31 CD O O
24 and CC O O
24 a DT B-NP O
24 PCO2 NNP I-NP O
24 of IN B-VP O
24 55; CD O O
24 he PRP O O
24 was VBD B-VP O
24 tried VBN O O
24 on IN B-VP O
24 BiPAP NNP B-NP O
25 without IN B-VP O
25 improvement NN B-NP O
25 in IN B-VP O
25 either CC O O
25 PCO2 NNP B-NP O
25 or CC O O
25 PO2 NNP B-NP O
25 While IN B-VP O
25 being VBG O O
26 interviewed VBN O O
26 by IN B-VP O
26 the DT B-NP O
26 medical JJ I-NP O
26 residents NNS I-NP O
26 , , O O
26 he PRP O O
26 was VBD B-VP O
26 seen VBN O O
26 to TO O O
26 have VB O O
26 a DT B-NP O
27 30-second JJ I-NP O
27 apneic NN I-NP O
27 episode NN I-NP O
27 with IN B-VP O
27 loss NN B-NP O
27 of IN B-VP O
27 consciousness NN B-NP O
27 and CC O O
27 cyanosis; VB O O
28 his PRP$ O O
28 sensorium NN B-NP O
28 quickly RB O O
28 returned VBD B-VP O
28 after IN B-VP O
28 this DT B-NP O
28 event NN I-NP O
28 , , O O
28 although IN B-VP O
28 he PRP O O
29 retained VBD B-VP O
29 no DT B-NP O
29 memory NN I-NP O
29 of IN B-VP O
29 this DT B-NP O
29 occurrence NN I-NP O
29 He PRP O O
29 received VBD B-VP O
29 Lasix NNP B-NP B-m
29 80 CD O B-do
29 mg NN B-NP I-do
30 x1 NN I-NP B-du
30 , , O O
30 Solu-Medrol NNP B-NP B-m
30 , , O O
30 and CC O O
30 DuoNebs NNP B-NP B-m
30 in IN B-VP O
30 the DT B-NP O
30 ED NNP I-NP O
30 He PRP O O
30 was VBD B-VP O
30 admitted VBN O O
30 to TO O O
30 the DT B-NP O
31 CCU NNP I-NP O
31 initially RB O O
31 with IN B-VP O
31 CHF/apnea/sinus NNP B-NP O
31 arrest NN I-NP O
31 , , O O
31 and CC O O
31 subsequently RB O O
32 transferred VBN O O
32 to TO O O
32 the DT B-NP O
32 hospital NN I-NP O
32 floor NN I-NP O
32 when WRB O O
32 he PRP O O
32 was VBD B-VP O
32 stable JJ B-NP O
33 PAST NNP I-NP O
33 MEDICAL NNP I-NP O
33 HISTORY: NNP I-NP O
34 1 CD O O
34 Congestive NNP B-NP O
34 heart NN I-NP O
34 failure NN I-NP O
34 , , O O
34 nonischemic JJ O O
34 dilated VBD B-VP O
34 cardiomyopathy JJ O O
34 , , O O
35 8/21 CD O O
35 echo NN B-NP O
35 with IN B-VP O
35 an DT B-NP O
35 EF NNP I-NP O
35 of IN B-VP O
35 35% CD O O
35 and CC O O
35 global JJ O O
35 left VBD B-VP O
35 ventricular JJ B-NP O
36 hypokinesis; NN I-NP O
36 2/10 CD O O
36 echo NN B-NP O
36 with IN B-VP O
36 an DT B-NP O
36 EF NNP I-NP O
36 of IN B-VP O
36 55% CD O O
36 , , O O
36 without IN B-VP O
36 hypokinesis NN B-NP O
37 2 CD O O
37 Atrial NNP B-NP O
37 flutter NN I-NP O
37 , , O O
37 status NN B-NP O
37 post NN I-NP O
37 ablation NN I-NP O
37 ( ( O O
37 2003 CD O O
37 ) ) O O
38 3 CD O O
38 Atrial JJ B-NP O
38 fibrillation NN I-NP O
39 4 CD O O
39 Hyperostosis NNP B-NP O
39 frontalis VBD B-VP O
40 5 CD O O
40 Complex NNP B-NP O
40 renal JJ B-NP O
40 cyst NN I-NP O
40 versus NN I-NP O
40 angiomyolipoma NN I-NP O
40 , , O O
40 resected VBD B-VP O
40 via IN B-VP O
41 laparoscopy NN B-NP O
41 in IN B-VP O
41 6/9 CD O O
42 6 CD O O
42 Morbid NNP B-NP O
42 obesity NN I-NP O
42 with IN B-VP O
42 obesity NN B-NP O
42 hypoventilation NN I-NP O
42 syndrome VBD B-VP O
43 7 CD O O
43 Obstructive JJ B-NP O
43 sleep NN I-NP O
43 apnea NN I-NP O
44 8 CD O O
44 Chronic NNP B-NP O
44 renal JJ B-NP O
44 insufficiency NN I-NP O
44 ( ( O O
44 baseline JJ B-NP O
44 creatinine NN I-NP O
44 2 CD O O
44 ) ) O O
45 MEDICATIONS: NNP B-NP O
46 1 CD O O
46 Allopurinol NNP B-NP B-m
47 2 CD O O
47 Iron NNP B-NP B-m
48 3 CD O O
48 Lisinopril NNP B-NP B-m
49 4 CD O O
49 Toprol-XL NNP B-NP B-m
50 5 CD O O
50 Coumadin NNP B-NP B-m
50 ( ( O O
50 discontinued VBN O O
50 on IN B-VP O
50 2/4/05 CD O O
50 ) ) O O
51 6 CD O O
51 Albuterol NNP B-NP B-m
51 inhaler NN I-NP I-m
51 p.r.n NN I-NP B-f
52 7 CD O O
52 Aspirin NNP B-NP B-m
53 8 CD O O
53 Flomax NNP B-NP B-m
54 9 CD O O
54 Hytrin NNP B-NP B-m
55 SOCIAL NNP I-NP O
55 HISTORY: NNP I-NP O
56 The DT B-NP O
56 patient NN I-NP O
56 lives VBZ O O
56 alone RB O O
56 at IN B-VP O
56 Rys NNP B-NP O
56 Ville NNP I-NP O
56 Santster NNP I-NP O
56 He PRP O O
56 is VBZ O O
56 a DT B-NP O
56 retired JJ I-NP O
56 Burg NNP I-NP O
56 Bovalle NNP I-NP O
56 Ge NNP I-NP O
57 employee NN I-NP O
57 He PRP O O
57 is VBZ O O
57 an DT B-NP O
57 ex-smoker NN I-NP O
57 , , O O
57 quit NN B-NP O
57 in IN B-VP O
57 the DT B-NP O
57 1960s NNS I-NP O
57 He PRP O O
57 is VBZ O O
57 a DT B-NP O
57 heavy JJ I-NP O
58 drinker NN I-NP O
58 in IN B-VP O
58 his PRP$ O O
58 20s CD O O
58 , , O O
58 but CC O O
58 now RB O O
58 he PRP O O
58 rarely RB O O
58 drinks VBZ O O
58 alcohol NN B-NP O
59 FAMILY NNP I-NP O
59 HISTORY: NNP I-NP O
60 Gastric NNP I-NP O
60 cancer NN I-NP O
60 in IN B-VP O
60 his PRP$ O O
60 father NN B-NP O
61 ADMISSION NNP I-NP O
61 PHYSICAL NNP I-NP O
61 EXAMINATION: NNP I-NP O
62 Temperature NNP I-NP O
62 of IN B-VP O
62 96 CD O O
62 , , O O
62 pulse NN B-NP O
62 of IN B-VP O
62 53 CD O O
62 , , O O
62 blood NN B-NP O
62 pressure NN I-NP O
62 of IN B-VP O
62 125/65 CD O O
62 , , O O
62 and CC O O
63 saturating VBG O O
63 94% CD O O
63 on IN B-VP O
63 2 CD O O
63 liters NNS B-NP O
63 by IN B-VP O
63 nasal JJ B-NP O
63 cannula NN I-NP O
63 In IN B-VP O
63 general JJ O O
63 , , O O
63 alert JJ O O
64 and CC O O
64 oriented VBN O O
64 , , O O
64 in IN B-VP O
64 no DT B-NP O
64 acute NN I-NP O
64 distress NN I-NP O
64 HEENT: NNP I-NP O
64 Pupils NNP I-NP O
64 are VBP O O
64 equally RB O O
65 round JJ O O
65 and CC O O
65 reactive JJ O O
65 to TO O O
65 light JJ O O
65 , , O O
65 sclerae EX O O
65 are VBP O O
65 anicteric JJ O O
65 , , O O
65 moist JJ B-NP O
65 mucous JJ I-NP O
66 membranes NNS I-NP O
66 Cardiovascular NNP I-NP O
66 exam: VBD B-VP O
66 Regular JJ B-NP O
66 rate NN I-NP O
66 and CC O O
66 rhythm NN B-NP O
66 , , O O
66 normal JJ B-NP O
67 S1 NNP I-NP O
67 and CC O O
67 S2 NNP B-NP O
67 , , O O
67 although IN B-VP O
67 JVP NNP B-NP O
67 difficult JJ O O
67 to TO O O
67 assess VB O O
67 due JJ O O
67 to TO O O
67 body NN B-NP O
67 habitus NN I-NP O
68 Lung NNP I-NP O
68 exam: VBD B-VP O
68 Clear JJ O O
68 to TO O O
68 auscultation VB O O
68 bilaterally RB O O
68 , , O O
68 no DT B-NP O
68 wheezes NN I-NP O
68 or CC O O
69 crackles NNS B-NP O
69 Abdomen: NNP I-NP O
69 Obese NNP I-NP O
69 , , O O
69 soft JJ O O
69 and CC O O
69 nontender JJ O O
69 , , O O
69 normal JJ B-NP O
69 abdominal JJ I-NP O
70 bowel NN I-NP O
70 sounds VBZ O O
70 Extremities: NNP B-NP O
70 2+ CD O O
70 edema NN B-NP O
71 LABORATORY NNP I-NP O
71 STUDIES NNP I-NP O
71 ON NNP I-NP O
71 ADMISSION: NNP I-NP O
72 Notable NNP I-NP O
72 for IN B-VP O
72 creatinine NN B-NP O
72 of IN B-VP O
72 2.3 CD O O
72 ( ( O O
72 at IN B-VP O
72 baseline NN B-NP O
72 ) ) O O
72 , , O O
72 BNP NNP B-NP O
72 of IN B-VP O
72 500 CD O O
72 His PRP$ O O
73 admission NN B-NP O
73 EKG: NNP I-NP O
73 Sinus NNP I-NP O
73 rhythm NN I-NP O
73 with IN B-VP O
73 occasional JJ B-NP O
73 bradycardia NN I-NP O
73 to TO O O
73 the DT O O
74 40s CD O O
74 , , O O
74 no DT B-NP O
74 ST NNP I-NP O
74 changes NNS I-NP O
75 SUMMARY NNP I-NP O
75 OF IN B-VP O
75 THE NNP B-NP O
75 HOSPITAL NNP I-NP O
75 COURSE NNP I-NP O
75 BY NNP I-NP O
75 ISSUE: NNP I-NP O
76 Assessment NNP I-NP O
76 and CC O O
76 Plan: NNP B-NP O
76 A NNP I-NP O
76 71-year-old JJ B-NP O
76 female NN I-NP O
76 with IN B-VP O
76 a DT B-NP O
76 history NN I-NP O
76 of IN B-VP O
77 obesity NN B-NP O
77 hypoventilation NN I-NP O
77 syndrome NN I-NP O
77 , , O O
77 restrictive JJ B-NP O
77 lung NN I-NP O
77 disease NN I-NP O
77 , , O O
78 diabetes VBZ O O
78 , , O O
78 nonischemic JJ O O
78 dilated VBD B-VP O
78 cardiomyopathy JJ O O
78 with IN B-VP O
78 a DT B-NP O
78 preserved JJ I-NP O
78 EF NNP I-NP O
78 , , O O
79 who WP O O
79 was VBD B-VP O
79 admitted VBN O O
79 for IN B-VP O
79 congestive JJ B-NP O
79 heart NN I-NP O
79 failure NN I-NP O
79 , , O O
79 sinus NN B-NP O
79 arrest NN I-NP O
79 , , O O
80 ultimately RB O O
80 treated VBN O O
80 with IN B-VP O
80 diuresis NN B-NP O
80 and CC O O
80 a DT B-NP O
80 pacemaker NN I-NP O
80 placement NN I-NP O
81 1 CD O O
81 Cardiovascular: NNP B-NP O
81 Ischemia: NNP I-NP O
81 No NNP I-NP O
81 active JJ B-NP O
81 issues NNS I-NP O
81 during IN B-VP O
81 this DT B-NP O
82 hospitalization NN I-NP O
82 Pump: NNP I-NP O
82 The DT B-NP O
82 patient NN I-NP O
82 had VBD B-VP O
82 a DT B-NP O
82 history NN I-NP O
82 nonischemic JJ O O
83 dilated VBD B-VP O
83 cardiomyopathy JJ O O
83 with IN B-VP O
83 a DT B-NP O
83 preserved JJ I-NP O
83 EF NNP I-NP O
83 , , O O
83 ( ( O O
83 an DT B-NP O
83 echo NN I-NP O
83 during IN B-VP O
83 this DT B-NP O
84 hospitalization NN I-NP O
84 revealed VBD B-VP O
84 an DT B-NP O
84 EF NNP I-NP O
84 of IN B-VP O
84 55% CD O O
84 without IN B-VP O
84 hypokinesis NN B-NP O
84 , , O O
85 although IN B-VP O
85 prior JJ B-NP O
85 echo NN I-NP O
85 in IN B-VP O
85 2003 CD O O
85 showed VBD B-VP O
85 an DT B-NP O
85 EF NNP I-NP O
85 of IN B-VP O
85 35% CD O O
85 with IN B-VP O
85 global JJ O O
85 left VBD B-VP O
86 ventricular JJ B-NP O
86 hypokinesis NN I-NP O
86 ) ) O O
86 On IN B-VP O
86 admission NN B-NP O
86 , , O O
86 the DT B-NP O
86 patient NN I-NP O
86 had VBD B-VP O
86 signs NNS B-NP O
87 and CC O O
87 symptoms NNS B-NP O
87 of IN B-VP O
87 volume NN B-NP O
87 overload NN I-NP O
87 in IN B-VP O
87 a DT B-NP O
87 setting NN I-NP O
87 of IN B-VP O
87 having VBG O O
87 not RB O O
87 taken VBN O O
88 his PRP$ O O
88 Lasix NNP B-NP B-m
88 for IN B-VP B-du
88 about RB O I-du
88 a DT B-NP I-du
88 week NN I-NP I-du
88 He PRP O O
88 was VBD B-VP O
88 admitted VBN O O
88 initially RB O O
88 to TO O O
88 the DT B-NP O
89 CCU NNP I-NP O
89 , , O O
89 and CC O O
89 subsequently RB O O
89 transferred VBN O O
89 to TO O O
89 the DT B-NP O
89 floor NN I-NP O
89 , , O O
89 with IN B-VP O
89 aggressive JJ B-NP O
90 diuresis NN I-NP O
90 of IN B-VP O
90 approximately RB O O
90 10 CD O O
90 kg NNS B-NP O
90 since IN B-VP O
90 admission NN B-NP O
90 ( ( O O
90 including VBG O O
91 diuresis NN B-NP O
91 with IN B-VP O
91 ultrafiltration NN B-NP O
91 in IN B-VP O
91 the DT B-NP O
91 CCU NNP I-NP O
91 ) ) O O
91 Following VBG O O
91 transfer NN B-NP O
91 to TO O O
92 the DT B-NP O
92 floor NN I-NP O
92 , , O O
92 he PRP O O
92 was VBD B-VP O
92 switched VBN O O
92 to TO O O
92 Lasix NNP B-NP B-m
92 diuresis NN I-NP B-r
92 , , O O
92 which WDT O O
92 was VBD B-VP O
92 titrated VBN O O
93 down RB O O
93 gradually RB O O
93 to TO O O
93 40 CD O B-do
93 mg NNS B-NP I-do
93 daily RB O B-f
93 , , O O
93 ( ( O O
93 cautioned VBN O O
93 with IN B-VP O
93 administration NN B-NP O
94 giving VBG O O
94 a DT B-NP O
94 rise NN I-NP O
94 in IN B-VP O
94 creatinine NN B-NP O
94 ) ) O O
94 The DT B-NP O
94 patient NN I-NP O
94 was VBD B-VP O
94 also RB O O
94 maintained VBN O O
94 on IN B-VP O
95 captopril NN B-NP B-m
95 , , O O
95 which WDT O O
95 was VBD B-VP O
95 up RB O O
95 titrated VBN O O
95 to TO O O
95 25 CD O B-do
95 mg NNS B-NP I-do
95 t.i.d NN I-NP B-f
95 ( ( O O
95 held VBN O O
95 at IN B-VP O
95 one CD O O
96 point NN B-NP O
96 due JJ O O
96 to TO O O
96 the DT B-NP O
96 rise NN I-NP O
96 in IN B-VP O
96 the DT B-NP O
96 creatinine NN I-NP O
96 ) ) O O
96 The DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 also RB O O
97 titrated VBN O O
97 up RP O O
97 on IN B-VP O
97 metoprolol NNS B-NP B-m
97 to TO O O
97 25 CD O B-do
97 mg NNS B-NP I-do
97 b.i.d JJ B-NP B-f
97 Rhythm: NNP I-NP O
97 The DT B-NP O
97 patient NN I-NP O
98 was VBD B-VP O
98 followed VBN O O
98 by IN B-VP O
98 the DT B-NP O
98 Electrophysiology NNP I-NP O
98 Service NNP I-NP O
98 In IN B-VP O
98 the DT B-NP O
98 CCU NNP I-NP O
98 , , O O
98 he PRP O O
99 was VBD B-VP O
99 noted VBN O O
99 to TO O O
99 have VB O O
99 sinus VBN O O
99 arrest NN B-NP O
99 of IN B-VP O
99 8-9 JJ B-NP O
99 seconds NNS I-NP O
99 in IN B-VP O
99 the DT B-NP O
99 setting NN I-NP O
99 of IN B-VP O
100 apnea NN B-NP O
100 Following VBG O O
100 transfer NN B-NP O
100 to TO O O
100 the DT B-NP O
100 floor NN I-NP O
100 , , O O
100 he PRP O O
100 was VBD B-VP O
100 noted VBN O O
100 to TO O O
100 have VB O O
101 sinus VBN O O
101 arrest NN B-NP O
101 of IN B-VP O
101 4 CD O O
101 seconds NNS B-NP O
101 , , O O
101 again RB O O
101 in IN B-VP O
101 the DT B-NP O
101 setting NN I-NP O
101 of IN B-VP O
101 apnea NN B-NP O
101 His PRP$ O O
102 last JJ B-NP O
102 such JJ I-NP O
102 episode NN I-NP O
102 was VBD B-VP O
102 on IN B-VP O
102 3/29/05 CD O O
102 In IN B-VP O
102 addition NN B-NP O
102 , , O O
102 the DT B-NP O
102 patient NN I-NP O
102 has VBZ O O
103 history NN B-NP O
103 of IN B-VP O
103 atrial JJ B-NP O
103 fibrillation/flutter NN I-NP O
103 , , O O
103 status NN B-NP O
103 post NN I-NP O
103 ablation NN I-NP O
103 On IN B-VP O
104 0/5/05 CD O O
104 , , O O
104 he PRP O O
104 underwent JJ B-NP O
104 pacemaker NN I-NP O
104 placement NN I-NP O
104 through IN B-VP O
104 cephalic JJ B-NP O
105 veins NNS I-NP O
105 , , O O
105 which WDT O O
105 he PRP O O
105 tolerated VBD B-VP O
105 well RB O O
106 2 CD O O
106 Pulmonary: NNP B-NP O
106 The DT B-NP O
106 patient NN I-NP O
106 , , O O
106 as IN B-VP O
106 noted VBN O O
106 above IN B-VP O
106 , , O O
106 had VBD B-VP O
106 several JJ B-NP O
106 episodes NNS I-NP O
107 of IN B-VP O
107 apnea NN B-NP O
107 , , O O
107 some DT O O
107 of IN B-VP O
107 which WDT O O
107 were VBD B-VP O
107 associated VBN O O
107 with IN B-VP O
107 sinus JJ B-NP O
107 arrest NN I-NP O
108 Following VBG O O
108 diuresis NN B-NP O
108 , , O O
108 the DT B-NP O
108 patient's NN I-NP O
108 apnea NN I-NP O
108 episodes VBZ O O
108 improved VBD B-VP O
108 He PRP O O
109 was VBD B-VP O
109 recommended VBN O O
109 for IN B-VP O
109 formal JJ B-NP O
109 sleep NN I-NP O
109 study NN I-NP O
109 as IN B-VP O
109 an DT O O
109 outpatient JJ O O
110 3 CD O O
110 Renal: NNP B-NP O
110 The DT B-NP O
110 patient NN I-NP O
110 was VBD B-VP O
110 admitted VBN O O
110 with IN B-VP O
110 a DT B-NP O
110 creatinine NN I-NP O
110 roughly RB O O
111 around IN B-VP O
111 baseline NN B-NP O
111 ( ( O O
111 2 CD O O
111 ) ) O O
111 , , O O
111 which WDT O O
111 rose VBD B-VP O
111 briskly NNS B-NP O
111 during IN B-VP O
111 his PRP$ O O
112 hospitalization NN B-NP O
112 to TO O O
112 a DT B-NP O
112 peak NN I-NP O
112 of IN B-VP O
112 3.2 CD O O
112 on IN B-VP O
112 0/5/05 CD O O
112 His PRP$ O O
112 FENa NN B-NP O
112 on IN B-VP O
113 admission NN B-NP O
113 was VBD B-VP O
113 6-8%; JJ O O
113 a DT B-NP O
113 repeat NN I-NP O
113 FENa NNP I-NP O
113 in IN B-VP O
113 the DT B-NP O
113 setting NN I-NP O
113 of IN B-VP O
113 his PRP$ O O
113 peak NN B-NP O
114 serum NN I-NP O
114 creatinine NN I-NP O
114 of IN B-VP O
114 3.2 CD O O
114 and CC O O
114 following VBG O O
114 10 CD O O
114 kg NNS B-NP O
114 of IN B-VP O
114 diuresis NN B-NP O
114 was VBD B-VP O
115 1.86% CD O O
115 His PRP$ O O
115 urine NN B-NP O
115 eosinophils NNS I-NP O
115 were VBD B-VP O
115 negative JJ O O
115 His PRP$ O O
115 UA NN B-NP O
115 showed VBD B-VP O
116 evidence NN B-NP O
116 of IN B-VP O
116 a DT B-NP O
116 UTI NNP I-NP O
116 plus CC O O
116 triple JJ B-NP O
116 phosphate NN I-NP O
116 crystals; NN I-NP O
116 urine JJ B-NP O
116 culture NN I-NP O
117 showed VBD B-VP O
117 greater JJR O O
117 than IN B-VP O
117 100 CD O O
117 , , O O
117 000 CD O O
117 colonies NNS B-NP O
117 of IN B-VP O
117 mixed JJ B-NP O
117 morphology NN I-NP O
117 It PRP O O
117 was VBD B-VP O
118 thought VBN O O
118 that IN B-VP O
118 the DT B-NP O
118 rise NN I-NP O
118 in IN B-VP O
118 the DT B-NP O
118 patient's NN I-NP O
118 creatinine NN I-NP O
118 was VBD B-VP O
118 likely JJ O O
118 due JJ O O
119 to TO O O
119 a DT B-NP O
119 combination NN I-NP O
119 of IN B-VP O
119 intravascular JJ B-NP O
119 depletion NN I-NP O
119 and CC O O
119 possibly RB O O
119 UTI NNP B-NP O
120 The DT B-NP O
120 patient NN I-NP O
120 was VBD B-VP O
120 started VBN O O
120 on IN B-VP O
120 antibiotics NNS B-NP B-m
120 following VBG O O
120 his PRP$ O O
120 pacemaker NN B-NP O
121 placement NN I-NP O
121 , , O O
121 which WDT O O
121 would MD O O
121 be VB O O
121 expected VBN O O
121 to TO O O
121 cover VB O O
121 GU NNP B-NP O
121 microbial JJ B-NP O
121 flora NNS I-NP O
122 and CC O O
122 SNHU NNP B-NP O
122 microbes VBD B-VP O
123 4 CD O O
123 Endocrine: NNP B-NP O
123 The DT B-NP O
123 patient NN I-NP O
123 had VBD B-VP O
123 a DT B-NP O
123 history NN I-NP O
123 of IN B-VP O
123 diabetes NNS B-NP B-r
123 and CC O O
123 was VBD B-VP O
124 maintained VBN O O
124 on IN B-VP O
124 a DT B-NP O
124 Regular JJ I-NP B-m
124 Insulin NNP I-NP I-m
124 sliding VBG O B-do
124 scale JJ O I-do
125 5 CD O O
125 ID: NNP B-NP O
125 The DT B-NP O
125 patient NN I-NP O
125 was VBD B-VP O
125 expected VBN O O
125 to TO O O
125 having VBG O O
125 an DT B-NP O
125 UTI NNP I-NP O
125 as IN B-VP O
125 noted VBN O O
126 above IN B-VP O
126 Following VBG O O
126 his PRP$ O O
126 pacemaker NN B-NP O
126 placement NN I-NP O
126 , , O O
126 he PRP O O
126 was VBD B-VP O
126 placed VBN O O
126 on IN B-VP O
127 cefazolin NN B-NP B-m
127 while IN B-VP B-du
127 in-house NN B-NP I-du
127 , , O O
127 followed VBN O O
127 by IN B-VP O
127 Keflex NNP B-NP B-m
127 The DT B-NP O
127 patient NN I-NP O
127 should MD O O
128 stay VB O O
128 on IN B-VP O
128 Keflex NNP B-NP B-m
128 for IN B-VP B-du
128 four CD O I-du
128 days NNS B-NP I-du
129 DISCHARGE NNP I-NP O
129 MEDICATIONS: NNP I-NP O
130 1 CD O O
130 Albuterol NNP B-NP B-m
130 inhaler NN I-NP I-m
130 two CD O B-do
130 puffs NNS B-NP I-do
130 inhaled VBD B-VP B-mo
130 q.i.d JJ B-NP B-f
130 p.r.n NN I-NP I-f
130 wheezing VBG O B-r
131 2 CD O O
131 Allopurinol NNP B-NP B-m
131 100 CD O B-do
131 mg NN B-NP I-do
131 p.o JJ O B-mo
131 daily JJ O B-f
132 3 CD O O
132 Captopril NNP B-NP B-m
132 25 CD O B-do
132 mg NN B-NP I-do
132 p.o NN I-NP B-mo
132 t.i.d VBD B-VP B-f
133 4 CD O O
133 Colace NNP B-NP B-m
133 100 CD O B-do
133 mg NN B-NP I-do
133 p.o NN I-NP B-mo
133 b.i.d VBD B-VP B-f
134 5 CD O O
134 Ferrous NNP B-NP B-m
134 sulfate NN I-NP I-m
134 325 CD O B-do
134 mg NN B-NP I-do
134 p.o JJ O B-mo
134 daily JJ O B-f
135 6 CD O O
135 Lasix NNP B-NP B-m
135 40 CD O B-do
135 mg NN B-NP I-do
135 p.o JJ O B-mo
135 daily JJ O B-f
136 7 CD O O
136 Heparin NNP B-NP B-m
136 5000 CD O B-do
136 units NNS B-NP I-do
136 subcutaneous JJ O B-mo
136 t.i.d JJ O B-f
137 8 CD O O
137 Regular JJ B-NP B-m
137 Insulin NNP I-NP I-m
137 sliding VBG O B-do
137 scale JJ B-NP I-do
137 subcutaneous JJ I-NP B-mo
137 q.a.c NN I-NP B-f
138 9 CD O O
138 Lopressor NNP B-NP B-m
138 25 CD O B-do
138 mg NN B-NP I-do
138 p.o NN I-NP B-mo
138 b.i.d VBD B-VP B-f
139 10 CD O O
139 Oxycodone NNP B-NP B-m
139 5 CD O B-do
139 mg NN B-NP I-do
139 to TO O I-do
139 10 CD O I-do
139 mg NNS B-NP I-do
139 p.o JJ B-NP B-mo
139 q.6h JJ I-NP B-f
139 p.r.n NN I-NP I-f
140 11 CD O O
140 Keflex NNP B-NP B-m
140 250 CD O B-do
140 mg NN B-NP I-do
140 p.o NN I-NP B-mo
140 q.i.d NN I-NP B-f
140 x12 NN I-NP B-du
140 doses NNS I-NP I-du
140 , , O O
140 starting VBG O O
140 on IN B-VP O
140 7/7/05 CD O O
141 12 CD O O
141 Flomax NNP B-NP B-m
141 0.4 CD O B-do
141 mg NN B-NP I-do
141 p.o JJ O B-mo
141 daily JJ O B-f
142 13 CD O O
142 Nexium NN B-NP B-m
142 20 CD O B-do
142 mg NN B-NP I-do
142 p.o JJ B-NP B-mo
142 daily JJ I-NP B-f
143 eScription NN I-NP O
143 document: VBZ O O
143 4-8315924 JJ B-NP O
143 EMSFocus NNP I-NP O
143 transcriptionists NNS I-NP O
144 Dictated VBD B-VP O
144 By: NNP B-NP O
144 DUBIEL NNP I-NP O
144 , , O O
144 SCOT NNP B-NP O
145 Attending: NNP I-NP O
145 MCGARITY NNP I-NP O
145 , , O O
145 LINCOLN NNP B-NP O
146 Dictation NNP I-NP O
146 ID NNP I-NP O
146 5034522 CD O O
147 D: NNP B-NP O
147 7/7/05 CD O O
148 T: NNP B-NP O
148 7/7/05 CD O O
149 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #573300 VBZ O O
2 219990133 CD O O
2 MHAMC NNP B-NP O
2 03057354 CD O O
2 9559708 CD O O
2 3/24/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 AORTIC NNP I-NP O
2 STENOSIS NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 8/17/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/23/2006 CD O O
4 ATTENDING: NNP B-NP O
4 FAVORITE NNP I-NP O
4 , , O O
4 HIPOLITO NNP B-NP O
4 MD NNP I-NP O
5 SERVICE: NNP I-NP O
6 Cardiac NNP I-NP O
6 Surgery NNP I-NP O
6 Service NNP I-NP O
7 DISPOSITION: NNP I-NP O
8 To TO O O
8 rehabilitation VB O O
9 PRINCIPAL NNP B-NP O
9 DISCHARGE NNP I-NP O
9 DIAGNOSIS: NNP I-NP O
10 Status NNP I-NP O
10 post NN I-NP O
10 AVR NNP I-NP O
10 with IN B-VP O
10 a DT O O
10 25 CD O O
10 CE NNP B-NP O
10 Magna NNP I-NP O
10 valve NN I-NP O
10 and CC O O
10 CABG NNP B-NP O
10 x2/LIMA NNP I-NP O
11 OTHER NNP I-NP O
11 DIAGNOSES: NNP I-NP O
12 Diabetes NNP I-NP O
12 mellitus NNP I-NP O
12 type NN I-NP O
12 II NNP I-NP O
12 , , O O
12 hypercholesterolemia NN B-NP O
12 , , O O
12 arthritis NN B-NP O
12 , , O O
12 and CC O O
13 increasing VBG O O
13 forgetfulness JJ B-NP O
14 HISTORY NNP I-NP O
14 OF NNP I-NP O
14 PRESENT NNP I-NP O
14 ILLNESS: NNP I-NP O
15 Mr NNP I-NP O
15 Esbenshade NNP I-NP O
15 is VBZ O O
15 a DT B-NP O
15 70-year-old JJ I-NP O
15 Caucasian JJ I-NP O
15 male NN I-NP O
15 with IN B-VP O
15 CAD NNP B-NP O
15 , , O O
15 stented VBD B-VP O
15 five CD O O
16 years NNS B-NP O
16 ago RB O O
16 , , O O
16 known VBN O O
16 as IN B-VP O
16 calcific JJ B-NP O
16 aortic JJ I-NP O
16 stenosis NN I-NP O
16 with IN B-VP O
16 progression NN B-NP O
16 of IN B-VP O
17 exertional JJ B-NP O
17 dyspnea NN I-NP O
17 He PRP O O
17 has VBZ O O
17 chronic JJ B-NP O
17 atrial JJ I-NP O
17 fibrillation NN I-NP O
17 He PRP O O
17 is VBZ O O
18 planned VBN O O
18 for IN B-VP O
18 catheter NN B-NP O
18 in IN B-VP O
18 the DT B-NP O
18 morning NN I-NP O
18 , , O O
18 AVR NNP B-NP O
18 and CC O O
18 possible JJ B-NP O
18 CABG NNP I-NP O
19 PREOPERATIVE NNP I-NP O
19 CARDIAC NNP I-NP O
19 STATUS: NNP I-NP O
20 Elective NNP I-NP O
20 The DT B-NP O
20 patient NN I-NP O
20 presented VBN O O
20 with IN B-VP O
20 critical JJ B-NP O
20 coronary JJ I-NP O
21 anatomy/valve NN I-NP O
21 dysfunction NN I-NP O
21 The DT B-NP O
21 patient NN I-NP O
21 has VBZ O O
21 a DT B-NP O
21 history NN I-NP O
21 of IN B-VP O
21 class NN B-NP O
21 II NNP I-NP O
22 angina NN I-NP O
22 There EX O O
22 has VBZ O O
22 been VBN O O
22 no DT B-NP O
22 recent JJ I-NP O
22 angina NN I-NP O
22 There EX O O
22 is VBZ O O
22 history NN B-NP O
22 of IN B-VP O
23 class NN B-NP O
23 III NNP I-NP O
23 heart NN I-NP O
23 failure NN I-NP O
23 The DT B-NP O
23 patient NN I-NP O
23 is VBZ O O
23 in IN B-VP O
23 atrial JJ B-NP O
23 fibrillation NN I-NP O
24 The DT B-NP O
24 patient NN I-NP O
24 has VBZ O O
24 history NN B-NP O
24 of IN B-VP O
24 Afib/flutter NNP B-NP B-r
24 treated VBD B-VP O
24 with IN B-VP O
25 drugs/beta-blocker NN B-NP B-m
26 PREVIOUS NNP I-NP O
26 CARDIOVASCULAR NNP I-NP O
26 INTERVENTIONS: NNP I-NP O
27 PTCA/atherectomy NNP I-NP O
27 in IN B-VP O
27 1996 CD O O
27 and CC O O
27 1997 CD O O
27 Stent NN B-NP O
27 in IN B-VP O
27 1996 CD O O
27 and CC O O
27 1997 CD O O
28 PAST NNP B-NP O
28 SURGICAL NNP I-NP O
28 HISTORY: NNP I-NP O
29 Right NNP I-NP O
29 ACL NNP I-NP O
29 repair NN I-NP O
29 , , O O
29 appendectomy NN B-NP O
29 , , O O
29 benign JJ B-NP O
29 breast NN I-NP O
29 mass NN I-NP O
29 excision NN I-NP O
29 in IN B-VP O
30 the DT B-NP O
30 right JJ I-NP O
30 side NN I-NP O
31 FAMILY NNP I-NP O
31 HISTORY: NNP I-NP O
32 No NNP I-NP O
32 family NN I-NP O
32 history NN I-NP O
32 of IN B-VP O
32 CAD NNP B-NP O
33 SOCIAL NNP I-NP O
33 HISTORY: NNP I-NP O
34 History NNP I-NP O
34 of IN B-VP O
34 tobacco NN B-NP O
34 150-pack-year JJ B-NP O
34 cigarette NN I-NP O
34 smoking VBG O O
34 history NN B-NP O
35 ALLERGIES: NNP I-NP O
36 No NNP I-NP O
36 known VBN O O
36 drug NN B-NP O
36 allergies NNS I-NP O
37 PREOP NNP I-NP O
37 MEDICATIONS: NNP I-NP O
38 Toprol NNP I-NP B-m
38 Toprol NNP I-NP B-m
38 50 CD O B-do
38 mg NN B-NP I-do
38 q.a.m NN I-NP B-f
38 and CC O O
38 25 CD O B-do
38 mg NN B-NP I-do
38 q.p.m NN I-NP B-f
38 , , O O
38 Coumadin NNP B-NP B-m
38 , , O O
38 Lasix NNP B-NP B-m
38 20 CD O B-do
38 mg JJ O I-do
39 daily RB O B-f
39 , , O O
39 atorvastatin VBD B-VP B-m
39 20 CD O B-do
39 mg JJ O I-do
39 daily RB O B-f
39 , , O O
39 Neurontin NNP B-NP B-m
39 100 CD O B-do
39 mg NN B-NP I-do
39 t.i.d NN I-NP B-f
39 , , O O
40 metformin NN B-NP B-m
40 1000 CD O B-do
40 mg NN B-NP I-do
40 b.i.d NN I-NP B-f
40 , , O O
40 and CC O O
40 glipizide RB O B-m
40 2.5 CD O B-do
40 mg NNS B-NP I-do
40 b.i.d JJ B-NP B-f
41 PHYSICAL NNP I-NP O
41 EXAMINATION: NNP I-NP O
42 Height NNP I-NP O
42 and CC O O
42 weight VBD B-VP O
42 5 CD O O
42 feet NNS B-NP O
42 10 CD O O
42 inches NNS B-NP O
42 , , O O
42 108 CD O O
42 kilos NN B-NP O
42 Vital NNP I-NP O
42 Signs: NNP I-NP O
43 Temperature NNP I-NP O
43 96.4 CD O O
43 , , O O
43 heart NN B-NP O
43 rate NN I-NP O
43 75 CD O O
43 , , O O
43 BP NNP B-NP O
43 right VBD B-VP O
43 arm NN B-NP O
43 127/62 CD O O
43 , , O O
43 left VBD B-VP O
43 arm NN B-NP O
44 110/75 CD O O
44 , , O O
44 oxygen NN B-NP O
44 saturation NN I-NP O
44 97% CD O O
44 on IN B-VP O
44 room NN B-NP O
44 air NN I-NP O
44 HEENT: NNP I-NP O
45 PERRLA/dentition NNP I-NP O
45 without IN B-VP O
45 evidence NN B-NP O
45 of IN B-VP O
45 infection/no JJ B-NP O
45 carotid NN I-NP O
46 bruits/edentulous JJ B-NP O
46 Chest: NNP I-NP O
46 No NNP I-NP O
46 incisions NNS I-NP O
46 Cardiovascular: NNP I-NP O
47 Regular NNP I-NP O
47 rhythm NN I-NP O
47 and CC O O
47 systolic JJ B-NP O
47 murmur NN I-NP O
47 All NNP I-NP O
47 distal JJ B-NP O
47 pulses NNS I-NP O
47 intact JJ O O
48 with IN B-VP O
48 the DT B-NP O
48 exception NN I-NP O
48 of IN B-VP O
48 the DT B-NP O
48 right NN I-NP O
48 dorsalis NN I-NP O
48 pedis NN I-NP O
48 , , O O
48 which WDT O O
48 was VBD B-VP O
48 present JJ O O
49 by IN B-VP O
49 Doppler NNP B-NP O
49 only RB O O
49 and CC O O
49 posterior JJ B-NP O
49 tibial JJ I-NP O
49 pulses NNS I-NP O
49 were VBD B-VP O
49 present JJ O O
49 by IN B-VP O
50 Doppler NNP B-NP O
50 bilaterally RB O O
50 Allen's NNP B-NP O
50 test NN I-NP O
50 left VBD B-VP O
50 upper JJ B-NP O
50 extremity NN I-NP O
50 normal JJ O O
50 , , O O
51 right JJ B-NP O
51 upper JJ I-NP O
51 extremity NN I-NP O
51 normal JJ B-NP O
51 Respiratory: NNP I-NP O
51 Breath NNP I-NP O
51 sounds VBZ O O
51 clear JJ O O
52 bilaterally RB O O
52 Abdomen: NNP B-NP O
52 No NNP I-NP O
52 incisions NNS I-NP O
52 , , O O
52 soft JJ O O
52 , , O O
52 no DT B-NP O
52 masses NNS I-NP O
53 Extremities: NNP I-NP O
53 Thread NNP I-NP O
53 veins NNS I-NP O
53 Minor NNP I-NP O
53 varicosities NNS I-NP O
53 Larger NNP I-NP O
54 varicosities NNS I-NP O
54 right RB O O
54 thigh VBP O O
54 Neuro: NNP B-NP O
54 Alert NNP I-NP O
54 and CC O O
54 oriented VBN O O
54 , , O O
54 no DT B-NP O
54 focal JJ I-NP O
55 deficits NNS I-NP O
56 PREOPERATIVE NNP I-NP O
56 LABORATORY NNP I-NP O
56 DATA: NNP I-NP O
57 Chemistries: NNP I-NP O
57 Sodium NNP I-NP O
57 138 CD O O
57 , , O O
57 potassium NN B-NP O
57 4.5 CD O O
57 , , O O
57 chloride RB O O
57 102 CD O O
57 , , O O
57 CO2 NNP B-NP O
57 of IN B-VP O
57 26 CD O O
57 , , O O
58 BUN NNP B-NP O
58 20 CD O O
58 , , O O
58 creatinine NN B-NP O
58 1 CD O O
58 , , O O
58 glucose VBD B-VP O
58 170 CD O O
58 Hematology: NNP B-NP O
58 WBC NNP I-NP O
58 8.25 CD O O
58 , , O O
59 hematocrit NN B-NP O
59 42.6 CD O O
59 , , O O
59 hemoglobin NN B-NP O
59 14.7 CD O O
59 , , O O
59 platelets NNS B-NP O
59 300 CD O O
59 , , O O
59 PT NNP B-NP O
59 18.2 CD O O
59 , , O O
59 INR NNP B-NP O
60 1.5 CD O O
60 , , O O
60 PTT NNP B-NP O
60 45.9 CD O O
60 UA NNP B-NP O
60 was VBD B-VP O
60 normal JJ B-NP O
60 Cardiac NNP I-NP O
60 catheterization NN I-NP O
60 data NNS I-NP O
60 from IN B-VP O
61 7/20/06 CD O O
61 performed VBN O O
61 at IN B-VP O
61 SH NNP B-NP O
61 showed VBD B-VP O
61 coronary JJ O O
61 anatomy RB O O
61 80% CD O O
61 proximal JJ B-NP O
62 RCA NNP I-NP O
62 stenosis NN I-NP O
62 , , O O
62 80% CD O O
62 mid NN B-NP O
62 RCA NNP I-NP O
62 , , O O
62 80% CD O O
62 distal JJ B-NP O
62 RCA NNP I-NP O
62 , , O O
62 50% CD O O
62 proximal JJ B-NP O
62 LAD NNP I-NP O
63 Echo NNP I-NP O
63 from IN B-VP O
63 10/29/05 CD O O
63 showed VBD B-VP O
63 45% CD O O
63 ejection NN B-NP O
63 fraction NN I-NP O
63 , , O O
63 aortic JJ B-NP O
63 stenosis NN I-NP O
63 , , O O
64 mean JJ B-NP O
64 gradient NN I-NP O
64 33 CD O O
64 mmHg NN B-NP O
64 , , O O
64 peak JJ B-NP O
64 gradient NN I-NP O
64 51 CD O O
64 , , O O
64 and CC O O
64 calculated VBD B-VP O
64 valve NNS B-NP O
65 area NN I-NP O
65 1 CD O O
65 cm2 NN B-NP O
65 , , O O
65 mild JJ B-NP O
65 aortic JJ I-NP O
65 insufficiency NN I-NP O
65 , , O O
65 moderate JJ B-NP O
65 mitral JJ I-NP O
66 insufficiency NN I-NP O
66 , , O O
66 trivial JJ B-NP O
66 tricuspid JJ I-NP O
66 insufficiency NN I-NP O
66 , , O O
66 aortic JJ B-NP O
66 root NN I-NP O
66 4.4 CD O O
67 cm NN B-NP O
67 EKG NNP I-NP O
67 from IN B-VP O
67 9/10/06 CD O O
67 showed VBD B-VP O
67 atrial JJ B-NP O
67 fibrillation NN I-NP O
67 rate NN I-NP O
67 of IN B-VP O
67 97 CD O O
67 , , O O
68 inverted VBN O O
68 T NNP B-NP O
68 waves NNS I-NP O
68 in IN B-VP O
68 leads NNS B-NP O
68 AVR NNP I-NP O
68 Chest NNP I-NP O
68 x-ray NN I-NP O
68 from IN B-VP O
68 9/10/06 CD O O
68 was VBD B-VP O
69 normal JJ O O
69 The DT B-NP O
69 patient NN I-NP O
69 was VBD B-VP O
69 admitted VBN O O
69 to TO O O
69 CSS NNP B-NP O
69 and CC O O
69 stabilized VBN O O
69 for IN B-VP O
70 surgery NN B-NP O
71 DATE NNP I-NP O
71 OF NNP I-NP O
71 SURGERY: NNP I-NP O
72 9/13/06 CD O O
73 PREOPERATIVE NNP B-NP O
73 DIAGNOSIS: NNP I-NP O
74 CAD NNP I-NP O
74 , , O O
74 AS NNP B-NP O
74 , , O O
74 and CC O O
74 Afib NNP B-NP O
75 PROCEDURE: NNP I-NP O
76 AVR NNP I-NP O
76 with IN B-VP O
76 a DT O O
76 25 CD O O
76 CE NNP B-NP O
76 magna NN I-NP O
76 valve NN I-NP O
76 , , O O
76 CABG NNP B-NP O
76 x2 NNP I-NP O
76 with IN B-VP O
76 LIMA NNP B-NP O
76 to TO O O
76 LAD NNP B-NP O
76 and CC O O
76 SVG1 NNP B-NP O
77 to TO O O
77 PDA NNP B-NP O
77 , , O O
77 pulmonary JJ B-NP O
77 vein NN I-NP O
77 isolation NN I-NP O
77 , , O O
77 and CC O O
77 left VBD B-VP O
77 atrial JJ B-NP O
77 appendage NN I-NP O
78 resection NN I-NP O
79 BYPASS NNP I-NP O
79 TIME: NNP I-NP O
80 171 CD O O
80 minutes NNS B-NP O
81 CROSSCLAMP NNP I-NP O
81 TIME: NNP I-NP O
82 107 CD O O
82 minutes NNS B-NP O
83 ??__04:13___?? JJ B-NP O
83 antegrade/retrograde JJ I-NP O
83 cardioplegia NN I-NP O
83 Patient NNP I-NP O
83 is VBZ O O
83 in IN B-VP O
84 normal JJ B-NP O
84 sinus NN I-NP O
84 rhythm NN I-NP O
84 , , O O
84 rate NN B-NP O
84 of IN B-VP O
84 80 CD O O
84 at IN B-VP O
84 end NN B-NP O
84 of IN B-VP O
84 case NN B-NP O
84 There EX O O
84 were VBD B-VP O
84 no DT B-NP O
85 complications NNS I-NP O
85 The DT B-NP O
85 patient NN I-NP O
85 was VBD B-VP O
85 transferred VBN O O
85 to TO O O
85 the DT B-NP O
85 unit NN I-NP O
85 in IN B-VP O
85 stable JJ B-NP O
86 fashion NN I-NP O
86 with IN B-VP O
86 lines NNS B-NP O
86 and CC O O
86 tubes NNS B-NP O
86 intact JJ O O
86 10/28/06 CD O O
86 , , O O
86 postop JJ B-NP O
86 day NN I-NP O
86 1 CD O O
86 , , O O
86 the DT B-NP O
87 patient NN I-NP O
87 was VBD B-VP O
87 slow JJ O O
87 to TO O O
87 ambulate VB O O
87 Postop NNP B-NP O
87 day NN I-NP O
87 2 CD O O
87 , , O O
87 responded VBD B-VP O
87 to TO O O
87 gentle VB O O
88 diuresis NN B-NP O
88 Meds NNP I-NP O
88 changed VBD B-VP O
88 to TO O O
88 p.o VB O O
88 Postop NNP B-NP O
88 day NN I-NP O
88 3 CD O O
88 , , O O
88 chest NN B-NP O
88 tubes NNS I-NP O
88 and CC O O
89 wires NNS B-NP O
89 were VBD B-VP O
89 discontinued VBN O O
89 Somnolence NNP B-NP O
89 resolved VBD B-VP O
89 Fluid NNP B-NP O
89 overloaded VBD B-VP O
90 Loss NNP B-NP O
90 of IN B-VP O
90 secretions NNS B-NP O
90 Able NNP I-NP O
90 to TO O O
90 clear VB O O
90 up RP O O
90 Postop NNP B-NP O
90 day NN I-NP O
90 4 CD O O
90 , , O O
90 failed VBD B-VP O
91 speech NN B-NP O
91 and CC O O
91 swallow JJ B-NP O
91 Wires NNP I-NP O
91 discontinued VBN O O
91 Hemodynamically NNP B-NP O
91 stable JJ O O
92 in IN B-VP O
92 Afib NNP B-NP O
92 since IN B-VP O
92 evening VBG O O
92 Rate NNP B-NP O
92 controlled VBD B-VP O
92 Diuresing NNP B-NP O
92 well RB O O
93 Transferred NNP B-NP O
93 to TO O O
93 Step-Down NNP B-NP O
93 Unit NNP I-NP O
93 on IN B-VP O
93 postoperative JJ B-NP O
93 day NN I-NP O
93 4 CD O O
94 SUMMARY NNP B-NP O
94 BY NNP I-NP O
94 SYSTEM: NNP I-NP O
95 Neurologic: NNP I-NP O
95 Mildly NNP I-NP O
95 confused VBD B-VP O
95 immediately RB O O
95 postoperative JJ O O
95 , , O O
95 now RB O O
96 resolved VBN O O
96 , , O O
96 neurologically RB O O
96 intact JJ B-NP O
97 Cardiovascular: NNP I-NP O
97 Cardiac NNP I-NP O
97 meds: NN I-NP O
97 Aspirin NNP I-NP B-m
97 , , O O
97 Lopressor NNP B-NP B-m
97 , , O O
97 and CC O O
97 Coumadin NNP B-NP B-m
98 Hemodynamically NNP I-NP O
98 stable JJ O O
98 on IN B-VP O
98 Lopressor NNP B-NP B-m
98 , , O O
98 now RB O O
98 back RB O O
98 in IN B-VP O
98 Afib NNP B-NP O
98 , , O O
98 stable JJ B-NP O
99 rate NN I-NP O
99 of IN B-VP O
99 90s CD O O
99 , , O O
99 respiratory NN B-NP O
99 ventilated VBD B-VP O
99 greater JJR O O
99 than IN B-VP O
99 24 CD O O
99 hours NNS B-NP O
100 postoperatively RB O O
100 Extubated VBN O O
100 on IN B-VP O
100 postoperative JJ B-NP O
100 day NN I-NP O
100 1 CD O O
100 without IN B-VP O
101 complication NN B-NP O
101 Currently NNP I-NP O
101 on IN B-VP O
101 5 CD O B-do
101 liters NNS B-NP I-do
101 of IN B-VP O
101 O2 NNP B-NP B-m
101 and CC O O
101 some DT B-NP O
101 pulmonary JJ I-NP B-r
102 edema NN I-NP O
102 , , O O
102 improving VBG O O
102 with IN B-VP O
102 Lasix NNP B-NP B-m
102 20 CD O B-do
102 mg NN B-NP I-do
102 IV NNP I-NP B-mo
102 t.i.d NN I-NP B-f
102 and CC O O
102 diuresis NN B-NP O
103 GI: NNP I-NP O
103 Failed VBD B-VP O
103 speech NN B-NP O
103 and CC O O
103 swallow JJ B-NP O
103 Bedside NNP I-NP O
103 Dobhoff NNP I-NP O
103 placed VBD B-VP O
103 Started NNP B-NP O
104 on IN B-VP O
104 Osmolite NNP B-NP B-m
104 tube NN I-NP B-mo
104 feeds NNS I-NP I-mo
104 at IN B-VP O
104 20 CD O B-do
104 mL FW O I-do
104 an DT B-NP B-f
104 hour NN I-NP I-f
104 Awaiting VBG O O
104 nutrition NN B-NP O
105 input NN I-NP O
105 for IN B-VP O
105 goals NNS B-NP O
105 Needs NNP I-NP O
105 video NN I-NP O
105 swallow NN I-NP O
105 to TO O O
105 assess VB O O
105 swallow JJ B-NP O
105 function NN I-NP O
106 Renal: NNP I-NP O
106 Appropriately NNP I-NP O
106 diuresing NN I-NP O
106 , , O O
106 maintaining VBG O O
106 1.5 CD O O
106 liters NNS B-NP O
106 negative JJ O O
107 until IN B-VP O
107 preop JJ B-NP O
107 weight NN I-NP O
108 Endocrine: NNP I-NP O
108 Stable NNP I-NP O
108 on IN B-VP O
108 CVI NNP B-NP O
108 Hematology: NNP I-NP O
108 Anticoagulation NNP I-NP O
109 Coumadin NNP I-NP B-m
109 and CC O O
109 aspirin NN B-NP B-m
109 for IN B-VP O
109 atrial JJ B-NP B-r
109 atrial JJ I-NP B-r
109 fibrillation NN I-NP I-r
109 fibrillation NN I-NP I-r
110 ID: NNP I-NP O
110 No NNP I-NP O
110 issues NNS I-NP O
110 Prophylactic NNP I-NP O
110 antibiotics NNS I-NP B-m
110 for IN B-VP O
110 chest JJS B-NP B-r
110 tubes NNS I-NP I-r
110 In IN B-VP O
111 step-down JJ B-NP O
111 unit NN I-NP O
111 proceeded VBD B-VP O
111 to TO O O
111 progress VB O O
111 well RB O O
111 Postop NNP B-NP O
111 day NN I-NP O
111 4 CD O O
111 strict JJ O O
112 n.p.o FW O O
112 per IN B-VP O
112 speech NN B-NP O
112 and CC O O
112 swallow NN B-NP O
112 for IN B-VP O
112 aspiration NN B-NP O
112 with IN B-VP O
112 all DT B-NP O
113 consistencies NNS I-NP O
113 , , O O
113 currently RB O O
113 on IN B-VP O
113 sitter NN B-NP O
113 Postop NNP I-NP O
113 day NN I-NP O
113 #5 NNP I-NP O
113 , , O O
113 the DT B-NP O
113 patient NN I-NP O
114 self NN I-NP O
114 discontinued VBD B-VP O
114 the DT B-NP O
114 Dobbhoff NNP I-NP O
114 feeding NN I-NP O
114 tube NN I-NP O
114 twice RB O O
114 last JJ B-NP O
114 night NN I-NP O
115 requiring VBG O O
115 meds NNS B-NP B-m
115 IV NNP I-NP B-mo
115 today NN I-NP O
115 until IN B-VP B-du
115 tube NN B-NP I-du
115 replaced VBD B-VP I-du
115 and CC O I-du
115 KUB NNP B-NP I-du
115 confirmed VBD B-VP I-du
115 tip NN B-NP I-du
116 this DT B-NP O
116 afternoon NN I-NP O
116 Dobbhoff NNP I-NP O
116 currently RB O O
116 okay VBZ O O
116 to TO O O
116 use VB O O
116 We PRP O O
116 will MD O O
116 resume VB O O
117 tube JJ B-NP O
117 feeds NNS I-NP O
117 Heart NNP I-NP O
117 rate NN I-NP O
117 elevated VBD B-VP O
117 to TO O O
117 90s-130s CD O O
117 and CC O O
117 also RB O O
117 run VB O O
117 of IN B-VP O
117 VT NNP B-NP O
117 , , O O
118 which WDT O O
118 was VBD B-VP O
118 asymptomatic JJ B-NP O
118 Rechecking NNP I-NP O
118 electrolytes NNS I-NP O
118 , , O O
118 BP NNP B-NP O
118 stable JJ B-NP O
119 Preop NNP I-NP O
119 EF NNP I-NP O
119 of IN B-VP O
119 45% CD O O
119 Ordered NNP B-NP O
119 echo NN I-NP O
119 to TO O O
119 assess VB O O
119 postop JJ B-NP O
119 EF NNP I-NP O
119 given VBN O O
119 run NN B-NP O
119 of IN B-VP O
120 VT NNP B-NP O
120 , , O O
120 which WDT O O
120 was VBD B-VP O
120 9 CD O O
120 beats NNS B-NP O
120 Normal NNP I-NP O
120 a.m NN I-NP O
120 electrolytes VBZ O O
120 Remains VBZ O O
120 on IN B-VP O
120 3 CD O B-do
121 liters NNS B-NP O
121 of IN B-VP O
121 O2 NNP B-NP B-m
121 , , O O
121 diuresing VBG O O
121 well RB O O
121 Speech NNP B-NP O
121 and CC O O
121 swallow VB O O
121 will MD O O
121 reassess VB O O
122 next JJ B-NP O
122 week NN I-NP O
122 Strict NNP I-NP O
122 n.p.o NN I-NP O
122 for IN B-VP O
122 history NN B-NP O
122 of IN B-VP O
122 aspiration NN B-NP O
122 Afebrile NNP I-NP O
123 White NNP I-NP O
123 count NN I-NP O
123 improved VBD B-VP O
123 to TO O O
123 10.9 CD O O
123 , , O O
123 remains VBZ O O
123 on IN B-VP O
123 sitter NN B-NP O
123 for IN B-VP O
123 mild JJ B-NP O
124 confusion NN I-NP O
124 Plan NN I-NP O
124 rehabilitation NN I-NP O
124 when WRB O O
124 ready JJ B-NP O
124 Postop NNP I-NP O
124 day NN I-NP O
124 6 CD O O
124 , , O O
125 chronic JJ B-NP O
125 Afib NNP I-NP B-r
125 , , O O
125 rate NN B-NP O
125 has VBZ O O
125 been VBN O O
125 difficult JJ O O
125 to TO O O
125 control VB O O
125 , , O O
125 patient NN B-NP O
125 was VBD B-VP O
125 on IN B-VP O
126 Lopressor NNP B-NP B-m
126 75 CD O B-do
126 mg NN B-NP I-do
126 p.o NN I-NP B-mo
126 q.i.d JJ B-NP B-f
126 postop NN I-NP O
126 via IN B-VP O
126 Dobbhoff NNP B-NP O
126 tube NN I-NP O
126 Patient NNP I-NP O
127 has VBZ O O
127 self VBN O O
127 discontinued VBN O O
127 Dobbhoff NNP B-NP O
127 several JJ B-NP O
127 times NNS I-NP O
127 and CC O O
127 is VBZ O O
127 quite RB O O
128 sensitive JJ O O
128 to TO O O
128 missed VBN O O
128 dose NN B-NP O
128 of IN B-VP O
128 oral JJ B-NP B-mo
128 Lopressor NNP I-NP B-m
128 so IN B-VP O
128 dosing VBG O O
128 IV NNP B-NP B-mo
128 Lopressor NNP I-NP B-m
129 currently RB O O
129 Heart NNP B-NP O
129 rate NN I-NP O
129 is VBZ O O
129 still RB O O
129 a DT B-NP O
129 bit NN I-NP O
129 elevated VBN O O
129 at IN B-VP O
129 100-120s JJ O O
129 , , O O
129 BP NNP B-NP O
130 stable JJ B-NP O
130 Mental NNP I-NP O
130 status NN I-NP O
130 improved VBD B-VP O
130 off RP O O
130 sitter NN B-NP O
130 Remains VBZ O O
130 on IN B-VP O
130 1.5 CD O B-do
131 liters NNS B-NP O
131 of IN B-VP O
131 O2 NNP B-NP B-m
131 junky NN I-NP O
131 cough NN I-NP O
131 , , O O
131 unable JJ O O
131 to TO O O
131 produce VB O O
131 sputum NN B-NP O
131 Afebrile NNP I-NP O
132 White NNP I-NP O
132 count NN I-NP O
132 stable NN I-NP O
132 at IN B-VP O
132 10.4 CD O O
133 Chest NNP B-NP O
133 x-ray JJ B-NP O
133 looks NNS I-NP O
133 okay IN B-VP O
133 No DT B-NP O
133 echo NN I-NP O
133 ordered VBD B-VP O
133 for IN B-VP O
133 her PRP$ O O
133 fellow JJ B-NP O
133 Repeat NNP I-NP O
134 electrolytes VBZ O B-m
134 Titrate NNP B-NP B-do
134 beta-blocker NN I-NP B-m
134 We PRP O O
134 will MD O O
134 reorder VB O O
134 echo NN B-NP O
134 if IN B-VP O
134 VT NNP B-NP O
135 recurs VBP O O
135 PT NNP B-NP O
135 consult NN I-NP O
135 placed VBD B-VP O
135 Postop NNP B-NP O
135 day NN I-NP O
135 7 CD O O
135 , , O O
135 past JJ B-NP O
135 video NN I-NP O
135 swallow NN I-NP O
136 exempted VBD B-VP O
136 Dobbhoff NNP B-NP O
136 out RP O O
136 on IN B-VP O
136 sitter NN B-NP O
136 because IN B-VP O
136 he PRP O O
136 is VBZ O O
136 having VBG O O
136 suicidal JJ B-NP O
137 ideations NNS I-NP O
137 He PRP O O
137 has VBZ O O
137 been VBN O O
137 quite RB O O
137 hyperglycemic JJ O O
137 with IN B-VP O
137 blood NN B-NP O
137 sugar NN I-NP O
137 in IN B-VP O
138 350 CD O O
138 range NN B-NP O
138 EMS NNP I-NP O
138 following VBG O O
138 Screening VBG O O
138 for IN B-VP O
138 rehabilitation NN B-NP O
138 Postop NNP I-NP O
139 day NN I-NP O
139 #8 NNP I-NP O
139 , , O O
139 running VBG O O
139 a DT B-NP O
139 bit NN I-NP O
139 fast JJ O O
139 in IN B-VP O
139 Afib NNP B-NP B-r
139 Increase NNP I-NP O
139 Lopressor NNP I-NP B-m
139 Mood NNP I-NP O
140 has VBZ O O
140 improved VBN O O
140 Will NNP B-NP O
140 most RBS O O
140 likely JJ O O
140 be VB O O
140 able JJ O O
140 to TO O O
140 discontinue VB O O
140 sitter RB O O
141 soon RB O O
141 Screen NNP B-NP O
141 for IN B-VP O
141 rehabilitation NN B-NP O
141 Postop NNP I-NP O
141 day NN I-NP O
141 #9 NNP I-NP O
141 in IN B-VP O
141 Afib NNP B-NP O
141 running VBG O O
142 between IN B-VP O
142 90-100 NNP B-NP O
142 , , O O
142 had VBD B-VP O
142 been VBN O O
142 on IN B-VP O
142 a DT B-NP O
142 sitter NN I-NP O
142 up RB O O
142 until IN B-VP O
142 this DT B-NP O
142 a.m NN I-NP O
142 for IN B-VP O
143 suicidal JJ B-NP O
143 ideation NN I-NP O
143 a DT B-NP O
143 couple NN I-NP O
143 of IN B-VP O
143 days NNS B-NP O
143 ago IN B-VP O
143 eating VBG O O
143 well RB O O
143 Screening VBG O O
144 for IN B-VP O
144 rehab JJ B-NP O
144 Postop NNP I-NP O
144 day NN I-NP O
144 10 CD O O
144 , , O O
144 rate NN B-NP O
144 controlled VBD B-VP O
144 Afib/room NNP B-NP O
144 air NN I-NP O
145 Patient NNP I-NP O
145 followed VBN O O
145 by IN B-VP O
145 psych NN B-NP O
145 for IN B-VP O
145 postoperative JJ B-NP B-r
145 confusion/possible JJ I-NP O
146 suicidal JJ I-NP O
146 ideation NN I-NP O
146 Patient NNP I-NP O
146 stable NN I-NP O
146 on IN B-VP O
146 Celexa NNP B-NP B-m
146 Patient's NNP I-NP O
146 UA NNP I-NP O
146 from IN B-VP O
147 10/5/06 CD O O
147 with IN B-VP O
147 probable JJ B-NP B-r
147 enterogram-negative JJ I-NP I-r
147 rods NNS I-NP I-r
147 Started VBD B-VP O
147 Cipro NNP B-NP B-m
148 x3 NNP I-NP B-du
148 days NNS I-NP I-du
148 Continue NNP I-NP O
148 rehabilitation NN I-NP O
148 screen NN I-NP O
148 Postop NNP I-NP O
148 day NN I-NP O
148 11 CD O O
148 , , O O
148 Afib NNP B-NP O
148 , , O O
149 rate NN B-NP O
149 controlled/room NN I-NP O
149 air NN I-NP O
149 Patient's NNP I-NP O
149 chest VBD B-VP O
149 x-ray NN B-NP O
149 with IN B-VP O
149 no DT B-NP O
149 edema NN I-NP O
149 , , O O
150 slight JJ O O
150 left VBD B-VP O
150 middle JJ B-NP O
150 lobe NN I-NP O
150 atelectasis NN I-NP O
150 Neurologically NNP I-NP O
150 stable JJ O O
150 and CC O O
151 Celexa NNP B-NP B-m
151 ordered VBD B-VP O
151 per IN B-VP O
151 psych NN B-NP B-r
151 Awaiting NNP I-NP O
151 rehabilitation NN I-NP O
151 bed VBD B-VP O
151 Postop NNP B-NP O
152 day NN I-NP O
152 12 CD O O
152 Afib/room NNP B-NP O
152 air NN I-NP O
152 doing VBG O O
152 well RB O O
152 with IN B-VP O
152 blood NN B-NP O
152 pressure NN I-NP O
152 Seen NNP I-NP O
152 by IN B-VP O
153 psych NN B-NP O
153 and CC O O
153 recommend NN B-NP O
153 follow VBP O O
153 up RP O O
153 with IN B-VP O
153 them PRP O O
153 post VBP O O
153 DC NNP B-NP O
153 for IN B-VP O
153 memory NN B-NP O
154 studies NNS I-NP O
154 No NNP I-NP O
154 new JJ B-NP O
154 ??__?? NNP I-NP O
154 Ready NNP I-NP O
154 for IN B-VP O
154 rehabilitation NN B-NP O
154 Just NNP I-NP O
154 waiting VBG O O
155 for IN B-VP O
155 acceptance NN B-NP O
155 and CC O O
155 bed VBD B-VP O
155 Postop NNP B-NP O
155 day NN I-NP O
155 13 CD O O
155 , , O O
155 rate NN B-NP O
155 controlled VBD B-VP O
155 Afib/room NNP B-NP O
156 air NN I-NP O
156 Patient NNP I-NP O
156 waiting VBG O O
156 for IN B-VP O
156 rehab NN B-NP O
156 bed NN I-NP O
156 On IN B-VP O
156 Coumadin NNP B-NP B-m
156 for IN B-VP O
156 Afib NNP B-NP B-r
156 , , O O
157 followed VBN O O
157 by IN B-VP O
157 psych NN B-NP O
157 for IN B-VP O
157 confusion/delirium NN B-NP O
157 and CC O O
157 note NN B-NP O
157 by IN B-VP O
157 them PRP O O
157 that IN B-VP O
158 they PRP O O
158 would MD O O
158 like VB O O
158 to TO O O
158 follow VB O O
158 up RP O O
158 with IN B-VP O
158 him PRP O O
158 when WRB O O
158 he PRP O O
158 is VBZ O O
158 discontinued VBN O O
159 Postop NNP B-NP O
159 day NN I-NP O
159 14 CD O O
159 , , O O
159 the DT B-NP O
159 patient NN I-NP O
159 was VBD B-VP O
159 evaluated VBN O O
159 by IN B-VP O
159 Cardiac NNP B-NP O
159 Surgery NNP I-NP O
160 Service NNP I-NP O
160 to TO O O
160 be VB O O
160 stable JJ O O
160 to TO O O
160 discharge VB O O
160 to TO O O
160 rehabilitation VB O O
160 with IN B-VP O
160 the DT O O
161 following VBG O O
161 discharge NN B-NP O
161 instructions: JJ B-NP O
162 DIET: NNP I-NP O
163 House NNP I-NP O
163 , , O O
163 low-cholesterol NN B-NP O
163 , , O O
163 low-saturated JJ B-NP O
163 fat NN I-NP O
163 , , O O
163 ADA NNP B-NP O
163 2100 CD O O
163 calories NNS B-NP O
163 per IN B-VP O
164 day NN B-NP O
165 FOLLOW-UP NNP I-NP O
165 APPOINTMENTS: NNP I-NP O
166 Dr NNP I-NP O
166 Bueti NNP I-NP O
166 , , O O
166 282-008-4347 JJ O O
166 in IN B-VP O
166 5-6 JJ B-NP O
166 weeks NNS I-NP O
166 , , O O
166 Dr NNP B-NP O
166 Happ NNP I-NP O
166 759-428-0145 JJ O O
167 in IN B-VP O
167 1-2 JJ B-NP O
167 weeks NNS I-NP O
167 , , O O
167 and CC O O
167 Dr NNP B-NP O
167 Hignite NNP I-NP O
167 384-136-0303 CD O O
167 in IN B-VP O
167 one CD O O
167 to TO O O
167 two CD O O
167 weeks NNS B-NP O
168 ADDITIONAL NNP I-NP O
168 COMMENTS: NNP I-NP O
169 Per NNP I-NP O
169 BH NNP I-NP O
169 psychiatry NN I-NP O
169 department NN I-NP O
169 they PRP O O
169 would MD O O
169 recommend VB O O
169 follow VB O O
169 up RP O O
169 as IN B-VP O
170 outpatient NN B-NP O
170 for IN B-VP O
170 continued JJ B-NP O
170 evaluation NN I-NP O
170 of IN B-VP O
170 forgetfullness/mental JJ B-NP O
171 status NN I-NP O
172 TO NNP I-NP O
172 DO NNP I-NP O
172 PLAN: NNP I-NP O
173 Make NNP I-NP O
173 all DT B-NP O
173 follow-up JJ I-NP O
173 appointments NNS I-NP O
173 , , O O
173 local JJ B-NP O
173 wound NN I-NP O
173 care NN I-NP O
173 , , O O
173 wash JJ B-NP O
173 wounds NNS I-NP O
174 daily JJ O O
174 with IN B-VP O
174 soap NN B-NP O
174 and CC O O
174 water NN B-NP O
174 , , O O
174 shower JJR O O
174 patient JJ O O
174 daily RB O O
174 , , O O
174 keep VB O O
174 legs NNS B-NP O
175 elevated VBN O O
175 while IN B-VP O
175 sitting/in JJ B-NP O
175 bed NNS I-NP O
175 Watch VBP O O
175 all DT B-NP O
175 wounds NNS I-NP O
175 for IN B-VP O
175 signs NNS B-NP O
175 of IN B-VP O
176 infection NN B-NP O
176 , , O O
176 redness NN B-NP O
176 , , O O
176 swelling VBG O O
176 , , O O
176 fever NN B-NP O
176 , , O O
176 pain NN B-NP O
176 , , O O
176 discharge NN B-NP O
176 , , O O
176 call VB O O
177 PCP/cardiologist NNP B-NP O
177 or CC O O
177 Anle NNP B-NP O
177 Health NNP I-NP O
177 Cardiac NNP I-NP O
177 Surgery NNP I-NP O
178 Service NNP I-NP O
178 at IN B-VP O
178 282-008-4347 JJ O O
178 with IN B-VP O
178 any DT B-NP O
178 questions NNS I-NP O
179 DISCHARGE NNP I-NP O
179 CONDITION: NNP I-NP O
180 Stable NNP I-NP O
181 DISCHARGE NNP I-NP O
181 MEDICATIONS: NNP I-NP O
182 Acetaminophen NNP I-NP B-m
182 Acetaminophen NNP I-NP B-m
182 325-650 JJ B-NP B-do
182 325-650 JJ I-NP B-do
182 mg NN I-NP I-do
182 mg NN I-NP I-do
182 q NN I-NP B-f
182 q VBD B-VP B-f
182 4h CD O I-f
182 4h CD O I-f
182 p.r.n NN B-NP I-f
182 p.r.n NN I-NP I-f
182 pain NN I-NP B-r
182 or CC O O
182 temperature NN B-NP B-r
183 greater JJR O O
183 than IN B-VP O
183 101 CD O O
183 , , O O
183 DuoNeb NNP B-NP B-m
183 q VBZ O B-f
183 6h CD O I-f
183 p.r.n NN B-NP I-f
183 wheezing NN I-NP B-r
183 , , O O
183 enteric-coated JJ B-NP B-m
184 aspirin NN I-NP O
184 81 CD O B-do
184 mg JJ O I-do
184 daily RB O B-f
184 , , O O
184 Dulcolax NNP B-NP B-m
184 10 CD O B-do
184 mg NN B-NP I-do
184 PR NNP I-NP B-mo
184 daily RB O B-f
184 p.r.n VBZ O I-f
184 constipation NN B-NP B-r
184 , , O O
185 Celexa NNP B-NP B-m
185 10 CD O B-do
185 mg JJ O I-do
185 daily RB O B-f
185 , , O O
185 Colace NNP B-NP B-m
185 100 CD O B-do
185 mg NN B-NP I-do
185 t.i.d NN I-NP B-f
185 , , O O
185 Nexium NNP B-NP B-m
185 20 CD O B-do
185 mg JJ O I-do
185 daily RB O B-f
185 , , O O
186 Lasix NNP B-NP B-m
186 20 CD O B-do
186 mg NNS B-NP I-do
186 daily RB O B-f
186 for IN B-VP B-du
186 5 CD O I-du
186 days NNS B-NP I-du
186 , , O O
186 Neurontin NNP B-NP B-m
186 100 CD O B-do
186 mg NN B-NP I-do
186 t.i.d NN I-NP B-f
186 , , O O
186 Robitussin NNP B-NP B-m
187 10 CD O B-do
187 mL NN B-NP I-do
187 q NN I-NP B-f
187 6h CD O I-f
187 p.r.n NN B-NP I-f
187 cough NN I-NP B-r
187 , , O O
187 NovoLog NNP B-NP B-m
187 NovoLog NNP I-NP B-m
187 insulin NN I-NP I-m
187 insulin NN I-NP I-m
187 on IN B-VP O
187 sliding VBG O B-do
187 sliding VBG O B-do
187 scale JJ B-NP I-do
187 scale NN I-NP I-do
188 q.a.c NN I-NP B-f
188 and CC O O
188 at IN B-VP B-f
188 bedtime NN B-NP I-f
188 , , O O
188 NovoLog NNP B-NP B-m
188 insulin VBZ O I-m
188 14 CD O B-do
188 units NNS B-NP I-do
188 subq VBN O B-mo
188 with IN B-VP B-f
188 lunch NN B-NP O
189 and CC O O
189 supper NN B-NP O
189 , , O O
189 NovoLog NNP B-NP B-m
189 insulin VBZ O I-m
189 22 CD O B-do
189 units NNS B-NP I-do
189 subq VBP O B-mo
189 with IN B-VP B-f
189 breakfast NN B-NP I-f
189 , , O O
189 Lantus NNP B-NP B-m
190 insulin VBZ O O
190 42 CD O B-do
190 units NNS B-NP I-do
190 subq VBP O B-mo
190 at IN B-VP B-f
190 10 CD O I-f
190 p.m NN B-NP I-f
190 , , O O
190 Atrovent NNP B-NP B-m
190 nebulizers NNS I-NP I-m
190 q.i.d RB O B-f
190 , , O O
191 K-Dur NNP B-NP B-m
191 10 CD O B-do
191 mEq NNS B-NP I-do
191 daily RB O B-f
191 for IN B-VP B-du
191 five CD O I-du
191 days NNS B-NP I-du
191 , , O O
191 Toprol-XL JJ O B-m
191 200 CD O B-do
191 mg NN B-NP I-do
191 b.i.d NN I-NP B-f
191 , , O O
192 miconazole JJ B-NP B-m
192 nitrate NN I-NP I-m
192 powder NN I-NP I-m
192 topical JJ B-NP B-mo
192 b.i.d NN I-NP B-f
192 , , O O
192 Niferex NNP B-NP B-m
192 150 CD O B-do
192 mg NN B-NP I-do
192 b.i.d NN I-NP B-f
192 , , O O
193 simvastatin VBD B-VP B-m
193 40 CD O B-do
193 mg NN B-NP I-do
193 at IN B-VP B-f
193 bedtime NN B-NP I-f
193 , , O O
193 multivitamin CC O B-m
193 therapeutic JJ O I-m
193 one CD O B-do
193 tab NN B-NP I-do
194 daily RB O B-f
194 , , O O
194 Coumadin NNP B-NP B-m
194 with IN B-VP O
194 variable JJ B-NP B-do
194 dosage NN I-NP I-do
194 to TO O O
194 be VB O O
194 determined VBN O O
194 based VBN O O
194 on IN B-VP O
195 INR NNP B-NP O
195 , , O O
195 and CC O O
195 Boudreaux's NNP B-NP B-m
195 Butt NNP I-NP I-m
195 Paste NNP I-NP I-m
195 topical JJ B-NP B-mo
195 apply NN I-NP I-mo
195 to TO O I-mo
195 effected VBN O I-mo
195 areas NNS B-NP I-mo
196 eScription VBP O O
196 document: JJ B-NP O
196 1-2683254 JJ I-NP O
196 EMSSten NNP I-NP O
196 Tel NNP I-NP O
197 Dictated NNP I-NP O
197 By: NNP I-NP O
197 PAULSEN NNP I-NP O
197 , , O O
197 JUDE NNP B-NP O
197 BILLIE NNP I-NP O
198 Attending: NNP I-NP O
198 CROMPTON NNP I-NP O
198 , , O O
198 DOMINIQUE NNP B-NP O
199 Dictation NNP I-NP O
199 ID NNP I-NP O
199 0797664 CD O O
200 D: NNP B-NP O
200 9/11/06 CD O O
201 T: NNP B-NP O
201 9/11/06 CD O O
202 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #578984 VBZ O O
2 131265124 CD O O
2 LHC NNP B-NP O
2 06281860 CD O O
2 5110719 CD O O
2 9/22/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 PULMONARY NNP I-NP O
2 EMBOLISM NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/8/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 11/8/2005 CD O O
4 ATTENDING: NNP B-NP O
4 EDMUNDO NNP I-NP O
4 STEVIE NNP I-NP O
4 BEDOKA NNP I-NP O
4 MD NNP I-NP O
5 SERVICE: NNP I-NP O
6 The DT B-NP O
6 patient NN I-NP O
6 was VBD B-VP O
6 admitted VBN O O
6 on IN B-VP O
6 the DT B-NP O
6 cardiac JJ I-NP O
6 surgical JJ I-NP O
6 service NN I-NP O
6 under IN B-VP O
7 the DT B-NP O
7 care NN I-NP O
7 of IN B-VP O
7 Dr NNP B-NP O
7 Kyle NNP I-NP O
7 Lennington NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
9 Mr NNP I-NP O
9 Heldman NNP I-NP O
9 is VBZ O O
9 a DT B-NP O
9 69-year-old JJ I-NP O
9 male NN I-NP O
9 with IN B-VP O
9 end-stage JJ B-NP O
9 renal JJ I-NP O
9 disease NN I-NP O
9 on IN B-VP O
10 hemodialysis NN B-NP O
10 He PRP O O
10 is VBZ O O
10 status NN B-NP O
10 post NN I-NP O
10 CABG NNP I-NP O
10 x1 NNP I-NP O
10 and CC O O
10 aortic JJ B-NP O
10 valve NN I-NP O
11 replacement NN I-NP O
11 in IN B-VP O
11 February NNP B-NP O
11 2004 CD O O
11 He PRP O O
11 presented VBD B-VP O
11 to TO O O
11 the DT B-NP O
11 emergency NN I-NP O
12 department NN I-NP O
12 prior RB O O
12 to TO O O
12 admission NN B-NP O
12 with IN B-VP O
12 shortness NN B-NP O
12 of IN B-VP O
12 breath NN B-NP O
12 Chest NNP I-NP O
13 x-ray NN I-NP O
13 was VBD B-VP O
13 taken VBN O O
13 that IN B-VP O
13 revealed VBD B-VP O
13 pulmonary JJ B-NP O
13 edema NN I-NP O
13 Stated VBD B-VP O
13 he PRP O O
13 had VBD B-VP O
14 been VBN O O
14 complaining VBG O O
14 of IN B-VP O
14 shortness NN B-NP O
14 of IN B-VP O
14 breath NN B-NP O
14 over IN B-VP O
14 the DT B-NP O
14 month NN I-NP O
14 prior RB O O
14 to TO O O
15 admission NN B-NP O
15 with IN B-VP O
15 no DT B-NP O
15 dyspnea NN I-NP O
15 on IN B-VP O
15 exertion NN B-NP O
15 or CC O O
15 chest JJS B-NP O
15 pain NN I-NP O
15 While IN B-VP O
15 in IN B-VP O
16 the DT B-NP O
16 emergency NN I-NP O
16 department NN I-NP O
16 , , O O
16 he PRP O O
16 had VBD B-VP O
16 respiratory JJ B-NP O
16 distress NN I-NP O
16 with IN B-VP O
16 O2 NNP B-NP O
17 oxygen NN I-NP O
17 saturations NNS I-NP O
17 69% CD O O
17 An DT B-NP O
17 echocardiogram NN I-NP O
17 was VBD B-VP O
17 done VBN O O
17 at IN B-VP O
17 that DT B-NP O
17 time NN I-NP O
18 It PRP O O
18 was VBD B-VP O
18 significant JJ O O
18 for IN B-VP O
18 showing VBG O O
18 evidence NN B-NP O
18 of IN B-VP O
18 a DT B-NP O
18 dehiscence NN I-NP O
18 of IN B-VP O
18 the DT B-NP O
19 bioprosthetic JJ I-NP O
19 aortic JJ I-NP O
19 valve NN I-NP O
19 with IN B-VP O
19 prolapse NN B-NP O
19 into IN B-VP O
19 the DT O O
19 left JJ O O
20 ventricular JJ O O
20 outflow IN B-VP O
20 tract NN B-NP O
20 It PRP O O
20 was VBD B-VP O
20 noted VBN O O
20 that IN B-VP O
20 there EX O O
20 is VBZ O O
20 at IN B-VP O
20 least JJS B-NP O
21 moderate JJ I-NP O
21 perivalvular JJ I-NP O
21 aortic JJ I-NP O
21 regurgitation NN I-NP O
21 It PRP O O
21 also RB O O
21 noted VBD B-VP O
21 mitral JJ B-NP O
22 valve NN I-NP O
22 had VBD B-VP O
22 moderate JJ O O
22 to TO O O
22 severe VB O O
22 mitral JJ B-NP O
22 regurgitation NN I-NP O
22 As IN B-VP O
22 stated VBN O O
23 previously RB O O
23 , , O O
23 he PRP O O
23 was VBD B-VP O
23 admitted VBN O O
23 to TO O O
23 the DT B-NP O
23 cardiac JJ I-NP O
23 surgical JJ I-NP O
23 service NN I-NP O
23 for IN B-VP O
24 repair/replacement NN B-NP O
24 of IN B-VP O
24 his PRP$ O O
24 aortic JJ O O
24 and CC O O
24 mitral JJ B-NP O
24 valves NNS I-NP O
25 PAST NNP I-NP O
25 MEDICAL NNP I-NP O
25 HISTORY: NNP I-NP O
26 Includes NNP I-NP O
26 hypertension NN I-NP O
26 , , O O
26 diabetes VBZ O O
26 mellitus NN B-NP O
26 , , O O
26 renal JJ B-NP O
26 failure NN I-NP O
26 , , O O
27 hyperlipidemia NN B-NP O
27 , , O O
27 gout NN B-NP O
27 , , O O
27 GERD NNP B-NP O
27 , , O O
27 closed VBD B-VP O
27 angle NN B-NP O
27 glaucoma NN I-NP O
27 , , O O
27 history NN B-NP O
27 of IN B-VP O
28 colonic JJ B-NP O
28 lymphoma NN I-NP O
29 PAST NNP I-NP O
29 SURGICAL NNP I-NP O
29 HISTORY: NNP I-NP O
30 Right NNP I-NP O
30 arm NN I-NP O
30 AV NNP I-NP O
30 fistula NN I-NP O
30 that WDT O O
30 was VBD B-VP O
30 originally RB O O
30 placed VBN O O
30 in IN B-VP O
30 the DT B-NP O
30 year NN I-NP O
30 2000 CD O O
31 and CC O O
31 revised VBN O O
31 in IN B-VP O
31 2001 CD O O
31 , , O O
31 2002 CD O O
31 , , O O
31 and CC O O
31 2003 CD O O
31 A NNP B-NP O
31 right JJ B-NP O
31 brachiocephalic NN I-NP O
32 stent NN I-NP O
32 was VBD B-VP O
32 also RB O O
32 placed VBN O O
33 SOCIAL NNP B-NP O
33 HISTORY: NNP I-NP O
34 No NNP I-NP O
34 history NN I-NP O
34 of IN B-VP O
34 tobacco NN B-NP O
34 use NN I-NP O
35 ALLERGIES: NNP I-NP O
36 No NNP I-NP O
36 known VBN O O
36 drug NN B-NP O
36 allergies NNS I-NP O
37 PREOPERATIVE NNP I-NP O
37 MEDICATIONS: NNP I-NP O
38 Labetalol NNP I-NP B-m
38 , , O O
38 100 CD O B-do
38 mg NN B-NP I-do
38 p.o NN I-NP B-mo
38 t.i.d NN I-NP B-f
38 , , O O
38 amlodipine VBP O B-m
38 10 CD O B-do
38 mg NNS B-NP I-do
38 p.o JJ O B-mo
38 daily RB O B-f
38 , , O O
39 lisinopril NN B-NP B-m
39 , , O O
39 20 CD O B-do
39 mg NN B-NP I-do
39 p.o NN I-NP B-mo
39 day NN I-NP B-f
39 , , O O
39 Zocor NNP B-NP B-m
39 40 CD O B-do
39 mg NN B-NP I-do
39 p.o JJ O B-mo
39 daily RB O B-f
39 , , O O
39 PhosLo NNP B-NP B-m
39 1334 CD O B-do
40 mg NN B-NP O
40 p.o NN I-NP B-mo
40 a.c JJ B-NP B-f
41 PHYSICAL NNP I-NP O
41 EXAMINATION: NNP I-NP O
42 Vital NNP I-NP O
42 signs NNS I-NP O
42 , , O O
42 temperature NN B-NP O
42 95.8 CD O O
42 , , O O
42 heart NN B-NP O
42 rate NN I-NP O
42 74 CD O O
42 , , O O
42 blood NN B-NP O
42 pressure NN I-NP O
42 in IN B-VP O
43 the DT B-NP O
43 right JJ I-NP O
43 arm NN I-NP O
43 134/62 CD O O
43 HEENT NNP B-NP O
43 , , O O
43 dentition NN B-NP O
43 without IN B-VP O
43 evidence NN B-NP O
43 of IN B-VP O
44 infection NN B-NP O
44 , , O O
44 no DT B-NP O
44 carotid NN I-NP O
44 bruit NN I-NP O
44 Cardiovascular NNP I-NP O
44 , , O O
44 regular JJ B-NP O
44 rate NN I-NP O
44 and CC O O
45 rhythm VB O O
45 Peripheral NNP B-NP O
45 pulses NNS I-NP O
45 are VBP O O
45 the DT O O
45 following JJ O O
45 , , O O
45 peripheral JJ B-NP O
45 pulses NNS I-NP O
46 are VBP O O
46 2+the CD O O
46 carotid NNS B-NP O
46 , , O O
46 radial JJ O O
46 , , O O
46 and CC O O
46 femoral JJ O O
46 The DT B-NP O
46 dorsalis NN I-NP O
46 pedis NN I-NP O
46 and CC O O
47 posterior JJ B-NP O
47 tibial NN I-NP O
47 are VBP O O
47 each DT O O
47 present JJ O O
47 by IN B-VP O
47 Doppler NNP B-NP O
47 bilaterally RB O O
48 Respiratory NNP B-NP O
48 rales NNS I-NP O
48 present JJ O O
48 bilaterally RB O O
48 Neuro NNP B-NP O
48 , , O O
48 cool JJ B-NP O
48 extremities NNS I-NP O
49 with IN B-VP O
49 monophasic JJ B-NP O
49 pulse JJ I-NP O
50 PREOPERATIVE NNP I-NP O
50 LABS: NNP I-NP O
51 Sodium NNP I-NP O
51 141 CD O O
51 , , O O
51 potassium NN B-NP O
51 4.4 CD O O
51 , , O O
51 chloride RB O O
51 102 CD O O
51 Carbon NNP B-NP O
51 dioxide NN I-NP O
51 29 CD O O
51 , , O O
51 BUN NNP B-NP O
52 26 CD O O
52 , , O O
52 creatinine NN B-NP O
52 5.8 CD O O
52 , , O O
52 glucose RB O O
52 195 CD O O
52 , , O O
52 magnesium NN B-NP O
52 1.9 CD O O
52 , , O O
52 white JJ B-NP O
52 blood NN I-NP O
52 cells NNS I-NP O
53 6.11 CD O O
53 , , O O
53 hematocrit NN B-NP O
53 28 CD O O
53 , , O O
53 hemoglobin NN B-NP O
53 9.5 CD O O
53 , , O O
53 and CC O O
53 platelets NNS B-NP O
53 98 CD O O
53 , , O O
53 000 CD O O
53 PT NNP B-NP O
54 14.8 CD O O
54 , , O O
54 INR NNP B-NP O
54 1.1 CD O O
54 , , O O
54 PTT NNP B-NP O
54 42.2 CD O O
54 Arterial NNP B-NP O
54 blood NN I-NP O
54 gas NN I-NP O
54 showed VBD B-VP O
54 pO2 NN B-NP O
54 of IN B-VP O
54 64 CD O O
54 , , O O
54 pH NN B-NP O
55 7.38 CD O O
55 , , O O
55 PCO2 NNP B-NP O
55 of IN B-VP O
55 52 CD O O
55 and CC O O
55 the DT B-NP O
55 base NN I-NP O
55 excess NN I-NP O
55 of IN B-VP O
55 4 CD O O
55 Cardiac NNP B-NP O
56 catheterization NN I-NP O
56 data NNS I-NP O
56 on IN B-VP O
56 1/3/04 CD O O
56 , , O O
56 coronary JJ B-NP O
56 anatomy NN I-NP O
56 , , O O
56 10% CD O O
56 proximal JJ B-NP O
57 LAD NNP I-NP O
57 , , O O
57 5% CD O O
57 proximal JJ B-NP O
57 circumflex NN I-NP O
57 , , O O
57 85% CD O O
57 mid NN B-NP O
57 RCA NNP I-NP O
57 with IN B-VP O
57 a DT B-NP O
57 codominant JJ I-NP O
58 circulation NN I-NP O
58 ECG NNP I-NP O
58 on IN B-VP O
58 10/0/05 CD O O
58 shows NNS B-NP O
58 first-degree JJ B-NP O
58 AV NNP I-NP O
58 block NN I-NP O
58 with IN B-VP O
59 left JJ B-NP O
59 anterior JJ I-NP O
59 hemiblock NN I-NP O
59 with IN B-VP O
59 inverted JJ B-NP O
59 Ts NNP I-NP O
59 Chest NNP I-NP O
59 x-ray NN I-NP O
59 on IN B-VP O
60 10/24/05 CD O O
60 consistent JJ O O
60 with IN B-VP O
60 congestive JJ B-NP O
60 heart NN I-NP O
60 failure NN I-NP O
61 Brachiocephalic NNP I-NP O
61 and CC O O
61 right JJ B-NP O
61 subclavian JJ I-NP O
61 stents NNS I-NP O
61 were VBD B-VP O
61 in IN B-VP O
61 place NN B-NP O
62 HOSPITAL NNP I-NP O
62 COURSE NNP I-NP O
63 BRIEF NNP I-NP O
63 OPERATIVE NNP I-NP O
63 NOTE: NNP I-NP O
64 Date NNP I-NP O
64 of IN B-VP O
64 surgery NN B-NP O
64 , , O O
64 2/13/05 CD O O
65 PREOPERATIVE NNP B-NP O
65 DIAGNOSIS: NNP I-NP O
66 See NNP I-NP O
66 magna NN I-NP O
66 valve VBD B-VP O
66 three CD O O
66 months NNS B-NP O
66 prior RB O O
66 EPL NNP B-NP O
66 on IN B-VP O
66 echo NN B-NP O
66 showed VBD B-VP O
66 grossly RB O O
67 mobile JJ O O
67 on IN B-VP O
67 the DT B-NP O
67 stable JJ I-NP O
67 aortic JJ I-NP O
67 valve NN I-NP O
67 prosthesis NN I-NP O
67 moderate NN I-NP O
67 , , O O
67 MR NNP B-NP O
67 No NNP I-NP O
68 vegetations NNS I-NP O
69 PROCEDURE: NNP I-NP O
70 Reoperation NNP I-NP O
70 of IN B-VP O
70 ascending VBG O O
70 aortic JJ B-NP O
70 dissection NN I-NP O
70 , , O O
70 aortic JJ B-NP O
70 valve NN I-NP O
71 replacement NN I-NP O
71 , , O O
71 #24 NNP B-NP O
71 homograph NN I-NP O
71 , , O O
71 MVP NNP B-NP O
71 with IN B-VP O
71 Alfieri NNP B-NP O
71 suture NN I-NP O
72 BYPASS NNP I-NP O
72 TIME: NNP I-NP O
73 355 CD O O
73 minutes NNS B-NP O
73 , , O O
74 CROSSCLAMP NNP B-NP O
74 TIME: NNP I-NP O
75 265 CD O O
75 minutes NNS B-NP O
76 One CD O O
76 ventricular NN B-NP O
76 wire NN I-NP O
76 , , O O
76 one CD O O
76 pericardial NN B-NP O
76 tube NN I-NP O
76 , , O O
76 one CD O O
76 retrosternal NN B-NP O
77 tube NN I-NP O
77 , , O O
77 two CD O O
77 left VBD B-VP O
77 pleural JJ B-NP O
77 tubes NNS I-NP O
77 and CC O O
77 two CD O O
77 right JJ B-NP O
77 pleural JJ I-NP O
77 tubes NNS I-NP O
77 were VBD B-VP O
78 placed VBN O O
79 FINDINGS: NNP B-NP O
80 Dense NNP I-NP O
80 inflammatory NN I-NP O
80 edematous JJ B-NP O
80 scar NN I-NP O
80 tissue NN I-NP O
80 throughout IN B-VP O
80 pericardium NN B-NP O
80 , , O O
81 especially RB O O
81 periaortic JJ B-NP O
81 Right NNP I-NP O
81 axillary JJ B-NP O
81 cannulation NN I-NP O
81 with IN B-VP O
81 6 CD O O
81 mm NNS B-NP O
82 Hemashield NNP I-NP O
82 side RB O O
82 Percutaneous NNP B-NP O
82 right JJ B-NP O
82 CF NNP I-NP O
82 decannulation NN I-NP O
83 Uneventful NNP I-NP O
83 re-sternotomy JJ B-NP O
84 Previous NNP I-NP O
84 SVG NNP I-NP O
84 PDA NNP I-NP O
84 injured VBD B-VP O
84 during IN B-VP O
84 dissection NN B-NP O
84 , , O O
84 repaired VBN O O
84 with IN B-VP O
85 interrupted JJ B-NP O
85 7-0 JJ I-NP O
85 Prolene NNP I-NP O
85 Aortic NNP I-NP O
85 valve NN I-NP O
85 prosthesis NN I-NP O
85 dehisced VBD B-VP O
85 3/4 CD O O
85 of IN B-VP O
86 circumference NN B-NP O
86 with IN B-VP O
86 question NN B-NP O
86 of IN B-VP O
86 an DT B-NP O
86 abscess JJ I-NP O
86 cavity NN I-NP O
86 near IN B-VP O
86 LCC/RCC NNP B-NP O
87 junction NN I-NP O
87 Debridement NNP I-NP O
87 , , O O
87 the DT B-NP O
87 annulus NN I-NP O
87 is VBZ O O
87 of IN B-VP O
87 extensive JJ B-NP O
87 inflammatory NN I-NP O
88 tissue NN I-NP O
88 Previous NNP I-NP O
88 Dacron NNP I-NP O
88 aortic JJ B-NP O
88 root NN I-NP O
88 patch NN I-NP O
88 removed VBD B-VP O
88 due JJ O O
88 to TO O O
88 pocket NN B-NP O
89 of IN B-VP O
89 pus NN B-NP O
89 on IN B-VP O
89 the DT B-NP O
89 anterior JJ I-NP O
89 aspect NN I-NP O
89 No NNP I-NP O
89 24 CD O O
89 allograft NN B-NP O
89 placed VBN O O
89 with IN B-VP O
90 double JJ B-NP O
90 layer NN I-NP O
90 proximal JJ B-NP O
90 suture NN I-NP O
90 line NN I-NP O
90 SVG NNP I-NP O
90 and CC O O
90 both DT B-NP O
90 coronary JJ I-NP O
91 arteries NNS I-NP O
91 implanted VBN O O
91 as IN B-VP O
91 buttons NNS B-NP O
91 Distal NNP I-NP O
91 suture NN I-NP O
91 line NN I-NP O
91 continuous JJ B-NP O
91 4-0 JJ I-NP O
92 Prolene NNP I-NP O
92 Transaortic NNP I-NP O
92 and CC O O
92 mitral JJ B-NP O
92 valves NNS I-NP O
92 replaced VBD B-VP O
93 After IN B-VP O
93 the DT B-NP O
93 operation NN I-NP O
93 , , O O
93 the DT B-NP O
93 patient NN I-NP O
93 was VBD B-VP O
93 transferred VBN O O
93 to TO O O
93 the DT B-NP O
93 cardiac JJ I-NP O
94 intensive JJ I-NP O
94 care NN I-NP O
94 unit NN I-NP O
94 in IN B-VP O
94 stable JJ B-NP O
94 condition NN I-NP O
94 His PRP$ O O
94 postoperative JJ B-NP O
95 course NN I-NP O
95 was VBD B-VP O
95 complicated VBN O O
95 by IN B-VP O
95 the DT B-NP O
95 following: NN I-NP O
96 1 CD O O
96 Infectious NNP B-NP O
96 disease: NN I-NP O
96 Although IN B-VP O
96 , , O O
96 Mr NNP B-NP O
96 Ownbey NNP I-NP O
96 had VBD B-VP O
96 multiple JJ B-NP O
96 blood NN I-NP O
97 cultures NNS I-NP O
97 , , O O
97 sent VBD B-VP O
97 , , O O
97 they PRP O O
97 all DT O O
97 proved VBD B-VP O
97 to TO O O
97 be VB O O
97 negative JJ O O
97 as IN B-VP O
97 of IN B-VP O
97 the DT B-NP O
97 date NN I-NP O
97 of IN B-VP O
98 discharge NN B-NP O
98 Although IN B-VP O
98 Mr NNP B-NP O
98 Cavitt NNP I-NP O
98 was VBD B-VP O
98 never RB O O
98 felt VBN O O
98 to TO O O
98 be VB O O
98 bacteremic JJ O O
98 , , O O
99 the DT B-NP O
99 cultures NNS I-NP O
99 that WDT O O
99 were VBD B-VP O
99 sent VBN O O
99 from IN B-VP O
99 the DT B-NP O
99 operating NN I-NP O
99 room NN I-NP O
99 were VBD B-VP O
99 of IN B-VP O
99 the DT B-NP O
100 aortic JJ I-NP O
100 valve NN I-NP O
100 prosthesis NN I-NP O
100 This DT O O
100 never RB O O
100 showed VBD B-VP O
100 the DT B-NP O
100 organisms NNS I-NP O
101 identified VBN O O
101 on IN B-VP O
101 Gram NNP B-NP O
101 stain NN I-NP O
101 and CC O O
101 MSSA NNP B-NP O
101 stain VBP O O
101 However RB O O
101 , , O O
101 the DT B-NP O
101 infectious JJ I-NP O
102 disease NN I-NP O
102 physicians NNS I-NP O
102 were VBD B-VP O
102 consulted VBN O O
102 and CC O O
102 felt VBD B-VP O
102 that IN B-VP O
102 Mr NNP B-NP O
102 Sanjurjo NNP I-NP O
102 should MD O O
103 be VB O O
103 on IN B-VP O
103 vancomycin NN B-NP B-m
103 , , O O
103 rifampin NN B-NP B-m
103 , , O O
103 and CC O O
103 gentamicin NN B-NP B-m
103 As IN B-VP O
103 at IN B-VP O
103 the DT B-NP O
103 time NN I-NP O
103 of IN B-VP O
104 discharge NN B-NP O
104 , , O O
104 Mr NNP B-NP O
104 Bersamin NNP I-NP O
104 has VBZ O O
104 finished VBN O O
104 his PRP$ O O
104 regimen NNS B-NP O
104 of IN B-VP O
104 gentamicin NN B-NP B-m
104 and CC O O
105 will MD O O
105 continue VB O O
105 to TO O O
105 be VB O O
105 on IN B-VP O
105 both DT B-NP O
105 vancomycin NN I-NP B-m
105 and CC O O
105 rifampin NN B-NP B-m
105 until IN B-VP B-du
105 until IN B-VP B-du
106 1/3/04 CD O O
106 The DT B-NP O
106 rifampin NN I-NP B-m
106 he PRP O O
106 will MD O O
106 take VB O O
106 orally RB O B-mo
106 and CC O O
106 the DT B-NP O
106 vancomycin NN I-NP B-m
106 he PRP O O
107 will MD O O
107 get VB O O
107 after IN B-VP O
107 dialysis NN B-NP O
107 three CD O B-f
107 times NNS B-NP I-f
107 a DT B-NP I-f
107 week NN I-NP I-f
107 While IN B-VP O
107 an DT B-NP O
107 inpatient NN I-NP O
107 , , O O
108 Mr NNP B-NP O
108 Rakus NNP I-NP O
108 never RB O O
108 had VBD B-VP O
108 any DT B-NP O
108 evidence NN I-NP O
108 of IN B-VP O
108 leukocytosis NN B-NP O
108 or CC O O
108 bacteremia NN B-NP O
109 2 CD O O
109 Cardiovascular: NNP B-NP O
109 Ms NNP I-NP O
109 Johe NNP I-NP O
109 was VBD B-VP O
109 noted VBN O O
109 to TO O O
109 have VB O O
109 a DT B-NP O
109 first-degree JJ I-NP O
110 AV NNP I-NP O
110 block NN I-NP O
110 on IN B-VP O
110 postoperative JJ B-NP O
110 day NN I-NP O
110 #7 NNP I-NP O
110 with IN B-VP O
110 a DT B-NP O
110 PR NNP I-NP O
110 interval NN I-NP O
110 of IN B-VP O
110 0.35 CD O O
110 Up NNP B-NP O
111 into IN B-VP O
111 this DT B-NP O
111 point NN I-NP O
111 he PRP O O
111 had VBD B-VP O
111 been VBN O O
111 receiving VBG O O
111 labetalol NN B-NP B-m
111 This DT O O
111 was VBD B-VP O
111 held VBN O O
112 and CC O O
112 the DT B-NP O
112 electrophysiology NN I-NP O
112 consult NN I-NP O
112 was VBD B-VP O
112 obtained VBN O O
112 The DT B-NP O
113 electrophysiology NN I-NP O
113 service NN I-NP O
113 saw VBD B-VP O
113 the DT B-NP O
113 patient NN I-NP O
113 agreed VBD B-VP O
113 to TO O O
113 be VB O O
113 an DT B-NP O
114 excellent JJ I-NP O
114 candidate NN I-NP O
114 for IN B-VP O
114 permanent JJ B-NP O
114 pacemaker NN I-NP O
114 Initially NNP I-NP O
114 they PRP O O
115 attempted VBD B-VP O
115 to TO O O
115 gain VB O O
115 access NN B-NP O
115 to TO O O
115 the DT B-NP O
115 right NN I-NP O
115 brachiocephalic/subclavian NN I-NP O
116 However RB O O
116 , , O O
116 this DT O O
116 proved VBD B-VP O
116 to TO O O
116 be VB O O
116 difficult JJ O O
116 and CC O O
116 ultimately RB O O
116 obtain VB O O
117 access NN B-NP O
117 through IN B-VP O
117 the DT B-NP O
117 left JJ I-NP O
117 iliac NN I-NP O
117 His PRP$ O O
117 permanent JJ B-NP O
117 pacemaker NN I-NP O
117 was VBD B-VP O
118 placed VBN O O
118 on IN B-VP O
118 1/29/05 CD O O
118 and CC O O
118 was VBD B-VP O
118 interrogated VBN O O
118 the DT B-NP O
118 following JJ I-NP O
118 day NN I-NP O
118 and CC O O
119 felt VBD B-VP O
119 to TO O O
119 be VB O O
119 functioning VBG O O
119 appropriately RB O O
119 He PRP O O
119 was VBD B-VP O
119 restarted VBN O O
119 on IN B-VP O
119 his PRP$ O O
120 labetalol NN B-NP B-m
120 and CC O O
120 as IN B-VP O
120 of IN B-VP O
120 the DT B-NP O
120 time NN I-NP O
120 of IN B-VP O
120 discharge NN B-NP O
120 , , O O
120 has VBZ O O
120 had VBN O O
120 no DT B-NP O
120 symptoms NNS I-NP O
121 Other JJ O O
121 than IN B-VP O
121 the DT B-NP O
121 above NN I-NP O
121 , , O O
121 Ms NNP B-NP O
121 Dingman NNP I-NP O
121 was VBD B-VP O
121 weaned VBN O O
121 from IN B-VP O
121 his PRP$ O O
121 oxygen NN B-NP O
122 requirement NN I-NP O
122 , , O O
122 mobilized VBN O O
122 rapidly RB O O
122 following VBG O O
122 surgery NN B-NP O
122 All DT B-NP O
122 epicardial JJ I-NP O
123 pacing NN I-NP O
123 wires NNS I-NP O
123 and CC O O
123 chest JJS B-NP O
123 tubes NNS I-NP O
123 were VBD B-VP O
123 removed VBN O O
123 without IN B-VP O
123 complication NN B-NP O
124 He PRP O O
124 will MD O O
124 be VB O O
124 discharged VBN O O
124 home NN B-NP O
124 on IN B-VP O
124 the DT B-NP O
124 following JJ I-NP O
124 medications NNS I-NP O
124 aspirin VBP O B-m
125 325 CD O B-do
125 mg NNS B-NP I-do
125 p.o JJ O B-mo
125 daily RB O B-f
125 , , O O
125 hydralazine PRP O B-m
125 100 CD O B-do
125 mg NN B-NP I-do
125 p.o NN I-NP B-mo
125 q.i.d NN I-NP B-f
125 , , O O
125 labetalol100 JJ B-NP B-m
126 mg NN I-NP O
126 p.o NN I-NP B-mo
126 t.i.d NN I-NP B-f
126 , , O O
126 lisinopril VBZ O B-m
126 40 CD O B-do
126 mg NN B-NP I-do
126 p.o NN I-NP B-mo
126 b.i.d NN I-NP B-f
126 , , O O
126 oxycodone RB O B-m
126 5 CD O B-do
126 mg NNS B-NP I-do
126 p.o RB O B-mo
127 6 CD O B-f
127 hours NNS B-NP I-f
127 p.r.n RB O I-f
127 pain VBP O B-r
127 , , O O
127 rifampin VBP O B-m
127 300 CD O B-do
127 mg NN B-NP I-do
127 p.o NN I-NP B-mo
127 q.8h NN I-NP B-f
127 , , O O
127 vancomycin NN B-NP B-m
127 for IN B-VP O
128 which WDT O O
128 he PRP O O
128 will MD O O
128 receive VB O O
128 following VBG O O
128 dialysis NN B-NP O
128 until IN B-VP B-du
128 5/14/05 CD O I-du
128 , , O O
128 Zocor NNP B-NP B-m
128 40 CD O B-do
129 mg NN B-NP O
129 p.o NN I-NP B-mo
129 q.h.s NN I-NP B-f
129 , , O O
129 losartan VBZ O B-m
129 100 CD O B-do
129 mg NN B-NP I-do
129 p.o JJ B-NP B-mo
129 daily JJ I-NP B-f
129 Mr NNP I-NP O
129 Llanez NNP I-NP O
129 will MD O O
130 follow VB O O
130 up RP O O
130 with IN B-VP O
130 Dr NNP B-NP O
130 Owston NNP I-NP O
130 , , O O
130 cardiac JJ B-NP O
130 surgeon NN I-NP O
130 , , O O
130 in IN B-VP O
130 six CD O O
130 weeks NNS B-NP O
130 , , O O
130 and CC O O
130 Dr NNP B-NP O
131 Geister NNP I-NP O
131 , , O O
131 cardiologist NN B-NP O
131 , , O O
131 in IN B-VP O
131 three CD O O
131 to TO O O
131 four CD O O
131 weeks NNS B-NP O
131 , , O O
131 Dr NNP B-NP O
131 Kmiecik NNP I-NP O
131 , , O O
131 the DT B-NP O
132 patient's NN I-NP O
132 primary JJ B-NP O
132 care NN I-NP O
132 physician NN I-NP O
132 , , O O
132 in IN B-VP O
132 one CD O O
132 to TO O O
132 two CD O O
132 weeks NNS B-NP O
132 and CC O O
132 Dr NNP B-NP O
133 Vaught NNP I-NP O
133 , , O O
133 cardiologist NN B-NP O
133 , , O O
133 in IN B-VP O
133 two CD O O
133 weeks NNS B-NP O
134 eScription NN I-NP O
134 document: IN B-VP O
134 3-6323131 JJ B-NP O
134 EMSSten NNP I-NP O
134 Tel NNP I-NP O
135 Dictated NNP I-NP O
135 By: NNP I-NP O
135 ORTMAN NNP I-NP O
135 , , O O
135 HUMBERTO NNP B-NP O
136 Attending: NNP I-NP O
136 ANENE NNP I-NP O
136 , , O O
136 WARREN NNP B-NP O
136 NICK NNP I-NP O
137 Dictation NNP I-NP O
137 ID NNP I-NP O
137 7068367 CD O O
138 D: NNP B-NP O
138 11/16/05 CD O O
139 T: NNP B-NP O
139 11/16/05 CD O O
140 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #579754 VBZ O O
4 252140420 CD O O
4 ACMH NNP B-NP O
4 97727998 CD O O
4 271243 CD O O
4 10/27/1997 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 UNSTABLE NNP I-NP O
4 ANGINA NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 10/27/1997 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/25/1997 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 MYOCARDIAL NNP I-NP O
7 INFARCTION NNP I-NP O
8 OTHER NNP I-NP O
8 DIAGNOSES: NNP I-NP O
9 1 CD O O
9 SARCOIDOSIS NNP B-NP O
10 2 CD O O
10 HYPERTENSION NNP B-NP O
11 3 CD O O
11 NON-INSULIN-DEPENDENT NNP B-NP O
11 DIABETES NNP I-NP O
11 MELLITUS NNP I-NP O
12 4 CD O O
12 STATUS NNP B-NP O
12 POST NNP I-NP O
12 PACEMAKER NNP I-NP O
12 PLACEMENT NNP I-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 is VBZ O O
13 a DT B-NP O
13 65-year-old JJ I-NP O
13 female NN I-NP O
14 with IN B-VP O
14 a DT B-NP O
14 history NN I-NP O
14 of IN B-VP O
14 hypertension NN B-NP O
14 , , O O
15 hypercholesterolemia NN B-NP O
15 , , O O
15 non-insulin-dependent JJ B-NP O
15 diabetes NNS I-NP O
15 mellitus NN I-NP O
15 , , O O
15 and CC O O
16 with IN B-VP O
16 no DT B-NP O
16 known JJ I-NP O
16 hx NN I-NP O
16 of IN B-VP O
16 CAD NNP B-NP O
16 admitted VBD B-VP O
16 with IN B-VP O
16 chest NN B-NP O
16 pain NN I-NP O
16 She PRP O O
16 has VBZ O O
16 had VBD B-VP O
17 several JJ B-NP O
17 days NNS I-NP O
17 of IN B-VP O
17 exertional JJ B-NP O
17 chest NN I-NP O
17 pain NN I-NP O
17 characterized VBN O O
17 by IN B-VP O
17 substernal JJ B-NP O
18 burning NN I-NP O
18 pain NN I-NP O
18 which WDT O O
18 , , O O
18 at IN B-VP O
18 times NNS B-NP O
18 , , O O
18 radiates VBZ O O
18 to TO O O
18 the DT B-NP O
18 left NN I-NP O
18 shoulder NN I-NP O
18 It PRP O O
18 is VBZ O O
19 sometimes RB O O
19 accompanied VBN O O
19 by IN B-VP O
19 shortness NN B-NP O
19 of IN B-VP O
19 breath NN B-NP O
19 without IN B-VP O
19 nausea NN B-NP O
19 and CC O O
20 occasional JJ B-NP O
20 diaphoresis NN I-NP O
20 She PRP O O
20 was VBD B-VP O
20 seen VBN O O
20 in IN B-VP O
20 the DT B-NP O
20 Emergency NNP I-NP O
20 Department NNP I-NP O
21 with IN B-VP O
21 chest JJS B-NP O
21 pain NN I-NP O
21 on IN B-VP O
21 November NNP B-NP O
21 , , O O
21 1997 CD O O
21 , , O O
21 with IN B-VP O
21 negative JJ B-NP O
21 troponins NNS I-NP O
21 and CC O O
22 negative JJ B-NP O
22 cardiac NN I-NP O
22 enzymes VBZ O O
22 An DT B-NP O
22 exercise NN I-NP O
22 treadmill NN I-NP O
22 test NN I-NP O
22 on IN B-VP O
22 May NNP B-NP O
22 , , O O
22 1997 CD O O
22 , , O O
22 for IN B-VP O
22 three CD O O
22 minutes NNS B-NP O
22 revealed VBD B-VP O
22 a DT B-NP O
22 maximal JJ I-NP O
22 heart NN I-NP O
22 rate NN I-NP O
22 of IN B-VP O
22 127 CD O O
23 and CC O O
23 maximal JJ B-NP O
23 blood NN I-NP O
23 pressure NN I-NP O
23 of IN B-VP O
23 134/80 CD O O
23 She PRP O O
23 experienced VBD B-VP O
23 chest JJS B-NP O
23 pain NN I-NP O
24 with IN B-VP O
24 1 CD O O
24 millimeter NN B-NP O
24 of IN B-VP O
24 ST NNP B-NP O
24 depression NN I-NP O
24 in IN B-VP O
24 V5 NNP B-NP O
24 and CC O O
24 T-wave NNP B-NP O
24 inversions NNS I-NP O
24 in IN B-VP O
25 V4-V6 NNP B-NP O
25 This DT B-NP O
25 study NN I-NP O
25 was VBD B-VP O
25 interpreted VBN O O
25 as IN B-VP O
25 consistent NN B-NP O
25 with IN B-VP O
25 , , O O
25 but CC O O
25 not RB O O
26 diagnostic JJ B-NP O
26 ischemia NN I-NP O
26 She PRP O O
26 was VBD B-VP O
26 started VBN O O
26 on IN B-VP O
26 aspirin NN B-NP B-m
26 and CC O O
26 atenolol NN B-NP B-m
26 On IN B-VP O
26 the DT B-NP O
27 morning NN I-NP O
27 of IN B-VP O
27 admission NN B-NP O
27 , , O O
27 she PRP O O
27 was VBD B-VP O
27 walking VBG O O
27 to TO O O
27 catch VB O O
27 a DT B-NP O
27 bus NN I-NP O
27 and CC O O
27 had VBD B-VP O
27 an DT B-NP O
28 episode NN I-NP O
28 of IN B-VP O
28 substernal JJ B-NP O
28 chest NN I-NP O
28 burning VBG O O
28 lasting VBG O O
28 less JJR O O
28 than IN B-VP O
28 10 CD O O
28 minutes NNS B-NP O
29 with IN B-VP O
29 shortness NN B-NP O
29 of IN B-VP O
29 breath NN B-NP O
29 , , O O
29 but CC O O
29 no DT B-NP O
29 nausea NN I-NP O
29 , , O O
29 vomiting VBG O O
29 , , O O
29 or CC O O
29 diaphoresis NN B-NP O
30 She PRP O O
30 came VBD B-VP O
30 by IN B-VP O
30 cab NN B-NP O
30 to TO O O
30 Rirel NNP B-NP O
30 Carleo NNP I-NP O
30 And CC O O
30 for IN B-VP O
30 her PRP$ O O
30 scheduled VBN O O
31 exercise NN B-NP O
31 ett/mibi NN I-NP O
31 test NN I-NP O
31 study NN I-NP O
31 and CC O O
31 was VBD B-VP O
31 noted VBN O O
31 to TO O O
31 have VB O O
31 T NNP B-NP O
31 wave VB O O
32 inversions NNS B-NP O
32 in IN B-VP O
32 II NNP B-NP O
32 , , O O
32 III NNP B-NP O
32 , , O O
32 F NNP B-NP O
32 , , O O
32 and CC O O
32 V3-V6 NNP B-NP O
33 On IN B-VP O
33 arrival NN B-NP O
33 to TO O O
33 the DT B-NP O
33 Emergency NNP I-NP O
33 Room NNP I-NP O
33 , , O O
33 the DT B-NP O
33 patient NN I-NP O
33 was VBD B-VP O
33 pain JJ O O
33 free JJ O O
33 She PRP O O
34 denied VBD B-VP O
34 lower JJR B-NP O
34 extremity NN I-NP O
34 edema NN I-NP O
34 and CC O O
34 had VBD B-VP O
34 mild VBN O O
34 orthopnea NN B-NP O
34 which WDT O O
34 was VBD B-VP O
35 unchanged JJ O O
35 She PRP O O
35 denied VBD B-VP O
35 bright JJ B-NP O
35 red JJ I-NP O
35 blood NN I-NP O
35 per IN B-VP O
35 rectum NN B-NP O
35 , , O O
35 and CC O O
35 stools NNS B-NP O
35 were VBD B-VP O
36 black JJ O O
36 secondary JJ O O
36 to TO O O
36 iron VB O B-m
36 supplementation NN B-NP I-m
36 Hematocrit NNP I-NP O
36 on IN B-VP O
36 June NNP B-NP O
36 , , O O
37 1997 CD O O
37 , , O O
37 was VBD B-VP O
37 noted VBN O O
37 to TO O O
37 be VB O O
37 29.3 CD O O
37 The DT B-NP O
37 patient NN I-NP O
37 had VBD B-VP O
37 been VBN O O
37 iron VBN O B-m
37 supplements NNS B-NP I-m
38 since IN B-VP O
38 that DT B-NP O
38 time NN I-NP O
38 She PRP O O
38 had VBD B-VP O
38 a DT B-NP O
38 history NN I-NP O
38 of IN B-VP O
38 colonic JJ B-NP O
38 polyps NNS I-NP O
39 PAST NNP I-NP O
39 MEDICAL NNP I-NP O
39 HISTORY: NNP I-NP O
39 1 CD O O
39 ) ) O O
39 Significant NN B-NP O
39 for IN B-VP O
39 a DT B-NP O
39 history NN I-NP O
39 of IN B-VP O
40 sarcoidosis NN B-NP O
40 Her NNP I-NP O
40 last JJ B-NP O
40 pulmonary JJ I-NP O
40 test NN I-NP O
40 was VBD B-VP O
40 in IN B-VP O
41 May NNP B-NP O
41 1995 CD O O
41 which WDT O O
41 showed VBD B-VP O
41 an DT B-NP O
41 FEV NNP I-NP O
41 1 CD O O
41 of IN B-VP O
41 1.61 CD O O
41 , , O O
41 72% CD O O
41 of IN B-VP O
41 predicted; NN B-NP O
41 FEV NNP I-NP O
42 1 CD O O
42 ratio NN B-NP O
42 to TO O O
42 FVC NNP B-NP O
42 was VBD B-VP O
42 80 CD O O
42 or CC O O
42 102% CD O O
42 of IN B-VP O
42 predicted VBN O O
42 FVC NNP B-NP O
42 was VBD B-VP O
42 2.01 CD O O
42 or CC O O
42 72% CD O O
42 of IN B-VP O
43 predicted VBN O O
43 In IN B-VP O
43 the DT B-NP O
43 past NN I-NP O
43 , , O O
43 she PRP O O
43 has VBZ O O
43 been VBN O O
43 treated VBN O O
43 with IN B-VP O
43 prednisone NN B-NP B-m
43 and CC O O
44 now RB O O
44 uses VBZ O O
44 Ventolin NNP B-NP B-m
44 inhalers NNS I-NP I-m
44 p.r.n VBP O B-f
44 2 CD O O
44 ) ) O O
44 History NN B-NP O
44 of IN B-VP O
44 seizure NN B-NP O
44 disorder NN I-NP O
45 3 CD O O
45 ) ) O O
45 Status NNP B-NP O
45 post NN I-NP O
45 pacemaker NN I-NP O
45 placement NN I-NP O
45 in IN B-VP O
45 March NNP B-NP O
45 1996 CD O O
45 for IN B-VP O
45 tachycardia JJ B-NP O
46 bradycardia NN I-NP O
46 syndrome NN I-NP O
46 4 CD O O
46 ) ) O O
46 Status NNP B-NP O
46 post NN I-NP O
46 appendectomy RB O O
46 5 CD O O
46 ) ) O O
46 Status NNP B-NP O
47 post NN I-NP O
47 total JJ B-NP O
47 abdominal JJ I-NP O
47 hysterectomy NN I-NP O
47 for IN B-VP O
47 cervical JJ B-NP O
47 cancer NN I-NP O
47 6 CD O O
47 ) ) O O
47 Adult NNP B-NP O
48 onset MD O O
48 diabetes VBZ O O
48 mellitus NNS B-NP O
48 , , O O
48 diet-controlled JJ O O
48 7 CD O O
48 ) ) O O
48 History NN B-NP O
48 of IN B-VP O
48 left JJ B-NP O
48 calf NN I-NP O
49 deep JJ B-NP O
49 vein NN I-NP O
49 thrombosis NN I-NP O
49 in IN B-VP O
49 1993 CD O O
49 8 CD O O
49 ) ) O O
49 History NN B-NP O
49 of IN B-VP O
49 colonic JJ B-NP O
49 polyps NNS I-NP O
49 with IN B-VP O
49 a DT B-NP O
50 colonic JJ I-NP O
50 adenoma NN I-NP O
50 diagnosed VBN O O
50 in IN B-VP O
50 1993 CD O O
51 MEDICATIONS NNP B-NP O
51 AT NNP I-NP O
51 THE NNP I-NP O
51 TIME NNP I-NP O
51 OF NNP I-NP O
51 ADMISSION: NNP I-NP O
51 Linsinopril NNP I-NP B-m
51 5 CD O B-do
51 mg NN B-NP I-do
51 q.d.; NN I-NP B-f
52 Pravachol NNP I-NP B-m
52 20 CD O B-do
52 mg NN B-NP I-do
52 q.h.s.; NN I-NP B-f
53 aspirin VBD B-VP B-m
53 325 CD O B-do
53 mg NN B-NP I-do
53 q NN I-NP B-f
53 day; NN I-NP I-f
53 atenolol VBD B-VP B-m
53 0.5 CD O B-do
53 mg NN B-NP I-do
53 b.i.d.; NN I-NP B-f
53 Dilantin NNP I-NP B-m
53 200 CD O B-do
53 mg NN B-NP I-do
54 b.i.d.; NN I-NP B-f
54 Ventolin NNP I-NP B-m
54 inhaler NN I-NP I-m
54 p.r.n.; NN I-NP B-f
54 ferrous JJ B-NP B-m
54 gluconate NN I-NP I-m
54 325 CD O B-do
54 mg NN B-NP I-do
54 t.i.d NN I-NP B-f
55 ALLERGIES: NNP I-NP O
55 Penicillin NNP I-NP O
55 and CC O O
55 erythromycin RB O O
55 , , O O
55 gives VBZ O O
55 rash JJ B-NP O
56 PHYSICAL NNP I-NP O
56 EXAMINATION: NNP I-NP O
56 She PRP O O
56 was VBD B-VP O
56 a DT B-NP O
56 pleasant JJ I-NP O
56 female NN I-NP O
56 in IN B-VP O
56 no DT B-NP O
56 acute NN I-NP O
57 distress NN I-NP O
57 Vital NNP I-NP O
57 signs NNS I-NP O
57 revealed VBD B-VP O
57 a DT B-NP O
58 temperature NN I-NP O
58 of IN B-VP O
58 97.9; CD O O
58 heart NN B-NP O
58 rate NN I-NP O
58 78; CD O O
58 blood NN B-NP O
58 pressure NN I-NP O
58 120/70; CD O O
59 respiratory NN B-NP O
59 rate NN I-NP O
59 19 CD O O
59 Saturation NNP B-NP O
59 was VBD B-VP O
59 99% CD O O
59 on IN B-VP O
59 two CD O O
59 liters NNS B-NP O
59 Head VBP O O
59 , , O O
60 eyes NNS B-NP O
60 , , O O
60 nose RB O O
60 , , O O
60 and CC O O
60 throat NN B-NP O
60 examination: NN I-NP O
60 Pupils NNP I-NP O
60 were VBD B-VP O
60 equal JJ O O
60 , , O O
60 round NN B-NP O
60 , , O O
60 and CC O O
61 reactive JJ O O
61 to TO O O
61 light JJ B-NP O
61 Extraocular JJ I-NP O
61 movements NNS I-NP O
61 intact JJ B-NP O
61 Oropharynx NNP I-NP O
61 was VBD B-VP O
62 clear JJ O O
62 and CC O O
62 edentulous JJ B-NP O
62 Jugular NNP I-NP O
62 venous JJ B-NP O
62 pressure NN I-NP O
62 was VBD B-VP O
62 8 CD O O
62 centimeters NNS B-NP O
63 No NNP I-NP O
63 lymphadenopathy JJ B-NP O
63 Carotids NNP I-NP O
63 were VBD B-VP O
63 2+ CD O O
63 bilaterally RB O O
63 , , O O
63 no DT B-NP O
63 bruits NNS I-NP O
64 Lungs: NNP I-NP O
64 Diffuse NNP I-NP O
64 , , O O
64 dry JJ O O
64 rales VBZ O O
64 No DT B-NP O
64 wheezes JJ I-NP O
64 Cardiac: NNP I-NP O
64 Regular NNP I-NP O
64 rate NN I-NP O
65 and CC O O
65 rhythm NN B-NP O
65 S4 NNP I-NP O
65 present JJ O O
65 1/6 CD O O
65 systolic JJ O O
65 murmur FW O O
65 heard NN B-NP O
65 at IN B-VP O
65 upper JJ O O
65 left VBD B-VP O
66 sternal JJ B-NP O
66 border NN I-NP O
66 Abdomen: NNP I-NP O
66 Cholecystectomy NNP I-NP O
66 scar NN I-NP O
66 Infraumbilical NNP I-NP O
67 midline NN I-NP O
67 scar NN I-NP O
67 No NNP I-NP O
67 masses VBZ O O
67 No DT B-NP O
67 hepatosplenomegaly JJ I-NP O
67 Positive NNP I-NP O
67 bowel NN I-NP O
68 sounds VBZ O O
68 Rectal: NNP B-NP O
68 Guaiac NNP I-NP O
68 negative JJ O O
68 per IN B-VP O
68 the DT B-NP O
68 Emergency NNP I-NP O
68 Room NNP I-NP O
69 Extremities: NNP I-NP O
69 Femoral NNP I-NP O
69 pulses NNS I-NP O
69 were VBD B-VP O
69 2+ CD O O
69 bilaterally RB O O
69 No NNP B-NP O
69 bruits VBZ O O
69 No DT B-NP O
70 lower JJR I-NP O
70 extremity NN I-NP O
70 edema NN I-NP O
70 Dorsalis NNP I-NP O
70 pedis NN I-NP O
70 and CC O O
70 posterior JJ B-NP O
70 tibialis NN I-NP O
71 pulses NNS I-NP O
71 were VBD B-VP O
71 2+ CD O O
71 bilaterally RB O O
71 Nonfocal JJ B-NP O
71 neurological JJ I-NP O
71 examination NN I-NP O
71 No NNP I-NP O
72 motor NN I-NP O
72 or CC O O
72 sensory JJ B-NP O
72 deficits NNS I-NP O
73 LABORATORY NNP I-NP O
73 DATA: NNP I-NP O
73 Chest NNP I-NP O
73 x-ray: JJ B-NP O
73 Bilateral NNP I-NP O
73 parenchymal NN I-NP O
73 opacities NNS I-NP O
73 , , O O
74 most JJS O O
74 prominent JJ O O
74 in IN B-VP O
74 the DT B-NP O
74 right JJ I-NP O
74 upper JJ I-NP O
74 lung NN I-NP O
74 fields NNS I-NP O
75 Stable JJ O O
75 and CC O O
75 consistent JJ O O
75 with IN B-VP O
75 previous JJ B-NP O
75 examinations NNS I-NP O
75 from IN B-VP O
75 March NNP B-NP O
75 , , O O
76 1997 CD O O
76 , , O O
76 consistent JJ O O
76 with IN B-VP O
76 chronic JJ B-NP O
76 sarcoidosis NN I-NP O
76 Pacer NNP I-NP O
76 wires NNS I-NP O
76 were VBD B-VP O
76 in IN B-VP O
77 good JJ B-NP O
77 position NN I-NP O
77 Electrocardiogram NNP I-NP O
77 on IN B-VP O
77 admission NN B-NP O
77 , , O O
77 May NNP B-NP O
77 , , O O
77 1997 CD O O
77 in IN B-VP O
78 the DT B-NP O
78 Emergency NNP I-NP O
78 Room NNP I-NP O
78 , , O O
78 normal JJ B-NP O
78 sinus NN I-NP O
78 rhythm NN I-NP O
78 at IN B-VP O
78 66 CD O O
78 T-wave JJ B-NP O
78 inversion NN I-NP O
78 in IN B-VP O
79 I PRP O O
79 , , O O
79 T-wave JJ B-NP O
79 inversion NN I-NP O
79 in IN B-VP O
79 II NNP B-NP O
79 and CC O O
79 AVF NNP B-NP O
79 , , O O
79 biphasic JJ B-NP O
79 T-waves NNS I-NP O
79 in IN B-VP O
79 V2 NNP B-NP O
79 , , O O
79 and CC O O
80 T-wave NNP B-NP O
80 inversions NNS I-NP O
80 in IN B-VP O
80 V3-V6 NNP B-NP O
80 Slightly NNP I-NP O
80 pronounced VBD B-VP O
80 when WRB O O
80 compared VBN O O
80 with IN B-VP O
81 previous JJ B-NP O
81 electrocardiogram NNS I-NP O
82 Sodium VBP O O
82 143; CD O O
82 potassium NN B-NP O
82 5.1; CD O O
82 chloride NN B-NP O
82 108; CD O O
82 bicarbonate NN B-NP O
82 23; CD O O
82 BUN NNP B-NP O
82 36; CD O O
83 creatinine NN B-NP O
83 1.8; CD O O
83 glucose JJ O O
83 255 CD O O
83 White NNP B-NP O
83 count NN I-NP O
83 6700; CD O O
83 hematocrit NN B-NP O
83 30.9; CD O O
84 platelets NNS B-NP O
84 143 CD O O
84 , , O O
84 000; CD O O
84 MCV NNP B-NP O
84 85.1 CD O O
84 Prothrombin NNP B-NP O
84 time NN I-NP O
84 was VBD B-VP O
84 11.4 CD O O
84 Partial NNP B-NP O
85 thromboplastin NN I-NP O
85 time NN I-NP O
85 was VBD B-VP O
85 25.2 CD O O
85 INR NNP B-NP O
85 was VBD B-VP O
85 0.9 CD O O
85 CK NNP B-NP O
85 was VBD B-VP O
85 79 CD O O
85 Troponin NNP B-NP O
86 0.0 CD O O
86 Dilantin: NNP B-NP O
86 Less NNP I-NP O
86 than IN B-VP O
86 assay VBP O O
86 Hematocrit NNP B-NP O
86 on IN B-VP O
86 June NNP B-NP O
86 , , O O
86 1997 CD O O
86 , , O O
87 was VBD B-VP O
87 29.3 CD O O
87 Cholesterol NNP B-NP O
87 total NN I-NP O
87 was VBD B-VP O
87 258; CD O O
87 LDH NNP B-NP O
87 43; CD O O
87 LDL NNP B-NP O
87 166 CD O O
88 HOSPITAL NNP B-NP O
88 COURSE: NNP I-NP O
88 Ms NNP I-NP O
88 Talburt NNP I-NP O
88 was VBD B-VP O
88 admitted VBN O O
88 for IN B-VP O
88 a DT B-NP O
88 rule NN I-NP O
88 out IN B-VP O
88 myocardial JJ B-NP O
89 infarction NN I-NP O
89 protocol NN I-NP O
89 and CC O O
89 underwent JJ B-NP O
89 serial JJ I-NP O
90 electrocardiograms NN I-NP O
90 and CC O O
90 her PRP$ O O
90 enzymes NNS B-NP O
90 were VBD B-VP O
90 studied VBN O O
90 She PRP O O
90 was VBD B-VP O
90 started VBN O O
91 on IN B-VP O
91 Nitrol NNP B-NP B-m
91 paste NN I-NP I-m
91 Aspirin NNP I-NP B-m
91 , , O O
91 linsinopril NN B-NP B-m
91 , , O O
91 and CC O O
91 atenolol RB O B-m
91 , , O O
91 were VBD B-VP O
92 continued VBN O O
92 Given NNP B-NP O
92 her PRP$ O O
92 low JJ B-NP O
92 hematocrit NN I-NP O
92 as IN B-VP O
92 a DT B-NP O
92 possible JJ I-NP O
92 etiology NN I-NP O
92 for IN B-VP O
93 her PRP$ O B-r
93 ischemia NN B-NP I-r
93 , , O O
93 she PRP O O
93 was VBD B-VP O
93 transfused VBN O O
93 with IN B-VP O
93 one CD O B-do
93 unit NN B-NP I-do
93 of IN B-VP O
93 packed JJ B-NP B-m
93 red JJ I-NP I-m
93 cells NNS I-NP I-m
94 Stools NNP I-NP O
94 were VBD B-VP O
94 guaiac JJ B-NP O
94 neg NN I-NP O
94 and CC O O
94 anemia NN B-NP O
94 workup NN I-NP O
94 was VBD B-VP O
94 initiated VBN O O
94 She PRP O O
94 was VBD B-VP O
95 continued VBN O O
95 on IN B-VP O
95 her PRP$ O O
95 albuterol NN B-NP B-m
95 inhale NN I-NP I-m
95 and CC O O
95 nebulizers NNS B-NP B-m
95 p.r.n VBP O B-f
95 p.r.n NN B-NP B-f
96 On IN B-VP O
96 February NNP B-NP O
96 , , O O
96 1997 CD O O
96 , , O O
96 the DT B-NP O
96 patient JJ I-NP O
96 underwent JJ I-NP O
96 cardiac NN I-NP O
96 catheterization NN I-NP O
97 which WDT O O
97 showed VBD B-VP O
97 a DT O O
97 70% CD O O
97 residual JJ B-NP O
97 osteal JJ I-NP O
97 diagonal JJ I-NP O
97 stenosis NN I-NP O
97 , , O O
97 0% CD O O
97 left VBD B-VP O
98 anterior JJ O O
98 descending VBG O O
98 stenosis NN B-NP O
98 A DT B-NP O
98 stent NN I-NP O
98 was VBD B-VP O
98 placed VBN O O
98 in IN B-VP O
98 the DT B-NP O
98 diagonal JJ I-NP O
99 artery NN I-NP O
99 with IN B-VP O
99 0% CD O O
99 residual JJ B-NP O
99 stenosis NN I-NP O
99 Later NNP I-NP O
99 than IN B-VP O
99 evening VBG O O
99 , , O O
99 the DT B-NP O
99 patient NN I-NP O
100 began VBD B-VP O
100 to TO O O
100 complain VB O O
100 of IN B-VP O
100 severe JJ O O
100 left VBN O O
100 arm NN B-NP O
100 pain NN I-NP O
100 radiating VBG O O
100 to TO O O
100 her PRP$ O O
100 left JJ B-NP O
101 chest NN I-NP O
101 Her PRP$ O O
101 electrocardiogram NN B-NP O
101 changes NNS I-NP O
101 showed VBD B-VP O
101 ST NNP B-NP O
101 elevation NN I-NP O
101 in IN B-VP O
101 VI NNP B-NP O
101 and CC O O
102 VII NNP B-NP O
102 , , O O
102 and CC O O
102 T-wave NNP B-NP O
102 more RBR O O
102 inverted JJ O O
102 in IN B-VP O
102 VIV NNP B-NP O
102 She PRP O O
102 received VBD B-VP O
102 morphine NN B-NP B-m
102 and CC O O
103 was VBD B-VP O
103 already RB O O
103 on IN B-VP O
103 a DT B-NP O
103 nitroglycerin JJ I-NP B-m
103 drip NN I-NP B-mo
103 , , O O
103 and CC O O
103 she PRP O O
103 was VBD B-VP O
103 taken VBN O O
103 back RB O O
103 to TO O O
103 the DT B-NP O
104 catheterization NN I-NP O
104 laboratory NN I-NP O
104 Her NNP I-NP O
104 spectral NN I-NP O
104 study NN I-NP O
104 on IN B-VP O
104 February NNP B-NP O
104 , , O O
105 1997 CD O O
105 , , O O
105 revealed VBD B-VP O
105 a DT O O
105 90% CD O O
105 mid NN B-NP O
105 left VBD B-VP O
105 anterior JJ B-NP O
105 descending NN I-NP O
105 and CC O O
105 95% CD O O
105 VI NNP B-NP O
105 , , O O
105 and CC O O
106 her PRP$ O O
106 left JJ B-NP O
106 anterior JJ I-NP O
106 descending NN I-NP O
106 was VBD B-VP O
106 stented VBN O O
106 at IN B-VP O
106 this DT B-NP O
106 time NN I-NP O
107 Following VBG O O
107 her PRP O O
107 two CD O O
107 cardiac JJ B-NP O
107 catheterizations NNS I-NP O
107 , , O O
107 she PRP O O
107 experienced VBD B-VP O
108 intermittent JJ B-NP O
108 atypical JJ I-NP O
108 chest NN I-NP O
108 which WDT O O
108 was VBD B-VP O
108 transient NN B-NP O
108 in IN B-VP O
108 nature NN B-NP O
108 without IN B-VP O
109 sustaining VBG O O
109 any DT B-NP O
109 electrocardiogram JJ I-NP O
109 changes NNS I-NP O
109 Her PRP$ O O
109 cardiac JJ B-NP O
109 enzymes NNS I-NP O
109 were VBD B-VP O
110 significant JJ O O
110 for IN B-VP O
110 a DT B-NP O
110 CK NNP I-NP O
110 of IN B-VP O
110 409 CD O O
110 with IN B-VP O
110 an DT B-NP O
110 MB NNP I-NP O
110 fraction NN I-NP O
110 o RB O O
110 21 CD O O
111 On IN B-VP O
111 March NNP B-NP O
111 , , O O
111 1997 CD O O
111 , , O O
111 it PRP O O
111 was VBD B-VP O
111 noted VBN O O
111 that IN B-VP O
111 her PRP$ O O
111 creatinine NN B-NP O
111 had VBD B-VP O
111 risen VBN O O
111 to TO O O
112 3.1 CD O O
112 , , O O
112 elevated VBN O O
112 from IN B-VP O
112 a DT B-NP O
112 level NN I-NP O
112 of IN B-VP O
112 1.9 CD O O
112 before IN B-VP O
112 the DT B-NP O
112 catheterization NN I-NP O
112 and CC O O
112 a DT B-NP O
113 diagnosis NN I-NP O
113 of IN B-VP O
113 radial JJ B-NP O
113 contrast NN I-NP O
113 induced VBD B-VP O
113 nephrotoxicity NN B-NP O
113 was VBD B-VP O
113 made VBN O O
113 Her NNP B-NP O
114 creatinine NN I-NP O
114 rose VBD B-VP O
114 and CC O O
114 rose VBD B-VP O
114 to TO O O
114 a DT B-NP O
114 peak JJ I-NP O
114 level NN I-NP O
114 of IN B-VP O
114 5.1 CD O O
114 on IN B-VP O
114 March NNP B-NP O
114 , , O O
115 1997 CD O O
115 , , O O
115 and CC O O
115 then RB O O
115 began VBD B-VP O
115 to TO O O
115 decrease VB O O
115 At IN B-VP O
115 the DT B-NP O
115 time NN I-NP O
115 of IN B-VP O
115 discharge NN B-NP O
115 , , O O
115 it PRP O O
115 was VBD B-VP O
116 down RB O O
116 to TO O O
116 2.2 CD O O
116 The DT B-NP O
116 patient NN I-NP O
116 continued VBD B-VP O
116 to TO O O
116 have VB O O
116 excellent JJ B-NP O
116 urine NN I-NP O
116 output NN I-NP O
117 throughout IN B-VP O
117 the DT B-NP O
117 rise NN I-NP O
117 in IN B-VP O
117 her PRP$ O O
117 creatinine NN B-NP O
117 and CC O O
117 was VBD B-VP O
117 normal JJ O O
117 by IN B-VP O
117 the DT B-NP O
117 time NN I-NP O
117 of IN B-VP O
118 discharge NN B-NP O
119 Her NNP I-NP O
119 laboratories NNS I-NP O
119 at IN B-VP O
119 the DT B-NP O
119 time NN I-NP O
119 of IN B-VP O
119 discharge NN B-NP O
119 were VBD B-VP O
119 a DT B-NP O
119 sodium NN I-NP O
119 of IN B-VP O
119 141; CD O O
120 potassium NN B-NP O
120 4.8; CD O O
120 chloride NN B-NP O
120 106; CD O O
120 bicarbonate NN B-NP O
120 20; CD O O
120 BUN NNP B-NP O
120 31; CD O O
120 creatinine NN B-NP O
121 2.2; CD O O
121 glucose JJ O O
121 90 CD O O
121 White NNP B-NP O
121 count NN I-NP O
121 6900; CD O O
121 hematocrit NN B-NP O
121 33.9; CD O O
121 platelets NNS B-NP O
121 were VBD B-VP O
122 203 CD O O
122 , , O O
122 000 CD O O
122 She PRP O O
122 had VBD B-VP O
122 an DT B-NP O
122 exercise NN I-NP O
122 tolerance NN I-NP O
122 test NN I-NP O
122 and CC O O
122 ED NNP B-NP O
122 study NN I-NP O
122 on IN B-VP O
123 November NNP B-NP O
123 , , O O
123 1997 CD O O
123 , , O O
123 which WDT O O
123 showed VBD B-VP O
123 an DT O O
123 essentially RB O O
123 negative JJ B-NP O
123 exercise NN I-NP O
124 treadmill NN I-NP O
124 test NN I-NP O
124 and CC O O
124 was VBD B-VP O
124 a DT B-NP O
124 suboptimal JJ I-NP O
124 study NN I-NP O
124 She PRP O O
124 exercised VBD B-VP O
124 for IN B-VP O
125 approximately RB O O
125 five CD O O
125 minutes NNS B-NP O
125 on IN B-VP O
125 submaximal JJ B-NP O
125 exercise NN I-NP O
125 treadmill NN I-NP O
125 test NN I-NP O
126 protocol NN I-NP O
126 with IN B-VP O
126 no DT B-NP O
126 evidence NN I-NP O
126 of IN B-VP O
126 ischemia NN B-NP O
126 , , O O
126 but CC O O
126 low JJ B-NP O
126 exercise NN I-NP O
126 tolerance NN I-NP O
127 Her NNP I-NP O
127 medications NNS I-NP O
127 at IN B-VP O
127 the DT B-NP O
127 time NN I-NP O
127 of IN B-VP O
127 discharge NN B-NP O
127 included: NN I-NP O
127 Ticlid NNP I-NP B-m
127 250 CD O B-do
127 mg NN B-NP I-do
128 p.o NN I-NP B-mo
128 b.i.d.; NN I-NP B-f
128 albuterol NN I-NP B-m
128 inhaler NN I-NP I-m
128 2 CD O B-do
128 puffs NNS B-NP I-do
128 q.i.d RB O B-f
128 as IN B-VP I-f
128 needed VBN O I-f
128 for IN B-VP O
129 shortness NN B-NP B-r
129 of IN B-VP I-r
129 breath; JJ B-NP I-r
129 enteric-coated JJ I-NP B-m
129 aspirin NN I-NP I-m
129 325 CD O B-do
129 mg NN B-NP I-do
129 p.o NN I-NP B-mo
129 q.d.; NN I-NP B-f
130 atenolol VBD B-VP B-m
130 37.5 CD O B-do
130 mg NN B-NP I-do
130 p.o NN I-NP B-mo
130 b.i.d.; NN I-NP B-f
130 nitroglycerin RB O B-m
130 1/150 CD O I-m
130 sublingual JJ O B-mo
130 one CD O B-do
131 tablet NN B-NP O
131 q NN I-NP B-f
131 5 CD O I-f
131 minutes NNS B-NP I-f
131 times NNS I-NP I-f
131 three CD O I-f
131 for IN B-VP O
131 chest NN B-NP B-r
131 pain; NN I-NP I-r
131 and CC O O
131 Dilantin NNP B-NP B-m
131 200 CD O B-do
131 mg NN B-NP I-do
132 p.o NN I-NP B-mo
132 b.i.d NN I-NP B-f
133 She PRP O O
133 is VBZ O O
133 scheduled VBN O O
133 to TO O O
133 followup VB O O
133 with IN B-VP O
133 Dr NNP B-NP O
133 Doug NNP I-NP O
133 Millis NNP I-NP O
133 in IN B-VP O
133 her PRP$ O O
133 office NN B-NP O
134 in IN B-VP O
134 one CD O O
134 week NN B-NP O
134 and CC O O
134 will MD O O
134 follow VB O O
134 up RP O O
134 with IN B-VP O
134 cardiology NN B-NP O
134 as IN B-VP O
134 an DT B-NP O
134 outpatient NN I-NP O
135 Dictated NNP I-NP O
135 By: NNP I-NP O
135 CLEVELAND NNP I-NP O
135 PRINCEVALLE NNP I-NP O
135 , , O O
135 M.D NNP B-NP O
135 IP95 NNP I-NP O
136 Attending: NNP I-NP O
136 COLEMAN NNP I-NP O
136 HOYLAND NNP I-NP O
136 , , O O
136 M.D NNP B-NP O
136 XF78 NNP I-NP O
136 GC702/3343 NNP I-NP O
137 Batch: NNP I-NP O
137 29248 CD O O
137 Index NNP B-NP O
137 No NNP I-NP O
137 DPIXVYL69 NNP I-NP O
137 D: NNP I-NP O
137 10/28/97 CD O O
138 T: NNP B-NP O
138 10/12/97 CD O O
139 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #589139 VBZ O O
4 624364932 CD O O
4 THS NNP B-NP O
4 28965512 CD O O
4 029873 CD O O
4 11/28/1997 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 SYNCOPE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 8/16/1997 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/20/1997 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 SYNCOPE NNP I-NP O
8 SIGNIFICANT NNP I-NP O
8 PROBLEMS: NNP I-NP O
8 1 CD O O
8 IDIOPATHIC NNP B-NP O
8 CARDIOMYOPATHY NNP I-NP O
9 2 CD O O
9 ATYPICAL NNP B-NP O
9 CHEST NNP I-NP O
9 PAIN NNP I-NP O
10 HISTORY NNP I-NP O
10 OF NNP I-NP O
10 PRESENT NNP I-NP O
10 ILLNESS: NNP I-NP O
10 The DT B-NP O
10 patient NN I-NP O
10 is VBZ O O
10 a DT B-NP O
10 64-year-old JJ I-NP O
10 woman NN I-NP O
10 who WP O O
11 has VBZ O O
11 lived VBN O O
11 in IN B-VP O
11 Tall NNP B-NP O
11 Dis NNP I-NP O
11 Thou NNP I-NP O
11 since IN B-VP O
11 1993 CD O O
12 She PRP O O
12 has VBZ O O
12 a DT B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 chest NN B-NP O
12 pain NN I-NP O
12 and CC O O
12 has VBZ O O
12 a DT B-NP O
12 baseline NN I-NP O
12 EKG NNP I-NP O
12 with IN B-VP O
12 an DT B-NP O
13 intraventricular JJ I-NP O
13 conduction NN I-NP O
13 delay NN I-NP O
13 , , O O
13 QRS NNP B-NP O
13 interval NN I-NP O
13 of IN B-VP O
13 0.10 CD O O
13 Her PRP$ O O
14 cardiac JJ B-NP O
14 history NN I-NP O
14 includes: NN I-NP O
14 In IN B-VP O
14 February NNP B-NP O
14 1988 CD O O
14 , , O O
14 she PRP O O
14 underwent VBD B-VP O
14 an DT B-NP O
15 exercise NN I-NP O
15 tolerance NN I-NP O
15 test NN I-NP O
15 for IN B-VP O
15 chest NN B-NP O
15 pain NN I-NP O
15 The DT B-NP O
15 patient NN I-NP O
15 went VBD B-VP O
15 7 CD O O
15 minutes NNS B-NP O
16 35 CD O O
16 seconds NNS B-NP O
16 and CC O O
16 had VBD B-VP O
16 a DT B-NP O
16 maximum JJ I-NP O
16 heart NN I-NP O
16 rate NN I-NP O
16 of IN B-VP O
16 100 CD O O
16 , , O O
16 maximum JJ B-NP O
16 blood NN I-NP O
17 pressure NN I-NP O
17 not RB O O
17 recorded VBN O O
17 She PRP O O
17 developed VBD B-VP O
17 a DT B-NP O
17 left NN I-NP O
17 bundle NN I-NP O
17 branch NN I-NP O
17 block NN I-NP O
18 with IN B-VP O
18 exercise NN B-NP O
18 A NNP I-NP O
18 thallium NN I-NP O
18 scan NN I-NP O
18 showed VBD B-VP O
18 no DT B-NP O
18 evidence NN I-NP O
18 of IN B-VP O
18 ischemia NN B-NP O
18 In IN B-VP O
19 July NNP B-NP O
19 1992 CD O O
19 , , O O
19 she PRP O O
19 had VBD B-VP O
19 an DT B-NP O
19 exercise NN I-NP O
19 tolerance NN I-NP O
19 test NN I-NP O
19 for IN B-VP O
19 chest NN B-NP O
19 pain NN I-NP O
19 and CC O O
20 shortness NN B-NP O
20 of IN B-VP O
20 breath NN B-NP O
20 She PRP O O
20 went VBD B-VP O
20 9 CD O O
20 minutes NNS B-NP O
20 0 CD O O
20 seconds NNS B-NP O
20 and CC O O
20 had VBD B-VP O
20 a DT B-NP O
21 maximum JJ I-NP O
21 heart NN I-NP O
21 rate NN I-NP O
21 of IN B-VP O
21 167 CD O O
21 with IN B-VP O
21 maximum JJ B-NP O
21 blood NN I-NP O
21 pressure NN I-NP O
21 138/60 CD O O
21 She PRP O O
22 developed VBD B-VP O
22 angina RB O O
22 during IN B-VP O
22 the DT B-NP O
22 test NN I-NP O
22 The DT B-NP O
22 SPECT NNP I-NP O
22 scan NN I-NP O
22 showed VBD B-VP O
22 a DT O O
22 moderate JJ O O
23 fixed VBN O O
23 defect NN B-NP O
23 in IN B-VP O
23 the DT B-NP O
23 apicolateral JJ I-NP O
23 wall NN I-NP O
23 In IN B-VP O
23 8/21 CD O O
23 , , O O
23 she PRP O O
23 had VBD B-VP O
23 an DT B-NP O
23 EKG NNP I-NP O
24 done VBN O O
24 which WDT O O
24 showed VBD B-VP O
24 normal JJ B-NP O
24 sinus NNS I-NP O
24 rhythm VBP O O
24 with IN B-VP O
24 a DT B-NP O
24 QRS NNP I-NP O
24 interval NN I-NP O
24 of IN B-VP O
24 0.10 CD O O
25 and CC O O
25 moderate JJ B-NP O
25 LVH NNP I-NP O
25 In IN B-VP O
25 1995 CD O O
25 , , O O
25 the DT B-NP O
25 patient NN I-NP O
25 states VBZ O O
25 that IN B-VP O
25 she PRP O O
25 had VBD B-VP O
25 a DT B-NP O
26 cardiac JJ I-NP O
26 catheterization NN I-NP O
26 in IN B-VP O
26 Auriend NNP B-NP O
26 Road NNP I-NP O
26 , , O O
26 Kane NNP B-NP O
26 Cho NNP I-NP O
26 , , O O
26 Mississippi NNP B-NP O
26 13286 CD O O
26 which WDT O O
26 showed VBD B-VP O
26 no DT B-NP O
26 coronary JJ I-NP O
27 disease NN I-NP O
27 , , O O
27 although IN B-VP O
27 she PRP O O
27 was VBD B-VP O
27 told VBN O O
27 that IN B-VP O
27 she PRP O O
27 had VBD B-VP O
27 a DT O O
27 cardiomyopathy JJ O O
27 The DT B-NP O
28 patient NN I-NP O
28 reports NNS I-NP O
28 feeling VBG O O
28 well RB O O
28 until IN B-VP O
28 the DT B-NP O
28 day NN I-NP O
28 of IN B-VP O
28 admission NN B-NP O
28 without IN B-VP O
28 any DT B-NP O
29 chest NN I-NP O
29 pain NN I-NP O
29 , , O O
29 shortness NN B-NP O
29 of IN B-VP O
29 breath NN B-NP O
29 , , O O
29 paroxysmal JJ B-NP O
29 nocturnal JJ I-NP O
29 dyspnea NN I-NP O
29 , , O O
29 or CC O O
30 orthopnea NN B-NP O
30 in IN B-VP O
30 the DT B-NP O
30 recent JJ I-NP O
30 past NN I-NP O
30 On IN B-VP O
30 the DT B-NP O
30 afternoon NN I-NP O
30 of IN B-VP O
30 admission NN B-NP O
30 , , O O
30 at IN B-VP O
31 about IN B-VP O
31 2 CD O O
31 o'clock NN B-NP O
31 in IN B-VP O
31 the DT B-NP O
31 afternoon NN I-NP O
31 , , O O
31 she PRP O O
31 was VBD B-VP O
31 watching VBG O O
31 television NN B-NP O
31 She PRP O O
32 arose VBD B-VP O
32 from IN B-VP O
32 the DT B-NP O
32 couch NN I-NP O
32 and CC O O
32 went VBD B-VP O
32 to TO O O
32 the DT B-NP O
32 kitchen NN I-NP O
32 to TO O O
32 get VB O O
32 a DT B-NP O
32 cup NN I-NP O
32 of IN B-VP O
33 coffee NN B-NP O
33 She PRP O O
33 recalls VBZ O O
33 filling VBG O O
33 her PRP$ O O
33 cup NN B-NP O
33 with IN B-VP O
33 water NN B-NP O
33 , , O O
33 then RB O O
33 recalls VBZ O O
34 nothing NN B-NP O
34 else RB O O
34 until IN B-VP O
34 she PRP O O
34 awoke VBD B-VP O
34 with IN B-VP O
34 her PRP$ O O
34 grandchildren NNS B-NP O
34 lying VBG O O
34 on IN B-VP O
34 half NN B-NP O
35 of IN B-VP O
35 her PRP$ O O
35 on IN B-VP O
35 the DT B-NP O
35 floor NN I-NP O
35 and CC O O
35 crying VBG O O
35 The DT B-NP O
35 patient NN I-NP O
35 was VBD B-VP O
35 oriented VBN O O
35 upon IN B-VP O
36 awakening VBG O O
36 and CC O O
36 recognized VBD B-VP O
36 her PRP$ O O
36 grandchildren NN B-NP O
36 immediately RB O O
36 She PRP O O
36 did VBD B-VP O
37 not RB O O
37 have VB O O
37 any DT B-NP O
37 incontinence NN I-NP O
37 or CC O O
37 tongue NN B-NP O
37 biting NN I-NP O
37 She PRP O O
37 denied VBD B-VP O
37 muscle NN B-NP O
38 aches NNS I-NP O
38 , , O O
38 somnolence NN B-NP O
38 , , O O
38 confusion NN B-NP O
38 , , O O
38 or CC O O
38 weakness NN B-NP O
38 She PRP O O
38 went VBD B-VP O
38 to TO O O
38 the DT B-NP O
38 couch NN I-NP O
39 to TO O O
39 sit VB O O
39 down RP O O
39 and CC O O
39 had VBD B-VP O
39 nausea NN B-NP O
39 and CC O O
39 vomiting VBG O O
39 about IN B-VP O
39 five CD O O
39 minutes NNS B-NP O
39 after IN B-VP O
40 her PRP$ O O
40 syncopal JJ B-NP O
40 episode NN I-NP O
40 She PRP O O
40 also RB O O
40 noted VBD B-VP O
40 a DT B-NP O
40 bump NN I-NP O
40 on IN B-VP O
40 the DT B-NP O
40 right JJ I-NP O
40 side NN I-NP O
40 of IN B-VP O
41 her PRP$ O O
41 head NN B-NP O
41 and CC O O
41 subsequently RB O O
41 developed VBD B-VP O
41 a DT B-NP O
41 headache NN I-NP O
41 She PRP O O
41 did VBD B-VP O
41 not RB O O
41 have VB O O
42 any DT B-NP O
42 neurologic JJ I-NP O
42 symptoms NNS I-NP O
42 , , O O
42 denied VBD B-VP O
42 any DT B-NP O
42 chest JJS I-NP O
42 pain NN I-NP O
42 or CC O O
42 shortness NN B-NP O
42 of IN B-VP O
43 breath NN B-NP O
43 She PRP O O
43 was VBD B-VP O
43 diaphoretic JJ O O
43 at IN B-VP O
43 the DT B-NP O
43 time NN I-NP O
43 that IN B-VP O
43 she PRP O O
43 was VBD B-VP O
43 sitting VBG O O
43 on IN B-VP O
44 the DT B-NP O
44 cough NN I-NP O
44 , , O O
44 nauseous JJ O O
44 and CC O O
44 vomiting VBG O O
44 afterwards NNS B-NP O
44 She PRP O O
44 had VBD B-VP O
44 no DT B-NP O
45 palpitations NNS I-NP O
45 and CC O O
45 she PRP O O
45 had VBD B-VP O
45 no DT B-NP O
45 presyncopal JJ I-NP O
45 sensation NN I-NP O
45 or CC O O
45 dizziness NN B-NP O
45 at IN B-VP O
46 any DT B-NP O
46 time NN I-NP O
46 She PRP O O
46 does VBZ O O
46 report VB O O
46 having VBG O O
46 a DT B-NP O
46 history NN I-NP O
46 of IN B-VP O
46 palpitations NNS B-NP O
46 in IN B-VP O
46 the DT O O
47 past JJ O O
47 , , O O
47 but CC O O
47 none NN B-NP O
47 on IN B-VP O
47 the DT B-NP O
47 day NN I-NP O
47 of IN B-VP O
47 admission NN B-NP O
47 She PRP O O
47 had VBD B-VP O
47 no DT B-NP O
47 fevers NNS I-NP O
47 , , O O
47 chills NNS B-NP O
47 , , O O
48 or CC O O
48 other JJ B-NP O
48 sick JJ I-NP O
48 contacts NNS I-NP O
48 She PRP O O
48 had VBD B-VP O
48 no DT B-NP O
48 prior JJ I-NP O
48 history NN I-NP O
48 of IN B-VP O
48 syncope NN B-NP O
48 or CC O O
49 loss NN B-NP O
49 of IN B-VP O
49 consciousness NN B-NP O
49 She PRP O O
49 had VBD B-VP O
49 no DT B-NP O
49 history NN I-NP O
49 of IN B-VP O
49 seizures NNS B-NP O
49 or CC O O
49 transient JJ B-NP O
50 neurologic NN I-NP O
50 symptoms NNS I-NP O
50 In IN B-VP O
50 addition NN B-NP O
50 , , O O
50 she PRP O O
50 does VBZ O O
50 report VB O O
50 that IN B-VP O
50 she PRP O O
50 has VBZ O O
50 a DT B-NP O
51 history NN I-NP O
51 of IN B-VP O
51 chest NN B-NP O
51 pain NN I-NP O
51 The DT B-NP O
51 last JJ I-NP O
51 time NN I-NP O
51 was VBD B-VP O
51 more JJR O O
51 than IN B-VP O
51 a DT B-NP O
51 year NN I-NP O
51 prior RB O O
51 to TO O O
52 admission NN B-NP O
52 She PRP O O
52 has VBZ O O
52 no DT B-NP O
52 paroxysmal JJ I-NP O
52 nocturnal JJ I-NP O
52 dyspnea NN I-NP O
52 , , O O
52 no DT B-NP O
52 pedal NN I-NP O
53 edema NN I-NP O
53 , , O O
53 no DT B-NP O
53 orthopnea NN I-NP O
53 , , O O
53 and CC O O
53 no DT B-NP O
53 change NN I-NP O
53 in IN B-VP O
53 exercise NN B-NP O
53 tolerance NN I-NP O
53 recently RB O O
54 She PRP O O
54 climbs VBZ O O
54 stairs NNS B-NP O
54 without IN B-VP O
54 any DT B-NP O
54 problems NNS I-NP O
55 PAST NNP I-NP O
55 MEDICAL NNP I-NP O
55 HISTORY: NNP I-NP O
55 1 CD O O
55 Hypertension NNP B-NP O
55 2 CD O O
55 Chest NNP B-NP O
55 pain NN I-NP O
55 , , O O
55 last JJ B-NP O
56 episode NN I-NP O
56 approximately RB O O
56 one CD O O
56 year NN B-NP O
56 prior RB O O
56 to TO O O
57 admission VB O O
57 3 CD O O
57 Palpitations NNS B-NP O
57 4 CD O O
57 Question NN B-NP O
57 of IN B-VP O
57 cardiomyopathy NN B-NP O
57 , , O O
58 diagnosed VBN O O
58 by IN B-VP O
58 cardiac JJ B-NP O
58 catheterization NN I-NP O
58 in IN B-VP O
58 Sa NNP B-NP O
58 in IN B-VP O
58 1995 CD O O
59 ADMISSION NNP B-NP O
59 MEDICATIONS: NNP I-NP O
59 1 CD O O
59 Vasotec NNP B-NP B-m
59 10 CD O B-do
59 mg NN B-NP I-do
59 p.o NN I-NP B-mo
59 q.day RB O B-f
59 2 CD O O
59 Digoxin NNP B-NP B-m
60 0.25 CD O B-do
60 mg NN B-NP I-do
60 p.o NN I-NP B-mo
60 q.day RB O B-f
60 3 CD O O
60 Lasix NNP B-NP B-m
60 20 CD O B-do
60 mg NN B-NP I-do
60 q.day NN I-NP B-f
61 ALLERGIES: NNP I-NP O
61 No NNP I-NP O
61 known VBN O O
61 drug NN B-NP O
61 allergies NNS I-NP O
62 FAMILY NNP I-NP O
62 HISTORY: NNP I-NP O
62 Negative NNP I-NP O
62 for IN B-VP O
62 coronary JJ B-NP O
62 artery NN I-NP O
62 disease NN I-NP O
62 , , O O
62 stroke NN B-NP O
62 , , O O
63 diabetes VBZ O O
63 mellitus NN B-NP O
63 , , O O
63 hypertension NN B-NP O
63 , , O O
63 and CC O O
63 sudden JJ B-NP O
63 death NN I-NP O
64 SOCIAL NNP I-NP O
64 HISTORY: NNP I-NP O
64 The DT B-NP O
64 patient NN I-NP O
64 does VBZ O O
64 not RB O O
64 smoke VB O O
64 , , O O
64 does VBZ O O
64 not RB O O
64 drink VB O O
65 alcohol NN B-NP O
65 , , O O
65 and CC O O
65 does VBZ O O
65 not RB O O
65 use VB O O
65 IV NNP B-NP O
65 drugs NNS I-NP O
65 She PRP O O
65 lives VBZ O O
66 with IN B-VP O
66 her PRP$ O O
66 daughter NN B-NP O
66 in IN B-VP O
66 Co NNP B-NP O
66 Ville NNP I-NP O
66 at IN B-VP O
66 this DT B-NP O
66 time NN I-NP O
66 of IN B-VP O
66 year NN B-NP O
66 She PRP O O
66 works VBZ O O
66 in IN B-VP O
66 an DT B-NP O
67 outreach NN I-NP O
67 program NN I-NP O
67 as IN B-VP O
67 a DT B-NP O
67 nurse NN I-NP O
67 She PRP O O
67 came VBD B-VP O
67 from IN B-VP O
67 Ige NNP B-NP O
67 Pkwy NNP I-NP O
67 , , O O
67 Norfsta NNP B-NP O
67 Olk NNP I-NP O
67 Mer NNP I-NP O
67 , , O O
67 New NNP B-NP O
67 Hampshire NNP I-NP O
67 25909 CD O O
67 where WRB O O
67 she PRP O O
68 has VBZ O O
68 been VBN O O
68 since IN B-VP O
68 1993 CD O O
68 Prior NNP B-NP O
68 to TO O O
68 that DT B-NP O
68 time NN I-NP O
68 , , O O
68 she PRP O O
68 was VBD B-VP O
68 living VBG O O
68 in IN B-VP O
68 Birhamstonro NNP B-NP O
69 and CC O O
69 receiving VBG O O
69 medical JJ B-NP O
69 care NN I-NP O
69 at IN B-VP O
69 the DT B-NP O
69 Cla NNP I-NP O
69 Du NNP I-NP O
69 Rencein NNP I-NP O
69 Hospital NNP I-NP O
70 PHYSICAL NNP I-NP O
70 EXAMINATION: NNP I-NP O
70 Vital NNP I-NP O
70 signs NNS I-NP O
70 included VBD B-VP O
70 a DT B-NP O
70 blood NN I-NP O
70 pressure NN I-NP O
70 of IN B-VP O
71 130/70 CD O O
71 , , O O
71 pulse RB O O
71 62 CD O O
71 ( ( O O
71 the DT B-NP O
71 patient NN I-NP O
71 had VBD B-VP O
71 a DT B-NP O
71 blood NN I-NP O
72 pressure NN I-NP O
72 of IN B-VP O
72 200/100 CD O O
72 when WRB O O
72 initially RB O O
72 seen VBN O O
72 in IN B-VP O
72 the DT B-NP O
72 Emergency NNP I-NP O
73 Department NNP I-NP O
73 ) ) O O
73 She PRP O O
73 was VBD B-VP O
73 an DT B-NP O
73 elderly JJ I-NP O
73 woman NN I-NP O
73 in IN B-VP O
73 no DT B-NP O
73 apparent JJ I-NP O
73 distress NN I-NP O
74 Her PRP$ O O
74 HEENT NNP B-NP O
74 examination NN I-NP O
74 was VBD B-VP O
74 remarkable JJ O O
74 for IN B-VP O
74 having VBG O O
74 poor JJ B-NP O
74 dentition NN I-NP O
75 Her NNP I-NP O
75 JVP NNP I-NP O
75 was VBD B-VP O
75 at IN B-VP O
75 8 CD O O
75 cm NN B-NP O
75 Her PRP$ O O
75 chest NN B-NP O
75 was VBD B-VP O
75 clear JJ B-NP O
75 Her NNP I-NP O
75 cardiovascular NN I-NP O
76 examination NN I-NP O
76 revealed VBD B-VP O
76 an DT B-NP O
76 S1 NNP I-NP O
76 , , O O
76 S2 NNP B-NP O
76 and CC O O
76 intermittent JJ B-NP O
76 S3 NNP I-NP O
76 , , O O
76 no DT B-NP O
76 murmurs NNS I-NP O
76 , , O O
77 with IN B-VP O
77 regular JJ B-NP O
77 rate NN I-NP O
77 Her PRP$ O O
77 abdomen NNS B-NP O
77 was VBD B-VP O
77 soft JJ O O
77 and CC O O
77 nontender VB O O
77 Her PRP$ O O
78 extremities NNS B-NP O
78 were VBD B-VP O
78 warm JJ O O
78 without IN B-VP O
78 any DT B-NP O
78 cyanosis NN I-NP O
78 , , O O
78 clubbing VBG O O
78 , , O O
78 or CC O O
78 edema VB O O
79 Neurological JJ B-NP O
79 examination NN I-NP O
79 was VBD B-VP O
79 unremarkable JJ B-NP O
79 Her NNP I-NP O
79 mental NN I-NP O
79 status NN I-NP O
79 was VBD B-VP O
80 entirely RB O O
80 intact JJ B-NP O
80 Cranial NNP I-NP O
80 nerve NN I-NP O
80 examination NN I-NP O
80 was VBD B-VP O
80 grossly RB O O
80 intact JJ B-NP O
81 Her NNP I-NP O
81 reflexes NNS I-NP O
81 were VBD B-VP O
81 2+ CD O O
81 throughout IN B-VP O
81 and CC O O
81 her PRP$ O O
81 toes NNS B-NP O
81 did VBD B-VP O
81 not RB O O
81 respond VB O O
81 to TO O O
81 the DT B-NP O
82 Babinski NNP I-NP O
82 stimulation NN I-NP O
83 LABORATORY NNP I-NP O
83 DATA: NNP I-NP O
83 She PRP O O
83 had VBD B-VP O
83 a DT B-NP O
83 CK NNP I-NP O
83 of IN B-VP O
83 119 CD O O
83 , , O O
83 magnesium NN B-NP O
83 2.2 CD O O
83 Her NNP B-NP O
83 digoxin NN I-NP O
84 level NN I-NP O
84 was VBD B-VP O
84 0.7 CD O O
84 Troponin NNP B-NP O
84 I PRP O O
84 was VBD B-VP O
84 0 CD O O
84 Electrolytes NNPS B-NP O
85 were VBD B-VP O
85 entirely RB O O
85 within IN B-VP O
85 normal JJ B-NP O
85 limits NNS I-NP O
85 , , O O
85 as IN B-VP O
85 were VBD B-VP O
85 BUN NNP B-NP O
85 and CC O O
85 creatinine JJ B-NP O
86 White NNP I-NP O
86 blood NN I-NP O
86 cell NN I-NP O
86 count NN I-NP O
86 was VBD B-VP O
86 10.3 CD O O
86 , , O O
86 hematocrit NN B-NP O
86 36.5 CD O O
86 , , O O
86 and CC O O
86 platelet NN B-NP O
87 count NN I-NP O
87 298 CD O O
87 Urinalysis NNP B-NP O
87 revealed VBD B-VP O
87 0-1 JJ B-NP O
87 white JJ I-NP O
87 cells NNS I-NP O
87 , , O O
87 0-1 JJ B-NP O
87 red JJ I-NP O
87 cells NNS I-NP O
87 , , O O
87 1+ CD O O
88 bacteria NNS B-NP O
88 , , O O
88 and CC O O
88 1+ CD O O
88 epithelial JJ B-NP O
88 cells NNS I-NP O
88 Chest NNP I-NP O
88 x-ray NN I-NP O
88 revealed VBD B-VP O
88 no DT B-NP O
89 evidence NN I-NP O
89 of IN B-VP O
89 congestive JJ B-NP O
89 heart NN I-NP O
89 failure NN I-NP O
89 or CC O O
89 infiltrate NN B-NP O
89 EKG NNP I-NP O
89 , , O O
89 at IN B-VP O
89 the DT B-NP O
90 time NN I-NP O
90 of IN B-VP O
90 admission NN B-NP O
90 , , O O
90 showed VBD B-VP O
90 normal JJ B-NP O
90 sinus NN I-NP O
90 rhythm NN I-NP O
90 at IN B-VP O
90 a DT B-NP O
90 rate NN I-NP O
90 of IN B-VP O
90 93 CD O O
90 with IN B-VP O
91 intervals NNS B-NP O
91 of IN B-VP O
91 0.183 CD O O
91 , , O O
91 0.15 CD O O
91 , , O O
91 and CC O O
91 0.417 CD O O
91 She PRP O O
91 had VBD B-VP O
91 a DT O O
91 left VBN O O
91 bundle NN B-NP O
91 branch NN I-NP O
92 block NN I-NP O
92 which WDT O O
92 was VBD B-VP O
92 new JJ O O
92 since IN B-VP O
92 her PRP$ O O
92 1993 CD O O
92 EKG NNP B-NP O
93 HOSPITAL NNP I-NP O
93 COURSE: NNP I-NP O
93 The DT B-NP O
93 patient NN I-NP O
93 was VBD B-VP O
93 admitted VBN O O
93 for IN B-VP O
93 work NN B-NP O
93 up RB O O
93 of IN B-VP O
93 her PRP$ O O
94 syncopal JJ B-NP O
94 episode NN I-NP O
94 By IN B-VP O
94 hospital JJ B-NP O
94 day NN I-NP O
94 one CD O O
94 , , O O
94 the DT B-NP O
95 patient NN I-NP O
95 underwent NN I-NP O
95 a DT B-NP O
95 rule NN I-NP O
95 out IN B-VP O
95 for IN B-VP O
95 myocardial JJ B-NP O
95 infarction NN I-NP O
95 Her PRP$ O O
96 enzymes NNS B-NP O
96 were VBD B-VP O
96 flat JJ O O
96 and CC O O
96 her PRP$ O O
96 EKG NNP B-NP O
96 showed VBD B-VP O
96 no DT B-NP O
96 changes NNS I-NP O
96 consistent VBP O O
96 with IN B-VP O
97 acute JJ B-NP O
97 myocardial JJ I-NP O
97 infarction NN I-NP O
97 In IN B-VP O
97 addition NN B-NP O
97 , , O O
97 she PRP O O
97 underwent VBD B-VP O
97 an DT B-NP O
98 echocardiogram NN I-NP O
98 which WDT O O
98 revealed VBD B-VP O
98 an DT B-NP O
98 ejection NN I-NP O
98 fraction NN I-NP O
98 of IN B-VP O
98 30%-35% JJ O O
98 She PRP O O
99 also RB O O
99 had VBD B-VP O
99 anterolateral JJ B-NP O
99 wall NN I-NP O
99 motion NN I-NP O
99 abnormalities NNS I-NP O
99 On IN B-VP O
99 the DT B-NP O
99 following JJ I-NP O
100 day NN I-NP O
100 , , O O
100 the DT B-NP O
100 patient NN I-NP O
100 underwent VBD B-VP O
100 a DT B-NP O
100 right NN I-NP O
100 sided VBN O O
100 heart NN B-NP O
100 catheterization NN I-NP O
100 , , O O
101 which WDT O O
101 revealed VBD B-VP O
101 that IN B-VP O
101 her PRP$ O O
101 coronary JJ B-NP O
101 arteries NNS I-NP O
101 were VBD B-VP O
101 completely RB O O
101 clean JJ O O
102 She PRP O O
102 underwent VBD B-VP O
102 an DT B-NP O
102 EP NNP I-NP O
102 study NN I-NP O
102 which WDT O O
102 was VBD B-VP O
102 entirely RB O O
102 normal JJ O O
102 On IN B-VP O
102 the DT B-NP O
103 following JJ I-NP O
103 hospital NN I-NP O
103 day NN I-NP O
103 , , O O
103 she PRP O O
103 underwent VBD B-VP O
103 an DT B-NP O
103 exercise NN I-NP O
103 tolerance NN I-NP O
103 test NN I-NP O
103 , , O O
104 and CC O O
104 no DT B-NP O
104 arrhythmias NN I-NP O
104 were VBD B-VP O
104 triggered VBN O O
104 by IN B-VP O
104 her PRP$ O O
104 exercise NN B-NP O
104 Carotid NNP I-NP O
105 noninvasive JJ B-NP O
105 studies NNS I-NP O
105 revealed VBD B-VP O
105 minimal JJ B-NP O
105 disease NN I-NP O
105 bilaterally RB O O
105 , , O O
105 and CC O O
105 the DT B-NP O
106 neurology NN I-NP O
106 service NN I-NP O
106 was VBD B-VP O
106 consulted VBN O O
106 The DT B-NP O
106 patient NN I-NP O
106 also RB O O
106 underwent VBD B-VP O
106 a DT B-NP O
106 tilt NN I-NP O
107 table NN I-NP O
107 study NN I-NP O
107 , , O O
107 which WDT O O
107 was VBD B-VP O
107 entirely RB O O
107 normal JJ O O
107 , , O O
107 with IN B-VP O
107 no DT B-NP O
107 suggestion NN I-NP O
107 of IN B-VP O
107 a DT B-NP O
108 vasovagal JJ I-NP O
108 response NN I-NP O
108 At IN B-VP O
108 the DT B-NP O
108 time NN I-NP O
108 of IN B-VP O
108 discharge NN B-NP O
108 , , O O
108 the DT B-NP O
108 patient NN I-NP O
108 had VBD B-VP O
108 had VBN O O
109 no DT B-NP O
109 further JJ I-NP O
109 symptoms NNS I-NP O
109 and CC O O
109 no DT B-NP O
109 further JJ I-NP O
109 episodes NNS I-NP O
109 of IN B-VP O
109 syncope NN B-NP O
109 while IN B-VP O
109 in IN B-VP O
110 hospital NN B-NP O
110 Her PRP$ O O
110 Holter NNP B-NP O
110 monitor NN I-NP O
110 results NNS I-NP O
110 are VBP O O
110 pending VBG O O
110 The DT B-NP O
110 feeling NN I-NP O
110 is VBZ O O
111 that IN B-VP O
111 her PRP$ O O
111 syncopal JJ B-NP O
111 event NN I-NP O
111 was VBD B-VP O
111 most RBS O O
111 likely JJ B-NP O
111 cardiac NN I-NP O
111 related VBN O O
111 , , O O
111 probably RB O O
112 related VBN O O
112 to TO O O
112 a DT B-NP O
112 tachycardic JJ I-NP O
112 arrhythmia NN I-NP O
112 However RB O O
112 , , O O
112 her PRP O O
112 neurologic JJ B-NP O
112 work NN I-NP O
113 up RB O O
113 is VBZ O O
113 still RB O O
113 underway JJ O O
113 She PRP O O
113 is VBZ O O
113 to TO O O
113 have VB O O
113 an DT B-NP O
113 MRI/MRA NNP I-NP O
113 as IN B-VP O
113 an DT B-NP O
113 outpatient NN I-NP O
114 and CC O O
114 to TO O O
114 follow VB O O
114 up RP O O
114 in IN B-VP O
114 DISPAN NNP B-NP O
114 NI NNP I-NP O
114 TI NNP I-NP O
114 HOSPITAL NNP I-NP O
114 clinic NN I-NP O
114 , , O O
114 as RB O O
114 well RB O O
114 as IN B-VP O
114 with IN B-VP O
114 Dr NNP B-NP O
114 Triche NNP I-NP O
114 for IN B-VP O
115 further JJ B-NP O
115 discussion NN I-NP O
115 as IN B-VP O
115 to TO O O
115 whether IN B-VP O
115 AICD NNP B-NP O
115 placement NN I-NP O
115 might MD O O
115 be VB O O
115 in IN B-VP O
115 order NN B-NP O
116 DISCHARGE NNP I-NP O
116 MEDICATIONS: NNP I-NP O
116 1 CD O O
116 Enteric NNP B-NP B-m
116 coated VBD B-VP I-m
116 aspirin RB O I-m
116 325 CD O B-do
116 mg NNS B-NP I-do
116 p.o JJ O B-mo
117 q.day RB O B-f
117 2 CD O O
117 Digoxin NNP B-NP B-m
117 0.25 CD O B-do
117 mg NN B-NP I-do
117 p.o NN I-NP B-mo
117 q.day RB O B-f
117 3 CD O O
118 Vasotec JJ O B-m
118 15 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
118 q.day RB O B-f
118 4 CD O O
118 Lasix NNP B-NP B-m
118 20 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
118 q.day RB O B-f
118 5 CD O O
118 Atenolol NNP B-NP B-m
119 12.5 CD O B-do
119 mg NN B-NP I-do
119 p.o NN I-NP B-mo
119 q.day NN I-NP B-f
120 DISPOSITION: NNP I-NP O
120 The DT B-NP O
120 patient NN I-NP O
120 was VBD B-VP O
120 discharged VBN O O
120 to TO O O
120 home NN B-NP O
120 to TO O O
120 follow VB O O
120 up RP O O
120 in IN B-VP O
121 I PRP O O
121 MINVIC NNP B-NP O
121 MEDICAL NNP I-NP O
121 CENTER NNP I-NP O
121 clinic NN I-NP O
121 with IN B-VP O
121 me PRP O O
121 ( ( O O
121 Leo NNP B-NP O
121 Paponetti NNP I-NP O
121 ) ) O O
121 on IN B-VP O
121 7/20/97 CD O O
121 She PRP O O
122 will MD O O
122 have VB O O
122 an DT B-NP O
122 MRA/MRI NNP I-NP O
122 of IN B-VP O
122 her PRP$ O O
122 brain NN B-NP O
122 scheduled VBN O O
122 as IN B-VP O
122 an DT B-NP O
122 outpatient NN I-NP O
122 In IN B-VP O
123 addition NN B-NP O
123 , , O O
123 she PRP O O
123 will MD O O
123 be VB O O
123 set VBN O O
123 up RP O O
123 with IN B-VP O
123 an DT B-NP O
123 ECG NNP I-NP O
123 loop NN I-NP O
123 recorder NN I-NP O
123 for IN B-VP O
123 further JJ B-NP O
124 monitoring NN I-NP O
124 of IN B-VP O
124 events NNS B-NP O
124 at IN B-VP O
124 home NN B-NP O
125 Dictated NNP I-NP O
125 By: NNP I-NP O
125 CHADWICK NNP I-NP O
125 METTA NNP I-NP O
125 , , O O
125 M.D NNP B-NP O
125 ZW08 NNP I-NP O
126 Attending: NNP I-NP O
126 STANTON NNP I-NP O
126 H NNP I-NP O
126 OTHMAN NNP I-NP O
126 , , O O
126 M.D NNP B-NP O
126 JP51 NNP I-NP O
126 LM638/0391 NNP I-NP O
127 Batch: NNP I-NP O
127 42029 CD O O
127 Index NNP B-NP O
127 No NNP I-NP O
127 A4XU7G90HE NNP I-NP O
127 D: NNP I-NP O
127 2/2/97 CD O O
128 T: NNP B-NP O
128 0/3/97 CD O O
129 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #595688 VBZ O O
2 641097022 CD O O
2 ELSUOMC NNP B-NP O
2 53507186 CD O O
2 541876 CD O O
2 11/16/1994 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 5/18/1994 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/17/1994 CD O O
4 PRINCIPLE NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 HYPOTENSIVE NNP I-NP O
4 EPISODE NNP I-NP O
5 SIGNIFICANT NNP I-NP O
5 PROBLEMS: NNP I-NP O
5 1 CD O O
5 End NNP B-NP O
5 stage NN I-NP O
5 renal JJ B-NP O
5 disease NN I-NP O
5 on IN B-VP O
5 chronic JJ B-NP O
6 hemodialysis NN I-NP O
6 2 CD O O
6 Mild NNP B-NP O
6 mental JJ B-NP O
6 retardation NN I-NP O
7 3 CD O O
7 Movement NNP B-NP O
7 disorder NN I-NP O
7 ( ( O O
7 tics NNS B-NP O
7 ) ) O O
7 4 CD O O
7 Status NNP B-NP O
7 post NN I-NP O
7 parathyroidectomy NN I-NP O
8 5 CD O O
8 Partial NNP B-NP O
8 thyroidectomy VBD B-VP O
8 6 CD O O
8 Status NNP B-NP O
8 post NN I-NP O
8 partial JJ B-NP O
8 gastrectomy NN I-NP O
8 for IN B-VP O
9 peptic JJ B-NP O
9 ulcer JJ I-NP O
9 disease NN I-NP O
9 7 CD O O
9 History NNP B-NP O
9 of IN B-VP O
9 MRSA NNP B-NP O
9 from IN B-VP O
9 wound NN B-NP O
9 in IN B-VP O
9 1988 CD O O
10 HISTORY NNP B-NP O
10 OF NNP I-NP O
10 PRESENT NNP I-NP O
10 ILLNESS: NNP I-NP O
10 The DT B-NP O
10 patient NN I-NP O
10 is VBZ O O
10 a DT B-NP O
10 46-year-old JJ I-NP O
11 gentleman NN I-NP O
11 with IN B-VP O
11 end NN B-NP O
11 stage NN I-NP O
11 renal JJ B-NP O
11 disease NN I-NP O
12 on IN B-VP O
12 chronic JJ B-NP O
12 hemodialysis NN I-NP O
12 who WP O O
12 was VBD B-VP O
12 admitted VBN O O
12 status NN B-NP O
12 post NN I-NP O
12 fall NN I-NP O
12 and CC O O
13 seizure NN B-NP O
13 The DT B-NP O
13 patient's JJ I-NP O
13 end NN I-NP O
13 stage NN I-NP O
13 renal JJ B-NP O
13 disease NN I-NP O
13 is VBZ O O
13 thought VBN O O
13 to TO O O
13 be VB O O
14 secondary JJ O O
14 to TO O O
14 hypertension NN B-NP O
14 , , O O
14 although IN B-VP O
14 he PRP O O
14 has VBZ O O
14 never RB O O
14 had VBD B-VP O
14 a DT B-NP O
14 renal JJ I-NP O
15 biopsy NN I-NP O
15 He PRP O O
15 has VBZ O O
15 been VBN O O
15 on IN B-VP O
15 hemodialysis NN B-NP O
15 since IN B-VP O
15 1987 CD O O
15 , , O O
15 having VBG O O
15 dialysis NN B-NP O
16 three CD O O
16 times NNS B-NP O
16 a DT B-NP O
16 week NN I-NP O
16 His PRP$ O O
16 dry JJ B-NP O
16 weight NN I-NP O
16 is VBZ O O
16 about RB O O
16 85 CD O O
16 to TO O O
16 86 CD O O
16 kilos VB O O
16 His PRP$ O O
17 dialysis NN B-NP O
17 has VBZ O O
17 been VBN O O
17 complicated VBN O O
17 by IN B-VP O
17 multiple JJ B-NP O
17 episodes NNS I-NP O
17 in IN B-VP O
17 the DT B-NP O
17 past NN I-NP O
17 of IN B-VP O
18 hypotension NN B-NP O
18 and CC O O
18 seizure NN B-NP O
18 activity NN I-NP O
18 occurring VBG O O
18 after IN B-VP O
18 dialysis NN B-NP O
18 These DT B-NP O
19 episodes NNS I-NP O
19 occur VBP O O
19 about IN B-VP O
19 once RB O O
19 a DT B-NP O
19 month NN I-NP O
20 On IN B-VP O
20 the DT B-NP O
20 day NN I-NP O
20 of IN B-VP O
20 admission NN B-NP O
20 , , O O
20 the DT B-NP O
20 patient NN I-NP O
20 came VBD B-VP O
20 home NN B-NP O
20 from IN B-VP O
20 routine JJ B-NP O
21 hemodialysis NN I-NP O
21 where WRB O O
21 he PRP O O
21 was VBD B-VP O
21 ultrafiltered JJ O O
21 5.5 CD O O
21 kilograms NNS B-NP O
21 of IN B-VP O
21 fluid NN B-NP O
21 and CC O O
22 his PRP$ O O
22 final JJ B-NP O
22 blood NN I-NP O
22 pressure NN I-NP O
22 after IN B-VP O
22 dialysis NN B-NP O
22 was VBD B-VP O
22 100/60 CD O O
22 At IN B-VP O
22 noon NN B-NP O
22 , , O O
22 the DT B-NP O
23 patient NN I-NP O
23 went VBD B-VP O
23 home NN B-NP O
23 , , O O
23 ate JJ B-NP O
23 lunch NN I-NP O
23 and CC O O
23 went VBD B-VP O
23 up RB O O
23 to TO O O
23 his PRP$ O O
23 room NN B-NP O
23 At IN B-VP O
23 that DT B-NP O
23 time NN I-NP O
24 he PRP O O
24 complained VBD B-VP O
24 of IN B-VP O
24 feeling VBG O O
24 dizzy NN B-NP O
24 and CC O O
24 sitting VBG O O
24 on IN B-VP O
24 the DT B-NP O
24 edge NN I-NP O
24 of IN B-VP O
24 the DT B-NP O
24 bed NN I-NP O
25 told VBD B-VP O
25 his PRP$ O O
25 uncle NN B-NP O
25 that IN B-VP O
25 he PRP O O
25 was VBD B-VP O
25 not RB O O
25 feeling VBG O O
25 well RB O O
25 and CC O O
25 then RB O O
25 slumped VBD B-VP O
25 onto IN B-VP O
26 the DT B-NP O
26 floor NN I-NP O
26 He PRP O O
26 does VBZ O O
26 not RB O O
26 believe VB O O
26 that IN B-VP O
26 he PRP O O
26 hurt VBD B-VP O
26 himself PRP O O
26 , , O O
26 i.e RB O O
26 , , O O
26 did VBD B-VP O
26 not RB O O
27 hurt VB O O
27 his PRP$ O O
27 head NN B-NP O
27 , , O O
27 although IN B-VP O
27 he PRP O O
27 did VBD B-VP O
27 complain NN B-NP O
27 of IN B-VP O
27 some DT B-NP O
27 right JJ I-NP O
27 foot NN I-NP O
27 pain NN I-NP O
28 He PRP O O
28 was VBD B-VP O
28 still RB O O
28 conscious JJ O O
28 as IN B-VP O
28 his PRP$ O O
28 uncle NN B-NP O
28 lifted VBD B-VP O
28 him PRP O O
28 back RB O O
28 to TO O O
28 bed NN B-NP O
28 and CC O O
28 then RB O O
29 an DT B-NP O
29 ambulance NN I-NP O
29 was VBD B-VP O
29 called VBN O O
30 After IN B-VP O
30 a DT B-NP O
30 few JJ I-NP O
30 minutes NNS I-NP O
30 , , O O
30 the DT B-NP O
30 patient NN I-NP O
30 lost VBD B-VP O
30 consciousness NN B-NP O
30 , , O O
30 rolling VBG O O
30 his PRP$ O O
31 eyes NNS B-NP O
31 back RP O O
31 with IN B-VP O
31 some DT B-NP O
31 facial JJ I-NP O
31 twitching NN I-NP O
31 bilaterally RB O O
31 and CC O O
31 tongue JJ B-NP O
32 retraction NN I-NP O
32 This DT B-NP O
32 episode NN I-NP O
32 lasted VBD B-VP O
32 about IN B-VP O
32 five CD O O
32 minutes NNS B-NP O
32 There EX O O
32 was VBD B-VP O
32 no DT B-NP O
33 tongue NN I-NP O
33 biting NN I-NP O
33 , , O O
33 no DT B-NP O
33 urinary JJ I-NP O
33 incontinence NN I-NP O
33 or CC O O
33 bowel NN B-NP O
33 incontinence NN I-NP O
33 The DT B-NP O
34 patient NN I-NP O
34 gained VBD B-VP O
34 full JJ B-NP O
34 recovery NN I-NP O
34 of IN B-VP O
34 his PRP$ O O
34 alertness NN B-NP O
34 upon IN B-VP O
34 waking VBG O O
34 up RP O O
34 but CC O O
35 was VBD B-VP O
35 a DT B-NP O
35 bit NN I-NP O
35 diaphoretic JJ O O
35 His PRP$ O O
35 aunt NN B-NP O
35 checked VBD B-VP O
35 his PRP$ O O
35 vital JJ B-NP O
35 signs NNS I-NP O
35 which WDT O O
35 were VBD B-VP O
36 blood NN B-NP O
36 pressure NN I-NP O
36 70/40 CD O O
36 , , O O
36 pulse RB O O
36 79 CD O O
36 The DT B-NP O
36 patient NN I-NP O
36 had VBD B-VP O
36 also RB O O
36 complained VBN O O
36 of IN B-VP O
37 chest NN B-NP O
37 pain NN I-NP O
37 for IN B-VP O
37 a DT B-NP O
37 few JJ I-NP O
37 minutes NNS I-NP O
37 prior RB O O
37 to TO O O
37 his PRP$ O O
37 episode NN B-NP O
37 When WRB O O
37 the DT B-NP O
37 EMTs NNP I-NP O
38 arrived VBD B-VP O
38 , , O O
38 the DT B-NP O
38 patient NN I-NP O
38 was VBD B-VP O
38 alert JJ O O
38 and CC O O
38 oriented VBD B-VP O
38 times NNS B-NP O
38 three CD O O
38 , , O O
38 cold NN B-NP O
38 and CC O O
39 clammy NN B-NP O
39 , , O O
39 temperature NN B-NP O
39 98.6 CD O O
39 , , O O
39 pulse RB O O
39 89 CD O O
39 , , O O
39 respirations NNS B-NP O
39 26 CD O O
39 , , O O
39 blood NN B-NP O
39 pressure NN I-NP O
40 82/60 CD O O
41 The DT B-NP O
41 patient NN I-NP O
41 was VBD B-VP O
41 brought VBN O O
41 to TO O O
41 the DT B-NP O
41 emergency NN I-NP O
41 room NN I-NP O
41 and CC O O
41 was VBD B-VP O
41 orthostatic JJ O O
42 by IN B-VP O
42 blood NN B-NP B-r
42 pressure NN I-NP I-r
42 ( ( O O
42 10 CD O O
42 points NNS B-NP O
42 ) ) O O
42 from IN B-VP O
42 lying VBG O O
42 to TO O O
42 sitting VBG O O
42 He PRP O O
42 was VBD B-VP O
42 given VBN O O
43 500 CD O B-do
43 ccs NN B-NP I-do
43 of IN B-VP O
43 normal JJ B-NP B-m
43 saline NN I-NP I-m
43 and CC O O
43 was VBD B-VP O
43 no RB O O
43 longer RBR O O
43 orthostatic JJ O O
43 , , O O
43 comfortably RB O O
44 sitting VBG O O
44 up RP O O
44 in IN B-VP O
44 the DT B-NP O
44 bed NN I-NP O
44 At IN B-VP O
44 about IN B-VP O
44 9:00 CD O O
44 p.m NN B-NP O
44 he PRP O O
44 complained VBD B-VP O
44 of IN B-VP O
44 feeling VBG O O
45 dizzy JJ O O
45 and CC O O
45 became VBD B-VP O
45 diaphoretic JJ O O
45 while IN B-VP O
45 trying VBG O O
45 to TO O O
45 stand VB O O
45 up RP O O
45 The DT B-NP O
45 patient NN I-NP O
46 was VBD B-VP O
46 again RB O O
46 brought VBN O O
46 into IN B-VP O
46 bed NN B-NP O
46 He PRP O O
46 became VBD B-VP O
46 unresponsive JJ O O
46 for IN B-VP O
46 one CD O O
46 minute NN B-NP O
47 with IN B-VP O
47 his PRP$ O O
47 eyes NNS B-NP O
47 rolled VBD B-VP O
47 up RP O O
47 and CC O O
47 some DT B-NP O
47 bilateral JJ I-NP O
47 face NN I-NP O
47 twitching VBG O O
47 This DT B-NP O
48 episode NN I-NP O
48 only RB O O
48 lasted VBD B-VP O
48 about IN B-VP O
48 one CD O O
48 minute NN B-NP O
48 The DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 admitted VBN O O
48 for IN B-VP O
49 observation NN B-NP O
50 Past NNP I-NP O
50 medical JJ B-NP O
50 history NN I-NP O
50 reveals VBZ O O
50 the DT B-NP O
50 following: NN I-NP O
50 1 CD O O
50 ) ) O O
50 Mild NNP B-NP O
50 mental JJ B-NP O
51 retardation NN I-NP O
51 since IN B-VP O
51 about IN B-VP O
51 10 CD O O
51 years NNS B-NP O
51 ago RB O O
51 2 CD O O
51 ) ) O O
51 Movement NN B-NP B-r
51 disorder NN I-NP I-r
51 ( ( O O
51 tics NNS B-NP O
51 ) ) O O
52 on IN B-VP O
52 Stelazine NNP B-NP B-m
52 3 CD O O
52 ) ) O O
52 End NN B-NP O
52 stage NN I-NP O
52 renal JJ B-NP O
52 disease NN I-NP O
52 thought VBD B-VP O
52 to TO O O
52 be VB O O
52 secondary JJ O O
53 to TO O O
53 hypertension VB O O
53 4 CD O O
53 ) ) O O
53 Status NNP B-NP O
53 post NN I-NP O
53 parathyroidectomy NN I-NP O
53 for IN B-VP O
53 secondary JJ B-NP O
54 hyperparathyroidism NN I-NP O
54 5 CD O O
54 ) ) O O
54 Partial NNP B-NP O
54 thyroidectomy NN I-NP O
54 for IN B-VP O
54 goiter NN B-NP O
55 incidentally RB O O
55 found VBN O O
55 at IN B-VP O
55 surgery NN B-NP O
55 6 CD O O
55 ) ) O O
55 Status NNP B-NP O
55 post NN I-NP O
55 partial JJ B-NP O
55 gastrectomy NN I-NP O
56 for IN B-VP O
56 peptic JJ B-NP O
56 ulcer JJ I-NP O
56 disease NN I-NP O
56 in IN B-VP O
56 the DT O O
56 1960's CD O O
56 7 CD O O
56 ) ) O O
56 History NN B-NP O
56 of IN B-VP O
56 MRSA NNP B-NP O
56 from IN B-VP O
57 wound NN B-NP O
57 in IN B-VP O
57 1988 CD O O
57 8 CD O O
57 ) ) O O
57 Hepatitis NN B-NP O
57 B NNP I-NP O
57 surface NN I-NP O
57 antibody NN I-NP O
57 positive JJ O O
57 and CC O O
58 hepatitis JJ B-NP O
58 C NNP I-NP O
58 virus NN I-NP O
58 positive JJ B-NP O
58 Medications NNS I-NP O
58 on IN B-VP O
58 admission: JJ B-NP O
58 Calcium NNP I-NP B-m
59 carbonate NN I-NP O
59 , , O O
59 1250 CD O B-do
59 mg NN B-NP I-do
59 PO NNP I-NP B-mo
59 tid; NN I-NP B-f
59 nephrocaps NNS I-NP B-m
59 , , O O
59 1 CD O B-do
59 PO NNP B-NP B-mo
59 qd; NN I-NP B-f
59 DHT NNP I-NP B-m
59 , , O O
59 0.2 CD O B-do
59 mg NN B-NP I-do
59 PO NNP I-NP B-mo
59 qd; NN I-NP B-f
60 Stelazine NNP I-NP B-m
60 , , O O
60 2 CD O B-do
60 mg NN B-NP I-do
60 PO NNP I-NP B-mo
60 tid NN I-NP B-f
60 There EX O O
60 are VBP O O
60 no DT B-NP O
60 known JJ I-NP O
60 allergies NNS I-NP O
60 Social NNP I-NP O
61 history: VBD B-VP O
61 The DT B-NP O
61 patient NN I-NP O
61 was VBD B-VP O
61 a DT B-NP O
61 former JJ I-NP O
61 smoker NN I-NP O
61 and CC O O
61 has VBZ O O
61 a DT B-NP O
61 history NN I-NP O
61 of IN B-VP O
62 alcohol NN B-NP O
62 abuse NN I-NP O
62 but CC O O
62 no DT B-NP O
62 IV NNP I-NP O
62 drug NN I-NP O
62 use NN I-NP O
62 He PRP O O
62 lives VBZ O O
62 with IN B-VP O
62 his PRP$ O O
62 aunt NN B-NP O
62 and CC O O
62 uncle NN B-NP O
63 and CC O O
63 is VBZ O O
63 mildly RB O O
63 retarded JJ B-NP O
64 PHYSICAL NNP I-NP O
64 EXAMINATION: NNP I-NP O
64 On IN B-VP O
64 physical JJ B-NP O
64 examination NN I-NP O
64 , , O O
64 vital JJ B-NP O
64 signs NNS I-NP O
65 showed VBD B-VP O
65 a DT O O
65 lying VBG O O
65 blood NN B-NP O
65 pressure NN I-NP O
65 of IN B-VP O
65 96/60 CD O O
65 , , O O
66 pulse RB O O
66 80 CD O O
66 , , O O
66 sitting VBG O O
66 up RP O O
66 blood NN B-NP O
66 pressure NN I-NP O
66 104/70 CD O O
66 , , O O
66 pulse RB O O
66 96 CD O O
66 , , O O
66 temperature NN B-NP O
67 97.5 CD O O
67 , , O O
67 O2 NNP B-NP O
67 sat VBD B-VP O
67 95% CD O O
67 on IN B-VP O
67 room NN B-NP O
67 air NN I-NP O
67 The DT B-NP O
67 patient NN I-NP O
67 was VBD B-VP O
67 a DT O O
67 well RB O O
67 nourished VBN O O
67 , , O O
68 black JJ B-NP O
68 male NN I-NP O
68 in IN B-VP O
68 no DT B-NP O
68 apparent JJ I-NP O
68 distress NN I-NP O
68 HEENT NNP I-NP O
68 exam NN I-NP O
68 was VBD B-VP O
68 unremarkable JJ B-NP O
69 Neck NNP I-NP O
69 showed VBD B-VP O
69 JVD NNP B-NP O
69 of IN B-VP O
69 4 CD O O
69 cms NN B-NP O
69 No NNP I-NP O
69 lymphadenopathy NN I-NP O
69 Chest NNP I-NP O
69 was VBD B-VP O
69 clear JJ O O
69 to TO O O
70 auscultation VB O O
70 Heart NNP B-NP O
70 revealed VBD B-VP O
70 S1 NNP B-NP O
70 , , O O
70 S2 NNP B-NP O
70 , , O O
70 normal JJ B-NP O
70 rate NN I-NP O
70 and CC O O
70 rhythm NN B-NP O
70 with IN B-VP O
70 a DT O O
71 1/6 CD O O
71 systolic JJ B-NP O
71 murmur NN I-NP O
71 best JJS B-NP O
71 heard NN I-NP O
71 at IN B-VP O
71 the DT B-NP O
71 left JJ I-NP O
71 upper JJ I-NP O
71 sternal JJ I-NP O
71 border NN I-NP O
72 No NNP I-NP O
72 CVA NNP I-NP O
72 tenderness NN I-NP O
72 Abdomen NNP I-NP O
72 was VBD B-VP O
72 soft JJ O O
72 , , O O
72 nontender NN B-NP O
72 , , O O
72 no DT B-NP O
72 masses NNS I-NP O
72 Bowel NNP I-NP O
73 sounds NNS I-NP O
73 were VBD B-VP O
73 positive JJ O O
73 The DT B-NP O
73 patient NN I-NP O
73 was VBD B-VP O
73 guaiac JJ O O
73 negative JJ O O
73 with IN B-VP O
73 brown JJ B-NP O
74 stool NN I-NP O
74 Extremities NNS I-NP O
74 revealed VBD B-VP O
74 a DT B-NP O
74 tender NN I-NP O
74 , , O O
74 edematous JJ B-NP O
74 dorsal NN I-NP O
74 aspect NN I-NP O
74 of IN B-VP O
75 right JJ B-NP O
75 foot NN I-NP O
75 , , O O
75 with IN B-VP O
75 full JJ B-NP O
75 range NN I-NP O
75 of IN B-VP O
75 motion NN B-NP O
75 at IN B-VP O
75 the DT B-NP O
75 ankle NN I-NP O
75 joint NN I-NP O
75 Left NNP I-NP O
76 extremity NN I-NP O
76 benign NN I-NP O
76 Neuro NNP I-NP O
76 exam NN I-NP O
76 was VBD B-VP O
76 grossly RB O O
76 nonfocal JJ B-NP O
77 LABORATORY NNP I-NP O
77 DATA: NNP I-NP O
77 On IN B-VP O
77 admission NN B-NP O
77 , , O O
77 sodium NN B-NP O
77 142 CD O O
77 , , O O
77 potassium NN B-NP O
77 4.8 CD O O
77 , , O O
78 chloride RB O O
78 94 CD O O
78 , , O O
78 bicarb NN B-NP O
78 32 CD O O
78 , , O O
78 BUN NNP B-NP O
78 38 CD O O
78 , , O O
78 creatinine NN B-NP O
78 8.6 CD O O
78 , , O O
79 glucose VBD B-VP O
79 168 CD O O
79 A NNP B-NP O
79 CBC NNP I-NP O
79 revealed VBD B-VP O
79 white JJ B-NP O
79 count NN I-NP O
79 of IN B-VP O
79 8.82 CD O O
79 , , O O
79 hematocrit NN B-NP O
79 35 CD O O
79 , , O O
80 platelets NNS B-NP O
80 246 CD O O
80 Calcium NNP B-NP O
80 was VBD B-VP O
80 9.7 CD O O
80 Chest NNP B-NP O
80 x-ray NN I-NP O
80 revealed VBD B-VP O
80 mild JJ B-NP O
81 pulmonary JJ I-NP O
81 vascular JJ I-NP O
81 redistribution NN I-NP O
81 with IN B-VP O
81 no DT B-NP O
81 significant JJ I-NP O
81 CHF NNP I-NP O
81 and CC O O
81 no DT B-NP O
82 infiltrates NNS I-NP O
82 Ankle VBP O O
82 x-rays NNS B-NP O
82 on IN B-VP O
82 the DT B-NP O
82 right NN I-NP O
82 revealed VBD B-VP O
82 no DT B-NP O
82 fracture NN I-NP O
82 or CC O O
83 dislocation NN B-NP O
83 EKG NNP I-NP O
83 revealed VBD B-VP O
83 normal JJ B-NP O
83 sinus NN I-NP O
83 rhythm NN I-NP O
83 at IN B-VP O
83 a DT B-NP O
83 rate NN I-NP O
83 of IN B-VP O
83 76 CD O O
83 , , O O
84 axis RB O O
84 2 CD O O
84 degrees NNS B-NP O
84 , , O O
84 some DT O O
84 1 CD O O
84 mm NNS B-NP O
84 ST NNP I-NP O
84 elevations NNS I-NP O
84 in IN B-VP O
84 I PRP O O
84 and CC O O
84 AVL NNP B-NP O
84 , , O O
84 T-waves NNP B-NP O
84 flat NN I-NP O
85 in IN B-VP O
85 lead JJ B-NP O
85 III NNP I-NP O
85 The DT B-NP O
85 slight JJ I-NP O
85 elevations NNS I-NP O
85 in IN B-VP O
85 ST NNP B-NP O
85 were VBD B-VP O
85 consistent JJ O O
85 with IN B-VP O
85 EKG NNP B-NP O
86 on IN B-VP O
86 1/2/94 CD O O
87 HOSPITAL NNP B-NP O
87 COURSE: NNP I-NP O
87 The DT B-NP O
87 patient NN I-NP O
87 was VBD B-VP O
87 observed VBN O O
87 overnight JJ O O
87 and CC O O
87 put VB O O
87 on IN B-VP O
88 an DT B-NP O
88 oral JJ I-NP O
88 renal JJ I-NP O
88 diet NN I-NP O
88 , , O O
88 checking VBG O O
88 orthostatics NNS B-NP O
89 frequently RB O O
89 The DT B-NP O
89 patient NN I-NP O
89 remained VBD B-VP O
89 asymptomatic JJ O O
89 throughout IN B-VP O
89 his PRP$ O O
90 hospital NN B-NP O
90 course NN I-NP O
90 and CC O O
90 remained VBD B-VP O
90 hemodynamically RB O O
90 stable JJ O O
90 with IN B-VP O
90 no DT B-NP O
91 orthostasis NN I-NP O
91 The DT B-NP O
91 patient NN I-NP O
91 was VBD B-VP O
91 evaluated VBN O O
91 by IN B-VP O
91 the DT B-NP O
91 renal JJ I-NP O
91 service NN I-NP O
91 who WP O O
92 assessed VBD B-VP O
92 that IN B-VP O
92 this DT B-NP O
92 episode NN I-NP O
92 was VBD B-VP O
92 most RBS O O
92 likely JJ O O
92 secondary JJ O O
92 to TO O O
92 the DT B-NP O
93 extensive JJ I-NP O
93 fluid NN I-NP O
93 removal NN I-NP O
93 from IN B-VP O
93 dialysis NN B-NP O
93 leading VBG O O
93 to TO O O
93 a DT B-NP O
93 low JJ I-NP O
93 blood NN I-NP O
94 pressure NN I-NP O
94 In IN B-VP O
94 addition NN B-NP O
94 , , O O
94 they PRP O O
94 noted VBD B-VP O
94 that IN B-VP O
94 seizures NNS B-NP O
94 and CC O O
94 orthostasis NN B-NP O
95 are VBP O O
95 often RB O O
95 seen VBN O O
95 status NN B-NP O
95 post NN I-NP O
95 dialysis NN I-NP O
95 in IN B-VP O
95 some DT B-NP O
95 patients NNS I-NP O
95 They PRP O O
96 recommended VBD B-VP O
96 no DT B-NP O
96 further JJ I-NP O
96 work NN I-NP O
96 up RB O O
96 of IN B-VP O
96 this DT B-NP O
96 seizure NN I-NP O
96 episode NN I-NP O
96 and CC O O
97 recommended VBD B-VP O
97 no DT B-NP O
97 prophylaxis NN I-NP O
97 with IN B-VP O
97 an DT O O
97 antiepileptic JJ O O
97 The DT B-NP O
97 patient JJ I-NP O
98 underwent JJ I-NP O
98 dialysis NN I-NP O
98 again RB O O
98 on IN B-VP O
98 1/25/94 CD O O
98 per IN B-VP O
98 schedule NN B-NP O
98 After IN B-VP O
98 this DT B-NP O
99 dialysis NN I-NP O
99 , , O O
99 the DT B-NP O
99 patient NN I-NP O
99 was VBD B-VP O
99 asymptomatic JJ O O
99 , , O O
99 not RB O O
99 orthostatic JJ O O
99 and CC O O
99 did VBD B-VP O
99 not RB O O
100 complain VB O O
100 of IN B-VP O
100 any DT B-NP O
100 light JJ I-NP O
100 headedness NN I-NP O
101 As IN B-VP O
101 the DT B-NP O
101 patient NN I-NP O
101 complained VBD B-VP O
101 of IN B-VP O
101 right JJ B-NP O
101 foot NN I-NP O
101 pain NN I-NP O
101 , , O O
101 right JJ B-NP O
101 foot NN I-NP O
101 films NNS I-NP O
101 were VBD B-VP O
102 obtained VBN O O
102 which WDT O O
102 revealed VBD B-VP O
102 nondisplaced JJ B-NP O
102 fractures NNS I-NP O
102 of IN B-VP O
102 the DT O O
102 second JJ O O
102 , , O O
103 third JJ O O
103 , , O O
103 fourth JJ O O
103 and CC O O
103 fifth JJ B-NP O
103 metatarsal NN I-NP O
103 bones NNS I-NP O
103 Orthopaedic NNP I-NP O
103 service NN I-NP O
103 was VBD B-VP O
104 consulted VBN O O
104 who WP O O
104 put VBD B-VP O
104 the DT B-NP O
104 patient NN I-NP O
104 in IN B-VP O
104 a DT B-NP O
104 bivalve NN I-NP O
104 cast NN I-NP O
104 with IN B-VP O
104 a DT B-NP O
104 toe NN I-NP O
104 plate NN I-NP O
105 Physical NNP I-NP O
105 therapy NN I-NP O
105 was VBD B-VP O
105 consulted VBN O O
105 The DT B-NP O
105 patient NN I-NP O
105 was VBD B-VP O
105 allowed VBN O O
105 to TO O O
105 sit VB O O
105 in IN B-VP O
106 a DT B-NP O
106 chair NN I-NP O
106 and CC O O
106 engage NN B-NP O
106 in IN B-VP O
106 nonweight JJ B-NP O
106 bearing NN I-NP O
106 activities NNS I-NP O
106 His PRP$ O O
106 foot NN B-NP O
106 was VBD B-VP O
107 elevated VBN O O
107 on IN B-VP O
107 three CD O O
107 pillows NNS B-NP O
107 for IN B-VP O
107 72 CD O O
107 hours NNS B-NP O
107 The DT B-NP O
107 patient NN I-NP O
107 remained VBD B-VP O
108 hemodynamically RB O O
108 stable JJ O O
108 and CC O O
108 now RB O O
108 awaits VBZ O O
108 placement NN B-NP O
108 into IN B-VP O
108 a DT B-NP O
108 skilled JJ I-NP O
109 nursing NN I-NP O
109 facility NN I-NP O
109 for IN B-VP O
109 rehabilitation NN B-NP O
109 , , O O
109 given VBN O O
109 his PRP$ O O
109 casted JJ B-NP O
109 right NN I-NP O
109 lower RBR O O
110 leg NN B-NP O
111 DISPOSITION: NNP I-NP O
111 The DT B-NP O
111 patient NN I-NP O
111 will MD O O
111 be VB O O
111 discharged VBN O O
111 on IN B-VP O
111 his PRP$ O O
111 medications NNS B-NP O
112 from IN B-VP O
112 admission NN B-NP O
112 which WDT O O
112 include: VBZ O O
112 1 CD O O
112 ) ) O O
112 Nephrocaps NNP B-NP B-m
112 , , O O
112 1 CD O B-do
112 PO NNP B-NP B-mo
113 qd RB O B-f
113 2 CD O O
113 ) ) O O
113 Calcium NN B-NP B-m
113 carbonate NN I-NP I-m
113 , , O O
113 1250 CD O B-do
113 mg NN B-NP I-do
113 PO NNP I-NP B-mo
113 tid VBZ O B-f
113 3 CD O O
113 ) ) O O
113 DHT NNP B-NP B-m
113 , , O O
113 0.2 CD O B-do
113 mg NN B-NP I-do
113 PO NNP I-NP B-mo
113 qd RB O B-f
114 4 CD O O
114 ) ) O O
114 Stelazine NNP B-NP B-m
114 , , O O
114 2 CD O B-do
114 mg NN B-NP I-do
114 PO NNP I-NP B-mo
114 tid VBZ O B-f
114 The DT B-NP O
114 patient NN I-NP O
114 will MD O O
114 be VB O O
114 seen VBN O O
114 again RB O O
114 in IN B-VP O
115 orthopaedics NNS B-NP O
115 clinic JJ O O
115 on IN B-VP O
115 Friday NNP B-NP O
115 , , O O
115 7/17/94 CD O O
115 at IN B-VP O
115 9:15 CD O O
115 a.m IN B-VP O
115 The DT B-NP O
115 patient NN I-NP O
115 is VBZ O O
116 discharged VBN O O
116 in IN B-VP O
116 stable JJ B-NP O
116 condition NN I-NP O
116 to TO O O
116 a DT B-NP O
116 rehab/skilled JJ I-NP O
116 nursing NN I-NP O
116 facility NN I-NP O
117 per IN B-VP O
117 wishes NNS B-NP O
117 of IN B-VP O
117 patient NN B-NP O
117 , , O O
117 family NN B-NP O
117 and CC O O
117 per IN B-VP O
117 recommendation NN B-NP O
117 of IN B-VP O
117 physical JJ B-NP O
118 therapy NN I-NP O
119 Dictated NNP I-NP O
119 By: NNP I-NP O
119 MAXIMO NNP I-NP O
119 RAUH NNP I-NP O
119 , , O O
119 M.D NNP B-NP O
120 Attending: NNP I-NP O
120 LUIS NNP I-NP O
120 B NNP I-NP O
120 DEPUGH NNP I-NP O
120 , , O O
120 M.D NNP B-NP O
120 NO72 NNP I-NP O
121 BJ379/1337 NNP I-NP O
122 Batch: NNP I-NP O
122 039 CD O O
122 Index NNP B-NP O
122 No NNP I-NP O
122 YQSP379ZHV NNP I-NP O
122 D: NNP I-NP O
122 9/17/94 CD O O
123 T: NNP B-NP O
123 9/17/94 CD O O
124 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #597307 VBZ O O
4 077894674 CD O O
4 ZH NNP B-NP O
4 13194350 CD O O
4 2481419 CD O O
4 11/14/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Pulmonary NNP I-NP O
4 hypertension NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/20/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/13/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 BRUSTER NNP I-NP O
8 , , O O
8 RANDAL NNP B-NP O
8 B NNP I-NP O
8 338-46-12-6 JJ B-NP O
9 Sas NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 1/12/06 CD O O
11 AT NNP B-NP O
11 05:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 HO NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 FITCH NNP I-NP O
14 , , O O
14 ERNIE NNP B-NP O
14 S NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 LIPITOR NNP I-NP B-m
20 ( ( O I-m
20 ATORVASTATIN NNP B-NP I-m
20 ) ) O I-m
20 80 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 BEDTIME NNP I-NP B-f
21 CALTRATE NNP I-NP B-m
21 600 CD O I-m
21 + NNP B-NP I-m
21 D NNP I-NP I-m
21 ( ( O I-m
21 CALCIUM NNP B-NP I-m
21 CARBONATE NNP I-NP I-m
21 1 CD O I-m
21 , , O I-m
21 500 CD O I-m
21 MG NNP B-NP I-m
21 ( ( O I-m
21 ) ) O I-m
22 2 CD O B-do
22 TAB NNP B-NP I-do
22 PO NNP I-NP B-mo
22 DAILY NNP I-NP B-f
23 PLAVIX NNP I-NP B-m
23 ( ( O I-m
23 CLOPIDOGREL NNP B-NP I-m
23 ) ) O I-m
23 75 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QAM NNP I-NP B-f
24 NEXIUM NNP I-NP B-m
24 ( ( O I-m
24 ESOMEPRAZOLE NNP B-NP I-m
24 ) ) O I-m
24 20 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QAM NNP I-NP B-f
25 Starting VBG O O
25 Today NNP B-NP O
25 ( ( O O
25 7/22 CD O O
25 ) ) O O
26 Instructions: NNP B-NP O
26 please NN I-NP O
26 give VB O O
26 before IN B-VP O
26 1st CD O O
26 meal NN B-NP O
26 of IN B-VP O
26 day NN B-NP O
27 LASIX NNP I-NP B-m
27 ( ( O I-m
27 FUROSEMIDE NNP B-NP I-m
27 ) ) O I-m
27 40 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QAM NNP I-NP B-f
28 INSULIN NNP I-NP B-m
28 70/30 CD O I-m
28 HUMAN NNP B-NP I-m
28 40 CD O B-do
28 UNITS NNP B-NP I-do
28 SC NNP I-NP B-mo
28 BID NNP I-NP B-f
29 IMDUR NNP I-NP B-m
29 ER NNP I-NP I-m
29 ( ( O I-m
29 ISOSORBIDE NNP B-NP I-m
29 MONONITRATE NNP I-NP I-m
29 ( ( O I-m
29 SR NNP B-NP I-m
29 ) ) O I-m
29 ) ) O I-m
29 60 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 DAILY NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 Give NNP I-NP O
31 on IN B-VP O
31 an DT B-NP O
31 empty JJ I-NP O
31 stomach NN I-NP O
31 ( ( O O
31 give JJ O O
31 1hr CD O O
31 before IN B-VP O
31 or CC O O
31 2hr CD O O
31 after IN B-VP O
32 food NN B-NP O
32 ) ) O O
33 LABETALOL NNP B-NP B-m
33 HCL NNP I-NP I-m
33 400 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 Q8H NNP I-NP B-f
33 Starting NNP I-NP O
33 Tonight NNP I-NP O
33 ( ( O O
33 2/22 CD O O
33 ) ) O O
34 Food/Drug NNP B-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Take NNP I-NP O
35 consistently RB O O
35 with IN B-VP O
35 meals NNS B-NP O
35 or CC O O
35 on IN B-VP O
35 empty JJ B-NP O
35 stomach NN I-NP O
36 LEVOXYL NNP I-NP B-m
36 ( ( O I-m
36 LEVOTHYROXINE NNP B-NP I-m
36 SODIUM NNP I-NP I-m
36 ) ) O I-m
36 112 CD O B-do
36 MCG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 DAILY NNP I-NP B-f
37 Starting VBG O O
37 Today NNP B-NP O
37 ( ( O O
37 5/26 CD O O
37 ) ) O O
37 Instructions: NNP B-NP O
37 to TO O O
37 start VB O O
37 as IN B-VP O
37 outpatient JJ B-NP O
38 OXYCODONE NNP I-NP B-m
38 5-10 JJ B-NP B-do
38 MG NNP I-NP I-do
38 PO NNP I-NP B-mo
38 Q4H NNP I-NP B-f
38 PRN NNP I-NP I-f
38 Pain NNP I-NP B-r
39 Alert NNP I-NP O
39 overridden: NNP I-NP O
39 Override NNP I-NP O
39 added VBD B-VP O
39 on IN B-VP O
39 9/11/06 CD O O
39 by IN B-VP O
40 PISELLI NNP B-NP O
40 , , O O
40 TRISTAN NNP B-NP O
40 M NNP I-NP O
40 , , O O
40 M.D NNP B-NP O
41 on IN B-VP O
41 order NN B-NP O
41 for IN B-VP O
41 OXYCODONE NNP B-NP B-m
41 PO NNP I-NP B-mo
41 ( ( O O
41 ref JJ O O
41 # # O O
41 931753288 CD O O
41 ) ) O O
42 Pt NNP B-NP O
42 has VBZ O O
42 a DT B-NP O
42 PROBABLE NNP I-NP O
42 allergy NN I-NP O
42 to TO O O
42 Codeine; NNP B-NP O
42 reaction NN I-NP O
42 is VBZ O O
42 NAUSEA NNP B-NP O
43 Reason NNP I-NP O
43 for IN B-VP O
43 override: NN B-NP O
43 pt NN I-NP O
43 states NNS I-NP O
43 takes VBZ O O
43 at IN B-VP O
43 home NN B-NP O
44 ALDACTONE NNP I-NP B-m
44 ( ( O I-m
44 SPIRONOLACTONE NNP B-NP I-m
44 ) ) O I-m
44 12.5 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 QAM NNP I-NP B-f
45 Food/Drug NNP I-NP O
45 Interaction NNP I-NP O
45 Instruction NNP I-NP O
45 Give NNP I-NP O
45 with IN B-VP O
45 meals NNS B-NP O
46 DIOVAN NNP I-NP B-m
46 ( ( O I-m
46 VALSARTAN NNP B-NP I-m
46 ) ) O I-m
46 160 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 DAILY NNP I-NP B-f
47 Number NNP I-NP B-du
47 of IN B-VP I-du
47 Doses NNP B-NP I-du
47 Required NNP I-NP I-du
47 ( ( O I-du
47 approximate JJ B-NP I-du
47 ): NN I-NP I-du
47 5 CD O I-du
48 DIET: NNP B-NP O
48 House NNP I-NP O
48 / VBD B-VP O
48 Low NNP B-NP O
48 chol/low NN I-NP O
48 sat VBD B-VP O
48 fat JJ B-NP O
49 DIET: NNP I-NP O
49 House NNP I-NP O
49 / NNP I-NP O
49 ADA NNP I-NP O
49 1800 CD O O
49 cals/dy NN B-NP O
50 RETURN NNP I-NP O
50 TO NNP I-NP O
50 WORK: NNP I-NP O
50 Not RB O O
50 Applicable NNP B-NP O
51 FOLLOW NNP I-NP O
51 UP NNP I-NP O
51 APPOINTMENT( NNP I-NP O
51 S NNP I-NP O
51 ): NNP I-NP O
52 Dr NNP I-NP O
52 Tyler NNP I-NP O
52 Brabston NNP I-NP O
52 , , O O
52 456-9721 JJ B-NP O
52 November NNP I-NP O
52 , , O O
52 2006 CD O O
52 @ NN B-NP O
52 9AM CD O O
52 scheduled VBN O O
52 , , O O
53 Dr NNP B-NP O
53 Statz NNP I-NP O
53 ( ( O O
53 PCP NNP B-NP O
53 ) ) O O
53 as IN B-VP O
53 previously RB O O
53 scheduled VBN O O
53 , , O O
54 ALLERGY: NNP B-NP O
54 AMOXICILLIN NNP I-NP O
54 , , O O
54 Codeine NNP B-NP O
54 , , O O
54 LISINOPRIL NNP B-NP O
54 , , O O
55 NUTS NNP B-NP O
55 AND NNP I-NP O
55 STRAWBERRIES NNP I-NP O
56 ADMIT NNP I-NP O
56 DIAGNOSIS: NNP I-NP O
57 chest JJS B-NP O
57 pain NN I-NP O
58 PRINCIPAL NNP I-NP O
58 DISCHARGE NNP I-NP O
58 DIAGNOSIS NNP I-NP O
58 ;Responsible JJ O O
58 After IN B-VP O
58 Study NNP B-NP O
58 for IN B-VP O
58 Causing NNP B-NP O
58 Admission NNP I-NP O
58 ) ) O O
59 Pulmonary NNP B-NP O
59 hypertension NN I-NP O
60 OTHER NNP I-NP O
60 DIAGNOSIS;Conditions NNP I-NP O
60 , , O O
60 Infections NNP B-NP O
60 , , O O
60 Complications NNP B-NP O
60 , , O O
60 affecting VBG O O
60 Treatment/Stay NNP B-NP O
61 S/P NNP I-NP O
61 R NNP I-NP O
61 CEA NNP I-NP O
61 ON NNP I-NP O
61 6/10 CD O O
61 DM NNP B-NP O
61 SINCE NNP I-NP O
61 1980 CD O O
61 S.P NNP B-NP O
61 L NNP I-NP O
62 CAD NNP I-NP O
62 w VBD B-VP O
62 cardiac JJ B-NP O
62 catheterization; NN I-NP O
62 2005 CD O O
62 and CC O O
62 2006 CD O O
62 with IN B-VP O
62 stent JJ B-NP O
62 placement NN I-NP O
62 in IN B-VP O
62 the DT B-NP O
63 LCX NNP I-NP O
63 , , O O
63 LAD NNP B-NP O
63 , , O O
63 RCA NNP B-NP O
63 THR NNP I-NP O
63 S/P NNP I-NP O
63 L NNP I-NP O
63 TIBIAL NNP I-NP O
63 FRACTURE NNP I-NP O
63 HTN NNP I-NP O
63 S/P NNP I-NP O
63 PTCA NNP I-NP O
63 6/28 CD O O
63 RCA NNP B-NP O
64 OPERATIONS NNP I-NP O
64 AND NNP I-NP O
64 PROCEDURES: NNP I-NP O
65 L NNP I-NP O
65 heart NN I-NP O
65 cardiac NN I-NP O
65 catheterization NN I-NP O
65 , , O O
65 which WDT O O
65 showed VBD B-VP O
65 no DT B-NP O
65 change NN I-NP O
65 from IN B-VP O
65 prior JJ B-NP O
66 studies NNS I-NP O
66 R NNP I-NP O
66 heart NN I-NP O
66 cardiac NN I-NP O
66 catheterization: NN I-NP O
66 pulmonary JJ B-NP O
66 hypertension NN I-NP O
67 OTHER NNP I-NP O
67 TREATMENTS/PROCEDURES NNP I-NP O
67 ( ( O O
67 NOT NNP B-NP O
67 IN NNP I-NP O
67 O.R NNP I-NP O
67 ) ) O O
68 None NN B-NP O
69 BRIEF NNP I-NP O
69 RESUME NNP I-NP O
69 OF NNP I-NP O
69 HOSPITAL NNP I-NP O
69 COURSE: NNP I-NP O
70 HPI: NNP I-NP O
70 77 CD O O
70 yo NNP B-NP O
70 woman NN I-NP O
70 with IN B-VP O
70 known VBN O O
70 CAD NNP B-NP O
70 ( ( O O
70 s/p JJ O O
70 4 CD O O
70 stents NNS B-NP O
70 to TO O O
70 LCX/LAD/RCA VB O O
70 on IN B-VP O
70 two CD O O
71 separate JJ B-NP O
71 occasions NNS I-NP O
71 ) ) O O
71 presents NNS B-NP O
71 w/ VBP O O
71 the DT B-NP O
71 sudden JJ I-NP O
71 onset NN I-NP O
71 of IN B-VP O
71 severe JJ B-NP O
71 sharp JJ I-NP O
71 chest NN I-NP O
72 pain NN I-NP O
72 at IN B-VP O
72 4AM CD O O
72 on IN B-VP O
72 the DT B-NP O
72 day NN I-NP O
72 of IN B-VP O
72 admission NN B-NP O
72 which WDT O O
72 awoke VBD B-VP O
72 her PRP O O
72 from IN B-VP O
72 sleep NN B-NP O
72 Severe NNP I-NP O
72 , , O O
73 L NNP B-NP O
73 sided VBD B-VP O
73 , , O O
73 worse JJR B-NP O
73 w JJ I-NP O
73 inspiration NN I-NP O
73 &amp; NNP I-NP O
73 a/b VBZ O O
73 nausea NN B-NP O
73 &amp; NNP I-NP O
73 diaphoresis; VBZ O O
73 no DT B-NP O
73 SOB NNP I-NP O
73 Pain NNP I-NP O
74 not RB O O
74 initially RB O O
74 relieved VBN O O
74 by IN B-VP O
74 nitro RB O B-m
74 Presented VBN O O
74 to TO O O
74 ED NNP B-NP O
74 where WRB O O
74 EKG NNP B-NP O
74 was VBD B-VP O
74 without IN B-VP O
75 changes NNS B-NP O
75 and CC O O
75 enzymes NNS B-NP O
75 neg RB O O
75 but CC O O
75 D NNP B-NP O
75 Dimer NNP I-NP O
75 elevated VBD B-VP O
75 at IN B-VP O
75 801 CD O O
75 Cont'd NNP B-NP O
75 to TO O O
75 c/o VB O O
75 chest JJS B-NP O
76 pain; NN I-NP O
76 heparin NN I-NP B-m
76 initiated VBN O O
76 , , O O
76 along IN B-VP O
76 w/ JJ B-NP O
76 ASA/Plavix NNP I-NP B-m
76 ( ( O O
76 home NN B-NP B-do
76 dose NN I-NP I-do
76 ); NNP I-NP O
76 found VBD B-VP O
76 to TO O O
76 have VB O O
77 HTN NNP B-NP O
77 at IN B-VP O
77 SBP NNP B-NP O
77 235 CD O O
77 b/l NN B-NP O
77 arms; NN I-NP O
77 In IN B-VP O
77 the DT B-NP O
77 emergency NN I-NP O
77 department NN I-NP O
77 , , O O
77 she PRP O O
77 was VBD B-VP O
77 treated VBN O O
77 with IN B-VP O
78 hydralazine NN B-NP B-m
78 , , O O
78 SL NNP B-NP B-mo
78 nitro RB O B-m
78 , , O O
78 nitro JJ B-NP B-m
78 drip NN I-NP B-mo
78 and CC O O
78 then RB O O
78 pain VB O O
78 free; RB O O
78 given VBN O O
78 lopressor NN B-NP B-m
78 25 CD O B-do
79 Admit NNP B-NP O
79 for IN B-VP O
79 w/u NN B-NP O
79 of IN B-VP O
79 pain NN B-NP O
80 ***** NNP I-NP O
81 PMHx: NNP I-NP O
81 IDDM NNP I-NP O
81 , , O O
81 diastolic JJ B-NP O
81 CHF NNP I-NP O
81 , , O O
81 hypothyroidism NN B-NP O
81 , , O O
81 s/p NN B-NP O
81 RCEA NNP I-NP O
81 , , O O
81 total JJ B-NP O
81 hip NN I-NP O
82 replacement NN I-NP O
83 Cards NNP I-NP O
83 HX: NNP I-NP O
83 0/4 CD O O
83 cath NN B-NP O
83 w NN I-NP O
83 stents NNS I-NP O
83 to TO O O
83 LAD/LCX VB O O
83 7/21 CD O O
83 cath NN B-NP O
83 w NN I-NP O
83 stents NNS I-NP O
83 x VBP O O
83 2 CD O O
83 to TO O O
84 RCA NNP B-NP O
85 Echo NNP I-NP O
85 data: NN I-NP O
85 known VBN O O
85 EF NNP B-NP O
85 55% CD O O
85 in IN B-VP O
85 '03 CD O O
86 ***** JJ B-NP O
87 ALL: NNP I-NP O
87 PEANUTS NNP I-NP O
87 &amp; NNP I-NP O
87 STRAWBERRIES NNP I-NP O
88 ***** NNP I-NP O
89 PE NNP I-NP O
89 on IN B-VP O
89 ADMIT: NNP B-NP O
89 NAD NNP I-NP O
89 , , O O
89 BP NNP B-NP O
89 142/56 CD O O
89 on IN B-VP O
89 nitro NN B-NP B-m
89 , , O O
89 RR NNP B-NP O
89 18 CD O O
89 , , O O
89 96% CD O O
89 on IN B-VP O
89 2L CD O O
89 , , O O
89 70 CD O O
89 , , O O
89 afeb; VBZ O O
89 no DT B-NP O
90 bruit; NN I-NP O
90 JVP NNP I-NP O
90 8cm; CD O O
90 rrr NN B-NP O
90 , , O O
90 no DT B-NP O
90 m/r/g NN I-NP O
90 , , O O
90 bibasilar JJ B-NP O
90 crackles NNS I-NP O
90 , , O O
90 reproducible JJ B-NP O
90 sharp JJ I-NP O
91 pain NN I-NP O
91 abd NN I-NP O
91 nl NN I-NP O
91 alert NN I-NP O
91 , , O O
91 oriented VBD B-VP O
91 x JJ O O
91 3 CD O O
91 tho NN B-NP O
91 sometimes RB O O
91 requires VBZ O O
92 repeating VBG O O
92 Nonfocal NNP B-NP O
93 ***** NNP I-NP O
94 **Labs: NNP I-NP O
94 Cr NNP I-NP O
94 1.8 CD O O
94 ( ( O O
94 b/l NN B-NP O
94 ) ) O O
94 Hct $ O O
94 34.4 CD O O
94 ( ( O O
94 b/l NN B-NP O
94 ) ) O O
94 D NNP B-NP O
94 Dimer NNP I-NP O
94 871 CD O O
94 CK NNP B-NP O
94 , , O O
94 MB NNP B-NP O
94 fraction NN I-NP O
94 , , O O
94 TNI NNP B-NP O
95 &lt;assay NNP I-NP O
95 three CD O O
95 times NNS B-NP O
96 **CXR: JJ B-NP O
96 cardiomegaly NN I-NP O
96 , , O O
96 no DT B-NP O
96 pulm NN I-NP O
96 edema VBZ O O
97 **V/Q NNP B-NP O
97 scan: NN I-NP O
97 intermediate NN I-NP O
97 prob NN I-NP O
98 **lenis NNP I-NP O
98 - : O O
98 neg NN B-NP O
99 **PE NN I-NP O
99 protocol NN I-NP O
99 chest NN I-NP O
99 CT: NNP I-NP O
99 neg NN I-NP O
99 for IN B-VP O
99 PE NNP B-NP O
99 Ground NNP I-NP O
99 glass NN I-NP O
99 diffusely RB O O
99 +LAD JJ B-NP O
99 Pulm NNP I-NP O
100 nodule NN I-NP O
100 , , O O
100 will MD O O
100 need VB O O
100 repeat NN B-NP O
100 for IN B-VP O
100 f/u NN B-NP O
100 in IN B-VP O
100 6-12 JJ B-NP O
100 months NNS I-NP O
101 ***** IN B-VP O
102 Discharge NNP B-NP O
102 Exam: NNP I-NP O
102 BP NNP I-NP O
102 systolic JJ O O
102 130s CD O O
102 , , O O
102 rare JJ B-NP O
102 chest NN I-NP O
102 pain NN I-NP O
102 , , O O
102 occ'l JJ B-NP O
102 crackles NNS I-NP O
102 at IN B-VP O
102 bases NNS B-NP O
103 which WDT O O
103 clear VBP O O
103 w IN B-VP O
103 coughing; NN B-NP O
103 alert NN I-NP O
103 , , O O
103 oriented VBD B-VP O
103 x JJ O O
103 3 CD O O
103 , , O O
103 somewhat RB O O
103 anxious JJ B-NP O
103 otw NN I-NP O
103 at IN B-VP O
104 baseline NN B-NP O
105 ***** NNP I-NP O
106 A/P: NNP I-NP O
106 77F CD O O
106 w NN B-NP O
106 ho NN I-NP O
106 CAD NNP I-NP O
106 p/w NN I-NP O
106 chest NN I-NP O
106 pain NN I-NP O
106 of IN B-VP O
106 sudden JJ B-NP O
106 onset: NN I-NP O
106 Original NNP I-NP O
106 ddx NN I-NP O
106 includes VBZ O O
107 acs/usa/PE/hypertensive JJ B-NP O
107 urgency NN I-NP O
107 or CC O O
107 emergency/msk/chf VB O O
107 Given VBN O O
107 the DT B-NP O
107 excellenet NN I-NP O
108 response NN I-NP O
108 to TO O O
108 heparin VB O B-m
108 and CC O O
108 a DT B-NP O
108 negative JJ I-NP O
108 cardiac JJ I-NP O
108 catheterization NN I-NP O
108 , , O O
108 and CC O O
108 the DT B-NP O
109 continuoation NN I-NP O
109 of IN B-VP O
109 pain NN B-NP O
109 despite IN B-VP O
109 control NN B-NP O
109 of IN B-VP O
109 hypertension NN B-NP O
109 , , O O
109 the DT B-NP O
109 cardiac JJ I-NP O
109 team NN I-NP O
110 felt VBD B-VP O
110 that IN B-VP O
110 the DT O O
110 most RBS O O
110 likely JJ B-NP O
110 diagnosis NN I-NP O
110 was VBD B-VP O
110 a DT B-NP B-r
110 pulmonary JJ I-NP I-r
110 embolism NN I-NP I-r
110 However RB O O
110 , , O O
110 had VBD B-VP O
111 neg VBN O O
111 lenis NN B-NP O
111 and CC O O
111 PE NNP B-NP O
111 CT NNP I-NP O
111 , , O O
111 so RB O O
111 unlikely JJ B-NP O
111 PE NNP I-NP O
111 She PRP O O
111 was VBD B-VP O
111 discharged VBN O O
111 home NN B-NP O
111 with IN B-VP O
111 follow JJ O O
111 up RP O O
112 with IN B-VP O
112 Dr NNP B-NP O
112 Sollitto NNP I-NP O
112 and CC O O
112 with IN B-VP O
112 her PRP$ O O
112 usual JJ B-NP O
112 PCP NNP I-NP O
112 Will NNP I-NP O
112 need VBP O O
112 monitoring NN B-NP O
112 of IN B-VP O
112 lytes NNS B-NP O
112 and CC O O
113 Cr NNP B-NP O
113 given VBN O O
113 possibility NN B-NP O
113 of IN B-VP O
113 contrast NN B-NP O
113 induced VBN O O
113 nephropathy JJ O O
113 in IN B-VP O
113 setting VBG O O
113 of IN B-VP O
114 underlying VBG O O
114 elev JJ B-NP O
114 Cr NNP I-NP O
115 **CV: NNP I-NP O
115 ( ( O O
115 i JJ O O
115 ): VBP O O
115 Chest JJS B-NP O
115 pain NN I-NP O
115 was VBD B-VP O
115 initially RB O O
115 concerning VBG O O
115 for IN B-VP O
115 ischemic JJ B-NP O
115 pain; NN I-NP O
116 however RB O O
116 , , O O
116 cardiac JJ B-NP O
116 catheterization NN I-NP O
116 was VBD B-VP O
116 unchanged JJ O O
116 from IN B-VP O
116 prior JJ B-NP O
116 cath NN I-NP O
116 She PRP O O
117 will MD O O
117 continue VB O O
117 asa/plavix/BB/statin; VB O B-m
117 she PRP O O
117 ruled VBD B-VP O
117 out RP O O
117 for IN B-VP O
117 MI NNP B-NP O
117 w VBP O O
117 serial JJ B-NP O
118 enzymes NNS I-NP O
118 and CC O O
118 ekgs VB O O
118 Given NNP B-NP O
118 an DT O O
118 intermediate JJ O O
118 to TO O O
118 high JJ B-NP O
118 probability NN I-NP O
118 story NN I-NP O
119 and CC O O
119 an DT B-NP O
119 intermediate JJ I-NP O
119 V-Q JJ I-NP O
119 scan NN I-NP O
119 , , O O
119 she PRP O O
119 was VBD B-VP O
119 continued VBN O O
119 on IN B-VP O
119 heparin NN B-NP B-m
119 and CC O O
119 PE NNP B-NP O
119 protocol VBP O O
120 CT NNP B-NP O
120 of IN B-VP O
120 chest NN B-NP O
120 was VBD B-VP O
120 obtained VBN O O
120 , , O O
120 which WDT O O
120 was VBD B-VP O
120 neg NN B-NP O
120 for IN B-VP O
120 PE NNP B-NP O
120 but CC O O
120 showed VBD B-VP O
120 a DT B-NP O
120 pulmonary JJ I-NP O
121 nodule; NN I-NP O
121 she PRP O O
121 will MD O O
121 need VB O O
121 repeat NN B-NP O
121 CT NNP I-NP O
121 for IN B-VP O
121 nodule NN B-NP O
121 f/u NN I-NP O
121 in IN B-VP O
121 6-12 JJ B-NP O
121 months NNS I-NP O
121 Excellent JJ B-NP O
122 oxygentation NN I-NP O
122 , , O O
122 stable JJ B-NP O
122 walking NN I-NP O
122 and CC O O
122 nearly RB O O
122 pain RB O O
122 free JJ O O
122 at IN B-VP O
122 time NN B-NP O
122 of IN B-VP O
122 discharge NN B-NP O
123 ( ( O O
123 r JJ O O
123 ): VBZ O O
123 no DT B-NP O
123 active JJ I-NP O
123 issues NNS I-NP O
123 , , O O
123 telemetry NN B-NP O
123 monitoring NN I-NP O
123 was VBD B-VP O
123 nl JJ O O
124 ( ( O O
124 p JJ B-NP O
124 ): NNP I-NP O
124 HTN NNP I-NP O
124 , , O O
124 w NN B-NP O
124 ss NN I-NP O
124 , , O O
124 uptitrated JJ B-NP B-do
124 labetalol NN I-NP B-m
124 for IN B-VP O
124 BP NNP B-NP B-r
125 **PULM: NNP I-NP O
125 PE NNP I-NP O
125 intermediate JJ B-NP O
125 pretest NN I-NP O
125 prob NN I-NP O
125 - : O O
125 elev NN B-NP O
125 d JJ B-NP O
125 dimer NN I-NP O
125 but CC O O
125 no DT B-NP O
125 ekg NN I-NP O
125 changes NNS I-NP O
125 , , O O
125 no DT B-NP O
126 o2 NN I-NP O
126 req NN I-NP O
126 , , O O
126 no DT O O
126 known VBN O O
126 ca MD O O
126 , , O O
126 no DT B-NP O
126 obvious JJ I-NP O
126 dvt NN I-NP O
126 risks NNS I-NP O
126 lenis RBR O O
126 negative JJ O O
126 , , O O
126 PE NNP B-NP O
126 CT NNP I-NP O
126 neg NN I-NP O
126 , , O O
126 so RB O O
126 PE NNP B-NP O
127 considered VBD B-VP O
127 unlikely JJ O O
127 , , O O
127 will MD O O
127 not RB O O
127 anticoagulate VB O O
127 Pulm NNP B-NP O
127 nodule NN I-NP O
127 on IN B-VP O
127 CT NNP B-NP O
127 , , O O
127 will MD O O
127 need VB O O
128 6-12 JJ B-NP O
128 month NN I-NP O
128 f/u JJ B-NP O
128 scan NN I-NP O
128 Of IN B-VP O
128 importance NN B-NP O
128 however RB O O
128 , , O O
128 has VBZ O O
129 pulm VBN O O
129 hypertension NN B-NP O
129 that WDT O O
129 is VBZ O O
129 new JJ O O
129 on IN B-VP O
129 R NNP B-NP O
129 heart NN I-NP O
129 cath NN I-NP O
129 and CC O O
129 given VBN O O
129 no DT B-NP O
129 other JJ I-NP O
130 explanation NN I-NP O
130 for IN B-VP O
130 sudden JJ B-NP O
130 pressure NN I-NP O
130 changes NNS I-NP O
130 ( ( O O
130 impressively RB O O
130 higher JJR O O
130 since IN B-VP O
130 last JJ B-NP O
131 cath NN I-NP O
131 ) ) O O
131 , , O O
131 may MD O O
131 have VB O O
131 primary JJ B-NP O
131 pulm NN I-NP O
131 HTN NNP I-NP O
131 Given NNP I-NP O
131 ground NN I-NP O
131 glass NN I-NP O
131 in IN B-VP O
131 lungs NNS B-NP O
131 and CC O O
131 pulm NN B-NP O
132 nodule NN I-NP O
132 , , O O
132 should MD O O
132 have VB O O
132 outpt VBN O O
132 pulm JJ B-NP O
132 eval NN I-NP O
132 for IN B-VP O
132 pulm NN B-NP O
132 parenchymal JJ B-NP O
132 disease NN I-NP O
132 in IN B-VP O
132 near JJ B-NP O
133 future NN I-NP O
134 **endo: NNP I-NP O
134 DM NNP I-NP O
134 on IN B-VP O
134 70/30 CD O O
134 at IN B-VP O
134 home NN B-NP O
134 Poor NNP I-NP O
134 control NN I-NP O
134 given VBN O O
134 HbA1c NNP B-NP O
134 elev NN I-NP O
134 and CC O O
134 high JJ B-NP O
135 finger NN I-NP O
135 sticks NNS I-NP O
135 in IN B-VP O
135 house NN B-NP O
135 Chgd NNP I-NP O
135 to TO O O
135 nph VB O B-m
135 and CC O O
135 short VB O O
135 acting VBG O O
135 pre-meal JJ B-NP B-f
135 insulin NN I-NP O
135 for IN B-VP O
136 tight JJ B-NP B-r
136 control NN I-NP I-r
136 Pt NNP I-NP O
136 agreed VBD B-VP O
136 to TO O O
136 incr VB O O
136 freq NN B-NP O
136 of IN B-VP O
136 SC NNP B-NP B-mo
136 insulin NN I-NP B-m
136 for IN B-VP O
136 tight JJ B-NP B-r
136 control NN I-NP I-r
136 , , O O
137 still RB O O
137 high JJ B-NP O
137 sugera NN I-NP O
137 in IN B-VP O
137 house NN B-NP O
137 Wanted VBD B-VP O
137 to TO O O
137 send VB O O
137 with IN B-VP O
137 NPH NNP B-NP B-m
137 and CC O O
137 short JJ O O
137 acting VBG O O
137 pre-meal JJ B-NP B-f
138 regimen NNS I-NP O
138 but CC O O
138 pt NNS B-NP O
138 refused VBD B-VP O
138 to TO O O
138 change VB O O
138 home NN B-NP O
138 regimen NNS I-NP O
138 despite IN B-VP O
138 repeated JJ B-NP O
138 explanations NNS I-NP O
139 of IN B-VP O
139 value NN B-NP O
139 of IN B-VP O
139 tighter JJR B-NP O
139 control NN I-NP O
139 Agreed VBD B-VP O
139 that IN B-VP O
139 she PRP O O
139 would MD O O
139 return VB O O
139 to TO O O
139 home VB O O
139 regimen NNS B-NP O
139 of IN B-VP O
140 70/30 CD O O
140 and CC O O
140 f/u JJ B-NP O
140 ASAP NNP I-NP O
140 with IN B-VP O
140 Dr NNP B-NP O
140 Douglas NNP I-NP O
140 Tippett NNP I-NP O
140 of IN B-VP O
140 Endocrinology NNP B-NP O
140 to TO O O
140 optimize VB O O
141 insulin NN B-NP B-m
141 regimen; NN I-NP I-m
141 also RB O O
141 should MD O O
141 f/u VB O O
141 with IN B-VP O
141 outpt JJ B-NP O
141 pcp NN I-NP O
141 for IN B-VP O
141 titration NN B-NP O
141 H/o NNP I-NP O
142 hypothyroidism NN I-NP O
142 TSH NNP I-NP O
142 elevated; NN I-NP O
142 gave VBD B-VP O
142 script NN B-NP O
142 for IN B-VP O
143 112 CD O B-do
143 mcg NN B-NP I-do
143 of IN B-VP O
143 levoxyl NN B-NP B-m
143 ( ( O O
143 an DT B-NP O
143 increase NN I-NP O
143 ) ) O O
143 and CC O O
143 contacted VBD B-VP O
143 her PRP$ O O
143 o/p JJ B-NP O
143 endocrinologist NN I-NP O
143 for IN B-VP O
144 follow VB O O
144 up RP O O
145 **MSK: NNP B-NP O
145 arthritis: IN B-VP O
145 oxycodone NN B-NP B-m
145 and CC O O
145 tylenol NN B-NP B-m
145 prn NN I-NP B-f
146 **FEN NNP I-NP O
146 mag/k/calcium NN I-NP B-m
147 **ppx: NNP I-NP O
147 heparin NN I-NP B-m
147 while IN B-VP B-du
147 in IN B-VP I-du
147 house NN B-NP I-du
148 **Code NN I-NP O
148 status: CC O O
148 FULL NNP B-NP O
148 CODE NNP I-NP O
149 ADDITIONAL NNP I-NP O
149 COMMENTS: NNP I-NP O
149 Work NNP I-NP O
149 with IN B-VP O
149 your PRP$ O O
149 VNA NNP B-NP O
149 for IN B-VP O
149 aggressive JJ B-NP O
149 diabetes NNS I-NP O
149 management NN I-NP O
149 Please NNP I-NP O
149 assess RB O O
150 blood VBD B-VP B-r
150 sugars NNS B-NP I-r
150 and CC O O
150 titrate JJ B-NP B-do
150 insulin NN I-NP B-m
150 as IN B-VP O
150 per IN B-VP O
150 your PRP$ O O
150 doctor NN B-NP O
150 Please NNP I-NP O
150 assess RB O O
150 blood NN B-NP O
151 pressures NNS I-NP O
151 as IN B-VP O
151 well RB O O
151 Check VB O O
151 your PRP$ O O
151 electrolytes NNS B-NP O
151 with IN B-VP O
151 VNA NNP B-NP O
151 in IN B-VP O
151 1 CD O O
151 week NN B-NP O
152 Continue NNP I-NP O
152 diabetes VBZ O O
152 teaching VBG O O
152 thank VB O O
152 you PRP O O
153 DISCHARGE NNP B-NP O
153 CONDITION: NNP I-NP O
153 Stable NNP I-NP O
154 TO NNP I-NP O
154 DO/PLAN: NNP I-NP O
155 Check NNP I-NP O
155 Cr NNP I-NP O
155 , , O O
155 lytes VBZ O O
155 in IN B-VP O
155 1 CD O O
155 week NN B-NP O
155 by IN B-VP O
155 VNA NNP B-NP O
155 given VBN O O
155 contrast NN B-NP O
155 load NN I-NP O
155 and CC O O
155 risk NN B-NP O
155 of IN B-VP O
156 nephropathy JJ B-NP O
156 Pulmonary NNP I-NP O
156 consult NN I-NP O
156 to TO O O
156 eval VB O O
156 for IN B-VP O
156 primary JJ B-NP O
156 pulm JJ I-NP O
157 disease NN I-NP O
157 Repeat NNP I-NP O
157 chest JJS B-NP O
157 CT NNP I-NP O
157 6-12 JJ B-NP O
157 months NNS I-NP O
157 to TO O O
157 f/u VB O O
157 nodule.Titrate JJ B-NP O
157 insulin NN I-NP B-m
157 by IN B-VP O
158 finger NN B-NP O
158 sticks NNS I-NP O
158 at IN B-VP O
158 PCP NNP B-NP O
158 Monitor NNP I-NP O
158 BP NNP I-NP O
159 No NNP I-NP O
159 dictated VBD B-VP O
159 summary JJ B-NP O
160 ENTERED NNP I-NP O
160 BY: NNP I-NP O
160 RIEKERT NNP I-NP O
160 , , O O
160 NEWTON NNP B-NP O
160 E NNP I-NP O
160 , , O O
160 M.D NNP B-NP O
160 , , O O
160 PH.D NNP B-NP O
160 ( ( O O
160 PS482 NNP B-NP O
160 ) ) O O
160 6/14/06 CD O O
160 @ $ O O
160 07:23 CD O O
160 PM NNP B-NP O
161 ****** JJ B-NP O
161 END NNP I-NP O
161 OF NNP I-NP O
161 DISCHARGE NNP I-NP O
161 ORDERS NNP I-NP O
161 ****** NNP I-NP O
162 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #600921 VBZ O O
4 787502532 CD O O
4 BRH NNP B-NP O
4 92648184 CD O O
4 361994 CD O O
4 3/0/1992 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/13/1992 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/2/1992 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 This DT O O
7 is VBZ O O
7 a DT O O
7 72 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 black JJ I-NP O
7 female NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
8 history NN I-NP O
8 of IN B-VP O
8 hypertension NN B-NP O
8 , , O O
9 angina NN B-NP O
9 , , O O
9 adult NN B-NP O
9 onset NN I-NP O
9 diabetes NNS I-NP O
9 , , O O
9 admitted VBN O O
9 after IN B-VP O
9 a DT B-NP O
9 syncopal JJ I-NP O
9 event NN I-NP O
9 She PRP O O
10 has VBZ O O
10 a DT O O
10 known VBN O O
10 history NN B-NP O
10 of IN B-VP O
10 syncope NN B-NP O
10 which WDT O O
10 dates VBZ O O
10 as IN B-VP O
10 far RB O O
10 back RB O O
10 as IN B-VP O
10 the DT B-NP O
10 late JJ I-NP O
11 1960s NNS I-NP O
11 In IN B-VP O
11 1970 CD O O
11 she PRP O O
11 had VBD B-VP O
11 an DT B-NP O
11 episode NN I-NP O
11 of IN B-VP O
11 loss NN B-NP O
11 of IN B-VP O
11 consciousness NN B-NP O
11 with IN B-VP O
11 30 CD O O
12 seconds NNS B-NP O
12 of IN B-VP O
12 generalized JJ B-NP O
12 tonic JJ I-NP O
12 convulsions NNS I-NP O
12 witnessed VBN O O
12 by IN B-VP O
12 her PRP$ O O
12 daughter NN B-NP O
13 An DT B-NP O
13 EEG NN I-NP O
13 at IN B-VP O
13 that DT B-NP O
13 time NN I-NP O
13 showed VBD B-VP O
13 diffuse IN B-VP O
13 theta NN B-NP O
13 waves NNS I-NP O
13 but CC O O
13 was VBD B-VP O
13 nonfocal JJ O O
14 The DT B-NP O
14 patient NN I-NP O
14 was VBD B-VP O
14 treated VBN O O
14 with IN B-VP O
14 Dilantin NNP B-NP B-m
14 for IN B-VP B-du
14 less JJR O I-du
14 than IN B-VP I-du
14 a DT B-NP I-du
14 year NN I-NP I-du
14 In IN B-VP O
15 1972 CD O O
15 she PRP O O
15 had VBD B-VP O
15 another DT B-NP O
15 episode NN I-NP O
15 of IN B-VP O
15 syncope NN B-NP O
15 associated VBN O O
15 with IN B-VP O
16 hyperventilation NN B-NP O
16 In IN B-VP O
16 1983 CD O O
16 she PRP O O
16 had VBD B-VP O
16 yet RB O O
16 another DT B-NP O
16 episode NN I-NP O
16 of IN B-VP O
16 syncope NN B-NP O
17 and CC O O
17 a DT O O
17 24 CD O O
17 hour NN B-NP O
17 Holter NNP I-NP O
17 started VBD B-VP O
17 after IN B-VP O
17 the DT B-NP O
17 event NN I-NP O
17 showed VBD B-VP O
17 a DT B-NP O
17 heart NN I-NP O
17 rate NN I-NP O
18 that WDT O O
18 went VBD B-VP O
18 as RB O O
18 low JJ O O
18 as IN B-VP O
18 38 CD O O
18 but CC O O
18 was VBD B-VP O
18 not RB O O
18 associated VBN O O
18 with IN B-VP O
18 any DT B-NP O
18 symptoms NNS I-NP O
18 In IN B-VP O
19 1987 CD O O
19 she PRP O O
19 had VBD B-VP O
19 a DT B-NP O
19 vasovagal JJ I-NP O
19 event NN I-NP O
19 which WDT O O
19 was VBD B-VP O
19 later RB O O
19 aggravated VBN O O
19 when WRB O O
19 her PRP$ O O
20 neighbor NN B-NP O
20 gave VBD B-VP O
20 her PRP O O
20 a DT B-NP O
20 nitroglycerin JJ I-NP B-m
20 tablet NN I-NP I-m
20 Throughout IN B-VP O
20 this DT B-NP O
20 time NN I-NP O
20 she PRP O O
21 has VBZ O O
21 had VBN O O
21 multiple VBN O O
21 other JJ B-NP O
21 episodes NNS I-NP O
21 of IN B-VP O
21 syncope NN B-NP O
21 Her NNP I-NP O
21 last JJ B-NP O
21 episode NN I-NP O
21 was VBD B-VP O
22 in IN B-VP O
22 1989 CD O O
22 , , O O
22 when WRB O O
22 she PRP O O
22 was VBD B-VP O
22 admitted VBN O O
22 to TO O O
22 the DT B-NP O
22 Cardiology NNP I-NP O
22 Team NNP I-NP O
22 for IN B-VP O
22 workup NN B-NP O
23 Her NNP I-NP O
23 EKG NNP I-NP O
23 was VBD B-VP O
23 unremarkable JJ O O
23 , , O O
23 24 CD O O
23 hour NN B-NP O
23 Holter NNP I-NP O
23 was VBD B-VP O
23 normal JJ O O
23 , , O O
23 an DT B-NP O
24 echocardiogram NN I-NP O
24 was VBD B-VP O
24 normal JJ O O
24 , , O O
24 and CC O O
24 she PRP O O
24 underwent VBD B-VP O
24 an DT B-NP O
24 exercise NN I-NP O
24 stress NN I-NP O
25 test NN I-NP O
25 which WDT O O
25 did VBD B-VP O
25 not RB O O
25 show VB O O
25 ischemic JJ B-NP O
25 changes NNS I-NP O
25 In IN B-VP O
25 March NNP B-NP O
25 of IN B-VP O
25 1992 CD O O
25 , , O O
25 she PRP O O
26 had VBD B-VP O
26 carotid NN B-NP O
26 ultrasounds NNS I-NP O
26 for IN B-VP O
26 symptoms NNS B-NP O
26 of IN B-VP O
26 right JJ B-NP O
26 hand NN I-NP O
26 and CC O O
26 leg NN B-NP O
27 numbness NN I-NP O
27 They PRP O O
27 did VBD B-VP O
27 not RB O O
27 show VB O O
27 significant JJ B-NP O
27 stenosis NN I-NP O
27 In IN B-VP O
27 March NNP B-NP O
27 of IN B-VP O
28 1992 CD O O
28 , , O O
28 she PRP O O
28 was VBD B-VP O
28 admitted VBN O O
28 and CC O O
28 ruled VBN O O
28 out RP O O
28 for IN B-VP O
28 a DT B-NP O
28 myocardial JJ I-NP O
28 infarction NN I-NP O
29 and CC O O
29 was VBD B-VP O
29 started VBN O O
29 on IN B-VP O
29 Isordil NNP B-NP B-m
29 and CC O O
29 Lopressor NNP B-NP B-m
29 empirically RB O O
29 but CC O O
29 these DT O O
29 were VBD B-VP O
30 later RB O O
30 discontinued VBN O O
30 In IN B-VP O
30 February NNP B-NP O
30 of IN B-VP O
30 1992 CD O O
30 she PRP O O
30 had VBD B-VP O
30 a DT B-NP O
30 clinic JJ I-NP O
30 visit NN I-NP O
30 with IN B-VP O
31 Dr NNP B-NP O
31 Ed NNP I-NP O
31 Ville NNP I-NP O
31 who WP O O
31 is VBZ O O
31 her PRP$ O O
31 CALL NNP B-NP O
31 MEDICAL NNP I-NP O
31 CENTER NNP I-NP O
31 doctor NN I-NP O
31 The DT B-NP O
31 patient NN I-NP O
31 indicates VBZ O O
32 that IN B-VP O
32 she PRP O O
32 has VBZ O O
32 stable JJ B-NP O
32 exertional JJ I-NP O
32 angina NN I-NP O
32 without IN B-VP O
32 limitation NN B-NP O
32 of IN B-VP O
32 daily JJ B-NP O
33 activity NN I-NP O
33 , , O O
33 chest NN B-NP B-r
33 pain NN I-NP I-r
33 is VBZ O O
33 relieved VBN O O
33 with IN B-VP O
33 nitroglycerin NN B-NP B-m
33 and CC O O
33 her PRP$ O O
33 most RBS O O
34 recent JJ B-NP O
34 episode NN I-NP O
34 was VBD B-VP O
34 last JJ B-NP O
34 week NN I-NP O
34 She PRP O O
34 has VBZ O O
34 also RB O O
34 been VBN O O
34 on IN B-VP O
34 a DT B-NP B-do
34 stable JJ I-NP I-do
34 dose NN I-NP I-do
35 of IN B-VP O
35 Micronase NNP B-NP B-m
35 for IN B-VP B-du
35 the DT B-NP I-du
35 last JJ I-NP I-du
35 couple NN I-NP I-du
35 of IN B-VP I-du
35 years NNS B-NP I-du
35 On IN B-VP O
35 the DT B-NP O
35 morning NN I-NP O
35 of IN B-VP O
36 admission NN B-NP O
36 , , O O
36 the DT B-NP O
36 patient NN I-NP O
36 awoke NN I-NP O
36 and CC O O
36 felt VBD B-VP O
36 fine JJ O O
36 , , O O
36 and CC O O
36 was VBD B-VP O
36 getting VBG O O
36 ready JJ O O
37 to TO O O
37 have VB O O
37 coffee NN B-NP O
37 with IN B-VP O
37 her PRP$ O O
37 friends NNS B-NP O
37 upstairs IN B-VP O
37 She PRP O O
37 was VBD B-VP O
37 reaching VBG O O
37 for IN B-VP O
38 something NN B-NP O
38 across IN B-VP O
38 the DT B-NP O
38 table NN I-NP O
38 and CC O O
38 suddenly RB O O
38 felt VBD B-VP O
38 a DT B-NP O
38 sharp JJ I-NP O
38 pain NN I-NP O
38 in IN B-VP O
38 her PRP$ O O
39 back NN B-NP O
39 and CC O O
39 fell VBD B-VP O
39 unconscious JJ O O
39 into IN B-VP O
39 the DT B-NP O
39 chair NN I-NP O
39 Estimated NNP I-NP O
39 loss NN I-NP O
39 of IN B-VP O
40 consciousness NN B-NP O
40 was VBD B-VP O
40 6-7 JJ B-NP O
40 minutes NNS I-NP O
40 She PRP O O
40 awoke VBD B-VP O
40 confused JJ O O
40 , , O O
40 did VBD B-VP O
40 not RB O O
40 know VB O O
41 her PRP$ O O
41 name NN B-NP O
41 and CC O O
41 had VBD B-VP O
41 a DT B-NP O
41 little JJ I-NP O
41 bit NN I-NP O
41 of IN B-VP O
41 difficulty NN B-NP O
41 seeing VBG O O
41 It PRP O O
41 was VBD B-VP O
41 unclear JJ O O
42 by IN B-VP O
42 her PRP$ O O
42 history NN B-NP O
42 whether IN B-VP O
42 her PRP$ O O
42 vision NN B-NP O
42 was VBD B-VP O
42 blurry NN B-NP O
42 or CC O O
42 whether IN B-VP O
42 she PRP O O
42 felt VBD B-VP O
43 that IN B-VP O
43 there EX O O
43 was VBD B-VP O
43 a DT O O
43 shade JJ O O
43 across IN B-VP O
43 her PRP$ O O
43 eyes NNS B-NP O
43 She PRP O O
43 denies VBZ O O
43 any DT B-NP O
43 double JJ I-NP O
44 vision NN I-NP O
44 Prior NNP I-NP O
44 to TO O O
44 this DT B-NP O
44 event NN I-NP O
44 she PRP O O
44 did VBD B-VP O
44 not RB O O
44 experience VB O O
44 any DT B-NP O
44 prodrome NN I-NP O
44 or CC O O
45 aura NN B-NP O
45 She PRP O O
45 also RB O O
45 denied VBD B-VP O
45 chest JJS B-NP O
45 pain NN I-NP O
45 , , O O
45 shortness NN B-NP O
45 of IN B-VP O
45 breath NN B-NP O
45 or CC O O
46 palpitations NNS B-NP O
46 There EX O O
46 was VBD B-VP O
46 no DT B-NP O
46 loss NN I-NP O
46 of IN B-VP O
46 bladder NN B-NP O
46 or CC O O
46 bowel NN B-NP O
46 function NN I-NP O
47 during IN B-VP O
47 the DT B-NP O
47 event NN I-NP O
47 The DT B-NP O
47 patient NN I-NP O
47 was VBD B-VP O
47 given VBN O O
47 orange NN B-NP O
47 juice NN I-NP O
47 after IN B-VP O
47 the DT B-NP O
48 episode NN I-NP O
48 and CC O O
48 gradually RB O O
48 she PRP O O
48 regained VBD B-VP O
48 awareness NN B-NP O
48 of IN B-VP O
48 her PRP$ O O
48 surroundings NNS B-NP O
49 Her NNP I-NP O
49 vital JJ B-NP O
49 signs NNS I-NP O
49 were VBD B-VP O
49 stable JJ O O
49 She PRP O O
49 was VBD B-VP O
49 brought VBN O O
49 to TO O O
49 Tia NNP B-NP O
49 Medical NNP I-NP O
49 Center NNP I-NP O
50 for IN B-VP O
50 evaluation NN B-NP O
50 There EX O O
50 was VBD B-VP O
50 a DT B-NP O
50 question NN I-NP O
50 of IN B-VP O
50 upper JJ B-NP O
50 extremity NN I-NP O
50 twitching NN I-NP O
51 by IN B-VP O
51 report NN B-NP O
51 from IN B-VP O
51 observers NNS B-NP O
51 PAST NNP I-NP O
51 MEDICAL NNP I-NP O
51 HISTORY: NNP I-NP O
51 Hypertension NNP I-NP O
52 dating VBG O O
52 at IN B-VP O
52 least JJS O O
52 10 CD O O
52 years NNS B-NP O
52 back RB O O
52 and CC O O
52 is VBZ O O
52 presently RB O O
52 not RB O O
52 requiring VBG O O
52 any DT B-NP O
53 treatment NN I-NP O
53 She PRP O O
53 has VBZ O O
53 a DT B-NP O
53 history NN I-NP O
53 , , O O
53 as IN B-VP O
53 mentioned VBN O O
53 , , O O
53 of IN B-VP O
53 recurrent NN B-NP O
53 syncopal JJ B-NP O
54 events NNS I-NP O
54 She PRP O O
54 was VBD B-VP O
54 diagnosed VBN O O
54 a DT B-NP O
54 couple NN I-NP O
54 of IN B-VP O
54 years NNS B-NP O
54 ago RB O O
54 with IN B-VP O
54 adult NN B-NP B-r
54 onset VBN O O
55 diabetes NNS B-NP O
55 and CC O O
55 has VBZ O O
55 been VBN O O
55 on IN B-VP O
55 a DT B-NP B-do
55 stable JJ I-NP I-do
55 dose NN I-NP I-do
55 of IN B-VP O
55 Micronase NNP B-NP B-m
55 The DT B-NP O
55 patient NN I-NP O
56 also RB O O
56 has VBZ O O
56 a DT B-NP O
56 history NN I-NP O
56 of IN B-VP O
56 multiple JJ B-NP O
56 colonic JJ I-NP O
56 polyps NNS I-NP O
56 and CC O O
56 in IN B-VP O
56 1983 CD O O
56 underwent NN B-NP O
57 a DT B-NP O
57 left JJ I-NP O
57 hemicolectomy NN I-NP O
57 for IN B-VP O
57 multiple JJ B-NP O
57 polyps NNS I-NP O
57 In IN B-VP O
57 1988 CD O O
57 she PRP O O
57 underwent VBD B-VP O
57 an DT B-NP O
58 ileal JJ I-NP O
58 resection NN I-NP O
58 for IN B-VP O
58 large JJ B-NP O
58 inflammatory JJ I-NP O
58 polyps NNS I-NP O
58 leading VBG O O
58 to TO O O
58 a DT B-NP O
58 small JJ I-NP O
59 bowel NN I-NP O
59 obstruction NN I-NP O
59 She PRP O O
59 has VBZ O O
59 had VBD B-VP O
59 a DT B-NP O
59 cholecystectomy NN I-NP O
59 and CC O O
59 an DT B-NP O
60 appendectomy NN I-NP O
60 in IN B-VP O
60 the DT O O
60 distant JJ O O
60 past IN B-VP O
60 The DT B-NP O
60 patient NN I-NP O
60 also RB O O
60 a DT B-NP O
60 history NN I-NP O
60 of IN B-VP O
61 glaucoma NN B-NP O
61 In IN B-VP O
61 1973 CD O O
61 and CC O O
61 1976 CD O O
61 she PRP O O
61 had VBD B-VP O
61 a DT B-NP O
61 right JJ I-NP O
61 lower JJR I-NP O
61 extremity NN I-NP O
61 DVT NNP I-NP O
61 , , O O
62 etiology NN B-NP O
62 was VBD B-VP O
62 unclear JJ O O
62 The DT B-NP O
62 patient NN I-NP O
62 does VBZ O O
62 not RB O O
62 smoke VB O O
62 , , O O
62 drink VB O O
62 or CC O O
62 use VB O O
62 any DT B-NP O
63 drugs NNS I-NP O
63 MEDICATIONS NNP I-NP O
63 ON NNP I-NP O
63 ADMISSION NNP I-NP O
63 include VBP O O
63 aspirin JJ O B-m
63 one CD O B-do
63 tablet NN B-NP I-do
63 q NN I-NP B-f
63 d NN I-NP I-f
63 , , O O
64 Questran NNP B-NP B-m
64 one CD O B-do
64 pack NN B-NP I-do
64 q NN I-NP B-f
64 d NN I-NP I-f
64 , , O O
64 Micronase NNP B-NP B-m
64 5 CD O B-do
64 mg NN B-NP I-do
64 po NN I-NP B-mo
64 q NN I-NP B-f
64 d NN I-NP I-f
64 , , O O
64 Betaxolol NNP B-NP B-m
64 eye NN I-NP I-m
64 drops NNS I-NP I-m
65 bid VBD B-VP B-f
65 to TO O B-mo
65 each DT B-NP I-mo
65 eye NN I-NP I-mo
65 , , O O
65 Pilocarpine NNP B-NP B-m
65 eye NN I-NP I-m
65 drops NNS I-NP I-m
65 tid VBP O B-f
65 to TO O B-mo
65 each DT B-NP I-mo
65 eye NN I-NP I-mo
65 , , O O
66 eye NN B-NP O
66 drops NNS I-NP O
66 bid VBD B-VP O
66 to TO O O
66 each DT B-NP O
66 eye NN I-NP O
66 The DT B-NP O
66 patient JJ I-NP O
66 receives NNS I-NP O
66 monthly JJ B-NP B-f
66 Vitamin NNP I-NP B-m
67 B12 NNP I-NP O
67 injections NNS I-NP B-mo
67 She PRP O O
67 also RB O O
67 takes VBZ O O
67 nitroglycerin NN B-NP B-m
67 with IN B-VP O
67 chest NN B-NP B-r
67 pain NN I-NP I-r
68 FAMILY NNP I-NP O
68 HISTORY NNP I-NP O
68 is VBZ O O
68 significant JJ O O
68 for IN B-VP O
68 a DT B-NP O
68 brother NN I-NP O
68 who WP O O
68 suffered VBD B-VP O
68 a DT B-NP O
68 stroke NN I-NP O
69 at IN B-VP O
69 the DT B-NP O
69 age NN I-NP O
69 of IN B-VP O
69 74 CD O O
69 There EX O O
69 is VBZ O O
69 also RB O O
69 a DT B-NP O
69 family NN I-NP O
69 history NN I-NP O
69 of IN B-VP O
69 heart NN B-NP O
69 attacks VBZ O O
70 No DT B-NP O
70 family NN I-NP O
70 history NN I-NP O
70 of IN B-VP O
70 gastrointestinal JJ B-NP O
70 cancer NN I-NP O
70 SOCIAL NNP I-NP O
70 HISTORY: NNP I-NP O
70 The DT B-NP O
71 patient NN I-NP O
71 is VBZ O O
71 separated VBN O O
71 and CC O O
71 lives NNS B-NP O
71 by IN B-VP O
71 herself PRP O O
71 in IN B-VP O
71 Hutmill NNP B-NP O
71 Rd NNP I-NP O
71 , , O O
71 Bock NNP B-NP O
71 Tonlake NNP I-NP O
71 Son NNP I-NP O
71 , , O O
71 North NNP B-NP O
71 Dakota NNP I-NP O
71 32472 CD O O
71 She PRP O O
71 has VBZ O O
72 eight CD O O
72 children NNS B-NP O
72 with IN B-VP O
72 many JJ B-NP O
72 grandchildren NNS I-NP O
72 REVIEW NNP I-NP O
72 OF NNP I-NP O
72 SYSTEMS NNP I-NP O
72 is VBZ O O
73 notable JJ O O
73 for IN B-VP O
73 episodes NNS B-NP O
73 of IN B-VP O
73 sweats NNS B-NP O
73 and CC O O
73 nervousness NN B-NP O
73 over IN B-VP O
73 the DT B-NP O
73 last JJ I-NP O
73 week NN I-NP O
74 which WDT O O
74 she PRP O O
74 describes VBZ O O
74 as IN B-VP O
74 being VBG O O
74 similar JJ O O
74 to TO O O
74 the DT B-NP O
74 hot JJ I-NP O
74 flashes NNS I-NP O
74 of IN B-VP O
75 menopause NN B-NP O
75 which WDT O O
75 she PRP O O
75 had VBD B-VP O
75 at IN B-VP O
75 age NN B-NP O
75 49 CD O O
75 These DT B-NP O
75 episodes NNS I-NP O
75 are VBP O O
75 occurring VBG O O
75 a DT B-NP O
76 few JJ I-NP O
76 times NNS I-NP O
76 a DT B-NP O
76 day NN I-NP O
76 but CC O O
76 do VBP O O
76 not RB O O
76 in IN B-VP O
76 any DT B-NP O
76 way NN I-NP O
76 coincide NN I-NP O
76 with IN B-VP O
76 her PRP$ O O
76 syncopal JJ B-NP O
77 events NNS I-NP O
77 She PRP O O
77 is VBZ O O
77 also RB O O
77 complaining VBG O O
77 of IN B-VP O
77 right JJ B-NP O
77 hand NN I-NP O
77 and CC O O
77 foot NN B-NP O
77 numbness NN I-NP O
78 which WDT O O
78 have VBP O O
78 increased VBN O O
78 in IN B-VP O
78 frequency NN B-NP O
78 The DT B-NP O
78 numbness NN I-NP O
78 occasionally RB O O
78 wakes VBZ O O
79 her PRP O O
79 up RP O O
79 at IN B-VP O
79 night NN B-NP O
79 She PRP O O
79 denies VBZ O O
79 any DT B-NP O
79 motor NN I-NP O
79 weakness NN I-NP O
79 whatsoever RB O O
80 PHYSICAL NNP B-NP O
80 EXAMINATION: NNP I-NP O
80 She PRP O O
80 is VBZ O O
80 an DT O O
80 elderly JJ O O
80 , , O O
80 mildly RB O O
80 obese JJ B-NP O
80 female NN I-NP O
80 , , O O
80 in IN B-VP O
81 no DT B-NP O
81 apparent JJ I-NP O
81 distress NN I-NP O
81 She PRP O O
81 was VBD B-VP O
81 afebrile RB O O
81 , , O O
81 with IN B-VP O
82 a DT B-NP O
82 blood NN I-NP O
82 pressure NN I-NP O
82 of IN B-VP O
82 126/70 CD O O
82 , , O O
82 a DT B-NP O
82 heart NN I-NP O
82 rate NN I-NP O
82 of IN B-VP O
82 60 CD O O
82 , , O O
82 and CC O O
82 a DT B-NP O
82 respiratory JJ I-NP O
83 rate NN I-NP O
83 of IN B-VP O
83 18 CD O O
83 HEENT NNP B-NP O
83 exam NN I-NP O
83 was VBD B-VP O
83 notable JJ O O
83 for IN B-VP O
83 pinpoint JJ B-NP O
83 constriction NN I-NP O
83 of IN B-VP O
84 her PRP$ O O
84 pupils NNS B-NP O
84 secondary JJ O O
84 to TO O O
84 her PRP$ O O
84 glaucoma NN B-NP B-m
84 eyedrops VBZ O I-m
84 Her PRP$ O O
84 pupils NNS B-NP O
84 were VBD B-VP O
85 reactive JJ B-NP O
85 Her NNP I-NP O
85 throat NN I-NP O
85 was VBD B-VP O
85 benign JJ O O
85 She PRP O O
85 had VBD B-VP O
85 dentures NNS B-NP O
85 Her NNP I-NP O
85 neck NN I-NP O
85 was VBD B-VP O
86 supple JJ O O
86 , , O O
86 without IN B-VP O
86 lymphadenopathy JJ O O
86 or CC O O
86 thyromegaly JJ B-NP O
86 Chest NNP I-NP O
86 exam NN I-NP O
87 revealed VBD B-VP O
87 bibasilar JJ O O
87 , , O O
87 coarse JJ B-NP O
87 crackles NNS I-NP O
87 On IN B-VP O
87 cardiac JJ B-NP O
87 exam NN I-NP O
87 she PRP O O
87 had VBD B-VP O
87 no DT B-NP O
88 jugular JJ I-NP O
88 venous JJ I-NP O
88 distention NN I-NP O
88 , , O O
88 and CC O O
88 carotids NNS B-NP O
88 were VBD B-VP O
88 normal JJ O O
88 without IN B-VP O
88 bruits NNS B-NP O
89 She PRP O O
89 had VBD B-VP O
89 a DT B-NP O
89 regular JJ I-NP O
89 rate NN I-NP O
89 and CC O O
89 rhythm NN B-NP O
89 with IN B-VP O
89 S1 NNP B-NP O
89 , , O O
89 S2 NNP B-NP O
89 , , O O
89 and CC O O
89 an DT B-NP O
89 occasional JJ I-NP O
90 S4 NNP I-NP O
90 There EX O O
90 were VBD B-VP O
90 no DT B-NP O
90 murmurs JJ I-NP O
90 Abdominal NNP I-NP O
90 exam NN I-NP O
90 was VBD B-VP O
90 benign JJ O O
90 The DT B-NP O
90 patient NN I-NP O
91 was VBD B-VP O
91 guaiac JJ B-NP O
91 negative JJ I-NP O
91 Extremities NNS I-NP O
91 were VBD B-VP O
91 without IN B-VP O
91 edema NN B-NP O
91 and CC O O
91 there EX O O
91 was VBD B-VP O
92 no DT B-NP O
92 calf NN I-NP O
92 tenderness VBD B-VP O
92 The DT B-NP O
92 neurologic JJ I-NP O
92 exam NN I-NP O
92 was VBD B-VP O
92 entirely RB O O
92 nonfocal JJ B-NP O
93 LABORATORY NNP I-NP O
93 DATA: NNP I-NP O
93 Includes VBZ O O
93 a DT B-NP O
93 sodium NN I-NP O
93 of IN B-VP O
93 143 CD O O
93 , , O O
93 potassium NN B-NP O
93 of IN B-VP O
93 4.3 CD O O
93 , , O O
94 chloride NN B-NP O
94 of IN B-VP O
94 109 CD O O
94 , , O O
94 bicarbonate NN B-NP O
94 of IN B-VP O
94 20 CD O O
94 , , O O
94 BUN NNP B-NP O
94 of IN B-VP O
94 21; CD O O
95 creatinine NN B-NP O
95 was VBD B-VP O
95 1.0 CD O O
95 The DT B-NP O
95 glucose NN I-NP O
95 was VBD B-VP O
95 160 CD O O
95 Her NNP B-NP O
95 calcium NN I-NP O
95 and CC O O
96 phosphate NN B-NP O
96 were VBD B-VP O
96 normal JJ B-NP O
96 Her NNP I-NP O
96 hematocrit NN I-NP O
96 was VBD B-VP O
96 43.4 CD O O
96 , , O O
96 her PRP$ O O
96 white JJ B-NP O
96 count NN I-NP O
97 6.45 CD O O
97 with IN B-VP O
97 a DT O O
97 normal JJ O O
97 differential JJ O O
97 Her PRP$ O O
97 coagulation NN B-NP O
97 factors NNS I-NP O
97 were VBD B-VP O
98 normal JJ B-NP O
98 Her NNP I-NP O
98 liver NN I-NP O
98 function NN I-NP O
98 tests NNS I-NP O
98 were VBD B-VP O
98 normal JJ B-NP O
98 A NNP I-NP O
98 chest NN I-NP O
98 X NN I-NP O
98 ray NN I-NP O
99 showed VBD B-VP O
99 a DT B-NP O
99 calcific JJ I-NP O
99 aorta NN I-NP O
99 but CC O O
99 was VBD B-VP O
99 otherwise RB O O
99 clear JJ B-NP O
99 C NNP I-NP O
99 spine NN I-NP O
99 X NNP I-NP O
99 ray NN I-NP O
99 and CC O O
100 head NN B-NP O
100 CT NNP I-NP O
100 on IN B-VP O
100 admission NN B-NP O
100 were VBD B-VP O
100 also RB O O
100 negative JJ O O
100 The DT B-NP O
100 EKG NNP I-NP O
100 showed VBD B-VP O
100 no DT B-NP O
100 changes NNS I-NP O
101 from IN B-VP O
101 her PRP$ O O
101 baseline JJ B-NP O
102 HOSPITAL NNP I-NP O
102 COURSE: NNP I-NP O
102 The DT B-NP O
102 patient NN I-NP O
102 was VBD B-VP O
102 placed VBN O O
102 on IN B-VP O
102 a DT B-NP O
102 cardiac JJ I-NP O
102 monitor NN I-NP O
102 , , O O
102 and CC O O
103 her PRP$ O O
103 Micronase NNP B-NP B-m
103 was VBD B-VP O
103 held VBN O O
103 In IN B-VP O
103 fact NN B-NP O
103 , , O O
103 her PRP$ O O
103 fingerstick NN B-NP O
104 glucose NN I-NP O
104 went VBD B-VP O
104 as RB O O
104 low JJ O O
104 as IN B-VP O
104 80 CD O O
104 that IN B-VP O
104 evening VBG O O
104 On IN B-VP O
104 day NN B-NP O
104 two CD O O
104 of IN B-VP O
104 admission NN B-NP O
104 , , O O
105 the DT B-NP O
105 patient NN I-NP O
105 had VBD B-VP O
105 syncopal JJ B-NP O
105 event NN I-NP O
105 while IN B-VP O
105 in IN B-VP O
105 house NN B-NP O
105 She PRP O O
105 was VBD B-VP O
105 apparently RB O O
106 walking VBG O O
106 about RB O O
106 after IN B-VP O
106 having VBG O O
106 washed VBD B-VP O
106 her PRP O O
106 face NN B-NP O
106 and CC O O
106 was VBD B-VP O
106 reaching VBG O O
106 to TO O O
106 pull VB O O
107 the DT B-NP O
107 curtain NN I-NP O
107 when WRB O O
107 she PRP O O
107 began VBD B-VP O
107 feeling VBG O O
107 lightheaded VBD B-VP O
107 She PRP O O
107 told VBD B-VP O
107 the DT B-NP O
107 nurse NN I-NP O
108 immediately RB O O
108 , , O O
108 who WP O O
108 tried VBD B-VP O
108 to TO O O
108 get VB O O
108 her PRP O O
108 on IN B-VP O
108 the DT B-NP O
108 bed NN I-NP O
108 , , O O
108 and CC O O
108 the DT B-NP O
108 patient NN I-NP O
109 collapsed VBD B-VP O
109 on IN B-VP O
109 the DT B-NP O
109 bed NN I-NP O
109 , , O O
109 was VBD B-VP O
109 limp VBN O O
109 and CC O O
109 lost VBN O O
109 consciousness NN B-NP O
109 for IN B-VP O
109 about IN B-VP O
109 3-5 JJ B-NP O
110 minutes NNS I-NP O
110 She PRP O O
110 had VBD B-VP O
110 a DT B-NP O
110 systolic JJ I-NP O
110 blood NN I-NP O
110 pressure NN I-NP O
110 of IN B-VP O
110 200/105 CD O O
110 and CC O O
110 a DT B-NP O
110 heart NN I-NP O
111 rate NN I-NP O
111 of IN B-VP O
111 90 CD O O
111 There EX O O
111 were VBD B-VP O
111 no DT B-NP O
111 changes NNS I-NP O
111 on IN B-VP O
111 the DT B-NP O
111 cardiac JJ I-NP O
111 monitor NN I-NP O
111 , , O O
111 and CC O O
111 the DT B-NP O
112 patient NN I-NP O
112 was VBD B-VP O
112 noted VBN O O
112 to TO O O
112 maintain VB O O
112 a DT B-NP O
112 strong JJ I-NP O
112 pulse NN I-NP O
112 at IN B-VP O
112 all DT B-NP O
112 times NNS I-NP O
112 She PRP O O
112 was VBD B-VP O
113 given VBN O O
113 Nitro NNP B-NP B-m
113 Paste NNP I-NP I-m
113 and CC O O
113 1 CD O B-do
113 amp NN B-NP I-do
113 of IN B-VP O
113 D50 NNP B-NP B-m
113 Fingerstick NNP I-NP O
113 glucose NN I-NP O
113 was VBD B-VP O
113 then RB O O
114 noted VBN O O
114 to TO O O
114 be VB O O
114 232 CD O O
114 The DT B-NP O
114 patient NN I-NP O
114 was VBD B-VP O
114 witnessed VBN O O
114 to TO O O
114 have VB O O
114 mild JJ B-NP O
114 twitching NN I-NP O
115 of IN B-VP O
115 her PRP$ O O
115 jaw NN B-NP O
115 and CC O O
115 eyelids NNS B-NP O
115 and CC O O
115 after IN B-VP O
115 five CD O O
115 minutes NNS B-NP O
115 , , O O
115 she PRP O O
115 opened VBD B-VP O
115 her PRP O O
115 eyes NNS B-NP O
116 but CC O O
116 was VBD B-VP O
116 not RB O O
116 able JJ O O
116 to TO O O
116 respond VB O O
116 When WRB O O
116 asked VBN O O
116 to TO O O
116 give VB O O
116 her PRP O O
116 name NN B-NP O
116 , , O O
116 she PRP O O
116 was VBD B-VP O
117 not RB O O
117 able JJ O O
117 to TO O O
117 answer VB O O
117 The DT B-NP O
117 confusion NN I-NP O
117 subsided VBD B-VP O
117 over IN B-VP O
117 the DT B-NP O
117 next JJ I-NP O
117 couple NN I-NP O
117 of IN B-VP O
118 minutes NNS B-NP O
118 , , O O
118 and CC O O
118 the DT B-NP O
118 patient NN I-NP O
118 was VBD B-VP O
118 able JJ O O
118 to TO O O
118 respond VB O O
118 and CC O O
118 was VBD B-VP O
118 alert JJ O O
118 and CC O O
119 oriented VBN O O
119 However RB O O
119 , , O O
119 she PRP O O
119 had VBD B-VP O
119 no DT B-NP O
119 recollection NN I-NP O
119 of IN B-VP O
119 the DT B-NP O
119 event NN I-NP O
119 Further NNP I-NP O
120 workup NN I-NP O
120 included VBD B-VP O
120 a DT B-NP O
120 head NN I-NP O
120 MRI NNP I-NP O
120 , , O O
120 MR NNP B-NP O
120 angiogram NN I-NP O
120 of IN B-VP O
120 her PRP$ O O
120 vertebrobasilar JJ B-NP O
121 circulation NN I-NP O
121 , , O O
121 a DT B-NP O
121 sleep NN I-NP O
121 deprived VBN O O
121 EEG NNP B-NP O
121 , , O O
121 a DT B-NP O
121 cardiac JJ I-NP O
121 echo NN I-NP O
121 , , O O
121 and CC O O
121 a DT O O
121 24 CD O O
121 hour NN B-NP O
122 Holter NNP I-NP O
122 All NNP I-NP O
122 of IN B-VP O
122 the DT B-NP O
122 above NN I-NP O
122 were VBD B-VP O
122 negative JJ O O
122 We PRP O O
122 also RB O O
122 applied VBD B-VP O
122 carotid JJ B-NP O
123 sinus JJ I-NP O
123 stimulation NN I-NP O
123 and CC O O
123 she PRP O O
123 showed VBD B-VP O
123 no DT B-NP O
123 change NN I-NP O
123 in IN B-VP O
123 heart NN B-NP O
123 rate NN I-NP O
123 to TO O O
123 either DT B-NP O
124 side NN I-NP O
124 The DT B-NP O
124 etiology NN I-NP O
124 of IN B-VP O
124 her PRP$ O O
124 syncopal JJ B-NP O
124 event NN I-NP O
124 is VBZ O O
124 not RB O O
124 completely RB O O
124 clear JJ O O
125 It PRP O O
125 appears VBZ O O
125 that IN B-VP O
125 the DT B-NP O
125 patient NN I-NP O
125 does VBZ O O
125 have VB O O
125 a DT B-NP O
125 history NN I-NP O
125 of IN B-VP O
125 a DT B-NP O
125 witnessed JJ I-NP O
126 seizure NN I-NP O
126 but CC O O
126 also RB O O
126 has VBZ O O
126 had VBN O O
126 syncopal JJ B-NP O
126 events NNS I-NP O
126 consistent JJ O O
126 with IN B-VP O
126 either DT B-NP O
127 bradycardia NN I-NP O
127 or CC O O
127 a DT B-NP O
127 vasovagal JJ I-NP O
127 event NN I-NP O
128 DISPOSITION: NNP I-NP O
128 The DT B-NP O
128 patient NN I-NP O
128 is VBZ O O
128 discharged VBN O O
128 to TO O O
128 home VB O O
128 with IN B-VP O
128 plans NNS B-NP O
128 for IN B-VP O
128 a DT B-NP O
129 repeat NN I-NP O
129 24 CD O O
129 hour NN B-NP O
129 Holter NNP I-NP O
129 as IN B-VP O
129 an DT B-NP O
129 outpatient NN I-NP O
129 FOLLOW NNP I-NP O
129 UP: NNP I-NP O
130 She PRP O O
130 will MD O O
130 follow VB O O
130 up RP O O
130 with IN B-VP O
130 Dr NNP B-NP O
130 Danilo NNP I-NP O
130 Mcquaid NNP I-NP O
130 in IN B-VP O
130 the DT B-NP O
130 THERPLEA NNP I-NP O
130 HOSPITAL NNP I-NP O
130 Clinic NNP I-NP O
131 CONDITION NNP I-NP O
131 ON NNP I-NP O
131 DISCHARGE: NNP I-NP O
131 Stable NNP I-NP O
131 DISCHARGE NNP I-NP O
131 MEDICATIONS NNP I-NP O
131 include VBP O O
132 aspirin JJ O B-m
132 one CD O B-do
132 tablet NN B-NP I-do
132 po NN I-NP B-mo
132 q NN I-NP B-f
132 d NN I-NP I-f
132 , , O O
132 Questran NNP B-NP B-m
132 one CD O B-do
132 package NN B-NP I-do
132 po NN I-NP B-mo
132 q NN I-NP B-f
132 d NN I-NP I-f
132 , , O O
132 Pilocarpine NNP B-NP B-m
133 eye NN I-NP O
133 drops NNS I-NP O
133 tid VBP O B-f
133 per IN B-VP B-mo
133 eye NN B-NP I-mo
133 , , O O
133 Betaxolol NNP B-NP B-m
133 eye NN I-NP I-m
133 drops NNS I-NP I-m
133 bid VBP O B-f
133 per IN B-VP B-mo
133 eye NN B-NP I-mo
133 , , O O
134 eye NN B-NP O
134 drops NNS I-NP O
134 bid VBP O O
134 per IN B-VP O
134 eye NN B-NP O
134 , , O O
134 sublingual JJ B-NP B-mo
134 nitroglycerin NN I-NP B-m
134 prn NN I-NP B-f
134 chest NN I-NP B-r
134 pain NN I-NP I-r
134 , , O O
135 Naprosyn NNP B-NP B-m
135 375 CD O B-do
135 mg NN B-NP I-do
135 tid NN I-NP B-f
135 prn NN I-NP I-f
136 DISCHARGE NNP I-NP O
136 DIAGNOSIS: NNP I-NP O
136 SYNCOPE NNP I-NP O
137 OTHER NNP I-NP O
137 DIAGNOSES: NNP I-NP O
137 BORDERLINE NNP I-NP O
137 TYPE NNP I-NP O
137 II NNP I-NP O
137 DIABETES NNP I-NP O
137 , , O O
137 STABLE NNP B-NP O
137 EXERTIONAL NNP I-NP O
138 ANGINA NNP I-NP O
138 , , O O
138 AND NNP B-NP O
138 GLAUCOMA NNP I-NP O
139 IQ732/2070 NNP I-NP O
140 CHUCK NNP I-NP O
140 VONDRASEK NNP I-NP O
140 , , O O
140 M.D NNP B-NP O
140 TN3 NNP I-NP O
140 D: NNP I-NP O
140 5/8/92 CD O O
141 Batch: NNP B-NP O
141 8886 CD O O
141 Report: NNP B-NP O
141 W5608N6 NNP I-NP O
141 T: NNP I-NP O
141 8/0/92 CD O O
142 Dictated NNP B-NP O
142 By: NNP I-NP O
142 GRUNER NNP I-NP O
142 , , O O
142 MAURO NNP B-NP O
142 RUPERT NNP I-NP O
142 KRAIG NNP I-NP O
143 cc: VBD B-VP O
143 1 CD O O
143 HARRIS NNP B-NP O
143 LEMBRICK NNP I-NP O
143 , , O O
143 M.D./DEPT NNP B-NP O
143 OF NNP I-NP O
143 MED NNP I-NP O
144 2 CD O O
144 ELBERT NNP B-NP O
144 STREJAN NNP I-NP O
144 , , O O
144 M.D./DEPT NNP B-NP O
144 OF NNP I-NP O
144 MED NNP I-NP O
145 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #603643 VBZ O O
2 168640048 CD O O
2 CHCC NNP B-NP O
2 77575346 CD O O
2 4523497 CD O O
2 0/20/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Diabetes NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 2/5/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/21/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 POUPARD NNP I-NP O
5 , , O O
5 RUBEN NNP B-NP O
5 ELIAS NNP I-NP O
5 414-48-72-5 JJ B-NP O
6 Hiypendwau NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 11/1/05 CD O O
8 AT NNP B-NP O
8 05:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 LILJEBERG NNP I-NP O
11 , , O O
11 PHILIP NNP B-NP O
11 C NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 INSULIN NNP I-NP B-m
16 NPH NNP I-NP I-m
16 HUMAN NNP I-NP I-m
16 40 CD O B-do
16 UNITS NNP B-NP I-do
16 SC NNP I-NP B-mo
16 QAM NNP I-NP B-f
16 Starting VBG O O
16 Today NNP B-NP O
16 ( ( O O
16 6/1 CD O O
16 ) ) O O
17 INSULIN NNP B-NP B-m
17 NPH NNP I-NP I-m
17 HUMAN NNP I-NP I-m
17 40 CD O B-do
17 UNITS NNP B-NP I-do
17 SC NNP I-NP B-mo
17 QPM NNP I-NP B-f
17 Starting VBG O O
17 Today NNP B-NP O
17 ( ( O O
17 6/1 CD O O
17 ) ) O O
18 INSULIN NNP B-NP B-m
18 REGULAR NNP I-NP I-m
18 HUMAN NNP I-NP I-m
18 15 CD O B-do
18 UNITS NNP B-NP I-do
18 SC NNP I-NP B-mo
18 QAM NNP I-NP B-f
19 Starting VBG O O
19 Today NNP B-NP O
19 ( ( O O
19 6/1 CD O O
19 ) ) O O
20 Instructions: NNP B-NP O
20 can MD O O
20 give VB O O
20 with IN B-VP O
20 am VBP O B-f
20 dose NN B-NP O
20 of IN B-VP O
20 nph JJ B-NP B-m
21 GLUCOMETER NNP I-NP O
21 1 CD O O
21 EA NNP B-NP O
21 SC NNP I-NP O
21 x1 NNP I-NP O
22 INSULIN NNP I-NP B-m
22 REGULAR NNP I-NP I-m
22 HUMAN NNP I-NP I-m
22 20 CD O B-do
22 UNITS NNP B-NP I-do
22 SC NNP I-NP B-mo
22 QPM NNP I-NP B-f
23 INSULIN NNP I-NP B-m
23 REGULAR NNP I-NP I-m
23 HUMAN NNP I-NP I-m
23 10 CD O B-do
23 UNITS NNP B-NP I-do
23 SC NNP I-NP B-mo
23 AC NNP I-NP B-f
24 Instructions: NNP I-NP O
24 Take VB O O
24 if IN B-VP O
24 pre-lunch JJ B-NP O
24 FS NNP I-NP O
24 &gt; NNP I-NP O
24 180 CD O O
25 METFORMIN NNP B-NP B-m
25 500 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 BID NNP I-NP B-f
26 DIET: NNP I-NP O
26 House NNP I-NP O
26 / NNP I-NP O
26 ADA NNP I-NP O
26 1800 CD O O
26 cals/dy NN B-NP O
27 ACTIVITY: NNP I-NP O
27 Resume NNP I-NP O
27 regular JJ B-NP O
27 exercise NN I-NP O
28 FOLLOW NNP I-NP O
28 UP NNP I-NP O
28 APPOINTMENT( NNP I-NP O
28 S NNP I-NP O
28 ): NNP I-NP O
29 Dr NNP I-NP O
29 Kohout NNP I-NP O
29 ( ( O O
29 new JJ B-NP O
29 PCP NNP I-NP O
29 ) ) O O
29 9/13/05 CD O O
29 @ $ O O
29 2:50pm CD O O
29 scheduled VBN O O
29 , , O O
30 Dr NNP B-NP O
30 Lackner NNP I-NP O
30 ( ( O O
30 Endocrine NNP B-NP O
30 ) ) O O
30 10/13/05 CD O O
30 @ $ O O
30 7:30pm CD O O
30 scheduled VBN O O
30 , , O O
31 ALLERGY: NNP B-NP O
31 NKA NNP I-NP O
32 ADMIT NNP I-NP O
32 DIAGNOSIS: NNP I-NP O
33 Diabetic NNP I-NP O
33 Ketoacidosis NNP I-NP O
34 PRINCIPAL NNP I-NP O
34 DISCHARGE NNP I-NP O
34 DIAGNOSIS NNP I-NP O
34 ;Responsible JJ O O
34 After IN B-VP O
34 Study NNP B-NP O
34 for IN B-VP O
34 Causing NNP B-NP O
34 Admission NNP I-NP O
34 ) ) O O
35 Diabetes VBZ O O
36 OTHER NNP B-NP O
36 DIAGNOSIS;Conditions NNP I-NP O
36 , , O O
36 Infections NNP B-NP O
36 , , O O
36 Complications NNP B-NP O
36 , , O O
36 affecting VBG O O
36 Treatment/Stay NNP B-NP O
37 Diabetes NNP I-NP O
37 ( ( O O
37 diabetes VBZ O O
37 mellitus NN B-NP O
37 ) ) O O
37 obesity NN B-NP O
37 ( ( O O
37 obesity NN B-NP O
37 ) ) O O
38 OPERATIONS NNP B-NP O
38 AND NNP I-NP O
38 PROCEDURES: NNP I-NP O
39 none NN I-NP O
40 OTHER NNP I-NP O
40 TREATMENTS/PROCEDURES NNP I-NP O
40 ( ( O O
40 NOT NNP B-NP O
40 IN NNP I-NP O
40 O.R NNP I-NP O
40 ) ) O O
41 none NN B-NP O
42 BRIEF NNP I-NP O
42 RESUME NNP I-NP O
42 OF NNP I-NP O
42 HOSPITAL NNP I-NP O
42 COURSE: NNP I-NP O
43 23 CD O O
43 yo NN B-NP O
43 M NNP I-NP O
43 w/ NN I-NP O
43 morbid NN I-NP O
43 obesity NN I-NP O
43 p/w VBP O O
43 1 CD O O
43 wk NN B-NP O
43 of IN B-VP O
43 polyuria NN B-NP O
43 and CC O O
43 polydypsia NN B-NP O
43 and CC O O
43 3 CD O O
43 days NNS B-NP O
44 of IN B-VP O
44 nausea NN B-NP O
44 and CC O O
44 vomiting VBG O O
44 Mr NNP B-NP O
44 Longo NNP I-NP O
44 was VBD B-VP O
44 in IN B-VP O
44 his PRP$ O O
44 usual JJ B-NP O
44 state NN I-NP O
44 of IN B-VP O
44 health NN B-NP O
45 until IN B-VP O
45 one CD O O
45 week NN B-NP O
45 ago RB O O
45 when WRB O O
45 he PRP O O
45 started VBD B-VP O
45 to TO O O
45 have VB O O
45 a DT B-NP O
45 decreased JJ I-NP O
45 apetitie NN I-NP O
45 , , O O
45 polyuria NN B-NP O
46 and CC O O
46 polydypsia NN B-NP O
46 He PRP O O
46 would MD O O
46 wake VB O O
46 up RP O O
46 every DT O O
46 2hours CD O O
46 at IN B-VP O
46 night NN B-NP O
46 to TO O O
46 urinate VB O O
46 He PRP O O
47 was VBD B-VP O
47 drinking VBG O O
47 vitamin JJ B-NP O
47 water NN I-NP O
47 and CC O O
47 Gatorade NNP B-NP O
47 to TO O O
47 keep VB O O
47 from IN B-VP O
47 being VBG O O
47 too RB O O
48 dehydrated VBN O O
48 He PRP O O
48 denies VBZ O O
48 any DT B-NP O
48 URI NNP I-NP O
48 symptoms NNS I-NP O
48 , , O O
48 cough NN B-NP O
48 , , O O
48 SOB NNP B-NP O
48 , , O O
48 dysuria NN B-NP O
48 , , O O
48 abdominal JJ B-NP O
49 pain NN I-NP O
49 or CC O O
49 diarrhea NN B-NP O
49 during IN B-VP O
49 the DT B-NP O
49 past JJ I-NP O
49 couple NN I-NP O
49 of IN B-VP O
49 weeks NNS B-NP O
49 He PRP O O
49 does VBZ O O
49 however RB O O
50 complain VB O O
50 of IN B-VP O
50 some DT B-NP O
50 DOE NNP I-NP O
50 in IN B-VP O
50 the DT B-NP O
50 past JJ I-NP O
50 week NN I-NP O
50 3 CD O O
50 days NNS B-NP O
50 ago RB O O
50 , , O O
50 he PRP O O
50 developed VBD B-VP O
50 morning NN B-NP O
51 nausea NN I-NP O
51 and CC O O
51 vomiting VBG O O
51 The DT B-NP O
51 vomit NN I-NP O
51 was VBD B-VP O
51 nonbilious JJ O O
51 , , O O
51 nonbloody JJ B-NP O
51 vomit NN I-NP O
51 and CC O O
51 no DT B-NP O
52 associated JJ I-NP O
52 abdominal JJ I-NP O
52 pain NN I-NP O
52 or CC O O
52 diarrhea NN B-NP O
52 He PRP O O
52 denies VBZ O O
52 any DT B-NP O
52 HA NNP I-NP O
52 , , O O
52 visual JJ B-NP O
52 changes NNS I-NP O
52 , , O O
53 changes NNS B-NP O
53 in IN B-VP O
53 mental JJ B-NP O
53 status NN I-NP O
53 or CC O O
53 dizziness NN B-NP O
53 He PRP O O
53 also RB O O
53 denies VBZ O O
53 sick JJ B-NP O
53 contacts NNS I-NP O
53 He PRP O O
54 has VBZ O O
54 not RB O O
54 had VBN O O
54 any DT B-NP O
54 change NN I-NP O
54 in IN B-VP O
54 weight NN B-NP O
55 PMH: NNP I-NP O
56 Morbid NNP I-NP O
56 obesity NN I-NP O
57 MEDICATIONS: NNP I-NP O
58 Pepcid NNP I-NP B-m
58 AC NNP I-NP I-m
58 QHS NNP I-NP B-f
59 ALLERGIES: NNP I-NP O
59 NKDA NNP I-NP O
60 SH: NNP I-NP O
60 Marital NNP I-NP O
60 Status: NNP I-NP O
60 not RB O O
60 married VBD B-VP O
60 Lives NNS B-NP O
60 with IN B-VP O
60 girlfriend NN B-NP O
60 Not RB O O
60 working VBG O O
61 TOB NNP B-NP O
61 negative; JJ B-NP O
61 ETOH NNP I-NP O
61 negative; NN I-NP O
61 ILLICITS NNP I-NP O
61 negative JJ B-NP O
62 FH: NNP I-NP O
62 Maternal NNP I-NP O
62 grandmother NN I-NP O
62 with IN B-VP O
62 DM/Htn NNP B-NP O
63 ROS: NNP I-NP O
63 See NNP I-NP O
63 HPI NNP I-NP O
63 for IN B-VP O
63 pertinent JJ B-NP O
63 positives NNS I-NP O
64 PHYSICAL NNP I-NP O
64 EXAM NNP I-NP O
64 ON NNP I-NP O
64 ADMISSION: NNP I-NP O
64 VS: NNP I-NP O
64 T NNP I-NP O
64 97.5 CD O O
64 , , O O
64 HR NNP B-NP O
64 103 CD O O
64 , , O O
64 BP NNP B-NP O
64 110/60 CD O O
64 , , O O
64 RR NNP B-NP O
64 20 CD O O
64 , , O O
64 O2sat NNP B-NP O
65 96%RA CD O O
65 GENERAL: NNP B-NP O
65 Morbidly NNP I-NP O
65 obese JJ B-NP O
65 young JJ I-NP O
65 man NN I-NP O
65 , , O O
65 lying VBG O O
65 in IN B-VP O
65 bed NN B-NP O
65 , , O O
65 comfortable JJ B-NP O
65 NAD NNP I-NP O
66 HEENT: NNP I-NP O
66 NCAT NNP I-NP O
66 , , O O
66 sclera NN B-NP O
66 anicteric; RB O O
66 mucous JJ B-NP O
66 membranes NNS I-NP O
66 are VBP O O
66 dry JJ O O
66 , , O O
66 OP NNP B-NP O
66 without IN B-VP O
67 erythema NN B-NP O
67 or CC O O
67 thrush NN B-NP O
67 Fundi NNP I-NP O
67 with IN B-VP O
67 clear JJ B-NP O
67 margins NNS I-NP O
67 CHEST:CTAB NNP I-NP O
68 CV: NNP I-NP O
68 RRR NNP I-NP O
68 , , O O
68 audible JJ B-NP O
68 S1 NNP I-NP O
68 and CC O O
68 S2 NNP B-NP O
68 , , O O
68 no DT B-NP O
68 m/r/g NN I-NP O
68 2+ CD O O
68 and CC O O
68 symmetric JJ B-NP O
68 radial NN I-NP O
68 , , O O
68 2+ CD O O
68 and CC O O
69 symmetric JJ B-NP O
69 pedal NN I-NP O
69 pulses VBZ O O
69 ABD: NNP B-NP O
69 Positive NNP I-NP O
69 bowel NN I-NP O
69 sounds VBZ O O
69 Obese JJ B-NP O
69 abdomen NNS I-NP O
70 Nontender NNP I-NP O
70 , , O O
70 non-distended JJ B-NP O
70 Hepatic NNP I-NP O
70 margin NN I-NP O
70 , , O O
70 soft JJ O O
70 , , O O
70 palpable JJ O O
70 just RB O O
70 under IN B-VP O
70 the DT B-NP O
71 costal JJ I-NP O
71 margin NN I-NP O
71 NEURO: NNP I-NP O
71 AOx3 NNP I-NP O
71 CNII-XII NNP I-NP O
71 intact JJ B-NP O
71 Strenght: NNP I-NP O
71 UE NNP I-NP O
71 5/5 CD O O
71 , , O O
71 LE NNP B-NP O
71 5/5 CD O O
72 bilaterally RB O O
72 Sensation NNP B-NP O
72 intact JJ O O
72 to TO O O
72 light JJ B-NP O
72 touch NN I-NP O
72 and CC O O
72 temperature NN B-NP O
72 Reflexes NNP I-NP O
72 1+ CD O O
73 brachial NN B-NP O
73 , , O O
73 brachioradialis NN B-NP O
73 and CC O O
73 patellar JJ B-NP O
74 DATA: NNP I-NP O
75 Chemistry NNP I-NP O
75 On IN B-VP O
75 admission: NN B-NP O
76 Chem7: NNP I-NP O
76 131/4/92/22/11/1.1/440 CD O O
77 ABG: NNP B-NP O
77 PO2 NNP I-NP O
77 82 CD O O
77 , , O O
77 PH NNP B-NP O
77 7.39 CD O O
77 , , O O
77 PCO2 NNP B-NP O
77 35 CD O O
78 TP NNP B-NP O
78 8.5 CD O O
78 , , O O
78 Alb NNP B-NP O
78 4.8 CD O O
78 , , O O
78 AST NNP B-NP O
78 42 CD O O
78 , , O O
78 ALT NNP B-NP O
78 76 CD O O
78 , , O O
78 Bt NNP B-NP O
78 0.5 CD O O
78 , , O O
78 Alk NNP B-NP O
78 80 CD O O
79 UA: NNP B-NP O
79 pH5 NN I-NP O
79 , , O O
79 3+ CD O O
79 gluc NN B-NP O
79 , , O O
79 2+ CD O O
79 ketones NNS B-NP O
79 , , O O
79 neg JJ B-NP O
79 bili NN I-NP O
79 , , O O
79 1+ CD O O
79 blood NN B-NP O
79 , , O O
79 neg JJ B-NP O
79 Leuks NNP I-NP O
79 , , O O
79 neg JJ B-NP O
79 nitrite JJ I-NP O
80 RADIOLOGY: NNP I-NP O
81 Chest NNP I-NP O
81 Xray: NNP I-NP O
81 no DT B-NP O
81 signs NNS I-NP O
81 of IN B-VP O
81 an DT B-NP O
81 acute JJ I-NP O
81 cardiopulm NN I-NP O
81 process NN I-NP O
82 EKG: NNP I-NP O
83 HR NNP I-NP O
83 100bpm CD O O
83 , , O O
83 normal JJ B-NP O
83 sinus NN I-NP O
83 rhythm NN I-NP O
83 , , O O
83 normal JJ B-NP O
83 PR NNP I-NP O
83 , , O O
83 QRS NNP B-NP O
83 and CC O O
83 QT NNP B-NP O
83 intervals VBZ O O
83 No DT B-NP O
83 ST-T JJ I-NP O
84 wave NN I-NP O
84 abnormalities NNS I-NP O
84 J-point NNP I-NP O
84 elevations NNS I-NP O
84 in IN B-VP O
84 v2-v6 JJ B-NP O
85 ASSESSMENT/HOSPITAL NNP I-NP O
85 COURSE: NNP I-NP O
86 23 CD O O
86 yo NN B-NP O
86 M NNP I-NP O
86 w/ NN I-NP O
86 morbid NN I-NP O
86 obesity NN I-NP O
86 who WP O O
86 p/w VBZ O O
86 polyuria NN B-NP O
86 , , O O
86 polydypsia NN B-NP O
86 , , O O
86 nausea NN B-NP O
86 and CC O O
87 vomiting VBG O O
87 Given NNP B-NP O
87 presentation NN I-NP O
87 and CC O O
87 lab NN B-NP O
87 values NNS I-NP O
87 , , O O
87 patient NN B-NP O
87 is VBZ O O
87 in IN B-VP O
87 diabetic JJ B-NP O
88 ketoacidosis: NN I-NP O
88 BS&gt;200 NNP I-NP O
88 , , O O
88 ketonuria NN B-NP O
88 , , O O
88 pH&lt;7.4 VBP O O
89 1 CD O O
89 DKA: NNP B-NP O
89 New NNP I-NP O
89 diagnosis NN I-NP O
89 of IN B-VP O
89 diabetes NNS B-NP O
89 Unclear IN B-VP O
89 what WP O O
89 the DT B-NP O
89 trigger NN I-NP O
89 was VBD B-VP O
89 for IN B-VP O
89 the DT B-NP O
90 DKA NNP I-NP O
90 - : O O
90 no DT B-NP O
90 signs/symptoms NNS I-NP O
90 of IN B-VP O
90 infection NN B-NP O
90 No NNP I-NP O
90 h/o NN I-NP O
90 of IN B-VP O
90 stress NN B-NP O
90 in IN B-VP O
90 recent JJ B-NP O
90 weeks NNS I-NP O
91 a DT B-NP O
91 Corrected NNP I-NP O
91 hyperglycemia NN I-NP B-r
91 and CC O O
91 acidosis NN B-NP B-r
91 with IN B-VP O
91 insulin NN B-NP B-m
91 insulin NN I-NP B-m
91 - : O O
91 anion NN B-NP O
91 gap NN I-NP O
91 resolved VBN O O
92 by IN B-VP O
92 HD#2 NNP B-NP O
93 b NN I-NP O
93 Repleted NNP I-NP O
93 volume NN I-NP O
93 and CC O O
93 electrolytes: JJ B-NP O
93 whole JJ I-NP O
93 body NN I-NP O
93 potassium NN I-NP O
93 depleted VBD B-VP O
93 - : O O
94 started VBN O O
94 NS NNP B-NP O
94 w/ VBD B-VP O
94 20mEQ CD O B-do
94 of IN B-VP O
94 KCl NNP B-NP B-m
94 ` `` O O
94 give VB O O
94 2L CD O O
94 of IN B-VP O
94 fluid NN B-NP O
94 in IN B-VP O
94 total JJ O O
94 Until IN B-VP B-du
94 gap NN B-NP O
95 normalized VBN O O
95 and CC O O
95 potassium JJ O O
95 became VBD B-VP O
95 stable JJ O O
95 at IN B-VP O
95 4 CD O O
96 c.Blood NN B-NP O
96 sugars NNS I-NP O
96 were VBD B-VP O
96 erratic JJ O O
96 during IN B-VP O
96 entire JJ B-NP O
96 Hospital NNP I-NP O
96 stay NN I-NP O
96 Difficult NNP I-NP O
97 to TO O O
97 control VB O O
97 on IN B-VP O
97 high JJ B-NP B-do
97 high JJ I-NP B-do
97 levels NNS I-NP I-do
97 levels NNS I-NP I-do
97 of IN B-VP O
97 NPH NNP B-NP B-m
97 and CC O O
97 regular JJ O B-m
97 alone RB O O
97 Adequate NNP B-NP O
97 control NN I-NP O
98 to TO O O
98 BS NNP B-NP O
98 = NNP I-NP O
98 200s CD O O
98 achieved VBD B-VP O
98 with: NN B-NP O
98 Metformin NNP I-NP B-m
98 500mg CD O B-do
98 bid; NN B-NP B-f
98 AM NNP I-NP B-f
98 AM NNP I-NP B-f
98 -- : O O
98 NPH NNP B-NP B-m
98 40u CD O B-do
98 , , O O
98 reg VBD B-VP B-m
98 15u; CD O B-do
99 lunch NN B-NP B-f
99 -- : O O
99 Reg NNP B-NP B-m
99 10u CD O B-do
99 if IN B-VP O
99 BS&gt;180; NNP B-NP O
99 PM NNP I-NP B-f
99 PM NNP I-NP B-f
99 NPH NNP I-NP B-m
99 40u CD O B-do
99 , , O O
99 reg VBD B-VP B-m
99 20u CD O B-do
99 Endocrine NNP B-NP O
99 was VBD B-VP O
99 consulted VBN O O
100 and CC O O
100 agreed VBN O O
100 with IN B-VP O
100 plan NN B-NP O
100 Antibodies NNS I-NP O
100 for IN B-VP O
100 ?typeI JJ B-NP O
100 DM NNP I-NP O
100 sent VBD B-VP O
100 F/U NNP B-NP O
100 with IN B-VP O
100 endocrine NN B-NP O
101 scheduled VBN O O
102 d.Patient NN B-NP O
102 was VBD B-VP O
102 placed VBN O O
102 on IN B-VP O
102 a DT B-NP O
102 diabetic JJ I-NP O
102 diet NN I-NP O
102 , , O O
102 received VBD B-VP O
102 a DT B-NP O
102 nutrition NN I-NP O
102 consult NN I-NP O
103 with IN B-VP O
103 diabetes NNS B-NP O
103 education NN I-NP O
103 He PRP O O
103 also RB O O
103 received VBD B-VP O
103 education NN B-NP O
103 on IN B-VP O
103 finger NN B-NP O
103 sticks NNS I-NP O
103 and CC O O
104 insulin JJ B-NP B-m
104 administration NN I-NP O
104 The DT B-NP O
104 importance NN I-NP O
104 of IN B-VP O
104 health NN B-NP O
104 care NN I-NP O
104 and CC O O
104 compliance NN B-NP O
104 was VBD B-VP O
105 asserted VBN O O
105 Regular JJ B-NP O
105 exercise NN I-NP O
105 and CC O O
105 only RB O O
105 3 CD O O
105 meals NNS B-NP O
105 a DT B-NP O
105 day NN I-NP O
105 w/ POS O O
105 limitation NN B-NP O
105 of IN B-VP O
105 snacks NNS B-NP O
106 was VBD B-VP O
106 encouraged VBN O O
107 e RB O O
107 Follow NNP B-NP O
107 up RP O O
107 appointments NNS B-NP O
107 w/ IN B-VP O
107 Dr NNP B-NP O
107 Duewall NNP I-NP O
107 and CC O O
107 Endocrine NNP B-NP O
107 were VBD B-VP O
107 obtained VBN O O
108 -------------------- NNP B-NP O
109 FULL NNP I-NP O
109 CODE NNP I-NP O
110 ADDITIONAL NNP I-NP O
110 COMMENTS: NNP I-NP O
110 -Be NNP I-NP O
110 sure NN I-NP O
110 to TO O O
110 continue VB O O
110 compliance NN B-NP O
110 with IN B-VP O
110 a DT B-NP O
110 diabetic JJ I-NP O
110 diet NN I-NP O
110 -- : O O
110 3 CD O O
110 meals NNS B-NP O
110 a DT B-NP O
110 day NN I-NP O
111 =Take VB O O
111 your PRP$ O O
111 insulin NN B-NP B-m
111 at IN B-VP O
111 the DT B-NP O
111 designated JJ I-NP O
111 times NNS I-NP O
112 -Take VBP O O
112 Metformin NNP B-NP B-m
112 once RB O B-f
112 a DT B-NP I-f
112 day NN I-NP I-f
113 -Continue NNP I-NP O
113 regular JJ B-NP O
113 exercise NN I-NP O
114 -Be NNP I-NP O
114 aware NN I-NP O
114 of IN B-VP O
114 potential JJ B-NP O
114 low JJ I-NP O
114 blood NN I-NP O
114 sugar NN I-NP O
114 levels NNS I-NP O
114 and CC O O
114 symptoms NNS B-NP O
115 -Folow VBP O O
115 up RP O O
115 with IN B-VP O
115 your PRP$ O O
115 PCP NNP B-NP O
115 Dr NNP I-NP O
115 Benett NNP I-NP O
115 in IN B-VP O
115 May NNP B-NP O
116 -Follow VB O O
116 up RP O O
116 with IN B-VP O
116 Endocrine NNP B-NP O
116 clinic NN I-NP O
116 -- : O O
116 Dr NNP B-NP O
116 Rataczak NNP I-NP O
116 -- : O O
116 on IN B-VP O
116 February NNP B-NP O
117 DISCHARGE NNP I-NP O
117 CONDITION: NNP I-NP O
117 Stable NNP I-NP O
118 TO NNP I-NP O
118 DO/PLAN: NNP I-NP O
119 -Diabetic NNP I-NP O
119 insulin NN I-NP B-m
119 regimen: NN I-NP O
120 QAM: NNP I-NP B-f
120 QAM: NNP I-NP B-f
120 40u CD O B-do
120 NPH NNP B-NP B-m
120 , , O O
120 15u CD O B-do
120 reg NN B-NP B-m
121 @noon: VBD B-VP B-f
121 10u CD O B-do
121 reg NN B-NP B-m
121 if IN B-VP O
121 BS&gt;180 NNP B-NP O
122 QPM: NNP I-NP B-f
122 QPM: NNP I-NP B-f
122 40u CD O B-do
122 NPH NNP B-NP B-m
122 , , O O
122 20u CD O B-do
122 reg NN B-NP B-m
123 Metformin NNP I-NP B-m
123 500mg CD O B-do
123 bid NN B-NP B-f
124 -Patient NN I-NP O
124 to TO O O
124 attempt VB O O
124 3meals CD O O
124 a DT B-NP O
124 day NN I-NP O
124 of IN B-VP O
124 diabetic JJ B-NP O
124 diet; NN I-NP O
124 check NN I-NP O
124 BS NNP I-NP O
124 qid; NN I-NP O
125 administer RB O O
125 insulin NN B-NP B-m
125 as IN B-VP O
125 recommended; NN B-NP O
125 have VBP O O
125 regular JJ B-NP O
125 exercise NN I-NP O
126 -F/U NN I-NP O
126 w/ NN I-NP O
126 PCP NNP I-NP O
126 and CC O O
126 Endocrine NNP B-NP O
126 at IN B-VP O
126 designated VBN O O
126 appointments NNS B-NP O
127 No RB O O
127 dictated VBD B-VP O
127 summary JJ B-NP O
128 ENTERED NNP I-NP O
128 BY: NNP I-NP O
128 PADAMADAN NNP I-NP O
128 , , O O
128 WILLIAMS NNP B-NP O
128 R NNP I-NP O
128 , , O O
128 M.D NNP B-NP O
128 ( ( O O
128 AM13 NNP B-NP O
128 ) ) O O
128 11/1/05 CD O O
128 @ $ O O
128 11 CD O O
129 ****** JJ B-NP O
129 END NN I-NP O
129 OF NNP I-NP O
129 DISCHARGE NNP I-NP O
129 ORDERS NNP I-NP O
129 ****** NNP I-NP O
130 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #610966 VBZ O O
2 329859652 CD O O
2 VGMUOHC NNP B-NP O
2 45873980 CD O O
2 8127980 CD O O
2 10/18/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 RULE NNP I-NP O
2 OUT NNP I-NP O
2 MYOCARDIAL NNP I-NP O
2 INFARCTION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 4/26/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 7/24/2005 CD O O
4 ATTENDING: NNP B-NP O
4 BRAMLETT NNP I-NP O
4 , , O O
4 BENNETT NNP B-NP O
4 MD NNP I-NP O
5 CHIEF NNP I-NP O
5 COMPLAINT: NNP I-NP O
5 Abdominal NNP I-NP O
5 pain NN I-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 This DT O O
6 is VBZ O O
6 a DT B-NP O
6 56-year-old JJ I-NP O
6 female NN I-NP O
7 transferred VBN O O
7 from IN B-VP O
7 the DT B-NP O
7 Internal NNP I-NP O
7 Medicine NNP I-NP O
7 Service NNP I-NP O
7 for IN B-VP O
7 acute JJ B-NP O
8 cholecystitis NN I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 presented VBN O O
8 with IN B-VP O
8 abdominal JJ B-NP O
8 pain NN I-NP O
8 for IN B-VP O
9 five CD O O
9 days NNS B-NP O
9 , , O O
9 nausea NN B-NP O
9 , , O O
9 vomiting VBG O O
9 and CC O O
9 shortness NN B-NP O
9 of IN B-VP O
9 breath NN B-NP O
9 The DT B-NP O
9 patient NN I-NP O
10 was VBD B-VP O
10 originally RB O O
10 admitted VBN O O
10 to TO O O
10 the DT B-NP O
10 Internal NNP I-NP O
10 Medicine NNP I-NP O
10 Service NNP I-NP O
10 where WRB O O
11 she PRP O O
11 received VBD B-VP O
11 a DT B-NP O
11 cardiac JJ I-NP O
11 rule NN I-NP O
11 out IN B-VP O
11 A NNP B-NP O
11 CT NNP I-NP O
11 scan NN I-NP O
11 was VBD B-VP O
11 obtained VBN O O
11 on IN B-VP O
12 4/26/2005 CD O O
12 , , O O
12 which WDT O O
12 showed VBD B-VP O
12 an DT B-NP O
12 inflamed JJ I-NP O
12 gallbladder NN I-NP O
12 , , O O
12 which WDT O O
13 corresponded VBD B-VP O
13 to TO O O
13 patient's VB O O
13 ongoing VBG O O
13 right JJ B-NP O
13 upper JJ I-NP O
13 quadrant NN I-NP O
13 pain NN I-NP O
14 PAST NNP I-NP O
14 MEDICAL NNP I-NP O
14 HISTORY: NNP I-NP O
15 1 CD O O
15 Hypertension NNP B-NP O
16 2 CD O O
16 Hypercholesterolemia NNP B-NP O
17 3 CD O O
17 Diabetes NNP B-NP O
17 mellitus VBD B-VP O
17 type JJ O O
17 2 CD O O
17 ( ( O O
17 untreated VBN O O
17 ) ) O O
18 OUTPATIENT NNP B-NP O
18 MEDICATIONS: NNP I-NP O
18 Atenolol NNP I-NP B-m
18 50 CD O B-do
18 mg NN B-NP I-do
18 p.o JJ O B-mo
18 daily RB O B-f
18 , , O O
19 hydrochlorothiazide RB O B-m
19 25 CD O B-do
19 mg NNS B-NP I-do
19 p.o JJ O B-mo
19 daily RB O B-f
19 , , O O
19 Nexium NNP B-NP B-m
19 40 CD O B-do
19 mg NN B-NP I-do
19 p.o JJ B-NP B-mo
19 daily JJ I-NP B-f
20 ALLERGIES: NNP I-NP O
20 No NNP I-NP O
20 known VBN O O
20 drug NN B-NP O
20 allergies NNS I-NP O
21 PHYSICAL NNP I-NP O
21 EXAMINATION: NNP I-NP O
21 Vitals: NNP I-NP O
21 98.4 CD O O
21 , , O O
21 heart NN B-NP O
21 rate NN I-NP O
21 101 CD O O
21 , , O O
21 pulse RB O O
21 82 CD O O
21 , , O O
22 blood NN B-NP O
22 pressure NN I-NP O
22 92/60 CD O O
22 , , O O
22 respirations NNS B-NP O
22 20 CD O O
22 , , O O
22 96% CD O O
22 on IN B-VP O
22 room NN B-NP O
22 air NN I-NP O
23 Appearance: NNP I-NP O
23 Comfortable NNP I-NP O
23 , , O O
23 in IN B-VP O
23 no DT B-NP O
23 acute NN I-NP O
23 distress NN I-NP O
23 Cardiovascular: NNP I-NP O
24 Regular NNP I-NP O
24 S1 NNP I-NP O
24 , , O O
24 S2 NNP B-NP O
24 No NNP I-NP O
24 gallops NN I-NP O
24 , , O O
24 rubs NN B-NP O
24 or CC O O
24 murmurs NNS B-NP O
24 Pulmonary: NNP I-NP O
24 Clear NNP I-NP O
25 to TO O O
25 auscultation VB O O
25 bilaterally RB O O
25 No NNP B-NP O
25 wheezes NN I-NP O
25 or CC O O
25 crackles NNS B-NP O
25 Abdomen: NNP I-NP O
26 Soft NNP I-NP O
26 , , O O
26 mildly RB O O
26 distended VBD B-VP O
26 , , O O
26 right JJ B-NP O
26 upper NN I-NP O
26 quadrant NN I-NP O
26 tenderness NN I-NP O
26 with IN B-VP O
27 guarding NN B-NP O
27 , , O O
27 positive JJ B-NP O
27 Murphy's NNP I-NP O
27 , , O O
27 no DT B-NP O
27 rebound NN I-NP O
27 , , O O
27 positive JJ B-NP O
27 bowel NN I-NP O
27 sounds NNS I-NP O
27 , , O O
28 no DT B-NP O
28 peritoneal JJ I-NP O
28 signs NNS I-NP O
28 Extremities: NNP I-NP O
28 No NNP I-NP O
28 clubbing NN I-NP O
28 , , O O
28 cyanosis NN B-NP O
28 or CC O O
29 edema NN B-NP O
29 Rectal: NNP I-NP O
29 Guaiac NNP I-NP O
29 negative JJ O O
29 , , O O
29 no DT B-NP O
29 masses NNS I-NP O
30 IMAGING: NNP I-NP O
30 CT NNP I-NP O
30 of IN B-VP O
30 the DT B-NP O
30 abdomen NNS I-NP O
30 , , O O
30 distended VBD B-VP O
30 gallbladder NN B-NP O
30 with IN B-VP O
31 gallbladder NN B-NP O
31 wall NN I-NP O
31 thickening NN I-NP O
31 , , O O
31 pericholecystic JJ B-NP O
31 fluid NN I-NP O
31 , , O O
31 bile JJ B-NP O
31 duct NN I-NP O
32 within IN B-VP O
32 normal JJ B-NP O
32 limits NNS I-NP O
33 HOSPITAL NNP I-NP O
33 COURSE NNP I-NP O
33 BY NNP I-NP O
33 PROBLEMS: NNP I-NP O
34 1 CD O O
34 Acute NNP B-NP O
34 cholecystitis: VBD B-VP O
34 The DT B-NP O
34 patient NN I-NP O
34 was VBD B-VP O
34 taken VBN O O
34 to TO O O
34 the DT B-NP O
34 operating NN I-NP O
35 room NN I-NP O
35 on IN B-VP O
35 8/21/2005 CD O O
35 for IN B-VP O
35 open JJ B-NP O
35 cholecystectomy NN I-NP O
35 There EX O O
35 were VBD B-VP O
35 no DT B-NP O
36 complications NNS I-NP O
36 and CC O O
36 the DT B-NP O
36 patient NN I-NP O
36 was VBD B-VP O
36 moved VBN O O
36 to TO O O
36 the DT B-NP O
36 general JJ I-NP O
36 surgical JJ I-NP O
37 floor NN I-NP O
37 and CC O O
37 continued VBD B-VP O
37 to TO O O
37 recover VB O O
37 without IN B-VP O
37 complication NN B-NP O
37 By IN B-VP O
38 postoperative JJ B-NP O
38 day NN I-NP O
38 #6 NNP I-NP O
38 , , O O
38 she PRP O O
38 was VBD B-VP O
38 tolerating VBG O O
38 a DT B-NP O
38 regular JJ I-NP O
38 diet NN I-NP O
38 and CC O O
39 ambulatory NN B-NP O
39 However RB O O
39 , , O O
39 the DT B-NP O
39 patient NN I-NP O
39 developed VBD B-VP O
39 productive JJ B-NP O
39 cough NN I-NP O
39 and CC O O
40 a DT B-NP O
40 chest JJ I-NP O
40 x-ray NN I-NP O
40 was VBD B-VP O
40 obtained VBN O O
40 , , O O
40 which WDT O O
40 failed VBD B-VP O
40 to TO O O
40 show VB O O
40 any DT B-NP O
40 infiltrate NN I-NP O
41 and CC O O
41 she PRP O O
41 remained VBD B-VP O
41 afebrile JJ O O
41 throughout IN B-VP O
41 her PRP$ O O
41 hospital NN B-NP O
41 stay NN I-NP O
41 She PRP O O
41 was VBD B-VP O
42 discharged VBN O O
42 with IN B-VP O
42 Robitussin NNP B-NP B-m
42 A-C NNP I-NP I-m
42 and CC O O
42 instruction NN B-NP O
42 to TO O O
42 call VB O O
42 or CC O O
42 return VB O O
43 to TO O O
43 the DT B-NP O
43 hospital NN I-NP O
43 if IN B-VP O
43 she PRP O O
43 developed VBD B-VP O
43 worsening VBG O O
43 cough NN B-NP O
43 , , O O
43 fever NN B-NP O
43 , , O O
43 vomiting VBG O O
44 or CC O O
44 had VBD B-VP O
44 any DT B-NP O
44 other JJ I-NP O
44 concerns NNS I-NP O
44 In IN B-VP O
44 addition NN B-NP O
44 , , O O
44 she PRP O O
44 was VBD B-VP O
44 instructed VBN O O
44 to TO O O
45 follow VB O O
45 up RP O O
45 with IN B-VP O
45 Dr NNP B-NP O
45 Sagaser NNP I-NP O
45 for IN B-VP O
45 staple JJ B-NP O
45 removal NN I-NP O
45 and CC O O
45 wound NN B-NP O
45 check NN I-NP O
45 as RB O O
46 well RB O O
46 as IN B-VP O
46 her PRP$ O O
46 primary JJ B-NP O
46 care NN I-NP O
46 doctor NN I-NP O
47 DISCHARGE NNP I-NP O
47 MEDICATIONS: NNP I-NP O
47 Aspirin NNP I-NP B-m
47 81 CD O B-do
47 mg NN B-NP I-do
47 p.o JJ O B-mo
47 daily RB O B-f
47 , , O O
47 atenolol VBZ O B-m
47 50 CD O B-do
47 mg NN B-NP I-do
48 p.o JJ O B-mo
48 daily RB O B-f
48 , , O O
48 hydrochlorothiazide RB O B-m
48 25 CD O B-do
48 mg NNS B-NP I-do
48 p.o JJ O B-mo
48 daily RB O B-f
48 , , O O
48 Lipitor NNP B-NP B-m
48 40 CD O B-do
48 mg NN B-NP I-do
49 p.o JJ B-NP B-mo
49 daily JJ I-NP B-f
50 DISCHARGE NNP I-NP O
50 RECOMMENDATIONS NNP I-NP O
50 AND NNP I-NP O
50 FOLLOWUP: NNP I-NP O
51 1 CD O O
51 The DT B-NP O
51 patient NN I-NP O
51 was VBD B-VP O
51 instructed VBN O O
51 to TO O O
51 follow VB O O
51 up RP O O
51 with IN B-VP O
51 Dr NNP B-NP O
51 Store NNP I-NP O
51 in IN B-VP O
52 one CD O O
52 week NN B-NP O
52 for IN B-VP O
52 wound NN B-NP O
52 check NN I-NP O
52 and CC O O
52 staple NN B-NP O
52 removal NN I-NP O
53 2 CD O O
53 The DT B-NP O
53 patient NN I-NP O
53 was VBD B-VP O
53 instructed VBN O O
53 to TO O O
53 follow VB O O
53 up RP O O
53 with IN B-VP O
53 her PRP$ O O
53 primary JJ B-NP O
53 care NN I-NP O
54 doctor NN I-NP O
54 An DT B-NP O
54 appointment NN I-NP O
54 was VBD B-VP O
54 scheduled VBN O O
54 for IN B-VP O
54 Dr NNP B-NP O
54 Dee NNP I-NP O
54 Vanosdol NNP I-NP O
54 on IN B-VP O
55 7/1/2005 CD O O
55 at IN B-VP O
55 11:30 CD O O
55 a.m IN B-VP O
55 The DT B-NP O
55 patient NN I-NP O
55 was VBD B-VP O
55 notified VBN O O
55 that IN B-VP O
55 she PRP O O
56 likely RB O O
56 has VBZ O O
56 untreated VBN O B-r
56 diabetes NNS B-NP I-r
56 and CC O O
56 needs NNS B-NP O
56 to TO O O
56 be VB O O
56 started VBN O O
56 on IN B-VP O
56 new JJ B-NP B-m
57 medications NNS I-NP O
58 eScription VBP O O
58 document: JJ B-NP O
58 4-5659606 JJ I-NP O
58 RFFocus NNP I-NP O
59 Dictated NNP I-NP O
59 By: NNP I-NP O
59 MARCINEK NNP I-NP O
59 , , O O
59 IRVING NNP B-NP O
60 Attending: NNP I-NP O
60 BEHL NNP I-NP O
60 , , O O
60 JORDON NNP B-NP O
61 Dictation NNP I-NP O
61 ID NNP I-NP O
61 4543867 CD O O
62 D: NNP B-NP O
62 8/28/05 CD O O
63 T: NNP B-NP O
63 8/28/05 CD O O
64 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #613230 VBZ O O
2 570681541 CD O O
2 FHC NNP B-NP O
2 61247160 CD O O
2 235280 CD O O
2 1/27/2001 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 chf NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/27/2001 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/18/2001 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 CZAPLINSKI NNP I-NP O
5 , , O O
5 LOGAN NNP B-NP O
5 833-08-42-8 CD O O
6 Ster NNP B-NP O
6 Ville NNP I-NP O
6 Perv NNP I-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 0/16/01 CD O O
8 AT NNP B-NP O
8 10:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 HO NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 GREANY NNP I-NP O
11 , , O O
11 QUINTON NNP B-NP O
11 NORBERT NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 DISPOSITION: NNP I-NP O
12 Home NNP I-NP O
13 DISCHARGE NNP I-NP O
13 MEDICATIONS: NNP I-NP O
14 ASA NNP I-NP B-m
14 ( ( O I-m
14 ACETYLSALICYLIC NNP B-NP I-m
14 ACID NNP I-NP I-m
14 ) ) O I-m
14 81 CD O B-do
14 MG NNP B-NP I-do
14 PO NNP I-NP B-mo
14 QD NNP I-NP B-f
15 Override NNP I-NP O
15 Notice: NNP I-NP O
15 Override NNP I-NP O
15 added VBD B-VP O
15 on IN B-VP O
15 10/10/01 CD O O
15 by IN B-VP O
16 LLANES NNP B-NP O
16 , , O O
16 GARLAND NNP B-NP O
16 D NNP I-NP O
16 , , O O
16 M.D NNP B-NP O
17 on IN B-VP O
17 order NN B-NP O
17 for IN B-VP O
17 COUMADIN NNP B-NP B-m
17 PO NNP I-NP B-mo
17 ( ( O O
17 ref JJ O O
17 # # O O
17 98904908 CD O O
17 ) ) O O
18 POTENTIALLY NNP B-NP O
18 SERIOUS NNP I-NP O
18 INTERACTION: NNP I-NP O
18 ASPIRIN NNP I-NP B-m
18 &amp; NNP I-NP O
18 WARFARIN NNP I-NP B-m
19 Reason NNP I-NP O
19 for IN B-VP O
19 override: NN B-NP O
19 will MD O O
19 monitor VB O O
20 ALLOPURINOL NNP B-NP B-m
20 300 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 DIGOXIN NNP I-NP B-m
21 0.25 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 FOLIC NNP I-NP B-m
22 ACID NNP I-NP I-m
22 1 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 LASIX NNP I-NP B-m
23 ( ( O I-m
23 FUROSEMIDE NNP B-NP I-m
23 ) ) O I-m
23 80 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 ATIVAN NNP I-NP B-m
24 ATIVAN NNP I-NP B-m
24 ( ( O I-m
24 ( ( O I-m
24 LORAZEPAM NNP B-NP I-m
24 LORAZEPAM NNP I-NP I-m
24 ) ) O I-m
24 ) ) O I-m
24 1 CD O B-do
24 1 CD O B-do
24 MG NNP B-NP I-do
24 MG NNP I-NP I-do
24 PO NNP I-NP B-mo
24 PO NNP I-NP B-mo
24 BID NNP I-NP B-f
24 BID NNP I-NP B-f
24 PRN NNP I-NP I-f
24 PRN NNP I-NP I-f
24 anxiety NN I-NP B-r
24 or CC O O
24 insomnia NN B-NP B-r
25 LOPRESSOR NNP I-NP B-m
25 ( ( O I-m
25 METOPROLOL NNP B-NP I-m
25 TARTRATE NNP I-NP I-m
25 ) ) O I-m
25 12.5 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 BID NNP I-NP B-f
26 HOLD NNP I-NP O
26 IF: NNP I-NP O
26 sbp&lt;90 NN I-NP O
26 , , O O
26 hr&lt;55 JJ B-NP O
26 Food/Drug NNP I-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 Take NNP I-NP O
27 consistently RB O O
27 with IN B-VP O
27 meals NNS B-NP O
27 or CC O O
27 on IN B-VP O
27 empty JJ B-NP O
27 stomach NN I-NP O
28 THIAMINE NNP I-NP B-m
28 ( ( O I-m
28 THIAMINE NNP B-NP I-m
28 HCL NNP I-NP I-m
28 ) ) O I-m
28 100 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 COUMADIN NNP I-NP B-m
29 ( ( O I-m
29 WARFARIN NNP B-NP I-m
29 SODIUM NNP I-NP I-m
29 ) ) O I-m
29 5 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QHS NNP I-NP B-f
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 No NNP I-NP O
31 high JJ B-NP O
31 Vitamin-K NNP I-NP O
31 containing VBG O O
31 foods NNS B-NP O
32 Alert NNP I-NP O
32 overridden: VBD B-VP O
32 Override NNP B-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 10/10/01 CD O O
32 by IN B-VP O
33 PECCIA NNP B-NP O
33 , , O O
33 IAN NNP B-NP O
33 M NNP I-NP O
33 , , O O
33 M.D NNP B-NP O
34 POTENTIALLY NNP I-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 ASPIRIN NNP I-NP B-m
34 &amp; NNP I-NP O
34 WARFARIN NNP I-NP B-m
35 POTENTIALLY NNP I-NP O
35 SERIOUS NNP I-NP O
35 INTERACTION: NNP I-NP O
35 SIMVASTATIN NNP I-NP B-m
35 &amp; NNP I-NP O
35 WARFARIN NNP I-NP B-m
36 POTENTIALLY NNP I-NP O
36 SERIOUS NNP I-NP O
36 INTERACTION: NNP I-NP O
36 LEVOFLOXACIN NNP I-NP B-m
36 &amp; NNP I-NP O
36 WARFARIN NNP I-NP B-m
37 Reason NNP I-NP O
37 for IN B-VP O
37 override: NN B-NP O
37 will MD O O
37 monitor VB O O
38 INSULIN NNP B-NP B-m
38 70/30 CD O I-m
38 ( ( O I-m
38 HUMAN NNP B-NP I-m
38 ) ) O I-m
38 30 CD O B-do
38 UNITS NNP B-NP I-do
38 SC NNP I-NP B-mo
38 BID NNP I-NP B-f
38 HOLD NNP I-NP O
38 IF: NNP I-NP O
38 fsg&lt;60 JJ B-NP O
39 Number NNP I-NP B-du
39 of IN B-VP I-du
39 Doses NNP B-NP I-du
39 Required NNP I-NP I-du
39 ( ( O I-du
39 approximate JJ B-NP I-du
39 ): NN I-NP I-du
39 10 CD O I-du
40 IMDUR NNP B-NP B-m
40 ( ( O I-m
40 ISOSORBIDE NNP B-NP I-m
40 MONONIT.( NNP I-NP I-m
40 SR NNP I-NP I-m
40 ) ) O I-m
40 ) ) O I-m
40 60 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 HOLD NNP I-NP O
41 IF: NNP I-NP O
41 sbp&lt;90 JJ B-NP O
41 Food/Drug NNP I-NP O
41 Interaction NNP I-NP O
41 Instruction NNP I-NP O
42 Give NNP I-NP O
42 on IN B-VP O
42 an DT B-NP O
42 empty JJ I-NP O
42 stomach NN I-NP O
42 ( ( O O
42 give JJ O O
42 1hr CD O O
42 before IN B-VP O
42 or CC O O
42 2hr CD O O
42 after IN B-VP O
43 food NN B-NP O
43 ) ) O O
44 KCL NNP B-NP B-m
44 SLOW NNP I-NP I-m
44 REL NNP I-NP I-m
44 20 CD O B-do
44 MEQ NNP B-NP I-do
44 X NNP I-NP B-du
44 1 CD O I-du
44 PO NNP B-NP B-mo
44 BID NNP I-NP B-f
45 As IN B-VP O
45 per IN B-VP O
45 LGRH NNP B-NP O
45 Potassium NNP I-NP O
45 Chloride NNP I-NP O
45 Policy: NNP I-NP O
46 each DT O O
46 20 CD O O
46 mEq NNS B-NP O
46 dose VB O O
46 to TO O O
46 be VB O O
46 given VBN O O
46 with IN B-VP O
46 4 CD O O
46 oz NNS B-NP O
46 of IN B-VP O
46 fluid NN B-NP O
47 ALLEGRA NNP I-NP B-m
47 ( ( O I-m
47 FEXOFENADINE NNP B-NP I-m
47 HCL NNP I-NP I-m
47 ) ) O I-m
47 60 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QD NNP I-NP B-f
48 Food/Drug NNP I-NP O
48 Interaction NNP I-NP O
48 Instruction NNP I-NP O
49 Avoid NNP I-NP O
49 grapefruit NN I-NP O
49 unless IN B-VP O
49 MD NNP B-NP O
49 instructs NNS I-NP O
49 otherwise RB O O
50 LEVOFLOXACIN NNP B-NP B-m
50 250 CD O B-do
50 MG NNP B-NP I-do
50 PO NNP I-NP B-mo
50 QD NNP I-NP B-f
50 Starting NNP I-NP O
50 IN NNP I-NP O
50 AM NNP I-NP O
50 ( ( O O
50 7/21 CD O O
50 ) ) O O
51 Food/Drug NNP B-NP O
51 Interaction NNP I-NP O
51 Instruction NNP I-NP O
52 If IN B-VP O
52 on IN B-VP O
52 tube NN B-NP O
52 feeds NNS I-NP O
52 , , O O
52 please VB O O
52 cycle NN B-NP O
52 ( ( O O
52 hold VB O O
52 1 CD O O
52 hr NN B-NP O
52 before IN B-VP O
52 to TO O O
52 2 CD O O
52 hr NNS B-NP O
53 after IN B-VP O
53 ) ) O O
53 Take VBP O O
53 2 CD O O
53 hours NNS B-NP O
53 before IN B-VP O
53 or CC O O
53 2 CD O O
53 hours NNS B-NP O
53 after IN B-VP O
53 dairy NN B-NP O
53 products NNS I-NP O
54 Override NNP I-NP O
54 Notice: NNP I-NP O
54 Override NNP I-NP O
54 added VBD B-VP O
54 on IN B-VP O
54 10/10/01 CD O O
54 by IN B-VP O
55 KAZEE NNP B-NP O
55 , , O O
55 KENT NNP B-NP O
55 R NNP I-NP O
55 , , O O
55 M.D NNP B-NP O
56 on IN B-VP O
56 order NN B-NP O
56 for IN B-VP O
56 COUMADIN NNP B-NP B-m
56 PO NNP I-NP B-mo
56 ( ( O O
56 ref JJ O O
56 # # O O
56 98904908 CD O O
56 ) ) O O
57 POTENTIALLY NNP B-NP O
57 SERIOUS NNP I-NP O
57 INTERACTION: NNP I-NP O
57 LEVOFLOXACIN NNP I-NP B-m
57 &amp; NNP I-NP O
57 WARFARIN NNP I-NP B-m
58 Reason NNP I-NP O
58 for IN B-VP O
58 override: NN B-NP O
58 will MD O O
58 monitor VB O O
59 AVAPRO NNP B-NP B-m
59 ( ( O I-m
59 IRBESARTAN NNP B-NP I-m
59 ) ) O I-m
59 300 CD O B-do
59 MG NNP B-NP I-do
59 PO NNP I-NP B-mo
59 QD NNP I-NP B-f
59 HOLD NNP I-NP O
59 IF: NNP I-NP O
59 sbp&lt;90 VBD B-VP O
60 Number NNP B-NP B-du
60 of IN B-VP I-du
60 Doses NNP B-NP I-du
60 Required NNP I-NP I-du
60 ( ( O I-du
60 approximate JJ B-NP I-du
60 ): NN I-NP I-du
60 5 CD O I-du
61 LIPITOR NNP B-NP B-m
61 ( ( O I-m
61 ATORVASTATIN NNP B-NP I-m
61 ) ) O I-m
61 20 CD O B-do
61 MG NNP B-NP I-do
61 PO NNP I-NP B-mo
61 QD NNP I-NP B-f
62 Alert NNP I-NP O
62 overridden: NNP I-NP O
62 Override NNP I-NP O
62 added VBD B-VP O
62 on IN B-VP O
62 0/16/01 CD O O
62 by IN B-VP O
62 : : O O
63 POTENTIALLY NNP B-NP O
63 SERIOUS NNP I-NP O
63 INTERACTION: NNP I-NP O
63 WARFARIN NNP I-NP B-m
63 &amp; NNP I-NP O
63 ATORVASTATIN NNP I-NP B-m
64 CALCIUM NNP I-NP O
64 Reason NNP I-NP O
64 for IN B-VP O
64 override: NN B-NP O
64 known VBN O O
65 DIET: NNP B-NP O
65 House NNP I-NP O
65 / VBD B-VP O
65 Low NNP B-NP O
65 chol/low NN I-NP O
65 sat VBD B-VP O
65 fat JJ B-NP O
66 Activity NNP I-NP O
66 - : O O
66 As IN B-VP O
66 tolerated JJ B-NP O
67 RETURN NNP I-NP O
67 TO NNP I-NP O
67 WORK: NNP I-NP O
67 After IN B-VP O
67 Appt NNP B-NP O
67 with IN B-VP O
67 local JJ B-NP O
67 physician NN I-NP O
68 FOLLOW NNP I-NP O
68 UP NNP I-NP O
68 APPOINTMENT( NNP I-NP O
68 S NNP I-NP O
68 ): NNP I-NP O
69 Dr NNP I-NP O
69 Gaines NNP I-NP O
69 1 CD O O
69 weeks NNS B-NP O
69 , , O O
70 Dr NNP B-NP O
70 Shorr NNP I-NP O
70 0/2/01 CD O O
70 scheduled VBN O O
70 , , O O
71 No DT B-NP O
71 Known NNP I-NP O
71 Allergies NNP I-NP O
72 ADMIT NNP I-NP O
72 DIAGNOSIS: NNP I-NP O
73 chf NN I-NP O
74 PRINCIPAL NNP I-NP O
74 DISCHARGE NNP I-NP O
74 DIAGNOSIS NNP I-NP O
74 ;Responsible JJ O O
74 After IN B-VP O
74 Study NNP B-NP O
74 for IN B-VP O
74 Causing NNP B-NP O
74 Admission NNP I-NP O
74 ) ) O O
75 chf VBZ O O
76 OTHER NNP B-NP O
76 DIAGNOSIS;Conditions NNP I-NP O
76 , , O O
76 Infections NNP B-NP O
76 , , O O
76 Complications NNP B-NP O
76 , , O O
76 affecting VBG O O
76 Treatment/Stay NNP B-NP O
77 RECURRENT NNP I-NP O
77 VT/VFIB NNP I-NP O
77 CAD NNP I-NP O
77 ( ( O O
77 coronary JJ B-NP O
77 artery NN I-NP O
77 disease NN I-NP O
77 ) ) O O
77 s/p NN B-NP O
77 MI NNP I-NP O
77 ( ( O O
77 S/P NNP B-NP O
78 myocardial NNP I-NP O
78 infarction NN I-NP O
78 ) ) O O
78 s/p NN B-NP O
78 CABG NNP I-NP O
78 x4 NNP I-NP O
78 ( ( O O
78 S/P NNP B-NP O
78 cardiac JJ B-NP O
78 bypass NN I-NP O
78 graft NN I-NP O
79 surgery NN I-NP O
79 ) ) O O
79 s/p NN B-NP O
79 AICD NNP I-NP O
79 ( ( O O
79 S/P NNP B-NP O
79 implanted VBD B-VP O
79 cardiac JJ B-NP O
79 defibrillator NN I-NP O
79 ) ) O O
79 s/p VBD B-VP O
79 sternal JJ B-NP O
80 wound NN I-NP O
80 infection NN I-NP O
80 ( ( O O
80 S/P NNP B-NP O
80 wound IN B-VP O
80 infection NN B-NP O
80 ) ) O O
80 s/p NN B-NP O
80 sternum NN I-NP O
81 resection NN I-NP O
81 IDDM NNP I-NP O
81 ( ( O O
81 diabetes VBZ O O
81 mellitus NN B-NP O
81 ) ) O O
81 chronic NN B-NP O
81 anemia NN I-NP O
82 ( ( O O
82 anemia NN B-NP O
82 ) ) O O
82 atrial JJ B-NP O
82 fibrillation NN I-NP O
82 ( ( O O
82 atrial JJ B-NP O
82 fibrillation NN I-NP O
82 ) ) O O
82 dyslipidemia NN B-NP O
83 ( ( O O
83 dyslipidemia NN B-NP O
83 ) ) O O
83 ?amiodarone NN B-NP O
83 toxicity NN I-NP O
84 OPERATIONS NNP I-NP O
84 AND NNP I-NP O
84 PROCEDURES: NNP I-NP O
85 OTHER NNP I-NP O
85 TREATMENTS/PROCEDURES NNP I-NP O
85 ( ( O O
85 NOT NNP B-NP O
85 IN NNP I-NP O
85 O.R NNP I-NP O
85 ) ) O O
86 none NN B-NP O
87 BRIEF NNP I-NP O
87 RESUME NNP I-NP O
87 OF NNP I-NP O
87 HOSPITAL NNP I-NP O
87 COURSE: NNP I-NP O
88 60 CD O O
88 yo NN B-NP O
88 M NNP I-NP O
88 w/ischemic JJ B-NP O
88 CMP NNP I-NP O
88 and CC O O
88 AFib NNP B-NP B-r
88 dx VBP O I-r
88 5 CD O O
88 weeks NNS B-NP O
88 ago RB O O
88 He PRP O O
89 was VBD B-VP O
89 started VBN O O
89 on IN B-VP O
89 coumadin NN B-NP B-m
89 then RB O O
89 , , O O
89 and CC O O
89 last JJ B-NP O
89 Tues NNP I-NP O
89 , , O O
89 was VBD B-VP O
89 cardioverted VBN O O
89 ( ( O O
89 via IN B-VP O
89 the DT B-NP O
90 AICD NNP I-NP O
90 ) ) O O
90 Later NNP B-NP O
90 that WDT O O
90 night NN B-NP O
90 , , O O
90 he PRP O O
90 developed VBD B-VP O
90 SOB NNP B-NP O
90 , , O O
90 this DT O O
90 became VBD B-VP O
90 severe JJ O O
90 and CC O O
91 assoc JJ B-NP O
91 w/ NN I-NP O
91 fever NN I-NP O
91 to TO O O
91 102.4 CD O O
91 yesterday NN B-NP O
91 Today NNP I-NP O
91 , , O O
91 went VBD B-VP O
91 to TO O O
91 local JJ B-NP O
92 ED NNP I-NP O
92 ( ( O O
92 in IN B-VP O
92 RI NNP B-NP O
92 ) ) O O
92 Got NNP B-NP O
92 lasix NN I-NP B-m
92 and CC O O
92 Rocephin NNP B-NP B-m
92 ( ( O O
92 due JJ O O
92 to TO O O
93 bibasilar JJ B-NP B-r
93 infiltrates NNS I-NP I-r
93 on IN B-VP O
93 CXR NNP B-NP O
93 ) ) O O
93 WBC NNP B-NP O
93 elevated VBD B-VP O
93 at IN B-VP O
93 12.2 CD O O
93 , , O O
94 Bcx's NNP B-NP O
94 pending VBG O O
94 Pt NNP B-NP O
94 was VBD B-VP O
94 sent VBN O O
94 to TO O O
94 LMH NNP B-NP O
94 at IN B-VP O
94 his PRP$ O O
94 request NN B-NP O
95 Here RB O O
95 , , O O
95 low JJ B-NP O
95 grade NN I-NP O
95 fever; NN I-NP O
95 requires VBZ O O
95 FM NNP B-NP B-mo
95 O2; NNP I-NP B-m
95 vitals NNS I-NP O
96 stable; VBD B-VP O
96 mild-mod JJ B-NP O
96 fluid NN I-NP O
96 overload NN I-NP O
96 Will NNP I-NP O
96 treat VB O O
97 empirically RB O O
97 with IN B-VP O
97 levofloxacin NN B-NP B-m
97 ( ( O O
97 ?aspiration NN B-NP O
97 , , O O
97 ?comm NNP B-NP B-r
97 acq VBZ O O
98 PNA NNP B-NP O
98 ) ) O O
98 Will NNP B-NP O
98 diurese JJ O O
98 ( ( O O
98 well RB O O
98 perfused VBN O O
98 ) ) O O
98 and CC O O
98 finally RB O O
98 will MD O O
99 need VB O O
99 to TO O O
99 assess VB O O
99 underlying JJ B-NP O
99 rhythm NN I-NP O
99 ( ( O O
99 not RB O O
99 all DT B-NP O
99 beats NNS I-NP O
100 paced VBD B-VP O
100 , , O O
100 need VBP O O
100 to TO O O
100 see VB O O
100 if IN B-VP O
100 back RB O O
100 in IN B-VP O
100 AFib NNP B-NP O
100 ) ) O O
100 Repeat NNP B-NP O
100 CXR NNP I-NP O
100 and CC O O
101 F/U NNP B-NP O
101 on IN B-VP O
101 cx's NN B-NP O
101 from IN B-VP O
102 SNESUHC NNP B-NP O
102 2/3 CD O O
102 cx's NN B-NP O
102 from IN B-VP O
102 SMH NNP B-NP O
102 NGTD NNP I-NP O
102 CXR NNP I-NP O
102 showed VBD B-VP O
102 interval JJ B-NP O
102 improvement NN I-NP O
102 from IN B-VP O
103 past JJ B-NP O
103 films NNS I-NP O
103 has VBZ O O
103 bilateral JJ B-NP O
103 small JJ I-NP O
103 effusions NNS I-NP O
103 that WDT O O
103 are VBP O O
103 stable JJ O O
103 and CC O O
103 ? . B-VP O
104 aspiration NN B-NP O
104 in IN B-VP O
104 right JJ B-NP O
104 base NN I-NP O
104 , , O O
104 but CC O O
104 overall JJ B-NP O
104 interval JJ I-NP O
104 improvement NN I-NP O
104 BCxs NNP I-NP O
104 from IN B-VP O
105 LWMH NNP B-NP O
105 are VBP O O
105 neg VBN O O
105 at IN B-VP O
105 3 CD O O
105 days NNS B-NP O
105 and CC O O
105 ECHO NNP B-NP O
105 is VBZ O O
105 pending VBG O O
105 at IN B-VP O
105 time NN B-NP O
105 of IN B-VP O
105 discharge NN B-NP O
106 discharged VBN O O
106 on IN B-VP O
106 po NN B-NP B-mo
106 diuretics NNS I-NP B-m
106 and CC O O
106 14 CD O B-du
106 day NN B-NP I-du
106 course NN I-NP I-du
106 of IN B-VP O
106 levoflox NN B-NP B-m
107 sating VBG O O
107 well RB O O
107 on IN B-VP O
107 RA NNP B-NP O
107 at IN B-VP O
107 time NN B-NP O
107 of IN B-VP O
107 discharge NN B-NP O
108 ADDITIONAL NNP I-NP O
108 COMMENTS: NNP I-NP O
108 Patient NNP I-NP O
108 should MD O O
108 seek VB O O
108 immediate VB O O
108 medical JJ B-NP O
108 attention NN I-NP O
108 if IN B-VP O
108 he PRP O O
108 develops VBZ O O
108 chest JJS B-NP O
109 pain NN I-NP O
109 , , O O
109 shortness NN B-NP O
109 of IN B-VP O
109 breath NN B-NP O
109 , , O O
109 lightheadedness NN B-NP O
109 , , O O
109 fever NN B-NP O
109 , , O O
109 chills NNS B-NP O
109 , , O O
110 palpitations NNS B-NP O
110 , , O O
110 or CC O O
110 falls VBZ O O
111 DISCHARGE NNP B-NP O
111 CONDITION: NNP I-NP O
111 Stable NNP I-NP O
112 TO NNP I-NP O
112 DO/PLAN: NNP I-NP O
113 No NNP I-NP O
113 dictated VBD B-VP O
113 summary JJ B-NP O
114 ENTERED NNP I-NP O
114 BY: NNP I-NP O
114 SWEERE NNP I-NP O
114 , , O O
114 DANE NNP B-NP O
114 W NNP I-NP O
114 , , O O
114 M.D NNP B-NP O
114 ( ( O O
114 NU37 NNP B-NP O
114 ) ) O O
114 0/16/01 CD O O
114 @ $ O O
114 09 CD O O
115 ****** JJ B-NP O
115 END NN I-NP O
115 OF NNP I-NP O
115 DISCHARGE NNP I-NP O
115 ORDERS NNP I-NP O
115 ****** NNP I-NP O
116 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #614396 VBZ O O
2 263375915 CD O O
2 CEMC NNP B-NP O
2 08942951 CD O O
2 5123692 CD O O
2 5/18/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CHF NNP I-NP O
2 exacerbation NN I-NP O
2 , , O O
2 UTI NNP B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/20/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/28/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 TEWA NNP I-NP O
5 , , O O
5 GERMAN NNP B-NP O
5 M NNP I-NP O
5 924-52-39-1 CD O O
6 NE NNP B-NP O
6 Profortment NNP I-NP O
6 O NNP I-NP O
6 Lona NNP I-NP O
6 Fay NNP I-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 3/21/05 CD O O
8 AT NNP B-NP O
8 06:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 POSER NNP I-NP O
11 , , O O
11 ROBIN NNP B-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ALLOPURINOL NNP I-NP B-m
16 100 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 BID NNP I-NP B-f
17 FERROUS NNP I-NP B-m
17 SULFATE NNP I-NP I-m
17 325 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 Food/Drug NNP I-NP O
18 Interaction NNP I-NP O
18 Instruction NNP I-NP O
18 Avoid NNP I-NP O
18 milk NN I-NP O
18 and CC O O
18 antacid JJ B-NP O
19 LASIX NNP I-NP B-m
19 ( ( O I-m
19 FUROSEMIDE NNP B-NP I-m
19 ) ) O I-m
19 60 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
19 Starting VBG O O
19 Today NNP B-NP O
19 ( ( O O
19 8/27 CD O O
19 ) ) O O
20 HYDRALAZINE NNP B-NP B-m
20 HCL NNP I-NP I-m
20 10 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 TID NNP I-NP B-f
20 HOLD NNP I-NP O
20 IF: NNP I-NP O
20 SBP NNP I-NP O
20 below IN B-VP O
20 90 CD O O
21 Food/Drug NNP B-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Take NNP I-NP O
22 consistently RB O O
22 with IN B-VP O
22 meals NNS B-NP O
22 or CC O O
22 on IN B-VP O
22 empty JJ B-NP O
22 stomach NN I-NP O
23 ISORDIL NNP I-NP B-m
23 ( ( O I-m
23 ISOSORBIDE NNP B-NP I-m
23 DINITRATE NNP I-NP I-m
23 ) ) O I-m
23 20 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 TID NNP I-NP B-f
24 HOLD NNP I-NP O
24 IF: NNP I-NP O
24 SBP NNP I-NP O
24 below IN B-VP O
24 90 CD O O
25 LISINOPRIL NNP B-NP B-m
25 20 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QD NNP I-NP B-f
25 HOLD NNP I-NP O
25 IF: NNP I-NP O
25 SBP NNP I-NP O
25 below IN B-VP O
25 90 CD O O
26 Override NNP B-NP O
26 Notice: NNP I-NP O
26 Override NNP I-NP O
26 added VBD B-VP O
26 on IN B-VP O
26 5/12/05 CD O O
26 by IN B-VP O
26 WROBLESKI NNP B-NP O
26 , , O O
26 JULIO NNP B-NP O
26 B NNP I-NP O
26 , , O O
26 M.D NNP B-NP O
26 , , O O
26 M.S.C NNP B-NP O
27 on IN B-VP O
27 order NN B-NP O
27 for IN B-VP O
27 KCL NNP B-NP B-m
27 IMMEDIATE NNP I-NP I-m
27 RELEASE NNP I-NP I-m
27 PO NNP I-NP B-mo
27 ( ( O O
27 ref JJ O O
27 # # O O
27 03030471 CD O O
27 ) ) O O
28 POTENTIALLY NNP B-NP O
28 SERIOUS NNP I-NP O
28 INTERACTION: NNP I-NP O
28 LISINOPRIL NNP I-NP B-m
28 &amp; NNP I-NP O
28 POTASSIUM NNP I-NP B-m
29 CHLORIDE NNP I-NP O
29 Reason NNP I-NP O
29 for IN B-VP O
29 override: NN B-NP O
29 noted VBD B-VP O
30 Previous NNP B-NP O
30 override IN B-VP O
30 information: JJ B-NP O
31 Override NNP I-NP O
31 added VBD B-VP O
31 on IN B-VP O
31 5/12/05 CD O O
31 by IN B-VP O
31 ALTONEN NNP B-NP O
31 , , O O
31 EDUARDO NNP B-NP O
31 C NNP I-NP O
31 , , O O
31 M.D NNP B-NP O
31 , , O O
31 M.S.C NNP B-NP O
32 on IN B-VP O
32 order NN B-NP O
32 for IN B-VP O
32 KCL NNP B-NP B-m
32 IMMEDIATE NNP I-NP I-m
32 RELEASE NNP I-NP I-m
32 PO NNP I-NP B-mo
32 ( ( O O
32 ref JJ O O
32 # # O O
32 01642329 CD O O
32 ) ) O O
33 POTENTIALLY NNP B-NP O
33 SERIOUS NNP I-NP O
33 INTERACTION: NNP I-NP O
33 LISINOPRIL NNP I-NP B-m
33 &amp; NNP I-NP O
33 POTASSIUM NNP I-NP B-m
34 CHLORIDE NNP I-NP O
34 Reason NNP I-NP O
34 for IN B-VP O
34 override: NN B-NP O
34 noted VBD B-VP O
35 Previous NNP B-NP O
35 override IN B-VP O
35 information: JJ B-NP O
36 Override NNP I-NP O
36 added VBD B-VP O
36 on IN B-VP O
36 10/29/05 CD O O
36 by IN B-VP O
36 BAGWELL NNP B-NP O
36 , , O O
36 TYSON NNP B-NP O
36 H NNP I-NP O
36 , , O O
36 M.D NNP B-NP O
36 , , O O
36 M.S.C NNP B-NP O
37 on IN B-VP O
37 order NN B-NP O
37 for IN B-VP O
37 KCL NNP B-NP B-m
37 IMMEDIATE NNP I-NP I-m
37 RELEASE NNP I-NP I-m
37 PO NNP I-NP B-mo
37 ( ( O O
37 ref JJ O O
37 # # O O
37 91907761 CD O O
37 ) ) O O
38 POTENTIALLY NNP B-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 LISINOPRIL NNP I-NP B-m
38 &amp; NNP I-NP O
38 POTASSIUM NNP I-NP B-m
39 CHLORIDE NNP I-NP O
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: NN B-NP O
39 noted VBD B-VP O
40 Previous NNP B-NP O
40 override IN B-VP O
40 information: JJ B-NP O
41 Override NNP I-NP O
41 added VBD B-VP O
41 on IN B-VP O
41 10/29/05 CD O O
41 by IN B-VP O
41 BIALEK NNP B-NP O
41 , , O O
41 CYRUS NNP B-NP O
41 O NNP I-NP O
41 , , O O
41 M.D NNP B-NP O
41 , , O O
41 M.S.C NNP B-NP O
42 on IN B-VP O
42 order NN B-NP O
42 for IN B-VP O
42 KCL NNP B-NP B-m
42 IMMEDIATE NNP I-NP I-m
42 RELEASE NNP I-NP I-m
42 PO NNP I-NP B-mo
42 ( ( O O
42 ref JJ O O
42 # # O O
42 15927551 CD O O
42 ) ) O O
43 POTENTIALLY NNP B-NP O
43 SERIOUS NNP I-NP O
43 INTERACTION: NNP I-NP O
43 LISINOPRIL NNP I-NP B-m
43 &amp; NNP I-NP O
43 POTASSIUM NNP I-NP B-m
44 CHLORIDE NNP I-NP O
44 Reason NNP I-NP O
44 for IN B-VP O
44 override: NN B-NP O
44 noted VBD B-VP O
45 Previous NNP B-NP O
45 override IN B-VP O
45 information: JJ B-NP O
46 Override NNP I-NP O
46 added VBD B-VP O
46 on IN B-VP O
46 10/29/05 CD O O
46 by IN B-VP O
46 HERT NNP B-NP O
46 , , O O
46 LEIGH NNP B-NP O
46 E NNP I-NP O
46 , , O O
46 M.D NNP B-NP O
46 , , O O
46 M.S.C NNP B-NP O
47 on IN B-VP O
47 order NN B-NP O
47 for IN B-VP O
47 KCL NNP B-NP B-m
47 IV NNP I-NP B-mo
47 ( ( O O
47 ref JJ O O
47 # # O O
47 78178294 CD O O
47 ) ) O O
48 POTENTIALLY NNP B-NP O
48 SERIOUS NNP I-NP O
48 INTERACTION: NNP I-NP O
48 LISINOPRIL NNP I-NP B-m
48 &amp; NNP I-NP O
48 POTASSIUM NNP I-NP B-m
49 CHLORIDE NNP I-NP O
49 Reason NNP I-NP O
49 for IN B-VP O
49 override: NN B-NP O
49 noted VBN O O
50 LIPITOR NNP B-NP B-m
50 ( ( O I-m
50 ATORVASTATIN NNP B-NP I-m
50 ) ) O I-m
50 10 CD O B-do
50 MG NNP B-NP I-do
50 PO NNP I-NP B-mo
50 QD NNP I-NP B-f
51 PROTONIX NNP I-NP B-m
51 ( ( O I-m
51 PANTOPRAZOLE NNP B-NP I-m
51 ) ) O I-m
51 40 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 QD NNP I-NP B-f
52 TOPROL NNP I-NP B-m
52 XL NNP I-NP I-m
52 ( ( O I-m
52 METOPROLOL NNP B-NP I-m
52 SUCCINATE NNP I-NP I-m
52 EXTENDED NNP I-NP I-m
52 RELEASE NNP I-NP I-m
52 ) ) O I-m
53 75 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 QD NNP I-NP B-f
53 Food/Drug NNP I-NP O
53 Interaction NNP I-NP O
53 Instruction NNP I-NP O
54 Take NNP I-NP O
54 consistently RB O O
54 with IN B-VP O
54 meals NNS B-NP O
54 or CC O O
54 on IN B-VP O
54 empty JJ B-NP O
54 stomach NN I-NP O
55 LEVAQUIN NNP I-NP B-m
55 ( ( O I-m
55 LEVOFLOXACIN NNP B-NP I-m
55 ) ) O I-m
55 250 CD O B-do
55 MG NNP B-NP I-do
55 PO NNP I-NP B-mo
55 QD NNP I-NP B-f
56 Food/Drug NNP I-NP O
56 Interaction NNP I-NP O
56 Instruction NNP I-NP O
57 Administer NNP I-NP O
57 iron NN I-NP B-m
57 products NNS I-NP O
57 a DT B-NP O
57 minimum NN I-NP O
57 of IN B-VP O
57 2 CD O O
57 hours NNS B-NP O
57 before IN B-VP O
57 or CC O O
58 after IN B-VP O
58 a DT B-NP O
58 levofloxacin NN I-NP B-m
58 or CC O O
58 ciprofloxacin NN B-NP B-m
58 dose VBP O O
58 dose JJ O O
59 If IN B-VP O
59 on IN B-VP O
59 tube NN B-NP O
59 feeds NNS I-NP O
59 , , O O
59 please VB O O
59 cycle NN B-NP O
59 ( ( O O
59 hold VB O O
59 1 CD O O
59 hr NN B-NP O
59 before IN B-VP O
59 to TO O O
59 2 CD O O
59 hr NNS B-NP O
60 after IN B-VP O
60 ) ) O O
60 Take VBP O O
60 2 CD O O
60 hours NNS B-NP O
60 before IN B-VP O
60 or CC O O
60 2 CD O O
60 hours NNS B-NP O
60 after IN B-VP O
60 dairy NN B-NP O
60 products NNS I-NP O
61 ACETYLSALICYLIC NNP I-NP B-m
61 ACID NNP I-NP I-m
61 325 CD O B-do
61 MG NNP B-NP I-do
61 PO NNP I-NP B-mo
61 QD NNP I-NP B-f
62 DIET: NNP I-NP O
62 Patient NNP I-NP O
62 should MD O O
62 measure VB O O
62 weight JJ B-NP O
62 daily JJ I-NP O
63 DIET: NNP I-NP O
63 Fluid NNP I-NP O
63 restriction: VBD B-VP O
63 2 CD O O
63 liters NNS B-NP O
64 DIET: NNP I-NP O
64 House NNP I-NP O
64 / VBD B-VP O
64 Low NNP B-NP O
64 chol/low NN I-NP O
64 sat VBD B-VP O
64 fat JJ B-NP O
65 DIET: NNP I-NP O
65 2 CD O O
65 gram NN B-NP O
65 Sodium NNP I-NP O
66 ACTIVITY: NNP I-NP O
66 Resume NNP I-NP O
66 regular JJ B-NP O
66 exercise NN I-NP O
67 Walking NNP I-NP O
67 as IN B-VP O
67 tolerated VBN O O
68 FOLLOW NNP B-NP O
68 UP NNP I-NP O
68 APPOINTMENT( NNP I-NP O
68 S NNP I-NP O
68 ): NNP I-NP O
69 Dr NNP I-NP O
69 Haworth NNP I-NP O
69 ( ( O O
69 in IN B-VP O
69 for IN B-VP O
69 Dr NNP B-NP O
69 Soulek NNP I-NP O
69 ) ) O O
69 , , O O
69 888-079-9738 JJ O O
69 0/7/05 CD O O
69 , , O O
69 11:30a CD O O
69 scheduled VBN O O
69 , , O O
70 ALLERGY: NNP B-NP O
70 Penicillins NNP I-NP O
71 ADMIT NNP I-NP O
71 DIAGNOSIS: NNP I-NP O
72 CHF NNP I-NP O
72 exacerbation NN I-NP O
73 PRINCIPAL NNP I-NP O
73 DISCHARGE NNP I-NP O
73 DIAGNOSIS NNP I-NP O
73 ;Responsible JJ O O
73 After IN B-VP O
73 Study NNP B-NP O
73 for IN B-VP O
73 Causing NNP B-NP O
73 Admission NNP I-NP O
73 ) ) O O
74 CHF NNP B-NP O
74 exacerbation NN I-NP O
74 , , O O
74 UTI NNP B-NP O
75 OTHER NNP I-NP O
75 DIAGNOSIS;Conditions NNP I-NP O
75 , , O O
75 Infections NNP B-NP O
75 , , O O
75 Complications NNP B-NP O
75 , , O O
75 affecting VBG O O
75 Treatment/Stay NNP B-NP O
76 HTN NNP I-NP O
76 , , O O
76 obesity NN B-NP O
76 , , O O
76 anemia NN B-NP O
76 , , O O
76 OA NNP B-NP O
76 , , O O
76 gout NN B-NP O
76 , , O O
76 GERD NNP B-NP O
76 , , O O
76 CRI NNP B-NP O
76 , , O O
76 CAD NNP B-NP O
76 , , O O
76 hyperlipidemia NN B-NP O
77 OPERATIONS NNP I-NP O
77 AND NNP I-NP O
77 PROCEDURES: NNP I-NP O
78 Cardiac NNP I-NP O
78 catheterization NN I-NP O
78 , , O O
78 9/4/05 CD O O
78 ; : O O
79 Echocardiogram NNP B-NP O
79 , , O O
79 9/4/05 CD O O
80 OTHER NNP B-NP O
80 TREATMENTS/PROCEDURES NNP I-NP O
80 ( ( O O
80 NOT NNP B-NP O
80 IN NNP I-NP O
80 O.R NNP I-NP O
80 ) ) O O
81 None NN B-NP O
82 BRIEF NNP I-NP O
82 RESUME NNP I-NP O
82 OF NNP I-NP O
82 HOSPITAL NNP I-NP O
82 COURSE: NNP I-NP O
83 CC: NNP I-NP O
83 Dyspnea NNP I-NP O
84 HPI: NNP I-NP O
84 74 CD O O
84 yo NN B-NP O
84 AAF NNP I-NP O
84 h/o NN I-NP O
84 NYHF NNP I-NP O
84 III NNP I-NP O
84 CHF NNP I-NP O
84 ( ( O O
84 EF NNP B-NP O
84 45% CD O O
84 ) ) O O
84 , , O O
84 PHT NNP B-NP O
84 , , O O
84 HTN-CMP NNP B-NP O
84 , , O O
84 p/w NN B-NP O
84 worsening VBG O O
85 fatigue NN B-NP O
85 , , O O
85 DOE NNP B-NP O
85 and CC O O
85 orthopnea NN B-NP O
85 over IN B-VP O
85 3-4 JJ B-NP O
85 w JJ I-NP O
85 Pt NNP I-NP O
85 presented VBD B-VP O
85 to TO O O
85 clinic VB O O
85 on IN B-VP O
85 day NN B-NP O
86 of IN B-VP O
86 admit NN B-NP O
86 and CC O O
86 was VBD B-VP O
86 admitted VBN O O
86 for IN B-VP O
86 acute JJ B-NP O
86 decompensation NN I-NP O
86 Pt NNP I-NP O
87 claims VBZ O O
87 compliance NN B-NP O
87 to TO O O
87 diet VB O O
87 but CC O O
87 there EX O O
87 is VBZ O O
87 some DT B-NP O
87 question NN I-NP O
87 from IN B-VP O
87 the DT B-NP O
87 ED NNP I-NP O
87 of IN B-VP O
88 dietary JJ B-NP O
88 indiscretion NN I-NP O
88 In IN B-VP O
88 addition NN B-NP O
88 , , O O
88 pt NN B-NP O
88 reports NNS I-NP O
88 not RB O O
88 being VBG O O
88 able JJ O O
88 to TO O O
88 get VB O O
89 dose NN B-NP O
89 of IN B-VP O
89 procrit NN B-NP O
89 x $ O O
89 3 CD O O
89 mo NN B-NP O
89 , , O O
89 due JJ O O
89 to TO O O
89 inconvenience VB O O
89 in IN B-VP O
89 aquiring VBG O O
90 it PRP O O
90 Pt NNP B-NP O
90 does VBZ O O
90 not RB O O
90 require VB O O
90 home NN B-NP O
90 O2 NNP I-NP O
90 Denies NNP I-NP O
90 CP NNP I-NP O
90 , , O O
90 SOB NNP B-NP O
90 at IN B-VP O
90 rest NN B-NP O
90 , , O O
90 PND NNP B-NP O
90 , , O O
91 palpitations NNS B-NP O
91 , , O O
91 or CC O O
91 dizziness NN B-NP O
91 No RB O O
91 cough NN B-NP O
91 , , O O
91 fever NN B-NP O
91 , , O O
91 or CC O O
91 sick JJ B-NP O
92 contacts NNS I-NP O
92 Echo VBP O O
92 5/28 CD O O
92 nl JJ B-NP O
92 septal JJ I-NP O
92 chamber NN I-NP O
92 size NN I-NP O
92 , , O O
92 mildly RB O O
92 enlarged VBD B-VP O
93 aL JJ B-NP O
93 atrium NN I-NP O
93 , , O O
93 mild JJ B-NP O
93 LVH NNP I-NP O
93 , , O O
93 1+ CD O O
93 MR NNP B-NP O
93 , , O O
93 mod NN B-NP O
93 TR NNP I-NP O
93 PE NNP I-NP O
93 on IN B-VP O
93 admit: NN B-NP O
93 VS NNP I-NP O
93 98.9 CD O O
93 96 CD O O
93 136/88 CD O O
94 100% CD O O
94 RA NNP B-NP O
94 NECK: NNP I-NP O
94 JVP NNP I-NP O
94 to TO O O
94 jaw VB O O
94 angle JJ B-NP O
94 w/ NN I-NP O
94 pulsatile NN I-NP O
94 v NN I-NP O
94 wave VBP O O
94 No DT B-NP O
94 bruits NNS I-NP O
94 CV: NNP I-NP O
95 RRR NNP I-NP O
95 , , O O
95 +s3 NNP B-NP O
95 , , O O
95 ? . B-VP O
95 systolic JJ B-NP O
95 murmur NN I-NP O
95 at IN B-VP O
95 LSB NNP B-NP O
95 , , O O
95 increased VBD B-VP O
95 but CC O O
95 non RB O O
95 displaced VBD B-VP O
95 pmi JJ B-NP O
96 LUNGS: NNP I-NP O
96 Crackles NNP I-NP O
96 to TO O O
96 2/3 CD O O
96 of IN B-VP O
96 lung NN B-NP O
96 B NNP I-NP O
96 EXT: NNP I-NP O
96 Warm NNP I-NP O
96 , , O O
96 2+ CD O O
96 DP NNP B-NP O
96 pulse NN I-NP O
96 B NNP I-NP O
96 1+ CD O O
97 pitting VBG O O
97 edema RB O O
97 2/3 CD O O
97 to TO O O
97 B NNP B-NP O
98 knees NNS I-NP O
98 Labs NNP I-NP O
98 on IN B-VP O
98 admit: NN B-NP O
98 Cr NNP I-NP O
98 2 CD O O
98 , , O O
98 Trop NNP B-NP O
98 0.24 CD O O
98 , , O O
98 CK NNP B-NP O
98 27 CD O O
98 , , O O
98 MB NNP B-NP O
98 0.6 CD O O
99 CXR: NNP B-NP O
99 increased VBD B-VP O
99 heart NN B-NP O
99 border NN I-NP O
99 , , O O
99 B NNP B-NP O
99 effusion NN I-NP O
99 BNP NNP I-NP O
99 2329 CD O O
99 UA NNP B-NP O
99 6-10 JJ B-NP O
99 wbc NN I-NP O
99 , , O O
99 2+ CD O O
100 bact NN B-NP O
100 EKG NNP I-NP O
100 no DT B-NP O
100 changes NNS I-NP O
100 , , O O
100 baseline NN B-NP O
100 diffuse NN I-NP O
100 flattened VBD B-VP O
101 TW NNP B-NP O
102 **************HOSPITAL NNP I-NP O
102 COURSE********************* NNP I-NP O
103 CV: NNP I-NP O
103 ( ( O O
103 P NNP B-NP O
103 ) ) O O
103 NYHA NNP B-NP O
103 III NNP I-NP O
103 CHF NNP I-NP O
103 ( ( O O
103 EF NNP B-NP O
103 45% CD O O
103 ) ) O O
103 in IN B-VP O
103 acute JJ B-NP O
103 decompensation NN I-NP O
103 Strict NNP I-NP O
103 I&amp;Os NNP I-NP O
103 , , O O
104 fluid JJ B-NP O
104 restriction NN I-NP O
104 Diurese NNP I-NP O
104 aggressively RB O O
104 w/ VBD B-VP O
104 lasix JJ O B-m
104 100 CD O B-do
104 bid NN B-NP B-f
104 , , O O
104 replete JJ B-NP O
105 lytes NNS I-NP O
105 , , O O
105 keeping VBG O O
105 in IN B-VP O
105 mind NN B-NP O
105 CRI NNP I-NP O
105 Cont NNP I-NP O
105 BB NNP I-NP B-m
105 , , O O
105 ACEI NNP B-NP B-m
105 Added NNP I-NP O
105 hydralazine/isordil NN I-NP B-m
106 on IN B-VP O
106 HD3 NNP B-NP O
106 Repeat NNP I-NP O
106 Echo NNP I-NP O
106 on IN B-VP O
106 HD3 NNP B-NP O
106 showed VBD B-VP O
106 decreased JJ B-NP O
106 EF NNP I-NP O
106 30-35% NNP I-NP O
107 ( ( O O
107 I PRP O O
107 ) ) O O
107 CAD NNP B-NP O
107 , , O O
107 hyperlipidemia: NN B-NP B-r
107 hyperlipidemia: NN I-NP B-r
107 hyperlipidemia: NN I-NP B-r
107 hyperlipidemia: NN I-NP B-r
107 BB NNP I-NP B-m
107 , , O O
107 ACEI NNP B-NP B-m
107 , , O O
107 statin NN B-NP B-m
107 , , O O
107 ASA NNP B-NP B-m
107 Lipids NNP I-NP O
107 nl RB O O
107 Suspected VBD B-VP O
108 ischemic JJ B-NP O
108 etiology NN I-NP O
108 to TO O O
108 worsening VBG O O
108 CHF NNP B-NP O
108 , , O O
108 given VBN O O
108 decreased VBD B-VP O
108 EF NNP B-NP O
108 on IN B-VP O
108 echo NN B-NP O
108 Did NNP I-NP O
108 cath NN I-NP O
109 on IN B-VP O
109 Na NNP B-NP O
109 Worth NNP I-NP O
109 Salt NNP I-NP O
109 however RB O O
109 w/o VBD B-VP O
109 lesions NNS B-NP O
109 ( ( O O
109 although IN B-VP O
109 confirming VBG O O
109 PHT NNP B-NP O
109 ) ) O O
110 ( ( O O
110 R NNP B-NP O
110 ) ) O O
110 No NNP B-NP O
110 issues NNS I-NP O
111 RENAL: NNP I-NP O
111 CRI NNP I-NP B-r
111 w/ NN I-NP I-r
111 anemia NN I-NP I-r
111 Given NNP I-NP O
111 mucomyst VBZ O B-m
111 post FW O O
111 cath NN B-NP O
112 HEME: NNP I-NP O
112 Anemia NNP I-NP B-r
112 Anemia NNP I-NP B-r
112 - : O O
112 Given NNP B-NP O
112 aranesp NN I-NP B-m
112 , , O O
112 FeSO4 NNP B-NP B-m
113 HTN: NNP I-NP O
113 BB NNP I-NP B-m
113 , , O O
113 ACEI NNP B-NP B-m
113 ID: NNP I-NP O
113 UTI NNP I-NP O
113 , , O O
113 E NNP B-NP O
113 coli VBP O O
113 in IN B-VP O
113 Ucx NNP B-NP O
113 , , O O
113 sensitivities VBZ O O
113 pending VBG O O
114 Empirically NNP B-NP O
114 tx JJ B-NP O
114 w/ NN I-NP O
114 Keflex NNP I-NP B-m
114 , , O O
114 changed VBD B-VP O
114 empirically RB O O
114 on IN B-VP O
114 HD4 NNP B-NP O
114 to TO O O
114 levo VB O B-m
115 ENDO: NNP B-NP O
115 R/o'd NNP I-NP O
115 Hyperthyroidism NNP I-NP O
115 w/ VBD B-VP O
115 nl JJ B-NP O
115 TSH NNP I-NP O
116 RHEUM: NNP I-NP O
116 Gout NNP I-NP B-r
116 - : O O
116 allopurinol JJ B-NP B-m
117 ADDITIONAL NNP I-NP O
117 COMMENTS: NNP I-NP O
118 DISCHARGE NNP I-NP O
118 CONDITION: NNP I-NP O
118 Satisfactory NNP I-NP O
119 TO NNP I-NP O
119 DO/PLAN: NNP I-NP O
120 No NNP I-NP O
120 dictated VBD B-VP O
120 summary JJ B-NP O
121 ENTERED NNP I-NP O
121 BY: NNP I-NP O
121 LOUKS NNP I-NP O
121 , , O O
121 CLAYTON NNP B-NP O
121 T NNP I-NP O
121 C NNP I-NP O
121 ( ( O O
121 UW22 NNP B-NP O
121 ) ) O O
121 3/21/05 CD O O
121 @ $ O O
121 05 CD O O
122 ****** JJ B-NP O
122 END NN I-NP O
122 OF NNP I-NP O
122 DISCHARGE NNP I-NP O
122 ORDERS NNP I-NP O
122 ****** NNP I-NP O
123 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #633499 VBZ O O
4 753455514 CD O O
4 GWH NNP B-NP O
4 15453858 CD O O
4 5156068 CD O O
4 5/8/2003 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CAD NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/18/2003 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/24/2003 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 GOODNESS NNP I-NP O
8 , , O O
8 GREGORY NNP B-NP O
8 079-03-97-6 NNP I-NP O
9 Sachua NNP I-NP O
9 Oaks NNP I-NP O
9 De NNP I-NP O
10 Service: NNP I-NP O
10 RNM NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 4/7/03 CD O O
11 AT NNP B-NP O
11 04:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Home NNP I-NP O
12 services NNS I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 KOS NNP I-NP O
14 , , O O
14 GENE NNP B-NP O
14 R NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ECASA NNP I-NP B-m
19 ( ( O I-m
19 ASPIRIN NNP B-NP I-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 ) ) O I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 ENALAPRIL NNP I-NP B-m
20 MALEATE NNP I-NP I-m
20 7.5 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 BID NNP I-NP B-f
20 HOLD NNP I-NP O
20 IF: NNP I-NP O
20 b/p&lt;100 VBZ O O
20 systolic JJ B-NP O
21 Instructions: NNP I-NP O
21 Hold NNP I-NP O
21 on IN B-VP O
21 the DT B-NP O
21 mornings NNS I-NP O
21 of IN B-VP O
21 dialysis NN B-NP O
22 Alert NNP I-NP O
22 overridden: NNP I-NP O
22 Override NNP I-NP O
22 added VBD B-VP O
22 on IN B-VP O
22 0/4/03 CD O O
22 by IN B-VP O
22 : : O O
23 DEFINITE NNP B-NP O
23 ALLERGY NNP I-NP O
23 ( ( O O
23 OR NNP B-NP O
23 SENSITIVITY NNP I-NP O
23 ) ) O O
23 to TO O O
23 ACE NNP B-NP O
23 INHIBITORS NNP I-NP O
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 monitoring NN I-NP O
24 K NNP I-NP O
24 Previous NNP I-NP O
24 Alert NNP I-NP O
24 overridden NNP I-NP O
25 Override NNP I-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 0/4/03 CD O O
25 by IN B-VP O
25 HIRSCHY NNP B-NP O
25 , , O O
25 EDGAR NNP B-NP O
25 , , O O
25 M.D NNP B-NP O
26 DEFINITE NNP I-NP O
26 ALLERGY NNP I-NP O
26 ( ( O O
26 OR NNP B-NP O
26 SENSITIVITY NNP I-NP O
26 ) ) O O
26 to TO O O
26 ACE NNP B-NP O
26 INHIBITORS NNP I-NP O
27 Reason NNP I-NP O
27 for IN B-VP O
27 override: NN B-NP O
27 Monitoring NNP I-NP O
27 K NNP I-NP O
27 Previous NNP I-NP O
27 override IN B-VP O
27 reason: JJ B-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 1/29/03 CD O O
28 by IN B-VP O
28 GOONEN NNP B-NP O
28 , , O O
28 WILL NNP B-NP O
28 , , O O
28 M.D NNP B-NP O
29 DEFINITE NNP I-NP O
29 ALLERGY NNP I-NP O
29 ( ( O O
29 OR NNP B-NP O
29 SENSITIVITY NNP I-NP O
29 ) ) O O
29 to TO O O
29 ACE NNP B-NP O
29 INHIBITORS NNP I-NP O
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 Pt NNP I-NP O
30 needs VBZ O O
30 for IN B-VP O
30 his PRP$ O O
30 heart NN B-NP O
30 Is VBZ O O
30 on IN B-VP O
30 HD NNP B-NP O
30 , , O O
31 will MD O O
31 monitor VB O O
31 his PRP$ O O
31 K NNP B-NP O
31 Previous NNP I-NP O
31 Alert NNP I-NP O
31 overridden NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 1/29/03 CD O O
32 by IN B-VP O
32 MAZA NNP B-NP O
32 , , O O
32 RUSTY NNP B-NP O
32 , , O O
32 M.D NNP B-NP O
33 DEFINITE NNP I-NP O
33 ALLERGY NNP I-NP O
33 ( ( O O
33 OR NNP B-NP O
33 SENSITIVITY NNP I-NP O
33 ) ) O O
33 to TO O O
33 ACE NNP B-NP O
33 INHIBITORS NNP I-NP O
34 Reason NNP I-NP O
34 for IN B-VP O
34 override: NN B-NP O
34 on IN B-VP O
34 dialysis NN B-NP O
34 , , O O
34 will MD O O
34 monitor VB O O
34 K NNP B-NP O
34 needs VBZ O O
35 ACE NNP B-NP B-m
35 for IN B-VP O
35 heart NN B-NP B-r
36 NPH NNP I-NP B-m
36 HUMULIN NNP I-NP I-m
36 INSULIN NNP I-NP I-m
36 ( ( O I-m
36 INSULIN NNP B-NP I-m
36 NPH NNP I-NP I-m
36 HUMAN NNP I-NP I-m
36 ) ) O I-m
36 2 CD O B-do
36 UNITS NNP B-NP I-do
36 SC NNP I-NP B-mo
36 QAM NNP I-NP B-f
37 NPH NNP I-NP B-m
37 HUMULIN NNP I-NP I-m
37 INSULIN NNP I-NP I-m
37 ( ( O I-m
37 INSULIN NNP B-NP I-m
37 NPH NNP I-NP I-m
37 HUMAN NNP I-NP I-m
37 ) ) O I-m
37 3 CD O B-do
37 UNITS NNP B-NP I-do
37 SC NNP I-NP B-mo
37 QPM NNP I-NP B-f
38 NITROGLYCERIN NNP I-NP B-m
38 1/150 CD O I-m
38 ( ( O I-m
38 0.4 CD O I-m
38 MG NNP B-NP I-m
38 ) ) O I-m
38 1 CD O B-do
38 TAB NNP B-NP I-do
38 SL NNP I-NP B-mo
38 q5min VBD B-VP B-f
38 x $ O O
38 3 CD O O
39 PRN NNP B-NP O
39 chest NN I-NP B-r
39 pain NN I-NP I-r
40 IMDUR NNP I-NP B-m
40 ( ( O I-m
40 ISOSORBIDE NNP B-NP I-m
40 MONONIT.( NNP I-NP I-m
40 SR NNP I-NP I-m
40 ) ) O I-m
40 ) ) O I-m
40 30 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 Instructions: NNP I-NP O
41 Hold NNP I-NP O
41 on IN B-VP O
41 the DT B-NP O
41 mornings NNS I-NP O
41 of IN B-VP O
41 dialysis NN B-NP O
42 Food/Drug NNP I-NP O
42 Interaction NNP I-NP O
42 Instruction NNP I-NP O
43 Give NNP I-NP O
43 on IN B-VP O
43 an DT B-NP O
43 empty JJ I-NP O
43 stomach NN I-NP O
43 ( ( O O
43 give JJ O O
43 1hr CD O O
43 before IN B-VP O
43 or CC O O
43 2hr CD O O
43 after IN B-VP O
44 food NN B-NP O
44 ) ) O O
45 NEPHROCAPS NNP B-NP B-m
45 ( ( O I-m
45 NEPHRO-VIT NNP B-NP I-m
45 RX NNP I-NP I-m
45 ) ) O I-m
45 1 CD O B-do
45 TAB NNP B-NP I-do
45 PO NNP I-NP B-mo
45 QD NNP I-NP B-f
46 NEXIUM NNP I-NP B-m
46 ( ( O I-m
46 ESOMEPRAZOLE NNP B-NP I-m
46 ) ) O I-m
46 20 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 QD NNP I-NP B-f
47 TOPROL NNP I-NP B-m
47 XL NNP I-NP I-m
47 ( ( O I-m
47 METOPROLOL NNP B-NP I-m
47 ( ( O I-m
47 SUST NNP B-NP I-m
47 REL NNP I-NP I-m
47 ) ) O I-m
47 ) ) O I-m
47 200 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QD NNP I-NP B-f
48 Food/Drug NNP I-NP O
48 Interaction NNP I-NP O
48 Instruction NNP I-NP O
49 Take NNP I-NP O
49 consistently RB O O
49 with IN B-VP O
49 meals NNS B-NP O
49 or CC O O
49 on IN B-VP O
49 empty JJ B-NP O
49 stomach NN I-NP O
50 DIET: NNP I-NP O
50 House NNP I-NP O
50 / NNP I-NP O
50 ADA NNP I-NP O
50 2000 CD O O
50 cals/day NN B-NP O
50 / NNP I-NP O
50 Low NNP I-NP O
50 saturated VBD B-VP O
50 fat JJ B-NP O
51 low JJ I-NP O
51 cholesterol NN I-NP O
51 / NNP I-NP O
51 Renal NNP I-NP O
51 diet JJ B-NP O
52 ACTIVITY: NNP I-NP O
52 Walking NNP I-NP O
52 as IN B-VP O
52 tolerated VBN O O
53 FOLLOW NNP B-NP O
53 UP NNP I-NP O
53 APPOINTMENT( NNP I-NP O
53 S NNP I-NP O
53 ): NNP I-NP O
54 Renal NNP I-NP O
54 Doctor NNP I-NP O
54 MWF NNP I-NP O
54 , , O O
55 Dr NNP B-NP O
55 Handrick NNP I-NP O
55 1-2 JJ B-NP O
55 weeks NNS I-NP O
55 , , O O
56 Dr NNP B-NP O
56 Donkle NNP I-NP O
56 , , O O
56 cardiology NN B-NP O
56 2 CD O O
56 weeks NNS B-NP O
56 , , O O
57 ALLERGY: NNP B-NP O
57 Lisinopril NNP I-NP O
57 , , O O
57 Zocor NNP B-NP O
57 ( ( O O
57 hmg JJ B-NP O
57 coa NN I-NP O
57 reductase NN I-NP O
57 inhibitors NNS I-NP O
57 ) ) O O
58 ADMIT VBP O O
58 DIAGNOSIS: NNP B-NP O
59 hypercalcemia NN I-NP O
59 , , O O
59 hyperkalemia NN B-NP O
59 CHF NNP I-NP O
60 PRINCIPAL NNP I-NP O
60 DISCHARGE NNP I-NP O
60 DIAGNOSIS NNP I-NP O
60 ;Responsible JJ O O
60 After IN B-VP O
60 Study NNP B-NP O
60 for IN B-VP O
60 Causing NNP B-NP O
60 Admission NNP I-NP O
60 ) ) O O
61 CAD NNP B-NP O
62 OTHER NNP I-NP O
62 DIAGNOSIS;Conditions NNP I-NP O
62 , , O O
62 Infections NNP B-NP O
62 , , O O
62 Complications NNP B-NP O
62 , , O O
62 affecting VBG O O
62 Treatment/Stay NNP B-NP O
63 1 CD O O
63 NIDDM NNP B-NP O
63 2 CD O O
63 AI/AS NNP B-NP O
63 , , O O
63 bicuspid JJ B-NP O
63 aortic JJ I-NP O
63 valve NN I-NP O
63 , , O O
63 LVH NNP B-NP O
63 3 CD O O
63 HTN NNP B-NP O
63 4 CD O O
63 s/p NN B-NP O
64 thyroglossal NN I-NP O
64 duct NN I-NP O
64 cyst NN I-NP O
64 excision NN I-NP O
64 5 CD O O
64 h/o NN B-NP O
65 noncompliance NN I-NP O
65 with IN B-VP O
65 meds NNS B-NP O
65 cad NNS I-NP O
65 ( ( O O
65 coronary JJ B-NP O
65 artery NN I-NP O
66 disease NN I-NP O
66 ) ) O O
66 ESRD NNP B-NP O
66 ON NNP I-NP O
66 HD NNP I-NP O
66 ( ( O O
66 end JJ B-NP O
66 stage NN I-NP O
66 renal JJ B-NP O
66 disease NN I-NP O
66 ) ) O O
66 CHF NNP B-NP O
66 , , O O
66 unclear JJ B-NP O
66 etiology NN I-NP O
67 ( ( O O
67 congestive JJ B-NP O
67 heart NN I-NP O
67 failure NN I-NP O
67 ) ) O O
67 hyperlipidemia NN B-NP O
68 ( ( O O
68 hyperlipidemia NN B-NP O
68 ) ) O O
68 h/o NN B-NP O
68 syphilis NN I-NP O
68 ( ( O O
68 H/O NNP B-NP O
68 syphilis NN I-NP O
68 ) ) O O
69 OPERATIONS NNP B-NP O
69 AND NNP I-NP O
69 PROCEDURES: NNP I-NP O
70 OTHER NNP I-NP O
70 TREATMENTS/PROCEDURES NNP I-NP O
70 ( ( O O
70 NOT NNP B-NP O
70 IN NNP I-NP O
70 O.R NNP I-NP O
70 ) ) O O
71 Routine NNP B-NP O
71 Hemodialysis NNP I-NP O
72 Right NNP I-NP O
72 heart NN I-NP O
72 catheterization NN I-NP O
73 BRIEF NNP I-NP O
73 RESUME NNP I-NP O
73 OF NNP I-NP O
73 HOSPITAL NNP I-NP O
73 COURSE: NNP I-NP O
74 56M CD O O
74 with IN B-VP O
74 SOB NNP B-NP O
74 admitted VBD B-VP O
74 on IN B-VP O
74 4/22 CD O O
74 Hx NNP B-NP O
74 of IN B-VP O
74 ESRD NNP B-NP O
74 on IN B-VP O
74 HD NNP B-NP O
74 , , O O
75 CHF NNP B-NP O
75 with IN B-VP O
75 EF NNP B-NP O
75 of IN B-VP O
75 25% CD O O
75 , , O O
75 DM NNP B-NP O
75 , , O O
75 HTN NNP B-NP O
75 Pt NNP I-NP O
75 became VBD B-VP O
75 acutely RB O O
75 sob VBN O O
75 on IN B-VP O
75 8/7 CD O O
75 at IN B-VP O
75 rest NN B-NP O
75 , , O O
76 but CC O O
76 then RB O O
76 states VBZ O O
76 sob NN B-NP O
76 for IN B-VP O
76 a DT B-NP O
76 few JJ I-NP O
76 days NNS I-NP O
76 No DT B-NP O
76 cp NN I-NP O
76 , , O O
76 occasional JJ B-NP O
76 epigastric JJ I-NP O
77 burning NN I-NP O
77 +PND NN I-NP O
77 , , O O
77 sleeps NNS B-NP O
77 on IN B-VP O
77 1 CD O O
77 pillow NN B-NP O
77 , , O O
77 no DT B-NP O
77 LE NNP I-NP O
78 edema NN I-NP O
78 CV NNP I-NP O
78 March NNP I-NP O
78 Cath NNP I-NP O
78 90% CD O O
78 LAD NNP B-NP O
78 , , O O
78 80% CD O O
78 Ramus NNP B-NP O
78 , , O O
78 80% CD O O
78 LCx NNP B-NP O
78 EF NNP I-NP O
79 25% CD O O
79 No NNP B-NP O
79 chest NN I-NP O
79 pain NN I-NP O
79 complaints NNS I-NP O
79 +Troponin VBP O O
79 likely JJ B-NP O
80 due JJ I-NP O
80 due JJ I-NP O
80 demand NN I-NP O
80 ischemia NN I-NP O
80 from IN B-VP O
80 volume NN B-NP O
80 overload NN I-NP O
80 Pt NNP I-NP O
81 on IN B-VP O
81 ASA NNP B-NP B-m
81 , , O O
81 Lopressor NNP B-NP B-m
81 which WDT O O
81 was VBD B-VP O
81 increased VBN O O
81 over IN B-VP O
81 2 CD O O
82 days NNS B-NP O
82 , , O O
82 Nitrates NNP B-NP B-m
82 , , O O
82 and CC O O
82 ACE-inh NNP B-NP B-m
82 Pt NNP I-NP O
82 will MD O O
82 maximize VB O O
83 medical JJ B-NP O
83 management NN I-NP O
83 of IN B-VP O
83 CV NNP B-NP O
83 status NN I-NP O
83 , , O O
83 and CC O O
83 dialysis NN B-NP O
83 done VBN O O
83 0/20 CD O O
84 Cardiology NNP B-NP O
84 Consult NNP I-NP O
84 0/20 CD O O
84 for IN B-VP O
84 Troponin NNP B-NP O
84 rising VBG O O
84 to TO O O
84 2.9 CD O O
84 ?if NNS B-NP O
84 CABG NNP I-NP O
84 candidate NN I-NP O
84 , , O O
85 cards NNS B-NP O
85 suggesting VBG O O
85 med VBD B-VP O
85 mgt NNS B-NP O
85 Increased VBD B-VP O
85 the DT B-NP O
85 lopressor NN I-NP B-m
85 with IN B-VP O
85 goal NN B-NP O
85 b/p NN I-NP O
86 &lt;130 NNP I-NP O
86 Troponin NNP I-NP O
86 max VBD B-VP O
86 2.99 CD O O
86 on IN B-VP O
86 0/20 CD O O
86 RHcath NN B-NP O
86 after IN B-VP O
87 dialysis NN B-NP O
87 3/24 CD O O
87 showed VBD B-VP O
87 increased VBN O O
87 filling NN B-NP O
87 pressures NNS I-NP O
88 and CC O O
88 adenosine JJ B-NP O
88 mibi NN I-NP O
88 on IN B-VP O
88 9/10 CD O O
88 showed VBD B-VP O
88 minimal JJ B-NP B-r
88 ischemia NN I-NP I-r
89 of IN B-VP O
89 inferior-lateral JJ B-NP O
89 wall NN I-NP O
89 and CC O O
89 ?defect NN B-NP O
89 in IN B-VP O
90 anterior JJ B-NP O
90 wall NN I-NP O
90 Will NNP I-NP O
90 switch VB O O
90 to TO O O
90 Toprol NNP B-NP B-m
90 XL NNP I-NP I-m
90 200 CD O B-do
90 QD NNP B-NP B-f
90 7/24 CD O O
90 p NN B-NP O
91 HD NNP I-NP O
91 6/10 CD O O
91 12 CD O O
91 beats NNS B-NP O
91 , , O O
91 and CC O O
91 3/24 CD O O
91 7 CD O O
91 beats NNS B-NP O
91 VT NNP I-NP O
91 follow VBP O O
92 lytes NNS B-NP O
92 , , O O
92 will MD O O
92 hold VB O O
92 off RP O O
92 on IN B-VP O
92 further JJ B-NP O
92 intervention NN I-NP O
92 for IN B-VP O
92 now RB O O
93 per IN B-VP O
93 cardiology NN B-NP O
93 ( ( O O
93 fellow JJ B-NP O
93 #07724 NN I-NP O
93 ) ) O O
93 BNP NNP B-NP O
93 after IN B-VP O
94 dialysis NN B-NP O
94 &gt;assay NNP I-NP O
95 FEN NNP I-NP O
95 ) ) O O
95 Hypercalcemia NNP B-NP O
95 15 CD O O
95 on IN B-VP O
95 admission NN B-NP O
95 Pt NNP I-NP O
95 recieving VBG O O
95 50mg CD O B-do
95 of IN B-VP O
95 Calcitonin NNP B-NP B-m
96 SC NNP I-NP B-mo
96 PTH NNP I-NP O
96 pending VBG O O
96 , , O O
96 SPEP NNP B-NP O
96 pending VBG O O
96 May NNP B-NP O
96 also RB O O
96 be VB O O
96 related VBN O O
96 to TO O O
96 Phos NNP B-NP O
96 Lo NNP I-NP O
96 or CC O O
97 tert JJ B-NP O
97 Hyper NNP I-NP O
97 pth NN I-NP O
97 Hyperkalemia NNP I-NP B-r
97 Hyperkalemia NNP I-NP B-r
97 without IN B-VP O
97 T NNP B-NP O
97 wave VBP O O
97 peaking VBG O O
98 Kayexelate NNP B-NP B-m
98 given VBN O O
98 with IN B-VP O
98 Lactulose NNP B-NP B-m
98 with IN B-VP O
98 good JJ B-NP O
98 results NNS I-NP O
98 Repeat NNP I-NP O
99 K NNP I-NP O
99 improving VBG O O
99 , , O O
99 dialysis NN B-NP O
100 MWF NNP I-NP O
100 PULM NNP I-NP O
100 ) ) O O
100 SOB NNP B-NP O
100 with IN B-VP O
100 hypoxia NN B-NP O
100 on IN B-VP O
100 admission NN B-NP O
100 from IN B-VP O
100 CHF NNP B-NP O
101 No NNP I-NP O
101 clear JJ B-NP O
101 infiltrates NNS I-NP O
101 Doing VBG O O
101 well RB O O
101 on IN B-VP O
101 NC NNP B-NP O
101 O2 NNP I-NP B-m
101 On IN B-VP O
102 review NN B-NP O
102 of IN B-VP O
102 Cxr NNP B-NP O
102 there EX O O
102 is VBZ O O
102 ?consolidation NN B-NP O
102 LLL NNP I-NP O
102 If IN B-VP O
103 spikes NNS B-NP O
103 then RB O O
103 culture NN B-NP O
103 and CC O O
103 add VB O O
103 pna JJ B-NP O
104 coverage NN I-NP O
104 GI NNP I-NP O
104 ) ) O O
104 Constipation NNP B-NP O
104 likely RB O O
104 related VBD B-VP O
104 to TO O O
105 hypercalcemia VB O O
105 Pt NNP B-NP O
105 on IN B-VP O
105 agressive JJ B-NP O
105 bowel NN I-NP O
106 regimen NNS I-NP O
106 RENAL NNP I-NP O
106 ) ) O O
106 ESRD NNP B-NP O
106 on IN B-VP O
106 HD NNP B-NP O
106 Dialysis NNP I-NP O
106 per IN B-VP O
106 Renal NNP B-NP O
106 team NN I-NP O
106 Pt NNP I-NP O
107 did VBD B-VP O
107 recieve VB O O
107 Vit NNP B-NP B-m
107 D NNP I-NP I-m
107 recently RB O O
107 which WDT O O
107 may MD O O
107 also RB O O
107 have VB O O
107 con NN B-NP O
107 tributed VBN O O
107 to TO O O
108 hypercalcemia VB O O
108 ENDO NNP B-NP O
108 ) ) O O
108 Pt NNP B-NP O
108 put VBD B-VP O
108 on IN B-VP O
108 decreased JJ B-NP O
108 NPH NNP I-NP B-m
108 regimen NNS I-NP O
108 bs NN I-NP O
108 of IN B-VP O
109 56 CD O O
109 on IN B-VP O
109 4/22 CD O O
109 , , O O
109 pt NN B-NP O
109 given VBN O O
109 D50x1 NNP B-NP B-m
109 and CC O O
109 NPH NNP B-NP B-m
109 decreased VBD B-VP O
109 further RBR O O
110 Will NNP B-NP O
110 try VB O O
110 to TO O O
110 maintain VB O O
110 tight JJ B-NP O
110 glycemic NNS I-NP O
110 control NN I-NP O
110 ADA NNP I-NP O
110 diet NN I-NP O
110 Last JJ B-NP O
110 A1C NNP I-NP O
110 8.3 CD O O
111 in IN B-VP O
111 10/19 CD O O
111 HEME NNP B-NP O
111 ) ) O O
111 Hct NNP B-NP O
111 high JJ O O
111 normal JJ O O
111 , , O O
111 ?intravascularly JJ B-NP O
111 dry NN I-NP O
111 , , O O
112 but CC O O
112 CHF NNP B-NP O
112 on IN B-VP O
112 exam NN B-NP O
112 and CC O O
112 CXR NNP B-NP O
112 TP NNP I-NP O
112 increased VBD B-VP O
112 with IN B-VP O
113 nl JJ B-NP O
113 albumin NN I-NP O
113 SPEP NNP I-NP O
113 and CC O O
113 UPEP NNP B-NP O
113 pending NN I-NP O
113 , , O O
113 pt NN B-NP O
113 did VBD B-VP O
114 have VB O O
114 increased VBN O O
114 gamma NN B-NP O
114 on IN B-VP O
114 spep NN B-NP O
114 in IN B-VP O
114 10/19 CD O O
114 , , O O
114 but CC O O
114 no DT B-NP O
115 monoclonal JJ I-NP O
115 spike NN I-NP O
115 Also RB O O
115 hx CD O O
115 of IN B-VP O
115 a-phospholipid JJ B-NP O
115 ab NN I-NP O
115 , , O O
115 but CC O O
115 no DT B-NP O
115 hx NN I-NP O
116 of IN B-VP O
116 clotting VBG O O
117 ??? NNP B-NP O
117 )Ant NNP I-NP O
117 mediastinal JJ B-NP O
117 mass NN I-NP O
117 , , O O
117 stable JJ O O
117 in IN B-VP O
117 appearance NN B-NP O
117 on IN B-VP O
117 CXR NNP B-NP O
117 Will NNP I-NP O
117 need VB O O
117 f/u RB O O
118 as IN B-VP O
118 outpatient JJ B-NP O
119 ADDITIONAL NNP I-NP O
119 COMMENTS: NNP I-NP O
119 Call NNP I-NP O
119 your PRP$ O O
119 doctor NN B-NP O
119 for IN B-VP O
119 any DT B-NP O
119 chest NN I-NP O
119 pains NNS I-NP O
119 , , O O
119 dizziness NN B-NP O
119 , , O O
119 trouble NN B-NP O
119 breathing NN I-NP O
119 , , O O
120 fevers NNS B-NP O
120 &gt;100.4 VBP O O
120 , , O O
120 or CC O O
120 any DT B-NP O
120 other JJ I-NP O
120 concerns NNS I-NP O
121 DISCHARGE NNP I-NP O
121 CONDITION: NNP I-NP O
121 Stable NNP I-NP O
122 TO NNP I-NP O
122 DO/PLAN: NNP I-NP O
123 Follow NNP I-NP O
123 up RB O O
123 chest RB O O
123 CT NNP B-NP O
124 Check NNP I-NP O
124 SPEP NNP I-NP O
124 , , O O
124 PTH NNP B-NP O
124 labs VBZ O O
125 No NNP B-NP O
125 dictated VBD B-VP O
125 summary JJ B-NP O
126 ENTERED NNP I-NP O
126 BY: NNP I-NP O
126 MCMEEN NNP I-NP O
126 , , O O
126 MARTY NNP B-NP O
126 , , O O
126 M.D NNP B-NP O
126 ( ( O O
126 WP104 NNP B-NP O
126 ) ) O O
126 4/7/03 CD O O
126 @ $ O O
126 01:22 CD O O
126 PM NNP B-NP O
127 ****** JJ B-NP O
127 END NNP I-NP O
127 OF NNP I-NP O
127 DISCHARGE NNP I-NP O
127 ORDERS NNP I-NP O
127 ****** NNP I-NP O
128 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #634712 VBZ O O
2 342590615 CD O O
2 LCH NNP B-NP O
2 47454253 CD O O
2 230530 CD O O
2 9/1/2000 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Syncope NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 10/26/2000 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/20/2000 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 KOMLOS NNP I-NP O
5 , , O O
5 COLEMAN NNP B-NP O
5 223-66-98-9 CD O O
6 Rieville NNP B-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/4 CD O O
8 AT NNP B-NP O
8 04:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 HO NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 DELFELDER NNP I-NP O
11 , , O O
11 MILLARD NNP B-NP O
11 L NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 TYLENOL NNP I-NP B-m
16 ( ( O I-m
16 ACETAMINOPHEN NNP B-NP I-m
16 ) ) O I-m
16 650-1 CD O B-do
16 , , O I-do
16 000 CD O I-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 Q4H NNP I-NP B-f
16 PRN NNP I-NP I-f
16 pain VBP O B-r
17 AMIODARONE NNP B-NP B-m
17 200 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 Override NNP I-NP O
18 Notice: NNP I-NP O
18 Override NNP I-NP O
18 added VBD B-VP O
18 on IN B-VP O
18 0/28 CD O O
18 by IN B-VP O
18 KNIGHTSTEP NNP B-NP O
18 , , O O
18 HAYDEN NNP B-NP O
18 S NNP I-NP O
18 on IN B-VP O
18 order NN B-NP O
18 for IN B-VP O
18 COUMADIN NNP B-NP B-m
18 PO NNP I-NP B-mo
18 ( ( O O
18 ref JJ O O
18 # # O O
18 03417627 CD O O
18 ) ) O O
19 POTENTIALLY NNP B-NP O
19 SERIOUS NNP I-NP O
19 INTERACTION: NNP I-NP O
19 AMIODARONE NNP I-NP B-m
19 HCL NNP I-NP I-m
19 &amp; NNP I-NP O
19 WARFARIN NNP I-NP B-m
20 Reason NNP I-NP O
20 for IN B-VP O
20 override: NN B-NP O
20 md NN I-NP O
20 aware JJ B-NP O
20 Previous NNP I-NP O
20 override NN I-NP O
20 information: NN I-NP O
21 Override NNP I-NP O
21 added VBD B-VP O
21 on IN B-VP O
21 10/17 CD O O
21 by IN B-VP O
21 SCRUDATO NNP B-NP O
21 , , O O
21 DWAYNE NNP B-NP O
21 MYLES NNP I-NP O
21 , , O O
21 M.D NNP B-NP O
22 on IN B-VP O
22 order NN B-NP O
22 for IN B-VP O
22 COUMADIN NNP B-NP B-m
22 PO NNP I-NP B-mo
22 VARIABLE NNP I-NP O
22 ( ( O O
22 ref JJ O O
22 # # O O
22 01479158 CD O O
22 ) ) O O
23 POTENTIALLY NNP B-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 AMIODARONE NNP I-NP B-m
23 HCL NNP I-NP I-m
23 &amp; NNP I-NP O
23 WARFARIN NNP I-NP B-m
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 tolerates NNS I-NP O
25 Previous NNP I-NP O
25 override IN B-VP O
25 information: JJ B-NP O
26 Override NNP I-NP O
26 added VBD B-VP O
26 on IN B-VP O
26 10/17 CD O O
26 by IN B-VP O
26 RECHEL NNP B-NP O
26 , , O O
26 JOSH NNP B-NP O
26 AVERY NNP I-NP O
26 , , O O
26 M.D NNP B-NP O
27 POTENTIALLY NNP I-NP O
27 SERIOUS NNP I-NP O
27 INTERACTION: NNP I-NP O
27 WARFARIN NNP I-NP B-m
27 &amp; NNP I-NP O
27 AMIODARONE NNP I-NP B-m
27 HCL NNP I-NP I-m
28 Reason NNP I-NP O
28 for IN B-VP O
28 override: NN B-NP O
28 tolerates NNS I-NP O
28 Previous NNP I-NP O
28 Alert NNP I-NP O
28 overridden NNP I-NP O
29 Override NNP I-NP O
29 added VBD B-VP O
29 on IN B-VP O
29 10/17 CD O O
29 by IN B-VP O
29 FURNAS NNP B-NP O
29 , , O O
29 CLAUD NNP B-NP O
29 PHIL NNP I-NP O
29 , , O O
29 M.D NNP B-NP O
30 POTENTIALLY NNP I-NP O
30 SERIOUS NNP I-NP O
30 INTERACTION: NNP I-NP O
30 WARFARIN NNP I-NP B-m
30 &amp; NNP I-NP O
30 AMIODARONE NNP I-NP B-m
30 HCL NNP I-NP I-m
31 Reason NNP I-NP O
31 for IN B-VP O
31 override: NN B-NP O
31 tolerates/monitored VBN O O
32 COLACE NNP B-NP B-m
32 ( ( O I-m
32 DOCUSATE NNP B-NP I-m
32 SODIUM NNP I-NP I-m
32 ) ) O I-m
32 100 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
33 LASIX NNP I-NP B-m
33 ( ( O I-m
33 FUROSEMIDE NNP B-NP I-m
33 ) ) O I-m
33 80 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 BID NNP I-NP B-f
34 Alert NNP I-NP O
34 overridden: NNP I-NP O
34 Override NNP I-NP O
34 added VBD B-VP O
34 on IN B-VP O
34 10/17 CD O O
34 by IN B-VP O
35 MCWHINNEY NNP B-NP O
35 , , O O
35 VALENTINE NNP B-NP O
35 BUCK NNP I-NP O
35 , , O O
35 M.D NNP B-NP O
36 POSSIBLE NNP I-NP O
36 ALLERGY NNP I-NP O
36 ( ( O O
36 OR NNP B-NP O
36 SENSITIVITY NNP I-NP O
36 ) ) O O
36 to TO O O
36 SULFA NNP B-NP O
37 Reason NNP I-NP O
37 for IN B-VP O
37 override: NN B-NP O
37 tolerates NNS I-NP O
37 Previous NNP I-NP O
37 Alert NNP I-NP O
37 overridden NNP I-NP O
38 Override NNP I-NP O
38 added VBD B-VP O
38 on IN B-VP O
38 10/17 CD O O
38 by IN B-VP O
38 GOLA NNP B-NP O
38 , , O O
38 TODD NNP B-NP O
38 AARON NNP I-NP O
38 , , O O
38 M.D NNP B-NP O
39 POSSIBLE NNP I-NP O
39 ALLERGY NNP I-NP O
39 ( ( O O
39 OR NNP B-NP O
39 SENSITIVITY NNP I-NP O
39 ) ) O O
39 to TO O O
39 SULFA NNP B-NP O
40 Reason NNP I-NP O
40 for IN B-VP O
40 override: NN B-NP O
40 tolerates NNS I-NP O
40 Previous NNP I-NP O
40 Alert NNP I-NP O
40 overridden NNP I-NP O
41 Override NNP I-NP O
41 added VBD B-VP O
41 on IN B-VP O
41 10/17 CD O O
41 by IN B-VP O
41 QUAIN NNP B-NP O
41 , , O O
41 ETHAN NNP B-NP O
41 CURT NNP I-NP O
41 , , O O
41 M.D NNP B-NP O
42 POSSIBLE NNP I-NP O
42 ALLERGY NNP I-NP O
42 ( ( O O
42 OR NNP B-NP O
42 SENSITIVITY NNP I-NP O
42 ) ) O O
42 to TO O O
42 SULFA NNP B-NP O
43 Reason NNP I-NP O
43 for IN B-VP O
43 override: NN B-NP O
43 tolerates NNS I-NP O
44 MICRONASE NNP I-NP B-m
44 ( ( O I-m
44 GLYBURIDE NNP B-NP I-m
44 ) ) O I-m
44 10 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 BID NNP I-NP B-f
45 Alert NNP I-NP O
45 overridden: NNP I-NP O
45 Override NNP I-NP O
45 added VBD B-VP O
45 on IN B-VP O
45 10/17 CD O O
45 by IN B-VP O
46 FARUG NNP B-NP O
46 , , O O
46 CHAUNCEY NNP B-NP O
46 STANFORD NNP I-NP O
46 , , O O
46 M.D NNP B-NP O
47 POSSIBLE NNP I-NP O
47 ALLERGY NNP I-NP O
47 ( ( O O
47 OR NNP B-NP O
47 SENSITIVITY NNP I-NP O
47 ) ) O O
47 to TO O O
47 SULFA NNP B-NP O
48 Reason NNP I-NP O
48 for IN B-VP O
48 override: NN B-NP O
48 tolerates NNS I-NP O
48 Previous NNP I-NP O
48 Alert NNP I-NP O
48 overridden NNP I-NP O
49 Override NNP I-NP O
49 added VBD B-VP O
49 on IN B-VP O
49 10/17 CD O O
49 by IN B-VP O
49 GERETY NNP B-NP O
49 , , O O
49 LINWOOD NNP B-NP O
49 KAREEM NNP I-NP O
49 , , O O
49 M.D NNP B-NP O
50 POSSIBLE NNP I-NP O
50 ALLERGY NNP I-NP O
50 ( ( O O
50 OR NNP B-NP O
50 SENSITIVITY NNP I-NP O
50 ) ) O O
50 to TO O O
50 SULFA NNP B-NP O
51 Reason NNP I-NP O
51 for IN B-VP O
51 override: NN B-NP O
51 tolerates NNS I-NP O
51 Previous NNP I-NP O
51 Alert NNP I-NP O
51 overridden NNP I-NP O
52 Override NNP I-NP O
52 added VBD B-VP O
52 on IN B-VP O
52 10/17 CD O O
52 by IN B-VP O
52 TESSITORE NNP B-NP O
52 , , O O
52 ALDEN NNP B-NP O
52 GUY NNP I-NP O
52 , , O O
52 M.D NNP B-NP O
53 POSSIBLE NNP I-NP O
53 ALLERGY NNP I-NP O
53 ( ( O O
53 OR NNP B-NP O
53 SENSITIVITY NNP I-NP O
53 ) ) O O
53 to TO O O
53 SULFA NNP B-NP O
54 Reason NNP I-NP O
54 for IN B-VP O
54 override: NN B-NP O
54 tolerates NNS I-NP O
55 PLAQUENIL NNP I-NP B-m
55 ( ( O I-m
55 HYDROXYCHLOROQUINE NNP B-NP I-m
55 ) ) O I-m
55 200 CD O B-do
55 MG NNP B-NP I-do
55 PO NNP I-NP B-mo
55 BID NNP I-NP B-f
56 Food/Drug NNP I-NP O
56 Interaction NNP I-NP O
56 Instruction NNP I-NP O
56 Give NNP I-NP O
56 with IN B-VP O
56 meals NNS B-NP O
57 ISORDIL NNP I-NP B-m
57 ( ( O I-m
57 ISOSORBIDE NNP B-NP I-m
57 DINITRATE NNP I-NP I-m
57 ) ) O I-m
57 40 CD O B-do
57 MG NNP B-NP I-do
57 PO NNP I-NP B-mo
57 TID NNP I-NP B-f
58 HOLD NNP I-NP O
58 IF: NNP I-NP O
58 sbp VBD B-VP O
58 &lt;90 NNP B-NP O
59 LISINOPRIL NNP I-NP B-m
59 20 CD O B-do
59 MG NNP B-NP I-do
59 PO NNP I-NP B-mo
59 BID NNP I-NP B-f
59 HOLD NNP I-NP O
59 IF: NNP I-NP O
59 sbp VBD B-VP O
59 &lt;100 NNP B-NP O
60 Override NNP I-NP O
60 Notice: NNP I-NP O
60 Override NNP I-NP O
60 added VBD B-VP O
60 on IN B-VP O
60 10/17 CD O O
60 by IN B-VP O
61 SIWEK NNP B-NP O
61 , , O O
61 ASHLEY NNP B-NP O
61 KENNITH NNP I-NP O
61 , , O O
61 M.D NNP B-NP O
62 on IN B-VP O
62 order NN B-NP O
62 for IN B-VP O
62 KCL NNP B-NP B-m
62 IMMEDIATE NNP I-NP I-m
62 REL NNP I-NP I-m
62 PO NNP I-NP B-mo
62 SCALE NNP I-NP O
62 QD NNP I-NP B-f
62 ( ( O O
62 ref JJ O O
62 # # O O
63 65848216 CD O O
63 ) ) O O
64 POTENTIALLY NNP B-NP O
64 SERIOUS NNP I-NP O
64 INTERACTION: NNP I-NP O
64 LISINOPRIL NNP I-NP B-m
64 &amp; NNP I-NP O
64 POTASSIUM NNP I-NP B-m
65 CHLORIDE NNP I-NP O
65 Reason NNP I-NP O
65 for IN B-VP O
65 override: NN B-NP O
65 tolerates NNS I-NP O
66 Previous NNP I-NP O
66 override IN B-VP O
66 information: JJ B-NP O
67 Override NNP I-NP O
67 added VBD B-VP O
67 on IN B-VP O
67 10/17 CD O O
67 by IN B-VP O
67 ALKIRE NNP B-NP O
67 , , O O
67 EUSEBIO NNP B-NP O
67 LYLE NNP I-NP O
67 , , O O
67 M.D NNP B-NP O
68 POTENTIALLY NNP I-NP O
68 SERIOUS NNP I-NP O
68 INTERACTION: NNP I-NP O
68 POTASSIUM NNP I-NP B-m
68 CHLORIDE NNP I-NP I-m
68 &amp; NNP I-NP O
69 LISINOPRIL NNP I-NP B-m
69 Reason NNP I-NP O
69 for IN B-VP O
69 override: NN B-NP O
69 tolerates NNS I-NP O
70 Previous NNP I-NP O
70 Override NNP I-NP O
70 Notice NNP I-NP O
71 Override NNP I-NP O
71 added VBD B-VP O
71 on IN B-VP O
71 10/17 CD O O
71 by IN B-VP O
71 KUPRES NNP B-NP O
71 , , O O
71 OSWALDO NNP B-NP O
71 DEVIN NNP I-NP O
71 , , O O
71 M.D NNP B-NP O
72 on IN B-VP O
72 order NN B-NP O
72 for IN B-VP O
72 KCL NNP B-NP B-m
72 IMMEDIATE NNP I-NP I-m
72 REL NNP I-NP I-m
72 PO NNP I-NP B-mo
72 ( ( O O
72 ref JJ O O
72 # # O O
72 65848216 CD O O
72 ) ) O O
73 POTENTIALLY NNP B-NP O
73 SERIOUS NNP I-NP O
73 INTERACTION: NNP I-NP O
73 LISINOPRIL NNP I-NP B-m
73 &amp; NNP I-NP O
73 POTASSIUM NNP I-NP B-m
74 CHLORIDE NNP I-NP O
74 Reason NNP I-NP O
74 for IN B-VP O
74 override: NN B-NP O
74 monitored VBN O O
75 LOPRESSOR NNP B-NP B-m
75 ( ( O I-m
75 METOPROLOL NNP B-NP I-m
75 TARTRATE NNP I-NP I-m
75 ) ) O I-m
75 25 CD O B-do
75 MG NNP B-NP I-do
75 PO NNP I-NP B-mo
75 BID NNP I-NP B-f
76 HOLD NNP I-NP O
76 IF: NNP I-NP O
76 sbp VBD B-VP O
76 &lt;100 NNP B-NP O
76 HR NNP I-NP O
76 60 CD O O
76 Food/Drug NNP B-NP O
76 Interaction NNP I-NP O
76 Instruction NNP I-NP O
77 Take NNP I-NP O
77 with IN B-VP O
77 food NN B-NP O
78 Alert NNP I-NP O
78 overridden: NNP I-NP O
78 Override NNP I-NP O
78 added VBD B-VP O
78 on IN B-VP O
78 10/17 CD O O
78 by IN B-VP O
79 SIEBERT NNP B-NP O
79 , , O O
79 DOUGLAS NNP B-NP O
79 GERALD NNP I-NP O
79 , , O O
79 M.D NNP B-NP O
80 DEFINITE NNP I-NP O
80 ALLERGY NNP I-NP O
80 ( ( O O
80 OR NNP B-NP O
80 SENSITIVITY NNP I-NP O
80 ) ) O O
80 to TO O O
80 BETA-BLOCKERS NNP B-NP O
81 Reason NNP I-NP O
81 for IN B-VP O
81 override: NN B-NP O
81 tolerates NNS I-NP O
81 Previous NNP I-NP O
81 Alert NNP I-NP O
81 overridden NNP I-NP O
82 Override NNP I-NP O
82 added VBD B-VP O
82 on IN B-VP O
82 10/17 CD O O
82 by IN B-VP O
82 CENTANO NNP B-NP O
82 , , O O
82 LEVI NNP B-NP O
82 CLAUD NNP I-NP O
82 , , O O
82 M.D NNP B-NP O
83 DEFINITE NNP I-NP O
83 ALLERGY NNP I-NP O
83 ( ( O O
83 OR NNP B-NP O
83 SENSITIVITY NNP I-NP O
83 ) ) O O
83 to TO O O
83 BETA-BLOCKERS NNP B-NP O
84 Reason NNP I-NP O
84 for IN B-VP O
84 override: NN B-NP O
84 monitored VBD B-VP O
85 NITROGLYCERIN NNP B-NP B-m
85 1/150 CD O I-m
85 ( ( O I-m
85 0.4 CD O I-m
85 MG NNP B-NP I-m
85 ) ) O I-m
85 1 CD O B-do
85 TAB NNP B-NP I-do
85 SL NNP I-NP B-mo
85 q5min VBD B-VP B-f
85 x $ O O
85 3 CD O O
86 PRN NNP B-NP O
86 chest NN I-NP B-r
86 pain NN I-NP I-r
86 HOLD NNP I-NP O
86 IF: NNP I-NP O
86 SBP NNP I-NP O
86 &lt; VBD B-VP O
86 100 CD O O
87 COUMADIN NNP B-NP B-m
87 COUMADIN NNP I-NP B-m
87 ( ( O I-m
87 ( ( O I-m
87 WARFARIN NNP B-NP I-m
87 WARFARIN NNP I-NP I-m
87 SODIUM NNP I-NP I-m
87 SODIUM NNP I-NP I-m
87 ) ) O I-m
87 ) ) O I-m
88 EVEN NNP B-NP O
88 days: $ O O
88 5 CD O B-do
88 MG NNP B-NP I-do
88 qTTHSat; NN I-NP B-f
88 ODD NNP I-NP O
88 days: VBZ O O
88 2.5 CD O B-do
88 MG NNP B-NP I-do
88 qMWF NN I-NP B-f
88 PO NNP I-NP B-mo
88 PO NNP I-NP B-mo
88 QD NNP I-NP O
89 Starting VBG O O
89 Today NNP B-NP O
89 ( ( O O
89 6/1 CD O O
89 ) ) O O
90 HOLD NNP B-NP O
90 IF: NNP I-NP O
90 INR NNP I-NP O
90 &gt;3.0 NNP I-NP O
90 and CC O O
90 call VB O O
90 primary JJ B-NP O
90 doctor NN I-NP O
91 Food/Drug NNP I-NP O
91 Interaction NNP I-NP O
91 Instruction NNP I-NP O
92 No NNP I-NP O
92 high JJ B-NP O
92 Vitamin-K NNP I-NP O
92 containing VBG O O
92 foods NNS B-NP O
93 Alert NNP I-NP O
93 overridden: VBD B-VP O
93 Override NNP B-NP O
93 added VBD B-VP O
93 on IN B-VP O
93 0/28 CD O O
93 by IN B-VP O
93 MCCLISH NNP B-NP O
93 , , O O
93 ZACK NNP B-NP O
93 R NNP I-NP O
94 POTENTIALLY NNP I-NP O
94 SERIOUS NNP I-NP O
94 INTERACTION: NNP I-NP O
94 AMIODARONE NNP I-NP B-m
94 HCL NNP I-NP I-m
94 &amp; NNP I-NP O
94 WARFARIN NNP I-NP B-m
95 Reason NNP I-NP O
95 for IN B-VP O
95 override: NN B-NP O
95 md NN I-NP O
95 aware JJ B-NP O
96 NORVASC NNP I-NP B-m
96 ( ( O I-m
96 AMLODIPINE NNP B-NP I-m
96 ) ) O I-m
96 10 CD O B-do
96 MG NNP B-NP I-do
96 PO NNP I-NP B-mo
96 QD NNP I-NP B-f
96 HOLD NNP I-NP O
96 IF: NNP I-NP O
96 sbp VBD B-VP O
96 &lt;100 NNP B-NP O
97 LOVENOX NNP I-NP B-m
97 ( ( O I-m
97 ENOXAPARIN NNP B-NP I-m
97 ) ) O I-m
97 70 CD O B-do
97 MG NNP B-NP I-do
97 SC NNP I-NP B-mo
97 Q12H NNP I-NP B-f
97 X NNP I-NP B-du
97 4 CD O I-du
97 Days NNPS B-NP I-du
98 Starting VBG O O
98 Today NNP B-NP O
98 ( ( O O
98 6/1 CD O O
98 ) ) O O
98 HOLD NNP B-NP O
98 IF: NNP I-NP O
98 INR NNP I-NP O
98 is VBZ O O
98 2-3 JJ B-NP O
99 Instructions: NNP I-NP O
99 Please NNP I-NP O
99 give VB O O
99 first RB O O
99 dose JJ B-NP O
99 today NN I-NP O
99 and CC O O
99 provide VB O O
100 teaching VBG O O
100 Would MD O O
100 have VB O O
100 her PRP$ O O
100 visiting VBG O O
100 nurse JJ O O
100 give VBP O O
100 the DT B-NP O
100 injections NNS I-NP O
101 if IN B-VP O
101 INR NNP B-NP O
101 is VBZ O O
101 not RB O O
101 2-3 JJ B-NP O
102 DIET: NNP I-NP O
102 No NNP I-NP O
102 Restrictions NNP I-NP O
103 RETURN NNP I-NP O
103 TO NNP I-NP O
103 WORK: NNP I-NP O
103 Not RB O O
103 Applicable NNP B-NP O
104 FOLLOW NNP I-NP O
104 UP NNP I-NP O
104 APPOINTMENT( NNP I-NP O
104 S NNP I-NP O
104 ): NNP I-NP O
105 Dr NNP I-NP O
105 Wilber NNP I-NP O
105 Tussing NNP I-NP O
105 1-2 JJ B-NP O
105 weeks NNS I-NP O
105 , , O O
105 patient NN B-NP O
105 to TO O O
105 call VB O O
105 for IN B-VP O
105 an DT B-NP O
105 appointment NN I-NP O
105 , , O O
106 Dr NNP B-NP O
106 Heriberto NNP I-NP O
106 Mertins NNP I-NP O
106 , , O O
106 Cardiology NNP B-NP O
106 2-3 JJ B-NP O
106 weeks NNS I-NP O
106 , , O O
106 patient NN B-NP O
106 to TO O O
106 call VB O O
106 for IN B-VP O
106 appointment NN B-NP O
106 , , O O
107 ALLERGY: NNP B-NP O
107 Sotalol NNP I-NP O
107 , , O O
107 Procainamide NNP B-NP O
107 , , O O
107 Aspirin NNP B-NP O
107 , , O O
107 Penicillins NNP B-NP O
107 , , O O
107 Sulfa NNP B-NP O
107 , , O O
108 Quinaglute NNP B-NP O
108 , , O O
108 Asa NNP B-NP O
109 ADMIT NNP I-NP O
109 DIAGNOSIS: NNP I-NP O
110 Syncope NNP I-NP O
110 , , O O
110 R/O NNP B-NP O
110 MI NNP I-NP O
111 PRINCIPAL NNP I-NP O
111 DISCHARGE NNP I-NP O
111 DIAGNOSIS NNP I-NP O
111 ;Responsible JJ O O
111 After IN B-VP O
111 Study NNP B-NP O
111 for IN B-VP O
111 Causing NNP B-NP O
111 Admission NNP I-NP O
111 ) ) O O
112 Syncope NNP B-NP O
113 OTHER NNP I-NP O
113 DIAGNOSIS;Conditions NNP I-NP O
113 , , O O
113 Infections NNP B-NP O
113 , , O O
113 Complications NNP B-NP O
113 , , O O
113 affecting VBG O O
113 Treatment/Stay NNP B-NP O
114 OPERATIONS NNP I-NP O
114 AND NNP I-NP O
114 PROCEDURES: NNP I-NP O
115 OTHER NNP I-NP O
115 TREATMENTS/PROCEDURES NNP I-NP O
115 ( ( O O
115 NOT NNP B-NP O
115 IN NNP I-NP O
115 O.R NNP I-NP O
115 ) ) O O
116 BRIEF NNP B-NP O
116 RESUME NNP I-NP O
116 OF NNP I-NP O
116 HOSPITAL NNP I-NP O
116 COURSE: NNP I-NP O
117 *** VBZ O O
117 0/28 CD O O
117 *** NN B-NP O
118 10/16 CD O O
118 78F CD O O
118 w/ NN B-NP O
118 HTN NNP I-NP O
118 , , O O
118 PAFon NNP B-NP O
118 amiodarone NN I-NP B-m
118 , , O O
118 MS NNP B-NP O
118 s/p VBZ O O
118 MVR NNP B-NP B-r
119 on IN B-VP O
119 coumadin NN B-NP B-m
119 , , O O
119 ?CAD/IMI NN B-NP O
119 with IN B-VP O
119 clean JJ B-NP O
119 coronaries NNS I-NP O
119 on IN B-VP O
120 cath NN B-NP O
120 '91 CD O O
120 , , O O
120 h/o NN B-NP O
120 CHF NNP I-NP O
120 , , O O
120 now RB O O
120 presenting VBG O O
120 with IN B-VP O
120 2 CD O O
120 episodes NNS B-NP O
121 of IN B-VP O
121 ?syncope NN B-NP O
121 First NNP I-NP O
121 episode NN I-NP O
121 while IN B-VP O
121 sitting VBG O O
121 , , O O
122 ?LOC NNP B-NP O
122 , , O O
122 second JJ B-NP O
122 episode NN I-NP O
122 while IN B-VP O
122 leaning VBG O O
122 over RP O O
122 , , O O
122 likely JJ O O
122 no DT B-NP O
123 LOC NNP I-NP O
123 , , O O
123 both DT B-NP O
123 episodes NNS I-NP O
123 without IN B-VP O
123 pre- JJ O O
123 or CC O O
124 post-syncopal JJ B-NP O
124 SOB/palpitations/lightheadedness/confusion NN I-NP O
125 or CC O O
125 other JJ B-NP O
125 sx NN I-NP O
125 In IN B-VP O
125 ED NNP B-NP O
125 had VBD B-VP O
125 Lleg/armpain NNP B-NP O
125 and CC O O
125 HA NNP B-NP O
126 Had NNP I-NP O
126 negative JJ B-NP O
126 Head NNP I-NP O
126 CT NNP I-NP O
126 , , O O
126 neg JJ B-NP O
126 Lextremity NNP I-NP O
126 films NNS I-NP O
127 Meds NNP I-NP O
127 noteable JJ O O
127 for IN B-VP O
127 extensive JJ B-NP O
127 cardiac JJ I-NP B-m
127 regimen NNS I-NP I-m
128 including VBG O O
128 lopressor NN B-NP B-m
128 , , O O
128 coumadin NN B-NP B-m
128 , , O O
129 amio NN B-NP B-m
129 , , O O
129 norvasc RB O B-m
129 , , O O
129 lisinopril NN B-NP B-m
129 , , O O
129 lasix NN B-NP B-m
129 , , O O
129 isordil NN B-NP B-m
129 CXR NNP I-NP O
129 showed VBD B-VP O
129 mild JJ B-NP O
129 CHF NNP I-NP O
130 ?Lbase NNP I-NP O
130 effusion NN I-NP O
130 ECHO NNP I-NP O
130 29 CD O O
130 of IN B-VP O
130 July NNP B-NP O
130 EF65% NNP I-NP O
130 , , O O
130 EKG NNP B-NP O
130 old JJ B-NP O
130 inferior JJ I-NP O
131 MI NNP I-NP O
131 changes/primary NN I-NP O
131 AVblock NNP I-NP O
131 Noted VBD B-VP O
131 bradycardia NN B-NP O
131 to TO O O
132 30s CD O O
132 while IN B-VP O
132 asleep NN B-NP O
132 on IN B-VP O
132 night NN B-NP O
132 of IN B-VP O
133 admission NN B-NP O
133 CV: NNP I-NP O
133 unclear JJ B-NP O
133 etiology NN I-NP O
133 of IN B-VP O
133 syncopal JJ B-NP O
133 episodes NNS I-NP O
133 but CC O O
134 CV NNP B-NP O
134 likely RB O O
134 given VBN O O
134 her PRP$ O O
134 history NN B-NP O
134 Will NNP I-NP O
134 call VB O O
134 Cards NNP B-NP O
135 consult NN I-NP O
135 in IN B-VP O
135 a.m JJ B-NP O
135 Important NNP I-NP O
135 to TO O O
135 assess VB O O
135 specific JJ B-NP O
136 etiology NN I-NP O
136 given VBN O O
136 need VBP O O
136 for IN B-VP O
136 coumadin NN B-NP B-m
136 for IN B-VP O
136 MVR NNP B-NP B-r
136 versus NN I-NP O
136 fall NN I-NP O
137 risk NN I-NP O
137 with IN B-VP O
137 the DT B-NP O
137 syncopal JJ I-NP O
137 episodes.Orthostatics NNS I-NP O
138 negative JJ B-NP O
138 Cardiology NNP I-NP O
138 consulted VBD B-VP O
138 , , O O
138 and CC O O
138 recommended VBD B-VP O
138 an DT B-NP O
138 event NN I-NP O
138 monitor NN I-NP O
138 to TO O O
139 assess VB O O
139 for IN B-VP O
139 specific JJ B-NP O
139 rhythms NN I-NP O
139 while IN B-VP O
139 she PRP O O
139 is VBZ O O
139 symptomatic JJ O O
139 Over IN B-VP O
139 her PRP$ O O
139 hospital JJ B-NP O
140 course NN I-NP O
140 , , O O
140 she PRP O O
140 had VBD B-VP O
140 one CD O O
140 episode NN B-NP O
140 of IN B-VP O
140 near-syncope JJ O O
140 similar JJ O O
140 to TO O O
140 her PRP$ O O
140 weekend NN B-NP O
141 symptoms NNS I-NP O
141 There EX O O
141 was VBD B-VP O
141 no DT B-NP O
141 typical JJ I-NP O
141 rhythm NN I-NP O
141 noted VBD B-VP O
141 on IN B-VP O
141 telemetry NN B-NP O
141 at IN B-VP O
141 that DT B-NP O
141 time NN I-NP O
142 Cardiology NNP I-NP O
142 recommended VBD B-VP O
142 monitoring NN B-NP O
142 HR NNP I-NP O
142 and CC O O
142 BP NNP B-NP O
142 and CC O O
142 consider VB O O
142 d/c'ing VBG O O
143 Lopressor NNP B-NP B-m
143 if IN B-VP O
143 it PRP O O
143 is VBZ O O
143 excessively RB O O
143 low JJ O O
143 and CC O O
143 correlating VBG O O
143 with IN B-VP O
143 symptoms NNS B-NP O
144 Would MD O O
144 follow VB O O
144 up RP O O
144 on IN B-VP O
144 event NN B-NP O
144 monitor NN I-NP O
144 to TO O O
144 determine VB O O
144 need NN B-NP O
144 for IN B-VP O
144 further JJ B-NP O
145 intervention NN I-NP O
146 Neuro: NNP I-NP O
146 Head NNP I-NP O
146 MR NNP I-NP O
146 negative; RB O O
146 ruled VBD B-VP O
146 out RP O O
146 intracranial JJ B-NP O
147 ischemia/bleed NN I-NP O
147 Heme: NNP I-NP O
147 INR NNP I-NP O
147 4.3 CD O O
147 on IN B-VP O
147 admission NN B-NP O
147 and CC O O
147 restarted VBN O O
147 after IN B-VP O
147 holding VBG O O
148 for IN B-VP O
148 one CD O O
148 day NN B-NP O
148 Restarted VBD B-VP O
148 coumadin NN B-NP B-m
148 at IN B-VP O
148 usual JJ B-NP O
148 home NN I-NP B-do
148 dosing NN I-NP I-do
148 On IN B-VP O
148 3/28 CD O O
148 INR NNP B-NP O
148 was VBD B-VP O
149 2.1 CD O O
149 so RB O O
149 arranged VBN O O
149 for IN B-VP B-du
149 4days CD O I-du
149 of IN B-VP O
149 Lovenox NNP B-NP B-m
149 to TO O O
149 be VB O O
149 given VBN O O
149 if IN B-VP O
149 INR NNP B-NP O
149 is VBZ O O
149 not RB O O
150 therapeutic JJ B-NP O
151 Follow NNP I-NP O
151 up RP O O
151 plan: NN B-NP O
151 Event NNP I-NP O
151 monitor NN I-NP O
151 to TO O O
151 be VB O O
151 ordered VBN O O
151 Patient NNP B-NP O
151 to TO O O
151 follow VB O O
151 up RP O O
151 with IN B-VP O
152 Dr NNP B-NP O
152 Bergerson NNP I-NP O
152 and CC O O
152 Dr NNP B-NP O
152 Gamma NNP I-NP O
152 in IN B-VP O
152 1-2 JJ B-NP O
152 weeks NNS I-NP O
152 Visiting VBG O O
152 nurse NN B-NP O
152 to TO O O
152 do VB O O
152 home NN B-NP O
152 safety NN I-NP O
153 eval NN I-NP O
153 , , O O
153 and CC O O
153 monitor NN B-NP O
153 INR/administer NNP I-NP O
153 Lovenox NNP I-NP B-m
153 if IN B-VP O
153 needed VBN O O
153 , , O O
153 and CC O O
153 check VB O O
154 BP/HR/symptoms NNP B-NP O
155 ADDITIONAL NNP I-NP O
155 COMMENTS: NNP I-NP O
155 For IN B-VP O
155 visiting VBG O O
155 nurse: JJ B-NP O
155 Please NNP I-NP O
155 draw VB O O
155 blood NN B-NP O
155 qd NN I-NP O
155 for IN B-VP O
155 5 CD O O
155 days NNS B-NP O
155 to TO O O
155 check VB O O
155 INR NNP B-NP O
155 If IN B-VP O
155 it PRP O O
156 is VBZ O O
156 less JJR O O
156 than IN B-VP O
156 2 CD O O
156 please NN B-NP O
156 give VB O O
156 the DT B-NP O
156 Lovenox NNP I-NP B-m
156 injections NNS I-NP B-mo
156 for IN B-VP O
156 the DT B-NP O
156 day NN I-NP O
156 If IN B-VP O
156 it PRP O O
157 remains VBZ O O
157 in IN B-VP O
157 2-3 JJ B-NP O
157 range NN I-NP O
157 , , O O
157 just RB O O
157 continue VB O O
157 the DT B-NP O
157 regular JJ I-NP B-do
157 Coumadin NNP I-NP B-m
157 dosing VBG O O
157 Please NNP B-NP O
158 check VB O O
158 BP NNP B-NP O
158 and CC O O
158 heart NN B-NP O
158 rate NN I-NP O
158 and CC O O
158 call VB O O
158 primary JJ B-NP O
158 doctor NN I-NP O
158 Dr NNP I-NP O
158 Mickles NNP I-NP O
158 if IN B-VP O
158 it PRP O O
158 is VBZ O O
159 excessively RB O O
159 low JJ O O
159 or CC O O
159 high JJ O O
159 and CC O O
159 patient JJ O O
159 is VBZ O O
159 complaining VBG O O
159 of IN B-VP O
159 symptoms NNS B-NP O
159 Please NNP I-NP O
160 ensure VB O O
160 she PRP O O
160 is VBZ O O
160 wearing VBG O O
160 her PRP$ O O
160 event NN B-NP O
160 monitor NN I-NP O
161 DISCHARGE NNP I-NP O
161 CONDITION: NNP I-NP O
161 Stable NNP I-NP O
162 TO NNP I-NP O
162 DO/PLAN: NNP I-NP O
163 No NNP I-NP O
163 dictated VBD B-VP O
163 summary JJ B-NP O
164 ENTERED NNP I-NP O
164 BY: NNP I-NP O
164 DRIEVER NNP I-NP O
164 , , O O
164 LOGAN NNP B-NP O
164 W NNP I-NP O
164 , , O O
164 M.D NNP B-NP O
164 ( ( O O
164 HJ06 NNP B-NP O
164 ) ) O O
164 9/4 CD O O
164 @ $ O O
164 01 CD O O
165 ****** JJ B-NP O
165 END NN I-NP O
165 OF NNP I-NP O
165 DISCHARGE NNP I-NP O
165 ORDERS NNP I-NP O
165 ****** NNP I-NP O
166 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #640167 VBZ O O
2 349403045 CD O O
2 VTH NNP B-NP O
2 15063553 CD O O
2 5309751 CD O O
2 0/2/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 research NN I-NP O
2 study NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/3/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/1/2004 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 WEINGARTEN NNP I-NP O
5 , , O O
5 LAVERNE NNP B-NP O
5 721-51-59-9 CD O O
6 Bock NNP B-NP O
6 Pit NNP I-NP O
6 Magaford NNP I-NP O
6 Hfortro NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 5/10/04 CD O O
8 AT NNP B-NP O
8 08:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 completion NN I-NP O
9 of IN B-VP O
9 study NN B-NP O
9 protocol NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 GAWRONSKI NNP I-NP O
11 , , O O
11 KELLEY NNP B-NP O
11 L NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 DIET: NNP I-NP O
16 House NNP I-NP O
16 / NNP I-NP O
16 study NN I-NP O
16 diet JJ B-NP O
17 ACTIVITY: NNP I-NP O
17 activity NN I-NP O
17 as IN B-VP O
17 tolerated JJ B-NP O
18 NO NNP I-NP O
18 FOLLOW NNP I-NP O
18 APPOINTMRNT NNP I-NP O
18 REQUIRED NNP I-NP O
19 No NNP I-NP O
19 Known NNP I-NP O
19 Allergies NNP I-NP O
20 ADMIT NNP I-NP O
20 DIAGNOSIS: NNP I-NP O
21 research NN I-NP O
22 PRINCIPAL NNP I-NP O
22 DISCHARGE NNP I-NP O
22 DIAGNOSIS NNP I-NP O
22 ;Responsible JJ O O
22 After IN B-VP O
22 Study NNP B-NP O
22 for IN B-VP O
22 Causing NNP B-NP O
22 Admission NNP I-NP O
22 ) ) O O
23 research NN B-NP O
23 study NN I-NP O
24 OTHER NNP I-NP O
24 DIAGNOSIS;Conditions NNP I-NP O
24 , , O O
24 Infections NNP B-NP O
24 , , O O
24 Complications NNP B-NP O
24 , , O O
24 affecting VBG O O
24 Treatment/Stay NNP B-NP O
25 dm NN I-NP O
25 ( ( O O
25 diabetes VBZ O O
25 mellitus NN B-NP O
25 ) ) O O
25 htn NN B-NP O
25 ( ( O O
25 hypertension NN B-NP O
25 ) ) O O
25 sleep NN B-NP O
25 apnea NN I-NP O
25 ( ( O O
25 sleep JJ B-NP O
26 apnea NN I-NP O
26 ) ) O O
26 gout NN B-NP O
26 ( ( O O
26 gout NN B-NP O
26 ) ) O O
26 depression NN B-NP O
27 ( ( O O
27 depression NN B-NP O
27 ) ) O O
27 obesity NN B-NP O
27 ( ( O O
27 obesity NN B-NP O
27 ) ) O O
27 left VBD B-VP O
27 total JJ B-NP O
27 hip NN I-NP O
27 replacement NN I-NP O
28 OPERATIONS NNP I-NP O
28 AND NNP I-NP O
28 PROCEDURES: NNP I-NP O
29 n/a FW O O
30 OTHER NNP B-NP O
30 TREATMENTS/PROCEDURES NNP I-NP O
30 ( ( O O
30 NOT NNP B-NP O
30 IN NNP I-NP O
30 O.R NNP I-NP O
30 ) ) O O
31 as IN B-VP O
31 per IN B-VP O
31 study NN B-NP O
31 protocol NN I-NP O
32 BRIEF NNP I-NP O
32 RESUME NNP I-NP O
32 OF NNP I-NP O
32 HOSPITAL NNP I-NP O
32 COURSE: NNP I-NP O
33 pt NN I-NP O
33 admitted VBD B-VP O
33 for IN B-VP O
33 research NN B-NP O
33 study NN I-NP O
34 ADDITIONAL NNP I-NP O
34 COMMENTS: NNP I-NP O
35 DISCHARGE NNP I-NP O
35 CONDITION: NNP I-NP O
35 Stable NNP I-NP O
36 TO NNP I-NP O
36 DO/PLAN: NNP I-NP O
37 No NNP I-NP O
37 dictated VBD B-VP O
37 summary JJ B-NP O
38 ENTERED NNP I-NP O
38 BY: NNP I-NP O
38 CICHONSKI NNP I-NP O
38 , , O O
38 BOB NNP B-NP O
38 B NNP I-NP O
38 , , O O
38 M.D NNP B-NP O
38 ( ( O O
38 QH06 NNP B-NP O
38 ) ) O O
38 5/10/04 CD O O
38 @ $ O O
38 03 CD O O
39 ****** JJ B-NP O
39 END NN I-NP O
39 OF NNP I-NP O
39 DISCHARGE NNP I-NP O
39 ORDERS NNP I-NP O
39 ****** NNP I-NP O
40 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #647217 VBZ O O
4 593111043 CD O O
4 PSUH NNP B-NP O
4 01580237 CD O O
4 763408 CD O O
4 1/0/2002 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 UNSTABLE NNP I-NP O
4 ANGINA NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/8/2002 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/5/2002 CD O O
7 CHIEF NNP B-NP O
7 COMPLAINT: NNP I-NP O
7 CHEST NNP I-NP O
7 PAIN NNP I-NP O
7 , , O O
7 SHORTNESS NNP B-NP O
7 OF NNP I-NP O
7 BREATH NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT B-NP O
8 65-year-old JJ I-NP O
8 woman NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 insulin-dependent JJ B-NP O
9 diabetes NNS I-NP O
10 mellitus NN I-NP O
10 , , O O
10 HTN NNP B-NP O
10 , , O O
10 IPF NNP B-NP O
10 and CC O O
10 some DT B-NP O
10 CAD NNP I-NP O
10 who WP O O
10 presents VBZ O O
10 with IN B-VP O
10 the DT B-NP O
10 first JJ I-NP O
10 episode NN I-NP O
11 of IN B-VP O
11 chest NN B-NP O
11 pain NN I-NP O
11 and CC O O
11 shortness NN B-NP O
11 of IN B-VP O
11 breath NN B-NP O
11 The DT B-NP O
11 patient NN I-NP O
11 first RB O O
12 experienced VBD B-VP O
12 a DT B-NP O
12 sudden JJ I-NP O
12 onset NN I-NP O
12 of IN B-VP O
12 substernal JJ B-NP O
12 chest NN I-NP O
12 pressure NN I-NP O
12 and CC O O
12 severe JJ B-NP O
13 shortness NN I-NP O
13 of IN B-VP O
13 breath NN B-NP O
13 five CD O O
13 days NNS B-NP O
13 prior RB O O
13 to TO O O
13 admission NN B-NP O
13 which WDT O O
13 resolved VBD B-VP O
13 in IN B-VP O
14 one CD O O
14 hour NN B-NP O
14 but CC O O
14 continued VBD B-VP O
14 to TO O O
14 have VB O O
14 some DT B-NP O
14 substernal JJ I-NP O
14 chest NN I-NP O
14 pain NN I-NP O
14 and CC O O
15 dyspnea NN B-NP O
15 on IN B-VP O
15 exertion NN B-NP O
15 with IN B-VP O
15 even RB O O
15 mild JJ B-NP O
15 exertion NN I-NP O
15 , , O O
15 i.e NN B-NP O
15 , , O O
15 crossing VBG O O
15 the DT B-NP O
16 room NN I-NP O
16 This DT O O
16 occurred VBD B-VP O
16 over IN B-VP O
16 the DT B-NP O
16 next JJ I-NP O
16 several JJ I-NP O
16 days NNS I-NP O
16 The DT B-NP O
16 patient NN I-NP O
17 described VBD B-VP O
17 the DT B-NP O
17 substernal JJ I-NP O
17 chest NN I-NP O
17 pressure NN I-NP O
17 as IN B-VP O
17 being VBG O O
17 like IN B-VP O
17 hit VBN O O
17 in IN B-VP O
17 the DT B-NP O
18 chest NN I-NP O
18 and CC O O
18 this DT O O
18 lasted VBN O O
18 about IN B-VP O
18 fifteen JJ B-NP O
18 minutes NNS I-NP O
18 The DT B-NP O
18 patient NN I-NP O
18 did VBD B-VP O
18 have VB O O
19 some DT B-NP O
19 nausea NN I-NP O
19 and CC O O
19 vomiting NN B-NP O
19 associated VBN O O
19 with IN B-VP O
19 her PRP$ O O
19 symptoms NNS B-NP O
19 and CC O O
19 was VBD B-VP O
19 most RBS O O
20 comfortable JJ O O
20 sitting VBG O O
20 up RP O O
20 The DT B-NP O
20 patient NN I-NP O
20 did VBD B-VP O
20 continue VB O O
20 to TO O O
20 have VB O O
20 increased VBN O O
21 shortness NN B-NP O
21 of IN B-VP O
21 breath NN B-NP O
21 at IN B-VP O
21 rest NN B-NP O
21 and CC O O
21 worsened VBD B-VP O
21 dyspnea NN B-NP O
21 on IN B-VP O
21 exertion NN B-NP O
21 with IN B-VP O
22 around IN B-VP O
22 two CD O O
22 episodes NNS B-NP O
22 per IN B-VP O
22 day NN B-NP O
22 of IN B-VP O
22 severe JJ B-NP O
22 chest NN I-NP O
22 pressure/dyspnea/pain NN I-NP O
23 that WDT O O
23 required VBD B-VP O
23 her PRP O O
23 to TO O O
23 remain VB O O
23 still RB O O
23 over IN B-VP O
23 the DT O O
23 next JJ O O
23 five CD O O
23 days NNS B-NP O
23 She PRP O O
24 also RB O O
24 noted VBD B-VP O
24 diaphoresis NN B-NP O
24 with IN B-VP O
24 all PDT O O
24 those DT O O
24 episodes IN B-VP O
24 She PRP O O
24 denied VBD B-VP O
24 any DT B-NP O
25 fever NN I-NP O
25 , , O O
25 chills NNS B-NP O
25 , , O O
25 URI NNP B-NP O
25 symptoms NNS I-NP O
25 , , O O
25 cough NN B-NP O
25 , , O O
25 change NN B-NP O
25 in IN B-VP O
25 bowel NN B-NP O
25 movements NNS I-NP O
25 The DT B-NP O
26 patient NN I-NP O
26 did VBD B-VP O
26 complain NN B-NP O
26 of IN B-VP O
26 some DT B-NP O
26 bilateral JJ I-NP O
26 foot NN I-NP O
26 edema RB O O
26 1-2 JJ B-NP O
26 weeks NNS I-NP O
26 prior RB O O
27 to TO O O
27 admission VB O O
27 The DT B-NP O
27 patient NN I-NP O
27 has VBZ O O
27 had VBN O O
27 stable JJ B-NP O
27 two-pillow JJ I-NP O
27 orthopnea NN I-NP O
27 and CC O O
28 notes VBZ O O
28 no DT B-NP O
28 weight NN I-NP O
28 gain NN I-NP O
28 or CC O O
28 loss NN B-NP O
28 , , O O
28 but CC O O
28 notes NNS B-NP O
28 decreased VBD B-VP O
28 exercise NN B-NP O
29 tolerance NN I-NP O
29 over IN B-VP O
29 the DT B-NP O
29 past JJ I-NP O
29 month NN I-NP O
29 The DT B-NP O
29 patient NN I-NP O
29 presented VBD B-VP O
29 to TO O O
29 her PRP$ O O
30 primary JJ B-NP O
30 care NN I-NP O
30 physician JJ B-NP O
30 today NN I-NP O
30 secondary JJ O O
30 to TO O O
30 continued JJ B-NP O
30 shortness NN I-NP O
30 of IN B-VP O
31 breath NN B-NP O
31 and CC O O
31 was VBD B-VP O
31 sent VBN O O
31 to TO O O
31 the DT B-NP O
31 emergency NN I-NP O
31 department NN I-NP O
31 where WRB O O
32 electrocardiogram NN B-NP O
32 revealed VBD B-VP O
32 some DT B-NP O
32 ST NNP I-NP O
32 depressions NNS I-NP O
32 anterolaterally RB O O
32 with IN B-VP O
33 a DT B-NP O
33 troponin NN I-NP O
33 leak NN I-NP O
33 with IN B-VP O
33 a DT B-NP O
33 troponin JJ I-NP O
33 level NN I-NP O
33 of IN B-VP O
33 0.19 CD O O
33 and CC O O
33 was VBD B-VP O
33 thus RB O O
33 admitted VBN O O
34 to TO O O
34 the DT B-NP O
34 cardiology NN I-NP O
34 Memp NNP I-NP O
34 Mont NNP I-NP O
34 service NN I-NP O
35 PAST NNP I-NP O
35 MEDICAL NNP I-NP O
35 HISTORY: NNP I-NP O
35 Insulin-dependent NNP I-NP O
35 diabetes VBZ O O
35 mellitus JJ O O
35 x $ O O
35 30 CD O O
36 years NNS B-NP O
36 , , O O
36 hypertension NN B-NP O
36 , , O O
36 IPF NNP B-NP B-r
36 IPF NNP I-NP B-r
36 diagnosed VBD B-VP O
36 in IN B-VP O
36 1986 CD O O
37 treated VBD B-VP O
37 with IN B-VP O
37 digoxin NN B-NP B-m
37 and CC O O
37 prednisone NN B-NP B-m
37 , , O O
37 osteoarthritis NN B-NP O
37 , , O O
37 obesity NN B-NP O
37 , , O O
38 pneumonia NN B-NP O
38 , , O O
38 colonic JJ B-NP O
38 polyps NNS I-NP O
38 with IN B-VP O
38 guaiac-positive JJ B-NP O
38 stool NN I-NP O
38 , , O O
38 TKR NNP B-NP O
38 on IN B-VP O
38 9/24 CD O O
38 , , O O
39 cholecystectomy NN B-NP O
39 , , O O
39 Bell's NNP B-NP O
39 palsy VBZ O O
39 x $ O O
39 20 CD O O
39 years NNS B-NP O
39 , , O O
39 LBP NNP B-NP O
39 , , O O
39 right JJ B-NP O
39 cataracts NNS I-NP O
39 , , O O
40 catheterization NN B-NP O
40 in IN B-VP O
40 1998 CD O O
40 showed VBD B-VP O
40 a DT B-NP O
40 LAD NNP I-NP O
40 lesion NN I-NP O
40 of IN B-VP O
40 40% CD O O
40 and CC O O
40 a DT B-NP O
40 circ JJ I-NP O
41 lesion NN I-NP O
41 of IN B-VP O
41 30% CD O O
41 , , O O
41 RCA NNP B-NP O
41 lesion NN I-NP O
41 of IN B-VP O
41 30% CD O O
42 MEDICATIONS NNP B-NP O
42 ON NNP I-NP O
42 ADMISSION: NNP I-NP O
42 Captopril NNP I-NP B-m
42 50 CD O B-do
42 mg NN B-NP I-do
42 b.i.d.; NN I-NP B-f
42 Lasix NNP I-NP B-m
42 40 CD O B-do
42 mg NN B-NP I-do
43 q.d.; NN I-NP B-f
43 Lopid NNP I-NP B-m
43 600 CD O B-do
43 mg NN B-NP I-do
43 b.i.d.; NN I-NP B-f
43 Axid NNP I-NP B-m
43 150 CD O B-do
43 mg NN B-NP I-do
44 b.i.d.; NN I-NP B-f
44 insulin NN I-NP B-m
44 insulin NN I-NP B-m
44 70/30 CD O I-m
44 70/30 CD O I-m
44 90 CD O B-do
44 q NN B-NP B-f
44 a.m NN I-NP I-f
44 and CC O O
44 40 CD O B-do
44 q NN B-NP B-f
44 p.m.; NN I-NP I-f
44 atenolol VBD B-VP B-m
44 50 CD O B-do
44 mg NN B-NP I-do
45 q.d NN I-NP B-f
46 ALLERGIES: NNP I-NP O
46 IV NNP I-NP O
46 contrast NN I-NP O
46 , , O O
46 patient JJ O O
46 gets VBZ O O
46 hives NNS B-NP O
46 Bactrim NNP I-NP O
46 , , O O
46 also RB O O
46 hives VBZ O O
47 FAMILY NNP B-NP O
47 HISTORY: NNP I-NP O
47 Father NNP I-NP O
47 died VBD B-VP O
47 of IN B-VP O
47 myocardial JJ B-NP O
47 infarction NN I-NP O
47 at IN B-VP O
47 age NN B-NP O
47 81 CD O O
47 , , O O
48 brother JJR O O
48 died VBD B-VP O
48 of IN B-VP O
48 myocardial JJ B-NP O
48 infarction NN I-NP O
48 at IN B-VP O
48 age NN B-NP O
48 38 CD O O
48 , , O O
49 mother JJR O O
49 died VBD B-VP O
49 of IN B-VP O
49 myocardial JJ B-NP O
49 infarction NN I-NP O
49 at IN B-VP O
49 age NN B-NP O
49 73 CD O O
50 SOCIAL NNP B-NP O
50 HISTORY: NNP I-NP O
50 A NNP I-NP O
50 housekeeper NN I-NP O
50 , , O O
50 lives VBZ O O
50 with IN B-VP O
50 her PRP$ O O
50 granddaughter NN B-NP O
50 , , O O
50 has VBZ O O
51 a DT B-NP O
51 boyfriend JJ I-NP O
52 PHYSICAL NNP I-NP O
52 EXAMINATION: NNP I-NP O
52 VITAL NNP I-NP O
52 SIGNS: NNP I-NP O
52 Temperature NNP I-NP O
52 98.4 CD O O
52 , , O O
52 heart NN B-NP O
52 rate NN I-NP O
53 65 CD O O
53 , , O O
53 respiratory NN B-NP O
53 rate NN I-NP O
53 20 CD O O
53 , , O O
53 blood NN B-NP O
53 pressure NN I-NP O
54 142/64 CD O O
54 , , O O
54 oxygen NN B-NP O
54 saturation NN I-NP O
54 99% CD O O
54 on IN B-VP O
54 three CD O O
54 liters NNS B-NP O
54 of IN B-VP O
54 O2 NNP B-NP O
54 GENERAL: NNP I-NP O
55 Lying NNP I-NP O
55 in IN B-VP O
55 bed NN B-NP O
55 , , O O
55 labored VBD B-VP O
55 breathing VBG O O
55 HEENT: NNP B-NP O
55 NC/AT NNP I-NP O
55 EOMI NNP I-NP O
55 , , O O
55 PERRLA NNP B-NP O
56 NECK: NNP I-NP O
56 JVP NNP I-NP O
56 around IN B-VP O
56 8 CD O O
56 cm NN B-NP O
56 , , O O
56 no DT B-NP O
56 carotid NN I-NP O
56 bruits VBZ O O
56 PULMONARY: NNP B-NP O
56 Dry NNP I-NP O
56 , , O O
56 fine JJ B-NP O
57 crackles NNS I-NP O
57 one-third NN I-NP O
57 of IN B-VP O
57 the DT B-NP O
57 way NN I-NP O
57 up RP O O
57 bilaterally RB O O
57 No NNP B-NP O
57 wheezes NN I-NP O
57 , , O O
57 no DT B-NP O
57 focal JJ I-NP O
58 dullness NN I-NP O
58 CARDIOVASCULAR: NNP I-NP O
58 Distant NNP I-NP O
58 heart NN I-NP O
58 sounds VBZ O O
58 , , O O
58 regular JJ B-NP O
58 rate NN I-NP O
58 and CC O O
59 rhythm NN B-NP O
59 , , O O
59 normal JJ B-NP O
59 S1S2 NNP I-NP O
59 , , O O
59 no DT B-NP O
59 murmurs NN I-NP O
59 , , O O
59 rubs NN B-NP O
59 or CC O O
59 gallops NNS B-NP O
59 ABDOMEN: NNP I-NP O
59 Obese NNP I-NP O
59 , , O O
60 soft JJ O O
60 , , O O
60 nontender NN B-NP O
60 , , O O
60 positive JJ B-NP O
60 bowel NN I-NP O
60 sounds VBZ O O
60 EXTREMITIES: NNP B-NP O
60 Trace NNP I-NP O
60 pedal NN I-NP O
61 edema NN I-NP O
61 NEURO: NNP I-NP O
61 Alert NNP I-NP O
61 and CC O O
61 oriented VBD B-VP O
61 x $ O O
61 3 CD O O
61 DTRs NNP B-NP O
61 2+ CD O O
61 Sensation NNP B-NP O
61 intact JJ O O
62 distally RB O O
63 LABORATORY NNP B-NP O
63 DATA: NNP I-NP O
63 White NNP I-NP O
63 count NN I-NP O
63 8.44 CD O O
63 , , O O
63 hematocrit NN B-NP O
63 34.2 CD O O
63 platelets NNS B-NP O
63 408 CD O O
63 , , O O
64 sodium NN B-NP O
64 138 CD O O
64 , , O O
64 potassium NN B-NP O
64 5.6 CD O O
64 , , O O
64 chloride/bicarb NN B-NP O
65 109/19 CD O O
65 , , O O
65 BUN/creatinine NNP B-NP O
65 20/1.1 CD O O
65 , , O O
65 glucose RB O O
65 249 CD O O
65 , , O O
65 ALT NNP B-NP O
65 13 CD O O
65 , , O O
65 AST NNP B-NP O
65 16 CD O O
65 , , O O
65 CK NNP B-NP O
65 68 CD O O
65 , , O O
66 alk VBP O O
66 phos JJ O O
66 119 CD O O
66 , , O O
66 TP NNP B-NP O
66 7.4 CD O O
66 , , O O
66 albumin RB O O
66 4.2 CD O O
66 , , O O
66 CA NNP B-NP O
66 9.2 CD O O
66 , , O O
66 TB NNP B-NP O
66 0.4 CD O O
66 , , O O
66 troponin NN B-NP O
66 0.19 CD O O
66 , , O O
67 INR NNP B-NP O
67 1.1 CD O O
67 , , O O
67 D-dimer NNP B-NP O
67 573 CD O O
67 , , O O
67 PTT NNP B-NP O
67 29.3 CD O O
68 Electrocardiogram NNP B-NP O
68 normal JJ B-NP O
68 sinus NN I-NP O
68 rhythm NN I-NP O
68 at IN B-VP O
68 67 CD O O
68 , , O O
68 LAD NNP B-NP O
68 , , O O
68 LDH NNP B-NP O
68 , , O O
68 RBBB NNP B-NP O
68 , , O O
68 ST NNP B-NP O
69 depressions VBZ O O
69 V3-V6 NNP B-NP O
69 , , O O
69 0.5 CD O O
69 mm NN B-NP O
69 in IN B-VP O
69 2 CD O O
69 and CC O O
69 3 CD O O
69 Echo NNP B-NP O
69 5/4/01: CD O O
69 Ejection NNP B-NP O
70 fraction NN I-NP O
70 55-60% CD O O
70 , , O O
70 no DT B-NP O
70 wall NN I-NP O
70 motion NN I-NP O
70 abnormalities NNS I-NP O
70 , , O O
70 trace NN B-NP O
70 AI NNP I-NP O
70 , , O O
70 trace NN B-NP O
70 MR NNP I-NP O
70 , , O O
71 mild JJ B-NP O
71 TR NNP I-NP O
71 1/17 CD O O
71 adenosine NN B-NP O
71 MIBI: NNP I-NP O
71 No NNP I-NP O
71 symptoms NNS I-NP O
71 , , O O
71 1 CD O O
71 mm NN B-NP O
71 ST NNP I-NP O
72 depressions NNS I-NP O
72 in IN B-VP O
72 1 CD O O
72 , , O O
72 2 CD O O
72 and CC O O
72 V4-V6 JJ B-NP O
72 Chest NNP I-NP O
72 x-ray: NN I-NP O
72 Positive NNP I-NP O
72 for IN B-VP O
72 mild JJ B-NP O
73 pulmonary JJ I-NP O
73 edema NN I-NP O
73 , , O O
73 retrocardial JJ B-NP O
73 infiltrate NN I-NP O
73 and CC O O
73 left VBD B-VP O
73 effusion NN B-NP O
74 HOSPITAL NNP I-NP O
74 COURSE: NNP I-NP O
74 This DT O O
74 is VBZ O O
74 a DT B-NP O
74 65-year-old JJ I-NP O
74 female NN I-NP O
74 with IN B-VP O
74 a DT B-NP O
74 history NN I-NP O
74 of IN B-VP O
75 coronary JJ B-NP O
75 artery NN I-NP O
75 disease NN I-NP O
75 , , O O
75 hypertension NN B-NP O
75 , , O O
75 diabetes VBZ O O
75 , , O O
76 IPF NNP B-NP O
76 who WP O O
76 presented VBD B-VP O
76 with IN B-VP O
76 five CD O O
76 days NNS B-NP O
76 of IN B-VP O
76 chest JJ B-NP O
76 pain/SOB NN I-NP O
76 beginning VBG O O
76 with IN B-VP O
77 sudden JJ B-NP O
77 onset NN I-NP O
77 five CD O O
77 days NNS B-NP O
77 prior RB O O
77 to TO O O
77 admission NN B-NP O
77 and CC O O
77 had VBD B-VP O
77 EKG NNP B-NP O
77 changes NNS I-NP O
78 consistent VBP O O
78 with IN B-VP O
78 a DT B-NP O
78 non-Q-wave JJ I-NP O
78 myocardial JJ I-NP O
78 infarction NN I-NP O
78 anterolaterally RB O O
79 Of IN B-VP O
79 note NN B-NP O
79 her PRP$ O O
79 troponin NN B-NP O
79 was VBD B-VP O
79 0.19 CD O O
79 The DT B-NP O
79 differential JJ I-NP O
79 diagnosis NN I-NP O
79 included VBD B-VP O
80 unstable JJ B-NP O
80 angina NN I-NP O
80 and CC O O
80 PE NNP B-NP O
80 with IN B-VP O
80 worsening VBG O O
80 IPF NNP B-NP O
80 superimposed VBN O O
80 on IN B-VP O
80 heart NN B-NP O
81 disease NN I-NP O
81 From IN B-VP O
81 a DT B-NP O
81 cardiovascular JJ I-NP O
81 standpoint NN I-NP O
81 the DT B-NP O
81 patient NN I-NP O
81 has VBZ O O
81 known VBN O O
82 coronary JJ B-NP O
82 artery NN I-NP O
82 disease NN I-NP O
82 with IN B-VP O
82 EKG NNP B-NP O
82 changes NNS I-NP O
82 which WDT O O
82 is VBZ O O
82 likely JJ B-NP O
82 status NN I-NP O
83 post NN I-NP O
83 non-Q-wave JJ B-NP O
83 myocardial JJ I-NP O
83 infarction NN I-NP O
83 with IN B-VP O
83 a DT B-NP O
83 question NN I-NP O
83 of IN B-VP O
83 continued JJ O O
84 unstable JJ O O
84 angina IN B-VP O
84 The DT B-NP O
84 patient NN I-NP O
84 was VBD B-VP O
84 initially RB O O
84 put VBN O O
84 on IN B-VP O
84 aspirin NN B-NP B-m
84 , , O O
85 Lopressor NNP B-NP B-m
85 37.5 CD O B-do
85 t.i.d NN B-NP B-f
85 , , O O
85 heparin NN B-NP B-m
85 , , O O
85 oxygen NN B-NP B-m
85 and CC O O
85 hooked VBD B-VP O
85 up RB O O
85 to TO O O
85 a DT B-NP O
85 cardiac JJ I-NP O
86 monitor NN I-NP O
86 and CC O O
86 EKG NNP B-NP O
86 q.d NN I-NP O
86 and CC O O
86 was VBD B-VP O
86 ruled VBN O O
86 out RP O O
86 for IN B-VP O
86 enzymes RB O O
86 The DT B-NP O
86 patient NN I-NP O
87 underwent JJ B-NP O
87 cardiac JJ I-NP O
87 catheterization NN I-NP O
87 which WDT O O
87 revealed VBD B-VP O
87 LAD NNP B-NP O
87 ostial JJ O O
87 90% CD O O
87 , , O O
88 proximal JJ O O
88 80% CD O O
88 , , O O
88 diag VBP O O
88 ostial JJ O O
88 90% CD O O
88 , , O O
88 left VBD B-VP O
88 circ NN B-NP O
88 90% CD O O
88 , , O O
88 80% CD O O
88 lesions NNS B-NP O
88 , , O O
88 marginal JJ O O
89 1 CD O O
89 , , O O
89 TUB NNP B-NP O
89 90% CD O O
89 , , O O
89 RCA NNP B-NP O
89 50% CD O O
89 The DT B-NP O
89 patient NN I-NP O
89 underwent JJ B-NP O
89 PTCA NNP I-NP O
89 and CC O O
89 stent JJ B-NP O
89 x NN I-NP O
89 2 CD O O
89 with IN B-VP O
90 good JJ B-NP O
90 results NNS I-NP O
90 The DT B-NP O
90 patient NN I-NP O
90 remained VBD B-VP O
90 chest JJS B-NP O
90 pain NN I-NP O
90 free JJ O O
90 and CC O O
90 had VBD B-VP O
90 no DT B-NP O
91 chest JJS I-NP O
91 pain NN I-NP O
91 on IN B-VP O
91 exertion NN B-NP O
91 , , O O
91 i.e NN B-NP O
91 , , O O
91 with IN B-VP O
91 ambulation NN B-NP O
91 The DT B-NP O
91 echo NN I-NP O
91 showed VBD B-VP O
92 preserved JJ O O
92 left VBD B-VP O
92 ventricular JJ B-NP O
92 function NN I-NP O
92 with IN B-VP O
92 a DT B-NP O
92 good JJ I-NP O
92 ejection NN I-NP O
92 fraction NN I-NP O
93 The DT B-NP O
93 ejection NN I-NP O
93 fraction NN I-NP O
93 was VBD B-VP O
93 found VBN O O
93 to TO O O
93 be VB O O
93 55% CD O O
93 There EX O O
93 was VBD B-VP O
93 no DT B-NP O
93 discrete JJ I-NP O
94 evidence NN I-NP O
94 of IN B-VP O
94 wall NN B-NP O
94 motion NN I-NP O
94 abnormality NN I-NP O
94 although IN B-VP O
94 the DT O O
94 inferior JJ O O
94 and CC O O
95 posterior JJ B-NP O
95 segments NNS I-NP O
95 were VBD B-VP O
95 not RB O O
95 well RB O O
95 visualized IN B-VP O
95 There EX O O
95 was VBD B-VP O
95 left VBN O O
96 ventricular JJ B-NP O
96 hypertrophy NN I-NP O
96 There EX O O
96 was VBD B-VP O
96 stromal JJ B-NP O
96 mild JJ I-NP O
96 right JJ I-NP O
96 ventricular NN I-NP O
97 hypertrophy NN I-NP O
97 and CC O O
97 overall JJ B-NP O
97 right JJ I-NP O
97 heart NN I-NP O
97 function NN I-NP O
97 appeared VBD B-VP O
97 to TO O O
97 be VB O O
98 preserved VBN O O
98 There EX O O
98 was VBD B-VP O
98 trivial JJ O O
98 to TO O O
98 1+ CD O O
98 tricuspid JJ B-NP O
98 regurgitation NN I-NP O
98 with IN B-VP O
99 right JJ B-NP O
99 heart NN I-NP O
99 pressures NNS I-NP O
99 within IN B-VP O
99 normal JJ B-NP O
99 limits NNS I-NP O
99 There EX O O
99 was VBD B-VP O
99 thickened VBN O O
100 aortic JJ B-NP O
100 leaflets NNS I-NP O
100 with IN B-VP O
100 trivial JJ B-NP O
100 central JJ I-NP O
100 insufficiency NN I-NP O
100 and CC O O
100 no DT B-NP O
100 evidence NN I-NP O
101 of IN B-VP O
101 any DT B-NP O
101 outflow JJ I-NP O
101 tract NN I-NP O
101 obstruction NN I-NP O
101 There EX O O
101 was VBD B-VP O
101 similar JJ B-NP O
101 mild JJ I-NP O
101 mitral JJ I-NP O
102 regurgitation NN I-NP O
102 with IN B-VP O
102 the DT B-NP O
102 elliptic JJ I-NP O
102 ring NN I-NP O
102 , , O O
102 the DT B-NP O
102 left JJ I-NP O
102 atrial JJ I-NP O
102 size NN I-NP O
102 was VBD B-VP O
103 slightly RB O O
103 increased VBN O O
103 and CC O O
103 there EX O O
103 was VBD B-VP O
103 no DT B-NP O
103 evidence NN I-NP O
103 of IN B-VP O
103 any DT B-NP O
103 effusion NN I-NP O
103 From IN B-VP O
104 a DT B-NP O
104 pulmonary JJ I-NP O
104 standpoint NN I-NP O
104 the DT B-NP O
104 patient NN I-NP O
104 had VBD B-VP O
104 LENIs NNP B-NP O
104 which WDT O O
104 were VBD B-VP O
104 negative JJ O O
105 for IN B-VP O
105 a DT B-NP O
105 deep JJ I-NP O
105 venous JJ I-NP O
105 thrombosis NN I-NP O
105 PFCs NNP I-NP O
105 revealed VBD B-VP O
105 a DT B-NP O
105 restrictive JJ I-NP O
106 physiology NN I-NP O
106 and CC O O
106 poor JJ B-NP O
106 diffusion NN I-NP O
106 consistent NN I-NP O
106 with IN B-VP O
106 IPF NNP B-NP O
106 The DT B-NP O
106 FEV1 NNP I-NP O
106 was VBD B-VP O
107 69% CD O O
107 predicted VBN O O
107 , , O O
107 TLC NNP B-NP O
107 was VBD B-VP O
107 63% CD O O
107 predicted VBN O O
107 , , O O
107 with IN B-VP O
107 a DT B-NP O
107 DLCO NNP I-NP O
107 of IN B-VP O
107 56% CD O O
107 predicted VBD B-VP O
108 The DT B-NP O
108 patient NN I-NP O
108 did VBD B-VP O
108 have VB O O
108 a DT B-NP B-r
108 retrocardiac JJ I-NP I-r
108 infiltrate NN I-NP I-r
108 on IN B-VP O
108 chest JJ B-NP O
108 x-ray NN I-NP O
108 and CC O O
109 the DT B-NP O
109 patient NN I-NP O
109 was VBD B-VP O
109 treated VBN O O
109 with IN B-VP O
109 levofloxacin JJ O B-m
109 500 CD O B-do
109 mg NN B-NP I-do
109 q.d NN I-NP B-f
109 for IN B-VP B-du
109 fourteen JJ B-NP O
110 days NNS I-NP O
110 From IN B-VP O
110 a DT B-NP O
110 GI NNP I-NP O
110 perspective NN I-NP O
110 the DT B-NP O
110 patient NN I-NP O
110 had VBD B-VP O
110 a DT B-NP O
110 history NN I-NP O
110 of IN B-VP O
110 colonic JJ B-NP O
111 polyps NNS I-NP O
111 but CC O O
111 tolerated VBD B-VP O
111 the DT B-NP O
111 aspirin NN I-NP B-m
111 and CC O O
111 was VBD B-VP O
111 put VBN O O
111 on IN B-VP O
111 Nexium NNP B-NP B-m
111 prophylaxis VBP O O
112 The DT B-NP O
112 patient NN I-NP O
112 was VBD B-VP O
112 hypokalemic JJ O B-r
112 on IN B-VP O
112 10/23 CD O O
112 with IN B-VP O
112 a DT B-NP O
112 curious JJ I-NP O
112 whitening NN I-NP O
112 on IN B-VP O
113 EKG NNP B-NP O
113 and CC O O
113 peak JJ B-NP O
113 T NNP I-NP O
113 waves VBZ O O
113 The DT B-NP O
113 patient NN I-NP O
113 was VBD B-VP O
113 treated VBN O O
113 with IN B-VP O
113 insulin NN B-NP B-m
113 , , O O
113 given VBN O O
114 calcium NN B-NP B-m
114 and CC O O
114 treated VBN O O
114 with IN B-VP O
114 Kayexalate NNP B-NP B-m
114 x NNP I-NP B-du
114 3 CD O I-du
114 and CC O O
114 the DT B-NP O
114 hypokalemia NN I-NP O
114 quickly RB O O
115 resolved VBD B-VP O
115 The DT B-NP O
115 origin NN I-NP O
115 of IN B-VP O
115 the DT B-NP O
115 hypokalemia NN I-NP O
115 was VBD B-VP O
115 unclear JJ O O
115 The DT B-NP O
115 patient NN I-NP O
116 did VBD B-VP O
116 have VB O O
116 an DT B-NP O
116 elevated JJ I-NP O
116 potassium NN I-NP O
116 with IN B-VP O
116 a DT B-NP O
116 low JJ I-NP O
116 bicarb NN I-NP O
116 which WDT O O
116 was VBD B-VP O
117 consistent JJ O O
117 with IN B-VP O
117 a DT B-NP O
117 type NN I-NP O
117 4 CD O O
117 RTA NNP B-NP O
117 and CC O O
117 also RB O O
117 had VBD B-VP O
117 hypoglycemia NN B-NP B-r
117 which WDT O O
117 was VBD B-VP O
118 then RB O O
118 treated VBN O O
118 with IN B-VP O
118 prednisone NN B-NP B-m
118 overnight NN I-NP B-du
118 for IN B-VP O
118 IV NNP B-NP O
118 contrast NN I-NP O
118 dye NN I-NP O
118 allergy IN B-VP O
119 The DT B-NP O
119 patient NN I-NP O
119 was VBD B-VP O
119 also RB O O
119 on IN B-VP O
119 Captopril NNP B-NP B-m
119 which WDT O O
119 was VBD B-VP O
119 discontinued VBN O O
119 secondary JJ O O
120 to TO O O
120 her PRP$ O O
120 renal JJ B-NP O
120 issues NNS I-NP O
121 DISCHARGE NNP I-NP O
121 MEDICATIONS: NNP I-NP O
121 ASA NNP I-NP B-m
121 325 CD O B-do
121 mg NN B-NP I-do
121 p.o.q.d.; NN I-NP B-mo
121 atenolol VBD B-VP B-m
121 75 CD O B-do
121 mg NN B-NP I-do
121 p.o NN I-NP B-mo
122 b.i.d.; NN I-NP B-f
122 Lasix NNP I-NP B-m
122 40 CD O B-do
122 mg NN B-NP I-do
122 p.o.q.d.; NN I-NP B-mo
122 Lopid NNP I-NP B-m
122 600 CD O B-do
122 mg NN B-NP I-do
123 p.o NN I-NP B-mo
123 b.i.d.; NN I-NP B-f
123 nitroglycerin RB O B-m
123 1/150 CD O I-m
123 one CD O B-do
123 tab NN B-NP I-do
123 q VBZ O O
123 5 CD O O
123 minutes NNS B-NP O
123 x VBP O B-du
123 3 CD O I-du
123 p.r.n JJ B-NP O
124 chest NN I-NP B-r
124 pain; NN I-NP I-r
124 Zocor NNP I-NP B-m
124 10 CD O B-do
124 mg NN B-NP I-do
124 p.o NN I-NP B-mo
124 q.h.s.; NN I-NP B-f
124 Norvasc NNP I-NP B-m
124 5 CD O B-do
124 mg NN B-NP I-do
124 p.o.q.d.; NN I-NP B-mo
124 xalatan NNP I-NP B-m
125 one CD O B-do
125 drop NN B-NP I-do
125 OU NNP I-NP B-mo
125 q.h.s.; NN I-NP B-f
125 Alphagan NNP I-NP B-m
125 one CD O B-do
125 drop NN B-NP I-do
125 OU NNP I-NP B-mo
125 b.i.d.; NN I-NP B-f
125 levofloxacin VBD B-VP B-m
125 500 CD O B-do
126 mg NN B-NP O
126 p.o.q.d.; NN I-NP B-mo
126 clopidogrel NN I-NP B-m
126 75 CD O B-do
126 mg NN B-NP I-do
126 p.o.q.d.; NN I-NP B-mo
126 insulin NN I-NP B-m
126 insulin NN I-NP B-m
126 70/30 CD O I-m
126 70/30 CD O I-m
126 90 CD O B-do
126 units NNS B-NP I-do
126 q RB O B-f
127 a.m RB O O
127 , , O O
127 40 CD O B-do
127 units NNS B-NP I-do
127 q RB O B-f
127 p.m VBP O I-f
127 subcu; JJ B-NP B-mo
127 Axid NNP I-NP B-m
127 150 CD O B-do
127 mg NN B-NP I-do
127 p.o NN I-NP B-mo
127 b.i.d NN I-NP B-f
128 Dictated NNP I-NP O
128 By: NNP I-NP O
128 GARTH NNP I-NP O
128 KILLE NNP I-NP O
128 , , O O
128 M.D NNP B-NP O
128 RX628 NNP I-NP O
129 Attending: NNP I-NP O
129 NORMAND NNP I-NP O
129 PERRUZZA NNP I-NP O
129 , , O O
129 M.D NNP B-NP O
129 DG98 NNP I-NP O
129 LX446/691450 NNP I-NP O
130 Batch: NNP I-NP O
130 19985 CD O O
130 Index NNP B-NP O
130 No NNP I-NP O
130 FEAYNM1BTQ NNP I-NP O
130 D: NNP I-NP O
130 8/29/02 CD O O
131 T: NNP B-NP O
131 8/29/02 CD O O
132 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #650471 VBZ O O
2 100417558 CD O O
2 CHO NNP B-NP O
2 71347001 CD O O
2 261218 CD O O
2 9/3/2000 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ANGINA NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/17/2000 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/11/2000 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 MYOCARDIAL NNP I-NP O
4 INFARCTION NNP I-NP O
5 SIGNIFICANT NNP I-NP O
5 PROBLEMS: NNP I-NP O
5 1 CD O O
5 CORONARY NNP B-NP O
5 ARTERY NNP I-NP O
5 DISEASE NNP I-NP O
6 2 CD O O
6 HYPERCHOLESTEROLEMIA NNP B-NP O
7 3 CD O O
7 HYPERTENSION NNP B-NP O
8 4 CD O O
8 ANEMIA NNP B-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 Ms NNP I-NP O
9 Christin NNP I-NP O
9 is VBZ O O
9 an DT O O
9 80 CD O O
9 year NN B-NP O
9 old JJ B-NP O
9 female NN I-NP O
9 who WP O O
10 presents VBZ O O
10 to TO O O
10 an DT B-NP O
10 outside JJ I-NP O
10 hospital NN I-NP O
10 with IN B-VP O
11 chest NN B-NP O
11 pain NN I-NP O
11 She PRP O O
11 states VBZ O O
11 the DT B-NP O
11 night NN I-NP O
11 prior RB O O
11 to TO O O
11 admission VB O O
11 she PRP O O
11 felt VBD B-VP O
11 some DT B-NP O
12 shortness NN I-NP B-r
12 of IN B-VP I-r
12 breath NN B-NP I-r
12 and CC O O
12 tightness NN B-NP O
12 in IN B-VP O
12 her PRP$ O O
12 chest NN B-NP O
12 upon IN B-VP O
12 laying VBG O O
12 down RP O O
13 She PRP O O
13 took VBD B-VP O
13 one CD O B-do
13 sublingual JJ B-NP B-mo
13 Nitroglycerin NNP I-NP B-m
13 without IN B-VP O
13 relief NN B-NP O
13 Thirty NNP I-NP O
14 minutes NNS I-NP O
14 later RB O O
14 took VBD B-VP O
14 another DT B-NP O
14 sublingual JJ I-NP B-mo
14 Nitroglycerin NNP I-NP B-m
14 , , O O
14 again RB O O
14 without IN B-VP O
15 relief NN B-NP O
15 Shortness NNP I-NP B-r
15 of IN B-VP I-r
15 breath NN B-NP I-r
15 was VBD B-VP O
15 accompanied VBN O O
15 with IN B-VP O
15 increasing VBG O O
16 feeling NN B-NP O
16 of IN B-VP O
16 chest NN B-NP O
16 tightness NN I-NP O
16 rated VBD B-VP O
16 approximately RB O O
16 8/10 CD O O
16 Took NNP B-NP O
16 a DT B-NP O
16 third JJ I-NP O
17 Nitroglycerin NNP I-NP B-m
17 without IN B-VP O
17 relief NN B-NP O
17 and CC O O
17 felt VBD B-VP O
17 her PRP$ O O
17 breathing NN B-NP O
17 became VBD B-VP O
17 wheezy JJ O O
18 She PRP O O
18 then RB O O
18 drove VBD B-VP O
18 herself PRP O O
18 to TO O O
18 an DT B-NP O
18 outside JJ I-NP O
18 hospital NN I-NP O
18 for IN B-VP O
18 evaluation NN B-NP O
18 She PRP O O
19 was VBD B-VP O
19 there RB O O
19 treated VBN O O
19 with IN B-VP O
19 intravenous JJ B-NP B-mo
19 Lasix NNP I-NP B-m
19 , , O O
19 morphine NN B-NP B-m
19 and CC O O
20 Nitroglycerin NNP B-NP B-m
20 with IN B-VP O
20 resolution NN B-NP O
20 of IN B-VP O
20 her PRP$ O B-r
20 her PRP$ O B-r
20 pain NN B-NP I-r
20 pain NN I-NP I-r
20 EKG NNP I-NP O
20 at IN B-VP O
20 outside JJ B-NP O
20 hospital NN I-NP O
21 showed VBD B-VP O
21 anterolateral JJ B-NP O
21 ST NNP I-NP O
21 depression NN I-NP O
21 and CC O O
21 her PRP$ O O
21 enzymes NNS B-NP O
21 were VBD B-VP O
21 negative JJ B-NP O
22 ruling NN I-NP O
22 out RP O O
22 for IN B-VP O
22 myocardial JJ B-NP O
22 infarction NN I-NP O
22 She PRP O O
22 has VBZ O O
22 cardiac JJ B-NP O
22 risk NN I-NP O
22 factors NNS I-NP O
23 of IN B-VP O
23 hypertension NN B-NP O
23 , , O O
23 hypercholesterolemia NN B-NP O
23 and CC O O
23 age NN B-NP O
23 Her PRP$ O O
23 cardiac JJ B-NP O
24 symptomatology NN I-NP O
24 began VBD B-VP O
24 in IN B-VP O
24 the DT B-NP O
24 fall NN I-NP O
24 of IN B-VP O
24 1999 CD O O
24 when WRB O O
24 she PRP O O
24 began VBD B-VP O
24 to TO O O
25 experience VB O O
25 chest JJS B-NP O
25 discomfort NN I-NP O
25 with IN B-VP O
25 exertion NN B-NP O
25 and CC O O
25 rest NN B-NP O
25 Evaluation NN I-NP O
25 by IN B-VP O
26 Dr NNP B-NP O
26 Jose NNP I-NP O
26 Esparza NNP I-NP O
26 showed VBD B-VP O
26 high JJ B-NP O
26 cholesterol NN I-NP O
26 with IN B-VP O
26 an DT B-NP O
26 LDL NNP I-NP O
26 141 CD O O
26 , , O O
26 EKG NNP B-NP O
26 with IN B-VP O
26 LVH NNP B-NP O
27 and CC O O
27 nonspecific JJ B-NP O
27 T NNP I-NP O
27 wave NN I-NP O
27 flattening VBG O O
27 A NNP B-NP O
27 Thallium NNP I-NP O
27 stress NN I-NP O
27 test NN I-NP O
27 in IN B-VP O
28 November NNP B-NP O
28 of IN B-VP O
28 1999 CD O O
28 was VBD B-VP O
28 three CD O O
28 minutes NNS B-NP O
28 , , O O
28 fifty-two JJ B-NP O
28 seconds NNS I-NP O
28 duration NN I-NP O
28 , , O O
29 stopped VBD B-VP O
29 secondary JJ O O
29 to TO O O
29 shortness VB O O
29 of IN B-VP O
29 breath NN B-NP O
29 , , O O
29 and CC O O
29 there EX O O
29 were VBD B-VP O
30 inferolateral JJ B-NP O
30 ST NNP I-NP O
30 depressions NNS I-NP O
30 with IN B-VP O
30 inferior JJ B-NP O
30 apical JJ I-NP O
30 ischemia NN I-NP O
30 on IN B-VP O
31 imaging VBG O O
31 She PRP O O
31 had VBD B-VP O
31 her PRP O O
31 symptoms NNS B-NP O
31 managed VBD B-VP O
31 medically RB O O
31 with IN B-VP O
31 cholesterol NN B-NP O
32 lowering NN I-NP O
32 and CC O O
32 antihypertensive JJ B-NP O
32 therapy NN I-NP O
33 PAST NNP I-NP O
33 MEDICAL NNP I-NP O
33 HISTORY: NNP I-NP O
33 Significant NNP I-NP O
33 for IN B-VP O
33 hypertension NN B-NP O
33 , , O O
34 hypercholesterolemia NN B-NP O
34 , , O O
34 angina NN B-NP O
34 , , O O
34 Paget's NNP B-NP O
35 disease NN I-NP O
35 , , O O
35 anemia NN B-NP O
35 , , O O
35 osteoarthritis FW O O
36 FAMILY NNP B-NP O
36 HISTORY: NNP I-NP O
36 Noncontributory NNP I-NP O
37 SOCIAL NNP I-NP O
37 HISTORY: NNP I-NP O
37 She PRP O O
37 is VBZ O O
37 widowed VBN O O
37 , , O O
37 she PRP O O
37 lives VBZ O O
37 alone RB O O
37 Has NNP B-NP O
37 many JJ B-NP O
37 friends NNS I-NP O
38 and CC O O
38 support NN B-NP O
38 in IN B-VP O
38 the DT B-NP O
38 area NN I-NP O
38 Owns NNP I-NP O
38 her PRP$ O O
38 own JJ B-NP O
38 store NN I-NP O
38 No NNP I-NP O
39 tobacco NN I-NP O
39 , , O O
39 no DT B-NP O
39 alcohol NN I-NP O
39 , , O O
39 no DT B-NP O
39 drug NN I-NP O
39 use NN I-NP O
40 REVIEW NNP I-NP O
40 OF NNP I-NP O
40 SYSTEMS: NNP I-NP O
40 Positive NNP I-NP O
40 for IN B-VP O
40 orthopnea NN B-NP O
40 increasing VBG O O
40 over IN B-VP O
40 the DT B-NP O
41 past JJ I-NP O
41 month NN I-NP O
41 No NNP I-NP O
41 palpitations VBZ O O
41 No DT B-NP O
41 claudication NN I-NP O
42 No RB O O
42 lower JJR B-NP O
42 extremity NN I-NP O
42 edema VBZ O O
42 No NNP B-NP O
42 syncope NN I-NP O
42 No NNP I-NP O
42 melena NN I-NP O
42 , , O O
42 diarrhea NN B-NP O
42 , , O O
43 hemoptysis NN B-NP O
43 or CC O O
43 bright JJ B-NP O
43 red JJ I-NP O
43 blood NN I-NP O
43 per IN B-VP O
43 rectum NN B-NP O
44 ALLERGIES: NNP I-NP O
44 No NNP I-NP O
44 known VBN O O
44 drug NN B-NP O
44 allergies NNS I-NP O
45 ADMISSION NNP I-NP O
45 PHYSICAL NNP I-NP O
45 EXAMINATION: NNP I-NP O
45 VITAL NNP I-NP O
45 SIGNS NNP I-NP O
45 - : O O
45 She PRP O O
45 is VBZ O O
45 afebrile JJ O O
45 at IN B-VP O
46 98.3 CD O O
46 degrees NNS B-NP O
46 , , O O
46 heart NN B-NP O
46 rate NN I-NP O
46 52 CD O O
46 , , O O
46 blood NN B-NP O
47 pressure NN I-NP O
47 160/68 CD O O
47 , , O O
47 oxygen NN B-NP O
47 saturation NN I-NP O
47 97% CD O O
47 on IN B-VP O
47 room NN B-NP O
47 air NN I-NP O
47 GENERAL NNP I-NP O
47 - : O O
47 She PRP O O
48 is VBZ O O
48 a DT O O
48 petite JJ O O
48 , , O O
48 elderly JJ B-NP O
48 woman NN I-NP O
48 sitting VBG O O
48 in IN B-VP O
48 bed NN B-NP O
48 in IN B-VP O
48 no DT B-NP O
48 apparent JJ I-NP O
48 distress NN I-NP O
49 HEENT NNP I-NP O
49 - : O O
49 Pupils NNS B-NP O
49 are VBP O O
49 equally RB O O
49 round JJ O O
49 and CC O O
49 reactive JJ O O
49 to TO O O
49 light JJ B-NP O
49 Oropharynx NNP I-NP O
50 is VBZ O O
50 clear JJ B-NP O
50 NECK NNP I-NP O
50 - : O O
50 JV NNP B-NP O
50 pressure NN I-NP O
50 approximately RB O O
50 6 CD O O
50 cm NN B-NP O
50 of IN B-VP O
50 water NN B-NP O
50 , , O O
50 2+ CD O O
51 carotids NNS B-NP O
51 , , O O
51 no DT B-NP O
51 bruits NNS I-NP O
51 LUNGS NNP I-NP O
51 - : O O
51 Crackles NNS B-NP O
51 bilaterally RB O O
51 at IN B-VP O
51 the DT B-NP O
51 bases NNS I-NP O
51 , , O O
51 no DT O O
52 wheezing VBG O O
52 HEART: NNP B-NP O
52 Distant NNP I-NP O
52 heart NN I-NP O
52 sounds VBZ O O
52 S1 NNP B-NP O
52 , , O O
52 S2 NNP B-NP O
52 Soft NNP I-NP O
52 grade VBD B-VP O
52 I/VI NNP B-NP O
53 systolic JJ B-NP O
53 ejection NN I-NP O
53 murmur VBZ O O
53 No DT B-NP O
53 gallop NN I-NP O
53 ABDOMEN NNP I-NP O
53 - : O O
53 Soft JJ O O
53 , , O O
53 non-tender JJ O O
53 , , O O
54 nondistended JJ B-NP O
54 Normal NNP I-NP O
54 bowel NN I-NP O
54 sounds VBZ O O
54 No DT B-NP O
54 masses NNS I-NP O
54 , , O O
54 guarding VBG O O
54 or CC O O
55 rebound VB O O
55 EXTREMITIES: NNP B-NP O
55 Warm NNP I-NP O
55 No NNP I-NP O
55 clubbing NN I-NP O
55 , , O O
55 cyanosis NN B-NP O
55 or CC O O
55 edema NN B-NP O
55 , , O O
55 1+ CD O O
56 dorsalis NN B-NP O
56 pedis NN I-NP O
56 pulses VBZ O O
56 bilaterally RB O O
56 NEURO: NNP B-NP O
56 Nonfocal NNP I-NP O
57 ADMISSION NNP I-NP O
57 LABORATORY NNP I-NP O
57 DATA: NNP I-NP O
57 Significant NNP I-NP O
57 for IN B-VP O
57 a DT B-NP O
57 sodium NN I-NP O
57 of IN B-VP O
57 140 CD O O
57 , , O O
58 potassium NN B-NP O
58 of IN B-VP O
58 4.4 CD O O
58 , , O O
58 BUN NNP B-NP O
58 of IN B-VP O
58 40 CD O O
58 , , O O
58 creatinine NN B-NP O
59 of IN B-VP O
59 1.6 CD O O
59 CK NNP B-NP O
59 of IN B-VP O
59 459 CD O O
59 with IN B-VP O
59 an DT B-NP O
59 MB NNP I-NP O
59 of IN B-VP O
59 28.7 CD O O
59 White NNP B-NP O
59 blood NN I-NP O
59 cell NN I-NP O
59 count NN I-NP O
59 of IN B-VP O
60 8 CD O O
60 , , O O
60 000 CD O O
60 , , O O
60 hematocrit NN B-NP O
60 26.9 CD O O
60 , , O O
60 platelet NN B-NP O
60 count NN I-NP O
60 238 CD O O
60 Urinalysis NN B-NP O
60 was VBD B-VP O
61 negative JJ B-NP O
61 EKG NNP I-NP O
61 on IN B-VP O
61 admission NN B-NP O
61 showed VBD B-VP O
61 normal JJ B-NP O
61 sinus NN I-NP O
61 rhythm NN I-NP O
61 at IN B-VP O
61 60 CD O O
61 beats NNS B-NP O
62 per IN B-VP O
62 minute NN B-NP O
62 with IN B-VP O
62 ST NNP B-NP O
62 segment NN I-NP O
62 depression NN I-NP O
62 V4 NNP I-NP O
62 through IN B-VP O
62 V6 NNP B-NP O
62 approximately RB O O
62 1 CD O O
63 mm NNS B-NP O
63 and CC O O
63 approximately RB O O
63 1 CD O O
63 mm NNS B-NP O
63 ST NNP I-NP O
63 depression NN I-NP O
63 in IN B-VP O
63 lead JJ B-NP O
63 II NNP I-NP O
64 HOSPITAL NNP I-NP O
64 COURSE: NNP I-NP O
64 Ms NNP I-NP O
64 Dison NNP I-NP O
64 was VBD B-VP O
64 admitted VBN O O
64 to TO O O
64 Ster NNP B-NP O
64 Hospital NNP I-NP O
64 for IN B-VP O
64 evaluation NN B-NP O
64 of IN B-VP O
64 her PRP$ O O
64 angina NN B-NP O
64 after IN B-VP O
65 ruling VBG O O
65 out RP O O
65 at IN B-VP O
65 an DT B-NP O
65 outside JJ I-NP O
65 hospital NN I-NP O
65 , , O O
65 however RB O O
65 , , O O
65 on IN B-VP O
65 presentation NN B-NP O
65 her PRP$ O O
66 laboratory NN B-NP O
66 values NNS I-NP O
66 were VBD B-VP O
66 consistent JJ O O
66 with IN B-VP O
66 a DT B-NP O
66 myocardial JJ I-NP O
66 infarction NN I-NP O
66 and CC O O
67 her PRP$ O O
67 hospital JJ B-NP O
67 course NN I-NP O
67 is VBZ O O
67 summarized VBN O O
67 as IN B-VP O
67 follows VBZ O O
68 1 CD O O
68 CARDIOVASCULAR: NNP B-NP O
68 Ms NNP I-NP O
68 Berish NNP I-NP O
68 ruled VBD B-VP O
68 in IN B-VP O
68 for IN B-VP O
68 a DT B-NP O
68 myocardial JJ I-NP O
68 infarction NN I-NP O
69 with IN B-VP O
69 a DT B-NP O
69 peak JJ I-NP O
69 CK NNP I-NP O
69 of IN B-VP O
69 459 CD O O
69 with IN B-VP O
69 an DT B-NP O
69 MB NNP I-NP O
69 of IN B-VP O
69 28.7 CD O O
69 This DT O O
69 decreased VBN O O
69 to TO O O
69 328 CD O O
70 with IN B-VP O
70 an DT B-NP O
70 MB NNP I-NP O
70 of IN B-VP O
70 15.4 CD O O
70 the DT B-NP O
70 following JJ I-NP O
70 morning NN I-NP O
70 Her PRP$ O O
70 troponin NN B-NP O
70 was VBD B-VP O
70 15 CD O O
71 She PRP O O
71 , , O O
71 however RB O O
71 , , O O
71 remained VBD B-VP O
71 asymptomatic JJ O O
71 and CC O O
71 pain NN B-NP O
71 free JJ O O
71 throughout IN B-VP O
71 her PRP$ O O
72 hospitalization NN B-NP O
72 She PRP O O
72 underwent JJ B-NP O
72 cardiac JJ I-NP O
72 catheterization NN I-NP O
72 on IN B-VP O
72 May NNP B-NP O
72 , , O O
72 2000 CD O O
72 which WDT O O
72 showed VBD B-VP O
72 an DT B-NP O
72 okay NN I-NP O
72 left VBD B-VP O
72 main JJ O O
72 , , O O
72 LAD NNP B-NP O
72 with IN B-VP O
72 proximal JJ O O
72 90% CD O O
73 stenosis NN B-NP O
73 , , O O
73 which WDT O O
73 underwent JJ B-NP O
73 PTCA NNP I-NP O
73 and CC O O
73 stenting VBG O O
73 with IN B-VP O
73 good JJ B-NP O
73 result NN I-NP O
73 , , O O
73 an DT O O
74 osteal JJ O O
74 D-1 JJ O O
74 80% CD O O
74 lesion NN B-NP O
74 which WDT O O
74 underwent JJ B-NP O
74 PTCA NNP I-NP O
74 with IN B-VP O
74 good JJ B-NP O
74 result NN I-NP O
74 , , O O
74 a DT O O
75 totally RB O O
75 occluded JJ B-NP O
75 proximal NN I-NP O
75 left VBD B-VP O
75 circumflex JJ O O
75 and CC O O
75 a DT B-NP O
75 right JJ I-NP O
75 coronary NN I-NP O
75 with IN B-VP O
76 a DT O O
76 proximal JJ O O
76 30% CD O O
76 to TO O O
76 40% CD O O
76 stenosis NN B-NP O
76 She PRP O O
76 tolerated VBD B-VP O
76 this DT B-NP O
76 procedure NN I-NP O
76 well RB O O
77 and CC O O
77 without IN B-VP O
77 complications NNS B-NP O
77 Her NNP I-NP O
77 medical JJ B-NP O
77 regimen NN I-NP O
77 was VBD B-VP O
77 altered VBN O O
77 to TO O O
78 include VB O O
78 beta NN B-NP B-m
78 blockade NN I-NP I-m
78 , , O O
78 ACE NNP B-NP B-m
78 inhibition NN I-NP I-m
78 and CC O O
78 antihypertensives NNS B-NP B-m
78 and CC O O
79 ischemics NNS B-NP B-m
79 , , O O
79 as IN B-VP O
79 outlined VBN O O
79 below IN B-VP O
79 Of IN B-VP O
79 note NN B-NP O
79 , , O O
79 left VBD B-VP O
79 ventriculogram NN B-NP O
79 on IN B-VP O
79 her PRP$ O O
80 catheterization NN B-NP O
80 showed VBD B-VP O
80 anterior JJ B-NP O
80 hypokinesis NN I-NP O
80 with IN B-VP O
80 3+ CD O O
80 mitral JJ B-NP O
81 regurgitation NN I-NP O
82 2 CD O O
82 ANEMIA: NNP B-NP O
82 Ms NNP I-NP O
82 Flewellen NNP I-NP O
82 has VBZ O O
82 a DT O O
82 known VBN O O
82 normochromic JJ O O
82 , , O O
82 normocytic JJ B-NP O
82 anemia NN I-NP O
83 which WDT O O
83 was VBD B-VP O
83 worked VBN O O
83 up RP O O
83 during IN B-VP O
83 this DT B-NP O
83 hospitalization NN I-NP O
83 She PRP O O
83 had VBD B-VP O
83 a DT B-NP O
84 hematocrit NN I-NP B-r
84 of IN B-VP O
84 26.9 CD O O
84 on IN B-VP O
84 admission NN B-NP O
84 for IN B-VP O
84 which WDT O O
84 she PRP O O
84 was VBD B-VP O
84 transfused VBN O O
84 one CD O B-do
85 unit NN B-NP O
85 of IN B-VP O
85 packed JJ B-NP B-m
85 red JJ I-NP I-m
85 blood NN I-NP I-m
85 cells NNS I-NP I-m
85 Her PRP$ O O
85 workup NN B-NP O
85 showed VBD B-VP O
85 an DT B-NP O
85 iron NN I-NP O
85 of IN B-VP O
85 74 CD O O
85 , , O O
85 a DT B-NP O
86 TIBC NNP I-NP O
86 of IN B-VP O
86 244 CD O O
86 , , O O
86 a DT B-NP O
86 ferritin NN I-NP O
86 of IN B-VP O
86 224 CD O O
86 , , O O
86 B-12 NNP B-NP O
86 of IN B-VP O
86 241 CD O O
86 ( ( O O
86 borderline VB O O
86 low NN B-NP O
86 ) ) O O
87 Folate NNP B-NP O
87 and CC O O
87 Epogen NNP B-NP O
87 levels NNS I-NP O
87 were VBD B-VP O
87 pending VBG O O
87 at IN B-VP O
87 the DT B-NP O
87 time NN I-NP O
87 of IN B-VP O
87 discharge NN B-NP O
88 She PRP O O
88 also RB O O
88 had VBD B-VP O
88 a DT B-NP O
88 TSH NNP I-NP O
88 which WDT O O
88 was VBD B-VP O
88 normal JJ O O
88 at IN B-VP O
88 2.86 CD O O
88 , , O O
88 reticulocyte NN B-NP O
88 count NN I-NP O
88 of IN B-VP O
89 3% CD O O
89 and CC O O
89 a DT O O
89 pending VBG O O
89 serum NN B-NP O
89 protein NN I-NP O
89 electrophoresis NN I-NP O
89 She PRP O O
89 was VBD B-VP O
89 seen VBN O O
89 by IN B-VP O
90 the DT B-NP O
90 Hematology NNP I-NP O
90 Consult NNP I-NP O
90 Service NNP I-NP O
90 and CC O O
90 was VBD B-VP O
90 scheduled VBN O O
90 for IN B-VP O
90 follow-up NN B-NP O
90 with IN B-VP O
91 Dr NNP B-NP O
91 Esteves NNS I-NP O
91 in IN B-VP O
91 the DT B-NP O
91 Hematology NNP I-NP O
91 Clinic NNP I-NP O
91 Her NNP I-NP O
91 hematocrit NN I-NP O
91 at IN B-VP O
91 the DT B-NP O
91 time NN I-NP O
92 of IN B-VP O
92 discharge NN B-NP O
92 was VBD B-VP O
92 30 CD O O
93 Ms NNP B-NP O
93 Bottoni NNP I-NP O
93 was VBD B-VP O
93 stable JJ O O
93 for IN B-VP O
93 discharge NN B-NP O
93 on IN B-VP O
93 February NNP B-NP O
93 , , O O
93 2000 CD O O
93 Follow-up NN B-NP O
94 with IN B-VP O
94 Dr NNP B-NP O
94 Porter NNP I-NP O
94 Luckenbaugh NNP I-NP O
94 in IN B-VP O
94 SH NNP B-NP O
94 Cardiovascular NNP I-NP O
94 Group NNP I-NP O
94 on IN B-VP O
94 January NNP B-NP O
94 at IN B-VP O
95 1:00 CD O O
95 p.m NN B-NP O
95 and CC O O
95 with IN B-VP O
95 Dr NNP B-NP O
95 Sammy NNP I-NP O
95 Kleindienst NNP I-NP O
95 in IN B-VP O
95 the DT B-NP O
95 Greenetons NNP I-NP O
95 Opi NNP I-NP O
95 Hospital NNP I-NP O
95 Hematology NNP I-NP O
95 Clinic NNP I-NP O
96 DISCHARGE NNP I-NP O
96 MEDICATIONS: NNP I-NP O
96 Aspirin NNP I-NP B-m
96 81 CD O B-do
96 mg JJ O I-do
96 daily RB O B-f
96 , , O O
96 iron NN B-NP B-m
96 300 CD O B-do
96 mg NN B-NP I-do
96 three CD O B-f
97 times NNS B-NP O
97 a DT B-NP O
97 day NN I-NP O
97 , , O O
97 Hydrochlorothiazide NNP B-NP B-m
97 25 CD O B-do
97 mg JJ O I-do
98 daily RB O B-f
98 , , O O
98 Lisinopril NNP B-NP B-m
98 5 CD O B-do
98 mg JJ O I-do
98 daily RB O B-f
98 , , O O
98 multivitamin PRP O B-m
98 one CD O B-do
98 daily RB O B-f
98 , , O O
98 Relafen NNP B-NP B-m
98 500 CD O B-do
99 mg NN B-NP O
99 orally RB O B-mo
99 a DT B-NP B-f
99 day NN I-NP I-f
99 , , O O
99 Imdur NNP B-NP B-m
99 60 CD O B-do
99 mg NN B-NP I-do
99 orally RB O B-mo
99 a DT B-NP B-f
99 day NN I-NP I-f
99 , , O O
99 Plavix NNP B-NP B-m
99 75 CD O B-do
99 mg NNS B-NP I-do
99 daily RB O B-f
99 for IN B-VP B-du
100 29 CD O O
100 days NNS B-NP O
100 , , O O
100 Lipitor NNP B-NP B-m
100 40 CD O B-do
100 mg JJ O I-do
100 daily RB O B-f
100 , , O O
100 Atenolol NNP B-NP B-m
100 25 CD O B-do
100 mg NN B-NP I-do
100 orally RB O B-mo
100 a DT B-NP B-f
100 day NN I-NP I-f
100 , , O O
101 magnesium NN B-NP B-m
101 oxide RB O I-m
101 420 CD O B-do
101 mg JJ O I-do
101 daily RB O B-f
102 Dictated NNP B-NP O
102 By: NNP I-NP O
102 CLINTON NNP I-NP O
102 DARVILLE NNP I-NP O
102 , , O O
102 M.D NNP B-NP O
102 BE00 NNP I-NP O
103 Attending: NNP I-NP O
103 ARNULFO NNP I-NP O
103 L NNP I-NP O
103 BASNETT NNP I-NP O
103 , , O O
103 M.D NNP B-NP O
103 EG9 NNP I-NP O
104 XQ978/3171 NNP I-NP O
105 Batch: NNP I-NP O
105 60071 CD O O
105 Index NNP B-NP O
105 No NNP I-NP O
105 W7NX6M31MH NNP I-NP O
105 D: NNP I-NP O
105 4/8 CD O O
106 T: NNP B-NP O
106 4/8 CD O O
107 CC: NNP B-NP O
107 1 CD O O
107 ANTIONE NNP B-NP O
107 R NNP I-NP O
107 SULENTIC NNP I-NP O
107 , , O O
107 M.D NNP B-NP O
107 EG9 NNP I-NP O
108 2 CD O O
108 VITO NNP B-NP O
108 B NNP I-NP O
108 LADO NNP I-NP O
108 , , O O
108 M.D NNP B-NP O
108 NY6 NNP I-NP O
109 3 CD O O
109 FOREST NNP B-NP O
109 G NNP I-NP O
109 NICODEMUS NNP I-NP O
109 , , O O
109 M.D NNP B-NP O
109 WZ6 NNP I-NP O
110 4 CD O O
110 DR NNP B-NP O
110 OHRT NNP I-NP O
110 , , O O
110 Ster NNP B-NP O
111 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #652612 VBZ O O
4 148900251 CD O O
4 EMHAHS NNP B-NP O
4 69939492 CD O O
4 0604964 CD O O
4 1/3/2003 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/17/2003 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
7 CHIEF NNP I-NP O
7 COMPLAINT: NNP I-NP O
7 At IN B-VP O
7 the DT B-NP O
7 time NN I-NP O
7 of IN B-VP O
7 admission NN B-NP O
7 , , O O
7 altered VBD B-VP O
7 mental JJ B-NP O
7 status NN I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 Patient NNP I-NP O
8 is VBZ O O
8 a DT B-NP O
8 73-year-old JJ I-NP O
8 man NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 prior JJ B-NP O
9 delirious JJ I-NP O
9 episodes NNS I-NP O
9 as RB O O
10 well RB O O
10 as IN B-VP O
10 a DT B-NP O
10 history NN I-NP O
10 of IN B-VP O
10 chronic JJ B-NP O
10 diarrhea NN I-NP O
10 who WP O O
10 , , O O
10 on IN B-VP O
10 the DT B-NP O
10 night NN I-NP O
10 before IN B-VP O
11 admission NN B-NP O
11 , , O O
11 was VBD B-VP O
11 noted VBN O O
11 to TO O O
11 no DT O O
11 longer RBR O O
11 recognize VB O O
11 people NNS B-NP O
11 at IN B-VP O
11 home NN B-NP O
11 and CC O O
11 to TO O O
12 be VB O O
12 confused VBN O O
12 about IN B-VP O
12 his PRP$ O O
12 location NN B-NP O
12 On IN B-VP O
12 the DT B-NP O
12 morning NN I-NP O
12 of IN B-VP O
12 admission NN B-NP O
12 , , O O
12 the DT B-NP O
13 patient NN I-NP O
13 had VBD B-VP O
13 had VBN O O
13 intractable JJ B-NP O
13 explosive JJ I-NP O
13 diarrhea NN I-NP O
13 He PRP O O
13 does VBZ O O
13 have VB O O
13 a DT B-NP O
14 history NN I-NP O
14 of IN B-VP O
14 chronic JJ B-NP O
14 diarrhea NN I-NP O
14 but CC O O
14 the DT B-NP O
14 diarrhea NN I-NP O
14 on IN B-VP O
14 the DT B-NP O
14 date NN I-NP O
14 of IN B-VP O
15 admission NN B-NP O
15 was VBD B-VP O
15 significantly RB O O
15 more RBR O O
15 severe JJ O O
15 than IN B-VP O
15 usual JJ B-NP O
16 REVIEW NNP I-NP O
16 OF NNP I-NP O
16 SYSTEMS: NNP I-NP O
16 The DT B-NP O
16 patient NN I-NP O
16 denied VBD B-VP O
16 any DT B-NP O
16 chest JJS I-NP O
16 pain NN I-NP O
16 , , O O
16 nausea NN B-NP O
16 , , O O
17 vomiting VBG O O
17 , , O O
17 urinary JJ B-NP O
17 tract NN I-NP O
17 infection NN I-NP O
17 , , O O
17 or CC O O
17 decrease NN B-NP O
18 in IN B-VP O
18 his PRP$ O O
18 p.o NN B-NP O
18 intake NN I-NP O
19 PAST NNP I-NP O
19 MEDICAL NNP I-NP O
19 HISTORY: NNP I-NP O
19 Significant NNP I-NP O
19 for IN B-VP O
19 congestive JJ B-NP O
19 heart NN I-NP O
19 failure NN I-NP O
20 with IN B-VP O
20 an DT B-NP O
20 ejection NN I-NP O
20 fraction NN I-NP O
20 of IN B-VP O
20 50% CD O O
20 , , O O
20 coronary JJ B-NP O
21 artery NN I-NP O
21 disease NN I-NP O
21 status NN I-NP O
21 post NN I-NP O
21 five CD O O
21 vessel NN B-NP O
21 coronary JJ B-NP O
21 artery NN I-NP O
21 bypass NN I-NP O
21 graft NN I-NP O
22 in IN B-VP O
22 March NNP B-NP O
22 2002 CD O O
22 , , O O
22 myelodysplastic JJ B-NP O
22 syndrome NN I-NP O
22 , , O O
22 peripheral JJ B-NP O
22 vascular JJ I-NP O
23 disease NN I-NP O
23 , , O O
23 gastrointestinal JJ B-NP O
23 bleed NN I-NP O
23 status NN I-NP O
23 post NN I-NP O
23 right RB O O
23 colectomy NN B-NP O
23 , , O O
24 prostate NN B-NP O
24 cancer NN I-NP O
24 status NN I-NP O
24 post NN I-NP O
24 transurethral JJ B-NP O
24 resection NN I-NP O
24 of IN B-VP O
24 the DT B-NP O
25 prostate NN I-NP O
25 , , O O
25 and CC O O
25 macular JJ B-NP O
25 degeneration NN I-NP O
26 CURRENT NNP I-NP O
26 MEDICATIONS: NNP I-NP O
26 At IN B-VP O
26 the DT B-NP O
26 time NN I-NP O
26 of IN B-VP O
26 admission NN B-NP O
26 included VBD B-VP O
26 opium JJ B-NP B-m
27 tincture NN I-NP O
27 , , O O
27 aspirin NN B-NP B-m
27 , , O O
27 Lomotil NNP B-NP B-m
27 , , O O
27 Lasix NNP B-NP B-m
27 , , O O
27 Ditropan NNP B-NP B-m
27 , , O O
28 Lopid NNP B-NP B-m
28 , , O O
28 Zocor NNP B-NP B-m
28 , , O O
28 Atapryl NNP B-NP B-m
28 , , O O
28 and CC O O
28 iron VB O B-m
29 PHYSICAL NNP B-NP O
29 EXAMINATION: NNP I-NP O
29 At IN B-VP O
29 the DT B-NP O
29 time NN I-NP O
29 of IN B-VP O
29 admission NN B-NP O
29 , , O O
29 patient NN B-NP O
29 was VBD B-VP O
30 afebrile RB O O
30 , , O O
30 his PRP$ O O
30 heart NN B-NP O
30 rate NN I-NP O
30 was VBD B-VP O
30 60 CD O O
30 , , O O
30 his PRP$ O O
30 blood NN B-NP O
31 pressure NN I-NP O
31 was VBD B-VP O
31 145/68 CD O O
31 , , O O
31 and CC O O
31 he PRP O O
31 was VBD B-VP O
31 saturating VBG O O
31 95% CD O O
31 on IN B-VP O
31 room NN B-NP O
31 air NN I-NP O
31 His PRP$ O O
32 physical JJ B-NP O
32 examination NN I-NP O
32 was VBD B-VP O
32 notable JJ O O
32 for IN B-VP O
32 a DT B-NP O
32 jugular JJ I-NP O
32 venous JJ I-NP O
32 pressure NN I-NP O
32 at IN B-VP O
32 5 CD O O
33 cm NN B-NP O
33 , , O O
33 moist VBP O O
33 mucous JJ B-NP O
33 membranes NNS I-NP O
33 , , O O
33 and CC O O
33 soft JJ O O
33 , , O O
33 nontender NN B-NP O
33 , , O O
33 nondistended VBD B-VP O
34 abdominal JJ B-NP O
34 examination NN I-NP O
34 On IN B-VP O
34 rectal JJ B-NP O
34 examination NN I-NP O
34 , , O O
34 the DT B-NP O
34 patient NN I-NP O
34 was VBD B-VP O
35 noted VBN O O
35 to TO O O
35 have VB O O
35 guaiac JJ B-NP O
35 positive JJ I-NP O
35 brown JJ I-NP O
35 stool NN I-NP O
36 LABORATORY NNP I-NP O
36 EXAMINATION: NNP I-NP O
36 Head NNP I-NP O
36 CT NNP I-NP O
36 at IN B-VP O
36 the DT B-NP O
36 time NN I-NP O
36 of IN B-VP O
36 admission NN B-NP O
36 was VBD B-VP O
37 negative JJ O O
37 for IN B-VP O
37 any DT B-NP O
37 acute JJ I-NP O
37 change NN I-NP O
37 , , O O
37 chest JJS B-NP O
37 x-ray NN I-NP O
38 was VBD B-VP O
38 negative JJ O O
38 for IN B-VP O
38 any DT B-NP O
38 evidence NN I-NP O
38 of IN B-VP O
38 pneumonia NN B-NP O
38 , , O O
38 and CC O O
38 the DT B-NP O
38 patient's NN I-NP O
38 EKG NNP I-NP O
39 was VBD B-VP O
39 reviewed VBN O O
39 and CC O O
39 shown VBN O O
39 to TO O O
39 be VB O O
39 without IN B-VP O
39 change NN B-NP O
39 from IN B-VP O
39 prior JJ B-NP O
39 studies NNS I-NP O
40 HOSPITAL NNP I-NP O
40 COURSE: NNP I-NP O
40 1 CD O O
40 Neurological NNP B-NP O
40 - : O O
40 The DT B-NP O
40 patient's JJ I-NP O
40 mental JJ I-NP O
40 status NN I-NP O
41 improved VBD B-VP O
41 quickly RB O O
41 on IN B-VP O
41 admission NN B-NP O
41 As IN B-VP O
41 noted VBN O O
41 above IN B-VP O
41 , , O O
42 his PRP$ O O
42 head NN B-NP O
42 CT NNP I-NP O
42 was VBD B-VP O
42 negative JJ O O
42 It PRP O O
42 was VBD B-VP O
42 thought VBN O O
42 that IN B-VP O
42 his PRP$ O O
42 mental JJ B-NP O
42 status NN I-NP O
43 changes NNS I-NP O
43 were VBD B-VP O
43 likely JJ O O
43 secondary JJ O O
43 to TO O O
43 dehydration NN B-NP O
43 and CC O O
43 were VBD B-VP O
43 resolved VBN O O
43 at IN B-VP O
44 the DT B-NP O
44 time NN I-NP O
44 of IN B-VP O
44 discharge NN B-NP O
45 2 CD O O
45 Pulmonary NNP B-NP O
45 - : O O
45 During IN B-VP O
45 resuscitation NN B-NP O
45 of IN B-VP O
45 the DT B-NP O
45 patient's NN I-NP O
45 dehydration NN I-NP O
45 , , O O
46 he PRP O O
46 developed VBD B-VP O
46 an DT B-NP O
46 O2 NNP I-NP O
46 requirement NN I-NP O
46 although IN B-VP O
46 chest JJ B-NP O
46 x-ray NN I-NP O
46 did VBD B-VP O
46 not RB O O
46 show VB O O
47 any DT B-NP O
47 evidence NN I-NP O
47 for IN B-VP O
47 fluid NN B-NP O
47 overload NN I-NP O
47 or CC O O
47 infiltrates VBZ O O
47 Occasional JJ B-NP O
47 wheezes NNS I-NP B-r
48 were VBD B-VP O
48 appreciated VBN O O
48 on IN B-VP O
48 examination NN B-NP O
48 and CC O O
48 the DT B-NP O
48 patient's NN I-NP O
48 symptoms NNS I-NP O
48 improved VBN O O
49 significantly RB O O
49 with IN B-VP O
49 occasional JJ B-NP B-f
49 nebulizer NN I-NP B-mo
49 treatments NNS I-NP O
49 of IN B-VP O
49 Albuterol NNP B-NP B-m
49 and CC O O
50 Atrovent NNP B-NP B-m
50 At IN B-VP O
50 the DT B-NP O
50 time NN I-NP O
50 of IN B-VP O
50 discharge NN B-NP O
50 , , O O
50 the DT B-NP O
50 patient NN I-NP O
50 was VBD B-VP O
50 oxygenating VBG O O
51 well RB O O
52 3 CD O O
52 Cardiovascular JJ O O
52 - : O O
52 There EX O O
52 were VBD B-VP O
52 no DT B-NP O
52 acute JJ I-NP O
52 cardiac JJ I-NP O
52 issues NNS I-NP O
52 during IN B-VP O
52 this DT B-NP O
53 hospitalization NN I-NP O
53 Patient's NNP I-NP O
53 losartan NN I-NP B-m
53 was VBD B-VP O
53 held VBN O O
53 at IN B-VP O
53 admission NN B-NP O
53 given VBN O O
54 his PRP$ O O
54 acute JJ B-NP O
54 renal JJ I-NP O
54 failure NN I-NP O
54 but CC O O
54 other JJ B-NP O
54 outpatient JJ I-NP B-m
54 medications NNS I-NP I-m
54 were VBD B-VP O
55 continued VBN O O
56 4 CD O O
56 Hematology NNP B-NP O
56 - : O O
56 The DT B-NP O
56 patient NN I-NP O
56 had VBD B-VP O
56 a DT B-NP O
56 history NN I-NP O
56 of IN B-VP O
56 MDS NNP B-NP O
56 and CC O O
56 was VBD B-VP O
56 a DT B-NP O
56 patient NN I-NP O
57 of IN B-VP O
57 Dr NNP B-NP O
57 Boivin NNP I-NP O
57 At IN B-VP O
57 the DT B-NP O
57 time NN I-NP O
57 of IN B-VP O
57 admission NN B-NP O
57 , , O O
57 the DT B-NP O
57 patient's NN I-NP O
57 hematocrit NN I-NP O
58 dropped VBD B-VP O
58 10 CD O O
58 points NNS B-NP O
58 but CC O O
58 was VBD B-VP O
58 thought VBN O O
58 to TO O O
58 be VB O O
58 likely RB O O
58 due JJ O O
58 to TO O O
58 hydration NN B-NP O
59 Since IN B-VP O
59 that DT B-NP O
59 time NN I-NP O
59 , , O O
59 the DT B-NP O
59 patient's NN I-NP O
59 hematocrit NN I-NP O
59 has VBZ O O
59 remained VBN O O
59 stable JJ O O
59 at IN B-VP O
60 35 CD O O
61 5 CD O O
61 Infectious JJ B-NP O
61 disease NN I-NP O
61 - : O O
61 At IN B-VP O
61 the DT B-NP O
61 time NN I-NP O
61 of IN B-VP O
61 admission NN B-NP O
61 , , O O
61 the DT B-NP O
61 patient's NN I-NP O
62 blood NN I-NP O
62 cultures NNS I-NP O
62 , , O O
62 urine JJ B-NP O
62 cultures NNS I-NP O
62 , , O O
62 and CC O O
62 stool NN B-NP O
62 cultures NNS I-NP O
62 were VBD B-VP O
62 all DT B-NP O
63 negative JJ I-NP O
63 Chest NNP I-NP O
63 x-ray NN I-NP O
63 on IN B-VP O
63 March NNP B-NP O
63 , , O O
63 2003 CD O O
63 was VBD B-VP O
63 clear JJ O O
63 It PRP O O
63 was VBD B-VP O
63 felt VBN O O
64 that IN B-VP O
64 the DT O O
64 most RBS O O
64 likely JJ B-NP O
64 etiology NN I-NP O
64 of IN B-VP O
64 his PRP$ O O
64 acute JJ B-NP O
64 worsening NN I-NP O
64 of IN B-VP O
64 his PRP$ O O
65 diarrhea NN B-NP O
65 was VBD B-VP O
65 viral JJ B-NP O
65 gastroenteritis NN I-NP O
65 He PRP O O
65 also RB O O
65 did VBD B-VP O
65 receive VB O O
65 a DT O B-du
65 a DT B-NP B-du
65 7-day JJ I-NP O
66 course NN I-NP O
66 of IN B-VP O
66 levofloxacin NN B-NP B-m
66 and CC O O
66 Flagyl NNP B-NP B-m
66 for IN B-VP O
66 empiric JJ B-NP B-r
66 empiric JJ I-NP B-r
66 abdominal JJ I-NP I-r
66 abdominal JJ I-NP I-r
66 coverage NN I-NP I-r
66 coverage NN I-NP I-r
67 The DT B-NP O
67 patient NN I-NP O
67 remained VBD B-VP O
67 afebrile JJ O O
67 since IN B-VP O
67 the DT B-NP O
67 time NN I-NP O
67 of IN B-VP O
67 his PRP$ O O
67 antibiotics NNS B-NP B-m
68 6 CD O O
68 Gastrointestinal NNP B-NP O
68 - : O O
68 The DT B-NP O
68 patient NN I-NP O
68 is VBZ O O
68 status NN B-NP O
68 post NN I-NP O
68 right RB O O
69 hemicolectomy NN B-NP O
69 He PRP O O
69 has VBZ O O
69 a DT B-NP O
69 long JJ I-NP O
69 history NN I-NP O
69 of IN B-VP O
69 diarrhea NN B-NP O
69 and CC O O
69 presented VBN O O
69 to TO O O
70 this DT B-NP O
70 admission NN I-NP O
70 with IN B-VP O
70 explosive JJ B-NP B-r
70 explosive JJ I-NP B-r
70 diarrhea NN I-NP I-r
70 diarrhea NN I-NP I-r
70 and CC O O
70 guaiac JJ B-NP B-r
70 guaiac NN I-NP B-r
70 positive JJ B-NP O
70 brown JJ I-NP O
71 stool NN I-NP O
71 At IN B-VP O
71 the DT B-NP O
71 time NN I-NP O
71 of IN B-VP O
71 admission NN B-NP O
71 , , O O
71 Kaopectate NNP B-NP B-m
71 Kaopectate NNP I-NP B-m
71 and CC O O
71 Lomotil NNP B-NP B-m
71 Lomotil NNP I-NP B-m
71 were VBD B-VP O
72 started VBN O O
72 On IN B-VP O
72 August NNP B-NP O
72 , , O O
72 2003 CD O O
72 , , O O
72 he PRP O O
72 was VBD B-VP O
72 noted VBN O O
72 to TO O O
72 have VB O O
72 increased VBN O O
73 distention NN B-NP O
73 but CC O O
73 a DT B-NP O
73 KUB NNP I-NP O
73 was VBD B-VP O
73 negative JJ O O
73 at IN B-VP O
73 that DT B-NP O
73 time NN I-NP O
73 for IN B-VP O
73 partial JJ B-NP O
74 obstruction NN I-NP O
74 or CC O O
74 impaction NN B-NP O
74 There EX O O
74 were VBD B-VP O
74 concerns NNS B-NP O
74 that IN B-VP O
74 the DT B-NP O
74 patient's JJ I-NP O
75 abdominal JJ I-NP O
75 symptoms NNS I-NP O
75 might MD O O
75 be VB O O
75 secondary JJ O O
75 to TO O O
75 ischemia VB O O
75 so RB O O
75 an DT B-NP O
75 MRI NNP I-NP O
75 was VBD B-VP O
76 obtained VBN O O
76 which WDT O O
76 showed VBD B-VP O
76 proximal JJ B-NP O
76 disease NN I-NP O
76 in IN B-VP O
76 the DT B-NP O
76 SMA NNP I-NP O
76 , , O O
76 IMA NNP B-NP O
76 , , O O
76 and CC O O
76 celiac NN B-NP O
77 but CC O O
77 overall JJ O O
77 with IN B-VP O
77 good JJ B-NP O
77 distal NN I-NP O
77 flow NN I-NP O
77 An DT B-NP O
77 abdominal JJ I-NP O
77 CT NNP I-NP O
77 was VBD B-VP O
77 obtained VBN O O
78 which WDT O O
78 showed VBD B-VP O
78 a DT B-NP O
78 thick JJ I-NP O
78 small JJ I-NP O
78 bowel NN I-NP O
78 and CC O O
78 dilated VBD B-VP O
78 gallbladder NN B-NP O
78 with IN B-VP O
79 stranding VBG O O
79 but CC O O
79 no DT B-NP O
79 evidence NN I-NP O
79 for IN B-VP O
79 ischemia JJ B-NP O
79 Gastrointestinal NNP I-NP O
80 consultation NN I-NP O
80 was VBD B-VP O
80 obtained VBN O O
80 and CC O O
80 on IN B-VP O
80 June NNP B-NP O
80 , , O O
80 2003 CD O O
80 , , O O
80 and CC O O
81 esophagogastroduodenoscopy NN B-NP O
81 was VBD B-VP O
81 performed VBN O O
81 which WDT O O
81 revealed VBD B-VP O
81 grade NN B-NP B-r
81 IV NNP I-NP O
82 gastritis NN I-NP O
82 As IN B-VP O
82 a DT B-NP O
82 result NN I-NP O
82 , , O O
82 the DT B-NP O
82 patient NN I-NP O
82 was VBD B-VP O
82 started VBN O O
82 on IN B-VP O
82 Nexium NN B-NP B-m
82 40 CD O B-do
83 b.i.d NN B-NP B-f
84 7 CD O O
84 Renal NNP B-NP O
84 - : O O
84 The DT B-NP O
84 patient NN I-NP O
84 has VBZ O O
84 a DT B-NP O
84 history NN I-NP O
84 of IN B-VP O
84 chronic JJ B-NP O
84 renal JJ I-NP O
85 insufficiency NN I-NP O
85 The DT B-NP O
85 entire JJ I-NP O
85 hospitalization NN I-NP O
85 , , O O
85 his PRP$ O O
85 BUN NNP B-NP O
85 was VBD B-VP O
85 in IN B-VP O
85 the DT B-NP O
86 fifties NNS I-NP O
86 with IN B-VP O
86 a DT B-NP O
86 creatinine NN I-NP O
86 of IN B-VP O
86 2.2 CD O O
86 His PRP$ O O
86 FENA NNP B-NP O
86 was VBD B-VP O
86 less JJR O O
86 than IN B-VP O
86 0.1% CD O O
86 and CC O O
87 the DT B-NP O
87 patient NN I-NP O
87 was VBD B-VP O
87 thought VBN O O
87 to TO O O
87 be VB O O
87 extremely RB O O
87 intervascularly JJ O O
87 dry JJ O O
87 With IN B-VP O
88 gentle JJ B-NP O
88 hydration NN I-NP O
88 , , O O
88 the DT B-NP O
88 patient's NN I-NP O
88 creatinine NN I-NP O
88 eventually RB O O
88 improved VBN O O
88 to TO O O
89 1.9 CD O O
89 at IN B-VP O
89 the DT B-NP O
89 time NN I-NP O
89 of IN B-VP O
89 this DT B-NP O
89 dictation NN I-NP O
90 OPERATIONS NNP I-NP O
90 AND NNP I-NP O
90 PROCEDURES: NNP I-NP O
90 Included NNP I-NP O
90 esophagogastroduodenoscopy NN I-NP O
91 revealing VBG O O
91 gastritis NN B-NP O
91 as IN B-VP O
91 discussed VBN O O
91 above IN B-VP O
92 DISPOSITION: NNP B-NP O
92 Diet NNP I-NP O
92 includes VBZ O O
92 that IN B-VP O
92 the DT B-NP O
92 patient NN I-NP O
92 is VBZ O O
92 discharged VBN O O
92 on IN B-VP O
92 a DT B-NP O
93 full JJ I-NP O
93 p.o NN I-NP O
93 diet NN I-NP O
93 He PRP O O
93 was VBD B-VP O
93 also RB O O
93 instructed VBN O O
93 to TO O O
93 supplement VB O O
94 his PRP$ O O
94 diet NN B-NP O
94 with IN B-VP O
94 high JJ B-NP O
94 nutrition NN I-NP O
94 Boost NNP I-NP O
94 shakes VBZ O O
94 Nutrition NNP B-NP O
94 followed VBD B-VP O
94 the DT B-NP O
95 patient NN I-NP O
95 closely RB O O
95 during IN B-VP O
95 the DT B-NP O
95 admission NN I-NP O
95 and CC O O
95 thought VBD B-VP O
95 that IN B-VP O
95 he PRP O O
95 would MD O O
95 need VB O O
96 close RB O O
96 follow-up JJ O O
96 as IN B-VP O
96 an DT B-NP O
96 outpatient NN I-NP O
96 for IN B-VP O
96 his PRP$ O O
96 nutrition NN B-NP O
96 status NN I-NP O
97 DISCHARGE NNP I-NP O
97 MEDICATIONS: NNP I-NP O
97 Will MD O O
97 be VB O O
97 dictated VBN O O
97 in IN B-VP O
97 an DT B-NP O
97 Addendum NNP I-NP O
97 to TO O O
97 this DT B-NP O
98 Discharge NNP I-NP O
98 Summary NNP I-NP O
99 FOLLOW-UP: NNP I-NP O
99 The DT B-NP O
99 patient NN I-NP O
99 will MD O O
99 follow-up VB O O
99 with IN B-VP O
99 Dr NNP B-NP O
99 Venzor NNP I-NP O
99 following VBG O O
100 discharge NN B-NP O
101 Dictated NNP I-NP O
101 By: NNP I-NP O
101 LUCIO NNP I-NP O
101 MAN NNP I-NP O
101 GRAMS NNP I-NP O
101 , , O O
101 M.D NNP B-NP O
101 VM675 NNP I-NP O
102 Attending: NNP I-NP O
102 ERASMO NNP I-NP O
102 N NNP I-NP O
102 MATHUR NNP I-NP O
102 , , O O
102 M.D NNP B-NP O
102 NI4 NNP I-NP O
102 OG097/562852 NNP I-NP O
103 Batch: NNP I-NP O
103 0836 CD O O
103 Index NNP B-NP O
103 No NNP I-NP O
103 OUHR0Y5GN5 NNP I-NP O
103 D: NNP I-NP O
103 3/28/03 CD O O
104 T: NNP B-NP O
104 3/28/03 CD O O
105 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #654297 VBZ O O
4 242524874 CD O O
4 LMH NNP B-NP O
4 52961901 CD O O
4 969014 CD O O
4 2/18/1999 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 RULE NNP I-NP O
4 OUT NNP I-NP O
4 MYOCARDIAL NNP I-NP O
4 INFARCTION NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/18/1999 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/0/1999 CD O O
7 IDENTIFICATION: NNP B-NP O
7 A NNP I-NP O
7 73-year-old JJ B-NP O
7 man NN I-NP O
7 with IN B-VP O
7 a DT B-NP O
7 past JJ I-NP O
7 medical JJ I-NP O
7 history NN I-NP O
8 significant JJ O O
8 for IN B-VP O
8 extensive JJ B-NP O
8 coronary JJ I-NP O
8 artery NN I-NP O
8 disease NN I-NP O
8 , , O O
8 diabetes VBZ O O
8 , , O O
9 hypertension NN B-NP O
9 , , O O
9 hypercholesterolemia NN B-NP O
9 , , O O
9 and CC O O
9 smoking NN B-NP O
9 , , O O
9 who WP O O
9 presents VBZ O O
9 with IN B-VP O
10 chest NN B-NP O
10 pain NN I-NP O
10 , , O O
10 and CC O O
10 is VBZ O O
10 admitted VBN O O
10 for IN B-VP O
10 rule NN B-NP O
10 out IN B-VP O
10 myocardial JJ B-NP O
10 infarction NN I-NP O
11 HISTORY NNP I-NP O
11 OF NNP I-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
11 Mr NNP I-NP O
11 Boyles NNP I-NP O
11 has VBZ O O
11 a DT B-NP O
11 long JJ I-NP O
11 history NN I-NP O
11 of IN B-VP O
12 coronary JJ B-NP O
12 artery NN I-NP O
12 disease NN I-NP O
12 with IN B-VP O
12 a DT B-NP O
12 coronary JJ I-NP O
12 artery NN I-NP O
12 bypass NN I-NP O
12 graft NN I-NP O
12 in IN B-VP O
13 1989 CD O O
13 , , O O
13 left VBD B-VP O
13 internal JJ B-NP O
13 mammary JJ I-NP O
13 artery NN I-NP O
13 to TO O O
13 the DT O O
13 left VBN O O
13 anterior JJ O O
13 descending VBG O O
14 artery NN B-NP O
14 , , O O
14 saphenous JJ B-NP O
14 vein NN I-NP O
14 graft NN I-NP O
14 to TO O O
14 the DT O O
14 diagonal JJ O O
14 one CD O O
14 , , O O
14 saphenous JJ B-NP O
14 vein NN I-NP O
15 graft NN I-NP O
15 to TO O O
15 the DT B-NP O
15 posterior JJ I-NP O
15 descending NN I-NP O
15 artery NN I-NP O
15 , , O O
15 and CC O O
15 saphenous JJ B-NP O
15 vein NN I-NP O
15 graft NN I-NP O
16 to TO O O
16 the DT B-NP O
16 obtuse NN I-NP O
16 marginal JJ B-NP O
16 artery NN I-NP O
16 three CD O O
16 In IN B-VP O
16 1992 CD O O
16 he PRP O O
16 had VBD B-VP O
16 unstable JJ B-NP O
17 angina NN I-NP O
17 , , O O
17 and CC O O
17 catheterization NN B-NP O
17 showed VBD B-VP O
17 that IN B-VP O
17 the DT B-NP O
17 distal JJ I-NP O
17 grafts NNS I-NP O
17 were VBD B-VP O
18 totally RB O O
18 occluded VBN O O
18 He PRP O O
18 had VBD B-VP O
18 a DT B-NP O
18 redo JJ I-NP O
18 coronary JJ I-NP O
18 artery NN I-NP O
18 bypass NN I-NP O
18 graft NN I-NP O
18 with IN B-VP O
19 saphenous JJ B-NP O
19 vein NN I-NP O
19 graft NN I-NP O
19 to TO O O
19 the DT B-NP O
19 posterior JJ I-NP O
19 descending NN I-NP O
19 artery NN I-NP O
19 and CC O O
19 the DT B-NP O
20 left NN I-NP O
20 circumflex NN I-NP O
20 , , O O
20 his PRP$ O O
20 postoperative JJ B-NP O
20 course NN I-NP O
20 being VBG O O
20 complicated VBN O O
20 by IN B-VP O
21 atrial JJ B-NP O
21 fibrillation NN I-NP O
21 In IN B-VP O
21 1996 CD O O
21 , , O O
21 he PRP O O
21 had VBD B-VP O
21 a DT B-NP O
21 non-Q JJ I-NP O
21 wave NN I-NP O
21 myocardial JJ B-NP O
22 infarction NN I-NP O
22 with IN B-VP O
22 a DT B-NP O
22 percutaneous JJ I-NP O
22 transluminal JJ I-NP O
22 coronary JJ I-NP O
22 angioplasty NN I-NP O
22 of IN B-VP O
23 the DT B-NP O
23 saphenous JJ I-NP O
23 vein NN I-NP O
23 graft NN I-NP O
23 to TO O O
23 the DT B-NP O
23 diagonal JJ I-NP O
23 one NN I-NP O
23 , , O O
23 and CC O O
23 saphenous JJ B-NP O
23 vein NN I-NP O
24 graft NN I-NP O
24 to TO O O
24 the DT B-NP O
24 posterior JJ I-NP O
24 descending NN I-NP O
24 artery NN I-NP O
24 In IN B-VP O
24 1997 CD O O
24 , , O O
24 he PRP O O
24 had VBD B-VP O
24 a DT B-NP O
24 repeat NN I-NP O
25 percutaneous JJ B-NP O
25 transluminal JJ I-NP O
25 coronary JJ I-NP O
25 angioplasty NN I-NP O
25 with IN B-VP O
25 an DT B-NP O
25 saphenous JJ I-NP O
26 vein NN I-NP O
26 graft NN I-NP O
26 to TO O O
26 the DT B-NP O
26 diagonal JJ I-NP O
26 one NN I-NP O
26 , , O O
26 and CC O O
26 an DT B-NP O
26 saphenous JJ I-NP O
26 vein NN I-NP O
26 graft NN I-NP O
26 to TO O O
26 the DT B-NP O
27 posterior JJ I-NP O
27 descending NN I-NP O
27 artery NN I-NP O
27 Most RBS O O
27 recently RB O O
27 he PRP O O
27 was VBD B-VP O
27 admitted VBN O O
27 in IN B-VP O
28 March NNP B-NP O
28 of IN B-VP O
28 1999 CD O O
28 with IN B-VP O
28 an DT B-NP O
28 exercise NN I-NP O
28 tolerance NN I-NP O
28 test NN I-NP O
28 mibi NN I-NP O
28 , , O O
28 for IN B-VP O
28 which WDT O O
29 exercise NN B-NP O
29 for IN B-VP O
29 four CD O O
29 minutes NNS B-NP O
29 and CC O O
29 seven CD O O
29 seconds NNS B-NP O
29 he PRP O O
29 had VBD B-VP O
29 inferolateral JJ B-NP O
30 ischemia NN I-NP O
30 Echocardiogram NNP I-NP O
30 showed VBD B-VP O
30 an DT B-NP O
30 left JJ I-NP O
30 ventricular JJ I-NP O
30 ejection NN I-NP O
31 fraction NN I-NP O
31 of IN B-VP O
31 50 CD O O
31 percent NN B-NP O
31 , , O O
31 anterior JJ B-NP O
31 inferior JJ I-NP O
31 posterior JJ I-NP O
31 hypokinesis NN I-NP O
31 , , O O
31 1 CD O O
32 to TO O O
32 2+ CD O O
32 mitral JJ B-NP O
32 regurgitation NN I-NP O
32 , , O O
32 pulmonary JJ B-NP O
32 artery NN I-NP O
32 systolic JJ B-NP O
32 pressure NN I-NP O
32 of IN B-VP O
33 42.0 CD O O
33 millimeters NNS B-NP O
33 of IN B-VP O
33 mercury NN B-NP O
33 plus CC O O
33 right JJ B-NP O
33 atrial JJ I-NP O
33 pressure NN I-NP O
33 of IN B-VP O
33 6 CD O O
34 Catheterization NN B-NP O
34 showed VBD B-VP O
34 100 CD O O
34 percent JJ B-NP O
34 occlusion NN I-NP O
34 of IN B-VP O
34 his PRP$ O O
34 saphenous JJ B-NP O
34 vein NN I-NP O
35 graft NN I-NP O
35 to TO O O
35 the DT O O
35 diagonal JJ O O
35 one CD O O
35 , , O O
35 which WDT O O
35 was VBD B-VP O
35 stented VBN O O
35 His PRP$ O O
35 right JJ B-NP O
35 coronary JJ I-NP O
36 artery NN I-NP O
36 and CC O O
36 diagonal JJ O O
36 one CD O O
36 were VBD B-VP O
36 totally RB O O
36 occluded VBN O O
36 His PRP$ O O
36 left JJ O O
36 anterior JJ O O
37 descending VBG O O
37 artery NN B-NP O
37 was VBD B-VP O
37 95 CD O O
37 percent NN B-NP O
37 His PRP$ O O
37 left JJ B-NP O
37 circumflex NN I-NP O
37 was VBD B-VP O
37 clear JJ O O
38 At IN B-VP O
38 that DT B-NP O
38 time NN I-NP O
38 he PRP O O
38 was VBD B-VP O
38 randomized VBN O O
38 to TO O O
38 the DT B-NP O
38 Airssylv NNP I-NP O
38 Medical NNP I-NP O
38 Center NNP I-NP O
38 trial NN I-NP O
38 At IN B-VP O
38 baseline NN B-NP O
38 , , O O
39 Mr NNP B-NP O
39 Dodwell NNP I-NP O
39 denies VBZ O O
39 exertional JJ B-NP O
39 chest NN I-NP O
39 pain NN I-NP O
39 or CC O O
39 any DT B-NP O
39 angina NN I-NP O
39 He PRP O O
39 does VBZ O O
39 get VB O O
40 short JJ O O
40 of IN B-VP O
40 breath NN B-NP O
40 with IN B-VP O
40 one CD O O
40 flight NN B-NP O
40 of IN B-VP O
40 stairs NNS B-NP O
40 , , O O
40 or CC O O
40 going VBG O O
40 uphill JJ O O
40 for IN B-VP O
40 one CD O O
41 block NN B-NP O
41 He PRP O O
41 gets VBZ O O
41 claudication NN B-NP O
41 after IN B-VP O
41 walking VBG O O
41 three CD O O
41 house NN B-NP O
41 lots NNS I-NP O
42 He PRP O O
42 was VBD B-VP O
42 in IN B-VP O
42 his PRP$ O O
42 usual JJ B-NP O
42 state NN I-NP O
42 of IN B-VP O
42 health NN B-NP O
42 until IN B-VP O
42 one CD O O
42 day NN B-NP O
42 prior RB O O
42 to TO O O
43 admission NN B-NP O
43 when WRB O O
43 he PRP O O
43 noted VBD B-VP O
43 the DT B-NP O
43 onset NN I-NP O
43 of IN B-VP O
43 4/10 CD O O
43 aching VBG O O
43 chest NN B-NP O
43 , , O O
43 shoulder NN B-NP O
43 , , O O
44 and CC O O
44 left VBD B-VP O
44 arm NN B-NP O
44 pain NN I-NP O
44 while IN B-VP O
44 watching VBG O O
44 television NN B-NP O
44 , , O O
44 and CC O O
44 it PRP O O
44 was VBD B-VP O
44 associated VBN O O
45 with IN B-VP O
45 shortness NN B-NP O
45 of IN B-VP O
45 breath NN B-NP O
45 He PRP O O
45 sat VBD B-VP O
45 still RB O O
45 , , O O
45 waited VBD B-VP O
45 for IN B-VP O
45 it PRP O O
45 to TO O O
46 dissipate VB O O
46 At IN B-VP O
46 7:00 CD O O
46 p.m NN B-NP O
46 , , O O
46 he PRP O O
46 took VBD B-VP O
46 one CD O B-do
46 sublingual JJ B-NP B-mo
46 nitroglycerin NN I-NP B-m
46 with IN B-VP O
47 a DT B-NP O
47 decrease NN I-NP O
47 of IN B-VP O
47 pain NN B-NP B-r
47 At IN B-VP O
47 11:00 CD O O
47 p.m NN B-NP O
47 , , O O
47 he PRP O O
47 took VBD B-VP O
47 one CD O B-do
47 sublingual JJ B-NP B-mo
48 nitroglycerin NN I-NP B-m
48 and CC O O
48 went VBD B-VP O
48 to TO O O
48 sleep VB O O
48 before IN B-VP O
48 noting VBG O O
48 no DT B-NP O
48 change NN I-NP O
48 in IN B-VP O
48 the DT B-NP O
49 pain NN I-NP B-r
49 He PRP O O
49 was VBD B-VP O
49 driving VBG O O
49 to TO O O
49 his PRP$ O O
49 appointment NN B-NP O
49 with IN B-VP O
49 Dr NNP B-NP O
49 Stolberg NNP I-NP O
49 , , O O
49 his PRP$ O O
50 primary JJ B-NP O
50 cardiologist NN I-NP O
50 on IN B-VP O
50 the DT B-NP O
50 morning NN I-NP O
50 of IN B-VP O
50 admission NN B-NP O
50 , , O O
50 with IN B-VP O
50 the DT B-NP O
50 return NN I-NP O
51 of IN B-VP O
51 the DT B-NP O
51 chest JJS I-NP O
51 pain NN I-NP O
51 for IN B-VP O
51 one CD O O
51 to TO O O
51 two CD O O
51 minutes NNS B-NP O
51 and CC O O
51 it PRP O O
51 was VBD B-VP O
51 gone VBN O O
52 spontaneously RB O O
52 At IN B-VP O
52 Dr NNP B-NP O
52 Boulanger NNP I-NP O
52 office NN I-NP O
52 , , O O
52 he PRP O O
52 was VBD B-VP O
52 noted VBN O O
52 to TO O O
52 have VB O O
52 new JJ B-NP O
53 lateral JJ I-NP O
53 T NNP I-NP O
53 wave NN I-NP O
53 inversions NNS I-NP O
53 and CC O O
53 was VBD B-VP O
53 sent VBN O O
53 down RB O O
53 to TO O O
53 the DT B-NP O
53 Emergency NNP I-NP O
53 Room NNP I-NP O
54 for IN B-VP O
54 admission NN B-NP O
55 Mr NNP I-NP O
55 Demik NNP I-NP O
55 denies VBZ O O
55 any DT B-NP O
55 associated JJ I-NP O
55 nausea NN I-NP O
55 , , O O
55 vomiting VBG O O
55 , , O O
55 diaphoresis NN B-NP O
55 , , O O
56 exertional JJ O O
56 or CC O O
56 pleuritic JJ B-NP O
56 chest NN I-NP O
56 pain NN I-NP O
56 currently RB O O
56 , , O O
56 fever RB O O
56 , , O O
56 chills NNS B-NP O
56 , , O O
56 or CC O O
57 cough NN B-NP O
57 He PRP O O
57 does VBZ O O
57 report VB O O
57 stable VB O O
57 lower JJR B-NP O
57 extremity NN I-NP O
57 edema NN I-NP O
57 , , O O
57 but CC O O
57 denies VBZ O O
58 orthopnea NN B-NP O
58 , , O O
58 paroxysmal JJ B-NP O
58 nocturnal JJ I-NP O
58 dyspnea NN I-NP O
58 , , O O
58 or CC O O
58 palpitations NNS B-NP O
58 He PRP O O
58 has VBZ O O
59 poor JJ B-NP O
59 exercise NN I-NP O
59 tolerance NN I-NP O
60 His PRP$ O O
60 cardiac JJ B-NP O
60 risk NN I-NP O
60 factors NNS I-NP O
60 include VBP O O
60 the DT B-NP O
60 following: JJ I-NP O
60 Age NNP I-NP O
60 , , O O
60 diabetes VBZ O O
60 , , O O
61 hypertension NN B-NP O
61 , , O O
61 cholesterol NN B-NP O
61 , , O O
61 smoking NN B-NP O
61 , , O O
61 and CC O O
61 family NN B-NP O
61 history NN I-NP O
62 PAST NNP I-NP O
62 MEDICAL NNP I-NP O
62 HISTORY: NNP I-NP O
62 His PRP$ O O
62 past JJ B-NP O
62 medical JJ I-NP O
62 history NN I-NP O
62 is VBZ O O
62 as IN B-VP O
62 follows: JJ O O
62 1 CD O O
63 Hypertension NNP B-NP O
63 2 CD O O
63 Diabetes VBZ O O
63 with IN B-VP O
63 fingersticks NNS B-NP O
63 of IN B-VP O
63 120 CD O O
63 to TO O O
63 160 CD O O
63 at IN B-VP O
64 home NN B-NP O
64 3 CD O O
64 Hypercholesterolemia NNP B-NP O
64 , , O O
64 his PRP$ O O
64 last JJ B-NP O
64 panel NN I-NP O
64 in IN B-VP O
64 November NNP B-NP O
64 of IN B-VP O
64 1999 CD O O
65 with IN B-VP O
65 cholesterol NN B-NP O
65 of IN B-VP O
65 164 CD O O
65 , , O O
65 HDL NNP B-NP O
65 of IN B-VP O
65 31 CD O O
65 , , O O
65 LDL NNP B-NP O
65 of IN B-VP O
65 93 CD O O
65 4 CD O O
65 Atrial JJ B-NP O
66 fibrillation NN I-NP O
66 5 CD O O
66 Chronic NNP B-NP O
66 renal JJ B-NP O
66 insufficiency NN I-NP O
66 6 CD O O
66 Benign NNP B-NP O
67 prostatic JJ B-NP O
67 hypertrophy NN I-NP O
67 7 CD O O
67 Peripheral NNP B-NP O
67 vascular JJ B-NP O
67 disease NN I-NP O
67 , , O O
67 status NN B-NP O
68 post NN I-NP O
68 carotid NN I-NP O
68 endarterectomies NNS I-NP O
68 bilaterally RB O O
68 8 CD O O
68 Status NNP B-NP O
68 post NN I-NP O
69 cholecystectomy NN I-NP O
69 and CC O O
69 inguinal JJ B-NP O
69 hernia NN I-NP O
69 repair NN I-NP O
70 ALLERGIES: NNP I-NP O
70 His PRP$ O O
70 allergies NNS B-NP O
70 include VBP O O
70 Quinaglute NNP B-NP O
70 , , O O
70 lisinopril NN B-NP O
70 , , O O
70 and CC O O
71 verapamil NN B-NP O
71 He PRP O O
71 thinks VBZ O O
71 they PRP O O
71 cause VBP O O
71 gastrointestinal JJ B-NP O
71 upset JJ I-NP O
72 MEDICATIONS: NNP I-NP O
72 His PRP$ O O
72 medications NNS B-NP O
72 include VBP O O
72 the DT O O
72 following: JJ O O
72 1 CD O O
72 Coumadin NNP B-NP B-m
73 5 CD O B-do
73 milligrams NNS B-NP I-do
73 q.d RB O B-f
73 2 CD O O
73 Atenolol NNP B-NP B-m
73 25 CD O B-do
73 milligrams NNS B-NP I-do
73 q.d RB O B-f
73 3 CD O O
73 Mitozalone NNP B-NP B-m
74 5 CD O B-do
74 milligrams NNS B-NP I-do
74 q.d RB O B-f
74 4 CD O O
74 Lasix NNP B-NP B-m
74 160 CD O B-do
74 milligrams NNS B-NP I-do
74 q.d RB O B-f
74 5 CD O O
74 Atorvastatin NNP B-NP B-m
75 20 CD O B-do
75 milligrams NNS B-NP I-do
75 q.h.s RB O B-f
75 6 CD O O
75 K-Dur JJ O B-m
75 60 CD O B-do
75 mEq NN B-NP I-do
75 q.d NN I-NP B-f
75 7 CD O O
75 Rezulin NNP B-NP B-m
75 400 CD O B-do
75 q.d NN B-NP B-f
76 8 CD O O
76 NPH NNP B-NP B-m
76 NPH NNP I-NP B-m
76 34 CD O B-do
76 q.a.m NN B-NP B-f
76 , , O O
76 10 CD O B-do
76 q.p.m NN B-NP B-f
76 , , O O
76 regular JJ B-NP B-m
76 insulin NN I-NP I-m
76 4 CD O B-do
76 q.p.m NN B-NP B-f
76 9 CD O O
77 Finasteride NNP B-NP B-m
77 5 CD O B-do
77 q.d NN B-NP B-f
77 10 CD O O
77 Colchicine NNP B-NP B-m
77 0.6 CD O B-do
77 milligrams NNS B-NP I-do
77 p.r.n VBP O B-f
77 11 CD O O
78 Aspirin NNP B-NP B-m
78 81 CD O B-do
78 milligrams NNS B-NP I-do
78 q.d RB O B-f
78 12 CD O O
78 Restoril NNP B-NP B-m
78 30 CD O B-do
78 milligrams NNS B-NP I-do
78 p.r.n VBP O B-f
79 SOCIAL NNP B-NP O
79 HISTORY: NNP I-NP O
79 He PRP O O
79 occasionally RB O O
79 drinks VBZ O O
79 alcohol NN B-NP O
79 He PRP O O
79 has VBZ O O
79 a DT O O
79 120 CD O O
79 pack NN B-NP O
80 year NN I-NP O
80 smoking VBG O O
80 history NN B-NP O
80 , , O O
80 quit NN B-NP O
80 in IN B-VP O
80 1989 CD O O
80 He PRP O O
80 is VBZ O O
80 a DT B-NP O
80 retired JJ I-NP O
80 machinist NN I-NP O
80 and CC O O
81 lives VBZ O O
81 with IN B-VP O
81 his PRP$ O O
81 wife NN B-NP O
81 of IN B-VP O
81 53 CD O O
81 years NNS B-NP O
82 FAMILY NNP I-NP O
82 HISTORY: NNP I-NP O
82 His PRP$ O O
82 father NN B-NP O
82 died VBD B-VP O
82 of IN B-VP O
82 a DT B-NP O
82 myocardial JJ I-NP O
82 infarction NN I-NP O
82 at IN B-VP O
82 77 CD O O
83 His PRP$ O O
83 sister NN B-NP O
83 had VBD B-VP O
83 a DT B-NP O
83 coronary JJ I-NP O
83 artery NN I-NP O
83 bypass NN I-NP O
83 graft NN I-NP O
83 at IN B-VP O
83 70 CD O O
83 He PRP O O
83 has VBZ O O
83 many JJ O O
84 brother RB O O
84 , , O O
84 one CD O O
84 of IN B-VP O
84 whom WP O O
84 is VBZ O O
84 71 CD O O
84 who WP O O
84 had VBD B-VP O
84 a DT B-NP O
84 myocardial JJ I-NP O
84 infarction NN I-NP O
84 at IN B-VP O
84 44 CD O O
84 , , O O
85 and CC O O
85 one CD O O
85 who WP O O
85 had VBD B-VP O
85 a DT B-NP O
85 coronary JJ I-NP O
85 artery NN I-NP O
85 bypass NN I-NP O
85 graft NN I-NP O
85 at IN B-VP O
85 70 CD O O
86 PHYSICAL NNP B-NP O
86 EXAMINATION: NNP I-NP O
86 On IN B-VP O
86 physical JJ B-NP O
86 examination NN I-NP O
86 in IN B-VP O
86 general JJ O O
86 , , O O
86 he PRP O O
86 is VBZ O O
86 a DT B-NP O
87 pleasant JJ I-NP O
87 elderly JJ I-NP O
87 man NN I-NP O
87 in IN B-VP O
87 no DT B-NP O
87 apparent JJ I-NP O
87 distress NN I-NP O
87 His PRP$ O O
87 vital JJ B-NP O
87 signs NNS I-NP O
87 , , O O
87 his PRP$ O O
88 heart NN B-NP O
88 rate NN I-NP O
88 was VBD B-VP O
88 96 CD O O
88 , , O O
88 blood NN B-NP O
88 pressure NN I-NP O
88 174/64 CD O O
88 , , O O
88 saturating VBG O O
88 95 CD O O
88 percent NN B-NP O
88 on IN B-VP O
89 room NN B-NP O
89 air NN I-NP O
89 He PRP O O
89 had VBD B-VP O
89 carotid VBN O O
89 bruits NNS B-NP O
89 bilaterally RB O O
89 His PRP$ O O
89 lungs NNS B-NP O
89 were VBD B-VP O
90 clear JJ O O
90 His PRP$ O O
90 jugular JJ B-NP O
90 venous JJ I-NP O
90 pressure NN I-NP O
90 was VBD B-VP O
90 less JJR O O
90 than IN B-VP O
90 5.0 CD O O
90 centimeters NNS B-NP O
91 His PRP$ O O
91 PMI NNP B-NP O
91 was VBD B-VP O
91 nonpalpable JJ O O
91 He PRP O O
91 had VBD B-VP O
91 a DT B-NP O
91 regular JJ I-NP O
91 rate NN I-NP O
91 with IN B-VP O
91 a DT O O
91 1/6 CD O O
91 systolic JJ B-NP O
92 ejection NN I-NP O
92 murmur NN I-NP O
92 at IN B-VP O
92 the DT B-NP O
92 left JJ I-NP O
92 upper JJ I-NP O
92 sternal JJ I-NP O
92 border NN I-NP O
92 without IN B-VP O
92 radiation NN B-NP O
93 Extremities NNS I-NP O
93 , , O O
93 he PRP O O
93 had VBD B-VP O
93 a DT B-NP O
93 left JJ I-NP O
93 femoral JJ I-NP O
93 thrill NN I-NP O
93 and CC O O
93 bilateral JJ B-NP O
93 femoral JJ I-NP O
94 bruits NNS I-NP O
94 He PRP O O
94 had VBD B-VP O
94 1+ CD O O
94 dorsalis NNS B-NP O
94 pedis JJ B-NP O
94 pulses NNS I-NP O
94 bilaterally RB O O
94 His PRP$ O O
95 extremities NNS B-NP O
95 were VBD B-VP O
95 warm JJ O O
95 without IN B-VP O
95 edema VBG O O
95 His PRP$ O O
95 neurologic JJ B-NP O
95 examination NN I-NP O
96 was VBD B-VP O
96 non-focal JJ B-NP O
97 LABORATORY NNP I-NP O
97 DATA: NNP I-NP O
97 His PRP$ O O
97 labs NN B-NP O
97 on IN B-VP O
97 admission NN B-NP O
97 were VBD B-VP O
97 significant JJ O O
97 for IN B-VP O
97 a DT B-NP O
97 BUN NNP I-NP O
98 and CC O O
98 creatinine NN B-NP O
98 of IN B-VP O
98 49 CD O O
98 and CC O O
98 1.3 CD O O
98 , , O O
98 hematocrit NN B-NP O
98 of IN B-VP O
98 40.5 CD O O
98 His PRP$ O O
98 urinalysis NN B-NP O
99 was VBD B-VP O
99 normal JJ B-NP O
99 Electrocardiogram NNP I-NP O
99 shows NNS I-NP O
99 sinus VBP O O
99 bradycardia NN B-NP O
99 at IN B-VP O
99 53 CD O O
99 , , O O
99 left VBD B-VP O
100 axis JJ B-NP O
100 deviation NN I-NP O
100 , , O O
100 right JJ B-NP O
100 bundle NN I-NP O
100 branch NN I-NP O
100 block NN I-NP O
100 , , O O
100 no DT B-NP O
100 hypertrophy NN I-NP O
100 , , O O
100 no DT B-NP O
100 Q NNP I-NP O
100 , , O O
101 new JJ B-NP O
101 T NNP I-NP O
101 wave NN I-NP O
101 inversion NN I-NP O
101 in IN B-VP O
101 V4 NNP B-NP O
101 through IN B-VP O
101 V6 NNP B-NP O
101 Chest NNP I-NP O
101 x-ray NN I-NP O
101 was VBD B-VP O
101 clear JJ O O
101 His PRP$ O O
102 Troponin NNP B-NP O
102 was VBD B-VP O
102 0.45 CD O O
102 , , O O
102 CK NNP B-NP O
102 was VBD B-VP O
102 197 CD O O
102 , , O O
102 his PRP$ O O
102 myoglobin NN B-NP O
102 was VBD B-VP O
102 159 CD O O
102 , , O O
102 his PRP$ O O
102 INR NNP B-NP O
102 was VBD B-VP O
103 1.5 CD O O
104 HOSPITAL NNP B-NP O
104 COURSE: NNP I-NP O
104 In IN B-VP O
104 summary JJ O O
104 , , O O
104 this DT O O
104 is VBZ O O
104 a DT B-NP O
104 73-year-old JJ I-NP O
104 man NN I-NP O
104 with IN B-VP O
105 extensive JJ B-NP O
105 coronary JJ I-NP O
105 artery NN I-NP O
105 disease NN I-NP O
105 , , O O
105 who WP O O
105 presents VBZ O O
105 with IN B-VP O
105 one CD O O
105 day NN B-NP O
105 of IN B-VP O
105 his PRP$ O O
106 typical JJ B-NP O
106 anginal JJ I-NP O
106 pain NN I-NP O
106 , , O O
106 multiple JJ B-NP O
106 bruits NNS I-NP O
106 , , O O
106 new JJ B-NP O
106 lateral JJ I-NP O
106 T NNP I-NP O
106 wave NN I-NP O
107 inversions NNS I-NP O
107 , , O O
107 admitted VBN O O
107 for IN B-VP O
107 a DT B-NP O
107 rule NN I-NP O
107 out IN B-VP O
107 myocardial JJ B-NP O
107 infarction NN I-NP O
107 His PRP$ O O
108 hospital NN B-NP O
108 course NN I-NP O
108 by IN B-VP O
108 issue: JJ O O
109 1 CD O O
109 Cardiovascular: NNP B-NP O
109 Mr NNP I-NP O
109 Jinkerson NNP I-NP O
109 was VBD B-VP O
109 catheterized VBN O O
109 on IN B-VP O
109 the DT B-NP O
109 evening NN I-NP O
109 of IN B-VP O
110 admission NN B-NP O
110 , , O O
110 and CC O O
110 he PRP O O
110 was VBD B-VP O
110 found VBN O O
110 to TO O O
110 have VB O O
110 the DT B-NP O
110 following NN I-NP O
110 He PRP O O
110 was VBD B-VP O
110 found VBN O O
110 to TO O O
111 have VB O O
111 a DT B-NP O
111 saphenous JJ I-NP O
111 vein NN I-NP O
111 graft NN I-NP O
111 to TO O O
111 the DT B-NP O
111 diagonal JJ I-NP O
111 one NN I-NP O
111 was VBD B-VP O
111 100 CD O O
111 percent NN B-NP O
112 occluded VBD B-VP O
112 Saphenous NNP B-NP O
112 vein NN I-NP O
112 graft NN I-NP O
112 to TO O O
112 the DT B-NP O
112 posterior JJ I-NP O
112 descending NN I-NP O
112 artery NN I-NP O
113 was VBD B-VP O
113 open JJ O O
113 His PRP$ O O
113 left JJ O O
113 main JJ O O
113 was VBD B-VP O
113 30 CD O O
113 percent NN B-NP O
113 occluded VBD B-VP O
113 His PRP$ O O
113 left JJ O O
114 anterior JJ O O
114 descending VBG O O
114 artery NN B-NP O
114 was VBD B-VP O
114 99 CD O O
114 percent NN B-NP O
114 occluded VBD B-VP O
114 His PRP$ O O
114 diagonal JJ B-NP O
115 one NN I-NP O
115 was VBD B-VP O
115 100 CD O O
115 percent NN B-NP O
115 occluded VBD B-VP O
115 His PRP$ O O
115 left JJ B-NP O
115 circumflex NN I-NP O
115 was VBD B-VP O
115 80 CD O O
115 percent NN B-NP O
116 occluded VBD B-VP O
116 His PRP$ O O
116 left NN B-NP O
116 subclavian NN I-NP O
116 which WDT O O
116 was VBD B-VP O
116 supplying VBG O O
116 his PRP$ O O
116 left JJ B-NP O
117 internal JJ I-NP O
117 mammary JJ I-NP O
117 artery NN I-NP O
117 was VBD B-VP O
117 100 CD O O
117 percent NN B-NP O
117 occluded VBD B-VP O
117 He PRP O O
117 was VBD B-VP O
117 taken VBN O O
118 back RB O O
118 to TO O O
118 the DT B-NP O
118 Catheterization NNP I-NP O
118 Laboratory NNP I-NP O
118 the DT B-NP O
118 next JJ I-NP O
118 day NN I-NP O
118 with IN B-VP O
118 Dr NNP B-NP O
119 Devincenzo NNP I-NP O
119 who WP O O
119 performed VBD B-VP O
119 a DT B-NP O
119 left JJ I-NP O
119 subclavian JJ I-NP O
119 artery NN I-NP O
119 stent NN I-NP O
119 and CC O O
119 also RB O O
119 a DT B-NP O
120 left JJ I-NP O
120 brachial JJ I-NP O
120 artery NN I-NP O
120 angioplasty NN I-NP O
120 Mr NNP I-NP O
120 Maheu NNP I-NP O
120 tolerated VBD B-VP O
120 this DT B-NP O
121 procedure NN I-NP O
121 well RB O O
121 He PRP O O
121 had VBD B-VP O
121 no DT B-NP O
121 return NN I-NP O
121 of IN B-VP O
121 his PRP$ O O
121 chest NN B-NP O
121 pain NN I-NP O
121 after IN B-VP O
121 the DT B-NP O
122 procedure NN I-NP O
122 , , O O
122 and CC O O
122 his PRP$ O O
122 pulses NNS B-NP O
122 remained VBD B-VP O
122 normal JJ O O
122 , , O O
122 he PRP O O
122 had VBD B-VP O
122 no DT B-NP O
122 groin NN I-NP O
123 hematoma NN I-NP O
123 He PRP O O
123 was VBD B-VP O
123 placed VBN O O
123 on IN B-VP O
123 Plavix NNP B-NP B-m
123 He PRP O O
123 also RB O O
123 continued VBD B-VP O
123 his PRP$ O O
123 aspirin NN B-NP B-m
123 , , O O
124 and CC O O
124 his PRP$ O O
124 Coumadin NNP B-NP B-m
124 was VBD B-VP O
124 restarted VBN O O
124 after IN B-VP O
124 the DT B-NP O
124 heparin NN I-NP B-m
124 and CC O O
124 intravenous JJ B-NP B-mo
125 TNG NNP I-NP B-m
125 which WDT O O
125 were VBD B-VP O
125 originally RB O O
125 put VBN O O
125 on IN B-VP O
125 board NN B-NP O
125 to TO O O
125 prevent VB O O
125 arterial JJ B-NP O
125 spasm NN I-NP O
126 after IN B-VP O
126 the DT B-NP O
126 procedure NN I-NP O
126 , , O O
126 were VBD B-VP O
126 discontinued VBN O O
126 His PRP$ O O
126 next JJ B-NP O
126 cardiovascular JJ I-NP O
127 issue NN I-NP O
127 was VBD B-VP O
127 his PRP$ O O
127 blood NN B-NP O
127 pressure NN I-NP O
127 He PRP O O
127 was VBD B-VP O
127 originally RB O O
127 on IN B-VP O
127 atenolol JJ O B-m
127 25 CD O B-do
128 milligrams NNS B-NP O
128 q.d RB O B-f
128 , , O O
128 we PRP O O
128 added VBD B-VP O
128 back RB O O
128 Cozaar NNP B-NP B-m
128 25 CD O B-do
128 milligrams NNS B-NP I-do
128 q.d RB O B-f
128 which WDT O O
128 he PRP O O
129 had VBD B-VP O
129 been VBN O O
129 on IN B-VP O
129 before IN B-VP O
129 admission NN B-NP O
129 and CC O O
129 had VBD B-VP O
129 been VBN O O
129 stopped VBN O O
129 a DT B-NP O
129 month NN I-NP O
129 prior RB O O
130 because IN B-VP O
130 he PRP O O
130 had VBD B-VP O
130 low JJ B-NP O
130 blood NN I-NP O
130 pressure NN I-NP O
130 with IN B-VP O
130 a DT B-NP O
130 systolic NN I-NP O
130 in IN B-VP O
130 the DT O O
130 80s CD O O
131 However RB O O
131 , , O O
131 his PRP$ O O
131 first JJ B-NP O
131 day NN I-NP O
131 here RB O O
131 , , O O
131 his PRP$ O O
131 systolic JJ B-NP O
131 pressure NN I-NP O
131 was VBD B-VP O
131 120 CD O O
131 to TO O O
131 130 CD O O
131 , , O O
132 and CC O O
132 restarted VBD B-VP O
132 it PRP O O
132 He PRP O O
132 had VBD B-VP O
132 no DT B-NP O
132 problems NNS I-NP O
132 with IN B-VP O
132 that DT O O
132 His PRP$ O O
132 blood NN B-NP O
133 pressure NN I-NP O
133 a DT B-NP O
133 few JJ I-NP O
133 days NNS I-NP O
133 after IN B-VP O
133 admission NN B-NP O
133 was VBD B-VP O
133 in IN B-VP O
133 the DT O O
133 150 CD O O
133 to TO O O
133 160 CD O O
133 systolic NN B-NP O
134 over IN B-VP O
134 70 CD O O
134 , , O O
134 and CC O O
134 amlodipine NN B-NP B-m
134 was VBD B-VP O
134 added VBN O O
134 to TO O O
134 his PRP$ O O
134 regimen NNS B-NP O
134 He PRP O O
134 was VBD B-VP O
134 continued VBN O O
135 on IN B-VP O
135 his PRP$ O O
135 outpatient JJ B-NP O
135 doses NNS I-NP O
135 of IN B-VP O
135 Lasix NNP B-NP B-m
135 160 CD O B-do
135 milligrams NNS B-NP I-do
135 q.a.m RB O B-f
135 and CC O O
136 mitozalone RB O B-m
136 5 CD O B-do
136 q.d NN B-NP B-f
136 He PRP O O
136 ruled VBD B-VP O
136 out RP O O
136 for IN B-VP O
136 a DT B-NP O
136 myocardial JJ I-NP O
136 infarction NN I-NP O
137 2 CD O O
137 Renal: NNP B-NP O
137 After IN B-VP O
137 the DT B-NP O
137 first JJ I-NP O
137 catheterization NN I-NP O
137 , , O O
137 Mr NNP B-NP O
137 Ong NNP I-NP O
137 creatinine NN I-NP O
138 went VBD B-VP O
138 from IN B-VP O
138 1.3 CD O O
138 to TO O O
138 1.8 CD O O
138 However RB O O
138 , , O O
138 it PRP O O
138 went VBD B-VP O
138 back RB O O
138 to TO O O
138 1.3 CD O O
138 the DT B-NP O
138 next JJ I-NP O
138 day NN I-NP O
139 After IN B-VP O
139 the DT B-NP O
139 second JJ I-NP O
139 catheterization NN I-NP O
139 it PRP O O
139 went VBD B-VP O
139 up RB O O
139 to TO O O
139 a DT B-NP O
139 peak NN I-NP O
139 of IN B-VP O
139 4.3 CD O O
140 However RB O O
140 , , O O
140 his PRP$ O O
140 urine JJ B-NP O
140 output NN I-NP O
140 remained VBD B-VP O
140 at IN B-VP O
140 100 CD O O
140 to TO O O
140 150 CD O O
140 cc NNS B-NP O
140 an DT B-NP O
140 hour NN I-NP O
140 with IN B-VP O
141 Lasix NNP B-NP B-m
141 Lasix NNP I-NP B-m
141 100 CD O B-do
141 milligrams NNS B-NP I-do
141 intravenous JJ B-NP B-mo
141 p.r.n NNS I-NP B-f
141 , , O O
141 in IN B-VP O
141 addition NN B-NP O
141 to TO O O
141 his PRP$ O O
141 morning NN B-NP O
142 dose NN I-NP O
142 of IN B-VP O
142 160 CD O B-do
142 milligrams NNS B-NP I-do
142 q.a.m RB O B-f
142 , , O O
142 and CC O O
142 he PRP O O
142 was VBD B-VP O
142 given VBN O O
142 normal JJ B-NP O
142 saline NN I-NP O
143 intravenous JJ B-NP B-mo
143 fluids NNS I-NP O
143 to TO O O
143 equalize VB O O
143 his PRP$ O O
143 ins NNS B-NP O
143 and CC O O
143 outs NNS B-NP O
143 He PRP O O
143 did VBD B-VP O
143 not RB O O
143 have VB O O
144 any DT B-NP O
144 signs NNS I-NP O
144 of IN B-VP O
144 cholesterol NN B-NP O
144 emboli NN I-NP O
144 , , O O
144 no DT B-NP O
144 levator NN I-NP O
144 reticularis NN I-NP O
144 , , O O
144 no DT B-NP O
145 eosinophilia NN I-NP O
145 , , O O
145 no DT B-NP O
145 blue NN I-NP O
145 toes VBZ O O
146 3 CD O O
146 Fluids NNP B-NP O
146 , , O O
146 Electrolytes NNP B-NP O
146 , , O O
146 Nutrition: NNP B-NP O
146 He PRP O O
146 had VBD B-VP O
146 a DT B-NP O
146 low JJ I-NP O
146 potassium NN I-NP O
146 on IN B-VP O
146 the DT B-NP O
147 morning NN I-NP O
147 of IN B-VP O
147 admission NN B-NP O
147 with IN B-VP O
147 a DT B-NP O
147 potassium NN I-NP O
147 of IN B-VP O
147 2.7 CD O O
147 because IN B-VP O
147 he PRP O O
147 had VBD B-VP O
147 missed VBN O O
148 his PRP$ O O
148 outpatient JJ B-NP O
148 K-Dur NNP I-NP B-m
148 of IN B-VP O
148 60 CD O B-do
148 mEq NNS B-NP I-do
148 q.d RB O B-f
148 He PRP O O
148 had VBD B-VP O
148 no DT B-NP O
148 symptoms NNS I-NP O
148 , , O O
148 he PRP O O
148 had VBD B-VP O
148 no DT B-NP O
149 electrocardiogram NN I-NP O
149 changes VBZ O O
149 He PRP O O
149 was VBD B-VP O
149 repleted VBN O O
149 throughout IN B-VP O
149 admission NN B-NP O
150 and CC O O
150 was VBD B-VP O
150 kept VBN O O
150 on IN B-VP O
150 his PRP$ O B-do
150 outpatient NN B-NP I-do
150 dose NN I-NP I-do
150 of IN B-VP O
150 K-Dur NNP B-NP B-m
150 and CC O O
150 had VBD B-VP O
150 no DT B-NP O
150 problems NNS I-NP O
151 further RBR O O
151 with IN B-VP O
151 potassium NN B-NP O
151 In IN B-VP O
151 addition NN B-NP O
151 , , O O
151 he PRP O O
151 was VBD B-VP O
151 discharged VBN O O
151 on IN B-VP O
151 a DT O B-do
152 standing VBG O O
152 dose NN B-NP O
152 of IN B-VP O
152 magnesium NN B-NP B-m
152 because IN B-VP O
152 his PRP$ O B-r
152 magnesium NN B-NP I-r
152 was VBD B-VP O
152 routinely RB O O
152 low JJ O O
153 throughout IN B-VP O
153 admission NN B-NP O
153 , , O O
153 on IN B-VP O
153 the DT B-NP O
153 order NN I-NP O
153 of IN B-VP O
153 1.5 CD O O
153 to TO O O
153 1.8 CD O O
154 4 CD O O
154 Hematology: NNP B-NP O
154 On IN B-VP O
154 the DT B-NP O
154 day NN I-NP O
154 after IN B-VP O
154 his PRP$ O O
154 catheterization NN B-NP O
154 , , O O
154 his PRP$ O O
155 hematocrit NN B-NP O
155 dropped VBD B-VP O
155 from IN B-VP O
155 33.0 CD O O
155 to TO O O
155 28.0 CD O O
155 He PRP O O
155 was VBD B-VP O
155 transfused VBN O O
155 two CD O O
155 units NNS B-NP O
156 with IN B-VP O
156 an DT B-NP O
156 appropriate JJ I-NP O
156 bump NN I-NP O
156 back RB O O
156 to TO O O
156 33.0 CD O O
156 He PRP O O
156 tolerated VBD B-VP O
156 this DT O O
156 without IN B-VP O
157 any DT B-NP O
157 problems NNS I-NP O
158 5 CD O O
158 Diabetes: NNP B-NP B-r
158 Diabetes: NNP I-NP B-r
158 He PRP O O
158 was VBD B-VP O
158 maintained VBN O O
158 on IN B-VP O
158 his PRP$ O O
158 outpatient JJ B-NP O
158 regimen NNS I-NP O
158 of IN B-VP O
158 NPH NNP B-NP B-m
158 NPH NNP I-NP B-m
159 30/10 CD O O
159 and CC O O
159 4 CD O B-do
159 regular JJ B-NP I-do
159 q.p.m NN I-NP B-f
159 , , O O
159 and CC O O
159 Rezulin NNP B-NP B-m
159 His PRP$ O O
159 blood NN B-NP O
159 sugars NNS I-NP O
159 were VBD B-VP O
160 maintained VBN O O
160 throughout IN B-VP O
160 admission NN B-NP O
161 6 CD O O
161 Genitourinary: NNP B-NP O
161 He PRP O O
161 was VBD B-VP O
161 maintained VBN O O
161 on IN B-VP O
161 his PRP$ O O
161 finasteride NN B-NP B-m
161 for IN B-VP O
161 benign JJ B-NP B-r
162 prostatic JJ I-NP O
162 hypertrophy NN I-NP O
162 In IN B-VP O
162 addition NN B-NP O
162 , , O O
162 he PRP O O
162 had VBD B-VP O
162 a DT B-NP O
162 biopsy NN I-NP O
162 prior RB O O
162 to TO O O
163 admission NN B-NP O
163 which WDT O O
163 had VBD B-VP O
163 shown VBN O O
163 chronic JJ B-NP B-r
163 prostatitis NN I-NP I-r
163 His PRP$ O O
163 outpatient JJ B-NP O
164 urologist NN I-NP O
164 had VBD B-VP O
164 recommended VBN O O
164 ciprofloxacin RB O B-m
164 500 CD O B-do
164 milligrams NNS B-NP I-do
164 b.i.d VBP O B-f
164 for IN B-VP B-du
165 thirty NN B-NP O
165 days NNS I-NP O
165 Since IN B-VP O
165 the DT B-NP O
165 hospital NN I-NP O
165 does VBZ O O
165 not RB O O
165 carry VB O O
165 ciprofloxacin NN B-NP B-m
165 , , O O
165 we PRP O O
166 put VBD B-VP O
166 him PRP O O
166 on IN B-VP O
166 Levofloxacin NNP B-NP B-m
166 500 CD O B-do
166 milligrams NNS B-NP I-do
166 q.d RB O B-f
166 He PRP O O
166 had VBD B-VP O
166 no DT B-NP O
166 return NN I-NP O
166 of IN B-VP O
167 those DT B-NP O
167 symptoms NNS I-NP O
168 7 CD O O
168 Musculoskeletal: NNP B-NP O
168 On IN B-VP O
168 hospital JJ B-NP O
168 day NN I-NP O
168 number NN I-NP O
168 four CD O O
168 , , O O
168 he PRP O O
168 developed VBD B-VP O
169 excruciating VBG O O
169 point NN B-NP O
169 tenderness NN I-NP O
169 in IN B-VP O
169 the DT B-NP O
169 medial JJ I-NP O
169 aspect NN I-NP O
169 of IN B-VP O
169 his PRP$ O O
169 right JJ B-NP O
170 knee NN I-NP O
170 The DT B-NP O
170 knee NN I-NP O
170 did VBD B-VP O
170 not RB O O
170 appear VB O O
170 swollen NN B-NP O
170 or CC O O
170 red JJ O O
170 , , O O
170 and CC O O
170 he PRP O O
170 had VBD B-VP O
170 no DT B-NP O
170 source NN I-NP O
171 of IN B-VP O
171 trauma NN B-NP O
171 However RB O O
171 , , O O
171 it PRP O O
171 was VBD B-VP O
171 thought VBN O O
171 it PRP O O
171 might MD O O
171 be VB O O
171 a DT B-NP O
171 recrudescence NN I-NP O
171 of IN B-VP O
172 his PRP$ O O
172 gout NN B-NP O
172 The DT B-NP O
172 next JJ I-NP O
172 day NN I-NP O
172 it PRP O O
172 was VBD B-VP O
172 more RBR O O
172 warm JJ O O
172 and CC O O
172 slightly RB O O
172 swollen JJ B-NP O
173 Colchicine NNP I-NP B-m
173 helped VBD B-VP O
173 somewhat RB O O
173 , , O O
173 and CC O O
173 he PRP O O
173 was VBD B-VP O
173 then RB O O
173 put VBN O O
173 on IN B-VP O
173 a DT B-NP O
173 prednisone NN I-NP B-m
174 taper NN I-NP O
174 starting VBG O O
174 at IN B-VP O
174 40 CD O B-do
174 milligrams NNS B-NP I-do
174 and CC O O
174 tolerated VBD B-VP O
174 this DT B-NP O
174 well NN I-NP O
175 DISPOSITION: NNP I-NP O
175 He PRP O O
175 was VBD B-VP O
175 discharged VBN O O
175 to TO O O
175 home NN B-NP O
175 in IN B-VP O
175 stable JJ B-NP O
175 condition NN I-NP O
175 on IN B-VP O
176 March NNP B-NP O
176 , , O O
176 1999 CD O O
176 He PRP O O
176 has VBZ O O
176 follow-up JJ B-NP O
176 appointments NNS I-NP O
176 with IN B-VP O
176 his PRP$ O O
176 primary JJ B-NP O
177 doctor NN I-NP O
177 , , O O
177 Dr NNP B-NP O
177 Eslinger NNP I-NP O
177 , , O O
177 on IN B-VP O
177 November NNP B-NP O
177 , , O O
177 2000 CD O O
177 , , O O
177 his PRP$ O O
177 primary JJ B-NP O
177 cardiologist NN I-NP O
177 , , O O
178 Dr NNP B-NP O
178 Edd NNP I-NP O
178 , , O O
178 on IN B-VP O
178 March NNP B-NP O
178 , , O O
178 1999 CD O O
178 , , O O
178 and CC O O
178 Dr NNP B-NP O
178 Notowich NNP I-NP O
178 who WP O O
178 performed VBD B-VP O
179 the DT B-NP O
179 procedure NN I-NP O
179 on IN B-VP O
179 the DT B-NP O
179 subclavian JJ I-NP O
179 artery NN I-NP O
179 on IN B-VP O
179 March NNP B-NP O
179 , , O O
179 2000 CD O O
180 MEDICATIONS NNP B-NP O
180 ON NNP I-NP O
180 DISCHARGE: NNP I-NP O
180 His PRP$ O O
180 medications NNS B-NP O
180 on IN B-VP O
180 discharge NN B-NP O
180 are VBP O O
180 the DT O O
181 following: JJ O O
181 1 CD O O
181 Cozaar NNP B-NP B-m
181 25 CD O B-do
181 milligrams NNS B-NP I-do
181 q.d RB O B-f
181 2 CD O O
181 Restoril NNP B-NP B-m
181 30 CD O B-do
182 milligrams NNS B-NP O
182 q.d JJ B-NP B-f
182 q.h.s JJ I-NP I-f
182 p.r.n NN I-NP I-f
182 3 CD O O
182 Nitroglycerin NNP B-NP B-m
182 0.4 CD O B-do
182 milligrams NNS B-NP I-do
183 p.r.n VBP O O
183 chest JJS B-NP B-r
183 pain NN I-NP I-r
183 , , O O
183 sublingual JJ O B-mo
183 , , O O
183 may MD O O
183 repeat VB O O
183 times NNS B-NP O
183 three CD O O
183 q.5 NN B-NP O
183 minutes NNS I-NP O
184 4 CD O O
184 Regular JJ B-NP B-m
184 insulin NN I-NP I-m
184 4 CD O B-do
184 units NNS B-NP I-do
184 q.p.m RB O B-f
184 , , O O
184 NPH NNP B-NP B-m
184 NPH NNP I-NP B-m
184 34 CD O B-do
184 units NNS B-NP I-do
184 q.a.m RB O B-f
184 10 CD O B-do
184 units NNS B-NP I-do
185 q.p.m RB O B-f
185 5 CD O O
185 Rezulin NNP B-NP B-m
185 400 CD O B-do
185 milligrams NNS B-NP I-do
185 q.d RB O B-f
185 6 CD O O
185 Aspirin NNP B-NP B-m
185 81 CD O B-do
185 milligrams NNS B-NP I-do
186 q.d RB O B-f
186 7 CD O O
186 Coumadin NNP B-NP B-m
186 5 CD O B-do
186 milligrams NNS B-NP I-do
186 q.d RB O B-f
186 8 CD O O
186 Clopidogrel NNP B-NP B-m
186 75 CD O B-do
186 milligrams NNS B-NP I-do
187 q.d RB O B-f
187 9 CD O O
187 Magnesium NNP B-NP B-m
187 oxide RB O I-m
187 280 CD O B-do
187 milligrams NNS B-NP I-do
187 q.d RB O B-f
187 10 CD O O
187 Colchicine NNP B-NP B-m
187 0.6 CD O B-do
188 milligrams NNS B-NP O
188 p.r.n VBP O B-f
188 11 CD O O
188 K-Dur JJ O B-m
188 60 CD O B-do
188 mEq NN B-NP I-do
188 q.d NN I-NP B-f
188 12 CD O O
188 Lasix NNP B-NP B-m
188 160 CD O B-do
189 milligrams NNS B-NP O
189 q.d RB O B-f
189 13 CD O O
189 Mitozalone NNP B-NP B-m
189 5 CD O B-do
189 milligrams NNS B-NP I-do
189 q.d RB O B-f
189 14 CD O O
189 Atenolol NNP B-NP B-m
190 25 CD O B-do
190 milligrams NNS B-NP I-do
190 q.d RB O B-f
190 15 CD O O
190 Atorvastatin NNP B-NP B-m
190 20 CD O B-do
190 milligrams NNS B-NP I-do
190 q.h.s RB O B-f
190 16 CD O O
191 Finasteride NNP B-NP B-m
191 5 CD O B-do
191 milligrams NNS B-NP I-do
191 q.d RB O B-f
191 17 CD O O
191 Ciprofloxacin NNP B-NP B-m
191 500 CD O B-do
191 milligrams NNS B-NP I-do
192 b.i.d RB O B-f
193 Dictated NNP B-NP O
193 By: NNP I-NP O
193 BEAU NNP I-NP O
193 GROOMES NNP I-NP O
193 , , O O
193 M.D NNP B-NP O
193 ZT84 NNP I-NP O
194 Attending: NNP I-NP O
194 KRIS NNP I-NP O
194 N NNP I-NP O
194 DEASE NNP I-NP O
194 , , O O
194 M.D NNP B-NP O
194 VI5 NNP I-NP O
194 NF166/9758 NNP I-NP O
195 Batch: NNP I-NP O
195 68854 CD O O
195 Index NNP B-NP O
195 No NNP I-NP O
195 S4CL2C19K0 NNP I-NP O
195 D: NNP I-NP O
195 8/23/99 CD O O
196 T: NNP B-NP O
196 7/24/99 CD O O
197 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #655922 VBZ O O
2 060262714 CD O O
2 SMC NNP B-NP O
2 34620616 CD O O
2 6090030 CD O O
2 3/4/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 unstable JJ B-NP O
2 angina NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/8/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/25/2004 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 DILEO NNP I-NP O
5 , , O O
5 DOUGLASS NNP B-NP O
5 W NNP I-NP O
5 004-09-86-5 JJ B-NP O
6 O53 NNP I-NP O
6 Room: NNP I-NP O
6 00E-984 JJ B-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 11/23/04 CD O O
8 AT NNP B-NP O
8 04:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 ambulatory NN I-NP O
9 O2 NNP I-NP O
9 sat VBD B-VP O
9 &gt;90% NNP B-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 KLOKE NNP I-NP O
11 , , O O
11 BRADLEY NNP B-NP O
11 RICHIE NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ENTERIC NNP I-NP B-m
16 COATED NNP I-NP I-m
16 ASA NNP I-NP I-m
16 ( ( O I-m
16 ASPIRIN NNP B-NP I-m
16 ENTERIC NNP I-NP I-m
16 COATED NNP I-NP I-m
16 ) ) O I-m
17 325 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 Alert NNP I-NP O
18 overridden: NNP I-NP O
18 Override NNP I-NP O
18 added VBD B-VP O
18 on IN B-VP O
18 11/10/04 CD O O
18 by IN B-VP O
19 PHELP NNP B-NP O
19 , , O O
19 RYAN NNP B-NP O
19 KENNETH NNP I-NP O
19 , , O O
19 M.D NNP B-NP O
20 on IN B-VP O
20 order NN B-NP O
20 for IN B-VP O
20 ENTERIC NNP B-NP B-m
20 COATED NNP I-NP I-m
20 ASA NNP I-NP I-m
20 PO NNP I-NP B-mo
20 325 CD O B-do
20 MG NNP B-NP I-do
20 QD NNP I-NP B-f
20 ( ( O O
20 ref JJ O O
20 # # O O
21 49885688 CD O O
21 ) ) O O
22 Pt NNP B-NP O
22 has VBZ O O
22 a DT B-NP O
22 POSSIBLE NNP I-NP O
22 allergy NN I-NP O
22 to TO O O
22 NSAIDs; NNP B-NP O
22 reaction NN I-NP O
22 is VBZ O O
22 Unknown JJ B-NP O
23 Reason NNP I-NP O
23 for IN B-VP O
23 override: NN B-NP O
23 tolerates NNS I-NP O
23 Previous NNP I-NP O
23 Alert NNP I-NP O
23 overridden NNP I-NP O
24 Override NNP I-NP O
24 added VBD B-VP O
24 on IN B-VP O
24 6/18/04 CD O O
24 by IN B-VP O
24 PUCIO NNP B-NP O
24 , , O O
24 JERROLD NNP B-NP O
24 GERMAN NNP I-NP O
24 , , O O
24 M.D NNP B-NP O
25 on IN B-VP O
25 order NN B-NP O
25 for IN B-VP O
25 ENTERIC NNP B-NP B-m
25 COATED NNP I-NP I-m
25 ASA NNP I-NP I-m
25 PO NNP I-NP B-mo
25 325 CD O B-do
25 MG NNP B-NP I-do
25 QD NNP I-NP B-f
25 ( ( O O
25 ref JJ O O
25 # # O O
26 90327323 CD O O
26 ) ) O O
27 Pt NNP B-NP O
27 has VBZ O O
27 a DT B-NP O
27 POSSIBLE NNP I-NP O
27 allergy NN I-NP O
27 to TO O O
27 NSAIDs; NNP B-NP O
27 reaction NN I-NP O
27 is VBZ O O
27 Unknown JJ B-NP O
28 Reason NNP I-NP O
28 for IN B-VP O
28 override: NN B-NP O
28 has VBZ O O
28 tolerated VBN O O
28 Previous NNP B-NP O
28 override IN B-VP O
28 reason: JJ B-NP O
29 Override NNP I-NP O
29 added VBD B-VP O
29 on IN B-VP O
29 5/24/04 CD O O
29 by IN B-VP O
29 SWENK NNP B-NP O
29 , , O O
29 RILEY NNP B-NP O
29 RICKY NNP I-NP O
29 , , O O
29 M.D NNP B-NP O
29 , , O O
29 PH.D NNP B-NP O
30 on IN B-VP O
30 order NN B-NP O
30 for IN B-VP O
30 ECASA NNP B-NP B-m
30 PO NNP I-NP B-mo
30 325 CD O B-do
30 MG NNP B-NP I-do
30 QD NNP I-NP B-f
30 ( ( O O
30 ref JJ O O
30 # # O O
30 57541802 CD O O
30 ) ) O O
31 Pt NNP B-NP O
31 has VBZ O O
31 a DT B-NP O
31 POSSIBLE NNP I-NP O
31 allergy NN I-NP O
31 to TO O O
31 NSAIDs; NNP B-NP O
31 reaction NN I-NP O
31 is VBZ O O
31 Unknown JJ B-NP O
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: JJ B-NP O
32 patient NN I-NP O
32 takes VBZ O O
32 at IN B-VP O
32 home NN B-NP O
33 INSULIN NNP I-NP B-m
33 INSULIN NNP I-NP B-m
33 INSULIN NNP I-NP B-m
33 INSULIN NNP I-NP B-m
33 NPH NNP I-NP I-m
33 NPH NNP I-NP I-m
33 NPH NNP I-NP I-m
33 NPH NNP I-NP I-m
33 HUMAN NNP I-NP I-m
33 HUMAN NNP I-NP I-m
33 HUMAN NNP I-NP I-m
33 HUMAN NNP I-NP I-m
33 36 CD O B-do
33 UNITS NNP B-NP I-do
33 QAM; NNP I-NP B-f
33 QAM; NNP I-NP B-f
33 40 CD O B-do
33 UNITS NNP B-NP I-do
33 QPM NNP I-NP B-f
33 SC NNP I-NP B-mo
34 36 CD O B-do
34 UNITS NNP B-NP I-do
34 QAM NNP I-NP O
34 40 CD O B-do
34 UNITS NNP B-NP I-do
34 QPM NNP I-NP B-f
35 NEURONTIN NNP I-NP B-m
35 ( ( O I-m
35 GABAPENTIN NNP B-NP I-m
35 ) ) O I-m
35 600 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 BID NNP I-NP B-f
36 PLAVIX NNP I-NP B-m
36 ( ( O I-m
36 CLOPIDOGREL NNP B-NP I-m
36 ) ) O I-m
36 75 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 QD NNP I-NP B-f
37 ZETIA NNP I-NP B-m
37 ( ( O I-m
37 EZETIMIBE NNP B-NP I-m
37 ) ) O I-m
37 10 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
38 LISINOPRIL NNP I-NP B-m
38 40 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 QD NNP I-NP B-f
39 HYDROCHLOROTHIAZIDE NNP I-NP B-m
39 25 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 QD NNP I-NP B-f
40 PREVACID NNP I-NP B-m
40 ( ( O I-m
40 LANSOPRAZOLE NNP B-NP I-m
40 ) ) O I-m
40 30 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 GLUCOPHAGE NNP I-NP B-m
41 ( ( O I-m
41 METFORMIN NNP B-NP I-m
41 ) ) O I-m
41 1 CD O B-do
41 , , O I-do
41 000 CD O I-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 BID NNP I-NP B-f
42 IBUPROFEN NNP I-NP B-m
42 600-800 JJ B-NP B-do
42 MG NNP I-NP I-do
42 PO NNP I-NP B-mo
42 Q6H NNP I-NP B-f
42 PRN NNP I-NP I-f
42 Pain NNP I-NP B-r
43 Food/Drug NNP I-NP O
43 Interaction NNP I-NP O
43 Instruction NNP I-NP O
43 Take NNP I-NP O
43 with IN B-VP O
43 food NN B-NP O
44 Alert NNP I-NP O
44 overridden: NNP I-NP O
44 Override NNP I-NP O
44 added VBD B-VP O
44 on IN B-VP O
44 11/23/04 CD O O
44 by IN B-VP O
44 : : O O
45 on IN B-VP O
45 order NN B-NP O
45 for IN B-VP O
45 IBUPROFEN NNP B-NP B-m
45 PO NNP I-NP B-mo
45 ( ( O O
45 ref JJ O O
45 # # O O
45 20352570 CD O O
45 ) ) O O
46 Pt NNP B-NP O
46 has VBZ O O
46 a DT B-NP O
46 PROBABLE NNP I-NP O
46 allergy NN I-NP O
46 to TO O O
46 NSAIDs; NNP B-NP O
46 reaction NN I-NP O
46 is VBZ O O
46 Unknown JJ B-NP O
47 Reason NNP I-NP O
47 for IN B-VP O
47 override: NN B-NP O
47 Patient NNP I-NP O
47 has VBZ O O
47 tolerated VBN O O
47 in IN B-VP O
47 past JJ B-NP O
48 Previous NNP I-NP O
48 Alert NNP I-NP O
48 overridden NNP I-NP O
48 Override NNP I-NP O
48 added VBD B-VP O
48 on IN B-VP O
48 11/23/04 CD O O
48 by IN B-VP O
48 : : O O
49 POTENTIALLY NNP B-NP O
49 SERIOUS NNP I-NP O
49 INTERACTION: NNP I-NP O
49 CLOPIDOGREL NNP I-NP B-m
49 BISULFATE NNP I-NP I-m
49 &amp; NNP I-NP O
50 IBUPROFEN NNP I-NP B-m
50 Reason NNP I-NP O
50 for IN B-VP O
50 override: NN B-NP O
50 Monitoring NNP I-NP O
50 HCT NNP I-NP O
51 ATENOLOL NNP I-NP B-m
51 25 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 QD NNP I-NP B-f
52 Instructions: NNP I-NP O
52 take VB O O
52 1/2 CD O O
52 your PRP$ O O
52 regular JJ B-NP O
52 home NN I-NP O
52 dose NN I-NP O
52 until IN B-VP O
52 you PRP O O
53 see VBP O O
53 your PRP$ O O
53 cardiologist/PCP JJ B-NP O
54 DIET: NNP I-NP O
54 House NNP I-NP O
54 / VBD B-VP O
54 Low NNP B-NP O
54 chol/low NN I-NP O
54 sat VBD B-VP O
54 fat JJ B-NP O
55 DIET: NNP I-NP O
55 House NNP I-NP O
55 / NNP I-NP O
55 ADA NNP I-NP O
55 2100 CD O O
55 cals/dy NN B-NP O
56 ACTIVITY: NNP I-NP O
56 Walking NNP I-NP O
56 as IN B-VP O
56 tolerated VBN O O
57 FOLLOW NNP B-NP O
57 UP NNP I-NP O
57 APPOINTMENT( NNP I-NP O
57 S NNP I-NP O
57 ): NNP I-NP O
58 Dr NNP I-NP O
58 Brechbiel NNP I-NP O
58 his PRP$ O O
58 office NN B-NP O
58 will MD O O
58 call VB O O
58 you PRP O O
58 re: JJ B-NP O
58 appointment NN I-NP O
58 in IN B-VP O
58 2 CD O O
58 weeks NNS B-NP O
58 , , O O
59 Dr NNP B-NP O
59 Damms NNP I-NP O
59 's POS O O
59 office NN B-NP O
59 is VBZ O O
59 setting VBG O O
59 up RP O O
59 right JJ B-NP O
59 leg NN I-NP O
59 ultrasound NN I-NP O
59 for IN B-VP O
59 2-4 JJ B-NP O
59 weeks NNS I-NP O
59 , , O O
60 ALLERGY: NNP B-NP O
60 SIMVASTATIN NNP I-NP O
60 , , O O
60 NSAIDs NNP B-NP O
60 , , O O
60 SHELLFISH NNP B-NP O
60 , , O O
60 Codeine NNP B-NP O
61 ADMIT NNP I-NP O
61 DIAGNOSIS: NNP I-NP O
62 unstable JJ B-NP O
62 angina NN I-NP O
63 PRINCIPAL NNP I-NP O
63 DISCHARGE NNP I-NP O
63 DIAGNOSIS NNP I-NP O
63 ;Responsible JJ O O
63 After IN B-VP O
63 Study NNP B-NP O
63 for IN B-VP O
63 Causing NNP B-NP O
63 Admission NNP I-NP O
63 ) ) O O
64 unstable JJ B-NP O
64 angina NN I-NP O
65 OTHER NNP I-NP O
65 DIAGNOSIS;Conditions NNP I-NP O
65 , , O O
65 Infections NNP B-NP O
65 , , O O
65 Complications NNP B-NP O
65 , , O O
65 affecting VBG O O
65 Treatment/Stay NNP B-NP O
66 diabetes NNS I-NP O
66 ( ( O O
66 diabetes NNS B-NP O
66 mellitus VBP O O
66 ) ) O O
66 s/p FW O O
66 stent JJ B-NP O
66 placement NN I-NP O
66 ( ( O O
66 S/P NNP B-NP O
66 angioplasty RB O O
66 ) ) O O
67 high JJ B-NP O
67 cholesterol NN I-NP O
67 ( ( O O
67 elevated VBN O O
67 cholesterol NN B-NP O
67 ) ) O O
67 htn NN B-NP O
68 ( ( O O
68 hypertension NN B-NP O
68 ) ) O O
68 fibromyalgia NN B-NP O
68 ( ( O O
68 fibromyalgia NN B-NP O
68 ) ) O O
68 gallstones NNS B-NP O
68 ( ( O O
68 biliary JJ B-NP O
68 stones NNS I-NP O
68 ) ) O O
69 OPERATIONS NNP B-NP O
69 AND NNP I-NP O
69 PROCEDURES: NNP I-NP O
70 6/18/04 CD O O
70 Cardiac NNP B-NP O
70 cath NN I-NP O
71 OTHER NNP I-NP O
71 TREATMENTS/PROCEDURES NNP I-NP O
71 ( ( O O
71 NOT NNP B-NP O
71 IN NNP I-NP O
71 O.R NNP I-NP O
71 ) ) O O
72 none NN B-NP O
73 BRIEF NNP I-NP O
73 RESUME NNP I-NP O
73 OF NNP I-NP O
73 HOSPITAL NNP I-NP O
73 COURSE: NNP I-NP O
74 64 CD O O
74 y/o NN B-NP O
74 F NNP I-NP O
74 w/ NN I-NP O
74 DM NNP I-NP O
74 , , O O
74 CAD NNP B-NP O
74 s/p VBD B-VP O
74 OM1 NNP B-NP O
74 stent NN I-NP O
74 '99 NN I-NP O
74 , , O O
74 w/ RB O O
74 1 CD O O
74 month NN B-NP O
74 h/o NN I-NP O
74 worsened VBD B-VP O
75 exertional JJ B-NP O
75 angina NN I-NP O
75 ( ( O O
75 jaw JJ B-NP O
75 tightness NN I-NP O
75 ) ) O O
75 , , O O
75 and CC O O
75 2 CD O O
75 day NN B-NP O
75 h/o VBD B-VP O
75 worsening VBG O O
76 intermittent JJ B-NP O
76 jaw NN I-NP O
76 pain NN I-NP O
76 , , O O
76 SOB NNP B-NP O
76 , , O O
76 presented VBD B-VP O
76 after IN B-VP O
76 2nd CD O O
76 episode NN B-NP O
76 of IN B-VP O
76 pain NN B-NP O
76 at IN B-VP O
76 rest NN B-NP O
77 to TO O O
77 G NNP B-NP O
77 ED NNP I-NP O
77 Initial NNP I-NP O
77 enzymes NNS I-NP O
77 were VBD B-VP O
77 negative JJ O O
77 , , O O
77 patient NN B-NP O
77 was VBD B-VP O
77 heparinized VBN O O
77 for IN B-VP O
78 EKG NNP B-NP O
78 changes NNS I-NP O
78 and CC O O
78 transferred VBD B-VP O
78 to TO O O
78 PMBMC NNP B-NP O
78 ED NNP I-NP O
78 where WRB O O
78 B-set NNP B-NP O
78 TnI NNP I-NP O
78 positive; NN I-NP O
78 TWI NNP I-NP O
79 in IN B-VP O
79 anterior JJ B-NP O
79 leads NNS I-NP O
79 Cath NNP I-NP O
79 results NNS I-NP O
79 below IN B-VP O
80 Initial NNP B-NP O
80 exam SYM O O
80 - : O O
80 BP NNP B-NP O
80 140s CD O O
80 , , O O
80 HR NNP B-NP O
80 50s CD O O
80 , , O O
80 afebrile RB O O
80 , , O O
80 soft JJ B-NP O
80 systolic JJ I-NP O
80 murmur NN I-NP O
80 , , O O
80 clear JJ B-NP O
81 lungs NNS I-NP O
81 EKG- NNP I-NP O
81 NSR NNP I-NP O
81 , , O O
81 TWI NNP B-NP O
81 in IN B-VP O
81 anterior JJ B-NP O
81 leads NNS I-NP O
81 , , O O
81 Troponin NNP B-NP O
81 0.67 CD O O
81 , , O O
81 MB NNP B-NP O
81 7.4 CD O O
81 , , O O
81 CK NNP B-NP O
81 303 CD O O
81 , , O O
82 CK NNP B-NP O
82 303 CD O O
82 HCT NNP B-NP O
82 39.1 CD O O
83 PMHx: NNP B-NP O
83 DM NNP I-NP O
83 , , O O
83 CAD NNP B-NP O
83 s/p VBD B-VP O
83 Om1 NNP B-NP O
83 stent NN I-NP O
83 , , O O
83 hyperlipidemia NN B-NP O
83 , , O O
83 HTN NNP B-NP O
83 , , O O
83 fibromyalgia NN B-NP O
83 , , O O
83 s/p NN B-NP O
84 CCY NNP I-NP O
84 , , O O
84 spinal JJ B-NP O
84 stenosis NN I-NP O
84 , , O O
84 obesity NN B-NP O
84 , , O O
84 s/p JJ B-NP O
84 TAH NNP I-NP O
85 **Hospital NNP I-NP O
85 Course** NNP I-NP O
86 CV/HEME: NNP I-NP O
87 Patient NNP I-NP O
87 underwent JJ B-NP O
87 cardiac JJ I-NP O
87 cath NN I-NP O
87 on IN B-VP O
87 6/18/04 CD O O
87 - : O O
87 LAD NN B-NP O
87 90% CD O O
87 lesion NN B-NP O
87 and CC O O
87 OM2 NNP B-NP O
87 99% CD O O
88 lesion NN B-NP O
88 both DT O O
88 successfully RB O O
88 stented VBN O O
88 with IN B-VP O
88 cypher NN B-NP O
88 Remaining VBG O O
88 100% CD O O
88 PDA NNP B-NP O
89 Following NNP I-NP O
89 cath NN I-NP O
89 , , O O
89 patient NN B-NP O
89 had VBD B-VP O
89 bradycardia VBN O O
89 to TO O O
89 20-30's JJ O O
89 in IN B-VP O
89 setting VBG O O
89 of IN B-VP O
90 femoral JJ B-NP O
90 hematoma NN I-NP O
90 BP NNP I-NP B-r
90 initially RB O O
90 measured VBD B-VP O
90 in IN B-VP O
90 60s CD O O
90 , , O O
90 thought VBN O O
90 to TO O O
90 be VB O O
90 vagal JJ O O
90 2/2 CD O O
91 femoral JJ B-NP O
91 hematoma NN I-NP O
91 Received NNP I-NP O
91 atropine NN I-NP B-m
91 x NNP I-NP B-du
91 1 CD O I-du
91 and CC O O
91 Fem NNP B-NP O
91 stop NN I-NP O
91 placed VBD B-VP O
91 over IN B-VP O
91 cath NN B-NP O
92 site NN I-NP O
92 for IN B-VP O
92 compression NN B-NP O
92 - : O O
92 BP NNP B-NP O
92 dropped VBD B-VP O
92 again RB O O
92 with IN B-VP O
92 bradycardia- NN B-NP O
92 transferred VBN O O
93 to TO O O
93 CCU NNP B-NP O
93 and CC O O
93 briefly NN B-NP O
93 on IN B-VP O
93 dopamine NN B-NP B-m
93 CT NNP I-NP O
93 ruled VBD B-VP O
93 out RP O O
93 retroperitoneal JJ B-NP O
94 bleed NN I-NP O
94 Hct NNP I-NP O
94 stable JJ B-NP O
94 Transferred NNP I-NP O
94 back RB O O
94 to TO O O
94 floor NN B-NP O
94 within IN B-VP O
94 24 CD O O
94 hours NNS B-NP O
95 Patient NNP I-NP O
95 also RB O O
95 noted VBD B-VP O
95 occasional JJ B-NP O
95 mild JJ I-NP O
95 abdominal JJ I-NP O
95 discomfort NN I-NP O
95 , , O O
95 but CC O O
95 had VBD B-VP O
96 negative JJ B-NP O
96 LFTs NNP I-NP O
96 and CC O O
96 lipase NN B-NP O
96 She PRP O O
96 also RB O O
96 noted VBD B-VP O
96 right JJ B-NP O
96 calf NN I-NP O
96 pain NN I-NP O
96 and CC O O
96 was VBD B-VP O
96 found VBN O O
97 to TO O O
97 have VB O O
97 a DT B-NP O
97 below-the JJ I-NP O
97 knee NN I-NP O
97 right JJ B-NP O
97 tibial JJ I-NP O
97 vein NN I-NP O
97 DVT NNP I-NP O
97 , , O O
97 was VBD B-VP O
97 not RB O O
97 anticoagulated VBN O O
98 for IN B-VP O
98 this DT B-NP O
98 below-the JJ I-NP O
98 knee NN I-NP O
98 clot NN I-NP O
98 because IN B-VP O
98 of IN B-VP O
98 low JJ B-NP O
98 risk NN I-NP O
98 of IN B-VP O
98 embolization NN B-NP O
98 and CC O O
98 he PRP O O
99 r VB O O
99 recent JJ B-NP O
99 HCT NNP I-NP B-r
99 drop/hematoma NN I-NP I-r
99 LENI NNP I-NP B-m
99 was VBD B-VP O
99 repeated VBN O O
99 on IN B-VP O
99 day NN B-NP O
99 of IN B-VP O
99 discharge NN B-NP O
100 and CC O O
100 showed VBD B-VP O
100 no DT B-NP O
100 progression NN I-NP O
100 One CD O O
100 the DT O O
100 two CD O O
100 days NNS B-NP O
100 prior RB O O
100 to TO O O
100 admission NN B-NP O
100 , , O O
101 her PRP$ O B-r
101 HCT NNP B-NP I-r
101 dropped VBD B-VP O
101 from IN B-VP O
101 32 CD O O
101 to TO O O
101 26 CD O O
101 , , O O
101 and CC O O
101 she PRP O O
101 was VBD B-VP O
101 trandfused VBN O B-mo
101 2 CD O B-do
101 U NNP B-NP I-do
101 PRBC NNP I-NP B-m
102 w/HCT VBD B-VP O
102 bump NN B-NP O
102 to TO O O
102 34.1 CD O O
102 Repeat NNP B-NP O
102 CT NNP I-NP O
102 showed VBD B-VP O
102 shrinkage NN B-NP O
102 of IN B-VP O
102 hematoma NN B-NP O
102 , , O O
102 so IN B-VP O
103 pt JJ O O
103 is VBZ O O
103 being VBG O O
103 discharged VBN O O
103 with IN B-VP O
103 plans NNS B-NP O
103 to TO O O
103 have VB O O
103 PCP NNP B-NP O
103 recheck VB O O
103 HCT NNP B-NP O
103 at IN B-VP O
103 home NN B-NP O
104 in IN B-VP O
104 2 CD O O
104 days NNS B-NP O
105 MSK: NNP I-NP O
105 Patient NNP I-NP O
105 complained VBD B-VP O
105 of IN B-VP O
105 left JJ B-NP O
105 knee NN I-NP O
105 pain NN I-NP O
105 after IN B-VP O
105 fall NN B-NP O
105 one CD O O
105 week NN B-NP O
105 prior RB O O
106 X-ray NNP B-NP O
106 shoed VBD B-VP O
106 only RB O O
106 osteoarthritis RB O O
106 , , O O
106 although IN B-VP O
106 knee NN B-NP O
106 was VBD B-VP O
106 somewhat RB O O
106 warm JJ O O
107 There EX O O
107 was VBD B-VP O
107 no DT B-NP O
107 clear JJ I-NP O
107 effusion NN I-NP O
107 , , O O
107 so RB O O
107 patient JJ O O
107 is VBZ O O
107 being VBG O O
107 given VBN O O
108 ibuprofen NNS B-NP B-m
108 PRN NNP I-NP B-f
108 for IN B-VP O
108 now RB O O
109 ______ VBZ O O
110 Anti-ischemic JJ B-NP B-m
110 regimen NNS I-NP I-m
110 at IN B-VP O
110 discharge: NN B-NP O
110 ASA NNP I-NP B-m
110 , , O O
110 Plavix NNP B-NP B-m
110 , , O O
110 Atenolol NNP B-NP B-m
110 , , O O
110 Lisinopril NNP B-NP B-m
111 ( ( O O
111 no DT B-NP O
111 Statin NNP I-NP B-m
111 because IN B-VP O
111 of IN B-VP O
111 muscle NN B-NP O
111 pain NN I-NP O
111 hx NN I-NP O
111 ) ) O O
111 Will NNP B-NP O
111 continue VBP O O
111 home NN B-NP O
111 diabetic JJ B-NP B-m
112 regimen NNS I-NP O
112 and CC O O
112 followup NN B-NP O
112 with IN B-VP O
112 PCP/cardiology NNP B-NP O
113 ADDITIONAL NNP I-NP O
113 COMMENTS: NNP I-NP O
113 You PRP O O
113 should MD O O
113 return VB O O
113 to TO O O
113 the DT B-NP O
113 hospital NN I-NP O
113 or CC O O
113 call VB O O
113 your PRP$ O O
113 doctor NN B-NP O
113 if IN B-VP O
113 you PRP O O
113 have VBP O O
113 chest VBN O O
114 pain NN B-NP O
114 or CC O O
114 difficulty NN B-NP O
114 breathing VBG O O
115 Dr NNP B-NP O
115 Estrello NNP I-NP O
115 's POS O O
115 office NN B-NP O
115 will MD O O
115 send VB O O
115 someone NN B-NP O
115 to TO O O
115 your PRP$ O O
115 home NN B-NP O
115 on IN B-VP O
115 Sunday NNP B-NP O
115 3/6 CD O O
115 to TO O O
116 draw VB O O
116 your PRP$ O O
116 blood NN B-NP O
116 levels NNS I-NP O
116 Your VBP O O
116 hematocrit NN B-NP O
116 on IN B-VP O
116 discharge NN B-NP O
116 today NN I-NP O
116 is VBZ O O
116 34.1 CD O O
117 DISCHARGE NNP B-NP O
117 CONDITION: NNP I-NP O
117 Stable NNP I-NP O
118 TO NNP I-NP O
118 DO/PLAN: NNP I-NP O
119 You PRP O O
119 should MD O O
119 have VB O O
119 a DT B-NP O
119 repeat NN I-NP O
119 right JJ B-NP O
119 leg NN I-NP O
119 ultrasound JJ B-NP O
119 test NN I-NP O
119 ( ( O O
119 "LENI" NN B-NP O
119 ) ) O O
119 to TO O O
119 follow VB O O
120 the DT B-NP O
120 small JJ I-NP O
120 blood NN I-NP O
120 clot NN I-NP O
120 in IN B-VP O
120 your PRP$ O O
120 leg NN B-NP O
120 You PRP O O
120 will MD O O
120 need VB O O
120 to TO O O
120 schedule VB O O
120 this DT B-NP O
120 test NN I-NP O
121 to TO O O
121 occur VB O O
121 in IN B-VP O
121 the DT B-NP O
121 next JJ I-NP O
121 3-4 JJ I-NP O
121 weeks NNS I-NP O
121 through IN B-VP O
121 Dr NNP B-NP O
121 Gino NNP I-NP O
121 Onisick NNP I-NP O
121 office NN I-NP O
122 No RB O O
122 dictated VBD B-VP O
122 summary JJ B-NP O
123 ENTERED NNP I-NP O
123 BY: NNP I-NP O
123 MILLISOR NNP I-NP O
123 , , O O
123 JERE NNP B-NP O
123 L NNP I-NP O
123 , , O O
123 M.D NNP B-NP O
123 , , O O
123 M.S NNP B-NP O
123 ( ( O O
123 XD73 NNP B-NP O
123 ) ) O O
123 11/23/04 CD O O
123 @ $ O O
123 05 CD O O
124 ****** JJ B-NP O
124 END NN I-NP O
124 OF NNP I-NP O
124 DISCHARGE NNP I-NP O
124 ORDERS NNP I-NP O
124 ****** NNP I-NP O
125 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #658896 VBZ O O
2 521830719 CD O O
2 BH NNP B-NP O
2 27567873 CD O O
2 628764 CD O O
2 10/27/1995 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 5/25/1995 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/26/1995 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 RIGHT NNP I-NP O
4 BREAST NNP I-NP O
4 ABSCESS NNP I-NP O
5 SIGNIFICANT NNP I-NP O
5 PROBLEMS: NNP I-NP O
5 1 CD O O
5 ) ) O O
5 OBESITY NNP B-NP O
6 2 CD O O
6 ) ) O O
6 DEPRESSION NNP B-NP O
7 3 CD O O
7 ) ) O O
7 HYPERTENSION NNP B-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 The DT B-NP O
8 patient NN I-NP O
8 is VBZ O O
8 a DT B-NP O
8 57 JJ I-NP O
8 year-old JJ I-NP O
8 woman NN I-NP O
9 followed VBN O O
9 by IN B-VP O
9 Dr NNP B-NP O
9 Haggard NNP I-NP O
9 in IN B-VP O
9 the DT B-NP O
9 IWAKE NNP I-NP O
9 HEALTHCARE NNP I-NP O
10 Clinic NNP I-NP O
10 for IN B-VP O
10 problems NNS B-NP O
10 related VBN O O
10 to TO O O
10 obesity NN B-NP O
10 , , O O
10 depression NN B-NP O
10 and CC O O
10 poorly RB O O
11 controlled VBN O O
11 hypertension NN B-NP O
11 In IN B-VP O
11 February NNP B-NP O
11 of IN B-VP O
11 1994 CD O O
11 , , O O
11 she PRP O O
11 complained VBD B-VP O
11 of IN B-VP O
12 right JJ B-NP O
12 breast NN I-NP O
12 tenderness NN I-NP O
12 with IN B-VP O
12 a DT B-NP O
12 palpable JJ I-NP O
12 nodule NN I-NP O
12 A DT B-NP O
12 mammogram NN I-NP O
12 at IN B-VP O
13 that DT B-NP O
13 time NN I-NP O
13 revealed VBD B-VP O
13 mildly RB O O
13 dense JJ B-NP O
13 parenchyma NN I-NP O
13 and CC O O
13 no DT B-NP O
13 calcium NN I-NP O
13 and CC O O
13 an DT B-NP O
14 ultrasound NN I-NP O
14 revealed VBD B-VP O
14 4 CD O O
14 mm NN B-NP O
14 hypoechoic NN I-NP O
14 nodule NN I-NP O
14 compatible JJ B-NP O
14 duct NN I-NP O
15 obstruction NN I-NP O
15 with IN B-VP O
15 debris NN B-NP O
15 Her PRP$ O O
15 symptoms NNS B-NP O
15 of IN B-VP O
15 right JJ B-NP O
15 breast NN I-NP O
15 tenderness NN I-NP O
16 waxed VBD B-VP O
16 and CC O O
16 waned VBD B-VP O
16 and CC O O
16 follow-up JJ B-NP O
16 ultrasound NN I-NP O
16 in IN B-VP O
16 May NNP B-NP O
16 of IN B-VP O
16 1994 CD O O
17 revealed VBD B-VP O
17 a DT O O
17 1 CD O O
17 X NN B-NP O
17 0.5 CD O O
17 cm JJ B-NP O
17 mass NN I-NP O
17 unchanged JJ O O
17 from IN B-VP O
17 the DT O O
17 previous JJ O O
17 ultrasound IN B-VP O
18 She PRP O O
18 was VBD B-VP O
18 advise RB O O
18 to TO O O
18 return VB O O
18 in IN B-VP O
18 three CD O O
18 months NNS B-NP O
18 for IN B-VP O
18 repeat NN B-NP O
18 ultrasound NN I-NP O
18 and CC O O
19 aspiration NN B-NP O
19 In IN B-VP O
19 March NNP B-NP O
19 of IN B-VP O
19 1995 CD O O
19 , , O O
19 she PRP O O
19 had VBD B-VP O
19 a DT B-NP O
19 palpable JJ I-NP O
19 indurated JJ I-NP O
19 area NN I-NP O
19 at IN B-VP O
20 12:00 CD O O
20 on IN B-VP O
20 the DT B-NP O
20 right NN I-NP O
20 breast NN I-NP O
20 She PRP O O
20 was VBD B-VP O
20 seen VBN O O
20 by IN B-VP O
20 Dr NNP B-NP O
20 Noguchi NNP I-NP O
20 in IN B-VP O
20 the DT B-NP O
21 Surgery NNP I-NP O
21 Clinic NNP I-NP O
21 and CC O O
21 scheduled VBN O O
21 for IN B-VP O
21 a DT B-NP O
21 right JJ I-NP O
21 breast NN I-NP O
21 biopsy NN I-NP O
21 , , O O
21 but CC O O
21 because IN B-VP O
22 of IN B-VP O
22 persistent JJ B-NP O
22 hypertension NN I-NP O
22 as IN B-VP O
22 an DT B-NP O
22 outpatient NN I-NP O
22 , , O O
22 she PRP O O
22 is VBZ O O
22 now RB O O
22 admitted VBN O O
23 for IN B-VP O
23 blood NN B-NP O
23 pressure NN I-NP O
23 control NN I-NP O
23 prior RB O O
23 to TO O O
23 the DT B-NP O
23 breast NN I-NP O
23 biopsy NN I-NP O
23 on IN B-VP O
23 November NNP B-NP O
23 , , O O
24 1995 CD O O
25 PAST NNP B-NP O
25 MEDICAL NNP I-NP O
25 HISTORY: NNP I-NP O
25 Significant NNP I-NP O
25 for IN B-VP O
25 1 CD O O
25 ) ) O O
25 Hypertension NN B-NP O
25 , , O O
25 2 CD O O
25 ) ) O O
25 Obesity NN B-NP O
25 , , O O
26 3 CD O O
26 ) ) O O
26 Tobacco NN B-NP O
26 use NN I-NP O
26 , , O O
26 4 CD O O
26 ) ) O O
26 Depression NNP B-NP O
26 , , O O
26 5 CD O O
26 ) ) O O
26 Uterine NNP B-NP O
27 leiomyoma NN I-NP O
27 , , O O
27 6 CD O O
27 ) ) O O
27 Polymyalgia NNP B-NP O
27 rheumatica NN I-NP O
28 MEDICATIONS NNP I-NP O
28 ON NNP I-NP O
28 ADMISSION: NNP I-NP O
28 1 CD O O
28 ) ) O O
28 Lisinopril FW O B-m
28 20 CD O B-do
28 mg NN B-NP I-do
28 p.o NN I-NP B-mo
28 q JJ B-NP B-f
28 day NN I-NP I-f
28 2 CD O O
28 ) ) O O
29 Diltiazem NNP B-NP B-m
29 240 CD O B-do
29 mg NN B-NP I-do
29 p.o NN I-NP B-mo
29 q JJ B-NP B-f
29 day NN I-NP I-f
30 ALLERGIES: NNP I-NP O
30 The DT B-NP O
30 patient NN I-NP O
30 had VBD B-VP O
30 no DT O O
30 known VBN O O
30 drug NN B-NP O
30 allergies NNS I-NP O
31 SOCIAL NNP I-NP O
31 HISTORY: NNP I-NP O
31 Significant NNP I-NP O
31 for IN B-VP O
31 six CD O O
31 children NNS B-NP O
31 She PRP O O
31 is VBZ O O
31 divorced VBN O O
32 She PRP O O
32 has VBZ O O
32 a DT O O
32 40 CD O O
32 pack NN B-NP O
32 year NN I-NP O
32 history NN I-NP O
32 of IN B-VP O
32 smoking NN B-NP O
32 and CC O O
33 denies VBZ O O
33 alcohol NN B-NP O
33 abuse IN B-VP O
34 FAMILY NNP B-NP O
34 HISTORY: NNP I-NP O
34 Positive NNP I-NP O
34 for IN B-VP O
34 hypertension NN B-NP O
34 and CC O O
34 cerebral JJ B-NP O
34 vascular JJ I-NP O
35 disease NN I-NP O
36 PHYSICAL NNP I-NP O
36 EXAMINATION: NNP I-NP O
36 The DT B-NP O
36 patient NN I-NP O
36 is VBZ O O
36 an DT B-NP O
36 obese JJ I-NP O
36 woman NN I-NP O
36 in IN B-VP O
36 no DT B-NP O
36 apparent JJ I-NP O
37 distress NN I-NP O
37 Vital NNP I-NP O
37 signs: VBD B-VP O
37 Blood NNP B-NP O
37 pressure NN I-NP O
38 170/110 CD O O
38 , , O O
38 heart NN B-NP O
38 rate NN I-NP O
38 80 CD O O
38 Her NNP B-NP O
38 pupils NNS I-NP O
38 equal JJ O O
38 , , O O
38 round NN B-NP O
38 and CC O O
38 reactive JJ O O
38 to TO O O
39 light JJ B-NP O
39 Discs NNP I-NP O
39 are VBP O O
39 sharp JJ O O
39 and CC O O
39 there EX O O
39 are VBP O O
39 narrowed JJ B-NP O
39 vessels NNS I-NP O
39 on IN B-VP O
40 fundoscopic NN B-NP O
40 examination NN I-NP O
40 She PRP O O
40 has VBZ O O
40 no DT B-NP O
40 lymphadenopathy NN I-NP O
40 and CC O O
40 no DT B-NP O
40 bruits NNS I-NP O
41 Her PRP$ O O
41 lungs NNS B-NP O
41 are VBP O O
41 clear JJ O O
41 to TO O O
41 auscultation VB O O
41 Her NNP B-NP O
41 right NN I-NP O
41 breast NN I-NP O
41 shows NNS I-NP O
42 indurated VBD B-VP O
42 2 CD O O
42 X NNP B-NP O
42 3 CD O O
42 cm JJ B-NP O
42 mass NN I-NP O
42 just RB O O
42 above IN B-VP O
42 the DT B-NP O
42 right JJ I-NP O
42 nipple NN I-NP O
42 , , O O
42 with IN B-VP O
42 an DT O O
43 overlying VBG O O
43 erythema NN B-NP O
43 which WDT O O
43 is VBZ O O
43 moderately RB O O
43 tender JJ B-NP O
43 Her NNP I-NP O
43 cardiac NN I-NP O
44 examination NN I-NP O
44 reveals VBZ O O
44 a DT B-NP O
44 normal JJ I-NP O
44 S1 NNP I-NP O
44 and CC O O
44 S2 NNP B-NP O
44 and CC O O
44 regular JJ B-NP O
44 rate NN I-NP O
44 and CC O O
44 rhythm NN B-NP O
45 with IN B-VP O
45 a DT O O
45 two CD O O
45 out IN B-VP O
45 of IN B-VP O
45 six CD O O
45 systolic JJ B-NP O
45 ejection NN I-NP O
45 murmur FW O O
45 heard NN B-NP O
45 best JJS O O
45 at IN B-VP O
45 the DT B-NP O
46 left JJ I-NP O
46 upper JJ I-NP O
46 sternal JJ I-NP O
46 border NN I-NP O
46 Her PRP$ O O
46 abdomen NNS B-NP O
46 is VBZ O O
46 obese JJ O O
46 with IN B-VP O
46 a DT B-NP O
46 midline NN I-NP O
47 scar NN I-NP O
47 , , O O
47 positive JJ B-NP O
47 bowel NN I-NP O
47 sounds NNS I-NP O
47 and CC O O
47 no DT B-NP O
47 hepatosplenomegaly NN I-NP O
47 Her PRP$ O O
48 extremities NNS B-NP O
48 revealed VBD B-VP O
48 no DT B-NP O
48 clubbing NN I-NP O
48 , , O O
48 cyanosis NN B-NP O
48 or CC O O
48 edema NN B-NP O
48 and CC O O
48 she PRP O O
48 has VBZ O O
49 diminished VBN O O
49 peripheral JJ B-NP O
49 pulses NNS I-NP O
49 Her PRP$ O O
49 neurological JJ B-NP O
49 examination NN I-NP O
49 is VBZ O O
50 grossly RB O O
50 intact JJ B-NP O
51 LABORATORY: NNP I-NP O
51 On IN B-VP O
51 admission NN B-NP O
51 , , O O
51 her PRP$ O O
51 EKG NNP B-NP O
51 shows VBZ O O
51 normal JJ B-NP O
51 sinus NNS I-NP O
51 rhythm VBP O O
52 without IN B-VP O
52 any DT B-NP O
52 ischemic JJ I-NP O
52 changes NNS I-NP O
52 , , O O
52 unchanged JJ O O
52 from IN B-VP O
52 EKG NNP B-NP O
52 in IN B-VP O
53 July NNP B-NP O
53 of IN B-VP O
53 1992 CD O O
54 HOSPITAL NNP B-NP O
54 COURSE: NNP I-NP O
54 The DT B-NP O
54 patient NN I-NP O
54 was VBD B-VP O
54 admitted VBN O O
54 to TO O O
54 the DT B-NP O
54 General NNP I-NP O
54 Medical NNP I-NP O
55 Service NNP I-NP O
55 and CC O O
55 given VBN O O
55 more RBR O O
55 aggressive JJ B-NP O
55 hypertensive JJ I-NP O
56 medications NNS I-NP O
56 including VBG O O
56 increasing VBG O O
56 her PRP$ O O
56 ACE NNP B-NP B-m
56 inhibitor NN I-NP I-m
56 to TO O O
56 Lisinopril NNP B-NP B-m
56 40 CD O B-do
57 mg NN B-NP O
57 p.o NN I-NP B-mo
57 q JJ B-NP B-f
57 day NN I-NP I-f
57 and CC O O
57 discontinuing VBG O O
57 her PRP$ O O
57 Diltiazem NNP B-NP B-m
57 and CC O O
57 started VBD B-VP O
57 on IN B-VP O
58 Hydrochlorothiazide NNP B-NP B-m
58 25 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 q JJ O B-f
58 daily JJ O I-f
58 and CC O O
58 starting VBG O O
58 Beta NNP B-NP B-m
58 blocker NN I-NP I-m
59 Lopressor NNP I-NP B-m
59 25 CD O B-do
59 mg NN B-NP I-do
59 p.o NN I-NP B-mo
59 q.i.d NN I-NP B-f
59 and CC O O
59 increasing VBG O O
59 as RB O O
59 tolerated VBN O O
59 according VBG O O
60 to TO O O
60 her PRP$ O O
60 blood NN B-NP O
60 pressure NN I-NP O
60 She PRP O O
60 was VBD B-VP O
60 taken VBN O O
60 to TO O O
60 surgery VB O O
60 on IN B-VP O
60 November NNP B-NP O
60 , , O O
60 1995 CD O O
61 The DT B-NP O
61 right JJ I-NP O
61 breast NN I-NP O
61 abscess NN I-NP O
61 was VBD B-VP O
61 drained VBN O O
61 without IN B-VP O
61 incident NN B-NP O
61 Post NNP I-NP O
62 surgery NN I-NP O
62 , , O O
62 she PRP O O
62 was VBD B-VP O
62 started VBN O O
62 on IN B-VP O
62 IV NNP B-NP B-mo
62 antibiotics NNS I-NP B-m
62 which WDT O O
62 included VBD B-VP O
62 Ancef NNP B-NP B-m
62 1 CD O B-do
63 gram NN B-NP O
63 IV NNP I-NP B-mo
63 q RB O B-f
63 8h CD O I-f
63 Other JJ B-NP O
63 notable JJ I-NP O
63 events NNS I-NP O
63 in IN B-VP O
63 the DT B-NP O
63 hospital NN I-NP O
63 included VBD B-VP O
63 a DT B-NP O
64 Psychiatry NNP I-NP O
64 consult NN I-NP O
64 who WP O O
64 suggested VBD B-VP O
64 that IN B-VP O
64 the DT B-NP O
64 patient NN I-NP O
64 had VBD B-VP O
64 a DT B-NP O
64 history NN I-NP O
64 of IN B-VP O
65 major JJ B-NP O
65 depression NN I-NP O
65 and CC O O
65 recommended VBD B-VP O
65 ruling NN B-NP O
65 organic JJ B-NP O
65 brain NN I-NP O
65 disease NN I-NP O
65 A NNP I-NP O
66 polysonography NN I-NP O
66 was VBD B-VP O
66 done VBN O O
66 for IN B-VP O
66 monitoring NN B-NP O
66 of IN B-VP O
66 sleep JJ B-NP O
66 apnea NN I-NP O
66 and CC O O
66 an DT B-NP O
66 MMTI NNP I-NP O
67 for IN B-VP O
67 further JJ B-NP O
67 diagnostic JJ I-NP O
67 evaluation NN I-NP O
67 The DT B-NP O
67 patient NN I-NP O
67 had VBD B-VP O
67 an DT B-NP O
67 uneventful JJ I-NP O
68 postoperative JJ I-NP O
68 course NN I-NP O
68 with IN B-VP O
68 her PRP$ O O
68 blood NN B-NP O
68 pressure NN I-NP O
68 remaining VBG O O
68 moderately RB O O
69 elevated VBN O O
69 and CC O O
69 resolution NN B-NP O
69 of IN B-VP O
69 her PRP$ O O
69 symptoms NNS B-NP O
69 of IN B-VP O
69 right JJ B-NP O
69 breast NN I-NP O
69 tenderness NN I-NP O
70 which WDT O O
70 was VBD B-VP O
70 followed VBN O O
70 by IN B-VP O
70 the DT B-NP O
70 Zonhend NNP I-NP O
70 Manggu NNP I-NP O
70 Community NNP I-NP O
70 Memorial NNP I-NP O
70 Hospital NNP I-NP O
70 Surgical NNP I-NP O
70 Service NNP I-NP O
70 The DT B-NP O
70 patient NN I-NP O
71 was VBD B-VP O
71 discharged VBN O O
71 home NN B-NP O
71 on IN B-VP O
71 Keflex NNP B-NP B-m
71 and CC O O
71 Cephradine NNP B-NP B-m
71 with IN B-VP O
71 follow-up NN B-NP O
71 in IN B-VP O
71 the DT B-NP O
72 TLET NNP I-NP O
72 HOSPITAL NNP I-NP O
72 Clinic NNP I-NP O
72 with IN B-VP O
72 Dr NNP B-NP O
72 Mcgowan NNP I-NP O
72 and CC O O
72 in IN B-VP O
72 a DT B-NP O
72 Hmotmed NNP I-NP O
72 Dell NNP I-NP O
72 An DT B-NP O
72 Community NNP I-NP O
72 Hospital NNP I-NP O
72 Medical NNP I-NP O
72 Service NNP I-NP O
73 MEDICATIONS NNP I-NP O
73 ON NNP I-NP O
73 DISCHARGE: NNP I-NP O
73 1 CD O O
73 ) ) O O
73 Enteric NNP B-NP B-m
73 coated VBD B-VP I-m
73 aspirin RB O I-m
73 325 CD O B-do
73 mg NNS B-NP I-do
73 p.o JJ B-NP B-mo
74 q JJ I-NP B-f
74 day NN I-NP I-f
74 2 CD O O
74 ) ) O O
74 Colace NN B-NP B-m
74 100 CD O B-do
74 mg NN B-NP I-do
74 p.o NN I-NP B-mo
74 b.i.d IN B-VP B-f
75 3 CD O O
75 ) ) O O
75 Hydrochlorothiazide $ O B-m
75 25 CD O B-do
75 mg NN B-NP I-do
75 p.o NN I-NP B-mo
75 q VBD B-VP B-f
75 daily RB O I-f
75 4 CD O O
75 ) ) O O
75 Lisinopril FW O B-m
75 40 CD O B-do
75 mg NN B-NP I-do
76 p.o NN I-NP B-mo
76 q VBD B-VP B-f
76 daily RB O I-f
76 5 CD O O
76 ) ) O O
76 Tylox NNP B-NP B-m
76 1-2 JJ B-NP B-do
76 capsules NNS I-NP I-do
76 p.o VBP O B-mo
76 q JJ B-NP B-f
76 4-6h JJ I-NP I-f
76 p.r.n NN I-NP I-f
76 pain NN I-NP B-r
77 6 CD O O
77 ) ) O O
77 Atenolol $ O B-m
77 100 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
77 q VBD B-VP B-f
77 daily RB O I-f
77 7 CD O O
77 ) ) O O
77 Cephradine NN B-NP B-m
77 100 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
78 q.i.d NN I-NP B-f
78 times NNS I-NP B-du
78 five CD O I-du
78 days NNS B-NP I-du
79 Dictated VBN O O
79 By: NNP B-NP O
79 BURL NNP I-NP O
79 G NNP I-NP O
79 NORLUND NNP I-NP O
79 , , O O
79 M.D NNP B-NP O
79 /D.PHIL NNP I-NP O
79 ZT7 NNP I-NP O
80 Attending: NNP I-NP O
80 EDMUNDO NNP I-NP O
80 Z NNP I-NP O
80 VARGO NNP I-NP O
80 , , O O
80 M.D NNP B-NP O
80 OT63 NNP I-NP O
81 XK927/4459 NNP I-NP O
82 Batch: NNP I-NP O
82 37149 CD O O
82 Index NNP B-NP O
82 No NNP I-NP O
82 LSCARH4YI NNP I-NP O
82 D: NNP I-NP O
82 10/14/96 CD O O
83 T: NNP B-NP O
83 5/17/96 CD O O
84 CC: NNP B-NP O
84 LENARD NNP I-NP O
84 A NNP I-NP O
84 PLUMLEE NNP I-NP O
84 , , O O
84 M.D NNP B-NP O
84 TV63 NNP I-NP O
85 WILBURN NNP I-NP O
85 I PRP O O
85 UXA NNP B-NP O
85 , , O O
85 M.D NNP B-NP O
85 KO36 NNP I-NP O
86 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #661928 VBZ O O
4 457962568 CD O O
4 OMC NNP B-NP O
4 15325194 CD O O
4 7149373 CD O O
4 5/5/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 chf JJ B-NP O
4 exacerbation NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/8/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/1/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 EVANKO NNP I-NP O
8 , , O O
8 BENEDICT NNP B-NP O
8 205-94-27-9 CD O O
9 Dalemilci NNP B-NP O
9 Lake NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 8/4/06 CD O O
11 AT NNP B-NP O
11 11:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 RHATIGAN NNP I-NP O
14 , , O O
14 WENDELL NNP B-NP O
14 E NNP I-NP O
14 E NNP I-NP O
14 M NNP I-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 ATORVASTATIN NNP I-NP B-m
20 80 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 DAILY NNP I-NP B-f
21 COREG NNP I-NP B-m
21 ( ( O I-m
21 CARVEDILOL NNP B-NP I-m
21 ) ) O I-m
21 3.125 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 BID NNP I-NP B-f
22 HOLD NNP I-NP O
22 IF: NNP I-NP O
22 SBP&lt;90 NNP I-NP O
22 or CC O O
22 P&lt;55 NNP B-NP O
23 Instructions: NNP I-NP O
23 if IN B-VP O
23 held VBN O O
23 , , O O
23 please VB O O
23 call VB O O
23 HO NNP B-NP O
24 Food/Drug NNP I-NP O
24 Interaction NNP I-NP O
24 Instruction NNP I-NP O
25 Take NNP I-NP O
25 consistently RB O O
25 with IN B-VP O
25 meals NNS B-NP O
25 or CC O O
25 on IN B-VP O
25 empty JJ B-NP O
25 stomach NN I-NP O
26 Number NNP I-NP O
26 of IN B-VP O
26 Doses NNP B-NP O
26 Required NNP I-NP O
26 ( ( O O
26 approximate JJ B-NP O
26 ): NN I-NP O
26 6 CD O O
27 PLAVIX NNP B-NP B-m
27 ( ( O I-m
27 CLOPIDOGREL NNP B-NP I-m
27 ) ) O I-m
27 75 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 DAILY NNP I-NP B-f
28 LASIX NNP I-NP B-m
28 ( ( O I-m
28 FUROSEMIDE NNP B-NP I-m
28 ) ) O I-m
28 80 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 DAILY NNP I-NP B-f
28 Starting NNP I-NP O
28 IN NNP I-NP O
28 AM NNP I-NP O
28 March NNP I-NP O
29 INSULIN NNP I-NP B-m
29 INSULIN NNP I-NP B-m
29 INSULIN NNP I-NP B-m
29 INSULIN NNP I-NP B-m
29 70/30 CD O I-m
29 70/30 CD O I-m
29 70/30 CD O I-m
29 70/30 CD O I-m
29 HUMAN NNP B-NP I-m
29 HUMAN NNP I-NP I-m
29 HUMAN NNP I-NP I-m
29 HUMAN NNP I-NP I-m
29 50 CD O B-do
29 UNITS NNP B-NP I-do
29 QAM; NNP I-NP B-f
29 35 CD O B-do
29 UNITS NNP B-NP I-do
29 QPM NNP I-NP B-f
29 SC NNP I-NP B-mo
30 50 CD O B-do
30 UNITS NNP B-NP I-do
30 QAM NNP I-NP B-f
30 35 CD O B-do
30 35 CD O I-f
30 UNITS NNP B-NP I-do
30 QPM NNP I-NP B-f
31 IMDUR NNP I-NP B-m
31 ER NNP I-NP I-m
31 ( ( O I-m
31 ISOSORBIDE NNP B-NP I-m
31 MONONITRATE NNP I-NP I-m
31 ( ( O I-m
31 SR NNP B-NP I-m
31 ) ) O I-m
31 ) ) O I-m
31 30 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 DAILY NNP I-NP B-f
32 Starting NNP I-NP O
32 IN NNP I-NP O
32 AM NNP I-NP O
32 March NNP I-NP O
32 Food/Drug NNP I-NP O
32 Interaction NNP I-NP O
32 Instruction NNP I-NP O
33 Give NNP I-NP O
33 on IN B-VP O
33 an DT B-NP O
33 empty JJ I-NP O
33 stomach NN I-NP O
33 ( ( O O
33 give JJ O O
33 1hr CD O O
33 before IN B-VP O
33 or CC O O
33 2hr CD O O
33 after IN B-VP O
34 food NN B-NP O
34 ) ) O O
35 LISINOPRIL NNP B-NP B-m
35 10 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 DAILY NNP I-NP B-f
35 HOLD NNP I-NP O
35 IF: NNP I-NP O
35 SBP NNP I-NP O
35 &lt; NNP I-NP O
35 90 CD O O
35 and CC O O
35 call VB O O
35 HO NNP B-NP O
36 Alert NNP I-NP O
36 overridden: NNP I-NP O
36 Override NNP I-NP O
36 added VBD B-VP O
36 on IN B-VP O
36 4/15/06 CD O O
36 by IN B-VP O
37 REICKS NNP B-NP O
37 , , O O
37 JACQUES NNP B-NP O
37 M NNP I-NP O
37 , , O O
37 M.D NNP B-NP O
37 , , O O
37 M.P.H NNP B-NP O
38 POTENTIALLY NNP I-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 SPIRONOLACTONE NNP I-NP B-m
38 &amp; NNP I-NP O
39 LISINOPRIL NNP I-NP B-m
40 POTENTIALLY NNP I-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 POTASSIUM NNP I-NP B-m
40 CHLORIDE NNP I-NP I-m
40 &amp; NNP I-NP O
41 LISINOPRIL NNP I-NP B-m
42 POTENTIALLY NNP I-NP O
42 SERIOUS NNP I-NP O
42 INTERACTION: NNP I-NP O
42 POTASSIUM NNP I-NP B-m
42 CHLORIDE NNP I-NP I-m
42 &amp; NNP I-NP O
43 LISINOPRIL NNP I-NP B-m
43 Reason NNP I-NP O
43 for IN B-VP O
43 override: NN B-NP O
43 monitor NN I-NP O
44 METAMUCIL NNP I-NP B-m
44 SUGAR NNP I-NP I-m
44 FREE NNP I-NP I-m
44 ( ( O I-m
44 PSYLLIUM NNP B-NP I-m
44 ( ( O I-m
44 METAMUCIL NNP B-NP I-m
44 ) ) O I-m
44 SU NNP B-NP I-m
44 ) ) O I-m
45 1 CD O B-do
45 PACKET NNP B-NP I-do
45 PO NNP I-NP B-mo
45 DAILY NNP I-NP B-f
46 SPIRONOLACTONE NNP I-NP B-m
46 50 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 DAILY NNP I-NP B-f
46 HOLD NNP I-NP O
46 IF: NNP I-NP O
46 SBP&lt;90 NNP I-NP O
47 Food/Drug NNP I-NP O
47 Interaction NNP I-NP O
47 Instruction NNP I-NP O
47 Give NNP I-NP O
47 with IN B-VP O
47 meals NNS B-NP O
48 Override NNP I-NP O
48 Notice: NNP I-NP O
48 Override NNP I-NP O
48 added VBD B-VP O
48 on IN B-VP O
48 4/15/06 CD O O
48 by IN B-VP O
49 VAZZANA NNP B-NP O
49 , , O O
49 JAN NNP B-NP O
49 M NNP I-NP O
49 , , O O
49 M.D NNP B-NP O
49 , , O O
49 M.P.H NNP B-NP O
50 on IN B-VP O
50 order NN B-NP O
50 for IN B-VP O
50 LISINOPRIL NNP B-NP B-m
50 PO NNP I-NP B-mo
50 ( ( O O
50 ref JJ O O
50 # # O O
50 166373866 CD O O
50 ) ) O O
51 POTENTIALLY NNP B-NP O
51 SERIOUS NNP I-NP O
51 INTERACTION: NNP I-NP O
51 SPIRONOLACTONE NNP I-NP B-m
51 &amp; NNP I-NP O
52 LISINOPRIL NNP I-NP B-m
52 Reason NNP I-NP O
52 for IN B-VP O
52 override: NN B-NP O
52 monitor NN I-NP O
53 Previous NNP I-NP O
53 override IN B-VP O
53 information: JJ B-NP O
54 Override NNP I-NP O
54 added VBD B-VP O
54 on IN B-VP O
54 4/15/06 CD O O
54 by IN B-VP O
54 SOLARSKI NNP B-NP O
54 , , O O
54 ERICH NNP B-NP O
54 S NNP I-NP O
54 , , O O
54 M.D NNP B-NP O
54 , , O O
54 M.P.H NNP B-NP O
55 on IN B-VP O
55 order NN B-NP O
55 for IN B-VP O
55 KCL NNP B-NP B-m
55 IMMEDIATE NNP I-NP I-m
55 RELEASE NNP I-NP I-m
55 PO NNP I-NP B-mo
55 ( ( O O
55 ref JJ O O
55 # # O O
56 040984307 CD O O
56 ) ) O O
57 SERIOUS NNP B-NP O
57 INTERACTION: NNP I-NP O
57 SPIRONOLACTONE NNP I-NP B-m
57 &amp; NNP I-NP O
57 POTASSIUM NNP I-NP B-m
57 CHLORIDE NNP I-NP I-m
58 Reason NNP I-NP O
58 for IN B-VP O
58 override: NN B-NP O
58 monitored VBD B-VP O
59 Previous NNP B-NP O
59 override IN B-VP O
59 information: JJ B-NP O
60 Override NNP I-NP O
60 added VBD B-VP O
60 on IN B-VP O
60 10/16/06 CD O O
60 by IN B-VP O
60 SCHWISOW NNP B-NP O
60 , , O O
60 CHUNG NNP B-NP O
60 P NNP I-NP O
60 , , O O
60 M.D NNP B-NP O
60 , , O O
60 M.P.H NNP B-NP O
61 on IN B-VP O
61 order NN B-NP O
61 for IN B-VP O
61 POTASSIUM NNP B-NP B-m
61 CHLORIDE NNP I-NP I-m
61 IMMED NNP I-NP I-m
61 REL NNP I-NP I-m
61 PO NNP I-NP B-mo
61 ( ( O O
61 ref JJ O O
61 # # O O
62 573534645 CD O O
62 ) ) O O
63 SERIOUS NNP B-NP O
63 INTERACTION: NNP I-NP O
63 SPIRONOLACTONE NNP I-NP B-m
63 &amp; NNP I-NP O
63 POTASSIUM NNP I-NP B-m
63 CHLORIDE NNP I-NP I-m
64 Reason NNP I-NP O
64 for IN B-VP O
64 override: NN B-NP O
64 monitor NN I-NP O
64 Previous NNP I-NP O
64 override IN B-VP O
64 information: JJ B-NP O
65 Override NNP I-NP O
65 added VBD B-VP O
65 on IN B-VP O
65 10/16/06 CD O O
65 by IN B-VP O
65 TROTZ NNP B-NP O
65 , , O O
65 HEATH NNP B-NP O
65 D NNP I-NP O
65 , , O O
65 M.D NNP B-NP O
65 , , O O
65 PH.D NNP B-NP O
66 on IN B-VP O
66 order NN B-NP O
66 for IN B-VP O
66 CAPTOPRIL NNP B-NP B-m
66 PO NNP I-NP B-mo
66 ( ( O O
66 ref JJ O O
66 # # O O
66 244774599 CD O O
66 ) ) O O
67 POTENTIALLY NNP B-NP O
67 SERIOUS NNP I-NP O
67 INTERACTION: NNP I-NP O
67 SPIRONOLACTONE NNP I-NP B-m
67 &amp; NNP I-NP O
67 CAPTOPRIL NNP I-NP B-m
68 Reason NNP I-NP O
68 for IN B-VP O
68 override: NN B-NP O
68 aware JJ B-NP O
69 INSULIN NNP I-NP B-m
69 INSULIN NNP I-NP B-m
69 INSULIN NNP I-NP B-m
69 INSULIN NNP I-NP B-m
69 INSULIN NNP I-NP B-m
69 INSULIN NNP I-NP B-m
69 INSULIN NNP I-NP B-m
69 INSULIN NNP I-NP B-m
69 ASPART NNP I-NP I-m
69 ASPART NNP I-NP I-m
69 ASPART NNP I-NP I-m
69 ASPART NNP I-NP I-m
69 ASPART NNP I-NP I-m
69 ASPART NNP I-NP I-m
69 ASPART NNP I-NP I-m
69 ASPART NNP I-NP I-m
69 Sliding NNP I-NP B-do
69 Scale NNP I-NP I-do
69 ( ( O B-mo
69 subcutaneously RB O I-mo
69 ) ) O I-mo
69 SC NNP B-NP I-mo
69 AC NNP I-NP B-f
70 If IN B-VP O
70 BS NNP B-NP O
70 is VBZ O O
70 less JJR O O
70 than IN B-VP O
70 125 CD O O
70 , , O O
70 then RB O O
70 give VB O O
70 0 CD O B-do
70 units NNS B-NP I-do
70 subcutaneously RB O B-mo
71 If IN B-VP O
71 BS NNP B-NP O
71 is VBZ O O
71 125-150 JJ O O
71 , , O O
71 then RB O O
71 give VB O O
71 2 CD O B-do
71 units NNS B-NP I-do
71 subcutaneously RB O B-mo
72 If IN B-VP O
72 BS NNP B-NP O
72 is VBZ O O
72 151-200 CD O O
72 , , O O
72 then RB O O
72 give VB O O
72 3 CD O B-do
72 units NNS B-NP I-do
72 subcutaneously RB O B-mo
73 If IN B-VP O
73 BS NNP B-NP O
73 is VBZ O O
73 201-250 JJ O O
73 , , O O
73 then RB O O
73 give VB O O
73 4 CD O B-do
73 units NNS B-NP I-do
73 subcutaneously RB O B-mo
74 If IN B-VP O
74 BS NNP B-NP O
74 is VBZ O O
74 251-300 JJ O O
74 , , O O
74 then RB O O
74 give VB O O
74 6 CD O B-do
74 units NNS B-NP I-do
74 subcutaneously RB O B-mo
75 If IN B-VP O
75 BS NNP B-NP O
75 is VBZ O O
75 301-350 JJ O O
75 , , O O
75 then RB O O
75 give VB O O
75 8 CD O B-do
75 units NNS B-NP I-do
75 subcutaneously RB O B-mo
76 If IN B-VP O
76 BS NNP B-NP O
76 is VBZ O O
76 351-400 CD O O
76 , , O O
76 then RB O O
76 give VB O O
76 10 CD O B-do
76 units NNS B-NP I-do
76 subcutaneously RB O B-mo
76 and CC O O
77 call VB O O
77 HO NNP B-NP O
77 Call NNP I-NP O
77 HO NNP I-NP O
77 if IN B-VP O
77 BS NNP B-NP O
77 is VBZ O O
77 greater JJR O O
77 than IN B-VP O
77 400 CD O O
78 DIET: NNP B-NP O
78 Fluid NNP I-NP O
78 restriction NN I-NP O
79 DIET: NNP I-NP O
79 House NNP I-NP O
79 / VBD B-VP O
79 Low NNP B-NP O
79 chol/low NN I-NP O
79 sat VBD B-VP O
79 fat JJ B-NP O
80 DIET: NNP I-NP O
80 2 CD O O
80 gram NN B-NP O
80 Sodium NNP I-NP O
81 ACTIVITY: NNP I-NP O
81 Walking NNP I-NP O
81 as IN B-VP O
81 tolerated VBN O O
82 FOLLOW NNP B-NP O
82 UP NNP I-NP O
82 APPOINTMENT( NNP I-NP O
82 S NNP I-NP O
82 ): NNP I-NP O
83 cardiology NN I-NP O
83 dr NN I-NP O
83 lelonek VBD B-VP O
83 714.815.2497 CD O O
83 1-4 JJ B-NP O
83 weeks NNS I-NP O
83 , , O O
84 pcp NN B-NP O
84 dr NN I-NP O
84 hoyt NN I-NP O
84 shimek VBD B-VP O
84 556-913-5202 JJ O O
84 2 CD O O
84 weeks NNS B-NP O
84 , , O O
85 ALLERGY: NNP B-NP O
85 NKA NNP I-NP O
86 ADMIT NNP I-NP O
86 DIAGNOSIS: NNP I-NP O
87 chf NN I-NP O
87 , , O O
87 unstable JJ B-NP O
87 angina NN I-NP O
88 PRINCIPAL NNP I-NP O
88 DISCHARGE NNP I-NP O
88 DIAGNOSIS NNP I-NP O
88 ;Responsible JJ O O
88 After IN B-VP O
88 Study NNP B-NP O
88 for IN B-VP O
88 Causing NNP B-NP O
88 Admission NNP I-NP O
88 ) ) O O
89 chf VBP O O
89 exacerbation NN B-NP O
90 OTHER NNP I-NP O
90 DIAGNOSIS;Conditions NNP I-NP O
90 , , O O
90 Infections NNP B-NP O
90 , , O O
90 Complications NNP B-NP O
90 , , O O
90 affecting VBG O O
90 Treatment/Stay NNP B-NP O
91 chf JJ B-NP O
91 exacerbation NN I-NP O
92 OPERATIONS NNP I-NP O
92 AND NNP I-NP O
92 PROCEDURES: NNP I-NP O
93 none NN I-NP O
94 OTHER NNP I-NP O
94 TREATMENTS/PROCEDURES NNP I-NP O
94 ( ( O O
94 NOT NNP B-NP O
94 IN NNP I-NP O
94 O.R NNP I-NP O
94 ) ) O O
95 echo VBP O O
95 10/7 CD O O
95 -with JJ B-NP O
95 EF NNP I-NP O
95 20-25% CD O O
95 , , O O
95 wall DT B-NP O
95 motion NN I-NP O
95 abnl NN I-NP O
95 , , O O
95 dil NN B-NP O
95 ivc NN I-NP O
95 , , O O
95 tr NN B-NP O
95 , , O O
95 mr JJ B-NP O
95 evidence NN I-NP O
95 of IN B-VP O
96 atrial JJ B-NP O
96 septal JJ I-NP O
96 defect NN I-NP O
96 noted VBD B-VP O
97 Mibi/PET-CT NNP B-NP O
97 6/1 CD O O
97 test NN B-NP O
97 results NNS I-NP O
97 are VBP O O
97 abnormal JJ O O
97 and CC O O
97 c/w VBZ O O
97 the DT B-NP O
97 following: NN I-NP O
98 1 CD O O
98 A NNP B-NP O
98 medium NN I-NP O
98 sized JJ B-NP O
98 region NN I-NP O
98 of IN B-VP O
98 myocardial JJ B-NP O
98 scar NN I-NP O
98 without IN B-VP O
98 residual JJ B-NP O
99 ischemia NN I-NP O
99 or CC O O
99 viability NN B-NP O
99 in IN B-VP O
99 the DT B-NP O
99 distribution NN I-NP O
99 of IN B-VP O
99 the DT B-NP O
99 mid-LAD JJ I-NP O
99 coronary JJ I-NP O
100 artery NN I-NP O
101 2 CD O O
101 A NNP B-NP O
101 small JJ B-NP O
101 region NN I-NP O
101 of IN B-VP O
101 myocardial JJ B-NP O
101 scar NN I-NP O
101 without IN B-VP O
101 residual JJ B-NP O
101 ischemia NN I-NP O
102 or CC O O
102 viability NN B-NP O
102 in IN B-VP O
102 the DT B-NP O
102 distribution NN I-NP O
102 of IN B-VP O
102 the DT B-NP O
102 PDA NNP I-NP O
102 coronary JJ B-NP O
102 artery NN I-NP O
103 3 CD O O
103 Moderate NNP B-NP O
103 global JJ B-NP O
103 LV NNP I-NP O
103 systolic JJ B-NP O
103 dysfunction NN I-NP O
104 BRIEF NNP I-NP O
104 RESUME NNP I-NP O
104 OF NNP I-NP O
104 HOSPITAL NNP I-NP O
104 COURSE: NNP I-NP O
105 CC- NNP I-NP O
105 sent VBD B-VP O
105 in IN B-VP O
105 by IN B-VP O
105 pcp NN B-NP O
105 for IN B-VP O
105 chest JJ B-NP O
105 pressure NN I-NP O
106 HPI-66yo NNP I-NP O
106 M NNP I-NP O
106 spanish JJ B-NP O
106 speaking NN I-NP O
106 from IN B-VP O
106 O NNP B-NP O
106 Ankament NNP I-NP O
106 Ta NNP I-NP O
106 1/10 CD O O
106 had VBD B-VP O
106 labs VBN O O
106 drawn VBN O O
106 at IN B-VP O
107 frelawn NN B-NP O
107 dinghung NN I-NP O
107 ant VBP O O
107 hospital NN B-NP O
107 11/17 CD O O
107 saw NN B-NP O
107 pcp NN I-NP O
107 , , O O
107 reported VBD B-VP O
107 sig.cardiac JJ B-NP O
107 hx NN I-NP O
107 and CC O O
107 over IN B-VP O
107 the DT B-NP O
107 past JJ I-NP O
108 few JJ I-NP O
108 months NNS I-NP O
108 has VBZ O O
108 had VBD B-VP O
108 an DT B-NP O
108 increase NN I-NP O
108 in IN B-VP O
108 chest JJ B-NP O
108 pressure NN I-NP O
108 , , O O
108 nonradiating VBG O O
108 , , O O
108 initially RB O O
109 sx VB O O
109 on IN B-VP O
109 exertion NN B-NP O
109 , , O O
109 most RBS O O
109 recently RB O O
109 at IN B-VP O
109 rest NN B-NP O
109 On IN B-VP O
109 sunday NN B-NP O
109 , , O O
110 he PRP O O
110 was VBD B-VP O
110 lying VBG O O
110 on IN B-VP O
110 couch NN B-NP O
110 when WRB O O
110 the DT B-NP B-r
110 sx NN I-NP I-r
110 started VBD B-VP O
110 , , O O
110 took VBD B-VP O
110 two CD O B-do
110 nitro NN B-NP B-m
110 with IN B-VP O
110 good JJ B-NP O
111 resolution NN I-NP O
111 no DT B-NP O
111 sob NN I-NP O
111 , , O O
111 no DT B-NP O
111 n/v/diaphoresis/fevers NNS I-NP O
111 he PRP O O
111 has VBZ O O
111 also RB O O
111 noted VBN O O
112 worsening VBG O O
112 LE NNP B-NP O
112 edema NN I-NP O
112 and CC O O
112 weight JJ B-NP O
112 gain NN I-NP O
112 of IN B-VP O
112 30lbs CD O O
112 over IN B-VP O
112 this DT B-NP O
112 time NN I-NP O
112 period NN I-NP O
112 He PRP O O
113 admits VBZ O O
113 to TO O O
113 missing VBG O O
113 his PRP$ O O
113 meds NNS B-NP B-m
113 and CC O O
113 to TO O O
113 eating VBG O O
113 a DT B-NP O
113 lot NN I-NP O
113 of IN B-VP O
113 salt NN B-NP O
114 He PRP O O
114 was VBD B-VP O
114 worked VBN O O
114 up RP O O
114 at IN B-VP O
114 A NNP B-NP O
114 in IN B-VP O
114 Tonusni NNP B-NP O
114 for IN B-VP O
114 several JJ B-NP O
114 months NNS I-NP O
114 to TO O O
115 try VB O O
115 and CC O O
115 determine VB O O
115 how WRB O O
115 to TO O O
115 best VB O O
115 treat NN B-NP O
115 his PRP$ O O
115 cardiac JJ B-NP O
115 disease NN I-NP O
115 Per NNP I-NP O
115 the DT B-NP O
115 pt NN I-NP O
115 , , O O
115 they PRP O O
116 said VBD B-VP O
116 they PRP O O
116 couldn't VBP O O
116 do VB O O
116 anything NN B-NP O
116 for IN B-VP O
116 him PRP O O
117 In IN B-VP O
117 ED NNP B-NP O
117 , , O O
117 afebrile JJ B-NP O
117 hr NN I-NP O
117 60s CD O O
117 , , O O
117 BP NNP B-NP O
117 110s CD O O
117 sat VBD B-VP O
117 100%RA CD O O
117 Tx NNP B-NP O
117 with IN B-VP O
117 lasix JJ O B-m
117 80iiv CD O B-do
117 , , O O
117 asa RB O B-m
118 325 CD O B-do
118 , , O O
118 coreg NN B-NP B-m
119 6.25 CD O B-do
119 , , O O
119 inuslin NN B-NP B-m
119 8u CD O B-do
119 OU NNP B-NP O
119 1500 CD O O
119 CXR NNP B-NP O
119 c/w NN I-NP O
119 pulm NN I-NP O
119 edema NN I-NP O
120 Exam NNP I-NP O
121 Gen- NNP I-NP O
121 resting VBG O O
121 comfortably RB O O
121 in IN B-VP O
121 bed NN B-NP O
121 , , O O
121 no DT B-NP O
121 c/o JJ I-NP O
122 HEENT- NNP I-NP O
122 jvp NN I-NP O
122 to TO O O
122 jaw VB O O
123 Pulm- NNP B-NP O
123 b/l NN I-NP O
123 crackles NNS I-NP O
123 at IN B-VP O
123 bases NNS B-NP O
124 Abd- NNP I-NP O
124 soft JJ O O
124 , , O O
124 NT NNP B-NP O
124 , , O O
124 ND NNP B-NP O
125 Ext- NNP I-NP O
125 c/o NN I-NP O
125 rt NN I-NP O
125 foot NN I-NP O
125 pain NN I-NP O
125 , , O O
125 no DT B-NP O
125 signs NNS I-NP O
125 of IN B-VP O
125 trauma NN B-NP O
125 slight JJ B-NP O
125 edema NN I-NP O
125 , , O O
125 b/l NN B-NP O
125 , , O O
125 c/o NN B-NP O
125 ttp NN I-NP O
126 along IN B-VP O
126 top NN B-NP O
126 of IN B-VP O
126 left JJ B-NP O
126 DPs NNP I-NP O
126 not RB O O
126 palpable JJ B-NP O
127 Home NNP I-NP O
127 meds NNS I-NP O
128 plavix75 VBP O B-m
129 asa81 JJ B-NP B-m
130 carnitidine NN I-NP B-m
130 ( ( O O
130 ? . B-VP O
130 ) ) O O
130 150 CD O B-do
130 bid NN B-NP B-f
131 imdur NN I-NP B-m
131 30 CD O B-do
132 digitek NN B-NP B-m
132 0.125 CD O B-do
133 lasix NN B-NP B-m
133 80 CD O B-do
134 coreg NN B-NP B-m
134 6.25 CD O B-do
135 spironolactone NN B-NP B-m
135 50 CD O B-do
136 insulin NN B-NP B-m
136 insulin NN I-NP B-m
136 70/30 CD O I-m
136 70/30 CD O I-m
136 50qam CD O B-do
136 , , O O
136 35 CD O B-do
136 qpm NN B-NP B-f
137 NKDA NNP I-NP O
138 PMH NNP I-NP O
139 mi NN I-NP O
139 x3 NNP I-NP O
139 ( ( O O
139 1993 CD O O
139 ) ) O O
139 - : O O
139 ? . B-VP O
139 cath NN B-NP O
139 , , O O
139 ?inoperable JJ O O
139 , , O O
139 knows VBZ O O
139 he PRP O O
139 has VBZ O O
139 3v CD O O
140 dz NN B-NP O
141 htn NN I-NP O
142 chf NN I-NP O
143 gerd NN I-NP O
144 dm NN I-NP O
145 Shx NNP I-NP O
146 from IN B-VP O
146 U NNP B-NP O
146 Salosra NNP I-NP O
146 Scot NNP I-NP O
147 exsmoker NN I-NP O
147 quit VBD B-VP O
147 5y CD O O
147 pta NN B-NP O
148 no DT B-NP O
148 etoh NN I-NP O
148 , , O O
148 no DT B-NP O
148 ivdu NN I-NP O
149 FHx NNP I-NP O
150 brother NN I-NP O
150 died VBD B-VP O
150 of IN B-VP O
150 MI NNP B-NP O
150 10/22 CD O O
150 in IN B-VP O
150 50s CD O O
151 parents NNS B-NP O
151 died VBD B-VP O
151 of IN B-VP O
151 CAD NNP B-NP O
151 in IN B-VP O
151 70s/80s CD O O
152 htn NN B-NP O
152 , , O O
152 dm JJ B-NP O
153 studies NNS I-NP O
154 cxr VBP O O
154 6/10 CD O O
154 cardiomegaly NN B-NP O
154 , , O O
154 increased VBD B-VP O
154 interstitial JJ B-NP O
154 marking NN I-NP O
154 c/w NN I-NP O
154 pulm NN I-NP O
154 edema VBD B-VP O
155 ekg- JJ O O
155 nsr JJ O O
155 1 CD O O
155 degree NN B-NP O
155 avblock NN I-NP O
155 , , O O
155 nl JJ B-NP O
155 axis NN I-NP O
155 , , O O
155 q NN B-NP O
155 in IN B-VP O
155 v1-v3 NN B-NP O
155 , , O O
155 poor JJ B-NP O
155 r NN I-NP O
155 waves NNS I-NP O
155 in IN B-VP O
155 v4-v5 NN B-NP O
155 , , O O
155 T NNP B-NP O
156 inversion NN I-NP O
156 3 CD O O
156 , , O O
156 avf NN B-NP O
156 , , O O
156 biphasic JJ B-NP O
156 Ts NNP I-NP O
156 and CC O O
156 mild JJ B-NP O
156 depression NN I-NP O
156 ( ( O O
156 &lt;0.5mm NN B-NP O
156 ) ) O O
156 in IN B-VP O
156 v5 NN B-NP O
157 echo VBP O O
157 10/7 CD O O
157 -with JJ B-NP O
157 EF NNP I-NP O
157 20-25% CD O O
157 , , O O
157 wall DT B-NP O
157 motion NN I-NP O
157 abnl NN I-NP O
157 , , O O
157 dil NN B-NP O
157 ivc NN I-NP O
157 , , O O
157 tr NN B-NP O
157 , , O O
157 mr JJ B-NP O
157 evidence NN I-NP O
157 of IN B-VP O
158 ASD NNP B-NP O
158 seen VBN O O
159 Mibi NNP B-NP O
159 6/1 CD O O
159 no DT B-NP O
159 evidence NN I-NP O
159 of IN B-VP O
159 reversible JJ B-NP O
159 ischemia NN I-NP O
160 assessment NN I-NP O
160 and CC O O
160 plan NN B-NP O
161 66yo CD O O
161 with IN B-VP O
161 cad/mi NN B-NP O
161 , , O O
161 dm NN B-NP O
161 , , O O
161 chf NN B-NP O
161 , , O O
161 admitted VBN O O
161 for IN B-VP O
161 chf JJ B-NP O
161 exacerbation NN I-NP O
161 and CC O O
161 r/o VB O O
161 MI NNP B-NP O
162 1.CV- JJ B-NP O
163 a. NN I-NP O
163 ischemia- JJ B-NP O
163 sig NN I-NP O
163 cad NN I-NP O
163 with IN B-VP O
163 hx NN B-NP O
163 of IN B-VP O
163 chest JJ B-NP O
163 presure NN I-NP O
163 at IN B-VP O
163 rest NN B-NP O
163 , , O O
163 ce VBP O O
163 -x2 JJ B-NP O
163 ekg NN I-NP O
164 abnl NN I-NP O
164 w/o NN I-NP O
164 priors NNS I-NP O
164 , , O O
164 concerning VBG O O
164 for IN B-VP O
164 unstable JJ B-NP B-r
164 angina NN I-NP I-r
164 given VBN O O
164 asa NNS B-NP B-m
164 , , O O
164 carvedilol NN B-NP B-m
165 ( ( O O
165 changed VBN O O
165 to TO O O
165 lisinopril VB O B-m
165 5/26 CD O O
165 ) ) O O
165 , , O O
165 lipitor NN B-NP B-m
165 , , O O
165 plavix NN B-NP B-m
165 and CC O O
165 started VBD B-VP O
165 on IN B-VP O
165 lovenox NN B-NP B-m
165 100 CD O B-do
166 sq NN B-NP B-mo
166 Lovenox NNP I-NP B-m
166 was VBD B-VP O
166 stopped VBN O O
166 when WRB O O
166 ce JJ O O
166 neg RB O O
166 x3 VBP O O
166 on IN B-VP O
166 10/7 CD O O
166 Lipid JJ B-NP O
166 panel NN I-NP O
166 ok NN I-NP O
166 , , O O
166 continue VBP O O
167 on IN B-VP O
167 lipitor NN B-NP B-m
167 80 CD O B-do
167 Has NNP B-NP O
167 been VBN O O
167 CP NNP B-NP O
167 free JJ O O
167 since IN B-VP O
167 Sunday NNP B-NP O
167 Stressed VBD B-VP O
167 on IN B-VP O
167 5/26 CD O O
167 , , O O
167 results NNS B-NP O
168 show VBP O O
168 no DT B-NP O
168 evidence NN I-NP O
168 of IN B-VP O
168 reversible JJ B-NP O
168 ischemia NN I-NP O
168 and CC O O
168 pt NN B-NP O
168 has VBZ O O
168 had VBN O O
168 no DT B-NP O
168 CP NNP I-NP O
168 while IN B-VP O
168 in IN B-VP O
168 the DT B-NP O
169 hospital NN I-NP O
170 b.pump SYM O O
170 - : O O
170 chf NN B-NP O
170 exacerbation NN I-NP O
170 , , O O
170 likely RB O O
170 2/2 CD O O
170 not RB O O
170 taking VBG O O
170 meds NNS B-NP O
170 and CC O O
170 poor JJ B-NP O
170 diet JJ I-NP O
171 control NN I-NP O
171 will MD O O
171 txc VB O O
171 with IN B-VP O
171 lasix JJ O B-m
171 40iv CD O B-do
171 bid NN B-NP B-f
171 , , O O
171 goals NNS B-NP O
171 -1liter/day VBP O O
171 pt JJ O O
171 already RB O O
172 improving- JJ B-NP O
172 good JJ I-NP O
172 diuresis NN I-NP O
172 with IN B-VP O
172 lasix JJ O B-m
172 40iv CD O B-do
172 continue VBP O O
172 home NN B-NP O
172 spironolactone NN I-NP B-m
172 , , O O
173 restarted VBN O O
173 on IN B-VP O
173 home NN B-NP O
173 imdur NN I-NP B-m
173 ACEi NNP I-NP B-m
173 ACEi NNP I-NP B-m
173 started VBD B-VP O
173 and CC O O
173 increased VBD B-VP O
173 to TO O O
173 10mg CD O B-do
173 qd NNS B-NP B-f
173 fluid RB O O
174 restricted VBD B-VP O
174 to TO O O
174 2L CD O O
175 echo NNS B-NP O
175 10/7 CD O O
175 with IN B-VP O
175 EF NNP B-NP O
175 20-25% CD O O
175 , , O O
175 wall DT B-NP O
175 motion NN I-NP O
175 abnl NN I-NP O
175 , , O O
175 dil NN B-NP O
175 ivc NN I-NP O
175 , , O O
175 tr NN B-NP O
175 , , O O
175 mr NN B-NP O
175 Patient NNP I-NP O
175 has VBZ O O
176 diuresed VBN O O
176 well RB O O
176 during IN B-VP O
176 his PRP$ O O
176 time NN B-NP O
176 in IN B-VP O
176 house NN B-NP O
176 with IN B-VP O
176 a DT B-NP O
176 weight NN I-NP O
176 on IN B-VP O
176 dc NN B-NP O
176 of IN B-VP O
176 82 CD O O
177 kg.Continue NN B-NP O
177 on IN B-VP O
177 lasix JJ O B-m
177 80po CD O B-do
177 daily JJ B-NP B-f
178 c. NNS I-NP O
178 rhythm- JJ B-NP O
178 sinus NN I-NP O
178 , , O O
178 on IN B-VP O
178 tele NNS B-NP O
178 long JJ B-NP O
178 Pr NNP I-NP O
178 interval NN I-NP O
178 noted VBD B-VP O
178 , , O O
178 dig NN B-NP O
178 stopped VBD B-VP O
178 to TO O O
179 avoid VB O O
179 any DT B-NP O
179 additional JJ I-NP O
179 PR NNP I-NP O
179 prolongation NN I-NP O
179 may MD O O
179 need VB O O
179 EP NNP B-NP O
179 workup NN I-NP O
179 in IN B-VP O
179 the DT B-NP O
179 future JJ I-NP O
180 2.pulm- JJ I-NP O
180 cardiogenic JJ I-NP O
180 pulm NN I-NP O
180 edema NN I-NP O
180 , , O O
180 imprving VBG O O
180 sat VBD B-VP O
180 stable JJ O O
180 on IN B-VP O
180 RA NNP B-NP O
181 continue VBP O O
181 diuresis NN B-NP O
181 On IN B-VP O
181 room NN B-NP O
181 air NN I-NP O
181 throughout IN B-VP O
181 his PRP$ O O
181 time NN B-NP O
181 in IN B-VP O
181 house NN B-NP O
181 , , O O
181 appears VBZ O O
181 very RB O O
182 comfortable JJ O O
183 3. CD O O
183 GI- JJ B-NP O
183 mild JJ I-NP O
183 transaminitis- NNS I-NP O
183 decreased VBN O O
183 over IN B-VP O
183 the DT B-NP O
183 course NN I-NP O
183 of IN B-VP O
183 his PRP$ O O
183 time NN B-NP O
184 here RB O O
184 and CC O O
184 normal JJ B-NP O
184 AST/ALT/Tbili NNP I-NP O
184 on IN B-VP O
184 day NN B-NP O
184 of IN B-VP O
184 discharge NN B-NP O
184 Alk NNP I-NP O
184 phos NN I-NP O
184 contiues NNS I-NP O
184 to TO O O
185 be VB O O
185 elevated VBN O O
185 at IN B-VP O
185 175 CD O O
185 Will NNP B-NP O
185 need VBP O O
185 pcp NNS B-NP O
185 follow VB O O
185 up RP O O
185 evaluation NN B-NP O
185 , , O O
185 but CC O O
185 no DT B-NP O
185 abdominal JJ I-NP O
186 complaints NNS I-NP O
187 4.Heme- JJ O O
187 on IN B-VP O
187 lovenox NN B-NP O
187 for IN B-VP B-m
187 UA NNP B-NP O
187 , , O B-r
187 transitioned VBD B-VP O
187 to TO O O
187 SC NNP B-NP O
187 DVT NNP I-NP O
187 ppx NN I-NP O
187 dosing VBG O O
187 on IN B-VP O
188 10/7 CD O O
188 , , O O
188 on IN B-VP O
188 plavix NN B-NP B-m
188 for IN B-VP O
188 ? . B-VP O
188 stent NN B-NP B-r
188 Will NNP I-NP O
188 continue VBP O O
188 on IN B-VP O
188 plavix NN B-NP B-m
188 and CC O O
188 asa NN B-NP B-m
188 as IN B-VP O
188 outpt JJ B-NP O
189 5.endo- JJ I-NP O
189 nph NN I-NP O
189 18 CD O B-m
189 18 CD O B-m
189 18 CD O B-m
189 bid NN B-NP B-do
189 for IN B-VP B-f
189 now RB O O
189 ( ( O O
189 inc NN B-NP O
189 from IN B-VP O
189 home NN B-NP O
189 10 CD O O
189 ) ) O B-do
189 , , O O
189 6u CD O O
189 ac NN B-NP B-do
189 and CC O B-mo
189 ss NN B-NP O
189 hgb NN I-NP O
190 a1c IN B-VP O
190 10.4- JJ O O
190 indicating VBG O O
190 need NN B-NP O
190 for IN B-VP O
190 tighter JJR B-NP B-r
190 tighter NN I-NP B-r
190 tighter NN I-NP B-r
190 glucose VBP O I-r
190 glucose JJ B-NP I-r
190 glucose JJ I-NP I-r
190 control NN I-NP I-r
190 control NN I-NP I-r
190 control NN I-NP I-r
190 He PRP O O
190 will MD O O
190 go VB O O
190 home NN B-NP O
190 on IN B-VP O
191 an DT O B-do
191 increased VBN O I-do
191 dose NN B-NP I-do
191 on IN B-VP O
191 NPH NNP B-NP B-m
191 and CC O O
191 advised VBD B-VP O
191 to TO O O
191 keep VB O O
191 tight JJ B-NP O
191 control NN I-NP O
191 over IN B-VP O
191 his PRP$ O B-r
191 blood NN B-NP O
192 sugar NN I-NP O
193 6.msk- JJ B-NP O
193 c/o NN I-NP O
193 left VBD B-VP O
193 foot NN B-NP O
193 pain NN I-NP O
193 , , O O
193 unclear JJ B-NP O
193 source NN I-NP O
193 xray NNP I-NP O
193 final JJ B-NP O
193 read NN I-NP O
193 shows NNS I-NP O
194 degenerative VBP O O
194 changes NNS B-NP O
194 able JJ O O
194 to TO O O
194 doppler VB O O
194 DPs NNP B-NP O
194 ? . B-VP O
194 claudication? NN B-NP O
194 Patient NNP I-NP O
194 is VBZ O O
195 pain JJ O O
195 free JJ O O
195 now RB O O
196 7.fen- JJ B-NP O
196 ada NN I-NP O
196 , , O O
196 cardiac JJ B-NP O
196 diet NN I-NP O
196 Lytes NNP I-NP O
196 repleted VBD B-VP O
196 while IN B-VP O
196 in IN B-VP O
196 house NN B-NP O
196 , , O O
196 all DT O O
196 normal JJ O O
197 on IN B-VP O
197 discharge NN B-NP O
198 8.Patient CD O O
198 is VBZ O O
198 staible JJ O O
198 for IN B-VP O
198 discharge NN B-NP O
198 home NN I-NP O
198 He PRP O O
198 will MD O O
198 need VB O O
198 to TO O O
198 followup VB O O
199 with IN B-VP O
199 cardiology NN B-NP O
199 as IN B-VP O
199 an DT B-NP O
199 outpt JJ I-NP O
200 ADDITIONAL NNP I-NP O
200 COMMENTS: NNP I-NP O
200 1 CD O O
200 take VBP O O
200 all DT O O
200 your PRP$ O B-m
200 medications NNS B-NP B-m
200 medications NNS I-NP I-m
200 as IN B-VP O
200 directed JJ O O
201 2 CD O O
201 Weigh NNP B-NP O
201 yourself PRP O O
201 daily RB O O
201 , , O O
201 if IN B-VP O
201 you PRP O O
201 start VBP O O
201 to TO O O
201 gain VB O O
201 weight NN B-NP O
201 ( ( O O
201 even RB O O
201 5 CD O O
201 pounds NNS B-NP O
201 ) ) O O
201 , , O O
201 you PRP O O
202 need VBP O O
202 to TO O O
202 contact VB O O
202 your PRP$ O O
202 doctor NN B-NP O
202 about IN B-VP O
202 increasing VBG O O
202 your PRP$ O O
202 lasix NN B-NP B-m
202 dose VBD B-VP O
203 3 CD O O
203 Follow NNP B-NP O
203 up RB O O
203 with IN B-VP O
203 cardiology NN B-NP O
203 as IN B-VP O
203 directed JJ O O
204 4 CD O O
204 check NN B-NP O
204 you PRP O O
204 blood VBP O B-r
204 sugars NNS B-NP I-r
204 in IN B-VP O
204 the DT B-NP O
204 morning NN I-NP O
204 and CC O O
204 with IN B-VP O
204 meals NNS B-NP O
204 adjust VBP O O
204 your PRP$ O O
205 insulin NN B-NP B-m
205 as IN B-VP B-f
205 needed VBN O I-f
205 dr NN B-NP O
205 erick NN I-NP O
205 bedaw NN I-NP O
205 at IN B-VP O
205 carlekadl JJ B-NP O
205 rine JJ I-NP O
205 calccal JJ I-NP O
205 memorial JJ I-NP O
205 hospital NN I-NP O
205 of IN B-VP O
205 county NN B-NP O
205 will MD O O
205 be VB O O
205 following VBG O O
205 his PRP$ O O
206 blood NN B-NP O
206 sugars NNS I-NP O
207 5 CD O O
207 get VBP O O
207 a DT B-NP O
207 recheck NN I-NP O
207 of IN B-VP O
207 your PRP$ O O
207 lfts NNS B-NP O
207 as IN B-VP O
207 an DT B-NP O
207 outpt NN I-NP O
207 , , O O
207 your PRP$ O O
207 Alk NNP B-NP O
207 Phos NNP I-NP O
207 and CC O O
207 GGT NNP B-NP O
207 were VBD B-VP O
208 elevated VBN O O
209 DISCHARGE NNP B-NP O
209 CONDITION: NNP I-NP O
209 Stable NNP I-NP O
210 TO NNP I-NP O
210 DO/PLAN: NNP I-NP O
211 1 CD O O
211 take VBP O O
211 all DT O O
211 your PRP$ O B-m
211 medications NNS B-NP B-m
211 medications NNS I-NP I-m
211 as IN B-VP O
211 directed JJ O O
212 2 CD O O
212 Weigh NNP B-NP O
212 yourself PRP O O
212 daily RB O O
212 , , O O
212 if IN B-VP O
212 you PRP O O
212 start VBP O O
212 to TO O O
212 gain VB O O
212 weight NN B-NP O
212 ( ( O O
212 even RB O O
212 5 CD O O
212 pounds NNS B-NP O
212 ) ) O O
212 , , O O
212 you PRP O O
213 need VBP O O
213 to TO O O
213 contact VB O O
213 your PRP$ O O
213 doctor NN B-NP O
213 about IN B-VP O
213 increasing VBG O O
213 your PRP$ O O
213 lasix NN B-NP B-m
213 dose VBD B-VP B-do
214 3 CD O O
214 Follow NNP B-NP O
214 up RB O O
214 with IN B-VP O
214 cardiology NN B-NP O
214 as IN B-VP O
214 directed JJ B-NP O
215 No NNP I-NP O
215 dictated VBD B-VP O
215 summary JJ B-NP O
216 ENTERED NNP I-NP O
216 BY: NNP I-NP O
216 DONNA NNP I-NP O
216 , , O O
216 EMMANUEL NNP B-NP O
216 E NNP I-NP O
216 , , O O
216 M.D NNP B-NP O
216 , , O O
216 M.P.H NNP B-NP O
216 ( ( O O
216 YH225 NNP B-NP O
216 ) ) O O
216 8/4/06 CD O O
216 @ $ O O
216 12:54 CD O O
216 PM NNP B-NP O
217 ****** JJ B-NP O
217 END NNP I-NP O
217 OF NNP I-NP O
217 DISCHARGE NNP I-NP O
217 ORDERS NNP I-NP O
217 ****** NNP I-NP O
218 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #681606 VBZ O O
2 765120422 CD O O
2 COH NNP B-NP O
2 85296554 CD O O
2 3810112 CD O O
2 9/8/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 asthma JJ B-NP O
2 exacerbation NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/24/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/12/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 RUMBLE NNP I-NP O
5 , , O O
5 LUPE NNP B-NP O
5 646-77-20-0 CD O O
6 Washington NNP B-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 5/1/06 CD O O
8 AT NNP B-NP O
8 01:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 KOETS NNP I-NP O
11 , , O O
11 LEN NNP B-NP O
11 D NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ALBUTEROL NNP I-NP B-m
16 INHALER NNP I-NP I-m
16 2 CD O B-do
16 PUFF NNP B-NP I-do
16 INH NNP I-NP B-mo
16 QID NNP I-NP B-f
17 ALBUTEROL NNP I-NP B-m
17 ALBUTEROL NNP I-NP B-m
17 NEBULIZER NNP I-NP I-m
17 NEBULIZER NNP I-NP I-m
17 2.5 CD O B-do
17 2.5 CD O B-do
17 MG NNP B-NP I-do
17 MG NNP I-NP I-do
17 NEB NNP I-NP B-mo
17 NEB NNP I-NP B-mo
17 Q4H NNP I-NP O
18 Starting VBG O O
18 Today NNP B-NP O
18 ( ( O O
18 5/12 CD O O
18 ) ) O O
18 PRN NNP B-NP O
18 Shortness NNP I-NP B-r
18 of IN B-VP I-r
18 Breath NNP B-NP I-r
18 , , O O
18 Wheezing NNP B-NP B-r
19 ADVAIR NNP I-NP B-m
19 DISKUS NNP I-NP I-m
19 500/50 CD O I-m
19 ( ( O I-m
19 FLUTICASONE NNP B-NP I-m
19 PROPIONATE/ NNP I-NP I-m
19 ) ) O I-m
20 1 CD O B-do
20 PUFF NNP B-NP I-do
20 INH NNP I-NP B-mo
20 BID NNP I-NP B-f
21 COMBIVENT NNP I-NP B-m
21 ( ( O I-m
21 IPRATROPIUM NNP B-NP I-m
21 AND NNP I-NP I-m
21 ALBUTEROL NNP I-NP I-m
21 SULFATE NNP I-NP I-m
21 ) ) O I-m
22 2 CD O B-do
22 PUFF NNP B-NP I-do
22 INH NNP I-NP B-mo
22 TID NNP I-NP B-f
23 LISINOPRIL NNP I-NP B-m
23 20 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 DAILY NNP I-NP B-f
24 Override NNP I-NP O
24 Notice: NNP I-NP O
24 Override NNP I-NP O
24 added VBD B-VP O
24 on IN B-VP O
24 1/10/06 CD O O
24 by IN B-VP O
25 SICKEL NNP B-NP O
25 , , O O
25 SON NNP B-NP O
25 ORVILLE NNP I-NP O
25 , , O O
25 M.D NNP B-NP O
26 on IN B-VP O
26 order NN B-NP O
26 for IN B-VP O
26 KCL NNP B-NP B-m
26 IMMEDIATE NNP I-NP I-m
26 RELEASE NNP I-NP I-m
26 PO NNP I-NP B-mo
26 ( ( O O
26 ref JJ O O
26 # # O O
27 108524680 CD O O
27 ) ) O O
28 POTENTIALLY NNP B-NP O
28 SERIOUS NNP I-NP O
28 INTERACTION: NNP I-NP O
28 LISINOPRIL NNP I-NP B-m
28 &amp; NNP I-NP O
28 POTASSIUM NNP I-NP B-m
29 CHLORIDE NNP I-NP O
30 POTENTIALLY NNP I-NP O
30 SERIOUS NNP I-NP O
30 INTERACTION: NNP I-NP O
30 LISINOPRIL NNP I-NP B-m
30 &amp; NNP I-NP O
30 POTASSIUM NNP I-NP B-m
31 CHLORIDE NNP I-NP O
31 Reason NNP I-NP O
31 for IN B-VP O
31 override: NN B-NP O
31 aware JJ B-NP O
32 SINGULAIR NNP I-NP B-m
32 ( ( O I-m
32 MONTELUKAST NNP B-NP I-m
32 ) ) O I-m
32 10 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 DAILY NNP I-NP B-f
33 PREDNISONE NNP I-NP B-m
33 PREDNISONE NNP I-NP B-m
33 PREDNISONE NNP I-NP B-m
33 PREDNISONE NNP I-NP B-m
33 PREDNISONE NNP I-NP B-m
33 PREDNISONE NNP I-NP B-m
33 PREDNISONE NNP I-NP B-m
33 PREDNISONE NNP I-NP B-m
33 Taper NNP I-NP I-m
33 Taper NNP I-NP I-m
33 Taper NNP I-NP I-m
33 Taper NNP I-NP I-m
33 Taper NNP I-NP I-m
33 Taper NNP I-NP I-m
33 Taper NNP I-NP I-m
33 Taper NNP I-NP I-m
33 PO NNP I-NP B-mo
33 PO NNP I-NP B-mo
33 PO NNP I-NP B-mo
33 Give NNP I-NP O
33 60 CD O B-do
33 60 CD O B-do
33 mg NN B-NP I-do
33 mg NN I-NP I-do
33 q NN I-NP B-f
33 q VBD B-VP B-f
33 24 CD O I-f
33 24 CD O I-f
33 h NN B-NP I-f
33 h NN I-NP I-f
33 X NNP I-NP B-du
33 X NNP I-NP I-f
33 2 CD O I-du
33 2 CD O I-f
33 dose( NN B-NP I-du
33 dose( NN I-NP I-f
33 s NN I-NP I-du
33 s NN I-NP I-f
33 ) ) O I-du
33 ) ) O I-f
33 , , O O
33 then RB O O
34 Give VB O O
34 50 CD O B-do
34 mg NN B-NP I-do
34 q NN I-NP B-f
34 24 CD O I-f
34 h NN B-NP I-f
34 X NNP I-NP B-du
34 3 CD O I-du
34 dose( NN B-NP I-du
34 s NN I-NP I-du
34 ) ) O I-du
34 , , O O
34 then RB O O
35 Give VB O O
35 40 CD O B-do
35 mg NN B-NP I-do
35 q NN I-NP B-f
35 24 CD O I-f
35 h NN B-NP I-f
35 X NNP I-NP B-du
35 3 CD O I-du
35 dose( NN B-NP I-du
35 s NN I-NP I-du
35 ) ) O I-du
35 , , O O
35 then RB O O
36 Give VB O O
36 30 CD O B-do
36 30 CD O B-do
36 mg NN B-NP I-do
36 mg NN I-NP I-do
36 q NN I-NP B-f
36 q VBD B-VP B-f
36 24 CD O I-f
36 24 CD O I-f
36 h NN B-NP I-f
36 h NN I-NP I-f
36 X NNP I-NP B-du
36 X NNP I-NP I-f
36 X NNP I-NP B-du
36 3 CD O I-du
36 3 CD O I-f
36 3 CD O I-du
36 dose( NN B-NP I-du
36 dose( NN I-NP I-du
36 s NN I-NP I-du
36 s NN I-NP I-du
36 ) ) O I-du
36 ) ) O I-du
36 , , O O
36 then RB O O
37 Give VB O O
37 20 CD O B-do
37 mg NN B-NP I-do
37 q NN I-NP B-f
37 24 CD O I-f
37 h NN B-NP I-f
37 X NNP I-NP B-du
37 3 CD O I-du
37 dose( NN B-NP I-du
37 s NN I-NP I-du
37 ) ) O I-du
37 , , O O
37 then RB O O
38 Give VB O O
38 10 CD O B-do
38 mg NN B-NP I-do
38 q NN I-NP B-f
38 24 CD O I-f
38 h NN B-NP I-f
38 X NNP I-NP B-du
38 2 CD O I-du
38 dose( NN B-NP I-du
38 s NN I-NP I-du
38 ) ) O I-du
38 , , O O
38 then RB O O
38 Starting VBG O O
38 IN NNP B-NP O
38 AM NNP I-NP O
38 ( ( O O
38 7/21 CD O O
38 ) ) O O
39 DIET: NNP B-NP O
39 2 CD O O
39 gram NN B-NP O
39 Sodium NNP I-NP O
40 ACTIVITY: NNP I-NP O
40 Activity NNP I-NP O
40 as IN B-VP O
40 tolerated VBN O O
41 FOLLOW NNP B-NP O
41 UP NNP I-NP O
41 APPOINTMENT( NNP I-NP O
41 S NNP I-NP O
41 ): NNP I-NP O
42 Please NNP I-NP O
42 arrange NN I-NP O
42 to TO O O
42 see VB O O
42 Dr NNP B-NP O
42 Minium NNP I-NP O
42 by IN B-VP O
42 the DT B-NP O
42 end NN I-NP O
42 of IN B-VP O
42 the DT B-NP O
42 week NN I-NP O
42 , , O O
43 ALLERGY: NNP B-NP O
43 AMOX./CLAV.ACID NNP I-NP O
43 250/125 CD O O
43 , , O O
43 Codeine NNP B-NP O
44 ADMIT NNP I-NP O
44 DIAGNOSIS: NNP I-NP O
45 Asthma NNP I-NP O
45 exacerbation NN I-NP O
46 PRINCIPAL NNP I-NP O
46 DISCHARGE NNP I-NP O
46 DIAGNOSIS NNP I-NP O
46 ;Responsible JJ O O
46 After IN B-VP O
46 Study NNP B-NP O
46 for IN B-VP O
46 Causing NNP B-NP O
46 Admission NNP I-NP O
46 ) ) O O
47 asthma VBP O O
47 exacerbation NN B-NP O
48 OTHER NNP I-NP O
48 DIAGNOSIS;Conditions NNP I-NP O
48 , , O O
48 Infections NNP B-NP O
48 , , O O
48 Complications NNP B-NP O
48 , , O O
48 affecting VBG O O
48 Treatment/Stay NNP B-NP O
49 asthma NN I-NP O
49 ( ( O O
49 asthma NN B-NP O
49 ) ) O O
49 HTN NNP B-NP O
49 ( ( O O
49 hypertension NN B-NP O
49 ) ) O O
49 obesity NN B-NP O
50 ( ( O O
50 obesity NN B-NP O
50 ) ) O O
50 HTN NNP B-NP O
50 ( ( O O
50 hypertension NN B-NP O
50 ) ) O O
50 hyperglycemia NN B-NP O
50 on IN B-VP O
50 steriods NNS B-NP O
50 ( ( O O
50 elevated VBN O O
51 glucose RB O O
51 ) ) O O
51 hirsutism NN B-NP O
51 ( ( O O
51 hirsutism NN B-NP O
51 ) ) O O
51 spinal JJ B-NP O
51 stenosis NN I-NP O
51 ( ( O O
51 spinal JJ B-NP O
52 stenosis NN I-NP O
52 ) ) O O
52 LBP NNP B-NP O
52 ( ( O O
52 low JJ O O
52 back RB O O
52 pain NN B-NP O
52 ) ) O O
52 chiari NN B-NP O
53 malformation NN I-NP O
53 spinal JJ B-NP O
53 syrinx NN I-NP O
53 C3-T2 NNP I-NP O
53 ( ( O O
53 8 CD O O
53 ) ) O O
54 OPERATIONS NN B-NP O
54 AND CC O O
54 PROCEDURES: NNP B-NP O
55 none NN I-NP O
56 OTHER NNP I-NP O
56 TREATMENTS/PROCEDURES NNP I-NP O
56 ( ( O O
56 NOT NNP B-NP O
56 IN NNP I-NP O
56 O.R NNP I-NP O
56 ) ) O O
57 none NN B-NP O
58 BRIEF NNP I-NP O
58 RESUME NNP I-NP O
58 OF NNP I-NP O
58 HOSPITAL NNP I-NP O
58 COURSE: NNP I-NP O
59 42 CD O O
59 yo NN B-NP O
59 F NNP I-NP O
59 w/ NN I-NP O
59 h/o NN I-NP O
59 asthma NN I-NP O
59 p/w NN I-NP O
59 SOB NNP I-NP O
59 in IN B-VP O
59 setting NN B-NP O
59 of IN B-VP O
59 recent JJ B-NP O
59 asthma NN I-NP O
59 flare NN I-NP O
60 ****************** NNP I-NP O
61 Pt NNP I-NP O
61 was VBD B-VP O
61 in IN B-VP O
61 her PRP$ O O
61 USOH NNP B-NP O
61 until IN B-VP O
61 1wk CD O O
61 PTA NNS B-NP O
61 when WRB O O
61 experienced VBN O O
61 URI NNP B-NP O
61 sx NN I-NP O
61 , , O O
61 productive JJ B-NP O
62 cough NN I-NP O
62 and CC O O
62 low JJ B-NP O
62 grade NN I-NP O
62 fevers NNS I-NP O
62 Seen NNP I-NP O
62 at IN B-VP O
62 Tasleyka NNP B-NP O
62 Medical NNP I-NP O
62 where WRB O O
62 rx'd NN B-NP O
62 with IN B-VP O
63 nebs NNS B-NP B-m
63 , , O O
63 steroids NNS B-NP B-m
63 and CC O O
63 d/c'd NN B-NP O
63 on IN B-VP O
63 pred JJ O B-m
63 taper IN B-VP O
63 starting VBG O O
63 at IN B-VP O
63 40mg CD O B-do
63 qd NN B-NP B-f
63 Pt NNP I-NP O
63 was VBD B-VP O
63 told VBN O O
64 that IN B-VP O
64 her PRP$ O O
64 CXR NNP B-NP O
64 was VBD B-VP O
64 c/w JJ B-NP O
64 PNA NNP I-NP O
64 Also RB O O
64 rx'd VBD B-VP O
64 Z-pack NNP B-NP B-m
64 which WDT O O
64 she PRP O O
64 has VBZ O O
64 completed VBN O O
65 Cough NNP B-NP O
65 and CC O O
65 URI NNP B-NP O
65 sx NNS I-NP O
65 have VBP O O
65 improved VBN O O
65 but CC O O
65 she PRP O O
65 has VBZ O O
65 had VBN O O
65 persistent JJ B-NP O
65 DOE NNP I-NP O
65 Peak NNP I-NP O
65 flow NN I-NP O
66 has VBZ O O
66 been VBN O O
66 150 CD O O
66 , , O O
66 decreased VBN O O
66 from IN B-VP O
66 baseline NN B-NP O
66 of IN B-VP O
66 300-350 JJ B-NP O
66 Seen NNP I-NP O
66 in IN B-VP O
66 TNH NNP B-NP O
67 urgent JJ B-NP O
67 care NN I-NP O
67 today NN I-NP O
67 where WRB O O
67 reportedly RB O O
67 she PRP O O
67 was VBD B-VP O
67 hypertensive JJ O O
67 and CC O O
67 O2 NNP B-NP O
67 sat VBD B-VP O
68 94-95% CD O O
68 on IN B-VP O
68 RA NNP B-NP O
68 , , O O
68 referred VBD B-VP O
68 to TO O O
68 OAKMA NNP B-NP O
68 VALLEY NNP I-NP O
68 HOSPITAL NNP I-NP O
68 for IN B-VP O
68 asthma NN B-NP O
68 flare NN I-NP O
68 refractory NN I-NP O
68 to TO O O
68 current JJ B-NP O
69 treatment NN I-NP O
69 No NNP I-NP O
69 CP NNP I-NP O
69 , , O O
69 HA NNP B-NP O
69 or CC O O
69 focal JJ B-NP O
69 neurological JJ I-NP O
69 deficits NNS I-NP O
69 Pt NNP I-NP O
69 c/o NN I-NP O
69 +increased VBD B-VP O
70 LE NNP B-NP O
70 edema NN I-NP O
70 L&gt;R NNP I-NP O
70 , , O O
70 +orthopnea NNP B-NP O
70 , , O O
70 and CC O O
70 +PND VBZ O O
70 No DT B-NP O
70 sick JJ I-NP O
70 contacts NNS I-NP O
71 **** VBP O O
72 ED: NNP B-NP O
72 97.4 CD O O
72 p126 NN B-NP O
72 181/95 CD O O
72 30 CD O O
72 94% CD O O
72 RA NNP B-NP O
72 , , O O
72 CXR NNP B-NP O
72 and CC O O
72 EKG NNP B-NP O
72 performed VBD B-VP O
72 , , O O
72 rx'd VB O O
73 prednisone NN B-NP B-m
73 60mg CD O B-do
73 x1 NN B-NP B-f
73 , , O O
73 nebs JJ B-NP B-mo
74 ************** NNP I-NP O
75 PMH: NNP I-NP O
75 Asthma NNP I-NP B-r
75 - : O O
75 no DT B-NP O
75 h/o JJ I-NP O
75 intubation NN I-NP O
75 , , O O
75 multiple JJ B-NP O
75 admissions NNS I-NP O
75 and CC O O
75 courses NNS B-NP O
75 of IN B-VP O
76 steroids NNS B-NP B-m
76 , , O O
76 HTN NNP B-NP O
76 , , O O
76 Obesity NNP B-NP O
76 , , O O
76 Hyperlipidemia NNP B-NP O
76 , , O O
76 Hyperglycemia NNP B-NP O
76 - : O O
76 when WRB O O
76 on IN B-VP O
76 steroids NNS B-NP B-m
76 , , O O
77 Hirsutism NNP B-NP O
77 , , O O
77 Chiari NNP B-NP O
77 Malformation NNP I-NP O
77 - : O O
77 s/p NN B-NP O
77 decompression NN I-NP O
77 , , O O
77 Spinal NNP B-NP O
77 Stenosis NNP I-NP O
77 , , O O
78 Spinal NNP B-NP O
78 Syrinx NNP I-NP O
78 - : O O
78 C3-T2 JJ O O
78 , , O O
78 Low NNP B-NP B-r
78 back RB O I-r
78 pain VBP O I-r
78 - : O O
78 s/p NN B-NP O
78 multiple JJ B-NP O
78 epidural JJ I-NP B-mo
78 steroid NN I-NP B-m
79 injections NNS I-NP O
80 ************* VBP O O
81 MEDS: NNP B-NP O
81 prednisone NN I-NP B-m
81 30mg CD O B-do
81 qd NN B-NP B-f
81 ( ( O O
81 taper NN B-NP O
81 ) ) O O
81 , , O O
81 advair NN B-NP B-m
81 , , O O
81 albuterol NN B-NP B-m
81 , , O O
81 combivent NN B-NP B-m
81 , , O O
82 singulair NN B-NP B-m
82 , , O O
82 lisinopril JJ B-NP B-m
83 *********** NNP I-NP O
84 EXAM: NNP I-NP O
84 Afeb NNP I-NP O
84 p104 VBD B-VP O
84 199/104 CD O O
84 rr25 NN B-NP O
84 96% CD O O
84 2L CD O O
85 Pt NNP B-NP O
85 appeared VBD B-VP O
85 in IN B-VP O
85 mild JJ B-NP O
85 respiratory NN I-NP O
85 distress NN I-NP O
85 , , O O
85 sitting VBG O O
85 up RP O O
85 reading VBG O O
85 a DT B-NP O
86 book NN I-NP O
86 , , O O
86 very RB O O
86 pleasant JJ B-NP O
86 obese JJ I-NP O
86 woman NN I-NP O
87 HEENT: NNP I-NP O
87 JVP NNP I-NP O
87 not RB O O
87 elevated VBD B-VP O
88 LUNGS: NNP B-NP O
88 prolonged VBD B-VP O
88 expiratory JJ B-NP O
88 phase NN I-NP O
89 CVS: NNP I-NP O
89 rrr NN I-NP O
89 , , O O
89 nl JJ B-NP O
89 S1S2 NNP I-NP O
89 , , O O
89 no DT B-NP O
89 m/g/r NN I-NP O
90 ABD: NNP I-NP O
90 obese NN I-NP O
90 , , O O
90 BS+ NNP B-NP O
90 , , O O
90 NT/ND NNP B-NP O
91 EXT: NNP I-NP O
91 TR NNP I-NP O
91 to TO O O
91 1+ CD O O
91 edema NN B-NP O
91 to TO O O
91 mid VB O O
91 calf NN B-NP O
91 bilat NN I-NP O
91 , , O O
91 L&gt;R NNP B-NP O
92 *************** NNP I-NP O
93 LABS: NNP I-NP O
93 WBC NNP I-NP O
93 14 CD O O
94 STUDIES: NNP B-NP O
95 EKG: NNP I-NP O
95 sinus VBD B-VP O
95 tach $ O O
95 104 CD O O
96 CXR( NNP B-NP O
96 : : O O
96 linear JJ B-NP O
96 opacity NN I-NP O
96 in IN B-VP O
96 RLL NNP B-NP O
96 most JJS O O
96 c/w VBP O O
96 platelike JJ B-NP O
96 atelectasis NN I-NP O
96 but CC O O
96 cannot NN B-NP O
96 r/o NN I-NP O
97 resolving VBG O O
97 or CC O O
97 new JJ B-NP O
97 PNA NNP I-NP O
98 *************** NNP I-NP O
99 HOSITAL NNP I-NP O
99 COURSE: NNP I-NP O
100 42 CD O O
100 yo NN B-NP O
100 F NNP I-NP O
100 w/ NN I-NP O
100 asthma NN I-NP O
100 and CC O O
100 tobacco NN B-NP O
100 use NN I-NP O
100 presents NNS I-NP O
100 with IN B-VP O
100 asthma/COPD JJ B-NP O
100 flare NN I-NP O
101 refractory NN I-NP O
101 to TO O O
101 initial JJ B-NP O
101 treatment NN I-NP O
102 * NNP I-NP O
102 PULM: NNP I-NP O
102 SOB NNP I-NP O
102 most RBS O O
102 likely JJ O O
102 2/2 CD O O
102 reactive JJ B-NP O
102 airway NN I-NP O
102 disease NN I-NP O
103 Substantial NNP I-NP O
103 smoking VBG O O
103 history NN B-NP O
103 raises VBZ O O
103 question NN B-NP O
103 of IN B-VP O
103 COPD NNP B-NP O
103 as IN B-VP O
104 contributor NN B-NP O
104 or CC O O
104 dominant JJ B-NP O
104 factor NN I-NP O
104 in IN B-VP O
104 her PRP$ O O
104 pulmonary JJ B-NP O
104 disease NN I-NP O
105 Pt NNP I-NP O
105 was VBD B-VP O
105 treated VBN O O
105 with IN B-VP O
105 duonebs JJ B-NP B-m
105 q4h NN I-NP B-f
105 with IN B-VP O
105 Albuterol NNP B-NP B-m
105 q2h VBP O B-f
105 prn NN B-NP I-f
105 Pt NNP I-NP O
105 was VBD B-VP O
105 continued VBN O O
106 on IN B-VP O
106 advair NN B-NP B-m
106 , , O O
106 singulair NN B-NP B-m
106 She PRP O O
106 was VBD B-VP O
106 started VBN O O
106 on IN B-VP O
106 Prednisone NNP B-NP B-m
106 60 CD O B-do
106 daily RB O B-f
106 for IN B-VP B-du
106 4 CD O I-du
106 days NNS B-NP I-du
107 and CC O O
107 then RB O O
107 slowy VB O O
107 tapered VBD B-VP O
107 No DT B-NP O
107 abx NN I-NP O
107 at IN B-VP O
107 this DT B-NP O
107 time NN I-NP O
107 as IN B-VP O
107 she PRP O O
107 just RB O O
107 completed VBD B-VP O
107 course NN B-NP O
108 WBC NNP I-NP O
108 elevation NN I-NP O
108 likely RB O O
108 2/2 CD O O
108 steroids NNS B-NP B-m
108 At IN B-VP O
108 D/C NNP B-NP O
108 , , O O
108 peak NN B-NP O
108 flow NN I-NP O
108 had VBD B-VP O
108 improved VBN O O
108 to TO O O
108 250 CD O O
109 and CC O O
109 ambulating VBG O O
109 O2 NNP B-NP O
109 sat NN I-NP O
109 was VBD B-VP O
109 92-94% JJ B-NP O
109 Pt's NNP I-NP O
109 breathing NN I-NP O
109 had VBD B-VP O
109 significantly RB O O
110 improved VBN O O
110 Smoking NNP B-NP B-r
110 cessation NN I-NP I-r
110 encouraged VBD B-VP O
110 Pt NNP B-NP O
110 was VBD B-VP O
110 interested JJ O O
110 in IN B-VP O
110 trying VBG O O
111 nicotine JJ B-NP B-m
111 patch NN I-NP I-m
112 * NNP I-NP O
112 CV: NNP I-NP O
112 PUMP: NNP I-NP O
112 HTN: NNP I-NP O
112 Lisinopril NNP I-NP B-m
112 Lisinopril NNP I-NP B-m
112 was VBD B-VP O
112 increased VBN O O
112 to TO O O
112 20mg CD O B-do
112 daily RB O B-f
112 due JJ O O
112 to TO O O
113 hypertension VB O B-r
113 hypertension NN B-NP B-r
113 No DT B-NP O
113 evidence NN I-NP O
113 of IN B-VP O
113 end-organ JJ B-NP O
113 damage NN I-NP O
113 in IN B-VP O
113 w/u JJ B-NP O
113 UA NNP I-NP O
113 neg NN I-NP O
114 for IN B-VP O
114 proteinuria NN B-NP O
115 * NNP I-NP O
115 PPX: NNP I-NP O
115 lovenox NN I-NP B-m
116 CODE: NNP I-NP O
116 full JJ B-NP O
117 ADDITIONAL NNP I-NP O
117 COMMENTS: NNP I-NP O
117 1 CD O O
117 ) ) O O
117 Continue NNP B-NP O
117 all DT O O
117 of IN B-VP O
117 your PRP$ O O
117 home NN B-NP B-m
117 medications NNS I-NP I-m
117 Your VBP O O
117 lisinopril JJ B-NP B-m
117 lisinopril NN I-NP B-m
117 was VBD B-VP O
117 increased VBN O O
118 to TO O O
118 20mg CD O B-do
118 daily RB O B-f
119 2 CD O O
119 ) ) O O
119 Take VB O O
119 prednisone NN B-NP B-m
119 prednisone NN I-NP B-m
119 prednisone NN I-NP B-m
119 prednisone NN I-NP B-m
119 prednisone NN I-NP B-m
119 prednisone NN I-NP B-m
119 60mg CD O B-do
119 daily NN B-NP B-f
119 for IN B-VP B-du
119 2 CD O I-du
119 days NNS B-NP I-du
119 ( ( O O
119 starting VBG O O
119 tomorrow NN B-NP O
119 ) ) O O
119 , , O O
119 then RB O O
119 50mg CD O B-do
120 daily JJ O B-f
120 x RB O B-du
120 3days CD O I-du
120 , , O O
120 then RB O O
120 40mg CD O B-do
120 daily JJ B-NP B-f
120 x3 NNP I-NP B-du
120 days NNS I-NP I-du
120 , , O O
120 then RB O O
120 30mg CD O B-do
120 daily JJ O B-f
120 x RB O B-du
120 3days CD O I-du
120 , , O O
120 then RB O O
121 20mg CD O B-do
121 daily JJ B-NP B-f
121 x3 NNP I-NP B-du
121 days NNS I-NP I-du
121 , , O O
121 and CC O O
121 then RB O O
121 10mg CD O B-do
121 daily JJ B-NP B-f
121 x2 NNP I-NP B-du
121 days NNS I-NP I-du
121 and CC O O
121 stop VB O O
122 3 CD O O
122 ) ) O O
122 Please NNP B-NP O
122 arrnge NN I-NP O
122 to TO O O
122 see VB O O
122 Dr NNP B-NP O
122 Portune NNP I-NP O
122 by IN B-VP O
122 the DT B-NP O
122 end NN I-NP O
122 of IN B-VP O
122 the DT B-NP O
122 week NN I-NP O
122 She PRP O O
122 will MD O O
123 advise VB O O
123 you PRP O O
123 of IN B-VP O
123 any DT B-NP O
123 change NN I-NP O
123 in IN B-VP O
123 your PRP$ O O
123 prednisone NN B-NP B-m
123 taper IN B-VP O
124 4 CD O O
124 ) ) O O
124 Call VB O O
124 Dr NNP B-NP O
124 Schmatz NNP I-NP O
124 or CC O O
124 come VBN O O
124 back RB O O
124 to TO O O
124 the DT B-NP O
124 emergency NN I-NP O
124 room NN I-NP O
124 if IN B-VP O
124 you PRP O O
124 experience VBP O O
125 worsening VBG O O
125 of IN B-VP O
125 your PRP$ O O
125 breathing NN B-NP O
125 or CC O O
125 fever VB O O
126 DISCHARGE NNP B-NP O
126 CONDITION: NNP I-NP O
126 Stable NNP I-NP O
127 TO NNP I-NP O
127 DO/PLAN: NNP I-NP O
128 ** NNP I-NP O
128 Dr NNP I-NP O
128 Tremmel NNP I-NP O
128 ** NNP I-NP O
129 Please NNP I-NP O
129 taper VB O O
129 prednisone NN B-NP B-m
129 as IN B-VP O
129 tolerated VBN O O
129 by IN B-VP O
129 patient JJ B-NP O
130 No NNP I-NP O
130 dictated VBD B-VP O
130 summary JJ B-NP O
131 ENTERED NNP I-NP O
131 BY: NNP I-NP O
131 DANIELS NNP I-NP O
131 , , O O
131 BOB NNP B-NP O
131 T NNP I-NP O
131 ( ( O O
131 GN51 NNP B-NP O
131 ) ) O O
131 5/1/06 CD O O
131 @ $ O O
131 12:40 CD O O
131 PM NNP B-NP O
132 ****** JJ B-NP O
132 END NNP I-NP O
132 OF NNP I-NP O
132 DISCHARGE NNP I-NP O
132 ORDERS NNP I-NP O
132 ****** NNP I-NP O
133 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #683679 VBZ O O
4 315194766 CD O O
4 TH NNP B-NP O
4 10418500 CD O O
4 1689655 CD O O
4 1/27/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHF NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/24/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/25/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 SWARR NNP I-NP O
8 , , O O
8 BLAKE NNP B-NP O
8 R NNP I-NP O
8 752-23-91-8 JJ B-NP O
9 Ma NNP I-NP O
10 Service: NNP I-NP O
10 RNM NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 8/27/06 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 SWEEDEN NNP I-NP O
14 , , O O
14 JOHNATHON NNP B-NP O
14 PERCY NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ASPIRIN NNP I-NP B-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 Instructions: NNP I-NP O
20 At IN B-VP O
20 12 CD O O
20 noon NN B-NP O
21 LIPITOR NNP I-NP B-m
21 ( ( O I-m
21 ATORVASTATIN NNP B-NP I-m
21 ) ) O I-m
21 10 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 DAILY NNP I-NP B-f
22 Instructions: NNP I-NP O
22 take VB O O
22 at IN B-VP O
22 noon RB O O
23 COLESTIPOL NNP B-NP B-m
23 HYDROCHLORIDE NNP I-NP I-m
23 10 CD O B-do
23 GM NNP B-NP I-do
23 PO NNP I-NP B-mo
23 DAILY NNP I-NP B-f
24 Instructions: NNP I-NP O
24 At IN B-VP O
24 6PM CD O O
24 Food/Drug NNP B-NP O
24 Interaction NNP I-NP O
24 Instruction NNP I-NP O
25 Take NNP I-NP O
25 before IN B-VP O
25 meals NNS B-NP O
25 Monitor NNP I-NP O
25 fat VBD B-VP O
25 soluble JJ B-NP O
25 vitamins NNS I-NP O
26 Number NNP I-NP O
26 of IN B-VP O
26 Doses NNP B-NP O
26 Required NNP I-NP O
26 ( ( O O
26 approximate JJ B-NP O
26 ): NN I-NP O
26 5 CD O B-du
27 INSULIN NNP B-NP B-m
27 GLARGINE NNP I-NP I-m
27 14 CD O B-do
27 UNITS NNP B-NP I-do
27 SC NNP I-NP B-mo
27 DAILY NNP I-NP B-f
28 HUMALOG NNP I-NP B-m
28 HUMALOG NNP I-NP B-m
28 INSULIN NNP I-NP I-m
28 INSULIN NNP I-NP I-m
28 ( ( O I-m
28 ( ( O I-m
28 INSULIN NNP B-NP I-m
28 INSULIN NNP I-NP I-m
28 LISPRO NNP I-NP I-m
28 LISPRO NNP I-NP I-m
28 ) ) O I-m
28 ) ) O I-m
29 Sliding VBG O B-do
29 Sliding VBG O B-do
29 Scale NNP B-NP I-do
29 Scale NNP I-NP I-do
29 ( ( O O
29 subcutaneous JJ O B-mo
29 subcutaneous JJ O B-mo
29 ) ) O I-mo
29 ) ) O I-mo
29 SC NNP B-NP I-mo
29 SC NNP I-NP I-mo
29 AC NNP I-NP B-f
30 Instructions: NNP I-NP O
30 pt NN I-NP O
30 takes VBZ O O
30 his PRP$ O O
30 own JJ B-NP O
30 scale NN I-NP O
30 Low NNP I-NP O
30 Scale NNP I-NP O
31 Call NNP I-NP O
31 HO NNP I-NP O
31 if IN B-VP O
31 BS NNP B-NP O
31 less JJR O O
31 than IN B-VP O
31 60 CD O O
32 If IN B-VP O
32 BS NNP B-NP O
32 is VBZ O O
32 less JJR O O
32 than IN B-VP O
32 125 CD O O
32 , , O O
32 then RB O O
32 DO NNP B-NP O
32 NOT NNP I-NP O
32 Administer NNP I-NP O
33 supplemental NN I-NP O
33 ( ( O O
33 sliding VBG O O
33 scale NN B-NP O
33 ) ) O O
33 insulin NN B-NP O
34 If IN B-VP O
34 BS NNP B-NP O
34 is VBZ O O
34 125-150 JJ O O
34 , , O O
34 then RB O O
34 give VB O O
34 0 CD O O
34 units NNS B-NP O
34 subcutaneously RB O O
35 If IN B-VP O
35 BS NNP B-NP O
35 is VBZ O O
35 151-200 CD O O
35 , , O O
35 then RB O O
35 give VB O O
35 1 CD O O
35 units NNS B-NP O
35 subcutaneously RB O O
36 If IN B-VP O
36 BS NNP B-NP O
36 is VBZ O O
36 201-250 JJ O O
36 , , O O
36 then RB O O
36 give VB O O
36 2 CD O O
36 units NNS B-NP O
36 subcutaneously RB O O
37 If IN B-VP O
37 BS NNP B-NP O
37 is VBZ O O
37 251-300 JJ O O
37 , , O O
37 then RB O O
37 give VB O O
37 3 CD O O
37 units NNS B-NP O
37 subcutaneously RB O O
38 If IN B-VP O
38 BS NNP B-NP O
38 is VBZ O O
38 301-350 JJ O O
38 , , O O
38 then RB O O
38 give VB O O
38 4 CD O O
38 units NNS B-NP O
38 subcutaneously RB O O
39 If IN B-VP O
39 BS NNP B-NP O
39 is VBZ O O
39 351-400 CD O O
39 , , O O
39 then RB O O
39 give VB O O
39 5 CD O O
39 units NNS B-NP O
39 subcutaneously RB O O
40 Call NNP B-NP O
40 HO NNP I-NP O
40 if IN B-VP O
40 BS NNP B-NP O
40 is VBZ O O
40 greater JJR O O
40 than IN B-VP O
40 350 CD O O
41 Please NNP B-NP O
41 give VB O O
41 at IN B-VP O
41 the DT B-NP O
41 same JJ I-NP O
41 time NN I-NP O
41 and CC O O
41 in IN B-VP O
41 addition NN B-NP O
41 to TO O O
41 standing VBG O O
42 mealtime JJ B-NP O
42 insulin NN I-NP O
43 IMDUR NNP I-NP B-m
43 ER NNP I-NP I-m
43 ( ( O I-m
43 ISOSORBIDE NNP B-NP I-m
43 MONONITRATE NNP I-NP I-m
43 ( ( O I-m
43 SR NNP B-NP I-m
43 ) ) O I-m
43 ) ) O I-m
43 60 CD O B-do
43 MG NNP B-NP I-do
43 PO NNP I-NP B-mo
43 DAILY NNP I-NP B-f
44 HOLD NNP I-NP O
44 IF: NNP I-NP O
44 sbp&lt;100 NN I-NP O
44 , , O O
44 please NN B-NP O
44 hold VB O O
44 prior JJ O O
44 to TO O O
44 dialysis VB O O
45 Instructions: NNP B-NP O
45 12 CD O O
45 noon NN B-NP O
45 , , O O
45 unless IN B-VP O
45 patient NN B-NP O
45 is VBZ O O
45 at IN B-VP O
45 dialysis NN B-NP O
46 Food/Drug NNP I-NP O
46 Interaction NNP I-NP O
46 Instruction NNP I-NP O
47 Give NNP I-NP O
47 on IN B-VP O
47 an DT B-NP O
47 empty JJ I-NP O
47 stomach NN I-NP O
47 ( ( O O
47 give JJ O O
47 1hr CD O O
47 before IN B-VP O
47 or CC O O
47 2hr CD O O
47 after IN B-VP O
48 food NN B-NP O
48 ) ) O O
49 KLOR-CON NNP B-NP B-m
49 ( ( O I-m
49 KCL NNP B-NP I-m
49 SLOW NNP I-NP I-m
49 RELEASE NNP I-NP I-m
49 ) ) O I-m
49 20 CD O B-do
49 MEQ NNP B-NP I-do
49 PO NNP I-NP B-mo
49 DAILY NNP I-NP B-f
50 As IN B-VP O
50 per IN B-VP O
50 IMC NNP B-NP O
50 Potassium NNP I-NP B-m
50 Chloride NNP I-NP I-m
50 Policy: NNP I-NP O
51 each DT O O
51 20 CD O B-do
51 mEq NNS B-NP I-do
51 dose VB O O
51 to TO O O
51 be VB O O
51 given VBN O O
51 with IN B-VP O
51 4 CD O O
51 oz NNS B-NP O
51 of IN B-VP O
51 fluid NN B-NP O
52 TOPROL NNP I-NP B-m
52 XL NNP I-NP I-m
52 ( ( O I-m
52 METOPROLOL NNP B-NP I-m
52 SUCCINATE NNP I-NP I-m
52 EXTENDED NNP I-NP I-m
52 RELEASE NNP I-NP I-m
52 ) ) O I-m
53 50 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 BEDTIME NNP I-NP B-f
54 HOLD NNP I-NP O
54 IF: NNP I-NP O
54 sbp&lt;100 VBD B-VP O
54 or CC O O
54 hr&lt;60 NN B-NP O
54 and CC O O
54 notify VB O O
54 HO NNP B-NP O
54 if IN B-VP O
54 holding VBG O O
55 Food/Drug NNP B-NP O
55 Interaction NNP I-NP O
55 Instruction NNP I-NP O
56 Take NNP I-NP O
56 consistently RB O O
56 with IN B-VP O
56 meals NNS B-NP O
56 or CC O O
56 on IN B-VP O
56 empty JJ B-NP O
56 stomach NN I-NP O
57 Number NNP I-NP O
57 of IN B-VP O
57 Doses NNP B-NP O
57 Required NNP I-NP O
57 ( ( O O
57 approximate JJ B-NP O
57 ): NN I-NP O
57 5 CD O O
58 FLOMAX NNP B-NP B-m
58 ( ( O I-m
58 TAMSULOSIN NNP B-NP I-m
58 ) ) O I-m
58 0.4 CD O B-do
58 MG NNP B-NP I-do
58 PO NNP I-NP B-mo
58 DAILY NNP I-NP B-f
59 Instructions: NNP I-NP O
59 At IN B-VP O
59 12 CD O O
59 noon NN B-NP O
60 TORSEMIDE NNP I-NP B-m
60 150 CD O B-do
60 MG NNP B-NP I-do
60 PO NNP I-NP B-mo
60 DAILY NNP I-NP B-f
61 HOLD NNP I-NP O
61 IF: NNP I-NP O
61 sbp&lt;100 NN I-NP O
61 and CC O O
61 notify VB O O
61 HO NNP B-NP O
61 if IN B-VP O
61 holding VBG O O
62 DIET: NNP B-NP O
62 House NNP I-NP O
62 / VBD B-VP O
62 2 CD O O
62 gm NN B-NP O
62 Na NNP I-NP O
62 / VBZ O O
62 2 CD O O
62 gram NN B-NP O
62 K+ NNP I-NP O
63 ACTIVITY: NNP I-NP O
63 Resume NNP I-NP O
63 regular JJ B-NP O
63 exercise NN I-NP O
64 FOLLOW NNP I-NP O
64 UP NNP I-NP O
64 APPOINTMENT( NNP I-NP O
64 S NNP I-NP O
64 ): NNP I-NP O
65 LH NNP I-NP O
65 dialysis NN I-NP O
65 unit NN I-NP O
65 Monday NNP I-NP O
65 6/30 CD O O
65 10:30am CD O O
65 scheduled VBN O O
65 , , O O
66 ALLERGY: NNP B-NP O
66 Penicillins NNP I-NP O
66 , , O O
66 LISINOPRIL NNP B-NP O
67 ADMIT NNP I-NP O
67 DIAGNOSIS: NNP I-NP O
68 CHF NNP I-NP O
69 PRINCIPAL NNP I-NP O
69 DISCHARGE NNP I-NP O
69 DIAGNOSIS NNP I-NP O
69 ;Responsible JJ O O
69 After IN B-VP O
69 Study NNP B-NP O
69 for IN B-VP O
69 Causing NNP B-NP O
69 Admission NNP I-NP O
69 ) ) O O
70 CHF NNP B-NP O
71 OTHER NNP I-NP O
71 DIAGNOSIS;Conditions NNP I-NP O
71 , , O O
71 Infections NNP B-NP O
71 , , O O
71 Complications NNP B-NP O
71 , , O O
71 affecting VBG O O
71 Treatment/Stay NNP B-NP O
72 ESRD NNP I-NP O
72 , , O O
72 PVD NNP B-NP O
72 , , O O
72 CAD NNP B-NP O
72 s/p VBD B-VP O
72 3MIs CD O O
72 3vCABG CD O O
72 , , O O
72 ischemic JJ B-NP O
72 cardiomyopathy NN I-NP O
72 25% CD O O
73 OPERATIONS NNP B-NP O
73 AND NNP I-NP O
73 PROCEDURES: NNP I-NP O
74 OTHER NNP I-NP O
74 TREATMENTS/PROCEDURES NNP I-NP O
74 ( ( O O
74 NOT NNP B-NP O
74 IN NNP I-NP O
74 O.R NNP I-NP O
74 ) ) O O
75 4/10 CD O O
75 placement NN B-NP O
75 of IN B-VP O
75 tunneled JJ B-NP O
75 catheter NN I-NP O
75 in IN B-VP O
75 RIJ NNP B-NP O
76 1/19 CD O O
76 Hemodialysis NNP B-NP O
77 BRIEF NNP I-NP O
77 RESUME NNP I-NP O
77 OF NNP I-NP O
77 HOSPITAL NNP I-NP O
77 COURSE: NNP I-NP O
78 CC: NNP I-NP O
78 admitted VBD B-VP O
78 for IN B-VP O
78 HD NNP B-NP O
78 initiation NN I-NP O
79 ****** NNP I-NP O
80 HPI: NNP I-NP O
80 This DT O O
80 is VBZ O O
80 a DT B-NP O
80 54 JJ I-NP O
80 yo NN I-NP O
80 male NN I-NP O
80 with IN B-VP O
80 ischemic JJ B-NP O
80 cardiomyopathy NN I-NP O
80 with IN B-VP O
80 EF NNP B-NP O
80 25% CD O O
80 , , O O
81 severe JJ B-NP O
81 pulmonary JJ I-NP O
81 HTN NNP I-NP O
81 , , O O
81 and CC O O
81 chronic JJ B-NP O
81 kidney NN I-NP O
81 disease NN I-NP O
81 bl VBD B-VP O
81 Cr NNP B-NP O
81 2.5 CD O O
81 who WP O O
81 was VBD B-VP O
82 admitted VBN O O
82 3 CD O O
82 weeks NNS B-NP O
82 ago RB O O
82 to TO O O
82 MSCH NNP B-NP O
82 for IN B-VP O
82 CHF NNP B-NP O
82 and CC O O
82 diuresis NN B-NP O
82 He PRP O O
82 was VBD B-VP O
82 begun VBN O O
82 on IN B-VP O
83 metolazone NN B-NP B-m
83 on IN B-VP O
83 as IN B-VP B-f
83 needed JJ B-NP I-f
83 basis NN I-NP O
83 for IN B-VP O
83 weight NN B-NP O
83 , , O O
83 but CC O O
83 presented VBD B-VP O
83 to TO O O
83 ED NNP B-NP O
83 with IN B-VP O
83 Cr NNP B-NP O
83 5.1 CD O O
84 and CC O O
84 looking VBG O O
84 dehydrated VBD B-VP O
84 He PRP O O
84 was VBD B-VP O
84 volume NN B-NP O
84 resuscitated VBN O O
84 with IN B-VP O
84 creatinine NN B-NP O
85 decreasing VBG O O
85 to TO O O
85 3.9 CD O O
85 Metolazone NNP B-NP B-m
85 was VBD B-VP O
85 held VBN O O
85 on IN B-VP O
85 d/c NN B-NP O
85 with IN B-VP O
85 Cr NNP B-NP O
85 dec NN I-NP O
85 to TO O O
85 3.4 CD O O
85 , , O O
85 but CC O O
85 pt RB O O
86 appeared VBD B-VP O
86 at IN B-VP O
86 renal JJ B-NP O
86 clinic NN I-NP O
86 on IN B-VP O
86 2/3 CD O O
86 with IN B-VP O
86 extreme JJ B-NP O
86 SOB NNP I-NP O
86 and CC O O
86 inability NN B-NP O
86 to TO O O
86 sleep VB O O
87 at IN B-VP O
87 night NN B-NP O
87 Pt NNP I-NP O
87 has VBZ O O
87 DOE NNP B-NP O
87 +orthopnea NNP I-NP O
87 , , O O
87 sleeps VBZ O O
87 in IN B-VP O
87 chair NN B-NP O
87 Denies NNP I-NP O
87 any DT B-NP O
87 CP NNP I-NP O
87 or CC O O
88 dizziness NN B-NP O
88 BUN/Cr NNP I-NP O
88 102/3.3 CD O O
88 Due NNP B-NP O
88 to TO O O
88 the DT B-NP O
88 pt's NN I-NP O
88 difficult JJ O O
88 to TO O O
88 control VB O O
88 volume NN B-NP O
89 status NN I-NP O
89 , , O O
89 pt JJ B-NP O
89 underwent JJ I-NP O
89 14-french JJ I-NP O
89 double JJ I-NP O
89 IJ NNP I-NP O
89 TC NNP I-NP O
89 placement NN I-NP O
89 today NN I-NP O
89 in IN B-VP O
89 IR NNP B-NP O
90 Presently NNP I-NP O
90 , , O O
90 he PRP O O
90 is VBZ O O
90 complaining VBG O O
90 of IN B-VP O
90 soreness NN B-NP O
90 at IN B-VP O
90 the DT B-NP O
90 R NNP I-NP O
90 tunnel NN I-NP O
90 catheter NN I-NP O
90 site NN I-NP O
91 Denies NNPS I-NP O
91 CP NNP I-NP O
91 but CC O O
91 has VBZ O O
91 some DT B-NP O
91 SOB NNP I-NP O
91 Planned VBD B-VP O
91 for IN B-VP O
91 HD NNP B-NP O
91 tomorrow NN I-NP O
91 AM NNP I-NP O
92 ****** NNP I-NP O
93 PMH: NNP I-NP O
93 Coronary NNP I-NP O
93 artery NN I-NP O
93 disease NN I-NP O
93 status NN I-NP O
93 post NN I-NP O
93 3v CD O O
93 CABG NNP B-NP O
93 1996; CD O O
93 PVD NNP B-NP O
93 s/p NN I-NP O
93 R NNP I-NP O
93 AKA NNP I-NP O
94 s/p JJ B-NP O
94 bilateral JJ I-NP O
94 femoral-popliteal NN I-NP O
94 and CC O O
94 bypass NN B-NP O
94 graft; NN I-NP O
94 DM NNP I-NP O
94 type NN I-NP O
94 1 CD O O
94 x NN B-NP O
94 44 CD O O
94 yrs NN B-NP O
94 , , O O
94 c/b JJ B-NP O
95 diabetic JJ I-NP O
95 nephropathy NN I-NP O
95 , , O O
95 diabetic JJ B-NP O
95 retinopathy NN I-NP O
95 , , O O
95 and CC O O
95 diabetic JJ B-NP O
95 neuropathy; NN I-NP O
96 ischemic JJ B-NP O
96 cardiomyopathy NN I-NP O
96 with IN B-VP O
96 ejection NN B-NP O
96 fraction NN I-NP O
96 of IN B-VP O
96 25% CD O O
96 to TO O O
96 30% CD O O
96 , , O O
96 severe JJ B-NP O
97 pulmonary JJ I-NP O
97 hypertension NN I-NP O
97 , , O O
97 BPH NNP B-NP O
97 , , O O
97 lactose JJ B-NP O
97 intolerance NN I-NP O
97 , , O O
97 COPD NNP B-NP O
97 , , O O
97 Right NNP B-NP O
98 hydronephrosis NN I-NP O
98 secondary JJ O O
98 to TO O O
98 a DT B-NP O
98 right JJ I-NP O
98 ureteral JJ I-NP O
98 stricture NN I-NP O
98 Bilateral NNP I-NP O
98 renal JJ B-NP O
99 artery NN I-NP O
99 stenosis NN I-NP O
100 ****** NNP I-NP O
101 ALLERGIES: NNP I-NP O
101 penicillin NN I-NP O
101 causes VBZ O O
101 rash JJ B-NP O
102 ****** JJ I-NP O
103 Medications NNS I-NP O
103 at IN B-VP O
103 home: NN B-NP O
104 Aspirin NNP I-NP B-m
104 81 CD O B-do
104 qd NN B-NP B-f
104 , , O O
104 torsemide RB O B-m
104 150 CD O B-do
104 qd NN B-NP B-f
104 , , O O
104 lipitor NN B-NP B-m
104 10 CD O B-do
104 , , O O
104 imdur NN B-NP B-m
104 ER NNP I-NP I-m
104 60 CD O B-do
104 , , O O
104 zemplar JJ O B-m
104 1mg CD O B-do
105 daily RB O B-f
105 , , O O
105 klorcon NN B-NP B-m
105 slow JJ B-NP I-m
105 release NN I-NP I-m
105 20 CD O B-do
105 mEq JJ O I-do
105 daily RB O B-f
105 , , O O
105 Flomax NNP B-NP B-m
105 0.4 CD O B-do
105 qd NN B-NP B-f
105 , , O O
105 colestipol VBP O B-m
105 1g CD O B-do
106 qd NN B-NP B-f
106 , , O O
106 toprol-XL JJ O B-m
106 50 CD O B-do
106 qhs NN B-NP B-f
106 , , O O
106 lantus VBZ O B-m
106 14 CD O B-do
106 unit NN B-NP I-do
106 sc NN I-NP B-mo
106 , , O O
106 humalog NN B-NP B-m
106 scale NN I-NP O
106 , , O O
106 metolazone RB O B-m
106 5mg CD O B-do
106 as IN B-VP B-f
107 needed VBN O O
108 ****** NN B-NP O
109 ADMISSION NNP I-NP O
109 EXAM: NNP I-NP O
110 VS NNP I-NP O
110 T NNP I-NP O
110 95.5 CD O O
110 , , O O
110 HR NNP B-NP O
110 64 CD O O
110 , , O O
110 BP NNP B-NP O
110 100/56 CD O O
110 , , O O
110 RR NNP B-NP O
110 18 CD O O
110 , , O O
110 O2sat NNP B-NP O
110 99% CD O O
110 RA NNP B-NP O
111 Gen: NNP I-NP O
111 in IN B-VP O
111 no DT B-NP O
111 acute NN I-NP O
111 distress NN I-NP O
111 sitting VBG O O
111 at IN B-VP O
111 45 CD O O
111 degrees NNS B-NP O
112 HEENT: NNP I-NP O
112 PERRL NNP I-NP O
112 3mm CD O O
112 pupils NNS B-NP O
112 Arcus NNP I-NP O
112 senilus CC O O
112 EOMI NNP B-NP O
112 O/p NNP I-NP O
112 clear JJ B-NP O
112 No NNP I-NP O
112 LAD NNP I-NP O
113 Tenderness NNP I-NP O
113 at IN B-VP O
113 R NNP B-NP O
113 tunnel NN I-NP O
113 cath NN I-NP O
113 site NN I-NP O
113 o/w IN B-VP O
113 dressing VBG O O
113 c/d/i NN B-NP O
114 Chest: NNP I-NP O
114 bilateral JJ B-NP O
114 base NN I-NP O
114 crackles NNS I-NP O
114 Decreased VBN O O
114 BS NNP B-NP O
114 to TO O O
114 = VB O O
114 way NN B-NP O
114 up IN B-VP O
115 CV: NNP B-NP O
115 RRR NNP I-NP O
115 S1 NNP I-NP O
115 and CC O O
115 widely RB O O
115 split VBD B-VP O
115 S2 NNP B-NP O
115 3/6 CD O O
115 harsh NN B-NP O
115 SEM NNP I-NP O
115 loudest JJS O O
115 in IN B-VP O
115 pulmonic JJ B-NP O
115 area NN I-NP O
116 +RV NNS I-NP O
116 heave VBP O O
116 JVP NNP B-NP O
116 &gt; $ O O
116 15cm CD O O
116 ( ( O O
116 to TO O O
116 jaw VB O O
116 standing VBG O O
116 up RP O O
116 ) ) O O
117 Abd: NNP B-NP O
117 soft JJ B-NP O
117 nontender NN I-NP O
117 +BS NNP I-NP O
118 Ext: NNP I-NP O
118 R NNP I-NP O
118 above IN B-VP O
118 the DT B-NP O
118 knee NN I-NP O
118 amputation NN I-NP O
118 2+ CD O O
118 pitting VBG O O
118 edema NN B-NP O
118 in IN B-VP O
118 left JJ B-NP O
118 leg NN I-NP O
118 No NNP I-NP O
119 ulcers NNS I-NP O
119 in IN B-VP O
119 left JJ B-NP O
119 foot NN I-NP O
119 0-1+ JJ B-NP O
119 DP NNP I-NP O
119 pulses VBZ O O
120 Neuro: NNP B-NP O
120 AO NNP I-NP O
120 x VBD B-VP O
120 3 CD O O
120 CN2-12 JJ B-NP O
120 intact JJ I-NP O
120 Motor NNP I-NP O
120 strength NN I-NP O
120 grossly RB O O
120 intact JJ B-NP O
120 Sensation NNP I-NP O
121 intact NN I-NP O
121 except IN B-VP O
121 decreased VBN O O
121 in IN B-VP O
121 left JJ B-NP O
121 foot NN I-NP O
122 ****** NNP I-NP O
123 LABORATORY NNP I-NP O
123 DATA: NNP I-NP O
124 0/16 CD O O
124 Na NNP B-NP O
124 137 CD O O
124 , , O O
124 K NNP B-NP O
124 3.3 CD O O
124 , , O O
124 Cl NNP B-NP O
124 97 CD O O
124 , , O O
124 CO2 NNP B-NP O
124 29 CD O O
124 , , O O
124 BUN NNP B-NP O
124 102 CD O O
124 , , O O
124 Cr NNP B-NP O
124 3.3 CD O O
124 , , O O
124 Glc NNP B-NP O
124 293 CD O O
125 4/13 CD O O
125 AST NNP B-NP O
125 20 CD O O
125 , , O O
125 ALT NNP B-NP O
125 17 CD O O
125 , , O O
125 ALKP NNP B-NP O
125 118 CD O O
125 , , O O
125 TB NNP B-NP O
125 1.0 CD O O
126 4/13 CD O O
126 WBC NNP B-NP O
126 7.4 CD O O
126 , , O O
126 HCT NNP B-NP O
126 34.3 CD O O
126 , , O O
126 PLT NNP B-NP O
126 211 CD O O
127 7/14 CD O O
127 PT NNP B-NP O
127 14.4 CD O O
127 , , O O
127 PTT NNP B-NP O
127 33.7 CD O O
127 , , O O
127 INR NNP B-NP O
127 1.1 CD O O
128 2/2/06 CD O O
128 : : O O
128 UA NNP B-NP O
128 neg MD O O
129 ****** VB O O
130 MAJOR NNP B-NP O
130 STUDIES: NNP I-NP O
131 ECG NNP I-NP O
131 4/5/06 CD O O
131 : : O O
131 NSR NN B-NP O
131 68 CD O O
131 , , O O
131 LAD NNP B-NP O
131 , , O O
131 biatrial JJ B-NP O
131 enlargement NN I-NP O
131 , , O O
131 QRS NNP B-NP O
131 196 CD O O
131 , , O O
131 BBB NNP B-NP O
131 V4-V6 NNP I-NP O
131 Q NNP I-NP O
132 waves NNS I-NP O
132 and CC O O
132 Tw NNP B-NP O
132 inv VBP O O
132 V5-V6 NNP B-NP O
132 vs NN I-NP O
132 prior RB O O
132 study NN B-NP O
132 on IN B-VP O
132 11/11 CD O O
132 unchanged JJ B-NP O
133 PA/lateral NNP I-NP O
133 CXR NNP I-NP O
133 0/23/06 CD O O
133 : : O O
133 Interval NN B-NP O
133 worsening VBG O O
133 pulmonary JJ B-NP O
133 edema NN I-NP O
133 Persistent NNP I-NP O
134 small JJ B-NP O
134 bilateral JJ I-NP O
134 pleural JJ I-NP O
134 effusions NNS I-NP O
135 TTE VBP O O
135 6/28 CD O O
135 Overall JJ B-NP O
135 LVEF NNP I-NP O
135 20% CD O O
135 Global NNP B-NP O
135 hypokinesis NN I-NP O
135 with IN B-VP O
135 regional JJ B-NP O
135 variation NN I-NP O
136 Global NNP I-NP O
136 RVSF NNP I-NP O
136 reduced VBD B-VP O
136 Severe NNP B-NP O
136 LAE NNP I-NP O
136 RAE NNP I-NP O
136 Trace NNP I-NP O
136 AR NNP I-NP O
136 Mod NNP I-NP O
136 MR NNP I-NP O
136 Mild NNP I-NP O
136 -mod NNP I-NP O
136 TR NNP I-NP O
137 Mild NNP I-NP O
137 PR NNP I-NP O
138 ******** NNP I-NP O
139 HOSPITAL NNP I-NP O
139 COURSE NNP I-NP O
139 BY NNP I-NP O
139 PROBLEM: NNP I-NP O
139 In IN B-VP O
139 summary JJ O O
139 , , O O
139 this DT O O
139 is VBZ O O
139 a DT B-NP O
139 54yo JJ I-NP O
139 man NN I-NP O
139 with IN B-VP O
139 CKD NNP B-NP O
139 and CC O O
140 poorly RB O O
140 controlled VBD B-VP O
140 volume NN B-NP O
140 status NN I-NP O
140 2/2 CD O O
140 diuresis NN B-NP O
140 limited VBN O O
140 by IN B-VP O
140 azotemia NN B-NP O
140 admitted VBN O O
141 for IN B-VP O
141 tunnel NN B-NP O
141 catheter NN I-NP O
141 placement NN I-NP O
141 and CC O O
141 initiation NN B-NP O
141 of IN B-VP O
141 HD NNP B-NP O
142 *Renal: NNP I-NP O
142 On IN B-VP O
142 admission NN B-NP O
142 , , O O
142 the DT B-NP O
142 patient NN I-NP O
142 was VBD B-VP O
142 volume NN B-NP O
142 overloaded VBN O O
142 by IN B-VP O
142 exam NN B-NP O
142 He PRP O O
143 underwent JJ B-NP O
143 TC NNP I-NP O
143 without IN B-VP O
143 complications NNS B-NP O
143 on IN B-VP O
143 4/10 CD O O
143 The DT B-NP O
143 patient NN I-NP O
143 underwent NN I-NP O
143 first JJ B-NP O
144 hemodialysis NN I-NP O
144 on IN B-VP O
144 1/19 CD O O
144 with IN B-VP O
144 improvement NN B-NP O
144 of IN B-VP O
144 volume NN B-NP O
144 status NN I-NP O
144 ( ( O O
144 decreased JJ B-NP O
145 crackles NNS I-NP O
145 , , O O
145 decreased VBD B-VP O
145 JVP NNP B-NP O
145 , , O O
145 less JJR B-NP O
145 edema NN I-NP O
145 On IN B-VP O
145 discharge NN B-NP O
145 , , O O
145 we PRP O O
145 have VBP O O
145 held VBN O O
145 zemplar JJ O B-m
146 and CC O O
146 metolazone NN B-NP B-m
146 , , O O
146 and CC O O
146 told VBD B-VP O
146 pt NN B-NP O
146 to TO O O
146 continue VB O O
146 his PRP$ O O
146 home NN B-NP B-m
146 medications NNS I-NP I-m
146 otherwise RB O O
147 ( ( O O
147 see VB O O
147 todo/plan NN B-NP O
147 ) ) O O
147 The DT B-NP O
147 pt NN I-NP O
147 is VBZ O O
147 to TO O O
147 return VB O O
147 Monday NNP B-NP O
147 for IN B-VP O
147 his PRP$ O O
147 second JJ B-NP O
147 dialysis NN I-NP O
147 run VB O O
148 *Code NNP B-NP O
148 status: NN I-NP O
148 Presently NNP I-NP O
148 , , O O
148 full JJ B-NP O
148 code NN I-NP O
148 He PRP O O
148 does VBZ O O
148 not RB O O
148 have VB O O
148 formal JJ B-NP O
148 HCP NNP I-NP O
148 but CC O O
148 we PRP O O
149 have VBP O O
149 discussed VBN O O
149 the DT B-NP O
149 importance NN I-NP O
149 of IN B-VP O
149 arranging VBG O O
149 for IN B-VP O
149 one CD O O
150 ********* NN B-NP O
151 Discharge NNP I-NP O
151 meds: NNS I-NP O
151 take VBP O O
151 all DT B-NP O
151 medications NNS I-NP O
151 as IN B-VP O
151 at IN B-VP O
151 home NN B-NP O
151 with IN B-VP O
151 the DT O O
151 following VBG O O
152 changes: NN B-NP O
153 1.Hold CD O O
153 zemplar JJ O O
154 2.Hold CD O O
154 metolazone NN B-NP O
155 3.Take CD O O
155 Torsemide NNP B-NP O
155 and CC O B-m
155 Klor-Con NNP B-NP O
155 as IN B-VP B-m
155 per IN B-VP O
155 your PRP$ O O
155 normal JJ B-NP O
155 routine JJ I-NP O
155 Do NNP I-NP O
155 not RB O O
156 take VB O O
156 Torsemide NN B-NP B-m
156 on IN B-VP O
156 Monday NNP B-NP O
157 ADDITIONAL NNP I-NP O
157 COMMENTS: NNP I-NP O
158 DISCHARGE NNP I-NP O
158 CONDITION: NNP I-NP O
158 Stable NNP I-NP O
159 TO NNP I-NP O
159 DO/PLAN: NNP I-NP O
160 take VB O O
160 all DT B-NP O
160 medications NNS I-NP O
160 as IN B-VP O
160 at IN B-VP O
160 home NN B-NP O
160 with IN B-VP O
160 the DT O O
160 following VBG O O
160 changes: NN B-NP O
161 1 CD O O
161 Hold NNP B-NP O
161 zemplar NN I-NP B-m
162 2 CD O O
162 Hold NNP B-NP O
162 metolazone NN I-NP B-m
163 3 CD O O
163 Take NNP B-NP O
163 Torsemide NNP I-NP B-m
163 and CC O O
163 Klor-Con NNP B-NP B-m
163 as IN B-VP O
163 per IN B-VP O
163 your PRP$ O O
163 normal JJ B-NP O
163 routine JJ I-NP O
163 Do NNP I-NP O
163 not RB O O
163 take VB O O
164 Torsemide NN B-NP B-m
164 on IN B-VP O
164 Monday NNP B-NP O
165 4 CD O O
165 Your NNP B-NP O
165 dialysis NN I-NP O
165 appointment NN I-NP O
165 is VBZ O O
165 on IN B-VP O
165 Monday NNP B-NP O
165 6/30 CD O O
165 at IN B-VP O
165 10:30am CD O O
165 at IN B-VP O
165 the DT B-NP O
165 Lankewoo NNP I-NP O
165 Valley NNP I-NP O
165 Hospital NNP I-NP O
166 dialysis NN I-NP O
166 unit NN I-NP O
167 No NNP I-NP O
167 dictated VBD B-VP O
167 summary JJ B-NP O
168 ENTERED NNP I-NP O
168 BY: NNP I-NP O
168 CLACK NNP I-NP O
168 , , O O
168 KERMIT NNP B-NP O
168 O NNP I-NP O
168 , , O O
168 M.D NNP B-NP O
168 ( ( O O
168 KC06 NNP B-NP O
168 ) ) O O
168 8/27/06 CD O O
168 @ $ O O
168 01:26 CD O O
168 PM NNP B-NP O
169 ****** JJ B-NP O
169 END NNP I-NP O
169 OF NNP I-NP O
169 DISCHARGE NNP I-NP O
169 ORDERS NNP I-NP O
169 ****** NNP I-NP O
170 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #686140 VBZ O O
2 028440356 CD O O
2 VMH NNP B-NP O
2 34902422 CD O O
2 2806858 CD O O
2 2/1/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 s/p JJ B-NP O
2 ICD NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/15/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/27/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 COOPERWOOD NNP I-NP O
5 , , O O
5 GLEN NNP B-NP O
5 334-73-41-9 CD O O
6 Ny NNP B-NP O
6 Villea NNP I-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 6/11/05 CD O O
8 AT NNP B-NP O
8 12:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 ZANIS NNP I-NP O
11 , , O O
11 CLEO NNP B-NP O
11 BERNIE NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ACETYLSALICYLIC NNP I-NP B-m
16 ACID NNP I-NP I-m
16 81 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 Alert NNP I-NP O
17 overridden: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 8/24/05 CD O O
17 by IN B-VP O
18 ZACHMANN NNP B-NP O
18 , , O O
18 JONATHON NNP B-NP O
18 F NNP I-NP O
18 , , O O
18 M.D NNP B-NP O
19 POTENTIALLY NNP I-NP O
19 SERIOUS NNP I-NP O
19 INTERACTION: NNP I-NP O
19 WARFARIN NNP I-NP B-m
19 &amp; NNP I-NP O
19 ASPIRIN NNP I-NP B-m
20 Reason NNP I-NP O
20 for IN B-VP O
20 override: NN B-NP O
20 needs NNS I-NP O
20 both DT B-NP O
21 INSULIN NNP I-NP B-m
21 NPH NNP I-NP I-m
21 HUMAN NNP I-NP I-m
21 10 CD O B-do
21 UNITS NNP B-NP I-do
21 SC NNP I-NP B-mo
21 BID NNP I-NP B-f
22 LISINOPRIL NNP I-NP B-m
22 10 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 OXYCODONE NNP I-NP B-m
23 5-10 JJ B-NP B-do
23 MG NNP I-NP I-do
23 PO NNP I-NP B-mo
23 Q6H NNP I-NP B-f
23 PRN NNP I-NP I-f
23 Pain NNP I-NP B-r
24 COUMADIN NNP I-NP B-m
24 ( ( O I-m
24 WARFARIN NNP B-NP I-m
24 SODIUM NNP I-NP I-m
24 ) ) O I-m
24 5 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QPM NNP I-NP B-f
25 Starting NNP I-NP O
25 ROUTINE NNP I-NP O
25 , , O O
25 20:00 CD O O
25 ( ( O O
25 Standard NNP B-NP O
25 Admin NNP I-NP O
25 Time NNP I-NP O
25 ) ) O O
26 Food/Drug NNP B-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 No NNP I-NP O
27 high JJ B-NP O
27 Vitamin-K NNP I-NP O
27 containing VBG O O
27 foods NNS B-NP O
28 Override NNP I-NP O
28 Notice: NNP I-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 8/24/05 CD O O
28 by IN B-VP O
29 KRUIS NNP B-NP O
29 , , O O
29 MAJOR NNP B-NP O
29 F NNP I-NP O
29 , , O O
29 M.D NNP B-NP O
30 on IN B-VP O
30 order NN B-NP O
30 for IN B-VP O
30 TRICOR NNP B-NP B-m
30 PO NNP I-NP B-mo
30 ( ( O O
30 ref JJ O O
30 # # O O
30 76717119 CD O O
30 ) ) O O
31 POTENTIALLY NNP B-NP O
31 SERIOUS NNP I-NP O
31 INTERACTION: NNP I-NP O
31 WARFARIN NNP I-NP B-m
31 &amp; NNP I-NP O
31 FENOFIBRATE NNP I-NP B-m
31 , , O O
32 MICRONIZED NNP B-NP O
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: NN B-NP O
32 monitoring NN I-NP O
32 INR NNP I-NP O
33 Previous NNP I-NP O
33 override IN B-VP O
33 information: JJ B-NP O
34 Override NNP I-NP O
34 added VBD B-VP O
34 on IN B-VP O
34 8/24/05 CD O O
34 by IN B-VP O
34 BICE NNP B-NP O
34 , , O O
34 DALTON NNP B-NP O
34 D NNP I-NP O
34 , , O O
34 M.D NNP B-NP O
35 on IN B-VP O
35 order NN B-NP O
35 for IN B-VP O
35 ACETYLSALICYLIC NNP B-NP B-m
35 ACID NNP I-NP I-m
35 PO NNP I-NP B-mo
35 ( ( O O
35 ref JJ O O
35 # # O O
35 02538787 CD O O
35 ) ) O O
36 POTENTIALLY NNP B-NP O
36 SERIOUS NNP I-NP O
36 INTERACTION: NNP I-NP O
36 WARFARIN NNP I-NP B-m
36 &amp; NNP I-NP O
36 ASPIRIN NNP I-NP B-m
37 Reason NNP I-NP O
37 for IN B-VP O
37 override: NN B-NP O
37 needs NNS I-NP O
37 both DT B-NP O
38 KEFLEX NNP I-NP B-m
38 KEFLEX NNP I-NP B-m
38 ( ( O I-m
38 ( ( O I-m
38 CEPHALEXIN NNP B-NP I-m
38 CEPHALEXIN NNP I-NP I-m
38 ) ) O I-m
38 ) ) O I-m
38 250 CD O B-do
38 250 CD O B-do
38 MG NNP B-NP I-do
38 MG NNP I-NP I-do
38 PO NNP I-NP B-mo
38 PO NNP I-NP B-mo
38 QID NNP I-NP B-f
38 QID NNP I-NP B-f
38 X NNP I-NP B-du
38 12 CD O I-du
38 doses NNS B-NP I-du
39 Starting VBG O O
39 when WRB O O
39 IV NNP B-NP B-mo
39 ANTIBIOTICS NNP I-NP B-m
39 END NNP I-NP O
40 Number NNP I-NP B-du
40 of IN B-VP I-du
40 Doses NNP B-NP I-du
40 Required NNP I-NP I-du
40 ( ( O I-du
40 approximate JJ B-NP I-du
40 ): NN I-NP I-du
40 20 CD O I-du
41 TOPROL NNP B-NP B-m
41 XL NNP I-NP I-m
41 ( ( O I-m
41 METOPROLOL NNP B-NP I-m
41 SUCCINATE NNP I-NP I-m
41 EXTENDED NNP I-NP I-m
41 RELEASE NNP I-NP I-m
41 ) ) O I-m
42 25 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 QD NNP I-NP B-f
42 Food/Drug NNP I-NP O
42 Interaction NNP I-NP O
42 Instruction NNP I-NP O
43 Take NNP I-NP O
43 consistently RB O O
43 with IN B-VP O
43 meals NNS B-NP O
43 or CC O O
43 on IN B-VP O
43 empty JJ B-NP O
43 stomach NN I-NP O
44 Number NNP I-NP B-du
44 of IN B-VP I-du
44 Doses NNP B-NP I-du
44 Required NNP I-NP I-du
44 ( ( O I-du
44 approximate JJ B-NP I-du
44 ): NN I-NP I-du
44 2 CD O I-du
45 TRICOR NNP B-NP B-m
45 ( ( O I-m
45 FENOFIBRATE NNP B-NP I-m
45 ) ) O I-m
45 145 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 QD NNP I-NP B-f
46 Alert NNP I-NP O
46 overridden: NNP I-NP O
46 Override NNP I-NP O
46 added VBD B-VP O
46 on IN B-VP O
46 8/24/05 CD O O
46 by IN B-VP O
47 DEPPEN NNP B-NP O
47 , , O O
47 VINCENT NNP B-NP O
47 J NNP I-NP O
47 , , O O
47 M.D NNP B-NP O
48 POTENTIALLY NNP I-NP O
48 SERIOUS NNP I-NP O
48 INTERACTION: NNP I-NP O
48 WARFARIN NNP I-NP B-m
48 &amp; NNP I-NP O
48 FENOFIBRATE NNP I-NP B-m
48 , , O O
49 MICRONIZED NNP B-NP O
49 Reason NNP I-NP O
49 for IN B-VP O
49 override: NN B-NP O
49 monitoring NN I-NP O
49 INR NNP I-NP O
50 Number NNP I-NP B-du
50 of IN B-VP I-du
50 Doses NNP B-NP I-du
50 Required NNP I-NP I-du
50 ( ( O I-du
50 approximate JJ B-NP I-du
50 ): NN I-NP I-du
50 2 CD O I-du
51 PRILOSEC NNP B-NP B-m
51 ( ( O I-m
51 OMEPRAZOLE NNP B-NP I-m
51 ) ) O I-m
51 20 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 QD NNP I-NP B-f
52 DIET: NNP I-NP O
52 House NNP I-NP O
52 / VBD B-VP O
52 Low NNP B-NP O
52 chol/low NN I-NP O
52 sat VBD B-VP O
52 fat JJ B-NP O
53 ACTIVITY: NNP I-NP O
53 No NNP I-NP O
53 heavy JJ B-NP O
53 lifting NN I-NP O
53 and CC O O
53 do VB O O
53 not RB O O
53 lift VB O O
53 L NNP B-NP O
53 elbow FW O O
53 above IN B-VP O
53 L NNP B-NP O
53 shoulder NN I-NP O
53 x VBD B-VP O
53 1 CD O O
53 month NN B-NP O
54 FOLLOW NNP I-NP O
54 UP NNP I-NP O
54 APPOINTMENT( NNP I-NP O
54 S NNP I-NP O
54 ): NNP I-NP O
55 Dr NNP I-NP O
55 Vuckovich NNP I-NP O
55 June NNP I-NP O
55 10:40am CD O O
55 scheduled VBN O O
55 , , O O
56 Arrange NNP B-NP O
56 INR NNP I-NP O
56 to TO O O
56 be VB O O
56 drawn VBN O O
56 on IN B-VP O
56 2/1/05 CD O O
56 with IN B-VP O
56 f/u JJ B-NP O
56 INR's NNP I-NP O
56 to TO O O
56 be VB O O
56 drawn VBN O O
56 every DT B-NP O
57 4-7 JJ I-NP O
57 days NNS I-NP O
57 INR's NNP I-NP O
57 will MD O O
57 be VB O O
57 followed VBN O O
57 by IN B-VP O
57 PCP NNP B-NP O
58 ALLERGY: NNP I-NP O
58 NKA NNP I-NP O
59 ADMIT NNP I-NP O
59 DIAGNOSIS: NNP I-NP O
60 s/p VBD B-VP O
60 ICD NNP B-NP O
61 PRINCIPAL NNP I-NP O
61 DISCHARGE NNP I-NP O
61 DIAGNOSIS NNP I-NP O
61 ;Responsible JJ O O
61 After IN B-VP O
61 Study NNP B-NP O
61 for IN B-VP O
61 Causing NNP B-NP O
61 Admission NNP I-NP O
61 ) ) O O
62 s/p VBP O O
62 ICD NNP B-NP O
63 OTHER NNP I-NP O
63 DIAGNOSIS;Conditions NNP I-NP O
63 , , O O
63 Infections NNP B-NP O
63 , , O O
63 Complications NNP B-NP O
63 , , O O
63 affecting VBG O O
63 Treatment/Stay NNP B-NP O
64 CHF NNP I-NP O
64 ( ( O O
64 congestive JJ B-NP O
64 heart NN I-NP O
64 failure NN I-NP O
64 ) ) O O
64 CAD NNP B-NP O
64 ( ( O O
64 coronary JJ B-NP O
64 artery NN I-NP O
64 disease NN I-NP O
64 ) ) O O
64 s/p NN B-NP O
64 CABG NNP I-NP O
65 ( ( O O
65 S/P NNP B-NP O
65 cardiac JJ B-NP O
65 bypass NN I-NP O
65 graft NN I-NP O
65 surgery NN I-NP O
65 ) ) O O
65 dm NN B-NP O
65 ( ( O O
65 diabetes VBZ O O
66 mellitus NN B-NP O
66 ) ) O O
66 htn NN B-NP O
66 ( ( O O
66 hypertension NN B-NP O
66 ) ) O O
66 hyperchol NN B-NP O
66 ( ( O O
66 elevated VBN O O
67 cholesterol NN B-NP O
67 ) ) O O
67 cri NN B-NP O
67 ( ( O O
67 chronic JJ B-NP O
67 renal JJ I-NP O
67 dysfunction NN I-NP O
67 ) ) O O
68 OPERATIONS NNP B-NP O
68 AND NNP I-NP O
68 PROCEDURES: NNP I-NP O
69 none NN I-NP O
70 OTHER NNP I-NP O
70 TREATMENTS/PROCEDURES NNP I-NP O
70 ( ( O O
70 NOT NNP B-NP O
70 IN NNP I-NP O
70 O.R NNP I-NP O
70 ) ) O O
71 s/p VBP O O
71 dual JJ B-NP O
71 chamber NN I-NP O
71 ICD NNP I-NP O
72 BRIEF NNP I-NP O
72 RESUME NNP I-NP O
72 OF NNP I-NP O
72 HOSPITAL NNP I-NP O
72 COURSE: NNP I-NP O
73 69 CD O O
73 y/o NN B-NP O
73 man NN I-NP O
73 with IN B-VP O
73 ischemic JJ B-NP O
73 CMP NNP I-NP O
73 ( ( O O
73 EF NNP B-NP O
73 25-30% CD O O
73 ) ) O O
73 , , O O
73 recent JJ B-NP O
74 admit NN I-NP O
74 for IN B-VP O
74 atrial JJ B-NP O
74 flutter NN I-NP O
74 , , O O
74 s/p JJ B-NP O
74 ablation NN I-NP O
74 , , O O
74 and CC O O
74 NSVT NNP B-NP O
74 Primary NNP I-NP O
74 prevention NN I-NP O
75 ICD NNP I-NP O
75 placed VBD B-VP O
75 without IN B-VP O
75 complicaiton NN B-NP O
75 Had NNP I-NP O
75 short JJ B-NP O
75 runs NNS I-NP O
75 of IN B-VP O
75 AF NNP B-NP O
75 during IN B-VP O
76 procedure NN B-NP O
76 For IN B-VP O
76 coumadin NN B-NP B-m
76 , , O O
76 baby NN B-NP B-m
76 ASA NNP I-NP I-m
76 Also RB O O
76 h/o VBD B-VP O
76 HTN NNP B-NP O
76 , , O O
76 DM NNP B-NP O
76 , , O O
76 CRI NNP B-NP O
76 , , O O
77 CHF NNP B-NP O
78 ADDITIONAL NNP I-NP O
78 COMMENTS: NNP I-NP O
78 Continue NNP I-NP O
78 coumadin VBD B-VP B-m
78 5mg CD O B-do
78 each DT B-NP B-f
78 night NN I-NP I-f
78 Have VBP O O
78 your PRP$ O O
78 INR/coumadin NNP B-NP O
78 level NN I-NP O
78 checked VBD B-VP O
79 on IN B-VP O
79 Monday NNP B-NP O
79 , , O O
79 March NNP B-NP O
80 DISCHARGE NNP I-NP O
80 CONDITION: NNP I-NP O
80 Stable NNP I-NP O
81 TO NNP I-NP O
81 DO/PLAN: NNP I-NP O
82 No NNP I-NP O
82 dictated VBD B-VP O
82 summary JJ B-NP O
83 ENTERED NNP I-NP O
83 BY: NNP I-NP O
83 WEALER NNP I-NP O
83 , , O O
83 ROYAL NNP B-NP O
83 R NNP I-NP O
83 , , O O
83 PA-C NNP B-NP O
83 ( ( O O
83 NY43 NNP B-NP O
83 ) ) O O
83 6/11/05 CD O O
83 @ $ O O
83 10 CD O O
84 ****** JJ B-NP O
84 END NN I-NP O
84 OF NNP I-NP O
84 DISCHARGE NNP I-NP O
84 ORDERS NNP I-NP O
84 ****** NNP I-NP O
85 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #689300 VBZ O O
2 717528703 CD O O
2 MHH NNP B-NP O
2 11030451 CD O O
2 5310269 CD O O
2 2/14/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Non NNP I-NP O
2 cardiac JJ B-NP O
2 chest NN I-NP O
2 pain NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/12/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/13/2005 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 BEBEE NNP I-NP O
5 , , O O
5 MITCHEL NNP B-NP O
5 900-43-64-1 CD O O
6 Xandnew NNP B-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/29/05 CD O O
8 AT NNP B-NP O
8 06:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 DEAVERS NNP I-NP O
11 , , O O
11 TEDDY NNP B-NP O
11 N NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 SYNTHROID NNP I-NP B-m
16 ( ( O I-m
16 LEVOTHYROXINE NNP B-NP I-m
16 SODIUM NNP I-NP I-m
16 ) ) O I-m
16 100 CD O B-do
16 MCG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 NEXIUM NNP I-NP B-m
17 ( ( O I-m
17 ESOMEPRAZOLE NNP B-NP I-m
17 ) ) O I-m
17 40 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 LIPITOR NNP I-NP B-m
18 ( ( O I-m
18 ATORVASTATIN NNP B-NP I-m
18 ) ) O I-m
18 10 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 TOPROL NNP I-NP B-m
19 XL NNP I-NP I-m
19 ( ( O I-m
19 METOPROLOL NNP B-NP I-m
19 ( ( O I-m
19 SUST NNP B-NP I-m
19 REL NNP I-NP I-m
19 ) ) O I-m
19 ) ) O I-m
19 50 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Food/Drug NNP I-NP O
20 Interaction NNP I-NP O
20 Instruction NNP I-NP O
21 Take NNP I-NP O
21 consistently RB O O
21 with IN B-VP O
21 meals NNS B-NP O
21 or CC O O
21 on IN B-VP O
21 empty JJ B-NP O
21 stomach NN I-NP O
22 DIET: NNP I-NP O
22 No NNP I-NP O
22 Restrictions NNP I-NP O
23 ACTIVITY: NNP I-NP O
23 Resume NNP I-NP O
23 regular JJ B-NP O
23 exercise NN I-NP O
24 FOLLOW NNP I-NP O
24 UP NNP I-NP O
24 APPOINTMENT( NNP I-NP O
24 S NNP I-NP O
24 ): NNP I-NP O
25 Dr NNP I-NP O
25 Decambra NNP I-NP O
25 1-2 JJ B-NP O
25 wks NN I-NP O
25 scheduled VBN O O
25 , , O O
26 ALLERGY: NNP B-NP O
26 Sulfa NNP I-NP O
26 , , O O
26 Cephalosporins NNP B-NP O
26 , , O O
26 IV NNP B-NP O
26 Contrast NNP I-NP O
27 ADMIT NNP I-NP O
27 DIAGNOSIS: NNP I-NP O
28 Atypical NNP I-NP O
28 chest NN I-NP O
28 pain NN I-NP O
29 PRINCIPAL NNP I-NP O
29 DISCHARGE NNP I-NP O
29 DIAGNOSIS NNP I-NP O
29 ;Responsible JJ O O
29 After IN B-VP O
29 Study NNP B-NP O
29 for IN B-VP O
29 Causing NNP B-NP O
29 Admission NNP I-NP O
29 ) ) O O
30 Non NNP B-NP O
30 cardiac JJ B-NP O
30 chest NN I-NP O
30 pain NN I-NP O
31 OTHER NNP I-NP O
31 DIAGNOSIS;Conditions NNP I-NP O
31 , , O O
31 Infections NNP B-NP O
31 , , O O
31 Complications NNP B-NP O
31 , , O O
31 affecting VBG O O
31 Treatment/Stay NNP B-NP O
32 HTN NNP I-NP O
32 , , O O
32 obesity NN B-NP O
32 , , O O
32 seasonal JJ B-NP O
32 allergies NNS I-NP O
33 OPERATIONS NNP I-NP O
33 AND NNP I-NP O
33 PROCEDURES: NNP I-NP O
34 adenosine NN I-NP O
34 MIBI NNP I-NP O
34 -&gt;negative NNP I-NP O
35 OTHER NNP I-NP O
35 TREATMENTS/PROCEDURES NNP I-NP O
35 ( ( O O
35 NOT NNP B-NP O
35 IN NNP I-NP O
35 O.R NNP I-NP O
35 ) ) O O
36 none NN B-NP O
37 BRIEF NNP I-NP O
37 RESUME NNP I-NP O
37 OF NNP I-NP O
37 HOSPITAL NNP I-NP O
37 COURSE: NNP I-NP O
38 CC: NNP I-NP O
38 atypical JJ B-NP O
38 CP NNP I-NP O
39 HPI:76F NNP I-NP O
39 with IN B-VP O
39 hyperlipidemia NN B-NP O
39 , , O O
39 HTN NNP B-NP O
39 admitted VBD B-VP O
39 after IN B-VP O
39 4hrs CD O O
39 burning VBG O B-r
40 epigastric JJ B-NP O
40 pain NN I-NP O
40 ( ( O O
40 resolved VBN O O
40 with IN B-VP O
40 opiates NNS B-NP B-m
40 in IN B-VP O
40 ED NNP B-NP O
40 ) ) O O
40 EKG NNP B-NP O
40 no DT B-NP O
40 changes NNS I-NP O
40 , , O O
41 negative JJ B-NP O
41 cardiac JJ I-NP O
41 markers NNS I-NP O
41 x3 VBP O O
41 but CC O O
41 nondiagnostic JJ B-NP O
41 ETT NNP I-NP O
41 so RB O O
41 admitted VBD B-VP O
41 for IN B-VP O
42 adenosine JJ B-NP O
42 MIBI NNP I-NP O
42 in IN B-VP O
42 AM NNP B-NP O
42 Pain NNP I-NP O
42 described VBD B-VP O
42 as IN B-VP O
42 substernal JJ B-NP O
42 burning NN I-NP O
42 and CC O O
42 pressure NN B-NP O
43 which WDT O O
43 began VBD B-VP O
43 after IN B-VP O
43 pt NN B-NP O
43 had VBD B-VP O
43 eaten VBN O O
43 hotdog JJ B-NP O
43 wine NN I-NP O
43 and CC O O
43 potato NN B-NP O
43 salad NN I-NP O
43 and CC O O
43 gone VBN O O
43 to TO O O
44 sleep VB O O
44 in IN B-VP O
44 recliner NN B-NP O
44 chair NN I-NP O
45 PMH:hyperlipidemia/HTN/hypothyroidism NNP I-NP O
46 Meds:toprol NNP I-NP O
46 xl VBD B-VP O
46 50/lipitor CD O O
46 10/synthroid CD O O
46 100 CD O O
46 ALL:PCNs NNP B-NP O
46 , , O O
46 sulfa NN B-NP O
46 , , O O
47 iodine JJ B-NP O
48 EXAM: NNP I-NP O
49 96.6 CD O O
49 57 CD O O
49 102/75 CD O O
49 16 CD O O
49 98%RA CD O O
50 obese JJ O O
50 , , O O
50 NAD NNP B-NP O
50 JVP NNP I-NP O
50 flat JJ O O
50 , , O O
50 CTA NNP B-NP O
50 , , O O
50 RRR NNP B-NP O
50 ( ( O O
50 slow JJ O O
50 ) ) O O
50 , , O O
50 no DT B-NP O
51 edema NN I-NP O
52 Labs:cardiac NNP I-NP O
52 markers NNS I-NP O
52 neg VBP O O
52 x3 NNP B-NP O
52 EKG:SB NNP I-NP O
52 no DT B-NP O
52 TW/ST NNP I-NP O
52 changes NNS I-NP O
53 CXR:negative NNP I-NP O
54 ABD NNP I-NP O
54 CT:negative NNP I-NP O
54 except IN B-VP O
54 for IN B-VP O
54 3 CD O O
54 cm NN B-NP O
54 LN NNP I-NP O
54 in IN B-VP O
54 mesentery NN B-NP O
54 ? . B-VP O
54 etiology NN B-NP O
54 -&gt;recommended VBD B-VP O
55 follow VB O O
55 up RP O O
55 CT NNP B-NP O
55 in IN B-VP O
55 3 CD O O
55 months NNS B-NP O
56 HOSPITAL NNP I-NP O
56 COURSE NNP I-NP O
57 Atypical NNP I-NP O
57 CP-&gt;admitted NNP I-NP O
57 for IN B-VP O
57 adenosine NN B-NP O
57 MIBI NNP I-NP O
57 after IN B-VP O
57 non JJ B-NP O
57 diagnostic JJ I-NP O
58 ETT NNP I-NP O
58 Adenosine NNP I-NP O
58 MIBI NNP I-NP O
58 was VBD B-VP O
58 negative JJ B-NP O
59 ISCH:low NNP I-NP O
59 suspicion NN I-NP O
59 given VBN O O
59 history NN B-NP O
59 and CC O O
59 normal JJ B-NP O
59 EKG NNP I-NP O
59 and CC O O
59 cardiac JJ B-NP O
60 markers NNS I-NP O
60 Adenosine VBP O O
60 MIBI NNP B-NP O
60 was VBD B-VP O
60 negative JJ B-NP O
61 RR:no NNP I-NP O
61 arrhythmias NN I-NP O
61 on IN B-VP O
61 telemetry NN B-NP O
62 Endo:continued NNP I-NP O
62 home NN I-NP O
62 synthroid NN I-NP B-m
63 FOLLOW NNP I-NP O
63 UP:Pt NNP I-NP O
63 had VBD B-VP O
63 an DT B-NP O
63 abdominal JJ I-NP O
63 CT NNP I-NP O
63 in IN B-VP O
63 the DT B-NP O
63 ED NNP I-NP O
63 which WDT O O
63 did VBD B-VP O
63 not RB O O
63 elucidate VB O O
63 an DT B-NP O
64 etiology NN I-NP O
64 of IN B-VP O
64 her PRP$ O O
64 abdominal JJ B-NP O
64 pain NN I-NP O
64 but CC O O
64 did VBD B-VP O
64 show VB O O
64 a DT O O
64 3 CD O O
64 cm NN B-NP O
64 mesenteric JJ B-NP O
64 lymph NN I-NP O
64 node IN B-VP O
65 She PRP O O
65 should MD O O
65 have VB O O
65 a DT B-NP O
65 repeat NN I-NP O
65 CT NNP I-NP O
65 in IN B-VP O
65 3 CD O O
65 months NNS B-NP O
66 ADDITIONAL NNP I-NP O
66 COMMENTS: NNP I-NP O
66 The DT B-NP O
66 stress JJ I-NP O
66 test NN I-NP O
66 of IN B-VP O
66 your PRP$ O O
66 heart NN B-NP O
66 was VBD B-VP O
66 negative JJ B-NP O
67 DISCHARGE NNP I-NP O
67 CONDITION: NNP I-NP O
67 Stable NNP I-NP O
68 TO NNP I-NP O
68 DO/PLAN: NNP I-NP O
69 You PRP O O
69 need VBP O O
69 to TO O O
69 have VB O O
69 a DT B-NP O
69 repeat NN I-NP O
69 abdominal JJ B-NP O
69 CAT NNP I-NP O
69 scan NN I-NP O
69 in IN B-VP O
69 3 CD O O
69 months NNS B-NP O
69 or CC O O
69 so RB O O
70 No RB O O
70 dictated JJ B-NP O
70 summary NN I-NP O
71 ENTERED NNP I-NP O
71 BY: NNP I-NP O
71 HIX NNP I-NP O
71 , , O O
71 GROVER NNP B-NP O
71 , , O O
71 M.D NNP B-NP O
71 ( ( O O
71 IP14 NNP B-NP O
71 ) ) O O
71 9/29/05 CD O O
71 @ $ O O
71 05 CD O O
72 ****** JJ B-NP O
72 END NN I-NP O
72 OF NNP I-NP O
72 DISCHARGE NNP I-NP O
72 ORDERS NNP I-NP O
72 ****** NNP I-NP O
73 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #691620 VBZ O O
4 649480096 CD O O
4 VMC NNP B-NP O
4 04502391 CD O O
4 9678698 CD O O
4 7/10/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Atypical NNP I-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 8/14/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 9/24/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 WITTIE NNP I-NP O
8 , , O O
8 DEWEY NNP B-NP O
8 857-68-84-4 CD O O
9 Kna NNP B-NP O
9 Street NNP I-NP O
9 , , O O
9 Beau NNP B-NP O
9 Cam NNP I-NP O
9 Rie NNP I-NP O
9 , , O O
9 Arkansas NNP B-NP O
9 57131 CD O O
10 Service: NNP B-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 10/5/06 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 GROTHEN NNP I-NP O
14 , , O O
14 ALPHONSO NNP B-NP O
14 E NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 AMITRIPTYLINE NNP I-NP B-m
17 HCL NNP I-NP I-m
17 50 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 BEDTIME NNP I-NP B-f
18 ENTERIC NNP I-NP B-m
18 COATED NNP I-NP I-m
18 ASPIRIN NNP I-NP I-m
18 ( ( O I-m
18 ASPIRIN NNP B-NP I-m
18 ENTERIC NNP I-NP I-m
18 COATED NNP I-NP I-m
18 ) ) O I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 ATENOLOL NNP I-NP B-m
20 ATENOLOL NNP I-NP B-m
20 ATENOLOL NNP I-NP B-m
20 ATENOLOL NNP I-NP B-m
20 50 CD O B-do
20 MG NNP B-NP I-do
20 QAM; NNP I-NP B-f
20 25 CD O B-do
20 MG NNP B-NP I-do
20 QPM NNP I-NP B-f
20 PO NNP I-NP B-mo
20 50 CD O B-do
20 MG NNP B-NP I-do
20 QAM NNP I-NP B-f
20 25 CD O B-do
20 MG NNP B-NP I-do
20 QPM NNP I-NP B-f
21 CALTRATE NNP I-NP B-m
21 600 CD O I-m
21 + NNP B-NP I-m
21 D NNP I-NP I-m
21 ( ( O I-m
21 CALCIUM NNP B-NP I-m
21 CARBONATE NNP I-NP I-m
21 1 CD O I-m
21 , , O I-m
21 500 CD O I-m
21 MG NNP B-NP I-m
21 ( ( O I-m
21 ) ) O I-m
22 2 CD O B-do
22 TAB NNP B-NP I-do
22 PO NNP I-NP B-mo
22 DAILY NNP I-NP B-f
23 FLUOXETINE NNP I-NP B-m
23 HCL NNP I-NP I-m
23 20 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 DAILY NNP I-NP B-f
24 LISINOPRIL NNP I-NP B-m
24 20 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 DAILY NNP I-NP B-f
24 HOLD NNP I-NP O
24 IF: NNP I-NP O
24 o MD O O
25 Override NNP B-NP O
25 Notice: NNP I-NP O
25 Override NNP I-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 10/18/06 CD O O
25 by IN B-VP O
26 LIEFER NNP B-NP O
26 , , O O
26 STACEY NNP B-NP O
26 , , O O
26 M.D NNP B-NP O
27 on IN B-VP O
27 order NN B-NP O
27 for IN B-VP O
27 KCL NNP B-NP B-m
27 IMMEDIATE NNP I-NP I-m
27 RELEASE NNP I-NP I-m
27 PO NNP I-NP B-mo
27 ( ( O O
27 ref JJ O O
27 # # O O
28 985891392 CD O O
28 ) ) O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 LISINOPRIL NNP I-NP B-m
29 &amp; NNP I-NP O
29 POTASSIUM NNP I-NP B-m
30 CHLORIDE NNP I-NP O
31 POTENTIALLY NNP I-NP O
31 SERIOUS NNP I-NP O
31 INTERACTION: NNP I-NP O
31 LISINOPRIL NNP I-NP B-m
31 &amp; NNP I-NP O
31 POTASSIUM NNP I-NP B-m
32 CHLORIDE NNP I-NP O
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: NN B-NP O
32 aware JJ B-NP O
33 METFORMIN NNP I-NP B-m
33 1 CD O B-do
33 , , O I-do
33 000 CD O I-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 BID NNP I-NP B-f
34 AVADIA NNP I-NP B-m
34 8 CD O B-do
34 UNIT NNP B-NP I-do
34 DAILY NNP I-NP B-f
35 GLYBURIDE NNP I-NP B-m
35 10 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 BID NNP I-NP B-f
36 DIET: NNP I-NP O
36 House NNP I-NP O
36 / VBD B-VP O
36 Low NNP B-NP O
36 chol/low NN I-NP O
36 sat VBD B-VP O
36 fat JJ B-NP O
37 DIET: NNP I-NP O
37 House NNP I-NP O
37 / NNP I-NP O
37 ADA NNP I-NP O
37 1800 CD O O
37 cals/dy NN B-NP O
38 DIET: NNP I-NP O
38 4 CD O O
38 gram NN B-NP O
38 Sodium NNP I-NP O
39 ACTIVITY: NNP I-NP O
39 Resume NNP I-NP O
39 regular JJ B-NP O
39 exercise NN I-NP O
40 FOLLOW NNP I-NP O
40 UP NNP I-NP O
40 APPOINTMENT( NNP I-NP O
40 S NNP I-NP O
40 ): NNP I-NP O
41 Please NNP I-NP O
41 scedule VBD B-VP O
41 an DT B-NP O
41 appointment NN I-NP O
41 with IN B-VP O
41 your PRP$ O O
41 primary JJ B-NP O
41 care NN I-NP O
41 , , O O
42 ALLERGY: NNP B-NP O
42 NKA NNP I-NP O
43 ADMIT NNP I-NP O
43 DIAGNOSIS: NNP I-NP O
44 chest JJS B-NP O
44 pain NN I-NP O
45 PRINCIPAL NNP I-NP O
45 DISCHARGE NNP I-NP O
45 DIAGNOSIS NNP I-NP O
45 ;Responsible JJ O O
45 After IN B-VP O
45 Study NNP B-NP O
45 for IN B-VP O
45 Causing NNP B-NP O
45 Admission NNP I-NP O
45 ) ) O O
46 Atypical NNP B-NP O
46 chest NN I-NP O
46 pain NN I-NP O
47 OTHER NNP I-NP O
47 DIAGNOSIS;Conditions NNP I-NP O
47 , , O O
47 Infections NNP B-NP O
47 , , O O
47 Complications NNP B-NP O
47 , , O O
47 affecting VBG O O
47 Treatment/Stay NNP B-NP O
48 HTN NNP I-NP O
48 ( ( O O
48 hypertension NN B-NP O
48 ) ) O O
48 NIDDM NNP B-NP O
48 ( ( O O
48 diabetes VBZ O O
48 mellitus NN B-NP O
48 ) ) O O
48 sleep NN B-NP O
48 apnea NN I-NP O
48 ( ( O O
48 sleep JJ B-NP O
49 apnea NN I-NP O
49 ) ) O O
49 obesity NN B-NP O
49 ( ( O O
49 obesity NN B-NP O
49 ) ) O O
50 OPERATIONS NNP B-NP O
50 AND NNP I-NP O
50 PROCEDURES: NNP I-NP O
51 ETT NNP I-NP O
52 OTHER NNP I-NP O
52 TREATMENTS/PROCEDURES NNP I-NP O
52 ( ( O O
52 NOT NNP B-NP O
52 IN NNP I-NP O
52 O.R NNP I-NP O
52 ) ) O O
53 None NN B-NP O
54 BRIEF NNP I-NP O
54 RESUME NNP I-NP O
54 OF NNP I-NP O
54 HOSPITAL NNP I-NP O
54 COURSE: NNP I-NP O
55 CC: NNP I-NP O
55 Atypical NNP I-NP O
55 Chest NNP I-NP O
55 pain NN I-NP O
56 **** NNP I-NP O
57 HPI: NNP I-NP O
57 54 CD O O
57 hispanic JJ B-NP O
57 woman NN I-NP O
57 with IN B-VP O
57 morbid NN B-NP O
57 obesity NN I-NP O
57 , , O O
57 HTN NNP B-NP O
57 , , O O
57 NIDDM NNP B-NP O
57 , , O O
57 sleep JJ B-NP O
57 apnea NN I-NP O
58 on IN B-VP O
58 CPAP NNP B-NP O
58 , , O O
58 who WP O O
58 presented VBD B-VP O
58 with IN B-VP O
58 one CD O O
58 week NN B-NP O
58 history NN I-NP O
58 of IN B-VP O
58 intermittent NN B-NP B-r
58 left VBD B-VP O
58 arm JJ B-NP O
59 pain NN I-NP O
59 while IN B-VP O
59 washing VBG O O
59 dishes NNS B-NP O
59 , , O O
59 lasting VBG O O
59 15 CD O O
59 minutes NNS B-NP O
59 , , O O
59 sometimes RB O O
60 radiating VBG O O
60 to TO O O
60 her PRP$ O O
60 left JJ B-NP O
60 chest NN I-NP O
60 , , O O
60 positional JJ O O
60 , , O O
60 no DT O O
60 associated VBN O O
60 with IN B-VP O
60 SOB NNP B-NP O
60 , , O O
61 N/V/D NNP B-NP O
61 Responds NNP I-NP O
61 to TO O O
61 SL NNP B-NP B-mo
61 NTG NNP I-NP B-m
61 ( ( O O
61 however RB O O
61 within IN B-VP O
61 5-10min JJ O O
61 ) ) O O
61 She PRP O O
61 has VBZ O O
61 history NN B-NP O
62 of IN B-VP O
62 atypical JJ B-NP O
62 chest NN I-NP O
62 pain NN I-NP O
62 , , O O
62 last JJ B-NP O
62 ETT NNP I-NP O
62 1998 CD O O
62 , , O O
62 walked VBD B-VP O
62 3min CD O O
62 , , O O
62 HR-128 NNP B-NP O
62 , , O O
62 non JJ B-NP O
63 ischemic JJ I-NP O
63 Cardiac NNP I-NP O
63 risk NN I-NP O
63 factors: NN I-NP O
63 Age NNP I-NP O
63 , , O O
63 HTN NNP B-NP O
63 , , O O
63 DM NNP B-NP O
63 , , O O
63 Obesity NNP B-NP O
63 , , O O
64 FH NNP B-NP O
64 In IN B-VP O
64 ED NNP B-NP O
64 pain NN I-NP O
64 free JJ O O
64 , , O O
64 no DT B-NP O
64 changes NNS I-NP O
64 in IN B-VP O
64 EKG NNP B-NP O
64 , , O O
64 first RB O O
64 set VBN O O
64 of IN B-VP O
64 cardiac JJ B-NP O
64 enzymes NNS I-NP O
65 is VBZ O O
65 negative JJ B-NP O
65 Received NNP I-NP O
65 ASA NNP I-NP B-m
65 , , O O
65 Heparin NNP B-NP B-m
65 gtt NN I-NP B-mo
65 started VBD B-VP O
66 **** NNP B-NP O
67 PMH: NNP I-NP O
68 1 CD O O
68 NIDDM NNP B-NP O
69 2 CD O O
69 HTN NNP B-NP O
70 3 CD O O
70 Morbid NNP B-NP O
70 obesity NN I-NP O
71 4 CD O O
71 OSA NNP B-NP O
71 -&gt;Home NNP I-NP O
71 CPAP NNP I-NP O
72 5 CD O O
72 Chronic NNP B-NP O
72 back RB O O
72 pain VBP O O
73 **** JJ B-NP O
74 Home NNP I-NP O
74 meds: NN I-NP O
74 Atenolol NNP I-NP B-m
74 50AM/25PM CD O B-do
74 , , O O
74 Avadia NNP B-NP B-m
74 8 CD O B-do
74 , , O O
74 Fluoxetine NNP B-NP B-m
74 20 CD O B-do
74 , , O O
74 Metformin NNP B-NP B-m
74 1gm CD O B-do
75 BID NNP B-NP B-f
75 , , O O
75 Glyburide NNP B-NP B-m
75 10BID CD O B-do
75 , , O O
75 Lisinopril NNP B-NP B-m
75 20 CD O B-do
75 , , O O
75 CaCO3 NNP B-NP B-m
75 1200QD CD O B-do
75 , , O O
75 Amitriptyline NNP B-NP B-m
76 50QHS CD O B-do
77 **** NNP B-NP O
78 Exam: NNP I-NP O
78 T- NNP I-NP O
78 98.6 CD O O
78 HR-86R NNP B-NP O
78 , , O O
78 BP-117/55 NNP B-NP O
78 , , O O
78 RA-18 NNP B-NP O
78 , , O O
79 97%RA CD O O
79 General: NNP B-NP O
79 Obese NNP I-NP O
79 , , O O
80 NAD NNP B-NP O
80 HEENT:MMM NNP I-NP O
80 , , O O
81 PEEEL NNP B-NP O
81 CV: NNP I-NP O
81 Flat NNP I-NP O
81 JVP NNP I-NP O
81 , , O O
81 RRR NNP B-NP O
81 , , O O
81 S1 NNP B-NP O
81 , , O O
81 S2 NNP B-NP O
81 , , O O
81 no DT B-NP O
82 MRG NNP I-NP O
82 Lungs: NNP I-NP O
82 CTA NNP I-NP O
83 B/L NNP I-NP O
83 Abdomen: NNP I-NP O
83 soft JJ O O
83 , , O O
83 NTND NNP B-NP O
83 , , O O
83 +BS NNP B-NP O
84 Ext: NNP I-NP O
84 Warm NNP I-NP O
84 , , O O
84 no DT B-NP O
84 edema NN I-NP O
85 **** NNP I-NP O
86 Hospital NNP I-NP O
86 course: VBD B-VP O
87 54F CD O O
87 with IN B-VP O
87 multiple JJ B-NP O
87 cardiac JJ I-NP O
87 risk NN I-NP O
87 factors NNS I-NP O
87 admitted VBD B-VP O
88 with IN B-VP O
88 atypical JJ B-NP O
88 chest NN I-NP O
88 pain NN I-NP O
88 , , O O
88 no DT B-NP O
88 evidence NN I-NP O
88 for IN B-VP O
88 ACS NNP B-NP O
89 *CV: NNP I-NP O
90 ( ( O O
90 I PRP O O
90 ) ) O O
90 Completed VBD B-VP O
90 ROMI NNP B-NP O
90 , , O O
90 ETT NNP B-NP O
90 walked VBD B-VP O
90 for IN B-VP O
90 2 CD O O
90 minutes NNS B-NP O
90 and CC O O
90 33 CD O O
90 sec NN B-NP O
90 , , O O
90 75% CD O O
90 MPHR NNP B-NP O
90 , , O O
91 stopped VBD B-VP O
91 due JJ O O
91 to TO O O
91 fatigue VB O O
91 , , O O
91 no DT B-NP O
91 EKG NNP I-NP O
91 changes NNS I-NP O
91 Can NNP I-NP O
91 continue VBP O O
91 home NN B-NP O
91 ASA NNP I-NP B-m
91 , , O O
91 BB NNP B-NP B-m
91 , , O O
92 Risk NNP B-NP O
92 stratification: VBP O O
92 Lipid NNP B-NP O
92 profile NN I-NP O
92 , , O O
92 A1C NNP B-NP O
92 are VBP O O
92 pending VBG O O
93 ( ( O O
93 P NNP B-NP O
93 ) ) O O
93 ETT NNP B-NP O
93 in IN B-VP O
93 ED NNP B-NP O
93 with IN B-VP O
93 EF-55% NNP B-NP O
93 , , O O
93 not RB O O
93 in IN B-VP O
93 failure NN B-NP O
93 , , O O
93 htn NN B-NP B-r
93 htn NN I-NP B-r
93 controlled VBN O O
93 with IN B-VP O
93 BB NNP B-NP B-m
93 , , O O
93 ACEI NNP B-NP B-m
94 ( ( O O
94 R NNP B-NP O
94 ) ) O O
94 No NNP B-NP O
94 events NNS I-NP O
95 *Endo: RB O O
95 RISS NNP B-NP B-m
95 , , O O
95 return NN B-NP O
95 to TO O O
95 home NN B-NP B-m
95 meds NNS I-NP I-m
95 , , O O
95 A1C NNP B-NP O
95 pending VBG O O
96 ADDITIONAL NNP B-NP O
96 COMMENTS: NNP I-NP O
96 1 CD O O
96 You PRP O O
96 did VBD B-VP O
96 not RB O O
96 have VB O O
96 heart NN B-NP O
96 attack!! VBZ O O
97 2 CD O O
97 Continue NNP B-NP O
97 all DT O O
97 your PRP$ O B-m
97 medications NNS B-NP I-m
98 DISCHARGE NNP I-NP O
98 CONDITION: NNP I-NP O
98 Stable NNP I-NP O
99 TO NNP I-NP O
99 DO/PLAN: NNP I-NP O
100 1 CD O O
100 follow VBP O O
100 up RB O O
100 A1C NNP B-NP O
100 , , O O
100 lipid JJ B-NP O
100 profile NN I-NP O
101 2 CD O O
101 Weight NNP B-NP O
101 reduction NN I-NP O
102 No NNP I-NP O
102 dictated VBD B-VP O
102 summary JJ B-NP O
103 ENTERED NNP I-NP O
103 BY: NNP I-NP O
103 GOSHEN NNP I-NP O
103 , , O O
103 TUAN NNP B-NP O
103 , , O O
103 M.D NNP B-NP O
103 ( ( O O
103 HO91 NNP B-NP O
103 ) ) O O
103 10/5/06 CD O O
103 @ $ O O
103 12:00 CD O O
103 PM NNP B-NP O
104 ****** JJ B-NP O
104 END NNP I-NP O
104 OF NNP I-NP O
104 DISCHARGE NNP I-NP O
104 ORDERS NNP I-NP O
104 ****** NNP I-NP O
105 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #698005 VBZ O O
2 585164725 CD O O
2 FH NNP B-NP O
2 16469218 CD O O
2 7093317 CD O O
2 4/0/2003 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 MITRAL NNP I-NP O
2 REGURGITATION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 10/6/2003 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/6/2003 CD O O
4 Date NNP B-NP O
4 of IN B-VP O
4 Discharge: NNP B-NP O
4 10/6/2003 CD O O
5 ATTENDING: NNP B-NP O
5 EUSEBIO NNP I-NP O
5 HENDLER NNP I-NP O
5 MD NNP I-NP O
6 PRIMARY NNP I-NP O
6 DIAGNOSIS: NNP I-NP O
6 Mitral NNP I-NP O
6 valve POS O O
6 regurgitation NN B-NP O
7 HISTORY NNP I-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 The DT B-NP O
7 patient NN I-NP O
7 is VBZ O O
7 a DT B-NP O
7 26-year-old JJ I-NP O
7 female NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
8 past JJ I-NP O
8 medical JJ I-NP O
8 history NN I-NP O
8 significant JJ O O
8 for IN B-VP O
8 Hodgkin's NNP B-NP O
8 lymphoma NN I-NP O
9 requiring VBG O O
9 chemotherapy NN B-NP O
9 and CC O O
9 radiation NN B-NP O
9 therapy NN I-NP O
9 , , O O
9 as RB O O
9 well RB O O
9 as IN B-VP O
9 a DT B-NP O
10 history NN I-NP O
10 of IN B-VP O
10 splenectomy NN B-NP O
10 , , O O
10 asthma NN B-NP O
10 , , O O
10 and CC O O
10 history NN B-NP O
10 of IN B-VP O
10 tobacco NN B-NP O
10 use NN I-NP O
10 , , O O
10 who WP O O
11 presents VBZ O O
11 to TO O O
11 our PRP$ O O
11 service NN B-NP O
11 with IN B-VP O
11 symptoms NNS B-NP O
11 of IN B-VP O
11 congestive JJ B-NP O
11 heart NN I-NP O
11 failure NN I-NP O
12 including VBG O O
12 dyspnea NN B-NP O
12 on IN B-VP O
12 exertion NN B-NP O
12 , , O O
12 lower JJR B-NP O
12 extremity NN I-NP O
12 bilateral JJ B-NP O
12 edema NN I-NP O
12 , , O O
13 and CC O O
13 decrease NN B-NP O
13 exercise NN I-NP O
13 tolerance NN I-NP O
13 On IN B-VP O
13 the DT B-NP O
13 day NN I-NP O
13 of IN B-VP O
13 admission NN B-NP O
13 , , O O
14 2/17/03 CD O O
14 , , O O
14 she PRP O O
14 underwent JJ B-NP O
14 cardiac JJ I-NP O
14 catheterization NN I-NP O
14 , , O O
14 which WDT O O
14 revealed VBD B-VP O
15 clean JJ B-NP O
15 coronary JJ I-NP O
15 arteries NNS I-NP O
15 On IN B-VP O
15 November NNP B-NP O
15 , , O O
15 2003 CD O O
15 , , O O
15 she PRP O O
15 then RB O O
16 underwent VBD B-VP O
16 an DT B-NP O
16 elective JJ I-NP O
16 mitral NN I-NP O
16 valvuloplasty NN I-NP O
16 , , O O
16 26 CD O O
16 Carpentier-Edwards JJ B-NP O
17 pericardial NN I-NP O
17 , , O O
17 with IN B-VP O
17 size NN B-NP O
17 26 CD O O
17 Cosgrove-Edwards JJ B-NP O
17 ring NN I-NP O
17 and CC O O
17 vegectomy NN B-NP O
18 In IN B-VP O
18 the DT B-NP O
18 immediate JJ I-NP O
18 postoperative JJ I-NP O
18 period NN I-NP O
18 , , O O
18 she PRP O O
18 was VBD B-VP O
18 transferred VBN O O
18 to TO O O
18 the DT B-NP O
19 Cardiac NNP I-NP O
19 Surgery NNP I-NP O
19 Intensive NNP I-NP O
19 Care NNP I-NP O
19 Unit NNP I-NP O
19 initially RB O O
19 requiring VBG O O
19 0.5 CD O B-do
19 of IN B-VP O
20 epinephrine NN B-NP B-m
20 to TO O O
20 maintain VB O O
20 proper JJ B-NP B-r
20 pressure NN I-NP I-r
20 Epinephrine NNP I-NP B-m
20 was VBD B-VP O
20 weaned VBN O O
21 to TO O O
21 off VB O O
21 on IN B-VP O
21 postoperative JJ B-NP O
21 day NN I-NP O
21 #1 IN B-VP O
21 She PRP O O
21 was VBD B-VP O
21 extubated VBN O O
21 in IN B-VP O
21 the DT B-NP O
21 evening NN I-NP O
22 of IN B-VP O
22 the DT B-NP O
22 day NN I-NP O
22 of IN B-VP O
22 surgery NN B-NP O
22 and CC O O
22 epinephrine NN B-NP B-m
22 was VBD B-VP O
22 subsequently RB O O
22 weaned VBN O O
22 to TO O O
23 off VB O O
23 Gentle NNP B-NP O
23 diuresis NN I-NP O
23 was VBD B-VP O
23 begun VBN O O
23 on IN B-VP O
23 postoperative JJ B-NP O
23 day NN I-NP O
23 #1 NNP I-NP O
23 as RB O O
23 well RB O O
24 as IN B-VP O
24 low JJ B-NP B-do
24 dose NN I-NP I-do
24 beta NN I-NP B-m
24 blocker NN I-NP I-m
24 , , O O
24 which WDT O O
24 she PRP O O
24 tolerated VBD B-VP O
24 well RB O O
24 She PRP O O
24 was VBD B-VP O
25 transferred VBN O O
25 to TO O O
25 the DT B-NP O
25 Cardiac NNP I-NP O
25 Surgery NNP I-NP O
25 Step NNP I-NP O
25 Down NNP I-NP O
25 Unit NNP I-NP O
25 on IN B-VP O
26 postoperative JJ B-NP O
26 day NN I-NP O
26 #1 NNP I-NP O
26 , , O O
26 where WRB O O
26 diuresis NN B-NP O
26 was VBD B-VP O
26 increased VBN O O
26 Baby NNP B-NP B-m
26 aspirin NN I-NP I-m
27 was VBD B-VP O
27 begun VBN O O
27 , , O O
27 and CC O O
27 the DT B-NP O
27 patient NN I-NP O
27 continued VBD B-VP O
27 to TO O O
27 make VB O O
27 excellent JJ B-NP O
28 cardiovascular JJ I-NP O
28 progress NN I-NP O
28 On IN B-VP O
28 February NNP B-NP O
28 , , O O
28 2003 CD O O
28 , , O O
28 she PRP O O
28 began VBD B-VP O
28 to TO O O
29 complain VB O O
29 of IN B-VP O
29 some DT B-NP O
29 persistent JJ I-NP O
29 numbness NN I-NP O
29 and CC O O
29 tingling NN B-NP O
29 of IN B-VP O
29 the DT B-NP O
29 left NN I-NP O
30 lower JJR B-NP O
30 extremity NN I-NP O
30 , , O O
30 which WDT O O
30 she PRP O O
30 felt VBD B-VP O
30 to TO O O
30 be VB O O
30 interrupting VBG O O
30 her PRP$ O O
30 attempts NNS B-NP O
31 to TO O O
31 stand VB O O
31 and CC O O
31 maintain VB O O
31 balance NN B-NP O
31 For IN B-VP O
31 further JJ B-NP O
31 treatment NN I-NP O
31 , , O O
31 a DT B-NP O
32 Neurology NNP I-NP O
32 consult NN I-NP O
32 was VBD B-VP O
32 obtained VBN O O
32 Per NNP B-NP O
32 Neurology NNP I-NP O
32 , , O O
32 she PRP O O
32 was VBD B-VP O
32 found VBN O O
32 to TO O O
33 have VB O O
33 no DT B-NP O
33 weakness NN I-NP O
33 at IN B-VP O
33 the DT B-NP O
33 left NN I-NP O
33 lower JJR B-NP O
33 leg NN I-NP O
33 and CC O O
33 foot NN B-NP O
33 , , O O
33 although IN B-VP O
33 when WRB O O
34 pressure NN B-NP O
34 was VBD B-VP O
34 exerted VBN O O
34 on IN B-VP O
34 the DT B-NP O
34 foot NN I-NP O
34 , , O O
34 she PRP O O
34 reported VBD B-VP O
34 an DT B-NP O
34 uncomfortable JJ I-NP O
35 tingling NN I-NP O
35 throughout IN B-VP O
35 the DT B-NP O
35 leg NN I-NP O
35 She PRP O O
35 reported VBD B-VP O
35 no DT B-NP O
35 back NN I-NP O
35 pain NN I-NP O
35 and CC O O
35 no DT B-NP O
36 change NN I-NP O
36 in IN B-VP O
36 bowel NN B-NP O
36 or CC O O
36 bladder VB O O
36 control NN B-NP O
36 Sensory NNP I-NP O
36 examination NN I-NP O
36 was VBD B-VP O
37 found VBN O O
37 to TO O O
37 be VB O O
37 intact JJ O O
37 , , O O
37 however RB O O
37 , , O O
37 soft JJ B-NP O
37 touch NN I-NP O
37 and CC O O
37 pin JJ B-NP O
37 sensation NN I-NP O
37 tested VBN O O
38 in IN B-VP O
38 the DT B-NP O
38 lateral JJ I-NP O
38 leg NN I-NP O
38 below IN B-VP O
38 the DT B-NP O
38 knee NN I-NP O
38 caused VBD B-VP O
38 a DT B-NP O
38 spreading NN I-NP O
38 tingling VBG O O
39 sensation NN B-NP O
39 throughout IN B-VP O
39 the DT B-NP O
39 left NN I-NP O
39 lower JJR B-NP O
39 extremity NN I-NP O
39 Per NNP I-NP O
39 Neurology NNP I-NP O
40 recommendations NNS I-NP O
40 , , O O
40 Neurontin NNP B-NP B-m
40 300 CD O B-do
40 mg NN B-NP I-do
40 q.d NN I-NP B-f
40 was VBD B-VP O
40 begun VBN O O
40 and CC O O
40 it PRP O O
40 was VBD B-VP O
41 recommended VBN O O
41 that IN B-VP O
41 she PRP O O
41 follow VBD B-VP O
41 up RB O O
41 with IN B-VP O
41 the DT B-NP O
41 Department NNP I-NP O
41 of IN B-VP O
41 Neurology NNP B-NP O
42 following VBG O O
42 discharge NN B-NP O
42 if IN B-VP O
42 the DT B-NP O
42 tingling NN I-NP O
42 sensation NN I-NP O
42 has VBZ O O
42 not RB O O
42 improved VBN O O
43 With IN B-VP O
43 aggressive JJ B-NP O
43 diuresis NN I-NP O
43 , , O O
43 the DT B-NP O
43 patient NN I-NP O
43 was VBD B-VP O
43 able JJ O O
43 to TO O O
43 regain VB O O
43 her PRP$ O O
44 postoperative JJ B-NP O
44 weight NN I-NP O
44 and CC O O
44 by IN B-VP O
44 the DT B-NP O
44 day NN I-NP O
44 of IN B-VP O
44 discharge NN B-NP O
44 was VBD B-VP O
44 1.7 CD O O
45 kilograms NNS B-NP O
45 below IN B-VP O
45 her PRP$ O O
45 preoperative JJ B-NP O
45 weight NN I-NP O
45 She PRP O O
45 has VBZ O O
45 made VBN O O
45 excellent JJ B-NP O
46 cardiovascular JJ I-NP O
46 progress NN I-NP O
46 following VBG O O
46 this DT B-NP O
46 surgery NN I-NP O
46 and CC O O
46 is VBZ O O
46 anticipated VBN O O
47 to TO O O
47 continue VB O O
47 her PRP$ O O
47 rehabilitation NN B-NP O
47 at IN B-VP O
47 home NN B-NP O
47 with IN B-VP O
47 VNA NNP B-NP O
47 System NNP I-NP O
48 PHYSICAL NNP I-NP O
48 EXAMINATION: NNP I-NP O
48 The DT B-NP O
48 patient NN I-NP O
48 is VBZ O O
48 an DT B-NP O
48 obese JJ I-NP O
48 young JJ I-NP O
48 woman NN I-NP O
48 alert NN I-NP O
49 and CC O O
49 oriented VBD B-VP O
49 x $ O O
49 3 CD O O
49 HEENT: NNP B-NP O
49 No NNP I-NP O
49 carotid NN I-NP O
49 bruits NNS I-NP O
49 or CC O O
49 JVD NNP B-NP O
49 present JJ B-NP O
50 Pulmonary: NNP I-NP O
50 Lungs NNP I-NP O
50 are VBP O O
50 clear JJ O O
50 to TO O O
50 auscultation VB O O
50 bilaterally RB O O
51 Coronary: NNP B-NP O
51 Regular NNP I-NP O
51 rate NN I-NP O
51 and CC O O
51 rhythm NN B-NP O
51 Normal NNP I-NP O
51 S1 NNP I-NP O
51 , , O O
51 S2 NNP B-NP O
51 No NNP I-NP O
51 murmurs NN I-NP O
51 , , O O
52 rubs NN B-NP O
52 , , O O
52 or CC O O
52 gallops NNS B-NP O
52 appreciated VBN O O
52 Abdomen: NNP B-NP O
52 Obese NNP I-NP O
52 , , O O
52 nontender NN B-NP O
52 , , O O
52 and CC O O
53 nondistended VBD B-VP O
53 Positive NNP B-NP O
53 bowel NN I-NP O
53 sounds VBZ O O
53 Extremities: NNP B-NP O
53 2+ CD O O
53 pulses NNS B-NP O
53 at IN B-VP O
54 all DT B-NP O
54 extremities NNS I-NP O
54 bilaterally RB O O
54 Trace NNP B-NP O
54 edema NN I-NP O
54 at IN B-VP O
54 the DT B-NP O
54 bilateral JJ I-NP O
54 lower JJR I-NP O
55 extremities NNS I-NP O
55 to TO O O
55 mid VB O O
55 calf JJ B-NP O
55 Skin: NNP I-NP O
55 Midline NNP I-NP O
55 sternotomy NN I-NP O
55 incision NN I-NP O
55 well RB O O
56 approximated VBN O O
56 , , O O
56 healing VBG O O
56 well RB O O
56 No NNP B-NP O
56 areas NNS I-NP O
56 of IN B-VP O
56 erythema NN B-NP O
56 or CC O O
56 drainage NN B-NP O
57 noted JJ B-NP O
58 LABORATORY NNP I-NP O
58 DATA: NNP I-NP O
58 On IN B-VP O
58 the DT B-NP O
58 day NN I-NP O
58 of IN B-VP O
58 discharge NN B-NP O
58 , , O O
58 sodium NN B-NP O
58 141 CD O O
58 , , O O
58 potassium NN B-NP O
59 4.2 CD O O
59 , , O O
59 BUN NNP B-NP O
59 17 CD O O
59 , , O O
59 creatinine NN B-NP O
59 1.0 CD O O
59 , , O O
59 calcium NN B-NP O
59 8.9 CD O O
59 , , O O
59 magnesium NN B-NP O
59 2.6 CD O O
59 , , O O
59 white JJ B-NP O
60 blood NN I-NP O
60 cell NN I-NP O
60 count NN I-NP O
60 11.3 CD O O
60 , , O O
60 hematocrit NN B-NP O
60 33.5 CD O O
60 , , O O
60 platelets NNS B-NP O
60 361 CD O O
60 , , O O
60 and CC O O
60 INR NNP B-NP O
61 1.0 CD O O
62 PROCEDURES: NNP B-NP O
62 On IN B-VP O
62 7/27/2003 CD O O
62 , , O O
62 elective JJ B-NP O
62 mitral JJ I-NP O
62 valvuloplasty NN I-NP O
62 , , O O
62 26 CD O O
63 Cosgrove-Edwards NNS B-NP O
63 ring VBG O O
63 with IN B-VP O
63 vegectomy NN B-NP O
63 , , O O
63 small JJ B-NP O
63 sterile JJ I-NP O
63 vegetations NNS I-NP O
64 on IN B-VP O
64 A2 NNP B-NP O
64 and CC O O
64 P2 NNP B-NP O
64 debrided VBD B-VP O
64 , , O O
64 and CC O O
64 found VBN O O
64 by IN B-VP O
64 lab NN B-NP O
64 testing VBG O O
64 to TO O O
64 be VB O O
64 sterile JJ B-NP O
65 vegetations NNS I-NP O
65 Cross NNP I-NP O
65 clamp NN I-NP O
65 times NNS I-NP O
65 were VBD B-VP O
65 confirmed VBN O O
65 by IN B-VP O
65 Gram NNP B-NP O
65 stain NN I-NP O
65 as IN B-VP O
66 sterile JJ O O
66 and CC O O
66 debrided VBD B-VP O
66 intraoperatively RB O O
66 Please NNP B-NP O
66 refer VB O O
66 to TO O O
66 operative JJ B-NP O
67 note NN I-NP O
67 for IN B-VP O
67 details NNS B-NP O
68 CONSULT: NNP I-NP O
68 Consulted NNP I-NP O
68 Department NNP I-NP O
68 of IN B-VP O
68 Neurology NNP B-NP O
68 with IN B-VP O
68 followup JJ B-NP O
69 recommendations NNS I-NP O
69 implemented VBN O O
69 during IN B-VP O
69 this DT B-NP O
69 patient's NN I-NP O
69 stay NN I-NP O
70 DISPOSITION: NNP I-NP O
70 The DT B-NP O
70 patient NN I-NP O
70 will MD O O
70 be VB O O
70 discharged VBN O O
70 today NN B-NP O
70 to TO O O
70 her PRP$ O O
70 home NN B-NP O
71 with IN B-VP O
71 VNA NNP B-NP O
71 assistance NN I-NP O
72 DISCHARGE NNP I-NP O
72 MEDICATIONS: NNP I-NP O
72 Enteric-coated NNP I-NP B-m
72 aspirin VBZ O I-m
72 81 CD O B-do
72 mg NN B-NP I-do
72 p.o NN I-NP B-mo
72 q.d NN I-NP B-f
72 , , O O
73 Colace NNP B-NP B-m
73 100 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 b.i.d NN I-NP B-f
73 x $ O B-du
73 7 CD O I-du
73 days NNS B-NP I-du
73 , , O O
73 Lasix NNP B-NP B-m
73 60 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 q.d NN I-NP B-f
73 , , O O
74 ibuprofen JJ O B-m
74 800 CD O B-do
74 mg NN B-NP I-do
74 p.o NN I-NP B-mo
74 q.8h NN I-NP B-f
74 p.r.n NN I-NP I-f
74 pain NN I-NP B-r
74 , , O O
74 Lopressor NNP B-NP B-m
74 25 CD O B-do
74 mg NN B-NP I-do
74 p.o NN I-NP B-mo
75 t.i.d NN I-NP B-f
75 , , O O
75 Niferex NNP B-NP B-m
75 150 CD O B-do
75 mg NN B-NP I-do
75 p.o NN I-NP B-mo
75 b.i.d NN I-NP B-f
75 , , O O
75 Atrovent NNP B-NP B-m
75 nebulizer RB O I-m
75 0.5 CD O B-do
75 mg NNS B-NP I-do
76 nebulized VBN O B-mo
76 q.i.d RB O B-f
76 , , O O
76 Neurontin NNP B-NP B-m
76 300 CD O B-do
76 mg NN B-NP I-do
76 p.o NN I-NP B-mo
76 q.d NN I-NP B-f
76 , , O O
76 K-Dur NNP B-NP B-m
76 30 CD O B-do
76 mEq NN B-NP I-do
76 p.o NN I-NP B-mo
77 q.d NN I-NP B-f
77 to TO O O
77 be VB O O
77 discontinued VBN O O
77 or CC O O
77 decreased VBN O O
77 if IN B-VP O
77 Lasix NNP B-NP B-m
77 dose NN I-NP O
77 is VBZ O O
77 changed VBN O O
77 , , O O
78 and CC O O
78 Flovent NNP B-NP B-m
78 44 CD O B-do
78 mcg/inh NN B-NP I-do
78 b.i.d VBD B-VP B-f
79 The DT B-NP O
79 patient NN I-NP O
79 has VBZ O O
79 been VBN O O
79 instructed VBN O O
79 to TO O O
79 call VB O O
79 to TO O O
79 schedule VB O O
79 follow VB O O
79 up RP O O
80 appointments NNS B-NP O
80 with IN B-VP O
80 Cogang NNP B-NP O
80 Medical NNP I-NP O
80 Center NNP I-NP O
80 Department NNP I-NP O
80 of IN B-VP O
81 Cardiac NNP B-NP O
81 Surgery NNP I-NP O
81 , , O O
81 Dr NNP B-NP O
81 Elbert NNP I-NP O
81 Reitzes NNP I-NP O
81 , , O O
81 within IN B-VP O
81 6-8 JJ B-NP O
81 weeks NNS I-NP O
81 following VBG O O
82 discharge NN B-NP O
82 as RB O O
82 well RB O O
82 as IN B-VP O
82 her PRP$ O O
82 primary JJ B-NP O
82 care NN I-NP O
82 physician NN I-NP O
82 , , O O
82 Dr NNP B-NP O
82 Keith NNP I-NP O
82 Lapusnak NNP I-NP O
82 in IN B-VP O
82 approximately RB O O
82 1-2 JJ B-NP O
82 weeks NNS I-NP O
82 as RB O O
82 well RB O O
82 as IN B-VP O
82 with IN B-VP O
82 her PRP$ O O
83 Cardiologist NNP B-NP O
83 , , O O
83 Dr NNP B-NP O
83 Wilbur NNP I-NP O
83 Nuzzo NNP I-NP O
83 in IN B-VP O
83 1-2 JJ B-NP O
83 weeks NNS I-NP O
83 She PRP O O
83 will MD O O
84 call VB O O
84 on IN B-VP O
84 recommendation NN B-NP O
84 from IN B-VP O
84 her PRP$ O O
84 primary JJ B-NP O
84 care NN I-NP O
84 physician NN I-NP O
84 to TO O O
85 schedule NN B-NP O
85 follow VB O O
85 up RP O O
85 appointment NN B-NP O
85 with IN B-VP O
85 Tor's NNP B-NP O
85 Community NNP I-NP O
85 Hospital NNP I-NP O
85 Medical NNP I-NP O
85 Center NNP I-NP O
86 Department NNP I-NP O
86 of IN B-VP O
86 Neurology NNP B-NP O
86 should MD O O
86 her PRP$ O O
86 left VBD B-VP O
86 lower JJR B-NP O
86 extremity NN I-NP O
86 tingling VBG O O
87 not RB O O
87 resolve VB O O
87 At IN B-VP O
87 that DT B-NP O
87 time NN I-NP O
87 , , O O
87 she PRP O O
87 would MD O O
87 be VB O O
87 advised VBN O O
87 to TO O O
87 pursue VB O O
87 EMG NNP B-NP O
88 testing VBG O O
88 for IN B-VP O
88 further JJ B-NP O
88 workup NN I-NP O
88 of IN B-VP O
88 dysasthesia NN B-NP O
88 The DT B-NP O
88 patient NN I-NP O
88 has VBZ O O
88 made VBN O O
89 excellent JJ B-NP O
89 progress NN I-NP O
89 following VBG O O
89 her PRP$ O O
89 mitral JJ B-NP O
89 valvuloplasty NN I-NP O
89 surgery NN I-NP O
89 and CC O O
90 is VBZ O O
90 anticipated VBN O O
90 that IN B-VP O
90 she PRP O O
90 will MD O O
90 return VB O O
90 to TO O O
90 her PRP$ O O
90 full JJ B-NP O
90 preoperative JJ I-NP O
91 level NN I-NP O
91 of IN B-VP O
91 independent JJ O O
91 functioning VBG O O
91 with IN B-VP O
91 continued JJ B-NP O
91 cardiovascular JJ I-NP O
92 rehabilitation NN I-NP O
92 and CC O O
92 VNA NNP B-NP O
92 assistance NN I-NP O
93 Please NNP I-NP O
93 call VB O O
93 if IN B-VP O
93 further JJ B-NP O
93 questions NNS I-NP O
93 or CC O O
93 concerns NNS B-NP O
94 Thank NNP I-NP O
94 you PRP O O
94 for IN B-VP O
94 referring VBG O O
94 this DT B-NP O
94 patient NN I-NP O
94 to TO O O
94 our PRP$ O O
94 service NN B-NP O
95 eScription NN I-NP O
95 document: VBZ O O
95 6-9587956 JJ B-NP O
95 ISSten NNP I-NP O
95 Tel NNP I-NP O
96 CC: NNP I-NP O
96 Alvaro NNP I-NP O
96 Claud NNP I-NP O
96 M.D NNP I-NP O
97 ELT NNP I-NP O
97 GP1 NNP I-NP O
97 , , O O
97 Sleyapa NNP B-NP O
97 Hospital NNP I-NP O
98 Gene NNP I-NP O
98 Osta NNP I-NP O
98 Ford NNP I-NP O
98 , , O O
98 RI NNP B-NP O
99 West NNP I-NP O
99 Hampmo NNP I-NP O
99 Nor NNP I-NP O
100 CC: NNP I-NP O
100 Roberto NNP I-NP O
100 Mellecker NNP I-NP O
100 MD NNP I-NP O
101 DIVISION NNP I-NP O
101 OF NNP I-NP O
101 CARDIAC NNP I-NP O
101 SURGERY NNP I-NP O
102 I PRP O O
102 Ni NNP B-NP O
102 Son NNP I-NP O
103 Ton NNP I-NP O
103 Ha NNP I-NP O
103 Napro NNP I-NP O
104 CC: NNP I-NP O
104 Jonah NNP I-NP O
104 Debiasi NNP I-NP O
104 M.D NNP I-NP O
105 DEP NNP I-NP O
105 DWARDAIN NNP I-NP O
105 MEDICAL NNP I-NP O
105 CENTER NNP I-NP O
106 Naca NNP I-NP O
106 Scond NNP I-NP O
106 Paul NNP I-NP O
107 Den NNP I-NP O
108 Dictated NNP I-NP O
108 By: NNP I-NP O
108 KIZZIE NNP I-NP O
108 , , O O
108 ROBERTO NNP B-NP O
109 Attending: NNP I-NP O
109 OLIVIO NNP I-NP O
109 , , O O
109 LEWIS NNP B-NP O
110 Dictation NNP I-NP O
110 ID NNP I-NP O
110 1644899 CD O O
111 D: NNP B-NP O
111 6/14/03 CD O O
112 T: NNP B-NP O
112 0/29/03 CD O O
113 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #698248 VBZ O O
4 694272750 CD O O
4 EGH NNP B-NP O
4 55957670 CD O O
4 6256055 CD O O
4 6/14/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHF NNP I-NP O
4 flare NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/26/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/4/2005 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 LEBEL NNP I-NP O
8 , , O O
8 LUCIEN NNP B-NP O
8 889-75-18-3 CD O O
9 O NNP B-NP O
9 Westhend NNP I-NP O
9 Gle NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 2/17/05 CD O O
11 AT NNP B-NP O
11 01:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 TAKAI NNP I-NP O
14 , , O O
14 AARON NNP B-NP O
14 E NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Override NNP I-NP O
20 Notice: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 7/1/05 CD O O
20 by IN B-VP O
21 LEGER NNP B-NP O
21 , , O O
21 GROVER NNP B-NP O
21 G NNP I-NP O
21 , , O O
21 M.D NNP B-NP O
22 on IN B-VP O
22 order NN B-NP O
22 for IN B-VP O
22 COUMADIN NNP B-NP B-m
22 PO NNP I-NP B-mo
22 ( ( O O
22 ref JJ O O
22 # # O O
22 90193915 CD O O
22 ) ) O O
23 POTENTIALLY NNP B-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 ASPIRIN NNP I-NP B-m
23 &amp; NNP I-NP O
23 WARFARIN NNP I-NP B-m
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 mda NN I-NP O
25 ATENOLOL NNP I-NP B-m
25 50 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QAM NNP I-NP B-f
25 Starting VBG O O
25 Today NNP B-NP O
25 July NNP I-NP O
26 ENALAPRIL NNP I-NP B-m
26 MALEATE NNP I-NP I-m
26 10 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 QD NNP I-NP B-f
27 LASIX NNP I-NP B-m
27 ( ( O I-m
27 FUROSEMIDE NNP B-NP I-m
27 ) ) O I-m
27 80 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
27 Starting VBG O O
27 Today NNP B-NP O
27 November NNP I-NP O
28 HOLD NNP I-NP O
28 IF: NNP I-NP O
28 sbp VBD B-VP O
28 &lt; $ O O
28 100 CD O O
29 NPH NNP B-NP B-m
29 INSULIN NNP I-NP I-m
29 HUMAN NNP I-NP I-m
29 ( ( O I-m
29 INSULIN NNP B-NP I-m
29 NPH NNP I-NP I-m
29 HUMAN NNP I-NP I-m
29 ) ) O I-m
29 60 CD O B-do
29 UNITS NNP B-NP I-do
29 SC NNP I-NP B-mo
29 QAM NNP I-NP B-f
30 Starting VBG O O
30 Today NNP B-NP O
30 July NNP I-NP O
31 NPH NNP I-NP B-m
31 INSULIN NNP I-NP I-m
31 HUMAN NNP I-NP I-m
31 ( ( O I-m
31 INSULIN NNP B-NP I-m
31 NPH NNP I-NP I-m
31 HUMAN NNP I-NP I-m
31 ) ) O I-m
31 60 CD O B-do
31 UNITS NNP B-NP I-do
31 SC NNP I-NP B-mo
31 QPM NNP I-NP B-f
32 Starting VBG O O
32 Today NNP B-NP O
32 November NNP I-NP O
33 COUMADIN NNP I-NP B-m
33 ( ( O I-m
33 WARFARIN NNP B-NP I-m
33 SODIUM NNP I-NP I-m
33 ) ) O I-m
33 5 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QPM NNP I-NP B-f
34 Starting VBG O O
34 NOW NNP B-NP O
34 November NNP I-NP O
35 Instructions: NNP I-NP O
35 Take NNP I-NP O
35 every DT B-NP O
35 Monday NNP I-NP O
35 , , O O
35 Wed NNP B-NP O
35 , , O O
35 Fri NNP B-NP O
35 , , O O
35 Sat NNP B-NP O
35 , , O O
35 Sun NNP B-NP O
36 Food/Drug NNP I-NP O
36 Interaction NNP I-NP O
36 Instruction NNP I-NP O
37 No NNP I-NP O
37 high JJ B-NP O
37 Vitamin-K NNP I-NP O
37 containing VBG O O
37 foods NNS B-NP O
38 Override NNP I-NP O
38 Notice: NNP I-NP O
38 Override NNP I-NP O
38 added VBD B-VP O
38 on IN B-VP O
38 7/1/05 CD O O
38 by IN B-VP O
39 PALLA NNP B-NP O
39 , , O O
39 REYES NNP B-NP O
39 H NNP I-NP O
39 , , O O
39 M.D NNP B-NP O
40 on IN B-VP O
40 order NN B-NP O
40 for IN B-VP O
40 SIMVASTATIN NNP B-NP B-m
40 PO NNP I-NP B-mo
40 ( ( O O
40 ref JJ O O
40 # # O O
40 13797611 CD O O
40 ) ) O O
41 POTENTIALLY NNP B-NP O
41 SERIOUS NNP I-NP O
41 INTERACTION: NNP I-NP O
41 WARFARIN NNP I-NP B-m
41 &amp; NNP I-NP O
41 SIMVASTATIN NNP I-NP B-m
42 Reason NNP I-NP O
42 for IN B-VP O
42 override: NN B-NP O
42 mda VBP O O
42 Previous NNP B-NP O
42 override IN B-VP O
42 information: JJ B-NP O
43 Override NNP I-NP O
43 added VBD B-VP O
43 on IN B-VP O
43 7/1/05 CD O O
43 by IN B-VP O
43 IZZO NNP B-NP O
43 , , O O
43 ROCKY NNP B-NP O
43 R NNP I-NP O
43 , , O O
43 M.D NNP B-NP O
44 POTENTIALLY NNP I-NP O
44 SERIOUS NNP I-NP O
44 INTERACTION: NNP I-NP O
44 ASPIRIN NNP I-NP B-m
44 &amp; NNP I-NP O
44 WARFARIN NNP I-NP B-m
45 Reason NNP I-NP O
45 for IN B-VP O
45 override: NN B-NP O
45 mda NN I-NP O
46 PAXIL NNP I-NP B-m
46 ( ( O I-m
46 PAROXETINE NNP B-NP I-m
46 ) ) O I-m
46 50 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 QD NNP I-NP B-f
47 SEROQUEL NNP I-NP B-m
47 ( ( O I-m
47 QUETIAPINE NNP B-NP I-m
47 ) ) O I-m
47 800 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QPM NNP I-NP B-f
48 Number NNP I-NP B-du
48 of IN B-VP I-du
48 Doses NNP B-NP I-du
48 Required NNP I-NP I-du
48 ( ( O I-du
48 approximate JJ B-NP I-du
48 ): NN I-NP I-du
48 4 CD O I-du
49 DEPAKOTE NNP B-NP B-m
49 ER NNP I-NP I-m
49 ( ( O I-m
49 DIVALPROEX NNP B-NP I-m
49 SODIUM NNP I-NP I-m
49 ER NNP I-NP I-m
49 ) ) O I-m
49 1 CD O B-do
49 , , O I-do
49 000 CD O I-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 QPM NNP I-NP B-f
50 LIPITOR NNP I-NP B-m
50 ( ( O I-m
50 ATORVASTATIN NNP B-NP I-m
50 ) ) O I-m
50 60 CD O B-do
50 MG NNP B-NP I-do
50 PO NNP I-NP B-mo
50 QD NNP I-NP B-f
51 Alert NNP I-NP O
51 overridden: NNP I-NP O
51 Override NNP I-NP O
51 added VBD B-VP O
51 on IN B-VP O
51 0/1/05 CD O O
51 by IN B-VP O
51 : : O O
52 POTENTIALLY NNP B-NP O
52 SERIOUS NNP I-NP O
52 INTERACTION: NNP I-NP O
52 WARFARIN NNP I-NP B-m
52 &amp; NNP I-NP O
52 ATORVASTATIN NNP I-NP B-m
53 CALCIUM NNP I-NP O
53 Reason NNP I-NP O
53 for IN B-VP O
53 override: NN B-NP O
53 mda NN I-NP O
54 PROTONIX NNP I-NP B-m
54 ( ( O I-m
54 PANTOPRAZOLE NNP B-NP I-m
54 ) ) O I-m
54 40 CD O B-do
54 MG NNP B-NP I-do
54 PO NNP I-NP B-mo
54 QD NNP I-NP B-f
55 DIET: NNP I-NP O
55 Patient NNP I-NP O
55 should MD O O
55 measure VB O O
55 weight JJ B-NP O
55 daily JJ I-NP O
56 DIET: NNP I-NP O
56 House NNP I-NP O
56 / VBD B-VP O
56 Low NNP B-NP O
56 chol/low NN I-NP O
56 sat VBD B-VP O
56 fat JJ B-NP O
57 DIET: NNP I-NP O
57 House NNP I-NP O
57 / NNP I-NP O
57 ADA NNP I-NP O
57 1800 CD O O
57 cals/dy NN B-NP O
58 DIET: NNP I-NP O
58 2 CD O O
58 gram NN B-NP O
58 Sodium NNP I-NP O
59 ACTIVITY: NNP I-NP O
59 Resume NNP I-NP O
59 regular JJ B-NP O
59 exercise NN I-NP O
60 FOLLOW NNP I-NP O
60 UP NNP I-NP O
60 APPOINTMENT( NNP I-NP O
60 S NNP I-NP O
60 ): NNP I-NP O
61 Dorsey NNP I-NP O
61 Deases NNP I-NP O
61 November NNP I-NP O
61 2:30 CD O O
61 PM NNP B-NP O
61 scheduled VBN O O
61 , , O O
62 Dr NNP B-NP O
62 Lavern NNP I-NP O
62 Bringhurst NNP I-NP O
62 February NNP I-NP O
62 scheduled VBD B-VP O
62 , , O O
63 Arrange NNP B-NP O
63 INR NNP I-NP O
63 to TO O O
63 be VB O O
63 drawn VBN O O
63 on IN B-VP O
63 0/4/05 CD O O
63 with IN B-VP O
63 f/u JJ B-NP O
63 INR's NNP I-NP O
63 to TO O O
63 be VB O O
63 drawn VBN O O
63 every DT O O
64 7 CD O O
64 days NNS B-NP O
64 INR's NNP I-NP O
64 will MD O O
64 be VB O O
64 followed VBN O O
64 by IN B-VP O
64 Dr NNP B-NP O
64 Lesley NNP I-NP O
64 Bertling NNP I-NP O
65 ALLERGY: NNP I-NP O
65 NKA NNP I-NP O
66 ADMIT NNP I-NP O
66 DIAGNOSIS: NNP I-NP O
67 Aflutter NNP I-NP O
67 with IN B-VP O
67 RVR NNP B-NP O
68 PRINCIPAL NNP I-NP O
68 DISCHARGE NNP I-NP O
68 DIAGNOSIS NNP I-NP O
68 ;Responsible JJ O O
68 After IN B-VP O
68 Study NNP B-NP O
68 for IN B-VP O
68 Causing NNP B-NP O
68 Admission NNP I-NP O
68 ) ) O O
69 CHF NNP B-NP O
69 flare NN I-NP O
70 OTHER NNP I-NP O
70 DIAGNOSIS;Conditions NNP I-NP O
70 , , O O
70 Infections NNP B-NP O
70 , , O O
70 Complications NNP B-NP O
70 , , O O
70 affecting VBG O O
70 Treatment/Stay NNP B-NP O
71 CAD NNP I-NP O
71 ( ( O O
71 coronary JJ B-NP O
71 artery NN I-NP O
71 disease NN I-NP O
71 ) ) O O
71 s/p NN B-NP O
71 MI NNP I-NP O
71 2000 CD O O
71 ( ( O O
71 S/P NNP B-NP O
71 myocardial NNP I-NP O
71 infarction NN I-NP O
71 ) ) O O
72 PE NNP B-NP O
72 ( ( O O
72 pulmonary JJ B-NP O
72 embolism NN I-NP O
72 ) ) O O
72 Schizophrenia NNP B-NP O
73 ( ( O O
73 schizophrenia NN B-NP O
73 ) ) O O
73 gut NN B-NP O
73 malrotation NN I-NP O
73 ( ( O O
73 3 CD O O
73 ) ) O O
73 Atrial NNP B-NP O
73 fibrillation NN I-NP O
73 ( ( O O
73 atrial JJ B-NP O
74 fibrillation NN I-NP O
74 ) ) O O
74 IDDM NNP B-NP O
74 ( ( O O
74 diabetes VBZ O O
74 mellitus VBP O O
74 type JJ O O
74 2 CD O O
74 ) ) O O
74 HTN NNP B-NP O
75 ( ( O O
75 hypertension NN B-NP O
75 ) ) O O
75 dysfunctional JJ B-NP O
75 uterine JJ I-NP O
75 bleeding NN I-NP O
75 ( ( O O
75 dysfunctional JJ B-NP O
75 uterine NN I-NP O
76 bleeding NN I-NP O
76 ) ) O O
76 uterine NN B-NP O
76 fibroid NN I-NP O
76 ( ( O O
76 uterine JJ B-NP O
76 fibroids NNS I-NP O
76 ) ) O O
76 h/o VBP O O
76 rheumatic JJ B-NP O
76 fever NN I-NP O
76 ( ( O O
76 H/O NNP B-NP O
77 rheumatic JJ B-NP O
77 fever NN I-NP O
77 ) ) O O
77 s/p VBD B-VP O
77 c-section NN B-NP O
77 x2 NN I-NP O
77 ( ( O O
77 S/P NNP B-NP O
77 cesarean VBP O O
77 section NN B-NP O
77 ) ) O O
78 OPERATIONS NNP B-NP O
78 AND NNP I-NP O
78 PROCEDURES: NNP I-NP O
79 OTHER NNP I-NP O
79 TREATMENTS/PROCEDURES NNP I-NP O
79 ( ( O O
79 NOT NNP B-NP O
79 IN NNP I-NP O
79 O.R NNP I-NP O
79 ) ) O O
80 CXR NNP B-NP O
80 - : O O
80 clear JJ B-NP O
81 EKG NNP I-NP O
81 - : O O
81 Aflutter NNP B-NP O
82 Lower NNP I-NP O
82 Extremity NNP I-NP O
82 Vascular NNP I-NP O
82 Ultrasound NNP I-NP O
82 - : O O
82 negative JJ O O
82 for IN B-VP O
82 DVT NNP B-NP O
82 bilaterally RB O O
83 BRIEF NNP B-NP O
83 RESUME NNP I-NP O
83 OF NNP I-NP O
83 HOSPITAL NNP I-NP O
83 COURSE: NNP I-NP O
84 --- NNP I-NP O
85 ID: NNP I-NP O
85 52 CD O O
85 year NN B-NP O
85 old JJ B-NP O
85 woman NN I-NP O
85 --- NNP I-NP O
86 CC: NNP I-NP O
86 SOB NNP I-NP O
86 , , O O
86 weight VBD B-VP O
86 gain NN B-NP O
86 --- NN I-NP O
87 DX: NNP I-NP O
87 CHF NNP I-NP O
88 HPI: NNP I-NP O
88 52 CD O O
88 yr NN B-NP O
88 old JJ B-NP O
88 woman NN I-NP O
88 w/ VBZ O O
88 a DT B-NP O
88 h/o NN I-NP O
88 of IN B-VP O
88 rheumatic JJ B-NP O
88 heart NN I-NP O
88 disease NN I-NP O
88 , , O O
88 CHF NNP B-NP O
88 , , O O
88 HTN NNP B-NP O
88 , , O O
89 Type NNP B-NP B-r
89 2 CD O I-r
89 DM NNP B-NP I-r
89 on IN B-VP O
89 insulin NN B-NP B-m
89 , , O O
89 CAD NNP B-NP O
89 , , O O
89 s/p NN B-NP O
89 MI NNP I-NP O
89 2000 CD O O
89 , , O O
89 and CC O O
89 A NNP B-NP O
89 fib/flutter NN I-NP O
89 , , O O
89 who WP O O
90 presents VBZ O O
90 with IN B-VP O
90 2 CD O O
90 days NNS B-NP O
90 of IN B-VP O
90 increasing VBG O O
90 SOB NNP B-NP O
90 and CC O O
90 weight VBD B-VP O
90 gain NN B-NP O
90 Per NNP I-NP O
90 patient NN I-NP O
90 - : O O
91 came VBD B-VP O
91 in IN B-VP O
91 to TO O O
91 ED NNP B-NP O
91 because IN B-VP O
91 CHF NNP B-NP O
91 nurse RB O O
91 noted VBD B-VP O
91 weight JJ B-NP O
91 gain NN I-NP O
91 Pt NNP I-NP O
91 also RB O O
92 describes VBZ O O
92 2 CD O O
92 days NNS B-NP O
92 of IN B-VP O
92 swelling VBG O O
92 in IN B-VP O
92 her PRP$ O O
92 legs NNS B-NP O
92 and CC O O
92 an DT O O
92 increasing VBG O O
92 SOB NNP B-NP O
92 Pt NNP I-NP O
93 had VBD B-VP O
93 to TO O O
93 sleep VB O O
93 with IN B-VP O
93 3 CD O O
93 pillows NNS B-NP O
93 , , O O
93 rather RB O O
93 than IN B-VP O
93 her PRP$ O O
93 usual JJ O O
93 2 CD O O
93 1 CD O O
93 day NN B-NP O
93 PTA NNP I-NP O
94 patient NN I-NP O
94 developed VBD B-VP O
94 pain NN B-NP O
94 in IN B-VP O
94 her PRP$ O O
94 L NNP B-NP O
94 lower JJR B-NP O
94 leg NN I-NP O
94 , , O O
94 described VBN O O
94 as IN B-VP O
94 a DT B-NP O
94 "knot NN I-NP O
94 in IN B-VP O
95 her PRP$ O O
95 calf." JJ B-NP O
95 Day NNP I-NP O
95 of IN B-VP O
95 admission NN B-NP O
95 , , O O
95 patient JJ B-NP O
95 weight NN I-NP O
95 was VBD B-VP O
95 noticed VBN O O
95 to TO O O
95 be VB O O
95 +10 JJ B-NP O
95 lbs NN I-NP O
96 and CC O O
96 she PRP O O
96 was VBD B-VP O
96 recommended VBN O O
96 to TO O O
96 come VB O O
96 to TO O O
96 the DT B-NP O
96 ED NNP I-NP O
96 Patient NNP I-NP O
96 has VBZ O O
97 +orthopnea VBN O O
97 , , O O
97 PND NNP B-NP O
97 , , O O
97 fatigue NN B-NP O
97 At IN B-VP O
97 baseline JJ B-NP O
97 patient NN I-NP O
97 becomes NNS I-NP O
97 SOB NNP I-NP O
97 when WRB O O
98 climbing VBG O O
98 2 CD O O
98 stairs NNS B-NP O
98 She PRP O O
98 denies VBZ O O
98 any DT B-NP O
98 palpitations NNS I-NP O
98 , , O O
98 cp NN B-NP O
98 , , O O
98 n/v/d JJ B-NP O
98 Admits NNP I-NP O
99 auditory NN I-NP O
99 and CC O O
99 visual JJ B-NP O
99 hallucinations NNS I-NP O
99 ( ( O O
99 men NNS B-NP O
99 and CC O O
99 women NNS B-NP O
99 crawling VBG O O
99 on IN B-VP O
99 the DT B-NP O
100 wall NN I-NP O
100 saying VBG O O
100 things NNS B-NP O
100 about IN B-VP O
101 me PRP O O
101 ) ) O O
101 PMH: NNP B-NP O
101 Htn NNP I-NP O
101 , , O O
101 CAD NNP B-NP O
101 s/p VBZ O O
101 MI NNP B-NP O
101 2000 CD O O
101 , , O O
101 Rheumatic NNP B-NP O
101 Fever NNP I-NP O
101 c VBP O O
101 valve NN B-NP O
101 dz NN I-NP O
101 , , O O
102 CHF NNP B-NP O
102 , , O O
102 IDDM NNP B-NP O
102 , , O O
102 Depression NNP B-NP O
102 , , O O
102 Schizophrenia NNP B-NP O
102 , , O O
102 Afib/flutter NNP B-NP O
102 , , O O
102 Fibroids NNP B-NP O
102 , , O O
103 Dysfunctional NNP B-NP O
103 Uterine NNP I-NP O
103 Bleeding NNP I-NP O
103 , , O O
103 h/o NN B-NP O
103 PE NNP I-NP O
103 , , O O
103 h/o NN B-NP O
103 domestic JJ B-NP O
103 violence NN I-NP O
104 --- NNP I-NP O
104 EVENTS: NNP I-NP O
105 In IN B-VP O
105 the DT B-NP O
105 ED NNP I-NP O
105 , , O O
105 EKG NNP B-NP O
105 showed VBD B-VP O
105 the DT B-NP O
105 patient NN I-NP O
105 to TO O O
105 be VB O O
105 in IN B-VP O
105 A DT B-NP B-r
105 flutter NN I-NP O
105 with IN B-VP O
105 HR NNP B-NP O
105 in IN B-VP O
105 the DT O O
106 110s CD O O
106 She PRP O O
106 was VBD B-VP O
106 given VBN O O
106 25 CD O B-do
106 mg JJ B-NP I-do
106 PO NNP I-NP B-mo
106 Lopressor NNP I-NP B-m
106 x NNP I-NP B-du
106 2 CD O I-du
106 , , O O
106 which WDT O O
106 brought VBD B-VP O
106 her PRP O O
106 HR NNP B-NP O
106 down RB O O
107 to TO O O
107 the DT O O
107 80s CD O O
107 Patient NNP B-NP O
107 described VBD B-VP O
107 a DT B-NP O
107 period NN I-NP O
107 of IN B-VP O
107 chest NN B-NP O
107 pain NN I-NP O
107 while IN B-VP O
107 in IN B-VP O
107 the DT B-NP O
108 ED NNP I-NP O
108 , , O O
108 which WDT O O
108 lasted VBD B-VP O
108 for IN B-VP O
108 seconds NNS B-NP O
108 The DT B-NP O
108 pain NN I-NP O
108 was VBD B-VP O
108 described VBN O O
108 as IN B-VP O
108 sharp JJ O O
108 , , O O
109 midline NN B-NP O
109 , , O O
109 and CC O O
109 pleuritic JJ O O
110 10/17 CD O O
110 - : O O
110 no DT B-NP O
110 O/N NNP I-NP O
110 events NNS I-NP O
110 0/12 CD O O
110 - : O O
110 no DT B-NP O
110 O/N NNP I-NP O
111 events NNS I-NP O
111 --- VBP O O
112 STATUS: NNP B-NP O
112 VS: NNP I-NP O
112 T: NNP I-NP O
112 97.1 CD O O
112 , , O O
112 HR NNP B-NP O
112 80 CD O O
112 , , O O
112 BP NNP B-NP O
112 106/67 CD O O
112 , , O O
112 RR NNP B-NP O
112 18 CD O O
112 , , O O
112 O2sat NNP B-NP O
112 98% CD O O
112 on IN B-VP O
112 RA NNP B-NP O
112 GEN: NNP I-NP O
113 breathing NN I-NP O
113 comfortably RB O O
113 , , O O
114 NAD NNP B-NP O
114 NECK: NNP I-NP O
114 JVP NNP I-NP O
115 flat JJ B-NP O
115 PULM: NNP I-NP O
116 CTAB NNP I-NP O
116 CV: NNP I-NP O
116 NL NNP I-NP O
116 S1 NNP I-NP O
116 and CC O O
116 S2 NNP B-NP O
116 No NNP I-NP O
117 MRG's NNP I-NP O
117 ABD: NNP I-NP O
117 obese JJ B-NP O
117 soft JJ I-NP O
117 NT NNP I-NP O
117 mild NN I-NP O
117 distention NN I-NP O
117 +BS VBZ O O
117 No DT B-NP O
117 masses NNS I-NP O
118 or CC O O
118 bruits NNS B-NP O
118 EXT: NNP I-NP O
118 DP NNP I-NP O
118 and CC O O
118 TP NNP B-NP O
118 2+ CD O O
118 , , O O
118 1+ CD O O
118 pitting VBG O O
118 edema NN B-NP O
118 bilaterally RB O O
119 Left NNP B-NP O
119 calf NN I-NP O
119 , , O O
119 ankle JJ B-NP O
119 tender NN I-NP O
119 anteriorly RB O O
119 and CC O O
119 posteriorly RB O O
119 + JJ B-NP O
119 Homan's NNP I-NP O
120 sign NN I-NP O
120 --- NNP I-NP O
121 STUDIES/TESTS: NNP I-NP O
121 8/4/05 CD O O
121 CXR: NNP B-NP O
121 mild JJ B-NP O
121 kyphosis NN I-NP O
121 , , O O
121 no DT B-NP O
121 effusion NN I-NP O
121 , , O O
121 moderate JJ B-NP O
122 cardiomegaly NN I-NP O
122 no DT B-NP O
122 change NN I-NP O
122 since IN B-VP O
122 6/15/05 CD O O
122 8 CD O O
122 EKG: NNP B-NP O
122 HR NNP I-NP O
122 118 CD O O
122 , , O O
122 A NNP B-NP O
122 flutter RB O O
123 Previous NNP B-NP O
123 EKG NNP I-NP O
123 ( ( O O
123 9/24/05 CD O O
123 ) ) O O
123 showed VBD B-VP O
123 A DT B-NP O
123 fib NN I-NP O
123 , , O O
123 which WDT O O
123 was VBD B-VP O
123 changed VBN O O
123 from IN B-VP O
123 a DT B-NP O
124 previous JJ I-NP O
124 A NNP I-NP O
124 flutter NN I-NP O
125 0/12 CD O O
125 - : O O
125 Bilat NNP B-NP O
125 Lenis NNP I-NP O
125 - : O O
125 neg NN B-NP O
125 for IN B-VP O
125 DVT NNP B-NP O
125 --- NNP I-NP O
126 PROBLEM NNP I-NP O
126 LIST: NNP I-NP O
126 1 CD O O
126 ) ) O O
126 Pulm NNP B-NP O
126 - : O O
126 Currently RB O O
126 treating VBG O O
126 this DT O O
126 as IN B-VP O
126 a DT B-NP O
126 CHF NNP I-NP O
126 exacerbation NN I-NP O
127 - : O O
127 etiology NN B-NP O
127 likely JJ B-NP O
127 diet JJ I-NP O
127 non-compliance JJ I-NP O
127 Very NNP I-NP O
128 mild NN I-NP O
128 BLE NNP I-NP O
128 edema NN I-NP O
128 , , O O
128 inc JJ B-NP O
128 abd NN I-NP O
128 girth NN I-NP O
128 and CC O O
128 wt JJ B-NP O
128 gain NN I-NP O
128 Ischemia NNP I-NP O
128 ruled VBD B-VP O
129 out RP O O
129 2 CD O O
129 ) ) O O
129 CV NNP B-NP O
129 - : O O
129 I: NNP B-NP O
129 ruled VBD B-VP O
129 out RP O O
129 with IN B-VP O
129 enzymes NNS B-NP O
129 x3 VBP O O
129 Continue NNP B-NP O
129 ASA NNP I-NP B-m
129 , , O O
129 Metop NNP B-NP B-m
129 , , O O
130 Statin NNP B-NP B-m
130 , , O O
130 ACE NNP B-NP B-m
130 P NNP I-NP I-m
130 - : O O
130 CHF NN B-NP O
130 , , O O
130 likely RB O O
130 minor JJ B-NP O
130 flare NN I-NP O
131 2/2 CD O O
131 diet JJ B-NP O
131 non-compliance JJ I-NP O
131 Continue NNP I-NP O
131 Lasix NNP I-NP B-m
131 R: NNP I-NP O
131 pt NN I-NP O
131 appears VBZ O O
131 to TO O O
131 have VB O O
131 history NN B-NP O
132 of IN B-VP O
132 Afib/flutter NNP B-NP O
132 , , O O
132 unclear JJ O O
132 if IN B-VP O
132 goes VBZ O O
132 in IN B-VP O
132 and CC O O
132 out IN B-VP O
132 , , O O
132 but CC O O
132 pt VBP O O
132 states NNS B-NP O
132 always RB O O
132 in IN B-VP O
133 Afib NNP B-NP B-r
133 Rate NNP I-NP B-r
133 Rate NNP I-NP B-r
133 control NN I-NP I-r
133 control NN I-NP I-r
133 with IN B-VP O
133 BB NNP B-NP B-m
133 BB NNP I-NP B-m
133 , , O O
133 coumadin SYM O B-m
133 - : O O
133 last JJ B-NP O
133 INR NNP I-NP O
134 2.8 CD O O
134 3 CD O O
134 ) ) O O
134 Endo NNP B-NP O
134 - : O O
134 h/o NN B-NP O
134 DM NNP I-NP O
134 - : O O
134 FS NNP B-NP O
134 high VBP O O
134 on IN B-VP O
134 HD1 NNP B-NP O
134 , , O O
134 now RB O O
134 140s CD O O
134 -150s NNS B-NP O
134 after IN B-VP O
135 increased VBN O O
135 NPH NNP B-NP B-m
135 NPH NNP I-NP B-m
135 dose VBD B-VP O
135 to TO O O
135 60 CD O B-do
135 60 CD O B-do
135 QAM NNP B-NP B-f
135 QAM NNP I-NP B-f
135 and CC O I-f
135 QPM NNP B-NP I-f
135 - : O O
135 cont NN B-NP O
135 RISS NNP I-NP B-m
135 4 CD O O
135 ) ) O O
135 Psych NNP B-NP O
135 - : O O
135 h/o NN B-NP O
136 schizophrenia NN I-NP O
136 , , O O
136 with IN B-VP O
136 active JJ B-NP O
136 aud NN I-NP O
136 and CC O O
136 vis NN B-NP O
136 hallucinations NNS I-NP O
136 ( ( O O
136 chronic JJ O O
136 , , O O
136 for IN B-VP O
137 years NNS B-NP O
137 ) ) O O
137 ALso NNP B-NP O
137 , , O O
137 was VBD B-VP O
137 issue NN B-NP O
137 of IN B-VP O
137 domestic JJ B-NP O
137 violence NN I-NP O
137 from IN B-VP O
137 first JJ B-NP O
137 husband NN I-NP O
137 but CC O O
137 per IN B-VP O
138 social JJ B-NP O
138 work NN I-NP O
138 - : O O
138 this DT O O
138 appears VBZ O O
138 to TO O O
138 be VB O O
138 remote JJ B-NP O
138 SW NNP I-NP O
138 spoke VBD B-VP O
138 with IN B-VP O
138 patient NN B-NP O
138 in IN B-VP O
138 ED NNP B-NP O
139 No NNP I-NP O
139 psych NN I-NP O
139 consult NN I-NP O
139 at IN B-VP O
139 this DT B-NP O
140 time NN I-NP O
140 as IN B-VP O
140 psych JJ B-NP O
140 issues NNS I-NP O
140 appear VBP O O
140 to TO O O
140 be VB O O
140 at IN B-VP O
140 baseline JJ B-NP O
140 Social NNP I-NP O
140 Work NNP I-NP O
140 is VBZ O O
141 seeing VBG O O
141 patient JJ O O
141 regarding VBG O O
141 getting VBG O O
141 her PRP$ O O
141 section NN B-NP O
141 8 CD O O
141 housing NN B-NP O
141 5 CD O O
141 ) ) O O
141 FEN NNP B-NP O
141 - : O O
142 Monitor NN B-NP O
142 Lytes VBZ O O
142 , , O O
142 replace VB O O
142 Mg NNP B-NP O
142 , , O O
142 K NNP B-NP O
142 as IN B-VP O
142 needed VBN O O
142 6 CD O O
142 ) ) O O
142 Ppx NNP B-NP O
142 - : O O
142 on IN B-VP O
143 Coumadin NNP B-NP B-m
143 7 CD O O
143 ) ) O O
143 CODE NNP B-NP O
143 - : O O
143 Full NNP B-NP O
144 ADDITIONAL NNP I-NP O
144 COMMENTS: NNP I-NP O
145 DISCHARGE NNP I-NP O
145 CONDITION: NNP I-NP O
145 Stable NNP I-NP O
146 TO NNP I-NP O
146 DO/PLAN: NNP I-NP O
147 follow VB O O
147 up RP O O
147 with IN B-VP O
147 Sol NNP B-NP O
147 Kragt NNP I-NP O
147 , , O O
147 the DT B-NP O
147 CHF NNP I-NP O
147 nurse NN I-NP O
148 it PRP O O
148 is VBZ O O
148 very RB O O
148 important JJ O O
148 that IN B-VP O
148 you PRP O O
148 maintain VBP O O
148 your PRP$ O O
148 careful JJ B-NP O
148 low JJ I-NP O
148 salt NN I-NP O
148 diet NN I-NP O
148 and CC O O
148 do VBP O O
149 not RB O O
149 drink VB O O
149 too RB O O
149 many JJ B-NP O
149 fluids NNS I-NP O
149 Otherwise VBP O O
149 you PRP O O
149 will MD O O
149 end VB O O
149 up RP O O
149 back RB O O
149 in IN B-VP O
149 the DT B-NP O
150 hospital NN I-NP O
150 Continue NNP I-NP O
150 to TO O O
150 measure VB O O
150 your PRP$ O O
150 daily JJ B-NP O
150 weights NNS I-NP O
150 Be VB O O
150 very RB O O
150 strict JJ O O
150 about IN B-VP O
151 taking VBG O O
151 your PRP$ O O
151 insulin NN B-NP B-m
152 Seek NNP I-NP O
152 medical JJ B-NP O
152 attention NN I-NP O
152 if IN B-VP O
152 you PRP O O
152 develop VBP O O
152 worsening VBG O O
152 shortness NN B-NP O
152 of IN B-VP O
152 breath NN B-NP O
152 , , O O
153 chest NN B-NP O
153 pain NN I-NP O
153 , , O O
153 lightheadedness NN B-NP O
153 , , O O
153 dizziness NN B-NP O
153 , , O O
153 or CC O O
153 any DT B-NP O
153 other JJ I-NP O
153 concerning NN I-NP O
153 symptoms NNS I-NP O
154 No DT B-NP O
154 dictated JJ I-NP O
154 summary NN I-NP O
155 ENTERED NNP I-NP O
155 BY: NNP I-NP O
155 SCHEFFEL NNP I-NP O
155 , , O O
155 SHANE NNP B-NP O
155 L NNP I-NP O
155 , , O O
155 M.D NNP B-NP O
155 ( ( O O
155 GI832 NNP B-NP O
155 ) ) O O
155 2/17/05 CD O O
155 @ $ O O
155 10:56 CD O O
155 AM NNP B-NP O
156 ****** JJ B-NP O
156 END NN I-NP O
156 OF NNP I-NP O
156 DISCHARGE NNP I-NP O
156 ORDERS NNP I-NP O
156 ****** NNP I-NP O
157 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #699364 VBZ O O
2 048372102 CD O O
2 VSTMC NNP B-NP O
2 63794588 CD O O
2 4661987 CD O O
2 0/23/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CONGESTIVE NNP I-NP O
2 HEART NNP I-NP O
2 FAILURE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/16/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 5/25/2005 CD O O
4 ATTENDING: NNP B-NP O
4 VANDERBIE NNP I-NP O
4 , , O O
4 SEBASTIAN NNP B-NP O
4 J NNP I-NP O
4 MD NNP I-NP O
4 , , O O
4 PHD NNP B-NP O
5 ADDENDUM NNP I-NP O
6 Please NNP I-NP O
6 note VB O O
6 this DT O O
6 is VBZ O O
6 an DT B-NP O
6 addendum NN I-NP O
6 to TO O O
6 the DT O O
6 previously RB O O
6 dictated VBN O O
7 discharge NN B-NP O
7 summary JJ B-NP O
7 #2200332 NNP I-NP O
8 INTERIM NNP I-NP O
8 HISTORY: NNP I-NP O
8 In IN B-VP O
8 the DT B-NP O
8 interim NN I-NP O
8 , , O O
8 since IN B-VP O
8 the DT O O
8 previously RB O O
8 dictated VBN O O
9 discharge NN B-NP O
9 summary NN I-NP O
9 , , O O
9 the DT B-NP O
9 patient NN I-NP O
9 has VBZ O O
9 continued VBN O O
9 to TO O O
9 progress VB O O
9 from IN B-VP O
9 a DT B-NP O
10 cardiac JJ I-NP O
10 standpoint NN I-NP O
11 HOSPITAL NNP I-NP O
11 COURSE: NNP I-NP O
11 His PRP$ O O
11 hospital NN B-NP O
11 course NN I-NP O
11 by IN B-VP O
11 system NN B-NP O
11 from IN B-VP O
11 9/24/05 CD O O
12 through IN B-VP O
12 the DT B-NP O
12 date NN I-NP O
12 of IN B-VP O
12 discharge NN B-NP O
12 is VBZ O O
12 as IN B-VP O
12 follows: JJ O O
13 1 CD O O
13 Ischemia: NNP B-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 had VBD B-VP O
13 continued VBN O O
13 to TO O O
13 remain VB O O
13 stable JJ O O
13 from IN B-VP O
13 an DT B-NP O
14 ischemia NN I-NP O
14 standpoint NN I-NP O
14 He PRP O O
14 continues VBZ O O
14 on IN B-VP O
14 aspirin NN B-NP B-m
14 and CC O O
14 statin VB O B-m
14 A DT B-NP O
15 beta-blocker NN I-NP B-m
15 has VBZ O O
15 been VBN O O
15 added VBN O O
15 back RB O O
15 to TO O O
15 his PRP$ O O
15 regimen NNS B-NP O
15 and CC O O
15 was VBD B-VP O
15 titrated VBN O B-do
16 to TO O O
16 a DT B-NP O
16 dose NN I-NP O
16 of IN B-VP O
16 Lopressor NNP B-NP B-m
16 12.5 CD O B-do
16 mg NN B-NP I-do
16 p.o NN I-NP B-mo
16 t.i.d IN B-VP B-f
16 The DT B-NP O
16 patient NN I-NP O
16 has VBZ O O
16 not RB O O
17 been VBN O O
17 started VBN O O
17 on IN B-VP O
17 an DT B-NP O
17 ACE NNP I-NP O
17 inhibitor NN I-NP O
17 secondary NN I-NP O
17 to TO O O
17 his PRP$ O O
17 elevated JJ B-NP O
18 creatinine NN I-NP O
18 at IN B-VP O
18 this DT B-NP O
18 time NN I-NP O
18 He PRP O O
18 has VBZ O O
18 had VBN O O
18 no DT B-NP O
18 further JJ I-NP O
18 episodes NNS I-NP O
18 of IN B-VP O
18 chest NN B-NP O
19 pain NN I-NP O
20 2 CD O O
20 Pump: NNP B-NP O
20 The DT B-NP O
20 patient's NN I-NP O
20 congestive JJ B-NP O
20 heart NN I-NP O
20 failure NN I-NP O
20 regimen NN I-NP O
20 was VBD B-VP O
21 titrated VBN O O
21 The DT B-NP O
21 patient NN I-NP O
21 continues VBZ O O
21 on IN B-VP O
21 Isordil NNP B-NP B-m
21 20 CD O B-do
21 mg NN B-NP I-do
21 p.o NN I-NP B-mo
21 t.i.d NN I-NP B-f
21 and CC O O
22 hydralazine NN B-NP B-m
22 50 CD O B-do
22 mg NN B-NP I-do
22 p.o NN I-NP B-mo
22 t.i.d NN I-NP B-f
22 for IN B-VP O
22 after IN B-VP O
22 load NN B-NP O
22 reduction NN I-NP O
22 He PRP O O
22 was VBD B-VP O
23 restarted VBN O O
23 on IN B-VP O
23 a DT B-NP O
23 low-dose JJ I-NP O
23 beta-blocker NN I-NP B-m
23 beta-blocker NN I-NP B-m
23 at IN B-VP O
23 12.5 CD O B-do
23 12.5 CD O B-do
23 mg NN B-NP I-do
23 mg NN I-NP I-do
23 p.o NN I-NP B-mo
23 p.o NN I-NP B-mo
23 t.i.d NN I-NP B-f
23 as RB O O
24 well RB O O
24 as IN B-VP O
24 digoxin NN B-NP B-m
24 at IN B-VP O
24 0.125 CD O B-do
24 mg NN B-NP I-do
24 p.o NN I-NP B-mo
24 q.o.d VBD B-VP B-f
24 The DT B-NP O
24 patient NN I-NP O
24 was VBD B-VP O
25 aggressively RB O O
25 diuresed VBN O O
25 with IN B-VP O
25 intravenous JJ B-NP B-mo
25 Lasix NNP I-NP B-m
25 and CC O O
25 Zaroxolyn NNP B-NP B-m
26 followed VBN O O
26 by IN B-VP O
26 conversion NN B-NP O
26 to TO O O
26 oral JJ B-NP B-mo
26 diuresis NN I-NP O
26 with IN B-VP O
26 torsemide NN B-NP B-m
26 at IN B-VP O
26 the DT B-NP O
27 time NN I-NP O
27 of IN B-VP O
27 discharge NN B-NP O
27 The DT B-NP O
27 patient NN I-NP O
27 will MD O O
27 be VB O O
27 followed VBN O O
27 by IN B-VP O
27 Dr NNP B-NP O
27 Rayford NNP I-NP O
27 Hogenmiller NNP I-NP O
27 in IN B-VP O
27 the DT B-NP O
27 Clevesa NNP I-NP O
27 Irvca NNP I-NP O
27 Sideenandri NNP I-NP O
27 as RB O O
27 well RB O O
27 as IN B-VP O
27 by IN B-VP O
27 the DT B-NP O
28 CHF NNP I-NP O
28 Service NNP I-NP O
28 at IN B-VP O
28 Sher-ship NNP B-NP O
28 Rimark's NNP I-NP O
28 Medical NNP I-NP O
28 Center NNP I-NP O
28 At IN B-VP O
28 the DT B-NP O
28 time NN I-NP O
28 of IN B-VP O
29 discharge NN B-NP O
29 , , O O
29 the DT B-NP O
29 patient NN I-NP O
29 was VBD B-VP O
29 felt VBN O O
29 to TO O O
29 be VB O O
29 nearing VBG O O
29 euvolemia JJ O O
29 with IN B-VP O
30 estimated VBN O O
30 dry JJ B-NP O
30 weight NN I-NP O
30 of IN B-VP O
30 approximately RB O O
30 76 CD O O
30 to TO O O
30 77 CD O O
30 kg NNS B-NP O
31 3 CD O O
31 Rhythm: NNP B-NP O
31 The DT B-NP O
31 patient NN I-NP O
31 continued VBD B-VP O
31 to TO O O
31 have VB O O
31 atrial JJ B-NP O
31 flutter NN I-NP O
31 with IN B-VP O
31 a DT B-NP O
32 block NN I-NP O
32 His PRP$ O O
32 heart NN B-NP O
32 rate NN I-NP O
32 remained VBD B-VP O
32 in IN B-VP O
32 the DT B-NP O
32 rate NN I-NP O
32 of IN B-VP O
32 100 CD O O
32 to TO O O
32 110 CD O O
32 at IN B-VP O
32 the DT B-NP O
33 time NN I-NP O
33 of IN B-VP O
33 discharge NN B-NP O
33 He PRP O O
33 had VBD B-VP O
33 decreased VBN O O
33 episodes NNS B-NP O
33 of IN B-VP O
33 more RBR O O
33 rapid JJ B-NP O
34 dysrhythmia NN I-NP O
34 following VBG O O
34 addition NN B-NP O
34 of IN B-VP O
34 beta-blocker NN B-NP B-m
34 and CC O O
34 digoxin NN B-NP B-m
34 to TO O O
34 his PRP$ O O
35 medication NN B-NP O
35 regimen NNS I-NP O
35 He PRP O O
35 also RB O O
35 continues VBZ O O
35 on IN B-VP O
35 amiodarone NN B-NP B-m
35 at IN B-VP O
35 200 CD O B-do
35 mg NN B-NP I-do
36 p.o NN I-NP B-mo
36 q.d NN I-NP B-f
36 As IN B-VP O
36 mentioned VBN O O
36 , , O O
36 the DT B-NP O
36 patient NN I-NP O
36 was VBD B-VP O
36 found VBN O O
36 to TO O O
36 have VB O O
36 atrial JJ B-NP B-r
36 atrial JJ I-NP B-r
37 clot NN I-NP O
37 on IN B-VP O
37 transesophageal JJ B-NP O
37 echocardiogram NN I-NP O
37 and CC O O
37 thus RB O O
37 was VBD B-VP O
37 started VBN O O
37 on IN B-VP O
37 a DT B-NP O
38 heparin NN I-NP B-m
38 drip NN I-NP B-mo
38 and CC O O
38 transitioned VBN O O
38 on IN B-VP O
38 Coumadin NNP B-NP B-m
38 However RB O O
38 , , O O
38 after IN B-VP O
38 a DT B-NP O
39 substantial JJ I-NP O
39 discussion NN I-NP O
39 with IN B-VP O
39 the DT B-NP O
39 Congestive NNP I-NP O
39 Heart NNP I-NP O
39 Failure NNP I-NP O
39 Service NNP I-NP O
40 and CC O O
40 the DT B-NP O
40 patient's JJ I-NP O
40 outpatient NN I-NP O
40 CHF NNP I-NP O
40 Care NNP I-NP O
40 Team NNP I-NP O
40 , , O O
40 it PRP O O
40 was VBD B-VP O
40 felt VBN O O
40 that IN B-VP O
40 the DT B-NP O
41 risks NNS I-NP O
41 of IN B-VP O
41 Coumadin NNP B-NP B-m
41 in IN B-VP O
41 this DT B-NP O
41 patient NN I-NP O
41 who WP O O
41 has VBZ O O
41 a DT B-NP O
41 history NN I-NP O
41 of IN B-VP O
42 significant JJ B-NP O
42 noncompliance NN I-NP O
42 were VBD B-VP O
42 greater JJR O O
42 than IN B-VP O
42 the DT O O
42 known VBN O O
42 risk NN B-NP O
42 of IN B-VP O
43 thromboembolic JJ B-NP O
43 disease NN I-NP O
43 in IN B-VP O
43 the DT B-NP O
43 setting NN I-NP O
43 of IN B-VP O
43 his PRP$ O O
43 known VBN O O
43 atrial JJ B-NP B-r
43 atrial JJ I-NP B-r
43 clot NN I-NP I-r
43 clot NN I-NP I-r
44 and CC O O
44 thus RB O O
44 the DT B-NP O
44 patient NN I-NP O
44 was VBD B-VP O
44 not RB O O
44 continued VBN O O
44 on IN B-VP O
44 Coumadin NNP B-NP B-m
45 anticoagulation NN I-NP O
45 Rather NNP I-NP O
45 , , O O
45 he PRP O O
45 was VBD B-VP O
45 given VBN O O
45 aspirin NNS B-NP B-m
45 and CC O O
45 Plavix NNP B-NP B-m
45 at IN B-VP O
45 full JJ O B-do
45 full JJ O B-do
46 doses VBZ O O
46 The DT B-NP O
46 use NN I-NP O
46 of IN B-VP O
46 Coumadin NNP B-NP B-m
46 in IN B-VP O
46 this DT B-NP O
46 patient NN I-NP O
46 could MD O O
46 be VB O O
46 re-evaluated JJ O O
47 as IN B-VP O
47 an DT B-NP O
47 outpatient NN I-NP O
47 based VBN O O
47 on IN B-VP O
47 the DT B-NP O
47 patient's JJ I-NP O
47 follow-up NN I-NP O
47 as IN B-VP O
47 deemed VBN O O
48 appropriate NN B-NP O
48 by IN B-VP O
48 his PRP$ O O
48 outpatient NN B-NP O
48 providers NNS I-NP O
49 4 CD O O
49 Endocrine: NNP B-NP O
49 The DT B-NP O
49 patient NN I-NP O
49 remained VBD B-VP O
49 on IN B-VP O
49 stable JJ B-NP O
49 diabetes NNS I-NP O
49 mellitus VBP O O
50 regimen NNS B-NP O
50 of IN B-VP O
50 Lantus NNP B-NP B-m
50 5 CD O B-do
50 units NNS B-NP I-do
50 q.p.m RB O B-f
50 and CC O O
50 standing VBG O O
50 NovoLog NNP B-NP B-m
50 3 CD O B-do
50 units NNS B-NP I-do
51 q.a.c RB O B-f
51 as RB O O
51 well RB O O
51 as IN B-VP O
51 the DT B-NP O
51 NovoLog NNP I-NP B-m
51 sliding VBG O B-do
51 scale NN B-NP I-do
51 The DT B-NP O
51 patient's NN I-NP O
52 insulin NN I-NP B-m
52 regimen NNS I-NP I-m
52 can MD O O
52 be VB O O
52 adjusted VBN O O
52 as IN B-VP O
52 an DT B-NP O
52 outpatient NN I-NP O
52 and CC O O
52 possibly RB O O
53 oral JJ B-NP B-mo
53 diabetes NNS I-NP B-m
53 medications NNS I-NP I-m
53 restarted VBD B-VP O
54 5 CD O O
54 Pulmonary: NNP B-NP O
54 The DT B-NP O
54 patient NN I-NP O
54 remained VBD B-VP O
54 stable JJ O O
54 from IN B-VP O
54 the DT O O
54 pulmonary JJ O O
55 with IN B-VP O
55 good JJ B-NP O
55 oxygen NN I-NP O
55 saturations NNS I-NP O
55 on IN B-VP O
55 room NN B-NP O
55 air NN I-NP O
55 at IN B-VP O
55 rest NN B-NP O
55 and CC O O
55 with IN B-VP O
56 ambulation NN B-NP O
57 6 CD O O
57 Renal: NNP B-NP O
57 The DT B-NP O
57 patient's NN I-NP O
57 creatinine NN I-NP O
57 on IN B-VP O
57 the DT B-NP O
57 day NN I-NP O
57 prior RB O O
57 to TO O O
58 discharge VB O O
58 was VBD B-VP O
58 1.6 CD O O
58 improved VBN O O
58 from IN B-VP O
58 the DT B-NP O
58 peak NN I-NP O
58 of IN B-VP O
58 greater JJR O O
58 than IN B-VP O
58 2 CD O O
59 Renal JJ B-NP O
59 toxic NN I-NP O
59 medications NNS I-NP O
59 were VBD B-VP O
59 avoided VBN O O
59 The DT B-NP O
59 patient NN I-NP O
59 had VBD B-VP O
59 not RB O O
59 been VBN O O
60 restarted VBN O O
60 on IN B-VP O
60 ACE NNP B-NP B-m
60 inhibitor NN I-NP I-m
60 , , O O
60 which WDT O O
60 could MD O O
60 be VB O O
60 done VBN O O
60 as IN B-VP O
60 an DT B-NP O
60 outpatient NN I-NP O
61 as IN B-VP O
61 his PRP$ O O
61 renal JJ B-NP O
61 function NN I-NP O
61 stabilizes VBZ O O
61 His PRP$ O O
61 electrolytes NNS B-NP O
61 were VBD B-VP O
62 monitored VBN O O
62 and CC O O
62 repleted VBN O O
62 aggressively RB O O
63 7 CD O O
63 Hematology: NNP B-NP O
63 As NNP I-NP O
63 mentioned VBD B-VP O
63 , , O O
63 the DT B-NP O
63 decision NN I-NP O
63 was VBD B-VP O
63 made VBN O O
63 not RB O O
63 to TO O O
64 anticoagulate VB O O
64 the DT B-NP O
64 patient NN I-NP O
64 with IN B-VP O
64 outpatient JJ B-NP O
64 Coumadin NNP I-NP O
64 He PRP O O
64 was VBD B-VP O
65 started VBN O O
65 on IN B-VP O
65 aspirin NN B-NP B-m
65 and CC O O
65 Plavix NNP B-NP B-m
65 Of IN B-VP O
65 note NN B-NP O
65 , , O O
65 the DT B-NP O
65 patient NN I-NP O
65 also RB O O
65 had VBD B-VP O
66 decreased VBN O O
66 platelets NNS B-NP O
66 in IN B-VP O
66 the DT B-NP O
66 setting NN I-NP O
66 of IN B-VP O
66 heparin JJ B-NP B-m
66 anticoagulation NN I-NP O
66 and CC O O
67 thus RB O O
67 anti-P4 JJ B-NP O
67 antibody NN I-NP O
67 was VBD B-VP O
67 sent VBN O O
67 This DT B-NP O
67 test NN I-NP O
67 is VBZ O O
67 pending VBG O O
67 at IN B-VP O
67 the DT B-NP O
67 time NN I-NP O
68 of IN B-VP O
68 the DT B-NP O
68 dictation NN I-NP O
68 , , O O
68 but CC O O
68 should MD O O
68 be VB O O
68 followed VBN O O
68 up RP O O
68 by IN B-VP O
68 the DT B-NP O
68 patient's JJ I-NP O
69 outpatient JJ I-NP O
69 providers NNS I-NP O
69 as IN B-VP O
69 it PRP O O
69 may MD O O
69 input VB O O
69 further JJ B-NP O
69 treatment NN I-NP O
69 In IN B-VP O
69 the DT B-NP O
70 meantime NN I-NP O
70 , , O O
70 recommend VBP O O
70 no DT B-NP O
70 heparin NN I-NP O
70 products NNS I-NP O
70 As IN B-VP O
70 mentioned VBN O O
70 , , O O
70 the DT B-NP O
71 decision NN I-NP O
71 was VBD B-VP O
71 made VBN O O
71 by IN B-VP O
71 the DT B-NP O
71 CHF NNP I-NP O
71 Team NNP I-NP O
71 who WP O O
71 will MD O O
71 be VB O O
71 following VBG O O
71 the DT B-NP O
72 patient NN I-NP O
72 as IN B-VP O
72 an DT B-NP O
72 outpatient NN I-NP O
72 not RB O O
72 to TO O O
72 continue VB O O
72 Coumadin NNP B-NP B-m
73 anticoagulation NN I-NP O
74 8 CD O O
74 Neuro: NNP B-NP O
74 Of IN B-VP O
74 note NN B-NP O
74 , , O O
74 on IN B-VP O
74 the DT B-NP O
74 evening NN I-NP O
74 of IN B-VP O
74 6/13/05 CD O O
74 , , O O
74 the DT B-NP O
74 patient NN I-NP O
75 complained VBD B-VP O
75 of IN B-VP O
75 left-sided JJ B-NP O
75 blurry NN I-NP O
75 vision NN I-NP O
75 , , O O
75 which WDT O O
75 was VBD B-VP O
75 new JJ O O
75 for IN B-VP O
75 the DT B-NP O
76 patient NN I-NP O
76 He PRP O O
76 does VBZ O O
76 have VB O O
76 chronic VBN O O
76 right JJ B-NP O
76 visual JJ I-NP O
76 changes NNS I-NP O
76 In IN B-VP O
76 light NN B-NP O
76 of IN B-VP O
77 the DT B-NP O
77 patient's NN I-NP O
77 known VBN O O
77 peripheral JJ B-NP O
77 atherosclerotic JJ I-NP O
77 disease NN I-NP O
77 and CC O O
77 atrial JJ B-NP O
78 clot NN I-NP O
78 , , O O
78 the DT B-NP O
78 patient NN I-NP O
78 was VBD B-VP O
78 seen VBN O O
78 by IN B-VP O
78 the DT B-NP O
78 Stroke NNP I-NP O
78 Team NNP I-NP O
78 for IN B-VP O
78 a DT B-NP O
78 question NN I-NP O
78 of IN B-VP O
79 acute NN B-NP O
79 stroke NN I-NP O
79 He PRP O O
79 had VBD B-VP O
79 MRI NNP B-NP O
79 at IN B-VP O
79 that DT B-NP O
79 time NN I-NP O
79 , , O O
79 which WDT O O
79 did VBD B-VP O
79 show VB O O
79 multiple JJ B-NP O
80 old JJ I-NP O
80 infarcts NNS I-NP O
80 in IN B-VP O
80 the DT B-NP O
80 right JJ I-NP O
80 frontal NN I-NP O
80 , , O O
80 right JJ B-NP O
80 occipital NN I-NP O
80 , , O O
80 left VBD B-VP O
81 occipitoparietal JJ O O
81 , , O O
81 left VBD B-VP O
81 posterior JJ B-NP O
81 frontal JJ I-NP O
81 areas NNS I-NP O
81 There EX O O
81 was VBD B-VP O
81 , , O O
82 however RB O O
82 , , O O
82 no DT B-NP O
82 new JJ I-NP O
82 stroke NN I-NP O
82 seen VBN O O
82 on IN B-VP O
82 the DT B-NP O
82 MRI NNP I-NP O
82 The DT B-NP O
82 left JJ I-NP O
82 internal JJ I-NP O
83 carotid NN I-NP O
83 artery NN I-NP O
83 was VBD B-VP O
83 not RB O O
83 evaluated VBN O O
83 , , O O
83 not RB O O
83 visualized VBN O O
83 on IN B-VP O
83 the DT B-NP O
83 MRI NNP I-NP O
83 and CC O O
84 there EX O O
84 was VBD B-VP O
84 concern NN B-NP O
84 for IN B-VP O
84 left NN B-NP O
84 carotid NN I-NP O
84 artery NN I-NP O
84 occlusion NN I-NP O
84 versus IN B-VP O
85 stenosis NN B-NP O
85 The DT B-NP O
85 patient NN I-NP O
85 declined VBD B-VP O
85 any DT B-NP O
85 procedure NN I-NP O
85 such JJ O O
85 as IN B-VP O
85 carotid JJ B-NP O
86 endarterectomy NN I-NP O
86 or CC O O
86 carotid NN B-NP O
86 stenting NN I-NP O
86 for IN B-VP O
86 his PRP$ O O
86 possible JJ B-NP O
86 carotid NN I-NP O
87 stenosis NN I-NP O
87 and CC O O
87 due JJ O O
87 to TO O O
87 this DT O O
87 denial JJ O O
87 no DT B-NP O
87 workup NN I-NP O
87 with IN B-VP O
87 the DT B-NP O
87 CTA NNP I-NP O
87 was VBD B-VP O
87 done VBN O O
88 It PRP O O
88 was VBD B-VP O
88 felt VBN O O
88 that IN B-VP O
88 because IN B-VP O
88 the DT B-NP O
88 patient NN I-NP O
88 would MD O O
88 decline VB O O
88 any DT B-NP O
89 intervention NN I-NP O
89 the DT B-NP O
89 risk NN I-NP O
89 of IN B-VP O
89 contrast NN B-NP O
89 in IN B-VP O
89 the DT B-NP O
89 setting NN I-NP O
89 of IN B-VP O
89 his PRP$ O O
89 acute JJ B-NP O
90 renal JJ I-NP O
90 insufficiency NN I-NP O
90 would MD O O
90 outweigh VB O O
90 the DT B-NP O
90 benefits NNS I-NP O
90 of IN B-VP O
90 the DT B-NP O
90 study NN I-NP O
91 The DT B-NP O
91 patient NN I-NP O
91 declined VBD B-VP O
91 any DT B-NP O
91 intervention NN I-NP O
91 for IN B-VP O
91 his PRP$ O O
91 carotid NN B-NP O
91 arteries NNS I-NP O
91 on IN B-VP O
92 several JJ B-NP O
92 occasions NNS I-NP O
92 A DT B-NP O
92 carotid NN I-NP O
92 noninvasives NNS I-NP O
92 were VBD B-VP O
92 ordered VBN O O
92 and CC O O
92 are VBP O O
93 pending VBG O O
93 at IN B-VP O
93 the DT B-NP O
93 time NN I-NP O
93 of IN B-VP O
93 this DT B-NP O
93 dictation NN I-NP O
93 to TO O O
93 evaluate VB O O
93 the DT B-NP O
93 severity NN I-NP O
93 of IN B-VP O
94 disease NN B-NP O
95 9 CD O O
95 Social: NNP B-NP O
95 The DT B-NP O
95 patient's NN I-NP O
95 sister NN I-NP O
95 , , O O
95 Alexis NNP B-NP O
95 Fernendez NNP I-NP O
95 , , O O
95 is VBZ O O
95 his PRP$ O O
95 health NN B-NP O
95 care NN I-NP O
96 proxy IN B-VP O
96 The DT B-NP O
96 patient NN I-NP O
96 in IN B-VP O
96 her PRP$ O O
96 presence NN B-NP O
96 has VBZ O O
96 declined VBN O O
96 coronary JJ B-NP O
96 artery NN I-NP O
97 bypass NN I-NP O
97 grafting NN I-NP O
97 and CC O O
97 heart NN B-NP O
97 transplant NN I-NP O
97 evaluation NN I-NP O
97 The DT B-NP O
97 patient NN I-NP O
97 has VBZ O O
98 also RB O O
98 declined VBN O O
98 further JJ B-NP O
98 procedure NN I-NP O
98 for IN B-VP O
98 his PRP$ O O
98 probable JJ B-NP O
98 carotid NN I-NP O
98 artery NN I-NP O
99 stenosis NN I-NP O
100 10 CD O O
100 Disposition: NNP B-NP O
100 The DT B-NP O
100 patient NN I-NP O
100 will MD O O
100 be VB O O
100 discharged VBN O O
100 to TO O O
100 the DT B-NP O
100 Com NNP I-NP O
100 Medical NNP I-NP O
100 Center NNP I-NP O
100 for IN B-VP O
100 further JJ B-NP O
100 rehabilitation NN I-NP O
100 He PRP O O
100 will MD O O
100 follow VB O O
100 up RP O O
100 with IN B-VP O
100 Dr NNP B-NP O
101 Kyle NNP I-NP O
101 Yandle NNP I-NP O
101 in IN B-VP O
101 the DT B-NP O
101 T NNP I-NP O
101 Las NNP I-NP O
101 on IN B-VP O
101 2/28/05 CD O O
101 at IN B-VP O
101 08:30 CD O O
101 a.m NN B-NP O
101 as RB O O
101 well RB O O
102 as IN B-VP O
102 with IN B-VP O
102 Dr NNP B-NP O
102 Clyde NNP I-NP O
102 Chatampaya NNP I-NP O
102 of IN B-VP O
102 Elmert NNP B-NP O
102 Hospital NNP I-NP O
103 Cardiology NNP I-NP O
103 9/26/05 CD O O
103 He PRP O O
103 also RB O O
103 has VBZ O O
103 a DT B-NP O
103 follow-up JJ I-NP O
103 appointment NN I-NP O
103 with IN B-VP O
104 TRISTONTERN NNP B-NP O
104 MEDICAL NNP I-NP O
104 CENTER NNP I-NP O
104 PCP NNP I-NP O
104 , , O O
104 Raymond NNP B-NP O
104 Banaag NNP I-NP O
104 , , O O
104 on IN B-VP O
104 10/3/05 CD O O
104 at IN B-VP O
104 01:50 CD O O
104 p.m IN B-VP O
104 The DT B-NP O
104 patient NN I-NP O
105 requires VBZ O O
105 substantial JJ B-NP O
105 social JJ I-NP O
105 support NN I-NP O
105 at IN B-VP O
105 this DT B-NP O
105 time NN I-NP O
105 , , O O
105 which WDT O O
105 is VBZ O O
105 being VBG O O
106 provided VBN O O
106 by IN B-VP O
106 his PRP$ O O
106 sister NN B-NP O
107 MEDICATIONS NNP I-NP O
107 AT NNP I-NP O
107 THE NNP I-NP O
107 TIME NNP I-NP O
107 OF NNP I-NP O
107 DISCHARGE: NNP I-NP O
108 1 CD O O
108 Aspirin NNP B-NP B-m
108 325 CD O B-do
108 mg NN B-NP I-do
108 p.o NN I-NP B-mo
108 q.d VBD B-VP B-f
109 2 CD O O
109 Amiodarone NNP B-NP B-m
109 200 CD O B-do
109 mg NN B-NP I-do
109 p.o NN I-NP B-mo
109 q.d VBD B-VP B-f
110 3 CD O O
110 Digoxin NNP B-NP B-m
110 0.125 CD O B-do
110 mg NN B-NP I-do
110 p.o NN I-NP B-mo
110 q.o.d VBD B-VP B-f
111 4 CD O O
111 Colace NNP B-NP B-m
111 100 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 b.i.d VBD B-VP B-f
112 5 CD O O
112 Folate NNP B-NP B-m
112 1 CD O B-do
112 mg NN B-NP I-do
112 p.o NN I-NP B-mo
112 q.d VBD B-VP B-f
113 6 CD O O
113 Robitussin NNP B-NP B-m
113 A-C NNP I-NP I-m
113 5 CD O B-do
113 mL NN B-NP I-do
113 p.o NN I-NP B-mo
113 q.4h NN I-NP B-f
113 p.r.n VBD B-VP I-f
113 cough JJ O B-r
114 7 CD O O
114 Hydralazine NNP B-NP B-m
114 50 CD O B-do
114 mg NN B-NP I-do
114 p.o NN I-NP B-mo
114 t.i.d VBD B-VP B-f
115 8 CD O O
115 Isordil NNP B-NP B-m
115 20 CD O B-do
115 mg NN B-NP I-do
115 p.o NN I-NP B-mo
115 t.i.d VBD B-VP B-f
116 9 CD O O
116 Lopressor NNP B-NP B-m
116 12.5 CD O B-do
116 mg NN B-NP I-do
116 p.o NN I-NP B-mo
116 q.6h VBD B-VP B-f
117 10 CD O O
117 Simethicone NNP B-NP B-m
117 80 CD O B-do
117 mg NN B-NP I-do
117 p.o NN I-NP B-mo
117 q.i.d NN I-NP B-f
117 p.r.n NN I-NP I-f
117 upset JJ B-NP B-r
117 stomach NN I-NP I-r
118 11 CD O O
118 Multivitamin NNP B-NP B-m
118 one CD O B-do
118 tab NN B-NP I-do
118 p.o NN I-NP B-mo
118 q.d VBD B-VP B-f
119 12 CD O O
119 Compazine NNP B-NP B-m
119 5-10 JJ B-NP B-do
119 mg NN I-NP I-do
119 p.o NN I-NP B-mo
119 q.6h NN I-NP B-f
119 p.r.n NN I-NP I-f
119 nausea NN I-NP B-r
120 13 CD O O
120 Tessalon NNP B-NP B-m
120 100 CD O B-do
120 mg NN B-NP I-do
120 p.o NN I-NP B-mo
120 t.i.d NN I-NP B-f
120 p.r.n VBD B-VP I-f
120 cough JJ O B-r
121 14 CD O O
121 Torsemide NNP B-NP B-m
121 100 CD O B-do
121 mg NN B-NP I-do
121 p.o NN I-NP B-mo
121 q.d VBD B-VP B-f
122 15 CD O O
122 Lipitor NNP B-NP B-m
122 80 CD O B-do
122 mg NN B-NP I-do
122 p.o NN I-NP B-mo
122 q.d VBD B-VP B-f
123 16 CD O O
123 Plavix NNP B-NP B-m
123 75 CD O B-do
123 mg NN B-NP I-do
123 p.o NN I-NP B-mo
123 q.d VBD B-VP B-f
124 17 CD O O
124 Lantus NNP B-NP B-m
124 5 CD O B-do
124 units NNS B-NP I-do
124 subcu VBD B-VP B-mo
124 q.p.m RB O B-f
125 18 CD O O
125 NovoLog NNP B-NP B-m
125 3 CD O B-do
125 units NNS B-NP I-do
125 subcu VBP O B-mo
125 a.c JJ B-NP B-f
125 Instructions NNP I-NP O
125 , , O O
125 give VB O O
125 only RB O O
125 if IN B-VP O
125 food NN B-NP O
126 in IN B-VP O
126 room NN B-NP O
126 and CC O O
126 the DT B-NP O
126 patient NN I-NP O
126 eating NN I-NP O
126 , , O O
126 hold VBP O O
126 if IN B-VP O
126 n.p.o JJ O O
127 19 CD O O
127 NovoLog NNP B-NP B-m
127 sliding VBG O B-do
127 scale NN B-NP I-do
127 , , O O
127 please VB O O
127 do VB O O
127 not RB O O
127 give VB O O
127 any DT O O
127 sliding VBG O O
127 scale JJ B-NP O
128 coverage NN I-NP O
128 at IN B-VP O
128 h.s NN B-NP O
128 but CC O O
128 do VBP O O
128 record VB O O
128 fingerstick VB O O
128 blood NN B-NP O
128 glucose NN I-NP O
128 at IN B-VP O
128 h.s NN B-NP O
128 , , O O
129 hold VBP O O
129 if IN B-VP O
129 n.p.o JJ B-NP O
130 eScription NN I-NP O
130 document: VBZ O O
130 3-4123789 JJ B-NP O
130 CS NNP I-NP O
131 Dictated NNP I-NP O
131 By: NNP I-NP O
131 JANISZEWSKI NNP I-NP O
131 , , O O
131 TRAVIS NNP B-NP O
132 Attending: NNP I-NP O
132 INNES NNP I-NP O
132 , , O O
132 BRITT NNP B-NP O
132 P NNP I-NP O
133 Dictation NNP I-NP O
133 ID NNP I-NP O
133 7325126 CD O O
134 D: NNP B-NP O
134 4/6/05 CD O O
135 T: NNP B-NP O
135 4/6/05 CD O O
136 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #700421 VBZ O O
2 599469946 CD O O
2 CLKH NNP B-NP O
2 55995690 CD O O
2 8330433 CD O O
2 8/19/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/30/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
4 ATTENDING: NNP I-NP O
4 KRIEGE NNP I-NP O
4 , , O O
4 DERRICK NNP B-NP O
4 M.D NNP I-NP O
5 CHIEF NNP I-NP O
5 COMPLAINT: NNP I-NP O
5 Right NNP I-NP O
5 thigh NN I-NP O
5 burn NN I-NP O
5 , , O O
5 cellulitis NN B-NP O
5 and CC O O
5 diabetic JJ B-NP O
6 ketoacidosis NN I-NP O
7 HISTORY NNP I-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 Ms NNP I-NP O
7 Hesby NNP I-NP O
7 is VBZ O O
7 a DT B-NP O
7 36-year-old JJ I-NP O
7 woman NN I-NP O
8 with IN B-VP O
8 very RB O O
8 poorly RB O O
8 controlled VBN O O
8 type NN B-NP O
8 1 CD O O
8 diabetes NNS B-NP O
8 and CC O O
8 extensive JJ B-NP O
8 end NN I-NP O
9 organ JJ B-NP O
9 damage NN I-NP O
9 including VBG O O
9 end-stage JJ B-NP O
9 renal JJ I-NP O
9 disease NN I-NP O
9 on IN B-VP O
9 hemodialysis NN B-NP O
9 , , O O
10 right JJ B-NP O
10 eye NN I-NP O
10 blindness NN I-NP O
10 , , O O
10 lower JJR B-NP O
10 extremity NN I-NP O
10 neuropathy NN I-NP O
10 , , O O
10 gastroparesis NN B-NP O
11 and CC O O
11 a DT B-NP O
11 history NN I-NP O
11 of IN B-VP O
11 extensive JJ B-NP O
11 infections NNS I-NP O
11 including VBG O O
11 VRE NNP B-NP O
11 line NN I-NP O
11 sepsis NN I-NP O
11 , , O O
12 MRSA NNP B-NP O
12 , , O O
12 abdominal JJ B-NP O
12 abscesses NNS I-NP O
12 and CC O O
12 chronic JJ B-NP O
12 dermal NN I-NP O
12 ulcers NNS I-NP O
12 Due NNP I-NP O
12 to TO O O
12 her PRP$ O O
13 dermal JJ B-NP O
13 ulcers NNS I-NP O
13 , , O O
13 she PRP O O
13 developed VBD B-VP O
13 left VBD B-VP O
13 ankle JJ O O
13 osteomyelitis IN B-VP O
13 requiring VBG O O
14 below-the-knee JJ B-NP O
14 amputation NN I-NP O
14 She PRP O O
14 was VBD B-VP O
14 transferred VBN O O
14 from IN B-VP O
14 Shiredo NNP B-NP O
14 Sert NNP I-NP O
14 Of IN B-VP O
14 Valley NNP B-NP O
14 on IN B-VP O
14 3/28/06 CD O O
14 in IN B-VP O
14 DKA NNP B-NP O
14 in IN B-VP O
14 the DT B-NP O
14 setting NN I-NP O
14 of IN B-VP O
14 a DT B-NP O
14 right JJ I-NP O
14 thigh NN I-NP O
14 burn NN I-NP O
15 and CC O O
15 possible JJ B-NP O
15 infection NN I-NP O
16 The DT B-NP O
16 patient NN I-NP O
16 was VBD B-VP O
16 in IN B-VP O
16 her PRP$ O O
16 usual JJ B-NP O
16 state NN I-NP O
16 of IN B-VP O
16 health NN B-NP O
16 until IN B-VP O
16 three CD O O
16 days NNS B-NP O
17 prior RB O O
17 to TO O O
17 admission NN B-NP O
17 when WRB O O
17 she PRP O O
17 spilled VBD B-VP O
17 hot JJ B-NP O
17 broth NN I-NP O
17 on IN B-VP O
17 her PRP$ O O
17 right JJ B-NP O
17 thigh NN I-NP O
18 and CC O O
18 developed VBD B-VP O
18 a DT B-NP O
18 painful JJ I-NP O
18 red JJ I-NP O
18 bullae NN I-NP O
18 She PRP O O
18 presented VBD B-VP O
18 to TO O O
18 Path NNP B-NP O
18 Community NNP I-NP O
18 Hospital NNP I-NP O
18 two CD O O
18 days NNS B-NP O
18 prior RB O O
18 to TO O O
18 admission NN B-NP O
18 , , O O
18 but CC O O
18 still RB O O
18 she PRP O O
18 had VBD B-VP O
18 an DT B-NP B-r
19 infection NN I-NP O
19 She PRP O O
19 was VBD B-VP O
19 given VBN O O
19 a DT B-NP O
19 prescription NN I-NP O
19 for IN B-VP O
19 antibiotics NNS B-NP B-m
19 , , O O
19 which WDT O O
20 she PRP O O
20 did VBD B-VP O
20 not RB O O
20 fill VB O O
20 The DT B-NP O
20 area NN I-NP O
20 of IN B-VP O
20 swelling VBG O O
20 in IN B-VP O
20 her PRP$ O O
20 right JJ B-NP O
20 leg NN I-NP O
20 did VBD B-VP O
20 not RB O O
21 spread VB O O
21 from IN B-VP O
21 the DT B-NP O
21 original JJ I-NP O
21 blister NN I-NP O
21 area NN I-NP O
21 all PDT O O
21 the DT B-NP O
21 way NN I-NP O
21 up IN B-VP O
21 to TO O O
21 her PRP$ O O
21 groin NN B-NP O
22 and CC O O
22 grossly RB O O
22 became VBD B-VP O
22 more RBR O O
22 tender NN B-NP O
22 and CC O O
22 warm NN B-NP O
22 On IN B-VP O
22 the DT B-NP O
22 day NN I-NP O
22 of IN B-VP O
23 admission NN B-NP O
23 , , O O
23 she PRP O O
23 returned VBD B-VP O
23 to TO O O
23 the DT B-NP O
23 Threei NNP I-NP O
23 Cent NNP I-NP O
23 Hospital NNP I-NP O
23 Emergency NNP I-NP O
23 Room NNP I-NP O
24 for IN B-VP O
24 evaluation NN B-NP O
24 Of IN B-VP O
24 note NN B-NP O
24 , , O O
24 in IN B-VP O
24 going VBG O O
24 to TO O O
24 the DT B-NP O
24 emergency NN I-NP O
24 room NN I-NP O
24 , , O O
24 she PRP O O
25 missed VBD B-VP O
25 her PRP O O
25 regular JJ B-NP O
25 hemodialysis NN I-NP O
25 In IN B-VP O
25 the DT B-NP O
25 Ingsparks NNP I-NP O
25 Down NNP I-NP O
25 Health NNP I-NP O
26 Emergency NNP I-NP O
26 room NN I-NP O
26 , , O O
26 the DT B-NP O
26 following JJ I-NP O
26 vital JJ I-NP O
26 signs NNS I-NP O
26 were VBD B-VP O
26 noted VBN O O
27 Temperature NNP B-NP O
27 afebrile NN I-NP O
27 , , O O
27 heart NN B-NP O
27 rate NN I-NP O
27 60 CD O O
27 , , O O
27 blood NN B-NP O
27 pressure NN I-NP O
27 150/50 CD O O
27 , , O O
28 oxygen NN B-NP O
28 saturation NN I-NP O
28 95% CD O O
28 on IN B-VP O
28 room NN B-NP O
28 air NN I-NP O
28 WBC NNP I-NP O
28 4.3 CD O O
28 , , O O
28 hematocrit NN B-NP O
28 38 CD O O
28 , , O O
29 sodium NN B-NP O
29 126 CD O O
29 , , O O
29 potassium NN B-NP O
29 7.9 CD O O
29 , , O O
29 glucose JJ O O
29 1221 CD O O
29 , , O O
29 anion NN B-NP O
29 gap NN I-NP O
29 13 CD O O
29 , , O O
29 acetone RB O O
30 negative JJ O O
30 , , O O
30 AST NNP B-NP O
30 385 CD O O
30 , , O O
30 ALT NNP B-NP O
30 127 CD O O
30 and CC O O
30 alk VB O O
30 phos NN B-NP O
30 411 CD O O
30 EKG NNP B-NP O
30 revealed VBD B-VP O
30 peak JJ B-NP O
30 Q NNP I-NP O
31 waves VBZ O O
31 The DT B-NP O
31 patient NN I-NP O
31 was VBD B-VP O
31 given VBN O O
31 20 CD O B-do
31 units NNS B-NP I-do
31 of IN B-VP O
31 IV NNP B-NP B-mo
31 insulin NN I-NP B-m
31 and CC O O
31 then RB O O
31 was VBD B-VP O
32 started VBN O O
32 on IN B-VP O
32 an DT B-NP O
32 insulin NN I-NP B-m
32 drip NN I-NP B-mo
32 8 CD O B-do
32 units NNS B-NP I-do
32 per IN B-VP B-f
32 hour NN B-NP I-f
32 She PRP O O
32 also RB O O
32 received VBD B-VP O
32 2 CD O B-do
33 amps NNS B-NP O
33 of IN B-VP O
33 calcium NN B-NP B-m
33 gluconate NN I-NP I-m
33 as RB O O
33 well RB O O
33 as IN B-VP O
33 Kayexalate NNP B-NP B-m
33 and CC O O
33 albuterol VB O B-m
34 nebs FW O B-mo
34 A DT B-NP O
34 repeat NN I-NP O
34 Chem-7 NNP I-NP O
34 in IN B-VP O
34 the DT B-NP O
34 Amoore NNP I-NP O
34 Medical NNP I-NP O
34 Center NNP I-NP O
34 ED NNP I-NP O
34 showed VBD B-VP O
34 a DT B-NP O
34 glucose NN I-NP O
34 of IN B-VP O
35 1100 CD O O
35 and CC O O
35 an DT B-NP O
35 anion NN I-NP O
35 gap NN I-NP O
35 of IN B-VP O
35 18 CD O O
35 with IN B-VP O
35 potassium NN B-NP O
35 5.4 CD O O
35 The DT B-NP O
35 patient NN I-NP O
35 was VBD B-VP O
36 transferred VBN O O
36 to TO O O
36 the DT B-NP O
36 MICU NNP I-NP O
36 at IN B-VP O
36 EH NNP B-NP O
36 for IN B-VP O
36 further JJ B-NP O
36 management NN I-NP O
36 At IN B-VP O
36 the DT B-NP O
37 time NN I-NP O
37 of IN B-VP O
37 her PRP$ O O
37 transfer NN B-NP O
37 , , O O
37 she PRP O O
37 noted VBD B-VP O
37 left-sided JJ B-NP O
37 headache NN I-NP O
37 , , O O
37 a DT B-NP O
37 warm JJ I-NP O
38 feeling NN I-NP O
38 over IN B-VP O
38 her PRP$ O O
38 right JJ B-NP O
38 thigh NN I-NP O
38 She PRP O O
38 denied VBD B-VP O
38 any DT B-NP O
38 recent JJ I-NP O
38 fever NN I-NP O
38 , , O O
39 shortness NN B-NP O
39 of IN B-VP O
39 breath NN B-NP O
39 , , O O
39 abdominal JJ B-NP O
39 pain NN I-NP O
39 , , O O
39 nausea NN B-NP O
39 , , O O
39 vomiting VBG O O
39 or CC O O
40 diarrhea VB O O
40 She PRP O O
40 did VBD B-VP O
40 note NN B-NP O
40 that IN B-VP O
40 her PRP$ O O
40 last JJ B-NP O
40 bowel JJ I-NP O
40 movement NN I-NP O
40 was VBD B-VP O
40 three CD O O
41 days NNS B-NP O
41 prior RB O O
41 to TO O O
41 admission VB O O
42 PAST NNP B-NP O
42 MEDICAL NNP I-NP O
42 HISTORY: NNP I-NP O
43 1 CD O O
43 Poor NNP B-NP O
43 controlled VBD B-VP O
43 type JJ O O
43 1 CD O O
43 diabetes VBZ O O
44 2 CD O O
44 End-stage JJ B-NP O
44 renal JJ I-NP O
44 disease NN I-NP O
44 on IN B-VP O
44 hemodialysis NN B-NP O
44 Monday NNP I-NP O
44 , , O O
44 Wednesday NNP B-NP O
44 and CC O O
45 Friday NNP B-NP O
45 - : O O
45 left VBD B-VP O
45 chest JJ B-NP O
45 hemodialysis NN I-NP O
45 catheter NN I-NP O
45 for IN B-VP O
45 access NN B-NP O
46 3 CD O O
46 History NNP B-NP O
46 of IN B-VP O
46 VRE NNP B-NP O
46 line NN I-NP O
46 sepsis NN I-NP O
47 4 CD O O
47 History NNP B-NP O
47 of IN B-VP O
47 MRSA NNP B-NP O
48 5 CD O O
48 History NNP B-NP O
48 of IN B-VP O
48 abdominal JJ B-NP O
48 abscess NN I-NP O
49 6 CD O O
49 Chronic NNP B-NP O
49 dermal JJ B-NP O
49 ulcers NNS I-NP O
50 7 CD O O
50 CHF NNP B-NP O
51 8 CD O O
51 History NNP B-NP O
51 of IN B-VP O
51 cardiac JJ B-NP O
51 murmur NN I-NP O
52 9 CD O O
52 Seizure NNP B-NP O
52 disorder NN I-NP O
53 10 CD O O
53 Multiple NNP B-NP O
53 strokes NNS I-NP O
54 11 CD O O
54 Chronic NNP B-NP O
54 nausea NN I-NP O
55 12 CD O O
55 Personality NNP B-NP O
55 disorder NN I-NP O
55 , , O O
55 deemed VBD B-VP O
55 not RB O O
55 to TO O O
55 have VB O O
55 capacity NN B-NP O
55 - : O O
55 guardian NN B-NP O
56 is VBZ O O
56 Carlton NNP B-NP O
56 Wender NNP I-NP O
56 # # O O
56 880-357-5648 JJ B-NP O
57 HOME NNP I-NP O
57 MEDICATIONS: NNP I-NP O
58 1 CD O O
58 Lantus NNP B-NP B-m
58 24 CD O B-do
58 units NNS B-NP I-do
58 subcu RB O B-mo
58 each DT B-NP B-f
58 night NN I-NP I-f
59 2 CD O O
59 NovoLog NNP B-NP B-m
59 sliding VBG O B-do
59 scale JJ O I-do
60 3 CD O O
60 PhosLo NNP B-NP B-m
61 4 CD O O
61 Nephrocaps NNP B-NP B-m
62 5 CD O O
62 Vitamin NNP B-NP B-m
62 D NNP I-NP I-m
63 6 CD O O
63 Sevelamer NNP B-NP B-m
63 1600 CD O B-do
63 t.i.d NN B-NP B-f
64 7 CD O O
64 Toprol NNP B-NP B-m
64 100 CD O B-do
64 mg NN B-NP I-do
64 p.o JJ O B-mo
64 daily JJ O B-f
65 8 CD O O
65 Lisinopril NNP B-NP B-m
65 5 CD O B-do
65 mg NN B-NP I-do
65 p.o JJ O B-mo
65 daily JJ O B-f
66 9 CD O O
66 Plavix NNP B-NP B-m
66 75 CD O B-do
66 mg NN B-NP I-do
66 p.o JJ O B-mo
66 daily JJ O B-f
67 10 CD O O
67 Keppra NNP B-NP B-m
67 500 CD O B-do
67 mg NN B-NP I-do
67 p.o NN I-NP B-mo
67 b.i.d VBD B-VP B-f
68 11 CD O O
68 Flovent NNP B-NP B-m
68 two CD O B-do
68 puffs NNS B-NP I-do
68 b.i.d VBD B-VP B-f
69 12 CD O O
69 Albuterol NNP B-NP B-m
69 p.r.n NN I-NP B-f
70 13 CD O O
70 Baclofen NNP B-NP B-m
70 5 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 t.i.d VBD B-VP B-f
71 14 CD O O
71 Ambien NNP B-NP B-m
71 10 CD O B-do
71 mg NN B-NP I-do
71 p.o NN I-NP B-mo
71 at IN B-VP B-f
71 bedtime NN B-NP I-f
71 p.r.n NN I-NP I-f
72 TRANSFER NNP I-NP O
72 MEDICATIONS: NNP I-NP O
72 None NNP I-NP O
73 ALLERGIES: NNP I-NP O
73 Aspirin NNP I-NP O
73 causes VBZ O O
73 tongue JJ O O
73 swelling VBG O O
73 Codeine NNP B-NP O
73 , , O O
74 erythromycin NN B-NP O
74 beef NN I-NP O
74 , , O O
74 poke NN B-NP O
74 and CC O O
74 insulin NN B-NP O
74 all DT O O
74 caused VBD B-VP O
74 unknown JJ B-NP O
74 reactions NNS I-NP O
75 SOCIAL NNP I-NP O
75 HISTORY: NNP I-NP O
75 The DT B-NP O
75 patient NN I-NP O
75 lives VBZ O O
75 with IN B-VP O
75 a DT B-NP O
75 personal JJ I-NP O
75 care NN I-NP O
75 assistant NN I-NP O
76 and CC O O
76 her PRP$ O O
76 daughter NN B-NP O
76 She PRP O O
76 has VBZ O O
76 four CD O O
76 children NNS B-NP O
76 ages VBZ O O
76 5 CD O O
76 to TO O O
76 20 CD O O
76 She PRP O O
77 denies VBZ O O
77 tobacco NN B-NP O
77 use NN I-NP O
77 or CC O O
77 alcohol NN B-NP O
77 use NN I-NP O
77 She PRP O O
77 denies VBZ O O
77 any DT B-NP O
77 illegal JJ I-NP O
77 drug NN I-NP O
78 use NN I-NP O
78 Guardian NNP I-NP O
78 is VBZ O O
78 Malik NNP B-NP O
78 Conly NNP I-NP O
78 , , O O
78 telephone NN B-NP O
78 number NN I-NP O
78 880-357-5648 JJ B-NP O
79 Per NNP I-NP O
79 court NN I-NP O
79 order NN I-NP O
79 , , O O
79 the DT B-NP O
79 patient NN I-NP O
79 does VBZ O O
79 not RB O O
79 have VB O O
79 capacity NN B-NP O
79 to TO O O
79 make VB O O
80 medical JJ B-NP O
80 decisions NNS I-NP O
81 FAMILY NNP I-NP O
81 HISTORY: NNP I-NP O
81 Noncontributory NNP I-NP O
82 NOTABLE NNP I-NP O
82 ADMISSION NNP I-NP O
82 EXAM: NNP I-NP O
82 Weight NNP I-NP O
82 70 CD O O
82 kg NN B-NP O
82 General NNP I-NP O
82 , , O O
82 sleepy NN B-NP O
82 , , O O
82 but CC O O
83 arousable JJ B-NP O
83 A&amp;O NNP I-NP O
83 x3 NNP I-NP O
83 , , O O
83 conversant NN B-NP O
83 and CC O O
83 cooperative JJ B-NP O
83 HEENT NNP I-NP O
83 , , O O
83 blind RB O O
83 right JJ B-NP O
84 eye NN I-NP O
84 , , O O
84 left VBD B-VP O
84 eye NN B-NP O
84 reactive JJ B-NP O
84 OP NNP I-NP O
84 clear JJ O O
84 with IN B-VP O
84 moist JJ B-NP O
84 mucous JJ I-NP O
84 membranes NNS I-NP O
85 Neck NNP I-NP O
85 supple NN I-NP O
85 Chest NNP I-NP O
85 clear JJ O O
85 to TO O O
85 auscultation VB O O
85 bilaterally RB O O
85 No NNP B-NP O
86 dullness NN I-NP O
86 Cardiovascular NNP I-NP O
86 , , O O
86 JVP NNP B-NP O
86 flat JJ B-NP O
86 Regular NNP I-NP O
86 rate NN I-NP O
86 and CC O O
86 rhythm $ O O
87 3/6 CD O O
87 systolic JJ B-NP O
87 ejection NN I-NP O
87 murmur NN I-NP O
87 at IN B-VP O
87 the DT B-NP O
87 left JJ I-NP O
87 upper JJ I-NP O
87 sternal JJ I-NP O
87 border NN I-NP O
88 with IN B-VP O
88 low JJ B-NP O
88 rumble NN I-NP O
88 at IN B-VP O
88 the DT B-NP O
88 left NN I-NP O
88 lower RBR O O
88 sternal JJ B-NP O
88 border NN I-NP O
88 radiating VBG O O
88 to TO O O
88 the DT B-NP O
89 apex NN I-NP O
89 No NNP I-NP O
89 delaying NN I-NP O
89 carotid NN I-NP O
89 upstrokes JJ B-NP O
89 Abdomen NNP I-NP O
89 distended VBD B-VP O
90 Positive NNP B-NP O
90 bowel NN I-NP O
90 sounds VBZ O O
90 Nontender NNP B-NP O
90 Visible NNP I-NP O
90 old JJ B-NP O
90 peritoneal JJ I-NP O
91 dialysis NN I-NP O
91 site NN I-NP O
91 with IN B-VP O
91 serosanguinous JJ B-NP O
91 drainage NN I-NP O
91 and CC O O
91 granulation NN B-NP O
91 , , O O
92 otherwise RB O O
92 noninflamed VBN O O
92 and CC O O
92 nontender JJ B-NP O
92 Extremities NNS I-NP O
92 , , O O
92 left VBD B-VP O
92 BKA NNP B-NP O
92 , , O O
92 well RB O O
93 healed VBN O O
93 Right NNP B-NP O
93 thigh $ O O
93 4 CD O O
93 x JJ B-NP O
93 5-cm JJ I-NP O
93 open JJ I-NP O
93 bullae NN I-NP O
93 with IN B-VP O
93 clear JJ B-NP O
93 drainage NN I-NP O
93 and CC O O
94 a DT O O
94 surrounding VBG O O
94 tender NN B-NP O
94 area NN I-NP O
94 of IN B-VP O
94 erythema NN B-NP O
94 and CC O O
94 warmth NN B-NP O
94 extending VBG O O
94 up RP O O
94 to TO O O
95 the DT B-NP O
95 groin NN I-NP O
95 and CC O O
95 down RB O O
95 to TO O O
95 the DT B-NP O
95 knee NN I-NP O
95 , , O O
95 2+ CD O O
95 dorsalis NN B-NP O
95 pedis NN I-NP O
95 pulse NN I-NP O
95 on IN B-VP O
95 the DT B-NP O
96 right JJ I-NP O
96 Neurological NNP I-NP O
96 , , O O
96 A&amp;O NNP B-NP O
96 x3 NNP I-NP O
96 , , O O
96 cooperative JJ O O
96 , , O O
96 anxious JJ O O
96 about IN B-VP O
96 getting VBG O O
97 IV NNP B-NP O
97 access NN I-NP O
97 Skin NNP I-NP O
97 , , O O
97 multiple JJ B-NP O
97 excoriation NN I-NP O
97 , , O O
97 all DT B-NP O
97 subcentimeter NN I-NP O
98 macules NNS I-NP O
99 NOTABLE NNP I-NP O
99 LABS: NNP I-NP O
99 Sodium NNP I-NP O
99 133 CD O O
99 , , O O
99 potassium NN B-NP O
99 4.3 CD O O
99 , , O O
99 chloride RB O O
99 98 CD O O
99 , , O O
100 bicarbonate NN B-NP O
100 19 CD O O
100 , , O O
100 BUN NNP B-NP O
100 47 CD O O
100 , , O O
100 creatinine NN B-NP O
100 8.3 CD O O
100 , , O O
100 calcium NN B-NP O
100 8.5 CD O O
100 , , O O
100 magnesium NN B-NP O
101 2.1 CD O O
101 , , O O
101 phosphate NN B-NP O
101 2.9 CD O O
101 , , O O
101 anion NN B-NP O
101 gap NN I-NP O
101 15 CD O O
101 , , O O
101 ALT NNP B-NP O
101 84 CD O O
101 , , O O
101 AST NNP B-NP O
101 186 CD O O
101 , , O O
101 alk VBP O O
101 phos JJ O O
101 264 CD O O
101 , , O O
102 T NNP B-NP O
102 bili VBD B-VP O
102 1.0 CD O O
102 , , O O
102 troponin NN B-NP O
102 less JJR O O
102 than IN B-VP O
102 assay NN B-NP O
102 , , O O
102 BNP NNP B-NP O
102 4900 CD O O
102 , , O O
102 amylase NN B-NP O
102 and CC O O
103 lipase NN B-NP O
103 normal JJ O O
103 , , O O
103 serum JJ O O
103 osms FW O O
103 337 CD O O
103 , , O O
103 lactate NN B-NP O
103 4.7 CD O O
103 , , O O
103 WBC NNP B-NP O
103 5.3 CD O O
103 , , O O
103 hematocrit NN B-NP O
104 31.6 CD O O
104 , , O O
104 platelets NNS B-NP O
104 208 CD O O
104 , , O O
104 000 CD O O
104 , , O O
104 INR NNP B-NP O
104 1.3 CD O O
104 ABG NNP B-NP O
104 7.28/42/128 CD O O
104 EKG NNP B-NP O
104 normal JJ B-NP O
105 sinus NN I-NP O
105 rhythm NN I-NP O
105 at IN B-VP O
105 74 CD O O
105 , , O O
105 normal JJ B-NP O
105 axis NN I-NP O
105 , , O O
105 normal JJ B-NP O
105 intervals NNS I-NP O
105 , , O O
105 no DT B-NP O
105 ischemia NN I-NP O
105 , , O O
106 no DT B-NP O
106 peak JJ I-NP O
106 T-waves NNS I-NP O
106 Echo NNP I-NP O
106 in IN B-VP O
106 July NNP B-NP O
106 2006 CD O O
106 , , O O
106 mild FW O O
106 LVH NNP B-NP O
106 , , O O
106 EF NNP B-NP O
106 65% CD O O
106 to TO O O
106 70% CD O O
106 , , O O
106 no DT B-NP O
107 wall NN I-NP O
107 motion NN I-NP O
107 abnormalities NNS I-NP O
107 , , O O
107 mildly RB O O
107 enlarged VBD B-VP O
107 right JJ B-NP O
107 ventricle NN I-NP O
107 , , O O
108 normal JJ B-NP O
108 RV NNP I-NP O
108 outflow NN I-NP O
108 tract NN I-NP O
108 , , O O
108 mild JJ O O
108 left VBD B-VP O
108 atrial JJ B-NP O
108 enlargement NN I-NP O
108 , , O O
108 mild VB O O
108 right JJ B-NP O
109 atrial JJ I-NP O
109 enlargement NN I-NP O
109 , , O O
109 mild JJ B-NP O
109 aortic JJ I-NP O
109 stenosis NN I-NP O
109 , , O O
109 trace NN B-NP O
109 mitral JJ B-NP O
110 regurgitation NN I-NP O
110 , , O O
110 trace NN B-NP O
110 tricuspid JJ B-NP O
110 regurgitation NN I-NP O
110 , , O O
110 pulmonary JJ B-NP O
110 artery NN I-NP O
111 pressure NN I-NP O
111 of IN B-VP O
111 48 CD O O
111 , , O O
111 IVC NNP B-NP O
111 dilated VBD B-VP O
111 with IN B-VP O
111 diminished JJ B-NP O
111 respirophasic JJ I-NP O
112 variation NN I-NP O
112 consistent NN I-NP O
112 with IN B-VP O
112 markedly RB O O
112 elevated VBN O O
112 right JJ B-NP O
112 atrial JJ I-NP O
113 pressure NN I-NP O
114 HOSPITAL NNP I-NP O
114 COURSE: NNP I-NP O
115 1 CD O O
115 DKA: NNP B-NP B-r
115 The DT B-NP O
115 patient NN I-NP O
115 was VBD B-VP O
115 stabilized VBN O O
115 in IN B-VP O
115 the DT B-NP O
115 MICU NNP I-NP O
115 on IN B-VP O
115 an DT B-NP O
115 insulin NN I-NP B-m
116 drip NN I-NP B-mo
116 and CC O O
116 was VBD B-VP O
116 then RB O O
116 transferred VBN O O
116 to TO O O
116 General NNP B-NP O
116 Medicine NNP I-NP O
116 for IN B-VP O
116 further JJ B-NP O
117 management NN I-NP O
117 Causes NNP I-NP O
117 of IN B-VP O
117 DKA NNP B-NP O
117 that WDT O O
117 were VBD B-VP O
117 ruled VBN O O
117 out RP O O
117 included VBD B-VP O
117 the DT O O
118 following JJ O O
118 - : O O
118 negative JJ B-NP O
118 cardiac JJ I-NP O
118 enzymes NNS I-NP O
118 , , O O
118 unimpressive JJ B-NP O
118 pancreatic JJ I-NP O
119 enzymes NNS I-NP O
119 , , O O
119 unimpressive JJ B-NP O
119 lactate NN I-NP O
119 , , O O
119 normal JJ B-NP O
119 LFTs NNP I-NP O
119 The DT B-NP O
119 patient's NN I-NP O
119 DKA NNP I-NP O
120 was VBD B-VP O
120 presumed VBN O O
120 to TO O O
120 be VB O O
120 due JJ O O
120 to TO O O
120 her PRP$ O B-r
120 right JJ B-NP I-r
120 thigh NN I-NP I-r
120 cellulitis NN I-NP I-r
120 in IN B-VP O
120 the DT B-NP O
121 setting NN I-NP O
121 of IN B-VP O
121 a DT B-NP O
121 local JJ I-NP O
121 burn NN I-NP O
121 She PRP O O
121 initially RB O O
121 was VBD B-VP O
121 given VBN O O
121 500 CD O B-do
121 mL JJ B-NP I-do
121 normal JJ I-NP B-m
121 normal JJ I-NP B-m
122 saline NN I-NP O
122 boluses NNS I-NP B-mo
122 and CC O O
122 then RB O O
122 several JJ O O
122 250 CD O B-do
122 mL JJ B-NP I-do
122 boluses NNS I-NP B-mo
122 As IN B-VP O
122 she PRP O O
122 is VBZ O O
123 aneuric JJ O O
123 , , O O
123 her PRP$ O O
123 boluses NNS B-NP O
123 were VBD B-VP O
123 stopped VBN O O
123 once RB O O
123 the DT B-NP O
123 blood NN I-NP O
123 sugars NNS I-NP O
123 were VBD B-VP O
124 below IN B-VP O
124 500 CD O O
124 She PRP O O
124 initially RB O O
124 was VBD B-VP O
124 placed VBN O O
124 on IN B-VP O
124 insulin NN B-NP B-m
124 drip NN I-NP B-mo
124 that WDT O O
124 was VBD B-VP O
125 then RB O O
125 transitioned VBN O O
125 to TO O O
125 NPH NNP B-NP B-m
125 and CC O O
125 finally RB O O
125 to TO O O
125 Lantus NNP B-NP B-m
125 24 CD O B-do
125 units NNS B-NP I-do
125 subcu JJ O B-mo
126 daily JJ O B-f
126 Of IN B-VP O
126 note NN B-NP O
126 , , O O
126 the DT B-NP O
126 patient NN I-NP O
126 intermittently RB O O
126 refused VBD B-VP O
126 to TO O O
126 take VB O O
126 both DT O O
127 her PRP$ O O
127 long-acting NN B-NP O
127 and CC O O
127 her PRP$ O O
127 insulin NN B-NP B-m
127 sliding VBG O B-do
127 scale NN B-NP I-do
127 As IN B-VP O
127 a DT B-NP O
127 result NN I-NP O
127 , , O O
127 an DT B-NP O
128 endocrinology NN I-NP O
128 consult NN I-NP O
128 was VBD B-VP O
128 called VBN O O
128 The DT B-NP O
128 patient NN I-NP O
128 was VBD B-VP O
128 noted VBN O O
128 to TO O O
128 be VB O O
129 ordering VBG O O
129 extra JJ B-NP O
129 food NN I-NP O
129 from IN B-VP O
129 the DT B-NP O
129 kitchen NN I-NP O
129 , , O O
129 which WDT O O
129 could MD O O
129 in IN B-VP O
129 part NN B-NP O
129 explain VBP O O
130 her PRP$ O O
130 labile JJ B-NP O
130 sugars NNS I-NP O
130 Despite IN B-VP O
130 careful JJ O O
130 diet JJ O O
130 and CC O O
130 glucose JJ B-NP O
130 control NN I-NP O
131 efforts NNS I-NP O
131 , , O O
131 the DT B-NP O
131 patient NN I-NP O
131 still RB O O
131 had VBD B-VP O
131 sugars NNS B-NP O
131 at IN B-VP O
131 times NNS B-NP O
131 to TO O O
131 the DT O O
131 500s CD O O
132 Endocrinology NNP B-NP O
132 continues VBZ O O
132 to TO O O
132 leave VB O O
132 recommendations NNS B-NP O
132 about IN B-VP O
132 AC NNP B-NP O
133 standing VBG O O
133 insulin NN B-NP O
133 in IN B-VP O
133 addition NN B-NP O
133 to TO O O
133 her PRP$ O O
133 NovoLog NNP B-NP B-m
133 sliding VBG O B-do
133 scale NN B-NP I-do
133 and CC O O
134 Lantus NNP B-NP B-m
134 insulin VBP O I-m
134 The DT B-NP O
134 patient NN I-NP O
134 has VBZ O O
134 a DT B-NP O
134 history NN I-NP O
134 of IN B-VP O
134 gastroparesis NN B-NP O
134 and CC O O
135 therefore NN B-NP O
135 may MD O O
135 not RB O O
135 tolerate VB O O
135 AC NNP B-NP B-f
135 insulin NN I-NP B-m
135 very RB O O
135 well RB O O
135 The DT B-NP O
135 patient's NN I-NP O
136 new JJ O O
136 covering VBG O O
136 team NN B-NP O
136 will MD O O
136 continue VB O O
136 to TO O O
136 follow VB O O
136 up RP O O
136 with IN B-VP O
136 Endocrinology NNP B-NP O
137 2 CD O O
137 Right NNP B-NP B-r
137 Right NNP I-NP B-r
137 Right NNP I-NP B-r
137 thigh RB O I-r
137 thigh RB O I-r
137 thigh JJ B-NP I-r
137 cellulitis: NN I-NP I-r
137 cellulitis: NN I-NP I-r
137 cellulitis: VBD B-VP I-r
137 The DT B-NP O
137 patient NN I-NP O
137 was VBD B-VP O
137 placed VBN O O
137 on IN B-VP O
137 Augmentin NNP B-NP B-m
138 and CC O O
138 IV NNP B-NP B-mo
138 IV NNP I-NP B-mo
138 vancomycin VBD B-VP B-m
138 Her NNP B-NP O
138 area NN I-NP O
138 of IN B-VP O
138 cellulitis NN B-NP O
138 has VBZ O O
138 completely RB O O
139 resolved VBN O O
139 at IN B-VP O
139 the DT B-NP O
139 present JJ I-NP O
139 time NN I-NP O
139 with IN B-VP O
139 slight JJ B-NP O
139 sloughing NN I-NP O
139 of IN B-VP O
139 the DT O O
140 overlying VBG O O
140 skin VBD B-VP O
140 The DT B-NP O
140 underlying JJ I-NP O
140 skin NN I-NP O
140 is VBZ O O
140 pink VBN O O
140 with IN B-VP O
140 evidence NN B-NP O
140 of IN B-VP O
141 good JJ B-NP O
141 granulation NN I-NP O
141 and CC O O
141 no DT B-NP O
141 further JJ I-NP O
141 evidence NN I-NP O
141 of IN B-VP O
141 infection NN B-NP O
141 Given NNP I-NP O
142 that IN B-VP O
142 her PRP$ O O
142 IV NNP B-NP O
142 access NN I-NP O
142 is VBZ O O
142 very RB O O
142 difficult JJ O O
142 , , O O
142 the DT B-NP O
142 patient NN I-NP O
142 received VBD B-VP O
142 some DT B-NP O
143 vancomycin NN I-NP B-m
143 , , O O
143 as IN B-VP O
143 she PRP O O
143 finishes VBZ O O
143 hemodialysis NN B-NP O
143 every DT B-NP B-f
143 other JJ I-NP I-f
143 day NN I-NP I-f
144 3 CD O O
144 End-stage JJ B-NP O
144 renal JJ I-NP O
144 disease: NN I-NP O
144 The DT B-NP O
144 patient NN I-NP O
144 missed VBD B-VP O
144 her PRP$ O O
144 dialysis NN B-NP O
144 on IN B-VP O
145 the DT B-NP O
145 day NN I-NP O
145 of IN B-VP O
145 admission NN B-NP O
145 Once NNP I-NP O
145 in IN B-VP O
145 the DT B-NP O
145 hospital NN I-NP O
145 , , O O
145 her PRP$ O O
145 potassium NN B-NP O
145 was VBD B-VP O
146 very RB O O
146 difficult JJ O O
146 to TO O O
146 control VB O O
146 in IN B-VP O
146 part NN B-NP O
146 due JJ O O
146 to TO O O
146 poor JJ B-NP O
146 adherence NN I-NP O
146 with IN B-VP O
146 her PRP$ O O
147 renal JJ B-NP O
147 diet NN I-NP O
147 and CC O O
147 in IN B-VP O
147 part NN B-NP O
147 due JJ O O
147 to TO O O
147 her PRP$ O O
147 very RB O O
147 labile JJ B-NP O
147 sugars NNS I-NP O
147 At IN B-VP O
147 times NNS B-NP O
147 , , O O
148 her PRP$ O O
148 potassium NN B-NP O
148 would MD O O
148 rapidly RB O O
148 increase VB O O
148 to TO O O
148 a DT B-NP O
148 level NN I-NP O
148 higher JJR O O
148 than IN B-VP O
148 6.5 CD O O
149 requiring VBG O O
149 urgent JJ B-NP O
149 dialysis NN I-NP O
149 At IN B-VP O
149 the DT B-NP O
149 present JJ I-NP O
149 time NN I-NP O
149 , , O O
149 the DT B-NP O
149 patient NN I-NP O
149 has VBZ O O
150 been VBN O O
150 dialyzed VBN O O
150 daily JJ O O
150 since IN B-VP O
150 her PRP$ O O
150 admission NN B-NP O
150 She PRP O O
150 is VBZ O O
150 closely RB O O
150 followed VBN O O
151 by IN B-VP O
151 renal JJ O O
151 with IN B-VP O
151 plans NNS B-NP O
151 to TO O O
151 continue VB O O
151 dialysis NN B-NP O
151 while IN B-VP O
151 in IN B-VP O
151 the DT B-NP O
151 hospital NN I-NP O
152 She PRP O O
152 should MD O O
152 not RB O O
152 receive VB O O
152 any DT O O
152 further RB O O
152 intravenous JJ B-NP O
152 fluids NNS I-NP O
152 unless IN B-VP O
152 she PRP O O
153 has VBZ O O
153 evidence NN B-NP O
153 of IN B-VP O
153 recurrent NN B-NP O
153 DKA NNP I-NP O
153 , , O O
153 given VBN O O
153 her PRP$ O O
153 anuric JJ B-NP O
153 state NN I-NP O
153 Should NNP I-NP O
154 she PRP O O
154 become VBD B-VP O
154 acidotic JJ O O
154 , , O O
154 the DT B-NP O
154 patient NN I-NP O
154 can MD O O
154 be VB O O
154 managed VBN O O
154 with IN B-VP O
154 sodium NN B-NP B-m
155 bicarbonate NN I-NP O
155 and CC O O
155 D5W NNP B-NP B-m
155 in IN B-VP O
155 small JJ B-NP O
155 boluses NNS I-NP O
156 4 CD O O
156 Cardiovascular: NNP B-NP O
156 Ischemia NNP I-NP O
156 , , O O
156 there EX O O
156 was VBD B-VP O
156 no DT B-NP O
156 evidence NN I-NP O
156 of IN B-VP O
156 chest NN B-NP O
157 pain NN I-NP O
157 The DT B-NP O
157 patient NN I-NP O
157 has VBZ O O
157 showed VBN O O
157 no DT B-NP O
157 EKG NNP I-NP O
157 signs NNS I-NP O
157 of IN B-VP O
157 ischemia NN B-NP O
157 Her NNP I-NP O
158 cardiac NN I-NP O
158 enzymes NNS I-NP O
158 remained VBD B-VP O
158 negative JJ B-NP O
158 Lipids NNP I-NP O
158 are VBP O O
158 pending VBG O O
158 at IN B-VP O
158 the DT B-NP O
159 present JJ I-NP O
159 time NN I-NP O
159 Lipid NNP I-NP O
159 profile NN I-NP O
159 check NN I-NP O
159 is VBZ O O
159 pending VBG O O
159 at IN B-VP O
159 the DT B-NP O
159 present JJ I-NP O
160 time NN I-NP O
160 Pump NNP I-NP O
160 , , O O
160 the DT B-NP O
160 patient NN I-NP O
160 has VBZ O O
160 a DT B-NP O
160 history NN I-NP O
160 of IN B-VP O
160 CHF NNP B-NP O
160 with IN B-VP O
160 evidence NN B-NP O
160 of IN B-VP O
161 right JJ B-NP O
161 heart NN I-NP O
161 failure NN I-NP O
161 likely RB O O
161 due JJ O O
161 to TO O O
161 valvular JJ B-NP O
161 disease NN I-NP O
161 in IN B-VP O
161 some DT B-NP O
161 aspect NN I-NP O
162 of IN B-VP O
162 the DT B-NP O
162 diastolic JJ I-NP O
162 dysfunction NN I-NP O
162 given VBN O O
162 her PRP$ O O
162 preserved JJ B-NP O
162 ejection NN I-NP O
163 fraction NN I-NP O
163 Her NNP I-NP O
163 weight NN I-NP O
163 on IN B-VP O
163 admission NN B-NP O
163 was VBD B-VP O
163 70 CD O O
163 kg NN B-NP O
163 We PRP O O
163 did VBD B-VP O
163 not RB O O
163 know VB O O
164 her PRP$ O O
164 dry JJ B-NP O
164 weight NN I-NP O
164 Dialysis NNP I-NP O
164 is VBZ O O
164 helping VBG O O
164 to TO O O
164 manage VB O O
164 her PRP$ O O
164 fluids NNS B-NP O
164 given VBN O O
165 her PRP$ O O
165 aneuric JJ B-NP O
165 status NN I-NP O
165 Her NNP I-NP O
165 O2 NNP I-NP O
165 sats NNS I-NP O
165 remained VBD B-VP O
165 stable JJ O O
165 on IN B-VP O
165 room NN B-NP O
165 air NN I-NP O
166 throughout IN B-VP O
166 the DT B-NP O
166 hospitalization NN I-NP O
166 Her NNP I-NP B-r
166 hypertension NN I-NP I-r
166 has VBZ O O
166 been VBN O O
167 somewhat RB O O
167 poorly RB O O
167 controlled VBN O O
167 and CC O O
167 for IN B-VP O
167 that DT B-NP O
167 reason NN I-NP O
167 she PRP O O
167 was VBD B-VP O
167 continued VBN O O
168 on IN B-VP O
168 her PRP$ O O
168 home NN B-NP O
168 dose NN I-NP O
168 of IN B-VP O
168 Lopressor NNP B-NP B-m
168 25 CD O B-do
168 q.i.d NN B-NP B-f
168 and CC O O
168 switched VBD B-VP O
168 to TO O O
169 Captopril NNP B-NP B-m
169 , , O O
169 which WDT O O
169 we PRP O O
169 continued VBD B-VP O
169 to TO O O
169 titrate VB O O
169 at IN B-VP O
169 the DT B-NP O
169 present JJ I-NP O
169 time NN I-NP O
170 Rhythm NNP I-NP O
170 , , O O
170 normal JJ B-NP O
170 sinus NN I-NP O
170 rhythm VBD B-VP O
170 The DT B-NP O
170 patient NN I-NP O
170 is VBZ O O
170 currently RB O O
170 on IN B-VP O
171 telemetry NN B-NP O
171 with IN B-VP O
171 no DT B-NP O
171 signs NNS I-NP O
171 of IN B-VP O
171 arrhythmia NN B-NP O
172 5 CD O O
172 Fluids NNP B-NP O
172 , , O O
172 electrolytes VBZ O O
172 , , O O
172 nutrition: VBZ O O
172 The DT B-NP O
172 patient NN I-NP O
172 was VBD B-VP O
172 placed VBN O O
172 on IN B-VP O
172 a DT B-NP O
173 cardiac NN I-NP O
173 , , O O
173 renal JJ O O
173 and CC O O
173 diabetic JJ B-NP O
173 diet NN I-NP O
173 She PRP O O
173 was VBD B-VP O
173 noted VBN O O
173 to TO O O
173 repeatedly RB O O
174 order NN B-NP O
174 extra JJ B-NP O
174 food NN I-NP O
174 from IN B-VP O
174 the DT B-NP O
174 kitchen NN I-NP O
174 supervisor NN I-NP O
174 Nutrition NNP I-NP O
175 endocrinology NN I-NP O
175 and CC O O
175 nursing JJ B-NP O
175 staff NN I-NP O
175 are VBP O O
175 all DT O O
175 aware JJ O O
175 and CC O O
175 are VBP O O
175 working VBG O O
176 diligently RB O O
176 to TO O O
176 prevent VB O O
176 the DT B-NP O
176 patient NN I-NP O
176 from IN B-VP O
176 receiving VBG O O
176 more JJR O O
176 than IN B-VP O
176 2000 CD O O
177 calories NNS B-NP O
177 per VBP O O
177 day NN B-NP O
177 as IN B-VP O
177 specified VBN O O
177 by IN B-VP O
177 her PRP$ O O
177 ADA NNP B-NP O
177 diet NN I-NP O
177 She PRP O O
177 is VBZ O O
177 continuing VBG O O
178 her PRP$ O O
178 Nephrocaps NNP B-NP B-m
178 and CC O O
178 sevelamer JJR B-NP B-m
178 Prophylaxis NNP I-NP B-r
178 Prophylaxis NNP I-NP B-r
178 , , O O
178 heparin NN B-NP B-m
178 5000 CD O B-do
178 units NNS B-NP I-do
179 subcu VBP O B-mo
179 t.i.d SYM O B-f
179 - : O O
179 the DT B-NP O
179 patient NN I-NP O
179 has VBZ O O
179 consistently RB O O
179 refused VBN O O
179 her PRP$ O O
179 heparin NN B-NP B-m
180 6 CD O O
180 Consent: NNP B-NP O
180 All NNP I-NP O
180 interventions NNS I-NP O
180 require VBP O O
180 consent NN B-NP O
180 from IN B-VP O
180 the DT B-NP O
181 patient's NN I-NP O
181 medical JJ B-NP O
181 guardian NN I-NP O
181 , , O O
181 Stanley NNP B-NP O
181 Paneque NNP I-NP O
181 ( ( O O
181 please VB O O
181 see VB O O
181 number NN B-NP O
182 above IN B-VP O
182 ) ) O O
183 7 CD O O
183 Code NNP B-NP O
183 status: VBD B-VP O
183 The DT B-NP O
183 patient NN I-NP O
183 is VBZ O O
183 full JJ B-NP O
183 code NN I-NP O
183 and CC O O
183 this DT O O
183 has VBZ O O
183 been VBN O O
184 confirmed VBN O O
184 with IN B-VP O
184 the DT B-NP O
184 guardian JJ I-NP O
185 ADDENDUM NNP I-NP O
186 Of IN B-VP O
186 note NN B-NP O
186 , , O O
186 on IN B-VP O
186 the DT B-NP O
186 night NN I-NP O
186 of IN B-VP O
186 1/26/06 CD O O
186 , , O O
186 the DT B-NP O
186 patient NN I-NP O
186 complained VBD B-VP O
186 of IN B-VP O
187 severe JJ B-NP O
187 cramping NN I-NP O
187 , , O O
187 right JJ B-NP O
187 lower JJR I-NP O
187 quadrant NN I-NP O
187 pain NN I-NP O
187 , , O O
187 which WDT O O
187 is VBZ O O
187 new JJ O O
187 She PRP O O
188 noted VBD B-VP O
188 this DT B-NP O
188 pain NN I-NP O
188 has VBZ O O
188 increased VBN O O
188 rapidly RB O O
188 in IN B-VP O
188 the DT B-NP O
188 setting NN I-NP O
188 of IN B-VP O
188 diarrhea JJ B-NP O
189 Several NNP I-NP O
189 C NNP I-NP O
189 diff NN I-NP O
189 studies NNS I-NP O
189 , , O O
189 which WDT O O
189 were VBD B-VP O
189 sent VBN O O
189 recently RB O O
189 have VBP O O
189 been VBN O O
190 negative JJ O O
190 and CC O O
190 the DT B-NP O
190 patient NN I-NP O
190 has VBZ O O
190 had VBN O O
190 no DT B-NP O
190 blood NN I-NP O
190 in IN B-VP O
190 her PRP$ O O
190 diarrhea NN B-NP B-r
191 Presumed NNP I-NP O
191 cause NN I-NP O
191 is VBZ O O
191 Augmentin NNP B-NP B-m
191 , , O O
191 which WDT O O
191 has VBZ O O
191 been VBN O O
191 stopped VBN O O
191 The DT B-NP O
191 patient NN I-NP O
192 has VBZ O O
192 continued VBN O O
192 to TO O O
192 eat VB O O
192 freely RB O O
192 and CC O O
192 is VBZ O O
192 passing VBG O O
192 diarrhea JJ O O
192 despite IN B-VP O
192 her PRP$ O O
193 complaints NNS B-NP O
193 of IN B-VP O
193 10/10 CD O O
193 severe JJ B-NP O
193 abdominal JJ I-NP O
193 pain NN I-NP O
193 A NNP I-NP O
193 CT NNP I-NP O
193 scan NN I-NP O
193 of IN B-VP O
193 her PRP$ O O
194 abdomen NNS B-NP O
194 was VBD B-VP O
194 ordered VBN O O
194 , , O O
194 but CC O O
194 she PRP O O
194 refused VBD B-VP O
194 to TO O O
194 take VB O O
194 oral JJ O O
194 or CC O O
194 IV NNP B-NP O
194 contrast VBP O O
195 The DT B-NP O
195 results NNS I-NP O
195 of IN B-VP O
195 this DT B-NP O
195 CT NNP I-NP O
195 scan NN I-NP O
195 are VBP O O
195 pending VBG O O
195 and CC O O
195 will MD O O
195 be VB O O
195 followed VBN O O
195 up RP O O
196 by IN B-VP O
196 the DT B-NP O
196 new JJ I-NP O
196 medical JJ I-NP O
196 team NN I-NP O
197 eScription NN I-NP O
197 document: VBD B-VP O
197 3-4408397 JJ B-NP O
197 CSSten NNP I-NP O
197 Tel NNP I-NP O
198 Dictated NNP I-NP O
198 By: NNP I-NP O
198 TARONE NNP I-NP O
198 , , O O
198 ANTONIA NNP B-NP O
199 Attending: NNP I-NP O
199 JAME NNP I-NP O
199 CHATTERTON NNP I-NP O
199 , , O O
199 M.D NNP B-NP O
199 LD63 NNP I-NP O
200 Dictation NNP I-NP O
200 ID NNP I-NP O
200 5989686 CD O O
201 D: NNP B-NP O
201 11/29/06 CD O O
202 T: NNP B-NP O
202 11/29/06 CD O O
203 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #701307 VBZ O O
4 214970012 CD O O
4 MH NNP B-NP O
4 93476909 CD O O
4 8756858 CD O O
4 6/21/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 6/19/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/13/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 DESIATO NNP I-NP O
8 , , O O
8 LLOYD NNP B-NP O
8 443-91-88-7 CD O O
9 Charljer NNP B-NP O
9 Ster NNP I-NP O
9 Po NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 10/22/06 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 HO NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 STEINHART NNP I-NP O
14 , , O O
14 JR NNP B-NP O
14 , , O O
14 FEDERICO NNP B-NP O
14 J NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 AMIODARONE NNP I-NP B-m
17 200 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 BID NNP I-NP B-f
18 ECASA NNP I-NP B-m
18 325 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 ISOSORBIDE NNP I-NP B-m
19 DINITRATE NNP I-NP I-m
19 30 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 TID NNP I-NP B-f
19 HOLD NNP I-NP O
19 IF: NNP I-NP O
19 sbp&lt;100 NN I-NP O
20 LOPRESSOR NNP I-NP B-m
20 ( ( O I-m
20 METOPROLOL NNP B-NP I-m
20 TARTRATE NNP I-NP I-m
20 ) ) O I-m
20 50 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 BID NNP I-NP B-f
21 HOLD NNP I-NP O
21 IF: NNP I-NP O
21 hr&lt;60 NN I-NP O
21 , , O O
21 SBP&lt;100 NNP B-NP O
21 Food/Drug NNP I-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Take NNP I-NP O
22 consistently RB O O
22 with IN B-VP O
22 meals NNS B-NP O
22 or CC O O
22 on IN B-VP O
22 empty JJ B-NP O
22 stomach NN I-NP O
23 NITROGLYCERIN NNP I-NP B-m
23 NITROGLYCERIN NNP I-NP B-m
23 1/150 CD O I-m
23 1/150 CD O I-m
23 ( ( O I-m
23 ( ( O I-m
23 0.4 CD O I-m
23 0.4 CD O I-m
23 MG NNP B-NP I-m
23 MG NNP I-NP I-m
23 ) ) O I-m
23 ) ) O I-m
23 1 CD O B-do
23 1 CD O B-do
23 TAB NNP B-NP I-do
23 TAB NNP I-NP I-do
23 SL NNP I-NP B-mo
23 SL NNP I-NP B-mo
23 q5min NN I-NP B-f
23 x NNP I-NP B-du
23 x VBD B-VP B-du
23 3 CD O I-du
23 3 CD O I-du
24 PRN NNP B-NP O
24 chest NN I-NP B-r
24 chest NN I-NP B-r
24 pain NN I-NP I-r
24 pain NN I-NP I-r
24 HOLD NNP I-NP O
24 IF: NNP I-NP O
24 SBP NNP I-NP O
24 &lt; VBD B-VP O
24 100 CD O O
25 KEFLEX NNP B-NP B-m
25 ( ( O I-m
25 CEPHALEXIN NNP B-NP I-m
25 ) ) O I-m
25 500 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QID NNP I-NP B-f
26 Instructions: NNP I-NP O
26 for IN B-VP O
26 chronic JJ B-NP B-r
26 osteomyelitis NN I-NP I-r
26 right JJ B-NP I-r
26 foot NN I-NP I-r
27 ALTACE NNP I-NP B-m
27 ( ( O I-m
27 RAMIPRIL NNP B-NP I-m
27 ) ) O I-m
27 1.25 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 Alert NNP I-NP O
28 overridden: NNP I-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 0/9/06 CD O O
28 by IN B-VP O
28 INGARGIOLA NNP B-NP O
28 , , O O
28 CARMINE NNP B-NP O
28 J NNP I-NP O
28 D NNP I-NP O
28 , , O O
28 M.D NNP B-NP O
29 POTENTIALLY NNP I-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 POTASSIUM NNP I-NP B-m
29 CHLORIDE NNP I-NP I-m
29 &amp; NNP I-NP O
30 RAMIPRIL NNP I-NP B-m
31 POTENTIALLY NNP I-NP O
31 SERIOUS NNP I-NP O
31 INTERACTION: NNP I-NP O
31 POTASSIUM NNP I-NP B-m
31 CHLORIDE NNP I-NP I-m
31 &amp; NNP I-NP O
32 RAMIPRIL NNP I-NP B-m
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: NN B-NP O
32 pt NN I-NP O
32 takes VBZ O O
33 PLAVIX NNP B-NP B-m
33 ( ( O I-m
33 CLOPIDOGREL NNP B-NP I-m
33 ) ) O I-m
33 75 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
34 NEXIUM NNP I-NP B-m
34 ( ( O I-m
34 ESOMEPRAZOLE NNP B-NP I-m
34 ) ) O I-m
34 20 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QD NNP I-NP B-f
35 DIET: NNP I-NP O
35 House NNP I-NP O
35 / VBD B-VP O
35 Low NNP B-NP O
35 chol/low NN I-NP O
35 sat VBD B-VP O
35 fat JJ B-NP O
36 ACTIVITY: NNP I-NP O
36 Resume NNP I-NP O
36 regular JJ B-NP O
36 exercise NN I-NP O
37 FOLLOW NNP I-NP O
37 UP NNP I-NP O
37 APPOINTMENT( NNP I-NP O
37 S NNP I-NP O
37 ): NNP I-NP O
38 Please NNP I-NP O
38 see VB O O
38 your PRP$ O O
38 PCP NNP B-NP O
38 in IN B-VP O
38 Own NNP B-NP O
38 within IN B-VP O
38 2 CD O O
38 weeks NNS B-NP O
38 , , O O
39 ALLERGY: NNP B-NP O
39 statins VBZ O O
40 ADMIT NNP B-NP O
40 DIAGNOSIS: NNP I-NP O
41 chest JJS B-NP O
41 pain NN I-NP O
42 PRINCIPAL NNP I-NP O
42 DISCHARGE NNP I-NP O
42 DIAGNOSIS NNP I-NP O
42 ;Responsible JJ O O
42 After IN B-VP O
42 Study NNP B-NP O
42 for IN B-VP O
42 Causing NNP B-NP O
42 Admission NNP I-NP O
42 ) ) O O
43 chest JJS B-NP O
43 pain NN I-NP O
44 OTHER NNP I-NP O
44 DIAGNOSIS;Conditions NNP I-NP O
44 , , O O
44 Infections NNP B-NP O
44 , , O O
44 Complications NNP B-NP O
44 , , O O
44 affecting VBG O O
44 Treatment/Stay NNP B-NP O
45 HTN NNP I-NP O
45 CAD NNP I-NP O
45 dyslipidemia NN I-NP O
46 OPERATIONS NNP I-NP O
46 AND NNP I-NP O
46 PROCEDURES: NNP I-NP O
47 OTHER NNP I-NP O
47 TREATMENTS/PROCEDURES NNP I-NP O
47 ( ( O O
47 NOT NNP B-NP O
47 IN NNP I-NP O
47 O.R NNP I-NP O
47 ) ) O O
48 ETT NNP B-NP O
49 BRIEF NNP I-NP O
49 RESUME NNP I-NP O
49 OF NNP I-NP O
49 HOSPITAL NNP I-NP O
49 COURSE: NNP I-NP O
50 66 CD O O
50 yo NN B-NP O
50 man NN I-NP O
50 w/ VBZ O O
50 CAD NNP B-NP O
50 s/p NN I-NP O
50 MI's NNP I-NP O
50 ( ( O O
50 76 CD O O
50 , , O O
50 98 CD O O
50 ) ) O O
50 , , O O
50 and CC O O
50 2v CD O O
50 CABG NNP B-NP O
51 5/13 CD O O
51 and CC O O
51 stenting VBG O O
51 to TO O O
51 grafts VB O O
51 5/12 CD O O
51 and CC O O
51 multiple JJ B-NP O
51 admits NNS I-NP O
51 at IN B-VP O
51 multiple JJ B-NP O
52 hospitals NNS I-NP O
52 in IN B-VP O
52 multiple JJ B-NP O
52 states NNS I-NP O
52 for IN B-VP O
52 CP NNP B-NP O
52 evals NNS I-NP O
52 presents NNS I-NP O
52 with IN B-VP O
52 10/10 CD O O
52 CP NNP B-NP O
53 Just NNP I-NP O
53 discharged VBD B-VP O
53 same JJ B-NP O
53 day NN I-NP O
53 for IN B-VP O
53 identical JJ B-NP O
53 presentation NN I-NP O
53 at IN B-VP O
53 SGH NNP B-NP O
53 where WRB O O
54 enzymes NNS B-NP O
54 and CC O O
54 ekg NN B-NP O
54 showed VBD B-VP O
54 no DT B-NP O
54 ischemia NN I-NP O
54 despite IN B-VP O
54 ongoing VBG O O
54 CP NNP B-NP O
54 , , O O
54 and CC O O
54 adenosine JJ B-NP O
55 mibi NN I-NP O
55 was VBD B-VP O
55 poor JJ B-NP O
55 study NN I-NP O
55 but CC O O
55 could MD O O
55 not RB O O
55 rule VB O O
55 out IN B-VP O
55 small JJ B-NP O
55 area NN I-NP O
55 of IN B-VP O
55 ischemia NN B-NP O
55 in IN B-VP O
56 lat JJ B-NP O
56 wall NN I-NP O
56 He PRP O O
56 was VBD B-VP O
56 not RB O O
56 re-cath'd JJ B-NP O
56 Today NN I-NP O
56 at IN B-VP O
56 bus NN B-NP O
56 stop NN I-NP O
56 , , O O
56 developed VBD B-VP O
57 recurrence NN B-NP O
57 of IN B-VP O
57 CP NNP B-NP O
57 and CC O O
57 has VBZ O O
57 not RB O O
57 been VBN O O
57 responsive JJ O O
57 to TO O O
57 NTG NNP B-NP B-m
57 , , O O
57 and CC O O
57 his PRP$ O O
57 enzyme NN B-NP O
57 on IN B-VP O
58 presentation NN B-NP O
58 was VBD B-VP O
58 negative JJ O O
58 and CC O O
58 ekg JJ B-NP O
58 w/ NN I-NP O
58 only RB O O
58 nonspecific JJ B-NP O
58 Tw NNP I-NP O
58 flat NN I-NP O
58 in IN B-VP O
59 II NNP B-NP O
59 , , O O
59 III NNP B-NP O
59 and CC O O
59 V2-V3 NNP B-NP O
59 previously RB O O
59 noted VBD B-VP O
60 In IN B-VP O
60 ED: NNP B-NP O
60 86 CD O O
60 118/60 CD O O
60 99% CD O O
60 Got NNP B-NP O
60 sl JJ B-NP B-mo
60 Nitro NNP I-NP B-m
60 x NNP I-NP B-du
60 2-&gt;BP JJ O I-du
60 87/59 CD O O
60 P86 NNP B-NP O
60 118/60 CD O O
60 Got NNP B-NP O
60 sl JJ O B-mo
61 ntg RB O B-m
61 x2-&gt; JJ B-NP B-du
61 BP NNP I-NP O
61 87/59 CD O O
61 cp NN B-NP O
61 10/10-&gt;4/10 JJ B-NP O
61 Pt NNP I-NP O
61 sitting VBG O O
61 up RP O O
61 laughing VBG O O
61 c/o JJ B-NP O
61 6-7/10 JJ I-NP O
62 cp NN I-NP B-r
62 radiating VBG O O
62 to TO O O
62 neck VB O O
62 and CC O O
62 jaw VB O O
62 sl JJ O B-mo
62 ntg JJ O B-m
62 given VBN O O
62 w/out RP O O
63 relief JJ B-NP O
63 PMH: NNP I-NP O
63 CAD NNP I-NP O
63 MI NNP I-NP O
63 '76 NNP I-NP O
63 , , O O
63 '98 NNP B-NP O
63 ( ( O O
63 HMC NNP B-NP O
63 ) ) O O
63 , , O O
63 PCI NNP B-NP O
63 6/4 CD O O
63 Poll NNP B-NP O
63 Hospital NNP I-NP O
64 Sabeth NNP I-NP O
64 Otte NNP I-NP O
64 Den NNP I-NP O
64 , , O O
64 s/p VBD B-VP O
64 2V CD O O
64 CABG NNP B-NP O
64 5/13 CD O O
64 Ocitor's NNP B-NP O
64 Tianneyvass NNP I-NP O
64 Gentburke NNP I-NP O
64 Hospital NNP I-NP O
64 , , O O
64 sternal JJ B-NP O
64 surgery NN I-NP O
64 for IN B-VP O
64 Staph NNP B-NP O
65 infection NN I-NP O
65 3/24 CD O O
65 , , O O
65 PCI NNP B-NP O
65 to TO O O
65 grafts VB O O
65 6/7 CD O O
65 Stillpen NNP B-NP O
65 Hospital NNP I-NP O
65 , , O O
65 + NNP B-NP O
65 ETT NNP I-NP O
65 w VBD B-VP O
65 ?PCI NNP B-NP O
66 CC NNP I-NP O
66 6/25 CD O O
66 , , O O
66 PM NNP B-NP O
66 placement VBD B-VP O
66 4/10 CD O O
66 Di NNP B-NP O
66 Pendsti NNP I-NP O
66 adenosine-MIBI JJ B-NP O
66 RCH NNP I-NP O
67 9/11/06 CD O O
67 -&gt;LVEF NNP B-NP O
67 68% CD O O
67 , , O O
67 mild-mod JJ B-NP O
67 lateral JJ I-NP O
67 wall NN I-NP O
67 ischemia NN I-NP O
67 vs NN I-NP O
67 artifact NN I-NP O
67 9/9 CD O O
67 , , O O
68 obsesity NN B-NP O
68 , , O O
68 GERD NNP B-NP O
68 , , O O
68 chronic JJ B-NP B-r
68 osteomyelitis NN I-NP I-r
68 rt JJ B-NP O
68 foot NN I-NP O
68 on IN B-VP O
68 keflex NN B-NP B-m
68 , , O O
68 DM2 NNP B-NP O
68 ( ( O O
68 '92 POS O O
68 ) ) O O
69 CHF NNP B-NP O
69 , , O O
69 pAF NN B-NP O
69 ( ( O O
69 no DT B-NP O
69 t NN I-NP O
69 on IN B-VP O
69 coumadin NN B-NP O
69 ) ) O O
69 , , O O
69 hyperlipidemia NN B-NP O
69 , , O O
69 HTN NNP B-NP O
69 , , O O
69 CVA NNP B-NP O
69 w NN I-NP O
69 left VBD B-VP O
70 sided JJ B-NP O
70 wkns NN I-NP O
70 meds:ASA NN I-NP B-m
70 325 CD O B-do
70 , , O O
70 amiodarone RB O B-m
70 200 CD O B-do
70 bid NN B-NP B-f
70 , , O O
70 lopressor VBZ O B-m
70 50 CD O B-do
70 bid NN B-NP B-f
70 , , O O
71 imdur JJ O B-m
71 60 CD O B-do
71 bid NN B-NP B-f
71 , , O O
71 plavix NN B-NP B-m
71 75 CD O B-do
71 , , O O
71 protonix NN B-NP B-m
71 , , O O
71 keflex VBD B-VP B-m
71 500 CD O B-do
71 q4 NN B-NP B-f
71 , , O O
71 lasix JJ O B-m
71 60 CD O B-do
71 bid NN B-NP B-f
71 , , O O
71 kcl VB O B-m
72 40 CD O B-do
72 qd NN B-NP B-f
72 , , O O
72 metformin RB O B-m
72 500 CD O B-do
72 bid NN B-NP B-f
72 , , O O
72 micronase VB O B-m
72 10 CD O B-do
72 bid NN B-NP B-f
72 , , O O
72 tylenol EX O B-m
72 c JJ B-NP I-m
72 codeine NN I-NP I-m
72 , , O O
72 ativan RB O B-m
73 5 CD O B-do
73 mg NNS B-NP I-do
73 prn JJ B-NP B-f
74 all: NN I-NP O
74 ?statins NNS I-NP O
74 SH: NNP I-NP O
74 divorced VBD B-VP O
74 x2 NNP B-NP O
74 , , O O
74 son NN B-NP O
74 died VBD B-VP O
74 from IN B-VP O
74 HL NNP B-NP O
74 age NN I-NP O
74 10; CD O O
74 son NN B-NP O
74 living NN I-NP O
75 in IN B-VP O
75 Pla NNP B-NP O
75 Odownde NNP I-NP O
75 Lake NNP I-NP O
75 , , O O
75 quit VBD B-VP O
75 tob JJ O O
75 20 CD O O
75 y NN B-NP O
75 ago RB O O
75 , , O O
75 no DT B-NP O
75 etoh JJ I-NP O
75 antique NN I-NP O
75 dealer NN I-NP O
75 FH: NNP I-NP O
76 CAD; NNP I-NP O
76 PE NNP I-NP O
76 T NNP I-NP O
76 97 CD O O
76 102/62 CD O O
76 68 CD O O
76 18 CD O O
77 98% CD O O
77 Gen: NNP B-NP O
77 obese JJ O O
77 in IN B-VP O
77 good JJ B-NP O
77 spirit NN I-NP O
78 NAD NNP I-NP O
78 HEENT: NNP I-NP O
78 JVP NNP I-NP O
79 flat JJ B-NP O
79 Cor: NNP I-NP O
79 RRR NNP I-NP O
79 , , O O
79 3/6 CD O O
79 SM NNP B-NP O
80 USB NNP I-NP O
80 Pulm: NNP I-NP O
81 CTA NNP I-NP O
81 Abd: NNP I-NP O
82 benign NN I-NP O
82 Ext: NNP I-NP O
82 no DT B-NP O
82 edema NN I-NP O
82 , , O O
82 1 CD O O
82 cm NN B-NP O
82 red JJ B-NP O
82 spot NN I-NP O
82 rt NN I-NP O
82 ankle NN I-NP O
82 nontender; JJ B-NP O
83 WWP NNP I-NP O
83 neuro: NN I-NP O
83 slight VBD B-VP O
83 dec JJ O O
83 strenth JJ O O
83 left VBD B-VP O
84 side JJ B-NP O
84 labs: NN I-NP O
84 Cr NNP I-NP O
84 1.8 CD O O
84 ( ( O O
84 bs VB O O
84 1.5 CD O O
84 ) ) O O
84 , , O O
84 CK NNP B-NP O
84 69 CD O O
84 , , O O
84 1.5 CD O O
84 TnI&lt;ass NNP B-NP O
84 , , O O
84 HCT NNP B-NP O
84 39 CD O O
84 , , O O
85 WBC NNP B-NP O
85 9 CD O O
85 , , O O
85 PLT NNP B-NP O
85 354 CD O O
85 INR NNP B-NP O
85 1.0 CD O O
85 PTT NNP B-NP O
85 29 CD O O
85 EKG: NNP B-NP O
85 NSR NNP I-NP O
85 68 CD O O
85 Twave NNP B-NP O
85 flat JJ B-NP O
85 II NNP I-NP O
85 , , O O
85 III NNP B-NP O
85 , , O O
85 V2-V3 NNP B-NP O
86 no DT B-NP O
86 new JJ I-NP O
86 changes NNS I-NP O
87 Impression: VBP O O
87 66 CD O O
87 yo NNS B-NP O
87 M NNP I-NP O
87 w VBP O O
87 h/o NN B-NP O
87 CAD NNP I-NP O
87 s/p NN I-NP O
87 MI NNP I-NP O
87 , , O O
87 CABG NNP B-NP O
87 + NNP I-NP O
87 PCI NNP I-NP O
87 w VBD B-VP O
87 recent JJ B-NP O
87 admits NNS I-NP O
87 for IN B-VP O
88 same JJ O O
88 and CC O O
88 ?+ JJ B-NP O
88 MIBI NNP I-NP O
88 1/8 CD O O
88 admitted VBN O O
88 with IN B-VP O
88 chest NN B-NP O
88 pain NN I-NP O
88 high JJ B-NP O
88 prob NN I-NP O
88 low-int NN I-NP O
89 risk NN I-NP O
89 CP NNP I-NP O
89 in IN B-VP O
89 patient NN B-NP O
89 with IN B-VP O
89 known VBN O O
89 CAD NNP B-NP O
89 and CC O O
90 ongoing VBG O O
90 RF's NNP B-NP O
90 While IN B-VP O
90 story NN B-NP O
90 and CC O O
90 his PRP$ O O
90 behavior NN B-NP O
90 and CC O O
90 presentation NN B-NP O
90 and CC O O
90 lack NN B-NP O
91 of IN B-VP O
91 response NN B-NP O
91 to TO O O
91 antianginal JJ B-NP B-m
91 therapy NN I-NP I-m
91 , , O O
91 argue NN B-NP O
91 against IN B-VP O
91 ischemic JJ O O
91 , , O O
91 we PRP O O
91 will MD O O
92 need VB O O
92 to TO O O
92 monitor VB O O
92 carefully RB O O
93 1 CD O O
93 CV NNP B-NP O
93 ( ( O O
93 I PRP O O
93 )tele VBP O O
93 r/o JJ B-NP O
93 w/ NN I-NP O
93 enzymes NNS I-NP O
93 , , O O
93 ekg JJ B-NP O
93 heparininze NN I-NP O
93 until IN B-VP O
93 ruled VBN O O
93 out RP O O
93 , , O O
93 given VBN O O
94 ongoing VBG O O
94 pain NN B-NP O
94 no DT B-NP O
94 further JJ I-NP O
94 sL NN I-NP B-mo
94 nitro RB O B-m
94 given VBN O O
94 no DT B-NP O
94 relief NN I-NP O
94 and CC O O
94 BP NNP B-NP O
95 drops NNS I-NP O
95 continue VBP O O
95 asa RB O B-m
95 , , O O
95 plavix NN B-NP B-m
95 , , O O
95 oral JJ B-NP B-mo
96 nitrate NN I-NP B-m
96 -ETT VBD B-VP O
96 1/5 CD O O
96 2 CD O O
96 min NN B-NP O
96 stopped VBD B-VP O
96 2/2 CD O O
96 chest JJS B-NP O
96 pain NN I-NP O
96 no DT B-NP O
97 ischemic JJ I-NP O
97 EKG NNP I-NP O
97 changes NNS I-NP O
97 ( ( O O
97 P NNP B-NP O
97 ) ) O O
97 EF NNP B-NP O
97 68 CD O O
97 % NN B-NP O
97 euvolemic JJ B-NP O
97 cont NN I-NP O
98 nitrate NN I-NP B-m
98 ( ( O O
98 R NNP B-NP O
98 ) ) O O
98 tele VBP O O
98 cont JJ B-NP O
98 bblocker NN I-NP B-m
98 NSR NNP I-NP O
98 monitor NN I-NP O
98 for IN B-VP O
98 pAF NN B-NP O
98 cont NN I-NP O
99 amiodarone NN I-NP B-m
99 2 CD O O
99 Endo: NNP B-NP O
99 check NN I-NP O
99 A1c NNP I-NP O
99 hold VB O O
99 oral JJ B-NP B-mo
99 agents NNS I-NP B-m
99 SS VBP O O
100 3 CD O O
100 Renal: NNP B-NP O
100 elevated VBD B-VP B-r
100 BUN/Cr NNP B-NP I-r
100 gentle JJ B-NP O
100 hydration NN I-NP O
100 IVF NNP I-NP B-m
100 100 CD O B-do
100 cc/h NN B-NP I-do
101 trend NN I-NP O
101 4 CD O O
101 ID- JJ B-NP O
101 chronic JJ I-NP B-r
101 osteomyletis NN I-NP I-r
101 cont NN I-NP O
101 keflex NNP I-NP B-m
101 normal JJ B-NP O
102 WBC NNP I-NP O
102 , , O O
102 afebrile IN B-VP O
102 no DT B-NP O
102 sign NN I-NP O
102 of IN B-VP O
102 acute JJ B-NP O
102 infection NN I-NP O
102 5 CD O O
102 FEN: NNP B-NP O
102 NPO NNP I-NP O
102 cont NN I-NP O
102 PPI NNP I-NP B-m
102 for IN B-VP O
103 GERD NNP B-NP B-r
103 5 CD O O
103 ppx: NN B-NP O
103 PPI NNP I-NP B-m
103 , , O O
103 sc VBD B-VP B-mo
103 hep JJ O B-m
104 6 CD O O
104 dispo: NN B-NP O
104 FC NNP I-NP O
105 ADDITIONAL NNP I-NP O
105 COMMENTS: NNP I-NP O
105 please NN I-NP O
105 f/u NN I-NP O
105 with IN B-VP O
105 your PRP$ O O
105 PCP NNP B-NP O
105 in IN B-VP O
105 Ton NNP B-NP O
105 Ronatlleighing NNP I-NP O
105 Rill NNP I-NP O
105 You PRP O O
105 will MD O O
105 need VB O O
105 to TO O O
105 discuss VB O O
105 the DT B-NP O
105 issue NN I-NP O
106 starting VBG O O
106 coumadin JJ B-NP B-m
106 therapy NN I-NP O
106 given VBN O O
106 your PRP$ O O
106 history NN B-NP O
106 of IN B-VP O
106 atrial JJ B-NP B-r
106 fibrillation NN I-NP I-r
107 DISCHARGE NNP I-NP O
107 CONDITION: NNP I-NP O
107 Stable NNP I-NP O
108 TO NNP I-NP O
108 DO/PLAN: NNP I-NP O
109 No NNP I-NP O
109 dictated VBD B-VP O
109 summary JJ B-NP O
110 ENTERED NNP I-NP O
110 BY: NNP I-NP O
110 FAUPEL NNP I-NP O
110 , , O O
110 LAWERENCE NNP B-NP O
110 K NNP I-NP O
110 , , O O
110 M.D NNP B-NP O
110 , , O O
110 PH.D NNP B-NP O
110 ( ( O O
110 LP51 NNP B-NP O
110 ) ) O O
110 10/22/06 CD O O
110 @ $ O O
110 11:08 CD O O
110 AM NNP B-NP O
111 ****** JJ B-NP O
111 END NN I-NP O
111 OF NNP I-NP O
111 DISCHARGE NNP I-NP O
111 ORDERS NNP I-NP O
111 ****** NNP I-NP O
112 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #708298 VBZ O O
4 649982356 CD O O
4 BUMC NNP B-NP O
4 28224594 CD O O
4 1786897 CD O O
4 1/3/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 ischemic JJ B-NP O
4 cardiomyopathy NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/3/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/13/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 BRIGNOLO NNP I-NP O
8 , , O O
8 CHUCK NNP B-NP O
8 753-20-74-1 CD O O
9 Platnof NNP B-NP O
9 Ave NNP I-NP O
9 , , O O
9 Chibroke NNP B-NP O
9 Ri NNP I-NP O
9 Ce NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 9/5/05 CD O O
11 AT NNP B-NP O
11 05:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 HO NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 ROURK NNP I-NP O
14 , , O O
14 BRYON NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 ECASA NNP I-NP B-m
17 ( ( O I-m
17 ASPIRIN NNP B-NP I-m
17 ENTERIC NNP I-NP I-m
17 COATED NNP I-NP I-m
17 ) ) O I-m
17 325 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 ATENOLOL NNP I-NP B-m
18 50 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 BID NNP I-NP B-f
18 Starting VBG O O
18 Today NNP B-NP O
18 ( ( O O
18 0/17 CD O O
18 ) ) O O
19 GLYBURIDE NNP B-NP B-m
19 10 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 LEVOTHYROXINE NNP I-NP B-m
20 SODIUM NNP I-NP I-m
20 75 CD O B-do
20 MCG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 NITROGLYCERIN NNP I-NP B-m
21 1/150 CD O I-m
21 ( ( O I-m
21 0.4 CD O I-m
21 MG NNP B-NP I-m
21 ) ) O I-m
21 1 CD O B-do
21 TAB NNP B-NP I-do
21 SL NNP I-NP B-mo
21 Q5MIN NNP I-NP O
21 X NNP I-NP B-du
21 2 CD O I-du
21 doses NNS B-NP I-du
22 PRN NNP I-NP O
22 Chest NNP I-NP B-r
22 Pain NNP I-NP I-r
22 HOLD NNP I-NP O
22 IF: NNP I-NP O
22 sbp VBZ O O
22 less JJR O O
22 than IN B-VP O
22 100 CD O O
22 mmHg JJ B-NP O
23 PLAVIX NNP I-NP B-m
23 ( ( O I-m
23 CLOPIDOGREL NNP B-NP I-m
23 ) ) O I-m
23 75 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QD NNP I-NP B-f
24 LIPITOR NNP I-NP B-m
24 ( ( O I-m
24 ATORVASTATIN NNP B-NP I-m
24 ) ) O I-m
24 80 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QHS NNP I-NP B-f
25 Starting VBG O O
25 Today NNP B-NP O
25 ( ( O O
25 0/17 CD O O
25 ) ) O O
26 LASIX NNP B-NP B-m
26 ( ( O I-m
26 FUROSEMIDE NNP B-NP I-m
26 ) ) O I-m
26 80 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 QD NNP I-NP B-f
27 GLUCOPHAGE NNP I-NP B-m
27 ( ( O I-m
27 METFORMIN NNP B-NP I-m
27 ) ) O I-m
27 500 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 BID NNP I-NP B-f
28 BENICAR NNP I-NP B-m
28 20 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 DIET: NNP I-NP O
29 Patient NNP I-NP O
29 should MD O O
29 measure VB O O
29 weight JJ B-NP O
29 daily JJ I-NP O
30 DIET: NNP I-NP O
30 Fluid NNP I-NP O
30 restriction: VBD B-VP O
30 2 CD O O
30 liters NNS B-NP O
31 DIET: NNP I-NP O
31 House NNP I-NP O
31 / VBD B-VP O
31 Low NNP B-NP O
31 chol/low NN I-NP O
31 sat VBD B-VP O
31 fat JJ B-NP O
32 DIET: NNP I-NP O
32 2 CD O O
32 gram NN B-NP O
32 Sodium NNP I-NP O
33 ACTIVITY: NNP I-NP O
33 Walking NNP I-NP O
33 as IN B-VP O
33 tolerated VBN O O
34 FOLLOW NNP B-NP O
34 UP NNP I-NP O
34 APPOINTMENT( NNP I-NP O
34 S NNP I-NP O
34 ): NNP I-NP O
35 Dr NNP I-NP O
35 Knickrehm NNP I-NP O
35 on IN B-VP O
35 February NNP B-NP O
35 , , O O
35 2005 CD O O
35 at IN B-VP O
35 Bipa NNP B-NP O
35 Healthcare NNP I-NP O
35 Center NNP I-NP O
35 724-105-6354 JJ O O
35 1:00p CD O O
35 scheduled VBN O O
35 , , O O
36 Dr NNP B-NP O
36 Gavilanes NNP I-NP O
36 at IN B-VP O
36 Nysi NNP B-NP O
36 Medical NNP I-NP O
36 Center NNP I-NP O
36 You PRP O O
36 will MD O O
36 be VB O O
36 contacted VBN O O
36 with IN B-VP O
36 an DT B-NP O
36 appt NN I-NP O
36 in IN B-VP O
36 2-3wks JJ O O
36 367-645-9837 JJ O O
36 , , O O
37 CHF NNP B-NP O
37 program NN I-NP O
37 on IN B-VP O
37 Thurs NNP B-NP O
37 June NNP I-NP O
37 with IN B-VP O
37 Devin NNP B-NP O
37 Apana NNP I-NP O
37 at IN B-VP O
37 Sadeland NNP B-NP O
37 Hospital NNP I-NP O
37 367-645-9837 JJ O O
37 2:30p CD O O
37 scheduled VBN O O
37 , , O O
38 ALLERGY: NNP B-NP O
38 Penicillins NNP I-NP O
39 ADMIT NNP I-NP O
39 DIAGNOSIS: NNP I-NP O
40 CHF NNP I-NP O
41 PRINCIPAL NNP I-NP O
41 DISCHARGE NNP I-NP O
41 DIAGNOSIS NNP I-NP O
41 ;Responsible JJ O O
41 After IN B-VP O
41 Study NNP B-NP O
41 for IN B-VP O
41 Causing NNP B-NP O
41 Admission NNP I-NP O
41 ) ) O O
42 ischemic VBP O O
42 cardiomyopathy JJ B-NP O
43 OTHER NNP I-NP O
43 DIAGNOSIS;Conditions NNP I-NP O
43 , , O O
43 Infections NNP B-NP O
43 , , O O
43 Complications NNP B-NP O
43 , , O O
43 affecting VBG O O
43 Treatment/Stay NNP B-NP O
44 TYPE NNP I-NP O
44 IV NNP I-NP O
44 HYPERCHOLESTEROLEMI NNP I-NP O
44 SMOKER NNP I-NP O
44 FHX NNP I-NP O
44 HTN NNP I-NP O
44 s/p VBD B-VP O
44 CABG NNP B-NP O
44 CAD NNP I-NP O
45 OPERATIONS NNP I-NP O
45 AND NNP I-NP O
45 PROCEDURES: NNP I-NP O
46 Cardiac NNP I-NP O
46 catherization NN I-NP O
46 w/stent NN I-NP O
46 for IN B-VP O
46 SVG NNP B-NP O
46 to TO O O
46 RPDA NNP B-NP O
46 and CC O O
46 LIMA NNP B-NP O
46 to TO O O
46 LAD VB O O
47 OTHER NNP B-NP O
47 TREATMENTS/PROCEDURES NNP I-NP O
47 ( ( O O
47 NOT NNP B-NP O
47 IN NNP I-NP O
47 O.R NNP I-NP O
47 ) ) O O
48 none NN B-NP O
49 BRIEF NNP I-NP O
49 RESUME NNP I-NP O
49 OF NNP I-NP O
49 HOSPITAL NNP I-NP O
49 COURSE: NNP I-NP O
50 48 CD O O
50 M NNP B-NP O
50 admitted VBD B-VP O
50 via IN B-VP O
50 ED NNP B-NP O
50 with IN B-VP O
50 2 CD O O
50 weeks NNS B-NP O
50 of IN B-VP O
50 dyspnoea NN B-NP O
50 on IN B-VP O
51 exertion NN B-NP O
51 and CC O O
51 2 CD O O
51 days NNS B-NP O
51 of IN B-VP O
51 severe JJ B-NP O
51 peripheral JJ I-NP O
51 oedema NN I-NP O
51 HCC NNP I-NP O
52 : : O O
52 48 CD O O
52 N NNP B-NP O
52 with IN B-VP O
52 CAD NNP B-NP O
52 s/p NN I-NP O
52 CABG NNP I-NP O
52 1997 CD O O
52 , , O O
52 Type NNP B-NP O
52 II NNP I-NP O
53 DM NNP I-NP O
53 , , O O
53 hypercholesterolaemia NN B-NP O
53 , , O O
53 hypertension NN B-NP O
53 , , O O
53 EtOH NNP B-NP O
53 use NN I-NP O
54 who WP O O
54 presents VBZ O O
54 with IN B-VP O
54 2 CD O O
54 weeks NNS B-NP O
54 of IN B-VP O
54 progressive JJ B-NP O
55 SOBOE NNP I-NP O
55 associated VBN O O
55 with IN B-VP O
55 2-3 JJ B-NP O
55 days NNS I-NP O
55 of IN B-VP O
55 severe JJ B-NP O
56 peripheral JJ I-NP O
56 oedema NN I-NP O
56 Describes NNP I-NP O
56 clear JJ B-NP O
56 history NN I-NP O
56 of IN B-VP O
56 orthopnoea NN B-NP O
57 and CC O O
57 PND NNP B-NP O
57 Denies NNP I-NP O
57 chest JJS B-NP O
57 pain NN I-NP O
57 , , O O
58 palpitations NNS B-NP O
58 , , O O
58 light-headedness JJ O O
58 , , O O
58 syncope NN B-NP O
58 , , O O
58 fevers NNS B-NP O
58 , , O O
58 chills NNS B-NP O
58 , , O O
59 weight JJ B-NP O
59 loss NN I-NP O
59 , , O O
59 malaise NN B-NP O
59 or CC O O
59 other JJ B-NP O
59 systemic JJ I-NP O
60 upset JJ I-NP O
60 PMH NN I-NP O
60 : : O O
60 CAD NNP B-NP O
60 , , O O
60 Diabetes NNP B-NP O
60 , , O O
60 alcohol NN B-NP O
60 , , O O
60 CABG NNP B-NP O
61 1997 CD O O
61 , , O O
61 hyperchol NN B-NP O
61 , , O O
62 htn JJ B-NP O
62 DH NNP I-NP O
62 : : O O
62 ASA NNP B-NP B-m
62 , , O O
62 atenolol RB O B-m
62 50 CD O B-do
62 , , O O
62 benicar NN B-NP B-m
62 20 CD O B-do
62 , , O O
62 lipitor NN B-NP B-m
63 20 CD O B-do
63 , , O O
63 glyburide JJ B-NP B-m
64 FH NNP I-NP O
64 : : O O
64 Nil NN B-NP O
64 of IN B-VP O
64 note NN B-NP O
64 SH NNP I-NP O
64 : : O O
64 Smokes NNS B-NP O
64 1ppd CD O O
64 , , O O
64 EtoH NNP B-NP O
64 6 CD O O
65 beers/day NN B-NP O
65 O/E NNP I-NP O
65 : : O O
65 Mildly RB O O
65 SOB NNP B-NP O
65 , , O O
65 T NNP B-NP O
65 97.9 CD O O
65 , , O O
65 BP NNP B-NP O
65 147/105 CD O O
65 , , O O
65 HR NNP B-NP O
65 108 CD O O
65 , , O O
65 RR NNP B-NP O
66 24 CD O O
66 , , O O
66 Sats NNP B-NP O
66 99% CD O O
66 on IN B-VP O
66 room NN B-NP O
66 air NN I-NP O
66 Facial NNP I-NP O
66 plethora NN I-NP O
66 &amp; NNP I-NP O
66 dusky NN I-NP O
66 hue NN I-NP O
66 No NNP I-NP O
66 jaundice NN I-NP O
66 , , O O
67 pallor NN B-NP O
67 , , O O
67 clubbing VBG O O
67 , , O O
67 lymphadenopathy JJ B-NP O
67 JVP NNP I-NP O
67 -&gt; NNP I-NP O
67 earlobes VBZ O O
67 HS NNP B-NP O
67 I PRP O O
67 + VBP O O
67 II NNP B-NP O
67 + NNP I-NP O
68 S3 NNP I-NP O
68 with IN B-VP O
68 gallop JJ B-NP O
68 Occasional NNP I-NP O
68 bibasal NN I-NP O
68 coarse NN I-NP O
68 crackles NNS I-NP O
69 Abdomen NNP I-NP O
69 distended VBD B-VP O
69 with IN B-VP O
69 shifting VBG O O
69 dullness NN B-NP O
69 &amp; NNP I-NP O
69 mild NN I-NP O
69 RUQ NNP I-NP O
69 tenderness NN I-NP O
69 3+++ CD O O
70 pitting VBG O O
70 oedema NN B-NP O
70 to TO O O
70 knees VB O O
70 bilaterally RB O O
70 Rash NNP B-NP O
70 behind IN B-VP O
71 calves NNS B-NP O
71 LABS NNP I-NP O
71 : : O O
71 BNP NN B-NP O
71 1900 CD O O
71 , , O O
71 TnI NNP B-NP O
71 -ve NNP I-NP O
71 , , O O
71 Hct NNP B-NP O
72 52 CD O O
72 CXR NNP B-NP O
72 : : O O
72 New NNP B-NP O
72 cardiomegaly VBZ O O
72 No DT B-NP O
72 pulmonary JJ I-NP O
73 oedema NN I-NP O
73 ECG NNP I-NP O
73 : : O O
73 Unchanged VBN O O
73 TWI NNP B-NP O
73 V4-V6 NNP I-NP O
73 Nil NNP I-NP O
74 acutely RB O O
74 ischaemic JJ B-NP O
75 IMPRESSION NN I-NP O
75 : : O O
75 1 CD O O
75 New NNP B-NP O
75 onset NN I-NP O
75 R NNP I-NP O
75 &gt; NNP I-NP O
75 L NNP I-NP O
75 dilated VBD B-VP O
75 heart NN B-NP O
75 failure NN I-NP O
76 Most NNP I-NP O
76 likely RB O O
76 due JJ O O
76 to TO O O
76 ischemic VB O O
76 dz NN B-NP O
76 and CC O O
76 occlusion NN B-NP O
76 of IN B-VP O
76 grafts NNS B-NP O
76 from IN B-VP O
77 previous JJ B-NP O
77 cabg NNS I-NP O
78 Hospital NNP I-NP O
78 Course: NNP I-NP O
78 CV: NNP I-NP O
78 Upon NNP I-NP O
78 admission NN I-NP O
78 , , O O
78 pt's JJ B-NP O
78 cardiac JJ I-NP O
78 enzymes NNS I-NP O
78 were VBD B-VP O
79 cycled VBN O O
79 x RB O O
79 3 CD O O
79 w/a JJ B-NP O
79 troponin NN I-NP O
79 bump NN I-NP O
79 on IN B-VP O
79 second NN B-NP O
79 set NN I-NP O
79 which WDT O O
79 resolved VBN O O
79 by IN B-VP O
79 3rd CD O O
80 set NN B-NP O
80 He PRP O O
80 r/o'd VBZ O O
80 for IN B-VP O
80 hemochromatosis NN B-NP O
80 and CC O O
80 multiple JJ B-NP O
80 myeloma NN I-NP O
80 W/u NNP I-NP O
80 of IN B-VP O
80 pt's JJ B-NP O
81 new-onset JJ I-NP O
81 chf NN I-NP O
81 included VBD B-VP O
81 an DT B-NP O
81 echo NN I-NP O
81 which WDT O O
81 showed VBD B-VP O
81 global JJ B-NP O
81 hypokinesis NN I-NP O
81 w/EF VBD B-VP O
82 20-25% CD O O
82 The DT B-NP O
82 pt NN I-NP O
82 then RB O O
82 recieved VBD B-VP O
82 cardiac JJ B-NP O
82 catherization NN I-NP O
82 on IN B-VP O
82 4/29 CD O O
82 which WDT O O
82 was VBD B-VP O
83 remarkable JJ O O
83 for IN B-VP O
83 1.elevated CD O O
83 L NNP B-NP O
83 heart NN I-NP O
83 filling NN I-NP O
83 pressures NNS I-NP O
83 at IN B-VP O
83 29mmHg CD O O
83 and CC O O
83 PA NNP B-NP O
84 sat VBD B-VP O
84 fo $ O O
84 49% CD O O
84 c/w JJ B-NP O
84 Lheart NNP I-NP O
84 failure; NN I-NP O
84 2 CD O O
84 LIMA NNP B-NP O
84 to TO O O
84 LAD NNP B-NP O
84 patent NN I-NP O
84 , , O O
84 but CC O O
84 70-80% JJ B-NP O
85 stenosis NN I-NP O
85 at IN B-VP O
85 distal JJ B-NP O
85 anastomotic JJ I-NP O
85 site; NN I-NP O
85 3 CD O O
85 diminished JJ B-NP O
85 baseline NN I-NP O
85 flow NN I-NP O
85 of IN B-VP O
85 SVG NNP B-NP O
86 to TO O O
86 PDA NNP B-NP O
86 s/p NN I-NP O
86 stent NN I-NP O
86 Pt NNP I-NP O
86 had VBD B-VP O
86 transient JJ B-NP O
86 ST NNP I-NP O
86 elevation NN I-NP O
86 during IN B-VP O
86 cath NN B-NP O
86 , , O O
86 relieved VBD B-VP O
87 w/ng JJ B-NP O
87 O/N NNP I-NP O
87 pt NN I-NP O
87 had VBD B-VP O
87 a DT B-NP O
87 couple NN I-NP O
87 episodes VBZ O O
87 NSVT NNP B-NP O
87 Re-cathed NNP I-NP O
87 on IN B-VP O
87 10/19 CD O O
87 as IN B-VP O
87 planned VBN O O
88 after IN B-VP O
88 diuresis NN B-NP O
88 for IN B-VP O
88 stenting VBG O O
88 of IN B-VP O
88 LIMA NNP B-NP O
88 to TO O O
88 LAD NNP B-NP O
88 There EX O O
88 was VBD B-VP O
88 one CD O O
88 episode NN B-NP O
88 of IN B-VP O
89 NSVT NNP B-NP O
89 one CD O O
89 day NN B-NP O
89 following VBG O O
89 2nd CD O O
89 cath JJ B-NP O
89 procedure NN I-NP O
89 Pt NNP I-NP O
89 remained VBD B-VP O
89 in IN B-VP O
90 stable JJ B-NP O
90 condition NN I-NP O
90 w/steady JJ B-NP O
90 improvement NN I-NP O
90 qd NN I-NP O
90 By IN B-VP O
90 d/c NN B-NP O
90 , , O O
90 pt's NN B-NP O
90 sob NN I-NP O
90 , , O O
90 orthopnea NN B-NP O
91 and CC O O
91 pnd NN B-NP O
91 had VBD B-VP O
91 resolved VBN O O
91 Jvp NNP B-NP O
91 was VBD B-VP O
91 wnl JJ O O
91 , , O O
91 hepatic JJ B-NP O
91 congestion NN I-NP O
91 resolved VBD B-VP O
91 , , O O
91 abd VBZ O O
91 no RB O O
92 longer RBR O O
92 distended VBD B-VP O
92 , , O O
92 LE NNP B-NP O
92 swelling VBG O O
92 resolved VBD B-VP O
92 His PRP$ O O
92 dry JJ B-NP O
92 d/c NN I-NP O
92 wt NN I-NP O
92 was VBD B-VP O
92 194.0 CD O O
92 lb JJ B-NP O
93 Pt NNP I-NP O
93 to TO O O
93 f/u VB O O
93 w/CHF JJ B-NP O
93 program NN I-NP O
93 in IN B-VP O
93 1 CD O O
93 wk NN B-NP O
93 , , O O
93 cardiologist NN B-NP O
93 in IN B-VP O
93 2-3wks JJ O O
93 and CC O O
93 EP NNP B-NP O
93 service NN I-NP O
94 in IN B-VP O
94 6wks CD O O
94 Pt NNP B-NP O
94 needs NNS I-NP O
94 f/u VBP O O
94 echo JJ O O
94 b/4 IN B-VP O
94 his PRP$ O O
94 EF NNP B-NP O
94 appt NN I-NP O
94 in IN B-VP O
94 March NNP B-NP O
95 ENDO: NNP I-NP O
95 Pt's NNP I-NP O
95 blood NN I-NP O
95 sugars NNS I-NP O
95 were VBD B-VP O
95 well RB O O
95 controlled VBN O O
95 during IN B-VP O
96 admission NN B-NP O
96 Upon IN B-VP O
96 d/c NN B-NP O
96 , , O O
96 metformin NN B-NP B-m
96 was VBD B-VP O
96 added VBN O O
96 to TO O O
96 his PRP$ O O
96 home NN B-NP O
96 diabetic JJ B-NP O
96 regimen NNS I-NP O
97 FEN: NNP I-NP O
97 pt NN I-NP O
97 had VBD B-VP O
97 a DT B-NP O
97 nutrition NN I-NP O
97 consult NN I-NP O
97 to TO O O
97 review VB O O
97 2g CD O O
97 sodium/2L JJ B-NP O
97 fluid JJ I-NP O
98 restriction NN I-NP O
98 diet JJ B-NP O
99 PSYCH: NNP I-NP O
99 Seen NNP I-NP O
99 by IN B-VP O
99 the DT B-NP O
99 addiction NN I-NP O
99 team NN I-NP O
99 Had VBD B-VP O
99 no DT B-NP O
99 signs/symptoms NNS I-NP O
99 of IN B-VP O
99 etoh NN B-NP O
100 withdrawal NN I-NP O
100 during IN B-VP O
100 admission NN B-NP O
100 Declined VBD B-VP O
100 antidepressants NNS B-NP B-m
100 , , O O
100 nicotine JJ B-NP B-m
100 patch NN I-NP I-m
101 but CC O O
101 agreed VBD B-VP O
101 to TO O O
101 counseling VBG O O
101 as IN B-VP O
101 outpt JJ B-NP O
101 Pt NNP I-NP O
101 encouraged VBD B-VP O
101 to TO O O
101 stop VB O O
101 drinking NN B-NP O
101 and CC O O
102 to TO O O
102 quit VB O O
102 smoking VBG O O
103 CONDITION: NNP B-NP O
103 stable JJ B-NP O
104 DISPO: NNP I-NP O
104 home NN I-NP O
104 w/close NN I-NP O
104 CHF NNP I-NP O
104 program NN I-NP O
104 f/u VBD B-VP O
105 ADDITIONAL NNP B-NP O
105 COMMENTS: NNP I-NP O
105 call NN I-NP O
105 md NN I-NP O
105 for IN B-VP O
105 chest NN B-NP O
105 pain NN I-NP O
105 , , O O
105 shortness NN B-NP O
105 of IN B-VP O
105 breath NN B-NP O
105 , , O O
105 temp NN B-NP O
105 over IN B-VP O
105 100.4 CD O O
105 or CC O O
106 anything NN B-NP O
106 concerning VBG O O
107 DISCHARGE NNP B-NP O
107 CONDITION: NNP I-NP O
107 Stable NNP I-NP O
108 TO NNP I-NP O
108 DO/PLAN: NNP I-NP O
109 Echo NNP I-NP O
109 in IN B-VP O
109 4-6 JJ B-NP O
109 wks NN I-NP O
109 before IN B-VP O
109 appt JJ B-NP O
109 w/Dr NN I-NP O
109 Stith NNP I-NP O
109 on IN B-VP O
109 10/30/05 CD O O
110 No NNP B-NP O
110 dictated VBD B-VP O
110 summary JJ B-NP O
111 ENTERED NNP I-NP O
111 BY: NNP I-NP O
111 RAVE NNP I-NP O
111 , , O O
111 VINCE NNP B-NP O
111 R NNP I-NP O
111 , , O O
111 M.D NNP B-NP O
111 , , O O
111 PH.D NNP B-NP O
111 ( ( O O
111 GA516 NNP B-NP O
111 ) ) O O
111 3/2/04 CD O O
111 @ $ O O
111 11:34 CD O O
111 AM NNP B-NP O
112 ****** JJ B-NP O
112 END NN I-NP O
112 OF NNP I-NP O
112 DISCHARGE NNP I-NP O
112 ORDERS NNP I-NP O
112 ****** NNP I-NP O
113 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #716292 VBZ O O
2 149683203 CD O O
2 EH NNP B-NP O
2 90044612 CD O O
2 779283 CD O O
2 7/5/1991 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/23/1991 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/29/1991 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 The DT B-NP O
4 patient NN I-NP O
4 is VBZ O O
4 a DT B-NP O
4 61-year-old JJ I-NP O
4 man NN I-NP O
5 from IN B-VP O
5 Dr NNP B-NP O
5 , , O O
5 Ro NNP B-NP O
5 Rouge NNP I-NP O
5 Berkesti NNP I-NP O
5 , , O O
5 South NNP B-NP O
5 Dakota NNP I-NP O
5 20513 CD O O
5 , , O O
5 with IN B-VP O
5 a DT B-NP O
5 his- JJ I-NP O
6 tory NN I-NP O
6 of IN B-VP O
6 ischemic JJ B-NP O
6 cardiomyopathy NN I-NP O
6 and CC O O
6 congestive JJ B-NP O
6 heart NN I-NP O
6 failure NN I-NP O
6 , , O O
6 who WP O O
7 was VBD B-VP O
7 transferred VBN O O
7 to TO O O
7 the DT B-NP O
7 Ret NNP I-NP O
7 Health NNP I-NP O
7 Services NNP I-NP O
7 for IN B-VP O
7 transplant JJ B-NP O
7 evalua- JJ I-NP O
8 tion NN I-NP O
8 In IN B-VP O
8 1975 CD O O
8 , , O O
8 he PRP O O
8 suffered VBD B-VP O
8 a DT B-NP O
8 myocardial JJ I-NP O
8 infarction NN I-NP O
8 and CC O O
8 subse- JJ O O
9 quently RB O O
9 had VBD B-VP O
9 exertional JJ B-NP O
9 angina NN I-NP O
9 In IN B-VP O
9 8 CD O O
9 of IN B-VP O
9 November NNP B-NP O
9 he PRP O O
9 suffered VBD B-VP O
9 a DT B-NP O
9 second JJ I-NP O
9 MI NNP I-NP O
10 and CC O O
10 underwent JJ B-NP O
10 three-vessel JJ I-NP O
10 coronary JJ I-NP O
10 artery NN I-NP O
10 bypass NN I-NP O
10 graft NN I-NP O
10 in IN B-VP O
10 21 CD O O
10 of IN B-VP O
10 April NNP B-NP O
11 At IN B-VP O
11 that DT B-NP O
11 time NN I-NP O
11 his PRP$ O O
11 ejection NN B-NP O
11 fraction NN I-NP O
11 was VBD B-VP O
11 21% CD O O
11 Over IN B-VP O
11 the DT B-NP O
11 ensuing JJ I-NP O
12 months NNS I-NP O
12 , , O O
12 the DT B-NP O
12 patient NN I-NP O
12 noted VBD B-VP O
12 markedly RB O O
12 worsening VBG O O
12 symptoms NNS B-NP O
12 of IN B-VP O
12 CHF NNP B-NP O
12 with IN B-VP O
13 orthopnea NN B-NP O
13 , , O O
13 paroxysmal JJ B-NP O
13 nocturnal JJ I-NP O
13 dyspnea NN I-NP O
13 , , O O
13 and CC O O
13 dyspnea NN B-NP O
13 on IN B-VP O
13 exertion NN B-NP O
14 One CD O O
14 week NN B-NP O
14 prior RB O O
14 to TO O O
14 transfer VB O O
14 , , O O
14 the DT B-NP O
14 patient NN I-NP O
14 was VBD B-VP O
14 admitted VBN O O
14 to TO O O
14 Ment NNP B-NP O
14 Hospital NNP I-NP O
14 for IN B-VP O
14 management NN B-NP O
14 of IN B-VP O
14 his PRP$ O B-r
14 his PRP$ O B-r
14 congestive JJ B-NP I-r
14 congestive JJ I-NP I-r
14 heart NN I-NP I-r
14 heart NN I-NP I-r
14 failure NN I-NP I-r
14 failure NN I-NP I-r
14 He PRP O O
14 was VBD B-VP O
15 initially RB O O
15 treated VBN O O
15 with IN B-VP O
15 afterload NN B-NP O
15 reduction NN I-NP O
15 , , O O
15 digoxin NN B-NP B-m
15 and CC O O
15 Lasix NNP B-NP B-m
16 On IN B-VP O
16 this DT B-NP B-m
16 regimen NNS I-NP I-m
16 , , O O
16 a DT B-NP O
16 PA NNP I-NP O
16 line NN I-NP O
16 was VBD B-VP O
16 placed VBN O O
16 with IN B-VP O
16 the DT O O
16 following VBG O O
16 read- JJ B-NP O
17 ings: JJ I-NP O
17 RA NNP I-NP O
17 8 CD O O
17 , , O O
17 RV NNP B-NP O
17 76/4 CD O O
17 , , O O
17 TA NNP B-NP O
17 80/36 CD O O
17 , , O O
17 pulmonary JJ B-NP O
17 capillary JJ I-NP O
17 wedge NN I-NP O
17 pres- JJ O O
18 sure JJ O O
18 34 CD O O
18 , , O O
18 and CC O O
18 cardiac JJ B-NP O
18 index NN I-NP O
18 1.49 CD O O
18 Echocardiogram NNP B-NP O
18 revealed VBD B-VP O
18 dilated VBN O O
19 left JJ B-NP O
19 ventricle NN I-NP O
19 with IN B-VP O
19 global JJ B-NP O
19 hypokinesis NN I-NP O
19 , , O O
19 tricuspid JJ B-NP O
19 regurgitation NN I-NP O
19 , , O O
20 and CC O O
20 PA NNP B-NP O
20 systolic JJ B-NP O
20 pressure NN I-NP O
20 80mmHg CD O O
20 The DT B-NP O
20 patient NN I-NP O
20 was VBD B-VP O
20 treated VBN O O
20 with IN B-VP O
21 dobutamine NN B-NP B-m
21 , , O O
21 intravenous JJ B-NP B-mo
21 TNG NNP I-NP B-m
21 , , O O
21 and CC O O
21 nitroprusside RB O B-m
21 with IN B-VP O
21 symptomatic JJ B-NP O
22 relief NN I-NP O
22 and CC O O
22 hemodynamic JJ B-NP O
22 stabilization NN I-NP O
22 with IN B-VP O
22 wedge NN B-NP O
22 pressure NN I-NP O
22 falling VBG O O
23 to TO O O
23 18 CD O O
23 TNG NNP B-NP B-m
23 and CC O O
23 Nipride NNP B-NP B-m
23 were VBD B-VP O
23 successfully RB O O
23 weaned VBN O O
23 However RB O O
23 , , O O
23 the DT B-NP O
24 patient NN I-NP O
24 remained VBD B-VP O
24 dobutamine JJ B-NP B-m
24 dependent NN I-NP O
25 The DT B-NP O
25 patient NN I-NP O
25 was VBD B-VP O
25 transferred VBN O O
25 to TO O O
25 the DT B-NP O
25 Edpointe NNP I-NP O
25 Soupied NNP I-NP O
25 Cantjean NNP I-NP O
25 Hospital NNP I-NP O
25 for IN B-VP O
25 evalu- JJ B-NP O
26 ation NN I-NP O
26 for IN B-VP O
26 transplantation NN B-NP O
26 At IN B-VP O
26 the DT B-NP O
26 time NN I-NP O
26 of IN B-VP O
26 admission NN B-NP O
26 he PRP O O
26 noted VBD B-VP O
27 dyspnea NN B-NP O
27 on IN B-VP O
27 minimal JJ B-NP O
27 exertion NN I-NP O
27 but CC O O
27 not RB O O
27 at IN B-VP O
27 rest NN B-NP O
27 He PRP O O
27 denied VBD B-VP O
27 chest JJS B-NP O
28 pain NN I-NP O
28 , , O O
28 palpitations NNS B-NP O
28 , , O O
28 lightheadedness NN B-NP O
28 , , O O
28 or CC O O
28 syncope VB O O
28 The DT B-NP O
28 patient NN I-NP O
28 is VBZ O O
29 married VBN O O
29 , , O O
29 and CC O O
29 worked VBD B-VP O
29 as IN B-VP O
29 a DT B-NP O
29 janitor NN I-NP O
29 until IN B-VP O
29 March NNP B-NP O
29 of IN B-VP O
29 1991 CD O O
29 He PRP O O
29 is VBZ O O
30 married JJ O O
30 with IN B-VP O
30 seven CD O O
30 children NNS B-NP O
30 and CC O O
30 lives NNS B-NP O
30 in IN B-VP O
30 S NNP B-NP O
31 The DT B-NP O
31 patient's NN I-NP O
31 PAST NNP I-NP O
31 MEDICAL NNP I-NP O
31 HISTORY NNP I-NP O
31 is VBZ O O
31 significant JJ O O
31 for IN B-VP O
31 severe JJ B-NP O
32 abdominal JJ I-NP O
32 trauma NN I-NP O
32 many JJ B-NP O
32 years NNS I-NP O
32 ago RB O O
32 , , O O
32 having VBG O O
32 been VBN O O
32 gored VBN O O
32 by IN B-VP O
32 a DT B-NP O
32 bull JJ I-NP O
33 PHYSICAL NNP I-NP O
33 EXAMINATION: NNP I-NP O
33 Discharge NNP I-NP O
33 physical JJ B-NP O
33 examination NN I-NP O
33 is VBZ O O
33 nota- JJ O O
34 ble JJ O O
34 for IN B-VP O
34 a DT B-NP O
34 blood NN I-NP O
34 pressure NN I-NP O
34 of IN B-VP O
34 100/50 CD O O
34 , , O O
34 a DT B-NP O
35 heart NN I-NP O
35 rate NN I-NP O
35 of IN B-VP O
35 between IN B-VP O
35 100 CD O O
35 and CC O O
35 110 CD O O
35 , , O O
35 a DT B-NP O
35 respiratory JJ I-NP O
35 rate NN I-NP O
35 of IN B-VP O
35 18 CD O O
35 , , O O
35 a DT B-NP O
36 blood NN I-NP O
36 pressure NN I-NP O
36 of IN B-VP O
36 112/66 CD O O
36 , , O O
36 a DT B-NP O
36 temperature NN I-NP O
36 of IN B-VP O
36 97.1 CD O O
36 , , O O
36 and CC O O
36 a DT B-NP O
36 weight NN I-NP O
36 of IN B-VP O
37 80.4 CD O O
37 kilograms NNS B-NP O
37 The DT B-NP O
37 patient NN I-NP O
37 is VBZ O O
37 in IN B-VP O
37 normal JJ B-NP O
37 sinus NNS I-NP O
37 rhythm VBP O O
37 with IN B-VP O
37 occa- JJ B-NP O
38 sional JJ I-NP O
38 short JJ I-NP O
38 bursts NNS I-NP O
38 of IN B-VP O
38 ventricular JJ B-NP O
38 tachycardia NN I-NP O
38 last JJ O O
38 two CD O O
38 days NNS B-NP O
39 prior RB O O
39 to TO O O
39 discharge VB O O
39 LUNGS: NNP B-NP O
39 Occasional NNP I-NP O
39 crackles NNS I-NP O
39 HEART: NNP I-NP O
39 Sounds NNP I-NP O
40 distant JJ B-NP O
40 ABDOMEN: NNP I-NP O
40 Benign NNP I-NP O
40 EXTREMITIES: NNP I-NP O
40 Trace NNP I-NP O
40 edema VBZ O O
41 LABORATORY NNP B-NP O
41 DATA: NNP I-NP O
41 Discharge NNP I-NP O
41 sodium NN I-NP O
41 134 CD O O
41 , , O O
41 potassium NN B-NP O
41 4.2 CD O O
41 , , O O
41 BUN NNP B-NP O
42 32 CD O O
42 , , O O
42 creatinine NN B-NP O
42 1.4 CD O O
42 White NNP B-NP O
42 count NN I-NP O
42 9.8 CD O O
42 , , O O
43 hematocrit NN B-NP O
43 29.2 CD O O
43 , , O O
43 platelets NNS B-NP O
43 253 CD O O
43 ALT NNP B-NP O
43 14 CD O O
43 , , O O
43 AST NNP B-NP O
43 8 CD O O
43 , , O O
43 LDH NNP B-NP O
43 223 CD O O
43 , , O O
43 total JJ B-NP O
44 bilirubin NN I-NP O
44 0.6 CD O O
44 , , O O
44 direct JJ B-NP O
44 bilirubin NN I-NP O
44 0.3 CD O O
44 , , O O
44 albumin RB O O
44 2.8 CD O O
44 , , O O
44 total JJ B-NP O
44 protein NN I-NP O
45 5.9 CD O O
45 , , O O
45 cholesterol NN B-NP O
45 106 CD O O
46 MEDICATIONS NNP B-NP O
46 at IN B-VP O
46 time NN B-NP O
46 of IN B-VP O
46 discharge NN B-NP O
46 include VBP O O
46 dobutamine NN B-NP B-m
46 at IN B-VP O
46 15 CD O B-do
46 mcg NNS B-NP O
46 per IN B-VP O
47 kilogram NN B-NP O
47 per IN B-VP B-f
47 minute; NN B-NP I-f
47 captopril NN I-NP B-m
47 25 CD O B-do
47 mg NN B-NP I-do
47 p.o NN I-NP B-mo
47 t.i.d.; NN I-NP B-f
47 digoxin NN I-NP B-m
47 0.125 CD O B-do
48 mg NN B-NP O
48 p.o NN I-NP B-mo
48 q.d.; NN I-NP B-f
48 Lasix NNP I-NP B-m
48 160 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 b.i.d.; NN I-NP B-f
48 potassium NN I-NP B-m
48 chloride NN I-NP I-m
48 20 CD O B-do
48 mEq NN B-NP I-do
49 p.o NN I-NP B-mo
49 b.i.d.; NN I-NP B-f
49 Coumadin NNP I-NP B-m
49 1 CD O B-do
49 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 q.d.; NN I-NP B-f
49 Atrovent NNP I-NP B-m
49 , , O O
49 two CD O B-do
49 puffs NNS B-NP I-do
49 q.i.d.; JJ B-NP B-f
50 Azmacort NNP I-NP B-m
50 , , O O
50 eight CD O B-do
50 puffs NNS B-NP I-do
50 b.i.d.; VBD B-VP B-f
50 Pepcid NNP B-NP B-m
50 20 CD O B-do
50 mg NN B-NP I-do
50 p.o NN I-NP B-mo
50 b.i.d.; VBD B-VP B-f
50 Colace NNP B-NP B-m
51 100 CD O B-do
51 mg NN B-NP I-do
51 p.o NN I-NP B-mo
51 t.i.d.; NN I-NP B-f
51 vancomycin VBD B-VP B-m
51 1 CD O B-do
51 gm NN B-NP I-do
51 q NN I-NP B-f
51 12 CD O I-f
51 , , O O
51 discontinued VBN O O
51 9-23 CD O O
51 a.m NNS B-NP O
52 after IN B-VP O
52 14 CD O B-du
52 days; JJ B-NP I-du
52 ampicillin NN I-NP B-m
52 2 CD O B-do
52 gm NN B-NP I-do
52 IV NNP I-NP B-mo
52 q VBZ O B-f
52 6 CD O I-f
52 ( ( O O
52 24 CD O O
52 of IN B-VP O
52 June NNP B-NP O
52 equals NNS I-NP O
52 day NN I-NP O
52 number NN I-NP O
53 five CD O O
53 ); JJ B-NP O
53 Halcion NN I-NP B-m
53 0.125 CD O B-do
53 p.o NN B-NP B-mo
53 q.h.s NN I-NP B-f
53 prn; NN I-NP I-f
53 Serax NNP I-NP B-m
53 15 CD O B-do
53 mg NN B-NP I-do
53 p.o NN I-NP B-mo
53 q VBD B-VP B-f
53 6 CD O O
53 hours NNS B-NP O
54 prn JJ B-NP O
55 HOSPITAL NNP I-NP O
55 COURSE: NNP I-NP O
55 1 CD O O
55 Transplant NNP B-NP O
55 Listing: NNP I-NP O
55 The DT B-NP O
55 patient NN I-NP O
55 has VBZ O O
56 been VBN O O
56 listed VBN O O
56 for IN B-VP O
56 cardiac JJ B-NP O
56 transplant NN I-NP O
56 , , O O
57 has VBZ O O
57 had VBN O O
57 all PDT O O
57 the DT B-NP O
57 necessary JJ I-NP O
57 preoperative JJ I-NP O
57 workup NN I-NP O
57 including VBG O O
57 pulmonary JJ B-NP O
58 function NN I-NP O
58 tests NNS I-NP O
58 and CC O O
58 tissue NN B-NP O
58 typing NN I-NP O
58 Should MD O O
58 a DT B-NP O
58 heart NN I-NP O
58 become VBN O O
58 avail- JJ O O
59 able JJ O O
59 , , O O
59 he PRP O O
59 could MD O O
59 be VB O O
59 Medivacked VBN O O
59 back RB O O
59 to TO O O
59 the DT B-NP O
59 Peters NNP I-NP O
59 Of IN B-VP O
59 for IN B-VP O
59 surgery NN B-NP O
60 The DT B-NP O
60 patient's JJ I-NP O
60 hospital NN I-NP O
60 course NN I-NP O
60 was VBD B-VP O
60 significant JJ O O
60 for IN B-VP O
60 the DT B-NP O
60 following JJ I-NP O
61 workup: NN I-NP O
61 He PRP O O
61 had VBD B-VP O
61 a DT B-NP O
61 catheterization NN I-NP O
61 15 CD O O
61 of IN B-VP O
61 October NNP B-NP O
61 , , O O
61 which WDT O O
61 showed VBD B-VP O
61 patent NN B-NP O
62 grafts NNS I-NP O
62 and CC O O
62 occluded VBD B-VP O
62 native JJ O O
62 left VBD B-VP O
62 anterior JJ B-NP O
62 descending NN I-NP O
62 and CC O O
62 obtuse IN B-VP O
63 marginal JJ B-NP O
63 branch NN I-NP O
63 An DT B-NP O
63 echocardiogram NN I-NP O
63 on IN B-VP O
63 28 CD O O
63 of IN B-VP O
63 June NNP B-NP O
63 showed VBD B-VP O
63 mitral JJ B-NP O
63 regurg- JJ I-NP O
64 itation NN I-NP O
64 , , O O
64 an DT B-NP O
64 ejection NN I-NP O
64 fraction NN I-NP O
64 of IN B-VP O
64 less JJR O O
64 than IN B-VP O
64 20% CD O O
64 , , O O
64 and CC O O
64 no DT B-NP O
64 vegeta- JJ I-NP O
65 tions NNS I-NP O
65 on IN B-VP O
65 the DT B-NP O
65 valve NN I-NP O
66 The DT B-NP O
66 patient's NN I-NP O
66 most RBS O O
66 significant JJ B-NP O
66 problem NN I-NP O
66 during IN B-VP O
66 his PRP$ O O
66 hospital JJ B-NP O
66 course NN I-NP O
67 included VBD B-VP O
67 temperatures NNS B-NP O
67 On IN B-VP O
67 1 CD O O
67 of IN B-VP O
67 May NNP B-NP O
67 , , O O
67 he PRP O O
67 had VBD B-VP O
67 an DT O O
67 increased VBN O O
67 temperature NN B-NP O
68 to TO O O
68 101 CD O O
68 and CC O O
68 increased VBD B-VP O
68 white JJ B-NP O
68 count NN I-NP O
68 with IN B-VP O
68 left JJ B-NP O
68 shift NN I-NP O
68 His PRP$ O O
68 central JJ B-NP O
69 line NN I-NP O
69 was VBD B-VP O
69 pulled VBN O O
69 , , O O
69 and CC O O
69 the DT B-NP O
69 tip NN I-NP O
69 grew VBD B-VP O
69 gram JJ B-NP O
69 positive JJ I-NP O
69 cocci NN I-NP O
69 The DT B-NP O
70 patient NN I-NP O
70 also RB O O
70 grew VBD B-VP O
70 gram JJ B-NP B-r
70 positive JJ I-NP I-r
70 cocci NN I-NP I-r
70 from IN B-VP O
70 two CD O O
70 blood NN B-NP O
70 cultures NNS I-NP O
71 He PRP O O
71 was VBD B-VP O
71 started VBN O O
71 on IN B-VP O
71 vancomycin NN B-NP B-m
71 and CC O O
71 defervesced VBN O O
71 , , O O
71 and CC O O
71 has VBZ O O
71 been VBN O O
72 afebrile RB O O
72 for IN B-VP O
72 four CD O O
72 days NNS B-NP O
73 Subsequently RB O O
73 , , O O
73 the DT B-NP O
73 patient NN I-NP O
73 again RB O O
73 became VBD B-VP O
73 febrile JJ O O
73 approximately RB O O
73 one CD O O
74 week NN B-NP O
74 into IN B-VP O
74 his PRP$ O O
74 vancomycin JJ B-NP B-m
74 course NN I-NP O
74 At IN B-VP O
74 this DT B-NP O
74 point NN I-NP O
74 he PRP O O
74 was VBD B-VP O
74 recul- JJ O O
75 tured JJ O O
75 , , O O
75 and CC O O
75 those DT B-NP O
75 cultures NNS I-NP O
75 grew VBD B-VP O
75 gram JJ B-NP O
75 negative JJ I-NP O
75 rods NNS I-NP O
75 in IN B-VP O
75 one CD O O
75 out IN B-VP O
75 of IN B-VP O
76 four CD O O
76 blood NN B-NP O
76 culture NN I-NP O
76 specimens VBZ O O
76 These DT O O
76 were VBD B-VP O
76 gram NNS B-NP B-r
76 negative JJ B-NP O
76 enteric JJ I-NP O
77 rods NNS I-NP O
77 , , O O
77 pan-sensitive JJ O O
77 , , O O
77 for IN B-VP O
77 which WDT O O
77 the DT B-NP O
77 patient NN I-NP O
77 was VBD B-VP O
77 started VBN O O
77 on IN B-VP O
78 ampicillin NN B-NP B-m
78 2 CD O B-do
78 gm NN B-NP I-do
78 IV NNP I-NP B-mo
78 q RB O B-f
78 6 CD O I-f
78 This DT O O
78 was VBD B-VP O
78 felt VBN O O
78 most JJS O O
78 likely JJ O O
78 secondary JJ O O
78 to TO O O
79 a DT B-NP O
79 urinary JJ I-NP O
79 tract NN I-NP O
79 infection NN I-NP O
79 from IN B-VP O
79 the DT B-NP O
79 Foley NNP I-NP O
79 catheter NN I-NP O
79 , , O O
79 which WDT O O
79 has VBZ O O
79 been VBN O O
80 discontinued VBN O O
81 At IN B-VP O
81 the DT B-NP O
81 time NN I-NP O
81 of IN B-VP O
81 discharge NN B-NP O
81 , , O O
81 the DT B-NP O
81 patient NN I-NP O
81 is VBZ O O
81 stable JJ O O
81 , , O O
81 dobutamine JJ B-NP B-m
82 dependent NN I-NP O
82 , , O O
82 without IN B-VP O
82 chest NN B-NP O
82 pain NN I-NP O
82 , , O O
82 able JJ O O
82 to TO O O
82 ambulate VB O O
82 from IN B-VP O
82 chair NN B-NP O
82 to TO O O
83 commode VB O O
83 without IN B-VP O
83 shortness NN B-NP O
83 of IN B-VP O
83 breath NN B-NP O
83 , , O O
83 palpitations NNS B-NP O
83 , , O O
83 or CC O O
83 light- JJ B-NP O
84 headedness NN I-NP O
84 He PRP O O
84 is VBZ O O
84 eager JJ O O
84 to TO O O
84 be VB O O
84 transferred VBN O O
84 back RB O O
84 to TO O O
84 the DT B-NP O
84 Ston NNP I-NP O
84 area NN I-NP O
84 to TO O O
84 await VB O O
84 heart NN B-NP O
84 transplant NN I-NP O
85 With IN B-VP O
85 any DT B-NP O
85 questions NNS I-NP O
85 , , O O
85 please VB O O
85 contact JJ B-NP O
85 Doctor NNP I-NP O
85 Wilmer NNP I-NP O
85 Priore NNP I-NP O
85 Tucap NNP I-NP O
85 Anathens NNP I-NP O
85 Sol NNP I-NP O
85 Health NNP I-NP O
85 Services NNP I-NP O
85 265-8948 CD O O
85 , , O O
85 beeper IN B-VP O
85 number NN B-NP O
85 7217 CD O O
85 , , O O
85 the DT B-NP O
85 patient's NN I-NP O
86 medical JJ O O
86 intern VBZ O O
87 The DT B-NP O
87 patient's JJ I-NP O
87 condition NN I-NP O
87 at IN B-VP O
87 time NN B-NP O
87 of IN B-VP O
87 discharge NN B-NP O
87 is VBZ O O
87 fair JJ B-NP O
88 DISPOSITION: NNP I-NP O
88 Continuing NNP I-NP O
88 care NN I-NP O
88 in IN B-VP O
88 the DT B-NP O
88 coronary JJ I-NP O
88 care NN I-NP O
89 unit NN I-NP O
89 of IN B-VP O
89 the DT B-NP O
89 hospital NN I-NP O
89 inpatient NN I-NP O
89 near IN B-VP O
90 patient's NN B-NP O
90 home NN I-NP O
90 The DT B-NP O
90 patient NN I-NP O
90 will MD O O
90 be VB O O
90 under IN B-VP O
90 the DT B-NP O
90 care NN I-NP O
90 of IN B-VP O
90 a DT B-NP O
90 Doctor NNP I-NP O
91 Daren NNP I-NP O
91 Swasey NNP I-NP O
92 Dictated NNP I-NP O
92 By: NNP I-NP O
92 JESS NNP I-NP O
92 HESSER NNP I-NP O
92 , , O O
92 M.D NNP B-NP O
92 MI73 NNP I-NP O
93 AM887/4014 NNP I-NP O
94 MCKINLEY NNP I-NP O
94 STACEY NNP I-NP O
94 DILLOW NNP I-NP O
94 , , O O
94 M.D NNP B-NP O
94 JR4 NNP I-NP O
94 D: NNP I-NP O
94 3/22/91 CD O O
95 T: NNP B-NP O
95 3/22/91 CD O O
96 Batch: NNP B-NP O
96 O270 NNP I-NP O
96 Report: NNP I-NP O
96 KH817R19 NNP I-NP O
96 T: NNP I-NP O
97 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #718365 VBZ O O
4 593085640 CD O O
4 BAH NNP B-NP O
4 60698702 CD O O
4 952684 CD O O
4 0/12/1998 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 FAILED NNP I-NP O
4 RT NNP I-NP O
4 TOTAL NNP I-NP O
4 HIP NNP I-NP O
4 REPLACEMENT NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/13/1998 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/22/1998 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 FAILED NNP I-NP O
7 HEMIARTHROPLASTY NNP I-NP O
7 , , O O
7 RIGHT NNP B-NP O
7 HIP NNP I-NP O
8 PRINCIPAL NNP I-NP O
8 PROCEDURE: NNP I-NP O
8 CONVERSION NNP I-NP O
8 OF NNP I-NP O
8 HEMIARTHROPLASTY NNP I-NP O
8 TO NNP I-NP O
8 TOTAL NNP I-NP O
9 HIP NNP I-NP O
9 REPLACEMENT NNP I-NP O
9 OF NNP I-NP O
9 RIGHT NNP I-NP O
9 HIP NNP I-NP O
10 HISTORY NNP I-NP O
10 OF NNP I-NP O
10 PRESENT NNP I-NP O
10 ILLNESS: NNP I-NP O
10 This DT B-NP O
10 63-year-old JJ I-NP O
10 female NN I-NP O
10 is VBZ O O
10 status NN B-NP O
11 post NN I-NP O
11 right RB O O
11 bipolar JJ B-NP O
11 hemiarthroplasty NN I-NP O
12 in IN B-VP O
12 1992 CD O O
12 The DT B-NP O
12 patient NN I-NP O
12 has VBZ O O
12 a DT B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 arteriovenous JJ B-NP O
12 malformation NN I-NP O
13 The DT B-NP O
13 patient NN I-NP O
13 did VBD B-VP O
13 well RB O O
13 until IN B-VP O
13 9 CD O O
13 of IN B-VP O
13 February NNP B-NP O
13 when WRB O O
13 she PRP O O
13 heard VBD B-VP O
13 a DT B-NP O
13 large JJ I-NP O
13 noise NN I-NP O
13 with IN B-VP O
14 the DT B-NP O
14 feeling NN I-NP O
14 of IN B-VP O
14 increased JJ B-NP O
14 pain NN I-NP O
14 in IN B-VP O
14 the DT B-NP O
14 right JJ I-NP O
14 hip NN I-NP O
14 The DT B-NP O
14 patient NN I-NP O
15 underwent NN I-NP O
15 a DT B-NP O
15 closed JJ I-NP O
15 reduction NN I-NP O
15 in IN B-VP O
15 the DT B-NP O
15 emergency NN I-NP O
15 room NN I-NP O
15 and CC O O
15 was VBD B-VP O
16 subsequently RB O O
16 discharged VBN O O
16 with IN B-VP O
16 a DT B-NP O
16 hip NN I-NP O
16 abduction NN I-NP O
16 arthrosis IN B-VP O
16 The DT B-NP O
17 patient NN I-NP O
17 presents NNS I-NP O
17 , , O O
17 however RB O O
17 , , O O
17 here RB O O
17 for IN B-VP O
17 conversion NN B-NP O
17 of IN B-VP O
17 her PRP$ O O
17 right JJ B-NP O
17 bipolar NN I-NP O
18 to TO O O
18 a DT B-NP O
18 right JJ I-NP O
18 total NN I-NP O
18 hip NN I-NP O
18 replacement NN I-NP O
19 PAST NNP I-NP O
19 SURGICAL NNP I-NP O
19 HISTORY: NNP I-NP O
19 Status NNP I-NP O
19 post NN I-NP O
19 cholecystectomy NN I-NP O
19 Status NNP I-NP O
20 post NN I-NP O
20 bipolar NN I-NP O
20 hemiarthroplasty NN I-NP O
20 in IN B-VP O
20 1992 CD O O
21 Status NNP B-NP O
21 post NN I-NP O
21 breast NN I-NP O
21 reduction NN I-NP O
21 Status NNP I-NP O
21 post NN I-NP O
21 left VBD B-VP O
21 hip JJ B-NP O
21 revision NN I-NP O
21 in IN B-VP O
22 1993 CD O O
22 of IN B-VP O
22 the DT B-NP O
22 femoral JJ I-NP O
22 component NN I-NP O
22 of IN B-VP O
22 the DT B-NP O
22 left JJ I-NP O
22 hip NN I-NP O
22 Status NNP I-NP O
22 post NN I-NP O
22 left VBD B-VP O
23 femoral JJ B-NP O
23 nerve NN I-NP O
23 exploration NN I-NP O
23 in IN B-VP O
23 1993 CD O O
23 Status NNP B-NP O
23 post NN I-NP O
23 right RB O O
23 total JJ B-NP O
23 knee JJ I-NP O
24 replacement NN I-NP O
24 in IN B-VP O
24 1997 CD O O
25 ALLERGIES: NNP B-NP O
25 With IN B-VP O
25 penicillin NN B-NP O
25 she PRP O O
25 gets VBZ O O
25 hives NNS B-NP O
26 MEDICATIONS: NNP I-NP O
26 None NNP I-NP O
27 HABITS: NNP I-NP O
27 No NNP I-NP O
27 tobacco NN I-NP O
27 , , O O
27 no DT B-NP O
27 alcohol NN I-NP O
28 HOSPITAL NNP I-NP O
28 COURSE: NNP I-NP O
28 The DT B-NP O
28 patient NN I-NP O
28 tolerated VBD B-VP O
28 the DT B-NP O
28 procedure NN I-NP O
28 well RB O O
28 and CC O O
29 was VBD B-VP O
29 transferred VBN O O
29 to TO O O
29 the DT B-NP O
29 Orthopaedic NNP I-NP O
29 Floor NNP I-NP O
30 postoperatively RB O O
30 for IN B-VP O
30 pain NN B-NP O
30 control NN I-NP O
30 and CC O O
30 for IN B-VP O
30 physical JJ B-NP O
30 therapy NN I-NP O
30 The DT B-NP O
31 patient NN I-NP O
31 rapidly RB O O
31 progressed VBD B-VP O
31 over IN B-VP O
31 the DT B-NP O
31 next JJ I-NP O
31 several JJ I-NP O
31 days NNS I-NP O
31 and CC O O
31 did VBD B-VP O
31 quite RB O O
32 well RB O O
32 She PRP O O
32 was VBD B-VP O
32 ambulating VBG O O
32 with IN B-VP O
32 assistance NN B-NP O
32 , , O O
32 partial JJ O O
32 weightbearing VBG O O
33 with IN B-VP O
33 physical JJ B-NP O
33 therapy NN I-NP O
33 without IN B-VP O
33 difficulty NN B-NP O
33 Her PRP$ O O
33 wound NN B-NP O
33 is VBZ O O
33 clean JJ O O
33 , , O O
33 dry JJ O O
33 , , O O
34 and CC O O
34 intact JJ O O
34 with IN B-VP O
34 minimal JJ B-NP O
34 drainage NN I-NP O
34 from IN B-VP O
34 the DT B-NP O
34 old JJ I-NP O
34 drain NN I-NP O
34 site NN I-NP O
34 She PRP O O
34 was VBD B-VP O
35 afebrile RB O O
35 throughout IN B-VP O
35 her PRP$ O O
35 hospital JJ B-NP O
35 course NN I-NP O
35 and CC O O
35 required VBD B-VP O
35 one CD O B-do
35 unit NN B-NP I-do
35 of IN B-VP O
36 blood NN B-NP B-m
36 during IN B-VP O
36 her PRP$ O O
36 hospital JJ B-NP O
36 course NN I-NP O
36 to TO O O
36 maintain VB O O
36 her PRP$ O O
36 blood NN B-NP O
36 count NN I-NP O
37 greater JJR O O
37 than IN B-VP O
37 30 CD O O
37 She PRP O O
37 otherwise RB O O
37 did VBD B-VP O
37 remarkably RB O O
37 well RB O O
37 and CC O O
37 was VBD B-VP O
37 quite RB O O
38 comfortable JJ O O
38 prior JJ O O
38 to TO O O
38 discharge VB O O
39 Her NNP B-NP O
39 discharge NN I-NP O
39 medications NNS I-NP O
39 were VBD B-VP O
39 Percocet NNP B-NP B-m
39 1-2 JJ B-NP B-do
39 tabs NNS I-NP I-do
39 p.o JJ B-NP B-mo
39 q JJ I-NP B-f
39 4-6 JJ I-NP I-f
39 p.r.n NN I-NP I-f
40 She PRP O O
40 was VBD B-VP O
40 also RB O O
40 discharged VBN O O
40 on IN B-VP O
40 Coumadin NNP B-NP B-m
40 3.5 CD O B-do
40 mg NN B-NP I-do
40 p.o NN I-NP B-mo
40 q JJ B-NP B-f
40 day NN I-NP I-f
40 and CC O O
40 should MD O O
41 maintain VB O O
41 Coumadin NNP B-NP B-m
41 therapy NN I-NP O
41 for IN B-VP B-du
41 for IN B-VP B-du
41 six CD O I-du
41 six CD O I-du
41 weeks NNS B-NP I-du
41 weeks NNS I-NP I-du
41 time NN I-NP O
41 The DT B-NP O
41 patient NN I-NP O
41 should MD O O
42 have VB O O
42 a DT B-NP O
42 prothrombin JJ I-NP O
42 time NN I-NP O
42 checked VBD B-VP O
42 biweekly RB O O
42 to TO O O
42 maintain VB O O
42 an DT B-NP O
42 INR NNP I-NP O
42 between IN B-VP O
43 14 CD O O
43 and CC O O
43 17 CD O O
43 She PRP O O
43 otherwise RB O O
43 did VBD B-VP O
43 quite RB O O
43 well RB O O
43 and CC O O
43 we PRP O O
43 are VBP O O
43 quite RB O O
43 pleased JJ O O
44 with IN B-VP O
44 her PRP$ O O
44 progress NN B-NP O
44 We PRP O O
44 will MD O O
44 see VB O O
44 her PRP$ O O
44 back NN B-NP O
44 in IN B-VP O
44 the DT B-NP O
44 office NN I-NP O
44 in IN B-VP O
44 six CD O O
44 weeks NNS B-NP O
45 time NN I-NP O
45 for IN B-VP O
45 x-rays NNS B-NP O
45 and CC O O
45 follow-up NN B-NP O
46 Dictated NNP I-NP O
46 By: NNP I-NP O
46 JEFFRY NNP I-NP O
46 CYBULSKI NNP I-NP O
46 , , O O
46 M.D NNP B-NP O
46 MW86 NNP I-NP O
47 Attending: NNP I-NP O
47 JAMIE NNP I-NP O
47 T NNP I-NP O
47 PERMAN NNP I-NP O
47 , , O O
47 M.D NNP B-NP O
47 EZ96 NNP I-NP O
47 LT842/4419 NNP I-NP O
48 Batch: NNP I-NP O
48 8644 CD O O
48 Index NNP B-NP O
48 No NNP I-NP O
48 ATHCND8508 NNP I-NP O
48 D: NNP I-NP O
48 4/29/98 CD O O
49 T: NNP B-NP O
49 4/29/98 CD O O
50 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #723978 VBZ O O
2 342590615 CD O O
2 RHC NNP B-NP O
2 47454253 CD O O
2 5842115 CD O O
2 1/4/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 pneumonia NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/15/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/18/2004 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 STETTLER NNP I-NP O
5 , , O O
5 HAL NNP B-NP O
5 223-66-98-9 CD O O
6 Well NNP B-NP O
6 Spo NNP I-NP O
6 Uxsmouth NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 1/29/04 CD O O
8 AT NNP B-NP O
8 05:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Attending NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 KOLKMAN NNP I-NP O
11 , , O O
11 ISIDRO NNP B-NP O
11 S NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 AMIODARONE NNP I-NP B-m
16 200 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 Override NNP I-NP O
17 Notice: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 2/19/04 CD O O
17 by IN B-VP O
18 MCCRABB NNP B-NP O
18 , , O O
18 FREDDY NNP B-NP O
18 A NNP I-NP O
18 , , O O
18 M.D NNP B-NP O
18 , , O O
18 PH.D NNP B-NP O
19 on IN B-VP O
19 order NN B-NP O
19 for IN B-VP O
19 COUMADIN NNP B-NP B-m
19 PO NNP I-NP B-mo
19 ( ( O O
19 ref JJ O O
19 # # O O
19 17623917 CD O O
19 ) ) O O
20 POTENTIALLY NNP B-NP O
20 SERIOUS NNP I-NP O
20 INTERACTION: NNP I-NP O
20 AMIODARONE NNP I-NP B-m
20 HCL NNP I-NP I-m
20 &amp; NNP I-NP O
20 WARFARIN NNP I-NP B-m
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: NN B-NP O
21 monitioring VBG O O
22 Previous NNP B-NP O
22 override IN B-VP O
22 information: JJ B-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 2/19/04 CD O O
23 by IN B-VP O
23 STOCKBRIDGE NNP B-NP O
23 , , O O
23 TRENT NNP B-NP O
23 A NNP I-NP O
23 , , O O
23 M.D NNP B-NP O
23 , , O O
23 PH.D NNP B-NP O
24 on IN B-VP O
24 order NN B-NP O
24 for IN B-VP O
24 COUMADIN NNP B-NP B-m
24 PO NNP I-NP B-mo
24 ( ( O O
24 ref JJ O O
24 # # O O
24 70172290 CD O O
24 ) ) O O
25 POTENTIALLY NNP B-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 AMIODARONE NNP I-NP B-m
25 HCL NNP I-NP I-m
25 &amp; NNP I-NP O
25 WARFARIN NNP I-NP B-m
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 monitoring NN I-NP O
27 Previous NNP I-NP O
27 override IN B-VP O
27 information: JJ B-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 2/19/04 CD O O
28 by IN B-VP O
28 SCHWEINER NNP B-NP O
28 , , O O
28 MICHAL NNP B-NP O
28 H NNP I-NP O
28 , , O O
28 M.D NNP B-NP O
28 , , O O
28 PH.D NNP B-NP O
29 POTENTIALLY NNP I-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 LEVOFLOXACIN NNP I-NP B-m
29 &amp; NNP I-NP O
29 AMIODARONE NNP I-NP B-m
30 HCL NNP I-NP O
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 monitoring NN I-NP O
31 GLIPIZIDE NNP I-NP B-m
31 2.5 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 Alert NNP I-NP O
32 overridden: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 2/19/04 CD O O
32 by IN B-VP O
33 SAGUIL NNP B-NP O
33 , , O O
33 CLAYTON NNP B-NP O
33 M NNP I-NP O
33 , , O O
33 M.D NNP B-NP O
33 , , O O
33 PH.D NNP B-NP O
34 POSSIBLE NNP I-NP O
34 ALLERGY NNP I-NP O
34 ( ( O O
34 OR NNP B-NP O
34 SENSITIVITY NNP I-NP O
34 ) ) O O
34 to TO O O
34 SULFA NNP B-NP O
35 Reason NNP I-NP O
35 for IN B-VP O
35 override: NN B-NP O
35 tolerates NNS I-NP O
35 glyburide VBP O B-m
35 at IN B-VP O
35 home NN B-NP O
36 Previous NNP I-NP O
36 Alert NNP I-NP O
36 overridden NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 2/19/04 CD O O
37 by IN B-VP O
37 HOBEREK NNP B-NP O
37 , , O O
37 JEWELL NNP B-NP O
37 A NNP I-NP O
37 , , O O
37 M.D NNP B-NP O
37 , , O O
37 PH.D NNP B-NP O
38 POSSIBLE NNP I-NP O
38 ALLERGY NNP I-NP O
38 ( ( O O
38 OR NNP B-NP O
38 SENSITIVITY NNP I-NP O
38 ) ) O O
38 to TO O O
38 SULFA NNP B-NP O
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: NN B-NP O
39 tolerates NNS I-NP O
39 at IN B-VP O
39 home NN B-NP O
40 GUAIFENESIN NNP I-NP B-m
40 10 CD O B-do
40 MILLILITERS NNP B-NP I-do
40 PO NNP I-NP B-mo
40 Q6H NNP I-NP O
40 Starting VBG O O
40 Today NNP B-NP O
40 ( ( O O
40 2/12 CD O O
40 ) ) O O
41 PRN NNP B-NP O
41 Other:cough NNP I-NP B-r
42 ISORDIL NNP I-NP B-m
42 ( ( O I-m
42 ISOSORBIDE NNP B-NP I-m
42 DINITRATE NNP I-NP I-m
42 ) ) O I-m
42 20 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 TID NNP I-NP B-f
43 HOLD NNP I-NP O
43 IF: NNP I-NP O
43 sbp&lt;110 NN I-NP O
43 , , O O
43 call VB O O
43 ho NN B-NP O
43 if IN B-VP O
43 holding VBG O O
44 SARNA NNP B-NP B-m
44 TOPICAL NNP I-NP B-mo
44 TP NNP I-NP I-mo
44 QD NNP I-NP B-f
44 Instructions: NNP I-NP O
44 to TO O O
44 lower VB O O
44 extremities NNS B-NP O
45 COUMADIN NNP I-NP B-m
45 COUMADIN NNP I-NP B-m
45 ( ( O I-m
45 ( ( O I-m
45 WARFARIN NNP B-NP I-m
45 WARFARIN NNP I-NP I-m
45 SODIUM NNP I-NP I-m
45 SODIUM NNP I-NP I-m
45 ) ) O I-m
45 ) ) O I-m
45 2.5 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 PO NNP I-NP B-mo
45 QOD NNP I-NP B-f
46 Starting VBG O O
46 Today NNP B-NP O
46 ( ( O O
46 2/12 CD O O
46 ) ) O O
47 Instructions: NNP B-NP O
47 alternating VBG O O
47 with IN B-VP O
47 5mg CD O B-do
47 qod NNS B-NP B-f
48 Food/Drug NNP I-NP O
48 Interaction NNP I-NP O
48 Instruction NNP I-NP O
49 No NNP I-NP O
49 high JJ B-NP O
49 Vitamin-K NNP I-NP O
49 containing VBG O O
49 foods NNS B-NP O
50 Alert NNP I-NP O
50 overridden: VBD B-VP O
50 Override NNP B-NP O
50 added VBD B-VP O
50 on IN B-VP O
50 2/19/04 CD O O
50 by IN B-VP O
51 DERENTIS NNP B-NP O
51 , , O O
51 EDUARDO NNP B-NP O
51 A NNP I-NP O
51 , , O O
51 M.D NNP B-NP O
51 , , O O
51 PH.D NNP B-NP O
52 POTENTIALLY NNP I-NP O
52 SERIOUS NNP I-NP O
52 INTERACTION: NNP I-NP O
52 LEVOFLOXACIN NNP I-NP B-m
52 &amp; NNP I-NP O
52 WARFARIN NNP I-NP B-m
53 POTENTIALLY NNP I-NP O
53 SERIOUS NNP I-NP O
53 INTERACTION: NNP I-NP O
53 LEVOFLOXACIN NNP I-NP B-m
53 &amp; NNP I-NP O
53 WARFARIN NNP I-NP B-m
54 POTENTIALLY NNP I-NP O
54 SERIOUS NNP I-NP O
54 INTERACTION: NNP I-NP O
54 AMIODARONE NNP I-NP B-m
54 HCL NNP I-NP I-m
54 &amp; NNP I-NP O
54 WARFARIN NNP I-NP B-m
55 Reason NNP I-NP O
55 for IN B-VP O
55 override: NN B-NP O
55 monitoring NN I-NP O
56 HYDROCORTISONE NNP I-NP B-m
56 1% CD O I-m
56 -TOPICAL NNP B-NP I-m
56 CREAM NNP I-NP I-m
56 TP NNP I-NP B-mo
56 BID NNP I-NP B-f
57 Instructions: NNP I-NP O
57 to TO O O
57 R NNP B-NP B-r
57 elbow NN I-NP I-r
57 eczema NN I-NP I-r
58 LEVOFLOXACIN NNP I-NP B-m
58 250 CD O B-do
58 MG NNP B-NP I-do
58 PO NNP I-NP B-mo
58 QD NNP I-NP B-f
58 Starting NNP I-NP O
58 IN NNP I-NP O
58 AM NNP I-NP O
58 ( ( O O
58 3/0 CD O O
58 ) ) O O
59 Food/Drug NNP B-NP O
59 Interaction NNP I-NP O
59 Instruction NNP I-NP O
60 Administer NNP I-NP O
60 iron NN I-NP B-m
60 products NNS I-NP I-m
60 a DT B-NP O
60 minimum NN I-NP O
60 of IN B-VP O
60 2 CD O O
60 hours NNS B-NP O
60 before IN B-VP O
60 or CC O O
61 after IN B-VP O
61 a DT B-NP O
61 levofloxacin NN I-NP B-m
61 or CC O O
61 ciprofloxacin NN B-NP B-m
61 dose VBP O O
61 dose JJ O O
62 If IN B-VP O
62 on IN B-VP O
62 tube NN B-NP O
62 feeds NNS I-NP O
62 , , O O
62 please VB O O
62 cycle NN B-NP O
62 ( ( O O
62 hold VB O O
62 1 CD O O
62 hr NN B-NP O
62 before IN B-VP O
62 to TO O O
62 2 CD O O
62 hr NNS B-NP O
63 after IN B-VP O
63 ) ) O O
63 Take VBP O O
63 2 CD O O
63 hours NNS B-NP O
63 before IN B-VP O
63 or CC O O
63 2 CD O O
63 hours NNS B-NP O
63 after IN B-VP O
63 dairy NN B-NP O
63 products NNS I-NP O
64 Override NNP I-NP O
64 Notice: NNP I-NP O
64 Override NNP I-NP O
64 added VBD B-VP O
64 on IN B-VP O
64 2/19/04 CD O O
64 by IN B-VP O
65 DADLANI NNP B-NP O
65 , , O O
65 DANNY NNP B-NP O
65 L NNP I-NP O
65 , , O O
65 M.D NNP B-NP O
65 , , O O
65 PH.D NNP B-NP O
66 on IN B-VP O
66 order NN B-NP O
66 for IN B-VP O
66 COUMADIN NNP B-NP B-m
66 PO NNP I-NP B-mo
66 ( ( O O
66 ref JJ O O
66 # # O O
66 17623917 CD O O
66 ) ) O O
67 POTENTIALLY NNP B-NP O
67 SERIOUS NNP I-NP O
67 INTERACTION: NNP I-NP O
67 LEVOFLOXACIN NNP I-NP B-m
67 &amp; NNP I-NP O
67 WARFARIN NNP I-NP B-m
68 POTENTIALLY NNP I-NP O
68 SERIOUS NNP I-NP O
68 INTERACTION: NNP I-NP O
68 LEVOFLOXACIN NNP I-NP B-m
68 &amp; NNP I-NP O
68 WARFARIN NNP I-NP B-m
69 Reason NNP I-NP O
69 for IN B-VP O
69 override: NN B-NP O
69 monitioring VBG O O
70 Previous NNP B-NP O
70 override IN B-VP O
70 information: JJ B-NP O
71 Override NNP I-NP O
71 added VBD B-VP O
71 on IN B-VP O
71 2/19/04 CD O O
71 by IN B-VP O
71 WANDS NNP B-NP O
71 , , O O
71 TREY NNP B-NP O
71 V NNP I-NP O
71 , , O O
71 M.D NNP B-NP O
71 , , O O
71 PH.D NNP B-NP O
72 on IN B-VP O
72 order NN B-NP O
72 for IN B-VP O
72 COUMADIN NNP B-NP B-m
72 PO NNP I-NP B-mo
72 ( ( O O
72 ref JJ O O
72 # # O O
72 70172290 CD O O
72 ) ) O O
73 POTENTIALLY NNP B-NP O
73 SERIOUS NNP I-NP O
73 INTERACTION: NNP I-NP O
73 LEVOFLOXACIN NNP I-NP B-m
73 &amp; NNP I-NP O
73 WARFARIN NNP I-NP B-m
74 POTENTIALLY NNP I-NP O
74 SERIOUS NNP I-NP O
74 INTERACTION: NNP I-NP O
74 LEVOFLOXACIN NNP I-NP B-m
74 &amp; NNP I-NP O
74 WARFARIN NNP I-NP B-m
75 Reason NNP I-NP O
75 for IN B-VP O
75 override: NN B-NP O
75 monitoring NN I-NP O
76 Previous NNP I-NP O
76 override IN B-VP O
76 information: JJ B-NP O
77 Override NNP I-NP O
77 added VBD B-VP O
77 on IN B-VP O
77 2/19/04 CD O O
77 by IN B-VP O
77 DUESTERBACK NNP B-NP O
77 , , O O
77 CARROL NNP B-NP O
77 M NNP I-NP O
77 , , O O
77 M.D NNP B-NP O
77 , , O O
77 PH.D NNP B-NP O
78 on IN B-VP O
78 order NN B-NP O
78 for IN B-VP O
78 AMIODARONE NNP B-NP B-m
78 PO NNP I-NP B-mo
78 ( ( O O
78 ref JJ O O
78 # # O O
78 76482971 CD O O
78 ) ) O O
79 POTENTIALLY NNP B-NP O
79 SERIOUS NNP I-NP O
79 INTERACTION: NNP I-NP O
79 LEVOFLOXACIN NNP I-NP B-m
79 &amp; NNP I-NP O
79 AMIODARONE NNP I-NP B-m
80 HCL NNP I-NP O
80 Reason NNP I-NP O
80 for IN B-VP O
80 override: NN B-NP O
80 monitoring NN I-NP O
81 NIZORAL NNP I-NP B-m
81 2% CD O O
81 SHAMPOO NNP B-NP O
81 ( ( O O
81 KETOCONAZOLE NNP B-NP O
81 2% CD O O
81 SHAMPOO NNP B-NP O
81 ) ) O O
82 TOPICAL NNP B-NP B-mo
82 TP NNP I-NP I-mo
82 tiweek VBD B-VP B-f
83 SYNALAR NNP B-NP B-m
83 0.025% CD O O
83 CREAM NNP B-NP O
83 ( ( O O
83 FLUOCINOLONE NNP B-NP O
83 0.025% CD O O
83 CREAM NNP B-NP O
83 ) ) O O
84 TOPICAL NNP B-NP B-mo
84 TP NNP I-NP I-mo
84 BID NNP I-NP B-f
84 Instructions: NNP I-NP O
84 ` `` O O
85 apply RB O O
85 below IN B-VP O
85 knees NNS B-NP O
85 on IN B-VP O
85 both DT B-NP O
85 legs JJ I-NP O
86 PLAQUENIL NNP I-NP B-m
86 ( ( O I-m
86 HYDROXYCHLOROQUINE NNP B-NP I-m
86 ) ) O I-m
86 200 CD O B-do
86 MG NNP B-NP I-do
86 PO NNP I-NP B-mo
86 BID NNP I-NP B-f
87 Food/Drug NNP I-NP O
87 Interaction NNP I-NP O
87 Instruction NNP I-NP O
87 Take NNP I-NP O
87 with IN B-VP O
87 food NN B-NP O
88 NORVASC NNP I-NP B-m
88 ( ( O I-m
88 AMLODIPINE NNP B-NP I-m
88 ) ) O I-m
88 10 CD O B-do
88 MG NNP B-NP I-do
88 PO NNP I-NP B-mo
88 QD NNP I-NP B-f
89 Food/Drug NNP I-NP O
89 Interaction NNP I-NP O
89 Instruction NNP I-NP O
90 Avoid NNP I-NP O
90 grapefruit NN I-NP O
90 unless IN B-VP O
90 MD NNP B-NP O
90 instructs NNS I-NP O
90 otherwise RB O O
91 DIET: NNP B-NP O
91 House NNP I-NP O
91 / NNP I-NP O
91 ADA NNP I-NP O
91 2100 CD O O
91 cals/dy NN B-NP O
92 DIET: NNP I-NP O
92 2 CD O O
92 gram NN B-NP O
92 Sodium NNP I-NP O
93 ACTIVITY: NNP I-NP O
93 Resume NNP I-NP O
93 regular JJ B-NP O
93 exercise NN I-NP O
94 FOLLOW NNP I-NP O
94 UP NNP I-NP O
94 APPOINTMENT( NNP I-NP O
94 S NNP I-NP O
94 ): NNP I-NP O
95 Dr NNP I-NP O
95 Freed NNP I-NP O
95 , , O O
95 Friday NNP B-NP O
95 August NNP I-NP O
95 10:30AM CD O O
95 scheduled VBN O O
95 , , O O
96 Arrange NNP B-NP O
96 INR NNP I-NP O
96 to TO O O
96 be VB O O
96 drawn VBN O O
96 on IN B-VP O
96 6/1 CD O O
96 with IN B-VP O
96 f/u JJ B-NP O
96 INR's NNP I-NP O
96 to TO O O
96 be VB O O
96 drawn VBN O O
96 every DT O O
97 3 CD O O
97 days NNS B-NP O
97 INR's NNP I-NP O
97 will MD O O
97 be VB O O
97 followed VBN O O
97 by IN B-VP O
97 Dewitt NNP B-NP O
97 Luckhardt NNP I-NP O
97 , , O O
97 388-436-1231 JJ B-NP O
98 ALLERGY: NNP I-NP O
98 Sotalol NNP I-NP O
98 , , O O
98 Procainamide NNP B-NP O
98 , , O O
98 Aspirin NNP B-NP O
98 , , O O
98 Penicillins NNP B-NP O
98 , , O O
98 Sulfa NNP B-NP O
98 , , O O
99 Quinaglute NNP B-NP O
99 , , O O
99 Asa NNP B-NP O
100 ADMIT NNP I-NP O
100 DIAGNOSIS: NNP I-NP O
101 pneumonia NN I-NP O
101 , , O O
101 transient JJ B-NP O
101 ischemic JJ I-NP O
101 attack NN I-NP O
101 vs NN I-NP O
101 exacerbation NN I-NP O
101 of IN B-VP O
101 underlying VBG O O
102 neurologic JJ B-NP O
102 deficits NNS I-NP O
103 PRINCIPAL NNP I-NP O
103 DISCHARGE NNP I-NP O
103 DIAGNOSIS NNP I-NP O
103 ;Responsible JJ O O
103 After IN B-VP O
103 Study NNP B-NP O
103 for IN B-VP O
103 Causing NNP B-NP O
103 Admission NNP I-NP O
103 ) ) O O
104 pneumonia VBZ O O
105 OTHER NNP B-NP O
105 DIAGNOSIS;Conditions NNP I-NP O
105 , , O O
105 Infections NNP B-NP O
105 , , O O
105 Complications NNP B-NP O
105 , , O O
105 affecting VBG O O
105 Treatment/Stay NNP B-NP O
106 HTN; NNP I-NP O
106 CHF;s/p NNP I-NP O
106 St NNP I-NP O
106 Jude NNP I-NP O
106 MVR NNP I-NP O
106 for IN B-VP O
106 MS NNP B-NP O
106 ( ( O O
106 S/P NNP B-NP O
106 cardiac VBP O O
106 valve FW O O
106 replacement NN B-NP O
106 ) ) O O
106 Hx NNP B-NP O
107 AFib/flutter NNP I-NP O
107 ( ( O O
107 H/O NNP B-NP O
107 atrial JJ B-NP O
107 fibrillation NN I-NP O
107 ) ) O O
107 s/p NN B-NP O
107 IMI NNP I-NP O
107 ( ( O O
107 S/P NNP B-NP O
107 myocardial NNP I-NP O
108 infarction NN I-NP O
108 ) ) O O
108 NIDDM NNP B-NP O
108 ( ( O O
108 diabetes VBZ O O
108 mellitus NN B-NP O
108 ) ) O O
108 gout NN B-NP O
108 ( ( O O
108 gout NN B-NP O
108 ) ) O O
108 Hx NNP B-NP O
108 DVT NNP I-NP O
108 '70 NNP I-NP O
108 ( ( O O
108 H/O NNP B-NP O
109 deep RB O O
109 venous JJ B-NP O
109 thrombosis NN I-NP O
109 ) ) O O
109 s/p NN B-NP O
109 appy JJ O O
109 ( ( O O
109 S/P NNP B-NP O
109 appendectomy RB O O
109 ) ) O O
109 s/p VB O O
109 umbilical JJ B-NP O
110 hernia NN I-NP O
110 repair NN I-NP O
110 ( ( O O
110 S/P NNP B-NP O
110 hernia NNP I-NP O
110 repair NN I-NP O
110 ) ) O O
110 s/p NN B-NP O
110 sigmoidectomy NN I-NP O
110 for IN B-VP O
111 diverticulitis NN B-NP O
111 s/p NN I-NP O
111 L NNP I-NP O
111 hip NN I-NP O
111 # # O O
111 '95 NNP B-NP O
111 ( ( O O
111 S/P NNP B-NP O
111 hip NN I-NP O
112 fracture NN I-NP O
112 ) ) O O
112 PE NNP B-NP O
112 ( ( O O
112 pulmonary JJ B-NP O
112 embolism NN I-NP O
112 ) ) O O
113 OPERATIONS NNP B-NP O
113 AND NNP I-NP O
113 PROCEDURES: NNP I-NP O
114 None NNP I-NP O
115 OTHER NNP I-NP O
115 TREATMENTS/PROCEDURES NNP I-NP O
115 ( ( O O
115 NOT NNP B-NP O
115 IN NNP I-NP O
115 O.R NNP I-NP O
115 ) ) O O
116 None NN B-NP O
117 BRIEF NNP I-NP O
117 RESUME NNP I-NP O
117 OF NNP I-NP O
117 HOSPITAL NNP I-NP O
117 COURSE: NNP I-NP O
118 Mrs NNP I-NP O
118 Marnett NNP I-NP O
118 is VBZ O O
118 an DT O O
118 81 CD O O
118 y.o NN B-NP O
118 woman NN I-NP O
118 who WP O O
118 presents VBZ O O
118 with IN B-VP O
118 one CD O O
118 day NN B-NP O
118 of IN B-VP O
119 chest NN B-NP O
119 pain NN I-NP O
119 , , O O
119 difficulty NN B-NP O
119 speaking NN I-NP O
119 , , O O
119 nausea NN B-NP O
119 , , O O
119 and CC O O
119 lightheadedness NN B-NP O
119 She PRP O O
119 had VBD B-VP O
120 URI NNP B-NP O
120 symptoms NNS I-NP O
120 about IN B-VP O
120 two CD O O
120 weeks NNS B-NP O
120 ago RB O O
120 and CC O O
120 then RB O O
120 5d CD O O
120 pta NN B-NP O
120 developed VBD B-VP O
120 minimal JJ B-NP O
121 ly JJ I-NP O
121 productive JJ I-NP O
121 cough NN I-NP O
121 and CC O O
121 then RB O O
121 SOB NNP B-NP O
121 for IN B-VP O
121 the DT B-NP O
121 past JJ I-NP O
121 2-3 JJ I-NP O
121 days NNS I-NP O
121 She PRP O O
121 denies VBZ O O
121 any DT B-NP O
122 noctural JJ I-NP O
122 dyspnea NN I-NP O
122 or CC O O
122 increase VB O O
122 in IN B-VP O
122 number NN B-NP O
122 of IN B-VP O
122 pillows NNS B-NP O
122 She PRP O O
122 lives VBZ O O
122 alone RB O O
122 , , O O
123 and CC O O
123 a DT B-NP O
123 reverend NN I-NP O
123 checks VBZ O O
123 up RP O O
123 on IN B-VP O
123 her PRP O O
123 daily; VBP O O
123 the DT B-NP O
123 day NN I-NP O
123 prior RB O O
123 to TO O O
123 admission NN B-NP O
123 he PRP O O
124 suggested VBD B-VP O
124 she PRP O O
124 go VB O O
124 to TO O O
124 the DT B-NP O
124 hospital NN I-NP O
124 She PRP O O
124 does VBZ O O
124 not RB O O
124 feel VB O O
124 that IN B-VP O
124 she PRP O O
124 had VBD B-VP O
124 any DT B-NP O
125 speech NN I-NP O
125 difficulties NNS I-NP O
125 at IN B-VP O
125 that DT B-NP O
125 time NN I-NP O
125 , , O O
125 but CC O O
125 when WRB O O
125 she PRP O O
125 awoke VBD B-VP O
125 she PRP O O
125 noted VBD B-VP O
126 heaviness NN B-NP O
126 of IN B-VP O
126 her PRP$ O O
126 tongue NN B-NP O
126 and CC O O
126 workd NN B-NP O
126 finding VBG O O
126 difficulties NNS B-NP O
126 In IN B-VP O
126 addition NN B-NP O
126 , , O O
126 she PRP O O
127 had VBD B-VP O
127 sweating VBG O O
127 and CC O O
127 chest JJS B-NP O
127 pain NN I-NP O
127 that WDT O O
127 radiated VBD B-VP O
127 to TO O O
127 her PRP$ O O
127 shoulder NN B-NP O
127 ( ( O O
127 L&gt;R NNP B-NP O
127 ) ) O O
127 , , O O
127 and CC O O
128 back RB O O
128 This DT O O
128 was VBD B-VP O
128 different JJ O O
128 than IN B-VP O
128 her PRP$ O O
128 usual JJ B-NP O
128 anginal JJ I-NP O
128 symptoms NNS I-NP O
128 ( ( O O
128 which WDT O O
128 do VBP O O
128 not RB O O
129 involve VB O O
129 back RB O O
129 radiation NN B-NP O
129 ) ) O O
129 The DT B-NP O
129 pain NN I-NP O
129 was VBD B-VP O
129 pleuritic JJ O O
129 in IN B-VP O
129 nature NN B-NP O
129 , , O O
129 and CC O O
129 she PRP O O
130 denied VBD B-VP O
130 palpitations NNS B-NP O
130 She PRP O O
130 also RB O O
130 noticed VBD B-VP O
130 nausea NN B-NP O
130 and CC O O
130 had VBD B-VP O
130 several JJ B-NP O
130 episodes NNS I-NP O
131 of IN B-VP O
131 dry JJ O O
131 heaving VBG O O
131 While IN B-VP O
131 leaving VBG O O
131 the DT B-NP O
131 bathroom NN I-NP O
131 she PRP O O
131 had VBD B-VP O
131 a DT B-NP O
131 single JJ I-NP O
131 episode NN I-NP O
131 of IN B-VP O
132 "lightheadness." NN B-NP O
132 This DT O O
132 did VBD B-VP O
132 not RB O O
132 involve VB O O
132 any DT B-NP O
132 sensation NN I-NP O
132 of IN B-VP O
132 vertigo NN B-NP O
132 , , O O
132 or CC O O
132 any DT B-NP O
133 vision NN I-NP O
133 changes NNS I-NP O
133 She PRP O O
133 sat VBD B-VP O
133 down RB O O
133 immediately RB O O
133 , , O O
133 and CC O O
133 felt VBD B-VP O
133 better RBR O O
133 within IN B-VP O
133 a DT B-NP O
133 few JJ I-NP O
134 seconds NNS I-NP O
134 There EX O O
134 was VBD B-VP O
134 no DT B-NP O
134 fall NN I-NP O
134 and CC O O
134 no DT B-NP O
134 LOC NNP I-NP O
134 Around IN B-VP O
134 8am CD O O
134 , , O O
134 her PRP$ O O
134 housekeeper NN B-NP O
135 came VBD B-VP O
135 , , O O
135 and CC O O
135 immediately RB O O
135 noticed VBD B-VP O
135 a DT B-NP O
135 change NN I-NP O
135 in IN B-VP O
135 Mrs NNP B-NP O
135 Cooney NNP I-NP O
135 's POS O O
135 voice NN B-NP O
135 Mrs NNP I-NP O
136 Solberg NNP I-NP O
136 describes VBZ O O
136 the DT B-NP O
136 change NN I-NP O
136 as IN B-VP O
136 a DT B-NP O
136 "thickening NN I-NP O
136 of IN B-VP O
136 my PRP$ O O
136 tongue" NN B-NP O
136 and CC O O
136 some DT B-NP O
137 problems NNS I-NP O
137 finding VBG O O
137 words NNS B-NP O
137 She PRP O O
137 has VBZ O O
137 been VBN O O
137 taking VBG O O
137 all DT O O
137 of IN B-VP O
137 her PRP$ O O
137 medications NNS B-NP O
137 as IN B-VP O
138 prescribed VBN O O
138 over IN B-VP O
138 the DT B-NP O
138 last JJ I-NP O
138 week NN I-NP O
139 ROS: NNP I-NP O
139 On IN B-VP O
139 arrival NN B-NP O
139 to TO O O
139 the DT B-NP O
139 floor NN I-NP O
139 , , O O
139 Mrs NNP B-NP O
139 Shoman NNP I-NP O
139 noted VBD B-VP O
139 a DT O O
139 raised VBN O O
139 , , O O
139 painful JJ B-NP O
140 area NN I-NP O
140 on IN B-VP O
140 her PRP$ O O
140 L NNP B-NP O
140 forearm NN I-NP O
140 She PRP O O
140 does VBZ O O
140 not RB O O
140 recall VB O O
140 any DT B-NP O
140 trauma NN I-NP O
140 to TO O O
140 the DT B-NP O
140 area NN I-NP O
140 She PRP O O
141 denies VBZ O O
141 any DT B-NP O
141 fever NN I-NP O
142 PMedHx: NNP I-NP O
143 1 CD O O
143 H/o NNP B-NP O
143 agina NN I-NP O
143 ( ( O O
143 a DT O O
143 ) ) O O
143 Echo NNP B-NP O
143 ( ( O O
143 1/29 CD O O
143 ) ) O O
143 , , O O
143 EF NNP B-NP O
143 55% CD O O
143 , , O O
143 abnormal JJ B-NP O
143 septal JJ I-NP O
143 motion NN I-NP O
143 , , O O
143 mild JJ B-NP O
143 AR NNP I-NP O
143 , , O O
144 no DT B-NP O
144 MR NNP I-NP O
144 ( ( O O
144 through IN B-VP O
144 mech NN B-NP O
144 valve NN I-NP O
144 ) ) O O
144 , , O O
144 mod JJ B-NP O
144 TR NNP I-NP O
144 ( ( O O
144 b NN B-NP O
144 ) ) O O
144 Holter $ O O
144 0/2 CD O O
144 - : O O
144 multiform NN B-NP O
144 VE NNP I-NP O
145 ( ( O O
145 bigem NN B-NP O
145 , , O O
145 cooup NN B-NP O
145 ) ) O O
145 , , O O
145 SVE's NNP B-NP O
145 1st CD O O
145 degree JJ B-NP O
145 A-V NNP I-NP O
145 block NN I-NP O
146 2 CD O O
146 D.M NNP B-NP O
146 AGA1c NNP I-NP O
146 6.1 CD O O
146 ( ( O O
146 6/17 CD O O
146 ) ) O O
147 3 CD O O
147 subacute JJ B-NP O
147 thalamic JJ I-NP O
147 stroke NN I-NP O
147 noted VBD B-VP O
147 on IN B-VP O
147 CT NNP B-NP O
147 1/29 CD O O
148 4 CD O O
148 Afib NNP B-NP B-r
148 - : O O
148 on IN B-VP O
148 coumadin NN B-NP B-m
149 5 CD O O
149 Mitral NNP B-NP O
149 stenosis NN I-NP O
149 - : O O
149 MVR NNP B-NP O
149 St NNP I-NP O
149 Jude NNP I-NP O
149 ( ( O O
149 4/27 CD O O
149 ) ) O O
150 6 CD O O
150 CHF NNP B-NP O
150 , , O O
150 admitted VBD B-VP O
150 many JJ B-NP O
150 times NNS I-NP O
150 , , O O
150 latest JJS O O
150 0/29 CD O O
151 7 CD O O
151 Restrictive JJ B-NP O
151 lung NN I-NP O
151 disease- JJ O O
151 5/23 CD O O
151 PFTs NNP B-NP O
151 FVC NNP I-NP O
151 1.33 CD O O
151 , , O O
151 FEV1 NNP B-NP O
151 0.98 CD O O
152 8 CD O O
152 Sigmoid NNP B-NP O
152 colostomy NN I-NP O
153 9 CD O O
153 Ventral NNP B-NP O
153 hernia NN I-NP O
153 repair NN I-NP O
154 10 CD O O
154 Bladder NNP B-NP O
154 calcifications NNS I-NP O
154 on IN B-VP O
154 CT NNP B-NP O
154 urogram NNP I-NP O
154 ( ( O O
154 1/29 CD O O
154 ) ) O O
154 - : O O
154 needs VBZ O O
154 cystoscopy JJ O O
155 11 CD O O
155 HTN NNP B-NP O
156 12 CD O O
156 RA NNP B-NP O
157 13 CD O O
157 Recent NNP B-NP O
157 eye NN I-NP O
157 hemorrhage NN I-NP O
158 Physical: NNP I-NP O
159 VS: NNP I-NP O
159 T NNP I-NP O
159 98.9 CD O O
159 P NNP B-NP O
159 103 CD O O
159 , , O O
159 BP NNP B-NP O
159 160/74 CD O O
159 , , O O
159 RR NNP B-NP O
159 20 CD O O
159 , , O O
159 OxySat NNP B-NP O
159 97% CD O O
159 2L CD O O
159 NC NNP B-NP O
159 , , O O
159 FSG NNP B-NP O
159 172 CD O O
160 Gen: NNP B-NP O
160 soft JJ B-NP O
160 voice NN I-NP O
160 , , O O
160 audible JJ O O
160 clicking VBG O O
160 sound NN B-NP O
160 , , O O
160 NAD NNP B-NP O
161 HEENT: NNP I-NP O
161 PERRL NNP I-NP O
161 , , O O
161 EOMI NNP B-NP O
162 Card: NNP I-NP O
162 irregularly RB O O
162 irregular JJ O O
162 , , O O
162 no DT B-NP O
162 S1 NNP I-NP O
162 , , O O
162 mechanical JJ B-NP O
162 S2 NNP I-NP O
162 , , O O
162 II/VI NNP B-NP O
162 early RB O O
162 systolic JJ B-NP O
163 murmur NN I-NP O
163 , , O O
163 loudest JJS O O
163 at IN B-VP O
163 base NN B-NP O
163 of IN B-VP O
163 heart NN B-NP O
164 Pulm: NNP I-NP O
164 reduced VBD B-VP O
164 breath JJ B-NP O
164 sounds NNS I-NP O
164 at IN B-VP O
165 dependant JJ O O
165 1/3 CD O O
165 b/l NN B-NP O
165 No NNP I-NP O
165 wheezes VBZ O O
165 heard RB O O
166 Abd: NNP B-NP O
166 well RB O O
166 healed VBD B-VP O
166 midline JJ B-NP O
166 scars NNS I-NP O
166 No DT B-NP O
166 bruits NNS I-NP O
166 ascultated VBN O O
166 , , O O
166 +BS JJ B-NP O
166 Soft NNP I-NP O
166 , , O O
166 NT NNP B-NP O
166 , , O O
167 ND NNP B-NP O
167 , , O O
167 no DT B-NP O
167 masses NNS I-NP O
168 Integ: NNP I-NP O
168 diffuse IN B-VP O
168 macular JJ O O
168 ( ( O O
168 5-10mm JJ O O
168 ) ) O O
168 hyperpigmented VBD B-VP O
168 rash JJ B-NP O
168 distal NN I-NP O
168 to TO O O
168 knees VB O O
169 b/l JJ B-NP O
170 Ext: NNP I-NP O
170 2x3 CD O O
170 cm NN B-NP O
170 raised VBN O O
170 tender NN B-NP O
170 area NN I-NP O
170 on IN B-VP O
170 L NNP B-NP O
170 forearm NN I-NP O
170 , , O O
170 no DT B-NP O
170 skin NN I-NP O
170 changes VBZ O O
170 &lt;3 NNP B-NP O
170 s NN I-NP O
170 cap NN I-NP O
171 refill NN I-NP O
171 L NNP I-NP O
171 hand NN I-NP O
171 Full NNP I-NP O
171 ROM NNP I-NP O
171 of IN B-VP O
171 left JJ B-NP O
171 fingers NNS I-NP O
171 ( ( O O
171 with IN B-VP O
171 pain NN B-NP O
171 ) ) O O
171 2+ CD O O
171 PT NNP B-NP O
171 pulses NNS I-NP O
172 b/l NN I-NP O
172 , , O O
172 1+ CD O O
172 DP NNP B-NP O
172 pulses NNS I-NP O
172 b/l VBP O O
172 2+ CD O O
172 radial/ulnar NN B-NP O
172 pulses NNS I-NP O
172 b/l VBP O O
173 Neuro: NNP B-NP O
173 A&amp;O NNP I-NP O
173 x NNP I-NP O
173 3 CD O O
173 , , O O
173 attentive JJ O O
173 , , O O
173 cooperative.Naming VBG O O
173 intact JJ O O
173 , , O O
173 follows VBZ O O
173 commands NNS B-NP O
173 , , O O
174 repetition NN B-NP O
174 intact JJ O O
174 , , O O
174 fluent JJ B-NP O
174 English NNP I-NP O
174 CN NNP I-NP O
174 2-12: JJ B-NP O
174 reactive NN I-NP O
174 pupils NNS I-NP O
174 , , O O
174 Eomi NNP B-NP O
174 , , O O
175 sensation NN B-NP O
175 intact JJ O O
175 throughout IN B-VP O
175 , , O O
175 hearing VBG O O
175 intact JJ O O
175 to TO O O
175 finger VB O O
175 rub NN B-NP O
175 , , O O
175 palate NN B-NP O
176 elevates NNS I-NP O
176 , , O O
176 tongue NN B-NP O
176 midline NN I-NP O
176 , , O O
176 full JJ B-NP O
176 strength NN I-NP O
176 trap NN I-NP O
176 and CC O O
176 SCM NNP B-NP O
176 Face NNP I-NP O
176 symmetric JJ B-NP O
177 Motor: NNP I-NP O
177 Strength: NNP I-NP O
177 R NNP I-NP O
177 arm: VBD B-VP O
177 5/5 CD O O
177 Del/Bi/Tri NNP B-NP O
177 , , O O
177 L NNP B-NP O
177 arm VBZ O O
177 4/5 CD O O
177 with IN B-VP O
177 giveway JJ B-NP O
178 character NN I-NP O
178 Del/Bi/Tri NNP I-NP O
178 L NNP I-NP O
178 leg VBD B-VP O
178 4-/5 JJ B-NP O
178 HF NNP I-NP O
178 5/5 CD O O
178 KE/PF/DF NNP B-NP O
178 R NNP I-NP O
178 leg VBD B-VP O
178 5/5 CD O O
179 HF/KE/PF/DFTone: NNP B-NP O
179 normalCoordination: JJ B-NP O
179 FNF NNP I-NP O
179 normal JJ B-NP O
179 b/l NN I-NP O
179 , , O O
179 heel-shin JJ B-NP O
179 R NNP I-NP O
179 leg NN I-NP O
180 normal JJ O O
180 , , O O
180 effort NN B-NP O
180 limited VBD B-VP O
180 L NNP B-NP O
180 leg NN I-NP O
181 Gait: NNP I-NP O
181 not RB O O
181 assessed VBD B-VP O
182 Hospital NNP B-NP O
182 course NN I-NP O
182 by IN B-VP O
182 system: JJ B-NP O
183 Neuro: NNP I-NP O
183 Speech NNP I-NP O
183 difficulties: NN I-NP O
183 resolved VBN O O
183 by IN B-VP O
183 the DT B-NP O
183 time NN I-NP O
183 pt NN I-NP O
183 was VBD B-VP O
183 in IN B-VP O
183 ER NNP B-NP O
183 , , O O
183 making VBG O O
184 diagnosis NN B-NP O
184 difficult JJ B-NP O
184 Possible JJ I-NP O
184 etiologies NNS I-NP O
184 include VBP O O
184 TIA NNP B-NP O
184 or CC O O
184 illness JJ O O
185 exacerbating VBG O O
185 deficits NNS B-NP O
185 from IN B-VP O
185 old JJ B-NP O
185 stroke NN I-NP O
185 Head NNP I-NP O
185 CT NNP I-NP O
185 in IN B-VP O
185 ER NNP B-NP O
185 showed VBD B-VP O
185 old JJ B-NP O
186 infarcts NNS I-NP O
186 , , O O
186 but CC O O
186 no DT B-NP O
186 acute JJ I-NP O
186 process NN I-NP O
186 Patient NNP I-NP O
186 did VBD B-VP O
186 not RB O O
186 have VB O O
186 any DT B-NP O
186 speech NN I-NP O
187 difficulties NNS I-NP O
187 throughout IN B-VP O
187 admission NN B-NP O
187 or CC O O
187 other JJ B-NP O
187 neurologic JJ I-NP O
187 findings NNS I-NP O
188 CV: NNP I-NP O
188 ischemia: VBZ O O
188 No DT B-NP O
188 ST NNP I-NP O
188 changes NNS I-NP O
188 on IN B-VP O
188 EKG NNP B-NP O
188 , , O O
188 one CD O O
188 set NN B-NP O
188 of IN B-VP O
188 cardiac JJ B-NP O
188 enzymes NNS I-NP O
188 were VBD B-VP O
189 negative JJ B-NP O
189 Given NNP I-NP O
189 low JJ B-NP O
189 probability NN I-NP O
189 of IN B-VP O
189 ischemia NN B-NP O
189 , , O O
189 no DT B-NP O
189 further JJ I-NP O
189 enzymes NNS I-NP O
189 were VBD B-VP O
190 drawn VBN O O
190 Pump: NNP B-NP O
190 EF NNP I-NP O
190 55% CD O O
190 , , O O
190 patient NN B-NP O
190 was VBD B-VP O
190 normotensive JJ O O
190 even RB O O
190 after IN B-VP O
190 d/c NN B-NP O
190 of IN B-VP O
191 some DT O O
191 of IN B-VP O
191 her PRP$ O O
191 home NN B-NP O
191 HTN NNP I-NP B-m
191 meds NNS I-NP I-m
191 ( ( O O
191 see VB O O
191 renal NN B-NP O
191 ) ) O O
191 Rhythm: NNP B-NP O
191 pt NN I-NP O
191 was VBD B-VP O
191 on IN B-VP O
191 telemetry NN B-NP O
191 for IN B-VP O
192 first JJ B-NP O
192 day NN I-NP O
192 of IN B-VP O
192 admission NN B-NP O
192 , , O O
192 and CC O O
192 alternated VBD B-VP O
192 between IN B-VP O
192 sinus NN B-NP O
192 rhythm NN I-NP O
192 and CC O O
192 afib JJ B-NP O
193 Pulm: NNP I-NP O
193 PNA: NNP I-NP O
193 pt NN I-NP O
193 had VBD B-VP O
193 left VBN O O
193 lower JJR B-NP O
193 lobe NN I-NP O
193 opacity NN I-NP O
193 on IN B-VP O
193 CXR NNP B-NP O
193 Decision NNP I-NP O
193 was VBD B-VP O
193 made VBN O O
193 to TO O O
194 start VB O O
194 antibiotics NNS B-NP B-m
194 Pt NNP I-NP O
194 had VBD B-VP O
194 a DT B-NP O
194 positive JJ I-NP O
194 d-dimer NN I-NP O
194 , , O O
194 but CC O O
194 PE NNP B-NP O
194 was VBD B-VP O
194 very RB O O
194 unlikely JJ O O
195 in IN B-VP O
195 the DT B-NP O
195 setting NN I-NP O
195 of IN B-VP O
195 therapeutic JJ B-NP O
195 anticoagulation NN I-NP O
195 The DT B-NP O
195 patient NN I-NP O
195 has VBZ O O
195 a DT B-NP O
196 history NN I-NP O
196 of IN B-VP O
196 CHF NNP B-NP O
196 , , O O
196 but CC O O
196 had VBD B-VP O
196 no DT B-NP O
196 signs NNS I-NP O
196 of IN B-VP O
196 CHF NNP B-NP O
196 on IN B-VP O
196 exam NN B-NP O
196 during IN B-VP O
196 this DT B-NP O
197 hospitalizaiton NN I-NP O
197 although IN B-VP O
197 her PRP$ O O
197 cxr NN B-NP O
197 was VBD B-VP O
197 read VBN O O
197 as IN B-VP O
197 mild JJ B-NP O
197 pulmonary JJ I-NP O
197 edema NN I-NP O
198 Renal: NNP I-NP O
198 ARF: NNP I-NP O
198 Creatine NNP I-NP O
198 on IN B-VP O
198 admission NN B-NP O
198 was VBD B-VP O
198 1.8 CD O O
198 , , O O
198 up RB O O
198 from IN B-VP O
198 a DT B-NP O
198 baseline NN I-NP O
198 of IN B-VP O
199 1.2-1.3 JJ B-NP O
199 Given NNP I-NP O
199 her PRP$ O O
199 h/o NN B-NP O
199 poor JJ B-NP O
199 po NNS I-NP O
199 intake VBP O O
199 and CC O O
199 euvolemic VBP O O
199 to TO O O
199 dry VB O O
199 exam NN B-NP O
199 , , O O
200 this DT O O
200 was VBD B-VP O
200 thought VBN O O
200 likely RB O O
200 due JJ O O
200 to TO O O
200 prerenal JJ B-NP O
200 hypovolemia NN I-NP O
200 Her NNP I-NP O
201 lasix NN I-NP B-m
201 , , O O
201 lisinopril NN B-NP B-m
201 and CC O O
201 colchicine NN B-NP B-m
201 were VBD B-VP O
201 held VBN O O
201 , , O O
201 as IN B-VP O
201 they PRP O O
201 might MD O O
201 contribute VB O O
201 to TO O O
202 further JJ B-NP O
202 ARF NNP I-NP O
202 , , O O
202 and CC O O
202 she PRP O O
202 got VBD B-VP O
202 gentle JJ B-NP O
202 ivf NN I-NP B-m
202 ( ( O O
202 approximately RB O B-do
202 1L CD O I-do
202 ) ) O O
202 and CC O O
202 her PRP$ O O
203 creatinine NN B-NP O
203 improved VBN O O
203 However RB O O
203 , , O O
203 after IN B-VP O
203 restarting VBG O O
203 her PRP$ O O
203 medications NNS B-NP O
203 her PRP$ O O
203 Cr NNP B-NP O
204 again RB O O
204 bumped VBD B-VP O
204 to TO O O
204 1.8 CD O O
204 Her NNP B-NP O
204 UA NNP I-NP O
204 was VBD B-VP O
204 unremarkable JJ O O
204 She PRP O O
204 was VBD B-VP O
204 d/c JJ B-NP O
204 home NN I-NP O
204 off IN B-VP O
205 lasix NN B-NP B-m
205 , , O O
205 lisinopril NN B-NP B-m
205 and CC O O
205 colchicine NN B-NP B-m
205 with IN B-VP O
205 a DT B-NP O
205 Cr NNP I-NP O
205 of IN B-VP O
205 1.8 CD O O
205 presuming VBG O O
205 that IN B-VP O
205 sh NN B-NP O
206 e NN I-NP O
206 was VBD B-VP O
206 still RB O O
206 prerenal JJ O O
206 The DT B-NP O
206 plan NN I-NP O
206 is VBZ O O
206 for IN B-VP O
206 VNA NNP B-NP O
206 to TO O O
206 check VB O O
206 her PRP$ O O
206 chem7 NN B-NP O
206 in IN B-VP O
206 3days CD O O
207 days NNS B-NP O
207 , , O O
207 results NNS B-NP O
207 to TO O O
207 go VB O O
207 to TO O O
207 Dr NNP B-NP O
207 Skibo NNP I-NP O
207 for IN B-VP O
207 monitoring NN B-NP O
207 and CC O O
207 deciding VBG O O
207 when WRB O O
207 to TO O O
208 restart VB O O
208 her PRP$ O O
208 medications NNS B-NP O
209 MSK: NNP I-NP O
209 Pt NNP I-NP O
209 developed VBD B-VP O
209 the DT B-NP O
209 left JJ I-NP O
209 forearm NN I-NP O
209 swelling NN I-NP O
209 and CC O O
209 pain NN B-NP O
209 while IN B-VP O
209 in IN B-VP O
209 the DT B-NP O
209 hosp NN I-NP O
210 for IN B-VP O
210 the DT B-NP O
210 first JJ I-NP O
210 night NN I-NP O
210 A NNP I-NP O
210 radiograph NN I-NP O
210 was VBD B-VP O
210 negative JJ O O
210 for IN B-VP O
210 fracture NN B-NP O
210 and CC O O
210 it PRP O O
210 was VBD B-VP O
211 felt VBN O O
211 to TO O O
211 be VB O O
211 a DT B-NP O
211 small JJ I-NP O
211 hematoma NN I-NP O
211 The DT B-NP O
211 pain NN I-NP B-r
211 remitted VBD B-VP O
211 with IN B-VP O
211 Tylenol NNP B-NP B-m
211 At IN B-VP O
212 discharge NN B-NP O
212 the DT B-NP O
212 pain NN I-NP O
212 was VBD B-VP O
212 a DT B-NP O
212 dull JJ I-NP O
212 ache NN I-NP O
212 , , O O
212 and CC O O
212 the DT B-NP O
212 swelling NN I-NP O
212 was VBD B-VP O
212 reduced VBN O O
213 Heme: NNP B-NP O
213 Anticoagulation NNP I-NP O
213 She PRP O O
213 was VBD B-VP O
213 maintained VBN O O
213 on IN B-VP O
213 her PRP$ O O
213 home NN B-NP O
213 dose NN I-NP O
213 of IN B-VP O
213 INR NNP B-NP O
213 was VBD B-VP O
214 maintained VBN O O
214 in IN B-VP O
214 a DT B-NP O
214 theraputic JJ I-NP O
214 range NN I-NP O
214 This DT O O
214 will MD O O
214 have VB O O
214 to TO O O
214 be VB O O
214 closely RB O O
215 monitored VBN O O
215 as IN B-VP O
215 an DT B-NP O
215 outpatient NN I-NP O
215 while IN B-VP O
215 on IN B-VP O
215 levofloxacin IN B-VP B-m
215 Her NNP B-NP O
215 INR NNP I-NP O
215 was VBD B-VP O
215 3 CD O O
215 after IN B-VP O
215 2 CD O B-du
216 days NNS B-NP O
216 of IN B-VP O
216 levofloxacin NN B-NP B-m
216 and CC O O
216 will MD O O
216 be VB O O
216 checked VBN O O
216 again RB O O
216 by IN B-VP O
216 VNA NNP B-NP O
216 3 CD O O
216 days NNS B-NP O
217 after IN B-VP O
217 discharge NN B-NP O
217 , , O O
217 results NNS B-NP O
217 to TO O O
217 be VB O O
217 followed VBN O O
217 by IN B-VP O
217 Sheldon NNP B-NP O
217 Dingmann NNP I-NP O
218 Endo: NNP I-NP O
218 D.M NNP I-NP O
218 Pt NNP I-NP O
218 was VBD B-VP O
218 switched VBN O O
218 from IN B-VP O
218 micronase NN B-NP B-m
218 to TO O O
218 glipizide VB O B-m
218 2.5mg CD O B-do
218 qd NN B-NP B-f
218 given VBN O O
219 her PRP$ O O
219 worsening VBG O O
219 renal JJ B-NP O
219 insufficiency NN I-NP O
219 Fingersticks NNP I-NP O
219 remained VBD B-VP O
219 in IN B-VP O
219 acceptable JJ B-NP O
220 range NN I-NP O
220 ( ( O O
220 100-148 JJ O O
220 ) ) O O
220 during IN B-VP O
220 admission NN B-NP O
221 Dispo: NNP I-NP O
221 to TO O O
221 home NN B-NP O
221 with IN B-VP O
221 close JJ B-NP O
221 VNA NNP I-NP O
221 followup NN I-NP O
221 ( ( O O
221 daily JJ O O
221 ) ) O O
221 Pt NNP B-NP O
221 will MD O O
221 have VB O O
221 weight NN B-NP O
222 and CC O O
222 BP NNP B-NP O
222 checked VBD B-VP O
222 qd JJ O O
222 She PRP O O
222 will MD O O
222 have VB O O
222 Chem-7 NNP B-NP O
222 and CC O O
222 INR NNP B-NP O
222 drawn NN I-NP O
222 on IN B-VP O
222 Thursday NNP B-NP O
222 and CC O O
223 Monday NNP B-NP O
223 , , O O
223 and CC O O
223 the DT B-NP O
223 results NNS I-NP O
223 will MD O O
223 be VB O O
223 called VBN O O
223 to TO O O
223 Dr NNP B-NP O
223 Benamati NNP I-NP O
223 ( ( O O
223 TERT NNP B-NP O
223 VALLEY NNP I-NP O
223 HOSPITAL NNP I-NP O
223 CENTER NNP I-NP O
223 ) ) O O
223 She PRP O O
223 will MD O O
224 finish VB O O
224 6 CD O B-du
224 more JJR B-NP I-du
224 days NNS I-NP I-du
224 of IN B-VP O
224 Levo NNP B-NP B-m
224 ( ( O O
224 total JJ O O
224 10 CD O O
224 ) ) O O
225 ADDITIONAL NNP B-NP O
225 COMMENTS: NNP I-NP O
225 If IN B-VP O
225 you PRP O O
225 develop VBP O O
225 a DT B-NP O
225 fever NN I-NP O
225 , , O O
225 become VB O O
225 short JJ O O
225 of IN B-VP O
225 breath NN B-NP O
225 , , O O
225 have VBP O O
225 increasing VBG O O
225 left VBN O O
225 arm NN B-NP O
226 pain NN I-NP O
226 , , O O
226 or CC O O
226 any DT B-NP O
226 other JJ I-NP O
226 symptoms NNS I-NP O
226 that IN B-VP O
226 concern NN B-NP O
226 you PRP O O
226 , , O O
226 call VB O O
226 your PRP$ O O
226 doctor NN B-NP O
227 The DT B-NP O
227 visiting NN I-NP O
227 nurse NN I-NP O
227 is VBZ O O
227 an DT B-NP O
227 important JJ I-NP O
227 followup NN I-NP O
227 to TO O O
227 your PRP$ O O
228 hospitalization.Your NN B-NP O
228 diabetes VBZ O B-m
228 medication NN B-NP I-m
228 was VBD B-VP O
228 changed VBN O O
228 to TO O O
228 glipizide VB O B-m
228 -stop NNP B-NP O
229 taking VBG O O
229 the DT B-NP O
229 micronase NN I-NP B-m
229 Your NNP I-NP O
229 lasix NN I-NP B-m
229 , , O O
229 lisinopril NN B-NP B-m
229 and CC O O
229 colchicine NN B-NP B-m
229 have VBP O O
229 been VBN O O
230 stopped VBN O O
230 , , O O
230 don't JJ O O
230 restart VB O O
230 them PRP O O
230 until IN B-VP O
230 Dr NNP B-NP O
230 Schoville NNP I-NP O
230 tells VBZ O O
230 you PRP O O
230 to TO O O
230 restart VB O O
230 Your PRP$ O O
230 othe JJ B-NP O
231 medications NNS I-NP O
231 are VBP O O
231 the DT B-NP O
231 same JJ I-NP O
231 Weigh NNP I-NP O
231 yourself PRP O O
231 daily RB O O
231 and CC O O
231 if IN B-VP O
231 your PRP$ O O
231 weight NN B-NP O
231 increa NN I-NP O
232 ses VBZ O O
232 more JJR O O
232 than IN B-VP O
232 2lbs CD O O
232 in IN B-VP O
232 2 CD O O
232 days NNS B-NP O
232 call VB O O
232 Dr NNP B-NP O
232 Szesterniak NNP I-NP O
233 DISCHARGE NNP I-NP O
233 CONDITION: NNP I-NP O
233 Stable NNP I-NP O
234 TO NNP I-NP O
234 DO/PLAN: NNP I-NP O
235 1 CD O O
235 VNA NNP B-NP O
235 will MD O O
235 check VB O O
235 BP NNP B-NP O
235 and CC O O
235 weight VBD B-VP O
235 qd NNS B-NP O
235 Any NNP I-NP O
235 BP NNP I-NP O
235 &gt; VBZ O O
235 140/90 CD O O
235 or CC O O
235 wt JJ B-NP O
235 gain NN I-NP O
235 of IN B-VP O
235 2 CD O O
236 lbs NNS B-NP O
236 in IN B-VP O
236 2 CD O O
236 days NNS B-NP O
236 will MD O O
236 be VB O O
236 called VBN O O
236 to TO O O
236 Dr NNP B-NP O
236 Kempf NNP I-NP O
236 ( ( O O
236 BROTHERSCIAL NNP B-NP O
236 GITER NNP I-NP O
236 HEALTHCARE NNP I-NP O
236 OF NNP I-NP O
236 773-511-3611 NNP I-NP O
236 ) ) O O
237 2 CD O O
237 Thursday NNP B-NP O
237 ( ( O O
237 3 CD O O
237 of IN B-VP O
237 May NNP B-NP O
237 ) ) O O
237 and CC O O
237 Mon NNP B-NP O
237 ( ( O O
237 26 CD O O
237 of IN B-VP O
237 January NNP B-NP O
237 ) ) O O
237 VNA NNP B-NP O
237 will MD O O
237 draw VB O O
237 a DT B-NP O
237 Chem-7 NNP I-NP O
237 and CC O O
237 INR NNP B-NP O
238 and CC O O
238 call VB O O
238 results NNS B-NP O
238 to TO O O
238 Dr NNP B-NP O
238 Maria NNP I-NP O
238 ( ( O O
238 WA NNP B-NP O
238 ASSPUNX NNP I-NP O
238 HOSPITAL NNP I-NP O
238 ); NNP I-NP O
238 INR NNP I-NP O
238 should MD O O
238 be VB O O
238 communicated VBN O O
238 to TO O O
238 Blaine NNP B-NP O
238 Lindquist NNP I-NP O
238 at IN B-VP O
238 207-809-4454 JJ O O
239 3 CD O O
239 Pt NNP B-NP O
239 has VBZ O O
239 followup VBN O O
239 appointment NN B-NP O
239 on IN B-VP O
239 24 CD O O
239 of IN B-VP O
239 September NNP B-NP O
239 at IN B-VP O
239 10:30am CD O O
239 with IN B-VP O
240 Dr NNP B-NP O
240 Speranza NNP I-NP O
240 4 CD O O
240 There EX O O
240 are VBP O O
240 6 CD O B-du
240 more JJR B-NP I-du
240 days NNS I-NP I-du
240 of IN B-VP O
240 Levofloxacin NNP B-NP B-m
240 course NN I-NP O
241 No NNP I-NP O
241 dictated VBD B-VP O
241 summary JJ B-NP O
242 ENTERED NNP I-NP O
242 BY: NNP I-NP O
242 BIRES NNP I-NP O
242 , , O O
242 LESLEY NNP B-NP O
242 C NNP I-NP O
242 , , O O
242 M.D NNP B-NP O
242 , , O O
242 PH.D NNP B-NP O
242 ( ( O O
242 EC039 NNP B-NP O
242 ) ) O O
242 1/29/04 CD O O
242 @ $ O O
242 05 CD O O
243 ****** JJ B-NP O
243 END NN I-NP O
243 OF NNP I-NP O
243 DISCHARGE NNP I-NP O
243 ORDERS NNP I-NP O
243 ****** NNP I-NP O
244 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #731937 VBZ O O
4 601682374 CD O O
4 S NNP B-NP O
4 45082046 CD O O
4 7656711 CD O O
4 1/19/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/19/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
7 ATTENDING: NNP I-NP O
7 CRUMBLE NNP I-NP O
7 , , O O
7 MODESTO NNP B-NP O
7 LEIF NNP I-NP O
7 MD NNP I-NP O
8 INTERIM NNP I-NP O
8 DICTATION NNP I-NP O
9 DATE NNP I-NP O
9 OF NNP I-NP O
9 SURGERY: NNP I-NP O
9 9/22/2005 CD O O
10 PREOPERATIVE NNP B-NP O
10 DIAGNOSES: NNP I-NP O
10 Infective NNP I-NP O
10 endocarditis NN I-NP O
10 , , O O
10 coronary JJ B-NP O
10 artery NN I-NP O
11 disease NN I-NP O
12 POSTOPERATIVE NNP I-NP O
12 DIAGNOSES: NNP I-NP O
12 Infective NNP I-NP O
12 endocarditis NN I-NP O
12 , , O O
12 coronary JJ B-NP O
12 artery NN I-NP O
13 disease NN I-NP O
14 PROCEDURE: NNP I-NP O
14 Mitral NNP I-NP O
14 valve FW O O
14 replacement NN B-NP O
14 , , O O
14 #28Other CC O O
14 annuloplasty JJ B-NP O
15 ring NN I-NP O
15 , , O O
15 ring VBG O O
15 annuloplasty NN B-NP O
15 , , O O
15 leaflet NN B-NP O
15 resection NN I-NP O
15 , , O O
15 post NN B-NP O
15 leaflet NN I-NP O
16 chordoplasty NN I-NP O
16 with IN B-VP O
16 Gore-Tex NNP B-NP O
16 suture NN I-NP O
16 , , O O
16 Vegetectomy NNP B-NP O
16 , , O O
16 SBE NNP B-NP O
16 , , O O
16 CABG NNP B-NP O
16 x1 NNP I-NP O
17 HISTORY NNP I-NP O
17 OF NNP I-NP O
17 PRESENT NNP I-NP O
17 ILLNESS: NNP I-NP O
17 The DT B-NP O
17 patient NN I-NP O
17 is VBZ O O
17 a DT B-NP O
17 64-year-old JJ I-NP O
17 male NN I-NP O
18 with IN B-VP O
18 signs NNS B-NP O
18 of IN B-VP O
18 past JJ B-NP O
18 medical JJ I-NP O
18 history NN I-NP O
18 of IN B-VP O
18 diet-controlled JJ B-NP O
18 diabetes NNS I-NP O
19 mellitus NN I-NP O
19 , , O O
19 type NN B-NP O
19 2; CD O O
19 HTN NNP B-NP O
19 , , O O
19 status NN B-NP O
19 post NN I-NP O
19 MI NNP I-NP O
19 with IN B-VP O
19 RCA NNP B-NP O
19 stent NN I-NP O
19 in IN B-VP O
19 1999 CD O O
19 who WP O O
20 presents VBZ O O
20 to TO O O
20 ICU NNP B-NP O
20 from IN B-VP O
20 emergency NN B-NP O
20 department NN I-NP O
20 after IN B-VP O
20 being VBG O O
20 found VBD B-VP O
20 down RB O O
21 at IN B-VP O
21 home NN B-NP O
21 with IN B-VP O
21 change NN B-NP O
21 in IN B-VP O
21 mental JJ B-NP O
21 status NN I-NP O
21 The DT B-NP O
21 patient NN I-NP O
21 was VBD B-VP O
21 in IN B-VP O
21 USOH NNP B-NP O
22 until IN B-VP O
22 approximately RB O O
22 six CD O O
22 to TO O O
22 seven CD O O
22 days NNS B-NP O
22 PTA NNP I-NP O
22 when WRB O O
22 he PRP O O
22 noticed VBD B-VP O
22 sudden JJ B-NP O
23 onset NN I-NP O
23 of IN B-VP O
23 sharp JJ B-NP O
23 left JJ I-NP O
23 shoulder NN I-NP O
23 pain NN I-NP O
23 without IN B-VP O
23 substernal JJ B-NP O
23 chest NN I-NP O
23 pain NN I-NP O
24 or CC O O
24 pressure NN B-NP O
24 The DT B-NP O
24 patient NN I-NP O
24 notes VBZ O O
24 that IN B-VP O
24 the DT B-NP O
24 pain NN I-NP O
24 in IN B-VP O
24 his PRP$ O O
24 body NN B-NP O
24 all DT O O
25 over IN B-VP O
25 and CC O O
25 his PRP$ O O
25 shoulder NN B-NP O
25 continued VBD B-VP O
25 to TO O O
25 be VB O O
25 excruciating VBG O O
25 and CC O O
25 without IN B-VP O
26 relent NN B-NP O
26 He PRP O O
26 also RB O O
26 noted VBD B-VP O
26 onset NN B-NP O
26 of IN B-VP O
26 upper JJ O O
26 and CC O O
26 lower JJR B-NP O
26 extremity NN I-NP O
27 weakness NN I-NP O
27 and CC O O
27 that IN B-VP O
27 his PRP$ O O
27 legs NNS B-NP O
27 felt VBD B-VP O
27 heavy JJ O O
27 After IN B-VP O
27 he PRP O O
27 did VBD B-VP O
27 not RB O O
27 show VB O O
27 up RP O O
28 to TO O O
28 work VB O O
28 for IN B-VP O
28 several JJ B-NP O
28 days NNS I-NP O
28 , , O O
28 the DT B-NP O
28 patient NN I-NP O
28 was VBD B-VP O
28 found VBN O O
28 down RP O O
28 in IN B-VP O
28 his PRP$ O O
28 house NN B-NP O
29 incontinent NN I-NP O
29 of IN B-VP O
29 urine NN B-NP O
29 He PRP O O
29 was VBD B-VP O
29 found VBN O O
29 to TO O O
29 have VB O O
29 profound VBN O O
29 metabolic JJ B-NP O
30 acidosis NN I-NP O
30 , , O O
30 hypertensive JJ O O
30 , , O O
30 hypovolemic JJ O O
30 , , O O
30 febrile JJ O O
30 , , O O
30 covered VBD B-VP O
30 all DT O O
30 over IN B-VP O
31 the DT B-NP O
31 skin NN I-NP O
31 with IN B-VP O
31 hemorrhagic JJ B-NP B-r
31 rash NN I-NP I-r
31 and CC O O
31 required VBN O O
31 fluid JJ B-NP O
31 resuscitation NN I-NP O
32 and CC O O
32 Levophed NNP B-NP B-m
32 infusion NN I-NP B-mo
32 Lumbar NNP I-NP O
32 puncture NN I-NP O
32 showed VBD B-VP O
32 over IN B-VP O
32 100 CD O O
32 white JJ B-NP O
33 blood NN I-NP O
33 cells NNS I-NP O
33 Urine NNP I-NP O
33 was VBD B-VP O
33 dirty JJ O O
33 and CC O O
33 the DT B-NP O
33 patient NN I-NP O
33 found VBD B-VP O
33 to TO O O
33 have VB O O
33 rash NN B-NP O
34 on IN B-VP O
34 back NN B-NP O
34 and CC O O
34 extremities NNS B-NP O
34 , , O O
34 which WDT O O
34 were VBD B-VP O
34 biopsied VBN O O
34 by IN B-VP O
34 dermatologist NN B-NP O
34 on IN B-VP O
35 1/30/2005 CD O O
35 The DT B-NP O
35 patient NN I-NP O
35 has VBZ O O
35 since IN B-VP O
35 had VBD B-VP O
35 four CD O O
35 of IN B-VP O
35 four CD O O
35 blood NN B-NP O
36 cultures NNS I-NP O
36 positive JJ O O
36 for IN B-VP O
36 gram-positive JJ B-NP O
36 cocci NN I-NP O
36 in IN B-VP O
36 clusters( NN B-NP O
37 preliminary JJ B-NP O
37 Staphylococcus NNP I-NP O
37 aureus NN I-NP O
37 , , O O
37 MSSA NNP B-NP O
37 ) ) O O
37 Two CD O O
37 of IN B-VP O
37 four CD O O
37 bottles NNS B-NP O
37 of IN B-VP O
38 gram-negative JJ B-NP O
38 rods NNS I-NP O
38 enteric JJ O O
38 and CC O O
38 pink NN B-NP O
38 , , O O
38 status NN B-NP O
38 post NN I-NP O
38 stenting NN I-NP O
38 and CC O O
38 had VBD B-VP O
39 more JJR O O
39 than IN B-VP O
39 1100 CD O O
39 Staphylococcus NNP B-NP O
39 aureus NN I-NP O
39 from IN B-VP O
39 1/19/2005 CD O O
39 urine JJ B-NP O
40 culture NN I-NP O
40 TTE NNP I-NP O
40 on IN B-VP O
40 1/30/2005 CD O O
40 showing VBG O O
40 vegetation NN B-NP O
40 on IN B-VP O
40 mitral JJ B-NP O
40 valve NNS I-NP O
41 PREOPERATIVE NNP I-NP O
41 CARDIAC NNP I-NP O
41 STATUS: NNP I-NP O
41 Urgent: NNP I-NP O
41 The DT B-NP O
41 patient NN I-NP O
41 presented VBN O O
41 with IN B-VP O
42 infection NN B-NP O
42 of IN B-VP O
42 myocardial JJ B-NP O
42 infarction NN I-NP O
42 in IN B-VP O
42 March NNP B-NP O
42 1999 CD O O
42 requiring VBG O O
43 hospitalization NN B-NP O
43 associated VBN O O
43 with IN B-VP O
43 prolonged JJ B-NP O
43 chest NN I-NP O
43 pain NN I-NP O
43 The DT B-NP O
44 patient NN I-NP O
44 does VBZ O O
44 not RB O O
44 have VB O O
44 symptoms NNS B-NP O
44 of IN B-VP O
44 heart NN B-NP O
44 failure NN I-NP O
44 Recent NNP I-NP O
44 signs NNS I-NP O
45 and CC O O
45 symptoms NNS B-NP O
45 of IN B-VP O
45 congestive JJ B-NP O
45 heart NN I-NP O
45 failure NN I-NP O
45 include VBP O O
45 pedal JJ O O
45 edema VBP O O
46 The DT B-NP O
46 patient NN I-NP O
46 is VBZ O O
46 in IN B-VP O
46 normal JJ B-NP O
46 sinus NN I-NP O
46 rhythm VBP O O
47 PREVIOUS NNP B-NP O
47 CARDIOVASCULAR NNP I-NP O
47 INTERVENTIONS: NNP I-NP O
47 Stent NNP I-NP O
47 in IN B-VP O
47 March NNP B-NP O
47 1999 CD O O
48 PAST NNP B-NP O
48 MEDICAL NNP I-NP O
48 HISTORY: NNP I-NP O
48 Stroke NNP I-NP O
48 , , O O
48 extremity NN B-NP O
48 weakness NN I-NP O
48 , , O O
48 history NN B-NP O
48 of IN B-VP O
49 permanent JJ B-NP O
49 muscle NN I-NP O
49 weakness NN I-NP O
49 of IN B-VP O
49 all DT O O
49 four CD O O
49 extremities NNS B-NP O
49 , , O O
49 loss NN B-NP O
49 of IN B-VP O
50 consciousness NN B-NP O
50 The DT B-NP O
50 patient NN I-NP O
50 was VBD B-VP O
50 found VBN O O
50 at IN B-VP O
50 home NN B-NP O
50 unconscious JJ O O
50 within IN B-VP O
51 two CD O O
51 weeks NNS B-NP O
51 of IN B-VP O
51 surgery NN B-NP O
51 , , O O
51 diabetes VBZ O B-r
51 mellitus NN B-NP I-r
51 , , O O
51 insulin NN B-NP B-m
51 therapy NN I-NP O
51 , , O O
52 infective JJ B-NP B-r
52 infective JJ I-NP B-r
52 infective JJ I-NP B-r
52 infective JJ I-NP B-r
52 infective JJ I-NP B-r
52 infective JJ I-NP B-r
52 endocarditis:active JJ I-NP I-r
52 endocarditis:active JJ I-NP I-r
52 endocarditis:active JJ I-NP I-r
52 endocarditis:active JJ I-NP I-r
52 endocarditis:active JJ I-NP I-r
52 endocarditis:active NN I-NP I-r
52 , , O O
52 receiving VBG O O
52 vancomycin NN B-NP B-m
52 , , O O
53 levofloxacin NN B-NP B-m
53 , , O O
53 Flagyl NNP B-NP B-m
53 , , O O
53 ceftazidime NN B-NP B-m
53 , , O O
53 gentamicin NN B-NP B-m
53 , , O O
53 Nafcillin NNP B-NP B-m
53 , , O O
54 hypercholesterolemia NN B-NP O
54 , , O O
54 heparin-induced JJ B-NP O
54 thrombocytopenia NN I-NP O
54 , , O O
54 HAT NNP B-NP O
55 during IN B-VP O
55 hospitalization NN B-NP O
55 in IN B-VP O
55 1999 CD O O
55 , , O O
55 creatinine JJ B-NP O
55 clearance NN I-NP O
55 158.18 CD O O
56 PAST NNP B-NP O
56 SURGICAL NNP I-NP O
56 HISTORY: NNP I-NP O
56 None NNP I-NP O
57 FAMILY NNP I-NP O
57 HISTORY: NNP I-NP O
57 No NNP I-NP O
57 family NN I-NP O
57 history NN I-NP O
57 of IN B-VP O
57 coronary JJ B-NP O
57 artery NN I-NP O
57 disease NN I-NP O
58 SOCIAL NNP I-NP O
58 HISTORY: NNP I-NP O
58 No NNP I-NP O
58 history NN I-NP O
58 of IN B-VP O
58 tobacco NN B-NP O
58 use NN I-NP O
59 ALLERGIES: NNP I-NP O
59 Heparin NNP I-NP O
59 , , O O
59 HIT NNP B-NP O
60 ADMISSION NNP I-NP O
60 MEDICATIONS: NNP I-NP O
60 Heparin NNP I-NP B-m
60 low JJ B-NP I-m
60 molecular NN I-NP I-m
60 weight NN I-NP I-m
60 last JJ B-NP O
60 dose NN I-NP O
61 less JJR O O
61 than IN B-VP O
61 24 CD O B-du
61 hours NNS B-NP I-du
61 , , O O
61 enoxaparin NN B-NP B-m
61 , , O O
61 Lovenox NNP B-NP B-m
61 40 CD O B-do
61 mg NN B-NP I-do
61 subcu JJ O B-mo
61 daily RB O B-f
61 , , O O
62 norepinephrine JJ O B-m
62 3 CD O B-do
62 mcg NN B-NP I-do
62 per IN B-VP I-do
62 kg FW O I-do
62 per IN B-VP I-do
62 minute NN B-NP I-do
62 continuous JJ O I-do
62 , , O O
62 simvastatin JJ O B-m
62 40 CD O B-do
63 mg JJ O O
63 p.o JJ O B-mo
63 daily JJ O B-f
63 , , O O
63 Nexium NNP B-NP B-m
63 40 CD O B-do
63 mg NN B-NP I-do
63 p.o JJ O B-mo
63 daily RB O B-f
63 , , O O
63 ceftazidime JJ O B-m
63 2000 CD O B-do
63 mg NN B-NP I-do
63 IV NNP I-NP B-mo
64 q8h NN I-NP B-f
64 , , O O
64 gentamicin VBP O B-m
64 560 CD O B-do
64 mg NN B-NP I-do
64 IV NNP I-NP B-mo
64 q.24h NN I-NP B-f
64 , , O O
64 penicillin NN B-NP B-m
64 G NNP I-NP I-m
64 , , O O
64 potassium NN B-NP B-m
64 3 CD O B-do
65 million CD O O
65 units NNS B-NP O
65 IV NNP I-NP B-mo
66 PHYSICAL NNP I-NP O
66 EXAMINATION: NNP I-NP O
66 Height NNP I-NP O
66 and CC O O
66 Weight: NNP B-NP O
66 5 CD O O
66 feet NNS B-NP O
66 9 CD O O
66 inches NNS B-NP O
66 , , O O
66 92.7 CD O O
67 kg NN B-NP O
67 Vital NNP I-NP O
67 Signs: NNP I-NP O
67 Temperature NNP I-NP O
67 99 CD O O
67 , , O O
67 heart NN B-NP O
67 rate NN I-NP O
67 120 CD O O
67 , , O O
67 blood NN B-NP O
67 pressure NN I-NP O
68 right JJ B-NP O
68 arm NN I-NP O
68 107/65 CD O O
68 , , O O
68 extubated VBN O O
68 on IN B-VP O
68 9/0/2005 CD O O
68 6 CD O O
68 p.m NN B-NP O
68 , , O O
68 FiO2 NNP B-NP O
68 4 CD O O
68 L NNP B-NP O
68 nasal JJ B-NP O
69 cannula NN I-NP O
69 , , O O
69 ambulating VBG O O
69 , , O O
69 oxygen NN B-NP O
69 saturation NN I-NP O
69 99% CD O O
69 HEENT: NNP B-NP O
69 PERRLA NNP I-NP O
70 Dentition NNP I-NP O
70 without IN B-VP O
70 evidence NN B-NP O
70 of IN B-VP O
70 infection NN B-NP O
70 No NNP I-NP O
70 carotid NN I-NP O
70 bruits NNS I-NP O
71 Chest: NNP I-NP O
71 No NNP I-NP O
71 incisions NNS I-NP O
71 Cardiovascular: NNP I-NP O
71 No NNP I-NP O
71 murmurs NN I-NP O
71 Respiratory: NNP I-NP O
72 Rales NNP I-NP O
72 present JJ O O
72 bilaterally RB O O
72 Abdomen: NNP B-NP O
72 No NNP I-NP O
72 incisions NNS I-NP O
72 , , O O
72 soft JJ B-NP O
72 No NNP I-NP O
73 masses NNS I-NP O
73 Rectal: NNP I-NP O
73 Deferred NNP I-NP O
73 Extremities: NNP I-NP O
73 Leg NNP I-NP O
73 edematous JJ O O
73 1+ CD O O
73 2+ CD O O
73 , , O O
74 diminished VBD B-VP O
74 muscle NN B-NP O
74 strength NN I-NP O
74 4/5 CD O O
74 Neuro: NNP B-NP O
74 Alert NNP I-NP O
74 and CC O O
74 oriented VBD B-VP O
74 No NNP B-NP O
75 focal JJ B-NP O
75 deficits NNS I-NP O
76 PREOP NNP I-NP O
76 LABS: NNP I-NP O
76 On IN B-VP O
76 7/9/2005 CD O O
76 , , O O
76 sodium NN B-NP O
76 143 CD O O
76 , , O O
76 potassium NN B-NP O
76 4.1 CD O O
76 , , O O
76 chloride RB O O
77 114 CD O O
77 , , O O
77 CO2 NNP B-NP O
77 21 CD O O
77 , , O O
77 BUN NNP B-NP O
77 11 CD O O
77 , , O O
77 creatinine NN B-NP O
77 0.7 CD O O
77 , , O O
77 glucose RB O O
77 110 CD O O
77 , , O O
77 magnesium NN B-NP O
77 2.1 CD O O
78 Hematology NNP B-NP O
78 on IN B-VP O
78 9/0/2005 CD O O
78 , , O O
78 white JJ B-NP O
78 blood NN I-NP O
78 cells NNS I-NP O
78 423 CD O O
78 , , O O
78 hematocrit NN B-NP O
78 32.2 CD O O
78 , , O O
79 hemoglobin NN B-NP O
79 10.9 CD O O
79 , , O O
79 platelets NNS B-NP O
79 73 CD O O
79 , , O O
79 PT NNP B-NP O
79 14.9 CD O O
79 , , O O
79 INR NNP B-NP O
79 1.2 CD O O
79 , , O O
79 PTT NNP B-NP O
79 28.4 CD O O
79 ABGs; NNP B-NP O
80 PO2 NNP I-NP O
80 72 CD O O
80 , , O O
80 pH NN B-NP O
80 7.52 CD O O
80 , , O O
80 PCO2 NNP B-NP O
80 28 CD O O
80 , , O O
80 total JJ B-NP O
80 CO2 NNP I-NP O
80 23 CD O O
80 , , O O
80 base NN B-NP O
80 excess JJ O O
80 0 CD O O
81 Urinalysis NN B-NP O
81 consisted VBN O O
81 with IN B-VP O
81 infection NN B-NP O
82 CARDIAC NNP I-NP O
82 CATHETERIZATION NNP I-NP O
82 DATA: NNP I-NP O
82 On IN B-VP O
82 9/0/2005 CD O O
82 performed VBN O O
82 at IN B-VP O
82 N NNP B-NP O
83 Coronary NNP I-NP O
83 anatomy VBD B-VP O
83 50% CD O O
83 LAD NNP B-NP O
83 , , O O
83 45% CD O O
83 mid NN B-NP O
83 Ramus NNP I-NP O
83 , , O O
83 dominant JJ B-NP O
83 circulation NN I-NP O
83 , , O O
84 LVEDP NNP B-NP O
84 15 CD O O
84 mmHg NN B-NP O
84 Echo NNP I-NP O
84 on IN B-VP O
84 1/30/2005 CD O O
84 , , O O
84 55% CD O O
84 ejection NN B-NP O
84 fraction NN I-NP O
84 , , O O
84 mild JJ B-NP O
85 mitral JJ I-NP O
85 insufficiency NN I-NP O
85 , , O O
85 trivial JJ B-NP O
85 pulmonic JJ I-NP O
85 insufficiency NN I-NP O
85 , , O O
85 the DT B-NP O
85 mitral JJ I-NP O
86 valve NN I-NP O
86 is VBZ O O
86 myxomatous JJ O O
86 There EX O O
86 is VBZ O O
86 a DT B-NP O
86 2-cm JJ I-NP O
86 focal JJ I-NP O
86 leaflet NN I-NP O
86 mass NN I-NP O
86 on IN B-VP O
86 the DT B-NP O
87 mitral JJ I-NP O
87 leaflet NN I-NP O
87 that WDT O O
87 could MD O O
87 represent VB O O
87 a DT B-NP O
87 vegetation NN I-NP O
87 EKG NNP I-NP O
87 on IN B-VP O
88 1/30/2005 CD O O
88 , , O O
88 normal JJ B-NP O
88 sinus NN I-NP O
88 rhythm NN I-NP O
88 at IN B-VP O
88 117 CD O O
88 Chest NNP B-NP O
88 x-ray NN I-NP O
88 on IN B-VP O
89 9/0/2005 CD O O
89 consistent JJ O O
89 with IN B-VP O
89 congestive JJ B-NP O
89 heart NN I-NP O
89 failure NN I-NP O
89 and CC O O
89 left VBD B-VP O
89 base NN B-NP O
90 opacity NN I-NP O
90 , , O O
90 probably RB O O
90 atelectasis NN B-NP O
90 has VBZ O O
90 worsened VBN O O
90 There EX O O
90 is VBZ O O
90 minimal JJ B-NP O
90 new JJ I-NP O
91 right JJ I-NP O
91 basilar NN I-NP O
91 atelectasis NN I-NP O
91 Upper NNP I-NP O
91 lung NN I-NP O
91 zones NNS I-NP O
91 remain VBP O O
91 clear JJ O O
91 The DT B-NP O
92 heart NN I-NP O
92 is VBZ O O
92 enlarged VBN O O
92 with IN B-VP O
92 vascular JJ B-NP O
92 engorgement NN I-NP O
92 , , O O
92 but CC O O
92 no DT B-NP O
92 frank JJ I-NP O
93 pulmonary JJ I-NP O
93 edema JJ I-NP O
93 Central NNP I-NP O
93 line NN I-NP O
93 remains VBZ O O
93 in IN B-VP O
93 the DT B-NP O
93 CVC NNP I-NP O
93 There EX O O
93 is VBZ O O
93 no DT B-NP O
94 pneumothorax NN I-NP O
94 seen VBN O O
95 PROCEDURE: NNP B-NP O
95 MVP NNP I-NP O
95 #28 NNP I-NP O
95 Other JJ B-NP O
95 annuloplasty JJ I-NP O
95 ring NN I-NP O
95 , , O O
95 ring VBG O O
95 annuloplasty NN B-NP O
95 , , O O
96 leaflet NN B-NP O
96 resection NN I-NP O
96 , , O O
96 post NN B-NP O
96 leaflet NN I-NP O
96 chordoplasty NN I-NP O
96 with IN B-VP O
96 Gore-Tex NNP B-NP O
97 suture NN I-NP O
97 , , O O
97 Vegetectomy NNP B-NP O
97 , , O O
97 SBE NNP B-NP O
97 , , O O
97 CABG NNP B-NP O
97 x1 NNP I-NP O
98 BYPASS: NNP I-NP O
98 350 CD O O
98 minutes NNS B-NP O
99 CROSS NNP I-NP O
99 CLAMP: NNP I-NP O
99 288 CD O O
99 minutes NNS B-NP O
100 Open JJ O O
100 chest VBP O O
100 one CD O O
100 ventricular NN B-NP O
100 wire NN I-NP O
100 , , O O
100 one CD O O
100 pericardial NN B-NP O
100 tube NN I-NP O
100 , , O O
100 one CD O O
101 retrosternal NN B-NP O
101 tube NN I-NP O
101 , , O O
101 two CD O O
101 pleural JJ B-NP O
101 tubes NNS I-NP O
101 Open NNP I-NP O
101 chest/semarch NN I-NP O
101 with IN B-VP O
102 bridge NN B-NP O
102 fashioned VBN O O
102 from IN B-VP O
102 60 CD O O
102 mL NNS B-NP O
102 syringe NN I-NP O
102 and CC O O
102 single JJ B-NP O
102 lap NN I-NP O
102 pad NN I-NP O
102 left VBD B-VP O
102 in IN B-VP O
103 place NN B-NP O
104 ICU NNP I-NP O
104 PROGRESS NNP I-NP O
104 EVENT NNP I-NP O
104 SUMMARY: NNP I-NP O
104 POD NNP I-NP O
104 1 CD O O
104 on IN B-VP O
104 7/6/2005 CD O O
104 ; : O O
104 admitted VBN O O
104 to TO O O
104 ICU NNP B-NP O
105 postop NN I-NP O
105 with IN B-VP O
105 open JJ B-NP O
105 chest NN I-NP O
105 after IN B-VP O
105 6 CD O O
105 hour NN B-NP O
105 pump NN I-NP O
105 run.Overnight NN I-NP O
106 vasodilated VBN O B-r
106 vasodilated VBD B-VP B-r
106 vasodilated JJ O B-r
106 , , O O
106 requiring VBG O O
106 pressors NNS B-NP B-m
106 , , O O
106 inotrops NNS B-NP B-m
106 and CC O O
106 methylene NN B-NP B-m
106 blue JJ B-NP I-m
106 POD NNP I-NP O
107 2 CD O O
107 , , O O
107 Weaned VBN O O
107 of IN B-VP O
107 onoptrops NNS B-NP B-m
107 successfully; VBP O O
107 Cultured VBN O O
107 from IN B-VP O
107 OR- JJ B-NP O
107 Staff NNP I-NP O
107 , , O O
108 antibiotics NNS B-NP B-m
108 changed VBD B-VP O
108 Previous NNP B-NP O
108 allergy NN I-NP O
108 ceftriaxone NN I-NP O
108 , , O O
108 gentamicin NN B-NP O
108 , , O O
109 levofloxacin JJ O O
109 discontinued VBN O O
109 , , O O
109 one CD O B-do
109 unit NN B-NP I-do
109 of IN B-VP O
109 packed JJ B-NP B-m
109 red JJ I-NP I-m
109 blood NN I-NP I-m
109 cells NNS I-NP I-m
110 given VBN O O
110 , , O O
110 SVO2 NNP B-NP O
110 improved; VBP O O
110 hematocrit NN B-NP O
110 stable JJ B-NP O
110 Chest NNP I-NP O
110 open NN I-NP O
110 on IN B-VP O
110 fentanyl NN B-NP B-m
111 and CC O O
111 Versed/semarch NNP B-NP B-m
111 On IN B-VP O
111 3/28/2005 CD O O
111 POD NNP B-NP O
111 3 CD O O
111 difficult JJ O O
111 to TO O O
111 wean VB O O
112 inotrops JJ B-NP B-m
112 Culture NN I-NP O
112 from IN B-VP O
112 OR NNP B-NP O
112 staff NN I-NP O
112 Antibiotics NNS I-NP B-m
112 changed VBD B-VP O
112 Previous NNP B-NP O
113 allergy NN I-NP O
113 ceftriaxone NN I-NP O
113 , , O O
113 gentamicin NN B-NP O
113 , , O O
113 levofloxacin JJ O O
113 discontinued VBN O O
114 Chest NNP B-NP O
114 washout NN I-NP O
114 yesterday NN I-NP O
114 , , O O
114 hematocrit NN B-NP O
114 stable JJ B-NP O
114 Chest NNP I-NP O
114 remains; NN I-NP O
114 open JJ O O
115 on IN B-VP O
115 fentanyl NN B-NP B-m
115 and CC O O
115 Versed VBD B-VP B-m
115 ;for NNP B-NP O
115 2ND CD O B-r
115 2ND CD O B-r
115 washout+/- JJ B-NP I-r
115 washout+/- JJ I-NP I-r
115 closure NN I-NP I-r
115 closure NN I-NP I-r
115 later RBR O O
115 this DT B-NP O
116 week NN I-NP O
116 POD NNP I-NP O
116 4 CD O O
116 stable JJ O O
116 , , O O
116 remains VBZ O O
116 on IN B-VP O
116 epi NN B-NP B-m
116 and CC O O
116 vaso NN B-NP B-m
116 , , O O
116 diuresing.Plan NN B-NP O
116 to TO O O
117 close VB O O
117 chest JJ B-NP O
117 tomorrow.POD NN I-NP O
117 5Pressors CD O O
117 continued VBD B-VP O
117 , , O O
117 continued VBD B-VP O
118 diuresis NN B-NP O
118 Abx NNP I-NP O
118 adjustments NNS I-NP O
118 made VBN O O
118 per IN B-VP O
118 ID NNP B-NP O
118 recommendations NNS I-NP O
118 , , O O
119 discontinue NN B-NP O
119 vancomycin NN I-NP B-m
119 and CC O O
119 gentamicin NN B-NP B-m
119 POD NNP I-NP O
119 6 CD O O
119 , , O O
119 chest NN B-NP O
119 closed VBD B-VP O
120 yesterday NN B-NP O
120 , , O O
120 ongoing VBG O O
120 pressor NN B-NP B-m
120 requirement NN I-NP O
120 POD NNP I-NP O
120 7 CD O O
120 , , O O
120 ventilation NN B-NP O
120 weaned VBD B-VP O
121 to TO O O
121 pressure VB O O
121 support NN B-NP O
121 ventilation NN I-NP O
121 , , O O
121 sedation NN B-NP B-m
121 weaned VBD B-VP O
121 , , O O
121 epinephrine NN B-NP B-m
122 weaned VBD B-VP O
122 to TO O O
122 off/ VB O O
122 , , O O
122 vasopressin NN B-NP B-m
122 weaned VBD B-VP O
122 Coffee-ground NNP B-NP O
122 output NN I-NP O
122 via IN B-VP O
123 nasogastric JJ B-NP O
123 tube NN I-NP O
123 today NN I-NP O
123 POD NNP I-NP O
123 8 CD O O
123 , , O O
123 developed VBD B-VP O
123 fluctuant JJ B-NP O
123 collection NN I-NP O
123 , , O O
124 left VBD B-VP O
124 supraclavicular JJ B-NP O
124 fossa NN I-NP O
124 CT NNP I-NP O
124 confirmed VBD B-VP O
124 probable JJ B-NP O
124 collection NN I-NP O
124 in IN B-VP O
125 clavicular JJ B-NP O
125 scapular JJ I-NP O
125 region NN I-NP O
125 , , O O
125 no DT B-NP O
125 bony NN I-NP O
125 involvement NN I-NP O
125 Aspiration NNP I-NP O
126 revealed VBD B-VP O
126 gram-positive JJ B-NP O
126 cocci NN I-NP O
126 Orthopedics NNP I-NP O
126 aware NN I-NP O
126 , , O O
126 will MD O O
126 review VB O O
127 today NN B-NP O
127 , , O O
127 remains VBZ O O
127 vasodilated VBN O O
127 on IN B-VP O
127 vasopressin NN B-NP B-m
127 Diuresed VBN O O
127 well RB O O
127 POD NNP B-NP O
128 9 CD O O
128 , , O O
128 had VBD B-VP O
128 I&amp;D NNP B-NP O
128 of IN B-VP O
128 collection NN B-NP O
128 yesterday NN I-NP O
128 , , O O
128 hypertensive JJ O O
128 0f CD O O
128 pressors NNS B-NP B-m
128 , , O O
129 requiring VBG O O
129 increasing VBG O O
129 Lopressor NNP B-NP B-m
129 doses NNS I-NP O
129 , , O O
129 now RB O O
129 on IN B-VP O
129 minimal JJ B-NP O
129 ventilator NN I-NP O
130 support NN I-NP O
130 POD NNP I-NP O
130 10 CD O O
130 , , O O
130 extubated VBN O O
130 , , O O
130 hypertensive JJ O B-r
130 , , O O
130 requiring VBG O O
130 Lopressor NNP B-NP B-m
130 , , O O
131 TNG NNP B-NP B-m
131 , , O O
131 Hydralazine NNP B-NP B-m
131 Temperature NNP I-NP O
131 102 CD O O
131 , , O O
131 failed VBD B-VP O
131 speech JJ B-NP O
131 evaluation NN I-NP O
131 POD NNP I-NP O
132 11 CD O O
132 , , O O
132 remains VBZ O O
132 on IN B-VP O
132 nicardipine JJ B-NP B-m
132 drip NN I-NP B-mo
132 for IN B-VP O
132 hypertension NN B-NP B-r
132 , , O O
132 febrile JJ O O
132 102 CD O O
133 POD NNP B-NP O
133 12 CD O O
133 , , O O
133 off RB O O
133 nicardipine JJ B-NP B-m
133 drip NN I-NP B-mo
133 Abscess NNP I-NP O
133 in IN B-VP O
133 right JJ B-NP O
133 thigh NN I-NP O
133 discharged VBD B-VP O
134 spontaneously RB O O
134 PICC NNP B-NP O
134 line NN I-NP O
134 now RB O O
134 in IN B-VP O
134 Small NNP B-NP O
134 amount NN I-NP O
134 of IN B-VP O
134 fresh JJ B-NP O
134 blood NN I-NP O
135 per IN B-VP O
135 rectum NN B-NP O
135 No NNP I-NP O
135 drop NN I-NP O
135 in IN B-VP O
135 hematocrit NN B-NP O
135 Afebrile NNP I-NP O
135 , , O O
135 taking VBG O O
135 p.o JJ B-NP O
135 diet NN I-NP O
135 , , O O
136 diuresing VBG O O
136 MRSA NNP B-NP O
136 POD NNP I-NP O
136 14 CD O O
136 , , O O
136 MRSA NNP B-NP B-r
136 in IN B-VP O
136 sputum NN B-NP O
136 , , O O
136 started VBD B-VP O
136 on IN B-VP O
136 vancomycin NN B-NP B-m
137 Arterial NNP I-NP O
137 line NN I-NP O
137 discontinued VBN O O
137 POD NNP B-NP O
137 15 CD O O
137 , , O O
137 started VBN O O
137 on IN B-VP O
137 tube NN B-NP O
137 feeds NNS I-NP O
137 , , O O
138 hypertensive JJ O O
138 , , O O
138 Lopressor NNP B-NP B-m
138 dose RB O O
138 reduced VBD B-VP O
138 to TO O O
138 50 CD O B-do
138 POD NNP B-NP O
138 16 CD O O
138 , , O O
139 sputum-growing JJ B-NP O
139 MRSA NNP I-NP O
139 Right-sided NNP I-NP O
139 effusion NN I-NP O
139 seen VBN O O
139 on IN B-VP O
139 chest JJS O O
139 x-ray JJ O O
140 with IN B-VP O
140 elevation NN B-NP O
140 of IN B-VP O
140 right NN B-NP O
140 diaphragm.Pulled VBN O O
140 out RP O O
140 dop-hof JJ B-NP O
140 overnight JJ I-NP O
141 POD NNP I-NP O
141 17 CD O O
141 , , O O
141 VRE NNP B-NP O
141 isolated VBD B-VP O
141 from IN B-VP O
141 right JJ B-NP O
141 side NN I-NP O
141 abscess RB O O
141 Now RB O O
141 oriented VBN O O
141 x3 NN B-NP O
142 ICU NNP I-NP O
142 TRANSFER NNP I-NP O
142 NOTE: NNP I-NP O
142 Date NNP I-NP O
142 of IN B-VP O
142 transfer NN B-NP O
142 , , O O
142 7/9/2005 CD O O
143 SUMMARY NN B-NP O
143 BY NNP I-NP O
143 SYSTEM: NNP I-NP O
144 1 CD O O
144 Neurologic: NNP B-NP O
144 Mental NNP I-NP O
144 status NN I-NP O
144 intact JJ O O
144 , , O O
144 alert JJ O O
144 , , O O
144 and CC O O
144 oriented VBD B-VP O
145 Neurological NNP B-NP O
145 exam NN I-NP O
145 , , O O
145 no DT B-NP O
145 focal JJ I-NP O
145 deficits NNS I-NP O
145 Now RB O O
145 oriented VBN O O
145 to TO O O
145 place VB O O
145 , , O O
146 month NN B-NP O
146 and CC O O
146 year NN B-NP O
146 Marked NNP I-NP O
146 improvement NN I-NP O
147 2 CD O O
147 Cardiovascular: NNP B-NP O
147 Cardiac NNP I-NP O
147 medications: NN I-NP O
147 Aspirin NNP I-NP B-m
147 , , O O
147 Lopressor NNP B-NP B-m
147 , , O O
148 Heart NNP B-NP O
148 rate NN I-NP O
148 , , O O
148 normal JJ B-NP O
148 sinus NN I-NP O
148 rhythm NN I-NP O
148 at IN B-VP O
148 95 CD O O
148 , , O O
148 blood NN B-NP O
148 pressure NN I-NP O
148 120/60 CD O O
149 ECG NNP B-NP O
149 , , O O
149 preop JJ B-NP O
149 ejection NN I-NP O
149 fraction NN I-NP O
149 65% CD O O
149 EF NNP B-NP O
149 Echo NNP I-NP O
149 on IN B-VP O
149 1/30/2005 CD O O
150 Cardiac NNP B-NP B-m
150 meds NNS I-NP I-m
150 , , O O
150 Lopressor NNP B-NP B-m
150 37.5 CD O B-do
150 p.o NN B-NP B-mo
150 q.6h NN I-NP B-f
150 Exam NNP I-NP O
150 , , O O
150 RRR NNP B-NP O
150 S1 NNP I-NP O
150 , , O O
150 S2 NNP B-NP O
150 , , O O
150 WNL NNP B-NP O
151 3 CD O O
151 Respiratory: NNP B-NP O
151 Ventilated VBD B-VP O
151 more JJR O O
151 than IN B-VP O
151 24 CD O O
151 hours NNS B-NP O
151 postoperatively RB O O
152 Extubated VBD B-VP O
152 on IN B-VP O
152 10/26/2005 CD O O
152 , , O O
152 FiO2 NNP B-NP O
152 3 CD O O
152 L NNP B-NP O
152 nasal JJ B-NP O
152 cannula NN I-NP O
152 , , O O
152 out IN B-VP O
152 of IN B-VP O
152 bed NN B-NP O
153 Chest NNP I-NP O
153 x-ray NN I-NP O
153 findings: NN I-NP O
153 Extubated VBD B-VP O
153 on IN B-VP O
153 10/26/2005 CD O O
153 , , O O
153 POD NNP B-NP O
153 9 CD O O
154 4 CD O O
154 GI: NNP B-NP O
154 Diet NNP I-NP O
154 Mechanical NNP I-NP O
154 soft JJ O O
154 , , O O
154 liquid JJ B-NP O
154 consistency NN I-NP O
154 , , O O
154 nectar NN B-NP O
154 , , O O
154 tube NN B-NP O
155 feeds NNS I-NP O
155 , , O O
155 Jevity NNP B-NP O
155 1.2 CD O O
155 tube NN B-NP O
155 feeds NNS I-NP O
155 , , O O
155 rate NN B-NP O
155 100 CD O O
155 mL NN B-NP O
155 /hr NN I-NP O
155 , , O O
155 0 CD O O
155 scoops/day JJ B-NP O
156 calories NNS I-NP O
157 5 CD O O
157 Renal: NNP B-NP O
157 Fluid NNP I-NP O
157 in IN B-VP O
157 1700 CD O O
157 mL NN B-NP O
157 24 CD O O
157 hours NNS B-NP O
157 , , O O
157 urine JJ B-NP O
157 output NN I-NP O
157 3200 CD O O
157 mL NN B-NP O
157 , , O O
158 balance NN B-NP O
158 -1500 NNP I-NP O
159 Weight: NNP I-NP O
159 Previous NNP I-NP O
159 day NN I-NP O
159 weight VBD B-VP O
159 84.5 CD O O
159 kg NN B-NP O
160 6 CD O O
160 Endocrine: NNP B-NP O
160 Diabetes NNP I-NP B-r
160 Diabetes NNP I-NP B-r
160 Meds NNP I-NP O
160 , , O O
160 insulin NN B-NP B-m
160 10 CD O B-do
160 units NNS B-NP I-do
160 subcutaneously RB O B-mo
161 at IN B-VP O
161 10 CD O B-f
161 p.m NN B-NP I-f
161 , , O O
161 Lantus NNP B-NP B-m
161 22 CD O B-do
161 units NNS B-NP I-do
161 SC NNP I-NP B-mo
161 q.p.m RB O B-f
162 7 CD O O
162 Heme: NNP B-NP O
162 Anticoagulation NNP I-NP B-r
162 Aspirin NNP I-NP B-m
163 8 CD O O
163 ID: NNP B-NP O
163 Septicemia NNP I-NP B-r
163 Septicemia NNP I-NP B-r
163 Septicemia NNP I-NP B-r
163 Septicemia NNP I-NP B-r
163 Organism NNP I-NP O
163 , , O O
163 Staphylococcus NNP B-NP O
163 aureus NN I-NP O
164 Antibiotics NNP I-NP B-m
164 , , O O
164 vancomycin NN B-NP B-m
164 started VBD B-VP O
164 on IN B-VP O
164 9/22/2005 CD O O
164 , , O O
164 penicillin NN B-NP B-m
164 G NNP I-NP I-m
164 , , O O
165 potassium NN B-NP B-m
165 3 CD O B-do
165 million CD O I-do
165 units NNS B-NP I-do
165 IV NNP I-NP B-mo
165 Skin NNP I-NP B-r
165 Skin NNP I-NP B-r
165 Skin NNP I-NP B-r
165 lesion NN I-NP I-r
165 lesion NN I-NP I-r
165 lesion NN I-NP I-r
165 infection NN I-NP I-r
165 infection NN I-NP I-r
165 infection NN I-NP I-r
165 Organism NNP I-NP O
165 , , O O
166 VRE NNP B-NP O
166 Antibiotics NNP I-NP B-m
166 , , O O
166 ceftriaxone NN B-NP B-m
166 2000 CD O B-do
166 mg NN B-NP I-do
166 IV NNP I-NP B-mo
166 daily RB O B-f
166 , , O O
166 penicillin NN B-NP B-m
166 G NNP I-NP I-m
166 , , O O
167 potassium NN B-NP B-m
167 4 CD O B-do
167 million CD O I-do
167 units NNS B-NP I-do
167 started VBD B-VP O
167 on IN B-VP O
167 9/14/2005 CD O O
167 Current JJ B-NP O
168 antibiotics NNS I-NP B-m
168 , , O O
168 vancomycin JJ B-NP B-m
168 day NN I-NP O
168 18 CD O O
168 for IN B-VP O
168 Staph NNP B-NP B-r
168 Staph NNP I-NP B-r
168 aureus VBZ O I-r
168 aureus JJ B-NP I-r
168 septicemia NN I-NP I-r
168 septicemia NN I-NP I-r
168 , , O O
169 penicillin NN B-NP B-m
169 G NNP I-NP I-m
169 3 CD O B-do
169 million CD O I-do
169 units NNS B-NP I-do
169 IV NNP I-NP B-mo
169 , , O O
169 ceftriaxone NN B-NP B-m
169 2000 CD O B-do
169 mg NN B-NP I-do
169 IV NNP I-NP B-mo
169 daily RB O B-f
169 , , O O
170 penicillin NN B-NP B-m
170 G NNP I-NP I-m
170 , , O O
170 potassium NN B-NP B-m
170 4 CD O B-do
170 million CD O I-do
170 units NNS B-NP I-do
170 day NN I-NP O
170 13 CD O O
170 for IN B-VP O
170 Staph NNP B-NP B-r
170 Staph NNP I-NP B-r
170 Staph NNP I-NP B-r
170 Staph NNP I-NP B-r
170 aureus NN I-NP O
171 septicemia NN I-NP O
171 , , O O
171 VRE NNP B-NP O
171 skin FW O O
171 lesion NN B-NP O
171 infection NN I-NP O
171 T-max NNP I-NP O
171 99.2 CD O O
171 Fahrenheit NNP B-NP O
172 ID NNP I-NP O
172 consult NN I-NP O
172 declined VBD B-VP O
172 , , O O
172 needs VBZ O O
172 inLineziline NN B-NP O
172 for IN B-VP O
172 right JJ B-NP O
172 side NN I-NP O
172 abscess RB O O
173 9 CD O O
173 Neurologic NNP B-NP O
173 plan: NN I-NP O
173 Continue NNP I-NP O
173 to TO O O
173 monitor VB O O
173 neurologic JJ B-NP O
173 progress NN I-NP O
174 10 CD O O
174 Cardiovascular JJ B-NP O
174 plan: NN I-NP O
174 Watch NNP I-NP O
174 blood NN I-NP B-r
174 pressure NN I-NP I-r
174 , , O O
174 titrate NN B-NP B-do
175 Lopressor NNP I-NP B-m
175 as IN B-VP O
175 tolerated VBN O O
175 while IN B-VP O
175 diuresing VBG O O
176 11 CD O O
176 Respiratory NNP B-NP O
176 plan:OOB NN I-NP O
176 with IN B-VP O
176 PT NNP B-NP O
176 , , O O
176 wean JJ B-NP O
176 oxygen NN I-NP B-m
177 12 CD O O
177 Gastrointestinal NNP B-NP O
177 plan: NN I-NP O
177 Did NNP I-NP O
177 well RB O O
177 with IN B-VP O
177 oral JJ B-NP O
177 diet NN I-NP O
177 yesterday NN I-NP O
178 Continue NNP I-NP O
178 to TO O O
178 encourage VB O O
178 oral JJ B-NP O
178 diet NN I-NP O
178 and CC O O
178 monitor NN B-NP O
178 calorie NNS I-NP O
178 intake VBP O O
179 13 CD O O
179 Renal NNP B-NP O
179 plan: NN I-NP O
179 Continue NNP I-NP O
179 gentle JJ B-NP O
179 diuresis NN I-NP O
180 14 CD O O
180 Endocrine: NNP B-NP O
180 Controlled VBD B-VP O
181 15 CD O O
181 Hematologic NNP B-NP O
181 plan: NN I-NP O
181 Monitor NNP I-NP O
181 hematocrit NN I-NP O
181 Ensue NNP I-NP O
181 his PRP$ O O
181 wearing VBG O O
182 pneumatic JJ B-NP O
182 boots NNS I-NP O
182 Minor NNP I-NP O
182 procedures: NN I-NP O
182 Bronchoscopy NNP I-NP O
182 , , O O
182 therapeutic JJ B-NP O
183 respiration NN I-NP O
184 MOST NNP I-NP O
184 RECENT NNP I-NP O
184 MEDICATIONS: NNP I-NP O
184 Lopressor NNP I-NP B-m
184 37.5 CD O B-do
184 mg NN B-NP I-do
184 p.o NN I-NP B-mo
184 q.6h NN I-NP B-f
184 , , O O
184 Lasix NNP B-NP B-m
184 20 CD O B-do
185 mg NN B-NP O
185 p.o NN I-NP B-mo
185 t.i.d NN I-NP B-f
185 , , O O
185 acetylsalicylic JJ O B-m
185 acid VBP O I-m
185 325 CD O B-do
185 mg NN B-NP I-do
185 p.o NN I-NP B-mo
185 , , O O
185 Naturale NNP B-NP B-m
185 Tears NNP I-NP I-m
186 one CD O B-do
186 drop NN B-NP I-do
186 O.U NNP I-NP B-mo
186 , , O O
186 Colace NNP B-NP B-m
186 100 CD O B-do
186 mg NN B-NP I-do
186 p.o NN I-NP B-mo
186 t.i.d NN I-NP B-f
186 , , O O
186 insulin NN B-NP B-m
186 regular JJ B-NP I-m
186 Humulin NNP I-NP I-m
187 4 CD O B-do
187 units NNS B-NP I-do
187 subcu RB O B-mo
187 , , O O
187 lactinex JJ B-NP B-m
187 granules NNS I-NP I-m
187 2 CD O B-do
187 tabs NNS B-NP I-do
187 p.o NN I-NP B-mo
187 , , O O
187 magnesium NN B-NP B-m
187 sulfate NN I-NP I-m
187 , , O O
188 sliding VBG O B-do
188 scale NN B-NP I-do
188 intravenously RB O B-mo
188 , , O O
188 penicillin NN B-NP B-m
188 G NNP I-NP I-m
188 , , O O
188 potassium NN B-NP B-m
188 4 CD O B-do
188 million CD O O
189 units NNS B-NP O
189 IV NNP I-NP B-mo
189 , , O O
189 vancomycin NN B-NP B-m
189 1000 CD O B-do
189 mg NN B-NP I-do
189 IV NNP I-NP B-mo
189 , , O O
189 Nexium NNP B-NP B-m
189 20 CD O B-do
189 mg NN B-NP I-do
189 p.o JJ O B-mo
189 daily RB O B-f
189 , , O O
189 Lantus NNP B-NP B-m
190 22 CD O B-do
190 units NNS B-NP I-do
190 subcu JJ O B-mo
190 q.p.m RB O B-f
190 , , O O
190 NovoLog NNP B-NP B-m
190 sliding VBG O B-do
190 scale JJ B-NP I-do
190 SC NNP I-NP B-mo
191 eScription NN I-NP O
191 document: VBD B-VP O
191 1-4775276 JJ B-NP O
191 HFFocus NNP I-NP O
192 Dictated NNP I-NP O
192 By: NNP I-NP O
192 GAIN NNP I-NP O
192 , , O O
192 LENNY NNP B-NP O
193 Attending: NNP I-NP O
193 DITUCCI NNP I-NP O
193 , , O O
193 KIETH NNP B-NP O
193 CLAUD NNP I-NP O
194 Dictation NNP I-NP O
194 ID NNP I-NP O
194 7748550 CD O O
195 D: NNP B-NP O
195 7/4/05 CD O O
196 T: NNP B-NP O
196 3/15/05 CD O O
197 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #733459 VBZ O O
2 185449655 CD O O
2 HMH NNP B-NP O
2 41698736 CD O O
2 6101075 CD O O
2 9/10/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CONGESTIVE NNP I-NP O
2 HEART NNP I-NP O
2 FAILURE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/10/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/12/2005 CD O O
4 ATTENDING: NNP B-NP O
4 WUITSCHICK NNP I-NP O
4 , , O O
4 LEROY NNP B-NP O
4 M.D NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Heart NNP I-NP O
5 failure NN I-NP O
6 LISTS NNP I-NP O
6 OF NNP I-NP O
6 PROBLEMS NNP I-NP O
6 AND NNP I-NP O
6 DIAGNOSES: NNP I-NP O
6 Status NNP I-NP O
6 post NN I-NP O
6 cardiac NN I-NP O
6 transplant NN I-NP O
7 in IN B-VP O
7 1993 CD O O
7 , , O O
7 obesity NN B-NP O
7 , , O O
7 chronic JJ B-NP O
7 obstructive JJ I-NP O
7 pulmonary JJ I-NP O
7 disease NN I-NP O
7 , , O O
8 insulin-dependent JJ B-NP O
8 diabetes NNS I-NP O
8 mellitus NN I-NP O
8 , , O O
8 chronic JJ B-NP O
8 renal JJ I-NP O
8 insufficiency NN I-NP O
9 with IN B-VP O
9 a DT B-NP O
9 baseline NN I-NP O
9 of IN B-VP O
9 creatinine NN B-NP O
9 of IN B-VP O
9 1.5 CD O O
9 , , O O
9 hepatitis NN B-NP O
9 B NNP I-NP O
9 , , O O
9 hypertension NN B-NP O
9 , , O O
10 osteoporosis NN B-NP O
10 , , O O
10 status NN B-NP O
10 post NN I-NP O
10 L3 NNP I-NP O
10 compression NN I-NP O
10 fracture NN I-NP O
10 , , O O
10 status NN B-NP O
10 post NN I-NP O
11 left VBD B-VP O
11 hip JJ B-NP O
11 fracture NN I-NP O
11 with IN B-VP O
11 replacement NN B-NP O
11 in IN B-VP O
11 July NNP B-NP O
11 2005 CD O O
11 , , O O
11 complicated VBN O O
11 by IN B-VP O
12 infection NN B-NP O
12 necessitating VBG O O
12 removal NN B-NP O
12 , , O O
12 debridement NN B-NP O
12 , , O O
12 and CC O O
12 deconditioning VBG O O
13 BRIEF NNP B-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 Ms NNP I-NP O
13 Halnon NNP I-NP O
13 is VBZ O O
13 a DT B-NP O
13 67-year-old JJ I-NP O
14 female NN I-NP O
14 with IN B-VP O
14 multiple JJ B-NP O
14 medical JJ I-NP O
14 comorbidities NNS I-NP O
14 and CC O O
14 a DT B-NP O
14 past JJ I-NP O
14 medical JJ I-NP O
15 history NN I-NP O
15 significant JJ O O
15 for IN B-VP O
15 cardiac JJ B-NP O
15 transplant NN I-NP O
15 in IN B-VP O
15 1993 CD O O
15 , , O O
15 and CC O O
15 hip NN B-NP O
16 replacement NN I-NP O
16 in IN B-VP O
16 July NNP B-NP O
16 2005 CD O O
16 , , O O
16 complicated VBN O O
16 by IN B-VP O
16 wound NN B-NP O
16 infection NN I-NP O
16 , , O O
16 and CC O O
16 need VBP O O
17 for IN B-VP O
17 prolonged JJ B-NP O
17 rehabilitation NN I-NP O
17 who WP O O
17 presented VBD B-VP O
17 from IN B-VP O
17 Port NNP B-NP O
17 Medical NNP I-NP O
17 Center NNP I-NP O
17 to TO O O
17 Ephma NNP B-NP O
17 Mersources NNP I-NP O
17 Ni NNP I-NP O
17 Memorial NNP I-NP O
17 Hospital NNP I-NP O
17 with IN B-VP O
17 three CD O O
17 days NNS B-NP O
17 of IN B-VP O
18 progressive JJ O O
18 worsening VBG O O
18 shortness NN B-NP O
18 of IN B-VP O
18 breath NN B-NP O
18 Her NNP I-NP O
18 chest NN I-NP O
18 x-ray NN I-NP O
18 was VBD B-VP O
19 consistent JJ O O
19 with IN B-VP O
19 congestive JJ B-NP O
19 heart NN I-NP O
19 failure NN I-NP O
19 , , O O
19 and CC O O
19 she PRP O O
19 was VBD B-VP O
19 transferred VBN O O
20 to TO O O
20 Ckmond NNP B-NP O
20 Kinga NNP I-NP O
20 Quinaualv NNP I-NP O
20 Medical NNP I-NP O
20 Center NNP I-NP O
20 with IN B-VP O
20 the DT B-NP O
20 request NN I-NP O
20 of IN B-VP O
20 her PRP$ O O
20 daughter NN B-NP O
21 for IN B-VP O
21 further JJ B-NP O
21 management NN I-NP O
21 of IN B-VP O
21 her PRP$ O O
21 heart NN B-NP O
21 failure NN I-NP O
21 Here RB O O
21 , , O O
21 her PRP O O
21 mental JJ B-NP O
22 status NN I-NP O
22 was VBD B-VP O
22 borderline JJ O O
22 upon IN B-VP O
22 admission NN B-NP O
22 , , O O
22 but CC O O
22 it PRP O O
22 improved VBD B-VP O
22 with IN B-VP O
23 discontinuation NN B-NP O
23 of IN B-VP O
23 standing VBG O O
23 analgesic JJ O B-m
23 and CC O O
23 decreasing NN B-NP O
23 of IN B-VP O
23 her PRP$ O O
24 clonazepam NN B-NP B-m
24 A DT B-NP O
24 head NN I-NP O
24 CT NNP I-NP O
24 showed VBD B-VP O
24 no DT B-NP O
24 acute NN I-NP O
24 processes VBZ O O
24 She PRP O O
24 had VBD B-VP O
24 a DT B-NP O
25 right JJ I-NP O
25 upper JJ I-NP O
25 arm NN I-NP O
25 cellulitis NN I-NP O
25 and CC O O
25 urinary JJ B-NP O
25 tract NN I-NP O
25 infection NN I-NP O
25 on IN B-VP O
26 screening VBG O O
26 urinalysis NN B-NP O
26 She PRP O O
26 was VBD B-VP O
26 anemic JJ O O
26 She PRP O O
26 was VBD B-VP O
26 found VBN O O
26 to TO O O
26 be VB O O
27 vancomycin JJ B-NP O
27 resistant JJ I-NP O
27 Enterococcus NNP I-NP O
27 positive JJ O O
27 , , O O
27 but CC O O
27 repeated VBD B-VP O
27 cultures NNS B-NP O
28 demonstrated VBD B-VP O
28 MRSA NNP B-NP O
28 negative JJ B-NP O
28 Her NNP I-NP O
28 inpatient NN I-NP O
28 issues NNS I-NP O
28 included VBD B-VP O
29 management NN B-NP O
29 of IN B-VP O
29 her PRP$ O O
29 heart NN B-NP O
29 failure NN I-NP O
29 , , O O
29 right JJ B-NP O
29 upper JJ I-NP O
29 extremity NN I-NP O
30 cellulitis NN I-NP O
30 , , O O
30 urinary JJ B-NP O
30 tract NN I-NP O
30 infection NN I-NP O
30 , , O O
30 chronic JJ B-NP O
30 anemia NN I-NP O
30 , , O O
30 diabetes VBZ O O
30 , , O O
31 and CC O O
31 evaluation NN B-NP O
31 of IN B-VP O
31 her PRP$ O O
31 hip NN B-NP O
31 by IN B-VP O
31 orthopedics NNS B-NP O
32 ALLERGIES: NNP I-NP O
32 She PRP O O
32 had VBD B-VP O
32 allergies NNS B-NP O
32 to TO O O
32 penicillin VB O O
32 and CC O O
32 codeine VB O O
32 , , O O
32 but CC O O
32 the DT B-NP O
33 reactions NNS I-NP O
33 are VBP O O
33 unknown JJ B-NP O
34 MEDICATIONS NNP I-NP O
34 ON NNP I-NP O
34 ADMISSION: NNP I-NP O
34 Vitamin NNP I-NP B-m
34 C NNP I-NP I-m
34 , , O O
34 Imuran NNP B-NP B-m
34 , , O O
34 PhosLo NNP B-NP B-m
34 , , O O
34 iron NN B-NP B-m
35 sulfate NN I-NP O
35 , , O O
35 Deltasone NNP B-NP B-m
35 , , O O
35 Coumadin NNP B-NP B-m
35 , , O O
35 Aranesp NNP B-NP B-m
35 , , O O
35 Dilaudid NNP B-NP B-m
35 for IN B-VP O
35 pain NN B-NP B-r
35 , , O O
36 lactulose RB O B-m
36 , , O O
36 Reglan NNP B-NP B-m
36 , , O O
36 Sarna NNP B-NP B-m
36 topical NN I-NP B-mo
36 , , O O
36 Senokot NNP B-NP B-m
36 , , O O
36 Ambien NNP B-NP B-m
36 for IN B-VP O
36 sleep NN B-NP B-r
36 , , O O
37 miconazole JJ B-NP B-m
37 powder NN I-NP I-m
37 , , O O
37 cyclosporine NN B-NP B-m
37 , , O O
37 Celexa NNP B-NP B-m
37 , , O O
37 and CC O O
37 Lasix NNP B-NP B-m
37 80 CD O B-do
37 mg NN B-NP I-do
37 once RB O B-f
37 per IN B-VP O
38 day NN B-NP O
39 PHYSICAL NNP I-NP O
39 EXAMINATION: NNP I-NP O
39 She PRP O O
39 was VBD B-VP O
39 afebrile IN B-VP O
39 Her NNP B-NP O
39 blood NN I-NP O
39 pressure NN I-NP O
39 was VBD B-VP O
40 130/57 CD O O
40 , , O O
40 and CC O O
40 her PRP$ O O
40 pulse JJ O O
40 120 CD O O
40 in IN B-VP O
40 sinus NN B-NP O
40 tachycardia NN I-NP O
40 She PRP O O
40 was VBD B-VP O
40 95% CD O O
41 saturated VBN O O
41 on IN B-VP O
41 3 CD O O
41 liters NNS B-NP O
41 Physical JJ B-NP O
41 exam NN I-NP O
41 was VBD B-VP O
41 significant JJ O O
41 for IN B-VP O
42 bibasilar JJ B-NP O
42 crackles NNS I-NP O
42 in IN B-VP O
42 her PRP$ O O
42 lungs NNS B-NP O
42 2+ CD O O
42 edema NN B-NP O
42 in IN B-VP O
42 her PRP$ O O
42 legs NN B-NP O
42 to TO O O
42 her PRP$ O O
43 knees NNS B-NP O
43 A DT O O
43 5 CD O O
43 cm NN B-NP O
43 x VBD B-VP O
43 5 CD O O
43 cm JJ B-NP O
43 area NN I-NP O
43 of IN B-VP O
43 warm JJ B-NP O
43 erythema NN I-NP O
43 in IN B-VP O
43 her PRP$ O O
43 right JJ B-NP O
43 upper JJ I-NP O
44 extremity NN I-NP O
44 and CC O O
44 a DT B-NP O
44 left JJ I-NP O
44 hip NN I-NP O
44 wound NN I-NP O
44 with IN B-VP O
44 packing VBG O O
44 in IN B-VP O
44 place NN B-NP O
44 granulation NN I-NP O
45 tissue NN I-NP O
46 OPERATIONS NNP I-NP O
46 AND NNP I-NP O
46 PROCEDURES: NNP I-NP O
46 CT NNP I-NP O
46 of IN B-VP O
46 her PRP$ O O
46 head NN B-NP O
46 , , O O
46 which WDT O O
46 showed VBD B-VP O
46 no DT B-NP O
46 acute NN I-NP O
47 processes VBZ O O
47 Echocardiogram NNP B-NP O
47 of IN B-VP O
47 her PRP$ O O
47 heart NN B-NP O
47 showed VBD B-VP O
47 an DT B-NP O
47 ejection NN I-NP O
48 fraction NN I-NP O
48 of IN B-VP O
48 55% CD O O
48 Normal NNP B-NP O
48 right JJ B-NP O
48 ventricle NN I-NP O
48 and CC O O
48 structure NN B-NP O
48 with IN B-VP O
48 mild JJ O O
49 to TO O O
49 moderately RB O O
49 reduced JJ B-NP O
49 systolic JJ I-NP O
49 function NN I-NP O
49 in IN B-VP O
49 her PRP$ O O
49 right JJ B-NP O
49 ventricle NN I-NP O
50 Moderately RB O O
50 dilated VBD B-VP O
50 left JJ B-NP O
50 atrium NN I-NP O
50 , , O O
50 moderately RB O O
50 dilated VBD B-VP O
50 right JJ B-NP O
50 atrium NN I-NP O
50 , , O O
51 normal JJ B-NP O
51 aortic JJ I-NP O
51 valve NN I-NP O
51 , , O O
51 mild NN B-NP O
51 to TO O O
51 moderate VB O O
51 mitral JJ B-NP O
51 regurgitation NN I-NP O
51 , , O O
51 and CC O O
52 structurally RB O O
52 normal JJ B-NP O
52 tricuspid JJ I-NP O
52 valve NN I-NP O
52 Right NNP I-NP O
52 upper JJ B-NP O
52 arm NN I-NP O
52 ultrasound NN I-NP O
52 , , O O
53 which WDT O O
53 showed VBD B-VP O
53 no DT B-NP O
53 evidence NN I-NP O
53 of IN B-VP O
53 venous JJ B-NP O
53 obstruction NN I-NP O
54 HOSPITAL NNP I-NP O
54 COURSE NNP I-NP O
54 BY NNP I-NP O
54 PROBLEM: NNP I-NP O
54 Ms NNP I-NP O
54 Gockley NNP I-NP O
54 's POS O O
54 inpatient NN B-NP O
54 issues NNS I-NP O
55 included VBD B-VP O
55 management NN B-NP O
55 of IN B-VP O
55 her PRP$ O O
55 heart NN B-NP O
55 failure NN I-NP O
55 , , O O
55 right JJ B-NP O
55 upper JJ I-NP O
55 arm NN I-NP O
56 extremity NN I-NP O
56 cellulitis NN I-NP O
56 , , O O
56 urinary JJ B-NP O
56 tract NN I-NP O
56 infection NN I-NP O
56 , , O O
56 chronic JJ B-NP O
56 anemia NN I-NP O
56 , , O O
57 diabetes NNS B-NP O
57 and CC O O
57 evaluation NN B-NP O
57 of IN B-VP O
57 her PRP$ O O
57 hip NN B-NP O
57 by IN B-VP O
57 orthopedics NNS B-NP O
57 For IN B-VP O
57 her PRP$ O B-r
57 her PRP$ O B-r
57 her PRP$ O B-r
57 heart NN B-NP O
58 failure NN I-NP O
58 , , O O
58 she PRP O O
58 was VBD B-VP O
58 diuresed VBN O O
58 with IN B-VP O
58 IV NNP B-NP B-mo
58 and CC O O
58 transitioned VBD B-VP O
58 to TO O O
58 oral JJ B-NP B-mo
59 torsemide NN I-NP B-m
59 torsemide NN I-NP B-m
59 and CC O O
59 they PRP O O
59 entered VBD B-VP O
59 discharge NN B-NP O
59 dose NN I-NP O
59 of IN B-VP O
59 torsemide JJ O B-m
59 200 CD O B-do
59 mg NN B-NP I-do
60 p.o NN I-NP B-mo
60 twice RB O B-f
60 per IN B-VP I-f
60 day NN B-NP I-f
60 Her PRP$ O O
60 admission NN B-NP O
60 weight NN I-NP O
60 was VBD B-VP O
60 133 CD O O
60 kg NN B-NP O
60 and CC O O
60 her PRP$ O O
61 discharge NN B-NP O
61 weight VBD B-VP O
61 122 CD O O
61 kg NNS B-NP O
61 She PRP O O
61 should MD O O
61 continue VB O O
61 on IN B-VP O
61 her PRP O O
61 current JJ B-NP O
62 torsemide NN I-NP B-m
62 and CC O O
62 limit NN B-NP O
62 her PRP$ O O
62 daily JJ B-NP O
62 salt NN I-NP O
62 intake NN I-NP O
62 , , O O
62 and CC O O
62 restrict VB O O
62 herself PRP O O
63 to TO O O
63 2 CD O O
63 liters NNS B-NP O
63 per IN B-VP O
63 day NN B-NP O
63 for IN B-VP O
63 her PRP$ O O
63 right JJ B-NP O
63 upper JJ I-NP O
63 extremity NN I-NP O
63 cellulitis NN I-NP O
64 She PRP O O
64 was VBD B-VP O
64 given VBN O O
64 a DT B-NP B-du
64 five-day JJ I-NP I-du
64 course NN I-NP I-du
64 of IN B-VP O
64 levofloxacin NN B-NP B-m
64 ( ( O O
64 used VBN O O
64 to TO O O
64 address VB O O
65 recurrent JJ B-NP B-r
65 UTI NNP I-NP I-r
65 ) ) O O
65 and CC O O
65 then RB O O
65 a DT B-NP B-du
65 two-day JJ I-NP I-du
65 course NN I-NP I-du
65 of IN B-VP O
65 Ancef NNP B-NP B-m
65 , , O O
65 her PRP$ O B-r
65 cellulitis NN B-NP I-r
66 cleared VBD B-VP O
66 with IN B-VP O
66 this DT B-NP O
66 regimen NN I-NP O
66 For IN B-VP O
66 her PRP$ O B-r
66 her PRP$ O B-r
66 urinary JJ B-NP I-r
66 urinary JJ I-NP I-r
66 tract NN I-NP I-r
66 tract JJ B-NP I-r
66 infection NN I-NP I-r
66 infection NN I-NP I-r
66 , , O O
66 she PRP O O
67 was VBD B-VP O
67 initially RB O O
67 treated VBN O O
67 with IN B-VP O
67 levofloxacin NN B-NP B-m
67 and CC O O
67 transitioned VBD B-VP O
67 to TO O O
68 Bactrim NNP B-NP B-m
68 based VBN O O
68 on IN B-VP O
68 antibiogram JJ B-NP O
68 sensitivities NNS I-NP O
68 A DT B-NP O
68 long-term JJ I-NP O
68 Foley NNP I-NP O
69 catheter NN I-NP O
69 was VBD B-VP O
69 removed VBN O O
69 Repeat NNP B-NP O
69 cultures NNS I-NP O
69 showed VBD B-VP O
69 bacteria NNS B-NP O
69 in IN B-VP O
69 her PRP$ O O
70 urine; JJ O O
70 however RB O O
70 , , O O
70 she PRP O O
70 was VBD B-VP O
70 clinically RB O O
70 asymptomatic JJ O O
70 , , O O
70 it PRP O O
70 was VBD B-VP O
70 felt VBN O O
70 that IN B-VP O
71 this DT O O
71 is VBZ O O
71 more RBR O O
71 consistent JJ O O
71 with IN B-VP O
71 colonization NN B-NP O
71 and CC O O
71 no DT B-NP O
71 further JJ I-NP O
72 treatment NN I-NP O
72 was VBD B-VP O
72 instituted VBN O O
72 If IN B-VP O
72 needed VBN O O
72 for IN B-VP O
72 further JJ B-NP O
72 antibiotics NNS I-NP O
72 , , O O
72 a DT B-NP O
73 PICC NNP I-NP O
73 line NN I-NP O
73 was VBD B-VP O
73 placed VBN O O
73 on IN B-VP O
73 March NNP B-NP O
73 , , O O
73 2005 CD O O
73 , , O O
73 after IN B-VP O
73 her PRP$ O O
73 prior JJ B-NP O
73 PICC NNP I-NP O
74 line NN I-NP O
74 clotted VBD B-VP O
74 Prior NNP B-NP O
74 to TO O O
74 discharge VB O O
74 , , O O
74 a DT B-NP O
74 new JJ I-NP O
74 Foley NNP I-NP O
74 catheter NN I-NP O
74 was VBD B-VP O
75 placed VBN O O
75 and CC O O
75 she PRP O O
75 was VBD B-VP O
75 incontinent NN B-NP O
75 of IN B-VP O
75 urine JJ O O
75 and CC O O
75 overall JJ O O
75 more RBR O O
76 comfortable JJ O O
76 with IN B-VP O
76 catheter NN B-NP O
76 in IN B-VP O
76 place NN B-NP O
76 While IN B-VP O
76 on IN B-VP O
76 Bactrim NNP B-NP B-m
76 for IN B-VP O
76 her PRP$ O B-r
77 UTI NNP B-NP O
77 , , O O
77 her PRP$ O O
77 creatinine NN B-NP O
77 rose VBD B-VP O
77 to TO O O
77 a DT B-NP O
77 peak NN I-NP O
77 of IN B-VP O
77 2.0 CD O O
77 , , O O
77 it PRP O O
77 was VBD B-VP O
77 unclear JJ O O
77 whether IN B-VP O
78 this DT B-NP O
78 raise NN I-NP O
78 was VBD B-VP O
78 due JJ O O
78 to TO O O
78 diuresis VB O O
78 or CC O O
78 the DT O O
78 antibiotic JJ O B-m
78 With IN B-VP O
78 cessation NN B-NP O
79 of IN B-VP O
79 the DT O O
79 antibiotic JJ O B-m
79 , , O O
79 her PRP$ O O
79 creatinine NN B-NP O
79 trended VBD B-VP O
79 downward RB O O
79 to TO O O
79 her PRP$ O O
80 baseline NN B-NP O
80 at IN B-VP O
80 1.6 CD O O
80 For IN B-VP O
80 her PRP$ O B-r
80 her PRP$ O B-r
80 chronic JJ B-NP I-r
80 chronic JJ I-NP I-r
80 anemia NN I-NP I-r
80 anemia NN I-NP I-r
80 , , O O
80 the DT B-NP O
80 patient NN I-NP O
80 was VBD B-VP O
81 continued VBN O O
81 on IN B-VP O
81 iron NN B-NP B-m
81 ( ( O O
81 which WDT O O
81 was VBD B-VP O
81 increased VBN O O
81 to TO O O
81 three CD O B-f
81 times NNS B-NP I-f
81 per IN B-VP I-f
81 day NN B-NP I-f
81 ) ) O O
82 and CC O O
82 darbepoetin NN B-NP B-m
82 , , O O
82 folate NN B-NP B-m
82 was VBD B-VP O
82 added VBN O O
82 She PRP O O
82 was VBD B-VP O
82 asymptomatic JJ O O
82 from IN B-VP O
82 her PRP$ O B-r
82 her PRP$ O B-r
83 chronic JJ B-NP O
83 anemia NN I-NP O
83 She PRP O O
83 was VBD B-VP O
83 given VBN O O
83 two CD O B-do
83 units NNS B-NP I-do
83 of IN B-VP O
83 packed JJ B-NP B-m
83 packed NNS I-NP B-m
83 red JJ B-NP O
83 blood NN I-NP O
84 cells NNS I-NP O
84 in IN B-VP O
84 March NNP B-NP O
84 , , O O
84 2005 CD O O
84 , , O O
84 and CC O O
84 two CD O O
84 more JJR B-NP O
84 units NNS I-NP O
84 on IN B-VP O
84 February NNP B-NP O
84 , , O O
85 2005 CD O O
85 , , O O
85 and CC O O
85 she PRP O O
85 responded VBD B-VP O
85 appropriately RB O O
85 to TO O O
85 this DT B-NP O
85 Her NNP I-NP O
85 discharge NN I-NP O
86 hematocrit NN I-NP O
86 was VBD B-VP O
86 30 CD O O
86 Her NNP B-NP O
86 hip NN I-NP O
86 was VBD B-VP O
86 evaluated VBN O O
86 by IN B-VP O
86 orthopedics NNS B-NP O
86 They PRP O O
87 felt VBD B-VP O
87 her PRP O O
87 hip NN B-NP O
87 was VBD B-VP O
87 healing VBG O O
87 well RB O O
87 She PRP O O
87 should MD O O
87 be VB O O
87 continued VBN O O
87 on IN B-VP O
88 wet-to-dry JJ B-NP O
88 dressings NNS I-NP O
88 No DT B-NP O
88 further JJ I-NP O
88 orthopedic JJ I-NP O
88 intervention NN I-NP O
88 is VBZ O O
89 planned VBN O O
89 She PRP O O
89 can MD O O
89 bear VB O O
89 her PRP$ O O
89 full JJ B-NP O
89 weight NN I-NP O
89 on IN B-VP O
89 her PRP$ O O
89 hip NN B-NP O
89 At IN B-VP O
89 discharge NN B-NP O
89 , , O O
90 the DT B-NP O
90 patient NN I-NP O
90 was VBD B-VP O
90 hemodynamically RB O O
90 stable JJ O O
90 , , O O
90 afebrile JJ O O
90 , , O O
90 and CC O O
90 breathing VBG O O
91 comfortably RB O O
91 on IN B-VP O
91 three CD O B-do
91 liters NNS B-NP I-do
91 of IN B-VP O
91 oxygen NN B-NP B-m
91 She PRP O O
91 was VBD B-VP O
91 discharged VBN O O
91 to TO O O
92 Naor NNP B-NP O
92 Viewmor NNP I-NP O
92 Hospital NNP I-NP O
92 and CC O O
92 should MD O O
92 work VB O O
92 aggressively RB O O
92 towards NNS B-NP O
93 reconditioning VBG O O
94 DISCHARGE NNP B-NP O
94 MEDICATIONS: NNP I-NP O
94 Vitamin NNP I-NP B-m
94 C NNP I-NP I-m
94 500 CD O B-do
94 mg NN B-NP I-do
94 twice RB O B-f
94 per IN B-VP I-f
94 day NN B-NP I-f
94 , , O O
94 Imuran NNP B-NP B-m
94 25 CD O B-do
95 mg JJ O O
95 daily RB O B-f
95 , , O O
95 PhosLo NNP B-NP B-m
95 667 CD O B-do
95 mg NN B-NP I-do
95 three CD O B-f
95 times NNS B-NP I-f
95 per IN B-VP I-f
95 day NN B-NP I-f
95 , , O O
95 clonazepam VBP O B-m
95 0.25 CD O B-do
95 mg JJ O I-do
96 twice RB O B-f
96 per IN B-VP I-f
96 day NN B-NP I-f
96 , , O O
96 cyclosporine VBP O B-m
96 50 CD O B-do
96 mg JJ O I-do
96 twice RB O B-f
96 daily RB O I-f
96 , , O O
96 Colace NNP B-NP B-m
96 100 CD O B-do
96 mg NN B-NP I-do
97 twice RB O B-f
97 daily RB O I-f
97 , , O O
97 iron NN B-NP B-m
97 sulfate NN I-NP I-m
97 325 CD O B-do
97 mg NN B-NP I-do
97 three CD O B-f
97 times NNS B-NP I-f
97 per IN B-VP I-f
97 day NN B-NP I-f
97 , , O O
97 folate VBP O B-m
97 1 CD O B-do
97 mg JJ O I-do
98 daily RB O B-f
98 , , O O
98 Dilaudid NNP B-NP B-m
98 2 CD O B-do
98 mg NN B-NP I-do
98 every DT O B-f
98 six CD O I-f
98 hours NNS B-NP I-f
98 as IN B-VP I-f
98 needed VBN O I-f
98 for IN B-VP O
98 pain NN B-NP B-r
98 , , O O
98 please NN B-NP O
99 hold VB O O
99 this DT O O
99 sedated VBN O O
99 for IN B-VP O
99 respirations NNS B-NP O
99 less JJR O O
99 than IN B-VP O
99 10 CD O O
99 per IN B-VP O
99 minute NN B-NP O
99 , , O O
100 insulin NN B-NP B-m
100 NPH NNP I-NP I-m
100 14 CD O B-do
100 units NNS B-NP I-do
100 every DT B-NP B-f
100 evening NN I-NP I-f
100 , , O O
100 insulin NN B-NP B-m
100 NPH NNP I-NP I-m
100 46 CD O B-do
100 units NNS B-NP I-do
100 every DT B-NP B-f
101 morning NN I-NP O
101 , , O O
101 lactulose RB O B-m
101 30 CD O B-do
101 mL NNS B-NP I-do
101 four CD O B-f
101 times NNS B-NP I-f
101 per RB O I-f
101 day NN B-NP I-f
101 as IN B-VP I-f
101 needed VBN O I-f
101 for IN B-VP O
102 constipation NN B-NP B-r
102 , , O O
102 prednisone NN B-NP B-m
102 5 CD O B-do
102 mg NN B-NP I-do
102 every DT B-NP B-f
102 morning NN I-NP I-f
102 , , O O
102 Sarna NNP B-NP B-m
102 topical JJ O B-mo
102 every DT B-NP B-f
103 day NN I-NP O
103 apply VB O O
103 to TO O O
103 affected JJ B-NP O
103 areas NNS I-NP O
103 , , O O
103 multivitamin JJ O B-m
103 daily RB O B-f
103 , , O O
103 Coumadin NNP B-NP B-m
103 2.5 CD O B-do
103 mg JJ O I-do
104 daily RB O B-f
104 , , O O
104 goal NN B-NP O
104 INR NNP I-NP O
104 2 CD O O
104 to TO O O
104 3 CD O O
104 , , O O
104 zinc NN B-NP B-m
104 sulfate NN I-NP I-m
104 220 CD O B-do
104 mg JJ O I-do
104 daily RB O B-f
104 , , O O
104 Ambien NNP B-NP B-m
104 5 CD O B-do
104 mg NN B-NP I-do
105 before RB O B-f
105 bed VBD B-VP I-f
105 as IN B-VP I-f
105 needed VBN O I-f
105 for IN B-VP O
105 insomnia NN B-NP B-r
105 , , O O
105 torsemide RB O B-m
105 200 CD O B-do
105 mg NNS B-NP I-do
105 by IN B-VP B-mo
105 mouth NN B-NP I-mo
105 two CD O B-f
106 times NNS B-NP O
106 per IN B-VP O
106 day NN B-NP O
106 , , O O
106 Fosamax NNP B-NP B-m
106 70 CD O B-do
106 mg NN B-NP I-do
106 once RB O B-f
106 per IN B-VP I-f
106 week NN B-NP I-f
106 , , O O
106 miconazole JJ B-NP B-m
106 nitrate NN I-NP O
106 2% CD O O
107 powder NN B-NP O
107 topical JJ O B-mo
107 two CD O O
107 times NNS B-NP O
107 per IN B-VP O
107 day NN B-NP O
107 apply VB O O
107 to TO O O
107 affected JJ B-NP O
107 areas NNS I-NP O
107 as IN B-VP O
108 needed VBN O O
108 , , O O
108 Advair NNP B-NP B-m
108 Diskus NNP I-NP I-m
108 250/50 CD O I-m
108 one CD O B-do
108 puff NN B-NP I-do
108 inhaled VBD B-VP B-mo
108 twice RB O B-f
108 per IN B-VP I-f
108 day NN B-NP I-f
108 , , O O
109 esomeprazole JJ O B-m
109 20 CD O B-do
109 mg NN B-NP I-do
109 once RB O B-f
109 per IN B-VP I-f
109 day NN B-NP I-f
109 , , O O
109 DuoNeb NNP B-NP B-m
109 3/0.5 CD O B-do
109 mg NN B-NP I-do
109 inhaled VBN O B-mo
109 every DT O B-f
110 six CD O O
110 hours NNS B-NP O
110 as IN B-VP O
110 needed VBN O O
110 for IN B-VP O
110 shortness NN B-NP B-r
110 of IN B-VP I-r
110 breath NN B-NP I-r
110 , , O O
110 Aranesp NNP B-NP B-m
110 50 CD O B-do
110 mcg NN B-NP I-do
111 subcutaneously RB O B-mo
111 once RB O B-f
111 per IN B-VP I-f
111 week NN B-NP I-f
111 , , O O
111 NovoLog NNP B-NP B-m
111 sliding VBG O B-do
111 scale NN B-NP I-do
111 before IN B-VP B-f
111 meals NNS B-NP I-f
111 , , O O
112 Lexapro NNP B-NP B-m
112 20 CD O B-do
112 mg NN B-NP I-do
112 once RB O B-f
112 per IN B-VP I-f
112 day NN B-NP I-f
112 , , O O
112 Maalox NNP B-NP B-m
112 one CD O B-do
112 to TO O I-do
112 two CD O I-do
112 tablets NNS B-NP I-do
112 every DT O B-f
112 six CD O O
113 hours NNS B-NP O
113 as IN B-VP O
113 needed VBN O O
113 for IN B-VP O
113 upset JJ B-NP B-r
113 stomach NN I-NP I-r
113 , , O O
113 and CC O O
113 Lipitor NNP B-NP B-m
113 20 CD O B-do
113 mg NN B-NP I-do
113 once RB O B-f
113 per IN B-VP O
114 day NN B-NP O
115 OUTSTANDING NNP I-NP O
115 ISSUES: NNP I-NP O
115 Include NNP I-NP O
115 following VBG O O
115 INR NNP B-NP O
115 the DT B-NP O
115 goal NN I-NP O
115 of IN B-VP O
115 2 CD O O
115 to TO O O
115 3 CD O O
115 , , O O
116 following VBG O O
116 weight NN B-NP O
116 and CC O O
116 clinical JJ B-NP O
116 signs NNS I-NP O
116 of IN B-VP O
116 volume NN B-NP O
116 overload NN I-NP O
116 , , O O
116 following VBG O O
117 up RP O O
117 on IN B-VP O
117 loose JJ B-NP O
117 stools NNS I-NP O
117 for IN B-VP O
117 possible JJ B-NP O
117 Clostridium NNP I-NP O
117 difficile NN I-NP O
117 infection NN I-NP O
118 Following VBG O O
118 clinical JJ B-NP O
118 signs NNS I-NP O
118 for IN B-VP O
118 evidence NN B-NP O
118 of IN B-VP O
118 urinary JJ B-NP B-r
118 tract NN I-NP I-r
118 infection NN I-NP I-r
119 treating VBG O O
119 with IN B-VP O
119 antibiotics NNS B-NP B-m
119 as IN B-VP O
119 necessary JJ B-NP O
120 PRIMARY NNP I-NP O
120 CARE NNP I-NP O
120 PHYSICIAN: NNP I-NP O
120 Dr NNP I-NP O
120 Rodolfo NNP I-NP O
120 Love NNP I-NP O
121 eScription NN I-NP O
121 document: VBD B-VP O
121 0-2962105 JJ B-NP O
121 SSSten NNP I-NP O
121 Tel NNP I-NP O
122 CC: NNP I-NP O
122 Hyman NNP I-NP O
122 Footman NNP I-NP O
122 M.D NNP I-NP O
123 Delp NNP I-NP O
123 Coscotaence NNP I-NP O
123 Las NNP I-NP O
124 Newsbrid NNP I-NP O
125 Dictated NNP I-NP O
125 By: NNP I-NP O
125 SINOR NNP I-NP O
125 , , O O
125 ROGER NNP B-NP O
126 Attending: NNP I-NP O
126 BRASSEAUX NNP I-NP O
126 , , O O
126 JOSEPH NNP B-NP O
127 Dictation NNP I-NP O
127 ID NNP I-NP O
127 6681514 CD O O
128 D: NNP B-NP O
128 4/7/05 CD O O
129 T: NNP B-NP O
129 4/7/05 CD O O
130 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #734280 VBZ O O
2 746472700 CD O O
2 PAMC NNP B-NP O
2 03453039 CD O O
2 0162843 CD O O
2 8/28/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 viral JJ B-NP O
2 URI NNP I-NP O
2 , , O O
2 pulmonary JJ B-NP O
2 HTN NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 4/21/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/22/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 LIBRIZZI NNP I-NP O
5 , , O O
5 MARIANO NNP B-NP O
5 915-22-38-9 CD O O
6 New NNP B-NP O
6 Hi NNP I-NP O
6 A NNP I-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 2/17/05 CD O O
8 AT NNP B-NP O
8 08:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 CADENAS NNP I-NP O
11 , , O O
11 HONG NNP B-NP O
11 BROOKS NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 DISPOSITION: NNP I-NP O
12 Home NNP I-NP O
13 DISCHARGE NNP I-NP O
13 MEDICATIONS: NNP I-NP O
14 ECASA NNP I-NP B-m
14 ( ( O I-m
14 ASPIRIN NNP B-NP I-m
14 ENTERIC NNP I-NP I-m
14 COATED NNP I-NP I-m
14 ) ) O I-m
14 81 CD O B-do
14 MG NNP B-NP I-do
14 PO NNP I-NP B-mo
14 QD NNP I-NP B-f
15 Alert NNP I-NP O
15 overridden: NNP I-NP O
15 Override NNP I-NP O
15 added VBD B-VP O
15 on IN B-VP O
15 9/4/05 CD O O
15 by IN B-VP O
16 LEVER NNP B-NP O
16 , , O O
16 DARYL NNP B-NP O
16 , , O O
16 M.D NNP B-NP O
17 POTENTIALLY NNP I-NP O
17 SERIOUS NNP I-NP O
17 INTERACTION: NNP I-NP O
17 WARFARIN NNP I-NP B-m
17 &amp; NNP I-NP O
17 ASPIRIN NNP I-NP B-m
18 Reason NNP I-NP O
18 for IN B-VP O
18 override: NN B-NP O
18 aware JJ B-NP O
19 COLACE NNP I-NP B-m
19 ( ( O I-m
19 DOCUSATE NNP B-NP I-m
19 SODIUM NNP I-NP I-m
19 ) ) O I-m
19 100 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 LASIX NNP I-NP B-m
20 ( ( O I-m
20 FUROSEMIDE NNP B-NP I-m
20 ) ) O I-m
20 160 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 BID NNP I-NP B-f
21 GLIPIZIDE NNP I-NP B-m
21 10 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 BID NNP I-NP B-f
22 OCEAN NNP I-NP B-m
22 SPRAY NNP I-NP I-m
22 ( ( O I-m
22 SODIUM NNP B-NP I-m
22 CHLORIDE NNP I-NP I-m
22 0.65% CD O I-m
22 ) ) O I-m
22 2 CD O B-do
22 SPRAY NNP B-NP I-do
22 NA NNP I-NP B-mo
22 QID NNP I-NP B-f
23 PRN NNP I-NP O
23 Other:dried NNP I-NP B-r
23 nasal NN I-NP I-r
23 mucosa NN I-NP I-r
24 COUMADIN NNP I-NP B-m
24 ( ( O I-m
24 WARFARIN NNP B-NP I-m
24 SODIUM NNP I-NP I-m
24 ) ) O I-m
24 5 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QPM NNP I-NP B-f
25 Starting NNP I-NP O
25 NOW NNP I-NP O
25 , , O O
25 Within NNP B-NP O
25 Hour NNP I-NP O
25 of IN B-VP O
25 Pharmacy NNP B-NP O
25 Approval NNP I-NP O
26 Food/Drug NNP I-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 No NNP I-NP O
27 high JJ B-NP O
27 Vitamin-K NNP I-NP O
27 containing VBG O O
27 foods NNS B-NP O
28 Override NNP I-NP O
28 Notice: NNP I-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 9/4/05 CD O O
28 by IN B-VP O
29 JERICH NNP B-NP O
29 , , O O
29 JOSPEH NNP B-NP O
29 , , O O
29 M.D NNP B-NP O
29 on IN B-VP O
29 order NN B-NP O
29 for IN B-VP O
29 ECASA NNP B-NP B-m
29 PO NNP I-NP B-mo
29 ( ( O O
29 ref JJ O O
29 # # O O
29 91585860 CD O O
29 ) ) O O
30 POTENTIALLY NNP B-NP O
30 SERIOUS NNP I-NP O
30 INTERACTION: NNP I-NP O
30 WARFARIN NNP I-NP B-m
30 &amp; NNP I-NP O
30 ASPIRIN NNP I-NP B-m
31 Reason NNP I-NP O
31 for IN B-VP O
31 override: NN B-NP O
31 aware JJ B-NP O
32 ZOLOFT NNP I-NP B-m
32 ( ( O I-m
32 SERTRALINE NNP B-NP I-m
32 ) ) O I-m
32 150 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 AMBIEN NNP I-NP B-m
33 ( ( O I-m
33 ZOLPIDEM NNP B-NP I-m
33 TARTRATE NNP I-NP I-m
33 ) ) O I-m
33 10 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QHS NNP I-NP B-f
34 Food/Drug NNP I-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Give NNP I-NP O
35 on IN B-VP O
35 an DT B-NP O
35 empty JJ I-NP O
35 stomach NN I-NP O
35 ( ( O O
35 give JJ O O
35 1hr CD O O
35 before IN B-VP O
35 or CC O O
35 2hr CD O O
35 after IN B-VP O
36 food NN B-NP O
36 ) ) O O
37 KCL NNP B-NP B-m
37 SLOW NNP I-NP I-m
37 RELEASE NNP I-NP I-m
37 20 CD O B-do
37 MEQ NNP B-NP I-do
37 PO NNP I-NP B-mo
37 BID NNP I-NP B-f
38 As IN B-VP O
38 per IN B-VP O
38 L NNP B-NP O
38 Potassium NNP I-NP O
38 Chloride NNP I-NP O
38 Policy: NNP I-NP O
39 each DT O O
39 20 CD O O
39 mEq NNS B-NP O
39 dose VB O O
39 to TO O O
39 be VB O O
39 given VBN O O
39 with IN B-VP O
39 4 CD O O
39 oz NNS B-NP O
39 of IN B-VP O
39 fluid JJ B-NP O
40 ATROVENT NNP I-NP B-m
40 NASAL NNP I-NP I-m
40 0.06% CD O I-m
40 ( ( O I-m
40 IPRATROPIUM NNP B-NP I-m
40 NASAL NNP I-NP I-m
40 0.06% CD O I-m
40 ) ) O I-m
41 2 CD O B-do
41 SPRAY NNP B-NP I-do
41 NA NNP I-NP B-mo
41 TID NNP I-NP B-f
42 Number NNP I-NP B-du
42 of IN B-VP I-du
42 Doses NNP B-NP I-du
42 Required NNP I-NP I-du
42 ( ( O I-du
42 approximate JJ B-NP I-du
42 ): NN I-NP I-du
42 10 CD O I-du
43 NEXIUM NNP B-NP B-m
43 ( ( O I-m
43 ESOMEPRAZOLE NNP B-NP I-m
43 ) ) O I-m
43 20 CD O B-do
43 MG NNP B-NP I-do
43 PO NNP I-NP B-mo
43 QD NNP I-NP B-f
44 TRACLEER NNP I-NP B-m
44 ( ( O I-m
44 BOSENTAN NNP B-NP I-m
44 ) ) O I-m
44 125 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 BID NNP I-NP B-f
45 Number NNP I-NP B-du
45 of IN B-VP I-du
45 Doses NNP B-NP I-du
45 Required NNP I-NP I-du
45 ( ( O I-du
45 approximate JJ B-NP I-du
45 ): NN I-NP I-du
45 10 CD O I-du
46 VENTAVIS NNP B-NP B-m
46 1 CD O B-do
46 neb NN B-NP I-do
46 NEB NNP I-NP B-mo
46 Q3H NNP I-NP B-f
46 Instructions: NNP I-NP O
46 during IN B-VP B-du
46 wake NN B-NP I-du
46 hours NNS I-NP I-du
47 ALBUTEROL NNP I-NP B-m
47 ALBUTEROL NNP I-NP B-m
47 INHALER NNP I-NP I-m
47 INHALER NNP I-NP I-m
47 2 CD O B-do
47 2 CD O B-do
47 PUFF NNP B-NP I-do
47 PUFF NNP I-NP I-do
47 INH NNP I-NP B-mo
47 INH NNP I-NP B-mo
47 Q4H NNP I-NP B-f
47 Q4H NNP I-NP B-f
48 PRN NNP I-NP O
48 Shortness NNP I-NP B-r
48 of IN B-VP I-r
48 Breath NNP B-NP I-r
48 , , O O
48 Wheezing NNP B-NP B-r
49 DIET: NNP I-NP O
49 House NNP I-NP O
49 / VBD B-VP O
49 Low NNP B-NP O
49 chol/low NN I-NP O
49 sat VBD B-VP O
49 fat JJ B-NP O
50 DIET: NNP I-NP O
50 4 CD O O
50 gram NN B-NP O
50 Sodium NNP I-NP O
51 ACTIVITY: NNP I-NP O
51 Walking NNP I-NP O
51 as IN B-VP O
51 tolerated VBN O O
52 FOLLOW NNP B-NP O
52 UP NNP I-NP O
52 APPOINTMENT( NNP I-NP O
52 S NNP I-NP O
52 ): NNP I-NP O
53 TFHC NNP I-NP O
53 per IN B-VP O
53 TLHO NNP B-NP O
53 team NN I-NP O
53 , , O O
54 Arrange NNP B-NP O
54 INR NNP I-NP O
54 to TO O O
54 be VB O O
54 drawn VBN O O
54 on IN B-VP O
54 0/1/05 CD O O
54 with IN B-VP O
54 f/u JJ B-NP O
54 INR's NNP I-NP O
54 to TO O O
54 be VB O O
54 drawn VBN O O
54 every DT B-NP O
55 perclinic JJ I-NP O
55 days NNS I-NP O
55 INR's NNP I-NP O
55 will MD O O
55 be VB O O
55 followed VBN O O
55 by IN B-VP O
55 prior JJ B-NP O
55 clinic JJ I-NP O
56 ALLERGY: NNP I-NP O
56 Cephalosporins NNP I-NP O
56 , , O O
56 ACE NNP B-NP O
56 Inhibitor NNP I-NP O
57 ADMIT NNP I-NP O
57 DIAGNOSIS: NNP I-NP O
58 Viral NNP I-NP O
58 infection NN I-NP O
58 , , O O
58 severe JJ B-NP O
58 pulmonary JJ I-NP O
58 hypertension NN I-NP O
59 PRINCIPAL NNP I-NP O
59 DISCHARGE NNP I-NP O
59 DIAGNOSIS NNP I-NP O
59 ;Responsible JJ O O
59 After IN B-VP O
59 Study NNP B-NP O
59 for IN B-VP O
59 Causing NNP B-NP O
59 Admission NNP I-NP O
59 ) ) O O
60 viral JJ B-NP O
60 URI NNP I-NP O
60 , , O O
60 pulmonary JJ B-NP O
60 HTN NNP I-NP O
61 OTHER NNP I-NP O
61 DIAGNOSIS;Conditions NNP I-NP O
61 , , O O
61 Infections NNP B-NP O
61 , , O O
61 Complications NNP B-NP O
61 , , O O
61 affecting VBG O O
61 Treatment/Stay NNP B-NP O
62 HTN NNP I-NP O
62 H/O NNP I-NP O
62 PUD NNP I-NP O
62 dm NN I-NP O
62 ( ( O O
62 diabetes VBZ O O
63 mellitus NN B-NP O
63 ) ) O O
63 pulmonary JJ B-NP O
63 hypertension NN I-NP O
63 ( ( O O
63 pulmonary JJ B-NP O
63 hypertension NN I-NP O
63 ) ) O O
63 osa NN B-NP O
63 ( ( O O
63 sleep JJ B-NP O
64 apnea NN I-NP O
64 ) ) O O
64 gerd NN B-NP O
64 ( ( O O
64 gastroesophageal JJ B-NP O
64 reflux NN I-NP O
64 disease NN I-NP O
64 ) ) O O
65 OPERATIONS NNP B-NP O
65 AND NNP I-NP O
65 PROCEDURES: NNP I-NP O
66 None NNP I-NP O
67 OTHER NNP I-NP O
67 TREATMENTS/PROCEDURES NNP I-NP O
67 ( ( O O
67 NOT NNP B-NP O
67 IN NNP I-NP O
67 O.R NNP I-NP O
67 ) ) O O
68 None NN B-NP O
69 BRIEF NNP I-NP O
69 RESUME NNP I-NP O
69 OF NNP I-NP O
69 HOSPITAL NNP I-NP O
69 COURSE: NNP I-NP O
70 CC: NNP I-NP O
70 SOB NNP I-NP O
71 HPI: NNP I-NP O
71 51 CD O O
71 F NNP B-NP O
71 w/ NN I-NP O
71 h/o NN I-NP O
71 severe JJ B-NP O
71 pulmonary JJ I-NP O
71 HTN NNP I-NP O
71 , , O O
71 DM NNP B-NP O
71 , , O O
71 OSA NNP B-NP O
71 , , O O
71 obesity NN B-NP O
71 , , O O
71 on IN B-VP O
71 chronic JJ B-NP O
72 home NN I-NP O
72 O2 NNP I-NP B-m
72 ( ( O O
72 8L CD O B-do
72 NC NNP B-NP O
72 ) ) O O
72 She PRP O O
72 is VBZ O O
72 followed VBN O O
72 by IN B-VP O
72 the DT B-NP O
72 AH NNP I-NP O
72 service NN I-NP O
72 , , O O
72 at IN B-VP O
73 her PRP$ O O
73 baseline NN B-NP O
73 until IN B-VP O
73 about IN B-VP O
73 one CD O O
73 week NN B-NP O
73 ago RB O O
73 , , O O
73 having VBG O O
73 returned VBN O O
74 from IN B-VP O
74 Pe NNP B-NP O
74 Ale NNP I-NP O
74 two CD O O
74 weeks NNS B-NP O
74 ago RB O O
74 , , O O
74 she PRP O O
74 began VBD B-VP O
74 to TO O O
74 experience VB O O
74 dyspnea NN B-NP O
74 on IN B-VP O
75 exertion NN B-NP O
75 and CC O O
75 chest NN B-NP O
75 tightness NN I-NP O
75 She PRP O O
75 also RB O O
75 reports VBZ O O
75 productive JJ B-NP O
75 cough NN I-NP O
76 ( ( O O
76 greenish JJ O O
76 ) ) O O
76 , , O O
76 rhinorrhea NN B-NP O
76 , , O O
76 sinus NN B-NP O
76 tenderness NN I-NP O
76 , , O O
76 N/V NNP B-NP O
76 , , O O
76 malaise NN B-NP O
76 She PRP O O
76 denies VBZ O O
77 palpitations NNS B-NP O
77 or CC O O
77 radiating VBG O O
77 chest JJS B-NP O
77 pain NN I-NP O
77 The DT B-NP O
77 day NN I-NP O
77 PTA NNP I-NP O
77 , , O O
77 VNA NNP B-NP O
77 found VBD B-VP O
77 the DT B-NP O
78 patient NN I-NP O
78 to TO O O
78 desat VB O O
78 to TO O O
78 82% CD O O
78 with IN B-VP O
78 exertion NN B-NP O
78 She PRP O O
78 went VBD B-VP O
78 to TO O O
78 Gas NNP B-NP O
78 Healthcare NNP I-NP O
78 , , O O
79 where WRB O O
79 she PRP O O
79 was VBD B-VP O
79 found VBN O O
79 to TO O O
79 have VB O O
79 an DT B-NP O
79 SpO2 NNP I-NP O
79 of IN B-VP O
79 99% CD O O
79 on IN B-VP O
79 8L CD O O
79 , , O O
79 no DT B-NP O
79 EKG NNP I-NP O
80 changes NNS I-NP O
80 , , O O
80 NAD NNP B-NP O
80 on IN B-VP O
80 CXR NNP B-NP O
81 She PRP O O
81 was VBD B-VP O
81 hospitalized VBN O O
81 in IN B-VP O
81 July NNP B-NP O
81 2005 CD O O
81 at IN B-VP O
81 CRT NNP B-NP O
81 with IN B-VP O
81 simlar JJ B-NP O
81 SOB NNP I-NP O
81 At IN B-VP O
81 this DT B-NP O
82 time NN I-NP O
82 , , O O
82 she PRP O O
82 underwent VBD B-VP O
82 a DT B-NP O
82 RHC NNP I-NP O
82 which WDT O O
82 showed VBD B-VP O
82 PA NNP B-NP O
82 pressures NNS I-NP O
82 70-80% JJ O O
82 ( ( O O
82 110/40/60-65 JJ O O
82 ) ) O O
83 of IN B-VP O
83 sytemic JJ B-NP O
83 pressures NNS I-NP O
83 She PRP O O
83 also RB O O
83 had VBD B-VP O
83 a DT B-NP O
83 negative JJ I-NP O
83 MIBI NNP I-NP O
83 , , O O
83 negative JJ B-NP O
84 swallowing NN I-NP O
84 study NN I-NP O
84 Since IN B-VP O
84 discharge NN B-NP O
84 , , O O
84 she PRP O O
84 reports VBZ O O
84 being VBG O O
84 med VBN O O
84 compliant NN B-NP O
84 , , O O
84 and CC O O
85 diet JJ B-NP O
85 compliant NN I-NP O
85 Her NNP I-NP O
85 weight NN I-NP O
85 has VBZ O O
85 been VBN O O
85 stable JJ O O
85 at IN B-VP O
85 238 CD O O
85 lbs NN B-NP O
85 She PRP O O
85 feels VBZ O O
85 that IN B-VP O
86 her PRP$ O O
86 depression NN B-NP O
86 has VBZ O O
86 been VBN O O
86 worse JJR O O
86 of IN B-VP O
86 late JJ B-NP O
86 ALL: NNP I-NP O
86 ACEi NNP I-NP B-m
86 , , O O
87 cephalopsporins VBZ O B-m
88 MEDS: NNP B-NP O
88 K-Dur NNP I-NP B-m
88 20 CD O B-do
88 BID NNP B-NP B-f
88 , , O O
88 Nexium NNP B-NP B-m
88 20 CD O B-do
88 , , O O
88 lasix VBD B-VP B-m
88 160 CD O B-do
88 BID NNP B-NP B-f
88 , , O O
89 tracleer RB O B-m
89 125 CD O B-do
89 BID NNP B-NP B-f
89 , , O O
89 Glipizide NNP B-NP B-m
89 80 CD O B-do
89 BID NNP B-NP B-f
89 , , O O
89 Coumadin NNP B-NP B-m
89 5/7.5 CD O B-do
89 , , O O
89 ECASA NNP B-NP B-m
89 81 CD O B-do
89 , , O O
89 Zoloft NNP B-NP B-m
90 100 CD O B-do
90 , , O O
90 MVI NNP B-NP B-m
90 , , O O
90 Oceanspray NNP B-NP B-m
90 , , O O
90 Ambien NNP B-NP B-m
90 10 CD O B-do
90 QHS NNP B-NP B-f
90 , , O O
90 Ventavis NNP B-NP B-m
90 nebs FW O B-mo
91 Q3H NNP B-NP B-f
92 PE:96.8 NNP I-NP O
92 , , O O
92 83 CD O O
92 , , O O
92 114/76 CD O O
92 , , O O
92 97-98% CD O O
92 on IN B-VP O
92 8L CD O O
93 NC NNP B-NP O
93 JVP NNP I-NP O
93 14 CD O O
93 , , O O
93 RRR NNP B-NP O
93 , , O O
93 loud JJ B-NP O
93 P2 NNP I-NP O
93 , , O O
93 no DT B-NP O
93 M NNP I-NP O
93 CTA NNP I-NP O
93 Obese NNP I-NP O
94 Labs: NNP I-NP O
94 K NNP I-NP O
94 3.5 CD O O
94 , , O O
94 Cr NNP B-NP O
94 1.4 CD O O
94 , , O O
94 WBC NNP B-NP O
94 8.2 CD O O
94 , , O O
94 CK/TNI NNP B-NP O
94 neg NN I-NP O
94 , , O O
94 BNP NNP B-NP O
94 443 CD O O
95 ****************Hospital JJ B-NP O
95 Course****************** NNP I-NP O
96 A/P NNP I-NP O
96 51F CD O O
96 with IN B-VP O
96 sever NN B-NP O
96 pHTN NN I-NP O
96 , , O O
96 OSA NNP B-NP O
96 , , O O
96 DM NNP B-NP O
96 , , O O
96 obesity NN B-NP O
96 , , O O
96 p/w NN B-NP O
96 SOB NNP I-NP O
96 and CC O O
96 URI-type NNP B-NP O
96 Sx NNP I-NP O
97 Near NNP I-NP O
97 pulmonary JJ B-NP O
97 baseline NN I-NP O
98 1 CD O O
98 Pulm: NNP B-NP O
98 Severe NNP I-NP O
98 pHTN NN I-NP O
98 with IN B-VP O
98 very RB O O
98 elevated JJ B-NP O
98 PA NNP I-NP O
98 pressures NNS I-NP O
98 Likely NNP I-NP O
98 subjective JJ B-NP O
99 SOB NNP I-NP O
99 in IN B-VP O
99 the DT B-NP O
99 context NN I-NP O
99 of IN B-VP O
99 viral JJ B-NP O
99 URI NNP I-NP O
99 Cont NNP I-NP O
99 Ilprost NNP I-NP O
99 , , O O
99 home NN B-NP O
99 O2 NNP I-NP B-m
99 , , O O
99 tracleer NN B-NP B-m
99 , , O O
100 albuterol VBP O B-m
100 Pulmonary JJ B-NP O
100 status NN I-NP O
100 stable JJ O O
100 , , O O
100 but CC O O
100 patient NN B-NP O
100 is VBZ O O
100 uneasy JJ O O
100 with IN B-VP O
100 going VBG O O
101 home NN B-NP O
101 , , O O
101 and CC O O
101 so RB O O
101 will MD O O
101 stay VB O O
101 - : O O
101 stable JJ B-NP O
101 enought NN I-NP O
101 to TO O O
101 go VB O O
101 home NN B-NP O
102 2 CD O O
102 CV: NNP B-NP O
102 Recent NNP I-NP O
102 ECHO NNP I-NP O
102 , , O O
102 Cath NNP B-NP O
102 , , O O
102 probably RB O O
102 no DT B-NP O
102 need NN I-NP O
102 to TO O O
102 do VB O O
102 further RB O O
102 w/u VB O O
102 ROMI NNP B-NP O
102 by IN B-VP O
103 serial JJ B-NP O
103 enzymes/EKG NN I-NP O
103 Continue NNP I-NP O
103 Lasix NNP I-NP B-m
103 , , O O
103 KCl NNP B-NP B-m
103 , , O O
103 ASA NNP B-NP B-m
103 81 CD O B-do
104 3 CD O O
104 Psych: NNP B-NP O
104 h/o NN I-NP O
104 depression NN I-NP B-r
104 depression NN I-NP B-r
104 Inpatient NNP I-NP O
104 psych NN I-NP O
104 consult NN I-NP O
104 Cont NNP I-NP O
104 zoloft NNP I-NP B-m
104 , , O O
104 ambien VBZ O B-m
105 4 CD O O
105 DM: NNP B-NP O
105 Will NNP I-NP O
105 follow VB O O
105 FSBS NNP B-NP O
106 5 CD O O
106 Heme: NNP B-NP O
106 Coumadin NNP I-NP B-m
106 for IN B-VP O
106 pulmonary JJ B-NP B-r
106 microclots NNS I-NP I-r
106 on IN B-VP O
106 Bx NNP B-NP O
106 in IN B-VP O
107 past NN B-NP O
107 WIll NNP I-NP O
107 increase VB O O
107 Coumadin NNP B-NP B-m
107 since IN B-VP O
107 INR NNP B-NP O
107 1.9 CD O O
107 , , O O
107 recheck NN B-NP O
107 QD NNP I-NP O
108 6 CD O O
108 FEN: NNP B-NP O
108 low JJ B-NP O
108 salt NN I-NP O
108 , , O O
108 low JJ B-NP O
108 fat NN I-NP O
108 diet JJ O O
109 7 CD O O
109 ID: NNP B-NP O
109 Likely JJ B-NP O
109 viral JJ I-NP O
109 URI NNP I-NP O
109 BCx NNP I-NP O
109 taken VBN O O
110 WIll NNP B-NP O
110 recheck VB O O
110 CXR NNP B-NP O
110 if IN B-VP O
110 clinically RB O O
111 warranted VBD B-VP O
112 8 CD O O
112 GI: NNP B-NP O
112 GERD NNP I-NP B-r
112 , , O O
112 nexium NN B-NP B-m
112 prophylaxis VBP O O
113 ADDITIONAL NNP B-NP O
113 COMMENTS: NNP I-NP O
113 Call NNP I-NP O
113 you PRP O O
113 doctor VBP O O
113 if IN B-VP O
113 you PRP O O
113 become VBP O O
113 more JJR O O
113 short JJ O O
113 of IN B-VP O
113 breath NN B-NP O
114 DISCHARGE NNP I-NP O
114 CONDITION: NNP I-NP O
114 Satisfactory NNP I-NP O
115 TO NNP I-NP O
115 DO/PLAN: NNP I-NP O
116 No NNP I-NP O
116 dictated VBD B-VP O
116 summary JJ B-NP O
117 ENTERED NNP I-NP O
117 BY: NNP I-NP O
117 EVERLY NNP I-NP O
117 , , O O
117 ARRON NNP B-NP O
117 J NNP I-NP O
117 , , O O
117 M.D NNP B-NP O
117 ( ( O O
117 TC12 NNP B-NP O
117 ) ) O O
117 2/17/05 CD O O
117 @ $ O O
117 07 CD O O
118 ****** JJ B-NP O
118 END NN I-NP O
118 OF NNP I-NP O
118 DISCHARGE NNP I-NP O
118 ORDERS NNP I-NP O
118 ****** NNP I-NP O
119 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #741076 VBZ O O
4 327485275 CD O O
4 RHMC NNP B-NP O
4 26315643 CD O O
4 1360418 CD O O
4 10/25/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 10/2/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/24/2004 CD O O
7 ATTENDING: NNP B-NP O
7 LAZARO NNP I-NP O
7 HINSHAW NNP I-NP O
7 MD NNP I-NP O
8 ADMITTING NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
8 CHF NNP I-NP O
8 exacerbation NN I-NP O
9 LIST NNP I-NP O
9 OF NNP I-NP O
9 PROBLEMS NNP I-NP O
9 AND NNP I-NP O
9 DIAGNOSES: NNP I-NP O
10 1 CD O O
10 CHF NNP B-NP O
11 2 CD O O
11 CAD NNP B-NP O
11 status NN I-NP O
11 post NN I-NP O
11 CABG NNP I-NP O
11 in IN B-VP O
11 1988 CD O O
12 3 CD O O
12 Chronic NNP B-NP O
12 renal JJ B-NP O
12 insufficiency NN I-NP O
13 4 CD O O
13 Type NNP B-NP O
13 II NNP I-NP O
13 diabetes VBZ O O
14 5 CD O O
14 Glaucoma NNP B-NP O
15 6 CD O O
15 Hypercholesterolemia NNP B-NP O
16 7 CD O O
16 History NNP B-NP O
16 of IN B-VP O
16 bowel NN B-NP O
16 resection NN I-NP O
16 for IN B-VP O
16 diverticulitis NN B-NP O
17 8 CD O O
17 Question NN B-NP O
17 of IN B-VP O
17 TIA NNP B-NP O
17 in IN B-VP O
17 the DT O O
17 past JJ O O
17 with IN B-VP O
17 right-sided JJ B-NP O
17 numbness JJ I-NP O
18 BRIEF NNP I-NP O
18 HISTORY NNP I-NP O
18 OF NNP I-NP O
18 PRESENT NNP I-NP O
18 ILLNESS: NNP I-NP O
19 Ms NNP I-NP O
19 Elter NNP I-NP O
19 is VBZ O O
19 an DT B-NP O
19 83-year-old JJ I-NP O
19 Spanish-speaking JJ I-NP O
19 female NN I-NP O
19 with IN B-VP O
19 history NN B-NP O
20 of IN B-VP O
20 CAD NNP B-NP O
20 , , O O
20 distant JJ B-NP O
20 three-vessel NN I-NP O
20 CABG NNP I-NP O
20 , , O O
20 CRI NNP B-NP O
20 , , O O
20 NSTEMI NNP B-NP O
20 in IN B-VP O
20 4/20 CD O O
20 , , O O
21 treated VBN O O
21 with IN B-VP O
21 just RB O O
21 medications NNS B-NP O
21 , , O O
21 EF NNP B-NP O
21 of IN B-VP O
21 75% CD O O
21 in IN B-VP O
21 4/20 CD O O
21 , , O O
21 who WP O O
22 presented VBD B-VP O
22 one CD O O
22 week NN B-NP O
22 of IN B-VP O
22 PND NNP B-NP O
22 , , O O
22 dyspnea NN B-NP O
22 on IN B-VP O
22 exertion NN B-NP O
22 , , O O
22 and CC O O
22 chest JJS B-NP O
23 heaviness NN I-NP O
23 This DT B-NP O
23 chest JJS I-NP O
23 sensation NN I-NP O
23 did VBD B-VP O
23 not RB O O
23 radiate VB O O
23 and CC O O
23 was VBD B-VP O
24 unassociated VBN O O
24 with IN B-VP O
24 nausea NN B-NP O
24 , , O O
24 vomiting VBG O O
24 , , O O
24 diaphoresis NN B-NP O
24 or CC O O
25 lightheadedness VB O O
25 The DT B-NP O
25 patient NN I-NP O
25 also RB O O
25 had VBD B-VP O
25 cough VBN O O
25 with IN B-VP O
25 green JJ B-NP O
25 sputum NN I-NP O
25 x1 CD O O
26 year NN B-NP O
26 , , O O
26 no DT B-NP O
26 fevers NNS I-NP O
26 or CC O O
26 chills NNS B-NP O
26 , , O O
26 no DT B-NP O
26 sick JJ I-NP O
26 contacts NNS I-NP O
26 EMS NNP I-NP O
26 gave VBD B-VP O
26 Lasix NNP B-NP B-m
26 and CC O O
27 Nitrospray NNP B-NP B-m
27 In IN B-VP O
27 the DT B-NP O
27 ED NNP I-NP O
27 , , O O
27 she PRP O O
27 was VBD B-VP O
27 briefly NN B-NP O
27 on IN B-VP O
27 a DT B-NP O
27 nonrebreather NN I-NP O
27 mask NN I-NP O
27 , , O O
28 responded VBD B-VP O
28 to TO O O
28 80 CD O B-do
28 mg NN B-NP I-do
28 of IN B-VP O
28 IV NNP B-NP B-mo
28 Lasix NNP I-NP B-m
28 , , O O
28 K NNP B-NP O
28 was VBD B-VP O
28 5.8 CD O O
28 and CC O O
28 got VBD B-VP O
28 Kayexalate NNP B-NP B-m
29 She PRP O O
29 became VBD B-VP O
29 comfortable JJ O O
29 , , O O
29 sitting VBG O O
29 at IN B-VP O
29 75 CD O O
29 degrees NNS B-NP O
29 , , O O
29 chest JJS B-NP O
29 pain-free NN I-NP O
30 Also RB O O
30 , , O O
30 noted VBD B-VP O
30 no DT B-NP O
30 change NN I-NP O
30 in IN B-VP O
30 bowel/bladder NN B-NP O
30 habits NNS I-NP O
30 , , O O
30 no DT B-NP O
30 change NN I-NP O
30 in IN B-VP O
30 meds NNS B-NP O
31 and CC O O
31 no DT B-NP O
31 dietary JJ I-NP O
31 changes NNS I-NP O
31 She PRP O O
31 had VBD B-VP O
31 positive JJ B-NP O
31 progressive JJ I-NP O
31 lower JJR I-NP O
32 extremity NN I-NP O
32 edema VBP O O
32 x2 JJ B-NP O
32 weeks NNS I-NP O
33 ALLERGIES: NNP I-NP O
34 Lisinopril NNP I-NP O
34 leading VBG O O
34 to TO O O
34 hyperkalemia VB O O
35 SOCIAL NNP B-NP O
35 HISTORY: NNP I-NP O
36 Retired NNP I-NP O
36 textile NN I-NP O
36 worker NN I-NP O
36 from IN B-VP O
36 Ral NNP B-NP O
36 , , O O
36 lives VBZ O O
36 with IN B-VP O
36 daughter NN B-NP O
36 , , O O
36 and CC O O
36 is VBZ O O
37 Spanish JJ O O
37 speaking VBG O O
38 HOME NNP B-NP O
38 MEDICATIONS: NNP I-NP O
39 Aspirin NNP I-NP B-m
39 , , O O
39 metoprolol NN B-NP B-m
39 , , O O
39 allopurinol NN B-NP B-m
39 , , O O
39 valsartan NN B-NP B-m
39 , , O O
39 glipizide NN B-NP B-m
39 , , O O
39 Lipitor NNP B-NP B-m
39 , , O O
40 and CC O O
40 nifedipine JJ B-NP B-m
41 PHYSICAL NNP I-NP O
41 EXAMINATION NNP I-NP O
41 ON NNP I-NP O
41 ADMISSION: NNP I-NP O
42 Temperature NNP I-NP O
42 was VBD B-VP O
42 96 CD O O
42 , , O O
42 pulse NN B-NP O
42 was VBD B-VP O
42 70 CD O O
42 , , O O
42 blood NN B-NP O
42 pressure NN I-NP O
42 was VBD B-VP O
42 148/56 CD O O
42 , , O O
43 respiratory NN B-NP O
43 rate NN I-NP O
43 was VBD B-VP O
43 20 CD O O
43 , , O O
43 and CC O O
43 saturating VBG O O
43 100% CD O O
43 on IN B-VP O
43 nonrebreather NN B-NP O
43 and CC O O
44 eventually RB O O
44 in IN B-VP O
44 the DT O O
44 high JJ O O
44 90s CD O O
44 on IN B-VP O
44 a DT B-NP B-do
44 couple NN I-NP I-do
44 of IN B-VP I-do
44 liters NNS B-NP I-do
44 of IN B-VP O
44 oxygen NN B-NP B-m
44 In IN B-VP O
45 general JJ O O
45 , , O O
45 she PRP O O
45 was VBD B-VP O
45 in IN B-VP O
45 no DT B-NP O
45 acute NN I-NP O
45 distress NN I-NP O
45 , , O O
45 JVP NNP B-NP O
45 12 CD O O
45 cm NN B-NP O
45 with IN B-VP O
45 positive JJ B-NP O
46 hepatojugular NN I-NP O
46 reflux NN I-NP O
46 , , O O
46 soft JJ B-NP O
46 bibasilar NN I-NP O
46 rales NNS I-NP O
46 , , O O
46 regular JJ B-NP O
46 rate NN I-NP O
46 and CC O O
47 rhythm NN B-NP O
47 , , O O
47 2-3/6 JJ B-NP O
47 systolic JJ I-NP O
47 murmur NN I-NP O
47 , , O O
47 loudest JJS O O
47 at IN B-VP O
47 the DT B-NP O
47 left JJ I-NP O
47 upper JJ I-NP O
47 sternal JJ I-NP O
48 border NN I-NP O
48 , , O O
48 ( ( O O
48 mild JJ O O
48 AS IN B-VP O
48 on IN B-VP O
48 echo NN B-NP O
48 from IN B-VP O
48 0/21 CD O O
48 ) ) O O
48 Abdomen NNP B-NP O
48 was VBD B-VP O
48 soft JJ O O
48 , , O O
49 nontender NN B-NP O
49 , , O O
49 and CC O O
49 nondistended VBD B-VP O
49 , , O O
49 bowel VB O O
49 sounds NNS B-NP O
49 positive JJ B-NP O
49 Extremities NNS I-NP O
50 showed VBD B-VP O
50 3+ CD O O
50 bilateral JJ O O
50 pitting VBG O O
50 ankle JJ B-NP O
50 edema NN I-NP O
50 with IN B-VP O
50 weak JJ B-NP O
50 distal JJ I-NP O
50 pulses NNS I-NP O
51 LABORATORY NNP I-NP O
51 DATA: NNP I-NP O
52 Showed VBD B-VP O
52 a DT B-NP O
52 sodium NN I-NP O
52 of IN B-VP O
52 129 CD O O
52 , , O O
52 potassium NN B-NP O
52 of IN B-VP O
52 5.7 CD O O
52 , , O O
52 creatinine NN B-NP O
52 of IN B-VP O
52 2.8 CD O O
52 with IN B-VP O
53 a DT B-NP O
53 baseline NN I-NP O
53 anywhere RB O O
53 between IN B-VP O
53 2 CD O O
53 and CC O O
53 3.5 CD O O
53 , , O O
53 cardiac JJ O O
53 enzymes RB O O
53 negative JJ B-NP O
54 x1 NN I-NP O
54 , , O O
54 BNP NNP B-NP O
54 of IN B-VP O
54 1448 CD O O
54 EKG NNP B-NP O
54 showed VBD B-VP O
54 normal JJ B-NP O
54 sinus NN I-NP O
54 rhythm NN I-NP O
54 at IN B-VP O
54 73 CD O O
54 , , O O
54 septal JJ B-NP O
55 Qs NNP I-NP O
55 , , O O
55 QTC NNP B-NP O
55 of IN B-VP O
55 456 CD O O
55 Chest NNP B-NP O
55 x-ray NN I-NP O
55 showed VBD B-VP O
55 cardiomegaly NNS B-NP O
55 , , O O
55 small JJ B-NP O
55 bilateral JJ I-NP O
56 effusions NNS I-NP O
56 , , O O
56 no DT B-NP O
56 infiltrate JJ I-NP O
57 HOSPITAL NNP I-NP O
57 COURSE NNP I-NP O
57 BY NNP I-NP O
57 PROBLEMS: NNP I-NP O
58 1 CD O O
58 Cardiovascular: NNP B-NP O
58 Ischemia: NNP I-NP O
58 Rule NNP I-NP O
58 out IN B-VP O
58 MI NNP B-NP O
58 by IN B-VP O
58 enzymes NNS B-NP O
58 and CC O O
58 EKG NNP B-NP O
59 with IN B-VP O
59 a DT B-NP O
59 full JJ I-NP O
59 set NN I-NP O
59 negative JJ O O
59 Continued VBD B-VP O
59 her PRP$ O O
59 aspirin NN B-NP B-m
59 , , O O
59 beta-blockers NNS B-NP B-m
59 , , O O
60 and CC O O
60 statin NN B-NP B-m
60 for IN B-VP O
60 coronary JJ B-NP B-r
60 artery NN I-NP I-r
60 disease NN I-NP I-r
60 Pump: NNP I-NP O
60 CHF NNP I-NP O
60 flare NN I-NP O
60 with IN B-VP O
61 elevated JJ B-NP O
61 BNP NNP I-NP O
61 , , O O
61 volume NN B-NP O
61 overload NN I-NP O
61 , , O O
61 diuresed VBN O O
61 with IN B-VP O
61 Lasix NNP B-NP B-m
61 and CC O O
61 Diuril; NNP B-NP B-m
62 salt/water NN I-NP O
62 restricted VBD B-VP O
62 , , O O
62 kept VBD B-VP O
62 strict JJ B-NP O
62 I/O NNP I-NP O
62 with IN B-VP O
62 moderate JJ B-NP O
62 diuresis NN I-NP O
63 After IN B-VP O
63 load NN B-NP O
63 reduced VBN O O
63 with IN B-VP O
63 ARB NNP B-NP B-m
63 , , O O
63 weaned VBD B-VP O
63 off RP O O
63 her PRP$ O O
63 previous JJ B-NP O
63 home NN I-NP O
63 calcium NN I-NP B-m
64 channel NN I-NP O
64 blocker NN I-NP O
64 Rhythm: NNP I-NP O
64 Telemetry NNP I-NP O
64 showing VBG O O
64 transient JJ B-NP O
64 new JJ I-NP O
64 atrial JJ I-NP O
65 fibrillation NN I-NP O
65 with IN B-VP O
65 a DT B-NP O
65 maximum JJ I-NP O
65 heart NN I-NP O
65 rate NN I-NP O
65 of IN B-VP O
65 less JJR O O
65 than IN B-VP O
65 70 CD O O
65 , , O O
65 which WDT O O
66 spontaneously RB O O
66 resolved VBD B-VP O
66 after IN B-VP O
66 several JJ B-NP O
66 hours NNS I-NP O
66 An DT B-NP O
66 echo NN I-NP O
66 showed VBD B-VP O
67 stable JJ B-NP O
67 aortic JJ I-NP O
67 stenosis NN I-NP O
67 without IN B-VP O
67 any DT B-NP O
67 acute NN I-NP O
67 worsening NN I-NP O
67 She PRP O O
67 also RB O O
67 had VBD B-VP O
68 a DT B-NP O
68 rhythm JJ I-NP O
68 strip NN I-NP O
68 on IN B-VP O
68 the DT B-NP O
68 telemetry NN I-NP O
68 showing VBG O O
68 a DT B-NP O
68 regular JJ I-NP O
68 focus NN I-NP O
68 of IN B-VP O
69 ventricular JJ B-NP B-r
69 ectopy NN I-NP I-r
69 , , O O
69 also RB O O
69 spontaneously RB O O
69 resolving VBG O O
69 This DT O O
69 was VBD B-VP O
70 treated VBN O O
70 with IN B-VP O
70 continued JJ B-NP O
70 beta-blockers NNS I-NP B-m
70 At IN B-VP O
70 the DT B-NP O
70 time NN I-NP O
70 of IN B-VP O
70 discharge NN B-NP O
70 , , O O
71 she PRP O O
71 was VBD B-VP O
71 in IN B-VP O
71 normal JJ B-NP O
71 sinus NN I-NP O
71 rhythm VBD B-VP O
72 2 CD O O
72 Renal: NNP B-NP O
72 Chronic NNP I-NP O
72 renal JJ B-NP O
72 insufficiency NN I-NP O
72 with IN B-VP O
72 baseline JJ B-NP O
72 creatinine NN I-NP O
73 of IN B-VP O
73 2.8 CD O O
73 to TO O O
73 3.3 CD O O
73 , , O O
73 with IN B-VP O
73 acute JJ O O
73 worsening VBG O O
73 in-house NN B-NP O
73 , , O O
73 most RBS O O
73 likely JJ O O
74 secondary JJ O O
74 to TO O O
74 over IN B-VP O
74 diuresis NN B-NP O
74 with IN B-VP O
74 Diuril/Lasix NNP B-NP B-m
74 , , O O
74 also RB O O
74 some DT B-NP O
74 prerenal JJ I-NP O
75 component NN I-NP O
75 secondary JJ O O
75 to TO O O
75 fluid VB O O
75 restriction NN B-NP O
75 Her NNP I-NP O
75 potassium NN I-NP O
75 was VBD B-VP O
76 elevated VBN O O
76 initially RB O O
76 , , O O
76 got VBD B-VP O
76 Kayexalate NNP B-NP B-m
76 , , O O
76 and CC O O
76 then RB O O
76 was VBD B-VP O
76 low/low JJ O O
76 normal JJ O O
77 after IN B-VP O
77 Lasix NNP B-NP B-m
77 Creatinine NNP I-NP O
77 peaked VBD B-VP O
77 at IN B-VP O
77 4.1 CD O O
77 , , O O
77 Lasix NNP B-NP B-m
77 and CC O O
77 ARBs NNP B-NP B-m
77 were VBD B-VP O
77 held VBN O O
78 Urine NNP B-NP O
78 study NN I-NP O
78 showed VBD B-VP O
78 a DT B-NP O
78 prerenal JJ I-NP O
78 component NN I-NP O
78 , , O O
78 also RB O O
78 showed VBD B-VP O
78 some DT B-NP O
79 proteinuria NNS I-NP O
79 Her PRP$ O O
79 creatinine NN B-NP O
79 eventually RB O O
79 improved VBN O O
79 to TO O O
79 3.3 CD O O
79 , , O O
79 and CC O O
79 her PRP$ O O
80 bicarb NN B-NP O
80 improved VBN O O
80 from IN B-VP O
80 17 CD O O
80 to TO O O
80 23 CD O O
80 with IN B-VP O
80 the DT B-NP O
80 closing NN I-NP O
80 of IN B-VP O
80 her PRP$ O O
80 acid JJ B-NP O
80 gap NN I-NP O
81 from IN B-VP O
81 17 CD O O
81 to TO O O
81 11 CD O O
81 Potassium NNP B-NP O
81 was VBD B-VP O
81 4.5 CD O O
81 at IN B-VP O
81 the DT B-NP O
81 time NN I-NP O
81 of IN B-VP O
81 discharge NN B-NP O
81 The DT B-NP O
82 patient NN I-NP O
82 will MD O O
82 need VB O O
82 to TO O O
82 follow VB O O
82 up RP O O
82 with IN B-VP O
82 Dr NNP B-NP O
82 Dasgupta NNP I-NP O
82 , , O O
82 her PRP$ O O
83 nephrologist NN B-NP O
83 , , O O
83 and CC O O
83 she PRP O O
83 was VBD B-VP O
83 set VBN O O
83 up RP O O
83 for IN B-VP O
83 an DT B-NP O
83 appointment NN I-NP O
83 on IN B-VP O
83 10/24/04 CD O O
84 3 CD O O
84 Endocrine: NNP B-NP O
84 DM-2 NNP I-NP O
84 , , O O
84 she PRP O O
84 was VBD B-VP O
84 treated VBN O O
84 with IN B-VP O
84 regular JJ O O
84 sliding VBG O B-do
84 scale JJ B-NP I-do
85 insulin NN I-NP O
85 with IN B-VP O
85 good JJ B-NP O
85 blood NN I-NP O
85 sugar NN I-NP O
85 control NN I-NP O
85 Her NNP I-NP O
85 glipizide NN I-NP B-m
85 was VBD B-VP O
85 held VBN O O
86 given VBN O O
86 that IN B-VP O
86 her PRP$ O O
86 creatinine JJ B-NP O
86 clearance NN I-NP O
86 was VBD B-VP O
86 worsening VBG O O
86 We PRP O O
86 did VBD B-VP O
86 not RB O O
87 restart VB O O
87 her PRP$ O O
87 glipizide NN B-NP B-m
87 at IN B-VP O
87 the DT B-NP O
87 time NN I-NP O
87 of IN B-VP O
87 discharge NN B-NP O
87 until IN B-VP O
87 follow VB O O
87 up RP O O
88 with IN B-VP O
88 Dr NNP B-NP O
88 Ohlenbusch NNP I-NP O
88 given VBN O O
88 her PRP$ O O
88 overall JJ B-NP O
88 worsening NN I-NP O
88 creatinine NN I-NP O
89 clearance NN I-NP O
90 4 CD O O
90 Rheumatology: NNP B-NP O
90 History NNP I-NP O
90 of IN B-VP O
90 gout NN B-NP O
90 , , O O
90 change VBP O O
90 her PRP$ O O
90 allopurinol NN B-NP B-m
90 allopurinol NN I-NP B-m
90 to TO O O
91 q.72h VB O B-f
91 from IN B-VP O
91 q.o.d JJ O B-f
91 secondary JJ O O
91 to TO O O
91 creatinine VB O O
91 clearance NN B-NP O
91 She PRP O O
91 did VBD B-VP O
92 complain NN B-NP O
92 of IN B-VP O
92 some DT B-NP O
92 left JJ I-NP O
92 heel NN I-NP O
92 pain NN I-NP O
92 and CC O O
92 left VBD B-VP O
92 foot NN B-NP O
92 pain NN I-NP O
92 , , O O
92 thought VBD B-VP O
93 secondary JJ O O
93 to TO O O
93 her PRP$ O O
93 gout NN B-NP O
93 This DT O O
93 improved VBN O O
93 at IN B-VP O
93 the DT B-NP O
93 time NN I-NP O
93 of IN B-VP O
93 discharge NN B-NP O
94 5 CD O O
94 Heme: NNP B-NP O
94 Hematocrit NNP I-NP O
94 dropped VBD B-VP O
94 from IN B-VP O
94 29 CD O O
94 to TO O O
94 25 CD O O
94 , , O O
94 her PRP$ O O
94 guaiac NN B-NP O
94 was VBD B-VP O
95 negative JJ O O
95 on IN B-VP O
95 the DT O O
95 3/20/04 CD O O
95 She PRP O O
95 also RB O O
95 has VBZ O O
95 epistaxis VBN O B-r
95 epistaxis RB O B-r
95 at IN B-VP O
95 night NN B-NP O
95 for IN B-VP O
96 four CD O O
96 to TO O O
96 five CD O O
96 days NNS B-NP O
96 She PRP O O
96 was VBD B-VP O
96 placed VBN O O
96 on IN B-VP O
96 humidified JJ B-NP O
96 room NN I-NP O
96 air NN I-NP O
96 given VBN O O
97 nasal JJ B-NP B-m
97 saline NN I-NP I-m
97 sprays NNS I-NP B-mo
97 and CC O O
97 Afrin NNP B-NP B-m
97 Because IN B-VP O
97 of IN B-VP O
97 her PRP$ O O
97 coronary JJ B-NP O
97 artery NN I-NP O
98 disease NN I-NP O
98 , , O O
98 she PRP O O
98 was VBD B-VP O
98 transfused JJ B-NP O
98 total NN I-NP O
98 of IN B-VP O
98 3 CD O O
98 units NNS B-NP O
98 over IN B-VP O
98 the DT B-NP O
98 course NN I-NP O
98 of IN B-VP O
99 her PRP$ O O
99 hospital NN B-NP O
99 stay NN I-NP O
99 to TO O O
99 keep VB O O
99 her PRP$ O O
99 hematocrit NN B-NP O
99 greater JJR O O
99 than IN B-VP O
99 30 CD O O
99 She PRP O O
100 was VBD B-VP O
100 given VBN O O
100 Lasix NNP B-NP B-m
100 after IN B-VP O
100 her PRP$ O O
100 transfusions NNS B-NP O
100 An DT B-NP O
100 ENT NNP I-NP O
100 evaluation NN I-NP O
100 showed VBD B-VP O
101 a DT B-NP O
101 small JJ I-NP O
101 area NN I-NP O
101 of IN B-VP O
101 ulceration NN B-NP O
101 in IN B-VP O
101 her PRP$ O O
101 posterior JJ B-NP O
101 nasopharynx NN I-NP O
101 , , O O
101 which WDT O O
102 will MD O O
102 need VB O O
102 a DT O O
102 follow VB O O
102 up RP O O
102 possibly RB O O
102 with IN B-VP O
102 a DT B-NP O
102 CT NNP I-NP O
102 as IN B-VP O
102 an DT B-NP O
102 outpatient NN I-NP O
102 to TO O O
102 rule VB O O
103 out RP O O
103 malignancy NN B-NP O
103 At IN B-VP O
103 the DT B-NP O
103 time NN I-NP O
103 of IN B-VP O
103 her PRP$ O O
103 discharge NN B-NP O
103 , , O O
103 her PRP$ O O
103 hematocrit NN B-NP O
103 was VBD B-VP O
104 36 CD O O
104 Initially NNP B-NP O
104 , , O O
104 Coumadin NNP B-NP B-m
104 was VBD B-VP O
104 started VBN O O
104 given VBN O O
104 her PRP$ O O
104 new JJ B-NP O
104 onset NN I-NP O
104 of IN B-VP O
105 atrial JJ B-NP B-r
105 fibrillation NN I-NP I-r
105 After IN B-VP O
105 consideration NN B-NP O
105 of IN B-VP O
105 risks NNS B-NP O
105 versus JJ B-NP O
105 benefit NN I-NP O
106 of IN B-VP O
106 anticoagulation NN B-NP O
106 , , O O
106 her PRP$ O O
106 transient JJ B-NP O
106 atrial JJ I-NP O
106 fibrillation NN I-NP O
106 which WDT O O
107 resolved VBD B-VP O
107 spontaneously RB O O
107 , , O O
107 it PRP O O
107 was VBD B-VP O
107 decided VBN O O
107 to TO O O
107 continue VB O O
107 any DT B-NP O
107 further JJ I-NP O
108 anticoagulation NN I-NP O
108 and CC O O
108 send VB O O
108 her PRP O O
108 out RP O O
108 just RB O O
108 on IN B-VP O
108 aspirin JJ O B-m
108 She PRP O O
108 did VBD B-VP O
109 receive VB O O
109 subcutaneous JJ B-NP B-mo
109 heparin NN I-NP B-m
109 for IN B-VP O
109 DVT NNP B-NP B-r
109 prophylaxis NN I-NP I-r
109 while IN B-VP B-du
109 in-house JJ B-NP I-du
110 GI: NNP I-NP O
110 The DT B-NP O
110 patient NN I-NP O
110 initially RB O O
110 had VBD B-VP O
110 some DT B-NP O
110 constipation NN I-NP B-r
110 , , O O
110 which WDT O O
110 was VBD B-VP O
111 relieved VBN O O
111 with IN B-VP O
111 stool NN B-NP B-m
111 softeners NNS I-NP I-m
111 The DT B-NP O
111 patient's NN I-NP O
111 stool NN I-NP O
111 was VBD B-VP O
111 guaiac JJ O O
112 negative JJ O O
112 The DT B-NP O
112 patient NN I-NP O
112 received VBD B-VP O
112 the DT B-NP O
112 PPI NNP I-NP B-m
113 DISPOSITION: NNP I-NP O
114 The DT B-NP O
114 daughter NN I-NP O
114 who WP O O
114 is VBZ O O
114 the DT B-NP O
114 patient's NN I-NP O
114 healthcare NN I-NP O
114 proxy NN I-NP O
114 was VBD B-VP O
114 made VBN O O
114 aware NN B-NP O
115 of IN B-VP O
115 the DT B-NP O
115 patient's NN I-NP O
115 status NN I-NP O
115 and CC O O
115 disposition NN B-NP O
115 throughout IN B-VP O
115 her PRP$ O O
115 hospital JJ B-NP O
116 course NN I-NP O
116 A DT B-NP O
116 PT NNP I-NP O
116 evaluation NN I-NP O
116 indicated VBD B-VP O
116 that IN B-VP O
116 the DT B-NP O
116 patient NN I-NP O
116 would MD O O
116 benefit VB O O
117 from IN B-VP O
117 a DT B-NP O
117 period NN I-NP O
117 of IN B-VP O
117 re-stay NN B-NP O
117 at IN B-VP O
117 rehab NN B-NP O
117 , , O O
117 however RB O O
117 the DT B-NP O
117 patient JJ I-NP O
117 family NN I-NP O
118 preferred VBD B-VP O
118 the DT B-NP O
118 patient NN I-NP O
118 to TO O O
118 go VB O O
118 home NN B-NP O
118 and CC O O
118 was VBD B-VP O
118 constant JJ O O
118 that IN B-VP O
118 they PRP O O
118 would MD O O
119 be VB O O
119 able JJ O O
119 to TO O O
119 provide VB O O
119 24/7 CD O O
119 support NN B-NP O
119 over IN B-VP O
119 the DT B-NP O
119 next JJ I-NP O
119 week NN I-NP O
119 as IN B-VP O
119 the DT B-NP O
119 patient NN I-NP O
120 will MD O O
120 need VB O O
120 help NN B-NP O
120 in IN B-VP O
120 navigating VBG O O
120 her PRP$ O O
120 home NN B-NP O
120 which WDT O O
120 included VBD B-VP O
120 two CD O O
120 flights NNS B-NP O
121 of IN B-VP O
121 stairs NNS B-NP O
121 PT NNP I-NP O
121 was VBD B-VP O
121 comfortable JJ O O
121 with IN B-VP O
121 this DT O O
121 and CC O O
121 this DT O O
121 was VBD B-VP O
121 explained VBN O O
122 thoroughly RB O O
122 to TO O O
122 the DT B-NP O
122 patient NN I-NP O
122 and CC O O
122 her PRP$ O O
122 family NN B-NP O
122 with IN B-VP O
122 regard NN B-NP O
122 to TO O O
122 the DT B-NP O
122 risks NNS I-NP O
123 versus VBP O O
123 benefit NN B-NP O
123 of IN B-VP O
123 going VBG O O
123 home NN B-NP O
123 versus NN I-NP O
123 going VBG O O
123 to TO O O
123 rehab VB O O
123 The DT B-NP O
123 patient NN I-NP O
124 will MD O O
124 follow VB O O
124 up RP O O
124 with IN B-VP O
124 Dr NNP B-NP O
124 Heingartner NNP I-NP O
124 in IN B-VP O
124 one CD O O
124 to TO O O
124 two CD O O
124 weeks NNS B-NP O
124 , , O O
124 which WDT O O
124 has VBZ O O
125 not RB O O
125 been VBN O O
125 scheduled VBN O O
125 , , O O
125 and CC O O
125 with IN B-VP O
125 Dr NNP B-NP O
125 Tsunoda NNP I-NP O
125 with IN B-VP O
125 Nephrology NNP B-NP O
125 which WDT O O
126 has VBZ O O
126 been VBN O O
126 scheduled VBN O O
126 for IN B-VP O
126 10/24/04 CD O O
126 Communication NN B-NP O
126 was VBD B-VP O
126 made VBN O O
126 with IN B-VP O
126 Dr NNP B-NP O
127 Smyth NNP I-NP O
127 regarding VBG O O
127 her PRP$ O O
127 admission NN B-NP O
127 here RB O O
127 The DT B-NP O
127 patient NN I-NP O
127 will MD O O
127 be VB O O
127 sent VBN O O
128 home NN B-NP O
128 with IN B-VP O
128 VNA NNP B-NP O
128 support NN I-NP O
128 to TO O O
128 follow VB O O
128 up RP O O
128 on IN B-VP O
128 her PRP$ O O
128 weights NNS B-NP O
128 and CC O O
128 fluid NN B-NP O
129 status NN I-NP O
129 , , O O
129 she PRP O O
129 will MD O O
129 also RB O O
129 have VB O O
129 home NN B-NP O
129 physical JJ B-NP O
129 therapy NN I-NP O
130 CODE NNP I-NP O
130 STATUS: NNP I-NP O
131 Full NNP I-NP O
131 code NN I-NP O
132 MEDICATIONS: NNP I-NP O
133 1 CD O O
133 Lasix NNP B-NP B-m
133 20 CD O B-do
133 mg NN B-NP I-do
133 p.o NN I-NP B-mo
133 q.d VBD B-VP B-f
134 2 CD O O
134 Lipitor NNP B-NP B-m
134 80 CD O B-do
134 mg NN B-NP I-do
134 p.o NN I-NP B-mo
134 q.d VBD B-VP B-f
135 3 CD O O
135 Metoprolol NNP B-NP B-m
135 sustained VBD B-VP I-m
135 release NN B-NP I-m
135 100 CD O B-do
135 mg NN B-NP I-do
135 p.o NN I-NP B-mo
135 b.i.d VBD B-VP B-f
136 4 CD O O
136 Colace NNP B-NP B-m
136 100 CD O B-do
136 mg NN B-NP I-do
136 p.o NN I-NP B-mo
136 b.i.d NN I-NP B-f
136 p.r.n NN I-NP I-f
136 for IN B-VP O
136 constipation NN B-NP B-r
137 5 CD O O
137 Allopurinol NNP B-NP B-m
137 100 CD O B-do
137 mg NN B-NP I-do
137 p.o NN I-NP B-mo
137 q.72h VBD B-VP B-f
138 4 CD O O
138 Aspirin NNP B-NP B-m
138 325 CD O B-do
138 mg NN B-NP I-do
138 p.o NN I-NP B-mo
138 q.d VBD B-VP B-f
139 5 CD O O
139 Valsartan NNP B-NP B-m
139 160 CD O B-do
139 mg NN B-NP I-do
139 p.o NN I-NP B-mo
139 q.d NN I-NP B-f
140 PRIMARY NNP I-NP O
140 CARE NNP I-NP O
140 PHYSICIAN: NNP I-NP O
141 Buck NNP I-NP O
141 Kuerbitz NNP I-NP O
141 , , O O
141 M.D NNP B-NP O
142 eScription NN I-NP O
142 document: VBD B-VP O
142 3-6433525 JJ B-NP O
142 BFFocus NNP I-NP O
143 Dictated NNP I-NP O
143 By: NNP I-NP O
143 ZURHEIDE NNP I-NP O
143 , , O O
143 EARL NNP B-NP O
144 Attending: NNP I-NP O
144 PROPER NNP I-NP O
144 , , O O
144 ANDREW NNP B-NP O
145 Dictation NNP I-NP O
145 ID NNP I-NP O
145 8504921 CD O O
146 D: NNP B-NP O
146 0/20/04 CD O O
147 T: NNP B-NP O
147 1/26/04 CD O O
148 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #744366 VBZ O O
4 411326611 CD O O
4 CH NNP B-NP O
4 65470446 CD O O
4 403034 CD O O
4 2/29/1995 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 3/17/1995 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/16/1995 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 The DT B-NP O
7 patient NN I-NP O
7 is VBZ O O
7 a DT O O
7 50 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 man NN I-NP O
7 with IN B-VP O
8 unstable JJ B-NP O
8 angina NNS I-NP O
8 who WP O O
8 was VBD B-VP O
8 referred VBN O O
8 to TO O O
9 the DT B-NP O
9 Rhalca NNP I-NP O
9 Medical NNP I-NP O
9 Center NNP I-NP O
9 for IN B-VP O
9 cardiac JJ B-NP O
9 catheterization NN I-NP O
9 and CC O O
10 coronary JJ B-NP O
10 artery NN I-NP O
10 bypass NN I-NP O
10 grafting VBG O O
10 The DT B-NP O
10 patient NN I-NP O
10 has VBZ O O
10 a DT B-NP O
10 four-year JJ I-NP O
11 history NN I-NP O
11 of IN B-VP O
11 coronary JJ B-NP O
11 artery NN I-NP O
11 disease NN I-NP O
11 who WP O O
11 presented VBD B-VP O
11 with IN B-VP O
11 left-sided JJ B-NP O
12 chest NN I-NP O
12 pain NN I-NP O
12 four CD O O
12 days NNS B-NP O
12 prior RB O O
12 to TO O O
12 admission NN B-NP O
12 He PRP O O
12 describes VBZ O O
12 episodes NNS B-NP O
12 of IN B-VP O
13 chest NN B-NP O
13 pain NN I-NP O
13 occurring VBG O O
13 approximately RB O O
13 q JJ O O
13 two CD O O
13 months NNS B-NP O
13 as RB O O
13 well RB O O
13 as IN B-VP O
14 evidence NN B-NP O
14 of IN B-VP O
14 shortness NN B-NP O
14 of IN B-VP O
14 breath NN B-NP O
14 although IN B-VP O
14 he PRP O O
14 has VBZ O O
14 a DT B-NP O
14 noted JJ I-NP O
14 picture NN I-NP O
14 of IN B-VP O
15 chronic JJ B-NP O
15 obstructive JJ I-NP O
15 pulmonary JJ I-NP O
15 disease NN I-NP O
16 ETT NNP I-NP O
16 in IN B-VP O
16 1989 CD O O
16 was VBD B-VP O
16 negative JJ O O
16 and CC O O
16 he PRP O O
16 recently RB O O
16 described VBD B-VP O
16 progressively RB O O
17 poor JJ B-NP O
17 exercise NN I-NP O
17 tolerance NN I-NP O
17 to TO O O
17 the DT B-NP O
17 point NN I-NP O
17 that IN B-VP O
17 he PRP O O
17 was VBD B-VP O
17 taking VBG O O
17 sublingual JJ B-NP B-mo
18 NTG NNP I-NP B-m
18 on IN B-VP O
18 a DT B-NP O
18 twice JJ I-NP B-f
18 daily JJ I-NP I-f
18 basis NN I-NP O
18 for IN B-VP O
18 exertional JJ B-NP B-r
18 angina NN I-NP I-r
18 One CD O O
18 week NN B-NP O
18 prior RB O O
19 to TO O O
19 admission NN B-NP O
19 he PRP O O
19 developed VBD B-VP O
19 severe JJ B-NP O
19 substernal JJ I-NP O
19 chest NN I-NP O
19 discomfort NN I-NP O
19 at IN B-VP O
20 rest NN B-NP O
20 , , O O
20 lasting VBG O O
20 approximately RB O O
20 10 CD O O
20 minutes NNS B-NP O
20 Then RB O O
20 , , O O
20 after IN B-VP O
20 taking VBG O O
20 a DT B-NP O
21 sublingual JJ I-NP B-mo
21 NTG NNP I-NP B-m
21 , , O O
21 he PRP O O
21 reported VBD B-VP O
21 loss NN B-NP O
21 of IN B-VP O
21 consciousness NN B-NP O
21 for IN B-VP O
21 a DT B-NP O
21 duration NN I-NP O
21 of IN B-VP O
22 20 CD O O
22 to TO O O
22 30 CD O O
22 seconds NNS B-NP O
22 at IN B-VP O
22 which WDT O O
22 point NN B-NP O
22 he PRP O O
22 was VBD B-VP O
22 taken VBN O O
22 to TO O O
22 the DT B-NP O
22 Spena NNP I-NP O
22 Hospital NNP I-NP O
22 by IN B-VP O
23 an DT B-NP O
23 EMT NNP I-NP O
23 At IN B-VP O
23 the DT B-NP O
23 clinic NN I-NP O
23 he PRP O O
23 received VBD B-VP O
23 intravenous JJ B-NP B-mo
23 NTG NNP I-NP B-m
23 , , O O
23 heparin NN B-NP B-m
23 and CC O O
24 Diltiazem NNP B-NP B-m
25 An DT B-NP O
25 ETT NNP I-NP O
25 Thallium NNP I-NP O
25 demonstrated VBD B-VP O
25 reperfusion NN B-NP O
25 abnormalities NNS I-NP O
25 in IN B-VP O
25 the DT O O
26 inferior JJ O O
26 and CC O O
26 anterior JJ B-NP O
26 walls NNS I-NP O
26 He PRP O O
26 left VBD B-VP O
26 the DT B-NP O
26 Ca NNP I-NP O
26 Awythe NNP I-NP O
26 Stosit NNP I-NP O
26 Memorial NNP I-NP O
26 Hospital NNP I-NP O
26 AMA NNP I-NP O
26 to TO O O
26 see VB O O
27 his PRP$ O O
27 cardiologist NN B-NP O
27 on IN B-VP O
27 the DT B-NP O
27 11th NNS I-NP O
27 who WP O O
27 referred VBD B-VP O
27 him PRP O O
27 to TO O O
27 the DT B-NP O
27 Troydale NNP I-NP O
27 Health NNP I-NP O
27 for IN B-VP O
27 elective JJ B-NP O
27 catheterization NN I-NP O
27 At IN B-VP O
27 the DT B-NP O
27 time NN I-NP O
27 of IN B-VP O
28 presentation NN B-NP O
28 he PRP O O
28 denied VBD B-VP O
28 chest JJS B-NP O
28 pain NN I-NP O
28 or CC O O
28 shortness NN B-NP O
28 of IN B-VP O
28 breath NN B-NP O
28 Cardiac NNP I-NP O
29 risk NN I-NP O
29 factors NNS I-NP O
29 are VBP O O
29 notably RB O O
29 an DT B-NP O
29 80-pack JJ I-NP O
29 year NN I-NP O
29 smoking NN I-NP O
29 history NN I-NP O
29 , , O O
29 family NN B-NP O
30 history NN I-NP O
30 of IN B-VP O
30 heart NN B-NP O
30 disease NN I-NP O
30 , , O O
30 hypercholesterolemia NN B-NP O
30 and CC O O
30 non JJ B-NP O
31 insulin-dependent JJ I-NP O
31 diabetes NNS I-NP O
31 mellitus VBP O O
32 PAST NNP B-NP O
32 MEDICAL NNP I-NP O
32 HISTORY: NNP I-NP O
32 Notable NNP I-NP O
32 for IN B-VP O
32 history NN B-NP O
32 of IN B-VP O
32 interstitial JJ B-NP O
32 lung NN I-NP O
33 disease NN I-NP O
33 , , O O
33 hyperlipidemia NN B-NP O
33 , , O O
33 GE NNP B-NP O
33 reflux NN I-NP O
33 , , O O
33 chronic JJ B-NP O
33 bronchitis NN I-NP O
33 and CC O O
34 obstructive JJ B-NP O
34 sleep NN I-NP O
34 apnea NN I-NP O
34 MEDICATIONS NNP I-NP O
34 ON NNP I-NP O
34 ADMIT: NNP I-NP O
34 Cardizem NNP I-NP B-m
34 120mg CD O B-do
35 p.o.b.i.d NN B-NP B-mo
35 , , O O
35 Mevacor NNP B-NP B-m
35 20mg CD O B-do
35 p.o.b.i.d NN B-NP B-mo
35 , , O O
35 Pepcid NNP B-NP B-m
35 40mg CD O B-do
35 p.o.q.d NN B-NP B-mo
35 , , O O
35 Ventolin NNP B-NP B-m
36 and CC O O
36 Seldane NNP B-NP B-m
36 taken VBN O O
36 on IN B-VP O
36 a DT B-NP O
36 prn NN I-NP B-f
36 prn JJ B-NP B-f
36 basis NN I-NP O
36 ALLERGIES: NNP I-NP O
36 NKDA NNP I-NP O
37 PHYSICAL NNP I-NP O
37 EXAMINATION: NNP I-NP O
37 Six NNP I-NP O
37 centimeters NNS I-NP O
37 of IN B-VP O
37 JVD NNP B-NP O
37 , , O O
37 normal JJ B-NP O
37 cardiac JJ I-NP O
38 examination NN I-NP O
38 with IN B-VP O
38 intact JJ B-NP O
38 distal JJ I-NP O
38 pulses NNS I-NP O
39 Diminished NNP I-NP O
39 breath NN I-NP O
39 sounds VBZ O O
39 bilaterally RB O O
40 LABORATORY NNP B-NP O
40 EVALUATION: NNP I-NP O
40 Unremarkable NNP I-NP O
41 HOSPITAL NNP I-NP O
41 COURSE: NNP I-NP O
41 The DT B-NP O
41 patient NN I-NP O
41 was VBD B-VP O
41 admitted VBN O O
41 to TO O O
41 the DT B-NP O
41 Cardiology NNP I-NP O
42 Service NNP I-NP O
42 and CC O O
42 underwent JJ B-NP O
42 cardiac JJ I-NP O
42 catheterization NN I-NP O
43 demonstrating VBG O O
43 80% CD O O
43 distal JJ B-NP O
43 stenosis NN I-NP O
43 of IN B-VP O
43 the DT B-NP O
43 left NN I-NP O
43 main JJ O O
43 as RB O O
43 well RB O O
43 as IN B-VP O
43 the DT B-NP O
44 origin NN I-NP O
44 of IN B-VP O
44 the DT B-NP O
44 LAD NNP I-NP O
44 with IN B-VP O
44 additional JJ B-NP O
44 occlusion NN I-NP O
44 of IN B-VP O
44 the DT B-NP O
44 midportion NN I-NP O
44 of IN B-VP O
45 the DT B-NP O
45 LAD NNP I-NP O
45 and CC O O
45 distal JJ B-NP O
45 carotid NN I-NP O
45 , , O O
45 80% CD O O
45 stenosis NN B-NP O
45 of IN B-VP O
45 midportion NN B-NP O
45 of IN B-VP O
45 left JJ B-NP O
46 circumflex NN I-NP O
46 and CC O O
46 proximal JJ B-NP O
46 occlusion NN I-NP O
46 of IN B-VP O
46 the DT B-NP O
46 right JJ I-NP O
46 coronary NN I-NP O
46 Previous NNP I-NP O
47 pulmonary JJ B-NP O
47 function NN I-NP O
47 tests NNS I-NP O
47 performed VBD B-VP O
47 in IN B-VP O
47 March NNP B-NP O
47 included VBD B-VP O
47 an DT B-NP O
47 FEV-1 NNP I-NP O
47 of IN B-VP O
48 2.53 CD O O
48 , , O O
48 FEV-1/FVC NNP B-NP O
48 of IN B-VP O
48 83 CD O O
48 , , O O
48 FVC NNP B-NP O
48 3.05 CD O O
48 He PRP O O
48 was VBD B-VP O
48 seen VBN O O
48 preoperatively RB O O
48 by IN B-VP O
48 the DT B-NP O
49 Dental NNP I-NP O
49 Service NNP I-NP O
49 He PRP O O
49 was VBD B-VP O
49 felt VBN O O
49 to TO O O
49 have VB O O
49 a DT B-NP B-r
49 possible JJ I-NP I-r
49 periodontal JJ I-NP I-r
49 abscess NN I-NP I-r
50 of IN B-VP O
50 tooth JJ B-NP O
50 #32 NNP I-NP O
50 for IN B-VP O
50 which WDT O O
50 a DT B-NP B-du
50 course NN I-NP I-du
50 of IN B-VP O
50 p.o JJ B-NP B-mo
50 penicillin NN I-NP B-m
50 was VBD B-VP O
50 recommended VBN O O
51 and CC O O
51 completed VBN O O
52 On IN B-VP O
52 the DT O O
52 26 CD O O
52 of IN B-VP O
52 May NNP B-NP O
52 , , O O
52 the DT B-NP O
52 patient NN I-NP O
52 received VBD B-VP O
52 double JJ B-NP O
52 coronary JJ I-NP O
52 artery NN I-NP O
52 bypass NN I-NP O
53 graft NN I-NP O
53 including VBG O O
53 pedicle NN B-NP O
53 LIMA NNP I-NP O
53 bypass NN I-NP O
53 to TO O O
53 the DT B-NP O
53 LAD NNP I-NP O
53 and CC O O
53 LAD NNP B-NP O
53 patch VBP O O
54 angioplasty NN B-NP O
54 with IN B-VP O
54 a DT B-NP O
54 single JJ I-NP O
54 aortocoronary JJ I-NP O
54 saphenous JJ I-NP O
54 vein NN I-NP O
54 bypass NN I-NP O
54 graft NN I-NP O
55 to TO O O
55 the DT B-NP O
55 obtuse NN I-NP O
55 marginal NN I-NP O
55 He PRP O O
55 tolerated VBD B-VP O
55 the DT B-NP O
55 procedure NN I-NP O
55 well RB O O
55 He PRP O O
55 was VBD B-VP O
56 admitted VBN O O
56 to TO O O
56 the DT B-NP O
56 Cardiac NNP I-NP O
56 Surgery NNP I-NP O
56 Intensive NNP I-NP O
56 Care NNP I-NP O
56 Unit NNP I-NP O
56 in IN B-VP O
56 routine JJ B-NP O
57 fashion NN I-NP O
57 without IN B-VP O
57 complications NNS B-NP O
57 He PRP O O
57 was VBD B-VP O
57 stable JJ O O
57 in IN B-VP O
57 sinus NN B-NP O
57 rhythm NN I-NP O
57 He PRP O O
58 had VBD B-VP O
58 a DT O O
58 somewhat RB O O
58 higher JJR O O
58 than IN B-VP O
58 normal JJ B-NP O
58 O2 NNP I-NP O
58 requirement NN I-NP O
58 which WDT O O
58 diminished VBD B-VP O
59 with IN B-VP O
59 diuresis NN B-NP O
60 His PRP$ O O
60 hospital NN B-NP O
60 course NN I-NP O
60 proceeded VBD B-VP O
60 without IN B-VP O
60 complications NNS B-NP O
60 although IN B-VP O
60 he PRP O O
60 did VBD B-VP O
61 demonstrate VB O O
61 a DT B-NP B-r
61 low-grade JJ I-NP I-r
61 fever NN I-NP I-r
61 and CC O O
61 leukocytosis NN B-NP B-r
61 up RB O O
61 to TO O O
61 20 CD O O
61 , , O O
61 000 CD O O
61 for IN B-VP O
62 which WDT O O
62 he PRP O O
62 was VBD B-VP O
62 started VBN O O
62 on IN B-VP O
62 an DT B-NP O
62 empiric JJ I-NP O
62 course NN I-NP O
62 of IN B-VP O
62 cefuroxime NN B-NP B-m
62 cefuroxime NN I-NP B-m
62 for IN B-VP O
63 radiographic JJ B-NP O
63 infiltrate NN I-NP O
63 although IN B-VP O
63 his PRP$ O O
63 sputum NN B-NP O
63 cultures NNS I-NP O
63 were VBD B-VP O
63 not RB O O
64 definitive JJ O O
64 He PRP O O
64 was VBD B-VP O
64 evaluated VBN O O
64 by IN B-VP O
64 the DT B-NP O
64 ID NNP I-NP O
64 Service NNP I-NP O
64 and CC O O
64 cultured VBD B-VP O
65 appropriately RB O O
65 with IN B-VP O
65 continuation NN B-NP O
65 of IN B-VP O
65 empiric JJ B-NP B-m
65 antibiotics NNS I-NP I-m
65 He PRP O O
66 continued VBD B-VP O
66 to TO O O
66 demonstate VB O O
66 low-grade JJ B-NP O
66 fevers NNS I-NP O
66 during IN B-VP O
66 the DT B-NP O
66 course NN I-NP O
66 of IN B-VP O
66 his PRP$ O O
67 hospital NN B-NP O
67 stay NN I-NP O
67 with IN B-VP O
67 persistent JJ B-NP O
67 leukocytosis NN I-NP O
67 in IN B-VP O
67 the DT B-NP O
67 range NN I-NP O
67 of IN B-VP O
67 14 CD O O
67 to TO O O
68 16K CD O O
68 prior RB O O
68 to TO O O
68 discharge VB O O
68 No NNP B-NP O
68 definite NNP I-NP O
68 source NN I-NP O
68 of IN B-VP O
68 infection NN B-NP O
68 was VBD B-VP O
69 identified VBN O O
70 All DT O O
70 of IN B-VP O
70 his PRP$ O O
70 wound NN B-NP O
70 sites VBZ O O
70 looked JJ O O
70 clean JJ O O
70 and CC O O
70 cultures NNS B-NP O
70 remained VBD B-VP O
70 negative JJ O O
71 He PRP O O
71 was VBD B-VP O
71 weaned VBN O O
71 off RP O O
71 oxygen NN B-NP B-m
71 for IN B-VP B-du
71 some DT B-NP I-du
71 time NN I-NP I-du
71 He PRP O O
71 had VBD B-VP O
71 no DT B-NP O
71 productive JJ I-NP O
72 cough NN I-NP O
72 On IN B-VP O
72 the DT O O
72 24 CD O O
72 of IN B-VP O
72 September NNP B-NP O
72 we PRP O O
72 discharged VBD B-VP O
72 him PRP O O
72 to TO O O
72 home NN B-NP O
72 AMA NNP I-NP O
72 , , O O
72 although IN B-VP O
73 encouraged VBN O O
73 a DT B-NP O
73 stay NN I-NP O
73 for IN B-VP O
73 further JJ B-NP O
73 evaluation NN I-NP O
73 of IN B-VP O
73 his PRP$ O O
73 fever NN B-NP O
73 and CC O O
74 leukocytosis NN B-NP O
75 DISPOSITION: NNP I-NP O
75 Aspirin NNP I-NP B-m
75 325mg CD O B-do
75 q.d NN B-NP B-f
75 , , O O
75 Diltiazem NNP B-NP B-m
75 120mg CD O B-do
75 p.o.t.i.d NN B-NP B-mo
75 , , O O
76 Colace NNP B-NP B-m
76 100mg CD O B-do
76 t.i.d NN B-NP B-f
76 , , O O
76 iron NN B-NP B-m
76 sulfate NN I-NP I-m
76 300mg CD O B-do
76 t.i.d NN B-NP B-f
76 , , O O
76 Lasix NNP B-NP B-m
77 80mg CD O B-do
77 p.o.b.i.d NN B-NP B-mo
77 , , O O
77 Mevacor NNP B-NP B-m
77 20mg CD O B-do
77 p.o.b.i.d NN B-NP B-mo
77 , , O O
77 MVI NNP B-NP B-m
77 one CD O B-do
77 p.o.q.d NN B-NP B-mo
77 , , O O
78 Percocet NNP B-NP B-m
78 one CD O B-do
78 to TO O I-do
78 two CD O I-do
78 tabs NNS B-NP I-do
78 q VBP O B-f
78 4 CD O I-f
78 prn NN B-NP I-f
78 , , O O
78 KCl NNP B-NP B-m
78 40mil/eq CD O B-do
78 p.o.b.i.d NN B-NP B-mo
78 and CC O O
79 ciprofloxacin NN B-NP B-m
79 500mg CD O B-do
79 p.o.b.i.d NN B-NP B-mo
79 X NNP I-NP B-du
79 X NNP I-NP B-du
79 10 CD O I-du
79 10 CD O I-du
79 days NNS B-NP I-du
79 days NNS I-NP I-du
79 taken VBN O O
79 with IN B-VP O
79 clindamycin JJ O B-m
80 300mg CD O B-do
80 p.o.q.i.d NN B-NP B-mo
80 He PRP O O
80 was VBD B-VP O
80 encouraged VBN O O
80 to TO O O
80 see VB O O
80 his PRP$ O O
80 cardiologist NN B-NP O
80 for IN B-VP O
81 follow-up NN B-NP O
81 over IN B-VP O
81 the DT B-NP O
81 following JJ I-NP O
81 week NN I-NP O
81 and CC O O
81 should MD O O
81 return VB O O
81 to TO O O
82 Dr NNP B-NP O
82 Donnie NNP I-NP O
82 Daidone NNP I-NP O
82 office NN I-NP O
82 during IN B-VP O
82 this DT B-NP O
82 interval JJ I-NP O
82 prior NN I-NP O
82 to TO O O
82 completion NN B-NP O
83 of IN B-VP O
83 his PRP$ O O
83 antibiotics NNS B-NP B-m
84 Dictated VBD B-VP O
84 By: NNP B-NP O
84 HARLEY NNP I-NP O
84 C NNP I-NP O
84 ARNOLD NNP I-NP O
84 , , O O
84 M.D NNP B-NP O
84 WR30 NNP I-NP O
85 Attending: NNP I-NP O
85 ALEXIS NNP I-NP O
85 E NNP I-NP O
85 NEWBROUGH NNP I-NP O
85 , , O O
85 M.D NNP B-NP O
85 XS1 NNP I-NP O
85 LT739/3299 NNP I-NP O
86 Batch: NNP I-NP O
86 91766 CD O O
86 Index NNP B-NP O
86 No NNP I-NP O
86 KFACZB580S NNP I-NP O
86 D: NNP I-NP O
86 6/19/95 CD O O
87 T: NNP B-NP O
87 6/19/95 CD O O
88 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #752897 VBZ O O
4 141305871 CD O O
4 PH NNP B-NP O
4 32338118 CD O O
4 008024 CD O O
4 8/20/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 coronary JJ B-NP O
4 artery NN I-NP O
4 disease NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 5/30/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 6/17/2001 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 PRUNIER NNP I-NP O
8 , , O O
8 VANCE NNP B-NP O
8 799-40-56-9 CD O O
9 Ring NNP B-NP O
9 Hwy NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 1/26/01 CD O O
11 AT NNP B-NP O
11 11:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 CODE NNP I-NP O
14 STATUS: NNP I-NP O
15 Full NNP I-NP O
15 code NN I-NP O
16 DISPOSITION: NNP I-NP O
16 Home NNP I-NP O
17 DISCHARGE NNP I-NP O
17 MEDICATIONS: NNP I-NP O
18 EC NNP I-NP B-m
18 ASA NNP I-NP I-m
18 ( ( O I-m
18 ASPIRIN NNP B-NP I-m
18 ENTERIC NNP I-NP I-m
18 COATED NNP I-NP I-m
18 ) ) O I-m
18 325 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
19 ATENOLOL NNP I-NP B-m
19 50 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QPM NNP I-NP B-f
19 Food/Drug NNP I-NP O
19 Interaction NNP I-NP O
19 Instruction NNP I-NP O
20 Take NNP I-NP O
20 consistently RB O O
20 with IN B-VP O
20 meals NNS B-NP O
20 or CC O O
20 on IN B-VP O
20 empty JJ B-NP O
20 stomach NN I-NP O
21 ATENOLOL NNP I-NP B-m
21 75 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QAM NNP I-NP B-f
21 Food/Drug NNP I-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Take NNP I-NP O
22 consistently RB O O
22 with IN B-VP O
22 meals NNS B-NP O
22 or CC O O
22 on IN B-VP O
22 empty JJ B-NP O
22 stomach NN I-NP O
23 CIPRO NNP I-NP B-m
23 ( ( O I-m
23 CIPROFLOXACIN NNP B-NP I-m
23 ) ) O I-m
23 250 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 Food/Drug NNP I-NP O
24 Interaction NNP I-NP O
24 Instruction NNP I-NP O
25 If IN B-VP O
25 on IN B-VP O
25 tube NN B-NP O
25 feeds NNS I-NP O
25 , , O O
25 please VB O O
25 cycle NN B-NP O
25 ( ( O O
25 hold VB O O
25 1 CD O O
25 hr NN B-NP O
25 before IN B-VP O
25 to TO O O
25 2 CD O O
25 hr NNS B-NP O
26 after IN B-VP O
26 ) ) O O
26 Take VBP O O
26 2 CD O O
26 hours NNS B-NP O
26 before IN B-VP O
26 or CC O O
26 2 CD O O
26 hours NNS B-NP O
26 after IN B-VP O
26 dairy NN B-NP O
26 products NNS I-NP O
27 Number NNP I-NP O
27 of IN B-VP O
27 Doses NNP B-NP O
27 Required NNP I-NP O
27 ( ( O O
27 approximate JJ B-NP O
27 ): NN I-NP O
27 3 CD O O
28 INSULIN NNP B-NP B-m
28 NPH NNP I-NP I-m
28 HUMAN NNP I-NP I-m
28 30 CD O B-do
28 UNITS NNP B-NP I-do
28 SC NNP I-NP B-mo
28 QAM NNP I-NP B-f
29 INSULIN NNP I-NP B-m
29 NPH NNP I-NP I-m
29 HUMAN NNP I-NP I-m
29 20 CD O B-do
29 UNITS NNP B-NP I-do
29 SC NNP I-NP B-mo
29 before IN B-VP B-f
29 dinner NN B-NP I-f
30 INSULIN NNP I-NP B-m
30 REGULAR NNP I-NP I-m
30 ( ( O I-m
30 HUMAN NNP B-NP I-m
30 ) ) O I-m
30 18 CD O B-do
30 UNITS NNP B-NP I-do
30 SC NNP I-NP B-mo
30 QAM NNP I-NP B-f
31 INSULIN NNP I-NP B-m
31 REGULAR NNP I-NP I-m
31 ( ( O I-m
31 HUMAN NNP B-NP I-m
31 ) ) O I-m
31 14 CD O B-do
31 UNITS NNP B-NP I-do
31 SC NNP I-NP B-mo
31 before IN B-VP B-f
31 dinner NN B-NP I-f
32 LEVOXYL NNP I-NP B-m
32 ( ( O I-m
32 LEVOTHYROXINE NNP B-NP I-m
32 SODIUM NNP I-NP I-m
32 ) ) O I-m
32 75 CD O B-do
32 MCG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 LISINOPRIL NNP I-NP B-m
33 20 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
34 NITROGLYCERIN NNP I-NP B-m
34 1/150 CD O I-m
34 ( ( O I-m
34 0.4 CD O I-m
34 MG NNP B-NP I-m
34 ) ) O I-m
34 1 CD O B-do
34 TAB NNP B-NP I-do
34 SL NNP I-NP B-mo
34 Q5 NNP I-NP O
34 MIN NNP I-NP O
34 X NNP I-NP B-du
34 3 CD O I-du
35 PRN NNP B-NP O
35 Chest NNP I-NP B-r
35 Pain NNP I-NP I-r
35 HOLD NNP I-NP O
35 IF: NNP I-NP O
35 SBP&lt;[ NNP I-NP O
35 ] NNP I-NP O
36 PRAVACHOL NNP I-NP B-m
36 ( ( O I-m
36 PRAVASTATIN NNP B-NP I-m
36 ) ) O I-m
36 20 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 QHS NNP I-NP B-f
37 Food/Drug NNP I-NP O
37 Interaction NNP I-NP O
37 Instruction NNP I-NP O
38 Avoid NNP I-NP O
38 grapefruit NN I-NP O
38 unless IN B-VP O
38 MD NNP B-NP O
38 instructs NNS I-NP O
38 otherwise RB O O
39 AMLODIPINE NNP B-NP B-m
39 5 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 QD NNP I-NP B-f
39 Food/Drug NNP I-NP O
39 Interaction NNP I-NP O
39 Instruction NNP I-NP O
40 Avoid NNP I-NP O
40 grapefruit NN I-NP O
40 unless IN B-VP O
40 MD NNP B-NP O
40 instructs NNS I-NP O
40 otherwise RB O O
41 IMDUR NNP B-NP B-m
41 ( ( O I-m
41 ISOSORBIDE NNP B-NP I-m
41 MONONIT.( NNP I-NP I-m
41 SR NNP I-NP I-m
41 ) ) O I-m
41 ) ) O I-m
41 60 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 QD NNP I-NP B-f
42 Food/Drug NNP I-NP O
42 Interaction NNP I-NP O
42 Instruction NNP I-NP O
43 Give NNP I-NP O
43 on IN B-VP O
43 an DT B-NP O
43 empty JJ I-NP O
43 stomach NN I-NP O
43 ( ( O O
43 give JJ O O
43 1hr CD O O
43 before IN B-VP O
43 or CC O O
43 2hr CD O O
43 after IN B-VP O
44 food NN B-NP O
44 ) ) O O
45 WELLBUTRIN NNP B-NP B-m
45 SR NNP I-NP I-m
45 ( ( O I-m
45 BUPROPION NNP B-NP I-m
45 HCL NNP I-NP I-m
45 SR NNP I-NP I-m
45 ) ) O I-m
45 150 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 BID NNP I-NP B-f
46 Number NNP I-NP B-du
46 of IN B-VP I-du
46 Doses NNP B-NP I-du
46 Required NNP I-NP I-du
46 ( ( O I-du
46 approximate JJ B-NP I-du
46 ): NN I-NP I-du
46 2 CD O I-du
47 CLOPIDOGREL NNP B-NP B-m
47 75 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QD NNP I-NP B-f
48 DIET: NNP I-NP O
48 House NNP I-NP O
48 / VBD B-VP O
48 Low NNP B-NP O
48 chol/low NN I-NP O
48 sat VBD B-VP O
48 fat JJ B-NP O
49 Activity NNP I-NP O
49 - : O O
50 RETURN NN B-NP O
50 TO NNP I-NP O
50 WORK: NNP I-NP O
50 After IN B-VP O
50 Appt NNP B-NP O
50 with IN B-VP O
50 local JJ B-NP O
50 physician NN I-NP O
51 FOLLOW NNP I-NP O
51 UP NNP I-NP O
51 APPOINTMENT( NNP I-NP O
51 S NNP I-NP O
51 ): NNP I-NP O
52 Dr NNP I-NP O
52 Minear NNP I-NP O
52 1-2 JJ B-NP O
52 weeks NNS I-NP O
52 , , O O
53 Dr NNP B-NP O
53 Givens NNP I-NP O
53 call NN I-NP O
53 , , O O
54 ALLERGY: NNP B-NP O
54 Penicillins NNP I-NP O
55 ADMIT NNP I-NP O
55 DIAGNOSIS: NNP I-NP O
56 cad NN I-NP O
57 PRINCIPAL NNP I-NP O
57 DISCHARGE NNP I-NP O
57 DIAGNOSIS NNP I-NP O
57 ;Responsible JJ O O
57 After IN B-VP O
57 Study NNP B-NP O
57 for IN B-VP O
57 Causing NNP B-NP O
57 Admission NNP I-NP O
57 ) ) O O
58 coronary JJ B-NP O
58 artery NN I-NP O
58 disease NN I-NP O
59 OTHER NNP I-NP O
59 DIAGNOSIS;Conditions NNP I-NP O
59 , , O O
59 Infections NNP B-NP O
59 , , O O
59 Complications NNP B-NP O
59 , , O O
59 affecting VBG O O
59 Treatment/Stay NNP B-NP O
60 HTN NNP I-NP O
60 DEPRESSION NNP I-NP O
60 CABG( NNP I-NP O
60 SVG-&gt;LAD NNP I-NP O
60 ) ) O O
60 1973 CD O O
60 H/O NNP B-NP O
60 menorrhagia NN I-NP O
60 MI NNP I-NP O
61 1986 CD O O
61 cabg NN B-NP O
61 3v CD O O
61 w/rad JJ O O
61 art-rca JJ O O
61 1/5 CD O O
61 type NN B-NP O
61 I PRP O O
61 DM NNP B-NP O
62 OPERATIONS NNP I-NP O
62 AND NNP I-NP O
62 PROCEDURES: NNP I-NP O
63 OTHER NNP I-NP O
63 TREATMENTS/PROCEDURES NNP I-NP O
63 ( ( O O
63 NOT NNP B-NP O
63 IN NNP I-NP O
63 O.R NNP I-NP O
63 ) ) O O
64 BRIEF NNP B-NP O
64 RESUME NNP I-NP O
64 OF NNP I-NP O
64 HOSPITAL NNP I-NP O
64 COURSE: NNP I-NP O
65 57 CD O O
65 y.o NN B-NP O
65 lady NN I-NP O
65 with IN B-VP O
65 DM NNP B-NP O
65 , , O O
65 HT NNP B-NP O
65 , , O O
65 hyperlipidemia NN B-NP O
65 and CC O O
65 known VBN O O
66 CAD NNP B-NP O
66 S/P NNP I-NP O
66 CABG NNP I-NP O
66 25 CD O O
66 year NN B-NP O
66 ago RB O O
66 and CC O O
66 multiple JJ B-NP O
66 PCIs NNP I-NP O
66 presented VBD B-VP O
66 with IN B-VP O
66 recent JJ B-NP O
67 worsening NN I-NP O
67 of IN B-VP O
67 exercise NN B-NP O
67 capacity NN I-NP O
67 Cath NNP I-NP O
67 today NN I-NP O
67 showed VBD B-VP O
67 severe JJ B-NP O
67 native JJ I-NP O
68 TVD NNP I-NP O
68 , , O O
68 patent NN B-NP O
68 LIMA NNP I-NP O
68 to TO O O
68 LAD NNP B-NP O
68 , , O O
68 occluded VBD B-VP O
68 SVG-OM NNP B-NP O
68 and CC O O
69 radial JJ B-NP O
69 graft NN I-NP O
69 to TO O O
69 PDA VB O O
69 80% CD O O
69 stenosis NN B-NP O
69 PCI NNP I-NP O
69 of IN B-VP O
69 radial JJ B-NP O
70 graft NN I-NP O
70 lesion NN I-NP O
70 with IN B-VP O
70 Nir NNP B-NP O
70 2.5x15mm CD O O
70 and CC O O
70 S660 NNP B-NP O
70 2.5x12mm CD O O
71 stents NNS B-NP O
71 resulting VBG O O
71 in IN B-VP O
71 0% CD O O
71 residual JJ B-NP O
71 Plan NN I-NP O
71 for IN B-VP B-du
71 16 CD O O
72 hours NNS B-NP O
72 Integrilin NNP I-NP B-m
72 and CC O O
72 30 CD O B-du
72 days NNS B-NP I-du
72 Plavix NNP I-NP B-m
73 Angioseal NNP I-NP O
73 applied VBD B-VP O
73 to TO O O
73 RFA NNP B-NP O
73 Uncomplicated NNP I-NP O
73 postop JJ B-NP O
73 course NN I-NP O
73 and CC O O
73 home NN B-NP O
73 on IN B-VP O
74 9/9/01 CD O O
75 ADDITIONAL NNP B-NP O
75 COMMENTS: NNP I-NP O
75 call NN I-NP O
75 for IN B-VP O
75 any DT B-NP O
75 further JJ I-NP O
75 chest NN I-NP O
75 pain NN I-NP O
75 , , O O
75 groin NN B-NP O
75 pain NN I-NP O
75 , , O O
75 swelling VBG O O
75 or CC O O
75 bleeding VBG O O
76 DISCHARGE NNP B-NP O
76 CONDITION: NNP I-NP O
76 Stable NNP I-NP O
77 TO NNP I-NP O
77 DO/PLAN: NNP I-NP O
78 ENTERED NNP I-NP O
78 BY: NNP I-NP O
78 HAROLDSEN NNP I-NP O
78 , , O O
78 DANE NNP B-NP O
78 FLOYD NNP I-NP O
78 ( ( O O
78 ZN50 NNP B-NP O
78 ) ) O O
78 1/26/01 CD O O
78 @ $ O O
78 10:18 CD O O
78 AM NNP B-NP O
79 ****** JJ B-NP O
79 END NN I-NP O
79 OF NNP I-NP O
79 DISCHARGE NNP I-NP O
79 ORDERS NNP I-NP O
79 ****** NNP I-NP O
80 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #758638 VBZ O O
4 195121411 CD O O
4 EMC NNP B-NP O
4 83762037 CD O O
4 0098987 CD O O
4 10/6/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 1 CD O O
4 ) ) O O
4 Angina NNP B-NP O
4 , , O O
4 R/o NNP B-NP O
4 MI NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/6/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/22/2005 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 CONTINENZA NNP I-NP O
8 , , O O
8 WHITNEY NNP B-NP O
8 A NNP I-NP O
8 042-45-92-1 JJ B-NP O
9 Rock NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 2/16/05 CD O O
11 AT NNP B-NP O
11 01:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 BIRKEY NNP I-NP O
14 , , O O
14 MERLIN NNP B-NP O
14 KEVEN NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ECASA NNP I-NP B-m
19 ( ( O I-m
19 ASPIRIN NNP B-NP I-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 ) ) O I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Starting VBG O O
20 Today NNP B-NP O
20 ( ( O O
20 8/7 CD O O
20 ) ) O O
21 FERROUS NNP B-NP B-m
21 SULFATE NNP I-NP I-m
21 325 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 TID NNP I-NP B-f
22 Food/Drug NNP I-NP O
22 Interaction NNP I-NP O
22 Instruction NNP I-NP O
22 Avoid NNP I-NP O
22 milk NN I-NP O
22 and CC O O
22 antacid JJ B-NP O
23 LASIX NNP I-NP B-m
23 ( ( O I-m
23 FUROSEMIDE NNP B-NP I-m
23 ) ) O I-m
23 60 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 HYDRALAZINE NNP I-NP B-m
24 HCL NNP I-NP I-m
24 90 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 TID NNP I-NP B-f
24 Starting VBG O O
24 Today NNP B-NP O
24 ( ( O O
24 0/12 CD O O
24 ) ) O O
25 HOLD NNP B-NP O
25 IF: NNP I-NP O
25 SBP NNP I-NP O
25 &lt;95 NNP I-NP O
25 Food/Drug NNP I-NP O
25 Interaction NNP I-NP O
25 Instruction NNP I-NP O
26 Take NNP I-NP O
26 consistently RB O O
26 with IN B-VP O
26 meals NNS B-NP O
26 or CC O O
26 on IN B-VP O
26 empty JJ B-NP O
26 stomach NN I-NP O
27 LABETALOL NNP I-NP B-m
27 HCL NNP I-NP I-m
27 600 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 TID NNP I-NP B-f
27 HOLD NNP I-NP O
27 IF: NNP I-NP O
27 sbp&lt;90 NN I-NP O
27 , , O O
27 hr&lt;50 JJ B-NP O
28 Food/Drug NNP I-NP O
28 Interaction NNP I-NP O
28 Instruction NNP I-NP O
29 Take NNP I-NP O
29 consistently RB O O
29 with IN B-VP O
29 meals NNS B-NP O
29 or CC O O
29 on IN B-VP O
29 empty JJ B-NP O
29 stomach NN I-NP O
30 NITROGLYCERIN NNP I-NP B-m
30 1/150 CD O I-m
30 ( ( O I-m
30 0.4 CD O I-m
30 MG NNP B-NP I-m
30 ) ) O I-m
30 1 CD O B-do
30 TAB NNP B-NP I-do
30 SL NNP I-NP B-mo
30 q5min VBD B-VP B-f
30 x $ O O
30 3 CD O O
31 PRN NNP B-NP O
31 chest NN I-NP B-r
31 pain NN I-NP I-r
31 HOLD NNP I-NP O
31 IF: NNP I-NP O
31 SBP NNP I-NP O
31 &lt; VBD B-VP O
31 100 CD O O
32 CLARITIN NNP B-NP B-m
32 ( ( O I-m
32 LORATADINE NNP B-NP I-m
32 ) ) O I-m
32 10 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 Food/Drug NNP I-NP O
33 Interaction NNP I-NP O
33 Instruction NNP I-NP O
34 Avoid NNP I-NP O
34 grapefruit NN I-NP O
34 unless IN B-VP O
34 MD NNP B-NP O
34 instructs NNS I-NP O
34 otherwise RB O O
35 Give VBP O O
35 on IN B-VP O
35 an DT B-NP O
35 empty JJ I-NP O
35 stomach NN I-NP O
35 ( ( O O
35 give JJ O O
35 1hr CD O O
35 before IN B-VP O
35 or CC O O
35 2hr CD O O
35 after IN B-VP O
36 food NN B-NP O
36 ) ) O O
37 COZAAR NNP B-NP B-m
37 ( ( O I-m
37 LOSARTAN NNP B-NP I-m
37 ) ) O I-m
37 100 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 QD NNP I-NP B-f
37 HOLD NNP I-NP O
37 IF: NNP I-NP O
37 SBP NNP I-NP O
37 95 CD O O
38 Number NNP B-NP B-du
38 of IN B-VP I-du
38 Doses NNP B-NP I-du
38 Required NNP I-NP I-du
38 ( ( O I-du
38 approximate JJ B-NP I-du
38 ): NN I-NP I-du
38 3 CD O I-du
39 METFORMIN NNP B-NP B-m
39 850 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 BID NNP I-NP B-f
40 VYTORIN NNP I-NP B-m
40 10/40 CD O I-m
40 ( ( O I-m
40 EZETIMIBE NNP B-NP I-m
40 10 CD O I-m
40 MG NNP B-NP I-m
40 - : O I-m
40 SIMVASTATIN NNP B-NP I-m
40 ) ) O I-m
41 1 CD O B-do
41 TAB NNP B-NP I-do
41 PO NNP I-NP B-mo
41 QD NNP I-NP B-f
42 DIET: NNP I-NP O
42 Patient NNP I-NP O
42 should MD O O
42 measure VB O O
42 weight JJ B-NP O
42 daily JJ I-NP O
43 DIET: NNP I-NP O
43 House NNP I-NP O
43 / VBD B-VP O
43 Low NNP B-NP O
43 chol/low NN I-NP O
43 sat VBD B-VP O
43 fat JJ B-NP O
44 DIET: NNP I-NP O
44 House NNP I-NP O
44 / NNP I-NP O
44 ADA NNP I-NP O
44 1800 CD O O
44 cals/dy NN B-NP O
45 DIET: NNP I-NP O
45 2 CD O O
45 gram NN B-NP O
45 Sodium NNP I-NP O
46 ACTIVITY: NNP I-NP O
46 Resume NNP I-NP O
46 regular JJ B-NP O
46 exercise NN I-NP O
47 FOLLOW NNP I-NP O
47 UP NNP I-NP O
47 APPOINTMENT( NNP I-NP O
47 S NNP I-NP O
47 ): NNP I-NP O
48 Dr NNP I-NP O
48 Rob NNP I-NP O
48 Mulroy NNP I-NP O
48 1 CD O O
48 wk NN B-NP O
48 , , O O
49 ALLERGY: NNP B-NP O
49 Latex NNP I-NP O
50 ADMIT NNP I-NP O
50 DIAGNOSIS: NNP I-NP O
51 1 CD O O
51 )Atypical JJ B-NP O
51 Chest NNP I-NP O
51 Pain NNP I-NP O
51 2 CD O O
51 ) ) O O
51 HTN NNP B-NP O
51 3 CD O O
51 ) ) O O
51 NIDDM NNP B-NP O
51 4 CD O O
51 ) ) O O
51 Hypercholesterolemia NNP B-NP O
51 5 CD O O
51 ) ) O O
51 h/o NN B-NP O
52 Renal NNP I-NP O
52 Cell NNP I-NP O
52 Carcinoma NNP I-NP O
52 s/p VBZ O O
52 resection NN B-NP O
53 PRINCIPAL NNP I-NP O
53 DISCHARGE NNP I-NP O
53 DIAGNOSIS NNP I-NP O
53 ;Responsible JJ O O
53 After IN B-VP O
53 Study NNP B-NP O
53 for IN B-VP O
53 Causing NNP B-NP O
53 Admission NNP I-NP O
53 ) ) O O
54 1 CD O O
54 ) ) O O
54 Angina NNP B-NP O
54 , , O O
54 R/o NNP B-NP O
54 MI NNP I-NP O
55 OTHER NNP I-NP O
55 DIAGNOSIS;Conditions NNP I-NP O
55 , , O O
55 Infections NNP B-NP O
55 , , O O
55 Complications NNP B-NP O
55 , , O O
55 affecting VBG O O
55 Treatment/Stay NNP B-NP O
56 HYPERTENSION NNP I-NP O
56 S/P NNP I-NP O
56 MVA NNP I-NP O
56 -&gt; NNP I-NP O
56 RLE NNP I-NP O
56 FRX NNP I-NP O
56 ( ( O O
56 1977 CD O O
56 ) ) O O
56 S/P NNP B-NP O
56 RLE NNP I-NP O
56 SKIN NNP I-NP O
56 GRAFT NNP I-NP O
57 ( ( O O
57 1977 CD O O
57 ) ) O O
57 MEDICAL NNP B-NP O
57 NON-COMPLIANCE NNP I-NP O
57 OBESITY NNP I-NP O
57 ? . B-VP O
57 HYPERCHOLESTEROLEMIA NNP B-NP O
58 OPERATIONS NNP I-NP O
58 AND NNP I-NP O
58 PROCEDURES: NNP I-NP O
59 None NNP I-NP O
60 OTHER NNP I-NP O
60 TREATMENTS/PROCEDURES NNP I-NP O
60 ( ( O O
60 NOT NNP B-NP O
60 IN NNP I-NP O
60 O.R NNP I-NP O
60 ) ) O O
61 Adenosine NNP B-NP B-m
61 MIBI: NNP I-NP O
61 ( ( O O
61 Preliminary NNP B-NP O
61 report NN I-NP O
61 ) ) O O
61 Poor NNP B-NP O
61 quality NN I-NP O
61 study NN I-NP O
61 due JJ O O
61 to TO O O
61 body NN B-NP O
62 habitus VB O O
62 LVEF NNP B-NP O
62 44% CD O O
62 LV NNP B-NP O
62 dilated VBD B-VP O
62 No DT B-NP O
62 perfusion NN I-NP O
62 defects VBZ O O
63 BRIEF NNP B-NP O
63 RESUME NNP I-NP O
63 OF NNP I-NP O
63 HOSPITAL NNP I-NP O
63 COURSE: NNP I-NP O
64 CC:chest NNP I-NP O
64 pain NN I-NP O
65 HPI: NNP I-NP O
65 43 CD O O
65 yo NN B-NP O
65 M NNP I-NP O
65 w/hx NN I-NP O
65 of IN B-VP O
65 HTN NNP B-NP O
65 , , O O
65 DM NNP B-NP O
65 p/w VBZ O O
65 atypical JJ B-NP O
65 CP NNP I-NP O
65 , , O O
65 concerning VBG O O
65 for IN B-VP O
65 unstable JJ B-NP O
66 angina NN I-NP O
66 P/w NNP I-NP O
66 1 CD O O
66 day NN B-NP O
66 h/o VBD B-VP O
66 L NNP B-NP O
66 sided VBD B-VP O
66 dull JJ B-NP O
66 CP NNP I-NP O
66 radiating NN I-NP O
66 to TO O O
66 his PRP$ O O
66 L NNP B-NP O
66 arm NN I-NP O
66 , , O O
66 started VBD B-VP O
67 6/17 CD O O
67 Started NNP B-NP O
67 at IN B-VP O
67 rest NN B-NP O
67 , , O O
67 remained VBD B-VP O
67 for IN B-VP O
67 4 CD O O
67 hrs JJ B-NP O
67 +Diaphoresis NN I-NP O
67 , , O O
67 +nausea NN B-NP O
67 , , O O
68 mild JJ B-NP O
68 SOB NNP I-NP O
68 Cardiac NNP I-NP O
68 RF NNP I-NP O
68 include VBP O O
68 DM NNP B-NP O
68 , , O O
68 HTN NNP B-NP O
68 , , O O
68 Hyperchol NNP B-NP O
68 , , O O
68 FH NNP B-NP O
68 , , O O
68 h/o NN B-NP O
68 smoking NN I-NP O
68 TnI NNP I-NP O
69 at IN B-VP O
69 ASH NNP B-NP O
69 neg SYM O O
69 - : O O
69 0.04 CD O O
69 and CC O O
69 0.05 CD O O
69 but CC O O
69 continued VBD B-VP B-r
69 pain NN B-NP I-r
69 requiring VBG O O
69 NTG NNP B-NP B-m
69 drip NN I-NP B-mo
69 EKG NNP I-NP O
70 with IN B-VP O
70 TWI NNP B-NP O
70 concerning VBG O O
70 for IN B-VP O
70 anterolateral JJ B-NP O
70 ischemia NN I-NP O
70 Initiated VBN O O
71 on IN B-VP O
71 Heparin NNP B-NP B-m
71 , , O O
71 transferred VBD B-VP O
71 to TO O O
71 M NNP B-NP O
71 for IN B-VP O
71 management NN B-NP O
71 , , O O
71 possible JJ B-NP O
71 cath NN I-NP O
72 ---------------------------------- NNP I-NP O
73 PMH: NNP I-NP O
73 CHF NNP I-NP O
73 ( ( O O
73 dxed JJ O O
73 1997 CD O O
73 while IN B-VP O
73 actively RB O O
73 using VBG O O
73 cocaine NN B-NP O
73 ) ) O O
73 , , O O
73 HTN NNP B-NP O
73 , , O O
74 Hypercholesterolemia NNP B-NP O
74 , , O O
74 Renal NNP B-NP O
74 Cell NNP I-NP O
74 Carcinoma NNP I-NP O
74 s/p VBZ O O
74 resection NN B-NP O
75 ------------ NNP I-NP O
76 Status: NNP I-NP O
76 ( ( O O
76 at IN B-VP O
76 admission NN B-NP O
76 ) ) O O
76 T100.5 NNP B-NP O
76 P NNP I-NP O
76 82 CD O O
76 R NNP B-NP O
76 18 CD O O
76 BP NNP B-NP O
76 148/70 CD O O
76 Pox NNP B-NP O
76 99% CD O O
76 2L CD O O
76 Gen: NNP B-NP O
77 Pleaseant NNP I-NP O
77 obese JJ B-NP O
77 M NNP I-NP O
77 , , O O
77 NAD NNP B-NP O
77 CV: NNP I-NP O
77 RRR NNP I-NP O
77 , , O O
77 I/VI NNP B-NP O
77 SEM NNP I-NP O
77 LSB NNP I-NP O
77 , , O O
77 +S3 NNP B-NP O
77 Resp: NNP I-NP O
77 CTAB NNP I-NP O
77 , , O O
77 Ab: NNP B-NP O
78 soft JJ O O
78 , , O O
78 NT NNP B-NP O
78 , , O O
78 mild NN B-NP O
78 distended VBD B-VP O
78 Ext: NNP B-NP O
78 trace NN I-NP O
78 edema RB O O
78 bilateral JJ B-NP O
78 Guaic NNP I-NP O
78 , , O O
78 no DT B-NP O
78 stool NN I-NP O
79 in IN B-VP O
79 vault NN B-NP O
80 --- NNP I-NP O
81 Procedures/Tests: NNP I-NP O
81 Labs: NNP I-NP O
81 Trop NNP I-NP O
81 OSH NNP I-NP O
81 0.04 CD O O
81 , , O O
81 0.05 CD O O
81 , , O O
81 K2.9 NNP B-NP O
81 , , O O
81 Hct NNP B-NP O
81 35.5 CD O O
81 , , O O
81 creat NN B-NP O
82 2.0 CD O O
82 EKG: NNP B-NP O
82 NSR NNP I-NP O
82 , , O O
82 LVH NNP B-NP O
82 with IN B-VP O
82 repolarization NN B-NP O
82 , , O O
82 TWI NNP B-NP O
82 II NNP I-NP O
82 , , O O
82 III NNP B-NP O
82 , , O O
82 F NNP B-NP O
83 V4-6 NNP I-NP O
83 CXR: NNP I-NP O
83 9/16: CD O O
83 Cardiomegaly NNP B-NP O
83 , , O O
83 mild JJ B-NP O
83 pul JJ I-NP O
83 vasculature NN I-NP O
83 engorgement NN I-NP O
84 No NNP I-NP O
84 acute NN I-NP O
84 pul NN I-NP O
84 infiltrate NN I-NP O
84 Adenosine NNP I-NP O
84 MIBI: NNP I-NP O
84 2/3 CD O O
84 Poor NNP B-NP O
84 quality NN I-NP O
84 study NN I-NP O
84 due JJ O O
84 to TO O O
85 body NN B-NP O
86 habitus VB O O
86 EF NNP B-NP O
86 44% CD O O
86 LV NNP B-NP O
86 dilated VBD B-VP O
86 No DT B-NP O
86 perfusion NN I-NP O
86 defects VBZ O O
87 --- NNP B-NP O
88 A/P: NNP I-NP O
88 43 CD O O
88 M NNP B-NP O
88 admitted VBN O O
88 with IN B-VP O
88 atypical JJ B-NP O
88 chest NN I-NP O
88 pain NN I-NP O
88 Concern NNP I-NP O
88 for IN B-VP O
88 unstable JJ O O
89 angina/NSTEMI JJ O O
90 1 CD O O
91 CV NNP B-NP O
91 ISCHEMIA: NNP I-NP O
91 significant JJ B-NP O
91 cardiac JJ I-NP O
91 hx NN I-NP O
91 with IN B-VP O
91 borderline JJ B-NP O
91 TNI NNP I-NP O
91 at IN B-VP O
91 ASH NNP B-NP O
92 ( ( O O
92 0.04-0.05 JJ O O
92 ) ) O O
92 Admitted VBD B-VP O
92 to TO O O
92 WO NNP B-NP O
92 , , O O
92 started VBD B-VP O
92 on IN B-VP O
92 Heparin NNP B-NP B-m
92 , , O O
92 ASA NNP B-NP B-m
92 , , O O
92 BB NNP B-NP B-m
93 ( ( O O
93 labetalol NN B-NP O
93 ) ) O O
93 , , O O
93 statin UH O B-m
93 , , O O
93 ARB NNP B-NP B-m
93 ( ( O I-m
93 ANGIOEDEMA NNP B-NP I-m
93 w/ACE NN I-NP I-m
93 ) ) O I-m
93 , , O O
93 NTG NNP B-NP B-m
93 drip NN I-NP B-mo
93 , , O O
93 O2 NNP B-NP B-m
93 Remained VBD B-VP O
94 chest JJS B-NP O
94 pain NN I-NP O
94 free JJ B-NP O
94 overnight NN I-NP O
94 On IN B-VP O
94 8/18 CD O O
94 , , O O
94 NTG NNP B-NP B-m
94 drip NN I-NP B-mo
94 tapered VBD B-VP O
94 , , O O
94 hydralazine NN B-NP B-m
94 and CC O O
95 labetalol NN B-NP B-m
95 increased VBD B-VP O
95 Pt NNP B-NP O
95 underwent JJ B-NP O
95 MIBI NNP I-NP O
95 , , O O
95 notable JJ O O
95 for IN B-VP O
95 LV NNP B-NP O
95 dilation NN I-NP O
95 , , O O
95 EF NNP B-NP O
96 44% CD O O
96 , , O O
96 no DT B-NP O
96 perfusion NN I-NP O
96 defects VBZ O O
96 Pt NNP B-NP O
96 remained VBD B-VP O
96 overnight JJ O O
96 to TO O O
96 ensure VB O O
96 adequate JJ B-NP O
97 BP NNP I-NP O
97 with IN B-VP O
97 new JJ B-NP O
97 medications NNS I-NP O
97 Will MD O O
97 likely RB O O
97 need VB O O
97 continued JJ B-NP O
97 titration NN I-NP O
97 of IN B-VP O
98 antihypertensives NNS B-NP B-m
99 PUMP: NNP I-NP O
99 CHF: NNP I-NP O
99 euvolemic; VBD B-VP O
99 LVEF NNP B-NP O
99 44% CD O O
99 via IN B-VP O
99 MIBI NNP B-NP O
99 BP NNP I-NP O
99 control NN I-NP O
99 as IN B-VP O
99 above IN B-VP O
100 RENAL: NNP B-NP O
100 CRI NNP I-NP O
100 at IN B-VP O
100 baseline JJ B-NP O
100 Cr NNP I-NP O
100 of IN B-VP O
100 2.0 CD O O
100 Renal NNP B-NP O
100 dose NN I-NP O
100 meds NNS I-NP O
101 2 CD O O
101 ENDO: NNP B-NP O
101 Metformin NNP I-NP B-m
101 held VBD B-VP O
101 , , O O
101 NPH NNP B-NP B-m
101 and CC O O
101 Novolog NNP B-NP B-m
101 SSI NNP I-NP I-m
101 initiated VBD B-VP O
101 for IN B-VP O
101 BS NNP B-NP B-r
101 control NN I-NP I-r
101 FS NNP I-NP O
102 AC NNP I-NP O
102 , , O O
102 excellent JJ B-NP O
102 BS NNP I-NP O
102 with IN B-VP O
102 range NN B-NP O
102 110-150 JJ O O
103 3 CD O O
103 ID: NNP B-NP O
103 low JJ B-NP O
103 grade NN I-NP O
103 temps NNS I-NP O
103 - : O O
103 UA NNP B-NP O
103 negative JJ O O
103 , , O O
103 CXR NNP B-NP O
103 negative JJ B-NP O
103 No NNP I-NP O
103 signs NNS I-NP O
103 of IN B-VP O
103 systemic JJ B-NP O
104 illness NN I-NP O
105 4 CD O O
105 GI: NNP B-NP O
105 h/o NN I-NP O
105 hematochezia NN I-NP O
105 , , O O
105 no DT B-NP O
105 stool NN I-NP O
105 on IN B-VP O
105 DRE NNP B-NP O
105 Guiac NNP I-NP O
105 stools VBZ O O
105 x RB O O
105 3 CD O O
105 as IN B-VP O
105 on IN B-VP O
105 Heparin NNP B-NP B-m
106 5 CD O O
106 FEN: NNP B-NP O
106 SLIV NNP I-NP O
106 Replete NNP I-NP O
106 electrolytes VBZ O O
106 aggressively RB O O
106 Cardiac NNP B-NP O
106 diet JJ O O
107 6 CD O O
107 Resp: NNP B-NP O
107 Stable NNP I-NP O
107 Supp NNP I-NP O
107 O2 NNP I-NP O
107 PRN NNP I-NP O
108 FULL NNP I-NP O
108 CODE NNP I-NP O
109 CODE NNP I-NP O
110 ADDITIONAL NNP I-NP O
110 COMMENTS: NNP I-NP O
110 Call NNP I-NP O
110 Dr NNP I-NP O
110 Racioppo NNP I-NP O
110 ( ( O O
110 869 CD O O
110 ) ) O O
110 959 CD O O
110 5481 CD O O
110 upon IN B-VP O
110 discharge NN B-NP O
110 to TO O O
110 schedule VB O O
110 an DT B-NP O
110 appt NN I-NP O
110 within IN B-VP O
111 1 CD O O
111 wk NN B-NP O
111 Bring NNP I-NP O
111 this DT B-NP O
111 document NN I-NP O
111 to TO O O
111 the DT B-NP O
111 appt NN I-NP O
111 Comply NNP I-NP O
111 with IN B-VP O
111 low JJ B-NP O
111 chol NNS I-NP O
111 , , O O
111 low JJ B-NP O
111 fat NN I-NP O
111 , , O O
111 &lt;2g NNP B-NP O
112 sodium NN I-NP O
112 diet JJ B-NP O
112 Weigh NNP I-NP O
112 yourself PRP O O
112 daily RB O O
112 , , O O
112 if IN B-VP O
112 you PRP O O
112 gain VBP O O
112 more JJR O O
112 than IN B-VP O
112 2 CD O O
112 lbs NNS B-NP O
112 in IN B-VP O
112 1 CD O O
112 day NN B-NP O
112 or CC O O
113 5 CD O O
113 lbs NNS B-NP O
113 in IN B-VP O
113 a DT B-NP O
113 week NN I-NP O
113 contact VB O O
113 your PRP$ O O
113 doctor NN B-NP O
113 as IN B-VP O
113 this DT O O
113 is VBZ O O
113 a DT B-NP O
113 symptom NN I-NP O
113 of IN B-VP O
113 CHF NNP B-NP O
113 Continue NNP I-NP O
114 your PRP$ O O
114 discharge NN B-NP O
114 medications NNS I-NP O
114 as IN B-VP O
114 advised VBN O O
114 Do NNP B-NP O
114 not RB O O
114 resume VB O O
114 the DT B-NP O
114 Norvasc NNP I-NP B-m
114 or CC O O
115 Enalapril NNP B-NP B-m
115 until IN B-VP O
115 instructed VBN O O
115 to TO O O
115 do VB O O
115 so RB O O
115 by IN B-VP O
115 Dr NNP B-NP O
115 Kozola NNP I-NP O
115 Seek NNP I-NP O
115 medical JJ B-NP O
115 attention NN I-NP O
116 for IN B-VP O
116 worsening VBG O O
116 chest JJS B-NP O
116 pain NN I-NP O
116 , , O O
116 shortness NN B-NP O
116 of IN B-VP O
116 breath NN B-NP O
116 marked VBN O O
116 weight JJ B-NP O
116 gain NN I-NP O
117 DISCHARGE NNP I-NP O
117 CONDITION: NNP I-NP O
117 Stable NNP I-NP O
118 TO NNP I-NP O
118 DO/PLAN: NNP I-NP O
119 1 CD O O
119 ) ) O O
119 F/u NN B-NP O
119 with IN B-VP O
119 Dr NNP B-NP O
119 Pulfrey NNP I-NP O
119 within IN B-VP O
119 1 CD O O
119 wk NN B-NP O
119 for IN B-VP O
119 BP NNP B-NP O
119 check NN I-NP O
119 May NNP I-NP O
119 need VB O O
119 medication NN B-NP O
120 titration NN I-NP O
120 including VBG O O
120 reinstitution NN B-NP O
120 of IN B-VP O
120 Norvasc.Consider NNP B-NP B-m
120 further JJ B-NP O
120 w/u NN I-NP O
120 anemia NN I-NP O
121 ( ( O O
121 IDA NNP B-NP O
121 +/- NNP I-NP O
121 AOCD NNP I-NP O
121 ) ) O O
121 Pt NNP B-NP O
121 has VBZ O O
121 a DT B-NP O
121 h/o NN I-NP O
121 hematochezia NN I-NP O
121 , , O O
121 unclear JJ O O
121 when WRB O O
121 prior RB O O
122 colonoscopy VBP O O
123 No NNP B-NP O
123 dictated VBD B-VP O
123 summary JJ B-NP O
124 ENTERED NNP I-NP O
124 BY: NNP I-NP O
124 BERNT NNP I-NP O
124 , , O O
124 SHON NNP B-NP O
124 A NNP I-NP O
124 , , O O
124 M.D NNP B-NP O
124 , , O O
124 PH.D NNP B-NP O
124 ( ( O O
124 PA72 NNP B-NP O
124 ) ) O O
124 2/16/05 CD O O
124 @ $ O O
124 11:38 CD O O
124 AM NNP B-NP O
125 ****** JJ B-NP O
125 END NN I-NP O
125 OF NNP I-NP O
125 DISCHARGE NNP I-NP O
125 ORDERS NNP I-NP O
125 ****** NNP I-NP O
126 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #762933 VBZ O O
4 665720079 CD O O
4 SHS NNP B-NP O
4 59097921 CD O O
4 965909 CD O O
4 6/0/1995 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/25/1995 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/17/1995 CD O O
7 PRINCIPAL NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 LEFT NNP I-NP O
7 LOWER NNP I-NP O
7 EXTREMITY NNP I-NP O
7 WOUND NNP I-NP O
7 INFECTION NNP I-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT O O
8 54 CD O O
8 year NN B-NP O
8 old JJ B-NP O
8 gentleman NN I-NP O
9 who WP O O
9 is VBZ O O
9 status NN B-NP O
9 post NN I-NP O
9 a DT O O
9 four CD O O
9 vessel NN B-NP O
10 coronary JJ B-NP O
10 artery NN I-NP O
10 bypass NN I-NP O
10 graft NN I-NP O
10 on IN B-VP O
10 6/17/95 CD O O
10 at IN B-VP O
10 an DT B-NP O
10 outside JJ I-NP O
10 hospital NN I-NP O
11 The DT B-NP O
11 patient's NN I-NP O
11 postoperative JJ B-NP O
11 course NN I-NP O
11 was VBD B-VP O
11 complicated VBN O O
11 by IN B-VP O
11 respiratory JJ B-NP O
12 failure NN I-NP O
12 secondary JJ O O
12 to TO O O
12 presumed VB O O
12 phrenic JJ B-NP O
12 nerve NN I-NP O
12 injury NN I-NP O
12 The DT B-NP O
12 patient NN I-NP O
13 also RB O O
13 developed VBD B-VP O
13 congestive JJ B-NP O
13 heart NN I-NP O
13 failure NN I-NP O
13 In IN B-VP O
13 addition NN B-NP O
13 , , O O
13 the DT B-NP O
13 patient NN I-NP O
14 had VBD B-VP O
14 undergone JJ B-NP O
14 embolectomy NN I-NP O
14 and CC O O
14 left VBD B-VP O
14 lower JJR B-NP O
14 extremity NN I-NP O
14 fasciotomy NN I-NP O
14 for IN B-VP O
15 left VBD B-VP O
15 lower JJR B-NP O
15 extremity NN I-NP O
15 ischemia NN I-NP O
15 on IN B-VP O
15 11/27/95 CD O O
15 The DT B-NP O
15 patient NN I-NP O
15 now RB O O
15 presents VBZ O O
16 to TO O O
16 Dr NNP B-NP O
16 Jaysura NNP I-NP O
16 with IN B-VP O
16 infected JJ O O
16 left VBD B-VP O
16 lower JJR B-NP O
16 leg NN I-NP O
16 pressure NN I-NP O
16 ulcer NN I-NP O
16 with IN B-VP O
17 open JJ O O
17 and CC O O
17 gangrenous JJ B-NP O
17 muscle NN I-NP O
17 exposed VBN O O
17 through IN B-VP O
17 this DT B-NP O
17 posterior NN I-NP O
17 wound IN B-VP O
18 The DT B-NP O
18 patient NN I-NP O
18 was VBD B-VP O
18 at IN B-VP O
18 the DT B-NP O
18 rehabilitation NN I-NP O
18 center NN I-NP O
18 prior RB O O
18 to TO O O
18 this DT B-NP O
18 transfer NN I-NP O
19 to TO O O
19 the DT B-NP O
19 Wickpro NNP I-NP O
19 Conch NNP I-NP O
19 Medical NNP I-NP O
19 Center NNP I-NP O
19 The DT B-NP O
19 patient NN I-NP O
19 had VBD B-VP O
19 no DT O O
19 documented VBN O O
20 febrile NN B-NP O
20 episodes NNS I-NP O
21 PAST NNP I-NP O
21 MEDICAL NNP I-NP O
21 HISTORY: NNP I-NP O
21 Significant NNP I-NP O
21 for IN B-VP O
21 insulin NN B-NP O
21 dependent NN I-NP O
22 diabetes VBZ O O
22 mellitus RBS O O
22 , , O O
22 peripheral JJ B-NP O
22 vascular JJ I-NP O
23 disease NN I-NP O
23 , , O O
23 coronary JJ B-NP O
23 artery NN I-NP O
23 disease NN I-NP O
23 , , O O
23 congestive JJ B-NP O
23 heart NN I-NP O
23 failure NN I-NP O
23 , , O O
23 history NN B-NP O
24 of IN B-VP O
24 atrial JJ B-NP O
24 fibrillation/flutter NN I-NP O
24 , , O O
24 right JJ B-NP O
24 sacroiliac NN I-NP O
24 joint NN I-NP O
24 decubitus NN I-NP O
25 ulcer NN I-NP O
26 PAST NNP I-NP O
26 SURGICAL NNP I-NP O
26 HISTORY: NNP I-NP O
26 As IN B-VP O
26 above IN B-VP O
26 Coronary NNP B-NP O
26 artery NN I-NP O
26 bypass NN I-NP O
26 graft NN I-NP O
27 on IN B-VP O
27 0/13/95 CD O O
27 Left NNP B-NP O
27 lower JJR B-NP O
27 extremity NN I-NP O
28 fasciotomy NN I-NP O
28 on IN B-VP O
28 11/27/95 CD O O
29 MEDICATIONS NNP B-NP O
29 ON NNP I-NP O
29 ADMISSION: NNP I-NP O
30 1 CD O O
30 Aspirin NNP B-NP B-m
30 81 CD O B-do
30 mg NN B-NP I-do
30 po NN I-NP B-mo
30 qd VBD B-VP B-f
31 2 CD O O
31 Digoxin NNP B-NP B-m
31 0.325 CD O B-do
31 mg NN B-NP I-do
31 po NN I-NP B-mo
31 qd VBD B-VP B-f
32 3 CD O O
32 Azmacort NNP B-NP B-m
32 6 CD O B-do
32 puffs NNS B-NP I-do
32 inhaled VBD B-VP B-mo
32 bid NN B-NP B-f
33 4 CD O O
33 Heparin NNP B-NP B-m
33 5000 CD O B-do
33 units NNS B-NP I-do
33 subcu VBD B-VP B-mo
33 bid NN B-NP B-f
34 5 CD O O
34 Zantac NNP B-NP B-m
34 150 CD O B-do
34 mg NN B-NP I-do
34 po NN I-NP B-mo
34 bid NN I-NP B-f
35 6 CD O O
35 Lasix NNP B-NP B-m
35 40 CD O B-do
35 mg NN B-NP I-do
35 po NN I-NP B-mo
35 qd VBD B-VP B-f
36 7 CD O O
36 Capoten NNP B-NP B-m
36 25 CD O B-do
36 mg NN B-NP I-do
36 q VBD B-VP B-f
36 8 CD O I-f
37 8 CD O O
37 Albuterol NNP B-NP B-m
37 nebulizers NNS I-NP I-m
37 0.5 CD O B-do
37 cc NN B-NP I-do
37 in IN B-VP O
37 2.5 CD O O
37 cc NN B-NP O
37 normal JJ B-NP B-m
37 saline NN I-NP I-m
37 qid NN I-NP B-f
37 qid VBD B-VP B-f
38 9 CD O O
38 NPH NNP B-NP B-m
38 insulin NN I-NP I-m
38 38 CD O B-do
38 units NNS B-NP I-do
38 subcu VBD B-VP B-mo
38 bid NN B-NP B-f
39 10 CD O O
39 Nystatin NNP B-NP B-m
39 swish JJ O O
39 and CC O O
39 swallow JJ O O
39 5 CD O B-do
39 cc NN B-NP I-do
39 po NN I-NP O
39 qid VBD B-VP B-f
40 11 CD O O
40 Bactrim NNP B-NP B-m
40 DS NNP I-NP I-m
40 one CD O B-do
40 tab NN B-NP I-do
40 po NN I-NP B-mo
40 bid VBD B-VP B-f
41 THE NNP B-NP O
41 PATIENT NNP I-NP O
41 HAS NNP I-NP O
41 NO NNP I-NP O
41 KNOWN NNP I-NP O
41 DRUG NNP I-NP O
41 ALLERGIES NNP I-NP O
42 SOCIAL NNP I-NP O
42 HISTORY: NNP I-NP O
42 Significant NNP I-NP O
42 for IN B-VP O
42 100 CD O O
42 pack/year JJ B-NP O
42 history NN I-NP O
43 PHYSICAL NNP I-NP O
43 EXAMINATION: NNP I-NP O
43 Temperature NNP I-NP O
43 100 CD O O
43 Blood NNP B-NP O
43 pressure NN I-NP O
43 120/47 CD O O
43 , , O O
44 pulse RB O O
44 103 CD O O
44 , , O O
44 sinus JJ B-NP O
44 tachycardia NN I-NP O
44 In IN B-VP O
45 general JJ O O
45 , , O O
45 the DT B-NP O
45 patient NN I-NP O
45 was VBD B-VP O
45 trached VBN O O
45 and CC O O
45 in IN B-VP O
45 no DT B-NP O
45 acute NN I-NP O
45 distress VBZ O O
45 The DT B-NP O
46 patient's NN I-NP O
46 skin NN I-NP O
46 revealed VBD B-VP O
46 mottled JJ B-NP O
46 distal JJ I-NP O
46 extremities NNS I-NP O
46 HEENT: NNP I-NP O
47 normocephalic NN I-NP O
47 , , O O
47 atraumatic JJ B-NP O
47 head NN I-NP O
47 Trach NNP I-NP O
47 was VBD B-VP O
47 in IN B-VP O
47 place NN B-NP O
47 with IN B-VP O
47 a DT B-NP O
47 collar JJ I-NP O
48 Lungs: NNP I-NP O
48 bilateral JJ B-NP O
48 inspiratory NN I-NP O
48 wheezes NNS I-NP O
48 , , O O
48 scattered VBD B-VP O
48 throughout IN B-VP O
49 Heart: NNP B-NP O
49 regular JJ B-NP O
49 rhythm NN I-NP O
49 with IN B-VP O
49 sinus JJ B-NP O
49 tachycardia NN I-NP O
49 Distant NNP I-NP O
49 heart NN I-NP O
50 sounds VBZ O O
50 No DT B-NP O
50 S3 NNP I-NP O
50 or CC O O
50 S4 NNP B-NP O
50 were VBD B-VP O
50 noted VBN O O
50 The DT B-NP O
50 patient NN I-NP O
50 had VBD B-VP O
50 no DT B-NP O
50 obvious JJ I-NP O
51 murmurs NNS I-NP O
51 Abdomen: NNP I-NP O
51 positive JJ B-NP O
51 bowel NN I-NP O
51 sounds VBZ O O
51 The DT B-NP O
51 patient NN I-NP O
51 was VBD B-VP O
51 obese JJ B-NP O
52 Abdomen NNP I-NP O
52 was VBD B-VP O
52 nontender JJR O O
52 , , O O
52 nondistended VBN O O
52 with IN B-VP O
52 no DT O O
52 palpable JJ O O
52 masses VBZ O O
52 The DT B-NP O
53 patient NN I-NP O
53 had VBD B-VP O
53 multiple JJ B-NP O
53 ecchymoses NNS I-NP O
53 Neurologic: VBP O O
53 the DT B-NP O
53 patient NN I-NP O
53 was VBD B-VP O
54 alert JJ O O
54 and CC O O
54 oriented VBD B-VP O
54 times NNS B-NP O
54 three CD O O
54 Cranial NNP B-NP O
54 nerves NNS I-NP O
54 II NNP I-NP O
54 through IN B-VP O
54 XII NNP B-NP O
55 grossly RB O O
55 intact JJ B-NP O
55 Extremities: NNP I-NP O
55 right NN I-NP O
55 buttock NN I-NP O
55 with IN B-VP O
55 approximately RB O O
55 a DT O O
56 10 CD O O
56 square JJ B-NP O
56 centimeter NN I-NP O
56 decubitus NN I-NP O
56 ulcer IN B-VP O
56 The DT B-NP O
56 patient's NN I-NP O
56 right RB O O
56 lower JJR B-NP O
57 extremity NN I-NP O
57 revealed VBD B-VP O
57 a DT B-NP O
57 previous JJ I-NP O
57 harvest NN I-NP O
57 scar NN I-NP O
57 with IN B-VP O
57 about IN B-VP O
57 a DT O O
57 2 CD O O
57 cm NN B-NP O
58 incision NN I-NP O
58 and CC O O
58 breakdown NN B-NP O
58 over IN B-VP O
58 the DT B-NP O
58 calf JJ I-NP O
58 area NN I-NP O
58 Distal NNP I-NP O
58 foot NN I-NP O
58 has VBZ O O
58 a DT O O
59 mottled VBN O O
59 appearance NN B-NP O
59 but CC O O
59 has VBZ O O
59 Dopplerable JJ B-NP O
59 posterior JJ I-NP O
59 tibial NN I-NP O
59 and CC O O
60 dorsalis NN B-NP O
60 pedis NN I-NP O
60 pulses VBZ O O
60 The DT B-NP O
60 toes NNS I-NP O
60 are VBP O O
60 cool JJ O O
60 and CC O O
60 insensate JJ B-NP O
60 Left NNP I-NP O
61 lower JJR B-NP O
61 extremity NN I-NP O
61 revealed VBD B-VP O
61 three CD O O
61 open JJ B-NP O
61 ulcers NNS I-NP O
61 with IN B-VP O
61 marked JJ B-NP O
61 gangrenous JJ I-NP O
62 muscle NN I-NP O
62 exposure NN I-NP O
62 The DT B-NP O
62 patient NN I-NP O
62 had VBD B-VP O
62 a DT B-NP O
62 Dopplerable JJ I-NP O
62 posterior JJ I-NP O
62 tibial NN I-NP O
63 with IN B-VP O
63 cold JJ B-NP O
63 pulses NNS I-NP O
63 but CC O O
63 no DT B-NP O
63 Dopplerable NNP I-NP O
63 dorsalis NN I-NP O
63 pedis NN I-NP O
63 pulse IN B-VP O
63 The DT B-NP O
64 patient NN I-NP O
64 was VBD B-VP O
64 insensate JJ O O
64 distally RB O O
64 from IN B-VP O
64 the DT B-NP O
64 region NN I-NP O
64 of IN B-VP O
64 the DT B-NP O
64 wounds NNS I-NP O
64 down RP O O
65 to TO O O
65 the DT B-NP O
65 feet NNS I-NP O
66 HOSPITAL NNP I-NP O
66 COURSE: NNP I-NP O
66 The DT B-NP O
66 patient NN I-NP O
66 was VBD B-VP O
66 taken VBN O O
66 to TO O O
66 the DT B-NP O
66 Operating NN I-NP O
66 Room NNP I-NP O
67 on IN B-VP O
67 7/25/95 CD O O
67 for IN B-VP O
67 a DT B-NP O
67 preoperative JJ I-NP O
67 diagnosis NN I-NP O
67 of IN B-VP O
67 a DT B-NP O
68 left NN I-NP O
68 lower JJR B-NP O
68 extremity NN I-NP O
68 infected JJ B-NP O
68 pressure NN I-NP O
68 sore RBR O O
68 Intraoperatively RB O O
68 , , O O
68 the DT B-NP O
69 patient NN I-NP O
69 was VBD B-VP O
69 noted VBN O O
69 to TO O O
69 have VB O O
69 necrosis NN B-NP O
69 of IN B-VP O
69 both DT B-NP O
69 heads NNS I-NP O
69 of IN B-VP O
69 the DT B-NP O
70 gastrocnemius JJ I-NP O
70 muscle NN I-NP O
70 including VBG O O
70 the DT B-NP O
70 soleus NN I-NP O
70 and CC O O
70 also RB O O
70 a DT B-NP O
70 portion NN I-NP O
70 of IN B-VP O
70 the DT B-NP O
71 lateral JJ I-NP O
71 compartment NN I-NP O
71 The DT B-NP O
71 muscle NN I-NP O
71 appeared VBD B-VP O
71 black JJ O O
71 and CC O O
71 necrotic JJ O O
71 and CC O O
72 there EX O O
72 was VBD B-VP O
72 a DT B-NP O
72 marked JJ I-NP O
72 amount NN I-NP O
72 of IN B-VP O
72 purulence NN B-NP O
72 Aerobic NNP I-NP O
72 and CC O O
72 anaerobic JJ B-NP O
73 cultures NNS I-NP O
73 were VBD B-VP O
73 obtained VBN O O
73 at IN B-VP O
73 this DT B-NP O
73 time NN I-NP O
73 and CC O O
73 sent VBD B-VP O
73 to TO O O
73 Microbiology NNP B-NP O
73 for IN B-VP O
74 gram NN B-NP O
74 stains NNS I-NP O
74 and CC O O
74 cultures VBZ O O
74 All DT O O
74 of IN B-VP O
74 the DT B-NP O
74 visibly NN I-NP O
74 blackened VBD B-VP O
74 and CC O O
75 necrotic JJ B-NP O
75 muscle NN I-NP O
75 was VBD B-VP O
75 removed VBN O O
75 and CC O O
75 the DT B-NP O
75 wound NN I-NP B-r
75 was VBD B-VP O
75 irrigated VBN O B-mo
75 with IN B-VP O
76 copious JJ B-NP O
76 amounts NNS I-NP O
76 of IN B-VP O
76 antibiotic-containing JJ B-NP B-m
76 solution NN I-NP I-m
76 The DT B-NP O
76 patient NN I-NP O
77 appeared VBD B-VP O
77 to TO O O
77 tolerate VB O O
77 the DT B-NP O
77 procedure NN I-NP O
77 well RB O O
77 and CC O O
77 was VBD B-VP O
77 sent VBN O O
77 to TO O O
77 the DT B-NP O
78 Intensive NNP I-NP O
78 Care NNP I-NP O
78 Unit NNP I-NP O
78 , , O O
78 given VBN O O
78 the DT B-NP O
78 patient's JJ I-NP O
78 cardiac JJ I-NP O
78 history NN I-NP O
78 as RB O O
78 well RB O O
78 as IN B-VP O
79 his PRP$ O O
79 ventilator NN B-NP O
79 dependence NN I-NP O
80 The DT B-NP O
80 patient NN I-NP O
80 was VBD B-VP O
80 seen VBN O O
80 by IN B-VP O
80 the DT B-NP O
80 Infectious NNP I-NP O
80 Disease NNP I-NP O
80 service NN I-NP O
80 and CC O O
80 was VBD B-VP O
81 started VBN O O
81 on IN B-VP O
81 Ampicillin NNP B-NP B-m
81 , , O O
81 Gentamicin NNP B-NP B-m
81 and CC O O
81 Flagyl NNP B-NP B-m
81 empirically RB O O
81 until IN B-VP B-du
81 until IN B-VP B-du
81 until IN B-VP B-du
82 culture NN B-NP O
82 results NNS I-NP O
82 returned VBD B-VP O
82 The DT B-NP O
82 patient NN I-NP O
82 was VBD B-VP O
82 taken VBN O O
82 back RB O O
82 on IN B-VP O
82 2/29/95 CD O O
83 for IN B-VP O
83 a DT B-NP O
83 second JJ I-NP O
83 irrigation NN I-NP O
83 and CC O O
83 debridement JJ B-NP O
83 procedure NN I-NP O
83 During IN B-VP O
83 this DT B-NP O
84 procedure NN I-NP O
84 , , O O
84 some DT B-NP O
84 necrotic JJ I-NP O
84 skin NN I-NP O
84 , , O O
84 subcutaneous JJ B-NP O
84 tissue NN I-NP O
84 and CC O O
84 fascia NN B-NP O
84 were VBD B-VP O
85 noted VBN O O
85 and CC O O
85 were VBD B-VP O
85 sharply RB O O
85 debrided VBN O O
85 free JJ O O
85 The DT B-NP O
85 wound NN I-NP O
85 was VBD B-VP O
85 relatively RB O O
86 clean JJ O O
86 upon IN B-VP O
86 completion NN B-NP O
86 of IN B-VP O
86 the DT B-NP O
86 procedure NN I-NP O
86 with IN B-VP O
86 no DT B-NP O
86 apparent JJ I-NP O
86 loculations NNS I-NP O
87 or CC O O
87 collections NNS B-NP O
87 or CC O O
87 purulence VB O O
87 The DT B-NP O
87 muscle NN I-NP O
87 also RB O O
87 at IN B-VP O
87 this DT B-NP O
87 time NN I-NP O
87 appeared VBD B-VP O
88 viable JJ O O
88 and CC O O
88 it PRP O O
88 was VBD B-VP O
88 considered VBN O O
88 that IN B-VP O
88 the DT B-NP O
88 wound NN I-NP O
88 may MD O O
88 heal VB O O
88 on IN B-VP O
88 its PRP$ O O
88 own JJ O O
89 The DT B-NP O
89 patient NN I-NP O
89 was VBD B-VP O
89 seen VBN O O
89 by IN B-VP O
89 the DT B-NP O
89 Vascular NNP I-NP O
89 Surgery NNP I-NP O
89 service NN I-NP O
89 as RB O O
89 well RB O O
89 for IN B-VP O
90 his PRP$ O O
90 history NN B-NP O
90 of IN B-VP O
90 left NN B-NP O
90 lower JJR B-NP O
90 extremity NN I-NP O
90 ischemia NN I-NP O
90 and CC O O
90 for IN B-VP O
90 his PRP$ O O
90 loss NN B-NP O
90 of IN B-VP O
91 his PRP$ O O
91 dorsalis NN B-NP O
91 pedis NN I-NP O
91 pulse NN I-NP O
91 on IN B-VP O
91 his PRP$ O O
91 left JJ B-NP O
91 foot NN I-NP O
91 The DT B-NP O
91 left JJ I-NP O
91 foot NN I-NP O
91 remained VBD B-VP O
92 cool JJ O O
92 and CC O O
92 insensate JJ O O
92 with IN B-VP O
92 no DT B-NP O
92 motor NN I-NP O
92 function NN I-NP O
92 The DT B-NP O
92 patient NN I-NP O
92 did VBD B-VP O
92 however RB O O
93 have VB O O
93 flexion NN B-NP O
93 and CC O O
93 extension NN B-NP O
93 at IN B-VP O
93 the DT B-NP O
93 knee NN I-NP O
94 After IN B-VP O
94 adequate JJ B-NP O
94 irrigation NN I-NP O
94 and CC O O
94 debridement NN B-NP O
94 , , O O
94 it PRP O O
94 was VBD B-VP O
94 felt VBN O O
94 that IN B-VP O
94 the DT B-NP O
95 patient NN I-NP O
95 would MD O O
95 not RB O O
95 require VB O O
95 amputation NN B-NP O
95 of IN B-VP O
95 his PRP$ O O
95 lower JJR B-NP O
95 extremity NN I-NP O
95 given VBN O O
96 the DT B-NP O
96 viability NN I-NP O
96 of IN B-VP O
96 the DT B-NP O
96 muscle NN I-NP O
97 NEUROLOGIC NNP I-NP O
97 The DT B-NP O
97 patient NN I-NP O
97 was VBD B-VP O
97 alert JJ O O
97 and CC O O
97 awake VB O O
97 postoperatively RB O O
97 The DT B-NP O
98 patient NN I-NP O
98 was VBD B-VP O
98 appropriate JJ O O
98 in IN B-VP O
98 his PRP$ O O
98 neurologic JJ B-NP O
98 status NN I-NP O
98 The DT B-NP O
98 patient NN I-NP O
99 however RB O O
99 did VBD B-VP O
99 appear VB O O
99 to TO O O
99 have VB O O
99 some DT B-NP O
99 episodes NNS I-NP O
99 of IN B-VP O
99 anxiety NN B-NP B-r
99 for IN B-VP O
99 which WDT O O
99 he PRP O O
100 was VBD B-VP O
100 placed VBN O O
100 on IN B-VP O
100 Klonopin NNP B-NP B-m
100 1 CD O B-do
100 mg NN B-NP I-do
100 po NN I-NP B-mo
100 tid IN B-VP B-f
100 The DT B-NP O
100 patient NN I-NP O
100 continued VBD B-VP O
100 to TO O O
100 do VB O O
101 well RB O O
101 and CC O O
101 had VBD B-VP O
101 his PRP$ O B-r
101 pain NN B-NP I-r
101 adequately RB O O
101 controlled VBN O O
101 with IN B-VP O
101 po NN B-NP B-mo
101 Percocet NNP I-NP B-m
102 RESPIRATORY NNP I-NP O
102 The DT B-NP O
102 patient NN I-NP O
102 was VBD B-VP O
102 initially RB O O
102 weaned VBN O O
102 off RP O O
102 the DT B-NP O
102 ventilator NN I-NP O
103 to TO O O
103 continue VB O O
103 his PRP$ O O
103 positive JJ B-NP O
103 airway NN I-NP O
103 pressure NN I-NP O
103 with IN B-VP O
103 5 CD O O
103 of IN B-VP O
103 PEEP NNP B-NP O
103 and CC O O
103 5 CD O O
103 of IN B-VP O
104 pressure NN B-NP O
104 support NN I-NP O
104 with IN B-VP O
104 50% CD O O
104 FIO2 NNP B-NP O
104 The DT B-NP O
104 patient's NN I-NP O
104 tidal JJ B-NP O
104 volumes NNS I-NP O
104 were VBD B-VP O
105 consistently RB O O
105 elevated VBN O O
105 over IN B-VP O
105 600 CD O O
105 and CC O O
105 the DT B-NP O
105 patient NN I-NP O
105 had VBD B-VP O
105 no DT B-NP O
105 subjective JJ I-NP O
106 complaints NNS I-NP O
106 of IN B-VP O
106 shortness NN B-NP O
106 of IN B-VP O
106 breath NN B-NP O
106 However RB O O
106 , , O O
106 on IN B-VP O
106 postoperative JJ B-NP O
106 day NN I-NP O
107 #4 NNP I-NP O
107 and CC O O
107 #2 NNP B-NP O
107 , , O O
107 the DT B-NP O
107 patient NN I-NP O
107 noted VBD B-VP O
107 some DT B-NP O
107 difficulty NN I-NP O
107 catching VBG O O
107 his PRP$ O O
107 breath NN B-NP O
108 Pressure NN I-NP O
108 support NN I-NP O
108 was VBD B-VP O
108 increased VBN O O
108 back RB O O
108 up RB O O
108 to TO O O
108 10 CD O O
108 This DT B-NP O
108 inability NN I-NP O
108 of IN B-VP O
109 the DT B-NP O
109 patient NN I-NP O
109 to TO O O
109 maintain VB O O
109 his PRP$ O O
109 spontaneous JJ B-NP O
109 tidal JJ I-NP O
109 volumes NNS I-NP O
109 was VBD B-VP O
110 consistent JJ O O
110 with IN B-VP O
110 a DT B-NP O
110 respiratory NN I-NP O
110 fatigue NN I-NP O
110 secondary JJ O O
110 to TO O O
110 his PRP$ O O
111 diaphragmatic JJ B-NP O
111 dysfunction NN I-NP O
111 However RB O O
111 because IN B-VP O
111 the DT B-NP O
111 patient NN I-NP O
111 appeared VBD B-VP O
111 to TO O O
112 be VB O O
112 weaning VBG O O
112 from IN B-VP O
112 the DT B-NP O
112 ventilator NN I-NP O
112 initially RB O O
112 postop RB O O
112 , , O O
112 it PRP O O
112 was VBD B-VP O
112 decided VBN O O
113 that IN B-VP O
113 the DT B-NP O
113 patient NN I-NP O
113 should MD O O
113 have VB O O
113 his PRP$ O O
113 diaphragmatic JJ B-NP O
113 function NN I-NP O
113 assessed VBD B-VP O
113 to TO O O
114 see VB O O
114 if IN B-VP O
114 there EX O O
114 had VBD B-VP O
114 been VBN O O
114 any DT B-NP O
114 change NN I-NP O
115 The DT B-NP O
115 patient NN I-NP O
115 underwent NN I-NP O
115 a DT B-NP O
115 fluoroscopy NN I-NP O
115 study NN I-NP O
115 to TO O O
115 assess VB O O
115 his PRP$ O O
116 diaphragmatic JJ B-NP O
116 excursions NNS I-NP O
116 on IN B-VP O
116 2/8/95 CD O O
116 The DT B-NP O
116 test NN I-NP O
116 revealed VBD B-VP O
116 no DT B-NP O
117 diaphragmatic JJ I-NP O
117 excursion NN I-NP O
117 consistent NN I-NP O
117 with IN B-VP O
117 phrenic JJ B-NP O
117 nerve NN I-NP O
117 injury NN I-NP O
117 It PRP O O
118 was VBD B-VP O
118 decided VBN O O
118 at IN B-VP O
118 this DT B-NP O
118 time NN I-NP O
118 that IN B-VP O
118 the DT B-NP O
118 patient NN I-NP O
118 would MD O O
118 remain VB O O
118 on IN B-VP O
118 his PRP$ O O
119 previous JJ B-NP O
119 ventilator NN I-NP O
119 settings NNS I-NP O
119 of IN B-VP O
119 10 CD O O
119 of IN B-VP O
119 pressure NN B-NP O
119 support NN I-NP O
119 and CC O O
119 5 CD O O
119 of IN B-VP O
120 CPAP NNP B-NP O
120 and CC O O
120 50% CD O O
120 FIO2 NNP B-NP O
120 and CC O O
120 no DT B-NP O
120 further JJ I-NP O
120 weaning NN I-NP O
120 would MD O O
120 be VB O O
120 attempted VBN O O
121 GASTROINTESTINAL NNP B-NP O
121 The DT B-NP O
121 patient NN I-NP O
121 arrived VBD B-VP O
121 on IN B-VP O
121 tube JJ B-NP O
121 feedings NNS I-NP O
121 of IN B-VP O
121 Promote NNP B-NP O
122 Because IN B-VP O
122 we PRP O O
122 do VBP O O
122 not RB O O
122 have VB O O
122 this DT O O
122 at IN B-VP O
122 our PRP$ O O
122 institution NN B-NP O
122 , , O O
122 the DT B-NP O
122 patient NN I-NP O
122 was VBD B-VP O
123 started VBN O O
123 on IN B-VP O
123 a DT B-NP O
123 similar JJ I-NP O
123 formula NN I-NP O
123 of IN B-VP O
123 full JJ B-NP O
123 strength NN I-NP O
123 Ensure NNP I-NP O
123 High NNP I-NP O
123 Protein NNP I-NP O
124 at IN B-VP O
124 105 CD O O
124 cc/hour NN B-NP O
124 This DT O O
124 meets VBZ O O
124 the DT B-NP O
124 patient's NN I-NP O
124 full JJ B-NP O
124 nutritional JJ I-NP O
125 requirements NNS I-NP O
126 However RB O O
126 , , O O
126 because IN B-VP O
126 the DT B-NP O
126 patient NN I-NP O
126 appears VBZ O O
126 to TO O O
126 have VB O O
126 no DT B-NP O
126 reason NN I-NP O
126 for IN B-VP O
126 not RB O O
127 encouraging VBG O O
127 his PRP$ O O
127 oral JJ B-NP O
127 intake NN I-NP O
127 , , O O
127 the DT B-NP O
127 patient's NN I-NP O
127 tube NN I-NP O
127 feeds NNS I-NP O
127 were VBD B-VP O
128 decreased VBN O O
128 to TO O O
128 50 CD O O
128 cc/hour NNS B-NP O
128 throughout IN B-VP O
128 the DT B-NP O
128 day NN I-NP O
128 for IN B-VP O
128 a DT O O
128 12 CD O O
128 hour NN B-NP O
128 period NN I-NP O
128 and CC O O
129 po JJ B-NP O
129 intake NN I-NP O
129 at IN B-VP O
129 this DT B-NP O
129 time NN I-NP O
129 was VBD B-VP O
129 encouraged VBN O O
129 The DT B-NP O
129 patient NN I-NP O
129 then RB O O
129 received VBD B-VP O
130 12 CD O O
130 hours NNS B-NP O
130 of IN B-VP O
130 his PRP$ O O
130 tube NN B-NP O
130 feeds NNS I-NP O
130 at IN B-VP O
130 105 CD O O
130 from IN B-VP O
130 7 CD O O
130 p.m NN B-NP O
130 to TO O O
130 7 CD O O
130 a.m PDT O O
130 The DT B-NP O
131 patient NN I-NP O
131 was VBD B-VP O
131 placed VBN O O
131 back RP O O
131 on IN B-VP O
131 his PRP$ O O
131 normal JJ B-NP O
131 subcutaneous JJ I-NP B-mo
131 subcutaneous JJ I-NP B-mo
131 doses NNS I-NP O
131 of IN B-VP O
131 insulin NN B-NP B-m
131 insulin NN I-NP B-m
132 NPH NNP I-NP O
132 38 CD O B-do
132 units NNS B-NP I-do
132 in IN B-VP B-f
132 the DT B-NP I-f
132 morning NN I-NP I-f
132 and CC O O
132 38 CD O B-do
132 units NNS B-NP I-do
132 at IN B-VP B-f
132 night NN B-NP I-f
133 The DT B-NP O
133 patient NN I-NP O
133 has VBZ O O
133 been VBN O O
133 treated VBN O O
133 intermittently RB O O
133 with IN B-VP O
133 insulin NN B-NP B-m
133 drip NN I-NP I-m
133 for IN B-VP O
134 control NN B-NP O
134 of IN B-VP O
134 his PRP$ O B-r
134 blood NN B-NP I-r
134 sugars NNS I-NP I-r
134 during IN B-VP O
134 the DT B-NP O
134 times NNS I-NP O
134 he PRP O O
134 was VBD B-VP O
134 taken VBN O O
134 to TO O O
134 and CC O O
135 from IN B-VP O
135 the DT B-NP O
135 Operating NN I-NP O
135 Room NNP I-NP O
135 Our PRP$ O O
135 goal NN B-NP O
135 for IN B-VP O
135 this DT B-NP O
135 patient NN I-NP O
135 is VBZ O O
135 to TO O O
135 attempt VB O O
136 to TO O O
136 encourage VB O O
136 his PRP$ O O
136 oral JJ B-NP O
136 intake NN I-NP O
136 and CC O O
136 to TO O O
136 cycle NN B-NP O
136 his PRP$ O O
136 tube NN B-NP O
136 feeds VBZ O O
136 only RB O O
136 at IN B-VP O
137 night NN B-NP O
137 The DT B-NP O
137 patient NN I-NP O
137 should MD O O
137 have VB O O
137 24 CD O O
137 hour NN B-NP O
137 calorie NN I-NP O
137 counts VBZ O O
137 initiated VBN O O
137 to TO O O
138 assess VB O O
138 the DT B-NP O
138 adequacy NN I-NP O
138 of IN B-VP O
138 this DT B-NP O
138 oral JJ I-NP O
138 intake NN I-NP O
139 GU NNP I-NP O
139 The DT B-NP O
139 patient NN I-NP O
139 has VBZ O O
139 a DT B-NP O
139 Foley NNP I-NP O
139 catheter NN I-NP O
139 in IN B-VP O
139 place NN B-NP O
139 and CC O O
139 has VBZ O O
139 good JJ B-NP O
139 urine NN I-NP O
140 output NN I-NP O
140 The DT B-NP O
140 patient NN I-NP O
140 has VBZ O O
140 excoriations VBN O O
140 around IN B-VP O
140 his PRP$ O O
140 inner NN B-NP O
140 thighs NNS I-NP O
140 which WDT O O
141 prevented VBD B-VP O
141 us PRP O O
141 from IN B-VP O
141 removing VBG O O
141 his PRP$ O O
141 Foley NNP B-NP O
141 in IN B-VP O
141 case NN B-NP O
141 the DT B-NP O
141 pt NN I-NP O
141 has VBZ O O
141 episodes NNS B-NP O
141 of IN B-VP O
142 urinary JJ B-NP O
142 incontinence NN I-NP O
142 Once IN B-VP O
142 the DT B-NP O
142 patient's NN I-NP O
142 inner NN I-NP O
142 thighs NNS I-NP O
142 heal NN I-NP O
142 , , O O
142 the DT B-NP O
143 patient NN I-NP O
143 may MD O O
143 have VB O O
143 the DT B-NP O
143 Foley NNP I-NP O
143 removed VBD B-VP O
143 and CC O O
143 the DT B-NP O
143 patient NN I-NP O
143 may MD O O
143 be VB O O
143 able JJ O O
143 to TO O O
144 void VB O O
144 on IN B-VP O
144 his PRP$ O O
144 own JJ O O
144 in IN B-VP O
144 either CC O O
144 a DT O O
144 bedside JJ O O
144 urinal JJ O O
144 or CC O O
144 with IN B-VP O
144 a DT B-NP O
144 condom NN I-NP O
144 cath NN I-NP O
144 in IN B-VP O
145 place NN B-NP O
145 The DT B-NP O
145 patient NN I-NP O
145 is VBZ O O
145 receiving VBG O O
145 his PRP$ O O
145 Lasix NNP B-NP B-m
145 40 CD O B-do
145 mg VBD B-VP I-do
145 a DT B-NP B-f
145 day NN I-NP I-f
146 CARDIOVASCULAR NNP I-NP O
146 The DT B-NP O
146 patient NN I-NP O
146 was VBD B-VP O
146 initially RB O O
146 ruled VBN O O
146 out RP O O
146 for IN B-VP O
146 a DT B-NP O
147 myocardial JJ I-NP O
147 infarction NN I-NP O
147 following VBG O O
147 his PRP$ O O
147 first JJ B-NP O
147 operative JJ I-NP O
147 procedure NN I-NP O
147 The DT B-NP O
148 patient NN I-NP O
148 has VBZ O O
148 had VBN O O
148 no DT B-NP O
148 complaints NNS I-NP O
148 of IN B-VP O
148 chest NN B-NP O
148 pain NN I-NP O
148 The DT B-NP O
148 patient's NN I-NP O
149 cardiovascular NN I-NP O
149 status NN I-NP O
149 has VBZ O O
149 been VBN O O
149 stable JJ O O
149 with IN B-VP O
149 CVP's NNP B-NP O
149 running VBG O O
149 in IN B-VP O
149 the DT O O
149 12 CD O O
150 to TO O O
150 13 CD O O
150 range NN B-NP O
150 The DT B-NP O
150 patient NN I-NP O
150 had VBD B-VP O
150 no DT B-NP O
150 episodes NNS I-NP O
150 of IN B-VP O
150 hypotension NN B-NP O
150 and CC O O
150 has VBZ O O
151 been VBN O O
151 continued VBN O O
151 on IN B-VP O
151 his PRP$ O O
151 Capoten NNP B-NP B-m
152 HEMATOLOGIC NNP I-NP O
152 The DT B-NP O
152 patient NN I-NP O
152 has VBZ O O
152 been VBN O O
152 stable JJ O O
152 with IN B-VP O
152 no DT B-NP O
152 issues NNS I-NP O
152 The DT B-NP O
153 patient NN I-NP O
153 continues VBZ O O
153 on IN B-VP O
153 subcutaneous JJ B-NP B-mo
153 heparin NN I-NP B-m
154 INFECTIOUS NNP I-NP O
154 DISEASE NNP I-NP O
154 The DT B-NP O
154 patient NN I-NP O
154 was VBD B-VP O
154 treated VBN O O
154 with IN B-VP O
154 Ampicillin NNP B-NP B-m
154 , , O O
155 Gentamicin NNP B-NP B-m
155 and CC O O
155 Flagyl NNP B-NP B-m
155 The DT B-NP O
155 patient's NN I-NP O
155 intraoperative JJ B-NP O
155 cultures NNS I-NP O
155 from IN B-VP O
156 his PRP$ O O
156 left JJ B-NP O
156 leg NN I-NP O
156 ulcer NN I-NP O
156 grew VBD B-VP O
156 out RP O O
156 E NNP B-NP O
156 coli NNS I-NP O
156 , , O O
156 sensitive JJ O O
156 to TO O O
156 Ampicillin NNP B-NP O
156 and CC O O
157 Ofloxacin NNP B-NP O
157 The DT B-NP O
157 patient NN I-NP O
157 also RB O O
157 grew VBD B-VP O
157 out RP O O
157 Enterococcus NNP B-NP B-r
157 Enterococcus NNP I-NP B-r
157 , , O O
157 sensitive JJ O O
157 also RB O O
158 to TO O O
158 Ampicillin NNP B-NP B-m
158 and CC O O
158 Ofloxacin NNP B-NP B-m
158 and CC O O
158 Enterobacter NNP B-NP B-r
158 Enterobacter NNP I-NP B-r
158 cloacae NN I-NP I-r
158 cloacae NN I-NP I-r
158 , , O O
158 sensitive JJ O O
158 to TO O O
159 Gentamicin NNP B-NP B-m
159 and CC O O
159 Ofloxacin NNP B-NP B-m
159 The DT B-NP O
159 patient NN I-NP O
159 was VBD B-VP O
159 switched VBN O O
159 over IN B-VP O
159 from IN B-VP O
160 Gentamicin NNP B-NP B-m
160 to TO O O
160 Ofloxacin NNP B-NP B-m
160 to TO O O
160 continue VB O O
160 his PRP$ O O
160 antibiotic JJ B-NP O
160 course NN I-NP O
160 The DT B-NP O
161 patient NN I-NP O
161 has VBZ O O
161 been VBN O O
161 followed VBN O O
161 by IN B-VP O
161 the DT B-NP O
161 Infectious NNP I-NP O
161 Disease NNP I-NP O
161 service NN I-NP O
162 Because IN B-VP O
162 of IN B-VP O
162 the DT B-NP O
162 time NN I-NP O
162 of IN B-VP O
162 operation NN B-NP O
162 , , O O
162 it PRP O O
162 was VBD B-VP O
162 considered VBN O O
162 that IN B-VP O
162 the DT B-NP O
163 infectious JJ I-NP O
163 tissue NN I-NP O
163 was VBD B-VP O
163 completely RB O O
163 debrided VBN O O
163 , , O O
163 and CC O O
163 the DT B-NP O
163 patient NN I-NP O
163 does VBZ O O
163 not RB O O
164 need VB O O
164 to TO O O
164 continue VB O O
164 on IN B-VP O
164 an DT B-NP O
164 extensive JJ I-NP O
164 antibiotic JJ I-NP O
164 course NN I-NP O
165 The DT B-NP O
165 patient NN I-NP O
165 will MD O O
165 receive VB O O
165 7 CD O B-du
165 more JJR B-NP I-du
165 days NNS I-NP I-du
165 of IN B-VP O
165 po JJ B-NP B-mo
165 Ofloxacin NNP I-NP B-m
165 as IN B-VP O
165 an DT B-NP O
166 outpatient NN I-NP O
166 as IN B-VP O
166 per IN B-VP O
166 the DT B-NP O
166 ID NNP I-NP O
166 service NN I-NP O
166 The DT B-NP O
166 patient NN I-NP O
166 will MD O O
166 have VB O O
166 received VBN O O
166 , , O O
167 prior RB O O
167 to TO O O
167 discharge VB O O
167 , , O O
167 a DT O B-du
167 a DT B-NP B-du
167 total JJ I-NP I-du
167 total NN I-NP I-du
167 of IN B-VP I-du
167 of IN B-VP I-du
167 7 CD O I-du
167 7 CD O I-du
167 days NNS B-NP I-du
167 days NNS I-NP I-du
167 of IN B-VP O
167 IV NNP B-NP B-mo
167 IV NNP I-NP B-mo
167 Ampicillin NNP I-NP B-m
167 and CC O O
168 Ofloxacin NNP B-NP B-m
168 The DT B-NP O
168 Flagyl NNP I-NP B-m
168 was VBD B-VP O
168 discontinued VBN O O
168 after IN B-VP O
168 day NN B-NP O
168 #6 VBD B-VP O
169 TUBES/LINES/DRAINS NNP B-NP O
169 The DT B-NP O
169 patient NN I-NP O
169 had VBD B-VP O
169 a DT B-NP O
169 triple JJ I-NP O
169 lumen NNS I-NP O
169 catheter NN I-NP O
169 in IN B-VP O
170 place NN B-NP O
170 which WDT O O
170 was VBD B-VP O
170 removed VBN O O
170 on IN B-VP O
170 the DT B-NP O
170 day NN I-NP O
170 prior RB O O
170 to TO O O
170 discharge VB O O
170 The DT B-NP O
170 patient NN I-NP O
171 had VBD B-VP O
171 a DT B-NP O
171 peripheral JJ I-NP O
171 IV NNP I-NP O
171 placed VBD B-VP O
171 in IN B-VP O
171 instead RB O O
171 The DT B-NP O
171 patient NN I-NP O
171 will MD O O
171 not RB O O
171 be VB O O
172 receiving VBG O O
172 any DT B-NP O
172 IV NNP I-NP O
172 medications NNS I-NP O
172 and CC O O
172 will MD O O
172 continue VB O O
172 on IN B-VP O
172 oral JJ B-NP B-mo
172 antibiotic JJ I-NP B-m
173 dosings NNS I-NP O
174 ADDENDUM NNP I-NP O
175 DISCHARGE NNP I-NP O
175 MEDICATIONS: NNP I-NP O
175 The DT B-NP O
175 patient's NN I-NP O
175 medication NN I-NP O
175 upon IN B-VP O
175 discharge NN B-NP O
176 which WDT O O
176 include: VBZ O O
176 1 CD O O
176 ) ) O O
176 Tylenol $ O B-m
176 650 CD O B-do
176 mg NN B-NP I-do
176 p.o NN I-NP B-mo
176 q4h NN I-NP B-f
177 p.r.n NN I-NP O
177 headache NN I-NP B-r
177 2 CD O O
177 ) ) O O
177 Aspirin $ O B-m
177 81 CD O B-do
177 mg NN B-NP I-do
177 p.o NN I-NP B-mo
177 qd $ O B-f
177 3 CD O O
177 ) ) O O
177 Albuterol NNP B-NP B-m
177 nebulizer $ O I-m
178 0.5 CD O B-do
178 cc NN B-NP I-do
178 in IN B-VP O
178 2.5 CD O B-do
178 cc NN B-NP I-do
178 of IN B-VP O
178 normal JJ B-NP B-m
178 saline JJ I-NP I-m
178 q.i.d NN I-NP B-f
178 q.i.d RB O B-f
178 4 CD O O
178 ) ) O O
178 Capoten NNP B-NP B-m
178 25 CD O B-do
178 mg NN B-NP I-do
178 p.o NN I-NP B-mo
178 qh $ O B-f
179 5 CD O O
179 ) ) O O
179 Chloral NNP B-NP B-m
179 hydrate $ O I-m
179 500 CD O B-do
179 mg NN B-NP I-do
179 p.o NN I-NP B-mo
179 q.h.s NN I-NP B-f
179 p.r.n NN I-NP I-f
179 insomnia VBP O B-r
179 6 CD O O
179 ) ) O O
179 Clonopin NNP B-NP B-m
180 1 CD O B-do
180 mg NN B-NP I-do
180 p.o NN I-NP B-mo
180 t.i.d IN B-VP B-f
180 7 CD O O
180 ) ) O O
180 Digoxin NN B-NP B-m
180 0.375 CD O B-do
180 mg NN B-NP I-do
180 p.o NN I-NP B-mo
180 qd $ O B-f
180 8 CD O O
180 ) ) O O
180 Colace NN B-NP B-m
180 100 CD O B-do
180 mg NN B-NP I-do
180 p.o NN I-NP B-mo
181 b.i.d IN B-VP B-f
181 9 CD O O
181 ) ) O O
181 Lasix FW O B-m
181 40 CD O B-do
181 mg NN B-NP I-do
181 p.o NN I-NP B-mo
181 q NN I-NP B-f
181 d VBZ O I-f
181 10 CD O O
181 ) ) O O
181 Heparin NN B-NP B-m
181 5000 CD O B-do
181 units NNS B-NP I-do
181 subcu VBD B-VP B-mo
181 b.i.d RB O B-f
182 11 CD O O
182 ) ) O O
182 Insulin NNP B-NP B-m
182 NPH NNP I-NP I-m
182 38 CD O B-do
182 units NNS B-NP I-do
182 subcu VBD B-VP B-mo
182 b.i.d RB O B-f
182 12 CD O O
182 ) ) O O
182 Milk NN B-NP B-m
182 of IN B-VP I-m
182 Magnesia NNP B-NP I-m
182 30 CD O B-do
182 cc NN B-NP I-do
183 p.o NN I-NP B-mo
183 qd NN I-NP B-f
183 p.r.n NN I-NP I-f
183 constipation NN I-NP B-r
183 13 CD O O
183 ) ) O O
183 Multivitamins VBZ O B-m
183 one CD O B-do
183 capsule NN B-NP I-do
183 p.o NN I-NP B-mo
183 qd $ O B-f
184 14 CD O O
184 ) ) O O
184 Mycostatin NNP B-NP B-m
184 5 CD O B-do
184 cc NN B-NP I-do
184 p.o NN I-NP B-mo
184 q.i.d $ O B-f
184 15 CD O O
184 ) ) O O
184 Percocet NNP B-NP B-m
184 one CD O B-do
184 or CC O I-do
184 two CD O I-do
184 tabs NNS B-NP I-do
184 p.o IN B-VP B-mo
185 q3-4h JJ B-NP B-f
185 p.r.n NN I-NP I-f
185 pain NN I-NP B-r
185 16 CD O O
185 ) ) O O
185 Metamucil NNP B-NP B-m
185 one CD O B-do
185 packet NN B-NP I-do
185 p.o NN I-NP B-mo
185 qd $ O B-f
185 17 CD O O
185 ) ) O O
185 Azmacort NNP B-NP B-m
186 six CD O B-do
186 puffs NNS B-NP I-do
186 inhaled VBD B-VP B-mo
186 b.i.d RB O B-f
186 18 CD O O
186 ) ) O O
186 Axid $ O B-m
186 150 CD O B-do
186 mg NN B-NP I-do
186 p.o NN I-NP B-mo
186 b.i.d IN B-VP B-f
186 19 CD O O
186 ) ) O O
186 Ofloxacin FW O B-m
187 200 CD O B-do
187 mg NN B-NP I-do
187 p.o NN I-NP B-mo
187 b.i.d NN I-NP B-f
187 x $ O B-du
187 7 CD O I-du
187 days NNS B-NP I-du
188 Dictated VBN O O
188 By: NNP B-NP O
188 JOSIAH NNP I-NP O
188 H NNP I-NP O
188 OLIVOS NNP I-NP O
188 , , O O
188 M.D NNP B-NP O
188 WE35 NNP I-NP O
189 Attending: NNP I-NP O
189 MICHEL NNP I-NP O
189 STOCKON NNP I-NP O
189 , , O O
189 M.D NNP B-NP O
189 QH94 NNP I-NP O
189 IM717/6506 NNP I-NP O
190 Batch: NNP I-NP O
190 246 CD O O
190 Index NNP B-NP O
190 No NNP I-NP O
190 LYZPS19RL8 NNP I-NP O
190 D: NNP I-NP O
190 6/6/95 CD O O
191 T: NNP B-NP O
191 6/6/95 CD O O
192 CC: NNP B-NP O
192 1 CD O O
192 NUMBERS NNP B-NP O
192 CARISTO NNP I-NP O
192 , , O O
192 M.D NNP B-NP O
192 EV45 NNP I-NP O
193 2 CD O O
193 DEWAYNE NNP B-NP O
193 G NNP I-NP O
193 GETTEL NNP I-NP O
193 , , O O
193 M.D NNP B-NP O
193 XJ6 NNP I-NP O
194 3 CD O O
194 REGGIE NNP B-NP O
194 W NNP I-NP O
194 MARZETT NNP I-NP O
194 , , O O
194 M.D NNP B-NP O
194 ZK19 NNP I-NP O
195 4 CD O O
195 HARPSTRICT NNP B-NP O
195 A NNP I-NP O
195 MEMORIAL NNP I-NP O
195 HOSPITAL NNP I-NP O
196 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #767415 VBZ O O
2 896632781 CD O O
2 EH NNP B-NP O
2 70876885 CD O O
2 395974 CD O O
2 7/5/1991 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/23/1991 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 9/28/1991 CD O O
4 HISTORY: NNP B-NP O
4 The DT B-NP O
4 patient NN I-NP O
4 is VBZ O O
4 a DT O O
4 62 CD O O
4 year NN B-NP O
4 old JJ B-NP O
4 rug NN I-NP O
5 salesman NN I-NP O
5 admitted VBD B-VP O
5 with IN B-VP O
5 increasing VBG O O
6 angina NN B-NP O
6 In IN B-VP O
6 1981 CD O O
6 he PRP O O
6 was VBD B-VP O
6 first RB O O
6 diagnosed VBN O O
6 with IN B-VP O
6 exertional JJ B-NP O
6 chest NN I-NP O
7 pain NN I-NP O
7 and CC O O
7 hospitalized VBN O O
7 for IN B-VP O
7 a DT O O
7 strongly RB O O
7 positive JJ B-NP O
7 stress NN I-NP O
7 test NN I-NP O
8 catheterization NN I-NP O
8 at IN B-VP O
8 Gapi NNP B-NP O
8 Nic, NNP I-NP O
8 Health NNP I-NP O
8 with IN B-VP O
8 an DT O O
8 80% CD O O
9 proximal NN B-NP O
9 circumflex NN I-NP O
9 and CC O O
9 50% CD O O
9 left VBD B-VP O
9 anterior JJ O O
9 descending VBG O O
9 coronary JJ B-NP O
10 artery NN I-NP O
11 Since IN B-VP O
11 that DT B-NP O
11 time NN I-NP O
11 he PRP O O
11 has VBZ O O
11 been VBN O O
11 managed VBN O O
11 medically RB O O
11 and CC O O
11 recently RB O O
11 felt VBD B-VP O
12 that IN B-VP O
12 his PRP$ O O
12 angina NN B-NP O
12 consisted VBD B-VP O
12 of IN B-VP O
12 chest NN B-NP O
12 aching NN I-NP O
12 , , O O
12 throat NN B-NP O
12 aching NN I-NP O
12 and CC O O
13 dryness NN B-NP O
13 of IN B-VP O
13 the DT B-NP O
13 throat NN I-NP O
13 This DT O O
13 worsened VBN O O
14 On IN B-VP O
14 January NNP B-NP O
14 , , O O
14 1991 CD O O
14 he PRP O O
14 had VBD B-VP O
14 an DT B-NP O
14 exercise NN I-NP O
14 treadmill NN I-NP O
14 test NN I-NP O
14 He PRP O O
14 went VBD B-VP O
15 eight CD O O
15 minutes NNS B-NP O
15 and CC O O
15 0 CD O O
15 seconds NNS B-NP O
15 and CC O O
15 attained VBD B-VP O
15 a DT B-NP O
15 peak JJ I-NP O
15 heart NN I-NP O
15 rate NN I-NP O
15 of IN B-VP O
16 110 CD O O
16 , , O O
16 70% CD O O
16 of IN B-VP O
16 predicted VBN O O
16 and CC O O
16 a DT B-NP O
16 peak JJ I-NP O
16 blood NN I-NP O
16 pressure NN I-NP O
16 of IN B-VP O
16 198/90 CD O O
16 The DT B-NP O
17 test NN I-NP O
17 was VBD B-VP O
17 stopped VBN O O
17 due JJ O O
17 to TO O O
17 1 CD O O
17 mm NNS B-NP O
17 ST NNP I-NP O
17 depression NN I-NP O
17 in IN B-VP O
17 Leads NNP B-NP O
17 II NNP I-NP O
17 , , O O
17 III NNP B-NP O
17 , , O O
17 F NNP B-NP O
18 and CC O O
18 V4 NNP B-NP O
18 to TO O O
18 V6 VB O O
18 He PRP O O
18 developed VBD B-VP O
18 chest JJS B-NP O
18 discomfort NN I-NP O
18 Normal NNP I-NP O
18 blood NN I-NP O
19 pressure NN I-NP O
19 responds VBZ O O
19 to TO O O
19 exercise VB O O
19 and CC O O
19 the DT B-NP O
19 ischemic JJ I-NP O
19 changes NNS I-NP O
19 were VBD B-VP O
20 similar JJ O O
20 to TO O O
20 previous JJ B-NP O
20 tests NNS I-NP O
20 on IN B-VP O
20 August NNP B-NP O
20 , , O O
20 1989 CD O O
20 but CC O O
20 a DT B-NP O
20 lower JJR I-NP O
20 exercise NN I-NP O
21 capacity NN I-NP O
21 His PRP$ O O
21 exercise NN B-NP O
21 discomfort NN I-NP O
21 is VBZ O O
21 exertional JJ O O
21 and CC O O
21 he PRP O O
21 used VBD B-VP O
21 to TO O O
22 notice VB O O
22 it PRP O O
22 when WRB O O
22 he PRP O O
22 carried VBD B-VP O
22 his PRP$ O O
22 golf NN B-NP O
22 bag VBD B-VP O
22 up RP O O
22 a DT B-NP O
22 hill NN I-NP O
23 Yesterday NN I-NP O
23 he PRP O O
23 noticed VBD B-VP O
23 more RBR O O
23 frequent JJ B-NP O
23 anginal JJ I-NP O
23 pain NN I-NP O
23 , , O O
23 with IN B-VP O
23 throat NN B-NP O
23 , , O O
24 chest NN B-NP O
24 and CC O O
24 chest JJ B-NP O
24 pressure NN I-NP O
24 and CC O O
24 both DT B-NP O
24 arms NNS I-NP O
24 aching VBG O O
24 with IN B-VP O
24 dull JJ B-NP O
24 pain NN I-NP O
25 while IN B-VP O
25 playing VBG O O
25 golf NN B-NP O
25 He PRP O O
25 noticed VBD B-VP O
25 the DT B-NP O
25 symptoms NNS I-NP O
25 around IN B-VP O
25 the DT B-NP O
25 third JJ I-NP O
26 hole NN I-NP O
26 He PRP O O
26 was VBD B-VP O
26 then RB O O
26 able JJ O O
26 to TO O O
26 play VB O O
26 up RP O O
26 to TO O O
26 the DT B-NP O
26 14th JJ I-NP O
26 hole NN I-NP O
26 walking NN I-NP O
26 He PRP O O
27 took VBD B-VP O
27 one CD O B-do
27 nitroglycerin NN B-NP B-m
27 and CC O O
27 was VBD B-VP O
27 able JJ O O
27 to TO O O
27 finish VB O O
27 to TO O O
27 the DT O O
27 18th CD O O
27 hole NN B-NP O
28 On IN B-VP O
28 the DT B-NP O
28 day NN I-NP O
28 of IN B-VP O
28 admission NN B-NP O
28 he PRP O O
28 noticed VBD B-VP O
28 some DT B-NP O
28 pain NN I-NP O
28 at IN B-VP O
28 work NN B-NP O
28 while IN B-VP O
28 moving VBG O O
29 around IN B-VP O
29 the DT B-NP O
29 office NN I-NP O
29 , , O O
29 but CC O O
29 it PRP O O
29 did VBD B-VP O
29 not RB O O
29 last JJ O O
29 long JJ O O
29 enough RB O O
29 for IN B-VP O
29 him PRP O O
29 to TO O O
30 take VB O O
30 a DT B-NP O
30 nitroglycerin JJ I-NP O
31 Medications NNP I-NP O
31 on IN B-VP O
31 admission; NN B-NP O
31 LoPressor NNP I-NP B-m
31 50 CD O B-do
31 mg NN B-NP I-do
31 p.o NN I-NP B-mo
31 b.i.d NN I-NP B-f
31 , , O O
31 Isordil NNP B-NP B-m
31 20 CD O B-do
32 mg NN B-NP O
32 p.o NN I-NP B-mo
32 t.i.d NN I-NP B-f
32 , , O O
32 Verapamil NNP B-NP B-m
32 80 CD O B-do
32 mg NN B-NP I-do
32 p.o NN I-NP B-mo
32 t.i.d NN I-NP B-f
32 , , O O
32 Xanax NNP B-NP B-m
32 0.25 CD O B-do
32 mg NN B-NP I-do
32 p.o NN I-NP B-mo
33 b.i.d NN I-NP B-f
33 p.r.n NN I-NP I-f
33 , , O O
33 one CD O B-do
33 aspirin NN B-NP B-m
33 q.d NN I-NP B-f
33 and CC O O
33 p.r.n NN B-NP B-f
33 nitroglycerin JJ B-NP B-m
34 HOSPITAL NNP I-NP O
34 COURSE: NNP I-NP O
34 The DT B-NP O
34 patient NN I-NP O
34 ruled VBD B-VP O
34 out RP O O
34 for IN B-VP O
34 a DT B-NP O
34 myocardial JJ I-NP O
35 infarction NN I-NP O
35 On IN B-VP O
35 January NNP B-NP O
35 he PRP O O
35 had VBD B-VP O
35 a DT B-NP O
36 percutaneous JJ I-NP O
36 transluminal JJ I-NP O
36 coronary NN I-NP O
36 angioplasty NN I-NP O
36 in IN B-VP O
36 which WDT O O
36 a DT B-NP O
37 proximal NN I-NP O
37 circumflex NN I-NP O
37 was VBD B-VP O
37 dilated VBN O O
37 from IN B-VP O
37 95% CD O O
37 to TO O O
37 20% CD O O
37 The DT O O
37 only RB O O
37 other JJ B-NP O
38 lesion NN I-NP O
38 was VBD B-VP O
38 a DT B-NP O
38 right JJ I-NP O
38 coronary JJ I-NP O
38 artery NN I-NP O
38 of IN B-VP O
38 30% CD O O
39 The DT B-NP O
39 patient's NN I-NP O
39 post NN I-NP O
39 percutaneous JJ B-NP O
39 transluminal JJ I-NP O
39 coronary JJ I-NP O
39 angioplasty JJ I-NP O
40 course NN I-NP O
40 was VBD B-VP O
40 complicated VBN O O
40 by IN B-VP O
40 nausea NN B-NP O
40 and CC O O
40 vomiting VBG O O
40 A NNP B-NP O
40 KUB NNP I-NP O
40 was VBD B-VP O
40 non- JJ O O
41 specific JJ O O
41 The DT B-NP O
41 patient's NN I-NP O
41 nausea NN I-NP O
41 and CC O O
41 vomiting NN B-NP O
41 resolved VBN O O
41 over IN B-VP O
41 a DT B-NP O
42 course NN I-NP O
42 of IN B-VP O
42 two CD O O
42 days NNS B-NP O
42 and CC O O
42 he PRP O O
42 remained VBD B-VP O
42 well RB O O
42 and CC O O
42 was VBD B-VP O
42 able JJ O O
42 to TO O O
42 tolerate VB O O
43 p.o NNS B-NP O
43 intake VB O O
43 well RB O O
43 Throughout IN B-VP O
43 his PRP$ O O
43 episodes NNS B-NP O
43 of IN B-VP O
43 nausea NN B-NP O
43 and CC O O
43 vomiting VBG O O
44 the DT B-NP O
44 electrocardiogram NN I-NP O
44 remained VBD B-VP O
44 unchanged JJ O O
44 and CC O O
44 he PRP O O
44 denied VBD B-VP O
44 any DT O O
44 of IN B-VP O
44 his PRP$ O O
45 usual JJ B-NP O
45 anginal JJ I-NP O
45 symptoms NNS I-NP O
46 DISPOSITION: VBP O O
46 The DT B-NP O
46 patient NN I-NP O
46 was VBD B-VP O
46 discharged VBN O O
46 home NN B-NP O
46 in IN B-VP O
47 excellent JJ B-NP O
47 condition NN I-NP O
47 on IN B-VP O
47 LoPressor NNP B-NP B-m
48 50 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 b.i.d NN I-NP B-f
48 , , O O
48 Isordil NNP B-NP B-m
48 20 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 t.i.d NN I-NP B-f
48 , , O O
48 Verapamil NNP B-NP B-m
48 80 CD O B-do
48 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 t.i.d NN I-NP B-f
49 , , O O
49 one CD O B-do
49 aspirin NN B-NP B-m
49 q.d NN I-NP B-f
49 and CC O O
49 Pepcid NNP B-NP B-m
49 20 CD O B-do
49 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 b.i.d NN I-NP B-f
50 Dictated NNP I-NP O
50 By: NNP I-NP O
50 REID NNP I-NP O
50 STULL NNP I-NP O
50 , , O O
50 M.D NNP B-NP O
50 OJ04 NNP I-NP O
51 KG9 NNP I-NP O
51 /4067 NNP I-NP O
52 BARRETT NNP I-NP O
52 DALLISON NNP I-NP O
52 , , O O
52 M.D NNP B-NP O
52 VP05 NNP I-NP O
52 D: NNP I-NP O
52 1/13/91 CD O O
53 T: NNP B-NP O
53 4/27/91 CD O O
54 Batch: NNP B-NP O
54 Z507 NNP I-NP O
54 Report: NNP I-NP O
54 AY580E10 NNP I-NP O
54 T: NNP I-NP O
55 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #767633 VBZ O O
2 573750392 CD O O
2 RHMC NNP B-NP O
2 39369709 CD O O
2 3307799 CD O O
2 0/2/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Left NNP I-NP O
2 leg NN I-NP O
2 pain NN I-NP O
2 , , O O
2 hypocalcemia NN B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/2/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/15/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 SMALLIDGE NNP I-NP O
5 , , O O
5 JULIUS NNP B-NP O
5 969-13-74-7 CD O O
6 Gene NNP B-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 4/2/06 CD O O
8 AT NNP B-NP O
8 04:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 HILDEBRANDT NNP I-NP O
11 , , O O
11 LESLIE NNP B-NP O
11 L NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 No NNP I-NP O
13 CPR NNP I-NP O
13 , , O O
13 No NNP B-NP O
13 defib NN I-NP O
13 , , O O
13 No DT B-NP O
13 intubation NN I-NP O
13 , , O O
13 No NNP B-NP O
13 pressors NNS I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 CALCIUM NNP I-NP B-m
16 CARBONATE NNP I-NP I-m
16 1 CD O B-do
16 , , O I-do
16 500 CD O I-do
16 MG NNP B-NP I-do
16 ( ( O I-do
16 600 CD O I-do
16 MG NNP B-NP I-do
16 ELEM NNP I-NP I-do
16 CA NNP I-NP I-do
16 )/ NNP I-NP I-do
16 VIT NNP I-NP B-m
16 D NNP I-NP I-m
16 200 CD O B-do
16 IU NNP B-NP O
17 1 CD O O
17 TAB NNP B-NP O
17 PO NNP I-NP B-mo
17 BID NNP I-NP B-f
18 ACETYLSALICYLIC NNP I-NP B-m
18 ACID NNP I-NP I-m
18 81 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 DAILY NNP I-NP B-f
19 CALCITRIOL NNP I-NP B-m
19 0.5 CD O B-do
19 MCG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 PHOSLO NNP I-NP O
20 ( ( O O
20 CALCIUM NNP B-NP O
20 ACETATE NNP I-NP O
20 ( ( O O
20 1 CD O O
20 GELCAP=667 NNP B-NP O
20 MG NNP I-NP O
20 ) ) O O
20 ) ) O O
21 1 CD O B-do
21 , , O I-do
21 334 CD O I-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 TID NNP I-NP B-f
22 Number NNP I-NP B-du
22 of IN B-VP I-du
22 Doses NNP B-NP I-du
22 Required NNP I-NP I-du
22 ( ( O I-du
22 approximate JJ B-NP I-du
22 ): NN I-NP I-du
22 4 CD O I-du
23 NEXIUM NNP B-NP B-m
23 ( ( O I-m
23 ESOMEPRAZOLE NNP B-NP I-m
23 ) ) O I-m
23 40 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 DAILY NNP I-NP B-f
24 LASIX NNP I-NP B-m
24 ( ( O I-m
24 FUROSEMIDE NNP B-NP I-m
24 ) ) O I-m
24 40 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 DAILY NNP I-NP B-f
25 TOPROL NNP I-NP B-m
25 XL NNP I-NP I-m
25 ( ( O I-m
25 METOPROLOL NNP B-NP I-m
25 SUCCINATE NNP I-NP I-m
25 EXTENDED NNP I-NP I-m
25 RELEASE NNP I-NP I-m
25 ) ) O I-m
26 25 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 DAILY NNP I-NP O
26 Food/Drug NNP I-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 Take NNP I-NP O
27 consistently RB O O
27 with IN B-VP O
27 meals NNS B-NP O
27 or CC O O
27 on IN B-VP O
27 empty JJ B-NP O
27 stomach NN I-NP O
28 Number NNP I-NP O
28 of IN B-VP O
28 Doses NNP B-NP O
28 Required NNP I-NP O
28 ( ( O O
28 approximate JJ B-NP O
28 ): NN I-NP O
28 2 CD O O
29 NEPHROCAPS NNP B-NP B-m
29 ( ( O I-m
29 NEPHRO-VIT NNP B-NP I-m
29 RX NNP I-NP I-m
29 ) ) O I-m
29 1 CD O B-do
29 TAB NNP B-NP I-do
29 PO NNP I-NP B-mo
29 DAILY NNP I-NP B-f
30 Override NNP I-NP O
30 Notice: NNP I-NP O
30 Override NNP I-NP O
30 added VBD B-VP O
30 on IN B-VP O
30 5/15/06 CD O O
30 by IN B-VP O
30 NOURY NNP B-NP O
30 , , O O
30 QUINTON NNP B-NP O
30 GONZALO NNP I-NP O
30 , , O O
30 M.D NNP B-NP O
30 , , O O
30 PH.D NNP B-NP O
31 on IN B-VP O
31 order NN B-NP O
31 for IN B-VP O
31 SIMVASTATIN NNP B-NP B-m
31 PO NNP I-NP B-mo
31 ( ( O O
31 ref JJ O O
31 # # O O
31 977528686 CD O O
31 ) ) O O
32 POTENTIALLY NNP B-NP O
32 SERIOUS NNP I-NP O
32 INTERACTION: NNP I-NP O
32 NIACIN NNP I-NP B-m
32 , , O O
32 VIT NNP B-NP B-m
32 B-3 NNP I-NP I-m
32 &amp; NNP I-NP O
33 SIMVASTATIN NNP I-NP B-m
33 Reason NNP I-NP O
33 for IN B-VP O
33 override: NN B-NP O
33 md NN I-NP O
33 aware JJ B-NP O
34 SIMVASTATIN NNP I-NP B-m
34 10 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 BEDTIME NNP I-NP B-f
35 Food/Drug NNP I-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
36 Avoid NNP I-NP O
36 grapefruit NN I-NP O
36 unless IN B-VP O
36 MD NNP B-NP O
36 instructs NNS I-NP O
36 otherwise RB O O
37 Alert NNP B-NP O
37 overridden: NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 5/15/06 CD O O
37 by IN B-VP O
37 SEESHOLTZ NNP B-NP O
37 , , O O
37 SALVATORE NNP B-NP O
37 HILARIO NNP I-NP O
37 , , O O
37 M.D NNP B-NP O
37 , , O O
37 PH.D NNP B-NP O
38 POTENTIALLY NNP I-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 NIACIN NNP I-NP B-m
38 , , O O
38 VIT NNP B-NP B-m
38 B-3 NNP I-NP I-m
38 &amp; NNP I-NP O
39 SIMVASTATIN NNP I-NP B-m
40 POTENTIALLY NNP I-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 NIACIN NNP I-NP B-m
40 , , O O
40 VIT NNP B-NP B-m
40 B-3 NNP I-NP I-m
40 &amp; NNP I-NP O
41 SIMVASTATIN NNP I-NP B-m
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
41 md NN I-NP O
41 aware JJ B-NP O
42 DIET: NNP I-NP O
42 No NNP I-NP O
42 Restrictions NNP I-NP O
43 ACTIVITY: NNP I-NP O
43 Partial NNP I-NP O
43 weight-bearing NN I-NP O
44 FOLLOW NNP I-NP O
44 UP NNP I-NP O
44 APPOINTMENT( NNP I-NP O
44 S NNP I-NP O
44 ): NNP I-NP O
45 Orthopedic NNP I-NP O
45 clinic JJ B-NP O
45 Call NNP I-NP O
45 255-686-8127 NN I-NP O
45 on IN B-VP O
45 5/15/06 CD O O
45 , , O O
46 Dr NNP B-NP O
46 Emile NNP I-NP O
46 Kaanana NNP I-NP O
46 Please NNP I-NP O
46 followup VB O O
46 with IN B-VP O
46 your PRP$ O O
46 Primary JJ B-NP O
46 Provider NN I-NP O
46 in IN B-VP O
46 1-2 JJ B-NP O
46 weeks NNS I-NP O
46 after IN B-VP O
46 discharge NN B-NP O
46 , , O O
47 ALLERGY: NNP B-NP O
47 NKA NNP I-NP O
48 ADMIT NNP I-NP O
48 DIAGNOSIS: NNP I-NP O
49 Left NNP I-NP O
49 fibula/tibia JJ B-NP O
49 fracture NN I-NP O
50 PRINCIPAL NNP I-NP O
50 DISCHARGE NNP I-NP O
50 DIAGNOSIS NNP I-NP O
50 ;Responsible JJ O O
50 After IN B-VP O
50 Study NNP B-NP O
50 for IN B-VP O
50 Causing NNP B-NP O
50 Admission NNP I-NP O
50 ) ) O O
51 Left VBD B-VP O
51 leg JJ B-NP O
51 pain NN I-NP O
51 , , O O
51 hypocalcemia NN B-NP O
52 OTHER NNP I-NP O
52 DIAGNOSIS;Conditions NNP I-NP O
52 , , O O
52 Infections NNP B-NP O
52 , , O O
52 Complications NNP B-NP O
52 , , O O
52 affecting VBG O O
52 Treatment/Stay NNP B-NP O
53 CAD NNP I-NP O
53 ( ( O O
53 coronary JJ B-NP O
53 artery NN I-NP O
53 disease NN I-NP O
53 ) ) O O
53 CHF NNP B-NP O
53 ( ( O O
53 congestive JJ B-NP O
53 heart NN I-NP O
53 failure NN I-NP O
53 ) ) O O
53 CRF NNP B-NP O
54 ( ( O O
54 chronic JJ B-NP O
54 renal JJ I-NP O
54 dysfunction NN I-NP O
54 ) ) O O
54 HTN NNP B-NP O
55 ( ( O O
55 hypertension NN B-NP O
55 ) ) O O
55 DM NNP B-NP O
55 ( ( O O
55 diabetes VBZ O O
55 mellitus VBP O O
55 type JJ O O
55 2 CD O O
55 ) ) O O
55 hypocalcemia NN B-NP O
56 chronic JJ B-NP O
56 anemia NN I-NP O
56 ( ( O O
56 anemia NN B-NP O
56 ) ) O O
56 vitamin NN B-NP O
56 D NNP I-NP O
56 deficiency NN I-NP O
56 ( ( O O
56 vitamin JJ B-NP O
56 D NNP I-NP O
56 deficiency NN I-NP O
56 ) ) O O
57 OPERATIONS NNP B-NP O
57 AND NNP I-NP O
57 PROCEDURES: NNP I-NP O
58 None NNP I-NP O
59 OTHER NNP I-NP O
59 TREATMENTS/PROCEDURES NNP I-NP O
59 ( ( O O
59 NOT NNP B-NP O
59 IN NNP I-NP O
59 O.R NNP I-NP O
59 ) ) O O
60 None NN B-NP O
61 BRIEF NNP I-NP O
61 RESUME NNP I-NP O
61 OF NNP I-NP O
61 HOSPITAL NNP I-NP O
61 COURSE: NNP I-NP O
62 CC: NNP I-NP O
62 The DT B-NP O
62 patient NN I-NP O
62 was VBD B-VP O
62 brought VBN O O
62 to TO O O
62 the DT B-NP O
62 ESIH NNP I-NP O
62 ED NNP I-NP O
62 by IN B-VP O
62 her PRP$ O O
62 daughter NN B-NP O
62 with IN B-VP O
62 the DT B-NP O
62 chief JJ I-NP O
63 complaint NN I-NP O
63 of IN B-VP O
63 left JJ B-NP O
63 leg NN I-NP O
63 pain NN I-NP O
63 They PRP O O
63 were VBD B-VP O
63 concerned VBN O O
63 about IN B-VP O
63 the DT B-NP O
63 healing NN I-NP O
63 of IN B-VP O
63 her PRP$ O O
64 left JJ B-NP O
64 fibula/tibia JJ I-NP O
64 fracture NN I-NP O
65 --- NNP I-NP O
66 HPI: NNP I-NP O
66 The DT B-NP O
66 patient NN I-NP O
66 is VBZ O O
66 a DT B-NP O
66 72-year-old JJ I-NP O
66 woman NN I-NP O
66 with IN B-VP O
66 CAD NNP B-NP O
66 s/p NN I-NP O
66 CABG NNP I-NP O
66 , , O O
66 chronic JJ B-NP O
66 kidney NN I-NP O
67 disease NN I-NP O
67 ( ( O O
67 declined VBD B-VP O
67 HD NNP B-NP O
67 ) ) O O
67 , , O O
67 congestive JJ B-NP O
67 heart NN I-NP O
67 failure NN I-NP O
67 ( ( O O
67 EF NNP B-NP O
67 30% CD O O
67 ) ) O O
67 , , O O
67 HTN NNP B-NP O
67 , , O O
67 and CC O O
68 hypocalcemia NN B-NP O
68 She PRP O O
68 has VBZ O O
68 also RB O O
68 been VBN O O
68 hospitalized VBN O O
68 numerous JJ B-NP O
68 times NNS I-NP O
68 in IN B-VP O
68 the DT O O
68 past JJ O O
69 two CD O O
69 years NNS B-NP O
69 for IN B-VP O
69 CHF NNP B-NP O
69 exacerbations NNS I-NP O
69 in IN B-VP O
69 the DT B-NP O
69 setting NN I-NP O
69 of IN B-VP O
69 NSTEMI NNP B-NP O
69 She PRP O O
69 has VBZ O O
70 preferred VBN O O
70 not RB O O
70 to TO O O
70 take VB O O
70 any DT O O
70 of IN B-VP O
70 her PRP$ O O
70 prescribed JJ B-NP O
70 medications NNS I-NP O
70 despite IN B-VP O
70 repeated JJ B-NP O
71 discussions NNS I-NP O
71 about IN B-VP O
71 benefits NNS B-NP O
71 of IN B-VP O
71 decreased JJ B-NP O
71 mortality NN I-NP O
71 , , O O
71 prevention NN B-NP O
71 of IN B-VP O
72 re-hospitalization NN B-NP O
72 , , O O
72 and CC O O
72 symptom JJ B-NP O
72 management NN I-NP O
72 In IN B-VP O
72 May NNP B-NP O
72 2006 CD O O
72 she PRP O O
72 sustained VBD B-VP O
72 a DT B-NP O
73 displaced JJ I-NP O
73 LLE NNP I-NP O
73 tib/fib NN I-NP O
73 fx NN I-NP O
73 after IN B-VP O
73 banging VBG O O
73 her PRP$ O O
73 leg NN B-NP O
73 into IN B-VP O
73 her PRP$ O O
73 bed NN B-NP O
73 while IN B-VP O
73 driving VBG O O
74 her PRP$ O O
74 motorized JJ B-NP O
74 scooter NN I-NP O
74 in IN B-VP O
74 her PRP$ O O
74 apartment NN B-NP O
74 She PRP O O
74 has VBZ O O
74 been VBN O O
74 treated VBN O O
74 by IN B-VP O
74 Dr NNP B-NP O
75 Russel NNP I-NP O
75 Frausto NNP I-NP O
75 at IN B-VP O
75 PCHCOC NNP B-NP O
75 She PRP O O
75 initally RB O O
75 refused VBD B-VP O
75 surgical JJ B-NP O
75 repair NN I-NP O
75 and CC O O
75 was VBD B-VP O
76 casted VBN O O
76 , , O O
76 but CC O O
76 subsequent JJ B-NP O
76 films NNS I-NP O
76 have VBP O O
76 shown VBN O O
76 valgus JJ B-NP O
76 angulation NN I-NP O
76 and CC O O
76 poor JJ B-NP O
77 healing NN I-NP O
77 She PRP O O
77 declined VBD B-VP O
77 surgery NN B-NP O
77 ( ( O O
77 and CC O O
77 was VBD B-VP O
77 a DT B-NP O
77 high-risk JJ I-NP O
77 surgical JJ I-NP O
77 candidate NN I-NP O
78 given VBN O O
78 her PRP$ O O
78 multiple JJ B-NP O
78 comorbidities NNS I-NP O
78 On IN B-VP O
78 11/5/06 CD O O
78 the DT B-NP O
78 cast NN I-NP O
78 was VBD B-VP O
78 removed VBN O O
78 by IN B-VP O
79 Dr NNP B-NP O
79 Malhotra NNP I-NP O
79 and CC O O
79 has VBZ O O
79 been VBN O O
79 in IN B-VP O
79 a DT B-NP O
79 walking NN I-NP O
79 boot NN I-NP O
79 since IN B-VP O
79 then RB O O
79 She PRP O O
79 states VBZ O O
79 that IN B-VP O
80 she PRP O O
80 has VBZ O O
80 pain NN B-NP B-r
80 of IN B-VP O
80 the DT B-NP O
80 left NN I-NP O
80 midleg NN I-NP O
80 that IN B-VP O
80 she PRP O O
80 has VBZ O O
80 treated VBN O O
80 with IN B-VP O
80 Tylenol NNP B-NP B-m
80 and CC O O
81 that DT O O
81 has VBZ O O
81 limited VBN O O
81 her PRP$ O O
81 ability NN B-NP O
81 to TO O O
81 try VB O O
81 and CC O O
81 bear VB O O
81 weight NN B-NP O
82 Her NNP I-NP O
82 daughter NN I-NP O
82 brings VBZ O O
82 her PRP$ O O
82 in IN B-VP O
82 today NN B-NP O
82 because IN B-VP O
82 of IN B-VP O
82 concern NN B-NP O
82 for IN B-VP O
82 her PRP$ O O
82 mother's NN B-NP O
82 left VBD B-VP O
83 leg VBZ O O
83 The DT B-NP O
83 air NN I-NP O
83 cast NN I-NP O
83 was VBD B-VP O
83 taken VBN O O
83 off RP O O
83 yesterday NN B-NP O
83 and CC O O
83 since IN B-VP O
83 then RB O O
83 , , O O
83 she PRP O O
83 has VBZ O O
83 had VBD B-VP O
84 worsening VBG O O
84 pain NN B-NP O
84 of IN B-VP O
84 the DT B-NP O
84 leg NN I-NP O
84 She PRP O O
84 has VBZ O O
84 been VBN O O
84 unable JJ O O
84 to TO O O
84 move VB O O
84 it PRP O O
84 or CC O O
84 bear VB O O
84 any DT B-NP O
85 wait NN I-NP O
85 There EX O O
85 is VBZ O O
85 a DT B-NP O
85 valgus JJ I-NP O
85 deformity NN I-NP O
85 They PRP O O
85 are VBP O O
85 requesting VBG O O
85 orthopedic JJ B-NP O
86 evaluation NN I-NP O
86 She PRP O O
86 denies VBZ O O
86 new JJ O O
86 numbness/tingling VBG O O
86 or CC O O
86 weakness NN B-NP O
86 in IN B-VP O
86 the DT B-NP O
87 extremities NNS I-NP O
87 She PRP O O
87 also RB O O
87 notes VBZ O O
87 multiple JJ B-NP O
87 chronic JJ I-NP O
87 problems NNS I-NP O
87 including VBG O O
88 decreased VBD B-VP O
88 appetite NN B-NP O
88 with IN B-VP O
88 40lb CD O O
88 weight JJ B-NP O
88 loss NN I-NP O
88 over IN B-VP O
88 the DT B-NP O
88 past JJ I-NP O
88 4-6 JJ I-NP O
88 months NNS I-NP O
88 , , O O
89 lethargy NN B-NP O
89 , , O O
89 apathy JJ B-NP O
89 "I NN I-NP O
89 just RB O O
89 want VB O O
89 to TO O O
89 be VB O O
89 able JJ O O
89 to TO O O
89 walk VB O O
89 again RB O O
89 and CC O O
89 do VB O O
89 the DT B-NP O
90 things NNS I-NP O
90 I PRP O O
90 used VBD B-VP O
90 to TO O O
90 like VB O O
90 doing." NN B-NP O
90 ( ( O O
90 Going VBG O O
90 to TO O O
90 the DT B-NP O
90 horse NN I-NP O
90 track NN I-NP O
90 , , O O
90 walking VBG O O
91 outside NN B-NP O
91 ) ) O O
91 She PRP O O
91 states VBZ O O
91 that IN B-VP O
91 she PRP O O
91 is VBZ O O
91 NOT NNP B-NP O
91 depressed JJ O O
91 but CC O O
91 sleeps VBZ O O
91 most JJS O O
91 of IN B-VP O
91 the DT B-NP O
92 day NN I-NP O
93 The DT B-NP O
93 family NN I-NP O
93 has VBZ O O
93 discussed VBN O O
93 these DT B-NP O
93 symptoms NNS I-NP O
93 with IN B-VP O
93 her PRP$ O O
93 PCP NNP B-NP O
93 In IN B-VP O
93 the DT B-NP O
93 past NN I-NP O
93 , , O O
94 symptoms NNS B-NP O
94 have VBP O O
94 been VBN O O
94 attributed VBN O O
94 to TO O O
94 her PRP$ O O
94 worsening VBG O O
94 renal JJ B-NP O
94 failure NN I-NP O
94 , , O O
94 cardiac JJ B-NP O
95 status NN I-NP O
95 in IN B-VP O
95 this DT B-NP O
95 patient NN I-NP O
95 who WP O O
95 refuses VBZ O O
95 to TO O O
95 take VB O O
95 any DT B-NP O
95 medications NNS I-NP O
95 She PRP O O
95 has VBZ O O
96 wanted VBN O O
96 to TO O O
96 remain VB O O
96 home NN B-NP O
96 yet RB O O
96 has VBZ O O
96 had VBN O O
96 documented VBN O O
96 discussions NNS B-NP O
96 with IN B-VP O
96 PCP NNP B-NP O
96 about IN B-VP O
97 the DT B-NP O
97 benefits NNS I-NP O
97 of IN B-VP O
97 placement NN B-NP O
97 to TO O O
97 a DT B-NP O
97 nursing NN I-NP O
97 home NN I-NP O
97 for IN B-VP O
97 longterm JJ B-NP O
97 care NN I-NP O
97 Family NNP I-NP O
97 is VBZ O O
98 currently RB O O
98 looking VBG O O
98 into IN B-VP O
98 assisted VBN O O
98 living NN B-NP O
98 facilities NNS I-NP O
98 She PRP O O
98 also RB O O
98 has VBZ O O
99 requested VBN O O
99 DNR/DNI NNP B-NP O
99 status NN I-NP O
99 in IN B-VP O
99 the DT B-NP O
99 past JJ I-NP O
100 PAST NNP I-NP O
100 MEDICAL NNP I-NP O
100 HISTORY: NNP I-NP O
101 1 CD O O
101 Coronary NNP B-NP O
101 artery NN I-NP O
101 disease: NN I-NP O
101 s/p NN I-NP O
101 IMI NNP I-NP O
101 and CC O O
101 2-V-CABG JJ O O
101 , , O O
101 August NNP B-NP O
101 of IN B-VP O
101 2001 CD O O
102 ( ( O O
102 LIMA&gt;LAD NNP B-NP O
102 , , O O
102 SVG&gt;PDA NNP B-NP O
102 ) ) O O
102 Her PRP$ O O
102 anginal JJ B-NP O
102 equivalents NNS I-NP O
102 are VBP O O
102 N/V NNP B-NP O
102 but CC O O
102 not RB O O
102 CP NNP B-NP O
102 She PRP O O
102 is VBZ O O
103 followed VBN O O
103 by IN B-VP O
103 a DT B-NP O
103 cardiologist NN I-NP O
103 , , O O
103 Dr NNP B-NP O
103 Trent NNP I-NP O
103 Cannizzo NNP I-NP O
103 at IN B-VP O
103 CICGH NNP B-NP O
103 She PRP O O
103 is VBZ O O
103 uninterested JJ O O
104 in IN B-VP O
104 pursuing VBG O O
104 any DT B-NP O
104 additional JJ I-NP O
104 cardiac JJ I-NP O
104 evaluation NN I-NP O
105 2 CD O O
105 CHF NNP B-NP O
105 with IN B-VP O
105 EF NNP B-NP O
105 26% CD O O
105 ( ( O O
105 4/27 CD O O
105 ) ) O O
105 Mod-Severe NNP B-NP O
105 MR NNP I-NP O
105 Several NNP I-NP O
105 exacerbations NNS I-NP O
105 over IN B-VP O
106 past JJ B-NP O
106 yr NN I-NP O
106 in IN B-VP O
106 setting VBG O O
106 of IN B-VP O
106 NSTEMI NNP B-NP O
106 ( ( O O
106 3/23 CD O O
106 ) ) O O
107 3 CD O O
107 Hypertension NNP B-NP O
108 4 CD O O
108 Diabetes NNP B-NP O
108 mellitus VBD B-VP O
108 type JJ O O
108 2 CD O O
108 , , O O
108 non-insulin JJ O O
108 requiring VBG O O
108 Her PRP$ O O
108 most RBS O O
108 recent JJ B-NP O
109 hemoglobin NN I-NP O
109 A1c NNP I-NP O
109 was VBD B-VP O
109 less JJR O O
109 than IN B-VP O
109 6% CD O O
109 without IN B-VP O
109 medications NNS B-NP O
109 Her NNP I-NP O
109 diabetic JJ B-NP O
110 complications NNS I-NP O
110 include VBP O O
110 peripheral JJ O O
110 neuropathy JJ O O
110 and CC O O
110 chronic JJ B-NP O
110 kidney NN I-NP O
110 disease NN I-NP O
111 5 CD O O
111 Chronic NNP B-NP O
111 kidney NN I-NP O
111 disease NN I-NP O
111 2/2 CD O O
111 DM NNP B-NP O
111 with IN B-VP O
111 a DT B-NP O
111 baseline JJ I-NP O
111 creatinine NN I-NP O
111 of IN B-VP O
111 3.5 CD O O
111 to TO O O
111 4 CD O O
112 She PRP O O
112 has VBZ O O
112 no DT B-NP O
112 interest NN I-NP O
112 in IN B-VP O
112 hemodialysis NN B-NP O
113 6 CD O O
113 Hypocalcemia NNP B-NP O
113 secondary JJ O O
113 to TO O O
113 chronic VB O O
113 kidney NN B-NP O
113 disease NN I-NP O
113 and CC O O
113 profound NN B-NP O
113 vitamin NN I-NP O
114 D NNP I-NP O
114 deficiency NN I-NP O
114 with IN B-VP O
114 an DT O O
114 associated VBN O O
114 myopathy NN B-NP O
114 and CC O O
114 bone NN B-NP O
114 pain NN I-NP O
114 She PRP O O
114 also RB O O
114 has VBZ O O
115 severe JJ B-NP O
115 secondary JJ I-NP O
115 hyperparathyroidism NN I-NP O
116 7 CD O O
116 History NNP B-NP O
116 of IN B-VP O
116 colon NN B-NP O
116 cancer NN I-NP O
116 status NN I-NP O
116 post VBD B-VP O
116 a DT B-NP O
116 partial JJ I-NP O
116 colectomy NN I-NP O
116 The DT B-NP O
116 patient NN I-NP O
117 has VBZ O O
117 requested VBN O O
117 no DT B-NP O
117 follow-up NN I-NP O
117 for IN B-VP O
117 this DT B-NP O
117 problem NN I-NP O
118 8 CD O O
118 Osteoarthritis NN B-NP O
118 status NN I-NP O
118 post NN I-NP O
118 a DT B-NP O
118 left JJ I-NP O
118 total JJ I-NP O
118 hip NN I-NP O
118 replacement NN I-NP O
118 for IN B-VP O
118 aseptic JJ B-NP O
119 necrosis NN I-NP O
119 Since IN B-VP O
119 that DT B-NP O
119 time NN I-NP O
119 she PRP O O
119 has VBZ O O
119 a DT B-NP O
119 leg JJ I-NP O
119 length NN I-NP O
119 discrepancy NN I-NP O
119 and CC O O
119 uses VBZ O O
120 crutches NNS B-NP O
120 to TO O O
120 ambulate VB O O
120 until IN B-VP O
120 a DT B-NP O
120 recent JJ I-NP O
120 tib/fib NN I-NP O
120 fx NN I-NP O
120 which WDT O O
120 has VBZ O O
120 left VBN O O
120 her PRP$ O O
121 WC-dependent JJ O O
122 9 CD O O
122 Chronic NNP B-NP O
122 anemia NN I-NP O
122 secondary JJ O O
122 to TO O O
122 chronic VB O O
122 kidney NN B-NP O
122 disease NN I-NP O
122 She PRP O O
122 does VBZ O O
122 have VB O O
122 a DT B-NP O
123 history NN I-NP O
123 of IN B-VP O
123 prior JJ B-NP O
123 upper JJ I-NP O
123 GI NNP I-NP O
123 bleeding VBG O O
123 secondary JJ O O
123 to TO O O
123 peptic JJ B-NP O
123 ulcer JJ I-NP O
123 disease NN I-NP O
124 ROS: NNP I-NP O
124 No NNP I-NP O
124 recent JJ B-NP O
124 fevers/chills NNS I-NP O
124 or CC O O
124 night NN B-NP O
124 sweats NNS I-NP O
124 No NNP I-NP O
124 shortness NN I-NP O
124 of IN B-VP O
124 breath NN B-NP O
124 , , O O
125 cough NN B-NP O
125 or CC O O
125 chest JJS B-NP O
125 pain NN I-NP O
125 No DT B-NP O
125 abdominal JJ I-NP O
125 pain NN I-NP O
125 No NNP I-NP O
125 constipation/diarrhea NN I-NP O
125 No NNP I-NP O
126 dysuria NN I-NP O
126 Denies VBZ O O
126 numbness CC O O
126 or CC O O
126 tingling VBG O O
126 in IN B-VP O
126 extremities NNS B-NP O
127 ALLERGIES: NNP I-NP O
127 NKDA NNP I-NP O
128 MEDS: NNP I-NP O
128 SHE NNP I-NP O
128 STATES VBD B-VP O
128 THAT IN B-VP O
128 SHE NNP B-NP O
128 CURRENTLY NNP I-NP O
128 IS VBZ O O
128 NOT NNP B-NP O
128 TAKING NNP I-NP O
128 ANY NNP I-NP O
128 MEDICINES NNP I-NP O
128 THE NNP I-NP O
129 FOLLOWING NNP I-NP O
129 ARE NNP I-NP O
129 MEDICATIONS NNP I-NP O
129 THAT NNP I-NP O
129 ARE NNP I-NP O
129 PRESCRIBED NNP I-NP O
129 TO NNP I-NP O
129 HER: NNP I-NP O
130 aspirin VBZ O B-m
130 81 CD O B-do
130 mg NN B-NP I-do
130 po NN I-NP B-mo
130 qdcalcitriol VBD B-VP B-m
130 0.5mcg CD O B-do
130 PO NNP B-NP B-mo
130 qdcalcium NN I-NP B-m
130 carbonate NN I-NP I-m
130 500mg CD O B-do
130 po NN B-NP B-mo
131 tidLasix NN I-NP B-m
131 40 CD O B-do
131 mg NN B-NP I-do
131 po NN I-NP B-mo
131 qdLifeline VBP O O
131 personal JJ B-NP O
131 help NN I-NP O
131 Nephrocaps NNP I-NP B-m
131 1 CD O B-do
131 tab NN B-NP I-do
131 PO NNP I-NP B-mo
132 qdnitroglycerin VBZ O O
132 transdermal JJ B-NP B-m
132 patch NN I-NP B-mo
132 0.2mg/hr CD O B-do
132 transdermal JJ B-NP O
132 q24 NNS I-NP O
132 hrs.Toprol VBP O B-m
132 XL $ O I-m
133 25 CD O B-do
133 mg NN B-NP I-do
133 po NN I-NP B-mo
133 qdZocor NN I-NP B-f
133 qdZocor NN I-NP B-m
133 10mg CD O B-do
133 po NN B-NP B-mo
133 qhs JJ B-NP B-f
134 Social NNP I-NP O
134 Hx: NNP I-NP O
134 Lives VBZ O O
134 alone RB O O
134 Gets NNP B-NP O
134 VNA NNP I-NP O
134 and CC O O
134 PCA NNP B-NP O
134 Has NNP I-NP O
134 been VBN O O
134 using VBG O O
134 wheelchair NN B-NP O
134 to TO O O
135 ambulate VB O O
135 Has NNP B-NP O
135 3 CD O O
135 kids NNS B-NP O
135 ( ( O O
135 2 CD O O
135 daughters NNS B-NP O
135 and CC O O
135 son NN B-NP O
135 ) ) O O
136 Tobacco: NNP B-NP O
136 Remote NNP I-NP O
137 Etoh NNP I-NP O
137 :None NNP I-NP O
138 Physical NNP I-NP O
138 Exam: NNP I-NP O
139 VS NNP I-NP O
139 T NNP I-NP O
139 96.8 CD O O
139 BP NNP B-NP O
139 130/80 CD O O
139 HR NNP B-NP O
139 75 CD O O
139 RR NNP B-NP O
139 16 CD O O
139 Pulsox NNP B-NP O
139 100% CD O O
139 RA NNP B-NP O
140 General: NNP I-NP O
140 NAD NNP I-NP O
140 Poor NNP I-NP O
140 eye NN I-NP O
140 contact NN I-NP O
140 , , O O
140 looking VBG O O
140 down RP O O
140 often RB O O
140 Pale NNP B-NP O
141 HEENT: NNP I-NP O
141 EOM NNP I-NP O
141 full JJ B-NP O
141 Sclerae NNP I-NP O
141 anicteric NN I-NP O
141 OP NNP I-NP O
141 without IN B-VP O
141 erythema/thrush JJ B-NP O
141 No NNP I-NP O
142 thyromegaly NN I-NP O
142 No NNP I-NP O
142 cervical NN I-NP O
142 , , O O
142 supraclav NN B-NP O
142 lymphadenopathy JJ B-NP O
143 CV: NNP I-NP O
143 RRR NNP I-NP O
143 , , O O
143 S1 NNP B-NP O
143 , , O O
143 S2 NNP B-NP O
143 , , O O
143 2/6 CD O O
143 HSM NNP B-NP O
143 at IN B-VP O
143 apex JJ O O
143 no DT B-NP O
143 carotid NN I-NP O
143 bruits VBZ O O
143 JVP NNP B-NP O
143 + NNP I-NP O
143 14cm CD O O
144 Chest: NNP B-NP O
144 Crackles NNP I-NP O
144 halfway VBZ O O
144 up RP O O
144 bilaterally RB O O
144 No NNP B-NP O
144 wheezes VBZ O O
145 Abd: NNP B-NP O
145 Soft NNP I-NP O
145 Nontender NNP I-NP O
145 , , O O
145 nondistended VBD B-VP O
145 Liver NNP B-NP O
145 edge NN I-NP O
145 smooth RB O O
145 Palpated VBD B-VP O
145 on IN B-VP O
146 inspiration NN B-NP O
146 to TO O O
146 descend VB O O
146 2cm CD O O
146 below IN B-VP O
146 CM NNP B-NP O
147 Extrem: NNP I-NP O
147 RLE NNP I-NP O
147 with IN B-VP O
147 multiple JJ B-NP O
147 hyperpigmented JJ I-NP O
147 nodules NNS I-NP O
147 with IN B-VP O
147 superficial JJ B-NP O
148 excoriations NNS I-NP O
148 LLE NNP I-NP O
148 dry NN I-NP O
148 with IN B-VP O
148 cracked/flaking VBG O O
148 skin JJ B-NP O
148 Foot NNP I-NP O
148 is VBZ O O
148 edematous JJ B-NP O
149 Leg NNP I-NP O
149 appears VBZ O O
149 to TO O O
149 have VB O O
149 varus NN B-NP O
149 deformity NN I-NP O
149 Left NNP I-NP O
149 foot NN I-NP O
149 is VBZ O O
149 edematous JJ O O
149 There EX O O
149 is VBZ O O
149 a DT B-NP O
150 band NN I-NP O
150 of IN B-VP O
150 constriction NN B-NP O
150 where WRB O O
150 bandage NN B-NP O
150 was VBD B-VP O
150 wrapped VBN O O
150 Sensation NNP B-NP O
150 intact JJ O O
150 to TO O O
151 light JJ B-NP O
151 touch NN I-NP O
151 bilaterally RB O O
151 Pain NNP B-NP O
151 elicited VBD B-VP O
151 on IN B-VP O
151 movement NN B-NP O
151 of IN B-VP O
151 left JJ B-NP O
151 leg NN I-NP O
151 Cannot NNP I-NP O
152 logroll NN I-NP O
152 left VBD B-VP O
152 leg NN B-NP O
152 due JJ O O
152 to TO O O
152 pain VB O O
152 in IN B-VP O
152 tibia NN B-NP O
152 that WDT O O
152 is VBZ O O
152 elicited VBN O O
153 Neuro: NNP B-NP O
153 Aox3 NNP I-NP O
153 CN NNP I-NP O
153 II-XII NNP I-NP O
153 nl POS O O
153 5/5 CD O O
153 strength NN B-NP O
153 in IN B-VP O
153 UE NNP B-NP O
153 LLE NNP I-NP O
153 5/5 CD O O
153 RLE NNP B-NP O
153 4/5 CD O O
154 ankle NN B-NP O
154 dorsi/plantarflex JJ B-NP O
154 No NNP I-NP O
154 asterixis NN I-NP O
155 Labs: NNP I-NP O
156 Na NNP I-NP O
156 140/K CD O O
156 4.6/ CD O O
156 Cl108/ NNP B-NP O
156 Co2 NNP I-NP O
156 22/ CD O O
156 BUN NNP B-NP O
156 59/Cr CD O O
156 4.0/GLU CD O O
156 164 CD O O
157 Mg NNP B-NP O
157 2.0/ CD O O
157 Ca NNP B-NP O
157 5.6/ CD O O
157 IoCa NNP B-NP O
157 Unsat/ NNP I-NP O
158 WBC NNP I-NP O
158 4.01/HCT CD O O
158 36.6/PLT CD O O
158 167 CD O O
158 MCV NNP B-NP O
158 83.4 CD O O
158 RDW NNP B-NP O
158 16.6 CD O O
159 PTT NNP B-NP O
159 27.1/ CD O O
159 INR NNP B-NP O
159 1.2 CD O O
160 LFT's: NNP B-NP O
160 P NNP I-NP O
161 EKG: NNP I-NP O
161 SR NNP I-NP O
161 with IN B-VP O
161 first JJ B-NP O
161 degree NN I-NP O
161 AVB NNP I-NP O
161 Q's NNP I-NP O
161 in IN B-VP O
161 II NNP B-NP O
161 , , O O
161 III NNP B-NP O
161 , , O O
161 avF VBZ O O
161 No NNP B-NP O
161 change NN I-NP O
161 from IN B-VP O
161 prior JJ B-NP O
162 CXR: NNP I-NP O
162 Cardiomegaly NNP I-NP O
162 No NNP I-NP O
162 evidence NN I-NP O
162 edema NN I-NP O
162 or CC O O
162 infiltrate NN B-NP O
163 Pain NNP I-NP O
163 film NN I-NP O
163 of IN B-VP O
163 left JJ B-NP O
163 leg: JJ I-NP O
163 Transverse NN I-NP O
163 fractures NNS I-NP O
163 through IN B-VP O
163 the DT B-NP O
163 mid NN I-NP O
163 tibia NN I-NP O
163 and CC O O
164 fibula JJ B-NP O
164 diaphysis NN I-NP O
164 with IN B-VP O
164 mild JJ B-NP O
164 medial JJ I-NP O
164 displacement NN I-NP O
164 , , O O
164 and CC O O
164 valgus NN B-NP O
164 and CC O O
165 anterior JJ B-NP O
165 angulation NN I-NP O
165 , , O O
165 unchanged JJ B-NP O
166 _________________________________________ NNP I-NP O
167 IMPRESSION: NNP I-NP O
168 72F CD O O
168 with IN B-VP O
168 multiple JJ B-NP O
168 chronic JJ I-NP O
168 medical JJ I-NP O
168 problems NNS I-NP O
168 s/p JJ B-NP O
168 recent JJ I-NP O
168 tib/fib NN I-NP O
168 fx NN I-NP O
169 ( ( O O
169 non-surg JJ B-NP O
169 mgmt NN I-NP O
169 ) ) O O
169 admitted VBD B-VP O
169 for IN B-VP O
169 evaluation NN B-NP O
169 of IN B-VP O
169 her PRP$ O O
169 fracture NN B-NP O
169 She PRP O O
169 was VBD B-VP O
169 admitted VBN O O
170 to TO O O
170 medicine VB O O
170 for IN B-VP O
170 "longterm JJ B-NP O
170 placement." NN I-NP O
170 Yet NNP I-NP O
170 upon IN B-VP O
170 interview NN B-NP O
170 of IN B-VP O
170 the DT B-NP O
170 family NN I-NP O
171 they PRP O O
171 intend VBP O O
171 for IN B-VP O
171 Ms NNP B-NP O
171 Pall NNP I-NP O
171 to TO O O
171 go VB O O
171 home NN B-NP O
171 after IN B-VP O
171 this DT B-NP O
171 hospital NN I-NP O
171 stay NN I-NP O
171 From IN B-VP O
172 there RB O O
172 , , O O
172 she PRP O O
172 will MD O O
172 transition VB O O
172 to TO O O
172 assisted VBN O O
172 living NN B-NP O
172 Over IN B-VP O
172 the DT B-NP O
172 last JJ I-NP O
172 few JJ I-NP O
172 months NNS I-NP O
172 , , O O
173 she PRP O O
173 has VBZ O O
173 declined VBN O O
173 to TO O O
173 take VB O O
173 any DT B-NP O
173 medications NNS I-NP O
173 or CC O O
173 treatment NN B-NP O
173 for IN B-VP O
173 her PRP$ O O
173 chronic JJ B-NP O
174 kidney NN I-NP O
174 disease NN I-NP O
174 or CC O O
174 cardiac JJ B-NP O
174 disease NN I-NP O
174 This DT O O
174 has VBZ O O
174 led VBN O O
174 to TO O O
174 progressive VB O O
174 renal JJ B-NP O
175 disease NN I-NP O
175 , , O O
175 electrolyte JJ B-NP O
175 abnormalities NNS I-NP O
175 and CC O O
175 myopathy VB O O
175 The DT B-NP O
175 family NN I-NP O
175 brings VBZ O O
175 her PRP$ O O
176 in IN B-VP O
176 with IN B-VP O
176 concerns NNS B-NP O
176 regarding VBG O O
176 her PRP$ O O
176 left JJ B-NP O
176 leg NN I-NP O
176 While IN B-VP O
176 they PRP O O
176 do VBP O O
176 want VB O O
176 to TO O O
177 transition VB O O
177 to TO O O
177 assisted JJ B-NP O
177 living NN I-NP O
177 , , O O
177 they PRP O O
177 do VBP O O
177 not RB O O
177 intend VB O O
177 to TO O O
177 place VB O O
177 her PRP$ O O
177 directly RB O O
178 from IN B-VP O
178 DUOMC NNP B-NP O
178 to TO O O
178 RH NNP B-NP O
178 or CC O O
178 Rehab NNP B-NP O
178 They PRP O O
178 hope VBP O O
178 she PRP O O
178 will MD O O
178 go VB O O
178 home NN B-NP O
178 after IN B-VP O
178 this DT B-NP O
178 hospital NN I-NP O
179 stay NN I-NP O
179 and CC O O
179 continue NN B-NP O
179 with IN B-VP O
179 VNA/services NNP B-NP O
180 ORTHO: NNP I-NP O
180 Tib/fib NNP I-NP O
180 fracture NN I-NP O
180 Non-surgically RB O O
180 managed VBD B-VP O
180 Followed NNP B-NP O
180 by IN B-VP O
180 Dr NNP B-NP O
181 Alirez NNP I-NP O
181 Seen NNP I-NP O
181 by IN B-VP O
181 Orthopedic NNP B-NP O
181 service NN I-NP O
181 who WP O O
181 discussed VBD B-VP O
181 the DT O O
181 2 CD O O
181 options: NNS B-NP O
182 casting VBG O O
182 with IN B-VP O
182 patellar JJ B-NP O
182 tendon NNS I-NP O
182 bearing VBG O O
182 cast NN B-NP O
182 or CC O O
182 surgery NN B-NP O
182 As IN B-VP O
182 before RB O O
182 , , O O
183 patient NN B-NP O
183 declined VBD B-VP O
183 surgery NN B-NP O
183 ( ( O O
183 this DT B-NP O
183 decision NN I-NP O
183 has VBZ O O
183 been VBN O O
183 supported VBN O O
183 by IN B-VP O
183 her PRP$ O O
183 PCP NNP B-NP O
183 and CC O O
184 cardiologist NN B-NP O
184 as IN B-VP O
184 she PRP O O
184 is VBZ O O
184 a DT B-NP O
184 high JJ I-NP O
184 risk NN I-NP O
184 surgical JJ B-NP O
184 candidate NN I-NP O
184 ) ) O O
184 There EX O O
184 were VBD B-VP O
184 no DT O O
185 casting VBG O O
185 technicians NNS B-NP O
185 in-house RB O O
185 this DT B-NP O
185 weekend NN I-NP O
185 Therefore NNP I-NP O
185 she PRP O O
185 will MD O O
185 followup VB O O
185 in IN B-VP O
186 the DT B-NP O
186 Orthopedics NNP I-NP O
186 clinic NN I-NP O
186 on IN B-VP O
186 Wednesday NNP B-NP O
186 , , O O
186 as IN B-VP O
186 instructed VBN O O
186 by IN B-VP O
186 the DT B-NP O
186 ortho JJ I-NP O
186 resident NN I-NP O
187 on IN B-VP O
187 call NN B-NP O
189 CKD NNP I-NP O
189 Monitor NNP I-NP O
189 renal JJ B-NP O
189 function NN I-NP O
189 and CC O O
189 lytes VBZ O O
189 Patient NNP B-NP O
189 agreed VBD B-VP O
189 to TO O O
189 take VB O O
189 vitamin JJ B-NP B-m
190 supplements NNS I-NP O
190 such JJ O O
190 as IN B-VP O
190 nephrocaps NNS B-NP B-m
190 Phosphate NNP I-NP B-m
190 was VBD B-VP O
190 wnl JJ O O
190 despite IN B-VP O
190 not RB O O
190 taking VBG O O
191 phoslo NN B-NP O
191 at IN B-VP O
191 home NN B-NP O
193 CHRONIC NNP I-NP B-r
193 HYPOCALCEMIA: NNP I-NP I-r
193 Elevated NNP I-NP O
193 PTH NNP I-NP O
193 Patient NNP I-NP O
193 agreed VBD B-VP O
193 to TO O O
193 take VB O O
193 calcitriol NN B-NP B-m
195 ENDOCRINE: NNP I-NP O
195 recent JJ O O
195 elevated VBD B-VP O
195 TSH NNP B-NP O
195 T3/T4 NNP I-NP O
195 pending VBG O O
195 at IN B-VP O
195 discharge NN B-NP O
196 -H/o NNP I-NP O
196 Diabetes VBZ O O
196 yet RB O O
196 with IN B-VP O
196 progressive JJ B-NP O
196 renal JJ I-NP O
196 failure NN I-NP O
196 , , O O
196 does VBZ O O
196 not RB O O
196 require VB O O
197 insulin NN B-NP O
197 and CC O O
197 with IN B-VP O
197 nl JJ B-NP O
197 A1C NNP I-NP O
199 CV: NNP I-NP O
199 EF NNP I-NP O
199 30% CD O O
199 , , O O
199 multiple JJ B-NP O
199 prior JJ I-NP O
199 admits NNS I-NP O
199 for IN B-VP O
199 CHF NNP B-NP O
199 Was NNP I-NP O
199 in IN B-VP O
199 NOT NNP B-NP O
199 in IN B-VP O
199 CHF NNP B-NP O
199 on IN B-VP O
199 admission NN B-NP O
200 and CC O O
200 had VBD B-VP O
200 stable JJ B-NP O
200 O2 NNP I-NP O
200 saturation NN I-NP O
200 at IN B-VP O
200 98-100% CD O O
200 on IN B-VP O
200 RA NNP B-NP O
200 with IN B-VP O
200 no DT B-NP O
200 recent JJ I-NP O
200 increase NN I-NP O
200 in IN B-VP O
201 DOE NNP B-NP O
203 FEN: NNP I-NP O
203 House NNP I-NP O
203 diet JJ B-NP O
203 Needs NNP I-NP O
203 nutritional JJ B-NP B-m
203 supplements/boost NN I-NP I-m
203 Nephrocaps NNP I-NP B-m
204 DISPO: NNP I-NP O
204 screen NN I-NP O
204 for IN B-VP O
204 assisted JJ B-NP O
204 living NN I-NP O
205 -PT NN I-NP O
205 consult NN I-NP O
206 -SW NNP I-NP O
206 consult NN I-NP O
208 PROPH: NNP I-NP O
208 Heparin NNP I-NP B-m
208 TID NNP I-NP B-f
208 Nexium NNP I-NP B-m
208 ( ( O O
208 has VBZ O O
208 h/o VBN O O
208 esophagitis RB O B-r
208 esophagitis NN B-NP B-r
208 ) ) O O
210 CODE: NNP B-NP O
210 Has NNP I-NP O
210 been VBN O O
210 DNR/DNI NNP B-NP O
210 in IN B-VP O
210 past JJ B-NP O
210 Daughter NN I-NP O
210 wants VBZ O O
210 to TO O O
210 discuss VB O O
210 further JJ O O
210 with IN B-VP O
211 mother NN B-NP O
211 Will NNP I-NP O
211 discuss VBZ O O
211 tomorrow NN B-NP O
212 HC NNP I-NP O
212 proxy: NN I-NP O
212 Omar NNP I-NP O
212 Toting NNP I-NP O
212 729-547-1855 JJ O O
212 ( ( O O
212 cell NN B-NP O
212 ) ) O O
213 ADDITIONAL NNP B-NP O
213 COMMENTS: NNP I-NP O
213 No NNP I-NP O
213 changes NNS I-NP O
213 were VBD B-VP O
213 made VBN O O
213 to TO O O
213 your PRP$ O O
213 medications NNS B-NP O
213 We PRP O O
213 strongly RB O O
213 advise VBP O O
213 you PRP O O
213 to TO O O
213 take VB O O
214 the DT B-NP O
214 medications NNS I-NP O
214 that IN B-VP O
214 your PRP$ O O
214 cardiologist NN B-NP O
214 and CC O O
214 primary JJ B-NP O
214 care NN I-NP O
214 doctor NN I-NP O
214 have VBP O O
215 prescribed VBN O O
217 You PRP O O
217 were VBD B-VP O
217 seen VBN O O
217 by IN B-VP O
217 the DT B-NP O
217 Orthopedic NNP I-NP O
217 Surgery NNP I-NP O
217 service NN I-NP O
217 while IN B-VP O
217 you PRP O O
217 were VBD B-VP O
217 in IN B-VP O
218 hospital NN B-NP O
218 and CC O O
218 the DT B-NP O
218 recommendation NN I-NP O
218 is VBZ O O
218 that IN B-VP O
218 you PRP O O
218 are VBP O O
218 fitted VBN O O
218 for IN B-VP O
218 a DT B-NP O
218 special JJ I-NP O
218 cast NN I-NP O
219 called VBD B-VP O
219 a DT B-NP O
219 "patellar JJ I-NP O
219 tendon NN I-NP O
219 bearing NN I-NP O
219 cast." NN I-NP O
221 Please NNP I-NP O
221 contact VB O O
221 the DT B-NP O
221 Orthopedics NNP I-NP O
221 Clinic NNP I-NP O
221 first JJ B-NP O
221 thing NN I-NP O
221 on IN B-VP O
221 Tuesday NNP B-NP O
221 AM NNP I-NP O
222 260-199-2283 JJ O O
222 They PRP O O
222 will MD O O
222 arrange VB O O
222 for IN B-VP O
222 you PRP O O
222 to TO O O
222 see VB O O
222 Dr NNP B-NP O
222 Paonessa NNP I-NP O
222 on IN B-VP O
223 Wednesday NNP B-NP O
223 for IN B-VP O
223 casting VBG O O
224 DISCHARGE NNP B-NP O
224 CONDITION: NNP I-NP O
224 Stable NNP I-NP O
225 TO NNP I-NP O
225 DO/PLAN: NNP I-NP O
226 No NNP I-NP O
226 dictated VBD B-VP O
226 summary JJ B-NP O
227 ENTERED NNP I-NP O
227 BY: NNP I-NP O
227 ABREV NNP I-NP O
227 , , O O
227 SAMMY NNP B-NP O
227 R NNP I-NP O
227 , , O O
227 MD NNP B-NP O
227 ( ( O O
227 IX708 NNP B-NP O
227 ) ) O O
227 4/2/06 CD O O
227 @ $ O O
227 03 CD O O
228 ****** JJ B-NP O
228 END NN I-NP O
228 OF NNP I-NP O
228 DISCHARGE NNP I-NP O
228 ORDERS NNP I-NP O
228 ****** NNP I-NP O
229 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #771801 VBZ O O
2 245615272 CD O O
2 V NNP B-NP O
2 24092373 CD O O
2 8613599 CD O O
2 0/12/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 cad NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 1/14/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/25/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 CAPLAN NNP I-NP O
5 , , O O
5 JARRETT NNP B-NP O
5 356-18-18-9 CD O O
6 Lau NNP B-NP O
6 Room: NNP I-NP O
6 70G-872 JJ B-NP O
7 Service: NNP I-NP O
7 CAR NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 10/1/06 CD O O
8 AT NNP B-NP O
8 11:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 PARADISE NNP I-NP O
11 , , O O
11 JARROD NNP B-NP O
11 ERICH NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 DIGOXIN NNP I-NP B-m
16 0.25 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 DAILY NNP I-NP B-f
17 LASIX NNP I-NP B-m
17 ( ( O I-m
17 FUROSEMIDE NNP B-NP I-m
17 ) ) O I-m
17 20 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 EVERY NNP I-NP B-f
17 OTHER NNP I-NP I-f
17 DAY NNP I-NP I-f
18 GLYBURIDE NNP I-NP B-m
18 10 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 BID NNP I-NP B-f
19 ISORDIL NNP I-NP B-m
19 ( ( O I-m
19 ISOSORBIDE NNP B-NP I-m
19 DINITRATE NNP I-NP I-m
19 ) ) O I-m
19 20 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 TID NNP I-NP B-f
20 DILANTIN NNP I-NP B-m
20 DILANTIN NNP I-NP B-m
20 DILANTIN NNP I-NP B-m
20 DILANTIN NNP I-NP B-m
20 DILANTIN NNP I-NP B-m
20 DILANTIN NNP I-NP B-m
20 ( ( O I-m
20 ( ( O I-m
20 ( ( O I-m
20 ( ( O I-m
20 ( ( O I-m
20 ( ( O I-m
20 PHENYTOIN NNP B-NP I-m
20 PHENYTOIN NNP I-NP I-m
20 PHENYTOIN NNP I-NP I-m
20 PHENYTOIN NNP I-NP I-m
20 PHENYTOIN NNP I-NP I-m
20 PHENYTOIN NNP I-NP I-m
20 ) ) O I-m
20 ) ) O I-m
20 ) ) O I-m
20 ) ) O I-m
20 ) ) O I-m
20 ) ) O I-m
20 200 CD O B-do
20 MG NNP B-NP I-do
20 QAM; NNP I-NP B-f
20 250 CD O B-do
20 250 CD O B-do
20 MG NNP B-NP I-do
20 MG NNP I-NP I-do
20 QPM NNP I-NP B-f
20 QPM NNP I-NP B-f
20 PO NNP I-NP B-mo
20 PO NNP I-NP B-mo
20 PO NNP I-NP I-f
20 BEDTIME NNP I-NP I-f
21 200 CD O B-do
21 MG NNP B-NP I-do
21 QAM NNP I-NP B-f
21 250 CD O B-do
21 MG NNP B-NP I-do
21 QPM NNP I-NP B-f
21 Starting VBG O O
21 Today NNP B-NP O
21 ( ( O O
21 11/27 CD O O
21 ) ) O O
22 Instructions: NNP B-NP O
22 also RB O O
22 take VBP O O
22 200mg CD O B-do
22 every DT B-NP B-f
22 afternoon NN I-NP I-f
23 Food/Drug NNP I-NP O
23 Interaction NNP I-NP O
23 Instruction NNP I-NP O
24 If IN B-VP O
24 on IN B-VP O
24 tube NN B-NP O
24 feeds NNS I-NP O
24 , , O O
24 please VB O O
24 cycle NN B-NP O
24 ( ( O O
24 hold VB O O
24 1 CD O O
24 hr NN B-NP O
24 before IN B-VP O
24 to TO O O
24 2 CD O O
24 hr NNS B-NP O
25 after IN B-VP O
25 ) ) O O
26 TOPROL NNP B-NP B-m
26 XL NNP I-NP I-m
26 ( ( O I-m
26 METOPROLOL NNP B-NP I-m
26 SUCCINATE NNP I-NP I-m
26 EXTENDED NNP I-NP I-m
26 RELEASE NNP I-NP I-m
26 ) ) O I-m
27 100 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 DAILY NNP I-NP B-f
27 Food/Drug NNP I-NP O
27 Interaction NNP I-NP O
27 Instruction NNP I-NP O
28 Take NNP I-NP O
28 consistently RB O O
28 with IN B-VP O
28 meals NNS B-NP O
28 or CC O O
28 on IN B-VP O
28 empty JJ B-NP O
28 stomach NN I-NP O
29 Number NNP I-NP O
29 of IN B-VP O
29 Doses NNP B-NP O
29 Required NNP I-NP O
29 ( ( O O
29 approximate JJ B-NP O
29 ): NN I-NP O
29 2 CD O O
30 NEURONTIN NNP B-NP B-m
30 ( ( O I-m
30 GABAPENTIN NNP B-NP I-m
30 ) ) O I-m
30 300 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 TID NNP I-NP B-f
31 PLAVIX NNP I-NP B-m
31 ( ( O I-m
31 CLOPIDOGREL NNP B-NP I-m
31 ) ) O I-m
31 75 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 DAILY NNP I-NP B-f
32 BENAZEPRIL NNP I-NP B-m
32 10 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 DAILY NNP I-NP B-f
33 GLUCOPHAGE NNP I-NP B-m
33 ( ( O I-m
33 METFORMIN NNP B-NP I-m
33 ) ) O I-m
33 850 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 TID NNP I-NP B-f
34 Instructions: NNP I-NP O
34 resume NN I-NP O
34 tomorrow NN I-NP O
34 9/11/06 CD O O
35 CELONTIN NNP B-NP B-m
35 ( ( O I-m
35 METHSUXIMIDE NNP B-NP I-m
35 ) ) O I-m
35 300 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 TID NNP I-NP B-f
36 DIET: NNP I-NP O
36 House NNP I-NP O
36 / VBD B-VP O
36 Low NNP B-NP O
36 chol/low NN I-NP O
36 sat VBD B-VP O
36 fat JJ B-NP O
37 DIET: NNP I-NP O
37 House NNP I-NP O
37 / NNP I-NP O
37 ADA NNP I-NP O
37 2100 CD O O
37 cals/dy NN B-NP O
38 ACTIVITY: NNP I-NP O
38 no DT B-NP O
38 heavy JJ I-NP O
38 lifting NN I-NP O
38 for IN B-VP O
38 3-4 JJ B-NP O
38 days NNS I-NP O
39 FOLLOW NNP I-NP O
39 UP NNP I-NP O
39 APPOINTMENT( NNP I-NP O
39 S NNP I-NP O
39 ): NNP I-NP O
40 Dr NNP I-NP O
40 Nehring NNP I-NP O
40 call NN I-NP O
40 for IN B-VP O
40 appointment NN B-NP O
40 , , O O
41 ALLERGY: NNP B-NP O
41 NKA NNP I-NP O
42 ADMIT NNP I-NP O
42 DIAGNOSIS: NNP I-NP O
43 cad NN I-NP O
44 PRINCIPAL NNP I-NP O
44 DISCHARGE NNP I-NP O
44 DIAGNOSIS NNP I-NP O
44 ;Responsible JJ O O
44 After IN B-VP O
44 Study NNP B-NP O
44 for IN B-VP O
44 Causing NNP B-NP O
44 Admission NNP I-NP O
44 ) ) O O
45 cad VBZ O O
46 OTHER NNP B-NP O
46 DIAGNOSIS;Conditions NNP I-NP O
46 , , O O
46 Infections NNP B-NP O
46 , , O O
46 Complications NNP B-NP O
46 , , O O
46 affecting VBG O O
46 Treatment/Stay NNP B-NP O
47 dm NN I-NP O
47 ( ( O O
47 diabetes VBZ O O
47 mellitus NN B-NP O
47 ) ) O O
47 obesity NN B-NP O
47 ( ( O O
47 obesity NN B-NP O
47 ) ) O O
47 dyslipidemia NN B-NP O
48 ( ( O O
48 dyslipidemia NN B-NP O
48 ) ) O O
48 htn NN B-NP O
48 ( ( O O
48 hypertension NN B-NP O
48 ) ) O O
48 cad NN B-NP O
48 ( ( O O
48 coronary JJ B-NP O
48 artery NN I-NP O
49 disease NN I-NP O
49 ) ) O O
49 chf NN B-NP O
49 ( ( O O
49 congestive JJ B-NP O
49 heart NN I-NP O
49 failure NN I-NP O
49 ) ) O O
49 s/p NN B-NP O
49 cabg NN I-NP O
49 ( ( O O
49 S/P NNP B-NP O
49 cardiac JJ B-NP O
49 bypass NN I-NP O
50 graft NN I-NP O
50 surgery NN I-NP O
50 ) ) O O
50 seizure NN B-NP O
50 ( ( O O
50 seizure JJ B-NP O
50 disorder NN I-NP O
50 ) ) O O
51 OPERATIONS NNP B-NP O
51 AND NNP I-NP O
51 PROCEDURES: NNP I-NP O
52 OTHER NNP I-NP O
52 TREATMENTS/PROCEDURES NNP I-NP O
52 ( ( O O
52 NOT NNP B-NP O
52 IN NNP I-NP O
52 O.R NNP I-NP O
52 ) ) O O
53 s/p VBD B-VP O
53 cath JJ B-NP O
54 BRIEF NNP I-NP O
54 RESUME NNP I-NP O
54 OF NNP I-NP O
54 HOSPITAL NNP I-NP O
54 COURSE: NNP I-NP O
55 ID/CC: NNP I-NP O
56 63M CD O O
56 transferred VBD B-VP O
56 from IN B-VP O
56 LMC NNP B-NP O
56 with IN B-VP O
56 positive JJ B-NP O
56 stress NN I-NP O
56 test NN I-NP O
56 HPI NNP I-NP O
57 Pateint NNP I-NP O
57 has VBZ O O
57 h/o VBN O O
57 CABG NNP B-NP O
57 LIMA-D1 NNP I-NP O
57 , , O O
57 V-OM1 NNP B-NP O
57 , , O O
57 V-OM2 NNP B-NP O
57 , , O O
57 V NNP B-NP O
57 Y-graft NNP I-NP O
57 to TO O O
57 PDA NNP B-NP O
57 and CC O O
57 PLV NNP B-NP O
58 Presented NNP I-NP O
58 to TO O O
58 FAH NNP B-NP O
58 on IN B-VP O
58 Monday NNP B-NP O
58 with IN B-VP O
58 exertional JJ B-NP O
58 angina NNS I-NP O
58 ROMI NNP I-NP O
58 Nuclear NNP I-NP O
59 stress NN I-NP O
59 reveled VBD B-VP O
59 inferior JJ B-NP O
59 scar NN I-NP O
59 and CC O O
59 small JJ B-NP O
59 area NN I-NP O
59 of IN B-VP O
59 anterior JJ B-NP O
60 ischemia NN I-NP O
60 Transferred NNP I-NP O
60 to TO O O
60 CTMC NNP B-NP O
60 for IN B-VP O
60 cath NN B-NP O
60 PMH NNP I-NP O
61 Seizure NNP I-NP O
61 d/o NN I-NP O
61 , , O O
61 DM NNP B-NP O
61 , , O O
61 CHF NNP B-NP O
61 , , O O
61 CAD NNP B-NP O
61 , , O O
61 CABG NNP B-NP O
61 , , O O
61 HTN NNP B-NP O
61 COPD NNP I-NP O
61 , , O O
61 Schizo-affecitve NNP B-NP O
61 disorder NN I-NP O
61 , , O O
62 dyslipidemia NN B-NP O
62 Meds NNP I-NP O
62 on IN B-VP O
63 transfer: NN B-NP O
63 Dilantin300/300/250 NNP I-NP B-m
63 , , O O
63 glyburide RB O B-m
63 10 CD O B-do
63 BID NNP B-NP B-f
63 , , O O
63 metformin VBD B-VP B-m
64 850 CD O B-do
64 tid NN B-NP B-f
64 , , O O
64 toprol VB O B-m
64 100 CD O B-do
64 Daily NNP B-NP B-f
64 , , O O
64 ASA NNP B-NP B-m
64 325 CD O B-do
64 daily RB O B-f
64 , , O O
64 isordil JJ O B-m
64 20tid CD O B-do
64 , , O O
64 lasix VBD B-VP B-m
64 20 CD O B-do
65 QOD NNP B-NP B-f
65 , , O O
65 lipitor NN B-NP B-m
65 40 CD O B-do
65 Daily NNP B-NP B-f
65 , , O O
65 neurontin NN B-NP B-m
65 , , O O
65 celondin VBP O B-m
65 300 CD O B-do
65 TID NNP B-NP B-f
65 , , O O
65 digoxin VBZ O B-m
65 0.25 CD O B-do
66 Daily NNP B-NP B-f
66 , , O O
66 benazepril VBD B-VP B-m
66 10 CD O B-do
66 daily JJ B-NP B-f
67 Allergies: NNP I-NP O
67 None NNP I-NP O
67 SH: NNP I-NP O
67 lives VBZ O O
68 alone RB O O
69 ****Hospital JJ B-NP O
69 Course NNP I-NP O
70 1 CD O O
70 CV: NNP B-NP O
70 Cath NNP I-NP O
70 LIMA-LAD NNP I-NP O
70 patient NN I-NP O
70 SVG NNP I-NP O
70 Y NNP I-NP O
70 graft NN I-NP O
70 to TO O O
70 PDA NNP B-NP O
70 and CC O O
70 LV NNP B-NP O
70 mid VBD B-VP O
70 50% CD O O
70 in IN B-VP O
71 graft NN B-NP O
71 stenosis NN I-NP O
71 SVG NNP I-NP O
71 to TO O O
71 both DT B-NP O
71 OM NNP I-NP O
71 branches NNS I-NP O
71 occluded VBD B-VP O
71 RCA NNP B-NP O
71 100% CD O O
71 , , O O
71 LAD NNP B-NP O
71 mid VBD B-VP O
72 100% CD O O
72 , , O O
72 LCx NNP B-NP O
72 100%.Patient CD O O
72 was VBD B-VP O
72 found VBN O O
72 to TO O O
72 be VB O O
72 ASA NNP B-NP B-m
72 resistant JJ O O
72 will MD O O
73 change VB O O
73 to TO O O
73 plavix VB O B-m
73 75 CD O B-do
73 daily RB O B-f
73 Other JJ B-NP O
73 meds: NNS I-NP O
73 Toprol VBP O B-m
73 100 CD O B-do
73 daily RB O B-f
73 , , O O
73 isordil JJ O B-m
73 20 CD O B-do
74 tid NN B-NP B-f
74 Lasix NNP I-NP B-m
74 20 CD O B-do
74 QOD NNP B-NP B-f
74 atorva RB O B-m
74 switched VBD B-VP O
74 to TO O O
74 simva VB O B-m
74 in IN B-VP O
74 house NN B-NP O
74 , , O O
74 benazepril NN B-NP B-m
74 to TO O O
75 lisinopril VB O B-m
75 10 CD O B-do
75 , , O O
75 digoxin NN B-NP B-m
76 0.25 CD O B-do
76 2 CD O O
76 DM: NNP B-NP O
76 will MD O O
76 continue VB O O
76 to TO O O
76 hold VB O O
76 metformin NN B-NP B-m
76 , , O O
76 restart VB O O
77 glyburide NN B-NP B-m
77 and CC O O
77 start VB O O
77 RISS NNP B-NP B-m
77 3 CD O O
77 Staying VBG O O
77 overnight RB O O
77 as IN B-VP O
77 he PRP O O
77 lives VBZ O O
77 alone RB O O
77 , , O O
77 has VBZ O O
78 no DT B-NP O
78 way NN I-NP O
78 of IN B-VP O
78 getting VBG O O
78 home NN B-NP O
79 4 CD O O
79 Neuro: NNP B-NP O
79 Cont NNP I-NP O
79 neurontin RB O B-m
79 300 CD O B-do
79 TID NNP B-NP B-f
79 , , O O
79 dilantin NN B-NP B-m
79 200/200/250 CD O B-do
79 , , O O
79 celondin- JJ O B-m
80 listed VBN O O
80 on IN B-VP O
80 meds NNS B-NP B-m
80 on IN B-VP O
80 discharge NN B-NP O
80 , , O O
80 but CC O O
80 not RB O O
80 on IN B-VP O
80 home NN B-NP O
80 meds NNS I-NP B-m
80 It PRP O O
80 is VBZ O O
80 unclear JJ O O
80 if IN B-VP O
81 he PRP O O
81 should MD O O
81 be VB O O
81 on IN B-VP O
81 this DT O O
81 or CC O O
81 not RB O O
82 0/26/06 CD O O
83 pt NNS B-NP O
83 stable JJ O O
83 and CC O O
83 ready JJ O O
83 for IN B-VP O
83 d/c JJ B-NP O
84 ADDITIONAL NNP I-NP O
84 COMMENTS: NNP I-NP O
84 Please NNP I-NP O
84 take VB O O
84 all DT B-NP O
84 medications NNS I-NP B-m
84 as IN B-VP O
84 prescribed JJ B-NP O
85 Call NNP I-NP O
85 with IN B-VP O
85 any DT B-NP O
85 questions NNS I-NP O
85 or CC O O
85 concerns NNS B-NP O
86 DISCHARGE NNP I-NP O
86 CONDITION: NNP I-NP O
86 Stable NNP I-NP O
87 TO NNP I-NP O
87 DO/PLAN: NNP I-NP O
88 No NNP I-NP O
88 dictated VBD B-VP O
88 summary JJ B-NP O
89 ENTERED NNP I-NP O
89 BY: NNP I-NP O
89 BEHM NNP I-NP O
89 , , O O
89 CRISTOBAL NNP B-NP O
89 , , O O
89 PA NNP B-NP O
89 ( ( O O
89 EY28 NNP B-NP O
89 ) ) O O
89 10/1/06 CD O O
89 @ $ O O
89 10:50 CD O O
89 AM NNP B-NP O
90 ****** JJ B-NP O
90 END NN I-NP O
90 OF NNP I-NP O
90 DISCHARGE NNP I-NP O
90 ORDERS NNP I-NP O
90 ****** NNP I-NP O
91 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #781623 VBZ O O
4 863982363 CD O O
4 SHO NNP B-NP O
4 55476585 CD O O
4 8040272 CD O O
4 10/1/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Cellulitis NNP I-NP O
4 and CC O O
4 foor JJ B-NP O
4 ulcer- JJ I-NP O
4 Diabetic NNP I-NP O
4 foot NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 10/13/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/6/2005 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 SZALAY NNP I-NP O
8 , , O O
8 RANDY NNP B-NP O
8 021-73-77-2 CD O O
9 Amore NNP B-NP O
9 Sterfield NNP I-NP O
9 Rouge NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 0/27/05 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 KLEVENE NNP I-NP O
14 , , O O
14 CHADWICK NNP B-NP O
14 F NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
14 , , O O
14 PH.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 BENADRYL NNP I-NP B-m
19 ( ( O I-m
19 DIPHENHYDRAMINE NNP B-NP I-m
19 HCL NNP I-NP I-m
19 ) ) O I-m
19 25 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 Q6H NNP I-NP B-f
19 PRN NNP I-NP I-f
19 Itching NNP I-NP B-r
20 FUROSEMIDE NNP I-NP B-m
20 40 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
20 HOLD NNP I-NP O
20 IF: NNP I-NP O
20 sbp&lt;90 VBD B-VP O
21 GLYBURIDE NNP B-NP B-m
21 2.5 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 LISINOPRIL NNP I-NP B-m
22 10 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
22 HOLD NNP I-NP O
22 IF: NNP I-NP O
22 sbp&lt;90 VBD B-VP O
23 Override NNP B-NP O
23 Notice: NNP I-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 1/4/05 CD O O
23 by IN B-VP O
24 VIENNEAU NNP B-NP O
24 , , O O
24 KENNY NNP B-NP O
24 C NNP I-NP O
24 , , O O
24 M.D NNP B-NP O
25 on IN B-VP O
25 order NN B-NP O
25 for IN B-VP O
25 KCL NNP B-NP B-m
25 SLOW NNP I-NP I-m
25 RELEASE NNP I-NP I-m
25 PO NNP I-NP B-mo
25 ( ( O O
25 ref JJ O O
25 # # O O
25 38315645 CD O O
25 ) ) O O
26 POTENTIALLY NNP B-NP O
26 SERIOUS NNP I-NP O
26 INTERACTION: NNP I-NP O
26 LISINOPRIL NNP I-NP B-m
26 &amp; NNP I-NP O
26 POTASSIUM NNP I-NP B-m
27 CHLORIDE NNP I-NP O
27 Reason NNP I-NP O
27 for IN B-VP O
27 override: NN B-NP O
27 pt NN I-NP O
27 requires VBZ O O
28 COUMADIN NNP B-NP B-m
28 ( ( O I-m
28 WARFARIN NNP B-NP I-m
28 SODIUM NNP I-NP I-m
28 ) ) O I-m
28 2.5 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QPM NNP I-NP B-f
29 Starting NNP I-NP O
29 NOW NNP I-NP O
29 , , O O
29 Within NNP B-NP O
29 Hour NNP I-NP O
29 of IN B-VP O
29 Pharmacy NNP B-NP O
29 Approval NNP I-NP O
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 No NNP I-NP O
31 high JJ B-NP O
31 Vitamin-K NNP I-NP O
31 containing VBG O O
31 foods NNS B-NP O
32 Override NNP I-NP O
32 Notice: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 9/29/05 CD O O
32 by IN B-VP O
33 YEISER NNP B-NP O
33 , , O O
33 ALPHONSO NNP B-NP O
33 L NNP I-NP O
33 , , O O
33 M.D NNP B-NP O
34 on IN B-VP O
34 order NN B-NP O
34 for IN B-VP O
34 BACTRIM NNP B-NP B-m
34 DS NNP I-NP I-m
34 PO NNP I-NP B-mo
34 ( ( O O
34 ref JJ O O
34 # # O O
34 59937390 CD O O
34 ) ) O O
35 SERIOUS NNP B-NP O
35 INTERACTION: NNP I-NP O
35 WARFARIN NNP I-NP B-m
35 &amp; NNP I-NP O
35 SULFAMETHOXAZOLE NNP I-NP B-m
36 Reason NNP I-NP O
36 for IN B-VP O
36 override: NN B-NP O
36 ok VBP O O
36 Previous NNP B-NP O
36 override IN B-VP O
36 information: JJ B-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 1/4/05 CD O O
37 by IN B-VP O
37 PARMS NNP B-NP O
37 , , O O
37 WILFORD NNP B-NP O
37 M NNP I-NP O
37 , , O O
37 M.D NNP B-NP O
38 POTENTIALLY NNP I-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 SIMVASTATIN NNP I-NP B-m
38 &amp; NNP I-NP O
38 WARFARIN NNP I-NP B-m
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: NN B-NP O
39 ok JJ B-NP O
40 SIMVASTATIN NNP I-NP B-m
40 20 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QHS NNP I-NP B-f
40 Starting VBG O O
40 ON NNP B-NP O
40 10/11/2005 CD O O
40 ( ( O O
40 0/7 CD O O
40 ) ) O O
41 Food/Drug NNP B-NP O
41 Interaction NNP I-NP O
41 Instruction NNP I-NP O
42 Avoid NNP I-NP O
42 grapefruit NN I-NP O
42 unless IN B-VP O
42 MD NNP B-NP O
42 instructs NNS I-NP O
42 otherwise RB O O
43 Override NNP B-NP O
43 Notice: NNP I-NP O
43 Override NNP I-NP O
43 added VBD B-VP O
43 on IN B-VP O
43 1/4/05 CD O O
43 by IN B-VP O
44 SERVANO NNP B-NP O
44 , , O O
44 MAJOR NNP B-NP O
44 D NNP I-NP O
44 , , O O
44 M.D NNP B-NP O
45 on IN B-VP O
45 order NN B-NP O
45 for IN B-VP O
45 COUMADIN NNP B-NP B-m
45 PO NNP I-NP B-mo
45 ( ( O O
45 ref JJ O O
45 # # O O
45 28522744 CD O O
45 ) ) O O
46 POTENTIALLY NNP B-NP O
46 SERIOUS NNP I-NP O
46 INTERACTION: NNP I-NP O
46 SIMVASTATIN NNP I-NP B-m
46 &amp; NNP I-NP O
46 WARFARIN NNP I-NP B-m
47 Reason NNP I-NP O
47 for IN B-VP O
47 override: NN B-NP O
47 ok VBP O O
47 Previous NNP B-NP O
47 override IN B-VP O
47 information: JJ B-NP O
48 Override NNP I-NP O
48 added VBD B-VP O
48 on IN B-VP O
48 10/23/05 CD O O
48 by IN B-VP O
48 MCCULLORS NNP B-NP O
48 , , O O
48 ELDEN NNP B-NP O
48 RONNIE NNP I-NP O
48 , , O O
48 M.D NNP B-NP O
49 POTENTIALLY NNP I-NP O
49 SERIOUS NNP I-NP O
49 INTERACTION: NNP I-NP O
49 WARFARIN NNP I-NP B-m
49 &amp; NNP I-NP O
49 SIMVASTATIN NNP I-NP B-m
50 Reason NNP I-NP O
50 for IN B-VP O
50 override: NN B-NP O
50 will MD O O
50 follow VB O O
51 LINEZOLID NNP B-NP B-m
51 600 CD O B-do
51 MG NNP B-NP I-do
51 PO NNP I-NP B-mo
51 BID NNP I-NP B-f
51 Food/Drug NNP I-NP O
51 Interaction NNP I-NP O
51 Instruction NNP I-NP O
52 This DT B-NP O
52 order NN I-NP O
52 has VBZ O O
52 received VBN O O
52 infectious JJ B-NP O
52 disease NN I-NP O
52 approval NN I-NP O
52 from IN B-VP O
53 VANHEKKEN NNP B-NP O
53 , , O O
53 RICK NNP B-NP O
53 VANCE NNP I-NP O
53 , , O O
53 M.D NNP B-NP O
54 Alert NNP I-NP O
54 overridden: NNP I-NP O
54 Override NNP I-NP O
54 added VBD B-VP O
54 on IN B-VP O
54 9/29/05 CD O O
54 by IN B-VP O
55 SARNACKI NNP B-NP O
55 , , O O
55 GABRIEL NNP B-NP O
55 E NNP I-NP O
55 , , O O
55 M.D NNP B-NP O
56 SERIOUS NNP I-NP O
56 INTERACTION: NNP I-NP O
56 TRAMADOL NNP I-NP B-m
56 HCL NNP I-NP I-m
56 &amp; NNP I-NP O
56 LINEZOLID NNP I-NP B-m
57 Reason NNP I-NP O
57 for IN B-VP O
57 override: JJ B-NP O
58 Number NNP I-NP O
58 of IN B-VP O
58 Doses NNP B-NP O
58 Required NNP I-NP O
58 ( ( O O
58 approximate JJ B-NP O
58 ): NN I-NP O
58 6 CD O O
59 DIET: NNP B-NP O
59 No NNP I-NP O
59 Restrictions NNP I-NP O
60 ACTIVITY: NNP I-NP O
60 Resume NNP I-NP O
60 regular JJ B-NP O
60 exercise NN I-NP O
61 FOLLOW NNP I-NP O
61 UP NNP I-NP O
61 APPOINTMENT( NNP I-NP O
61 S NNP I-NP O
61 ): NNP I-NP O
62 derm NN I-NP O
62 clinic NN I-NP O
62 , , O O
63 vascular JJ B-NP O
63 surgery NN I-NP O
63 , , O O
64 orthopedic JJ B-NP O
64 surgery NN I-NP O
64 , , O O
65 PCP NNP B-NP O
65 , , O O
66 Arrange NNP B-NP O
66 INR NNP I-NP O
66 to TO O O
66 be VB O O
66 drawn VBN O O
66 on IN B-VP O
66 8/5/05 CD O O
66 with IN B-VP O
66 f/u JJ B-NP O
66 INR's NNP I-NP O
66 to TO O O
66 be VB O O
66 drawn VBN O O
66 every DT O O
67 7 CD O O
67 days NNS B-NP O
67 INR's NNP I-NP O
67 will MD O O
67 be VB O O
67 followed VBN O O
67 by IN B-VP O
67 PCP NNP B-NP O
68 ALLERGY: NNP I-NP O
68 Penicillins NNP I-NP O
68 , , O O
68 Cephalosporins NNP B-NP O
68 , , O O
68 QUINOLONES NNP B-NP O
68 , , O O
69 CIPROFLOXACIN NNP B-NP O
70 ADMIT NNP I-NP O
70 DIAGNOSIS: NNP I-NP O
71 Cellulitis NNP I-NP O
72 PRINCIPAL NNP I-NP O
72 DISCHARGE NNP I-NP O
72 DIAGNOSIS NNP I-NP O
72 ;Responsible JJ O O
72 After IN B-VP O
72 Study NNP B-NP O
72 for IN B-VP O
72 Causing NNP B-NP O
72 Admission NNP I-NP O
72 ) ) O O
73 Cellulitis NNP B-NP O
73 and CC O O
73 foor JJ B-NP O
73 ulcer- JJ I-NP O
73 Diabetic NNP I-NP O
73 foot NN I-NP O
74 OTHER NNP I-NP O
74 DIAGNOSIS;Conditions NNP I-NP O
74 , , O O
74 Infections NNP B-NP O
74 , , O O
74 Complications NNP B-NP O
74 , , O O
74 affecting VBG O O
74 Treatment/Stay NNP B-NP O
75 diabetes NNS I-NP O
75 ( ( O O
75 diabetes NNS B-NP O
75 mellitus VBP O O
75 ) ) O O
75 htn NN B-NP O
75 ( ( O O
75 hypertension NN B-NP O
75 ) ) O O
75 edema NN B-NP O
75 ( ( O O
75 peripheral JJ B-NP O
76 edema NN I-NP O
76 ) ) O O
76 obesity NN B-NP O
76 ( ( O O
76 obesity NN B-NP O
76 ) ) O O
76 recurrent NN B-NP O
76 cellulitis NN I-NP O
77 ( ( O O
77 cellulitis NN B-NP O
77 ) ) O O
77 mitral NN B-NP O
77 prolapse NN I-NP O
77 ( ( O O
77 mitral JJ B-NP O
77 valve NN I-NP O
77 prolapse NN I-NP O
77 ) ) O O
77 uti NN B-NP O
77 ( ( O O
77 urinary JJ B-NP O
78 tract NN I-NP O
78 infection NN I-NP O
78 ) ) O O
78 atopic NN B-NP O
78 dermatitis NN I-NP O
78 ( ( O O
78 dermatitis NN B-NP O
78 ) ) O O
79 OPERATIONS NNP B-NP O
79 AND NNP I-NP O
79 PROCEDURES: NNP I-NP O
80 debridement NN I-NP O
80 of IN B-VP O
80 R NNP B-NP O
80 foot NN I-NP O
80 ulcer NN I-NP O
80 by IN B-VP O
80 othopedics NNS B-NP O
81 OTHER NNP I-NP O
81 TREATMENTS/PROCEDURES NNP I-NP O
81 ( ( O O
81 NOT NNP B-NP O
81 IN NNP I-NP O
81 O.R NNP I-NP O
81 ) ) O O
82 bone NN B-NP O
82 scan JJ B-NP O
83 cxr NN I-NP O
84 BRIEF NNP I-NP O
84 RESUME NNP I-NP O
84 OF NNP I-NP O
84 HOSPITAL NNP I-NP O
84 COURSE: NNP I-NP O
85 ID: NNP I-NP O
85 60 CD O O
85 YO NNP B-NP O
85 female JJ B-NP O
86 --- NNP I-NP O
86 CC: NNP I-NP O
86 RLE NNP I-NP O
87 ulceration/redness/pain JJ B-NP O
87 --- NNP I-NP O
88 DX: NNP I-NP O
88 Diabetic NNP I-NP O
88 foot NN I-NP O
88 ulcer NN I-NP O
88 --- NNP I-NP O
89 HPI: NNP I-NP O
89 60 CD O O
89 YO NNP B-NP O
89 female NN I-NP O
89 with IN B-VP O
89 DMII NNP B-NP O
89 , , O O
89 PVD NNP B-NP O
89 , , O O
89 chronic JJ B-NP B-r
89 AF NNP I-NP I-r
89 now RB O O
89 with IN B-VP O
90 DDI NNP B-NP O
90 pacer NN I-NP O
90 on IN B-VP O
90 coumadin NN B-NP B-m
90 who WP O O
90 has VBZ O O
90 had VBD B-VP O
90 history NN B-NP O
90 of IN B-VP O
90 recurrent NN B-NP O
90 LE NNP I-NP O
90 ulcerations NNS I-NP O
91 and CC O O
91 infections NNS B-NP O
91 She PRP O O
91 had VBD B-VP O
91 the DT B-NP O
91 left JJ I-NP O
91 foot NN I-NP O
91 amputated VBD B-VP O
91 9/13 CD O O
91 and CC O O
91 has VBZ O O
91 been VBN O O
92 considering VBG O O
92 amputation NN B-NP O
92 of IN B-VP O
92 the DT B-NP O
92 right NN I-NP O
92 An DT B-NP O
92 ulcer NN I-NP O
92 developed VBD B-VP O
92 2/4 CD O O
92 treated VBN O O
93 with IN B-VP O
93 dressing NN B-NP O
93 changes NNS I-NP O
93 and CC O O
93 local JJ B-NP O
93 care NN I-NP O
93 Now RB O O
93 having VBG O O
94 swelling/erythema/pain VBN O O
94 X JJ O O
94 2 CD O O
94 days NNS B-NP O
94 Admitted VBN O O
94 for IN B-VP O
94 IV NNP B-NP B-mo
95 abx NN I-NP B-m
95 --- NNP I-NP O
96 STATUS: NNP I-NP O
96 VS: NNP I-NP O
96 T:98.4 NNP I-NP O
96 HR:84 NNP I-NP O
96 BP:112/70 NNP I-NP O
96 RR: NNP I-NP O
96 20 CD O O
97 SaO2:100%RA NNP B-NP O
97 GEN: NNP I-NP O
97 NAD NNP I-NP O
97 NECK: NNP I-NP O
97 no DT B-NP O
97 JVD NNP I-NP O
97 CHEST: NNP I-NP O
97 CTA NNP I-NP O
97 bilaterally RB O O
97 CV: NNP B-NP O
98 RRR NNP I-NP O
98 S1 NNP I-NP O
98 , , O O
98 S2 NNP B-NP O
98 3/6 CD O O
98 SEM NNP B-NP O
98 at IN B-VP O
98 base NN B-NP O
98 , , O O
98 no DT B-NP O
98 gallop NN I-NP O
98 ABD: NNP I-NP O
98 soft JJ O O
98 , , O O
98 NT NNP B-NP O
98 , , O O
98 ND NNP B-NP O
98 , , O O
98 bowel NN B-NP O
98 sounds NNS I-NP O
99 present JJ B-NP O
99 EXT: NNP I-NP O
99 Left NNP I-NP O
99 foot NN I-NP O
99 amputated VBD B-VP O
99 , , O O
99 R NNP B-NP O
99 with IN B-VP O
99 charcot JJ B-NP O
99 joint/hindfoot NN I-NP O
100 varus NN I-NP O
100 , , O O
100 erthema NN B-NP O
100 , , O O
100 draining VBG O O
100 ulcer JJ B-NP O
100 fifth JJ I-NP O
100 metatarcel NN I-NP O
100 , , O O
101 edema FW O O
101 --- NNP B-NP O
102 EVENTS: NNP I-NP O
102 10/16 CD O O
102 admitted VBD B-VP O
102 to TO O O
103 medicine VB O O
103 --- NNP B-NP O
104 TESTS/PROCEDURES: NNP I-NP O
104 10/16 CD O O
104 - : O O
104 RLE NN B-NP O
104 plain NN I-NP O
104 films NNS I-NP O
104 - : O O
104 no DT B-NP O
104 evidence NN I-NP O
104 of IN B-VP O
105 osteo $ O O
105 10/16 CD O O
105 - : O O
105 MR NNP B-NP O
105 RLE NNP I-NP O
105 - : O O
106 pending VBG O O
106 --- NNP B-NP O
107 CONSULTS: NNP I-NP O
107 5/12 CD O O
107 ID NNP B-NP O
107 - : O O
107 has VBZ O O
107 multiple JJ B-NP O
107 allergies NNS I-NP O
107 and CC O O
107 has VBZ O O
107 been VBN O O
107 on IN B-VP O
108 several JJ B-NP O
108 agents NNS I-NP O
108 in IN B-VP O
108 the DT O O
108 past JJ O O
108 5/12 CD O O
108 Ortho NNP B-NP O
108 - : O O
108 followed VBN O O
108 by IN B-VP O
108 Dr NNP B-NP O
109 Klose NNP I-NP O
109 --- NNP I-NP O
110 PROBLEM NNP I-NP O
110 LIST NNP I-NP O
110 --- NNP I-NP O
111 1 CD O O
111 ) ) O O
111 RLE NNP B-NP O
111 ulcer JJ O O
111 - : O O
111 diabetic JJ B-NP B-r
111 foot NN I-NP I-r
111 ulcer NN I-NP I-r
111 with IN B-VP O
111 ? . B-VP O
111 osteo NN B-NP O
111 Plain NNP I-NP O
111 films NNS I-NP O
112 negative JJ O O
112 but CC O O
112 early JJ B-NP O
112 signs NNS I-NP O
112 may MD O O
112 be VB O O
112 absent JJ O O
112 Started VBN O O
112 on IN B-VP O
112 unasyn NN B-NP B-m
112 in IN B-VP O
112 ED NNP B-NP O
112 and CC O O
113 toleratied VBD B-VP O
113 Allergic NNP B-NP O
113 to TO O O
113 quinolones NNS B-NP O
113 and CC O O
113 cephlosporins VBZ O O
113 Bone NNP B-NP O
113 scan JJ O O
114 ordered VBD B-VP O
114 Wound NNP B-NP O
114 swap NN I-NP O
114 cx NN I-NP O
114 grew VBD B-VP O
114 2+ CD O O
114 staph NN B-NP O
114 aureus.Susceptibilities NNS I-NP O
115 showed VBD B-VP O
115 MRSA.ID NNP B-NP O
115 consult NN I-NP O
115 recommended VBD B-VP O
115 to TO O O
115 cont VB O O
115 unasyn JJ O B-m
115 and CC O O
115 switch VB O O
115 to TO O O
115 Po NNP B-NP B-mo
116 linezolid NN I-NP B-m
116 as IN B-VP O
116 outpt NN B-NP O
116 since IN B-VP O
116 pt NN B-NP O
116 refused VBD B-VP O
116 to TO O O
116 take VB O O
116 bactrim JJ O B-m
116 stating VBG O O
116 allergy NN B-NP O
116 to TO O O
117 med VB O O
118 Ortho NNP B-NP O
118 consult- NN I-NP O
118 debrided VBD B-VP O
118 wound NN B-NP O
118 to TO O O
118 vaible JJ B-NP O
118 tissue NN I-NP O
118 Pt NNP I-NP O
118 Was NNP I-NP O
118 seen VBN O O
118 by IN B-VP O
118 Dr NNP B-NP O
118 Linkous NNP I-NP O
119 her PRP O O
119 out RP O O
119 pt JJ B-NP O
119 orthopedist- NN I-NP O
119 will MD O O
119 have VB O O
119 out RP O O
119 pt JJ B-NP O
119 reconstructive JJ I-NP O
119 theapy NN I-NP O
119 of IN B-VP O
119 her PRP$ O O
120 right JJ B-NP O
120 foot NN I-NP O
120 after IN B-VP O
120 vascular JJ B-NP O
120 eval NN I-NP O
121 On IN B-VP O
121 10/22 CD O O
121 pt NN B-NP O
121 developed VBD B-VP O
121 rash NN B-NP O
121 on IN B-VP O
121 her PRP$ O O
121 legs NNS B-NP O
121 and CC O O
121 attributed VBD B-VP O
121 it PRP O O
121 to TO O O
121 the DT O O
121 unasyn JJ O B-m
121 She PRP O O
122 had VBD B-VP O
122 no DT O O
122 breathing VBG O O
122 difficulty NN B-NP O
122 or CC O O
122 any DT B-NP O
122 other JJ I-NP O
122 symptoms NNS I-NP O
122 She PRP O O
122 was VBD B-VP O
122 treated VBN O O
122 with IN B-VP O
123 benadry NN B-NP B-m
123 and CC O O
123 the DT B-NP O
123 unasyn NN I-NP B-m
123 was VBD B-VP O
123 discontinued VBN O O
124 As IN B-VP O
124 at IN B-VP O
124 discharge NN B-NP O
124 pt NN I-NP O
124 had VBD B-VP O
124 shown VBN O O
124 marked JJ B-NP O
124 improvement NN I-NP O
124 of IN B-VP O
124 both DT B-NP O
124 cellulitis NN I-NP O
124 and CC O O
125 ulcer JJ B-NP O
125 Pt NNP I-NP O
125 to TO O O
125 follow VB O O
125 up RP O O
125 with IN B-VP O
125 out RP O O
125 patient NN B-NP O
125 care NN I-NP O
125 takers NNS I-NP O
126 --- VBP O O
127 2 CD O O
127 ) ) O O
127 DMII NNP B-NP B-r
127 DMII NNP I-NP B-r
127 - : O O
127 on IN B-VP O
127 glyburide NN B-NP B-m
127 , , O O
127 ADA NNP B-NP O
127 diet NN I-NP O
127 , , O O
127 RISS NNP B-NP B-m
127 --- NNP I-NP O
128 3 CD O O
128 ) ) O O
128 AF/SSS NNP B-NP B-r
128 - : O O
128 has VBZ O O
128 DDI VBN O O
128 PPM NNP B-NP O
128 in IN B-VP O
128 and CC O O
128 is VBZ O O
128 on IN B-VP O
128 coumadin NN B-NP B-m
128 Last JJ B-NP O
128 INR NNP I-NP O
128 check NN I-NP O
128 was VBD B-VP O
129 subtherapeutic JJ O O
129 at IN B-VP O
129 1.3 CD O O
129 Pt NNP B-NP O
129 to TO O O
129 follow VB O O
129 up RP O O
129 with IN B-VP O
129 coumadin NN B-NP O
129 clinic JJ B-NP O
130 --- NNP I-NP O
131 4 CD O O
131 ) ) O O
131 CKD NNP B-NP O
131 - : O O
131 likely JJ O O
131 secondary JJ O O
131 to TO O O
131 DM NNP B-NP O
131 - : O O
131 at IN B-VP O
131 baseline NN B-NP O
131 --- NNP I-NP O
132 5 CD O O
132 ) ) O O
132 FULL NNP B-NP O
132 CODE NNP I-NP O
133 ADDITIONAL NNP I-NP O
133 COMMENTS: NNP I-NP O
133 Please NNP I-NP O
133 follow VB O O
133 up RP O O
133 with IN B-VP O
133 your PRP$ O O
133 PCP NNP B-NP O
133 in IN B-VP O
133 1-2 JJ B-NP O
133 wks NN I-NP O
134 Please NNP I-NP O
134 ensure VB O O
134 your PRP$ O O
134 right JJ B-NP O
134 foot NN I-NP O
134 is VBZ O O
134 elevated VBN O O
134 and CC O O
134 wound IN B-VP O
134 dressing NN B-NP O
134 changes NNS I-NP O
134 are VBP O O
135 done VBN O O
135 daily JJ B-NP O
136 pls NNS I-NP O
136 follow VBP O O
136 up RP O O
136 with IN B-VP O
136 all DT O O
136 your PRP$ O O
136 out RP O O
136 patient JJ B-NP O
136 doctors NNS I-NP O
137 Pls NNP I-NP O
137 call VB O O
137 urgent JJ B-NP O
137 care NN I-NP O
137 clinic NN I-NP O
137 on IN B-VP O
137 thurs NNS B-NP O
137 at IN B-VP O
137 6/13/05 CD O O
137 at IN B-VP O
137 372 CD O O
137 568 CD O O
137 4157 CD O O
137 to TO O O
137 have VB O O
137 a DT B-NP O
138 doctor NN I-NP O
138 check VB O O
138 your PRP$ O O
138 ulcer JJ B-NP O
139 pls NN I-NP O
139 follow VB O O
139 up RP O O
139 with IN B-VP O
139 your PRP$ O O
139 coumadin NN B-NP O
139 clinic NN I-NP O
139 to TO O O
139 have VB O O
139 INR NNP B-NP O
139 checked VBN O O
140 Pls NNP B-NP O
140 take VB O O
140 antibiotics NNS B-NP B-m
140 for IN B-VP B-du
140 7 CD O I-du
140 days NNS B-NP I-du
141 DISCHARGE NNP I-NP O
141 CONDITION: NNP I-NP O
141 Stable NNP I-NP O
142 TO NNP I-NP O
142 DO/PLAN: NNP I-NP O
143 follow VB O O
143 up RP O O
143 with IN B-VP O
143 otho NN B-NP O
143 , , O O
143 vascular JJ B-NP O
143 surg NN I-NP O
143 , , O O
143 derm NN B-NP O
143 and CC O O
143 PCP NNP B-NP O
144 Follow NNP I-NP O
144 up RP O O
144 with IN B-VP O
144 coumadin NN B-NP O
144 clinic JJ B-NP O
145 Cont NNP I-NP O
145 daily RB O O
145 wet VBZ O O
145 to TO O O
145 dry VB O O
145 wound NN B-NP O
145 dressings VBZ O O
146 No NNP B-NP O
146 dictated VBD B-VP O
146 summary JJ B-NP O
147 ENTERED NNP I-NP O
147 BY: NNP I-NP O
147 MARRIETTA NNP I-NP O
147 , , O O
147 TRENT NNP B-NP O
147 E NNP I-NP O
147 , , O O
147 M.D NNP B-NP O
147 ( ( O O
147 GD1 NNP B-NP O
147 ) ) O O
147 0/27/05 CD O O
147 @ $ O O
147 12:06 CD O O
147 PM NNP B-NP O
148 ****** JJ B-NP O
148 END NNP I-NP O
148 OF NNP I-NP O
148 DISCHARGE NNP I-NP O
148 ORDERS NNP I-NP O
148 ****** NNP I-NP O
149 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #787886 VBZ O O
4 671218080 CD O O
4 KLCBEH NNP B-NP O
4 47810552 CD O O
4 6298900 CD O O
4 9/0/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 tremor NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/0/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 7/6/2005 CD O O
7 ****** NNP B-NP O
7 INCOMPLETE NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 RINGHAND NNP I-NP O
8 , , O O
8 ISMAEL NNP B-NP O
8 R NNP I-NP O
8 345-92-23-0 JJ B-NP O
9 Tlau NNP I-NP O
9 Lo NNP I-NP O
9 Poau NNP I-NP O
9 , , O O
9 Wisconsin NNP B-NP O
9 57220 CD O O
10 Service: NNP B-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 10/0/05 CD O O
11 AT NNP B-NP O
11 03:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 DEPIETRO NNP I-NP O
14 , , O O
14 RUSTY NNP B-NP O
14 ABDUL NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 Incomplete NNP I-NP O
17 Discharge NNP I-NP O
18 DISPOSITION: NNP I-NP O
18 Rehabilitation NNP I-NP O
19 DISCHARGE NNP I-NP O
19 MEDICATIONS: NNP I-NP O
20 CEFTRIAXONE NNP I-NP B-m
20 2 CD O B-do
20 , , O I-do
20 000 CD O I-do
20 MG NNP B-NP I-do
20 IV NNP I-NP B-mo
20 QD NNP I-NP B-f
21 DIGOXIN NNP I-NP B-m
21 0.25 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QOD NNP I-NP B-f
22 COLACE NNP I-NP B-m
22 ( ( O I-m
22 DOCUSATE NNP B-NP I-m
22 SODIUM NNP I-NP I-m
22 ) ) O I-m
22 100 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 BID NNP I-NP B-f
23 LASIX NNP I-NP B-m
23 ( ( O I-m
23 FUROSEMIDE NNP B-NP I-m
23 ) ) O I-m
23 20 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QOD NNP I-NP B-f
24 ISORDIL NNP I-NP B-m
24 ( ( O I-m
24 ISOSORBIDE NNP B-NP I-m
24 DINITRATE NNP I-NP I-m
24 ) ) O I-m
24 40 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 BID NNP I-NP B-f
25 HOLD NNP I-NP O
25 IF: NNP I-NP O
25 SBP NNP I-NP O
25 &lt; VBD B-VP O
25 100 CD O O
26 PRIMIDONE NNP B-NP B-m
26 50 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 BID NNP I-NP B-f
27 VANCOMYCIN NNP I-NP B-m
27 HCL NNP I-NP I-m
27 1 CD O B-do
27 GM NNP B-NP I-do
27 IV NNP I-NP B-mo
27 Q36H NNP I-NP B-f
27 Starting NNP I-NP O
27 STAT NNP I-NP O
27 ( ( O O
27 0/17 CD O O
27 ) ) O O
28 SIMVASTATIN NNP B-NP B-m
28 20 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QHS NNP I-NP B-f
29 Food/Drug NNP I-NP O
29 Interaction NNP I-NP O
29 Instruction NNP I-NP O
30 Avoid NNP I-NP O
30 grapefruit NN I-NP O
30 unless IN B-VP O
30 MD NNP B-NP O
30 instructs NNS I-NP O
30 otherwise RB O O
31 NORVASC NNP B-NP B-m
31 ( ( O I-m
31 AMLODIPINE NNP B-NP I-m
31 ) ) O I-m
31 5 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 Food/Drug NNP I-NP O
32 Interaction NNP I-NP O
32 Instruction NNP I-NP O
33 Avoid NNP I-NP O
33 grapefruit NN I-NP O
33 unless IN B-VP O
33 MD NNP B-NP O
33 instructs NNS I-NP O
33 otherwise RB O O
34 LOVENOX NNP B-NP B-m
34 ( ( O I-m
34 ENOXAPARIN NNP B-NP I-m
34 ) ) O I-m
34 30 CD O B-do
34 MG NNP B-NP I-do
34 SC NNP I-NP B-mo
34 QD NNP I-NP B-f
35 COREG NNP I-NP B-m
35 ( ( O I-m
35 CARVEDILOL NNP B-NP I-m
35 ) ) O I-m
35 25 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 BID NNP I-NP B-f
35 HOLD NNP I-NP O
35 IF: NNP I-NP O
35 SBP&lt;90 NNP I-NP O
35 , , O O
35 HR&lt;50 NNP B-NP O
36 Food/Drug NNP I-NP O
36 Interaction NNP I-NP O
36 Instruction NNP I-NP O
37 Take NNP I-NP O
37 consistently RB O O
37 with IN B-VP O
37 meals NNS B-NP O
37 or CC O O
37 on IN B-VP O
37 empty JJ B-NP O
37 stomach NN I-NP O
38 Number NNP I-NP B-du
38 of IN B-VP I-du
38 Doses NNP B-NP I-du
38 Required NNP I-NP I-du
38 ( ( O I-du
38 approximate JJ B-NP I-du
38 ): NN I-NP I-du
38 2 CD O I-du
39 FLOMAX NNP B-NP B-m
39 ( ( O I-m
39 TAMSULOSIN NNP B-NP I-m
39 ) ) O I-m
39 0.4 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 QPM NNP I-NP B-f
40 ESOMEPRAZOLE NNP I-NP B-m
40 20 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 LANTUS NNP I-NP B-m
41 ( ( O I-m
41 INSULIN NNP B-NP I-m
41 GLARGINE NNP I-NP I-m
41 ) ) O I-m
41 7 CD O B-do
41 UNITS NNP B-NP I-do
41 SC NNP I-NP B-mo
41 QD NNP I-NP B-f
42 INSULIN NNP I-NP B-m
42 INSULIN NNP I-NP B-m
42 INSULIN NNP I-NP B-m
42 INSULIN NNP I-NP B-m
42 INSULIN NNP I-NP B-m
42 INSULIN NNP I-NP B-m
42 INSULIN NNP I-NP B-m
42 INSULIN NNP I-NP B-m
42 ASPART NNP I-NP I-m
42 ASPART NNP I-NP I-m
42 ASPART NNP I-NP I-m
42 ASPART NNP I-NP I-m
42 ASPART NNP I-NP I-m
42 ASPART NNP I-NP I-m
42 ASPART NNP I-NP I-m
42 ASPART NNP I-NP I-m
42 Sliding NNP I-NP B-do
42 Sliding NNP I-NP B-do
42 Scale NNP I-NP I-do
42 Scale NNP I-NP I-do
42 ( ( O B-mo
42 subcutaneously RB O I-mo
42 ) ) O I-mo
42 SC NNP B-NP I-mo
42 AC NNP I-NP B-f
42 AC NNP I-NP B-f
43 If IN B-VP O
43 BS NNP B-NP O
43 is VBZ O O
43 less JJR O O
43 than IN B-VP O
43 125 CD O O
43 , , O O
43 then RB O O
43 give VB O O
43 0 CD O O
43 units NNS B-NP O
43 subcutaneously RB O O
44 If IN B-VP O
44 BS NNP B-NP O
44 is VBZ O O
44 125-150 JJ O O
44 , , O O
44 then RB O O
44 give VB O O
44 2 CD O B-do
44 units NNS B-NP I-do
44 subcutaneously RB O B-mo
45 If IN B-VP O
45 BS NNP B-NP O
45 is VBZ O O
45 151-200 CD O O
45 , , O O
45 then RB O O
45 give VB O O
45 3 CD O B-do
45 units NNS B-NP I-do
45 subcutaneously RB O B-mo
46 If IN B-VP O
46 BS NNP B-NP O
46 is VBZ O O
46 201-250 JJ O O
46 , , O O
46 then RB O O
46 give VB O O
46 4 CD O B-do
46 units NNS B-NP I-do
46 subcutaneously RB O B-mo
47 If IN B-VP O
47 BS NNP B-NP O
47 is VBZ O O
47 251-300 JJ O O
47 , , O O
47 then RB O O
47 give VB O O
47 6 CD O B-do
47 units NNS B-NP I-do
47 subcutaneously RB O B-mo
48 If IN B-VP O
48 BS NNP B-NP O
48 is VBZ O O
48 301-350 JJ O O
48 , , O O
48 then RB O O
48 give VB O O
48 8 CD O B-do
48 units NNS B-NP I-do
48 subcutaneously RB O B-mo
49 If IN B-VP O
49 BS NNP B-NP O
49 is VBZ O O
49 351-400 CD O O
49 , , O O
49 then RB O O
49 give VB O O
49 10 CD O B-do
49 units NNS B-NP I-do
49 subcutaneously RB O B-mo
49 and CC O O
50 call VB O O
50 HO NNP B-NP O
50 Call NNP I-NP O
50 HO NNP I-NP O
50 if IN B-VP O
50 BS NNP B-NP O
50 is VBZ O O
50 greater JJR O O
50 than IN B-VP O
50 400 CD O O
51 INSULIN NNP B-NP B-m
51 ASPART NNP I-NP I-m
51 17 CD O B-do
51 UNITS NNP B-NP I-do
51 SC NNP I-NP B-mo
51 AC NNP I-NP B-f
51 Starting VBG O O
51 Today NNP B-NP O
51 ( ( O O
51 8/5 CD O O
51 ) ) O O
52 DIET: NNP B-NP O
52 House NNP I-NP O
52 / VBD B-VP O
52 Low NNP B-NP O
52 chol/low NN I-NP O
52 sat VBD B-VP O
52 fat JJ B-NP O
53 RETURN NNP I-NP O
53 TO NNP I-NP O
53 WORK: NNP I-NP O
53 Not RB O O
53 Applicable NNP B-NP O
54 FOLLOW NNP I-NP O
54 UP NNP I-NP O
54 APPOINTMENT( NNP I-NP O
54 S NNP I-NP O
54 ): NNP I-NP O
55 primary JJ B-NP O
55 care NN I-NP O
55 doctor NN I-NP O
55 1 CD O O
55 week NN B-NP O
55 after IN B-VP O
55 d/c NN B-NP O
55 from IN B-VP O
55 rehab NN B-NP O
55 , , O O
56 ALLERGY: NNP B-NP O
56 NKA NNP I-NP O
57 ADMIT NNP I-NP O
57 DIAGNOSIS: NNP I-NP O
58 r/o NN I-NP O
58 MI NNP I-NP O
59 PRINCIPAL NNP I-NP O
59 DISCHARGE NNP I-NP O
59 DIAGNOSIS NNP I-NP O
59 ;Responsible JJ O O
59 After IN B-VP O
59 Study NNP B-NP O
59 for IN B-VP O
59 Causing NNP B-NP O
59 Admission NNP I-NP O
59 ) ) O O
60 tremor NN B-NP O
61 OTHER NNP I-NP O
61 DIAGNOSIS;Conditions NNP I-NP O
61 , , O O
61 Infections NNP B-NP O
61 , , O O
61 Complications NNP B-NP O
61 , , O O
61 affecting VBG O O
61 Treatment/Stay NNP B-NP O
62 htn NN I-NP O
62 ( ( O O
62 hypertension NN B-NP O
62 ) ) O O
62 dm NN B-NP O
62 ( ( O O
62 diabetes VBZ O O
62 mellitus NN B-NP O
62 ) ) O O
62 afib NN B-NP O
62 ( ( O O
62 atrial JJ B-NP O
63 fibrillation NN I-NP O
63 ) ) O O
63 cad NN B-NP O
63 ( ( O O
63 coronary JJ B-NP O
63 artery NN I-NP O
63 disease NN I-NP O
63 ) ) O O
63 bph NN B-NP O
63 ( ( O O
63 benign JJ B-NP O
63 prostatic JJ I-NP O
64 hypertrophy NN I-NP O
64 ) ) O O
64 gerd NN B-NP O
64 ( ( O O
64 gastroesophageal JJ B-NP O
64 reflux NN I-NP O
64 disease NN I-NP O
64 ) ) O O
64 hiatal NN B-NP O
64 hernia NN I-NP O
65 ( ( O O
65 hiatal JJ B-NP O
65 hernia NN I-NP O
65 ) ) O O
65 djd NN B-NP O
65 ( ( O O
65 degenerative JJ B-NP O
65 joint NN I-NP O
66 disease NN I-NP O
66 ) ) O O
66 pmr NN B-NP O
66 ( ( O O
66 polymyalgia JJ B-NP O
66 rheumatica NN I-NP O
66 ) ) O O
66 diverticulitis NN B-NP O
67 ( ( O O
67 diverticulitis NN B-NP O
67 ) ) O O
67 s/p NN B-NP O
67 AAA NNP I-NP O
67 repair NN I-NP O
67 1994 CD O O
67 ( ( O O
67 10 CD O O
67 ) ) O O
68 OPERATIONS NN B-NP O
68 AND CC O O
68 PROCEDURES: NNP B-NP O
69 none NN I-NP O
70 OTHER NNP I-NP O
70 TREATMENTS/PROCEDURES NNP I-NP O
70 ( ( O O
70 NOT NNP B-NP O
70 IN NNP I-NP O
70 O.R NNP I-NP O
70 ) ) O O
71 none NN B-NP O
72 BRIEF NNP I-NP O
72 RESUME NNP I-NP O
72 OF NNP I-NP O
72 HOSPITAL NNP I-NP O
72 COURSE: NNP I-NP O
73 88 CD O O
73 year NN B-NP O
73 old JJ B-NP O
73 man NN I-NP O
73 who WP O O
73 comes VBZ O O
73 in IN B-VP O
73 from IN B-VP O
73 rehab NN B-NP O
73 with IN B-VP O
73 ?hypothermia NN B-NP O
73 and CC O O
73 rigors NNS B-NP O
73 6 CD O O
74 weeks NNS B-NP O
74 ago RB O O
74 the DT B-NP O
74 patient NN I-NP O
74 was VBD B-VP O
74 diagnosed VBN O O
74 with IN B-VP O
74 osteomyelitis NN B-NP O
74 of IN B-VP O
74 the DT B-NP O
74 finger NN I-NP O
74 He PRP O O
75 had VBD B-VP O
75 a DT B-NP O
75 PICC NNP I-NP O
75 line NN I-NP O
75 placed VBD B-VP O
75 and CC O O
75 was VBD B-VP O
75 discharged VBN O O
75 with IN B-VP O
75 IV NNP B-NP B-mo
75 abx NN I-NP B-m
75 At IN B-VP O
75 the DT B-NP O
75 tail JJ I-NP O
75 end NN I-NP O
75 of IN B-VP O
76 his PRP$ O O
76 antibiotic JJ B-NP B-m
76 regimen NNS I-NP I-m
76 he PRP O O
76 spiked VBD B-VP O
76 a DT B-NP O
76 fever NN I-NP O
76 and CC O O
76 was VBD B-VP O
76 admitted VBN O O
76 to TO O O
76 VOWH VB O O
76 His PRP$ O O
77 course NN B-NP O
77 of IN B-VP O
77 antibiotics NNS B-NP B-m
77 was VBD B-VP O
77 extended VBN O O
77 and CC O O
77 he PRP O O
77 was VBD B-VP O
77 discharged VBN O O
77 to TO O O
77 rehab VB O O
77 on IN B-VP O
78 ceftriaxone NN B-NP B-m
78 and CC O O
78 vanc NN B-NP B-m
78 Today NN I-NP O
78 at IN B-VP O
78 the DT B-NP O
78 nursing NN I-NP O
78 home NN I-NP O
78 he PRP O O
78 was VBD B-VP O
78 observed VBN O O
78 to TO O O
78 be VB O O
79 "shaking" JJ O O
79 and CC O O
79 the DT B-NP O
79 staff NN I-NP O
79 was VBD B-VP O
79 concerned VBN O O
79 for IN B-VP O
79 rigors NNS B-NP O
79 However RB O O
79 , , O O
79 the DT B-NP O
79 patient NN I-NP O
80 says VBZ O O
80 his PRP$ O O
80 hands NNS B-NP O
80 were VBD B-VP O
80 just RB O O
80 quivering VBG O O
80 At IN B-VP O
80 the DT B-NP O
80 time NN I-NP O
80 , , O O
80 his PRP$ O O
80 temp NN B-NP O
80 at IN B-VP O
80 rehab NN B-NP O
80 was VBD B-VP O
80 92 CD O O
81 degrees NNS B-NP O
81 He PRP O O
81 was VBD B-VP O
81 sent VBN O O
81 to TO O O
81 the DT B-NP O
81 ED NNP I-NP O
81 for IN B-VP O
81 evaluation NN B-NP O
82 In IN B-VP O
82 the DT B-NP O
82 ED NNP I-NP O
82 , , O O
82 his PRP$ O O
82 temperature NN B-NP O
82 was VBD B-VP O
82 normal JJ O O
82 He PRP O O
82 was VBD B-VP O
82 not RB O O
82 complaining VBG O O
82 of IN B-VP O
82 further JJ B-NP O
83 chills NNS I-NP O
83 or CC O O
83 rigors NNS B-NP O
83 However RB O O
83 , , O O
83 his PRP$ O O
83 EKG NNP B-NP O
83 demonstrated VBD B-VP O
83 new JJ B-NP O
83 ST NNP I-NP O
83 depressions NNS I-NP O
83 in IN B-VP O
84 V3-V5 NNP B-NP O
84 The DT B-NP O
84 patient NN I-NP O
84 denied VBD B-VP O
84 any DT B-NP O
84 CP/N/SOB/diaphoresis NNP I-NP O
84 His PRP$ O O
84 first JJ B-NP O
84 set NN I-NP O
84 of IN B-VP O
85 enzymes NNS B-NP O
85 were VBD B-VP O
85 negative JJ O O
85 He PRP O O
85 was VBD B-VP O
85 given VBN O O
85 aspirin RP O B-m
86 PMH: NNP B-NP O
86 HTN NNP I-NP O
86 , , O O
86 CAD NNP B-NP O
86 , , O O
86 DM NNP B-NP O
86 , , O O
86 AFib NNP B-NP O
86 , , O O
86 PMR NNP B-NP O
86 , , O O
86 BPH NNP B-NP O
86 , , O O
86 DJD NNP B-NP O
86 , , O O
86 hiatal JJ B-NP O
86 hernia NN I-NP O
86 AAA NNP I-NP O
86 repair NN I-NP O
86 and CC O O
87 sigmoid JJ B-NP O
87 colectomy NN I-NP O
88 All: NNP I-NP O
88 NKDA NNP I-NP O
89 Medications NNP I-NP O
89 on IN B-VP O
89 Admission: NNP B-NP O
89 Lasix NNP I-NP B-m
89 20 CD O B-do
89 qod NN B-NP B-f
89 , , O O
89 Isordil NNP B-NP B-m
89 40 CD O B-do
89 bid NN B-NP B-f
89 , , O O
89 Prednisone NNP B-NP B-m
89 2 CD O B-do
89 qd NN B-NP B-f
89 , , O O
90 Primidone NNP B-NP B-m
90 50 CD O B-do
90 bid NN B-NP B-f
90 , , O O
90 Norvasc NNP B-NP B-m
90 5 CD O B-do
90 qd NN B-NP B-f
90 , , O O
90 Coreg NNP B-NP B-m
90 25 CD O B-do
90 bid NN B-NP B-f
90 , , O O
90 Flomax NNP B-NP B-m
90 0.4 CD O B-do
90 qd NN B-NP B-f
90 , , O O
90 Prilosec NNP B-NP B-m
90 OTC NNP I-NP I-m
91 20 CD O B-do
91 qd NN B-NP B-f
91 , , O O
91 Lipitor NNP B-NP B-m
91 20 CD O B-do
91 qd NN B-NP B-f
91 , , O O
91 ISS NNP B-NP B-m
91 , , O O
91 Lantus NNP B-NP B-m
91 7 CD O B-do
91 qd NN B-NP B-f
91 , , O O
91 Novolog NNP B-NP B-m
91 17 CD O B-do
91 qac NN B-NP B-f
91 , , O O
91 Lovenox NNP B-NP B-m
91 30 CD O B-do
91 qd NN B-NP B-f
91 , , O O
92 Vancomycin NNP B-NP B-m
92 1 CD O B-do
92 gm NN B-NP I-do
92 qod NN I-NP B-f
92 , , O O
92 Ceftriaxone NNP B-NP B-m
92 2 CD O B-do
92 gm NN B-NP I-do
92 qd NN I-NP B-f
92 , , O O
92 Digoxin NNP B-NP B-m
92 0.25 CD O B-do
92 qod NN B-NP B-f
92 , , O O
92 Colace NNP B-NP B-m
92 100 CD O B-do
92 bid NN B-NP B-f
93 Medications NNS I-NP O
93 in IN B-VP O
93 ED: NNP B-NP O
93 NS NNP I-NP B-m
93 500 CD O B-do
93 cc NN B-NP I-do
93 , , O O
93 Aspirin NNP B-NP B-m
94 PE:97.2 NNP I-NP O
94 150/70 CD O O
94 76 CD O O
94 14 CD O O
94 97 CD O O
94 RA NNP B-NP O
95 elderly JJ O O
95 , , O O
95 NAD NNP B-NP O
95 , , O O
95 NCAT NNP B-NP O
95 , , O O
95 JVP NNP B-NP O
95 flat JJ O O
95 , , O O
95 CTAB NNP B-NP O
95 , , O O
95 RRR NNP B-NP O
95 3/6 CD O O
95 SEM NNP B-NP O
95 at IN B-VP O
95 RUSB NNP B-NP O
95 , , O O
95 soft JJ O O
95 , , O O
95 NT/ND NNP B-NP O
95 , , O O
96 guiac NN B-NP O
96 neg NN I-NP O
96 , , O O
96 no DT B-NP O
96 C/C/E NNP I-NP O
96 , , O O
96 fine JJ B-NP O
96 tremor NN I-NP O
96 in IN B-VP O
96 both DT B-NP O
96 hands NNS I-NP O
96 ( ( O O
96 not RB O O
96 pill NN B-NP O
96 rolling VBG O O
96 ) ) O O
96 CN NNP B-NP O
97 grossly RB O O
97 intact JJ O O
97 , , O O
97 no DT B-NP O
97 rashes NNS I-NP O
98 *** VBP O O
99 EKG: NNP B-NP O
99 new JJ B-NP O
99 ST NNP I-NP O
99 depressions NNS I-NP O
99 laterally RB O O
99 with IN B-VP O
99 TWI NNP B-NP O
99 , , O O
99 remained VBD B-VP O
99 unchanged JJ O O
99 through IN B-VP O
100 hospital JJ B-NP O
100 course NN I-NP O
101 Labs: NNP I-NP O
101 notable JJ O O
101 for IN B-VP O
101 negative JJ B-NP O
101 cardiac JJ I-NP O
101 enzymes NNS I-NP O
101 x VBP O O
101 3 CD O O
102 *** JJ B-NP O
103 Hospital NNP I-NP O
103 Course: NNP I-NP O
104 CV: NNP I-NP O
104 The DT B-NP O
104 patient NN I-NP O
104 had VBD B-VP O
104 3 CD O O
104 sets NNS B-NP O
104 of IN B-VP O
104 negative JJ O O
104 cardiac JJ O O
104 enzymes VBZ O O
104 His PRP$ O O
104 EKG NNP B-NP O
104 remained VBD B-VP O
105 unchanged JJ O O
105 It PRP O O
105 is VBZ O O
105 not RB O O
105 clear JJ O O
105 how WRB O O
105 old JJ O O
105 these DT B-NP O
105 EKG NNP I-NP O
105 changes NNS I-NP O
105 may MD O O
105 be VB O O
105 We PRP O O
105 recommend VBP O O
106 outpatient JJ B-NP O
106 stress NN I-NP O
106 test NN I-NP O
106 and CC O O
106 cardiology NN B-NP O
106 follow-up VBP O O
106 The DT B-NP O
106 patient NN I-NP O
106 was VBD B-VP O
107 bradycardic JJ O O
107 to TO O O
107 the DT B-NP O
107 hi NN I-NP O
107 30s CD O O
107 overnight NN B-NP O
107 without IN B-VP O
107 symptoms NNS B-NP O
107 His PRP$ O O
107 EKG NNP B-NP O
107 showed VBD B-VP O
107 A DT B-NP O
107 Fib NNP I-NP O
108 with IN B-VP O
108 no DT B-NP O
108 evidence NN I-NP O
108 of IN B-VP O
108 junctional JJ B-NP O
108 escape NN I-NP O
108 rhythm NN I-NP O
108 or CC O O
108 Digoxin NNP B-NP O
108 toxicity NN I-NP O
108 His PRP$ O O
109 Digoxin NNP B-NP O
109 level NN I-NP O
109 was VBD B-VP O
109 1.9 CD O O
109 His PRP$ O O
109 morning NN B-NP B-f
109 Coreg NNP I-NP B-m
109 was VBD B-VP O
109 held VBN O O
109 and CC O O
109 his PRP$ O O
109 HR NNP B-NP O
109 remained VBD B-VP O
109 in IN B-VP O
110 the DT O O
110 50s CD O O
110 during IN B-VP O
110 the DT B-NP O
110 day NN I-NP O
110 with IN B-VP O
110 no DT B-NP O
110 symptoms NNS I-NP O
110 voiced VBN O O
110 by IN B-VP O
110 the DT B-NP O
110 patient NN I-NP O
110 He PRP O O
110 will MD O O
110 be VB O O
111 discharged VBN O O
111 to TO O O
111 rehab VB O O
111 on IN B-VP O
111 his PRP$ O O
111 admission NN B-NP O
111 regimen VBZ O O
111 The DT B-NP O
111 patient's NN I-NP O
111 A NNP I-NP O
111 Fib NNP I-NP O
111 is VBZ O O
111 old JJ O O
112 and CC O O
112 he PRP O O
112 is VBZ O O
112 currently RB O O
112 anticoagulated VBN O O
112 with IN B-VP O
112 Lovenox NNP B-NP B-m
112 No NNP I-NP O
112 changes NNS I-NP O
112 were VBD B-VP O
112 made VBN O O
112 to TO O O
113 this DT B-NP O
113 regimen NNS I-NP O
114 Neuro: VBP O O
114 The DT B-NP O
114 patient NN I-NP O
114 has VBZ O O
114 a DT B-NP O
114 history NN I-NP O
114 of IN B-VP O
114 tremor NN B-NP B-r
114 and CC O O
114 is VBZ O O
114 treated VBN O O
114 with IN B-VP O
114 Primidone NNP B-NP B-m
115 No NNP I-NP O
115 changes NNS I-NP O
115 were VBD B-VP O
115 made VBN O O
115 to TO O O
115 this DT B-NP O
115 regimen NNS I-NP O
116 ID: VBP O O
116 The DT B-NP O
116 patient NN I-NP O
116 is VBZ O O
116 being VBG O O
116 treated VBN O O
116 for IN B-VP O
116 osteomyelitis NN B-NP B-r
116 osteomyelitis NN I-NP B-r
116 His PRP$ O O
116 Ceftriaxone NN B-NP B-m
116 and CC O O
117 Vancomycin NNP B-NP B-m
117 were VBD B-VP O
117 continued VBN O O
117 His PRP$ O O
117 temperature NN B-NP O
117 remained VBD B-VP O
117 normal JJ O O
117 during IN B-VP O
117 the DT B-NP O
118 hospital JJ I-NP O
118 course NN I-NP O
118 and CC O O
118 no DT B-NP O
118 rigors NNS I-NP O
118 were VBD B-VP O
118 observed VBN O O
118 The DT B-NP O
118 patient NN I-NP O
118 did VBD B-VP O
118 not RB O O
118 complain VB O O
119 of IN B-VP O
119 any DT B-NP O
119 further JJ I-NP O
119 chills NNS I-NP O
119 Blood NNP I-NP O
119 cultures NNS I-NP O
119 showed VBD B-VP O
119 NGTD NNP B-NP O
119 at IN B-VP O
119 the DT B-NP O
119 time NN I-NP O
119 of IN B-VP O
120 discharge NN B-NP O
121 ENDO: NNP I-NP O
121 The DT B-NP O
121 patient NN I-NP O
121 was VBD B-VP O
121 continued VBN O O
121 on IN B-VP O
121 his PRP$ O O
121 outpatient JJ B-NP O
121 regimen NNS I-NP O
121 of IN B-VP O
121 Lantus NNP B-NP B-m
121 , , O O
122 standing VBG O O
122 insulin NN B-NP B-m
122 qAC NN I-NP B-f
122 and CC O O
122 insulin NN B-NP B-m
122 SS NNP I-NP B-do
123 GU: NNP I-NP O
123 The DT B-NP O
123 patient NN I-NP O
123 was VBD B-VP O
123 continued VBN O O
123 on IN B-VP O
123 Flomax NNP B-NP B-m
123 for IN B-VP O
123 his PRP$ O B-r
123 BPH NNP B-NP I-r
124 PPX: NNP I-NP O
124 The DT B-NP O
124 patient NN I-NP O
124 is VBZ O O
124 on IN B-VP O
124 Lovenox NNP B-NP B-m
124 and CC O O
124 required VBN O O
124 no DT B-NP O
124 further JJ I-NP O
124 anticoagulation NN I-NP O
125 Full NNP I-NP O
125 Code NNP I-NP O
126 ADDITIONAL NNP I-NP O
126 COMMENTS: NNP I-NP O
127 DISCHARGE NNP I-NP O
127 CONDITION: NNP I-NP O
127 Stable NNP I-NP O
128 TO NNP I-NP O
128 DO/PLAN: NNP I-NP O
129 Please NNP I-NP O
129 follow VB O O
129 up RP O O
129 with IN B-VP O
129 you PRP O O
129 PCP VBP O O
129 within IN B-VP O
129 2 CD O O
129 weeks NNS B-NP O
130 No RB O O
130 dictated VBD B-VP O
130 summary JJ B-NP O
131 ENTERED NNP I-NP O
131 BY: NNP I-NP O
131 ALLENBACH NNP I-NP O
131 , , O O
131 CORDELL NNP B-NP O
131 W NNP I-NP O
131 , , O O
131 M.D NNP B-NP O
131 , , O O
131 M.B.A NNP B-NP O
131 ( ( O O
131 ZG28 NNP B-NP O
131 ) ) O O
131 10/0/05 CD O O
131 @ $ O O
131 02:50 CD O O
131 PM NNP B-NP O
132 ****** JJ B-NP O
132 END NNP I-NP O
132 OF NNP I-NP O
132 DISCHARGE NNP I-NP O
132 ORDERS NNP I-NP O
132 ****** NNP I-NP O
133 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #789693 VBZ O O
2 783259770 CD O O
2 THO NNP B-NP O
2 08608227 CD O O
2 2588970 CD O O
2 4/11/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Change NNP I-NP O
2 in IN B-VP O
2 mental JJ B-NP O
2 status NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 8/17/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 8/10/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 ALEQUIN NNP I-NP O
5 , , O O
5 GARLAND NNP B-NP O
5 180-38-64-0 CD O O
6 Troit NNP B-NP O
6 West NNP I-NP O
6 Ville NNP I-NP O
6 , , O O
6 North NNP B-NP O
6 Carolina NNP I-NP O
6 93245 CD O O
7 Service: NNP B-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/11/06 CD O O
8 AT NNP B-NP O
8 02:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 WIXSON NNP I-NP O
11 , , O O
11 MATT NNP B-NP O
11 SAMMIE NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
11 , , O O
11 M.P.H NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Skilled VBD B-VP O
14 Nursing NNP B-NP O
14 Facility NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 VITAMIN NNP I-NP B-m
16 C NNP I-NP I-m
16 ( ( O I-m
16 ASCORBIC NNP B-NP I-m
16 ACID NNP I-NP I-m
16 ) ) O I-m
16 500 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 BID NNP I-NP B-f
17 CIPROFLOXACIN NNP I-NP B-m
17 400 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 Q12H NNP I-NP B-f
17 Starting VBG O O
17 Today NNP B-NP O
17 ( ( O O
17 5/29 CD O O
17 ) ) O O
18 Instructions: NNP B-NP O
18 Please NNP I-NP O
18 take VB O O
18 until IN B-VP O
18 3/28/06 CD O O
19 Number NNP B-NP B-du
19 of IN B-VP I-du
19 Doses NNP B-NP I-du
19 Required NNP I-NP I-du
19 ( ( O I-du
19 approximate JJ B-NP I-du
19 ): NN I-NP I-du
19 2 CD O I-du
20 FOLATE NNP B-NP B-m
20 ( ( O I-m
20 FOLIC NNP B-NP I-m
20 ACID NNP I-NP I-m
20 ) ) O I-m
20 1 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 DAILY NNP I-NP B-f
21 LASIX NNP I-NP B-m
21 ( ( O I-m
21 FUROSEMIDE NNP B-NP I-m
21 ) ) O I-m
21 40 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 DAILY NNP I-NP B-f
22 LACTULOSE NNP I-NP B-m
22 30 CD O B-do
22 MILLILITERS NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QID NNP I-NP B-f
22 Starting VBG O O
22 Today NNP B-NP O
22 ( ( O O
22 5/29 CD O O
22 ) ) O O
23 Instructions: NNP B-NP O
23 please NN I-NP O
23 do VB O O
23 not RB O O
23 skip VB O O
23 doses NNS B-NP O
23 even RB O O
23 if IN B-VP O
23 many JJ B-NP O
23 loose JJ I-NP O
24 stools NNS I-NP O
25 FLAGYL NNP I-NP B-m
25 ( ( O I-m
25 METRONIDAZOLE NNP B-NP I-m
25 ) ) O I-m
25 500 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 Q8H NNP I-NP B-f
26 Starting VBG O O
26 Today NNP B-NP O
26 ( ( O O
26 5/29 CD O O
26 ) ) O O
27 Instructions: NNP B-NP O
27 Stop NNP I-NP O
27 taking VBG O O
27 on IN B-VP O
27 3/28/06 CD O O
28 ALDACTONE NNP B-NP B-m
28 ( ( O I-m
28 SPIRONOLACTONE NNP B-NP I-m
28 ) ) O I-m
28 75 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 BID NNP I-NP B-f
29 Food/Drug NNP I-NP O
29 Interaction NNP I-NP O
29 Instruction NNP I-NP O
29 Give NNP I-NP O
29 with IN B-VP O
29 meals NNS B-NP O
30 Override NNP I-NP O
30 Notice: NNP I-NP O
30 Override NNP I-NP O
30 added VBD B-VP O
30 on IN B-VP O
30 5/11/06 CD O O
30 by IN B-VP O
31 STARZYNSKI NNP B-NP O
31 , , O O
31 DANIEL NNP B-NP O
31 O NNP I-NP O
31 , , O O
31 M.D NNP B-NP O
32 on IN B-VP O
32 order NN B-NP O
32 for IN B-VP O
32 KCL NNP B-NP B-m
32 IV NNP I-NP B-mo
32 ( ( O O
32 ref JJ O O
32 # # O O
32 403310506 CD O O
32 ) ) O O
33 SERIOUS NNP B-NP O
33 INTERACTION: NNP I-NP O
33 SPIRONOLACTONE NNP I-NP B-m
33 &amp; NNP I-NP O
33 POTASSIUM NNP I-NP B-m
33 CHLORIDE NNP I-NP I-m
34 Reason NNP I-NP O
34 for IN B-VP O
34 override: NN B-NP O
34 monitoring NN I-NP O
35 THIAMINE NNP I-NP B-m
35 HCL NNP I-NP I-m
35 100 CD O B-do
35 MG NNP B-NP I-do
35 PO NNP I-NP B-mo
35 DAILY NNP I-NP B-f
36 MULTIVITAMIN NNP I-NP B-m
36 THERAPEUTIC NNP I-NP I-m
36 ( ( O I-m
36 THERAPEUTIC NNP B-NP I-m
36 MULTIVI NNP I-NP I-m
36 ) ) O I-m
37 1 CD O B-do
37 TAB NNP B-NP I-do
37 PO NNP I-NP B-mo
37 DAILY NNP I-NP B-f
38 MSIR NNP I-NP B-m
38 ( ( O I-m
38 MORPHINE NNP B-NP I-m
38 IMMEDIATE NNP I-NP I-m
38 RELEASE NNP I-NP I-m
38 ) ) O I-m
38 7.5 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 Q4H NNP I-NP B-f
38 PRN NNP I-NP I-f
38 Pain NNP I-NP B-r
39 FLOVENT NNP I-NP B-m
39 HFA NNP I-NP I-m
39 ( ( O I-m
39 FLUTICASONE NNP B-NP I-m
39 PROPIONATE NNP I-NP I-m
39 ) ) O I-m
39 220 CD O B-do
39 MCG NNP B-NP I-do
39 INH NNP I-NP B-mo
39 BID NNP I-NP B-f
40 CELEXA NNP I-NP B-m
40 ( ( O I-m
40 CITALOPRAM NNP B-NP I-m
40 ) ) O I-m
40 20 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 DAILY NNP I-NP B-f
41 CELECOXIB NNP I-NP B-m
41 100 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 DAILY NNP I-NP O
41 Starting VBG O O
41 Today NNP B-NP O
41 ( ( O O
41 5/29 CD O O
41 ) ) O O
42 PRN NNP B-NP O
42 Pain NNP I-NP B-r
43 Instructions: NNP I-NP O
43 Please NNP I-NP O
43 do VB O O
43 not RB O O
43 increasing VBG O O
43 dosing VBG O O
43 to TO O O
43 BID NNP B-NP O
43 , , O O
44 given VBN O O
44 risk NN B-NP O
44 of IN B-VP O
44 cardiac JJ B-NP O
44 side NN I-NP O
44 effects NNS I-NP O
45 Food/Drug NNP I-NP O
45 Interaction NNP I-NP O
45 Instruction NNP I-NP O
45 Take NNP I-NP O
45 with IN B-VP O
45 food NN B-NP O
46 KEPPRA NNP I-NP B-m
46 ( ( O I-m
46 LEVETIRACETAM NNP B-NP I-m
46 ) ) O I-m
46 1 CD O B-do
46 , , O I-do
46 000 CD O I-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 BID NNP I-NP B-f
47 CALTRATE NNP I-NP B-m
47 600 CD O I-m
47 + NNP B-NP I-m
47 D NNP I-NP I-m
47 ( ( O I-m
47 CALCIUM NNP B-NP I-m
47 CARBONATE NNP I-NP I-m
47 1 CD O I-m
47 , , O I-m
47 500 CD O I-m
47 MG NNP B-NP I-m
47 ( ( O I-m
47 ) ) O I-m
48 1 CD O B-do
48 TAB NNP B-NP I-do
48 PO NNP I-NP B-mo
48 BID NNP I-NP B-f
49 LIDODERM NNP I-NP B-m
49 5% CD O I-m
49 PATCH NNP B-NP I-m
49 ( ( O I-m
49 LIDOCAINE NNP B-NP I-m
49 5% CD O I-m
49 PATCH NNP B-NP I-m
49 ) ) O I-m
49 TOPICAL NNP B-NP B-mo
49 TP NNP I-NP I-mo
49 DAILY NNP I-NP B-f
50 Starting VBG O O
50 Today NNP B-NP O
50 ( ( O O
50 5/29 CD O O
50 ) ) O O
51 Instructions: NNP B-NP O
51 one CD O O
51 to TO O O
51 lumbar VB O O
51 area NN B-NP O
51 apply NN I-NP O
51 for IN B-VP O
51 12 CD O O
51 hr NN B-NP O
51 and CC O O
52 remove VB O O
52 for IN B-VP O
52 12 CD O O
52 hr NN B-NP O
53 NOVOLOG NNP I-NP B-m
53 NOVOLOG NNP I-NP B-m
53 NOVOLOG NNP I-NP B-m
53 NOVOLOG NNP I-NP B-m
53 NOVOLOG NNP I-NP B-m
53 NOVOLOG NNP I-NP B-m
53 NOVOLOG NNP I-NP B-m
53 NOVOLOG NNP I-NP B-m
53 ( ( O I-m
53 ( ( O I-m
53 ( ( O I-m
53 ( ( O I-m
53 ( ( O I-m
53 ( ( O I-m
53 ( ( O I-m
53 ( ( O I-m
53 INSULIN NNP B-NP I-m
53 INSULIN NNP I-NP I-m
53 INSULIN NNP I-NP I-m
53 INSULIN NNP I-NP I-m
53 INSULIN NNP I-NP I-m
53 INSULIN NNP I-NP I-m
53 INSULIN NNP I-NP I-m
53 INSULIN NNP I-NP I-m
53 ASPART NNP I-NP I-m
53 ASPART NNP I-NP I-m
53 ASPART NNP I-NP I-m
53 ASPART NNP I-NP I-m
53 ASPART NNP I-NP I-m
53 ASPART NNP I-NP I-m
53 ASPART NNP I-NP I-m
53 ASPART NNP I-NP I-m
53 ) ) O I-m
53 ) ) O I-m
53 ) ) O I-m
53 ) ) O I-m
53 ) ) O I-m
53 ) ) O I-m
53 ) ) O I-m
53 ) ) O I-m
54 Sliding VBG O B-do
54 Scale NNP B-NP I-do
54 ( ( O B-mo
54 subcutaneously RB O I-mo
54 ) ) O I-mo
54 SC NNP B-NP I-mo
54 AC NNP I-NP B-f
55 If IN B-VP O
55 BS NNP B-NP B-r
55 is VBZ O O
55 less JJR O O
55 than IN B-VP O
55 125 CD O O
55 , , O O
55 then RB O O
55 give VB O O
55 0 CD O B-do
55 units NNS B-NP I-do
55 subcutaneously RB O B-mo
56 If IN B-VP O
56 BS NNP B-NP B-r
56 is VBZ O O
56 125-150 JJ O O
56 , , O O
56 then RB O O
56 give VB O O
56 2 CD O B-do
56 units NNS B-NP I-do
56 subcutaneously RB O B-mo
57 If IN B-VP O
57 BS NNP B-NP B-r
57 is VBZ O O
57 151-200 CD O O
57 , , O O
57 then RB O O
57 give VB O O
57 3 CD O B-do
57 units NNS B-NP I-do
57 subcutaneously RB O B-mo
58 If IN B-VP O
58 BS NNP B-NP B-r
58 is VBZ O O
58 201-250 JJ O O
58 , , O O
58 then RB O O
58 give VB O O
58 4 CD O B-do
58 units NNS B-NP I-do
58 subcutaneously RB O B-mo
59 If IN B-VP O
59 BS NNP B-NP B-r
59 is VBZ O O
59 251-300 JJ O O
59 , , O O
59 then RB O O
59 give VB O O
59 6 CD O B-do
59 units NNS B-NP I-do
59 subcutaneously RB O B-mo
60 If IN B-VP O
60 BS NNP B-NP B-r
60 is VBZ O O
60 301-350 JJ O O
60 , , O O
60 then RB O O
60 give VB O O
60 8 CD O B-do
60 units NNS B-NP I-do
60 subcutaneously RB O B-mo
61 If IN B-VP O
61 BS NNP B-NP B-r
61 is VBZ O O
61 351-400 CD O O
61 , , O O
61 then RB O O
61 give VB O O
61 10 CD O B-do
61 units NNS B-NP I-do
61 subcutaneously RB O B-mo
61 and CC O O
62 call VB O O
62 HO NNP B-NP O
62 Call NNP I-NP O
62 HO NNP I-NP O
62 if IN B-VP O
62 BS NNP B-NP O
62 is VBZ O O
62 greater JJR O O
62 than IN B-VP O
62 400 CD O O
63 MAALOX-TABLETS JJ B-NP B-m
63 QUICK NNP I-NP I-m
63 DISSOLVE/CHEWABLE NNP I-NP I-m
63 1-2 JJ B-NP B-do
63 TAB NNP I-NP I-do
63 PO NNP I-NP B-mo
63 Q6H NNP I-NP B-f
64 PRN NNP I-NP O
64 Upset NNP I-NP B-r
64 Stomach NNP I-NP I-r
65 VITAMIN NNP I-NP B-m
65 K NNP I-NP I-m
65 ( ( O I-m
65 PHYTONADIONE NNP B-NP I-m
65 ) ) O I-m
65 5 CD O B-do
65 MG NNP B-NP I-do
65 PO NNP I-NP B-mo
65 DAILY NNP I-NP B-f
66 PROTONIX NNP I-NP B-m
66 ( ( O I-m
66 PANTOPRAZOLE NNP B-NP I-m
66 ) ) O I-m
66 40 CD O B-do
66 MG NNP B-NP I-do
66 PO NNP I-NP B-mo
66 DAILY NNP I-NP B-f
67 TOPROL NNP I-NP B-m
67 XL NNP I-NP I-m
67 ( ( O I-m
67 METOPROLOL NNP B-NP I-m
67 SUCCINATE NNP I-NP I-m
67 EXTENDED NNP I-NP I-m
67 RELEASE NNP I-NP I-m
67 ) ) O I-m
68 50 CD O B-do
68 MG NNP B-NP I-do
68 PO NNP I-NP B-mo
68 DAILY NNP I-NP B-f
68 Food/Drug NNP I-NP O
68 Interaction NNP I-NP O
68 Instruction NNP I-NP O
69 Take NNP I-NP O
69 consistently RB O O
69 with IN B-VP O
69 meals NNS B-NP O
69 or CC O O
69 on IN B-VP O
69 empty JJ B-NP O
69 stomach NN I-NP O
70 MAGNESIUM NNP I-NP B-m
70 OXIDE NNP I-NP I-m
70 420 CD O B-do
70 MG NNP B-NP I-do
70 PO NNP I-NP B-mo
70 BID NNP I-NP B-f
71 DIET: NNP I-NP O
71 House NNP I-NP O
71 / VBD B-VP O
71 2 CD O O
71 gm NN B-NP O
71 Na NNP I-NP O
71 / NNP I-NP O
71 low JJ B-NP O
71 protein NN I-NP O
71 (I) NN I-NP O
71 (FDI) NNP I-NP O
72 DIET: NNP I-NP O
72 2 CD O O
72 gram NN B-NP O
72 Sodium NNP I-NP O
73 ACTIVITY: NNP I-NP O
73 Resume NNP I-NP O
73 regular JJ B-NP O
73 exercise NN I-NP O
74 FOLLOW NNP I-NP O
74 UP NNP I-NP O
74 APPOINTMENT( NNP I-NP O
74 S NNP I-NP O
74 ): NNP I-NP O
75 Dr NNP I-NP O
75 Gillogly NNP I-NP O
75 rheumatology VBZ O O
75 - : O O
75 arthritis NN B-NP O
75 center NN I-NP O
75 312-483-9315 JJ O O
75 8/15 CD O O
75 @ JJ O O
75 12:30 CD O O
75 pm NN B-NP O
75 scheduled VBN O O
75 , , O O
76 Dr NNP B-NP O
76 Mikos NNP I-NP O
76 IMC NNP I-NP O
76 6/18 CD O O
76 @ NNP B-NP O
76 2:30 CD O O
76 scheduled VBN O O
76 , , O O
77 Dr NNP B-NP O
77 Cramblit NNP I-NP O
77 - : O O
77 please NN B-NP O
77 call NN I-NP O
77 for IN B-VP O
77 appointment NN B-NP O
77 Next NNP I-NP O
77 available JJ O O
77 , , O O
78 ALLERGY: NNP B-NP O
78 HALOPERIDOL NNP I-NP O
78 , , O O
78 LORAZEPAM NNP B-NP O
79 ADMIT NNP I-NP O
79 DIAGNOSIS: NNP I-NP O
80 Change NNP I-NP O
80 in IN B-VP O
80 mental JJ B-NP O
80 status NN I-NP O
81 PRINCIPAL NNP I-NP O
81 DISCHARGE NNP I-NP O
81 DIAGNOSIS NNP I-NP O
81 ;Responsible JJ O O
81 After IN B-VP O
81 Study NNP B-NP O
81 for IN B-VP O
81 Causing NNP B-NP O
81 Admission NNP I-NP O
81 ) ) O O
82 Change NNP B-NP O
82 in IN B-VP O
82 mental JJ B-NP O
82 status NN I-NP O
83 OTHER NNP I-NP O
83 DIAGNOSIS;Conditions NNP I-NP O
83 , , O O
83 Infections NNP B-NP O
83 , , O O
83 Complications NNP B-NP O
83 , , O O
83 affecting VBG O O
83 Treatment/Stay NNP B-NP O
84 s/p JJ B-NP O
84 gi NNS I-NP O
84 bleed VBP O O
84 ( ( O O
84 S/P NNP B-NP O
84 upper NNP I-NP O
84 GI NNP I-NP O
84 bleeding VBG O O
84 ) ) O O
84 EtOH NNP B-NP O
84 abuse NN I-NP O
84 ( ( O O
84 alcohol JJ B-NP O
84 abuse NN I-NP O
84 ) ) O O
85 coagulopathy NN B-NP O
86 cirrhosis NN I-NP O
86 , , O O
86 hepatic JJ B-NP O
86 encephalopathy NN I-NP O
86 COPD NNP I-NP O
86 ( ( O O
86 chronic JJ O O
86 obstructive VBP O O
86 pulmonary JJ B-NP O
87 disease NN I-NP O
87 ) ) O O
87 fracture NN B-NP O
87 of IN B-VP O
87 left JJ B-NP O
87 hand NN I-NP O
87 - : O O
87 2nd/3rd CD O O
87 metacarpals NNS B-NP O
87 , , O O
87 4th/5th CD O O
87 proximal JJ B-NP O
88 phalanges NNS I-NP O
89 OPERATIONS NNP I-NP O
89 AND NNP I-NP O
89 PROCEDURES: NNP I-NP O
90 OTHER NNP I-NP O
90 TREATMENTS/PROCEDURES NNP I-NP O
90 ( ( O O
90 NOT NNP B-NP O
90 IN NNP I-NP O
90 O.R NNP I-NP O
90 ) ) O O
91 Chest NNP B-NP O
91 x-ray NN I-NP O
91 , , O O
91 head NN B-NP O
91 CT NNP I-NP O
91 , , O O
91 right JJ B-NP O
91 upper NN I-NP O
91 quadrant NN I-NP O
91 ultrasound NN I-NP O
91 , , O O
91 right JJ B-NP O
91 lower JJR I-NP O
92 extremity NN I-NP O
92 ultrasound JJ B-NP O
93 BRIEF NNP I-NP O
93 RESUME NNP I-NP O
93 OF NNP I-NP O
93 HOSPITAL NNP I-NP O
93 COURSE: NNP I-NP O
94 CC: NNP I-NP O
94 Change NNP I-NP O
94 in IN B-VP O
94 mental JJ B-NP O
94 status NN I-NP O
95 ----- NNP I-NP O
96 HPI: NNP I-NP O
96 57 CD O O
96 yo NN B-NP O
96 F NNP I-NP O
96 with IN B-VP O
96 complex JJ B-NP O
96 PMH NNP I-NP O
96 including VBG O O
96 squamous JJ B-NP O
97 cell NN I-NP O
97 lung NN I-NP O
97 cancer NN I-NP O
97 s/p NN I-NP O
97 RML NNP I-NP O
97 lobectomy NN I-NP O
97 3/29 CD O O
97 Has NNP B-NP O
97 h/o VBN O O
97 cirrhosis NN B-NP O
97 and CC O O
98 hepatic JJ B-NP O
98 encephalopathy NN I-NP O
98 Came NNP I-NP O
98 to TO O O
98 ED NNP B-NP O
98 obtunded NNP I-NP O
98 ( ( O O
98 no DT B-NP O
98 spontaneous JJ I-NP O
98 conversation NN I-NP O
98 ) ) O O
99 with IN B-VP O
99 decreased VBN O O
99 BP NNP B-NP O
99 Reportedly RB O O
99 received VBD B-VP O
99 all DT O O
99 of IN B-VP O
99 her PRP$ O O
99 medications NNS B-NP O
99 as IN B-VP O
100 prescribed VBN O O
100 in IN B-VP O
100 morning NN B-NP O
100 at IN B-VP O
100 her PRP$ O O
100 nursing NN B-NP O
100 home NN I-NP O
100 In IN B-VP O
100 ED NNP B-NP O
100 , , O O
100 received VBD B-VP O
100 thiamine NN B-NP B-m
100 and CC O O
101 narcan JJ B-NP B-m
101 Became NNP I-NP O
101 more RBR O O
101 responsive JJ O O
101 and CC O O
101 uncomfortable JJ O O
101 after IN B-VP O
101 narcan JJ B-NP B-m
101 Ammonia NNP I-NP O
102 level NN I-NP O
102 elevated VBD B-VP O
102 at IN B-VP O
102 233 CD O O
103 ----- JJ B-NP O
104 PMH: NNP I-NP O
105 ++Lung NNP I-NP O
105 cancer NN I-NP O
105 - : O O
105 squamous JJ B-NP O
105 cell NN I-NP O
105 , , O O
105 s/p JJ B-NP O
105 RML NNP I-NP O
105 lobectomy NN I-NP O
105 and CC O O
105 RUL NNP B-NP O
105 wedge VBP O O
105 resection NN B-NP O
106 ++Cirrhosis NN I-NP O
106 - : O O
106 alcoholic NN B-NP O
106 and CC O O
106 hep NN B-NP O
106 C NNP I-NP O
106 virus NN I-NP O
106 , , O O
106 h/o JJ B-NP O
106 esophageal NN I-NP O
106 varices NNS I-NP O
106 and CC O O
106 GI NNP B-NP O
107 bleed VBD B-VP O
108 ++COPD NNP B-NP O
108 - : O O
108 not RB O O
108 on IN B-VP O
108 home NN B-NP O
108 oxygen NN I-NP O
109 ++HTN NNP I-NP O
110 ++PVD NNP I-NP O
111 ++Seizure NN I-NP B-r
111 disorder NN I-NP I-r
111 - : O O
111 on IN B-VP O
111 Keppra NNP B-NP B-m
112 ++h/o NNP I-NP O
112 SDH NNP I-NP O
112 - : O O
112 had VBD B-VP O
112 craniotomy JJ B-NP O
113 ++large NNP I-NP O
113 abdominal JJ B-NP O
113 ventral JJ I-NP O
113 hernia NN I-NP O
114 ++chronic NNP I-NP O
114 back RB O O
114 pain VBP O O
114 - : O O
114 known VBN O O
114 spinal JJ B-NP O
114 compression NN I-NP O
114 fractures NNS I-NP O
114 at IN B-VP O
114 T8 NNP B-NP O
114 and CC O O
115 bilateral JJ B-NP O
115 sacral JJ I-NP O
115 insufficiency NN I-NP O
115 fractures NNS I-NP O
116 ----- VBP O O
117 SHx: NNP B-NP O
117 Nursing NNP I-NP O
117 home NN I-NP O
117 resident NN I-NP O
117 for IN B-VP O
117 past JJ O O
117 2 CD O O
117 years NNS B-NP O
117 30 CD O O
117 pack-year JJ O O
117 smoking VBG O O
118 history NN B-NP O
118 Significant NNP I-NP O
118 EtOH NNP I-NP O
118 history NN I-NP O
118 Has NNP I-NP O
118 2 CD O O
118 daughters NNS B-NP O
118 involved VBN O O
118 in IN B-VP O
118 her PRP$ O O
118 care NN B-NP O
119 ----- JJ B-NP O
120 FHx: NNP I-NP O
120 Mother NNP I-NP O
120 COPD NNP I-NP O
120 , , O O
120 Father NNP B-NP O
120 prostate NN I-NP O
120 cancer NN I-NP O
120 / NNP I-NP O
120 CAD NNP I-NP O
121 ----- NNP I-NP O
122 Admit NNP I-NP O
122 PE: NNP I-NP O
122 T NNP I-NP O
122 96.5 CD O O
122 P NNP B-NP O
122 64 CD O O
122 BP NNP B-NP O
122 98/53 CD O O
122 RR NNP B-NP O
122 14 CD O O
122 SaO2 NNP B-NP O
122 93%RA CD O O
122 97%3L CD O O
123 Gen NNP B-NP O
123 - : O O
123 Awakens NNS B-NP O
123 briefly VBP O O
123 when WRB O O
123 spoken VBN O O
123 to TO O O
123 Able VB O O
123 to TO O O
123 respond VB O O
123 only RB O O
123 with IN B-VP O
123 single JJ B-NP O
124 words NNS I-NP O
124 to TO O O
124 simple VB O O
124 questions NNS B-NP O
124 Appears NNP I-NP O
124 sedated VBD B-VP O
125 HEENT NNP B-NP O
125 - : O O
125 PERRL NN B-NP O
125 , , O O
125 scleral JJ B-NP O
125 icterus NN I-NP O
126 NECK NNP I-NP O
126 - : O O
126 No DT B-NP O
126 LAN NNP I-NP O
126 , , O O
126 no DT B-NP O
126 bruits NNS I-NP O
126 , , O O
126 JVP NNP B-NP O
126 flat JJ B-NP O
127 CHEST NNP I-NP O
127 - : O O
127 Bilateral NNP B-NP O
127 expiratory NN I-NP O
127 wheezes VBZ O O
128 HEART NNP B-NP O
128 - : O O
128 RRR NNP B-NP O
128 , , O O
128 nl JJ B-NP O
128 S1/S2 NNP I-NP O
128 , , O O
128 no DT B-NP O
128 m/r/g NN I-NP O
129 ABD NNP I-NP O
129 - : O O
129 Full-appearing NN B-NP O
129 , , O O
129 large JJ B-NP O
129 ventral JJ I-NP O
129 hernia NN I-NP O
129 , , O O
129 multiple JJ B-NP O
129 scars NNS I-NP O
129 , , O O
129 soft JJ O O
129 , , O O
130 non-tender JJ O O
130 , , O O
130 +BS NNP B-NP O
130 , , O O
130 no DT B-NP O
130 masses NNS I-NP O
130 , , O O
130 no DT B-NP O
130 HSM NNP I-NP O
131 EXT NNP I-NP O
131 - : O O
131 1+ CD O O
131 edema NN B-NP O
131 bilaterally RB O O
131 ( ( O O
131 R&gt;L NNP B-NP O
131 ) ) O O
132 SKIN NNP B-NP O
132 - : O O
132 jaundiced VBD B-VP O
132 , , O O
132 palmar NN B-NP O
132 erythema NN I-NP O
132 , , O O
132 bruises VBZ O O
132 spread VBP O O
132 diffusely RB O O
133 RECTAL NNP B-NP O
133 - : O O
133 Guaiac NNP B-NP O
133 pos NN I-NP O
133 , , O O
133 light JJ B-NP O
133 brown JJ I-NP O
133 soft JJ I-NP O
133 stool NN I-NP O
134 NEURO NNP I-NP O
134 - : O O
134 Oriented VBN O O
134 to TO O O
134 place NN B-NP O
134 and CC O O
134 person NN B-NP O
134 Year NNP I-NP O
134 is VBZ O O
134 "1993" JJ B-NP O
134 Drifting NNP I-NP O
134 in IN B-VP O
134 and CC O O
134 out IN B-VP O
135 of IN B-VP O
135 ability NN B-NP O
135 to TO O O
135 communicate VB O O
135 Perseverates NNS B-NP O
135 on IN B-VP O
135 answers NNS B-NP O
135 to TO O O
135 questions: VB O O
135 this DT O O
135 is VBZ O O
136 a DT O O
136 "hospital JJ O O
136 , , O O
136 hospital NN B-NP O
136 , , O O
136 hospital" NN B-NP O
136 , , O O
136 CN NNP B-NP O
136 II NNP I-NP O
136 through IN B-VP O
136 XII NNP B-NP O
136 intact JJ O O
136 , , O O
136 DTR's NNP B-NP O
136 2+ CD O O
137 symmetric NN B-NP O
137 in IN B-VP O
137 LE NNP B-NP O
137 + NNP I-NP O
137 UE NNP I-NP O
137 , , O O
137 toes VBZ O O
137 downgoing VBG O O
137 bilaterally RB O O
138 ----- JJ B-NP O
139 Studies: NNP I-NP O
140 +CXR NNP I-NP O
140 7/6 CD O O
140 - : O O
140 no DT B-NP O
140 acute JJ I-NP O
140 cardiopulmonary JJ I-NP O
140 process NN I-NP O
141 +Head VBD B-VP O
141 CT NNP B-NP O
141 7/6 CD O O
141 - : O O
141 negative JJ O O
142 +RUQ VBP O O
142 US PRP O O
142 7/6 CD O O
142 - : O O
142 gallstones NNS B-NP O
142 , , O O
142 biliary JJ B-NP O
142 sludge NN I-NP O
143 +RLE NNP I-NP O
143 LENI NNP I-NP O
143 7/6 CD O O
143 - : O O
143 neg NN B-NP O
143 for IN B-VP O
143 DVT NNP B-NP O
144 ----- NNP I-NP O
145 Hospital NNP I-NP O
145 Course: NNP I-NP O
146 57 CD O O
146 yo NN B-NP O
146 F NNP I-NP O
146 with IN B-VP O
146 complex JJ B-NP O
146 medical JJ I-NP O
146 history NN I-NP O
146 here RB O O
146 with IN B-VP O
146 mental JJ B-NP O
146 status NN I-NP O
147 change NN I-NP O
147 likely RB O O
147 secondary JJ O O
147 to TO O O
147 hepatic JJ B-NP O
147 encephalopathy NN I-NP O
147 with IN B-VP O
147 some DT B-NP O
147 component NN I-NP O
147 of IN B-VP O
148 medication-induced JJ B-NP O
148 delirium NN I-NP O
148 ( ( O O
148 from IN B-VP O
148 opiates NNS B-NP B-m
148 ) ) O O
149 ++Mental VBP O B-r
149 Status NNP B-NP I-r
149 - : O O
149 Avoided VBD B-VP O
149 increasing VBG O O
149 narcotics NNS B-NP B-m
149 Given NNP I-NP O
149 lactulose VBD B-VP B-m
149 QID NNP B-NP B-f
150 Mental NNP I-NP O
150 status NN I-NP O
150 improved VBD B-VP O
150 significantly RB O O
150 in IN B-VP O
150 first JJ O O
150 24 CD O O
150 hours NNS B-NP O
150 of IN B-VP O
151 hospitalization NN B-NP O
151 Patient NNP I-NP O
151 then RB O O
151 remained VBD B-VP O
151 at IN B-VP O
151 her PRP$ O O
151 baseline NN B-NP O
151 mental NN I-NP O
151 status NN I-NP O
151 for IN B-VP O
152 rest NN B-NP O
152 of IN B-VP O
152 hospital NN B-NP O
152 stay NN I-NP O
153 ++MSK NNP I-NP O
153 - : O O
153 Patient NN B-NP O
153 has VBZ O O
153 history NN B-NP O
153 of IN B-VP O
153 chronic JJ O O
153 low JJ O O
153 back RB O O
153 pain NN B-NP O
153 that WDT O O
153 is VBZ O O
154 likely JJ O O
154 related VBN O O
154 to TO O O
154 bilateral JJ B-NP O
154 sacral JJ I-NP O
154 insufficiency NN I-NP O
154 fractures NNS I-NP O
154 seen VBN O O
154 on IN B-VP O
154 MRI NNP B-NP O
154 on IN B-VP O
155 5/1/06 CD O O
155 We PRP O O
155 avoided VBD B-VP O
155 increasing VBG O O
155 her PRP$ O O
155 narcotic JJ B-NP B-m
155 dose NN I-NP O
155 for IN B-VP O
155 concern NN B-NP O
155 of IN B-VP O
155 her PRP$ O O
156 altered JJ B-NP O
156 mental JJ I-NP O
156 status NN I-NP O
156 Pain NNP I-NP B-r
156 was VBD B-VP O
156 controlled VBN O O
156 effectively RB O O
156 with IN B-VP O
156 MSIR NNP B-NP B-m
156 prn NN I-NP B-f
156 , , O O
157 celecoxib JJ B-NP B-m
157 daily JJ I-NP B-f
157 prn NN I-NP I-f
157 ( ( O O
157 should MD O O
157 not RB O O
157 increase VB O O
157 to TO O O
157 bid VB O O
157 given VBN O O
157 ? . B-VP O
157 increase NN B-NP O
157 risk NN I-NP O
157 of IN B-VP O
158 cardiac JJ B-NP O
158 side NN I-NP O
158 effects NNS I-NP O
158 ) ) O O
158 , , O O
158 and CC O O
158 a DT B-NP O
158 lidoderm JJ I-NP B-m
158 patch NN I-NP I-m
158 over IN B-VP O
158 her PRP$ O O
158 lower JJR B-NP O
158 back NN I-NP O
158 Other JJ B-NP O
159 NSAIDS NNP I-NP B-m
159 were VBD B-VP O
159 avoided VBN O O
159 given VBN O O
159 h/o RBR O O
159 GI NNP B-NP O
159 bleed NN I-NP O
159 Patient NNP I-NP O
159 is VBZ O O
159 scheduled VBN O O
159 to TO O O
159 f/u VB O O
159 with IN B-VP O
160 Dr NNP B-NP O
160 Stayner NNP I-NP O
160 ( ( O O
160 Rheumatology NNP B-NP O
160 ) ) O O
160 for IN B-VP O
160 management NN B-NP O
160 of IN B-VP O
160 her PRP$ O O
160 back NN B-NP O
160 pain NN I-NP O
160 and CC O O
161 consideration NN B-NP O
161 of IN B-VP O
161 sacroplasty JJ B-NP O
161 Patient NNP I-NP O
161 should MD O O
161 be VB O O
161 seen VBN O O
161 by IN B-VP O
161 PT NNP B-NP O
161 at IN B-VP O
161 her PRP$ O O
161 nursing NN B-NP O
162 home NN I-NP O
162 to TO O O
162 help VB O O
162 her PRP$ O O
162 with IN B-VP O
162 her PRP$ O O
162 walking VBG O O
163 ++GI/ID JJ O O
163 - : O O
163 Had VBD B-VP O
163 low-grade JJ B-NP O
163 fevers NNS I-NP O
163 overnight MD O O
163 on IN B-VP O
163 HD NNP B-NP O
163 1 CD O O
163 and CC O O
163 2 CD O O
163 Patient NNP B-NP O
163 had VBD B-VP O
163 mild VBN O O
164 RUQ NNP B-NP O
164 tenderness NN I-NP O
164 which WDT O O
164 raised VBD B-VP O
164 a DT B-NP O
164 question NN I-NP O
164 of IN B-VP O
164 possible JJ B-NP O
164 GI NNP I-NP O
164 / NNP I-NP O
164 biliary JJ B-NP O
164 source NN I-NP O
164 of IN B-VP O
165 infection NN B-NP O
165 Blood NNP I-NP O
165 cultures NNS I-NP O
165 were VBD B-VP O
165 positive JJ O O
165 for IN B-VP O
165 coag JJ B-NP B-r
165 coag JJ I-NP B-r
165 negative JJ I-NP I-r
165 negative JJ I-NP I-r
165 staph NN I-NP I-r
165 staph NN I-NP I-r
165 in IN B-VP O
165 2/4 CD O O
166 bottles NNS B-NP O
166 She PRP O O
166 was VBD B-VP O
166 treated VBN O O
166 with IN B-VP O
166 Ciprofloxacin NNP B-NP B-m
166 and CC O O
167 Metronidazol NNP B-NP B-m
167 starting VBG O O
167 on IN B-VP O
167 HD NNP B-NP O
167 1 CD O O
167 , , O O
167 and CC O O
167 vancomycin NN B-NP B-m
167 until IN B-VP B-du
167 speciation NN B-NP O
167 of IN B-VP O
167 blood NN B-NP O
168 cultures NNS I-NP O
168 Blood NNP I-NP O
168 cultures NNS I-NP O
168 repeated VBD B-VP O
168 on IN B-VP O
168 2/3 CD O O
168 and CC O O
168 9/5 CD O O
169 were VBD B-VP O
169 negative JJ O O
169 to TO O O
169 date NN B-NP O
169 Coag NNP I-NP O
169 neg CC O O
169 staph JJ B-NP O
169 blood NN I-NP O
169 cultures NNS I-NP O
169 were VBD B-VP O
169 thought VBN O O
169 to TO O O
169 be VB O O
170 due JJ O O
170 to TO O O
170 contamination NN B-NP O
170 Patient NNP I-NP O
170 has VBZ O O
170 remained VBN O O
170 afebrile JJ O O
170 and CC O O
170 abdominal JJ B-NP O
171 tenderness NN I-NP O
171 has VBZ O O
171 resolved VBN O O
171 over IN B-VP O
171 hospital JJ B-NP O
171 stay NN I-NP O
171 Vancomycin NNP I-NP B-m
171 was VBD B-VP O
171 discontinued VBN O O
172 on IN B-VP O
172 HD NNP B-NP O
172 3 CD O O
172 and CC O O
172 Cipro NNP B-NP B-m
172 and CC O O
172 Flagyl NNP B-NP B-m
172 were VBD B-VP O
172 continued VBN O O
172 She PRP O O
172 was VBD B-VP O
172 discharged VBN O O
172 with IN B-VP O
173 instructions NNS B-NP O
173 to TO O O
173 complete VB O O
173 a DT B-NP O
173 14-day JJ I-NP O
173 course NN I-NP O
173 of IN B-VP O
173 Cipro NNP B-NP B-m
173 and CC O O
173 Flagyl NNP B-NP B-m
173 Her NNP I-NP O
173 WBC NNP I-NP O
174 count NN I-NP O
174 and CC O O
174 platelets NNS B-NP O
174 decreased VBN O O
174 gradually RB O O
174 throughout IN B-VP O
174 her PRP$ O O
174 hospital NN B-NP O
174 stay NN I-NP O
174 and CC O O
175 were VBD B-VP O
175 3.88 CD O O
175 and CC O O
175 122 CD O O
175 respectively RB O O
175 A NNP B-NP O
175 CBC NNP I-NP O
175 should MD O O
175 be VB O O
175 checked VBN O O
175 on IN B-VP O
175 Monday NNP B-NP O
175 3/21 CD O O
175 to TO O O
176 make VB O O
176 sure JJ O O
176 that IN B-VP O
176 she PRP O O
176 is VBZ O O
176 not RB O O
176 becoming VBG O O
176 neutropenic JJ O O
176 or CC O O
176 thrombocytopenic JJ O O
177 ++Pulm SYM O O
177 - : O O
177 The DT B-NP O
177 possibility NN I-NP O
177 of IN B-VP O
177 PE NNP B-NP O
177 was VBD B-VP O
177 considered VBN O O
177 given VBN O O
177 lower JJR B-NP O
177 extremity NN I-NP O
178 swelling NN I-NP O
178 and CC O O
178 her PRP$ O O
178 change NN B-NP O
178 in IN B-VP O
178 mental JJ B-NP O
178 status NN I-NP O
178 Given VBN O O
178 that IN B-VP O
178 she PRP O O
178 was VBD B-VP O
178 at IN B-VP O
178 her PRP$ O O
179 baseline NN B-NP O
179 oxygen NN I-NP O
179 requirement NN I-NP O
179 and CC O O
179 had VBD B-VP O
179 negative JJ B-NP O
179 LENIs NNP I-NP O
179 , , O O
179 PE NNP B-NP O
179 was VBD B-VP O
179 thought VBN O O
179 to TO O O
179 be VB O O
180 low JJ B-NP O
180 probability NN I-NP O
180 She PRP O O
180 remained VBD B-VP O
180 at IN B-VP O
180 her PRP$ O O
180 baseline NN B-NP O
180 oxygen NN I-NP O
180 saturation NN I-NP O
180 ( ( O O
180 93-98% CD O O
181 on IN B-VP O
181 room NN B-NP O
181 air NN I-NP O
181 ) ) O O
181 for IN B-VP O
181 the DT B-NP O
181 duration NN I-NP O
181 of IN B-VP O
181 her PRP$ O O
181 hospitalization NN B-NP O
181 Given NNP I-NP O
181 flovent NN I-NP B-m
181 for IN B-VP O
182 known VBN O B-r
182 COPD NNP B-NP I-r
183 ++CV NNP I-NP O
183 - : O O
183 EKG NN B-NP O
183 at IN B-VP O
183 admission NN B-NP O
183 was VBD B-VP O
183 unchanged JJ O O
183 from IN B-VP O
183 previous JJ B-NP O
183 EKGs NNP I-NP O
183 Patient's NNP I-NP O
183 dose NN I-NP O
184 of IN B-VP O
184 Lopressor NNP B-NP B-m
184 was VBD B-VP O
184 decreased VBN O O
184 , , O O
184 given VBN O O
184 her PRP$ O O
184 low JJ B-NP O
184 BP NNP I-NP O
184 at IN B-VP O
184 time NN B-NP O
184 of IN B-VP O
184 admission NN B-NP O
184 Her NNP I-NP O
185 heart NN I-NP O
185 rate NN I-NP O
185 and CC O O
185 blood NN B-NP O
185 pressure NN I-NP O
185 remained VBD B-VP O
185 in IN B-VP O
185 the DT B-NP O
185 normal JJ I-NP O
185 range NN I-NP O
185 throughout IN B-VP O
185 her PRP$ O O
186 admission NN B-NP O
187 ++Endo: NN I-NP O
187 MRI NNP I-NP O
187 read VBD B-VP O
187 from IN B-VP O
187 0/12/06 CD O O
187 showed VBD B-VP O
187 evidence NN B-NP O
187 of IN B-VP O
187 osteoporosis NN B-NP O
187 Started NNP I-NP O
188 caltrate NN I-NP B-m
188 , , O O
188 vit NN B-NP B-m
188 D NNP I-NP I-m
188 Unable NNP I-NP O
188 to TO O O
188 give VB O O
188 fosamax NN B-NP B-m
188 because IN B-VP O
188 of IN B-VP O
188 history NN B-NP O
188 of IN B-VP O
188 esophageal JJ B-NP O
189 varices NNS I-NP O
189 Giving VBG O O
189 zometa NN B-NP B-m
189 x $ O B-du
189 1 CD O I-du
189 Corrected NNP B-NP O
189 calcium NN I-NP O
189 was VBD B-VP O
189 normal JJ B-NP O
189 Will NNP I-NP O
189 need MD O O
189 to TO O O
190 re-check VB O O
190 calcium NN B-NP B-m
190 in IN B-VP O
190 1 CD O B-du
190 week NN B-NP I-du
191 ++FEN SYM O O
191 - : O O
191 Given VBN O O
191 thiamine NN B-NP B-m
191 , , O O
191 folate NN B-NP B-m
191 , , O O
191 fluids NNS B-NP B-m
191 , , O O
191 Is/Os NNP B-NP O
191 , , O O
191 weights NNS B-NP O
192 ++PPX VBP O O
192 - : O O
192 Lovenox NNP B-NP B-m
192 , , O O
192 nexium NN B-NP B-m
192 , , O O
192 aspiration NN B-NP O
192 precautions NNS I-NP O
193 ADDITIONAL NNP I-NP O
193 COMMENTS: NNP I-NP O
193 You PRP O O
193 are VBP O O
193 being VBG O O
193 discharged VBN O O
193 from IN B-VP O
193 the DT B-NP O
193 hospital NN I-NP O
193 to TO O O
193 your PRP$ O O
193 nursing NN B-NP O
193 home NN I-NP O
193 in IN B-VP O
194 Smerfortn NNP B-NP O
194 Blvd NNP I-NP O
194 , , O O
194 Stin NNP B-NP O
194 with IN B-VP O
194 a DT B-NP O
194 few JJ I-NP O
194 changes NNS I-NP O
194 in IN B-VP O
194 your PRP$ O O
194 medications NNS B-NP O
194 We PRP O O
194 have VBP O O
194 changed VBN O O
194 your PRP$ O O
194 pain NN B-NP B-m
194 pain NN I-NP B-r
195 medication NN I-NP O
195 to TO O O
195 MSIR NNP B-NP B-m
195 every DT O B-f
195 4 CD O I-f
195 hr NN B-NP I-f
195 as IN B-VP I-f
195 needed VBN O I-f
195 , , O O
195 celebrex NN B-NP B-m
195 , , O O
195 and CC O O
195 lidoderm JJ B-NP B-m
195 patch NN I-NP I-m
196 Please NNP I-NP O
196 call VB O O
196 your PRP$ O O
196 doctor NN B-NP O
196 if IN B-VP O
196 you PRP O O
196 are VBP O O
196 feeling VBG O O
196 that IN B-VP O
196 your PRP$ O O
196 thinking NN B-NP O
196 is VBZ O O
196 not RB O O
197 clear JJ O O
197 or CC O O
197 if IN B-VP O
197 you PRP O O
197 start VBP O O
197 to TO O O
197 have VB O O
197 fevers NNS B-NP O
197 And CC O O
197 please VB O O
197 return NN B-NP O
197 to TO O O
197 the DT B-NP O
197 emergency NN I-NP O
198 department NN I-NP O
198 if IN B-VP O
198 you PRP O O
198 are VBP O O
198 having VBG O O
198 increased VBN O O
198 abdominal JJ B-NP O
198 pain NN I-NP O
198 , , O O
198 chest NN B-NP O
198 pain NN I-NP O
198 , , O O
199 difficulty NN B-NP O
199 breathing NN I-NP O
199 , , O O
199 or CC O O
199 other JJ O O
199 concerning VBG O O
199 symptoms NNS B-NP O
199 You PRP O O
199 should MD O O
199 have VB O O
199 your PRP$ O O
200 blood NN B-NP O
200 counts NNS I-NP O
200 checked VBD B-VP O
200 on IN B-VP O
200 Monday NNP B-NP O
200 and CC O O
200 your PRP$ O O
200 calcium NN B-NP O
200 checked VBD B-VP O
200 next JJ B-NP O
200 week NN I-NP O
201 DISCHARGE NNP I-NP O
201 CONDITION: NNP I-NP O
201 Stable NNP I-NP O
202 TO NNP I-NP O
202 DO/PLAN: NNP I-NP O
203 Follow NNP I-NP O
203 up RP O O
203 with IN B-VP O
203 Dr NNP B-NP O
203 Vargas NNP I-NP O
203 at IN B-VP O
203 next JJ B-NP O
203 available JJ I-NP O
203 appointment NN I-NP O
203 Please NNP I-NP O
203 call VB O O
203 Dr NNP B-NP O
204 Megeath NNP I-NP O
204 office NN I-NP O
204 to TO O O
204 schedule NN B-NP O
204 Follow NNP I-NP O
204 up RP O O
204 with IN B-VP O
204 Dr NNP B-NP O
204 Blandin NNP I-NP O
204 and CC O O
204 Dr NNP B-NP O
204 Pfleider NNP I-NP O
205 as IN B-VP O
205 scheduled JJ B-NP O
205 Patient NNP I-NP O
205 should MD O O
205 be VB O O
205 seen VBN O O
205 by IN B-VP O
205 physical JJ B-NP O
205 therapy NN I-NP O
205 at IN B-VP O
205 her PRP$ O O
205 nursing NN B-NP O
206 home NN I-NP O
206 Patient NNP I-NP O
206 should MD O O
206 have VB O O
206 a DT B-NP O
206 CBC NNP I-NP O
206 drawn NN I-NP O
206 on IN B-VP O
206 Monday NNP B-NP O
206 3/21 CD O O
206 to TO O O
206 check VB O O
206 her PRP$ O O
206 white JJ B-NP O
207 count NN I-NP O
207 and CC O O
207 platements NNS B-NP O
207 , , O O
207 which WDT O O
207 were VBD B-VP O
207 trending VBG O O
207 down RP O O
207 slowly RB O O
207 throughout IN B-VP O
207 her PRP$ O O
208 admission NN B-NP O
208 and CC O O
208 recheck VB O O
208 calcium NN B-NP O
208 ( ( O O
208 corrected VBN O O
208 for IN B-VP O
208 albumin NN B-NP O
208 ) ) O O
208 in IN B-VP O
208 one CD O O
208 week NN B-NP O
209 No RB O O
209 dictated VBD B-VP O
209 summary JJ B-NP O
210 ENTERED NNP I-NP O
210 BY: NNP I-NP O
210 MIAH NNP I-NP O
210 , , O O
210 RUDY NNP B-NP O
210 E NNP I-NP O
210 , , O O
210 M.D NNP B-NP O
210 ( ( O O
210 RX97 NNP B-NP O
210 ) ) O O
210 9/11/06 CD O O
210 @ $ O O
210 11 CD O O
211 ****** JJ B-NP O
211 END NN I-NP O
211 OF NNP I-NP O
211 DISCHARGE NNP I-NP O
211 ORDERS NNP I-NP O
211 ****** NNP I-NP O
212 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #793453 VBZ O O
4 331676950 CD O O
4 SMMC NNP B-NP O
4 88209373 CD O O
4 203910 CD O O
4 9/30/2002 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Non NNP I-NP O
4 cardiac JJ B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/29/2002 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/21/2002 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 VANOVER NNP I-NP O
8 , , O O
8 JR NNP B-NP O
8 , , O O
8 ISAAC NNP B-NP O
8 034-41-95-4 CD O O
9 En NNP B-NP O
9 O NNP I-NP O
9 Brid NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 3/0/02 CD O O
11 AT NNP B-NP O
11 04:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 KLAPPER NNP I-NP O
14 , , O O
14 NEWTON NNP B-NP O
14 FREDRIC NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ECASA NNP I-NP B-m
19 ( ( O I-m
19 ASPIRIN NNP B-NP I-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 ) ) O I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 COLACE NNP I-NP B-m
20 ( ( O I-m
20 DOCUSATE NNP B-NP I-m
20 SODIUM NNP I-NP I-m
20 ) ) O I-m
20 100 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 BID NNP I-NP B-f
20 PRN NNP I-NP I-f
20 constipation NN I-NP B-r
21 ENALAPRIL NNP I-NP B-m
21 MALEATE NNP I-NP I-m
21 5 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QAM NNP I-NP B-f
21 HOLD NNP I-NP O
21 IF: NNP I-NP O
21 SBP&lt;100 NNP I-NP O
22 Alert NNP I-NP O
22 overridden: NNP I-NP O
22 Override NNP I-NP O
22 added VBD B-VP O
22 on IN B-VP O
22 3/0/02 CD O O
22 by IN B-VP O
23 DWIRE NNP B-NP O
23 , , O O
23 LINDSEY NNP B-NP O
23 NORMAN NNP I-NP O
23 , , O O
23 M.D NNP B-NP O
24 POTENTIALLY NNP I-NP O
24 SERIOUS NNP I-NP O
24 INTERACTION: NNP I-NP O
24 POTASSIUM NNP I-NP B-m
24 CHLORIDE NNP I-NP I-m
24 &amp; NNP I-NP O
25 ENALAPRIL NNP I-NP B-m
25 MALEATE NNP I-NP I-m
25 Reason NNP I-NP O
25 for IN B-VP O
25 override: NN B-NP O
25 aware JJ B-NP O
26 Previous NNP I-NP O
26 override NN I-NP O
26 reason: NN I-NP O
27 Override NNP I-NP O
27 added VBD B-VP O
27 on IN B-VP O
27 4/7/02 CD O O
27 by IN B-VP O
27 DEWISPELAERE NNP B-NP O
27 , , O O
27 MARION NNP B-NP O
27 , , O O
27 M.D NNP B-NP O
28 on IN B-VP O
28 order NN B-NP O
28 for IN B-VP O
28 KCL NNP B-NP B-m
28 IMMEDIATE NNP I-NP I-m
28 RELEASE NNP I-NP I-m
28 PO NNP I-NP B-mo
28 ( ( O O
28 ref JJ O O
28 # # O O
28 56599393 CD O O
28 ) ) O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 ENALAPRIL NNP I-NP B-m
29 MALEATE NNP I-NP I-m
29 &amp; NNP I-NP O
30 POTASSIUM NNP I-NP B-m
30 CHLORIDE NNP I-NP I-m
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 will MD O O
30 follow VB O O
31 ENALAPRIL NNP B-NP B-m
31 MALEATE NNP I-NP I-m
31 10 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QPM NNP I-NP B-f
31 HOLD NNP I-NP O
31 IF: NNP I-NP O
31 SBP&lt;100 NNP I-NP O
32 Alert NNP I-NP O
32 overridden: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 3/0/02 CD O O
32 by IN B-VP O
33 KITZMAN NNP B-NP O
33 , , O O
33 JEWELL NNP B-NP O
33 MICHAEL NNP I-NP O
33 , , O O
33 M.D NNP B-NP O
34 POTENTIALLY NNP I-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 POTASSIUM NNP I-NP B-m
34 CHLORIDE NNP I-NP I-m
34 &amp; NNP I-NP O
35 ENALAPRIL NNP I-NP B-m
35 MALEATE NNP I-NP I-m
35 Reason NNP I-NP O
35 for IN B-VP O
35 override: NN B-NP O
35 aware JJ B-NP O
36 ATIVAN NNP I-NP B-m
36 ( ( O I-m
36 LORAZEPAM NNP B-NP I-m
36 ) ) O I-m
36 1 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 TID NNP I-NP O
36 Starting VBG O O
36 Today NNP B-NP O
36 March NNP I-NP O
37 PRN NNP I-NP O
37 anxiety NN I-NP B-r
37 HOLD NNP I-NP O
37 IF: NNP I-NP O
37 RR&lt;12 NNP I-NP O
37 or CC O O
37 pt NN B-NP O
37 is VBZ O O
37 lethargic JJ B-NP O
38 NITROGLYCERIN NNP I-NP B-m
38 1/150 CD O I-m
38 ( ( O I-m
38 0.4 CD O I-m
38 MG NNP B-NP I-m
38 ) ) O I-m
38 1 CD O B-do
38 TAB NNP B-NP I-do
38 SL NNP I-NP B-mo
38 q5min VBD B-VP B-f
38 x $ O O
38 3 CD O O
39 PRN NNP B-NP O
39 chest NN I-NP B-r
39 pain NN I-NP I-r
39 HOLD NNP I-NP O
39 IF: NNP I-NP O
39 SBP NNP I-NP O
39 &lt; VBD B-VP O
39 100 CD O O
40 ZOLOFT NNP B-NP B-m
40 ( ( O I-m
40 SERTRALINE NNP B-NP I-m
40 ) ) O I-m
40 100 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 ZOCOR NNP I-NP B-m
41 ( ( O I-m
41 SIMVASTATIN NNP B-NP I-m
41 ) ) O I-m
41 20 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 QHS NNP I-NP B-f
42 Food/Drug NNP I-NP O
42 Interaction NNP I-NP O
42 Instruction NNP I-NP O
43 Avoid NNP I-NP O
43 grapefruit NN I-NP O
43 unless IN B-VP O
43 MD NNP B-NP O
43 instructs NNS I-NP O
43 otherwise RB O O
44 PLAVIX NNP B-NP B-m
44 ( ( O I-m
44 CLOPIDOGREL NNP B-NP I-m
44 ) ) O I-m
44 75 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 QD NNP I-NP B-f
45 VIOXX NNP I-NP B-m
45 ( ( O I-m
45 ROFECOXIB NNP B-NP I-m
45 ) ) O I-m
45 25 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 QD NNP I-NP B-f
46 Food/Drug NNP I-NP O
46 Interaction NNP I-NP O
46 Instruction NNP I-NP O
46 Take NNP I-NP O
46 with IN B-VP O
46 food NN B-NP O
47 ZANTAC NNP I-NP B-m
47 ( ( O I-m
47 RANITIDINE NNP B-NP I-m
47 HCL NNP I-NP I-m
47 ) ) O I-m
47 150 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 BID NNP I-NP B-f
47 PRN NNP I-NP I-f
47 dyspepsia NN I-NP B-r
48 ATENOLOL NNP I-NP B-m
48 25 CD O B-do
48 MG NNP B-NP I-do
48 PO NNP I-NP B-mo
48 QD NNP I-NP B-f
48 Food/Drug NNP I-NP O
48 Interaction NNP I-NP O
48 Instruction NNP I-NP O
49 Take NNP I-NP O
49 consistently RB O O
49 with IN B-VP O
49 meals NNS B-NP O
49 or CC O O
49 on IN B-VP O
49 empty JJ B-NP O
49 stomach NN I-NP O
50 DIET: NNP I-NP O
50 House NNP I-NP O
50 / VBD B-VP O
50 Low NNP B-NP O
50 chol/low NN I-NP O
50 sat VBD B-VP O
50 fat JJ B-NP O
51 Activity NNP I-NP O
51 - : O O
51 As IN B-VP O
51 tolerated JJ B-NP O
52 RETURN NNP I-NP O
52 TO NNP I-NP O
52 WORK: NNP I-NP O
52 Immediately RB O O
53 FOLLOW NNP B-NP O
53 UP NNP I-NP O
53 APPOINTMENT( NNP I-NP O
53 S NNP I-NP O
53 ): NNP I-NP O
54 Bob NNP I-NP O
54 Yampolsky NNP I-NP O
54 , , O O
54 MD NNP B-NP O
54 2-4 CD O O
54 wks NN B-NP O
54 , , O O
55 ALLERGY: NNP B-NP O
55 Atarax NNP I-NP O
55 ( ( O O
55 hydroxyzine JJ B-NP O
55 hcl NN I-NP O
55 ) ) O O
55 , , O O
55 Sulfa NNP B-NP O
56 ADMIT NNP I-NP O
56 DIAGNOSIS: NNP I-NP O
57 chest JJS B-NP O
57 pain NN I-NP O
58 PRINCIPAL NNP I-NP O
58 DISCHARGE NNP I-NP O
58 DIAGNOSIS NNP I-NP O
58 ;Responsible JJ O O
58 After IN B-VP O
58 Study NNP B-NP O
58 for IN B-VP O
58 Causing NNP B-NP O
58 Admission NNP I-NP O
58 ) ) O O
59 Non NNP B-NP O
59 cardiac JJ B-NP O
59 chest NN I-NP O
59 pain NN I-NP O
60 OTHER NNP I-NP O
60 DIAGNOSIS;Conditions NNP I-NP O
60 , , O O
60 Infections NNP B-NP O
60 , , O O
60 Complications NNP B-NP O
60 , , O O
60 affecting VBG O O
60 Treatment/Stay NNP B-NP O
61 HTN NNP I-NP O
61 ( ( O O
61 ) ) O O
61 CAD NNP B-NP O
61 ( ( O O
61 prior JJ B-NP O
61 MI NNP I-NP O
61 x2 NNP I-NP O
61 , , O O
61 4/14 CD O O
61 ( ( O O
61 ) ) O O
61 high VBP O O
61 cholesterol NN B-NP O
61 ( ( O O
61 ) ) O O
61 OSA NNP B-NP O
61 ( ( O O
61 ) ) O O
61 OA NNP B-NP O
62 ( ( O O
62 ) ) O O
62 depression NN B-NP O
62 ( ( O O
62 ) ) O O
62 anxiety NN B-NP O
62 ( ( O O
62 ) ) O O
63 OPERATIONS NNP B-NP O
63 AND NNP I-NP O
63 PROCEDURES: NNP I-NP O
64 Cardiac NNP I-NP O
64 catheterization NN I-NP O
64 ( ( O O
64 8/18/02 CD O O
64 ) ) O O
65 OTHER NNP B-NP O
65 TREATMENTS/PROCEDURES NNP I-NP O
65 ( ( O O
65 NOT NNP B-NP O
65 IN NNP I-NP O
65 O.R NNP I-NP O
65 ) ) O O
66 None NN B-NP O
67 BRIEF NNP I-NP O
67 RESUME NNP I-NP O
67 OF NNP I-NP O
67 HOSPITAL NNP I-NP O
67 COURSE: NNP I-NP O
68 44 CD O O
68 yo NN B-NP O
68 man NN I-NP O
68 with IN B-VP O
68 h/o JJ B-NP O
68 CAD NNP I-NP O
68 s/p NN I-NP O
68 MI NNP I-NP O
68 x2 VBZ O O
68 4/14 CD O O
68 with IN B-VP O
68 PCI NNP B-NP O
68 , , O O
69 in IN B-VP O
69 stent JJ B-NP O
69 thrombosis NN I-NP O
69 , , O O
69 and CC O O
69 re-stenting NN B-NP O
69 subsequently RB O O
69 admitted VBN O O
69 multiple JJ B-NP O
70 times NNS I-NP O
70 for IN B-VP O
70 CP NNP B-NP O
70 , , O O
70 cath NN B-NP O
70 performed VBD B-VP O
70 0/29 CD O O
70 and CC O O
70 4/13 CD O O
70 showed VBD B-VP O
70 mild JJ B-NP O
70 CAD NNP I-NP O
70 , , O O
70 presented VBD B-VP O
71 to TO O O
71 KMH NNP B-NP O
71 with IN B-VP O
71 increasing VBG O O
71 CP NNP B-NP O
71 at IN B-VP O
71 rest NN B-NP O
72 associated VBN O O
72 with IN B-VP O
72 fatigue NN B-NP O
72 and CC O O
72 SOB NNP B-NP O
72 Managed NNP I-NP O
72 on IN B-VP O
72 Hep NNP B-NP B-m
72 , , O O
72 TNG NNP B-NP B-m
73 gtt NN I-NP B-mo
73 , , O O
73 plavix NN B-NP B-m
73 , , O O
73 ACE NNP B-NP B-m
73 , , O O
73 B NNP B-NP B-m
73 blocker NN I-NP I-m
73 , , O O
73 demerol; JJ B-NP B-m
73 ROMI'd NNP I-NP O
73 But CC O O
74 pain NN B-NP O
74 recurred VBD B-VP O
74 , , O O
74 transferred VBD B-VP O
74 to TO O O
74 BVH NNP B-NP O
74 for IN B-VP O
75 cath NN B-NP O
75 Fam NNP I-NP O
75 Hx: NNP I-NP O
75 F-MI NNP I-NP O
75 , , O O
75 53 CD O O
75 Soc NNP B-NP O
75 Hx: NNP I-NP O
75 past JJ B-NP O
75 smoker NN I-NP O
75 ( ( O O
75 40 CD O O
76 py NN B-NP O
76 ) ) O O
76 PE: VBD B-VP O
76 80 CD O O
76 102/72 CD O O
76 18 CD O O
77 93%RA CD O O
77 CV: NNP B-NP O
77 RR NNP I-NP O
77 , , O O
77 nl JJ B-NP O
77 S1 NNP I-NP O
77 S2 NNP I-NP O
77 , , O O
77 no DT B-NP O
77 murm NN I-NP O
77 , , O O
77 no DT B-NP O
77 carotid NN I-NP O
78 bruits NNS I-NP O
78 , , O O
78 JVP=10 NNP B-NP O
78 Ext: NNP I-NP O
78 trace NN I-NP O
78 edema NN I-NP O
78 Rectal: NNP I-NP O
78 trace NN I-NP O
78 heme NN I-NP O
79 pos NN I-NP O
79 Labs: NNP I-NP O
79 EKG: NNP I-NP O
79 NSR75; NNP I-NP O
79 LAE NNP I-NP O
79 , , O O
79 TWI NNP B-NP O
79 1 CD O O
79 , , O O
79 L; NNP B-NP O
79 Q NNP I-NP O
79 1 CD O O
79 , , O O
79 L NNP B-NP O
79 , , O O
80 V1-3 NNP B-NP O
80 CK NNP I-NP O
80 63; CD O O
80 TnI NNP B-NP O
80 .03 NNP I-NP O
80 CXR:pending NNP I-NP O
80 Cr NNP I-NP O
81 .9 NNP I-NP O
81 CV: NNP I-NP O
81 Pain NNP I-NP O
81 may MD O O
81 not RB O O
81 be VB O O
81 cardiac JJ O O
81 , , O O
81 but CC O O
81 poss VBZ O O
81 cath NN B-NP O
81 to TO O O
82 r/o VB O O
82 ASA NNP B-NP B-m
82 , , O O
82 Plavix NNP B-NP B-m
82 , , O O
82 Hep NNP B-NP B-m
82 IV NNP I-NP B-mo
82 , , O O
82 B NNP B-NP B-m
82 Blocker NNP I-NP I-m
82 , , O O
82 ACE NNP B-NP B-m
82 , , O O
83 Zocor NNP B-NP B-m
83 Mild NNP I-NP B-r
83 fluid NN I-NP I-r
83 overload NN I-NP I-r
83 , , O O
83 will MD O O
83 plan VB O O
83 Lasix NNP B-NP B-m
83 to TO O O
83 keep VB O O
84 I/0's NNP B-NP O
84 500-1000cc JJ B-NP O
84 neg NN I-NP O
84 Pain NNP I-NP O
84 could MD O O
84 represent VB O O
85 pericarditis NN B-NP O
85 , , O O
85 but CC O O
85 dx NN B-NP O
85 of IN B-VP O
85 exclusion NN B-NP O
85 Cardiomegaly NNP I-NP O
85 on IN B-VP O
85 CXR NNP B-NP O
86 present JJ O O
86 since IN B-VP O
86 prev NN B-NP O
86 echo VBP O O
86 showing VBG O O
86 no DT B-NP O
87 effusion NN I-NP O
87 Pt NNP I-NP O
87 has VBZ O O
87 had VBN O O
87 mult VBN O O
87 episodes NNS B-NP O
87 of IN B-VP O
87 2-8/10 JJ B-NP O
87 CP NNP I-NP O
87 during IN B-VP O
88 hosp NN B-NP O
88 without IN B-VP O
88 EKG NNP B-NP O
88 changes NNS I-NP O
88 , , O O
88 responsive NN B-NP O
88 to TO O O
88 NTG NNP B-NP B-m
88 , , O O
89 managed VBD B-VP O
89 with IN B-VP O
89 prn JJ B-NP B-f
89 Demerol NNP I-NP B-m
89 and CC O O
89 standing VBG O O
89 Ativan NNP B-NP B-m
89 to TO O O
90 pain-free JJ B-NP B-r
90 Hep NNP I-NP B-m
90 gtt NN I-NP B-mo
90 maintained VBD B-VP O
90 until IN B-VP O
91 cath JJ B-NP O
91 Cath NNP I-NP O
91 8/18/02 CD O O
91 : : O O
91 NON-OBSTRUCTIVE JJ B-NP O
91 CAD NNP I-NP O
91 LMCA: NNP I-NP O
91 OK; NNP I-NP O
92 LAD: NNP I-NP O
92 prox VBD B-VP O
92 tubular JJ O O
92 30%; CD O O
92 LCx: NNP B-NP O
92 OK; NNP I-NP O
92 RCA: NNP I-NP O
93 OK NNP I-NP O
93 Pulm: NNP I-NP O
93 Level NNP I-NP O
93 of IN B-VP O
93 suspicion NN B-NP O
93 for IN B-VP O
93 PE NNP B-NP O
93 is VBZ O O
94 low JJ B-NP O
94 Will NNP I-NP O
94 send VB O O
94 D-dimer; NNP B-NP O
94 pt NN I-NP O
94 is VBZ O O
94 already RB O O
94 starting VBG O O
95 Hep NNP B-NP B-m
95 , , O O
95 will MD O O
95 pursue VB O O
95 CT NNP B-NP O
95 angio NN I-NP O
95 if IN B-VP O
95 necessary JJ B-NP O
95 D-dimer NNP I-NP O
95 neg NN I-NP O
95 , , O O
96 PE NNP B-NP O
96 RULED NNP I-NP O
97 OUT NNP I-NP O
97 Proph: NNP I-NP O
97 TEDS NNP I-NP O
97 , , O O
97 ambulation NN B-NP O
97 after IN B-VP O
98 r/o NN B-NP O
98 Psych: NNP I-NP O
98 Ativan NNP I-NP B-m
98 prn NN I-NP B-f
98 anxiety NN I-NP B-r
98 Zoloft NNP I-NP B-m
98 Ativan NNP I-NP B-m
98 Ativan NNP I-NP B-m
99 changed VBD B-VP O
99 to TO O O
99 1 CD O B-do
99 mg NNS B-NP I-do
99 tid RB O B-f
99 standing VBG O O
99 to TO O O
99 decrease VB O O
99 anxiety NN B-NP B-r
100 related JJ B-NP O
100 factors NNS I-NP O
100 Given VBN O O
100 lack NN B-NP O
100 of IN B-VP O
100 present JJ B-NP O
100 sig NN I-NP O
100 CAD NNP I-NP O
100 , , O O
100 ruled VBD B-VP O
101 out RP O O
101 for IN B-VP O
101 PE NNP B-NP O
101 , , O O
101 and CC O O
101 low JJ B-NP O
101 suspicion NN I-NP O
101 for IN B-VP O
102 pericarditis NN B-NP O
102 , , O O
102 psychiatric JJ B-NP O
102 etiology NN I-NP O
102 for IN B-VP O
102 CP NNP B-NP O
102 becomes VBZ O O
102 more RBR O O
103 likely JJ O O
103 , , O O
103 would MD O O
103 recommend VB O O
103 psych NN B-NP O
103 f/u NN I-NP O
103 and CC O O
103 tx NN B-NP O
103 for IN B-VP O
103 anxiety NN B-NP O
104 and CC O O
104 depression NN B-NP O
105 ID: NNP I-NP O
105 WBC NNP I-NP O
105 count NN I-NP O
105 increasing VBG O O
105 4/10 CD O O
105 but CC O O
105 no DT B-NP O
105 other JJ I-NP O
105 sign/sx JJ I-NP O
105 infection NN I-NP O
105 Will NNP I-NP O
106 monitor NNP I-NP O
106 CXR NNP I-NP O
106 no DT B-NP O
106 infiltrates NNS I-NP O
106 WBC NNP I-NP O
106 decreased VBD B-VP O
106 10/16 CD O O
106 to TO O O
106 13.1 CD O O
106 , , O O
106 still RB O O
106 no DT B-NP O
107 indication NN I-NP O
107 of IN B-VP O
107 infection NN B-NP O
108 ADDITIONAL NNP I-NP O
108 COMMENTS: NNP I-NP O
108 Please NNP I-NP O
108 schedule VBD B-VP O
108 an DT B-NP O
108 appointment NN I-NP O
108 with IN B-VP O
108 your PRP$ O O
108 primary JJ B-NP O
108 doctor NN I-NP O
108 within IN B-VP O
108 2-4 JJ B-NP O
109 weeks NNS I-NP O
109 If IN B-VP O
109 chest JJS B-NP O
109 pain NN I-NP O
109 changes NNS I-NP O
109 in IN B-VP O
109 character NN B-NP O
109 ( ( O O
109 becomes JJ O O
109 different JJ O O
109 in IN B-VP O
110 location NN B-NP O
110 , , O O
110 sensation NN B-NP O
110 ) ) O O
110 or CC O O
110 is VBZ O O
110 associated VBN O O
110 with IN B-VP O
110 new JJ B-NP O
110 symptoms NNS I-NP O
110 ( ( O O
110 such JJ O O
110 as IN B-VP O
110 nausea NN B-NP O
111 and CC O O
111 vomiting NN B-NP O
111 , , O O
111 or CC O O
111 severe JJ B-NP O
111 shortness NN I-NP O
111 of IN B-VP O
111 breath NN B-NP O
111 ) ) O O
111 , , O O
111 notify RB O O
111 your PRP$ O O
111 doctor NN B-NP O
111 or CC O O
112 call VB O O
112 911 CD O O
112 Please NNP B-NP O
112 give VB O O
112 a DT B-NP O
112 copy NN I-NP O
112 of IN B-VP O
112 these DT B-NP O
112 instructions NNS I-NP O
112 to TO O O
112 your PRP$ O O
112 primary JJ B-NP O
113 doctor NN I-NP O
113 at IN B-VP O
113 your PRP$ O O
113 next JJ B-NP O
113 visit NN I-NP O
114 DISCHARGE NNP I-NP O
114 CONDITION: NNP I-NP O
114 Stable NNP I-NP O
115 TO NNP I-NP O
115 DO/PLAN: NNP I-NP O
116 As IN B-VP O
116 above IN B-VP O
117 No NNP B-NP O
117 dictated VBD B-VP O
117 summary JJ B-NP O
118 ENTERED NNP I-NP O
118 BY: NNP I-NP O
118 MATSUKI NNP I-NP O
118 , , O O
118 JAMISON NNP B-NP O
118 SCOTTY NNP I-NP O
118 , , O O
118 M.D NNP B-NP O
118 ( ( O O
118 GC93 NNP B-NP O
118 ) ) O O
118 3/0/02 CD O O
118 @ $ O O
118 04:17 CD O O
118 PM NNP B-NP O
119 ****** JJ B-NP O
119 END NNP I-NP O
119 OF NNP I-NP O
119 DISCHARGE NNP I-NP O
119 ORDERS NNP I-NP O
119 ****** NNP I-NP O
120 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #795740 VBZ O O
2 315194766 CD O O
2 VIMC NNP B-NP O
2 10418500 CD O O
2 4031002 CD O O
2 7/27/2003 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 LEFT NNP I-NP O
2 GROIN NNP I-NP O
2 INFECTION NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 7/27/2003 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/20/2003 CD O O
4 ATTENDING: NNP B-NP O
4 ALFRED NNP I-NP O
4 JUZA NNP I-NP O
4 MD NNP I-NP O
5 ATTENDING NNP I-NP O
5 PHYSICIAN: NNP I-NP O
5 Johnathon NNP I-NP O
5 Jamieson NNP I-NP O
5 , , O O
5 M.D NNP B-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 Mr NNP I-NP O
6 Wizar NNP I-NP O
6 is VBZ O O
6 a DT B-NP O
6 51-year-old JJ I-NP O
6 man NN I-NP O
6 who WP O O
7 was VBD B-VP O
7 recently RB O O
7 admitted VBN O O
7 for IN B-VP O
7 repair NN B-NP O
7 of IN B-VP O
7 left JJ B-NP O
7 pseudoaneurysm NN I-NP O
7 in IN B-VP O
7 his PRP$ O O
8 groin NN B-NP O
8 He PRP O O
8 was VBD B-VP O
8 in IN B-VP O
8 home NN B-NP O
8 and CC O O
8 doing VBG O O
8 fine JJ O O
8 after IN B-VP O
8 discharge NN B-NP O
8 from IN B-VP O
9 Ea NNP B-NP O
9 Naron NNP I-NP O
9 Medical NNP I-NP O
9 Center NNP I-NP O
9 on IN B-VP O
9 5/29/2003 CD O O
9 One CD O O
9 week NN B-NP O
9 later RB O O
9 , , O O
9 he PRP O O
10 noticed VBD B-VP O
10 pus NN B-NP O
10 draining VBG O O
10 from IN B-VP O
10 his PRP$ O O
10 wound NN B-NP O
10 site NN I-NP O
10 He PRP O O
10 was VBD B-VP O
10 doing VBG O O
10 daily JJ O O
11 dressing VBG O O
11 changes NNS B-NP O
11 at IN B-VP O
11 home NN B-NP O
11 He PRP O O
11 was VBD B-VP O
11 seen VBN O O
11 in IN B-VP O
11 Dr NNP B-NP O
11 Hearston NNP I-NP O
11 's POS O O
11 office NN B-NP O
11 on IN B-VP O
12 7/27/2003 CD O O
12 with IN B-VP O
12 only JJ B-NP O
12 mild JJ I-NP O
12 improvement NN I-NP O
12 He PRP O O
12 was VBD B-VP O
12 admitted VBN O O
12 from IN B-VP O
13 clinic NN B-NP O
13 for IN B-VP O
13 more RBR O O
13 aggressive JJ B-NP O
13 management NN I-NP O
13 He PRP O O
13 has VBZ O O
13 no DT B-NP O
13 history NN I-NP O
13 of IN B-VP O
14 fever NN B-NP O
14 , , O O
14 chills NNS B-NP O
14 , , O O
14 nausea NN B-NP O
14 , , O O
14 vomiting VBG O O
14 , , O O
14 constipation NN B-NP O
14 , , O O
14 or CC O O
14 diarrhea VBZ O O
14 No DT B-NP O
15 chest NN I-NP O
15 pain NN I-NP O
15 and CC O O
15 no DT B-NP O
15 shortness NN I-NP O
15 of IN B-VP O
15 breath NN B-NP O
16 PHYSICAL NNP I-NP O
16 EXAMINATION: NNP I-NP O
16 On IN B-VP O
16 exam NN B-NP O
16 , , O O
16 he PRP O O
16 was VBD B-VP O
16 afebrile JJ B-NP O
16 Vital JJ I-NP O
16 sings NNS I-NP O
16 are VBP O O
17 stable JJ O O
17 He PRP O O
17 is VBZ O O
17 100% CD O O
17 on IN B-VP O
17 room NN B-NP O
17 air NN I-NP O
17 He PRP O O
17 had VBD B-VP O
17 on IN B-VP O
17 the DT B-NP O
17 left NN I-NP O
17 , , O O
17 2+ CD O O
17 femoral JJ O O
17 , , O O
18 no DT B-NP O
18 DP NNP I-NP O
18 , , O O
18 monophasic JJ B-NP O
18 PT NNP I-NP O
18 pulse NN I-NP O
18 with IN B-VP O
18 cold JJ B-NP O
18 foot NN I-NP O
18 On IN B-VP O
18 the DT B-NP O
18 right NN I-NP O
18 , , O O
18 TMA NNP B-NP O
18 , , O O
19 warm JJ B-NP O
19 foot NN I-NP O
19 , , O O
19 femoral JJ O O
19 2+ CD O O
19 , , O O
19 DP NNP B-NP O
19 monophasic NN I-NP O
19 , , O O
19 PT NNP B-NP O
19 monophasic FW O O
19 Wound NNP B-NP O
19 site NN I-NP O
20 with IN B-VP O
20 some DT B-NP O
20 erythema NN I-NP O
20 and CC O O
20 drainage NN B-NP O
20 , , O O
20 nontender NN B-NP O
20 , , O O
20 no DT B-NP O
20 odor NN I-NP O
21 PAST NNP I-NP O
21 MEDICAL NNP I-NP O
21 HISTORY: NNP I-NP O
21 Includes NNP I-NP O
21 coronary JJ B-NP O
21 artery NN I-NP O
21 disease NN I-NP O
21 status NN I-NP O
22 post NN I-NP O
22 CABG NNP I-NP O
22 , , O O
22 peripheral JJ B-NP O
22 vascular JJ I-NP O
22 disease NN I-NP O
22 status NN I-NP O
22 post NN I-NP O
22 aortobifemoral JJ B-NP O
23 bypass NN I-NP O
23 and CC O O
23 status NN B-NP O
23 post NN I-NP O
23 femoropopliteal JJ B-NP O
23 bypass NN I-NP O
23 , , O O
23 COPD NNP B-NP O
23 , , O O
23 chronic JJ B-NP O
24 renal JJ I-NP O
24 failure NN I-NP O
24 , , O O
24 and CC O O
24 diabetes VBZ O O
24 mellitus NNS B-NP O
25 PAST NNP I-NP O
25 SURGICAL NNP I-NP O
25 HISTORY: NNP I-NP O
25 Repair NNP I-NP O
25 of IN B-VP O
25 pseudoaneurysm NN B-NP O
26 MEDICATIONS: NNP I-NP O
26 Aspirin NNP I-NP B-m
26 325 CD O B-do
26 mg NN B-NP I-do
26 once RB O B-f
26 a DT B-NP I-f
26 day; NN I-NP I-f
26 digoxin NN I-NP B-m
26 0.125 CD O B-do
26 mg NN B-NP I-do
26 once RB O B-f
26 a DT B-NP O
27 day; NN I-NP O
27 Zestril NNP I-NP B-m
27 2.5 CD O B-do
27 mg NN B-NP I-do
27 once RB O B-f
27 a DT B-NP I-f
27 day; NN I-NP I-f
27 Ultralente NNP I-NP B-m
27 Ultralente NNP I-NP B-m
27 14 CD O B-do
27 mg NN B-NP I-do
27 q.a.m NN I-NP B-f
27 , , O O
27 4 CD O B-do
27 mg NN B-NP I-do
28 q.p.m.; NN I-NP B-f
28 Zocor NNP I-NP B-m
28 10 CD O B-do
28 mg NN B-NP I-do
28 once RB O B-f
28 a DT B-NP I-f
28 day; NN I-NP I-f
28 Toprol NNP I-NP B-m
28 25 CD O B-do
28 mg NN B-NP I-do
28 once RB O B-f
28 a DT B-NP I-f
28 day; NN I-NP I-f
28 Imdur NNP I-NP B-m
28 30 CD O B-do
29 mg NN B-NP O
29 once RB O B-f
29 a DT B-NP I-f
29 day; NN I-NP I-f
29 torsemide RB O B-m
29 100 CD O B-do
29 mg NN B-NP I-do
29 once RB O B-f
29 a DT B-NP I-f
29 day; NN I-NP I-f
29 and CC O O
29 Dilaudid NNP B-NP B-m
29 p.r.n VB O B-f
30 ALLERGY: NNP B-NP O
30 He PRP O O
30 has VBZ O O
30 an DT B-NP O
30 allergy NN I-NP O
30 to TO O O
30 penicillin VB O O
31 SOCIAL NNP B-NP O
31 HISTORY: NNP I-NP O
31 One NNP I-NP O
31 pack NN I-NP O
31 a DT B-NP O
31 day NN I-NP O
31 smoker NN I-NP O
31 Occasional NNP I-NP O
31 alcohol NN I-NP O
32 EMERGENCY NNP I-NP O
32 DEPARTMENT NNP I-NP O
32 COURSE: NNP I-NP O
32 The DT B-NP O
32 patient NN I-NP O
32 was VBD B-VP O
32 admitted VBN O O
32 for IN B-VP O
32 IV NNP B-NP B-mo
33 antibiotics NNS I-NP B-m
33 and CC O O
33 further JJ B-NP O
33 surgical JJ I-NP O
33 therapy NN I-NP O
33 with IN B-VP O
33 the DT B-NP O
33 diagnosis NN I-NP O
33 of IN B-VP O
34 dehiscence NN B-NP O
34 of IN B-VP O
34 left JJ B-NP B-r
34 thigh JJ I-NP I-r
34 bypass NN I-NP I-r
34 graft NN I-NP I-r
34 wound NN I-NP I-r
34 He PRP O O
34 received VBD B-VP O
35 wet-to-dry JJ B-NP O
35 dressing NN I-NP O
35 changes NNS I-NP O
35 t.i.d VBP O O
35 initially RB O O
35 On IN B-VP O
35 6/3/2003 CD O O
35 , , O O
35 he PRP O O
36 was VBD B-VP O
36 taken VBN O O
36 to TO O O
36 the DT B-NP O
36 operating NN I-NP O
36 room NN I-NP O
36 for IN B-VP O
36 left JJ B-NP O
36 groin JJ I-NP O
36 closure NN I-NP O
36 with IN B-VP O
36 flap NN B-NP O
37 by IN B-VP O
37 Plastic NNP B-NP O
37 Surgery NNP I-NP O
37 and CC O O
37 Vascular NNP B-NP O
37 Surgery NNP I-NP O
37 The DT B-NP O
37 flap NN I-NP O
37 initially RB O O
37 was VBD B-VP O
38 pink JJ O O
38 and CC O O
38 viable JJ O O
38 , , O O
38 however RB O O
38 , , O O
38 on IN B-VP O
38 4/20/2003 CD O O
38 , , O O
38 there EX O O
38 were VBD B-VP O
38 noted VBN O O
38 some DT B-NP O
39 pale JJ I-NP O
39 areas NNS I-NP O
39 and CC O O
39 mottling NN B-NP O
39 of IN B-VP O
39 the DT B-NP O
39 flap NN I-NP O
39 He PRP O O
39 was VBD B-VP O
39 injected VBN O O
39 with IN B-VP O
40 heparin JJ B-NP B-m
40 solution NN I-NP I-m
40 Following VBG O O
40 this DT O O
40 , , O O
40 flap VBZ O O
40 received VBN O O
40 serial JJ B-NP O
40 needle JJ I-NP O
41 pricks NNS I-NP O
41 and CC O O
41 the DT B-NP O
41 appearance NN I-NP O
41 gradually RB O O
41 improved VBN O O
41 as IN B-VP O
41 such JJ O O
41 there EX O O
41 was VBD B-VP O
41 no DT B-NP O
42 further JJ I-NP O
42 pallor NN I-NP O
42 or CC O O
42 mottling VBG O O
42 The DT B-NP O
42 patient NN I-NP O
42 developed VBD B-VP O
42 diarrhea NN B-NP O
42 He PRP O O
43 was VBD B-VP O
43 on IN B-VP O
43 vancomycin NN B-NP B-m
43 , , O O
43 levofloxacin NN B-NP B-m
43 , , O O
43 with IN B-VP O
43 p.o JJ B-NP B-mo
43 Flagyl NNP I-NP B-m
43 for IN B-VP O
43 empiric JJ B-NP O
44 treatment NN I-NP O
44 for IN B-VP O
44 C NNP B-NP B-r
44 diff NN I-NP I-r
44 C NNP I-NP O
44 diff NN I-NP O
44 cultures NNS I-NP O
44 were VBD B-VP O
44 negative JJ O O
44 on IN B-VP O
45 0/7/2003 CD O O
45 , , O O
45 in IN B-VP O
45 addition NN B-NP O
45 his PRP$ O O
45 drain NN B-NP O
45 cultures NNS I-NP O
45 on IN B-VP O
45 10/6/2003 CD O O
45 , , O O
45 showed VBD B-VP O
46 rare JJ B-NP O
46 Staphylococcus NNP I-NP O
46 aureus NN I-NP O
46 On IN B-VP O
46 6/3/2003 CD O O
46 , , O O
46 repeat JJ B-NP O
46 culture NN I-NP O
46 of IN B-VP O
47 the DT B-NP O
47 groin NN I-NP O
47 were VBD B-VP O
47 negative JJ O O
47 He PRP O O
47 had VBD B-VP O
47 an DT B-NP O
47 episode NN I-NP O
47 of IN B-VP O
47 nausea NN B-NP B-r
47 , , O O
47 which WDT O O
48 improved VBD B-VP O
48 after IN B-VP O
48 Flagyl NNP B-NP B-m
48 was VBD B-VP O
48 discontinued VBN O O
48 The DT B-NP O
48 patient NN I-NP O
48 was VBD B-VP O
48 seen VBN O O
48 by IN B-VP O
49 Cardiology NNP B-NP O
49 during IN B-VP O
49 his PRP$ O O
49 stay NN B-NP O
49 here RB O O
49 On IN B-VP O
49 postoperative JJ B-NP O
49 #2 NN I-NP O
49 , , O O
49 he PRP O O
49 was VBD B-VP O
50 noted VBN O O
50 to TO O O
50 be VB O O
50 volume NN B-NP O
50 overloaded VBD B-VP O
50 His PRP$ O O
50 torsemide JJ B-NP B-m
50 torsemide NN I-NP B-m
50 was VBD B-VP O
50 increased VBN O O
50 to TO O O
51 100 CD O B-do
51 mg NNS B-NP I-do
51 b.i.d NN I-NP B-f
51 with IN B-VP O
51 goal NN B-NP O
51 diuresis NN I-NP O
51 of IN B-VP O
51 1-2 JJ B-NP O
51 liters NNS I-NP O
51 per IN B-VP O
51 day NN B-NP O
51 IV NNP I-NP B-mo
51 Lasix NNP I-NP B-m
52 was VBD B-VP O
52 added VBN O O
52 p.r.n NN B-NP B-f
52 to TO O O
52 achieve VB O O
52 this DT B-NP O
52 goal NN I-NP O
52 After IN B-VP O
52 his PRP$ O O
52 episode NN B-NP O
52 of IN B-VP O
53 nausea NN B-NP O
53 , , O O
53 his PRP$ O O
53 EKG NNP B-NP O
53 was VBD B-VP O
53 checked VBN O O
53 to TO O O
53 rule VB O O
53 out RP O O
53 any DT B-NP O
53 sort NN I-NP O
53 of IN B-VP O
53 cardio NN B-NP O
54 ischemic JJ B-NP O
54 cause NN I-NP O
54 for IN B-VP O
54 this DT B-NP O
54 nausea NN I-NP O
54 , , O O
54 EKG NNP B-NP O
54 was VBD B-VP O
54 normal JJ O O
54 His PRP$ O O
54 morphine NN B-NP B-m
54 was VBD B-VP O
55 discontinued VBN O O
55 as IN B-VP O
55 a DT B-NP O
55 possible JJ I-NP O
55 cause NN I-NP O
55 He PRP O O
55 did VBD B-VP O
55 well RB O O
55 with IN B-VP O
55 p.o NN B-NP B-mo
55 pain NN I-NP B-m
56 medications NNS I-NP O
56 Renal: NNP I-NP O
56 His PRP$ O O
56 Zestril NNP B-NP B-m
56 was VBD B-VP O
56 held VBN O O
56 secondary JJ O O
56 to TO O O
56 an DT B-NP O
57 elevation NN I-NP O
57 in IN B-VP O
57 creatinine NN B-NP O
57 to TO O O
57 3.3 CD O O
57 from IN B-VP O
57 his PRP$ O O
57 baseline NN B-NP O
57 of IN B-VP O
57 1.8 CD O O
57 This DT O O
58 gradually RB O O
58 resolved VBN O O
58 Creatinine NNP B-NP O
58 was VBD B-VP O
58 2.5 CD O O
58 at IN B-VP O
58 the DT B-NP O
58 time NN I-NP O
58 of IN B-VP O
58 discharge NN B-NP O
59 The DT B-NP O
59 patient NN I-NP O
59 was VBD B-VP O
59 also RB O O
59 seen VBN O O
59 by IN B-VP O
59 the DT B-NP O
59 Nutrition NNP I-NP O
59 and CC O O
59 recommended VBD B-VP O
60 supplements NNS B-NP B-m
60 , , O O
60 vitamin FW O B-m
60 C NNP B-NP I-m
60 , , O O
60 and CC O O
60 Zinc NNP B-NP B-m
60 for IN B-VP O
60 wound NN B-NP B-r
60 wound NN I-NP B-r
60 wound IN B-VP B-r
60 healing VBG O I-r
60 healing VBG O I-r
60 healing NN B-NP I-r
60 By IN B-VP O
61 0/7/2003 CD O O
61 , , O O
61 the DT B-NP O
61 patient's NN I-NP O
61 flap NN I-NP O
61 was VBD B-VP O
61 stable JJ O O
61 , , O O
61 pink VB O O
61 , , O O
61 and CC O O
61 viable JJ O O
61 He PRP O O
62 had VBD B-VP O
62 lower JJR B-NP O
62 extremity NN I-NP O
62 pulses NNS I-NP O
62 that WDT O O
62 were VBD B-VP O
62 Dopplerable NNP B-NP O
62 He PRP O O
62 was VBD B-VP O
63 discharged VBN O O
63 home NN B-NP O
63 in IN B-VP O
63 stable JJ B-NP O
63 condition NN I-NP O
63 with IN B-VP O
63 services NNS B-NP O
64 Discharge NNP I-NP O
64 medications NNS I-NP O
64 include VBP O O
64 enteric-coated JJ O B-m
64 aspirin JJ O I-m
64 325 CD O B-do
64 mg NN B-NP I-do
64 once RB O B-f
65 a DT B-NP O
65 day; NN I-NP O
65 digoxin NN I-NP B-m
65 0.125 CD O B-do
65 once RB O B-f
65 a DT B-NP I-f
65 day; NN I-NP I-f
65 Ultralente NNP I-NP B-m
65 Ultralente NNP I-NP B-m
65 16 CD O B-do
65 units NNS B-NP I-do
65 q.a.m RB O B-f
65 , , O O
65 4 CD O B-do
66 units NNS B-NP O
66 q.p.m.; VBD B-VP B-f
66 Zocor NNP B-NP B-m
66 10 CD O B-do
66 mg NN B-NP I-do
66 once RB O B-f
66 a DT B-NP I-f
66 day; NN I-NP I-f
66 Toprol NNP I-NP B-m
66 25 CD O B-do
66 mg NN B-NP I-do
66 once RB O B-f
66 a DT B-NP I-f
66 day; NN I-NP I-f
67 Imdur NNP I-NP B-m
67 30 CD O B-do
67 mg NN B-NP I-do
67 once RB O B-f
67 a DT B-NP I-f
67 day; NN I-NP I-f
67 torsemide RB O B-m
67 100 CD O B-do
67 mg NN B-NP I-do
67 once RB O B-f
67 a DT B-NP I-f
67 day; NN I-NP I-f
67 lisinopril NN I-NP B-m
68 2.5 CD O B-do
68 mg NN B-NP I-do
68 once RB O B-f
68 a DT B-NP I-f
68 day; NN I-NP I-f
68 colace; NN I-NP B-m
68 and CC O O
68 Percocet NNP B-NP B-m
69 eScription NN I-NP O
69 document: VBD B-VP O
69 3-1417736 JJ B-NP O
69 BF NNP I-NP O
70 Dictated NNP I-NP O
70 By: NNP I-NP O
70 DEVIVO NNP I-NP O
70 , , O O
70 REYES NNP B-NP O
70 DARRYL NNP I-NP O
71 Attending: NNP I-NP O
71 OVERLY NNP I-NP O
71 , , O O
71 DALTON NNP B-NP O
72 Dictation NNP I-NP O
72 ID NNP I-NP O
72 6036613 CD O O
73 D: NNP B-NP O
73 11/15/03 CD O O
74 T: NNP B-NP O
74 9/9/03 CD O O
75 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #796843 VBZ O O
2 621798787 CD O O
2 CUC NNP B-NP O
2 35982795 CD O O
2 444950 CD O O
2 7/11/1994 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 10/1/1994 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 6/16/1994 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 CONGESTIVE NNP I-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
5 SECONDARY NNP I-NP O
5 DIAGNOSES: NNP I-NP O
5 1 CD O O
5 PULMONARY NNP B-NP O
5 EMBOLUS NNP I-NP O
6 2 CD O O
6 DILATED NNP B-NP O
6 CARDIOMYOPATHY NNP I-NP O
7 HISTORY NNP I-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 The DT B-NP O
7 patient NN I-NP O
7 is VBZ O O
7 a DT O O
7 65 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 woman NN I-NP O
8 with IN B-VP O
8 dilated VBN O O
8 cardiomyopathy JJ O O
8 secondary JJ O O
9 to TO O O
9 Adriamycin NNP B-NP B-m
9 Adriamycin NNP I-NP B-m
9 , , O O
9 status NN B-NP O
9 post NN I-NP O
9 recent JJ B-NP O
9 admission NN I-NP O
9 for IN B-VP O
9 increased JJ B-NP O
9 shortness NN I-NP B-r
10 of IN B-VP O
10 breath NN B-NP O
10 and CC O O
10 left VBD B-VP B-r
10 pleural JJ B-NP I-r
10 effusion NN I-NP I-r
10 He PRP O O
10 returns VBZ O O
10 now RB O O
10 with IN B-VP O
10 increased VBN O O
11 cough NN B-NP O
11 productive NN I-NP O
11 of IN B-VP O
11 white JJ B-NP O
11 phlegm NN I-NP O
11 and CC O O
11 progressive JJ B-NP O
11 dyspnea NN I-NP O
11 on IN B-VP O
12 exertion NN B-NP O
12 The DT B-NP O
12 patient NN I-NP O
12 has VBZ O O
12 a DT B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 breast NN B-NP O
12 carcinoma NN I-NP O
12 in IN B-VP O
12 1989 CD O O
12 , , O O
13 treated VBN O O
13 with IN B-VP O
13 left JJ B-NP O
13 lumpectomy NN I-NP O
13 x VBD B-VP O
13 2 CD O O
13 and CC O O
13 XRT NNP B-NP O
13 , , O O
13 accompanied VBN O O
13 by IN B-VP O
14 chemotherapy NN B-NP O
14 completed VBN O O
14 in IN B-VP O
14 early JJ O O
14 1990 CD O O
14 The DT B-NP O
14 patient NN I-NP O
14 then RB O O
14 presented VBN O O
14 in IN B-VP O
15 August NNP B-NP O
15 of IN B-VP O
15 1992 CD O O
15 with IN B-VP O
15 progressive JJ B-NP O
15 dyspnea NN I-NP O
15 on IN B-VP O
15 exertion NN B-NP O
15 , , O O
15 found VBN O O
15 to TO O O
15 have VB O O
16 an DT B-NP O
16 ejection NN I-NP O
16 fraction NN I-NP O
16 of IN B-VP O
16 17% CD O O
16 She PRP O O
16 was VBD B-VP O
16 diagnosed VBN O O
16 with IN B-VP O
16 cardiomyopathy JJ O O
17 felt VBD B-VP O
17 secondary JJ O O
17 to TO O O
17 Adriamycin NNP B-NP B-m
17 toxicity NN I-NP O
17 She PRP O O
17 was VBD B-VP O
17 then RB O O
17 treated VBN O O
17 with IN B-VP O
18 Digoxin NNP B-NP B-m
18 , , O O
18 Lasix NNP B-NP B-m
18 , , O O
18 Captopril NNP B-NP B-m
18 and CC O O
18 Coumadin NNP B-NP B-m
18 with IN B-VP O
18 good JJ B-NP O
18 result NN I-NP O
18 She PRP O O
18 had VBD B-VP O
19 subsequent JJ B-NP O
19 development NN I-NP O
19 of IN B-VP O
19 SVT NNP B-NP O
19 with IN B-VP O
19 a DT B-NP O
19 rapid JJ I-NP O
19 ventricular JJ I-NP O
19 rate NN I-NP O
19 of IN B-VP O
20 approximately RB O O
20 180 CD O O
20 The DT B-NP O
20 patient NN I-NP O
20 eventually RB O O
20 underwent JJ B-NP O
20 EPEP NNP I-NP O
20 studies NNS I-NP O
21 with IN B-VP O
21 therapeutic JJ B-NP O
21 ablation NN I-NP O
21 Subsequently NNP I-NP O
21 she PRP O O
21 had VBD B-VP O
21 done VBN O O
21 quite RB O O
21 well RB O O
22 until IN B-VP O
22 February NNP B-NP O
22 of IN B-VP O
22 1994 CD O O
22 when WRB O O
22 she PRP O O
22 presented VBD B-VP O
22 with IN B-VP O
22 mild JJ B-NP B-r
22 cough JJ I-NP I-r
23 productive NN I-NP O
23 of IN B-VP O
23 white JJ B-NP O
23 phlegm NN I-NP O
23 and CC O O
23 increasing VBG O O
23 symptoms NNS B-NP O
23 of IN B-VP O
23 right JJ O O
23 and CC O O
24 left-sided JJ B-NP B-r
24 left-sided JJ I-NP B-r
24 heart NN I-NP I-r
24 heart NN I-NP I-r
24 failure NN I-NP I-r
24 failure NN I-NP I-r
24 She PRP O O
24 was VBD B-VP O
24 treated VBN O O
24 with IN B-VP O
24 increased JJ B-NP O
24 Lasix NNP I-NP B-m
24 Lasix NNP I-NP B-m
24 and CC O O
25 Digoxin NNP B-NP B-m
25 and CC O O
25 an DT B-NP O
25 empiric JJ I-NP O
25 course NN I-NP O
25 of IN B-VP O
25 amoxicillin NN B-NP B-m
25 with IN B-VP O
25 little JJ B-NP O
25 change NN I-NP O
25 in IN B-VP O
26 her PRP$ O O
26 symptoms NNS B-NP O
26 She PRP O O
26 was VBD B-VP O
26 then RB O O
26 admitted VBN O O
26 on IN B-VP O
26 0/29 CD O O
26 after IN B-VP O
26 she PRP O O
26 was VBD B-VP O
26 found VBN O O
26 to TO O O
27 have VB O O
27 a DT B-NP O
27 large JJ I-NP O
27 left-sided JJ I-NP O
27 pleural JJ I-NP O
27 effusion NN I-NP O
27 The DT B-NP O
27 patient JJ I-NP O
27 underwent NN I-NP O
28 ultrasound NN I-NP O
28 guided VBD B-VP O
28 thoracentesis NN B-NP O
28 complicated VBN O O
28 by IN B-VP O
28 a DT B-NP O
28 pneumothorax NN I-NP O
29 requiring VBG O O
29 chest JJS B-NP O
29 tube NN I-NP O
29 placement JJ B-NP O
29 Evaluation NN I-NP O
29 of IN B-VP O
29 the DT B-NP O
29 pleural JJ I-NP O
29 fluid NN I-NP O
30 revealed VBD B-VP O
30 a DT B-NP O
30 transudative JJ I-NP B-r
30 effusion NN I-NP I-r
30 with IN B-VP O
30 all DT B-NP O
30 cultures NNS I-NP O
30 and CC O O
30 cytology NN B-NP O
31 remaining VBG O O
31 negative JJ O O
31 The DT B-NP O
31 patient NN I-NP O
31 was VBD B-VP O
31 treated VBN O O
31 with IN B-VP O
31 Ancef NNP B-NP B-m
31 for IN B-VP B-du
32 approximately RB O O
32 7 CD O O
32 days NNS B-NP O
32 while IN B-VP O
32 the DT B-NP O
32 chest JJS I-NP O
32 tube NN I-NP O
32 was VBD B-VP O
32 in IN B-VP O
32 place NN B-NP O
32 and CC O O
32 then RB O O
33 discharged VBD B-VP O
33 on IN B-VP O
33 11/30/94 CD O O
33 Since IN B-VP O
33 that DT B-NP O
33 time NN I-NP O
33 the DT B-NP O
33 patient NN I-NP O
33 has VBZ O O
33 had VBN O O
33 no DT B-NP O
34 improvement NN I-NP O
34 in IN B-VP O
34 her PRP$ O O
34 symptoms NNS B-NP O
34 but CC O O
34 rather RB O O
34 notes NNS B-NP O
34 increasing VBG O O
34 cough NN B-NP O
34 which WDT O O
35 remains VBZ O O
35 productive JJ O O
35 of IN B-VP O
35 white JJ B-NP O
35 sputum NN I-NP O
35 with IN B-VP O
35 occasional JJ B-NP O
35 "specks NNS I-NP O
35 of IN B-VP O
35 red" NN B-NP O
36 and CC O O
36 progression NN B-NP O
36 of IN B-VP O
36 her PRP$ O O
36 dyspnea NN B-NP O
36 on IN B-VP O
36 exertion NN B-NP O
36 She PRP O O
36 is VBZ O O
36 now RB O O
36 unable JJ O O
36 to TO O O
37 go VB O O
37 greater JJR O O
37 than IN B-VP O
37 six CD O O
37 steps NNS B-NP O
37 of IN B-VP O
37 stair NN B-NP O
37 without IN B-VP O
37 significant JJ B-NP O
37 dyspnea NN I-NP O
38 This DT O O
38 is VBZ O O
38 a DT B-NP O
38 significant JJ I-NP O
38 change NN I-NP O
38 from IN B-VP O
38 approximately RB O O
38 one CD O O
38 month NN B-NP O
38 ago IN B-VP O
38 where WRB O O
39 she PRP O O
39 was VBD B-VP O
39 able JJ O O
39 to TO O O
39 go VB O O
39 two CD O O
39 flights NNS B-NP O
39 without IN B-VP O
39 extreme NN B-NP O
39 difficulty NN I-NP O
39 She PRP O O
39 has VBZ O O
40 stable JJ O O
40 3 CD O O
40 + JJ B-NP O
40 pillow JJ I-NP O
40 orthopnea NN I-NP O
40 and CC O O
40 pedal JJ B-NP O
40 edema NN I-NP O
40 Her NNP I-NP O
40 weight NN I-NP O
40 has VBZ O O
41 increased VBN O O
41 only RB O O
41 slightly RB O O
41 recently RB O O
41 She PRP O O
41 denies VBZ O O
41 any DT B-NP O
41 fever NN I-NP O
41 , , O O
41 chills NNS B-NP O
41 , , O O
42 sweats NNS B-NP O
42 , , O O
42 chest JJS B-NP O
42 discomfort NN I-NP O
42 or CC O O
42 pleuritic JJ B-NP O
42 chest NN I-NP O
42 pain NN I-NP O
42 She PRP O O
42 does VBZ O O
42 not RB O O
43 anorexia VB O O
43 and CC O O
43 malaise VB O O
43 without IN B-VP O
43 myalgias NN B-NP O
43 or CC O O
43 arthralgias VB O O
43 PAST NNP B-NP O
43 MEDICAL NNP I-NP O
44 HISTORY: NNP I-NP O
44 1 CD O O
44 Dilated NNP B-NP O
44 cardiomyopathy NN I-NP O
44 as IN B-VP O
44 above IN B-VP O
44 2 CD O O
44 Breast NNP B-NP O
44 carcinoma NN I-NP O
45 as IN B-VP O
45 above IN B-VP O
45 3 CD O O
45 Hypothyroid $ O O
45 4 CD O O
45 Depression NNP B-NP O
45 ALLERGIES: NNP I-NP O
45 No NNP I-NP O
45 known VBN O O
45 drug NN B-NP O
46 allergies NNS I-NP O
46 Habits NNP I-NP O
46 , , O O
46 distant JJ B-NP O
46 tobacco NN I-NP O
46 use NN I-NP O
46 , , O O
46 none NN B-NP O
46 since IN B-VP O
46 1967 CD O O
46 , , O O
46 no DT B-NP O
46 ETOH NNP I-NP O
47 MEDICATIONS: NNP I-NP O
47 Digoxin NNP I-NP B-m
47 0.25 CD O B-do
47 mg NN B-NP I-do
47 q NN I-NP B-f
47 day NN I-NP I-f
47 , , O O
47 Lasix NNP B-NP B-m
47 80 CD O B-do
47 mg NN B-NP I-do
47 q NN I-NP B-f
47 day NN I-NP I-f
47 , , O O
47 Capoten NNP B-NP B-m
47 50 CD O B-do
48 mg NN B-NP O
48 t.i.d NN I-NP B-f
48 , , O O
48 aspirin VBP O B-m
48 one CD O B-do
48 per IN B-VP B-f
48 day NN B-NP I-f
48 , , O O
48 Synthroid NNP B-NP B-m
48 2 CD O B-do
48 gr NN B-NP I-do
48 per IN B-VP B-f
48 day NN B-NP I-f
48 , , O O
48 Tamoxifen NNP B-NP B-m
49 10 CD O B-do
49 mg NN B-NP I-do
49 b.i.d NN I-NP B-f
49 , , O O
49 Elavil NNP B-NP B-m
49 75 CD O B-do
49 mg NN B-NP I-do
49 q NN I-NP B-f
49 day NN I-NP I-f
49 , , O O
49 K-Dur NNP B-NP B-m
49 1 CD O B-do
49 q NN B-NP B-f
49 day NN I-NP I-f
49 SOCIAL NNP I-NP O
49 HISTORY: NNP I-NP O
50 The DT B-NP O
50 patient NN I-NP O
50 lives VBZ O O
50 with IN B-VP O
50 her PRP$ O O
50 boyfriend NN B-NP O
50 , , O O
50 she PRP O O
50 is VBZ O O
50 widowed VBN O O
50 without IN B-VP O
51 children NNS B-NP O
51 She PRP O O
51 is VBZ O O
51 a DT B-NP O
51 semi-retired JJ I-NP O
51 Accounts NNP I-NP O
51 Manager NNP I-NP O
51 FAMILY NNP I-NP O
51 HISTORY: NNP I-NP O
52 There EX O O
52 is VBZ O O
52 no DT B-NP O
52 family NN I-NP O
52 history NN I-NP O
52 of IN B-VP O
52 cardiac JJ B-NP O
52 disease NN I-NP O
53 PHYSICAL NNP I-NP O
53 EXAMINATION: NNP I-NP O
53 Temperature NNP I-NP O
53 100.6 CD O O
53 , , O O
53 blood NN B-NP O
53 pressure NN I-NP O
53 116/65 CD O O
53 , , O O
54 heart NN B-NP O
54 rate NN I-NP O
54 is VBZ O O
54 100 CD O O
54 , , O O
54 respiratory NN B-NP O
54 rate NN I-NP O
54 18 CD O O
54 02 CD O O
55 saturation NN B-NP O
55 90% CD O O
55 on IN B-VP O
55 room NN B-NP O
55 air NN I-NP O
55 The DT B-NP O
55 patient NN I-NP O
55 is VBZ O O
55 alert JJ O O
55 , , O O
55 responsive JJ O O
55 , , O O
56 febrile JJ O O
56 and CC O O
56 in IN B-VP O
56 no DT B-NP O
56 acute NN I-NP O
56 distress NN I-NP O
56 Her NNP I-NP O
56 conjunctiva NN I-NP O
56 are VBP O O
56 clear JJ O O
56 , , O O
57 extraocular JJ B-NP O
57 movements NNS I-NP O
57 intact JJ O O
57 , , O O
57 her PRP$ O O
57 oropharynx NN B-NP O
57 is VBZ O O
57 clear JJ O O
57 She PRP O O
57 has VBZ O O
57 no DT B-NP O
58 lymphadenopathy JJ I-NP O
58 Jugular NNP I-NP O
58 venous JJ B-NP O
58 pressure NN I-NP O
58 is VBZ O O
58 approximately RB O O
58 8 CD O O
58 cm NNS B-NP O
58 at IN B-VP O
59 30 CD O O
59 degrees NNS B-NP O
59 Lung NNP I-NP O
59 examination NN I-NP O
59 is VBZ O O
59 remarkable JJ O O
59 for IN B-VP O
59 a DT B-NP O
59 few JJ I-NP O
59 rales NNS I-NP O
59 at IN B-VP O
59 the DT B-NP O
60 left JJ I-NP O
60 base NN I-NP O
60 , , O O
60 decreased VBN O O
60 breath NN B-NP O
60 sounds NNS I-NP O
60 at IN B-VP O
60 the DT B-NP O
60 right JJ I-NP O
60 base NN I-NP O
60 with IN B-VP O
60 dullness NN B-NP O
61 to TO O O
61 percussion NN B-NP O
61 Cardiac NNP I-NP O
61 examination NN I-NP O
61 , , O O
61 regular JJ B-NP O
61 rate NN I-NP O
61 and CC O O
61 rhythm NN B-NP O
61 with IN B-VP O
62 normal JJ B-NP O
62 SI NNP I-NP O
62 , , O O
62 SII NNP B-NP O
62 , , O O
62 positive JJ B-NP O
62 SIII NNP I-NP O
62 Abdomen NNP I-NP O
62 is VBZ O O
62 soft JJ O O
62 and CC O O
62 non-tender JJ O O
62 , , O O
63 slightly RB O O
63 distended VBN O O
63 She PRP O O
63 has VBZ O O
63 pitting VBG O O
63 edema RB O O
63 almost RB O O
63 to TO O O
63 the DT B-NP O
63 knees NNS I-NP O
64 bilaterally RB O O
64 Neurological NNP B-NP O
64 examination NN I-NP O
64 is VBZ O O
64 non JJ B-NP O
64 focal JJ I-NP O
65 LABORATORY NNP I-NP O
65 DATA: NNP I-NP O
65 SMA-7 NNP I-NP O
65 is VBZ O O
65 notable JJ O O
65 for IN B-VP O
65 a DT B-NP O
65 potassium NN I-NP O
65 of IN B-VP O
65 5.4 CD O O
65 and CC O O
66 creatinine NN B-NP O
66 of IN B-VP O
66 1.2 CD O O
66 with IN B-VP O
66 a DT B-NP O
66 BUN NNP I-NP O
66 of IN B-VP O
66 20 CD O O
66 CBC NNP B-NP O
67 demonstrated VBD B-VP O
67 a DT B-NP O
67 white JJ I-NP O
67 count NN I-NP O
67 of IN B-VP O
67 14 CD O O
67 , , O O
67 hematocrit NN B-NP O
67 of IN B-VP O
67 42.9 CD O O
67 , , O O
67 platelets NNS B-NP O
68 289 CD O O
68 , , O O
68 Digoxin NNP B-NP O
68 level NN I-NP O
68 was VBD B-VP O
68 1.2 CD O O
68 Chest NNP B-NP O
68 x-ray NN I-NP O
68 showed VBD B-VP O
68 a DT B-NP O
68 left JJ I-NP O
68 pleural JJ I-NP O
69 effusion NN I-NP O
69 which WDT O O
69 is VBZ O O
69 unchanged JJ O O
69 , , O O
69 a DT B-NP O
69 new JJ I-NP O
69 right JJ I-NP O
69 pleural JJ I-NP O
69 effusion NN I-NP O
69 +- JJ B-NP O
70 consolidation NN I-NP O
70 EKG NNP I-NP O
70 showed VBD B-VP O
70 sinus JJ B-NP O
70 rhythm NN I-NP O
70 at IN B-VP O
70 98 CD O O
70 , , O O
70 left VBD B-VP O
70 axis JJ B-NP O
70 deviation NN I-NP O
70 , , O O
71 normal JJ B-NP O
71 intervals NNS I-NP O
71 , , O O
71 low JJ B-NP O
71 voltage NN I-NP O
71 with IN B-VP O
71 poor JJ B-NP O
71 R NNP I-NP O
71 wave NN I-NP O
71 progression NN I-NP O
71 , , O O
71 no DT B-NP O
72 significant JJ I-NP O
72 change NN I-NP O
72 compared VBN O O
72 with IN B-VP O
72 2/12/94 CD O O
73 HOSPITAL NNP B-NP O
73 COURSE: NNP I-NP O
73 The DT B-NP O
73 patient NN I-NP O
73 was VBD B-VP O
73 admitted VBN O O
73 with IN B-VP O
73 a DT B-NP O
73 picture NN I-NP O
73 of IN B-VP O
73 chronic JJ B-NP O
74 productive JJ I-NP O
74 cough NN I-NP O
74 , , O O
74 progressive JJ B-NP O
74 dyspnea NN I-NP O
74 with IN B-VP O
74 low JJ B-NP O
75 grade NN I-NP O
75 fevers NNS I-NP O
75 and CC O O
75 increased VBD B-VP O
75 white JJ B-NP O
75 blood NN I-NP O
75 cell NN I-NP O
75 count NN I-NP O
75 , , O O
75 in IN B-VP O
75 addition NN B-NP O
75 to TO O O
76 new JJ B-NP O
76 opacity NN I-NP O
76 on IN B-VP O
76 chest JJS B-NP O
76 x-ray NN I-NP O
76 This DT B-NP O
76 clinical JJ I-NP O
76 picture NN I-NP O
76 was VBD B-VP O
76 felt VBN O O
76 to TO O O
76 be VB O O
77 mostly RB O O
77 from IN B-VP O
77 a DT B-NP O
77 progressive JJ I-NP O
77 infectious JJ I-NP O
77 process NN I-NP O
77 superimposed VBN O O
77 on IN B-VP O
78 underlying VBG O O
78 congestive JJ B-NP O
78 heart NN I-NP O
78 failure NN I-NP O
78 versus IN B-VP O
78 post-obstructive JJ B-NP O
79 infection NN I-NP O
79 versus IN B-VP O
79 atelectasis NN B-NP O
79 with IN B-VP O
79 an DT B-NP O
79 endobronchial JJ I-NP O
79 lesion NN I-NP O
79 The DT B-NP O
80 patient NN I-NP O
80 was VBD B-VP O
80 started VBN O O
80 on IN B-VP O
80 empiric JJ B-NP O
80 course NN I-NP O
80 of IN B-VP O
80 antibiotics NNS B-NP B-m
80 including VBG O O
81 cefotaxime NN B-NP B-m
81 and CC O O
81 clarithromycin NN B-NP B-m
81 She PRP O O
81 was VBD B-VP O
81 seen VBN O O
81 in IN B-VP O
81 consultation NN B-NP O
81 by IN B-VP O
81 the DT B-NP O
82 Pulmonary NNP I-NP O
82 Service NNP I-NP O
82 which WDT O O
82 felt VBD B-VP O
82 that IN B-VP O
82 a DT B-NP O
82 therapeutic JJ I-NP O
82 trial NN I-NP O
82 of IN B-VP O
82 aggressive JJ B-NP O
83 diuresis NN I-NP O
83 was VBD B-VP O
83 warranted VBN O O
83 prior RB O O
83 to TO O O
83 any DT O O
83 more RBR O O
83 aggressive JJ B-NP O
83 intervention NN I-NP O
84 such JJ O O
84 as IN B-VP O
84 bronchoscopy NN B-NP O
84 or CC O O
84 repeat NN B-NP O
84 thoracentesis IN B-VP O
84 The DT B-NP O
84 patient NN I-NP O
84 was VBD B-VP O
84 thus RB O O
85 treated VBN O O
85 with IN B-VP O
85 aggressive JJ B-NP O
85 IV NNP I-NP O
85 diuresis NN I-NP O
85 with IN B-VP O
85 excellent JJ B-NP O
85 symptomatic JJ I-NP O
86 result NN I-NP O
86 As IN B-VP O
86 her PRP$ O O
86 symptoms NNS B-NP O
86 and CC O O
86 chest JJS B-NP O
86 x-ray JJ I-NP O
86 cleared NN I-NP O
86 , , O O
86 it PRP O O
86 was VBD B-VP O
86 felt VBN O O
86 that IN B-VP O
87 a DT B-NP O
87 chest NN I-NP O
87 CT NNP I-NP O
87 would MD O O
87 be VB O O
87 valuable JJ O O
87 in IN B-VP O
87 evaluating VBG O O
87 her PRP$ O O
87 left JJ B-NP O
87 lower JJR I-NP O
87 lobe NN I-NP O
87 for IN B-VP O
88 possible JJ B-NP O
88 endobronchial JJ I-NP O
88 lesion NN I-NP O
88 leading VBG O O
88 to TO O O
88 volume NN B-NP O
88 loss NN I-NP O
88 She PRP O O
88 thus RB O O
89 underwent VBD B-VP O
89 a DT B-NP O
89 chest NN I-NP O
89 CT NNP I-NP O
89 on IN B-VP O
89 5/16/94 CD O O
89 with IN B-VP O
89 demonstration NN B-NP O
89 of IN B-VP O
89 a DT B-NP O
89 large JJ I-NP O
90 peripheral NN I-NP O
90 , , O O
90 red JJ O O
90 , , O O
90 right JJ B-NP O
90 lower JJR I-NP O
90 lobe NN I-NP O
90 opacity NN I-NP O
90 , , O O
90 highly RB O O
90 suggestive JJ O O
90 of IN B-VP O
90 a DT B-NP O
91 right JJ I-NP O
91 lower JJR I-NP O
91 lobe NN I-NP O
91 pulmonary JJ B-NP O
91 infarction NN I-NP O
91 No NNP I-NP O
91 endobronchial JJ B-NP O
91 lesions NNS I-NP O
91 or CC O O
92 lymphadenopathy NNS B-NP O
92 were VBD B-VP O
92 noted VBN O O
92 Given NNP B-NP O
92 the DT B-NP O
92 patient's JJ I-NP O
92 history NN I-NP O
92 of IN B-VP O
92 dilated VBN O O
93 cardiomyopathy NN B-NP O
93 , , O O
93 off RB O O
93 anticoagulation NN B-NP O
93 , , O O
93 an DT B-NP O
93 extensive JJ I-NP O
93 discussion NN I-NP O
93 of IN B-VP O
93 the DT B-NP O
94 chest JJS I-NP O
94 CT JJ I-NP O
94 findings NNS I-NP O
94 with IN B-VP O
94 the DT B-NP O
94 Chest NNP I-NP O
94 Radiologist NNP I-NP O
94 and CC O O
94 Pulmonary NNP B-NP O
94 Consult NNP I-NP O
95 Team NNP I-NP O
95 , , O O
95 it PRP O O
95 was VBD B-VP O
95 felt VBN O O
95 that IN B-VP O
95 the DT B-NP O
95 patient NN I-NP O
95 should MD O O
95 be VB O O
95 treated VBN O O
95 empirically RB O O
96 for IN B-VP O
96 a DT B-NP O
96 pulmonary JJ I-NP B-r
96 embolus NN I-NP I-r
96 She PRP O O
96 was VBD B-VP O
96 thus RB O O
96 started VBN O O
96 on IN B-VP O
96 IV NNP B-NP B-mo
96 Heparin NNP I-NP B-m
96 with IN B-VP O
97 achievement NN B-NP O
97 of IN B-VP O
97 therapeutic JJ B-NP O
97 PTT NNP I-NP O
97 prior RB O O
97 to TO O O
97 switching VBG O O
97 to TO O O
97 oral JJ B-NP B-mo
97 Coumadin NNP I-NP B-m
98 without IN B-VP O
98 complications NNS B-NP O
98 In IN B-VP O
98 addition NN B-NP O
98 the DT B-NP O
98 patient NN I-NP O
98 underwent NN I-NP O
98 lower JJR B-NP O
99 extremity NN I-NP O
99 non-invasives NNS I-NP O
99 which WDT O O
99 were VBD B-VP O
99 negative JJ O O
99 for IN B-VP O
99 deep JJ B-NP O
99 venous JJ I-NP O
100 thrombosis NN I-NP O
100 as RB O O
100 well RB O O
100 as IN B-VP O
100 a DT B-NP O
100 cardiac NN I-NP O
100 echocardiogram NN I-NP O
100 which WDT O O
100 showed VBD B-VP O
100 no DT B-NP O
101 evidence NN I-NP O
101 of IN B-VP O
101 RV NNP B-NP O
101 strain NN I-NP O
101 or CC O O
101 right JJ B-NP O
101 ventricular JJ I-NP O
101 thrombus NN I-NP O
101 Of IN B-VP O
101 note NN B-NP O
101 , , O O
101 this DT B-NP O
102 echocardiogram NN I-NP O
102 again RB O O
102 demonstrated VBD B-VP O
102 moderately RB O O
102 large JJ O O
102 left VBD B-VP O
102 ventricle NN B-NP O
103 with IN B-VP O
103 severely RB O O
103 depressed JJ B-NP O
103 systolic JJ I-NP O
103 function NN I-NP O
103 and CC O O
103 an DT O O
103 estimated VBN O O
103 ejection NN B-NP O
104 fraction NN I-NP O
104 of IN B-VP O
104 15-20% JJ O O
104 Though IN B-VP O
104 the DT B-NP O
104 possibility NN I-NP O
104 that IN B-VP O
104 the DT B-NP O
104 wedge NN I-NP O
104 shaped VBD B-VP O
105 opacification NN B-NP O
105 seen VBN O O
105 on IN B-VP O
105 CT NNP B-NP O
105 was VBD B-VP O
105 due JJ O O
105 to TO O O
105 pneumonia VB O O
105 rather RB O O
105 than IN B-VP O
106 infarction NN B-NP O
106 , , O O
106 it PRP O O
106 was VBD B-VP O
106 felt VBN O O
106 that IN B-VP O
106 given VBN O O
106 the DT B-NP O
106 patient's NN I-NP O
106 low JJ B-NP O
106 ejection NN I-NP O
107 fraction NN I-NP O
107 she PRP O O
107 would MD O O
107 need VB O O
107 to TO O O
107 be VB O O
107 anticoagulated VBN O O
107 on IN B-VP O
107 this DT B-NP O
107 basis NN I-NP O
107 alone RB O O
107 , , O O
108 and CC O O
108 thus RB O O
108 pulmonary JJ B-NP O
108 angiogram NN I-NP O
108 or CC O O
108 VQ NNP B-NP O
108 scan NNS I-NP O
108 would MD O O
108 not RB O O
108 be VB O O
108 likely RB O O
108 to TO O O
109 alter VB O O
109 management NN B-NP O
109 The DT B-NP O
109 patient NN I-NP O
109 was VBD B-VP O
109 discharged VBN O O
109 to TO O O
109 home VB O O
110 DISPOSITION: NNP B-NP O
110 The DT B-NP O
110 patient NN I-NP O
110 was VBD B-VP O
110 discharged VBN O O
110 to TO O O
110 home VB O O
110 MEDICATIONS: NNP B-NP O
111 Elavil NNP I-NP B-m
111 75 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 q NN I-NP B-f
111 h.s.; NN I-NP I-f
111 Captopril NNP I-NP B-m
111 50 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 t.i.d.; NN I-NP B-f
112 Biaxin NNP I-NP B-m
112 500 CD O B-do
112 mg NN B-NP I-do
112 p.o NN I-NP B-mo
112 b.i.d.; NN I-NP B-f
112 Digoxin NNP I-NP B-m
112 Digoxin NNP I-NP B-m
112 0.125 CD O B-do
112 0.125 CD O B-do
112 mg NNS B-NP I-do
112 alternating VBG O B-mo
112 with IN B-VP O
112 0.25 CD O O
113 mg NNS B-NP O
113 q JJ B-NP B-f
113 q JJ I-NP B-f
113 day; NN I-NP I-f
113 day; NN I-NP I-f
113 Lasix NNP I-NP B-m
113 80 CD O B-do
113 mg NN B-NP I-do
113 p.o NN I-NP B-mo
113 b.i.d.; NN I-NP B-f
113 Tamoxifen NNP I-NP B-m
113 10 CD O B-do
113 mg NN B-NP I-do
113 p.o NN I-NP B-mo
113 b.i.d.; NN I-NP B-f
114 Thyroid NNP I-NP B-m
114 2 CD O B-do
114 grains NNS B-NP I-do
114 p.o JJ B-NP B-mo
114 q JJ I-NP B-f
114 day; NN I-NP I-f
114 Coumadin NNP I-NP B-m
114 5 CD O B-do
114 mg NN B-NP I-do
114 p.o NN I-NP B-mo
114 q JJ B-NP B-f
114 day; JJ I-NP I-f
114 K-Dur NNP I-NP B-m
114 20 CD O B-do
114 mg NN B-NP I-do
115 p.o NN I-NP B-mo
115 b.i.d.; NN I-NP B-f
115 Ambien NNP I-NP B-m
115 10 CD O B-do
115 mg NN B-NP I-do
115 p.o NN I-NP B-mo
115 q NN I-NP B-f
115 h.s NN I-NP I-f
115 Followup NNP I-NP O
115 with IN B-VP O
115 Dr NNP B-NP O
115 Gunsolus NNP I-NP O
115 at IN B-VP O
116 the DT B-NP O
116 Leyer NNP I-NP O
116 Memorial NNP I-NP O
116 Hospital NNP I-NP O
117 Dictated NNP I-NP O
117 By: NNP I-NP O
117 AHMED NNP I-NP O
117 M NNP I-NP O
117 HEILIGER NNP I-NP O
117 , , O O
117 M.D NNP B-NP O
117 GW87 NNP I-NP O
118 Attending: NNP I-NP O
118 ELWOOD NNP I-NP O
118 A NNP I-NP O
118 COGGSDALE NNP I-NP O
118 , , O O
118 M.D NNP B-NP O
118 VG9 NNP I-NP O
119 GF161/5805 NNP I-NP O
120 Batch: NNP I-NP O
120 7200 CD O O
120 Index NNP B-NP O
120 No NNP I-NP O
120 BRLF3LS21 NNP I-NP O
120 D: NNP I-NP O
120 10/25/94 CD O O
121 T: NNP B-NP O
121 10/4/94 CD O O
122 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #797772 VBZ O O
4 670298908 CD O O
4 MH NNP B-NP O
4 16618177 CD O O
4 720662 CD O O
4 8/17/1999 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 SYNCOPE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/21/1999 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/13/1999 CD O O
7 SERVICE: NNP B-NP O
7 The DT B-NP O
7 patient NN I-NP O
7 was VBD B-VP O
7 cared VBN O O
7 for IN B-VP O
7 on IN B-VP O
7 Cardiology NNP B-NP O
7 Team NNP I-NP O
7 Pro NNP I-NP O
7 Tampi NNP I-NP O
7 Corp NNP I-NP O
8 PRINCIPAL NNP I-NP O
8 DIAGNOSIS: NNP I-NP O
8 Syncope NNP I-NP O
9 ADDITIONAL NNP I-NP O
9 DIAGNOSES NNP I-NP O
9 INCLUDE: NNP I-NP O
9 1 CD O O
9 Coronary NNP B-NP O
9 artery NN I-NP O
9 disease NN I-NP O
9 2 CD O O
10 Bradycardia NNP B-NP O
10 3 CD O O
10 Diabetes NNP B-NP O
10 mellitus VBD B-VP O
10 4 CD O O
10 Hypertension NNP B-NP O
10 5 CD O O
11 Chronic NNP B-NP O
11 renal JJ B-NP O
11 insufficiency NN I-NP O
12 HISTORY NNP I-NP O
12 OF NNP I-NP O
12 PRESENT NNP I-NP O
12 ILLNESS: NNP I-NP O
12 The DT B-NP O
12 patient NN I-NP O
12 is VBZ O O
12 a DT B-NP O
12 74-year-old JJ I-NP O
12 male NN I-NP O
12 with IN B-VP O
13 history NN B-NP O
13 of IN B-VP O
13 acute JJ B-NP O
13 inferior JJ I-NP O
13 myocardial JJ I-NP O
13 infarction NN I-NP O
13 in IN B-VP O
13 February NNP B-NP O
13 of IN B-VP O
14 1998 CD O O
14 , , O O
14 with IN B-VP O
14 total JJ B-NP O
14 occlusion NN I-NP O
14 of IN B-VP O
14 the DT B-NP O
14 mid NN I-NP O
14 circumflex NN I-NP O
14 , , O O
14 with IN B-VP O
14 fresh JJ B-NP O
15 thrombus NN I-NP O
15 which WDT O O
15 was VBD B-VP O
15 percutaneous JJ B-NP O
15 transluminal JJ I-NP O
15 coronary NN I-NP O
15 angioplastied VBD B-VP O
16 and CC O O
16 stented VBD B-VP O
16 At IN B-VP O
16 catheterization NN B-NP O
16 in IN B-VP O
16 February NNP B-NP O
16 , , O O
16 he PRP O O
16 was VBD B-VP O
16 noted VBN O O
16 to TO O O
16 have VB O O
17 50 CD O O
17 percent NN B-NP O
17 right RB O O
17 coronary JJ O O
17 artery RB O O
17 , , O O
17 as IN B-VP O
17 well RB O O
17 His PRP$ O O
17 hospital NN B-NP O
17 course NN I-NP O
17 at IN B-VP O
18 that DT B-NP O
18 time NN I-NP O
18 was VBD B-VP O
18 complicated VBN O O
18 by IN B-VP O
18 atrial JJ B-NP B-r
18 fibrillation NN I-NP I-r
18 with IN B-VP O
18 Mobitz NNP B-NP O
18 type NN I-NP O
18 I PRP O O
19 block VBP O O
19 The DT B-NP O
19 patient NN I-NP O
19 was VBD B-VP O
19 loaded VBN O O
19 on IN B-VP O
19 procainamide NN B-NP B-m
19 He PRP O O
19 also RB O O
19 had VBD B-VP O
20 several JJ B-NP O
20 episodes NNS I-NP O
20 of IN B-VP O
20 congestive JJ B-NP O
20 heart NN I-NP O
20 failure NN I-NP O
20 Echocardiogram NNP I-NP O
20 in IN B-VP O
21 February NNP B-NP O
21 showed VBD B-VP O
21 right JJ B-NP O
21 ventricular JJ I-NP O
21 dysfunction NN I-NP O
21 At IN B-VP O
21 discharge NN B-NP O
21 , , O O
21 a DT B-NP O
22 submaximum JJ I-NP O
22 exercise NN I-NP O
22 tolerance NN I-NP O
22 test NN I-NP O
22 , , O O
22 the DT B-NP O
22 patient NN I-NP O
22 went VBD B-VP O
22 three CD O O
22 minutes NNS B-NP O
23 and CC O O
23 twenty-one JJ B-NP O
23 seconds NNS I-NP O
23 without IN B-VP O
23 evidence NN B-NP O
23 of IN B-VP O
23 ischemia NN B-NP O
23 On IN B-VP O
23 the DT B-NP O
23 day NN I-NP O
23 of IN B-VP O
24 admission NN B-NP O
24 , , O O
24 the DT B-NP O
24 patient NN I-NP O
24 was VBD B-VP O
24 in IN B-VP O
24 cardiac JJ B-NP O
24 rehabilitation NN I-NP O
24 class NN I-NP O
24 when WRB O O
24 he PRP O O
25 became VBD B-VP O
25 light-headed JJ O O
25 while IN B-VP O
25 seated VBN O O
25 and CC O O
25 lost VBN O O
25 consciousness NN B-NP O
25 for IN B-VP O
26 approximately RB O O
26 five CD O O
26 seconds NNS B-NP O
26 He PRP O O
26 regained VBD B-VP O
26 full JJ B-NP O
26 consciousness NN I-NP O
26 He PRP O O
27 denied VBD B-VP O
27 chest JJS B-NP O
27 pain NN I-NP O
27 , , O O
27 shortness NN B-NP O
27 of IN B-VP O
27 breath NN B-NP O
27 , , O O
27 chest NN B-NP O
27 tightness NN I-NP O
27 , , O O
27 fever NN B-NP O
27 , , O O
28 chills NNS B-NP O
28 , , O O
28 nausea NN B-NP O
28 or CC O O
28 vomiting NN B-NP O
28 He PRP O O
28 had VBD B-VP O
28 no DT B-NP O
28 urine NN I-NP O
28 or CC O O
28 stool NN B-NP O
28 incontinence NN I-NP O
28 , , O O
29 and CC O O
29 no DT B-NP O
29 focal JJ I-NP O
29 abnormal JJ I-NP O
29 motor NN I-NP O
29 movements NNS I-NP O
29 were VBD B-VP O
29 noted VBN O O
29 by IN B-VP O
29 observers NNS B-NP O
29 A NNP I-NP O
30 code NN I-NP O
30 blue NN I-NP O
30 was VBD B-VP O
30 called VBN O O
30 , , O O
30 and CC O O
30 he PRP O O
30 went VBD B-VP O
30 to TO O O
30 the DT B-NP O
30 Emergency NNP I-NP O
30 Department NNP I-NP O
31 Electrocardiogram NNP I-NP O
31 showed VBD B-VP O
31 old JJ B-NP O
31 inferior JJ I-NP O
31 Qs NNP I-NP O
31 , , O O
31 PRWP NNP B-NP O
31 , , O O
31 and CC O O
31 slightly RB O O
32 elevated VBD B-VP O
32 T NNP B-NP O
32 wave NN I-NP O
32 in IN B-VP O
32 V2 NNP B-NP O
32 with IN B-VP O
32 left JJ B-NP O
32 anterior JJ I-NP O
32 fascicular JJ I-NP O
32 block NN I-NP O
32 with IN B-VP O
33 heart NN B-NP O
33 rate NN I-NP O
33 of IN B-VP O
33 49 CD O O
33 Initial JJ B-NP O
33 CK NNP I-NP O
33 was VBD B-VP O
33 39 CD O O
33 with IN B-VP O
33 a DT B-NP O
33 Troponin NNP I-NP O
33 I PRP O O
33 of IN B-VP O
33 0.02 CD O O
33 He PRP O O
34 was VBD B-VP O
34 admitted VBN O O
34 to TO O O
34 Wa NNP B-NP O
34 T NNP I-NP O
34 S NNP I-NP O
34 for IN B-VP O
34 further JJ B-NP O
34 workup NN I-NP O
34 and CC O O
34 treatment NN B-NP O
35 PAST NNP I-NP O
35 MEDICAL NNP I-NP O
35 HISTORY: NNP I-NP O
35 1 CD O O
35 Coronary NNP B-NP O
35 artery NN I-NP O
35 disease NN I-NP O
35 2 CD O O
35 Diabetes NNPS B-NP B-r
36 mellitus NN I-NP O
36 on IN B-VP O
36 insulin NN B-NP B-m
36 3 CD O O
36 Hypertension NNP B-NP O
36 4 CD O O
36 Status NNP B-NP O
36 post NN I-NP O
36 bilateral JJ B-NP O
37 knee NN I-NP O
37 replacements NNS I-NP O
37 5 CD O O
37 Asbestos NNP B-NP O
37 exposure NN I-NP O
37 6 CD O O
37 Chronic NNP B-NP O
37 renal JJ B-NP O
38 insufficiency NN I-NP O
39 ALLERGIES: NNP I-NP O
39 Allergies NNP I-NP O
39 to TO O O
39 penicillin VB O O
40 MEDICATIONS NNP B-NP O
40 ON NNP I-NP O
40 ADMISSION: NNP I-NP O
40 1 CD O O
40 Aspirin NNP B-NP B-m
40 325 CD O B-do
40 mg NN B-NP I-do
40 q.d NN I-NP B-f
40 2 CD O O
40 Captopril NNP B-NP B-m
41 75 CD O B-do
41 mg NN B-NP I-do
41 t.i.d NN I-NP B-f
41 3 CD O O
41 NPH NNP B-NP B-m
41 NPH NNP I-NP B-m
41 insulin NN I-NP I-m
41 insulin NN I-NP I-m
41 18 CD O B-do
41 q.a.m NN B-NP B-f
41 and CC O O
41 8 CD O B-do
41 q.p.m NN B-NP B-f
41 4 CD O O
42 Procainamide NNP B-NP B-m
42 500 CD O B-do
42 mg NN B-NP I-do
42 t.i.d NN I-NP B-f
42 5 CD O O
42 Simvastatin NNP B-NP B-m
42 20 CD O B-do
42 mg NN B-NP I-do
42 once RB O B-f
42 a DT B-NP I-f
42 day NN I-NP I-f
43 SOCIAL NNP I-NP O
43 HISTORY: NNP I-NP O
43 A NNP I-NP O
43 40 CD O O
43 pack NN B-NP O
43 year NN I-NP O
43 history NN I-NP O
43 , , O O
43 quit VB O O
43 four CD O O
43 years NNS B-NP O
43 ago RB O O
44 Denies VBZ O O
44 alcohol NN B-NP O
45 PHYSICAL NNP I-NP O
45 EXAMINATION NNP I-NP O
45 ON NNP I-NP O
45 ADMISSION: NNP I-NP O
45 A NNP I-NP O
45 well-appearing JJ B-NP O
45 gentleman NN I-NP O
45 , , O O
45 in IN B-VP O
46 no DT B-NP O
46 apparent JJ I-NP O
46 distress NN I-NP O
46 Vital NNP I-NP O
46 signs NNS I-NP O
46 , , O O
46 afebrile NN B-NP O
46 , , O O
46 heart NN B-NP O
46 rate NN I-NP O
46 50 CD O O
46 , , O O
46 blood NN B-NP O
47 pressure NN I-NP O
47 111/87 CD O O
47 , , O O
47 respirations NNS B-NP O
47 16 CD O O
47 , , O O
47 98 CD O O
47 percent NN B-NP O
47 on IN B-VP O
47 two CD O O
47 liters NNS B-NP O
47 HEENT NNP I-NP O
47 , , O O
48 atraumatic JJ O O
48 , , O O
48 normocephalic JJ O O
48 , , O O
48 oropharynx JJ B-NP O
48 clear JJ I-NP O
48 Neck NNP I-NP O
48 , , O O
48 carotids VBZ O O
48 2+ CD O O
48 , , O O
48 no DT B-NP O
49 bruits NNS I-NP O
49 , , O O
49 no DT B-NP O
49 cervical JJ I-NP O
49 adenopathy NN I-NP O
49 with IN B-VP O
49 the DT B-NP O
49 exception NN I-NP O
49 of IN B-VP O
49 a DT O O
49 2.0 CD O O
50 centimeter NN B-NP O
50 node NN I-NP O
50 in IN B-VP O
50 the DT B-NP O
50 occipital JJ I-NP O
50 region NN I-NP O
50 Chest NNP I-NP O
50 , , O O
50 clear JJ O O
50 to TO O O
51 auscultation VB O O
51 bilaterally RB O O
51 Cardiovascular NNP B-NP O
51 , , O O
51 bradycardic NN B-NP O
51 , , O O
51 regular JJ B-NP O
52 rate NN I-NP O
52 and CC O O
52 rhythm NN B-NP O
52 , , O O
52 normal JJ B-NP O
52 S1 NNP I-NP O
52 and CC O O
52 S2 NNP B-NP O
52 Abdomen NNP I-NP O
52 , , O O
52 positive JJ B-NP O
52 bowel NN I-NP O
52 sounds NNS I-NP O
52 , , O O
53 soft JJ O O
53 , , O O
53 non-tender JJ O O
53 , , O O
53 nondistended JJ O O
53 , , O O
53 no DT B-NP O
53 hepatosplenomegaly NN I-NP O
54 Extremities NNS I-NP O
54 , , O O
54 no DT B-NP O
54 edema NN I-NP O
54 , , O O
54 no DT B-NP O
54 other JJ I-NP O
54 lymphadenopathy JJ I-NP O
54 Neurological NNP I-NP O
55 examination NN I-NP O
55 , , O O
55 alert NN B-NP O
55 and CC O O
55 oriented VBD B-VP O
55 x NNP B-NP O
55 three CD O O
55 , , O O
55 non-focal JJ B-NP O
56 LABORATORY NNP I-NP O
56 DATA: NNP I-NP O
56 Admission NNP I-NP O
56 laboratory NN I-NP O
56 is VBZ O O
56 significant JJ O O
56 for IN B-VP O
56 a DT B-NP O
57 creatinine NN I-NP O
57 of IN B-VP O
57 1.6 CD O O
57 and CC O O
57 a DT B-NP O
57 potassium NN I-NP O
57 of IN B-VP O
57 5.1 CD O O
57 Blood NNP B-NP O
57 count NN I-NP O
57 were VBD B-VP O
57 white JJ B-NP O
58 blood NN I-NP O
58 cell NN I-NP O
58 count NN I-NP O
58 5.5 CD O O
58 , , O O
58 hematocrit NN B-NP O
58 44.6 CD O O
58 , , O O
58 platelets NNS B-NP O
58 233 CD O O
58 CK NNP B-NP O
58 39 CD O O
58 , , O O
59 cardiac JJ B-NP O
59 Troponin NNP I-NP O
59 I PRP O O
59 0.02 VBP O O
60 HOSPITAL NNP B-NP O
60 COURSE: NNP I-NP O
60 The DT B-NP O
60 patient NN I-NP O
60 is VBZ O O
60 a DT B-NP O
60 74-year-old JJ I-NP O
60 male NN I-NP O
60 with IN B-VP O
60 history NN B-NP O
60 of IN B-VP O
61 acute JJ B-NP O
61 inferior JJ I-NP O
61 myocardial JJ I-NP O
61 infarction NN I-NP O
61 in IN B-VP O
61 February NNP B-NP O
61 , , O O
61 complicated VBN O O
61 by IN B-VP O
62 postmyocardial JJ B-NP O
62 infarction NN I-NP O
62 atrial JJ B-NP O
62 fibrillation NN I-NP O
62 and CC O O
62 Mobitz NNP B-NP O
62 type NN I-NP O
62 I PRP O O
63 block VBP O O
63 , , O O
63 now RB O O
63 admitted VBN O O
63 following VBG O O
63 syncopal JJ O O
63 episode IN B-VP O
63 The DT B-NP O
64 Electrophysiology NNP I-NP O
64 Service NNP I-NP O
64 was VBD B-VP O
64 consulted VBN O O
64 and CC O O
64 prior JJ O O
64 to TO O O
65 electrophysiology VB O O
65 study VB O O
65 the DT B-NP O
65 patient JJ I-NP O
65 underwent JJ I-NP O
65 evaluation NN I-NP O
65 for IN B-VP O
66 possible JJ B-NP O
66 ischemic JJ I-NP O
66 causes NNS I-NP O
66 of IN B-VP O
66 an DT B-NP O
66 arrhythmia NN I-NP O
66 He PRP O O
66 was VBD B-VP O
66 initially RB O O
66 ruled VBN O O
67 out RP O O
67 for IN B-VP O
67 myocardial JJ B-NP O
67 infarction NN I-NP O
67 by IN B-VP O
67 serial JJ B-NP O
67 enzymes NNS I-NP O
67 and CC O O
68 electrocardiograms NNS B-NP O
68 On IN B-VP O
68 standard JJ B-NP O
68 Bruce NNP I-NP O
68 protocol NN I-NP O
68 exercise NN I-NP O
68 tolerance NN I-NP O
69 test NN I-NP O
69 mibi NN I-NP O
69 , , O O
69 May NNP B-NP O
69 , , O O
69 1999 CD O O
69 , , O O
69 the DT O O
69 patient JJ O O
69 went VBD B-VP O
69 four CD O O
69 minutes NNS B-NP O
69 and CC O O
70 thirty JJ B-NP O
70 seconds NNS I-NP O
70 , , O O
70 maximum JJ B-NP O
70 heart NN I-NP O
70 rate NN I-NP O
70 121 CD O O
70 , , O O
70 maximum JJ B-NP O
70 blood NN I-NP O
70 pressure NN I-NP O
71 210/85 CD O O
71 He PRP O O
71 had VBD B-VP O
71 typical JJ B-NP O
71 chest NN I-NP O
71 pain NN I-NP O
71 for IN B-VP O
71 angina NN B-NP O
71 and CC O O
71 chest JJS B-NP O
71 tightness NN I-NP O
72 at IN B-VP O
72 peak NN B-NP O
72 exercise NN I-NP O
72 which WDT O O
72 was VBD B-VP O
72 relieved VBN O O
72 with IN B-VP O
72 rest NN B-NP O
72 There EX O O
72 were VBD B-VP O
72 no DT B-NP O
73 electrocardiogram NN I-NP O
73 changes VBZ O O
73 He PRP O O
73 remained VBD B-VP O
73 in IN B-VP O
73 sinus NN B-NP O
73 rhythm NN I-NP O
73 Mibi NNP I-NP O
74 images VBZ O O
74 showed VBD B-VP O
74 a DT B-NP O
74 mixed JJ I-NP O
74 MI NNP I-NP O
74 in IN B-VP O
74 basilar JJ B-NP O
74 half NN I-NP O
74 of IN B-VP O
74 the DT B-NP O
74 inferior JJ I-NP O
74 wall NN I-NP O
74 in IN B-VP O
75 4/20 CD O O
75 segments NNS B-NP O
75 , , O O
75 mild JJ B-NP O
75 peri-infarct JJ I-NP O
75 ischemia NN I-NP O
75 in IN B-VP O
75 3/20 CD O O
75 segments NNS B-NP O
75 in IN B-VP O
75 the DT B-NP O
76 right JJ I-NP O
76 coronary JJ I-NP O
76 artery NN I-NP O
76 territory NN I-NP O
76 He PRP O O
76 had VBD B-VP O
76 normal JJ B-NP O
76 left JJ I-NP O
76 ventricular JJ I-NP O
77 function NN I-NP O
77 , , O O
77 normal JJ O O
77 left VBD B-VP O
77 ventricular JJ B-NP O
77 volume NN I-NP O
77 , , O O
77 and CC O O
77 global JJ B-NP O
77 systolic NN I-NP O
77 left VBD B-VP O
78 ventricular JJ B-NP O
78 function NN I-NP O
78 with IN B-VP O
78 left JJ B-NP O
78 ventricular JJ I-NP O
78 ejection NN I-NP O
78 fraction NN I-NP O
78 of IN B-VP O
78 55 CD O O
79 percent NN B-NP O
79 , , O O
79 wall JJ B-NP O
79 motion NN I-NP O
79 abnormalities NNS I-NP O
79 and CC O O
79 severe JJ B-NP O
79 inferior NN I-NP O
79 wall NN I-NP O
80 hypokinesis NN I-NP O
80 and CC O O
80 mild JJ B-NP O
80 septal JJ I-NP O
80 hypokinesis NN I-NP O
80 Based VBN O O
80 on IN B-VP O
80 the DT B-NP O
80 results NNS I-NP O
80 of IN B-VP O
81 the DT B-NP O
81 exercise NN I-NP O
81 tolerance NN I-NP O
81 test NN I-NP O
81 mibi NN I-NP O
81 , , O O
81 the DT B-NP O
81 patient JJ I-NP O
81 underwent JJ I-NP O
81 cardiac JJ I-NP O
82 catheterization NN I-NP O
82 on IN B-VP O
82 May NNP B-NP O
82 , , O O
82 1999 CD O O
82 which WDT O O
82 revealed VBD B-VP O
82 a DT B-NP O
82 normal JJ I-NP O
82 left NN I-NP O
83 main JJ O O
83 , , O O
83 left VBD B-VP O
83 anterior RP O O
83 descending VBG O O
83 artery NN B-NP O
83 with IN B-VP O
83 minor JJ B-NP O
83 irregularities NNS I-NP O
83 , , O O
84 left VBD B-VP O
84 circumflex NN B-NP O
84 with IN B-VP O
84 90 CD O O
84 percent JJ B-NP O
84 in-stent JJ I-NP O
84 restenosis NN I-NP O
84 in IN B-VP O
84 proximal JJ B-NP O
85 segment NN I-NP O
85 with IN B-VP O
85 a DT B-NP O
85 dominant JJ I-NP O
85 left NN I-NP O
85 circumflex NN I-NP O
85 , , O O
85 and CC O O
85 right RB O O
85 coronary JJ B-NP O
85 artery NN I-NP O
86 with IN B-VP O
86 a DT B-NP O
86 mid NN I-NP O
86 50 CD O O
86 percent NN B-NP O
86 lesion NN I-NP O
86 The DT B-NP O
86 patient NN I-NP O
86 underwent JJ B-NP O
86 successful JJ I-NP O
87 percutaneous JJ I-NP O
87 transluminal JJ I-NP O
87 coronary JJ I-NP O
87 angioplasty NN I-NP O
87 of IN B-VP O
87 the DT B-NP B-r
87 in-stent JJ I-NP O
88 restenosis NN I-NP O
88 He PRP O O
88 was VBD B-VP O
88 subsequently RB O O
88 continued VBN O O
88 on IN B-VP O
88 aspirin IN B-VP B-m
88 The DT B-NP O
89 Electrophysiology NNP I-NP O
89 Service NNP I-NP O
89 recommended VBD B-VP O
89 that IN B-VP O
89 the DT B-NP O
89 patient's NN I-NP O
90 procainamide RB O B-m
90 be VB O O
90 stopped VBN O O
90 Of IN B-VP O
90 note NN B-NP O
90 , , O O
90 the DT B-NP O
90 patient's NN I-NP O
90 QT NNP I-NP O
90 interval NN I-NP O
90 was VBD B-VP O
91 not RB O O
91 prolonged VBN O O
91 while IN B-VP O
91 on IN B-VP O
91 procainamide NN B-NP B-m
91 After IN B-VP O
91 the DT B-NP O
91 procainamide NN I-NP B-m
91 was VBD B-VP O
92 held VBN O O
92 , , O O
92 the DT B-NP O
92 patient JJ I-NP O
92 underwent JJ I-NP O
92 electrophysiology NN I-NP O
92 study NN I-NP O
92 on IN B-VP O
92 March NNP B-NP O
92 , , O O
93 1999 CD O O
93 revealing VBG O O
93 normal JJ B-NP O
93 sinus NN I-NP O
93 node JJ B-NP O
93 recovery NN I-NP O
93 time NN I-NP O
93 , , O O
93 impaired JJ B-NP O
93 AV NNP I-NP O
93 nodal JJ B-NP O
94 conduction NN I-NP O
94 , , O O
94 no DT O O
94 inducible JJ O O
94 sustained VBD B-VP O
94 ventricular JJ B-NP O
94 tachycardia NN I-NP O
94 , , O O
94 and CC O O
94 no DT B-NP O
95 inducible JJ I-NP O
95 supraventricular JJ I-NP O
95 tachycardia NN I-NP O
95 or CC O O
95 atrial JJ B-NP O
95 fibrillation NN I-NP O
95 The DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 discharged VBN O O
96 to TO O O
96 home VB O O
96 with IN B-VP O
96 plans NNS B-NP O
96 to TO O O
96 follow-up NN B-NP O
96 with IN B-VP O
96 his PRP$ O O
97 primary JJ B-NP O
97 cardiologist NN I-NP O
97 , , O O
97 perhaps RB O O
97 with IN B-VP O
97 a DT B-NP O
97 Holter NNP I-NP O
97 or CC O O
97 event NN B-NP O
97 monitor NN I-NP O
98 DISCHARGE NNP I-NP O
98 MEDICATIONS NNP I-NP O
98 INCLUDE: NNP I-NP O
98 1 CD O O
98 Aspirin NNP B-NP B-m
98 325 CD O B-do
98 mg NN B-NP I-do
98 q.d NN I-NP B-f
98 2 CD O O
99 Captopril NNP B-NP B-m
99 75 CD O B-do
99 mg NN B-NP I-do
99 t.i.d NN I-NP B-f
99 3 CD O O
99 NPH NNP B-NP B-m
99 NPH NNP I-NP B-m
99 Humulin NNP I-NP I-m
99 Humulin NNP I-NP I-m
99 insulin NN I-NP I-m
99 insulin NN I-NP I-m
99 18 CD O B-do
99 units NNS B-NP I-do
99 q.a.m RB O B-f
99 and CC O O
100 8 CD O B-do
100 units NNS B-NP I-do
100 q.p.m RB O B-f
100 4 CD O O
100 Nitroglycerin NNP B-NP B-m
100 sublingual JJ B-NP I-m
100 tablets NNS I-NP I-m
100 5 CD O O
100 Vitamin NNP B-NP B-m
101 E NNP I-NP O
101 6 CD O O
101 Simvastatin NNP B-NP B-m
101 20 CD O B-do
101 mg NN B-NP I-do
101 q.h.s NN I-NP B-f
102 FOLLOW-UP: NNP I-NP O
102 The DT B-NP O
102 patient NN I-NP O
102 will MD O O
102 be VB O O
102 followed VBN O O
102 up RP O O
102 by IN B-VP O
102 his PRP$ O O
102 primary JJ B-NP O
102 care NN I-NP O
103 doctor NN I-NP O
103 , , O O
103 in IN B-VP O
103 particular JJ O O
103 the DT B-NP O
103 posterior JJ I-NP O
103 cervical JJ I-NP O
103 single JJ I-NP O
103 lymph NN I-NP O
103 node NN I-NP O
104 should MD O O
104 be VB O O
104 followed VBN O O
104 up RP O O
104 by IN B-VP O
104 his PRP$ O O
104 primary JJ B-NP O
104 care NN I-NP O
104 physician NN I-NP O
105 Dictated NNP I-NP O
105 By: NNP I-NP O
105 WOODROW NNP I-NP O
105 BEAUDINE NNP I-NP O
105 , , O O
105 M.D NNP B-NP O
105 UU390 NNP I-NP O
106 Attending: NNP I-NP O
106 TYREE NNP I-NP O
106 R NNP I-NP O
106 CAPELLAN NNP I-NP O
106 , , O O
106 M.D NNP B-NP O
106 JJ5 NNP I-NP O
106 RB352/3807 NNP I-NP O
107 Batch: NNP I-NP O
107 77762 CD O O
107 Index NNP B-NP O
107 No NNP I-NP O
107 I2QFIO8GCI NNP I-NP O
107 D: NNP I-NP O
107 5/21/99 CD O O
108 T: NNP B-NP O
108 9/7/99 CD O O
109 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #799726 VBZ O O
2 418921992 CD O O
2 DCH NNP B-NP O
2 35725579 CD O O
2 2107440 CD O O
2 0/14/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CORONARY NNP I-NP O
2 ARTERY NNP I-NP O
2 DISEASE NNP I-NP O
2 Unsigned VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 7/16/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/2/2006 CD O O
4 ATTENDING: NNP B-NP O
4 FUGATE NNP I-NP O
4 , , O O
4 TIM NNP B-NP O
4 MD NNP I-NP O
5 SERVICE: NNP I-NP O
6 Cardiac NNP I-NP O
6 Surgery NNP I-NP O
6 Service NNP I-NP O
7 HISTORY NNP I-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
8 Mr NNP I-NP O
8 Lewter NNP I-NP O
8 is VBZ O O
8 a DT B-NP O
8 65-year-old JJ I-NP O
8 gentleman NN I-NP O
8 with IN B-VP O
8 history NN B-NP O
8 of IN B-VP O
9 non-insulin-dependent JJ B-NP O
9 diabetes NNS I-NP O
9 mellitus NN I-NP O
9 , , O O
9 hypertension NN B-NP O
9 , , O O
10 dyslipidemia NN B-NP O
10 , , O O
10 and CC O O
10 peripheral JJ B-NP O
10 vascular JJ I-NP O
10 disease NN I-NP O
10 who WP O O
10 presented VBD B-VP O
10 to TO O O
11 Tci NNP B-NP O
11 Prosamp NNP I-NP O
11 Memorial NNP I-NP O
11 Hospital NNP I-NP O
11 on IN B-VP O
11 5/1/06 CD O O
11 with IN B-VP O
11 unstable JJ O O
11 angina VBP O O
11 The DT B-NP O
11 patient NN I-NP O
12 reports NNS I-NP O
12 that IN B-VP O
12 he PRP O O
12 had VBD B-VP O
12 been VBN O O
12 having VBG O O
12 intermittent JJ B-NP O
12 left-sided JJ I-NP O
12 chest NN I-NP O
13 pressure NN I-NP O
13 at IN B-VP O
13 rest NN B-NP O
13 over IN B-VP O
13 the DT O O
13 past JJ O O
13 three CD O O
13 days NNS B-NP O
13 associated VBN O O
13 with IN B-VP O
14 shortness NN B-NP O
14 of IN B-VP O
14 breath NN B-NP O
14 , , O O
14 each DT B-NP O
14 episode NN I-NP O
14 lasting VBG O O
14 approximately RB O O
14 10 CD O O
15 minutes NNS B-NP O
15 EKG NNP I-NP O
15 on IN B-VP O
15 admission NN B-NP O
15 revealed VBN O O
15 sinus JJ B-NP O
15 tachycardia NN I-NP O
15 with IN B-VP O
15 a DT O O
15 new JJ O O
16 incomplete JJ O O
16 left VBN O O
16 bundle-branch JJ B-NP O
16 block NN I-NP O
16 and CC O O
16 downsloping VBG O O
16 1-1.5 JJ B-NP O
16 mm NN I-NP O
16 ST NNP I-NP O
17 depressions NNS I-NP O
17 in IN B-VP O
17 V3 NNP B-NP O
17 through IN B-VP O
17 V6 NNP B-NP O
17 and CC O O
17 1 CD O O
17 mm NN B-NP O
17 depression NN I-NP O
17 in IN B-VP O
17 aVL PDT O O
17 The DT B-NP O
18 patient NN I-NP O
18 was VBD B-VP O
18 deemed VBN O O
18 to TO O O
18 have VB O O
18 a DT B-NP O
18 NSTEMI NNP I-NP O
18 and CC O O
18 unstable JJ B-NP O
18 angina NN I-NP O
18 He PRP O O
18 was VBD B-VP O
19 not RB O O
19 heparinized VBN O O
19 due JJ O O
19 to TO O O
19 the DT B-NP O
19 fact NN I-NP O
19 that IN B-VP O
19 he PRP O O
19 was VBD B-VP O
19 on IN B-VP O
19 Coumadin NNP B-NP B-m
19 for IN B-VP O
20 peripheral JJ B-NP B-r
20 vascular JJ I-NP I-r
20 disease NN I-NP I-r
20 with IN B-VP O
20 a DT B-NP O
20 therapeutic JJ I-NP O
20 INR NNP I-NP O
20 On IN B-VP O
20 9/18/06 CD O O
20 , , O O
20 the DT B-NP O
20 patient JJ I-NP O
21 underwent JJ I-NP O
21 cardiac JJ I-NP O
21 catheterization NN I-NP O
21 , , O O
21 which WDT O O
21 revealed VBD B-VP O
21 the DT B-NP O
21 following: NN I-NP O
21 Left NNP I-NP O
22 circumflex NN I-NP O
22 coronary JJ B-NP O
22 artery NN I-NP O
22 with IN B-VP O
22 an DT O O
22 ostial JJ O O
22 100% CD O O
22 stenosis NN B-NP O
22 , , O O
22 left VBD B-VP O
23 anterior RP O O
23 descending VBG O O
23 coronary JJ B-NP O
23 artery NN I-NP O
23 with IN B-VP O
23 a DT O O
23 proximal JJ O O
23 60% CD O O
23 stenosis NN B-NP O
24 and CC O O
24 a DT O O
24 mid JJ O O
24 50% CD O O
24 stenosis NN B-NP O
24 , , O O
24 right JJ B-NP O
24 coronary JJ I-NP O
24 artery NN I-NP O
24 with IN B-VP O
24 a DT O O
24 proximal JJ O O
24 80% CD O O
25 stenosis NN B-NP O
25 and CC O O
25 a DT O O
25 mid JJ O O
25 60% CD O O
25 stenosis NN B-NP O
25 , , O O
25 right JJ B-NP O
25 dominant JJ I-NP O
25 circulation NN I-NP O
25 , , O O
26 ejection NN B-NP O
26 fraction NN I-NP O
26 of IN B-VP O
26 30% CD O O
26 , , O O
26 collateral NN B-NP O
26 flow NN I-NP O
26 from IN B-VP O
26 the DT B-NP O
26 second JJ I-NP O
27 diagonal NN I-NP O
27 to TO O O
27 the DT B-NP O
27 third JJ I-NP O
27 marginal NN I-NP O
27 in IN B-VP O
27 the DT B-NP O
27 right JJ I-NP O
27 posterior NN I-NP O
27 left VBD B-VP O
28 ventricular JJ B-NP O
28 branch NN I-NP O
28 to TO O O
28 the DT B-NP O
28 second JJ I-NP O
28 marginal NN I-NP O
28 , , O O
28 left VBD B-VP O
28 ventricular JJ B-NP O
29 hypokinesis NN I-NP O
29 , , O O
29 severe JJ B-NP O
29 inferior NN I-NP O
29 and CC O O
29 apical JJ B-NP O
30 PAST NNP I-NP O
30 MEDICAL NNP I-NP O
30 AND NNP I-NP O
30 SURGICAL NNP I-NP O
30 HISTORY: NNP I-NP O
31 Significant NNP I-NP O
31 for IN B-VP O
31 myocardial JJ B-NP O
31 infarction NN I-NP O
31 with IN B-VP O
31 a DT B-NP O
31 peak JJ I-NP O
31 CK NNP I-NP O
31 of IN B-VP O
31 87 CD O O
31 , , O O
32 troponin NN B-NP O
32 0.48 CD O O
32 , , O O
32 history NN B-NP O
32 of IN B-VP O
32 class NN B-NP O
32 IV NNP I-NP O
32 angina NN I-NP O
32 with IN B-VP O
32 inability NN B-NP O
32 to TO O O
32 carry VB O O
33 on IN B-VP O
33 any DT B-NP O
33 physical JJ I-NP O
33 activity NN I-NP O
33 , , O O
33 history NN B-NP O
33 of IN B-VP O
33 class NN B-NP O
33 II NNP I-NP O
33 heart NN I-NP O
33 failure NN I-NP O
33 with IN B-VP O
34 slight JJ B-NP O
34 limitation NN I-NP O
34 of IN B-VP O
34 physical JJ B-NP O
34 activity NN I-NP O
34 , , O O
34 congestive JJ B-NP O
34 heart NN I-NP O
34 failure NN I-NP O
34 , , O O
35 paroxysmal JJ B-NP O
35 nocturnal JJ I-NP O
35 dyspnea NN I-NP O
35 , , O O
35 dyspnea NN B-NP O
35 on IN B-VP O
35 exertion NN B-NP O
35 , , O O
35 hypertension NN B-NP O
35 , , O O
36 peripheral JJ B-NP O
36 vascular JJ I-NP O
36 disease NN I-NP O
36 , , O O
36 status NN B-NP O
36 post NN I-NP O
36 bilateral JJ B-NP O
36 fem-pop JJ I-NP O
36 bypass NN I-NP O
37 and CC O O
37 status NN B-NP O
37 post NN I-NP O
37 bilateral JJ B-NP O
37 transmetatarsal NN I-NP O
37 amputations NNS I-NP O
37 , , O O
38 non-insulin-dependent JJ B-NP O
38 diabetes NNS I-NP O
38 mellitus NN I-NP O
38 , , O O
38 dyslipidemia NN B-NP O
38 , , O O
38 history NN B-NP O
38 of IN B-VP O
39 gastrointestinal JJ B-NP O
39 bleeding NN I-NP O
39 , , O O
39 anxiety NN B-NP O
39 disorder NN I-NP O
39 , , O O
39 eosinophilia NN B-NP O
39 , , O O
40 chronic JJ O O
40 back RB O O
40 pain NN B-NP O
40 , , O O
40 anemia NN B-NP O
41 ALLERGIES: NNP I-NP O
42 The DT B-NP O
42 patient NN I-NP O
42 has VBZ O O
42 no DT O O
42 known VBN O O
42 drug NN B-NP O
42 allergies NNS I-NP O
43 MEDICATIONS NNP I-NP O
43 AT NNP I-NP O
43 TIME NNP I-NP O
43 OF NNP I-NP O
43 ADMISSION: NNP I-NP O
44 Lopressor NNP I-NP B-m
44 37.5 CD O B-do
44 mg NN B-NP I-do
44 b.i.d NN I-NP B-f
44 , , O O
44 aspirin RB O B-m
44 325 CD O B-do
44 mg JJ O I-do
44 daily RB O B-f
44 , , O O
44 Colace NNP B-NP B-m
44 100 CD O B-do
44 mg NN B-NP I-do
45 b.i.d NN I-NP B-f
45 , , O O
45 Pepcid NNP B-NP B-m
45 20 CD O B-do
45 mg NN B-NP I-do
45 IV NNP I-NP B-mo
45 q.12h NN I-NP B-f
45 , , O O
45 insulin NN B-NP B-m
45 sliding VBG O B-do
45 scale NN B-NP I-do
45 , , O O
46 atorvastatin RB O B-m
46 80 CD O B-do
46 mg JJ O I-do
46 daily RB O B-f
46 , , O O
46 glipizide NN B-NP B-m
46 , , O O
46 Avandia NNP B-NP B-m
46 , , O O
46 Zestril NNP B-NP B-m
46 , , O O
46 metformin NN B-NP B-m
46 , , O O
47 meclizine NN B-NP B-m
47 , , O O
47 lactulose RB O B-m
47 , , O O
47 vitamin FW O B-m
47 C NNP B-NP I-m
47 , , O O
47 Protonix NNP B-NP B-m
47 , , O O
47 Niaspan NNP B-NP B-m
47 , , O O
47 Neurontin NNP B-NP B-m
47 , , O O
48 Zincate NNP B-NP B-m
48 , , O O
48 Coumadin NNP B-NP B-m
48 for IN B-VP O
48 peripheral JJ B-NP B-r
48 vascular JJ I-NP I-r
48 disease NN I-NP I-r
49 PHYSICAL NNP I-NP O
49 EXAMINATION: NNP I-NP O
50 Cardiac NNP I-NP O
50 exam: VBZ O O
50 Regular JJ B-NP O
50 rate NN I-NP O
50 and CC O O
50 rhythm NN B-NP O
50 with IN B-VP O
50 no DT B-NP O
50 murmurs NNS I-NP O
50 , , O O
50 lifts NNS B-NP O
50 or CC O O
51 heaves VBZ O O
51 Peripheral NNP B-NP O
51 vascular JJ O O
51 2+ CD O O
51 pulses NNS B-NP O
51 bilaterally RB O O
51 in IN B-VP O
51 the DT B-NP O
52 carotid NN I-NP O
52 , , O O
52 radial JJ O O
52 , , O O
52 femoral JJ B-NP O
52 pulses NNS I-NP O
52 and CC O O
52 1+ CD O O
52 bilaterally RB O O
52 in IN B-VP O
52 the DT B-NP O
53 dorsalis NN I-NP O
53 pedis NN I-NP O
53 and CC O O
53 posterior JJ B-NP O
53 tibialis NN I-NP O
53 pulses NNS I-NP O
53 Respiratory: NNP I-NP O
54 Breath NNP I-NP O
54 sounds VBZ O O
54 clear JJ O O
54 bilaterally RB O O
54 Allen's NNP B-NP O
54 test NN I-NP O
54 of IN B-VP O
54 the DT B-NP O
54 left JJ I-NP O
55 upper JJ I-NP O
55 extremity NN I-NP O
55 , , O O
55 abnormal JJ B-NP O
55 intermittent NN I-NP O
55 waveform NN I-NP O
55 with IN B-VP O
55 radial NN B-NP O
56 occluded VBD B-VP O
56 using VBG O O
56 a DT B-NP O
56 pulse JJ I-NP O
56 oximeter NN I-NP O
56 , , O O
56 right JJ B-NP O
56 upper JJ I-NP O
56 extremity NN I-NP O
57 abnormal JJ B-NP O
57 poor JJ I-NP O
57 intermittent NN I-NP O
57 wave NN I-NP O
57 form NN I-NP O
57 with IN B-VP O
57 the DT B-NP O
57 radial NN I-NP O
57 occluded VBD B-VP O
57 , , O O
58 also RB O O
58 with IN B-VP O
58 a DT B-NP O
58 pulse JJ I-NP O
58 oximeter NN I-NP O
58 Physical NNP I-NP O
58 exam NN I-NP O
58 otherwise NN I-NP O
58 is VBZ O O
59 noncontributory JJ B-NP O
60 ADMISSION NNP I-NP O
60 LABS: NNP I-NP O
61 Sodium NNP I-NP O
61 128 CD O O
61 , , O O
61 potassium NN B-NP O
61 4.2 CD O O
61 , , O O
61 chloride NN B-NP O
61 of IN B-VP O
61 99 CD O O
61 , , O O
61 CO2 NNP B-NP O
61 21 CD O O
61 , , O O
61 BUN NNP B-NP O
61 of IN B-VP O
61 23 CD O O
61 , , O O
62 creatinine NN B-NP O
62 1.1 CD O O
62 , , O O
62 glucose NN B-NP O
62 of IN B-VP O
62 201 CD O O
62 , , O O
62 magnesium NN B-NP O
62 1.7 CD O O
62 , , O O
62 WBC NNP B-NP O
62 5.81 CD O O
62 , , O O
63 hematocrit NN B-NP O
63 28.6 CD O O
63 , , O O
63 hemoglobin NN B-NP O
63 10.2 CD O O
63 , , O O
63 platelets NNS B-NP O
63 of IN B-VP O
63 132 CD O O
63 , , O O
63 PT NNP B-NP O
63 of IN B-VP O
63 18.2 CD O O
63 , , O O
64 PT/INR NNP B-NP O
64 1.5 CD O O
64 , , O O
64 PTT NNP B-NP O
64 of IN B-VP O
64 33.7 CD O O
65 HOSPITAL NNP B-NP O
65 COURSE: NNP I-NP O
66 Mr NNP I-NP O
66 Jana NNP I-NP O
66 was VBD B-VP O
66 brought VBN O O
66 to TO O O
66 the DT B-NP O
66 operating NN I-NP O
66 room NN I-NP O
66 on IN B-VP O
66 7/28/06 CD O O
66 where WRB O O
66 he PRP O O
67 underwent VBD B-VP O
67 a DT B-NP O
67 coronary JJ I-NP O
67 artery NN I-NP O
67 bypass NN I-NP O
67 graft NN I-NP O
67 x3 NN I-NP O
67 with IN B-VP O
67 left JJ B-NP O
67 internal JJ I-NP O
68 mammary JJ I-NP O
68 artery NN I-NP O
68 to TO O O
68 left VB O O
68 anterior RP O O
68 descending VBG O O
68 coronary JJ B-NP O
68 artery NN I-NP O
68 , , O O
68 a DT B-NP O
69 sequential JJ I-NP O
69 graft NN I-NP O
69 and CC O O
69 a DT B-NP O
69 vein NN I-NP O
69 graft NN I-NP O
69 connecting VBG O O
69 from IN B-VP O
69 the DT B-NP O
69 aorta NN I-NP O
69 to TO O O
70 the DT B-NP O
70 second JJ I-NP O
70 obtuse NN I-NP O
70 marginal JJ B-NP O
70 coronary JJ I-NP O
70 artery NN I-NP O
70 and CC O O
70 then RB O O
70 to TO O O
70 the DT B-NP O
70 left NN I-NP O
71 ventricular JJ B-NP O
71 branch NN I-NP O
71 Total NNP I-NP O
71 bypass NN I-NP O
71 time NN I-NP O
71 was VBD B-VP O
71 55 CD O O
71 minutes NNS B-NP O
71 , , O O
71 total JJ B-NP O
72 crossclamp NN I-NP O
72 time NN I-NP O
72 was VBD B-VP O
72 46 CD O O
72 minutes NNS B-NP O
72 The DT B-NP O
72 patient NN I-NP O
72 did VBD B-VP O
72 well RB O O
73 intraoperatively RB O O
73 , , O O
73 came VBD B-VP O
73 off RP O O
73 bypass NN B-NP O
73 without IN B-VP O
73 incident NN B-NP O
73 , , O O
73 was VBD B-VP O
73 brought VBN O O
74 to TO O O
74 the DT B-NP O
74 Intensive NNP I-NP O
74 Care NNP I-NP O
74 Unit NNP I-NP O
74 in IN B-VP O
74 normal JJ B-NP O
74 sinus NN I-NP O
74 rhythm NN I-NP O
74 and CC O O
74 in IN B-VP O
74 stable JJ B-NP O
75 condition NN I-NP O
75 Postoperatively RB O O
75 , , O O
75 the DT B-NP O
75 patient NN I-NP O
75 did VBD B-VP O
75 well RB O O
75 His PRP$ O O
75 CK-MB NN B-NP O
76 trended VBD B-VP O
76 down RB O O
76 and CC O O
76 EKG NNP B-NP O
76 normalized VBD B-VP O
76 The DT B-NP O
76 patient's NN I-NP O
76 postop JJ B-NP O
76 chest NN I-NP O
76 x-ray NN I-NP O
77 revealed VBD B-VP O
77 moderate-to-severe JJ B-NP O
77 pulmonary JJ I-NP O
77 venous JJ I-NP O
77 congestion NN I-NP O
77 bibasally RB O O
78 requiring VBG O O
78 vigorous JJ B-NP O
78 pulmonary JJ I-NP O
78 toilet NN I-NP O
78 The DT B-NP O
78 patient NN I-NP O
78 was VBD B-VP O
78 extubated VBN O O
78 on IN B-VP O
79 10/3/06 CD O O
79 The DT B-NP O
79 patient NN I-NP O
79 was VBD B-VP O
79 also RB O O
79 followed VBN O O
79 by IN B-VP O
79 the DT B-NP O
79 Diabetes NNP I-NP O
79 Mellitus NNP I-NP O
80 Service NNP I-NP O
80 for IN B-VP O
80 his PRP$ O O
80 non-insulin-dependent JJ B-NP O
80 diabetes NNS I-NP O
80 mellitus VBD B-VP O
80 His PRP$ O O
81 blood NN B-NP O
81 glucoses NNS I-NP O
81 were VBD B-VP O
81 well RB O O
81 controlled VBN O O
81 He PRP O O
81 was VBD B-VP O
81 started VBN O O
81 back RP O O
81 on IN B-VP O
81 his PRP$ O O
82 oral JJ B-NP B-mo
82 medication NN I-NP O
82 of IN B-VP O
82 glipizide JJ O B-m
82 5 CD O B-do
82 mg NN B-NP I-do
82 and CC O O
82 was VBD B-VP O
82 covered VBN O O
82 with IN B-VP O
82 a DT B-NP O
82 NovoLog NNP I-NP B-m
83 sliding VBG O B-do
83 scale NN B-NP I-do
83 The DT B-NP O
83 patient NN I-NP O
83 was VBD B-VP O
83 transfused VBN O O
83 3 CD O B-do
83 units NNS B-NP I-do
83 of IN B-VP O
83 packed JJ B-NP B-m
83 red JJ I-NP O
84 blood NN I-NP O
84 cells NNS I-NP O
84 postoperatively RB O O
84 , , O O
84 and CC O O
84 was VBD B-VP O
84 re-started VBN O O
84 on IN B-VP O
84 Coumadin NNP B-NP B-m
84 for IN B-VP O
84 his PRP$ O B-r
85 peripheral JJ B-NP O
85 vascular JJ I-NP O
85 disease NN I-NP O
85 The DT B-NP O
85 patient's NN I-NP O
85 platelet NN I-NP O
85 count NN I-NP O
86 dropped VBD B-VP O
86 to TO O O
86 as RB O O
86 low JJ O O
86 as IN B-VP O
86 59 CD O O
86 , , O O
86 000 CD O O
86 He PRP O O
86 had VBD B-VP O
86 a DT B-NP O
86 HIT NNP I-NP O
86 panel NN I-NP O
86 sent VBD B-VP O
86 off RP O O
86 which WDT O O
87 came VBD B-VP O
87 back RB O O
87 negative JJ O O
87 and CC O O
87 platelets NNS B-NP O
87 trended VBD B-VP O
87 up RP O O
87 at IN B-VP O
87 time NN B-NP O
87 of IN B-VP O
87 discharge NN B-NP O
88 to TO O O
88 143 CD O O
88 , , O O
88 000 CD O O
88 Mr NNP B-NP O
88 Gier NNP I-NP O
88 was VBD B-VP O
88 transferred VBN O O
88 to TO O O
88 the DT B-NP O
88 Step-Down JJ I-NP O
88 Unit NNP I-NP O
88 on IN B-VP O
89 postoperative JJ B-NP O
89 day NN I-NP O
89 #3 VB O O
89 His PRP$ O O
89 pacing VBG O O
89 wires NNS B-NP O
89 were VBD B-VP O
89 removed VBN O O
89 , , O O
89 and CC O O
89 he PRP O O
89 was VBD B-VP O
90 screened VBN O O
90 for IN B-VP O
90 rehabilitation NN B-NP O
90 for IN B-VP O
90 discharge NN B-NP O
90 The DT B-NP O
90 patient NN I-NP O
90 also RB O O
90 had VBD B-VP O
91 some DT B-NP B-r
91 urinary JJ I-NP I-r
91 retention NN I-NP I-r
91 postoperatively RB O O
91 and CC O O
91 did VBD B-VP O
91 require VB O O
91 Foley NNP B-NP O
92 reinsertion NN I-NP O
92 and CC O O
92 was VBD B-VP O
92 started VBN O O
92 on IN B-VP O
92 Flomax NNP B-NP B-m
92 0.4 CD O B-do
92 mg NN B-NP I-do
92 once RB O B-f
92 a DT B-NP I-f
92 day NN I-NP I-f
92 He PRP O O
93 failed VBD B-VP O
93 a DT B-NP O
93 second JJ I-NP O
93 voiding NN I-NP O
93 trial NN I-NP O
93 and CC O O
93 will MD O O
93 be VB O O
93 discharged VBN O O
93 with IN B-VP O
93 a DT B-NP O
93 leg NN I-NP O
94 bag NN I-NP O
94 and CC O O
94 follow VB O O
94 up RP O O
94 in IN B-VP O
94 the DT B-NP O
94 Urology NNP I-NP O
94 Clinic NNP I-NP O
94 in IN B-VP O
94 one CD O O
94 week NN B-NP O
94 and CC O O
94 continue VB O O
95 on IN B-VP O
95 his PRP$ O O
95 Flomax NNP B-NP B-m
95 until IN B-VP B-du
95 that DT B-NP I-du
95 time NN I-NP I-du
96 DISCHARGE NNP I-NP O
96 LABS: NNP I-NP O
97 The DT B-NP O
97 discharge NN I-NP O
97 labs NN I-NP O
97 for IN B-VP O
97 Mr NNP B-NP O
97 Howlingwolf NNP I-NP O
97 were VBD B-VP O
97 as IN B-VP O
97 follows: JJ B-NP O
97 Glucose NNP I-NP O
97 of IN B-VP O
98 150 CD O O
98 , , O O
98 BUN NNP B-NP O
98 of IN B-VP O
98 39 CD O O
98 , , O O
98 creatinine NN B-NP O
98 1.2 CD O O
98 , , O O
98 sodium NN B-NP O
98 138 CD O O
98 , , O O
98 potassium NN B-NP O
98 3.6 CD O O
98 , , O O
99 chloride RB O O
99 103 CD O O
99 , , O O
99 CO2 NNP B-NP O
99 23 CD O O
99 , , O O
99 magnesium NN B-NP O
99 1.9 CD O O
99 , , O O
99 WBC NNP B-NP O
99 8.6 CD O O
99 , , O O
99 hemoglobin NN B-NP O
99 11 CD O O
99 , , O O
100 hematocrit NN B-NP O
100 31.4 CD O O
100 , , O O
100 platelets NNS B-NP O
100 of IN B-VP O
100 143 CD O O
100 , , O O
100 PT NNP B-NP O
100 of IN B-VP O
100 17.1 CD O O
100 , , O O
100 PT/INR NNP B-NP O
100 of IN B-VP O
100 1.4 CD O O
101 Urinalysis NN B-NP O
101 from IN B-VP O
101 11/21/06 CD O O
101 was VBD B-VP O
101 negative JJ B-NP O
101 Urine JJ I-NP O
101 culture NN I-NP O
101 is VBZ O O
101 no DT B-NP O
102 growth NN I-NP O
102 so RB O O
102 far RB O O
102 at IN B-VP O
102 time NN B-NP O
102 of IN B-VP O
102 discharge NN B-NP O
103 DISCHARGE NNP I-NP O
103 MEDICATIONS: NNP I-NP O
104 Enteric-coated NNP I-NP B-m
104 aspirin VBZ O I-m
104 81 CD O B-do
104 mg NN B-NP I-do
104 QD NNP I-NP B-f
104 , , O O
104 Colace NNP B-NP B-m
104 100 CD O B-do
104 mg NN B-NP I-do
104 b.i.d NN I-NP B-f
105 while IN B-VP O
105 taking VBG O O
105 Dilaudid NNP B-NP B-m
105 , , O O
105 Lasix NNP B-NP B-m
105 40 CD O B-do
105 mg NN B-NP I-do
105 QD NNP I-NP B-f
105 x3 NNP I-NP B-du
105 doses VBZ O I-du
105 , , O O
105 glipizide RB O B-m
105 5 CD O B-do
105 mg JJ O I-do
106 daily RB O B-f
106 , , O O
106 Dilaudid NNP B-NP B-m
106 2-4 CD O B-do
106 mg NN B-NP I-do
106 every DT O B-f
106 three CD O I-f
106 hours NNS B-NP I-f
106 p.r.n VBP O I-f
106 pain NN B-NP B-r
106 , , O O
106 lisinopril VBZ O B-m
107 2.5 CD O B-do
107 mg JJ O I-do
107 daily RB O B-f
107 , , O O
107 Niferex NNP B-NP B-m
107 150 CD O B-do
107 mg NN B-NP I-do
107 b.i.d NN I-NP B-f
107 , , O O
107 Toprol-XL NNP B-NP B-m
107 150 CD O B-do
107 mg NN B-NP I-do
107 QD NNP I-NP B-f
107 , , O O
108 Lipitor NNP B-NP B-m
108 80 CD O B-do
108 mg JJ O I-do
108 daily RB O B-f
108 , , O O
108 Flomax NNP B-NP B-m
108 0.4 CD O B-do
108 mg NN B-NP I-do
108 QD NNP I-NP B-f
108 , , O O
108 potassium NN B-NP B-m
108 chloride NN I-NP O
108 slow JJ B-NP O
109 release NN I-NP O
109 10 CD O B-do
109 mEq NN B-NP I-do
109 QD NNP I-NP B-f
109 x3 NNP I-NP B-du
109 doses VBZ O I-du
109 with IN B-VP O
109 Lasix NNP B-NP B-m
109 and CC O O
109 Coumadin NNP B-NP B-m
109 QD NNP I-NP B-f
109 per IN B-VP I-f
109 INR NNP B-NP I-f
109 result VBP O I-f
109 The DT B-NP O
110 patient NN I-NP O
110 will MD O O
110 receive VB O O
110 4 CD O B-do
110 mg NN B-NP I-do
110 of IN B-VP O
110 Coumadin NNP B-NP B-m
110 this DT B-NP B-f
110 evening NN I-NP I-f
110 for IN B-VP O
110 his PRP$ O B-r
111 peripheral JJ B-NP O
111 vascular JJ I-NP O
111 disease NN I-NP O
111 His PRP$ O O
111 Coumadin NNP B-NP B-m
111 dosing NN I-NP O
111 will MD O O
111 be VB O O
112 followed VBN O O
112 by IN B-VP O
112 Dr NNP B-NP O
112 Kurt NNP I-NP O
112 Goodwill NNP I-NP O
112 at IN B-VP O
112 ( ( O O
112 320 CD O O
112 ) ) O O
112 582-9691 JJ B-NP O
113 FOLLOW-UP JJ I-NP O
113 PLANS: NNP I-NP O
114 He PRP O O
114 will MD O O
114 follow VB O O
114 up RP O O
114 with IN B-VP O
114 Dr NNP B-NP O
114 Bert NNP I-NP O
114 Levering NNP I-NP O
114 in IN B-VP O
114 six CD O O
114 weeks NNS B-NP O
114 , , O O
114 his PRP$ O O
115 cardiologist NN B-NP O
115 Dr NNP I-NP O
115 Reuben NNP I-NP O
115 Duttinger NNP I-NP O
115 in IN B-VP O
115 one CD O O
115 week NN B-NP O
115 , , O O
115 his PRP$ O O
115 heart NN B-NP O
115 failure NN I-NP O
116 cardiologist NN I-NP O
116 Dr NNP I-NP O
116 Wilton NNP I-NP O
116 Durkee NNP I-NP O
116 on IN B-VP O
116 11/10/06 CD O O
116 at IN B-VP O
116 1:30 CD O O
116 in IN B-VP O
116 the DT B-NP O
117 afternoon NN I-NP O
117 , , O O
117 and CC O O
117 Urology NNP B-NP O
117 Clinic NNP I-NP O
117 at IN B-VP O
117 the DT B-NP O
117 Centsson NNP I-NP O
117 Medical NNP I-NP O
117 Center NNP I-NP O
118 for IN B-VP O
118 his PRP$ O O
118 urinary JJ B-NP O
118 retention NN I-NP O
118 in IN B-VP O
118 one CD O O
118 week NN B-NP O
118 Clinic NNP I-NP O
118 number NN I-NP O
118 ( ( O O
118 427 CD O O
118 ) ) O O
118 363-3236 CD O O
119 DISPOSITION: NNP B-NP O
120 Mr NNP I-NP O
120 Fagin NNP I-NP O
120 is VBZ O O
120 discharged VBN O O
120 to TO O O
120 rehab VB O O
120 in IN B-VP O
120 stable JJ B-NP O
120 condition NN I-NP O
121 eScription NN I-NP O
121 document: VBZ O O
121 0-3585478 JJ B-NP O
121 EMSSten NNP I-NP O
121 Tel NNP I-NP O
122 Dictated NNP I-NP O
122 By: NNP I-NP O
122 ARROWOOD NNP I-NP O
122 , , O O
122 TIM NNP B-NP O
123 Attending: NNP I-NP O
123 ARRANTS NNP I-NP O
123 , , O O
123 CLIFTON NNP B-NP O
124 Dictation NNP I-NP O
124 ID NNP I-NP O
124 3130923 CD O O
125 D: NNP B-NP O
125 9/15/06 CD O O
126 T: NNP B-NP O
126 9/15/06 CD O O
127 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #801284 VBZ O O
4 515984806 CD O O
4 DH NNP B-NP O
4 10446912 CD O O
4 685016 CD O O
4 9/26/2001 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 s/p JJ B-NP O
4 PTCA NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/26/2001 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/27/2001 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 LAPINSKY NNP I-NP O
8 , , O O
8 DARREN NNP B-NP O
8 S NNP I-NP O
8 312-34-40-6 JJ B-NP O
9 Encin NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 1/26/01 CD O O
11 AT NNP B-NP O
11 04:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 GUDERJAHN NNP I-NP O
14 , , O O
14 AUGUSTUS NNP B-NP O
14 R NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ALBUTEROL NNP I-NP B-m
19 INHALER NNP I-NP I-m
19 2 CD O B-do
19 PUFF NNP B-NP I-do
19 INH NNP I-NP B-mo
19 QID NNP I-NP B-f
19 PRN NNP I-NP I-f
19 SOB NNP I-NP B-r
20 ECASA NNP I-NP B-m
20 ( ( O I-m
20 ASPIRIN NNP B-NP I-m
20 ENTERIC NNP I-NP I-m
20 COATED NNP I-NP I-m
20 ) ) O I-m
20 325 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 ATENOLOL NNP I-NP B-m
21 50 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
21 Food/Drug NNP I-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Take NNP I-NP O
22 consistently RB O O
22 with IN B-VP O
22 meals NNS B-NP O
22 or CC O O
22 on IN B-VP O
22 empty JJ B-NP O
22 stomach NN I-NP O
23 LISINOPRIL NNP I-NP B-m
23 5 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QD NNP I-NP B-f
24 NITROGLYCERIN NNP I-NP B-m
24 1/150 CD O I-m
24 ( ( O I-m
24 0.4 CD O I-m
24 MG NNP B-NP I-m
24 ) ) O I-m
24 1 CD O B-do
24 TAB NNP B-NP I-do
24 SL NNP I-NP B-mo
24 Q5 NNP I-NP B-f
24 MIN NNP I-NP O
24 X NNP I-NP O
24 3 CD O O
25 PRN NNP B-NP O
25 Chest NNP I-NP B-r
25 Pain NNP I-NP I-r
25 HOLD NNP I-NP O
25 IF: NNP I-NP O
25 SBP&lt;[ NNP I-NP O
25 ] NNP I-NP O
26 Instructions: NNP I-NP O
26 As IN B-VP O
26 per IN B-VP O
26 chest NN B-NP O
26 pain NN I-NP O
26 protocol NN I-NP O
27 TERBUTALINE NNP I-NP B-m
27 ( ( O I-m
27 TERBUTALINE NNP B-NP I-m
27 SULFATE NNP I-NP I-m
27 ) ) O I-m
27 5 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QID NNP I-NP B-f
28 AZMACORT NNP I-NP B-m
28 ( ( O I-m
28 TRIAMCINOLONE NNP B-NP I-m
28 ACETONIDE NNP I-NP I-m
28 ) ) O I-m
28 2 CD O B-do
28 PUFF NNP B-NP I-do
28 INH NNP I-NP B-mo
28 QID NNP I-NP B-f
29 KEFLEX NNP I-NP B-m
29 ( ( O I-m
29 CEPHALEXIN NNP B-NP I-m
29 ) ) O I-m
29 500 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QID NNP I-NP B-f
30 IMDUR NNP I-NP B-m
30 ( ( O I-m
30 ISOSORBIDE NNP B-NP I-m
30 MONONIT.( NNP I-NP I-m
30 SR NNP I-NP I-m
30 ) ) O I-m
30 ) ) O I-m
30 30 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 QD NNP I-NP B-f
31 Food/Drug NNP I-NP O
31 Interaction NNP I-NP O
31 Instruction NNP I-NP O
32 Give NNP I-NP O
32 on IN B-VP O
32 an DT B-NP O
32 empty JJ I-NP O
32 stomach NN I-NP O
32 ( ( O O
32 give JJ O O
32 1hr CD O O
32 before IN B-VP O
32 or CC O O
32 2hr CD O O
32 after IN B-VP O
33 food NN B-NP O
33 ) ) O O
34 DIET: NNP B-NP O
34 House NNP I-NP O
34 / VBD B-VP O
34 Low NNP B-NP O
34 chol/low NN I-NP O
34 sat VBD B-VP O
34 fat JJ B-NP O
35 RETURN NNP I-NP O
35 TO NNP I-NP O
35 WORK: NNP I-NP O
35 After IN B-VP O
35 Appt NNP B-NP O
35 with IN B-VP O
35 local JJ B-NP O
35 physician NN I-NP O
36 FOLLOW NNP I-NP O
36 UP NNP I-NP O
36 APPOINTMENT( NNP I-NP O
36 S NNP I-NP O
36 ): NNP I-NP O
37 Dr NNP I-NP O
37 Ned NNP I-NP O
37 Wendt NNP I-NP O
37 , , O O
37 Cardiology NNP B-NP O
37 3/30/01 CD O O
37 scheduled VBN O O
37 , , O O
38 Dr NNP B-NP O
38 Elias NNP I-NP O
38 Forgey NNP I-NP O
38 , , O O
38 SMH NNP B-NP O
38 , , O O
39 ALLERGY: NNP B-NP O
39 Shellfish NNP I-NP O
39 , , O O
39 Morphine NNP B-NP O
40 ADMIT NNP I-NP O
40 DIAGNOSIS: NNP I-NP O
41 s/p VBD B-VP O
41 PTCA NNP B-NP O
42 PRINCIPAL NNP I-NP O
42 DISCHARGE NNP I-NP O
42 DIAGNOSIS NNP I-NP O
42 ;Responsible JJ O O
42 After IN B-VP O
42 Study NNP B-NP O
42 for IN B-VP O
42 Causing NNP B-NP O
42 Admission NNP I-NP O
42 ) ) O O
43 s/p VBP O O
43 PTCA NNP B-NP O
44 OTHER NNP I-NP O
44 DIAGNOSIS;Conditions NNP I-NP O
44 , , O O
44 Infections NNP B-NP O
44 , , O O
44 Complications NNP B-NP O
44 , , O O
44 affecting VBG O O
44 Treatment/Stay NNP B-NP O
45 hodgkins VBZ O O
45 lymphoma FW O O
45 ( ( O O
45 Hodgkins NNP B-NP O
45 disease NN I-NP O
45 ) ) O O
45 Asthma NNP B-NP O
45 ( ( O O
45 asthma NN B-NP O
45 ) ) O O
45 R NNP B-NP O
45 total JJ B-NP O
45 hip NN I-NP O
46 replacement NN I-NP O
46 ( ( O O
46 total JJ B-NP O
46 hip NN I-NP O
46 replacement NN I-NP O
46 ) ) O O
46 septic JJ B-NP O
46 joint NN I-NP O
46 ( ( O O
46 total JJ B-NP O
46 hip NN I-NP O
47 replacement NN I-NP O
47 ) ) O O
47 non NN B-NP O
47 Q NNP I-NP O
47 wave NN I-NP O
47 MI NNP I-NP O
48 OPERATIONS NNP I-NP O
48 AND NNP I-NP O
48 PROCEDURES: NNP I-NP O
49 OTHER NNP I-NP O
49 TREATMENTS/PROCEDURES NNP I-NP O
49 ( ( O O
49 NOT NNP B-NP O
49 IN NNP I-NP O
49 O.R NNP I-NP O
49 ) ) O O
50 Cardiac NNP B-NP O
50 catheterization NN I-NP O
50 , , O O
50 11/17/01: CD O O
51 1 CD O O
51 ) ) O O
51 Chronic NNP B-NP O
51 total JJ B-NP O
51 occlusion NN I-NP O
51 of IN B-VP O
51 the DT B-NP O
51 proximal JJ I-NP O
51 L.circumflex NNP I-NP O
51 artery NN I-NP O
51 with IN B-VP O
52 collaterals NNS B-NP O
52 to TO O O
52 distal JJ B-NP O
52 vessels NNS I-NP O
53 2 CD O O
53 ) ) O O
53 RCA NNP B-NP O
53 ostial JJ B-NP O
53 discrete NN I-NP O
53 45% CD O O
53 lesion NN B-NP O
54 Unsuccessful NNP I-NP O
54 angioplasty NN I-NP O
54 of IN B-VP O
54 LCX; NNP B-NP O
54 no DT O O
54 stenting VBG O O
55 3 CD O O
55 ) ) O O
55 No DT B-NP O
55 significant JJ I-NP O
55 LM NNP I-NP O
55 or CC O O
55 LAD NNP B-NP O
55 lesions NNS I-NP O
56 BRIEF NNP I-NP O
56 RESUME NNP I-NP O
56 OF NNP I-NP O
56 HOSPITAL NNP I-NP O
56 COURSE: NNP I-NP O
57 Mr NNP I-NP O
57 Sherburn NNP I-NP O
57 is VBZ O O
57 a DT B-NP O
57 58 JJ I-NP O
57 yo NN I-NP O
57 man NN I-NP O
57 w/a VBZ O O
57 hx NN B-NP O
57 of IN B-VP O
57 Hodgkins NNP B-NP O
57 lymphoma FW O O
57 s/p NN B-NP O
57 radiation NN I-NP O
58 tx NN I-NP O
58 , , O O
58 hypertension NN B-NP O
58 , , O O
58 and CC O O
58 non-Q JJ B-NP O
58 wave NN I-NP O
58 MI NNP I-NP O
58 admiited VBD B-VP O
58 to TO O O
58 LMC NNP B-NP O
58 for IN B-VP O
58 cardiac JJ B-NP O
59 catheterization NN I-NP O
59 and CC O O
59 observation NN B-NP O
59 s/p NNS I-NP O
59 cath VBP O O
59 Catheterization NNP B-NP O
59 results NNS I-NP O
59 as IN B-VP O
60 above IN B-VP O
60 Mr NNP B-NP O
60 Muthart NNP I-NP O
60 tolerated VBD B-VP O
60 the DT B-NP O
60 procedure NN I-NP O
60 well RB O O
60 without IN B-VP O
60 adverse JJ B-NP O
60 event NN I-NP O
60 or CC O O
61 complication NN B-NP O
61 at IN B-VP O
61 the DT B-NP O
61 groin NN I-NP O
61 site NN I-NP O
61 He PRP O O
61 remained VBD B-VP O
61 afebrile JJ O O
61 , , O O
61 with IN B-VP O
61 stable JJ B-NP O
62 electrolytes NNS I-NP O
62 , , O O
62 hematocrit NN B-NP O
62 and CC O O
62 WBC NNP B-NP O
62 EKG NNP I-NP O
62 was VBD B-VP O
62 without IN B-VP O
62 evidence NN B-NP O
62 of IN B-VP O
62 acute JJ B-NP O
63 ischemia NN I-NP O
63 and CC O O
63 cardiac JJ B-NP O
63 enzymes NNS I-NP O
63 remained VBD B-VP O
63 flat JJ O O
63 His PRP$ O B-r
63 SBP NNP B-NP I-r
63 ran NN I-NP O
63 in IN B-VP O
63 the DT O O
63 90's CD O O
63 to TO O O
64 low VB O O
64 100's CD O O
64 and CC O O
64 his PRP$ O O
64 Lisinopril NNP B-NP B-m
64 was VBD B-VP O
64 decreased VBN O O
64 as IN B-VP O
64 a DT B-NP O
64 result NN I-NP O
64 Imdur NNP I-NP B-m
64 was VBD B-VP O
64 also RB O O
65 added VBN O O
65 to TO O O
65 his PRP$ O O
65 cardiac JJ B-NP B-m
65 regimen NNS I-NP I-m
66 ADDITIONAL NNP I-NP O
66 COMMENTS: NNP I-NP O
67 DISCHARGE NNP I-NP O
67 CONDITION: NNP I-NP O
67 Stable NNP I-NP O
68 TO NNP I-NP O
68 DO/PLAN: NNP I-NP O
69 No NNP I-NP O
69 dictated VBD B-VP O
69 summary JJ B-NP O
70 ENTERED NNP I-NP O
70 BY: NNP I-NP O
70 COFFER NNP I-NP O
70 , , O O
70 RANDALL NNP B-NP O
70 P NNP I-NP O
70 , , O O
70 M.D NNP B-NP O
70 , , O O
70 M.P.H NNP B-NP O
70 ( ( O O
70 BN01 NNP B-NP O
70 ) ) O O
70 1/26/01 CD O O
70 @ $ O O
70 03:37 CD O O
70 PM NNP B-NP O
71 ****** JJ B-NP O
71 END NNP I-NP O
71 OF NNP I-NP O
71 DISCHARGE NNP I-NP O
71 ORDERS NNP I-NP O
71 ****** NNP I-NP O
72 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #802249 VBZ O O
2 142488549 CD O O
2 EMH NNP B-NP O
2 11717781 CD O O
2 168608 CD O O
2 9/27/1996 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/27/1996 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 1/11/1997 CD O O
4 PRINCIPAL NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 UNSTABLE NNP I-NP O
4 ANGINA NNP I-NP O
5 HISTORY NNP I-NP O
5 OF NNP I-NP O
5 PRESENT NNP I-NP O
5 ILLNESS: NNP I-NP O
5 The DT B-NP O
5 patient NN I-NP O
5 is VBZ O O
5 a DT O O
5 60 CD O O
5 year-old JJ B-NP O
5 woman NN I-NP O
6 with IN B-VP O
6 adult NN B-NP O
6 onset VBN O O
6 diabetes NNS B-NP O
6 mellitus RBR O O
6 , , O O
7 hypertension NN B-NP O
7 admitted VBN O O
7 with IN B-VP O
7 chest NN B-NP O
7 pain NN I-NP O
7 , , O O
7 bradycardia NN B-NP O
7 , , O O
7 decreased VBD B-VP O
7 blood NN B-NP O
8 pressure NN I-NP O
8 , , O O
8 no DT B-NP O
8 previous JJ I-NP O
8 history NN I-NP O
8 of IN B-VP O
8 chest NN B-NP O
8 symptoms NNS I-NP O
8 Risk NNP I-NP O
8 factors NNS I-NP O
9 include VBP O O
9 positive JJ B-NP O
9 adult NN I-NP O
9 onset NN I-NP O
9 diabetes VBZ O O
9 mellitus RBS O O
9 , , O O
9 hypertension NN B-NP O
9 , , O O
10 smoker NN B-NP O
10 , , O O
10 elevated VBN O O
10 cholesterol NN B-NP O
10 , , O O
10 no DT B-NP O
10 family NN I-NP O
10 history NN I-NP O
10 Her PRP$ O O
10 present JJ B-NP O
11 history NN I-NP O
11 is VBZ O O
11 notable JJ O O
11 for IN B-VP O
11 mid JJ B-NP O
11 sternal JJ I-NP O
11 chest NN I-NP O
11 pressure NN I-NP O
11 at IN B-VP O
11 three CD O O
11 out IN B-VP O
11 of IN B-VP O
12 ten NNS B-NP O
12 while IN B-VP O
12 sitting VBG O O
12 and CC O O
12 watching VBG O O
12 television NN B-NP O
12 The DT B-NP O
12 pain NN I-NP O
12 did VBD B-VP O
12 not RB O O
13 radiate VB O O
13 There EX O O
13 was VBD B-VP O
13 no DT B-NP O
13 shortness NN I-NP O
13 of IN B-VP O
13 breath NN B-NP O
13 , , O O
13 diaphoresis NN B-NP O
13 or CC O O
13 nausea NN B-NP O
13 , , O O
14 except IN B-VP O
14 for IN B-VP O
14 pressure NN B-NP O
14 on IN B-VP O
14 left JJ B-NP O
14 side NN I-NP O
14 of IN B-VP O
14 neck NN B-NP O
14 which WDT O O
14 is VBZ O O
14 typical JJ O O
14 for IN B-VP O
14 her PRP$ O O
15 when WRB O O
15 her PRP$ O B-r
15 blood NN B-NP I-r
15 pressure NN I-NP I-r
15 is VBZ O O
15 elevated VBN O O
15 The DT B-NP O
15 patient NN I-NP O
15 took VBD B-VP O
15 Nifedipine NNP B-NP B-m
16 without IN B-VP O
16 relief NN B-NP O
16 and CC O O
16 went VBD B-VP O
16 to TO O O
16 the DT B-NP O
16 bedroom NN I-NP O
16 to TO O O
16 rest VB O O
16 There EX O O
16 the DT B-NP O
16 pressure NN I-NP O
17 became VBD B-VP O
17 pain NN B-NP B-r
17 , , O O
17 three CD O O
17 to TO O O
17 four CD O O
17 out IN B-VP O
17 of IN B-VP O
17 ten NN B-NP O
17 She PRP O O
17 took VBD B-VP O
17 Cardizem NNP B-NP B-m
17 without IN B-VP O
18 relief NN B-NP O
18 She PRP O O
18 called VBD B-VP O
18 EMS NNP B-NP O
18 The DT B-NP O
18 pain NN I-NP B-r
18 was VBD B-VP O
18 relieved VBN O O
18 with IN B-VP O
18 the DT B-NP O
18 EMTs NNP I-NP O
18 gave VBD B-VP O
19 nitroglycerin JJ B-NP B-m
19 times NNS I-NP B-du
19 two CD O I-du
19 This DT O O
19 lasted VBD B-VP O
19 30 CD O O
19 minutes NNS B-NP O
19 EMTs NNP I-NP O
19 found VBD B-VP O
19 her PRP$ O O
20 to TO O O
20 have VB O O
20 blood NN B-NP O
20 pressure NN I-NP O
20 of IN B-VP O
20 190/100 CD O O
20 , , O O
20 heart NN B-NP O
20 rate NN I-NP O
20 76 CD O O
20 , , O O
20 normal JJ B-NP O
20 sinus NN I-NP O
21 rhythm NN I-NP O
21 They PRP O O
21 gave VBD B-VP O
21 two CD O B-do
21 nitrospray NN B-NP B-m
21 , , O O
21 blood NN B-NP B-r
21 pressure NN I-NP I-r
21 decreased VBD B-VP O
21 to TO O O
22 150/80 CD O O
22 , , O O
22 heart NN B-NP O
22 rate NN I-NP O
22 76 CD O O
22 and CC O O
22 after IN B-VP O
22 two CD O O
22 minutes NNS B-NP O
22 in IN B-VP O
22 the DT B-NP O
22 vehicle NN I-NP O
22 , , O O
22 she PRP O O
22 had VBD B-VP O
23 sinus VBN O O
23 bradycardia NN B-NP O
23 at IN B-VP O
23 30-40 JJ O O
23 , , O O
23 blood NN B-NP B-r
23 pressure NN I-NP I-r
23 120/80 CD O O
23 She PRP O O
23 was VBD B-VP O
23 given VBN O O
24 0.5 CD O B-do
24 mg NN B-NP I-do
24 of IN B-VP O
24 Atropine NNP B-NP B-m
24 times CC O B-du
24 one CD O I-du
24 without IN B-VP O
24 any DT O O
24 affect JJ O O
24 She PRP O O
24 was VBD B-VP O
24 brought VBN O O
25 to TO O O
25 the DT B-NP O
25 Chcine NNP I-NP O
25 Medical NNP I-NP O
25 Center NNP I-NP O
25 , , O O
25 but CC O O
25 initially RB O O
25 she PRP O O
25 was VBD B-VP O
26 normotensive JJ O O
26 with IN B-VP O
26 a DT B-NP O
26 systolic JJ I-NP O
26 blood NN I-NP O
26 pressure NN I-NP O
26 of IN B-VP O
26 100 CD O O
26 Then RB O O
26 suddenly RB O O
27 she PRP O O
27 had VBD B-VP O
27 bradycardia VBN O O
27 with IN B-VP O
27 heart NN B-NP O
27 rate NN I-NP O
27 of IN B-VP O
27 30-40 JJ O O
27 and CC O O
27 systolic JJ B-NP B-r
27 blood NN I-NP O
28 pressure NN I-NP O
28 of IN B-VP O
28 75 CD O O
28 She PRP O O
28 was VBD B-VP O
28 given VBN O O
28 intravenous JJ B-NP B-m
28 intravenous JJ I-NP B-mo
28 fluids NNS I-NP I-m
28 and CC O O
28 Atropine NNP B-NP B-m
28 0.5 CD O B-do
29 mg NN B-NP O
29 times NNS I-NP B-du
29 one CD O I-du
29 This DT B-NP O
29 lead NN I-NP O
29 to TO O O
29 an DT B-NP O
29 increase NN I-NP O
29 in IN B-VP O
29 her PRP$ O O
29 blood NN B-NP O
29 pressure NN I-NP O
30 systolic NN I-NP O
30 of IN B-VP O
30 100 CD O O
30 and CC O O
30 her PRP$ O O
30 heart NN B-NP O
30 rate NN I-NP O
30 increased VBD B-VP O
30 to TO O O
30 60 CD O O
30 On IN B-VP O
30 transfer NN B-NP O
30 to TO O O
31 the DT B-NP O
31 floor NN I-NP O
31 , , O O
31 she PRP O O
31 was VBD B-VP O
31 without IN B-VP O
31 chest JJS B-NP O
31 pain NN I-NP O
31 , , O O
31 normotensive JJ O O
31 and CC O O
31 in IN B-VP O
31 normal JJ B-NP O
32 sinus NN I-NP O
32 rhythm NN I-NP O
33 REVIEW NNP I-NP O
33 OF NNP I-NP O
33 SYSTEMS: NNP I-NP O
33 She PRP O O
33 denies VBZ O O
33 lower JJR B-NP O
33 extremity NN I-NP O
33 edema NN I-NP O
33 , , O O
33 orthopnea NN B-NP O
33 , , O O
34 paroxysmal JJ B-NP O
34 nocturnal JJ I-NP O
34 dyspnea NN I-NP O
34 , , O O
34 fever NN B-NP O
34 , , O O
34 chills NNS B-NP O
34 , , O O
35 cough NN B-NP O
35 , , O O
35 abdominal JJ B-NP O
35 pain NN I-NP O
36 PAST NNP I-NP O
36 MEDICAL NNP I-NP O
36 HISTORY: NNP I-NP O
36 1 CD O O
36 ) ) O O
36 Adult NNP B-NP O
36 onset MD O O
36 diabetes VBZ O B-r
36 mellitus NNS B-NP I-r
36 on IN B-VP O
37 Glucotrol NNP B-NP B-m
37 2 CD O O
37 ) ) O O
37 Hypertension NNP B-NP O
37 3 CD O O
37 ) ) O O
38 Palpitations NNS B-NP O
38 4 CD O O
38 ) ) O O
38 Cerebrovascular JJ B-NP O
38 accident NN I-NP O
38 about IN B-VP O
38 four CD O O
38 months NNS B-NP O
38 ago IN B-VP O
39 The DT B-NP O
39 history NN I-NP O
39 of IN B-VP O
39 this DT O O
39 is VBZ O O
39 unclear JJ O O
39 She PRP O O
39 is VBZ O O
39 followed VBN O O
39 by IN B-VP O
39 Chang NNP B-NP O
39 Stoudmire NNP I-NP O
40 at IN B-VP O
40 the DT B-NP O
40 Wooci NNP I-NP O
40 Warmso NNP I-NP O
40 Rai NNP I-NP O
40 Community NNP I-NP O
40 Hospital NNP I-NP O
41 MEDICATIONS NNP I-NP O
41 ON NNP I-NP O
41 ADMISSION: NNP I-NP O
41 1 CD O O
41 ) ) O O
41 Nifedipine NN B-NP B-m
41 10 CD O B-do
41 mg NN B-NP I-do
41 p.o NN I-NP B-mo
41 p.r.n NN I-NP B-f
41 for IN B-VP O
42 elevated JJ B-NP B-r
42 blood NN I-NP I-r
42 pressure NN I-NP I-r
42 2 CD O O
42 ) ) O O
42 Lasix FW O B-m
42 20 CD O B-do
43 mg NN B-NP O
43 p.o NN I-NP B-mo
43 q JJ B-NP B-f
43 day NN I-NP I-f
43 3 CD O O
43 ) ) O O
43 Glucotrol NNP B-NP B-m
43 15 CD O B-do
43 mg NN B-NP I-do
43 p.o NN I-NP B-mo
43 q JJ B-NP B-f
43 day NN I-NP I-f
43 4 CD O O
43 ) ) O O
43 Cardizem NNP B-NP B-m
43 300 CD O B-do
44 mg NN B-NP O
44 p.o NN I-NP B-mo
44 q JJ B-NP B-f
44 day NN I-NP I-f
44 5 CD O O
44 ) ) O O
44 Coumadin NNP B-NP B-m
44 3.75 CD O B-do
44 mg NN B-NP I-do
44 p.o NN I-NP B-mo
44 q JJ B-NP B-f
44 day NN I-NP I-f
44 6 CD O O
44 ) ) O O
44 Colace NN B-NP B-m
44 100 CD O B-do
45 mg NN B-NP O
45 p.o NN I-NP B-mo
45 b.i.d IN B-VP B-f
45 7 CD O O
45 ) ) O O
45 Iron NNP B-NP B-m
45 325 CD O B-do
45 mg NN B-NP I-do
45 p.o NN I-NP B-mo
45 q JJ B-NP B-f
45 day NN I-NP I-f
46 ALLERGIES: NNP I-NP O
46 The DT B-NP O
46 patient NN I-NP O
46 had VBD B-VP O
46 no DT O O
46 known VBN O O
46 drug NN B-NP O
46 allergies NNS I-NP O
47 SOCIAL NNP I-NP O
47 HISTORY: NNP I-NP O
47 The DT B-NP O
47 patient NN I-NP O
47 lives VBZ O O
47 in IN B-VP O
47 Angelesrangego NNP B-NP O
47 She PRP O O
47 is VBZ O O
48 married JJ O O
48 She PRP O O
48 is VBZ O O
48 unemployed JJ O O
48 She PRP O O
48 has VBZ O O
48 eight CD O O
49 children NNS B-NP O
49 She PRP O O
49 has VBZ O O
49 no DT B-NP O
49 alcohol NN I-NP O
49 use NN I-NP O
49 She PRP O O
49 was VBD B-VP O
49 a DT B-NP O
49 smoker NN I-NP O
49 , , O O
49 discontinued VBN O O
50 three CD O O
50 months NNS B-NP O
50 ago IN B-VP O
50 She PRP O O
50 smoked VBD B-VP O
50 three CD O O
50 cigarettes NNS B-NP O
50 per IN B-VP O
50 day NN B-NP O
50 times NNS I-NP O
50 43 CD O O
51 years NNS B-NP O
52 PHYSICAL NNP I-NP O
52 EXAMINATION: NNP I-NP O
52 Vital NNP I-NP O
52 signs: VBD B-VP O
52 Temperature NNP B-NP O
52 97.9 CD O O
52 degrees NNS B-NP O
52 , , O O
53 heart NN B-NP O
53 rate NN I-NP O
53 62 CD O O
53 , , O O
53 blood NN B-NP O
53 pressure NN I-NP O
53 144/86 CD O O
53 , , O O
53 SAO2 NNP B-NP O
54 96% CD O O
54 on IN B-VP O
54 two CD O O
54 liters NNS B-NP O
54 General: NNP I-NP O
54 Well NNP I-NP O
54 appearing VBG O O
54 , , O O
54 Spanish JJ O O
54 speaking VBG O O
55 woman NN B-NP O
55 in IN B-VP O
55 no DT B-NP O
55 apparent JJ I-NP O
55 distress NN I-NP O
55 HEENT NNP I-NP O
55 was VBD B-VP O
55 normocephalic JJ O O
55 , , O O
56 atraumatic JJ B-NP O
56 Pupils NNS I-NP O
56 were VBD B-VP O
56 equal JJ O O
56 , , O O
56 round NN B-NP O
56 and CC O O
56 reactive JJ O O
56 to TO O O
56 light JJ B-NP O
57 Oropharynx NNP I-NP O
57 revealed VBD B-VP O
57 lower JJR O O
57 and CC O O
57 upper JJ B-NP O
57 dentures NNS I-NP O
57 Neck NNP I-NP O
57 with IN B-VP O
57 full JJ B-NP O
57 range NN I-NP O
58 of IN B-VP O
58 motion NN B-NP O
58 , , O O
58 supple NN B-NP O
58 , , O O
58 jugular JJ B-NP O
58 venous JJ I-NP O
58 pressure NN I-NP O
58 8 CD O O
58 cm NN B-NP O
58 , , O O
58 carotids NNS B-NP O
58 2+ CD O O
58 , , O O
58 no DT B-NP O
59 bruits NNS I-NP O
59 Chest NNP I-NP O
59 revealed VBD B-VP O
59 basilar JJ B-NP O
59 rales NNS I-NP O
59 bilaterally RB O O
59 Cardiovascular NNP B-NP O
60 was VBD B-VP O
60 regular JJ B-NP O
60 rate NN I-NP O
60 and CC O O
60 rhythm NN B-NP O
60 , , O O
60 normal JJ B-NP O
60 S1 NNP I-NP O
60 and CC O O
60 S2 NNP B-NP O
60 , , O O
60 no DT B-NP O
60 murmurs NNS I-NP O
60 Abdomen NNP I-NP O
61 was VBD B-VP O
61 non-tender JJ O O
61 , , O O
61 no DT B-NP O
61 hepatosplenomegaly NN I-NP O
61 , , O O
61 positive JJ B-NP O
61 bowel NN I-NP O
61 sounds VBZ O O
62 Extremities NNS B-NP O
62 revealed VBD B-VP O
62 no DT B-NP O
62 clubbing NN I-NP O
62 , , O O
62 cyanosis NN B-NP O
62 or CC O O
62 edema NN B-NP O
62 , , O O
62 2+ CD O O
62 dorsalis NN B-NP O
63 pedis NN I-NP O
63 and CC O O
63 posterior JJ B-NP O
63 tibial JJ I-NP O
63 pulses NNS I-NP O
63 bilaterally RB O O
63 Neurological NNP B-NP O
64 revealed VBD B-VP O
64 motor NN B-NP O
64 in IN B-VP O
64 upper JJ B-NP O
64 extremities NNS I-NP O
64 and CC O O
64 lower JJR B-NP O
64 extremities NNS I-NP O
64 at IN B-VP O
64 five CD O O
65 out IN B-VP O
65 of IN B-VP O
65 five CD O O
65 The DT B-NP O
65 patient NN I-NP O
65 was VBD B-VP O
65 alert JJ O O
65 and CC O O
65 oriented VBD B-VP O
65 times NNS B-NP O
65 three CD O O
66 LABORATORY: NNP B-NP O
66 Laboratory NNP I-NP O
66 studies NNS I-NP O
66 revealed VBD B-VP O
66 a DT B-NP O
66 sodium NN I-NP O
66 of IN B-VP O
66 143 CD O O
66 , , O O
66 potassium NN B-NP O
67 4.1 CD O O
67 , , O O
67 chloride RB O O
67 100 CD O O
67 , , O O
67 bicarbonate NN B-NP O
67 47 CD O O
67 , , O O
67 BUN NNP B-NP O
67 26 CD O O
67 , , O O
67 creatinine NN B-NP O
68 1.1 CD O O
68 , , O O
68 glucose RB O O
68 244 CD O O
68 , , O O
68 white JJ B-NP O
68 blood NN I-NP O
68 cell NN I-NP O
68 count NN I-NP O
68 9 CD O O
68 , , O O
68 hematocrit NN B-NP O
68 33.9 CD O O
68 , , O O
69 platelets NNS B-NP O
69 276 CD O O
69 Troponin NNP B-NP O
69 was VBD B-VP O
69 0.0 CD O O
69 CK NNP B-NP O
69 was VBD B-VP O
69 75 CD O O
69 PT NNP B-NP O
69 14.7 CD O O
69 , , O O
69 INR NNP B-NP O
69 1.5 CD O O
69 , , O O
70 PTT NNP B-NP O
70 32 CD O O
70 Chest NNP B-NP O
70 x-ray NN I-NP O
70 showed VBD B-VP O
70 cardiomegaly NNS B-NP O
70 , , O O
70 no DT B-NP O
70 congestive JJ I-NP O
70 heart NN I-NP O
71 failure NN I-NP O
71 , , O O
71 no DT B-NP O
71 infiltrates NNS I-NP O
71 EKG NNP I-NP O
71 revealed VBD B-VP O
71 sinus JJ B-NP O
71 bradycardia NN I-NP O
71 at IN B-VP O
71 58 CD O O
71 , , O O
72 0.158/092/0.47 CD O O
72 , , O O
72 no DT B-NP O
72 ST NNP I-NP O
72 or CC O O
72 T-wave NNP B-NP O
72 changes NNS I-NP O
72 , , O O
72 no DT B-NP O
72 Q-waves NNS I-NP O
72 , , O O
72 no DT B-NP O
72 old JJ I-NP O
72 EKG NNP I-NP O
72 for IN B-VP O
73 comparison NN B-NP O
73 at IN B-VP O
73 the DT B-NP O
73 time NN I-NP O
73 of IN B-VP O
73 admission NN B-NP O
74 HOSPITAL NNP I-NP O
74 COURSE: NNP I-NP O
74 The DT B-NP O
74 patient JJ I-NP O
74 underwent JJ I-NP O
74 exercise NN I-NP O
74 tolerance NN I-NP O
74 test NN I-NP O
74 on IN B-VP O
75 a DT B-NP O
75 standard JJ I-NP O
75 Bruce NNP I-NP O
75 protocol NN I-NP O
75 She PRP O O
75 completed VBD B-VP O
75 6 CD O O
76 minutes NNS B-NP O
76 , , O O
76 32 CD O O
76 seconds NNS B-NP O
76 but CC O O
76 stopped VBD B-VP O
76 secondary JJ O O
76 to TO O O
76 leg VB O O
76 fatigue NN B-NP O
76 She PRP O O
76 has VBZ O O
77 no DT B-NP O
77 chest NN I-NP O
77 pain NN I-NP O
77 EKG NNP I-NP O
77 was VBD B-VP O
77 without IN B-VP O
77 changes NNS B-NP O
77 during IN B-VP O
77 exercise NN B-NP O
77 , , O O
77 but CC O O
77 at IN B-VP O
78 recovery NN B-NP O
78 , , O O
78 developed VBD B-VP O
78 EKG NNP B-NP O
78 changes NNS I-NP O
78 in IN B-VP O
78 both DT O O
78 inferior JJ O O
78 and CC O O
78 lateral JJ B-NP O
78 leads NNS I-NP O
79 This DT O O
79 was VBD B-VP O
79 consistent JJ O O
79 but CC O O
79 not RB O O
79 diagnostic JJ O O
79 of IN B-VP O
79 ischemia NN B-NP O
79 She PRP O O
79 underwent VBD B-VP O
80 angiography NN B-NP O
80 which WDT O O
80 showed VBD B-VP O
80 left VBD B-VP O
80 main JJ B-NP O
80 OK NNP I-NP O
80 , , O O
80 LAD NNP B-NP O
80 proximal VBZ O O
80 20% CD O O
80 , , O O
80 D2 NNP B-NP O
80 60% CD O O
80 , , O O
81 ostial JJ O O
81 90% CD O O
81 mid NN B-NP O
81 , , O O
81 left VBD B-VP O
81 circumflex JJ B-NP O
81 mid NN I-NP O
81 30% CD O O
81 , , O O
81 OM2 NNP B-NP O
81 distal JJ O O
81 60-70% JJ O O
81 , , O O
81 OM1 NNP B-NP O
82 mild NN I-NP O
82 diffuse NN I-NP O
82 disease NN I-NP O
82 She PRP O O
82 underwent JJ B-NP O
82 PTCA NNP I-NP O
82 of IN B-VP O
82 her PRP$ O O
82 diagonal JJ O O
82 two CD O O
82 which WDT O O
83 went VBD B-VP O
83 from IN B-VP O
83 90% CD O O
83 to TO O O
83 0% CD O O
83 stenosis NN B-NP B-r
83 She PRP O O
83 received VBD B-VP O
83 Heparin NNP B-NP B-m
83 overnight MD O B-du
83 and CC O O
84 the DT B-NP O
84 sheaths NNS I-NP O
84 were VBD B-VP O
84 pulled VBN O O
84 on IN B-VP O
84 the DT B-NP O
84 following JJ I-NP O
84 day NN I-NP O
84 In IN B-VP O
84 addition NN B-NP O
84 , , O O
84 she PRP O O
85 underwent JJ B-NP O
85 modification NN I-NP O
85 of IN B-VP O
85 her PRP$ O O
85 medical JJ B-NP O
85 regimen NN I-NP O
85 She PRP O O
85 was VBD B-VP O
85 given VBN O O
86 aspirin RB O B-m
86 , , O O
86 Beta NNP B-NP B-m
86 blocker NN I-NP I-m
86 , , O O
86 Isordil NNP B-NP B-m
86 , , O O
86 and CC O O
86 ACE NNP B-NP B-m
86 inhibitor NN I-NP I-m
87 MEDICATIONS NNP I-NP O
87 ON NNP I-NP O
87 DISCHARGE: NNP I-NP O
87 1 CD O O
87 ) ) O O
87 Aspirin $ O B-m
87 325 CD O B-do
87 mg NN B-NP I-do
87 p.o NN I-NP B-mo
87 q JJ B-NP B-f
87 day NN I-NP I-f
87 2 CD O O
87 ) ) O O
88 Atenolol $ O B-m
88 50 CD O B-do
88 mg NN B-NP I-do
88 p.o NN I-NP B-mo
88 q JJ B-NP B-f
88 day NN I-NP I-f
88 3 CD O O
88 ) ) O O
89 Lisinopril FW O B-m
89 10 CD O B-do
89 mg NN B-NP I-do
89 p.o NN I-NP B-mo
89 q JJ B-NP B-f
89 day NN I-NP I-f
89 4 CD O O
89 ) ) O O
89 Pravachol VBD B-VP B-m
89 20 CD O B-do
89 mg NN B-NP I-do
89 p.o NN I-NP B-mo
89 q JJ B-NP B-f
89 day NN I-NP I-f
89 5 CD O O
89 ) ) O O
90 Glucotrol NNP B-NP B-m
90 XL $ O I-m
90 15 CD O B-do
90 mg NN B-NP I-do
90 p.o NN I-NP B-mo
90 q NN I-NP B-f
90 AM NNP I-NP I-f
90 6 CD O O
90 ) ) O O
90 Lasix FW O B-m
90 20 CD O B-do
90 mg NN B-NP I-do
90 p.o NN I-NP B-mo
90 q JJ B-NP B-f
90 day NN I-NP I-f
90 7 CD O O
90 ) ) O O
91 Nitroglycerin NNP B-NP B-m
91 tablets VBZ O I-m
91 sublingual JJ B-NP B-mo
91 p.r.n NN I-NP B-f
91 chest JJS B-NP B-r
91 pain NN I-NP I-r
92 FOLLOW-UP: CD O O
92 The DT B-NP O
92 patient NN I-NP O
92 is VBZ O O
92 to TO O O
92 follow-up JJ O O
92 in IN B-VP O
92 the DT B-NP O
92 VERAREA NNP I-NP O
92 UNIVERSITY NNP I-NP O
92 HOSPITAL NNP I-NP O
92 Clinic NNP I-NP O
92 with IN B-VP O
92 Dr NNP B-NP O
93 Van NNP I-NP O
93 Rothenberg NNP I-NP O
94 Dictated NNP I-NP O
94 By: NNP I-NP O
94 ZACHARIAH NNP I-NP O
94 TINGSTROM NNP I-NP O
94 , , O O
94 M.D NNP B-NP O
94 KP59 NNP I-NP O
95 Attending: NNP I-NP O
95 BRICE NNP I-NP O
95 LEZO NNP I-NP O
95 , , O O
95 M.D NNP B-NP O
95 MK60 NNP I-NP O
96 TN341/1946 NNP I-NP O
97 Batch: NNP I-NP O
97 19920 CD O O
97 Index NNP B-NP O
97 No NNP I-NP O
97 HCGD2C3J1P NNP I-NP O
97 D: NNP I-NP O
97 1/13/97 CD O O
98 T: NNP B-NP O
98 10/6/97 CD O O
99 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #808959 VBZ O O
4 022039090 CD O O
4 UGH NNP B-NP O
4 34853160 CD O O
4 4624027 CD O O
4 7/5/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 RULE NNP I-NP O
4 OUT NNP I-NP O
4 MYCOCARDIAL NNP I-NP O
4 INFARCTION NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/17/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/6/2005 CD O O
7 ATTENDING: NNP B-NP O
7 WEISSMANN NNP I-NP O
7 , , O O
7 RORY NNP B-NP O
7 M.D NNP I-NP O
8 DATE NNP I-NP O
8 OF NNP I-NP O
8 SURGERY: NNP I-NP O
9 2/11/05 CD O O
10 HISTORY NNP B-NP O
10 AND NNP I-NP O
10 PHYSICAL: NNP I-NP O
11 This DT O O
11 is VBZ O O
11 a DT B-NP O
11 74-year-old JJ I-NP O
11 gentleman NN I-NP O
11 with IN B-VP O
11 a DT B-NP O
11 history NN I-NP O
11 on IN B-VP O
12 insulin-dependent JJ B-NP O
12 diabetes NNS I-NP O
12 mellitus NN I-NP O
12 , , O O
12 hypertension NN B-NP O
12 , , O O
12 coronary JJ B-NP O
13 artery NN I-NP O
13 disease NN I-NP O
13 , , O O
13 with IN B-VP O
13 substernal JJ B-NP O
13 chest NN I-NP O
13 pain NN I-NP O
13 on IN B-VP O
13 exertion NN B-NP O
13 , , O O
13 which WDT O O
13 had VBD B-VP O
14 been VBN O O
14 increasing VBG O O
14 for IN B-VP O
14 the DT B-NP O
14 month NN I-NP O
14 prior RB O O
14 to TO O O
14 surgery VB O O
14 He PRP O O
14 denies VBZ O O
14 any DT B-NP O
15 shortness NN I-NP O
15 of IN B-VP O
15 breath NN B-NP O
15 , , O O
15 PND NNP B-NP O
15 or CC O O
15 orthopnea NN B-NP O
15 He PRP O O
15 has VBZ O O
15 a DT B-NP O
15 history NN I-NP O
15 of IN B-VP O
16 three-vessel JJ B-NP O
16 disease NN I-NP O
16 on IN B-VP O
16 catheterization NN B-NP O
16 back RB O O
16 in IN B-VP O
16 1996 CD O O
16 , , O O
16 status NN B-NP O
16 post NN I-NP O
17 angioplasty NN I-NP O
17 without IN B-VP O
17 stenting VBG O O
17 He PRP O O
17 reportedly RB O O
17 had VBD B-VP O
17 an DT B-NP O
17 abnormal JJ I-NP O
18 exercise NN I-NP O
18 tolerance NN I-NP O
18 test NN I-NP O
18 in IN B-VP O
18 1996 CD O O
18 and CC O O
18 in IN B-VP O
18 1999 CD O O
18 He PRP O O
18 was VBD B-VP O
18 admitted VBN O O
18 via IN B-VP O
19 his PRP$ O O
19 primary JJ B-NP O
19 care NN I-NP O
19 physician's NN I-NP O
19 office NN I-NP O
19 on IN B-VP O
19 6/13/05 CD O O
19 with IN B-VP O
19 substernal JJ B-NP O
20 chest NN I-NP O
20 pain NN I-NP O
20 and CC O O
20 T NNP B-NP O
20 wave VBP O O
20 inversions NNS B-NP O
20 in IN B-VP O
20 leads NNS B-NP O
20 V3 NNP I-NP O
20 and CC O O
20 V4 NNP B-NP O
20 Enzymes NNP I-NP O
21 were VBD B-VP O
21 cycled VBN O O
21 and CC O O
21 they PRP O O
21 were VBD B-VP O
21 negative JJ O O
21 x4 IN B-VP O
21 The DT B-NP O
21 patient NN I-NP O
21 went VBD B-VP O
21 to TO O O
21 the DT B-NP O
22 cath NN I-NP O
22 on IN B-VP O
22 0/18/05 CD O O
22 and CC O O
22 was VBD B-VP O
22 found VBN O O
22 to TO O O
22 have VB O O
22 coronary JJ B-NP O
22 artery NN I-NP O
22 disease NN I-NP O
23 He PRP O O
23 was VBD B-VP O
23 scheduled VBN O O
23 for IN B-VP O
23 CABG NNP B-NP O
24 PAST NNP I-NP O
24 MEDICAL NNP I-NP O
24 HISTORY: NNP I-NP O
25 1 CD O O
25 Hypertension NNP B-NP O
26 2 CD O O
26 Diabetes NNP B-NP B-r
26 mellitus NN I-NP I-r
26 , , O O
26 on IN B-VP O
26 insulin NN B-NP B-m
26 therapy NN I-NP O
27 3 CD O O
27 Hypercholesterolemia NNP B-NP O
28 PAST NNP I-NP O
28 SURGICAL NNP I-NP O
28 HISTORY: NNP I-NP O
29 Unknown NNP I-NP O
30 MEDICATIONS NNP I-NP O
30 ON NNP I-NP O
30 ADMISSION: NNP I-NP O
31 1 CD O O
31 Lopressor NNP B-NP B-m
31 50 CD O B-do
31 mg NN B-NP I-do
31 p.o NN I-NP B-mo
31 t.i.d VBD B-VP B-f
32 2 CD O O
32 Lisinopril NNP B-NP B-m
32 40 CD O B-do
32 mg NN B-NP I-do
32 p.o JJ O B-mo
32 daily JJ O B-f
33 3 CD O O
33 Aspirin NNP B-NP B-m
33 325 CD O B-do
33 mg NN B-NP I-do
33 p.o JJ O B-mo
33 daily JJ O B-f
34 4 CD O O
34 Hydrochlorothiazide/triamterene NNP B-NP B-m
34 one CD O B-do
34 tablet NN B-NP I-do
34 daily RB O B-f
35 5 CD O O
35 Atorvastatin NNP B-NP B-m
35 80 CD O B-do
35 mg NN B-NP I-do
35 p.o JJ O B-mo
35 daily JJ O B-f
36 6 CD O O
36 Lantus NNP B-NP B-m
36 50 CD O B-do
36 cc JJ B-NP I-do
36 daily JJ I-NP B-f
37 ALLERGIES: NNP I-NP O
38 The DT B-NP O
38 patient NN I-NP O
38 has VBZ O O
38 no DT O O
38 known VBN O O
38 drug NN B-NP O
38 allergies NNS I-NP O
39 SOCIAL NNP I-NP O
39 HISTORY: NNP I-NP O
40 No NNP I-NP O
40 known VBN O O
40 social JJ B-NP O
40 history NN I-NP O
41 FAMILY NNP I-NP O
41 HISTORY: NNP I-NP O
42 No NNP I-NP O
42 family NN I-NP O
42 history NN I-NP O
42 of IN B-VP O
42 coronary JJ B-NP O
42 artery NN I-NP O
42 disease NN I-NP O
43 PHYSICAL NNP I-NP O
43 EXAMINATION: NNP I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 stands VBZ O O
44 5 CD O O
44 feet NNS B-NP O
44 6 CD O O
44 inches NNS B-NP O
44 tall JJ O O
44 , , O O
44 weighs VBZ O O
44 97.9 CD O O
44 kg NN B-NP O
45 Temperature NN I-NP O
45 was VBD B-VP O
45 97 CD O O
45 , , O O
45 heart NN B-NP O
45 rate NN I-NP O
45 was VBD B-VP O
45 62 CD O O
45 , , O O
45 and CC O O
45 blood NN B-NP O
45 pressure NN I-NP O
45 was VBD B-VP O
46 110/64 CD O O
46 He PRP O O
46 was VBD B-VP O
46 on IN B-VP O
46 a DT B-NP O
46 face NN I-NP O
46 mask NN I-NP O
46 with IN B-VP O
46 an DT B-NP O
46 oxygen NN I-NP O
46 saturation NN I-NP O
46 at IN B-VP O
46 95% CD O O
47 On IN B-VP O
47 physical JJ B-NP O
47 examination NN I-NP O
47 , , O O
47 he PRP O O
47 was VBD B-VP O
47 alert JJ O O
47 and CC O O
47 oriented VBN O O
47 , , O O
47 with IN B-VP O
47 no DT B-NP O
47 focal JJ I-NP O
48 deficits NNS I-NP O
48 HEENT NNP I-NP O
48 showed VBD B-VP O
48 PERRLA NNP B-NP O
48 No NNP I-NP O
48 teeth NN I-NP O
48 , , O O
48 both DT O O
48 upper JJ O O
48 and CC O O
48 lower JJR O O
49 dentures VBZ O O
49 No DT B-NP O
49 carotid NN I-NP O
49 bruits VBZ O O
49 Cardiovascular: NNP B-NP O
49 Regular NNP I-NP O
49 rate NN I-NP O
49 and CC O O
50 rhythm NN B-NP O
50 , , O O
50 with IN B-VP O
50 no DT B-NP O
50 murmurs NNS I-NP O
50 , , O O
50 rubs NNS B-NP O
50 or CC O O
50 gallops VB O O
50 His PRP$ O O
50 Allen's NNP B-NP O
50 test NN I-NP O
50 on IN B-VP O
51 the DT B-NP O
51 left JJ I-NP O
51 upper JJ I-NP O
51 extremity NN I-NP O
51 was VBD B-VP O
51 normal JJ O O
51 , , O O
51 on IN B-VP O
51 the DT B-NP O
51 right JJ I-NP O
51 upper JJ I-NP O
51 extremity NN I-NP O
52 was VBD B-VP O
52 normal JJ B-NP O
52 Respiratory: NNP I-NP O
52 He PRP O O
52 had VBD B-VP O
52 clear JJ B-NP O
52 breath NN I-NP O
52 sounds VBZ O O
53 bilaterally RB O O
53 Adomen: NNP B-NP O
53 Soft NNP I-NP O
53 , , O O
53 nontender NN B-NP O
53 , , O O
53 no DT B-NP O
53 masses NNS I-NP O
53 , , O O
53 noted VBD B-VP O
53 to TO O O
53 be VB O O
54 obese JJ B-NP O
54 Extremities: NNP I-NP O
54 Without NNP I-NP O
54 scarring NN I-NP O
54 , , O O
54 varicosities NNS B-NP O
54 or CC O O
54 edema NN B-NP O
55 Pulses NNS I-NP O
55 , , O O
55 carotid NN B-NP O
55 left VBD B-VP O
55 and CC O O
55 right JJ O O
55 were VBD B-VP O
55 2+ CD O O
55 , , O O
55 radial JJ B-NP O
55 left NN I-NP O
55 and CC O O
55 right NN B-NP O
56 were VBD B-VP O
56 2+ CD O O
56 , , O O
56 femoral JJ B-NP O
56 left NN I-NP O
56 and CC O O
56 right NN B-NP O
56 were VBD B-VP O
56 2+ CD O O
56 , , O O
56 dorsalis NNS B-NP O
56 pedis VBP O O
56 were VBD B-VP O
56 left VBN O O
57 and CC O O
57 right JJ B-NP O
57 present NN I-NP O
57 by IN B-VP O
57 Doppler NNP B-NP O
57 , , O O
57 and CC O O
57 posterior JJ B-NP O
57 tibial NN I-NP O
57 were VBD B-VP O
57 left VBN O O
57 and CC O O
58 right JJ B-NP O
58 present NN I-NP O
58 by IN B-VP O
58 Doppler NNP B-NP O
59 ADMISSION NNP I-NP O
59 LABORATORY NNP I-NP O
59 VALUES: NNP I-NP O
60 Sodium NNP I-NP O
60 of IN B-VP O
60 137 CD O O
60 , , O O
60 K NNP B-NP O
60 of IN B-VP O
60 4.2 CD O O
60 , , O O
60 BUN NNP B-NP O
60 of IN B-VP O
60 35 CD O O
60 , , O O
60 and CC O O
60 creatinine NN B-NP O
60 of IN B-VP O
60 1.3 CD O O
60 White NNP B-NP O
61 blood NN I-NP O
61 cell NN I-NP O
61 count NN I-NP O
61 was VBD B-VP O
61 7 CD O O
61 , , O O
61 hematocrit NN B-NP O
61 was VBD B-VP O
61 38 CD O O
61 , , O O
61 and CC O O
61 platelet NN B-NP O
61 count NN I-NP O
61 was VBD B-VP O
62 179 CD O O
62 , , O O
62 000 CD O O
62 INR NNP B-NP O
62 was VBD B-VP O
62 1.1 CD O O
62 His PRP$ O O
62 UA NN B-NP O
62 was VBD B-VP O
62 described VBN O O
62 as IN B-VP O
62 contaminated JJ B-NP O
63 Cardiac NNP I-NP O
63 cath NN I-NP O
63 from IN B-VP O
63 0/18/05 CD O O
63 , , O O
63 which WDT O O
63 was VBD B-VP O
63 performed VBN O O
63 at IN B-VP O
63 the DT B-NP O
63 Adli NNP I-NP O
63 Corn11 NNP I-NP O
63 Health NNP I-NP O
63 Center NNP I-NP O
63 , , O O
64 showed VBD B-VP O
64 a DT O O
64 95% CD O O
64 ostial JJ B-NP O
64 LAD NNP I-NP O
64 lesion NN I-NP O
64 , , O O
64 a DT O O
64 60% CD O O
64 mid NN B-NP O
64 LAD NNP I-NP O
64 lesion NN I-NP O
64 , , O O
64 an DT O O
64 80% CD O O
65 distal NN B-NP O
65 LAD NNP I-NP O
65 lesion NN I-NP O
65 , , O O
65 a DT O O
65 70% CD O O
65 proximal JJ B-NP O
65 D1 NNP I-NP O
65 lesion NN I-NP O
65 , , O O
65 a DT O O
65 40% CD O O
65 proximal JJ B-NP O
66 circumflex JJ I-NP O
66 lesion NN I-NP O
66 , , O O
66 a DT O O
66 90% CD O O
66 ostial JJ B-NP O
66 OM1 NNP I-NP O
66 lesion NN I-NP O
66 , , O O
66 a DT O O
66 100% CD O O
66 proximal JJ B-NP O
66 RCA NNP I-NP O
67 lesion NN I-NP O
67 , , O O
67 and CC O O
67 a DT B-NP O
67 right JJ I-NP O
67 dominant JJ I-NP O
67 circulation NN I-NP O
67 Echo NNP I-NP O
67 from IN B-VP O
67 4/26/05 CD O O
68 showed VBD B-VP O
68 a DT O O
68 60% CD O O
68 ejection NN B-NP O
68 fraction NN I-NP O
68 , , O O
68 with IN B-VP O
68 trace NN B-NP O
68 to TO O O
68 mild VB O O
68 mitral JJ B-NP O
69 regurgitation NN I-NP O
69 , , O O
69 no DT B-NP O
69 wall NN I-NP O
69 motion NN I-NP O
69 abnormalities VBZ O O
69 An DT B-NP O
69 EKG NNP I-NP O
69 on IN B-VP O
69 0/18/05 CD O O
70 showed VBD B-VP O
70 a DT B-NP O
70 normal JJ I-NP O
70 sinus NN I-NP O
70 rhythm NN I-NP O
70 with IN B-VP O
70 a DT B-NP O
70 rate NN I-NP O
70 of IN B-VP O
70 52 CD O O
70 , , O O
70 inverted VBN O O
70 T NNP B-NP O
70 waves NNS I-NP O
71 in IN B-VP O
71 V3 NNP B-NP O
71 , , O O
71 V4 NNP B-NP O
71 , , O O
71 V5 NNP B-NP O
71 and CC O O
71 V6 NNP B-NP O
71 A NNP I-NP O
71 chest JJ B-NP O
71 x-ray NN I-NP O
71 from IN B-VP O
71 4/27/05 CD O O
71 was VBD B-VP O
71 read VBN O O
71 out RP O O
72 as IN B-VP O
72 normal JJ B-NP O
73 HOSPITAL NNP I-NP O
73 COURSE: NNP I-NP O
74 The DT B-NP O
74 patient NN I-NP O
74 was VBD B-VP O
74 taken VBN O O
74 to TO O O
74 Surgery NNP B-NP O
74 on IN B-VP O
74 2/11/05 CD O O
74 The DT B-NP O
74 preoperative JJ I-NP O
74 diagnosis NN I-NP O
74 was VBD B-VP O
75 unstable JJ B-NP O
75 angina NN I-NP O
75 , , O O
75 three-vessel JJ B-NP O
75 disease NN I-NP O
75 and CC O O
75 morbid NN B-NP O
75 obesity NN I-NP O
75 The DT B-NP O
75 procedure NN I-NP O
75 was VBD B-VP O
75 a DT B-NP O
76 CABG NNP I-NP O
76 x3 VBZ O B-du
76 The DT B-NP O
76 patient NN I-NP O
76 had VBD B-VP O
76 an DT B-NP O
76 anaphylactoid JJ I-NP O
76 response NN I-NP O
76 to TO O O
76 aprotinin VB O B-m
76 and CC O O
77 subsequently RB O O
77 had VBD B-VP O
77 an DT O O
77 all DT B-NP O
77 vein JJ I-NP O
77 CABG NNP I-NP O
77 There EX O O
77 was VBD B-VP O
77 a DT B-NP O
77 Y NNP I-NP O
77 graft NN I-NP O
77 , , O O
77 SVG1 NNP B-NP O
77 connecting VBG O O
77 SVG2 NNP B-NP O
78 to TO O O
78 the DT B-NP O
78 LAD NNP I-NP O
78 , , O O
78 SVG2 NNP B-NP O
78 connecting VBG O O
78 the DT B-NP O
78 aorta NN I-NP O
78 to TO O O
78 OM1 NNP B-NP O
78 , , O O
78 and CC O O
78 SVG3 NNP B-NP O
78 connecting VBG O O
78 to TO O O
78 PDA VB O O
78 The DT B-NP O
79 patient NN I-NP O
79 was VBD B-VP O
79 brought VBN O O
79 up RP O O
79 from IN B-VP O
79 the DT B-NP O
79 operating NN I-NP O
79 room NN I-NP O
79 to TO O O
79 the DT B-NP O
79 Cardiac NNP I-NP O
79 Surgery NNP I-NP O
80 Intensive NNP I-NP O
80 Care NNP I-NP O
80 Unit NNP I-NP O
80 in IN B-VP O
80 stable JJ B-NP O
80 condition NN I-NP O
80 He PRP O O
80 was VBD B-VP O
80 extubated VBN O O
80 on IN B-VP O
80 postoperative JJ B-NP O
81 day NN I-NP O
81 #1 IN B-VP O
81 He PRP O O
81 did VBD B-VP O
81 well RB O O
81 over IN B-VP O
81 the DT B-NP O
81 next JJ I-NP O
81 several JJ I-NP O
81 days NNS I-NP O
81 He PRP O O
81 had VBD B-VP O
81 some DT B-NP O
81 intermittent JJ I-NP O
82 confusion NN I-NP O
82 , , O O
82 but CC O O
82 neuro JJ B-NP O
82 exam NN I-NP O
82 was VBD B-VP O
82 essentially RB O O
82 nonfocal JJ O O
82 , , O O
82 and CC O O
82 the DT B-NP O
82 patient NN I-NP O
82 was VBD B-VP O
83 transferred VBN O O
83 to TO O O
83 the DT B-NP O
83 Step-Down JJ I-NP O
83 Unit NNP I-NP O
83 on IN B-VP O
83 postoperative JJ B-NP O
83 day NN I-NP O
83 #4 VB O O
83 At IN B-VP O
83 that DT B-NP O
83 time NN I-NP O
83 , , O O
84 neurologically RB O O
84 , , O O
84 he PRP O O
84 was VBD B-VP O
84 intact JJ O O
84 Of IN B-VP O
84 note NN B-NP O
84 , , O O
84 he PRP O O
84 had VBD B-VP O
84 a DT B-NP O
84 ventricular JJ I-NP O
84 fibrillation NN I-NP O
85 arrest NN I-NP O
85 in IN B-VP O
85 the DT B-NP O
85 operating NN I-NP O
85 room NN I-NP O
85 because IN B-VP O
85 of IN B-VP O
85 the DT B-NP O
85 aprotinin JJ I-NP O
85 reaction NN I-NP O
85 in IN B-VP O
85 the DT B-NP O
86 operating NN I-NP O
86 room NN I-NP O
86 with IN B-VP O
86 systolic JJ B-NP O
86 pressures NNS I-NP O
86 in IN B-VP O
86 the DT O O
86 40s CD O O
86 Open NNP B-NP O
86 cardiac JJ B-NP O
86 massage NN I-NP O
86 was VBD B-VP O
87 required VBN O O
87 , , O O
87 and CC O O
87 he PRP O O
87 was VBD B-VP O
87 defibrillated VBN O O
87 They PRP O O
87 used VBD B-VP O
87 lidocaine NN B-NP B-m
87 and CC O O
87 amiodarone NN B-NP B-m
87 during IN B-VP B-du
88 the DT B-NP O
88 code NN I-NP O
88 His PRP$ O O
88 CK-MB NNP B-NP O
88 rose VBD B-VP O
88 to TO O O
88 37.5 CD O O
88 , , O O
88 and CC O O
88 his PRP$ O O
88 CK NN B-NP O
88 was VBD B-VP O
88 1646 CD O O
88 After IN B-VP O
88 his PRP$ O O
88 procedure NN B-NP O
88 , , O O
89 the DT B-NP O
89 patient NN I-NP O
89 did VBD B-VP O
89 wake VB O O
89 up RP O O
89 and CC O O
89 was VBD B-VP O
89 neurologically RB O O
89 intact JJ O O
89 The DT B-NP O
89 patient NN I-NP O
89 was VBD B-VP O
89 on IN B-VP O
89 a DT B-NP O
90 regular JJ I-NP O
90 diet NN I-NP O
90 He PRP O O
90 had VBD B-VP O
90 had VBN O O
90 problems NNS B-NP O
90 with IN B-VP O
90 abdominal JJ B-NP O
90 distention NN I-NP O
90 , , O O
90 but CC O O
90 this DT O O
90 had VBD B-VP O
91 resolved VBN O O
91 The DT B-NP O
91 patient NN I-NP O
91 had VBD B-VP O
91 also RB O O
91 been VBN O O
91 noted VBN O O
91 to TO O O
91 have VB O O
91 an DT O O
91 increased VBN O O
91 creatinine NN B-NP O
92 However RB O O
92 , , O O
92 this DT O O
92 also RB O O
92 resolved VBD B-VP O
92 The DT B-NP O
92 patient NN I-NP O
92 was VBD B-VP O
92 a DT O B-r
92 a DT O B-r
92 known VBN O I-r
92 known VBN O I-r
92 diabetic JJ B-NP I-r
92 diabetic NN I-NP I-r
92 and CC O O
92 was VBD B-VP O
92 on IN B-VP O
93 NovoLog NNP B-NP B-m
93 sliding VBG O B-do
93 scale NN B-NP I-do
93 , , O O
93 and CC O O
93 also RB O O
93 receiving VBG O O
93 Lantus NNP B-NP B-m
93 The DT B-NP O
93 patient NN I-NP O
93 has VBZ O O
93 no DT B-NP O
94 infectious JJ I-NP O
94 disease NN I-NP O
94 issues NNS I-NP O
94 at IN B-VP O
94 that DT B-NP O
94 time NN I-NP O
94 The DT B-NP O
94 patient NN I-NP O
94 was VBD B-VP O
94 in IN B-VP O
94 the DT B-NP O
94 Step-Down JJ I-NP O
94 Unit NNP I-NP O
94 , , O O
95 and CC O O
95 on IN B-VP O
95 postoperative JJ B-NP O
95 day NN I-NP O
95 #5 NNP I-NP O
95 , , O O
95 he PRP O O
95 was VBD B-VP O
95 noted VBN O O
95 to TO O O
95 spike VB O O
95 Cultures NNS B-NP O
95 were VBD B-VP O
95 sent VBN O O
95 off RP O O
96 which WDT O O
96 grew VBD B-VP O
96 out RP O O
96 3+ CD O O
96 Gram-native JJ B-NP O
96 rods NNS I-NP O
96 He PRP O O
96 was VBD B-VP O
96 started VBN O O
96 on IN B-VP O
96 Flagyl NNP B-NP B-m
96 for IN B-VP O
96 presumed JJ B-NP B-r
97 aspiration NN I-NP O
97 pneumonia NN I-NP O
97 He PRP O O
97 also RB O O
97 is VBZ O O
97 noted VBN O O
97 to TO O O
97 have VB O O
97 a DT B-NP B-r
97 positive JJ I-NP I-r
97 UTI NNP I-NP I-r
97 and CC O O
97 was VBD B-VP O
97 started VBN O O
98 on IN B-VP O
98 levofloxacin NN B-NP B-m
98 at IN B-VP O
98 that DT B-NP O
98 time NN I-NP O
98 He PRP O O
98 also RB O O
98 was VBD B-VP O
98 noted VBN O O
98 to TO O O
98 have VB O O
98 a DT B-NP O
98 rise NN I-NP O
98 in IN B-VP O
98 his PRP$ O O
99 creatinine NN B-NP O
99 and CC O O
99 this DT O O
99 was VBD B-VP O
99 followed VBN O O
99 as RB O O
99 well RB O O
99 On IN B-VP O
99 postoperative JJ B-NP O
99 day NN I-NP O
99 #8 NNP I-NP O
99 , , O O
99 the DT B-NP O
100 patient NN I-NP O
100 was VBD B-VP O
100 again RB O O
100 spiked VBN O O
100 up RP O O
100 to TO O O
100 101 CD O O
100 Pancultures NNS B-NP O
100 were VBD B-VP O
100 sent VBN O O
100 out RP O O
100 as RB O O
100 well RB O O
100 He PRP O O
100 was VBD B-VP O
101 found VBN O O
101 to TO O O
101 have VB O O
101 a DT B-NP O
101 beta-lactamase-resistant JJ I-NP O
101 E NN I-NP O
101 coli NNS I-NP O
101 in IN B-VP O
101 his PRP$ O O
101 urine NN B-NP O
101 This DT O O
101 prompted VBD B-VP O
102 an DT B-NP O
102 ID NNP I-NP O
102 consult NN I-NP O
102 , , O O
102 and CC O O
102 the DT B-NP O
102 patient NN I-NP O
102 was VBD B-VP O
102 started VBN O O
102 on IN B-VP O
102 nitrofurantoin NN B-NP B-m
102 Also RB O O
102 , , O O
102 at IN B-VP O
102 this DT B-NP O
103 time NN I-NP O
103 , , O O
103 around IN B-VP O
103 postoperative JJ B-NP O
103 day NN I-NP O
103 #9 NNP I-NP O
103 , , O O
103 it PRP O O
103 was VBD B-VP O
103 noted VBN O O
103 that IN B-VP O
103 the DT B-NP O
103 patient NN I-NP O
103 began VBD B-VP O
103 to TO O O
103 have VB O O
104 some DT B-NP O
104 serous JJ I-NP O
104 drainage NN I-NP O
104 from IN B-VP O
104 his PRP$ O O
104 sternal JJ B-NP O
104 wound NN I-NP O
104 He PRP O O
104 was VBD B-VP O
104 followed VBN O O
104 by IN B-VP O
104 Infectious JJ B-NP O
105 Disease NNP I-NP O
105 at IN B-VP O
105 that DT B-NP O
105 time NN I-NP O
105 , , O O
105 and CC O O
105 over IN B-VP O
105 the DT B-NP O
105 course NN I-NP O
105 of IN B-VP O
105 the DT B-NP O
105 next JJ I-NP O
105 several JJ I-NP O
105 days NNS I-NP O
105 , , O O
105 it PRP O O
105 was VBD B-VP O
106 discovered VBN O O
106 that IN B-VP O
106 the DT B-NP O
106 wound NN I-NP O
106 grew VBD B-VP O
106 out RP O O
106 Gram-negative JJ B-NP O
106 rods NNS I-NP O
106 A NNP I-NP O
106 Plastic NNP I-NP O
106 Surgery NNP I-NP O
107 consult NN I-NP O
107 was VBD B-VP O
107 obtained VBN O O
107 for IN B-VP O
107 the DT B-NP O
107 patient NN I-NP O
107 after IN B-VP O
107 a DT B-NP O
107 CT NNP I-NP O
107 scan NN I-NP O
107 showed VBD B-VP O
107 some DT B-NP O
107 nonunion NN I-NP O
107 of IN B-VP O
108 the DT B-NP O
108 sternal JJ I-NP O
108 table NN I-NP O
108 and CC O O
108 collection NN B-NP O
108 of IN B-VP O
108 fluid JJ O O
108 underneath IN B-VP O
108 the DT B-NP O
108 sternum NN I-NP O
108 On IN B-VP O
109 postoperative JJ B-NP O
109 day NN I-NP O
109 #11 NNP I-NP O
109 , , O O
109 it PRP O O
109 was VBD B-VP O
109 decided VBN O O
109 that IN B-VP O
109 the DT B-NP O
109 patient NN I-NP O
109 would MD O O
109 benefit VB O O
109 from IN B-VP O
110 incision NN B-NP O
110 and CC O O
110 drainage NN B-NP O
110 plus CC O O
110 pectoral JJ B-NP O
110 flap NN I-NP O
110 or CC O O
110 omental JJ B-NP O
110 flap NN I-NP O
110 for IN B-VP O
110 sternal JJ B-NP O
110 wound NN I-NP O
111 infection NN I-NP O
111 , , O O
111 so IN B-VP O
111 the DT B-NP O
111 patient NN I-NP O
111 was VBD B-VP O
111 taken VBN O O
111 back RB O O
111 to TO O O
111 the DT B-NP O
111 operating NN I-NP O
111 room NN I-NP O
111 on IN B-VP O
111 6/29/05 CD O O
111 for IN B-VP O
112 incision NN B-NP O
112 and CC O O
112 drainage NN B-NP O
112 of IN B-VP O
112 a DT B-NP O
112 deep JJ I-NP O
112 sternal NN I-NP O
112 wound NN I-NP O
112 infection NN I-NP O
112 At IN B-VP O
112 the DT B-NP O
112 time NN I-NP O
112 of IN B-VP O
113 surgery NN B-NP O
113 , , O O
113 a DT B-NP O
113 purulent NN I-NP O
113 liquid JJ B-NP O
113 material NN I-NP O
113 was VBD B-VP O
113 expressed VBN O O
113 through IN B-VP O
113 the DT B-NP O
113 skin NN I-NP O
113 The DT B-NP O
114 incision NN I-NP O
114 was VBD B-VP O
114 made VBN O O
114 The DT B-NP O
114 sternum NN I-NP O
114 was VBD B-VP O
114 noted VBN O O
114 to TO O O
114 be VB O O
114 totally RB O O
114 separated VBN O O
114 with IN B-VP O
114 most JJS O O
114 of IN B-VP O
115 the DT B-NP O
115 wires NNS I-NP O
115 having VBG O O
115 been VBN O O
115 pulled VBN O O
115 through IN B-VP O
115 The DT B-NP O
115 wound NN I-NP O
115 was VBD B-VP O
115 irrigated VBN O O
115 , , O O
115 and CC O O
115 an DT B-NP O
115 omental JJ I-NP O
116 flap NN I-NP O
116 with IN B-VP O
116 pectoral JJ B-NP O
116 advancement NN I-NP O
116 was VBD B-VP O
116 performed VBN O O
116 The DT B-NP O
116 patient NN I-NP O
116 returned VBD B-VP O
116 from IN B-VP O
116 the DT B-NP O
117 operating NN I-NP O
117 room NN I-NP O
117 to TO O O
117 the DT B-NP O
117 Surgery NNP I-NP O
117 Intensive NNP I-NP O
117 Care NNP I-NP O
117 Unit NNP I-NP O
117 where WRB O O
117 he PRP O O
117 was VBD B-VP O
117 again RB O O
117 confused JJ O O
117 , , O O
118 however RB O O
118 , , O O
118 was VBD B-VP O
118 able JJ O O
118 to TO O O
118 be VB O O
118 easily RB O O
118 returned VBN O O
118 to TO O O
118 baseline VB O O
118 Following VBG O O
118 these DT B-NP O
119 recommendations NNS I-NP O
119 , , O O
119 the DT B-NP O
119 nitrofurantoin NN I-NP B-m
119 was VBD B-VP O
119 discontinued VBN O O
119 and CC O O
119 the DT B-NP O
119 patient NN I-NP O
119 was VBD B-VP O
120 started VBN O O
120 on IN B-VP O
120 imipenem NN B-NP B-m
120 Also RB O O
120 , , O O
120 the DT B-NP O
120 patient NN I-NP O
120 was VBD B-VP O
120 noted VBN O O
120 to TO O O
120 be VB O O
120 growing VBG O O
120 Enterobacter NNP B-NP B-r
121 in IN B-VP O
121 his PRP$ O O
121 urine NN B-NP O
121 and CC O O
121 he PRP O O
121 was VBD B-VP O
121 started VBN O O
121 no DT B-NP O
121 ceftazidime NN I-NP B-m
121 The DT B-NP O
121 patient NN I-NP O
121 did VBD B-VP O
121 well RB O O
121 in IN B-VP O
121 the DT B-NP O
122 ICU NNP I-NP O
122 He PRP O O
122 improved VBD B-VP O
122 from IN B-VP O
122 a DT B-NP O
122 neuro NN I-NP O
122 status NN I-NP O
122 His PRP$ O O
122 chest NN B-NP O
122 wound NN I-NP O
122 healed VBD B-VP O
122 without IN B-VP O
123 difficulty NN B-NP O
123 He PRP O O
123 had VBD B-VP O
123 one CD O O
123 brief NN B-NP O
123 episode NN I-NP O
123 of IN B-VP O
123 atrial JJ B-NP O
123 fibrillation NN I-NP O
123 during IN B-VP O
123 a DT B-NP O
123 coughing NN I-NP O
124 spell NN I-NP O
124 , , O O
124 but CC O O
124 this DT O O
124 also RB O O
124 resolved VBN O O
124 , , O O
124 and CC O O
124 the DT B-NP O
124 patient NN I-NP O
124 was VBD B-VP O
124 continued VBN O O
124 on IN B-VP O
124 his PRP$ O O
125 antihypertensive JJ B-NP B-m
125 medication NN I-NP I-m
125 The DT B-NP O
125 patient NN I-NP O
125 was VBD B-VP O
125 deemed VBN O O
125 fit NN B-NP O
125 for IN B-VP O
125 transfer NN B-NP O
125 on IN B-VP O
125 a DT B-NP O
126 postoperative JJ I-NP O
126 day NN I-NP O
126 #18 NNP I-NP O
126 back RB O O
126 from IN B-VP O
126 the DT B-NP O
126 ICU NNP I-NP O
126 once RB O O
126 again RB O O
126 to TO O O
126 the DT B-NP O
126 Step-Down JJ I-NP O
126 Unit NNP I-NP O
127 SUMMARY NNP I-NP O
127 BY NNP I-NP O
127 SYSTEM: NNP I-NP O
128 1 CD O O
128 Neurologically NNP B-NP O
128 , , O O
128 the DT B-NP O
128 patient NN I-NP O
128 is VBZ O O
128 Spanish-speaking VBG O O
128 only RB O O
128 He PRP O O
128 is VBZ O O
129 intact JJ O O
129 , , O O
129 moving VBG O O
129 all DT B-NP O
129 extremities NNS I-NP O
129 , , O O
129 getting VBG O O
129 in IN B-VP O
129 and CC O O
129 out IN B-VP O
129 of IN B-VP O
129 bed NN B-NP O
129 , , O O
129 and CC O O
130 very RB O O
130 independent JJ O O
131 2 CD O O
131 Cardiovascular: NNP B-NP O
131 The DT B-NP O
131 patient's JJ I-NP O
131 heart NN I-NP O
131 rate NN I-NP O
131 is VBZ O O
131 in IN B-VP O
131 70 CD O O
131 to TO O O
131 80 CD O O
131 , , O O
132 sinus VBD B-VP O
132 Blood NNP B-NP O
132 pressure NN I-NP O
132 is VBZ O O
132 100s CD O O
132 to TO O O
132 150s CD O O
132 , , O O
132 means NNS B-NP O
132 are VBP O O
132 70s CD O O
132 to TO O O
132 100s CD O O
133 He PRP O O
133 is VBZ O O
133 on IN B-VP O
133 Lopressor NNP B-NP B-m
133 25 CD O B-do
133 mg NN B-NP I-do
133 q.6h NN I-NP B-f
133 and CC O O
133 on IN B-VP O
133 amlodipine JJ O B-m
133 5 CD O B-do
133 mg NN B-NP I-do
133 b.i.d NN I-NP B-f
134 3 CD O O
134 Respiratory: NNP B-NP O
134 The DT B-NP O
134 patient NN I-NP O
134 is VBZ O O
134 on IN B-VP O
134 room NN B-NP O
134 air NN I-NP O
134 , , O O
134 saturating VBG O O
134 98% CD O O
135 4 CD O O
135 GI: NNP B-NP O
135 The DT B-NP O
135 patient NN I-NP O
135 is VBZ O O
135 advanced JJ O O
135 diet JJ O O
135 as IN B-VP O
135 tolerated VBN O O
135 , , O O
135 having VBG O O
135 bowel NN B-NP O
136 movements NNS I-NP O
136 , , O O
136 on IN B-VP O
136 a DT O O
136 diabetic JJ O O
136 diet JJ O O
137 5 CD O O
137 Renal: NNP B-NP O
137 The DT B-NP O
137 patient's NN I-NP O
137 Foley NNP I-NP O
137 is VBZ O O
137 out RP O O
137 , , O O
137 running VBG O O
137 negative JJ O O
137 340 CD O O
137 for IN B-VP O
138 the DT B-NP O
138 day NN I-NP O
138 before IN B-VP O
138 , , O O
138 on IN B-VP O
138 Lasix NNP B-NP B-m
138 20 CD O B-do
138 mg NN B-NP I-do
138 p.o NN I-NP B-mo
138 b.i.d NN I-NP B-f
138 Recommendations NNP I-NP O
138 would MD O O
139 be VB O O
139 to TO O O
139 have VB O O
139 an DT B-NP O
139 extra JJ I-NP O
139 dose NN I-NP O
139 or CC O O
139 so RB O O
139 of IN B-VP O
139 Lasix NNP B-NP B-m
139 since IN B-VP O
139 chest JJS B-NP O
139 x-ray NN I-NP O
139 this DT B-NP O
140 morning NN I-NP O
140 was VBD B-VP O
140 noted VBN O O
140 to TO O O
140 be VB O O
140 slightly RB O O
140 wet JJ O O
141 6 CD O O
141 Endocrine: NNP B-NP O
141 He PRP O O
141 is VBZ O O
141 a DT O O
141 diabetic JJ O O
141 He PRP O O
141 is VBZ O O
141 on IN B-VP O
141 Lantus NNP B-NP B-m
141 , , O O
141 NovoLog NNP B-NP B-m
141 , , O O
142 insulin NN B-NP B-m
142 , , O O
142 and CC O O
142 Diabetes NNP B-NP B-r
142 Diabetes NNP I-NP B-r
142 Diabetes NNP I-NP B-r
142 Management NNP I-NP I-r
142 Management NNP I-NP I-r
142 Management NNP I-NP I-r
142 is VBZ O O
142 following VBG O O
143 7 CD O O
143 Heme: NNP B-NP O
143 The DT B-NP O
143 patient NN I-NP O
143 is VBZ O O
143 on IN B-VP O
143 aspirin NN B-NP B-m
143 and CC O O
143 atorvastatin NN B-NP B-m
143 He PRP O O
143 still RB O O
144 has VBZ O O
144 chest NN B-NP O
144 drains NNS I-NP O
144 , , O O
144 which WDT O O
144 are VBP O O
144 being VBG O O
144 followed VBN O O
144 by IN B-VP O
144 Plastics NNS B-NP O
144 who WP O O
144 wants VBZ O O
145 to TO O O
145 keep VB O O
145 them PRP O O
145 in IN B-VP O
146 8 CD O O
146 ID: NNP B-NP O
146 He PRP O O
146 has VBZ O O
146 got VBD B-VP O
146 a DT B-NP B-r
146 deep JJ I-NP I-r
146 sternal JJ I-NP I-r
146 infection NN I-NP I-r
146 with IN B-VP O
146 E NNP B-NP O
146 coli NNS I-NP O
146 and CC O O
146 is VBZ O O
146 status NN B-NP O
146 post NN I-NP O
146 a DT B-NP O
147 pectus NN I-NP O
147 as RB O O
147 well RB O O
147 as IN B-VP O
147 a DT B-NP O
147 omental JJ I-NP O
147 flap NN I-NP O
147 closure NN I-NP O
147 Imipenem NNP I-NP B-m
147 was VBD B-VP O
147 started VBN O O
147 on IN B-VP O
147 2/22/05 CD O O
147 per IN B-VP O
148 ID's NNP B-NP O
148 recommendation NN I-NP O
148 , , O O
148 needs VBZ O O
148 to TO O O
148 continue VB O O
148 for IN B-VP B-du
148 six CD O I-du
148 weeks NNS B-NP I-du
148 UTI NNP I-NP O
148 growing VBG O O
148 out RP O O
149 Klebsiella NNP B-NP O
149 and CC O O
149 Enterobacter NNP B-NP O
149 Imipenem NNP I-NP B-m
149 was VBD B-VP O
149 stared VBN O O
149 on IN B-VP O
149 2/22/05 CD O O
149 , , O O
149 again RB O O
149 , , O O
149 this DT O O
149 will MD O O
150 need VB O O
150 to TO O O
150 be VB O O
150 continued VBN O O
150 for IN B-VP B-du
150 six CD O I-du
150 weeks NNS B-NP I-du
150 The DT B-NP O
150 patient NN I-NP O
150 is VBZ O O
150 also RB O O
150 on IN B-VP O
150 vancomycin NN B-NP B-m
150 for IN B-VP O
150 his PRP$ O B-r
151 sternal JJ B-NP O
151 wound NN I-NP O
151 infection NN I-NP O
151 This DT O O
151 was VBD B-VP O
151 started VBN O O
151 on IN B-VP O
151 6/29/05 CD O O
151 and CC O O
151 needs NNS B-NP O
151 to TO O O
151 continue VB O O
152 for IN B-VP B-du
152 six CD O I-du
152 weeks NNS B-NP I-du
152 Currently RB O O
152 , , O O
152 the DT B-NP O
152 patient NN I-NP O
152 is VBZ O O
152 afebrile JJ B-NP O
152 White NNP I-NP O
152 blood NN I-NP O
152 cell NN I-NP O
152 count NN I-NP O
152 is VBZ O O
153 10 CD O O
153 The DT B-NP O
153 chest NN I-NP O
153 wound NN I-NP O
153 was VBD B-VP O
153 noted VBN O O
153 to TO O O
153 have VB O O
153 a DT B-NP O
153 small JJ I-NP O
153 area NN I-NP O
153 of IN B-VP O
153 erythema NN B-NP O
153 , , O O
153 however RB O O
153 , , O O
153 it PRP O O
153 is VBZ O O
154 intact JJ O O
154 , , O O
154 and CC O O
154 he PRP O O
154 is VBZ O O
154 being VBG O O
154 followed VBN O O
154 by IN B-VP O
154 Plastics NNPS B-NP O
155 The DT B-NP O
155 rest NN I-NP O
155 of IN B-VP O
155 the DT B-NP O
155 dictation NN I-NP O
155 will MD O O
155 follow VB O O
155 when WRB O O
155 the DT B-NP O
155 patient NN I-NP O
155 is VBZ O O
156 discharged VBN O O
157 eScription NN B-NP O
157 document: VBZ O O
157 6-3812703 JJ B-NP O
157 EMS NNP I-NP O
158 Dictated NNP I-NP O
158 By: NNP I-NP O
158 WESTERMEIER NNP I-NP O
158 , , O O
158 SIMON NNP B-NP O
159 Attending: NNP I-NP O
159 BERLINGHOF NNP I-NP O
159 , , O O
159 WINFRED NNP B-NP O
160 Dictation NNP I-NP O
160 ID NNP I-NP O
160 3963571 CD O O
161 D: NNP B-NP O
161 10/9/05 CD O O
162 T: NNP B-NP O
162 10/9/05 CD O O
163 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #809465 VBZ O O
4 997937050 CD O O
4 R NNP B-NP O
4 11953807 CD O O
4 994292 CD O O
4 11/22/1990 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/22/1990 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/7/1990 CD O O
7 DISCHARGE NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 1 CD O O
7 )MYOCARDIAL NNP B-NP O
7 INFARCTION NNP I-NP O
8 2 CD O O
8 )CONGESTIVE NNP B-NP O
8 HEART NNP I-NP O
8 FAILURE NNP I-NP O
9 3 CD O O
9 )HYPERTENSION NNP B-NP O
10 HISTORY NNP I-NP O
10 OF NNP I-NP O
10 PRESENT NNP I-NP O
10 ILLNESS: NNP I-NP O
10 This DT B-NP O
10 patient NN I-NP O
10 is VBZ O O
10 a DT B-NP O
10 60-year-old JJ I-NP O
10 white JJ I-NP O
11 male NN I-NP O
11 who WP O O
11 presented VBD B-VP O
11 with IN B-VP O
11 a DT O O
11 two CD O O
11 week NN B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 paroxysmal JJ B-NP O
12 nocturnal JJ I-NP O
12 dyspnea NN I-NP O
12 and CC O O
12 dyspnea NN B-NP O
12 on IN B-VP O
12 exertion NN B-NP O
13 admitted VBN O O
13 with IN B-VP O
13 new JJ B-NP O
13 EKG NNP I-NP O
13 changes NNS I-NP O
13 consistent VBP O O
13 with IN B-VP O
13 myocardial JJ B-NP O
13 infarction NN I-NP O
14 for IN B-VP O
14 rule NN B-NP O
14 out IN B-VP O
14 MI NNP B-NP O
14 The DT B-NP O
14 patient's NN I-NP O
14 cardiac JJ B-NP O
14 risk NN I-NP O
14 factors NNS I-NP O
14 are VBP O O
14 diabetes NNS B-NP O
14 , , O O
15 hypertension NN B-NP O
15 , , O O
15 distant JJ B-NP O
15 smoking NN I-NP O
15 history NN I-NP O
15 There EX O O
15 is VBZ O O
15 no DT B-NP O
15 history NN I-NP O
15 of IN B-VP O
16 increased VBN O O
16 cholesterol NN B-NP O
16 and CC O O
16 no DT B-NP O
16 family NN I-NP O
16 history NN I-NP O
16 of IN B-VP O
16 heart NN B-NP O
16 disease NN I-NP O
16 The DT B-NP O
17 patient NN I-NP O
17 noted VBD B-VP O
17 the DT B-NP O
17 onset NN I-NP O
17 of IN B-VP O
17 exertional JJ B-NP O
17 shortness NN I-NP O
17 of IN B-VP O
17 breath NN B-NP O
17 around IN B-VP O
18 the DT B-NP O
18 beginning NN I-NP O
18 of IN B-VP O
18 7 CD O O
18 of IN B-VP O
18 August NNP B-NP O
18 At IN B-VP O
18 that DT B-NP O
18 time NN I-NP O
18 the DT B-NP O
18 patient NN I-NP O
18 was VBD B-VP O
18 experiencing VBG O O
19 increased JJ B-NP O
19 stress NN I-NP O
19 because IN B-VP O
19 of IN B-VP O
19 the DT B-NP O
19 recent JJ I-NP O
19 death NN I-NP O
19 of IN B-VP O
19 the DT B-NP O
19 patient's JJ I-NP O
20 sister-in-law NN I-NP O
20 The DT B-NP O
20 patient NN I-NP O
20 consulted VBD B-VP O
20 his PRP$ O O
20 local JJ B-NP O
20 physician NN I-NP O
20 , , O O
20 Dr NNP B-NP O
21 Bret NNP I-NP O
21 Langner NNP I-NP O
21 , , O O
21 on IN B-VP O
21 7 CD O O
21 of IN B-VP O
21 April NNP B-NP O
21 An DT B-NP O
21 EKG NNP I-NP O
21 at IN B-VP O
21 that DT B-NP O
21 time NN I-NP O
21 showed VBD B-VP O
21 no DT B-NP O
21 change NN I-NP O
22 from IN B-VP O
22 an DT B-NP O
22 EKG NNP I-NP O
22 of IN B-VP O
22 a DT B-NP O
22 year NN I-NP O
22 earlier RB O O
22 Over IN B-VP O
22 the DT B-NP O
22 next JJ I-NP O
22 week NN I-NP O
22 the DT B-NP O
22 patient NN I-NP O
23 reported VBD B-VP O
23 feeling JJ O O
23 weak JJ O O
23 , , O O
23 general JJ B-NP O
23 malaise NN I-NP O
23 , , O O
23 experienced VBD B-VP O
23 occasional JJ B-NP O
24 chills NNS I-NP O
24 with IN B-VP O
24 continuing VBG O O
24 dyspnea NN B-NP O
24 on IN B-VP O
24 exertion NN B-NP O
24 There EX O O
24 was VBD B-VP O
24 one CD O O
24 event NN B-NP O
24 on IN B-VP O
25 20 CD O O
25 of IN B-VP O
25 February NNP B-NP O
25 where WRB O O
25 the DT B-NP O
25 patient NN I-NP O
25 experienced VBD B-VP O
25 chest JJS B-NP O
25 pain NN I-NP O
25 with IN B-VP O
25 severe JJ B-NP O
26 diaphoresis NN I-NP O
26 and CC O O
26 a DT B-NP O
26 chill NN I-NP O
26 which WDT O O
26 he PRP O O
26 attributed VBD B-VP O
26 to TO O O
26 the DT B-NP O
26 flu NN I-NP O
26 although IN B-VP O
26 the DT B-NP O
27 patient NN I-NP O
27 did VBD B-VP O
27 not RB O O
27 seek VB O O
27 medical JJ B-NP O
27 attention NN I-NP O
27 at IN B-VP O
27 that DT B-NP O
27 time NN I-NP O
27 Over IN B-VP O
27 the DT O O
27 last JJ O O
28 10 CD O O
28 to TO O O
28 14 CD O O
28 days NNS B-NP O
28 prior RB O O
28 to TO O O
28 admission VB O O
28 the DT B-NP O
28 patient NN I-NP O
28 noted VBD B-VP O
28 increasing VBG O O
29 exertional JJ B-NP O
29 dyspnea NN I-NP O
29 , , O O
29 three CD O O
29 episodes NNS B-NP O
29 of IN B-VP O
29 paroxysmal JJ B-NP O
29 nocturnal JJ I-NP O
29 dyspnea NN I-NP O
30 associated VBN O O
30 with IN B-VP O
30 right JJ B-NP O
30 chest NN I-NP O
30 discomfort NN I-NP O
30 There EX O O
30 was VBD B-VP O
30 no DT B-NP O
30 nausea NN I-NP O
30 , , O O
31 vomiting VBG O O
31 , , O O
31 diaphoresis NN B-NP O
31 , , O O
31 cyanosis VBP O O
31 The DT B-NP O
31 patient NN I-NP O
31 also RB O O
31 noted VBD B-VP O
31 edema NN B-NP O
31 in IN B-VP O
32 his PRP$ O O
32 lower JJR B-NP O
32 extremities NNS I-NP O
32 over IN B-VP O
32 the DT O O
32 last JJ O O
32 two CD O O
32 weeks NNS B-NP O
32 The DT B-NP O
32 last JJ I-NP O
32 episode NN I-NP O
32 of IN B-VP O
33 paroxysmal JJ B-NP O
33 nocturnal JJ I-NP O
33 dyspnea NN I-NP O
33 was VBD B-VP O
33 this DT B-NP O
33 past JJ I-NP O
33 weekend NN I-NP O
33 On IN B-VP O
33 the DT B-NP O
33 day NN I-NP O
33 of IN B-VP O
34 admission NN B-NP O
34 the DT B-NP O
34 patient NN I-NP O
34 saw VBD B-VP O
34 Dr NNP B-NP O
34 Mugrage NNP I-NP O
34 once RB O O
34 again RB O O
34 and CC O O
34 EKG NNP B-NP O
35 demonstrated VBD B-VP O
35 marked JJ B-NP O
35 anterolateral JJ I-NP O
35 changes NNS I-NP O
35 that WDT O O
35 were VBD B-VP O
35 new JJ O O
35 since IN B-VP O
35 the DT B-NP O
36 EKG NNP I-NP O
36 taken VBN O O
36 on IN B-VP O
36 7 CD O O
36 of IN B-VP O
36 April NNP B-NP O
36 The DT B-NP O
36 patient NN I-NP O
36 presented VBD B-VP O
36 to TO O O
36 the DT B-NP O
36 Lacon NNP I-NP O
36 Hospital NNP I-NP O
36 Emergency NNP I-NP O
36 Ward NNP I-NP O
36 PAST NNP I-NP O
36 MEDICAL NNP I-NP O
36 HISTORY: NNP I-NP O
36 Significant NNP I-NP O
37 for IN B-VP O
37 hypertension NN B-NP O
37 of IN B-VP O
37 approximately RB O O
37 10 CD O O
37 years NNS B-NP O
37 , , O O
37 non-insulin JJ B-NP O
37 dependent NN I-NP O
38 diabetes VBZ O O
38 mellitus NN B-NP O
38 of IN B-VP O
38 approximately RB O O
38 12 CD O O
38 years NNS B-NP O
38 , , O O
38 left VBD B-VP O
38 Bell's NNP B-NP O
38 palsy NN I-NP O
38 in IN B-VP O
39 1985 CD O O
39 treated VBD B-VP O
39 with IN B-VP O
39 prednisone NN B-NP B-m
39 , , O O
39 type NN B-NP O
39 IV NNP I-NP O
39 hypolipoproteinemia VBZ O O
39 The DT B-NP O
40 patient NN I-NP O
40 was VBD B-VP O
40 also RB O O
40 admitted VBN O O
40 for IN B-VP O
40 right JJ B-NP O
40 face NN I-NP O
40 and CC O O
40 arm NN B-NP O
40 pain NN I-NP O
40 at IN B-VP O
40 the DT B-NP O
41 Skastem, NNP I-NP O
41 Medical NNP I-NP O
41 Center NNP I-NP O
41 in IN B-VP O
41 1 CD O O
41 of IN B-VP O
41 October NNP B-NP O
41 This DT O O
41 was VBD B-VP O
41 attributed VBN O O
41 to TO O O
41 TIA NNP B-NP O
41 Carotid NNP I-NP O
42 non-invasives NNS I-NP O
42 at IN B-VP O
42 that DT B-NP O
42 time NN I-NP O
42 along IN B-VP O
42 with IN B-VP O
42 a DT B-NP O
42 head NN I-NP O
42 CT NNP I-NP O
42 were VBD B-VP O
42 reportedly RB O O
43 negative JJ O O
43 The DT B-NP O
43 patient NN I-NP O
43 also RB O O
43 had VBD B-VP O
43 a DT B-NP O
43 right JJ I-NP O
43 cranial NN I-NP O
43 nerve NN I-NP O
43 III NNP I-NP O
43 palsy NN I-NP O
43 in IN B-VP O
44 30 CD O O
44 of IN B-VP O
44 April NNP B-NP O
44 MEDICATIONS: NNP I-NP B-m
44 Micronase NNP I-NP B-do
44 10 CD O I-do
44 mg NN B-NP B-mo
44 po NN I-NP B-f
44 bid NN I-NP O
44 , , O B-m
44 Persantine NNP B-NP B-do
44 60 CD O I-do
44 mg NN B-NP B-mo
44 po NN I-NP O
45 tid NN I-NP B-f
45 , , O O
45 aspirin VBP O B-m
45 one CD O B-do
45 po NN B-NP B-mo
45 q NN I-NP B-f
45 d NN I-NP I-f
45 , , O O
45 Lisinopril NNP B-NP B-m
45 5 CD O B-do
45 mg NN B-NP I-do
45 po NN I-NP B-mo
45 q NN I-NP B-f
45 d NN I-NP I-f
45 , , O O
45 and CC O O
45 Atenolol NNP B-NP B-m
45 50 CD O B-do
45 mg NN B-NP I-do
46 po NN I-NP B-mo
46 q NN I-NP B-f
46 d NN I-NP I-f
46 ALLERGIES: NNP I-NP O
46 None NNP I-NP O
46 known VBN O O
46 SOCIAL NNP B-NP O
46 HISTORY: NNP I-NP O
46 There EX O O
46 is VBZ O O
47 approximately RB O O
47 20 CD O O
47 pack JJ B-NP O
47 year NN I-NP O
47 history NN I-NP O
47 of IN B-VP O
47 smoking VBG O O
47 The DT B-NP O
47 patient NN I-NP O
47 quit NN I-NP O
48 cigarettes VBZ O O
48 20 CD O O
48 years NNS B-NP O
48 ago RB O O
48 Ethanol NNP B-NP O
48 history NN I-NP O
48 was VBD B-VP O
48 social JJ O O
48 The DT B-NP O
48 patient NN I-NP O
49 is VBZ O O
49 married VBN O O
49 , , O O
49 has VBZ O O
49 two CD O O
49 grown JJ B-NP O
49 children NNS I-NP O
49 He PRP O O
49 currently RB O O
49 works VBZ O O
49 in IN B-VP O
49 a DT B-NP O
49 short JJ I-NP O
50 term NN I-NP O
50 storage NN I-NP O
50 warehouse NN I-NP O
50 office NN I-NP O
50 , , O O
50 apparently RB O O
50 recently RB O O
50 lost VBD B-VP O
50 his PRP$ O O
50 tobacco NN B-NP O
51 shop NN I-NP O
51 business NN I-NP O
51 and CC O O
51 there EX O O
51 is VBZ O O
51 certainly RB O O
51 a DT B-NP O
51 potential JJ I-NP O
51 stress NN I-NP O
51 regarding VBG O O
52 his PRP$ O O
52 employment NN B-NP O
52 situation NN I-NP O
52 and CC O O
52 recent JJ B-NP O
52 death NN I-NP O
52 of IN B-VP O
52 his PRP$ O O
52 sister-in-law NN B-NP O
53 following VBG O O
53 a DT B-NP O
53 prolonged JJ I-NP O
53 illness NN I-NP O
53 FAMILY NNP I-NP O
53 HISTORY: NNP I-NP O
53 The DT B-NP O
53 patient NN I-NP O
53 reports VBZ O O
54 his PRP$ O O
54 parents NNS B-NP O
54 are VBP O O
54 still RB O O
54 living VBG O O
54 , , O O
54 has VBZ O O
54 single JJ B-NP O
54 sibling NN I-NP O
54 who WP O O
54 is VBZ O O
54 alive JJ O O
54 and CC O O
55 well RB O O
55 He PRP O O
55 denies VBZ O O
55 family NN B-NP O
55 history NN I-NP O
55 of IN B-VP O
55 coronary JJ B-NP O
55 artery NN I-NP O
55 disease NN I-NP O
55 , , O O
56 hypertension NN B-NP O
56 or CC O O
56 diabetes VBZ O O
56 REVIEW NNP B-NP O
56 OF NNP I-NP O
56 SYSTEMS: NNP I-NP O
56 Non-contributory NNP I-NP O
57 PHYSICAL NNP I-NP O
57 EXAMINATION: NNP I-NP O
57 The DT B-NP O
57 patient NN I-NP O
57 was VBD B-VP O
57 a DT B-NP O
57 thin JJ I-NP O
57 white JJ I-NP O
57 male NN I-NP O
57 in IN B-VP O
57 no DT B-NP O
58 acute NN I-NP O
58 distress NN I-NP O
58 sitting VBG O O
58 up RP O O
58 on IN B-VP O
58 the DT B-NP O
58 stretcher NN I-NP O
59 Vital NNP I-NP O
59 signs NNS I-NP O
59 demonstrated VBD B-VP O
59 he PRP O O
59 was VBD B-VP O
59 afebrile RB O O
59 , , O O
59 blood NN B-NP O
59 pressure NN I-NP O
59 140/90 CD O O
59 , , O O
60 pulse RB O O
60 88 CD O O
60 , , O O
60 respirations NNS B-NP O
60 18 CD O O
60 His PRP$ O O
60 room NN B-NP O
60 air NN I-NP O
60 O2 NNP I-NP O
60 sat VBD B-VP O
60 was VBD B-VP O
60 96% CD O O
60 HEENT NNP B-NP O
61 exam NN I-NP O
61 normocephalic NN I-NP O
61 , , O O
61 atraumatic JJ B-NP O
61 Left NNP I-NP O
61 pupil NN I-NP O
61 was VBD B-VP O
61 5 CD O O
61 mm NN B-NP O
61 and CC O O
61 contracted VBD B-VP O
62 to TO O O
62 3; CD O O
62 right JJ B-NP O
62 pupil NN I-NP O
62 was VBD B-VP O
62 4 CD O O
62 mm NN B-NP O
62 and CC O O
62 contracted VBD B-VP O
62 to TO O O
62 3 CD O O
62 His PRP$ O O
62 extraocular JJ B-NP O
63 movements NNS I-NP O
63 were VBD B-VP O
63 intact JJ B-NP O
63 Fundi NNP I-NP O
63 were VBD B-VP O
63 poorly RB O O
63 visualized VBN O O
63 secondary JJ O O
63 to TO O O
64 possible JJ B-NP O
64 partial JJ I-NP O
64 cataract NN I-NP O
64 Oropharynx NNP I-NP O
64 was VBD B-VP O
64 only RB O O
64 remarkable JJ O O
64 for IN B-VP O
65 extensive JJ B-NP O
65 upper JJ I-NP O
65 bridge NN I-NP O
65 work NN I-NP O
65 Neck NNP I-NP O
65 was VBD B-VP O
65 supple JJ O O
65 , , O O
65 no DT O O
65 adenopathy JJ O O
65 His PRP$ O O
66 carotids NNS B-NP O
66 were VBD B-VP O
66 1+ CD O O
66 bilaterally RB O O
66 without IN B-VP O
66 bruits NNS B-NP O
66 His PRP$ O O
66 chest JJS B-NP O
66 exam NN I-NP O
66 was VBD B-VP O
67 remarkable JJ O O
67 for IN B-VP O
67 decreased JJ B-NP O
67 breath NN I-NP O
67 sounds VBZ O O
67 halfway VBZ O O
67 up RP O O
67 , , O O
67 right RB O O
67 greater JJR O O
68 than IN B-VP O
68 left VBD B-VP O
68 , , O O
68 with IN B-VP O
68 absent JJ B-NP O
68 breath NN I-NP O
68 sounds NNS I-NP O
68 at IN B-VP O
68 the DT B-NP O
68 bases NNS I-NP O
68 The DT B-NP O
68 chest NN I-NP O
68 was VBD B-VP O
69 dull JJ O O
69 to TO O O
69 percussion VB O O
69 halfway RB O O
69 up RP O O
69 , , O O
69 however RB O O
69 , , O O
69 there EX O O
69 were VBD B-VP O
69 no DT B-NP O
69 rales NNS I-NP O
69 , , O O
70 wheezes VBZ O O
70 or CC O O
70 rhonchi VB O O
70 noted JJ B-NP O
70 Cardiac NNP I-NP O
70 exam NN I-NP O
70 revealed VBD B-VP O
70 jugular JJ B-NP O
70 venous JJ I-NP O
71 pulse NN I-NP O
71 was VBD B-VP O
71 approximately RB O O
71 7 CD O O
71 cm NNS B-NP O
71 at IN B-VP O
71 30 CD O O
71 degrees NNS B-NP O
71 , , O O
71 regular JJ B-NP O
71 rate NN I-NP O
71 and CC O O
72 rhythm NN B-NP O
72 , , O O
72 S1 NNP B-NP O
72 and CC O O
72 S2 NNP B-NP O
72 with IN B-VP O
72 loud JJ B-NP O
72 S4 NNP I-NP O
72 , , O O
72 otherwise RB O O
72 no DT B-NP O
72 murmur NN I-NP O
72 or CC O O
72 rub VB O O
73 Abdominal NNP B-NP O
73 exam NN I-NP O
73 demonstrated VBD B-VP O
73 bowel JJ B-NP O
73 sounds NNS I-NP O
73 were VBD B-VP O
73 present JJ O O
73 , , O O
73 non-tender JJ O O
73 , , O O
74 liver RB O O
74 span VBZ O O
74 8 CD O O
74 cm NN B-NP O
74 in IN B-VP O
74 midclavicular JJ B-NP O
74 line NN I-NP O
74 There EX O O
74 was VBD B-VP O
74 no DT B-NP O
74 spleen JJ I-NP O
74 tip NN I-NP O
75 palpable JJ B-NP O
75 Rectal NNP I-NP O
75 exam NN I-NP O
75 normal JJ B-NP O
75 tone NN I-NP O
75 with IN B-VP O
75 a DT B-NP O
75 firm NN I-NP O
75 prostate NN I-NP O
75 without IN B-VP O
76 masses NNS B-NP O
76 and CC O O
76 stool NN B-NP O
76 was VBD B-VP O
76 guaiac JJ B-NP O
76 negative JJ I-NP O
76 Back NNP I-NP O
76 exam NN I-NP O
76 revealed VBD B-VP O
76 no DT B-NP O
76 spinal NN I-NP O
77 or CC O O
77 CVA NNP B-NP O
77 tenderness RB O O
77 noted VBD B-VP O
77 There EX O O
77 was VBD B-VP O
77 slight JJ B-NP O
77 buffalo NN I-NP O
77 hump NN I-NP O
77 present NN I-NP O
77 , , O O
78 however RB O O
78 Extremities NNP B-NP O
78 - : O O
78 Radial JJ B-NP O
78 pulses NNS I-NP O
78 3+ CD O O
78 , , O O
78 femoral JJ O O
78 2+ CD O O
78 , , O O
78 posterior JJ O O
79 tibial JJ O O
79 2+ CD O O
79 on IN B-VP O
79 the DT B-NP O
79 right NN I-NP O
79 and CC O O
79 1+ CD O O
79 on IN B-VP O
79 the DT B-NP O
79 left NN I-NP O
79 , , O O
79 dorsal NN B-NP O
79 pedis VBD B-VP O
79 1+ CD O O
80 bilaterally RB O O
80 There EX O O
80 are VBP O O
80 no DT B-NP O
80 femoral JJ I-NP O
80 bruits NNS I-NP O
80 There EX O O
80 was VBD B-VP O
80 1+ CD O O
80 pitting VBG O O
81 ankle NN B-NP O
81 edema NN I-NP O
81 bilaterally RB O O
81 Neuro NNP B-NP O
81 exam NN I-NP O
81 was VBD B-VP O
81 non-focal JJ B-NP O
82 LABORATORY NNP I-NP O
82 DATA: NNP I-NP O
82 On IN B-VP O
82 admission NN B-NP O
82 sodium NN I-NP O
82 141 CD O O
82 , , O O
82 potassium NN B-NP O
82 4.6 CD O O
82 , , O O
82 chloride RB O O
83 105 CD O O
83 , , O O
83 CO2 NNP B-NP O
83 24 CD O O
83 , , O O
83 BUN NNP B-NP O
83 19 CD O O
83 , , O O
83 creatinine NN B-NP O
83 0.9 CD O O
83 , , O O
83 glucose VBD B-VP O
83 178 CD O O
84 ALT NNP B-NP O
84 20 CD O O
84 , , O O
84 AST NNP B-NP O
84 18 CD O O
84 , , O O
84 LDH NNP B-NP O
84 177 CD O O
84 CK NNP B-NP O
84 107 CD O O
84 Alk NNP B-NP O
84 phos NN I-NP O
84 98 CD O O
84 , , O O
84 bili VBD B-VP O
84 total JJ O O
84 0.5 CD O O
84 , , O O
85 direct JJ O O
85 0.2 CD O O
85 Cholesterol NNP B-NP O
85 236 CD O O
85 , , O O
85 triglycerides VBZ O O
85 320 CD O O
85 Total NNP B-NP O
85 protein NN I-NP O
86 7.0 CD O O
86 , , O O
86 globulin NN B-NP O
86 4.6 CD O O
86 , , O O
86 albumin RB O O
86 2.4 CD O O
86 , , O O
86 calcium NN B-NP O
86 9.9 CD O O
86 , , O O
86 phosphate NN B-NP O
86 3.8 CD O O
86 White NNP B-NP O
87 count NN I-NP O
87 6.6 CD O O
87 , , O O
87 Hct NNP B-NP O
87 39.8 CD O O
87 , , O O
87 platelets NNS B-NP O
87 260 CD O O
87 , , O O
87 000 CD O O
87 , , O O
87 three CD O O
87 point NN B-NP O
87 differential NN I-NP O
88 revealed VBD B-VP O
88 26% CD O O
88 lymphocytes NNS B-NP O
88 , , O O
88 5.8% CD O O
88 monocytes NNS B-NP O
88 , , O O
88 68.2% CD O O
88 granulocytes NNS B-NP O
88 PT NNP I-NP O
89 was VBD B-VP O
89 12.6 CD O O
89 , , O O
89 PTT NNP B-NP O
89 31.0 CD O O
89 UA NNP B-NP O
89 was VBD B-VP O
89 pending VBG O O
89 EKG NNP B-NP O
89 showed VBD B-VP O
89 normal JJ B-NP O
89 sinus NN I-NP O
90 rhythm NN I-NP O
90 at IN B-VP O
90 a DT B-NP O
90 rate NN I-NP O
90 of IN B-VP O
90 84 CD O O
90 , , O O
90 PR NNP B-NP O
90 interval NN I-NP O
90 160 CD O O
90 , , O O
90 QRS NNP B-NP O
90 84 CD O O
90 , , O O
90 QTC NNP B-NP O
90 0.44 CD O O
90 , , O O
90 axis RB O O
91 +30 VBZ O O
91 The DT B-NP O
91 EKG NNP I-NP O
91 was VBD B-VP O
91 remarkable JJ O O
91 for IN B-VP O
91 Q NNP B-NP O
91 wave VBP O O
91 in IN B-VP O
91 T NNP B-NP O
91 and CC O O
91 F NNP B-NP O
91 and CC O O
91 extensively RB O O
92 across IN B-VP O
92 the DT B-NP O
92 precordium NN I-NP O
92 , , O O
92 T NNP B-NP O
92 wave VBP O O
92 inversions NNS B-NP O
92 in IN B-VP O
92 1 CD O O
92 , , O O
92 2 CD O O
92 , , O O
92 and CC O O
92 R NNP B-NP O
92 ST NNP I-NP O
93 elevations NNS I-NP O
93 of IN B-VP O
93 2 CD O O
93 to TO O O
93 3 CD O O
93 mm NNS B-NP O
93 in IN B-VP O
93 V2 NNP B-NP O
93 , , O O
93 V3 NNP B-NP O
93 , , O O
93 and CC O O
93 V4 NNP B-NP O
93 with IN B-VP O
93 T NNP B-NP O
93 wave VBP O O
93 inversion NN B-NP O
93 in IN B-VP O
94 V2 NNP B-NP O
94 through IN B-VP O
94 V6 NNP B-NP O
94 , , O O
94 all DT O O
94 of IN B-VP O
94 these DT B-NP O
94 changes NNS I-NP O
94 new JJ O O
94 since IN B-VP O
94 1 CD O O
94 of IN B-VP O
94 October NNP B-NP O
94 Portable NNP I-NP O
95 chest JJS B-NP O
95 x-ray NN I-NP O
95 demonstrated VBD B-VP O
95 bilateral JJ B-NP O
95 pleural JJ I-NP O
95 effusions NNS I-NP O
95 with IN B-VP O
95 fluid NN B-NP O
95 in IN B-VP O
96 the DT B-NP O
96 minor JJ I-NP O
96 fissures NNS I-NP O
96 , , O O
96 question NN B-NP O
96 of IN B-VP O
96 cardiomegaly NN B-NP O
96 , , O O
96 increasing VBG O O
96 pulmonary JJ B-NP O
97 vascular JJ I-NP O
97 redistribution NN I-NP O
97 consistent NN I-NP O
97 with IN B-VP O
97 congestive JJ B-NP O
97 heart NN I-NP O
97 failure NN I-NP O
98 HOSPITAL NNP I-NP O
98 COURSE: NNP I-NP O
98 The DT B-NP O
98 patient NN I-NP O
98 was VBD B-VP O
98 admitted VBN O O
98 to TO O O
98 the DT B-NP O
98 General NNP I-NP O
98 Medical NNP I-NP O
99 Service NNP I-NP O
99 Ri NNP I-NP O
99 Jotonmavilleceance NNP I-NP O
99 Lisker NNP I-NP O
99 and CC O O
99 subsequently RB O O
99 ruled VBD B-VP O
99 out RP O O
99 for IN B-VP O
99 MI NNP B-NP O
100 by IN B-VP O
100 enzymes VBG O O
100 His PRP$ O O
100 initial JJ B-NP O
100 CK NNP I-NP O
100 was VBD B-VP O
100 107 CD O O
100 Eight NNP B-NP O
100 hours NNS I-NP O
100 later RB O O
100 his PRP$ O O
100 CK NNP B-NP O
101 drawn NN I-NP O
101 was VBD B-VP O
101 45 CD O O
101 and CC O O
101 final JJ B-NP O
101 CK NNP I-NP O
101 was VBD B-VP O
101 89 CD O O
101 However RB O O
101 , , O O
101 the DT B-NP O
101 patient JJ I-NP O
101 underwent JJ I-NP O
102 echocardiography NN I-NP O
102 and CC O O
102 the DT B-NP O
102 echocardiogram NN I-NP O
102 demonstrated VBD B-VP O
102 a DT O O
102 moderately RB O O
103 dilated JJ O O
103 left VBD B-VP O
103 ventricle NN B-NP O
103 with IN B-VP O
103 decreased JJ B-NP O
103 global JJ I-NP O
103 contractile NN I-NP O
103 function NN I-NP O
103 , , O O
104 roughly RB O O
104 estimated VBN O O
104 at IN B-VP O
104 around IN B-VP O
104 25% CD O O
104 There EX O O
104 were VBD B-VP O
104 extensive JJ B-NP O
104 wall NN I-NP O
104 motion NN I-NP O
105 abnormalities NNS I-NP O
105 with IN B-VP O
105 mid NN B-NP O
105 to TO O O
105 distal JJ B-NP O
105 septal JJ I-NP O
105 akinesis NN I-NP O
105 , , O O
105 anterior RB O O
105 , , O O
106 anterolateral JJ O O
106 , , O O
106 and CC O O
106 septal JJ B-NP O
106 apex NN I-NP O
106 dyskinesis NN I-NP O
106 consistent NN I-NP O
106 with IN B-VP O
106 a DT B-NP O
106 large JJ I-NP O
107 anterior JJ I-NP O
107 myocardial JJ I-NP O
107 infarction NN I-NP O
107 However RB O O
107 , , O O
107 there EX O O
107 was VBD B-VP O
107 no DT B-NP O
107 mural JJ I-NP O
108 thrombus NN I-NP O
108 seen VBN O O
108 although IN B-VP O
108 occult NN B-NP O
108 thrombi NNS I-NP O
108 could MD O O
108 not RB O O
108 be VB O O
108 excluded VBN O O
108 at IN B-VP O
108 that DT B-NP O
109 time NN I-NP O
109 Because IN B-VP O
109 of IN B-VP O
109 the DT B-NP O
109 echocardiogram JJ I-NP O
109 result NN I-NP O
109 and CC O O
109 the DT B-NP O
109 fact NN I-NP O
109 that IN B-VP O
109 the DT B-NP O
110 patient NN I-NP O
110 ruled VBD B-VP O
110 out RP O O
110 for IN B-VP O
110 a DT B-NP O
110 recent JJ I-NP O
110 MI NNP I-NP O
110 the DT B-NP O
110 clinical JJ I-NP O
110 picture NN I-NP O
110 was VBD B-VP O
111 consistent JJ O O
111 with IN B-VP O
111 an DT B-NP O
111 evolved JJ I-NP O
111 myocardial JJ I-NP O
111 infarction NN I-NP O
111 within IN B-VP O
111 the DT B-NP O
111 time NN I-NP O
112 between IN B-VP O
112 the DT B-NP O
112 patient's JJ I-NP O
112 initial JJ I-NP O
112 presentation NN I-NP O
112 to TO O O
112 Dr NNP B-NP O
112 Connelley NNP I-NP O
112 in IN B-VP O
112 7 CD O O
112 of IN B-VP O
112 August NNP B-NP O
113 and CC O O
113 the DT B-NP O
113 patient's JJ I-NP O
113 presentation NN I-NP O
113 in IN B-VP O
113 21 CD O O
113 of IN B-VP O
113 January NNP B-NP O
113 Consequently NNP I-NP O
113 the DT B-NP O
113 plan NN I-NP O
113 was VBD B-VP O
114 made VBN O O
114 to TO O O
114 manage VB O O
114 the DT B-NP O
114 patient NN I-NP O
114 with IN B-VP O
114 gentle JJ B-NP O
114 Lasix NNP I-NP B-m
114 diuresis NN I-NP O
114 The DT B-NP O
115 patient's NN I-NP O
115 beta NN I-NP B-m
115 blocker NN I-NP I-m
115 was VBD B-VP O
115 held VBN O O
115 because IN B-VP O
115 of IN B-VP O
115 the DT B-NP O
115 concern NN I-NP O
115 for IN B-VP O
115 wall NN B-NP O
116 motion NN I-NP O
116 abnormalities NNS I-NP O
116 and CC O O
116 possible JJ B-NP O
116 aneurysm NN I-NP O
116 formation NN I-NP O
116 The DT B-NP O
116 patient NN I-NP O
117 was VBD B-VP O
117 anticoagulated VBN O O
117 on IN B-VP O
117 heparin NN B-NP B-m
117 and CC O O
117 subsequently RB O O
117 was VBD B-VP O
117 loaded VBN O O
117 on IN B-VP O
118 Coumadin NNP B-NP B-m
118 In IN B-VP O
118 addition NN B-NP O
118 the DT B-NP B-r
118 patient's NN I-NP I-r
118 afterload NN I-NP I-r
118 reduction NN I-NP I-r
118 was VBD B-VP O
119 increased VBN O O
119 and CC O O
119 changed VBN O O
119 to TO O O
119 Captopril NNP B-NP B-m
119 In IN B-VP O
119 addition NN B-NP O
119 the DT B-NP O
119 patient NN I-NP O
120 underwent VBD B-VP O
120 an DT B-NP O
120 exercise NN I-NP O
120 tolerance NN I-NP O
120 test NN I-NP O
120 with IN B-VP O
120 thallium NN B-NP O
120 scan NN I-NP O
120 on IN B-VP O
121 26 CD O O
121 of IN B-VP O
121 January NNP B-NP O
121 During IN B-VP O
121 this DT B-NP O
121 procedure NN I-NP O
121 the DT B-NP O
121 patient NN I-NP O
121 exercised VBD B-VP O
121 for IN B-VP O
121 6 CD O O
122 minutes NNS B-NP O
122 on IN B-VP O
122 modified JJ B-NP O
122 Bruce NNP I-NP O
122 protocol NN I-NP O
122 The DT B-NP O
122 test NN I-NP O
122 was VBD B-VP O
122 stopped VBN O O
122 secondary JJ O O
123 to TO O O
123 leg VB O O
123 fatigue VB O O
123 The DT B-NP O
123 patient's JJ I-NP O
123 heart NN I-NP O
123 rate NN I-NP O
123 rose VBD B-VP O
123 from IN B-VP O
123 98 CD O O
123 to TO O O
123 150 CD O O
123 , , O O
124 blood NN B-NP O
124 pressure NN I-NP O
124 rose VBD B-VP O
124 from IN B-VP O
124 126/72 CD O O
124 to TO O O
124 148/76 CD O O
124 The DT B-NP O
124 patient NN I-NP O
124 had VBD B-VP O
124 no DT B-NP O
125 chest JJS I-NP O
125 pain NN I-NP O
125 There EX O O
125 was VBD B-VP O
125 no DT B-NP O
125 evidence NN I-NP O
125 for IN B-VP O
125 ischemia NN B-NP O
125 Thallium NN I-NP O
125 images NNS I-NP O
126 showed VBD B-VP O
126 a DT O O
126 moderately RB O O
126 severe JJ B-NP O
126 perfusion NN I-NP O
126 defect NN I-NP O
126 at IN B-VP O
126 the DT B-NP O
126 apex NN I-NP O
126 sustained VBD B-VP O
127 to TO O O
127 the DT B-NP O
127 low JJ I-NP O
127 anterior NN I-NP O
127 wall NN I-NP O
127 , , O O
127 inferolateral JJ B-NP O
127 wall NN I-NP O
127 , , O O
127 and CC O O
127 septum VB O O
127 This DT B-NP O
128 defect NN I-NP O
128 was VBD B-VP O
128 unchanged JJ O O
128 on IN B-VP O
128 late JJ B-NP O
128 images NNS I-NP O
128 There EX O O
128 were VBD B-VP O
128 , , O O
128 therefore RB O O
128 , , O O
128 no DT B-NP O
129 signs NNS I-NP O
129 of IN B-VP O
129 ischemia NN B-NP O
129 , , O O
129 however RB O O
129 , , O O
129 there EX O O
129 was VBD B-VP O
129 some DT B-NP O
129 mild JJ I-NP O
129 transient JJ I-NP O
129 loss NN I-NP O
129 of IN B-VP O
130 uptake JJ O O
130 consistent JJ O O
130 with IN B-VP O
130 CHF NNP B-NP O
130 The DT B-NP O
130 overall JJ I-NP O
130 impression NN I-NP O
130 was VBD B-VP O
130 of IN B-VP O
130 a DT B-NP O
130 fixed JJ I-NP O
131 defect JJ I-NP O
131 consistent NN I-NP O
131 with IN B-VP O
131 an DT B-NP O
131 evolved JJ I-NP O
131 myocardial JJ I-NP O
131 infarction NN I-NP O
131 Because IN B-VP O
132 of IN B-VP O
132 the DT B-NP O
132 evidence NN I-NP O
132 for IN B-VP O
132 an DT B-NP O
132 evolved JJ I-NP O
132 myocardial JJ I-NP O
132 infarction NN I-NP O
132 the DT B-NP O
132 decision NN I-NP O
133 was VBD B-VP O
133 made VBN O O
133 that IN B-VP O
133 this DT B-NP O
133 patient NN I-NP O
133 would MD O O
133 not RB O O
133 be VB O O
133 a DT B-NP O
133 candidate NN I-NP O
133 for IN B-VP O
133 coronary JJ B-NP O
134 artery NN I-NP O
134 bypass NN I-NP O
134 grafting NN I-NP O
134 and CC O O
134 so RB O O
134 cardiac JJ B-NP O
134 catheterization NN I-NP O
134 was VBD B-VP O
134 deferred VBN O O
135 at IN B-VP O
135 this DT B-NP O
135 time NN I-NP O
135 The DT B-NP O
135 patient NN I-NP O
135 was VBD B-VP O
135 discharged VBN O O
135 to TO O O
135 home VB O O
135 on IN B-VP O
135 19 CD O O
135 of IN B-VP O
135 April NNP B-NP O
135 At IN B-VP O
136 the DT B-NP O
136 time NN I-NP O
136 of IN B-VP O
136 discharge NN B-NP O
136 a DT B-NP O
136 UA NNP I-NP O
136 and CC O O
136 sediment NN B-NP O
136 were VBD B-VP O
136 pending VBG O O
137 DISPOSITION: NNP B-NP O
137 DISCHARGE NNP I-NP O
137 MEDICATIONS: NNP I-NP O
137 Lasix NNP I-NP B-m
137 40 CD O B-do
137 mg NN B-NP I-do
137 po NN I-NP B-mo
137 q NN I-NP B-f
137 d NN I-NP I-f
137 , , O O
137 Captopril NNP B-NP B-m
138 37.5 CD O B-do
138 mg NN B-NP I-do
138 po NN I-NP B-mo
138 tid NN I-NP B-f
138 , , O O
138 Ecotrin NNP B-NP B-m
138 325 CD O B-do
138 mg NN B-NP I-do
138 po NN I-NP B-mo
138 q NN I-NP B-f
138 d NN I-NP I-f
138 , , O O
138 Coumadin NNP B-NP B-m
138 5 CD O B-do
138 mg NN B-NP I-do
139 po NN I-NP B-mo
139 q NN I-NP B-f
139 h.s NN I-NP I-f
139 , , O O
139 magnesium NN B-NP B-m
139 oxide RB O I-m
139 two CD O B-do
139 tablets NNS B-NP I-do
139 po VBP O B-mo
139 q JJ B-NP B-f
139 d NN I-NP I-f
139 , , O O
139 Isordil NNP B-NP B-m
139 10 CD O B-do
139 mg NN B-NP I-do
139 po NN I-NP B-mo
139 tid NN I-NP B-f
140 with IN B-VP O
140 meals NNS B-NP O
140 , , O O
140 and CC O O
140 Micronase NNP B-NP B-m
140 10 CD O B-do
140 mg NN B-NP I-do
140 po NN I-NP B-mo
140 bid NN I-NP B-f
140 CONDITION NNP I-NP O
140 ON NNP I-NP O
140 DISCHARGE: NNP I-NP O
141 Stable NNP I-NP O
141 FOLLOW-UP: NNP I-NP O
141 With IN B-VP O
141 Dr NNP B-NP O
141 Luciano NNP I-NP O
141 Catignani NNP I-NP O
141 in IN B-VP O
141 his PRP$ O O
141 office NN B-NP O
141 on IN B-VP O
142 Tuesday NNP B-NP O
142 , , O O
142 15 CD O O
142 of IN B-VP O
142 October NNP B-NP O
142 , , O O
142 at IN B-VP O
142 3 CD O O
142 p.m JJ B-NP O
143 ________________________________ NNP I-NP O
143 BH523/9938 NNP I-NP O
144 BRIAN NNP I-NP O
144 S NNP I-NP O
144 MORE NNP I-NP O
144 , , O O
144 M.D NNP B-NP O
144 HQ7 NNP I-NP O
144 D: NNP I-NP O
144 5/15/90 CD O O
145 Batch: NNP B-NP O
145 7967 CD O O
145 Report: NNP B-NP O
145 M9636S2 NNP I-NP O
145 T: NNP I-NP O
145 3/1/90 CD O O
146 Dictated NNP B-NP O
146 By: NNP I-NP O
146 TERRY NNP I-NP O
146 SCALESE NNP I-NP O
146 HXM5 NNP I-NP O
147 cc: VBD B-VP O
147 1 CD O O
147 HUBERT NNP B-NP O
147 GRIM NNP I-NP O
147 , , O O
147 M.D NNP B-NP O
148 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #810190 VBZ O O
4 194535648 CD O O
4 THC NNP B-NP O
4 12782558 CD O O
4 3516041 CD O O
4 9/6/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 bacteremia NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/0/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/23/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 MORELL NNP I-NP O
8 , , O O
8 PARKER NNP B-NP O
8 L NNP I-NP O
8 918-56-28-4 CD O O
9 Verl NNP B-NP O
9 Tri NNP I-NP O
9 Nard NNP I-NP O
9 , , O O
9 Maryland NNP B-NP O
10 Service: NNP I-NP O
10 ONC NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 8/6/06 CD O O
11 AT NNP B-NP O
11 11:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 SNF/rehab NNP I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 RIOJAS NNP I-NP O
14 , , O O
14 HANS NNP B-NP O
14 B NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Skilled VBD B-VP O
17 Nursing NNP B-NP O
17 Facility NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 TYLENOL NNP I-NP B-m
19 TYLENOL NNP I-NP B-m
19 TYLENOL NNP I-NP B-m
19 ( ( O I-m
19 ( ( O I-m
19 ( ( O I-m
19 ACETAMINOPHEN NNP B-NP I-m
19 ACETAMINOPHEN NNP I-NP I-m
19 ACETAMINOPHEN NNP I-NP I-m
19 ) ) O I-m
19 ) ) O I-m
19 ) ) O I-m
19 650 CD O B-do
19 650 CD O B-do
19 650 CD O B-do
19 MG NNP B-NP I-do
19 MG NNP I-NP I-do
19 MG NNP I-NP I-do
19 PO NNP I-NP B-mo
19 PO NNP I-NP B-mo
19 PO NNP I-NP B-mo
19 Q6H NNP I-NP B-f
19 Q6H NNP I-NP B-f
19 Q6H NNP I-NP B-f
20 PRN NNP I-NP O
20 Pain NNP I-NP B-r
20 , , O O
20 Temperature NNP B-NP B-r
20 greater JJR B-NP O
20 than:101 NN I-NP O
20 , , O O
20 Other:transfusion NNP B-NP B-r
21 premedication NN I-NP O
22 ALBUTEROL NNP I-NP B-m
22 NEBULIZER NNP I-NP I-m
22 2.5 CD O B-do
22 MG NNP B-NP I-do
22 INH NNP I-NP B-mo
22 Q4H NNP I-NP B-f
22 PRN NNP I-NP I-f
22 Wheezing NNP I-NP B-r
23 TESSALON NNP I-NP B-m
23 PERLES NNP I-NP I-m
23 ( ( O I-m
23 BENZONATATE NNP B-NP I-m
23 ) ) O I-m
23 100 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 TID NNP I-NP B-f
24 PRN NNP I-NP O
24 Other:congestion NNP I-NP B-r
25 CALTRATE NNP I-NP B-m
25 600 CD O I-m
25 + NNP B-NP I-m
25 D NNP I-NP I-m
25 ( ( O I-m
25 CALCIUM NNP B-NP I-m
25 CARBONATE NNP I-NP I-m
25 1 CD O I-m
25 , , O I-m
25 500 CD O I-m
25 MG NNP B-NP I-m
25 ( ( O I-m
25 ) ) O I-m
26 2 CD O B-do
26 TAB NNP B-NP I-do
26 PO NNP I-NP B-mo
26 BID NNP I-NP B-f
27 PERIDEX NNP I-NP B-m
27 MOUTHWASH NNP I-NP I-m
27 ( ( O I-m
27 CHLORHEXIDINE NNP B-NP I-m
27 MOUTHWASH NNP I-NP I-m
27 0.12% CD O I-m
27 ) ) O I-m
28 15 CD O B-do
28 MILLILITERS NNP B-NP I-do
28 MO NNP I-NP B-mo
28 BID NNP I-NP B-f
29 Instructions: NNP I-NP O
29 pls NN I-NP O
29 use NN I-NP O
29 this DT O O
29 or CC O O
29 nystatin JJ B-NP B-m
29 s+s NN I-NP O
30 BENADRYL NNP I-NP B-m
30 ( ( O I-m
30 DIPHENHYDRAMINE NNP B-NP I-m
30 ) ) O I-m
30 12.5 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 x1 NNP I-NP B-f
31 PRN NNP I-NP O
31 Other:pre-transfusion NNP I-NP B-r
32 COLACE NNP I-NP B-m
32 ( ( O I-m
32 DOCUSATE NNP B-NP I-m
32 SODIUM NNP I-NP I-m
32 ) ) O I-m
32 100 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
32 PRN NNP I-NP I-f
32 Constipation NNP I-NP B-r
33 ENOXAPARIN NNP I-NP B-m
33 40 CD O B-do
33 MG NNP B-NP I-do
33 SC NNP I-NP B-mo
33 DAILY NNP I-NP B-f
34 NEXIUM NNP I-NP B-m
34 ( ( O I-m
34 ESOMEPRAZOLE NNP B-NP I-m
34 ) ) O I-m
34 40 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 DAILY NNP I-NP B-f
35 FLOVENT NNP I-NP B-m
35 HFA NNP I-NP I-m
35 ( ( O I-m
35 FLUTICASONE NNP B-NP I-m
35 PROPIONATE NNP I-NP I-m
35 ) ) O I-m
35 110 CD O B-do
35 MCG NNP B-NP I-do
35 INH NNP I-NP B-mo
35 BID NNP I-NP B-f
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 INSULIN NNP I-NP B-m
36 ASPART NNP I-NP I-m
36 ASPART NNP I-NP I-m
36 ASPART NNP I-NP I-m
36 ASPART NNP I-NP I-m
36 ASPART NNP I-NP I-m
36 ASPART NNP I-NP I-m
36 ASPART NNP I-NP I-m
36 Sliding NNP I-NP O
36 Scale NNP I-NP O
36 ( ( O O
36 subcutaneously RB O O
36 ) ) O O
36 SC NNP B-NP O
36 AC NNP I-NP O
37 Starting VBG O O
37 Today NNP B-NP O
37 ( ( O O
37 3/24 CD O O
37 ) ) O O
38 If IN B-VP O
38 BS NNP B-NP B-r
38 is VBZ O I-r
38 less JJR O I-r
38 than IN B-VP I-r
38 125 CD O I-r
38 , , O O
38 then RB O O
38 give VB O O
38 0 CD O B-do
38 units NNS B-NP I-do
38 subcutaneously RB O B-mo
39 If IN B-VP O
39 BS NNP B-NP B-r
39 is VBZ O I-r
39 125-150 JJ O I-r
39 , , O O
39 then RB O O
39 give VB O O
39 2 CD O B-do
39 units NNS B-NP I-do
39 subcutaneously RB O B-mo
39 subcutaneously RB O B-mo
40 If IN B-VP O
40 BS NNP B-NP B-r
40 is VBZ O I-r
40 151-200 CD O I-r
40 , , O O
40 then RB O O
40 give VB O O
40 3 CD O B-do
40 units NNS B-NP I-do
40 subcutaneously RB O O
41 If IN B-VP O
41 BS NNP B-NP B-r
41 is VBZ O I-r
41 201-250 JJ O I-r
41 , , O O
41 then RB O O
41 give VB O O
41 4 CD O B-do
41 units NNS B-NP I-do
41 subcutaneously RB O B-mo
42 If IN B-VP O
42 BS NNP B-NP B-r
42 is VBZ O I-r
42 251-300 JJ O I-r
42 , , O O
42 then RB O O
42 give VB O O
42 6 CD O B-do
42 units NNS B-NP I-do
42 subcutaneously RB O B-mo
43 If IN B-VP O
43 BS NNP B-NP B-r
43 is VBZ O I-r
43 301-350 JJ O I-r
43 , , O O
43 then RB O O
43 give VB O O
43 8 CD O B-do
43 units NNS B-NP I-do
43 subcutaneously RB O B-mo
44 If IN B-VP O
44 BS NNP B-NP B-r
44 is VBZ O I-r
44 351-400 CD O I-r
44 , , O O
44 then RB O O
44 give VB O O
44 10 CD O B-do
44 units NNS B-NP I-do
44 subcutaneously RB O B-mo
44 and CC O O
45 call VB O O
45 HO NNP B-NP O
45 Call NNP I-NP O
45 HO NNP I-NP O
45 if IN B-VP O
45 BS NNP B-NP O
45 is VBZ O O
45 greater JJR O O
45 than IN B-VP O
45 400 CD O O
46 INSULIN NNP B-NP B-m
46 NPH NNP I-NP I-m
46 HUMAN NNP I-NP I-m
46 10 CD O B-do
46 UNITS NNP B-NP I-do
46 SC NNP I-NP B-mo
46 QAM NNP I-NP B-f
47 ATROVENT NNP I-NP B-m
47 NEBULIZER NNP I-NP I-m
47 ( ( O I-m
47 IPRATROPIUM NNP B-NP I-m
47 NEBULIZER NNP I-NP I-m
47 ) ) O I-m
48 0.5 CD O B-do
48 MG NNP B-NP I-do
48 INH NNP I-NP B-mo
48 QID NNP I-NP B-f
49 POTASSIUM NNP I-NP B-m
49 CHLORIDE NNP I-NP I-m
49 IMMED NNP I-NP I-m
49 REL NNP I-NP I-m
49 ( ( O I-m
49 KCL NNP B-NP I-m
49 IMMEDIATE NNP I-NP I-m
49 ) ) O I-m
50 ***LOW VBP O O
50 KCL NNP B-NP B-m
50 IMMEDIATE NNP I-NP I-m
50 RELEASE NNP I-NP I-m
50 REPLACEMENT NNP I-NP O
50 SCALE NNP I-NP O
50 ORAL NNP I-NP B-mo
50 ORAL NNP I-NP B-mo
50 PO NNP I-NP I-mo
50 PO NNP I-NP I-mo
51 Scale NNP I-NP O
51 Frequency NNP I-NP O
52 1 CD O O
52 Only RB O O
52 KCL NNP B-NP B-m
52 Immediate NNP I-NP I-m
52 Release NNP I-NP I-m
52 products NNS I-NP O
52 may MD O O
52 be VB O O
52 used VBN O O
52 for IN B-VP O
52 KCL NNP B-NP O
53 scales NNS I-NP O
54 2 CD O O
54 Do NNP B-NP O
54 not RB O O
54 use VB O O
54 sustained-release JJ B-NP O
54 potassium NN I-NP O
54 for IN B-VP O
54 KCL NNP B-NP O
54 scale NN I-NP O
55 doses VBZ O O
55 3 CD O O
55 Replace NNP B-NP O
55 KCL NNP I-NP O
55 based VBN O O
55 on IN B-VP O
55 lab NN B-NP O
55 values NNS I-NP O
56 4 CD O O
56 As IN B-VP O
56 per IN B-VP O
56 NM NNP B-NP O
56 Potassium NNP I-NP B-m
56 Chloride NNP I-NP I-m
56 Policy: NNP I-NP O
56 each DT O O
56 20 CD O B-do
56 mEq NN B-NP I-do
56 dose NN I-NP O
57 is VBZ O O
57 to TO O O
57 be VB O O
57 given VBN O O
57 with IN B-VP O
57 4 CD O O
57 oz NNS B-NP O
57 of IN B-VP O
57 fluid NN B-NP O
58 5 CD O O
58 A NNP B-NP O
58 serum NN I-NP O
58 creatinine NN I-NP O
58 must MD O O
58 be VB O O
58 ordered VBN O O
58 and CC O O
58 checked VBN O O
58 daily RB O O
59 while IN B-VP O
59 patient NN B-NP O
59 is VBZ O O
59 ordered VBN O O
59 for IN B-VP O
59 a DT O O
59 K-scale JJ O O
60 6 CD O O
60 K-scale JJ B-NP O
60 cannot NN I-NP O
60 be VB O O
60 used VBN O O
60 on IN B-VP O
60 patients NNS B-NP O
60 with: JJ O O
61 * VBP O O
61 A DT B-NP O
61 serum NN I-NP O
61 creatinine NN I-NP O
61 greater JJR O O
61 than IN B-VP O
61 or CC O O
61 equal JJ O O
61 to TO O O
61 2.0 CD O O
61 mg/dl; NN B-NP O
61 or CC O O
62 * VB O O
62 A DT B-NP O
62 serum NN I-NP O
62 creatinine JJ B-NP O
62 increase NN I-NP O
62 of IN B-VP O
62 0.5 CD O O
62 mg/dl NNS B-NP O
62 within IN B-VP O
62 24 CD O O
62 hours NNS B-NP O
63 * VBP O O
63 Hold NNP B-NP O
63 scale NN I-NP O
63 and CC O O
63 contact NN B-NP O
63 MD NNP I-NP O
63 if IN B-VP O
63 SCr NNP B-NP O
63 greater JJR O O
63 than IN B-VP O
63 2.0 CD O O
64 ----------------------------------------------------------- JJ B-NP O
65 ----------- NN I-NP O
65 If IN B-VP O
65 K+ NNP B-NP O
65 Level NNP I-NP O
65 is VBZ O O
65 less JJR O O
65 than IN B-VP O
65 3.1 CD O O
65 then RB O O
65 call VB O O
65 H.O NNP B-NP O
66 If IN B-VP O
66 K+ NNP B-NP B-r
66 Level NNP I-NP I-r
66 is VBZ O O
66 3.1-3.3 JJ O O
66 , , O O
66 then RB O O
66 administer RB O O
66 KCL NNP B-NP B-m
66 KCL NNP I-NP B-m
66 40 CD O B-do
66 40 CD O B-do
66 meq NN B-NP I-do
66 meq NN I-NP I-do
66 orally RB O B-mo
66 orally RB O B-mo
67 followed VBN O O
67 by IN B-VP O
67 20 CD O O
68 meq NNS B-NP O
68 orally RB O O
68 2 CD O O
68 hours NNS B-NP O
68 later RB O O
68 Recheck NNP B-NP O
68 K+ NNP I-NP O
68 Level NNP I-NP O
68 2 CD O O
68 hours NNS B-NP O
68 after IN B-VP O
69 dose NN B-NP O
69 was VBD B-VP O
69 given VBN O O
70 If IN B-VP O
70 K+ NNP B-NP B-r
70 Level NNP I-NP I-r
70 is VBZ O O
70 3.4-3.6 JJ O O
70 , , O O
70 then RB O O
70 administer RB O O
70 KCL NNP B-NP B-m
70 40 CD O B-do
70 meq NN B-NP I-do
70 orally RB O B-mo
71 Recheck NNP B-NP O
71 K+ NNP I-NP O
71 Level NNP I-NP O
71 2 CD O O
71 hours NNS B-NP O
71 after IN B-VP O
71 dose NN B-NP O
71 was VBD B-VP O
71 given VBN O O
72 If IN B-VP O
72 K+ NNP B-NP B-r
72 Level NNP I-NP I-r
72 is VBZ O O
72 3.7-4.0 JJ O O
72 , , O O
72 then RB O O
72 administer RB O O
72 KCL NNP B-NP B-m
72 20 CD O B-do
72 meq NN B-NP I-do
72 orally RB O B-mo
73 Recheck NNP B-NP O
73 K+ NNP I-NP O
73 Level NNP I-NP O
73 2 CD O O
73 hours NNS B-NP O
73 after IN B-VP O
73 dose NN B-NP O
73 was VBD B-VP O
73 given VBN O O
74 If IN B-VP O
74 K+ NNP B-NP O
74 Level NNP I-NP O
74 is VBZ O O
74 4.1-5.0 JJ O O
74 , , O O
74 then RB O O
74 DO NNP B-NP O
74 NOT NNP I-NP O
74 administer VB O O
74 KCL NNP B-NP O
75 Recheck NNP I-NP O
75 K+ NNP I-NP O
75 Level NNP I-NP O
75 in IN B-VP O
75 QAM NNP B-NP O
76 If IN B-VP O
76 K+ NNP B-NP O
76 Level NNP I-NP O
76 is VBZ O O
76 greater JJR O O
76 than IN B-VP O
76 5.0 CD O O
76 then RB O O
76 call VB O O
76 H.O NNP B-NP O
77 ----------------------------------------------------------- NNP I-NP O
78 ----------- NNP I-NP O
79 POTASSIUM NNP I-NP B-m
79 CHLORIDE NNP I-NP I-m
79 SLOW NNP I-NP I-m
79 REL NNP I-NP I-m
79 ( ( O I-m
79 KCL NNP B-NP I-m
79 SLOW NNP I-NP I-m
79 RELEASE NNP I-NP I-m
79 ) ) O I-m
80 40 CD O B-do
80 MEQ NNP B-NP I-do
80 PO NNP I-NP B-mo
80 DAILY NNP I-NP B-f
80 As IN B-VP O
80 per IN B-VP O
80 EKMC NNP B-NP O
80 Potassium NNP I-NP B-m
80 Chloride NNP I-NP I-m
80 Policy: NNP I-NP O
81 each DT O O
81 20 CD O B-do
81 mEq NNS B-NP I-do
81 dose VB O O
81 to TO O O
81 be VB O O
81 given VBN O O
81 with IN B-VP O
81 4 CD O O
81 oz NNS B-NP O
81 of IN B-VP O
81 fluid NN B-NP O
82 LACTULOSE NNP I-NP B-m
82 30 CD O B-do
82 MILLILITERS NNP B-NP I-do
82 PO NNP I-NP B-mo
82 DAILY NNP I-NP B-f
82 PRN NNP I-NP I-f
82 Constipation NNP I-NP B-r
83 ATIVAN NNP I-NP B-m
83 ( ( O I-m
83 LORAZEPAM NNP B-NP I-m
83 ) ) O I-m
83 0.5-1 CD O B-do
83 MG NNP B-NP I-do
83 IV NNP I-NP B-mo
83 Q8H NNP I-NP B-f
83 PRN NNP I-NP I-f
83 Nausea NNP I-NP B-r
84 HOLD NNP I-NP O
84 IF: NNP I-NP O
84 sedate NN I-NP O
84 or CC O O
84 rr&lt;10 VB O O
85 MAALOX-TABLETS NNP B-NP B-m
85 QUICK NNP I-NP I-m
85 DISSOLVE/CHEWABLE NNP I-NP I-m
85 1-2 JJ B-NP B-do
85 TAB NNP I-NP I-do
85 PO NNP I-NP B-mo
85 Q6H NNP I-NP B-f
86 PRN NNP I-NP O
86 Upset NNP I-NP B-r
86 Stomach NNP I-NP I-r
87 MAGNESIUM NNP I-NP B-m
87 GLUCONATE NNP I-NP I-m
87 Sliding NNP I-NP B-do
87 Scale NNP I-NP I-do
87 PO NNP I-NP B-mo
87 ( ( O I-mo
87 orally RB O I-mo
87 ) ) O I-mo
87 DAILY NNP B-NP B-f
88 -&gt; NNP I-NP O
88 Mg-scales NNP I-NP O
88 cannot NN I-NP O
88 be VB O O
88 used VBN O O
88 and CC O O
88 magnesium JJ B-NP O
88 doses NNS I-NP O
88 must MD O O
88 be VB O O
89 individualized VBN O O
89 for IN B-VP O
89 patients NNS B-NP O
89 who WP O O
89 have: VBP O O
90 - : O O
90 a DT B-NP O
90 serum JJ I-NP O
90 creatinine NN I-NP O
90 greater JJR O O
90 than IN B-VP O
90 or CC O O
90 equal JJ O O
90 to TO O O
90 2.0 CD O O
90 mg/dL; NN B-NP O
90 or CC O O
91 - : O O
91 a DT B-NP O
91 serum JJ I-NP O
91 creatinine NN I-NP O
91 greater JJR O O
91 than IN B-VP O
91 or CC O O
91 equal JJ O O
91 to TO O O
91 1.5 CD O O
91 mg/dL NN B-NP O
92 and CC O O
92 an DT B-NP O
92 increase NN I-NP O
92 of IN B-VP O
92 0.5mg/dL CD O O
92 within IN B-VP O
92 24 CD O O
92 hours NNS B-NP O
93 Call NNP I-NP O
93 HO NNP I-NP O
93 if IN B-VP O
93 Mg NNP B-NP O
93 level NN I-NP O
93 is VBZ O O
93 less JJR O O
93 than IN B-VP O
93 0.8 CD O O
94 If IN B-VP O
94 Mg NNP B-NP B-r
94 level NN I-NP I-r
94 is VBZ O O
94 less JJR O O
94 than IN B-VP O
94 1 CD O O
94 , , O O
94 then RB O O
94 give VB O O
94 3 CD O B-do
94 gm NN B-NP I-do
94 Mg NNP I-NP B-m
94 Gluconate NNP I-NP I-m
95 orally RB O B-mo
95 and CC O O
95 call VB O O
95 HO NNP B-NP O
96 If IN B-VP O
96 Mg NNP B-NP B-r
96 level NN I-NP I-r
96 is VBZ O O
96 1.0-1.5 JJ O O
96 , , O O
96 then RB O O
96 give VB O O
96 2 CD O B-do
96 gm NN B-NP I-do
96 Mg NNP I-NP B-m
96 Gluconate NNP I-NP I-m
96 orally RB O B-mo
97 If IN B-VP O
97 Mg NNP B-NP B-r
97 level NN I-NP I-r
97 is VBZ O O
97 1.6-1.9 JJ O O
97 , , O O
97 then RB O O
97 give VB O O
97 1 CD O B-do
97 gm NN B-NP I-do
97 Mg NNP I-NP B-m
97 Gluconate NNP I-NP I-m
97 orally RB O B-mo
98 If IN B-VP O
98 Mg NNP B-NP O
98 level NN I-NP O
98 is VBZ O O
98 2.0-2.5 JJ O O
98 , , O O
98 then RB O O
98 Do NNP B-NP O
98 Not RB O O
98 administer VB O O
98 Mg NNP B-NP O
99 Gluconate NNP I-NP O
99 Call NNP I-NP O
99 HO NNP I-NP O
99 if IN B-VP O
99 Mg NNP B-NP O
99 level NN I-NP O
99 is VBZ O O
99 greater JJR O O
99 than IN B-VP O
99 2.5 CD O O
100 MAGNESIUM NNP B-NP B-m
100 SULFATE NNP I-NP I-m
100 Sliding NNP I-NP B-do
100 Scale NNP I-NP I-do
100 IV NNP I-NP B-mo
100 ( ( O I-mo
100 intravenously RB O I-mo
100 ) ) O I-mo
100 DAILY NNP B-NP B-f
101 ----------------------------------------------------------- NNP I-NP O
102 ------ NNP I-NP O
102 Physician NNP I-NP O
102 Instructions: NNP I-NP O
103 Magnesium NNP I-NP O
103 scales VBZ O O
103 cannot RB O O
103 be VB O O
103 used VBN O O
103 on IN B-VP O
103 patients NNS B-NP O
103 with: JJ O O
104 -&gt; VBP O O
104 A DT B-NP O
104 serum NN I-NP O
104 creatinine NN I-NP O
104 greater JJR O O
104 than IN B-VP O
104 or CC O O
104 equal JJ O O
104 to TO O O
104 2.0 CD O O
104 mg/dL; NN B-NP O
105 or CC O O
106 -&gt; VB O O
106 A DT B-NP O
106 serum NN I-NP O
106 creatinine JJ B-NP O
106 increase NN I-NP O
106 of IN B-VP O
106 0.5 CD O O
106 mg/dL NNS B-NP O
106 within IN B-VP O
106 24 CD O O
107 hours NNS B-NP O
108 ----------------------------------------------------------- JJ B-NP O
109 -------- NNP I-NP O
109 Call NNP I-NP O
109 HO NNP I-NP O
109 if IN B-VP O
109 Mg NNP B-NP O
109 level NN I-NP O
109 is VBZ O O
109 less JJR O O
109 than IN B-VP O
109 1.2 CD O O
110 Hold JJ B-NP O
110 order NN I-NP O
110 if IN B-VP O
110 creatinine NN B-NP O
110 is VBZ O O
110 greater JJR O O
110 than IN B-VP O
110 1.9 CD O O
111 If IN B-VP O
111 serum JJ B-NP B-r
111 Mg NNP I-NP I-r
111 level NN I-NP I-r
111 is VBZ O O
111 less JJR O O
111 than IN B-VP O
111 1.4 CD O O
111 , , O O
111 then RB O O
111 give VB O O
111 5 CD O B-do
111 gm NN B-NP I-do
111 Mg NNP I-NP B-m
112 Sulfate NNP I-NP O
112 intravenously RB O B-mo
112 and CC O O
112 call VB O O
112 HO NNP B-NP O
113 If IN B-VP O
113 serum JJ B-NP B-r
113 Mg NNP I-NP I-r
113 level NN I-NP I-r
113 is VBZ O O
113 less JJR O O
113 than IN B-VP O
113 1.6 CD O O
113 , , O O
113 then RB O O
113 give VB O O
113 4 CD O B-do
113 gm NN B-NP I-do
113 Mg NNP I-NP B-m
114 sulfate NN I-NP O
114 intravenously RB O B-mo
115 If IN B-VP O
115 serum JJ B-NP B-r
115 Mg NNP I-NP I-r
115 level NN I-NP I-r
115 is VBZ O O
115 less JJR O O
115 than IN B-VP O
115 1.8 CD O O
115 , , O O
115 then RB O O
115 give VB O O
115 3 CD O B-do
115 gm NN B-NP I-do
115 Mg NNP I-NP B-m
116 Sulfate NNP I-NP O
116 intravenously RB O B-mo
117 If IN B-VP O
117 serum JJ B-NP B-r
117 Mg NNP I-NP I-r
117 level NN I-NP I-r
117 is VBZ O O
117 less JJR O O
117 than IN B-VP O
117 2.0 CD O O
117 , , O O
117 then RB O O
117 give VB O O
117 2 CD O B-do
117 gm NN B-NP I-do
117 Mg NNP I-NP B-m
118 Sulfate NNP I-NP O
118 intravenously RB O B-mo
119 Call NNP B-NP O
119 HO NNP I-NP O
119 if IN B-VP O
119 Mg NNP B-NP O
119 level NN I-NP O
119 is VBZ O O
119 greater JJR O O
119 than IN B-VP O
119 2.5 CD O O
120 MS NNP B-NP B-m
120 CONTIN NNP I-NP I-m
120 ( ( O I-m
120 MORPHINE NNP B-NP I-m
120 CONTROLLED NNP I-NP I-m
120 RELEASE NNP I-NP I-m
120 ) ) O I-m
120 15 CD O B-do
120 MG NNP B-NP I-do
120 PO NNP I-NP B-mo
120 BID NNP I-NP B-f
121 Starting VBG O O
121 Today NNP B-NP O
121 ( ( O O
121 3/24 CD O O
121 ) ) O O
121 HOLD NNP B-NP O
121 IF: NNP I-NP O
121 rr&lt;10 NN I-NP O
121 or CC O O
121 very RB O O
121 sleepy JJ B-NP O
122 NYSTATIN NNP I-NP B-m
122 SUSPENSION NNP I-NP I-m
122 10 CD O B-do
122 MILLILITERS NNP B-NP I-do
122 PO NNP I-NP B-mo
122 QID NNP I-NP B-f
123 Instructions: NNP I-NP O
123 use NN I-NP O
123 this DT O O
123 or CC O O
123 chlorhexidine VB O B-m
124 ZOFRAN NNP B-NP B-m
124 ( ( O I-m
124 POST-OP NNP B-NP I-m
124 N/V NNP I-NP I-m
124 ) ) O I-m
124 ( ( O I-m
124 ONDANSETRON NNP B-NP I-m
124 HCL NNP I-NP I-m
124 ( ( O I-m
124 POST- NNP B-NP I-m
124 ) ) O I-m
125 1 CD O B-do
125 MG NNP B-NP I-do
125 IV NNP I-NP B-mo
125 Q6H NNP I-NP O
125 X NNP I-NP B-du
125 2 CD O I-du
125 doses NNS B-NP I-du
125 PRN NNP I-NP O
125 Nausea NNP I-NP B-r
126 OXYCODONE NNP I-NP B-m
126 5 CD O B-do
126 MG NNP B-NP I-do
126 PO NNP I-NP B-mo
126 Q6H NNP I-NP B-f
126 PRN NNP I-NP I-f
126 Pain NNP I-NP B-r
127 KCL NNP I-NP B-m
127 ( ( O I-m
127 POTASSIUM NNP B-NP I-m
127 CHLORIDE NNP I-NP I-m
127 ) ) O I-m
128 ***MODERATE VBP O O
128 KCL NNP B-NP B-m
128 REPLACEMENT NNP I-NP B-do
128 SCALE NNP I-NP I-do
128 10 CD O I-do
128 mEq/HR NN B-NP I-do
128 IV NNP I-NP B-mo
128 Scale NNP I-NP O
129 Frequency NNP I-NP O
129 1 CD O O
129 Replace NNP B-NP O
129 KCL NNP I-NP B-m
129 based VBN O O
129 on IN B-VP O
129 lab NN B-NP O
129 values NNS I-NP O
130 2 CD O O
130 An DT B-NP O
130 infusion NN I-NP O
130 pump NN I-NP O
130 is VBZ O O
130 required VBN O O
130 for IN B-VP O
130 all DT B-NP O
130 intermittent JJ I-NP O
130 bolus NN I-NP O
131 infusions NNS I-NP O
132 3 CD O O
132 KCL NNP B-NP B-m
132 10 CD O B-do
132 mEq/100ml/hr NN B-NP I-do
132 is VBZ O O
132 intermittent JJ B-NP O
132 bolus JJ I-NP O
132 infusion NN I-NP O
133 standard VBD B-VP O
134 4 CD O O
134 A NNP B-NP O
134 serum NN I-NP O
134 creatinine NN I-NP O
134 must MD O O
134 be VB O O
134 ordered VBN O O
134 and CC O O
134 checked VBN O O
134 daily RB O O
135 while IN B-VP O
135 patient NN B-NP O
135 is VBZ O O
135 ordered VBN O O
135 for IN B-VP O
135 a DT O O
135 K-scale JJ O O
136 5 CD O O
136 K-scale JJ B-NP O
136 cannot NN I-NP O
136 be VB O O
136 used VBN O O
136 on IN B-VP O
136 patients NNS B-NP O
136 with: JJ O O
137 * VBP O O
137 A DT B-NP O
137 serum NN I-NP O
137 creatinine NN I-NP O
137 greater JJR O O
137 than IN B-VP O
137 or CC O O
137 equal JJ O O
137 to TO O O
137 2.0 CD O O
137 mg/dl; NN B-NP O
137 or CC O O
138 * VB O O
138 A DT B-NP O
138 serum NN I-NP O
138 creatinine JJ B-NP O
138 increase NN I-NP O
138 of IN B-VP O
138 0.5 CD O O
138 mg/dl NNS B-NP O
138 within IN B-VP O
138 24 CD O O
138 hours NNS B-NP O
139 * VBP O O
139 Hold NNP B-NP O
139 scale NN I-NP O
139 and CC O O
139 contact NN B-NP O
139 MD NNP I-NP O
139 if IN B-VP O
139 SCr NNP B-NP O
139 greater JJR O O
139 than IN B-VP O
139 2.0 CD O O
140 ----------------------------------------------------------- JJ B-NP O
141 ----------- NN I-NP O
141 If IN B-VP O
141 K+ NNP B-NP O
141 Level NNP I-NP O
141 is VBZ O O
141 less JJR O O
141 than IN B-VP O
141 3.1 CD O O
141 then RB O O
141 call VB O O
141 H.O NNP B-NP O
142 If IN B-VP O
142 K+ NNP B-NP B-r
142 Level NNP I-NP I-r
142 is VBZ O O
142 3.1-3.3 JJ O O
142 , , O O
142 then RB O O
142 administer RB O O
142 KCL NNP B-NP B-m
142 10 CD O B-do
142 meq NN B-NP I-do
142 x5 NNP I-NP B-du
143 Recheck NNP I-NP O
143 K+ NNP I-NP O
143 Level NNP I-NP O
143 1 CD O O
143 to TO O O
143 4 CD O O
143 hours NNS B-NP O
143 after IN B-VP O
143 infusion NN B-NP O
143 finished VBN O O
144 If IN B-VP O
144 K+ NNP B-NP B-r
144 Level NNP I-NP I-r
144 is VBZ O O
144 3.4-3.6 JJ O O
144 , , O O
144 then RB O O
144 administer RB O O
144 KCL NNP B-NP B-m
144 10 CD O B-do
144 meq NN B-NP I-do
144 x4 NNP I-NP B-du
145 Recheck NNP I-NP O
145 K+ NNP I-NP O
145 Level NNP I-NP O
145 1 CD O O
145 to TO O O
145 4 CD O O
145 hours NNS B-NP O
145 after IN B-VP O
145 infusion NN B-NP O
145 finished VBN O O
146 If IN B-VP O
146 K+ NNP B-NP B-r
146 Level NNP I-NP I-r
146 is VBZ O O
146 3.7-4.0 JJ O O
146 , , O O
146 then RB O O
146 administer RB O O
146 KCL NNP B-NP B-m
146 10 CD O B-do
146 meq NN B-NP I-do
146 x3 NNP I-NP B-du
147 Recheck NNP I-NP O
147 K+ NNP I-NP O
147 Level NNP I-NP O
147 1 CD O O
147 to TO O O
147 4 CD O O
147 hours NNS B-NP O
147 after IN B-VP O
147 infusion NN B-NP O
147 finished VBN O O
148 If IN B-VP O
148 K+ NNP B-NP B-r
148 Level NNP I-NP I-r
148 is VBZ O O
148 4.1-4.5 JJ O O
148 , , O O
148 then RB O O
148 administer RB O O
148 KCL NNP B-NP B-m
148 10 CD O B-do
148 meq NN B-NP I-do
148 x2 NNP I-NP B-du
149 Recheck NNP I-NP O
149 K+ NNP I-NP O
149 Level NNP I-NP O
149 1 CD O O
149 to TO O O
149 4 CD O O
149 hours NNS B-NP O
149 after IN B-VP O
149 infusion NN B-NP O
149 finished VBN O O
150 If IN B-VP O
150 K+ NNP B-NP O
150 Level NNP I-NP O
150 is VBZ O O
150 4.6-5.0 JJ O O
150 , , O O
150 then RB O O
150 DO NNP B-NP O
150 NOT NNP I-NP O
150 administer VB O O
150 KCL NNP B-NP O
151 Recheck NNP I-NP O
151 K+ NNP I-NP O
151 Level NNP I-NP O
151 in IN B-VP O
151 QAM NNP B-NP O
152 If IN B-VP O
152 K+ NNP B-NP O
152 Level NNP I-NP O
152 is VBZ O O
152 greater JJR O O
152 than IN B-VP O
152 5.0 CD O O
152 then RB O O
152 call VB O O
152 H.O NNP B-NP O
153 ----------------------------------------------------------- NNP I-NP O
154 ----------- NNP I-NP O
155 SENNA NNP I-NP B-m
155 TABLETS NNP I-NP I-m
155 ( ( O I-m
155 SENNOSIDES NNP B-NP I-m
155 ) ) O I-m
155 2 CD O B-do
155 TAB NNP B-NP I-do
155 PO NNP I-NP B-mo
155 BID NNP I-NP B-f
155 PRN NNP I-NP I-f
155 Constipation NNP I-NP B-r
156 ZOLOFT NNP I-NP B-m
156 ( ( O I-m
156 SERTRALINE NNP B-NP I-m
156 ) ) O I-m
156 25 CD O B-do
156 MG NNP B-NP I-do
156 PO NNP I-NP B-mo
156 BEDTIME NNP I-NP B-f
157 Starting VBG O O
157 Today NNP B-NP O
157 ( ( O O
157 3/24 CD O O
157 ) ) O O
158 Override NNP B-NP O
158 Notice: NNP I-NP O
158 Override NNP I-NP O
158 added VBD B-VP O
158 on IN B-VP O
158 6/18/06 CD O O
158 by IN B-VP O
159 HAGON NNP B-NP O
159 , , O O
159 AUBREY NNP B-NP O
159 R NNP I-NP O
159 , , O O
159 M.D NNP B-NP O
160 on IN B-VP O
160 order NN B-NP O
160 for IN B-VP O
160 GEODON NNP B-NP B-m
160 PO NNP I-NP B-mo
160 ( ( O O
160 ref JJ O O
160 # # O O
160 639530057 CD O O
160 ) ) O O
161 SERIOUS NNP B-NP O
161 INTERACTION: NNP I-NP O
161 SERTRALINE NNP I-NP B-m
161 HCL NNP I-NP I-m
161 &amp; NNP I-NP O
161 ZIPRASIDONE NNP I-NP B-m
161 HCL NNP I-NP I-m
162 Reason NNP I-NP O
162 for IN B-VP O
162 override: NN B-NP O
162 md NN I-NP O
162 aware JJ B-NP O
163 MULTIVITAMIN NNP I-NP B-m
163 THERAPEUTIC NNP I-NP I-m
163 ( ( O I-m
163 THERAPEUTIC NNP B-NP I-m
163 MULTIVI NNP I-NP I-m
163 ) ) O I-m
164 5 CD O B-do
164 MILLILITERS NNP B-NP I-do
164 PO NNP I-NP B-mo
164 DAILY NNP I-NP B-f
165 VANCOMYCIN NNP I-NP B-m
165 HCL NNP I-NP I-m
165 1 CD O B-do
165 GM NNP B-NP I-do
165 IV NNP I-NP B-mo
165 Q12H NNP I-NP B-f
166 Instructions: NNP I-NP O
166 plan NN I-NP O
166 14 CD O B-du
166 days NNS B-NP I-du
166 , , O O
166 started VBD B-VP O
166 2/22 CD O O
166 , , O O
166 end VBP O O
166 7/25 CD O O
167 COMPAZINE NNP B-NP B-m
167 ( ( O I-m
167 PROCHLORPERAZINE NNP B-NP I-m
167 ) ) O I-m
167 5-10 JJ B-NP B-do
167 MG NNP I-NP I-do
167 PO NNP I-NP B-mo
167 Q6H NNP I-NP B-f
167 PRN NNP I-NP I-f
167 Nausea NNP I-NP B-r
168 Alert NNP I-NP O
168 overridden: NNP I-NP O
168 Override NNP I-NP O
168 added VBD B-VP O
168 on IN B-VP O
168 8/6/06 CD O O
168 by IN B-VP O
168 : : O O
169 POTENTIALLY NNP B-NP O
169 SERIOUS NNP I-NP O
169 INTERACTION: NNP I-NP O
169 IPRATROPIUM NNP I-NP B-m
169 BROMIDE NNP I-NP I-m
169 &amp; NNP I-NP O
170 PROCHLORPERAZINE NNP I-NP B-m
170 Reason NNP I-NP O
170 for IN B-VP O
170 override: NN B-NP O
170 md NN I-NP O
170 aware JJ B-NP O
171 DIET: NNP I-NP O
171 No NNP I-NP O
171 Restrictions NNP I-NP O
172 ACTIVITY: NNP I-NP O
172 Walking NNP I-NP O
172 as IN B-VP O
172 tolerated VBN O O
173 FOLLOW NNP B-NP O
173 UP NNP I-NP O
173 APPOINTMENT( NNP I-NP O
173 S NNP I-NP O
173 ): NNP I-NP O
174 pls NN I-NP O
174 f/u NN I-NP O
174 with IN B-VP O
174 primary JJ B-NP O
174 oncologist NN I-NP O
174 as IN B-VP O
174 scheduled VBN O O
174 , , O O
175 ALLERGY: NNP B-NP O
175 NKA NNP I-NP O
176 ADMIT NNP I-NP O
176 DIAGNOSIS: NNP I-NP O
177 hypotension NN I-NP O
178 PRINCIPAL NNP I-NP O
178 DISCHARGE NNP I-NP O
178 DIAGNOSIS NNP I-NP O
178 ;Responsible JJ O O
178 After IN B-VP O
178 Study NNP B-NP O
178 for IN B-VP O
178 Causing NNP B-NP O
178 Admission NNP I-NP O
178 ) ) O O
179 bacteremia NN B-NP O
180 OTHER NNP I-NP O
180 DIAGNOSIS;Conditions NNP I-NP O
180 , , O O
180 Infections NNP B-NP O
180 , , O O
180 Complications NNP B-NP O
180 , , O O
180 affecting VBG O O
180 Treatment/Stay NNP B-NP O
181 iddm NN I-NP O
181 ( ( O O
181 diabetes VBZ O O
181 mellitus NN B-NP O
181 ) ) O O
181 hypercholesterolemia NN B-NP O
181 ( ( O O
181 elevated VBN O O
181 cholesterol NN B-NP O
181 ) ) O O
182 htn NN B-NP O
182 ( ( O O
182 hypertension NN B-NP O
182 ) ) O O
182 asthma NN B-NP O
182 ( ( O O
182 asthma NN B-NP O
182 ) ) O O
182 arthritis NN B-NP O
182 ( ( O O
182 arthritis NN B-NP O
182 ) ) O O
182 obesity NN B-NP O
183 ( ( O O
183 obesity NN B-NP O
183 ) ) O O
183 s/p NN B-NP O
183 ccy NN I-NP O
183 ( ( O O
183 S/P NNP B-NP O
183 cholecystectomy NN I-NP O
183 ) ) O O
183 metastatic JJ B-NP O
183 breast NN I-NP O
183 cancer NN I-NP O
184 ( ( O O
184 breast JJ B-NP O
184 cancer NN I-NP O
184 ) ) O O
184 pulmonary JJ B-NP O
184 embolism NN I-NP O
184 ( ( O O
184 pulmonary JJ B-NP O
185 embolism NN I-NP O
185 ) ) O O
185 depression NN B-NP O
185 ( ( O O
185 depression NN B-NP O
185 ) ) O O
186 OPERATIONS NNP B-NP O
186 AND NNP I-NP O
186 PROCEDURES: NNP I-NP O
187 OTHER NNP I-NP O
187 TREATMENTS/PROCEDURES NNP I-NP O
187 ( ( O O
187 NOT NNP B-NP O
187 IN NNP I-NP O
187 O.R NNP I-NP O
187 ) ) O O
188 na VBP O O
189 BRIEF JJ B-NP O
189 RESUME NNP I-NP O
189 OF NNP I-NP O
189 HOSPITAL NNP I-NP O
189 COURSE: NNP I-NP O
190 CC: NNP I-NP O
190 Tachycardia NNP I-NP O
191 HISTORY NNP I-NP O
191 OF NNP I-NP O
191 PRESENT NNP I-NP O
191 ILLNESS: NNP I-NP O
191 This DT B-NP O
191 59-year-old JJ I-NP O
191 woman NN I-NP O
191 from IN B-VP O
191 Vi NNP B-NP O
191 Ca NNP I-NP O
191 Beth NNP I-NP O
191 presents NNS I-NP O
191 with IN B-VP O
191 fever NN B-NP O
191 and CC O O
191 tachycardia NN B-NP O
192 since IN B-VP O
192 10/5/06 CD O O
192 It PRP O O
192 is VBZ O O
192 very RB O O
192 difficult JJ O O
192 to TO O O
192 elicit VB O O
192 a DT B-NP O
192 clear JJ I-NP O
192 story NN I-NP O
192 The DT B-NP O
193 patient NN I-NP O
193 has VBZ O O
193 had VBN O O
193 cough VBN O O
193 productive NN B-NP O
193 of IN B-VP O
193 variably RB O O
193 colored VBN O O
193 sputum NN B-NP O
193 ( ( O O
193 yellow JJ O O
194 to TO O O
194 green VB O O
194 to TO O O
194 orange VB O O
194 , , O O
194 without IN B-VP O
194 hemoptysis NN B-NP O
194 ) ) O O
194 but CC O O
194 it PRP O O
194 seems VBZ O O
194 she PRP O O
194 may MD O O
195 have VB O O
195 had VBD B-VP O
195 a DT B-NP O
195 similar JJ I-NP O
195 cough NN I-NP O
195 for IN B-VP O
195 months NNS B-NP O
195 Similarly RB O O
195 , , O O
195 she PRP O O
195 notes VBZ O O
195 dysuria NNS B-NP O
196 and CC O O
196 increased VBD B-VP O
196 frequency NN B-NP O
196 which WDT O O
196 it PRP O O
196 seems VBZ O O
196 has VBZ O O
196 also RB O O
196 been VBN O O
196 present JJ O O
196 for IN B-VP O
197 weeks NNS B-NP O
197 to TO O O
197 months NNS B-NP O
197 She PRP O O
197 is VBZ O O
197 not RB O O
197 short JJ O O
197 of IN B-VP O
197 breath NN B-NP O
197 and CC O O
197 has VBZ O O
197 no DT B-NP O
197 headache NN I-NP O
197 , , O O
198 chest NN B-NP O
198 pain NN I-NP O
198 , , O O
198 hemoptysis NN B-NP O
198 , , O O
198 abdominal JJ B-NP O
198 pain NN I-NP O
198 , , O O
198 nausea NN B-NP O
198 , , O O
198 vomiting VBG O O
198 , , O O
198 diarrhea NN B-NP O
198 , , O O
199 numbness RB O O
199 , , O O
199 LE NNP B-NP O
199 swelling VBG O O
199 , , O O
199 LE NNP B-NP O
199 pain NN I-NP O
199 , , O O
199 rash NN B-NP O
199 She PRP O O
199 does VBZ O O
199 have VB O O
199 some DT B-NP O
199 bumps NNS I-NP O
199 on IN B-VP O
200 her PRP$ O O
200 abdominal JJ B-NP O
200 wall NN I-NP O
200 which WDT O O
200 are VBP O O
200 painful-it JJ B-NP O
200 sounds NNS I-NP O
200 like IN B-VP O
200 these DT O O
200 are VBP O O
200 a DT B-NP O
201 direct JJ I-NP O
201 result NN I-NP O
201 of IN B-VP O
201 the DT B-NP O
201 enoxaprin NN I-NP B-m
201 she PRP O O
201 had VBD B-VP O
201 been VBN O O
201 getting VBG O O
201 for IN B-VP O
201 a DT B-NP O
201 PE NNP I-NP O
201 in IN B-VP O
202 March NNP B-NP O
202 of IN B-VP O
202 this DT B-NP O
202 year NN I-NP O
203 The DT B-NP O
203 ZH NNP I-NP O
203 ER NNP I-NP O
203 doctor NN I-NP O
203 spoke VBD B-VP O
203 with IN B-VP O
203 Senz NNP B-NP O
203 at IN B-VP O
203 the DT B-NP O
203 nursing NN I-NP O
203 home NN I-NP O
203 She PRP O O
203 said VBD B-VP O
204 that IN B-VP O
204 the DT B-NP O
204 patient NN I-NP O
204 had VBD B-VP O
204 an DT O O
204 x-ray JJ O O
204 two CD O O
204 days NNS B-NP O
204 ago RB O O
204 which WDT O O
204 revealed VBD B-VP O
204 pneumonia NN B-NP O
204 , , O O
205 and CC O O
205 her PRP$ O O
205 referral JJ B-NP O
205 states NNS I-NP O
205 that IN B-VP O
205 the DT B-NP B-r
205 pneumonia NN I-NP I-r
205 was VBD B-VP O
205 in IN B-VP O
205 the DT B-NP O
205 left JJ I-NP O
205 upper JJ I-NP O
206 lobe NN I-NP O
206 and CC O O
206 left VBD B-VP O
206 lower JJR O O
206 lobe; IN B-VP O
206 the DT B-NP O
206 patient NN I-NP O
206 was VBD B-VP O
206 started VBN O O
206 on IN B-VP O
206 Levaquin NNP B-NP B-m
206 500 CD O B-do
206 mg NN B-NP I-do
207 p.o NN I-NP B-mo
207 at IN B-VP O
207 that DT B-NP O
207 time NN I-NP O
207 In IN B-VP O
207 the DT B-NP O
207 FMC NNP I-NP O
207 emergency NN I-NP O
207 room NN I-NP O
207 , , O O
207 the DT B-NP O
207 patient NN I-NP O
207 was VBD B-VP O
207 hydrated VBN O O
208 with IN B-VP O
208 3 CD O B-do
208 liters NNS B-NP I-do
208 of IN B-VP O
208 normal JJ B-NP B-m
208 saline NN I-NP I-m
208 and CC O O
208 her PRP$ O O
208 pulse NN B-NP O
208 still RB O O
208 remains VBZ O O
208 in IN B-VP O
208 the DT O O
209 130s CD O O
209 She PRP O O
209 was VBD B-VP O
209 given VBN O O
209 Levofloxacin NNP B-NP B-m
209 500 CD O B-do
209 mg NN B-NP I-do
209 IV NNP I-NP B-mo
209 The DT B-NP O
209 ER NNP I-NP O
209 physician NN I-NP O
209 was VBD B-VP O
210 worried VBN O O
210 about IN B-VP O
210 a DT B-NP O
210 pulmonary JJ I-NP O
210 embolus NN I-NP O
210 , , O O
210 did VBD B-VP O
210 not RB O O
210 do VB O O
210 a DT B-NP O
210 chest NN I-NP O
210 CT NN I-NP O
210 here RB O O
211 because IN B-VP O
211 of IN B-VP O
211 her PRP$ O O
211 elevated JJ B-NP O
211 creatinine NN I-NP O
211 of IN B-VP O
211 1.9 CD O O
211 She PRP O O
211 was VBD B-VP O
211 transferred VBN O O
211 to TO O O
212 the DT B-NP O
212 Chamvine NNP I-NP O
212 Tionbradvar NNP I-NP O
212 General NNP I-NP O
212 Hospital NNP I-NP O
212 for IN B-VP O
212 an DT B-NP O
212 MRA NNP I-NP O
212 to TO O O
212 rule VB O O
212 out RP O O
212 PE NNP B-NP O
212 In IN B-VP O
212 ER NNP B-NP O
212 here RB O O
212 , , O O
212 IJ NNP B-NP O
212 central JJ B-NP O
212 line NN I-NP O
213 placed VBN O O
213 ( ( O O
213 CVP~20 NNP B-NP O
213 ) ) O O
213 and CC O O
213 patient JJ O O
213 given VBN O O
213 1L CD O O
213 NS NNP B-NP O
213 Blood NNP I-NP B-r
213 pressure NN I-NP I-r
213 systolic VBD B-VP O
214 initially RB O O
214 120s CD O O
214 but CC O O
214 decreased VBD B-VP O
214 to TO O O
214 90s CD O O
214 ( ( O O
214 MAPS&gt;70 NNP B-NP O
214 ) ) O O
214 , , O O
214 and CC O O
214 norepinephrine NN B-NP B-m
215 started VBD B-VP O
215 The DT B-NP O
215 NE NNP I-NP O
215 was VBD B-VP O
215 discontinued VBN O O
215 promptly RB O O
215 given VBN O O
215 BP NNP B-NP O
215 improvement NN I-NP O
216 immediately RB O O
216 , , O O
216 and CC O O
216 continued VBD B-VP O
217 SBP&gt;100 NNP B-NP O
217 PAST NNP I-NP O
217 MEDICAL NNP I-NP O
217 HISTORY: NNP I-NP O
217 Metastatic NNP I-NP O
217 breast VBD B-VP O
217 CA-bone NNP B-NP O
218 scan JJ O O
218 which WDT O O
218 revealed VBD B-VP O
218 widespread JJ B-NP O
218 osseous JJ I-NP O
218 metastasis NN I-NP O
218 , , O O
218 and CC O O
219 CNS NNP B-NP O
219 involvement NN I-NP O
219 on IN B-VP O
219 head NN B-NP O
219 CT NNP I-NP O
219 , , O O
219 bone NN B-NP O
219 marrow NN I-NP O
219 bx NN I-NP O
219 with IN B-VP O
219 invasive JJ B-NP O
219 disease NN I-NP O
219 , , O O
220 status NN B-NP O
220 post NN I-NP O
220 brain NN I-NP O
220 radiotherapy NN I-NP O
220 10/5 CD O O
220 diabetes NNS B-NP O
220 , , O O
220 PE NNP B-NP O
220 5/13 CD O O
220 , , O O
220 tx NN B-NP O
220 with IN B-VP O
221 enoxaprin NN B-NP O
221 through IN B-VP O
221 0/7 CD O O
221 ( ( O O
221 discontinued VBN O O
221 because IN B-VP O
221 of IN B-VP O
221 doubt NN B-NP O
221 over IN B-VP O
221 original JJ B-NP O
222 dx NN I-NP O
222 and CC O O
222 significant JJ B-NP O
222 pain NN I-NP O
222 at IN B-VP O
222 injection NN B-NP O
222 sites NNS I-NP O
222 ) ) O O
222 , , O O
222 hypertension NN B-NP O
222 , , O O
222 arthritis NN B-NP O
222 , , O O
223 depression NN B-NP O
223 , , O O
223 bipolar JJ B-NP O
223 disorder NN I-NP O
223 , , O O
223 asthma NN B-NP O
223 , , O O
223 high JJ B-NP O
223 cholesterol NN I-NP O
223 , , O O
223 anemia NN B-NP O
223 , , O O
223 and CC O O
224 obesity NN B-NP O
225 ONC NNP I-NP O
225 HISTORY: NNP I-NP O
225 Pt NNP I-NP O
225 presented VBD B-VP O
225 with IN B-VP O
225 grade NN B-NP O
225 III NNP I-NP O
225 , , O O
225 ER/PR/HER2-negative NNP B-NP O
225 in IN B-VP O
226 March NNP B-NP O
226 2004 CD O O
226 In IN B-VP O
226 March NNP B-NP O
226 2004 CD O O
226 , , O O
226 she PRP O O
226 underwent VBD B-VP O
226 right JJ B-NP O
226 breast NN I-NP O
226 lumpectomy NN I-NP O
227 with IN B-VP O
227 pathology NN B-NP O
227 demonstrating VBG O O
227 4.1 CD O O
227 cm NN B-NP O
227 IDC NNP I-NP O
227 , , O O
227 no DT B-NP O
227 LVI NNP I-NP O
227 , , O O
228 negative JJ B-NP O
228 sentinel NN I-NP O
228 lymph NN I-NP O
228 nodes IN B-VP O
228 She PRP O O
228 underwent JJ B-NP O
228 partial JJ I-NP O
228 breast NN I-NP O
228 radiation NN I-NP O
229 in IN B-VP O
229 March NNP B-NP O
229 2004 CD O O
229 and CC O O
229 deferred VBD B-VP O
229 on IN B-VP O
229 adjuvant JJ B-NP O
229 therapy NN I-NP O
229 In IN B-VP O
229 November NNP B-NP O
229 2005 CD O O
229 , , O O
229 she PRP O O
230 presented VBD B-VP O
230 with IN B-VP O
230 atypical JJ B-NP O
230 chest NN I-NP O
230 wall NN I-NP O
230 pain NN I-NP O
230 and CC O O
230 imaging NN B-NP O
230 showed VBD B-VP O
230 bilateral JJ B-NP O
231 pulmonary JJ I-NP O
231 nodules NNS I-NP O
231 , , O O
231 thoracic NN B-NP O
231 lymphadenopathy NN I-NP O
231 , , O O
231 and CC O O
231 pleural JJ B-NP O
231 effusion NN I-NP O
232 consistent NN I-NP O
232 with IN B-VP O
232 metastatic JJ B-NP O
232 disease NN I-NP O
232 A NNP I-NP O
232 bone NN I-NP O
232 scan NN I-NP O
232 showed VBD B-VP O
232 wide JJ B-NP O
233 spread NN I-NP O
233 osseous JJ B-NP B-r
233 metastatic JJ I-NP I-r
233 disease NN I-NP I-r
233 and CC O O
233 head NN B-NP O
233 CT NNP I-NP O
233 demonstrated VBD B-VP O
233 a DT B-NP O
233 CNS NNP I-NP O
234 involvement NN I-NP O
234 She PRP O O
234 was VBD B-VP O
234 treated VBN O O
234 with IN B-VP O
234 whole JJ B-NP O
234 brain NN I-NP O
234 radiotherapy NN I-NP O
234 in IN B-VP O
234 March NNP B-NP O
235 2006 CD O O
235 and CC O O
235 with IN B-VP O
235 weekly JJ B-NP B-f
235 Taxol NNP I-NP B-m
235 She PRP O O
235 continued VBD B-VP O
235 through IN B-VP O
235 March NNP B-NP O
236 2006 CD O O
236 Restaging NNP B-NP O
236 studies NNS I-NP O
236 showed VBD B-VP O
236 stable JJ B-NP O
236 visceral JJ I-NP O
236 disease NN I-NP O
236 but CC O O
237 progression NN B-NP O
237 of IN B-VP O
237 bony NN B-NP B-r
237 metastatic JJ B-NP I-r
237 disease NN I-NP I-r
237 Therefore NNP I-NP O
237 on IN B-VP O
237 January NNP B-NP O
237 , , O O
237 2006 CD O O
237 , , O O
238 she PRP O O
238 initiated VBD B-VP O
238 a DT B-NP O
238 second-line JJ I-NP O
238 Navelbine NNP I-NP B-m
238 Navelbine NNP I-NP B-m
239 therapy NN I-NP O
239 PHYSICAL NNP I-NP O
240 EXAMINATION: NNP I-NP O
240 VITAL NNP I-NP O
240 SIGNS: NNP I-NP O
240 Temperature NNP I-NP O
240 99.3po CD O O
240 , , O O
240 pulse RB O O
240 112 CD O O
240 regular JJ O O
240 , , O O
241 BP NNP B-NP O
241 120/75 CD O O
241 , , O O
241 respirations NNS B-NP O
241 18 CD O O
241 , , O O
241 sO2=100% NN B-NP O
241 on IN B-VP O
241 ambient NN B-NP O
241 air NN I-NP O
242 GENERAL NNP I-NP O
242 APPEARANCE: NNP I-NP O
242 Laying NNP I-NP O
242 in IN B-VP O
242 bed NN B-NP O
242 , , O O
242 coughing VBG O O
242 paroxysms NNS B-NP O
242 No NNP I-NP O
242 use NN I-NP O
242 of IN B-VP O
243 accessory NN B-NP O
243 muscles NNS I-NP O
243 HEENT: NNP I-NP O
243 Mucosa NNP I-NP O
243 dry VBZ O O
243 No NNP B-NP O
243 jaundice NN I-NP O
243 +conjunctival NNP I-NP O
244 pallor NN I-NP O
244 Pupils NNP I-NP O
244 reactive VBP O O
244 bilaterally RB O O
244 NECK: NNP B-NP O
244 Supple NNP I-NP O
244 and CC O O
244 nontender RB O O
245 Right NNP B-NP O
245 IJ NNP I-NP O
245 in IN B-VP O
245 place NN B-NP O
245 HEART: NNP I-NP O
245 S1 NNP I-NP O
245 , , O O
245 S2 NNP B-NP O
245 , , O O
245 tachycardic NN B-NP O
245 without IN B-VP O
245 murmurs VBZ O O
245 No DT B-NP O
246 heaves NNS I-NP O
246 LUNGS: NNP I-NP O
246 Crackles NNP I-NP O
246 in IN B-VP O
246 the DT B-NP O
246 left NN I-NP O
246 lower JJR O O
246 chest JJS O O
247 posteriorly RB O O
247 , , O O
247 and CC O O
247 diffuse VB O O
247 expiratory NN B-NP O
247 wheezes NNS I-NP O
247 ABDOMEN: NNP I-NP O
247 Soft NNP I-NP O
247 and CC O O
248 nontender VB O O
248 Small NNP B-NP O
248 nodule JJ B-NP O
248 RUQ NNP I-NP O
248 subcutaneous JJ O O
248 , , O O
248 mildly RB O O
248 tender NN B-NP O
248 to TO O O
249 palpation VB O O
249 BACK: NNP B-NP O
249 No NNP I-NP O
250 CVAT NNP I-NP O
250 NEUROLOGIC: NNP I-NP O
250 A&amp;Ox4 NNP I-NP O
250 , , O O
250 but CC O O
250 somewhat RB O O
250 sedate JJ O O
250 and CC O O
250 with IN B-VP O
251 poor JJ B-NP O
251 attention NN I-NP O
251 Radial NNP I-NP O
251 and CC O O
251 DP NNP B-NP O
251 pulses NNS I-NP O
251 are VBP O O
251 2+ CD O O
251 Sensation NNP B-NP O
251 and CC O O
251 strength NN B-NP O
252 are VBP O O
252 grossly RB O O
252 intact JJ B-NP O
252 EXTREMITIES: NNP I-NP O
252 No NNP I-NP O
252 calf NN I-NP O
252 warmth NN I-NP O
252 , , O O
252 erythema NN B-NP O
252 , , O O
252 or CC O O
253 tenderness NN B-NP O
253 Mild NNP I-NP O
253 right JJ B-NP O
253 heel NN I-NP O
253 and CC O O
253 Achilles NNP B-NP O
253 tendon VBP O O
253 tenderness JJ B-NP O
254 LABORATORY NNP I-NP O
254 RESULTS NNP I-NP O
254 AT NNP I-NP O
254 DMC NNP I-NP O
254 WBC NNP I-NP O
254 3.2 CD O O
254 , , O O
254 hemoglobin VBD B-VP O
254 7.5 CD O O
254 MCV=76 NNP B-NP O
254 , , O O
254 platelets VBZ O O
255 482 CD O O
255 , , O O
255 neutrophils RB O O
255 61% CD O O
255 , , O O
255 sodium NN B-NP O
255 141 CD O O
255 , , O O
255 potassium NN B-NP O
255 3.2 CD O O
255 , , O O
255 chloride RB O O
255 122 CD O O
255 , , O O
255 CO2 NNP B-NP O
256 17 CD O O
256 , , O O
256 BUN NNP B-NP O
256 20 CD O O
256 , , O O
256 creatinine NN B-NP O
256 1.5 CD O O
256 , , O O
256 glucose VBD B-VP O
256 181 CD O O
256 LDH NNP B-NP O
256 542 CD O O
256 , , O O
256 Ca NNP B-NP O
256 6.7 CD O O
256 Alb NNP B-NP O
257 2.2 CD O O
257 Urinalysis: NNP B-NP O
257 3+ CD O O
257 heme NN B-NP O
257 , , O O
257 WBC NNP B-NP O
257 25-50 CD O O
257 , , O O
257 RBC NNP B-NP O
257 15-25 CD O O
257 , , O O
257 bacteria NNS B-NP O
257 1+ CD O O
257 , , O O
257 2+LE CD O O
257 , , O O
258 neg JJ B-NP O
258 nitrites NNS I-NP O
258 INR VBP O O
258 2.0 CD O O
258 PTT NNP B-NP O
258 43.3 CD O O
259 LABORATORY NNP B-NP O
259 RESULTS NNP I-NP O
259 AT NNP I-NP O
259 MR NNP I-NP O
259 WBC NNP I-NP O
259 3.5 CD O O
259 , , O O
259 hemoglobin NN B-NP O
259 9 CD O O
259 , , O O
259 hematocrit NN B-NP O
259 28 CD O O
259 , , O O
260 platelets NNS B-NP O
260 592 CD O O
260 , , O O
260 neutrophils RB O O
260 68% CD O O
260 , , O O
260 sodium NN B-NP O
260 142 CD O O
260 , , O O
260 potassium NN B-NP O
260 3.5 CD O O
260 , , O O
260 chloride RB O O
261 111 CD O O
261 , , O O
261 CO2 NNP B-NP O
261 14 CD O O
261 , , O O
261 BUN NNP B-NP O
261 23 CD O O
261 , , O O
261 creatinine NN B-NP O
261 1.9 CD O O
261 , , O O
261 glucose RB O O
261 217 CD O O
261 , , O O
261 alkaline JJ B-NP O
262 phosphatase NN I-NP O
262 261 CD O O
262 , , O O
262 AST NNP B-NP O
262 26 CD O O
262 , , O O
262 ALT NNP B-NP O
262 27 CD O O
262 Urinalysis: NNP B-NP O
262 Large NNP I-NP O
262 heme NN I-NP O
262 , , O O
262 WBC NNP B-NP O
262 6-10 CD O O
262 , , O O
263 RBC NNP B-NP O
263 0-2 CD O O
263 , , O O
263 bacteria NNS B-NP O
263 trace VBP O O
263 Blood NNP B-NP O
263 cultures: NN I-NP O
263 Pending NNP I-NP O
263 Urine NNP I-NP O
263 culture NN I-NP O
264 9/13/06: CD O O
264 No NNP B-NP O
264 growth NN I-NP O
265 Chest NNP I-NP O
265 x-ray: NN I-NP O
265 Revealed NNP I-NP O
265 questionable JJ O O
265 left VBD B-VP O
265 lobe JJ B-NP O
265 infiltrate NN I-NP O
265 with IN B-VP O
266 metastasis NN B-NP O
266 EKG: NNP I-NP O
266 120 CD O O
266 per IN B-VP O
266 minute NN B-NP O
266 , , O O
266 sinus JJ B-NP O
267 tachycardia NN I-NP O
267 CXR: NNP I-NP O
267 LLL NNP I-NP O
267 opacity NN I-NP O
267 , , O O
267 LUL NNP B-NP O
267 opacity NN I-NP O
267 Hilar NNP I-NP O
267 fullness NN I-NP O
267 on IN B-VP O
268 the DT B-NP O
268 righT&gt;l NN I-NP O
268 , , O O
268 and CC O O
268 prominent JJ B-NP O
268 bronchi NN I-NP O
268 ( ( O O
268 ?cuffing VBG O O
268 ) ) O O
268 on IN B-VP O
268 right JJ B-NP O
268 Vertebral NNP I-NP O
269 fractures NNS I-NP O
269 LLL NNP I-NP O
269 unchanged JJ O O
269 from IN B-VP O
269 0/0 CD O O
269 , , O O
269 and CC O O
269 LUL NNP B-NP O
269 improved VBD B-VP O
269 C/w NNP B-NP O
269 known VBN O O
270 metastatic JJ B-NP O
270 disease NN I-NP O
271 ASSESSMENT: NNP I-NP O
271 59 CD O O
271 year-old JJ B-NP O
271 woman NN I-NP O
271 with IN B-VP O
271 metastatic JJ B-NP O
271 breast NN I-NP O
271 cancer NN I-NP O
271 and CC O O
271 a DT B-NP O
272 history NN I-NP O
272 of IN B-VP O
272 pulmonary JJ B-NP O
272 embolus NN I-NP O
272 presenting VBG O O
272 with IN B-VP O
272 one CD O O
272 week NN B-NP O
272 of IN B-VP O
272 fatigue NN B-NP O
272 , , O O
273 lethargy NN B-NP O
273 , , O O
273 tachycardia NN B-NP O
273 and CC O O
273 fever JJ B-NP O
273 History NNP I-NP O
273 notable JJ O O
273 for IN B-VP O
274 productive JJ B-NP O
274 cough NN I-NP O
274 and CC O O
274 dysuria NN B-NP O
274 , , O O
274 although IN B-VP O
274 the DT B-NP O
274 chronicity NN I-NP O
274 of IN B-VP O
274 these DT B-NP O
274 issues NNS I-NP O
275 is VBZ O O
275 unclear JJ O O
275 Now RB O O
275 growing VBG O O
275 1 CD O O
275 bottle NN B-NP O
275 from IN B-VP O
275 WBH NNP B-NP O
275 as RB O O
275 well RB O O
275 as IN B-VP O
275 NBH NNP B-NP O
275 of IN B-VP O
275 GPC NNP B-NP O
275 in IN B-VP O
276 clusters NNS B-NP O
276 empirically RB O O
276 on IN B-VP O
276 Vanco NNP B-NP B-m
276 , , O O
276 now RB O O
276 looks VBZ O O
276 to TO O O
276 be VB O O
276 coag NNS B-NP O
277 neg.Discussed VBN O O
277 with IN B-VP O
277 ID NNP B-NP O
277 , , O O
277 would MD O O
277 like VB O O
277 to TO O O
277 keep VB O O
277 vanco NN B-NP B-m
277 PLAN: NNP I-NP O
278 *Tachycardia: VBZ O O
278 Most JJS O O
278 likely JJ O O
278 secondary JJ O O
278 to TO O O
278 an DT B-NP O
278 infection NN I-NP O
278 , , O O
278 either DT O O
279 pulmonary JJ O O
279 or CC O O
279 urinary JJ O O
279 With IN B-VP O
279 improvement NN B-NP O
279 in IN B-VP O
279 Cr NNP B-NP O
279 PE NNP I-NP O
279 CT NNP I-NP O
279 was VBD B-VP O
279 obtained VBN O O
279 which WDT O O
280 was VBD B-VP O
280 negative.Stable JJ B-NP O
280 d/c JJ I-NP O
280 ASA NNP I-NP B-m
280 and CC O O
280 statin NN B-NP B-m
280 as IN B-VP O
280 no DT B-NP O
280 role NN I-NP O
280 for IN B-VP O
280 long JJ B-NP O
280 term NN I-NP O
280 risk NN I-NP O
281 reduction NN I-NP O
281 at IN B-VP O
281 this DT B-NP O
281 time NN I-NP O
282 *Cough: VBZ O O
282 Productive JJ B-NP O
282 cough NN I-NP O
282 , , O O
282 yellow VB O O
282 to TO O O
282 green JJ B-NP O
282 sputum NN I-NP O
282 Seems NNPS I-NP O
282 to TO O O
282 have VB O O
282 been VBN O O
283 present JJ O O
283 for IN B-VP O
283 months NNS B-NP O
283 , , O O
283 and CC O O
283 it PRP O O
283 is VBZ O O
283 unclear JJ O O
283 how WRB O O
283 much RB O O
283 this DT O O
283 has VBZ O O
283 changed VBN O O
283 in IN B-VP O
284 the DT B-NP O
284 past JJ I-NP O
284 week NN I-NP O
284 May NNP I-NP O
284 be VB O O
284 chronic JJ O O
284 secondary JJ O O
284 to TO O O
284 tumor VB O O
284 , , O O
284 or CC O O
284 may MD O O
285 represent VB O O
285 acute JJ B-NP O
285 infection NN I-NP O
285 Aspiration NNP I-NP O
285 plausible JJ O O
285 given VBN O O
285 mental JJ B-NP O
285 status NN I-NP O
286 The DT B-NP O
286 CT NNPS I-NP O
286 did VBD B-VP O
286 not RB O O
286 demonstrate VB O O
286 any DT B-NP O
286 acute JJ I-NP O
286 etiology NN I-NP O
286 for IN B-VP O
286 her PRP$ O O
286 symptoms NNS B-NP O
287 *Dysuria: NN I-NP O
287 Again NNP I-NP O
287 , , O O
287 chronicity NN B-NP O
287 unclear JJ B-NP O
287 UA NNP I-NP O
287 and CC O O
287 urine JJ B-NP O
287 culture NN I-NP O
287 at IN B-VP O
287 HNH NNP B-NP O
287 not RB O O
288 very RB O O
288 suggestive JJ O O
288 of IN B-VP O
288 UTI NNP B-NP O
288 , , O O
288 but CC O O
288 UA NNP B-NP O
288 here RB O O
288 with IN B-VP O
288 25 CD O O
288 wbc NNS B-NP O
288 and CC O O
288 LE+ NNP B-NP O
288 Has NNP I-NP O
288 been VBN O O
288 on IN B-VP O
289 levofloxacin NN B-NP B-m
289 , , O O
289 so RB O O
289 will MD O O
289 treat VB O O
289 until IN B-VP O
289 cultures NNS B-NP O
289 return VBP O O
289 with IN B-VP O
289 ceftazidime NN B-NP B-m
290 ( ( O O
290 d/c JJ O O
290 0/7 CD O O
290 ) ) O O
290 *Bacteremia: NN B-NP O
290 coag NN I-NP O
290 neg JJ B-NP O
290 staph NN I-NP O
290 x2 NN I-NP O
290 , , O O
290 Vanc NNP B-NP O
290 Sens NNP I-NP O
290 , , O O
290 plan NN B-NP O
290 to TO O O
291 treat VB O O
291 via IN B-VP O
291 PICC NNP B-NP O
291 w/Vancomycin VBP O B-m
291 x14days NNS B-NP B-du
291 *Oncology: VB O O
291 Discussion NNP B-NP O
291 with IN B-VP O
291 Dr NNP B-NP O
292 Clusky NNP I-NP O
292 , , O O
292 her PRP$ O O
292 primary JJ B-NP O
292 oncologic JJ I-NP O
292 fellow NN I-NP O
292 , , O O
292 who WP O O
292 noted VBD B-VP O
292 that IN B-VP O
292 from IN B-VP O
292 my PRP$ O O
293 description NN B-NP O
293 the DT B-NP O
293 patient NN I-NP O
293 does VBZ O O
293 not RB O O
293 sound VB O O
293 much RB O O
293 different JJ O O
293 from IN B-VP O
293 her PRP$ O O
294 baseline NN B-NP O
294 state NN I-NP O
294 She PRP O O
294 is VBZ O O
294 mildly RB O O
294 tachycardic JJ O O
294 at IN B-VP O
294 baseline NN B-NP O
294 ( ( O O
294 although IN B-VP O
294 not RB O O
295 to TO O O
295 this DT B-NP O
295 degree NN I-NP O
295 ) ) O O
295 , , O O
295 and CC O O
295 has VBZ O O
295 chronic JJ B-NP O
295 productive JJ I-NP O
295 cough NN I-NP O
295 and CC O O
296 dysuria NN B-NP O
296 5 CD O O
296 Renal: NNP B-NP O
296 ARF NNP I-NP O
296 , , O O
296 improving VBG O O
296 with IN B-VP O
296 IVF NNP B-NP B-m
296 Likely NNP I-NP O
296 prerenal JJ B-NP O
297 azotemia NN I-NP O
297 6.Heme: CD O O
297 Chronic NNP B-NP O
297 anemia NN I-NP O
297 Given NNP I-NP O
297 1UPRBC CD O B-m
297 in IN B-VP O
297 ER NNP B-NP O
298 Unfortuantely NNP I-NP O
298 , , O O
298 the DT B-NP O
298 blood NN I-NP O
298 was VBD B-VP O
298 given VBN O O
298 before IN B-VP O
298 hemolysis NN B-NP O
298 or CC O O
298 iron NN B-NP O
298 studies NNS I-NP O
299 sent VBD B-VP O
299 Would MD O O
299 be VB O O
299 indicated VBN O O
299 , , O O
299 especially RB O O
299 in IN B-VP O
299 setting VBG O O
299 of IN B-VP O
299 markedly RB O O
299 elevated VBN O O
300 PT NNP B-NP O
300 Should MD O O
300 be VB O O
300 sent VBN O O
300 in IN B-VP O
300 future JJ O O
300 I PRP O O
300 have VBP O O
300 called VBN O O
300 and CC O O
300 added VBN O O
301 on IN B-VP O
301 a DT B-NP O
301 peripheral JJ I-NP O
301 manual JJ I-NP O
301 blood NN I-NP O
301 smear NN I-NP O
301 Last JJ B-NP O
301 INR NNP I-NP O
301 similarly RB O O
301 elevated VBD B-VP O
301 ( ( O O
301 but CC O O
302 I PRP O O
302 believe VBP O O
302 patient NN B-NP O
302 was VBD B-VP O
302 on IN B-VP O
302 enoxaprin NN B-NP B-m
302 at IN B-VP O
302 that DT B-NP O
302 time NN I-NP O
302 ) ) O O
302 Not RB O O
302 on IN B-VP O
302 enoxaprin NN B-NP O
303 or CC O O
303 warfarin NN B-NP B-m
303 now RB O O
303 May NNP B-NP O
303 be VB O O
303 dues NNS B-NP O
303 to TO O O
303 malnutrition NN B-NP O
303 , , O O
303 but CC O O
304 concerning VBG O O
304 for IN B-VP O
304 DIC NNP B-NP O
304 or CC O O
304 liver RB O B-r
304 disease.Administered VBN O I-r
304 vitamin NN B-NP B-m
304 vitamin NN I-NP B-m
305 K NNP I-NP O
305 7.Psych: CD O O
305 Resumed NNP B-NP O
305 home NN I-NP O
305 zoloft NN I-NP B-m
305 , , O O
305 restart VB O O
306 geodon NN B-NP B-m
306 prn JJ O B-f
306 8.Goals CD O O
306 of IN B-VP O
306 care: NNS B-NP O
306 Discussed VBN O O
306 with IN B-VP O
306 the DT B-NP O
306 patient NN I-NP O
306 and CC O O
307 Dr NNP B-NP O
307 Pinion NNP I-NP O
307 The DT B-NP O
307 patient NN I-NP O
307 expresses VBZ O O
307 that IN B-VP O
307 she PRP O O
307 wants VBZ O O
307 to TO O O
307 be VB O O
307 intubated VBN O O
307 or CC O O
308 have VBP O O
308 defibrillation NN B-NP O
308 if IN B-VP O
308 needed VBN O O
308 Dr NNP B-NP O
308 Ellestad NNP I-NP O
308 has VBZ O O
308 discussed VBN O O
308 this DT B-NP O
308 numerous JJ I-NP O
309 times NNS I-NP O
309 with IN B-VP O
309 her PRP O O
309 , , O O
309 and CC O O
309 will MD O O
309 readdress VB O O
310 ADDITIONAL NNP B-NP O
310 COMMENTS: NNP I-NP O
311 DISCHARGE NNP I-NP O
311 CONDITION: NNP I-NP O
311 Stable NNP I-NP O
312 TO NNP I-NP O
312 DO/PLAN: NNP I-NP O
313 f/u NN I-NP O
313 with IN B-VP O
313 primary JJ B-NP O
313 oncologist NN I-NP O
314 call NN I-NP O
314 oncologist NN I-NP O
314 or CC O O
314 return NN B-NP O
314 to TO O O
314 ed VB O O
314 with IN B-VP O
314 any DT B-NP O
314 change NN I-NP O
314 in IN B-VP O
314 symptoms JJ B-NP O
315 No NNP I-NP O
315 dictated VBD B-VP O
315 summary JJ B-NP O
316 ENTERED NNP I-NP O
316 BY: NNP I-NP O
316 FENCEROY NNP I-NP O
316 , , O O
316 TAYLOR NNP B-NP O
316 C NNP I-NP O
316 , , O O
316 M.D NNP B-NP O
316 ( ( O O
316 PN858 NNP B-NP O
316 ) ) O O
316 8/6/06 CD O O
316 @ $ O O
316 11:03 CD O O
316 AM NNP B-NP O
317 ****** JJ B-NP O
317 END NN I-NP O
317 OF NNP I-NP O
317 DISCHARGE NNP I-NP O
317 ORDERS NNP I-NP O
317 ****** NNP I-NP O
318 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #811352 VBZ O O
4 466605453 CD O O
4 FMIH NNP B-NP O
4 88455449 CD O O
4 7789103 CD O O
4 7/9/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 HEART NNP I-NP O
4 FAILURE NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 6/29/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/15/2006 CD O O
7 ATTENDING: NNP B-NP O
7 KAPPLER NNP I-NP O
7 , , O O
7 TRINIDAD NNP B-NP O
7 MD NNP I-NP O
8 CHIEF NNP I-NP O
8 COMPLAINT: NNP I-NP O
8 Shortness NNP I-NP O
8 of IN B-VP O
8 breath JJ B-NP O
9 HISTORY NNP I-NP O
9 OF NNP I-NP O
9 PRESENT NNP I-NP O
9 ILLNESS: NNP I-NP O
9 This DT O O
9 is VBZ O O
9 a DT B-NP O
9 70-year-old JJ I-NP O
9 woman NN I-NP O
9 with IN B-VP O
9 a DT B-NP O
10 history NN I-NP O
10 of IN B-VP O
10 an DT B-NP O
10 ischemic JJ I-NP O
10 cardiomyopathy NN I-NP O
10 with IN B-VP O
10 an DT B-NP O
10 ejection NN I-NP O
10 fraction NN I-NP O
11 of IN B-VP O
11 35% CD O O
11 and CC O O
11 also RB O O
11 a DT B-NP O
11 history NN I-NP O
11 of IN B-VP O
11 coronary JJ B-NP O
11 artery NN I-NP O
11 disease NN I-NP O
11 status NN I-NP O
11 post NN I-NP O
12 MI NNP I-NP O
12 , , O O
12 insulin-dependent JJ B-NP O
12 diabetes NNS I-NP O
12 , , O O
12 peripheral JJ B-NP O
12 vascular JJ I-NP O
12 disease NN I-NP O
12 and CC O O
13 chronic JJ B-NP O
13 renal JJ I-NP O
13 insufficiency NN I-NP O
13 who WP O O
13 presented VBD B-VP O
13 with IN B-VP O
13 volume NN B-NP O
13 overloaded VBD B-VP O
14 The DT B-NP O
14 patient NN I-NP O
14 was VBD B-VP O
14 recently RB O O
14 discharged VBN O O
14 after IN B-VP O
14 a DT B-NP O
14 9-day JJ I-NP O
14 admission NN I-NP O
14 from IN B-VP O
15 3/30/2006 CD O O
15 to TO O O
15 05 CD O O
15 for IN B-VP O
15 a DT B-NP O
15 CHF NNP I-NP O
15 exacerbation NN I-NP O
15 During IN B-VP O
15 the DT B-NP O
16 previous JJ I-NP O
16 admission NN I-NP O
16 , , O O
16 she PRP O O
16 had VBD B-VP O
16 been VBN O O
16 diuresed VBN O O
16 with IN B-VP O
16 a DT B-NP O
16 Lasix NNP I-NP B-m
16 drip NN I-NP B-mo
16 and CC O O
17 then RB O O
17 started VBD B-VP O
17 on IN B-VP O
17 amiodarone NN B-NP B-m
17 and CC O O
17 Coumadin NNP B-NP B-m
17 for IN B-VP O
17 a DT O B-r
17 a DT B-NP B-r
17 new JJ I-NP O
17 paroxysmal JJ I-NP O
18 atrial JJ I-NP O
18 fibrillation NN I-NP O
18 After IN B-VP O
18 discharge NN B-NP O
18 , , O O
18 she PRP O O
18 presented VBD B-VP O
18 to TO O O
18 NSCHC NNP B-NP O
19 Cardiology NNP I-NP O
19 Clinic NNP I-NP O
19 on IN B-VP O
19 9/28/2006 CD O O
19 with IN B-VP O
19 a DT B-NP O
19 jugular JJ I-NP O
19 venous JJ I-NP O
19 pressure NN I-NP O
19 at IN B-VP O
20 15 CD O O
20 cm NN B-NP O
20 and CC O O
20 severe JJ B-NP O
20 bilateral JJ I-NP O
20 lower JJR I-NP O
20 extremity NN I-NP O
20 edema NN I-NP O
20 and CC O O
20 a DT B-NP O
20 BNP NNP I-NP O
20 of IN B-VP O
21 2500 CD O O
21 The DT B-NP O
21 assessment NN I-NP O
21 in IN B-VP O
21 clinic NN B-NP O
21 was VBD B-VP O
21 that IN B-VP O
21 she PRP O O
21 had VBD B-VP O
21 been VBN O O
21 under IN B-VP O
22 diuresed VBN O O
22 in IN B-VP O
22 the DT B-NP O
22 previous JJ I-NP O
22 admission NN I-NP O
22 and CC O O
22 therefore RB O O
22 she PRP O O
22 was VBD B-VP O
22 directly RB O O
23 admitted VBN O O
23 to TO O O
23 Poredtiesbarre NNP B-NP O
23 General NNP I-NP O
23 Hospital NNP I-NP O
23 for IN B-VP O
23 reinitiation NN B-NP O
23 of IN B-VP O
23 aggressive JJ B-NP O
24 diuresis NN I-NP O
24 Of IN B-VP O
24 note NN B-NP O
24 , , O O
24 the DT B-NP O
24 patient NN I-NP O
24 had VBD B-VP O
24 recently RB O O
24 changed VBN O O
24 from IN B-VP O
24 Lasix NNP B-NP B-m
25 to TO O O
25 torsemide VB O B-m
25 after IN B-VP O
25 the DT B-NP O
25 last JJ I-NP O
25 discharge NN I-NP O
25 as IN B-VP O
25 her PRP$ O O
25 outpatient JJ B-NP O
26 medication NN I-NP O
26 She PRP O O
26 endorsed VBD B-VP O
26 worsened JJ B-NP O
26 orthopnea NN I-NP O
26 , , O O
26 dyspnea NN B-NP O
26 on IN B-VP O
27 exertion NN B-NP O
27 , , O O
27 paroxysmal JJ B-NP O
27 nocturnal JJ I-NP O
27 dyspnea NN I-NP O
27 as RB O O
27 well RB O O
27 as IN B-VP O
27 early JJ B-NP O
27 satiety NN I-NP O
28 She PRP O O
28 denied VBD B-VP O
28 any DT B-NP O
28 chest JJS I-NP O
28 pain NN I-NP O
28 or CC O O
28 other JJ B-NP O
28 anginal JJ I-NP O
28 equivalents NNS I-NP O
29 PAST NNP I-NP O
29 MEDICAL NNP I-NP O
29 HISTORY: NNP I-NP O
30 1 CD O O
30 Ischemic NNP B-NP O
30 cardiomyopathy NN I-NP O
30 with IN B-VP O
30 an DT B-NP O
30 ejection NN I-NP O
30 fraction NN I-NP O
30 of IN B-VP O
30 30%-35% JJ O O
31 2 CD O O
31 Paroxysmal NNP B-NP B-r
31 Paroxysmal NNP I-NP B-r
31 atrial JJ B-NP I-r
31 atrial JJ I-NP I-r
31 fibrillation NN I-NP I-r
31 fibrillation NN I-NP I-r
31 , , O O
31 newly RB O O
31 on IN B-VP O
31 Coumadin NNP B-NP B-m
31 and CC O O
32 amiodarone RB O B-m
33 3 CD O O
33 Coronary JJ B-NP O
33 artery NN I-NP O
33 disease NN I-NP O
33 status NN I-NP O
33 post NN I-NP O
33 MI NNP I-NP O
34 4 CD O O
34 Peripheral NNP B-NP O
34 vascular JJ B-NP O
34 disease NN I-NP O
34 status NN I-NP O
34 post NN I-NP O
34 left VBD B-VP O
34 tibial JJ B-NP O
34 bypass NN I-NP O
35 and CC O O
35 fem-pop JJ B-NP O
35 bypass NN I-NP O
36 5 CD O O
36 Hypertension NNP B-NP O
37 6 CD O O
37 Hyperlipidemia NNP B-NP O
38 7 CD O O
38 Glaucoma NNP B-NP O
39 8 CD O O
39 Diabetes VBZ O O
39 with IN B-VP O
39 retinopathy JJ O O
40 9 CD O O
40 Osteoarthritis NNP B-NP O
41 10 CD O O
41 Anemia NNP B-NP O
42 11 CD O O
42 Obesity NNP B-NP O
43 12 CD O O
43 Chronic NNP B-NP O
43 renal JJ B-NP O
43 insufficiency NN I-NP O
43 with IN B-VP O
43 a DT B-NP O
43 baseline JJ I-NP O
43 creatinine NN I-NP O
43 of IN B-VP O
44 2.9 CD O O
44 followed VBN O O
44 by IN B-VP O
44 SVMC NNP B-NP O
44 Renal NNP I-NP O
44 Clinic NNP I-NP O
45 MEDICATIONS NNP I-NP O
45 AT NNP I-NP O
45 HOME: NNP I-NP O
46 1 CD O O
46 Torsemide NNP B-NP B-m
46 Torsemide NNP I-NP B-m
46 100 CD O B-do
46 mg NN B-NP I-do
46 q.a.m NN I-NP B-f
46 and CC O O
46 50 CD O B-do
46 mg NN B-NP I-do
46 q.p.m NN I-NP B-f
47 2 CD O O
47 Ativan NNP B-NP B-m
47 0.5 CD O B-do
47 mg NN B-NP I-do
47 p.o NN I-NP B-mo
47 t.i.d NN I-NP B-f
47 p.r.n NN I-NP I-f
47 anxiety NN I-NP B-r
48 3 CD O O
48 Folate NNP B-NP B-m
48 1 CD O B-do
48 mg NN B-NP I-do
48 p.o JJ O B-mo
48 daily JJ O B-f
49 4 CD O O
49 Lipitor NNP B-NP B-m
49 80 CD O B-do
49 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 at IN B-VP B-f
49 bedtime JJ O I-f
50 5 CD O O
50 Lantus NNP B-NP B-m
50 18 CD O B-do
50 units NNS B-NP I-do
50 subcutaneously RB O B-mo
50 nightly RB O B-f
51 6 CD O O
51 Coumadin NNP B-NP B-m
51 1 CD O B-do
51 mg NN B-NP I-do
51 q.p.m NN I-NP B-f
52 7 CD O O
52 Lopressor NNP B-NP B-m
52 25 CD O B-do
52 mg NN B-NP I-do
52 p.o NN I-NP B-mo
52 b.i.d VBD B-VP B-f
53 8 CD O O
53 Procrit NNP B-NP B-m
53 40 CD O B-do
53 , , O I-do
53 000 CD O I-do
53 units NNS B-NP I-do
53 subcutaneously RB O B-mo
53 every DT B-NP B-f
53 other JJ I-NP I-f
53 week NN I-NP I-f
54 9 CD O O
54 Nitroglycerin NNP B-NP B-m
54 sublingual JJ B-NP B-mo
54 p.r.n NN I-NP B-f
54 chest NN I-NP B-r
54 pain NN I-NP I-r
55 10 CD O O
55 Aspirin NNP B-NP B-m
55 81 CD O B-do
55 mg NN B-NP I-do
55 p.o JJ O B-mo
55 daily JJ O B-f
56 11 CD O O
56 Vitamin NNP B-NP B-m
56 B12 NNP I-NP I-m
56 subcutaneous JJ B-NP B-mo
56 injections NNS I-NP I-mo
56 at IN B-VP O
56 clinic JJ O O
57 12 CD O O
57 Amiodarone $ O B-m
57 200 CD O B-do
57 mg JJ O I-do
57 p.o JJ O B-mo
57 daily JJ O B-f
58 13 CD O O
58 Iron NNP B-NP B-m
58 325 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 t.i.d VBD B-VP B-f
59 14 CD O O
59 Metolazone NNP B-NP B-m
59 p.r.n NN I-NP B-f
60 ALLERGIES: NNP I-NP O
60 Lisinopril NNP I-NP O
60 and CC O O
60 nonsteroidal JJ B-NP O
60 anti-inflammatory JJ I-NP O
60 agents NNS I-NP O
61 SOCIAL NNP I-NP O
61 HISTORY: NNP I-NP O
61 The DT B-NP O
61 patient NN I-NP O
61 is VBZ O O
61 married JJ O O
61 and CC O O
61 lives VBZ O O
61 at IN B-VP O
61 home NN B-NP O
61 with IN B-VP O
62 her PRP$ O O
62 husband NN B-NP O
62 She PRP O O
62 quit VBD B-VP O
62 tobacco NN B-NP O
62 with IN B-VP O
62 rare JJ B-NP O
62 alcohol NN I-NP O
62 use NN I-NP O
62 and CC O O
62 no DT B-NP O
63 drugs NNS I-NP O
64 FAMILY NNP I-NP O
64 HISTORY: NNP I-NP O
64 Noncontributory NNP I-NP O
64 There EX O O
64 is VBZ O O
64 no DT B-NP O
64 family NN I-NP O
64 history NN I-NP O
64 of IN B-VP O
65 cardiac JJ B-NP O
65 disease NN I-NP O
66 PHYSICAL NNP I-NP O
66 EXAMINATION: NNP I-NP O
66 On IN B-VP O
66 admission NN B-NP O
66 , , O O
66 temperature NN B-NP O
66 was VBD B-VP O
66 98.9 CD O O
66 , , O O
66 heart NN B-NP O
67 rate NN I-NP O
67 70 CD O O
67 , , O O
67 blood NN B-NP O
67 pressure NN I-NP O
67 104/50 CD O O
67 , , O O
67 respiratory JJ B-NP O
67 rate NN I-NP O
67 of IN B-VP O
67 20 CD O O
67 , , O O
67 oxygen NN B-NP O
68 saturation NN I-NP O
68 95% CD O O
68 on IN B-VP O
68 room NN B-NP O
68 air NN I-NP O
68 In IN B-VP O
68 general JJ O O
68 , , O O
68 the DT B-NP O
68 patient NN I-NP O
68 was VBD B-VP O
69 comfortable JJ O O
69 in IN B-VP O
69 no DT B-NP O
69 acute NN I-NP O
69 distress NN I-NP O
69 HEENT NNP I-NP O
69 , , O O
69 Pupils NNP B-NP O
69 were VBD B-VP O
69 equal JJ O O
69 , , O O
70 round NN B-NP O
70 , , O O
70 and CC O O
70 reactive JJ B-NP O
70 Oropharynx NNP I-NP O
70 was VBD B-VP O
70 clear JJ O O
70 The DT B-NP O
70 JVP NNP I-NP O
70 was VBD B-VP O
70 greater JJR O O
71 than IN B-VP O
71 15 CD O O
71 cm NN B-NP O
71 , , O O
71 chest NN B-NP O
71 exam NN I-NP O
71 showed VBD B-VP O
71 bilateral JJ B-NP O
71 crackles NNS I-NP O
71 at IN B-VP O
71 the DT B-NP O
71 bases NNS I-NP O
72 with IN B-VP O
72 bibasilar JJ B-NP O
72 dullness NN I-NP O
72 well RB O O
72 as RB O O
72 well RB O O
72 as IN B-VP O
72 right NN B-NP O
72 greater JJR O O
72 than IN B-VP O
72 left JJ B-NP O
73 base NN I-NP O
73 Cardiovascular NNP I-NP O
73 was VBD B-VP O
73 regular JJ B-NP O
73 rate NN I-NP O
73 and CC O O
73 rhythm NN B-NP O
73 with IN B-VP O
73 a DT B-NP O
73 S3 NNP I-NP O
73 and CC O O
74 no DT B-NP O
74 murmur JJ I-NP O
74 Abdomen NNP I-NP O
74 soft NN I-NP O
74 , , O O
74 nontender NN B-NP O
74 , , O O
74 nondistended VBN O O
74 with IN B-VP O
74 a DT B-NP O
75 nonpulsatile JJ I-NP O
75 liver NN I-NP O
75 Extremities NNS I-NP O
75 showed VBD B-VP O
75 3+ CD O O
75 pitting VBG O O
75 edema NN B-NP O
76 bilaterally RB O O
76 to TO O O
76 the DT B-NP O
76 hips NNS I-NP O
76 with IN B-VP O
76 bilateral JJ B-NP O
76 changes NNS I-NP O
76 of IN B-VP O
76 arterial JJ O O
76 and CC O O
77 venous JJ B-NP O
77 insufficiency NN I-NP O
77 Laboratory NNP I-NP O
77 studies NNS I-NP O
77 were VBD B-VP O
77 significant JJ O O
77 for IN B-VP O
77 an DT B-NP O
78 INR NNP I-NP O
78 of IN B-VP O
78 1.6 CD O O
78 , , O O
78 BUN NNP B-NP O
78 of IN B-VP O
78 110 CD O O
78 , , O O
78 creatinine NN B-NP O
78 3 CD O O
78 , , O O
78 white JJ B-NP O
78 blood NN I-NP O
78 cell NN I-NP O
78 count NN I-NP O
78 of IN B-VP O
79 11.7 CD O O
79 and CC O O
79 a DT B-NP O
79 hematocrit NN I-NP O
79 of IN B-VP O
79 27.9 CD O O
80 EKG NNP B-NP O
80 on IN B-VP O
80 admission NN B-NP O
80 was VBD B-VP O
80 a DT B-NP O
80 normal JJ I-NP O
80 sinus NN I-NP O
80 rhythm NN I-NP O
80 with IN B-VP O
80 evidence NN B-NP O
80 of IN B-VP O
80 a DT B-NP O
81 previous JJ I-NP O
81 anterior JJ I-NP O
81 MI NNP I-NP O
81 with IN B-VP O
81 lateral JJ B-NP O
81 repolarization NN I-NP O
81 , , O O
81 ST NNP B-NP O
81 and CC O O
81 T NNP B-NP O
81 wave VBP O O
82 abnormalities NNS B-NP O
82 , , O O
82 and CC O O
82 possible JJ B-NP O
82 LVH NNP I-NP O
83 Chest NNP I-NP O
83 x-ray NN I-NP O
83 showed VBD B-VP O
83 bilateral JJ B-NP O
83 effusions NNS I-NP O
83 , , O O
83 left VBD B-VP O
83 greater JJR O O
83 than IN B-VP O
83 right JJ O O
84 with IN B-VP O
84 increased JJ B-NP O
84 vascular JJ I-NP O
84 markings NNS I-NP O
84 and CC O O
84 fluid NN B-NP O
84 in IN B-VP O
84 the DT B-NP O
84 right JJ I-NP O
84 fissure NN I-NP O
84 , , O O
85 but CC O O
85 no DT O O
85 discrete JJ O O
85 infiltrates VBZ O O
86 IMPRESSION: NNP B-NP O
86 This DT O O
86 is VBZ O O
86 a DT B-NP O
86 70-year-old JJ I-NP O
86 woman NN I-NP O
86 with IN B-VP O
86 ischemic JJ B-NP O
87 cardiomyopathy NN I-NP O
87 with IN B-VP O
87 an DT B-NP O
87 EF NNP I-NP O
87 of IN B-VP O
87 35% CD O O
87 , , O O
87 coronary JJ B-NP O
87 artery NN I-NP O
87 disease NN I-NP O
87 status NN I-NP O
88 post NN I-NP O
88 MI NNP I-NP O
88 , , O O
88 insulin-dependent JJ B-NP O
88 diabetes NNS I-NP O
88 , , O O
88 peripheral JJ B-NP O
88 vascular JJ I-NP O
88 disease NN I-NP O
88 , , O O
89 chronic JJ B-NP O
89 renal JJ I-NP O
89 insufficiency NN I-NP O
89 who WP O O
89 presented VBD B-VP O
89 in IN B-VP O
89 volume NN B-NP O
89 overload NN I-NP O
90 after IN B-VP O
90 a DT B-NP O
90 recent JJ I-NP O
90 admission NN I-NP O
90 with IN B-VP O
90 insufficient JJ B-NP O
90 diuresis NN I-NP O
91 HOSPITAL NNP I-NP O
91 COURSE NNP I-NP O
91 BY NNP I-NP O
91 PROBLEM: NNP I-NP O
92 1 CD O O
92 Cardiovascular NNP B-NP O
92 In IN B-VP O
92 terms NNS B-NP O
92 of IN B-VP O
92 pump NN B-NP O
92 , , O O
92 the DT B-NP O
92 patient NN I-NP O
92 was VBD B-VP O
92 clearly RB O O
92 in IN B-VP O
93 gross JJ B-NP O
93 volume NN I-NP O
93 overload NN I-NP O
93 from IN B-VP O
93 both CC O O
93 the DT B-NP O
93 right NN I-NP O
93 sided VBD B-VP O
93 and CC O O
93 left-sided JJ B-NP O
94 failure NN I-NP O
94 on IN B-VP O
94 presentation NN B-NP O
94 Her NNP I-NP O
94 blood NN I-NP O
94 pressure NN I-NP O
94 was VBD B-VP O
94 stable JJ O O
94 and CC O O
94 she PRP O O
95 had VBD B-VP O
95 no DT B-NP O
95 evidence NN I-NP O
95 of IN B-VP O
95 severely RB O O
95 decreased JJ B-NP O
95 cardiac JJ I-NP O
95 output NN I-NP O
95 or/and VBP O O
95 organ JJ B-NP O
96 perfusion NN I-NP O
96 She PRP O O
96 was VBD B-VP O
96 started VBN O O
96 on IN B-VP O
96 the DT B-NP O
96 Lasix NNP I-NP B-m
96 drip NN I-NP I-m
96 at IN B-VP O
96 10 CD O B-do
96 mg NNS B-NP I-do
96 per IN B-VP B-f
96 hour NN B-NP I-f
97 and CC O O
97 Zaroxolyn NNP B-NP B-m
97 at IN B-VP O
97 2.5 CD O B-do
97 mg NNS B-NP I-do
97 p.o JJ O B-mo
97 daily JJ O B-f
97 Her PRP$ O O
97 Lopressor NNP B-NP B-m
97 was VBD B-VP O
97 held VBN O O
97 for IN B-VP O
97 a DT B-NP B-r
98 decompensated JJ I-NP O
98 heart NN I-NP O
98 failure NN I-NP O
98 She PRP O O
98 initially RB O O
98 diuresed VBD B-VP O
98 well RB O O
99 overnight; JJ O O
99 however RB O O
99 , , O O
99 on IN B-VP O
99 the DT B-NP O
99 second JJ I-NP O
99 day NN I-NP O
99 her PRP$ O B-r
99 her PRP$ O B-r
99 diuresis NN B-NP I-r
99 diuresis NN I-NP I-r
99 tapered VBD B-VP O
99 off RB O O
100 and CC O O
100 her PRP$ O O
100 Lasix NNP B-NP B-m
100 drip NN I-NP I-m
100 drip NN I-NP B-mo
100 was VBD B-VP O
100 turned VBN O O
100 up RP O O
100 to TO O O
100 20 CD O B-do
100 mg NNS B-NP I-do
100 per IN B-VP B-f
100 hour NN B-NP I-f
100 and CC O O
100 the DT B-NP O
101 Zaroxolyn NNP I-NP B-m
101 was VBD B-VP O
101 increased VBN O O
101 to TO O O
101 b.i.d VB O B-f
101 She PRP O O
101 met VBD B-VP O
101 her PRP O O
101 I&amp;O NNP B-NP O
101 goal NN I-NP O
101 of IN B-VP O
102 greater JJR O O
102 than IN B-VP O
102 1 CD O O
102 liter JJ O O
102 negative JJ O O
102 overnight VBD B-VP O
102 the DT B-NP O
102 following JJ I-NP O
102 night NN I-NP O
102 , , O O
103 however RB O O
103 , , O O
103 a DT B-NP O
103 day NN I-NP O
103 later RB O O
103 , , O O
103 she PRP O O
103 again RB O O
103 had VBD B-VP O
103 poor JJ B-NP O
103 diuresis NN I-NP O
103 and CC O O
103 the DT B-NP O
104 Zaroxolyn NNP I-NP B-m
104 was VBD B-VP O
104 changed VBN O O
104 to TO O O
104 Diuril NNP B-NP B-m
104 At IN B-VP O
104 this DT B-NP O
104 time NN I-NP O
104 , , O O
104 a DT B-NP O
104 repeat NN I-NP O
104 chest NN I-NP O
105 x-ray NN I-NP O
105 showed VBD B-VP O
105 a DT O O
105 very RB O O
105 little JJ B-NP O
105 change NN I-NP O
105 in IN B-VP O
105 her PRP$ O O
105 bilateral JJ B-NP O
105 pleural JJ I-NP O
106 effusions NNS I-NP O
106 , , O O
106 so IN B-VP O
106 her PRP$ O O
106 diuresis NN B-NP O
106 up RB O O
106 to TO O O
106 this DT B-NP O
106 point NN I-NP O
106 was VBD B-VP O
106 felt VBN O O
106 to TO O O
106 be VB O O
107 insufficient JJ O O
107 After IN B-VP O
107 the DT B-NP O
107 transition NN I-NP O
107 from IN B-VP O
107 Zaroxolyn NNP B-NP B-m
107 to TO O O
107 Diuril NNP B-NP B-m
107 , , O O
108 which WDT O O
108 was VBD B-VP O
108 given VBN O O
108 250 CD O B-do
108 mg JJ B-NP I-do
108 IV NNP I-NP B-mo
108 b.i.d NN I-NP B-f
108 , , O O
108 she PRP O O
108 was VBD B-VP O
108 noted VBN O O
108 to TO O O
108 have VB O O
108 an DT B-NP O
109 increase NN I-NP O
109 in IN B-VP O
109 creatinine NN B-NP O
109 from IN B-VP O
109 2.9 CD O O
109 gradually RB O O
109 up RB O O
109 to TO O O
109 3.2; CD O O
109 however RB O O
109 , , O O
110 remained VBD B-VP O
110 stable JJ O O
110 for IN B-VP O
110 the DT B-NP O
110 next JJ I-NP O
110 few JJ I-NP O
110 days NNS I-NP O
110 and CC O O
110 the DT B-NP O
110 patient NN I-NP O
110 was VBD B-VP O
110 able JJ O O
110 to TO O O
111 maintain VB O O
111 good JJ B-NP O
111 diuresis NN I-NP O
111 on IN B-VP O
111 this DT B-NP O
111 regimen NNS I-NP O
111 without IN B-VP O
111 bump NN B-NP O
111 in IN B-VP O
111 her PRP$ O O
112 creatinine NN B-NP O
113 On IN B-VP O
113 6/27/2006 CD O O
113 , , O O
113 she PRP O O
113 was VBD B-VP O
113 noted VBN O O
113 to TO O O
113 have VB O O
113 greatly RB O O
113 improved VBN O O
113 lower JJR B-NP O
114 extremity NN I-NP O
114 edema NN I-NP O
114 and CC O O
114 that DT O O
114 improved VBD B-VP O
114 lung NN B-NP O
114 exam NN I-NP O
114 and CC O O
114 she PRP O O
114 had VBD B-VP O
114 met VBN O O
114 her PRP$ O O
115 goal NN B-NP O
115 weight NN I-NP O
115 of IN B-VP O
115 less JJR O O
115 than IN B-VP O
115 85 CD O O
115 kilograms NNS B-NP O
115 Lasix NNP I-NP B-m
115 drip NN I-NP B-mo
115 was VBD B-VP O
116 discontinued VBN O O
116 in IN B-VP O
116 the DT B-NP O
116 afternoon NN I-NP O
116 on IN B-VP O
116 6/27/2006 CD O O
116 and CC O O
116 she PRP O O
116 was VBD B-VP O
116 restarted VBN O O
117 on IN B-VP O
117 her PRP$ O O
117 home NN B-NP O
117 p.o NN I-NP O
117 torsemide IN B-VP B-m
117 torsemide JJ B-NP B-m
117 regimen NNS I-NP I-m
117 regimen NNS I-NP I-m
117 of IN B-VP O
117 100 CD O B-do
117 mg NNS B-NP I-do
117 p.o JJ B-NP B-mo
117 q.a.m NN I-NP B-f
117 and CC O O
117 50 CD O B-do
118 mg NN B-NP O
118 p.o NN I-NP B-mo
118 q.p.m NN I-NP B-f
118 for IN B-VP O
118 anticipated JJ B-NP O
118 discharge NN I-NP O
118 home NN I-NP O
118 on IN B-VP O
118 5/15/2006 CD O O
118 The DT B-NP O
119 Diuril NNP I-NP B-m
119 was VBD B-VP O
119 also RB O O
119 discontinued VBN O O
119 The DT B-NP O
119 patient NN I-NP O
119 was VBD B-VP O
119 anticipated VBN O O
119 to TO O O
119 be VB O O
120 stable JJ O O
120 on IN B-VP O
120 b.i.d JJ B-NP B-f
120 torsemide NN I-NP B-m
120 and CC O O
120 p.o NN B-NP B-mo
120 on IN B-VP O
120 metolazone NN B-NP B-m
120 at IN B-VP O
120 home NN B-NP O
120 Her NNP I-NP O
121 new JJ B-NP O
121 dry JJ I-NP O
121 weight NN I-NP O
121 on IN B-VP O
121 this DT B-NP O
121 admission NN I-NP O
121 was VBD B-VP O
121 established VBN O O
121 at IN B-VP O
121 85 CD O O
121 kilograms NNS B-NP O
122 and CC O O
122 this DT O O
122 should MD O O
122 be VB O O
122 at IN B-VP O
122 a DT B-NP O
122 goal NN I-NP O
122 for IN B-VP O
122 diuresis NN B-NP O
122 should MD O O
122 she PRP O O
122 require VB O O
123 admission NN B-NP O
123 in IN B-VP O
123 the DT B-NP O
123 future NN I-NP O
124 She PRP O O
124 will MD O O
124 follow VB O O
124 up RP O O
124 with IN B-VP O
124 her PRP$ O O
124 CSH NNP B-NP O
124 cardiologist NN I-NP O
124 for IN B-VP O
124 further JJ B-NP O
125 monitoring NN I-NP O
125 of IN B-VP O
125 her PRP$ O O
125 volume NN B-NP O
125 status NN I-NP O
125 after IN B-VP O
125 discharge NN B-NP O
125 In IN B-VP O
125 terms NNS B-NP O
125 of IN B-VP O
126 rhythm NN B-NP O
126 , , O O
126 the DT B-NP O
126 patient NN I-NP O
126 had VBD B-VP O
126 a DT B-NP O
126 new JJ I-NP O
126 presentation NN I-NP O
126 of IN B-VP O
126 atrial JJ B-NP B-r
126 atrial JJ I-NP B-r
126 fibrillation NN I-NP I-r
126 fibrillation NN I-NP I-r
127 on IN B-VP O
127 the DT B-NP O
127 prior JJ I-NP O
127 admission NN I-NP O
127 and CC O O
127 was VBD B-VP O
127 started VBN O O
127 on IN B-VP O
127 amiodarone NN B-NP B-m
127 and CC O O
127 Coumadin NNP B-NP B-m
128 at IN B-VP O
128 that DT B-NP O
128 time NN I-NP O
128 She PRP O O
128 was VBD B-VP O
128 in IN B-VP O
128 normal JJ B-NP O
128 sinus NN I-NP O
128 rhythm NN I-NP O
128 on IN B-VP O
128 presentation NN B-NP O
128 at IN B-VP O
129 this DT B-NP O
129 admission NN I-NP O
129 and CC O O
129 remained VBD B-VP O
129 in IN B-VP O
129 normal JJ B-NP O
129 sinus NN I-NP O
129 rhythm NN I-NP O
129 throughout IN B-VP O
129 the DT B-NP O
130 admission NN I-NP O
130 and CC O O
130 was VBD B-VP O
130 monitored VBN O O
130 on IN B-VP O
130 telemetry NN B-NP O
130 with IN B-VP O
130 no DT B-NP O
130 other JJ I-NP O
130 events NNS I-NP O
131 She PRP O O
131 was VBD B-VP O
131 continued VBN O O
131 on IN B-VP O
131 her PRP$ O O
131 home NN B-NP B-do
131 dose NN I-NP I-do
131 of IN B-VP O
131 amiodarone NN B-NP B-m
131 and CC O O
131 continued VBN O O
131 on IN B-VP O
132 Coumadin; NNP B-NP B-m
132 Coumadin; NNP I-NP B-m
132 however RB O O
132 despite IN B-VP O
132 the DT B-NP O
132 dose NN I-NP O
132 being VBG O O
132 decreased VBN O O
132 from IN B-VP O
132 her PRP$ O O
132 home NN B-NP O
133 dose NN I-NP O
133 of IN B-VP O
133 1 CD O B-do
133 mg NNS B-NP I-do
133 q.p.m RB O B-f
133 to TO O O
133 a DT O O
133 0.5 CD O B-do
133 mg NN B-NP I-do
133 q.p.m NN I-NP B-f
133 , , O O
133 her PRP$ O O
133 INR NNP B-NP O
133 continued VBD B-VP O
133 to TO O O
133 rise VB O O
134 and CC O O
134 was VBD B-VP O
134 eventually RB O O
134 3.5 CD O O
134 Her NNP B-NP O
134 Coumadin NNP I-NP B-m
134 was VBD B-VP O
134 discontinued VBN O O
134 She PRP O O
134 was VBD B-VP O
135 recommended VBN O O
135 to TO O O
135 be VB O O
135 discharged VBN O O
135 off RP O O
135 Coumadin NNP B-NP B-m
135 and CC O O
135 follow VB O O
135 up RP O O
135 with IN B-VP O
135 her PRP$ O O
136 primary JJ B-NP O
136 care NN I-NP O
136 provider NN I-NP O
136 during IN B-VP O
136 the DT B-NP O
136 week NN I-NP O
136 following VBG O O
136 discharge NN B-NP O
136 to TO O O
137 recheck VB O O
137 her PRP$ O O
137 INR NNP B-NP O
137 and CC O O
137 restart VB O O
137 her PRP$ O O
137 Coumadin NNP B-NP B-m
137 when WRB O O
137 it PRP O O
137 falls VBZ O O
137 below IN B-VP O
137 2.5 CD O O
138 In IN B-VP O
138 terms NNS B-NP O
138 of IN B-VP O
138 ischemia NN B-NP O
138 , , O O
138 the DT B-NP O
138 patient NN I-NP O
138 had VBD B-VP O
138 no DT B-NP O
138 acute JJ I-NP O
138 evidence NN I-NP O
138 of IN B-VP O
139 ischemia NN B-NP O
139 on IN B-VP O
139 presentation NN B-NP O
139 Denied NNP I-NP O
139 any DT B-NP O
139 chest NN I-NP O
139 pain NN I-NP O
139 and CC O O
139 had VBD B-VP O
139 no DT B-NP O
140 changes NNS I-NP O
140 consistent VBP O O
140 with IN B-VP O
140 ischemia NN B-NP O
140 on IN B-VP O
140 her PRP$ O O
140 EKG NNP B-NP O
140 She PRP O O
140 was VBD B-VP O
140 continued VBN O O
141 on IN B-VP O
141 aspirin NN B-NP B-m
141 and CC O O
141 Lipitor NNP B-NP B-m
141 throughout IN B-VP B-du
141 throughout IN B-VP B-du
141 the DT O I-du
141 the DT B-NP I-du
141 admission NN I-NP I-du
141 admission NN I-NP I-du
142 2 CD O O
142 Renal: NNP B-NP O
142 The DT B-NP O
142 patient NN I-NP O
142 has VBZ O O
142 chronic JJ B-NP O
142 renal JJ I-NP O
142 insufficiency NN I-NP O
142 at IN B-VP O
143 baseline NN B-NP O
143 Her NNP I-NP O
143 creatinine NN I-NP O
143 did VBD B-VP O
143 increase VB O O
143 from IN B-VP O
143 a DT B-NP O
143 baseline NN I-NP O
143 of IN B-VP O
143 2.9 CD O O
143 to TO O O
144 3.2 CD O O
144 During IN B-VP O
144 this DT B-NP O
144 admission NN I-NP O
144 , , O O
144 however RB O O
144 , , O O
144 remained VBD B-VP O
144 stable JJ O O
144 after IN B-VP O
144 that DT B-NP O
145 point NN I-NP O
145 She PRP O O
145 continued VBD B-VP O
145 on IN B-VP O
145 renally-dosed JJ B-NP O
145 medications NNS I-NP O
145 and CC O O
145 actually RB O O
146 required JJ B-NP O
146 repletion NN I-NP O
146 of IN B-VP O
146 both DT B-NP O
146 potassium NN I-NP B-m
146 and CC O O
146 magnesium NN B-NP B-m
146 despite IN B-VP O
146 her PRP$ O O
147 renal JJ B-NP O
147 insufficiency NN I-NP O
147 throughout IN B-VP B-du
147 the DT B-NP I-du
147 admission NN I-NP I-du
147 in IN B-VP O
147 the DT B-NP O
147 setting NN I-NP O
147 of IN B-VP O
148 aggressive JJ B-NP O
148 diuresis NN I-NP O
148 Her PRP$ O O
148 electrolytes NNS B-NP O
148 were VBD B-VP O
148 stable JJ O O
148 prior JJ O O
148 to TO O O
149 discharge VB O O
149 home NN B-NP O
149 She PRP O O
149 was VBD B-VP O
149 followed VBN O O
149 by IN B-VP O
149 the DT B-NP O
149 LCH NNP I-NP O
149 Renal NNP I-NP O
149 Clinic NNP I-NP O
149 with IN B-VP O
150 whom WP O O
150 she PRP O O
150 has VBZ O O
150 had VBD B-VP O
150 a DT B-NP O
150 previous JJ I-NP O
150 conversations NNS I-NP O
150 about IN B-VP O
150 the DT B-NP O
150 possibility NN I-NP O
151 of IN B-VP O
151 hemodialysis NN B-NP O
151 in IN B-VP O
151 the DT B-NP O
151 future NN I-NP O
151 and CC O O
151 she PRP O O
151 will MD O O
151 see VB O O
151 them PRP O O
151 shortly RB O O
151 after IN B-VP O
152 this DT B-NP O
152 discharge: NN I-NP O
153 3 CD O O
153 Pulmonary: NNP B-NP O
153 The DT B-NP O
153 patient NN I-NP O
153 had VBD B-VP O
153 dyspnea VBN O O
153 on IN B-VP O
153 exertion NN B-NP O
153 and CC O O
153 bilateral JJ B-NP O
154 pleural JJ I-NP O
154 effusions NNS I-NP O
154 on IN B-VP O
154 her PRP$ O O
154 chest JJS B-NP O
154 x-ray NN I-NP O
154 on IN B-VP O
154 admission NN B-NP O
154 This DT O O
154 was VBD B-VP O
154 all DT O O
155 felt VBD B-VP O
155 to TO O O
155 be VB O O
155 consistent JJ O O
155 with IN B-VP O
155 her PRP$ O O
155 heart NN B-NP O
155 failure NN I-NP O
155 She PRP O O
155 did VBD B-VP O
155 have VB O O
155 no DT B-NP O
156 signs NNS I-NP O
156 or CC O O
156 symptoms NNS B-NP O
156 of IN B-VP O
156 any DT B-NP O
156 infectious JJ I-NP O
156 etiology NN I-NP O
156 either CC O O
156 on IN B-VP O
156 imaging NN B-NP O
156 or CC O O
157 as IN B-VP O
157 a DT B-NP O
157 part NN I-NP O
157 of IN B-VP O
157 her PRP$ O O
157 clinical JJ B-NP O
157 picture NN I-NP O
157 Her NNP I-NP O
157 dyspnea NN I-NP O
157 on IN B-VP O
157 exertion NN B-NP O
157 and CC O O
158 her PRP$ O O
158 lung NN B-NP O
158 exam IN B-VP O
158 both DT O O
158 improved JJ O O
158 with IN B-VP O
158 her PRP$ O O
158 aggressive JJ B-NP O
158 diuresis NN I-NP O
159 4 CD O O
159 Endocrine: NNP B-NP O
159 The DT B-NP O
159 patient NN I-NP O
159 had VBD B-VP O
159 erratic JJ B-NP O
159 fingersticks NNS I-NP O
159 early RB O O
159 in IN B-VP O
159 the DT B-NP O
160 admission NN I-NP O
160 with IN B-VP O
160 a DT O O
160 very RB O O
160 low JJ B-NP O
160 fingerstick NN I-NP O
160 blood NN I-NP O
160 glucoses NNS I-NP O
160 in IN B-VP O
160 the DT B-NP O
161 morning NN I-NP O
161 initially RB O O
161 , , O O
161 so IN B-VP O
161 her PRP$ O O
161 p.m NN B-NP O
161 Lantus NNP I-NP B-m
161 Lantus NNP I-NP B-m
161 dose NN I-NP O
161 was VBD B-VP O
161 decreased VBN O O
161 from IN B-VP O
161 18 CD O B-do
162 units NNS B-NP O
162 to TO O O
162 16 CD O B-do
162 units NNS B-NP I-do
162 and CC O O
162 the DT B-NP O
162 NovoLog NNP I-NP B-m
162 sliding VBG O B-do
162 scale NN B-NP I-do
162 was VBD B-VP O
162 started VBN O O
163 On IN B-VP O
163 0/12/2006 CD O O
163 , , O O
163 she PRP O O
163 was VBD B-VP O
163 noted VBN O O
163 to TO O O
163 continue VB O O
163 to TO O O
163 have VB O O
163 lower JJR B-NP O
163 sugars NNS I-NP O
163 in IN B-VP O
164 the DT B-NP O
164 morning NN I-NP O
164 , , O O
164 but CC O O
164 routinely RB O O
164 elevated JJ B-NP O
164 sugars NNS I-NP O
164 in IN B-VP O
164 the DT B-NP O
164 afternoon NN I-NP O
165 greater JJR O O
165 than IN B-VP O
165 200 CD O O
165 She PRP O O
165 was VBD B-VP O
165 started VBN O O
165 on IN B-VP O
165 q.a.c NN B-NP B-f
165 NovoLog NNP I-NP B-m
165 regimen NNS I-NP I-m
166 However RB O O
166 , , O O
166 on IN B-VP O
166 this DT B-NP O
166 regimen NN I-NP O
166 , , O O
166 she PRP O O
166 was VBD B-VP O
166 found VBN O O
166 1 CD O O
166 morning NN B-NP O
166 to TO O O
166 have VB O O
166 a DT B-NP O
167 fingerstick JJ I-NP O
167 blood NN I-NP O
167 glucose NN I-NP O
167 of IN B-VP O
167 33 CD O O
167 and CC O O
167 to TO O O
167 be VB O O
167 hypothermic JJ O O
167 with IN B-VP O
167 a DT B-NP O
168 temperature NN I-NP O
168 of IN B-VP O
168 94 CD O O
168 taken VBN O O
168 rectally RB O O
168 This DT O O
168 was VBD B-VP O
168 thought VBN O O
168 to TO O O
168 be VB O O
169 secondary JJ O O
169 to TO O O
169 hypoglycemia VB O O
169 which WDT O O
169 may MD O O
169 have VB O O
169 progressed VBN O O
169 over IN B-VP O
169 several JJ B-NP O
170 hours NNS I-NP O
170 prior RB O O
170 to TO O O
170 assessment NN B-NP O
170 and CC O O
170 her PRP$ O O
170 temperature NN B-NP O
170 returned VBN O O
170 to TO O O
170 normal JJ O O
171 at IN B-VP O
171 98 CD O O
171 after IN B-VP O
171 her PRP$ O O
171 blood NN B-NP O
171 glucose NN I-NP O
171 was VBD B-VP O
171 aggressively RB O O
171 repleted VBN O O
171 It PRP O O
171 was VBD B-VP O
172 felt VBN O O
172 that IN B-VP O
172 the DT B-NP O
172 patient NN I-NP O
172 likely RB O O
172 had VBD B-VP O
172 decreased VBN O O
172 metabolism NN B-NP O
172 of IN B-VP O
172 her PRP$ O O
173 injected JJ B-NP O
173 insulin NN I-NP B-m
173 in IN B-VP O
173 the DT B-NP O
173 setting NN I-NP O
173 of IN B-VP O
173 worsening VBG O O
173 renal JJ B-NP O
173 failure NN I-NP O
173 , , O O
173 so RB O O
173 , , O O
174 her PRP O O
174 Lantus NNP B-NP B-m
174 was VBD B-VP O
174 decreased VBN O O
174 in IN B-VP O
174 accordance NN B-NP O
174 with IN B-VP O
174 a DT B-NP O
174 curbside JJ I-NP O
175 consultation NN I-NP O
175 with IN B-VP O
175 the DT B-NP O
175 diabetes NNS I-NP O
175 management NN I-NP O
175 service NN I-NP O
175 She PRP O O
175 will MD O O
175 be VB O O
176 discharged VBN O O
176 home NN B-NP O
176 on IN B-VP O
176 a DT B-NP O
176 similar JJ I-NP O
176 regimen NN I-NP O
176 to TO O O
176 her PRP$ O O
176 home NN B-NP B-m
176 regimen NNS I-NP I-m
176 simply RB O O
177 with IN B-VP O
177 a DT B-NP O
177 decreased JJ I-NP O
177 Lantus NNP I-NP B-m
177 Lantus NNP I-NP B-m
177 dose VBD B-VP O
177 down RB O O
177 to TO O O
177 12 CD O B-do
177 units NNS B-NP I-do
177 nightly RB O B-f
177 She PRP O O
178 should MD O O
178 continue VB O O
178 to TO O O
178 monitor VB O O
178 her PRP$ O O
178 fingerstick JJ B-NP O
178 blood NN I-NP O
178 glucoses NNS I-NP O
178 at IN B-VP O
179 home NN B-NP O
179 We PRP O O
179 were VBD B-VP O
179 hesitant JJ O O
179 to TO O O
179 change VB O O
179 the DT B-NP O
179 types NNS I-NP O
179 or CC O O
179 timing NN B-NP O
179 of IN B-VP O
179 her PRP$ O O
180 insulin NN B-NP B-m
180 during IN B-VP B-du
180 this DT B-NP I-du
180 hospitalization NN I-NP I-du
180 I PRP O O
180 left VBD B-VP O
180 that DT B-NP O
180 item NN I-NP O
180 to TO O O
180 be VB O O
181 further RB O O
181 managed VBN O O
181 by IN B-VP O
181 her PRP$ O O
181 primary JJ B-NP O
181 care NN I-NP O
181 provider NN I-NP O
181 after IN B-VP O
181 discharge: NN B-NP O
182 5 CD O O
182 Hematologic: NNP B-NP O
182 The DT B-NP O
182 patient NN I-NP O
182 has VBZ O O
182 a DT B-NP O
